ammatory Agents|anti-inflammatory agents|mesh-ancestor
43542861|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542862|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43542863|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43542864|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542865|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43542866|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43542867|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542868|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
43542869|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43542870|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
43542871|NCT03699254|Valganciclovir|valganciclovir|mesh-list
43542872|NCT03699254|Ganciclovir|ganciclovir|mesh-list
43542873|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43542875|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542876|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43542877|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542878|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542879|NCT03699215|Simendan|simendan|mesh-list
43542880|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43542881|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
43542882|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43849810|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542887|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542889|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
43542890|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542891|NCT03699033|Paclitaxel|paclitaxel|mesh-list
43542892|NCT03699033|Carboplatin|carboplatin|mesh-list
43542893|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43542894|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542895|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542896|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542897|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
43542898|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542899|NCT03698916|Celecoxib|celecoxib|mesh-list
43542900|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43542901|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43542902|NCT03698916|Analgesics|analgesics|mesh-ancestor
43542903|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
43542904|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542905|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542906|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542907|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542908|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43542909|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43542910|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542911|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542912|NCT03698851|Methamphetamine|methamphetamine|mesh-list
43542913|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43542914|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542915|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
43542916|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
43542917|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542918|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
43542919|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542920|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542921|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
43542922|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43542923|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43542924|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43732984|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43542925|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43542926|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
43639128|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542933|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542934|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542935|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43542936|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
43542937|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542938|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43542939|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
43542940|NCT03698695|Mefloquine|mefloquine|mesh-list
43542941|NCT03698695|Donepezil|donepezil|mesh-list
43542942|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43542943|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542944|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542945|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
43542946|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542948|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
43542949|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
43542950|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43542951|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43668355|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43668356|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668357|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668358|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43668359|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43542952|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542965|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43542967|NCT03698630|Prednisolone|prednisolone|mesh-list
43542968|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43542969|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
43542970|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43542971|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
43542972|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43542973|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
43542974|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542975|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
43542976|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
43733061|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
43733062|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43733063|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
43733064|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733065|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733066|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43733067|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43733068|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43733069|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
43733070|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
43733071|NCT02546349|Hormones|hormones|mesh-ancestor
43733072|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733073|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
43733074|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43733075|NCT02546154|Hematinics|hematinics|mesh-ancestor
43542977|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542978|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542979|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43542980|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
43542981|NCT03698630|Hormones|hormones|mesh-ancestor
43542982|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43542983|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43542984|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542985|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43542986|NCT03698630|Protective Agents|protective agents|mesh-ancestor
43542987|NCT03698617|Propofol|propofol|mesh-list
43849811|NCT03891355|Dexamethasone|dexamethasone|mesh-list
43542997|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43542998|NCT03698513|Analgesics|analgesics|mesh-ancestor
43542999|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
43543000|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543001|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543002|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543003|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543004|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43543005|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43543006|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543007|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43543008|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43543009|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543010|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
43543011|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43543012|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43543013|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43543014|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
43543023|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543024|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543026|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543027|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43543028|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
43543029|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43668360|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668361|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
43668362|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668363|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668364|NCT03504956|Metoprolol|metoprolol|mesh-list
43668365|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43543030|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43543031|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543032|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
43543033|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543034|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
43543035|NCT03698474|Protective Agents|protective agents|mesh-ancestor
43543036|NCT03698474|Vitamins|vitamins|mesh-ancestor
43543037|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
43543038|NCT03698474|Cathartics|cathartics|mesh-ancestor
43543039|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43543040|NCT03698435|Valganciclovir|valganciclovir|mesh-list
43543041|NCT03698435|Ganciclovir|ganciclovir|mesh-list
43543042|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43733106|NCT02545751|Thymalfasin|thymalfasin|mesh-list
43733107|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43733108|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
43733109|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733110|NCT02545712|Ethanol|ethanol|mesh-list
43733111|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
43849812|NCT03891355|Lenalidomide|lenalidomide|mesh-list
43849813|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543050|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543051|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543052|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43543053|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543054|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543055|NCT03698292|Metoclopramide|metoclopramide|mesh-list
43543056|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
43543057|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
43543058|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543059|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543060|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43543061|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43543062|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43543063|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
43543064|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543065|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543066|NCT03698227|Doxorubicin|doxorubicin|mesh-list
43543067|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
43543068|NCT03698227|Razoxane|razoxane|mesh-list
43543069|NCT03698227|Olaratumab|olaratumab|mesh-list
43543070|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43543071|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543072|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43543073|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43543074|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543075|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849814|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
43543078|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543079|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
43543080|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
43543081|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43543082|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43543083|NCT03697889|Naproxen|naproxen|mesh-list
43543084|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43543086|NCT03697889|Analgesics|analgesics|mesh-ancestor
43543087|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
43543088|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543089|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543090|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543091|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543092|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
43543093|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43733112|NCT02545712|Sorbitol|sorbitol|mesh-list
43733113|NCT02545712|Glycerol|glycerol|mesh-list
43733114|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43733115|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733116|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733117|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733118|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43733119|NCT02545712|Protective Agents|protective agents|mesh-ancestor
43733120|NCT02545712|Cathartics|cathartics|mesh-ancestor
43733121|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43543094|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668366|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43668367|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43668368|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
43668369|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
43668370|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668371|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668372|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43668373|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43543095|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543096|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
43543098|NCT03697824|Fludarabine|fludarabine|mesh-list
43543099|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543100|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
43543101|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543102|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543103|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43543104|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
43543105|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543106|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543107|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43543108|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543109|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43543110|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43543111|NCT03697746|Acetaminophen|acetaminophen|mesh-list
43733122|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
43733123|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
43733124|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
43733125|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733126|NCT02545777|Diclofenac|diclofenac|mesh-list
43733127|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43733128|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43733129|NCT02545777|Analgesics|analgesics|mesh-ancestor
43733130|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
43733131|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733132|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733144|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834209|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43834210|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
43834211|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
43834212|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
43834213|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43834214|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43834215|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43834216|NCT05157841|Bupivacaine|bupivacaine|mesh-list
43834217|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
43834218|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
43834219|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543135|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543136|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43543138|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543139|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
43543149|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543151|NCT03697564|Antiviral Agents|antiviral agents|mesh-ancestor
43668374|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
43668375|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668376|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668377|NCT03421639|Leuprolide|leuprolide|mesh-list
43668378|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43668379|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43668380|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43668381|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
43668382|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543152|NCT03697564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543153|NCT03697564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543154|NCT03697564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543165|NCT03697239|Paclitaxel|paclitaxel|mesh-list
43543168|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43543169|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543170|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
43543171|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
43543172|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
43543173|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543174|NCT03697239|Vitamins|vitamins|mesh-ancestor
43543175|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
43543176|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543177|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43543178|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
43543179|NCT03697239|Antiviral Agents|antiviral agents|mesh-ancestor
43543180|NCT03697239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543181|NCT03697239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543182|NCT03697239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543183|NCT03697239|Immunologic Factors|immunologic factors|mesh-ancestor
43543184|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
43543185|NCT03697239|Protective Agents|protective agents|mesh-ancestor
43543186|NCT03697161|Gaboxadol|gaboxadol|mesh-list
43543187|NCT03697161|Analgesics|analgesics|mesh-ancestor
43543188|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
43543189|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543190|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543191|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
43543192|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
43543193|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
43543194|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543195|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543196|NCT03697057|Anesthetics|anesthetics|mesh-list
43543197|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834220|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834221|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
43834222|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834223|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
43543198|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543199|NCT03697044|Irinotecan|irinotecan|mesh-list
43543200|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43543201|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43543202|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543203|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543204|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543205|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
43543206|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
43543207|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43543208|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543209|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849815|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
43543210|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
43543211|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43543212|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543213|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543215|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43668383|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668384|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668385|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668386|NCT03421639|Hormones|hormones|mesh-ancestor
43668387|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668388|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43668389|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543216|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43543217|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
43733157|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733158|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733159|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
43733160|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
43733161|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733162|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43733163|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
43733164|NCT02545959|Hormones|hormones|mesh-ancestor
43733165|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733166|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43733167|NCT02545959|Protective Agents|protective agents|mesh-ancestor
43733168|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43733169|NCT02545634|Sulfalene|sulfalene|mesh-list
43733170|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733171|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43733187|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43733189|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43543218|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543219|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43543231|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43543232|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543233|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543234|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
43543235|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43543236|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43543237|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543238|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43543239|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43543249|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43543250|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
43543251|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43543252|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43543253|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43543254|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543255|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
43543256|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543257|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543259|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43543260|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543261|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
43543262|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543263|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543264|NCT03696186|Phenobarbital|phenobarbital|mesh-list
43543265|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
43543266|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43543267|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543268|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543269|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43543270|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43543271|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543272|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849816|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543273|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
43543274|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
43543275|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43543276|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43543277|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43543278|NCT03696095|Ropivacaine|ropivacaine|mesh-list
43543279|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
43543280|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
43543289|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543290|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733204|NCT02545452|Anastrozole|anastrozole|mesh-list
43543292|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43668390|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668391|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43668392|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
43668393|NCT03413800|Dexamethasone|dexamethasone|mesh-list
43668394|NCT03413800|Lenalidomide|lenalidomide|mesh-list
43668395|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43668396|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
43668397|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
43668398|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543293|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
43543294|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
43543295|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543296|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543297|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543298|NCT03695887|Analgesics|analgesics|mesh-ancestor
43543299|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
43543300|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543301|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43543302|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43543303|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543304|NCT03695835|Sargramostim|sargramostim|mesh-list
43543305|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
43543306|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543307|NCT03695822|Mirabegron|mirabegron|mesh-list
43543308|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43543309|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43543310|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43543311|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
43543312|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543313|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543314|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543315|NCT03695822|Urological Agents|urological agents|mesh-ancestor
43543316|NCT03695744|Dexamethasone|dexamethasone|mesh-list
43543317|NCT03695744|Bortezomib|bortezomib|mesh-list
43543318|NCT03695744|Daratumumab|daratumumab|mesh-list
43543332|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43543333|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543334|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43543335|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43543336|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43543337|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543338|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543339|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543340|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43543341|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43543342|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
43543365|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543366|NCT03695029|Tenofovir|tenofovir|mesh-list
43543367|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
43543368|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543369|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43543370|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43543371|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543372|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543373|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43543374|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43543375|NCT03694977|Spartalizumab|spartalizumab|mesh-list
43543376|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43543377|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543378|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543379|NCT03694886|Caffeine|caffeine|mesh-list
43733237|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
43733238|NCT02545010|Paclitaxel|paclitaxel|mesh-list
43543380|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43543381|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543382|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43543383|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543384|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543385|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43543386|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43543387|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
43543388|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543389|NCT03694873|Celecoxib|celecoxib|mesh-list
43543390|NCT03694873|Tramadol|tramadol|mesh-list
43543391|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43543392|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543393|NCT03694873|Analgesics|analgesics|mesh-ancestor
43543394|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
43543395|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543396|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543397|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543398|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543399|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43543400|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43543401|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543402|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543403|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43543405|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543406|NCT03694587|Ibuprofen|ibuprofen|mesh-list
43543407|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43543408|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543409|NCT03694587|Analgesics|analgesics|mesh-ancestor
43543423|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543424|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43543426|NCT03694236|Durvalumab|durvalumab|mesh-list
43543427|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543428|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543429|NCT03694119|Phenelzine|phenelzine|mesh-list
43543430|NCT03694119|Ozanimod|ozanimod|mesh-list
43543431|NCT03694119|Tyramine|tyramine|mesh-list
43543432|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43562135|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562136|NCT01516918|Ribavirin|ribavirin|mesh-list
43562137|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43562138|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
43562139|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562140|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
43562141|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562142|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
43562143|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43562144|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43562145|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
43733239|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43543433|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543434|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543435|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
43543436|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543437|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
43543438|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43668403|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849817|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668404|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668405|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668407|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43668408|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43668409|NCT03413800|Growth Substances|growth substances|mesh-ancestor
43668410|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
43668411|NCT03354013|Calcium|calcium|mesh-list
43668412|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43668413|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668414|NCT03338387|Acipimox|acipimox|mesh-list
43668415|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43668416|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
43668417|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668418|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43668419|NCT03335839|Plasminogen|plasminogen|mesh-list
43543439|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43543440|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543441|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
43543442|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
43543443|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543444|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43543445|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43543446|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43543447|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
43543448|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543449|NCT03694080|Calcium|calcium|mesh-list
43543450|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543451|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543452|NCT03693976|Xylometazoline|xylometazoline|mesh-list
43543453|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
43543454|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43543455|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
43543456|NCT03693885|Oxytocin|oxytocin|mesh-list
43543457|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
43543458|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543459|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543460|NCT03693872|Dopamine|dopamine|mesh-list
43543461|NCT03693872|Apomorphine|apomorphine|mesh-list
43543462|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
43543463|NCT03693872|Emetics|emetics|mesh-ancestor
43543464|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543465|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
43543466|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543467|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43543468|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
43543469|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543470|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543476|NCT03693638|Fentanyl|fentanyl|mesh-list
43543477|NCT03693638|Bupivacaine|bupivacaine|mesh-list
43543478|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
43543479|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
43543480|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543481|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543482|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
43543483|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543484|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43668420|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43668421|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43668423|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668424|NCT03268382|Doxorubicin|doxorubicin|mesh-list
43668425|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43733250|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43733251|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733252|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733253|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43733254|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
43733255|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
43733256|NCT02544880|Tadalafil|tadalafil|mesh-list
43733257|NCT02544880|Vaccines|vaccines|mesh-list
43733258|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
43733259|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733260|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
43733261|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43733262|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43733263|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733264|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733265|NCT02544880|Urological Agents|urological agents|mesh-ancestor
43733266|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
43733267|NCT02544893|Bupivacaine|bupivacaine|mesh-list
43733268|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
43733269|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
43733270|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733271|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733272|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
43668426|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43668427|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668428|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43668429|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43668430|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668431|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543485|NCT03693638|Narcotics|narcotics|mesh-ancestor
43543486|NCT03693638|Analgesics|analgesics|mesh-ancestor
43543487|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43543488|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43543489|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
43543490|NCT03693599|Carbetocin|carbetocin|mesh-list
43543491|NCT03693599|Syntometrine|syntometrine|mesh-list
43543492|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
43543493|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543494|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543495|NCT03693573|Bevacizumab|bevacizumab|mesh-list
43543496|NCT03693573|Atezolizumab|atezolizumab|mesh-list
43543497|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543498|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543499|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43543500|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43543501|NCT03693573|Growth Substances|growth substances|mesh-ancestor
43543502|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543503|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
43543504|NCT03693560|Metformin|metformin|mesh-list
43543505|NCT03693560|Glimepiride|glimepiride|mesh-list
43543506|NCT03693560|Vildagliptin|vildagliptin|mesh-list
43543507|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43543508|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543509|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43543510|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543511|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
43543512|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43733273|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543513|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
43733274|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43733276|NCT02544893|Analgesics|analgesics|mesh-ancestor
43543514|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543515|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543516|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43543517|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43543518|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43543519|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
43543520|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543521|NCT03693391|Fluorides|fluorides|mesh-list
43543522|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
43543523|NCT03693391|Protective Agents|protective agents|mesh-ancestor
43543524|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543525|NCT03693326|Spartalizumab|spartalizumab|mesh-list
43543526|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43543527|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543528|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543530|NCT03693248|Carboplatin|carboplatin|mesh-list
43543531|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43543532|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543533|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
43543534|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
43543535|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
43668432|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
43668433|NCT03249012|Calcitriol|calcitriol|mesh-list
43668434|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
43668436|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43668437|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668438|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43668439|NCT03249012|Antacids|antacids|mesh-ancestor
43543536|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543537|NCT03693222|Morphine|morphine|mesh-list
43543538|NCT03693222|Tramadol|tramadol|mesh-list
43543539|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43543540|NCT03693222|Narcotics|narcotics|mesh-ancestor
43543541|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543542|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543543|NCT03693222|Analgesics|analgesics|mesh-ancestor
43543547|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43733313|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733314|NCT02544776|Amlodipine|amlodipine|mesh-list
43733315|NCT02544776|Clomiphene|clomiphene|mesh-list
43733316|NCT02544776|Enclomiphene|enclomiphene|mesh-list
43733317|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
43733318|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733319|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43733320|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43733321|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733322|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543548|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43543549|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543550|NCT03693183|Analgesics|analgesics|mesh-ancestor
43543551|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
43543552|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543562|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
43543563|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43543564|NCT03693066|Disinfectants|disinfectants|mesh-list
43543565|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43543566|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543567|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
43543568|NCT03692819|Amoxicillin|amoxicillin|mesh-list
43543569|NCT03692819|Metronidazole|metronidazole|mesh-list
43543570|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43543571|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543572|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43543573|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43543574|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
43543575|NCT03692754|Dexamethasone|dexamethasone|mesh-list
43543576|NCT03692754|Atorvastatin|atorvastatin|mesh-list
43543578|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543579|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
43543580|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
43543581|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543583|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43543585|NCT03692754|Hormones|hormones|mesh-ancestor
43543586|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43543587|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43543588|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543589|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543590|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43543591|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43733341|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
43733342|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733343|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733344|NCT02544737|Apatinib|apatinib|mesh-list
43733345|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733346|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43733347|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733348|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733349|NCT02544724|Interleukin-12|interleukin-12|mesh-list
43733350|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43733351|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
43733352|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733353|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43733354|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43733355|NCT02544724|Growth Substances|growth substances|mesh-ancestor
43733356|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
43733357|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733358|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43543592|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43543593|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
43543594|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543595|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43543596|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43668440|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668441|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43668442|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43668443|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668444|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43668445|NCT03249012|Vitamins|vitamins|mesh-ancestor
43668446|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
43668447|NCT03233828|Aldesleukin|aldesleukin|mesh-list
43668448|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668449|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43668450|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43668451|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
43668452|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668453|NCT03223103|Poly ICLC|poly iclc|mesh-list
43668454|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
43668455|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
43668456|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668457|NCT03202628|Dexamethasone|dexamethasone|mesh-list
43668458|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
43668459|NCT03202628|Pomalidomide|pomalidomide|mesh-list
43668460|NCT03202628|Ixazomib|ixazomib|mesh-list
43668461|NCT03202628|Ichthammol|ichthammol|mesh-list
43668462|NCT03202628|BB 1101|bb 1101|mesh-list
43668463|NCT03202628|Glycine|glycine|mesh-list
43849819|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
43849820|NCT03891355|Hormones|hormones|mesh-ancestor
43849821|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849822|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43543622|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
43543623|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543624|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43543625|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543626|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
43543627|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543628|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43543629|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43668468|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668469|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43668470|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
43668471|NCT03202628|Hormones|hormones|mesh-ancestor
43668472|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668473|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668474|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668475|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668476|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
43668477|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668478|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
43668479|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43668480|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43668481|NCT03202628|Growth Substances|growth substances|mesh-ancestor
43668482|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
43543632|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
43543633|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543634|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43543635|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43543636|NCT03692416|Protective Agents|protective agents|mesh-ancestor
43543637|NCT03692299|Metronidazole|metronidazole|mesh-list
43543638|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543639|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43733359|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43543640|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43543641|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43543642|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
43543643|NCT03692286|Calcium|calcium|mesh-list
43543644|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543645|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543646|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43543647|NCT03692143|Alendronate|alendronate|mesh-list
43543648|NCT03692143|Teriparatide|teriparatide|mesh-list
43543649|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43543650|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543651|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543652|NCT03692026|Melatonin|melatonin|mesh-list
43543653|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
43543654|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
43543655|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543656|NCT03692026|Protective Agents|protective agents|mesh-ancestor
43543657|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543658|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543659|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43543660|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
43849823|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849824|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
43543661|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
43543662|NCT03692013|Losartan|losartan|mesh-list
43543663|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43543664|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43543665|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43543666|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43668483|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
43668484|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
43668485|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668486|NCT03199794|Factor VIII|factor viii|mesh-list
43668487|NCT03199794|Coagulants|coagulants|mesh-ancestor
43543667|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543668|NCT03691922|Epinephrine|epinephrine|mesh-list
43543669|NCT03691922|Racepinephrine|racepinephrine|mesh-list
43543670|NCT03691922|Bupivacaine|bupivacaine|mesh-list
43562188|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562189|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43562190|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
43562191|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562192|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562193|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562194|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
43562195|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
43562196|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43562197|NCT01516073|Fluticasone|fluticasone|mesh-list
43562198|NCT01516073|Xhance|xhance|mesh-list
43543671|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
43543672|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
43543673|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
43543674|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543675|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543676|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
43543677|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543678|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43543679|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43543680|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
43543681|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849825|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43849826|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43849827|NCT03891355|Growth Substances|growth substances|mesh-ancestor
43849828|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
43849829|NCT03891173|Cisplatin|cisplatin|mesh-list
43849830|NCT03891173|Vinorelbine|vinorelbine|mesh-list
43849831|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849832|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43543682|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543683|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43543684|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43543685|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
43543686|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43543694|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543696|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
43543697|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43543698|NCT03691818|Ibuprofen|ibuprofen|mesh-list
43543699|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43543700|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543701|NCT03691818|Analgesics|analgesics|mesh-ancestor
43543702|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
43543703|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543704|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543705|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543706|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543707|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43543708|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543709|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543710|NCT03691688|Aspirin|aspirin|mesh-list
43543711|NCT03691688|Clopidogrel|clopidogrel|mesh-list
43543712|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43543713|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543714|NCT03691688|Analgesics|analgesics|mesh-ancestor
43543715|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
43543716|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543717|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543718|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543719|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543720|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43543721|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43543722|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543723|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43733378|NCT02544425|Asparaginase|asparaginase|mesh-list
43733379|NCT02544425|Ifosfamide|ifosfamide|mesh-list
43733380|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543724|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43543725|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543726|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
43543727|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43543728|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43543729|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43543730|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
43543731|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543732|NCT03691662|Timolol|timolol|mesh-list
43543733|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43543734|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43543735|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43543736|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43543737|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
43668493|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43668494|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668495|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668496|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43668497|NCT03097939|Nivolumab|nivolumab|mesh-list
43668498|NCT03097939|Ipilimumab|ipilimumab|mesh-list
43668499|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668500|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668501|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43639129|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43849833|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
43668507|NCT03047473|Avelumab|avelumab|mesh-list
43668508|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668509|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543738|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543739|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543740|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543741|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43543742|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43733407|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
43733408|NCT02544282|Atracurium|atracurium|mesh-list
43733409|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43733410|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733411|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733412|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43733413|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
43733414|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
43733415|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43733416|NCT02544282|Analgesics|analgesics|mesh-ancestor
43543743|NCT03691649|Timolol|timolol|mesh-list
43543744|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43543745|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43543746|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43543747|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43543748|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
43543749|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543750|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543751|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543752|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43543753|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43543760|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543762|NCT03691467|Protective Agents|protective agents|mesh-ancestor
43543763|NCT03691454|Docetaxel|docetaxel|mesh-list
43543764|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
43543765|NCT03691454|Trastuzumab|trastuzumab|mesh-list
43543766|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543767|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
43849834|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
43849835|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
43849836|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543781|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543782|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543783|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
43543784|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43543785|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43543786|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543787|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543788|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43562232|NCT01508026|Nebivolol|nebivolol|mesh-list
43562233|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43562234|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43543789|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43543790|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543791|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43543793|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43543794|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43543795|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543796|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43543797|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43543798|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
43543799|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543800|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43543801|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43543802|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543803|NCT03690739|Gemcitabine|gemcitabine|mesh-list
43543804|NCT03690739|Paclitaxel|paclitaxel|mesh-list
43543805|NCT03690739|Bevacizumab|bevacizumab|mesh-list
43543806|NCT03690739|Cisplatin|cisplatin|mesh-list
43543807|NCT03690739|Carboplatin|carboplatin|mesh-list
43543808|NCT03690739|Trabectedin|trabectedin|mesh-list
43543809|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43543810|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543811|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
43543812|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
43543813|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
43543814|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543815|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543816|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43543817|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43543818|NCT03690739|Growth Substances|growth substances|mesh-ancestor
43543819|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543820|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
43543821|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43543822|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
43543823|NCT03690739|Antiviral Agents|antiviral agents|mesh-ancestor
43543832|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668520|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668521|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
43668522|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43668523|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43668525|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668526|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668527|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
43668528|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668529|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668530|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43733441|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733442|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733443|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43733444|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43733445|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
43733446|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733447|NCT02544243|Gemcitabine|gemcitabine|mesh-list
43733448|NCT02544243|Cisplatin|cisplatin|mesh-list
43733449|NCT02544243|Vinorelbine|vinorelbine|mesh-list
43733450|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668531|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668533|NCT03013218|Rituximab|rituximab|mesh-list
43668534|NCT03013218|Cisplatin|cisplatin|mesh-list
43668535|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
43668536|NCT03013218|Trastuzumab|trastuzumab|mesh-list
43543833|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543834|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543835|NCT03690622|Analgesics|analgesics|mesh-ancestor
43543836|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
43543837|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543838|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43543839|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43543840|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43543841|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
43543842|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543843|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543844|NCT03690583|Zinc|zinc|mesh-list
43543845|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
43543846|NCT03690583|Trace Elements|trace elements|mesh-ancestor
43543847|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
43543848|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543849|NCT03690583|Astringents|astringents|mesh-ancestor
43543850|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
43543851|NCT03691337|Bupivacaine|bupivacaine|mesh-list
43543852|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43543853|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
43543854|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
43543855|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543856|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543857|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
43543858|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543859|NCT03690414|Atropine|atropine|mesh-list
43543860|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43849843|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
43849844|NCT03889418|Narcotics|narcotics|mesh-ancestor
43849845|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849848|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
43849849|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849850|NCT03889275|Durvalumab|durvalumab|mesh-list
43849851|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834235|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
43834236|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
43834237|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43834238|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43733472|NCT02544061|Interleukin-12|interleukin-12|mesh-list
43733473|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43733474|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
43733475|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733476|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43733477|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43733478|NCT02544061|Growth Substances|growth substances|mesh-ancestor
43668538|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43562258|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
43668539|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668540|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
43668541|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
43668542|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
43668543|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543874|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
43543875|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543876|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543877|NCT03690323|Gemcitabine|gemcitabine|mesh-list
43543878|NCT03690323|Paclitaxel|paclitaxel|mesh-list
43543879|NCT03690323|Folfirinox|folfirinox|mesh-list
43543880|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43543881|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543882|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
43543883|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
43543884|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
43849852|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543885|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543886|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43543887|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
43543888|NCT03690323|Antiviral Agents|antiviral agents|mesh-ancestor
43543889|NCT03690323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543890|NCT03690323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543891|NCT03690323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543900|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543901|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543903|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
43543904|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543905|NCT03689998|Protective Agents|protective agents|mesh-ancestor
43543906|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543907|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543908|NCT03689972|Natalizumab|natalizumab|mesh-list
43543909|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
43543910|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543911|NCT03689894|Rituximab|rituximab|mesh-list
43543912|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543913|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543914|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
43543915|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543916|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543917|NCT03689465|Cyclosporine|cyclosporine|mesh-list
43543918|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
43543919|NCT03689465|Methotrexate|methotrexate|mesh-list
43543920|NCT03689465|Cyclosporins|cyclosporins|mesh-list
43562270|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562271|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562272|NCT01497704|Apatinib|apatinib|mesh-list
43562273|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562274|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43562275|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562276|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562277|NCT01495247|Paclitaxel|paclitaxel|mesh-list
43562278|NCT01495247|Dactolisib|dactolisib|mesh-list
43562279|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43562280|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733481|NCT02543879|Azacitidine|azacitidine|mesh-list
43733482|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43733483|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
43733484|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543921|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43543922|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
43543923|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543924|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543925|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43543926|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
43543927|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543928|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543929|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
43543930|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543931|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43543932|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543933|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
43543934|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543935|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43543936|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
43543937|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543938|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43543939|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43543940|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43668544|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668545|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
43668546|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668547|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668548|NCT02942498|Vitamins|vitamins|mesh-list
43668549|NCT02942498|Ascorbic Acid|ascorbic acid|mesh-list
43668550|NCT02942498|Vitamin E|vitamin e|mesh-list
43668551|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
43543941|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
43543942|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43543944|NCT03689114|Lamotrigine|lamotrigine|mesh-list
43543945|NCT03689114|Zonisamide|zonisamide|mesh-list
43543946|NCT03689114|Carbamazepine|carbamazepine|mesh-list
43543947|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
43543948|NCT03689114|Gabapentin|gabapentin|mesh-list
43543949|NCT03689114|Levetiracetam|levetiracetam|mesh-list
43543950|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
43543951|NCT03689114|Valproic Acid|valproic acid|mesh-list
43543952|NCT03689114|Analgesics|analgesics|mesh-ancestor
43543953|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
43543954|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543955|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543956|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43543957|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43543958|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543959|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43543960|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43543975|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43543976|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43543977|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43543979|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543980|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
43733485|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733486|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733487|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
43733488|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543981|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543982|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43543983|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543984|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543985|NCT03689010|Azelaic acid|azelaic acid|mesh-list
43849853|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
43543986|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543987|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
43543988|NCT03688971|Ketoconazole|ketoconazole|mesh-list
43543989|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
43543990|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543991|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43543992|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43543993|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543994|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543995|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43543996|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
43543997|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43543998|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543999|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43544000|NCT03688958|Iodine|iodine|mesh-list
43544001|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
43544002|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43544003|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544004|NCT03688958|Trace Elements|trace elements|mesh-ancestor
43544005|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
43849854|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43849855|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
43849856|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849857|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849858|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43544006|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544008|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544009|NCT03688659|Vancomycin|vancomycin|mesh-list
43544010|NCT03688659|Gentamicins|gentamicins|mesh-list
43544011|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544012|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544013|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43544014|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544015|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544016|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
43668552|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668553|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
43668554|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668555|NCT02942498|Protective Agents|protective agents|mesh-ancestor
43826704|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544017|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733504|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
43544018|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43544019|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544023|NCT03688464|Melatonin|melatonin|mesh-list
43544024|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
43544025|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544026|NCT03688464|Protective Agents|protective agents|mesh-ancestor
43544027|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544028|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544029|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43544030|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43733505|NCT05225831|Fludarabine|fludarabine|mesh-list
43733506|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733507|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
43733508|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544031|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
43544032|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
43544033|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
43544034|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544035|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
43544036|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
43544037|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544038|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43544039|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
43544040|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
43544041|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544042|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43544043|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
43544044|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
43544045|NCT03688451|Rituximab|rituximab|mesh-list
43544046|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43544047|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544048|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
43544049|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544050|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43544051|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43544052|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43544053|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544054|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
43544055|NCT03688269|Dexamethasone|dexamethasone|mesh-list
43544056|NCT03688269|Ropivacaine|ropivacaine|mesh-list
43544057|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544058|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
43544059|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
43544060|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544061|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544062|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544063|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
43544064|NCT03688269|Hormones|hormones|mesh-ancestor
43544065|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544066|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544067|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544068|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
43544069|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
43849860|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43544070|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544071|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
43544072|NCT03688230|Cetuximab|cetuximab|mesh-list
43544073|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43544074|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544075|NCT03688191|Sirolimus|sirolimus|mesh-list
43544076|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544077|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544078|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43544079|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544080|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
43544081|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43544082|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
43544083|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826705|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826706|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43733517|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
43733518|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733519|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826707|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826708|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43826709|NCT05495061|Latanoprost|latanoprost|mesh-list
43826710|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43826711|NCT05495035|Dexamethasone|dexamethasone|mesh-list
43544084|NCT03687931|Dexamethasone|dexamethasone|mesh-list
43544085|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544086|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
43544087|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
43544089|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544090|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544091|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
43544092|NCT03687931|Hormones|hormones|mesh-ancestor
43544094|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544095|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544097|NCT03687905|Chloroquine|chloroquine|mesh-list
43544098|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
43544099|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43544100|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43544101|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544102|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544103|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544104|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43544105|NCT03687905|Amebicides|amebicides|mesh-ancestor
43544106|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43544107|NCT03687606|Menotropins|menotropins|mesh-list
43544108|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544109|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544110|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43544111|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
43544112|NCT03687515|Prednisone|prednisone|mesh-list
43544113|NCT03687515|Budesonide|budesonide|mesh-list
43544114|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544115|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
43544116|NCT03687515|Hormones|hormones|mesh-ancestor
43544118|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544119|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544120|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544121|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43544122|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
43544123|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544124|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43544125|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
43544127|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43544128|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
43544129|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544130|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544131|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544132|NCT03687268|Naloxone|naloxone|mesh-list
43544133|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43544134|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544135|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
43733532|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43544136|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544137|NCT03687255|Tazobactam|tazobactam|mesh-list
43544138|NCT03687255|Piperacillin|piperacillin|mesh-list
43544139|NCT03687255|Cefepime|cefepime|mesh-list
43544140|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43544141|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
43544142|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544143|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544144|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43544145|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544146|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544147|NCT03687229|Insulin|insulin|mesh-list
43544148|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43826712|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826713|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
43826714|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
43826715|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826716|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826717|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826718|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
43826719|NCT05495035|Hormones|hormones|mesh-ancestor
43826720|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826721|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826722|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826723|NCT05494775|Mitogens|mitogens|mesh-list
43826724|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
43826725|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
43826726|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826727|NCT05494775|Growth Substances|growth substances|mesh-ancestor
43826728|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826730|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826731|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826732|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43826733|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
43544149|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544151|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
43544152|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43544153|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544154|NCT03687073|Protective Agents|protective agents|mesh-ancestor
43544155|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544156|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43544157|NCT03687034|Temozolomide|temozolomide|mesh-list
43544158|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43544159|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
43544160|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544161|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544162|NCT03687021|Progesterone|progesterone|mesh-list
43544163|NCT03687021|Progestins|progestins|mesh-ancestor
43544164|NCT03687021|Hormones|hormones|mesh-ancestor
43544165|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544166|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544175|NCT03686787|Coagulants|coagulants|mesh-ancestor
43544176|NCT03686774|Memantine|memantine|mesh-list
43544177|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43544178|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43544179|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
43544180|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544181|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733573|NCT05155436|Amlodipine|amlodipine|mesh-list
43733574|NCT05155436|Telmisartan|telmisartan|mesh-list
43733575|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43733576|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43733577|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733578|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733579|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43544182|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544183|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43544184|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43544185|NCT03686722|Metformin|metformin|mesh-list
43544186|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43544187|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826735|NCT05494645|Bupivacaine|bupivacaine|mesh-list
43826736|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
43826737|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
43826738|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826739|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826740|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
43826741|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826742|NCT05494593|Rituximab|rituximab|mesh-list
43826743|NCT05494593|Methotrexate|methotrexate|mesh-list
43826744|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
43826745|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43826746|NCT05494593|Antibodies|antibodies|mesh-list
43826747|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
43826748|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43826749|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826750|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544188|NCT03686657|Metformin|metformin|mesh-list
43544189|NCT03686657|Celecoxib|celecoxib|mesh-list
43544190|NCT03686657|Valsartan|valsartan|mesh-list
43544191|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43544192|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544193|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43733580|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733581|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
43733582|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43733583|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43733584|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
43733585|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43733586|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733595|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
43733596|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733597|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834239|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43834240|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
43834241|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834242|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834243|NCT05157711|Protective Agents|protective agents|mesh-ancestor
43834244|NCT05157711|Antacids|antacids|mesh-ancestor
43834245|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834246|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834247|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
43544194|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43834252|NCT05157672|Letrozole|letrozole|mesh-list
43544195|NCT03686657|Analgesics|analgesics|mesh-ancestor
43544196|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
43544197|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544198|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544199|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43544200|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43544201|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43544202|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544203|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544204|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43544205|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43544206|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43544208|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544209|NCT03686618|Hormones|hormones|mesh-ancestor
43544210|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544211|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544212|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
43544213|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
43544214|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43544215|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544216|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544217|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
43544218|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43544219|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544220|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544221|NCT03686254|Bevacizumab|bevacizumab|mesh-list
43544222|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43544223|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544224|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43544225|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43544226|NCT03686254|Growth Substances|growth substances|mesh-ancestor
43544227|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826751|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
43826752|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826753|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826754|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43826755|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
43544228|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
43544229|NCT03686163|Mitogens|mitogens|mesh-list
43544230|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
43834256|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544231|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544232|NCT03686085|Dinoprostone|dinoprostone|mesh-list
43544233|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
43544234|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544235|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544236|NCT03685630|Brivaracetam|brivaracetam|mesh-list
43544237|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
43544239|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43544240|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544241|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43544249|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
43544250|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43544251|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544252|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544254|NCT03685032|Ondansetron|ondansetron|mesh-list
43544255|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544256|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
43544257|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
43544258|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544259|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544260|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544261|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
43544262|NCT03685032|Hormones|hormones|mesh-ancestor
43544263|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544264|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544265|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544266|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
43544267|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
43733624|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733632|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43733635|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
43733636|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
43733637|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43733638|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
43733639|NCT04721626|Tetracycline|tetracycline|mesh-list
43733640|NCT04721626|Doxycycline|doxycycline|mesh-list
43733641|NCT04721626|Povidone|povidone|mesh-list
43733642|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43733643|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733644|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
43733645|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
43733646|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
43733647|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
43733648|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544268|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43544269|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
43544270|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544271|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544272|NCT03685032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43544273|NCT03685032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43544274|NCT03685032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544275|NCT03685032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43544276|NCT03685032|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43544278|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43544279|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43544280|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544281|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
43544282|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
43544283|NCT03684876|Diuretics|diuretics|mesh-list
43544284|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
43544285|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544286|NCT03684863|Capecitabine|capecitabine|mesh-list
43544287|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43544288|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
43544289|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544290|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544291|NCT03684837|Vitamin D|vitamin d|mesh-list
43544292|NCT03684837|Vitamins|vitamins|mesh-ancestor
43544293|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
43544294|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544295|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43826756|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43826757|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826758|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
43826759|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668557|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43668558|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43668559|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668560|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
43668561|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
43668562|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668564|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668565|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43668566|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544296|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43544297|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
43544298|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43544299|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
43544300|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544301|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544302|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43544303|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544304|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544306|NCT03684772|Furosemide|furosemide|mesh-list
43733671|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544307|NCT03684772|Diuretics|diuretics|mesh-ancestor
43733672|NCT04634162|Cangrelor|cangrelor|mesh-list
43544308|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
43544309|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544310|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43544313|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43544314|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43544315|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544316|NCT03684772|Protective Agents|protective agents|mesh-ancestor
43544318|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43544319|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544320|NCT03684395|Warfarin|warfarin|mesh-list
43544321|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
43544322|NCT03684395|Dabigatran|dabigatran|mesh-list
43544323|NCT03684395|Apixaban|apixaban|mesh-list
43544324|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
43544325|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43544326|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
43544327|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43544330|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544332|NCT03684330|Vitamins|vitamins|mesh-ancestor
43544333|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
43544334|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544335|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43544336|NCT03683914|Dinoprostone|dinoprostone|mesh-list
43544337|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
43544338|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544339|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544340|NCT03683563|Citric Acid|citric acid|mesh-list
43544341|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
43544342|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
43544343|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43668567|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668568|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43668569|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43668570|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
43668571|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668572|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668573|NCT02781519|Dronabinol|dronabinol|mesh-list
43668574|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
43668575|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668576|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43668577|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43544344|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
43544345|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
43544346|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544347|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43544348|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733692|NCT04627753|Rituximab|rituximab|mesh-list
43733693|NCT04627753|Lenalidomide|lenalidomide|mesh-list
43733694|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43733695|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733696|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
43544349|NCT03683277|Dexamethasone|dexamethasone|mesh-list
43544350|NCT03683277|Pomalidomide|pomalidomide|mesh-list
43544352|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544353|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
43544354|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
43544355|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544356|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544357|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544358|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
43544359|NCT03683277|Hormones|hormones|mesh-ancestor
43544360|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544361|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544362|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544363|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
43544364|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43544365|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43544366|NCT03683277|Growth Substances|growth substances|mesh-ancestor
43544367|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
43544368|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
43544369|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544370|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544371|NCT03683108|Resveratrol|resveratrol|mesh-list
43544372|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
43849864|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43849865|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
43849866|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
43849867|NCT05703191|Protective Agents|protective agents|mesh-ancestor
43849868|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
43849869|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849870|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544373|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544374|NCT03683108|Protective Agents|protective agents|mesh-ancestor
43544375|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544376|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544377|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43544378|NCT03683043|Leuprolide|leuprolide|mesh-list
43544379|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43544380|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
43544381|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544382|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544383|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544384|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544385|NCT03682952|Alprostadil|alprostadil|mesh-list
43544394|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43733727|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733728|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
43733729|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
43733730|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733731|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733732|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43733733|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
43733734|NCT04366115|Hormones|hormones|mesh-ancestor
43544395|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
43544396|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544397|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544398|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43544399|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544401|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43668578|NCT02781519|Analgesics|analgesics|mesh-ancestor
43668579|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
43544402|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
43544403|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544404|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544405|NCT03682653|Azithromycin|azithromycin|mesh-list
43544406|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544407|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544408|NCT03682640|Insulin|insulin|mesh-list
43544409|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43544410|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
43544411|NCT03682640|Azithromycin|azithromycin|mesh-list
43544412|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43544413|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544414|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544415|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544416|NCT03682497|Spironolactone|spironolactone|mesh-list
43544417|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43544418|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
43544419|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544420|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544421|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43544422|NCT03682497|Diuretics|diuretics|mesh-ancestor
43544423|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
43544424|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
43544425|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43544426|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544428|NCT03682211|Morphine|morphine|mesh-list
43544429|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43544430|NCT03682211|Narcotics|narcotics|mesh-ancestor
43733750|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43544431|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544432|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544433|NCT03682211|Analgesics|analgesics|mesh-ancestor
43544434|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
43544435|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544436|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43544437|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43544438|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
43544439|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
43544440|NCT03682198|Phenylephrine|phenylephrine|mesh-list
43733751|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43733752|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733753|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733754|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
43562302|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43562303|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562304|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
43562305|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
43562306|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562307|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544441|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
43544442|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43544443|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
43544444|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
43544445|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544446|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544447|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
43544448|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43544449|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
43544450|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
43544451|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43544452|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43544479|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544480|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544481|NCT03681548|Doxorubicin|doxorubicin|mesh-list
43544482|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43668580|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668581|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43668582|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43668583|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668584|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668586|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668587|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
43668588|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43668589|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
43668590|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
43668592|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668593|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
43544483|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43544484|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544485|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43544486|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43544487|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544488|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544489|NCT03681509|Pramipexole|pramipexole|mesh-list
43544490|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
43544491|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544492|NCT03681509|Protective Agents|protective agents|mesh-ancestor
43544493|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544494|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43544495|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43544496|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
43544497|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
43544498|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544499|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
43544500|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544501|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544503|NCT03681197|Clomiphene|clomiphene|mesh-list
43544504|NCT03681197|Enclomiphene|enclomiphene|mesh-list
43544505|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
43544506|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43544507|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544508|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43544509|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
43544510|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544511|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43544512|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
43544513|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544514|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43544515|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43544517|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544519|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
43544521|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544522|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849884|NCT05703048|Esmolol|esmolol|mesh-list
43849885|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43849886|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849887|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562315|NCT01489046|Efavirenz|efavirenz|mesh-list
43849888|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849889|NCT05703048|Analgesics|analgesics|mesh-ancestor
43849890|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
43668604|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43668605|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
43544549|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43544550|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43544552|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
43544553|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544554|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544555|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43544556|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544557|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544558|NCT03680573|Allopurinol|allopurinol|mesh-list
43544559|NCT03680573|Nitroprusside|nitroprusside|mesh-list
43544560|NCT03680573|Nitroarginine|nitroarginine|mesh-list
43544561|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
43544562|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
43544563|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544564|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544565|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
43544566|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43544567|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43544568|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
43668606|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668607|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668608|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43668609|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43849891|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668611|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
43668618|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668619|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544569|NCT03680573|Protective Agents|protective agents|mesh-ancestor
43544570|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544571|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43544572|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
43544573|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43544574|NCT03680560|Trastuzumab|trastuzumab|mesh-list
43544575|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43544576|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544577|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
43544578|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43544579|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43544580|NCT03680495|Prednisolone|prednisolone|mesh-list
43544585|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
43544586|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
43544587|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544588|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544589|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544590|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
43544592|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544593|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43544594|NCT03680495|Protective Agents|protective agents|mesh-ancestor
43544595|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544596|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544598|NCT03680404|Phenylephrine|phenylephrine|mesh-list
43544599|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
43544600|NCT03680404|Tempol|tempol|mesh-list
43544601|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43544602|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
43544603|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
43544604|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544605|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544606|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
43544607|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43544608|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
43544609|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
43544610|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43544611|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43544612|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43544613|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
43544614|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544615|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544616|NCT03680404|Protective Agents|protective agents|mesh-ancestor
43544617|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
43544618|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544619|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
43544620|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43544621|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43544622|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
43544623|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43544624|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43544625|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43849892|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43544628|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544629|NCT03680339|Misoprostol|misoprostol|mesh-list
43544630|NCT03680339|Oxytocin|oxytocin|mesh-list
43668620|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43668623|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
43668624|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
43668625|NCT02607748|Protective Agents|protective agents|mesh-ancestor
43668626|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668627|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43668628|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668629|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
43668630|NCT02546583|Furosemide|furosemide|mesh-list
43668631|NCT02546583|Bumetanide|bumetanide|mesh-list
43668632|NCT02546583|Diuretics|diuretics|mesh-list
43544631|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
43544632|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544633|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544634|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43544635|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
43544636|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43544637|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544638|NCT03680183|Entecavir|entecavir|mesh-list
43544639|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
43544640|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544641|NCT03679897|Ropivacaine|ropivacaine|mesh-list
43544642|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
43544643|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43544644|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
43544645|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
43544646|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544647|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544648|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
43849893|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43849894|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43849895|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
43849896|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849897|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849898|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43562323|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43562324|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43562325|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43733758|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43733760|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733761|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733762|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43733763|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733764|NCT04183790|Ivacaftor|ivacaftor|mesh-list
43733765|NCT04183790|Elexacaftor|elexacaftor|mesh-list
43849899|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43849900|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43849901|NCT05702996|Eculizumab|eculizumab|mesh-list
43849902|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43849903|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43544650|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
43544652|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43544653|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544654|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
43544655|NCT03679481|Coagulants|coagulants|mesh-ancestor
43544656|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
43544660|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43544662|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544663|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
43544664|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544665|NCT03679442|Expectorants|expectorants|mesh-ancestor
43544666|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
43544667|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43544668|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
43544669|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544670|NCT03679442|Protective Agents|protective agents|mesh-ancestor
43544672|NCT03679390|Analgesics|analgesics|mesh-ancestor
43544673|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
43544674|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544675|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544676|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43544677|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43544678|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
43544679|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
43544680|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544681|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43544682|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43544683|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544684|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544685|NCT03679325|Vitamin D|vitamin d|mesh-list
43544686|NCT03679325|Vitamins|vitamins|mesh-ancestor
43544687|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
43668633|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43668634|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
43668635|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668636|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668637|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668638|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43668639|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43668647|NCT02502253|Resveratrol|resveratrol|mesh-list
43668648|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
43668649|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668650|NCT02502253|Protective Agents|protective agents|mesh-ancestor
43668651|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668652|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668653|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43668654|NCT02499354|Iron|iron|mesh-list
43668655|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43668656|NCT02499354|Trace Elements|trace elements|mesh-ancestor
43544688|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733766|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43544690|NCT03679182|Olanzapine|olanzapine|mesh-list
43544691|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
43544692|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
43544693|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544694|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544695|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544696|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43544697|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43544698|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544699|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43544700|NCT03679182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43544701|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43544702|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43544703|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544704|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544705|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
43544706|NCT03679065|Acetaminophen|acetaminophen|mesh-list
43544707|NCT03679065|Dexamethasone|dexamethasone|mesh-list
43544708|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
43544709|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43544710|NCT03679065|BB 1101|bb 1101|mesh-list
43544712|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
43544713|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
43544714|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544715|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544716|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544717|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
43544718|NCT03679065|Hormones|hormones|mesh-ancestor
43544719|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544720|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43544721|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544722|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
43544723|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544724|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544725|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43544726|NCT03679065|Analgesics|analgesics|mesh-ancestor
43668657|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
43668658|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668659|NCT02499354|Hematinics|hematinics|mesh-ancestor
43668660|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43668661|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43668662|NCT02492776|Omeprazole|omeprazole|mesh-list
43668663|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43668664|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544727|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
43544728|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
43544729|NCT03679052|Clonidine|clonidine|mesh-list
43544740|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43544741|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
43544742|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544743|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544744|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
43544745|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43544746|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43544747|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
43544748|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
43544749|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43544750|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43544752|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43544754|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43544755|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43544756|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43544757|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
43733791|NCT04015115|Analgesics|analgesics|mesh-ancestor
43544758|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43544759|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
43544760|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43544761|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544762|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43544763|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
43544764|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43544766|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544767|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544768|NCT03678792|Morphine|morphine|mesh-list
43544769|NCT03678792|Buprenorphine|buprenorphine|mesh-list
43544770|NCT03678792|Tramadol|tramadol|mesh-list
43544771|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43544772|NCT03678792|Naloxone|naloxone|mesh-list
43544773|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43544774|NCT03678792|Narcotics|narcotics|mesh-ancestor
43544775|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544776|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544777|NCT03678792|Analgesics|analgesics|mesh-ancestor
43544778|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
43544779|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544780|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43544781|NCT03678649|Capecitabine|capecitabine|mesh-list
43544782|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43544783|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
43544784|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544785|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544786|NCT03678610|Ionomycin|ionomycin|mesh-list
43544787|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
43544788|NCT03678610|Ionophores|ionophores|mesh-ancestor
43544789|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43544790|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544791|NCT03678532|Midazolam|midazolam|mesh-list
43544792|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43544793|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43544794|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668665|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43668666|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668667|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668668|NCT02335944|Nazartinib|nazartinib|mesh-list
43668669|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668670|NCT02293980|Nivolumab|nivolumab|mesh-list
43544805|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544806|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43544807|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43544808|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544809|NCT03678428|Leucovorin|leucovorin|mesh-list
43544810|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
43544811|NCT03678428|Irinotecan|irinotecan|mesh-list
43544812|NCT03678428|Floxuridine|floxuridine|mesh-list
43544813|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544814|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43544815|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43544816|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544817|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544818|NCT03678428|Antidotes|antidotes|mesh-ancestor
43544819|NCT03678428|Protective Agents|protective agents|mesh-ancestor
43544820|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544821|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
43733806|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43733807|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43544822|NCT03678428|Vitamins|vitamins|mesh-ancestor
43733808|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43733809|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43733810|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
43544823|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
43544824|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43544825|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
43544826|NCT03678233|Testosterone|testosterone|mesh-list
43544827|NCT03678233|Androgens|androgens|mesh-ancestor
43544828|NCT03678233|Hormones|hormones|mesh-ancestor
43544829|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544830|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544831|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43544832|NCT03678142|Vancomycin|vancomycin|mesh-list
43544833|NCT03678142|Imipenem|imipenem|mesh-list
43544834|NCT03678142|Floxacillin|floxacillin|mesh-list
43544835|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544836|NCT03678116|Caffeine|caffeine|mesh-list
43544837|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43544838|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544839|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43544840|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544841|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544842|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43849904|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
43544844|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
43544845|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544846|NCT03678090|Plasminogen|plasminogen|mesh-list
43544847|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43544848|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43544849|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43544850|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544851|NCT03678038|Triamcinolone|triamcinolone|mesh-list
43544852|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43544853|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43544854|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43544855|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544856|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
43544857|NCT03678038|Hormones|hormones|mesh-ancestor
43544858|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544859|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544860|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43544878|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43544879|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544880|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544881|NCT03677466|Tenecteplase|tenecteplase|mesh-list
43544882|NCT03677466|Streptokinase|streptokinase|mesh-list
43562326|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43562327|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43562328|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43544883|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43544884|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43668671|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562329|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43562330|NCT01486849|Riluzole|riluzole|mesh-list
43562331|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
43562332|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43562333|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43562334|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562335|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562336|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562337|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43668672|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668673|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43544885|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544886|NCT03677336|Progesterone|progesterone|mesh-list
43544887|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
43544888|NCT03677336|Progestins|progestins|mesh-ancestor
43544889|NCT03677336|Hormones|hormones|mesh-ancestor
43544890|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544891|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544892|NCT03677323|Sufentanil|sufentanil|mesh-list
43544893|NCT03677323|Droperidol|droperidol|mesh-list
43544894|NCT03677323|Propofol|propofol|mesh-list
43544895|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43544896|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544897|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544898|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43544899|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
43544901|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43544902|NCT03677323|Narcotics|narcotics|mesh-ancestor
43544903|NCT03677323|Analgesics|analgesics|mesh-ancestor
43544904|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
43544905|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544906|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43544907|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
43544908|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
43544909|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544910|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43544911|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43544912|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43544913|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43544914|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43544915|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
43544916|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544917|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544918|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43544919|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43544920|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43544930|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
43544931|NCT03677258|Protective Agents|protective agents|mesh-ancestor
43544932|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43544934|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
43544935|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43544936|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
43544937|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544938|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544939|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43544940|NCT03676959|Antibodies|antibodies|mesh-list
43544941|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
43544942|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43544943|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
43544944|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544945|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544946|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43544947|NCT03676946|Antibodies|antibodies|mesh-list
43544948|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
43544949|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43544950|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
43544951|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544952|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544953|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
43544954|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
43544955|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544956|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
43544957|NCT03676621|Misoprostol|misoprostol|mesh-list
43544958|NCT03676621|Oxytocin|oxytocin|mesh-list
43544959|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
43544960|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544961|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544962|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43544963|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
43668674|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668675|NCT02236013|Cytarabine|cytarabine|mesh-list
43668676|NCT02236013|Daunorubicin|daunorubicin|mesh-list
43668677|NCT02236013|Idarubicin|idarubicin|mesh-list
43668678|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43668679|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
43544964|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43544965|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544966|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
43544967|NCT03676504|Fludarabine|fludarabine|mesh-list
43544968|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562341|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43544969|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
43544970|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544972|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43544973|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
43544974|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544975|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544976|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43544977|NCT03676413|Fluticasone|fluticasone|mesh-list
43544978|NCT03676413|Xhance|xhance|mesh-list
43544979|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43544980|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43544981|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544982|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43544983|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
43544984|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544985|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544986|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43544987|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
43544996|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
43544997|NCT03676413|Hormones|hormones|mesh-ancestor
43544998|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544999|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
43545000|NCT03676374|Prucalopride|prucalopride|mesh-list
43545001|NCT03676374|Laxatives|laxatives|mesh-ancestor
43545002|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545003|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43545004|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43562342|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43562343|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
43562344|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
43562345|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562346|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562347|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562348|NCT01483742|Ritonavir|ritonavir|mesh-list
43545005|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
43545006|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545007|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545008|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545009|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43545010|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
43545011|NCT03676361|Coagulants|coagulants|mesh-ancestor
43545012|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43545013|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
43545014|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545016|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43545017|NCT03676296|Puerarin|puerarin|mesh-list
43545018|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
43545019|NCT03676140|Azithromycin|azithromycin|mesh-list
43545020|NCT03676140|Ivermectin|ivermectin|mesh-list
43545021|NCT03676140|Albendazole|albendazole|mesh-list
43545022|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
43545023|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43545024|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545025|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43545026|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
43545027|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
43545028|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43545029|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43545030|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
43545031|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
43545032|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
43545033|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545034|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545035|NCT03676140|Filaricides|filaricides|mesh-ancestor
43545036|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
43545037|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43668680|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668681|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668682|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
43668683|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668684|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668685|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
43668686|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668687|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43668688|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43668689|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43668690|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668691|NCT02229877|Omeprazole|omeprazole|mesh-list
43668692|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43668693|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43668694|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43668695|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545038|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545039|NCT03676114|Ketamine|ketamine|mesh-list
43545040|NCT03676114|Analgesics|analgesics|mesh-ancestor
43545041|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
43562355|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545042|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545043|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545044|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43545045|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545046|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
43545048|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545068|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545069|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
43545070|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
43545071|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43545072|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545073|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
43545074|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43545075|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43545076|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43545077|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545078|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545079|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545080|NCT03675802|Misoprostol|misoprostol|mesh-list
43545081|NCT03675802|Dinoprostone|dinoprostone|mesh-list
43545082|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43545083|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
43545084|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43668696|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668698|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
43668699|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
43668700|NCT02178410|Vitamins|vitamins|mesh-list
43668701|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
43668702|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668703|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43668704|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43668705|NCT02102113|Dronabinol|dronabinol|mesh-list
43668706|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
43668707|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668708|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43668709|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43668710|NCT02102113|Analgesics|analgesics|mesh-ancestor
43668711|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
43668712|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668713|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43668714|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43668715|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668716|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668717|NCT02102113|Hormones|hormones|mesh-ancestor
43545085|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545086|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43545087|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545088|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
43545089|NCT03675646|Morphine|morphine|mesh-list
43545090|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43545091|NCT03675646|Narcotics|narcotics|mesh-ancestor
43733824|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733825|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43733826|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733827|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
43733828|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43834263|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834264|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43834270|NCT05157126|Gentamicins|gentamicins|mesh-list
43545092|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545093|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545094|NCT03675646|Analgesics|analgesics|mesh-ancestor
43545095|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
43545096|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545097|NCT03675594|Cobalt|cobalt|mesh-list
43545098|NCT03675594|Chromium|chromium|mesh-list
43545099|NCT03675594|Trace Elements|trace elements|mesh-ancestor
43545100|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
43545101|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545103|NCT03675555|Mirtazapine|mirtazapine|mesh-list
43545104|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43545105|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545106|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
43545107|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
43545108|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545109|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545110|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545111|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
43545112|NCT03675555|Hormones|hormones|mesh-ancestor
43545113|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545114|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668718|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668719|NCT01854684|Temoporfin|temoporfin|mesh-list
43668720|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668721|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43668724|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
43668725|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668726|NCT01715714|Atorvastatin|atorvastatin|mesh-list
43668727|NCT01715714|Simvastatin|simvastatin|mesh-list
43545115|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545116|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
43545117|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43545118|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43545119|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
43545120|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
43545121|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545122|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545123|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43545124|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43545125|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545126|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43545127|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43545128|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43545137|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545138|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43545139|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43545140|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43545141|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545142|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
43545143|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
43545144|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
43545145|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834274|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562356|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43562357|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43562358|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
43545146|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
43545147|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545148|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
43545149|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43545150|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545151|NCT03674866|Insulin|insulin|mesh-list
43545152|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43545153|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545154|NCT03674671|Ketamine|ketamine|mesh-list
43545155|NCT03674671|Analgesics|analgesics|mesh-ancestor
43545156|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
43545157|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545158|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545159|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43545160|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545161|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
43545162|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
43545163|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545164|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43545165|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43545166|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545167|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545168|NCT03674658|Propafenone|propafenone|mesh-list
43545169|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43545170|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43545171|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43545172|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668728|NCT01715714|Pravastatin|pravastatin|mesh-list
43668729|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43668730|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43668731|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
43668732|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668733|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43668734|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43668735|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545175|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43545176|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43545177|NCT03674606|Analgesics|analgesics|mesh-ancestor
43545178|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
43545179|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545180|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545181|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545182|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545183|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43545184|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43545185|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545186|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43545187|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43545188|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545189|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
43545190|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
43545191|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
43545192|NCT03674411|Melphalan|melphalan|mesh-list
43545193|NCT03674411|Busulfan|busulfan|mesh-list
43545194|NCT03674411|Fludarabine|fludarabine|mesh-list
43545195|NCT03674411|Tacrolimus|tacrolimus|mesh-list
43545204|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545205|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43545206|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43545207|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545208|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43545209|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43545210|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
43545211|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43545212|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545213|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43545214|NCT03674385|Vitamin E|vitamin e|mesh-list
43545215|NCT03674385|Metformin|metformin|mesh-list
43545216|NCT03674385|Clomiphene|clomiphene|mesh-list
43545217|NCT03674385|Enclomiphene|enclomiphene|mesh-list
43545218|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
43545219|NCT03674385|Vitamins|vitamins|mesh-ancestor
43545220|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
43545221|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545222|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43545223|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545224|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
43545225|NCT03674385|Protective Agents|protective agents|mesh-ancestor
43545226|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43545227|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
43545228|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545229|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43545230|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
43545231|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43545232|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43545233|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43545234|NCT03674333|Folic Acid|folic acid|mesh-list
43545235|NCT03674333|Hematinics|hematinics|mesh-ancestor
43545236|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
43545237|NCT03674333|Vitamins|vitamins|mesh-ancestor
43545238|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
43545239|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668736|NCT01656343|Abatacept|abatacept|mesh-list
43668737|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43668738|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43668739|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668740|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668741|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668742|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
43668743|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545240|NCT03674294|Dexamethasone|dexamethasone|mesh-list
43545241|NCT03674294|Aprepitant|aprepitant|mesh-list
43545242|NCT03674294|Palonosetron|palonosetron|mesh-list
43545243|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545244|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
43545245|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
43545246|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545247|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545248|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43562382|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43562383|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43562385|NCT01480583|Trastuzumab|trastuzumab|mesh-list
43562386|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43545249|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
43562388|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
43545250|NCT03674294|Hormones|hormones|mesh-ancestor
43545251|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545252|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43545253|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545254|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43545255|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545256|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545257|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43545258|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43545262|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
43545263|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
43545264|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43545265|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43545267|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
43545268|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
43545269|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43545270|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
43545271|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545272|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
43545273|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
43545274|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545275|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545276|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545277|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
43545278|NCT03674099|Hormones|hormones|mesh-ancestor
43545279|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545280|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43545281|NCT03674099|Protective Agents|protective agents|mesh-ancestor
43545282|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43545283|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545284|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43545285|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545286|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545287|NCT03674073|Vaccines|vaccines|mesh-list
43545288|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
43562392|NCT01480479|Rindopepimut|rindopepimut|mesh-list
43545289|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545290|NCT03674060|Sorafenib|sorafenib|mesh-list
43545291|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545292|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43545293|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545294|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545296|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43545297|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545298|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545299|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545300|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
43545301|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
43545302|NCT03673995|Inositol|inositol|mesh-list
43668744|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668745|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668746|NCT01540253|Docetaxel|docetaxel|mesh-list
43668747|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562393|NCT01480479|Sargramostim|sargramostim|mesh-list
43562394|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43562395|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
43668748|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
43668749|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
43668750|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
43668751|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668752|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43668753|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43668754|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668755|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
43545303|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
43545304|NCT03673995|Vitamins|vitamins|mesh-ancestor
43545305|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
43545306|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545309|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545310|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43545311|NCT03673605|Warfarin|warfarin|mesh-list
43545312|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
43545313|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
43545314|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43545315|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
43545316|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43545317|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
43545318|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849905|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545321|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545322|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43545323|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43545324|NCT03673501|Growth Substances|growth substances|mesh-ancestor
43545325|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545326|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
43545327|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43545328|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545329|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545330|NCT03673384|Fluticasone|fluticasone|mesh-list
43545331|NCT03673384|Xhance|xhance|mesh-list
43545332|NCT03673384|Histamine|histamine|mesh-list
43545333|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545334|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43545336|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545337|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545339|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
43545340|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
43545341|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43545342|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
43733832|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733833|NCT03912298|Analgesics|analgesics|mesh-ancestor
43733834|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
43733835|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545343|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
43545344|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545345|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545346|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43545347|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545348|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545350|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43545351|NCT03673280|Narcotics|narcotics|mesh-ancestor
43545352|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545353|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545354|NCT03673280|Analgesics|analgesics|mesh-ancestor
43545355|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
43545356|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545357|NCT03673163|Lidocaine|lidocaine|mesh-list
43545358|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
43545359|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
43668757|NCT01497392|Capecitabine|capecitabine|mesh-list
43668758|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43668759|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
43668760|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668761|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668762|NCT01497392|Antiviral Agents|antiviral agents|mesh-ancestor
43668763|NCT01497392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545360|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545361|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545362|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
43545363|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545364|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43545365|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43545366|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43545367|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43545368|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545369|NCT03673137|Gemcitabine|gemcitabine|mesh-list
43545370|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43545371|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
43545374|NCT03673137|Antiviral Agents|antiviral agents|mesh-ancestor
43545375|NCT03673137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545376|NCT03673137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545377|NCT03673137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43545378|NCT03673137|Immunologic Factors|immunologic factors|mesh-ancestor
43545379|NCT03673137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545380|NCT03672812|Liraglutide|liraglutide|mesh-list
43545381|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43545382|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545383|NCT03672812|Incretins|incretins|mesh-ancestor
43545384|NCT03672812|Hormones|hormones|mesh-ancestor
43545385|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545387|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
43545388|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
43545389|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545390|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545391|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
43545392|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545393|NCT03672357|Liver Extracts|liver extracts|mesh-list
43545394|NCT03672357|Hematinics|hematinics|mesh-ancestor
43545395|NCT03672149|Cefazolin|cefazolin|mesh-list
43545396|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43545397|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545398|NCT03672071|Ephedrine|ephedrine|mesh-list
43545399|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
43545400|NCT03672071|Norepinephrine|norepinephrine|mesh-list
43545401|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43545402|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545403|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
43545404|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
43545405|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545406|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43545407|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
43545408|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545413|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
43545414|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43545415|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43545416|NCT03672045|Carbetocin|carbetocin|mesh-list
43545417|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
43545418|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43545419|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545421|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43545422|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43545423|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43545424|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43545425|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
43545426|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545427|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545431|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545432|NCT03671733|Liraglutide|liraglutide|mesh-list
43545433|NCT03671733|Exenatide|exenatide|mesh-list
43545434|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43545435|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545436|NCT03671733|Incretins|incretins|mesh-ancestor
43545437|NCT03671733|Hormones|hormones|mesh-ancestor
43545438|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545439|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43545440|NCT03671707|Nicotine|nicotine|mesh-list
43545441|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43545442|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
43545443|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545444|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545445|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43545446|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43545447|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
43545448|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545449|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545450|NCT03671655|Paclitaxel|paclitaxel|mesh-list
43545451|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43545452|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545453|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
43545454|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
43545456|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545457|NCT03671538|Cisplatin|cisplatin|mesh-list
43545458|NCT03671538|Pemetrexed|pemetrexed|mesh-list
43545459|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545460|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545461|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545462|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43545463|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43545464|NCT03671265|Apatinib|apatinib|mesh-list
43545465|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545466|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43545467|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545468|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545469|NCT03671174|Aspirin|aspirin|mesh-list
43545470|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
43545471|NCT03671174|Prednisone|prednisone|mesh-list
43545472|NCT03671174|Heparin|heparin|mesh-list
43545473|NCT03671174|Enoxaparin|enoxaparin|mesh-list
43545474|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43545475|NCT03671174|Tinzaparin|tinzaparin|mesh-list
43545476|NCT03671174|Dalteparin|dalteparin|mesh-list
43545477|NCT03671174|Nadroparin|nadroparin|mesh-list
43545478|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545479|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
43545480|NCT03671174|Hormones|hormones|mesh-ancestor
43545487|NCT03671174|Analgesics|analgesics|mesh-ancestor
43545488|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
43545489|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545490|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545491|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43545492|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43733868|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733869|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733870|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
43545493|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545494|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43545495|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43545523|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43545524|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
43545525|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
43545526|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
43545527|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43545528|NCT03671057|Midazolam|midazolam|mesh-list
43545529|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43545530|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43545531|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545532|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545533|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43545534|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43545535|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43545536|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545537|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
43545538|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
43545539|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
43545540|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
43545541|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545542|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545544|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545545|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
43545546|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
43545547|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
43545548|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545557|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545558|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545559|NCT03670901|Rituximab|rituximab|mesh-list
43545560|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43545561|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545562|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
43545563|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545564|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545565|NCT03670888|Rituximab|rituximab|mesh-list
43545566|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43545567|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545568|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
43545569|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545570|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545571|NCT03670875|Curcumin|curcumin|mesh-list
43545572|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43545573|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43545574|NCT03670875|Analgesics|analgesics|mesh-ancestor
43545575|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
43545576|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545577|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545578|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545579|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545580|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545581|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545596|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43545597|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43545598|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43562410|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43562411|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
43545599|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
43545600|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545601|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562412|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562413|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562414|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562415|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43545602|NCT03670212|Urological Agents|urological agents|mesh-ancestor
43545604|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43545605|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43545606|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
43545607|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545608|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545609|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545610|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43545611|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43545612|NCT03670043|Metformin|metformin|mesh-list
43545613|NCT03670043|Psyllium|psyllium|mesh-list
43545614|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43545615|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545622|NCT03669783|Vincristine|vincristine|mesh-list
43545623|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545624|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43545625|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43545626|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43545627|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545628|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545629|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43545630|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43545631|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545632|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43545633|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43545634|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
43545635|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
43545636|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
43545637|NCT03669757|Betamethasone|betamethasone|mesh-list
43545638|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
43545639|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43545640|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
43545641|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43545642|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545643|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
43545644|NCT03669757|Hormones|hormones|mesh-ancestor
43545645|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545646|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545647|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43545648|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
43545649|NCT03669601|Gemcitabine|gemcitabine|mesh-list
43545650|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43545651|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
43545652|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545653|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545654|NCT03669601|Antiviral Agents|antiviral agents|mesh-ancestor
43545655|NCT03669601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545656|NCT03669601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562418|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562419|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562420|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
43562421|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
43562422|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
43562423|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43562424|NCT01474135|Travoprost|travoprost|mesh-list
43562425|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43562426|NCT01472198|Gemcitabine|gemcitabine|mesh-list
43545657|NCT03669601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43545658|NCT03669601|Immunologic Factors|immunologic factors|mesh-ancestor
43545659|NCT03669601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545660|NCT03669562|Alprostadil|alprostadil|mesh-list
43668770|NCT01367002|Trastuzumab|trastuzumab|mesh-list
43668771|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43668773|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
43545662|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
43545663|NCT03669562|Urological Agents|urological agents|mesh-ancestor
43545664|NCT03669484|Fentanyl|fentanyl|mesh-list
43545665|NCT03669484|Bromides|bromides|mesh-list
43545666|NCT03669484|Propofol|propofol|mesh-list
43545667|NCT03669484|Rocuronium|rocuronium|mesh-list
43545668|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43545669|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545670|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545671|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545672|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
43545673|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
43545674|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43545675|NCT03669484|Narcotics|narcotics|mesh-ancestor
43545676|NCT03669484|Analgesics|analgesics|mesh-ancestor
43545677|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
43545678|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545679|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43545680|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
43545681|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43545682|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43545683|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43545684|NCT03669445|Dexamethasone|dexamethasone|mesh-list
43545685|NCT03669445|Lenalidomide|lenalidomide|mesh-list
43545686|NCT03669445|Daratumumab|daratumumab|mesh-list
43545687|NCT03669445|Ixazomib|ixazomib|mesh-list
43545688|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545693|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545694|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
43545695|NCT03669445|Hormones|hormones|mesh-ancestor
43545696|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545697|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43545698|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545699|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
43545700|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43545701|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43545702|NCT03669445|Growth Substances|growth substances|mesh-ancestor
43545703|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
43545704|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
43545705|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545706|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545707|NCT03669328|Anesthetics|anesthetics|mesh-list
43545708|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545709|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545710|NCT03669263|Fentanyl|fentanyl|mesh-list
43545711|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43545712|NCT03669263|Narcotics|narcotics|mesh-ancestor
43545713|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545714|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545715|NCT03669263|Analgesics|analgesics|mesh-ancestor
43545716|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
43545717|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562436|NCT01472198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562437|NCT01470131|Dexamethasone|dexamethasone|mesh-list
43562438|NCT01470131|Bortezomib|bortezomib|mesh-list
43562439|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562440|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
43562441|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
43545718|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43545719|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545720|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
43545721|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
43545722|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
43545723|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43668774|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
43668775|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
43668776|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668777|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668778|NCT01310192|Choline|choline|mesh-list
43545724|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43545725|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545726|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
43545727|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
43545728|NCT03669029|Golimumab|golimumab|mesh-list
43545729|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43545730|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43545731|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545732|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43545733|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
43545734|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545735|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43545736|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
43545737|NCT03669003|Coagulants|coagulants|mesh-ancestor
43545738|NCT03668964|Vitamin D|vitamin d|mesh-list
43545739|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
43545741|NCT03668964|Vitamin E|vitamin e|mesh-list
43545742|NCT03668964|Tocopherols|tocopherols|mesh-list
43545743|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
43545744|NCT03668964|Vitamin A|vitamin a|mesh-list
43545745|NCT03668964|Riboflavin|riboflavin|mesh-list
43545746|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
43545747|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
43545748|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545749|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43545750|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43545751|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
43545752|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545753|NCT03668964|Protective Agents|protective agents|mesh-ancestor
43545754|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43545755|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
43545756|NCT03668860|Dexamethasone|dexamethasone|mesh-list
43545757|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
43545758|NCT03668860|Betamethasone|betamethasone|mesh-list
43545759|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
43545760|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43545761|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
43545762|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
43545763|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43545768|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545769|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545770|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545771|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
43545772|NCT03668860|Hormones|hormones|mesh-ancestor
43545773|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545774|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43545775|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545776|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
43545777|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545778|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545779|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43545780|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
43545781|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43545782|NCT03668730|Paclitaxel|paclitaxel|mesh-list
43545783|NCT03668730|Cisplatin|cisplatin|mesh-list
43545784|NCT03668730|Fluorouracil|fluorouracil|mesh-list
43545785|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43545786|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545787|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
43545789|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
43545790|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545791|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
43545792|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43545793|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43545794|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
43668779|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
43668780|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43668781|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
43668782|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668783|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545795|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545796|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
43545797|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43545798|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
43545799|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545800|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
43545801|NCT03668665|Protective Agents|protective agents|mesh-ancestor
43545802|NCT03668470|Dulaglutide|dulaglutide|mesh-list
43545803|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43545804|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545805|NCT03668418|Gemcitabine|gemcitabine|mesh-list
43545806|NCT03668418|Camptothecin|camptothecin|mesh-list
43545808|NCT03668418|Fluorouracil|fluorouracil|mesh-list
43545809|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
43545810|NCT03668418|Irinotecan|irinotecan|mesh-list
43545811|NCT03668418|Epirubicin|epirubicin|mesh-list
43545813|NCT03668418|Antimetabolites|antimetabolites|mesh-list
43545814|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43545815|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545817|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
43545818|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
43545819|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545820|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43545821|NCT03668418|Antiviral Agents|antiviral agents|mesh-ancestor
43545822|NCT03668418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545823|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545824|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43545825|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
43545826|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545827|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43545828|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43545829|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43545830|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43545831|NCT03668262|Atracurium|atracurium|mesh-list
43562456|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562457|NCT01460511|Epinephrine|epinephrine|mesh-list
43545832|NCT03668262|Cisatracurium|cisatracurium|mesh-list
43562458|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43545833|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43545845|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545846|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43545847|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43545848|NCT03668054|Growth Substances|growth substances|mesh-ancestor
43545849|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545850|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
43545851|NCT03668015|Sorbitol|sorbitol|mesh-list
43545852|NCT03668015|Cathartics|cathartics|mesh-ancestor
43545853|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545854|NCT03667963|Lactulose|lactulose|mesh-list
43545855|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545856|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43545857|NCT03667937|Laxatives|laxatives|mesh-ancestor
43545858|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545859|NCT03667677|Amlodipine|amlodipine|mesh-list
43545860|NCT03667677|Tandospirone|tandospirone|mesh-list
43545861|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43545877|NCT03667352|Narcotics|narcotics|mesh-ancestor
43545878|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545879|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545880|NCT03667352|Analgesics|analgesics|mesh-ancestor
43545881|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
43545882|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545883|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43545884|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545885|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
43545886|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
43545887|NCT03667300|Linagliptin|linagliptin|mesh-list
43545888|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43545889|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545890|NCT03667300|Incretins|incretins|mesh-ancestor
43545891|NCT03667300|Hormones|hormones|mesh-ancestor
43545892|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545893|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43545894|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
43545895|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545896|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545897|NCT03667235|Glutaral|glutaral|mesh-list
43545898|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
43545899|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545900|NCT03667222|Minocycline|minocycline|mesh-list
43545901|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43545902|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545903|NCT03667131|Enalapril|enalapril|mesh-list
43545904|NCT03667131|Enalaprilat|enalaprilat|mesh-list
43545905|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43545906|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43545907|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545908|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
43545913|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43545915|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
43545916|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545917|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545918|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545919|NCT03667001|Lidocaine|lidocaine|mesh-list
43545920|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
43545921|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
43562469|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
43545922|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545923|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668795|NCT00945152|Vancomycin|vancomycin|mesh-list
43668796|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43668797|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668798|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43545924|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
43545925|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545927|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43545928|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43545929|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43545932|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545933|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545934|NCT03666884|Cyclosporine|cyclosporine|mesh-list
43545935|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43545936|NCT03666884|Cyclosporins|cyclosporins|mesh-list
43545937|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43545938|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545939|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545940|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43545941|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
43545942|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545943|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
43545944|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545945|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
43545946|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545947|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43545948|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43545949|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
43545950|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43545951|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545952|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545953|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43545954|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43545955|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43545956|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
43545957|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545958|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545959|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43545960|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43545961|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
43545962|NCT03666650|Edoxaban|edoxaban|mesh-list
43545963|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43545964|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
43545965|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43545966|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
43545967|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545968|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545969|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
43545970|NCT03666546|Methamphetamine|methamphetamine|mesh-list
43545971|NCT03666546|Lactulose|lactulose|mesh-list
43545972|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545973|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43545974|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545975|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
43545977|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545979|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545980|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545981|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
43545982|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43545983|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43545984|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43545985|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43545986|NCT03666494|Fentanyl|fentanyl|mesh-list
43545987|NCT03666494|Ketamine|ketamine|mesh-list
43545988|NCT03666494|Propofol|propofol|mesh-list
43545989|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43668800|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668801|NCT00659711|Incretins|incretins|mesh-ancestor
43668802|NCT00659711|Hormones|hormones|mesh-ancestor
43668803|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668804|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43668805|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
43668806|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668807|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668808|NCT00611572|Flumazenil|flumazenil|mesh-list
43668809|NCT00611572|Antidotes|antidotes|mesh-ancestor
43668810|NCT00611572|Protective Agents|protective agents|mesh-ancestor
43668811|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668812|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
43668813|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
43668814|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668815|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668816|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
43668817|NCT02581007|Melphalan|melphalan|mesh-list
43668818|NCT02581007|Fludarabine|fludarabine|mesh-list
43668819|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668820|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
43545990|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545991|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545992|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545993|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
43545994|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
43545995|NCT03666494|Analgesics|analgesics|mesh-ancestor
43545996|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
43545997|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545998|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43545999|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43546000|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43546001|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546002|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546003|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43546004|NCT03666494|Narcotics|narcotics|mesh-ancestor
43733902|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
43733903|NCT02543099|Policosanol|policosanol|mesh-list
43546005|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43546006|NCT03666390|Midazolam|midazolam|mesh-list
43546007|NCT03666390|Ketamine|ketamine|mesh-list
43546008|NCT03666390|Analgesics|analgesics|mesh-ancestor
43546009|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
43546010|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546011|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546012|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43546013|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43546014|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
43546015|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
43546016|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546017|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43546019|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546020|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668821|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668822|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668823|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43668824|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
43668825|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668826|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668827|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43668828|NCT02540330|Fulvestrant|fulvestrant|mesh-list
43668829|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668830|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668831|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43668832|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43668833|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
43668834|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546021|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43546022|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43546023|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43546024|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43546025|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43546026|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
43546027|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
43546028|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
43546029|NCT03666325|Cetuximab|cetuximab|mesh-list
43546030|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43546031|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546032|NCT03666299|Lidocaine|lidocaine|mesh-list
43546033|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
43546034|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
43546035|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546036|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546037|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
43546038|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546039|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43546040|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43546041|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43546042|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546043|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562509|NCT01443728|Vitamin D|vitamin d|mesh-list
43562510|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
43562511|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
43562513|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
43562514|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562515|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43562516|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43562517|NCT01442090|Everolimus|everolimus|mesh-list
43733910|NCT02543086|Piperaquine|piperaquine|mesh-list
43733911|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
43546044|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
43849907|NCT05702970|Vitamins|vitamins|mesh-ancestor
43546058|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43546059|NCT03666195|Protective Agents|protective agents|mesh-ancestor
43546060|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546061|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
43546062|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43546063|NCT03665779|Pyridoxine|pyridoxine|mesh-list
43546064|NCT03665779|Isosorbide|isosorbide|mesh-list
43546065|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43546066|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43546067|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43546068|NCT03665779|Diuretics|diuretics|mesh-ancestor
43668835|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668836|NCT02474368|Cisplatin|cisplatin|mesh-list
43668837|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668838|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
43668839|NCT02467361|Nivolumab|nivolumab|mesh-list
43546069|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
43546070|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546071|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
43546072|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43546073|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546074|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
43546075|NCT03665779|Vitamins|vitamins|mesh-ancestor
43546076|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
43546077|NCT03665766|Cycloserine|cycloserine|mesh-list
43546078|NCT03665766|Tacrolimus|tacrolimus|mesh-list
43546079|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43546080|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
43546081|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546082|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43546083|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546084|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546085|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43546086|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546087|NCT03665766|Renal Agents|renal agents|mesh-ancestor
43546088|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43546089|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
43546090|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546091|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
43546092|NCT03665753|Ketorolac|ketorolac|mesh-list
43546093|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43546094|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43546095|NCT03665753|Analgesics|analgesics|mesh-ancestor
43546099|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546100|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546101|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43546102|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546103|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546104|NCT03665740|Resveratrol|resveratrol|mesh-list
43546105|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
43546106|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546107|NCT03665740|Protective Agents|protective agents|mesh-ancestor
43546108|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546109|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546110|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43546112|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43546113|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546114|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43546115|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
43546116|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546117|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43546118|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43546124|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43546125|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43546126|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
43546127|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
43546128|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546129|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546131|NCT03665428|Antacids|antacids|mesh-ancestor
43546132|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546133|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546134|NCT03665402|Isoniazid|isoniazid|mesh-list
43546135|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
43546136|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546137|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546138|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43546139|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43546140|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
43668841|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668842|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668843|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43546141|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546142|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43546143|NCT03665350|Insulin|insulin|mesh-list
43546144|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43546145|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546146|NCT03665181|Bismuth|bismuth|mesh-list
43546147|NCT03665181|Antacids|antacids|mesh-ancestor
43546148|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546149|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546152|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
43546153|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546154|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546155|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
43546156|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546157|NCT03664908|Antibodies|antibodies|mesh-list
43546158|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
43546159|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546160|NCT03664869|Mitomycins|mitomycins|mesh-list
43546161|NCT03664869|Mitomycin|mitomycin|mesh-list
43546162|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43546163|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546164|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
43546165|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546166|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43562525|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43546167|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546168|NCT03664622|Ketamine|ketamine|mesh-list
43546169|NCT03664622|Morphine|morphine|mesh-list
43562527|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546170|NCT03664622|Analgesics|analgesics|mesh-ancestor
43546171|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
43546172|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546173|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546174|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43546176|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
43546177|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
43546178|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546179|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43546180|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43546181|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546182|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546183|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43546184|NCT03664622|Narcotics|narcotics|mesh-ancestor
43546185|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43546186|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43546193|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546194|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
43546195|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546196|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43546197|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43546198|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43546199|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43546200|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
43546201|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43546202|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546203|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546204|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43546205|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43546206|NCT03664414|Protective Agents|protective agents|mesh-ancestor
43546207|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546208|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
43546209|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43668844|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668845|NCT02352558|Dexamethasone|dexamethasone|mesh-list
43668846|NCT02352558|Bortezomib|bortezomib|mesh-list
43668847|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
43546210|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
43546211|NCT03664388|Clopidogrel|clopidogrel|mesh-list
43546212|NCT03664388|Ticagrelor|ticagrelor|mesh-list
43546213|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43546214|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43546215|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43546216|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43546217|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
43546218|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546219|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546220|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733932|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43733933|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
43733934|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733935|NCT02542852|Ritonavir|ritonavir|mesh-list
43546221|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
43546222|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43546223|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43546224|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43546225|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546226|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546227|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
43546228|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546229|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546230|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43546231|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546232|NCT03664115|Itraconazole|itraconazole|mesh-list
43546233|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
43546234|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546235|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43546236|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43546238|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546239|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43546240|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
43546241|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546242|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546243|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43546244|NCT03664063|Azithromycin|azithromycin|mesh-list
43546247|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
43546248|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546249|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546250|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43546251|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
43546252|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
43546255|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
43546256|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
43546257|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
43546258|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546259|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546260|NCT03664063|Filaricides|filaricides|mesh-ancestor
43546261|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
43546262|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43546263|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546264|NCT03664050|Letrozole|letrozole|mesh-list
43546265|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546266|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43546267|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43546268|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546269|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546270|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43546271|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
43546272|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546273|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546274|NCT03664037|Dexamethasone|dexamethasone|mesh-list
43546275|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43668848|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43668849|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
43668850|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
43668851|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668852|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668853|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546276|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546277|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
43546278|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
43546279|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733955|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
43546280|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546281|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546282|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
43546284|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546285|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43546286|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546287|NCT03663751|Decitabine|decitabine|mesh-list
43546288|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43546289|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
43546290|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546291|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546292|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546293|NCT03663673|Decanoic acid|decanoic acid|mesh-list
43546294|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
43546295|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546296|NCT03663478|Ropivacaine|ropivacaine|mesh-list
43546297|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
43546298|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
43546299|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546300|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546301|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
43546302|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546303|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
43546304|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43546305|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546306|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546307|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43546308|NCT03663114|Lenvatinib|lenvatinib|mesh-list
43546309|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546310|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43546311|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546312|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546313|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
43546314|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43546315|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
43546316|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546317|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43546318|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43546319|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43546320|NCT03662958|Leuprolide|leuprolide|mesh-list
43546321|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43546322|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
43546323|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43546328|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43546329|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
43546330|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546331|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546332|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546334|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43546335|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43546336|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43733965|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43546337|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43546338|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
43546339|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546340|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733966|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733967|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733968|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
43733969|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668854|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
43668855|NCT02352558|Hormones|hormones|mesh-ancestor
43849908|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
43668856|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668857|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668858|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546341|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546343|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546344|NCT03662620|Amlodipine|amlodipine|mesh-list
43546345|NCT03662620|Telmisartan|telmisartan|mesh-list
43546346|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
43546347|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43546348|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43546349|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546350|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546351|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43546352|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546353|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
43546354|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43546355|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43546356|NCT03662620|Diuretics|diuretics|mesh-ancestor
43546357|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
43546358|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43546359|NCT03662568|Ritonavir|ritonavir|mesh-list
43546360|NCT03662568|Tenofovir|tenofovir|mesh-list
43546361|NCT03662568|Entecavir|entecavir|mesh-list
43546362|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43546363|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43546364|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
43546365|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733970|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733971|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
43733972|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43562542|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43562544|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562545|NCT01435369|Pidilizumab|pidilizumab|mesh-list
43562546|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562547|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562548|NCT01435226|Ribavirin|ribavirin|mesh-list
43562549|NCT01435226|Ledipasvir|ledipasvir|mesh-list
43562550|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
43546366|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546367|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43546368|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43546369|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
43546370|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546371|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43546372|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43546373|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43546374|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43546375|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
43546376|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43546377|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
43546378|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
43546379|NCT03662516|Estradiol|estradiol|mesh-list
43546380|NCT03662516|Abrocitinib|abrocitinib|mesh-list
43546382|NCT03662516|Hormones|hormones|mesh-ancestor
43546383|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546384|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546385|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43546386|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43546387|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43546388|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43546389|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43546390|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43546391|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546392|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546393|NCT03662425|Oxytocin|oxytocin|mesh-list
43546396|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546397|NCT03662412|Sirolimus|sirolimus|mesh-list
43546398|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546399|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546400|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43546402|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
43546403|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43546405|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668859|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43668860|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668861|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826760|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
43826761|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546407|NCT03662269|Omeprazole|omeprazole|mesh-list
43546408|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43546409|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546410|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43546411|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546412|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733993|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43834321|NCT05150496|Vaccines|vaccines|mesh-list
43546413|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43546414|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43546415|NCT03662269|Analgesics|analgesics|mesh-ancestor
43546416|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
43546417|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546418|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546419|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546420|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546421|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
43546422|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
43546423|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43546424|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43546425|NCT03662113|Domperidone|domperidone|mesh-list
43546426|NCT03662113|Simethicone|simethicone|mesh-list
43546427|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
43546428|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
43546429|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546430|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546431|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546432|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43546433|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
43546434|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546435|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546436|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
43546437|NCT03662113|Emollients|emollients|mesh-ancestor
43546438|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
43546439|NCT03662100|Mirikizumab|mirikizumab|mesh-list
43546440|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43546441|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43546442|NCT03662100|Analgesics|analgesics|mesh-ancestor
43546443|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
43546444|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546445|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546446|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546447|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546448|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43546449|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546450|NCT03662035|Apatinib|apatinib|mesh-list
43546451|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546452|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43546453|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546454|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546455|NCT03661892|Dronabinol|dronabinol|mesh-list
43546456|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
43546457|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546458|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43546459|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43546460|NCT03661892|Analgesics|analgesics|mesh-ancestor
43546461|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
43546462|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546463|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43546465|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546466|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546489|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43546490|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
43826762|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43826763|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826764|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43826765|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43826766|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826767|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826768|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826769|NCT05494567|Tadalafil|tadalafil|mesh-list
43826770|NCT05494567|Tamsulosin|tamsulosin|mesh-list
43826771|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
43826772|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
43668863|NCT02324283|Desflurane|desflurane|mesh-list
43546491|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43546492|NCT03661684|Prednisone|prednisone|mesh-list
43546493|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546494|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
43546495|NCT03661684|Hormones|hormones|mesh-ancestor
43546496|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546497|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546498|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43546499|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546500|NCT03661515|Cytarabine|cytarabine|mesh-list
43546501|NCT03661515|Fludarabine|fludarabine|mesh-list
43546502|NCT03661515|Idarubicin|idarubicin|mesh-list
43546503|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546504|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43546505|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
43546506|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546507|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43546508|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
43546509|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546510|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
43546511|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546512|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43546513|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43546514|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43546515|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546516|NCT03661489|Propofol|propofol|mesh-list
43546517|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43546524|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43546525|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43546526|NCT03661463|Analgesics|analgesics|mesh-ancestor
43546527|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
43546528|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546529|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546530|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546531|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546532|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43546533|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43546534|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546535|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43546536|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43546539|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
43562591|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43546540|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43546541|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
43562592|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734029|NCT02542111|Cisplatin|cisplatin|mesh-list
43546542|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546543|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546544|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43668864|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43668865|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668866|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668867|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43668868|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
43668869|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
43668870|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43668871|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43668872|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668873|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668874|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43668875|NCT02240407|Acetaminophen|acetaminophen|mesh-list
43668876|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
43668877|NCT02240407|Promethazine|promethazine|mesh-list
43668879|NCT02240407|Rituximab|rituximab|mesh-list
43668880|NCT02240407|Lidocaine|lidocaine|mesh-list
43668881|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668882|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668883|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
43668884|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668885|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546545|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
43546546|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43546547|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
43546548|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546549|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546550|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43546551|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
43546552|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
43546553|NCT03661385|Protective Agents|protective agents|mesh-ancestor
43546554|NCT03661125|Saracatinib|saracatinib|mesh-list
43546555|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546556|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546557|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546559|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
43546560|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43546561|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43546562|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546563|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546564|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546565|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43546566|NCT03660917|Protective Agents|protective agents|mesh-ancestor
43546567|NCT03660761|Apatinib|apatinib|mesh-list
43546568|NCT03660761|Temozolomide|temozolomide|mesh-list
43546569|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668887|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
43668888|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668889|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
43546575|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
43546576|NCT03660436|BMS-986165|bms-986165|mesh-list
43546577|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43546578|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546579|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43546580|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
43546581|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546582|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546583|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546584|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546585|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
43546595|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546596|NCT03660293|Captopril|captopril|mesh-list
43546597|NCT03660293|Atorvastatin|atorvastatin|mesh-list
43546614|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43546615|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43546616|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
43546617|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546618|NCT03660020|Anesthetics|anesthetics|mesh-list
43734036|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546620|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546621|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546622|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
43546623|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546624|NCT03659851|Simendan|simendan|mesh-list
43546625|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43546626|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
43546627|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43546628|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43546629|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546630|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546631|NCT03659851|Protective Agents|protective agents|mesh-ancestor
43546632|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546633|NCT03659435|Rivastigmine|rivastigmine|mesh-list
43546635|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546636|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546637|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
43546638|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546639|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546640|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43546641|NCT03659435|Protective Agents|protective agents|mesh-ancestor
43546642|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43546643|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546644|NCT03659305|Bevacizumab|bevacizumab|mesh-list
43546645|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43546646|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668890|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668892|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43668893|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43668894|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668895|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668896|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43668897|NCT02240407|Analgesics|analgesics|mesh-ancestor
43668898|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
43668899|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43668900|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668901|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43668902|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
43668903|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668904|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43668905|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43668906|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
43668907|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
43546647|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43546648|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43546649|NCT03659305|Growth Substances|growth substances|mesh-ancestor
43546650|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546660|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43546661|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43546662|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546663|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546664|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43546665|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
43546666|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546667|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546668|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43546669|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43546670|NCT03659084|Deferasirox|deferasirox|mesh-list
43546671|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43546672|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
43546673|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
43546674|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546676|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43546677|NCT03659058|Antioxidants|antioxidants|mesh-list
43546678|NCT03659058|Silymarin|silymarin|mesh-list
43546679|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
43546680|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546681|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
43546682|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
43546683|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
43546684|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546685|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546686|NCT03659058|Protective Agents|protective agents|mesh-ancestor
43546687|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546688|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43546689|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546690|NCT03658993|Rifaximin|rifaximin|mesh-list
43546691|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43668908|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43668909|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43546693|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546694|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43546695|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43546697|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
43546698|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546699|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43546700|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546701|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734040|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43546702|NCT03658785|Aldesleukin|aldesleukin|mesh-list
43546703|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
43546704|NCT03658785|Fludarabine|fludarabine|mesh-list
43546705|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43546706|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
43546707|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546709|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43546710|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
43546711|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546712|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546713|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43546714|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43546715|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43546716|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
43546717|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546720|NCT03658746|Metronidazole|metronidazole|mesh-list
43546721|NCT03658746|Clarithromycin|clarithromycin|mesh-list
43546722|NCT03658746|Levofloxacin|levofloxacin|mesh-list
43546723|NCT03658746|Ofloxacin|ofloxacin|mesh-list
43546724|NCT03658746|Tetracycline|tetracycline|mesh-list
43546725|NCT03658746|Tinidazole|tinidazole|mesh-list
43546727|NCT03658746|Furazolidone|furazolidone|mesh-list
43546728|NCT03658746|Bismuth|bismuth|mesh-list
43546729|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43546730|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546731|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
43546732|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43546733|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43546734|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43546735|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546736|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546737|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43546738|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43546739|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43546740|NCT03658746|Renal Agents|renal agents|mesh-ancestor
43546741|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43546742|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43546743|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546744|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43546745|NCT03658746|Antacids|antacids|mesh-ancestor
43734041|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734042|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43734043|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
43734044|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734045|NCT02542111|Antiviral Agents|antiviral agents|mesh-ancestor
43546746|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734046|NCT02542111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546747|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43546748|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43546749|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43546750|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
43546751|NCT03658733|Amoxicillin|amoxicillin|mesh-list
43546752|NCT03658733|Tetracycline|tetracycline|mesh-list
43546753|NCT03658733|Furazolidone|furazolidone|mesh-list
43546754|NCT03658733|Esomeprazole|esomeprazole|mesh-list
43546755|NCT03658733|Rabeprazole|rabeprazole|mesh-list
43546756|NCT03658733|Bismuth|bismuth|mesh-list
43546757|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546758|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546759|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43546760|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546761|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43546762|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546763|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546764|NCT03658733|Antacids|antacids|mesh-ancestor
43546765|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43546766|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43668910|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
43668911|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
43668912|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668913|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43668914|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
43668915|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
43546767|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43546769|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43546770|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43546771|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43546772|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43546774|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43546775|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43546776|NCT03658720|Analgesics|analgesics|mesh-ancestor
43546778|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546779|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546780|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546781|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546782|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43546783|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546784|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546785|NCT03658590|Dexamethasone|dexamethasone|mesh-list
43546786|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546787|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
43546788|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
43546789|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546790|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546791|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546792|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
43546793|NCT03658590|Hormones|hormones|mesh-ancestor
43546794|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546808|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
43546809|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43546810|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734048|NCT02542111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734049|NCT02542111|Immunologic Factors|immunologic factors|mesh-ancestor
43734050|NCT02542007|Sirolimus|sirolimus|mesh-list
43734051|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546811|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546812|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43546813|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734052|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546814|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43546815|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
43546816|NCT03658473|Protective Agents|protective agents|mesh-ancestor
43546817|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
43546818|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43546819|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546820|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
43546821|NCT03658421|Morphine|morphine|mesh-list
43546822|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43546823|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546824|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546825|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43546826|NCT03658421|Analgesics|analgesics|mesh-ancestor
43546827|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
43546828|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546829|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43546830|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43546831|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43546832|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
43546833|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546834|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546835|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43546836|NCT03658421|Narcotics|narcotics|mesh-ancestor
43546837|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
43849909|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849910|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43849911|NCT05702957|Letrozole|letrozole|mesh-list
43849912|NCT05702957|Clomiphene|clomiphene|mesh-list
43849913|NCT05702957|Enclomiphene|enclomiphene|mesh-list
43546838|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43546839|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546840|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546841|NCT03658330|Naltrexone|naltrexone|mesh-list
43546842|NCT03658330|Ketamine|ketamine|mesh-list
43546843|NCT03658330|Analgesics|analgesics|mesh-ancestor
43546844|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
43668916|NCT02231723|Leucovorin|leucovorin|mesh-list
43668917|NCT02231723|Gemcitabine|gemcitabine|mesh-list
43668918|NCT02231723|Paclitaxel|paclitaxel|mesh-list
43668919|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43546845|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546846|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546847|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43546848|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43546849|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
43546850|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
43546851|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546852|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43546853|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43546854|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546855|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546856|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43546860|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546862|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546863|NCT03658291|Levofloxacin|levofloxacin|mesh-list
43546864|NCT03658291|Ofloxacin|ofloxacin|mesh-list
43546865|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43546866|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546867|NCT03658291|Renal Agents|renal agents|mesh-ancestor
43546868|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546869|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43849914|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
43849915|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849916|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734063|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734064|NCT02542098|Analgesics|analgesics|mesh-ancestor
43734065|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
43734069|NCT02541734|Exenatide|exenatide|mesh-list
43849917|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43546870|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43546871|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546872|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546873|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546874|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43546875|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43546876|NCT03658213|Goserelin|goserelin|mesh-list
43546877|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43546878|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546879|NCT03658109|Lidocaine|lidocaine|mesh-list
43546880|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
43546881|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
43546882|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546883|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546884|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
43546885|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546886|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43546887|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43546888|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43546889|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546890|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546891|NCT03658057|Rocuronium|rocuronium|mesh-list
43546892|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43546893|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43546894|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43546895|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546896|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546897|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
43546898|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43546899|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546900|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43546901|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546902|NCT03657979|Ropivacaine|ropivacaine|mesh-list
43546903|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
43546904|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
43546905|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546906|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546907|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
43546908|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849918|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43849919|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849920|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43849921|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
43849922|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849923|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849924|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43849925|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
43546909|NCT03657966|Gemcitabine|gemcitabine|mesh-list
43546910|NCT03657966|Paclitaxel|paclitaxel|mesh-list
43546911|NCT03657966|Carboplatin|carboplatin|mesh-list
43546912|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43546913|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546914|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
43668920|NCT02231723|Fluorouracil|fluorouracil|mesh-list
43668921|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
43668922|NCT02231723|Irinotecan|irinotecan|mesh-list
43668923|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43668924|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668925|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
43668926|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
43734074|NCT02541734|Incretins|incretins|mesh-ancestor
43668927|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
43668928|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668929|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43668930|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
43668931|NCT02231723|Antiviral Agents|antiviral agents|mesh-ancestor
43668932|NCT02231723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668933|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668934|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668935|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
43668936|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668937|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43668938|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43668939|NCT02231723|Antidotes|antidotes|mesh-ancestor
43668940|NCT02231723|Protective Agents|protective agents|mesh-ancestor
43668941|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
43668942|NCT02231723|Vitamins|vitamins|mesh-ancestor
43668943|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
43668944|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43668945|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43668946|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668947|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
43668949|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43546915|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
43546916|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
43546917|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546918|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43546919|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
43546920|NCT03657966|Antiviral Agents|antiviral agents|mesh-ancestor
43546921|NCT03657966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546922|NCT03657966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546923|NCT03657966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43546924|NCT03657966|Immunologic Factors|immunologic factors|mesh-ancestor
43546925|NCT03657966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546926|NCT03657862|Fluorides|fluorides|mesh-list
43546927|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
43546928|NCT03657862|Protective Agents|protective agents|mesh-ancestor
43546929|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668950|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668951|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
43668952|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
43668953|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
43668954|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668955|NCT02909088|Ecopipam|ecopipam|mesh-list
43668956|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43668957|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43668958|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668959|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546930|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43546931|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546932|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43546933|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43546934|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43849926|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43849927|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43849928|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43849929|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
43849930|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43546945|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546946|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43546947|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546949|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43546950|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
43546951|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43546952|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
43546953|NCT03657550|Vitamins|vitamins|mesh-ancestor
43546954|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
43546955|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
43546956|NCT03657472|Atorvastatin|atorvastatin|mesh-list
43546957|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43546958|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43546959|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
43546960|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546961|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43546962|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43546963|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546964|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43546965|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
43546966|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546967|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546968|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43546969|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43546971|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546972|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849931|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43546978|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546979|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546980|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546981|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
43546982|NCT03657420|Hormones|hormones|mesh-ancestor
43546983|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668961|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43668962|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
43668963|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668964|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668965|NCT02909049|Midazolam|midazolam|mesh-list
43668966|NCT02909049|Ketamine|ketamine|mesh-list
43668967|NCT02909049|Mepivacaine|mepivacaine|mesh-list
43546984|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43546985|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546986|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
43546987|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43546988|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43546989|NCT03657420|Growth Substances|growth substances|mesh-ancestor
43546990|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
43546991|NCT03657381|Antibodies|antibodies|mesh-list
43546992|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43546993|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
43849932|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
43546994|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546995|NCT03657355|Zolpidem|zolpidem|mesh-list
43546996|NCT03657355|Suvorexant|suvorexant|mesh-list
43546997|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43546998|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43546999|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547000|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547010|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547011|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547012|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43547013|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
43547014|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
43547015|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547016|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547017|NCT03656965|Acyclovir|acyclovir|mesh-list
43547018|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
43547019|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562595|NCT01422148|Amiodarone|amiodarone|mesh-list
43562596|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43547020|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
43547021|NCT03656952|PF-06700841|pf-06700841|mesh-list
43547022|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43547023|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547024|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43547025|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43547026|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547027|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547028|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547029|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43547030|NCT03656783|Tenofovir|tenofovir|mesh-list
43547032|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43547034|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547035|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43547036|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43547037|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547038|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547039|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43547040|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43547041|NCT03656679|Iodine|iodine|mesh-list
43547042|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43547043|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547044|NCT03656679|Trace Elements|trace elements|mesh-ancestor
43547045|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
43547046|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547047|NCT03656666|Thalidomide|thalidomide|mesh-list
43547048|NCT03656666|Apremilast|apremilast|mesh-list
43547049|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547050|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547051|NCT03656666|Analgesics|analgesics|mesh-ancestor
43668969|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
43668970|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668971|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547052|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
43547053|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547054|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547055|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547056|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547057|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43547058|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43547059|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547060|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547061|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734106|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734107|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734108|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43547063|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
43547064|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43547065|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547068|NCT03656666|Growth Substances|growth substances|mesh-ancestor
43547069|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
43547070|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547072|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547073|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547074|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43547075|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547077|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43547078|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547079|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547080|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
43547081|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547082|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547083|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43547084|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
43547085|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547086|NCT03656588|Iodine|iodine|mesh-list
43547087|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
43547088|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43547089|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
43547090|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43547091|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43547092|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547093|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
43547094|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
43547095|NCT03656588|Trace Elements|trace elements|mesh-ancestor
43547096|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
43547097|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547098|NCT03656484|Metronidazole|metronidazole|mesh-list
43547099|NCT03656484|Tetracycline|tetracycline|mesh-list
43547100|NCT03656484|Melatonin|melatonin|mesh-list
43547101|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
43849933|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547102|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547103|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43547104|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43547105|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43547106|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
43547107|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547108|NCT03656484|Protective Agents|protective agents|mesh-ancestor
43547109|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547110|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547111|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43547112|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
43547113|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
43547114|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43547115|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547116|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
43547117|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43547118|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43547119|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547120|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
43547121|NCT03656445|Coagulants|coagulants|mesh-ancestor
43547122|NCT03656432|Fluorides|fluorides|mesh-list
43734139|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668972|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43668973|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43668974|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
43668976|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668977|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43668978|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43668979|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668980|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668982|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43668983|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43668984|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43668985|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43668986|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
43668987|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
43668988|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
43668989|NCT02908581|Folic Acid|folic acid|mesh-list
43668990|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
43668991|NCT02908581|Hematinics|hematinics|mesh-ancestor
43668992|NCT02908581|Vitamins|vitamins|mesh-ancestor
43668993|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
43668994|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668995|NCT02908711|Ropivacaine|ropivacaine|mesh-list
43668996|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
43547123|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
43547124|NCT03656432|Protective Agents|protective agents|mesh-ancestor
43547125|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547126|NCT03656393|Carboplatin|carboplatin|mesh-list
43547127|NCT03656393|Vinorelbine|vinorelbine|mesh-list
43547128|NCT03656393|Gefitinib|gefitinib|mesh-list
43547129|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547130|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43547131|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
43547132|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
43547133|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
43547134|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547135|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43547136|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547137|NCT03656289|Etonogestrel|etonogestrel|mesh-list
43547139|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
43547140|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43547141|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547158|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
43547159|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
43547160|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547161|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547162|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547163|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43668997|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
43668998|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668999|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547164|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43547165|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43547167|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43547168|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
43547169|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547170|NCT03655964|Olmesartan|olmesartan|mesh-list
43562632|NCT01418222|Protective Agents|protective agents|mesh-ancestor
43547171|NCT03655964|Nebivolol|nebivolol|mesh-list
43547172|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
43547173|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43547174|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43547175|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547176|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
43547177|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43547178|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43547179|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43547180|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
43547181|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547182|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547183|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
43547184|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43547185|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547186|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547187|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547188|NCT03655847|Analgesics|analgesics|mesh-ancestor
43547189|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
43547190|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547191|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43547192|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43547193|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43547194|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
43547195|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547196|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547197|NCT03655834|Pemetrexed|pemetrexed|mesh-list
43547198|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547199|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547207|NCT03655665|Renal Agents|renal agents|mesh-ancestor
43547208|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43547209|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43547210|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43547211|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547212|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547213|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547214|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43547217|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43547218|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547219|NCT03655457|Poractant alfa|poractant alfa|mesh-list
43547220|NCT03655457|Beractant|beractant|mesh-list
43547221|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43547222|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
43547223|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
43547224|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43547225|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
43547226|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547227|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547228|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43547229|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
43547230|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43547231|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
43547232|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547233|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547234|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43547235|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
43547236|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
43547237|NCT03655392|Protective Agents|protective agents|mesh-ancestor
43547238|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43547239|NCT03654794|Tacrolimus|tacrolimus|mesh-list
43547240|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669000|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
43669001|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669002|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43669003|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43669004|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
43669005|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669006|NCT02908698|Prednisone|prednisone|mesh-list
43734148|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
43669007|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669009|NCT02908698|Hormones|hormones|mesh-ancestor
43669010|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669011|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669012|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43669013|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669014|NCT02908438|Hormones|hormones|mesh-list
43669015|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669016|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669017|NCT02908412|Bupivacaine|bupivacaine|mesh-list
43669018|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
43669019|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
43669020|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547241|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
43547242|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547243|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43547244|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547245|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547246|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
43547247|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43547248|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
43547249|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547250|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547251|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43547252|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
43547253|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547254|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547255|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43547256|NCT03654612|Apatinib|apatinib|mesh-list
43547257|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547258|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43547259|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547260|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547261|NCT03654365|Caffeine|caffeine|mesh-list
43547262|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43547263|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547264|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43547265|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849934|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849935|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849936|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43849937|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
43849938|NCT05702905|Metformin|metformin|mesh-list
43849939|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43849940|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849941|NCT05702879|Prednisolone|prednisolone|mesh-list
43547284|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43547285|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43547286|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547288|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547289|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
43547290|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
43547291|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
43547292|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547293|NCT03653845|Epinephrine|epinephrine|mesh-list
43547294|NCT03653845|Racepinephrine|racepinephrine|mesh-list
43547295|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
43734156|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547296|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43547297|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43547298|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
43547299|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547300|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547301|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547302|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43547303|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43547304|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
43547305|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547306|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43547307|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
43547308|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
43547309|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
43547310|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43547311|NCT03653663|Simvastatin|simvastatin|mesh-list
43547312|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43547320|NCT03653520|Tramadol|tramadol|mesh-list
43547321|NCT03653520|Ondansetron|ondansetron|mesh-list
43547322|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
43547323|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
43547324|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547325|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547326|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547327|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
43547328|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
43547329|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43547330|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
43547331|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547332|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547335|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547336|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43547337|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43547338|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43547339|NCT03653520|Narcotics|narcotics|mesh-ancestor
43547340|NCT03653520|Analgesics|analgesics|mesh-ancestor
43547341|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
43547342|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43547343|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
43547344|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43547345|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43547346|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43547347|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43547348|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
43547349|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
43547350|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
43547351|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
43547352|NCT03653260|Lidocaine|lidocaine|mesh-list
43547353|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
43547354|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
43547355|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43562657|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43562658|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
43547356|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547357|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
43562659|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562660|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547358|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547359|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43849942|NCT05702879|Adalimumab|adalimumab|mesh-list
43547371|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547372|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43547373|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547374|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547375|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43547376|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
43547377|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
43547378|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
43547379|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43547380|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43547381|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43547382|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547383|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
43547384|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43547385|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
43547386|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547387|NCT03652753|Expectorants|expectorants|mesh-ancestor
43547388|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
43547389|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43547390|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
43547391|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547392|NCT03652753|Protective Agents|protective agents|mesh-ancestor
43547393|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547394|NCT03652753|Antidotes|antidotes|mesh-ancestor
43547395|NCT03652714|Anesthetics|anesthetics|mesh-list
43547396|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
43547397|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547398|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547399|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
43547400|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547402|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43547403|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
43547404|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43547405|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43547407|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43547408|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547409|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
43547432|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43547433|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547434|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
43547435|NCT03652467|Deferoxamine|deferoxamine|mesh-list
43547436|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43547437|NCT03652467|Estrogens|estrogens|mesh-ancestor
43562678|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43562679|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43547438|NCT03652467|Hormones|hormones|mesh-ancestor
43829678|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43547449|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547451|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
43547452|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43547453|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43547454|NCT03652376|Benralizumab|benralizumab|mesh-list
43547455|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43547456|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
43547457|NCT03652233|Nivolumab|nivolumab|mesh-list
43547458|NCT03652233|Afatinib|afatinib|mesh-list
43547459|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547460|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547461|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43547462|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547463|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43547464|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547465|NCT03652142|Nivolumab|nivolumab|mesh-list
43547466|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547467|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547468|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43547469|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547472|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
43547474|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547475|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547476|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
43547477|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547478|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43547486|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547487|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
43547488|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547490|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43547491|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547493|NCT03651934|Selenium|selenium|mesh-list
43547494|NCT03651934|Trace Elements|trace elements|mesh-ancestor
43547495|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
43547496|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547497|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
43547498|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547499|NCT03651934|Protective Agents|protective agents|mesh-ancestor
43547500|NCT03651882|Oxytocin|oxytocin|mesh-list
43547501|NCT03651882|Carbetocin|carbetocin|mesh-list
43547502|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
43547503|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43547504|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547505|NCT03651726|Palmidrol|palmidrol|mesh-list
43547506|NCT03651726|Dronabinol|dronabinol|mesh-list
43547507|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
43547508|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547509|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43547510|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547511|NCT03651726|Analgesics|analgesics|mesh-ancestor
43547512|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
43547513|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547515|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43547516|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547517|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734176|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
43734177|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43547518|NCT03651726|Hormones|hormones|mesh-ancestor
43669030|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43547519|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43547520|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547521|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547522|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547523|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
43547524|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547525|NCT03651674|Olanzapine|olanzapine|mesh-list
43547526|NCT03651674|Clozapine|clozapine|mesh-list
43547527|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
43547528|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
43547529|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547530|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547531|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547532|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43547533|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43547534|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547535|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43547536|NCT03651674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43547537|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43547538|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43547539|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547540|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547541|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
43547542|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43547543|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
43547544|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
43547545|NCT03651661|Insulin|insulin|mesh-list
43547546|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43547547|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43547548|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547549|NCT03651557|Salicylates|salicylates|mesh-list
43547550|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547559|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829679|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
43849943|NCT05702879|Etanercept|etanercept|mesh-list
43547560|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547562|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43547563|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547565|NCT03651427|Estrogens|estrogens|mesh-ancestor
43547566|NCT03651427|Hormones|hormones|mesh-ancestor
43547567|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43547568|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547569|NCT03651219|Irinotecan|irinotecan|mesh-list
43547570|NCT03651219|Apatinib|apatinib|mesh-list
43562695|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
43562696|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734195|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
43734196|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43734197|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43734198|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43734199|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
43734200|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734202|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
43547571|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43547572|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43547573|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547574|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669032|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669033|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43669034|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43669035|NCT02908295|Misoprostol|misoprostol|mesh-list
43669036|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43669037|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
43547575|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547576|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43547577|NCT03650998|Ropivacaine|ropivacaine|mesh-list
43547578|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
43547579|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
43547580|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547581|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547582|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
43547583|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547584|NCT03650881|Adapalene|adapalene|mesh-list
43547585|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43547586|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
43547587|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547588|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547589|NCT03650881|Analgesics|analgesics|mesh-ancestor
43547590|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
43547591|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547592|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547593|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547594|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547596|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
43547597|NCT03650738|Paclitaxel|paclitaxel|mesh-list
43547598|NCT03650738|Carboplatin|carboplatin|mesh-list
43547599|NCT03650738|Apatinib|apatinib|mesh-list
43547600|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43547601|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547602|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
43547603|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
43547604|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
43547605|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547606|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43547607|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547608|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43547609|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43547610|NCT03650582|Glucagon|glucagon|mesh-list
43547611|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547612|NCT03650582|Hormones|hormones|mesh-ancestor
43547613|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43547614|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547617|NCT03650543|Omeprazole|omeprazole|mesh-list
43547618|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43547619|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547631|NCT03650361|Analgesics|analgesics|mesh-ancestor
43547632|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
43547633|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547634|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547635|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547636|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547637|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
43547638|NCT03650348|Atezolizumab|atezolizumab|mesh-list
43547639|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547640|NCT03650270|Phenytoin|phenytoin|mesh-list
43547641|NCT03650270|Midazolam|midazolam|mesh-list
43547642|NCT03650270|Phenobarbital|phenobarbital|mesh-list
43547643|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43547644|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43547645|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547646|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547647|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43547648|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43547649|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43547650|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43547651|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
43669038|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669039|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669040|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43669041|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43669042|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
43669043|NCT02908165|Sorafenib|sorafenib|mesh-list
43669044|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
43547652|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
43547653|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
43547654|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
43547655|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547656|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547657|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
43547658|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43547659|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43547660|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43547661|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43547662|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43547663|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43547664|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43547665|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43547666|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43547668|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43547669|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
43547670|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547671|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547672|NCT03650023|Chitosan|chitosan|mesh-list
43547673|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43547674|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43547675|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
43547676|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547677|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43547678|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
43547679|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
43547680|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
43547681|NCT03650023|Coagulants|coagulants|mesh-ancestor
43547682|NCT03649945|Docetaxel|docetaxel|mesh-list
43547683|NCT03649945|Endostar protein|endostar protein|mesh-list
43547692|NCT03649945|Growth Substances|growth substances|mesh-ancestor
43562705|NCT01402401|Trastuzumab|trastuzumab|mesh-list
43562706|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562707|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547693|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562708|NCT01399684|Leucovorin|leucovorin|mesh-list
43547694|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
43547695|NCT03649763|Lidocaine|lidocaine|mesh-list
43547696|NCT03649763|Bupivacaine|bupivacaine|mesh-list
43547697|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
43547698|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
43547699|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547700|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547701|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
43547702|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849945|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43547720|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547721|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43669045|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669046|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43669047|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669048|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849946|NCT05702879|Infliximab|infliximab|mesh-list
43849947|NCT05702879|Ustekinumab|ustekinumab|mesh-list
43849948|NCT05702879|Vedolizumab|vedolizumab|mesh-list
43547727|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43547728|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547729|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547730|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547731|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547732|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43547733|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547734|NCT03649269|Bezafibrate|bezafibrate|mesh-list
43547735|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43547736|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
43547737|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547738|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43547739|NCT03649243|Propolis|propolis|mesh-list
43547740|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547741|NCT03649230|Palonosetron|palonosetron|mesh-list
43547742|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
43547743|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
43547744|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547745|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547746|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547747|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43547748|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43547749|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
43547750|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547756|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547757|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547758|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
43734214|NCT02541032|Minocycline|minocycline|mesh-list
43734215|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734216|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734217|NCT02541019|Ondansetron|ondansetron|mesh-list
43734218|NCT02541019|Palonosetron|palonosetron|mesh-list
43734222|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734224|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
43734225|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
43547760|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
43547761|NCT03649009|Metoclopramide|metoclopramide|mesh-list
43547762|NCT03649009|Vitamins|vitamins|mesh-ancestor
43547763|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
43547764|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547765|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547766|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
43547767|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
43547768|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
43562742|NCT01393639|Prednisone|prednisone|mesh-list
43547769|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547770|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547771|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43710581|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43710582|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710584|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710585|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710586|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
43710587|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710588|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43710589|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43710600|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
43710601|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710602|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562771|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562772|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43562773|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43710603|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710604|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
43710605|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43710606|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43710607|NCT02696369|Lidocaine|lidocaine|mesh-list
43710608|NCT02696369|Epinephrine|epinephrine|mesh-list
43710609|NCT02696369|Racepinephrine|racepinephrine|mesh-list
43562823|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710610|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
43710611|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710612|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
43710613|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710614|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710615|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
43710616|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710617|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43710618|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43710619|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43547798|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43547799|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547800|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547801|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43547802|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43547803|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
43547804|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547806|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43547807|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547808|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547809|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43547810|NCT03648671|Protective Agents|protective agents|mesh-ancestor
43547811|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547812|NCT03648658|Acetaminophen|acetaminophen|mesh-list
43547813|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547814|NCT03648658|Analgesics|analgesics|mesh-ancestor
43547815|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
43547816|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547817|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547818|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
43547819|NCT03648554|Dulaglutide|dulaglutide|mesh-list
43547820|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43547821|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547839|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547840|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
43547841|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43547842|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43547843|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43547844|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
43547845|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43547846|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
43710620|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710621|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710622|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43710623|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43734317|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734318|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
43734319|NCT02540720|Hormones|hormones|mesh-ancestor
43734324|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
43710624|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
43710625|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710626|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43710627|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43710628|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
43547848|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
43547850|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43547851|NCT03648229|Latanoprost|latanoprost|mesh-list
43547852|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43547853|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43547854|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43547855|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
43547856|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547857|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547858|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547859|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43547860|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43547861|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
43734385|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
43734386|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734387|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43547862|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547863|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
43547864|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
43547865|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
43547866|NCT03648034|Ropivacaine|ropivacaine|mesh-list
43547867|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
43547868|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
43547869|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547870|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547871|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
43734443|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43734444|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547872|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547875|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43547876|NCT03648008|Narcotics|narcotics|mesh-ancestor
43547877|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547878|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547879|NCT03648008|Analgesics|analgesics|mesh-ancestor
43547880|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
43547881|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547885|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547886|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43547887|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43547888|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547889|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
43547890|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734527|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43734528|NCT02539394|Protective Agents|protective agents|mesh-ancestor
43734531|NCT02539394|Coagulants|coagulants|mesh-ancestor
43547891|NCT03647956|Bevacizumab|bevacizumab|mesh-list
43547892|NCT03647956|Carboplatin|carboplatin|mesh-list
43547893|NCT03647956|Pemetrexed|pemetrexed|mesh-list
43547894|NCT03647956|Atezolizumab|atezolizumab|mesh-list
43547895|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547896|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547897|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43547898|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43547899|NCT03647956|Growth Substances|growth substances|mesh-ancestor
43547900|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547901|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
43547902|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547903|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547904|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43547905|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43547906|NCT03647839|Nivolumab|nivolumab|mesh-list
43710629|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43734542|NCT02538926|Asparaginase|asparaginase|mesh-list
43734543|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
43734544|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43710630|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
43710631|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
43710632|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
43710633|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43710634|NCT02696122|Anesthetics|anesthetics|mesh-list
43710635|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710636|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710637|NCT02696148|Liraglutide|liraglutide|mesh-list
43710638|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43547907|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547908|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547909|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43547910|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547911|NCT03647670|Midazolam|midazolam|mesh-list
43547912|NCT03647670|Abrocitinib|abrocitinib|mesh-list
43849950|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547915|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547916|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547917|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43547918|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43547919|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43547920|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43547921|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
43547922|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
43547923|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
43547924|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
43547925|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547926|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547927|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43547928|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547929|NCT03647579|Midazolam|midazolam|mesh-list
43547930|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
43547931|NCT03647579|Ketamine|ketamine|mesh-list
43849951|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
43547932|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43547933|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547934|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547935|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547937|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
43547938|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547939|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43547940|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43547941|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43547942|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
43547943|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734565|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43734566|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43734567|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
43734568|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
43734569|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
43734570|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734571|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
43563038|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
43547944|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547945|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43547946|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43547947|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
43547948|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
43547949|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43547950|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43547951|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43547952|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43547959|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
43563060|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43563061|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43563062|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43563063|NCT01337752|Dexamethasone|dexamethasone|mesh-list
43563064|NCT01337752|Bortezomib|bortezomib|mesh-list
43563065|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43563066|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563067|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
43563068|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
43563069|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563070|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563071|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43563072|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
43563073|NCT01337752|Hormones|hormones|mesh-ancestor
43563074|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43563075|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43563076|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734572|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
43734573|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
43734574|NCT02538939|Antidotes|antidotes|mesh-ancestor
43734575|NCT02538939|Protective Agents|protective agents|mesh-ancestor
43734576|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734577|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
43734578|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734579|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
43734580|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734581|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563077|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
43563078|NCT01336686|Colchicine|colchicine|mesh-list
43547960|NCT03647423|Cetuximab|cetuximab|mesh-list
43547961|NCT03647423|Avelumab|avelumab|mesh-list
43547962|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43547963|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
43547964|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547965|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547966|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43547967|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
43547968|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710639|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710641|NCT02696148|Hormones|hormones|mesh-ancestor
43734589|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
43734590|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43563087|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43563088|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
43563089|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563090|NCT01332812|Dexamethasone|dexamethasone|mesh-list
43563091|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
43563092|NCT01332812|BB 1101|bb 1101|mesh-list
43563093|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563094|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
43563095|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
43563096|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563097|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563098|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43563099|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
43563100|NCT01332812|Hormones|hormones|mesh-ancestor
43563101|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43563102|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43563104|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
43710642|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710643|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
43710644|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43710645|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43710646|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710647|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
43710648|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710650|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
43710651|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43710652|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547969|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547970|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43547971|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547972|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43547973|NCT03647280|Epirubicin|epirubicin|mesh-list
43547974|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547975|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547976|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43547977|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43547978|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43547979|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547980|NCT03647150|Amoxicillin|amoxicillin|mesh-list
43547981|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43547982|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547983|NCT03647072|Famotidine|famotidine|mesh-list
43547984|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43547985|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547986|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43547987|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
43547988|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
43547989|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547990|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547991|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547992|NCT03646916|Dexamethasone|dexamethasone|mesh-list
43734654|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
43734655|NCT02538432|Gemcitabine|gemcitabine|mesh-list
43734656|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43734657|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
43734658|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734659|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734660|NCT02538432|Antiviral Agents|antiviral agents|mesh-ancestor
43734661|NCT02538432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734662|NCT02538432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734663|NCT02538432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734666|NCT02538237|Ibuprofen|ibuprofen|mesh-list
43734667|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547993|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
43547994|NCT03646916|BB 1101|bb 1101|mesh-list
43547995|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547996|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
43547997|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
43547998|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547999|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548000|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734668|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43734669|NCT02538237|Analgesics|analgesics|mesh-ancestor
43734670|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
43734671|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734672|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734673|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734674|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43548002|NCT03646916|Hormones|hormones|mesh-ancestor
43548003|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849952|NCT05702879|Hormones|hormones|mesh-ancestor
43548007|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548008|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548009|NCT03646825|Antioxidants|antioxidants|mesh-list
43548010|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548011|NCT03646825|Protective Agents|protective agents|mesh-ancestor
43548012|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548013|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43548014|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43548015|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548016|NCT03646721|Incretins|incretins|mesh-ancestor
43548017|NCT03646721|Hormones|hormones|mesh-ancestor
43710653|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43710654|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710655|NCT02695797|Prednisolone|prednisolone|mesh-list
43710656|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710657|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
43710658|NCT02695797|Hormones|hormones|mesh-ancestor
43710659|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710660|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710661|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43710662|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710663|NCT02695654|Clonidine|clonidine|mesh-list
43710664|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
43710665|NCT02695654|Analgesics|analgesics|mesh-ancestor
43710666|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
43710667|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710668|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710669|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43548018|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43548019|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43548020|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
43548021|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548025|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
43548026|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43548027|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548028|NCT03646526|Analgesics|analgesics|mesh-ancestor
43548030|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548031|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548032|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43548033|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43548034|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548035|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548036|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
43548037|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548039|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43548040|NCT03646500|Narcotics|narcotics|mesh-ancestor
43548041|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548042|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548043|NCT03646500|Analgesics|analgesics|mesh-ancestor
43548044|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
43548045|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548056|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43548057|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43710670|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
43710671|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
43710672|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43710673|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43710674|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43710675|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
43710676|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563162|NCT01318642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710677|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710678|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710679|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
43710680|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710681|NCT02695771|Gemcitabine|gemcitabine|mesh-list
43710682|NCT02695771|Mitomycins|mitomycins|mesh-list
43710683|NCT02695771|Mitomycin|mitomycin|mesh-list
43710684|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43710685|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
43710686|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710687|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710688|NCT02695771|Antiviral Agents|antiviral agents|mesh-ancestor
43710689|NCT02695771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710690|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831644|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831645|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831646|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43831647|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
43831648|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831649|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831650|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43831651|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43548058|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43548059|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43548060|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
43548061|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548062|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548063|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548064|NCT03646318|Ketanserin|ketanserin|mesh-list
43829680|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
43548092|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563172|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563173|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548093|NCT03645980|Sorafenib|sorafenib|mesh-list
43548094|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548095|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43563174|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
43548096|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563175|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43548097|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548098|NCT03645876|Capecitabine|capecitabine|mesh-list
43548099|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
43548100|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43548101|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
43548102|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548103|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548111|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
43548112|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548113|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
43548114|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
43548115|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548116|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43548117|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43548118|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43548119|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43548120|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
43548121|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548122|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548124|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
43548125|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
43548137|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548139|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
43548140|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548141|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563206|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548142|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548143|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43548144|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43548145|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43548146|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548147|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548148|NCT03645109|Vitamin D|vitamin d|mesh-list
43548153|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43563241|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43563242|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43563252|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43563253|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43563254|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
43563255|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563256|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734726|NCT02537847|Ertapenem|ertapenem|mesh-list
43734734|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43734735|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43734736|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734738|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43734739|NCT02537925|Nedaplatin|nedaplatin|mesh-list
43734740|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43734741|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548154|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43548155|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43548156|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548157|NCT03644823|Atezolizumab|atezolizumab|mesh-list
43548158|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548159|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
43548160|NCT03644706|Diuretics|diuretics|mesh-ancestor
43548161|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
43548162|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548163|NCT03644706|Expectorants|expectorants|mesh-ancestor
43548164|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
43548165|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
43548166|NCT03644667|Prednisone|prednisone|mesh-list
43548167|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
43548168|NCT03644667|Tacrolimus|tacrolimus|mesh-list
43548169|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43548170|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548171|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
43548172|NCT03644667|Hormones|hormones|mesh-ancestor
43548173|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43548174|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548175|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43548176|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548177|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43548178|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
43548179|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548180|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548195|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548196|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548197|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43548198|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
43548199|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
43548200|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43548201|NCT03644589|Cisplatin|cisplatin|mesh-list
43548202|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
43548203|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
43548204|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
43710707|NCT02695563|Lactoferrin|lactoferrin|mesh-list
43710708|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710709|NCT02695550|Conteltinib|conteltinib|mesh-list
43710710|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43710711|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710712|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710713|NCT02695459|Everolimus|everolimus|mesh-list
43710714|NCT02695459|Cisplatin|cisplatin|mesh-list
43710715|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710716|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43563348|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43563349|NCT01265901|Growth Substances|growth substances|mesh-ancestor
43563350|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
43710717|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
43710718|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710719|NCT02695641|Bevacizumab|bevacizumab|mesh-list
43710720|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710721|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548205|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548206|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43548207|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
43548208|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548209|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
43548210|NCT03644576|Ephedrine|ephedrine|mesh-list
43548211|NCT03644576|Ozanimod|ozanimod|mesh-list
43548212|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43548213|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
43548214|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548215|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548216|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43548217|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
43548218|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
43548219|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43548220|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43548221|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
43710729|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43710731|NCT02695745|Analgesics|analgesics|mesh-ancestor
43710732|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
43710733|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710734|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710735|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710736|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710737|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43710738|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43548229|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548230|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43548231|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548232|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548233|NCT03644446|Bisoprolol|bisoprolol|mesh-list
43548234|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43548235|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
43548236|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
43548237|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548238|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548239|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43548240|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43548241|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43548242|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
43548243|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548244|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548245|NCT03644264|Sevelamer|sevelamer|mesh-list
43548246|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
43548247|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
43548248|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548249|NCT03644147|Acetaminophen|acetaminophen|mesh-list
43548250|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43734779|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
43734780|NCT02537353|Epinephrine|epinephrine|mesh-list
43734781|NCT02537353|Racepinephrine|racepinephrine|mesh-list
43734782|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
43563365|NCT01261312|Guadecitabine|guadecitabine|mesh-list
43548251|NCT03644147|Analgesics|analgesics|mesh-ancestor
43548252|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
43548253|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548254|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548255|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
43548256|NCT03643900|Indomethacin|indomethacin|mesh-list
43548257|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43548258|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548259|NCT03643900|Analgesics|analgesics|mesh-ancestor
43548260|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
43548261|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710739|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710740|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710741|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
43710742|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710743|NCT02695732|Carvedilol|carvedilol|mesh-list
43710744|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43710745|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43710746|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
43710747|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710748|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710749|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710750|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43710751|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
43548270|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548271|NCT03643874|Albuterol|albuterol|mesh-list
43548272|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43548273|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
43548274|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548275|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849953|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849954|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548276|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43548277|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
43548278|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
43710752|NCT02695732|Protective Agents|protective agents|mesh-ancestor
43710753|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43710754|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548279|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43548280|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43548281|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43548282|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43548283|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
43548284|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548285|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548286|NCT03643757|Bupivacaine|bupivacaine|mesh-list
43548287|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
43548288|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
43548289|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548290|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548291|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
43548296|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
43548297|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
43548298|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548299|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548300|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43548301|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
43548302|NCT03643666|Hormones|hormones|mesh-ancestor
43548303|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43548304|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43548305|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548306|NCT03643666|Analgesics|analgesics|mesh-ancestor
43548307|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
43548308|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
43548309|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548310|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43548312|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43548313|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548314|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548315|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43548316|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
43548317|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43548318|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
43548319|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43548320|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
43548325|NCT03643549|Bortezomib|bortezomib|mesh-list
43548326|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43548327|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
43548329|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548330|NCT03643497|Meropenem|meropenem|mesh-list
43548331|NCT03643497|Linezolid|linezolid|mesh-list
43548332|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
43548333|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43849955|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849956|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849957|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849958|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43849959|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849960|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
43849961|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43548335|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548336|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548337|NCT03642990|Niacinamide|niacinamide|mesh-list
43548338|NCT03642990|Niacin|niacin|mesh-list
43548339|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
43548340|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
43548341|NCT03642990|Vitamins|vitamins|mesh-ancestor
43548342|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
43548343|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548344|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43548345|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
43710755|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43710756|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
43710757|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43710758|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43710759|NCT02695381|Etodolac|etodolac|mesh-list
43710760|NCT02695381|Lidocaine|lidocaine|mesh-list
43710761|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710762|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
43710763|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563368|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43563369|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
43563370|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710764|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710765|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
43710766|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710767|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43548346|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548347|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43548348|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
43548349|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43548350|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
43548351|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548352|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43548353|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43548354|NCT03642665|Estradiol|estradiol|mesh-list
43548355|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43548356|NCT03642665|Progesterone|progesterone|mesh-list
43548357|NCT03642665|Estrogens|estrogens|mesh-ancestor
43548358|NCT03642665|Hormones|hormones|mesh-ancestor
43548359|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43548360|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548361|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43548362|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
43548363|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43548364|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43548365|NCT03642665|Progestins|progestins|mesh-ancestor
43548366|NCT03642626|Vidarabine|vidarabine|mesh-list
43548367|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
43548368|NCT03642626|Fludarabine|fludarabine|mesh-list
43548369|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
43548370|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43548371|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
43548372|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548373|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43548374|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43548375|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
43548376|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548377|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548378|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43548379|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43548380|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
43548381|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
43548382|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548384|NCT03642600|Inositol|inositol|mesh-list
43548385|NCT03642600|Liraglutide|liraglutide|mesh-list
43849962|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849963|NCT05702879|Analgesics|analgesics|mesh-ancestor
43849964|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
43548387|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548389|NCT03642600|Hormones|hormones|mesh-ancestor
43710768|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43710769|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43710770|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710771|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710772|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43710773|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43710774|NCT02695381|Analgesics|analgesics|mesh-ancestor
43710775|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710776|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710777|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43563382|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43710778|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43548390|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43548391|NCT03642600|Hematinics|hematinics|mesh-ancestor
43548392|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
43548393|NCT03642600|Vitamins|vitamins|mesh-ancestor
43548394|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
43548395|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43548396|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43548397|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
43548398|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
43548399|NCT03642509|Apixaban|apixaban|mesh-list
43548400|NCT03642509|Edoxaban|edoxaban|mesh-list
43548401|NCT03642509|Dabigatran|dabigatran|mesh-list
43548402|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43548412|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
43548413|NCT03642353|Protective Agents|protective agents|mesh-ancestor
43548414|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548415|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43548416|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548417|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43548420|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548422|NCT03642184|Empagliflozin|empagliflozin|mesh-list
43548423|NCT03642184|Linagliptin|linagliptin|mesh-list
43548424|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43548425|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548426|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43548427|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548428|NCT03642184|Incretins|incretins|mesh-ancestor
43548429|NCT03642184|Hormones|hormones|mesh-ancestor
43548430|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43548431|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43548432|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
43548433|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548434|NCT03642145|Deflazacort|deflazacort|mesh-list
43548435|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548436|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43548437|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
43548438|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548439|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
43548440|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43548441|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43548442|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43548443|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548444|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548445|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
43548446|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548447|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548448|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43710781|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43710782|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710783|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43710784|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43710785|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849965|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710793|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
43710794|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710795|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710796|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548450|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
43548451|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43548452|NCT03641456|Dexamethasone|dexamethasone|mesh-list
43563397|NCT01256762|Growth Substances|growth substances|mesh-ancestor
43563398|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563399|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
43563400|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563401|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43548453|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
43548454|NCT03641456|Lenalidomide|lenalidomide|mesh-list
43548455|NCT03641456|Bortezomib|bortezomib|mesh-list
43548456|NCT03641456|BB 1101|bb 1101|mesh-list
43548457|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548458|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
43548459|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
43548460|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548461|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548462|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43548463|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
43548464|NCT03641456|Hormones|hormones|mesh-ancestor
43548465|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43548466|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43548467|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548468|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
43548469|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548493|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
43548494|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548495|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43548496|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43548497|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548498|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548499|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43548500|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43548501|NCT03640650|Triamcinolone|triamcinolone|mesh-list
43548502|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43548503|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43548504|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43548505|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43548506|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43548507|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
43548508|NCT03640650|Hormones|hormones|mesh-ancestor
43710797|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710798|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43710799|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43710800|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710801|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710802|NCT02695004|Donepezil|donepezil|mesh-list
43548509|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43548510|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548511|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43548559|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43548560|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548561|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548562|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548564|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
43548565|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548566|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43548567|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43548568|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43548569|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
43548570|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548571|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548572|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
43548573|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43548574|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
43548575|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43548576|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548577|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43734808|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
43548578|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
43548579|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43548580|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43548581|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43548582|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
43548583|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43548584|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
43548585|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849966|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
43849967|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43849968|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548597|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548598|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548599|NCT03640247|Acetaminophen|acetaminophen|mesh-list
43548600|NCT03640247|Ibuprofen|ibuprofen|mesh-list
43548601|NCT03640247|Oxycodone|oxycodone|mesh-list
43548602|NCT03640247|Tramadol|tramadol|mesh-list
43548603|NCT03640247|Hydrocodone|hydrocodone|mesh-list
43548604|NCT03640247|Narcotics|narcotics|mesh-list
43548611|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43548624|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
43548626|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
43548627|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548628|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43548629|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548630|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548631|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43548632|NCT03640156|Oxytocin|oxytocin|mesh-list
43548633|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
43548634|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43548635|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548636|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
43548637|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548645|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548646|NCT03639896|Analgesics|analgesics|mesh-ancestor
43548647|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
43548648|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548649|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43548650|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43548651|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43548652|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
43849969|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
43548653|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548654|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548655|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43548656|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
43548657|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734817|NCT02537600|Vemurafenib|vemurafenib|mesh-list
43548658|NCT03639727|Mannitol|mannitol|mesh-list
43548659|NCT03639727|Citric Acid|citric acid|mesh-list
43548660|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
43548661|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43548662|NCT03639727|Diuretics|diuretics|mesh-ancestor
43548663|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
43548664|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548665|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
43548666|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43548667|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
43548668|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
43548669|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548670|NCT03639714|Nivolumab|nivolumab|mesh-list
43548671|NCT03639714|Ipilimumab|ipilimumab|mesh-list
43548672|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43548685|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43548686|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548687|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548688|NCT03639545|Metformin|metformin|mesh-list
43548689|NCT03639545|Empagliflozin|empagliflozin|mesh-list
43548690|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43548691|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548692|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43548693|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548694|NCT03639532|Tacrine|tacrine|mesh-list
43548695|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43548697|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548698|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
43548699|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548700|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548701|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43548702|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
43548703|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548704|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
43548710|NCT03639519|Vitamins|vitamins|mesh-ancestor
43548711|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
43548712|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
43849972|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
43849973|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849974|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849975|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43849976|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
43849977|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710808|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710809|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
43710810|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
43710811|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43710812|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710813|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
43710814|NCT02694809|Estrogens|estrogens|mesh-list
43710815|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43710817|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710818|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548713|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43548714|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43563427|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43563428|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563429|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43548715|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43548716|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
43548717|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548718|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43548719|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43548720|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548721|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43548722|NCT03639480|Amlodipine|amlodipine|mesh-list
43548723|NCT03639480|Valsartan|valsartan|mesh-list
43548724|NCT03639480|Atorvastatin|atorvastatin|mesh-list
43548725|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43548726|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43548727|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
43548728|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548729|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43548730|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43548731|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548732|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43548733|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43548744|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
43548745|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548746|NCT03639467|Antiviral Agents|antiviral agents|mesh-ancestor
43548747|NCT03639467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548748|NCT03639467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548749|NCT03639467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43548750|NCT03639467|Immunologic Factors|immunologic factors|mesh-ancestor
43548751|NCT03639467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548752|NCT03639428|Midazolam|midazolam|mesh-list
43548753|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43548754|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43548755|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548756|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548757|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43710819|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43710820|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43710821|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
43710822|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43710823|NCT02694848|Aspirin|aspirin|mesh-list
43710824|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43710825|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43710826|NCT02694848|Analgesics|analgesics|mesh-ancestor
43548766|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548770|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548771|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548772|NCT03639415|Analgesics|analgesics|mesh-ancestor
43548773|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
43548774|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548775|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
43548776|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43548777|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43548778|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548779|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
43548780|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
43548781|NCT03639168|Cisplatin|cisplatin|mesh-list
43548782|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548783|NCT03639155|Glycine|glycine|mesh-list
43548784|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
43548785|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548786|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548787|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548788|NCT03638960|Bupivacaine|bupivacaine|mesh-list
43548789|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
43548792|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548793|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
43548794|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548795|NCT03638869|Methadone|methadone|mesh-list
43548796|NCT03638869|D-methadone|d-methadone|mesh-list
43548797|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43548798|NCT03638869|Narcotics|narcotics|mesh-ancestor
43548799|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548800|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548801|NCT03638869|Analgesics|analgesics|mesh-ancestor
43548802|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
43548803|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548804|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
43548805|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
43548806|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548807|NCT03638856|Misoprostol|misoprostol|mesh-list
43548808|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43548809|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
43548810|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43548811|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710827|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
43710828|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710829|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710830|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710831|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710832|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43710833|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43710834|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710835|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43710836|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43710837|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849978|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849979|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43849980|NCT05702827|Meloxicam|meloxicam|mesh-list
43849981|NCT05702827|Bupivacaine|bupivacaine|mesh-list
43849982|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
43849983|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
43849984|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849985|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849986|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
43849987|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710839|NCT02694653|Acetaminophen|acetaminophen|mesh-list
43710840|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43710841|NCT02694653|Analgesics|analgesics|mesh-ancestor
43710842|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
43710843|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710844|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710845|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
43548813|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43548814|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
43548815|NCT03638726|Atropine|atropine|mesh-list
43548816|NCT03638726|Phenylephrine|phenylephrine|mesh-list
43548817|NCT03638726|Epinephrine|epinephrine|mesh-list
43548818|NCT03638726|Racepinephrine|racepinephrine|mesh-list
43548819|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
43548820|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
43548821|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
43548822|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43548823|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43548824|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
43548825|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548826|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548827|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548828|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43548829|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43548830|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
43548831|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548832|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43548833|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
43548834|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
43548835|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
43548836|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43548837|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43548838|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
43548839|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43548840|NCT03638726|Protective Agents|protective agents|mesh-ancestor
43548841|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43548842|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43548843|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
43548844|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43548845|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43548846|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
43710847|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43710848|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710850|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43710851|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710852|NCT02694263|Pioglitazone|pioglitazone|mesh-list
43710853|NCT02694263|Glimepiride|glimepiride|mesh-list
43710855|NCT02694263|Repaglinide|repaglinide|mesh-list
43710856|NCT02694263|Gliclazide|gliclazide|mesh-list
43710857|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43710858|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710859|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43710860|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710861|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
43710862|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43548847|NCT03638648|Capecitabine|capecitabine|mesh-list
43548848|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43548849|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
43548850|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548851|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548852|NCT03638440|Naloxegol|naloxegol|mesh-list
43548853|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43548854|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548855|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
43548856|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548857|NCT03638401|Morphine|morphine|mesh-list
43548858|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43548859|NCT03638401|Narcotics|narcotics|mesh-ancestor
43548860|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548861|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548862|NCT03638401|Analgesics|analgesics|mesh-ancestor
43548863|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
43548864|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548867|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548868|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43548869|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548870|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548871|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
43548872|NCT03638297|Antibodies|antibodies|mesh-list
43849989|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849990|NCT05702827|Analgesics|analgesics|mesh-ancestor
43849991|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849992|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43548873|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
43548874|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548875|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548876|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548877|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43548878|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548879|NCT03638297|Analgesics|analgesics|mesh-ancestor
43548880|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
43548881|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548882|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548883|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43548884|NCT03638076|Ritonavir|ritonavir|mesh-list
43548885|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43548886|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43548887|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
43548888|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548889|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548890|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43548891|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43710863|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710864|NCT02694146|Hylan|hylan|mesh-list
43710865|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
43710866|NCT02694146|Protective Agents|protective agents|mesh-ancestor
43710867|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710868|NCT02693769|Fluticasone|fluticasone|mesh-list
43710869|NCT02693769|Xhance|xhance|mesh-list
43710870|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
43710871|NCT02693769|Bromides|bromides|mesh-list
43710872|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
43710873|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710874|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43710875|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
43710876|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710877|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710878|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43710879|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
43710880|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710881|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43710882|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43710883|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43710884|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43710885|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
43710886|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710887|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548892|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
43548893|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548894|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43548895|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43548896|NCT03638063|Adenosine|adenosine|mesh-list
43548897|NCT03638063|Capsaicin|capsaicin|mesh-list
43548898|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
43548899|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
43548900|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
43548901|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548902|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548903|NCT03638063|Analgesics|analgesics|mesh-ancestor
43548904|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43548905|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
43548906|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43548907|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
43548908|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
43548909|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548910|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548911|NCT03638037|Vitamin D|vitamin d|mesh-list
43548912|NCT03638037|Vitamins|vitamins|mesh-ancestor
43548913|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
43548914|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548915|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43548916|NCT03637790|Rifampin|rifampin|mesh-list
43548917|NCT03637790|Abrocitinib|abrocitinib|mesh-list
43710888|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
43710889|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43710890|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43710891|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43710892|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
43710893|NCT02694224|Paclitaxel|paclitaxel|mesh-list
43548926|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43548927|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43548928|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43548929|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43548930|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43548931|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43548932|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43548933|NCT03637582|Lidocaine|lidocaine|mesh-list
43548934|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
43548935|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
43548936|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548955|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43548956|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548957|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548958|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43710901|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710902|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710903|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
43710904|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710905|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710906|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43710907|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
43710908|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43710909|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43710910|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43710911|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43710912|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710913|NCT02693951|Cefotiam|cefotiam|mesh-list
43710914|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43710915|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710916|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43710917|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
43710918|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710919|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
43710920|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43710921|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
43710922|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831661|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43831662|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43831663|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43831664|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831665|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43831666|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
43710934|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43710935|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710936|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710937|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43710938|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43710939|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43710940|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43710942|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43710943|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43710944|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710945|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43548959|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43548960|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43548961|NCT03637361|Methadone|methadone|mesh-list
43548962|NCT03637361|D-methadone|d-methadone|mesh-list
43548963|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43548964|NCT03637361|Narcotics|narcotics|mesh-ancestor
43548965|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548966|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548967|NCT03637361|Analgesics|analgesics|mesh-ancestor
43563454|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
43563455|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43563456|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548968|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
43548969|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548970|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
43548971|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
43548972|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548973|NCT03637335|Carboplatin|carboplatin|mesh-list
43548974|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548975|NCT03637049|Midazolam|midazolam|mesh-list
43548976|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43548977|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43548978|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548979|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548980|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43548981|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43548982|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43548983|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43548984|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
43548985|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
43548986|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
43548987|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
43710946|NCT02693470|Ustekinumab|ustekinumab|mesh-list
43710947|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710948|NCT02693444|Lidocaine|lidocaine|mesh-list
43710949|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710950|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
43710951|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710957|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43548988|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548989|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548990|NCT03636971|Mannitol|mannitol|mesh-list
43548991|NCT03636971|Sorbitol|sorbitol|mesh-list
43548992|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
43548995|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548996|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
43548997|NCT03636971|Protective Agents|protective agents|mesh-ancestor
43548998|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43548999|NCT03636971|Diuretics|diuretics|mesh-ancestor
43549000|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
43549001|NCT03636971|Cathartics|cathartics|mesh-ancestor
43549002|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549003|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
43549004|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43549005|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
43549006|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549007|NCT03636932|Expectorants|expectorants|mesh-ancestor
43549008|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
43549009|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43549010|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
43549011|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549012|NCT03636932|Protective Agents|protective agents|mesh-ancestor
43549013|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549028|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43549029|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43549030|NCT03636659|Amphotericin B|amphotericin b|mesh-list
43549031|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43549032|NCT03636659|Amebicides|amebicides|mesh-ancestor
43549033|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43549034|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43549035|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549036|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43710958|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710959|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710960|NCT02693288|Anesthetics|anesthetics|mesh-list
43549037|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
43549038|NCT03636555|Oxytocin|oxytocin|mesh-list
43549039|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
43549040|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43549041|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549042|NCT03636477|Nivolumab|nivolumab|mesh-list
43549043|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43549044|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549045|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43549046|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549047|NCT03636373|Triamcinolone|triamcinolone|mesh-list
43549048|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43549049|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43549050|NCT03636373|Etanercept|etanercept|mesh-list
43549051|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43549052|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43549054|NCT03636373|Hormones|hormones|mesh-ancestor
43549055|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549056|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549057|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43549058|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
43549059|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549060|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549091|NCT03636048|Propofol|propofol|mesh-list
43549092|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
43549093|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549094|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549095|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
43549096|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549097|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549098|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43549099|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
43549100|NCT03635931|Mitogens|mitogens|mesh-list
43549101|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
43549102|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549103|NCT03635905|Gabapentin|gabapentin|mesh-list
43549104|NCT03635905|Analgesics|analgesics|mesh-ancestor
43549105|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
43549106|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549107|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710961|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710962|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710964|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43710965|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549108|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
43549109|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43549110|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43549111|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549112|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43549113|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43549114|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43549115|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549116|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549119|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43549120|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
43549121|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
43549122|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734873|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549123|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549124|NCT03635684|Acetaminophen|acetaminophen|mesh-list
43549137|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549138|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43549139|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
43549149|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43549150|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43549151|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43549152|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
43549153|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
43549154|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
43549155|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
43549156|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549157|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549158|NCT03635372|Sucralfate|sucralfate|mesh-list
43549159|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
43549160|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43549161|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549162|NCT03635372|Antacids|antacids|mesh-ancestor
43549163|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549164|NCT03635125|Metoprolol|metoprolol|mesh-list
43549165|NCT03635125|Nebivolol|nebivolol|mesh-list
43549166|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43549167|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43549168|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
43549169|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
43549170|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710966|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
43710967|NCT02693483|Povidone|povidone|mesh-list
43710968|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
43710969|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
43710970|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43710971|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710972|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43710973|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
43710974|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710975|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
43710976|NCT02693210|Rituximab|rituximab|mesh-list
43710977|NCT02693210|Methotrexate|methotrexate|mesh-list
43710978|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710979|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
43710980|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710981|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43549171|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549172|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43549173|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43549174|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43549182|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
43549183|NCT03634917|Acamprosate|acamprosate|mesh-list
43549184|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
43549185|NCT03634917|Calcium|calcium|mesh-list
43549186|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43549187|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549188|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43549189|NCT03634917|Antacids|antacids|mesh-ancestor
43549190|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549191|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549192|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43549193|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
43549194|NCT03634852|Dexamethasone|dexamethasone|mesh-list
43549195|NCT03634852|Triamcinolone|triamcinolone|mesh-list
43549196|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43549197|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43549198|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43563488|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563489|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549199|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43549200|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43549201|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43549202|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
43549203|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
43549204|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549205|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549206|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549207|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
43549208|NCT03634852|Hormones|hormones|mesh-ancestor
43549209|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549210|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43549211|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549212|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43549213|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549214|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43549215|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43549216|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549217|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549218|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43549219|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
43549220|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43549221|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43710982|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43710984|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710985|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710986|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43710987|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710988|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43710989|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
43710990|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43710991|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43710992|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
43549222|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43549223|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43549241|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43549244|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549245|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43710995|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43710996|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43710998|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710999|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711001|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
43711002|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711003|NCT02692534|Cocaine|cocaine|mesh-list
43711004|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
43549256|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549257|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43549258|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43549259|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711005|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
43711006|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711007|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711008|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
43711009|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711010|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43849993|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43549263|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549264|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549265|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43549266|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43549267|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43549268|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43549269|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549270|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43549271|NCT03634345|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43549272|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43549273|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43549274|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549275|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
43549276|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43549277|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
43549278|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43549279|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43549281|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43549285|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
43549286|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549287|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549288|NCT03634189|Cannabidiol|cannabidiol|mesh-list
43549289|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
43549290|NCT03634137|Afamelanotide|afamelanotide|mesh-list
43549291|NCT03634137|alpha-MSH|alpha-msh|mesh-list
43549292|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
43549293|NCT03634137|Hormones|hormones|mesh-ancestor
43549294|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549295|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549296|NCT03634111|Morphine|morphine|mesh-list
43549297|NCT03634111|Ropivacaine|ropivacaine|mesh-list
43549298|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43549299|NCT03634111|Narcotics|narcotics|mesh-ancestor
43549300|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549301|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549302|NCT03634111|Analgesics|analgesics|mesh-ancestor
43549303|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
43549304|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549305|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
43549306|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
43549307|NCT03634059|Apatinib|apatinib|mesh-list
43711021|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43711022|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711023|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
43711024|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711025|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711026|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711027|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
43711028|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
43549308|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549309|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43549310|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549311|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549312|NCT03634020|Sirolimus|sirolimus|mesh-list
43549313|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43549318|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43549320|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549322|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
43549323|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43549324|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43549325|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549331|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549332|NCT03633747|Propranolol|propranolol|mesh-list
43549333|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43549334|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43549335|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549336|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549337|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549338|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549339|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43549340|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43549341|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
43549342|NCT03633734|Folfirinox|folfirinox|mesh-list
43549343|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549344|NCT03633604|HBOC 201|hboc 201|mesh-list
43549345|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
43549346|NCT03633591|Tolcapone|tolcapone|mesh-list
43549347|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43549348|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43549349|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43549350|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549351|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549352|NCT03633565|Prednisolone|prednisolone|mesh-list
43549353|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43549354|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
43549355|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43549356|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
43549357|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
43549358|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43549359|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
43549360|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
43549361|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43549362|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
43549363|NCT03633565|Hormones|hormones|mesh-ancestor
43549364|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549365|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549366|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43549367|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711029|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711030|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711031|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
43711032|NCT02692248|Hormones|hormones|mesh-ancestor
43711033|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711034|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711035|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43711036|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
43711037|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711038|NCT02692248|Antiviral Agents|antiviral agents|mesh-ancestor
43711039|NCT02692248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711040|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711041|NCT02692248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43711042|NCT02692365|Manganese|manganese|mesh-list
43711043|NCT02692365|Trace Elements|trace elements|mesh-ancestor
43711044|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
43711045|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711046|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
43549368|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
43549369|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
43549370|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549371|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549372|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43549373|NCT03633565|Protective Agents|protective agents|mesh-ancestor
43549374|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
43549375|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43549378|NCT03633565|Urological Agents|urological agents|mesh-ancestor
43549380|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43549381|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
43549382|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549388|NCT03633175|Hormones|hormones|mesh-ancestor
43549389|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549390|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549391|NCT03632915|Lacosamide|lacosamide|mesh-list
43549392|NCT03632915|Phenytoin|phenytoin|mesh-list
43549393|NCT03632915|Ketamine|ketamine|mesh-list
43549394|NCT03632915|Levetiracetam|levetiracetam|mesh-list
43549395|NCT03632915|Valproic Acid|valproic acid|mesh-list
43549396|NCT03632915|Phenobarbital|phenobarbital|mesh-list
43549397|NCT03632915|Analgesics|analgesics|mesh-ancestor
43549398|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
43549399|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549400|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549401|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43549402|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43849994|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43849995|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849996|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849997|NCT05702762|Gentamicins|gentamicins|mesh-list
43849998|NCT05702762|Cephalexin|cephalexin|mesh-list
43849999|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
43850000|NCT05702762|Cefdinir|cefdinir|mesh-list
43850001|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43850002|NCT05702762|Trimethoprim|trimethoprim|mesh-list
43850003|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
43549403|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
43549404|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
43549405|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549406|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43549407|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43549408|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711047|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43711048|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711049|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43711050|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
43711051|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43711052|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711053|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711054|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711056|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
43711057|NCT02691910|Primaquine|primaquine|mesh-list
43711058|NCT02691910|Amebicides|amebicides|mesh-ancestor
43711059|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43711060|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43711061|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549409|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549410|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
43549411|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
43549412|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549413|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
43549414|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
43549415|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43549416|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43549417|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43549418|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43549419|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43549420|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43549421|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43549422|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549423|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
43549424|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43549425|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43549426|NCT03632876|Vitamin A|vitamin a|mesh-list
43549427|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
43549428|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
43549429|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549439|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549441|NCT03632824|Coagulants|coagulants|mesh-ancestor
43549442|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
43549443|NCT03632772|Mirabegron|mirabegron|mesh-list
43549444|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43549445|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43549446|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
43549447|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549448|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549449|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549451|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43549452|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43549453|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43549454|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549455|NCT03632733|Tetracycline|tetracycline|mesh-list
43549456|NCT03632733|Clotrimazole|clotrimazole|mesh-list
43549457|NCT03632733|Miconazole|miconazole|mesh-list
43549458|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43549459|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549460|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43549461|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711062|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
43711063|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711064|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43711065|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43711067|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
43711068|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711069|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711070|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711071|NCT02691910|Filaricides|filaricides|mesh-ancestor
43549462|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549463|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43549464|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
43549465|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43549466|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43549467|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43549468|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
43549469|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549470|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549471|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43549472|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43549473|NCT03632681|Insulin|insulin|mesh-list
43549474|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43549475|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43549476|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549477|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
43549478|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
43549479|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
43549480|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549481|NCT03632590|Analgesics|analgesics|mesh-ancestor
43549482|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
43549483|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549484|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549485|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
43549486|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549487|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43549488|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
43549489|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43549490|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43549491|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43549492|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
43549493|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43549494|NCT03632590|Cathartics|cathartics|mesh-ancestor
43549498|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
43549499|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43549500|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43549501|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
43549502|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549503|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549504|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
43549505|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549506|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549507|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549508|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43549509|NCT03632460|Analgesics|analgesics|mesh-ancestor
43549510|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
43549511|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549512|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43711073|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
43711074|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
43711075|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43711076|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711077|NCT02691871|Docetaxel|docetaxel|mesh-list
43711078|NCT02691871|Apatinib|apatinib|mesh-list
43711079|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711080|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
43549516|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549517|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549518|NCT03632408|Zopiclone|zopiclone|mesh-list
43549519|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549520|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549521|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549522|NCT03632330|Midazolam|midazolam|mesh-list
43549523|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
43549524|NCT03632330|Propofol|propofol|mesh-list
43549525|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549526|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549527|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549528|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43549529|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
43549530|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
43549531|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43549532|NCT03632330|Analgesics|analgesics|mesh-ancestor
43549533|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
43549534|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549535|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43549536|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43549537|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43549538|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549539|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549540|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549541|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43850004|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43850005|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850006|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43549542|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43549543|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43549544|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43549545|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
43549546|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
43549547|NCT03632317|Everolimus|everolimus|mesh-list
43549548|NCT03632317|Panobinostat|panobinostat|mesh-list
43549549|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549550|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43549551|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
43549552|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549553|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43549554|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549555|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549556|NCT03632304|Anesthetics|anesthetics|mesh-list
43549557|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549558|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549559|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
43549560|NCT03632161|Bupivacaine|bupivacaine|mesh-list
43549561|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
43549562|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
43563523|NCT01232595|Vancomycin|vancomycin|mesh-list
43563526|NCT01231347|Gemcitabine|gemcitabine|mesh-list
43549563|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549564|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549565|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
43549572|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43711081|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
43711082|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
43711083|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711084|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43711085|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831694|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831695|NCT05302284|Antiviral Agents|antiviral agents|mesh-ancestor
43831696|NCT05302284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831697|NCT05302284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831698|NCT05302284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831699|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
43831700|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831702|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43831703|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
43831704|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831705|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43831706|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43831707|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
43549573|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549574|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549575|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549576|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43549577|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43549578|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43549579|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549580|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
43549581|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549582|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549584|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549585|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43549586|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549587|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549588|NCT03631901|Diazepam|diazepam|mesh-list
43549589|NCT03631901|Melatonin|melatonin|mesh-list
43549590|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
43549591|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549592|NCT03631901|Protective Agents|protective agents|mesh-ancestor
43549593|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549594|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549595|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43549597|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
43549598|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
43549599|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549600|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549601|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549602|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43549603|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43549604|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43549605|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43549606|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43549607|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43549608|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
43549609|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
43831708|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831709|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831710|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43831711|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
43831712|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43831713|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563541|NCT01229982|Latanoprost|latanoprost|mesh-list
43831714|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831715|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43831716|NCT05300802|Analgesics|analgesics|mesh-ancestor
43831717|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
43831718|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831719|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43831720|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43831721|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43831722|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
43831723|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831724|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711086|NCT02691754|Acetaminophen|acetaminophen|mesh-list
43711087|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43711088|NCT02691754|Analgesics|analgesics|mesh-ancestor
43711089|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
43711090|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711091|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711092|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
43711093|NCT02691897|Melatonin|melatonin|mesh-list
43711094|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
43711095|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711096|NCT02691897|Protective Agents|protective agents|mesh-ancestor
43711100|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43711101|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43711102|NCT02691780|Sorafenib|sorafenib|mesh-list
43711107|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43711108|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43711109|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43711110|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43711111|NCT02691325|Charcoal|charcoal|mesh-list
43711112|NCT02691325|Nemiralisib|nemiralisib|mesh-list
43711113|NCT02691325|Antidotes|antidotes|mesh-ancestor
43711114|NCT02691325|Protective Agents|protective agents|mesh-ancestor
43711115|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549610|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
43549611|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
43549612|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549613|NCT03631875|Ketamine|ketamine|mesh-list
43549614|NCT03631875|Propofol|propofol|mesh-list
43549615|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549616|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549617|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549618|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43549619|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
43549620|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
43549621|NCT03631875|Analgesics|analgesics|mesh-ancestor
43549622|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
43549623|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549624|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43549625|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43549626|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43549627|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549628|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549629|NCT03631862|Apatinib|apatinib|mesh-list
43549630|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549631|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43549632|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549633|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549643|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
43549644|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
43549645|NCT03631823|Temozolomide|temozolomide|mesh-list
43563551|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43549646|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43549647|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
43549648|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549649|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549650|NCT03631641|Nivolumab|nivolumab|mesh-list
43549651|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43549652|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549653|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43549654|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549655|NCT03631615|Antibodies|antibodies|mesh-list
43549656|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
43549657|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549658|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
43549659|NCT03631602|Clotrimazole|clotrimazole|mesh-list
43549660|NCT03631602|Miconazole|miconazole|mesh-list
43549661|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549662|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43549663|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43549664|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43549665|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549666|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549667|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43549668|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711116|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43711117|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711118|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711119|NCT02691403|Bupivacaine|bupivacaine|mesh-list
43711120|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
43711121|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
43711122|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
43549670|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549671|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43549672|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43549673|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43549674|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
43549675|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549676|NCT03631316|Valganciclovir|valganciclovir|mesh-list
43549677|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
43549678|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549679|NCT03631277|Calcium|calcium|mesh-list
43549680|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43549681|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549682|NCT03631147|Rifaximin|rifaximin|mesh-list
43549683|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43549684|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549685|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549686|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43549687|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549688|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43549689|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549690|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
43549691|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43549692|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549695|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43549696|NCT03630952|Growth Substances|growth substances|mesh-ancestor
43549705|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549706|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549708|NCT03630614|Varenicline|varenicline|mesh-list
43549709|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43549710|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
43549711|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549712|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549713|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43549714|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43549715|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
43549716|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549717|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549718|NCT03630367|Dexamethasone|dexamethasone|mesh-list
43549719|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43549720|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
43549721|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
43549722|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549723|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549724|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549725|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
43549726|NCT03630367|Hormones|hormones|mesh-ancestor
43549727|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549728|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43549729|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549730|NCT03630341|Clomiphene|clomiphene|mesh-list
43549731|NCT03630341|Enclomiphene|enclomiphene|mesh-list
43549732|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
43549733|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43711124|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711125|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
43711126|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711127|NCT02691442|Epinephrine|epinephrine|mesh-list
43711128|NCT02691442|Ropivacaine|ropivacaine|mesh-list
43711129|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
43549734|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
43549735|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549736|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549737|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43549738|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
43549739|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43549740|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43549741|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43549743|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
43549744|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43549745|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549746|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
43549747|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549748|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43563555|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
43563556|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563557|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43563558|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563559|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563560|NCT01225393|Adalimumab|adalimumab|mesh-list
43563561|NCT01225393|Methotrexate|methotrexate|mesh-list
43563562|NCT01225393|Leflunomide|leflunomide|mesh-list
43563563|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43563564|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
43563565|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43563566|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563567|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43563568|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
43547825|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549749|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43549751|NCT03629847|Everolimus|everolimus|mesh-list
43549752|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549753|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43549754|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
43549755|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549757|NCT03629717|Denosumab|denosumab|mesh-list
43549758|NCT03629717|Calcium|calcium|mesh-list
43549759|NCT03629717|Vitamins|vitamins|mesh-ancestor
43549760|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
43549761|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549762|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43549765|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43549766|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549767|NCT03629600|Indomethacin|indomethacin|mesh-list
43549768|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43549769|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43549770|NCT03629600|Analgesics|analgesics|mesh-ancestor
43549771|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
43549772|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549773|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549774|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43549775|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43549776|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
43549777|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
43549778|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43549779|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43549780|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549781|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549782|NCT03629522|Ondansetron|ondansetron|mesh-list
43549783|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
43549784|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
43549785|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549786|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549787|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549788|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
43549789|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
43549790|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43549791|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
43549792|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549793|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549794|NCT03629522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43549795|NCT03629522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43549796|NCT03629522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548224|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548225|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43548226|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43548227|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
43548228|NCT03644511|Sorafenib|sorafenib|mesh-list
43548292|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548293|NCT03643666|Dexamethasone|dexamethasone|mesh-list
43548294|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
43548295|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548328|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548404|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43548405|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
43548406|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548408|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
43549797|NCT03629522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43711131|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
43711132|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711133|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711134|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
43711135|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711136|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43711137|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43711138|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
43711139|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711140|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549798|NCT03629522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43549799|NCT03629418|Phenylephrine|phenylephrine|mesh-list
43549800|NCT03629418|Norepinephrine|norepinephrine|mesh-list
43549801|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43549802|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
43549803|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
43549804|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549805|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549806|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
43549807|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43549808|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
43549809|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
43549810|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43549811|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43549812|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43549813|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549814|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549815|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549816|NCT03629418|Protective Agents|protective agents|mesh-ancestor
43549817|NCT03629379|Ustekinumab|ustekinumab|mesh-list
43549818|NCT03629379|Vedolizumab|vedolizumab|mesh-list
43549819|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
43549820|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549822|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
43549823|NCT03629262|Dsuvia|dsuvia|mesh-list
43549824|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549825|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549826|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549827|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43549828|NCT03629262|Analgesics|analgesics|mesh-ancestor
43549830|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549831|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43549832|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43549834|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549835|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549836|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549837|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43549840|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43536671|NCT04509050|Ivacaftor|ivacaftor|mesh-list
43734904|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548530|NCT03640468|Analgesics|analgesics|mesh-ancestor
43549841|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
43549842|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
43549843|NCT03629210|Dexamethasone|dexamethasone|mesh-list
43549844|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43549845|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
43549846|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
43549847|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549848|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549849|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549850|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
43549851|NCT03629210|Hormones|hormones|mesh-ancestor
43549852|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549853|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711141|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43711142|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43711143|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
43711144|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43711145|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
43711146|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
43711147|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
43711148|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43711149|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
43711150|NCT02691156|Bilirubin|bilirubin|mesh-list
43711151|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
43711152|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711153|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
43711154|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711155|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711156|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
43711157|NCT02691156|Protective Agents|protective agents|mesh-ancestor
43711158|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
43549854|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549855|NCT03629093|Anesthetics|anesthetics|mesh-list
43549856|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
43549857|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549858|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549859|NCT03628625|Letrozole|letrozole|mesh-list
43549860|NCT03628625|Misoprostol|misoprostol|mesh-list
43549861|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549862|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43549863|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43549864|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549865|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549866|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43549867|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
43549868|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549869|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549878|NCT03628521|Pemetrexed|pemetrexed|mesh-list
43549879|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43549880|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549881|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43549883|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549884|NCT03628521|Antiviral Agents|antiviral agents|mesh-ancestor
43549885|NCT03628521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549886|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549887|NCT03628521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43549888|NCT03628521|Immunologic Factors|immunologic factors|mesh-ancestor
43549889|NCT03628521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549890|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43549891|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43549892|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43549893|NCT03628443|Mitogens|mitogens|mesh-list
43549894|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
43711159|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43711160|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711161|NCT02691195|Ropivacaine|ropivacaine|mesh-list
43711163|NCT02691195|Anesthetics|anesthetics|mesh-list
43711164|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711165|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711166|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
43711167|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711168|NCT02691078|Octreotide|octreotide|mesh-list
43711169|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711170|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711171|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549895|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549897|NCT03628430|Epinephrine|epinephrine|mesh-list
43549898|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
43549899|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
43549900|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549901|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549902|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
43549903|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549904|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43549905|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43549906|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43549907|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43549908|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549909|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43549910|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43549911|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549916|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43549917|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
43549919|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
43549920|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43549921|NCT03628131|Carboplatin|carboplatin|mesh-list
43549922|NCT03628131|Etoposide|etoposide|mesh-list
43549923|NCT03628131|Ifosfamide|ifosfamide|mesh-list
43549924|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549925|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43549926|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43549927|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43549928|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549929|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711174|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711175|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711176|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43711177|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43734920|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43734921|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
43734922|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43711178|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
43711179|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711180|NCT02690987|Exenatide|exenatide|mesh-list
43711181|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43711182|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711183|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43711185|NCT02690987|Hormones|hormones|mesh-ancestor
43711186|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711187|NCT02690922|Dexamethasone|dexamethasone|mesh-list
43711188|NCT02690922|Prednisone|prednisone|mesh-list
43711189|NCT02690922|Methotrexate|methotrexate|mesh-list
43711190|NCT02690922|Dasatinib|dasatinib|mesh-list
43711191|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711192|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
43549934|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
43549935|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43549936|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549937|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
43549938|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
43549939|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
43549940|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549941|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549942|NCT03628053|Blinatumomab|blinatumomab|mesh-list
43549943|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43549944|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549945|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43549946|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43549947|NCT03628040|Ropivacaine|ropivacaine|mesh-list
43549948|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
43549949|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
43549950|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549951|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549952|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
43549953|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549954|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43549955|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
43549956|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43549957|NCT03627546|Velpatasvir|velpatasvir|mesh-list
43549958|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
43711194|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711195|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711196|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711197|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
43711198|NCT02690922|Hormones|hormones|mesh-ancestor
43711199|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549959|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549960|NCT03627390|Molybdenum|molybdenum|mesh-list
43549961|NCT03627390|Trace Elements|trace elements|mesh-ancestor
43549962|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
43549963|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549964|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
43549965|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43549966|NCT03627260|Protective Agents|protective agents|mesh-ancestor
43549967|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549968|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
43549969|NCT03627039|Metformin|metformin|mesh-list
43549970|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
43549971|NCT03627039|Empagliflozin|empagliflozin|mesh-list
43549972|NCT03627039|Canagliflozin|canagliflozin|mesh-list
43549973|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43549974|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549976|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549978|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43549979|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43549980|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
43549981|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549982|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43549983|NCT03626753|Acetaminophen|acetaminophen|mesh-list
43549984|NCT03626753|Piroxicam|piroxicam|mesh-list
43549985|NCT03626753|Nefopam|nefopam|mesh-list
43549986|NCT03626753|Proroxan|proroxan|mesh-list
43549999|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43550001|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
43550002|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550003|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43550004|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
43550005|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43550006|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43550007|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
43550008|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
43550009|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550010|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550011|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43550012|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43550013|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550014|NCT03626519|Menthol|menthol|mesh-list
43550015|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
43550016|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
43550017|NCT03626506|Amlodipine|amlodipine|mesh-list
43550018|NCT03626506|Indapamide|indapamide|mesh-list
43550019|NCT03626506|Spironolactone|spironolactone|mesh-list
43550020|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43550021|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43550022|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550023|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550024|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43550025|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550026|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
43550027|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43550028|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
43550029|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711200|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711201|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711202|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43711203|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
43711204|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43711205|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43711206|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
43711207|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711208|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
43550030|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43550032|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
43550033|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43550034|NCT03626298|Niacinamide|niacinamide|mesh-list
43550035|NCT03626298|Niacin|niacin|mesh-list
43550036|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
43550037|NCT03626298|Adapalene|adapalene|mesh-list
43550038|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
43550039|NCT03626298|Vitamins|vitamins|mesh-ancestor
43550040|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
43550041|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550042|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43550043|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
43550044|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550045|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43550046|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
43550047|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43550048|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43550063|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
43550064|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43550065|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43550066|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43550068|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43550069|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
43550070|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550071|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550072|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43550073|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43550074|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
43550075|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550076|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550077|NCT03625960|Cantharidin|cantharidin|mesh-list
43550078|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550079|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550080|NCT03625830|Paclitaxel|paclitaxel|mesh-list
43550081|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43550082|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550083|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
43550084|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
43550085|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
43550086|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550087|NCT03625739|Amoxicillin|amoxicillin|mesh-list
43550088|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
43550089|NCT03625739|Levofloxacin|levofloxacin|mesh-list
43550090|NCT03625739|Isoniazid|isoniazid|mesh-list
43550091|NCT03625739|Cycloserine|cycloserine|mesh-list
43550092|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
43550093|NCT03625739|Imipenem|imipenem|mesh-list
43550094|NCT03625739|Amikacin|amikacin|mesh-list
43550095|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
43550096|NCT03625739|Ethambutol|ethambutol|mesh-list
43550097|NCT03625739|Bedaquiline|bedaquiline|mesh-list
43550098|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43550099|NCT03625739|Clofazimine|clofazimine|mesh-list
43550100|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
43711209|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711210|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43711211|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43711212|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
43711213|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43550101|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
43550103|NCT03625739|Ethionamide|ethionamide|mesh-list
43550104|NCT03625739|Kanamycin|kanamycin|mesh-list
43550105|NCT03625739|Capreomycin|capreomycin|mesh-list
43550106|NCT03625739|Thioacetazone|thioacetazone|mesh-list
43550107|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
43550108|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43550109|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550110|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43550111|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43550114|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550115|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43550117|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43550118|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43550119|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43550120|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
43550121|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43550122|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43550123|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
43550124|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43550125|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43550126|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550127|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43550128|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43550129|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43550132|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550133|NCT03625531|Letrozole|letrozole|mesh-list
43550134|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550135|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43550136|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43550137|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550138|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550139|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43550140|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
43550141|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550142|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550144|NCT03625518|Dinoprostone|dinoprostone|mesh-list
43550145|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
43550146|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43550147|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550148|NCT03625505|Venetoclax|venetoclax|mesh-list
43550149|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550150|NCT03625310|Listerine|listerine|mesh-list
43550151|NCT03625310|Fluorides|fluorides|mesh-list
43550152|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
43550153|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
43550154|NCT03625310|Protective Agents|protective agents|mesh-ancestor
43550155|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550156|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43550157|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550158|NCT03625219|Prednisone|prednisone|mesh-list
43550159|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550160|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
43550161|NCT03625219|Hormones|hormones|mesh-ancestor
43550162|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550163|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550164|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43550165|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550166|NCT03625167|Petrolatum|petrolatum|mesh-list
43550167|NCT03625167|Emollients|emollients|mesh-ancestor
43550168|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
43550169|NCT03625089|Atorvastatin|atorvastatin|mesh-list
43711214|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43711215|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43711216|NCT02690883|Exenatide|exenatide|mesh-list
43711217|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43711218|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711219|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43711220|NCT02690883|Incretins|incretins|mesh-ancestor
43711221|NCT02690883|Hormones|hormones|mesh-ancestor
43711222|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711223|NCT02690844|Clonazepam|clonazepam|mesh-list
43711224|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
43711225|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
43550181|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
43550182|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550183|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550184|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
43550190|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550191|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43550192|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43550193|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
43550194|NCT03625050|Celecoxib|celecoxib|mesh-list
43550195|NCT03625050|Esomeprazole|esomeprazole|mesh-list
43550196|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43550197|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43550198|NCT03625050|Analgesics|analgesics|mesh-ancestor
43550199|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
43711226|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
43711227|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711228|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711229|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711231|NCT02690870|Clomiphene|clomiphene|mesh-list
43711232|NCT02690870|Enclomiphene|enclomiphene|mesh-list
43550203|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43550204|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43550205|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43550206|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550207|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550208|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43550209|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43550210|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43550211|NCT03625011|Gabapentin|gabapentin|mesh-list
43550212|NCT03625011|Analgesics|analgesics|mesh-ancestor
43550213|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
43550214|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550215|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550216|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
43550217|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43550218|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43550219|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550220|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43550221|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43550222|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43550223|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550224|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550225|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
43711245|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43711246|NCT02690792|Vitamin E|vitamin e|mesh-list
43711247|NCT02690792|Vitamins|vitamins|mesh-ancestor
43711248|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
43711249|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711250|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
43711251|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711252|NCT02690792|Protective Agents|protective agents|mesh-ancestor
43711253|NCT02690506|Pregabalin|pregabalin|mesh-list
43711254|NCT02690506|Analgesics|analgesics|mesh-ancestor
43550238|NCT03624959|Itraconazole|itraconazole|mesh-list
43550239|NCT03624959|Rifampin|rifampin|mesh-list
43550240|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
43550241|NCT03624959|Ozanimod|ozanimod|mesh-list
43550242|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
43550243|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550247|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550249|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
43550250|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550251|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550256|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
43550257|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43550258|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43550259|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43550260|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43550261|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43550262|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43550263|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43550264|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43550265|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43550266|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
43550267|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43550268|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
43550269|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43550270|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43550271|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
43550272|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43550273|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550274|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550275|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43550276|NCT03624595|Analgesics|analgesics|mesh-ancestor
43550277|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
43550278|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550279|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43550280|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43550281|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43550282|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
43550283|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550284|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711255|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
43711256|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850007|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711258|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
43711259|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43711260|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43711261|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711262|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43711263|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43711264|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43711265|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711266|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43711267|NCT02690389|Flumazenil|flumazenil|mesh-list
43711268|NCT02690389|Antidotes|antidotes|mesh-ancestor
43711269|NCT02690389|Protective Agents|protective agents|mesh-ancestor
43711270|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711271|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
43711272|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
43711273|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550286|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
43550287|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
43550288|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550289|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550290|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43550291|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43550292|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43550293|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550294|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43550295|NCT03624322|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43550296|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43550297|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550298|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550299|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550300|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
43550301|NCT03624309|Docetaxel|docetaxel|mesh-list
43550302|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550303|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
43550304|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
43550305|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
43550306|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550307|NCT03624283|Betahistine|betahistine|mesh-list
43550308|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
43550309|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
43550310|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
43550312|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834436|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
43550313|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550314|NCT03624244|Letrozole|letrozole|mesh-list
43550315|NCT03624244|Exemestane|exemestane|mesh-list
43550316|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43550317|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711274|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711275|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43711276|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43550330|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43550331|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550332|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
43550333|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
43550334|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
43550335|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550336|NCT03624166|Ketamine|ketamine|mesh-list
43550337|NCT03624166|Anesthetics|anesthetics|mesh-list
43550338|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
43550339|NCT03624166|Analgesics|analgesics|mesh-ancestor
43550340|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
43550341|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550342|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550343|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43550344|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43550345|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550346|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43550347|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43550348|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550349|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550351|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43550352|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
43550353|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43550354|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43550355|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550356|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550357|NCT03624010|Protective Agents|protective agents|mesh-ancestor
43550358|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550359|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
43550360|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
43550361|NCT03623789|Hemostatics|hemostatics|mesh-list
43550362|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43550363|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43550364|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550365|NCT03623789|Coagulants|coagulants|mesh-ancestor
43550366|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
43550367|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43550368|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43550369|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550370|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43550371|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43550372|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550373|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550374|NCT03623776|Carboplatin|carboplatin|mesh-list
43550375|NCT03623776|Pemetrexed|pemetrexed|mesh-list
43550376|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550377|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550378|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550379|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43550388|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550390|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550391|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43550392|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
43550393|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43550394|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550395|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43550396|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
43550397|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43550398|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43550399|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550400|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43550401|NCT03623711|Analgesics|analgesics|mesh-ancestor
43550402|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
43550403|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
43711277|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711278|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
43711279|NCT02690480|Fulvestrant|fulvestrant|mesh-list
43711280|NCT02690480|Palbociclib|palbociclib|mesh-list
43711281|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711282|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711283|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43711285|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711286|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711287|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711288|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43711289|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711290|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711291|NCT02689999|Rabeprazole|rabeprazole|mesh-list
43711292|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43711293|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711294|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43711295|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711296|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550404|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550405|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
43550406|NCT03623529|Giapreza|giapreza|mesh-list
43550407|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
43550408|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43550409|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43550410|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
43550411|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550412|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550413|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43550414|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43550415|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550416|NCT03623256|Fentanyl|fentanyl|mesh-list
43550417|NCT03623256|Bupivacaine|bupivacaine|mesh-list
43550418|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
43550419|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
43550420|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550421|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550422|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
43550423|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550424|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43550425|NCT03623256|Narcotics|narcotics|mesh-ancestor
43550426|NCT03623256|Analgesics|analgesics|mesh-ancestor
43550427|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43550428|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43550429|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
43550430|NCT03623230|Bupivacaine|bupivacaine|mesh-list
43550431|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43550432|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
43550433|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
43550434|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550435|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550437|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711297|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
43711298|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43711299|NCT02690038|Antibodies|antibodies|mesh-list
43711300|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
43711301|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43711302|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
43711303|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831725|NCT05300269|Capecitabine|capecitabine|mesh-list
43831726|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
43831727|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43831728|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
43831729|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831730|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831731|NCT05300087|Albuterol|albuterol|mesh-list
43831732|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43831733|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
43711305|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
43550438|NCT03623087|Gemcitabine|gemcitabine|mesh-list
43550439|NCT03623087|Dexamethasone|dexamethasone|mesh-list
43550441|NCT03623087|Etoposide|etoposide|mesh-list
43550442|NCT03623087|Asparaginase|asparaginase|mesh-list
43550443|NCT03623087|Ifosfamide|ifosfamide|mesh-list
43550444|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550445|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
43550446|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
43550447|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550458|NCT03623087|Antiviral Agents|antiviral agents|mesh-ancestor
43550459|NCT03623087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550460|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550461|NCT03623087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43550462|NCT03623087|Immunologic Factors|immunologic factors|mesh-ancestor
43550463|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43550464|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43550465|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43550466|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43550467|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
43550468|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
43550469|NCT03623048|Propolis|propolis|mesh-list
43550470|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43550471|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550472|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
43550473|NCT03622918|Rifampin|rifampin|mesh-list
43550474|NCT03622918|Colistin|colistin|mesh-list
43550475|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43550476|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
43550477|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43550478|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550479|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
43550480|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43550481|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550482|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550483|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43550484|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43550485|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43550486|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43550487|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43550488|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43550489|NCT03622827|Endostar protein|endostar protein|mesh-list
43550490|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43711306|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711307|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
43711308|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711309|NCT02690155|Vitamin K|vitamin k|mesh-list
43711310|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
43711311|NCT02690155|Vitamins|vitamins|mesh-ancestor
43550495|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550497|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550498|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43550499|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550500|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550501|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
43550502|NCT03622502|Remifentanil|remifentanil|mesh-list
43550503|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43550504|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550505|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550506|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43550507|NCT03622502|Analgesics|analgesics|mesh-ancestor
43550508|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
43550509|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550511|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43550512|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43550513|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
43550514|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550515|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550516|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43550518|NCT03622489|Acetaminophen|acetaminophen|mesh-list
43550519|NCT03622489|Dipyrone|dipyrone|mesh-list
43550520|NCT03622489|Ibuprofen|ibuprofen|mesh-list
43550521|NCT03622489|Morphine|morphine|mesh-list
43550522|NCT03622489|Tramadol|tramadol|mesh-list
43550523|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43550524|NCT03622489|Narcotics|narcotics|mesh-ancestor
43550525|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550526|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550527|NCT03622489|Analgesics|analgesics|mesh-ancestor
43550528|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
43550529|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550530|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43711318|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711319|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711321|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43711322|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43711323|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
43711324|NCT02690155|Coagulants|coagulants|mesh-ancestor
43711325|NCT02690129|Progesterone|progesterone|mesh-list
43711326|NCT02690129|Progestins|progestins|mesh-ancestor
43711327|NCT02690129|Hormones|hormones|mesh-ancestor
43711328|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550531|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
43550532|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43550533|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550534|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43550535|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43550536|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550537|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550538|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
43550539|NCT03622450|Levofloxacin|levofloxacin|mesh-list
43550540|NCT03622450|Gentamicins|gentamicins|mesh-list
43550541|NCT03622450|Meropenem|meropenem|mesh-list
43550542|NCT03622450|Amikacin|amikacin|mesh-list
43550543|NCT03622450|Colistin|colistin|mesh-list
43550544|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43550545|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550546|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43550547|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43550548|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550549|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550550|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550551|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43550552|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43550553|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43550554|NCT03622450|Renal Agents|renal agents|mesh-ancestor
43550555|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43550556|NCT03622060|Nicardipine|nicardipine|mesh-list
43550557|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
43550558|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
43550559|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43550560|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43550561|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550562|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550563|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43550564|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550565|NCT03622047|Sufentanil|sufentanil|mesh-list
43550566|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
43550567|NCT03622047|Ropivacaine|ropivacaine|mesh-list
43550568|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43550569|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550570|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550571|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43550572|NCT03622047|Analgesics|analgesics|mesh-ancestor
43550573|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
43550574|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550575|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43550576|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43711329|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711330|NCT02689960|Prednisone|prednisone|mesh-list
43711331|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711332|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
43711333|NCT02689960|Hormones|hormones|mesh-ancestor
43711334|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711335|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711336|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711337|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711338|NCT02689882|Niacinamide|niacinamide|mesh-list
43711340|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
43711341|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
43711342|NCT02689882|Vitamins|vitamins|mesh-ancestor
43711343|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
43711344|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711345|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43550577|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43550578|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
43550579|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550580|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550581|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
43550582|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
43550586|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43550587|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
43550588|NCT03621995|Catalase|catalase|mesh-list
43550589|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
43550590|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550592|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550593|NCT03621800|Menthol|menthol|mesh-list
43550594|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
43550595|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
43550596|NCT03621683|Antioxidants|antioxidants|mesh-list
43550597|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550598|NCT03621683|Protective Agents|protective agents|mesh-ancestor
43550599|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550600|NCT03621618|Dobutamine|dobutamine|mesh-list
43550601|NCT03621618|Norepinephrine|norepinephrine|mesh-list
43550602|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43550603|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43550604|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
43550605|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550606|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550607|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550608|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
43550615|NCT03621618|Protective Agents|protective agents|mesh-ancestor
43550616|NCT03621527|Remifentanil|remifentanil|mesh-list
43550617|NCT03621527|Anesthetics|anesthetics|mesh-list
43563660|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43563665|NCT01204762|Entecavir|entecavir|mesh-list
43550618|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550619|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550620|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43550621|NCT03621527|Narcotics|narcotics|mesh-ancestor
43550622|NCT03621527|Analgesics|analgesics|mesh-ancestor
43550623|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
43711347|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711348|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43711349|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
43711350|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
43711351|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
43711352|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711353|NCT02690012|Cathartics|cathartics|mesh-ancestor
43711354|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711355|NCT02690012|Antacids|antacids|mesh-ancestor
43711356|NCT02689986|Rituximab|rituximab|mesh-list
43711357|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43711358|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43711359|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711360|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
43550624|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550625|NCT03621514|Lidocaine|lidocaine|mesh-list
43550626|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
43550627|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
43550628|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550629|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550630|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
43550631|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550632|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43550633|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43550634|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43550635|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550636|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550637|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
43550638|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
43550639|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43550640|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734937|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734938|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734939|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43734940|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
43734941|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
43734942|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43734947|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
43550641|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550642|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
43550643|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43550644|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550645|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550646|NCT03621072|Fluconazole|fluconazole|mesh-list
43550647|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
43550648|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711361|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711362|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711363|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43711364|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
43711365|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711367|NCT02689921|Pertuzumab|pertuzumab|mesh-list
43711368|NCT02689921|Letrozole|letrozole|mesh-list
43711369|NCT02689921|Anastrozole|anastrozole|mesh-list
43711370|NCT02689921|Leuprolide|leuprolide|mesh-list
43711371|NCT02689921|Exemestane|exemestane|mesh-list
43711372|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43711373|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711374|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43711375|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43550676|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550677|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550678|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43550679|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
43550680|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43550681|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43550683|NCT03620916|Morphine|morphine|mesh-list
43550684|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43550685|NCT03620916|Narcotics|narcotics|mesh-ancestor
43550686|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550687|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550688|NCT03620916|Analgesics|analgesics|mesh-ancestor
43550689|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
43550690|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550691|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
43550692|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
43550693|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43550694|NCT03620838|Progesterone|progesterone|mesh-list
43550695|NCT03620838|Progestins|progestins|mesh-ancestor
43550696|NCT03620838|Hormones|hormones|mesh-ancestor
43550697|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550698|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550699|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43550700|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43550701|NCT03620825|Indomethacin|indomethacin|mesh-list
43550702|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43550703|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43711379|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711380|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550705|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
43550706|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550707|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550708|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550709|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43550710|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
43550711|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
43550712|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43550722|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550723|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550724|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550725|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43550734|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43550735|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43550736|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
43550737|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550739|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
43550740|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
43550741|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550742|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550743|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
43550744|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550745|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43550746|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43550747|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43550748|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550749|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550750|NCT03620526|Iloprost|iloprost|mesh-list
43550751|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43550752|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
43550753|NCT03620513|Lidocaine|lidocaine|mesh-list
43550754|NCT03620513|Phenylephrine|phenylephrine|mesh-list
43550755|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
43550756|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
43550757|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
43550758|NCT03620513|Ephedrine|ephedrine|mesh-list
43550759|NCT03620513|Anesthetics|anesthetics|mesh-list
43550760|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
43550761|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550762|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550763|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
43550764|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550765|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43550776|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43550777|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
43550778|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43550779|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
43550780|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43550781|NCT03620513|Protective Agents|protective agents|mesh-ancestor
43550782|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43550783|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43550784|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43550785|NCT03620461|Gemcitabine|gemcitabine|mesh-list
43550786|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43550787|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43550788|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
43550789|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550800|NCT03620422|Albuterol|albuterol|mesh-list
43550801|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43550802|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
43550803|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550804|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550805|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43550806|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
43550807|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
43550808|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43550809|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43550810|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43550811|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43550812|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
43550813|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550814|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550815|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43550816|NCT03620422|Diuretics|diuretics|mesh-ancestor
43550817|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
43550818|NCT03620318|Crenolanib|crenolanib|mesh-list
43550824|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43550825|NCT03620292|Growth Substances|growth substances|mesh-ancestor
43550826|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734972|NCT02536495|Docetaxel|docetaxel|mesh-list
43550832|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43550833|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43550834|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550836|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43550837|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550838|NCT03620032|Vinorelbine|vinorelbine|mesh-list
43550839|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
43550840|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43550841|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550842|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
43550843|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
43550844|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
43550845|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550846|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43550847|NCT03619876|Adalimumab|adalimumab|mesh-list
43550848|NCT03619876|Abatacept|abatacept|mesh-list
43550849|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550850|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43550851|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43550852|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550853|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550854|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43711381|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711382|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711383|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43711384|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
43711385|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43711386|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43711387|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
43711388|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711389|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
43711390|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43711391|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43711392|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43711393|NCT02689856|Lidocaine|lidocaine|mesh-list
43711394|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
43711395|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
43711396|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711397|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711398|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
43711399|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711400|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43711401|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43711402|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43711403|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43711405|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711421|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
43711422|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
43711423|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711424|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43711425|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
43711426|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43711428|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43711429|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
43711430|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734975|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
43734976|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
43734977|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734978|NCT02536417|Melatonin|melatonin|mesh-list
43734979|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
43734980|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734981|NCT02536417|Protective Agents|protective agents|mesh-ancestor
43711431|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711432|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
43711433|NCT02689713|Voriconazole|voriconazole|mesh-list
43550862|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550863|NCT03619824|Antiviral Agents|antiviral agents|mesh-ancestor
43550864|NCT03619824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550865|NCT03619824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550866|NCT03619824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43550867|NCT03619824|Immunologic Factors|immunologic factors|mesh-ancestor
43550868|NCT03619824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550869|NCT03619785|Acetaminophen|acetaminophen|mesh-list
43550870|NCT03619785|Ibuprofen|ibuprofen|mesh-list
43550871|NCT03619785|Ketorolac|ketorolac|mesh-list
43550872|NCT03619785|Fentanyl|fentanyl|mesh-list
43550873|NCT03619785|Ketamine|ketamine|mesh-list
43550874|NCT03619785|Morphine|morphine|mesh-list
43550875|NCT03619785|Gabapentin|gabapentin|mesh-list
43550876|NCT03619785|Hydromorphone|hydromorphone|mesh-list
43550877|NCT03619785|Hydrocodone|hydrocodone|mesh-list
43550878|NCT03619785|Bupivacaine|bupivacaine|mesh-list
43550879|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
43550880|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
43550881|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550882|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550883|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
43550884|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550885|NCT03619785|Analgesics|analgesics|mesh-ancestor
43550886|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43550887|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43550888|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
43550889|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43550890|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43550891|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550892|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550893|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43550894|NCT03619785|Narcotics|narcotics|mesh-ancestor
43550895|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43550896|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43550897|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
43550898|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43550899|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550900|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43550901|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43550902|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550903|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
43550904|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43550905|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43711435|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711436|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43711437|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43711438|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711439|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711440|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43711441|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711442|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711443|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550906|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43550907|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
43550908|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
43550909|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
43550910|NCT03619538|Nefopam|nefopam|mesh-list
43550911|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43550912|NCT03619538|Analgesics|analgesics|mesh-ancestor
43550913|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
43550914|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550915|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711444|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43711445|NCT02689778|Pirfenidone|pirfenidone|mesh-list
43711446|NCT02689778|Analgesics|analgesics|mesh-ancestor
43711447|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
43711451|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43711452|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711453|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711454|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711455|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43711456|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43711457|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711458|NCT02689362|Incretins|incretins|mesh-ancestor
43711459|NCT02689362|Hormones|hormones|mesh-ancestor
43550917|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550918|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43550919|NCT03619330|Liraglutide|liraglutide|mesh-list
43550920|NCT03619330|Testosterone|testosterone|mesh-list
43550921|NCT03619330|Androgens|androgens|mesh-ancestor
43550922|NCT03619330|Hormones|hormones|mesh-ancestor
43550923|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550924|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550925|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43550926|NCT03619330|Incretins|incretins|mesh-ancestor
43550927|NCT03619057|Anesthetics|anesthetics|mesh-list
43550930|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43550931|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43550933|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550934|NCT03618953|Atezolizumab|atezolizumab|mesh-list
43550935|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550936|NCT03618797|Fenofibrate|fenofibrate|mesh-list
43550937|NCT03618797|Pitavastatin|pitavastatin|mesh-list
43550938|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43550939|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
43550940|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550941|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43550942|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43550943|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43550944|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550945|NCT03618758|Paclitaxel|paclitaxel|mesh-list
43550946|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43550947|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550948|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
43550949|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
43550950|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
43550951|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550953|NCT03618589|Analgesics|analgesics|mesh-ancestor
43550954|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
43550955|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711460|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711461|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43711462|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
43711463|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711464|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711465|NCT02689596|Oxytocin|oxytocin|mesh-list
43711466|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
43711467|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43711468|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711469|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43711470|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43711471|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711472|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
43711473|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43711474|NCT02689401|Hematinics|hematinics|mesh-ancestor
43711475|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43711476|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43711477|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43711478|NCT02689141|Ofatumumab|ofatumumab|mesh-list
43711479|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43711480|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
43711481|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550956|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550959|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550960|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550961|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43550962|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43563682|NCT01204099|Docetaxel|docetaxel|mesh-list
43550963|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43550964|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550965|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43550966|NCT03618472|Metformin|metformin|mesh-list
43550967|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43550968|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550969|NCT03618355|Sirolimus|sirolimus|mesh-list
43550970|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43550971|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550972|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43550973|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550974|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
43550975|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43550976|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
43550977|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550978|NCT03618316|Cimetidine|cimetidine|mesh-list
43550979|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43550980|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43550981|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43711482|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711484|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
43711485|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
43711486|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711487|NCT02689180|Furosemide|furosemide|mesh-list
43711488|NCT02689180|Diuretics|diuretics|mesh-ancestor
43711489|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
43711490|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711491|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43711492|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550982|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
43550983|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
43550984|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550985|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550986|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550987|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43550988|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43550989|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550990|NCT03618264|Dexamethasone|dexamethasone|mesh-list
43550991|NCT03618264|Ropivacaine|ropivacaine|mesh-list
43550992|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550993|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
43550994|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
43550995|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550996|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550997|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43550998|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
43550999|NCT03618264|Hormones|hormones|mesh-ancestor
43551000|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551015|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551016|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
43551017|NCT03618173|Hormones|hormones|mesh-ancestor
43551018|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551019|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43551020|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551021|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
43551022|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551023|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551024|NCT03618108|Azithromycin|azithromycin|mesh-list
43551025|NCT03618108|Doxycycline|doxycycline|mesh-list
43551026|NCT03618108|Rifabutin|rifabutin|mesh-list
43551027|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551028|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551029|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
43551030|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43551031|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43551032|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43551033|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
43551034|NCT03618082|Desflurane|desflurane|mesh-list
43551035|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43551036|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
43551037|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
43551038|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551039|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551040|NCT03617900|Acetaminophen|acetaminophen|mesh-list
43551041|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551042|NCT03617900|Analgesics|analgesics|mesh-ancestor
43551043|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
43551044|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551045|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551046|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
43551047|NCT03617575|Lactoferrin|lactoferrin|mesh-list
43711493|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711494|NCT02689245|Tenofovir|tenofovir|mesh-list
43711495|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
43711496|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711497|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43711500|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711501|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43711502|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43711503|NCT02689336|Temozolomide|temozolomide|mesh-list
43711504|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43711505|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43551048|NCT03617575|Fesoterodine|fesoterodine|mesh-list
43551049|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551050|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43551051|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43551052|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
43551053|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551054|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551055|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551056|NCT03617575|Urological Agents|urological agents|mesh-ancestor
43551057|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
43551058|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43551059|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551060|NCT03617510|Analgesics|analgesics|mesh-ancestor
43551061|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
43551062|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551063|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551068|NCT03617471|Acetaminophen|acetaminophen|mesh-list
43551069|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551070|NCT03617471|Analgesics|analgesics|mesh-ancestor
43551071|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
43551072|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551073|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551074|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
43551075|NCT03617432|Prednisone|prednisone|mesh-list
43551076|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
43551077|NCT03617432|Doxorubicin|doxorubicin|mesh-list
43551078|NCT03617432|Etoposide|etoposide|mesh-list
43551079|NCT03617432|Vincristine|vincristine|mesh-list
43551080|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43551081|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
43551082|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551083|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43551084|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43551085|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
43551086|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551087|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551088|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43551089|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43551090|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43551091|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43551092|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551093|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551094|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
43551095|NCT03617432|Hormones|hormones|mesh-ancestor
43551096|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551097|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43551098|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43711506|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
43711507|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711508|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711509|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43711510|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711511|NCT02689089|Rifapentine|rifapentine|mesh-list
43711512|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43711513|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
43711514|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43711515|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711516|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
43711517|NCT02689024|Acetaminophen|acetaminophen|mesh-list
43711518|NCT02689024|Dipyrone|dipyrone|mesh-list
43711519|NCT02689024|Ibuprofen|ibuprofen|mesh-list
43711520|NCT02689024|Diclofenac|diclofenac|mesh-list
43711521|NCT02689024|Naproxen|naproxen|mesh-list
43711522|NCT02689024|Fentanyl|fentanyl|mesh-list
43711523|NCT02689024|Morphine|morphine|mesh-list
43711524|NCT02689024|Bupivacaine|bupivacaine|mesh-list
43711525|NCT02689024|Ropivacaine|ropivacaine|mesh-list
43711526|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
43711527|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
43711528|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
43711529|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711530|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551100|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
43551101|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
43551102|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
43551103|NCT03617289|Analgesics|analgesics|mesh-ancestor
43551104|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
43551105|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551106|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551107|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
43551108|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551109|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551110|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
43551111|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43551112|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551113|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551114|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43551115|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
43551116|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43551117|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
43551118|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43551169|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43551170|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43551171|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43551172|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551173|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551174|NCT03616509|Hormones|hormones|mesh-list
43551175|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551178|NCT03616405|Tetracycline|tetracycline|mesh-list
43551179|NCT03616405|Furazolidone|furazolidone|mesh-list
43551180|NCT03616405|Rabeprazole|rabeprazole|mesh-list
43551181|NCT03616405|Bismuth|bismuth|mesh-list
43551182|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551183|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551184|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43551185|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551186|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43551187|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551188|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551189|NCT03616405|Antacids|antacids|mesh-ancestor
43760767|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
43551190|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43551191|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43551192|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43551193|NCT03616405|Renal Agents|renal agents|mesh-ancestor
43551194|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43551195|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43563691|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
43551196|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43551197|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43551198|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43551226|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551227|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551228|NCT03616236|Analgesics|analgesics|mesh-ancestor
43551229|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
43551230|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551231|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43551232|NCT03616132|Sirolimus|sirolimus|mesh-list
43551233|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551235|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43551236|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551237|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
43551238|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43551239|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
43551240|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551241|NCT03615950|Vitamin D|vitamin d|mesh-list
43551242|NCT03615950|Vitamins|vitamins|mesh-ancestor
43551243|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
43551244|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551245|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43551246|NCT03615833|Vitamin D|vitamin d|mesh-list
43551247|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
43551248|NCT03615833|Vitamins|vitamins|mesh-ancestor
43551249|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
43551250|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551252|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43551253|NCT03615768|Clindamycin|clindamycin|mesh-list
43551254|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
43551255|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
43551256|NCT03615768|Adapalene|adapalene|mesh-list
43551257|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551258|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551273|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551274|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43551275|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551276|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551277|NCT03615430|Anesthetics|anesthetics|mesh-list
43551278|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
43551279|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551280|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711557|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711558|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43711559|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43711560|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711561|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43711562|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43711563|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711564|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
43711565|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43711566|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43711567|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43711568|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
43711569|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711570|NCT02688803|Paclitaxel|paclitaxel|mesh-list
43551281|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
43551282|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551283|NCT03615417|Anesthetics|anesthetics|mesh-list
43551284|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551285|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551292|NCT03614832|Ticagrelor|ticagrelor|mesh-list
43551293|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43551294|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43551295|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43551296|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43563705|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43551297|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
43551298|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551299|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551300|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551301|NCT03614715|Interferons|interferons|mesh-list
43551302|NCT03614715|Interferon-beta|interferon-beta|mesh-list
43551303|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
43551304|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551305|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
43551306|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551307|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
43551308|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551309|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43551310|NCT03614533|Vaccines|vaccines|mesh-list
43551311|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
43551312|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711571|NCT02688803|Docetaxel|docetaxel|mesh-list
43711572|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43711573|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
43711574|NCT02688803|Doxorubicin|doxorubicin|mesh-list
43711575|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43711576|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43711577|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711578|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
43711579|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
43711580|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
43711581|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711582|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43711583|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
43711584|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551313|NCT03614455|Itraconazole|itraconazole|mesh-list
43551314|NCT03614455|Posaconazole|posaconazole|mesh-list
43551315|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
43551316|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
43551317|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551318|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43551319|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43551320|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551321|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551324|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551325|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551326|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43551332|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
43551333|NCT03614403|Vitamin D|vitamin d|mesh-list
43551334|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
43551335|NCT03614403|Vitamins|vitamins|mesh-ancestor
43551336|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
43551337|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551338|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43551339|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43551351|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
43551352|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551353|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43551354|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
43551355|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
43551356|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
43551357|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43551358|NCT03614221|Tacrolimus|tacrolimus|mesh-list
43551359|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43551360|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
43551361|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551362|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43551363|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551364|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551365|NCT03614065|Endostar protein|endostar protein|mesh-list
43711585|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711586|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43711587|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
43711588|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43711589|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43711590|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43711591|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43711592|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711593|NCT02688738|Doxycycline|doxycycline|mesh-list
43711594|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43711595|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711596|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
43711597|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43711598|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43711599|NCT02688465|Apomorphine|apomorphine|mesh-list
43711600|NCT02688465|Emetics|emetics|mesh-ancestor
43711601|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711602|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
43711603|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551366|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
43551367|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43551368|NCT03614065|Growth Substances|growth substances|mesh-ancestor
43551369|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551370|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
43551371|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551372|NCT03614052|Tamsulosin|tamsulosin|mesh-list
43551373|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43551374|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43551375|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43551376|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551391|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551392|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551393|NCT03613961|Anesthetics|anesthetics|mesh-list
43551394|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551395|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551396|NCT03613857|Clopidogrel|clopidogrel|mesh-list
43551404|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551405|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551407|NCT03613792|Midazolam|midazolam|mesh-list
43551408|NCT03613792|Ketamine|ketamine|mesh-list
43551409|NCT03613792|Remifentanil|remifentanil|mesh-list
43711604|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711606|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
43711607|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711608|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711609|NCT02688907|Adavosertib|adavosertib|mesh-list
43711610|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711611|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711612|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43711613|NCT02688634|Amoxicillin|amoxicillin|mesh-list
43711614|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711615|NCT02688491|Sunitinib|sunitinib|mesh-list
43711616|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711617|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43711618|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43711619|NCT02688491|Growth Substances|growth substances|mesh-ancestor
43711620|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711621|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
43711622|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43711623|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711624|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711626|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711627|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711628|NCT02688400|Celecoxib|celecoxib|mesh-list
43551410|NCT03613792|Analgesics|analgesics|mesh-ancestor
43551411|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
43551412|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734989|NCT02536209|Analgesics|analgesics|mesh-ancestor
43551413|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551414|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43551415|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43551416|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
43551417|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
43551418|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551419|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43551420|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43551421|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551422|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551424|NCT03613792|Narcotics|narcotics|mesh-ancestor
43551425|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43551426|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43551427|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43551428|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43551429|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43551430|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
43551431|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
43551432|NCT03613753|Irinotecan|irinotecan|mesh-list
43551433|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43711629|NCT02688400|Diacetylrhein|diacetylrhein|mesh-list
43711630|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43711631|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43711632|NCT02688400|Analgesics|analgesics|mesh-ancestor
43711633|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
43711634|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711635|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711636|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711637|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711638|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43711639|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43711640|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831734|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711641|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711642|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
43711643|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43711644|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43711645|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
43711646|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711647|NCT02688361|Expectorants|expectorants|mesh-ancestor
43711648|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
43711649|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43551434|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43551435|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551436|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551437|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551438|NCT03613597|Cisplatin|cisplatin|mesh-list
43551439|NCT03613597|Etoposide|etoposide|mesh-list
43551440|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
43551441|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551442|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43551443|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43551444|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43551445|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551446|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735000|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551447|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
43551448|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43551449|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551450|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551451|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551452|NCT03613558|Analgesics|analgesics|mesh-ancestor
43551453|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
43551454|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551455|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43551456|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43551457|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43551458|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551459|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551460|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711650|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
43711651|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711652|NCT02688361|Protective Agents|protective agents|mesh-ancestor
43711653|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711657|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43711658|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711660|NCT02688127|Coagulants|coagulants|mesh-ancestor
43831735|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831736|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43831737|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
43831738|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
43831739|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43831740|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43831741|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43831742|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43831743|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551461|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43551463|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
43551479|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
43551480|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551481|NCT03613389|Vitamin E|vitamin e|mesh-list
43551482|NCT03613389|Vitamins|vitamins|mesh-ancestor
43551483|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
43551484|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551485|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
43551486|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551487|NCT03613389|Protective Agents|protective agents|mesh-ancestor
43551488|NCT03613259|Alovudine|alovudine|mesh-list
43551489|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
43551490|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551491|NCT03613207|Lidocaine|lidocaine|mesh-list
43551492|NCT03613207|Prilocaine|prilocaine|mesh-list
43551493|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
43551494|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
43551495|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551496|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551497|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
43551498|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551499|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551500|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43551501|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43551502|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551503|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551504|NCT03613168|Trastuzumab|trastuzumab|mesh-list
43551505|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43551506|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551507|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
43551508|NCT03612947|Bupivacaine|bupivacaine|mesh-list
43551509|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
43551510|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
43831744|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831745|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831747|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43831748|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831749|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43831750|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43831751|NCT05299476|Growth Substances|growth substances|mesh-ancestor
43831752|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831753|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
43831754|NCT05299398|Trazodone|trazodone|mesh-list
43831755|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43831756|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43831757|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831759|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43831760|NCT05299398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43831761|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43831762|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43831763|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831764|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831765|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
43831766|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43831767|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
43831768|NCT05299086|Fluticasone|fluticasone|mesh-list
43831769|NCT05299086|Xhance|xhance|mesh-list
43831770|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831783|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831784|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43831785|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43831786|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
43831787|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831788|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711661|NCT02688374|Nicotine|nicotine|mesh-list
43711662|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43711663|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
43711664|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711665|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711666|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43711667|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43711668|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
43711669|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711670|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711671|NCT02688322|Sulbactam|sulbactam|mesh-list
43711672|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43711675|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711704|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43711705|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
43711706|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711707|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43711708|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43711709|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711710|NCT02688023|Antidotes|antidotes|mesh-ancestor
43711711|NCT02688023|Protective Agents|protective agents|mesh-ancestor
43711712|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
43711713|NCT02688023|Vitamins|vitamins|mesh-ancestor
43711714|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
43711715|NCT02687724|Golimumab|golimumab|mesh-list
43711716|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43711717|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711718|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43711719|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
43711720|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711721|NCT02687958|Everolimus|everolimus|mesh-list
43711722|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551512|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551513|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
43551514|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551516|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551517|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
43551518|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43551519|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551520|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551521|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43551522|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
43551523|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43551524|NCT03612817|Timolol|timolol|mesh-list
43551529|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551530|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551538|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551539|NCT03612557|Penicillins|penicillins|mesh-list
43551541|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43551542|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
43551543|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551544|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551545|NCT03612492|Lidocaine|lidocaine|mesh-list
43551546|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
43551547|NCT03612492|Anesthetics|anesthetics|mesh-list
43551548|NCT03612492|Esmolol|esmolol|mesh-list
43551549|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551550|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551551|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
43551552|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551553|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551554|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43711723|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43711724|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
43711725|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711726|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
43711727|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43711728|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711729|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551557|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551558|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43551559|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43551560|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551561|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551562|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43551563|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
43551564|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43551565|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551566|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551567|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551568|NCT03612440|Analgesics|analgesics|mesh-ancestor
43551569|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
43551570|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551571|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43551572|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43551573|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43551574|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551575|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551576|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551577|NCT03612401|Mirabegron|mirabegron|mesh-list
43551578|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43551579|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43551580|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43551581|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551582|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551583|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551584|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551585|NCT03612401|Urological Agents|urological agents|mesh-ancestor
43551591|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
43551592|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
43551593|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711734|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
43711735|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43711736|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
43711737|NCT02687932|Valsartan|valsartan|mesh-list
43711738|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43711739|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43711740|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43711741|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43711742|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711743|NCT02687867|Vitamin K|vitamin k|mesh-list
43711744|NCT02687867|Dabigatran|dabigatran|mesh-list
43711745|NCT02687867|Vitamins|vitamins|mesh-ancestor
43711746|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
43711747|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711748|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
43711749|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43551597|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43551598|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551599|NCT03612323|Analgesics|analgesics|mesh-ancestor
43551600|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551601|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43551602|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43551603|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551604|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551605|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43551606|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551607|NCT03612219|Cisplatin|cisplatin|mesh-list
43551608|NCT03612219|Apatinib|apatinib|mesh-list
43551609|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551610|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43551611|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551612|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551613|NCT03612180|Metoprolol|metoprolol|mesh-list
43551614|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551615|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43551616|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
43551617|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
43551618|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551619|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551620|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43551621|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43551622|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43551623|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551624|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551625|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551626|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
43711750|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
43711751|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711753|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
43711754|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43711755|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43711756|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
43711757|NCT02687867|Coagulants|coagulants|mesh-ancestor
43711758|NCT02687854|Vitamin K|vitamin k|mesh-list
43711759|NCT02687854|Apixaban|apixaban|mesh-list
43711760|NCT02687854|Vitamins|vitamins|mesh-ancestor
43711761|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
43711762|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711763|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43711764|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
43711765|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43711766|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
43711768|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711769|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
43711770|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43711771|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43711772|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
43551627|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
43551628|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551629|NCT03612037|Protective Agents|protective agents|mesh-ancestor
43551630|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551631|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
43551632|NCT03612037|Vitamins|vitamins|mesh-ancestor
43551633|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
43551634|NCT03611985|Taxane|taxane|mesh-list
43551635|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551636|NCT03611920|Tetracycline|tetracycline|mesh-list
43551637|NCT03611920|Dexamethasone|dexamethasone|mesh-list
43551638|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551639|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
43735037|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
43735038|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735039|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735040|NCT02535767|Primaquine|primaquine|mesh-list
43735041|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
43735042|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43735043|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43735044|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735045|NCT02535689|Tofacitinib|tofacitinib|mesh-list
43735046|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43735047|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735048|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735049|NCT02535351|Sunitinib|sunitinib|mesh-list
43735050|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735051|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43735052|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43566055|NCT00840281|Cefprozil|cefprozil|mesh-list
43551640|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
43551641|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551642|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551643|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551644|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
43551645|NCT03611920|Hormones|hormones|mesh-ancestor
43551646|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551647|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43551648|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551649|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43711778|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43711779|NCT02687347|Narcotics|narcotics|mesh-ancestor
43711780|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711781|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711782|NCT02687347|Analgesics|analgesics|mesh-ancestor
43711783|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
43711784|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711785|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
43711786|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
43711787|NCT02687425|Pioglitazone|pioglitazone|mesh-list
43711788|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
43551657|NCT03611504|Coagulants|coagulants|mesh-ancestor
43551658|NCT03611491|Lidocaine|lidocaine|mesh-list
43551659|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
43551660|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
43551668|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551669|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551671|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
43551672|NCT03611426|Coagulants|coagulants|mesh-ancestor
43551673|NCT03611348|Latanoprost|latanoprost|mesh-list
43551674|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43551675|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43551676|NCT03611244|Benzocaine|benzocaine|mesh-list
43551677|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
43551678|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
43551679|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551680|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551681|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
43551682|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551683|NCT03611179|Bevacizumab|bevacizumab|mesh-list
43551684|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43551685|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551686|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43551689|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551690|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
43551691|NCT03611049|Vitamin D|vitamin d|mesh-list
43551692|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
43551693|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
43551694|NCT03611049|Vitamins|vitamins|mesh-list
43551695|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
43551696|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551697|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43551698|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43551699|NCT03610945|Fluconazole|fluconazole|mesh-list
43551700|NCT03610945|Quinidine|quinidine|mesh-list
43551701|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
43551702|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711798|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43711799|NCT02687256|Heparin|heparin|mesh-list
43711800|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
43711801|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43711802|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43711803|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711804|NCT02687269|Ranolazine|ranolazine|mesh-list
43711805|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43711806|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551705|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551706|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551707|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43551708|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
43551709|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551710|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551711|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43551712|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43551713|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43551714|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43551715|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551716|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551717|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551718|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
43551719|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43551722|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43551724|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43551725|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43551726|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551727|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43551729|NCT03610932|Vitamins|vitamins|mesh-ancestor
43551730|NCT03610932|Micronutrients|micronutrients|mesh-ancestor
43551735|NCT03610893|Dexamethasone|dexamethasone|mesh-list
43551736|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
43551737|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551738|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
43551739|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
43551740|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711807|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711808|NCT02687204|Enoxaparin|enoxaparin|mesh-list
43711809|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
43711810|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
43711811|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43711812|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43711813|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711814|NCT02686983|Betamethasone|betamethasone|mesh-list
43711815|NCT02686983|Anesthetics|anesthetics|mesh-list
43711816|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
43711817|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711818|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711819|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
43711820|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711821|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711822|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
43711823|NCT02686983|Hormones|hormones|mesh-ancestor
43711824|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711825|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43711826|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
43711827|NCT02687178|Canrenone|canrenone|mesh-list
43711828|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43711829|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711830|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711831|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551741|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551742|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551743|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
43551744|NCT03610893|Hormones|hormones|mesh-ancestor
43551745|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551746|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43551747|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551748|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43551749|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551754|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43551755|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43551756|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551757|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551758|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551761|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551762|NCT03610685|Prednisolone|prednisolone|mesh-list
43711832|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43711833|NCT02687178|Diuretics|diuretics|mesh-ancestor
43711834|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
43711835|NCT02687009|Niclosamide|niclosamide|mesh-list
43711836|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
43711837|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43711838|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
43711839|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43711840|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711841|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
43711842|NCT02687100|Beclomethasone|beclomethasone|mesh-list
43711843|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711844|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
43711846|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711847|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711848|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43711849|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
43711850|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
43711852|NCT02686905|Vitamins|vitamins|mesh-list
43711853|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
43711854|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
43711855|NCT02686905|Calcium|calcium|mesh-list
43711856|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
43711857|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760768|NCT02443311|Hormones|hormones|mesh-ancestor
43551763|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551764|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
43551765|NCT03610685|Hormones|hormones|mesh-ancestor
43551766|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551767|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551768|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43551769|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551770|NCT03610347|Paclitaxel|paclitaxel|mesh-list
43551771|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43551772|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551773|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
43551775|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
43551776|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551777|NCT03610321|Gefarnate|gefarnate|mesh-list
43551778|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43551779|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551783|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551784|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551785|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43551786|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
43551787|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
43711858|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43711859|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43711860|NCT02686905|Hematinics|hematinics|mesh-ancestor
43711861|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
43711862|NCT02686619|Cyclosporine|cyclosporine|mesh-list
43711864|NCT02686619|Prednisolone|prednisolone|mesh-list
43711865|NCT02686619|Cyclosporins|cyclosporins|mesh-list
43711866|NCT02686619|Daclizumab|daclizumab|mesh-list
43711867|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711868|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711869|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43711870|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
43711871|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711872|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
43711873|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711874|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
43711875|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711876|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43551788|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43551789|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43551790|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43551791|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551804|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43551805|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43551806|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551808|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
43551810|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
43551811|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551812|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43551813|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43551814|NCT03610100|Gemcitabine|gemcitabine|mesh-list
43551815|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43551816|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
43551817|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551818|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551819|NCT03610100|Antiviral Agents|antiviral agents|mesh-ancestor
43551820|NCT03610100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551821|NCT03610100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551822|NCT03610100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43551823|NCT03610100|Immunologic Factors|immunologic factors|mesh-ancestor
43551824|NCT03610100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551825|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
43551826|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
43551827|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
43551828|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551829|NCT03609996|Ranibizumab|ranibizumab|mesh-list
43551830|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43551831|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43551832|NCT03609996|Growth Substances|growth substances|mesh-ancestor
43551833|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551834|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
43551835|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551837|NCT03609970|Vitamins|vitamins|mesh-ancestor
43711877|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43711878|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43711879|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711880|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711881|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
43711882|NCT02686619|Hormones|hormones|mesh-ancestor
43711883|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711884|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711885|NCT02686710|Propofol|propofol|mesh-list
43711886|NCT02686710|Sevoflurane|sevoflurane|mesh-list
43711887|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43711888|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711889|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711890|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43711891|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
43711892|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
43711893|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43711894|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43711895|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43711896|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
43711897|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43563755|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711898|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
43711899|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711900|NCT02686645|Metronidazole|metronidazole|mesh-list
43711901|NCT02686645|Vancomycin|vancomycin|mesh-list
43711902|NCT02686645|Loperamide|loperamide|mesh-list
43711903|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
43711904|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711905|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43711906|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43711907|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43711908|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551838|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
43551839|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551840|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43551841|NCT03609892|Amoxicillin|amoxicillin|mesh-list
43551842|NCT03609892|Tetracycline|tetracycline|mesh-list
43551843|NCT03609892|Furazolidone|furazolidone|mesh-list
43551844|NCT03609892|Esomeprazole|esomeprazole|mesh-list
43551845|NCT03609892|Bismuth|bismuth|mesh-list
43551846|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551847|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551848|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43551849|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551850|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43551851|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711909|NCT02686853|Amphotericin B|amphotericin b|mesh-list
43711910|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43711911|NCT02686853|Amebicides|amebicides|mesh-ancestor
43711912|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43711913|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43711914|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711915|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43711916|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
43711917|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43711918|NCT02686840|Misoprostol|misoprostol|mesh-list
43711919|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43711920|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
43711921|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43711922|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711923|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43711924|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711925|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
43711926|NCT02686827|Vitamin D|vitamin d|mesh-list
43711927|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
43711928|NCT02686827|Vitamins|vitamins|mesh-ancestor
43711929|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
43711930|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711931|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43847449|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43847450|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
43847451|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847452|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
43711946|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711947|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711948|NCT02686385|Protective Agents|protective agents|mesh-ancestor
43711949|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
43551852|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551853|NCT03609892|Antacids|antacids|mesh-ancestor
43551854|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43551855|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43551856|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43551857|NCT03609892|Renal Agents|renal agents|mesh-ancestor
43551858|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43551859|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43551876|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551877|NCT03609775|Ethanol|ethanol|mesh-list
43551878|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43551879|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551880|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551881|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551882|NCT03609489|Capecitabine|capecitabine|mesh-list
43551883|NCT03609489|Apatinib|apatinib|mesh-list
43551884|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43551885|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
43551886|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551887|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551888|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43551889|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551890|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
43551891|NCT03609359|Lenvatinib|lenvatinib|mesh-list
43551892|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43551893|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551894|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43551895|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551896|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551897|NCT03609307|Bevacizumab|bevacizumab|mesh-list
43551898|NCT03609307|Propranolol|propranolol|mesh-list
43551899|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43551900|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551901|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43551902|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43551903|NCT03609307|Growth Substances|growth substances|mesh-ancestor
43551904|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551911|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551912|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43551913|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
43551915|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43551916|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551917|NCT03609294|Incretins|incretins|mesh-ancestor
43711968|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711969|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711970|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711971|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43711972|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43711973|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711974|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711975|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43711976|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711977|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
43711978|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
43711980|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711981|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711982|NCT02686086|Albuterol|albuterol|mesh-list
43711983|NCT02686086|Ipratropium|ipratropium|mesh-list
43711984|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43711985|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
43711986|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711987|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711988|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43551927|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551928|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551929|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43551930|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43551931|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
43551932|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
43551933|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551934|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43551935|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43551936|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551937|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551938|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43551939|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43551940|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
43551941|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551942|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711989|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
43711990|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
43711991|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43711992|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43711993|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43711994|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43711995|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
43711996|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711997|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711998|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43711999|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
43712000|NCT02686177|Metformin|metformin|mesh-list
43712001|NCT02686177|Liraglutide|liraglutide|mesh-list
43712002|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43712003|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712004|NCT02686177|Incretins|incretins|mesh-ancestor
43712005|NCT02686177|Hormones|hormones|mesh-ancestor
43712006|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712007|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
43712009|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43712010|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
43712011|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712012|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
43712013|NCT02686047|Protective Agents|protective agents|mesh-ancestor
43712014|NCT02685852|Exenatide|exenatide|mesh-list
43712015|NCT02685852|Acarbose|acarbose|mesh-list
43712016|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43712017|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712018|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43712019|NCT02685852|Incretins|incretins|mesh-ancestor
43712020|NCT02685852|Hormones|hormones|mesh-ancestor
43712021|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712023|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712025|NCT02686021|Dipyrone|dipyrone|mesh-list
43712026|NCT02686021|Ibuprofen|ibuprofen|mesh-list
43712028|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43712030|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
43712031|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712032|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712033|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712034|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712035|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43712036|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712037|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712038|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
43712039|NCT02685748|Aspirin|aspirin|mesh-list
43712040|NCT02685748|Pantoprazole|pantoprazole|mesh-list
43712041|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43712042|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43712043|NCT02685748|Analgesics|analgesics|mesh-ancestor
43712044|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
43712045|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712046|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712047|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712048|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712049|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43712050|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43712051|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712052|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43712053|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43712054|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712055|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
43712056|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43712057|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712058|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43712071|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
43712072|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712073|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712074|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43712075|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
43712076|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
43712077|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
43712078|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43712079|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43712080|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43712081|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712082|NCT02685774|Metformin|metformin|mesh-list
43712083|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43712084|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712085|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
43712086|NCT02685670|Fludarabine|fludarabine|mesh-list
43712087|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712088|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
43712089|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712090|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712091|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43563757|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43712092|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
43712093|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712094|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712095|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43712096|NCT02686008|Olaparib|olaparib|mesh-list
43712097|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43712098|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712099|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712100|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712101|NCT02685618|Iloprost|iloprost|mesh-list
43712114|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43712115|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
43712116|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43712118|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43712119|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712120|NCT02685462|Digoxin|digoxin|mesh-list
43712121|NCT02685462|Caffeine|caffeine|mesh-list
43712122|NCT02685462|Atorvastatin|atorvastatin|mesh-list
43712123|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43712124|NCT02685462|Simvastatin|simvastatin|mesh-list
43712125|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43712126|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43712127|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
43712128|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712129|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43712130|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43712131|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712132|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43712133|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712134|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43712135|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43712136|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43712137|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
43712138|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712139|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43712140|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43712141|NCT02685462|Protective Agents|protective agents|mesh-ancestor
43712142|NCT02685306|Paclitaxel|paclitaxel|mesh-list
43712143|NCT02685306|Taxane|taxane|mesh-list
43712160|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43712161|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
43712162|NCT02685228|Gemcitabine|gemcitabine|mesh-list
43712163|NCT02685228|Decitabine|decitabine|mesh-list
43712164|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43712165|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
43712166|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712167|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712168|NCT02685228|Antiviral Agents|antiviral agents|mesh-ancestor
43712169|NCT02685228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712225|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712226|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43563762|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43712227|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
43712238|NCT02685176|Protective Agents|protective agents|mesh-ancestor
43712239|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712240|NCT02685085|Misoprostol|misoprostol|mesh-list
43712241|NCT02685085|Dinoprostone|dinoprostone|mesh-list
43712242|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43712243|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
43712244|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43712245|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712246|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43712247|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712248|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
43712249|NCT02685059|Paclitaxel|paclitaxel|mesh-list
43712276|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43712277|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712278|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712279|NCT02684708|Prednisone|prednisone|mesh-list
43712280|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
43712281|NCT02684708|Dacarbazine|dacarbazine|mesh-list
43712282|NCT02684708|Vincristine|vincristine|mesh-list
43712283|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712284|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
43712285|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712286|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712287|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43712288|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
43712289|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712290|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712291|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43712292|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712293|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
43712294|NCT02684708|Hormones|hormones|mesh-ancestor
43831813|NCT05294835|Ketamine|ketamine|mesh-list
43712352|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
43712353|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712354|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712355|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43712356|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43712357|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
43712358|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43712359|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43712361|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
43712405|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43712406|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43712407|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712408|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712409|NCT02683837|Remifentanil|remifentanil|mesh-list
43712410|NCT02683837|Sevoflurane|sevoflurane|mesh-list
43712411|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43712412|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43712413|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
43712414|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
43712416|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712417|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43712418|NCT02683837|Narcotics|narcotics|mesh-ancestor
43712419|NCT02683837|Analgesics|analgesics|mesh-ancestor
43712420|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
43712464|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712465|NCT02683603|Imipenem|imipenem|mesh-list
43712466|NCT02683603|Colistin|colistin|mesh-list
43712467|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43712468|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712469|NCT02683369|Iron|iron|mesh-list
43712470|NCT02683369|Trace Elements|trace elements|mesh-ancestor
43712471|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
43712472|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712473|NCT02682953|Plerixafor|plerixafor|mesh-list
43712474|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43712475|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43712476|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
43712477|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712478|NCT02683031|Ionophores|ionophores|mesh-list
43712486|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712487|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
43712488|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712489|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43712490|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
43712510|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
43712511|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712512|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43712513|NCT02683070|Narcotics|narcotics|mesh-ancestor
43712514|NCT02683070|Analgesics|analgesics|mesh-ancestor
43712515|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
43712516|NCT02683291|Sirolimus|sirolimus|mesh-list
43712517|NCT02683291|Prednisone|prednisone|mesh-list
43712518|NCT02683291|Tacrolimus|tacrolimus|mesh-list
43712519|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
43712520|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43712521|NCT02683291|Basiliximab|basiliximab|mesh-list
43712522|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712523|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
43712524|NCT02683291|Hormones|hormones|mesh-ancestor
43712525|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712526|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712527|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43712528|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712529|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712530|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
43712531|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43712532|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712533|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712534|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43712535|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43712544|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
43712545|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712546|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712547|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43712548|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
43712549|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
43712550|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43712551|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
43712552|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712553|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712554|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
43831823|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43831824|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43831825|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831826|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831827|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43831828|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43831829|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43831831|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43831832|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43831833|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43831834|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43831835|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
43735107|NCT05299164|Gemcitabine|gemcitabine|mesh-list
43831836|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831838|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831859|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831860|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831861|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
43831862|NCT05293210|Hormones|hormones|mesh-ancestor
43831863|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831864|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43712555|NCT02682693|Denosumab|denosumab|mesh-list
43712556|NCT02682693|Paclitaxel|paclitaxel|mesh-list
43712557|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
43712558|NCT02682693|Carboplatin|carboplatin|mesh-list
43712559|NCT02682693|Trastuzumab|trastuzumab|mesh-list
43712560|NCT02682693|Epirubicin|epirubicin|mesh-list
43712561|NCT02682693|Pertuzumab|pertuzumab|mesh-list
43712562|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43712563|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712564|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
43712565|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
43712566|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
43712567|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712568|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712569|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
43712581|NCT02682680|Ezetimibe|ezetimibe|mesh-list
43712604|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
43712605|NCT02682485|Neomycin|neomycin|mesh-list
43712606|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712607|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43712608|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43712609|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43712610|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43712611|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43712612|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712613|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712614|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712615|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43712616|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43712617|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43831865|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831866|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43831867|NCT05292872|Cathartics|cathartics|mesh-ancestor
43831868|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831869|NCT05292690|Caffeine|caffeine|mesh-list
43831870|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43831871|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831872|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43831873|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831874|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831876|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43712640|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
43712641|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712642|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712643|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712644|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
43712645|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712646|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
43712647|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43712706|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712708|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
43712709|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712710|NCT02681887|Protective Agents|protective agents|mesh-ancestor
43712711|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712712|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712715|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
43712716|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712717|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712718|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43712719|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
43712720|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43712722|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
43712723|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712724|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712725|NCT02681783|Aflibercept|aflibercept|mesh-list
43712726|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43712727|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43712728|NCT02681783|Growth Substances|growth substances|mesh-ancestor
43712729|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712730|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
43712731|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712733|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43712734|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43712735|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43712736|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43712737|NCT02681679|Analgesics|analgesics|mesh-ancestor
43712738|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
43712739|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712740|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712741|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712762|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43712763|NCT02681471|Diuretics|diuretics|mesh-ancestor
43712764|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
43712765|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712766|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43712767|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
43712768|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
43712769|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43712770|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43712771|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712772|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
43712773|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43712774|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43712775|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43712776|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712777|NCT02681796|Bupivacaine|bupivacaine|mesh-list
43712778|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712779|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
43712780|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712781|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712816|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712817|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712818|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712819|NCT02680938|Oxytocin|oxytocin|mesh-list
43712820|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
43712821|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43712822|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712823|NCT02680951|Cytarabine|cytarabine|mesh-list
43712824|NCT02680951|Fludarabine|fludarabine|mesh-list
43712825|NCT02680951|Dasatinib|dasatinib|mesh-list
43712826|NCT02680951|Idarubicin|idarubicin|mesh-list
43712827|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712828|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43712829|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
43712872|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712873|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
43712874|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712875|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712876|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
43712877|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712878|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712879|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
43712880|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
43712881|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712882|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
43712883|NCT02680548|Hormones|hormones|mesh-ancestor
43712884|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712885|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43712886|NCT02680548|Protective Agents|protective agents|mesh-ancestor
43712887|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43712888|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712889|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
43712890|NCT02680626|Ropivacaine|ropivacaine|mesh-list
43712891|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712892|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
43712893|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712894|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712895|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
43712896|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712897|NCT02680626|Analgesics|analgesics|mesh-ancestor
43712898|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43712902|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712903|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43712905|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43712906|NCT02680808|Olorofim|olorofim|mesh-list
43712907|NCT02680808|Midazolam|midazolam|mesh-list
43712910|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712911|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712912|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43712913|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43712914|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43712915|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43712916|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
43712917|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
43712918|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
43712919|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
43712920|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712956|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712957|NCT02679963|Olaparib|olaparib|mesh-list
43712958|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43712959|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712960|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712961|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712962|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
43712963|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43712964|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
43712965|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712966|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
43712967|NCT02679924|Protective Agents|protective agents|mesh-ancestor
43712968|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43712969|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43712970|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43712971|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
43712972|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712973|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43712974|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43712975|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712976|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
43712977|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
43712978|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
43712979|NCT02679833|Vitamins|vitamins|mesh-ancestor
43712980|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
43712981|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712982|NCT02679833|Hematinics|hematinics|mesh-ancestor
43712983|NCT02679820|Copper|copper|mesh-list
43712984|NCT02679820|Trace Elements|trace elements|mesh-ancestor
43712985|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
43712986|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712987|NCT02679339|Lidocaine|lidocaine|mesh-list
43712988|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712989|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
43712990|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712991|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712992|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
43551943|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43551944|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43712993|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712994|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43712998|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712999|NCT02679456|Fluconazole|fluconazole|mesh-list
43713000|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
43713001|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
43713002|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713003|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43713004|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43713005|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713006|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713007|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43713008|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
43713009|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713010|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713011|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43571679|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
43713012|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43713013|NCT02679261|Atorvastatin|atorvastatin|mesh-list
43713014|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43713015|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43713016|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
43713017|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713018|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43713020|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713035|NCT02679014|Petesicatib|petesicatib|mesh-list
43713036|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713037|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713038|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43713039|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713040|NCT02679131|Belinostat|belinostat|mesh-list
43713041|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713042|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43713043|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713044|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713045|NCT02679092|Misoprostol|misoprostol|mesh-list
43713046|NCT02679092|Mifepristone|mifepristone|mesh-list
43713047|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43713048|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
43713049|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43713050|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713051|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43713052|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43713053|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
43713054|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43713055|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43713056|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43713057|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43713083|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43713084|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43713085|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43713086|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
43713087|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713088|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713089|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
43713090|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43713091|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713092|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713093|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713094|NCT02678728|Analgesics|analgesics|mesh-ancestor
43713095|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
43713096|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713097|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43713098|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43713099|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43713100|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
43713101|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713102|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831891|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43831892|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831893|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43831894|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43831895|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43831896|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831897|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
43831898|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
43831899|NCT05291845|Vaccines|vaccines|mesh-list
43831900|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
43831901|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831902|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
43831903|NCT05290662|Fludarabine|fludarabine|mesh-list
43831904|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831905|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
43831906|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713108|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43713109|NCT02678767|Hematinics|hematinics|mesh-ancestor
43713110|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43713111|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43713113|NCT02678520|Bicalutamide|bicalutamide|mesh-list
43713117|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713134|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713135|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43713136|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43713138|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43713139|NCT02678338|Magrolimab|magrolimab|mesh-list
43713140|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43713141|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713142|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
43713143|NCT02678507|Narcotics|narcotics|mesh-ancestor
43713144|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713145|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713146|NCT02678507|Analgesics|analgesics|mesh-ancestor
43713147|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
43713148|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713149|NCT02678598|Micafungin|micafungin|mesh-list
43713150|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
43713151|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713152|NCT02678364|Vitamin D|vitamin d|mesh-list
43713153|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
43713154|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43713155|NCT02678364|Calcifediol|calcifediol|mesh-list
43713156|NCT02678364|Vitamins|vitamins|mesh-ancestor
43713157|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
43713158|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713159|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43713160|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43713161|NCT02678585|Lidocaine|lidocaine|mesh-list
43713183|NCT02678260|Spartalizumab|spartalizumab|mesh-list
43713184|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43713185|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713186|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713187|NCT02678195|Amoxicillin|amoxicillin|mesh-list
43713188|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43713189|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713190|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
43713191|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43713192|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43713193|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713194|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
43713195|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
43713196|NCT02678221|Aspirin|aspirin|mesh-list
43713197|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
43713198|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43713199|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713200|NCT02678221|Analgesics|analgesics|mesh-ancestor
43713201|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
43713202|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713203|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713204|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713205|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713206|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43713207|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43713208|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713209|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43713210|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43713211|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713212|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
43713213|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
43713221|NCT02678234|Vitamins|vitamins|mesh-ancestor
43713225|NCT02678234|Analgesics|analgesics|mesh-ancestor
43713226|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
43713227|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713228|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
43713229|NCT02678234|Antioxidants|antioxidants|mesh-ancestor
43713230|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713231|NCT02678234|Protective Agents|protective agents|mesh-ancestor
43713232|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43713233|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
43713234|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
43713235|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
43713236|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43713237|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
43713238|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
43713239|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43713240|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43713241|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43713242|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
43713243|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713244|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
43713245|NCT02678117|Pregabalin|pregabalin|mesh-list
43713246|NCT02678117|Analgesics|analgesics|mesh-ancestor
43713247|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
43713248|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713249|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713250|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
43713251|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43713252|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713253|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713254|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43713270|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713272|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43713273|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43713274|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713275|NCT02677597|Paclitaxel|paclitaxel|mesh-list
43713276|NCT02677597|Cisplatin|cisplatin|mesh-list
43713277|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43713278|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713279|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
43713280|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
43713281|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
43713282|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713283|NCT02677584|Caffeine|caffeine|mesh-list
43713284|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
43713285|NCT02677584|Citric Acid|citric acid|mesh-list
43713286|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
43713287|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
43713288|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43713289|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
43713290|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
43713291|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713292|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43713293|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713294|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43713295|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713319|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713321|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
43713322|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713323|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713324|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
43713325|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43713326|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43713327|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
43713328|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
43713329|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
43713330|NCT02677519|Methylphenidate|methylphenidate|mesh-list
43713331|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43713332|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713333|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43713334|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43713335|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713336|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713337|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
43713338|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713339|NCT02677415|Anesthetics|anesthetics|mesh-list
43713340|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
43713341|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713342|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713343|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
43713344|NCT02677376|Listerine|listerine|mesh-list
43713345|NCT02677376|Fluorides|fluorides|mesh-list
43713350|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43713352|NCT02677155|Rituximab|rituximab|mesh-list
43713360|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43713361|NCT02677259|Estradiol|estradiol|mesh-list
43713362|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43713363|NCT02677259|Progesterone|progesterone|mesh-list
43713364|NCT02677259|Estrogens|estrogens|mesh-ancestor
43713365|NCT02677259|Hormones|hormones|mesh-ancestor
43713366|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713367|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713368|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43713369|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
43713370|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43713371|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43713372|NCT02677259|Progestins|progestins|mesh-ancestor
43713373|NCT02677246|Denosumab|denosumab|mesh-list
43713374|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43713375|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713376|NCT02677077|Natalizumab|natalizumab|mesh-list
43713377|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
43713378|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713379|NCT02676986|Exemestane|exemestane|mesh-list
43713380|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713381|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43713382|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43713383|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713384|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713385|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43713386|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
43713387|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713388|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713389|NCT02676934|Anesthetics|anesthetics|mesh-list
43713390|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713391|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713392|NCT02676622|Aldesleukin|aldesleukin|mesh-list
43713393|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
43713394|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
43713395|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43713396|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
43713397|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713398|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713399|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43713400|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
43713401|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713402|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713403|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43713404|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43713405|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43713406|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
43713407|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831912|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43831913|NCT05290116|Apatinib|apatinib|mesh-list
43831914|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831915|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831916|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831917|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831918|NCT05290025|Nicotine|nicotine|mesh-list
43831919|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43831920|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
43831921|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831922|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831923|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43551945|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831924|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43831925|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
43831926|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831927|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831928|NCT05289869|Oxytocin|oxytocin|mesh-list
43831929|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
43831930|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43831934|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43831936|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831937|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831938|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
43735138|NCT05298761|Analgesics|analgesics|mesh-ancestor
43831939|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831940|NCT05289830|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43831941|NCT05289830|Antidepressive Agents|antidepressive agents|mesh-ancestor
43831942|NCT05289830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43831943|NCT05288400|Amlodipine|amlodipine|mesh-list
43831944|NCT05288400|Bisoprolol|bisoprolol|mesh-list
43831945|NCT05288400|Perindopril|perindopril|mesh-list
43831946|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43831947|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43831948|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43831949|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831950|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43831951|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831952|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
43831953|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
43831954|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
43831955|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831956|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43831957|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43551946|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551947|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551948|NCT03609086|Melatonin|melatonin|mesh-list
43551949|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
43831958|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43831959|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
43831960|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831961|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43831962|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
43831963|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831964|NCT05288348|Sufentanil|sufentanil|mesh-list
43831965|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43831966|NCT05288348|Narcotics|narcotics|mesh-ancestor
43831967|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831968|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831969|NCT05288348|Analgesics|analgesics|mesh-ancestor
43831970|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
43831971|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831972|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43831973|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43713408|NCT02676674|Vitamin D|vitamin d|mesh-list
43713409|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
43713410|NCT02676674|Vitamins|vitamins|mesh-ancestor
43713411|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
43713412|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713413|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43713414|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43713415|NCT02676609|Insulin|insulin|mesh-list
43713416|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43735148|NCT05298683|Acetaminophen|acetaminophen|mesh-list
43713417|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713418|NCT02676739|Adderall|adderall|mesh-list
43713419|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43713440|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713441|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713442|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713443|NCT02676154|Urological Agents|urological agents|mesh-ancestor
43713444|NCT02676310|Bimatoprost|bimatoprost|mesh-list
43713445|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43713446|NCT02676323|Leucovorin|leucovorin|mesh-list
43713447|NCT02676323|Cytarabine|cytarabine|mesh-list
43713448|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
43713449|NCT02676323|Methotrexate|methotrexate|mesh-list
43713450|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
43713451|NCT02676323|Fludarabine|fludarabine|mesh-list
43713452|NCT02676323|Panobinostat|panobinostat|mesh-list
43713453|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
43713454|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713455|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43713456|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
43713457|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43713458|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43713459|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
43713460|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713461|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713462|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
43713463|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713464|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43713465|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43713466|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
43713467|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713468|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43713469|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
43713470|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713471|NCT02676323|Antidotes|antidotes|mesh-ancestor
43713472|NCT02676323|Protective Agents|protective agents|mesh-ancestor
43713473|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
43713474|NCT02676323|Vitamins|vitamins|mesh-ancestor
43713475|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
43713476|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713480|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43713481|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713482|NCT02676336|Trace Elements|trace elements|mesh-ancestor
43713483|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
43713544|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
43713545|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43713546|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43713547|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713548|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
43713549|NCT02675647|Coagulants|coagulants|mesh-ancestor
43713550|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43713551|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
43713552|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43713553|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
43713554|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713556|NCT02675530|Analgesics|analgesics|mesh-ancestor
43713557|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
43713558|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713572|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713573|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43713574|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43713575|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43834468|NCT05133817|Norepinephrine|norepinephrine|mesh-list
43713576|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713577|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
43713578|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713579|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43713580|NCT02675309|Simvastatin|simvastatin|mesh-list
43713581|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43713582|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43713583|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
43713584|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713585|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43713586|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43713587|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713588|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
43713589|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43713590|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
43713591|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
43713592|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713593|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713594|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713620|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43713621|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713622|NCT02675205|Analgesics|analgesics|mesh-ancestor
43713623|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
43713624|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713625|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713626|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713627|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713628|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43713629|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43713630|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713631|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43713632|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43713633|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713635|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43713636|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43713637|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43713638|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
43713639|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713640|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
43713674|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713675|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
43713676|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713677|NCT02675140|Protective Agents|protective agents|mesh-ancestor
43713678|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43713679|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713680|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
43713681|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43713682|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713683|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
43713684|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43713685|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43713686|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
43713687|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
43713688|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
43713689|NCT02675023|Adalimumab|adalimumab|mesh-list
43713690|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713691|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713692|NCT02674906|Heparin|heparin|mesh-list
43713693|NCT02674906|Calcium heparin|calcium heparin|mesh-list
43713694|NCT02674906|Anticoagulants|anticoagulants|mesh-list
43713695|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713696|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43713715|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713717|NCT02674737|Narcotics|narcotics|mesh-ancestor
43713718|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43713719|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713720|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713721|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43713722|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713723|NCT02674893|Liraglutide|liraglutide|mesh-list
43713724|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43713725|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713772|NCT02674191|Mepivacaine|mepivacaine|mesh-list
43713773|NCT02674191|Benzocaine|benzocaine|mesh-list
43713774|NCT02674191|Povidone|povidone|mesh-list
43713775|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43713864|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43713865|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43713866|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713867|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713868|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
43713869|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713876|NCT02672995|Bevacizumab|bevacizumab|mesh-list
43713877|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43713878|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713879|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43713880|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43713881|NCT02672995|Growth Substances|growth substances|mesh-ancestor
43713882|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713883|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
43713884|NCT02672709|Apixaban|apixaban|mesh-list
43713885|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43713886|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
43713887|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43713888|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
43713889|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713890|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713916|NCT02672488|Sorafenib|sorafenib|mesh-list
43713917|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43713918|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713919|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713920|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43713985|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713986|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
43713987|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43713988|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713989|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713990|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
43713992|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
43713993|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
43713994|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713995|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713996|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713997|NCT02671578|Analgesics|analgesics|mesh-ancestor
43714000|NCT02671695|Amlodipine|amlodipine|mesh-list
43832028|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832029|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
43832030|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
43832031|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832032|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714075|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43714076|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43714077|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714078|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43714079|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43714080|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43714081|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
43735201|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
43714082|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714083|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43714084|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43714085|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714086|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
43714087|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
43714126|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714127|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43714128|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43714129|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43714130|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714131|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714132|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43714133|NCT02670759|Bupivacaine|bupivacaine|mesh-list
43714134|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
43714135|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
43714190|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714191|NCT02670317|Prednisone|prednisone|mesh-list
43714192|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
43714193|NCT02670317|Doxorubicin|doxorubicin|mesh-list
43714194|NCT02670317|Vincristine|vincristine|mesh-list
43714195|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
43714196|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43714197|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
43714198|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714199|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714200|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43714201|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
43714211|NCT02670317|Hormones|hormones|mesh-ancestor
43714252|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714253|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43714254|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43714268|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714269|NCT02670135|Triclosan|triclosan|mesh-list
43714270|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43714271|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714272|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43714273|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43714303|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43714304|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43714305|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43714306|NCT02669641|Choline|choline|mesh-list
43714307|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
43714308|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43714309|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
43714310|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714311|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714312|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43714313|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
43714314|NCT02669589|Heparin|heparin|mesh-list
43714315|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
43714316|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714392|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43714394|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43714395|NCT02668796|Estrogens|estrogens|mesh-ancestor
43714396|NCT02668796|Hormones|hormones|mesh-ancestor
43714397|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714398|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714399|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43714400|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
43714401|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43714402|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43714403|NCT02668861|Vitamin D|vitamin d|mesh-list
43714408|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43714410|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43714411|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
43714412|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714413|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43714445|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
43714446|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43714447|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43714448|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43735209|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714449|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43714450|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714451|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714452|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
43714453|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714454|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714455|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43714456|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714457|NCT02668588|Octreotide|octreotide|mesh-list
43714458|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714459|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714460|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714461|NCT02668016|Atorvastatin|atorvastatin|mesh-list
43714462|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43714463|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43714464|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43714465|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
43714466|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714493|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43714494|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43714495|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714496|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714497|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43714498|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43714499|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
43714500|NCT02668094|Analgesics|analgesics|mesh-ancestor
43714501|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
43714502|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43714571|NCT02667262|Narcotics|narcotics|mesh-ancestor
43714572|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714573|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714574|NCT02667262|Analgesics|analgesics|mesh-ancestor
43714575|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
43714576|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714577|NCT02667223|Bococizumab|bococizumab|mesh-list
43714584|NCT02667353|Etomidate|etomidate|mesh-list
43714633|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714634|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714635|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
43714636|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714640|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43714641|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43714642|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714643|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714644|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43714645|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
43714646|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714647|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714648|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43714649|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43714650|NCT02666768|Interferons|interferons|mesh-list
43714651|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
43714652|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714653|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
43714654|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714655|NCT02666651|Tolvaptan|tolvaptan|mesh-list
43714656|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43714657|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714658|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
43714659|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714660|NCT02666534|Lidocaine|lidocaine|mesh-list
43832097|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43832103|NCT05280769|Nicotine|nicotine|mesh-list
43832104|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43832105|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
43832106|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832107|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832108|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43832109|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43832110|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
43832111|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832112|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832113|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
43832114|NCT05280496|Metformin|metformin|mesh-list
43832115|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43832116|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714867|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
43714868|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43714892|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43714893|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43714894|NCT02665533|Analgesics|analgesics|mesh-ancestor
43714895|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
43714896|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714897|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43714898|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43714899|NCT02665533|Narcotics|narcotics|mesh-ancestor
43714900|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714901|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
43714902|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
43714903|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
43714904|NCT02665624|Sennosides|sennosides|mesh-list
43714905|NCT02665624|Senna Extract|senna extract|mesh-list
43714906|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43714907|NCT02665624|Calcium|calcium|mesh-list
43714908|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43551950|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551951|NCT03609086|Protective Agents|protective agents|mesh-ancestor
43551952|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551954|NCT03608761|Rebamipide|rebamipide|mesh-list
43551955|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43551956|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551957|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
43551958|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551959|NCT03608761|Protective Agents|protective agents|mesh-ancestor
43551960|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551961|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829681|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551971|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43551992|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
43551993|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551994|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714909|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714910|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43714911|NCT02665624|Laxatives|laxatives|mesh-ancestor
43714912|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714913|NCT02665624|Cathartics|cathartics|mesh-ancestor
43714914|NCT02665351|Peramivir|peramivir|mesh-list
43714915|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
43714916|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714917|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714918|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714919|NCT02665416|Bevacizumab|bevacizumab|mesh-list
43714920|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43714921|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714922|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43714923|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43714924|NCT02665416|Growth Substances|growth substances|mesh-ancestor
43714925|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714926|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
43552022|NCT03608241|Estradiol|estradiol|mesh-list
43552023|NCT03608241|Estrogens|estrogens|mesh-ancestor
43552024|NCT03608241|Hormones|hormones|mesh-ancestor
43552025|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552026|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552027|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43552028|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43552029|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43714932|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43714933|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43714934|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
43714935|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714936|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714939|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714940|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43714941|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
43714942|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714943|NCT02665039|Antiviral Agents|antiviral agents|mesh-ancestor
43714950|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
43714951|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
43714952|NCT02664857|Vitamins|vitamins|mesh-list
43714953|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
43714954|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714955|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43714965|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
43714966|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43714967|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43552085|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552087|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43552088|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552089|NCT03607643|Leucovorin|leucovorin|mesh-list
43552090|NCT03607643|Gemcitabine|gemcitabine|mesh-list
43552091|NCT03607643|Bevacizumab|bevacizumab|mesh-list
43552092|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
43552093|NCT03607643|Irinotecan|irinotecan|mesh-list
43552095|NCT03607643|Bortezomib|bortezomib|mesh-list
43552096|NCT03607643|Cannabidiol|cannabidiol|mesh-list
43552097|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43552098|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552099|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43552100|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43552101|NCT03607643|Growth Substances|growth substances|mesh-ancestor
43552102|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552103|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
43552104|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43552105|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
43552106|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552107|NCT03607643|Antiviral Agents|antiviral agents|mesh-ancestor
43552108|NCT03607643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552109|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552110|NCT03607643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552111|NCT03607643|Immunologic Factors|immunologic factors|mesh-ancestor
43552112|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43552113|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43552114|NCT03607643|Antidotes|antidotes|mesh-ancestor
43552115|NCT03607643|Protective Agents|protective agents|mesh-ancestor
43552116|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
43552117|NCT03607643|Vitamins|vitamins|mesh-ancestor
43552118|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
43552119|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43552120|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
43552121|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
43552122|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
43552123|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43552124|NCT03607578|Protective Agents|protective agents|mesh-ancestor
43552125|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552126|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
43552127|NCT03607383|Red yeast rice|red yeast rice|mesh-list
43552128|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43552129|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43552130|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43552131|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
43552132|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552133|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552134|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43552135|NCT03607331|Citalopram|citalopram|mesh-list
43552136|NCT03607331|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43552137|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43552138|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552139|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552141|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
43552142|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714969|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
43714970|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43714971|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
43714972|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714973|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
43714976|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714977|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714978|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
43714979|NCT02664493|Hormones|hormones|mesh-ancestor
43714980|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714981|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43714982|NCT02664493|Protective Agents|protective agents|mesh-ancestor
43714983|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714984|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714985|NCT02664116|Diclofenac|diclofenac|mesh-list
43714986|NCT02664116|Ketorolac|ketorolac|mesh-list
43714987|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43714988|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43714989|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43714990|NCT02664116|Analgesics|analgesics|mesh-ancestor
43714991|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
43714992|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714993|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714994|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714995|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714996|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43714997|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552143|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43552144|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
43552145|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43552153|NCT03607175|Triamcinolone|triamcinolone|mesh-list
43552154|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43552155|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552156|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
43552158|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552159|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552160|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552161|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
43552162|NCT03607149|Pemetrexed|pemetrexed|mesh-list
43552163|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552164|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714998|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714999|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
43715000|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43715001|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
43715002|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715003|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715005|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
43715006|NCT02664142|Anesthetics|anesthetics|mesh-list
43715007|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715008|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715009|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43715010|NCT02664168|Laxatives|laxatives|mesh-ancestor
43715011|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715019|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
43715020|NCT02664103|Capecitabine|capecitabine|mesh-list
43715021|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43715022|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
43715023|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715024|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715025|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43715026|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
43715027|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552165|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552166|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43552167|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43552168|NCT03607110|Fentanyl|fentanyl|mesh-list
43552169|NCT03607110|Ketamine|ketamine|mesh-list
43552170|NCT03607110|Analgesics|analgesics|mesh-ancestor
43552171|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
43552172|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552173|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552174|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43552175|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43552176|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
43552177|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
43715028|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715029|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43715030|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43715031|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
43715032|NCT02663999|Diazepam|diazepam|mesh-list
43715033|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43715034|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
43715035|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
43715036|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
43715037|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715038|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552178|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552179|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43552180|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43552181|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552182|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552183|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43552184|NCT03607110|Narcotics|narcotics|mesh-ancestor
43552185|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43552186|NCT03607071|Prednisolone|prednisolone|mesh-list
43552187|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552188|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
43552189|NCT03607071|Hormones|hormones|mesh-ancestor
43552190|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552191|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552192|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43552193|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552194|NCT03606928|Leucovorin|leucovorin|mesh-list
43552195|NCT03606928|Docetaxel|docetaxel|mesh-list
43552196|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
43552197|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552198|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
43552203|NCT03606928|Protective Agents|protective agents|mesh-ancestor
43552204|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552205|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
43552207|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
43552208|NCT03606902|Fentanyl|fentanyl|mesh-list
43552209|NCT03606902|Bupivacaine|bupivacaine|mesh-list
43552210|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
43552222|NCT03606824|Pitavastatin|pitavastatin|mesh-list
43552223|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43552224|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43552225|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43552226|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
43552227|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552228|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552229|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43552230|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
43552231|NCT03606681|Calcium|calcium|mesh-list
43552232|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43552233|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552234|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43715041|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715042|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43715044|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43715045|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43715046|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43715047|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43715048|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
43715049|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
43715050|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
43715051|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
43552245|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
43552246|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552247|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715052|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715053|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715054|NCT02664012|Menthol|menthol|mesh-list
43715055|NCT02664012|Nicotine|nicotine|mesh-list
43715056|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43715057|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
43715058|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715059|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552256|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43552257|NCT03606577|Growth Substances|growth substances|mesh-ancestor
43552258|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
43552259|NCT03606473|Amphetamine|amphetamine|mesh-list
43552260|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
43552261|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43552262|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552263|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
43552264|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
43552265|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552266|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
43552267|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552268|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552269|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552270|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43552271|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43552272|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552273|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43552274|NCT03606369|Ondansetron|ondansetron|mesh-list
43552275|NCT03606369|Palonosetron|palonosetron|mesh-list
43552292|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43552295|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43552296|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552297|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43552298|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552299|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
43552300|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43552302|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552303|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43552304|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43552305|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552306|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552307|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552308|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43552309|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
43552310|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43552311|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552312|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43552313|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43552314|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43552316|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43552317|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
43552318|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43552319|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552320|NCT03605940|Methoxsalen|methoxsalen|mesh-list
43552321|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43715072|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43552332|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
43552333|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43552334|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
43552352|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
43552353|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552354|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43552368|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552369|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43552370|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552371|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
43552372|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43552373|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43552374|NCT03605056|Growth Substances|growth substances|mesh-ancestor
43552375|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
43552376|NCT03604796|Acetaminophen|acetaminophen|mesh-list
43552377|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43552378|NCT03604796|Analgesics|analgesics|mesh-ancestor
43552379|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
43552380|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552395|NCT03604627|Calcium|calcium|mesh-list
43552396|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43552397|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715073|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
43715074|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715075|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715076|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715077|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
43715078|NCT02663830|Clomiphene|clomiphene|mesh-list
43715079|NCT02663830|Enclomiphene|enclomiphene|mesh-list
43715080|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
43715081|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715082|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
43715083|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43715084|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43715085|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715086|NCT02663830|Urological Agents|urological agents|mesh-ancestor
43552399|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43552400|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
43552401|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43552402|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552403|NCT03604471|Atorvastatin|atorvastatin|mesh-list
43552404|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43552405|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43552406|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
43552407|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552408|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43552409|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43552410|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552411|NCT03604419|Metformin|metformin|mesh-list
43552412|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43552413|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552414|NCT03604354|Pregabalin|pregabalin|mesh-list
43552415|NCT03604354|Tapentadol|tapentadol|mesh-list
43552416|NCT03604354|Analgesics|analgesics|mesh-ancestor
43552417|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
43552418|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552419|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552421|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43552422|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552423|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552424|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43552425|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43552426|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43552427|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552428|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43552429|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43552430|NCT03604354|Narcotics|narcotics|mesh-ancestor
43552431|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43552432|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43552434|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552435|NCT03604224|Canagliflozin|canagliflozin|mesh-list
43552436|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43552437|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552438|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43552439|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552441|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
43552442|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715087|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43715088|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
43715089|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43715090|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715091|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43715092|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
43715093|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43715094|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43715095|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43715096|NCT02663700|Artesunate|artesunate|mesh-list
43715097|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
43715098|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43715099|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43715100|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715101|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715102|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
43715104|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43832118|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43832119|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832120|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832121|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832122|NCT05280223|Analgesics|analgesics|mesh-ancestor
43832123|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
43552454|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552455|NCT03603938|Losartan|losartan|mesh-list
43552456|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43552457|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43552458|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43552459|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43552460|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552462|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43552463|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
43552464|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
43552465|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552466|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552467|NCT03603834|Leucovorin|leucovorin|mesh-list
43552468|NCT03603834|Fluorouracil|fluorouracil|mesh-list
43552469|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
43552470|NCT03603834|Irinotecan|irinotecan|mesh-list
43552471|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
43552472|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552473|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43832124|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715107|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715108|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715109|NCT02663570|Melatonin|melatonin|mesh-list
43715110|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
43715111|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715112|NCT02663570|Protective Agents|protective agents|mesh-ancestor
43552474|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552475|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552476|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
43552477|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552478|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43552479|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43552480|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552481|NCT03603834|Antidotes|antidotes|mesh-ancestor
43552482|NCT03603834|Protective Agents|protective agents|mesh-ancestor
43552483|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
43552484|NCT03603834|Vitamins|vitamins|mesh-ancestor
43552485|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
43552486|NCT03603756|Paclitaxel|paclitaxel|mesh-list
43552487|NCT03603756|Irinotecan|irinotecan|mesh-list
43552490|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43552491|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552493|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
43552494|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
43552495|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552496|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43552497|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43552498|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552499|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43552500|NCT03603626|Pregabalin|pregabalin|mesh-list
43552501|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552502|NCT03603626|Analgesics|analgesics|mesh-ancestor
43552503|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
43552504|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552507|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552508|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552509|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43552510|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43552511|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43552512|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552513|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43552515|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552516|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
43552517|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552518|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43552519|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552520|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552521|NCT03603418|Dexamethasone|dexamethasone|mesh-list
43552522|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
43552523|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43552525|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552526|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
43552527|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
43552528|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552529|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552530|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43552531|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
43552532|NCT03603418|Hormones|hormones|mesh-ancestor
43552533|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552534|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43715113|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715114|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715115|NCT02663440|Temozolomide|temozolomide|mesh-list
43715116|NCT02663440|Molgramostim|molgramostim|mesh-list
43715117|NCT02663440|Sargramostim|sargramostim|mesh-list
43715118|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43715119|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
43715120|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552535|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552536|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
43552537|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552538|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552539|NCT03603366|Aspirin|aspirin|mesh-list
43552540|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43552541|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43552542|NCT03603366|Analgesics|analgesics|mesh-ancestor
43552543|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
43552565|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552574|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43552575|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552577|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43552578|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43552579|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43552580|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
43552581|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
43552582|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
43552583|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
43552584|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552585|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552586|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
43552587|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
43552588|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43552589|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
43552590|NCT03603119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43552591|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43552592|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43715121|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715122|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
43715123|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715124|NCT02663323|Sirolimus|sirolimus|mesh-list
43715125|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715126|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715127|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43552600|NCT03602898|Tacrolimus|tacrolimus|mesh-list
43552602|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43552603|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552604|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
43552605|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552606|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43552607|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43552608|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
43552609|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552610|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552611|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43552612|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43552613|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
43552614|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43552615|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43552616|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
43552617|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
43552618|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735289|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735290|NCT05297123|Tretinoin|tretinoin|mesh-list
43735291|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
43735292|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735293|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
43735294|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
43552619|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43552620|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43552621|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43552622|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
43552623|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552624|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43552625|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552626|NCT03602690|Ritonavir|ritonavir|mesh-list
43552644|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43552645|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552646|NCT03602638|Incretins|incretins|mesh-ancestor
43552647|NCT03602638|Hormones|hormones|mesh-ancestor
43552648|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552649|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43552650|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
43552651|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552652|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552653|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43552654|NCT03602547|Vorolanib|vorolanib|mesh-list
43552655|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43552666|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43552667|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
43552668|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552669|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552670|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552672|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43552674|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43552675|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552676|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
43552677|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
43552678|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552679|NCT03602469|Bupivacaine|bupivacaine|mesh-list
43552681|NCT03602469|Sevoflurane|sevoflurane|mesh-list
43552682|NCT03602469|Rocuronium|rocuronium|mesh-list
43552683|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
43850009|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43552689|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43552690|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43552691|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
43552692|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43552693|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43552694|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43552695|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43552696|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43552698|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
43552699|NCT03602430|Vitamins|vitamins|mesh-ancestor
43552700|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
43552701|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552702|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43552703|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43552704|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
43552705|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552717|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552719|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43552720|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552721|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
43552722|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
43552723|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552724|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
43552725|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829682|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43589323|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552736|NCT03602131|Cladribine|cladribine|mesh-list
43552737|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43552738|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
43552739|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552740|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552741|NCT03602131|Antiviral Agents|antiviral agents|mesh-ancestor
43552742|NCT03602131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552743|NCT03602131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552744|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552745|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
43552746|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552747|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
43552748|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43552749|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43552750|NCT03602118|Phenobarbital|phenobarbital|mesh-list
43552751|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
43552752|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43552753|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552754|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552755|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43552756|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43552757|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552758|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552759|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
43552760|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
43552761|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43552762|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43552763|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43552764|NCT03602027|Gefitinib|gefitinib|mesh-list
43552765|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552766|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43552770|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43552771|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43552772|NCT03601975|Gemcitabine|gemcitabine|mesh-list
43552774|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552775|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43552776|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
43552777|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552778|NCT03601975|Antiviral Agents|antiviral agents|mesh-ancestor
43552779|NCT03601975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552780|NCT03601975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552781|NCT03601975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552782|NCT03601975|Immunologic Factors|immunologic factors|mesh-ancestor
43552783|NCT03601975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552784|NCT03601897|Paclitaxel|paclitaxel|mesh-list
43552785|NCT03601897|Rebastinib|rebastinib|mesh-list
43552786|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43552787|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552788|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
43552789|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
43552790|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
43552791|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552792|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43552793|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552794|NCT03601871|Thalidomide|thalidomide|mesh-list
43552795|NCT03601871|Dexamethasone|dexamethasone|mesh-list
43552796|NCT03601871|Palonosetron|palonosetron|mesh-list
43552797|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
43552798|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552799|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
43735295|NCT05276102|Emollients|emollients|mesh-list
43735296|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
43735297|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43735298|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43589924|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43552800|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
43552801|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552802|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552803|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43552804|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
43552805|NCT03601871|Hormones|hormones|mesh-ancestor
43552806|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552807|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43552808|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552809|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552810|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
43715128|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715129|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
43850010|NCT05702762|Renal Agents|renal agents|mesh-ancestor
43715130|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43715131|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
43715132|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715134|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43715135|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715136|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715137|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
43552811|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
43552812|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43552813|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552814|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43552815|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43552816|NCT03601871|Growth Substances|growth substances|mesh-ancestor
43552817|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
43552818|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43552819|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
43552820|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552821|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552822|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
43552823|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43552824|NCT03601624|Dexamethasone|dexamethasone|mesh-list
43552825|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
43552826|NCT03601624|Pomalidomide|pomalidomide|mesh-list
43552827|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552828|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
43552829|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552830|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43552831|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43552832|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
43552833|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552834|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552835|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43552836|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552837|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
43552838|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
43552849|NCT03601611|Prednisolone|prednisolone|mesh-list
43552850|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552851|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
43552853|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552854|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552855|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43552856|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552858|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43552859|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552860|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
43552861|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43552862|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43552863|NCT03601338|Bemiparin|bemiparin|mesh-list
43552864|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
43552865|NCT03601260|Allopurinol|allopurinol|mesh-list
43552866|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
43552867|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552868|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552869|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
43552870|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43552871|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43552872|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
43552873|NCT03601260|Protective Agents|protective agents|mesh-ancestor
43715138|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715139|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715140|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
43715141|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43715142|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715143|NCT02663284|Ropivacaine|ropivacaine|mesh-list
43715144|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
43715145|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
43715146|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715147|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715148|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
43715149|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715150|NCT02663141|Bevacizumab|bevacizumab|mesh-list
43715151|NCT02663141|Losartan|losartan|mesh-list
43715153|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715154|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43715155|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43715156|NCT02663141|Growth Substances|growth substances|mesh-ancestor
43715157|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715158|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
43715159|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43715160|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43715161|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43715162|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43715163|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715164|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43715165|NCT02663050|Diclofenac|diclofenac|mesh-list
43715166|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43715167|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715180|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43715181|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715182|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715183|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
43715184|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715185|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715186|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43715187|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715189|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43715190|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43715191|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715192|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715193|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715194|NCT02662894|Valsartan|valsartan|mesh-list
43715195|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43715196|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43715197|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43715198|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
43715199|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715200|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43552874|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552875|NCT03601091|Midazolam|midazolam|mesh-list
43552876|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
43552877|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43552878|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552879|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552880|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43552881|NCT03601091|Analgesics|analgesics|mesh-ancestor
43552882|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
43552890|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43552891|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43552892|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43552893|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43552894|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43552895|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
43552896|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
43552897|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
43552898|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
43552899|NCT03600974|Domperidone|domperidone|mesh-list
43552901|NCT03600974|Esomeprazole|esomeprazole|mesh-list
43552902|NCT03600974|Omeprazole|omeprazole|mesh-list
43552903|NCT03600974|Rabeprazole|rabeprazole|mesh-list
43552904|NCT03600974|Pantoprazole|pantoprazole|mesh-list
43552905|NCT03600974|Lansoprazole|lansoprazole|mesh-list
43552906|NCT03600974|Mosapride|mosapride|mesh-list
43715201|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43715202|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715203|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43715204|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43715205|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43715207|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
43715208|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715209|NCT02662647|Cytarabine|cytarabine|mesh-list
43715210|NCT02662647|Decitabine|decitabine|mesh-list
43715211|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
43715212|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43715213|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
43715214|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552907|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
43552908|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43552909|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43552910|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43552914|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43552915|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552918|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43552919|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
43552920|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43552921|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
43552922|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552923|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
43552924|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43552925|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
43552926|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43552927|NCT03600961|Sirolimus|sirolimus|mesh-list
43552928|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43552929|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552930|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43552931|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552932|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
43552933|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552934|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
43552935|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552936|NCT03600948|Sirolimus|sirolimus|mesh-list
43552937|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43552938|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552939|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43552940|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552941|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
43552942|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43552943|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
43552944|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552945|NCT03600870|Midodrine|midodrine|mesh-list
43552946|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
43552947|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
43552948|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552949|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552950|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43552951|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43552952|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43552953|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43552954|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552955|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715215|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715216|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
43715217|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715218|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43715219|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
43715220|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715221|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715222|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43715223|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43715224|NCT02662660|Acetaminophen|acetaminophen|mesh-list
43715225|NCT02662660|Dipyrone|dipyrone|mesh-list
43715226|NCT02662660|Bupivacaine|bupivacaine|mesh-list
43715227|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
43715228|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
43715229|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
43715230|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715231|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715232|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
43715233|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715234|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715235|NCT02662660|Analgesics|analgesics|mesh-ancestor
43715236|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
43715237|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43715238|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715239|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715240|NCT02662725|Ipilimumab|ipilimumab|mesh-list
43715241|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43715242|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715243|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43715244|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715245|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
43715246|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43715247|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43715248|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43715249|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715251|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
43715254|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43715255|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715257|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
43715258|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715259|NCT02662504|Cisplatin|cisplatin|mesh-list
43715260|NCT02662504|Pemetrexed|pemetrexed|mesh-list
43715261|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43715262|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715263|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715264|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715265|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43715266|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43715267|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
43715268|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43715269|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
43715270|NCT02662491|Vitamin D|vitamin d|mesh-list
43715271|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
43715272|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
43715273|NCT02662491|Vitamins|vitamins|mesh-list
43715274|NCT02662491|Calcium|calcium|mesh-list
43715275|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
43715276|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715277|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43715278|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43715279|NCT02662426|Oseltamivir|oseltamivir|mesh-list
43715280|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
43715281|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552959|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
43552960|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43552961|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552962|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43552963|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43552964|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
43552965|NCT03600831|Cisplatin|cisplatin|mesh-list
43552966|NCT03600831|Docetaxel|docetaxel|mesh-list
43552967|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552968|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
43552969|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
43552970|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
43552971|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552972|NCT03600766|Mirabegron|mirabegron|mesh-list
43552973|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43715283|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715285|NCT02662348|Interleukin-2|interleukin-2|mesh-list
43715286|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715287|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715288|NCT02662348|Analgesics|analgesics|mesh-ancestor
43715289|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
43715290|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552974|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43552975|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43552976|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552977|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552978|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552979|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552980|NCT03600766|Urological Agents|urological agents|mesh-ancestor
43552981|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
43552991|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
43552992|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552993|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43552994|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43552996|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552997|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552998|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552999|NCT03600623|Gemcitabine|gemcitabine|mesh-list
43553000|NCT03600623|Paclitaxel|paclitaxel|mesh-list
43553001|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43553018|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
43553019|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553020|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43553021|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43553022|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
43553023|NCT03600506|Sympatholytics|sympatholytics|mesh-list
43553024|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43553025|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553026|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553028|NCT03600506|Analgesics|analgesics|mesh-ancestor
43553029|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
43553030|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553031|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43553032|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43553033|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43553034|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
43553035|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553036|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553037|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
43553039|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
43553040|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553041|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
43553042|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553043|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715291|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715292|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43715293|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43715294|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
43715295|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715296|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43715297|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715298|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715299|NCT02662283|Acteoside|acteoside|mesh-list
43715300|NCT02662283|Prednisolone|prednisolone|mesh-list
43715301|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715302|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
43715303|NCT02662283|Hormones|hormones|mesh-ancestor
43715304|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43715305|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715306|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43715307|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715308|NCT02662283|Protective Agents|protective agents|mesh-ancestor
43715309|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563818|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
43715310|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43715311|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
43715312|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715313|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
43715314|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
43715315|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43715316|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
43715317|NCT02662296|Idelalisib|idelalisib|mesh-list
43715318|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715319|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715320|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715321|NCT02662309|Atezolizumab|atezolizumab|mesh-list
43715322|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715323|NCT02662374|Nystatin|nystatin|mesh-list
43715324|NCT02662374|Calcium|calcium|mesh-list
43715325|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43715329|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
43715330|NCT02662374|Ionophores|ionophores|mesh-ancestor
43715331|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715332|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832125|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43832126|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43832127|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43832128|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
43832129|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639151|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
43832130|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832132|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43832133|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
43832135|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832136|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832137|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
43832138|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832139|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43832140|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43832141|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43832142|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832143|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832144|NCT05279807|Amlodipine|amlodipine|mesh-list
43832145|NCT05279807|Zofenopril|zofenopril|mesh-list
43832146|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43832147|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43832148|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832149|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832150|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43832151|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832160|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43832161|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
43832162|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832163|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832164|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832165|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43832166|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43832167|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
43715333|NCT02661893|Rifampin|rifampin|mesh-list
43715334|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43715335|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
43715336|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715337|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715338|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
43715339|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43715340|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715341|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563825|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715342|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43715343|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43715344|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43715345|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43715346|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43715347|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43553044|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
43553045|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553046|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43553047|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43553048|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43553052|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553054|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43553055|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43553056|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43553057|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
43553058|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553059|NCT03600467|Seviteronel|seviteronel|mesh-list
43553060|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553061|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43553062|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553063|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553064|NCT03600454|Anesthetics|anesthetics|mesh-list
43553065|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553066|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553067|NCT03600363|Metformin|metformin|mesh-list
43553068|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43553069|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715348|NCT02661711|Aflibercept|aflibercept|mesh-list
43715349|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43715350|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43715351|NCT02661711|Growth Substances|growth substances|mesh-ancestor
43715352|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715353|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
43715354|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715355|NCT02661789|Goserelin|goserelin|mesh-list
43715356|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43715357|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715358|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
43553070|NCT03600311|Vitamin D|vitamin d|mesh-list
43553071|NCT03600311|Calcium|calcium|mesh-list
43553072|NCT03600311|Vitamins|vitamins|mesh-ancestor
43553073|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
43553074|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553075|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43553076|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43553077|NCT03600129|Ropivacaine|ropivacaine|mesh-list
43553078|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553079|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
43553080|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553081|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553082|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
43553083|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553084|NCT03600064|Misoprostol|misoprostol|mesh-list
43553085|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43553086|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
43553087|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43553088|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553089|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43553090|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43553091|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
43553092|NCT03598959|Tofacitinib|tofacitinib|mesh-list
43553093|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43553094|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553095|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553096|NCT03598452|Ganciclovir|ganciclovir|mesh-list
43553097|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43735347|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553098|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
43553099|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553100|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43553101|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553102|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553105|NCT03597945|Epinephrine|epinephrine|mesh-list
43553106|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553107|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
43553108|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553109|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553110|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
43553111|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553112|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43553114|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43553115|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553116|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553117|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43553118|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43553119|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
43553131|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43553132|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43715359|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
43715360|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715362|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43715363|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43715364|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
43715365|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715366|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43715367|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43715368|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553133|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
43850011|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
43553134|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43553136|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43553137|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43553138|NCT03597815|Growth Substances|growth substances|mesh-ancestor
43553139|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553140|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
43553141|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553142|NCT03597087|Anesthetics|anesthetics|mesh-list
43553143|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553144|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553145|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
43553146|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43553147|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553148|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553149|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553150|NCT03596775|Analgesics|analgesics|mesh-ancestor
43553151|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
43553152|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553153|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43553154|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43553155|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43553156|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
43553157|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553158|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553159|NCT03596749|Sevelamer|sevelamer|mesh-list
43553160|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
43553161|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
43553166|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553167|NCT03594825|Valsartan|valsartan|mesh-list
43553168|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43553169|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43553170|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43553171|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553172|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
43553173|NCT03594604|Norethindrone|norethindrone|mesh-list
43735374|NCT04430036|Cisplatin|cisplatin|mesh-list
43553174|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
43553175|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
43553176|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43553177|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43553178|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553179|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43553180|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43553181|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43553182|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43553192|NCT03594513|Analgesics|analgesics|mesh-ancestor
43553193|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
43553194|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553195|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715369|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715370|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
43715371|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715372|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715373|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43715374|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43715375|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715376|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715377|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715378|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43715379|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43553196|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553197|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553198|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
43553199|NCT03593707|Metformin|metformin|mesh-list
43553200|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43553201|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553202|NCT03592537|Fentanyl|fentanyl|mesh-list
43553203|NCT03592537|Midazolam|midazolam|mesh-list
43553204|NCT03592537|Bupivacaine|bupivacaine|mesh-list
43553205|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553207|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553208|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553209|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
43553210|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553211|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43553212|NCT03592537|Narcotics|narcotics|mesh-ancestor
43553213|NCT03592537|Analgesics|analgesics|mesh-ancestor
43553214|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43553215|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43553216|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
43553217|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43553228|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553229|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43553230|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43553231|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
43850012|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43553232|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43553233|NCT03592199|Sunitinib|sunitinib|mesh-list
43553234|NCT03592199|Axitinib|axitinib|mesh-list
43553235|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553236|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43553237|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43553238|NCT03592199|Growth Substances|growth substances|mesh-ancestor
43553239|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553240|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
43553241|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43715380|NCT02661347|Risperidone|risperidone|mesh-list
43715381|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43715382|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
43715383|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715384|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715385|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715386|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43715387|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43715388|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715389|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43715390|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43715391|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
43715392|NCT02661477|Interferons|interferons|mesh-list
43715393|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
43715394|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
43715395|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715396|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
43715397|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715398|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
43715399|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715400|NCT02661152|Nimorazole|nimorazole|mesh-list
43715401|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43715402|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43715403|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43553242|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553243|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553245|NCT03591549|Goserelin|goserelin|mesh-list
43553246|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43553247|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553248|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43553249|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43553250|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
43553261|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43553262|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553264|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553265|NCT03590197|Melatonin|melatonin|mesh-list
43553266|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
43553267|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553268|NCT03590197|Protective Agents|protective agents|mesh-ancestor
43553269|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553270|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553271|NCT03588078|Azacitidine|azacitidine|mesh-list
43553272|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553273|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
43553274|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553275|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553276|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553277|NCT03587441|Neostigmine|neostigmine|mesh-list
43553278|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43715404|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715405|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
43715406|NCT02661191|Vitamin D|vitamin d|mesh-list
43832168|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715407|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43715408|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715409|NCT02661191|Vitamins|vitamins|mesh-ancestor
43715410|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
43715411|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43715412|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
43715413|NCT02661100|Poly ICLC|poly iclc|mesh-list
43715414|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43715415|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715416|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
43553279|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563891|NCT01171313|Levodopa|levodopa|mesh-list
43553280|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553281|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
43553282|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553283|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553284|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43553285|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
43553286|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553288|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43553289|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43553290|NCT03587077|Misoprostol|misoprostol|mesh-list
43553291|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43553292|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
43553293|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43553294|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553295|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43553296|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43553297|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
43553298|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43553299|NCT03587077|Diuretics|diuretics|mesh-ancestor
43553300|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
43553301|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
43553302|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43553303|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553304|NCT03587025|Amitriptyline|amitriptyline|mesh-list
43553305|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43553306|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
43553307|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43553308|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553309|NCT03587025|Analgesics|analgesics|mesh-ancestor
43553310|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
43553311|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553312|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553313|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43553314|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43553317|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
43553318|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553321|NCT03586934|Ketorolac|ketorolac|mesh-list
43553322|NCT03586934|Meloxicam|meloxicam|mesh-list
43553323|NCT03586934|Morphine|morphine|mesh-list
43553324|NCT03586934|Oxycodone|oxycodone|mesh-list
43553325|NCT03586934|Tramadol|tramadol|mesh-list
43553326|NCT03586934|Hydrocodone|hydrocodone|mesh-list
43715417|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
43715418|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715419|NCT02660840|Flupenthixol|flupenthixol|mesh-list
43715420|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
43715421|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43715422|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43715423|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715424|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715425|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43715426|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43715427|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
43715428|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553327|NCT03586934|Ropivacaine|ropivacaine|mesh-list
43553328|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43553330|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553331|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553332|NCT03586934|Analgesics|analgesics|mesh-ancestor
43553333|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
43563922|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553334|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553335|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553336|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
43553337|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553338|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
43553339|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43553340|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553341|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553342|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43553343|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43553344|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553345|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553346|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
43553347|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
43553348|NCT03586154|Ketamine|ketamine|mesh-list
43553349|NCT03586154|Bupivacaine|bupivacaine|mesh-list
43553350|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553355|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553358|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43553359|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
43553362|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553363|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553364|NCT03585894|Ketorolac|ketorolac|mesh-list
43553365|NCT03585894|Sumatriptan|sumatriptan|mesh-list
43553366|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43553367|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553368|NCT03585894|Analgesics|analgesics|mesh-ancestor
43553369|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
43553370|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553371|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553372|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553373|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553374|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43553375|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715429|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715431|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43715432|NCT02660736|Incretins|incretins|mesh-ancestor
43715433|NCT02660736|Hormones|hormones|mesh-ancestor
43715434|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43715435|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553376|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553377|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43553378|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43553379|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43553380|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
43553381|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553382|NCT03585413|Micronutrients|micronutrients|mesh-list
43553383|NCT03585413|Trace Elements|trace elements|mesh-list
43553384|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553385|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
43553386|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43553387|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553388|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553389|NCT03585062|Paclitaxel|paclitaxel|mesh-list
43553390|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43553391|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553400|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553401|NCT03584360|Calcitriol|calcitriol|mesh-list
43553411|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43553412|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553413|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43553414|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
43553415|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
43553416|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43553417|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43553418|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735392|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553419|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553420|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43553422|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
43553423|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43553424|NCT03583229|Aspirin|aspirin|mesh-list
43553425|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43553426|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553427|NCT03583229|Analgesics|analgesics|mesh-ancestor
43553428|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
43553429|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553430|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553431|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553432|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553433|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43553434|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43553435|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553436|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43553437|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43553438|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715437|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43715438|NCT02660762|Cytarabine|cytarabine|mesh-list
43715439|NCT02660762|Dexamethasone|dexamethasone|mesh-list
43715440|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
43715441|NCT02660762|Prednisone|prednisone|mesh-list
43715442|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
43715443|NCT02660762|Methotrexate|methotrexate|mesh-list
43715444|NCT02660762|Etoposide|etoposide|mesh-list
43715445|NCT02660762|Vincristine|vincristine|mesh-list
43715446|NCT02660762|Daunorubicin|daunorubicin|mesh-list
43715467|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43553439|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
43553440|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
43553441|NCT03582878|Sirolimus|sirolimus|mesh-list
43553442|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43553443|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553444|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43553445|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
43553446|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43553447|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553448|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553449|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553450|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
43553451|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553452|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
43553453|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553454|NCT03582865|Tamoxifen|tamoxifen|mesh-list
43553455|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43553456|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
43553471|NCT03580889|Atropine|atropine|mesh-list
43553472|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
43553473|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43553474|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43553475|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43553476|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
43553477|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553478|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553479|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43553480|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
43553481|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
43553482|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
43553483|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43553484|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43553485|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
43553486|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553487|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553488|NCT03580005|Methylphenidate|methylphenidate|mesh-list
43553489|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43553490|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553491|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43553499|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553501|NCT03579927|Rituximab|rituximab|mesh-list
43553502|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43553503|NCT03579927|Etoposide|etoposide|mesh-list
43553504|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
43553505|NCT03579927|Melphalan|melphalan|mesh-list
43553506|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
43553507|NCT03579927|Carmustine|carmustine|mesh-list
43553508|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
43553509|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43553510|NCT03579927|Antibodies|antibodies|mesh-list
43553511|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
43553512|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43715468|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43715469|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
43715470|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715471|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43715472|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
43715473|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43715474|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43715475|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
43715476|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
43715477|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43715478|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43715479|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43715480|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43715481|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43715482|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
43715483|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715484|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
43715485|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
43715486|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
43715487|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43715488|NCT02660684|Cyclosporine|cyclosporine|mesh-list
43715489|NCT02660684|Methotrexate|methotrexate|mesh-list
43715491|NCT02660684|Cyclosporins|cyclosporins|mesh-list
43715492|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43715493|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
43715494|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43715495|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553513|NCT03579927|Lenograstim|lenograstim|mesh-list
43553522|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715496|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43715497|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
43715498|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715499|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715500|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
43715501|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715512|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715513|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715514|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715515|NCT02660658|Analgesics|analgesics|mesh-ancestor
43715516|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
43715517|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715518|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43715519|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43715520|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43715521|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
43715522|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715523|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715525|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43715526|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
43715527|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43715528|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715529|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
43715530|NCT02660606|Narcotics|narcotics|mesh-ancestor
43715531|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553524|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
43553525|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
43553526|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553527|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553528|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43735405|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43553529|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43553530|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
43553531|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43553532|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
43553533|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
43553534|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
43553535|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
43553536|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
43553537|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
43553539|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553540|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
43553541|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553542|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553543|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43553544|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
43553545|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553546|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553547|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43553548|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
43553549|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
43553550|NCT03579875|Busulfan|busulfan|mesh-list
43553551|NCT03579875|Rituximab|rituximab|mesh-list
43553552|NCT03579875|Fludarabine|fludarabine|mesh-list
43553553|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553554|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
43553556|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553557|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43553558|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
43553559|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553560|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553561|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43715532|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715534|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
43715535|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715536|NCT02660346|Vancomycin|vancomycin|mesh-list
43715537|NCT02660346|Daptomycin|daptomycin|mesh-list
43715538|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43715539|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715540|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715541|NCT02660255|Cannabidiol|cannabidiol|mesh-list
43715542|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
43715543|NCT02660177|Dipyrone|dipyrone|mesh-list
43715544|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43715545|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715546|NCT02660177|Analgesics|analgesics|mesh-ancestor
43715547|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
43715548|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715549|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715550|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715551|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715552|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
43715553|NCT02660008|Glucagon|glucagon|mesh-list
43553562|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43553563|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553564|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
43553565|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
43553566|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553567|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43553568|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
43553569|NCT03579875|Hormones|hormones|mesh-ancestor
43553570|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43553571|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43850013|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43850014|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43553572|NCT03579875|Protective Agents|protective agents|mesh-ancestor
43553573|NCT03579836|Gemcitabine|gemcitabine|mesh-list
43553574|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553576|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553577|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553578|NCT03579836|Antiviral Agents|antiviral agents|mesh-ancestor
43553579|NCT03579836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553591|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553592|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
43553593|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
43553594|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
43553595|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553596|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43553597|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43553598|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553600|NCT03579758|Cisplatin|cisplatin|mesh-list
43553601|NCT03579758|Capecitabine|capecitabine|mesh-list
43553602|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553603|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553604|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
43715554|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43715555|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715556|NCT02660008|Hormones|hormones|mesh-ancestor
43715557|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43715558|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715559|NCT02660008|Incretins|incretins|mesh-ancestor
43715560|NCT02660060|Pramipexole|pramipexole|mesh-list
43715561|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
43715562|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553612|NCT03579732|Aspirin|aspirin|mesh-list
43553613|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43553614|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553615|NCT03579732|Analgesics|analgesics|mesh-ancestor
43553616|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
43553617|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553618|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553619|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553620|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553621|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43553622|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43553623|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553624|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43553625|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43553626|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553627|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
43553628|NCT03579589|Neostigmine|neostigmine|mesh-list
43553629|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43553631|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553632|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
43553633|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553634|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553635|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43553637|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553638|NCT03579576|Ribavirin|ribavirin|mesh-list
43553639|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
43553640|NCT03579576|Velpatasvir|velpatasvir|mesh-list
43553641|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
43553642|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553643|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
43553644|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715578|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715579|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43715581|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715582|NCT02659761|Lamivudine|lamivudine|mesh-list
43850015|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43715586|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43715587|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43715588|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715589|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715590|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
43715591|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715592|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43715593|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43715594|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43715595|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43832170|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
43832171|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
43832172|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
43832173|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43832174|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
43832175|NCT05279456|Paraproteins|paraproteins|mesh-list
43832176|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
43832177|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553648|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553649|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553650|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553651|NCT03579043|Cocaine|cocaine|mesh-list
43715628|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715630|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43715631|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715632|NCT02659254|Sirolimus|sirolimus|mesh-list
43715633|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715634|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715635|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43715636|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715637|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
43715638|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43715639|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
43715640|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715641|NCT02659228|Anesthetics|anesthetics|mesh-list
43715642|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
43715643|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715644|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715645|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
43715646|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43715647|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43715648|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715649|NCT02659293|Dexamethasone|dexamethasone|mesh-list
43715650|NCT02659293|Lenalidomide|lenalidomide|mesh-list
43715678|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43715679|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715691|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
43715692|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
43715693|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715694|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715695|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715696|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
43715697|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43715698|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715699|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715701|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43715713|NCT02658838|Calcium heparin|calcium heparin|mesh-list
43715714|NCT02658838|Enoxaparin|enoxaparin|mesh-list
43715715|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43715716|NCT02658838|Tinzaparin|tinzaparin|mesh-list
43715717|NCT02658838|Dalteparin|dalteparin|mesh-list
43715718|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
43715719|NCT02658838|Ticagrelor|ticagrelor|mesh-list
43715720|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43715721|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
43715722|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43715723|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43715724|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715725|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43715726|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43715727|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43715728|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
43715729|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715730|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715731|NCT02658799|Diclofenac|diclofenac|mesh-list
43715734|NCT02658799|Analgesics|analgesics|mesh-ancestor
43715767|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715768|NCT02658760|Analgesics|analgesics|mesh-ancestor
43715769|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43597387|NCT03309163|Tramadol|tramadol|mesh-list
43715770|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43715786|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715787|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
43715788|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832197|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43832198|NCT05279092|Prednisolone|prednisolone|mesh-list
43832199|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
43832200|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
43832201|NCT05279092|Bupivacaine|bupivacaine|mesh-list
43832202|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43832203|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
43832204|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43832206|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832207|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
43832208|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
43832209|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832210|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832211|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43832212|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
43832213|NCT05279092|Hormones|hormones|mesh-ancestor
43832214|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832215|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43832216|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832217|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
43832218|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
43832219|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832220|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
43832221|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43832222|NCT05279092|Protective Agents|protective agents|mesh-ancestor
43832223|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
43832224|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832225|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832226|NCT05277896|Ketamine|ketamine|mesh-list
43832235|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
43832236|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832237|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43832238|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43832239|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832240|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832241|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43832242|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43832243|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43832244|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832245|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832246|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43832247|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832248|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832249|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
43832250|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832251|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
43832252|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43832253|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715917|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
43715918|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
43715919|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715920|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850016|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43715963|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715964|NCT02657291|Ropivacaine|ropivacaine|mesh-list
43715965|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
43715966|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
43715967|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715968|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715969|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
43715970|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715971|NCT02657473|Tobramycin|tobramycin|mesh-list
43715972|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43715973|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715975|NCT02657187|Rocuronium|rocuronium|mesh-list
43716001|NCT02657096|Hybenx|hybenx|mesh-list
43716002|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
43716003|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
43716004|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716005|NCT02656901|Anesthetics|anesthetics|mesh-list
43716006|NCT02656901|Sevoflurane|sevoflurane|mesh-list
43716007|NCT02656901|Desflurane|desflurane|mesh-list
43716013|NCT02656979|Latanoprost|latanoprost|mesh-list
43716014|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43716015|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43716016|NCT02656810|Teriparatide|teriparatide|mesh-list
43716017|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43716018|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716020|NCT02656771|Metronidazole|metronidazole|mesh-list
43716058|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
43716059|NCT02656121|Vitamin D|vitamin d|mesh-list
43716060|NCT02656121|Clomiphene|clomiphene|mesh-list
43716061|NCT02656121|Vitamins|vitamins|mesh-ancestor
43716062|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
43716063|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716064|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43716065|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43716066|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
43716068|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43716069|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
43716070|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43716071|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43716072|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43716073|NCT02656342|Cycloserine|cycloserine|mesh-list
43716074|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43716075|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716076|NCT02656342|Renal Agents|renal agents|mesh-ancestor
43716077|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43716078|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
43716079|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43716080|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
43716081|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716082|NCT02656095|Heparin|heparin|mesh-list
43716083|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
43716084|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43832259|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43832260|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43716099|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43716100|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43716101|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716102|NCT02655757|Incretins|incretins|mesh-ancestor
43716104|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716105|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43716106|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
43716107|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716108|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716109|NCT02655770|Liraglutide|liraglutide|mesh-list
43716110|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43716111|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716112|NCT02655770|Incretins|incretins|mesh-ancestor
43716113|NCT02655770|Hormones|hormones|mesh-ancestor
43716114|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716115|NCT02655874|Vaccines|vaccines|mesh-list
43716116|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
43716117|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716118|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
43716119|NCT02655913|Vitamins|vitamins|mesh-ancestor
43716120|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
43716121|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716122|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
43553653|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
43553654|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553655|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553656|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
43553657|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553658|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43553659|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43553660|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43553661|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553662|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553663|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
43553664|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553666|NCT03579004|Cisplatin|cisplatin|mesh-list
43553667|NCT03579004|Fluorouracil|fluorouracil|mesh-list
43553668|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43553669|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553670|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
43553671|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
43716123|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716124|NCT02655913|Protective Agents|protective agents|mesh-ancestor
43716125|NCT02655822|Atezolizumab|atezolizumab|mesh-list
43716126|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716128|NCT02655965|Ropivacaine|ropivacaine|mesh-list
43716129|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
43716130|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
43716131|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716132|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716133|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
43716134|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716135|NCT02655965|Analgesics|analgesics|mesh-ancestor
43716143|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716144|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716145|NCT02655705|Cyclosporine|cyclosporine|mesh-list
43716146|NCT02655705|Methotrexate|methotrexate|mesh-list
43716147|NCT02655705|Cyclosporins|cyclosporins|mesh-list
43716148|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43716149|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
43716150|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43716151|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553672|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
43553673|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553674|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
43553675|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553676|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553677|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
43553678|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553679|NCT03578900|Citric Acid|citric acid|mesh-list
43553680|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
43553681|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
43553682|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43553683|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
43553684|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
43553685|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553686|NCT03578874|Capecitabine|capecitabine|mesh-list
43553687|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
43553688|NCT03578874|Sorafenib|sorafenib|mesh-list
43716152|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43716153|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
43716154|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716155|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716156|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
43716157|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716158|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43716159|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43716160|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
43716161|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716162|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43716163|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
43716164|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716167|NCT02655614|Caffeine|caffeine|mesh-list
43716168|NCT02655614|Rabeprazole|rabeprazole|mesh-list
43716169|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43716170|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43716171|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716172|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716173|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43553689|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553690|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
43553691|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553692|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553693|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43553694|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553695|NCT03578822|Aspirin|aspirin|mesh-list
43553696|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43553697|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553698|NCT03578822|Analgesics|analgesics|mesh-ancestor
43553699|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
43553700|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553701|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553702|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553703|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553704|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43553705|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43553706|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553717|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43553719|NCT03578432|Everolimus|everolimus|mesh-list
43553720|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716174|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43850027|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43850028|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43850029|NCT05702463|Analgesics|analgesics|mesh-ancestor
43850030|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
43850031|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850032|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850033|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43850034|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716176|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716178|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
43716179|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
43716180|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
43716181|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716182|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716183|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43553721|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553722|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
43553723|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553725|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
43553726|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43553727|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43553729|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
43553730|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850035|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43850036|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43850037|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850038|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43850039|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43850040|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850041|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
43850042|NCT05702398|Vitamins|vitamins|mesh-list
43850043|NCT05702398|Vitamin A|vitamin a|mesh-list
43850044|NCT05702398|Niacin|niacin|mesh-list
43553742|NCT03578263|Ergonovine|ergonovine|mesh-list
43553743|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
43553744|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43553745|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553746|NCT03578042|Losartan|losartan|mesh-list
43553747|NCT03578042|Amlodipine|amlodipine|mesh-list
43553748|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43850045|NCT05702398|Niacinamide|niacinamide|mesh-list
43850046|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
43850047|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
43850048|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850049|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
43850050|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850051|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43850052|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
43850053|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43553749|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43553750|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43553751|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553752|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553753|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43553755|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
43553756|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43553757|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43553758|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43553760|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
43553761|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43553762|NCT03577977|Interferons|interferons|mesh-list
43553763|NCT03577977|Interferon-beta|interferon-beta|mesh-list
43553764|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
43553765|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553766|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
43553767|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553768|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
43553769|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553770|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43553771|NCT03577912|Anesthetics|anesthetics|mesh-list
43553772|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553773|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553774|NCT03577899|Aflibercept|aflibercept|mesh-list
43553775|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43716184|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43716185|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716186|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43716187|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43716188|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
43716189|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43716190|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43716191|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43716192|NCT02655536|Bevacizumab|bevacizumab|mesh-list
43716193|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43716194|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43716195|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716196|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832261|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43716197|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43716198|NCT02655536|Growth Substances|growth substances|mesh-ancestor
43716199|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716200|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
43716201|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43716202|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716203|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716204|NCT02655380|Ketamine|ketamine|mesh-list
43716205|NCT02655380|Remifentanil|remifentanil|mesh-list
43716206|NCT02655380|Analgesics|analgesics|mesh-ancestor
43716207|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
43716208|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716209|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716210|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43553776|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43716211|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716212|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
43716213|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
43716214|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716215|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43716216|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43716217|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716218|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716219|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43716220|NCT02655380|Narcotics|narcotics|mesh-ancestor
43716221|NCT02655458|Lenalidomide|lenalidomide|mesh-list
43716222|NCT02655458|Elotuzumab|elotuzumab|mesh-list
43716223|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
43716224|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716225|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43553777|NCT03577899|Growth Substances|growth substances|mesh-ancestor
43553778|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850054|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
43553792|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43553793|NCT03577743|Bevacizumab|bevacizumab|mesh-list
43553794|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43553795|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553796|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43553797|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43553800|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
43553801|NCT03577652|Ticagrelor|ticagrelor|mesh-list
43553802|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43553803|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43553804|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43553805|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43553806|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
43553807|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553808|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553809|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553810|NCT03577626|Hemay005|hemay005|mesh-list
43553811|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
43553812|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43553813|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43553814|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553816|NCT03577574|Anesthetics|anesthetics|mesh-list
43553817|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553818|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553819|NCT03577496|Peppermint oil|peppermint oil|mesh-list
43553820|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
43553821|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
43553822|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716226|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43716227|NCT02655458|Growth Substances|growth substances|mesh-ancestor
43716228|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
43716229|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716230|NCT02655471|Zidovudine|zidovudine|mesh-list
43716231|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
43716232|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
43716233|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716234|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43716235|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43716236|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716237|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
43716238|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716239|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43716240|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43716241|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43716242|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43716243|NCT02655276|Glycine|glycine|mesh-list
43716244|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
43716245|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716246|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716247|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716248|NCT02655198|Fenfluramine|fenfluramine|mesh-list
43716249|NCT02655198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43716250|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43716251|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43716252|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716254|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
43716255|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553823|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553824|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43553825|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
43553826|NCT03577457|Oxytocin|oxytocin|mesh-list
43553827|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
43553828|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43553829|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553830|NCT03577392|Capecitabine|capecitabine|mesh-list
43553831|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
43553832|NCT03577392|Endostatins|endostatins|mesh-list
43553833|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553834|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
43716256|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43716258|NCT02655146|Estradiol|estradiol|mesh-list
43716259|NCT02655146|Progestins|progestins|mesh-ancestor
43716260|NCT02655146|Hormones|hormones|mesh-ancestor
43716261|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716262|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716263|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
43716264|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43553838|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43553839|NCT03577392|Growth Substances|growth substances|mesh-ancestor
43553840|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553841|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
43553842|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
43553843|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43553844|NCT03577184|Metformin|metformin|mesh-list
43553845|NCT03577184|Vildagliptin|vildagliptin|mesh-list
43553846|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43553847|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553848|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43553849|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
43553851|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553852|NCT03577158|Insulin|insulin|mesh-list
43553853|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43553854|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553855|NCT03577132|Atezolizumab|atezolizumab|mesh-list
43553856|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553858|NCT03576963|Guadecitabine|guadecitabine|mesh-list
43553859|NCT03576963|Azacitidine|azacitidine|mesh-list
43553860|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43553861|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553862|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43553863|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553864|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553865|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
43553866|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553867|NCT03576911|Ubiquinone|ubiquinone|mesh-list
43553868|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
43553869|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
43553870|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553871|NCT03576911|Vitamins|vitamins|mesh-ancestor
43553872|NCT03576820|Lidocaine|lidocaine|mesh-list
43553876|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553877|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553878|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
43553879|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553880|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43553881|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43553882|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43553883|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553884|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553885|NCT03576794|Prednisolone|prednisolone|mesh-list
43553886|NCT03576794|Leflunomide|leflunomide|mesh-list
43553887|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735431|NCT04240626|Gabapentin|gabapentin|mesh-list
43553888|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
43735432|NCT04240626|Hydromorphone|hydromorphone|mesh-list
43735433|NCT04240626|Hydrocodone|hydrocodone|mesh-list
43553890|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716268|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43716269|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716270|NCT02655146|Estrogens|estrogens|mesh-ancestor
43716271|NCT02654847|Norepinephrine|norepinephrine|mesh-list
43716272|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43716273|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43716274|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
43716275|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716276|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716277|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716278|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
43716279|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
43716280|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716281|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43716282|NCT02655029|Amlodipine|amlodipine|mesh-list
43716283|NCT02655029|Perindopril|perindopril|mesh-list
43716284|NCT02655029|Indapamide|indapamide|mesh-list
43716326|NCT02654730|Primaquine|primaquine|mesh-list
43716327|NCT02654730|Artenimol|artenimol|mesh-list
43716328|NCT02654730|Artemisinins|artemisinins|mesh-list
43716329|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
43716331|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43716332|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716333|NCT02654678|Enalapril|enalapril|mesh-list
43716334|NCT02654678|Enalaprilat|enalaprilat|mesh-list
43716335|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43716336|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
43716337|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716338|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716339|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43716340|NCT02654587|Docetaxel|docetaxel|mesh-list
43716341|NCT02654587|Pemetrexed|pemetrexed|mesh-list
43716342|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716343|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
43716344|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
43716345|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
43716346|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716347|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716348|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43716349|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43716351|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
43716352|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
43716353|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716354|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716355|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716356|NCT02654379|Rituximab|rituximab|mesh-list
43716357|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43716358|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716364|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43563928|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716365|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43716366|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716367|NCT02654093|Vitamins|vitamins|mesh-ancestor
43563929|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43563930|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
43563931|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563943|NCT01167166|ON 01910|on 01910|mesh-list
43716368|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
43716369|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43716370|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43716371|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
43716372|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716373|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43553893|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553894|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553895|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553896|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553897|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
43553898|NCT03576677|Simendan|simendan|mesh-list
43553899|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43553908|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43553909|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553910|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43553911|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43553912|NCT03576651|Growth Substances|growth substances|mesh-ancestor
43716374|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43832262|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
43832263|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832264|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832266|NCT05276531|Progestins|progestins|mesh-ancestor
43832267|NCT05276531|Hormones|hormones|mesh-ancestor
43832268|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850057|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
43716388|NCT02654288|Antiviral Agents|antiviral agents|mesh-ancestor
43716389|NCT02654288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716390|NCT02654288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716391|NCT02654288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43716392|NCT02654288|Immunologic Factors|immunologic factors|mesh-ancestor
43716393|NCT02654288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716394|NCT02654041|Methimazole|methimazole|mesh-list
43716395|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
43716396|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
43716397|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716398|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716399|NCT02653898|Artesunate|artesunate|mesh-list
43716400|NCT02653898|Piperaquine|piperaquine|mesh-list
43716401|NCT02653898|Primaquine|primaquine|mesh-list
43716402|NCT02653898|Artenimol|artenimol|mesh-list
43716403|NCT02653898|Mefloquine|mefloquine|mesh-list
43716404|NCT02653898|Permethrin|permethrin|mesh-list
43716433|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43716434|NCT02653742|Narcotics|narcotics|mesh-ancestor
43716435|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716436|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716437|NCT02653742|Analgesics|analgesics|mesh-ancestor
43716438|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
43716439|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716440|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43716441|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716442|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
43716443|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
43716444|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43716445|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43716446|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716447|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716448|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43716449|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716450|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716451|NCT02653651|Lidocaine|lidocaine|mesh-list
43716452|NCT02653651|Ketamine|ketamine|mesh-list
43716453|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
43716454|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
43850058|NCT05702359|Vitamins|vitamins|mesh-list
43716457|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
43716481|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
43716482|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43716483|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43716484|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716485|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716486|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
43716487|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43716488|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43716489|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716491|NCT02653261|Coagulants|coagulants|mesh-ancestor
43716492|NCT02653196|Cyclosporine|cyclosporine|mesh-list
43716493|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
43716494|NCT02653196|Fludarabine|fludarabine|mesh-list
43716495|NCT02653196|Etoposide|etoposide|mesh-list
43716496|NCT02653196|Melphalan|melphalan|mesh-list
43716497|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
43716498|NCT02653196|Thiotepa|thiotepa|mesh-list
43716499|NCT02653196|Tacrolimus|tacrolimus|mesh-list
43716500|NCT02653196|Cyclosporins|cyclosporins|mesh-list
43716501|NCT02653196|Mitogens|mitogens|mesh-list
43716502|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716503|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716504|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43716505|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
43716506|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716507|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43716508|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43716509|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43716510|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716511|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43716512|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
43716513|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716514|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
43716523|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
43716524|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43716525|NCT02653209|Pioglitazone|pioglitazone|mesh-list
43563946|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563947|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716526|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43716527|NCT02653209|Canagliflozin|canagliflozin|mesh-list
43716528|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43716529|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716530|NCT02653209|Incretins|incretins|mesh-ancestor
43716531|NCT02653209|Hormones|hormones|mesh-ancestor
43716532|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716533|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43716534|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
43716536|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716537|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43716538|NCT02653339|Loratadine|loratadine|mesh-list
43716539|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
43716540|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
43716541|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43716542|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43716543|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43716544|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
43716545|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
43716546|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716547|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716548|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716549|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43716550|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43716551|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43716552|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716553|NCT02653131|Incretins|incretins|mesh-ancestor
43716555|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716556|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
43716557|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716558|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716559|NCT02653027|Ivacaftor|ivacaftor|mesh-list
43716560|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43716561|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43716562|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716563|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
43563984|NCT01143064|Progestins|progestins|mesh-ancestor
43563985|NCT01143064|Hormones|hormones|mesh-ancestor
43563986|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43563987|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563988|NCT01140217|Norethindrone|norethindrone|mesh-list
43563989|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
43563990|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43563991|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43563992|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43563993|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
43563994|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43563995|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563996|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43563997|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43563998|NCT01138163|Docetaxel|docetaxel|mesh-list
43563999|NCT01138163|Bavituximab|bavituximab|mesh-list
43564000|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564001|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
43716564|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43716565|NCT02653014|Hormones|hormones|mesh-ancestor
43716575|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43716577|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716578|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
43716579|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716580|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43716581|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43716582|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43716598|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716599|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716600|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
43716601|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716602|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43716603|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
43716604|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716605|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43716620|NCT02652650|Hormones|hormones|mesh-ancestor
43716636|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43716637|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43716638|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716639|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716640|NCT02652728|Enalapril|enalapril|mesh-list
43716641|NCT02652728|Enalaprilat|enalaprilat|mesh-list
43716642|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43716643|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
43716644|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716645|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716646|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43716647|NCT02652598|Tolcapone|tolcapone|mesh-list
43716648|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43716649|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43716692|NCT02652312|Ondansetron|ondansetron|mesh-list
43716693|NCT02652312|Propofol|propofol|mesh-list
43716699|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716700|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
43716701|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
43716702|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43716703|NCT02652312|Analgesics|analgesics|mesh-ancestor
43716704|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
43716705|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716706|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43716707|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43716708|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43716709|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
43716710|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716711|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716731|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43716732|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43716733|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43716735|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43716736|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43564002|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
43564003|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
43564004|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564006|NCT01137968|Bevacizumab|bevacizumab|mesh-list
43716737|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
43716738|NCT02652325|Iodine|iodine|mesh-list
43716739|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
43716740|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
43716741|NCT02652325|Povidone|povidone|mesh-list
43716742|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43716743|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716744|NCT02652325|Trace Elements|trace elements|mesh-ancestor
43716745|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
43716746|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716747|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
43716748|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
43832287|NCT05275426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832288|NCT05275374|Trametinib|trametinib|mesh-list
43832289|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832290|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43832291|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716749|NCT02652234|Endostar protein|endostar protein|mesh-list
43716750|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43716751|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43716752|NCT02652234|Growth Substances|growth substances|mesh-ancestor
43716819|NCT02651610|Taxane|taxane|mesh-list
43716820|NCT02651610|Bavituximab|bavituximab|mesh-list
43716821|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43716822|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716823|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
43716824|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
43716825|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
43716826|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716827|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43716828|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
43716829|NCT02651623|Sertraline|sertraline|mesh-list
43716830|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43716831|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716832|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43716833|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43716834|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716835|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553913|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553914|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
43553915|NCT03576638|Levodopa|levodopa|mesh-list
43553916|NCT03576638|Carbidopa|carbidopa|mesh-list
43553917|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43553918|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43553919|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43553920|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
43553921|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553922|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553923|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553924|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43553925|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553926|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43553927|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
43553928|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
43564020|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43564021|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564033|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43564034|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553929|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
43553930|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43553931|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553933|NCT03576508|Epinephrine|epinephrine|mesh-list
43553934|NCT03576508|Capsaicin|capsaicin|mesh-list
43553935|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553936|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
43553937|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553938|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553939|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
43553940|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553941|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43553942|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43553943|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43553945|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553946|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43716836|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716837|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716838|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
43716839|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43716840|NCT02651623|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43716841|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43716842|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43716844|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
43716845|NCT02651727|Gemcitabine|gemcitabine|mesh-list
43716846|NCT02651727|Paclitaxel|paclitaxel|mesh-list
43564035|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43564036|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43564037|NCT01133990|Growth Substances|growth substances|mesh-ancestor
43716847|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43564038|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564039|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
43564040|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43564041|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
43564042|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564043|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564044|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564045|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
43564046|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43564047|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43564048|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564049|NCT01133990|Antidotes|antidotes|mesh-ancestor
43716848|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43716849|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716850|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
43716851|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
43716852|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
43716853|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716854|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43716855|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
43716856|NCT02651727|Antiviral Agents|antiviral agents|mesh-ancestor
43716857|NCT02651727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716858|NCT02651727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716859|NCT02651727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553947|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43553948|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
43553949|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553950|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43553952|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
43553953|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43553954|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
43553956|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
43553957|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43553958|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
43553959|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
43553960|NCT03576469|Complement C1s|complement c1s|mesh-list
43553961|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43553962|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43553963|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
43553964|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553965|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43553966|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553968|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43553969|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553970|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553971|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43553972|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43553973|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43553974|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
43564082|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564083|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43553975|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
43716860|NCT02651727|Immunologic Factors|immunologic factors|mesh-ancestor
43716861|NCT02651727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716862|NCT02651519|Ropivacaine|ropivacaine|mesh-list
43716863|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
43716864|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
43716865|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716866|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716867|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
43716868|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716869|NCT02651636|Folic Acid|folic acid|mesh-list
43716870|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
43716871|NCT02651636|Inositol|inositol|mesh-list
43850059|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
43564084|NCT01129674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43716874|NCT02651636|Vitamins|vitamins|mesh-ancestor
43716875|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
43716876|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716877|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
43553976|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564085|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43553977|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553978|NCT03576378|Prednisone|prednisone|mesh-list
43553979|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
43553980|NCT03576378|Etoposide|etoposide|mesh-list
43553981|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
43553982|NCT03576378|Procarbazine|procarbazine|mesh-list
43553983|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553984|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
43553985|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553986|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553987|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43553988|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
43553989|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553990|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553991|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43553992|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553993|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
43553994|NCT03576378|Hormones|hormones|mesh-ancestor
43553995|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43553996|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43553997|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43553998|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43850060|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553999|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43554000|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554001|NCT03576378|Analgesics|analgesics|mesh-ancestor
43554002|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
43554003|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554004|NCT03576287|Apremilast|apremilast|mesh-list
43554005|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43554007|NCT03576287|Analgesics|analgesics|mesh-ancestor
43554008|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
43554009|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554010|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554011|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554012|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564104|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43564105|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564106|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43564107|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564108|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554013|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43554014|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43554015|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554016|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554017|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
43716878|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716879|NCT02651636|Protective Agents|protective agents|mesh-ancestor
43716880|NCT02651441|Gemcitabine|gemcitabine|mesh-list
43716882|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716883|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43716884|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
43716885|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716886|NCT02651441|Antiviral Agents|antiviral agents|mesh-ancestor
43716887|NCT02651441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716889|NCT02651441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43716890|NCT02651441|Immunologic Factors|immunologic factors|mesh-ancestor
43716891|NCT02651441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716892|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
43850061|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43554044|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
43554045|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
43554046|NCT03576040|Edotreotide|edotreotide|mesh-list
43554047|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43554048|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554049|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
43554050|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554051|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716907|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716908|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43716909|NCT02651350|Protective Agents|protective agents|mesh-ancestor
43716910|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43716911|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716913|NCT02651324|Analgesics|analgesics|mesh-ancestor
43716914|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
43716915|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564143|NCT01122784|Vaccines|vaccines|mesh-list
43716916|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716917|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43716918|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716919|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
43716920|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
43716921|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716922|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43716923|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43716924|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716925|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716926|NCT02651311|Ibuprofen|ibuprofen|mesh-list
43716927|NCT02651311|Fentanyl|fentanyl|mesh-list
43716928|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43716929|NCT02651311|Narcotics|narcotics|mesh-ancestor
43716930|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716931|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716932|NCT02651311|Analgesics|analgesics|mesh-ancestor
43716933|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
43716934|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716935|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43716936|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716937|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
43716938|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
43716939|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43554053|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
43554054|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
43716940|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43716941|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716942|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716943|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43716944|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716945|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716946|NCT02651168|Aflibercept|aflibercept|mesh-list
43716947|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43716948|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43716949|NCT02651168|Growth Substances|growth substances|mesh-ancestor
43716950|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716951|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
43716952|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716953|NCT02651207|Lidocaine|lidocaine|mesh-list
43716954|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
43716955|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
43716956|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
43716957|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
43716958|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716959|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716960|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
43716961|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554059|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43554060|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554061|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43554062|NCT03575637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43554063|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43554064|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43554065|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554066|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554067|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
43554068|NCT03575598|Nivolumab|nivolumab|mesh-list
43554069|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554070|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554071|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43554072|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554073|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
43554074|NCT03575520|Doxorubicin|doxorubicin|mesh-list
43554075|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554076|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
43554077|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554078|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43554079|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43554080|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
43554081|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554082|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554097|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554098|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
43554099|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554101|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43716963|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43716964|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43716965|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43716966|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716967|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43716968|NCT02651038|Micafungin|micafungin|mesh-list
43716969|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
43716970|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716971|NCT02650752|Capecitabine|capecitabine|mesh-list
43716972|NCT02650752|Lapatinib|lapatinib|mesh-list
43716973|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43554102|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
43554103|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554104|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554105|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43554106|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554107|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43554108|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43554109|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43554111|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43554112|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554113|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554114|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554115|NCT03574909|Aspirin|aspirin|mesh-list
43554116|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43554117|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43554118|NCT03574909|Analgesics|analgesics|mesh-ancestor
43554119|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
43554120|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554121|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554122|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554123|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43554124|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43554125|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43554126|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554127|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43554128|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43554149|NCT03574649|Fluorouracil|fluorouracil|mesh-list
43554150|NCT03574649|Avelumab|avelumab|mesh-list
43554151|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43554152|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554153|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
43554154|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
43716974|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
43716975|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716976|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716977|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43716978|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716979|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
43716980|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43716981|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43716982|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716983|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
43716984|NCT02650791|Coagulants|coagulants|mesh-ancestor
43716985|NCT02650713|Atezolizumab|atezolizumab|mesh-list
43716986|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716987|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
43716988|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43554155|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
43554156|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554157|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554158|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
43554159|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554160|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43554161|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43554162|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
43554163|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43554164|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
43554165|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43554166|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554167|NCT03574376|Bupivacaine|bupivacaine|mesh-list
43554168|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554169|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
43554170|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554171|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554172|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
43554173|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554174|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
43554175|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43554176|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43554177|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554178|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43554179|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43554180|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
43554181|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554182|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554183|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
43554184|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43554185|NCT03574246|Benzydamine|benzydamine|mesh-list
43554186|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43554187|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554188|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
43554189|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
43554190|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554191|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
43554192|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554193|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554194|NCT03574090|Amoxicillin|amoxicillin|mesh-list
43554195|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
43554196|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
43554197|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43716989|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43716990|NCT02650609|Prednisolone|prednisolone|mesh-list
43716991|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
43716992|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43716993|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
43716994|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716995|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
43554198|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43554199|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554200|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43554201|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554202|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554204|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
43554205|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43554206|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554207|NCT03574064|Hormones|hormones|mesh-ancestor
43554208|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554209|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554210|NCT03574064|Incretins|incretins|mesh-ancestor
43554211|NCT03573999|Mannitol|mannitol|mesh-list
43554212|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43554213|NCT03573999|Diuretics|diuretics|mesh-ancestor
43554214|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
43554218|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554219|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43554220|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43554221|NCT03573986|Growth Substances|growth substances|mesh-ancestor
43554222|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554223|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
43554224|NCT03573934|Glucagon|glucagon|mesh-list
43554225|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43554226|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554227|NCT03573934|Hormones|hormones|mesh-ancestor
43554228|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554229|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554230|NCT03573934|Incretins|incretins|mesh-ancestor
43554232|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
43554233|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
43554234|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554235|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
43554236|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43554237|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43554238|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554239|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43554240|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43554241|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
43554242|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554243|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554244|NCT03573596|Dasatinib|dasatinib|mesh-list
43554245|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554246|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43554247|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554248|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554249|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
43554250|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43554260|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43716996|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
43716997|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716998|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716999|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717000|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
43717001|NCT02650609|Hormones|hormones|mesh-ancestor
43717002|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717003|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43717004|NCT02650609|Protective Agents|protective agents|mesh-ancestor
43717005|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717006|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717007|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
43717008|NCT02650635|Lenograstim|lenograstim|mesh-list
43717009|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43717010|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
43554262|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
43554263|NCT03573284|Protective Agents|protective agents|mesh-ancestor
43554264|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
43554265|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43554266|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43554267|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554268|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
43554269|NCT03573245|Coagulants|coagulants|mesh-ancestor
43554270|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43554271|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43554272|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554273|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554274|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554275|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
43554276|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43554277|NCT03573063|Androgens|androgens|mesh-list
43554278|NCT03573063|Hormones|hormones|mesh-ancestor
43554279|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554281|NCT03573050|Rivastigmine|rivastigmine|mesh-list
43554282|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43554283|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554284|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717011|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717012|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717013|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43717014|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
43717015|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717016|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717017|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43717018|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43717019|NCT02650596|Liraglutide|liraglutide|mesh-list
43717020|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717021|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717022|NCT02650596|Incretins|incretins|mesh-ancestor
43717023|NCT02650596|Hormones|hormones|mesh-ancestor
43717024|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554285|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
43554291|NCT03572959|Triamcinolone|triamcinolone|mesh-list
43554292|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43554293|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43554294|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43554295|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554296|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
43554297|NCT03572959|Hormones|hormones|mesh-ancestor
43554298|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554299|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554300|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554301|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
43554302|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554303|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554305|NCT03572829|Ondansetron|ondansetron|mesh-list
43554306|NCT03572829|Aprepitant|aprepitant|mesh-list
43554307|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554308|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
43554309|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
43554310|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554311|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554312|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554313|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
43554317|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554318|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554319|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
43554320|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
43554321|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43554322|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
43554323|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554324|NCT03572829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43554325|NCT03572829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43554326|NCT03572829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554327|NCT03572829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43554328|NCT03572829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43554329|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43554330|NCT03572686|Dexamethasone|dexamethasone|mesh-list
43554331|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
43554332|NCT03572686|Ropivacaine|ropivacaine|mesh-list
43554333|NCT03572686|BB 1101|bb 1101|mesh-list
43554334|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554335|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
43554336|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
43717025|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43717026|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717027|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43717028|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717029|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735542|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43717030|NCT02650427|Incretins|incretins|mesh-ancestor
43717032|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717033|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43717034|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
43717035|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717036|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717037|NCT02650479|Exenatide|exenatide|mesh-list
43717038|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
43717041|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717042|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43717043|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43717044|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717045|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717046|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717047|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717048|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717049|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43717050|NCT02650479|Incretins|incretins|mesh-ancestor
43717051|NCT02650479|Hormones|hormones|mesh-ancestor
43717052|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717053|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
43717054|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
43717055|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717056|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554337|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554338|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554339|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554341|NCT03572686|Hormones|hormones|mesh-ancestor
43717058|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43717059|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
43717060|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717061|NCT02650544|Mirtazapine|mirtazapine|mesh-list
43717062|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
43717063|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43717064|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43717065|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
43717066|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
43717067|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717107|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717109|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43717110|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717111|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43717112|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43717113|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
43717118|NCT02650102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43554342|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554343|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43554344|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554345|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
43554346|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554347|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554348|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554349|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
43554350|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554351|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
43554352|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
43554353|NCT03572647|Hematinics|hematinics|mesh-ancestor
43554354|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43554355|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43554356|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554357|NCT03572517|Morphine|morphine|mesh-list
43554360|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554361|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554362|NCT03572517|Analgesics|analgesics|mesh-ancestor
43554363|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
43554364|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554365|NCT03572400|Gemcitabine|gemcitabine|mesh-list
43554366|NCT03572400|Durvalumab|durvalumab|mesh-list
43554367|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43554368|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
43735553|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43554369|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554370|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554371|NCT03572400|Antiviral Agents|antiviral agents|mesh-ancestor
43554372|NCT03572400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554373|NCT03572400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554374|NCT03572400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554375|NCT03572400|Immunologic Factors|immunologic factors|mesh-ancestor
43554376|NCT03572400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554377|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554378|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43554379|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
43554380|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43554381|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43554382|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43554383|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554384|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554385|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
43554387|NCT03572231|Fesoterodine|fesoterodine|mesh-list
43554388|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43717119|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43717120|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43717122|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
43717123|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43717124|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43717125|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43717126|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43717127|NCT02649920|Dinoprostone|dinoprostone|mesh-list
43717128|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
43717129|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43717130|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717131|NCT02649998|Furosemide|furosemide|mesh-list
43717132|NCT02649998|Isosorbide|isosorbide|mesh-list
43717133|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43717134|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43717135|NCT02649998|Diuretics|diuretics|mesh-ancestor
43717136|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
43717137|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717138|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43717139|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43717140|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717141|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43717142|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
43717143|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43717144|NCT02649751|Roscovitine|roscovitine|mesh-list
43554389|NCT03572231|Oxybutynin|oxybutynin|mesh-list
43554390|NCT03572231|Darifenacin|darifenacin|mesh-list
43554391|NCT03572231|Propiverine|propiverine|mesh-list
43554392|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43554393|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43735557|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735559|NCT03547427|Insulin|insulin|mesh-list
43735602|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735603|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43735604|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43735605|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43735606|NCT02991365|Insulin|insulin|mesh-list
43735607|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43735608|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834478|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834479|NCT05132114|Lugol's solution|lugol's solution|mesh-list
43834480|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
43554394|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
43554395|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554396|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554397|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554398|NCT03572231|Urological Agents|urological agents|mesh-ancestor
43554399|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43554400|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43554401|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43554402|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
43554403|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
43554404|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
43554405|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717145|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717146|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
43717147|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717148|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43717149|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717150|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717151|NCT02649686|Trastuzumab|trastuzumab|mesh-list
43717152|NCT02649686|Durvalumab|durvalumab|mesh-list
43717153|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43717154|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717155|NCT02649582|Temozolomide|temozolomide|mesh-list
43717156|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43717157|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
43717158|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717159|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717160|NCT02649530|LGK974|lgk974|mesh-list
43717161|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717162|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717164|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43717165|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
43717166|NCT02649504|Dexamethasone|dexamethasone|mesh-list
43717167|NCT02649504|Rituximab|rituximab|mesh-list
43717168|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43717169|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717170|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
43717171|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554406|NCT03572088|Terlipressin|terlipressin|mesh-list
43554407|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43554408|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43554410|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43554411|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43554412|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
43554413|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554414|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554415|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554416|NCT03572010|Urological Agents|urological agents|mesh-ancestor
43554417|NCT03571919|Lidocaine|lidocaine|mesh-list
43554418|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554419|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
43554420|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554421|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632815|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
43632816|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632817|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
43632819|NCT05616442|Protective Agents|protective agents|mesh-ancestor
43632888|NCT05615727|Zolpidem|zolpidem|mesh-list
43632889|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43632890|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633026|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
43554422|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
43554423|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554424|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43554425|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43554426|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43717173|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717174|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
43717175|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
43717176|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717177|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717178|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
43717179|NCT02649504|Hormones|hormones|mesh-ancestor
43717180|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717181|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717182|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43717183|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43717184|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
43554427|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43554435|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554436|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43554437|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554438|NCT03571737|Ibuprofen|ibuprofen|mesh-list
43554439|NCT03571737|Lidocaine|lidocaine|mesh-list
43554440|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554441|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
43554442|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554443|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554444|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
43554445|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554446|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43554447|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43554448|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43554449|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43554450|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554451|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43554452|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43554453|NCT03571737|Analgesics|analgesics|mesh-ancestor
43554454|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554455|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43554456|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43554457|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554458|NCT03571711|Meropenem|meropenem|mesh-list
43554459|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43554460|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554461|NCT03571594|Octreotide|octreotide|mesh-list
43717185|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43717186|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717187|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717188|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717190|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43717191|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43717192|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717193|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43717194|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
43717206|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717207|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
43554462|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554463|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43554464|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735609|NCT02866747|Durvalumab|durvalumab|mesh-list
43735610|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735611|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735612|NCT02550197|Vaccines|vaccines|mesh-list
43735613|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
43554465|NCT03571490|Ropivacaine|ropivacaine|mesh-list
43554466|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554467|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
43717209|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717210|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
43717211|NCT02649465|Glimepiride|glimepiride|mesh-list
43717212|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
43717213|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43717214|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717215|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717216|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43717217|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
43717218|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43717219|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717220|NCT02649179|Ropivacaine|ropivacaine|mesh-list
43717221|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
43717222|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
43717223|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717224|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717225|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
43717226|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717227|NCT02649335|Propranolol|propranolol|mesh-list
43717228|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43717268|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
43717269|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717270|NCT02648906|Choline|choline|mesh-list
43717271|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
43717272|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43717273|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
43717274|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717275|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717276|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43717277|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
43554468|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554469|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554470|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
43554471|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554472|NCT03571438|Sirolimus|sirolimus|mesh-list
43554473|NCT03571438|Sunitinib|sunitinib|mesh-list
43554474|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735639|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43554475|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43554476|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43554477|NCT03571438|Growth Substances|growth substances|mesh-ancestor
43717279|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43717280|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
43717281|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717282|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
43717283|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43717284|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717285|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43717286|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43717287|NCT02649101|Growth Substances|growth substances|mesh-ancestor
43717288|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
43717289|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717290|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43554478|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554479|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
43554480|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43554481|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554482|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554483|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43554484|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554485|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43554486|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
43554487|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554488|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
43554489|NCT03571321|Cytarabine|cytarabine|mesh-list
43554490|NCT03571321|Dexamethasone|dexamethasone|mesh-list
43554491|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
43554492|NCT03571321|Rituximab|rituximab|mesh-list
43554493|NCT03571321|Doxorubicin|doxorubicin|mesh-list
43554494|NCT03571321|Methotrexate|methotrexate|mesh-list
43554495|NCT03571321|Vincristine|vincristine|mesh-list
43554496|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
43554497|NCT03571321|Pegaspargase|pegaspargase|mesh-list
43554498|NCT03571321|Thioguanine|thioguanine|mesh-list
43554499|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554500|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
43554501|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554502|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43554503|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43554504|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
43554505|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554506|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554507|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43554508|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554509|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554512|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554513|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554514|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
43554515|NCT03571321|Hormones|hormones|mesh-ancestor
43554516|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554517|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43554518|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43554519|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43554520|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43554521|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717291|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717292|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717293|NCT02648425|Leucovorin|leucovorin|mesh-list
43717294|NCT02648425|Cisplatin|cisplatin|mesh-list
43717295|NCT02648425|Fluorouracil|fluorouracil|mesh-list
43717296|NCT02648425|Capecitabine|capecitabine|mesh-list
43717297|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717298|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
43717299|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717300|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43717301|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43717302|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
43717303|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717304|NCT02648425|Antidotes|antidotes|mesh-ancestor
43717305|NCT02648425|Protective Agents|protective agents|mesh-ancestor
43717306|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
43717307|NCT02648425|Vitamins|vitamins|mesh-ancestor
43717308|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
43717309|NCT02648711|Leucovorin|leucovorin|mesh-list
43717310|NCT02648711|Bevacizumab|bevacizumab|mesh-list
43717311|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
43717312|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43717313|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717314|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43717315|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43717316|NCT02648711|Growth Substances|growth substances|mesh-ancestor
43717317|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717318|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
43717319|NCT02648711|Antidotes|antidotes|mesh-ancestor
43717320|NCT02648711|Protective Agents|protective agents|mesh-ancestor
43554522|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43554523|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
43554524|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43554525|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43554526|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
43554527|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
43554528|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43554532|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43554533|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
43554534|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
43554535|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
43554536|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43554537|NCT03571230|Amoxicillin|amoxicillin|mesh-list
43554538|NCT03571230|Metronidazole|metronidazole|mesh-list
43554539|NCT03571230|Clarithromycin|clarithromycin|mesh-list
43717321|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
43717322|NCT02648711|Vitamins|vitamins|mesh-ancestor
43717323|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
43717324|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
43717328|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717329|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717330|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717331|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717332|NCT02648503|Atropine|atropine|mesh-list
43717333|NCT02648503|Rocuronium|rocuronium|mesh-list
43717334|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43717335|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43717336|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43554540|NCT03571230|Levofloxacin|levofloxacin|mesh-list
43554541|NCT03571230|Tetracycline|tetracycline|mesh-list
43554542|NCT03571230|Tinidazole|tinidazole|mesh-list
43554543|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43554544|NCT03571230|Furazolidone|furazolidone|mesh-list
43554545|NCT03571230|Bismuth|bismuth|mesh-list
43554546|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43554547|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554548|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
43554549|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43554550|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43554551|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43554552|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554553|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554554|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43554555|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43554556|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43554557|NCT03571230|Renal Agents|renal agents|mesh-ancestor
43554558|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43554559|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43554560|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554581|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832306|NCT05272969|Vitamins|vitamins|mesh-ancestor
43832307|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
43832308|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832309|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43832313|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832314|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
43832315|NCT05272254|Povidone|povidone|mesh-list
43832316|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
43832317|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
43832318|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43832319|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554585|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43554594|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554595|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43554596|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43554597|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554598|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
43832320|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
43832321|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832322|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832323|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
43832324|NCT05271084|Dexetimide|dexetimide|mesh-list
43832325|NCT05271084|Citalopram|citalopram|mesh-list
43832326|NCT05271084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43832327|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43832328|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832329|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832330|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832332|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832333|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43832334|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
43832335|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43832336|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43832337|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43832338|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
43832339|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
43832340|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832341|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43832343|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
43832344|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43554599|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43554600|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43554601|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554602|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
43554603|NCT03570710|Coagulants|coagulants|mesh-ancestor
43554604|NCT03570645|Dexamethasone|dexamethasone|mesh-list
43554605|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
43554606|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554607|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
43554608|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
43554613|NCT03570645|Hormones|hormones|mesh-ancestor
43735740|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
43735751|NCT05300490|Hormones|hormones|mesh-ancestor
43554614|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554615|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43554616|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554617|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43847468|NCT04105946|Narcotics|narcotics|mesh-ancestor
43847469|NCT04104646|Morphine|morphine|mesh-list
43847470|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43847471|NCT04104646|Narcotics|narcotics|mesh-ancestor
43847472|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717352|NCT02648490|Acetaminophen|acetaminophen|mesh-list
43717353|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
43717354|NCT02648490|Promethazine|promethazine|mesh-list
43717355|NCT02648490|Dexamethasone|dexamethasone|mesh-list
43717356|NCT02648490|Ondansetron|ondansetron|mesh-list
43717357|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717358|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
43717359|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
43717360|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554623|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43554624|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43554625|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
43554626|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554627|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554647|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554648|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
43554649|NCT03570320|Narcotics|narcotics|mesh-ancestor
43554650|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554651|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554652|NCT03570320|Analgesics|analgesics|mesh-ancestor
43554653|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
43554654|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554667|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43554669|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43554670|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
43554671|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554672|NCT03570164|Sevoflurane|sevoflurane|mesh-list
43554673|NCT03570164|Desflurane|desflurane|mesh-list
43554674|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43554675|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43554676|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
43554677|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
43554678|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554679|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554680|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
43554681|NCT03570112|Velpatasvir|velpatasvir|mesh-list
43554682|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
43554683|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554684|NCT03569995|Cytarabine|cytarabine|mesh-list
43554685|NCT03569995|Rituximab|rituximab|mesh-list
43554686|NCT03569995|Methotrexate|methotrexate|mesh-list
43554687|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554697|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554699|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554700|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43554701|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554702|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43554703|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
43554704|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554705|NCT03569696|Nivolumab|nivolumab|mesh-list
43554706|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554707|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554708|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43554709|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554710|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
43554711|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43554712|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
43554713|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554714|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
43554715|NCT03569683|Protective Agents|protective agents|mesh-ancestor
43554716|NCT03569579|Memantine|memantine|mesh-list
43554717|NCT03569579|Donepezil|donepezil|mesh-list
43554718|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43554720|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554722|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717378|NCT02648490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43717379|NCT02648490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43717380|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717381|NCT02648490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43717382|NCT02648490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43717383|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43717384|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43717387|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43717388|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
43717389|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
43717392|NCT02648633|Valproic Acid|valproic acid|mesh-list
43717393|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43717394|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717395|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43717396|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717397|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
43717398|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717421|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717422|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717423|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43717424|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43717425|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
43717426|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
43717427|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717428|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43717429|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43717430|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717431|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717432|NCT02648048|Pirfenidone|pirfenidone|mesh-list
43717433|NCT02648048|Analgesics|analgesics|mesh-ancestor
43717434|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
43717435|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832352|NCT05270200|Azacitidine|azacitidine|mesh-list
43717436|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554739|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554740|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
43554741|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554742|NCT03568968|Niacinamide|niacinamide|mesh-list
43564219|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
43554743|NCT03568968|Niacin|niacin|mesh-list
43554744|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
43554745|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
43554747|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
43554748|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554749|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43554750|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
43554751|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554752|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43554753|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
43554754|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
43554755|NCT03568916|Apixaban|apixaban|mesh-list
43554756|NCT03568916|Dabigatran|dabigatran|mesh-list
43554757|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43554758|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
43554759|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43554760|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
43554761|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554762|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554763|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
43554764|NCT03568721|Acetaminophen|acetaminophen|mesh-list
43554765|NCT03568721|Ibuprofen|ibuprofen|mesh-list
43554766|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43554767|NCT03568721|Analgesics|analgesics|mesh-ancestor
43554768|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
43554769|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554770|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554771|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
43554772|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43554773|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554774|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43554775|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43554776|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554777|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717437|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43717438|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43717439|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717440|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717441|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717442|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43717443|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43717447|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
43717449|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43717450|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717452|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717453|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717454|NCT02647567|Caffeine|caffeine|mesh-list
43717455|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43717456|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717457|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43717458|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717459|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717460|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43717461|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43717462|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
43717463|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735775|NCT05300386|Antidepressive Agents|antidepressive agents|mesh-ancestor
43717464|NCT02647515|Ranibizumab|ranibizumab|mesh-list
43717465|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43717466|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43554778|NCT03568578|Entecavir|entecavir|mesh-list
43554779|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
43554780|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554781|NCT03568513|Curcumin|curcumin|mesh-list
43554782|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43554783|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43554784|NCT03568513|Analgesics|analgesics|mesh-ancestor
43554785|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
43554786|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717467|NCT02647515|Growth Substances|growth substances|mesh-ancestor
43717468|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717469|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
43717470|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717472|NCT02647424|Clomiphene|clomiphene|mesh-list
43717473|NCT02647424|Enclomiphene|enclomiphene|mesh-list
43717475|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717476|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43717477|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43717478|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717479|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717480|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43717481|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
43717482|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717483|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717484|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43717485|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
43554787|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554788|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554789|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43554790|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554791|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554792|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554793|NCT03568474|Fluorides|fluorides|mesh-list
43554799|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554800|NCT03567941|Acetaminophen|acetaminophen|mesh-list
43554801|NCT03567941|Hydrocodone|hydrocodone|mesh-list
43554802|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43554803|NCT03567941|Analgesics|analgesics|mesh-ancestor
43554804|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
43554805|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554806|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554807|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
43554808|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43554809|NCT03567941|Narcotics|narcotics|mesh-ancestor
43554810|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554811|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
43554812|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
43554813|NCT03567928|Propofol|propofol|mesh-list
43554814|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43554815|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554816|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554817|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43554818|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
43554819|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
43554820|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
43554821|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
43554822|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43554823|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43554824|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43554825|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554826|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43554827|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43554828|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43717486|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43717487|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43717488|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43717490|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
43717491|NCT02647632|Grazoprevir|grazoprevir|mesh-list
43717492|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43717493|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
43717494|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717495|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
43717496|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717497|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43717498|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43717499|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
43717500|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717501|NCT02647489|Antacids|antacids|mesh-ancestor
43717502|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717503|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554829|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43554830|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
43554831|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43554832|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554833|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43554834|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43554835|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43554836|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554838|NCT03567629|Leucovorin|leucovorin|mesh-list
43554839|NCT03567629|Bevacizumab|bevacizumab|mesh-list
43554840|NCT03567629|Cetuximab|cetuximab|mesh-list
43554841|NCT03567629|Fluorouracil|fluorouracil|mesh-list
43554842|NCT03567629|Capecitabine|capecitabine|mesh-list
43554843|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
43554844|NCT03567629|Irinotecan|irinotecan|mesh-list
43554845|NCT03567629|Calcium|calcium|mesh-list
43554846|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
43554847|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554848|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554849|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43554850|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43554851|NCT03567629|Growth Substances|growth substances|mesh-ancestor
43554852|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554853|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
43554854|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43554855|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43554856|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
43554857|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554858|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43554859|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43554860|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
43554861|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43554862|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43554863|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554865|NCT03567629|Protective Agents|protective agents|mesh-ancestor
43554866|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
43554868|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
43554869|NCT03567447|Droxidopa|droxidopa|mesh-list
43554870|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43717504|NCT02647190|Asparaginase|asparaginase|mesh-list
43717505|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717506|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
43717507|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43717508|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43717509|NCT02647255|Prednisolone|prednisolone|mesh-list
43717510|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
43717555|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
43717556|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717557|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43717558|NCT02647047|Analgesics|analgesics|mesh-ancestor
43717559|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
43717560|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43717561|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717562|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717563|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43717564|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717565|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717566|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43717567|NCT02647047|Narcotics|narcotics|mesh-ancestor
43717568|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43717569|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43735789|NCT05300360|Adenosine|adenosine|mesh-list
43735790|NCT05300360|Analgesics|analgesics|mesh-ancestor
43735791|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
43717570|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
43717572|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
43717573|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554880|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
43554881|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554882|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554884|NCT03567395|Melatonin|melatonin|mesh-list
43554885|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
43554886|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554887|NCT03567395|Protective Agents|protective agents|mesh-ancestor
43554888|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554889|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554890|NCT03567369|Dexamethasone|dexamethasone|mesh-list
43554891|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
43554892|NCT03567369|BB 1101|bb 1101|mesh-list
43554893|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43554894|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
43554895|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
43554896|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554897|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554898|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554899|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
43554900|NCT03567369|Hormones|hormones|mesh-ancestor
43554901|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554954|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
43554955|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43554956|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43554957|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554958|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43554959|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43554960|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43554961|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554962|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554963|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
43554964|NCT03566329|Lidocaine|lidocaine|mesh-list
43554965|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
43554966|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554967|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
43554968|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554969|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554970|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
43554971|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554972|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564302|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564303|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564304|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
43564305|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43564306|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564307|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564308|NCT01101594|Doxorubicin|doxorubicin|mesh-list
43564309|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640441|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640570|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640571|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43640572|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43554973|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43717624|NCT02646709|Rocuronium|rocuronium|mesh-list
43717625|NCT02646709|Analgesics|analgesics|mesh-ancestor
43717626|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
43717627|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717628|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717629|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43717630|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43717631|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
43717632|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
43717633|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717634|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43717635|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43717636|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717637|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717638|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43717639|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43717640|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43717641|NCT02646735|Fulvestrant|fulvestrant|mesh-list
43717642|NCT02646735|Exemestane|exemestane|mesh-list
43717643|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717644|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554975|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43554976|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554978|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
43554979|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43564310|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564311|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43564312|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43735795|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
43735796|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43564313|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564314|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554980|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43554981|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
43554984|NCT03566316|Telmisartan|telmisartan|mesh-list
43554985|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43554986|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43554987|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43554988|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43554989|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43717645|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43554992|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832360|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832361|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832362|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43832363|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847473|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717654|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43717655|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43717657|NCT02646397|Benidipine|benidipine|mesh-list
43717658|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43717659|NCT02646397|Diuretics|diuretics|mesh-ancestor
43717660|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
43717661|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717662|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43717663|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43717664|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717665|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43717666|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
43717667|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717668|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43717669|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43717670|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
43717671|NCT02646592|Alfentanil|alfentanil|mesh-list
43717672|NCT02646592|Propofol|propofol|mesh-list
43717673|NCT02646592|Sevoflurane|sevoflurane|mesh-list
43717674|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43717675|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717679|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
43717680|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43717681|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43717682|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43717683|NCT02646592|Narcotics|narcotics|mesh-ancestor
43717684|NCT02646592|Analgesics|analgesics|mesh-ancestor
43717685|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
43717686|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735814|NCT05300334|Analgesics|analgesics|mesh-ancestor
43735816|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717687|NCT02646670|Ranibizumab|ranibizumab|mesh-list
43717688|NCT02646670|Aflibercept|aflibercept|mesh-list
43717689|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43717690|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43717691|NCT02646670|Growth Substances|growth substances|mesh-ancestor
43717692|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717693|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
43717694|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717695|NCT02646657|Vedolizumab|vedolizumab|mesh-list
43717696|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717698|NCT02646540|Furosemide|furosemide|mesh-list
43717699|NCT02646540|Tolvaptan|tolvaptan|mesh-list
43717700|NCT02646540|Diuretics|diuretics|mesh-list
43717701|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
43717702|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554993|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
43554994|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43554995|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43554996|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
43554997|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43554998|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43554999|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555000|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43555001|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43555004|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
43555005|NCT03566303|Vitamins|vitamins|mesh-ancestor
43555006|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
43555007|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555008|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
43735846|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43735847|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43735848|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
43735849|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735851|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555009|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43555010|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
43555012|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
43555013|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555014|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555015|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43555016|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43717703|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43717704|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564361|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43717705|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717706|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43717707|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43717708|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43717709|NCT02646111|Ribavirin|ribavirin|mesh-list
43717710|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
43717712|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
43717713|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717714|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
43717715|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43717716|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717717|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
43717722|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717723|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717724|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717726|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43717727|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847474|NCT04104646|Analgesics|analgesics|mesh-ancestor
43717728|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43717729|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555017|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
43555018|NCT03566303|Coagulants|coagulants|mesh-ancestor
43555019|NCT03566225|Metformin|metformin|mesh-list
43555020|NCT03566225|Pioglitazone|pioglitazone|mesh-list
43555021|NCT03566225|Clomiphene|clomiphene|mesh-list
43555022|NCT03566225|Enclomiphene|enclomiphene|mesh-list
43555023|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
43555024|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43555025|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555026|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43555027|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
43555028|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555029|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43555030|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
43717730|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
43717731|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43717732|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
43717733|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717734|NCT02646267|Warfarin|warfarin|mesh-list
43717735|NCT02646267|Dabigatran|dabigatran|mesh-list
43717736|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
43717737|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
43717738|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43717739|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
43717740|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717741|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717742|NCT02646189|Interferons|interferons|mesh-list
43564362|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717743|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
43564363|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43717744|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
43717745|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43717746|NCT02646189|REP 2139|rep 2139|mesh-list
43717747|NCT02646189|Thymalfasin|thymalfasin|mesh-list
43717748|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717749|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
43717750|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717789|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43717790|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555031|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43555032|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43555033|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43555034|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
43555036|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43555037|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43555038|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
43555039|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555040|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555041|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555042|NCT03566134|Urological Agents|urological agents|mesh-ancestor
43555043|NCT03566069|Oxytocin|oxytocin|mesh-list
43555044|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
43555045|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43555046|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555047|NCT03566030|Tenofovir|tenofovir|mesh-list
43564386|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43564387|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43564388|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564389|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43564390|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43564393|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555048|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
43555049|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555050|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43555051|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43555052|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555053|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555054|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43555055|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43555056|NCT03565536|Sorafenib|sorafenib|mesh-list
43555057|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555058|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43555059|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555060|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555061|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
43555062|NCT03565458|Empagliflozin|empagliflozin|mesh-list
43555063|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43555064|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555065|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43735918|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43735919|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555066|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555067|NCT03565406|Nivolumab|nivolumab|mesh-list
43834482|NCT05127876|Ephedrine|ephedrine|mesh-list
43735924|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
43717792|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43717793|NCT02645734|Growth Substances|growth substances|mesh-ancestor
43717794|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717795|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
43717796|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
43717797|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43717798|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43717799|NCT02645565|Prednisolone|prednisolone|mesh-list
43717800|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
43717801|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
43717802|NCT02645565|Azathioprine|azathioprine|mesh-list
43555068|NCT03565406|Ipilimumab|ipilimumab|mesh-list
43555069|NCT03565406|Mocetinostat|mocetinostat|mesh-list
43555070|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555071|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555072|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43555074|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43555075|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555076|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43555079|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
43555080|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43555082|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555083|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555084|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43555085|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
43555086|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43555088|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43555089|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
43555090|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555091|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555092|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
43555093|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
43555094|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43555095|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
43555096|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43555097|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43555098|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555099|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
43555100|NCT03565276|Coagulants|coagulants|mesh-ancestor
43555101|NCT03565133|Quinine|quinine|mesh-list
43555102|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
43555103|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43555104|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43555105|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555107|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555108|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43555109|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555110|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43555111|NCT03565133|Analgesics|analgesics|mesh-ancestor
43555112|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
43555113|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
43555114|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43555115|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
43555116|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555117|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555118|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717803|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43717804|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
43717805|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43717806|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
43717807|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717808|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717809|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43717810|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
43717811|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717813|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43717814|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717815|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
43717816|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
43717817|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717818|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717819|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
43555119|NCT03564912|Capecitabine|capecitabine|mesh-list
43555120|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
43555121|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43555122|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
43555123|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555124|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555125|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
43555126|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43555127|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555128|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555129|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43555130|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43555143|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43555144|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
43555145|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555147|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43555148|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
43555149|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555150|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555151|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43555152|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555153|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
43555154|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
43555155|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555156|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555157|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
43555158|NCT03564704|Hormones|hormones|mesh-ancestor
43717820|NCT02645565|Hormones|hormones|mesh-ancestor
43717821|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717822|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43717823|NCT02645565|Protective Agents|protective agents|mesh-ancestor
43717824|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717825|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
43717826|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43717827|NCT02645903|Morphine|morphine|mesh-list
43717828|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717829|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717830|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43717831|NCT02645903|Narcotics|narcotics|mesh-ancestor
43717832|NCT02645903|Analgesics|analgesics|mesh-ancestor
43717833|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
43555159|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555160|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43555161|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43555162|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
43555163|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43555164|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43555165|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
43555166|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
43555167|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555168|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43555169|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43555170|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43555171|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43555172|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43555173|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
43555174|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555175|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
43555176|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
43555177|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
43555178|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43555179|NCT03564652|Azithromycin|azithromycin|mesh-list
43555180|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555181|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555182|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43555183|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43555184|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43555185|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43555186|NCT03564548|Morphine|morphine|mesh-list
43555187|NCT03564548|Oxycodone|oxycodone|mesh-list
43555188|NCT03564548|Hydromorphone|hydromorphone|mesh-list
43555189|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43555190|NCT03564548|Narcotics|narcotics|mesh-ancestor
43555191|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555192|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555193|NCT03564548|Analgesics|analgesics|mesh-ancestor
43555194|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
43555195|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555196|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43555197|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43555198|NCT03564509|Hormones|hormones|mesh-ancestor
43555199|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555200|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555201|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43555202|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
43717834|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717836|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717837|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43717838|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717839|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717840|NCT02646020|Loratadine|loratadine|mesh-list
43717841|NCT02646020|Aprepitant|aprepitant|mesh-list
43717842|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
43717843|NCT02646020|Desloratadine|desloratadine|mesh-list
43717844|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
43736033|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
43717845|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
43717846|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555203|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555204|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555205|NCT03564301|Metronidazole|metronidazole|mesh-list
43555206|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555207|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555208|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43555209|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43555210|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
43555211|NCT03564158|Meropenem|meropenem|mesh-list
43555212|NCT03564158|Vaborbactam|vaborbactam|mesh-list
43555215|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43555216|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43555217|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555218|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555219|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555220|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43555221|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
43555222|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43555223|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43555224|NCT03564106|Prednisolone|prednisolone|mesh-list
43555225|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
43555226|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43555227|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
43555245|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
43555246|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555247|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555248|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
43555249|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555250|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43555251|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43555253|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43555254|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555255|NCT03563950|Rifampin|rifampin|mesh-list
43555256|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43555257|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
43555258|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555259|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555260|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
43555261|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43555262|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555263|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555264|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43555265|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43555266|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43717847|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717848|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717849|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43717850|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717851|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717852|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43717853|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
43555267|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43555268|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43555269|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43555270|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
43555271|NCT03563937|Apixaban|apixaban|mesh-list
43555272|NCT03563937|Edoxaban|edoxaban|mesh-list
43555273|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
43555274|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43555275|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
43555276|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43555277|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
43555278|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555279|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555280|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
43555281|NCT03563833|Anesthetics|anesthetics|mesh-list
43555282|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555283|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555284|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
43555285|NCT03563794|Vildagliptin|vildagliptin|mesh-list
43555286|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43555294|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
43555295|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555296|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555297|NCT03563625|Bupivacaine|bupivacaine|mesh-list
43555298|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
43555299|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
43555300|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555301|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555302|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
43555303|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555304|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43736061|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555305|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555306|NCT03563534|Fluorides|fluorides|mesh-list
43555307|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
43555308|NCT03563534|Protective Agents|protective agents|mesh-ancestor
43555309|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555311|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43555312|NCT03563365|Resveratrol|resveratrol|mesh-list
43555313|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
43555314|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555315|NCT03563365|Protective Agents|protective agents|mesh-ancestor
43555316|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555317|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555318|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43555319|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
43555320|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43555321|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43555322|NCT03563365|Analgesics|analgesics|mesh-ancestor
43555323|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
43555324|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555325|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555326|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43555328|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43555329|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717854|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43717855|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43717856|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
43717857|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
43555330|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43555331|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43555332|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555333|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43555335|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
43555336|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43555337|NCT03563170|Leucovorin|leucovorin|mesh-list
43555338|NCT03563170|Paclitaxel|paclitaxel|mesh-list
43555339|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
43555340|NCT03563170|Fluorouracil|fluorouracil|mesh-list
43555341|NCT03563170|Capecitabine|capecitabine|mesh-list
43555342|NCT03563170|Cetuximab|cetuximab|mesh-list
43555343|NCT03563170|Sorafenib|sorafenib|mesh-list
43555344|NCT03563170|Avelumab|avelumab|mesh-list
43555345|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43555346|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555347|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
43555348|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
43555349|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
43555350|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555351|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43555352|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
43555353|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555354|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736094|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
43555355|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43555361|NCT03563170|Protective Agents|protective agents|mesh-ancestor
43555362|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
43555364|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
43555365|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555366|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43555367|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555368|NCT03563144|Leucovorin|leucovorin|mesh-list
43555369|NCT03563144|Gemcitabine|gemcitabine|mesh-list
43555370|NCT03563144|Paclitaxel|paclitaxel|mesh-list
43555371|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
43555372|NCT03563144|Bevacizumab|bevacizumab|mesh-list
43555373|NCT03563144|Fluorouracil|fluorouracil|mesh-list
43555374|NCT03563144|Capecitabine|capecitabine|mesh-list
43555375|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
43555376|NCT03563144|Avelumab|avelumab|mesh-list
43555377|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43555378|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555379|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
43555380|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
43555381|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
43555382|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555383|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43555384|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
43555385|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555386|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43555387|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43555388|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
43555389|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43555390|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555391|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43555392|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43555393|NCT03563144|Growth Substances|growth substances|mesh-ancestor
43555394|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
43555404|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
43555405|NCT03563040|Methoxsalen|methoxsalen|mesh-list
43555406|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43717858|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
43717859|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
43717860|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43717861|NCT02645656|Curcumin|curcumin|mesh-list
43717862|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43717863|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43717864|NCT02645656|Analgesics|analgesics|mesh-ancestor
43717865|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
43717866|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717867|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717868|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717869|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717870|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736108|NCT04955158|Analgesics|analgesics|mesh-ancestor
43736109|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
43736110|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736111|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43736112|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43736113|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736114|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736115|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736116|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736117|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43736118|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43736119|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
43717871|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717872|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717873|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
43717874|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43717875|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43717876|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717877|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
43717878|NCT02645552|Coagulants|coagulants|mesh-ancestor
43717879|NCT02645370|Topiramate|topiramate|mesh-list
43555407|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
43555408|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43555409|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555410|NCT03563001|Budesonide|budesonide|mesh-list
43555411|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
43555412|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555413|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43555414|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
43555415|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555416|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555417|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43555418|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
43555419|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
43555420|NCT03563001|Hormones|hormones|mesh-ancestor
43717880|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
43717881|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717882|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717883|NCT02645461|Palmidrol|palmidrol|mesh-list
43717884|NCT02645461|Riluzole|riluzole|mesh-list
43717887|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43717888|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717946|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717948|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717949|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
43832365|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
43832367|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43832368|NCT05268120|Doxycycline|doxycycline|mesh-list
43832369|NCT05268120|Rifampin|rifampin|mesh-list
43832370|NCT05268120|Trimethoprim|trimethoprim|mesh-list
43832371|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43832372|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832373|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
43832374|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43832375|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43832417|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832418|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
43832419|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43832420|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
43832421|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832422|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43832423|NCT05266456|Vaccines|vaccines|mesh-list
43832424|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43832425|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
43832426|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832427|NCT05265975|Rituximab|rituximab|mesh-list
43832428|NCT05265975|Lenalidomide|lenalidomide|mesh-list
43832429|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832430|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736121|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43736122|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43834484|NCT05127876|Ondansetron|ondansetron|mesh-list
43832431|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
43832432|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832433|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717952|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
43717953|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717954|NCT02644980|Anesthetics|anesthetics|mesh-list
43717955|NCT02644980|Propofol|propofol|mesh-list
43717956|NCT02644980|Etomidate|etomidate|mesh-list
43717957|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717958|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717959|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43717960|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43717961|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
43717984|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717985|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717986|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717987|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43717988|NCT02644707|Selenium|selenium|mesh-list
43717989|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
43717990|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717992|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717993|NCT02644707|Trace Elements|trace elements|mesh-ancestor
43717994|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
43717995|NCT02644720|Dexamethasone|dexamethasone|mesh-list
43717996|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717997|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
43717998|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
43717999|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718000|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718001|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43718002|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
43718003|NCT02644720|Hormones|hormones|mesh-ancestor
43718004|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43718005|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43718006|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718007|NCT02644863|Paclitaxel|paclitaxel|mesh-list
43718008|NCT02644863|Cisplatin|cisplatin|mesh-list
43718033|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43718035|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718036|NCT02644811|Anesthetics|anesthetics|mesh-list
43718037|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718038|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718039|NCT02644616|Torsemide|torsemide|mesh-list
43718040|NCT02644616|Tolvaptan|tolvaptan|mesh-list
43718041|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43718042|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555421|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555422|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43555423|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43555425|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
43555426|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834509|NCT05127395|Acyclovir|acyclovir|mesh-list
43555427|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555428|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43555430|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
43555431|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555432|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555433|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43555434|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
43555435|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
43555436|NCT03562923|Hormones|hormones|mesh-ancestor
43555437|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555438|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
43555439|NCT03562780|Acetaminophen|acetaminophen|mesh-list
43555440|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43555441|NCT03562780|Analgesics|analgesics|mesh-ancestor
43555442|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
43555443|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555444|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555445|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
43555446|NCT03562754|Heparin|heparin|mesh-list
43555447|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
43555448|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555449|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43555450|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43555451|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
43555452|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
43555453|NCT03562611|Nalbuphine|nalbuphine|mesh-list
43555454|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43555455|NCT03562611|Narcotics|narcotics|mesh-ancestor
43555456|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555457|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555458|NCT03562611|Analgesics|analgesics|mesh-ancestor
43555459|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
43555460|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555461|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43555462|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43555463|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555464|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43555465|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43555466|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555467|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555469|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43555470|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
43555471|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555472|NCT03562533|Paclitaxel|paclitaxel|mesh-list
43718043|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
43718044|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718045|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43718047|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43718048|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718049|NCT02644499|Folic Acid|folic acid|mesh-list
43718050|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
43718055|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43718057|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718068|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718069|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43718070|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718071|NCT02644499|Hormones|hormones|mesh-ancestor
43718072|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43718073|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43555473|NCT03562533|Carboplatin|carboplatin|mesh-list
43555474|NCT03562533|Doxorubicin|doxorubicin|mesh-list
43555475|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43555476|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43555477|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555478|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
43555479|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
43555480|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718075|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43718076|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43718077|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718078|NCT02644499|Hematinics|hematinics|mesh-ancestor
43718079|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
43718080|NCT02644499|Vitamins|vitamins|mesh-ancestor
43718081|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
43718082|NCT02644590|Melatonin|melatonin|mesh-list
43718083|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
43718084|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718085|NCT02644590|Protective Agents|protective agents|mesh-ancestor
43718086|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718093|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718095|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
43718096|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43718097|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43718098|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718099|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718100|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43718101|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718102|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
43718103|NCT02644395|Diuretics|diuretics|mesh-ancestor
43718104|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
43718105|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43718106|NCT02644304|Cabergoline|cabergoline|mesh-list
43718107|NCT02644304|Clomiphene|clomiphene|mesh-list
43718108|NCT02644304|Enclomiphene|enclomiphene|mesh-list
43718109|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
43718110|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718111|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43718112|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
43564450|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564451|NCT01037166|Entecavir|entecavir|mesh-list
43718113|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43718114|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718115|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43718116|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
43555494|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
43555495|NCT03562468|Vitamins|vitamins|mesh-ancestor
43555496|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
43555497|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555498|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43555499|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
43555500|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555501|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43555502|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
43555503|NCT03562416|Nintedanib|nintedanib|mesh-list
43555504|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555505|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43555507|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555508|NCT03562390|Irinotecan|irinotecan|mesh-list
43555509|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43555510|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43555511|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555512|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555513|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555514|NCT03562169|Thalidomide|thalidomide|mesh-list
43555515|NCT03562169|Dexamethasone|dexamethasone|mesh-list
43555516|NCT03562169|Ixazomib|ixazomib|mesh-list
43555517|NCT03562169|Glycine|glycine|mesh-list
43555518|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555519|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
43555520|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
43718117|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718118|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43718119|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43718120|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43718121|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43718122|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
43718123|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
43718124|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718126|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43718127|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43718128|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43718129|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
43718130|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718131|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718132|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43555521|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555522|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555523|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555524|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
43555525|NCT03562169|Hormones|hormones|mesh-ancestor
43555526|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555527|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43555528|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555537|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
43555538|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
43555539|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555540|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555542|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555543|NCT03562143|Iron|iron|mesh-list
43555544|NCT03562143|Trace Elements|trace elements|mesh-ancestor
43555546|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555548|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555549|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43555550|NCT03562130|Protective Agents|protective agents|mesh-ancestor
43555551|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555552|NCT03561935|Propafenone|propafenone|mesh-list
43555553|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43555554|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43555555|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43555556|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43555557|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555558|NCT03561740|Capecitabine|capecitabine|mesh-list
43555559|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43555560|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
43718133|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43718134|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43718135|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718136|NCT02644486|Irbesartan|irbesartan|mesh-list
43718137|NCT02644486|Sevelamer|sevelamer|mesh-list
43718138|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43718139|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43718140|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43718141|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718142|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
43718143|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
43718145|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43718146|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43718147|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718148|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
43718149|NCT02644473|Coagulants|coagulants|mesh-ancestor
43718150|NCT02644577|Metformin|metformin|mesh-list
43718151|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43718152|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718153|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43718154|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
43718155|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43718156|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
43555561|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555562|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555563|NCT03561675|Acetazolamide|acetazolamide|mesh-list
43555564|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
43555565|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43555566|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555567|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555568|NCT03561675|Diuretics|diuretics|mesh-ancestor
43555569|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
43555570|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555571|NCT03561649|Adalimumab|adalimumab|mesh-list
43555572|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555573|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43555574|NCT03561558|Ibuprofen|ibuprofen|mesh-list
43555575|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43555581|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555582|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43555583|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43555584|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555585|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718157|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718158|NCT02644421|Lidocaine|lidocaine|mesh-list
43718159|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
43718160|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
43718161|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718162|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718163|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
43718164|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718165|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43718166|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43718167|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43718168|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718169|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718170|NCT02644252|Tocotrienols|tocotrienols|mesh-list
43718172|NCT02644252|Tocopherols|tocopherols|mesh-list
43718173|NCT02644252|Cisplatin|cisplatin|mesh-list
43718174|NCT02644252|Carboplatin|carboplatin|mesh-list
43718175|NCT02644252|Vinorelbine|vinorelbine|mesh-list
43718176|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718177|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43718178|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
43718179|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
43718180|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718181|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555586|NCT03561415|Posaconazole|posaconazole|mesh-list
43555587|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
43555588|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555589|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43555590|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43555592|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43555593|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43555594|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555595|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555596|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43555597|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
43555598|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555599|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555601|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43555602|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43555603|NCT03561402|Analgesics|analgesics|mesh-ancestor
43555604|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
43555605|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555606|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555607|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555608|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718182|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
43718183|NCT02644252|Protective Agents|protective agents|mesh-ancestor
43718184|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718185|NCT02644252|Vitamins|vitamins|mesh-ancestor
43718186|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
43718187|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
43718188|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
43718189|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718190|NCT02644226|Sevoflurane|sevoflurane|mesh-list
43718191|NCT02644226|Desflurane|desflurane|mesh-list
43718192|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43718193|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43718194|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
43718195|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
43718196|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718197|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555609|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43555610|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
43555611|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
43555612|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555613|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43555614|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555615|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555616|NCT03561233|Omeprazole|omeprazole|mesh-list
43555617|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43555618|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555619|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43555620|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555621|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555622|NCT03561181|Vaccines|vaccines|mesh-list
43555623|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
43555624|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555625|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43555626|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43555627|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555628|NCT03560973|Gemcitabine|gemcitabine|mesh-list
43555629|NCT03560973|Ramucirumab|ramucirumab|mesh-list
43555632|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555633|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555634|NCT03560973|Antiviral Agents|antiviral agents|mesh-ancestor
43555635|NCT03560973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555636|NCT03560973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555637|NCT03560973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43555638|NCT03560973|Immunologic Factors|immunologic factors|mesh-ancestor
43555639|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555641|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555642|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43555644|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555645|NCT03560856|Fulvestrant|fulvestrant|mesh-list
43555646|NCT03560856|Palbociclib|palbociclib|mesh-list
43555647|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43555648|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555649|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43555650|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43736283|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
43736284|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736285|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736286|NCT04503252|Cefazolin|cefazolin|mesh-list
43736287|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43736288|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736289|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
43736290|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43849567|NCT03916003|Primaquine|primaquine|mesh-list
43849568|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
43849569|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43849570|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43718198|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43718199|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43718200|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
43718201|NCT02644044|Methotrexate|methotrexate|mesh-list
43718202|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43718203|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
43718204|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718205|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718206|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43718207|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
43718208|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718209|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718210|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
43718211|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718212|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43718213|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43718214|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
43718215|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718216|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43718217|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
43718218|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43718219|NCT02644057|Dobutamine|dobutamine|mesh-list
43718220|NCT02644057|Milrinone|milrinone|mesh-list
43718221|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43718222|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
43718223|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
43718224|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718225|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555651|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
43555652|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555653|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555655|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555656|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555658|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
43555659|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43555660|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43555661|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43555662|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555663|NCT03560804|Diuretics|diuretics|mesh-ancestor
43555664|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
43555665|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555666|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43555667|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43555668|NCT03560583|Metoclopramide|metoclopramide|mesh-list
43718226|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43718227|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43718228|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43718229|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
43718230|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718231|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718232|NCT02644057|Protective Agents|protective agents|mesh-ancestor
43718233|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43736291|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736292|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43736293|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43736294|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
43736295|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736296|NCT04488159|Leucovorin|leucovorin|mesh-list
43736297|NCT04488159|Fluorouracil|fluorouracil|mesh-list
43736298|NCT04488159|Capecitabine|capecitabine|mesh-list
43736299|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
43736300|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
43718234|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
43718235|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43555669|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
43555670|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
43555671|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555672|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555673|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555682|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43555683|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43555684|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43555685|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43555686|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555687|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555688|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555689|NCT03560427|Analgesics|analgesics|mesh-ancestor
43555690|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
43555693|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43555694|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
43555695|NCT03560375|Empagliflozin|empagliflozin|mesh-list
43555696|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43555697|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555698|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43555699|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555700|NCT03560362|Epinephrine|epinephrine|mesh-list
43555701|NCT03560362|Bupivacaine|bupivacaine|mesh-list
43555702|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
43555703|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
43555704|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555705|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555706|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
43555707|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555708|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43555709|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43555710|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
43555711|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555712|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555713|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43555714|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43555715|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
43555716|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43555717|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
43555718|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
43555719|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
43718236|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43718237|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718239|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43718240|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
43718241|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718242|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718243|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43718244|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43718245|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
43736301|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736302|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43736303|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736304|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736326|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43736327|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43718246|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718247|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555720|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43555722|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43555723|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555724|NCT03560336|Incretins|incretins|mesh-ancestor
43555725|NCT03560336|Hormones|hormones|mesh-ancestor
43555726|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555727|NCT03560310|Ticagrelor|ticagrelor|mesh-list
43555728|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43555730|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43555731|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43555732|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
43555733|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555734|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555735|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555736|NCT03560232|Clindamycin|clindamycin|mesh-list
43555737|NCT03560232|Gentamicins|gentamicins|mesh-list
43555738|NCT03560232|Cefazolin|cefazolin|mesh-list
43555739|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
43555740|NCT03560232|Tazobactam|tazobactam|mesh-list
43555741|NCT03560232|Piperacillin|piperacillin|mesh-list
43555742|NCT03560232|Ampicillin|ampicillin|mesh-list
43555743|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43555744|NCT03560232|Sulbactam|sulbactam|mesh-list
43555745|NCT03560232|Sultamicillin|sultamicillin|mesh-list
43555746|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555747|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555748|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43555749|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555750|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555751|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43555752|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
43555754|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555755|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
43555756|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555757|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555758|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
43555759|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43555760|NCT03560011|Antibodies|antibodies|mesh-list
43555761|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
43555762|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555763|NCT03559920|Propofol|propofol|mesh-list
43555764|NCT03559920|Anesthetics|anesthetics|mesh-list
43555765|NCT03559920|Sevoflurane|sevoflurane|mesh-list
43555766|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43555767|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718249|NCT02643563|Bupivacaine|bupivacaine|mesh-list
43718250|NCT02643563|Ropivacaine|ropivacaine|mesh-list
43718251|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
43718252|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
43718253|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718254|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718255|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
43718256|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555768|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555769|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43736336|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43555770|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
43555771|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43555773|NCT03559803|Cisplatin|cisplatin|mesh-list
43736337|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
43555774|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555775|NCT03559790|Tenofovir|tenofovir|mesh-list
43555776|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
43555777|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555778|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43555779|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43555780|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555781|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555782|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43555783|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43555784|NCT03559751|Nicotine|nicotine|mesh-list
43555785|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43555786|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
43555787|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555788|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555789|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43555790|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43555791|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
43555792|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555793|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555794|NCT03559725|Menthol|menthol|mesh-list
43555795|NCT03559725|Nicotine|nicotine|mesh-list
43555799|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555800|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43555801|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43555802|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
43555803|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555804|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555805|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
43555806|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
43555807|NCT03559673|Lacosamide|lacosamide|mesh-list
43555808|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
43555809|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43555810|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43555811|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43736353|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736354|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43736355|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43736356|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
43736357|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736358|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43736371|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43736373|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43736374|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43555812|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555813|NCT03559504|Sevoflurane|sevoflurane|mesh-list
43555814|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43555815|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43555816|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
43555817|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
43555818|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555819|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555820|NCT03559413|Imiquimod|imiquimod|mesh-list
43555821|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43555822|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
43555823|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555824|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555825|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
43718257|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43718258|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43718259|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
43718260|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718261|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718262|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43718263|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43718264|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
43718265|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43718266|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
43718267|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
43718268|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
43718269|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43718270|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43718271|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43718272|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43718273|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
43718274|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718275|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43718276|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43718277|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718278|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
43718279|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43718280|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718281|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
43718282|NCT02643823|Methotrexate|methotrexate|mesh-list
43718283|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
43718284|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43736375|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43736376|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43736377|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736378|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
43736379|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736380|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736381|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43736382|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43718285|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
43718286|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718287|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718288|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43718289|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
43718290|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555826|NCT03559387|Lenograstim|lenograstim|mesh-list
43555827|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43555828|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
43718291|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718293|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718294|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43718295|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43718296|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
43718297|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43718298|NCT02643719|Topiramate|topiramate|mesh-list
43718299|NCT02643719|Naproxen|naproxen|mesh-list
43718300|NCT02643719|Sumatriptan|sumatriptan|mesh-list
43718301|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43718302|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43718303|NCT02643719|Analgesics|analgesics|mesh-ancestor
43718304|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
43718305|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718306|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718307|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718308|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718309|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
43718310|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43718311|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718312|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718313|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
43718314|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43718315|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43718316|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43718317|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43718318|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
43718319|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718320|NCT02643732|Methylphenidate|methylphenidate|mesh-list
43718321|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43718322|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834591|NCT05116254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834593|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
43834594|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834595|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43834596|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736387|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
43736388|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43736389|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43718323|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43555829|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555830|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43555831|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
43555835|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43555836|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43718324|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43718325|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718326|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718327|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
43718328|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718329|NCT02643550|Cetuximab|cetuximab|mesh-list
43718330|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43718331|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718332|NCT02643602|Theophylline|theophylline|mesh-list
43718333|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43718334|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
43718335|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718336|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718337|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43718338|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
43718339|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43718340|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718341|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718343|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43832450|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832451|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832453|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
43832454|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832455|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43832456|NCT05264025|Fexofenadine|fexofenadine|mesh-list
43832457|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43832458|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43718411|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
43718412|NCT02642861|Calcium|calcium|mesh-list
43718413|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43718414|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718415|NCT02642861|Antacids|antacids|mesh-ancestor
43718416|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718417|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43718420|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43718421|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43718422|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43718423|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718424|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43718425|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718426|NCT02642913|Sorafenib|sorafenib|mesh-list
43718427|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718428|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43718429|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718430|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718431|NCT02642874|Methocarbamol|methocarbamol|mesh-list
43718432|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
43718433|NCT02642874|Calcium|calcium|mesh-list
43718434|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43718435|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718437|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718438|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43718439|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43718440|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43718441|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718442|NCT02642939|Mifepristone|mifepristone|mesh-list
43718443|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43718444|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
43718445|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718446|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718449|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43718450|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
43718451|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43718452|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43718453|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639130|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718512|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
43718513|NCT02642419|Clopidogrel|clopidogrel|mesh-list
43718514|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43718515|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43718516|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43718517|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43718518|NCT02642419|Analgesics|analgesics|mesh-ancestor
43718571|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718572|NCT02642367|Rocuronium|rocuronium|mesh-list
43718573|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43718574|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43718575|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43718576|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718577|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718578|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
43736444|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736445|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43736446|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
43736447|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736448|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
43736449|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736450|NCT04204343|Bupivacaine|bupivacaine|mesh-list
43736451|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
43736452|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
43736453|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718579|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
43718580|NCT02642146|Calcium|calcium|mesh-list
43718586|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718635|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43718636|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43718637|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
43718638|NCT02641847|Antiviral Agents|antiviral agents|mesh-ancestor
43718639|NCT02641847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718640|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718641|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
43718642|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
43718643|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718701|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
43718702|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
43718703|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718704|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718705|NCT02641457|Ranibizumab|ranibizumab|mesh-list
43718706|NCT02641457|Aflibercept|aflibercept|mesh-list
43718707|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43718708|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43718709|NCT02641457|Growth Substances|growth substances|mesh-ancestor
43718710|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718711|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
43718712|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718713|NCT02641210|Albendazole|albendazole|mesh-list
43718714|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
43718715|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43718716|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718717|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
43718718|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43718719|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43718720|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
43718721|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
43718722|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718723|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718724|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718725|NCT02641431|Ajmaline|ajmaline|mesh-list
43718726|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43718727|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43832468|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832469|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43736454|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736455|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
43736456|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736457|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
43736458|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43736459|NCT04126538|Pirfenidone|pirfenidone|mesh-list
43736460|NCT04126538|Analgesics|analgesics|mesh-ancestor
43736461|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
43736462|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736463|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736464|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43736465|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736466|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832470|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832471|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832472|NCT05263284|Venetoclax|venetoclax|mesh-list
43832473|NCT05263284|Adenosine|adenosine|mesh-list
43832474|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832475|NCT05263284|Analgesics|analgesics|mesh-ancestor
43832476|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
43718785|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43718786|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43718787|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
43718788|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718843|NCT02640417|Vitamins|vitamins|mesh-ancestor
43718844|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
43718845|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718846|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
43718847|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43718848|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43718849|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718850|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
43718851|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
43718852|NCT02640495|Artesunate|artesunate|mesh-list
43718853|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
43718854|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43718855|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43718856|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718857|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718858|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
43718859|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
43718860|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43718861|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
43718862|NCT02640508|Lenvatinib|lenvatinib|mesh-list
43718863|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718864|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43718865|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718868|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718869|NCT02640365|Leucovorin|leucovorin|mesh-list
43718870|NCT02640365|Bevacizumab|bevacizumab|mesh-list
43718871|NCT02640365|Irinotecan|irinotecan|mesh-list
43718872|NCT02640365|Camptothecin|camptothecin|mesh-list
43718873|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43718874|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718875|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43718876|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43718877|NCT02640365|Growth Substances|growth substances|mesh-ancestor
43718878|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718879|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
43718880|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43718881|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43718882|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718883|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718884|NCT02640365|Antidotes|antidotes|mesh-ancestor
43718885|NCT02640365|Protective Agents|protective agents|mesh-ancestor
43718886|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
43718927|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718928|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718929|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718930|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43718931|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43718932|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
43718933|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43718934|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43718935|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718936|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
43718937|NCT02639819|Coagulants|coagulants|mesh-ancestor
43718938|NCT02639806|Lidocaine|lidocaine|mesh-list
43718939|NCT02639806|Sevoflurane|sevoflurane|mesh-list
43849572|NCT03915678|Atezolizumab|atezolizumab|mesh-list
43849573|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43849574|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718940|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
43718941|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
43718942|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718944|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
43718945|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718946|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43718947|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43718948|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43718949|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718976|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43718977|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718978|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43718979|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
43718980|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43718981|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43718982|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718983|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
43718984|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
43718985|NCT02639598|Topiramate|topiramate|mesh-list
43718986|NCT02639598|Flunarizine|flunarizine|mesh-list
43718987|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
43718990|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43718991|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718992|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718993|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43718994|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43718995|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
43718996|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
43718997|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718998|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
43718999|NCT02639520|Fosfomycin|fosfomycin|mesh-list
43719000|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719001|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832489|NCT05262777|Lidocaine|lidocaine|mesh-list
43832490|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
43832491|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
43832492|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832493|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832494|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
43832495|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832496|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43832500|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832502|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
43832503|NCT05260359|Petrolatum|petrolatum|mesh-list
43832504|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43832505|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832506|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832507|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832508|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43832509|NCT05260359|Protective Agents|protective agents|mesh-ancestor
43832510|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
43832512|NCT05259800|Peppermint oil|peppermint oil|mesh-list
43832513|NCT05259800|Mineral Oil|mineral oil|mesh-list
43736467|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736468|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736469|NCT04124601|Nivolumab|nivolumab|mesh-list
43736470|NCT04124601|Ipilimumab|ipilimumab|mesh-list
43736471|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43736472|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736473|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43736474|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832514|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
43832515|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
43832516|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832517|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832518|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43832519|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
43832520|NCT05259800|Emollients|emollients|mesh-ancestor
43832521|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
43832522|NCT05259709|Cemiplimab|cemiplimab|mesh-list
43832523|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832524|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832525|NCT05259241|Thrombin|thrombin|mesh-list
43832526|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
43832527|NCT05259241|Coagulants|coagulants|mesh-ancestor
43719066|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719067|NCT02638870|Amitriptyline|amitriptyline|mesh-list
43719068|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43719069|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
43719070|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719130|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719131|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719132|NCT02638506|Analgesics|analgesics|mesh-ancestor
43719133|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
43719134|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719135|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43719136|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43719137|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
43719201|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719202|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719203|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43719204|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
43719205|NCT02638415|Protective Agents|protective agents|mesh-ancestor
43719206|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43719207|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43719208|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43719209|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
43719210|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43719211|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43719213|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43719214|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
43719215|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43719216|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719217|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43719218|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
43719219|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43719220|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43719221|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43719222|NCT02638064|Surgiflo|surgiflo|mesh-list
43719223|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
43719224|NCT02638064|Coagulants|coagulants|mesh-ancestor
43719225|NCT02638142|Furosemide|furosemide|mesh-list
43719226|NCT02638142|Diuretics|diuretics|mesh-ancestor
43719227|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
43719229|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43719231|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719232|NCT02638116|Omeprazole|omeprazole|mesh-list
43719240|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719241|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43719242|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719244|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
43719245|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
43719246|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
43719247|NCT02637830|Protective Agents|protective agents|mesh-ancestor
43719248|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719249|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
43719250|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43719251|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43719252|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
43719253|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
43719254|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719255|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719256|NCT02637726|Remifentanil|remifentanil|mesh-list
43719257|NCT02637726|Propofol|propofol|mesh-list
43719258|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43719259|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719307|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719309|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
43719377|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43719378|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719380|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
43719381|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
43719382|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719383|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43719384|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43719386|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719387|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
43719398|NCT02636426|Sorafenib|sorafenib|mesh-list
43719439|NCT02636101|Calcipotriene|calcipotriene|mesh-list
43719440|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43719441|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43719442|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
43719443|NCT02636101|Hormones|hormones|mesh-ancestor
43736475|NCT04118010|Vitamin D|vitamin d|mesh-list
43736476|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
43736477|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
43736478|NCT04118010|Vitamins|vitamins|mesh-list
43736479|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
43736480|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736481|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43736482|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43736483|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43736484|NCT04086212|Icodextrin|icodextrin|mesh-list
43736485|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
43736486|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
43736487|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43736488|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736489|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
43736490|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43736491|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43736493|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43736494|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43736495|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736496|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
43736497|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
43736498|NCT05361057|Cytarabine|cytarabine|mesh-list
43736499|NCT05361057|Azacitidine|azacitidine|mesh-list
43736500|NCT05361057|Daunorubicin|daunorubicin|mesh-list
43736501|NCT05361057|Venetoclax|venetoclax|mesh-list
43608242|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719444|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43719445|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719446|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43719447|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
43719448|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
43719449|NCT02636088|Cetuximab|cetuximab|mesh-list
43719450|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43719451|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719452|NCT02635802|Lidocaine|lidocaine|mesh-list
43719453|NCT02635802|Midazolam|midazolam|mesh-list
43719500|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43719501|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719503|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43719504|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
43719505|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
43719506|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43719507|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719508|NCT02635750|Donepezil|donepezil|mesh-list
43719509|NCT02635750|BI 409306|bi 409306|mesh-list
43719510|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43719511|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719512|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719513|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
43719514|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719515|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719516|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
43719517|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43719518|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
43719519|NCT02635867|Calcium|calcium|mesh-list
43736502|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43736504|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736505|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736506|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
43736507|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736508|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736509|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
43736511|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719520|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43719521|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719522|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43719523|NCT02635893|Cycloserine|cycloserine|mesh-list
43719524|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43832592|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832594|NCT05256108|Tramadol|tramadol|mesh-list
43832595|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43832596|NCT05256108|Narcotics|narcotics|mesh-ancestor
43832597|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832598|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832599|NCT05256108|Analgesics|analgesics|mesh-ancestor
43832600|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
43832601|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832602|NCT05255770|Benzocaine|benzocaine|mesh-list
43832603|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
43832604|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
43832605|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832606|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832607|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
43832608|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832609|NCT05255653|Cisplatin|cisplatin|mesh-list
43832610|NCT05255653|Carboplatin|carboplatin|mesh-list
43832611|NCT05255653|Durvalumab|durvalumab|mesh-list
43832617|NCT05255653|Progestins|progestins|mesh-list
43832618|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736540|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
43736541|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
43736542|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736543|NCT05360602|Protective Agents|protective agents|mesh-ancestor
43736544|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736545|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
43736546|NCT05360602|Vitamins|vitamins|mesh-ancestor
43736547|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
43736548|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
43736549|NCT05360537|Liraglutide|liraglutide|mesh-list
43736550|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43736551|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736552|NCT05360537|Incretins|incretins|mesh-ancestor
43736553|NCT05360537|Hormones|hormones|mesh-ancestor
43736554|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736555|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
43736556|NCT05360511|Hematinics|hematinics|mesh-ancestor
43736557|NCT05360433|Oxycodone|oxycodone|mesh-list
43736558|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43736559|NCT05360433|Narcotics|narcotics|mesh-ancestor
43736560|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736568|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736569|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
43736570|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
43832619|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832620|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832621|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43832622|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719537|NCT02635334|Montelukast|montelukast|mesh-list
43719538|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43719539|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
43719540|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43719541|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
43719542|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43719543|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555837|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
43555838|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555839|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555840|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555841|NCT03558919|Urological Agents|urological agents|mesh-ancestor
43555842|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43555843|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43555844|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43555845|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
43555846|NCT03558880|Anesthetics|anesthetics|mesh-list
43555847|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736576|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
43736577|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736578|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43736579|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43736580|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736581|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
43736582|NCT05360342|Coagulants|coagulants|mesh-ancestor
43736583|NCT05360160|Venetoclax|venetoclax|mesh-list
43736584|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736585|NCT05360147|Metformin|metformin|mesh-list
43736586|NCT05360147|Liraglutide|liraglutide|mesh-list
43736587|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43736588|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
43736589|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736590|NCT05360147|Incretins|incretins|mesh-ancestor
43555848|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555849|NCT03558750|Rituximab|rituximab|mesh-list
43555850|NCT03558750|Nivolumab|nivolumab|mesh-list
43555851|NCT03558750|Lenalidomide|lenalidomide|mesh-list
43555852|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555853|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555854|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
43555855|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555856|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43555857|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43555858|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555859|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43555860|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43555861|NCT03558750|Growth Substances|growth substances|mesh-ancestor
43555862|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
43555863|NCT03558477|Esomeprazole|esomeprazole|mesh-list
43555864|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43555865|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555866|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43555867|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555868|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555869|NCT03558412|Decitabine|decitabine|mesh-list
43555879|NCT03558139|Magrolimab|magrolimab|mesh-list
43555880|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555881|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555882|NCT03557996|Listerine|listerine|mesh-list
43555883|NCT03557996|Fluorides|fluorides|mesh-list
43555884|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
43555885|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
43555886|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
43555887|NCT03557996|Protective Agents|protective agents|mesh-ancestor
43555888|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555889|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43555890|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555891|NCT03557983|Fenofibrate|fenofibrate|mesh-list
43555892|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43555893|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
43555894|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555895|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43555897|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43719544|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43719545|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43564520|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43564521|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43564523|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564524|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43834610|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43834611|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834612|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
43834613|NCT05114096|Hormones|hormones|mesh-ancestor
43834614|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834615|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719546|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719548|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43719549|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43719550|NCT02635230|Analgesics|analgesics|mesh-ancestor
43719551|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
43719552|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719553|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719554|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43719555|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719556|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43719557|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43719558|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719559|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43719560|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43719561|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719562|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
43719563|NCT02635360|Cisplatin|cisplatin|mesh-list
43719564|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
43719565|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555898|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555899|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43555900|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
43555901|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555902|NCT03557580|Isosorbide|isosorbide|mesh-list
43555903|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43555904|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43555905|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43555906|NCT03557580|Diuretics|diuretics|mesh-ancestor
43555907|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
43555908|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555909|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
43555910|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43555911|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555913|NCT03557437|Metronidazole|metronidazole|mesh-list
43555914|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
43555915|NCT03557437|Esomeprazole|esomeprazole|mesh-list
43555916|NCT03557437|Bismuth|bismuth|mesh-list
43555917|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555918|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555919|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555920|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43555921|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43555922|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43555923|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555924|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43555925|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555926|NCT03557437|Antacids|antacids|mesh-ancestor
43555927|NCT03557437|Diuretics|diuretics|mesh-ancestor
43719566|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43719567|NCT02635282|Fentanyl|fentanyl|mesh-list
43719568|NCT02635282|Midazolam|midazolam|mesh-list
43555928|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
43555929|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564530|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43555930|NCT03557437|Expectorants|expectorants|mesh-ancestor
43834631|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
43834632|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43736594|NCT05360030|Naloxone|naloxone|mesh-list
43736595|NCT05360030|Analgesics|analgesics|mesh-ancestor
43736596|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
43736597|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736598|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736602|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
43555931|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
43555932|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
43555933|NCT03557424|Cathartics|cathartics|mesh-ancestor
43555934|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555935|NCT03557255|Simendan|simendan|mesh-list
43555936|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43555937|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
43555938|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43555939|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43555940|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555944|NCT03557229|Vitamins|vitamins|mesh-list
43555945|NCT03557229|Ascorbic Acid|ascorbic acid|mesh-list
43555946|NCT03557229|Vitamin E|vitamin e|mesh-list
43555947|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
43555948|NCT03557229|Melatonin|melatonin|mesh-list
43555949|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43555951|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555952|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
43555953|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555954|NCT03557229|Protective Agents|protective agents|mesh-ancestor
43555955|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555956|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
43555957|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555958|NCT03557229|Expectorants|expectorants|mesh-ancestor
43555959|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
43555960|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43555961|NCT03557229|Antidotes|antidotes|mesh-ancestor
43555962|NCT03557112|Cisplatin|cisplatin|mesh-list
43555963|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
43555964|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555965|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555966|NCT03556917|Caffeine|caffeine|mesh-list
43564534|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
43555967|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43555968|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555969|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43564535|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564536|NCT01024062|Paclitaxel|paclitaxel|mesh-list
43564537|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43736603|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736604|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43736605|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43736607|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736608|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43736609|NCT05359939|Choline|choline|mesh-list
43555970|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555971|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555972|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43555973|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43555974|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
43555975|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555976|NCT03556852|Misoprostol|misoprostol|mesh-list
43555977|NCT03556852|Carbetocin|carbetocin|mesh-list
43719579|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43719580|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43719581|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719582|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719583|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43719584|NCT02635282|Narcotics|narcotics|mesh-ancestor
43719585|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43719586|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43719587|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43555988|NCT03556839|Carboplatin|carboplatin|mesh-list
43555989|NCT03556839|Atezolizumab|atezolizumab|mesh-list
43555990|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43555991|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555992|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
43555993|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
43555994|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
43555995|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555996|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555997|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43556001|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
43556002|NCT03556592|Metoprolol|metoprolol|mesh-list
43556003|NCT03556592|Midazolam|midazolam|mesh-list
43556004|NCT03556592|Caffeine|caffeine|mesh-list
43556005|NCT03556592|Omeprazole|omeprazole|mesh-list
43556006|NCT03556592|Warfarin|warfarin|mesh-list
43556007|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43556008|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43556010|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556012|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43556013|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556014|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43556022|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43556023|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556024|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43556025|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556026|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43556027|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43556028|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43556029|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43556030|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
43556031|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43736641|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43736642|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
43736643|NCT05359354|Vaccines|vaccines|mesh-list
43736644|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
43736672|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736674|NCT05357820|Rifampin|rifampin|mesh-list
43736675|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
43736676|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736677|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43736678|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43556032|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43736679|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556033|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
43556034|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
43556035|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556036|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43719589|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719590|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
43719592|NCT02635074|Cytarabine|cytarabine|mesh-list
43556050|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556051|NCT03556371|Antidotes|antidotes|mesh-ancestor
43556052|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
43556054|NCT03556098|Incretins|incretins|mesh-list
43556055|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556056|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556057|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556058|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
43556059|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43556064|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43556065|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556066|NCT03555994|Incretins|incretins|mesh-ancestor
43556067|NCT03555994|Hormones|hormones|mesh-ancestor
43556068|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556069|NCT03555929|Dexamethasone|dexamethasone|mesh-list
43556070|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556071|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
43556072|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
43556073|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556074|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556075|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556076|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
43556077|NCT03555929|Hormones|hormones|mesh-ancestor
43556078|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556079|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43719605|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43719606|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719607|NCT02635191|Amoxicillin|amoxicillin|mesh-list
43719608|NCT02635191|Metronidazole|metronidazole|mesh-list
43719609|NCT02635191|Clarithromycin|clarithromycin|mesh-list
43719610|NCT02635191|Esomeprazole|esomeprazole|mesh-list
43719611|NCT02635191|Omeprazole|omeprazole|mesh-list
43736684|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736685|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43736686|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43736687|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
43736688|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43736689|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
43736690|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43736691|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43736692|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43736693|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43736694|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43736695|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43736696|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43736697|NCT05357768|Formaldehyde|formaldehyde|mesh-list
43719612|NCT02635191|Rabeprazole|rabeprazole|mesh-list
43719613|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719618|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719619|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43719620|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719621|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719622|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43719623|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43719624|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43719626|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43719627|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43719628|NCT02634970|Growth Substances|growth substances|mesh-ancestor
43719629|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719630|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
43719631|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719632|NCT02634723|Factor VIII|factor viii|mesh-list
43719633|NCT02634723|Coagulants|coagulants|mesh-ancestor
43556080|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556081|NCT03555617|Itraconazole|itraconazole|mesh-list
43556082|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
43556087|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556088|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43556089|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
43556090|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556091|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556092|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43556094|NCT03555526|Metronidazole|metronidazole|mesh-list
43556095|NCT03555526|Clarithromycin|clarithromycin|mesh-list
43556096|NCT03555526|Levofloxacin|levofloxacin|mesh-list
43556097|NCT03555526|Ofloxacin|ofloxacin|mesh-list
43556098|NCT03555526|Tetracycline|tetracycline|mesh-list
43556099|NCT03555526|Esomeprazole|esomeprazole|mesh-list
43556100|NCT03555526|Bismuth|bismuth|mesh-list
43556101|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719635|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43719636|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719638|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
43719639|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43719642|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
43719643|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556102|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556103|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43556109|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556110|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43556123|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
43556124|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556125|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556126|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43556127|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
43556128|NCT03555383|Hemostatics|hemostatics|mesh-list
43556129|NCT03555383|Coagulants|coagulants|mesh-ancestor
43556149|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556150|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43556151|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43556152|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556153|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556156|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43556161|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43719644|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719645|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719646|NCT02634489|Urological Agents|urological agents|mesh-ancestor
43719647|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43719648|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43719649|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
43719651|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43719652|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719653|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719654|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719655|NCT02634528|Insulin|insulin|mesh-list
43719656|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43719657|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
43719658|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
43719659|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
43719660|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43556162|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43556163|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43556165|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
43556166|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556167|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43556168|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43556169|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556170|NCT03554980|Listerine|listerine|mesh-list
43556171|NCT03554980|Fluorides|fluorides|mesh-list
43556172|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
43556173|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
43556174|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
43556175|NCT03554980|Protective Agents|protective agents|mesh-ancestor
43556176|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556177|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43556178|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556179|NCT03554915|Midazolam|midazolam|mesh-list
43556180|NCT03554915|Ketamine|ketamine|mesh-list
43556181|NCT03554915|Analgesics|analgesics|mesh-ancestor
43556182|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
43556183|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556184|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556185|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43556186|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43556187|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
43556189|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736698|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
43736699|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736700|NCT05357547|Buspirone|buspirone|mesh-list
43736701|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43736713|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43736714|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736715|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736716|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736717|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736718|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736719|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43736720|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43736721|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
43736722|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736723|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43849580|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43556190|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43556191|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43556192|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556193|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556194|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43556195|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43556196|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43556197|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43556220|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43556222|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
43556223|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
43556224|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556225|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43556226|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43556227|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
43556233|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
43556234|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43556253|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556254|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556255|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556256|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43556257|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
43556258|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43556259|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556260|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43556261|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43556262|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43556263|NCT03554109|Leucovorin|leucovorin|mesh-list
43556264|NCT03554109|Paclitaxel|paclitaxel|mesh-list
43556265|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43556266|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
43556267|NCT03554109|Doxorubicin|doxorubicin|mesh-list
43556268|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43556269|NCT03554109|Fluorouracil|fluorouracil|mesh-list
43556271|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43564538|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564547|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564548|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
43564549|NCT01023295|Combretastatin|combretastatin|mesh-list
43564550|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43564551|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564552|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
43564554|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
43736724|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
43736725|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
43736726|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
43736727|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43736729|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43736730|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736731|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736732|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43556272|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556273|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
43556274|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
43556275|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
43556276|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556277|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43556278|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
43556279|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556280|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43556281|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43556282|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
43556283|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43556284|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43556285|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43556286|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43556287|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556288|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
43556289|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43556291|NCT03554109|Protective Agents|protective agents|mesh-ancestor
43556292|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
43556293|NCT03554109|Vitamins|vitamins|mesh-ancestor
43556294|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
43719690|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
43719691|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43719692|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
43719693|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43719694|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719695|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43719696|NCT02634294|Interferons|interferons|mesh-list
43719697|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
43719698|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
43719699|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43719700|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719701|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
43556295|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43556296|NCT03554031|Hormones|hormones|mesh-list
43556297|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556310|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
43556313|NCT03553537|Decitabine|decitabine|mesh-list
43556314|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43556315|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
43556316|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556317|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43556318|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43556319|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
43556320|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556321|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556322|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43556323|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43556324|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43556325|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43556326|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556327|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556328|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
43556329|NCT03553537|Hormones|hormones|mesh-ancestor
43736734|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
43736735|NCT05357326|Atropine|atropine|mesh-list
43556330|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556331|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43556332|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43556333|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
43556334|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
43556335|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
43556336|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43556337|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
43556338|NCT03553433|Apremilast|apremilast|mesh-list
43556339|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43556340|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43719713|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556356|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556357|NCT03553303|Valsartan|valsartan|mesh-list
43556358|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43556359|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43556360|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43556361|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43556362|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556375|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556376|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43556377|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43556378|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
43556379|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556380|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556381|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43556382|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556385|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556386|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556387|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
43556388|NCT03553238|Hormones|hormones|mesh-ancestor
43556389|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556390|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43556391|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43556392|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
43556393|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43556394|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43556395|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
43556396|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
43556397|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556398|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43556399|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43556400|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43556401|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43556402|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43556403|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
43556404|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556405|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
43556406|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
43556407|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
43556408|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43556409|NCT03553173|Bupropion|bupropion|mesh-list
43556410|NCT03553173|Varenicline|varenicline|mesh-list
43556414|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43736782|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556415|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43719714|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719715|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719716|NCT02634255|Fentanyl|fentanyl|mesh-list
43719717|NCT02634255|Propofol|propofol|mesh-list
43719718|NCT02634255|Rocuronium|rocuronium|mesh-list
43719719|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43719720|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719721|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719722|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43719728|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
43719729|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719730|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43556416|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43556417|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556418|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
43556419|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556420|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556421|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43556422|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43556423|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556424|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43556425|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43556426|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
43556427|NCT03553108|Olaparib|olaparib|mesh-list
43556428|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43556429|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556439|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
43556440|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43556441|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43556442|NCT03552770|Bevacizumab|bevacizumab|mesh-list
43556443|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43556444|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556445|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43556446|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43556448|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556449|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
43556451|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43556452|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43556453|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556454|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
43556455|NCT03552705|Coagulants|coagulants|mesh-ancestor
43556456|NCT03552666|Vitamin D|vitamin d|mesh-list
43556457|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
43556458|NCT03552666|Vitamins|vitamins|mesh-ancestor
43556459|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
43719731|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43719732|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43719733|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43719734|NCT02634034|Pitavastatin|pitavastatin|mesh-list
43719735|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43556460|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556461|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43556462|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43556463|NCT03552653|Vitamin D|vitamin d|mesh-list
43556464|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
43556465|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
43556466|NCT03552653|Vitamins|vitamins|mesh-list
43556467|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
43556468|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556469|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43736788|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556470|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43556472|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43556473|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556474|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
43556475|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
43556476|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556477|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
43556478|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556479|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556480|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
43556481|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43556482|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43556483|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43556512|NCT03552146|Propofol|propofol|mesh-list
43556514|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556515|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556516|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43556517|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
43556518|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
43556519|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43556520|NCT03552146|Analgesics|analgesics|mesh-ancestor
43556521|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
43556522|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556523|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43556524|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43556525|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43556526|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
43556527|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556531|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
43556532|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719736|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43719737|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43719738|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
43719739|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719746|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
43719747|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43556533|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
43556534|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43556535|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
43556536|NCT03551873|Plecanatide|plecanatide|mesh-list
43556538|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
43556539|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556541|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43556542|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43556543|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556544|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
43556545|NCT03551808|Ketorolac|ketorolac|mesh-list
43556546|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43556547|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43556555|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556556|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719756|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43719757|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736802|NCT05355610|Hormones|hormones|mesh-ancestor
43556582|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43556583|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556584|NCT03551210|Renal Agents|renal agents|mesh-ancestor
43556585|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43556586|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43556587|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43556588|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556589|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556590|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556591|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43556592|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43556593|NCT03551197|Budesonide|budesonide|mesh-list
43556594|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
43556595|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556596|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43556597|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
43556598|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556599|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556600|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43556601|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
43556602|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
43734431|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556604|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556605|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43556606|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43556607|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43556608|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
43556609|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556610|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556612|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43556613|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556614|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556615|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556616|NCT03551067|Midazolam|midazolam|mesh-list
43556617|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
43556618|NCT03551067|Ketamine|ketamine|mesh-list
43556619|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43556623|NCT03551067|Analgesics|analgesics|mesh-ancestor
43556624|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
43556625|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556626|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43556627|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43556636|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43719758|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719759|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556647|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43556649|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556651|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43556652|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556653|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43556654|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43556655|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43556656|NCT03550781|Prednisone|prednisone|mesh-list
43556657|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
43556664|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556666|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43556667|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556668|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
43556669|NCT03550781|Hormones|hormones|mesh-ancestor
43556670|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556671|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43556672|NCT03550677|Anesthetics|anesthetics|mesh-list
43556673|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556674|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556675|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
43556676|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43556677|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43556678|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719773|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
43719774|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719775|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719776|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43719777|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719778|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
43719779|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
43719780|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43719781|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43719782|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719783|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719784|NCT02633930|Amoxicillin|amoxicillin|mesh-list
43556679|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
43556680|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
43556681|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
43556682|NCT03550534|Calcium|calcium|mesh-list
43556683|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43556684|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556685|NCT03550534|Antacids|antacids|mesh-ancestor
43556686|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556687|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556688|NCT03550508|Antibodies|antibodies|mesh-list
43556689|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43556690|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
43556709|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556710|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556712|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43556713|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
43556715|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556716|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43556717|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
43556718|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
43556719|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43556720|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43556721|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43556722|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43556723|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
43556724|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556725|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556726|NCT03549832|Ritonavir|ritonavir|mesh-list
43556727|NCT03549832|Ribavirin|ribavirin|mesh-list
43556728|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
43556729|NCT03549832|Simeprevir|simeprevir|mesh-list
43556730|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43556731|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43556732|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
43556733|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556735|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43556736|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43719786|NCT02633930|Lansoprazole|lansoprazole|mesh-list
43719787|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
43719788|NCT02633930|Bismuth|bismuth|mesh-list
43719789|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719790|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719796|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43719797|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719798|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43719799|NCT02633930|Antacids|antacids|mesh-ancestor
43719800|NCT02633995|Anesthetics|anesthetics|mesh-list
43556738|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556739|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43834660|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834661|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834662|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
43556740|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43556741|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
43556742|NCT03549819|Cannabidiol|cannabidiol|mesh-list
43556743|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
43556744|NCT03549741|Cabergoline|cabergoline|mesh-list
43556745|NCT03549741|Clomiphene|clomiphene|mesh-list
43556746|NCT03549741|Enclomiphene|enclomiphene|mesh-list
43556747|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
43556748|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556756|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43556757|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43556759|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43556760|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
43556761|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
43556762|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556763|NCT03549728|Lenograstim|lenograstim|mesh-list
43556764|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43556765|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
43850113|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719811|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719812|NCT02633696|Protective Agents|protective agents|mesh-ancestor
43719813|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719814|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43719815|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556778|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43556779|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43556780|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556781|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556798|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556799|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556805|NCT03549611|Analgesics|analgesics|mesh-ancestor
43556806|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
43556807|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556808|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556809|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
43556810|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43556811|NCT03549611|Narcotics|narcotics|mesh-ancestor
43556812|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556813|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43556814|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556815|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43734432|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43556818|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556819|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556820|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
43556821|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43556822|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43556823|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556824|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43556825|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43556826|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556827|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
43556828|NCT03549312|Tenofovir|tenofovir|mesh-list
43556829|NCT03549312|Emtricitabine|emtricitabine|mesh-list
43556830|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
43556831|NCT03549312|Cobicistat|cobicistat|mesh-list
43850114|NCT05701995|BMS-986165|bms-986165|mesh-list
43556832|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43556834|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43556844|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43556845|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43556846|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43556847|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43556848|NCT03549221|Ketorolac|ketorolac|mesh-list
43556849|NCT03549221|Epinephrine|epinephrine|mesh-list
43556855|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556856|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556857|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43556858|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43556859|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
43556860|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556861|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43719817|NCT02633683|Analgesics|analgesics|mesh-ancestor
43719818|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
43719819|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719820|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719822|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43719823|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43719824|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719825|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719826|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43719827|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43719828|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719829|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719830|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
43719832|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
43719833|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832632|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43832635|NCT05255653|Hormones|hormones|mesh-ancestor
43832636|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832637|NCT05255406|Aflutinib|aflutinib|mesh-list
43832638|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43832639|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556863|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
43556864|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
43556865|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43556866|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43832645|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832646|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832647|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43556884|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556885|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556886|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556918|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556919|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43556920|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
43556921|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
43556922|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43556923|NCT03548493|Narcotics|narcotics|mesh-ancestor
43556924|NCT03548493|Analgesics|analgesics|mesh-ancestor
43832648|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43832649|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
43832650|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43832651|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
43832652|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
43832653|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832654|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832655|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832656|NCT05255146|Analgesics|analgesics|mesh-ancestor
43832657|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
43832658|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832660|NCT05255003|Dalteparin|dalteparin|mesh-list
43832661|NCT05255003|Tinzaparin|tinzaparin|mesh-list
43736977|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
43736978|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43556935|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43556936|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
43556937|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
43556938|NCT03548311|Vitamins|vitamins|mesh-ancestor
43556939|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
43556940|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556941|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
43556942|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43556943|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
43556944|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556945|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
43556946|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43556947|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556949|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556950|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43556951|NCT03548129|Fosfomycin|fosfomycin|mesh-list
43556952|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
43556953|NCT03547895|Vitamin K|vitamin k|mesh-list
43556954|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
43556955|NCT03547895|Ribavirin|ribavirin|mesh-list
43556956|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
43556957|NCT03547895|Furosemide|furosemide|mesh-list
43556958|NCT03547895|Spironolactone|spironolactone|mesh-list
43556959|NCT03547895|Silymarin|silymarin|mesh-list
43832662|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43832663|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
43832664|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43832665|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43832666|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832667|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
43832668|NCT05254925|Petrolatum|petrolatum|mesh-list
43832669|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43556960|NCT03547895|Vitamins|vitamins|mesh-ancestor
43556961|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
43556962|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556963|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
43556964|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556965|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
43556966|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556967|NCT03547895|Diuretics|diuretics|mesh-ancestor
43556973|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556975|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43556976|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43556978|NCT03547895|Coagulants|coagulants|mesh-ancestor
43556979|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
43556980|NCT03547895|Protective Agents|protective agents|mesh-ancestor
43556981|NCT03547830|Plerixafor|plerixafor|mesh-list
43556982|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43556983|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43556984|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
43556985|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556986|NCT03547804|Apatinib|apatinib|mesh-list
43556987|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556988|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43556989|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556990|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556991|NCT03547791|Betamethasone|betamethasone|mesh-list
43556992|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
43556993|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43556994|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
43556995|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43737006|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43556996|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
43556997|NCT03547791|Hormones|hormones|mesh-ancestor
43556998|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556999|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557000|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557001|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43557002|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
43557003|NCT03547778|Misoprostol|misoprostol|mesh-list
43557004|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43557005|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
43557008|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43557009|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43557010|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
43557011|NCT03547700|Ixazomib|ixazomib|mesh-list
43557012|NCT03547700|Romidepsin|romidepsin|mesh-list
43557013|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557014|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
43557016|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557017|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43557018|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
43557019|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
43557020|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43557022|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557023|NCT03547375|Apatinib|apatinib|mesh-list
43557024|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557025|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43557026|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832670|NCT05254925|Protective Agents|protective agents|mesh-ancestor
43832671|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832672|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
43832675|NCT05254912|Petrolatum|petrolatum|mesh-list
43832676|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43832677|NCT05254912|Protective Agents|protective agents|mesh-ancestor
43832678|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832679|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
43832680|NCT05254912|Emollients|emollients|mesh-ancestor
43832681|NCT05254626|Pioglitazone|pioglitazone|mesh-list
43832682|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
43832683|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43832684|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832685|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43832686|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832687|NCT05254236|Vaccines|vaccines|mesh-list
43832688|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
43832689|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557027|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557028|NCT03547362|Caseins|caseins|mesh-list
43557029|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
43557030|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
43557031|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557032|NCT03547232|Indomethacin|indomethacin|mesh-list
43557033|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43557034|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43557035|NCT03547232|Analgesics|analgesics|mesh-ancestor
43557036|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
43557046|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557048|NCT03547219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43557049|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43557050|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557051|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557052|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557053|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
43557055|NCT03547219|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43557056|NCT03547219|Antidepressive Agents|antidepressive agents|mesh-ancestor
43557057|NCT03547219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43557059|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
43557060|NCT03547024|Omeprazole|omeprazole|mesh-list
43557061|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
43557062|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43557063|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43557064|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
43557065|NCT03547024|Estradiol|estradiol|mesh-list
43737023|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
43557066|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43557067|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43557068|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557069|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557071|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43832690|NCT05254171|Gemcitabine|gemcitabine|mesh-list
43832691|NCT05254171|Paclitaxel|paclitaxel|mesh-list
43719836|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43719837|NCT02633852|Growth Substances|growth substances|mesh-ancestor
43719838|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719839|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
43719840|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719841|NCT02633774|Propafenone|propafenone|mesh-list
43719842|NCT02633774|Apixaban|apixaban|mesh-list
43719843|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43719844|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
43719845|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43719846|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
43719847|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557072|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43557073|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43557074|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
43557075|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
43557076|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
43557077|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
43557079|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557080|NCT03547024|Estrogens|estrogens|mesh-ancestor
43557081|NCT03547024|Hormones|hormones|mesh-ancestor
43557082|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557083|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43557084|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
43557085|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557086|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43557089|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43557090|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557091|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43557092|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43557093|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43557094|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
43557095|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
43557096|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43557097|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43557098|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43557099|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
43557124|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557125|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
43557126|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557127|NCT03546530|Protective Agents|protective agents|mesh-ancestor
43557128|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557129|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557130|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43557131|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
43557132|NCT03546426|Interleukin-2|interleukin-2|mesh-list
43557133|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43557134|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557135|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43557136|NCT03546426|Analgesics|analgesics|mesh-ancestor
43557137|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
43719848|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719849|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
43719850|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43719851|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43719852|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43719854|NCT02633709|Itraconazole|itraconazole|mesh-list
43719855|NCT02633709|Risdiplam|risdiplam|mesh-list
43719859|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43719860|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719861|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719862|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43719863|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
43557138|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557139|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557140|NCT03546400|Methylphenidate|methylphenidate|mesh-list
43557141|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43557142|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557143|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43557144|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43557145|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557146|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557147|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
43557148|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557153|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557155|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557157|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557158|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557159|NCT03546075|Resveratrol|resveratrol|mesh-list
43557160|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
43557161|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557162|NCT03546075|Protective Agents|protective agents|mesh-ancestor
43557163|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557164|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557165|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43557166|NCT03545997|Montelukast|montelukast|mesh-list
43557167|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43557168|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
43557169|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43557170|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
43557171|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557172|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557173|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43557174|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43557175|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719864|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43719865|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719868|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719869|NCT02633657|Gabapentin|gabapentin|mesh-list
43719870|NCT02633657|Analgesics|analgesics|mesh-ancestor
43719871|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
43719872|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719873|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719874|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
43719875|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43719876|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43734434|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
43719878|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719879|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43719880|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43719881|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557177|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43557178|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43557179|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557181|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557182|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
43557183|NCT03545516|Bupivacaine|bupivacaine|mesh-list
43557184|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
43557185|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
43557186|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557187|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557188|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
43557189|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557190|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43557191|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43557192|NCT03545516|Analgesics|analgesics|mesh-ancestor
43557193|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43557194|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43557195|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43557196|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
43557197|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557198|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557199|NCT03545373|Amoxicillin|amoxicillin|mesh-list
43557200|NCT03545373|Azithromycin|azithromycin|mesh-list
43557201|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43557202|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557203|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
43557204|NCT03545347|Nandrolone|nandrolone|mesh-list
43557206|NCT03545347|Androgens|androgens|mesh-ancestor
43557207|NCT03545347|Hormones|hormones|mesh-ancestor
43557208|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557209|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557210|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
43557211|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43557212|NCT03545308|Rocuronium|rocuronium|mesh-list
43719882|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719883|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
43719884|NCT02633761|Misoprostol|misoprostol|mesh-list
43719885|NCT02633761|Mifepristone|mifepristone|mesh-list
43719886|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43719887|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
43719888|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43719889|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557213|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43557214|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43557215|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43557216|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557217|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557218|NCT03545243|Pantoprazole|pantoprazole|mesh-list
43557244|NCT03544814|Pemetrexed|pemetrexed|mesh-list
43557245|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557246|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557247|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557248|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43557249|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43557250|NCT03544775|Anesthetics|anesthetics|mesh-list
43557251|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557252|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557253|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
43557255|NCT03544723|Durvalumab|durvalumab|mesh-list
43557256|NCT03544723|Atezolizumab|atezolizumab|mesh-list
43557257|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43557258|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557259|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43557260|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557261|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43557262|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557263|NCT03544671|Vitamin D|vitamin d|mesh-list
43557264|NCT03544671|Vitamins|vitamins|mesh-ancestor
43557265|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
43557266|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557267|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43557302|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
43557304|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43557305|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
43557306|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557307|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43557308|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43557309|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557317|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557318|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557319|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43557320|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43557321|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43557322|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557323|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43557324|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43737034|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43557325|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557327|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557328|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43719893|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43719894|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43557329|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
43557330|NCT03543657|Hematinics|hematinics|mesh-ancestor
43557331|NCT03543436|Meropenem|meropenem|mesh-list
43557332|NCT03543436|Imipenem|imipenem|mesh-list
43557333|NCT03543436|Temocillin|temocillin|mesh-list
43557334|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43557335|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557336|NCT03543306|Trametinib|trametinib|mesh-list
43557337|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557338|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43557339|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557340|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557341|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
43557342|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43557343|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43557344|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43557345|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557346|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557347|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
43557348|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557349|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557350|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43557351|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557354|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557355|NCT03543072|Diphosphonates|diphosphonates|mesh-list
43557356|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43557359|NCT03542955|Analgesics|analgesics|mesh-list
43539059|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
43737035|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43737036|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43557360|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
43557361|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557362|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557363|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43557364|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43557365|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557366|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43557367|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43557368|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43557369|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557370|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557371|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
43557372|NCT03542851|Convulsants|convulsants|mesh-ancestor
43557373|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43557374|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557375|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
43557376|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
43557377|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557387|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
43557388|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557389|NCT03542760|Methylene Blue|methylene blue|mesh-list
43557390|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557391|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557392|NCT03542617|Dexamethasone|dexamethasone|mesh-list
43557393|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557396|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557397|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557398|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43557399|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
43557400|NCT03542617|Hormones|hormones|mesh-ancestor
43557401|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557402|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43557403|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557404|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
43557405|NCT03542552|Nifedipine|nifedipine|mesh-list
43719895|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43719896|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43719897|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
43719898|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43719899|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43719900|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
43719901|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43719902|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
43557407|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
43557408|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557409|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557410|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
43557411|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557412|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43557413|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
43557414|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43557415|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557416|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557417|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43557418|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
43557419|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557420|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
43737037|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
43737038|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737039|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737040|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737042|NCT05270863|Miotics|miotics|mesh-ancestor
43557422|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557423|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43557424|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557425|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557426|NCT03542357|Calcitonin|calcitonin|mesh-list
43557427|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
43557428|NCT03542357|Sumatriptan|sumatriptan|mesh-list
43557429|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43557431|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43557432|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43557433|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43557434|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
43557435|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557436|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557437|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557438|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43557439|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43557440|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
43557441|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
43557442|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557443|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
43557452|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557453|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557454|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557455|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43557456|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557457|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557458|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557459|NCT03542214|Calcium|calcium|mesh-list
43557460|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43557461|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557462|NCT03542149|Tocopherols|tocopherols|mesh-list
43557463|NCT03542149|Vitamin E|vitamin e|mesh-list
43719905|NCT02633839|Carbidopa|carbidopa|mesh-list
43719906|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43719907|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43719908|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
43719909|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719910|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719911|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719912|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43719913|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719914|NCT02633579|Erythromycin|erythromycin|mesh-list
43719915|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
43719916|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43557464|NCT03542149|Tocotrienols|tocotrienols|mesh-list
43557465|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
43737058|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43737059|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43737060|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43737061|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
43737062|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
43737063|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737064|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737065|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737066|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43557466|NCT03542149|Piperaquine|piperaquine|mesh-list
43557467|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
43557468|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43557469|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43557470|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557471|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
43557472|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557473|NCT03542149|Protective Agents|protective agents|mesh-ancestor
43557474|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557475|NCT03542149|Vitamins|vitamins|mesh-ancestor
43557476|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
43557477|NCT03542058|Carvedilol|carvedilol|mesh-list
43557478|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43557479|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43557480|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
43557481|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557482|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557483|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557484|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43557485|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
43557486|NCT03542058|Protective Agents|protective agents|mesh-ancestor
43557487|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43557488|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557489|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43557491|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43557493|NCT03542006|Brinzolamide|brinzolamide|mesh-list
43557494|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43557495|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557496|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557497|NCT03541993|Resveratrol|resveratrol|mesh-list
43557498|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
43557499|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557501|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557502|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557503|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43557504|NCT03541928|Valacyclovir|valacyclovir|mesh-list
43557505|NCT03541928|Leuprolide|leuprolide|mesh-list
43557506|NCT03541928|Bicalutamide|bicalutamide|mesh-list
43557507|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43557508|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
43557516|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
43557517|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557518|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
43557519|NCT03541915|Analgesics|analgesics|mesh-ancestor
43719917|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
43719918|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
43719919|NCT02633579|Atropine|atropine|mesh-list
43719920|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43719921|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43719922|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43719923|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
43557520|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
43557521|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557522|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557523|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
43557524|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557525|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43557526|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
43557527|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43557528|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557529|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557530|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43557532|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557533|NCT03541837|Ropivacaine|ropivacaine|mesh-list
43557534|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
43557535|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
43557536|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557537|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557538|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
43557539|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557540|NCT03541798|Anesthetics|anesthetics|mesh-list
43557541|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557542|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557543|NCT03541759|Hydromorphone|hydromorphone|mesh-list
43557544|NCT03541759|Pirinitramide|pirinitramide|mesh-list
43557545|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43557546|NCT03541759|Narcotics|narcotics|mesh-ancestor
43557547|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557548|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557549|NCT03541759|Analgesics|analgesics|mesh-ancestor
43557550|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
43557551|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557553|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
43557554|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557555|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557556|NCT03541681|Hormones|hormones|mesh-ancestor
43557557|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557558|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43557559|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43557560|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43557561|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557562|NCT03541603|Simendan|simendan|mesh-list
43557563|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43557564|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
43557565|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43557566|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43557567|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557568|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557569|NCT03541603|Protective Agents|protective agents|mesh-ancestor
43737114|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737115|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
43737116|NCT05246943|Coagulants|coagulants|mesh-ancestor
43737117|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
43737118|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
43557570|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557571|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
43557572|NCT03541564|BMS-986165|bms-986165|mesh-list
43557573|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43557574|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557578|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557580|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
43557581|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43557582|NCT03541265|Bupivacaine|bupivacaine|mesh-list
43719924|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719925|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719926|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43719927|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
43719928|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
43719929|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
43719930|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43719931|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43719932|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
43719933|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719934|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719935|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43557583|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
43557584|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
43557585|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557586|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557587|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
43557588|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557589|NCT03541031|Micronutrients|micronutrients|mesh-list
43557590|NCT03541031|Trace Elements|trace elements|mesh-list
43557591|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557592|NCT03540979|Letrozole|letrozole|mesh-list
43557593|NCT03540979|Progesterone|progesterone|mesh-list
43557594|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557595|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43557596|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43557597|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557598|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557599|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43557600|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
43557601|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557602|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557603|NCT03540979|Progestins|progestins|mesh-ancestor
43557604|NCT03540979|Hormones|hormones|mesh-ancestor
43557605|NCT03540953|Mitomycins|mitomycins|mesh-list
43557606|NCT03540953|Mitomycin|mitomycin|mesh-list
43557607|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43557608|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737125|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
43557609|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
43557610|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557611|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43557612|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557613|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43557614|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43557615|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557616|NCT03540836|Cortisone|cortisone|mesh-list
43557617|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557618|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
43737126|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737127|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43737131|NCT05226351|Hormones|hormones|mesh-ancestor
43557619|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
43557620|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43557621|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43557622|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557623|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557624|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557625|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43557626|NCT03540628|Ascorbic Acid|ascorbic acid|mesh-list
43557627|NCT03540628|Thiamine|thiamine|mesh-list
43557628|NCT03540628|Vitamins|vitamins|mesh-ancestor
43557629|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
43557630|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557631|NCT03540628|Antioxidants|antioxidants|mesh-ancestor
43719936|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719937|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719938|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43719939|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719940|NCT02633618|Neurotropin|neurotropin|mesh-list
43719941|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43719942|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
43719943|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719944|NCT02633618|Analgesics|analgesics|mesh-ancestor
43719945|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
43719946|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719947|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
43719948|NCT02633384|Sorbitol|sorbitol|mesh-list
43719949|NCT02633384|SMOFlipid|smoflipid|mesh-list
43719950|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43719951|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43719952|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43719953|NCT02633384|Cathartics|cathartics|mesh-ancestor
43719954|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719955|NCT02633462|Inositol|inositol|mesh-list
43719956|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
43719957|NCT02633462|Vitamins|vitamins|mesh-ancestor
43719958|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
43719959|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719960|NCT02633202|Cisplatin|cisplatin|mesh-list
43719961|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719962|NCT02633176|Cisplatin|cisplatin|mesh-list
43719963|NCT02633176|Docetaxel|docetaxel|mesh-list
43719964|NCT02633176|Capecitabine|capecitabine|mesh-list
43557632|NCT03540628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557633|NCT03540628|Protective Agents|protective agents|mesh-ancestor
43557634|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
43557635|NCT03540472|Tacrolimus|tacrolimus|mesh-list
43557636|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43719965|NCT02633176|Cetuximab|cetuximab|mesh-list
43719966|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719967|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
43719968|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
43719969|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
43719970|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557658|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
43557659|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557660|NCT03540095|Bupivacaine|bupivacaine|mesh-list
43557661|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
43557662|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
43557663|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557664|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737139|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
43737140|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737141|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737142|NCT05213208|Propofol|propofol|mesh-list
43737143|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43557665|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
43557666|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557667|NCT03539887|Ketamine|ketamine|mesh-list
43557668|NCT03539887|Analgesics|analgesics|mesh-ancestor
43557670|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557671|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557672|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43557673|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43557674|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
43557675|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
43557676|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557677|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43557678|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43557679|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557680|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557682|NCT03539718|Heparin|heparin|mesh-list
43557683|NCT03539718|Calcium heparin|calcium heparin|mesh-list
43557684|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
43557685|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43557686|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43557687|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557688|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557689|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43719971|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43719972|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
43719973|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43719974|NCT02633189|Bevacizumab|bevacizumab|mesh-list
43719975|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43719976|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43719977|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719978|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43719979|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43719980|NCT02633189|Growth Substances|growth substances|mesh-ancestor
43719981|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557690|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557691|NCT03539562|Promethazine|promethazine|mesh-list
43557692|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
43557693|NCT03539562|Morphine|morphine|mesh-list
43557694|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43557695|NCT03539562|Narcotics|narcotics|mesh-ancestor
43557696|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557697|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557698|NCT03539562|Analgesics|analgesics|mesh-ancestor
43557699|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
43557700|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557702|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
43557703|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43557704|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
43557705|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
43557706|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557707|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557708|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43557709|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43557710|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43557711|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
43557715|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43557716|NCT03539328|Gemcitabine|gemcitabine|mesh-list
43557717|NCT03539328|Paclitaxel|paclitaxel|mesh-list
43557718|NCT03539328|Doxorubicin|doxorubicin|mesh-list
43557719|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43557720|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
43557721|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43557722|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557726|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557727|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43557728|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
43557729|NCT03539328|Antiviral Agents|antiviral agents|mesh-ancestor
43557730|NCT03539328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557731|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557732|NCT03539328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43557733|NCT03539328|Immunologic Factors|immunologic factors|mesh-ancestor
43557734|NCT03539328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557735|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43557736|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43557737|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43557738|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43557739|NCT03539224|Lamivudine|lamivudine|mesh-list
43557740|NCT03539224|Dolutegravir|dolutegravir|mesh-list
43557741|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43557744|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557745|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
43719982|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
43719983|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43719984|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719985|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719987|NCT02632916|Denosumab|denosumab|mesh-list
43719988|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43719989|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719990|NCT02633514|Cisplatin|cisplatin|mesh-list
43719991|NCT02633514|Etoposide|etoposide|mesh-list
43719992|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719993|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43719994|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43719995|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43719996|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719997|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719998|NCT02633007|Levodopa|levodopa|mesh-list
43719999|NCT02633007|Carbidopa|carbidopa|mesh-list
43720000|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43720001|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43720002|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
43720003|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720004|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720005|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557748|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43557749|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43557750|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43557751|NCT03539172|Apatinib|apatinib|mesh-list
43557752|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557753|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43557754|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557755|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834683|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
43834684|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
43834685|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
43834686|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834687|NCT05108259|Adalimumab|adalimumab|mesh-list
43834688|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834689|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834690|NCT05107999|Doxepin|doxepin|mesh-list
43834691|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
43834692|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
43834693|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43557756|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43557757|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43557758|NCT03539003|Remifentanil|remifentanil|mesh-list
43557759|NCT03539003|Propofol|propofol|mesh-list
43557760|NCT03539003|Sevoflurane|sevoflurane|mesh-list
43557761|NCT03539003|Desflurane|desflurane|mesh-list
43557762|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43557763|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557764|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557765|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43557766|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
43557767|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
43720008|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
43720009|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43720010|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720011|NCT02632877|Pirfenidone|pirfenidone|mesh-list
43720012|NCT02632877|Ketanserin|ketanserin|mesh-list
43720013|NCT02632877|Analgesics|analgesics|mesh-ancestor
43720014|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
43720015|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720016|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720017|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43557768|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43557769|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43557770|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43557772|NCT03539003|Analgesics|analgesics|mesh-ancestor
43557773|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
43557774|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557775|NCT03538704|Metformin|metformin|mesh-list
43557776|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43557777|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557778|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43557779|NCT03538691|Dexetimide|dexetimide|mesh-list
43557780|NCT03538691|Citalopram|citalopram|mesh-list
43557781|NCT03538691|Fluoxetine|fluoxetine|mesh-list
43557782|NCT03538691|Paroxetine|paroxetine|mesh-list
43557783|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43557784|NCT03538691|Sertraline|sertraline|mesh-list
43557785|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
43557786|NCT03538691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43557787|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43557788|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557789|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557790|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557791|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
43557792|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557793|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43557794|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
43557795|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43557796|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43557808|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43557809|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43557810|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557811|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
43557812|NCT03538496|Bupivacaine|bupivacaine|mesh-list
43557813|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
43557814|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
43557815|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557816|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557817|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
43557818|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557819|NCT03538483|Bupivacaine|bupivacaine|mesh-list
43557820|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
43557821|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
43557822|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557823|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557824|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
43557825|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557826|NCT03538327|Silybin|silybin|mesh-list
43720019|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720020|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720021|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720022|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43720023|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43720024|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43720025|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
43720026|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720027|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720028|NCT02632565|Lidocaine|lidocaine|mesh-list
43720029|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
43720030|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
43720031|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720032|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720033|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
43720035|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43720036|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43720037|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43720038|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43720039|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720040|NCT02632578|Vaccines|vaccines|mesh-list
43720041|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
43720042|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720043|NCT02632474|Tenofovir|tenofovir|mesh-list
43720044|NCT02632474|Lamivudine|lamivudine|mesh-list
43720045|NCT02632474|Efavirenz|efavirenz|mesh-list
43720046|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
43557827|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43557828|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557829|NCT03538327|Protective Agents|protective agents|mesh-ancestor
43557830|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557831|NCT03538171|Exemestane|exemestane|mesh-list
43557832|NCT03538171|Entinostat|entinostat|mesh-list
43557833|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557834|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43557835|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43557836|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557837|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557838|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43557839|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
43557840|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557842|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43557843|NCT03537950|Cannabidiol|cannabidiol|mesh-list
43720047|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720048|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43720049|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43720051|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720052|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43720053|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43720054|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43720055|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43720056|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43720057|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43720058|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43720059|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43720060|NCT02632331|Gabapentin|gabapentin|mesh-list
43720061|NCT02632331|Analgesics|analgesics|mesh-ancestor
43557844|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
43557845|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43557846|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
43557847|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43557848|NCT03537807|Riluzole|riluzole|mesh-list
43557849|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
43557850|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43557851|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43557852|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557853|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557854|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557855|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43557856|NCT03537807|Protective Agents|protective agents|mesh-ancestor
43557857|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
43557858|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
43557859|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43557860|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
43557870|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557871|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557872|NCT03537612|Analgesics|analgesics|mesh-ancestor
43557873|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
43557874|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557875|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43557876|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
43557877|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
43557878|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43557879|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43557880|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43557881|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
43557882|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557883|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557884|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
43557885|NCT03537573|Narcotics|narcotics|mesh-ancestor
43557886|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557887|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557888|NCT03537573|Analgesics|analgesics|mesh-ancestor
43557889|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
43557890|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557891|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
43557892|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
43720062|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
43737194|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43737195|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737196|NCT05170230|Terlipressin|terlipressin|mesh-list
43737197|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43737198|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43737199|NCT05167513|Metformin|metformin|mesh-list
43720063|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720064|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720066|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43720067|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43720068|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720069|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43720070|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43720071|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43557894|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43557895|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557896|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557897|NCT03537534|Lidocaine|lidocaine|mesh-list
43557898|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
43557899|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
43557900|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43557901|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557902|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
43557903|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557904|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43557905|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43557906|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43557907|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557908|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557909|NCT03537443|Vitamin D|vitamin d|mesh-list
43557910|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
43557911|NCT03537443|Vitamins|vitamins|mesh-ancestor
43557912|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
43557913|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557914|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43557915|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43557916|NCT03537326|Budesonide|budesonide|mesh-list
43557917|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557918|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43557919|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
43557920|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557921|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557922|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43557923|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
43557924|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
43557925|NCT03537326|Hormones|hormones|mesh-ancestor
43557926|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557931|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557932|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557934|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
43557935|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
43557936|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557937|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
43557938|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557939|NCT03537157|Rifaximin|rifaximin|mesh-list
43557940|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43557941|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557942|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43557943|NCT03537144|Acetaminophen|acetaminophen|mesh-list
43557944|NCT03537144|Indomethacin|indomethacin|mesh-list
43557945|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43557946|NCT03537144|Analgesics|analgesics|mesh-ancestor
43557948|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557949|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557950|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
43720072|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737203|NCT05167513|Incretins|incretins|mesh-ancestor
43720073|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720074|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
43720075|NCT02632019|Gemcitabine|gemcitabine|mesh-list
43720076|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43720077|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
43720078|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720079|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557951|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43557952|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557953|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43557954|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
43557955|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
43557956|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557957|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43557958|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557959|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557960|NCT03537027|Vitamin D|vitamin d|mesh-list
43557961|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
43557962|NCT03537027|Vitamins|vitamins|mesh-ancestor
43557963|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
43557964|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557965|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43557966|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43557967|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
43557968|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
43557969|NCT03536910|Coagulants|coagulants|mesh-ancestor
43557970|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43557971|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43557972|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
43557973|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557974|NCT03536845|Vitamin D|vitamin d|mesh-list
43557975|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
43557976|NCT03536845|Vitamins|vitamins|mesh-ancestor
43557977|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
43557978|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557979|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43557980|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43557983|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
43557984|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737214|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557985|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737215|NCT05154279|Terlipressin|terlipressin|mesh-list
43737216|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43737217|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43557986|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43557988|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
43557989|NCT03536780|Gemcitabine|gemcitabine|mesh-list
43557990|NCT03536780|Avelumab|avelumab|mesh-list
43557991|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43557992|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
43557993|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557994|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557995|NCT03536780|Antiviral Agents|antiviral agents|mesh-ancestor
43557996|NCT03536780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557997|NCT03536780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557998|NCT03536780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43737242|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737243|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
43737244|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43737245|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
43737246|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737247|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
43737248|NCT05130814|Protective Agents|protective agents|mesh-ancestor
43737249|NCT05129722|Empagliflozin|empagliflozin|mesh-list
43737250|NCT05129722|Eplerenone|eplerenone|mesh-list
43557999|NCT03536780|Immunologic Factors|immunologic factors|mesh-ancestor
43737251|NCT05129722|Bumetanide|bumetanide|mesh-list
43558003|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
43558004|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558005|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558006|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
43558007|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43558008|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43558009|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558011|NCT03536611|Dabigatran|dabigatran|mesh-list
43720080|NCT02632019|Antiviral Agents|antiviral agents|mesh-ancestor
43720081|NCT02632019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720082|NCT02632019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720083|NCT02632019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43720084|NCT02632019|Immunologic Factors|immunologic factors|mesh-ancestor
43720085|NCT02632019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720086|NCT02632279|Tryptophan|tryptophan|mesh-list
43720087|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43720088|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
43720089|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43720090|NCT02632305|Gemcitabine|gemcitabine|mesh-list
43720091|NCT02632305|Paclitaxel|paclitaxel|mesh-list
43720092|NCT02632305|Cisplatin|cisplatin|mesh-list
43720093|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720094|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720095|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720096|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720097|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720098|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720099|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43720100|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
43558012|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
43558015|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
43558016|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558017|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558018|NCT03536598|Amlodipine|amlodipine|mesh-list
43558019|NCT03536598|Valsartan|valsartan|mesh-list
43558020|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43558021|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43558022|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43558023|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43558024|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558025|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43558026|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558027|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
43558028|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43558029|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43558030|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
43737311|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737312|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
43737313|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
43737314|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
43737315|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737316|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43737317|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43737318|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43737319|NCT05065021|Growth Substances|growth substances|mesh-ancestor
43737324|NCT05059535|Acetaminophen|acetaminophen|mesh-list
43558031|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43558032|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43558033|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558034|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43558035|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43558036|NCT03536494|Mirabegron|mirabegron|mesh-list
43558037|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43558038|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43558039|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43720101|NCT02632305|Antiviral Agents|antiviral agents|mesh-ancestor
43720102|NCT02632305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720103|NCT02632305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720104|NCT02632305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43720105|NCT02632305|Immunologic Factors|immunologic factors|mesh-ancestor
43720106|NCT02632305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720108|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43720109|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43720110|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720111|NCT02631993|Furocoumarins|furocoumarins|mesh-list
43720112|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
43720113|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43558049|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558051|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43558052|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558053|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43558054|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43558055|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43558056|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558057|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
43558058|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558059|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43558060|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
43558061|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558062|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43558063|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
43558064|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43558065|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
43558066|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43558071|NCT03536208|Warfarin|warfarin|mesh-list
43558072|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
43558073|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
43558074|NCT03536065|Narcotics|narcotics|mesh-ancestor
43558075|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558076|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558077|NCT03536065|Analgesics|analgesics|mesh-ancestor
43558078|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
43720114|NCT02632136|Bupivacaine|bupivacaine|mesh-list
43720116|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
43720117|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720118|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720119|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
43720120|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720121|NCT02632071|Paclitaxel|paclitaxel|mesh-list
43720122|NCT02632071|Ricolinostat|ricolinostat|mesh-list
43558081|NCT03535961|Apatinib|apatinib|mesh-list
43737329|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737330|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
43737331|NCT05053087|Ropivacaine|ropivacaine|mesh-list
43737332|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
43737333|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
43737334|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737335|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737343|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
43849667|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
43558082|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43558083|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558084|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43558085|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43558086|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558087|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558088|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558089|NCT03535870|Fluticasone|fluticasone|mesh-list
43558092|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43558093|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558094|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43558095|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
43558096|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558097|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558098|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43558099|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
43558100|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
43558101|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43558102|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43558103|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43558104|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43558105|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558106|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558107|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558108|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
43558109|NCT03535870|Hormones|hormones|mesh-ancestor
43558110|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558111|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
43558112|NCT03535792|Fentanyl|fentanyl|mesh-list
43558113|NCT03535792|Nalbuphine|nalbuphine|mesh-list
43558114|NCT03535792|Bupivacaine|bupivacaine|mesh-list
43558115|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
43558116|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
43558117|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558118|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558119|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
43558120|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558121|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43558122|NCT03535792|Narcotics|narcotics|mesh-ancestor
43558123|NCT03535792|Analgesics|analgesics|mesh-ancestor
43558124|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43720123|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43558127|NCT03535753|Decitabine|decitabine|mesh-list
43558128|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558129|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
43558130|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558131|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558132|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558133|NCT03535701|Paclitaxel|paclitaxel|mesh-list
43737344|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737345|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737347|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43737348|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43737349|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737350|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
43737351|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558134|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43558135|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43558136|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558137|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
43558138|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
43558150|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558152|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43558153|NCT03535558|Azithromycin|azithromycin|mesh-list
43558154|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
43558155|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43558156|NCT03535558|Trimethoprim|trimethoprim|mesh-list
43558157|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
43558158|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43558166|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558167|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558168|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43558169|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43558170|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43558171|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43558173|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43834725|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834726|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834727|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834728|NCT05104983|Sirolimus|sirolimus|mesh-list
43834729|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43834730|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834731|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43737362|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43737363|NCT04944888|Eliglustat|eliglustat|mesh-list
43737364|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737365|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737366|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737367|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
43558174|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
43558175|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43558176|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558177|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558178|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
43558179|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558180|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558181|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
43558182|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558187|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43558189|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43558190|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
43558191|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558192|NCT03535415|Hormones|hormones|mesh-list
43558193|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558194|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558195|NCT03535259|Sorafenib|sorafenib|mesh-list
43558196|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558197|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558198|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558201|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43558202|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43558203|NCT03535233|Clobetasol|clobetasol|mesh-list
43558204|NCT03535233|Minoxidil|minoxidil|mesh-list
43558205|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43558206|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558207|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
43558208|NCT03535233|Hormones|hormones|mesh-ancestor
43558209|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558210|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558211|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43558212|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
43558213|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558214|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558215|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43558216|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
43558217|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
43558218|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
43558219|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
43558220|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558221|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558222|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43558223|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43558224|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43558225|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
43558226|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558227|NCT03535168|Midazolam|midazolam|mesh-list
43558228|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43558229|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43558230|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558231|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558232|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43558235|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43558247|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43558248|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43558249|NCT03535090|Prednisolone|prednisolone|mesh-list
43558250|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
43558251|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43558252|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
43558253|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558254|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
43558255|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
43558256|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558257|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558258|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558259|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
43558261|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558262|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43558263|NCT03535090|Protective Agents|protective agents|mesh-ancestor
43558264|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43558265|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558266|NCT03535051|Tacrolimus|tacrolimus|mesh-list
43558267|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43558268|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
43558269|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558270|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43558271|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558274|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43558275|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558276|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43558277|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558278|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558279|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43558280|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43558281|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
43558282|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558285|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558286|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558287|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43558288|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43720135|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558307|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
43558308|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
43558309|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
43737397|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43737398|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737399|NCT04902859|Clonidine|clonidine|mesh-list
43737400|NCT04902859|Analgesics|analgesics|mesh-ancestor
43737401|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
43737402|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737403|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737412|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737414|NCT04895306|Testosterone|testosterone|mesh-list
43737415|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
43737416|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
43737418|NCT04895306|Androgens|androgens|mesh-ancestor
43558310|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558312|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
43558313|NCT03534674|Vitamins|vitamins|mesh-ancestor
43558314|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
43558315|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558316|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43558317|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43558318|NCT03534661|Teduglutide|teduglutide|mesh-list
43558319|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
43558320|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734437|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43558321|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558322|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558323|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43558324|NCT03534661|Protective Agents|protective agents|mesh-ancestor
43558325|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558326|NCT03534505|Ketorolac|ketorolac|mesh-list
43558327|NCT03534505|Bupivacaine|bupivacaine|mesh-list
43558328|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
43558329|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
43558331|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558332|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
43558333|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558334|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43558335|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558336|NCT03534505|Analgesics|analgesics|mesh-ancestor
43558337|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558338|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43558339|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43558340|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558341|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558342|NCT03534492|Durvalumab|durvalumab|mesh-list
43558343|NCT03534492|Olaparib|olaparib|mesh-list
43558344|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43558351|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558353|NCT03534388|Eusol|eusol|mesh-list
43558354|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
43558355|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558356|NCT03534310|Liraglutide|liraglutide|mesh-list
43558357|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43832692|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43832693|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832694|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
43832695|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
43832696|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
43832697|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832698|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43832699|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
43832700|NCT05254171|Antiviral Agents|antiviral agents|mesh-ancestor
43832701|NCT05254171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832702|NCT05254171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832703|NCT05254171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43832704|NCT05254171|Immunologic Factors|immunologic factors|mesh-ancestor
43832705|NCT05254171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832706|NCT05253937|Epinephrine|epinephrine|mesh-list
43832707|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43832708|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43832709|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
43832710|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734438|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
43832714|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43832715|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
43832716|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832717|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43832718|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
43832719|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
43832720|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
43832737|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832739|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
43832740|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832741|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43832742|NCT05252429|Docetaxel|docetaxel|mesh-list
43832743|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
43832744|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832745|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
43832746|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
43558358|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558359|NCT03534310|Incretins|incretins|mesh-ancestor
43558360|NCT03534310|Hormones|hormones|mesh-ancestor
43558361|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558362|NCT03534297|Dapansutrile|dapansutrile|mesh-list
43558363|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558364|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
43558365|NCT03534102|Narcotics|narcotics|mesh-ancestor
43558366|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558367|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558368|NCT03534102|Analgesics|analgesics|mesh-ancestor
43558369|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
43558370|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558371|NCT03534037|Febuxostat|febuxostat|mesh-list
43558372|NCT03534037|Benzbromarone|benzbromarone|mesh-list
43558373|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
43558374|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43558375|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
43558376|NCT03534037|Renal Agents|renal agents|mesh-ancestor
43558377|NCT03534024|Curcumin|curcumin|mesh-list
43558378|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43558379|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558380|NCT03534024|Analgesics|analgesics|mesh-ancestor
43558381|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
43558382|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558383|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558384|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558385|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43558386|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558387|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558388|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558389|NCT03533803|Indomethacin|indomethacin|mesh-list
43558390|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43558391|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558392|NCT03533803|Analgesics|analgesics|mesh-ancestor
43558393|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
43558394|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737459|NCT04840888|Omeprazole|omeprazole|mesh-list
43737460|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43737461|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737462|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43737463|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737465|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
43558395|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558396|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558397|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43558398|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
43558399|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
43558400|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43558401|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43558402|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558403|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558404|NCT03533699|Propranolol|propranolol|mesh-list
43558405|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43832747|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
43832748|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832749|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832750|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43832751|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43832752|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
43832753|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832754|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832755|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832756|NCT05251714|Fulvestrant|fulvestrant|mesh-list
43832757|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43832758|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832759|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43720136|NCT02631694|Propranolol|propranolol|mesh-list
43720137|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43720138|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43720139|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
43720140|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720141|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720142|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720143|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43720144|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43720145|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
43720146|NCT02631616|Somatostatin|somatostatin|mesh-list
43720147|NCT02631616|Hormones|hormones|mesh-ancestor
43720148|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720149|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720151|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
43720153|NCT02631668|Micronutrients|micronutrients|mesh-ancestor
43720154|NCT02631668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720155|NCT02631668|Antioxidants|antioxidants|mesh-ancestor
43720156|NCT02631668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720157|NCT02631668|Protective Agents|protective agents|mesh-ancestor
43720158|NCT02631668|Hematinics|hematinics|mesh-ancestor
43720159|NCT02631603|Prednisolone|prednisolone|mesh-list
43720160|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720161|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
43720162|NCT02631603|Hormones|hormones|mesh-ancestor
43720174|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720175|NCT02631473|Ritonavir|ritonavir|mesh-list
43720176|NCT02631473|Lopinavir|lopinavir|mesh-list
43720177|NCT02631473|Efavirenz|efavirenz|mesh-list
43720178|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43720179|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43720180|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
43720181|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720182|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720183|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43720184|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43720185|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
43720186|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720190|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43720191|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43720192|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43720193|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43720194|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43720195|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43720196|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
43720197|NCT02631252|Etoposide|etoposide|mesh-list
43720198|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
43720199|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720200|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720201|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43720202|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43720203|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720204|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720205|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
43720206|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43558406|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43558407|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558408|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694093|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43558411|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43558412|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43558423|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558425|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43558426|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
43720219|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43720220|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43720222|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43720223|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720225|NCT02631239|Methotrexate|methotrexate|mesh-list
43720226|NCT02631239|Etoposide|etoposide|mesh-list
43720227|NCT02631239|Pegaspargase|pegaspargase|mesh-list
43720228|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720229|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
43720230|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
43720231|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720232|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720233|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43720234|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
43720235|NCT02631239|Hormones|hormones|mesh-ancestor
43720236|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720237|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43720238|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720253|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43720254|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43720255|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
43720256|NCT02631135|Remifentanil|remifentanil|mesh-list
43720257|NCT02631135|Propofol|propofol|mesh-list
43720258|NCT02631135|Rocuronium|rocuronium|mesh-list
43720259|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43720260|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558434|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43558435|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
43558437|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558438|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558439|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558440|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720271|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43720272|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
43720273|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720274|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720275|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43720276|NCT02631135|Narcotics|narcotics|mesh-ancestor
43720277|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43720278|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43720284|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720285|NCT02630862|Aspirin|aspirin|mesh-list
43720286|NCT02630862|Dipyridamole|dipyridamole|mesh-list
43720287|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43720288|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43720289|NCT02630862|Analgesics|analgesics|mesh-ancestor
43720290|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
43720291|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720292|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720293|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720294|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720295|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43720296|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43720304|NCT02631174|Antithrombins|antithrombins|mesh-list
43720305|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
43720306|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43720307|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
43720308|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720309|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720310|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
43720311|NCT02630888|Memantine|memantine|mesh-list
43720312|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43720313|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43720314|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
43720315|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720316|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720345|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43737549|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737550|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737551|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43558459|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43558460|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43558461|NCT03533179|Glucagon|glucagon|mesh-list
43558462|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43558463|NCT03533179|Esmolol|esmolol|mesh-list
43558464|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558465|NCT03533179|Hormones|hormones|mesh-ancestor
43558467|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558468|NCT03533179|Incretins|incretins|mesh-ancestor
43558469|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43558490|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43558491|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43558492|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43558493|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558494|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
43558495|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558496|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558497|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43558498|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558499|NCT03532919|Cystatins|cystatins|mesh-list
43558500|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43558501|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
43558502|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558503|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720346|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720347|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720348|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720349|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720350|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720351|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43720352|NCT02630511|Mannitol|mannitol|mesh-list
43720353|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
43720354|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43720355|NCT02630511|Diuretics|diuretics|mesh-ancestor
43720356|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
43720364|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43720365|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43720366|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
43720367|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558510|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558512|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
43558513|NCT03532867|Protective Agents|protective agents|mesh-ancestor
43720375|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720376|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43720377|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
43720378|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720379|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720380|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
43720381|NCT02630485|Vitamins|vitamins|mesh-ancestor
43720382|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
43558523|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43558525|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43558526|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43558527|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43558528|NCT03532841|Tramadol|tramadol|mesh-list
43558529|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43558530|NCT03532841|Narcotics|narcotics|mesh-ancestor
43720391|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
43720393|NCT02630264|Cisplatin|cisplatin|mesh-list
43720394|NCT02630264|Endostatins|endostatins|mesh-list
43720395|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720396|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720397|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
43558536|NCT03532802|Metoprolol|metoprolol|mesh-list
43558537|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43558544|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43558545|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43558546|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558547|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558548|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558550|NCT03532763|Vitamin E|vitamin e|mesh-list
43558551|NCT03532763|Tocopherols|tocopherols|mesh-list
43558552|NCT03532763|Tocovid|tocovid|mesh-list
43558553|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
43558554|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558555|NCT03532763|Protective Agents|protective agents|mesh-ancestor
43558556|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558557|NCT03532763|Vitamins|vitamins|mesh-ancestor
43558558|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
43558559|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
43558560|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43558561|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720406|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
43720407|NCT02630290|Ropivacaine|ropivacaine|mesh-list
43720408|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43720409|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720410|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737594|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737595|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737596|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737597|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
43737598|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
43737599|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737600|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737601|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
43737602|NCT04688788|Hormones|hormones|mesh-ancestor
43737603|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737604|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43849757|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
43849758|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
43720411|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43720412|NCT02630290|Analgesics|analgesics|mesh-ancestor
43720413|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
43720414|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558568|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558569|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
43558570|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558571|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558572|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558573|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43558574|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
43558575|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43558576|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43558577|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558579|NCT03532711|Protective Agents|protective agents|mesh-ancestor
43558580|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
43558581|NCT03532711|Vitamins|vitamins|mesh-ancestor
43558582|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
43720415|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43558584|NCT03532698|Osimertinib|osimertinib|mesh-list
43558585|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43558586|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558587|NCT03532698|Analgesics|analgesics|mesh-ancestor
43558588|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
43558589|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558590|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558591|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558592|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43558593|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43558594|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43558595|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558596|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43558597|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43558598|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558599|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
43558600|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720434|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720435|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720436|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43720437|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43720438|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
43720439|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43720440|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
43720441|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
43720442|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
43720443|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43720444|NCT02630277|Aflibercept|aflibercept|mesh-list
43720473|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832761|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
43832762|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720474|NCT02629848|Paclitaxel|paclitaxel|mesh-list
43720475|NCT02629848|Carboplatin|carboplatin|mesh-list
43720476|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
43720477|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720478|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720479|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720480|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720481|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720482|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720483|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43720484|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720485|NCT02629835|Dexamethasone|dexamethasone|mesh-list
43720486|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
43558636|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558637|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558638|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558639|NCT05262335|Paclitaxel|paclitaxel|mesh-list
43849764|NCT03895801|Prednisone|prednisone|mesh-list
43558640|NCT05262335|Docetaxel|docetaxel|mesh-list
43558641|NCT05262335|Cisplatin|cisplatin|mesh-list
43558642|NCT05262335|Capecitabine|capecitabine|mesh-list
43558643|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
43558644|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43558645|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558646|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
43558647|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
43558648|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
43558649|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558650|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558651|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
43558652|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
43558653|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43558654|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558655|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558656|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558657|NCT05262166|Analgesics|analgesics|mesh-ancestor
43558658|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
43720487|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43720488|NCT02629835|BB 1101|bb 1101|mesh-list
43720489|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720490|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
43720491|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
43720492|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720493|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720494|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43720495|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
43720496|NCT02629835|Hormones|hormones|mesh-ancestor
43720497|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558659|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558660|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43558661|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43558662|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43558663|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558664|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558670|NCT05261997|Pancrelipase|pancrelipase|mesh-list
43558671|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558672|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43558673|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558674|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720498|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43720499|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720500|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
43720501|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720502|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720503|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43720504|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720505|NCT02629744|Etrolizumab|etrolizumab|mesh-list
43720506|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43720507|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
43720508|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720509|NCT02629718|Paclitaxel|paclitaxel|mesh-list
43720510|NCT02629718|Cisplatin|cisplatin|mesh-list
43720511|NCT02629718|Carboplatin|carboplatin|mesh-list
43720512|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720513|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720514|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720515|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
43558689|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43558690|NCT05261581|Analgesics|analgesics|mesh-list
43558691|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
43558692|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737610|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
43558693|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558694|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
43558695|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43558696|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558697|NCT05223101|Telmisartan|telmisartan|mesh-list
43558698|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43558699|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43720516|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720517|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720518|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
43720519|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43558703|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
43558704|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43558705|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43558706|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558707|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558708|NCT05195775|Urological Agents|urological agents|mesh-ancestor
43558709|NCT05190315|Temozolomide|temozolomide|mesh-list
43558710|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
43558711|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43558712|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
43558713|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558714|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558715|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
43558716|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
43558717|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558718|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558719|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558720|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43558721|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43558722|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558723|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43558724|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43720529|NCT02629536|Antidotes|antidotes|mesh-ancestor
43720531|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720532|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43720533|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720534|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737617|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737618|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43720535|NCT02629627|Metformin|metformin|mesh-list
43737619|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737632|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43737634|NCT04624828|Androgens|androgens|mesh-list
43720536|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43720537|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720538|NCT02629575|Sirolimus|sirolimus|mesh-list
43720539|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43720540|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720541|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43720542|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720543|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
43720544|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43720545|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
43720546|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558750|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
43558751|NCT05172167|Antibodies|antibodies|mesh-list
43558752|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
43558753|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558754|NCT05164978|Antibodies|antibodies|mesh-list
43558755|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
43558756|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558757|NCT05162976|Nivolumab|nivolumab|mesh-list
43720561|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
43720562|NCT02629315|Formaldehyde|formaldehyde|mesh-list
43720563|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
43720564|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720565|NCT02629042|Prednisolone|prednisolone|mesh-list
43720566|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720567|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720568|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
43720569|NCT02629042|Hormones|hormones|mesh-ancestor
43720570|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720571|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43720572|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720573|NCT02629146|Fentanyl|fentanyl|mesh-list
43720574|NCT02629146|Midazolam|midazolam|mesh-list
43720575|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43720576|NCT02629146|Narcotics|narcotics|mesh-ancestor
43720577|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720578|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720579|NCT02629146|Analgesics|analgesics|mesh-ancestor
43558758|NCT05162976|Azacitidine|azacitidine|mesh-list
43558759|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43720581|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720582|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43720589|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43720591|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
43720592|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720593|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720594|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
43720595|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43720596|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
43720597|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720598|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
43849801|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43720599|NCT02629380|Protective Agents|protective agents|mesh-ancestor
43720600|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
43720601|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720602|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
43720603|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43720604|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43720605|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720606|NCT02628847|Urological Agents|urological agents|mesh-ancestor
43720608|NCT02628951|Ramucirumab|ramucirumab|mesh-list
43720609|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720610|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558765|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558766|NCT05151484|Alendronate|alendronate|mesh-list
43558767|NCT05151484|Teriparatide|teriparatide|mesh-list
43558768|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43558769|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558770|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43558772|NCT05092841|Baclofen|baclofen|mesh-list
43558773|NCT05092841|Sorbitol|sorbitol|mesh-list
43558774|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43558775|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43558776|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558777|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
43558778|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720618|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
43720619|NCT02628860|Hematinics|hematinics|mesh-ancestor
43720620|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43720621|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
43720622|NCT02628665|Trioxsalen|trioxsalen|mesh-list
43720623|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
43720624|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720625|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
43720626|NCT02628613|Paclitaxel|paclitaxel|mesh-list
43720627|NCT02628613|Vinorelbine|vinorelbine|mesh-list
43720628|NCT02628613|Epirubicin|epirubicin|mesh-list
43720629|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720630|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720631|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720632|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720633|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720634|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720635|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43720636|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43720637|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43720638|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558779|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43558780|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43558781|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43558782|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
43558783|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
43558784|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558785|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558786|NCT05092841|Cathartics|cathartics|mesh-ancestor
43558787|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558790|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558792|NCT05057130|Doxorubicin|doxorubicin|mesh-list
43558793|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43558794|NCT05057130|Methotrexate|methotrexate|mesh-list
43558795|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558796|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43558797|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43558806|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
43558807|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
43558808|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43558809|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43558810|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
43558811|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720653|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832783|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
43849802|NCT03891706|Analgesics|analgesics|mesh-ancestor
43558812|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43558813|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43558815|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43558829|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43558830|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832800|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832801|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832802|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
43832803|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832804|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43832805|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43832806|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43832807|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43558832|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558833|NCT05030519|Trastuzumab|trastuzumab|mesh-list
43558834|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43558835|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558836|NCT04983589|Pilocarpine|pilocarpine|mesh-list
43558837|NCT04983589|Miotics|miotics|mesh-ancestor
43558838|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
43558839|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558841|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43558850|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558851|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558853|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
43558854|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
43558855|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558856|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558857|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
43558858|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558859|NCT04929808|Emollients|emollients|mesh-list
43558860|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
43558861|NCT04907214|Empagliflozin|empagliflozin|mesh-list
43558862|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43558874|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
43832808|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832810|NCT05249972|Betamethasone|betamethasone|mesh-list
43832811|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
43832812|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43832815|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43832816|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832817|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
43832818|NCT05249972|Hormones|hormones|mesh-ancestor
43832819|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832820|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832821|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43832822|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
43832823|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
43832824|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43832825|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43832826|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832827|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737690|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737691|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737692|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737693|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737694|NCT04539223|Evolocumab|evolocumab|mesh-list
43737695|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43737696|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43737697|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
43737698|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720699|NCT02628197|Vitamin D|vitamin d|mesh-list
43720700|NCT02628197|Calcium|calcium|mesh-list
43720702|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
43720703|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720704|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43720708|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43720709|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
43720710|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
43720711|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720712|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720713|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720714|NCT02628132|Paclitaxel|paclitaxel|mesh-list
43720715|NCT02628132|Durvalumab|durvalumab|mesh-list
43720716|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720717|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720718|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720719|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720720|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720721|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720722|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43720723|NCT02628080|Atovaquone|atovaquone|mesh-list
43720724|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720725|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
43720726|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43720727|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43720728|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558875|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558876|NCT04806386|Psyllium|psyllium|mesh-list
43558877|NCT04806386|Cathartics|cathartics|mesh-ancestor
43558878|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558879|NCT04779554|Mitomycins|mitomycins|mesh-list
43558880|NCT04779554|Mitomycin|mitomycin|mesh-list
43558881|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43558882|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558883|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
43558884|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558885|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43558886|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720729|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720730|NCT02627989|Diflucortolone|diflucortolone|mesh-list
43720731|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
43720732|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720733|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
43720734|NCT02627989|Hormones|hormones|mesh-ancestor
43720735|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720736|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737699|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43737700|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
43737701|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43737702|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
43737711|NCT04505410|Infliximab|infliximab|mesh-list
43737713|NCT04505410|Tofacitinib|tofacitinib|mesh-list
43737715|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737716|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720737|NCT02627950|Metoclopramide|metoclopramide|mesh-list
43720738|NCT02627950|Ticagrelor|ticagrelor|mesh-list
43720739|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43720740|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43720741|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43720742|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43720764|NCT02627807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43720765|NCT02627807|Immunologic Factors|immunologic factors|mesh-ancestor
43720766|NCT02627807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720767|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720768|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720769|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720770|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
43720771|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43720772|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
43720773|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720774|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720775|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43720776|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
43558904|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43558905|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
43558906|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558907|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558908|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558909|NCT04634799|Plasminogen|plasminogen|mesh-list
43558910|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
43558911|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
43558913|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43558914|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558915|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43558916|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
43558917|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558918|NCT04581473|Paclitaxel|paclitaxel|mesh-list
43720793|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43720794|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
43558922|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43558923|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558924|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
43558925|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
43558926|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
43558927|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558940|NCT04544202|Dabrafenib|dabrafenib|mesh-list
43558941|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558942|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558943|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720795|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720796|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720797|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43720798|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43720799|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
43720800|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43720801|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720802|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43720803|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43720804|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
43720805|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43720806|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720807|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
43720808|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43720809|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43737781|NCT04460066|Antibodies|antibodies|mesh-list
43737782|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43849859|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
43849861|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
43849862|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849863|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720817|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43720818|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
43720819|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720820|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720821|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720822|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
43720823|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43720824|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43720826|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43720827|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43720828|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720829|NCT02627469|Listerine|listerine|mesh-list
43720830|NCT02627469|Fluorides|fluorides|mesh-list
43720831|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
43720832|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
43720833|NCT02627469|Protective Agents|protective agents|mesh-ancestor
43720834|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720835|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43720836|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720837|NCT02627417|Dapsone|dapsone|mesh-list
43720838|NCT02627417|Prednisone|prednisone|mesh-list
43720839|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720840|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
43720841|NCT02627417|Hormones|hormones|mesh-ancestor
43720842|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720843|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720844|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43720845|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720846|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720847|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
43720848|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43720849|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43720850|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43720851|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720852|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720853|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
43720854|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43720855|NCT02627430|Talazoparib|talazoparib|mesh-list
43720856|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43720857|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720858|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720859|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720860|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
43720861|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43720862|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
43720863|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43720864|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
43720865|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720866|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720867|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
43720868|NCT02627222|Vitamin A|vitamin a|mesh-list
43720869|NCT02627222|Provitamins|provitamins|mesh-list
43720870|NCT02627222|Vitamins|vitamins|mesh-ancestor
43720871|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
43720872|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720873|NCT02627027|Metformin|metformin|mesh-list
43720874|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43720875|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720876|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
43720877|NCT02627248|Docetaxel|docetaxel|mesh-list
43558944|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558945|NCT04542408|Heparin|heparin|mesh-list
43558946|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43558947|NCT04542408|Tinzaparin|tinzaparin|mesh-list
43558948|NCT04542408|Dalteparin|dalteparin|mesh-list
43558949|NCT04542408|Edoxaban|edoxaban|mesh-list
43720879|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43720880|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
43720881|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720882|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720883|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43720884|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
43720885|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720886|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720887|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43720888|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720889|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720898|NCT02626936|Hormones|hormones|mesh-list
43720899|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43558950|NCT04542408|Anticoagulants|anticoagulants|mesh-list
43558951|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43558952|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43558953|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558954|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43558955|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
43558956|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43558957|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
43558958|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558959|NCT04530383|Metformin|metformin|mesh-list
43558960|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43558961|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558962|NCT04528563|Ketorolac|ketorolac|mesh-list
43558963|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43558964|NCT04528563|Morphine|morphine|mesh-list
43558965|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43720901|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720902|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43720903|NCT02626754|Sunitinib|sunitinib|mesh-list
43720904|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720905|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43720906|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43832838|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832839|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43832840|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43832841|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
43832842|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832843|NCT05249621|Mannitol|mannitol|mesh-list
43832844|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43832845|NCT05249621|Diuretics|diuretics|mesh-ancestor
43720945|NCT02626208|Estrogens|estrogens|mesh-ancestor
43720946|NCT02626208|Hormones|hormones|mesh-ancestor
43720947|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720948|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720949|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43720950|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43720951|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43720952|NCT02626234|Digoxin|digoxin|mesh-list
43720953|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43720954|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43720955|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43720956|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
43720957|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720958|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43720959|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43720960|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720966|NCT02626481|Daratumumab|daratumumab|mesh-list
43720967|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720968|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
43720969|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
43720970|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720971|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720972|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43720973|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
43720974|NCT02626481|Hormones|hormones|mesh-ancestor
43720975|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720985|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
43720986|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43720987|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43720988|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720990|NCT02625948|Coagulants|coagulants|mesh-ancestor
43720991|NCT02625753|Acetaminophen|acetaminophen|mesh-list
43720992|NCT02625753|Codeine|codeine|mesh-list
43720993|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43720994|NCT02625753|Analgesics|analgesics|mesh-ancestor
43720995|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
43720996|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720997|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720998|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
43720999|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43721000|NCT02625753|Narcotics|narcotics|mesh-ancestor
43721001|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721002|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
43721003|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
43721004|NCT02625779|Valproic Acid|valproic acid|mesh-list
43721005|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
43721006|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721007|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721008|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
43721009|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721010|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834798|NCT05096845|Vaccines|vaccines|mesh-list
43834799|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
43834800|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721011|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
43721012|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43721013|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721018|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43721019|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43721020|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43721021|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721022|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
43721023|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721024|NCT02625740|Paclitaxel|paclitaxel|mesh-list
43721025|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43721026|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721027|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
43721028|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
43721029|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
43694096|NCT02770222|Selexipag|selexipag|mesh-list
43721030|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721031|NCT02625519|Hormones|hormones|mesh-list
43721032|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43721033|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721034|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721035|NCT02625636|Glucagon|glucagon|mesh-list
43721036|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43721037|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721038|NCT02625636|Hormones|hormones|mesh-ancestor
43721039|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721040|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721041|NCT02625636|Incretins|incretins|mesh-ancestor
43721042|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
43721043|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43721044|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
43721045|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721046|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
43721047|NCT02625727|Protective Agents|protective agents|mesh-ancestor
43721048|NCT02625506|Tramadol|tramadol|mesh-list
43721050|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43721052|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721053|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721054|NCT02625506|Analgesics|analgesics|mesh-ancestor
43721055|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
43721056|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721057|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721058|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
43721059|NCT02625558|Riociguat|riociguat|mesh-list
43721060|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
43721061|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558974|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558975|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43721062|NCT02625415|Vitamins|vitamins|mesh-list
43721063|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
43721064|NCT02625415|Pyridoxal|pyridoxal|mesh-list
43721065|NCT02625415|Pyridoxine|pyridoxine|mesh-list
43721066|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
43721067|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
43721068|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721069|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
43721070|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721071|NCT02625454|Acetaminophen|acetaminophen|mesh-list
43721092|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721093|NCT02625376|Protective Agents|protective agents|mesh-ancestor
43721094|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721095|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721096|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43558976|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43558977|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558978|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558980|NCT04521335|Disulfiram|disulfiram|mesh-list
43558981|NCT04521335|Trace Elements|trace elements|mesh-ancestor
43558983|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558984|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43558985|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43558986|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558987|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558988|NCT04507178|Nadroparin|nadroparin|mesh-list
43721097|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43849944|NCT05702879|Golimumab|golimumab|mesh-list
43721099|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721100|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43721101|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721115|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43721116|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
43721117|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
43721119|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721120|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721121|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
43721122|NCT02624856|Hormones|hormones|mesh-ancestor
43721123|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721124|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43721126|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721127|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
43721128|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721129|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
43721130|NCT02624973|Tamoxifen|tamoxifen|mesh-list
43721131|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
43721132|NCT02624973|Docetaxel|docetaxel|mesh-list
43721133|NCT02624973|Trastuzumab|trastuzumab|mesh-list
43721134|NCT02624973|Letrozole|letrozole|mesh-list
43721135|NCT02624973|Epirubicin|epirubicin|mesh-list
43721136|NCT02624973|Olaparib|olaparib|mesh-list
43721137|NCT02624973|Palbociclib|palbociclib|mesh-list
43721138|NCT02624973|Pertuzumab|pertuzumab|mesh-list
43721139|NCT02624973|Goserelin|goserelin|mesh-list
43721140|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43721141|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
43721142|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721143|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43721144|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43721145|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
43721146|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721147|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721148|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43721149|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
43721150|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
43721151|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
43721152|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721153|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43721154|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43721155|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737807|NCT04387240|Artemisinin|artemisinin|mesh-list
43737808|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
43737833|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737834|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43737835|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
43737836|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737837|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737838|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737839|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43737840|NCT04357457|Almitrine|almitrine|mesh-list
43737842|NCT04334330|Trastuzumab|trastuzumab|mesh-list
43721156|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43721157|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
43721158|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721159|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43721160|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43721161|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43721162|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43721163|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43721164|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43721165|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43721166|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43721167|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43721169|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43721170|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721171|NCT02624726|Leucovorin|leucovorin|mesh-list
43559007|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559008|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559009|NCT04500899|Protective Agents|protective agents|mesh-ancestor
43559011|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43559012|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559013|NCT04459286|Ritonavir|ritonavir|mesh-list
43559014|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43559015|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
43559016|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43721190|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
43721191|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43721192|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43721193|NCT02624726|Growth Substances|growth substances|mesh-ancestor
43721194|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
43721195|NCT02624830|Glyburide|glyburide|mesh-list
43721196|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43721197|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721198|NCT02624661|Glycerol|glycerol|mesh-list
43721199|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43721200|NCT02624661|Protective Agents|protective agents|mesh-ancestor
43721201|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721202|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
43721203|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43721205|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721206|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
43721207|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
43832849|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
43832850|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
43832851|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43832852|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832853|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832854|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43832855|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832856|NCT05248945|Analgesics|analgesics|mesh-ancestor
43737855|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832857|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
43832858|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832859|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43832860|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832861|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832862|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43832863|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43832864|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
43832865|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43832867|NCT05248334|Ranibizumab|ranibizumab|mesh-list
43832868|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832869|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43832870|NCT05248334|Growth Substances|growth substances|mesh-ancestor
43832871|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721215|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
43721216|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43721217|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43721218|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43721219|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43721220|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
43721221|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721222|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721223|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
43721224|NCT02624479|Antidotes|antidotes|mesh-ancestor
43559017|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43559018|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
43559019|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559020|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559021|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43559022|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43559023|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
43559024|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721225|NCT02624479|Protective Agents|protective agents|mesh-ancestor
43721226|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721227|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
43721228|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721229|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
43721230|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43721231|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721232|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
43721233|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
43721234|NCT02624570|Midostaurin|midostaurin|mesh-list
43721235|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721236|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43721243|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43721244|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43721245|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694097|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
43721246|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721247|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43721248|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
43721249|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721250|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559044|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
43559045|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559046|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559048|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43737881|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737882|NCT04293562|Cytarabine|cytarabine|mesh-list
43737883|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
43737884|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43737885|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43737886|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43737887|NCT04293562|Methotrexate|methotrexate|mesh-list
43721251|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43721252|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43721254|NCT02624388|Genistein|genistein|mesh-list
43721255|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43721256|NCT02624388|Protective Agents|protective agents|mesh-ancestor
43721257|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721258|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721259|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43721260|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721261|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721262|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
43721263|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43721264|NCT02624388|Estrogens|estrogens|mesh-ancestor
43721284|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721285|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43721286|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43721295|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43721296|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
43721297|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43721298|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
43721299|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43721300|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721301|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
43721302|NCT02624310|Droxidopa|droxidopa|mesh-list
43721303|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43721304|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43721305|NCT02624440|Clarithromycin|clarithromycin|mesh-list
43721306|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43721307|NCT02624440|Trimethoprim|trimethoprim|mesh-list
43559054|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43559065|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559066|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
43559068|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
43559069|NCT04333160|Protective Agents|protective agents|mesh-ancestor
43559070|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559071|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43559072|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43559074|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559075|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721308|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
43721309|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43721310|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721311|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43721312|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721313|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721314|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43721316|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43721317|NCT02624440|Renal Agents|renal agents|mesh-ancestor
43721318|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
43721319|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43721320|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43721321|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43721322|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43721323|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43721324|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
43721325|NCT02624063|Simeprevir|simeprevir|mesh-list
43721326|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
43559077|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559078|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559079|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
43559080|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559082|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
43559083|NCT04229368|Vitamins|vitamins|mesh-ancestor
43559084|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
43559085|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559086|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43559087|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43559088|NCT04225273|Lidocaine|lidocaine|mesh-list
43559089|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
43559090|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
43559091|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43559092|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559093|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
43559094|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559095|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43559096|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43559097|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43721334|NCT02623881|Progestins|progestins|mesh-ancestor
43721335|NCT02623881|Hormones|hormones|mesh-ancestor
43721336|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721337|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721338|NCT02624089|Ropivacaine|ropivacaine|mesh-list
43721339|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721340|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
43721341|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721342|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721343|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
43721344|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721345|NCT02623920|Rituximab|rituximab|mesh-list
43721362|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559098|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559099|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559100|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43559101|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43559102|NCT04209296|Ketamine|ketamine|mesh-list
43559103|NCT04209296|Analgesics|analgesics|mesh-ancestor
43559104|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
43559105|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559106|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559107|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43559108|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43721363|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
43721364|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43721366|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43721367|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
43721368|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43721369|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
43721370|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721371|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43721372|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43721373|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
43721374|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721375|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721376|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43721377|NCT02623673|Dexamethasone|dexamethasone|mesh-list
43721378|NCT02623673|Bevacizumab|bevacizumab|mesh-list
43721379|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721380|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721381|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43721382|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43721383|NCT02623673|Growth Substances|growth substances|mesh-ancestor
43721384|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721385|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
43721386|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43721387|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
43721388|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
43721403|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43721404|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43721405|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
43721410|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
43721411|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721412|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721413|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
43721414|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43721415|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721416|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
43721417|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43721418|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721419|NCT02623504|Carbamazepine|carbamazepine|mesh-list
43721420|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
43721422|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43721423|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721424|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721425|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43721426|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43721427|NCT02623504|Analgesics|analgesics|mesh-ancestor
43721428|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
43721429|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721430|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43721431|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43721432|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721433|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43721434|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43721435|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
43721436|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43721437|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721438|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
43721440|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721441|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721443|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721444|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43738064|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721445|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43721446|NCT02623127|Growth Substances|growth substances|mesh-ancestor
43721447|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721448|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
43721449|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43721450|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721451|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721452|NCT02623036|Enalapril|enalapril|mesh-list
43559117|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43559118|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43559119|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43721454|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43721455|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
43721456|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721457|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721458|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43721459|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43721460|NCT02623036|Protective Agents|protective agents|mesh-ancestor
43721461|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721462|NCT02623049|Anticoagulants|anticoagulants|mesh-list
43721463|NCT02623231|Citalopram|citalopram|mesh-list
43721464|NCT02623231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43721465|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43721466|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43721467|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721468|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559137|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43559138|NCT04163432|Carboplatin|carboplatin|mesh-list
43559139|NCT04163432|Pemetrexed|pemetrexed|mesh-list
43559140|NCT04163432|Durvalumab|durvalumab|mesh-list
43559141|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559142|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559143|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559144|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43559145|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43559146|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721469|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
43721470|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721471|NCT02623231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43721472|NCT02623231|Antidepressive Agents|antidepressive agents|mesh-ancestor
43721473|NCT02623231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43721474|NCT02623153|Docetaxel|docetaxel|mesh-list
43721475|NCT02623153|Capecitabine|capecitabine|mesh-list
43721476|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
43721477|NCT02623153|Tegafur|tegafur|mesh-list
43721478|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721479|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
43721480|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
43559154|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559156|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559157|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43559158|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43559159|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559160|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559161|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43559162|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
43559163|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559164|NCT04161456|Apremilast|apremilast|mesh-list
43559165|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43738251|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43738252|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738253|NCT03783442|Paclitaxel|paclitaxel|mesh-list
43738254|NCT03783442|Cisplatin|cisplatin|mesh-list
43738255|NCT03783442|Fluorouracil|fluorouracil|mesh-list
43738256|NCT03783442|Capecitabine|capecitabine|mesh-list
43738257|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
43738258|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738259|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738260|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
43738261|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
43738262|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
43738263|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738264|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
43738265|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43738266|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738267|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
43559166|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559167|NCT04161456|Analgesics|analgesics|mesh-ancestor
43559168|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
43559169|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559170|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559171|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559172|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559173|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43559174|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43559175|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721481|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
43721482|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721483|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43721484|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
43721492|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721494|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721495|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43721496|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
43721497|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
43721498|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43721499|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43738331|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43721500|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
43721501|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721502|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721503|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721504|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43721505|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43721506|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43721508|NCT02622906|Hormones|hormones|mesh-ancestor
43721509|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721510|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832875|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43832876|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
43832877|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43738410|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738411|NCT03540420|Atezolizumab|atezolizumab|mesh-list
43738412|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738413|NCT03537391|Fluorides|fluorides|mesh-list
43738414|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
43738415|NCT03537391|Protective Agents|protective agents|mesh-ancestor
43738416|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738417|NCT03527043|Citalopram|citalopram|mesh-list
43738418|NCT03527043|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43738419|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43738420|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43738440|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43738441|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
43738442|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738443|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43738444|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43738445|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43738446|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
43832878|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
43832879|NCT05248139|Triamcinolone|triamcinolone|mesh-list
43832880|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43832881|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43832894|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43832895|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43832896|NCT05248139|Protective Agents|protective agents|mesh-ancestor
43832897|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43832898|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
43832899|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43832900|NCT05247905|Capecitabine|capecitabine|mesh-list
43832901|NCT05247905|Temozolomide|temozolomide|mesh-list
43832902|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43832903|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43832904|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
43559176|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559177|NCT04114136|Metformin|metformin|mesh-list
43559178|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
43559179|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
43559180|NCT04114136|Nivolumab|nivolumab|mesh-list
43559199|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
43559200|NCT04093765|Antimalarials|antimalarials|mesh-list
43559201|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43559202|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43559203|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832905|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832906|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832907|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43832908|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
43832909|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43832910|NCT05247320|Sotalol|sotalol|mesh-list
43832911|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43832912|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43832913|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
43832914|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832915|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832916|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832917|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43832918|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
43832919|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
43832920|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832921|NCT05247125|Melatonin|melatonin|mesh-list
43832922|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832923|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
43832924|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832925|NCT05247125|Protective Agents|protective agents|mesh-ancestor
43559204|NCT04049864|Lenalidomide|lenalidomide|mesh-list
43559205|NCT04049864|Vaccines|vaccines|mesh-list
43559206|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
43559207|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559208|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43559209|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43559210|NCT04049864|Growth Substances|growth substances|mesh-ancestor
43738448|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738449|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738450|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738451|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738452|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
43832926|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43847499|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847500|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43721512|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43721513|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721514|NCT02622503|Rituximab|rituximab|mesh-list
43721515|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721516|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721517|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
43721528|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721529|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721530|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721531|NCT02622555|Urological Agents|urological agents|mesh-ancestor
43721532|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
43559211|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
43559212|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559213|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43721554|NCT02622477|Pirfenidone|pirfenidone|mesh-list
43721555|NCT02622477|Analgesics|analgesics|mesh-ancestor
43721556|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
43721557|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721558|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721559|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43721560|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43721561|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43721562|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43721567|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
43721568|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43721569|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721570|NCT02622334|Latanoprost|latanoprost|mesh-list
43721571|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43721572|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43721573|NCT02622126|Atropine|atropine|mesh-list
43721574|NCT02622126|Ephedrine|ephedrine|mesh-list
43721575|NCT02622126|Morphine|morphine|mesh-list
43721576|NCT02622126|Bupivacaine|bupivacaine|mesh-list
43721577|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721578|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
43721579|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721580|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721581|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
43721582|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721583|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43721584|NCT02622126|Narcotics|narcotics|mesh-ancestor
43721585|NCT02622126|Analgesics|analgesics|mesh-ancestor
43721586|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43721587|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43721588|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43721589|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
43721591|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
43721592|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
43721593|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
43721594|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43721595|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43721596|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
43721597|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721598|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738703|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
43564569|NCT01020097|Fluorides|fluorides|mesh-list
43721599|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43721600|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
43721601|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43721602|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
43721603|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
43721604|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
43721605|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43721606|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
43721607|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721608|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721609|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43721610|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
43721611|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
43721612|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43721613|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
43721615|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721616|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43832927|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
43721624|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
43721625|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721626|NCT02621957|Pravastatin|pravastatin|mesh-list
43721627|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43721628|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43721629|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
43721630|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721631|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43721632|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43721633|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721635|NCT02621970|Docetaxel|docetaxel|mesh-list
43721636|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721637|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
43721638|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
43721639|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
43721640|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721641|NCT02621905|Itraconazole|itraconazole|mesh-list
43721642|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43559214|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43559215|NCT04030143|Aripiprazole|aripiprazole|mesh-list
43559216|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
43721643|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
43721644|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721645|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43721646|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43721647|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721648|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721649|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43721650|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
43721651|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721652|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721661|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721663|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721664|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721665|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43721666|NCT02621515|Nivolumab|nivolumab|mesh-list
43721667|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43564599|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43564617|NCT01009775|Docetaxel|docetaxel|mesh-list
43721668|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721669|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43721670|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721671|NCT02621385|Midazolam|midazolam|mesh-list
43721672|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43721673|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43738817|NCT02095184|Anastrozole|anastrozole|mesh-list
43721674|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721675|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721676|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43721677|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43721678|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43721679|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43721680|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
43721682|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
43721683|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
43721684|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721685|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721686|NCT02621489|Metformin|metformin|mesh-list
43721687|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
43721688|NCT02621489|Exenatide|exenatide|mesh-list
43721689|NCT02621489|Biguanides|biguanides|mesh-list
43721690|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43721691|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721692|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43721696|NCT02621359|Doxycycline|doxycycline|mesh-list
43564654|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43564655|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43564656|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564657|NCT01007292|Rituximab|rituximab|mesh-list
43564658|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43564659|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721697|NCT02621359|Levofloxacin|levofloxacin|mesh-list
43564663|NCT01007097|Glimepiride|glimepiride|mesh-list
43564669|NCT01005108|Gabapentin|gabapentin|mesh-list
43721698|NCT02621359|Ofloxacin|ofloxacin|mesh-list
43721699|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
43721700|NCT02621359|Omeprazole|omeprazole|mesh-list
43721701|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43721702|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721703|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43721704|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721705|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721706|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43721707|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721708|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
43559225|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559226|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43559227|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43559228|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
43559229|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43559230|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43559231|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43559232|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43559234|NCT03957590|Cisplatin|cisplatin|mesh-list
43721726|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43832937|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
43832938|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43832939|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
43832940|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564731|NCT01001338|Renal Agents|renal agents|mesh-ancestor
43564732|NCT01001091|Dexamethasone|dexamethasone|mesh-list
43564733|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43564734|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43564735|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564736|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
43564737|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
43564738|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564739|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738905|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
43738906|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738907|NCT01933724|Hormones|hormones|mesh-ancestor
43834970|NCT05085496|Atezolizumab|atezolizumab|mesh-list
43738908|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738909|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738910|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738911|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564740|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43564741|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
43832941|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832942|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
43559245|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43559246|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559248|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
43559249|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559250|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738912|NCT01840592|Doxorubicin|doxorubicin|mesh-list
43738913|NCT01840592|Sorafenib|sorafenib|mesh-list
43738914|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43738915|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738916|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43738917|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43738918|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738919|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738920|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43738921|NCT01757626|Molgramostim|molgramostim|mesh-list
43738922|NCT01757626|Sargramostim|sargramostim|mesh-list
43738926|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
43738955|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43738957|NCT01345175|Rifaximin|rifaximin|mesh-list
43738958|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43738959|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738960|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
43738961|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43738962|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43738963|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43559251|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559252|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559253|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43559254|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43559255|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559256|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559257|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
43559267|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559268|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559269|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559270|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559271|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559272|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721735|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721736|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721737|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721738|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
43721739|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739004|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739005|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43739006|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43721740|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43721741|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43721742|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
43721744|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43721745|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
43721746|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721747|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721748|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
43721749|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
43721750|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721751|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
43721752|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43721753|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43721754|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721755|NCT02620995|Urological Agents|urological agents|mesh-ancestor
43721756|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
43721757|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43721758|NCT02620800|Leucovorin|leucovorin|mesh-list
43721759|NCT02620800|Paclitaxel|paclitaxel|mesh-list
43721760|NCT02620800|Bevacizumab|bevacizumab|mesh-list
43721761|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
43721762|NCT02620800|Calcium|calcium|mesh-list
43721763|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
43721764|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43721765|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721766|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
43721767|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
43721768|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
43559276|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43559278|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43559279|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43559280|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559281|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559282|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43559283|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559284|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559285|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
43559286|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559287|NCT03912233|Ivacaftor|ivacaftor|mesh-list
43559288|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43559289|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559290|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559291|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43559292|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43559293|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43559294|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559296|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43564772|NCT00992732|Valganciclovir|valganciclovir|mesh-list
43564773|NCT00992732|Ganciclovir|ganciclovir|mesh-list
43564774|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43564775|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
43564776|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
43559297|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559298|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559299|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
43559300|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559301|NCT03896009|Meloxicam|meloxicam|mesh-list
43721785|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721786|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
43721788|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721789|NCT02620605|Cabergoline|cabergoline|mesh-list
43721790|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43721791|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43721792|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
43721807|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721808|NCT02620501|Lidocaine|lidocaine|mesh-list
43721809|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721810|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
43721811|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721812|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721813|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
43721814|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721815|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43721816|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43721817|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43721818|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43721819|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721820|NCT02620631|Morphine|morphine|mesh-list
43721821|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43721822|NCT02620631|Narcotics|narcotics|mesh-ancestor
43721823|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721824|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721825|NCT02620631|Analgesics|analgesics|mesh-ancestor
43721826|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
43721827|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721828|NCT02620423|Leucovorin|leucovorin|mesh-list
43739136|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739137|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739138|NCT03819660|Amifampridine|amifampridine|mesh-list
43739139|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43739140|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739141|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739142|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43739143|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43721829|NCT02620423|Gemcitabine|gemcitabine|mesh-list
43721830|NCT02620423|Fluorouracil|fluorouracil|mesh-list
43721831|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
43721832|NCT02620423|Irinotecan|irinotecan|mesh-list
43721833|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43721834|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
43721835|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721837|NCT02620423|Antiviral Agents|antiviral agents|mesh-ancestor
43721838|NCT02620423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721839|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721840|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43721841|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
43721842|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721843|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721844|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43721845|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43721846|NCT02620423|Antidotes|antidotes|mesh-ancestor
43721847|NCT02620423|Protective Agents|protective agents|mesh-ancestor
43721848|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
43721849|NCT02620423|Vitamins|vitamins|mesh-ancestor
43721850|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
43721851|NCT02620163|Amlodipine|amlodipine|mesh-list
43721852|NCT02620163|Telmisartan|telmisartan|mesh-list
43721853|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
43721854|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43721855|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43721856|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43721857|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43721858|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721859|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43721860|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721861|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
43721862|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43721863|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43721864|NCT02620163|Diuretics|diuretics|mesh-ancestor
43721865|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
43721866|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43721867|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43721868|NCT02620124|Hormones|hormones|mesh-list
43721869|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721870|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721871|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
43721872|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43721873|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
43721875|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43721876|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43721877|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559305|NCT03896009|Analgesics|analgesics|mesh-ancestor
43721885|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721886|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721888|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
43721889|NCT02619981|Lidocaine|lidocaine|mesh-list
43721890|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721891|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
43721892|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721893|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564940|NCT00963885|Lactams|lactams|mesh-list
43721894|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
43721895|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721896|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43721897|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43721898|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43721899|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564956|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
43721900|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721901|NCT02619929|Vinorelbine|vinorelbine|mesh-list
43721902|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43721903|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721904|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
43721905|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
43721907|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721908|NCT02619994|Levofloxacin|levofloxacin|mesh-list
43721910|NCT02619994|Linezolid|linezolid|mesh-list
43721911|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
43721912|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43721913|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721914|NCT02619994|Renal Agents|renal agents|mesh-ancestor
43721915|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43721916|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43721917|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43721918|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721919|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721920|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721921|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43721922|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43721930|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43721931|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721932|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565086|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721933|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721934|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43721935|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43721936|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721938|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43721939|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721940|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43721941|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721942|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739440|NCT01472562|Lenalidomide|lenalidomide|mesh-list
43721944|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43721945|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721946|NCT02619669|Letrozole|letrozole|mesh-list
43721947|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721948|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43721949|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43721950|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721951|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721952|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43721953|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
43721954|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721955|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835069|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739553|NCT02534571|Epinephrine|epinephrine|mesh-list
43739554|NCT02534571|Hemostatics|hemostatics|mesh-list
43739555|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43739556|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43739557|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
43739558|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739559|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565109|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43565111|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565112|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
43565118|NCT00945646|Hormones|hormones|mesh-ancestor
43739609|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43739610|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
43739611|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43739612|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43739613|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43721959|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721960|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721961|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43721962|NCT02619513|Analgesics|analgesics|mesh-ancestor
43721963|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
43721970|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721971|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721972|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
43721973|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
43721974|NCT02619747|Antacids|antacids|mesh-ancestor
43721975|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721976|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721977|NCT02619448|Paclitaxel|paclitaxel|mesh-list
43721978|NCT02619448|Carboplatin|carboplatin|mesh-list
43559319|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43559320|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559321|NCT03881852|Reboxetine|reboxetine|mesh-list
43559328|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
43559329|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559330|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721979|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43721980|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721981|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
43721982|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
43721983|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
43721984|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721985|NCT02619578|Remifentanil|remifentanil|mesh-list
43721986|NCT02619578|Propofol|propofol|mesh-list
43721987|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
43721988|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43721989|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721990|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721991|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43721992|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
43722012|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722013|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722014|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722015|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43722016|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
43722017|NCT02619526|Protective Agents|protective agents|mesh-ancestor
43722018|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43722019|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43739731|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
43739732|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739733|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43739735|NCT02533648|Protective Agents|protective agents|mesh-ancestor
43739736|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739737|NCT02533440|Anesthetics|anesthetics|mesh-list
43739738|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
43559339|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559340|NCT03856047|Incretins|incretins|mesh-ancestor
43559341|NCT03856047|Hormones|hormones|mesh-ancestor
43832951|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43832952|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832953|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832954|NCT05245916|Rituximab|rituximab|mesh-list
43739766|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832955|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832956|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832957|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
43832958|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832959|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43832960|NCT05245877|Enoxaparin|enoxaparin|mesh-list
43832961|NCT05245877|Dalteparin|dalteparin|mesh-list
43832962|NCT05245877|Tinzaparin|tinzaparin|mesh-list
43832963|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43832964|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
43832965|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43832966|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43832967|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559342|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559343|NCT03844074|Bevacizumab|bevacizumab|mesh-list
43559344|NCT03844074|Ranibizumab|ranibizumab|mesh-list
43559345|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832968|NCT05244213|Paclitaxel|paclitaxel|mesh-list
43559349|NCT03844074|Growth Substances|growth substances|mesh-ancestor
43559350|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559351|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
43559353|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43559354|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559355|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559356|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
43559357|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559358|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559359|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43559360|NCT03840837|Protective Agents|protective agents|mesh-ancestor
43559361|NCT03832179|Dexamethasone|dexamethasone|mesh-list
43559362|NCT03832179|Bevacizumab|bevacizumab|mesh-list
43559363|NCT03832179|Ranibizumab|ranibizumab|mesh-list
43559364|NCT03832179|Aflibercept|aflibercept|mesh-list
43559365|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43559366|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559367|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832983|NCT05242692|Ketamine|ketamine|mesh-list
43832984|NCT05242692|Esketamine|esketamine|mesh-list
43832985|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43832986|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832987|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832988|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832989|NCT05242692|Analgesics|analgesics|mesh-ancestor
43832990|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
43832991|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832992|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43832993|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43835091|NCT05078463|Protective Agents|protective agents|mesh-ancestor
43832994|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43832995|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
43832996|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722027|NCT02619201|Ondansetron|ondansetron|mesh-list
43722028|NCT02619201|Metoclopramide|metoclopramide|mesh-list
43722029|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
43722030|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
43722031|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722032|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722033|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722034|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
43722035|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
43722036|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43722037|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
43722038|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722039|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722040|NCT02619201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43722041|NCT02619201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43722042|NCT02619201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43559379|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559380|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43559383|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43559384|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559385|NCT03818828|Trace Elements|trace elements|mesh-ancestor
43559386|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
43559387|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559388|NCT03798743|Docetaxel|docetaxel|mesh-list
43559389|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559397|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559398|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722045|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43722046|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43722047|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
43722048|NCT02619162|Letrozole|letrozole|mesh-list
43722049|NCT02619162|Nintedanib|nintedanib|mesh-list
43722050|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722051|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43722052|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43722053|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722054|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722055|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43722067|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722068|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43722069|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43722070|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43722071|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722072|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
43722073|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43722074|NCT02619149|Tazobactam|tazobactam|mesh-list
43722075|NCT02619149|Piperacillin|piperacillin|mesh-list
43722076|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43739858|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43739859|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739860|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43739861|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739862|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
43722077|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43722078|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722079|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43722080|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722081|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722082|NCT02619019|Dexamethasone|dexamethasone|mesh-list
43722083|NCT02619019|Meperidine|meperidine|mesh-list
43722084|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722085|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
43722086|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
43722087|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722088|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722089|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722090|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
43722091|NCT02619019|Hormones|hormones|mesh-ancestor
43694098|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43722116|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
43722117|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
43722118|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722119|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722120|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
43722121|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722122|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43722123|NCT02618876|Narcotics|narcotics|mesh-ancestor
43722159|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43722160|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43722161|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
43722162|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43722163|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43722167|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722168|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
43722169|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722170|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722171|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722191|NCT02618317|Minocycline|minocycline|mesh-list
43722192|NCT02618317|Heparin|heparin|mesh-list
43722193|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
43722194|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722195|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43722196|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43722197|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43722198|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722199|NCT02618096|Oxytocin|oxytocin|mesh-list
43722200|NCT02618096|Dinoprostone|dinoprostone|mesh-list
43722201|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
43722202|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43722203|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722204|NCT02618733|Clopidogrel|clopidogrel|mesh-list
43722205|NCT02618733|Ticagrelor|ticagrelor|mesh-list
43722206|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43722208|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43722209|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43722210|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
43722211|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722212|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722213|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722214|NCT02618057|Levofloxacin|levofloxacin|mesh-list
43722215|NCT02618057|Ofloxacin|ofloxacin|mesh-list
43722216|NCT02618057|Prednisolone|prednisolone|mesh-list
43722217|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722218|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
43722219|NCT02618057|Hormones|hormones|mesh-ancestor
43722220|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565181|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565182|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565183|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43565184|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565185|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
43722221|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722222|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43722223|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722224|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43722225|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722226|NCT02618057|Renal Agents|renal agents|mesh-ancestor
43722227|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43722228|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43722229|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43722230|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722231|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722232|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43722233|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43722234|NCT02617862|Anesthetics|anesthetics|mesh-list
43722235|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722236|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722237|NCT02617849|Paclitaxel|paclitaxel|mesh-list
43722238|NCT02617849|Carboplatin|carboplatin|mesh-list
43722239|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
43722240|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43722241|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722242|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
43722243|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
43722244|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
43722245|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722246|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43722247|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
43722248|NCT02617680|Desflurane|desflurane|mesh-list
43722249|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43722251|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722252|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722253|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43722254|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
43722255|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43722256|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
43722257|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722258|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722259|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43722260|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
43722261|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
43722262|NCT02617680|Protective Agents|protective agents|mesh-ancestor
43722263|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43722264|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
43722265|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
43722266|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832997|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832998|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43832999|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43833000|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
43833001|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
43833007|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
43833008|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43833009|NCT05239468|Bezafibrate|bezafibrate|mesh-list
43833010|NCT05239468|Cathartics|cathartics|mesh-ancestor
43833011|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43833012|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43833013|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
43833014|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833015|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43833017|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
43833018|NCT05239091|Anesthetics|anesthetics|mesh-list
43739876|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833019|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833020|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833021|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
43833022|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833023|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43833024|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43833025|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43833026|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43833027|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833029|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43833030|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43833031|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833034|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43833036|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43833037|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
43833039|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
43833040|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
43833041|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833042|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833043|NCT05238142|Insulin|insulin|mesh-list
43722267|NCT02617810|Midazolam|midazolam|mesh-list
43722268|NCT02617810|Warfarin|warfarin|mesh-list
43722269|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43722270|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43722271|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722272|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722273|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43722274|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43722275|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43722276|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43722277|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
43722278|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
43722279|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
43722280|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
43722281|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722282|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722283|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
43722284|NCT02617771|Vitamin D|vitamin d|mesh-list
43722285|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
43722286|NCT02617771|Vitamins|vitamins|mesh-ancestor
43722287|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
43722288|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722289|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43722290|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43722291|NCT02617459|Betaxolol|betaxolol|mesh-list
43722292|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43722293|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43722294|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43722295|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
43722296|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
43722297|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722302|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
43722303|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722304|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722305|NCT02617758|Fentanyl|fentanyl|mesh-list
43722306|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43722307|NCT02617758|Narcotics|narcotics|mesh-ancestor
43722308|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722309|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722310|NCT02617758|Analgesics|analgesics|mesh-ancestor
43722311|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
43722314|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43722315|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
43722316|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
43722317|NCT02617654|Liraglutide|liraglutide|mesh-list
43722318|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43722319|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722320|NCT02617654|Incretins|incretins|mesh-ancestor
43722325|NCT02617485|Rituximab|rituximab|mesh-list
43722326|NCT02617485|Doxorubicin|doxorubicin|mesh-list
43722327|NCT02617485|Vincristine|vincristine|mesh-list
43722328|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43722329|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
43722330|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722331|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43722332|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43722333|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
43722334|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722335|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722336|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43722337|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43722338|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43722339|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43722340|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43722341|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722342|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722343|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
43722344|NCT02617485|Hormones|hormones|mesh-ancestor
43722345|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722346|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43722347|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43722348|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
43722351|NCT02617121|Gabapentin|gabapentin|mesh-list
43722352|NCT02617121|Ramosetron|ramosetron|mesh-list
43722353|NCT02617121|Analgesics|analgesics|mesh-ancestor
43722354|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
43722355|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722356|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722357|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
43722358|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43722359|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43722360|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722361|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43722362|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43559407|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559408|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43559409|NCT03766295|Gemcitabine|gemcitabine|mesh-list
43559410|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43722363|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43722364|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722365|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722366|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
43722367|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
43722368|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
43722369|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722370|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43722371|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
43722372|NCT02617199|Fentanyl|fentanyl|mesh-list
43722373|NCT02617199|Analgesics|analgesics|mesh-list
43722374|NCT02617199|Ropivacaine|ropivacaine|mesh-list
43722375|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
43722376|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722377|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722378|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
43722379|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
43722381|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43722382|NCT02617199|Narcotics|narcotics|mesh-ancestor
43722383|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43722384|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43722385|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
43722386|NCT02617290|Clopidogrel|clopidogrel|mesh-list
43722387|NCT02617290|Ticagrelor|ticagrelor|mesh-list
43722388|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43722389|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43722390|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43722391|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43722392|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
43722393|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722394|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722395|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722396|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
43722397|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43722402|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722404|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43722405|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43722406|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722407|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722408|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43722409|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43722410|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
43722411|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722412|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722413|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
43722414|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43722415|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722416|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43722417|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43722418|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722433|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722434|NCT02616822|Protective Agents|protective agents|mesh-ancestor
43722435|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722436|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722437|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43722438|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
43722439|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43559417|NCT03766295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43722440|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43722441|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722442|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
43722443|NCT02616731|Coagulants|coagulants|mesh-ancestor
43722444|NCT02616874|Romidepsin|romidepsin|mesh-list
43722445|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43722446|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722447|NCT02616861|Praliciguat|praliciguat|mesh-list
43722448|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43722449|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
43722450|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722451|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722452|NCT02616848|Everolimus|everolimus|mesh-list
43722455|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
43722456|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722457|NCT02616640|Dexamethasone|dexamethasone|mesh-list
43722458|NCT02616640|Durvalumab|durvalumab|mesh-list
43722459|NCT02616640|Pomalidomide|pomalidomide|mesh-list
43722460|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722461|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
43722462|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
43722463|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722464|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739922|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739924|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722465|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722466|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
43722467|NCT02616640|Hormones|hormones|mesh-ancestor
43722468|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722469|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43722470|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722471|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43722472|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
43722473|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43722474|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43722475|NCT02616640|Growth Substances|growth substances|mesh-ancestor
43722476|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
43722477|NCT02616354|Imipenem|imipenem|mesh-list
43722478|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43722479|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722480|NCT02616367|Bupivacaine|bupivacaine|mesh-list
43722481|NCT02616367|Ropivacaine|ropivacaine|mesh-list
43722482|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
43722483|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
43722484|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722485|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722486|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
43722487|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722488|NCT02616289|Emollients|emollients|mesh-list
43722489|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
43722490|NCT02616497|Aspirin|aspirin|mesh-list
43722491|NCT02616497|Triflusal|triflusal|mesh-list
43722492|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43722493|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43722494|NCT02616497|Analgesics|analgesics|mesh-ancestor
43722495|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
43722496|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722497|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722498|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722499|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43722500|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43722501|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43722502|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722503|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43722504|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43722505|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722506|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
43722507|NCT02616419|Lidocaine|lidocaine|mesh-list
43722508|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
43722509|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
43722510|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722511|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722512|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
43722513|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722514|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43722515|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43722516|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43722517|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43722518|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722519|NCT02616315|Naltrexone|naltrexone|mesh-list
43722520|NCT02616315|Bupropion|bupropion|mesh-list
43722521|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43722522|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43722523|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722524|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
43722525|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722526|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43722535|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43739930|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739931|NCT02532491|Risperidone|risperidone|mesh-list
43722536|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43722537|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722538|NCT02616003|Liraglutide|liraglutide|mesh-list
43722539|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43722540|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722541|NCT02616003|Incretins|incretins|mesh-ancestor
43722543|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722544|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
43722545|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
43722546|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43722550|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722551|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43722552|NCT02615977|Ethanol|ethanol|mesh-list
43722553|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43722554|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722555|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722556|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722557|NCT02616068|Loxoprofen|loxoprofen|mesh-list
43722558|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43722559|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43722560|NCT02616068|Analgesics|analgesics|mesh-ancestor
43559418|NCT03766295|Immunologic Factors|immunologic factors|mesh-ancestor
43559419|NCT03766295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559420|NCT03761225|Prednisone|prednisone|mesh-list
43559421|NCT03761225|Docetaxel|docetaxel|mesh-list
43559422|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559423|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
43559424|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
43559425|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
43559426|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559427|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559428|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
43559429|NCT03761225|Hormones|hormones|mesh-ancestor
43559437|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559438|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43559439|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43559441|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559442|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559443|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43559445|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559446|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559447|NCT03737123|Gemcitabine|gemcitabine|mesh-list
43559448|NCT03737123|Carboplatin|carboplatin|mesh-list
43559449|NCT03737123|Docetaxel|docetaxel|mesh-list
43559450|NCT03737123|Atezolizumab|atezolizumab|mesh-list
43559451|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559452|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43559453|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
43559454|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559455|NCT03737123|Antiviral Agents|antiviral agents|mesh-ancestor
43559460|NCT03737123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722561|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
43722562|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722563|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722564|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722565|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43833044|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43833045|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722567|NCT02615873|Carbidopa|carbidopa|mesh-list
43722568|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43559461|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
43559462|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
43559463|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
43559465|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559466|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559467|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43559468|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43559469|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
43559470|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559471|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43559472|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43559473|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559474|NCT03727022|Lorecivivint|lorecivivint|mesh-list
43559475|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559476|NCT03724825|Testosterone|testosterone|mesh-list
43559477|NCT03724825|Androgens|androgens|mesh-ancestor
43559478|NCT03724825|Hormones|hormones|mesh-ancestor
43559479|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559480|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559481|NCT03721965|Prednisone|prednisone|mesh-list
43559482|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
43559483|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559484|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
43559485|NCT03721965|Hormones|hormones|mesh-ancestor
43559486|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559487|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559488|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43559489|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722572|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722573|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722574|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722575|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43722576|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722577|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43722578|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
43722579|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
43722580|NCT02615847|Memantine|memantine|mesh-list
43722581|NCT02615847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43722582|NCT02615847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43722583|NCT02615847|Dopamine Agents|dopamine agents|mesh-ancestor
43722584|NCT02615847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559496|NCT03720613|Naloxegol|naloxegol|mesh-list
43559497|NCT03720613|Lubiprostone|lubiprostone|mesh-list
43559498|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43559499|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559500|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559501|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43559502|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722585|NCT02615847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722586|NCT02615847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722587|NCT02615847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43722588|NCT02615847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43722589|NCT02615912|Castor Oil|castor oil|mesh-list
43722590|NCT02615912|Cathartics|cathartics|mesh-ancestor
43722591|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722592|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43722593|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
43722594|NCT02615639|Entecavir|entecavir|mesh-list
43722595|NCT02615639|Telbivudine|telbivudine|mesh-list
43722596|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
43722597|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
43722598|NCT02615639|Vaccines|vaccines|mesh-list
43722599|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
43565213|NCT00934921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43565214|NCT00934180|Ondansetron|ondansetron|mesh-list
43565215|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
43565216|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
43565217|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565218|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565219|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565220|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
43565221|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
43565222|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43565223|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
43739987|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739988|NCT02532270|Protective Agents|protective agents|mesh-ancestor
43739990|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
43739992|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
43739993|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739994|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43739995|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43739996|NCT02531984|Azithromycin|azithromycin|mesh-list
43739997|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43722600|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722601|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
43722602|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722603|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43722604|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722605|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722606|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722607|NCT02615730|Paclitaxel|paclitaxel|mesh-list
43722608|NCT02615730|GSK2636771|gsk2636771|mesh-list
43722609|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43722610|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722611|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
43722612|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
43722613|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
43722614|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722630|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722632|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43722633|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43722634|NCT02615496|Growth Substances|growth substances|mesh-ancestor
43722635|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722636|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
43722637|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722638|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
43722649|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722676|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722677|NCT02615288|Vitamin D|vitamin d|mesh-list
43722678|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
43722679|NCT02615288|Vitamins|vitamins|mesh-ancestor
43722680|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
43722681|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722682|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43722683|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43722684|NCT02615041|Meropenem|meropenem|mesh-list
43722685|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43722686|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722687|NCT02615340|Melatonin|melatonin|mesh-list
43722688|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
43722689|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722690|NCT02615340|Protective Agents|protective agents|mesh-ancestor
43722691|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722692|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722693|NCT02615301|Vitamin D|vitamin d|mesh-list
43722694|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
43722695|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
43722696|NCT02615301|Vitamins|vitamins|mesh-list
43722697|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
43722698|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722699|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43722700|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43722701|NCT02615080|Pemirolast|pemirolast|mesh-list
43722702|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
43722703|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
43722704|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722705|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722706|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722707|NCT02615106|Endostar protein|endostar protein|mesh-list
43722708|NCT02615106|Endostatins|endostatins|mesh-list
43722709|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43722710|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43722711|NCT02615106|Growth Substances|growth substances|mesh-ancestor
43722724|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722725|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43739999|NCT02532140|Cefepime|cefepime|mesh-list
43722726|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722728|NCT02614937|Ranibizumab|ranibizumab|mesh-list
43722729|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43722749|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43722750|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43722752|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
43722753|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43722754|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
43722755|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722756|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
43722757|NCT02614612|Hormones|hormones|mesh-ancestor
43722758|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722759|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722760|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43722761|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722763|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
43722764|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722765|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722766|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43722781|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722782|NCT02614482|Urological Agents|urological agents|mesh-ancestor
43722783|NCT02614456|Interferons|interferons|mesh-list
43722785|NCT02614456|Nivolumab|nivolumab|mesh-list
43722786|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43722787|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722788|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43722789|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722790|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
43722791|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722792|NCT02614352|Candesartan|candesartan|mesh-list
43722793|NCT02614352|Atorvastatin|atorvastatin|mesh-list
43722794|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43722795|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43722796|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
43722797|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722799|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43722800|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722801|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43722802|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43722803|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43722804|NCT02614339|Metformin|metformin|mesh-list
43722805|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43722806|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722807|NCT02614404|Piperaquine|piperaquine|mesh-list
43722808|NCT02614404|Artenimol|artenimol|mesh-list
43722809|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
43722811|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43722812|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722813|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722814|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
43722815|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43722816|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43722817|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722818|NCT02614118|Acetaminophen|acetaminophen|mesh-list
43722819|NCT02614118|Ketorolac|ketorolac|mesh-list
43722820|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43722832|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722833|NCT02614248|Protective Agents|protective agents|mesh-list
43722834|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833048|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833049|NCT05237687|Sirolimus|sirolimus|mesh-list
43833050|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43833051|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833052|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43833053|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833054|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
43722835|NCT02614508|Ofatumumab|ofatumumab|mesh-list
43722836|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43559509|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722837|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722838|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
43722839|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722841|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43722842|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43722843|NCT02613715|Ethanol|ethanol|mesh-list
43722844|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43722845|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722846|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722847|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722848|NCT02613585|Permethrin|permethrin|mesh-list
43722849|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722850|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722851|NCT02613676|Bilirubin|bilirubin|mesh-list
43722853|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722855|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722856|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
43722857|NCT02613494|Scopolamine|scopolamine|mesh-list
43722858|NCT02613494|Bromides|bromides|mesh-list
43722871|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722872|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
43722873|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
43722874|NCT02613455|Triamcinolone|triamcinolone|mesh-list
43722875|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43722876|NCT02613455|Lidocaine|lidocaine|mesh-list
43722877|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
43722878|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
43722879|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722880|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722881|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
43722882|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722883|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43722884|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43722885|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43722886|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43722887|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722888|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722889|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
43722891|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722892|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43722893|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
43722894|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43722895|NCT02613247|Hylan|hylan|mesh-list
43722896|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
43722897|NCT02613247|Protective Agents|protective agents|mesh-ancestor
43722898|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722899|NCT02613130|Fluorides|fluorides|mesh-list
43722900|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
43722901|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
43722902|NCT02613130|Protective Agents|protective agents|mesh-ancestor
43722903|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722904|NCT02613091|Clemastine|clemastine|mesh-list
43722905|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
43722906|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
43722907|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43722908|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
43722909|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
43722911|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722912|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722914|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43722916|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43722917|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43722918|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43722919|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722920|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722922|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43722923|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722924|NCT02613052|Propofol|propofol|mesh-list
43722925|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43722926|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722927|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722928|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43722929|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
43722930|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
43722931|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
43722932|NCT02613013|Pilocarpine|pilocarpine|mesh-list
43722933|NCT02613013|Miotics|miotics|mesh-ancestor
43722934|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
43722935|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722936|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722937|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43722938|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43722939|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
43722940|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722941|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722942|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
43722943|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
43722944|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722945|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
43722946|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
43722947|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
43722948|NCT02613039|Estrogens|estrogens|mesh-list
43722949|NCT02613039|Progestins|progestins|mesh-list
43722950|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43722951|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722952|NCT02613039|Hormones|hormones|mesh-ancestor
43722953|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722954|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43565254|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
43565255|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43565256|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43565257|NCT00927914|Ranirestat|ranirestat|mesh-list
43565258|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565259|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565260|NCT00927641|Ketoprofen|ketoprofen|mesh-list
43740012|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740013|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740014|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740015|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
43850103|NCT05702151|Morphine|morphine|mesh-list
43850104|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43850105|NCT05702151|Narcotics|narcotics|mesh-ancestor
43850106|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43850107|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850108|NCT05702151|Analgesics|analgesics|mesh-ancestor
43850109|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
43850111|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
43722955|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
43722956|NCT02613026|Docetaxel|docetaxel|mesh-list
43722957|NCT02613026|Pirarubicin|pirarubicin|mesh-list
43722958|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43722959|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
43722970|NCT02612896|Praziquantel|praziquantel|mesh-list
43722971|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
43722972|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43722973|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722974|NCT02612792|Atorvastatin|atorvastatin|mesh-list
43722975|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43722976|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43722978|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722979|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43722980|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43722981|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722982|NCT02612545|Piperaquine|piperaquine|mesh-list
43722995|NCT02612480|Analgesics|analgesics|mesh-ancestor
43722996|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
43722997|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722998|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722999|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723000|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723001|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43723002|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43723003|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723004|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43723005|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723006|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723007|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
43723008|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43723009|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43723010|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43723011|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
43723012|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723013|NCT02612701|Nicotine|nicotine|mesh-list
43723014|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43723015|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
43559510|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43723016|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723017|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723019|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43723020|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
43723021|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723022|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723024|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
43723025|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
43723026|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723027|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723028|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43723029|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43723030|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
43723031|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723032|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723033|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43723034|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43740016|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
43740017|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723035|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43723036|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
43723037|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723038|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43723039|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43723040|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723041|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
43723042|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43723061|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723062|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723064|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723065|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723066|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723067|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723068|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
43723069|NCT02612272|Hormones|hormones|mesh-ancestor
43723070|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43723071|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43723072|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
43723073|NCT02612298|Metoprolol|metoprolol|mesh-list
43723074|NCT02612298|Arotinolol|arotinolol|mesh-list
43723075|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43723076|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43723077|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
43723078|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
43723079|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723080|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723081|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43723082|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43723083|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43723084|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
43723085|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723086|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723107|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43723108|NCT02612233|Analgesics|analgesics|mesh-ancestor
43723109|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
43723110|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723111|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723112|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
43723113|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43723114|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565264|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
43565265|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565266|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565267|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565268|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43565269|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43565270|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565272|NCT00925535|Rifabutin|rifabutin|mesh-list
43723115|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723116|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43723117|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43723118|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43723119|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723120|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43723121|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43723122|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43723123|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723124|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
43723125|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
43723127|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
43723128|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723129|NCT02612207|Protective Agents|protective agents|mesh-ancestor
43723130|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723131|NCT02612116|Ticagrelor|ticagrelor|mesh-list
43723132|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43723133|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43723134|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43723135|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43723136|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
43723137|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723138|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723139|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723140|NCT02611973|Aspirin|aspirin|mesh-list
43723141|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
43723146|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723147|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723148|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723149|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723150|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43723151|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43723152|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723153|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43723154|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723155|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723156|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
43723157|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723158|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
43559513|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
43559514|NCT03712371|Coagulants|coagulants|mesh-ancestor
43559515|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43559516|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43559517|NCT03706521|Lorecivivint|lorecivivint|mesh-list
43559518|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559519|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
43559520|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43559521|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
43559522|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559523|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559524|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43559525|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
43559526|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559530|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559532|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
43559533|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559534|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723159|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43723161|NCT02612220|Coagulants|coagulants|mesh-ancestor
43723162|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43723163|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
43723164|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43723165|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723166|NCT02611921|Ketamine|ketamine|mesh-list
43723167|NCT02611921|Analgesics|analgesics|mesh-ancestor
43723168|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
43723169|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723170|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723171|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43723172|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43723174|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
43723175|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723176|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43723177|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43723178|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723179|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723180|NCT02611700|Paclitaxel|paclitaxel|mesh-list
43723181|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43723182|NCT02611700|Cisplatin|cisplatin|mesh-list
43723183|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
43723184|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43723185|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723186|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
43723187|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
43723188|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
43723189|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723190|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43723191|NCT02611596|Ranolazine|ranolazine|mesh-list
43723192|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43723200|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
43723201|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43723202|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
43723203|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43723204|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
43723205|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723206|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723207|NCT02611804|Diclofenac|diclofenac|mesh-list
43723208|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723209|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723210|NCT02611804|Analgesics|analgesics|mesh-ancestor
43723211|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
43723212|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723214|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723216|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723217|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723218|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723219|NCT02611492|Cytarabine|cytarabine|mesh-list
43723220|NCT02611492|Dexamethasone|dexamethasone|mesh-list
43723221|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43723222|NCT02611492|Methotrexate|methotrexate|mesh-list
43723223|NCT02611492|Vincristine|vincristine|mesh-list
43723224|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
43723225|NCT02611492|Lenograstim|lenograstim|mesh-list
43740030|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43740042|NCT02532153|Ketamine|ketamine|mesh-list
43723226|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723227|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
43723228|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
43723229|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723230|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723231|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43723232|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
43723233|NCT02611492|Hormones|hormones|mesh-ancestor
43723237|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43723238|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
43723239|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43723240|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43723241|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
43723242|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723243|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
43723244|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723245|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43723246|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43723247|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
43723248|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723249|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43723250|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43723251|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
43723252|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
43723253|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
43723254|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43723255|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
43723256|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723258|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43723259|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43723273|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43723274|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43723275|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723276|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723278|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43723279|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723280|NCT02611258|Tadalafil|tadalafil|mesh-list
43723281|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
43723282|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43723283|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43723284|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723285|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723286|NCT02611258|Urological Agents|urological agents|mesh-ancestor
43723287|NCT02611466|Naproxen|naproxen|mesh-list
43723288|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723289|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723290|NCT02611466|Analgesics|analgesics|mesh-ancestor
43723292|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723293|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723294|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723296|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
43723297|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723298|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723299|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723301|NCT02610920|Trace Elements|trace elements|mesh-ancestor
43723302|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
43723303|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723304|NCT02610933|Vitamin K|vitamin k|mesh-list
43723305|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
43723306|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
43723307|NCT02610933|Vitamins|vitamins|mesh-ancestor
43723308|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
43723309|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723310|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43723311|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
43723312|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43723313|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
43723314|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723315|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723316|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
43723317|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43723318|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43723330|NCT02610712|Analgesics|analgesics|mesh-ancestor
43723331|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
43723332|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723333|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723334|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43723335|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43723336|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
43723337|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
43723338|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723339|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43723340|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43723341|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723342|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723343|NCT02610829|Vitamin E|vitamin e|mesh-list
43723344|NCT02610829|Tocopherols|tocopherols|mesh-list
43723345|NCT02610829|Tocotrienols|tocotrienols|mesh-list
43559535|NCT03684278|Infliximab|infliximab|mesh-list
43559536|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
43559537|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43559538|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559539|NCT03676751|Azithromycin|azithromycin|mesh-list
43559540|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43559541|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559542|NCT03662542|Golimumab|golimumab|mesh-list
43559543|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43559544|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43559545|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559546|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43559547|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
43559548|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723346|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
43723347|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
43723349|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
43723350|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723351|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
43723352|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723353|NCT02610829|Protective Agents|protective agents|mesh-ancestor
43723354|NCT02610686|Chloroquine|chloroquine|mesh-list
43723355|NCT02610686|Amebicides|amebicides|mesh-ancestor
43723356|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43723357|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43723358|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723359|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
43723360|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723361|NCT02610647|Anesthetics|anesthetics|mesh-list
43723374|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43723375|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
43723376|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723377|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
43723378|NCT02610504|Protective Agents|protective agents|mesh-ancestor
43833055|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43833056|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
43833057|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833058|NCT05237492|Tramadol|tramadol|mesh-list
43833059|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43833060|NCT05237492|Narcotics|narcotics|mesh-ancestor
43833061|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833062|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833063|NCT05237492|Analgesics|analgesics|mesh-ancestor
43833064|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
43833065|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833066|NCT05237297|Celecoxib|celecoxib|mesh-list
43833067|NCT05237297|Naproxen|naproxen|mesh-list
43833068|NCT05237297|Aceclofenac|aceclofenac|mesh-list
43833069|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43833070|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43833071|NCT05237297|Analgesics|analgesics|mesh-ancestor
43833072|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
43833073|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833074|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833075|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43833076|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43833077|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43833078|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43833079|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833080|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833081|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
43833082|NCT05236543|Itraconazole|itraconazole|mesh-list
43833083|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
43833084|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833085|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43833086|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43833087|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833088|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833089|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43833090|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
43833091|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833092|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833093|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43833094|NCT05236530|Metformin|metformin|mesh-list
43833095|NCT05236530|Repaglinide|repaglinide|mesh-list
43833096|NCT05236530|Dolutegravir|dolutegravir|mesh-list
43833097|NCT05236530|Lumefantrine|lumefantrine|mesh-list
43833098|NCT05236530|Midazolam|midazolam|mesh-list
43833100|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43833101|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43833102|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833103|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43833104|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43833105|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833106|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43833107|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43833108|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43833109|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43833110|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
43833111|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
43833112|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
43833113|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
43833114|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833116|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43833118|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
43833119|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43833120|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43833121|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723379|NCT02610348|Vaccines|vaccines|mesh-list
43723380|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43723381|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
43723382|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723383|NCT02610153|Vitamin K|vitamin k|mesh-list
43723384|NCT02610153|Vitamins|vitamins|mesh-ancestor
43723385|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
43723386|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723387|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43723390|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
43723391|NCT02610153|Coagulants|coagulants|mesh-ancestor
43723392|NCT02610010|Cisplatin|cisplatin|mesh-list
43723393|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723394|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
43723431|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43723432|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43723433|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723434|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
43723435|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
43723436|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723437|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
43723438|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43723439|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
43723440|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
43723441|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723442|NCT02609802|Sevoflurane|sevoflurane|mesh-list
43723444|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43723445|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43723446|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
43723447|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
43723448|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723449|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723450|NCT02609646|Vancomycin|vancomycin|mesh-list
43723451|NCT02609646|Meropenem|meropenem|mesh-list
43723452|NCT02609646|Tazobactam|tazobactam|mesh-list
43723453|NCT02609646|Linezolid|linezolid|mesh-list
43723454|NCT02609646|Piperacillin|piperacillin|mesh-list
43723455|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43723456|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43723457|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723458|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43723459|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723460|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723461|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43723462|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
43723463|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723464|NCT02609490|Olmesartan|olmesartan|mesh-list
43723465|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43723466|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43723467|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43723468|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43723471|NCT02609711|Candesartan|candesartan|mesh-list
43723472|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
43723473|NCT02609711|Atorvastatin|atorvastatin|mesh-list
43723474|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43723475|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43723476|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
43565319|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565320|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43565321|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565322|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565323|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565324|NCT00917293|Pyridoxal|pyridoxal|mesh-list
43740048|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43740049|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
43740050|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
43740051|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723477|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723478|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43723479|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43723480|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723481|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43723482|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43723483|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43723484|NCT02609698|Aspirin|aspirin|mesh-list
43723485|NCT02609698|Clopidogrel|clopidogrel|mesh-list
43723486|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723487|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723488|NCT02609698|Analgesics|analgesics|mesh-ancestor
43723489|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
43723490|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723491|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723492|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723493|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723494|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43723495|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43723496|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723497|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43723498|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723499|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723501|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43723502|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43723503|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43723504|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
43723505|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723506|NCT02609477|Phentermine|phentermine|mesh-list
43723507|NCT02609477|Istradefylline|istradefylline|mesh-list
43723508|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43723509|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723510|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
43723511|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43723512|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
43723520|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43723521|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
43723522|NCT02609386|Zinc|zinc|mesh-list
43723523|NCT02609386|Indomethacin|indomethacin|mesh-list
43723524|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
43723525|NCT02609386|Omeprazole|omeprazole|mesh-list
43723526|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43723527|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43723528|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
43723529|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723530|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723531|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43723532|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
43723533|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723534|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723535|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43723537|NCT02609386|Trace Elements|trace elements|mesh-ancestor
43723538|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43723539|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43723540|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723541|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723542|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723543|NCT02609386|Analgesics|analgesics|mesh-ancestor
43723544|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
43723545|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723546|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723547|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
43723548|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
43740052|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43723552|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723554|NCT02609087|Sevoflurane|sevoflurane|mesh-list
43723555|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43723556|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723557|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723558|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43723559|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
43723560|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
43723561|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43723562|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43723563|NCT02608944|Adenosine|adenosine|mesh-list
43723564|NCT02608944|Regadenoson|regadenoson|mesh-list
43723565|NCT02608944|Analgesics|analgesics|mesh-ancestor
43723566|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
43723567|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723568|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723569|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43723570|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
43723571|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43723572|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
43723573|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
43723574|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723575|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723576|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43723577|NCT02609152|Esmolol|esmolol|mesh-list
43723608|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
43723609|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723610|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43723611|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43723612|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723613|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723614|NCT02608931|Hormones|hormones|mesh-ancestor
43723615|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43723616|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43723617|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43723618|NCT02608710|Verinurad|verinurad|mesh-list
43723619|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
43723620|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723621|NCT02608736|Valproic Acid|valproic acid|mesh-list
43723622|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
43723625|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
43723643|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723644|NCT02608619|Choline|choline|mesh-list
43723645|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
43723655|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
43723656|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723657|NCT02608606|Tacrolimus|tacrolimus|mesh-list
43723658|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43723659|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
43723660|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723661|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43723662|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723663|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833122|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43833123|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43833124|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43833125|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43833126|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
43833127|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833128|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
43833129|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43833130|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43833131|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
43833132|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
43833133|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43833134|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43833135|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
43833137|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43833147|NCT05235542|Paclitaxel|paclitaxel|mesh-list
43833160|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
43833161|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43833162|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43833163|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833164|NCT05235516|Cisplatin|cisplatin|mesh-list
43833165|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723665|NCT02608437|Guadecitabine|guadecitabine|mesh-list
43723666|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43723667|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723668|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43723669|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723670|NCT02608242|Amlodipine|amlodipine|mesh-list
43723671|NCT02608242|Telmisartan|telmisartan|mesh-list
43723672|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43723673|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43723674|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43723685|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43723686|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723687|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43723688|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43723689|NCT02608320|Fentanyl|fentanyl|mesh-list
43723690|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43723691|NCT02608320|Narcotics|narcotics|mesh-ancestor
43723692|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723693|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723694|NCT02608320|Analgesics|analgesics|mesh-ancestor
43723695|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
43723696|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723697|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43723698|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43723699|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
43723700|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
43723701|NCT02608164|Vitamin D|vitamin d|mesh-list
43723702|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
43723703|NCT02608164|Vitamins|vitamins|mesh-ancestor
43723704|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
43723705|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723724|NCT02607943|Insulin|insulin|mesh-list
43723739|NCT02608034|Vemurafenib|vemurafenib|mesh-list
43723740|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
43723741|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723742|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43723743|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43723744|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723745|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723746|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43723747|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
43723748|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43723749|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723750|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43723751|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43723752|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
43723753|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43723754|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
43565331|NCT00914602|Carbidopa|carbidopa|mesh-list
43565333|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43723755|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43723756|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43723757|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43723758|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43723759|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43723760|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43723761|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43723762|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723763|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43723765|NCT02608073|Capecitabine|capecitabine|mesh-list
43723766|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723767|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43723768|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
43723769|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723770|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
43723771|NCT02608060|Hematinics|hematinics|mesh-ancestor
43723777|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
43723778|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43723779|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723780|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43723782|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
43723783|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43723784|NCT02607696|Zolpidem|zolpidem|mesh-list
43723785|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43723786|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43723787|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723788|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723789|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43723790|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
43723791|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
43723792|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723793|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723794|NCT02607774|Midazolam|midazolam|mesh-list
43723795|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43723796|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43723797|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723798|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723799|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43723800|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43723801|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43723802|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43723803|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
43723804|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
43723805|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
43723806|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
43723807|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723808|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723818|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723819|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
43723820|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723821|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43723822|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43723823|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
43723826|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43723827|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43723828|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
43723829|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
43723830|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
43723831|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
43723832|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43723833|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43723834|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723835|NCT02607410|Incretins|incretins|mesh-ancestor
43723836|NCT02607410|Hormones|hormones|mesh-ancestor
43723837|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43723838|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
43723839|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723840|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723841|NCT02607436|Aspirin|aspirin|mesh-list
43723842|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
43723843|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723844|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723845|NCT02607436|Analgesics|analgesics|mesh-ancestor
43723846|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
43723847|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723848|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723849|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723850|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723851|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43723853|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723854|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43723855|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723856|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723858|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43723859|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
43723860|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723861|NCT02607592|Cisplatin|cisplatin|mesh-list
43723862|NCT02607592|Pemetrexed|pemetrexed|mesh-list
43723863|NCT02607592|Nedaplatin|nedaplatin|mesh-list
43723864|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723865|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723866|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723867|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43723868|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43723869|NCT02607488|Lidocaine|lidocaine|mesh-list
43723870|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
43723871|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
43723872|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723873|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723874|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
43723875|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723876|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43723877|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43723878|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43723879|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43723880|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723881|NCT02607423|Gemcitabine|gemcitabine|mesh-list
43723882|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
43723897|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
43723898|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
43723899|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
43723900|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43723901|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43723902|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43723903|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43723904|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43723906|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43723907|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723908|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
43723910|NCT02607371|Edoxaban|edoxaban|mesh-list
43723911|NCT02607371|Dabigatran|dabigatran|mesh-list
43723912|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43723913|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
43740077|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723914|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43723915|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
43723916|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723925|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723926|NCT02607072|Aspirin|aspirin|mesh-list
43723927|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723958|NCT02607202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723960|NCT02607111|Tinzaparin|tinzaparin|mesh-list
43723961|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43723962|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
43723963|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43723964|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43723965|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723966|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
43723967|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43723968|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723969|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723970|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723971|NCT02607163|Analgesics|analgesics|mesh-ancestor
43723972|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
43723973|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723974|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43723975|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43723976|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43723977|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
43723979|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723980|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
43723981|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
43723982|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723983|NCT02606773|Protective Agents|protective agents|mesh-ancestor
43723984|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723985|NCT02606773|Vitamins|vitamins|mesh-ancestor
43723986|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
43723987|NCT02606864|Nifurtimox|nifurtimox|mesh-list
43724001|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43724002|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43724003|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43724004|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724005|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43724006|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43724007|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
43724008|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
43724009|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43724010|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43724011|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
43724012|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
43724013|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724014|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43724016|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
43724017|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
43724018|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724019|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
43724020|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724021|NCT02606981|Protective Agents|protective agents|mesh-ancestor
43724022|NCT02606617|Mosapride|mosapride|mesh-list
43724023|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43724024|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43724025|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
43724026|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724027|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724028|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724029|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
43724030|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43724031|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724032|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
43724034|NCT02606409|Propofol|propofol|mesh-list
43724035|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43724036|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724037|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724038|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43724039|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
43724040|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
43724041|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724042|NCT02606409|Analgesics|analgesics|mesh-ancestor
43724043|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
43724044|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724045|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43724046|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43724047|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43724048|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
43724049|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724050|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833180|NCT05232994|Metformin|metformin|mesh-list
43833181|NCT05232994|Esomeprazole|esomeprazole|mesh-list
43833182|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43833183|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833184|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43833185|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43833186|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43833187|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833189|NCT05231694|Mitogens|mitogens|mesh-list
43724059|NCT02606552|Clopidogrel|clopidogrel|mesh-list
43724060|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724061|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724062|NCT02606552|Analgesics|analgesics|mesh-ancestor
43724063|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
43724064|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724065|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724066|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724068|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43724069|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43724070|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724071|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43724072|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724073|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724074|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
43724075|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43724076|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43724077|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43724078|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
43724079|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724111|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724113|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
43724114|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724115|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724116|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43724117|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
43724118|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43724119|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724120|NCT02606266|Valganciclovir|valganciclovir|mesh-list
43724121|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
43724124|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
43724125|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43724126|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
43724128|NCT02605915|Docetaxel|docetaxel|mesh-list
43724129|NCT02605915|Doxorubicin|doxorubicin|mesh-list
43724130|NCT02605915|Trastuzumab|trastuzumab|mesh-list
43724131|NCT02605915|Atezolizumab|atezolizumab|mesh-list
43724132|NCT02605915|Pertuzumab|pertuzumab|mesh-list
43724133|NCT02605915|Maytansine|maytansine|mesh-list
43724134|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43724135|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43724136|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
43724137|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724138|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724139|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43724140|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
43724141|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724142|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724143|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43724144|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
43724145|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
43724146|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
43559550|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43724147|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43724148|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43724149|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43724150|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724151|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43724152|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43724153|NCT02606032|Metronidazole|metronidazole|mesh-list
43724154|NCT02606032|Doxycycline|doxycycline|mesh-list
43724155|NCT02606032|Terbinafine|terbinafine|mesh-list
43724156|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724157|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43724158|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43724159|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43724160|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
43724161|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
43724162|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724163|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724164|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
43724165|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
43724166|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724167|NCT02605746|Ceritinib|ceritinib|mesh-list
43724168|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724169|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43724170|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724171|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724172|NCT02605772|Metformin|metformin|mesh-list
43724175|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43724176|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724177|NCT02605772|Incretins|incretins|mesh-ancestor
43724178|NCT02605772|Hormones|hormones|mesh-ancestor
43724179|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724180|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43724181|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
43724182|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724183|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724184|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43724186|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43724187|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
43724188|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724189|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724190|NCT02605460|Plerixafor|plerixafor|mesh-list
43724191|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
43724192|NCT02605460|Busulfan|busulfan|mesh-list
43724193|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43724194|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
43724195|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724196|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724197|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43724198|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
43724201|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43724202|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43724203|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43724204|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
43724205|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724206|NCT02605720|Piperaquine|piperaquine|mesh-list
43724207|NCT02605720|Artenimol|artenimol|mesh-list
43724208|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
43724209|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43724210|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43724211|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724212|NCT02605694|Prednisone|prednisone|mesh-list
43724213|NCT02605694|Rituximab|rituximab|mesh-list
43724226|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43724227|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43724228|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43724230|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724231|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724232|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724233|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43724234|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724235|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43724236|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
43724237|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
43724238|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
43724239|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43724240|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43724241|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724242|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
43724243|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
43724244|NCT02605356|Dexamethasone|dexamethasone|mesh-list
43724245|NCT02605356|Bortezomib|bortezomib|mesh-list
43724246|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43724247|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724248|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
43724249|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
43724250|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724276|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724277|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43833192|NCT05230758|Metformin|metformin|mesh-list
43724278|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43724279|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724280|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724281|NCT02604992|Hormones|hormones|mesh-ancestor
43724282|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724285|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724286|NCT02604966|Artesunate|artesunate|mesh-list
43724287|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
43724288|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43724289|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43724290|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724291|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724292|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
43724293|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
43724294|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43724295|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
43724296|NCT02605265|Capecitabine|capecitabine|mesh-list
43724297|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
43724298|NCT02605265|Irinotecan|irinotecan|mesh-list
43724299|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43724300|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
43724301|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724303|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43724304|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43724305|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724306|NCT02604914|Levodopa|levodopa|mesh-list
43724307|NCT02604914|Carbidopa|carbidopa|mesh-list
43724308|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43724309|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43724310|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43724311|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
43724312|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724313|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724314|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724315|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43565347|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43724316|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724317|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43724318|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
43724319|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
43724320|NCT02604849|Gentamicins|gentamicins|mesh-list
43724321|NCT02604849|Neomycin|neomycin|mesh-list
43724322|NCT02604849|Streptomycin|streptomycin|mesh-list
43724323|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43724324|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724325|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43724326|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724327|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724328|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
43724329|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43724330|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724331|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724332|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724333|NCT02604940|Analgesics|analgesics|mesh-ancestor
43724334|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
43724335|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724336|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43724337|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43724338|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43724339|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
43724340|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724341|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833232|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833233|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833234|NCT05225155|Enoxaparin|enoxaparin|mesh-list
43833235|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
43833236|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43833237|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43833238|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833239|NCT05222984|Decitabine|decitabine|mesh-list
43833240|NCT05222984|Venetoclax|venetoclax|mesh-list
43833241|NCT05222984|Navitoclax|navitoclax|mesh-list
43833242|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43833243|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
43833244|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833245|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833246|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833247|NCT05222165|Infigratinib|infigratinib|mesh-list
43833248|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833249|NCT05221749|Fluorides|fluorides|mesh-list
43833250|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
43833251|NCT05221749|Protective Agents|protective agents|mesh-ancestor
43833252|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833253|NCT05221658|Cisplatin|cisplatin|mesh-list
43833254|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833255|NCT05221554|Tacrine|tacrine|mesh-list
43833256|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43833257|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724344|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
43740126|NCT02531451|Aspirin|aspirin|mesh-list
43724345|NCT02604719|Ethamsylate|ethamsylate|mesh-list
43724349|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
43724354|NCT02604797|Dsuvia|dsuvia|mesh-list
43724355|NCT02604797|Nalbuphine|nalbuphine|mesh-list
43724356|NCT02604797|Ramosetron|ramosetron|mesh-list
43724357|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43724358|NCT02604797|Narcotics|narcotics|mesh-ancestor
43724359|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724360|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724361|NCT02604797|Analgesics|analgesics|mesh-ancestor
43724362|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
43724363|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724364|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43724365|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43724366|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
43724367|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
43724371|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724418|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43724419|NCT02604420|Eculizumab|eculizumab|mesh-list
43724420|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43724421|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43724422|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
43724423|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724425|NCT02604459|Anesthetics|anesthetics|mesh-list
43724426|NCT02604459|Propofol|propofol|mesh-list
43724427|NCT02604459|Sevoflurane|sevoflurane|mesh-list
43724428|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724429|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724430|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43724431|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43724432|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
43724433|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43724434|NCT02604459|Narcotics|narcotics|mesh-ancestor
43724435|NCT02604459|Analgesics|analgesics|mesh-ancestor
43724436|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
43740134|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724437|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724438|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43724439|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43740143|NCT02531529|Fentanyl|fentanyl|mesh-list
43724440|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43724441|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
43724442|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43724443|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
43724444|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
43724445|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724486|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
43724487|NCT02603757|Vitamins|vitamins|mesh-ancestor
43724488|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
43724489|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724490|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43724491|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43724492|NCT02603822|Indomethacin|indomethacin|mesh-list
43724493|NCT02603822|Mannitol|mannitol|mesh-list
43724494|NCT02603822|Lactulose|lactulose|mesh-list
43724495|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43724496|NCT02603822|Diuretics|diuretics|mesh-ancestor
43724497|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
43724498|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724499|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724500|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724501|NCT02603822|Analgesics|analgesics|mesh-ancestor
43724502|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
43724503|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724504|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724505|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724506|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
43724507|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
43724508|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43724509|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724510|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724511|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724512|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43724513|NCT02603861|Modafinil|modafinil|mesh-list
43724514|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43724520|NCT02603783|Capsaicin|capsaicin|mesh-list
43724532|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724533|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43724534|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43724535|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724536|NCT02603991|Levetiracetam|levetiracetam|mesh-list
43724537|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
43724538|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
43724539|NCT02603705|Oxycodone|oxycodone|mesh-list
43724540|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43724541|NCT02603705|Narcotics|narcotics|mesh-ancestor
43724542|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724543|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724544|NCT02603705|Analgesics|analgesics|mesh-ancestor
43565411|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
43724545|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
43724546|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724547|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
43724548|NCT02603406|Hematinics|hematinics|mesh-ancestor
43724549|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
43724550|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43724551|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724552|NCT02603575|Caspofungin|caspofungin|mesh-list
43724553|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
43724554|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
43724555|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
43724556|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724557|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
43724558|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
43724559|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724560|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724561|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43724562|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
43724563|NCT02603575|Hormones|hormones|mesh-ancestor
43724564|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724565|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43724566|NCT02603575|Protective Agents|protective agents|mesh-ancestor
43724573|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724574|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724575|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724576|NCT02603679|Tamoxifen|tamoxifen|mesh-list
43724577|NCT02603679|Paclitaxel|paclitaxel|mesh-list
43724578|NCT02603679|Letrozole|letrozole|mesh-list
43724579|NCT02603679|Palbociclib|palbociclib|mesh-list
43724580|NCT02603679|Anastrozole|anastrozole|mesh-list
43724581|NCT02603679|Exemestane|exemestane|mesh-list
43724582|NCT02603679|Goserelin|goserelin|mesh-list
43724583|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43724584|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43724585|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724586|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
43724587|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
43724588|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
43724589|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565433|NCT00905567|Topiramate|topiramate|mesh-list
43724590|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43724591|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724592|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43724593|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
43562917|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724599|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43724600|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43724602|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724603|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724604|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43724605|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
43724606|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724608|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
43724615|NCT02603159|Capecitabine|capecitabine|mesh-list
43724616|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43724617|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
43724618|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724619|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724620|NCT02603003|Cisplatin|cisplatin|mesh-list
43724621|NCT02603003|Pemetrexed|pemetrexed|mesh-list
43724622|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724623|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565509|NCT00892203|Sumatriptan|sumatriptan|mesh-list
43565510|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43724624|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724625|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43724626|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43724628|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724629|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724630|NCT02603081|Analgesics|analgesics|mesh-ancestor
43724631|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
43724632|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724633|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724634|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724635|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724636|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43724637|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43724638|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
43724639|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724640|NCT02603081|Protective Agents|protective agents|mesh-ancestor
43724641|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724642|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724643|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43724644|NCT02603276|Red yeast rice|red yeast rice|mesh-list
43724645|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43724659|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724660|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724661|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43724662|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43724663|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724664|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43724665|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724666|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724667|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
43559563|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559564|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43559565|NCT03653026|Upadacitinib|upadacitinib|mesh-list
43559566|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43559567|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43559568|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559569|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559570|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559571|NCT03647592|Bevacizumab|bevacizumab|mesh-list
43559572|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43559573|NCT03647592|Gefitinib|gefitinib|mesh-list
43565561|NCT00890149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43559574|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43559575|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559576|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43559577|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43559578|NCT03647592|Growth Substances|growth substances|mesh-ancestor
43559579|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559580|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
43559581|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43559582|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559583|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833258|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833259|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
43833260|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833261|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833262|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43833263|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
43833264|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833265|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
43833266|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
43833267|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43833268|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847502|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847503|NCT04099888|Antiviral Agents|antiviral agents|mesh-ancestor
43847504|NCT04099888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847505|NCT04099888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847506|NCT04099888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847507|NCT04099888|Immunologic Factors|immunologic factors|mesh-ancestor
43847508|NCT04099888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847509|NCT04098718|Prednisolone|prednisolone|mesh-list
43847510|NCT04098718|Benralizumab|benralizumab|mesh-list
43847511|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847512|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
43847513|NCT04098718|Hormones|hormones|mesh-ancestor
43847515|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724668|NCT02603198|Epinephrine|epinephrine|mesh-list
43724669|NCT02603198|Nordefrin|nordefrin|mesh-list
43724670|NCT02603198|Anesthetics|anesthetics|mesh-list
43724671|NCT02603198|Mepivacaine|mepivacaine|mesh-list
43724672|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724673|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724674|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43724675|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43724676|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
43724677|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724678|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724679|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43740243|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43724680|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43724681|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
43724682|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724683|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43724684|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
43724685|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
43724686|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
43724687|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43724688|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
43724689|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
43724690|NCT02603055|Vaccines|vaccines|mesh-list
43724691|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
43724692|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724693|NCT02602860|Levetiracetam|levetiracetam|mesh-list
43724694|NCT02602860|Brivaracetam|brivaracetam|mesh-list
43724695|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
43565602|NCT00886600|Diuretics|diuretics|mesh-ancestor
43724696|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
43724697|NCT02602743|Ketamine|ketamine|mesh-list
43724698|NCT02602743|Remifentanil|remifentanil|mesh-list
43724699|NCT02602743|Propofol|propofol|mesh-list
43724700|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43724701|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724702|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724705|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
43724717|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
43724718|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724719|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
43724720|NCT02602704|Calcium|calcium|mesh-list
43724721|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43724722|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724723|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43724724|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43724725|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
43724726|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724727|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43724728|NCT02602600|Liraglutide|liraglutide|mesh-list
43724729|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43724730|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724731|NCT02602600|Incretins|incretins|mesh-ancestor
43724732|NCT02602600|Hormones|hormones|mesh-ancestor
43565657|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740297|NCT02530879|Omeprazole|omeprazole|mesh-list
43724733|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724734|NCT02602444|Ticagrelor|ticagrelor|mesh-list
43724735|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43724736|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43724737|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43724738|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43724739|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
43724740|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724741|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724742|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724744|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
43724748|NCT02602509|Analgesics|analgesics|mesh-ancestor
43724749|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
43724753|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724755|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724756|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724757|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724758|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43724759|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
43724760|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43724761|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724762|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
43724763|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43724764|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43724765|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43724766|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43724767|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43724768|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43724769|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43724770|NCT02602470|Metronidazole|metronidazole|mesh-list
43724771|NCT02602470|Azelaic acid|azelaic acid|mesh-list
43724772|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43565749|NCT00870454|Pregabalin|pregabalin|mesh-list
43724773|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724774|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43724775|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43724776|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43724777|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43724778|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43724779|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43724780|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43724781|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
43724782|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724783|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724784|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724785|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724786|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
43559584|NCT03647111|Crizotinib|crizotinib|mesh-list
43724787|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
43724788|NCT02602483|Ibuprofen|ibuprofen|mesh-list
43724789|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724790|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724791|NCT02602483|Analgesics|analgesics|mesh-ancestor
43724792|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
43724793|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724794|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724795|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724796|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724797|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724798|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724799|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724800|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
43724801|NCT02602483|Protective Agents|protective agents|mesh-ancestor
43724802|NCT02602483|Vitamins|vitamins|mesh-ancestor
43724803|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
43724804|NCT02602197|Acetaminophen|acetaminophen|mesh-list
43724805|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43724806|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724807|NCT02602197|Analgesics|analgesics|mesh-ancestor
43724808|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
43724809|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724810|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724812|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724813|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724814|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724815|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
43724834|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724835|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724836|NCT02601989|Urological Agents|urological agents|mesh-ancestor
43724837|NCT02602028|Colchicine|colchicine|mesh-list
43724838|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
43724839|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724840|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
43740344|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724841|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
43724842|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
43724843|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724844|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724845|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
43724846|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
43724847|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43724848|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724849|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724850|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
43724851|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43724852|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724853|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724888|NCT02601898|Vitamins|vitamins|mesh-ancestor
43724889|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
43724890|NCT02601677|Fluoxetine|fluoxetine|mesh-list
43724891|NCT02601677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43724892|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43724893|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43724894|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724895|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724896|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
43724897|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724898|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43724899|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
43724900|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43724901|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43724902|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43724903|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724904|NCT02601703|Tacrolimus|tacrolimus|mesh-list
43724905|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43724906|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
43724907|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724908|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43740381|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43724909|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724910|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724911|NCT02601651|Lidocaine|lidocaine|mesh-list
43724912|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
43724913|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
43724914|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724915|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724916|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
43724917|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724918|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43724919|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43724920|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43724921|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43724923|NCT02601508|Rocuronium|rocuronium|mesh-list
43724925|NCT02601508|Cisatracurium|cisatracurium|mesh-list
43724926|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43724927|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43724928|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43724929|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724930|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724931|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43724932|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43724933|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
43724934|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724939|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724940|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724942|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43724950|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43724951|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724953|NCT02601157|Clopidogrel|clopidogrel|mesh-list
43724954|NCT02601157|Ticagrelor|ticagrelor|mesh-list
43724955|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43724956|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724957|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724958|NCT02601157|Analgesics|analgesics|mesh-ancestor
43724959|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
43724960|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724961|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724962|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724963|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724964|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43724965|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43724966|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724967|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43724968|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724969|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724970|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
43724971|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43724972|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43724976|NCT02601040|Vaccines|vaccines|mesh-list
43833288|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
43833289|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43833291|NCT05218889|Paclitaxel|paclitaxel|mesh-list
43833292|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43833293|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43833294|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833295|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
43833296|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
43833297|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
43833298|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833299|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43833300|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
43833301|NCT05218889|Antiviral Agents|antiviral agents|mesh-ancestor
43833302|NCT05218889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833303|NCT05218889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833304|NCT05218889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43833305|NCT05218889|Immunologic Factors|immunologic factors|mesh-ancestor
43725017|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725018|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43725019|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43725020|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43725021|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43725022|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725023|NCT02600806|Azithromycin|azithromycin|mesh-list
43725024|NCT02600806|Levofloxacin|levofloxacin|mesh-list
43725025|NCT02600806|Ofloxacin|ofloxacin|mesh-list
43725026|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43725027|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725028|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43725029|NCT02600806|Renal Agents|renal agents|mesh-ancestor
43725030|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43725031|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43725032|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725033|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725034|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725035|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43725036|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43725037|NCT02600780|Allopurinol|allopurinol|mesh-list
43725038|NCT02600780|Febuxostat|febuxostat|mesh-list
43725039|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
43725040|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725041|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559588|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559589|NCT03646994|Crizotinib|crizotinib|mesh-list
43559590|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559591|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43740411|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559592|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559593|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559594|NCT03646968|Docetaxel|docetaxel|mesh-list
43559595|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725042|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
43725043|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725044|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43725045|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
43725046|NCT02600780|Protective Agents|protective agents|mesh-ancestor
43725047|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725048|NCT02600741|Droperidol|droperidol|mesh-list
43725049|NCT02600741|Haloperidol|haloperidol|mesh-list
43725050|NCT02600741|Pimozide|pimozide|mesh-list
43725051|NCT02600741|Olanzapine|olanzapine|mesh-list
43725052|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
43725053|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
43725054|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
43725055|NCT02600741|Risperidone|risperidone|mesh-list
43725056|NCT02600741|Aripiprazole|aripiprazole|mesh-list
43725057|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43725058|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43725059|NCT02600741|Ziprasidone|ziprasidone|mesh-list
43725060|NCT02600741|Clozapine|clozapine|mesh-list
43725061|NCT02600741|Asenapine|asenapine|mesh-list
43725062|NCT02600741|Loxapine|loxapine|mesh-list
43725063|NCT02600741|Iloperidone|iloperidone|mesh-list
43725064|NCT02600741|Perphenazine|perphenazine|mesh-list
43725065|NCT02600741|Fluphenazine|fluphenazine|mesh-list
43725066|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
43725067|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
43725068|NCT02600741|Thioridazine|thioridazine|mesh-list
43725069|NCT02600741|Thiothixene|thiothixene|mesh-list
43725070|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43725071|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
43725072|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725073|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725074|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725075|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43725076|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43725078|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43725090|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43725091|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43725092|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43725093|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43725094|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43725095|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
43725096|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
43725097|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43725098|NCT02600650|Testosterone|testosterone|mesh-list
43725099|NCT02600650|Androgens|androgens|mesh-ancestor
43725100|NCT02600650|Hormones|hormones|mesh-ancestor
43725101|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43725102|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725103|NCT02600585|Vaccines|vaccines|mesh-list
43725104|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
43740450|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725105|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725106|NCT02600455|Abatacept|abatacept|mesh-list
43725107|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43725108|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725112|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725113|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725114|NCT02600468|Abatacept|abatacept|mesh-list
43725115|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43725116|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725117|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725118|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725120|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725121|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725123|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43725124|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
43725125|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725126|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725127|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43725128|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43725129|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
43725130|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725131|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725132|NCT02600247|Acetaminophen|acetaminophen|mesh-list
43725133|NCT02600247|Celecoxib|celecoxib|mesh-list
43725134|NCT02600247|Pregabalin|pregabalin|mesh-list
43725135|NCT02600247|Oxycodone|oxycodone|mesh-list
43725136|NCT02600247|Tramadol|tramadol|mesh-list
43725137|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43725138|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43725139|NCT02600247|Analgesics|analgesics|mesh-ancestor
43725140|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
43725141|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725142|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725143|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
43725144|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
43725145|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43725146|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725147|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725148|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43725149|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43725164|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
43725165|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
43725166|NCT02600260|Enoxaparin|enoxaparin|mesh-list
43725167|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
43725168|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
43725169|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43725170|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43725171|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725172|NCT02599701|Gabapentin|gabapentin|mesh-list
43725173|NCT02599701|Analgesics|analgesics|mesh-ancestor
43725174|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
43725175|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725176|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725177|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
43725178|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43725179|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43725180|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725181|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43725182|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43725196|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725197|NCT02599857|Bisoprolol|bisoprolol|mesh-list
43725198|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43725228|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
43725229|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725230|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725231|NCT02599623|Anesthetics|anesthetics|mesh-list
43725232|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725233|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725234|NCT02599493|Rifampin|rifampin|mesh-list
43725235|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43725236|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
43725237|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43725238|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725239|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
43725240|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43725241|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725242|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725243|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43725244|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43725245|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43725246|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43725247|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43725248|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43833308|NCT05218603|Daratumumab|daratumumab|mesh-list
43833309|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833310|NCT05218486|Isotretinoin|isotretinoin|mesh-list
43833311|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
43833312|NCT05217680|Bevacizumab|bevacizumab|mesh-list
43833313|NCT05217680|Ranibizumab|ranibizumab|mesh-list
43833314|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43725249|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43725250|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43725251|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43725252|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
43725253|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559596|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725254|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725255|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725256|NCT02599311|Urological Agents|urological agents|mesh-ancestor
43725258|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43725259|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43725260|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43725261|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
43725262|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725263|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725264|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725265|NCT02599480|Urological Agents|urological agents|mesh-ancestor
43725266|NCT02599337|Sorafenib|sorafenib|mesh-list
43725267|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725268|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43725269|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725270|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725271|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
43725272|NCT02599168|Propofol|propofol|mesh-list
43725273|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43725278|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
43725306|NCT02598830|Vitamins|vitamins|mesh-ancestor
43725307|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
43725308|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725309|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43725310|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43725311|NCT02599090|Temozolomide|temozolomide|mesh-list
43725312|NCT02599090|Sorafenib|sorafenib|mesh-list
43725313|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43725314|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
43725315|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725316|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725317|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43725318|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725319|NCT02598856|Naloxone|naloxone|mesh-list
43725320|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43725321|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725322|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
43725323|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725324|NCT02598869|Triamcinolone|triamcinolone|mesh-list
43725325|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43725326|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43725327|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43725328|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43725329|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
43725330|NCT02598869|Hormones|hormones|mesh-ancestor
43725331|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43725332|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725333|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725334|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
43725335|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725336|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725337|NCT02598596|Azathioprine|azathioprine|mesh-list
43725338|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
43725339|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725340|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43559597|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725341|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725342|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725343|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
43725344|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725345|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725357|NCT02598635|Vitamins|vitamins|mesh-ancestor
43725358|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
43725359|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43725360|NCT02598687|Paclitaxel|paclitaxel|mesh-list
43725361|NCT02598687|Carboplatin|carboplatin|mesh-list
43725362|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43725363|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725364|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725365|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725366|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
43725367|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725368|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
43725369|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43725370|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725371|NCT02598466|Abatacept|abatacept|mesh-list
43725372|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43725373|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725374|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725375|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725376|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
43725378|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725401|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43725402|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725403|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43725404|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43725405|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725406|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725407|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725408|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43725409|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43725410|NCT02598102|Diclofenac|diclofenac|mesh-list
43725411|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43725412|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43725413|NCT02598102|Analgesics|analgesics|mesh-ancestor
43725414|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
43725415|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725416|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725417|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43725418|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725419|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43725420|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725421|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725422|NCT02597998|BI 409306|bi 409306|mesh-list
43725423|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43725449|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725450|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
43725451|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725452|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725455|NCT02597699|Remifentanil|remifentanil|mesh-list
43725456|NCT02597699|Dsuvia|dsuvia|mesh-list
43725457|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
43725458|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
43725459|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725460|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725461|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
43725462|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725463|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43725464|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43725465|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43725466|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725467|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725468|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43725469|NCT02597699|Narcotics|narcotics|mesh-ancestor
43725470|NCT02597699|Analgesics|analgesics|mesh-ancestor
43725471|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43725472|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43833330|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43833331|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
43833332|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725486|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
43725487|NCT02597387|Analgesics|analgesics|mesh-ancestor
43725488|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
43725489|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725490|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725491|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725492|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43725493|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43725494|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725495|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725497|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43725498|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725500|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43725501|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43725502|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43725503|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725504|NCT02597283|Sirolimus|sirolimus|mesh-list
43725505|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43725506|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725507|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43725530|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
43725531|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725532|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725533|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
43725534|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725535|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43725536|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43725537|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43725538|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725539|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725540|NCT02597140|Lidocaine|lidocaine|mesh-list
43725541|NCT02597140|Propofol|propofol|mesh-list
43725542|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
43565885|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725543|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
43725544|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725545|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725546|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
43725547|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725548|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43725549|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43725622|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725623|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725624|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725625|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43725626|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43725627|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
43725628|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725629|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43725630|NCT02596776|Protective Agents|protective agents|mesh-ancestor
43725632|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43725633|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725634|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43725635|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725636|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43725637|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
43725638|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
43725639|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725640|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725641|NCT02596555|Dabigatran|dabigatran|mesh-list
43725642|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
43725643|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43725644|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
43725645|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559598|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
43725647|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
43725648|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
43725649|NCT02596373|Analgesics|analgesics|mesh-ancestor
43725650|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
43725651|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725652|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725653|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725654|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43725655|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43725656|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740514|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740516|NCT02529683|NuvaRing|nuvaring|mesh-list
43725657|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725658|NCT02596282|Anesthetics|anesthetics|mesh-list
43725659|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725660|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725661|NCT02596334|Lamivudine|lamivudine|mesh-list
43725662|NCT02596334|Abacavir|abacavir|mesh-list
43725663|NCT02596334|Dolutegravir|dolutegravir|mesh-list
43725664|NCT02596334|Triumeq|triumeq|mesh-list
43725665|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43725666|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43725667|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725668|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725669|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
43725670|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725671|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43725672|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43725673|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43725674|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43725675|NCT02596100|Betrixaban|betrixaban|mesh-list
43725676|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43725677|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
43725678|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43725679|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
43725680|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725681|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725682|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
43725687|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
43725688|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725690|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43725691|NCT02596269|Analgesics|analgesics|mesh-ancestor
43725692|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
43725693|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725694|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725695|NCT02596256|Docetaxel|docetaxel|mesh-list
43725696|NCT02596256|Apatinib|apatinib|mesh-list
43725698|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725699|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725700|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
43725701|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725702|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43725703|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725704|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
43725705|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43725706|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725707|NCT02595918|Nivolumab|nivolumab|mesh-list
43725708|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43725709|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725710|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43725711|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725712|NCT02595840|Pemetrexed|pemetrexed|mesh-list
43725713|NCT02595840|Afatinib|afatinib|mesh-list
43725714|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725715|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725716|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725717|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43725718|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43725719|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43725720|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
43725721|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43559602|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559603|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559604|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43725722|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
43725723|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725724|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
43725725|NCT02595606|Protective Agents|protective agents|mesh-ancestor
43725727|NCT02595554|Cisplatin|cisplatin|mesh-list
43725728|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43725729|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725730|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725731|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
43833381|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833382|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833383|NCT05214573|Incretins|incretins|mesh-ancestor
43833384|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
43833385|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833386|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833387|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43833388|NCT05214287|Nitrox|nitrox|mesh-list
43833389|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43833390|NCT05214287|Protective Agents|protective agents|mesh-ancestor
43833391|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833392|NCT05214001|Almotriptan|almotriptan|mesh-list
43725742|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
43725743|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43725744|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725745|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43725746|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43725747|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725748|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725750|NCT02595463|Lidocaine|lidocaine|mesh-list
43725751|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
43725752|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
43725753|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725754|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725755|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
43725756|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725757|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43725823|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725824|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725825|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43725826|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
43725827|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725828|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725829|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43725830|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43725831|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
43725832|NCT02595242|Hormones|hormones|mesh-ancestor
43725833|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43725834|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43725835|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43725836|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725837|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725838|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
43835163|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
43835167|NCT05072314|Lidocaine|lidocaine|mesh-list
43725839|NCT02595034|Clindamycin|clindamycin|mesh-list
43725840|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
43725841|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
43725842|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43725843|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43725844|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725845|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43725846|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725847|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725848|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
43725849|NCT02594579|Vitamin D|vitamin d|mesh-list
43725850|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
43725851|NCT02594579|Vitamins|vitamins|mesh-ancestor
43725852|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
43725853|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725854|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43725855|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43725856|NCT02594761|Trastuzumab|trastuzumab|mesh-list
43725857|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43725858|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725874|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43725875|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
43725876|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725877|NCT02594423|Bevacizumab|bevacizumab|mesh-list
43725878|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43725879|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725880|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43725881|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43725882|NCT02594423|Growth Substances|growth substances|mesh-ancestor
43725883|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725884|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
43725885|NCT02594410|Lercanidipine|lercanidipine|mesh-list
43725886|NCT02594410|Clopidogrel|clopidogrel|mesh-list
43725887|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43725888|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43725889|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43725890|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43725932|NCT02593942|Propofol|propofol|mesh-list
43725933|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43725934|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725935|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725936|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43725937|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
43725938|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
43725939|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43725940|NCT02593942|Narcotics|narcotics|mesh-ancestor
43725941|NCT02593942|Analgesics|analgesics|mesh-ancestor
43725942|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
43725943|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725944|NCT02593968|Interferons|interferons|mesh-list
43725945|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725946|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
43725947|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833393|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43833394|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
43833395|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833396|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833397|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833398|NCT05213728|Vaccines|vaccines|mesh-list
43833399|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
43833400|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833401|NCT05213104|Flecainide|flecainide|mesh-list
43833402|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43833403|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43833404|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43833405|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43833406|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833407|NCT05211791|Anesthetics|anesthetics|mesh-list
43833408|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833410|NCT05211609|Methyldopa|methyldopa|mesh-list
43833417|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43833418|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43833419|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
43833420|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833421|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833422|NCT05211154|Diclofenac|diclofenac|mesh-list
43833423|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43833424|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43833425|NCT05211154|Analgesics|analgesics|mesh-ancestor
43833426|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
43725948|NCT02593747|Loratadine|loratadine|mesh-list
43725949|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
43725950|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
43725951|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43725952|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43725953|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43725954|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
43725955|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
43725956|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725957|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725958|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725959|NCT02593734|Olanzapine|olanzapine|mesh-list
43725960|NCT02593734|Risperidone|risperidone|mesh-list
43725961|NCT02593734|Fluoxetine|fluoxetine|mesh-list
43725962|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43725963|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
43725964|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725965|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725966|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725967|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43725968|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43725969|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725970|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43725971|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43725972|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
43725973|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
43740562|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43740563|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43740564|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
43740565|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740566|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740567|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
43740568|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43740569|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740570|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43740571|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740572|NCT02528877|Sirolimus|sirolimus|mesh-list
43740573|NCT02528877|Fludarabine|fludarabine|mesh-list
43740574|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
43740575|NCT02528877|Melphalan|melphalan|mesh-list
43725974|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
43725975|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725976|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43725977|NCT02593734|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43725978|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43726022|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
43726023|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43726024|NCT02593526|Diuretics|diuretics|mesh-ancestor
43726025|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
43726026|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726027|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43726028|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726029|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726030|NCT02593643|Midazolam|midazolam|mesh-list
43726031|NCT02593643|Ketamine|ketamine|mesh-list
43726032|NCT02593643|Analgesics|analgesics|mesh-ancestor
43726033|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
43726034|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726035|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726036|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43726037|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43726038|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
43726039|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
43726069|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726070|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43726071|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
43726072|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
43726074|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726075|NCT02593383|Clindamycin|clindamycin|mesh-list
43726076|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
43726077|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
43726079|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43726080|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726081|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43726082|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726083|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726084|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43726085|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43726086|NCT02593383|Analgesics|analgesics|mesh-ancestor
43726087|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
43726095|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43726097|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726098|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
43726099|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726100|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43726101|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43740583|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726102|NCT02593474|Naltrexone|naltrexone|mesh-list
43726103|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43726104|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43726105|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726106|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
43726107|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726108|NCT02593448|Anesthetics|anesthetics|mesh-list
43726109|NCT02593448|Propofol|propofol|mesh-list
43726110|NCT02593448|Sevoflurane|sevoflurane|mesh-list
43726111|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726112|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726114|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43726115|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
43726116|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43726117|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43726118|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43726119|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43726120|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43726121|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
43726122|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726123|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43726124|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43726125|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726126|NCT02593370|Lidocaine|lidocaine|mesh-list
43726127|NCT02593370|Epinephrine|epinephrine|mesh-list
43726128|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43726129|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
43559605|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726130|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
43726131|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726132|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726133|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
43726134|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726135|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43726136|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43726137|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43726138|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43694099|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
43726203|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43726204|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43726205|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
43726206|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726207|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726208|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
43726209|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
43726211|NCT02592915|Anesthetics|anesthetics|mesh-list
43726212|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726213|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726214|NCT02592915|Analgesics|analgesics|mesh-ancestor
43726215|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
43726216|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726217|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43726218|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
43726219|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
43726220|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43726221|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43726222|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43726223|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
43726224|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726225|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726226|NCT02592720|Tenecteplase|tenecteplase|mesh-list
43726227|NCT02592720|Tirofiban|tirofiban|mesh-list
43726228|NCT02592720|Bivalirudin|bivalirudin|mesh-list
43726229|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
43726230|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43726231|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
43726232|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726233|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726234|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
43726235|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43726236|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43726237|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43726238|NCT02592746|Capecitabine|capecitabine|mesh-list
43726239|NCT02592746|Palbociclib|palbociclib|mesh-list
43726240|NCT02592746|Leuprolide|leuprolide|mesh-list
43726241|NCT02592746|Exemestane|exemestane|mesh-list
43726242|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43726243|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
43726244|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726245|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726246|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43726247|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726248|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43726249|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
43726250|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43726251|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726252|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43726253|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43726254|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43726255|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43726256|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
43726257|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726258|NCT02592694|Tenecteplase|tenecteplase|mesh-list
43726259|NCT02592694|Tirofiban|tirofiban|mesh-list
43726260|NCT02592694|Bivalirudin|bivalirudin|mesh-list
43740683|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43740684|NCT02528383|Estradiol|estradiol|mesh-list
43740685|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43740686|NCT02528383|Estrogens|estrogens|mesh-ancestor
43740687|NCT02528383|Hormones|hormones|mesh-ancestor
43835170|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740688|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740689|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740690|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43740691|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
43726261|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
43726262|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43726263|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
43726264|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726266|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
43726280|NCT02592278|Protective Agents|protective agents|mesh-ancestor
43726281|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726282|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43726283|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726284|NCT02592083|Tamoxifen|tamoxifen|mesh-list
43726285|NCT02592083|Goserelin|goserelin|mesh-list
43726286|NCT02592083|Palbociclib|palbociclib|mesh-list
43726287|NCT02592083|Exemestane|exemestane|mesh-list
43726288|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43726289|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43726290|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
43726291|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726292|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726293|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43726294|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726295|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43726296|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43726297|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43726298|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43726299|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726300|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726301|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43726302|NCT02592122|Bromides|bromides|mesh-list
43726303|NCT02592122|Albuterol|albuterol|mesh-list
43726304|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
43726320|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
43726321|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
43726322|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43726323|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726324|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
43726325|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43726326|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43726327|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43726328|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726329|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726330|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726331|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43726333|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
43726334|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726335|NCT02591914|Bevacizumab|bevacizumab|mesh-list
43726336|NCT02591914|Ranibizumab|ranibizumab|mesh-list
43726337|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43726338|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726339|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43726340|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43726344|NCT02591927|Insulin|insulin|mesh-list
43726345|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43726346|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726347|NCT02591888|Bupivacaine|bupivacaine|mesh-list
43726348|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
43726349|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
43726350|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726351|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726352|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
43726353|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726354|NCT02591771|Epinephrine|epinephrine|mesh-list
43726355|NCT02591771|Racepinephrine|racepinephrine|mesh-list
43726356|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
43726357|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43726358|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43726359|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
43726360|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726361|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726362|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726363|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43726364|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43726365|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
43726366|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726367|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43726368|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
43726369|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
43726370|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
43726371|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43726372|NCT02591836|Atorvastatin|atorvastatin|mesh-list
43726373|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43726374|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43726375|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
43726376|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726377|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43726378|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43726379|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726380|NCT02591849|Glucagon|glucagon|mesh-list
43726381|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43726382|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43726383|NCT02591849|Hormones|hormones|mesh-ancestor
43726402|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726403|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43726404|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
43726405|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726406|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
43726407|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
43726408|NCT02590900|Acetaminophen|acetaminophen|mesh-list
43726409|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43726410|NCT02590900|Analgesics|analgesics|mesh-ancestor
43726411|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
43726412|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726413|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726414|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
43726415|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43726416|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
43726417|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
43726418|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43726419|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
43726420|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43726438|NCT02591017|Ketamine|ketamine|mesh-list
43726464|NCT02591095|Navitoclax|navitoclax|mesh-list
43726492|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
43726493|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726494|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726495|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
43726496|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726497|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43726498|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43726499|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43740704|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
43740705|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43726500|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726501|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726502|NCT02590601|Bromocriptine|bromocriptine|mesh-list
43726503|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43726551|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833434|NCT05209906|Fentanyl|fentanyl|mesh-list
43833435|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43833436|NCT05209906|Narcotics|narcotics|mesh-ancestor
43833437|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833438|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833439|NCT05209906|Analgesics|analgesics|mesh-ancestor
43833440|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
43833441|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833442|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43833443|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43833444|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
43833445|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
43833446|NCT05209867|Cannabidiol|cannabidiol|mesh-list
43833447|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
43833448|NCT05209711|Lidocaine|lidocaine|mesh-list
43833449|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
43833450|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
43833451|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833452|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833453|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
43833454|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833455|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43833456|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43833457|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43833458|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726561|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
43726562|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726563|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43726564|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43726565|NCT02590133|Growth Substances|growth substances|mesh-ancestor
43726566|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
43726567|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
43726568|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43726569|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43726570|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43726571|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726572|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726573|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
43726574|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726575|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726576|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43726577|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726578|NCT02590055|Gemcitabine|gemcitabine|mesh-list
43726579|NCT02590055|Docetaxel|docetaxel|mesh-list
43726580|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43726581|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
43726582|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726583|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726584|NCT02590055|Antiviral Agents|antiviral agents|mesh-ancestor
43726585|NCT02590055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726586|NCT02590055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726608|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43740741|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726609|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
43726610|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726611|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
43726612|NCT02589717|Atezolizumab|atezolizumab|mesh-list
43726613|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726614|NCT02589457|Tenofovir|tenofovir|mesh-list
43726615|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
43726616|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726617|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43726618|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43726619|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726620|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726621|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43726622|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43726623|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
43726624|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43726625|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726626|NCT02589444|Vitamin D|vitamin d|mesh-list
43726632|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43726657|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
43726658|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
43726659|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726660|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726661|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
43726662|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726663|NCT02589041|Ropivacaine|ropivacaine|mesh-list
43726664|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
43726665|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
43726666|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726667|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726668|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
43726669|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726670|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43726671|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
43726672|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726674|NCT02589158|Darunavir|darunavir|mesh-list
43726716|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
43726717|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726718|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726719|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43726720|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43726721|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
43726722|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726723|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726724|NCT02588742|Melatonin|melatonin|mesh-list
43726725|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
43726726|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726727|NCT02588742|Protective Agents|protective agents|mesh-ancestor
43726728|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726729|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833461|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43833462|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833463|NCT05209490|Trace Elements|trace elements|mesh-ancestor
43833464|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
43833465|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833466|NCT05209425|Vitamin D|vitamin d|mesh-list
43833467|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
43833468|NCT05209425|Vitamins|vitamins|mesh-ancestor
43833469|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
43833470|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833471|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43833472|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43833473|NCT05208619|Anesthetics|anesthetics|mesh-list
43833474|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833475|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833476|NCT05206747|Methamphetamine|methamphetamine|mesh-list
43833477|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43833478|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833479|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
43833480|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
43833482|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
43726757|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726758|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43726759|NCT02588287|Tenofovir|tenofovir|mesh-list
43726760|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
43726761|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726762|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43726763|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43726764|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726765|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726766|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43726767|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43726768|NCT02588235|Atorvastatin|atorvastatin|mesh-list
43726769|NCT02588235|Ezetimibe|ezetimibe|mesh-list
43726770|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43726771|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43726772|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
43726773|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726774|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43726775|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43726776|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726804|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
43726805|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
43726806|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43726807|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43726808|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726809|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
43726810|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43726811|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43694100|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43726813|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
43726814|NCT02587845|Coagulants|coagulants|mesh-ancestor
43726815|NCT02587871|Cytarabine|cytarabine|mesh-list
43726816|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43726867|NCT02587260|Ticagrelor|ticagrelor|mesh-list
43726868|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43726869|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43726870|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43726871|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43726872|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43726873|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
43726874|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726875|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726876|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726877|NCT02587741|Metformin|metformin|mesh-list
43726878|NCT02587741|Acarbose|acarbose|mesh-list
43726879|NCT02587741|Gliclazide|gliclazide|mesh-list
43726880|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
43726881|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43726882|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726883|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43726884|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726885|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726886|NCT02587052|Tacrolimus|tacrolimus|mesh-list
43726887|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726888|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
43726889|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726890|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43726892|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726893|NCT02587130|Ketamine|ketamine|mesh-list
43726894|NCT02587130|Analgesics|analgesics|mesh-ancestor
43726895|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
43726896|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726897|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726898|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43726899|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43726900|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
43726901|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
43726902|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726903|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43726904|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43726905|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726906|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726907|NCT02587195|Teriflunomide|teriflunomide|mesh-list
43726908|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43726909|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43726910|NCT02587195|Analgesics|analgesics|mesh-ancestor
43726911|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
43726912|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726913|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726914|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726915|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43726916|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726917|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
43726918|NCT02587169|Doxorubicin|doxorubicin|mesh-list
43726919|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43726920|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43833557|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833559|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43833560|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833561|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43833562|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43847520|NCT04094948|Clenbuterol|clenbuterol|mesh-list
43726979|NCT02586636|Metformin|metformin|mesh-list
43726980|NCT02586636|Omeprazole|omeprazole|mesh-list
43726981|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43726982|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726983|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43726984|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43726985|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43740765|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43740766|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43740767|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740768|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43740769|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
43726986|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726987|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726989|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43726990|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43726991|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726992|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727003|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727004|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43727005|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
43727006|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
43727007|NCT02586259|Hormones|hormones|mesh-ancestor
43727008|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727009|NCT02586441|Bromides|bromides|mesh-list
43727010|NCT02586441|Propofol|propofol|mesh-list
43727011|NCT02586441|Rocuronium|rocuronium|mesh-list
43727012|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43727013|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727014|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727015|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43727016|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
43727017|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
43727019|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43727020|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43727021|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43727022|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559628|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43559630|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43559631|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559632|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559633|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43559634|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559635|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559636|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
43559637|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559638|NCT03611881|Nicotine|nicotine|mesh-list
43727025|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43727026|NCT02586454|Narcotics|narcotics|mesh-ancestor
43727027|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727028|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727029|NCT02586454|Analgesics|analgesics|mesh-ancestor
43727030|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
43727031|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727032|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
43727033|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
43727034|NCT02586363|Entecavir|entecavir|mesh-list
43727035|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
43559639|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43559640|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
43559641|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559642|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559643|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43559644|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43559645|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
43559646|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559647|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559648|NCT03603288|Idebenone|idebenone|mesh-list
43559649|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
43559650|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559651|NCT03603288|Protective Agents|protective agents|mesh-ancestor
43559652|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559653|NCT03571568|Rituximab|rituximab|mesh-list
43559654|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43559655|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559656|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
43559657|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559658|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559659|NCT03553498|Acetaminophen|acetaminophen|mesh-list
43559660|NCT03553498|Hydromorphone|hydromorphone|mesh-list
43559661|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559662|NCT03553498|Analgesics|analgesics|mesh-ancestor
43559663|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
43559664|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559665|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559666|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
43727036|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727037|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
43727038|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43727039|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
43727040|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727041|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43727042|NCT02586194|Peficitinib|peficitinib|mesh-list
43727043|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727044|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727045|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43727046|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
43727047|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727048|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
43727049|NCT02586181|Vitamin D|vitamin d|mesh-list
43727050|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
43727051|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
43727052|NCT02586181|Vitamins|vitamins|mesh-list
43727058|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43727059|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
43727060|NCT02586181|Hematinics|hematinics|mesh-ancestor
43727061|NCT02586129|Metformin|metformin|mesh-list
43727062|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43727063|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727064|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727065|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43727066|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43727067|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
43559690|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43559691|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43559692|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559693|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559694|NCT03515044|Rifaximin|rifaximin|mesh-list
43559695|NCT03515044|Lactulose|lactulose|mesh-list
43559696|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43559697|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559698|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43559699|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43559700|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43559701|NCT03475706|Solabegron|solabegron|mesh-list
43559702|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43559703|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43559704|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43559705|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727068|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727069|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43727070|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43727071|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727072|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
43727073|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
43727074|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43727076|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
43727077|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43727078|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
43727079|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727080|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43727095|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727096|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740770|NCT02527733|Ranibizumab|ranibizumab|mesh-list
43740771|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43740772|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43740773|NCT02527733|Growth Substances|growth substances|mesh-ancestor
43740798|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740799|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740800|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740801|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
43727097|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727098|NCT02585947|Tenofovir|tenofovir|mesh-list
43727099|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
43727100|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559706|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559707|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559708|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559716|NCT03448081|Calcipotriene|calcipotriene|mesh-list
43559717|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
43559718|NCT03446807|Droxidopa|droxidopa|mesh-list
43559719|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43559720|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43559721|NCT03427125|Sevelamer|sevelamer|mesh-list
43559722|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
43727101|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43727102|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43727103|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727104|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727106|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43727107|NCT02585882|Fluorides|fluorides|mesh-list
43727108|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
43727109|NCT02585882|Protective Agents|protective agents|mesh-ancestor
43727110|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727111|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43727112|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43727113|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
43727114|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727115|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727116|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
43727117|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43727118|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727119|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727120|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727121|NCT02585791|Glycerol|glycerol|mesh-list
43727122|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43727123|NCT02585791|Protective Agents|protective agents|mesh-ancestor
43727124|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727125|NCT02585765|Pioglitazone|pioglitazone|mesh-list
43727126|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727130|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43727131|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727132|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43727134|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727135|NCT02585531|Dexamethasone|dexamethasone|mesh-list
43727136|NCT02585531|Epinephrine|epinephrine|mesh-list
43727137|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727138|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
43727139|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
43727140|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727141|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727142|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727143|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
43727145|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727146|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43727147|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727148|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43727149|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43727150|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727151|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727152|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727153|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43727154|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43727155|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43727156|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
43727157|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
43727158|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
43727159|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43727160|NCT02585570|Phenylephrine|phenylephrine|mesh-list
43559723|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
43559724|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559725|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
43559726|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43559727|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43727162|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43727163|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
43727164|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
43727165|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727166|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727167|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
43727168|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43727169|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
43727170|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
43727171|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43727172|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43727173|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43727175|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727176|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727177|NCT02585570|Protective Agents|protective agents|mesh-ancestor
43727178|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
43727179|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
43727180|NCT02585479|Pirarubicin|pirarubicin|mesh-list
43727181|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43727182|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727183|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
43727184|NCT02585479|Coagulants|coagulants|mesh-ancestor
43740814|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43727185|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
43727186|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
43727187|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727205|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727206|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
43727207|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727208|NCT02585388|Letrozole|letrozole|mesh-list
43727209|NCT02585388|Vinorelbine|vinorelbine|mesh-list
43727210|NCT02585388|Anastrozole|anastrozole|mesh-list
43727211|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727212|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43727213|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43727214|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727215|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740815|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
43740816|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740817|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740818|NCT02527863|Tolvaptan|tolvaptan|mesh-list
43740819|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43740820|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740821|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
43740822|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740823|NCT02527772|Leucovorin|leucovorin|mesh-list
43740824|NCT02527772|Gemcitabine|gemcitabine|mesh-list
43727216|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43727217|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
43727218|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727219|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727220|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43727221|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
43727222|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
43727223|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
43727224|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43727225|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43727226|NCT02585141|Clindamycin|clindamycin|mesh-list
43727227|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
43727228|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
43727229|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727230|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43727231|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727232|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727233|NCT02585011|Epinephrine|epinephrine|mesh-list
43727234|NCT02585011|Ropivacaine|ropivacaine|mesh-list
43727235|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
43727236|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
43727237|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727238|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727239|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
43727240|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727241|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43559728|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559729|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
43559730|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
43727242|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43727254|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
43727255|NCT02584881|Narcotics|narcotics|mesh-ancestor
43727256|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727257|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727258|NCT02584881|Analgesics|analgesics|mesh-ancestor
43727259|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
43727260|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833563|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43833565|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
43833566|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43833569|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833570|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833571|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
43833572|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
43833573|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833574|NCT05203822|Itraconazole|itraconazole|mesh-list
43833575|NCT05203822|Tepotinib|tepotinib|mesh-list
43833576|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
43833577|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833578|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43833579|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43833580|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833581|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833582|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43833583|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
43833584|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833585|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833586|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43833587|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833588|NCT05202860|Vaccines|vaccines|mesh-list
43833589|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
43833590|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833591|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
43740826|NCT02527772|Doxorubicin|doxorubicin|mesh-list
43740827|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43833592|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833593|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43833594|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833595|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833596|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
43833601|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
43833602|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833603|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
43833611|NCT05201547|Carboplatin|carboplatin|mesh-list
43833612|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43833613|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833614|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
43833615|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
43833616|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
43833617|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833618|NCT05201313|Lidocaine|lidocaine|mesh-list
43833619|NCT05201313|Mepivacaine|mepivacaine|mesh-list
43833620|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
43727261|NCT02584816|Vaccines|vaccines|mesh-list
43727262|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
43727263|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727264|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
43727265|NCT02584751|Omeprazole|omeprazole|mesh-list
43727266|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43727267|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727268|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43727270|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727271|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43727272|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
43727273|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727274|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727275|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43727276|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
43727277|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43727278|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
43727298|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727300|NCT02584738|Protective Agents|protective agents|mesh-ancestor
43727301|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43727302|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559737|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559738|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559739|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43559740|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
43559741|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43559742|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43727303|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
43727304|NCT02584738|Analgesics|analgesics|mesh-ancestor
43727305|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
43727313|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
43727314|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43727315|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43727316|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43727317|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
43727318|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43727319|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43727320|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43727321|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727322|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727323|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43727324|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
43727325|NCT02584582|Liraglutide|liraglutide|mesh-list
43727326|NCT02584582|Exenatide|exenatide|mesh-list
43727327|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727328|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727329|NCT02584582|Incretins|incretins|mesh-ancestor
43727330|NCT02584582|Hormones|hormones|mesh-ancestor
43727331|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727332|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43727333|NCT02584543|Vaccines|vaccines|mesh-list
43559752|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43559753|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43559755|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559756|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
43559757|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559758|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
43727348|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727350|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43727351|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
43727352|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
43727353|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727354|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727355|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
43727356|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727357|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43727358|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43727360|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727361|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727362|NCT02584075|Metformin|metformin|mesh-list
43727363|NCT02584075|Exenatide|exenatide|mesh-list
43727364|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727365|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727366|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43727367|NCT02584075|Incretins|incretins|mesh-ancestor
43727368|NCT02584075|Hormones|hormones|mesh-ancestor
43727369|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727370|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43559760|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559761|NCT03340974|Protective Agents|protective agents|mesh-ancestor
43559762|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559774|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
43559775|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43559776|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43559777|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
43559778|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
43559779|NCT03301051|Vaccines|vaccines|mesh-list
43559780|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
43559781|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559782|NCT03288454|Apixaban|apixaban|mesh-list
43727391|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
43727392|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727393|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43727394|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43727395|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
43727396|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727397|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727398|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43727399|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43835185|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835186|NCT05069831|Abrocitinib|abrocitinib|mesh-list
43835187|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43727400|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43727401|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727402|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43727403|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
43727404|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727406|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43727407|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43727408|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727409|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727410|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727411|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727412|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43727413|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
43727414|NCT02583698|Protective Agents|protective agents|mesh-ancestor
43727415|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43727416|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727417|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43727418|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
43727419|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43727420|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43727421|NCT02583594|Loratadine|loratadine|mesh-list
43727442|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
43727443|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43727444|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43727445|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43727446|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
43559784|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
43559785|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43559786|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
43565906|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565907|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43565908|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43565909|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43565910|NCT00850577|Growth Substances|growth substances|mesh-ancestor
43565911|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565912|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
43565913|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
43565914|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
43565915|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43565916|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43565917|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43847698|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43847699|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43847700|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
43847701|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43847702|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43847703|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
43847704|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43847705|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559787|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559788|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559789|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
43559790|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43559791|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43559792|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
43559793|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727447|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
43727448|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727449|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727450|NCT02583633|Nifedipine|nifedipine|mesh-list
43727451|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
43727452|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43727453|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727454|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727455|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43727456|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727457|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
43727458|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
43727459|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43727475|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727476|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727477|NCT02583464|Tenofovir|tenofovir|mesh-list
43727478|NCT02583464|Emtricitabine|emtricitabine|mesh-list
43727479|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
43727480|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727481|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43727482|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43727483|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727484|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727485|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43727486|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43727487|NCT02583438|Saxagliptin|saxagliptin|mesh-list
43727488|NCT02583438|Incretins|incretins|mesh-ancestor
43727489|NCT02583438|Hormones|hormones|mesh-ancestor
43727490|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727492|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43727493|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
43727494|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727495|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727496|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727497|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43727498|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
43727499|NCT02583685|Ribavirin|ribavirin|mesh-list
43727500|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43727501|NCT02583685|Simeprevir|simeprevir|mesh-list
43727502|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
43727503|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727504|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
43727505|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727506|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
43727507|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727508|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
43727509|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727510|NCT02583516|Vemurafenib|vemurafenib|mesh-list
43727511|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559794|NCT03263273|Minocycline|minocycline|mesh-list
43559795|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43559796|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559797|NCT03250117|Ropinirole|ropinirole|mesh-list
43559798|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43559799|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43847709|NCT04082897|Atezolizumab|atezolizumab|mesh-list
43559800|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
43559801|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
43559802|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559803|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559812|NCT03198728|Testosterone|testosterone|mesh-list
43559813|NCT03198728|Androgens|androgens|mesh-ancestor
43559815|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559816|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559817|NCT03191864|Fluticasone|fluticasone|mesh-list
43727512|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43727513|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727514|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727515|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43727516|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43727517|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727518|NCT02582996|Acetaminophen|acetaminophen|mesh-list
43727519|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
43727520|NCT02582996|Metoclopramide|metoclopramide|mesh-list
43727521|NCT02582996|Caffeine|caffeine|mesh-list
43727522|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43727523|NCT02582996|Analgesics|analgesics|mesh-ancestor
43727524|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
43727525|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727526|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727527|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
43727528|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43727529|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43727530|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727553|NCT02583217|Analgesics|analgesics|mesh-ancestor
43727554|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
43727555|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727556|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43727557|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43727558|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43727559|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727560|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727561|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43727562|NCT02583217|Narcotics|narcotics|mesh-ancestor
43833621|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
43833622|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833623|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559819|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559820|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43559821|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
43559822|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559823|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559824|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43559825|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
43559826|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
43559827|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43559828|NCT03187834|Amoxicillin|amoxicillin|mesh-list
43559829|NCT03187834|Azithromycin|azithromycin|mesh-list
43559837|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43559839|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43847719|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559840|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
43559841|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559842|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559843|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
43559844|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
43559845|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43559846|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
43559847|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43559848|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
43559849|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559850|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559851|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
43559852|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43559853|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43727579|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
43727580|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43727581|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43727582|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727583|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
43727584|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43727585|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43727586|NCT02583022|Analgesics|analgesics|mesh-ancestor
43727587|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
43727588|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727589|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727590|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727591|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43727592|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
43727593|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43727596|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727598|NCT02582892|Vitamin D|vitamin d|mesh-list
43727599|NCT02582892|Vitamins|vitamins|mesh-ancestor
43727600|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
43727601|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727602|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43727603|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
43727604|NCT02582736|Haloperidol|haloperidol|mesh-list
43727605|NCT02582736|Pimozide|pimozide|mesh-list
43727606|NCT02582736|Olanzapine|olanzapine|mesh-list
43727607|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
43727608|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
43727609|NCT02582736|Risperidone|risperidone|mesh-list
43727610|NCT02582736|Aripiprazole|aripiprazole|mesh-list
43727611|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43727612|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43727613|NCT02582736|Ziprasidone|ziprasidone|mesh-list
43727614|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
43727615|NCT02582736|Clozapine|clozapine|mesh-list
43727616|NCT02582736|Loxapine|loxapine|mesh-list
43727617|NCT02582736|Perphenazine|perphenazine|mesh-list
43727618|NCT02582736|Fluphenazine|fluphenazine|mesh-list
43727619|NCT02582736|Thioridazine|thioridazine|mesh-list
43727620|NCT02582736|Flupenthixol|flupenthixol|mesh-list
43727621|NCT02582736|Clopenthixol|clopenthixol|mesh-list
43727622|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
43727623|NCT02582736|Fluspirilene|fluspirilene|mesh-list
43727624|NCT02582736|Thiothixene|thiothixene|mesh-list
43727625|NCT02582736|Mesoridazine|mesoridazine|mesh-list
43727626|NCT02582736|Chlormezanone|chlormezanone|mesh-list
43727627|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
43727628|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43565937|NCT00849485|Levetiracetam|levetiracetam|mesh-list
43727629|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
43727630|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727631|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727632|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727633|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43727634|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565938|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
43727635|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43727636|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43727637|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
43727638|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
43727639|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
43727640|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727641|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727642|NCT02582736|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43727643|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43727644|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727645|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
43727646|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
43727647|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43727648|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43727663|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
43727664|NCT02582372|Bupivacaine|bupivacaine|mesh-list
43727665|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
43727666|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
43727667|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727668|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727669|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
43727670|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727671|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43727672|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43727673|NCT02582372|Analgesics|analgesics|mesh-ancestor
43727674|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43727675|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43727676|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43727677|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727678|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559866|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43559868|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
43559869|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559870|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43559871|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
43559886|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559887|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43559888|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559890|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
43559891|NCT03118570|Calcium|calcium|mesh-list
43559892|NCT03118570|Vitamins|vitamins|mesh-ancestor
43727702|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
43727703|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
43847723|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43847724|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43847725|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43847726|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
43847727|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847728|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847729|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43847730|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43847731|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43847732|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43847733|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43559894|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847734|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
43559895|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43559896|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43559898|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43559899|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43559900|NCT05626153|Anesthetics|anesthetics|mesh-list
43559901|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43559902|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559903|NCT05624801|Vitamin D|vitamin d|mesh-list
43559904|NCT05624801|Vitamins|vitamins|mesh-ancestor
43559905|NCT05624801|Micronutrients|micronutrients|mesh-ancestor
43559906|NCT05624801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559907|NCT05624801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43559908|NCT05614089|Insulin|insulin|mesh-list
43559909|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43559910|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
43559911|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43559912|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559913|NCT05611905|Probenecid|probenecid|mesh-list
43559914|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
43559915|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
43559916|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559917|NCT05611905|Renal Agents|renal agents|mesh-ancestor
43559918|NCT05568940|Tibolone|tibolone|mesh-list
43559919|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
43559920|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
43559921|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559922|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559923|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43559924|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43559925|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559926|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43559927|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
43559928|NCT05568940|Hormones|hormones|mesh-ancestor
43559929|NCT05563480|Gemcitabine|gemcitabine|mesh-list
43559930|NCT05563480|Cisplatin|cisplatin|mesh-list
43559931|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559932|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43727704|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727705|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
43847743|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847744|NCT04081337|Tirzepatide|tirzepatide|mesh-list
43847745|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43847746|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847747|NCT04081337|Incretins|incretins|mesh-ancestor
43847748|NCT04081337|Hormones|hormones|mesh-ancestor
43740847|NCT02527668|Vitamin D|vitamin d|mesh-list
43727706|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43740848|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
43740849|NCT02527668|Calcifediol|calcifediol|mesh-list
43727707|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
43727708|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727709|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727710|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43727711|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
43727713|NCT02582476|Diuretics|diuretics|mesh-ancestor
43727714|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
43727715|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727716|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43727717|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727718|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727719|NCT02582190|Colchicine|colchicine|mesh-list
43727720|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
43727721|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43727722|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
43727723|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
43727724|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
43727744|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
43727746|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727747|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43727748|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727749|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
43727750|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727751|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727752|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43727753|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
43727754|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
43727755|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727756|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43727757|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43727758|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43727759|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
43727760|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43727761|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43727762|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43727764|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43727765|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43727766|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727767|NCT02582099|Gentamicins|gentamicins|mesh-list
43727768|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43727769|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727770|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43727771|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562918|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43727773|NCT02581969|Factor VIII|factor viii|mesh-list
43727774|NCT02581969|Coagulants|coagulants|mesh-ancestor
43727775|NCT02581826|Silodosin|silodosin|mesh-list
43727776|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43727777|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43740856|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43740857|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43740858|NCT02527603|Analgesics|analgesics|mesh-ancestor
43727778|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43727779|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
43559933|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
43559950|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727780|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727781|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727782|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727783|NCT02581826|Urological Agents|urological agents|mesh-ancestor
43727784|NCT02581761|Misoprostol|misoprostol|mesh-list
43727785|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43727786|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
43727787|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43727788|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727789|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43727790|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43559952|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43559953|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559954|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559955|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43559956|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559957|NCT05500326|Ivermectin|ivermectin|mesh-list
43559964|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
43559965|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43559966|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
43559967|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727808|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
43727810|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727811|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727812|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
43727813|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565965|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565966|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
43727815|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43727816|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
43565967|NCT00841698|Paroxetine|paroxetine|mesh-list
43565968|NCT00841698|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43565969|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43565970|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565971|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565972|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565973|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
43565974|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565975|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43565976|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
43565981|NCT00841659|Paroxetine|paroxetine|mesh-list
43727817|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43727818|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727819|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727820|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43727821|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
43727822|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43727823|NCT02581553|Allopurinol|allopurinol|mesh-list
43727824|NCT02581553|Lesinurad|lesinurad|mesh-list
43727825|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
43727826|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559972|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43559973|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559974|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
43559976|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559977|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559978|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43559979|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
43559980|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559981|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559982|NCT05413811|Fluorouracil|fluorouracil|mesh-list
43559983|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
43559984|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559985|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43559986|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559987|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43559988|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
43559989|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559997|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559998|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
43727840|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727841|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727842|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
43727843|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727844|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43727847|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43727848|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43727850|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727851|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727859|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43727860|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43727861|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
43727862|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727863|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727864|NCT02581501|Antiviral Agents|antiviral agents|mesh-ancestor
43727865|NCT02581501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727866|NCT02581501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727867|NCT02581501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43727868|NCT02581501|Immunologic Factors|immunologic factors|mesh-ancestor
43727869|NCT02581501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740884|NCT02527174|Cytarabine|cytarabine|mesh-list
43740885|NCT02527174|Idarubicin|idarubicin|mesh-list
43727870|NCT02581462|Trastuzumab|trastuzumab|mesh-list
43727871|NCT02581462|Pertuzumab|pertuzumab|mesh-list
43727872|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43727873|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727874|NCT02581631|Nivolumab|nivolumab|mesh-list
43727875|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43727876|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43727877|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727878|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43727879|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727880|NCT02581423|Capecitabine|capecitabine|mesh-list
43727881|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43727882|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
43727883|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727884|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727886|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727887|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43727888|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727889|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727890|NCT02581176|Apixaban|apixaban|mesh-list
43727891|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43727892|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
43727893|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43727894|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
43727895|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727896|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727897|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
43833626|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43833627|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43833628|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43833629|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43833630|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833631|NCT05201001|Carboplatin|carboplatin|mesh-list
43833632|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560006|NCT05358639|Navitoclax|navitoclax|mesh-list
43560007|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43560008|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560009|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560010|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560011|NCT05331690|Dexamethasone|dexamethasone|mesh-list
43560012|NCT05331690|Nepafenac|nepafenac|mesh-list
43560013|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560014|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
43560015|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
43560016|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560017|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560018|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560019|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
43560020|NCT05331690|Hormones|hormones|mesh-ancestor
43833649|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
43833651|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
43727898|NCT02580968|Flunarizine|flunarizine|mesh-list
43727899|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
43727900|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43727901|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727902|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727903|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43727904|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727905|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43727906|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
43727907|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
43727908|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727909|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
43727910|NCT02581046|Dexamethasone|dexamethasone|mesh-list
43727911|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727912|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
43727913|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
43727914|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727917|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
43727918|NCT02581046|Hormones|hormones|mesh-ancestor
43727919|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727920|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43727921|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727922|NCT02580773|Tinzaparin|tinzaparin|mesh-list
43727923|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
43727924|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43727925|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43727926|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727927|NCT02580604|Calcium|calcium|mesh-list
43565985|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565986|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565987|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
43727928|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43727929|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727930|NCT02580734|Melatonin|melatonin|mesh-list
43565988|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565989|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43565990|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
43565991|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43565992|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43740886|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740887|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
43740888|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740889|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727931|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
43727932|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727933|NCT02580734|Protective Agents|protective agents|mesh-ancestor
43727934|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727935|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727936|NCT02580344|Ibuprofen|ibuprofen|mesh-list
43727937|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43727938|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43727939|NCT02580344|Analgesics|analgesics|mesh-ancestor
43727940|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
43727941|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727942|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727943|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727945|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43727946|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727947|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727948|NCT02580448|Seviteronel|seviteronel|mesh-list
43727949|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727950|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43727951|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727952|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727953|NCT02580331|Metformin|metformin|mesh-list
43727954|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727955|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727956|NCT02580474|Asunaprevir|asunaprevir|mesh-list
43727957|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
43727958|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727959|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727960|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
43727961|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43727962|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
43727963|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727964|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
43727965|NCT02580695|Protective Agents|protective agents|mesh-ancestor
43727966|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
43727967|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43727968|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43727969|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727971|NCT02580227|Coagulants|coagulants|mesh-ancestor
43727972|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
43727973|NCT02580006|Hematinics|hematinics|mesh-ancestor
43727974|NCT02580149|Clopidogrel|clopidogrel|mesh-list
43727975|NCT02580149|Ticagrelor|ticagrelor|mesh-list
43727992|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
43727993|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727994|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43740890|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
43740899|NCT02527109|Nifedipine|nifedipine|mesh-list
43727995|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43727996|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727997|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727998|NCT02579902|Vitamin D|vitamin d|mesh-list
43727999|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
43728000|NCT02579902|Vitamins|vitamins|mesh-ancestor
43728001|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
43728002|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728003|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43728004|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43728005|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43728006|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
43728007|NCT02579590|Desogestrel|desogestrel|mesh-list
43728008|NCT02579590|Etonogestrel|etonogestrel|mesh-list
43728009|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43728010|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43728011|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43728012|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
43728013|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43728014|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728015|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43728016|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43728017|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43728018|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728031|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728032|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
43728033|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
43728034|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
43728035|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728036|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43728037|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
43728038|NCT02579564|Antiviral Agents|antiviral agents|mesh-ancestor
43728039|NCT02579564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728040|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728041|NCT02579564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43728042|NCT02579564|Immunologic Factors|immunologic factors|mesh-ancestor
43728043|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728044|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43728045|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43728046|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43833652|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43728047|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43728048|NCT02579564|Growth Substances|growth substances|mesh-ancestor
43728049|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
43728051|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728052|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728053|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728054|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43728055|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
43728074|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43728075|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43728076|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43728077|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
43728078|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
43728079|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
43728080|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
43728081|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740916|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43728082|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728083|NCT02579356|Telmisartan|telmisartan|mesh-list
43728084|NCT02579356|Atorvastatin|atorvastatin|mesh-list
43728085|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43728086|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43728087|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
43728088|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728089|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43728090|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43728091|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728092|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43728093|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43728094|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43833653|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
43833654|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
43833655|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
43833656|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833657|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833658|NCT05198843|Dasatinib|dasatinib|mesh-list
43833671|NCT05198544|Protective Agents|protective agents|mesh-ancestor
43833672|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43833673|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43833674|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847521|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43847522|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43847523|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
43847524|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847525|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847526|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847527|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43847528|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
43847529|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847530|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43847531|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
43847532|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
43728095|NCT02579187|Anesthetics|anesthetics|mesh-list
43728096|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566011|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43566012|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43566013|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43566014|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728097|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728098|NCT02579161|Metronidazole|metronidazole|mesh-list
43728099|NCT02579161|Clindamycin|clindamycin|mesh-list
43728100|NCT02579161|Clindamycin palmitate|clindamycin palmitate|mesh-list
43728101|NCT02579161|Clindamycin phosphate|clindamycin phosphate|mesh-list
43728102|NCT02579161|Sulbactam|sulbactam|mesh-list
43728103|NCT02579161|Cephalosporins|cephalosporins|mesh-list
43728104|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
43728105|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728122|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728123|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728124|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43728125|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43728126|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
43740930|NCT02527083|Analgesics|analgesics|mesh-ancestor
43740931|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
43740932|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740933|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43740934|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43740935|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43740936|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740937|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728127|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728128|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43728129|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43728130|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
43728131|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
43728132|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728133|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728135|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728136|NCT02578719|Bupivacaine|bupivacaine|mesh-list
43728137|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
43728138|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
43560099|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43560100|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43728139|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728140|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728141|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
43728142|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728144|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
43728145|NCT02578602|Antidotes|antidotes|mesh-ancestor
43728146|NCT02578602|Protective Agents|protective agents|mesh-ancestor
43728147|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728148|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
43728149|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
43728150|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728151|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43728152|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
43560114|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
43560115|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43560116|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
43560117|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43560118|NCT05204550|Heparin|heparin|mesh-list
43560119|NCT05204550|Calcium heparin|calcium heparin|mesh-list
43560120|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
43560121|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43560122|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43560123|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560124|NCT05199051|Cytarabine|cytarabine|mesh-list
43560125|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
43728169|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43728170|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43728171|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728172|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43728173|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43728180|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728181|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
43728182|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43728183|NCT02578251|Narcotics|narcotics|mesh-ancestor
43728184|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740956|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
43728185|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43728187|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43728188|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43728189|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
43728190|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728191|NCT02578537|Clopidogrel|clopidogrel|mesh-list
43728193|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43728194|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43728195|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43728196|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43728197|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
43728198|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728199|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560127|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
43560128|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560129|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560138|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43560139|NCT05177939|Prednisolone|prednisolone|mesh-list
43560140|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
43560141|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43560142|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
43560143|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
43560144|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43560145|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
43560146|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43560147|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560148|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
43560149|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
43560161|NCT05174507|Empagliflozin|empagliflozin|mesh-list
43560162|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43560163|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43560164|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560165|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43560166|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560167|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560168|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
43560169|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560170|NCT05157685|Azithromycin|azithromycin|mesh-list
43560171|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43741001|NCT02526875|Telmisartan|telmisartan|mesh-list
43741002|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43741003|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43741004|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43741005|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741011|NCT02526810|Insulin|insulin|mesh-list
43728218|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
43728219|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43728220|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43728221|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728222|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43728223|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728224|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728225|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
43728226|NCT02578108|Lidocaine|lidocaine|mesh-list
43560177|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560178|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560179|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
43560180|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560181|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560182|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560183|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
43562921|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728227|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
43728228|NCT02578108|Anesthetics|anesthetics|mesh-list
43741037|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
43741038|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43741039|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741041|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
43741042|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741043|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43741044|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
43741045|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43741046|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
43741047|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741048|NCT02526303|Nadroparin|nadroparin|mesh-list
43741049|NCT02526303|Warfarin|warfarin|mesh-list
43741050|NCT02526303|Calcium|calcium|mesh-list
43728229|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728230|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728231|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
43728232|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728233|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43728234|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43728235|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43728236|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43728237|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728238|NCT02577965|Everolimus|everolimus|mesh-list
43560205|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43560206|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43560207|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560208|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560209|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43560210|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43560211|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43560212|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43560213|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
43560214|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
43560215|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
43560216|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
43560217|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560218|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560219|NCT05105035|Meropenem|meropenem|mesh-list
43560220|NCT05105035|Ceftazidime|ceftazidime|mesh-list
43728241|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
43728242|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728243|NCT02578121|Dexamethasone|dexamethasone|mesh-list
43728244|NCT02578121|Pomalidomide|pomalidomide|mesh-list
43728245|NCT02578121|Ixazomib|ixazomib|mesh-list
43728246|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728248|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
43728254|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728255|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728257|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
43728258|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43728259|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43728260|NCT02578121|Growth Substances|growth substances|mesh-ancestor
43728261|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
43728262|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728263|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741072|NCT02526199|Bupivacaine|bupivacaine|mesh-list
43741073|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741074|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
43741075|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
43741076|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741077|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741078|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43741079|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
43741080|NCT02526199|Hormones|hormones|mesh-ancestor
43741082|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728264|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728265|NCT02577848|Liraglutide|liraglutide|mesh-list
43728266|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43728267|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728268|NCT02577848|Incretins|incretins|mesh-ancestor
43728269|NCT02577848|Hormones|hormones|mesh-ancestor
43728270|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728271|NCT02577809|Indomethacin|indomethacin|mesh-list
43728272|NCT02577809|Fentanyl|fentanyl|mesh-list
43728273|NCT02577809|Morphine|morphine|mesh-list
43728274|NCT02577809|Bupivacaine|bupivacaine|mesh-list
43728275|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
43728284|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43728285|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43728286|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
43728287|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43728288|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43728289|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728290|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43728291|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
43728292|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
43728293|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43728294|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43728295|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728296|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728298|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
43728299|NCT02577783|Doxorubicin|doxorubicin|mesh-list
43728300|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43728301|NCT02577783|BB 1101|bb 1101|mesh-list
43728302|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728303|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
43728304|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
43728305|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728306|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728307|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43728319|NCT02577575|Oxytocin|oxytocin|mesh-list
43728320|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
43728321|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43728322|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728323|NCT02577614|Coagulants|coagulants|mesh-list
43728324|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
43728325|NCT02577458|Everolimus|everolimus|mesh-list
43728326|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728327|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43728328|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
43741095|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43741096|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
43741107|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741108|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741109|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
43741110|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
43741111|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728329|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728330|NCT02577341|Cisplatin|cisplatin|mesh-list
43728331|NCT02577341|Docetaxel|docetaxel|mesh-list
43728332|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
43728333|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728334|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
43728335|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
43728336|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
43728337|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728338|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43728339|NCT02577497|Fluticasone|fluticasone|mesh-list
43728351|NCT02577497|Hormones|hormones|mesh-ancestor
43728352|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728353|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43728354|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
43728355|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728356|NCT02577393|Protective Agents|protective agents|mesh-ancestor
43728357|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728358|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43728359|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43728360|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728361|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43728362|NCT02577770|Caffeine|caffeine|mesh-list
43728363|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43728364|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728365|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43728366|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728367|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728368|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43728369|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43728370|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
43728371|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728372|NCT02577432|Fentanyl|fentanyl|mesh-list
43728373|NCT02577432|Bupivacaine|bupivacaine|mesh-list
43728374|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
43728375|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
43728376|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728377|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728378|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
43728379|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728380|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43728382|NCT02577432|Analgesics|analgesics|mesh-ancestor
43728383|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43728384|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43728385|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
43728386|NCT02577250|Ketamine|ketamine|mesh-list
43728387|NCT02577250|Analgesics|analgesics|mesh-ancestor
43835198|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
43835199|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835200|NCT05067894|Vaccines|vaccines|mesh-list
43835201|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
43835202|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835203|NCT05066607|Dexamethasone|dexamethasone|mesh-list
43835204|NCT05066607|Pomalidomide|pomalidomide|mesh-list
43835205|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728388|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
43728389|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728390|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728391|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43728392|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43728393|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
43728394|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
43728395|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728396|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43728397|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43728398|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728399|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833675|NCT05196932|Antibodies|antibodies|mesh-list
43833676|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
43833677|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833678|NCT05196815|Dobutamine|dobutamine|mesh-list
43833679|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43833680|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
43833681|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
43833682|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833683|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833684|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43833685|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43833686|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43833687|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
43835228|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43835229|NCT05065372|Metformin|metformin|mesh-list
43835230|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43835232|NCT05065216|Kallikreins|kallikreins|mesh-list
43833688|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833689|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833690|NCT05196815|Protective Agents|protective agents|mesh-ancestor
43833691|NCT05194293|Durvalumab|durvalumab|mesh-list
43833692|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
43833693|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43833694|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
43833695|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43833696|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833697|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
43833698|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833699|NCT05193318|Ketamine|ketamine|mesh-list
43833700|NCT05193318|Analgesics|analgesics|mesh-ancestor
43833701|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
43833702|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833726|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
43833727|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833728|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833730|NCT05190445|Ramucirumab|ramucirumab|mesh-list
43833731|NCT05190445|Tucatinib|tucatinib|mesh-list
43833732|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43833733|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833734|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
43833735|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
43741153|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741154|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741155|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43728400|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
43728401|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43728402|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43728403|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43728404|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43728405|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728406|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
43728407|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741158|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43741178|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43741179|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741180|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
43741181|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741182|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43741183|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43741184|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
43741185|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43741186|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43741187|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
43728408|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728409|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43728410|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728411|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43728412|NCT02576964|Capecitabine|capecitabine|mesh-list
43728413|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43728414|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
43728415|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728416|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728417|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
43728418|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728419|NCT02576782|Dexamethasone|dexamethasone|mesh-list
43728420|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
43728421|NCT02576782|Bupivacaine|bupivacaine|mesh-list
43560221|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43728441|NCT02577094|Fludarabine|fludarabine|mesh-list
43728443|NCT02577094|Epratuzumab|epratuzumab|mesh-list
43728444|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
43728445|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728446|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728447|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43728448|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
43728449|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728450|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
43728451|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43728452|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43728453|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43728454|NCT02577068|Propacetamol|propacetamol|mesh-list
43728455|NCT02577068|Nefopam|nefopam|mesh-list
43728456|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43728457|NCT02577068|Analgesics|analgesics|mesh-ancestor
43728458|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
43728459|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728460|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728474|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43728475|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
43728476|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
43728477|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728478|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728479|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728480|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
43728481|NCT02576626|Albuterol|albuterol|mesh-list
43728482|NCT02576626|Ipratropium|ipratropium|mesh-list
43728483|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43728484|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
43728485|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741201|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728486|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741202|NCT02525237|Apatinib|apatinib|mesh-list
43741203|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741204|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43741205|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741206|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741207|NCT02525276|Hormones|hormones|mesh-list
43741222|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741223|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
43741224|NCT02525081|Ramipril|ramipril|mesh-list
43741225|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43741226|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
43741227|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728487|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43728488|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
43728489|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
43728490|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43728491|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43728492|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43728493|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43728494|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
43728495|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728496|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728497|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43728498|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43728499|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43728500|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
43728501|NCT02576665|Flucytosine|flucytosine|mesh-list
43728502|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
43728503|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728504|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
43728505|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728506|NCT02576600|Remifentanil|remifentanil|mesh-list
43728517|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
43728518|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728519|NCT02576457|BMS-936559|bms-936559|mesh-list
43728520|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43728521|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728522|NCT02576353|Fentanyl|fentanyl|mesh-list
43728523|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43728524|NCT02576353|Narcotics|narcotics|mesh-ancestor
43728525|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728526|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728527|NCT02576353|Analgesics|analgesics|mesh-ancestor
43728528|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
43728529|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728530|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43728531|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43728532|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
43728533|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
43728534|NCT02576340|Octylonium|octylonium|mesh-list
43728535|NCT02576340|Bromides|bromides|mesh-list
43728536|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
43728537|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43728538|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43728539|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728540|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43728541|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728542|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43728543|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
43728544|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
43728545|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728560|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728561|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
43728562|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728563|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43728564|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
43728565|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728566|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43741231|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
43728567|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
43728568|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
43728569|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
43728570|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43728572|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728573|NCT02576288|Incretins|incretins|mesh-ancestor
43728574|NCT02576288|Hormones|hormones|mesh-ancestor
43728575|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728576|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43728577|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728578|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728579|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728580|NCT02576275|Rituximab|rituximab|mesh-list
43728581|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43728582|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43728583|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728584|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
43728585|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728586|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43728587|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43728588|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
43728589|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728590|NCT02576223|Ropivacaine|ropivacaine|mesh-list
43728602|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728604|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43728605|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728606|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728607|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43728608|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43728609|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43728610|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43728611|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43741249|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43741250|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
43741251|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
43741252|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43741253|NCT02525458|Protective Agents|protective agents|mesh-ancestor
43741254|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741255|NCT02524899|Guanfacine|guanfacine|mesh-list
43741256|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43741257|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43741258|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43741259|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43741260|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
43741261|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741262|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741263|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741264|NCT02524964|Tanshinone|tanshinone|mesh-list
43741265|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728612|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43728613|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
43728614|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43728615|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43728616|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43728617|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
43728618|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728619|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728620|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43728621|NCT02576327|Dexamethasone|dexamethasone|mesh-list
43728622|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
43728623|NCT02576327|Aprepitant|aprepitant|mesh-list
43728624|NCT02576327|Tropisetron|tropisetron|mesh-list
43728625|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43728626|NCT02576327|BB 1101|bb 1101|mesh-list
43728627|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728628|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
43728629|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
43728630|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728631|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728632|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43728633|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
43728634|NCT02576327|Hormones|hormones|mesh-ancestor
43728635|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728636|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728637|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728638|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728639|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728640|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728641|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43728642|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741292|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43728643|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43728644|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43728646|NCT02576015|Lidocaine|lidocaine|mesh-list
43728648|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
43728649|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
43728650|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728651|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728652|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
43741339|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741340|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
43728653|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728654|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43728655|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43728656|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43728657|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43728658|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728659|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
43728660|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728661|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43728662|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728663|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560222|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728665|NCT02576119|BMS-955176|bms-955176|mesh-list
43728666|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43728667|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728668|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43728669|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43728670|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728671|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728672|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728680|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728681|NCT02575859|Cisplatin|cisplatin|mesh-list
43728682|NCT02575859|Mitomycins|mitomycins|mesh-list
43728683|NCT02575859|Mitomycin|mitomycin|mesh-list
43728684|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728685|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43728686|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
43728687|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728688|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43728689|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566090|NCT00839930|Cilostazol|cilostazol|mesh-list
43728690|NCT02575885|Nicotine|nicotine|mesh-list
43728691|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43728692|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
43728693|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728694|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728695|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43728696|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43728697|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
43728698|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728704|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728705|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43728706|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
43728707|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43728708|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
43728709|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
43728710|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728711|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728712|NCT02575755|Azithromycin|azithromycin|mesh-list
43728713|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
43728714|NCT02575755|Piperaquine|piperaquine|mesh-list
43728715|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
43728716|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43728717|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43728718|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728719|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
43728720|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43728721|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43728722|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43566110|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728723|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728724|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728725|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43566112|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
43728726|NCT02575755|Renal Agents|renal agents|mesh-ancestor
43728727|NCT02575729|Betamethasone|betamethasone|mesh-list
43728728|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
43728729|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728731|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728732|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728733|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43728736|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43728737|NCT02575677|Narcotics|narcotics|mesh-ancestor
43728738|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728739|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728740|NCT02575677|Analgesics|analgesics|mesh-ancestor
43728741|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
43728742|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728744|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43728745|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43728746|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43728747|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728748|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728749|NCT02575534|Procainamide|procainamide|mesh-list
43728750|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43560223|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43560224|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
43560225|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
43560226|NCT05084378|Povidone|povidone|mesh-list
43560227|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43560228|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560229|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43728754|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728757|NCT02575521|Sevoflurane|sevoflurane|mesh-list
43728758|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43728759|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728760|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728761|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43728762|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
43728763|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
43560240|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560241|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560242|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560243|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43560244|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566163|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43566174|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43566175|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566176|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566177|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43566178|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43566181|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43560245|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560246|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43560247|NCT05081102|Narcotics|narcotics|mesh-ancestor
43560248|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560249|NCT05072262|Dexamethasone|dexamethasone|mesh-list
43560250|NCT05072262|Nepafenac|nepafenac|mesh-list
43560251|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560252|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
43560253|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
43560254|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560255|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560256|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560257|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
43560258|NCT05072262|Hormones|hormones|mesh-ancestor
43560259|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43560260|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728764|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43728765|NCT02575521|Analgesics|analgesics|mesh-ancestor
43728766|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
43728767|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728768|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43728769|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43728771|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
43728772|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728773|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728774|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43728775|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43728776|NCT02575638|Camptothecin|camptothecin|mesh-list
43728777|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43728778|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728779|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43728780|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43728781|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728796|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
43728797|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728798|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43728799|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43728800|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43728801|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560261|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560262|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43560263|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43560264|NCT05072262|Analgesics|analgesics|mesh-ancestor
43566198|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
43566199|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
43835272|NCT05062980|Docetaxel|docetaxel|mesh-list
43560265|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
43560266|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560267|NCT05041257|Maytansine|maytansine|mesh-list
43560268|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43560269|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560278|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43560279|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560280|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560281|NCT04984278|Nabiximols|nabiximols|mesh-list
43560282|NCT04984278|Analgesics|analgesics|mesh-ancestor
43560283|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
43560284|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728802|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
43728803|NCT02575508|Fluorouracil|fluorouracil|mesh-list
43728804|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
43728805|NCT02575508|Irinotecan|irinotecan|mesh-list
43728806|NCT02575508|Camptothecin|camptothecin|mesh-list
43728807|NCT02575508|Infigratinib|infigratinib|mesh-list
43728808|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
43728809|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728810|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43728811|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728812|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43728813|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
43728814|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728815|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43728816|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43728817|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728818|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43833736|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
43833744|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833745|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43833746|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833747|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833748|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43560291|NCT04981678|Analgesics|analgesics|mesh-ancestor
43560292|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
43560293|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560294|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43560296|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43560297|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43560298|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
43560299|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560300|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566213|NCT00835991|Metformin|metformin|mesh-list
43560301|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560302|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43560303|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43560304|NCT04921982|Propranolol|propranolol|mesh-list
43560305|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43560306|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43560307|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
43560308|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560309|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560310|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560311|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43560312|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43560313|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
43560315|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43560316|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560317|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560318|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560319|NCT04866056|Azacitidine|azacitidine|mesh-list
43560320|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560321|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
43833766|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43833768|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
43833769|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43833770|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833771|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
43833772|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
43833773|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
43833774|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833775|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43833776|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833777|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43833778|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43560327|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
43560328|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560329|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560330|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
43560331|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43560350|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43560352|NCT04818086|Naloxone|naloxone|mesh-list
43560353|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43560354|NCT04818086|Narcotics|narcotics|mesh-ancestor
43833780|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833781|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
43728820|NCT02575248|Clomiphene|clomiphene|mesh-list
43728821|NCT02575248|Enclomiphene|enclomiphene|mesh-list
43728822|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
43728823|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43728824|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
43728825|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835295|NCT05062889|Irinotecan|irinotecan|mesh-list
43835296|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
43835297|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
43728826|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728827|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43728828|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
43728829|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43560355|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560356|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560357|NCT04818086|Analgesics|analgesics|mesh-ancestor
43560358|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
43560359|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560360|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43560361|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43560362|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560363|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560364|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43560365|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43560366|NCT04789148|Oxytocin|oxytocin|mesh-list
43560367|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
43560368|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43560369|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560370|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43560371|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
43560372|NCT04740645|Coagulants|coagulants|mesh-ancestor
43560373|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43560374|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
43560375|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560376|NCT04738942|Vedolizumab|vedolizumab|mesh-list
43560377|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43728830|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43728831|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43728832|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43741378|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741379|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741380|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741381|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43741382|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43741383|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43741384|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741385|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43741386|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43728833|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
43741387|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741388|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
43741389|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43741407|NCT05671029|Pritelivir|pritelivir|mesh-list
43728834|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43728835|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43728836|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43728837|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43728838|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728839|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728840|NCT02575183|Varenicline|varenicline|mesh-list
43728841|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43728842|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43728843|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
43728844|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728845|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728846|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741411|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43728847|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43728848|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
43728849|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43728850|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728851|NCT02575222|Nivolumab|nivolumab|mesh-list
43728852|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43728853|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728854|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43728855|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728856|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43728857|NCT02574962|Hormones|hormones|mesh-ancestor
43728858|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728859|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728860|NCT02575092|Folic Acid|folic acid|mesh-list
43728861|NCT02575092|Enalapril|enalapril|mesh-list
43728863|NCT02575092|Maleic acid|maleic acid|mesh-list
43728864|NCT02575092|Hematinics|hematinics|mesh-ancestor
43728865|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
43728866|NCT02575092|Vitamins|vitamins|mesh-ancestor
43728867|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
43728868|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728869|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728870|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728871|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43728872|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728873|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43728874|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
43728875|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43728876|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43728877|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43728878|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728879|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
43741412|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43728880|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43728881|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728882|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
43728883|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728884|NCT02574975|Budesonide|budesonide|mesh-list
43728885|NCT02574975|Adenosine|adenosine|mesh-list
43728886|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
43728887|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
43728888|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728889|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43728890|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
43728891|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728892|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728893|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43728894|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
43728899|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43728900|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43728901|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
43728902|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728903|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728904|NCT02574975|Analgesics|analgesics|mesh-ancestor
43728905|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
43728906|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43728907|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
43728908|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43728909|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
43728910|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
43728911|NCT02574975|Miotics|miotics|mesh-ancestor
43728912|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43728913|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43728914|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43728915|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43728916|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
43728917|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
43728918|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43728928|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728930|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
43728931|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560378|NCT04735185|Anesthetics|anesthetics|mesh-list
43560379|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
43560380|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560381|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560382|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
43560383|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560384|NCT04721977|Capecitabine|capecitabine|mesh-list
43560385|NCT04721977|Trastuzumab|trastuzumab|mesh-list
43560386|NCT04721977|Tucatinib|tucatinib|mesh-list
43560387|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560388|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
43560389|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560390|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560391|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560392|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43560393|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560394|NCT04692831|Pertuzumab|pertuzumab|mesh-list
43560395|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560396|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560397|NCT04685135|Docetaxel|docetaxel|mesh-list
43560407|NCT04648020|Clonidine|clonidine|mesh-list
43560408|NCT04648020|Analgesics|analgesics|mesh-ancestor
43728932|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728933|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43728934|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43728935|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
43728936|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43728937|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43728938|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43728939|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43728941|NCT02574663|Folic Acid|folic acid|mesh-list
43728942|NCT02574663|Gemcitabine|gemcitabine|mesh-list
43728943|NCT02574663|Paclitaxel|paclitaxel|mesh-list
43728944|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43728945|NCT02574663|Bevacizumab|bevacizumab|mesh-list
43728946|NCT02574663|Fluorouracil|fluorouracil|mesh-list
43728947|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
43728973|NCT02574663|Hematinics|hematinics|mesh-ancestor
43728974|NCT02574468|Dexamethasone|dexamethasone|mesh-list
43728975|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
43728976|NCT02574468|BB 1101|bb 1101|mesh-list
43728977|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728978|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
43728979|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
43728980|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728981|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728982|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43728983|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
43728984|NCT02574468|Hormones|hormones|mesh-ancestor
43728985|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728986|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728987|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728988|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
43729000|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
43729001|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729002|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43729003|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43729004|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43729005|NCT02574754|Warfarin|warfarin|mesh-list
43729006|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
43560420|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560421|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43729007|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
43729008|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43729009|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
43729010|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43729011|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729012|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43729013|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43729014|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43729015|NCT02574403|Eculizumab|eculizumab|mesh-list
43729016|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43560431|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729026|NCT02574338|Misoprostol|misoprostol|mesh-list
43729027|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43729028|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
43729029|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43729030|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729031|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43729032|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43729033|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
43729034|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43741445|NCT05670795|Enclomiphene|enclomiphene|mesh-list
43741446|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
43741447|NCT05670795|Menotropins|menotropins|mesh-list
43741448|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43741449|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
43729035|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
43729036|NCT02574338|Urological Agents|urological agents|mesh-ancestor
43729037|NCT02574156|Insulin|insulin|mesh-list
43729038|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43847534|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
43729039|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729040|NCT02574130|Amikacin|amikacin|mesh-list
43729041|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729042|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729043|NCT02573935|Clarithromycin|clarithromycin|mesh-list
43729044|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729048|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729049|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43729050|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43729052|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43729053|NCT02573909|Narcotics|narcotics|mesh-ancestor
43729054|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729055|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729056|NCT02573909|Analgesics|analgesics|mesh-ancestor
43729057|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
43729058|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729059|NCT02573922|Oxycodone|oxycodone|mesh-list
43741470|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
43741471|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741472|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43741473|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43741474|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
43741475|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
43544126|NCT03687463|Decitabine|decitabine|mesh-list
43741476|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
43741488|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
43741489|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
43741490|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
43741491|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741492|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741500|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
43741501|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
43741502|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43741503|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729060|NCT02573922|Naloxone|naloxone|mesh-list
43729062|NCT02573922|Narcotics|narcotics|mesh-ancestor
43729063|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729064|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729065|NCT02573922|Analgesics|analgesics|mesh-ancestor
43729066|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
43729067|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729068|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43729069|NCT02573987|Lidocaine|lidocaine|mesh-list
43729070|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
43729071|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
43729072|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
43729073|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729074|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729075|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
43729076|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729077|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43729078|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43729079|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43729080|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43729081|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729082|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43729083|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
43729084|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729085|NCT02573987|Analgesics|analgesics|mesh-ancestor
43729086|NCT02573714|Ketamine|ketamine|mesh-list
43729087|NCT02573714|Analgesics|analgesics|mesh-ancestor
43729088|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
43729089|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729090|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729091|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43729092|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729093|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
43729094|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
43729095|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729096|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43729097|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43729098|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729099|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729100|NCT02573701|Risperidone|risperidone|mesh-list
43729101|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
43729102|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43729103|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
43729104|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729105|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729106|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729107|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43729119|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833782|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43833783|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
43833784|NCT05189015|Olmesartan|olmesartan|mesh-list
43833785|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43833786|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43833787|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43833788|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43833789|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833790|NCT05187182|Leucovorin|leucovorin|mesh-list
43833791|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
43833792|NCT05187182|Nivolumab|nivolumab|mesh-list
43833793|NCT05187182|Trastuzumab|trastuzumab|mesh-list
43833794|NCT05187182|Oxaliplatin|oxaliplatin|mesh-list
43833795|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43833796|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833797|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43741516|NCT05670184|Ethanol|ethanol|mesh-list
43833798|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833799|NCT05187182|Antidotes|antidotes|mesh-ancestor
43833800|NCT05187182|Protective Agents|protective agents|mesh-ancestor
43833801|NCT05187182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833802|NCT05187182|Vitamin B Complex|vitamin b complex|mesh-ancestor
43833803|NCT05187182|Vitamins|vitamins|mesh-ancestor
43833804|NCT05187182|Micronutrients|micronutrients|mesh-ancestor
43833805|NCT05186545|Fulvestrant|fulvestrant|mesh-list
43833806|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43833807|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833808|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43833809|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43833810|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
43833811|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833812|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833813|NCT05185999|Icodextrin|icodextrin|mesh-list
43833814|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
43833815|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43833816|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
43833817|NCT05185739|Lenvatinib|lenvatinib|mesh-list
43833818|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43833819|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833820|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43833821|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833822|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833823|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
43833824|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43833825|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847535|NCT04094688|Leucovorin|leucovorin|mesh-list
43847536|NCT04094688|Bevacizumab|bevacizumab|mesh-list
43847537|NCT04094688|Fluorouracil|fluorouracil|mesh-list
43847538|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
43847539|NCT04094688|Irinotecan|irinotecan|mesh-list
43847540|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
43847541|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847542|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847543|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43847544|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43847545|NCT04094688|Growth Substances|growth substances|mesh-ancestor
43847546|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741522|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
43847547|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
43847548|NCT04094688|Vitamins|vitamins|mesh-ancestor
43847549|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
43847550|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43847551|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43847552|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
43847553|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847554|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43847555|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847556|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
43847557|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43847558|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43847559|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847560|NCT04094688|Antidotes|antidotes|mesh-ancestor
43847561|NCT04094688|Protective Agents|protective agents|mesh-ancestor
43729120|NCT02573610|Levofloxacin|levofloxacin|mesh-list
43729121|NCT02573610|Ofloxacin|ofloxacin|mesh-list
43729122|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43729123|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729124|NCT02573610|Renal Agents|renal agents|mesh-ancestor
43729125|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729126|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43729127|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43729128|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729129|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729130|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729131|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43566235|NCT00835692|Clarithromycin|clarithromycin|mesh-list
43729132|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43729133|NCT02573597|Sufentanil|sufentanil|mesh-list
43729134|NCT02573597|Bupivacaine|bupivacaine|mesh-list
43729135|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
43566236|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729136|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
43729152|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566237|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729154|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566238|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43566239|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729155|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729156|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
43729157|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
43560454|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560455|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43560456|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560457|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560458|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43560459|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43560460|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43560461|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
43560462|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729169|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729170|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43833826|NCT05183737|Propolis|propolis|mesh-list
43729171|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43729172|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
43729173|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729174|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43729175|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
43729177|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
43835359|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835360|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741534|NCT05669989|Dexamethasone|dexamethasone|mesh-list
43741535|NCT05669989|Lenalidomide|lenalidomide|mesh-list
43741536|NCT05669989|Pomalidomide|pomalidomide|mesh-list
43741537|NCT05669989|Cemiplimab|cemiplimab|mesh-list
43741538|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741539|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
43741540|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
43741541|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741542|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741543|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43741544|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
43566249|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729178|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43729179|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43729180|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
43729181|NCT02573558|Propofol|propofol|mesh-list
43729182|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43729183|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729191|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729192|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43729193|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43729194|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43729195|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
43729196|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729197|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729198|NCT02573363|Cytarabine|cytarabine|mesh-list
43729199|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
43729200|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43729201|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
43729202|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729203|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729204|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
43729205|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729206|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43729207|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
43729208|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729209|NCT02573363|Analgesics|analgesics|mesh-ancestor
43729210|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
43729211|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729212|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43729213|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43729214|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729215|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
43729216|NCT02573064|Vancomycin|vancomycin|mesh-list
43729217|NCT02573064|Colistin|colistin|mesh-list
43729218|NCT02573064|Tigecycline|tigecycline|mesh-list
43729219|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729220|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729221|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43729222|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729223|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729224|NCT02573220|Leucovorin|leucovorin|mesh-list
43729225|NCT02573220|Fluorouracil|fluorouracil|mesh-list
43729226|NCT02573220|Irinotecan|irinotecan|mesh-list
43729227|NCT02573220|Cetuximab|cetuximab|mesh-list
43729228|NCT02573220|Camptothecin|camptothecin|mesh-list
43729229|NCT02573220|Calcium|calcium|mesh-list
43729230|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
43729231|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43729232|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729233|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
43729234|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729235|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43729236|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729237|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43729238|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
43729243|NCT02573220|Protective Agents|protective agents|mesh-ancestor
43729244|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
43729245|NCT02573220|Vitamins|vitamins|mesh-ancestor
43729246|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
43729247|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847562|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
43729248|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43729249|NCT02573038|Aflibercept|aflibercept|mesh-list
43729250|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43729251|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43729252|NCT02573038|Growth Substances|growth substances|mesh-ancestor
43729253|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729254|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
43729255|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729256|NCT02573051|Isosorbide|isosorbide|mesh-list
43729257|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43729258|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43729259|NCT02573051|Misoprostol|misoprostol|mesh-list
43729260|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43729261|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
43729262|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43729263|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729264|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43729265|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43729266|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
43729267|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43729268|NCT02573051|Diuretics|diuretics|mesh-ancestor
43729269|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
43729270|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
43729271|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43729272|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729273|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43729274|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
43729275|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
43729276|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
43729277|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
43729278|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729279|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
43729280|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729281|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729282|NCT02572986|Permethrin|permethrin|mesh-list
43729283|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729284|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729285|NCT02572960|Vitamin D|vitamin d|mesh-list
43729286|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
43729287|NCT02572960|Valsartan|valsartan|mesh-list
43729288|NCT02572960|Vitamins|vitamins|mesh-ancestor
43729289|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
43729290|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729291|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43729292|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43729293|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43729294|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43729295|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43729296|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729297|NCT02572947|Dolutegravir|dolutegravir|mesh-list
43729298|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43729299|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43729300|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729301|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729302|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43729303|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43729304|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
43729305|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729306|NCT02572505|Tenofovir|tenofovir|mesh-list
43729307|NCT02572505|Emtricitabine|emtricitabine|mesh-list
43729308|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43729309|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
43729310|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729311|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43729312|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43729313|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729314|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729316|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43729317|NCT02572583|Oseltamivir|oseltamivir|mesh-list
43729318|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
43729319|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729320|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729321|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729322|NCT02572687|Durvalumab|durvalumab|mesh-list
43729323|NCT02572687|Ramucirumab|ramucirumab|mesh-list
43729324|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43729325|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729326|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
43729327|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43729328|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
43729329|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729330|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729331|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43729332|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
43729333|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729335|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43729336|NCT02572492|Dexamethasone|dexamethasone|mesh-list
43729337|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
43729338|NCT02572492|Melphalan|melphalan|mesh-list
43729339|NCT02572492|BB 1101|bb 1101|mesh-list
43729340|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729341|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
43729342|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
43729343|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729344|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729345|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43729346|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
43729347|NCT02572492|Hormones|hormones|mesh-ancestor
43729348|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729349|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43729350|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729351|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
43729352|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729373|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
43729374|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729375|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
43729376|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
43729377|NCT02572375|Expectorants|expectorants|mesh-ancestor
43729378|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43729379|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43729380|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
43729381|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729382|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729383|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
43729384|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43729385|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
43729386|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
43729387|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
43729388|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43729389|NCT02572089|Naloxone|naloxone|mesh-list
43833829|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43833831|NCT05182151|Istradefylline|istradefylline|mesh-list
43833832|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
43833833|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43833834|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43741604|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43833835|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
43833836|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833837|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833838|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833839|NCT05181605|Folfirinox|folfirinox|mesh-list
43833840|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833841|NCT05180708|Sirolimus|sirolimus|mesh-list
43833842|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43833843|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833844|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43833845|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833846|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
43833847|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43729425|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729426|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729427|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729428|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43729429|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43729430|NCT02571881|Oxycodone|oxycodone|mesh-list
43729431|NCT02571881|Naloxone|naloxone|mesh-list
43729432|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43729433|NCT02571881|Narcotics|narcotics|mesh-ancestor
43741605|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
43741606|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741607|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566257|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
43729434|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729435|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729436|NCT02571881|Analgesics|analgesics|mesh-ancestor
43729437|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
43729438|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729439|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43729440|NCT02571608|Metformin|metformin|mesh-list
43729441|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43729442|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729443|NCT02571283|Epinephrine|epinephrine|mesh-list
43729444|NCT02571283|Bupivacaine|bupivacaine|mesh-list
43729445|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
43729446|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
43729447|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729448|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729449|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
43729450|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729451|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729452|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
43729453|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43729454|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43729455|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
43729456|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729457|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43729458|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43729459|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43729460|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
43729461|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
43729462|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
43729463|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43729470|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
43729471|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
43729472|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729473|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
43729474|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
43729475|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729476|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729477|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43729478|NCT02571517|Hormones|hormones|mesh-ancestor
43729479|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729480|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43729481|NCT02571517|Protective Agents|protective agents|mesh-ancestor
43729482|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43729483|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729484|NCT02571556|Dexamethasone|dexamethasone|mesh-list
43729485|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43729486|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43729487|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729488|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
43729489|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
43729490|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729491|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729492|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43729493|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
43729494|NCT02571556|Hormones|hormones|mesh-ancestor
43729495|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741624|NCT05669482|Gemcitabine|gemcitabine|mesh-list
43729496|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43729497|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729498|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43729499|NCT02571426|Propofol|propofol|mesh-list
43729500|NCT02571426|Sevoflurane|sevoflurane|mesh-list
43729501|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43729502|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729503|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729504|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729505|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
43729506|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
43729507|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43729508|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43729509|NCT02571361|Acetaminophen|acetaminophen|mesh-list
43729510|NCT02571361|Ibuprofen|ibuprofen|mesh-list
43729511|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729512|NCT02571361|Analgesics|analgesics|mesh-ancestor
43729513|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
43729514|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729516|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
43729517|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43729518|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729519|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729520|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43729521|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729522|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729523|NCT02571543|Ibuprofen|ibuprofen|mesh-list
43729524|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43729525|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729526|NCT02571543|Analgesics|analgesics|mesh-ancestor
43729527|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
43729528|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729529|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729530|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729532|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43729533|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729534|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729535|NCT02571205|Testosterone|testosterone|mesh-list
43729536|NCT02571205|Androgens|androgens|mesh-ancestor
43729537|NCT02571205|Hormones|hormones|mesh-ancestor
43729538|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729539|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729540|NCT02571296|Progesterone|progesterone|mesh-list
43729541|NCT02571296|Progestins|progestins|mesh-ancestor
43729542|NCT02571296|Hormones|hormones|mesh-ancestor
43729543|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729544|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729545|NCT02571192|Volixibat|volixibat|mesh-list
43729546|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43729547|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
43729548|NCT02571400|Analgesics|analgesics|mesh-list
43729549|NCT02571400|Narcotics|narcotics|mesh-ancestor
43729550|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741639|NCT05669482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729551|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729552|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
43729553|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729554|NCT02571491|Ketamine|ketamine|mesh-list
43729555|NCT02571491|Morphine|morphine|mesh-list
43729556|NCT02571491|Remifentanil|remifentanil|mesh-list
43729557|NCT02571491|Analgesics|analgesics|mesh-ancestor
43729558|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
43729569|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729570|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43729571|NCT02571491|Narcotics|narcotics|mesh-ancestor
43729572|NCT02571166|Valacyclovir|valacyclovir|mesh-list
43729573|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
43729574|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729575|NCT02571179|Fentanyl|fentanyl|mesh-list
43729576|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43729577|NCT02571179|Narcotics|narcotics|mesh-ancestor
43729578|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729579|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729580|NCT02571179|Analgesics|analgesics|mesh-ancestor
43729581|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
43729582|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729583|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43729584|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729585|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
43729586|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
43729587|NCT02570893|Paclitaxel|paclitaxel|mesh-list
43729588|NCT02570893|Carboplatin|carboplatin|mesh-list
43729589|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43729590|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729591|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
43729592|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
43729594|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729596|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43729597|NCT02570971|Diuretics|diuretics|mesh-ancestor
43729598|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
43729614|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43729615|NCT02570789|Growth Substances|growth substances|mesh-ancestor
43729616|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729617|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
43729618|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43729619|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729620|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729622|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729623|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729624|NCT02570581|Acetaminophen|acetaminophen|mesh-list
43729625|NCT02570581|Ramipril|ramipril|mesh-list
43729626|NCT02570581|Furosemide|furosemide|mesh-list
43729627|NCT02570581|Memantine|memantine|mesh-list
43729628|NCT02570581|Alprazolam|alprazolam|mesh-list
43729629|NCT02570581|Zopiclone|zopiclone|mesh-list
43729630|NCT02570581|Oxazepam|oxazepam|mesh-list
43729631|NCT02570581|Donepezil|donepezil|mesh-list
43729632|NCT02570581|Clopidogrel|clopidogrel|mesh-list
43729633|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43729634|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43729635|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43729646|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43729647|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729648|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
43729649|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
43729650|NCT02570581|Diuretics|diuretics|mesh-ancestor
43729651|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
43729653|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43729655|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43729656|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
43729657|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43729658|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43729659|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43729660|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
43729661|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43729662|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43729663|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729664|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43729665|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43729666|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43729667|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
43729668|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
43729669|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43560463|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43560472|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
43560473|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560474|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560475|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560476|NCT04528329|Dexamethasone|dexamethasone|mesh-list
43729670|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
43729671|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729672|NCT02570230|Ketamine|ketamine|mesh-list
43729673|NCT02570230|Analgesics|analgesics|mesh-ancestor
43729674|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
43729675|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729676|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729677|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43729678|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729679|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
43729680|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
43729681|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729682|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43729683|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43729684|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729685|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729688|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729690|NCT02570243|Calcium heparin|calcium heparin|mesh-list
43729691|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
43729692|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43729693|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43729694|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833856|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
43833857|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833858|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833859|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43833860|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43833861|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43833862|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833863|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43833864|NCT05179772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43833865|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43833866|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43833867|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833868|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833869|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
43833870|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43833871|NCT05178485|Bupivacaine|bupivacaine|mesh-list
43833872|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
43833873|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
43833874|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833875|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833876|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
43833877|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833878|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43833879|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
43833880|NCT05178485|Hormones|hormones|mesh-ancestor
43741683|NCT05667376|Curcumin|curcumin|mesh-list
43833881|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833882|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560488|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43560489|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560490|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
43560491|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560492|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560493|NCT04486833|Osimertinib|osimertinib|mesh-list
43560494|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560495|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43560496|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560497|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560498|NCT04484623|Dexamethasone|dexamethasone|mesh-list
43560499|NCT04484623|Bortezomib|bortezomib|mesh-list
43560500|NCT04484623|Pomalidomide|pomalidomide|mesh-list
43729706|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43729708|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
43729709|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729710|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729711|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729712|NCT02570035|Urological Agents|urological agents|mesh-ancestor
43729713|NCT02569970|Fluoxetine|fluoxetine|mesh-list
43729714|NCT02569970|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43729715|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43729716|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43729717|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560510|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43560511|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560512|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
43560513|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43560514|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43560515|NCT04484623|Growth Substances|growth substances|mesh-ancestor
43560516|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
43729718|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729719|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
43729720|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729721|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43729722|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
43729723|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43560527|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560528|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
43560529|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560530|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560535|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560536|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43560537|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43560538|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43560539|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560541|NCT04385290|Daunorubicin|daunorubicin|mesh-list
43560542|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
43560543|NCT04385290|Midostaurin|midostaurin|mesh-list
43560544|NCT04385290|Staurosporine|staurosporine|mesh-list
43560545|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560546|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
43741687|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
43741688|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741689|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741690|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741691|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43741692|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741693|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741694|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560547|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560548|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560549|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
43560550|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560551|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560552|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
43729724|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43729725|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43729726|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729727|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
43729729|NCT02569905|Analgesics|analgesics|mesh-ancestor
43729730|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
43729731|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729732|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560553|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560554|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43560555|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43560556|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43560557|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560558|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560559|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43560560|NCT04343235|Labetalol|labetalol|mesh-list
43560561|NCT04343235|Furosemide|furosemide|mesh-list
43560562|NCT04343235|Diuretics|diuretics|mesh-ancestor
43560563|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
43560564|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560565|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43560566|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43560567|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560573|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
43560574|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
43560575|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560576|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43560577|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43560578|NCT04235140|Ivacaftor|ivacaftor|mesh-list
43560579|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43560580|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43560581|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560582|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43560583|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560584|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
43560585|NCT04214418|Atezolizumab|atezolizumab|mesh-list
43560586|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560587|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
43560588|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43560589|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43560590|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729733|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43729734|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729735|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729736|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729737|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43729738|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729739|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729740|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43741697|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741698|NCT05667220|Incretins|incretins|mesh-ancestor
43741699|NCT05667220|Hormones|hormones|mesh-ancestor
43741700|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741701|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43741702|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
43741703|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741705|NCT05666362|Benoxinate|benoxinate|mesh-list
43729741|NCT02569814|Amlodipine|amlodipine|mesh-list
43729742|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43729743|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43729744|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43729745|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43729746|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729747|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43560591|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560592|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560593|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560594|NCT04210713|Minocycline|minocycline|mesh-list
43560595|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43560596|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560612|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
43729748|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729749|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
43729750|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43729751|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43729752|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
43729753|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43729755|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729756|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
43729757|NCT02569515|Hematinics|hematinics|mesh-ancestor
43729758|NCT02569463|Aldesleukin|aldesleukin|mesh-list
43729759|NCT02569463|Interleukin-2|interleukin-2|mesh-list
43729760|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729761|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729762|NCT02569463|Analgesics|analgesics|mesh-ancestor
43729763|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
43729764|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560613|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560614|NCT04046887|Gemcitabine|gemcitabine|mesh-list
43560616|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43560617|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560618|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
43560619|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
43560620|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
43560621|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560622|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560623|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
43729765|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729766|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43729767|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43729768|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
43729769|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729770|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
43729771|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43729772|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43729773|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729774|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43729775|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43729776|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
43729777|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729778|NCT02569554|Rabeprazole|rabeprazole|mesh-list
43729779|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43729780|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43729781|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43729782|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729783|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729784|NCT02569346|Triumeq|triumeq|mesh-list
43729787|NCT02569346|Dolutegravir|dolutegravir|mesh-list
43729788|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43729789|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43729790|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
43729791|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729792|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43729793|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43729794|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729795|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729796|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43729797|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43729798|NCT02569307|Minocycline|minocycline|mesh-list
43729799|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729800|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729801|NCT02569073|Dronabinol|dronabinol|mesh-list
43729802|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
43729806|NCT02569073|Analgesics|analgesics|mesh-ancestor
43729807|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
43729808|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729809|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43729810|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43729811|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729812|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729813|NCT02569073|Hormones|hormones|mesh-ancestor
43729814|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729815|NCT02569320|Dexamethasone|dexamethasone|mesh-list
43729816|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
43729817|NCT02569320|Pomalidomide|pomalidomide|mesh-list
43729818|NCT02569320|Ichthammol|ichthammol|mesh-list
43729819|NCT02569320|BB 1101|bb 1101|mesh-list
43729820|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43729821|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729822|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
43729823|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
43729824|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729825|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729826|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43729827|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
43729828|NCT02569320|Hormones|hormones|mesh-ancestor
43560624|NCT04046887|Antiviral Agents|antiviral agents|mesh-ancestor
43560625|NCT04046887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560626|NCT04046887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560627|NCT04046887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560628|NCT04046887|Immunologic Factors|immunologic factors|mesh-ancestor
43560629|NCT04046887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560630|NCT04016714|Vaccines|vaccines|mesh-list
43729829|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729830|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43729831|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729832|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
43729833|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729834|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729835|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
43729836|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43729837|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43729838|NCT02569320|Growth Substances|growth substances|mesh-ancestor
43729839|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
43729840|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
43729841|NCT02569125|Everolimus|everolimus|mesh-list
43729842|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729844|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
43729845|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729847|NCT02568995|Epinephrine|epinephrine|mesh-list
43729848|NCT02568995|Racepinephrine|racepinephrine|mesh-list
43729849|NCT02568995|Ropivacaine|ropivacaine|mesh-list
43729850|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
43729851|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
43729852|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
43729853|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729855|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
43729878|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729879|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43729880|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729881|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729882|NCT02568839|Docetaxel|docetaxel|mesh-list
43729883|NCT02568839|Trastuzumab|trastuzumab|mesh-list
43729884|NCT02568839|Pertuzumab|pertuzumab|mesh-list
43729885|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729886|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
43729887|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
43729888|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
43729889|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729890|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43729891|NCT02568800|Cefepime|cefepime|mesh-list
43729892|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729896|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43544502|NCT03681197|Metformin|metformin|mesh-list
43741731|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741732|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
43729897|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729898|NCT02568735|Etoricoxib|etoricoxib|mesh-list
43741733|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741734|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729899|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43729900|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43729901|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729902|NCT02568735|Analgesics|analgesics|mesh-ancestor
43729903|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
43729904|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729905|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729906|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729907|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729908|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43729909|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43729910|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729911|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729912|NCT02568618|Analgesics|analgesics|mesh-list
43729913|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
43729914|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729915|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729917|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43729918|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729919|NCT02568241|Interferons|interferons|mesh-list
43729920|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
43729921|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
43729922|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729923|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
43729924|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729925|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
43729926|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833885|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43833886|NCT05177718|Natalizumab|natalizumab|mesh-list
43833887|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
43833888|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833889|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43833890|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
43833891|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833892|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43833893|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43833894|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
43833895|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833896|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833897|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43833898|NCT05177133|Capecitabine|capecitabine|mesh-list
43833900|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43833901|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
43833902|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833903|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833904|NCT05176821|Amoxicillin|amoxicillin|mesh-list
43729927|NCT02568280|Insulin|insulin|mesh-list
43729928|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43729929|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
43729930|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
43729931|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43729932|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43741759|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741760|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43741761|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43741762|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
43741763|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741764|NCT05655806|Protective Agents|protective agents|mesh-ancestor
43729933|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729934|NCT02568176|Midazolam|midazolam|mesh-list
43729935|NCT02568176|Bupropion|bupropion|mesh-list
43729936|NCT02568176|Esketamine|esketamine|mesh-list
43729937|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43729938|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43729939|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729980|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729981|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729982|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
43729983|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
43729984|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43729985|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43729986|NCT02568423|Mirikizumab|mirikizumab|mesh-list
43560631|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43560632|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
43560633|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560635|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560636|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43560637|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43560638|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560639|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560640|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43560641|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
43560642|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43560643|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560644|NCT03956680|Nivolumab|nivolumab|mesh-list
43560645|NCT03956680|Ipilimumab|ipilimumab|mesh-list
43560646|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560647|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560648|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43560649|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560650|NCT03946800|Durvalumab|durvalumab|mesh-list
43560651|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560652|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729987|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43729989|NCT02568423|Analgesics|analgesics|mesh-ancestor
43729990|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
43729991|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729992|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729993|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729994|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729995|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43729996|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43729997|NCT02568111|Interferons|interferons|mesh-list
43729999|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
43730000|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43730001|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730002|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
43730003|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730004|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
43730005|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560659|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741773|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
43741774|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
43741775|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43741776|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
43741777|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741778|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43741779|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43741780|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43741781|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43560660|NCT03859687|Protective Agents|protective agents|mesh-ancestor
43560661|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43560662|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560663|NCT03844620|Trifluridine|trifluridine|mesh-list
43560664|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
43560665|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560666|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
43560702|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
43560703|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560704|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
43560705|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43560706|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
43560732|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
43560733|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
43560734|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
43560735|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560736|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560738|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560739|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
43560740|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560741|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560742|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560743|NCT03610061|Durvalumab|durvalumab|mesh-list
43560744|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560745|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560746|NCT03572283|Bethanechol|bethanechol|mesh-list
43560747|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43560748|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
43730018|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730020|NCT02568033|Docetaxel|docetaxel|mesh-list
43730021|NCT02568033|Cisplatin|cisplatin|mesh-list
43730022|NCT02568033|Carboplatin|carboplatin|mesh-list
43730023|NCT02568033|Pemetrexed|pemetrexed|mesh-list
43730024|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43730025|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730026|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
43730027|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
43560756|NCT03446040|Nivolumab|nivolumab|mesh-list
43560768|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560769|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43741785|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43741786|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
43741787|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741788|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43741789|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43741790|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741791|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43741792|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43560770|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43560771|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
43560773|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560774|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43560775|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43560776|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560777|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560779|NCT03321513|Aflibercept|aflibercept|mesh-list
43560780|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560781|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560782|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43560783|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43560784|NCT03321513|Growth Substances|growth substances|mesh-ancestor
43560785|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560786|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
43560787|NCT03287908|Dexamethasone|dexamethasone|mesh-list
43560788|NCT03287908|Pomalidomide|pomalidomide|mesh-list
43560789|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560790|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
43560791|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
43560792|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560793|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560794|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560795|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
43560796|NCT03287908|Hormones|hormones|mesh-ancestor
43560797|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43560798|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43560799|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560800|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
43730028|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
43730029|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730030|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730031|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43730032|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43730033|NCT02567916|Propofol|propofol|mesh-list
43730034|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43730035|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730036|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730037|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43730038|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
43741818|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43730039|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
43741819|NCT05644223|Protective Agents|protective agents|mesh-ancestor
43741820|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835361|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
43835362|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
43835375|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43835376|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835378|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
43835379|NCT05058976|Calcium|calcium|mesh-list
43730040|NCT02567929|Propofol|propofol|mesh-list
43730041|NCT02567929|Sevoflurane|sevoflurane|mesh-list
43730042|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43730043|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730044|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730045|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43730046|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
43730047|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
43730064|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730065|NCT02567773|Itraconazole|itraconazole|mesh-list
43730066|NCT02567773|GSK2881078|gsk2881078|mesh-list
43730067|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
43730068|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730069|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43730070|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43730071|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730072|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730075|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43730076|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730077|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43730078|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
43730079|NCT02567773|Hormones|hormones|mesh-ancestor
43730080|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
43730081|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
43730082|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
43730083|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730084|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730085|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
43730086|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730087|NCT02567383|Cisplatin|cisplatin|mesh-list
43730088|NCT02567383|Docetaxel|docetaxel|mesh-list
43730089|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730090|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
43730091|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
43730092|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
43730093|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730094|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
43560803|NCT03287908|Growth Substances|growth substances|mesh-ancestor
43560804|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
43835395|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835396|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43835397|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835398|NCT05057767|Midazolam|midazolam|mesh-list
43835399|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43835400|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43835401|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560805|NCT03270501|Golimumab|golimumab|mesh-list
43560806|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43560807|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560808|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560809|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
43560810|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560811|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
43560812|NCT03264404|Azacitidine|azacitidine|mesh-list
43560813|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560814|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560815|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43730096|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43730097|NCT02567461|Aspirin|aspirin|mesh-list
43730098|NCT02567461|Edoxaban|edoxaban|mesh-list
43730099|NCT02567461|Clopidogrel|clopidogrel|mesh-list
43741839|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730100|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43730101|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730102|NCT02567461|Analgesics|analgesics|mesh-ancestor
43730103|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
43730104|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730105|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730106|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43730107|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43730108|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43560816|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
43560817|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560818|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560838|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560839|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560840|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
43560841|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560842|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560843|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43560844|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43560845|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43730110|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730111|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43741909|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43741910|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
43741911|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741912|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741913|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43741914|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43741915|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
43741916|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741917|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43741918|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43741919|NCT05567601|Doxorubicin|doxorubicin|mesh-list
43741920|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43566272|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566273|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43566274|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
43566275|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
43566276|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566277|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730112|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43730113|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730114|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
43730115|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43730116|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43730121|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
43730122|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43730123|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
43730124|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
43730125|NCT02567396|Talazoparib|talazoparib|mesh-list
43730126|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43730127|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730128|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730129|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730130|NCT02567799|Paclitaxel|paclitaxel|mesh-list
43730131|NCT02567799|Carboplatin|carboplatin|mesh-list
43730132|NCT02567799|Genistein|genistein|mesh-list
43730134|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730135|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
43730136|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
43730137|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
43730138|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730139|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43730140|NCT02567799|Protective Agents|protective agents|mesh-ancestor
43730141|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566278|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730142|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43730143|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730144|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
43730145|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43730146|NCT02567799|Estrogens|estrogens|mesh-ancestor
43730147|NCT02567799|Hormones|hormones|mesh-ancestor
43833905|NCT05176821|Furazolidone|furazolidone|mesh-list
43694101|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560885|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566279|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43566280|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566281|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566282|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43566283|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43741921|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43741922|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741923|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43741924|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43741925|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741926|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560886|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560887|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43560888|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
43560889|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560890|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560899|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43560901|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43560902|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43560903|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43730175|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730176|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
43730177|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
43730178|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730179|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
43730180|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730181|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730182|NCT02566967|Tofacitinib|tofacitinib|mesh-list
43730183|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43730184|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730185|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560904|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560905|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43560906|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
43560907|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43560908|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560909|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
43560910|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
43560911|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43560912|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43560913|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43560914|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
43560915|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560916|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
43560917|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
43560918|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
43730187|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
43730188|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43730189|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
43730190|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730191|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730192|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43730193|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
43730194|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
43730195|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43730196|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
43730197|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730198|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730199|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43730200|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43730201|NCT02566824|Methylphenidate|methylphenidate|mesh-list
43730202|NCT02566824|Amphetamine|amphetamine|mesh-list
43730203|NCT02566824|Adderall|adderall|mesh-list
43730204|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
43730205|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43730206|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730207|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43730208|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43730233|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43741998|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43730234|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43730235|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741999|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
43742000|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742001|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43742002|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43742003|NCT05477108|Budesonide|budesonide|mesh-list
43742004|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
43730236|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730237|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
43730238|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730239|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43730240|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43730241|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43730242|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43730243|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
43730244|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43730245|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43730247|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43730248|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43730249|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
43730250|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730251|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
43730252|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730253|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730254|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833910|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43833911|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833912|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43560934|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43560936|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43560937|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560938|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
43560939|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560940|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
43560941|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560942|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43560943|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560944|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43560945|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43560946|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43560947|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
43560948|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43560949|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560950|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
43833924|NCT05176821|Renal Agents|renal agents|mesh-ancestor
43833925|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43833926|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43833927|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43833928|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43833929|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
43833930|NCT05175781|Ketamine|ketamine|mesh-list
43833931|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43833932|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833933|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833934|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43833935|NCT05175781|Analgesics|analgesics|mesh-ancestor
43833936|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
43833937|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833938|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43833939|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43833940|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43833941|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
43833942|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833943|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730267|NCT02566356|Oxytocin|oxytocin|mesh-list
43730268|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
43730269|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43742038|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742039|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43742040|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43742041|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742042|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
43742043|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742044|NCT05460871|Pregabalin|pregabalin|mesh-list
43742045|NCT05460871|Analgesics|analgesics|mesh-ancestor
43742046|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
43742050|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43742054|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43730270|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730271|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
43730272|NCT02566252|Albuterol|albuterol|mesh-list
43730273|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
43730274|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43730275|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
43730276|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730277|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730290|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43730291|NCT02565979|Resveratrol|resveratrol|mesh-list
43730292|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
43730293|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730294|NCT02565979|Protective Agents|protective agents|mesh-ancestor
43730295|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730296|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730297|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43730298|NCT02565953|Paclitaxel|paclitaxel|mesh-list
43730299|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43730300|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566325|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43566326|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43566327|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
43566328|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
43566329|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566330|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566331|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566332|NCT00835263|Lamotrigine|lamotrigine|mesh-list
43566333|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
43566334|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43566335|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566336|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566337|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566338|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742065|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43742066|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
43742067|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
43742068|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
43730301|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
43730302|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
43730303|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
43730304|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730305|NCT02566187|Atorvastatin|atorvastatin|mesh-list
43730306|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43730307|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43730308|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
43730309|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730310|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43730311|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43730312|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730313|NCT02566096|Morphine|morphine|mesh-list
43730314|NCT02566096|Bupivacaine|bupivacaine|mesh-list
43730315|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
43730316|NCT02566096|Anesthetics|anesthetics|mesh-list
43730317|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730318|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730319|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
43730320|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730321|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43730322|NCT02566096|Narcotics|narcotics|mesh-ancestor
43730323|NCT02566096|Analgesics|analgesics|mesh-ancestor
43730324|NCT02566226|Morphine|morphine|mesh-list
43730325|NCT02566226|Bupivacaine|bupivacaine|mesh-list
43730326|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
43730327|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
43730328|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730329|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730330|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
43730331|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730332|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43730333|NCT02566226|Narcotics|narcotics|mesh-ancestor
43730334|NCT02566226|Analgesics|analgesics|mesh-ancestor
43730335|NCT02565888|Ritonavir|ritonavir|mesh-list
43742094|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
43742117|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
43730336|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43730337|NCT02565888|Cobicistat|cobicistat|mesh-list
43730338|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43730339|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43730340|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
43730341|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730342|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730343|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43730344|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43730345|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
43730346|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730347|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43730348|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43730349|NCT02565719|Interferons|interferons|mesh-list
43730350|NCT02565719|Tenofovir|tenofovir|mesh-list
43730351|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
43730352|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
43730353|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43730354|NCT02565719|REP 2139|rep 2139|mesh-list
43730355|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730356|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
43730357|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730358|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43730359|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43730360|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730361|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730362|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43730363|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43730364|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
43730412|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43566393|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43742175|NCT05366816|Sunitinib|sunitinib|mesh-list
43730413|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730414|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
43730415|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43730416|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43730417|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43730418|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
43730419|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730420|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43730421|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
43730422|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43742217|NCT05351489|Bupivacaine|bupivacaine|mesh-list
43742218|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
43742219|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
43742220|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742221|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742222|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
43742223|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742224|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43742225|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43742226|NCT05351489|Analgesics|analgesics|mesh-ancestor
43742227|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43742228|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43742229|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43742230|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
43742231|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742232|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742233|NCT05347004|BI 425809|bi 425809|mesh-list
43742234|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
43742235|NCT05324358|Ketorolac|ketorolac|mesh-list
43742236|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43730423|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
43730424|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
43730425|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43730426|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
43730427|NCT02565602|Vitamin D|vitamin d|mesh-list
43730428|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
43730429|NCT02565602|Vitamins|vitamins|mesh-ancestor
43730430|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
43730431|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730432|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43730433|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43730434|NCT02565368|Metformin|metformin|mesh-list
43730435|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43730436|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730437|NCT02565212|Montelukast|montelukast|mesh-list
43730438|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43730439|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
43730440|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43730441|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
43730442|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43730451|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730452|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
43730453|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730454|NCT02565316|Sertraline|sertraline|mesh-list
43730455|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
43730456|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43730457|NCT02565316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43730458|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43730459|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730460|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730461|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730462|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
43730463|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730464|NCT02565173|Timolol|timolol|mesh-list
43742275|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43742276|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43742277|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742278|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43742279|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
43742280|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43742281|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742282|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43730465|NCT02565173|Adenosine|adenosine|mesh-list
43730466|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43730467|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43730468|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
43730469|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730470|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730471|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730472|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43730473|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43730474|NCT02565173|Analgesics|analgesics|mesh-ancestor
43730475|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
43730476|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730477|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
43730478|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43730479|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
43730480|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
43730481|NCT02564861|DS-1971a|ds-1971a|mesh-list
43730482|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43730483|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43730484|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730485|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833944|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43833945|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43566415|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566416|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43833946|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
43833947|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
43833948|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43833949|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43833950|NCT05174611|Vitamin D|vitamin d|mesh-list
43833951|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
43833952|NCT05174611|Vitamins|vitamins|mesh-ancestor
43833953|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
43730486|NCT02564536|Decitabine|decitabine|mesh-list
43566418|NCT00834873|Protective Agents|protective agents|mesh-ancestor
43566419|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43742300|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742301|NCT05297565|Nivolumab|nivolumab|mesh-list
43742302|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742303|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730544|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
43730545|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
43730546|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730547|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730548|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
43730549|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730566|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730567|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730568|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730569|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43730570|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
43730571|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
43730572|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730573|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730574|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
43730575|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730576|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43730577|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43730578|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43730579|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730580|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
43730581|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730583|NCT02563704|Quinine|quinine|mesh-list
43730584|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
43730585|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43730586|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43730587|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730588|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730589|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
43560954|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
43560955|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560956|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560965|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43560966|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560967|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43560969|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43835489|NCT05048524|Leucovorin|leucovorin|mesh-list
43560970|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43835490|NCT05048524|Gemcitabine|gemcitabine|mesh-list
43835491|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
43560971|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560972|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560973|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
43560974|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43560975|NCT02763579|Carboplatin|carboplatin|mesh-list
43560976|NCT02763579|Etoposide|etoposide|mesh-list
43560977|NCT02763579|Atezolizumab|atezolizumab|mesh-list
43730592|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
43730593|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43730594|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730595|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43730596|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730597|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730598|NCT02563704|Analgesics|analgesics|mesh-ancestor
43730599|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
43730600|NCT02563821|Clonidine|clonidine|mesh-list
43730601|NCT02563821|Sufentanil|sufentanil|mesh-list
43730602|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
43730603|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43730604|NCT02563821|Narcotics|narcotics|mesh-ancestor
43730605|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730606|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730607|NCT02563821|Analgesics|analgesics|mesh-ancestor
43730608|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
43730610|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43566436|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566442|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566443|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566445|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43742387|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43742388|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43742389|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43742391|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
43742392|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730611|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43730612|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
43730613|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
43730614|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43730615|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
43730616|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
43730617|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43730618|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43730619|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43730620|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
43730621|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566446|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566447|NCT00834717|Granisetron|granisetron|mesh-list
43566448|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
43566449|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
43566450|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566451|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566452|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43566453|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43566454|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
43566455|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566456|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566457|NCT00834639|Valproic Acid|valproic acid|mesh-list
43566458|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
43566459|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566460|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566461|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
43566462|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566463|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730622|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730623|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
43730625|NCT02563405|Nifedipine|nifedipine|mesh-list
43730626|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43730627|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730628|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730629|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43560990|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43561001|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43561002|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43561003|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43561004|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561005|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561006|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
43561007|NCT02733133|Testosterone|testosterone|mesh-list
43561008|NCT02733133|Androgens|androgens|mesh-ancestor
43561009|NCT02733133|Hormones|hormones|mesh-ancestor
43730630|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730631|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
43730632|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
43730633|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43730634|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43730635|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43730636|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43730637|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43730638|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
43730639|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730640|NCT02563340|Rituximab|rituximab|mesh-list
43561010|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561011|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561012|NCT02721082|Nicotine|nicotine|mesh-list
43561013|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43561014|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
43561015|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561016|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561017|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43561018|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43561019|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
43561020|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561021|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561022|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
43561023|NCT02657889|Niraparib|niraparib|mesh-list
43561031|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43561033|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561034|NCT02550002|Aflibercept|aflibercept|mesh-list
43561035|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43561036|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43561037|NCT02550002|Growth Substances|growth substances|mesh-ancestor
43561038|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561039|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
43561040|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561041|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
43561042|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
43730643|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566465|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566466|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566467|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566468|NCT00834613|Metformin|metformin|mesh-list
43566469|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566470|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566471|NCT00834587|Metformin|metformin|mesh-list
43566472|NCT00834587|Glipizide|glipizide|mesh-list
43566473|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566474|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730644|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
43730645|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730646|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43730647|NCT02563353|Teriparatide|teriparatide|mesh-list
43730648|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43694102|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
43561058|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561060|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43561061|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
43561062|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561063|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561064|NCT02250534|Nicotine|nicotine|mesh-list
43561065|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43561066|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
43561067|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561068|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561069|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43561070|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43561071|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
43561072|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561073|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561074|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
43730654|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
43730655|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
43730656|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
43730657|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43730658|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730659|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730660|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730661|NCT02563288|Analgesics|analgesics|mesh-ancestor
43730662|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
43742430|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
43730663|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742431|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742432|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742433|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43742434|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
43742435|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742436|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742437|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43742438|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742439|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43742442|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730664|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43730665|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730667|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43730668|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43730669|NCT02563327|Pyridoxine|pyridoxine|mesh-list
43730670|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
43730671|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
43730672|NCT02563327|Rifampin|rifampin|mesh-list
43730673|NCT02563327|Isoniazid|isoniazid|mesh-list
43730674|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
43730675|NCT02563327|Ethambutol|ethambutol|mesh-list
43730676|NCT02563327|Rifapentine|rifapentine|mesh-list
43730677|NCT02563327|Vitamins|vitamins|mesh-ancestor
43730678|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
43730723|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43730727|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
43730728|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
43730729|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
43730730|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
43730731|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833966|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730741|NCT02562417|Dexamethasone|dexamethasone|mesh-list
43730742|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43730743|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
43730744|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
43742536|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742537|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
43742538|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742539|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
43742540|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
43742541|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
43742542|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
43742543|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
43730745|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730746|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561084|NCT02229136|Hormones|hormones|mesh-ancestor
43561101|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730747|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43730749|NCT02562417|Hormones|hormones|mesh-ancestor
43730750|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43730751|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43730752|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730753|NCT02562651|Doxycycline|doxycycline|mesh-list
43730754|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43730755|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730756|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
43566495|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
43566496|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566497|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566498|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43566499|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43566500|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
43566501|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566502|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566503|NCT00834444|Famciclovir|famciclovir|mesh-list
43566504|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
43566505|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566506|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43566507|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566535|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566536|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43849045|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566537|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43566538|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43566539|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566540|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566541|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566542|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566543|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43566544|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
43730757|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43730758|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43730759|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
43561102|NCT02099123|Atorvastatin|atorvastatin|mesh-list
43561103|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43561104|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43561106|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561107|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43561108|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43561109|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561110|NCT01874860|Doxycycline|doxycycline|mesh-list
43561111|NCT01874860|Clindamycin|clindamycin|mesh-list
43561112|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
43561113|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
43561114|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
43561115|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
43561116|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43561117|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43561118|NCT01874860|Prednisolone|prednisolone|mesh-list
43742685|NCT05035836|Tamoxifen|tamoxifen|mesh-list
43742686|NCT05035836|Letrozole|letrozole|mesh-list
43561119|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
43561120|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
43561121|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43561122|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
43561123|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561124|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43561125|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730760|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43730773|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
43730774|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730775|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730776|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
43730777|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730778|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43730779|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43730780|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43730781|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730782|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730784|NCT02562300|Oxytocin|oxytocin|mesh-list
43730785|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
43730786|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43730787|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730788|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43730789|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
43730790|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43730791|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43730792|NCT02562118|Letrozole|letrozole|mesh-list
43730793|NCT02562118|Lenvatinib|lenvatinib|mesh-list
43730794|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730795|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43730796|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43730797|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730798|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730799|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43730800|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
43835536|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43835537|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566574|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835548|NCT05041842|Trastuzumab|trastuzumab|mesh-list
43835568|NCT05039632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835569|NCT05039632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730801|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43730802|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730803|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43730804|NCT02562183|Kallikreins|kallikreins|mesh-list
43730805|NCT02562183|Coagulants|coagulants|mesh-ancestor
43730806|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
43730807|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
43730808|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43730809|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730811|NCT02562287|Risperidone|risperidone|mesh-list
43742755|NCT05001880|Growth Substances|growth substances|mesh-ancestor
43730812|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43730813|NCT02562287|Clozapine|clozapine|mesh-list
43730814|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43561126|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
43561127|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43561128|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43561129|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
43561130|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
43561131|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561132|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561133|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561134|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
43561135|NCT01874860|Hormones|hormones|mesh-ancestor
43742756|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742757|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
43561136|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561137|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43742758|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
43742759|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742760|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742761|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43742762|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43742763|NCT04996719|Sirolimus|sirolimus|mesh-list
43742764|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43545740|NCT03668964|Vitamins|vitamins|mesh-list
43742767|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742768|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
43742769|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561138|NCT01874860|Protective Agents|protective agents|mesh-ancestor
43561139|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43561140|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561141|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43561142|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561143|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561144|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43561145|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
43566599|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561146|NCT01165645|Ritonavir|ritonavir|mesh-list
43561148|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43561149|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43561150|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
43561151|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561152|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561154|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43561155|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
43561156|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561157|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43561158|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43561159|NCT00135226|Aspirin|aspirin|mesh-list
43561160|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43561161|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43561162|NCT00135226|Analgesics|analgesics|mesh-ancestor
43561163|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
43561164|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742824|NCT04965090|Lazertinib|lazertinib|mesh-list
43742825|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43742826|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742827|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561165|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561166|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561167|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43730819|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43742853|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730820|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43730821|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730822|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43730823|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43730824|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
43730825|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
43730826|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
43730827|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730828|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43730829|NCT02562287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43730830|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43730831|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730832|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
43730833|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
43730834|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
43730835|NCT02562053|Fluoxetine|fluoxetine|mesh-list
43730836|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
43730837|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
43730838|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43730839|NCT02562053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43730840|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43730841|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730842|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730843|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730844|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
43730845|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730846|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43730847|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
43730848|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43730849|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43730850|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43730851|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730852|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43730853|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43730854|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
43730860|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742888|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742890|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43742891|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43742892|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742893|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
43742894|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730861|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730862|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
43730863|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730864|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43730865|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43730866|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
43730867|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
43730868|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43730869|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43730870|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730900|NCT02561767|Tacrolimus|tacrolimus|mesh-list
43730901|NCT02561767|Basiliximab|basiliximab|mesh-list
43730902|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43730903|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
43730904|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730905|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43730906|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730907|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730908|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43730909|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730910|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43730911|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
43730912|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43730913|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730914|NCT02561494|Nefopam|nefopam|mesh-list
43730915|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730916|NCT02561494|Analgesics|analgesics|mesh-ancestor
43730917|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
43742912|NCT04929223|Atezolizumab|atezolizumab|mesh-list
43742913|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742914|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742915|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43566662|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43566663|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
43566664|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
43566665|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566666|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566667|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566668|NCT00830206|Azithromycin|azithromycin|mesh-list
43566669|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566670|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566671|NCT00830102|Fluticasone|fluticasone|mesh-list
43566672|NCT00830102|Xhance|xhance|mesh-list
43566673|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
43566674|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43566675|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43730918|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730919|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730920|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43730921|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43730922|NCT02561468|Nefopam|nefopam|mesh-list
43730923|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730931|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43730932|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43730933|NCT02561169|Oseltamivir|oseltamivir|mesh-list
43730934|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
43730936|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730937|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43730938|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
43730939|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730940|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730943|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730944|NCT02561013|Monensin|monensin|mesh-list
43730945|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
43730946|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730947|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43730948|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43730949|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
43730950|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
43730951|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
43730952|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730953|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730955|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730956|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
43730957|NCT02560974|Capecitabine|capecitabine|mesh-list
43730958|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
43730959|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43566676|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
43566677|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566678|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742916|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43742921|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43742922|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
43742923|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
43742924|NCT04919629|Antibodies|antibodies|mesh-list
43730960|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
43742925|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
43742926|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43742927|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
43742928|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742929|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43742930|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43742931|NCT04919629|Growth Substances|growth substances|mesh-ancestor
43742932|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742933|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
43742934|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
43730961|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730962|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730963|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
43730964|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730965|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
43730966|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730967|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730968|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43730969|NCT02560909|Vaccines|vaccines|mesh-list
43730970|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
43730971|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833967|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833968|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43833969|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43833970|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
43833971|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833972|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43833973|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43833974|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833975|NCT05173324|Vaccines|vaccines|mesh-list
43847563|NCT04094584|Naltrexone|naltrexone|mesh-list
43847564|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43847565|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43847566|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742935|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
43742936|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43742939|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43847567|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
43847568|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847569|NCT04094558|Lactulose|lactulose|mesh-list
43847570|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43847571|NCT04094090|Riboflavin|riboflavin|mesh-list
43847572|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
43847573|NCT04094090|Vitamins|vitamins|mesh-ancestor
43847574|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
43847575|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847576|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43847577|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
43847578|NCT04092270|Doxorubicin|doxorubicin|mesh-list
43847579|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43847580|NCT04092270|Peposertib|peposertib|mesh-list
43847581|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43847582|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847583|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43847584|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43847585|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847586|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847587|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847588|NCT04090736|Azacitidine|azacitidine|mesh-list
43847589|NCT04090736|Pevonedistat|pevonedistat|mesh-list
43847590|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43847591|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
43847592|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847593|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847594|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847595|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
43847596|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43847597|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
43847598|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
43847599|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43847600|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847601|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43847602|NCT04089852|Analgesics|analgesics|mesh-ancestor
43847603|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
43742982|NCT04892173|Cetuximab|cetuximab|mesh-list
43742983|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847604|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847605|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
43847606|NCT04088864|Fludarabine|fludarabine|mesh-list
43847607|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847608|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
43730972|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
43730973|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43561168|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43730974|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43730975|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730976|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
43730977|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
43730978|NCT02560766|Gabapentin|gabapentin|mesh-list
43730979|NCT02560766|Analgesics|analgesics|mesh-ancestor
43730980|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
43730981|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730982|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730983|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
43730984|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43730985|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43730986|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730987|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43730988|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43730989|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43561177|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
43730990|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730991|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730992|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
43730993|NCT02560688|Clopidogrel|clopidogrel|mesh-list
43730994|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43743001|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730995|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43730996|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43743002|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43743003|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743004|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743005|NCT04853875|Amoxicillin|amoxicillin|mesh-list
43743006|NCT04853875|Metronidazole|metronidazole|mesh-list
43743007|NCT04853875|Clarithromycin|clarithromycin|mesh-list
43743008|NCT04853875|Tetracycline|tetracycline|mesh-list
43730997|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43730998|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
43730999|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731000|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731001|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731002|NCT02560649|Tenofovir|tenofovir|mesh-list
43731003|NCT02560649|Lamivudine|lamivudine|mesh-list
43731004|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43731005|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
43731006|NCT02560649|Entecavir|entecavir|mesh-list
43731007|NCT02560649|Adefovir|adefovir|mesh-list
43731008|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43743053|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
43743054|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43743055|NCT04830943|Protective Agents|protective agents|mesh-ancestor
43743056|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743057|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
43743058|NCT04792320|Charcoal|charcoal|mesh-list
43731009|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
43731010|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731029|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731032|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43731033|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731034|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
43731035|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731036|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43731037|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731038|NCT02560207|Cefotaxime|cefotaxime|mesh-list
43731039|NCT02560207|Cefoxitin|cefoxitin|mesh-list
43731040|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43731041|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731042|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
43731044|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43731045|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731046|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
43731047|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43731048|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43731049|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731050|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731051|NCT02559973|Buprenorphine|buprenorphine|mesh-list
43731052|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43731053|NCT02559973|Naloxone|naloxone|mesh-list
43731054|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43731055|NCT02559973|Narcotics|narcotics|mesh-ancestor
43731056|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731057|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731058|NCT02559973|Analgesics|analgesics|mesh-ancestor
43731059|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
43731060|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566738|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566739|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43566740|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43566741|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566742|NCT00829686|Renal Agents|renal agents|mesh-ancestor
43743090|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43743091|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743092|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43743094|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
43835583|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835584|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835585|NCT05037539|Fentanyl|fentanyl|mesh-list
43835586|NCT05037539|Morphine|morphine|mesh-list
43835587|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43835588|NCT05037539|Narcotics|narcotics|mesh-ancestor
43835589|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835590|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835591|NCT05037539|Analgesics|analgesics|mesh-ancestor
43731061|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43731062|NCT02559921|Vaccines|vaccines|mesh-list
43731063|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
43731064|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731065|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
43731066|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43731067|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
43731068|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731069|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
43731070|NCT02559908|Protective Agents|protective agents|mesh-ancestor
43731071|NCT02559791|Reslizumab|reslizumab|mesh-list
43731072|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43731074|NCT02559674|Gemcitabine|gemcitabine|mesh-list
43731075|NCT02559674|Paclitaxel|paclitaxel|mesh-list
43731076|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43731077|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731078|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
43731079|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
43731080|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
43731081|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731082|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43731083|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
43731084|NCT02559674|Antiviral Agents|antiviral agents|mesh-ancestor
43731085|NCT02559674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731086|NCT02559674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731087|NCT02559674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43731088|NCT02559674|Immunologic Factors|immunologic factors|mesh-ancestor
43731123|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43731124|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835592|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
43731126|NCT02559297|Desflurane|desflurane|mesh-list
43835593|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835605|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835606|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43835607|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743106|NCT04670081|Niacinamide|niacinamide|mesh-list
43743108|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
43743109|NCT04670081|Psilocybin|psilocybin|mesh-list
43743111|NCT04670081|Vitamins|vitamins|mesh-ancestor
43731127|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43731128|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43731129|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
43731130|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
43731131|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731132|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731133|NCT02559232|Anticoagulants|anticoagulants|mesh-list
43731134|NCT02559154|Thalidomide|thalidomide|mesh-list
43731135|NCT02559154|Dexamethasone|dexamethasone|mesh-list
43731136|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
43731137|NCT02559154|Doxorubicin|doxorubicin|mesh-list
43731138|NCT02559154|Bortezomib|bortezomib|mesh-list
43731139|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43731140|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
43731141|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731142|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43731143|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43731144|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
43731145|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731146|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731147|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43731148|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731149|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
43731150|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
43731151|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731152|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43731153|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
43731154|NCT02559154|Hormones|hormones|mesh-ancestor
43561182|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561183|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43561184|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561185|NCT03094416|Esomeprazole|esomeprazole|mesh-list
43561187|NCT03094416|Rabeprazole|rabeprazole|mesh-list
43561188|NCT03094416|Pantoprazole|pantoprazole|mesh-list
43561189|NCT03094416|Lansoprazole|lansoprazole|mesh-list
43561190|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
43561191|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43561192|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43561193|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561194|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561195|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561196|NCT03070951|OBE2109|obe2109|mesh-list
43561197|NCT03070951|Hormone Antagonists|hormone antagonists|mesh-ancestor
43731160|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731161|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
43731162|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43731163|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731164|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43561198|NCT03070951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43566776|NCT00829426|Alprazolam|alprazolam|mesh-list
43566777|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43566778|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566779|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566780|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43566781|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43561199|NCT03070951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561200|NCT03070899|OBE2109|obe2109|mesh-list
43561201|NCT03070899|Hormone Antagonists|hormone antagonists|mesh-ancestor
43561202|NCT03070899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561203|NCT03070899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561204|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43561205|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
43561206|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43561207|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
43561208|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43561209|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43561210|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561211|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43561212|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561213|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43561214|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561215|NCT03060980|Empagliflozin|empagliflozin|mesh-list
43561216|NCT03060980|Glimepiride|glimepiride|mesh-list
43561217|NCT03060980|Exenatide|exenatide|mesh-list
43561218|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43561219|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561220|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43561221|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561222|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43561223|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743131|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43561224|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
43561225|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43561226|NCT03060980|Incretins|incretins|mesh-ancestor
43561227|NCT03060980|Hormones|hormones|mesh-ancestor
43561228|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561229|NCT03060772|Pioglitazone|pioglitazone|mesh-list
43561230|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43561231|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561232|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43561233|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43561234|NCT02989597|Dexamethasone|dexamethasone|mesh-list
43561235|NCT02989597|Sufentanil|sufentanil|mesh-list
43731165|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43731166|NCT02559154|Growth Substances|growth substances|mesh-ancestor
43731167|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
43731168|NCT02559167|Cannabidiol|cannabidiol|mesh-list
43731169|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
43561238|NCT02989597|Methadone|methadone|mesh-list
43561239|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561240|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
43561241|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
43561242|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561243|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561244|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561245|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
43561246|NCT02989597|Hormones|hormones|mesh-ancestor
43561247|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561248|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43561249|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561250|NCT02989597|Analgesics|analgesics|mesh-ancestor
43561251|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
43743194|NCT04615013|Vitamins|vitamins|mesh-ancestor
43561252|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43561253|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43561254|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
43561256|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561257|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43561258|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43743233|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
43561259|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561260|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561261|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43561262|NCT02989597|Narcotics|narcotics|mesh-ancestor
43561263|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43561264|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
43561265|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
43561266|NCT02986659|Metformin|metformin|mesh-list
43561267|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43561268|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561269|NCT02978456|Sirolimus|sirolimus|mesh-list
43561270|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43561271|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561272|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43561273|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561274|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
43561275|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561276|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
43561277|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731176|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731177|NCT02559141|Dobutamine|dobutamine|mesh-list
43731178|NCT02559141|Norepinephrine|norepinephrine|mesh-list
43731179|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43731180|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43731181|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731182|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743301|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731183|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731184|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566832|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43566833|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566834|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566836|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43566837|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43566838|NCT00819169|Conatumumab|conatumumab|mesh-list
43566839|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43566840|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566841|NCT00818844|Nepafenac|nepafenac|mesh-list
43566842|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43566843|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43566844|NCT00818844|Analgesics|analgesics|mesh-ancestor
43731185|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
43731186|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
43731187|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731188|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43561292|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561293|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561294|NCT02933671|Ropivacaine|ropivacaine|mesh-list
43561295|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
43561296|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
43561297|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561298|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731189|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43731190|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43731191|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43731192|NCT02559141|Protective Agents|protective agents|mesh-ancestor
43731193|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
43731194|NCT02559102|Anesthetics|anesthetics|mesh-list
43731195|NCT02559102|Sevoflurane|sevoflurane|mesh-list
43731196|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731197|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731198|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43731199|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43731200|NCT02559102|Analgesics|analgesics|mesh-ancestor
43731201|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
43731202|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561299|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
43561300|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561301|NCT02920008|Guadecitabine|guadecitabine|mesh-list
43561302|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561303|NCT02917629|Pioglitazone|pioglitazone|mesh-list
43561304|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43561305|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561306|NCT02907359|Guadecitabine|guadecitabine|mesh-list
43561307|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561308|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
43561309|NCT02905188|Fludarabine|fludarabine|mesh-list
43561310|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43731211|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
43833979|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743303|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743304|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743305|NCT04570397|Ravulizumab|ravulizumab|mesh-list
43743306|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43743307|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743308|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
43743309|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743310|NCT04565990|Selexipag|selexipag|mesh-list
43743311|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43743314|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43743315|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833980|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43833981|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833982|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833983|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43833984|NCT05170841|Tramadol|tramadol|mesh-list
43833985|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43561329|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561330|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43561331|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
43561332|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43561333|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
43561334|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43833986|NCT05170841|Narcotics|narcotics|mesh-ancestor
43833987|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833988|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833989|NCT05170841|Analgesics|analgesics|mesh-ancestor
43833990|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
43833991|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833992|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43833993|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43833994|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43833995|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43833996|NCT05170438|Paclitaxel|paclitaxel|mesh-list
43833997|NCT05170438|Lenvatinib|lenvatinib|mesh-list
43833998|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43833999|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834000|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
43834003|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834004|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43834005|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834006|NCT05170256|Trastuzumab|trastuzumab|mesh-list
43834007|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834008|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834010|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43834011|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834012|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43834013|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561350|NCT02813447|Sertraline|sertraline|mesh-list
43561351|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
43561352|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43561353|NCT02813447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43561354|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43561355|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561356|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561357|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561358|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
43561359|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561361|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
43561362|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561363|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43561364|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43561365|NCT02811939|Analgesics|analgesics|mesh-ancestor
43561366|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
43561367|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561368|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43834021|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43561370|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561371|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566855|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561372|NCT02811939|Hormones|hormones|mesh-ancestor
43561373|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561374|NCT02811679|Blinatumomab|blinatumomab|mesh-list
43561378|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43561379|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43561380|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
43561381|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561382|NCT02804282|Furosemide|furosemide|mesh-list
43561383|NCT02804282|Diuretics|diuretics|mesh-ancestor
43561384|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
43561385|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561386|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43561387|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561388|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561389|NCT02804035|Furosemide|furosemide|mesh-list
43561390|NCT02804035|Diuretics|diuretics|mesh-ancestor
43561391|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
43561392|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561393|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43561394|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561395|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561396|NCT02802813|Piperaquine|piperaquine|mesh-list
43561397|NCT02802813|Primaquine|primaquine|mesh-list
43561398|NCT02802813|Artenimol|artenimol|mesh-list
43561399|NCT02802813|Artemisinins|artemisinins|mesh-list
43561400|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
43561401|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43561402|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43561403|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561404|NCT02784288|Paclitaxel|paclitaxel|mesh-list
43561405|NCT02784288|Carboplatin|carboplatin|mesh-list
43561406|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43561407|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561408|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
43561409|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
43561410|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
43561411|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561412|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
43561413|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43834022|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834023|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43834024|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834025|NCT05169684|Docetaxel|docetaxel|mesh-list
43834026|NCT05169684|Nivolumab|nivolumab|mesh-list
43834027|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834028|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
43834029|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
43834030|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
43731226|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43731227|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
43731228|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731229|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731230|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43731231|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43731232|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731233|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
43561442|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561443|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561444|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43731234|NCT02558868|Irinotecan|irinotecan|mesh-list
43731235|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731236|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43731237|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43731238|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731239|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731240|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
43731241|NCT02558816|Venetoclax|venetoclax|mesh-list
43731242|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43731243|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731244|NCT02558751|Vaccines|vaccines|mesh-list
43743368|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743369|NCT04549467|Tenofovir|tenofovir|mesh-list
43743370|NCT04549467|Lamivudine|lamivudine|mesh-list
43731245|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43731246|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
43731247|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731248|NCT02558595|Niacinamide|niacinamide|mesh-list
43731249|NCT02558595|Niacin|niacin|mesh-list
43731250|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
43731251|NCT02558595|Vitamins|vitamins|mesh-ancestor
43731252|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
43561445|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43561446|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561447|NCT02736968|Auranofin|auranofin|mesh-list
43561448|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43731253|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731254|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
43731255|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43731256|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
43731257|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731258|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43731259|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
43731260|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
43731261|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
43731262|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
43731263|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561457|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43561458|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
43561459|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561460|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561479|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43731264|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731265|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
43731266|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731267|NCT02558517|Prednisone|prednisone|mesh-list
43731268|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731269|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
43731271|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731273|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43731285|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731286|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731287|NCT02558205|Liver Extracts|liver extracts|mesh-list
43731288|NCT02558205|Hematinics|hematinics|mesh-ancestor
43731289|NCT02558283|Lidocaine|lidocaine|mesh-list
43731290|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
43731291|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
43731292|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731293|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561495|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43561496|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561497|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
43561498|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561499|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561508|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43561509|NCT02659397|Atorvastatin|atorvastatin|mesh-list
43561510|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43561511|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43561512|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
43561513|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561514|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43561515|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43561516|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561517|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43561518|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561519|NCT02654990|Dexamethasone|dexamethasone|mesh-list
43561522|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561523|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
43561524|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
43731294|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
43731295|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731296|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43731297|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43731298|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43731299|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43731300|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731301|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
43731302|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43731303|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731304|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43731305|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731306|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
43731307|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731308|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43731309|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731310|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
43731311|NCT02558218|Hormones|hormones|mesh-ancestor
43731312|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731313|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731314|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43731315|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43731316|NCT02558361|Apremilast|apremilast|mesh-list
43731317|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43731318|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43731319|NCT02558361|Analgesics|analgesics|mesh-ancestor
43731320|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
43731321|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731322|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731323|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731324|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43561533|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43566997|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
43567012|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43567013|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43567015|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43567016|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43567020|NCT00792727|Ketoprofen|ketoprofen|mesh-list
43561534|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561535|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561537|NCT02650804|Gemcitabine|gemcitabine|mesh-list
43561538|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43561539|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
43561540|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561541|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561542|NCT02650804|Antiviral Agents|antiviral agents|mesh-ancestor
43561543|NCT02650804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561544|NCT02650804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743433|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561545|NCT02650804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561546|NCT02650804|Immunologic Factors|immunologic factors|mesh-ancestor
43561547|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561548|NCT02650804|Vitamins|vitamins|mesh-ancestor
43561549|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
43561550|NCT02638805|Metformin|metformin|mesh-list
43561552|NCT02638805|Exenatide|exenatide|mesh-list
43561553|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43561554|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561555|NCT02638805|Incretins|incretins|mesh-ancestor
43561556|NCT02638805|Hormones|hormones|mesh-ancestor
43561557|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731325|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43731326|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43731327|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731328|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731329|NCT02558153|Paclitaxel|paclitaxel|mesh-list
43731330|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43731331|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731332|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
43731333|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
43731334|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
43567070|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567071|NCT00785226|Sorafenib|sorafenib|mesh-list
43567072|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731335|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731336|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43731337|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43731338|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
43731339|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731340|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731341|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43731342|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
43731343|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43731344|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43731345|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43731346|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731347|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731349|NCT02558114|Ribavirin|ribavirin|mesh-list
43731350|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
43731368|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731369|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43731370|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43731371|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43731372|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731373|NCT02557932|Bismuth|bismuth|mesh-list
43731374|NCT02557932|Antacids|antacids|mesh-ancestor
43731375|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731376|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561584|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43561585|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43561586|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43561587|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561589|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
43731378|NCT02557984|Amisulpride|amisulpride|mesh-list
43731379|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43731380|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43731381|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731382|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
43731383|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731384|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43731385|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43731386|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731387|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43731388|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43731389|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
43731390|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731391|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731392|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43561590|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561591|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43561592|NCT02620553|Insulin|insulin|mesh-list
43561593|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43561594|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43561595|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561596|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
43567135|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43561597|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43567136|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43567137|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43567138|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43567139|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567140|NCT00770848|Prednisone|prednisone|mesh-list
43567141|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
43743520|NCT04438330|Trace Elements|trace elements|mesh-ancestor
43561598|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561600|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43561601|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
43561602|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561603|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43561604|NCT02608697|Atorvastatin|atorvastatin|mesh-list
43561605|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43731393|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
43731394|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
43731395|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43731396|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43731397|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43731413|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43731414|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43567155|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43567156|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567157|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567158|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43567159|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
43567160|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43567161|NCT00770081|Vildagliptin|vildagliptin|mesh-list
43567162|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567163|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567164|NCT00770081|Incretins|incretins|mesh-ancestor
43567165|NCT00770081|Hormones|hormones|mesh-ancestor
43567166|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567167|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43567168|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
43567169|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567170|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567171|NCT00769795|Goserelin|goserelin|mesh-list
43567172|NCT00769795|Bicalutamide|bicalutamide|mesh-list
43567173|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567174|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567175|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
43567176|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
43731415|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43731416|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731417|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731418|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731419|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
43731420|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43731426|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731427|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731428|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43731429|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731431|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43731432|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731433|NCT02557581|Terbutaline|terbutaline|mesh-list
43731434|NCT02557581|Clenbuterol|clenbuterol|mesh-list
43731435|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43731436|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
43561606|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43561607|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
43561608|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561609|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43561610|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43561611|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561612|NCT02607930|Lamivudine|lamivudine|mesh-list
43731460|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731461|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
43731462|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43731463|NCT02557451|Growth Substances|growth substances|mesh-ancestor
43731464|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731465|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
43731466|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731467|NCT02557594|Tenofovir|tenofovir|mesh-list
43731468|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
43567177|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567178|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561627|NCT02606305|Maytansine|maytansine|mesh-list
43561628|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43567179|NCT00768482|Buprenorphine|buprenorphine|mesh-list
43567180|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43567181|NCT00768482|Narcotics|narcotics|mesh-ancestor
43567182|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43567183|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567184|NCT00768482|Analgesics|analgesics|mesh-ancestor
43567185|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
43567186|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567187|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43567188|NCT00765830|Vildagliptin|vildagliptin|mesh-list
43567189|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567202|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
43567203|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
43743542|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743543|NCT04413799|Analgesics|analgesics|mesh-ancestor
43743544|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43743545|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43561630|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43561631|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43561632|NCT02606305|Growth Substances|growth substances|mesh-ancestor
43561633|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731469|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731470|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43731471|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43731472|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743546|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
43743547|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43743548|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43743549|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835608|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835609|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
43835610|NCT05036681|Futibatinib|futibatinib|mesh-list
43835611|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835612|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835613|NCT05036577|Dexamethasone|dexamethasone|mesh-list
43835614|NCT05036577|Rituximab|rituximab|mesh-list
43835615|NCT05036577|Methotrexate|methotrexate|mesh-list
43835616|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835617|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731473|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731474|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43731475|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43731476|NCT02557542|Polidocanol|polidocanol|mesh-list
43731477|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
43731478|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43561634|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
43561635|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43561636|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43561637|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43561638|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835659|NCT05031975|Temozolomide|temozolomide|mesh-list
43561639|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561640|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43561641|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
43743564|NCT04397354|Dexamethasone|dexamethasone|mesh-list
43561642|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
43561643|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
43561645|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43561646|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43561647|NCT02602353|Analgesics|analgesics|mesh-ancestor
43561648|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
43561649|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561650|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561651|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561652|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43561653|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
43561654|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43561655|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
43561656|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43561657|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43731479|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43731480|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
43731481|NCT02557490|Raltitrexed|raltitrexed|mesh-list
43731482|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731483|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43731484|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
43731485|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731486|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43731487|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731488|NCT02557503|Fluorouracil|fluorouracil|mesh-list
43731489|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
43731490|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
43731491|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731492|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43561666|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43561667|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561668|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561669|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561670|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43561671|NCT02588677|Protective Agents|protective agents|mesh-ancestor
43561672|NCT02580708|Trametinib|trametinib|mesh-list
43561683|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
43561684|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561685|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561686|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43561687|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561688|NCT02580305|Memantine|memantine|mesh-list
43561689|NCT02580305|Donepezil|donepezil|mesh-list
43694103|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43561690|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
43561691|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43561693|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561694|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
43561695|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731493|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731494|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743648|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743649|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743650|NCT04317105|Nivolumab|nivolumab|mesh-list
43743651|NCT04317105|Ipilimumab|ipilimumab|mesh-list
43743652|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43731495|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
43731496|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731497|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
43731498|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
43731502|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
43731503|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731504|NCT02557373|Vitamins|vitamins|mesh-list
43834077|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43834078|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
43834079|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43834080|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834081|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43834082|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
43834083|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43834084|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43731514|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
43731515|NCT02557269|Azelastine|azelastine|mesh-list
43731516|NCT02557269|Prednisolone|prednisolone|mesh-list
43731517|NCT02557269|Xylometazoline|xylometazoline|mesh-list
43731524|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731525|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
43731526|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731527|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
43731528|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43731529|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43731530|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43731531|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
43731532|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43731533|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743687|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
43561696|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561697|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
43567333|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
43567334|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43567335|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567336|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567337|NCT00755287|Incretins|incretins|mesh-ancestor
43567338|NCT00755287|Hormones|hormones|mesh-ancestor
43567339|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567340|NCT00754988|Metformin|metformin|mesh-list
43567341|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43567342|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43567343|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567344|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567345|NCT00754988|Incretins|incretins|mesh-ancestor
43567346|NCT00754988|Hormones|hormones|mesh-ancestor
43567347|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567348|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43567349|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
43567350|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567351|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567352|NCT00754221|Reboxetine|reboxetine|mesh-list
43567353|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
43561698|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43694104|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731534|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731535|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43731536|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43731537|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
43731539|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731540|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
43731541|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43731543|NCT02557087|Scopolamine|scopolamine|mesh-list
43731544|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43731545|NCT02557087|Narcotics|narcotics|mesh-ancestor
43731547|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731548|NCT02557087|Analgesics|analgesics|mesh-ancestor
43731549|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
43731550|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731551|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43731552|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
43731553|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
43731554|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43731555|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
43731556|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43731557|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
43731558|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731559|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731560|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43731561|NCT02556905|Dexamethasone|dexamethasone|mesh-list
43731562|NCT02556905|Lenalidomide|lenalidomide|mesh-list
43731563|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731564|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
43731570|NCT02556905|Hormones|hormones|mesh-ancestor
43731578|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
43731579|NCT02556970|Acetaminophen|acetaminophen|mesh-list
43731580|NCT02556970|Diclofenac|diclofenac|mesh-list
43567355|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43567357|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43731581|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
43731582|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43731585|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561715|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
43561716|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43561717|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43561718|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43561719|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561720|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561721|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
43561722|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561723|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731625|NCT02556814|Caffeic acid|caffeic acid|mesh-list
43731626|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731627|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
43731628|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
43731629|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731630|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731631|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43731632|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
43561737|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561739|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43561740|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43561741|NCT02547818|Analgesics|analgesics|mesh-ancestor
43561742|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
43561743|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561744|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561762|NCT02539537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561763|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561764|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561765|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
43561766|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561767|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43561768|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43561769|NCT02539537|Antidotes|antidotes|mesh-ancestor
43561770|NCT02539537|Protective Agents|protective agents|mesh-ancestor
43561771|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
43567372|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43567373|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43567381|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43567382|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43567383|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43567384|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43567386|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
43561772|NCT02539537|Vitamins|vitamins|mesh-ancestor
43561773|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
43561774|NCT02539537|Hematinics|hematinics|mesh-ancestor
43731633|NCT02556814|Hormones|hormones|mesh-ancestor
43731634|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731635|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43731636|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731637|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
43731638|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731639|NCT02556814|Protective Agents|protective agents|mesh-ancestor
43731640|NCT02556840|Insulin|insulin|mesh-list
43731641|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43731642|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731643|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43731644|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731645|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43731646|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561775|NCT02521285|Aspirin|aspirin|mesh-list
43561776|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43561777|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43561778|NCT02521285|Analgesics|analgesics|mesh-ancestor
43561779|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
43561780|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561781|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561782|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561783|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43561784|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43561785|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43561786|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561787|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43743735|NCT04278404|Amiodarone|amiodarone|mesh-list
43743736|NCT04278404|Bosentan|bosentan|mesh-list
43743737|NCT04278404|Guanfacine|guanfacine|mesh-list
43561788|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43731647|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731649|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43731650|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43731651|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
43731652|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43731653|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731654|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43731655|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43561789|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561790|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
43561791|NCT02519439|Ganaxolone|ganaxolone|mesh-list
43561792|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
43561793|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561794|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561795|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561796|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
43561797|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
43561798|NCT02515175|Vaccines|vaccines|mesh-list
43561799|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
43561800|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561801|NCT02513303|Sirolimus|sirolimus|mesh-list
43561802|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43561803|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561804|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43561805|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561806|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
43561807|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561809|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561811|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43561812|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561813|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43561814|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561815|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43561816|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
43561817|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
43561818|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561819|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561820|NCT02510599|Solithromycin|solithromycin|mesh-list
43561821|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43561822|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561823|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
43561824|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43561825|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
43561826|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43561827|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743763|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561828|NCT02504580|Bupivacaine|bupivacaine|mesh-list
43561829|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
43561830|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
43731656|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43731657|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43731658|NCT02556411|Estrogens|estrogens|mesh-ancestor
43731660|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731661|NCT02556463|Durvalumab|durvalumab|mesh-list
43731662|NCT02556463|MEDI9197|medi9197|mesh-list
43731663|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43561831|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561832|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561833|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
43561834|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561835|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43561836|NCT02502669|Finasteride|finasteride|mesh-list
43731675|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43731676|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43731678|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
43731679|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
43743805|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43743844|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43743845|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43731680|NCT02556268|Riociguat|riociguat|mesh-list
43731681|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
43731682|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
43731683|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731684|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
43731685|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731686|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43731687|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43731688|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731689|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43731690|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43731692|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43731693|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43731694|NCT02556229|Growth Substances|growth substances|mesh-ancestor
43731712|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
43731725|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731726|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43731727|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43731728|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
43731729|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731730|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43731731|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43731732|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43731733|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43731734|NCT02555813|Gemcitabine|gemcitabine|mesh-list
43731735|NCT02555813|Paclitaxel|paclitaxel|mesh-list
43731736|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43731737|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43731738|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561849|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561850|NCT02490488|Antiviral Agents|antiviral agents|mesh-ancestor
43731739|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
43731740|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
43731741|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
43731742|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731743|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743846|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43743847|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43743848|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43743849|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43743850|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
43743851|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43743852|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43743853|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43743864|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43731744|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
43731745|NCT02555813|Antiviral Agents|antiviral agents|mesh-ancestor
43731753|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43731754|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731755|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43834085|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
43561851|NCT02490488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561852|NCT02490488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561853|NCT02490488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561854|NCT02490488|Immunologic Factors|immunologic factors|mesh-ancestor
43561855|NCT02490488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561871|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43561872|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561873|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561874|NCT01621243|Gemcitabine|gemcitabine|mesh-list
43561875|NCT01621243|Paclitaxel|paclitaxel|mesh-list
43561876|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43561894|NCT01619332|Incretins|incretins|mesh-ancestor
43561895|NCT01619332|Hormones|hormones|mesh-ancestor
43561896|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561897|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43561898|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
43561899|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561900|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561901|NCT01616524|Interferons|interferons|mesh-list
43561902|NCT01616524|Ribavirin|ribavirin|mesh-list
43561903|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
43561904|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
43561905|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43561918|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
43561919|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
43561920|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
43561921|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561922|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43561923|NCT01616199|Vemurafenib|vemurafenib|mesh-list
43561924|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561925|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43561926|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561927|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561928|NCT01610245|Oseltamivir|oseltamivir|mesh-list
43561929|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
43561939|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43561941|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561942|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43561943|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43561944|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561945|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561946|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43561947|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
43561948|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561951|NCT01593228|Paclitaxel|paclitaxel|mesh-list
43561952|NCT01593228|Carboplatin|carboplatin|mesh-list
43561953|NCT01593228|Doxorubicin|doxorubicin|mesh-list
43561954|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43561955|NCT01593228|Irinotecan|irinotecan|mesh-list
43561956|NCT01593228|Topotecan|topotecan|mesh-list
43561957|NCT01593228|Iniparib|iniparib|mesh-list
43561958|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43561959|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561960|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
43561961|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
43561962|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
43561963|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561964|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743918|NCT04215588|Hemostatics|hemostatics|mesh-list
43561965|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
43561966|NCT01593228|Antiviral Agents|antiviral agents|mesh-ancestor
43561967|NCT01593228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561968|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561969|NCT01593228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561970|NCT01593228|Immunologic Factors|immunologic factors|mesh-ancestor
43561971|NCT01593228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561972|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43561973|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43731775|NCT02555852|Lafutidine|lafutidine|mesh-list
43731776|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
43567438|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
43567451|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567452|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567453|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
43567454|NCT00749632|Oxybutynin|oxybutynin|mesh-list
43567455|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
43567456|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
43567457|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567458|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567459|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43567460|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43567461|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
43567462|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567463|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567464|NCT00749632|Urological Agents|urological agents|mesh-ancestor
43567465|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43567466|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567467|NCT00749632|Renal Agents|renal agents|mesh-ancestor
43567468|NCT00747318|Fluticasone|fluticasone|mesh-list
43567469|NCT00747318|Xhance|xhance|mesh-list
43743969|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743972|NCT04140305|Ozanimod|ozanimod|mesh-list
43743991|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43743993|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43731785|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731786|NCT02555852|Antacids|antacids|mesh-ancestor
43731787|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
43731788|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
43731789|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731790|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561989|NCT01590719|Fluorouracil|fluorouracil|mesh-list
43731791|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
43744011|NCT04079712|Ipilimumab|ipilimumab|mesh-list
43567470|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
43567471|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567472|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43567473|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
43567474|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567476|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43731792|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43731793|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43731794|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731795|NCT02555696|Paclitaxel|paclitaxel|mesh-list
43731796|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43731797|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731798|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
43731799|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
43731800|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
43731801|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731802|NCT02555644|Cisplatin|cisplatin|mesh-list
43731803|NCT02555644|Cetuximab|cetuximab|mesh-list
43731804|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731805|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43731806|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43731807|NCT02555761|Alcaftadine|alcaftadine|mesh-list
43731808|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43731809|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43744087|NCT04052880|Bortezomib|bortezomib|mesh-list
43744089|NCT04052880|Ixazomib|ixazomib|mesh-list
43731810|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
43731811|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
43731812|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731813|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731814|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731815|NCT02555748|Sunitinib|sunitinib|mesh-list
43731816|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731819|NCT02555748|Growth Substances|growth substances|mesh-ancestor
43731820|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731821|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
43731822|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43731823|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731824|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731825|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
43731826|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43561990|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
43731827|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731828|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731829|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43731830|NCT02555605|Analgesics|analgesics|mesh-ancestor
43731831|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
43731832|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744130|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744132|NCT04013542|Ipilimumab|ipilimumab|mesh-list
43744133|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744134|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744135|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744136|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744137|NCT03988634|Valsartan|valsartan|mesh-list
43731833|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43731834|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43731835|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43731836|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731837|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731838|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834087|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43834088|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43834089|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
43834090|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834091|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834092|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834093|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43834094|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43834095|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
43834096|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834097|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43834098|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
43834099|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
43834100|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
43834105|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
43834106|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43834107|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834108|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834109|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43834110|NCT05165836|Analgesics|analgesics|mesh-ancestor
43834111|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
43834112|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834113|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43834114|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43834115|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43834116|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
43834117|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834118|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834119|NCT05165732|Vaccines|vaccines|mesh-list
43834120|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
43834121|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834122|NCT05163041|Nivolumab|nivolumab|mesh-list
43834126|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834127|NCT05162222|Itraconazole|itraconazole|mesh-list
43744183|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43567540|NCT00743002|Metformin|metformin|mesh-list
43834129|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
43834130|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834131|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43834132|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43834133|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834134|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834135|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43834136|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
43834137|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834138|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834139|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43834140|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43834141|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43834142|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43834143|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43834144|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
43834145|NCT05162014|Empagliflozin|empagliflozin|mesh-list
43834146|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43834147|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43834148|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834150|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
43834151|NCT05161611|Astringents|astringents|mesh-ancestor
43731839|NCT02555488|Methylene Blue|methylene blue|mesh-list
43731840|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731841|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731843|NCT02555358|Capecitabine|capecitabine|mesh-list
43731844|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
43731845|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731846|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
43731847|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
43731848|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
43731849|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731850|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43731851|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
43731852|NCT02555423|Anesthetics|anesthetics|mesh-list
43731853|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
43731854|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
43731855|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731856|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731857|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
43731858|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731859|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
43731860|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43731861|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744206|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43731862|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43731863|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43731864|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731865|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731866|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731867|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43731868|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43731869|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43731871|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731899|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
43731900|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731901|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731903|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731904|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43731905|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43731920|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731921|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43731923|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43731924|NCT02554695|Denosumab|denosumab|mesh-list
43731925|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43731926|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731927|NCT02554357|Bupivacaine|bupivacaine|mesh-list
43731928|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
43731929|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
43731930|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731931|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731932|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
43731933|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731934|NCT02554175|Propofol|propofol|mesh-list
43731935|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43731936|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731937|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731938|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43731939|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
43731941|NCT02554344|Curcumin|curcumin|mesh-list
43567564|NCT00738387|Vadimezan|vadimezan|mesh-list
43567565|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731942|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43731943|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43731944|NCT02554344|Analgesics|analgesics|mesh-ancestor
43731945|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
43731946|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731948|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731949|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43731950|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731951|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731952|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731953|NCT02554123|Vitamin E|vitamin e|mesh-list
43731954|NCT02554123|Petrolatum|petrolatum|mesh-list
43731955|NCT02554123|Vitamins|vitamins|mesh-ancestor
43731956|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
43731957|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731958|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
43731959|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731960|NCT02554123|Protective Agents|protective agents|mesh-ancestor
43731961|NCT02554123|Emollients|emollients|mesh-ancestor
43731962|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
43731963|NCT02554045|Tadalafil|tadalafil|mesh-list
43731964|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
43731983|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731984|NCT02553551|Vitamins|vitamins|mesh-list
43731985|NCT02553551|Ascorbic Acid|ascorbic acid|mesh-list
43731986|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
43731987|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731988|NCT02553551|Antioxidants|antioxidants|mesh-ancestor
43731989|NCT02553551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731990|NCT02553551|Protective Agents|protective agents|mesh-ancestor
43731991|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
43731992|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43731993|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731994|NCT02553603|Hormones|hormones|mesh-list
43731995|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
43731996|NCT02553603|Tesamorelin|tesamorelin|mesh-list
43834170|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732007|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43732008|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732009|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
43732010|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43732011|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43732012|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43732013|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732014|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43732015|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732016|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732017|NCT02553018|Methotrexate|methotrexate|mesh-list
43732018|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43732045|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43732047|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
43732048|NCT02553044|Vitamins|vitamins|mesh-ancestor
43732049|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
43732050|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732051|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43732052|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43732053|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
43732054|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732055|NCT02552459|Sufentanil|sufentanil|mesh-list
43732056|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
43732057|NCT02552459|Dsuvia|dsuvia|mesh-list
43732058|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43732059|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732060|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732061|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732062|NCT02552459|Analgesics|analgesics|mesh-ancestor
43732063|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
43732064|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732065|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43732066|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43732067|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732068|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732069|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732070|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732071|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43732072|NCT02552459|Narcotics|narcotics|mesh-ancestor
43732073|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43732074|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43732075|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
43732076|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
43732078|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43732079|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43732080|NCT02552342|Prednisolone|prednisolone|mesh-list
43732081|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
43744293|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43744294|NCT03778229|Osimertinib|osimertinib|mesh-list
43732082|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43732083|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
43744295|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562010|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562011|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43562012|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562014|NCT01577654|Docetaxel|docetaxel|mesh-list
43562015|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
43562016|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562017|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
43562018|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
43562019|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562020|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562021|NCT01577654|Hematinics|hematinics|mesh-ancestor
43562022|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
43562023|NCT01577654|Vitamins|vitamins|mesh-ancestor
43562024|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
43562025|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562027|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562029|NCT01573351|Interferons|interferons|mesh-list
43562030|NCT01573351|Ribavirin|ribavirin|mesh-list
43562031|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
43562032|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
43562033|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43562034|NCT01573351|Asunaprevir|asunaprevir|mesh-list
43562035|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562036|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
43562037|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562038|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
43562039|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562040|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
43562041|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567715|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43567716|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43562042|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
43562043|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562044|NCT01557777|Navitoclax|navitoclax|mesh-list
43562045|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732139|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732141|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
43567717|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732142|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834171|NCT05158517|Vedolizumab|vedolizumab|mesh-list
43834172|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834173|NCT05157971|Cytarabine|cytarabine|mesh-list
43834174|NCT05157971|Prednisone|prednisone|mesh-list
43834175|NCT05157971|Cortisone|cortisone|mesh-list
43834178|NCT05157971|Vincristine|vincristine|mesh-list
43834179|NCT05157971|Daunorubicin|daunorubicin|mesh-list
43834181|NCT05157971|Asparaginase|asparaginase|mesh-list
43834182|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
43834183|NCT05157971|Pegaspargase|pegaspargase|mesh-list
43834184|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43834185|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
43732144|NCT02551536|Montelukast|montelukast|mesh-list
43732145|NCT02551536|Levocetirizine|levocetirizine|mesh-list
43732146|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43732147|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
43732148|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43732149|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
43732150|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732151|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732152|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43732153|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43732154|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732162|NCT02551796|Ofloxacin|ofloxacin|mesh-list
43732173|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732174|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732175|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732176|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
43732177|NCT02551796|Hormones|hormones|mesh-ancestor
43732178|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732180|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732181|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
43732182|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732183|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732184|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43732185|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732186|NCT02551796|Renal Agents|renal agents|mesh-ancestor
43732240|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
43732241|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732245|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43732246|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43732247|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
43732248|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43732249|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732250|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43732251|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43744337|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
43744338|NCT03706365|Hormones|hormones|mesh-ancestor
43732265|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732266|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43732267|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
43732268|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
43732269|NCT02551107|Protective Agents|protective agents|mesh-ancestor
43732270|NCT02551133|Dexamethasone|dexamethasone|mesh-list
43732271|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732272|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
43732273|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
43732274|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732275|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732276|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732277|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
43732278|NCT02551133|Hormones|hormones|mesh-ancestor
43732279|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732280|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43732281|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732282|NCT02550912|Vitamin D|vitamin d|mesh-list
43732283|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
43732284|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
43732285|NCT02550912|Vitamins|vitamins|mesh-list
43732286|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
43732287|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732288|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43732289|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43732290|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
43732291|NCT02550782|Bupivacaine|bupivacaine|mesh-list
43732292|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
43732293|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
43567731|NCT00717457|Hormones|hormones|mesh-ancestor
43567732|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567733|NCT00716534|Paclitaxel|paclitaxel|mesh-list
43567734|NCT00716534|Carboplatin|carboplatin|mesh-list
43567735|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43567736|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567737|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
43567738|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
43567739|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
43567740|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567741|NCT00714597|Enoxaparin|enoxaparin|mesh-list
43567742|NCT00714597|Semuloparin|semuloparin|mesh-list
43567743|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
43567744|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
43567745|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43567746|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43567747|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567748|NCT00713518|Ranibizumab|ranibizumab|mesh-list
43567760|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732294|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732295|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732296|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
43732297|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732298|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43732299|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732300|NCT02550782|Analgesics|analgesics|mesh-ancestor
43732301|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43732302|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43732303|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732304|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732305|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732306|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732307|NCT02550756|Capsaicin|capsaicin|mesh-list
43732308|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
43732309|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
43732310|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
43732311|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732312|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732313|NCT02550665|Donepezil|donepezil|mesh-list
43732314|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43732315|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732316|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744359|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732317|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
43732318|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732319|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732320|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
43732321|NCT02550483|Beta Carotene|beta carotene|mesh-list
43732322|NCT02550483|Lycopene|lycopene|mesh-list
43732323|NCT02550483|Carotenoids|carotenoids|mesh-list
43732346|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43732347|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43732348|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732349|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43732350|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43732351|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732353|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43732354|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43732355|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43732356|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
43732357|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732358|NCT02550444|Clonidine|clonidine|mesh-list
43732359|NCT02550444|Analgesics|analgesics|mesh-ancestor
43732360|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
43732361|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732362|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732363|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43732364|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
43732365|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
43732366|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43732367|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43732368|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732369|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732370|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694105|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732401|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43732402|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
43732403|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
43732404|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43562046|NCT01555554|Propranolol|propranolol|mesh-list
43562047|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43562048|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43732405|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
43732406|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43732407|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732408|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43732409|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43732410|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43732411|NCT02550067|Trace Elements|trace elements|mesh-ancestor
43732412|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
43732413|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43732414|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43732415|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43732416|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732417|NCT02550262|Fentanyl|fentanyl|mesh-list
43732418|NCT02550262|Bupivacaine|bupivacaine|mesh-list
43732419|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
43732421|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732422|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732423|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
43732424|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732425|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43732426|NCT02550262|Narcotics|narcotics|mesh-ancestor
43732473|NCT02550327|Gemcitabine|gemcitabine|mesh-list
43732474|NCT02550327|Paclitaxel|paclitaxel|mesh-list
43567808|NCT00708292|Dexamethasone|dexamethasone|mesh-list
43567809|NCT00708292|Bortezomib|bortezomib|mesh-list
43567810|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732475|NCT02550327|Cisplatin|cisplatin|mesh-list
43732476|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43732477|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43732478|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732482|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732484|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
43732485|NCT02550327|Antiviral Agents|antiviral agents|mesh-ancestor
43732486|NCT02550327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732487|NCT02550327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732488|NCT02550327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43732505|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732506|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732507|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43732508|NCT02549742|Bleomycin|bleomycin|mesh-list
43732509|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43732510|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732511|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
43732512|NCT02549963|Anticoagulants|anticoagulants|mesh-list
43732513|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43732514|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
43834193|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834194|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
43834195|NCT05157971|Hormones|hormones|mesh-ancestor
43834196|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834201|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43834202|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
43834203|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834204|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834205|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43834206|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43834207|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
43834208|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732519|NCT02549690|Testosterone|testosterone|mesh-list
43732520|NCT02549690|Androgens|androgens|mesh-ancestor
43732521|NCT02549690|Hormones|hormones|mesh-ancestor
43732522|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43562074|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
43562075|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562076|NCT01536041|Montelukast|montelukast|mesh-list
43562077|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562078|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
43562079|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43562080|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
43562082|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562083|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43562084|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43562085|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562087|NCT01535508|Vitamins|vitamins|mesh-ancestor
43562088|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
43562089|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562090|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43744459|NCT03580902|Analgesics|analgesics|mesh-ancestor
43562091|NCT01534403|Epratuzumab|epratuzumab|mesh-list
43562092|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562093|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562094|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
43562095|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43562096|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43732528|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732529|NCT02549768|Analgesics|analgesics|mesh-ancestor
43562104|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562105|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
43562106|NCT01522469|Crenolanib|crenolanib|mesh-list
43562107|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732540|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43732541|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732543|NCT02549261|Etoposide|etoposide|mesh-list
43732544|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
43732545|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732546|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43732547|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43732548|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43732549|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732550|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732551|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43732552|NCT02549326|Vitamin D|vitamin d|mesh-list
43732553|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
43732554|NCT02549326|Vitamins|vitamins|mesh-ancestor
43732555|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
43732556|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732557|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43732558|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43732559|NCT02549469|Naproxen|naproxen|mesh-list
43732560|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43732561|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732562|NCT02549469|Analgesics|analgesics|mesh-ancestor
43732563|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
43732564|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732565|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732567|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43732569|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43744479|NCT03570359|Interferon-beta|interferon-beta|mesh-list
43744480|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
43744481|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744482|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
43744483|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744484|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
43744485|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744486|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43744487|NCT03553563|Esomeprazole|esomeprazole|mesh-list
43744488|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43744489|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732570|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732571|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732572|NCT02549391|Cinacalcet|cinacalcet|mesh-list
43732573|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43732574|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732576|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
43732577|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732578|NCT02549430|Letrozole|letrozole|mesh-list
43732579|NCT02549430|Fulvestrant|fulvestrant|mesh-list
43732580|NCT02549430|Palbociclib|palbociclib|mesh-list
43732581|NCT02549430|Anastrozole|anastrozole|mesh-list
43732582|NCT02549430|Exemestane|exemestane|mesh-list
43732583|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732584|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43732585|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43732586|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732587|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732588|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43732589|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
43732628|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732629|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732631|NCT02549118|Meperidine|meperidine|mesh-list
43732632|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43732633|NCT02549118|Narcotics|narcotics|mesh-ancestor
43732634|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732635|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732636|NCT02549118|Analgesics|analgesics|mesh-ancestor
43732637|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
43732638|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732639|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43732640|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43835674|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835675|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43835676|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43835677|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
43835678|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835679|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835680|NCT05029596|Heparin|heparin|mesh-list
43835681|NCT05029596|Calcium heparin|calcium heparin|mesh-list
43835682|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
43835683|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43835684|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43732641|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732642|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732643|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43732644|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43732645|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732646|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732647|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43732653|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732654|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43732655|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43732656|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732657|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732658|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732659|NCT02549066|Milrinone|milrinone|mesh-list
43732660|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43732661|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43732662|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
43732663|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43732664|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43732665|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732666|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732667|NCT02549066|Protective Agents|protective agents|mesh-ancestor
43732668|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732669|NCT02548936|Simvastatin|simvastatin|mesh-list
43732670|NCT02548936|Ezetimibe|ezetimibe|mesh-list
43732671|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
43732672|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43732673|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43732674|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
43732675|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732676|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43732677|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43732678|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732679|NCT02548832|Magnesium Oxide|magnesium oxide|mesh-list
43732680|NCT02548832|Bezafibrate|bezafibrate|mesh-list
43732681|NCT02548832|Antacids|antacids|mesh-ancestor
43732686|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43732688|NCT02548806|Analgesics|analgesics|mesh-ancestor
43732689|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
43732690|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567915|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547595|NCT03650777|Warfarin|warfarin|mesh-list
43744514|NCT03504423|Leucovorin|leucovorin|mesh-list
43744515|NCT03504423|Folic Acid|folic acid|mesh-list
43744516|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
43744517|NCT03504423|Irinotecan|irinotecan|mesh-list
43744518|NCT03504423|Folfirinox|folfirinox|mesh-list
43744519|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
43744520|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744521|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43744522|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43744523|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704387|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732691|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732692|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43732693|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
43732694|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
43732695|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43732696|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43732697|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732698|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732699|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732700|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732701|NCT02548741|Metformin|metformin|mesh-list
43732702|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
43732703|NCT02548741|Calcium|calcium|mesh-list
43732704|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43732705|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732706|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43732707|NCT02548741|Antacids|antacids|mesh-ancestor
43732708|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732709|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732710|NCT02548780|Doxorubicin|doxorubicin|mesh-list
43732711|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43732712|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732713|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43732715|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732716|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732717|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
43732718|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
43732719|NCT02548468|Fludarabine|fludarabine|mesh-list
43732720|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
43732721|NCT02548468|Tacrolimus|tacrolimus|mesh-list
43732722|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43732723|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
43732724|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732735|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732736|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43744524|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744525|NCT03504423|Antidotes|antidotes|mesh-ancestor
43744526|NCT03504423|Protective Agents|protective agents|mesh-ancestor
43744527|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744528|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
43732737|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43732738|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
43732739|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43732740|NCT02548611|Clopidogrel|clopidogrel|mesh-list
43732741|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43732742|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43732743|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43732744|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43732745|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43732746|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
43732747|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732748|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732749|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732750|NCT02548533|Lidocaine|lidocaine|mesh-list
43732751|NCT02548533|Epinephrine|epinephrine|mesh-list
43732752|NCT02548533|Prilocaine|prilocaine|mesh-list
43732753|NCT02548533|Carticaine|carticaine|mesh-list
43732754|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43732755|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
43732756|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
43732757|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732758|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732760|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732761|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43732792|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732794|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567937|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43567938|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567939|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567940|NCT00690456|Hormones|hormones|mesh-ancestor
43567941|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43744539|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744541|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744542|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744543|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
43744544|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43744545|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
43732795|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732796|NCT02548117|Urological Agents|urological agents|mesh-ancestor
43732797|NCT02548195|Gemcitabine|gemcitabine|mesh-list
43732798|NCT02548195|Capecitabine|capecitabine|mesh-list
43732799|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
43732800|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43732803|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732804|NCT02548195|Antiviral Agents|antiviral agents|mesh-ancestor
43732812|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43732813|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43732814|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43732815|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732816|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43732817|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732818|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
43732819|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43732820|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43732821|NCT02548052|Betamethasone|betamethasone|mesh-list
43732822|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
43732823|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43732824|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
43732825|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43732846|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43732864|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732866|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43732867|NCT02547896|Diclofenac|diclofenac|mesh-list
43732868|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43732869|NCT02547896|Codeine|codeine|mesh-list
43732897|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43732898|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43732899|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43732900|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43744569|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43744570|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744571|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43744572|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744574|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
43744577|NCT03419234|Protective Agents|protective agents|mesh-ancestor
43744578|NCT03419234|Vitamins|vitamins|mesh-ancestor
43744579|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
43744580|NCT03419234|Estrogens|estrogens|mesh-ancestor
43744581|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
43744582|NCT03370276|Nivolumab|nivolumab|mesh-list
43744583|NCT03370276|Cetuximab|cetuximab|mesh-list
43732901|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43732903|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43732904|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732905|NCT02547350|Pirarubicin|pirarubicin|mesh-list
43732906|NCT02547350|Epirubicin|epirubicin|mesh-list
43732907|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732908|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43732909|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43732910|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43732911|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732912|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732913|NCT02547402|CXA-10|cxa-10|mesh-list
43732914|NCT02547402|Simvastatin|simvastatin|mesh-list
43732915|NCT02547402|Ezetimibe|ezetimibe|mesh-list
43732916|NCT02547402|Pravastatin|pravastatin|mesh-list
43732917|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
43732918|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43732919|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43732920|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
43732921|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732948|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43732949|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43732950|NCT02547025|Renal Agents|renal agents|mesh-ancestor
43732951|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43732952|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43732953|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732954|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43732955|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43732956|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732957|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43732958|NCT02547025|Antacids|antacids|mesh-ancestor
43732959|NCT02547155|Anesthetics|anesthetics|mesh-list
43562122|NCT01519804|Paclitaxel|paclitaxel|mesh-list
43732960|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732962|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
43732963|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43732964|NCT02547103|Mupirocin|mupirocin|mesh-list
43732965|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43732966|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732967|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
43732968|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
43732969|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43732970|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43732971|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732972|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732973|NCT02547116|Rifampin|rifampin|mesh-list
43732974|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43567969|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43567970|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43732975|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
43567971|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43567972|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567973|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732976|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43732977|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732978|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
43732979|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43732980|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732981|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732982|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43732983|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43732985|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43733005|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733006|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
43733007|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43733008|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733009|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
43733010|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
43733011|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43733012|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43733013|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43733014|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
43733015|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733016|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43733017|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43733018|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733019|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43733020|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43733021|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
43733022|NCT02546648|Coagulants|coagulants|mesh-ancestor
43733023|NCT02546531|Gemcitabine|gemcitabine|mesh-list
43567989|NCT00680472|Analgesics|analgesics|mesh-ancestor
43567990|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
43567991|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567992|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567993|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567994|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567995|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43744595|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744596|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43744597|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
43744598|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
43744599|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
43744600|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43744601|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43744602|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
43744603|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43744604|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744605|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43744606|NCT03318094|Nitroprusside|nitroprusside|mesh-list
43744607|NCT03318094|Phentolamine|phentolamine|mesh-list
43744608|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
43733024|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
43733025|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43733026|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
43733027|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733028|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733054|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
43733055|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733056|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733057|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43733058|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
43733059|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
43733060|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43733076|NCT02546297|Budesonide|budesonide|mesh-list
43733077|NCT02546297|Bromides|bromides|mesh-list
43733078|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
43733079|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
43733080|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43733081|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733082|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43733083|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
43834224|NCT05157711|Phenylephrine|phenylephrine|mesh-list
43834225|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
43834226|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
43834227|NCT05157711|Bismuth|bismuth|mesh-list
43834228|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43834229|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
43834230|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
43834231|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733145|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
43733146|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43733147|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43733148|NCT02545959|Prednisolone|prednisolone|mesh-list
43733149|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
43733150|NCT02545959|Rituximab|rituximab|mesh-list
43733151|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43733152|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
43733153|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43733154|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733155|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
43733156|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733188|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733191|NCT02545530|Analgesics|analgesics|mesh-ancestor
43733192|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
43733193|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733194|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733195|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43733196|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
43733197|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
43733198|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43733199|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43733200|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43733201|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
43733202|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733203|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733205|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
43733206|NCT02545452|Nonoxynol|nonoxynol|mesh-list
43733207|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43744609|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
43744610|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43744611|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
43744612|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43744613|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744614|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
43744615|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43704389|NCT05024006|Interferons|interferons|mesh-list
43733208|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733209|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43733210|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43733211|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733212|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733213|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43733214|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
43733215|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733216|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733217|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43733218|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
43744616|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744617|NCT03311958|Nivolumab|nivolumab|mesh-list
43744618|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744619|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744620|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744621|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744622|NCT03291847|Buprenorphine|buprenorphine|mesh-list
43744623|NCT03291847|Methadone|methadone|mesh-list
43567997|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567998|NCT00680342|Silymarin|silymarin|mesh-list
43733219|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43733220|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43733221|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43733222|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43733223|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43562124|NCT01519804|Carboplatin|carboplatin|mesh-list
43733233|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43744672|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744673|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733234|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
43733235|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43733236|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562126|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562127|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
43562128|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
43562129|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562130|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562131|NCT01517776|Temozolomide|temozolomide|mesh-list
43562132|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43562133|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
43744674|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43562134|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733240|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744675|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
43744676|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744677|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744678|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43744679|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
43744680|NCT03261375|Nifedipine|nifedipine|mesh-list
43744681|NCT03261375|Diuretics|diuretics|mesh-ancestor
43744682|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
43744690|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
43733241|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
43733242|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
43733243|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
43733244|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733245|NCT02544919|SMOFlipid|smoflipid|mesh-list
43733246|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43733247|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43733248|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43733249|NCT02544906|Propofol|propofol|mesh-list
43562167|NCT01516203|Ethambutol|ethambutol|mesh-list
43562168|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43562169|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
43733275|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43733277|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43733278|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43733279|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43733280|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
43733281|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733282|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733283|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43733284|NCT02545153|Aprotinin|aprotinin|mesh-list
43733285|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
43733286|NCT02545153|Coagulants|coagulants|mesh-ancestor
43733287|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43733288|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43733289|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
43733290|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733291|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733292|NCT02544932|Warfarin|warfarin|mesh-list
43733293|NCT02544932|Dabigatran|dabigatran|mesh-list
43733294|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
43733295|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
43733296|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43733297|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
43733298|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733299|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733302|NCT02544854|Propofol|propofol|mesh-list
43733303|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43733304|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733305|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733306|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43744739|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744740|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744741|NCT03114527|Everolimus|everolimus|mesh-list
43744742|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568020|NCT00679588|Semuloparin|semuloparin|mesh-list
43568021|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
43568022|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
43568023|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43568024|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43568025|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568026|NCT00678119|Sunitinib|sunitinib|mesh-list
43568027|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733307|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
43733308|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
43733309|NCT02545114|Tolvaptan|tolvaptan|mesh-list
43733310|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43733311|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733312|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
43733323|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733324|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
43733325|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43733326|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
43733327|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733328|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43733329|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
43733330|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43733331|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43733332|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43733333|NCT02544659|Pamidronate|pamidronate|mesh-list
43733334|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43733335|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733336|NCT02544698|Vaccines|vaccines|mesh-list
43733337|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
43733338|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744749|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744750|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744751|NCT03046017|Lidocaine|lidocaine|mesh-list
43733339|NCT02544789|Clofarabine|clofarabine|mesh-list
43733340|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43733360|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43733361|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
43562177|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43562178|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43562179|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43562180|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43562181|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43562182|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43562185|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43562186|NCT01516086|Fluticasone|fluticasone|mesh-list
43562199|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562200|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43562201|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
43562202|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733364|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43733365|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733366|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733367|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
43733368|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733369|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733370|NCT02544529|Miotics|miotics|mesh-ancestor
43733371|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
43733372|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733373|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43733374|NCT02544425|Dexamethasone|dexamethasone|mesh-list
43733375|NCT02544425|Etoposide|etoposide|mesh-list
43733376|NCT02544425|Melphalan|melphalan|mesh-list
43733377|NCT02544425|Busulfan|busulfan|mesh-list
43733381|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
43733382|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
43733391|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43733392|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43744805|NCT02994719|Carbidopa|carbidopa|mesh-list
43744806|NCT02994719|Pramipexole|pramipexole|mesh-list
43744807|NCT02994719|Ropinirole|ropinirole|mesh-list
43744808|NCT02994719|Entacapone|entacapone|mesh-list
43744809|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43733393|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43744810|NCT02994719|Tolcapone|tolcapone|mesh-list
43744811|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43733394|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733395|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733396|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43733397|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
43733398|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43733399|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733400|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
43733401|NCT02544282|Acetaminophen|acetaminophen|mesh-list
43733402|NCT02544282|Sufentanil|sufentanil|mesh-list
43733404|NCT02544282|Pirinitramide|pirinitramide|mesh-list
43733405|NCT02544282|Propofol|propofol|mesh-list
43733406|NCT02544282|Sevoflurane|sevoflurane|mesh-list
43733417|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
43562208|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
43562209|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43562210|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562211|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43562212|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43562213|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562214|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562215|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562216|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43562217|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43562218|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
43562219|NCT01510119|Everolimus|everolimus|mesh-list
43562220|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562221|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562223|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562224|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
43562225|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43562226|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43562227|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562228|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562229|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562231|NCT01508026|Valsartan|valsartan|mesh-list
43562235|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43562236|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562237|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
43562238|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43562239|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43562240|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43562241|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
43562242|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562243|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744828|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43562244|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43562245|NCT01501513|Laxatives|laxatives|mesh-ancestor
43562246|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43562247|NCT01499563|Risperidone|risperidone|mesh-list
43562248|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43562249|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
43733418|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733419|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
43733420|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43733421|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43733422|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43733423|NCT02544282|Narcotics|narcotics|mesh-ancestor
43733424|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43733425|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
43733426|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43733427|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43733428|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43733429|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43733430|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43733431|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
43733432|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733433|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733434|NCT02544191|Goserelin|goserelin|mesh-list
43733435|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43733436|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733437|NCT02544165|Caffeine|caffeine|mesh-list
43733438|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43733439|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733440|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43733451|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43733452|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
43733453|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733454|NCT02544243|Antiviral Agents|antiviral agents|mesh-ancestor
43733455|NCT02544243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733456|NCT02544243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733457|NCT02544243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733458|NCT02544243|Immunologic Factors|immunologic factors|mesh-ancestor
43733459|NCT02544243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733460|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43733479|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
43562259|NCT01498328|Bevacizumab|bevacizumab|mesh-list
43562260|NCT01498328|Rindopepimut|rindopepimut|mesh-list
43562261|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562262|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562263|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43562264|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43562265|NCT01498328|Growth Substances|growth substances|mesh-ancestor
43562266|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744890|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43568045|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
43568046|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568047|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568048|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
43568049|NCT00676832|Prednisolone|prednisolone|mesh-list
43568050|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43568051|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
43568052|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43568053|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
43568054|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43568055|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
43568056|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43568057|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
43568058|NCT00676832|Hormones|hormones|mesh-ancestor
43562267|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
43562268|NCT01497834|Asunaprevir|asunaprevir|mesh-list
43562269|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
43733489|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733490|NCT05226013|Rasburicase|rasburicase|mesh-list
43733491|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
43733492|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733493|NCT05225974|Liraglutide|liraglutide|mesh-list
43733494|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43733495|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733496|NCT05225974|Incretins|incretins|mesh-ancestor
43733497|NCT05225974|Hormones|hormones|mesh-ancestor
43733498|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733499|NCT05225844|Apatinib|apatinib|mesh-list
43733500|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733501|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43733502|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733503|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733509|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733510|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43733511|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
43733512|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733513|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733514|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43733515|NCT05225766|Bupivacaine|bupivacaine|mesh-list
43733516|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
43733520|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
43733521|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733522|NCT05225753|Chrysarobin|chrysarobin|mesh-list
43733523|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43733524|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43733525|NCT05225753|Analgesics|analgesics|mesh-ancestor
43733526|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
43733527|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733528|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733529|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733530|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733531|NCT05224492|Sulforaphane|sulforaphane|mesh-list
43733533|NCT05224492|Protective Agents|protective agents|mesh-ancestor
43733534|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733535|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733536|NCT05171972|Ofatumumab|ofatumumab|mesh-list
43733537|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568059|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733538|NCT05162131|Ticagrelor|ticagrelor|mesh-list
43733539|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43568060|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568061|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43733540|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43568062|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568063|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
43568064|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
43733541|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43733542|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43733543|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
43733544|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733545|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733546|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733547|NCT05157412|Doxycycline|doxycycline|mesh-list
43733548|NCT05157412|Prednisolone|prednisolone|mesh-list
43733549|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43733550|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
43733551|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43733568|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43733569|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733570|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
43733571|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43733572|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43834248|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43834249|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834250|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
43834251|NCT05157711|Coagulants|coagulants|mesh-ancestor
43834253|NCT05157672|Nicotine|nicotine|mesh-list
43834254|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43834255|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
43834257|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834258|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43834259|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43834260|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
43834261|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834262|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733598|NCT04861298|Quercetin|quercetin|mesh-list
43733599|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
43733600|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733601|NCT04861298|Protective Agents|protective agents|mesh-ancestor
43733602|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733603|NCT04844918|Tirzepatide|tirzepatide|mesh-list
43733604|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43733605|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733606|NCT04844918|Incretins|incretins|mesh-ancestor
43733607|NCT04844918|Hormones|hormones|mesh-ancestor
43733608|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733609|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
43733610|NCT04812366|Prednisone|prednisone|mesh-list
43733611|NCT04812366|Docetaxel|docetaxel|mesh-list
43568065|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568066|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43568067|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43568068|NCT00676832|Protective Agents|protective agents|mesh-ancestor
43568069|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
43568073|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568074|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
43733612|NCT04812366|Atezolizumab|atezolizumab|mesh-list
43733613|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
43733614|NCT04812366|Niraparib|niraparib|mesh-list
43733615|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733616|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
43733617|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
43733618|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
43733619|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733620|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733621|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
43733622|NCT04812366|Hormones|hormones|mesh-ancestor
43733623|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733649|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43733650|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733651|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733652|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
43733653|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43733654|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43733655|NCT04649203|Riboflavin|riboflavin|mesh-list
43733656|NCT04649203|Niacinamide|niacinamide|mesh-list
43733657|NCT04649203|Niacin|niacin|mesh-list
43733658|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
43733659|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
43733660|NCT04649203|Vitamins|vitamins|mesh-ancestor
43733661|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
43733662|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733667|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733668|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43733669|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
43733670|NCT04638465|Cisplatin|cisplatin|mesh-list
43733673|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43744922|NCT02888743|Tremelimumab|tremelimumab|mesh-list
43744923|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
43744924|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744925|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
43744926|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744927|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744928|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
43744929|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744930|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744931|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733674|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43733675|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43733676|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43733677|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
43733678|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733679|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733680|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733681|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
43562284|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733683|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733684|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
43733685|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733686|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733687|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43733688|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
43733689|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733690|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733691|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43733697|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733698|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733699|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43562285|NCT01495013|Glimepiride|glimepiride|mesh-list
43562286|NCT01495013|Atorvastatin|atorvastatin|mesh-list
43733700|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43733702|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
43733703|NCT04589676|Naloxone|naloxone|mesh-list
43733704|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43733705|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733706|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
43733707|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733708|NCT04545515|Ivacaftor|ivacaftor|mesh-list
43733709|NCT04545515|Elexacaftor|elexacaftor|mesh-list
43733710|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43733711|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733712|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733713|NCT04489628|Vitamin D|vitamin d|mesh-list
43733714|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
43733715|NCT04489628|Vitamins|vitamins|mesh-ancestor
43733716|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
43733726|NCT04366115|BB 1101|bb 1101|mesh-list
43733735|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733736|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43733737|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733738|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
43733739|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733740|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733742|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43733743|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
43733744|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43733745|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43733746|NCT04292470|Analgesics|analgesics|mesh-ancestor
43733747|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
43733748|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733749|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562308|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43562309|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43562310|NCT01493505|Growth Substances|growth substances|mesh-ancestor
43562311|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745010|NCT02864251|Cisplatin|cisplatin|mesh-list
43568130|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43745011|NCT02864251|Carboplatin|carboplatin|mesh-list
43745012|NCT02864251|Nivolumab|nivolumab|mesh-list
43745013|NCT02864251|Pemetrexed|pemetrexed|mesh-list
43745014|NCT02864251|Ipilimumab|ipilimumab|mesh-list
43745015|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745016|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745017|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43745018|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568139|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43568140|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43568152|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568153|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568154|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43568155|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
43568156|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
43562312|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
43562316|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
43562317|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562321|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733767|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733768|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733769|NCT04179396|Rucaparib|rucaparib|mesh-list
43733770|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43733771|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733772|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733773|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733774|NCT04140214|Carbocysteine|carbocysteine|mesh-list
43733775|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43733783|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43733784|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733785|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
43733786|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733788|NCT04015115|Narcotics|narcotics|mesh-ancestor
43733789|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733790|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733792|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
43733793|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733795|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43733796|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
43733797|NCT04012138|Albuterol|albuterol|mesh-list
43733798|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43733799|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733800|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43733801|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
43733802|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733803|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43733804|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
43733805|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
43562338|NCT01486849|Protective Agents|protective agents|mesh-ancestor
43562340|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43562349|NCT01483742|Ribavirin|ribavirin|mesh-list
43562350|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43568191|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43568192|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568193|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568194|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
43568195|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43568196|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43568197|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
43568198|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568199|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568200|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43568201|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
43745137|NCT02826486|Leucovorin|leucovorin|mesh-list
43745138|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
43745139|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745140|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745141|NCT02826486|Antidotes|antidotes|mesh-ancestor
43745142|NCT02826486|Protective Agents|protective agents|mesh-ancestor
43562351|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43562352|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43562353|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
43562354|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834265|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43834266|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834267|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43834268|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
43834269|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834271|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43834272|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834273|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43562359|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562360|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43562361|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43745143|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745144|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
43745145|NCT02826486|Vitamins|vitamins|mesh-ancestor
43745146|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
43745147|NCT02825940|Gemcitabine|gemcitabine|mesh-list
43745148|NCT02825940|Cisplatin|cisplatin|mesh-list
43745149|NCT02825940|Atezolizumab|atezolizumab|mesh-list
43745150|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745151|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43745152|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
43745153|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745154|NCT02825940|Antiviral Agents|antiviral agents|mesh-ancestor
43745155|NCT02825940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43745156|NCT02825940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745157|NCT02825940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745158|NCT02825940|Immunologic Factors|immunologic factors|mesh-ancestor
43745159|NCT02825940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745160|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43745161|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43562362|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
43562363|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43562364|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
43562365|NCT01482403|Ribavirin|ribavirin|mesh-list
43562366|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
43562367|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562368|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
43562369|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562370|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
43562371|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562372|NCT01482390|Ribavirin|ribavirin|mesh-list
43562373|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43562374|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
43562375|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562376|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
43562377|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562378|NCT01481077|Latanoprost|latanoprost|mesh-list
43562387|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562389|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834291|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43834292|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
43834293|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835710|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43835711|NCT05028348|Growth Substances|growth substances|mesh-ancestor
43835712|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
43835713|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43835714|NCT05026736|Antibodies|antibodies|mesh-list
43835715|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
43835716|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43835717|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
43835718|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835719|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835720|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
43835721|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834294|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834295|NCT05154383|Vaccines|vaccines|mesh-list
43834296|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
43834297|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834298|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
43834299|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43834300|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
43834301|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834302|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834303|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43834304|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
43834305|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834306|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834307|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43834308|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
43834309|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43834310|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834311|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43834312|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43834313|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43834314|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562390|NCT01480479|Temozolomide|temozolomide|mesh-list
43562391|NCT01480479|Molgramostim|molgramostim|mesh-list
43562396|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562397|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562398|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
43562404|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562405|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562406|NCT01476904|Epinephrine|epinephrine|mesh-list
43562407|NCT01476904|Racepinephrine|racepinephrine|mesh-list
43562408|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
43562409|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43834315|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834316|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43834317|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43745234|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43745235|NCT02568553|Growth Substances|growth substances|mesh-ancestor
43745236|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
43745237|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733829|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
43733831|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733836|NCT02543697|Epinephrine|epinephrine|mesh-list
43733837|NCT02543697|Racepinephrine|racepinephrine|mesh-list
43733838|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
43733839|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43733840|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43733841|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
43733842|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733843|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733844|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733845|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43733846|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43733847|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
43733848|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733849|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43733850|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
43733851|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
43733852|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
43733853|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43733855|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733856|NCT02543671|Vitamin D|vitamin d|mesh-list
43733857|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
43733858|NCT02543671|Vitamins|vitamins|mesh-ancestor
43733859|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
43733860|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733861|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43745286|NCT02502266|Paclitaxel|paclitaxel|mesh-list
43745287|NCT02502266|Doxorubicin|doxorubicin|mesh-list
43745288|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43745289|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43745290|NCT02502266|Topotecan|topotecan|mesh-list
43745291|NCT02502266|Olaparib|olaparib|mesh-list
43745292|NCT02502266|Cediranib|cediranib|mesh-list
43745293|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43745294|NCT02502266|Maleic acid|maleic acid|mesh-list
43745295|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43745296|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745297|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745298|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745299|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745300|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745301|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43745302|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43745303|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43745305|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43745306|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43745307|NCT02496208|Nivolumab|nivolumab|mesh-list
43745308|NCT02496208|Ipilimumab|ipilimumab|mesh-list
43745309|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745310|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733862|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43733863|NCT02543645|Atezolizumab|atezolizumab|mesh-list
43733864|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733865|NCT02543411|Lidocaine|lidocaine|mesh-list
43733866|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
43733867|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
43562416|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43562417|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
43562427|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43562428|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
43562429|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562430|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562431|NCT01472198|Antiviral Agents|antiviral agents|mesh-ancestor
43562432|NCT01472198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562433|NCT01472198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562434|NCT01472198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562435|NCT01472198|Immunologic Factors|immunologic factors|mesh-ancestor
43562442|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562443|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562444|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43733871|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733872|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43733873|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43733874|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43733875|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733876|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733877|NCT02543606|Esomeprazole|esomeprazole|mesh-list
43733878|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43733879|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43733880|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43733881|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733882|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733883|NCT02543385|Ketamine|ketamine|mesh-list
43562445|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
43562446|NCT01470131|Hormones|hormones|mesh-ancestor
43562447|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43562448|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43562450|NCT01464437|Metformin|metformin|mesh-list
43562451|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43562452|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562453|NCT01461317|Etrolizumab|etrolizumab|mesh-list
43562454|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43562455|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
43562459|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43568203|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43568204|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
43568215|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568216|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
43568217|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
43568218|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562460|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
43562461|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562462|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562463|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562464|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43562465|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43562466|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
43562467|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562468|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562470|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
43562471|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
43562472|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43562473|NCT01455090|Ribavirin|ribavirin|mesh-list
43562474|NCT01455090|Asunaprevir|asunaprevir|mesh-list
43562475|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
43562476|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562477|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
43562478|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562479|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
43562480|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562481|NCT01449591|Metronidazole|metronidazole|mesh-list
43562482|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562483|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43562484|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43562485|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43562486|NCT01449071|Epratuzumab|epratuzumab|mesh-list
43548383|NCT03642600|Folic Acid|folic acid|mesh-list
43745312|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745313|NCT02484443|Dinutuximab|dinutuximab|mesh-list
43745314|NCT02484443|Sargramostim|sargramostim|mesh-list
43745315|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
43745316|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745317|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745320|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43745321|NCT02465060|Nivolumab|nivolumab|mesh-list
43745322|NCT02465060|Trastuzumab|trastuzumab|mesh-list
43562487|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745323|NCT02465060|Pertuzumab|pertuzumab|mesh-list
43745324|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43745325|NCT02465060|Sunitinib|sunitinib|mesh-list
43745326|NCT02465060|Dasatinib|dasatinib|mesh-list
43568239|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43568240|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43568241|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568242|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568243|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43568244|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43568245|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
43562488|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562489|NCT01445899|Ranibizumab|ranibizumab|mesh-list
43562490|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43562491|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43562492|NCT01445899|Growth Substances|growth substances|mesh-ancestor
43562493|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733884|NCT02543385|Esketamine|esketamine|mesh-list
43733885|NCT02543385|Analgesics|analgesics|mesh-ancestor
43733886|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
43733887|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733888|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733889|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43733890|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43733891|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
43733892|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
43733893|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733894|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43733895|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43733896|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733897|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733898|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
43733899|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568252|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733900|NCT02543034|Petrolatum|petrolatum|mesh-list
43733901|NCT02543034|Emollients|emollients|mesh-ancestor
43733904|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43733905|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43733906|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
43733907|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733908|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43733909|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43562494|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
43562495|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562496|NCT01445795|Ribavirin|ribavirin|mesh-list
43562497|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
43562498|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562499|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
43562500|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562501|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43562502|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43562503|NCT01444365|Analgesics|analgesics|mesh-ancestor
43562504|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
43562505|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562506|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562507|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562508|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745384|NCT02446600|Immunologic Factors|immunologic factors|mesh-ancestor
43745385|NCT02446600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745386|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43745387|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43745388|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43745389|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43745390|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43745422|NCT02440464|Fludarabine|fludarabine|mesh-list
43745423|NCT02440464|Bortezomib|bortezomib|mesh-list
43745424|NCT02440464|Melphalan|melphalan|mesh-list
43745425|NCT02440464|Ixazomib|ixazomib|mesh-list
43745426|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745427|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745428|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745429|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
43568256|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568257|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43568258|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568259|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568260|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43568261|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43568262|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568263|NCT00658372|Paroxetine|paroxetine|mesh-list
43568264|NCT00658372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43733912|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43733913|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43733914|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733915|NCT02543229|Ranibizumab|ranibizumab|mesh-list
43733916|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43733917|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43733918|NCT02543229|Growth Substances|growth substances|mesh-ancestor
43733919|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733920|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
43733921|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733922|NCT02543060|Fluorides|fluorides|mesh-list
43733923|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
43733924|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
43733925|NCT02543060|Protective Agents|protective agents|mesh-ancestor
43733926|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733927|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
43733928|NCT02543073|Hormones|hormones|mesh-ancestor
43733929|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733930|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562518|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562519|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562520|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
43562521|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562522|NCT01437735|Montelukast|montelukast|mesh-list
43562523|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562524|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
43562528|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562529|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43562530|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43562531|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562532|NCT01436032|Ketorolac|ketorolac|mesh-list
43562533|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43562534|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43562535|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43562536|NCT01436032|Analgesics|analgesics|mesh-ancestor
43562537|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
43562538|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562539|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562540|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562541|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733936|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43733937|NCT02542852|Dolutegravir|dolutegravir|mesh-list
43568265|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568266|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43733938|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43733939|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43733940|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
43733941|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733942|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733943|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43568274|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43568275|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43733944|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43733946|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733947|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43733948|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43733949|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43733950|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43733951|NCT02542748|Norepinephrine|norepinephrine|mesh-list
43733952|NCT02542748|Ephedrine|ephedrine|mesh-list
43733953|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43733954|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43733956|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733957|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733958|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733959|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
43733960|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
43733961|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733962|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43733963|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43733964|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
43562551|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562552|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
43562553|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562554|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
43733973|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43733974|NCT02542592|Prednisolone|prednisolone|mesh-list
43733975|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
43733976|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43733977|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
43733978|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733979|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
43733980|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
43733981|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733982|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733983|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43733984|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
43733985|NCT02542592|Hormones|hormones|mesh-ancestor
43733986|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733987|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43733988|NCT02542592|Protective Agents|protective agents|mesh-ancestor
43733989|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43733990|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733991|NCT02542813|Oxytocin|oxytocin|mesh-list
43733992|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
43733994|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733995|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43734025|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
43734026|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834318|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568294|NCT00658008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43834319|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
43834320|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568295|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43745430|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745431|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43834322|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
43834323|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834324|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43834325|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834326|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
43834327|NCT05148949|Vaccines|vaccines|mesh-list
43834328|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
43834329|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834330|NCT05148078|Anesthetics|anesthetics|mesh-list
43834331|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43562555|NCT01435044|Ribavirin|ribavirin|mesh-list
43562556|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
43562557|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562558|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
43562559|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562560|NCT01434498|Ribavirin|ribavirin|mesh-list
43562561|NCT01434498|Ledipasvir|ledipasvir|mesh-list
43562562|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
43562563|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562564|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
43562565|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562566|NCT01431820|Luliconazole|luliconazole|mesh-list
43562567|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43562568|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
43562569|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562570|NCT01425970|Interferons|interferons|mesh-list
43562571|NCT01425970|Ribavirin|ribavirin|mesh-list
43562572|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
43562573|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
43562574|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43562575|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562576|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
43562577|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562578|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
43562579|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562580|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
43562581|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562582|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
43562583|NCT01423149|Combretastatin|combretastatin|mesh-list
43562584|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43562585|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562586|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
43562587|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
43562589|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562590|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
43834332|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734027|NCT02542111|Gemcitabine|gemcitabine|mesh-list
43734028|NCT02542111|Dexamethasone|dexamethasone|mesh-list
43734030|NCT02542111|Bortezomib|bortezomib|mesh-list
43734031|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734032|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
43745448|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43745449|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745452|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43745453|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43745454|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43745455|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745456|NCT02393859|Dexamethasone|dexamethasone|mesh-list
43745457|NCT02393859|Methotrexate|methotrexate|mesh-list
43745458|NCT02393859|Daunorubicin|daunorubicin|mesh-list
43745459|NCT02393859|Asparaginase|asparaginase|mesh-list
43745461|NCT02393859|Blinatumomab|blinatumomab|mesh-list
43734033|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
43734034|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734035|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734037|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
43734038|NCT02542111|Hormones|hormones|mesh-ancestor
43734039|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734047|NCT02542111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734053|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43734054|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734055|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
43734056|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734057|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
43734058|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734059|NCT02542098|Hydrocodone|hydrocodone|mesh-list
43734060|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43734061|NCT02542098|Narcotics|narcotics|mesh-ancestor
43734062|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734066|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734067|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
43734068|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734070|NCT02541734|Polygeline|polygeline|mesh-list
43734071|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43734072|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734073|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43734075|NCT02541734|Hormones|hormones|mesh-ancestor
43734076|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734077|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
43734078|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
43734079|NCT02541786|Rabeprazole|rabeprazole|mesh-list
43734080|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
43734081|NCT02541786|Lansoprazole|lansoprazole|mesh-list
43734082|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43734083|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734084|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43562593|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562594|NCT01422148|Minocycline|minocycline|mesh-list
43562597|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562598|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43562599|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
43562600|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43562610|NCT01421056|Flurbiprofen|flurbiprofen|mesh-list
43562611|NCT01421056|Analgesics|analgesics|mesh-ancestor
43745462|NCT02393859|Pegaspargase|pegaspargase|mesh-list
43745463|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43745464|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
43745465|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
43745468|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43562612|NCT01421056|Sensory System Agents|sensory system agents|mesh-ancestor
43562613|NCT01421056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562614|NCT01421056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562615|NCT01421056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43734097|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
43734098|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734099|NCT02541526|Mirtazapine|mirtazapine|mesh-list
43734100|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
43734101|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43734102|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43734103|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
43734104|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
43834333|NCT05148000|Botulinum Toxins|botulinum toxins|mesh-list
43734105|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734109|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43734110|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734111|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43734112|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43734113|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43734114|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
43734115|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43734116|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43734117|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
43734118|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43734122|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734123|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734124|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
43734125|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734126|NCT02541500|Minocycline|minocycline|mesh-list
43745522|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
43745523|NCT02298959|Aflibercept|aflibercept|mesh-list
43745527|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43745528|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43745529|NCT02298959|Growth Substances|growth substances|mesh-ancestor
43745530|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745531|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
43745532|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43745533|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43745534|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745536|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745537|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745538|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43745539|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745540|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43745541|NCT02245230|Trimethaphan|trimethaphan|mesh-list
43745542|NCT02245230|Phenylephrine|phenylephrine|mesh-list
43745543|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
43734131|NCT02541396|Analgesics|analgesics|mesh-ancestor
43734132|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
43734133|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734134|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734135|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43734136|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43734137|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
43734138|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
43734140|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43734141|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43734142|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734143|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734144|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43562620|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562621|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562623|NCT01418222|Bevacizumab|bevacizumab|mesh-list
43562624|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562625|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562626|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43562627|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43562628|NCT01418222|Growth Substances|growth substances|mesh-ancestor
43562629|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562630|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
43562631|NCT01418222|Antidotes|antidotes|mesh-ancestor
43562633|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
43562634|NCT01418222|Vitamins|vitamins|mesh-ancestor
43562635|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
43562636|NCT01416402|Colchicine|colchicine|mesh-list
43562637|NCT01416402|Febuxostat|febuxostat|mesh-list
43562638|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
43562639|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562640|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
43562641|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
43562642|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562643|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562644|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562645|NCT01416064|Molindone|molindone|mesh-list
43562646|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43562647|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43562648|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734145|NCT02541396|Narcotics|narcotics|mesh-ancestor
43734146|NCT02541383|Thalidomide|thalidomide|mesh-list
43734147|NCT02541383|Dexamethasone|dexamethasone|mesh-list
43734149|NCT02541383|Bortezomib|bortezomib|mesh-list
43734150|NCT02541383|Daratumumab|daratumumab|mesh-list
43734151|NCT02541383|BB 1101|bb 1101|mesh-list
43734152|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43734153|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734154|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
43734155|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
43734157|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734158|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734159|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
43734160|NCT02541383|Hormones|hormones|mesh-ancestor
43734161|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43562649|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562650|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43562651|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43562652|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43562653|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562654|NCT01414920|Incretins|incretins|mesh-ancestor
43562655|NCT01414920|Hormones|hormones|mesh-ancestor
43745554|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43745555|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43745556|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43745557|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
43745558|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43745559|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745560|NCT02245230|Protective Agents|protective agents|mesh-ancestor
43745561|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43745562|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
43745563|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43745564|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43745565|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43745566|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43745567|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
43745569|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43745570|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
43745571|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
43745572|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745573|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562656|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43562661|NCT01410695|Methotrexate|methotrexate|mesh-list
43562662|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43562667|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
43562668|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562669|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562670|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
43562671|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562672|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43562673|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562674|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
43562675|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562676|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43562677|NCT01410188|Latanoprost|latanoprost|mesh-list
43562680|NCT01408082|Azithromycin|azithromycin|mesh-list
43562681|NCT01408082|Dexamethasone|dexamethasone|mesh-list
43562682|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
43562683|NCT01408082|BB 1101|bb 1101|mesh-list
43562684|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562685|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
43562686|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
43562687|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562688|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745647|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745648|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43745650|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
43745651|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43745652|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745653|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43745654|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568323|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568324|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
43568325|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568326|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43568327|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43568328|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568329|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568333|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
43568334|NCT00654992|Hematinics|hematinics|mesh-ancestor
43568335|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43568336|NCT00654706|Sertindole|sertindole|mesh-list
43568337|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568338|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568339|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43568340|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43568341|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43568342|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568343|NCT00650949|Carboplatin|carboplatin|mesh-list
43562689|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43562690|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
43562691|NCT01408082|Hormones|hormones|mesh-ancestor
43562692|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734162|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43734164|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
43734165|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734166|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734167|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734168|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
43734169|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
43734170|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734171|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734172|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43734173|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43734174|NCT02541383|Growth Substances|growth substances|mesh-ancestor
43734175|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
43734178|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
43734179|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734180|NCT02541084|Aflibercept|aflibercept|mesh-list
43734181|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43734182|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43734183|NCT02541084|Growth Substances|growth substances|mesh-ancestor
43734184|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734185|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
43734186|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734187|NCT02541071|Clonidine|clonidine|mesh-list
43734188|NCT02541071|Yohimbine|yohimbine|mesh-list
43734189|NCT02541071|Analgesics|analgesics|mesh-ancestor
43734190|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
43745674|NCT02024230|Warfarin|warfarin|mesh-list
43745675|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
43548696|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745676|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
43745677|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43745679|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43745680|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
43745681|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745682|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734191|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734192|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734193|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43734201|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734203|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43734204|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43734205|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43734206|NCT02541071|Urological Agents|urological agents|mesh-ancestor
43734207|NCT02541045|Metadoxine|metadoxine|mesh-list
43734208|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43734209|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
43734210|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43734211|NCT02541227|Protective Agents|protective agents|mesh-ancestor
43734212|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734213|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
43562697|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562698|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43562699|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562700|NCT01407003|Licogliflozin|licogliflozin|mesh-list
43562701|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43562702|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562703|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43562704|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562709|NCT01399684|Folic Acid|folic acid|mesh-list
43562710|NCT01399684|Bevacizumab|bevacizumab|mesh-list
43562711|NCT01399684|Fluorouracil|fluorouracil|mesh-list
43562712|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
43562713|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
43562714|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562715|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562716|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43562717|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43562718|NCT01399684|Growth Substances|growth substances|mesh-ancestor
43562719|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562720|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
43562721|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
43562722|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562723|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43562724|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562725|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
43562726|NCT01399684|Antidotes|antidotes|mesh-ancestor
43568344|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568345|NCT00650832|Darunavir|darunavir|mesh-list
43568346|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43568347|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43568348|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
43568349|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568350|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568351|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43568352|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43568353|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
43568354|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562727|NCT01399684|Protective Agents|protective agents|mesh-ancestor
43562728|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
43562729|NCT01399684|Vitamins|vitamins|mesh-ancestor
43562730|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
43562731|NCT01399684|Hematinics|hematinics|mesh-ancestor
43562732|NCT01399580|Atrasentan|atrasentan|mesh-list
43734226|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43734227|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
43734228|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734229|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734230|NCT02541019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43562733|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568355|NCT00650702|Latanoprost|latanoprost|mesh-list
43568356|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43568357|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43568358|NCT00649025|Fluticasone|fluticasone|mesh-list
43745745|NCT01989585|Trametinib|trametinib|mesh-list
43745746|NCT01989585|Dabrafenib|dabrafenib|mesh-list
43745747|NCT01989585|Navitoclax|navitoclax|mesh-list
43745748|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745749|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43745750|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745751|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562734|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43562736|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562738|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
43562739|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43562740|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
43562741|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562743|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562744|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
43562745|NCT01393639|Hormones|hormones|mesh-ancestor
43562746|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43562747|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562748|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43562749|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562750|NCT01390545|Veltuzumab|veltuzumab|mesh-list
43562751|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562752|NCT01384383|Ledipasvir|ledipasvir|mesh-list
43745766|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43745767|NCT01979536|Antibodies|antibodies|mesh-list
43745768|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
43745769|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43745770|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
43745771|NCT01979536|BB 1101|bb 1101|mesh-list
43745772|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43568392|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
43568393|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
43568394|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568396|NCT00643383|Tramadol|tramadol|mesh-list
43568397|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43568398|NCT00643383|Analgesics|analgesics|mesh-ancestor
43568399|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
43704396|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
43562753|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
43562754|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562755|NCT01382654|Azelastine|azelastine|mesh-list
43562756|NCT01382654|Epinastine|epinastine|mesh-list
43562757|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43562758|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
43562759|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562760|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562761|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562762|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
43562763|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43562764|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562765|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734231|NCT02541019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43734232|NCT02541019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734233|NCT02541019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43734234|NCT02541019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43734235|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43734236|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
43734237|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734238|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734239|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
43734240|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43734241|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
43734242|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734243|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734244|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43734245|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734246|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
43734247|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43734257|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734258|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734259|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734260|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734261|NCT02540837|Bupivacaine|bupivacaine|mesh-list
43568400|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568401|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568402|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
43568403|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43568415|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568417|NCT00641732|Enoxaparin|enoxaparin|mesh-list
43568418|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
43568419|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
43568420|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43568421|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43568422|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568423|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43568424|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
43568425|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43568426|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
43568427|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568428|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43734262|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
43734263|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
43734264|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734265|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734266|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
43734267|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734268|NCT02540785|Levofloxacin|levofloxacin|mesh-list
43734269|NCT02540785|Ofloxacin|ofloxacin|mesh-list
43734270|NCT02540785|Tobramycin|tobramycin|mesh-list
43734271|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
43734272|NCT02540785|Dexamethasone|dexamethasone|mesh-list
43734273|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
43734274|NCT02540785|BB 1101|bb 1101|mesh-list
43734275|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
43734276|NCT02540785|Dipivefrin|dipivefrin|mesh-list
43734277|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734278|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
43734279|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
43562766|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43562767|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43562768|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43745773|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
43745774|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745775|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745776|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43745777|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
43745778|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745779|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745780|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43745781|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43745782|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
43745828|NCT01935778|Docetaxel|docetaxel|mesh-list
43745829|NCT01935778|Capecitabine|capecitabine|mesh-list
43745830|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
43745831|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745832|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745833|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745834|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562769|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
43562770|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
43562774|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43562775|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
43562776|NCT01379209|Sirolimus|sirolimus|mesh-list
43562777|NCT01379209|Methotrexate|methotrexate|mesh-list
43562778|NCT01379209|KRN 7000|krn 7000|mesh-list
43562779|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43734281|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734282|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734283|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
43734284|NCT02540785|Hormones|hormones|mesh-ancestor
43734285|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734286|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43562780|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43562781|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
43562782|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43562783|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562784|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43562785|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
43562786|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562787|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562788|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
43562789|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562790|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43562791|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562792|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
43562793|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562794|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43562795|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43562796|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43562797|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
43562798|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43562799|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562800|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
43562801|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43562803|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
43562804|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43562805|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43562806|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562807|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562808|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562809|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43562810|NCT01378676|Protective Agents|protective agents|mesh-ancestor
43562813|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562814|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43745859|NCT01873326|Ifosfamide|ifosfamide|mesh-list
43745860|NCT01873326|Bleomycin|bleomycin|mesh-list
43745861|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43562815|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43562816|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43562817|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562818|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
43562819|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562820|NCT01373086|Eplerenone|eplerenone|mesh-list
43562821|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43562822|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
43562824|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562825|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43562826|NCT01373086|Diuretics|diuretics|mesh-ancestor
43562827|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
43745886|NCT01863550|Hormones|hormones|mesh-ancestor
43562828|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43562829|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
43562830|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43562831|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
43562832|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562833|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
43562834|NCT01372475|Protective Agents|protective agents|mesh-ancestor
43562835|NCT01371578|Ribavirin|ribavirin|mesh-list
43562836|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43562837|NCT01371578|Ledipasvir|ledipasvir|mesh-list
43562838|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
43562839|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734287|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734288|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
43734289|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734290|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734291|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43734292|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734293|NCT02540785|Renal Agents|renal agents|mesh-ancestor
43734294|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734295|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43734296|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43734297|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43734298|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43734299|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43734300|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
43734301|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
43734302|NCT02540785|Protective Agents|protective agents|mesh-ancestor
43734303|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43734304|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568441|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
43568442|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568443|NCT00629980|Azithromycin|azithromycin|mesh-list
43734305|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734310|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43568444|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568445|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568446|NCT00629941|Azithromycin|azithromycin|mesh-list
43562840|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
43562841|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562842|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43562843|NCT01369095|Citalopram|citalopram|mesh-list
43562844|NCT01369095|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43562845|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43562846|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43562847|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562848|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562849|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
43562850|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562851|NCT01369095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43562852|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
43562853|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43562854|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562855|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43562856|NCT01369095|Analgesics|analgesics|mesh-ancestor
43562857|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
43562858|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
43562859|NCT01366131|Paclitaxel|paclitaxel|mesh-list
43734311|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43734312|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734313|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
43734314|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
43734315|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734316|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734320|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734321|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43734322|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734323|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
43734325|NCT02540642|Vitamins|vitamins|mesh-ancestor
43734326|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
43734327|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734328|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
43734329|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
43734330|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
43734331|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43734332|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734333|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
43734334|NCT02540707|Mirabegron|mirabegron|mesh-list
43734346|NCT02540460|Delpazolid|delpazolid|mesh-list
43568447|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568448|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568449|NCT00629590|Azithromycin|azithromycin|mesh-list
43734364|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734365|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
43734366|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734367|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43734368|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734369|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43734370|NCT02540239|Simethicone|simethicone|mesh-list
43734371|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
43734372|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734373|NCT02540239|Emollients|emollients|mesh-ancestor
43734384|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734388|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734389|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734390|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43734391|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734392|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43734393|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
43734394|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734395|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562860|NCT01366131|Bevacizumab|bevacizumab|mesh-list
43562861|NCT01366131|Carboplatin|carboplatin|mesh-list
43562862|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43562863|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562864|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
43562865|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
43562866|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562867|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562868|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43734396|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734397|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
43745978|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734399|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734400|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43734401|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
43734402|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
43562926|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43562927|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43562928|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562930|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562931|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562932|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43562933|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562934|NCT01357642|Epinephrine|epinephrine|mesh-list
43562935|NCT01357642|Racepinephrine|racepinephrine|mesh-list
43562936|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
43562939|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
43562940|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562941|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562942|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562943|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43562944|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43562946|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562947|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562948|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
43562949|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
43562950|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
43562951|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43562952|NCT01356849|Atrasentan|atrasentan|mesh-list
43562953|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734440|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734441|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
43734442|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
43734445|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734446|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43734447|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43734448|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734449|NCT02539979|Acetaminophen|acetaminophen|mesh-list
43734450|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43568490|NCT00625833|Reboxetine|reboxetine|mesh-list
43734451|NCT02539979|Analgesics|analgesics|mesh-ancestor
43734452|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
43734453|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734454|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734455|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
43734456|NCT02539966|Sirolimus|sirolimus|mesh-list
43734457|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734458|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734459|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43734460|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734461|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
43734462|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734463|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
43734464|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734465|NCT02539940|Paclitaxel|paclitaxel|mesh-list
43734466|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43734467|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734468|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
43568506|NCT00625664|Antiviral Agents|antiviral agents|mesh-ancestor
43734469|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
43734470|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
43734471|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734472|NCT02539849|Adalimumab|adalimumab|mesh-list
43734473|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734474|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43734481|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734482|NCT02539745|Vitamin D|vitamin d|mesh-list
43734483|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43734484|NCT02539745|Vitamins|vitamins|mesh-ancestor
43734485|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
43734486|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734487|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43734488|NCT02539641|Hormones|hormones|mesh-list
43734489|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734490|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734491|NCT02539628|Ropivacaine|ropivacaine|mesh-list
43734492|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
43734493|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
43734494|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734495|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734496|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
43734497|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734498|NCT02539316|SMOFlipid|smoflipid|mesh-list
43734499|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43734500|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43734501|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43734502|NCT02539199|Misoprostol|misoprostol|mesh-list
43734503|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43734504|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
43734505|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43734506|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734507|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43734508|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734509|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
43734513|NCT02539394|Prednisolone|prednisolone|mesh-list
43734525|NCT02539394|Hormones|hormones|mesh-ancestor
43734526|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734529|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43734530|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734532|NCT02538926|Prednisone|prednisone|mesh-list
43734533|NCT02538926|Cortisone|cortisone|mesh-list
43734534|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
43734535|NCT02538926|Rituximab|rituximab|mesh-list
43734536|NCT02538926|Doxorubicin|doxorubicin|mesh-list
43734537|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43562954|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43562955|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43746037|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
43746038|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746039|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
43746040|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746041|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562956|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562957|NCT01356160|Ribavirin|ribavirin|mesh-list
43562958|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43562959|NCT01356160|Ledipasvir|ledipasvir|mesh-list
43562960|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
43562961|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562962|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
43562963|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562964|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43562965|NCT01355393|Sargramostim|sargramostim|mesh-list
43562966|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
43562967|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568580|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43562968|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
43562970|NCT01354717|Fluorouracil|fluorouracil|mesh-list
43562971|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
43562972|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562973|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43562974|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562975|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562976|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
43562977|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562978|NCT01353248|Ribavirin|ribavirin|mesh-list
43562979|NCT01353248|Ledipasvir|ledipasvir|mesh-list
43562980|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
43562981|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562982|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
43562983|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562984|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
43562985|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43562986|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
43562987|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562988|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562989|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562990|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
43562991|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43562992|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43562993|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43568581|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568582|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568609|NCT00612820|Xhance|xhance|mesh-list
43562994|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
43562995|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562996|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562997|NCT01348919|Dexamethasone|dexamethasone|mesh-list
43562998|NCT01348919|Lenalidomide|lenalidomide|mesh-list
43562999|NCT01348919|Delanzomib|delanzomib|mesh-list
43563000|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734539|NCT02538926|Vincristine|vincristine|mesh-list
43734540|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
43734541|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
43734545|NCT02538926|Antibodies|antibodies|mesh-list
43734546|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
43734547|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43734548|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734549|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
43734550|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734551|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43734552|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43734553|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
43734554|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734555|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734556|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43563001|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
43563002|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
43563003|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563004|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563005|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43563006|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
43563007|NCT01348919|Hormones|hormones|mesh-ancestor
43746047|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746048|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
43746049|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
43746050|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568623|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568624|NCT00612742|Testosterone|testosterone|mesh-list
43563008|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568625|NCT00612742|Androgens|androgens|mesh-ancestor
43568626|NCT00612742|Hormones|hormones|mesh-ancestor
43568627|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568628|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568629|NCT00612170|Reboxetine|reboxetine|mesh-list
43568630|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568631|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568632|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43568633|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568634|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568635|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568636|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568637|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563012|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43563013|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43563014|NCT01348919|Growth Substances|growth substances|mesh-ancestor
43563015|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
43563016|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
43563017|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
43563018|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563019|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563020|NCT01345045|Pregabalin|pregabalin|mesh-list
43563021|NCT01345045|Analgesics|analgesics|mesh-ancestor
43563022|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
43563023|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563024|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563025|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
43563026|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43563027|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43563028|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563029|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43563030|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43563031|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43563032|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563033|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43563035|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43563036|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
43563037|NCT01344187|Vitamins|vitamins|mesh-ancestor
43734557|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43734558|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43734559|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43734560|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734561|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734562|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
43734564|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43563039|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563040|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43563041|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
43563042|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43563050|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563051|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563052|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
43563053|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563054|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43563055|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43563056|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43563057|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43563058|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43563059|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43563079|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
43563080|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43568642|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
43563081|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
43568643|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568644|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563082|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563083|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563084|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563085|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563103|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563106|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563107|NCT01332656|Paclitaxel|paclitaxel|mesh-list
43563108|NCT01332656|Carboplatin|carboplatin|mesh-list
43563109|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43563110|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563111|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563112|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563113|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
43734591|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43734592|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43734593|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43734594|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
43734595|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734596|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734598|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734599|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734600|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734601|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834355|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
43834356|NCT05142254|Tadalafil|tadalafil|mesh-list
43834357|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
43834358|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43834359|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43834360|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834361|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834362|NCT05142254|Urological Agents|urological agents|mesh-ancestor
43834363|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834364|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
43834365|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43834366|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43834367|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834368|NCT05141708|Talazoparib|talazoparib|mesh-list
43834369|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43834370|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834371|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834372|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834373|NCT05141149|Gemcitabine|gemcitabine|mesh-list
43746082|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
43746083|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
43746084|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746085|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
43746086|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746087|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
43746088|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834374|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43834375|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
43834376|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834377|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834381|NCT05141149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43834382|NCT05141149|Immunologic Factors|immunologic factors|mesh-ancestor
43834383|NCT05141149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834384|NCT05140499|Bupivacaine|bupivacaine|mesh-list
43834385|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
43834386|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
43834387|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834388|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834389|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
43834390|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834391|NCT05140278|Artesunate|artesunate|mesh-list
43834392|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
43834393|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43834394|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43834395|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834396|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834397|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
43834398|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
43834399|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43834400|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
43834402|NCT05139420|Phentermine|phentermine|mesh-list
43834403|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
43834404|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43834405|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734617|NCT02538224|Doxycycline|doxycycline|mesh-list
43734618|NCT02538224|Ketoprofen|ketoprofen|mesh-list
43734619|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734620|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734621|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
43734622|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43734623|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43746107|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
43746108|NCT01208090|Ponesimod|ponesimod|mesh-list
43746109|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43746110|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746111|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746112|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
43746113|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734624|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43746114|NCT01141712|Cytarabine|cytarabine|mesh-list
43734625|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43734626|NCT02538224|Analgesics|analgesics|mesh-ancestor
43734627|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
43734628|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734629|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734630|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734631|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43734632|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43734633|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734634|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734635|NCT02538211|Vaccines|vaccines|mesh-list
43734636|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43734637|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
43734638|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734639|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43734640|NCT02538302|Oxybutynin|oxybutynin|mesh-list
43734641|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
43734642|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
43734643|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734647|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
43734664|NCT02538432|Immunologic Factors|immunologic factors|mesh-ancestor
43734665|NCT02538432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563114|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563115|NCT01331850|Ritonavir|ritonavir|mesh-list
43563116|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43563117|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
43563118|NCT01331850|Ribavirin|ribavirin|mesh-list
43563119|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43563120|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43563121|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
43563122|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563123|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563124|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43563125|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43563126|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
43563127|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563128|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43563129|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43563130|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
43563131|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563132|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
43563133|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43563134|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43563135|NCT01328808|Acetaminophen|acetaminophen|mesh-list
43563136|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43563137|NCT01328808|Analgesics|analgesics|mesh-ancestor
43563138|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
43746147|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563139|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734675|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43734676|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734677|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734678|NCT02538172|Valganciclovir|valganciclovir|mesh-list
43734679|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
43734680|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734681|NCT02538003|Delpazolid|delpazolid|mesh-list
43734682|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
43734683|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734684|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734685|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43734686|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734687|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734688|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
43734689|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
43734690|NCT02538146|Vitamins|vitamins|mesh-ancestor
43734691|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
43734692|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734693|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
43734694|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
43734695|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43734696|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43734697|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734698|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
43563140|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563141|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
43563142|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
43746175|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746176|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43746177|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835751|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43835752|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835753|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835756|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
43835757|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835758|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43835759|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43835760|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43835761|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
43835762|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835763|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746187|NCT00720785|Bortezomib|bortezomib|mesh-list
43568652|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43568653|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
43568671|NCT00607256|Reboxetine|reboxetine|mesh-list
43563143|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
43563144|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563145|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563146|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
43563147|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43563148|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563149|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734699|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
43734700|NCT02538081|Risperidone|risperidone|mesh-list
43734701|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43734702|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
43563150|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43563151|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
43563152|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
43563153|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563154|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563155|NCT01318642|Gemcitabine|gemcitabine|mesh-list
43563156|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43563157|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
43568672|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568673|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568674|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43568675|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568676|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568677|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568678|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568679|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568680|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568681|NCT00606697|Vofopitant|vofopitant|mesh-list
43568682|NCT00606697|Vestipitant|vestipitant|mesh-list
43568683|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43568684|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849050|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563158|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563159|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563160|NCT01318642|Antiviral Agents|antiviral agents|mesh-ancestor
43563161|NCT01318642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563163|NCT01318642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43563164|NCT01318642|Immunologic Factors|immunologic factors|mesh-ancestor
43563165|NCT01318642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563166|NCT01318252|Latanoprost|latanoprost|mesh-list
43563167|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43563168|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43563169|NCT01314222|Pregabalin|pregabalin|mesh-list
43563170|NCT01314222|Analgesics|analgesics|mesh-ancestor
43563171|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
43563176|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43563177|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563178|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43563179|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43563180|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43563181|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563182|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568710|NCT00602602|Gemcitabine|gemcitabine|mesh-list
43568711|NCT00602602|Bevacizumab|bevacizumab|mesh-list
43568712|NCT00602602|Fluorouracil|fluorouracil|mesh-list
43568713|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
43568714|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568715|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568716|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43568717|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43568718|NCT00602602|Growth Substances|growth substances|mesh-ancestor
43568719|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568720|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
43568728|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
43568730|NCT00602329|Bevacizumab|bevacizumab|mesh-list
43568731|NCT00602329|Fluorouracil|fluorouracil|mesh-list
43568732|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
43568733|NCT00602329|Calcium|calcium|mesh-list
43568734|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
43568735|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568736|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568737|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43568738|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43568739|NCT00602329|Growth Substances|growth substances|mesh-ancestor
43568740|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568741|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
43568742|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43568743|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
43568746|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43563183|NCT01313572|Adenosine|adenosine|mesh-list
43563184|NCT01313572|Analgesics|analgesics|mesh-ancestor
43563185|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
43563186|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563187|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563188|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43563189|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
43563190|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43563191|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
43563192|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
43563193|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563194|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563196|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43563197|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43563198|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43563199|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563200|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563201|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563202|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43563203|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43568747|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
43568748|NCT00602329|Antidotes|antidotes|mesh-ancestor
43568749|NCT00602329|Protective Agents|protective agents|mesh-ancestor
43568750|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
43568751|NCT00602329|Vitamins|vitamins|mesh-ancestor
43568752|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
43568753|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43568754|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43568755|NCT00598312|Leuprolide|leuprolide|mesh-list
43568756|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43568757|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
43568758|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43568759|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563204|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43563205|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43563207|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563208|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563209|NCT01309945|Analgesics|analgesics|mesh-ancestor
43563210|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
43563211|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563212|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
43563213|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43563214|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
43734703|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734704|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568802|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568803|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568804|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568805|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568806|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43568807|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
43734705|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734706|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43734707|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43734708|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734709|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43734710|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43734711|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
43734713|NCT02537860|Bupivacaine|bupivacaine|mesh-list
43734714|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
43734715|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
43734716|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734717|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563215|NCT01309932|Interferons|interferons|mesh-list
43563216|NCT01309932|Ribavirin|ribavirin|mesh-list
43563217|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
43563218|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
43563219|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43563220|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
43563221|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
43563222|NCT01309932|Asunaprevir|asunaprevir|mesh-list
43563223|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563224|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
43563225|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563226|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
43563227|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568854|NCT00580125|Aripiprazole|aripiprazole|mesh-list
43568855|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568859|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43568860|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568861|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
43568862|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
43568863|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563228|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
43563229|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563231|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43563232|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43563233|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43563234|NCT01303783|Candesartan|candesartan|mesh-list
43563235|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
43563236|NCT01303783|Nifedipine|nifedipine|mesh-list
43563237|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43563238|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43563239|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43563240|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563257|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563258|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43563259|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43563260|NCT01301157|Calcipotriene|calcipotriene|mesh-list
43734718|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
43734719|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734720|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43734721|NCT02537860|Narcotics|narcotics|mesh-ancestor
43734722|NCT02537860|Analgesics|analgesics|mesh-ancestor
43734723|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43734724|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43734725|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
43734727|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
43734728|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
43734729|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734730|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734731|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43746259|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746260|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43746261|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43746262|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43563261|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
43746263|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746264|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43746265|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43563262|NCT01300208|CC-11050|cc-11050|mesh-list
43563263|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43563264|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43563265|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563266|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563267|NCT01298687|Travoprost|travoprost|mesh-list
43563268|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43563269|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43563270|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43563271|NCT01297543|Lenograstim|lenograstim|mesh-list
43563272|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43563273|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
43563274|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563275|NCT01295060|Octreotide|octreotide|mesh-list
43563276|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43563277|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43563278|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563279|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
43563280|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563281|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43563282|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563283|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563284|NCT01283594|Levodopa|levodopa|mesh-list
43563285|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43563286|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43563287|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
43563288|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563289|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563290|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563291|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43563292|NCT01281462|Cephalosporins|cephalosporins|mesh-list
43734732|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734733|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734742|NCT02537925|Analgesics|analgesics|mesh-ancestor
43734743|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
43734744|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563299|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563300|NCT01281254|Trebananib|trebananib|mesh-list
43563301|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43563302|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43568918|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
43568919|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
43568920|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734752|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
43734753|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43734754|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734755|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43734756|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734757|NCT02537691|Theophylline|theophylline|mesh-list
43734758|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43734759|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
43734760|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563303|NCT01281254|Growth Substances|growth substances|mesh-ancestor
43563304|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563305|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
43563306|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563308|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43563309|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
43563310|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563311|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563312|NCT01280331|Morphine|morphine|mesh-list
43563313|NCT01280331|Oxycodone|oxycodone|mesh-list
43563314|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43563315|NCT01280331|Narcotics|narcotics|mesh-ancestor
43563316|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563317|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563318|NCT01280331|Analgesics|analgesics|mesh-ancestor
43563319|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
43563320|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563321|NCT01269658|Azithromycin|azithromycin|mesh-list
43563322|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43563323|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43563324|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43563325|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563327|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43563328|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568921|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568922|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43568923|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
43568924|NCT00578955|Hormones|hormones|mesh-ancestor
43568925|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568926|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43568935|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568936|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563329|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563331|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563332|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563333|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
43563334|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
43563335|NCT01265901|Sunitinib|sunitinib|mesh-list
43563336|NCT01265901|Molgramostim|molgramostim|mesh-list
43563337|NCT01265901|Sargramostim|sargramostim|mesh-list
43563338|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
43563339|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563340|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43563341|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43563342|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43563343|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
43563344|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563345|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563346|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43563347|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43563351|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43563352|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563353|NCT01262261|Buprenorphine|buprenorphine|mesh-list
43563354|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43563355|NCT01262261|Narcotics|narcotics|mesh-ancestor
43734761|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734762|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43734763|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734764|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43734765|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734766|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734767|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
43734768|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43734769|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43734770|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
43734771|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734772|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
43734773|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43734774|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
43746320|NCT00408005|Doxorubicin|doxorubicin|mesh-list
43746321|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43746322|NCT00408005|Methotrexate|methotrexate|mesh-list
43746323|NCT00408005|Vincristine|vincristine|mesh-list
43746324|NCT00408005|Daunorubicin|daunorubicin|mesh-list
43746325|NCT00408005|Asparaginase|asparaginase|mesh-list
43746326|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
43746327|NCT00408005|Pegaspargase|pegaspargase|mesh-list
43746328|NCT00408005|Thioguanine|thioguanine|mesh-list
43746329|NCT00408005|BB 1101|bb 1101|mesh-list
43746330|NCT00408005|Calcium|calcium|mesh-list
43746331|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
43746332|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
43746333|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734775|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43734776|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
43734777|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734778|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734783|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43734784|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43734785|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
43734786|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734787|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734788|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563359|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
43563360|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746342|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43746343|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
43746344|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
43746345|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746346|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43746347|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
43746348|NCT00408005|Hormones|hormones|mesh-ancestor
43746349|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43746350|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43746351|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
43746368|NCT00408005|Antidotes|antidotes|mesh-ancestor
43563361|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43563362|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43563363|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
43563364|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563366|NCT01261312|Azacitidine|azacitidine|mesh-list
43563367|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563371|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563372|NCT01260870|Paclitaxel|paclitaxel|mesh-list
43734789|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43734790|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43734791|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
43734792|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734793|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43734794|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734795|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
43734796|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
43734797|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43734798|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
43734799|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43734800|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734801|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43734802|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734803|NCT02537561|Gemcitabine|gemcitabine|mesh-list
43734805|NCT02537561|Talazoparib|talazoparib|mesh-list
43563373|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43563374|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563375|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563380|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
43563381|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563383|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43563384|NCT01256762|Paclitaxel|paclitaxel|mesh-list
43563385|NCT01256762|Bevacizumab|bevacizumab|mesh-list
43563386|NCT01256762|Imetelstat|imetelstat|mesh-list
43563387|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
43563388|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43563389|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563390|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563391|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563392|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563393|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563394|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43563395|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43563396|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43563403|NCT01255709|Racepinephrine|racepinephrine|mesh-list
43563404|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
43563405|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43563406|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43563407|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
43563408|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563409|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734806|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734807|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43734809|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734810|NCT02537561|Antiviral Agents|antiviral agents|mesh-ancestor
43734811|NCT02537561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746392|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746393|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
43746394|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43746395|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43746396|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43746397|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568961|NCT00577148|Hormones|hormones|mesh-ancestor
43568962|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568965|NCT00576810|Cathartics|cathartics|mesh-ancestor
43734812|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734813|NCT02537561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43734814|NCT02537561|Immunologic Factors|immunologic factors|mesh-ancestor
43734815|NCT02537561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734816|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43734818|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734819|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734820|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734821|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734822|NCT02537379|Ribavirin|ribavirin|mesh-list
43734823|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
43734824|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734825|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
43734826|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563410|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563411|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43563412|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43563413|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
43563414|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563415|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43563416|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
43563417|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
43563418|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
43563419|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43563420|NCT01254370|Travoprost|travoprost|mesh-list
43563421|NCT01254370|Latanoprost|latanoprost|mesh-list
43563422|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43563423|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43563424|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43563425|NCT01254136|Trastuzumab|trastuzumab|mesh-list
43563426|NCT01254136|Vinorelbine|vinorelbine|mesh-list
43563430|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563431|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563432|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563433|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563434|NCT01253603|Fluticasone|fluticasone|mesh-list
43563435|NCT01253603|Xhance|xhance|mesh-list
43563436|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
43563437|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563446|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
43563447|NCT01253603|Growth Substances|growth substances|mesh-ancestor
43563448|NCT01252693|Goserelin|goserelin|mesh-list
43563449|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43734828|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43734829|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734833|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
43734834|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734835|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43734836|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43734837|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43734838|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
43734839|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694106|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43734840|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734841|NCT02537392|Folic Acid|folic acid|mesh-list
43734842|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
43563450|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563451|NCT01252628|Cetuximab|cetuximab|mesh-list
43563452|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43563453|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538599|NCT04585815|Axitinib|axitinib|mesh-list
43538602|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563457|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568980|NCT00576342|Dorzolamide|dorzolamide|mesh-list
43563458|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
43563459|NCT01235754|Testosterone|testosterone|mesh-list
43563460|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
43563461|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
43563462|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43563463|NCT01235754|Androgens|androgens|mesh-ancestor
43563465|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43563466|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563467|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43563468|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563469|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
43563470|NCT01235039|Insulin|insulin|mesh-list
43563471|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
43563472|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43563473|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43563474|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563475|NCT01234779|Olanzapine|olanzapine|mesh-list
43563476|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
43734846|NCT02537392|Hematinics|hematinics|mesh-ancestor
43734847|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
43734848|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43734849|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539555|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734850|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734851|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43734852|NCT02537249|Analgesics|analgesics|mesh-ancestor
43734853|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
43734854|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734855|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43734856|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43734858|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
43734859|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734860|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734861|NCT02537210|Mesalamine|mesalamine|mesh-list
43734862|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43734863|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43734864|NCT02537210|Analgesics|analgesics|mesh-ancestor
43734865|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
43734866|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734867|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568981|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43568982|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43568983|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43568984|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43568985|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568986|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568987|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568988|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734868|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734869|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43734870|NCT02537158|Sorafenib|sorafenib|mesh-list
43734871|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734872|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734874|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734875|NCT02537223|Cisplatin|cisplatin|mesh-list
43734876|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734877|NCT02537171|Apatinib|apatinib|mesh-list
43563486|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43563487|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43694107|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540465|NCT05224687|Daptomycin|daptomycin|mesh-list
43563490|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
43563491|NCT01234519|Doxorubicin|doxorubicin|mesh-list
43563492|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43563493|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563495|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43563496|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563497|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563498|NCT01234038|Paclitaxel|paclitaxel|mesh-list
43563499|NCT01234038|Carboplatin|carboplatin|mesh-list
43563500|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43541783|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563501|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563502|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563503|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563504|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563505|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563506|NCT01234025|Prednisone|prednisone|mesh-list
43563507|NCT01234025|Docetaxel|docetaxel|mesh-list
43563508|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563509|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563510|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563511|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
43542550|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43563512|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734878|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734879|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734880|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734881|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734883|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734884|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734885|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43734886|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43734887|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734888|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568989|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43568990|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43568999|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
43569000|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569001|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43746398|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746399|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43746400|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
43746401|NCT00336063|Azacitidine|azacitidine|mesh-list
43746402|NCT00336063|Vorinostat|vorinostat|mesh-list
43746403|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746404|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
43734889|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734891|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43734892|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43734893|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43734894|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563513|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563514|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
43563515|NCT01234025|Hormones|hormones|mesh-ancestor
43563516|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43563517|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563518|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43563519|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
43563520|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563521|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
43563522|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563524|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43563525|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563527|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43563528|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43563529|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
43563530|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563531|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563532|NCT01231347|Antiviral Agents|antiviral agents|mesh-ancestor
43563533|NCT01231347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563534|NCT01231347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563535|NCT01231347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43563536|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
43563537|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563538|NCT01230957|Vaccines|vaccines|mesh-list
43563539|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
43563540|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563542|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43563543|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43563544|NCT01229644|Crenolanib|crenolanib|mesh-list
43563545|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563546|NCT01228383|Vaccines|vaccines|mesh-list
43563547|NCT01228383|Antibodies|antibodies|mesh-list
43563548|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43563549|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
43563550|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
43563552|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43563553|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
43563554|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734895|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43734896|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734897|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
43734898|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
43734899|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43734900|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
43734901|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43734902|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
43734903|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546522|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
43563569|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563570|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563571|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
43563572|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563573|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43563574|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43563575|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
43563576|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43563577|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43563578|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563579|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43548527|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43548528|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548529|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548531|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43548532|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43548533|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
43548534|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43548535|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43734906|NCT02537054|Aflibercept|aflibercept|mesh-list
43734907|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43734908|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43734909|NCT02537054|Growth Substances|growth substances|mesh-ancestor
43734910|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734911|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
43734912|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734913|NCT02536989|Omeprazole|omeprazole|mesh-list
43734914|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43734915|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734916|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43734917|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734918|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734919|NCT02536859|Insulin|insulin|mesh-list
43548741|NCT03639467|Cisplatin|cisplatin|mesh-list
43734923|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734924|NCT02536937|Eliglustat|eliglustat|mesh-list
43563590|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563592|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563593|NCT01224262|Vaccines|vaccines|mesh-list
43563595|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563596|NCT01222702|Vancomycin|vancomycin|mesh-list
43563597|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
43563598|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43563599|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563600|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43549178|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
43549179|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43549180|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43549181|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43549242|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43549243|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43549314|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549315|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43549316|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549317|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
43549386|NCT03633175|Progesterone|progesterone|mesh-list
43563601|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563602|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563603|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43563604|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563605|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43563606|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563607|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563608|NCT01220947|Ritonavir|ritonavir|mesh-list
43563609|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43563610|NCT01220947|Lactams|lactams|mesh-list
43563611|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43563612|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43563613|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
43563614|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563615|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563616|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43563617|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43563618|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
43563619|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563620|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43569004|NCT00569387|Vaccines|vaccines|mesh-list
43563621|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43563622|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43563623|NCT01220271|Temozolomide|temozolomide|mesh-list
43563624|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43563625|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
43734925|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734926|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734927|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
43734928|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43734929|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
43734930|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734931|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
43734932|NCT02536807|Protective Agents|protective agents|mesh-ancestor
43834418|NCT05139043|BB 1101|bb 1101|mesh-list
43834419|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834420|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
43834421|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
43834422|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834423|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834424|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834425|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
43834426|NCT05139043|Hormones|hormones|mesh-ancestor
43834427|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834428|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834429|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834430|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
43834431|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834432|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834433|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834434|NCT05139030|Bupivacaine|bupivacaine|mesh-list
43834435|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
43552046|NCT03608046|Avelumab|avelumab|mesh-list
43552047|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43563626|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563627|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563628|NCT01207115|Naproxen|naproxen|mesh-list
43563629|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43563630|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43563632|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
43563633|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563634|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563635|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563636|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43563637|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
43552386|NCT03604744|Psilocybin|psilocybin|mesh-list
43552387|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
43552388|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552389|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43552390|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43552391|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43552392|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
43552394|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563638|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43563639|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563640|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563641|NCT01205061|Lidocaine|lidocaine|mesh-list
43563642|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
43834437|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834438|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834439|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
43834440|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834441|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
43552844|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834442|NCT05138614|Narcotics|narcotics|mesh-ancestor
43834443|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834444|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834445|NCT05138614|Analgesics|analgesics|mesh-ancestor
43834446|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
43834447|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834448|NCT05138549|Beta Carotene|beta carotene|mesh-list
43834449|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834450|NCT05138549|Provitamins|provitamins|mesh-ancestor
43834451|NCT05138549|Vitamins|vitamins|mesh-ancestor
43834452|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
43834453|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43834454|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
43834455|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834456|NCT05135910|Terbinafine|terbinafine|mesh-list
43554145|NCT03574649|Docetaxel|docetaxel|mesh-list
43834457|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
43834458|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834459|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834460|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834461|NCT05135273|Vaccines|vaccines|mesh-list
43834462|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
43834463|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834464|NCT05134922|Gedatolisib|gedatolisib|mesh-list
43834465|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734933|NCT02536690|Midazolam|midazolam|mesh-list
43734934|NCT02536690|Remifentanil|remifentanil|mesh-list
43734935|NCT02536690|Propofol|propofol|mesh-list
43563643|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
43563644|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563655|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
43563656|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563657|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563658|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
43563659|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555292|NCT03563664|Danazol|danazol|mesh-list
43563661|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43563662|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43563663|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43563664|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734936|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43734943|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43734944|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43734945|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43734946|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
43734948|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734949|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734950|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43734951|NCT02536690|Narcotics|narcotics|mesh-ancestor
43734952|NCT02536690|Analgesics|analgesics|mesh-ancestor
43734953|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
43734954|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734955|NCT02536911|Eliglustat|eliglustat|mesh-list
43734956|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734957|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734958|NCT02536742|Fulvestrant|fulvestrant|mesh-list
43734959|NCT02536742|Palbociclib|palbociclib|mesh-list
43734960|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43734961|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734962|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43734963|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43734964|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
43734965|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43734966|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734967|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43563666|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
43563667|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563668|NCT01204749|Paclitaxel|paclitaxel|mesh-list
43563669|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43563670|NCT01204749|Trebananib|trebananib|mesh-list
43563671|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
43563672|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43569009|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43569010|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569011|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569012|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569013|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
43569014|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563673|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563674|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563675|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563676|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
43734968|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734969|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734970|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43734971|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734973|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734974|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
43557314|NCT03543683|Analgesics|analgesics|mesh-ancestor
43734982|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734983|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563677|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563678|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43558619|NCT05262985|Durvalumab|durvalumab|mesh-list
43563679|NCT01204749|Growth Substances|growth substances|mesh-ancestor
43563680|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563681|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
43563683|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563684|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563685|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563686|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563687|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563688|NCT01198834|Etodolac|etodolac|mesh-list
43563689|NCT01198834|Lidocaine|lidocaine|mesh-list
43560154|NCT05177939|Hormones|hormones|mesh-ancestor
43563690|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
43563692|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563693|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563694|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
43563695|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563696|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43563697|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43563698|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43563699|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43563700|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563701|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43563702|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43563703|NCT01198834|Analgesics|analgesics|mesh-ancestor
43563704|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563719|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563720|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563721|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
43569015|NCT00566202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43569016|NCT00566202|Antidepressive Agents|antidepressive agents|mesh-ancestor
43569017|NCT00566202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43569018|NCT00564421|Epinastine|epinastine|mesh-list
43569019|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43569020|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
43569021|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
43569022|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563722|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563723|NCT01193361|Interferons|interferons|mesh-list
43563724|NCT01193361|Ribavirin|ribavirin|mesh-list
43560827|NCT03184870|Irinotecan|irinotecan|mesh-list
43560849|NCT03184870|Vitamins|vitamins|mesh-ancestor
43563725|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
43563726|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
43563727|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43563728|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734986|NCT02536209|Narcotics|narcotics|mesh-ancestor
43734987|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734988|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734990|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
43734991|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734992|NCT02536430|Ketorolac|ketorolac|mesh-list
43734993|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43734994|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43734995|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43734996|NCT02536430|Analgesics|analgesics|mesh-ancestor
43734997|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
43734998|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563588|NCT01224795|Peramivir|peramivir|mesh-list
43734999|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735001|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735002|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43735003|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735004|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735005|NCT02536352|Vitamins|vitamins|mesh-list
43735006|NCT02536352|Fluorides|fluorides|mesh-list
43735007|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
43735008|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563893|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43563894|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
43563895|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563896|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563897|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563898|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43563899|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563900|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43563958|NCT01160601|Bavituximab|bavituximab|mesh-list
43735009|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
43735010|NCT02536352|Protective Agents|protective agents|mesh-ancestor
43735011|NCT02535988|Thymalfasin|thymalfasin|mesh-list
43735012|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43735013|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
43735014|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735015|NCT02535910|Vitamin D|vitamin d|mesh-list
43735016|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
43563729|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
43563730|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564437|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564438|NCT01037179|Analgesics|analgesics|mesh-ancestor
43564439|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
43564472|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564473|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43564474|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43564475|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564476|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564477|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43564478|NCT01033292|Iniparib|iniparib|mesh-list
43564479|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564481|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564540|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
43564541|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
43564542|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564543|NCT01023880|Delanzomib|delanzomib|mesh-list
43564544|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
43564545|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
43564546|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564603|NCT01012895|Ribavirin|ribavirin|mesh-list
43564604|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
43564605|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
43564713|NCT01001715|Fasinumab|fasinumab|mesh-list
43564714|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564715|NCT01001715|Analgesics|analgesics|mesh-ancestor
43564716|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
43564717|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563731|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
43735018|NCT02535910|Vitamins|vitamins|mesh-ancestor
43735019|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
43735020|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735021|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43735022|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43735023|NCT02535975|Metformin|metformin|mesh-list
43735024|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43735025|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735026|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
43735027|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43735028|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735029|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735030|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735031|NCT02536014|Analgesics|analgesics|mesh-ancestor
43735032|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
43735033|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735034|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43735035|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43735036|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43565609|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43565610|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565611|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
43735053|NCT02535351|Growth Substances|growth substances|mesh-ancestor
43735054|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563732|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563733|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
43563734|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563735|NCT01193140|Temozolomide|temozolomide|mesh-list
43563736|NCT01193140|Veliparib|veliparib|mesh-list
43563737|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43563738|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
43735056|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43735057|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735058|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735059|NCT02535299|Metformin|metformin|mesh-list
43735060|NCT02535299|Liraglutide|liraglutide|mesh-list
43735061|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566150|NCT00838136|Lamotrigine|lamotrigine|mesh-list
43735062|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735063|NCT02535299|Incretins|incretins|mesh-ancestor
43735064|NCT02535299|Hormones|hormones|mesh-ancestor
43735065|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735066|NCT02535273|Lidocaine|lidocaine|mesh-list
43735067|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
43735068|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
43735069|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
43735070|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735071|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735072|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
43735073|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735074|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43563739|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563740|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563741|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43563742|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566566|NCT00834132|Azithromycin|azithromycin|mesh-list
43563743|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
43563744|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43563745|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563746|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563747|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43563748|NCT01192035|Ritonavir|ritonavir|mesh-list
43563749|NCT01192035|Lopinavir|lopinavir|mesh-list
43563750|NCT01192035|Nevirapine|nevirapine|mesh-list
43563751|NCT01192035|Efavirenz|efavirenz|mesh-list
43563752|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43563753|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43563754|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
43563756|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563758|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43563759|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
43563760|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563761|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43563763|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43563764|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43563765|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43563766|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43563774|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563775|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43563776|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
43563777|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
43563778|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43735075|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43735077|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735078|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735079|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43735080|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735081|NCT02535273|Analgesics|analgesics|mesh-ancestor
43735082|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43735083|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43735084|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43735085|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
43735086|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735088|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43735089|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
43735090|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735091|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735092|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735093|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43735094|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43735095|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735096|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43735097|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43735098|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
43735099|NCT05299203|Verapamil|verapamil|mesh-list
43735100|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43569647|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43735121|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735122|NCT05299164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569023|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569024|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735123|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43735124|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
43735125|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
43735126|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
43735127|NCT05299164|Analgesics|analgesics|mesh-ancestor
43735128|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
43735129|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735130|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43735131|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43735132|NCT05298761|Lidocaine|lidocaine|mesh-list
43735133|NCT05298761|Nalbuphine|nalbuphine|mesh-list
43735134|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43735135|NCT05298761|Narcotics|narcotics|mesh-ancestor
43735136|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735137|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735139|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
43735140|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735141|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
43735142|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
43735143|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43735144|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43735145|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43573502|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735146|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735147|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735168|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
43735169|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
43735170|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
43735171|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43735172|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43735173|NCT05298683|Growth Substances|growth substances|mesh-ancestor
43735174|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
43735175|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43735176|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43735177|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735178|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
43735179|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
43735180|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43735181|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
43735182|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
43735183|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735184|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735185|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43735186|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
43735187|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
43735188|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43735189|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43573795|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43573796|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43569031|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569032|NCT00564226|Urological Agents|urological agents|mesh-ancestor
43569033|NCT00563563|Naltrexone|naltrexone|mesh-list
43569034|NCT00563563|Bupropion|bupropion|mesh-list
43569035|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43569036|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43746418|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746419|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746420|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43549387|NCT03633175|Progestins|progestins|mesh-ancestor
43746421|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
43746422|NCT00335816|Antidotes|antidotes|mesh-ancestor
43746423|NCT00335816|Protective Agents|protective agents|mesh-ancestor
43746424|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
43834467|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735190|NCT05298462|Antibodies|antibodies|mesh-list
43735191|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
43735192|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735193|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43735194|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43735195|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43735196|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563779|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43563780|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43563781|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43563782|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574558|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563783|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563784|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563785|NCT01188187|Dexamethasone|dexamethasone|mesh-list
43563787|NCT01188187|Docetaxel|docetaxel|mesh-list
43563788|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43563789|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
43563790|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
43563791|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563792|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735197|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735198|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43575388|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43575390|NCT03507634|Analgesics|analgesics|mesh-ancestor
43735199|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735200|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735202|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735203|NCT05298176|Carboplatin|carboplatin|mesh-list
43735204|NCT05298176|Pemetrexed|pemetrexed|mesh-list
43735205|NCT05298176|Osimertinib|osimertinib|mesh-list
43735206|NCT05298176|Afatinib|afatinib|mesh-list
43735207|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735208|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576402|NCT03499171|Citalopram|citalopram|mesh-list
43735210|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43735211|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43735212|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43735213|NCT05298163|Calcitriol|calcitriol|mesh-list
43735214|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43735215|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735216|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43579715|NCT03468829|Gontivimab|gontivimab|mesh-list
43735217|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43581465|NCT03460145|Propofol|propofol|mesh-list
43735218|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735219|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43735220|NCT05298163|Vitamins|vitamins|mesh-ancestor
43735221|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
43735246|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
43735247|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735248|NCT05297968|Oseltamivir|oseltamivir|mesh-list
43735249|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
43735250|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735251|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735252|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735253|NCT05297929|Irbesartan|irbesartan|mesh-list
43735254|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43735255|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43735256|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43735257|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735258|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
43735259|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43735260|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735261|NCT05297669|Analgesics|analgesics|mesh-ancestor
43735262|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
43735263|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537024|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
43735264|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735265|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735266|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735267|NCT05297422|Ketamine|ketamine|mesh-list
43735268|NCT05297422|Ropivacaine|ropivacaine|mesh-list
43563793|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43563794|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
43563795|NCT01188187|Hormones|hormones|mesh-ancestor
43563796|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43563797|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43563798|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563799|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563800|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563801|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563802|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563803|NCT01186991|Paclitaxel|paclitaxel|mesh-list
43563804|NCT01186991|Bevacizumab|bevacizumab|mesh-list
43563805|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43563806|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43563807|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563808|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563809|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563810|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563811|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563812|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43563813|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43563814|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43563815|NCT01186991|Growth Substances|growth substances|mesh-ancestor
43563816|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563817|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
43735269|NCT05297422|Analgesics|analgesics|mesh-ancestor
43735270|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
43585648|NCT03419767|Melatonin|melatonin|mesh-list
43735271|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735272|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735273|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43735274|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43735275|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
43735276|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
43735277|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735278|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43735279|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43735280|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735281|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735282|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
43735283|NCT05297292|Ranibizumab|ranibizumab|mesh-list
43735284|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43587175|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
43587240|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
43587259|NCT03396250|Naproxen|naproxen|mesh-list
43735285|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43735286|NCT05297292|Growth Substances|growth substances|mesh-ancestor
43735287|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735288|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
43735299|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
43746425|NCT00335816|Vitamins|vitamins|mesh-ancestor
43746426|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
43735300|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735301|NCT05068232|Carboplatin|carboplatin|mesh-list
43735302|NCT05068232|Etoposide|etoposide|mesh-list
43735311|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43735312|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735313|NCT04920149|Mesalamine|mesalamine|mesh-list
43735314|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43735315|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735316|NCT04920149|Analgesics|analgesics|mesh-ancestor
43735317|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
43735318|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735319|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735320|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735321|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735322|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
43735323|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
43735324|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43735325|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43735326|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735327|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592127|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43735328|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563819|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43563820|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563821|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43563822|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563823|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563826|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43563827|NCT01180634|Levofloxacin|levofloxacin|mesh-list
43563828|NCT01180634|Ofloxacin|ofloxacin|mesh-list
43563829|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43563830|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563831|NCT01180634|Renal Agents|renal agents|mesh-ancestor
43563832|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593175|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43563833|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43563834|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43563844|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
43563846|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43563847|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
43563848|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563849|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43563850|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43563851|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
43563852|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563853|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563854|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43563855|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43563856|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
43563857|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563858|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
43746444|NCT00075803|Fluconazole|fluconazole|mesh-list
43746445|NCT00075803|Voriconazole|voriconazole|mesh-list
43746446|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
43746447|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746448|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43563859|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563860|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
43563861|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43563862|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43563863|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43563864|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
43563865|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43563866|NCT01174732|Albuterol|albuterol|mesh-list
43563867|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43735329|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735330|NCT04667078|Cangrelor|cangrelor|mesh-list
43735331|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43735332|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43735333|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43563868|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
43563869|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563870|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563871|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43563872|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
43563873|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
43563874|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43563875|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43563876|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43563877|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43563878|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
43735348|NCT04578613|Rituximab|rituximab|mesh-list
43735349|NCT04578613|Chlorambucil|chlorambucil|mesh-list
43735350|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735351|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735352|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
43735353|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735354|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735355|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43735356|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
43735357|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735358|NCT04576546|Inositol|inositol|mesh-list
43735359|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
43735360|NCT04576546|Vitamins|vitamins|mesh-ancestor
43735361|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
43735362|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834469|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43834470|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43834471|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43834472|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
43563879|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563880|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563881|NCT01173497|Irinotecan|irinotecan|mesh-list
43563882|NCT01173497|Iniparib|iniparib|mesh-list
43563883|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43563884|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43563885|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563886|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563887|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834473|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834474|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834475|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735363|NCT04551677|Vaccines|vaccines|mesh-list
43735364|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
43735365|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735366|NCT04530058|Metformin|metformin|mesh-list
43746449|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43746458|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43735367|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43735368|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594041|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43735369|NCT04487925|Hormones|hormones|mesh-list
43735370|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43735371|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735372|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735373|NCT04430036|Gemcitabine|gemcitabine|mesh-list
43735375|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735376|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43735377|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
43735378|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563888|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43563889|NCT01171313|Carbidopa|carbidopa|mesh-list
43563890|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43563901|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
43563902|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
43563903|NCT01170650|Doxorubicin|doxorubicin|mesh-list
43563904|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43563905|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43563906|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563907|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43563908|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43563909|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563910|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563911|NCT01168713|Levofloxacin|levofloxacin|mesh-list
43563914|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43563915|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563916|NCT01168713|Renal Agents|renal agents|mesh-ancestor
43563917|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43563918|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43563919|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43563920|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694108|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43563921|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735379|NCT04430036|Antiviral Agents|antiviral agents|mesh-ancestor
43735380|NCT04430036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735381|NCT04430036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735382|NCT04430036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746465|NCT00026312|Vitamin A|vitamin a|mesh-list
43746466|NCT00026312|Aldesleukin|aldesleukin|mesh-list
43746467|NCT00026312|Interleukin-2|interleukin-2|mesh-list
43746468|NCT00026312|Tretinoin|tretinoin|mesh-list
43746469|NCT00026312|Dinutuximab|dinutuximab|mesh-list
43746470|NCT00026312|Isotretinoin|isotretinoin|mesh-list
43746471|NCT00026312|Sargramostim|sargramostim|mesh-list
43746472|NCT00026312|Vitamins|vitamins|mesh-ancestor
43746473|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
43746474|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746475|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746476|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43746477|NCT00026312|Analgesics|analgesics|mesh-ancestor
43746478|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
43735383|NCT04430036|Immunologic Factors|immunologic factors|mesh-ancestor
43735384|NCT04430036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735385|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43735386|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43735387|NCT04397406|Fentanyl|fentanyl|mesh-list
43735388|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
43735389|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
43735390|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43735391|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735393|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735394|NCT04397406|Analgesics|analgesics|mesh-ancestor
43735396|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735397|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43735398|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43735399|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43735400|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
43735401|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735402|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735403|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43595282|NCT03326258|Ipilimumab|ipilimumab|mesh-list
43735406|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43735407|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
43735408|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
43735409|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
43735410|NCT04392921|Amiodarone|amiodarone|mesh-list
43735411|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43735412|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
43735413|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43735414|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43563923|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43563924|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43563925|NCT01168310|Fluticasone|fluticasone|mesh-list
43563926|NCT01168310|Xhance|xhance|mesh-list
43735415|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596488|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
43596489|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43735416|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43735417|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43735418|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43735419|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735420|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43735421|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43598155|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
43735422|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43735423|NCT04342585|Progesterone|progesterone|mesh-list
43735424|NCT04342585|Progestins|progestins|mesh-ancestor
43735425|NCT04342585|Hormones|hormones|mesh-ancestor
43746506|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735426|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735427|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735428|NCT04240626|Acetaminophen|acetaminophen|mesh-list
43735429|NCT04240626|Scopolamine|scopolamine|mesh-list
43735430|NCT04240626|Oxycodone|oxycodone|mesh-list
43746507|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735434|NCT04240626|Bupivacaine|bupivacaine|mesh-list
43735435|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
43735436|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43735437|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735438|NCT04240626|Analgesics|analgesics|mesh-ancestor
43735439|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
43563927|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
43563932|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563933|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43563934|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
43563935|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
43563936|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43563937|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43563938|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43563939|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43563940|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
43563941|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563942|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563944|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563945|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43563948|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
43563949|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43563950|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
43563951|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43563952|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563953|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43563954|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43563955|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43563956|NCT01160601|Paclitaxel|paclitaxel|mesh-list
43563957|NCT01160601|Carboplatin|carboplatin|mesh-list
43563967|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43563968|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563969|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43563970|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
43563971|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563972|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563973|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
43563974|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43563975|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563976|NCT01156415|S 20098|s 20098|mesh-list
43563977|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43563978|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563979|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563980|NCT01150695|Vaccines|vaccines|mesh-list
43563981|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
43563982|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563983|NCT01143064|Progesterone|progesterone|mesh-list
43564005|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43564007|NCT01137968|Imetelstat|imetelstat|mesh-list
43564008|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
43564009|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43564010|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564011|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43564012|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43564013|NCT01137968|Growth Substances|growth substances|mesh-ancestor
43564014|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564015|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
43564016|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564017|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564018|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43564019|NCT01137526|Donepezil|donepezil|mesh-list
43564055|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564056|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
43564057|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564058|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564059|NCT01130142|Antiviral Agents|antiviral agents|mesh-ancestor
43564060|NCT01130142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564072|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564073|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564074|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43564075|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43564076|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564077|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43564078|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43564079|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
43564080|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
43564081|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
43564086|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564087|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
43564088|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
43564089|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43564090|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43564091|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43564092|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43564093|NCT01129648|Allopurinol|allopurinol|mesh-list
43564094|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
43564095|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564096|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564109|NCT01128335|Tacrolimus|tacrolimus|mesh-list
43564110|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564111|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
43564112|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564113|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43564136|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43834477|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
43735440|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735441|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735442|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
43735443|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43735444|NCT04240626|Narcotics|narcotics|mesh-ancestor
43735445|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735446|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
43735447|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43735448|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43735449|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43735450|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43735451|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43735452|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735453|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735454|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
43564137|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564138|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
43564139|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564140|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564141|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43564142|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564144|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
43564145|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564146|NCT01120470|Prednisone|prednisone|mesh-list
43564147|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564148|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
43564149|NCT01120470|Hormones|hormones|mesh-ancestor
43735455|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
43735456|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
43735457|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
43735458|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
43735459|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43735460|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
43735461|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
43735462|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43735463|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
43735464|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43735465|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
43735466|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43735467|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
43735468|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43735469|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
43735470|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43735471|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43735472|NCT04126824|Triamcinolone|triamcinolone|mesh-list
43735473|NCT04126824|Bupivacaine|bupivacaine|mesh-list
43735474|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
43735475|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
43735476|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735477|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735478|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
43735479|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735480|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735481|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
43735482|NCT04126824|Hormones|hormones|mesh-ancestor
43735483|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735484|NCT04115956|Dexamethasone|dexamethasone|mesh-list
43735485|NCT04115956|Melphalan|melphalan|mesh-list
43628240|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43735486|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735487|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
43735488|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
43735489|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735490|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735491|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43735492|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
43735493|NCT04115956|Hormones|hormones|mesh-ancestor
43735494|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735495|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43569037|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569038|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
43569039|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569040|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43569041|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
43569042|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43735496|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735497|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43735498|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
43735499|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735500|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43735501|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43735502|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
43735503|NCT04095689|Docetaxel|docetaxel|mesh-list
43735504|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
43735505|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735506|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
43735507|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
43735508|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
43735509|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735510|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735511|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
43735512|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735513|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735514|NCT04069312|Azithromycin|azithromycin|mesh-list
43735515|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43735516|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735518|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564150|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43564151|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564152|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43564153|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564154|NCT01117584|Metformin|metformin|mesh-list
43564155|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
43564156|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564157|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564158|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43564159|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564160|NCT01116141|Folic Acid|folic acid|mesh-list
43564161|NCT01116141|Methotrexate|methotrexate|mesh-list
43564162|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43564163|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
43569049|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43569050|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43569051|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569052|NCT00563459|Topiramate|topiramate|mesh-list
43569053|NCT00563459|Levetiracetam|levetiracetam|mesh-list
43569054|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
43569055|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569071|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
43569072|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
43569073|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569074|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43569075|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43569076|NCT00562497|Protective Agents|protective agents|mesh-ancestor
43569077|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
43569078|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564164|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43564165|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564166|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564168|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735519|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735520|NCT04033263|Fluorides|fluorides|mesh-list
43735521|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
43735522|NCT04033263|Protective Agents|protective agents|mesh-ancestor
43735523|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735524|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
43735525|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43735526|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
43735527|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735528|NCT04013854|Nivolumab|nivolumab|mesh-list
43735529|NCT04013854|Ipilimumab|ipilimumab|mesh-list
43735530|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735531|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735532|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43694109|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43630462|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
43735533|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735534|NCT03932162|Insulin|insulin|mesh-list
43735535|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43735536|NCT03932162|Mitogens|mitogens|mesh-list
43735537|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43735538|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735539|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
43735540|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735541|NCT03799744|Durvalumab|durvalumab|mesh-list
43630874|NCT03047837|Aspirin|aspirin|mesh-list
43564169|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564170|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
43564181|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43564182|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43564183|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43564184|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564185|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564186|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564187|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564188|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43564189|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
43564190|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43564192|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43564193|NCT01114308|Narcotics|narcotics|mesh-ancestor
43569079|NCT00561743|Dexamethasone|dexamethasone|mesh-list
43569080|NCT00561743|Doxorubicin|doxorubicin|mesh-list
43569081|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43569082|NCT00561743|Bortezomib|bortezomib|mesh-list
43569083|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569084|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
43569085|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
43569086|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569087|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564194|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564195|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564196|NCT01114308|Analgesics|analgesics|mesh-ancestor
43564197|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
43564198|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564199|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43564200|NCT01113957|Doxorubicin|doxorubicin|mesh-list
43564201|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43564202|NCT01113957|Temozolomide|temozolomide|mesh-list
43564203|NCT01113957|Veliparib|veliparib|mesh-list
43735543|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735544|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
43735545|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43735546|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735547|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
43735548|NCT03612960|Nicotine|nicotine|mesh-list
43735549|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43735550|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
43735551|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735552|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631193|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735554|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43735555|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
43735556|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735614|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735615|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
43735616|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735617|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735618|NCT02256865|Ketoconazole|ketoconazole|mesh-list
43735641|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735642|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43735643|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
43735644|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43735645|NCT01751126|Cyclosporine|cyclosporine|mesh-list
43735646|NCT01751126|Cyclosporins|cyclosporins|mesh-list
43735647|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735648|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735649|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43735650|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
43735651|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735652|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
43735653|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735654|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
43735655|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735656|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43735657|NCT01307306|Metformin|metformin|mesh-list
43735658|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43735659|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735660|NCT01299753|Propranolol|propranolol|mesh-list
43735661|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43746508|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43746509|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
43746510|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
43746511|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43735662|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43735663|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
43735664|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735665|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735666|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735667|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43735682|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735683|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43735685|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43735686|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735687|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
43735688|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735689|NCT05301530|Docetaxel|docetaxel|mesh-list
43735690|NCT05301530|Trastuzumab|trastuzumab|mesh-list
43735691|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735692|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
43735693|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
43735694|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
43735695|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735696|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735697|NCT05301205|Gabapentin|gabapentin|mesh-list
43735698|NCT05301205|Analgesics|analgesics|mesh-ancestor
43634671|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43735699|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
43735700|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735702|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
43735735|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43735736|NCT05300854|Anesthetics|anesthetics|mesh-list
43735737|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735738|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735739|NCT05300555|Warfarin|warfarin|mesh-list
43735741|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
43735742|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43735743|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
43735744|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43735745|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
43735746|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735747|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735748|NCT05300490|Prednisolone|prednisolone|mesh-list
43735749|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735750|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
43735752|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735753|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735754|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43735755|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636114|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636115|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636116|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
43735756|NCT05300477|Acetazolamide|acetazolamide|mesh-list
43735757|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
43564204|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43564205|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564206|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43564207|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43564209|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746530|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
43746531|NCT02523911|Emollients|emollients|mesh-ancestor
43746532|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
43746533|NCT02523911|Cathartics|cathartics|mesh-ancestor
43569088|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43569089|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
43564210|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43564211|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
43564212|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43564213|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
43564214|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43564215|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
43564216|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564217|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564218|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43636506|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43564220|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43564221|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43564222|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43735759|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
43735760|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43735761|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735762|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735763|NCT05300477|Diuretics|diuretics|mesh-ancestor
43735764|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
43735765|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735766|NCT05300386|Citalopram|citalopram|mesh-list
43735767|NCT05300386|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43735768|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43735769|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735770|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735771|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735772|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
43735773|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735774|NCT05300386|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43564223|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
43564224|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564225|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564226|NCT01111955|Metformin|metformin|mesh-list
43564227|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564228|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564229|NCT01111773|Lidocaine|lidocaine|mesh-list
43564230|NCT01111773|Tetracaine|tetracaine|mesh-list
43564231|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
43564232|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
43564233|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564234|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564235|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
43637337|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564236|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564238|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43564240|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564241|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564242|NCT01110902|S 20098|s 20098|mesh-list
43564243|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43564244|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564245|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564246|NCT01110889|S 20098|s 20098|mesh-list
43564247|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43564248|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564249|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564250|NCT01110746|Insulin|insulin|mesh-list
43637848|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564251|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43746537|NCT02523898|Enclomiphene|enclomiphene|mesh-list
43746538|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
43746539|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43746541|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43564252|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564253|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564254|NCT01107496|Viloxazine|viloxazine|mesh-list
43564255|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43564261|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564262|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
43564263|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564264|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564265|NCT01106989|Lidocaine|lidocaine|mesh-list
43735776|NCT05300386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43735777|NCT05300373|Adenosine|adenosine|mesh-list
43735778|NCT05300373|Analgesics|analgesics|mesh-ancestor
43735779|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
43735780|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735781|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735782|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43735783|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
43735784|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43735785|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
43735786|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
43735787|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735788|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639243|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
43639307|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43639308|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
43639316|NCT03414684|Carboplatin|carboplatin|mesh-list
43735792|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735793|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735794|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564266|NCT01106989|Tetracaine|tetracaine|mesh-list
43564267|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
43564268|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
43564269|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564270|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564273|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564274|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43564275|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43564276|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564277|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564279|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
43564280|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43564281|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
43564282|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43564284|NCT01106807|Analgesics|analgesics|mesh-ancestor
43564285|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
43564286|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564287|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564288|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564289|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564290|NCT01105624|Azithromycin|azithromycin|mesh-list
43564291|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43564292|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43564293|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43564294|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564295|NCT01102660|Naproxen|naproxen|mesh-list
43564296|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43564297|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564298|NCT01102660|Analgesics|analgesics|mesh-ancestor
43564299|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
43564300|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564301|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564316|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43564317|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564318|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
43564319|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564320|NCT01097018|Capecitabine|capecitabine|mesh-list
43564321|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564322|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
43564323|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564324|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564325|NCT01096862|Peficitinib|peficitinib|mesh-list
43564326|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564327|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564328|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564329|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
43564330|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564331|NCT01094262|Oxycodone|oxycodone|mesh-list
43735797|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
43735798|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
43735799|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735800|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735802|NCT05300347|Analgesics|analgesics|mesh-ancestor
43735803|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
43735804|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735805|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735806|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43735807|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
43735808|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43735809|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
43735810|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
43735811|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746556|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43746557|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746558|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746559|NCT02524184|Urological Agents|urological agents|mesh-ancestor
43746560|NCT02523833|Albuterol|albuterol|mesh-list
43746561|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43746562|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
43569095|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43569096|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43569097|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569098|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569099|NCT00560183|Morphine|morphine|mesh-list
43569100|NCT00560183|Oxycodone|oxycodone|mesh-list
43569101|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43569102|NCT00560183|Narcotics|narcotics|mesh-ancestor
43569103|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569104|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569105|NCT00560183|Analgesics|analgesics|mesh-ancestor
43569106|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
43569107|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694142|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569108|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
43735812|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735813|NCT05300334|Adenosine|adenosine|mesh-list
43735817|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735818|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43735819|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
43735821|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
43847636|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
43847637|NCT04085315|Osimertinib|osimertinib|mesh-list
43847638|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847639|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847640|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847641|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847643|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43847644|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847645|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847646|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
43847647|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
43847648|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
43847649|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847650|NCT04085172|Guanfacine|guanfacine|mesh-list
43847651|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43847652|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43847653|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43847654|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43847655|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847656|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
43847657|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735845|NCT05299593|Timolol|timolol|mesh-list
43735850|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735852|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564332|NCT01094262|Analgesics|analgesics|mesh-list
43564333|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43564334|NCT01094262|Narcotics|narcotics|mesh-ancestor
43564335|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564336|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564337|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
43564338|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564339|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
43564340|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43564341|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735853|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43735854|NCT05299580|Trametinib|trametinib|mesh-list
43735855|NCT05299580|Dabrafenib|dabrafenib|mesh-list
43735856|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735857|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43735858|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735859|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735860|NCT05299567|Azithromycin|azithromycin|mesh-list
43735861|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43735862|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735863|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
43735864|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735865|NCT05277480|Apatinib|apatinib|mesh-list
43735866|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735867|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43735868|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564342|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43564343|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43564344|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
43564345|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564346|NCT01092065|Levodopa|levodopa|mesh-list
43564347|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43564348|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43564349|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
43564350|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564351|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564364|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43564365|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
43564366|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43564367|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
43564377|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564378|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564379|NCT01072981|Antiviral Agents|antiviral agents|mesh-ancestor
43564380|NCT01072981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564381|NCT01072981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564382|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564383|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564384|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43564392|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564394|NCT01071850|Metformin|metformin|mesh-list
43564395|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
43735869|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735870|NCT05259943|Psilocybin|psilocybin|mesh-list
43735871|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
43735872|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735873|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43735874|NCT05253287|Hormones|hormones|mesh-list
43735875|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735876|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735877|NCT05238649|Vaccines|vaccines|mesh-list
43735878|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
43735879|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735880|NCT05227300|Lidocaine|lidocaine|mesh-list
43735881|NCT05227300|Epinephrine|epinephrine|mesh-list
43735882|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
43735883|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
43735884|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735885|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735886|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
43735887|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735888|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43735889|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43735890|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43735891|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735892|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746571|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43746572|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
43746573|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746574|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746576|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43746577|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43746578|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746579|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43746580|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
43746581|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
43746582|NCT02523846|Morphine|morphine|mesh-list
43735893|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43735894|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43735895|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
43735910|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735912|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43735913|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735914|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43735915|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
43735916|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
43735917|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43735920|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735921|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43735922|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735923|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735925|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735926|NCT05179239|Paclitaxel|paclitaxel|mesh-list
43564396|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564397|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564398|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43564399|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735927|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43735928|NCT05179239|Cisplatin|cisplatin|mesh-list
43735929|NCT05179239|Carboplatin|carboplatin|mesh-list
43735930|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43735931|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735932|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
43735933|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
43735934|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
43735935|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735936|NCT05178628|Gemcitabine|gemcitabine|mesh-list
43735937|NCT05178628|Paclitaxel|paclitaxel|mesh-list
43735938|NCT05178628|Tinzaparin|tinzaparin|mesh-list
43735939|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43735940|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735941|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
43735942|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
43735943|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
43735944|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735965|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
43735966|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735967|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735968|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43735969|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735970|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
43735971|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
43735972|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735973|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43735974|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
43735976|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735977|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43735978|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43569117|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569118|NCT00549510|Lisinopril|lisinopril|mesh-list
43569119|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43569120|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
43569121|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569122|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569123|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43735979|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43735980|NCT05147493|Growth Substances|growth substances|mesh-ancestor
43735981|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
43735982|NCT05122182|Proxigermanium|proxigermanium|mesh-list
43735983|NCT05122182|Candesartan|candesartan|mesh-list
43735985|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43735986|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43735987|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43735988|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735989|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735991|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
43735992|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735993|NCT05070754|Cantharidin|cantharidin|mesh-list
43735994|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834483|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
43735995|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735996|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
43735997|NCT05061017|Nivolumab|nivolumab|mesh-list
43735998|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43735999|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
43736000|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736001|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736002|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43736003|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
43736004|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736005|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736006|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43736007|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43736008|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43736009|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
43736010|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43736011|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43736012|NCT05037812|Ketorolac|ketorolac|mesh-list
43736013|NCT05037812|Clonidine|clonidine|mesh-list
43736014|NCT05037812|Epinephrine|epinephrine|mesh-list
43736015|NCT05037812|Morphine|morphine|mesh-list
43736016|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43736017|NCT05037812|Narcotics|narcotics|mesh-ancestor
43736018|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736019|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736020|NCT05037812|Analgesics|analgesics|mesh-ancestor
43736021|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
43736022|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736023|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43736024|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736025|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736026|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736027|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736028|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43736029|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43569129|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43569130|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43569131|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569132|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569133|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569134|NCT00547066|Veltuzumab|veltuzumab|mesh-list
43746586|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746587|NCT02523846|Analgesics|analgesics|mesh-ancestor
43746588|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
43746589|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736030|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
43736031|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43736032|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
43736034|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
43736035|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43736036|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43736037|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736038|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736039|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736040|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43736041|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736042|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43736044|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43736045|NCT05012943|Vaccines|vaccines|mesh-list
43736046|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
43736056|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43736057|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43736058|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564409|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564410|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564411|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43564413|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43564414|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
43564415|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564416|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
43564417|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564418|NCT01038804|Docetaxel|docetaxel|mesh-list
43564419|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564420|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
43564421|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
43736059|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43694110|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43849508|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849509|NCT03919955|Oxybutynin|oxybutynin|mesh-list
43849510|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43849511|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43849512|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43849513|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849514|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849515|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
43849516|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849517|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849518|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
43849519|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
43849520|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849536|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
43736060|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736063|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43736064|NCT04979377|Hormones|hormones|mesh-list
43736065|NCT04979377|Testosterone|testosterone|mesh-list
43736066|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43736067|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43736068|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736069|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736070|NCT04979377|Androgens|androgens|mesh-ancestor
43746594|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746595|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
43746596|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746597|NCT02523547|Entecavir|entecavir|mesh-list
43746598|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
43746599|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746600|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
43746601|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
43746602|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43736071|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43736072|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
43736073|NCT04974996|Prednisone|prednisone|mesh-list
43736074|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
43736075|NCT04974996|Rituximab|rituximab|mesh-list
43736076|NCT04974996|Doxorubicin|doxorubicin|mesh-list
43736077|NCT04974996|Vincristine|vincristine|mesh-list
43736078|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43736079|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736080|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
43736081|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736082|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736083|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43736084|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
43849537|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43849538|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849539|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43849541|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849542|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849543|NCT03916341|Nicotine|nicotine|mesh-list
43736085|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736086|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736087|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43736088|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43736089|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43736090|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43736091|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43564422|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
43564423|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736095|NCT04974996|Hormones|hormones|mesh-ancestor
43736096|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736097|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43736098|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43736099|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
43736100|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
43736101|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
43736102|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
43736103|NCT04955158|Ketamine|ketamine|mesh-list
43736104|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43736105|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736106|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736107|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736120|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
43694111|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43834485|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
43834486|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
43746604|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746605|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746606|NCT02523638|Interferons|interferons|mesh-list
43746607|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
43569135|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569136|NCT00546793|Veltuzumab|veltuzumab|mesh-list
43569137|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569138|NCT00546780|Bortezomib|bortezomib|mesh-list
43834487|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834488|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834489|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834490|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
43834491|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834492|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43834493|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
43834494|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834495|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834496|NCT05127876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43834497|NCT05127876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43834498|NCT05127876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564431|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564432|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564433|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43564440|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564441|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564442|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564443|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564444|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43564445|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43564446|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43834506|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43834507|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
43834508|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
43834510|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
43834511|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834512|NCT05126342|Niraparib|niraparib|mesh-list
43834513|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43834514|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834515|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834516|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834517|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
43694112|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43834518|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43834519|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834520|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
43834521|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43564447|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
43564448|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
43564449|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694113|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
43564452|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
43564466|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43564467|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
43564468|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564469|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564471|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43564480|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564482|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43564483|NCT01033123|Iniparib|iniparib|mesh-list
43569139|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569140|NCT00546273|Vaccines|vaccines|mesh-list
43569141|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
43569142|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569143|NCT00544960|Docetaxel|docetaxel|mesh-list
43569144|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569145|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
43569146|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
43564484|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564485|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564486|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564487|NCT01030432|Ribavirin|ribavirin|mesh-list
43834522|NCT05124899|Protective Agents|protective agents|mesh-ancestor
43834523|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834524|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834525|NCT05124340|Vaccines|vaccines|mesh-list
43834526|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
43834527|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834528|NCT05123131|Dexamethasone|dexamethasone|mesh-list
43834529|NCT05123131|Lenalidomide|lenalidomide|mesh-list
43834530|NCT05123131|Bortezomib|bortezomib|mesh-list
43834531|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834532|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
43834533|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
43834534|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834535|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834536|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834537|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
43834538|NCT05123131|Hormones|hormones|mesh-ancestor
43834539|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834540|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834541|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834542|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
43834543|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43834544|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43834545|NCT05123131|Growth Substances|growth substances|mesh-ancestor
43834546|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
43834547|NCT05122884|Milrinone|milrinone|mesh-list
43834548|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43834549|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43834550|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
43834551|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43834552|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43834553|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834554|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834555|NCT05122884|Protective Agents|protective agents|mesh-ancestor
43834556|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834557|NCT05119920|Pilocarpine|pilocarpine|mesh-list
43736123|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
43736124|NCT04928391|Nalbuphine|nalbuphine|mesh-list
43736125|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43736126|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736127|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736128|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736129|NCT04928391|Analgesics|analgesics|mesh-ancestor
43736130|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
43736131|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736132|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43736133|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43736134|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736135|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736136|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736137|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736154|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
43736155|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736156|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43736157|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43736158|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736159|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736160|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736161|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736162|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43736163|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43736164|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
43736165|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
43736166|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43736167|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43736168|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
43736169|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43736170|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43736171|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736172|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
43736173|NCT04910464|Coagulants|coagulants|mesh-ancestor
43736174|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
43736175|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43736176|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43736177|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736178|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
43736201|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736202|NCT04767256|Analgesics|analgesics|mesh-ancestor
43736203|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
43736204|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43736205|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43736206|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736207|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736208|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736209|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736210|NCT04766983|Dimercaprol|dimercaprol|mesh-list
43736211|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
43736212|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
43736213|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736214|NCT04754815|Paclitaxel|paclitaxel|mesh-list
43736215|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43736216|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
43736217|NCT04754815|Pemetrexed|pemetrexed|mesh-list
43736218|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43736219|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736220|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
43736221|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
43736222|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
43736223|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736224|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43736225|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736226|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43736227|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43736228|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
43736229|NCT04696731|Fludarabine|fludarabine|mesh-list
43736230|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736231|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
43736232|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736233|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736234|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43736235|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
43694143|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43694144|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
43694145|NCT02769832|Antiviral Agents|antiviral agents|mesh-ancestor
43694146|NCT02769832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694147|NCT02769832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694148|NCT02769832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736236|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736237|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736238|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43736239|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43736240|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43736241|NCT04654351|Icatibant|icatibant|mesh-list
43736242|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43736243|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736244|NCT04654351|Analgesics|analgesics|mesh-ancestor
43736245|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
43736246|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736247|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736248|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736249|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736250|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43736251|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43736252|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736253|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43736254|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736255|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
43736256|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43736257|NCT04642352|Bupivacaine|bupivacaine|mesh-list
43736258|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
43736259|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
43736260|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736261|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736262|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
43736263|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736264|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736265|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
43736266|NCT04642352|Hormones|hormones|mesh-ancestor
43736268|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736277|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43736278|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43736279|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736280|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736281|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
43736282|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43736328|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
43736329|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43736330|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43736331|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43736332|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43736333|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43736334|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736335|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
43736339|NCT04394182|Lopinavir|lopinavir|mesh-list
43736340|NCT04394182|Azithromycin|azithromycin|mesh-list
43569155|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569156|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569157|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
43569158|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569159|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43569160|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
43569161|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43736341|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
43736342|NCT04394182|Tazobactam|tazobactam|mesh-list
43736343|NCT04394182|Piperacillin|piperacillin|mesh-list
43736344|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43736345|NCT04394182|Heparin|heparin|mesh-list
43736346|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43736347|NCT04394182|Tinzaparin|tinzaparin|mesh-list
43736348|NCT04394182|Dalteparin|dalteparin|mesh-list
43736349|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43736350|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43736351|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
43736352|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736383|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736384|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
43736385|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43736386|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43834558|NCT05119920|Miotics|miotics|mesh-ancestor
43834559|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
43834560|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834561|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834562|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43834563|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43834564|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
43834565|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834568|NCT05119140|Mesalamine|mesalamine|mesh-list
43834589|NCT05116254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43834590|NCT05116254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736390|NCT04377503|Prednisolone|prednisolone|mesh-list
43736391|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
43736392|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43736393|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
43736394|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736395|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
43736396|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
43736397|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736398|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736433|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43736434|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43736435|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736436|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
43736437|NCT04221828|Paclitaxel|paclitaxel|mesh-list
43736438|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43736439|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43736443|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
43736510|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736512|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43736513|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43736514|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43736515|NCT05360979|Endostatins|endostatins|mesh-list
43736516|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736517|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43736518|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43736519|NCT05360979|Growth Substances|growth substances|mesh-ancestor
43569166|NCT00544115|Melphalan|melphalan|mesh-list
43569167|NCT00544115|Busulfan|busulfan|mesh-list
43569168|NCT00544115|Methotrexate|methotrexate|mesh-list
43569169|NCT00544115|Fludarabine|fludarabine|mesh-list
43569170|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
43569171|NCT00544115|Etoposide|etoposide|mesh-list
43569172|NCT00544115|Tacrolimus|tacrolimus|mesh-list
43569173|NCT00544115|Cyclosporins|cyclosporins|mesh-list
43569174|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569175|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
43736520|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569176|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569177|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736521|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
43736522|NCT05360953|Clonidine|clonidine|mesh-list
43736523|NCT05360953|Doxazosin|doxazosin|mesh-list
43736524|NCT05360953|Analgesics|analgesics|mesh-ancestor
43736525|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
43736526|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736527|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736528|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43736529|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
43736530|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
43736531|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43736532|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43736533|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736534|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736535|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736536|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736537|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43736538|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43736539|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43736571|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
43736572|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736574|NCT05360342|Vitamin K|vitamin k|mesh-list
43736575|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
43736591|NCT05360147|Hormones|hormones|mesh-ancestor
43736592|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834597|NCT05115513|Analgesics|analgesics|mesh-ancestor
43834598|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
43834599|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834600|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43834601|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43834603|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834604|NCT05115513|Hormones|hormones|mesh-ancestor
43834605|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834606|NCT05114096|Betamethasone|betamethasone|mesh-list
43834607|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
43834608|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43834609|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
43564514|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43564515|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43564516|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
43564517|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564518|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564519|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849576|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834616|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43834617|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
43834618|NCT05113745|Reboxetine|reboxetine|mesh-list
43569178|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43569179|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
43569180|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569192|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43569193|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43569194|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43834619|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
43834620|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43834621|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43834622|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43834623|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564525|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
43564526|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
43564527|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
43564528|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43564529|NCT01024101|Paclitaxel|paclitaxel|mesh-list
43736599|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43736600|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43736601|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
43564531|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564532|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
43564533|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
43736610|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
43736611|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43736612|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
43736613|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736614|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43736615|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43736616|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
43736617|NCT05359874|Bevacizumab|bevacizumab|mesh-list
43736618|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43736619|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736620|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43736621|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43736634|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736636|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736637|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43736638|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
43736639|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736640|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43736680|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736681|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43736682|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
43736683|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736736|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43736737|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43736741|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
43736766|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
43736768|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736769|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736770|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736771|NCT05357066|Analgesics|analgesics|mesh-ancestor
43736772|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
43736773|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736774|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
43736775|NCT05357027|Fludarabine|fludarabine|mesh-list
43736776|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736777|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
43736778|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736779|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736780|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43736781|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
43736783|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736784|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43834633|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
43834634|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43834635|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
43834636|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834637|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834638|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
43834639|NCT05112263|Cyclosporine|cyclosporine|mesh-list
43834640|NCT05112263|Cyclosporins|cyclosporins|mesh-list
43834641|NCT05112263|Tofacitinib|tofacitinib|mesh-list
43834642|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834643|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834644|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43834645|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
43736789|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43736790|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
43736791|NCT05355610|Gentamicins|gentamicins|mesh-list
43736792|NCT05355610|Dexamethasone|dexamethasone|mesh-list
43736793|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
43736794|NCT05355610|BB 1101|bb 1101|mesh-list
43736795|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736796|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
43736797|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
43736798|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736799|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736800|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43736801|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
43736813|NCT05355597|Epinephrine|epinephrine|mesh-list
43736814|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43736815|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736816|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
43736817|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736818|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736819|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736820|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43736821|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43736822|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
43736823|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736824|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43736825|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
43736826|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
43736827|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
43736828|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43736829|NCT05355597|Analgesics|analgesics|mesh-ancestor
43736830|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
43736831|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43736832|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
43736853|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43736854|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
43736855|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
43736856|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736857|NCT05355272|Hormones|hormones|mesh-list
43736858|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736859|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736860|NCT05354986|Povidone|povidone|mesh-list
43736861|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
43736862|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
43736863|NCT05354700|Carboplatin|carboplatin|mesh-list
43736864|NCT05354700|Etoposide|etoposide|mesh-list
43736865|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736866|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43736867|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43736868|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43736869|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736870|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736871|NCT05348200|Clobetasol|clobetasol|mesh-list
43736872|NCT05348200|Lidocaine|lidocaine|mesh-list
43736873|NCT05348200|Halobetasol|halobetasol|mesh-list
43736874|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
43736875|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
43736876|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736877|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736878|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
43736879|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736880|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43736881|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43736882|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43736883|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43736884|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736885|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43736886|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736893|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736894|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736895|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43736896|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43736897|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
43736898|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736899|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736900|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43736901|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
43736902|NCT05346224|Pertuzumab|pertuzumab|mesh-list
43736903|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43736904|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834653|NCT05110417|Bromides|bromides|mesh-list
43834654|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43834655|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
43834656|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43834657|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834658|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834659|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
43834665|NCT05109364|Terazosin|terazosin|mesh-list
43736914|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736915|NCT05343260|Propofol|propofol|mesh-list
43736916|NCT05343260|Sevoflurane|sevoflurane|mesh-list
43736917|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43736918|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736919|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736920|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43736921|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
43736922|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
43736923|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43736924|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43736925|NCT05342467|Dinoprostone|dinoprostone|mesh-list
43736926|NCT05342467|Gemeprost|gemeprost|mesh-list
43736927|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
43736928|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43736929|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736930|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43736931|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
43736932|NCT05332587|Rituximab|rituximab|mesh-list
43736933|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43736934|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736935|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
43736936|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736937|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736938|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
43736939|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736940|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43736962|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
43736963|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736964|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736965|NCT05303220|Branebrutinib|branebrutinib|mesh-list
43736966|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43736967|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569206|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569207|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569208|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569209|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43569210|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
43736968|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736969|NCT05294965|Fenoterol|fenoterol|mesh-list
43736970|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43736971|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
43736972|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736973|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736974|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43736975|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
43736976|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
43736979|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43538982|NCT04019327|Temozolomide|temozolomide|mesh-list
43736980|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43736983|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736984|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736985|NCT05290753|Erythromycin|erythromycin|mesh-list
43736986|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43736987|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736988|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43736989|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43736990|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736992|NCT05290220|Lenvatinib|lenvatinib|mesh-list
43737003|NCT05283408|Analgesics|analgesics|mesh-ancestor
43737004|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
43737005|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737007|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43737008|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43737009|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
43737010|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737011|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737012|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
43737013|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43737014|NCT05281068|Danazol|danazol|mesh-list
43737015|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43737016|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
43737017|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737018|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737019|NCT05276284|Atezolizumab|atezolizumab|mesh-list
43737020|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
43737021|NCT05276284|Thioguanine|thioguanine|mesh-list
43737022|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737024|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737025|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43737026|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43737027|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
43737028|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737029|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43737030|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737031|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43737032|NCT05270863|Carbachol|carbachol|mesh-list
43737033|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43737041|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43737043|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
43737044|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737045|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43737046|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
43737067|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737069|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
43737070|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737071|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737072|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737073|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
43737074|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
43737075|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
43737076|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
43737077|NCT05254548|Midazolam|midazolam|mesh-list
43737078|NCT05254548|Omeprazole|omeprazole|mesh-list
43737079|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43737080|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43737081|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737082|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737083|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43737084|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43737085|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43737086|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43737087|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
43737088|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
43737089|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
43737090|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
43737091|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737092|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737093|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43737094|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737095|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43737096|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737097|NCT05254548|Analgesics|analgesics|mesh-ancestor
43737098|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
43737099|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737100|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43737101|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737102|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737103|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737104|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43737105|NCT05246982|Capecitabine|capecitabine|mesh-list
43737106|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
43737107|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43737108|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
43737112|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43737113|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43694114|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43737119|NCT05226351|Dronabinol|dronabinol|mesh-list
43737120|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
43737121|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737122|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43737123|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737124|NCT05226351|Analgesics|analgesics|mesh-ancestor
43737128|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43737129|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737130|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737132|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737133|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
43737135|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737136|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737137|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737138|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737144|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737145|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737146|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43737147|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
43737148|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
43737149|NCT05189002|Dalteparin|dalteparin|mesh-list
43737150|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
43737151|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43737152|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43737153|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834694|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43834695|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43834698|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43834699|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
43834700|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
43834701|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834702|NCT05107765|Pioglitazone|pioglitazone|mesh-list
43834703|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43834704|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834705|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
43834706|NCT05106127|Lenvatinib|lenvatinib|mesh-list
43834707|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834708|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834709|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43834710|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834711|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834712|NCT05105997|Dexamethasone|dexamethasone|mesh-list
43834713|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834714|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
43539194|NCT03604315|Fluorides|fluorides|mesh-list
43737154|NCT05183139|Dexamethasone|dexamethasone|mesh-list
43737155|NCT05183139|Lenalidomide|lenalidomide|mesh-list
43737156|NCT05183139|Pomalidomide|pomalidomide|mesh-list
43737157|NCT05183139|Ixazomib|ixazomib|mesh-list
43737158|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737159|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
43737160|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
43737161|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737162|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737163|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737164|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
43737165|NCT05183139|Hormones|hormones|mesh-ancestor
43737166|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737167|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43737168|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737169|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
43737170|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43737171|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43737172|NCT05183139|Growth Substances|growth substances|mesh-ancestor
43737173|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
43737174|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
43737175|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737176|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737177|NCT05176964|Capecitabine|capecitabine|mesh-list
43737178|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
43737179|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43737180|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
43737181|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737182|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737183|NCT05170789|Dexamethasone|dexamethasone|mesh-list
43737184|NCT05170789|Elotuzumab|elotuzumab|mesh-list
43737185|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737186|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
43737187|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
43737188|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737189|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737190|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737191|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
43737192|NCT05170789|Hormones|hormones|mesh-ancestor
43737193|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737200|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43737201|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43737202|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737204|NCT05167513|Hormones|hormones|mesh-ancestor
43737205|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737206|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43737207|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
43737209|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737210|NCT05162196|Niraparib|niraparib|mesh-list
43737211|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43737212|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737213|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849657|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43737218|NCT05154136|Itraconazole|itraconazole|mesh-list
43737219|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
43737220|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737221|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43737222|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43737223|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737224|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737225|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43737226|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
43737227|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539271|NCT03408340|Narcotics|narcotics|mesh-ancestor
43737228|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737229|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43737230|NCT05152472|Atezolizumab|atezolizumab|mesh-list
43737231|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
43737232|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737233|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737234|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737235|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737236|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
43737237|NCT05147558|Lenvatinib|lenvatinib|mesh-list
43737238|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43737239|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737240|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737241|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694117|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43737252|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43737253|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737254|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43737255|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737256|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43737257|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
43737258|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737259|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43737260|NCT05129722|Diuretics|diuretics|mesh-ancestor
43737261|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
43737262|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43737263|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43737264|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43737265|NCT05111002|Doxycycline|doxycycline|mesh-list
43737266|NCT05111002|Lefamulin|lefamulin|mesh-list
43737267|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43737268|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737269|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
43737270|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43737271|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43737272|NCT05076110|Acetaminophen|acetaminophen|mesh-list
43737273|NCT05076110|Ibuprofen|ibuprofen|mesh-list
43737274|NCT05076110|Oxycodone|oxycodone|mesh-list
43737275|NCT05076110|Gabapentin|gabapentin|mesh-list
43737276|NCT05076110|Methocarbamol|methocarbamol|mesh-list
43737277|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737278|NCT05076110|Analgesics|analgesics|mesh-ancestor
43737279|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
43737280|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737281|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737282|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
43737283|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43737284|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737285|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737286|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43737290|NCT05076110|Narcotics|narcotics|mesh-ancestor
43737303|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43737304|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737305|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737306|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737307|NCT05065021|Paclitaxel|paclitaxel|mesh-list
43737308|NCT05065021|Bevacizumab|bevacizumab|mesh-list
43737309|NCT05065021|Niraparib|niraparib|mesh-list
43737310|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43737320|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737321|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
43737322|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43737323|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737325|NCT05059535|Analgesics|analgesics|mesh-list
43737326|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737327|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
43737328|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737352|NCT04996017|Atezolizumab|atezolizumab|mesh-list
43737353|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737354|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
43737355|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43737356|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
43834720|NCT05105997|Hormones|hormones|mesh-ancestor
43834721|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834722|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834723|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834724|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
43737368|NCT04930237|Bisacodyl|bisacodyl|mesh-list
43737369|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
43737370|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
43737371|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
43737372|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
43737373|NCT04930237|Calcium|calcium|mesh-list
43737374|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43737375|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737376|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737377|NCT04930237|Cathartics|cathartics|mesh-ancestor
43737378|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737379|NCT04930237|Laxatives|laxatives|mesh-ancestor
43737380|NCT04930237|Antacids|antacids|mesh-ancestor
43737381|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43737382|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
43737383|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737385|NCT04928261|Trastuzumab|trastuzumab|mesh-list
43737386|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43737387|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737388|NCT04922944|Vaccines|vaccines|mesh-list
43737389|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
43737390|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737391|NCT04904536|Atorvastatin|atorvastatin|mesh-list
43737392|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43737393|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43737394|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
43737395|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737396|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43737417|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43737419|NCT04895306|Hormones|hormones|mesh-ancestor
43737420|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737421|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737422|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43737423|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737424|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
43737425|NCT04878107|Docetaxel|docetaxel|mesh-list
43737426|NCT04878107|Apatinib|apatinib|mesh-list
43737427|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737428|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
43737429|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
43737430|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
43737431|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737432|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737433|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737434|NCT04873063|Beclomethasone|beclomethasone|mesh-list
43737435|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737436|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
43737437|NCT04873063|Hormones|hormones|mesh-ancestor
43737438|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737439|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737440|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43737441|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
43737456|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737457|NCT04840888|Itraconazole|itraconazole|mesh-list
43737458|NCT04840888|Carbamazepine|carbamazepine|mesh-list
43737464|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737466|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737467|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43737468|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43737469|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43737470|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
43737471|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737472|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737473|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43737474|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
43737475|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
43737476|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43737477|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737478|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43737479|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737480|NCT04840888|Analgesics|analgesics|mesh-ancestor
43737487|NCT04828083|Lidocaine|lidocaine|mesh-list
43737502|NCT04754945|Dexamethasone|dexamethasone|mesh-list
43737503|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
43737504|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
43737505|NCT04754945|Bortezomib|bortezomib|mesh-list
43737506|NCT04754945|Ichthammol|ichthammol|mesh-list
43737507|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43737508|NCT04754945|BB 1101|bb 1101|mesh-list
43737509|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43737510|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
43737511|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737512|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737513|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43737514|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
43737515|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737516|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737517|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43737518|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737519|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
43737520|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
43569258|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
43569259|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569260|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569261|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569262|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43569263|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
43569264|NCT00537043|Protective Agents|protective agents|mesh-ancestor
43737521|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737522|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737523|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
43737524|NCT04754945|Hormones|hormones|mesh-ancestor
43737525|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737526|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43737527|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
43737528|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737529|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
43737530|NCT04748848|Azacitidine|azacitidine|mesh-list
43737531|NCT04748848|Venetoclax|venetoclax|mesh-list
43737532|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
43737533|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43737534|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
43737535|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737536|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737538|NCT04732182|Donepezil|donepezil|mesh-list
43737542|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
43737543|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737544|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737545|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
43737546|NCT04730362|Propofol|propofol|mesh-list
43737547|NCT04730362|Sevoflurane|sevoflurane|mesh-list
43737548|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
43737552|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43737553|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
43737554|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43737555|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43737556|NCT04726085|Ibuprofen|ibuprofen|mesh-list
43737557|NCT04726085|Indomethacin|indomethacin|mesh-list
43737558|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43737559|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737560|NCT04726085|Analgesics|analgesics|mesh-ancestor
43737561|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
43737562|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737563|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737564|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737565|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737566|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43737567|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834751|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
43834752|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834753|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43834754|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43834755|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43834756|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43834757|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847659|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43847660|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43847661|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43847662|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43847663|NCT04083898|Prednisone|prednisone|mesh-list
43847664|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43847665|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847666|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
43847667|NCT04083898|Hormones|hormones|mesh-ancestor
43569266|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569267|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43569268|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
43569269|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43569270|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43569271|NCT00535366|Fluticasone|fluticasone|mesh-list
43569272|NCT00535366|Ciclesonide|ciclesonide|mesh-list
43847668|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847669|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847670|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847671|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847672|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43847673|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
43847674|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847675|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
43847676|NCT04083183|Sirolimus|sirolimus|mesh-list
43737589|NCT04688788|Rituximab|rituximab|mesh-list
43737590|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
43737591|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43737592|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737593|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
43737605|NCT04688788|Protective Agents|protective agents|mesh-ancestor
43737606|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43737607|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43737608|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43737609|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
43737611|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737612|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737613|NCT04685694|Misoprostol|misoprostol|mesh-list
43737614|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43737615|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
43737616|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43737633|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737635|NCT04624828|Hormones|hormones|mesh-ancestor
43737636|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737637|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737638|NCT04615624|Furosemide|furosemide|mesh-list
43737639|NCT04615624|Diuretics|diuretics|mesh-ancestor
43737640|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
43737641|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737642|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43737643|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43737644|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737645|NCT04614909|Temozolomide|temozolomide|mesh-list
43737646|NCT04614909|Olaparib|olaparib|mesh-list
43737647|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43737648|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
43737649|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737650|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737651|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43737652|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737653|NCT04580147|Aflibercept|aflibercept|mesh-list
43737654|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43737655|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43737656|NCT04580147|Growth Substances|growth substances|mesh-ancestor
43737657|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737658|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
43737659|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737661|NCT04553133|Fulvestrant|fulvestrant|mesh-list
43737662|NCT04553133|Palbociclib|palbociclib|mesh-list
43737663|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737664|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43737665|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43737666|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737671|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737672|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43737673|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43737674|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737675|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
43737676|NCT04545762|Fludarabine|fludarabine|mesh-list
43737677|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
43737678|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43737679|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
43737680|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737681|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737682|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43737683|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
43737684|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737685|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737686|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43737687|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43737688|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
43737689|NCT04541680|Nintedanib|nintedanib|mesh-list
43849803|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
43849804|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849805|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849806|NCT03891576|Niraparib|niraparib|mesh-list
43849818|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737717|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737718|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737719|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737720|NCT04502095|Levofloxacin|levofloxacin|mesh-list
43737722|NCT04502095|Trimethoprim|trimethoprim|mesh-list
43737723|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43737724|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
43737725|NCT04502095|Clindamycin|clindamycin|mesh-list
43737726|NCT04502095|Ertapenem|ertapenem|mesh-list
43737775|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
43737776|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43737777|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737779|NCT04460066|Cisplatin|cisplatin|mesh-list
43737780|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43849846|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849847|NCT03889418|Analgesics|analgesics|mesh-ancestor
43737783|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737784|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
43737785|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
43737786|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
43737787|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737788|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
43737789|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737790|NCT04453137|Adalimumab|adalimumab|mesh-list
43834772|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834773|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
43834774|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
43834775|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834776|NCT05098210|Laxatives|laxatives|mesh-ancestor
43834777|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834778|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
43834779|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834780|NCT05098028|Rifaximin|rifaximin|mesh-list
43834781|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43834782|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834783|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834784|NCT05097261|Ketamine|ketamine|mesh-list
43834785|NCT05097261|Analgesics|analgesics|mesh-ancestor
43834786|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
43834787|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834788|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834789|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43834790|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43834791|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
43834792|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
43834793|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834794|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43834795|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43834796|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834797|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849906|NCT05702970|Vitamin D|vitamin d|mesh-list
43569273|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
43569274|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43569275|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569276|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43569277|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
43849054|NCT03970382|Analgesics|analgesics|mesh-ancestor
43569278|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834801|NCT05096832|Vaccines|vaccines|mesh-list
43834802|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
43834804|NCT05096728|Nifedipine|nifedipine|mesh-list
43834815|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
43834816|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
43834817|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
43834818|NCT05096663|Gemcitabine|gemcitabine|mesh-list
43834819|NCT05096663|Dexamethasone|dexamethasone|mesh-list
43834820|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
43834821|NCT05096663|Docetaxel|docetaxel|mesh-list
43834822|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
43834823|NCT05096663|Pemetrexed|pemetrexed|mesh-list
43834824|NCT05096663|Ramucirumab|ramucirumab|mesh-list
43834825|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43834826|NCT05096663|Antibodies|antibodies|mesh-list
43834827|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
43834828|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43834829|NCT05096663|Lexatumumab|lexatumumab|mesh-list
43737794|NCT04436926|Narcotics|narcotics|mesh-ancestor
43737795|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737796|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737797|NCT04436926|Analgesics|analgesics|mesh-ancestor
43737798|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
43737799|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737800|NCT04428372|Mannitol|mannitol|mesh-list
43737801|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43737802|NCT04428372|Diuretics|diuretics|mesh-ancestor
43737803|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
43737804|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737805|NCT04387240|Artesunate|artesunate|mesh-list
43737806|NCT04387240|Artemisinins|artemisinins|mesh-list
43737841|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
43737843|NCT04334330|Fulvestrant|fulvestrant|mesh-list
43737844|NCT04334330|Palbociclib|palbociclib|mesh-list
43737845|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43737846|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737847|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43737848|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43737849|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43737850|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
43737851|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737852|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737853|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43737854|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737856|NCT04331717|Leuprolide|leuprolide|mesh-list
43737857|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43737858|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
43737859|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43737860|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737861|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43737862|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737863|NCT04314570|Ropivacaine|ropivacaine|mesh-list
43737864|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
43737865|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
43737866|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737867|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737868|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
43737869|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737870|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
43737871|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737872|NCT04297332|Nicotine|nicotine|mesh-list
43737873|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43737874|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
43737875|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737876|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737878|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43737879|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
43737880|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737888|NCT04293562|Etoposide|etoposide|mesh-list
43569283|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43569284|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
43569285|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43737889|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
43737890|NCT04293562|Daunorubicin|daunorubicin|mesh-list
43737891|NCT04293562|Asparaginase|asparaginase|mesh-list
43737892|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
43737893|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
43737894|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
43737895|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
43737896|NCT04293562|Razoxane|razoxane|mesh-list
43737897|NCT04293562|Calicheamicins|calicheamicins|mesh-list
43737898|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43737899|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
43737900|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43737901|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737913|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43737914|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43737915|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43737916|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
43737917|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737918|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43737919|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737920|NCT04293562|Analgesics|analgesics|mesh-ancestor
43737921|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
43737922|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737923|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
43737924|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
43737925|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
43737926|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
43737927|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43737928|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43737929|NCT04293562|Protective Agents|protective agents|mesh-ancestor
43737930|NCT04286295|Nicotine|nicotine|mesh-list
43737931|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43737932|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
43737933|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737934|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737935|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43737936|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43737937|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
43737938|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737939|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737940|NCT04275713|Metformin|metformin|mesh-list
43737941|NCT04275713|Cisplatin|cisplatin|mesh-list
43737942|NCT04275713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737943|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43737944|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737945|NCT04271917|Acetaminophen|acetaminophen|mesh-list
43737946|NCT04271917|Ibuprofen|ibuprofen|mesh-list
43737947|NCT04271917|Cannabidiol|cannabidiol|mesh-list
43737955|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737956|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737957|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43737958|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737959|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737960|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
43737961|NCT04266353|Resveratrol|resveratrol|mesh-list
43737962|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
43737963|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737964|NCT04266353|Protective Agents|protective agents|mesh-ancestor
43737965|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737966|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737967|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43737968|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43737969|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
43737974|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
43737975|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737976|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737977|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43737978|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
43737979|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
43737980|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43738003|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738004|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
43738005|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738006|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738007|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43738008|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
43738009|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738010|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738011|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43738012|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43738013|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43738014|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738015|NCT04207060|Indomethacin|indomethacin|mesh-list
43738016|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43738017|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43738018|NCT04207060|Analgesics|analgesics|mesh-ancestor
43738019|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
43738020|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738021|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738022|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738023|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738024|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
43738025|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
43738026|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43738027|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43738028|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738030|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
43738050|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
43738051|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43738052|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738053|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
43738054|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738055|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
43569290|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43569291|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43569292|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
43569293|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
43569294|NCT00535366|Hormones|hormones|mesh-ancestor
43569295|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569296|NCT00534027|Conatumumab|conatumumab|mesh-list
43569297|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43569298|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569299|NCT00532311|Atorvastatin|atorvastatin|mesh-list
43569300|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43569301|NCT00532311|Simvastatin|simvastatin|mesh-list
43569302|NCT00532311|Pravastatin|pravastatin|mesh-list
43569303|NCT00532311|Lovastatin|lovastatin|mesh-list
43569304|NCT00532311|L 647318|l 647318|mesh-list
43738056|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43738057|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43738058|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
43738059|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738060|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738061|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738062|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
43738063|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
43738065|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
43738066|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43738067|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
43834830|NCT05096663|BB 1101|bb 1101|mesh-list
43834831|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
43834832|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834833|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
43834834|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834835|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
43834836|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
43834837|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834838|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834839|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
43834841|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834842|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834843|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834844|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
43834857|NCT05096663|Hematinics|hematinics|mesh-ancestor
43834858|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
43834859|NCT05096390|Axitinib|axitinib|mesh-list
43834860|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738068|NCT04122625|Nivolumab|nivolumab|mesh-list
43738069|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738070|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738071|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43746633|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43746634|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43746635|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746636|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43746637|NCT02523144|Analgesics|analgesics|mesh-ancestor
43746638|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
43746639|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746640|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43746641|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43746642|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43746643|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
43746644|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746645|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746646|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43746647|NCT02523092|Hormones|hormones|mesh-ancestor
43746648|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738072|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738073|NCT04102800|Benralizumab|benralizumab|mesh-list
43738074|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43738075|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
43738076|NCT04101461|Iron|iron|mesh-list
43738077|NCT04101461|Hepcidins|hepcidins|mesh-list
43738078|NCT04101461|Trace Elements|trace elements|mesh-ancestor
43738079|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
43738080|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738081|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738082|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
43738083|NCT04081545|Analgesics|analgesics|mesh-list
43738084|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
43738085|NCT04081545|Anesthetics|anesthetics|mesh-list
43738086|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43738087|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738088|NCT04081545|Narcotics|narcotics|mesh-ancestor
43738089|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
43738090|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738091|NCT04071769|Xenon|xenon|mesh-list
43738094|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
43738116|NCT04056624|Carotenoids|carotenoids|mesh-list
43738117|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
43738118|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738119|NCT04056624|Protective Agents|protective agents|mesh-ancestor
43738120|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738122|NCT04034862|Dolutegravir|dolutegravir|mesh-list
43738123|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43738124|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43738125|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738126|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738127|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
43738128|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738129|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43738130|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43738131|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43738132|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43738133|NCT03987022|Acetaminophen|acetaminophen|mesh-list
43738134|NCT03987022|Ketorolac|ketorolac|mesh-list
43738135|NCT03987022|Oxycodone|oxycodone|mesh-list
43738136|NCT03987022|Hydromorphone|hydromorphone|mesh-list
43738137|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43738138|NCT03987022|Narcotics|narcotics|mesh-ancestor
43738139|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43738140|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738141|NCT03987022|Analgesics|analgesics|mesh-ancestor
43738142|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
43738143|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738144|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43738145|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43738146|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738147|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738148|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43738149|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738158|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
43738159|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43738160|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738161|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738162|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
43738163|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43738164|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43738165|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
43738166|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738167|NCT03983876|Adalimumab|adalimumab|mesh-list
43738168|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738169|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738170|NCT03982082|Coal Tar|coal tar|mesh-list
43738171|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
43738172|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
43738173|NCT03949153|Nivolumab|nivolumab|mesh-list
43738174|NCT03949153|Ipilimumab|ipilimumab|mesh-list
43738175|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738176|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738177|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738178|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738179|NCT03944044|Acetaminophen|acetaminophen|mesh-list
43738180|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43738181|NCT03944044|Analgesics|analgesics|mesh-ancestor
43738182|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
43738183|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738184|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738185|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
43738186|NCT03926754|Mirabegron|mirabegron|mesh-list
43738187|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43738188|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43738189|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43738201|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738202|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738203|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43738204|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43738205|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
43738206|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738207|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738208|NCT03898986|Vaccines|vaccines|mesh-list
43738209|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
43738210|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738211|NCT03877809|Sirolimus|sirolimus|mesh-list
43738212|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43738213|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738214|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43738215|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738216|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
43746649|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746650|NCT02523053|Fluorouracil|fluorouracil|mesh-list
43746651|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
43746652|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746653|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746654|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746655|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746656|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
43746657|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746658|NCT02522897|Ranibizumab|ranibizumab|mesh-list
43746662|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746664|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738217|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43540387|NCT00092027|Alendronate|alendronate|mesh-list
43738218|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
43738219|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738221|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
43738222|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43738223|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738224|NCT03866421|Liver Extracts|liver extracts|mesh-list
43738225|NCT03866421|Hematinics|hematinics|mesh-ancestor
43738226|NCT03849313|Adalimumab|adalimumab|mesh-list
43738227|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738228|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738243|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738244|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
43738245|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43738246|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
43738247|NCT03795194|Ampicillin|ampicillin|mesh-list
43738248|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43738249|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738250|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738268|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738269|NCT03781817|Ketamine|ketamine|mesh-list
43738270|NCT03781817|Analgesics|analgesics|mesh-ancestor
43738271|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
43738272|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738273|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738274|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43738275|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43738276|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
43738277|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
43738278|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43738279|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43738280|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43738281|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835764|NCT05024747|Nicotine|nicotine|mesh-list
43835765|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43835766|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
43835767|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835768|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835769|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43835770|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43835771|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
43835772|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835773|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835774|NCT05023967|Metformin|metformin|mesh-list
43835775|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43738282|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738283|NCT03770455|Avelumab|avelumab|mesh-list
43738284|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834883|NCT05095922|Coagulants|coagulants|mesh-ancestor
43834884|NCT05095376|Temozolomide|temozolomide|mesh-list
43834885|NCT05095376|Lomustine|lomustine|mesh-list
43834886|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43834887|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
43834888|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834889|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834890|NCT05094427|Anesthetics|anesthetics|mesh-list
43834891|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
43834892|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834893|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834894|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
43834895|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834896|NCT05093621|Torsemide|torsemide|mesh-list
43834897|NCT05093621|Furosemide|furosemide|mesh-list
43834898|NCT05093621|Diuretics|diuretics|mesh-ancestor
43834899|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
43834900|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834901|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43834902|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43834903|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834904|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43834905|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
43834906|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43834907|NCT05090657|Methylene Blue|methylene blue|mesh-list
43540499|NCT05223907|Propofol|propofol|mesh-list
43738289|NCT03746275|Aspirin|aspirin|mesh-list
43738290|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
43738311|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43738312|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43738313|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43738314|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43738315|NCT03705585|Vaccines|vaccines|mesh-list
43738316|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
43738317|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738318|NCT03685890|Nivolumab|nivolumab|mesh-list
43738319|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738320|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738321|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738322|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738323|NCT03674424|Avelumab|avelumab|mesh-list
43738324|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738325|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738326|NCT03671330|Letrozole|letrozole|mesh-list
43738327|NCT03671330|Goserelin|goserelin|mesh-list
43738328|NCT03671330|Anastrozole|anastrozole|mesh-list
43738329|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738330|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43738332|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738333|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738334|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43738335|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
43738336|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738337|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738338|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738339|NCT03670355|Tenofovir|tenofovir|mesh-list
43738340|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
43738341|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738342|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43738343|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43738344|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738346|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43738349|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43738350|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43738351|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43738352|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43738353|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738354|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
43738355|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738356|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738357|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43738358|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738359|NCT03641755|Olaparib|olaparib|mesh-list
43738360|NCT03641755|Sapacitabine|sapacitabine|mesh-list
43738361|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43738362|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847682|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
43738363|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738364|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738365|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
43738366|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738367|NCT03576690|Atoltivimab|atoltivimab|mesh-list
43738368|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
43738369|NCT03576690|Odesivimab|odesivimab|mesh-list
43738370|NCT03576690|Maftivimab|maftivimab|mesh-list
43738371|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
43738372|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738373|NCT03567473|Dexamethasone|dexamethasone|mesh-list
43738374|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
43738375|NCT03567473|Epinephrine|epinephrine|mesh-list
43738376|NCT03567473|Racepinephrine|racepinephrine|mesh-list
43738377|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
43738378|NCT03567473|BB 1101|bb 1101|mesh-list
43738393|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43738394|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43738395|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
43738396|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738397|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43738398|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43738399|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43738400|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
43738401|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
43738402|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
43738403|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43738404|NCT03557294|Varenicline|varenicline|mesh-list
43738405|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43738406|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43738407|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
43738408|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738409|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738453|NCT03440892|Methotrexate|methotrexate|mesh-list
43738454|NCT03440892|Abatacept|abatacept|mesh-list
43738455|NCT03440892|Tofacitinib|tofacitinib|mesh-list
43738456|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43738457|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
43738458|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43738459|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738460|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43738461|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
43738462|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738463|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738464|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
43738465|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738466|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43738467|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738468|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
43738469|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738470|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43738471|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738472|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43738473|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834911|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834912|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834913|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834914|NCT05090384|Prednisone|prednisone|mesh-list
43834915|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834916|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
43834917|NCT05090384|Hormones|hormones|mesh-ancestor
43834918|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834919|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834920|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834921|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834922|NCT05090358|Canagliflozin|canagliflozin|mesh-list
43834923|NCT05090358|Fulvestrant|fulvestrant|mesh-list
43834924|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834925|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834926|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43834927|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43834928|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
43834929|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834930|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834931|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43834932|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834933|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43834934|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
43834935|NCT05089461|Analgesics|analgesics|mesh-ancestor
43834936|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
43834937|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834938|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834939|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835776|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835777|NCT05023473|Morphine|morphine|mesh-list
43835778|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43835779|NCT05023473|Narcotics|narcotics|mesh-ancestor
43835780|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835781|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835782|NCT05023473|Analgesics|analgesics|mesh-ancestor
43835783|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
43569306|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43569311|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43569312|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569314|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43834940|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43738484|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738485|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738486|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738487|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
43738488|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43738489|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43738490|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738491|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
43738492|NCT03361345|Coagulants|coagulants|mesh-ancestor
43738493|NCT03360916|Atorvastatin|atorvastatin|mesh-list
43738494|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43738495|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43738496|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
43738497|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738498|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43738499|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43738500|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738501|NCT03357419|Clindamycin|clindamycin|mesh-list
43738502|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
43738503|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
43738504|NCT03357419|Cephalexin|cephalexin|mesh-list
43738505|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43738507|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43738509|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738511|NCT03331289|Exenatide|exenatide|mesh-list
43738512|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43738513|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738514|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43738515|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738516|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43738517|NCT03331289|Incretins|incretins|mesh-ancestor
43738518|NCT03331289|Hormones|hormones|mesh-ancestor
43738519|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738520|NCT03324282|Avelumab|avelumab|mesh-list
43738521|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738522|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738523|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43738524|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738525|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738526|NCT03268057|Avelumab|avelumab|mesh-list
43738527|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738528|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738529|NCT03172936|Spartalizumab|spartalizumab|mesh-list
43738530|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738531|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738532|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738533|NCT03168464|Nivolumab|nivolumab|mesh-list
43738534|NCT03168464|Ipilimumab|ipilimumab|mesh-list
43738535|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738536|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738537|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738538|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738539|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
43738540|NCT03160079|Blinatumomab|blinatumomab|mesh-list
43738541|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738542|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738543|NCT03158064|Durvalumab|durvalumab|mesh-list
43738544|NCT03158064|Tremelimumab|tremelimumab|mesh-list
43738545|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738546|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569315|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43569325|NCT00531622|Citalopram|citalopram|mesh-list
43738547|NCT03138252|Oxytocin|oxytocin|mesh-list
43738548|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
43738549|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43738550|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738551|NCT03122717|Gefitinib|gefitinib|mesh-list
43738552|NCT03122717|Osimertinib|osimertinib|mesh-list
43738553|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738554|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43738555|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847683|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43704251|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43738556|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738557|NCT03034642|Dimercaprol|dimercaprol|mesh-list
43738558|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
43738559|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
43738560|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738561|NCT03011684|Tamoxifen|tamoxifen|mesh-list
43738562|NCT03011684|Letrozole|letrozole|mesh-list
43738563|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738564|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43738565|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43738566|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738567|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738568|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43738569|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
43738570|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738571|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738572|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738573|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43738574|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43738575|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43738576|NCT03002389|Fluticasone|fluticasone|mesh-list
43738582|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738594|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
43738595|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
43738596|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
43738597|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738598|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738599|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738600|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738601|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43738602|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43738603|NCT02939989|Ribavirin|ribavirin|mesh-list
43738604|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
43738605|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
43738606|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738607|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
43738608|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738609|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
43738610|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738611|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738612|NCT02917564|Triamcinolone|triamcinolone|mesh-list
43738613|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43738614|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43738615|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43738616|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738617|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
43569326|NCT00531622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43569327|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43569328|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569329|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569330|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738618|NCT02917564|Hormones|hormones|mesh-ancestor
43738619|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738620|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738621|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738622|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
43738623|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738624|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738625|NCT02903680|Dexamethasone|dexamethasone|mesh-list
43738626|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
43738627|NCT02903680|BB 1101|bb 1101|mesh-list
43738628|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738629|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
43738630|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
43738631|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738632|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738633|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43738634|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
43738635|NCT02903680|Hormones|hormones|mesh-ancestor
43738636|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738637|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738638|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738639|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
43738640|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738641|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738644|NCT02732288|Melatonin|melatonin|mesh-list
43738645|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
43738646|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564555|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738657|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738658|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738659|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43738660|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
43738661|NCT02726581|Hormones|hormones|mesh-ancestor
43738662|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738663|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738664|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738665|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738666|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738667|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738668|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
43738669|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43738670|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43738671|NCT02726581|Growth Substances|growth substances|mesh-ancestor
43738672|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
43738673|NCT02672098|Carboplatin|carboplatin|mesh-list
43569336|NCT00529503|Rituximab|rituximab|mesh-list
43569337|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
43569338|NCT00529503|Carboplatin|carboplatin|mesh-list
43835784|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835785|NCT05022784|Nintedanib|nintedanib|mesh-list
43835786|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835787|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43835788|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835789|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835790|NCT05022524|Acetic Acid|acetic acid|mesh-list
43738674|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738675|NCT02631759|Levetiracetam|levetiracetam|mesh-list
43738676|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
43738677|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
43738678|NCT02624518|Bombesin|bombesin|mesh-list
43738679|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738680|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738681|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564556|NCT01023204|Paclitaxel|paclitaxel|mesh-list
43834946|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43834948|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834949|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834950|NCT05085574|Celecoxib|celecoxib|mesh-list
43834951|NCT05085574|Famotidine|famotidine|mesh-list
43834952|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43834953|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43834954|NCT05085574|Analgesics|analgesics|mesh-ancestor
43834955|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
43834956|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834957|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834958|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834959|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834960|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43834961|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43834962|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834963|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834964|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43834965|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834966|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43834967|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
43834968|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
43834969|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835791|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43835792|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835794|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
43835795|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835796|NCT05022147|Dopamine|dopamine|mesh-list
43835797|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
43835798|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43835799|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
43835800|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
43835801|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835802|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835803|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
43835804|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835805|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835806|NCT05022147|Protective Agents|protective agents|mesh-ancestor
43835807|NCT05021484|Felzartamab|felzartamab|mesh-list
43569339|NCT00529503|Etoposide|etoposide|mesh-list
43569340|NCT00529503|Ifosfamide|ifosfamide|mesh-list
43569341|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835808|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540951|NCT02275546|NuvaRing|nuvaring|mesh-list
43738682|NCT02594384|Rituximab|rituximab|mesh-list
43738683|NCT02594384|Atezolizumab|atezolizumab|mesh-list
43738684|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738685|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738686|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
43738687|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738700|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43738701|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738702|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738704|NCT02524249|Caffeine|caffeine|mesh-list
43738705|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43738706|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738707|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43738708|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738709|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738710|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43738711|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43738712|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
43738713|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738714|NCT02501954|Paclitaxel|paclitaxel|mesh-list
43738715|NCT02501954|Cisplatin|cisplatin|mesh-list
43738716|NCT02501954|Carboplatin|carboplatin|mesh-list
43738717|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738718|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738719|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
43738720|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
43738721|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
43738722|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738723|NCT02488967|Paclitaxel|paclitaxel|mesh-list
43738724|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
43738725|NCT02488967|Carboplatin|carboplatin|mesh-list
43738726|NCT02488967|Doxorubicin|doxorubicin|mesh-list
43738727|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43738728|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43738729|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738730|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738731|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
43738732|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
43738733|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
43738734|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738735|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564557|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738736|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
43738737|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738738|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738739|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43738740|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
43738741|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43738742|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43738743|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43738744|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43738745|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738746|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
43738747|NCT02451982|Nivolumab|nivolumab|mesh-list
43738750|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738751|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738752|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43738753|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
43738754|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738755|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738756|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43738757|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835809|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
43549693|NCT03630952|Aflibercept|aflibercept|mesh-list
43746665|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
43738758|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43738759|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43738760|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
43738761|NCT02445131|Idelalisib|idelalisib|mesh-list
43738762|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43738763|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
43738764|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738765|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564558|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564559|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
43564560|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
43564561|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
43564562|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564563|NCT01022801|Entecavir|entecavir|mesh-list
43564564|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
43564565|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564566|NCT01020565|Entecavir|entecavir|mesh-list
43564567|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
43564568|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738766|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738767|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738769|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738770|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738771|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
43738772|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738773|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43738774|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
43738775|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738776|NCT02210559|Gemcitabine|gemcitabine|mesh-list
43738777|NCT02210559|Paclitaxel|paclitaxel|mesh-list
43738778|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738779|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738780|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
43738781|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
43738782|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
43738783|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738784|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43738785|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
43738786|NCT02210559|Antiviral Agents|antiviral agents|mesh-ancestor
43738787|NCT02210559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738788|NCT02210559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738789|NCT02210559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738790|NCT02210559|Immunologic Factors|immunologic factors|mesh-ancestor
43564570|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
43564571|NCT01020097|Protective Agents|protective agents|mesh-ancestor
43564572|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564573|NCT01019187|Modafinil|modafinil|mesh-list
43564574|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43564575|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564576|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43564577|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43564578|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43746673|NCT02522858|Atropine|atropine|mesh-list
43746674|NCT02522858|Ephedrine|ephedrine|mesh-list
43746675|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
43746676|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43746677|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43746678|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746697|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43746698|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43746699|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
43564579|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564580|NCT01018875|Donepezil|donepezil|mesh-list
43564584|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
43564585|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564586|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564587|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
43564588|NCT01016808|Morphine|morphine|mesh-list
43564589|NCT01016808|Oxycodone|oxycodone|mesh-list
43738791|NCT02210559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738792|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43738793|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43738794|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738795|NCT02174549|Tirapazamine|tirapazamine|mesh-list
43738796|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738797|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
43738798|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43738799|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
43738800|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738801|NCT02113163|Metformin|metformin|mesh-list
43738802|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43738803|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43738804|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738805|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43738806|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43738807|NCT02107937|Paclitaxel|paclitaxel|mesh-list
43738808|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43738809|NCT02107937|Carboplatin|carboplatin|mesh-list
43738810|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738811|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738812|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
43738813|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
43738814|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
43564590|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43564591|NCT01016808|Narcotics|narcotics|mesh-ancestor
43564592|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564593|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564594|NCT01016808|Analgesics|analgesics|mesh-ancestor
43564595|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
43564596|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564597|NCT01014078|Azithromycin|azithromycin|mesh-list
43564598|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43564600|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43564601|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564606|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43564607|NCT01012895|Asunaprevir|asunaprevir|mesh-list
43564608|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564609|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
43564610|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564611|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
43564612|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564613|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
43564614|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564615|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
43564616|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564618|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738815|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738818|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746700|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43746701|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
43746702|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43746703|NCT02522754|Vaccines|vaccines|mesh-list
43746704|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
43746705|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746706|NCT02522936|Muramidase|muramidase|mesh-list
43746707|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746708|NCT02522650|Amiloride|amiloride|mesh-list
43738819|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43738820|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43738821|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738822|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738823|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43738824|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
43738825|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738826|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738827|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738828|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
43738834|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43738836|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738837|NCT02094625|Protective Agents|protective agents|mesh-ancestor
43738838|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564619|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
43564620|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
43564621|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
43564622|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564624|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43564625|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
43564626|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43564627|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564628|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564629|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
43564630|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564631|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564632|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
43564633|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564634|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43564635|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564636|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
43564637|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564638|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43564639|NCT01007721|Fluticasone|fluticasone|mesh-list
43564640|NCT01007721|Xhance|xhance|mesh-list
43564641|NCT01007721|Montelukast|montelukast|mesh-list
43564642|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564643|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43564644|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
43738839|NCT02094625|Antidotes|antidotes|mesh-ancestor
43738840|NCT02085265|Telmisartan|telmisartan|mesh-list
43738841|NCT02085265|Perindopril|perindopril|mesh-list
43738842|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43738843|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43738844|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43738845|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738846|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43738847|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
43738848|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738849|NCT02043587|Leucovorin|leucovorin|mesh-list
43738850|NCT02043587|Cytarabine|cytarabine|mesh-list
43738851|NCT02043587|Prednisone|prednisone|mesh-list
43738852|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
43738853|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43738854|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43738855|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43564645|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564646|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564647|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43564648|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
43564649|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
43564650|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43564651|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43564652|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
43564653|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43564664|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564665|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564666|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564667|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564668|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
43564670|NCT01005108|Analgesics|analgesics|mesh-ancestor
43564671|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
43564672|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564673|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564674|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
43564675|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43738856|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
43738857|NCT02043587|Rituximab|rituximab|mesh-list
43738858|NCT02043587|Methotrexate|methotrexate|mesh-list
43738859|NCT02043587|Etoposide|etoposide|mesh-list
43738860|NCT02043587|Vincristine|vincristine|mesh-list
43738861|NCT02043587|Daunorubicin|daunorubicin|mesh-list
43738862|NCT02043587|Asparaginase|asparaginase|mesh-list
43738863|NCT02043587|Dasatinib|dasatinib|mesh-list
43738864|NCT02043587|Pegaspargase|pegaspargase|mesh-list
43738865|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738866|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
43738867|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738868|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738869|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43738870|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
43738871|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738872|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738873|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43738874|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738875|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738876|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
43738877|NCT02043587|Hormones|hormones|mesh-ancestor
43738878|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738879|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738880|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43738881|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
43564676|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43746712|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746713|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43746714|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43746715|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569342|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569343|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
43569344|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569345|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569346|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43569347|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43569348|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43569349|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569350|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569351|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43569352|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
43564677|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564678|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43564679|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43564680|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43564681|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564682|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564683|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
43564684|NCT01004081|Exemestane|exemestane|mesh-list
43564685|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564686|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43564687|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43564688|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564689|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564690|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43564691|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
43564692|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43564693|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564694|NCT01002248|Dexamethasone|dexamethasone|mesh-list
43564695|NCT01002248|Bortezomib|bortezomib|mesh-list
43564696|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564697|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
43564698|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
43738882|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43738884|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
43738885|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
43738886|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738887|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43738888|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43738889|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738890|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43738891|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43738892|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
43738893|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738894|NCT02043587|Antidotes|antidotes|mesh-ancestor
43738895|NCT02043587|Protective Agents|protective agents|mesh-ancestor
43738896|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
43738897|NCT02043587|Vitamins|vitamins|mesh-ancestor
43738898|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
43738899|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
43738900|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
43738901|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
43738902|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43738903|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43738904|NCT01933724|Prednisone|prednisone|mesh-list
43564699|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564700|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564701|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43564702|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
43564703|NCT01002248|Hormones|hormones|mesh-ancestor
43564704|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43564705|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43564706|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564707|NCT01001923|Fasinumab|fasinumab|mesh-list
43564708|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564709|NCT01001923|Analgesics|analgesics|mesh-ancestor
43564710|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
43564711|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564712|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564724|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
43564725|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564726|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43564727|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
43564728|NCT01001338|Protective Agents|protective agents|mesh-ancestor
43564729|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564730|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
43564742|NCT01001091|Hormones|hormones|mesh-ancestor
43564743|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43564744|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43564745|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564747|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43564748|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
43564749|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564750|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564751|NCT00994292|Darexaban|darexaban|mesh-list
43564752|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43564753|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
43564754|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43564755|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
43564756|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564757|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564758|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
43564759|NCT00993382|Amiodarone|amiodarone|mesh-list
43564760|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564761|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
43564762|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43564763|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564764|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564765|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43564766|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43564767|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43564768|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738964|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43738965|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43738966|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738967|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43738968|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
43738969|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738970|NCT01234532|Anastrozole|anastrozole|mesh-list
43738971|NCT01234532|Entinostat|entinostat|mesh-list
43738972|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738973|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738974|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43738975|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43738976|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738977|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738978|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43738979|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
43738980|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738981|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738982|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43738983|NCT01154335|Everolimus|everolimus|mesh-list
43738984|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738988|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
43738998|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738999|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43739001|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43739002|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43739003|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
43739007|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739008|NCT00488072|Mirtazapine|mirtazapine|mesh-list
43739009|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
43739010|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43739011|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43739012|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
43739013|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
43739014|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739015|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739016|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739017|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43739018|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43739019|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739020|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43739021|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43739022|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43739023|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
43739024|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43739025|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43739026|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
43739027|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43739028|NCT00456261|Gemcitabine|gemcitabine|mesh-list
43739029|NCT00456261|Bevacizumab|bevacizumab|mesh-list
43739030|NCT00456261|Carboplatin|carboplatin|mesh-list
43739031|NCT00456261|Pemetrexed|pemetrexed|mesh-list
43739032|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739033|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739034|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43739035|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43739036|NCT00456261|Growth Substances|growth substances|mesh-ancestor
43739037|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739038|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
43739039|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43739041|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739042|NCT00456261|Antiviral Agents|antiviral agents|mesh-ancestor
43739043|NCT00456261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739044|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739045|NCT00456261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739046|NCT00456261|Immunologic Factors|immunologic factors|mesh-ancestor
43739047|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43739048|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43569353|NCT00529178|Pravastatin|pravastatin|mesh-list
43569354|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43569355|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43569357|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569358|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43569359|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43569360|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569361|NCT00529152|Deferiprone|deferiprone|mesh-list
43739049|NCT00362219|Morphine|morphine|mesh-list
43739050|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43739051|NCT00362219|Narcotics|narcotics|mesh-ancestor
43564769|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43564770|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43564771|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43564786|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564787|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
43564788|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564790|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564791|NCT00991172|Analgesics|analgesics|mesh-ancestor
43564792|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
43564793|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564794|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564795|NCT00991068|Lidocaine|lidocaine|mesh-list
43564796|NCT00991068|Tetracaine|tetracaine|mesh-list
43564797|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
43564798|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
43564799|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564800|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564801|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
43564802|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564803|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43569362|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43569363|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
43569364|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
43569365|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569366|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43569367|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43569368|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43569369|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569370|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569371|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
43569372|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569373|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569375|NCT00528333|Lintuzumab|lintuzumab|mesh-list
43569376|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746716|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746717|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43746718|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43746719|NCT02522572|Plerixafor|plerixafor|mesh-list
43746720|NCT02522572|Bortezomib|bortezomib|mesh-list
43746721|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746722|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43746723|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43746724|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
43564804|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43564805|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43850055|NCT05702359|Vitamin D|vitamin d|mesh-list
43564806|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564807|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564808|NCT00990912|Carboplatin|carboplatin|mesh-list
43564809|NCT00990912|Irinotecan|irinotecan|mesh-list
43564810|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564811|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43564812|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43564813|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564814|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564815|NCT00990327|Adenosine|adenosine|mesh-list
43564816|NCT00990327|Analgesics|analgesics|mesh-ancestor
43739052|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739053|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739054|NCT00362219|Analgesics|analgesics|mesh-ancestor
43739055|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
43739056|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739057|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
43739058|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739059|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739060|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43541378|NCT05500170|Niacin|niacin|mesh-list
43739061|NCT00215813|Poly I-C|poly i-c|mesh-list
43739062|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
43739063|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739064|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
43739065|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
43739066|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739067|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43739068|NCT00110110|Cyclosporine|cyclosporine|mesh-list
43739069|NCT00110110|Carboplatin|carboplatin|mesh-list
43746728|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
43746729|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746730|NCT02522221|Warfarin|warfarin|mesh-list
43746731|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
43569389|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569390|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
43569391|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43569392|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43569393|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569394|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569395|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43569396|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
43569397|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569398|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569399|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43569400|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43739070|NCT00110110|Etoposide|etoposide|mesh-list
43739071|NCT00110110|Vincristine|vincristine|mesh-list
43739072|NCT00110110|Cyclosporins|cyclosporins|mesh-list
43739073|NCT00110110|Lenograstim|lenograstim|mesh-list
43739074|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739075|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43739076|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43739077|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43739078|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739079|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739080|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43739081|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
43739082|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739083|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
43834974|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834975|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
43834976|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
43834977|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43834978|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
43834979|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43834980|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43834981|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834982|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43834983|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834984|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834985|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43834986|NCT05085340|Renal Agents|renal agents|mesh-ancestor
43834987|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
43704252|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43834988|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834989|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834990|NCT05084404|Guanabenz|guanabenz|mesh-list
43834991|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43834992|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43834993|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43834994|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43834995|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
43834996|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834997|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834998|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834999|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
43835000|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
43835001|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847684|NCT04083183|Antibodies|antibodies|mesh-list
43847685|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
43847686|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43847687|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
43847688|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43847689|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43847690|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564817|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
43564818|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564819|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564820|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43847691|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
43847692|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847693|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847694|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43541404|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43847695|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
43847696|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847697|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739092|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
43739093|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
43739094|NCT00075387|Carboplatin|carboplatin|mesh-list
43739095|NCT00075387|Etoposide|etoposide|mesh-list
43739096|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
43739097|NCT00075387|Antidotes|antidotes|mesh-list
43739098|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739099|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
43739100|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739101|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739102|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43739103|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
43739104|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739105|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739106|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43739107|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43739108|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43739109|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43739110|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739111|NCT00075387|Protective Agents|protective agents|mesh-ancestor
43739112|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
43739113|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
43739114|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43739116|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
43739126|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739127|NCT03904381|Fluorouracil|fluorouracil|mesh-list
43739128|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
43739129|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739130|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43739131|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739132|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739133|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
43739134|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739135|NCT03876873|Anesthetics|anesthetics|mesh-list
43739144|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739145|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43739146|NCT03755973|Hormones|hormones|mesh-ancestor
43739147|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43739148|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739149|NCT03747159|Belimumab|belimumab|mesh-list
43739150|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739151|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
43739152|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739153|NCT03732495|Denosumab|denosumab|mesh-list
43739154|NCT03732495|Lenvatinib|lenvatinib|mesh-list
43739155|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739156|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43739157|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564821|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
43564822|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43564823|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
43564824|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
43564825|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564826|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564828|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43739158|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739159|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43739160|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739161|NCT03728426|Letermovir|letermovir|mesh-list
43739162|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43739163|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739164|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739165|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739166|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
43739167|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739168|NCT03715166|Bumetanide|bumetanide|mesh-list
43739169|NCT03715166|Diuretics|diuretics|mesh-ancestor
43739170|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
43739171|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739172|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43739173|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43739174|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569413|NCT00524277|Vaccines|vaccines|mesh-list
43564829|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564830|NCT00981357|Analgesics|analgesics|mesh-ancestor
43564831|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
43564832|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564833|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564834|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564835|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564836|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
43564837|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43564838|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564839|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564853|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
43564854|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564855|NCT00978497|Ribavirin|ribavirin|mesh-list
43564856|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
43564857|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564858|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
43564859|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564860|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
43564861|NCT00978016|Baclofen|baclofen|mesh-list
43739175|NCT03680053|Cetrorelix|cetrorelix|mesh-list
43739176|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
43739177|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43739178|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
43739179|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43739180|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739181|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
43739182|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43739183|NCT03680053|Progestins|progestins|mesh-ancestor
43739184|NCT03680053|Hormones|hormones|mesh-ancestor
43739185|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43739186|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43739187|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
43739188|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739189|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
43739190|NCT03636152|Chloroquine|chloroquine|mesh-list
43739191|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
43739192|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43739193|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43739195|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739196|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739197|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739198|NCT03636152|Amebicides|amebicides|mesh-ancestor
43739200|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
43739201|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739202|NCT03563157|Leucovorin|leucovorin|mesh-list
43739203|NCT03563157|Paclitaxel|paclitaxel|mesh-list
43739204|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
43564862|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43564863|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564864|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569415|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
43569416|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569417|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569418|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43569419|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43569420|NCT00523042|Insulin|insulin|mesh-list
43569421|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43569422|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
43569423|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564865|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43564866|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564867|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43564868|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564869|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43564870|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
43564871|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
43564872|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564873|NCT00975091|Entecavir|entecavir|mesh-list
43564874|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
43564875|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564876|NCT00973284|Mannitol|mannitol|mesh-list
43564877|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43564878|NCT00973284|Diuretics|diuretics|mesh-ancestor
43564879|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
43739205|NCT03563157|Fluorouracil|fluorouracil|mesh-list
43739206|NCT03563157|Capecitabine|capecitabine|mesh-list
43739207|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
43739208|NCT03563157|Cetuximab|cetuximab|mesh-list
43739209|NCT03563157|Avelumab|avelumab|mesh-list
43739210|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43739211|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739212|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
43739213|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
43739214|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
43739215|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739216|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739217|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
43739218|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739219|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739220|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43739221|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
43739222|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43739223|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
43739224|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43739225|NCT03563157|Antidotes|antidotes|mesh-ancestor
43739226|NCT03563157|Protective Agents|protective agents|mesh-ancestor
43564880|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564881|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43564882|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
43564883|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564884|NCT00969722|Tretinoin|tretinoin|mesh-list
43564885|NCT00969722|Molgramostim|molgramostim|mesh-list
43564886|NCT00969722|Isotretinoin|isotretinoin|mesh-list
43564887|NCT00969722|Sargramostim|sargramostim|mesh-list
43564888|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564889|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
43564890|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
43564891|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
43564892|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564893|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
43564894|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43564895|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43564896|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43564897|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564898|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569424|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569425|NCT00522834|Paclitaxel|paclitaxel|mesh-list
43569426|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43569428|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
43569429|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
43569430|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
43569431|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569432|NCT00520923|Olanzapine|olanzapine|mesh-list
43746732|NCT02522169|Infliximab|infliximab|mesh-list
43564899|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
43564900|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564901|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564902|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43564903|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564915|NCT00966953|Honokiol|honokiol|mesh-list
43564916|NCT00966953|Triclosan|triclosan|mesh-list
43564917|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43564918|NCT00966953|Fluorides|fluorides|mesh-list
43564919|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
43564920|NCT00966953|Protective Agents|protective agents|mesh-ancestor
43564921|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564922|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43564923|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739227|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
43739228|NCT03563157|Vitamins|vitamins|mesh-ancestor
43739229|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
43739230|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739231|NCT03546192|Vaccines|vaccines|mesh-list
43739232|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
43739233|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739234|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43739235|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739236|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739237|NCT03490292|Paclitaxel|paclitaxel|mesh-list
43739238|NCT03490292|Carboplatin|carboplatin|mesh-list
43739239|NCT03490292|Avelumab|avelumab|mesh-list
43739240|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43739241|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739242|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
43739243|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
43739244|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
43739245|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739246|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739247|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
43739248|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43739249|NCT03480698|Protective Agents|protective agents|mesh-ancestor
43739250|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739251|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
43739252|NCT03474094|Atezolizumab|atezolizumab|mesh-list
43739253|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43739254|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739255|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
43739256|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739257|NCT03387085|Leucovorin|leucovorin|mesh-list
43739258|NCT03387085|Paclitaxel|paclitaxel|mesh-list
43739259|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
43739260|NCT03387085|Bevacizumab|bevacizumab|mesh-list
43739261|NCT03387085|Cisplatin|cisplatin|mesh-list
43739262|NCT03387085|Fluorouracil|fluorouracil|mesh-list
43739263|NCT03387085|Capecitabine|capecitabine|mesh-list
43739264|NCT03387085|Avelumab|avelumab|mesh-list
43739265|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43739268|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
43739269|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
43739270|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739271|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739272|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
43739273|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739274|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739275|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43739276|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
43739277|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43739278|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739279|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43739280|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43739281|NCT03387085|Growth Substances|growth substances|mesh-ancestor
43739282|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
43739283|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
43739284|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43739285|NCT03387085|Antidotes|antidotes|mesh-ancestor
43739286|NCT03387085|Protective Agents|protective agents|mesh-ancestor
43739287|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
43739288|NCT03387085|Vitamins|vitamins|mesh-ancestor
43739289|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
43739290|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43739291|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43739292|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739293|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43564924|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43564926|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
43564927|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564928|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43564929|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564930|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43564931|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564932|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43564933|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564934|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43564935|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43564936|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43564937|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43564938|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43564939|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43739294|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43739295|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43739296|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739297|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
43739298|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739299|NCT03334318|Allopurinol|allopurinol|mesh-list
43739300|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
43739301|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739302|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739303|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
43739304|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739305|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43739306|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
43739307|NCT03334318|Protective Agents|protective agents|mesh-ancestor
43541620|NCT05130086|Islatravir|islatravir|mesh-list
43739308|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739309|NCT03292250|Durvalumab|durvalumab|mesh-list
43739310|NCT03292250|Tremelimumab|tremelimumab|mesh-list
43739311|NCT03292250|Nintedanib|nintedanib|mesh-list
43739312|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739313|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739314|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43739315|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739316|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739318|NCT03218085|Emtricitabine|emtricitabine|mesh-list
43739319|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
43739320|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739321|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43739322|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43739323|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739324|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564941|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
43564942|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564943|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43564944|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
43564945|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
43564946|NCT00961675|Dexamethasone|dexamethasone|mesh-list
43564947|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
43564948|NCT00961675|Povidone|povidone|mesh-list
43564949|NCT00961675|BB 1101|bb 1101|mesh-list
43746737|NCT02522208|Isosorbide|isosorbide|mesh-list
43564950|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564951|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
43564952|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
43564953|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739325|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43739326|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43835003|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43835004|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835005|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43835006|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43835007|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
43835008|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835009|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835010|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
43835011|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43835012|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
43835013|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835014|NCT05081479|Expectorants|expectorants|mesh-ancestor
43835015|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
43835016|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43564954|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564955|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43564957|NCT00961675|Hormones|hormones|mesh-ancestor
43564958|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43564959|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43564960|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564961|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
43564962|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564963|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564964|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43564965|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564966|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43564967|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43564978|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
43564979|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43564981|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564982|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
43564983|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564984|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564985|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
43564986|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564987|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43564988|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564989|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
43564990|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564991|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43564992|NCT00957918|Nicotine|nicotine|mesh-list
43564993|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43564994|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
43564995|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564996|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564997|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43564998|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43564999|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
43565000|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565001|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565002|NCT00955981|Lesinurad|lesinurad|mesh-list
43565003|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
43565004|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835018|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835019|NCT05081479|Protective Agents|protective agents|mesh-ancestor
43835020|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835021|NCT05081479|Antidotes|antidotes|mesh-ancestor
43835022|NCT05081466|Vitamin D|vitamin d|mesh-list
43835023|NCT05081466|Calcium|calcium|mesh-list
43835024|NCT05081466|Vitamins|vitamins|mesh-ancestor
43835025|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
43835026|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835027|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43835028|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43835029|NCT05080218|Adalimumab|adalimumab|mesh-list
43835030|NCT05080218|Etanercept|etanercept|mesh-list
43746740|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43835031|NCT05080218|Golimumab|golimumab|mesh-list
43835032|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43835033|NCT05080218|Abatacept|abatacept|mesh-list
43835034|NCT05080218|Upadacitinib|upadacitinib|mesh-list
43835035|NCT05080218|Ixekizumab|ixekizumab|mesh-list
43835036|NCT05080218|Tofacitinib|tofacitinib|mesh-list
43835037|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835038|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835039|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43835040|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43835041|NCT05080218|Analgesics|analgesics|mesh-ancestor
43835042|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
43835043|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835044|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565005|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
43565007|NCT00953420|Dexamethasone|dexamethasone|mesh-list
43565008|NCT00953420|Carboplatin|carboplatin|mesh-list
43565009|NCT00953420|Docetaxel|docetaxel|mesh-list
43565010|NCT00953420|Lenograstim|lenograstim|mesh-list
43565011|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565012|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
43565013|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
43565014|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565015|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565016|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565017|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
43565018|NCT00953420|Hormones|hormones|mesh-ancestor
43565019|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565020|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43565021|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565022|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
43565023|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
43565024|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
43565025|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565026|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43565027|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
43835045|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835046|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43835047|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
43835048|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43835049|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835050|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835051|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43835052|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835053|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43835054|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
43835056|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
43835057|NCT05079763|Protective Agents|protective agents|mesh-ancestor
43835058|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835059|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
43835060|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
43835061|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835062|NCT05079126|Protective Agents|protective agents|mesh-ancestor
43835063|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541702|NCT04796714|Aspirin|aspirin|mesh-list
43746741|NCT02522208|Diuretics|diuretics|mesh-ancestor
43746742|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
43746743|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746744|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
43746745|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43569433|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
43569434|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
43569435|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739327|NCT03123029|Venetoclax|venetoclax|mesh-list
43739328|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739329|NCT03012581|Nivolumab|nivolumab|mesh-list
43739330|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739331|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739332|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43739333|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739334|NCT02908269|Vaccines|vaccines|mesh-list
43739335|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
43739336|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739337|NCT02900664|Trametinib|trametinib|mesh-list
43739338|NCT02900664|Spartalizumab|spartalizumab|mesh-list
43739339|NCT02900664|Nazartinib|nazartinib|mesh-list
43739340|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739345|NCT02859012|Axitinib|axitinib|mesh-list
43739349|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739350|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
43739351|NCT02807467|Propofol|propofol|mesh-list
43739352|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43739353|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739354|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739355|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43739356|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
43739357|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
43739358|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43739359|NCT02807467|Analgesics|analgesics|mesh-ancestor
43739360|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
43739361|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739362|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43739363|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43739364|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43739365|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
43739366|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739367|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739368|NCT02688790|Dalbavancin|dalbavancin|mesh-list
43739369|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43739370|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739371|NCT02473276|Morphine|morphine|mesh-list
43739372|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43565028|NCT00950885|Melatonin|melatonin|mesh-list
43565029|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
43565030|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565031|NCT00950885|Protective Agents|protective agents|mesh-ancestor
43565032|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565033|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565044|NCT00948909|Donepezil|donepezil|mesh-list
43565045|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43565046|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565047|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565048|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
43565049|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565050|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565051|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
43565052|NCT00948753|Maraviroc|maraviroc|mesh-list
43565053|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43565054|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43565055|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565056|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43565057|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43565058|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
43565059|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565060|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43739373|NCT02473276|Narcotics|narcotics|mesh-ancestor
43739374|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739375|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739376|NCT02473276|Analgesics|analgesics|mesh-ancestor
43739377|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
43569436|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569437|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43739378|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739379|NCT02457702|Glycerol|glycerol|mesh-list
43739380|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43739381|NCT02457702|Protective Agents|protective agents|mesh-ancestor
43739382|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739383|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
43739384|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739385|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43739386|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
43739387|NCT02309645|Coagulants|coagulants|mesh-ancestor
43739388|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
43739389|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
43739390|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739391|NCT02286414|Vitamins|vitamins|mesh-list
43739392|NCT02286414|Vitamin K|vitamin k|mesh-list
43565062|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
43565063|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565064|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565065|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43565066|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565067|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565068|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
43565069|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43565070|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565071|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
43565072|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
43565073|NCT00945802|Dexamethasone|dexamethasone|mesh-list
43565074|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
43565075|NCT00945802|BB 1101|bb 1101|mesh-list
43565076|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565077|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
43565078|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
43565079|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565080|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565081|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565082|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
43565083|NCT00945802|Hormones|hormones|mesh-ancestor
43565084|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565085|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43565087|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
43565088|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565089|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565090|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565091|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565092|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43565093|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43565094|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43565095|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43565097|NCT00945763|Meloxicam|meloxicam|mesh-list
43569450|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569451|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43569452|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
43569453|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
43569454|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569455|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
43569456|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569457|NCT00517153|Miglustat|miglustat|mesh-list
43569458|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569459|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569460|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43565098|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43565099|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43739393|NCT02286414|Warfarin|warfarin|mesh-list
43739394|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
43739395|NCT02286414|Dabigatran|dabigatran|mesh-list
43739396|NCT02286414|Apixaban|apixaban|mesh-list
43739397|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
43739398|NCT02286414|Fluindione|fluindione|mesh-list
43739399|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
43739400|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739401|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
43739402|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43739403|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
43739404|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43739405|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
43739406|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739407|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739409|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43739410|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
43739411|NCT02286414|Coagulants|coagulants|mesh-ancestor
43739412|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
43739413|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739414|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739415|NCT02049905|Gemcitabine|gemcitabine|mesh-list
43739416|NCT02049905|Docetaxel|docetaxel|mesh-list
43739417|NCT02049905|Doxorubicin|doxorubicin|mesh-list
43739418|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43739419|NCT02049905|Ifosfamide|ifosfamide|mesh-list
43739420|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
43739421|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43739422|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
43739423|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739424|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739425|NCT02049905|Antiviral Agents|antiviral agents|mesh-ancestor
43739426|NCT02049905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739427|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739428|NCT02049905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739429|NCT02049905|Immunologic Factors|immunologic factors|mesh-ancestor
43739430|NCT02049905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739431|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
43739432|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
43739433|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
43565100|NCT00945763|Analgesics|analgesics|mesh-ancestor
43739434|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43739435|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43739436|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43739437|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43739438|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
43739441|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739442|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739443|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
43739444|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739445|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739446|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43739447|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43739448|NCT01472562|Growth Substances|growth substances|mesh-ancestor
43739449|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
43739450|NCT01302327|Exenatide|exenatide|mesh-list
43739451|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43739452|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739453|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43739454|NCT01302327|Incretins|incretins|mesh-ancestor
43739455|NCT01302327|Hormones|hormones|mesh-ancestor
43739456|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43739457|NCT01259648|Remifentanil|remifentanil|mesh-list
43739485|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43739486|NCT00762554|Narcotics|narcotics|mesh-ancestor
43739487|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739488|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739489|NCT00762554|Analgesics|analgesics|mesh-ancestor
43739490|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
43739491|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739492|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43739493|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43739494|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
43739495|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
43739496|NCT00590187|Sapacitabine|sapacitabine|mesh-list
43569467|NCT00517049|Rituximab|rituximab|mesh-list
43739497|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739498|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
43739499|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739500|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43739501|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
43739502|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739503|NCT02535104|Ranpirnase|ranpirnase|mesh-list
43739504|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739505|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43739506|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739507|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739508|NCT02535130|Amikacin|amikacin|mesh-list
43739511|NCT02534961|Cefazolin|cefazolin|mesh-list
43739536|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43739537|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
43739538|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739539|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739540|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43739541|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43739542|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
43739543|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739544|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43739545|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43739546|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
43739547|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
43739548|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739549|NCT02534753|Protective Agents|protective agents|mesh-ancestor
43739550|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739551|NCT02534753|Vitamins|vitamins|mesh-ancestor
43739552|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
43835064|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43835065|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835066|NCT05078944|Donepezil|donepezil|mesh-list
43835067|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43835068|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704253|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
43565113|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
43565114|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565115|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565116|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565117|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
43565119|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565120|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43565121|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565122|NCT00944970|Adenosine|adenosine|mesh-list
43565123|NCT00944970|Binodenoson|binodenoson|mesh-list
43739560|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739561|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43739562|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43739563|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
43739564|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739565|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43739566|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
43739567|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
43739568|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
43739571|NCT02534506|Nivolumab|nivolumab|mesh-list
43739572|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739573|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739574|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43739575|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739576|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
43739577|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43739578|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
43739579|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739580|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
43739581|NCT02534415|Protective Agents|protective agents|mesh-ancestor
43739582|NCT02534610|Etoricoxib|etoricoxib|mesh-list
43739583|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43739584|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43739585|NCT02534610|Analgesics|analgesics|mesh-ancestor
43739586|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
43739607|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739608|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43835070|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
43739614|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43739615|NCT02534376|Simvastatin|simvastatin|mesh-list
43739616|NCT02534376|Ezetimibe|ezetimibe|mesh-list
43739617|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43739618|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43739631|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739632|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
43739633|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739634|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43739635|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43739636|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43739637|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
43739638|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
43739639|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739640|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739641|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
43739642|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43739643|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739644|NCT02534467|Montelukast|montelukast|mesh-list
43739645|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43565124|NCT00944970|Analgesics|analgesics|mesh-ancestor
43565125|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
43565126|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565127|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565128|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565129|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
43565130|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43565131|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
43565132|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
43565133|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565134|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565135|NCT00944892|Fasinumab|fasinumab|mesh-list
43565136|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43565137|NCT00944892|Analgesics|analgesics|mesh-ancestor
43565138|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
43565139|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565140|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565141|NCT00944294|Adenosine|adenosine|mesh-list
43565142|NCT00944294|Binodenoson|binodenoson|mesh-list
43565143|NCT00944294|Analgesics|analgesics|mesh-ancestor
43565144|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
43565145|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565146|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565147|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565148|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
43565149|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43565150|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
43565151|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
43565152|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565153|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565154|NCT00939276|Nepafenac|nepafenac|mesh-list
43565155|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43565156|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43565157|NCT00939276|Analgesics|analgesics|mesh-ancestor
43565158|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
43565159|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565160|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565161|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565162|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43565163|NCT00938652|Gemcitabine|gemcitabine|mesh-list
43565164|NCT00938652|Carboplatin|carboplatin|mesh-list
43565165|NCT00938652|Iniparib|iniparib|mesh-list
43565166|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739646|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
43739647|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43739648|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
43739649|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43739650|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739651|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43739652|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43739653|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739655|NCT02534337|Gemcitabine|gemcitabine|mesh-list
43739656|NCT02534337|Fluorouracil|fluorouracil|mesh-list
43739657|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
43739658|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43739659|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
43739660|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739661|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739662|NCT02534337|Antiviral Agents|antiviral agents|mesh-ancestor
43739663|NCT02534337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739664|NCT02534337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739665|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739666|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
43739667|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739668|NCT02534337|Antidotes|antidotes|mesh-ancestor
43739669|NCT02534337|Protective Agents|protective agents|mesh-ancestor
43739670|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
43739671|NCT02534337|Vitamins|vitamins|mesh-ancestor
43739672|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
43739673|NCT02534623|Fentanyl|fentanyl|mesh-list
43739674|NCT02534623|Bupivacaine|bupivacaine|mesh-list
43739675|NCT02534623|Anesthetics|anesthetics|mesh-list
43739676|NCT02534623|Propofol|propofol|mesh-list
43739691|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43739692|NCT02534454|Nicotine|nicotine|mesh-list
43739693|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43739694|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
43739695|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739696|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739697|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43739698|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43739699|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
43739700|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739701|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739702|NCT02534402|Prednisone|prednisone|mesh-list
43739703|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43739704|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
43739706|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43739707|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739708|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43739709|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739710|NCT02533908|Fentanyl|fentanyl|mesh-list
43739711|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43739712|NCT02533908|Narcotics|narcotics|mesh-ancestor
43739713|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739714|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739715|NCT02533908|Analgesics|analgesics|mesh-ancestor
43739716|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
43739717|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739718|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43739719|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43739720|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
43739721|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
43739722|NCT02533973|Calcipotriene|calcipotriene|mesh-list
43739723|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
43739724|NCT02533791|Vaccines|vaccines|mesh-list
43739725|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
43739726|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739727|NCT02533648|Allopurinol|allopurinol|mesh-list
43739730|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739739|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739740|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739741|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
43739742|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739743|NCT02533765|Olaparib|olaparib|mesh-list
43739744|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43739745|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739746|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739747|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739748|NCT02533557|Lidocaine|lidocaine|mesh-list
43739749|NCT02533557|Epinephrine|epinephrine|mesh-list
43739750|NCT02533557|Racepinephrine|racepinephrine|mesh-list
43739751|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
43739752|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
43739753|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
43739754|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739755|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739756|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
43739757|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739758|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43739759|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43739760|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43739761|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43739762|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739763|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43565177|NCT00938587|Prednisone|prednisone|mesh-list
43565178|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565179|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
43565180|NCT00938587|Hormones|hormones|mesh-ancestor
43739764|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43739765|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
43739767|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43739768|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43739769|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
43739770|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43739771|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
43739772|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
43739773|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
43739774|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43739776|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
43739777|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739778|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43739779|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43739780|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739781|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739783|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43739784|NCT02533492|Triclosan|triclosan|mesh-list
43739785|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43739786|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739787|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43739788|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43739789|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
43739790|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739791|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43739792|NCT02533323|Gemcitabine|gemcitabine|mesh-list
43739793|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
43739812|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43739813|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739814|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739815|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
43739816|NCT02533284|Analgesics|analgesics|mesh-ancestor
43739817|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
43739818|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739819|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739820|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
43739821|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739822|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43739823|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
43739824|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43739825|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43739826|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739827|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43739828|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
43739829|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43739830|NCT02533141|Simvastatin|simvastatin|mesh-list
43739831|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43739832|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43739833|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
43739834|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739835|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43739836|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43739837|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835077|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43835078|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835079|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43835080|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
43835081|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
43835082|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
43835083|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835084|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835085|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
43835086|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835087|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43835088|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43835089|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
43835090|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835092|NCT05077332|Celecoxib|celecoxib|mesh-list
43835093|NCT05077332|Famotidine|famotidine|mesh-list
43835094|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43835095|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43835096|NCT05077332|Analgesics|analgesics|mesh-ancestor
43835097|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
43835098|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835099|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835100|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835101|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835102|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43835104|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835124|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
43835125|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
43835126|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
43835127|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835128|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43835129|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
43835130|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835131|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739849|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
43739851|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739852|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739853|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739855|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43739856|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
43739857|NCT02532790|Hormones|hormones|mesh-ancestor
43739863|NCT02532777|Prednisone|prednisone|mesh-list
43739864|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
43739865|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
43739866|NCT02532777|Leflunomide|leflunomide|mesh-list
43739867|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43739868|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43739869|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739870|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
43739871|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739872|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739873|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43739874|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
43565186|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565187|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739875|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739877|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43739878|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43739879|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
43739880|NCT02532777|Hormones|hormones|mesh-ancestor
43739881|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43739882|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43739883|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43739884|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43739885|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
43739886|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43739887|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739888|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
43739889|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
43739890|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739891|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43739892|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43739893|NCT02532777|Protective Agents|protective agents|mesh-ancestor
43739894|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
43739895|NCT02532413|Entecavir|entecavir|mesh-list
43739896|NCT02532413|Poly I-C|poly i-c|mesh-list
43739897|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
43739898|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739899|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
43739900|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
43739901|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739902|NCT02532634|Dexamethasone|dexamethasone|mesh-list
43739903|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
43739904|NCT02532634|Aprepitant|aprepitant|mesh-list
43739905|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
43739921|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739923|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43739925|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43739926|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43739928|NCT02532400|Goserelin|goserelin|mesh-list
43739929|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43739932|NCT02532491|Aripiprazole|aripiprazole|mesh-list
43739933|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43739934|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
43739935|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739936|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739937|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739938|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43739939|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43739940|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739941|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43739942|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43739943|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
43739944|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
43739945|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
43739946|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43739947|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43739948|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43739950|NCT02532569|Vaccines|vaccines|mesh-list
43739967|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
43739968|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43739969|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739970|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
43739971|NCT02532270|Phenylephrine|phenylephrine|mesh-list
43739972|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
43739973|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43739974|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
43739975|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
43739976|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739977|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739978|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
43739979|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43739980|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
43739981|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
43739982|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43739983|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43739984|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43739985|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
43739986|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565188|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43565189|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43565190|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565191|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565192|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565193|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
43565194|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43565195|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565196|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565197|NCT00934921|Ondansetron|ondansetron|mesh-list
43565198|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
43565199|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
43565200|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565201|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565202|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565203|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
43565205|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43565206|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
43565207|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565208|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565209|NCT00934921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43565210|NCT00934921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43565211|NCT00934921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565212|NCT00934921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43739998|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740000|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740001|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740002|NCT02532192|Cytarabine|cytarabine|mesh-list
43740003|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
43740004|NCT02532192|Fluconazole|fluconazole|mesh-list
43740005|NCT02532192|Dexamethasone|dexamethasone|mesh-list
43740006|NCT02532192|Rituximab|rituximab|mesh-list
43740007|NCT02532192|Cisplatin|cisplatin|mesh-list
43740008|NCT02532192|Belinostat|belinostat|mesh-list
43740009|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43740010|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740011|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
43565224|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565225|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565226|NCT00934180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43565227|NCT00934180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43565228|NCT00934180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565229|NCT00934180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43565239|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
43565240|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43565242|NCT00928590|Travoprost|travoprost|mesh-list
43565243|NCT00928590|Cloprostenol|cloprostenol|mesh-list
43565244|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43565245|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43565246|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
43565247|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565248|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565249|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565250|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565251|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565252|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
43565253|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43850110|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740018|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43740019|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
43740020|NCT02532192|Hormones|hormones|mesh-ancestor
43740021|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740022|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43740023|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740024|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
43740025|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740026|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
43740027|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565261|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43565262|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43565263|NCT00927641|Analgesics|analgesics|mesh-ancestor
43565271|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565273|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565274|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565275|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43565276|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
43565277|NCT00924833|Carvedilol|carvedilol|mesh-list
43565278|NCT00924833|Nebivolol|nebivolol|mesh-list
43565279|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43565280|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43565281|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
43565282|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565283|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565284|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565285|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565286|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
43565287|NCT00924833|Protective Agents|protective agents|mesh-ancestor
43565288|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43565289|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565290|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43565291|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
43565292|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43565293|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43565294|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43565312|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43565313|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565314|NCT00917826|Valganciclovir|valganciclovir|mesh-list
43565315|NCT00917826|Ganciclovir|ganciclovir|mesh-list
43565316|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43565317|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
43565318|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
43740028|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740029|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740031|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43740032|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740033|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43740034|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43740035|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
43740036|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43740037|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43740038|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
43740039|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43740040|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43740041|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43740043|NCT02532153|Analgesics|analgesics|mesh-ancestor
43740044|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
43740045|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740046|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740047|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43850115|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
43740053|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43740054|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740055|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740056|NCT02532322|Acetaminophen|acetaminophen|mesh-list
43740057|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740058|NCT02532322|Analgesics|analgesics|mesh-ancestor
43740059|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
43740060|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740061|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740062|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
43740063|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43565325|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
43565326|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
43565327|NCT00917293|Vitamins|vitamins|mesh-ancestor
43565328|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
43565329|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565330|NCT00914602|Levodopa|levodopa|mesh-list
43565332|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43565334|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43565335|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
43565336|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565337|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565338|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740064|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740065|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740068|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740069|NCT02532023|Analgesics|analgesics|mesh-ancestor
43740070|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
43740071|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740072|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740073|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740074|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740075|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740076|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740078|NCT02531854|Pemetrexed|pemetrexed|mesh-list
43740079|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740080|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740081|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740082|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43740083|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43740084|NCT02531490|Labetalol|labetalol|mesh-list
43740085|NCT02531490|Methyldopa|methyldopa|mesh-list
43740086|NCT02531490|Nifedipine|nifedipine|mesh-list
43740087|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43740088|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740089|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740090|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43740091|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740092|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
43740093|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
43740094|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43740095|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43740103|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43740104|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43740105|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
43740106|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43740107|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43740108|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43740109|NCT02531581|Furosemide|furosemide|mesh-list
43740110|NCT02531581|Diuretics|diuretics|mesh-list
43740111|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
43740112|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740113|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43740114|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740115|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740116|NCT02531672|Choline|choline|mesh-list
43740117|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
43740118|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43740119|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
43740120|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740121|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565339|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43565340|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565341|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43565342|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
43565343|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
43565344|NCT00914290|Baclofen|baclofen|mesh-list
43565345|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43565346|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565348|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565349|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43565350|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
43565351|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
43565352|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565365|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
43565366|NCT00911443|Dacarbazine|dacarbazine|mesh-list
43565367|NCT00911443|Thymalfasin|thymalfasin|mesh-list
43565368|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565369|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
43565370|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565371|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
43565372|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565373|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43565374|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
43565375|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565377|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
43565378|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43565379|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565380|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43565381|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
43565382|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740122|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43740123|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
43740125|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
43740127|NCT02531451|Ibuprofen|ibuprofen|mesh-list
43740128|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43740129|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740130|NCT02531451|Analgesics|analgesics|mesh-ancestor
43740131|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
43740132|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740133|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740135|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740136|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43740137|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740138|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740139|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43740140|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43740141|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43740142|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
43740144|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43565383|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565384|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565385|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565386|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43565387|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43565388|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565389|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43565391|NCT00909649|Coagulants|coagulants|mesh-ancestor
43565392|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43565393|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43565394|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565395|NCT00909597|Pioglitazone|pioglitazone|mesh-list
43565396|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43565397|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565398|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565399|NCT00909597|Incretins|incretins|mesh-ancestor
43565400|NCT00909597|Hormones|hormones|mesh-ancestor
43565401|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565402|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
43565403|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43565404|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565405|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43565406|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
43565407|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565408|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565409|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565410|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565412|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43565413|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740145|NCT02531529|Narcotics|narcotics|mesh-ancestor
43740146|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740147|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740148|NCT02531529|Analgesics|analgesics|mesh-ancestor
43740149|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
43740150|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740151|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43740152|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43740153|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
43740154|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
43740155|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
43740156|NCT02531841|Dexamethasone|dexamethasone|mesh-list
43740157|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
43740158|NCT02531841|Etoposide|etoposide|mesh-list
43740159|NCT02531841|Thiotepa|thiotepa|mesh-list
43740160|NCT02531841|Ifosfamide|ifosfamide|mesh-list
43740162|NCT02531841|Carmustine|carmustine|mesh-list
43740163|NCT02531841|Busulfan|busulfan|mesh-list
43740164|NCT02531841|BB 1101|bb 1101|mesh-list
43740165|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740166|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
43565414|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43565415|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
43565429|NCT00905606|Topiramate|topiramate|mesh-list
43565430|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
43565431|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565432|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565434|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
43565435|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565436|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565437|NCT00905346|Topiramate|topiramate|mesh-list
43565438|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
43565439|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565440|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565441|NCT00905164|Topiramate|topiramate|mesh-list
43565442|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
43565443|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565444|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565445|NCT00904943|Topiramate|topiramate|mesh-list
43565446|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
43565447|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565448|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565449|NCT00902928|Enoxaparin|enoxaparin|mesh-list
43565450|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
43565451|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43565452|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43565453|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565454|NCT00902291|Gemcitabine|gemcitabine|mesh-list
43565455|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43565456|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
43565457|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565458|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565459|NCT00902291|Antiviral Agents|antiviral agents|mesh-ancestor
43565460|NCT00902291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740167|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
43740168|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740169|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740170|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43740171|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
43740172|NCT02531841|Hormones|hormones|mesh-ancestor
43740173|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740174|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43740175|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740176|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
43740177|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740178|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740179|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43740180|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43740181|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43740182|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43740183|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
43740184|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43740185|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740186|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
43740187|NCT02531737|Docetaxel|docetaxel|mesh-list
43740188|NCT02531737|Nintedanib|nintedanib|mesh-list
43740189|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740190|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
43740191|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
43565461|NCT00902291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565462|NCT00902291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43565463|NCT00902291|Immunologic Factors|immunologic factors|mesh-ancestor
43565464|NCT00902291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565465|NCT00901979|Metformin|metformin|mesh-list
43565466|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43565467|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565468|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565470|NCT00901979|Hormones|hormones|mesh-ancestor
43565471|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565472|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43565473|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
43565474|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565475|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565476|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43565477|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43565478|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43565491|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565492|NCT00894530|Azithromycin|azithromycin|mesh-list
43740192|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
43740193|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740194|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43740195|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740196|NCT02531412|Spironolactone|spironolactone|mesh-list
43740197|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43542636|NCT03701256|Atracurium|atracurium|mesh-list
43740198|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
43740199|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740200|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740201|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43740203|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
43740204|NCT02531477|Propofol|propofol|mesh-list
43740205|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43740206|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740207|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740208|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43740209|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
43740210|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
43565493|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43565494|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43565495|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565496|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565497|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43565498|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43565499|NCT00892970|Azithromycin|azithromycin|mesh-list
43565500|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43565501|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43565502|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565503|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565504|NCT00892762|Travoprost|travoprost|mesh-list
43565505|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43565506|NCT00892762|Latanoprost|latanoprost|mesh-list
43565507|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43565508|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565511|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43565512|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43565513|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
43565514|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565515|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565516|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565517|NCT00890968|Triamcinolone|triamcinolone|mesh-list
43565518|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43565519|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43565520|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43565521|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565522|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
43565523|NCT00890968|Hormones|hormones|mesh-ancestor
43565524|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565525|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565526|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43565527|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
43565528|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740211|NCT02531724|Simendan|simendan|mesh-list
43740212|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43740213|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
43740214|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43740215|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43740216|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740217|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740218|NCT02531724|Protective Agents|protective agents|mesh-ancestor
43740219|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740220|NCT02531165|Aspirin|aspirin|mesh-list
43740221|NCT02531165|Heparin|heparin|mesh-list
43740222|NCT02531165|Fentanyl|fentanyl|mesh-list
43740223|NCT02531165|Morphine|morphine|mesh-list
43740224|NCT02531165|Ticagrelor|ticagrelor|mesh-list
43740225|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43740226|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740227|NCT02531165|Analgesics|analgesics|mesh-ancestor
43740228|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
43740229|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565529|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565530|NCT00890591|Amlodipine|amlodipine|mesh-list
43565531|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43565532|NCT00890591|Olmesartan|olmesartan|mesh-list
43565533|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43565534|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565535|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43565536|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565537|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565538|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43565539|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565540|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
43565541|NCT00890591|Diuretics|diuretics|mesh-ancestor
43565542|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
43565554|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565555|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
43565556|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
43565557|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43565558|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
43565559|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565560|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565562|NCT00890149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43565563|NCT00890149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565564|NCT00890149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43565565|NCT00890149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43565566|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
43565567|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565568|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565569|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43565570|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43565571|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565572|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565573|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694164|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565574|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43565575|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43565576|NCT00889382|Paclitaxel|paclitaxel|mesh-list
43565577|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43740230|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740231|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740232|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740233|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43740234|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43740235|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740236|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43740237|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43740238|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740239|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
43740240|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43740241|NCT02531165|Narcotics|narcotics|mesh-ancestor
43740242|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740245|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
43740247|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
43740248|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43740249|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43740250|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43565578|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565579|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
43565580|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
43565581|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
43565582|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565583|NCT00888355|Losartan|losartan|mesh-list
43565584|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565585|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565586|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43565587|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43565588|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565589|NCT00887250|Losartan|losartan|mesh-list
43565590|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565591|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565592|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43565593|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43565594|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565595|NCT00886600|Losartan|losartan|mesh-list
43565596|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43565597|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565598|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565599|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43565600|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43565601|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565603|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
43565614|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43565615|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740251|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
43740252|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740253|NCT02531191|Peficitinib|peficitinib|mesh-list
43740254|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740255|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740256|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740257|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
43740258|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740259|NCT02531152|Latanoprost|latanoprost|mesh-list
43740260|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43740261|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43565616|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569484|NCT00514267|Hormones|hormones|mesh-ancestor
43565618|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565619|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565620|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43565621|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565622|NCT00882440|Losartan|losartan|mesh-list
43565623|NCT00882440|Enalapril|enalapril|mesh-list
43565624|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565625|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565626|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43565627|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43565628|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565629|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43565630|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
43565631|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565632|NCT00881452|Citric Acid|citric acid|mesh-list
43565633|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
43565634|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43565635|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
43565636|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
43565637|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565638|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
43565639|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43565640|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
43565641|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565643|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43565644|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
43565645|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43565646|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43565647|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43565648|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
43565649|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565650|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565651|NCT00880217|Methylphenidate|methylphenidate|mesh-list
43565652|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43565653|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43565654|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565655|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43565656|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43565658|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565659|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
43565660|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565661|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43565662|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
43565663|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
43565676|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43565677|NCT00872885|Narcotics|narcotics|mesh-ancestor
43835132|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43835134|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43835135|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835136|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43835137|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43835138|NCT05075993|Growth Substances|growth substances|mesh-ancestor
43835139|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
43835140|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43835141|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835142|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835143|NCT05073679|Naltrexone|naltrexone|mesh-list
43740262|NCT02530918|Ranibizumab|ranibizumab|mesh-list
43740263|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43740264|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43740265|NCT02530918|Growth Substances|growth substances|mesh-ancestor
43740266|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740267|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
43740268|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740269|NCT02530788|Selenium|selenium|mesh-list
43740270|NCT02530788|Selenious Acid|selenious acid|mesh-list
43740271|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
43740272|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
43740273|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740274|NCT02530788|Protective Agents|protective agents|mesh-ancestor
43740275|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740276|NCT02530788|Trace Elements|trace elements|mesh-ancestor
43740277|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
43740278|NCT02530801|Bevacizumab|bevacizumab|mesh-list
43740279|NCT02530801|Fluorouracil|fluorouracil|mesh-list
43740280|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43740281|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565678|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565679|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565680|NCT00872885|Analgesics|analgesics|mesh-ancestor
43565681|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
43565682|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565683|NCT00872430|Laxatives|laxatives|mesh-list
43565684|NCT00872430|Cathartics|cathartics|mesh-list
43565685|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565686|NCT00872014|Sorafenib|sorafenib|mesh-list
43740283|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43740284|NCT02530801|Growth Substances|growth substances|mesh-ancestor
43740285|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740286|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
43740287|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
43740288|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740289|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740290|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740291|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
43740292|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
43740293|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
43740294|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740295|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43740296|NCT02530879|Esomeprazole|esomeprazole|mesh-list
43740298|NCT02530879|Lansoprazole|lansoprazole|mesh-list
43740299|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
43740300|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43740301|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43740302|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43740303|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740304|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740305|NCT02530632|Propofol|propofol|mesh-list
43740306|NCT02530632|Sevoflurane|sevoflurane|mesh-list
43565687|NCT00872014|Trebananib|trebananib|mesh-list
43565688|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565689|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43565690|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565691|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565692|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43565693|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43565694|NCT00872014|Growth Substances|growth substances|mesh-ancestor
43565695|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565696|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
43565697|NCT00871936|Metformin|metformin|mesh-list
43565698|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565699|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565700|NCT00871481|Aldesleukin|aldesleukin|mesh-list
43565701|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
43565702|NCT00871481|Ipilimumab|ipilimumab|mesh-list
43565703|NCT00871481|Interleukin-2|interleukin-2|mesh-list
43565704|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43565705|NCT00871481|Antibodies|antibodies|mesh-list
43565706|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
43565707|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43565708|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43565709|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
43565710|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565711|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43565712|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43740307|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
43740308|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740309|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740310|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43740311|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43740312|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
43740313|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43740314|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43740315|NCT02530411|Fulvestrant|fulvestrant|mesh-list
43740316|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43740317|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740318|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43740319|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43740320|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
43740321|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740322|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740323|NCT02530424|Trastuzumab|trastuzumab|mesh-list
43740324|NCT02530424|Pertuzumab|pertuzumab|mesh-list
43740325|NCT02530424|Fulvestrant|fulvestrant|mesh-list
43740326|NCT02530424|Palbociclib|palbociclib|mesh-list
43740327|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43565713|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
43565714|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565715|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565716|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43565717|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43565718|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43565719|NCT00871481|Analgesics|analgesics|mesh-ancestor
43565720|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
43565721|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565722|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43565723|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43565724|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
43565725|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565726|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
43565727|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43565728|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
43565729|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565730|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565731|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43565743|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565744|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565745|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
43565746|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43565747|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565748|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43565750|NCT00870454|Analgesics|analgesics|mesh-ancestor
43565751|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
43565752|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565753|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565755|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43740328|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740329|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43740330|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43740331|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43740332|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
43740333|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740334|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740335|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43740336|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835144|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43740337|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740338|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
43740339|NCT02530502|Temozolomide|temozolomide|mesh-list
43740340|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43740341|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740342|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43740343|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
43740345|NCT02530359|Pirfenidone|pirfenidone|mesh-list
43740346|NCT02530359|Analgesics|analgesics|mesh-ancestor
43740347|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
43740348|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740349|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740350|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43740351|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740352|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740353|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740354|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740355|NCT02530320|Palbociclib|palbociclib|mesh-list
43740360|NCT02529982|Curcumin|curcumin|mesh-list
43740368|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740369|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740370|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740371|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740372|NCT02530060|Tenofovir|tenofovir|mesh-list
43740373|NCT02530060|Emtricitabine|emtricitabine|mesh-list
43740374|NCT02530060|Rilpivirine|rilpivirine|mesh-list
43740375|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
43740376|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740377|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43740378|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43740379|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740380|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740382|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43740383|NCT02530047|Interferons|interferons|mesh-list
43740384|NCT02530047|Interferon-beta|interferon-beta|mesh-list
43740385|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740386|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
43740387|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740388|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
43565756|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565757|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565758|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43565759|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43565760|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43565761|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565762|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43565763|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43565764|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
43565765|NCT00869661|Ribavirin|ribavirin|mesh-list
43565766|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
43565767|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565768|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
43565769|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565770|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
43565771|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565772|NCT00869336|Luliconazole|luliconazole|mesh-list
43565773|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
43565774|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565775|NCT00869128|Melatonin|melatonin|mesh-list
43565776|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
43565777|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565778|NCT00869128|Protective Agents|protective agents|mesh-ancestor
43565779|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565780|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565781|NCT00864175|Docetaxel|docetaxel|mesh-list
43565782|NCT00864175|Trastuzumab|trastuzumab|mesh-list
43565783|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565784|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
43565785|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
43565786|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
43565787|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565788|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43740389|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740390|NCT02529969|Curcumin|curcumin|mesh-list
43740391|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43740392|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740393|NCT02529969|Analgesics|analgesics|mesh-ancestor
43740394|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
43740395|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740396|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740397|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740398|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740399|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740400|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740401|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740402|NCT02529878|Paclitaxel|paclitaxel|mesh-list
43740403|NCT02529878|Apatinib|apatinib|mesh-list
43740404|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43740405|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740406|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
43740407|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
43740408|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
43740409|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740410|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43740412|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
43740413|NCT02529839|Fludarabine|fludarabine|mesh-list
43740414|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
43740415|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740416|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
43740417|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740418|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740419|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43740420|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
43740422|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740430|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740431|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740432|NCT02529774|Leucovorin|leucovorin|mesh-list
43740433|NCT02529774|Dexamethasone|dexamethasone|mesh-list
43740434|NCT02529774|Capecitabine|capecitabine|mesh-list
43740435|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
43740436|NCT02529774|Fluorouracil|fluorouracil|mesh-list
43740440|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740441|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
43740442|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
43740443|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740444|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740445|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43740446|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
43740447|NCT02529774|Hormones|hormones|mesh-ancestor
43740448|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740449|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43740451|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740452|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
43740453|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740454|NCT02529774|Antidotes|antidotes|mesh-ancestor
43740455|NCT02529774|Protective Agents|protective agents|mesh-ancestor
43740456|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
43565789|NCT00863369|Gemcitabine|gemcitabine|mesh-list
43565790|NCT00863369|Rituximab|rituximab|mesh-list
43565791|NCT00863369|Bortezomib|bortezomib|mesh-list
43565792|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43565793|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565794|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
43565795|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565812|NCT00862524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43565813|NCT00862524|Immunologic Factors|immunologic factors|mesh-ancestor
43565814|NCT00862524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565815|NCT00860288|Metformin|metformin|mesh-list
43565816|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43565817|NCT00860288|Vildagliptin|vildagliptin|mesh-list
43565818|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565819|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565820|NCT00860288|Incretins|incretins|mesh-ancestor
43565821|NCT00860288|Hormones|hormones|mesh-ancestor
43565822|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565823|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43565824|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
43565825|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565826|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565827|NCT00859521|Levetiracetam|levetiracetam|mesh-list
43740457|NCT02529774|Vitamins|vitamins|mesh-ancestor
43740458|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
43740459|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740460|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
43740461|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
43740462|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43740463|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43740464|NCT02529514|Baclofen|baclofen|mesh-list
43740465|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43740466|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740467|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43740468|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740469|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43740470|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
43740471|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
43740472|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740473|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740474|NCT02529579|Gemcitabine|gemcitabine|mesh-list
43740475|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740476|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
43740477|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740478|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740479|NCT02529579|Antiviral Agents|antiviral agents|mesh-ancestor
43740480|NCT02529579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740481|NCT02529579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740482|NCT02529579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740483|NCT02529579|Immunologic Factors|immunologic factors|mesh-ancestor
43565828|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
43565829|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
43565830|NCT00859430|Levetiracetam|levetiracetam|mesh-list
43565831|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
43565832|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
43565833|NCT00858871|Sorafenib|sorafenib|mesh-list
43565834|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565835|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43565836|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565837|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565839|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43565840|NCT00858702|Diuretics|diuretics|mesh-list
43565841|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565842|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43565843|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43565844|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565845|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
43565846|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565847|NCT00857285|Losartan|losartan|mesh-list
43565848|NCT00857285|Olmesartan|olmesartan|mesh-list
43740484|NCT02529579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740485|NCT02529540|Methamphetamine|methamphetamine|mesh-list
43740486|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43740487|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740488|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
43740489|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
43740490|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740491|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
43740492|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740493|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740494|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
43740495|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43740496|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43740497|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740498|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43740499|NCT02529631|Orlistat|orlistat|mesh-list
43740500|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740501|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740502|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43740503|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43740504|NCT02529670|Lidocaine|lidocaine|mesh-list
43740505|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
43565849|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43565850|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565851|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565852|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43565853|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43565854|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565855|NCT00855764|Paclitaxel|paclitaxel|mesh-list
43565866|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43565867|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565868|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565869|NCT00851045|Leucovorin|leucovorin|mesh-list
43565870|NCT00851045|Bevacizumab|bevacizumab|mesh-list
43565871|NCT00851045|Fluorouracil|fluorouracil|mesh-list
43565872|NCT00851045|Irinotecan|irinotecan|mesh-list
43565873|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43565874|NCT00851045|Calcium|calcium|mesh-list
43565875|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
43565876|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43565877|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565878|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43565879|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43565880|NCT00851045|Growth Substances|growth substances|mesh-ancestor
43565881|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565882|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
43565883|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43565884|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
43565886|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43565887|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740506|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
43740507|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740508|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740509|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
43740510|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740511|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43740512|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43740513|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43740515|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740517|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43740518|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
43740519|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43740520|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740521|NCT02529761|Sorafenib|sorafenib|mesh-list
43740522|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740523|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43740524|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740525|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740526|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
43740527|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43740528|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740529|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43740530|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740531|NCT02529124|Caseins|caseins|mesh-list
43740532|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
43740533|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
43740534|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835145|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43835146|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835147|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
43565888|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
43565889|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43565890|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43565891|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835148|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835149|NCT05072782|Methotrexate|methotrexate|mesh-list
43835150|NCT05072782|Infliximab|infliximab|mesh-list
43835151|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43835152|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
43835153|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43835154|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835155|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43835156|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
43835157|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835158|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835159|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
43835160|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835161|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43835162|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43835164|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835165|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43835166|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835168|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
43835169|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
43740536|NCT02529059|Emtricitabine|emtricitabine|mesh-list
43740537|NCT02529059|Rilpivirine|rilpivirine|mesh-list
43740538|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
43740539|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740540|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43740541|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43740542|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740543|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740544|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43740545|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43740546|NCT02529241|Delpazolid|delpazolid|mesh-list
43740547|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
43740548|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740549|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740551|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740552|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740553|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
43740554|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43740555|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740556|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740557|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740558|NCT02529202|Analgesics|analgesics|mesh-ancestor
43740559|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
43740560|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740561|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43740576|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
43740577|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43740578|NCT02528877|Tacrolimus|tacrolimus|mesh-list
43740579|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740580|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740581|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
43740582|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740592|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43740593|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
43740594|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43740595|NCT02528825|Remifentanil|remifentanil|mesh-list
43740596|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43740597|NCT02528825|Narcotics|narcotics|mesh-ancestor
43740598|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740599|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740600|NCT02528825|Analgesics|analgesics|mesh-ancestor
43740601|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
43740602|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740603|NCT02528760|Erythromycin|erythromycin|mesh-list
43740604|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
43740605|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43740606|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
43740607|NCT02528760|Metoclopramide|metoclopramide|mesh-list
43740608|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
43740609|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
43740610|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740611|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740612|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43740613|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43740614|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43740615|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
43740616|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740617|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740618|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740619|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740620|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43740621|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740624|NCT02528526|Vitamins|vitamins|mesh-ancestor
43740638|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740639|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43740640|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
43740641|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
43740642|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740643|NCT02528513|Analgesics|analgesics|mesh-ancestor
43740644|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
43740645|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740646|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43740647|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43740648|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43740649|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
43740650|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740651|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740652|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43740653|NCT02528513|Narcotics|narcotics|mesh-ancestor
43740654|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43740655|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43740656|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43740657|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43740659|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
43740660|NCT02528175|Capecitabine|capecitabine|mesh-list
43740661|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740662|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
43740663|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740664|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740665|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
43740666|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43740667|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740692|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43740693|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43740694|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43740695|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
43740696|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43740697|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43740698|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740699|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
43740700|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43740701|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43740702|NCT02528136|Oxytocin|oxytocin|mesh-list
43740703|NCT02528136|Carbetocin|carbetocin|mesh-list
43740706|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740707|NCT02528123|Tobramycin|tobramycin|mesh-list
43740708|NCT02528123|Ofloxacin|ofloxacin|mesh-list
43740709|NCT02528123|Dexamethasone|dexamethasone|mesh-list
43740710|NCT02528123|Benoxinate|benoxinate|mesh-list
43740711|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
43740712|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740729|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740730|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740731|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43740732|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43740733|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
43740734|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
43740735|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740736|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
43740737|NCT02528019|Glimepiride|glimepiride|mesh-list
43740738|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43740739|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43740740|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43740742|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740743|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
43740744|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740745|NCT02527941|Metronidazole|metronidazole|mesh-list
43740746|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740747|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740748|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43740749|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43740750|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43740751|NCT02527993|Liraglutide|liraglutide|mesh-list
43740752|NCT02527993|Acarbose|acarbose|mesh-list
43740753|NCT02527993|Verapamil|verapamil|mesh-list
43740754|NCT02527993|Pasireotide|pasireotide|mesh-list
43740755|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43740756|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740757|NCT02527993|Incretins|incretins|mesh-ancestor
43740758|NCT02527993|Hormones|hormones|mesh-ancestor
43740802|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
43740803|NCT02527824|Irinotecan|irinotecan|mesh-list
43740804|NCT02527824|Tegafur|tegafur|mesh-list
43740805|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740806|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43740807|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43740808|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740809|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740810|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740811|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
43740812|NCT02527811|Urinastatin|urinastatin|mesh-list
43740813|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
43740828|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
43740841|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43740842|NCT02527772|Antidotes|antidotes|mesh-ancestor
43740843|NCT02527772|Protective Agents|protective agents|mesh-ancestor
43740844|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
43740846|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
43835171|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835172|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
43835173|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835174|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43835175|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43835176|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43835177|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43835178|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835179|NCT05071716|Rifaximin|rifaximin|mesh-list
43835180|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43835181|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835182|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835183|NCT05070156|Vaccines|vaccines|mesh-list
43835184|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
43835188|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835189|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565892|NCT00851045|Antidotes|antidotes|mesh-ancestor
43565893|NCT00851045|Protective Agents|protective agents|mesh-ancestor
43565894|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
43565896|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
43565897|NCT00850577|Paclitaxel|paclitaxel|mesh-list
43565898|NCT00850577|Bevacizumab|bevacizumab|mesh-list
43565899|NCT00850577|Carboplatin|carboplatin|mesh-list
43565900|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43565901|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43565903|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
43565904|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
43565905|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
43704254|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847706|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847707|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
43847708|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
43847710|NCT04082897|Venetoclax|venetoclax|mesh-list
43847711|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
43847712|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847713|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847714|NCT04082767|Midazolam|midazolam|mesh-list
43847715|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
43847716|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43847717|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43847718|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847720|NCT04082767|Analgesics|analgesics|mesh-ancestor
43847721|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
43565918|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565919|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43565920|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43565922|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
43565925|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
43565926|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43565927|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43565928|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565929|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565930|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43565931|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43565933|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43565934|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
43565935|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565936|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565939|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
43565940|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43565941|NCT00845299|Latanoprost|latanoprost|mesh-list
43565942|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
43565943|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43565944|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43565945|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43565946|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565947|NCT00843687|Risperidone|risperidone|mesh-list
43565948|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43565949|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
43847722|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847735|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
43847736|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
43847737|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
43847738|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
43847739|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847740|NCT04082364|Trastuzumab|trastuzumab|mesh-list
43847741|NCT04082364|Margetuximab|margetuximab|mesh-list
43847742|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43740850|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43565950|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565951|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565952|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565953|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43565954|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43746754|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565955|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565956|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43565957|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43565958|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
43565959|NCT00841815|Amlodipine|amlodipine|mesh-list
43565960|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565961|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43565962|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565963|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565964|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43740852|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
43740853|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740854|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43740855|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43740859|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
43740860|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740861|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740862|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740863|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740864|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43740865|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740866|NCT02527577|Ropivacaine|ropivacaine|mesh-list
43740867|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
43740868|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
43740869|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740870|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740871|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
43740872|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740873|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
43740874|NCT02527213|Antidotes|antidotes|mesh-ancestor
43740875|NCT02527213|Protective Agents|protective agents|mesh-ancestor
43740876|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565977|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43565978|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43565979|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43565980|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565982|NCT00841659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43565983|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43565984|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740877|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
43740878|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740879|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
43740880|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740881|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740882|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
43740883|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
43740891|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740892|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740893|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
43740894|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740895|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43740896|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43740897|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43740898|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740900|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43740901|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740902|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740903|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43740904|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740905|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
43740906|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
43740907|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43566002|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
43740908|NCT02527096|Lamivudine|lamivudine|mesh-list
43740909|NCT02527096|Dolutegravir|dolutegravir|mesh-list
43740910|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43740911|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43740912|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740913|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740914|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
43740915|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740917|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43740918|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43740919|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43740920|NCT02527083|Ketamine|ketamine|mesh-list
43740921|NCT02527083|Remifentanil|remifentanil|mesh-list
43740922|NCT02527083|Propofol|propofol|mesh-list
43740923|NCT02527083|Sevoflurane|sevoflurane|mesh-list
43740924|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43740925|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740926|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566003|NCT00840879|Meloxicam|meloxicam|mesh-list
43566004|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43566005|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43566007|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
43566008|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566009|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566010|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43566015|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566016|NCT00840866|Cefprozil|cefprozil|mesh-list
43566017|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566018|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566019|NCT00840840|Amoxicillin|amoxicillin|mesh-list
43566020|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
43566021|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
43566022|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43566023|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566024|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566025|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43566026|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566027|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566028|NCT00840632|Trandolapril|trandolapril|mesh-list
43566029|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566030|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566031|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566032|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566033|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566034|NCT00840476|Meloxicam|meloxicam|mesh-list
43566035|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43566036|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43566037|NCT00840476|Analgesics|analgesics|mesh-ancestor
43566038|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
43566039|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740927|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43740928|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
43740929|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
43740938|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43740939|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43740940|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43740941|NCT02527083|Narcotics|narcotics|mesh-ancestor
43740942|NCT02526888|Diltiazem|diltiazem|mesh-list
43740943|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43740944|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43740945|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43740946|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740947|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43740948|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566040|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566041|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43566042|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43566043|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43566044|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43566045|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566046|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566047|NCT00840411|Clarithromycin|clarithromycin|mesh-list
43566048|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566049|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566050|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43566051|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566052|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566061|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43566062|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566063|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746757|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43566064|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43566065|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43566066|NCT00840203|Mesalamine|mesalamine|mesh-list
43566067|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43566068|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43566069|NCT00840203|Analgesics|analgesics|mesh-ancestor
43566070|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
43566071|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566072|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740949|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
43740950|NCT02526914|Vasopressins|vasopressins|mesh-list
43740951|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
43740952|NCT02526914|Oxytocin|oxytocin|mesh-list
43740953|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
43740954|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43740955|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740957|NCT02526914|Coagulants|coagulants|mesh-ancestor
43740958|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43740959|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43740960|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
43740961|NCT02527005|Azithromycin|azithromycin|mesh-list
43740962|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
43740963|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
43740964|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43740965|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740966|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740967|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
43740968|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43740969|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43740970|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43740971|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740972|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740973|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43740974|NCT02527005|Renal Agents|renal agents|mesh-ancestor
43740975|NCT02526953|Paclitaxel|paclitaxel|mesh-list
43740976|NCT02526953|Capecitabine|capecitabine|mesh-list
43740977|NCT02526953|Mitomycins|mitomycins|mesh-list
43740978|NCT02526953|Mitomycin|mitomycin|mesh-list
43740986|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
43740997|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740998|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740999|NCT02526979|Urological Agents|urological agents|mesh-ancestor
43741000|NCT02526875|Amlodipine|amlodipine|mesh-list
43741006|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43741007|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741008|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
43741009|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43741010|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43741012|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43741013|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
43741014|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
43741015|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43746758|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43569490|NCT00511459|Trebananib|trebananib|mesh-list
43569491|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43569492|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569493|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
43569494|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
43569495|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
43829653|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741016|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741017|NCT02526758|Budesonide|budesonide|mesh-list
43741018|NCT02526758|Beclomethasone|beclomethasone|mesh-list
43741019|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
43741020|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741021|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43741022|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
43741023|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741024|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741025|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43741026|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
43741027|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
43741028|NCT02526758|Hormones|hormones|mesh-ancestor
43741029|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741036|NCT02526615|Metformin|metformin|mesh-list
43741051|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43741052|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741053|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
43741054|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43741055|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43741056|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741057|NCT02526394|Vaccines|vaccines|mesh-list
43741058|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
43741059|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741060|NCT02525991|Loxapine|loxapine|mesh-list
43741061|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43741062|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43741063|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741064|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741065|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43741066|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43741067|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
43741068|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566073|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43566074|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43566075|NCT00840099|Amoxicillin|amoxicillin|mesh-list
43566076|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
43566077|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
43566078|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43566079|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566080|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566081|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43566082|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566083|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566084|NCT00840073|Trandolapril|trandolapril|mesh-list
43741069|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741071|NCT02526199|Epinephrine|epinephrine|mesh-list
43741081|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741083|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741084|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
43741085|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
43741086|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741087|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
43741088|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43741089|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43741090|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
43741091|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741092|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741093|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43741094|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43741112|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741113|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43741114|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43741115|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
43741116|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43741117|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43741118|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43741119|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43835190|NCT05069350|Bupivacaine|bupivacaine|mesh-list
43835191|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
43835192|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
43835193|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608685|NCT03194815|Rituximab|rituximab|mesh-list
43835194|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835195|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
43835196|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835206|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
43835207|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
43835208|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835209|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835211|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
43835217|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43835218|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43835219|NCT05066607|Growth Substances|growth substances|mesh-ancestor
43835220|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
43835221|NCT05066308|Cannabidiol|cannabidiol|mesh-list
43835222|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
43835223|NCT05065918|Ethanol|ethanol|mesh-list
43835224|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43835225|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835226|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835227|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835231|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835233|NCT05065216|Coagulants|coagulants|mesh-ancestor
43835234|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
43835235|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
43835236|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43835237|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835238|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
43835239|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43835240|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
43835241|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835242|NCT05063786|Capecitabine|capecitabine|mesh-list
43835243|NCT05063786|Trastuzumab|trastuzumab|mesh-list
43835244|NCT05063786|Vinorelbine|vinorelbine|mesh-list
43835245|NCT05063786|Fulvestrant|fulvestrant|mesh-list
43835246|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43835247|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
43835248|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569496|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569500|NCT00511459|Growth Substances|growth substances|mesh-ancestor
43835249|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741121|NCT02525848|Gabapentin|gabapentin|mesh-list
43741122|NCT02525848|Aprepitant|aprepitant|mesh-list
43741123|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741130|NCT02525848|Hormones|hormones|mesh-ancestor
43741131|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741132|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43741133|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741134|NCT02525848|Analgesics|analgesics|mesh-ancestor
43741135|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
43741136|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
43741137|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43741138|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43741139|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741140|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43741141|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43741142|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43741143|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741144|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741145|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
43741146|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43741147|NCT02525822|Tazarotene|tazarotene|mesh-list
43741148|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
43741149|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
43741150|NCT02525484|Pirfenidone|pirfenidone|mesh-list
43741151|NCT02525484|Analgesics|analgesics|mesh-ancestor
43741152|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
43741188|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741189|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
43741190|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741191|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43741192|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741193|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43741194|NCT02525250|Lenalidomide|lenalidomide|mesh-list
43741195|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
43741197|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43569539|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741198|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43741199|NCT02525250|Growth Substances|growth substances|mesh-ancestor
43741200|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
43741228|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741229|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43741230|NCT02525016|Lidocaine|lidocaine|mesh-list
43741232|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
43741233|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741234|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741235|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
43741236|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741237|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43741238|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43741239|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43741240|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43741241|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741242|NCT02525003|Vitamin D|vitamin d|mesh-list
43741243|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
43741244|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
43741245|NCT02525003|Vitamins|vitamins|mesh-list
43741246|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
43741247|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741248|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43741266|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43741291|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43741293|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43741294|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569564|NCT00498836|Sorafenib|sorafenib|mesh-list
43741295|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43741297|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
43741298|NCT02524652|Ropivacaine|ropivacaine|mesh-list
43741299|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
43741300|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
43741301|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741302|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741303|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
43741304|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741305|NCT02524639|Sirolimus|sirolimus|mesh-list
43741306|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43741307|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741308|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43741309|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741310|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
43741311|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741312|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
43741313|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741314|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
43741315|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
43741316|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43741317|NCT02524444|Mefloquine|mefloquine|mesh-list
43746833|NCT02521714|Lenalidomide|lenalidomide|mesh-list
43741318|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
43741319|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43741320|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43741321|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741322|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43741323|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543943|NCT03689114|Topiramate|topiramate|mesh-list
43741324|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741330|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
43741331|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741333|NCT02524210|Rabeprazole|rabeprazole|mesh-list
43741334|NCT02524210|Dabigatran|dabigatran|mesh-list
43746848|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
43746849|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746850|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746851|NCT02521441|Lenograstim|lenograstim|mesh-list
43746852|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43746853|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
43746854|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746855|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43746856|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746857|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43746859|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43746861|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
43746862|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43746863|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
43746864|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43746865|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
43741335|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43741336|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43741337|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43741338|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741341|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43741342|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
43835251|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43835252|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
43835253|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
43835254|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
43566085|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566086|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566087|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566088|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566089|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566091|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43566092|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
43566093|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566094|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566095|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43566096|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
43566097|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43566098|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43566099|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566100|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43566101|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
43566102|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43566103|NCT00839930|Protective Agents|protective agents|mesh-ancestor
43566104|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43566105|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43566106|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566108|NCT00838799|Analgesics|analgesics|mesh-ancestor
43566109|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
43566111|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566113|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43566114|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566115|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566116|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566117|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43566144|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566145|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43566146|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43835255|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43835256|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43835257|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43835258|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
43835259|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835260|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835261|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
43835262|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43835263|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
43835264|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835265|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43835266|NCT05063201|Cariprazine|cariprazine|mesh-list
43835267|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43835268|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566147|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569738|NCT00481325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43566148|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566149|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43566151|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
43566152|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43566153|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566154|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566155|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566156|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566157|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43566158|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566159|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566160|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566161|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43566162|NCT00836901|Amoxicillin|amoxicillin|mesh-list
43566182|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566183|NCT00836069|Paroxetine|paroxetine|mesh-list
43566184|NCT00836069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43566185|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43566186|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566187|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566188|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566189|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
43566190|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566191|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43566192|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
43566193|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566194|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43566195|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43566196|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566197|NCT00836056|Clindamycin|clindamycin|mesh-list
43835269|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835270|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835271|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43835273|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
43835274|NCT05062980|Ramucirumab|ramucirumab|mesh-list
43835275|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835276|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
43835277|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
43835278|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
43835279|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835280|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835281|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
43835282|NCT05062954|Procyanidin|procyanidin|mesh-list
43835283|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
43835284|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835285|NCT05062954|Protective Agents|protective agents|mesh-ancestor
43835286|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835287|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43835288|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43835289|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566200|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566201|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566202|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43566203|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569752|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43569753|NCT00480831|Growth Substances|growth substances|mesh-ancestor
43566204|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566205|NCT00836004|Clindamycin|clindamycin|mesh-list
43566206|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
43566207|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
43566208|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566209|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566210|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43566211|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566212|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566214|NCT00835991|Glyburide|glyburide|mesh-list
43566215|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566216|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566217|NCT00835796|Finasteride|finasteride|mesh-list
43566218|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43566219|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43566220|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566221|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566222|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
43566223|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43566224|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566225|NCT00835796|Urological Agents|urological agents|mesh-ancestor
43566226|NCT00835705|Amoxicillin|amoxicillin|mesh-list
43566227|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43566231|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566232|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43566233|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566234|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835290|NCT05062889|Leucovorin|leucovorin|mesh-list
43835291|NCT05062889|Trifluridine|trifluridine|mesh-list
43835292|NCT05062889|Fluorouracil|fluorouracil|mesh-list
43835293|NCT05062889|Capecitabine|capecitabine|mesh-list
43835294|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
43835298|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835299|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43835300|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835301|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43835302|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
43835303|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835304|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43835305|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43741344|NCT05671562|Lycopene|lycopene|mesh-list
43741345|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741346|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
43741347|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741348|NCT05671562|Protective Agents|protective agents|mesh-ancestor
43741349|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741350|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43741351|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43741352|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741353|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
43741354|NCT05671497|Cilostazol|cilostazol|mesh-list
43569779|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
43569780|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569781|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569782|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43549896|NCT03628430|Lidocaine|lidocaine|mesh-list
43746869|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43746870|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
43746871|NCT02521298|Hormones|hormones|mesh-ancestor
43569787|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
43741377|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
43741390|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43741391|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43741392|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
43741393|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741394|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43741395|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
43741396|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43741397|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
43741398|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
43741399|NCT05671172|Bupivacaine|bupivacaine|mesh-list
43741400|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
43741404|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
43741405|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741406|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
43741408|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43741409|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43741410|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741413|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741414|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741415|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741416|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43741417|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
43741418|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43741419|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741420|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43741421|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43741422|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43741423|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
43741424|NCT05670886|Carbetocin|carbetocin|mesh-list
43741425|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
43741426|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43741427|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741428|NCT05670808|Epinephrine|epinephrine|mesh-list
43741429|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43741430|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43741431|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
43741432|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741433|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741434|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741435|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43741436|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43741444|NCT05670795|Clomiphene|clomiphene|mesh-list
43741450|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569790|NCT00468403|Basiliximab|basiliximab|mesh-list
43569792|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
43741451|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741452|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43741453|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
43741454|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43741455|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43741456|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43741457|NCT05670743|Fluorides|fluorides|mesh-list
43741458|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
43741459|NCT05670743|Protective Agents|protective agents|mesh-ancestor
43741460|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741461|NCT05670678|Lactoferrin|lactoferrin|mesh-list
43741462|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741463|NCT05670561|Sufentanil|sufentanil|mesh-list
43741464|NCT05670561|Esketamine|esketamine|mesh-list
43741465|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43741466|NCT05670561|Narcotics|narcotics|mesh-ancestor
43741467|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741468|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741469|NCT05670561|Analgesics|analgesics|mesh-ancestor
43741517|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43741518|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43741519|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741520|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741521|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741525|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
43835307|NCT05062889|Antidotes|antidotes|mesh-ancestor
43835308|NCT05062889|Protective Agents|protective agents|mesh-ancestor
43835309|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
43835310|NCT05062889|Vitamins|vitamins|mesh-ancestor
43835311|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
43835312|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
43835313|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835314|NCT05062837|Apatinib|apatinib|mesh-list
43835315|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835316|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43835317|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835318|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835319|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43835320|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43835321|NCT05060913|Lidocaine|lidocaine|mesh-list
43835322|NCT05060913|Prilocaine|prilocaine|mesh-list
43835323|NCT05060913|Benzocaine|benzocaine|mesh-list
43835324|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43835325|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
43835326|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
43835327|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835328|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835329|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
43835330|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835331|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43569820|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569821|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569822|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569823|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835332|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43835333|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43835334|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43835335|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566240|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566241|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43566242|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43566244|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43566245|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43566246|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566247|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566248|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
43835336|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43835337|NCT05060744|Antacids|antacids|mesh-list
43835338|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
43835339|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835340|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835341|NCT05060627|Dexamethasone|dexamethasone|mesh-list
43835342|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835343|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
43835344|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
43835345|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835346|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835347|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835348|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
43835349|NCT05060627|Hormones|hormones|mesh-ancestor
43835350|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835351|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43835352|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835353|NCT05059600|Pregnanolone|pregnanolone|mesh-list
43835354|NCT05059600|Brexanolone|brexanolone|mesh-list
43835355|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
43835356|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835357|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835358|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
43566250|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566251|NCT00835666|Urological Agents|urological agents|mesh-ancestor
43566252|NCT00835640|Fexofenadine|fexofenadine|mesh-list
43741545|NCT05669989|Hormones|hormones|mesh-ancestor
43741546|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741547|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43741548|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741549|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
43741550|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43741551|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43741552|NCT05669989|Growth Substances|growth substances|mesh-ancestor
43741553|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
43741554|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43741555|NCT05669963|Lactoferrin|lactoferrin|mesh-list
43741556|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746879|NCT02521246|Candesartan|candesartan|mesh-list
43741557|NCT05669924|Methylphenidate|methylphenidate|mesh-list
43741558|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43741559|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741560|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43741561|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43741562|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43741563|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741564|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
43741565|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741566|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
43544317|NCT03684707|Metformin|metformin|mesh-list
43741567|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
43741568|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43741569|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43741570|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741571|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741572|NCT05669885|Urological Agents|urological agents|mesh-ancestor
43741573|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
43566253|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43566254|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43741574|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43741575|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741577|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43741578|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741579|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741580|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
43741581|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741582|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
43741583|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
43741584|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43569861|NCT00465803|Timolol|timolol|mesh-list
43569862|NCT00465803|Travoprost|travoprost|mesh-list
43569863|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43569864|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43741585|NCT05669807|Paclitaxel|paclitaxel|mesh-list
43741586|NCT05669807|Irinotecan|irinotecan|mesh-list
43741587|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43741588|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43741589|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741590|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
43741591|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
43741592|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
43741593|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741594|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43741595|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43741596|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741597|NCT05669781|Metoclopramide|metoclopramide|mesh-list
43741598|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
43741599|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
43741600|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741601|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741602|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43741603|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43566255|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43566256|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
43566258|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741609|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43741610|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
43741611|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741612|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741613|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43741614|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741615|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43741616|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43741617|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43741619|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43741620|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741621|NCT05669547|Hormones|hormones|mesh-list
43741622|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741623|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741625|NCT05669482|Paclitaxel|paclitaxel|mesh-list
43741626|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43741627|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741628|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
43741629|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
43741630|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
43741631|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741632|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43741633|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
43741634|NCT05669482|Antiviral Agents|antiviral agents|mesh-ancestor
43741635|NCT05669482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741636|NCT05669482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741637|NCT05669482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741638|NCT05669482|Immunologic Factors|immunologic factors|mesh-ancestor
43544351|NCT03683277|Ixazomib|ixazomib|mesh-list
43746897|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43746898|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43746899|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43569907|NCT00464555|Analgesics|analgesics|mesh-ancestor
43741640|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
43741641|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43741642|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
43566259|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566260|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741643|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43741644|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
43569921|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569922|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569923|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569924|NCT00463242|S 20098|s 20098|mesh-list
43741645|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43741646|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
43741647|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741648|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741649|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
43741650|NCT05668663|Ascorbic Acid|ascorbic acid|mesh-list
43741651|NCT05668663|Vitamins|vitamins|mesh-ancestor
43741652|NCT05668663|Micronutrients|micronutrients|mesh-ancestor
43741653|NCT05668663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741654|NCT05668663|Antioxidants|antioxidants|mesh-ancestor
43741655|NCT05668663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741656|NCT05668663|Protective Agents|protective agents|mesh-ancestor
43741657|NCT05668572|Vaccines|vaccines|mesh-list
43741658|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
43741659|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569925|NCT00463242|Paroxetine|paroxetine|mesh-list
43569926|NCT00463242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43569927|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43569928|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569929|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569930|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569931|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
43741660|NCT05667818|Norfloxacin|norfloxacin|mesh-list
43741661|NCT05667818|Amlodipine|amlodipine|mesh-list
43741662|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43741663|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43741664|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43741665|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741666|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43741667|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741668|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
43741669|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43741670|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741671|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43741672|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43741673|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741674|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741675|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43741676|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43741684|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43741685|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43741686|NCT05667376|Analgesics|analgesics|mesh-ancestor
43741695|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43741696|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43741735|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43741736|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
43741737|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741738|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741739|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43569948|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43569949|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569950|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569959|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43569960|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569961|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
43569964|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569965|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43569966|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569968|NCT00459745|Pravastatin|pravastatin|mesh-list
43569969|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43569970|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
43569971|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569972|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43569973|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43569974|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43569975|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569976|NCT00459277|Fentanyl|fentanyl|mesh-list
43569977|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43569978|NCT00459277|Narcotics|narcotics|mesh-ancestor
43569979|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741740|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43741741|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
43741742|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
43741743|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741744|NCT05664737|Luspatercept|luspatercept|mesh-list
43741745|NCT05664737|Hematinics|hematinics|mesh-ancestor
43741746|NCT05661149|Insulin|insulin|mesh-list
43741747|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43741748|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741749|NCT05655806|Aminophylline|aminophylline|mesh-list
43741751|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
43741782|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741783|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43741784|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43741793|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
43741794|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43741795|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741796|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43741797|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43741798|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43741799|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741800|NCT05647447|SR 142801|sr 142801|mesh-list
43741801|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43741802|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43544516|NCT03680976|CXA-10|cxa-10|mesh-list
43544518|NCT03680885|Lidocaine|lidocaine|mesh-list
43741803|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741804|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741805|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43741814|NCT05644223|Edaravone|edaravone|mesh-list
43741815|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43741816|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
43741817|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835380|NCT05058976|Vitamins|vitamins|mesh-ancestor
43835381|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
43835382|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835383|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43835384|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43835385|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
43835386|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43835387|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835388|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43835389|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835390|NCT05058443|Denosumab|denosumab|mesh-list
43835391|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43835392|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835393|NCT05057819|Empagliflozin|empagliflozin|mesh-list
43569980|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569981|NCT00459277|Analgesics|analgesics|mesh-ancestor
43569982|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
43569984|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43835394|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43835402|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835403|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43835404|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43741821|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43741822|NCT05635786|Tenecteplase|tenecteplase|mesh-list
43741823|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43741824|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43741825|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741826|NCT05634369|Gemcitabine|gemcitabine|mesh-list
43741827|NCT05634369|Dexamethasone|dexamethasone|mesh-list
43741828|NCT05634369|Docetaxel|docetaxel|mesh-list
43741829|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741830|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
43741831|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
43741832|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741833|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741834|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43741835|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
43741836|NCT05634369|Hormones|hormones|mesh-ancestor
43741837|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741838|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43741840|NCT05634369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741841|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741842|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43741843|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
43566262|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566263|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746918|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746919|NCT02521051|Bevacizumab|bevacizumab|mesh-list
43746920|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43566264|NCT00835588|Pantoprazole|pantoprazole|mesh-list
43566265|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43566266|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43566267|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43566268|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566269|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566270|NCT00835575|Mirtazapine|mirtazapine|mesh-list
43566271|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
43741849|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
43741850|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
43741851|NCT05630794|TIC10 compound|tic10 compound|mesh-list
43741852|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741853|NCT05594095|Everolimus|everolimus|mesh-list
43741854|NCT05594095|Fulvestrant|fulvestrant|mesh-list
43741855|NCT05594095|Goserelin|goserelin|mesh-list
43741856|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43741857|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741858|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741859|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
43741860|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741861|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43741862|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43741863|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43741864|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
43741865|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741866|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43741867|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741868|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741869|NCT05591677|Cycloserine|cycloserine|mesh-list
43570042|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570043|NCT00450970|Satraplatin|satraplatin|mesh-list
43570045|NCT00449605|Metformin|metformin|mesh-list
43741870|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43741871|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741872|NCT05591677|Renal Agents|renal agents|mesh-ancestor
43741873|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43741874|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
43741875|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43741876|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
43741877|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741878|NCT05589688|Acyclovir|acyclovir|mesh-list
43741894|NCT05581901|Analgesics|analgesics|mesh-ancestor
43741895|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
43544671|NCT03679390|Ketamine|ketamine|mesh-list
43741896|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741897|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
43741898|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
43741899|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
43741900|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
43741901|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741902|NCT05571748|Protective Agents|protective agents|mesh-ancestor
43741903|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741904|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
43741905|NCT05571748|Vitamins|vitamins|mesh-ancestor
43741906|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
43741907|NCT05567952|Ritonavir|ritonavir|mesh-list
43741908|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43741927|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
43741928|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43741929|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741930|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43741931|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43741932|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741933|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741934|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741935|NCT05562947|Ranibizumab|ranibizumab|mesh-list
43741936|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43741937|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43741938|NCT05562947|Growth Substances|growth substances|mesh-ancestor
43741939|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741940|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
43741941|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741942|NCT05550142|Vaccines|vaccines|mesh-list
43741943|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
43741944|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570056|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741945|NCT05547256|Vaccines|vaccines|mesh-list
43741969|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570058|NCT00449605|Hormones|hormones|mesh-ancestor
43741970|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43746947|NCT02521038|Ticagrelor|ticagrelor|mesh-list
43741971|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43741973|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741974|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43741975|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43741976|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741977|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43741978|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
43741979|NCT05494866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741980|NCT05494866|Immunologic Factors|immunologic factors|mesh-ancestor
43741981|NCT05494866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741982|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
43741983|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
43741984|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741985|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
43741986|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741987|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741988|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
43741989|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43741990|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741991|NCT05487040|Ritonavir|ritonavir|mesh-list
43741992|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43741993|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43741994|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
43741995|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566284|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43566285|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
43566286|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43566287|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43566288|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
43566289|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43566290|NCT00835549|Cefdinir|cefdinir|mesh-list
43566291|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566292|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566293|NCT00835536|Ribavirin|ribavirin|mesh-list
43566294|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
43566295|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566296|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
43566297|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746965|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746966|NCT02521012|Vitamin D|vitamin d|mesh-list
43746967|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
43746968|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
43746969|NCT02521012|Vitamins|vitamins|mesh-list
43746970|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
43570062|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570063|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43570064|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43570065|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570066|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570067|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570068|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43570069|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43570070|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43570071|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566298|NCT00835497|Metformin|metformin|mesh-list
43566299|NCT00835497|Glipizide|glipizide|mesh-list
43566307|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566308|NCT00835367|Amlodipine|amlodipine|mesh-list
43566309|NCT00835367|Benazepril|benazepril|mesh-list
43741996|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741997|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43742005|NCT05477108|Charcoal|charcoal|mesh-list
43742006|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43742007|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43742008|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
43742009|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742010|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742011|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43742012|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
43742013|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
43742014|NCT05477108|Hormones|hormones|mesh-ancestor
43742015|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43742016|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43742017|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43742018|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43742019|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
43742020|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742021|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742022|NCT05477108|Antidotes|antidotes|mesh-ancestor
43742023|NCT05477108|Protective Agents|protective agents|mesh-ancestor
43835418|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43835419|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835420|NCT05055323|Pyrvinium|pyrvinium|mesh-list
43835421|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
43835422|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43835423|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835424|NCT05054881|Iodine|iodine|mesh-list
43835425|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43835426|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835427|NCT05054881|Trace Elements|trace elements|mesh-ancestor
43835428|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
43835429|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835430|NCT05054374|Fulvestrant|fulvestrant|mesh-list
43835431|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43835432|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835433|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43835434|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43835435|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
43835436|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835437|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835438|NCT05054361|Mannitol|mannitol|mesh-list
43835439|NCT05054361|Lactulose|lactulose|mesh-list
43835440|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43835441|NCT05054361|Diuretics|diuretics|mesh-ancestor
43835442|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
43550031|NCT03626506|Diuretics|diuretics|mesh-ancestor
43746971|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746972|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43746973|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43746974|NCT02520635|Temozolomide|temozolomide|mesh-list
43746975|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43746976|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
43746977|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746979|NCT02520752|Midazolam|midazolam|mesh-list
43835443|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835444|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835445|NCT05053854|Talazoparib|talazoparib|mesh-list
43835446|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43835447|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566310|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566311|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43566312|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566313|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566314|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566315|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566317|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566318|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566319|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566320|NCT00835354|Cefprozil|cefprozil|mesh-list
43566321|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566322|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566323|NCT00835276|Fexofenadine|fexofenadine|mesh-list
43566324|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43835448|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835449|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835450|NCT05053750|Paclitaxel|paclitaxel|mesh-list
43835451|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43835452|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43835453|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835454|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
43835455|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
43835456|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
43742031|NCT05472675|Bupivacaine|bupivacaine|mesh-list
43742032|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
43742033|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
43742034|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
43742035|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742036|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742037|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
43742069|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43742070|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43742071|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
43742072|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742073|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742074|NCT05445895|Clopidogrel|clopidogrel|mesh-list
43742075|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43742076|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43742077|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43742078|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43742079|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
43742080|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742081|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742083|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
43742092|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742093|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43742095|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43742096|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
43742097|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746980|NCT02520752|Caffeine|caffeine|mesh-list
43746981|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43742098|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742099|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43742100|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
43742101|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742102|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742103|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43742113|NCT05427162|Epoprostenol|epoprostenol|mesh-list
43742114|NCT05427162|Tezosentan|tezosentan|mesh-list
43742115|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566339|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43566340|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566341|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566342|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566343|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43566344|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43566345|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
43566346|NCT00835211|Coagulants|coagulants|mesh-ancestor
43566347|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43566348|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
43566349|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566350|NCT00835172|Glimepiride|glimepiride|mesh-list
43566351|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43566352|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566353|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566354|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43566355|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
43566356|NCT00835146|Ribavirin|ribavirin|mesh-list
43566357|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
43566358|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570084|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
43566359|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
43566360|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566361|NCT00835081|Cefadroxil|cefadroxil|mesh-list
43566362|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566363|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566364|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43566365|NCT00835042|Moexipril|moexipril|mesh-list
43566366|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43742116|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43742119|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43742120|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742121|NCT05415917|Gemcitabine|gemcitabine|mesh-list
43742122|NCT05415917|Capecitabine|capecitabine|mesh-list
43742123|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43742124|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
43742125|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742126|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742127|NCT05415917|Antiviral Agents|antiviral agents|mesh-ancestor
43742128|NCT05415917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742129|NCT05415917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742130|NCT05415917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43742131|NCT05415917|Immunologic Factors|immunologic factors|mesh-ancestor
43742132|NCT05415917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742133|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
43742134|NCT05412888|Ubiquinone|ubiquinone|mesh-list
43742135|NCT05412888|Vitamins|vitamins|mesh-ancestor
43742136|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
43742137|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742138|NCT05403450|Decitabine|decitabine|mesh-list
43742139|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43742140|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
43742141|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742142|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566367|NCT00835042|Diuretics|diuretics|mesh-ancestor
43566368|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
43566372|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566374|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
43746999|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43747000|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
43566375|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566376|NCT00834990|Valproic Acid|valproic acid|mesh-list
43566377|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
43566378|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566379|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566380|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
43566381|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566382|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566383|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
43566384|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566385|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566386|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566387|NCT00834977|Amlodipine|amlodipine|mesh-list
43566388|NCT00834977|Benazepril|benazepril|mesh-list
43566389|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566390|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43566391|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566392|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742143|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742144|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
43742145|NCT05393245|Olodaterol|olodaterol|mesh-list
43742146|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
43742147|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
43742148|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43742149|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
43742150|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742151|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742152|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43742153|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
43742154|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
43742155|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43742156|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742157|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742158|NCT05376319|Rituximab|rituximab|mesh-list
43742159|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
43742160|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742161|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742162|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
43742163|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742164|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742165|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
43742166|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43742167|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
43742168|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43742169|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43742170|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742171|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43566394|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566395|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
43566396|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566397|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566398|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566399|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43566400|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43566401|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43566402|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566403|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566405|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742172|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742173|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43742174|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742176|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742177|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43742178|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43742179|NCT05366816|Growth Substances|growth substances|mesh-ancestor
43742180|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742181|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
43742182|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43742183|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742184|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742185|NCT05359731|Dexamethasone|dexamethasone|mesh-list
43742186|NCT05359731|Bupivacaine|bupivacaine|mesh-list
43742187|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43742188|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
43742189|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
43742190|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742191|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742192|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43742193|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
43742194|NCT05359731|Hormones|hormones|mesh-ancestor
43742195|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43742196|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43742197|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742198|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
43742199|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
43742200|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742201|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
43742237|NCT05324358|Morphine|morphine|mesh-list
43742238|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43742239|NCT05324358|Narcotics|narcotics|mesh-ancestor
43742240|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742241|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742242|NCT05324358|Analgesics|analgesics|mesh-ancestor
43742243|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
43742246|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43742258|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742260|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
43742261|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
43742262|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742263|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742264|NCT05307705|Paclitaxel|paclitaxel|mesh-list
43742265|NCT05307705|Letrozole|letrozole|mesh-list
43742266|NCT05307705|Fulvestrant|fulvestrant|mesh-list
43742267|NCT05307705|Anastrozole|anastrozole|mesh-list
43742268|NCT05307705|Exemestane|exemestane|mesh-list
43566406|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43566407|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
43742269|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43742270|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742271|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
43742272|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
43742273|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
43742274|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742283|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43742284|NCT05305495|Empagliflozin|empagliflozin|mesh-list
43742285|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43742286|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742287|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43742288|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742289|NCT05302466|Silicon|silicon|mesh-list
43742290|NCT05302466|Trace Elements|trace elements|mesh-ancestor
43742291|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
43742292|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742293|NCT05301842|Durvalumab|durvalumab|mesh-list
43742294|NCT05301842|Lenvatinib|lenvatinib|mesh-list
43742295|NCT05301842|Tremelimumab|tremelimumab|mesh-list
43742296|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742297|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742298|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43742299|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566408|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566410|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43566411|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43566412|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
43566413|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566414|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742304|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43742305|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742307|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43742308|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742309|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43742310|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43742311|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742312|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742313|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742314|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43742315|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43742316|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742317|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
43742318|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
43742319|NCT05279898|Ketamine|ketamine|mesh-list
43742320|NCT05279898|Remifentanil|remifentanil|mesh-list
43742321|NCT05279898|Propofol|propofol|mesh-list
43742322|NCT05279898|Ropivacaine|ropivacaine|mesh-list
43742323|NCT05279898|Rocuronium|rocuronium|mesh-list
43570182|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570183|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43742324|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43742325|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742326|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742327|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43742328|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
43742329|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
43742330|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43742331|NCT05279898|Analgesics|analgesics|mesh-ancestor
43742332|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
43742333|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742340|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43742341|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43742342|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43742343|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
43747104|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43747105|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742344|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43742345|NCT05279898|Narcotics|narcotics|mesh-ancestor
43742346|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43742347|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43742348|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43835457|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835458|NCT05052931|Paclitaxel|paclitaxel|mesh-list
43835459|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
43835460|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43835461|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835462|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
43835463|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
43835464|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
43835465|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835466|NCT05050981|Hormones|hormones|mesh-list
43835467|NCT05050981|Serotonin|serotonin|mesh-list
43835468|NCT05050981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43835469|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835470|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835471|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43835472|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
43835473|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835474|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835475|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43835476|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43835477|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
43566420|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566421|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566422|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
43566423|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43566424|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43566425|NCT00834795|Carvedilol|carvedilol|mesh-list
43566426|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43566427|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43566428|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
43566429|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566430|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835478|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835479|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835480|NCT05048849|Somatomedin B|somatomedin b|mesh-list
43835481|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43835482|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43835483|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
43835484|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835485|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835486|NCT05048589|Vaccines|vaccines|mesh-list
43835487|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
43835488|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835492|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43835493|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
43835494|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835495|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835496|NCT05048524|Antiviral Agents|antiviral agents|mesh-ancestor
43835497|NCT05048524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835498|NCT05048524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835499|NCT05048524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43835500|NCT05048524|Immunologic Factors|immunologic factors|mesh-ancestor
43835501|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835502|NCT05048524|Antidotes|antidotes|mesh-ancestor
43835503|NCT05048524|Protective Agents|protective agents|mesh-ancestor
43570187|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
43570188|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43570189|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43835504|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
43835505|NCT05048524|Vitamins|vitamins|mesh-ancestor
43835506|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
43835507|NCT05048212|Nivolumab|nivolumab|mesh-list
43835508|NCT05048212|Ipilimumab|ipilimumab|mesh-list
43835509|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742356|NCT05257447|Baclofen|baclofen|mesh-list
43742357|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
43742358|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43742359|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742360|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43742361|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742362|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43742363|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
43742364|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
43742365|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570197|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43742366|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742369|NCT05249712|Androgens|androgens|mesh-list
43742370|NCT05249712|Hormones|hormones|mesh-ancestor
43742371|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43742372|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742373|NCT05230810|Fulvestrant|fulvestrant|mesh-list
43742374|NCT05230810|Tucatinib|tucatinib|mesh-list
43742375|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43742376|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742377|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43742378|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43742379|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
43742380|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43742381|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742382|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43742383|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742384|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747156|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43742385|NCT05223335|Clopidogrel|clopidogrel|mesh-list
43742386|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43566431|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566432|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566433|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
43566434|NCT00834795|Protective Agents|protective agents|mesh-ancestor
43566435|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43742393|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742394|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742395|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
43742396|NCT05217446|Cetuximab|cetuximab|mesh-list
43742397|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742398|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742399|NCT05211323|Gemcitabine|gemcitabine|mesh-list
43742400|NCT05211323|Bevacizumab|bevacizumab|mesh-list
43742401|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43742402|NCT05211323|Cisplatin|cisplatin|mesh-list
43742403|NCT05211323|Atezolizumab|atezolizumab|mesh-list
43742404|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
43742405|NCT05211323|Antibodies|antibodies|mesh-list
43742406|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
43742407|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43742408|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
43742409|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742410|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43742411|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43742412|NCT05211323|Growth Substances|growth substances|mesh-ancestor
43742413|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742414|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
43742415|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
43742416|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43742417|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
43742418|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742419|NCT05211323|Antiviral Agents|antiviral agents|mesh-ancestor
43835835|NCT05020522|Phenobarbital|phenobarbital|mesh-list
43835836|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
43835837|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43835838|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835839|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835840|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43835841|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43835842|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835847|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43742420|NCT05211323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742421|NCT05211323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742423|NCT05201248|Prednisone|prednisone|mesh-list
43742426|NCT05201248|Doxorubicin|doxorubicin|mesh-list
43742427|NCT05201248|Vincristine|vincristine|mesh-list
43742428|NCT05201248|Lenalidomide|lenalidomide|mesh-list
43742429|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43742440|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43742441|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43742443|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43742445|NCT05201248|Hormones|hormones|mesh-ancestor
43742464|NCT05194397|Vitamins|vitamins|mesh-ancestor
43742465|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
43742466|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742467|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43742468|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
43742483|NCT05179876|Macitentan|macitentan|mesh-list
43742484|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
43742485|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43742486|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43742487|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742488|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742489|NCT05179876|Urological Agents|urological agents|mesh-ancestor
43742490|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43742491|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43742492|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43742493|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43742494|NCT05176418|Nicotine|nicotine|mesh-list
43742495|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43566475|NCT00834574|Cefdinir|cefdinir|mesh-list
43566476|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566477|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566478|NCT00834561|Lamotrigine|lamotrigine|mesh-list
43566479|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
43566480|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43566481|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566482|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566483|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566484|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566485|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43566486|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43742496|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
43742497|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742498|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742499|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43742500|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43742501|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
43742502|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742503|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742504|NCT05172908|Dexamethasone|dexamethasone|mesh-list
43742505|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545386|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
43742506|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
43742507|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
43742508|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742509|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742510|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43742511|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
43742512|NCT05172908|Hormones|hormones|mesh-ancestor
43742513|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43742514|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43742515|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742516|NCT05167825|Macitentan|macitentan|mesh-list
43742517|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43742518|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43742519|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742520|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43742521|NCT05161533|Cisplatin|cisplatin|mesh-list
43742522|NCT05161533|Carboplatin|carboplatin|mesh-list
43742523|NCT05161533|Etoposide|etoposide|mesh-list
43742524|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
43742525|NCT05161533|Durvalumab|durvalumab|mesh-list
43835850|NCT05019885|Analgesics|analgesics|mesh-ancestor
43742526|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
43742527|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
43742528|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43566487|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566488|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566489|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43566490|NCT00834535|Cefdinir|cefdinir|mesh-list
43566491|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566492|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566493|NCT00834522|Granisetron|granisetron|mesh-list
43566494|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
43742529|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
43742530|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742531|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43742532|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43742533|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43742534|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742535|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742544|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
43742545|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
43742546|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742547|NCT05142241|Temozolomide|temozolomide|mesh-list
43742548|NCT05142241|Talazoparib|talazoparib|mesh-list
43742549|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43742550|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
43742551|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742552|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742553|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43742554|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742555|NCT05137717|Maribavir|maribavir|mesh-list
43742576|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
43742577|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742578|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742579|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43742580|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43742581|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43742582|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43742583|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43742584|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
43742585|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
43742586|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742587|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43835853|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742588|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43742589|NCT05130788|Nicotine|nicotine|mesh-list
43742590|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43742591|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
43742592|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742593|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742594|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43742595|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43742596|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
43742597|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742598|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742606|NCT05121324|Midazolam|midazolam|mesh-list
43747177|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
43742607|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43742615|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
43742616|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
43742617|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
43742618|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
43742619|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742620|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742621|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
43742622|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742623|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742624|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43742625|NCT05076799|Lactulose|lactulose|mesh-list
43742626|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43742627|NCT05070403|Afatinib|afatinib|mesh-list
43566546|NCT00834197|Mirtazapine|mirtazapine|mesh-list
43566547|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
43566548|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566549|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43566550|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
43566560|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43566561|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
43566562|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43742687|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742688|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43742689|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43742690|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742691|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742692|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43742693|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
43742694|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43742695|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742696|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43566563|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43566564|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
43566565|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43566567|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566568|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747178|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747179|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747180|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43747181|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566569|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43566570|NCT00834067|Moexipril|moexipril|mesh-list
43566571|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566572|NCT00834067|Diuretics|diuretics|mesh-ancestor
43566573|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
43742697|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43742698|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43742699|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43742700|NCT05027295|Riboflavin|riboflavin|mesh-list
43742701|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43742702|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43742703|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
43742705|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
43742706|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742707|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43742708|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
43742709|NCT05027048|Calcium|calcium|mesh-list
43747197|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
43742710|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43742711|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835516|NCT05046431|Golimumab|golimumab|mesh-list
43747199|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
43747200|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
43747201|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43747202|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43747203|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747204|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747205|NCT02519153|Urological Agents|urological agents|mesh-ancestor
43747206|NCT02519010|Amlodipine|amlodipine|mesh-list
43747207|NCT02519010|Valsartan|valsartan|mesh-list
43747208|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
43747209|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43747210|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43747211|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43747212|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747213|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43747214|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747215|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
43747216|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43747217|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43747218|NCT02518802|Pemetrexed|pemetrexed|mesh-list
43747219|NCT02518802|Gefitinib|gefitinib|mesh-list
43835517|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43835518|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835519|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43835520|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
43835521|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835522|NCT05045794|Liver Extracts|liver extracts|mesh-list
43835523|NCT05045794|Hematinics|hematinics|mesh-ancestor
43835524|NCT05043766|Naltrexone|naltrexone|mesh-list
43835525|NCT05043766|Oxycodone|oxycodone|mesh-list
43835526|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43835527|NCT05043766|Narcotics|narcotics|mesh-ancestor
43835528|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835529|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835530|NCT05043766|Analgesics|analgesics|mesh-ancestor
43835531|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
43835532|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835533|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43835534|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43835535|NCT05042973|Empagliflozin|empagliflozin|mesh-list
43704384|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566575|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43835538|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43835539|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835541|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43835542|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835543|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835544|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
43835545|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835546|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835547|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
43835549|NCT05041842|Pertuzumab|pertuzumab|mesh-list
43835550|NCT05041842|Tucatinib|tucatinib|mesh-list
43835551|NCT05041842|Hormones|hormones|mesh-list
43835552|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835553|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835554|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835555|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835556|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43835557|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835558|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835559|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
43835560|NCT05041153|Lenvatinib|lenvatinib|mesh-list
43835561|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835562|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835563|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43835564|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835565|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835566|NCT05039632|Nivolumab|nivolumab|mesh-list
43835567|NCT05039632|Ipilimumab|ipilimumab|mesh-list
43704385|NCT05029466|Psilocybin|psilocybin|mesh-list
43835570|NCT05039632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43835571|NCT05039632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835572|NCT05039281|Atezolizumab|atezolizumab|mesh-list
43835573|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43835575|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
43835576|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835577|NCT05038982|Abrocitinib|abrocitinib|mesh-list
43747284|NCT02518503|Lovastatin|lovastatin|mesh-list
43835578|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43835579|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835580|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835581|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43835582|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742712|NCT05014282|Nicotine|nicotine|mesh-list
43742713|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43742714|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
43742715|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742716|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742717|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43742718|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43742719|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
43742720|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747344|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
43747345|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742721|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742722|NCT05004987|Dexetimide|dexetimide|mesh-list
43742723|NCT05004987|Citalopram|citalopram|mesh-list
43742724|NCT05004987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43742725|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43742726|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43742727|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742728|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742729|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
43742730|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742731|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43570297|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570298|NCT00427154|Insulin|insulin|mesh-list
43566576|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566577|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566578|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566579|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566580|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566581|NCT00833937|Zolpidem|zolpidem|mesh-list
43566582|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43566583|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43566584|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566585|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566586|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43566587|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
43566588|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
43566589|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566590|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742732|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
43742733|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43742734|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43742735|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43742736|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
43742737|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
43742738|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742739|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43747372|NCT05585346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43742740|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43742741|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
43742742|NCT05001880|Bevacizumab|bevacizumab|mesh-list
43742743|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43742744|NCT05001880|Carboplatin|carboplatin|mesh-list
43742745|NCT05001880|Pemetrexed|pemetrexed|mesh-list
43742746|NCT05001880|Atezolizumab|atezolizumab|mesh-list
43742747|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
43742748|NCT05001880|Antibodies|antibodies|mesh-list
43742749|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
43742750|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43742751|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
43742752|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742753|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43742754|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43742770|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
43742771|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742772|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43742773|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43742774|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43742775|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742776|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742777|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43742778|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43742779|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742780|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
43742781|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742782|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43742783|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43566591|NCT00833664|Terbinafine|terbinafine|mesh-list
43566592|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
43566593|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566594|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566595|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566596|NCT00833586|Terbinafine|terbinafine|mesh-list
43566597|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
43566598|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566600|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566601|NCT00833521|Zolpidem|zolpidem|mesh-list
43566602|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43566603|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43566604|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566605|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742786|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742787|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43847761|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847762|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43847763|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847764|NCT04080076|Tacrolimus|tacrolimus|mesh-list
43847765|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847766|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
43847767|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847768|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43550496|NCT03622541|Sorafenib|sorafenib|mesh-list
43747394|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
43747395|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43570363|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43742788|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43742789|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742791|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742792|NCT04989816|Trastuzumab|trastuzumab|mesh-list
43742793|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742794|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742795|NCT04989218|Gemcitabine|gemcitabine|mesh-list
43742797|NCT04989218|Durvalumab|durvalumab|mesh-list
43742798|NCT04989218|Tremelimumab|tremelimumab|mesh-list
43742799|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742800|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43742801|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
43742802|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742803|NCT04989218|Antiviral Agents|antiviral agents|mesh-ancestor
43742804|NCT04989218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742805|NCT04989218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742806|NCT04989218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43742807|NCT04989218|Immunologic Factors|immunologic factors|mesh-ancestor
43742808|NCT04989218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742809|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742810|NCT04977908|Insulin|insulin|mesh-list
43742811|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566606|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43566607|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
43566608|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
43566609|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566610|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566611|NCT00833495|Prednisolone|prednisolone|mesh-list
43566612|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43566613|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
43566624|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43566625|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566626|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
43566627|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
43566628|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566629|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43566630|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43566631|NCT00833495|Protective Agents|protective agents|mesh-ancestor
43566632|NCT00832507|Cicletanine|cicletanine|mesh-list
43566633|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43566634|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566635|NCT00832507|Diuretics|diuretics|mesh-ancestor
43566636|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
43742812|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742813|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43742814|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43742815|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43742816|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43742817|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742818|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742819|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742820|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43742821|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
43742822|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43742823|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43742828|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742829|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742830|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
43742831|NCT04959175|Sirolimus|sirolimus|mesh-list
43742832|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
43742833|NCT04959175|Fludarabine|fludarabine|mesh-list
43570381|NCT00413114|Obatoclax|obatoclax|mesh-list
43570382|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570384|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43566637|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566638|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43566639|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43566640|NCT00831051|Morphine|morphine|mesh-list
43566642|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43566643|NCT00831051|Narcotics|narcotics|mesh-ancestor
43566644|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566645|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566646|NCT00831051|Analgesics|analgesics|mesh-ancestor
43566647|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
43570393|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570394|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43566648|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566649|NCT00830336|Azithromycin|azithromycin|mesh-list
43566650|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566651|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566652|NCT00830258|Pravastatin|pravastatin|mesh-list
43566653|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43566654|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43566655|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
43566656|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566657|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43566658|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43566659|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566660|NCT00830219|Ropinirole|ropinirole|mesh-list
43566661|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43742834|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43742835|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
43742836|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742837|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742838|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43545807|NCT03668418|Docetaxel|docetaxel|mesh-list
43742839|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
43742840|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742841|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742842|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43742843|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43570395|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43570396|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
43742844|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43742845|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
43742846|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43742847|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742848|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742849|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
43742851|NCT04949516|Colchicine|colchicine|mesh-list
43742852|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43704386|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
43742895|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742896|NCT04933149|Ketamine|ketamine|mesh-list
43742897|NCT04933149|Analgesics|analgesics|mesh-ancestor
43742898|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
43742899|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742900|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742901|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43742902|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43742903|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
43742904|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
43742905|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742906|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43742907|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43742908|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742909|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742910|NCT04929223|Bevacizumab|bevacizumab|mesh-list
43742911|NCT04929223|Cetuximab|cetuximab|mesh-list
43545873|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
43742937|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742938|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742940|NCT04916197|Analgesics|analgesics|mesh-ancestor
43742941|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
43742942|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742943|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43742944|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43742945|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43570409|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
43570410|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
43570411|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570412|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570413|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
43570415|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570416|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570417|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43570418|NCT00411385|Interferons|interferons|mesh-list
43570419|NCT00411385|Ribavirin|ribavirin|mesh-list
43570420|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
43742946|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
43742947|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742948|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742949|NCT04912505|Aspirin|aspirin|mesh-list
43742950|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43742951|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43742952|NCT04912505|Analgesics|analgesics|mesh-ancestor
43742953|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
43742954|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566679|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43566686|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
43742955|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742956|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43742957|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742958|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43742959|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43742960|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742961|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43742962|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43742963|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742964|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
43742965|NCT04905108|Riboflavin|riboflavin|mesh-list
43742966|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
43742967|NCT04905108|Vitamins|vitamins|mesh-ancestor
43742968|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
43742969|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570455|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
43570456|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
43570457|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
43570458|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570459|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570461|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43570462|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
43570463|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570464|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747396|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43747397|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747398|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747399|NCT05584956|Urological Agents|urological agents|mesh-ancestor
43747400|NCT05584878|Chitosan|chitosan|mesh-list
43747401|NCT05584878|Calcium|calcium|mesh-list
43747402|NCT05584878|Caseins|caseins|mesh-list
43747403|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43747404|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742970|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43742971|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
43742972|NCT04904549|Vaccines|vaccines|mesh-list
43742973|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
43742974|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742975|NCT04897503|Riboflavin|riboflavin|mesh-list
43742976|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
43742977|NCT04897503|Vitamins|vitamins|mesh-ancestor
43742978|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
43742979|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742980|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43742981|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
43742984|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742985|NCT04874480|Decitabine|decitabine|mesh-list
43566687|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566688|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566690|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43566691|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566692|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566693|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43566694|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566695|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566696|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
43566697|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
43566698|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566699|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566700|NCT00829998|Zaleplon|zaleplon|mesh-list
43566701|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
43566702|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43742986|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43742987|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
43742988|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742989|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742990|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742991|NCT04874194|Venetoclax|venetoclax|mesh-list
43742992|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
43742993|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742994|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43742995|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43742996|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742997|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742998|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
43742999|NCT04869137|Lenvatinib|lenvatinib|mesh-list
43835956|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743000|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743009|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43743010|NCT04853875|Bismuth|bismuth|mesh-list
43743011|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43743012|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743013|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43743014|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43743015|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43743016|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743017|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743028|NCT04852887|Tamoxifen|tamoxifen|mesh-list
43743029|NCT04852887|Letrozole|letrozole|mesh-list
43743030|NCT04852887|Exemestane|exemestane|mesh-list
43743031|NCT04852887|Anastrozole|anastrozole|mesh-list
43743032|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743033|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43743034|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43743035|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743036|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743037|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43743038|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
43743039|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43743040|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743041|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43743042|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43743043|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43743044|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43743045|NCT04851821|Quercetin|quercetin|mesh-list
43743046|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
43743047|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743048|NCT04851821|Protective Agents|protective agents|mesh-ancestor
43743049|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743059|NCT04792320|Antidotes|antidotes|mesh-ancestor
43747614|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43743072|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743073|NCT04762680|Vaccines|vaccines|mesh-list
43743074|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
43743075|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743076|NCT04739358|Tepotinib|tepotinib|mesh-list
43743077|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743078|NCT04733235|Progesterone|progesterone|mesh-list
43743079|NCT04733235|Hormones|hormones|mesh-ancestor
43743080|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43743081|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743082|NCT04733235|Progestins|progestins|mesh-ancestor
43743083|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
43743084|NCT04731376|Testosterone|testosterone|mesh-list
43743085|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
43743086|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
43743087|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43743088|NCT04731376|Androgens|androgens|mesh-ancestor
43743089|NCT04731376|Hormones|hormones|mesh-ancestor
43566703|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566704|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566705|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
43566706|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
43566707|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566708|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566709|NCT00829868|Zaleplon|zaleplon|mesh-list
43566710|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
43566711|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43566712|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566713|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566714|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
43566715|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
43566716|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566717|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566718|NCT00829790|Doxycycline|doxycycline|mesh-list
43566719|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566720|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566721|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
43566722|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43566723|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43566724|NCT00829764|Doxycycline|doxycycline|mesh-list
43566725|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566726|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566727|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
43566728|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43566729|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43566730|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
43566731|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43566732|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566733|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43566734|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43566735|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566736|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566737|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
43743110|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
43743112|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
43743113|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743114|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43743115|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
43743116|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743117|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43566743|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566744|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
43566745|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43566746|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43566747|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
43566758|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566759|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566760|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566761|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566763|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43566764|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43566765|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
43566766|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
43566767|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566768|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566769|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566770|NCT00829452|Ramipril|ramipril|mesh-list
43566771|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566772|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566773|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566774|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566775|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566782|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566783|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
43566784|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
43566785|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743118|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
43743119|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
43743120|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43743121|NCT04669665|Ketamine|ketamine|mesh-list
43743122|NCT04669665|Analgesics|analgesics|mesh-ancestor
43743123|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
43743124|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743125|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743126|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43743127|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43743128|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
43743129|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
43743130|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43743132|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43743133|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743134|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743135|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
43743136|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43743137|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743138|NCT04646005|Cemiplimab|cemiplimab|mesh-list
43743139|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743140|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743141|NCT04644796|Bupivacaine|bupivacaine|mesh-list
43743142|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
43743143|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
43743144|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43743145|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743146|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
43743147|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743162|NCT04620187|Carboplatin|carboplatin|mesh-list
43743163|NCT04620187|Trastuzumab|trastuzumab|mesh-list
43743164|NCT04620187|Maytansine|maytansine|mesh-list
43743165|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743166|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743167|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43743168|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
43743169|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
43743170|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
43747655|NCT05350943|Antiviral Agents|antiviral agents|mesh-ancestor
43743171|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743172|NCT04615013|Leucovorin|leucovorin|mesh-list
43743173|NCT04615013|Paclitaxel|paclitaxel|mesh-list
43743174|NCT04615013|Docetaxel|docetaxel|mesh-list
43743175|NCT04615013|Carboplatin|carboplatin|mesh-list
43743176|NCT04615013|Fluorouracil|fluorouracil|mesh-list
43743177|NCT04615013|Capecitabine|capecitabine|mesh-list
43743178|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
43743179|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43743180|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43743181|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743182|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
43743183|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
43743184|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
43743185|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743186|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
43743187|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743188|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743189|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
43743190|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743191|NCT04615013|Antidotes|antidotes|mesh-ancestor
43743192|NCT04615013|Protective Agents|protective agents|mesh-ancestor
43743193|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
43743208|NCT04607421|Bevacizumab|bevacizumab|mesh-list
43743209|NCT04607421|Cetuximab|cetuximab|mesh-list
43743210|NCT04607421|Fluorouracil|fluorouracil|mesh-list
43743211|NCT04607421|Capecitabine|capecitabine|mesh-list
43743212|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
43743213|NCT04607421|Irinotecan|irinotecan|mesh-list
43743214|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743215|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743216|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43743217|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43743218|NCT04607421|Growth Substances|growth substances|mesh-ancestor
43743219|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743220|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
43743227|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43743228|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743229|NCT04607421|Antidotes|antidotes|mesh-ancestor
43743230|NCT04607421|Protective Agents|protective agents|mesh-ancestor
43566786|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566787|NCT00829309|Pravastatin|pravastatin|mesh-list
43566788|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43566789|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43566790|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
43566791|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566792|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43566793|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43566794|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566795|NCT00828321|Ramipril|ramipril|mesh-list
43566796|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566797|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566798|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566799|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566800|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43566801|NCT00821977|Vildagliptin|vildagliptin|mesh-list
43566802|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566803|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566804|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43566805|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566806|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566807|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566819|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43566820|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43566821|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566822|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43566823|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
43743231|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
43743240|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43743241|NCT04602975|Vaccines|vaccines|mesh-list
43743242|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
43743243|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743244|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43743245|NCT04602975|Antacids|antacids|mesh-ancestor
43743246|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743247|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43743248|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
43743249|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43743250|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43743251|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743252|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
43743253|NCT04595786|Coagulants|coagulants|mesh-ancestor
43743254|NCT04588545|Trastuzumab|trastuzumab|mesh-list
43743255|NCT04588545|Pertuzumab|pertuzumab|mesh-list
43743256|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743257|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743258|NCT04580121|Acetaminophen|acetaminophen|mesh-list
43743259|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
43743260|NCT04580121|Promethazine|promethazine|mesh-list
43747680|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43743261|NCT04580121|Dexamethasone|dexamethasone|mesh-list
43743262|NCT04580121|Dasatinib|dasatinib|mesh-list
43743263|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43743264|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
43743265|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
43566824|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
43566825|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
43566826|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566827|NCT00821002|Latanoprost|latanoprost|mesh-list
43566828|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43566829|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43566830|NCT00820924|Lapatinib|lapatinib|mesh-list
43566831|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743266|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743267|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743268|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43743269|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
43743270|NCT04580121|Hormones|hormones|mesh-ancestor
43743271|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43743272|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43743273|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743274|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43743275|NCT04580121|Analgesics|analgesics|mesh-ancestor
43743276|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
43743277|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
43743278|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43743279|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743280|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743281|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43743282|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43743283|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43743284|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
43743285|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
43743286|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43743287|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
43743288|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
43743289|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743290|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43743291|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
43743292|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
43743293|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
43743294|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43743295|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743296|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
43743297|NCT04571944|Suvorexant|suvorexant|mesh-list
43743298|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43743299|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43743300|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43743316|NCT04559139|Gemcitabine|gemcitabine|mesh-list
43743317|NCT04559139|Cisplatin|cisplatin|mesh-list
43743318|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743319|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43566845|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
43566846|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566847|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566848|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43566849|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43566850|NCT00818571|Vildagliptin|vildagliptin|mesh-list
43566851|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566852|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566853|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43566854|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
43566856|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566857|NCT00818493|Acetaminophen|acetaminophen|mesh-list
43566858|NCT00818493|Morphine|morphine|mesh-list
43566859|NCT00818493|Oxycodone|oxycodone|mesh-list
43566860|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43566861|NCT00818493|Narcotics|narcotics|mesh-ancestor
43566862|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566863|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566864|NCT00818493|Analgesics|analgesics|mesh-ancestor
43566865|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
43566866|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566867|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43566868|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
43566869|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
43566870|NCT00817986|Baclofen|baclofen|mesh-list
43566871|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43747696|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566872|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566873|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43566889|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566891|NCT00813956|Carboplatin|carboplatin|mesh-list
43566892|NCT00813956|Iniparib|iniparib|mesh-list
43566893|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566894|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43566895|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
43743320|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
43743321|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743322|NCT04559139|Antiviral Agents|antiviral agents|mesh-ancestor
43743323|NCT04559139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743324|NCT04559139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743325|NCT04559139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743326|NCT04559139|Immunologic Factors|immunologic factors|mesh-ancestor
43743327|NCT04559139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743328|NCT04556773|Paclitaxel|paclitaxel|mesh-list
43743329|NCT04556773|Capecitabine|capecitabine|mesh-list
43743330|NCT04556773|Trastuzumab|trastuzumab|mesh-list
43743331|NCT04556773|Durvalumab|durvalumab|mesh-list
43743332|NCT04556773|Fulvestrant|fulvestrant|mesh-list
43743333|NCT04556773|Anastrozole|anastrozole|mesh-list
43743334|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43743335|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743336|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
43743337|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
43743338|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
43743339|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743340|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743341|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
43743342|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743343|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43743344|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43566896|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566897|NCT00813956|Antiviral Agents|antiviral agents|mesh-ancestor
43566898|NCT00813956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566899|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566900|NCT00813956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43566901|NCT00813956|Immunologic Factors|immunologic factors|mesh-ancestor
43566902|NCT00813956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566903|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43566904|NCT00813605|Conatumumab|conatumumab|mesh-list
43566905|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43566906|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566907|NCT00813163|Irinotecan|irinotecan|mesh-list
43566908|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43566909|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43566910|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566911|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566912|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566913|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
43566914|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566915|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43566916|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566917|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566919|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
43566920|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43743345|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43743346|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
43743347|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747725|NCT05243745|Fluorides|fluorides|mesh-list
43743348|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743349|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43743350|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43743351|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743352|NCT04551521|Trastuzumab|trastuzumab|mesh-list
43743353|NCT04551521|Pertuzumab|pertuzumab|mesh-list
43743354|NCT04551521|Atezolizumab|atezolizumab|mesh-list
43743355|NCT04551521|Vemurafenib|vemurafenib|mesh-list
43743356|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43743357|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743358|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743359|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
43743360|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743361|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43743362|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743363|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743364|NCT04550494|Talazoparib|talazoparib|mesh-list
43743365|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43743366|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743367|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566921|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566922|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566923|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566924|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566925|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
43566926|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
43566927|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43566928|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43566929|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43566930|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43566931|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
43566932|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566945|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43566946|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566947|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
43566948|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
43566949|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
43566950|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566951|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
43566952|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566953|NCT00806403|Reteplase|reteplase|mesh-list
43566954|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43566955|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43566956|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566957|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
43566958|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
43743371|NCT04549467|Emtricitabine|emtricitabine|mesh-list
43743372|NCT04549467|Dolutegravir|dolutegravir|mesh-list
43743373|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
43743374|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743375|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43743376|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43743377|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743378|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743379|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43743380|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43743381|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43743382|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43566959|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
43566960|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566961|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566962|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43566963|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43747731|NCT05232344|Estrogens|estrogens|mesh-ancestor
43747732|NCT05232344|Hormones|hormones|mesh-ancestor
43747733|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747734|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747736|NCT05231603|Ivermectin|ivermectin|mesh-list
43566964|NCT00805805|Growth Substances|growth substances|mesh-ancestor
43566965|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566966|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
43566967|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566968|NCT00805350|SR 46349B|sr 46349b|mesh-list
43566969|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43566970|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43566971|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566972|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43566973|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43566974|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
43566975|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566976|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566977|NCT00803114|Morphine|morphine|mesh-list
43566978|NCT00803114|Narcotics|narcotics|mesh-list
43566979|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43566980|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566981|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566983|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
43566984|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566985|NCT00799292|Vasopressins|vasopressins|mesh-list
43566986|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
43566987|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
43566988|NCT00799292|Coagulants|coagulants|mesh-ancestor
43566989|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43743412|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43743413|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43743414|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
43747739|NCT05212454|Capecitabine|capecitabine|mesh-list
43566992|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566993|NCT00796289|Citric Acid|citric acid|mesh-list
43566994|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
43566995|NCT00796289|Clomiphene|clomiphene|mesh-list
43566996|NCT00796289|Enclomiphene|enclomiphene|mesh-list
43747740|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43747741|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
43747742|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747743|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747744|NCT05200156|Choline|choline|mesh-list
43567017|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
43747745|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
43747746|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43747747|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
43747748|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747749|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747750|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43747751|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
43747752|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43567018|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567019|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43567021|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43567022|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43567023|NCT00792727|Analgesics|analgesics|mesh-ancestor
43567024|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
43567025|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567026|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567027|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567028|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567029|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43567030|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567031|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567032|NCT00791154|Cisplatin|cisplatin|mesh-list
43567033|NCT00791154|Carboplatin|carboplatin|mesh-list
43743415|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
43743416|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
43743417|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
43743418|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743419|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743420|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
43743421|NCT04533750|Peposertib|peposertib|mesh-list
43743422|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43743423|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743424|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743425|NCT04507503|Futibatinib|futibatinib|mesh-list
43743426|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743427|NCT04498468|Dexamethasone|dexamethasone|mesh-list
43743428|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43743429|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
43743430|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
43743431|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743432|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743434|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
43743435|NCT04498468|Hormones|hormones|mesh-ancestor
43743436|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43743437|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43743438|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743441|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743442|NCT04494438|Rituximab|rituximab|mesh-list
43743443|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743444|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743445|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
43567034|NCT00791154|Etoposide|etoposide|mesh-list
43567035|NCT00791154|Rilotumumab|rilotumumab|mesh-list
43567036|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567037|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43567038|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43567039|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43567040|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567041|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567042|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43567043|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
43567044|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43743446|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743447|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43743448|NCT04491942|Gemcitabine|gemcitabine|mesh-list
43743449|NCT04491942|Cisplatin|cisplatin|mesh-list
43743450|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743451|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743452|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
43743453|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743454|NCT04491942|Antiviral Agents|antiviral agents|mesh-ancestor
43743455|NCT04491942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743456|NCT04491942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743457|NCT04491942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743458|NCT04491942|Immunologic Factors|immunologic factors|mesh-ancestor
43743459|NCT04491942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743461|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
43743462|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743463|NCT04484675|Milrinone|milrinone|mesh-list
43743464|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43743465|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43743466|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
43743467|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43743468|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43743469|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567045|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567046|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567047|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567048|NCT00789633|Gemcitabine|gemcitabine|mesh-list
43567049|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43567050|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
43567051|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567052|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567053|NCT00789633|Antiviral Agents|antiviral agents|mesh-ancestor
43567054|NCT00789633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567055|NCT00789633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567065|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
43567066|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567067|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567068|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43567069|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
43567073|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43567074|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567075|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567076|NCT00782431|Vaccines|vaccines|mesh-list
43567077|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
43567078|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567079|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43567080|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567081|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43567082|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743470|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743471|NCT04484675|Protective Agents|protective agents|mesh-ancestor
43743473|NCT04471415|Atezolizumab|atezolizumab|mesh-list
43743474|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743475|NCT04464798|Rituximab|rituximab|mesh-list
43743476|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
43743477|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743478|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743479|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
43743480|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743481|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43743482|NCT04460885|Insulin|insulin|mesh-list
43743483|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43743484|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
43743485|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43743486|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743487|NCT04458324|Buspirone|buspirone|mesh-list
43743488|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43567083|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567084|NCT00776373|Cytarabine|cytarabine|mesh-list
43567085|NCT00776373|Sirolimus|sirolimus|mesh-list
43567086|NCT00776373|Etoposide|etoposide|mesh-list
43567087|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43567088|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567089|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43567090|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43567091|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567092|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567093|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43567094|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
43567095|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
43567096|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567097|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43567098|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
43567099|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567100|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43567101|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43567102|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
43567103|NCT00774761|Fluticasone|fluticasone|mesh-list
43567105|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
43567106|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567107|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43567108|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
43567109|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567110|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567111|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43567112|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
43567113|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
43567114|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43567115|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43567116|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43567117|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43567118|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
43743489|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43743490|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43743491|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743492|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43743493|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43743495|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743496|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743497|NCT04440358|Carboplatin|carboplatin|mesh-list
43743498|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743499|NCT04438382|Prednisone|prednisone|mesh-list
43743500|NCT04438382|Cortisone|cortisone|mesh-list
43743501|NCT04438382|Infliximab|infliximab|mesh-list
43743502|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
43743503|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43743504|NCT04438382|Antibodies|antibodies|mesh-list
43743505|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
43743506|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43743507|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
43743508|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43743509|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
43743510|NCT04438382|Hormones|hormones|mesh-ancestor
43743511|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43743512|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743513|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43743514|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743515|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
43743516|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
43743517|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43743518|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567119|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567120|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567122|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43567123|NCT00772785|Narcotics|narcotics|mesh-ancestor
43747768|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
43567132|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567133|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43567134|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
43743521|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
43743522|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743523|NCT04435782|Selexipag|selexipag|mesh-list
43743524|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43743525|NCT04421963|Olaparib|olaparib|mesh-list
43743526|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43743527|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743528|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743529|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743530|NCT04413799|Lidocaine|lidocaine|mesh-list
43743531|NCT04413799|Ketamine|ketamine|mesh-list
43743532|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
43743533|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
43743534|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43743535|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743537|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743538|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43743539|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43743540|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43743541|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43567142|NCT00770848|Rilotumumab|rilotumumab|mesh-list
43567143|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43567144|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567145|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
43567146|NCT00770848|Hormones|hormones|mesh-ancestor
43567147|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567148|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567149|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567150|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567151|NCT00770848|Analgesics|analgesics|mesh-ancestor
43567152|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
43567153|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567154|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43567204|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835618|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
43835619|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835620|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835621|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835622|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
43835623|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
43835624|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835625|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835626|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
43835627|NCT05036577|Hormones|hormones|mesh-ancestor
43835628|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835629|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43835630|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43835631|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
43835632|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43835633|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43835634|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
43570559|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570562|NCT00396357|Vildagliptin|vildagliptin|mesh-list
43835635|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835636|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
43835637|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835638|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43835639|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43835640|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43835641|NCT05034627|Asparaginase|asparaginase|mesh-list
43835642|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835643|NCT05033665|Benzocaine|benzocaine|mesh-list
43835644|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
43835645|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
43835646|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835647|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835648|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
43835649|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835650|NCT05032820|Lenalidomide|lenalidomide|mesh-list
43835651|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
43835652|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835656|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
43835657|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835660|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43743565|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
43743566|NCT04397354|BB 1101|bb 1101|mesh-list
43743567|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43743568|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
43743569|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
43743570|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743571|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743572|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43743573|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
43743574|NCT04397354|Hormones|hormones|mesh-ancestor
43743575|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43743576|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43743577|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743578|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
43743579|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743580|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743581|NCT04391049|Paclitaxel|paclitaxel|mesh-list
43743582|NCT04391049|Carboplatin|carboplatin|mesh-list
43743583|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43567205|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567206|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567207|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
43567209|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567210|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567211|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567212|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567213|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
43567214|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43567215|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
43567216|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
43567217|NCT00765700|Ketoprofen|ketoprofen|mesh-list
43567218|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43567219|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43567220|NCT00765700|Analgesics|analgesics|mesh-ancestor
43567221|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
43567222|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567223|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567224|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567225|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567226|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43567227|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835976|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43835987|NCT05008809|Leucovorin|leucovorin|mesh-list
43567228|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567229|NCT00765323|Octreotide|octreotide|mesh-list
43743584|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43743585|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743586|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
43743587|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
43743588|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
43743589|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743591|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43743592|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
43743593|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43743594|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743595|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43743596|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43743597|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43743598|NCT04367103|Phenylephrine|phenylephrine|mesh-list
43743599|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
43743600|NCT04367103|Norepinephrine|norepinephrine|mesh-list
43743601|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43743602|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
43743603|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
43567230|NCT00765323|Somatostatin|somatostatin|mesh-list
43567231|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567232|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567233|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567234|NCT00765323|Hormones|hormones|mesh-ancestor
43567235|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567236|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567237|NCT00764634|Vaccines|vaccines|mesh-list
43567238|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
43567239|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567240|NCT00763503|Calcitriol|calcitriol|mesh-list
43567241|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43567242|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567243|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43567244|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43567245|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567246|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43567247|NCT00763503|Vitamins|vitamins|mesh-ancestor
43567248|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
43567249|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43567250|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43567251|NCT00761709|Latanoprost|latanoprost|mesh-list
43567252|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43567271|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43567272|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
43567273|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567274|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567276|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43567277|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43567278|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567279|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567280|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
43743604|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743605|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743606|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
43743607|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43743608|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
43743609|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
43743610|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43743611|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43743612|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43743613|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
43743614|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743615|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743616|NCT04367103|Protective Agents|protective agents|mesh-ancestor
43743617|NCT04364048|Cisplatin|cisplatin|mesh-list
43743618|NCT04364048|Carboplatin|carboplatin|mesh-list
43743619|NCT04364048|Etoposide|etoposide|mesh-list
43743620|NCT04364048|Pemetrexed|pemetrexed|mesh-list
43743621|NCT04364048|Durvalumab|durvalumab|mesh-list
43743622|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43743623|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743624|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43567281|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567282|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567283|NCT00759135|Urological Agents|urological agents|mesh-ancestor
43567284|NCT00758966|Naltrexone|naltrexone|mesh-list
43567285|NCT00758966|Fluoxetine|fluoxetine|mesh-list
43567286|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43567287|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43567288|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567289|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
43567290|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567291|NCT00758966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43567292|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43567293|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43567294|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567295|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567296|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
43567297|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43567298|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
43567299|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43567300|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43567301|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43567302|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567303|NCT00758953|Danazol|danazol|mesh-list
43567304|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43567305|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
43567306|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567307|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567316|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43567317|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
43567318|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567319|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43567320|NCT00758290|Triclosan|triclosan|mesh-list
43743625|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43743626|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43743627|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743628|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743629|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43743630|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43743631|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743632|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
43743633|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743634|NCT04353661|Azithromycin|azithromycin|mesh-list
43743635|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43743636|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743637|NCT04343651|Leronlimab|leronlimab|mesh-list
43743638|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43743639|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43743640|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743641|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43743642|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43743643|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
43743644|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743645|NCT04324840|Temozolomide|temozolomide|mesh-list
43743646|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43743647|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
43743653|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743654|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43743655|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743656|NCT04309578|Cisplatin|cisplatin|mesh-list
43743657|NCT04309578|Capecitabine|capecitabine|mesh-list
43743658|NCT04309578|Trastuzumab|trastuzumab|mesh-list
43743659|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743660|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743661|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
43743662|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743663|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743665|NCT04302025|Vemurafenib|vemurafenib|mesh-list
43743666|NCT04302025|Pralsetinib|pralsetinib|mesh-list
43743667|NCT04302025|Entrectinib|entrectinib|mesh-list
43743668|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743669|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43743670|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743671|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743672|NCT04298034|Labetalol|labetalol|mesh-list
43743673|NCT04298034|Nifedipine|nifedipine|mesh-list
43743674|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43743675|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43743676|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743677|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43743678|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743679|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
43743680|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
43743681|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43743682|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43743683|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43743684|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
43743685|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743686|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43567321|NCT00758290|Fluorides|fluorides|mesh-list
43567322|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
43567323|NCT00758290|Protective Agents|protective agents|mesh-ancestor
43567324|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567325|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43567326|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567327|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43567328|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43567329|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
43567330|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567331|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43567332|NCT00755287|Metformin|metformin|mesh-list
43567354|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43567356|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43567358|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743688|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
43743689|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743690|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43743691|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43743695|NCT04297150|Dabigatran|dabigatran|mesh-list
43743696|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43743697|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
43743698|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43743699|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
43743700|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743701|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743702|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
43743703|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
43743704|NCT04284787|Azacitidine|azacitidine|mesh-list
43743705|NCT04284787|Venetoclax|venetoclax|mesh-list
43743706|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743707|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743708|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743709|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
43743710|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743711|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743712|NCT04282668|Tretinoin|tretinoin|mesh-list
43567359|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
43567360|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567361|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567362|NCT00752570|Trebananib|trebananib|mesh-list
43567363|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43567364|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43567365|NCT00752570|Growth Substances|growth substances|mesh-ancestor
43567366|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567367|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
43567368|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567369|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
43567370|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43567371|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43567385|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567387|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567388|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567389|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43567390|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567391|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
43567392|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43743713|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743714|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
43743715|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
43743716|NCT04278404|Metformin|metformin|mesh-list
43743717|NCT04278404|Interferons|interferons|mesh-list
43743718|NCT04278404|Ritonavir|ritonavir|mesh-list
43743719|NCT04278404|Ribavirin|ribavirin|mesh-list
43743720|NCT04278404|Lopinavir|lopinavir|mesh-list
43743721|NCT04278404|Oseltamivir|oseltamivir|mesh-list
43743722|NCT04278404|Remdesivir|remdesivir|mesh-list
43743723|NCT04278404|Azithromycin|azithromycin|mesh-list
43743724|NCT04278404|Clindamycin|clindamycin|mesh-list
43743725|NCT04278404|Meropenem|meropenem|mesh-list
43743726|NCT04278404|Voriconazole|voriconazole|mesh-list
43743727|NCT04278404|Ceftazidime|ceftazidime|mesh-list
43743728|NCT04278404|Fosfomycin|fosfomycin|mesh-list
43743729|NCT04278404|Cefepime|cefepime|mesh-list
43570605|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43743730|NCT04278404|Cefdinir|cefdinir|mesh-list
43743731|NCT04278404|Dexamethasone|dexamethasone|mesh-list
43743732|NCT04278404|Budesonide|budesonide|mesh-list
43743733|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
43743734|NCT04278404|Colchicine|colchicine|mesh-list
43743738|NCT04278404|Labetalol|labetalol|mesh-list
43743739|NCT04278404|Nicardipine|nicardipine|mesh-list
43743740|NCT04278404|Nifedipine|nifedipine|mesh-list
43743741|NCT04278404|Milrinone|milrinone|mesh-list
43743742|NCT04278404|Furosemide|furosemide|mesh-list
43743743|NCT04278404|Spironolactone|spironolactone|mesh-list
43743744|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
43743745|NCT04278404|Oxycodone|oxycodone|mesh-list
43567393|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43567394|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43567395|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43567396|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567397|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
43567398|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567399|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567400|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43567401|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567403|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43567404|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
43567405|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567406|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567407|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567408|NCT00751231|Clopidogrel|clopidogrel|mesh-list
43567409|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43567410|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43567411|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43567412|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43567413|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
43567414|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743747|NCT04278404|Nalbuphine|nalbuphine|mesh-list
43743748|NCT04278404|Clobazam|clobazam|mesh-list
43743749|NCT04278404|Zolpidem|zolpidem|mesh-list
43743750|NCT04278404|Risperidone|risperidone|mesh-list
43743751|NCT04278404|Amphetamine|amphetamine|mesh-list
43743752|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
43743753|NCT04278404|Sertraline|sertraline|mesh-list
43743754|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
43743755|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
43743756|NCT04278404|Terbutaline|terbutaline|mesh-list
43743757|NCT04278404|Sevelamer|sevelamer|mesh-list
43743758|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43743759|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
43743760|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
43546773|NCT03658720|Ibuprofen|ibuprofen|mesh-list
43743761|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743762|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743764|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
43743765|NCT04278404|Hormones|hormones|mesh-ancestor
43743766|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43743767|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43743768|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743769|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
43743770|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743771|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570611|NCT00393991|Xhance|xhance|mesh-list
43570612|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
43570613|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570614|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43570615|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
43570616|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570617|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570618|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43570619|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
43570620|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
43743772|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43743773|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43743774|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43743775|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43743776|NCT04278404|Analgesics|analgesics|mesh-ancestor
43743777|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
43743792|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43743793|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43743795|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43743796|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43743797|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
43743798|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43743799|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43743800|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
43743801|NCT04278404|Coagulants|coagulants|mesh-ancestor
43743802|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43743803|NCT04278404|Narcotics|narcotics|mesh-ancestor
43743804|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
43743806|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43743807|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43743808|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43743809|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43743810|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
43743811|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43743812|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
43743813|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43743814|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43743815|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
43743816|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
43743817|NCT04278404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43743818|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43743819|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43743820|NCT04278404|Diuretics|diuretics|mesh-ancestor
43743821|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
43743822|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43567415|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567416|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567417|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
43567418|NCT00750633|Dexamethasone|dexamethasone|mesh-list
43567419|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43747816|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
43747817|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
43747818|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
43747819|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
43747820|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747821|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43747822|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
43747823|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
43747824|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747825|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43747826|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
43567420|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43747827|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
43567421|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567422|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
43567423|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
43567424|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567425|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567426|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567428|NCT00750633|Hormones|hormones|mesh-ancestor
43743823|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
43743824|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
43743825|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
43743826|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
43743827|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43743828|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
43743829|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43743830|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43743831|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43743832|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43743833|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
43743834|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
43743835|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43743836|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
43743837|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43743838|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43743839|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43743840|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43743841|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
43743842|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
43743843|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43743865|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43743866|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43743868|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43743869|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43743870|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743871|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43743873|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43743874|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43743875|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743876|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43743877|NCT04252612|Pramlintide|pramlintide|mesh-list
43743878|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43743879|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743880|NCT04222972|Gemcitabine|gemcitabine|mesh-list
43743881|NCT04222972|Paclitaxel|paclitaxel|mesh-list
43743882|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43743883|NCT04222972|Cisplatin|cisplatin|mesh-list
43743884|NCT04222972|Carboplatin|carboplatin|mesh-list
43743885|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
43743886|NCT04222972|Pemetrexed|pemetrexed|mesh-list
43743887|NCT04222972|Pralsetinib|pralsetinib|mesh-list
43743888|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43743889|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747845|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
43743890|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
43743891|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
43743892|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
43743893|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743894|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743895|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
43743896|NCT04222972|Antiviral Agents|antiviral agents|mesh-ancestor
43743897|NCT04222972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743898|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743899|NCT04222972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743900|NCT04222972|Immunologic Factors|immunologic factors|mesh-ancestor
43743901|NCT04222972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743902|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743903|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43743904|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43743905|NCT04221555|Docetaxel|docetaxel|mesh-list
43743906|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
43743907|NCT04221555|Durvalumab|durvalumab|mesh-list
43743908|NCT04221555|Tremelimumab|tremelimumab|mesh-list
43743909|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43743910|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743911|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
43743912|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
43743913|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
43743914|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743915|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743916|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
43743917|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743919|NCT04215588|Coagulants|coagulants|mesh-ancestor
43743920|NCT04205305|Labetalol|labetalol|mesh-list
43743921|NCT04205305|Nicardipine|nicardipine|mesh-list
43743922|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43743923|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43743924|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
43743925|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743926|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743927|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743928|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43743929|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
43743930|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
43743931|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743932|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43743937|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
43743946|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
43743947|NCT04157985|Nivolumab|nivolumab|mesh-list
43743948|NCT04157985|Ipilimumab|ipilimumab|mesh-list
43743949|NCT04157985|Cemiplimab|cemiplimab|mesh-list
43743950|NCT04157985|Atezolizumab|atezolizumab|mesh-list
43743951|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43743952|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743953|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743954|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743955|NCT04155580|Decitabine|decitabine|mesh-list
43743956|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743957|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
43743958|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743959|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743960|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743961|NCT04149899|Timolol|timolol|mesh-list
43743962|NCT04149899|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43743963|NCT04149899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43743964|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43743965|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43743966|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
43743967|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743968|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567429|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567430|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567431|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567432|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43567433|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567434|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43567435|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43567436|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567437|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743992|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743994|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43743995|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743996|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
43743997|NCT04093362|Gemcitabine|gemcitabine|mesh-list
43743998|NCT04093362|Cisplatin|cisplatin|mesh-list
43743999|NCT04093362|Futibatinib|futibatinib|mesh-list
43744000|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744001|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43744002|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
43744003|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744004|NCT04093362|Antiviral Agents|antiviral agents|mesh-ancestor
43744005|NCT04093362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744006|NCT04093362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744007|NCT04093362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744008|NCT04093362|Immunologic Factors|immunologic factors|mesh-ancestor
43744009|NCT04093362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744010|NCT04079712|Nivolumab|nivolumab|mesh-list
43567475|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567477|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
43567478|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
43567479|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43567480|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43567481|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43567482|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43567483|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
43567484|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567485|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567486|NCT00745316|Adenosine|adenosine|mesh-list
43567487|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
43567488|NCT00745316|Analgesics|analgesics|mesh-ancestor
43567489|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
43567490|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567491|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567492|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43567493|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
43567494|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43567495|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
43567496|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
43567497|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567498|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567499|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43567500|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43744012|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744013|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744014|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744015|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744019|NCT04075747|Venetoclax|venetoclax|mesh-list
43744020|NCT04075747|Midostaurin|midostaurin|mesh-list
43744021|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744022|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744023|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744024|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744025|NCT04075526|Vancomycin|vancomycin|mesh-list
43744026|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
43744027|NCT04075526|Povidone|povidone|mesh-list
43744028|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43744029|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744030|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
43744031|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
43744032|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43744075|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
43744076|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
43744077|NCT04054999|Methylene Blue|methylene blue|mesh-list
43744078|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744079|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744080|NCT04054999|Hematinics|hematinics|mesh-ancestor
43744081|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
43744082|NCT04054999|Vitamins|vitamins|mesh-ancestor
43744083|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
43744084|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744085|NCT04052880|Dexamethasone|dexamethasone|mesh-list
43744086|NCT04052880|Lenalidomide|lenalidomide|mesh-list
43744088|NCT04052880|Daratumumab|daratumumab|mesh-list
43744090|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43744091|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
43744092|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
43744093|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744094|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744095|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43744096|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
43847753|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43847755|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43847756|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43847757|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43744109|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
43744110|NCT04046861|Vitamins|vitamins|mesh-ancestor
43744111|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
43744112|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744113|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
43744114|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744115|NCT04046861|Protective Agents|protective agents|mesh-ancestor
43744116|NCT04038099|Lidocaine|lidocaine|mesh-list
43744117|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
43744118|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
43744119|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43744120|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744121|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
43744122|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744123|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43744124|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43744125|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43744126|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43744127|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744128|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
43744129|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
43567510|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567511|NCT00744367|Incretins|incretins|mesh-ancestor
43567512|NCT00744367|Hormones|hormones|mesh-ancestor
43567513|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567514|NCT00744276|Danazol|danazol|mesh-list
43567515|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43567516|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
43567517|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567518|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567519|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43567520|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567521|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43567522|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567523|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567524|NCT00743925|Atorvastatin|atorvastatin|mesh-list
43567525|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
43567526|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43567527|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43567528|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
43567529|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567530|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43744138|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43744139|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43744140|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43744141|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43744142|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744143|NCT03983824|Cytarabine|cytarabine|mesh-list
43744144|NCT03983824|Etoposide|etoposide|mesh-list
43744145|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
43744146|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
43744147|NCT03983824|Peposertib|peposertib|mesh-list
43744148|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43744149|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744150|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43744151|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43744152|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744153|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744154|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43744155|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
43744156|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
43744157|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744158|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744159|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
43744167|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744169|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744170|NCT03953300|Benralizumab|benralizumab|mesh-list
43744171|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43744172|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
43744173|NCT03944304|Paclitaxel|paclitaxel|mesh-list
43744174|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43744175|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744176|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
43744177|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
43744178|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
43744179|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744180|NCT03942211|Selexipag|selexipag|mesh-list
43744181|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43744182|NCT03927274|Topotecan|topotecan|mesh-list
43744184|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43567535|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43567536|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
43567537|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567538|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
43567539|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567541|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567542|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567543|NCT00741715|Atorvastatin|atorvastatin|mesh-list
43567544|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43567545|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43567546|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
43567547|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567548|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43567549|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43567550|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567551|NCT00739349|Cyclosporine|cyclosporine|mesh-list
43567552|NCT00739349|Cyclosporins|cyclosporins|mesh-list
43567553|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567554|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567555|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744185|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744186|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744187|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744199|NCT03912220|Niacinamide|niacinamide|mesh-list
43744200|NCT03912220|Niacin|niacin|mesh-list
43744201|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
43744202|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
43744203|NCT03912220|Vitamins|vitamins|mesh-ancestor
43744204|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
43744205|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744207|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
43744208|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744209|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43744210|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
43744211|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43744212|NCT03907488|Nivolumab|nivolumab|mesh-list
43570680|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744213|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43744214|NCT03907488|Doxorubicin|doxorubicin|mesh-list
43744216|NCT03907488|Dacarbazine|dacarbazine|mesh-list
43744232|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744233|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43744234|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43744235|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
43744236|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43744237|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
43744238|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
43744239|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
43744240|NCT03904693|Tadalafil|tadalafil|mesh-list
43744241|NCT03904693|Macitentan|macitentan|mesh-list
43744242|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
43744243|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43567556|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
43567557|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567558|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
43567559|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567560|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
43567561|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567562|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43567563|NCT00738387|Docetaxel|docetaxel|mesh-list
43567566|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
43567567|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
43567580|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43567582|NCT00734435|Olanzapine|olanzapine|mesh-list
43567583|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
43567584|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
43567585|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747870|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
43567586|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567587|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567588|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43567589|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43567590|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43567591|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43567592|NCT00734435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43567593|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43567594|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43567595|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567596|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567597|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
43567598|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
43567599|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43567600|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43567601|NCT00734292|Fluticasone|fluticasone|mesh-list
43567602|NCT00734292|Xhance|xhance|mesh-list
43567603|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
43567604|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567605|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43567606|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
43567607|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567608|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567609|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43567610|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
43567611|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
43567612|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43567613|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43567614|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43567615|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43567616|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
43567617|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567618|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567619|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
43567620|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
43744244|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43744245|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744247|NCT03904693|Urological Agents|urological agents|mesh-ancestor
43744248|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43744249|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43744250|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43744251|NCT03896503|Topotecan|topotecan|mesh-list
43744252|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43744253|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43744254|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744255|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744256|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744257|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
43744258|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43744259|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43744260|NCT03875690|Prednisolone|prednisolone|mesh-list
43744261|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
43744262|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43744263|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
43744264|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43744265|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
43744266|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
43744267|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744268|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744269|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43744270|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
43744272|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43744273|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43744274|NCT03875690|Protective Agents|protective agents|mesh-ancestor
43567621|NCT00734253|Vitamins|vitamins|mesh-ancestor
43567622|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
43567623|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567624|NCT00730665|Esomeprazole|esomeprazole|mesh-list
43567625|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43567626|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567627|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43567628|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567642|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567643|NCT00726336|Tenofovir|tenofovir|mesh-list
43567644|NCT00726336|Dolutegravir|dolutegravir|mesh-list
43567645|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
43744275|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43744276|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744277|NCT03854344|Lidocaine|lidocaine|mesh-list
43744278|NCT03854344|Bupivacaine|bupivacaine|mesh-list
43744279|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
43744280|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
43744281|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43744282|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744283|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
43744284|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744285|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43744286|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43744287|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43744288|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43744289|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744290|NCT03806985|Psilocybin|psilocybin|mesh-list
43744291|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
43744292|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567646|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567647|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43567648|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43567649|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567650|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567651|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43567652|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43567653|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43567654|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43567655|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
43567656|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
43567657|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567658|NCT00725881|Protective Agents|protective agents|mesh-ancestor
43567659|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567660|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43567661|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567663|NCT00724841|Obatoclax|obatoclax|mesh-list
43567664|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43567665|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
43567666|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567667|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567668|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567669|NCT00724698|Desloratadine|desloratadine|mesh-list
43567670|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43567671|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
43567672|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567673|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567674|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567675|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43567676|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43567677|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
43567678|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
43567679|NCT00722917|Pioglitazone|pioglitazone|mesh-list
43567680|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567681|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744296|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744297|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744298|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744299|NCT03768492|Caffeine|caffeine|mesh-list
43744300|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43744301|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744302|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43744303|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744304|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744305|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43744306|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43744307|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
43744308|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43744309|NCT03751761|Paclitaxel|paclitaxel|mesh-list
43744310|NCT03751761|Durvalumab|durvalumab|mesh-list
43744311|NCT03751761|Tremelimumab|tremelimumab|mesh-list
43744312|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43567682|NCT00722592|Doxorubicin|doxorubicin|mesh-list
43567683|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43567684|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43567685|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567686|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43567687|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43567704|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567705|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567706|NCT00719550|Cisplatin|cisplatin|mesh-list
43567707|NCT00719550|Capecitabine|capecitabine|mesh-list
43567708|NCT00719550|Epirubicin|epirubicin|mesh-list
43567709|NCT00719550|Rilotumumab|rilotumumab|mesh-list
43567710|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567711|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43567712|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
43567713|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567714|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43567718|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43567719|NCT00718224|Enoxaparin|enoxaparin|mesh-list
43567720|NCT00718224|Semuloparin|semuloparin|mesh-list
43567721|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
43567722|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43567723|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43567724|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567725|NCT00717457|Exenatide|exenatide|mesh-list
43567726|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43567727|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567728|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567729|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43567730|NCT00717457|Incretins|incretins|mesh-ancestor
43747938|NCT04767191|Artemether|artemether|mesh-list
43747939|NCT04767191|Piperaquine|piperaquine|mesh-list
43747941|NCT04767191|Artenimol|artenimol|mesh-list
43744314|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
43744315|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
43744316|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
43744317|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744318|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744319|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
43744320|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43744321|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
43744322|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744323|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744324|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43744325|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
43744326|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43744327|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
43744328|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744329|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43744330|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43744331|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
43744332|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
43744333|NCT03718793|Protective Agents|protective agents|mesh-ancestor
43744334|NCT03706365|Prednisone|prednisone|mesh-list
43744335|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
43744336|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567761|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567762|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744351|NCT03673462|Vaccines|vaccines|mesh-list
43744352|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
43744353|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744354|NCT03658304|Mitomycins|mitomycins|mesh-list
43744355|NCT03658304|Mitomycin|mitomycin|mesh-list
43744356|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43744357|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744358|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
43744360|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43744361|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744362|NCT03641313|Irinotecan|irinotecan|mesh-list
43744363|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43744364|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43744365|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744368|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
43744381|NCT03630991|Antidotes|antidotes|mesh-ancestor
43744382|NCT03630991|Protective Agents|protective agents|mesh-ancestor
43744383|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43744384|NCT03614728|Azacitidine|azacitidine|mesh-list
43744385|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
43744386|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43744387|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
43744388|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744389|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744390|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744391|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
43744392|NCT03609424|Spartalizumab|spartalizumab|mesh-list
43744393|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744394|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744395|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744396|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744397|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744398|NCT03606967|Gemcitabine|gemcitabine|mesh-list
43744399|NCT03606967|Poly I-C|poly i-c|mesh-list
43567763|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567764|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43567765|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
43567766|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
43567768|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43567769|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567770|NCT00711555|Dexamethasone|dexamethasone|mesh-list
43567771|NCT00711555|Ondansetron|ondansetron|mesh-list
43567772|NCT00711555|Aprepitant|aprepitant|mesh-list
43567773|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567774|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
43567775|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
43747952|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567776|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567777|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567778|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567779|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
43567780|NCT00711555|Hormones|hormones|mesh-ancestor
43567781|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567782|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567783|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567784|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
43567785|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
43567786|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43567787|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
43567788|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567789|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567790|NCT00711555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43567791|NCT00711555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43567792|NCT00711555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43567793|NCT00711555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43567794|NCT00711555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43567795|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43567796|NCT00710580|Etanercept|etanercept|mesh-list
43567797|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43567798|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43567799|NCT00710580|Analgesics|analgesics|mesh-ancestor
43567800|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
43567801|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744400|NCT03606967|Paclitaxel|paclitaxel|mesh-list
43744401|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43744402|NCT03606967|Carboplatin|carboplatin|mesh-list
43744403|NCT03606967|Durvalumab|durvalumab|mesh-list
43744404|NCT03606967|Tremelimumab|tremelimumab|mesh-list
43744405|NCT03606967|Ipilimumab|ipilimumab|mesh-list
43744406|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43744407|NCT03606967|Vaccines|vaccines|mesh-list
43744408|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
43744409|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744410|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
43744411|NCT03606967|Poly ICLC|poly iclc|mesh-list
43744412|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
43744413|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744414|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43744415|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744416|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
43744417|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
43744418|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
43744419|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744420|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43744421|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
43744422|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
43744423|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744424|NCT03606967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744425|NCT03606967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43567802|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567803|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567804|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567805|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747956|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43747957|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747958|NCT04761887|Ropivacaine|ropivacaine|mesh-list
43747959|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
43747960|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
43570732|NCT00384904|Famotidine|famotidine|mesh-list
43570733|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43570734|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43567806|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43567807|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
43567811|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
43567812|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
43567820|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567822|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567823|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567824|NCT00698230|Metformin|metformin|mesh-list
43567825|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567826|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567827|NCT00697099|Enoxaparin|enoxaparin|mesh-list
43567828|NCT00697099|Semuloparin|semuloparin|mesh-list
43567829|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
43567830|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
43567832|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43567833|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567834|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
43567835|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
43567836|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43567837|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43744426|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744427|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744428|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
43744429|NCT03606967|Laxatives|laxatives|mesh-ancestor
43744430|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43744431|NCT03605927|Sirolimus|sirolimus|mesh-list
43744432|NCT03605927|Tacrolimus|tacrolimus|mesh-list
43744433|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744434|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
43744435|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744436|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43744437|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744438|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744439|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43744440|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744441|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43744442|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744443|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
43744444|NCT03581292|Temozolomide|temozolomide|mesh-list
43567838|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567839|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567840|NCT00694928|Clindamycin|clindamycin|mesh-list
43567841|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
43570735|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
43570736|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570737|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570738|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43570739|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43747968|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
43747970|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
43567842|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
43567843|NCT00694928|Butoconazole|butoconazole|mesh-list
43567844|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43567845|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567846|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43567847|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567848|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567849|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
43567850|NCT00694382|Semuloparin|semuloparin|mesh-list
43567851|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43567852|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43567853|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43567854|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567855|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
43567856|NCT00694135|Dexamethasone|dexamethasone|mesh-list
43567857|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
43567858|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43567859|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43567860|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43567861|NCT00694135|BB 1101|bb 1101|mesh-list
43567862|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567863|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
43567864|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
43567865|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567866|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567867|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567868|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
43567869|NCT00694135|Hormones|hormones|mesh-ancestor
43567870|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567871|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567872|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567873|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
43567874|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744446|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43744447|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
43744448|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744449|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744450|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43744451|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744452|NCT03580902|Buprenorphine|buprenorphine|mesh-list
43744453|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43744454|NCT03580902|Naloxone|naloxone|mesh-list
43744455|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43744456|NCT03580902|Narcotics|narcotics|mesh-ancestor
43744457|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43744458|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744460|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
43744461|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744462|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43744463|NCT03575325|Cytarabine|cytarabine|mesh-list
43744464|NCT03575325|Daunorubicin|daunorubicin|mesh-list
43744465|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43744466|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
43744467|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744468|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744469|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
43849047|NCT03970382|Nivolumab|nivolumab|mesh-list
43567875|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567876|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
43567877|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43567878|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
43567891|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43567892|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567893|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567894|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
43567895|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567896|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43567897|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
43567899|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43567900|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43567901|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
43567902|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
43567903|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567904|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43567905|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43567906|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
43567907|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43567908|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43567909|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43744471|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744472|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
43744473|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744474|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43744475|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43744476|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43744477|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744478|NCT03570359|Interferons|interferons|mesh-list
43744490|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43744491|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744492|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744493|NCT03543969|Vemurafenib|vemurafenib|mesh-list
43744494|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744495|NCT03543969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744496|NCT03543969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744497|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744498|NCT03537508|Vaccines|vaccines|mesh-list
43744499|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
43744500|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744501|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
43744502|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
43744503|NCT03516279|Dasatinib|dasatinib|mesh-list
43744504|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744505|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744509|NCT03513952|Atezolizumab|atezolizumab|mesh-list
43744510|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744511|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744512|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
43744513|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835670|NCT05030194|Nicotine|nicotine|mesh-list
43835671|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43835672|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
43835673|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835685|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835686|NCT05029401|Ibogaine|ibogaine|mesh-list
43835687|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
43835688|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835689|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43835690|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43835691|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43835692|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835693|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835694|NCT05028348|Dexamethasone|dexamethasone|mesh-list
43835695|NCT05028348|Pomalidomide|pomalidomide|mesh-list
43835696|NCT05028348|Elotuzumab|elotuzumab|mesh-list
43835697|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835698|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
43835699|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
43567911|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43567912|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43567913|NCT00691964|Analgesics|analgesics|mesh-ancestor
43567914|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
43835700|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570755|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835701|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835702|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43744529|NCT03504423|Vitamins|vitamins|mesh-ancestor
43744530|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
43744531|NCT03504423|Hematinics|hematinics|mesh-ancestor
43744532|NCT03503409|Ivosidenib|ivosidenib|mesh-list
43744533|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744534|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744535|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744536|NCT03492177|Selexipag|selexipag|mesh-list
43744537|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43744538|NCT03484819|Nivolumab|nivolumab|mesh-list
43567916|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567917|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567918|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567919|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567920|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43567921|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
43567922|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
43567923|NCT00691717|Anecortave|anecortave|mesh-list
43567924|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43567925|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43567926|NCT00691717|Growth Substances|growth substances|mesh-ancestor
43567927|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567928|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
43567929|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567930|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567931|NCT00690456|Metformin|metformin|mesh-list
43567932|NCT00690456|Rimonabant|rimonabant|mesh-list
43567933|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567934|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567935|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43567936|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43704388|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43744546|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43744547|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
43744548|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744549|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744550|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
43744551|NCT03422328|Macitentan|macitentan|mesh-list
43744552|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43744553|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43744554|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744555|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43744556|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
43744557|NCT03419234|Prednisone|prednisone|mesh-list
43744558|NCT03419234|Cortisone|cortisone|mesh-list
43744559|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
43744560|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
43744561|NCT03419234|Hormones|hormones|mesh-list
43744562|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43744563|NCT03419234|Androgens|androgens|mesh-list
43744564|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
43744565|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43744566|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
43744567|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43744568|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744584|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744585|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744586|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744587|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744588|NCT03334253|Atropine|atropine|mesh-list
43744589|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43744592|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43744593|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
43744594|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567942|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
43567943|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567944|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
43567960|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567961|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
43567962|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567963|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
43567964|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567965|NCT00682981|Carboplatin|carboplatin|mesh-list
43567966|NCT00682981|Etoposide|etoposide|mesh-list
43567967|NCT00682981|Obatoclax|obatoclax|mesh-list
43567968|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567974|NCT00680784|Ketoprofen|ketoprofen|mesh-list
43567975|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43567976|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43567977|NCT00680784|Analgesics|analgesics|mesh-ancestor
43567978|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
43567979|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567980|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567981|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567982|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567983|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43567984|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567985|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567986|NCT00680472|Ketoprofen|ketoprofen|mesh-list
43567987|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43567988|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43567999|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
43568000|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568001|NCT00680342|Protective Agents|protective agents|mesh-ancestor
43568002|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568003|NCT00679731|Methotrexate|methotrexate|mesh-list
43568004|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43568005|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
43568006|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43568017|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43568018|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43568019|NCT00679588|Enoxaparin|enoxaparin|mesh-list
43744624|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43744625|NCT03291847|Naloxone|naloxone|mesh-list
43744626|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43744627|NCT03291847|Narcotics|narcotics|mesh-ancestor
43744628|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43744629|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744630|NCT03291847|Analgesics|analgesics|mesh-ancestor
43744631|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
43744632|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744633|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43744634|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
43744635|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
43744636|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
43744637|NCT03276832|Imiquimod|imiquimod|mesh-list
43744638|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744639|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744640|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43744641|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
43744642|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744643|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
43744644|NCT03267433|Rituximab|rituximab|mesh-list
43744645|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744646|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570782|NCT00382460|Pravastatin|pravastatin|mesh-list
43744647|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
43744648|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744649|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43744650|NCT03263572|Cytarabine|cytarabine|mesh-list
43744651|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43744652|NCT03263572|Methotrexate|methotrexate|mesh-list
43744653|NCT03263572|Blinatumomab|blinatumomab|mesh-list
43744670|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744671|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43744683|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744684|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43744685|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43744686|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744687|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43744688|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43744689|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
43744691|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43744692|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43744693|NCT03258554|Cetuximab|cetuximab|mesh-list
43744694|NCT03258554|Durvalumab|durvalumab|mesh-list
43744718|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744719|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
43744720|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744721|NCT03212274|Olaparib|olaparib|mesh-list
43744722|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43744723|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744724|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744725|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744727|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43744728|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744729|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43744730|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744731|NCT03155620|Olaparib|olaparib|mesh-list
43744732|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43744733|NCT03155620|Palbociclib|palbociclib|mesh-list
43744734|NCT03155620|Vemurafenib|vemurafenib|mesh-list
43744735|NCT03155620|Tipifarnib|tipifarnib|mesh-list
43744736|NCT03155620|Ensartinib|ensartinib|mesh-list
43744737|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744738|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568028|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43568029|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43568030|NCT00678119|Growth Substances|growth substances|mesh-ancestor
43568031|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568033|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43568034|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744743|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744744|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
43744745|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744747|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744748|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744752|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
43744753|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
43744754|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43744755|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744756|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
43744757|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744758|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43744759|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43744760|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43744761|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43744762|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744763|NCT03038672|Nivolumab|nivolumab|mesh-list
43744764|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
43744765|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
43744766|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744767|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744768|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744769|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744770|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744771|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
43744772|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744773|NCT03031730|Dexamethasone|dexamethasone|mesh-list
43744774|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
43744775|NCT03031730|Lenalidomide|lenalidomide|mesh-list
43744782|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744783|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744784|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43744785|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
43744787|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43744789|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744790|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
43744791|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744792|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744793|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
43744794|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43744795|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43744796|NCT03031730|Growth Substances|growth substances|mesh-ancestor
43744797|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
43744798|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
43744799|NCT03015129|Durvalumab|durvalumab|mesh-list
43744800|NCT03015129|Tremelimumab|tremelimumab|mesh-list
43744801|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744802|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744803|NCT02994719|Amantadine|amantadine|mesh-list
43744804|NCT02994719|Levodopa|levodopa|mesh-list
43744812|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43547849|NCT03648229|Timolol|timolol|mesh-list
43744813|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
43568035|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568036|NCT00677079|Iniparib|iniparib|mesh-list
43568037|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43568038|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568039|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568040|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748006|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748007|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748008|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
43748009|NCT04323046|Nivolumab|nivolumab|mesh-list
43748010|NCT04323046|Ipilimumab|ipilimumab|mesh-list
43748012|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748017|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748018|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
43748019|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568041|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
43568042|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43568043|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
43568044|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43744814|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43744815|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744816|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744817|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43744819|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
43744820|NCT02994719|Protective Agents|protective agents|mesh-ancestor
43744821|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
43744822|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
43744823|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744824|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43744825|NCT02994719|Analgesics|analgesics|mesh-ancestor
43744826|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
43744827|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704390|NCT05024006|Ritonavir|ritonavir|mesh-list
43744829|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43744830|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
43744867|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43744868|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744869|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43744870|NCT02926859|Cannabidiol|cannabidiol|mesh-list
43744871|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
43744872|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43744873|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744874|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744875|NCT02908672|Atezolizumab|atezolizumab|mesh-list
43744876|NCT02908672|Vemurafenib|vemurafenib|mesh-list
43744877|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744878|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744879|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
43744880|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744881|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744882|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744883|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744884|NCT02893917|Olaparib|olaparib|mesh-list
43744885|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43744886|NCT02893917|Cediranib|cediranib|mesh-list
43744887|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744888|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744889|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568075|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568076|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43568077|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43568078|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
43568079|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
43568080|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568081|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568082|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568083|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
43568084|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43568085|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43568086|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
43568087|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568088|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568089|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43568090|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
43568091|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
43744920|NCT02888743|Durvalumab|durvalumab|mesh-list
43744921|NCT02888743|Ipilimumab|ipilimumab|mesh-list
43568092|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43568093|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
43568094|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568095|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568096|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43748020|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
43568097|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43568098|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43568099|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568100|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
43568101|NCT00673062|Ephedrine|ephedrine|mesh-list
43568102|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43568103|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
43568104|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568105|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568106|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43568107|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
43568108|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
43568109|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43568110|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43568111|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
43568112|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568113|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568114|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568115|NCT00672997|Timolol|timolol|mesh-list
43568116|NCT00672997|Travoprost|travoprost|mesh-list
43568117|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43568118|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43548001|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
43835703|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
43568119|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43568120|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43568121|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568122|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568123|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568124|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568125|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43568126|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43568127|NCT00672412|Lamivudine|lamivudine|mesh-list
43568128|NCT00672412|Zidovudine|zidovudine|mesh-list
43568129|NCT00672412|Nevirapine|nevirapine|mesh-list
43704391|NCT05024006|Lopinavir|lopinavir|mesh-list
43745162|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
43745163|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
43745164|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745165|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43745167|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745168|NCT02659241|Adavosertib|adavosertib|mesh-list
43745169|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745170|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745180|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
43745181|NCT02636725|Axitinib|axitinib|mesh-list
43745182|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745183|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745184|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43745185|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745186|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835704|NCT05028348|Hormones|hormones|mesh-ancestor
43835705|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835706|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43835707|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835708|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
43835709|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43835722|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835723|NCT05025800|Rituximab|rituximab|mesh-list
43835724|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43835725|NCT05025800|Lenalidomide|lenalidomide|mesh-list
43835743|NCT05025787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835744|NCT05025787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835745|NCT05025787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835746|NCT05025787|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43835747|NCT05025787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43835748|NCT05025787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835749|NCT05025787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745198|NCT02576574|Gemcitabine|gemcitabine|mesh-list
43745199|NCT02576574|Paclitaxel|paclitaxel|mesh-list
43745200|NCT02576574|Cisplatin|cisplatin|mesh-list
43745201|NCT02576574|Carboplatin|carboplatin|mesh-list
43745202|NCT02576574|Pemetrexed|pemetrexed|mesh-list
43745203|NCT02576574|Avelumab|avelumab|mesh-list
43745204|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43745205|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43745206|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745207|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745208|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745209|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745225|NCT02568553|Antibodies|antibodies|mesh-list
43745226|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
43745227|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43745228|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
43745229|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43745230|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
43745231|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745232|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745233|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43745238|NCT02567422|Cisplatin|cisplatin|mesh-list
43745239|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745240|NCT02560298|Paclitaxel|paclitaxel|mesh-list
43745241|NCT02560298|Cisplatin|cisplatin|mesh-list
43745242|NCT02560298|Carboplatin|carboplatin|mesh-list
43745243|NCT02560298|Fluorouracil|fluorouracil|mesh-list
43745244|NCT02560298|Capecitabine|capecitabine|mesh-list
43745245|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43745246|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43745247|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745248|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745249|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745250|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745251|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745252|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
43745253|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43745254|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745255|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
43745256|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745257|NCT02520921|Aspirin|aspirin|mesh-list
43745258|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43745259|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43745260|NCT02520921|Analgesics|analgesics|mesh-ancestor
43745261|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
43745265|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745266|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43745267|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43745268|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745269|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43745270|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43745271|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704392|NCT05024006|Interferon-beta|interferon-beta|mesh-list
43745311|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43568202|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
43568219|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568220|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
43568221|NCT00662506|Temozolomide|temozolomide|mesh-list
43568222|NCT00662506|Cediranib|cediranib|mesh-list
43568223|NCT00662506|Maleic acid|maleic acid|mesh-list
43568224|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43568225|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43568226|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
43568227|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568228|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568229|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568230|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43568231|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43568232|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
43568233|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
43568234|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568235|NCT00660881|Epratuzumab|epratuzumab|mesh-list
43568236|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568237|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568238|NCT00659191|Cabotegravir|cabotegravir|mesh-list
43568246|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568247|NCT00659061|Micronutrients|micronutrients|mesh-list
43568248|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568249|NCT00658762|Paroxetine|paroxetine|mesh-list
43849048|NCT03970382|Interleukin-2|interleukin-2|mesh-list
43849049|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568250|NCT00658762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43568251|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43704393|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
43568253|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568254|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568255|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
43745327|NCT02465060|Palbociclib|palbociclib|mesh-list
43745328|NCT02465060|Trametinib|trametinib|mesh-list
43745329|NCT02465060|Osimertinib|osimertinib|mesh-list
43745330|NCT02465060|Afatinib|afatinib|mesh-list
43745331|NCT02465060|Dabrafenib|dabrafenib|mesh-list
43745332|NCT02465060|Crizotinib|crizotinib|mesh-list
43745333|NCT02465060|Maytansine|maytansine|mesh-list
43745334|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43745335|NCT02465060|GSK2636771|gsk2636771|mesh-list
43745336|NCT02465060|Antibodies|antibodies|mesh-list
43745337|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
43745338|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43745339|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
43745340|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
43745341|NCT02465060|Adavosertib|adavosertib|mesh-list
43745342|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
43745343|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745344|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745345|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43745346|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745347|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43745348|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43745349|NCT02465060|Growth Substances|growth substances|mesh-ancestor
43745350|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
43745351|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43745352|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748042|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748043|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
43748044|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
43748045|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748046|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748047|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43745353|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43745354|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745355|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
43748048|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
43745356|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745357|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
43745358|NCT02457598|Idelalisib|idelalisib|mesh-list
43745359|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745360|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745361|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745362|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745371|NCT02446600|Maleic acid|maleic acid|mesh-list
43745372|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43745373|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745374|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745375|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745376|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745377|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745378|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43745379|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
43745380|NCT02446600|Antiviral Agents|antiviral agents|mesh-ancestor
43745381|NCT02446600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43745382|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745383|NCT02446600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43568277|NCT00658047|Methotrexate|methotrexate|mesh-list
43568278|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43568279|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
43568280|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43568281|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568282|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43568283|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
43568284|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568285|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568286|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
43568287|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568288|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43568289|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43568290|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
43568291|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43568292|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43568293|NCT00658008|Paroxetine|paroxetine|mesh-list
43745432|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
43745433|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43745434|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
43745435|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745436|NCT02425644|Teriflunomide|teriflunomide|mesh-list
43745437|NCT02425644|Ponesimod|ponesimod|mesh-list
43745438|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43745439|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43745441|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
43745442|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745443|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745444|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43745445|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745446|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745447|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
43704394|NCT05024006|Remdesivir|remdesivir|mesh-list
43745466|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745467|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745469|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
43745470|NCT02393859|Hormones|hormones|mesh-ancestor
43745471|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43745472|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43745473|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745474|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43745475|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
43745476|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43745477|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43745478|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
43745479|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745480|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
43745481|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745482|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43745483|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745484|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
43745485|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745486|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43745487|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43745489|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43745490|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43745491|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
43745544|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
43745545|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43745546|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
43745547|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
43745548|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745549|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745550|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
43745551|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43745552|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
43568296|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568297|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568298|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568299|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
43568300|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568301|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43568302|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568303|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568304|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43568305|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43568306|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568307|NCT00657501|Testosterone|testosterone|mesh-list
43568308|NCT00657501|Androgens|androgens|mesh-ancestor
43568310|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568311|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568312|NCT00657189|Sifalimumab|sifalimumab|mesh-list
43568313|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43568314|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
43568315|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568316|NCT00656539|Azithromycin|azithromycin|mesh-list
43568317|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568318|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568319|NCT00656357|Cocaine|cocaine|mesh-list
43745553|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
43704395|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
43745574|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
43745575|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43745576|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745577|NCT02233829|Protective Agents|protective agents|mesh-ancestor
43568320|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
43568321|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
43568322|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43745611|NCT02186834|Dexamethasone|dexamethasone|mesh-list
43745612|NCT02186834|Doxorubicin|doxorubicin|mesh-list
43745613|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43745614|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43745615|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
43745616|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
43745617|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570785|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
43745643|NCT02157610|Nicotine|nicotine|mesh-list
43745644|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43745645|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
43745646|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745752|NCT01979536|Cytarabine|cytarabine|mesh-list
43745753|NCT01979536|Dexamethasone|dexamethasone|mesh-list
43745754|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
43745755|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
43548762|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
43745756|NCT01979536|Ifosfamide|ifosfamide|mesh-list
43745757|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
43745759|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43745760|NCT01979536|Methotrexate|methotrexate|mesh-list
43745761|NCT01979536|Etoposide|etoposide|mesh-list
43745762|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
43745763|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43568360|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43568361|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43568362|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
43568363|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568364|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568365|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43568366|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
43568367|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
43568368|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43568369|NCT00647231|Ketoprofen|ketoprofen|mesh-list
43568370|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43568371|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43568372|NCT00647231|Analgesics|analgesics|mesh-ancestor
43568373|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
43568374|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568375|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568376|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43568377|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43568378|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43568379|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568380|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568381|NCT00646542|Vildagliptin|vildagliptin|mesh-list
43568382|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43568383|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568384|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43568385|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
43568386|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568387|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568389|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43568390|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568391|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745764|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
43745765|NCT01979536|Crizotinib|crizotinib|mesh-list
43568429|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43745835|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745836|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43745837|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
43745838|NCT01917552|Capecitabine|capecitabine|mesh-list
43745839|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43745840|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
43745841|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745842|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568430|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
43568431|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748091|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748092|NCT04088591|Vitamins|vitamins|mesh-ancestor
43748093|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
43748094|NCT03952091|Dexamethasone|dexamethasone|mesh-list
43748095|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
43748096|NCT03952091|Lenalidomide|lenalidomide|mesh-list
43748097|NCT03952091|BB 1101|bb 1101|mesh-list
43568432|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568433|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43568434|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
43568435|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43568436|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43568437|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43568438|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568439|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568440|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745856|NCT01873326|Paclitaxel|paclitaxel|mesh-list
43745857|NCT01873326|Etoposide|etoposide|mesh-list
43745858|NCT01873326|Cisplatin|cisplatin|mesh-list
43745862|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745863|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745864|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745865|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745866|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745867|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43745868|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43745869|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745870|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43745871|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
43745872|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43745873|NCT01863550|Dexamethasone|dexamethasone|mesh-list
43745874|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
43745875|NCT01863550|Lenalidomide|lenalidomide|mesh-list
43745876|NCT01863550|Bortezomib|bortezomib|mesh-list
43745877|NCT01863550|Ichthammol|ichthammol|mesh-list
43745878|NCT01863550|BB 1101|bb 1101|mesh-list
43745879|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43745880|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
43745881|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
43745882|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745883|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745884|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43745885|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
43745887|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43745902|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745903|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745904|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43745905|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
43745906|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745907|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745908|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43745910|NCT01856192|Cortisone|cortisone|mesh-list
43745911|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
43745912|NCT01856192|Rituximab|rituximab|mesh-list
43745913|NCT01856192|Doxorubicin|doxorubicin|mesh-list
43745914|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43745915|NCT01856192|Vincristine|vincristine|mesh-list
43745916|NCT01856192|Lenalidomide|lenalidomide|mesh-list
43745917|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43745918|NCT01856192|Antibodies|antibodies|mesh-list
43745919|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
43745920|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43745921|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745922|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
43745923|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745924|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745925|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43745926|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
43745927|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745928|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745929|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43745930|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43748098|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43745931|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43745932|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43745933|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745934|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43745935|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
43745936|NCT01856192|Hormones|hormones|mesh-ancestor
43745937|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43745938|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43745940|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745941|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745942|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745943|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43745944|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43745945|NCT01856192|Growth Substances|growth substances|mesh-ancestor
43745946|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
43745947|NCT01758328|Fludarabine|fludarabine|mesh-list
43745949|NCT01758328|Busulfan|busulfan|mesh-list
43745950|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43745951|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745952|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745953|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745954|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
43745955|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745956|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43745957|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
43745958|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43745959|NCT01755975|Lenalidomide|lenalidomide|mesh-list
43745960|NCT01755975|Romidepsin|romidepsin|mesh-list
43745961|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
43745962|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745963|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43745964|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43568450|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568451|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568452|NCT00629551|Paroxetine|paroxetine|mesh-list
43568453|NCT00629551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43568454|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568455|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568456|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568457|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568458|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
43568459|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568460|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43568461|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568462|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568463|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43568473|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568475|NCT00626106|Fulvestrant|fulvestrant|mesh-list
43745965|NCT01755975|Growth Substances|growth substances|mesh-ancestor
43745966|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
43745967|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745968|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43745969|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
43745970|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745971|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43745972|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745973|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745974|NCT01538966|Octreotide|octreotide|mesh-list
43745975|NCT01538966|Lanreotide|lanreotide|mesh-list
43745976|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43745977|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43745979|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
43745980|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745981|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
43745982|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745983|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745984|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43745985|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
43745986|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745987|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745988|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43745989|NCT01356290|Cytarabine|cytarabine|mesh-list
43745990|NCT01356290|Thalidomide|thalidomide|mesh-list
43745991|NCT01356290|Celecoxib|celecoxib|mesh-list
43745992|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
43745993|NCT01356290|Bevacizumab|bevacizumab|mesh-list
43745994|NCT01356290|Etoposide|etoposide|mesh-list
43745995|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
43745996|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
43745997|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745998|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
43568476|NCT00626106|Exemestane|exemestane|mesh-list
43568477|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43568478|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43745999|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746000|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43746001|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43746002|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
43746003|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746004|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746005|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43746006|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43746007|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43746008|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43746009|NCT01356290|Growth Substances|growth substances|mesh-ancestor
43746010|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
43746011|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43746012|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43746013|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43746014|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746015|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746016|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
43746017|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
43746018|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746019|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43746020|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43568479|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568480|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43568481|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43568482|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
43568483|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568484|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568485|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43568486|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43568487|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568488|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568489|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
43568491|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568492|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568493|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43568494|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568495|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568496|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568497|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568498|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568499|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568500|NCT00625664|Gemcitabine|gemcitabine|mesh-list
43568501|NCT00625664|Cisplatin|cisplatin|mesh-list
43568502|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568503|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43568504|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
43746021|NCT01356290|Analgesics|analgesics|mesh-ancestor
43746022|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
43746023|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746024|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43746025|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43746026|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43746027|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
43746028|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43746029|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43746030|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43746031|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43568505|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568507|NCT00625664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568508|NCT00625664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568509|NCT00625664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43568510|NCT00625664|Immunologic Factors|immunologic factors|mesh-ancestor
43568511|NCT00625664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568512|NCT00625651|Bevacizumab|bevacizumab|mesh-list
43568513|NCT00625651|Conatumumab|conatumumab|mesh-list
43568514|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568515|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568516|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43568517|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43568518|NCT00625651|Growth Substances|growth substances|mesh-ancestor
43568519|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568520|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
43568521|NCT00625326|Calcipotriene|calcipotriene|mesh-list
43568522|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
43568523|NCT00624858|Naltrexone|naltrexone|mesh-list
43568524|NCT00624858|Bupropion|bupropion|mesh-list
43568525|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43568526|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43568527|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748122|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568528|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
43568529|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568537|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
43568538|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568539|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43568540|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43568541|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568543|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568544|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568545|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
43568546|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568547|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43568548|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43568549|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568550|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568551|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
43568552|NCT00620256|Timolol|timolol|mesh-list
43568553|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43568554|NCT00620256|Latanoprost|latanoprost|mesh-list
43568555|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43568556|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43568557|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43568558|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568559|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568560|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568561|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568562|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43746033|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
43746034|NCT01339910|Melphalan|melphalan|mesh-list
43746035|NCT01339910|Busulfan|busulfan|mesh-list
43746036|NCT01339910|Fludarabine|fludarabine|mesh-list
43746042|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43746043|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
43746044|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568563|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43568567|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43568568|NCT00616811|Vildagliptin|vildagliptin|mesh-list
43568569|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43568570|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568571|NCT00616811|Incretins|incretins|mesh-ancestor
43568572|NCT00616811|Hormones|hormones|mesh-ancestor
43568573|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568574|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43568575|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
43568576|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568577|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568578|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
43568579|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43568583|NCT00616330|Clindamycin|clindamycin|mesh-list
43568584|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
43568585|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
43568586|NCT00616330|Butoconazole|butoconazole|mesh-list
43568587|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568588|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568589|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43568590|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568591|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748133|NCT03863184|Rituximab|rituximab|mesh-list
43748134|NCT03863184|Lenalidomide|lenalidomide|mesh-list
43748135|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
43748136|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568592|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
43748158|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
43568593|NCT00616148|Cenobamate|cenobamate|mesh-list
43568595|NCT00615251|Progesterone|progesterone|mesh-list
43568606|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568607|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568610|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
43568611|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43568612|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43568613|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
43568614|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568615|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568616|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43568617|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
43568618|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
43568619|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43568620|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43568621|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43568622|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746045|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746046|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43568638|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568639|NCT00612118|Azelastine|azelastine|mesh-list
43568640|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
43568641|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43568646|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
43568647|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43568648|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748164|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748165|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748166|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748167|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
43748169|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748171|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43568649|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568650|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43746069|NCT01261728|Cisplatin|cisplatin|mesh-list
43746070|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746071|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746072|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
43746073|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746074|NCT01261728|Antiviral Agents|antiviral agents|mesh-ancestor
43746075|NCT01261728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746076|NCT01261728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746077|NCT01261728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746078|NCT01261728|Immunologic Factors|immunologic factors|mesh-ancestor
43746079|NCT01261728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746080|NCT01247324|Interferons|interferons|mesh-list
43746081|NCT01247324|Interferon-beta|interferon-beta|mesh-list
43746089|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43746090|NCT01242267|Thalidomide|thalidomide|mesh-list
43746091|NCT01242267|Bortezomib|bortezomib|mesh-list
43746092|NCT01242267|Melphalan|melphalan|mesh-list
43746093|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746094|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43746095|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
43746096|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746097|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43746098|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746099|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
43746100|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746101|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
43746102|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43746103|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568651|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43746104|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43746105|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43746115|NCT01141712|Etoposide|etoposide|mesh-list
43746116|NCT01141712|Melphalan|melphalan|mesh-list
43549118|NCT03635827|Xenon|xenon|mesh-list
43746117|NCT01141712|Carmustine|carmustine|mesh-list
43746118|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43746119|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746120|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43746121|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43746122|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746123|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746124|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746125|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
43746126|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
43746127|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746128|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748204|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748205|NCT03664895|Goserelin|goserelin|mesh-list
43748206|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748207|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748208|NCT03662919|Adalimumab|adalimumab|mesh-list
43748209|NCT03662919|Infliximab|infliximab|mesh-list
43748210|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748211|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748235|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746129|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
43746130|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746131|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43746132|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
43746133|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43746134|NCT01093326|Ponesimod|ponesimod|mesh-list
43746135|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43746144|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
43746145|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43746146|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746148|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746149|NCT00903110|Mecasermin|mecasermin|mesh-list
43746150|NCT00903110|Growth Substances|growth substances|mesh-ancestor
43746151|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746152|NCT00799110|Imiquimod|imiquimod|mesh-list
43746153|NCT00799110|Vaccines|vaccines|mesh-list
43746154|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
43746155|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746156|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43746157|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746158|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
43746159|NCT00770809|Paclitaxel|paclitaxel|mesh-list
43746160|NCT00770809|Trastuzumab|trastuzumab|mesh-list
43746161|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43746162|NCT00770809|Lapatinib|lapatinib|mesh-list
43746163|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43746164|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43746165|NCT00770809|Antibodies|antibodies|mesh-list
43746166|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
43746167|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43746168|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43746169|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746170|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
43746171|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
43746172|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
43746173|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746174|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
43568654|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
43568655|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568664|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
43568665|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568666|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43568667|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43568668|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43568669|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568670|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568685|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568686|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568687|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
43568688|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
43568689|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568690|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43568691|NCT00603616|Rifaximin|rifaximin|mesh-list
43568692|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568693|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568694|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43568695|NCT00603577|Xaliproden|xaliproden|mesh-list
43748236|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43568696|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43568697|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43568698|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
43568699|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568700|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568701|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568702|NCT00602745|Fluorouracil|fluorouracil|mesh-list
43568703|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
43568704|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568705|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43568706|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568707|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43568708|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
43568709|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568744|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568745|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43568760|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43568763|NCT00595699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43568764|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568765|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568766|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568767|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568768|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
43568769|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568770|NCT00595699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43568771|NCT00595699|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568772|NCT00595699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568773|NCT00595426|Warfarin|warfarin|mesh-list
43568774|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
43568775|NCT00594984|Irinotecan|irinotecan|mesh-list
43568776|NCT00594984|Cetuximab|cetuximab|mesh-list
43568777|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43568778|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43568779|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568780|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568781|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568782|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568783|NCT00589875|Valacyclovir|valacyclovir|mesh-list
43568784|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
43568785|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568786|NCT00589823|Fentanyl|fentanyl|mesh-list
43568787|NCT00589823|Morphine|morphine|mesh-list
43568788|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43568789|NCT00589823|Narcotics|narcotics|mesh-ancestor
43568790|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43568801|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568808|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568809|NCT00583830|Paclitaxel|paclitaxel|mesh-list
43568810|NCT00583830|Carboplatin|carboplatin|mesh-list
43568811|NCT00583830|Mapatumumab|mapatumumab|mesh-list
43568812|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43568813|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43568814|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568815|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
43746188|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746189|NCT00697684|Clofarabine|clofarabine|mesh-list
43746190|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43746191|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746192|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
43568816|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
43568817|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
43568818|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568819|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
43568820|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568821|NCT00583674|Cisplatin|cisplatin|mesh-list
43568822|NCT00583674|Capecitabine|capecitabine|mesh-list
43568823|NCT00583674|Trebananib|trebananib|mesh-list
43568824|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568825|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43568826|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
43568827|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568828|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43568829|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43568830|NCT00583674|Growth Substances|growth substances|mesh-ancestor
43568831|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748243|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43748246|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
43568832|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
43568833|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43568834|NCT00583609|Laxatives|laxatives|mesh-ancestor
43568835|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43568836|NCT00581477|Droxidopa|droxidopa|mesh-list
43568837|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43568838|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43568839|NCT00580216|Biotin|biotin|mesh-list
43568840|NCT00580216|Warfarin|warfarin|mesh-list
43568841|NCT00580216|Idraparinux|idraparinux|mesh-list
43568842|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
43568843|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
43568844|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43568845|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
43568846|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43568847|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
43568848|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568849|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568850|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
43568851|NCT00580216|Vitamins|vitamins|mesh-ancestor
43568852|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
43568853|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568864|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568865|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43568866|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43568867|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
43568868|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43568869|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43568870|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43568871|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43568872|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
43568873|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43568874|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568875|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568876|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43568877|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43568878|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568879|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568880|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568881|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
43568882|NCT00579020|Dexamethasone|dexamethasone|mesh-list
43568883|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
43568884|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43568885|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43568886|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43568887|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43568888|NCT00579020|BB 1101|bb 1101|mesh-list
43568889|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43568890|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
43568891|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
43568892|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568893|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568894|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43746256|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43746257|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
43746258|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746266|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43746267|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746268|NCT00588991|Carboplatin|carboplatin|mesh-list
43746269|NCT00588991|Topotecan|topotecan|mesh-list
43746270|NCT00588991|Veliparib|veliparib|mesh-list
43746271|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746272|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43746273|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43746274|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748250|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746275|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746276|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43568895|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
43568896|NCT00579020|Hormones|hormones|mesh-ancestor
43568897|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568898|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43568899|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568900|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
43568901|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568902|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568903|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568904|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568905|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43568906|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43568907|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43568908|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
43568909|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43568910|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43568911|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43568912|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43568913|NCT00578955|Azithromycin|azithromycin|mesh-list
43568914|NCT00578955|Dexamethasone|dexamethasone|mesh-list
43568915|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
43568916|NCT00578955|BB 1101|bb 1101|mesh-list
43568917|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43568937|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43568938|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43568939|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568940|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568941|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568942|NCT00578474|Ofloxacin|ofloxacin|mesh-list
43568943|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43568944|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43568945|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568946|NCT00578474|Renal Agents|renal agents|mesh-ancestor
43568947|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568948|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43568949|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43568950|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568951|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746311|NCT00408005|Leucovorin|leucovorin|mesh-list
43746312|NCT00408005|Folic Acid|folic acid|mesh-list
43746313|NCT00408005|Cytarabine|cytarabine|mesh-list
43746314|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
43746315|NCT00408005|Dexamethasone|dexamethasone|mesh-list
43746316|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
43746317|NCT00408005|Prednisone|prednisone|mesh-list
43746318|NCT00408005|Cortisone|cortisone|mesh-list
43746319|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
43746334|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
43746335|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746336|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43746337|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43746338|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
43746339|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746340|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746341|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43568952|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568953|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43568954|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43568955|NCT00577148|Rimonabant|rimonabant|mesh-list
43568956|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43568957|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43568958|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43746352|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746353|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43746354|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43746355|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43746356|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43746357|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43746358|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43746359|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
43746360|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43746361|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746362|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
43746363|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
43746364|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43746365|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43746366|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
43746367|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746369|NCT00408005|Protective Agents|protective agents|mesh-ancestor
43746370|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
43746371|NCT00408005|Vitamins|vitamins|mesh-ancestor
43746372|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
43746373|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43746374|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
43746375|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
43746376|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
43746377|NCT00408005|Hematinics|hematinics|mesh-ancestor
43568959|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568960|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746379|NCT00406393|Methotrexate|methotrexate|mesh-list
43746380|NCT00406393|Tacrolimus|tacrolimus|mesh-list
43746381|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43746382|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
43748349|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
43748350|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748351|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
43748352|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43748353|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43748354|NCT02378298|Prednisolone|prednisolone|mesh-list
43748355|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
43748356|NCT02378298|Rituximab|rituximab|mesh-list
43748357|NCT02378298|Methotrexate|methotrexate|mesh-list
43748358|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43748359|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
43551586|NCT03612349|Menthol|menthol|mesh-list
43746383|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43746384|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746385|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746386|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
43746387|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746388|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746389|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
43746390|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746391|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43568963|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568964|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
43568966|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43568967|NCT00576667|Rimonabant|rimonabant|mesh-list
43568968|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43568969|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43568970|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43568971|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568972|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568973|NCT00576667|Hormones|hormones|mesh-ancestor
43568974|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568975|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568976|NCT00576537|Vaccines|vaccines|mesh-list
43568977|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
43568978|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568979|NCT00576342|Timolol|timolol|mesh-list
43746405|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748360|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748361|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746406|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746407|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746408|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43746409|NCT00335816|Leucovorin|leucovorin|mesh-list
43746410|NCT00335816|Fluorouracil|fluorouracil|mesh-list
43746411|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
43746412|NCT00335816|Calcium|calcium|mesh-list
43746413|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
43746414|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43746415|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746416|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
43704397|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746417|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569002|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43569003|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569005|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
43569006|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569007|NCT00566202|Citalopram|citalopram|mesh-list
43569008|NCT00566202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43704398|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
43569025|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43569026|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43569027|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43569028|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
43569029|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748362|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
43569030|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746479|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746480|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
43746481|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43746482|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43746483|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
43746484|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746485|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
43746486|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
43746501|NCT02523820|Fluticasone|fluticasone|mesh-list
43746503|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43746504|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43746505|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
43569043|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43569044|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43569045|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569046|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569047|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
43569048|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746512|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
43746513|NCT02523911|Simethicone|simethicone|mesh-list
43746514|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
43746515|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43746516|NCT02523911|Analgesics|analgesics|mesh-ancestor
43746517|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
43746518|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746519|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746520|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
43746521|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43746522|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43746523|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
43746524|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43746525|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43746526|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746527|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43746528|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
43746529|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43569090|NCT00561743|Hormones|hormones|mesh-ancestor
43569091|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569092|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43569093|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569094|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43746534|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43746535|NCT02523898|Metformin|metformin|mesh-list
43746536|NCT02523898|Clomiphene|clomiphene|mesh-list
43746540|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746542|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
43746543|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43746544|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43746545|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
43746546|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43748387|NCT02253108|Everolimus|everolimus|mesh-list
43746547|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43746548|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43746549|NCT02523768|Basiliximab|basiliximab|mesh-list
43746550|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746551|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
43746552|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746553|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
43746554|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
43746555|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43569109|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43746563|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746564|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746565|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43746566|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
43746567|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
43746568|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43746569|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43746570|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43746583|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43746584|NCT02523846|Narcotics|narcotics|mesh-ancestor
43746585|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569110|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43569111|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569112|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569124|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43569125|NCT00549510|Protective Agents|protective agents|mesh-ancestor
43569126|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849051|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43849052|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569127|NCT00547651|Topotecan|topotecan|mesh-list
43569128|NCT00547651|Amrubicin|amrubicin|mesh-list
43746590|NCT02523755|Ropivacaine|ropivacaine|mesh-list
43746591|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
43746592|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
43746593|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43746603|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569147|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
43569148|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569149|NCT00544466|Fludarabine|fludarabine|mesh-list
43569150|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
43569151|NCT00544466|Melphalan|melphalan|mesh-list
43569152|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569153|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43569154|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
43694149|NCT02769832|Immunologic Factors|immunologic factors|mesh-ancestor
43694150|NCT02769832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694151|NCT02769936|Cycloserine|cycloserine|mesh-list
43836012|NCT05007873|Decitabine|decitabine|mesh-list
43836013|NCT05007873|Dasatinib|dasatinib|mesh-list
43836015|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
43694152|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43694153|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694154|NCT02769936|Renal Agents|renal agents|mesh-ancestor
43694155|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43694156|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
43694157|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43694158|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
43694159|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694160|NCT02769910|Capsaicin|capsaicin|mesh-list
43694161|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
43694162|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
43694163|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
43569162|NCT00544115|Cyclosporine|cyclosporine|mesh-list
43569163|NCT00544115|Sirolimus|sirolimus|mesh-list
43569164|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
43746608|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
43746609|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746610|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
43746611|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746612|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
43746613|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746614|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
43569165|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
43748408|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569195|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43569196|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
43569197|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569198|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43569199|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43569200|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
43569201|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43569203|NCT00543582|Mocetinostat|mocetinostat|mesh-list
43849053|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43569204|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43569205|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
43569211|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569212|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
43569213|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569214|NCT00542724|Insulin|insulin|mesh-list
43569215|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43569216|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569217|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569219|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43569220|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569221|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569222|NCT00540358|Gemcitabine|gemcitabine|mesh-list
43569223|NCT00540358|Carboplatin|carboplatin|mesh-list
43569224|NCT00540358|Iniparib|iniparib|mesh-list
43569225|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569226|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43569227|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
43748412|NCT01842035|Regadenoson|regadenoson|mesh-list
43569228|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569229|NCT00540358|Antiviral Agents|antiviral agents|mesh-ancestor
43569230|NCT00540358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569231|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569232|NCT00540358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569233|NCT00540358|Immunologic Factors|immunologic factors|mesh-ancestor
43569234|NCT00540358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569235|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43569236|NCT00539721|Ondansetron|ondansetron|mesh-list
43569237|NCT00539721|Rolapitant|rolapitant|mesh-list
43569238|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
43569239|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
43748434|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
43748436|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569240|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746615|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43746616|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
43746617|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
43746618|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43746620|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
43746621|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746622|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746623|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43569241|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569242|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43569243|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
43569244|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
43569256|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43569257|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43569265|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43569279|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569280|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43569281|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
43569282|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
43569286|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
43569287|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569288|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569289|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43569305|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
43746625|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43746627|NCT02523300|Protective Agents|protective agents|mesh-ancestor
43746628|NCT02523131|Insulin|insulin|mesh-list
43746629|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43746630|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746631|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
43746632|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
43569316|NCT00532038|Analgesics|analgesics|mesh-ancestor
43569317|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
43569318|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569319|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569320|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569321|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569322|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43569323|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569324|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569331|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
43569332|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569333|NCT00531622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43569334|NCT00531622|Antidepressive Agents|antidepressive agents|mesh-ancestor
43569335|NCT00531622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43746666|NCT02522975|Hematinics|hematinics|mesh-ancestor
43746667|NCT02522910|Docetaxel|docetaxel|mesh-list
43746668|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746669|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
43746670|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
43746671|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
43746672|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746709|NCT02522650|Triamterene|triamterene|mesh-list
43746710|NCT02522650|Diuretics|diuretics|mesh-ancestor
43746711|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
43746725|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570842|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570843|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570844|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
43570845|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746726|NCT02522234|Lenograstim|lenograstim|mesh-list
43746727|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43569401|NCT00525941|Indiplon|indiplon|mesh-list
43569402|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43569403|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569404|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569405|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
43569406|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
43569407|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569408|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569409|NCT00525330|Metformin|metformin|mesh-list
43569410|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569411|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569412|NCT00524277|Molgramostim|molgramostim|mesh-list
43569414|NCT00524277|Sargramostim|sargramostim|mesh-list
43746733|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
43746734|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43746735|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43746736|NCT02522208|Hydralazine|hydralazine|mesh-list
43746738|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43746739|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43569438|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43569445|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569447|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
43569448|NCT00519142|Mitiglinide|mitiglinide|mesh-list
43569449|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569461|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43569462|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
43569463|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569464|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43569465|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43748513|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748514|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748515|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
43748516|NCT02517619|Hormones|hormones|mesh-ancestor
43748517|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748518|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43570847|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
43570848|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43570849|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43570850|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43570852|NCT00372944|Capecitabine|capecitabine|mesh-list
43570853|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43570854|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
43570855|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570856|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569466|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570857|NCT00372437|Gemcitabine|gemcitabine|mesh-list
43569468|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43569469|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569470|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
43569471|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569472|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569473|NCT00514371|Bortezomib|bortezomib|mesh-list
43569474|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569475|NCT00514267|Prednisone|prednisone|mesh-list
43569476|NCT00514267|Docetaxel|docetaxel|mesh-list
43569479|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
43569480|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
43569481|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569482|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569483|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
43569485|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569486|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569487|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43569488|NCT00511459|Paclitaxel|paclitaxel|mesh-list
43569489|NCT00511459|Bevacizumab|bevacizumab|mesh-list
43694165|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746746|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746747|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43746749|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43746750|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
43746751|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43746752|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746753|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43746755|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
43746756|NCT02522117|Atorvastatin|atorvastatin|mesh-list
43569497|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43569498|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43569499|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43569501|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569502|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
43569503|NCT00511043|Vatalanib|vatalanib|mesh-list
43569504|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43569505|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569511|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569512|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43569513|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
43569514|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
43569515|NCT00508989|Vitamins|vitamins|mesh-ancestor
43569516|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
43569517|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569518|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43569519|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
43569520|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569521|NCT00508625|Paclitaxel|paclitaxel|mesh-list
43569522|NCT00508625|Bevacizumab|bevacizumab|mesh-list
43569523|NCT00508625|Carboplatin|carboplatin|mesh-list
43570868|NCT00372437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570869|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43570870|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43570871|NCT00370383|Satraplatin|satraplatin|mesh-list
43570872|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570873|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43570874|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748528|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748529|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
43836041|NCT05006638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43569524|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43569525|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569526|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
43569527|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
43569528|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
43569529|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569530|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43569531|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43569532|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43569533|NCT00508625|Growth Substances|growth substances|mesh-ancestor
43569534|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569535|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
43569536|NCT00508066|Bupivacaine|bupivacaine|mesh-list
43569537|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
43569538|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
43569540|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569541|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
43746759|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
43746760|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746761|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43746762|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43746763|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746764|NCT02522130|Naproxen|naproxen|mesh-list
43746765|NCT02522130|Lidocaine|lidocaine|mesh-list
43746766|NCT02522130|Misoprostol|misoprostol|mesh-list
43746767|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
43746768|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
43746769|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43746770|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746771|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
43746772|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746773|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43746774|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43569542|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569543|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43569544|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43569545|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43569546|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569547|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569548|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569549|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569550|NCT00507936|Analgesics|analgesics|mesh-ancestor
43569551|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
43569552|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569553|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
43569554|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43569555|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
43569556|NCT00501709|Abatacept|abatacept|mesh-list
43569557|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43551759|NCT03610880|Yimitasvir|yimitasvir|mesh-list
43748530|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748531|NCT02517424|Dronabinol|dronabinol|mesh-list
43748532|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
43748533|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748534|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43748535|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43748536|NCT02517424|Analgesics|analgesics|mesh-ancestor
43748537|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
43748538|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748539|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43748540|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43569558|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43569559|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569560|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569561|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
43569562|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569563|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569565|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569566|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43569567|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569568|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569569|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
43569570|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43569571|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
43569572|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569573|NCT00495885|Volinanserin|volinanserin|mesh-list
43849055|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
43569582|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
43569583|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43569584|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569585|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
43569586|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569587|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
43569588|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746775|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43746776|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43746777|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746778|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43746779|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
43746780|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43746781|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43746782|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43746783|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
43746784|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43746785|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43746786|NCT02522130|Analgesics|analgesics|mesh-ancestor
43746787|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43746788|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43746789|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
43746790|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43746791|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746792|NCT02522039|Timolol|timolol|mesh-list
43746793|NCT02522039|Dorzolamide|dorzolamide|mesh-list
43746794|NCT02522039|Latanoprost|latanoprost|mesh-list
43746795|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43746796|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43746797|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
43746798|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746799|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746800|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746801|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43746802|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43746803|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43569589|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
43569590|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569591|NCT00491738|Bevacizumab|bevacizumab|mesh-list
43569592|NCT00491738|Sunitinib|sunitinib|mesh-list
43569593|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43569594|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569595|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43569596|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43569597|NCT00491738|Growth Substances|growth substances|mesh-ancestor
43569598|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569599|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
43569600|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43569601|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569602|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569603|NCT00489203|Beclomethasone|beclomethasone|mesh-list
43569604|NCT00489203|Methotrexate|methotrexate|mesh-list
43746804|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43746805|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43746806|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570906|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570907|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
43570909|NCT00366795|Satavaptan|satavaptan|mesh-list
43746808|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43746809|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
43746810|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746811|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746812|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43746813|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
43746814|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43746815|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43746816|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746817|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746818|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43746819|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43746820|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
43746821|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746822|NCT02522013|Protective Agents|protective agents|mesh-ancestor
43746824|NCT02521831|Anesthetics|anesthetics|mesh-list
43746825|NCT02521831|Isoflurane|isoflurane|mesh-list
43746826|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
43746827|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569605|NCT00489203|Tacrolimus|tacrolimus|mesh-list
43569606|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43569607|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
43569608|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43569609|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569610|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43569611|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
43569612|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569613|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569614|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
43569615|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569616|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43569617|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569618|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
43569619|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569620|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43569621|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43569622|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569623|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
43569624|NCT00489203|Hormones|hormones|mesh-ancestor
43569625|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569626|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43569627|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
43746828|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746829|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
43746830|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748576|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43746831|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43746832|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
43746834|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
43746835|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746836|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43746837|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43746838|NCT02521714|Growth Substances|growth substances|mesh-ancestor
43746839|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
43746840|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746842|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43569629|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43569630|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569631|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43569632|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569633|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43569634|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
43569635|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
43569636|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569637|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569638|NCT00488267|Ketoprofen|ketoprofen|mesh-list
43569639|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43569649|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569651|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
43569652|NCT00486512|Calcitriol|calcitriol|mesh-list
43748598|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
43748601|NCT02516904|Rezafungin|rezafungin|mesh-list
43569653|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43569654|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
43569655|NCT00486512|Calcium|calcium|mesh-list
43569656|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43569657|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569658|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43569659|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43569660|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43569661|NCT00486512|Analgesics|analgesics|mesh-ancestor
43569662|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
43569663|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569664|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570948|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569665|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569666|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43569667|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43569668|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569669|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43569670|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43569671|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569672|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
43569673|NCT00486512|Antacids|antacids|mesh-ancestor
43748670|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43748671|NCT02515968|Propofol|propofol|mesh-list
43569674|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43569675|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43569676|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569677|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43569678|NCT00486512|Vitamins|vitamins|mesh-ancestor
43569679|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
43569680|NCT00486200|Valacyclovir|valacyclovir|mesh-list
43569681|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
43746844|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746845|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746846|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43746847|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43746866|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
43746867|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746868|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569682|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569683|NCT00485563|Folic Acid|folic acid|mesh-list
43569684|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
43569685|NCT00485563|Interferons|interferons|mesh-list
43569686|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
43569687|NCT00485563|Interleukin-2|interleukin-2|mesh-list
43569688|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
43748717|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748718|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748719|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43748720|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
43748721|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43748722|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748723|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43748724|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43748725|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43569689|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569690|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
43569691|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569692|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
43569693|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569694|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43569696|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
43569697|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569698|NCT00485563|Hematinics|hematinics|mesh-ancestor
43569699|NCT00485563|Vitamins|vitamins|mesh-ancestor
43571185|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43571186|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43571187|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
43571188|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571189|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571190|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571191|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43571193|NCT00323037|Protective Agents|protective agents|mesh-ancestor
43571194|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43571195|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43571196|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43571197|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
43571198|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43571199|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43571200|NCT00322257|Insulin|insulin|mesh-list
43571201|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43571202|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
43571203|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
43571204|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571209|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569700|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
43569701|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43569702|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43569703|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
43569704|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43569705|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569706|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569707|NCT00484419|Incretins|incretins|mesh-ancestor
43569708|NCT00484419|Hormones|hormones|mesh-ancestor
43569734|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569736|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
43571234|NCT00318656|Glimepiride|glimepiride|mesh-list
43571235|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
43571236|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571237|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571238|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43571239|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571240|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
43571241|NCT00317486|Bosentan|bosentan|mesh-list
43571242|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43571243|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43569737|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829654|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569739|NCT00481325|Antidepressive Agents|antidepressive agents|mesh-ancestor
43569740|NCT00481325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43569741|NCT00480831|Paclitaxel|paclitaxel|mesh-list
43569742|NCT00480831|Bevacizumab|bevacizumab|mesh-list
43569743|NCT00480831|Carboplatin|carboplatin|mesh-list
43569744|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43569745|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569746|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
43569747|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
43569748|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
43569749|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569750|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43569751|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43569754|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748746|NCT02515734|Leucovorin|leucovorin|mesh-list
43569763|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569764|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569765|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43569766|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
43569767|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43569769|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43569770|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
43569771|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569772|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569774|NCT00468442|Rituximab|rituximab|mesh-list
43569775|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43569776|NCT00468442|Daclizumab|daclizumab|mesh-list
43569777|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43569778|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746872|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569783|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569784|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43569785|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
43569786|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569788|NCT00468403|Abatacept|abatacept|mesh-list
43569789|NCT00468403|Tacrolimus|tacrolimus|mesh-list
43569791|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569793|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569794|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43569795|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569796|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569797|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43569798|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569799|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43569800|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
43569801|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43569802|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569803|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43569804|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569805|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
43569806|NCT00468273|Antibodies|antibodies|mesh-list
43569807|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
43569808|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43569809|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43569810|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
43569811|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569812|NCT00468117|Etanercept|etanercept|mesh-list
43569813|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43569814|NCT00468117|Basiliximab|basiliximab|mesh-list
43569815|NCT00468117|Daclizumab|daclizumab|mesh-list
43569816|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43569817|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43569818|NCT00468117|Analgesics|analgesics|mesh-ancestor
43569819|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
43569824|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43569832|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
43569833|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569834|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569836|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43569837|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569838|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569839|NCT00467025|Sorafenib|sorafenib|mesh-list
43569840|NCT00467025|Trebananib|trebananib|mesh-list
43569841|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746873|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43746874|NCT02521298|Protective Agents|protective agents|mesh-ancestor
43746875|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43746876|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746878|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43746880|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
43746881|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
43746882|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43746883|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43746884|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43569842|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43569843|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569844|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571374|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571375|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
43571376|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43571377|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43571378|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571379|NCT00301262|Urological Agents|urological agents|mesh-ancestor
43571380|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43571381|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43571382|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43571384|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569845|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43569846|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43569847|NCT00467025|Growth Substances|growth substances|mesh-ancestor
43569848|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569849|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
43569850|NCT00465959|Trospium chloride|trospium chloride|mesh-list
43569851|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
43569852|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
43569853|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569854|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569855|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43569856|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43569857|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
43569858|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569859|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569860|NCT00465959|Urological Agents|urological agents|mesh-ancestor
43569865|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43569866|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43569867|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
43569868|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569869|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569870|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569871|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43569872|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43569873|NCT00465517|Ganaxolone|ganaxolone|mesh-list
43569874|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
43569875|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569876|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748976|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43569877|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569878|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
43569879|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
43569880|NCT00464633|Alvocidib|alvocidib|mesh-list
43569881|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569882|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
43569883|NCT00464633|Growth Substances|growth substances|mesh-ancestor
43569884|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569885|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43569886|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569887|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569888|NCT00464555|Sirolimus|sirolimus|mesh-list
43569889|NCT00464555|Lisofylline|lisofylline|mesh-list
43569890|NCT00464555|Tacrolimus|tacrolimus|mesh-list
43569891|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43569892|NCT00464555|Basiliximab|basiliximab|mesh-list
43746885|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43746886|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746888|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
43746889|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746891|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43746892|NCT02521233|Losartan|losartan|mesh-list
43746893|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43746894|NCT02521233|Candesartan|candesartan|mesh-list
43746895|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
43746896|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
43746900|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43569906|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43569908|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
43749053|NCT02513927|Metoprolol|metoprolol|mesh-list
43569909|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569910|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569911|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569912|NCT00464243|Volinanserin|volinanserin|mesh-list
43569913|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43569914|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
43569915|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569916|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569917|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569918|NCT00464061|Volinanserin|volinanserin|mesh-list
43569919|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43569920|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
43569932|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569933|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43569934|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
43569935|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43569936|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43569937|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43569938|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569939|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43569940|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569941|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
43569942|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
43569943|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43569944|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
43746901|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746902|NCT02521233|Diuretics|diuretics|mesh-ancestor
43746903|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
43746904|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746905|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43746906|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43746907|NCT02521207|Ibuprofen|ibuprofen|mesh-list
43746908|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43746909|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43746910|NCT02521207|Analgesics|analgesics|mesh-ancestor
43746911|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
43746912|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569945|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569946|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43569947|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43569983|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569985|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43569986|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
43569987|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
43569988|NCT00458978|Cediranib|cediranib|mesh-list
43569989|NCT00458978|Maleic acid|maleic acid|mesh-list
43569990|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569991|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569992|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569993|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43569994|NCT00458601|Temozolomide|temozolomide|mesh-list
43569995|NCT00458601|Molgramostim|molgramostim|mesh-list
43569996|NCT00458601|Rindopepimut|rindopepimut|mesh-list
43569997|NCT00458601|Sargramostim|sargramostim|mesh-list
43569998|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43569999|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
43570000|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570001|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746913|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746914|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43571410|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43571411|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571412|NCT00298987|Dasatinib|dasatinib|mesh-list
43571413|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571414|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43571415|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571416|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571417|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
43571418|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571419|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571420|NCT00297310|Tacrolimus|tacrolimus|mesh-list
43571421|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571422|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
43571436|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749126|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749127|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
43749129|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
43749130|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
43749131|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43571438|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43571439|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571440|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43571441|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746916|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43746917|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746921|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746922|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43746923|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43746924|NCT02521051|Growth Substances|growth substances|mesh-ancestor
43746925|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570002|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
43570003|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570004|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43749141|NCT02513342|Endostar protein|endostar protein|mesh-list
43749142|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749143|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
43749144|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
43749145|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
43749146|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749147|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43749148|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43749149|NCT02513342|Growth Substances|growth substances|mesh-ancestor
43749150|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749151|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
43749152|NCT02513004|Clopidogrel|clopidogrel|mesh-list
43749153|NCT02513004|Ticagrelor|ticagrelor|mesh-list
43749154|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43749155|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43749156|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43749157|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43749158|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
43570005|NCT00458276|Tezosentan|tezosentan|mesh-list
43570006|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
43570007|NCT00457457|Tamsulosin|tamsulosin|mesh-list
43570008|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43570009|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43570010|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43570011|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570012|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570013|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570014|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570015|NCT00457457|Urological Agents|urological agents|mesh-ancestor
43570016|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
43570017|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570018|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43570024|NCT00455156|Estrogens|estrogens|mesh-ancestor
43570025|NCT00455156|Hormones|hormones|mesh-ancestor
43570026|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749217|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
43570027|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570028|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43570030|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43570031|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43570032|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43570033|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43570034|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
43570035|NCT00451152|Anecortave|anecortave|mesh-list
43570036|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43570037|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43570038|NCT00451152|Growth Substances|growth substances|mesh-ancestor
43570039|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570040|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
43836103|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
43570041|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749265|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
43570044|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570046|NCT00449605|Glimepiride|glimepiride|mesh-list
43570047|NCT00449605|Rimonabant|rimonabant|mesh-list
43570048|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43570049|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570050|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43570051|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570052|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
43746926|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
43835810|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835811|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43835812|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43835813|NCT05021094|Estradiol|estradiol|mesh-list
43835814|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43835815|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
43835816|NCT05021094|Estrogens|estrogens|mesh-ancestor
43835817|NCT05021094|Hormones|hormones|mesh-ancestor
43835818|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749351|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
43749359|NCT02511574|Progesterone|progesterone|mesh-list
43835819|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835820|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43835821|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
43835822|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43835823|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43835824|NCT05021094|Progestins|progestins|mesh-ancestor
43746928|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
43746929|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
43746930|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43746931|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746932|NCT02521064|Prednisone|prednisone|mesh-list
43746933|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43746934|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
43746935|NCT02521064|Hormones|hormones|mesh-ancestor
43746936|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43746937|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746938|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43746939|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746940|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
43746941|NCT02521077|Vitamins|vitamins|mesh-ancestor
43746942|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
43836165|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43836166|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43836167|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
43746943|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836168|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43570053|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43749534|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570054|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43570055|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43570057|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570059|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570060|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
43570061|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43746944|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
43746945|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749604|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749605|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43749606|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
43749607|NCT02509429|Insulin|insulin|mesh-list
43749608|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43749609|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
43749610|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
43749611|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43749612|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
43749613|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43749614|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749615|NCT02509273|Clonidine|clonidine|mesh-list
43749616|NCT02509273|Midazolam|midazolam|mesh-list
43749617|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43749618|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43746946|NCT02521077|Protective Agents|protective agents|mesh-ancestor
43746948|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43746949|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43746950|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43746951|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43746952|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
43746953|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746954|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749697|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43749698|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
43749699|NCT02509208|Hemostatics|hemostatics|mesh-list
43749701|NCT02509195|Lamivudine|lamivudine|mesh-list
43746955|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746956|NCT02520934|Miglustat|miglustat|mesh-list
43746957|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746958|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746959|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43746960|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43746961|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
43746962|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43746963|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43746964|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43746978|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570072|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570073|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570074|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570075|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43570076|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
43746982|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43571606|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43571607|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
43746984|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746985|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43746986|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43746987|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43746988|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43746989|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
43746991|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
43746992|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
43746993|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570077|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43570078|NCT00447564|Buprenorphine|buprenorphine|mesh-list
43570079|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43570080|NCT00447564|Narcotics|narcotics|mesh-ancestor
43570081|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570082|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570083|NCT00447564|Analgesics|analgesics|mesh-ancestor
43570085|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570086|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43570087|NCT00445198|Navitoclax|navitoclax|mesh-list
43570088|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570089|NCT00443287|Cilostazol|cilostazol|mesh-list
43570092|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
43570093|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570094|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570095|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43570096|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
43570097|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43570098|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43571660|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570099|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849056|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570100|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43570101|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
43570102|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43570103|NCT00443287|Protective Agents|protective agents|mesh-ancestor
43570104|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43570105|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43570106|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570107|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
43570108|NCT00442104|Ganaxolone|ganaxolone|mesh-list
43570109|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
43570110|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570111|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570112|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570113|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
43570114|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
43570115|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
43570116|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
43570117|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43570118|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570119|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570120|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
43570121|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43570122|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43746994|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746995|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43746996|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43746997|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746998|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43747001|NCT02520570|Urinastatin|urinastatin|mesh-list
43747002|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
43747003|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43747004|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
43747005|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747006|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747007|NCT02520479|Pegaspargase|pegaspargase|mesh-list
43747008|NCT02520479|Asparaginase|asparaginase|mesh-list
43747009|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747010|NCT02520947|Desflurane|desflurane|mesh-list
43570123|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570124|NCT00441896|Ganaxolone|ganaxolone|mesh-list
43570125|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
43570126|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570127|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570128|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570129|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
43570130|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
43570131|NCT00440531|Vaccines|vaccines|mesh-list
43570132|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
43570133|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570134|NCT00440388|Rituximab|rituximab|mesh-list
43570135|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570136|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570137|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
43570138|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570139|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43570140|NCT00439738|Amlodipine|amlodipine|mesh-list
43570141|NCT00439738|Valsartan|valsartan|mesh-list
43570142|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43570143|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43570144|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43570145|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570146|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570147|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43570148|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570149|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
43570150|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43570151|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43570152|NCT00439738|Diuretics|diuretics|mesh-ancestor
43570153|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
43570154|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43570156|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43570157|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
43570158|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43570159|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570162|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
43570163|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747011|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43747013|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
43747014|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747015|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747016|NCT02520505|Citric Acid|citric acid|mesh-list
43747017|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
43747018|NCT02520505|Clomiphene|clomiphene|mesh-list
43747019|NCT02520505|Enclomiphene|enclomiphene|mesh-list
43747020|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
43747021|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
43747022|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43747023|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
43747024|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
43747025|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747026|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43747027|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
43747028|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747029|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747030|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43747031|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
43747032|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43747033|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43747034|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43747035|NCT02520453|Durvalumab|durvalumab|mesh-list
43747036|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747037|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747038|NCT02520817|Vitamins|vitamins|mesh-list
43747039|NCT02520817|Ascorbic Acid|ascorbic acid|mesh-list
43747040|NCT02520817|Vitamin E|vitamin e|mesh-list
43747041|NCT02520817|Vitamin A|vitamin a|mesh-list
43749787|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
43747042|NCT02520817|Lactulose|lactulose|mesh-list
43747043|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
43747044|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747045|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
43747046|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747052|NCT02520219|Growth Substances|growth substances|mesh-ancestor
43747053|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747054|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
43747055|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747064|NCT02520115|Dexamethasone|dexamethasone|mesh-list
43747065|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
43747066|NCT02520115|Valproic Acid|valproic acid|mesh-list
43747067|NCT02520115|Ichthammol|ichthammol|mesh-list
43747068|NCT02520115|BB 1101|bb 1101|mesh-list
43747069|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747070|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
43747071|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
43747072|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747073|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747074|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747075|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
43747076|NCT02520115|Hormones|hormones|mesh-ancestor
43747077|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747078|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43747079|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747080|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
43747081|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747082|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747083|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
43747084|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
43747085|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570164|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43570165|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
43570166|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570167|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
43570168|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570169|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570170|NCT00434850|Gusperimus|gusperimus|mesh-list
43747086|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
43747087|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43747088|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747089|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43747090|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747091|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
43747092|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43747093|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43747094|NCT02520102|Sargramostim|sargramostim|mesh-list
43747095|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
43747096|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747097|NCT02519543|Metformin|metformin|mesh-list
43747098|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43747099|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747100|NCT02519582|Niclosamide|niclosamide|mesh-list
43747101|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
43747102|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43570171|NCT00434850|Sirolimus|sirolimus|mesh-list
43570172|NCT00434850|Etanercept|etanercept|mesh-list
43570173|NCT00434850|Tacrolimus|tacrolimus|mesh-list
43570174|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43570175|NCT00434850|Basiliximab|basiliximab|mesh-list
43570176|NCT00434850|Daclizumab|daclizumab|mesh-list
43570177|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570178|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
43570179|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570180|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43570181|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747106|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
43747107|NCT02519699|Norepinephrine|norepinephrine|mesh-list
43747108|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43747109|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43747110|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
43747111|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747112|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747113|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747114|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
43747115|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
43747116|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747117|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43747119|NCT02519608|Clopidogrel|clopidogrel|mesh-list
43747120|NCT02519608|Ticagrelor|ticagrelor|mesh-list
43747121|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43747122|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43747123|NCT02519608|Analgesics|analgesics|mesh-ancestor
43747124|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
43570184|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570185|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43570186|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570190|NCT00434850|Analgesics|analgesics|mesh-ancestor
43570191|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
43570192|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570193|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570194|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43570195|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43570196|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43570198|NCT00434850|Protective Agents|protective agents|mesh-ancestor
43570199|NCT00434811|Sirolimus|sirolimus|mesh-list
43570200|NCT00434811|Etanercept|etanercept|mesh-list
43570201|NCT00434811|Tacrolimus|tacrolimus|mesh-list
43570202|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43570203|NCT00434811|Basiliximab|basiliximab|mesh-list
43570204|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570205|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
43570206|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570207|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43570208|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570209|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570210|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43570211|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570212|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43570213|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570214|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
43747125|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747126|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747127|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747128|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43747129|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43571741|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747130|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43747131|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747132|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43747133|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43747134|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747135|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
43747136|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43747137|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43570227|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43570228|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570229|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
43570230|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
43570231|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
43570232|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570233|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570234|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43570235|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43570238|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
43747138|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43747139|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
43747140|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747142|NCT02519660|Tetracaine|tetracaine|mesh-list
43747143|NCT02519660|Prilocaine|prilocaine|mesh-list
43747144|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43747145|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
43747146|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
43747147|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747148|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747149|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
43747150|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747151|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43747152|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43747153|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43747154|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43747155|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835848|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43835851|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
43835852|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836201|NCT04989699|Growth Substances|growth substances|mesh-ancestor
43836202|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836203|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
43836204|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836205|NCT04989491|Rituximab|rituximab|mesh-list
43836206|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836207|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749814|NCT02508753|Ceftolozane|ceftolozane|mesh-list
43749815|NCT02508753|Cephalosporins|cephalosporins|mesh-list
43749816|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43749817|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749818|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43749819|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43749820|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571743|NCT00141284|Zidovudine|zidovudine|mesh-list
43571744|NCT00141284|Nelfinavir|nelfinavir|mesh-list
43571745|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43835854|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43835855|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43835856|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
43835857|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
43835858|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835859|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43835860|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43835861|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835862|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835867|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835868|NCT05018117|Nicotine|nicotine|mesh-list
43747157|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43747158|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747159|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747160|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
43747161|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747162|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
43747163|NCT02519335|Razoxane|razoxane|mesh-list
43747164|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747165|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43747166|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43747167|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43747168|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747169|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747170|NCT02519335|Protective Agents|protective agents|mesh-ancestor
43747171|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747172|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
43747173|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
43747174|NCT02519322|Nivolumab|nivolumab|mesh-list
43747175|NCT02519322|Ipilimumab|ipilimumab|mesh-list
43747176|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
43747182|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
43747183|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747184|NCT02519400|Amitriptyline|amitriptyline|mesh-list
43747185|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43747186|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
43747188|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43747189|NCT02519400|Analgesics|analgesics|mesh-ancestor
43747190|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
43747191|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747192|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747193|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43747194|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43747195|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43747196|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747220|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747221|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747222|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747223|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43747224|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43747225|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43747227|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
43747229|NCT02518763|Vitamins|vitamins|mesh-list
43747230|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
43747231|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747232|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43747233|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43747234|NCT02518789|Fentanyl|fentanyl|mesh-list
43747235|NCT02518789|Midazolam|midazolam|mesh-list
43747236|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
43747237|NCT02518789|Remifentanil|remifentanil|mesh-list
43747238|NCT02518789|Propofol|propofol|mesh-list
43747239|NCT02518789|Etomidate|etomidate|mesh-list
43747240|NCT02518789|Atracurium|atracurium|mesh-list
43747241|NCT02518789|Rocuronium|rocuronium|mesh-list
43747242|NCT02518789|Cisatracurium|cisatracurium|mesh-list
43747243|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43747244|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747245|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747246|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43747247|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
43747248|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
43747249|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43747250|NCT02518789|Analgesics|analgesics|mesh-ancestor
43747251|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
43747252|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747253|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43747254|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43747255|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43747256|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
43747257|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747258|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747259|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43747260|NCT02518789|Narcotics|narcotics|mesh-ancestor
43747261|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43747262|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43747263|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43747264|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43747265|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
43747266|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
43747267|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43747268|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43747269|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43747270|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43747271|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43747272|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
43747273|NCT02518958|Nivolumab|nivolumab|mesh-list
43747274|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747275|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747276|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43747277|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747278|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43747279|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747280|NCT02518503|Atorvastatin|atorvastatin|mesh-list
43747281|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43747282|NCT02518503|Simvastatin|simvastatin|mesh-list
43747283|NCT02518503|Pravastatin|pravastatin|mesh-list
43747285|NCT02518503|L 647318|l 647318|mesh-list
43747286|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
43571749|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
43571760|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43571761|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
43571762|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571763|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43571764|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43571765|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571766|NCT00135421|Citalopram|citalopram|mesh-list
43571767|NCT00135421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43747287|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43747288|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43747289|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
43747290|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747291|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43747292|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43747293|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747295|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43747296|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43747297|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43747298|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747299|NCT02518373|Omeprazole|omeprazole|mesh-list
43747300|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43747301|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747302|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43747316|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43747317|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43747318|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747320|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43747321|NCT02518438|Narcotics|narcotics|mesh-ancestor
43747322|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747323|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747324|NCT02518438|Analgesics|analgesics|mesh-ancestor
43747325|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
43747326|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747327|NCT02518295|Sulfalene|sulfalene|mesh-list
43747328|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747329|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43747330|NCT02518295|Renal Agents|renal agents|mesh-ancestor
43747331|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
43747332|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43747333|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43747334|NCT02518152|Alendronate|alendronate|mesh-list
43747335|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43747336|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747337|NCT02518022|Insulin|insulin|mesh-list
43747338|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
43747339|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
43747340|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43747341|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747342|NCT02517814|Vitamin D|vitamin d|mesh-list
43747343|NCT02517814|Vitamins|vitamins|mesh-ancestor
43747346|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43747347|NCT05585359|Ascorbic Acid|ascorbic acid|mesh-list
43747348|NCT05585359|Vitamins|vitamins|mesh-ancestor
43570244|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570245|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43570246|NCT00430950|Olmesartan|olmesartan|mesh-list
43570247|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43570248|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43570249|NCT00430950|Diuretics|diuretics|mesh-ancestor
43570250|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
43570261|NCT00430508|Diuretics|diuretics|mesh-ancestor
43570262|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
43570263|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570264|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43570265|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43571768|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43571769|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43571770|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571771|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571772|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
43571773|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571774|NCT00135421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43570266|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570267|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43570268|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43570269|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
43570270|NCT00430092|Difluprednate|difluprednate|mesh-list
43570271|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
43570272|NCT00430092|Hormones|hormones|mesh-ancestor
43570273|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570274|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570275|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570276|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
43570277|NCT00429923|Difluprednate|difluprednate|mesh-list
43570278|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
43570279|NCT00429923|Hormones|hormones|mesh-ancestor
43570280|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570281|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570282|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570283|NCT00427856|Rituximab|rituximab|mesh-list
43570284|NCT00427856|Obatoclax|obatoclax|mesh-list
43570285|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747349|NCT05585359|Micronutrients|micronutrients|mesh-ancestor
43747350|NCT05585359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747351|NCT05585359|Antioxidants|antioxidants|mesh-ancestor
43747352|NCT05585359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747353|NCT05585359|Protective Agents|protective agents|mesh-ancestor
43747354|NCT05585346|Prednisolone|prednisolone|mesh-list
43747355|NCT05585346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43747356|NCT05585346|Methylprednisolone|methylprednisolone|mesh-list
43747357|NCT05585346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43747358|NCT05585346|Prednisolone acetate|prednisolone acetate|mesh-list
43747359|NCT05585346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43570286|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570287|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
43570288|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570289|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43570290|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570291|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570292|NCT00427440|Rilotumumab|rilotumumab|mesh-list
43570293|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43570294|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570295|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570296|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
43570299|NCT00427154|Metformin|metformin|mesh-list
43570300|NCT00427154|Glimepiride|glimepiride|mesh-list
43570301|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
43570302|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43571779|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43570303|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43570304|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571780|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43571781|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43571782|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571783|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571784|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571785|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571786|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571787|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
43571788|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571789|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43570305|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43570306|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570307|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
43570308|NCT00425100|Fesoterodine|fesoterodine|mesh-list
43570322|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43570323|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43570324|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570325|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43570326|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43849057|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570327|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43570328|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
43570329|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
43747360|NCT05585346|Prednisolone phosphate|prednisolone phosphate|mesh-list
43747361|NCT05585346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747362|NCT05585346|Glucocorticoids|glucocorticoids|mesh-ancestor
43747363|NCT05585346|Hormones|hormones|mesh-ancestor
43747364|NCT05585346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747365|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747366|NCT05585346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43747367|NCT05585346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747368|NCT05585346|Antiemetics|antiemetics|mesh-ancestor
43747369|NCT05585346|Autonomic Agents|autonomic agents|mesh-ancestor
43747370|NCT05585346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570330|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570331|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570332|NCT00422019|Rilotumumab|rilotumumab|mesh-list
43570333|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43570334|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570335|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570336|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
43570337|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570338|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43570339|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
43570340|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
43570341|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570342|NCT00417209|Fluorouracil|fluorouracil|mesh-list
43570343|NCT00417209|Capecitabine|capecitabine|mesh-list
43570344|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
43570345|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570346|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43570347|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570348|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570349|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
43570350|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570352|NCT00417118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43570353|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43570354|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570355|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570356|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570357|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
43570358|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747371|NCT05585346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747373|NCT05585346|Protective Agents|protective agents|mesh-ancestor
43747374|NCT05585229|Psilocybin|psilocybin|mesh-list
43747375|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
43747376|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747377|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43747378|NCT05585177|Hormones|hormones|mesh-list
43747380|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747381|NCT05585151|Evolocumab|evolocumab|mesh-list
43747382|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43747383|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43747384|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
43747385|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747386|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43747387|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43747388|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43571791|NCT00135382|Efavirenz|efavirenz|mesh-list
43747389|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
43747390|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747391|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747392|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835869|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43835870|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
43835871|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835872|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835873|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43835874|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43835875|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
43835876|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835877|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835878|NCT05016869|Capecitabine|capecitabine|mesh-list
43835879|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43570359|NCT00417118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43570360|NCT00417118|Antidepressive Agents|antidepressive agents|mesh-ancestor
43570361|NCT00417118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43570362|NCT00415623|Amlodipine|amlodipine|mesh-list
43835880|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
43835881|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835882|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835883|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
43835884|NCT05016609|Velpatasvir|velpatasvir|mesh-list
43835885|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43835886|NCT05016609|Antibodies|antibodies|mesh-list
43835887|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
43835888|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
43835889|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835890|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
43835891|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847758|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847759|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
43847760|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570364|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43570365|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570366|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570367|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43570380|NCT00415142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43570383|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570385|NCT00412932|Olmesartan|olmesartan|mesh-list
43570386|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43570387|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43570388|NCT00412932|Diuretics|diuretics|mesh-ancestor
43570389|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
43570390|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570391|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43570392|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570421|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
43570422|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43570423|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570424|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
43570425|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570426|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
43570427|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570428|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
43570429|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570435|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43570436|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570437|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570438|NCT00407303|Bortezomib|bortezomib|mesh-list
43570439|NCT00407303|Obatoclax|obatoclax|mesh-list
43570440|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570441|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570442|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747405|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
43570465|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
43570466|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747406|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
43571795|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747407|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747408|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43747409|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43747410|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
43747411|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43747412|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
43747413|NCT05584878|Coagulants|coagulants|mesh-ancestor
43747414|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43747415|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
43747416|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747417|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43747418|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
43747419|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747420|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747421|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43747422|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43747423|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43747424|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
43747428|NCT05584683|Amoxicillin|amoxicillin|mesh-list
43747429|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
43747430|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
43747431|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43747432|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43747433|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747434|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43747435|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747437|NCT05584644|Palbociclib|palbociclib|mesh-list
43747449|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747450|NCT05584228|Azathioprine|azathioprine|mesh-list
43747451|NCT05584228|Infliximab|infliximab|mesh-list
43747452|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747453|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747454|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43747455|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
43747456|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747457|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43747458|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747459|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747460|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
43747461|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747462|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43747463|NCT05584137|Antibodies|antibodies|mesh-list
43747464|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
43747465|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43747466|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
43747467|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747468|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747469|NCT05584007|Floxacillin|floxacillin|mesh-list
43747470|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43747471|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747472|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
43747473|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43747474|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747475|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747476|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43747477|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747478|NCT05583214|Dexamethasone|dexamethasone|mesh-list
43747479|NCT05583214|Ondansetron|ondansetron|mesh-list
43747481|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
43747492|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747493|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43747494|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
43747495|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747496|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571798|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43571799|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43571805|NCT00135369|Efavirenz|efavirenz|mesh-list
43747497|NCT05583214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43747498|NCT05583214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43747499|NCT05583214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747512|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43747513|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747514|NCT05576155|Compound 21|compound 21|mesh-list
43747515|NCT05576155|Losartan|losartan|mesh-list
43747516|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43747517|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43747518|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43747519|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43747522|NCT05567068|Mesalamine|mesalamine|mesh-list
43747537|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747538|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43747539|NCT05561062|Atorvastatin|atorvastatin|mesh-list
43747540|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43747541|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43747542|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
43747543|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747544|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43747545|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43747546|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835892|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
43835893|NCT05014776|Ipilimumab|ipilimumab|mesh-list
43835894|NCT05014776|Tadalafil|tadalafil|mesh-list
43835895|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835896|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835897|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43835898|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835899|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
43835900|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43835901|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43835902|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835903|NCT05014776|Urological Agents|urological agents|mesh-ancestor
43835904|NCT05014516|Xenon|xenon|mesh-list
43835905|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43835906|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
43835907|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
43835908|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835909|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835910|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43835911|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43835912|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43835913|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835914|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835915|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43835916|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43835917|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835918|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
43835919|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835920|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
43835921|NCT05012735|Provitamins|provitamins|mesh-list
43835922|NCT05012735|Vitamins|vitamins|mesh-ancestor
43835923|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
43835924|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835944|NCT05010772|Ivosidenib|ivosidenib|mesh-list
43835945|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43835946|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
43835947|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835948|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835949|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835950|NCT05010421|Clobetasol|clobetasol|mesh-list
43835951|NCT05010421|Emollients|emollients|mesh-list
43835952|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835953|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
43835954|NCT05010421|Hormones|hormones|mesh-ancestor
43835955|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835957|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
43835958|NCT05010200|Poly ICLC|poly iclc|mesh-list
43835959|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
43835960|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
43835961|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835962|NCT05009862|Aspirin|aspirin|mesh-list
43550704|NCT03620825|Analgesics|analgesics|mesh-ancestor
43835963|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
43835964|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43835965|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43835966|NCT05009862|Analgesics|analgesics|mesh-ancestor
43835967|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
43747547|NCT05555797|Betamethasone|betamethasone|mesh-list
43747548|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
43747549|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43747550|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
43747552|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43747553|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747554|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
43747555|NCT05555797|Hormones|hormones|mesh-ancestor
43747556|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747557|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747558|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43747559|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
43747560|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747561|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
43553244|NCT03591549|Fulvestrant|fulvestrant|mesh-list
43749821|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836228|NCT04987775|Protective Agents|protective agents|mesh-ancestor
43749822|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749823|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43749825|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43749826|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749827|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749828|NCT02508584|Antibodies|antibodies|mesh-list
43749835|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749836|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749837|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749838|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
43749839|NCT02508402|Hormones|hormones|mesh-ancestor
43749843|NCT02508350|Daptomycin|daptomycin|mesh-list
43747573|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
43747574|NCT05513807|Vitamins|vitamins|mesh-ancestor
43747575|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
43747576|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747577|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43747578|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
43747579|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747580|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43747581|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
43747582|NCT05509257|Naltrexone|naltrexone|mesh-list
43747583|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43747584|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43747585|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747586|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
43747587|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747588|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
43747589|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43747590|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
43570467|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570468|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
43747591|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747592|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747593|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43747594|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
43747595|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43747596|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
43747597|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747598|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747599|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43747600|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
43747601|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
43747602|NCT05505617|Protective Agents|protective agents|mesh-ancestor
43747603|NCT05504252|Fluorouracil|fluorouracil|mesh-list
43747604|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
43747605|NCT05504252|Nivolumab|nivolumab|mesh-list
43570469|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570470|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
43570471|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43570472|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570473|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43570474|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
43570475|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43570476|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747616|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747617|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43747618|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747619|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747620|NCT05480800|Vaccines|vaccines|mesh-list
43747621|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
43747622|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747623|NCT05450562|Cemiplimab|cemiplimab|mesh-list
43747624|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747625|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747626|NCT05439902|Tamsulosin|tamsulosin|mesh-list
43747627|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43747628|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43747629|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43570477|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570478|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570479|NCT00403169|Lenalidomide|lenalidomide|mesh-list
43570489|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
43570490|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
43570491|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43747631|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747632|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749851|NCT02508168|Hormones|hormones|mesh-ancestor
43747633|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747634|NCT05439902|Urological Agents|urological agents|mesh-ancestor
43747635|NCT05419050|Denosumab|denosumab|mesh-list
43747636|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43747637|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747638|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43747639|NCT05400265|Antibodies|antibodies|mesh-list
43747640|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
43747641|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43747642|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
43747643|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747644|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747645|NCT05364619|Bismuth|bismuth|mesh-list
43747646|NCT05364619|Antacids|antacids|mesh-ancestor
43570492|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570493|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
43570494|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570495|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
43570496|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570497|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
43747647|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747648|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747650|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
43747651|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43749861|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
43747652|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
43747653|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747654|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747656|NCT05350943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747657|NCT05350943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747658|NCT05350943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747659|NCT05350943|Immunologic Factors|immunologic factors|mesh-ancestor
43747660|NCT05350943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747661|NCT05342662|Methamphetamine|methamphetamine|mesh-list
43747662|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43747663|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747664|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
43747665|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
43747666|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747667|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
43747668|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747669|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747670|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
43747671|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43747677|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747678|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747679|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43550835|NCT03620149|Denosumab|denosumab|mesh-list
43747681|NCT05337137|Growth Substances|growth substances|mesh-ancestor
43747682|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747683|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
43747684|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43747685|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747686|NCT05334472|Ofatumumab|ofatumumab|mesh-list
43747687|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747688|NCT05324852|Midazolam|midazolam|mesh-list
43747689|NCT05324852|Loxapine|loxapine|mesh-list
43747690|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43747691|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43747692|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747693|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747694|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43747695|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43747697|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43747698|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
43747699|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
43749916|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43749917|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43749918|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
43749919|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
43749920|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749921|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749922|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747700|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
43747701|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
43747702|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747703|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747704|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43747705|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43747707|NCT05320133|Bismuth|bismuth|mesh-list
43747708|NCT05320133|Antacids|antacids|mesh-ancestor
43749923|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43749924|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
43749925|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43571830|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571861|NCT00131924|Estrogens|estrogens|mesh-list
43747709|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747710|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747711|NCT05306899|Ketamine|ketamine|mesh-list
43747712|NCT05306899|Analgesics|analgesics|mesh-ancestor
43747713|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
43747714|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747715|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570514|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
43570524|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43570526|NCT00401388|Protective Agents|protective agents|mesh-ancestor
43570527|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570528|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43570529|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
43570530|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570531|NCT00401011|Dexamethasone|dexamethasone|mesh-list
43570533|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570534|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
43570535|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
43570536|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570537|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747716|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43747717|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43747718|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
43747720|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747721|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43747722|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43747723|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747724|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747726|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
43747727|NCT05243745|Protective Agents|protective agents|mesh-ancestor
43747728|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747729|NCT05232344|Estradiol|estradiol|mesh-list
43747730|NCT05232344|Progesterone|progesterone|mesh-list
43747735|NCT05232344|Progestins|progestins|mesh-ancestor
43747753|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43570550|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43749947|NCT02507609|Rocuronium|rocuronium|mesh-list
43570551|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43747754|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747755|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747756|NCT05098704|Clopidogrel|clopidogrel|mesh-list
43747757|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43747758|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43747759|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43747760|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43747761|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
43747762|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747763|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747764|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747765|NCT05097118|Ketamine|ketamine|mesh-list
43747766|NCT05097118|Bupivacaine|bupivacaine|mesh-list
43747767|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
43747769|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747770|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747771|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
43747772|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747773|NCT05097118|Analgesics|analgesics|mesh-ancestor
43747774|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43747775|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43747776|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
43747777|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43747778|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43747779|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747780|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835968|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835969|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835970|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43835971|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835972|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43835973|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43570560|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570563|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43570564|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570565|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43570566|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
43570576|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
43570577|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570578|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43570579|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
43570580|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570581|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570582|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43570583|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
43835974|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835975|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43835977|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835978|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
43835979|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43835980|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
43835981|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43835982|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
43835983|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
43835984|NCT05008913|Adavosertib|adavosertib|mesh-list
43835985|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835986|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835988|NCT05008809|Fluorouracil|fluorouracil|mesh-list
43835989|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
43835990|NCT05008809|Irinotecan|irinotecan|mesh-list
43835991|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
43835992|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
43835993|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571874|NCT00125970|Vaccines|vaccines|mesh-list
43835994|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43835995|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835996|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43835997|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
43835998|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835999|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43847769|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747781|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43747782|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43747783|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747784|NCT05043506|Palbociclib|palbociclib|mesh-list
43747785|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43747786|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747787|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43747788|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747789|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747790|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43747791|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43747792|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
43747793|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747794|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747795|NCT05013437|Acetaminophen|acetaminophen|mesh-list
43747796|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
43747797|NCT05013437|Promethazine|promethazine|mesh-list
43570594|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
43570595|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570596|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43570598|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570599|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570600|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43570601|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
43570602|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
43570603|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43570604|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43570606|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43570607|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570608|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747798|NCT05013437|Melphalan|melphalan|mesh-list
43747799|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
43747800|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43747801|NCT05013437|Analgesics|analgesics|mesh-ancestor
43747802|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
43747803|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747804|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747805|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
43747806|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43747807|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
43747808|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747809|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747810|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43570609|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570610|NCT00393991|Fluticasone|fluticasone|mesh-list
43570621|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43570622|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43570623|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43747828|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43747829|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43747830|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43747831|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43747832|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
43747833|NCT05010629|Carboplatin|carboplatin|mesh-list
43747834|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747835|NCT04990128|Triamcinolone|triamcinolone|mesh-list
43747836|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747837|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
43747838|NCT04990128|Hormones|hormones|mesh-ancestor
43747839|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747840|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747841|NCT04968015|Cytarabine|cytarabine|mesh-list
43747842|NCT04968015|Venetoclax|venetoclax|mesh-list
43747843|NCT04968015|Idarubicin|idarubicin|mesh-list
43747844|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43747846|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570633|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
43570634|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570643|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570644|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570645|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570646|NCT00393068|Paclitaxel|paclitaxel|mesh-list
43570647|NCT00393068|Bevacizumab|bevacizumab|mesh-list
43570648|NCT00393068|Carboplatin|carboplatin|mesh-list
43570649|NCT00393068|Fluorouracil|fluorouracil|mesh-list
43570650|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43570651|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43570652|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570653|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
43570654|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
43570655|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
43570656|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570671|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747847|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747849|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747850|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747851|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
43747852|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747853|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43747854|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43747855|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43747856|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747857|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
43747858|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
43747859|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747860|NCT04921033|Prednisolone|prednisolone|mesh-list
43747861|NCT04921033|Budesonide|budesonide|mesh-list
43747862|NCT04921033|Azathioprine|azathioprine|mesh-list
43747863|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570672|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43570673|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43570674|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570675|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570676|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570677|NCT00391209|Insulin|insulin|mesh-list
43570678|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43570679|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43747864|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
43750020|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571881|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
43747866|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747867|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747868|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43747869|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747871|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747872|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43747873|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43747874|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
43747875|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
43747876|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747877|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43747878|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747879|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
43747880|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43747881|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
43747882|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43747894|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43747895|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
43747896|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
43747897|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
43747898|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747899|NCT04842292|Heparin|heparin|mesh-list
43747900|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
43747901|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43747902|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43570681|NCT00389779|Guanfacine|guanfacine|mesh-list
43570682|NCT00389779|Darusentan|darusentan|mesh-list
43570683|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43570684|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43570685|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43570686|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43570687|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570688|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570689|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570690|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570691|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43570692|NCT00389675|Guanfacine|guanfacine|mesh-list
43570693|NCT00389675|Darusentan|darusentan|mesh-list
43570694|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43747903|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747905|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43747906|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43747907|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747908|NCT04788615|Interferons|interferons|mesh-list
43747909|NCT04788615|Interferon-beta|interferon-beta|mesh-list
43747910|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
43747911|NCT04788615|Teriflunomide|teriflunomide|mesh-list
43747912|NCT04788615|Ofatumumab|ofatumumab|mesh-list
43747913|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
43747914|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43747915|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
43747916|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747917|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
43747918|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747919|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
43747920|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747921|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43747922|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747923|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747934|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747936|NCT04786613|Protective Agents|protective agents|mesh-ancestor
43747937|NCT04767191|Lumefantrine|lumefantrine|mesh-list
43570695|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43570696|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43570697|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43571891|NCT00120042|Oxytocin|oxytocin|mesh-list
43570698|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570699|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570700|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570720|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43570722|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570723|NCT00387907|Trastuzumab|trastuzumab|mesh-list
43570724|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570725|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570726|NCT00385515|Meclocycline|meclocycline|mesh-list
43570727|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43570728|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570729|NCT00384904|Ritonavir|ritonavir|mesh-list
43570730|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43570731|NCT00384904|Tenofovir|tenofovir|mesh-list
43747940|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43747942|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
43747943|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43747944|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43747945|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747946|NCT04766684|Lidocaine|lidocaine|mesh-list
43747947|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
43747948|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
43747949|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747950|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747951|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
43747953|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43747954|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43747955|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43747971|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747972|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43747974|NCT04657640|Trace Elements|trace elements|mesh-list
43570750|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
43570751|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570752|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570753|NCT00384150|Galiximab|galiximab|mesh-list
43570754|NCT00384150|Rituximab|rituximab|mesh-list
43570756|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570757|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
43570758|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570772|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43570773|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43570774|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
43570775|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570776|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849058|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43570777|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43570779|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43570780|NCT00382811|Carboplatin|carboplatin|mesh-list
43570781|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570783|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43747975|NCT04657640|Folic Acid|folic acid|mesh-list
43747976|NCT04657640|Micronutrients|micronutrients|mesh-list
43750037|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
43747977|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
43747978|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747979|NCT04657640|Hematinics|hematinics|mesh-ancestor
43747980|NCT04657640|Vitamins|vitamins|mesh-ancestor
43747981|NCT04651400|Antithrombins|antithrombins|mesh-list
43747982|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
43747983|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43747984|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
43747985|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747986|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747987|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
43747988|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43747989|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43747990|NCT04578639|Rituximab|rituximab|mesh-list
43747991|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
43747992|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747993|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747994|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
43747995|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747996|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43747997|NCT04551300|Sevelamer|sevelamer|mesh-list
43747998|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
43747999|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
43748000|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748001|NCT04550637|Apixaban|apixaban|mesh-list
43748002|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43748003|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
43748004|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43748005|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
43748021|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748022|NCT04279847|INCB057643|incb057643|mesh-list
43748023|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748024|NCT04278768|Azacitidine|azacitidine|mesh-list
43748025|NCT04278768|Venetoclax|venetoclax|mesh-list
43748026|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748027|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
43748028|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748029|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748030|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748031|NCT04245514|Durvalumab|durvalumab|mesh-list
43748032|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748033|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571909|NCT00116415|Didanosine|didanosine|mesh-list
43571910|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43571911|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571912|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571913|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571914|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
43571915|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571917|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571918|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43750044|NCT02507128|Glucagon|glucagon|mesh-list
43748034|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
43748035|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748036|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836000|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43836001|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836002|NCT05008809|Antidotes|antidotes|mesh-ancestor
43836003|NCT05008809|Protective Agents|protective agents|mesh-ancestor
43836004|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
43836005|NCT05008809|Vitamins|vitamins|mesh-ancestor
43836006|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
43836007|NCT05008484|Vitamin D|vitamin d|mesh-list
43836008|NCT05008484|Vitamins|vitamins|mesh-ancestor
43836009|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
43836010|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748038|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748039|NCT04189107|Dexamethasone|dexamethasone|mesh-list
43748040|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
43748049|NCT04189107|Hormones|hormones|mesh-ancestor
43748050|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748051|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748052|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748053|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
43748054|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748055|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748056|NCT04188314|Desflurane|desflurane|mesh-list
43748057|NCT04188314|Isoflurane|isoflurane|mesh-list
43748058|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43748059|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
43748060|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
43748070|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43748071|NCT04153760|Analgesics|analgesics|mesh-ancestor
43570784|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43748072|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
43748073|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748074|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748075|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748076|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748077|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43748078|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43748079|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748080|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43748081|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43750055|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748082|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748083|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
43748084|NCT04112199|Terlipressin|terlipressin|mesh-list
43748085|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43748086|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43748087|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
43748088|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
43748089|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748090|NCT04088591|Protective Agents|protective agents|mesh-ancestor
43748099|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
43748100|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
43748101|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748102|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748103|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748105|NCT03952091|Hormones|hormones|mesh-ancestor
43748106|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748107|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748108|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570786|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570787|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43570788|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43570789|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570790|NCT00382096|Metformin|metformin|mesh-list
43570791|NCT00382096|Vildagliptin|vildagliptin|mesh-list
43570792|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43570793|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570794|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43570795|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
43570796|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570797|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570798|NCT00380159|Lamivudine|lamivudine|mesh-list
43570799|NCT00380159|Emtricitabine|emtricitabine|mesh-list
43570800|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
43570801|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43570802|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43570803|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570804|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570805|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
43570806|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570807|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43570808|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43570809|NCT00379990|Prednisolone|prednisolone|mesh-list
43570810|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570811|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
43570812|NCT00379990|Hormones|hormones|mesh-ancestor
43570813|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570814|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570815|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43570816|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847808|NCT04075240|Analgesics|analgesics|mesh-ancestor
43847809|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
43847810|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847811|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847812|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43750072|NCT02506842|Folic Acid|folic acid|mesh-list
43750095|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570817|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43570818|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
43570819|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748109|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
43748110|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748111|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748112|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
43748113|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43748114|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43748115|NCT03952091|Growth Substances|growth substances|mesh-ancestor
43748116|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
43748117|NCT03923556|Neostigmine|neostigmine|mesh-list
43748118|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43748119|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748120|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748121|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
43748123|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571929|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571930|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571931|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571932|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
43571933|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571934|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571935|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571936|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43571937|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43571938|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43571939|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43571940|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43748124|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43748125|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
43748126|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748127|NCT03909334|Osimertinib|osimertinib|mesh-list
43748128|NCT03909334|Ramucirumab|ramucirumab|mesh-list
43748129|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748130|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43748131|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748132|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748137|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571985|NCT00110422|Diuretics|diuretics|mesh-ancestor
43750145|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748155|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748156|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748157|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43748159|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748160|NCT03834519|Prednisone|prednisone|mesh-list
43748161|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
43748162|NCT03834519|Olaparib|olaparib|mesh-list
43748163|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
43748172|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43748173|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748174|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750282|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43750283|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43750284|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43750285|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43750286|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43750287|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
43750288|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750289|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750290|NCT02505776|Bimatoprost|bimatoprost|mesh-list
43750291|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43750292|NCT02505971|Propranolol|propranolol|mesh-list
43750293|NCT02505971|Nadolol|nadolol|mesh-list
43750294|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43750295|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43750296|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
43750297|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750300|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43750301|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43750307|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
43750308|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750309|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750310|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
43750311|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750312|NCT02505633|Lidocaine|lidocaine|mesh-list
43750313|NCT02505633|Epinephrine|epinephrine|mesh-list
43750314|NCT02505633|Racepinephrine|racepinephrine|mesh-list
43750315|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
43750316|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
43750317|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
43750318|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750319|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750320|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
43748175|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43748176|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
43748177|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43748178|NCT03773302|Gemcitabine|gemcitabine|mesh-list
43748179|NCT03773302|Cisplatin|cisplatin|mesh-list
43748180|NCT03773302|Infigratinib|infigratinib|mesh-list
43748181|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748182|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748183|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
43748184|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748185|NCT03773302|Antiviral Agents|antiviral agents|mesh-ancestor
43748186|NCT03773302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748187|NCT03773302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748188|NCT03773302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748189|NCT03773302|Immunologic Factors|immunologic factors|mesh-ancestor
43748190|NCT03773302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748191|NCT03772028|Cisplatin|cisplatin|mesh-list
43748192|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748193|NCT03711474|Dexamethasone|dexamethasone|mesh-list
43748194|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748195|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
43748196|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
43748197|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748198|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748199|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748200|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
43748201|NCT03711474|Hormones|hormones|mesh-ancestor
43748202|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748203|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748237|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
43748238|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43748239|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
43748240|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
43748241|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750322|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43750323|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43572054|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
43748242|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748244|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43748245|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43748247|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
43748248|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748249|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
43748251|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748253|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
43748254|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748255|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43748287|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748288|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
43748289|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43748290|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43748291|NCT03030261|Growth Substances|growth substances|mesh-ancestor
43748292|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
43748293|NCT02911142|Prednisone|prednisone|mesh-list
43748294|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
43748295|NCT02911142|Rituximab|rituximab|mesh-list
43748296|NCT02911142|Doxorubicin|doxorubicin|mesh-list
43748297|NCT02911142|Vincristine|vincristine|mesh-list
43748298|NCT02911142|Lenalidomide|lenalidomide|mesh-list
43748299|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748300|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
43748301|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748302|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748303|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43748304|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
43748305|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748306|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748307|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43748308|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748309|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43748310|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43748311|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43748312|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748336|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
43748337|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748338|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
43748339|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748340|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748341|NCT02437370|Antiviral Agents|antiviral agents|mesh-ancestor
43748342|NCT02437370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748343|NCT02437370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748344|NCT02437370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748345|NCT02437370|Immunologic Factors|immunologic factors|mesh-ancestor
43748346|NCT02437370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748347|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
43748348|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
43748363|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748364|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748365|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43748366|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
43748367|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43748368|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748369|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
43748370|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748371|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
43748372|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748373|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43748374|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748375|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43748376|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748377|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
43748378|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
43748384|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43748385|NCT02378298|Protective Agents|protective agents|mesh-ancestor
43748386|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748388|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748389|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748390|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
43748391|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748392|NCT02176161|Metformin|metformin|mesh-list
43748393|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43748394|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748395|NCT02064036|Leuprolide|leuprolide|mesh-list
43748396|NCT02064036|Goserelin|goserelin|mesh-list
43748397|NCT02064036|Bicalutamide|bicalutamide|mesh-list
43748398|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43748399|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
43748400|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43748401|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748402|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748403|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748404|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
43748405|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
43748406|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836011|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43836014|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43836016|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836017|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836018|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836022|NCT05006638|Atropine|atropine|mesh-list
43836023|NCT05006638|Ondansetron|ondansetron|mesh-list
43836024|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
43836025|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
43836026|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
43836027|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
43836028|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836029|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836030|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836031|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
43836032|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
43836033|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43836034|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
43836035|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836036|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836037|NCT05006638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43836038|NCT05006638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43836039|NCT05006638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43836040|NCT05006638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43748407|NCT02015117|Trametinib|trametinib|mesh-list
43748409|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43748410|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748411|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748413|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43748414|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43748415|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
43748416|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
43748417|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748418|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748419|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748420|NCT01791478|Letrozole|letrozole|mesh-list
43748421|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
43748423|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43748424|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43748425|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748426|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748427|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43748428|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
43748429|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748430|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748431|NCT01700673|Azacitidine|azacitidine|mesh-list
43748432|NCT01700673|Sargramostim|sargramostim|mesh-list
43748433|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748435|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748437|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748438|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
43748439|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748440|NCT00673244|Furosemide|furosemide|mesh-list
43748441|NCT00673244|Diuretics|diuretics|mesh-ancestor
43748442|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
43748443|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748444|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43748451|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748452|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
43748453|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748454|NCT00198718|Protective Agents|protective agents|mesh-ancestor
43748455|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43748456|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748457|NCT02517827|Paclitaxel|paclitaxel|mesh-list
43748458|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43748459|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748460|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
43748461|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
43748462|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
43748463|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748464|NCT02517788|Interferons|interferons|mesh-list
43748465|NCT02517788|Interferon-beta|interferon-beta|mesh-list
43748466|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
43748467|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748468|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
43748469|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748470|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
43748471|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748472|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43748473|NCT02517957|Loperamide|loperamide|mesh-list
43748474|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
43748475|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748476|NCT02517736|Sorafenib|sorafenib|mesh-list
43748477|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748478|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43748479|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748480|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750344|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750345|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43750346|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43750347|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43750348|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
43750349|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750350|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750351|NCT02505451|Protective Agents|protective agents|mesh-ancestor
43750352|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
43748481|NCT02517684|Prednisolone|prednisolone|mesh-list
43748482|NCT02517684|Azathioprine|azathioprine|mesh-list
43748483|NCT02517684|Infliximab|infliximab|mesh-list
43748484|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748485|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
43748491|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748492|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
43748493|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748494|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
43748495|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748496|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748497|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748498|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
43748499|NCT02517619|Dexamethasone|dexamethasone|mesh-list
43748500|NCT02517619|Prednisolone|prednisolone|mesh-list
43748501|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43748502|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
43748503|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43748504|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
43570840|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43570841|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43639132|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570846|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43748505|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43748506|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43748507|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
43748508|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43748509|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748510|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
43748511|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
43748512|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570858|NCT00372437|Mocetinostat|mocetinostat|mesh-list
43570859|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748519|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748520|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43748521|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43748522|NCT02517619|Protective Agents|protective agents|mesh-ancestor
43748524|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
43748525|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
43570866|NCT00372437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570867|NCT00372437|Immunologic Factors|immunologic factors|mesh-ancestor
43639133|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
43748541|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748542|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748543|NCT02517424|Hormones|hormones|mesh-ancestor
43570882|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
43570883|NCT00369070|Imetelstat|imetelstat|mesh-list
43570884|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43570894|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570895|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
43570896|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43570897|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570898|NCT00367887|Ribavirin|ribavirin|mesh-list
43748544|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748545|NCT02517307|Heparin|heparin|mesh-list
43748546|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43748547|NCT02517307|Glycerol|glycerol|mesh-list
43748548|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
43748549|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43748550|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43748551|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750353|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43750354|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
43750355|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750356|NCT02505477|Expectorants|expectorants|mesh-ancestor
43750357|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750358|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43750359|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
43750370|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748552|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43748553|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43748554|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43748555|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43748556|NCT02517307|Protective Agents|protective agents|mesh-ancestor
43748557|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748558|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43570899|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
43570900|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43570901|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
43570902|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
43570903|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570904|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
43570905|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570908|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570910|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43570911|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570912|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
43570913|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570914|NCT00366704|Risperidone|risperidone|mesh-list
43570915|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43570916|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
43570917|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570918|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570919|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570920|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43570921|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43570922|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570923|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43570924|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43570926|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
43570927|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570928|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
43570929|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570930|NCT00364546|Tapentadol|tapentadol|mesh-list
43570931|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43570932|NCT00364546|Narcotics|narcotics|mesh-ancestor
43570933|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748559|NCT02517164|Calcifediol|calcifediol|mesh-list
43748560|NCT02517164|Vitamins|vitamins|mesh-ancestor
43748561|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
43748562|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748563|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43748564|NCT02516826|Olmesartan|olmesartan|mesh-list
43748565|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43748566|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43748567|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43748568|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43748569|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
43748570|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748571|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43748572|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43748573|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748574|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43748575|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43748577|NCT02517099|Azithromycin|azithromycin|mesh-list
43748578|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43750371|NCT02505581|Metronidazole|metronidazole|mesh-list
43748579|NCT02517099|Beclomethasone|beclomethasone|mesh-list
43748580|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43748581|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748582|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43748583|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748584|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748585|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748586|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
43748587|NCT02517099|Hormones|hormones|mesh-ancestor
43748588|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748589|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748590|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43748591|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
43570934|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570935|NCT00364546|Analgesics|analgesics|mesh-ancestor
43570936|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
43570937|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570938|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43570939|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43748593|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748594|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748595|NCT02516618|Fasinumab|fasinumab|mesh-list
43748596|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43748597|NCT02516618|Analgesics|analgesics|mesh-ancestor
43748599|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748600|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748602|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
43748603|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551807|NCT03610139|Vitamin D|vitamin d|mesh-list
43748605|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43748606|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
43748607|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43748608|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748609|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43748610|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748611|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
43748612|NCT02516527|Ipilimumab|ipilimumab|mesh-list
43748613|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748614|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748615|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43748630|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748631|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
43748632|NCT02516423|Hormones|hormones|mesh-ancestor
43748633|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748634|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748635|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748636|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
43748637|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43748638|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43748639|NCT02516423|Growth Substances|growth substances|mesh-ancestor
43748640|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
43748641|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43748642|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
43836062|NCT05003570|Analgesics|analgesics|mesh-ancestor
43836063|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
43836064|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836065|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43836066|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43836067|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
43836068|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
43836069|NCT05003453|Palmidrol|palmidrol|mesh-list
43836070|NCT05003453|Analgesics|analgesics|mesh-ancestor
43836071|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
43836072|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570940|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570941|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570942|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570943|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570944|NCT00364247|Tapentadol|tapentadol|mesh-list
43570945|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43570946|NCT00364247|Narcotics|narcotics|mesh-ancestor
43570947|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570957|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570958|NCT00363636|Galiximab|galiximab|mesh-list
43570959|NCT00363636|Rituximab|rituximab|mesh-list
43570960|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570961|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570962|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
43570963|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570964|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43570965|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570966|NCT00361582|Tapentadol|tapentadol|mesh-list
43570967|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43570968|NCT00361582|Narcotics|narcotics|mesh-ancestor
43570969|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570970|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836075|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43748646|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43748647|NCT02516436|Narcotics|narcotics|mesh-ancestor
43748648|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748649|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748650|NCT02516436|Analgesics|analgesics|mesh-ancestor
43748651|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
43748652|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748653|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43748654|NCT02516462|Hormones|hormones|mesh-list
43570976|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570977|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570978|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570979|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570980|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
43570981|NCT00360867|Imetelstat|imetelstat|mesh-list
43570982|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43570983|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570984|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570985|NCT00360035|Obatoclax|obatoclax|mesh-list
43570986|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570987|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570988|NCT00359450|Taxane|taxane|mesh-list
43570989|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570990|NCT00359437|Satavaptan|satavaptan|mesh-list
43570991|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43570992|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570993|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
43750404|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43750405|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570994|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570995|NCT00359086|Mocetinostat|mocetinostat|mesh-list
43570996|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43570997|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748655|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43748656|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748657|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748658|NCT02516085|Metformin|metformin|mesh-list
43748659|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43748660|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748661|NCT02516059|Oxycodone|oxycodone|mesh-list
43748662|NCT02516059|Naloxone|naloxone|mesh-list
43748663|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43748664|NCT02516059|Narcotics|narcotics|mesh-ancestor
43748665|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748666|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748667|NCT02516059|Analgesics|analgesics|mesh-ancestor
43748668|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
43748669|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748672|NCT02515968|Desflurane|desflurane|mesh-list
43748673|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43571003|NCT00358878|Satavaptan|satavaptan|mesh-list
43571004|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43571005|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571006|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
43571007|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571008|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43571009|NCT00356681|Niacinamide|niacinamide|mesh-list
43571010|NCT00356681|Paclitaxel|paclitaxel|mesh-list
43571011|NCT00356681|Bevacizumab|bevacizumab|mesh-list
43571021|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571022|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571023|NCT00356681|Growth Substances|growth substances|mesh-ancestor
43571024|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571025|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
43571026|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43571027|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571028|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
43571029|NCT00356681|Vitamins|vitamins|mesh-ancestor
43571030|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
43571031|NCT00356109|Insulin|insulin|mesh-list
43571032|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43571033|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
43571034|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571035|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571036|NCT00355849|Insulin|insulin|mesh-list
43571037|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43571038|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
43571039|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571040|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571041|NCT00355355|Talaporfin|talaporfin|mesh-list
43571042|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571043|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43571044|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
43571045|NCT00353574|Darusentan|darusentan|mesh-list
43571046|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43571047|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571048|NCT00353457|Capecitabine|capecitabine|mesh-list
43571049|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
43571050|NCT00353457|Cetuximab|cetuximab|mesh-list
43571051|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43571052|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
43571053|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571054|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748691|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748692|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748693|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
43748694|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43748695|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43571058|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43571059|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43571060|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571061|NCT00345748|Abatacept|abatacept|mesh-list
43571062|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43571063|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571064|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571065|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571066|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
43571067|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571070|NCT00345618|Enoxaparin|enoxaparin|mesh-list
43571071|NCT00345618|Warfarin|warfarin|mesh-list
43571072|NCT00345618|Idraparinux|idraparinux|mesh-list
43571073|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
43571074|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
43571075|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43571076|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43571077|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571078|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43571089|NCT00344045|Analgesics|analgesics|mesh-ancestor
43571090|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
43748696|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43748697|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43748698|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
43748699|NCT02515929|Procyanidin|procyanidin|mesh-list
43748700|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
43748701|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748702|NCT02515929|Protective Agents|protective agents|mesh-ancestor
43571091|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43571092|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571093|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
43571094|NCT00343109|Sargramostim|sargramostim|mesh-list
43571095|NCT00343109|Vaccines|vaccines|mesh-list
43571096|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
43571097|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571098|NCT00338104|Insulin|insulin|mesh-list
43571099|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43571100|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
43571101|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571108|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
43571109|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
43571110|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571112|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571113|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43571114|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571115|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571116|NCT00333502|Camptothecin|camptothecin|mesh-list
43571117|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571118|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571119|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43571120|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43571121|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571122|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571123|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
43571124|NCT00333216|Anecortave|anecortave|mesh-list
43571125|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571126|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571127|NCT00333216|Growth Substances|growth substances|mesh-ancestor
43571128|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571129|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
43571130|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571131|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43571132|NCT00332956|Vaccines|vaccines|mesh-list
43571133|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
43571134|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571135|NCT00332748|Taxane|taxane|mesh-list
43571136|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748703|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748704|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43748705|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43748706|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748707|NCT02515877|Carboplatin|carboplatin|mesh-list
43748708|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748709|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
43748710|NCT02515864|Dotinurad|dotinurad|mesh-list
43748711|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43748712|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43748713|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748714|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43748715|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43748716|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748726|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
43748727|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
43748728|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43571139|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571140|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571141|NCT00332657|Growth Substances|growth substances|mesh-ancestor
43571142|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571143|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
43571144|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571145|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43571146|NCT00330473|Insulin|insulin|mesh-list
43571149|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571151|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43571152|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571154|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43571155|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
43571156|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571157|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571158|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
43571159|NCT00326287|Linezolid|linezolid|mesh-list
43571160|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
43571161|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
43571162|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43571163|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571164|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43571165|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571166|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571167|NCT00325650|Rimonabant|rimonabant|mesh-list
43571168|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43571169|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43571170|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43571171|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571172|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571173|NCT00325650|Hormones|hormones|mesh-ancestor
43571174|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43571175|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571176|NCT00325364|Insulin|insulin|mesh-list
43571177|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43571178|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571179|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571180|NCT00324220|Mocetinostat|mocetinostat|mesh-list
43571182|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571183|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571205|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571206|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43571207|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571208|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43571210|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571211|NCT00321308|Pemetrexed|pemetrexed|mesh-list
43571212|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571213|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571214|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571215|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43571216|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571217|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
43571218|NCT00320203|Anecortave|anecortave|mesh-list
43571222|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571223|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
43571224|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571225|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43571226|NCT00319969|Topotecan|topotecan|mesh-list
43571227|NCT00319969|Amrubicin|amrubicin|mesh-list
43571228|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43571229|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43750426|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43750427|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750429|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571230|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571231|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571232|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571244|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571245|NCT00317395|Heparin|heparin|mesh-list
43571246|NCT00317395|Calcium heparin|calcium heparin|mesh-list
43571247|NCT00317395|Otamixaban|otamixaban|mesh-list
43571248|NCT00317395|Eptifibatide|eptifibatide|mesh-list
43571249|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
43571250|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43571251|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43748729|NCT02515864|Renal Agents|renal agents|mesh-ancestor
43748731|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
43748732|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43748733|NCT02515682|Estrogens|estrogens|mesh-ancestor
43571252|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571253|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43571254|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43571255|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
43571256|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43571257|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571258|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571259|NCT00315757|Bortezomib|bortezomib|mesh-list
43571260|NCT00315757|Mapatumumab|mapatumumab|mesh-list
43571261|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43571262|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571263|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
43571264|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571265|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
43571266|NCT00315640|Anecortave|anecortave|mesh-list
43571267|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571268|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571269|NCT00315640|Growth Substances|growth substances|mesh-ancestor
43571270|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571271|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
43571272|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571273|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43571274|NCT00313794|Tremelimumab|tremelimumab|mesh-list
43571275|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571276|NCT00313768|Paclitaxel|paclitaxel|mesh-list
43571277|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43571278|NCT00313768|Bevacizumab|bevacizumab|mesh-list
43571279|NCT00313768|Carboplatin|carboplatin|mesh-list
43571280|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571281|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571282|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
43571283|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
43571284|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
43748734|NCT02515682|Hormones|hormones|mesh-ancestor
43748735|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748736|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748737|NCT02515695|Interferons|interferons|mesh-list
43748738|NCT02515695|Interferon-beta|interferon-beta|mesh-list
43748739|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
43748740|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748741|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
43748742|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748743|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
43748744|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748745|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43748747|NCT02515734|Bevacizumab|bevacizumab|mesh-list
43748748|NCT02515734|Cetuximab|cetuximab|mesh-list
43748749|NCT02515734|Fluorouracil|fluorouracil|mesh-list
43748750|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
43748751|NCT02515734|Irinotecan|irinotecan|mesh-list
43748752|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748753|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748754|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43748755|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43748756|NCT02515734|Growth Substances|growth substances|mesh-ancestor
43748757|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748758|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
43748759|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
43748760|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748761|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748762|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748763|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
43748764|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43748765|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43748766|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748767|NCT02515734|Antidotes|antidotes|mesh-ancestor
43748776|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748777|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43748778|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748779|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
43748780|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43748781|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43748782|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748783|NCT02515526|Tolbutamide|tolbutamide|mesh-list
43748785|NCT02515526|Digoxin|digoxin|mesh-list
43748786|NCT02515526|Midazolam|midazolam|mesh-list
43748787|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
43748788|NCT02515526|Caffeine|caffeine|mesh-list
43748789|NCT02515526|Omeprazole|omeprazole|mesh-list
43748790|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43748791|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43748799|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
43748800|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
43748801|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
43748802|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748803|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748804|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43748805|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748806|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43571292|NCT00313248|Sagopilone|sagopilone|mesh-list
43571293|NCT00313248|Epothilones|epothilones|mesh-list
43571302|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571304|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43571305|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43571306|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571307|NCT00312975|Tremelimumab|tremelimumab|mesh-list
43571308|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571309|NCT00312091|Lamivudine|lamivudine|mesh-list
43571310|NCT00312091|Nevirapine|nevirapine|mesh-list
43571311|NCT00312091|Stavudine|stavudine|mesh-list
43571312|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43571313|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571314|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571315|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571316|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
43571317|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571318|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571319|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571320|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43571321|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43571322|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
43571323|NCT00311090|Idraparinux|idraparinux|mesh-list
43571324|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
43571325|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43571326|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
43571327|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43571328|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571329|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571330|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571331|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
43571332|NCT00310830|Bosentan|bosentan|mesh-list
43571333|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43571334|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43571335|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571336|NCT00309179|Cetuximab|cetuximab|mesh-list
43571337|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43571338|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748807|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748808|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43748810|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43748811|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43748812|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
43748813|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43748814|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748815|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43748816|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43748817|NCT02515526|Protective Agents|protective agents|mesh-ancestor
43748818|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
43748819|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
43748820|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43748821|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43748822|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43748823|NCT02515448|Gentamicins|gentamicins|mesh-list
43748824|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43748825|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748826|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43748827|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748828|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748829|NCT02515435|Apatinib|apatinib|mesh-list
43748830|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748831|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43748832|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748833|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748834|NCT02515565|Erythromycin|erythromycin|mesh-list
43748835|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
43748836|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43748837|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
43748838|NCT02515565|Cephalosporins|cephalosporins|mesh-list
43748839|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43748840|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748848|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
43748849|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43748850|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43748851|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748852|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748853|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43748854|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748855|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43748856|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
43748857|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748858|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
43748859|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748860|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748861|NCT02515422|Ketamine|ketamine|mesh-list
43748862|NCT02515422|Bupivacaine|bupivacaine|mesh-list
43748863|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
43748864|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
43748865|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748866|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748867|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
43748868|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748869|NCT02515422|Analgesics|analgesics|mesh-ancestor
43748870|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43748871|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43748872|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
43748873|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43748874|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43748875|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748876|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748877|NCT02515188|Acetaminophen|acetaminophen|mesh-list
43748878|NCT02515188|Propacetamol|propacetamol|mesh-list
43748899|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43748900|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43748901|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
43748902|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748903|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748904|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43748905|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43748906|NCT02514980|Ketamine|ketamine|mesh-list
43748907|NCT02514980|Bupivacaine|bupivacaine|mesh-list
43748908|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
43748909|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
43748910|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748911|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748912|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
43748913|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748942|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748943|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
43748944|NCT02514681|Antiviral Agents|antiviral agents|mesh-ancestor
43748945|NCT02514681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748946|NCT02514681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748947|NCT02514681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43748948|NCT02514681|Immunologic Factors|immunologic factors|mesh-ancestor
43748949|NCT02514681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748950|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748951|NCT02514642|Clopidogrel|clopidogrel|mesh-list
43748952|NCT02514642|Ticagrelor|ticagrelor|mesh-list
43748953|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43748954|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43748955|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43748956|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43748957|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
43748958|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552157|NCT03607175|Hormones|hormones|mesh-ancestor
43748959|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748960|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748962|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
43748964|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
43748965|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
43748966|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43748967|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43748968|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748969|NCT02514629|Androgens|androgens|mesh-ancestor
43748970|NCT02514629|Hormones|hormones|mesh-ancestor
43748971|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748972|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748973|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748974|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
43836076|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43836077|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43836078|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
43836079|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836080|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43836081|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43571340|NCT00307398|Anecortave|anecortave|mesh-list
43571341|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571342|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571343|NCT00307398|Growth Substances|growth substances|mesh-ancestor
43571344|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571345|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
43571346|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571347|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43571348|NCT00305656|Cediranib|cediranib|mesh-list
43571349|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571350|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571351|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571352|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43571353|NCT00305188|Leucovorin|leucovorin|mesh-list
43571354|NCT00305188|Fluorouracil|fluorouracil|mesh-list
43571355|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
43571356|NCT00305188|Xaliproden|xaliproden|mesh-list
43571357|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
43571358|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571359|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43571360|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571383|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43571385|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43571386|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43571387|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43571388|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
43571389|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571390|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571391|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43571392|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43750435|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750437|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43847770|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847771|NCT04079686|Cefazolin|cefazolin|mesh-list
43847772|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43847773|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847774|NCT04079257|Eculizumab|eculizumab|mesh-list
43847775|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43847776|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847777|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
43847778|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847779|NCT04079192|Umirolimus|umirolimus|mesh-list
43847780|NCT04079192|Paclitaxel|paclitaxel|mesh-list
43847781|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847782|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847783|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
43847784|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
43847785|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
43847786|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847787|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847788|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847789|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
43847790|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847791|NCT04077190|Cortisone|cortisone|mesh-list
43847792|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848977|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
43848978|NCT03976258|Naltrexone|naltrexone|mesh-list
43848979|NCT03976258|Buprenorphine|buprenorphine|mesh-list
43848980|NCT03976258|Methadone|methadone|mesh-list
43848981|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43848982|NCT03976258|Heroin|heroin|mesh-list
43848983|NCT03976258|Naloxone|naloxone|mesh-list
43848984|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43748975|NCT02514538|Acetaminophen|acetaminophen|mesh-list
43748977|NCT02514538|Analgesics|analgesics|mesh-ancestor
43748978|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
43748979|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748980|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748981|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
43748982|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
43748983|NCT02514343|Bupivacaine|bupivacaine|mesh-list
43748984|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
43748986|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748987|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748988|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
43748989|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748990|NCT02514343|Analgesics|analgesics|mesh-ancestor
43748991|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43748992|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
43748993|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43748994|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43748995|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748996|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43748997|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
43749031|NCT02513875|Vitamins|vitamins|mesh-ancestor
43749032|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
43749033|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749034|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43749035|NCT02513849|Tamoxifen|tamoxifen|mesh-list
43749036|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43749037|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
43749038|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749039|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749040|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43749041|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749042|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43749043|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43749044|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43749045|NCT02513862|Heparin|heparin|mesh-list
43749046|NCT02513862|Protamines|protamines|mesh-list
43749047|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
43749048|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43749049|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43836095|NCT04999761|Futibatinib|futibatinib|mesh-list
43552293|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
43749050|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749051|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
43749052|NCT02513862|Coagulants|coagulants|mesh-ancestor
43749054|NCT02513927|Nifedipine|nifedipine|mesh-list
43749055|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43749056|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43749057|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
43749058|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
43749059|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749060|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749061|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43749062|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43749063|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43749064|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749065|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749066|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749067|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43749068|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43749069|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43749070|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
43749071|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
43749081|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43749082|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749083|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43749084|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43749085|NCT02513888|Vitamin D|vitamin d|mesh-list
43749086|NCT02513888|Vitamins|vitamins|mesh-ancestor
43749087|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
43749088|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749089|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43749090|NCT02513693|Rocuronium|rocuronium|mesh-list
43749091|NCT02513693|Neostigmine|neostigmine|mesh-list
43749092|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43749093|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43749094|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43749095|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749096|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749097|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43749098|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749099|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749100|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
43749101|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749102|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43749103|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
43749104|NCT02513433|Bupivacaine|bupivacaine|mesh-list
43749105|NCT02513433|Ropivacaine|ropivacaine|mesh-list
43749106|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
43749107|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
43749108|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
43749109|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749110|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749111|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
43749112|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749113|NCT02513381|Vitamin D|vitamin d|mesh-list
43749114|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
43749115|NCT02513381|Vitamins|vitamins|mesh-ancestor
43749116|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
43749117|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749118|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43749119|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43749120|NCT02513355|Cisplatin|cisplatin|mesh-list
43749121|NCT02513355|Endostar protein|endostar protein|mesh-list
43749122|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749123|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43847793|NCT04075292|Rituximab|rituximab|mesh-list
43749124|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43749125|NCT02513355|Growth Substances|growth substances|mesh-ancestor
43571396|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571397|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571398|NCT00299507|Growth Substances|growth substances|mesh-ancestor
43571399|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571400|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
43571401|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571402|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43571404|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43571405|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43571406|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43571407|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571408|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571409|NCT00299325|Hormones|hormones|mesh-ancestor
43571442|NCT00287547|Abatacept|abatacept|mesh-list
43571443|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43571444|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571445|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571446|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571447|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
43571448|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571449|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43749159|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749160|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749161|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749162|NCT02513147|Lopinavir|lopinavir|mesh-list
43749163|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43749192|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
43749194|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749195|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749196|NCT02512562|Simeprevir|simeprevir|mesh-list
43749197|NCT02512562|Odalasvir|odalasvir|mesh-list
43749198|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
43749199|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749200|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
43749201|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749202|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749203|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
43749204|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43749205|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43749206|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43749207|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552440|NCT03604016|Tenofovir|tenofovir|mesh-list
43749208|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749209|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
43749213|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749214|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
43749215|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
43749216|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43749218|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749219|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43749220|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43749221|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43749222|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43749223|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571450|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
43571451|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571452|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571453|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43571454|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
43571455|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43571456|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571457|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43749224|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
43749225|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43749226|NCT02512471|Ropivacaine|ropivacaine|mesh-list
43749227|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
43749228|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
43749229|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749230|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749231|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
43749232|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749233|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43749234|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43749235|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749236|NCT02512523|Incretins|incretins|mesh-ancestor
43749237|NCT02512523|Hormones|hormones|mesh-ancestor
43749238|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749239|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43749240|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
43749241|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749242|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836096|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836097|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43836098|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836099|NCT04997902|Tipifarnib|tipifarnib|mesh-list
43836100|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571458|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43571459|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43571460|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
43571461|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571462|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571463|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43571464|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
43571465|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43571466|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571467|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43571468|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43571469|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43571470|NCT00284128|Losartan|losartan|mesh-list
43571471|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43571472|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43571473|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43571474|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43571475|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836101|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43836102|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
43836104|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
43836105|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836112|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
43571476|NCT00282867|Insulin|insulin|mesh-list
43571477|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571478|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571479|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
43571480|NCT00273650|Vitamins|vitamins|mesh-ancestor
43571481|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
43571496|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43571497|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43571498|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571499|NCT00265655|Satraplatin|satraplatin|mesh-list
43571500|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571501|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
43571502|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43571503|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43571504|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571505|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43571506|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43571507|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43571508|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43571509|NCT00263341|Estrogens|estrogens|mesh-ancestor
43571510|NCT00263341|Hormones|hormones|mesh-ancestor
43571511|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43571512|NCT00263042|Rimonabant|rimonabant|mesh-list
43571513|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43571514|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43836113|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43836114|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836115|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
43836116|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836117|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43836118|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43836119|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43836120|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43836121|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836122|NCT04993352|Antibodies|antibodies|mesh-list
43836123|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43836124|NCT04993352|Mitogens|mitogens|mesh-list
43836125|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
43836126|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
43836127|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836128|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
43836129|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749252|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749253|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
43749254|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
43749255|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
43749256|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749257|NCT02512055|Atropine|atropine|mesh-list
43749258|NCT02512055|Ketamine|ketamine|mesh-list
43749259|NCT02512055|Analgesics|analgesics|mesh-ancestor
43749260|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
43749261|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749262|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749263|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43749264|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43749266|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
43571517|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571518|NCT00263042|Hormones|hormones|mesh-ancestor
43571519|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749267|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749268|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43749269|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43749270|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749271|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749272|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43749273|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43749274|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43749275|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
43749276|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43749277|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
43749279|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
43749280|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43749281|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43749282|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
43749283|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
43749284|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43749285|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749286|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749287|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749296|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43749298|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43749307|NCT02511613|Protective Agents|protective agents|mesh-ancestor
43749308|NCT02511665|Metformin|metformin|mesh-list
43749309|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43749310|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749311|NCT02511847|Afatinib|afatinib|mesh-list
43749312|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749313|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43749314|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749315|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749316|NCT02511639|Everolimus|everolimus|mesh-list
43749317|NCT02511639|Letrozole|letrozole|mesh-list
43749318|NCT02511639|Anastrozole|anastrozole|mesh-list
43749319|NCT02511639|Exemestane|exemestane|mesh-list
43749320|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43749321|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749322|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43749323|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
43749324|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749325|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43749326|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749327|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749328|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43749329|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
43749330|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749331|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43749332|NCT02511483|Propranolol|propranolol|mesh-list
43749333|NCT02511483|Morphine|morphine|mesh-list
43749334|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43749335|NCT02511483|Narcotics|narcotics|mesh-ancestor
43749336|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749337|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749339|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
43749340|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749341|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43749342|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43749343|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749344|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750441|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749345|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749346|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43749347|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43749348|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
43749349|NCT02511704|Nicotine|nicotine|mesh-list
43749350|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43749352|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749353|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749354|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43749355|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43749356|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
43749357|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749358|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749360|NCT02511574|Progestins|progestins|mesh-ancestor
43749361|NCT02511574|Hormones|hormones|mesh-ancestor
43749362|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749374|NCT02511353|Artenimol|artenimol|mesh-list
43749375|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43749376|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749377|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
43749378|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43749379|NCT02511418|Simvastatin|simvastatin|mesh-list
43749380|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43749381|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43749382|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
43749383|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749385|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43749386|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749387|NCT02511366|Caseins|caseins|mesh-list
43749388|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
43749389|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
43749390|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749391|NCT02511340|HH-GV-678|hh-gv-678|mesh-list
43749392|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43749393|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749394|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749395|NCT02511223|Olaparib|olaparib|mesh-list
43749396|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43749397|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749398|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749399|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749400|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43749401|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43749402|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
43749403|NCT02511210|Anesthetics|anesthetics|mesh-list
43749404|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749405|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749406|NCT02511054|Chloroquine|chloroquine|mesh-list
43749407|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
43749408|NCT02511054|Amebicides|amebicides|mesh-ancestor
43749409|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43749410|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43749411|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749412|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
43749413|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43749414|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43749415|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749416|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749417|NCT02511067|Ranibizumab|ranibizumab|mesh-list
43750443|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43572105|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749418|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43749419|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43749420|NCT02511067|Growth Substances|growth substances|mesh-ancestor
43749421|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749422|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
43749423|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749424|NCT02510976|Prucalopride|prucalopride|mesh-list
43571535|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571536|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43571537|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571538|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571539|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571540|NCT00260078|Ritonavir|ritonavir|mesh-list
43749428|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43749429|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
43749430|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749431|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749432|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749433|NCT02510781|Carboplatin|carboplatin|mesh-list
43749435|NCT02510781|Trastuzumab|trastuzumab|mesh-list
43749436|NCT02510781|Epirubicin|epirubicin|mesh-list
43749437|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749438|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
43749439|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
43749440|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
43749441|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749442|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43571541|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43571550|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571551|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571552|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571553|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
43571554|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571555|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43571556|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43749445|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43749446|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749448|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43749449|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749450|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43749451|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749452|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749453|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43749454|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43749455|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
43749456|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749457|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43749458|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43749459|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749460|NCT02510950|Temozolomide|temozolomide|mesh-list
43749461|NCT02510950|Poly ICLC|poly iclc|mesh-list
43572117|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572118|NCT00064714|Exenatide|exenatide|mesh-list
43749462|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43836145|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43836146|NCT04991597|Lidocaine|lidocaine|mesh-list
43836147|NCT04991597|Epinephrine|epinephrine|mesh-list
43836148|NCT04991597|Racepinephrine|racepinephrine|mesh-list
43836149|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
43836150|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
43836151|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
43836152|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43836153|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836154|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
43836155|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836156|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43836157|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43836158|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43836159|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43836160|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836161|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43836162|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43836163|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
43836164|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836169|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
43836170|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
43836171|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
43571562|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43571563|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43571564|NCT00257205|Temozolomide|temozolomide|mesh-list
43836172|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43836173|NCT04991402|Dolutegravir|dolutegravir|mesh-list
43836174|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43836175|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43836176|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43836177|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836178|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836179|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43836180|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
43836181|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749487|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749488|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749489|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43749490|NCT02510612|Analgesics|analgesics|mesh-ancestor
43749491|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
43749492|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749493|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43749494|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43749495|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43749496|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749497|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749498|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749500|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
43749501|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749502|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43749503|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43749504|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749505|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749506|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43749507|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571569|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749508|NCT02510287|Lidocaine|lidocaine|mesh-list
43749509|NCT02510287|Fentanyl|fentanyl|mesh-list
43749510|NCT02510287|Bupivacaine|bupivacaine|mesh-list
43749511|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
43749512|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
43749513|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749514|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749515|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
43749516|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749530|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749532|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749533|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43749535|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749536|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
43749537|NCT02510222|Analgesics|analgesics|mesh-ancestor
43749538|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
43749539|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749540|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749541|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
43749542|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749543|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43749544|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
43749545|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43749546|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43749547|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749548|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43749549|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
43749550|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43749551|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
43749552|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43749553|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
43749554|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749555|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
43749556|NCT02510235|Protective Agents|protective agents|mesh-ancestor
43749557|NCT02510157|Dexamethasone|dexamethasone|mesh-list
43749558|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43749559|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
43749560|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
43749561|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749562|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749563|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749564|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
43749565|NCT02510157|Hormones|hormones|mesh-ancestor
43749566|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749567|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43749568|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749569|NCT02510053|Caspofungin|caspofungin|mesh-list
43749571|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749572|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749573|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749574|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
43749575|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43749576|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749577|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749578|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43749580|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
43749581|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43571570|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571571|NCT00255099|Etravirine|etravirine|mesh-list
43571572|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43749582|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43749583|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43749584|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43749585|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749586|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749587|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749588|NCT02509923|Rabeprazole|rabeprazole|mesh-list
43749589|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43749590|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749591|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43749592|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749593|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749594|NCT02509806|Apatinib|apatinib|mesh-list
43749595|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749596|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43749597|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749598|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749599|NCT02509728|Choline|choline|mesh-list
43749600|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
43749601|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43749602|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
43749603|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749619|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749620|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749621|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43749622|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43749623|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43749624|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43749625|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
43749626|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
43749627|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
43749628|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
43749629|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749630|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749631|NCT02509273|Analgesics|analgesics|mesh-ancestor
43749632|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
43749633|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749634|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43749635|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
43749636|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
43749637|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43749638|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43749639|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43749640|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749641|NCT02509468|Sirolimus|sirolimus|mesh-list
43749642|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43749643|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749644|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43749645|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749646|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
43749647|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43749648|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
43749649|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572148|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553038|NCT03600493|Lidocaine|lidocaine|mesh-list
43749691|NCT02509234|Trabectedin|trabectedin|mesh-list
43749692|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43749693|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43749694|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749695|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749696|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749700|NCT02509208|Coagulants|coagulants|mesh-ancestor
43749702|NCT02509195|Abacavir|abacavir|mesh-list
43749703|NCT02509195|Dolutegravir|dolutegravir|mesh-list
43749704|NCT02509195|Triumeq|triumeq|mesh-list
43749705|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43749706|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43749707|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572149|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43749708|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749709|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
43572150|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
43572151|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43572152|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572153|NCT00057980|Celecoxib|celecoxib|mesh-list
43572154|NCT00057980|Epirubicin|epirubicin|mesh-list
43572155|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43572157|NCT00057980|Analgesics|analgesics|mesh-ancestor
43749710|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749711|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43749712|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43749713|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43749714|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43749715|NCT02509143|Ramosetron|ramosetron|mesh-list
43749716|NCT02509143|Antiemetics|antiemetics|mesh-list
43749717|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
43571573|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571574|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571575|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571576|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
43571577|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571580|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571581|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43571582|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
43571583|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571584|NCT00254904|Antiviral Agents|antiviral agents|mesh-ancestor
43571585|NCT00254904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571586|NCT00254904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571587|NCT00254904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571588|NCT00254904|Immunologic Factors|immunologic factors|mesh-ancestor
43571589|NCT00254904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571591|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43571592|NCT00254891|Carboplatin|carboplatin|mesh-list
43749718|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749719|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749720|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749721|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43749722|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
43749723|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749724|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749725|NCT02508870|Azacitidine|azacitidine|mesh-list
43749726|NCT02508870|Atezolizumab|atezolizumab|mesh-list
43749727|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43749728|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
43749729|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571593|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571594|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571595|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
43571596|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
43571597|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
43571598|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571599|NCT00254579|Tremelimumab|tremelimumab|mesh-list
43571600|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571601|NCT00253968|SR 46349B|sr 46349b|mesh-list
43571602|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43571603|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43571604|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571605|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43571608|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571616|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571617|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
43571618|NCT00250822|Gemcitabine|gemcitabine|mesh-list
43571619|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
43571620|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43571621|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
43571622|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571623|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571624|NCT00250822|Antiviral Agents|antiviral agents|mesh-ancestor
43571625|NCT00250822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750448|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43750449|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43571626|NCT00250822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571627|NCT00250822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571628|NCT00250822|Immunologic Factors|immunologic factors|mesh-ancestor
43571629|NCT00250822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571630|NCT00243906|Plasminogen|plasminogen|mesh-list
43571631|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43571632|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43571633|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43571634|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571635|NCT00239694|Vaccines|vaccines|mesh-list
43571636|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43571637|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
43571638|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571639|NCT00232752|Sirolimus|sirolimus|mesh-list
43571640|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43571641|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571642|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43571643|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571644|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
43571645|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571646|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
43749733|NCT02509091|Dimercaprol|dimercaprol|mesh-list
43749734|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43749735|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749736|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
43749737|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
43749738|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749739|NCT02509052|Leflunomide|leflunomide|mesh-list
43749740|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749741|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749742|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571649|NCT00232141|Analgesics|analgesics|mesh-ancestor
43571650|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
43571651|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43571652|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571653|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
43571654|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43571655|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43571656|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571657|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43571658|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43571659|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43571661|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43571663|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43571664|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571665|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43571666|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571667|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
43571668|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571669|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
43571670|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571671|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
43571672|NCT00231153|Povidone|povidone|mesh-list
43571673|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
43571674|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
43571675|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43571676|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571677|NCT00229008|Linezolid|linezolid|mesh-list
43571682|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571683|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43571684|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571685|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571687|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43571688|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43571689|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43750460|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43571690|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571691|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571692|NCT00228176|Hormones|hormones|mesh-ancestor
43571693|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43571694|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571695|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
43571696|NCT00224003|Hematinics|hematinics|mesh-ancestor
43571697|NCT00216593|Galantamine|galantamine|mesh-list
43571698|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43571699|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571700|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571701|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
43749743|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
43749744|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749745|NCT02508857|Ketorolac|ketorolac|mesh-list
43749746|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
43749747|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43749748|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43749749|NCT02508857|Analgesics|analgesics|mesh-ancestor
43749750|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
43749752|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749753|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43749754|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43749755|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43749756|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749783|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43749784|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43749785|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639134|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749786|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749788|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43749789|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43749790|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
43749791|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
43749792|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43749793|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43749794|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43749795|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749796|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749797|NCT02509104|Tamsulosin|tamsulosin|mesh-list
43749798|NCT02509104|Dutasteride|dutasteride|mesh-list
43571702|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571703|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571704|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43571705|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
43571706|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43571707|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
43571708|NCT00162292|Methotrexate|methotrexate|mesh-list
43571709|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43571710|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
43571711|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43571712|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571713|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43571714|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
43571715|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571716|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571717|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
43571718|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571719|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43571720|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571721|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
43571722|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43571723|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571724|NCT00162279|Abatacept|abatacept|mesh-list
43571725|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43571726|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571727|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571728|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571729|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
43571730|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571731|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43571732|NCT00145431|Atorvastatin|atorvastatin|mesh-list
43571733|NCT00145431|Torcetrapib|torcetrapib|mesh-list
43571734|NCT00145431|Fenofibrate|fenofibrate|mesh-list
43571735|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43571736|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43571737|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
43571738|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571739|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43639135|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43571740|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43571742|NCT00141284|Lamivudine|lamivudine|mesh-list
43749799|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43749800|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43749801|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43749802|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749803|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749804|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749805|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749806|NCT02509104|Urological Agents|urological agents|mesh-ancestor
43749807|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43749808|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43749809|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749810|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
43749811|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836195|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
43836196|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836197|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43836199|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43836200|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571746|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571747|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571748|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571775|NCT00135421|Antidepressive Agents|antidepressive agents|mesh-ancestor
43571776|NCT00135421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43571778|NCT00135395|Lopinavir|lopinavir|mesh-list
43571790|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43571792|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43571793|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571794|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639136|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43571796|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
43571797|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571800|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43571801|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43571802|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43571803|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43571806|NCT00135369|Stavudine|stavudine|mesh-list
43750469|NCT02504983|Sorafenib|sorafenib|mesh-list
43750470|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750471|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43750474|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
43749840|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749841|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43749842|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749844|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43749845|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749846|NCT02508168|Metformin|metformin|mesh-list
43749847|NCT02508168|Alogliptin|alogliptin|mesh-list
43749848|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43749849|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749850|NCT02508168|Incretins|incretins|mesh-ancestor
43749852|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749853|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43749854|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
43749855|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749856|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749857|NCT02508246|Cisplatin|cisplatin|mesh-list
43749858|NCT02508246|Docetaxel|docetaxel|mesh-list
43749859|NCT02508246|Adavosertib|adavosertib|mesh-list
43749860|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749862|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
43571807|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43571808|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571809|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571810|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571811|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
43571812|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571813|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571814|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571815|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43571822|NCT00135343|Ritonavir|ritonavir|mesh-list
43571823|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43571824|NCT00135343|Efavirenz|efavirenz|mesh-list
43571825|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43571826|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43571827|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571828|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571829|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749863|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
43749864|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749865|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749866|NCT02508142|Scopolamine|scopolamine|mesh-list
43749867|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43749868|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43749869|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
43749870|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
43749871|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749872|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749873|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749874|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
43749875|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43749876|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
43749877|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749878|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749879|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43749880|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
43749881|NCT02508220|Oxytocin|oxytocin|mesh-list
43749883|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43749884|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749885|NCT02508064|Fostemsavir|fostemsavir|mesh-list
43749886|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43749887|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43749888|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
43749893|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
43749912|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749913|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749914|NCT02507635|Levocetirizine|levocetirizine|mesh-list
43749915|NCT02507635|Desloratadine|desloratadine|mesh-list
43571831|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571832|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
43571833|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571834|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43571835|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43571836|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43571837|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571838|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43571839|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43571840|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43571841|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43571842|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43571843|NCT00134264|Atorvastatin|atorvastatin|mesh-list
43571844|NCT00134264|Torcetrapib|torcetrapib|mesh-list
43571845|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43571846|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43571847|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
43571848|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571849|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43571850|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43571851|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571852|NCT00134238|Atorvastatin|atorvastatin|mesh-list
43571853|NCT00134238|Torcetrapib|torcetrapib|mesh-list
43571854|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43571855|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43571856|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
43571857|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571858|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43571859|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43571860|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571862|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
43571863|NCT00131924|Hormones|hormones|mesh-ancestor
43571864|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43571865|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571866|NCT00127634|Insulin|insulin|mesh-list
43571867|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43571868|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
43571869|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571870|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571871|NCT00126984|Vaccines|vaccines|mesh-list
43749926|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749927|NCT02507479|Thiotepa|thiotepa|mesh-list
43749928|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43749929|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
43749930|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749931|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749932|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43749933|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43749934|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
43749935|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749936|NCT02507700|Bupivacaine|bupivacaine|mesh-list
43749937|NCT02507700|Sevoflurane|sevoflurane|mesh-list
43749938|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
43749939|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
43749940|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749941|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749942|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
43749943|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572159|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572160|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572161|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43749944|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43749945|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43749946|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
43749948|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749949|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43749950|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43749951|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43749952|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749953|NCT02507440|Lidocaine|lidocaine|mesh-list
43749954|NCT02507440|Propofol|propofol|mesh-list
43749955|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
43749956|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
43749957|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749966|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43749967|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43749968|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
43749969|NCT02507362|Riboflavin|riboflavin|mesh-list
43749970|NCT02507362|Dextrans|dextrans|mesh-list
43749971|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
43749972|NCT02507362|Vitamins|vitamins|mesh-ancestor
43749973|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
43749974|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749975|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43749976|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
43749977|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
43749978|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
43749979|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
43749980|NCT02507323|Ticagrelor|ticagrelor|mesh-list
43749981|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43749982|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43749983|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43749984|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43749985|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43749986|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
43749987|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749988|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749989|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749990|NCT02507245|Hormones|hormones|mesh-list
43749991|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
43749992|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749993|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749994|NCT02507232|Temozolomide|temozolomide|mesh-list
43749995|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43749996|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
43571872|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
43571873|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571875|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
43571876|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571877|NCT00120393|Ritonavir|ritonavir|mesh-list
43571878|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43571879|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43571880|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43749997|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749998|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750000|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43750001|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750002|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
43572168|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572169|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572170|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572171|NCT00057473|Carboplatin|carboplatin|mesh-list
43572172|NCT00057473|Irinotecan|irinotecan|mesh-list
43572173|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572174|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43750003|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750011|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750012|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750013|NCT02507167|Rifampin|rifampin|mesh-list
43750014|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43750015|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
43750016|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43750017|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750018|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
43750019|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43750021|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750022|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43750023|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43750024|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43750025|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43750026|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43571882|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571888|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43571889|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43571892|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
43571893|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43750027|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43750029|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43750030|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
43750031|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750032|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750033|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43750034|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43750035|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
43750036|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750038|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
43750039|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
43750040|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750041|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571894|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571895|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43571896|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
43571897|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43571898|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43571899|NCT00117650|Etoposide|etoposide|mesh-list
43571900|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
43571901|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571902|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571903|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43571904|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43571905|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571906|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571907|NCT00116415|Lamivudine|lamivudine|mesh-list
43571908|NCT00116415|Efavirenz|efavirenz|mesh-list
43571919|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43571920|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43571921|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43750042|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750045|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43750046|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43750047|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750048|NCT02507128|Incretins|incretins|mesh-ancestor
43750049|NCT02507128|Hormones|hormones|mesh-ancestor
43572178|NCT00055575|Scopolamine|scopolamine|mesh-list
43572181|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
43750050|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43750051|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43750052|NCT02506803|Gemcitabine|gemcitabine|mesh-list
43750053|NCT02506803|Paclitaxel|paclitaxel|mesh-list
43750054|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43750056|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
43750057|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
43750058|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
43750059|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750060|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43750061|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
43750062|NCT02506803|Antiviral Agents|antiviral agents|mesh-ancestor
43750063|NCT02506803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750064|NCT02506803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750065|NCT02506803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43750066|NCT02506803|Immunologic Factors|immunologic factors|mesh-ancestor
43750067|NCT02506803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750068|NCT02507154|Cetuximab|cetuximab|mesh-list
43750069|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43750070|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836229|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847794|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
43847795|NCT04075292|Chlorambucil|chlorambucil|mesh-list
43847796|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847797|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847798|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
43847799|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847800|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847801|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43847802|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
43847803|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847804|NCT04075240|Aspirin|aspirin|mesh-list
43847805|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
43847806|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43847807|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750096|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750098|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
43750099|NCT02506777|Doxorubicin|doxorubicin|mesh-list
43750100|NCT02506777|Fluorouracil|fluorouracil|mesh-list
43750101|NCT02506777|Melatonin|melatonin|mesh-list
43750102|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43750103|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
43750104|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571922|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43571923|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43571924|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
43571926|NCT00116298|Efavirenz|efavirenz|mesh-list
43571927|NCT00116298|Stavudine|stavudine|mesh-list
43571928|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43639137|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
43571941|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43571942|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
43571943|NCT00116116|Lamivudine|lamivudine|mesh-list
43571944|NCT00116116|Efavirenz|efavirenz|mesh-list
43571945|NCT00116116|Stavudine|stavudine|mesh-list
43571946|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43571947|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571948|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750521|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43750522|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43750523|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43750524|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43750525|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
43750526|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
43750527|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
43750528|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
43571949|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571950|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
43571959|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43571960|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
43571961|NCT00115050|Darunavir|darunavir|mesh-list
43571962|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43571963|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43571964|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571965|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571966|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571967|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571968|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571969|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
43571970|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571971|NCT00113438|Paclitaxel|paclitaxel|mesh-list
43571972|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
43849059|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571973|NCT00113438|Combretastatin|combretastatin|mesh-list
43571974|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43571975|NCT00113438|Carboplatin|carboplatin|mesh-list
43571976|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571977|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571978|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
43571979|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
43571980|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
43571982|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43571984|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43571986|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
43571987|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571988|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43571989|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43571990|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571991|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43750105|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43750106|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43750107|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
43750108|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750109|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750110|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43750111|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43750112|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43750113|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43750114|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43750115|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750116|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
43750117|NCT02506777|Protective Agents|protective agents|mesh-ancestor
43750118|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750119|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
43750120|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43750121|NCT02506647|Insulin|insulin|mesh-list
43750533|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43750534|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750535|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
43750536|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750537|NCT02504398|Methamphetamine|methamphetamine|mesh-list
43750538|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43750539|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750540|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
43750541|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
43750122|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43750123|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
43571992|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43571993|NCT00099853|Pioglitazone|pioglitazone|mesh-list
43571994|NCT00099853|Vildagliptin|vildagliptin|mesh-list
43571995|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571996|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571997|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43571998|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571999|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572000|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572001|NCT00097357|Enoxaparin|enoxaparin|mesh-list
43572002|NCT00097357|Warfarin|warfarin|mesh-list
43572003|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
43572004|NCT00097357|Apixaban|apixaban|mesh-list
43572005|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
43572006|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43572007|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43750124|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43750125|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750126|NCT02506790|Toremifene|toremifene|mesh-list
43750127|NCT02506790|Metformin|metformin|mesh-list
43750128|NCT02506790|Melatonin|melatonin|mesh-list
43750129|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43750130|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750131|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
43750132|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750133|NCT02506790|Protective Agents|protective agents|mesh-ancestor
43750134|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750135|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43750136|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750137|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43750138|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43750139|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
43750140|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43750141|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43750144|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
43750146|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750147|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
43750148|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750149|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43750150|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
43750151|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43572008|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572009|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43572010|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
43572011|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43572012|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572013|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572014|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43572015|NCT00095550|Irbesartan|irbesartan|mesh-list
43572016|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43572032|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43572033|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572034|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572035|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572036|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43750153|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750154|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43750155|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
43750156|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43750157|NCT02506829|Nicotine|nicotine|mesh-list
43750158|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43750159|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
43750160|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750161|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750162|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43750163|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43750164|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
43750165|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750166|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750167|NCT02506686|Meropenem|meropenem|mesh-list
43750168|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43750169|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750170|NCT02506855|Ropivacaine|ropivacaine|mesh-list
43750171|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
43750172|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
43750173|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750174|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750175|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
43750176|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750177|NCT02506348|Diclofenac|diclofenac|mesh-list
43750178|NCT02506348|Nepafenac|nepafenac|mesh-list
43750179|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43750180|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750181|NCT02506348|Analgesics|analgesics|mesh-ancestor
43553587|NCT03579784|Paclitaxel|paclitaxel|mesh-list
43750182|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
43572037|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43572038|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43572039|NCT00093132|Satraplatin|satraplatin|mesh-list
43572040|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572041|NCT00080106|Vaccines|vaccines|mesh-list
43572042|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
43572043|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572044|NCT00079482|Cytarabine|cytarabine|mesh-list
43572045|NCT00079482|Etoposide|etoposide|mesh-list
43572047|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43750183|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750184|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750185|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43750186|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43750187|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43750188|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750189|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750191|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
43750192|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
43750193|NCT02506439|Vitamins|vitamins|mesh-list
43750194|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
43750195|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750196|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43750197|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43750198|NCT02506231|Leucovorin|leucovorin|mesh-list
43750199|NCT02506231|Folic Acid|folic acid|mesh-list
43750200|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
43750201|NCT02506231|Antidotes|antidotes|mesh-ancestor
43750202|NCT02506231|Protective Agents|protective agents|mesh-ancestor
43750203|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750204|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
43750205|NCT02506231|Vitamins|vitamins|mesh-ancestor
43750206|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
43750207|NCT02506231|Hematinics|hematinics|mesh-ancestor
43750208|NCT02506335|Cholic Acids|cholic acids|mesh-list
43750209|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43750210|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43750211|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
43750212|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750213|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750214|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43750229|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750230|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43750231|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43750232|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750234|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43750235|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43750236|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43750237|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
43750238|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750239|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43750240|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
43750241|NCT02506023|Coagulants|coagulants|mesh-ancestor
43750242|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43750243|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
43750244|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750245|NCT02505997|Midazolam|midazolam|mesh-list
43750246|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43750247|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43750248|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750249|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750250|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43750251|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43750252|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43750253|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43750254|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
43750255|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
43750256|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
43750257|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
43750258|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750259|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750260|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
43750261|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43750262|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
43572048|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572049|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572050|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572051|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572052|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750263|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43750264|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43750265|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750266|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750267|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
43554006|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43554027|NCT03576053|Lidocaine|lidocaine|mesh-list
43750548|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43750549|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750554|NCT02504359|Cytarabine|cytarabine|mesh-list
43750565|NCT02504359|Glycine|glycine|mesh-list
43750566|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43750268|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750269|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750270|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43750271|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750273|NCT02505841|Succinylcholine|succinylcholine|mesh-list
43750275|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
43750276|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
43750277|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750278|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750279|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
43750280|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750281|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43750321|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750324|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43750325|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750326|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572053|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43572055|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
43572056|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572057|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572058|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
43572059|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572060|NCT00079482|Analgesics|analgesics|mesh-ancestor
43572061|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
43572062|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572063|NCT00073866|Celecoxib|celecoxib|mesh-list
43572064|NCT00073866|Docetaxel|docetaxel|mesh-list
43572065|NCT00073866|Irinotecan|irinotecan|mesh-list
43572066|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572067|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
43572068|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
43572069|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
43572070|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572071|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43572072|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572092|NCT00069745|Prednisone|prednisone|mesh-list
43572093|NCT00069745|Satraplatin|satraplatin|mesh-list
43572094|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43572095|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
43572096|NCT00069745|Hormones|hormones|mesh-ancestor
43572097|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43572098|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572099|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43572100|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572101|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43572102|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572103|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572104|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
43750567|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
43750568|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43750569|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750570|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43750571|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
43750573|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750327|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43750328|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43750329|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
43750330|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750331|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43750332|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43750333|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
43750334|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43750335|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750336|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
43750337|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
43750338|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43750339|NCT02505451|Dobutamine|dobutamine|mesh-list
43750340|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43750341|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
43750342|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
43750343|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750372|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
43750373|NCT02505581|Cefuroxime|cefuroxime|mesh-list
43750374|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
43750375|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750376|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43750377|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43750378|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43750379|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43750380|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43750381|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750382|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750383|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750384|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43750385|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43750386|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
43750387|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43750388|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
43750389|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750390|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
43750391|NCT02505360|Protective Agents|protective agents|mesh-ancestor
43750392|NCT02505295|Selenium|selenium|mesh-list
43750393|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
43750394|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750395|NCT02505295|Protective Agents|protective agents|mesh-ancestor
43750587|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43750588|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
43750589|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43750590|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
43750591|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
43750592|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
43750597|NCT02504307|Sirolimus|sirolimus|mesh-list
43750610|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750611|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
43750396|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750397|NCT02505295|Trace Elements|trace elements|mesh-ancestor
43750398|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
43750399|NCT02505282|Vitamin K|vitamin k|mesh-list
43750400|NCT02505282|Vitamins|vitamins|mesh-ancestor
43750401|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
43750402|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750403|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43750406|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
43750410|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43750411|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43750412|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43750413|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43750414|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
43750415|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750416|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750417|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750418|NCT02505386|Ertapenem|ertapenem|mesh-list
43750419|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43750420|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750421|NCT02505009|Tenofovir|tenofovir|mesh-list
43750422|NCT02505009|Entecavir|entecavir|mesh-list
43750423|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
43750424|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750425|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43750428|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750430|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43836246|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
43836247|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836248|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836249|NCT04985890|UB-421|ub-421|mesh-list
43836250|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43836251|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
43836252|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836253|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43836254|NCT04985760|Vaccines|vaccines|mesh-list
43836255|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
43750432|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43750433|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750434|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750438|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750439|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43750440|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
43750442|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750444|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43572106|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572107|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572108|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572109|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
43572110|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572111|NCT00065728|Anecortave|anecortave|mesh-list
43572112|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43572113|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43750612|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750613|NCT02504333|Gemcitabine|gemcitabine|mesh-list
43750614|NCT02504333|Paclitaxel|paclitaxel|mesh-list
43750615|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43750616|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43750617|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750618|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
43750619|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
43750620|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
43572114|NCT00065728|Growth Substances|growth substances|mesh-ancestor
43572115|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572116|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
43572119|NCT00064714|Daclizumab|daclizumab|mesh-list
43572120|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43572121|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43572122|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572123|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43572124|NCT00064714|Incretins|incretins|mesh-ancestor
43572125|NCT00064714|Hormones|hormones|mesh-ancestor
43572126|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43572136|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
43572137|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43572138|NCT00058266|Estrogens|estrogens|mesh-ancestor
43572139|NCT00058266|Hormones|hormones|mesh-ancestor
43572140|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43572141|NCT00057993|Trastuzumab|trastuzumab|mesh-list
43572142|NCT00057993|Exemestane|exemestane|mesh-list
43572143|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43572144|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572145|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43572146|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43572147|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572156|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750445|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750446|NCT02504944|Propranolol|propranolol|mesh-list
43750447|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43750450|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43750451|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
43750452|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750453|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750454|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750455|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43750456|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43750457|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
43750458|NCT02504996|Acetaminophen|acetaminophen|mesh-list
43750459|NCT02504996|Morphine|morphine|mesh-list
43750461|NCT02504996|Narcotics|narcotics|mesh-ancestor
43750462|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750463|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750464|NCT02504996|Analgesics|analgesics|mesh-ancestor
43750465|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
43750466|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750467|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750468|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
43750472|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750473|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750475|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43750489|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
43750490|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750491|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750492|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43750493|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750494|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
43750496|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43750497|NCT02504450|Haloperidol|haloperidol|mesh-list
43750498|NCT02504450|Ziprasidone|ziprasidone|mesh-list
43750499|NCT02504450|Loxapine|loxapine|mesh-list
43750500|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
43750501|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
43750502|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750503|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750504|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43750625|NCT02504333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750626|NCT02504333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750627|NCT02504333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553932|NCT03576508|Lidocaine|lidocaine|mesh-list
43750505|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43750506|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43750507|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750508|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43750509|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43750510|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
43750511|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750512|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572158|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
43572162|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572163|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43572164|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43572165|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572166|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572167|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43572175|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572176|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572177|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572179|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43572180|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43572182|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
43750513|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43750514|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43750515|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
43750516|NCT02504476|Midazolam|midazolam|mesh-list
43750517|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43750518|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43750519|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750520|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750529|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750530|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750531|NCT02504463|Naltrexone|naltrexone|mesh-list
43750532|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43750542|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750543|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
43750544|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750545|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750546|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
43750547|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43750572|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750574|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
43750575|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750576|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43750577|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43750578|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
43750579|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43750580|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43750581|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43750582|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43750637|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43750658|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750659|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
43750660|NCT02504125|Coagulants|coagulants|mesh-ancestor
43750583|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43750584|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
43750585|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750586|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43750621|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750622|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43750623|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
43750624|NCT02504333|Antiviral Agents|antiviral agents|mesh-ancestor
43750628|NCT02504333|Immunologic Factors|immunologic factors|mesh-ancestor
43750629|NCT02504333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750631|NCT02504164|Midazolam|midazolam|mesh-list
43750632|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43750633|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43750634|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750635|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750636|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43750661|NCT02503826|Midazolam|midazolam|mesh-list
43750662|NCT02503826|Sufentanil|sufentanil|mesh-list
43750663|NCT02503826|Dsuvia|dsuvia|mesh-list
43750664|NCT02503826|Propofol|propofol|mesh-list
43750665|NCT02503826|Cisatracurium|cisatracurium|mesh-list
43750666|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43750667|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750668|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750669|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43750670|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
43750671|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
43750672|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43572183|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572184|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572185|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43572186|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
43572187|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43572188|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
43572189|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43572190|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572198|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
43572199|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572200|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572202|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572203|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
43572204|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572205|NCT00052520|Aldesleukin|aldesleukin|mesh-list
43572206|NCT00052520|Interleukin-2|interleukin-2|mesh-list
43572207|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572208|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43572209|NCT00052520|Analgesics|analgesics|mesh-ancestor
43572210|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
43572211|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572212|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572213|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572214|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572215|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
43572216|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572217|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
43572218|NCT00051129|Anecortave|anecortave|mesh-list
43572219|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43572220|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43572221|NCT00051129|Growth Substances|growth substances|mesh-ancestor
43572222|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572223|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
43572225|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43572226|NCT00051038|Entecavir|entecavir|mesh-list
43572227|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
43572435|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572436|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572437|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572438|NCT00004897|Leucovorin|leucovorin|mesh-list
43572439|NCT00004897|Interferons|interferons|mesh-list
43572440|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
43572441|NCT00004897|Cisplatin|cisplatin|mesh-list
43751203|NCT02499978|Cobicistat|cobicistat|mesh-list
43751204|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43751205|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43751206|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43751207|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751208|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751209|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43751210|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43751211|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
43751212|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751213|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43751214|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43751215|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
43751216|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43751217|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43751550|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751551|NCT02497326|Analgesics|analgesics|mesh-ancestor
43751552|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
43751553|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751554|NCT02497118|Cisplatin|cisplatin|mesh-list
43751555|NCT02497118|Vinorelbine|vinorelbine|mesh-list
43751591|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
43572228|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572229|NCT00050102|Ipilimumab|ipilimumab|mesh-list
43572230|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43572231|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572232|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43572233|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572234|NCT00049959|Verteporfin|verteporfin|mesh-list
43572235|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43750673|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43750674|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43750675|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43751592|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43751593|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
43751594|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751595|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43751596|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43751597|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
43751598|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43751599|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43751600|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751601|NCT02497157|Antidotes|antidotes|mesh-ancestor
43751602|NCT02497157|Protective Agents|protective agents|mesh-ancestor
43751603|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
43751604|NCT02497157|Vitamins|vitamins|mesh-ancestor
43751605|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
43751606|NCT02497365|Cefazolin|cefazolin|mesh-list
43751607|NCT02497365|Tobramycin|tobramycin|mesh-list
43751668|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
43751669|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43751670|NCT02496741|Metformin|metformin|mesh-list
43751671|NCT02496741|Chloroquine|chloroquine|mesh-list
43751672|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43751692|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
43751762|NCT02496182|Pirfenidone|pirfenidone|mesh-list
43751763|NCT02496182|Analgesics|analgesics|mesh-ancestor
43751764|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
43836412|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836413|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43836414|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43836415|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847828|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
43847829|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847830|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847831|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43847834|NCT04074746|Vidarabine|vidarabine|mesh-list
43751806|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43751807|NCT02495636|Atezolizumab|atezolizumab|mesh-list
43751808|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751809|NCT02495818|Lidocaine|lidocaine|mesh-list
43751810|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
43751811|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
43751812|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751813|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751814|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
43751815|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751816|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43751817|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43751818|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43751819|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750677|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
43750678|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750679|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750680|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43750681|NCT02503826|Narcotics|narcotics|mesh-ancestor
43750682|NCT02503826|Analgesics|analgesics|mesh-ancestor
43750683|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
43750684|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750685|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43750686|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43750687|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
43750688|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43750689|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751820|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751821|NCT02495662|Prednisolone|prednisolone|mesh-list
43751822|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43751823|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
43751824|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43751825|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
43751826|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43751827|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
43751828|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751829|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
43751830|NCT02495662|Hormones|hormones|mesh-ancestor
43751834|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751854|NCT02496052|Progestins|progestins|mesh-ancestor
43751855|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43751856|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
43751857|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751875|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
43751876|NCT02495220|Bupivacaine|bupivacaine|mesh-list
43751877|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
43751878|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
43751879|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751880|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751881|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
43751882|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751883|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43751884|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43751885|NCT02495220|Analgesics|analgesics|mesh-ancestor
43751886|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43751887|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43751888|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43751889|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
43751890|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751891|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750690|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43750691|NCT02503904|Metronidazole|metronidazole|mesh-list
43750692|NCT02503904|Lidocaine|lidocaine|mesh-list
43750693|NCT02503904|Epinephrine|epinephrine|mesh-list
43750694|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
43750695|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
43750696|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750697|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750698|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
43750724|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750726|NCT02503943|Hormones|hormones|mesh-ancestor
43704399|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751893|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
43751894|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
43751895|NCT02495272|Oxytocin|oxytocin|mesh-list
43751896|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
43751897|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43751898|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751901|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751902|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43572598|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
43572599|NCT00004172|Ifosfamide|ifosfamide|mesh-list
43572600|NCT00004172|Thiotepa|thiotepa|mesh-list
43572601|NCT00004172|Carboplatin|carboplatin|mesh-list
43572602|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572603|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
43751920|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43751921|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43751922|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
43751924|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751925|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43752054|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752056|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43752057|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
43752058|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
43752059|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752060|NCT02493933|Expectorants|expectorants|mesh-ancestor
43752061|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
43752062|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43752063|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
43752064|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752065|NCT02493933|Protective Agents|protective agents|mesh-ancestor
43752066|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752067|NCT02493933|Antidotes|antidotes|mesh-ancestor
43752068|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43752069|NCT02493933|Estrogens|estrogens|mesh-ancestor
43752070|NCT02493933|Hormones|hormones|mesh-ancestor
43572604|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572605|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572606|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572607|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
43572608|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752071|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836417|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43836419|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836420|NCT04972123|Phenylephrine|phenylephrine|mesh-list
43836421|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
43836423|NCT04972123|Capsaicin|capsaicin|mesh-list
43836424|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43836425|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836426|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43836427|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750727|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43750728|NCT02503761|Meropenem|meropenem|mesh-list
43750729|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43750730|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750731|NCT02503462|Ritonavir|ritonavir|mesh-list
43750732|NCT02503462|Darunavir|darunavir|mesh-list
43750733|NCT02503462|Cobicistat|cobicistat|mesh-list
43750734|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43750735|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43836428|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836429|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43836430|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43836431|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
43836432|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836433|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43836434|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
43836435|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
43836436|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836437|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
43836438|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43836439|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
43836440|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
43836441|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43836442|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43836443|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43836444|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
43836445|NCT04972123|Protective Agents|protective agents|mesh-ancestor
43836446|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
43836447|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
43836448|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
43836449|NCT04971499|Dapansutrile|dapansutrile|mesh-list
43836450|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
43836456|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43836457|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43836458|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43836459|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43836460|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836461|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
43752080|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752081|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752099|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752100|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752101|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43752102|NCT02493582|Apatinib|apatinib|mesh-list
43752103|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752104|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43752105|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752106|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752107|NCT02493504|Heparin|heparin|mesh-list
43752108|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
43752109|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43752163|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43752164|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43752165|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752166|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752167|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
43752168|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43752169|NCT02493231|Ketamine|ketamine|mesh-list
43752170|NCT02493231|Nefopam|nefopam|mesh-list
43752171|NCT02493231|Analgesics|analgesics|mesh-ancestor
43752172|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
43752173|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752174|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752175|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43752176|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43752177|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
43752178|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
43752179|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752180|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43752181|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43752182|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752183|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752184|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752185|NCT02493049|Domperidone|domperidone|mesh-list
43752186|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752187|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
43752197|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
43752198|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
43752199|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752200|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572643|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
43572644|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572645|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572646|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
43572647|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572657|NCT00004096|Vinorelbine|vinorelbine|mesh-list
43572658|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572659|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43572660|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
43572661|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
43572662|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
43572663|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572664|NCT00004093|Gemcitabine|gemcitabine|mesh-list
43572666|NCT00004093|Vinorelbine|vinorelbine|mesh-list
43572667|NCT00004093|Carboplatin|carboplatin|mesh-list
43572668|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43572669|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572670|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
43572671|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
43572672|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
43572673|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572674|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43572675|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
43572676|NCT00004093|Antiviral Agents|antiviral agents|mesh-ancestor
43750736|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
43750737|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750738|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750739|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43750740|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43750741|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
43750742|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750743|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43750744|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43750745|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
43750746|NCT02503319|Oxytocin|oxytocin|mesh-list
43572677|NCT00004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572678|NCT00004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572679|NCT00004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572680|NCT00004093|Immunologic Factors|immunologic factors|mesh-ancestor
43572681|NCT00004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752208|NCT02492503|Paclitaxel|paclitaxel|mesh-list
43752209|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43752210|NCT02492503|Carboplatin|carboplatin|mesh-list
43752211|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43752212|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752213|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
43752214|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
43752215|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
43752216|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752217|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43752218|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43752219|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43752220|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752221|NCT02492464|Red yeast rice|red yeast rice|mesh-list
43752222|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43752223|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43752224|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43752225|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
43752226|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752227|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752228|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43752229|NCT02492412|Cyclosporine|cyclosporine|mesh-list
43752230|NCT02492412|Cyclosporins|cyclosporins|mesh-list
43752231|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752232|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752233|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752234|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
43752255|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
43752256|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752258|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752259|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
43752260|NCT02492373|Hormones|hormones|mesh-ancestor
43752261|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752262|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752263|NCT02492490|Basiliximab|basiliximab|mesh-list
43752264|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752265|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
43750747|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
43750748|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43750749|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750750|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43750751|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43750752|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750753|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
43750754|NCT02503319|Coagulants|coagulants|mesh-ancestor
43750755|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43750756|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43836269|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
43836270|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43836271|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43836272|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836273|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836274|NCT04984993|Urological Agents|urological agents|mesh-ancestor
43836275|NCT04984837|Gemcitabine|gemcitabine|mesh-list
43572236|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
43572237|NCT00036608|Entecavir|entecavir|mesh-list
43572238|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
43572239|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572240|NCT00035789|Entecavir|entecavir|mesh-list
43752266|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752267|NCT02492308|Basiliximab|basiliximab|mesh-list
43752268|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752269|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
43555912|NCT03557437|Amoxicillin|amoxicillin|mesh-list
43752270|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752271|NCT02492360|Cisplatin|cisplatin|mesh-list
43752272|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752273|NCT02492282|Remifentanil|remifentanil|mesh-list
43752274|NCT02492282|Propofol|propofol|mesh-list
43752275|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43752276|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752277|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752278|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43752279|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
43752293|NCT02492230|Warfarin|warfarin|mesh-list
43752301|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752303|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
43752304|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43752305|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
43752306|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43752307|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752308|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43752309|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752310|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752311|NCT02492178|Analgesics|analgesics|mesh-ancestor
43572241|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
43572242|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572243|NCT00035633|Entecavir|entecavir|mesh-list
43836276|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
43836277|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43836278|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
43836279|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836280|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836281|NCT04984837|Antiviral Agents|antiviral agents|mesh-ancestor
43836282|NCT04984837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836283|NCT04984837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836284|NCT04984837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43836285|NCT04984837|Immunologic Factors|immunologic factors|mesh-ancestor
43836286|NCT04984837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836287|NCT04983966|Desflurane|desflurane|mesh-list
43836288|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43836289|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
43836290|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
43836291|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43836292|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836293|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
43836294|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836295|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752312|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
43752313|NCT02492217|Adalimumab|adalimumab|mesh-list
43752314|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752315|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43836462|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836463|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836464|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43836465|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836466|NCT04970355|Erenumab|erenumab|mesh-list
43836467|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43836468|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836469|NCT04970355|Analgesics|analgesics|mesh-ancestor
43836470|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
43836471|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752318|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43752319|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752320|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
43752321|NCT02492087|Coagulants|coagulants|mesh-ancestor
43752322|NCT02492074|Dronabinol|dronabinol|mesh-list
43752323|NCT02492074|Cannabidiol|cannabidiol|mesh-list
43752324|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
43752325|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
43752326|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752327|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43752328|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752330|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
43752331|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752332|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43752333|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43752334|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836296|NCT04983121|Antibodies|antibodies|mesh-list
43836297|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
43836298|NCT04983121|Mitogens|mitogens|mesh-list
43836299|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
43836300|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836301|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
43836302|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836303|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43836304|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43836305|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836306|NCT04982705|Incretins|incretins|mesh-ancestor
43836307|NCT04982705|Hormones|hormones|mesh-ancestor
43836308|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836309|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43752335|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752336|NCT02492074|Hormones|hormones|mesh-ancestor
43752337|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752373|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43752374|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43752375|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
43752376|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847843|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752377|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752378|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
43752379|NCT02491970|Hormones|hormones|mesh-ancestor
43752380|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752381|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
43752382|NCT02491879|Ketoprofen|ketoprofen|mesh-list
43752385|NCT02491879|Analgesics|analgesics|mesh-ancestor
43752389|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752390|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752391|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43752392|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752393|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752394|NCT02491723|Azithromycin|azithromycin|mesh-list
43752395|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43752396|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752398|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752399|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43752400|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43752401|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752402|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752403|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43752404|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
43752405|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752406|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752407|NCT02491242|Dolutegravir|dolutegravir|mesh-list
43752408|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43752409|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43752410|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752411|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752413|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43836310|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
43836316|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43836317|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836318|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
43836319|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
43836320|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
43836321|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554231|NCT03573687|Caseins|caseins|mesh-list
43836322|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43836323|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750757|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43750758|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43750759|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43750760|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43750761|NCT02502968|Cytarabine|cytarabine|mesh-list
43750763|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
43752414|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
43752415|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752416|NCT02491268|Cilostazol|cilostazol|mesh-list
43752417|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43752418|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
43752419|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752433|NCT02491606|Tafenoquine|tafenoquine|mesh-list
43752434|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
43752435|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43752436|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43752437|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752438|NCT02491515|Denosumab|denosumab|mesh-list
43752439|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43752440|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752441|NCT02491398|Rituximab|rituximab|mesh-list
43752442|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43752443|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43752444|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752445|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
43752446|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752447|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572682|NCT00002479|Tretinoin|tretinoin|mesh-list
43572683|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572684|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
43572685|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
43572687|NCT00002429|Zidovudine|zidovudine|mesh-list
43572688|NCT00002429|Stavudine|stavudine|mesh-list
43572689|NCT00002429|Didanosine|didanosine|mesh-list
43572690|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
43572691|NCT00002429|Nelfinavir|nelfinavir|mesh-list
43572692|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43572693|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572694|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572695|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572696|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
43572697|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572698|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572699|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572700|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
43572701|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572702|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572703|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
43750764|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750765|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572244|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
43572245|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572246|NCT00035568|Metformin|metformin|mesh-list
43572247|NCT00035568|Glyburide|glyburide|mesh-list
43572248|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43572249|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572704|NCT00002411|Lamivudine|lamivudine|mesh-list
43572705|NCT00002411|Zidovudine|zidovudine|mesh-list
43572706|NCT00002411|Stavudine|stavudine|mesh-list
43572707|NCT00002411|Didanosine|didanosine|mesh-list
43572708|NCT00002411|Nelfinavir|nelfinavir|mesh-list
43572709|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43572710|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572711|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572712|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572713|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
43572714|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572715|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572730|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572731|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572732|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572733|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
43572734|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572735|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572736|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572737|NCT00002246|Stavudine|stavudine|mesh-list
43572738|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
43752448|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43752449|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
43752450|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752451|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
43752452|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
43752453|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752454|NCT02491528|Insulin|insulin|mesh-list
43752455|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43752456|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
43752457|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
43752458|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43752459|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752460|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752461|NCT02491086|Nicotine|nicotine|mesh-list
43752462|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43752463|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
43752464|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752465|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752472|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43752496|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43752497|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
43752498|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43752499|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752500|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43752501|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43752502|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43752503|NCT02490865|RNS60|rns60|mesh-list
43752504|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43752505|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752506|NCT02490865|Analgesics|analgesics|mesh-ancestor
43752507|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
43752508|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752509|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572250|NCT00035542|Metformin|metformin|mesh-list
43572251|NCT00035542|Glyburide|glyburide|mesh-list
43572252|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43572253|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572254|NCT00035529|Abatacept|abatacept|mesh-list
43572255|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43572256|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572257|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572258|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752510|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752511|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752512|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43752513|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43752514|NCT02490839|Amoxicillin|amoxicillin|mesh-list
43752515|NCT02490839|Metronidazole|metronidazole|mesh-list
43752516|NCT02490839|Tetracycline|tetracycline|mesh-list
43752517|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43752518|NCT02490839|Rabeprazole|rabeprazole|mesh-list
43752519|NCT02490839|Bismuth|bismuth|mesh-list
43752520|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43752521|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752522|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
43752523|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43752524|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43752525|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43752526|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43752539|NCT02490540|Sufentanil|sufentanil|mesh-list
43752540|NCT02490540|Dsuvia|dsuvia|mesh-list
43752541|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43752542|NCT02490540|Narcotics|narcotics|mesh-ancestor
43752543|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752544|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752545|NCT02490540|Analgesics|analgesics|mesh-ancestor
43752546|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
43752547|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752548|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43752549|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43752550|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
43752551|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
43752552|NCT02490436|Cetuximab|cetuximab|mesh-list
43752553|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43752554|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752555|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
43752556|NCT02490449|Lansoprazole|lansoprazole|mesh-list
43752557|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43752558|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43752559|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43752560|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572259|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
43572260|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572261|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572262|NCT00031512|Pleconaril|pleconaril|mesh-list
43572263|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
43572292|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
43572293|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43572294|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
43752561|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836493|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836522|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836523|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43836524|NCT04967248|Fulvestrant|fulvestrant|mesh-list
43836525|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43836526|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848985|NCT03976258|Narcotics|narcotics|mesh-ancestor
43752562|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
43752563|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752564|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
43752565|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
43752566|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
43752567|NCT02490345|Gabapentin|gabapentin|mesh-list
43752568|NCT02490345|Analgesics|analgesics|mesh-ancestor
43752569|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
43752570|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752571|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752572|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
43752573|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43752574|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43752575|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752576|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43752577|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43752578|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43752579|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752580|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752581|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
43752582|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
43752583|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43572739|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572740|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43572741|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572742|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572743|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
43572744|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752584|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752585|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752586|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752587|NCT02490072|Analgesics|analgesics|mesh-ancestor
43752588|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
43752589|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752590|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43752591|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43752592|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43752593|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
43572295|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572296|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43572297|NCT00006225|Protective Agents|protective agents|mesh-ancestor
43572298|NCT00005918|Lamivudine|lamivudine|mesh-list
43572299|NCT00005918|Efavirenz|efavirenz|mesh-list
43572300|NCT00005918|Stavudine|stavudine|mesh-list
43572301|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43572302|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572303|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572304|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572305|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
43572306|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572307|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43752594|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752595|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752596|NCT02490085|Insulin|insulin|mesh-list
43752597|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43752598|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752599|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752600|NCT02489955|Tobramycin|tobramycin|mesh-list
43752601|NCT02489955|Amikacin|amikacin|mesh-list
43752602|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43752603|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752604|NCT02490176|Liraglutide|liraglutide|mesh-list
43752605|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752606|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752607|NCT02490176|Incretins|incretins|mesh-ancestor
43752608|NCT02490176|Hormones|hormones|mesh-ancestor
43752609|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752633|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752634|NCT02489760|Analgesics|analgesics|mesh-ancestor
43752635|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
43752636|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752637|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752638|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43752639|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752640|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
43752641|NCT02489929|Azacitidine|azacitidine|mesh-list
43752642|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43752643|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
43752645|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752646|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752647|NCT02489864|Terlipressin|terlipressin|mesh-list
43752648|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43752649|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43752651|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
43752652|NCT02489240|Vitamins|vitamins|mesh-ancestor
43752653|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
43752654|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752655|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43752656|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43752657|NCT02489461|Efavirenz|efavirenz|mesh-list
43752682|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43752683|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
43572309|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43572310|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43572311|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43750766|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
43750767|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750768|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43750769|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
43750770|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750771|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
43750772|NCT02502981|Spironolactone|spironolactone|mesh-list
43750773|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43750774|NCT02502981|Diuretics|diuretics|mesh-list
43752684|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752685|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43752686|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43752687|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43752688|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43752689|NCT02489266|Aldesleukin|aldesleukin|mesh-list
43752690|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
43752691|NCT02489266|Fludarabine|fludarabine|mesh-list
43752692|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752693|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
43752694|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752695|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752696|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43752697|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
43752698|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752699|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752700|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43752701|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43752702|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43752703|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
43752704|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752705|NCT02489513|Ivosidenib|ivosidenib|mesh-list
43752706|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752707|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752708|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752709|NCT02489409|Gemcitabine|gemcitabine|mesh-list
43752710|NCT02489409|Vinorelbine|vinorelbine|mesh-list
43752711|NCT02489409|Endostatins|endostatins|mesh-list
43752712|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43572745|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572746|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572747|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43572748|NCT00002240|Nelfinavir|nelfinavir|mesh-list
43752714|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752715|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752716|NCT02489409|Antiviral Agents|antiviral agents|mesh-ancestor
43752717|NCT02489409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752718|NCT02489409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752719|NCT02489409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752720|NCT02489409|Immunologic Factors|immunologic factors|mesh-ancestor
43752721|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752722|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43752723|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
43752724|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
43752725|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
43752726|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43752727|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43752728|NCT02489409|Growth Substances|growth substances|mesh-ancestor
43752729|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
43752730|NCT02489019|Fentanyl|fentanyl|mesh-list
43752731|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43752732|NCT02489019|Narcotics|narcotics|mesh-ancestor
43752733|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752734|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752735|NCT02489019|Analgesics|analgesics|mesh-ancestor
43572865|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572866|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572867|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
43572868|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
43753005|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753006|NCT02487849|Carboplatin|carboplatin|mesh-list
43753007|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753008|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
43753009|NCT02487329|Calcium|calcium|mesh-list
43753010|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43753011|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753012|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43753013|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
43753014|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
43753015|NCT02487355|Bupivacaine|bupivacaine|mesh-list
43753016|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
43753017|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
43753018|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753019|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753020|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
43753021|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753022|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43753023|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43753024|NCT02487355|Analgesics|analgesics|mesh-ancestor
43753025|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43753026|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43753027|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43753028|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
43753029|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753030|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753031|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43753032|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
43753172|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
43753173|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753174|NCT02486640|Interferons|interferons|mesh-list
43753175|NCT02486640|Interferon-beta|interferon-beta|mesh-list
43753176|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
43753177|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753178|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
43753179|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753180|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
43753203|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753205|NCT02486133|Darunavir|darunavir|mesh-list
43753206|NCT02486133|Tenofovir|tenofovir|mesh-list
43753207|NCT02486133|Lamivudine|lamivudine|mesh-list
43753208|NCT02486133|Emtricitabine|emtricitabine|mesh-list
43753209|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43753210|NCT02486133|Dolutegravir|dolutegravir|mesh-list
43753211|NCT02486133|Abacavir|abacavir|mesh-list
43753212|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43753279|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
43753280|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43753292|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43753293|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
43753294|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753295|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753296|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
43753297|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43753298|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43753299|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
43753300|NCT02485873|Coagulants|coagulants|mesh-ancestor
43753302|NCT02485548|Fluorouracil|fluorouracil|mesh-list
43753303|NCT02485548|Raltitrexed|raltitrexed|mesh-list
43753304|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753305|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
43753306|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572877|NCT03531437|Gestodene|gestodene|mesh-list
43572878|NCT03531437|Estradiol|estradiol|mesh-list
43572879|NCT03531437|Estrogens|estrogens|mesh-ancestor
43572880|NCT03531437|Hormones|hormones|mesh-ancestor
43572881|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43572882|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572883|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43572884|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
43572885|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43753367|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43753368|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753369|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
43753370|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753371|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753373|NCT02485145|Orphenadrine|orphenadrine|mesh-list
43753374|NCT02485145|Bupivacaine|bupivacaine|mesh-list
43753375|NCT02485145|Baclofen|baclofen|mesh-list
43753376|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
43753377|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
43753386|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43753387|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43753388|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753389|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753390|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43753391|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43753392|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43753393|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
43753394|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
43753395|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753396|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43753406|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43753407|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43753408|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753409|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753410|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
43753411|NCT02485262|Simeprevir|simeprevir|mesh-list
43753412|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
43753413|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753414|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
43753415|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753416|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753417|NCT02484885|Xenon|xenon|mesh-list
43753418|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43753419|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
43753420|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
43753421|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753422|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753423|NCT02484963|Zolpidem|zolpidem|mesh-list
43753424|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43753425|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43753426|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43572887|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43572888|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43572889|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43572891|NCT03531372|Antacids|antacids|mesh-list
43572892|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572893|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43572894|NCT03531359|Midazolam|midazolam|mesh-list
43572895|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43572896|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43572897|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43572898|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572899|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43572900|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43572901|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43572902|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43753449|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
43753450|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43753451|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753452|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43753453|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43753454|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753455|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753456|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43753457|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43753458|NCT02485106|Protective Agents|protective agents|mesh-ancestor
43753459|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753460|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753461|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43753462|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
43753463|NCT02485028|Mirodenafil|mirodenafil|mesh-list
43753464|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43753465|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43753466|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753468|NCT02485015|Apatinib|apatinib|mesh-list
43836628|NCT04963764|Amoxicillin|amoxicillin|mesh-list
43836629|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43836630|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836631|NCT04963439|Macitentan|macitentan|mesh-list
43836632|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43836633|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43836634|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836635|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43836636|NCT04959799|Dalbavancin|dalbavancin|mesh-list
43836637|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43753473|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43753474|NCT02484768|Hematinics|hematinics|mesh-ancestor
43753475|NCT02484833|Cetuximab|cetuximab|mesh-list
43753476|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43753477|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753478|NCT02484677|Cisplatin|cisplatin|mesh-list
43753479|NCT02484677|Docetaxel|docetaxel|mesh-list
43572903|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
43572904|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
43572905|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
43572906|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
43572907|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43572908|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572909|NCT03531294|Aflibercept|aflibercept|mesh-list
43572910|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43572911|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43572912|NCT03531294|Growth Substances|growth substances|mesh-ancestor
43572929|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572931|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572932|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43572933|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572934|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572935|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572936|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43572937|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43572938|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572939|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43572940|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
43572941|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
43572942|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
43572943|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
43572944|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
43572945|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
43572946|NCT03531047|Riboflavin|riboflavin|mesh-list
43572947|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
43572948|NCT03531047|Vitamins|vitamins|mesh-ancestor
43572949|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
43572950|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572951|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43753531|NCT02484261|Pravastatin|pravastatin|mesh-list
43753532|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753533|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43753534|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43753535|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
43753536|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753537|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43753538|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43753539|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753540|NCT02484053|Rituximab|rituximab|mesh-list
43753541|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43753542|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753543|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
43753544|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753545|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43753546|NCT02483767|Goserelin|goserelin|mesh-list
43753547|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43753548|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753549|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43753550|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43753551|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43753552|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
43753553|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753554|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43753559|NCT02483715|Metronidazole|metronidazole|mesh-list
43753560|NCT02483715|Tetracycline|tetracycline|mesh-list
43753585|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
43753586|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
43753587|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753588|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43753589|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43753590|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
43753600|NCT02483845|Natalizumab|natalizumab|mesh-list
43753601|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
43753602|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753609|NCT02483923|Ropivacaine|ropivacaine|mesh-list
43753610|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
43753611|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
43753612|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753613|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753614|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
43753615|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753626|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753627|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43753628|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43753629|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43753630|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
43750775|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
43750776|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
43750777|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
43750778|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43750779|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750780|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43750781|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
43750782|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43750783|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43572312|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43572320|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572321|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572322|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
43572323|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753631|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753632|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43753633|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43753634|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753636|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43753637|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43753638|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753639|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753640|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43753641|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43753642|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
43753643|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753665|NCT02483299|Incretins|incretins|mesh-ancestor
43753666|NCT02483299|Hormones|hormones|mesh-ancestor
43753667|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753668|NCT02483182|Acyclovir|acyclovir|mesh-list
43753669|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
43753670|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753671|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
43753672|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43753673|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
43753674|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753675|NCT02483130|Expectorants|expectorants|mesh-ancestor
43753676|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
43753677|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43753678|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
43753679|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753680|NCT02483130|Protective Agents|protective agents|mesh-ancestor
43753681|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753682|NCT02483130|Antidotes|antidotes|mesh-ancestor
43753683|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
43753684|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
43753685|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753686|NCT02483143|Expectorants|expectorants|mesh-ancestor
43753687|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
43753688|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43753689|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
43572952|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
43572953|NCT03530670|Midazolam|midazolam|mesh-list
43572954|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43572955|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43572956|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753690|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753691|NCT02483143|Protective Agents|protective agents|mesh-ancestor
43753692|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753693|NCT02483169|Aspirin|aspirin|mesh-list
43753694|NCT02483169|Cilostazol|cilostazol|mesh-list
43753695|NCT02483169|Probucol|probucol|mesh-list
43753696|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43753697|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43753698|NCT02483169|Analgesics|analgesics|mesh-ancestor
43753737|NCT02483221|Analgesics|analgesics|mesh-ancestor
43753738|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
43753739|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753741|NCT02483195|Spironolactone|spironolactone|mesh-list
43753742|NCT02483195|Finasteride|finasteride|mesh-list
43753743|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43753744|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
43753745|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753746|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753747|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43753748|NCT02483195|Diuretics|diuretics|mesh-ancestor
43753749|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
43753750|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43753751|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753752|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43753753|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43753775|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753776|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43753777|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43753778|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753779|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753780|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43753781|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
43753782|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753783|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753784|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43753785|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43753786|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43753787|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43753788|NCT02482766|Poractant alfa|poractant alfa|mesh-list
43753789|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43753790|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
43753791|NCT02482857|Aspirin|aspirin|mesh-list
43753792|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43753793|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43753794|NCT02482857|Analgesics|analgesics|mesh-ancestor
43753800|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43753801|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43753802|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753803|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43753804|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43753805|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753806|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
43753807|NCT02482961|Colistin|colistin|mesh-list
43753808|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43753810|NCT02482818|Pregabalin|pregabalin|mesh-list
43753811|NCT02482818|Analgesics|analgesics|mesh-ancestor
43753812|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
43753813|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753814|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753815|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
43753816|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43753817|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43753826|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43753827|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753829|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43753830|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43753831|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753832|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
43753833|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753834|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43572325|NCT00005608|Tegafur|tegafur|mesh-list
43572326|NCT00005608|Calcium|calcium|mesh-list
43572327|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
43572328|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43572329|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572330|NCT00005608|Antidotes|antidotes|mesh-ancestor
43572331|NCT00005608|Protective Agents|protective agents|mesh-ancestor
43572332|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
43572333|NCT00005608|Vitamins|vitamins|mesh-ancestor
43572334|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
43572335|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43572336|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
43572337|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753835|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
43753836|NCT02482636|Vaccines|vaccines|mesh-list
43753837|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43753838|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
43753839|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753840|NCT02482311|Adavosertib|adavosertib|mesh-list
43753841|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753843|NCT02482272|Lamivudine|lamivudine|mesh-list
43753848|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753849|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753850|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
43753851|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753852|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43753853|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43753854|NCT02482402|Iloprost|iloprost|mesh-list
43753855|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43753856|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753857|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
43753858|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
43753859|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753860|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43753861|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43753862|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43753863|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
43753864|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753865|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43753866|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43572957|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572958|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43572959|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43572960|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43572961|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43572962|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
43572963|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
43572964|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
43572965|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
43572966|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43572967|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572968|NCT03530488|Lidocaine|lidocaine|mesh-list
43572969|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
43753875|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43753877|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43753878|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753879|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753881|NCT02482090|Fludarabine|fludarabine|mesh-list
43753882|NCT02482090|Interleukin-2|interleukin-2|mesh-list
43753883|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43753884|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
43753885|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753886|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43753887|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572338|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572339|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
43572340|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572341|NCT00004916|Paclitaxel|paclitaxel|mesh-list
43572342|NCT00004916|Ifosfamide|ifosfamide|mesh-list
43572343|NCT00004916|Teniposide|teniposide|mesh-list
43572344|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43572345|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572346|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
43572347|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
43572348|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
43572349|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572350|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43753888|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
43753889|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753890|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753891|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43753892|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43753893|NCT02482090|Analgesics|analgesics|mesh-ancestor
43753894|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
43753895|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753896|NCT02482324|Ibuprofen|ibuprofen|mesh-list
43753911|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753912|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753913|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753914|NCT02481791|Remifentanil|remifentanil|mesh-list
43753915|NCT02481791|Propofol|propofol|mesh-list
43753916|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43753917|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753918|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753919|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43753920|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
43753921|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
43753922|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43753923|NCT02481791|Narcotics|narcotics|mesh-ancestor
43753924|NCT02481791|Analgesics|analgesics|mesh-ancestor
43753925|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
43753926|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753927|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43753928|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43753929|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753930|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
43753931|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43753932|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
43753933|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753951|NCT02481323|Cilostazol|cilostazol|mesh-list
43753952|NCT02481323|Isosorbide|isosorbide|mesh-list
43572995|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572996|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43573001|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573003|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
43573004|NCT03530462|Hormones|hormones|mesh-ancestor
43573005|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43573006|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43573007|NCT03530462|Protective Agents|protective agents|mesh-ancestor
43573008|NCT03530436|Curcumin|curcumin|mesh-list
43753954|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43753955|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43753956|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
43753957|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572351|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
43572352|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572353|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572354|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572355|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43572356|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43572357|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
43750784|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750785|NCT02502981|Hormones|hormones|mesh-ancestor
43750786|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
43750787|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43750788|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43750789|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750790|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
43750791|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
43750792|NCT02502643|Picibanil|picibanil|mesh-list
43750793|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750794|NCT02502565|Uric Acid|uric acid|mesh-list
43750795|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
43750796|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750797|NCT02502565|Protective Agents|protective agents|mesh-ancestor
43750798|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750799|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
43750800|NCT02502825|Miotics|miotics|mesh-ancestor
43753958|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753959|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43753960|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
43753961|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43753962|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43753963|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753964|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43753965|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753966|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43753967|NCT02481323|Protective Agents|protective agents|mesh-ancestor
43573009|NCT03530436|Turmeric extract|turmeric extract|mesh-list
43573010|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573011|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573013|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
43573014|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573015|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573016|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573017|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573018|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573019|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573020|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573021|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
43573022|NCT03530436|Protective Agents|protective agents|mesh-ancestor
43750801|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
43750802|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750803|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750804|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43750805|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43750821|NCT02502877|Midazolam|midazolam|mesh-list
43750837|NCT02502500|Celecoxib|celecoxib|mesh-list
43750838|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43750839|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750840|NCT02502500|Analgesics|analgesics|mesh-ancestor
43750841|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
43750842|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573023|NCT03530319|Azithromycin|azithromycin|mesh-list
43573024|NCT03530319|Doxycycline|doxycycline|mesh-list
43573025|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43573026|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573027|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
43573028|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43573029|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43573030|NCT03530280|Pregabalin|pregabalin|mesh-list
43573031|NCT03530280|Bupivacaine|bupivacaine|mesh-list
43849064|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
43573032|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
43573033|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
43573034|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573039|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
43573040|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43573041|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43753980|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43753981|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
43753982|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753983|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753984|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43836658|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43836659|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43836660|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
43573042|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573043|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43573044|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43573045|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43573046|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573047|NCT03530228|Esomeprazole|esomeprazole|mesh-list
43573048|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43573049|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573050|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43573053|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
43836661|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836662|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836663|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43836664|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43836665|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
43836666|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43836667|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
43836668|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43836669|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43836670|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43836671|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43836672|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43836673|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43836674|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43847844|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43847845|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
43847846|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847847|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847848|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43847849|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43847851|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
43847852|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847854|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
43847855|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
43847856|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43847857|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
43847858|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43753989|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753990|NCT02481180|T0001|t0001|mesh-list
43753991|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
43754007|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43754008|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
43754009|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573054|NCT03530176|Listerine|listerine|mesh-list
43573055|NCT03530176|Fluorides|fluorides|mesh-list
43573056|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
43573057|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
43573058|NCT03530176|Protective Agents|protective agents|mesh-ancestor
43573059|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573060|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43573061|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573062|NCT03530150|Pirfenidone|pirfenidone|mesh-list
43573063|NCT03530150|Analgesics|analgesics|mesh-ancestor
43573064|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
43754010|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43754011|NCT02481076|Monensin|monensin|mesh-list
43754012|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
43754013|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754014|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43754015|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43754016|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
43754017|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
43754018|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
43754019|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754020|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754021|NCT02481076|Ionophores|ionophores|mesh-ancestor
43754022|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43754023|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
43754025|NCT02480894|Fostemsavir|fostemsavir|mesh-list
43754026|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43754027|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43754028|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754029|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43754030|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43754031|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
43754032|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754033|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43754034|NCT02480881|Fostemsavir|fostemsavir|mesh-list
43573081|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573082|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
43573083|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43573084|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43573085|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573087|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
43573088|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
43573089|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754039|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754040|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43754041|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43754042|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43754043|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43754044|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
43754045|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43754046|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43754047|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43750843|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750844|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43750845|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43750846|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43750847|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43750848|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750849|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750850|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43754048|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
43754049|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754050|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43754051|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43754052|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754053|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
43754054|NCT02480647|Etonogestrel|etonogestrel|mesh-list
43754055|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43754056|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
43754057|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43754058|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754059|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43754060|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43754061|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43754062|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
43754063|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
43754064|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754065|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43754083|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754085|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43754086|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
43754087|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43754088|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43754089|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754090|NCT02480465|Incretins|incretins|mesh-ancestor
43754091|NCT02480465|Hormones|hormones|mesh-ancestor
43754092|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754093|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43754094|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
43754095|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754103|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754105|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754106|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43754108|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43754109|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43754110|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43754111|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
43754112|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
43754113|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754114|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43754115|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43754124|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
43754125|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
43754126|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754127|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754128|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754129|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43754130|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43754131|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
43754132|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754133|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754134|NCT02480335|Bosentan|bosentan|mesh-list
43573090|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573091|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
43573092|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573093|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43750851|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43750852|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43750853|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
43750854|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750855|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43750856|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43750857|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750858|NCT02502344|Metformin|metformin|mesh-list
43750859|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43573094|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43573095|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43573096|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43573097|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573098|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
43573099|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
43573100|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573101|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754135|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43754136|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43754137|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754138|NCT02480049|Montelukast|montelukast|mesh-list
43754139|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43754140|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
43754141|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43754142|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
43754143|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754144|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754145|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43754146|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43754147|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754148|NCT02479971|Clindamycin|clindamycin|mesh-list
43754149|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
43754150|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
43754151|NCT02479971|Gentamicins|gentamicins|mesh-list
43754152|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43754153|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754154|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43754156|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754158|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43754159|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
43754160|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43754161|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
43754162|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754163|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754164|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43754165|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43754166|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754167|NCT02479867|Cefadroxil|cefadroxil|mesh-list
43754168|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43754169|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754170|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
43754171|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
43573122|NCT03530007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573123|NCT03530007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43573124|NCT03529955|Apremilast|apremilast|mesh-list
43573125|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43750860|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750861|NCT02502175|Methadone|methadone|mesh-list
43750863|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43750885|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750887|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43750888|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
43750889|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750890|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750891|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43750892|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43750893|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43573126|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573127|NCT03529955|Analgesics|analgesics|mesh-ancestor
43573128|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
43573129|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573130|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573131|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573147|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573148|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573149|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573150|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
43573151|NCT03529929|Hormones|hormones|mesh-ancestor
43573152|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43573153|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43573154|NCT03529929|Protective Agents|protective agents|mesh-ancestor
43573155|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43573156|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573157|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
43573158|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43573159|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573160|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573161|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573162|NCT03529643|Analgesics|analgesics|mesh-ancestor
43573163|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
43754174|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
43754175|NCT02479789|Lidocaine|lidocaine|mesh-list
43754182|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43754183|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43754184|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43754185|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43754186|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754188|NCT02479815|Trace Elements|trace elements|mesh-list
43573168|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
43573169|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573170|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573171|NCT03529331|Acetaminophen|acetaminophen|mesh-list
43573172|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43573173|NCT03529331|Morphine|morphine|mesh-list
43573174|NCT03529331|Oxycodone|oxycodone|mesh-list
43573175|NCT03529331|Hydrocodone|hydrocodone|mesh-list
43573176|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43573177|NCT03529331|Narcotics|narcotics|mesh-ancestor
43573178|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573190|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43573192|NCT03529266|Coagulants|coagulants|mesh-ancestor
43573193|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43573194|NCT03529253|Calcium|calcium|mesh-list
43573195|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43750894|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43750895|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750896|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43750897|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
43750898|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43750900|NCT02501941|Analgesics|analgesics|mesh-ancestor
43750901|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
43750902|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750903|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750904|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43554386|NCT03572231|Mirabegron|mirabegron|mesh-list
43573196|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573197|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43573198|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43573199|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
43573200|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573201|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43573202|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43573203|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573204|NCT03529201|Fentanyl|fentanyl|mesh-list
43573205|NCT03529201|Oxycodone|oxycodone|mesh-list
43573206|NCT03529201|Sevoflurane|sevoflurane|mesh-list
43573207|NCT03529201|Rocuronium|rocuronium|mesh-list
43573208|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43573209|NCT03529201|Narcotics|narcotics|mesh-ancestor
43754189|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754190|NCT02479828|Ropivacaine|ropivacaine|mesh-list
43754191|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
43754192|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
43754193|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754194|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754195|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
43754196|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754197|NCT02479711|Methamphetamine|methamphetamine|mesh-list
43754198|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43754199|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754200|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
43754201|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
43754202|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754203|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
43754204|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754205|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754206|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
43754207|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43754208|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43754209|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43754210|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43754211|NCT02479620|Dexamethasone|dexamethasone|mesh-list
43754212|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
43754238|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754239|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754240|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43754241|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
43754243|NCT02479204|Diltiazem|diltiazem|mesh-list
43754244|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43754245|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43754246|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
43754247|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
43754248|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750905|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43750906|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
43750907|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
43750908|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750909|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43750910|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43754249|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754250|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43754251|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43754252|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43754253|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
43754254|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754255|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754256|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43754257|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43754259|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
43836675|NCT04957615|Nivolumab|nivolumab|mesh-list
43836676|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836677|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836678|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43836680|NCT04956432|Allopurinol|allopurinol|mesh-list
43836699|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836700|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836701|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836702|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43836703|NCT04955574|Metronidazole|metronidazole|mesh-list
43836704|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43836705|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836706|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
43836707|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43836708|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43836709|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
43836710|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
43836711|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
43836712|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836713|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836714|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836715|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43836716|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
43836717|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
43836718|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573210|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573211|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573212|NCT03529201|Analgesics|analgesics|mesh-ancestor
43573213|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
43573214|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573215|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43573216|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43573217|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
43573218|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
43573219|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43836725|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43836726|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836727|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
43836728|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
43836729|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43836730|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836731|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43836732|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43836733|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836734|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836735|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836736|NCT04953130|Vaccines|vaccines|mesh-list
43754260|NCT02479581|Floxacillin|floxacillin|mesh-list
43754261|NCT02479581|Dexamethasone|dexamethasone|mesh-list
43754262|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
43573224|NCT03529175|Gemcitabine|gemcitabine|mesh-list
43573225|NCT03529175|Paclitaxel|paclitaxel|mesh-list
43573226|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43573227|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43573228|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573229|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
43573230|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
43573231|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
43573232|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573233|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43573234|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
43754263|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43754265|NCT02479581|Morphine|morphine|mesh-list
43754266|NCT02479581|Anesthetics|anesthetics|mesh-list
43754267|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754268|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
43754269|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
43754270|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754271|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754272|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754273|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
43754274|NCT02479581|Hormones|hormones|mesh-ancestor
43754275|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754276|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754277|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754278|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754279|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754280|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43754281|NCT02479581|Narcotics|narcotics|mesh-ancestor
43754282|NCT02479581|Analgesics|analgesics|mesh-ancestor
43754283|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
43754284|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43754285|NCT02479581|Protective Agents|protective agents|mesh-ancestor
43754286|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43754287|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
43754288|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43754289|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
43754290|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754291|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43754292|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43573236|NCT03529175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573237|NCT03529175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573238|NCT03529175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43573239|NCT03529175|Immunologic Factors|immunologic factors|mesh-ancestor
43573240|NCT03529175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573241|NCT03529149|Diltiazem|diltiazem|mesh-list
43573242|NCT03529149|Urapidil|urapidil|mesh-list
43754295|NCT02479256|Citric Acid|citric acid|mesh-list
43754296|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
43754297|NCT02479256|Clomiphene|clomiphene|mesh-list
43754298|NCT02479256|Enclomiphene|enclomiphene|mesh-list
43754299|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
43754300|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
43754301|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43754302|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
43754303|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
43754304|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754305|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43754306|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
43754307|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754308|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754309|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754310|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754311|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43754312|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43754313|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43754314|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43754315|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
43754316|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43754317|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
43754318|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43754319|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754320|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43754321|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43754322|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754323|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754324|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754325|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
43754326|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
43754328|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43754329|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754330|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
43754331|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
43754332|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
43754333|NCT02479555|Dexamethasone|dexamethasone|mesh-list
43754334|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
43754335|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43558283|NCT03534895|Midazolam|midazolam|mesh-list
43754336|NCT02479555|BB 1101|bb 1101|mesh-list
43754337|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754338|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
43754339|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
43754340|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754341|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754342|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754343|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
43754344|NCT02479555|Hormones|hormones|mesh-ancestor
43754345|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754346|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754347|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754354|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43754355|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754357|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754370|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43754371|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
43754372|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754373|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754374|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754375|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
43754376|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
43754377|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754378|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43754379|NCT02479165|Oxycodone|oxycodone|mesh-list
43754380|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43754381|NCT02479165|Narcotics|narcotics|mesh-ancestor
43754382|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754383|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754384|NCT02479165|Analgesics|analgesics|mesh-ancestor
43754385|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
43754386|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754387|NCT02479022|Insulin|insulin|mesh-list
43754388|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43754389|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
43754390|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43754391|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754417|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43754418|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43754419|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754421|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
43754422|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754423|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43754424|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43754425|NCT02478645|Ramosetron|ramosetron|mesh-list
43754426|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
43754427|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
43754428|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754429|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754430|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754431|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43754432|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
43754433|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754434|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754435|NCT02478515|Ranibizumab|ranibizumab|mesh-list
43754436|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43754437|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43754438|NCT02478515|Growth Substances|growth substances|mesh-ancestor
43754439|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754440|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
43754441|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754442|NCT02478424|Cyclosporine|cyclosporine|mesh-list
43754443|NCT02478424|Methotrexate|methotrexate|mesh-list
43754444|NCT02478424|Cannabidiol|cannabidiol|mesh-list
43754445|NCT02478424|Cyclosporins|cyclosporins|mesh-list
43754446|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43754447|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
43754448|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43754452|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754453|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754454|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
43754455|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754457|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43754458|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
43754459|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43754460|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43754461|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
43754462|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754463|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43754464|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
43754466|NCT02478710|Tobramycin|tobramycin|mesh-list
43754467|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43754468|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750914|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
43754469|NCT02478294|Warfarin|warfarin|mesh-list
43754470|NCT02478294|Anticoagulants|anticoagulants|mesh-list
43754471|NCT02478281|Methylene Blue|methylene blue|mesh-list
43754472|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754473|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754474|NCT02478268|Xenon|xenon|mesh-list
43754475|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43754476|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
43754494|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754495|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
43754496|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573243|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43573244|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43573268|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573269|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573270|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573271|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43573272|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573273|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573274|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
43573275|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43573276|NCT03529084|Gefitinib|gefitinib|mesh-list
43573277|NCT03529084|Nazartinib|nazartinib|mesh-list
43573278|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573279|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43573280|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573281|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573282|NCT03529032|Methadone|methadone|mesh-list
43573283|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43573284|NCT03529032|Narcotics|narcotics|mesh-ancestor
43573285|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573286|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573287|NCT03529032|Analgesics|analgesics|mesh-ancestor
43754497|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754498|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754499|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
43754500|NCT02478047|Hormones|hormones|mesh-ancestor
43754501|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754502|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754503|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754504|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43754505|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
43754506|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754507|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754508|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43754509|NCT02478242|Nafamostat|nafamostat|mesh-list
43754510|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43754511|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573288|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
43573289|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573290|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
43573291|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
43573293|NCT03528967|Enoxaparin|enoxaparin|mesh-list
43573294|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573295|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750915|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43750916|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750917|NCT02501863|Fentanyl|fentanyl|mesh-list
43750918|NCT02501863|Ropivacaine|ropivacaine|mesh-list
43750919|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
43750920|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
43750921|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750922|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750923|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
43750924|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750925|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43750926|NCT02501863|Narcotics|narcotics|mesh-ancestor
43750927|NCT02501863|Analgesics|analgesics|mesh-ancestor
43573296|NCT03528967|Analgesics|analgesics|mesh-ancestor
43573306|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43573307|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573309|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
43573310|NCT03528954|Propofol|propofol|mesh-list
43573311|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43573312|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573313|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573315|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
43573316|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
43573317|NCT03528915|Rifamycins|rifamycins|mesh-list
43573318|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
43573319|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43573320|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573321|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573322|NCT03528824|Diclofenac|diclofenac|mesh-list
43573323|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573324|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573325|NCT03528824|Analgesics|analgesics|mesh-ancestor
43573326|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
43573327|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573328|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573329|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573330|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573331|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43573332|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573333|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573334|NCT03528785|Leucovorin|leucovorin|mesh-list
43573335|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
43849065|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43573336|NCT03528785|Irinotecan|irinotecan|mesh-list
43573337|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
43573338|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573339|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43754512|NCT02478242|Analgesics|analgesics|mesh-ancestor
43754513|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
43754514|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754515|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754516|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754517|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43754518|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
43754519|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
43754520|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754521|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754522|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43754523|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43754524|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43754525|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43754526|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
43754527|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
43754528|NCT02478229|Ledipasvir|ledipasvir|mesh-list
43754529|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
43754530|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754531|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
43754532|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754533|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
43754534|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754535|NCT02477956|Vitamin D|vitamin d|mesh-list
43754536|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
43754537|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
43754538|NCT02477956|Vitamins|vitamins|mesh-list
43754539|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
43754540|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754541|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43754553|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
43754554|NCT02477852|Ethambutol|ethambutol|mesh-list
43754555|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43754556|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
43754557|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43754558|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754559|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
43754560|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43754561|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754577|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754599|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754600|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43754601|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43754602|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43754603|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43754604|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
43754605|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
43754606|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
43754607|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
43754608|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754609|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754625|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754626|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
43754627|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
43754628|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573343|NCT03528785|Antidotes|antidotes|mesh-ancestor
43573344|NCT03528785|Protective Agents|protective agents|mesh-ancestor
43573345|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573346|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
43573348|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
43573349|NCT03528772|Minoxidil|minoxidil|mesh-list
43573350|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
43573380|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43573381|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43573382|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43754629|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43754630|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43754631|NCT02477488|Allopurinol|allopurinol|mesh-list
43754632|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
43754633|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754634|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754635|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
43754636|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43754637|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43754638|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
43754639|NCT02477488|Protective Agents|protective agents|mesh-ancestor
43754640|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754641|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
43754642|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43754643|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754644|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754645|NCT02477397|Fluticasone|fluticasone|mesh-list
43754646|NCT02477397|Xhance|xhance|mesh-list
43754647|NCT02477397|Budesonide|budesonide|mesh-list
43754648|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
43754649|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43754650|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43754655|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754656|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754657|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43754658|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
43754659|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
43754660|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43754661|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
43754663|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43573387|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43573388|NCT03528564|Hematinics|hematinics|mesh-ancestor
43573389|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
43573390|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43573391|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573392|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
43573393|NCT03528421|Fludarabine|fludarabine|mesh-list
43573394|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43573395|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
43573396|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573397|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573398|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43573399|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
43573400|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573401|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573402|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43573403|NCT03528070|Tranilast|tranilast|mesh-list
43573404|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573405|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573406|NCT03528070|Analgesics|analgesics|mesh-ancestor
43573407|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
43573408|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573409|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573410|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573411|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573412|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43573413|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43573414|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573415|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43573416|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43573417|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
43573420|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43754672|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43754674|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43754675|NCT02477267|Narcotics|narcotics|mesh-ancestor
43754676|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754677|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754678|NCT02477267|Analgesics|analgesics|mesh-ancestor
43754679|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
43754680|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754681|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43754682|NCT02477280|Methylphenidate|methylphenidate|mesh-list
43754683|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43754684|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754685|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43754686|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43754687|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43754688|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754689|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
43754690|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754691|NCT02477306|Rabeprazole|rabeprazole|mesh-list
43754692|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43754693|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754694|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43754695|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754696|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754697|NCT02476955|Paclitaxel|paclitaxel|mesh-list
43754698|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43754699|NCT02476955|Carboplatin|carboplatin|mesh-list
43754700|NCT02476955|Anastrozole|anastrozole|mesh-list
43754701|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43754704|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
43754705|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
43754706|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754707|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754708|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43754709|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43754710|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754711|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43754712|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
43754713|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754714|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754715|NCT02477007|Acetaminophen|acetaminophen|mesh-list
43754716|NCT02477007|Ibuprofen|ibuprofen|mesh-list
43754717|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43754718|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43754719|NCT02477007|Analgesics|analgesics|mesh-ancestor
43573434|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43573435|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43573436|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573438|NCT03527732|Albendazole|albendazole|mesh-list
43573439|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43573440|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573441|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
43573442|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
43573443|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43573444|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43573445|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
43573446|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
43573447|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
43754720|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
43754721|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754722|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754723|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754724|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43754725|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43754726|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754727|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754728|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
43754729|NCT02476799|Ketorolac|ketorolac|mesh-list
43754730|NCT02476799|Fentanyl|fentanyl|mesh-list
43754731|NCT02476799|Ropivacaine|ropivacaine|mesh-list
43754732|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
43754733|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
43754739|NCT02476799|Narcotics|narcotics|mesh-ancestor
43754740|NCT02476799|Analgesics|analgesics|mesh-ancestor
43754741|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43754742|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43754743|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
43573448|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573449|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573450|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
43573451|NCT03527628|Dacarbazine|dacarbazine|mesh-list
43754744|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43754745|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43754746|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754747|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43754748|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43754750|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754752|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
43754753|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
43754754|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754755|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754756|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
43754757|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754759|NCT02477072|Calcium heparin|calcium heparin|mesh-list
43573452|NCT03527628|Doxorubicin|doxorubicin|mesh-list
43573453|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43573454|NCT03527628|Bleomycin|bleomycin|mesh-list
43573455|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43573456|NCT03527628|Vinblastine|vinblastine|mesh-list
43573457|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43573458|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
43573459|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573460|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573461|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43573462|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
43573463|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573464|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573465|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43573466|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43573467|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43573468|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43573469|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573470|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43573471|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43573472|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
43573473|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
43754760|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
43754761|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43754762|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43754763|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754765|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43754766|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
43754767|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
43754768|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754769|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754770|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43754771|NCT02476929|Analgesics|analgesics|mesh-ancestor
43754772|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
43754773|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754774|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
43754775|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43754776|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
43754777|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754778|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
43754779|NCT02476903|Protective Agents|protective agents|mesh-ancestor
43754780|NCT02476864|Macitentan|macitentan|mesh-list
43754798|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
43754799|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573475|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
43573476|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43573477|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
43573478|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573479|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573480|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43573481|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
43573482|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43573483|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
43573484|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573485|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573486|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43573487|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
43573488|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
43573489|NCT03527381|Protective Agents|protective agents|mesh-ancestor
43573490|NCT03527355|Vaccines|vaccines|mesh-list
43573491|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
43573492|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573504|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573505|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573506|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573507|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573509|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
43573510|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754800|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43754801|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43754802|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43754803|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
43754804|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754805|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754806|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43754807|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43754808|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43754809|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43754810|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
43754811|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
43754812|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43754813|NCT02476981|Narcotics|narcotics|mesh-ancestor
43754814|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43754815|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
43754816|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
43754817|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43754818|NCT02476825|Fluticasone|fluticasone|mesh-list
43754820|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754821|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43754822|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
43754827|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
43754828|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43754829|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
43754830|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43754831|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
43754832|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754833|NCT02476526|Expectorants|expectorants|mesh-ancestor
43754834|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
43754835|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43754836|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
43754837|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754838|NCT02476526|Protective Agents|protective agents|mesh-ancestor
43754839|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754840|NCT02476526|Antidotes|antidotes|mesh-ancestor
43754841|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43754842|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43754843|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
43754886|NCT02476760|Buformin|buformin|mesh-list
43754887|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
43754888|NCT02476760|Gliquidone|gliquidone|mesh-list
43754898|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
43754899|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754900|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754901|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43754902|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43754903|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43754904|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
43573518|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43573519|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754906|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43754907|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754908|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754909|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754910|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43754912|NCT02476136|Paroxetine|paroxetine|mesh-list
43754913|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43754914|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43754915|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43754916|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43754917|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754918|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754919|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754920|NCT02476136|Analgesics|analgesics|mesh-ancestor
43754921|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
43754922|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754923|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
43754924|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43754925|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
43754926|NCT02476136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43754927|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
43754929|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43754955|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43754979|NCT02475915|Emtricitabine|emtricitabine|mesh-list
43754981|NCT02475915|Maraviroc|maraviroc|mesh-list
43754982|NCT02475915|Darunavir|darunavir|mesh-list
43754983|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
43754984|NCT02475915|Vorinostat|vorinostat|mesh-list
43754985|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
43754986|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754987|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43754988|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43754989|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754990|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754991|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43754995|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43754996|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43754997|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43754998|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43754999|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43755000|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43755001|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43755002|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43755003|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755004|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43755005|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43755006|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43755007|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43755008|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43755009|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43755010|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
43755011|NCT02475824|Midazolam|midazolam|mesh-list
43755021|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43755022|NCT02475824|Analgesics|analgesics|mesh-ancestor
43755023|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
43755024|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755025|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43755026|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43755027|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43755028|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
43755034|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43755035|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
43755036|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
43755037|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43755038|NCT02475824|Narcotics|narcotics|mesh-ancestor
43836744|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
43836745|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836746|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836747|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836748|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836749|NCT04952727|Vaccines|vaccines|mesh-list
43836750|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
43836751|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572358|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43572359|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572360|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43572361|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43572362|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43572363|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
43572364|NCT00004914|Hematinics|hematinics|mesh-ancestor
43572365|NCT00004912|Megestrol|megestrol|mesh-list
43572366|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
43750928|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43750929|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43750930|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
43750931|NCT02501798|Methylphenidate|methylphenidate|mesh-list
43750932|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43750933|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836752|NCT04951115|Cisplatin|cisplatin|mesh-list
43836753|NCT04951115|Carboplatin|carboplatin|mesh-list
43836754|NCT04951115|Etoposide|etoposide|mesh-list
43836755|NCT04951115|Durvalumab|durvalumab|mesh-list
43836756|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836757|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43836758|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43836759|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43755039|NCT02475746|Itraconazole|itraconazole|mesh-list
43755040|NCT02475746|PF-06372865|pf-06372865|mesh-list
43755041|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
43755042|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755043|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43755044|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43755045|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755046|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755047|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43755048|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
43750934|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43750935|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43750936|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750937|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750938|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
43750939|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750940|NCT02501850|Metformin|metformin|mesh-list
43750941|NCT02501850|Liraglutide|liraglutide|mesh-list
43750942|NCT02501850|Exenatide|exenatide|mesh-list
43750943|NCT02501850|Lixisenatide|lixisenatide|mesh-list
43750944|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43750945|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750946|NCT02501850|Incretins|incretins|mesh-ancestor
43755049|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755051|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43755052|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
43755053|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
43755054|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755055|NCT02475499|Metformin|metformin|mesh-list
43755056|NCT02475499|Pioglitazone|pioglitazone|mesh-list
43755057|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43755058|NCT02475499|Liraglutide|liraglutide|mesh-list
43755059|NCT02475499|Exenatide|exenatide|mesh-list
43755060|NCT02475499|Glimepiride|glimepiride|mesh-list
43755061|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
43755085|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43755086|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
43755087|NCT02475499|Incretins|incretins|mesh-list
43755088|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755089|NCT02475499|Hormones|hormones|mesh-ancestor
43755090|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755091|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
43755092|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755093|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755094|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43755095|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43755096|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755097|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
43755098|NCT02475421|Glucagon|glucagon|mesh-list
43755099|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755100|NCT02475421|Hormones|hormones|mesh-ancestor
43755101|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755102|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755103|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
43755104|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
43755105|NCT02475681|Chlorambucil|chlorambucil|mesh-list
43755106|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43755107|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755108|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43755109|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
43755110|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755111|NCT02475382|Nivolumab|nivolumab|mesh-list
43559081|NCT04229368|Vitamin D|vitamin d|mesh-list
43755112|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43755113|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755114|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43755115|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755116|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43573520|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573521|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43573522|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
43755117|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
43755118|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755119|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
43755120|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755121|NCT02475343|Riboflavin|riboflavin|mesh-list
43755122|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
43755123|NCT02475343|Vitamins|vitamins|mesh-ancestor
43755124|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
43755125|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755126|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43755127|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
43755128|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
43755129|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43755130|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
43755131|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43755132|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755133|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43755134|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43755135|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43755136|NCT02475135|Tenofovir|tenofovir|mesh-list
43755137|NCT02475135|Emtricitabine|emtricitabine|mesh-list
43755138|NCT02475135|Darunavir|darunavir|mesh-list
43755139|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43755140|NCT02475135|Cobicistat|cobicistat|mesh-list
43755141|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43755142|NCT02475135|Elvitegravir|elvitegravir|mesh-list
43755143|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43755144|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
43755205|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755207|NCT02474654|Narcotics|narcotics|mesh-ancestor
43755208|NCT02474654|Analgesics|analgesics|mesh-ancestor
43755209|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43755210|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43755211|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
43755212|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43755213|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43755214|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
43755215|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755216|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755217|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43755218|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43755219|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
43755220|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43755221|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
43755222|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
43755223|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
43755224|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43755225|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573523|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
43573524|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573525|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573526|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
43573527|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
43573528|NCT03526536|Insulin|insulin|mesh-list
43573529|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43573530|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43573531|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573532|NCT03526445|Glucagon|glucagon|mesh-list
43755226|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43755227|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43755228|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43755229|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43755230|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755231|NCT02474706|Imipenem|imipenem|mesh-list
43755232|NCT02474706|Cefoxitin|cefoxitin|mesh-list
43755233|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43755234|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755235|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43755236|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43755237|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43755238|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755239|NCT02474563|Prednisone|prednisone|mesh-list
43755240|NCT02474563|Bortezomib|bortezomib|mesh-list
43755241|NCT02474563|Melphalan|melphalan|mesh-list
43755242|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43755243|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
43755244|NCT02474563|Hormones|hormones|mesh-ancestor
43755245|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755246|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755247|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43755248|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755249|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43755250|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
43755251|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755252|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43755253|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755254|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
43755255|NCT02474511|Anesthetics|anesthetics|mesh-list
43755270|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43755271|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755272|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
43755273|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43755274|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43755275|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43755276|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755277|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755278|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
43755279|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755280|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43755281|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43755292|NCT02474225|Bevacizumab|bevacizumab|mesh-list
43755293|NCT02474225|Ranibizumab|ranibizumab|mesh-list
43755294|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
43755295|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43755296|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755297|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43755298|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43755299|NCT02474225|Growth Substances|growth substances|mesh-ancestor
43755313|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43755314|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43755315|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755316|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43755317|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755318|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
43755319|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43755320|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
43755321|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
43836761|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836762|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836763|NCT04950660|Caffeine|caffeine|mesh-list
43836764|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43836765|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836766|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43836767|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836768|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836769|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43836770|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43836771|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
43836772|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836798|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836799|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
43836800|NCT04947514|Coagulants|coagulants|mesh-ancestor
43836801|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
43836802|NCT04947254|Prednisone|prednisone|mesh-list
43755345|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755346|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755348|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
43755349|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
43755350|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755351|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755352|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755353|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
43755354|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
43755355|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43755356|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
43755357|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755358|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755359|NCT02473887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43755360|NCT02473887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43755361|NCT02473887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755362|NCT02473887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43755363|NCT02473887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43755364|NCT02473809|Liraglutide|liraglutide|mesh-list
43755365|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755377|NCT02473575|Caffeine|caffeine|mesh-list
43755378|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43755379|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755380|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43755381|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755385|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
43755391|NCT02473627|Omeprazole|omeprazole|mesh-list
43755392|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43755393|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43755394|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755395|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755396|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43755397|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43755398|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43755399|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43755400|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
43755401|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
43755402|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
43755403|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
43755404|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755405|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755406|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755407|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43755408|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755409|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43755410|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755411|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43755412|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43755413|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43755414|NCT02473601|Mivacurium|mivacurium|mesh-list
43755415|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43755416|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43755417|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43755439|NCT02473302|Protective Agents|protective agents|mesh-ancestor
43755440|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755441|NCT02473302|Vitamins|vitamins|mesh-ancestor
43755442|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
43755443|NCT02473406|Thymalfasin|thymalfasin|mesh-list
43755444|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43755445|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
43755446|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755447|NCT02473354|Remifentanil|remifentanil|mesh-list
43755448|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43755449|NCT02473354|Narcotics|narcotics|mesh-ancestor
43755450|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755451|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755452|NCT02473354|Analgesics|analgesics|mesh-ancestor
43755453|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
43755454|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755455|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
43755456|NCT02473263|Tazobactam|tazobactam|mesh-list
43755457|NCT02473263|Piperacillin|piperacillin|mesh-list
43755469|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
43755470|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755475|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755482|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
43755483|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
43755484|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43755485|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
43755486|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755487|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755489|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
43755490|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755491|NCT02473185|Methylphenidate|methylphenidate|mesh-list
43755492|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43755493|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755494|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43755495|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43755496|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43755497|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755498|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
43755499|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755500|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43755502|NCT02473198|Bupivacaine|bupivacaine|mesh-list
43755503|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
43755504|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
43755505|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755529|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755530|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755531|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43755532|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
43755533|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755534|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755535|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43755536|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
43755537|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755538|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
43755539|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755540|NCT02472782|Teriparatide|teriparatide|mesh-list
43755541|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43755542|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755543|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43755544|NCT02472717|Liraglutide|liraglutide|mesh-list
43750947|NCT02501850|Hormones|hormones|mesh-ancestor
43750948|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43750949|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43750950|NCT02501564|Naproxen|naproxen|mesh-list
43750951|NCT02501564|Codeine|codeine|mesh-list
43750952|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43750953|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750954|NCT02501564|Analgesics|analgesics|mesh-ancestor
43750955|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
43750956|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750957|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750958|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43572367|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43572368|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43572369|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43572370|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
43572371|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43572372|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572373|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43572374|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43572375|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43572376|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755545|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755546|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755547|NCT02472717|Incretins|incretins|mesh-ancestor
43755548|NCT02472717|Hormones|hormones|mesh-ancestor
43836810|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
43755549|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755561|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755563|NCT02472613|Fluoxetine|fluoxetine|mesh-list
43755564|NCT02472613|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43750959|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43750960|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
43750961|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43750963|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750965|NCT02501564|Narcotics|narcotics|mesh-ancestor
43750966|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750967|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
43750968|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750969|NCT02501616|Metformin|metformin|mesh-list
43750970|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
43750971|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755565|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43755566|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43755567|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755568|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755569|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
43755570|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755571|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43573533|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573534|NCT03526445|Hormones|hormones|mesh-ancestor
43573535|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43573536|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573537|NCT03526419|Bupivacaine|bupivacaine|mesh-list
43573538|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
43573539|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
43573540|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573541|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573542|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
43573543|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573544|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43573545|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43755573|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43755574|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43755575|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43755576|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755577|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43755578|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43755579|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755580|NCT02472600|Colistin|colistin|mesh-list
43755581|NCT02472600|Polymyxins|polymyxins|mesh-list
43755582|NCT02472600|Neomycin|neomycin|mesh-list
43755583|NCT02472600|Omeprazole|omeprazole|mesh-list
43755584|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43755585|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755586|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43755587|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755588|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755589|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43755590|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755591|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43755592|NCT02472574|Plasminogen|plasminogen|mesh-list
43755593|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43755594|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43755595|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43755596|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755597|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
43755598|NCT02472626|Cytarabine|cytarabine|mesh-list
43755599|NCT02472626|Daunorubicin|daunorubicin|mesh-list
43755600|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43573585|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43573586|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43573587|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573590|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43573591|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573592|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43573593|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573594|NCT03525912|Ketamine|ketamine|mesh-list
43573595|NCT03525912|Analgesics|analgesics|mesh-list
43755606|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755607|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
43755608|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755609|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43755610|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43755611|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43755612|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755613|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
43755614|NCT02472626|Protective Agents|protective agents|mesh-ancestor
43755615|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
43755616|NCT02472626|Vitamins|vitamins|mesh-ancestor
43755617|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
43755618|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
43755619|NCT02472392|Melphalan|melphalan|mesh-list
43755620|NCT02472392|Busulfan|busulfan|mesh-list
43755621|NCT02472392|Fludarabine|fludarabine|mesh-list
43755622|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
43755623|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43755667|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43755668|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755669|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
43755670|NCT02472080|Gemcitabine|gemcitabine|mesh-list
43755671|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
43755672|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43755673|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
43755674|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755675|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755676|NCT02472080|Antiviral Agents|antiviral agents|mesh-ancestor
43755677|NCT02472080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755678|NCT02472080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755679|NCT02472080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755680|NCT02472080|Immunologic Factors|immunologic factors|mesh-ancestor
43755681|NCT02472080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755682|NCT02472249|Norepinephrine|norepinephrine|mesh-list
43755683|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43755684|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43755685|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
43755686|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755687|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755688|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755689|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
43755690|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
43755691|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755692|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43836811|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43836812|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
43836813|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43750972|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750973|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43750974|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750975|NCT02501603|Paclitaxel|paclitaxel|mesh-list
43750976|NCT02501603|Afatinib|afatinib|mesh-list
43750977|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43750978|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750979|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
43750980|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
43750981|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
43836814|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836815|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43836825|NCT04947254|Vitamins|vitamins|mesh-ancestor
43836826|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
43836827|NCT04947254|Estrogens|estrogens|mesh-ancestor
43836828|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
43836829|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43836830|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43836831|NCT04946864|Palbociclib|palbociclib|mesh-list
43836832|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836833|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836834|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836835|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836836|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
43836837|NCT04946370|Androgens|androgens|mesh-list
43836838|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43836839|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836840|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836841|NCT04946370|Hormones|hormones|mesh-ancestor
43836842|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836843|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836844|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43836845|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836846|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43836847|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43836848|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836849|NCT04945148|Metformin|metformin|mesh-list
43836850|NCT04945148|Temozolomide|temozolomide|mesh-list
43836851|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43836852|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836853|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43836854|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
43836856|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755693|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
43755694|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43750982|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750983|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43750984|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836324|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43836325|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
43836326|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43836327|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
43755695|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43755696|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755697|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
43755698|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755699|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755700|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
43755701|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
43755702|NCT02472275|Hormones|hormones|mesh-list
43755703|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43755704|NCT02472275|Androgens|androgens|mesh-list
43755713|NCT02472275|Estrogens|estrogens|mesh-ancestor
43755714|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43755715|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755716|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
43573612|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573613|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43573614|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43573615|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
43573616|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
43573617|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573618|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43573619|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43573620|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573621|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573622|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
43573623|NCT03525730|Valproic Acid|valproic acid|mesh-list
43573624|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
43573625|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43755717|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
43755719|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43755720|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43755721|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755722|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755723|NCT02472236|Protective Agents|protective agents|mesh-ancestor
43755726|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43755727|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755729|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755730|NCT02471820|Dexamethasone|dexamethasone|mesh-list
43755731|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
43755732|NCT02471820|Lenalidomide|lenalidomide|mesh-list
43755733|NCT02471820|Doxorubicin|doxorubicin|mesh-list
43755734|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43755735|NCT02471820|BB 1101|bb 1101|mesh-list
43755736|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43755737|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
43755738|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
43755739|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755740|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755741|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755742|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
43755743|NCT02471820|Hormones|hormones|mesh-ancestor
43755744|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755745|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43755746|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755747|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
43755748|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755749|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755758|NCT02471950|Isoflurane|isoflurane|mesh-list
43755759|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43755760|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
43755761|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
43755762|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755763|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755764|NCT02471690|Oritavancin|oritavancin|mesh-list
43755765|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43755766|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755767|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43755768|NCT02471677|Hormones|hormones|mesh-ancestor
43755769|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755770|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755771|NCT02471846|Atezolizumab|atezolizumab|mesh-list
43755772|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755773|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43755774|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
43755775|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755776|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
43755777|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755778|NCT02471547|Mitomycins|mitomycins|mesh-list
43755779|NCT02471547|Mitomycin|mitomycin|mesh-list
43755780|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43755781|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755782|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
43755783|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755784|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43755785|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755786|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43755787|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43755788|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755789|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755790|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755791|NCT02471209|Sevoflurane|sevoflurane|mesh-list
43755792|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43755793|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43573626|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43573627|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573628|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43573629|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573630|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573631|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
43573632|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
43573633|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573634|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573635|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
43573636|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43573637|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573638|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573639|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43573641|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
43573642|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573643|NCT03525561|Acetazolamide|acetazolamide|mesh-list
43573644|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
43573645|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43573646|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573647|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573648|NCT03525561|Diuretics|diuretics|mesh-ancestor
43573649|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
43573650|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573651|NCT03525522|Betamethasone|betamethasone|mesh-list
43573652|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43573653|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573664|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573665|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573666|NCT03525509|Analgesics|analgesics|mesh-ancestor
43573667|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
43573668|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573669|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
43573670|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
43755794|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
43755796|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755797|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755798|NCT02471105|Bimatoprost|bimatoprost|mesh-list
43755799|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43755800|NCT02470832|Itraconazole|itraconazole|mesh-list
43755801|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
43755802|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755803|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43755804|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43755805|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755806|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755807|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43755808|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
43755809|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755810|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755811|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43755813|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43755814|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
43755815|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755816|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755817|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43755818|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43755819|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
43755820|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755822|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
43755840|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43755841|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755842|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43755843|NCT02470559|Analgesics|analgesics|mesh-ancestor
43755844|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
43755845|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755846|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755847|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
43755848|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43755849|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43755850|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
43755851|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755852|NCT02470637|Insulin|insulin|mesh-list
43755853|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43755854|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
43755855|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755856|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755857|NCT02470650|Ritonavir|ritonavir|mesh-list
43755858|NCT02470650|Darunavir|darunavir|mesh-list
43755859|NCT02470650|Tenofovir|tenofovir|mesh-list
43755860|NCT02470650|Lamivudine|lamivudine|mesh-list
43755861|NCT02470650|Emtricitabine|emtricitabine|mesh-list
43755862|NCT02470650|Abacavir|abacavir|mesh-list
43755863|NCT02470650|Cobicistat|cobicistat|mesh-list
43755864|NCT02470650|Rilpivirine|rilpivirine|mesh-list
43755865|NCT02470650|Elvitegravir|elvitegravir|mesh-list
43755902|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43755903|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755905|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755906|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755907|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
43755908|NCT02470663|Calcium|calcium|mesh-list
43755909|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43755910|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755911|NCT02470663|Antacids|antacids|mesh-ancestor
43755912|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755913|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836870|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
43836871|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836872|NCT04944017|Ketamine|ketamine|mesh-list
43836873|NCT04944017|Analgesics|analgesics|mesh-ancestor
43836874|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
43836875|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836876|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836877|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43836878|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43836879|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
43836880|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
43836881|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43836882|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43755918|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755919|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43755920|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755921|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755922|NCT02470026|Yohimbine|yohimbine|mesh-list
43755923|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
43755924|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
43755925|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755926|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755927|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43755928|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43755929|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43755930|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
43755931|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755932|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755933|NCT02470026|Urological Agents|urological agents|mesh-ancestor
43755934|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
43755935|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43755936|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43573680|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573681|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43573682|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43573683|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43573684|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
43573685|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573689|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573690|NCT03524937|Protective Agents|protective agents|mesh-ancestor
43573691|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573692|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573693|NCT03524872|Analgesics|analgesics|mesh-list
43573694|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573695|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
43573696|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573697|NCT03524846|Vitamins|vitamins|mesh-list
43573698|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
43573699|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
43573700|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573701|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
43573702|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573703|NCT03524846|Protective Agents|protective agents|mesh-ancestor
43573704|NCT03524833|Amoxicillin|amoxicillin|mesh-list
43573705|NCT03524833|Metronidazole|metronidazole|mesh-list
43573706|NCT03524833|Lansoprazole|lansoprazole|mesh-list
43573707|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
43573708|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43573709|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573710|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43573711|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43573712|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43573713|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573714|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43573715|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755937|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43755938|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43755939|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755941|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755942|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755943|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43755944|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755945|NCT02469974|Busulfan|busulfan|mesh-list
43755946|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
43755947|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755948|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
43755949|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755950|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755952|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755953|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43755955|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43755956|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43755957|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43755958|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755959|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755960|NCT02469740|Clopidogrel|clopidogrel|mesh-list
43755961|NCT02469740|Ticagrelor|ticagrelor|mesh-list
43755962|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43573716|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573717|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
43573718|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
43573719|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573729|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
43573730|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573731|NCT03524079|Ajmaline|ajmaline|mesh-list
43573732|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43573733|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43573734|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43573735|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43573736|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573737|NCT03523832|Celecoxib|celecoxib|mesh-list
43573738|NCT03523832|Pregabalin|pregabalin|mesh-list
43573739|NCT03523832|Analgesics|analgesics|mesh-ancestor
43573740|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
43573741|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755963|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43755980|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
43755981|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43755982|NCT02469259|Oxytocin|oxytocin|mesh-list
43755983|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
43755984|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43755985|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560080|NCT05260541|Pramoxine|pramoxine|mesh-list
43755986|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
43755987|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43755988|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43755989|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573742|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573743|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
43573744|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43573745|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43573746|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573747|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43573748|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43573749|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43573750|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573751|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573752|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573753|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573754|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573755|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573756|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43755990|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
43755992|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43755993|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43755994|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755995|NCT02469012|Ribavirin|ribavirin|mesh-list
43755996|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
43755997|NCT02469012|Ledipasvir|ledipasvir|mesh-list
43755998|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
43755999|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756000|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
43756001|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756002|NCT02468856|Modafinil|modafinil|mesh-list
43756003|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43756004|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573757|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43573758|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573759|NCT03523754|Isosorbide|isosorbide|mesh-list
43573760|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43573761|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43573762|NCT03523754|Misoprostol|misoprostol|mesh-list
43573763|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43573764|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
43573765|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43573766|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573767|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43573768|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573769|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
43573770|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43573771|NCT03523754|Diuretics|diuretics|mesh-ancestor
43573772|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
43573773|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
43573774|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43573775|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573776|NCT03523741|Clozapine|clozapine|mesh-list
43573777|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43573778|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
43573779|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573780|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573781|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573782|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43573783|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43756013|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756014|NCT02468791|Rituximab|rituximab|mesh-list
43756015|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43756016|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756017|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
43756018|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756019|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43756020|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43756021|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756022|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43756023|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756024|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756025|NCT02468518|Vitamin E|vitamin e|mesh-list
43756026|NCT02468518|Vitamins|vitamins|mesh-ancestor
43756027|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
43756028|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756029|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
43756030|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756031|NCT02468518|Protective Agents|protective agents|mesh-ancestor
43756033|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43756034|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
43573784|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573785|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573786|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
43573799|NCT03523572|Trastuzumab|trastuzumab|mesh-list
43573800|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43573801|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573802|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43573803|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573804|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
43573805|NCT03523455|Hematinics|hematinics|mesh-ancestor
43573806|NCT03523390|Avelumab|avelumab|mesh-list
43573815|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573817|NCT03523221|Hormones|hormones|mesh-ancestor
43573818|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43573819|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43573820|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573821|NCT03522987|Citalopram|citalopram|mesh-list
43573822|NCT03522987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43573823|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43573824|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756035|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
43756036|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756037|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756038|NCT02468323|Ondansetron|ondansetron|mesh-list
43756039|NCT02468323|Palonosetron|palonosetron|mesh-list
43756040|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
43756041|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
43756042|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756043|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756044|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756045|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
43756046|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
43756047|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43756048|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
43756049|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756050|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573825|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573826|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573827|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
43573828|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573829|NCT03522987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43573830|NCT03522987|Antidepressive Agents|antidepressive agents|mesh-ancestor
43573831|NCT03522987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573832|NCT03522935|Elafin|elafin|mesh-list
43573833|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
43573834|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573835|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573836|NCT03522922|Ascorbic Acid|ascorbic acid|mesh-list
43573837|NCT03522922|Vitamins|vitamins|mesh-ancestor
43573838|NCT03522922|Micronutrients|micronutrients|mesh-ancestor
43573839|NCT03522922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573840|NCT03522922|Antioxidants|antioxidants|mesh-ancestor
43573841|NCT03522922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573842|NCT03522922|Protective Agents|protective agents|mesh-ancestor
43573843|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
43573844|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43573845|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573846|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573847|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573848|NCT03522688|Analgesics|analgesics|mesh-ancestor
43573849|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
43573853|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43573854|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
43573855|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573867|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43573868|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43573869|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756051|NCT02468323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43756052|NCT02468323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43756053|NCT02468323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756054|NCT02468323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43836328|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750985|NCT02501213|Furosemide|furosemide|mesh-list
43572377|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
43572378|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43572379|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
43572380|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572388|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572389|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
43572390|NCT00004907|Busulfan|busulfan|mesh-list
43572391|NCT00004907|Etoposide|etoposide|mesh-list
43750986|NCT02501213|Spironolactone|spironolactone|mesh-list
43750987|NCT02501213|Diuretics|diuretics|mesh-ancestor
43750988|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
43750989|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750990|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43750991|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750992|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750993|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43756055|NCT02468323|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43756056|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43756057|NCT02468297|Ibuprofen|ibuprofen|mesh-list
43756058|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43756059|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43756060|NCT02468297|Analgesics|analgesics|mesh-ancestor
43756061|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
43756062|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756063|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756064|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756065|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43756066|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43756067|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756068|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836929|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836930|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836931|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43836932|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43836933|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
43836934|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
43836935|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43836936|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43836937|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43836938|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836939|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836940|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43836941|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
43836942|NCT04939987|Narcotics|narcotics|mesh-ancestor
43836943|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
43836944|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43836945|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43836946|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43836947|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
43836949|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756103|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756104|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756105|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750994|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
43750995|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43750996|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43750998|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43750999|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43751000|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
43751001|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751002|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43751003|NCT02501291|Thalidomide|thalidomide|mesh-list
43751004|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43751005|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
43751006|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751007|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
43751008|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43751009|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751010|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43756106|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756107|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756108|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
43756109|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
43756110|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756111|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
43756112|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43756128|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
43756129|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
43756137|NCT02467920|Exenatide|exenatide|mesh-list
43756151|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43756152|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43560314|NCT04915755|Niraparib|niraparib|mesh-list
43756153|NCT02467647|Growth Substances|growth substances|mesh-ancestor
43756154|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
43756155|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756156|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
43756157|NCT02467426|Analgesics|analgesics|mesh-ancestor
43756158|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
43756159|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756160|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756161|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756162|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43756163|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43756164|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756165|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756166|NCT02467556|Morphine|morphine|mesh-list
43756167|NCT02467556|Memantine|memantine|mesh-list
43756168|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756169|NCT02467556|Narcotics|narcotics|mesh-ancestor
43756170|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756171|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756172|NCT02467556|Analgesics|analgesics|mesh-ancestor
43756173|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
43756174|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756175|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43756176|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43756177|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
43756178|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751011|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43751012|NCT02501291|Growth Substances|growth substances|mesh-ancestor
43572392|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572393|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
43572394|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572395|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572396|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572397|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
43572398|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572399|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572400|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572401|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43572403|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572404|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756179|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756180|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43756181|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43756182|NCT02467595|Fentanyl|fentanyl|mesh-list
43756183|NCT02467595|Bromides|bromides|mesh-list
43756184|NCT02467595|Propofol|propofol|mesh-list
43756185|NCT02467595|Sevoflurane|sevoflurane|mesh-list
43573871|NCT03522649|Protective Agents|protective agents|mesh-ancestor
43573872|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
43573873|NCT03522649|Vitamins|vitamins|mesh-ancestor
43573874|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
43573875|NCT03522532|Zinc|zinc|mesh-list
43573876|NCT03522532|Trace Elements|trace elements|mesh-ancestor
43756186|NCT02467595|Rocuronium|rocuronium|mesh-list
43756187|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43756188|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756189|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756190|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43573881|NCT03522428|Vitamins|vitamins|mesh-ancestor
43573882|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
43573883|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573884|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
43573885|NCT03522428|Hematinics|hematinics|mesh-ancestor
43573886|NCT03522402|Sevoflurane|sevoflurane|mesh-list
43573887|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43573888|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43573889|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
43573890|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
43573891|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573892|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573893|NCT03522207|Trazodone|trazodone|mesh-list
43573894|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43573895|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43573896|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573897|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573898|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573899|NCT03522207|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43573900|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43573901|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43573902|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573903|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573904|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
43573905|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43573906|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
43573907|NCT03522194|Propofol|propofol|mesh-list
43573908|NCT03522194|Sevoflurane|sevoflurane|mesh-list
43573909|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43573910|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573911|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573912|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43573913|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
43573914|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
43573915|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43573916|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43573917|NCT03522181|Insulin|insulin|mesh-list
43573918|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43573919|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43573920|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573921|NCT03522077|Hemostatics|hemostatics|mesh-list
43573922|NCT03522077|Coagulants|coagulants|mesh-ancestor
43573923|NCT03522051|Calcium|calcium|mesh-list
43573945|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43573946|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573947|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43573948|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573949|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43756198|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43756199|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43756200|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43756201|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
43756202|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43756209|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756210|NCT02467686|Tamoxifen|tamoxifen|mesh-list
43756211|NCT02467686|Exemestane|exemestane|mesh-list
43756212|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43756213|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43756214|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
43756215|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43756216|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756217|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43573950|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573951|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573952|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
43573953|NCT03521713|Hematinics|hematinics|mesh-ancestor
43573954|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43573955|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43573956|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43573957|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
43573958|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573959|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43573960|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43573961|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573962|NCT03521492|Vitamin D|vitamin d|mesh-list
43573963|NCT03521492|Calcium|calcium|mesh-list
43573964|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
43573965|NCT03521492|Hormones|hormones|mesh-list
43573967|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
43573968|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573969|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43573970|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43573971|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43573972|NCT03521414|Sevoflurane|sevoflurane|mesh-list
43573973|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43573974|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43573975|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
43573976|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
43573978|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573979|NCT03521245|Trastuzumab|trastuzumab|mesh-list
43573980|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43573981|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573982|NCT03521219|Apatinib|apatinib|mesh-list
43573983|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572405|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
43572406|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751013|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
43751014|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751015|NCT02501278|Cisplatin|cisplatin|mesh-list
43751016|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751017|NCT02501109|Aripiprazole|aripiprazole|mesh-list
43751018|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
43751019|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43751020|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43751021|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43751022|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751023|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751024|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
43751025|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
43751026|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751027|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751028|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43751029|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43751030|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
43751031|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43751032|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43573984|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43756218|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756219|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43756220|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43756221|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43756222|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43756223|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756224|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756225|NCT02467335|Fostemsavir|fostemsavir|mesh-list
43756226|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43756227|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43756228|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
43756229|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756230|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43756231|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43756232|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756233|NCT02467400|Propranolol|propranolol|mesh-list
43756235|NCT02467400|Nebivolol|nebivolol|mesh-list
43756236|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43756237|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43756238|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756241|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756242|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43751033|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43751034|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43751035|NCT02500927|Naquotinib|naquotinib|mesh-list
43751064|NCT02500940|Protective Agents|protective agents|mesh-ancestor
43751065|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
43751066|NCT02500940|Vitamins|vitamins|mesh-ancestor
43751067|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
43751068|NCT02500667|Rifampin|rifampin|mesh-list
43751069|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43751070|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
43751071|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43751072|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751073|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
43751074|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43751075|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751076|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756243|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43756244|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
43756245|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
43756246|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
43756247|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756248|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43756249|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43756250|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43756251|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756252|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
43756255|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
43756256|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756257|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756258|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43756259|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43756260|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
43756262|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756263|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43756264|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43756265|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756266|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756267|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43756268|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
43756269|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43756270|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756271|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43756272|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
43756273|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43573985|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573990|NCT03521167|Ketamine|ketamine|mesh-list
43573991|NCT03521167|Gabapentin|gabapentin|mesh-list
43573992|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
43573993|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
43573994|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573995|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573996|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
43573997|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751077|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43751078|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43751079|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43751080|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43751081|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43751082|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43751083|NCT02500680|Vaccines|vaccines|mesh-list
43751084|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
43751085|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751086|NCT02500446|Dolutegravir|dolutegravir|mesh-list
43751087|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43751088|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43751089|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573998|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43573999|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43574000|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43574001|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574002|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574003|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43574004|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43574005|NCT03521167|Analgesics|analgesics|mesh-ancestor
43574006|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43574007|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43574008|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43574009|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574010|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574011|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43574012|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43574013|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
43574014|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43574015|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43574016|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
43574017|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43756274|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43756275|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43756277|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43756278|NCT02467673|Progesterone|progesterone|mesh-list
43756279|NCT02467673|Estrogens|estrogens|mesh-ancestor
43756280|NCT02467673|Hormones|hormones|mesh-ancestor
43756281|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43756282|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756300|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574018|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43574019|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574020|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
43574021|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
43574023|NCT03521063|Poractant alfa|poractant alfa|mesh-list
43574024|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574025|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43574026|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
43574027|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574028|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574029|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43574030|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
43574031|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
43574032|NCT03521063|Hormones|hormones|mesh-ancestor
43574033|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574034|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43574035|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
43756301|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560453|NCT04554459|Ponatinib|ponatinib|mesh-list
43751090|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751091|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43751092|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43751093|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
43572407|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
43572408|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572409|NCT00004899|Etoposide|etoposide|mesh-list
43572410|NCT00004899|Busulfan|busulfan|mesh-list
43572411|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43572412|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572413|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572414|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572415|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572416|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572417|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
43572418|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751094|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756302|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756304|NCT02467023|Analgesics|analgesics|mesh-ancestor
43756305|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43756306|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43756307|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
43756308|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43756309|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43756310|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43756311|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43756312|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
43756313|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
43756314|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756315|NCT02467127|Vitamin D|vitamin d|mesh-list
43756316|NCT02467127|Vitamins|vitamins|mesh-ancestor
43756317|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
43756318|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756319|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43756320|NCT02466984|Metoclopramide|metoclopramide|mesh-list
43756321|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
43756322|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
43756323|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756324|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756325|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756326|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43756335|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43756336|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756342|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
43756343|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756344|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43756345|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43756346|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
43756347|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756348|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756349|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43756350|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756351|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
43756352|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
43751095|NCT02500524|Permethrin|permethrin|mesh-list
43751096|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751097|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751099|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
43751100|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
43751101|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751102|NCT02500511|Vaccines|vaccines|mesh-list
43751103|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
43751104|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751105|NCT02500498|Abatacept|abatacept|mesh-list
43751106|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43751107|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751108|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751109|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43751110|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
43751111|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751112|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751113|NCT02500459|Topotecan|topotecan|mesh-list
43751114|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43751115|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43751116|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751117|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751118|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751119|NCT02500329|Acarbose|acarbose|mesh-list
43751120|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43751121|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751122|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756353|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756354|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756355|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
43756356|NCT02467010|Hormones|hormones|mesh-ancestor
43756357|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43756358|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43756359|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43756360|NCT02466828|Hematinics|hematinics|mesh-ancestor
43756361|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43756362|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43756363|NCT02466919|Amoxicillin|amoxicillin|mesh-list
43756364|NCT02466919|Metronidazole|metronidazole|mesh-list
43751123|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43751124|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751125|NCT02500225|Sevoflurane|sevoflurane|mesh-list
43572419|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
43572420|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572421|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572422|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572423|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
43572424|NCT00004898|Etoposide|etoposide|mesh-list
43849060|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
43849061|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751126|NCT02500225|Etomidate|etomidate|mesh-list
43751127|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43751128|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43751129|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
43751130|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
43756365|NCT02466919|Clarithromycin|clarithromycin|mesh-list
43756366|NCT02466919|Levofloxacin|levofloxacin|mesh-list
43756367|NCT02466919|Ofloxacin|ofloxacin|mesh-list
43756368|NCT02466919|Pantoprazole|pantoprazole|mesh-list
43756369|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43756370|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756371|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43756372|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43756373|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43756374|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756375|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756379|NCT02466919|Renal Agents|renal agents|mesh-ancestor
43756380|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43756381|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43756382|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756383|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43756384|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43756385|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756386|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43756387|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
43756388|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756389|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
43756390|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43756391|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43756392|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756393|NCT02466802|Urological Agents|urological agents|mesh-ancestor
43756394|NCT02466503|Fluticasone|fluticasone|mesh-list
43756396|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43756397|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756398|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43756399|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
43756400|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756401|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756402|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43756406|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43756407|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43756408|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756409|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756410|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756411|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756412|NCT02466568|Nivolumab|nivolumab|mesh-list
43756421|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43756422|NCT02466490|Diuretics|diuretics|mesh-ancestor
43756423|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
43756424|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756425|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43756426|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756427|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756428|NCT02466542|Esmolol|esmolol|mesh-list
43756429|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43756430|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43756431|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43756432|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756433|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756434|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756435|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756436|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43756437|NCT02466698|Metronidazole|metronidazole|mesh-list
43756438|NCT02466698|Vancomycin|vancomycin|mesh-list
43756439|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43756440|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43756441|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756442|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
43756443|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43756444|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43756445|NCT02466698|Laxatives|laxatives|mesh-ancestor
43756446|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756464|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756466|NCT02466347|Xhance|xhance|mesh-list
43756467|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43756468|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756469|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43756470|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
43756471|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756472|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756473|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43756474|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
43756475|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
43756476|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43756477|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43756478|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43756479|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756480|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756481|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756482|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756483|NCT02466438|Tazobactam|tazobactam|mesh-list
43756484|NCT02466438|Piperacillin|piperacillin|mesh-list
43756485|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43756486|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43756487|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756488|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43756489|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756490|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756491|NCT02466191|Gabapentin|gabapentin|mesh-list
43756492|NCT02466191|Memantine|memantine|mesh-list
43756493|NCT02466191|Analgesics|analgesics|mesh-ancestor
43756494|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
43756507|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43756508|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43756509|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
43756510|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43756511|NCT02466204|Hormones|hormones|mesh-ancestor
43704554|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756513|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756514|NCT02466022|Fentanyl|fentanyl|mesh-list
43756515|NCT02466022|Midazolam|midazolam|mesh-list
43756516|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
43756517|NCT02466022|Bupivacaine|bupivacaine|mesh-list
43756518|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
43756519|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
43756520|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756521|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756522|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
43756523|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756524|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43751131|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751132|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554620|NCT03570645|Analgesics|analgesics|mesh-ancestor
43751133|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43751134|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43751135|NCT02500212|Tacrolimus|tacrolimus|mesh-list
43751136|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43751137|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
43751138|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751139|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43751140|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751141|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751142|NCT02500017|Melatonin|melatonin|mesh-list
43756525|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43756526|NCT02466022|Analgesics|analgesics|mesh-ancestor
43756527|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43756528|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43756529|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756530|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756531|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756532|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756533|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756534|NCT02466022|Narcotics|narcotics|mesh-ancestor
43756535|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43756536|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43756537|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
43756538|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43756539|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43756540|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43756549|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
43756550|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43756551|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756552|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43756553|NCT02465827|Ropivacaine|ropivacaine|mesh-list
43756554|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
43756555|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
43756556|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756557|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756558|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
43756559|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756560|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
43756561|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43756562|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
43756563|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756564|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43756565|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43756566|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
43756567|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756568|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756569|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43756570|NCT02465749|Vitamins|vitamins|mesh-list
43574037|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
43574038|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574039|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751143|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
43751144|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751145|NCT02500017|Protective Agents|protective agents|mesh-ancestor
43751146|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751147|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751148|NCT02500108|Domperidone|domperidone|mesh-list
43751149|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
43751150|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
43751151|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751152|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574040|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574041|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
43574042|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43574043|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574044|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574046|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
43574047|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
43574048|NCT03520985|Dexamethasone|dexamethasone|mesh-list
43574049|NCT03520985|Pomalidomide|pomalidomide|mesh-list
43574050|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574051|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
43574054|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574055|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43574056|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
43574057|NCT03520985|Hormones|hormones|mesh-ancestor
43574058|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574059|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43574060|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574061|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
43574062|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43756581|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
43756582|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756583|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43756584|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43756585|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756586|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43756587|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43756588|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756589|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756590|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756591|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43756592|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
43756593|NCT02465645|Protective Agents|protective agents|mesh-ancestor
43756594|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43756595|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756596|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43756597|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
43756598|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43756599|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43756600|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
43560753|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
43756601|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43756602|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
43756603|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756604|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
43574067|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574068|NCT03520595|Diclofenac|diclofenac|mesh-list
43756605|NCT02465853|Protective Agents|protective agents|mesh-ancestor
43756606|NCT02465385|Linaclotide|linaclotide|mesh-list
43756607|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43756608|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
43756609|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756610|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756611|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
43756612|NCT02465359|Antibodies|antibodies|mesh-list
43756613|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
43756614|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43756615|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43756616|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
43756617|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756618|NCT02465320|Lidocaine|lidocaine|mesh-list
43756619|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
43756620|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
43756621|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756622|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756623|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
43756624|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756625|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43756626|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43756664|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43756665|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756666|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756667|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43756668|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
43756669|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
43756670|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43756671|NCT02464722|Analgesics|analgesics|mesh-ancestor
43756672|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
43756673|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756674|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43756675|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43756676|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756677|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756678|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756680|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756699|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
43554693|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
43751176|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751177|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43751178|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43751179|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751180|NCT02499874|Tenofovir|tenofovir|mesh-list
43751181|NCT02499874|Lamivudine|lamivudine|mesh-list
43751182|NCT02499874|Zidovudine|zidovudine|mesh-list
43751183|NCT02499874|Emtricitabine|emtricitabine|mesh-list
43751184|NCT02499874|Efavirenz|efavirenz|mesh-list
43751185|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
43751186|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
43751187|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756700|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756701|NCT02464813|Pregabalin|pregabalin|mesh-list
43756702|NCT02464813|Oxycodone|oxycodone|mesh-list
43756703|NCT02464813|Analgesics|analgesics|mesh-ancestor
43756704|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
43756705|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756706|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756707|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
43756708|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43756709|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756710|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756711|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43756712|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43756713|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43756714|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756715|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43756716|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756717|NCT02464813|Narcotics|narcotics|mesh-ancestor
43756718|NCT02464631|Ribavirin|ribavirin|mesh-list
43756719|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
43756720|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
43756721|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756722|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
43836960|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836985|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836986|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43836987|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43836989|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836990|NCT04939142|Dexamethasone|dexamethasone|mesh-list
43836991|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
43836992|NCT04939142|Bortezomib|bortezomib|mesh-list
43836993|NCT04939142|BB 1101|bb 1101|mesh-list
43836994|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43836995|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
43836996|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
43836997|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836998|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836999|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837000|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
43837001|NCT04939142|Hormones|hormones|mesh-ancestor
43837002|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751188|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43751189|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43751190|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751191|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751192|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43751193|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43751194|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
43751195|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43751196|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43751197|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43751198|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43751199|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43751200|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43751201|NCT02499978|Dolutegravir|dolutegravir|mesh-list
43751202|NCT02499978|Darunavir|darunavir|mesh-list
43572425|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572426|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
43572427|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572428|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572429|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572430|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
43572431|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572432|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572433|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572434|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43751218|NCT02499965|Anesthetics|anesthetics|mesh-list
43751219|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
43751220|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751221|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751222|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
43751223|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
43751224|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751225|NCT02499861|Decitabine|decitabine|mesh-list
43751226|NCT02499861|Genistein|genistein|mesh-list
43751227|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43751228|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
43704400|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43837003|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43837004|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837005|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
43837006|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837007|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837008|NCT04938856|Lamotrigine|lamotrigine|mesh-list
43837009|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
43837010|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43837011|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43837012|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837013|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43837014|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837015|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43756754|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
43756756|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756757|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756759|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756761|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43756762|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43756763|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
43756764|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43756765|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43756766|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756767|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756768|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43756769|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43756770|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43756776|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
43756777|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
43756778|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43756779|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
43756780|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
43756781|NCT02463825|Pimozide|pimozide|mesh-list
43756782|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43756783|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43756784|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756785|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756786|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43756787|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43756788|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
43756789|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756790|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756791|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43756792|NCT02463994|Atezolizumab|atezolizumab|mesh-list
43756793|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756794|NCT02464020|Vancomycin|vancomycin|mesh-list
43756802|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43756803|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43756804|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751229|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751230|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751231|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572442|NCT00004897|Fluorouracil|fluorouracil|mesh-list
43572443|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
43572444|NCT00004897|Calcium|calcium|mesh-list
43572445|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
43572446|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572460|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
43572461|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
43572462|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572463|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572464|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
43572465|NCT00004896|Busulfan|busulfan|mesh-list
43572466|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43756805|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43756806|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756807|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756808|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
43756809|NCT02464124|Lactulose|lactulose|mesh-list
43756810|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756811|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43756812|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756813|NCT02463591|Thrombin|thrombin|mesh-list
43756815|NCT02463591|Coagulants|coagulants|mesh-ancestor
43756817|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43756818|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43756819|NCT02463552|Analgesics|analgesics|mesh-ancestor
43756820|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
43756821|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756822|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756823|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756824|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43756825|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
43756826|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43756827|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756828|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756829|NCT02463643|Rabeprazole|rabeprazole|mesh-list
43756830|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43756831|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756832|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43756833|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756834|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756835|NCT02463682|Insulin|insulin|mesh-list
43756836|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43756837|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756838|NCT02463942|Doxycycline|doxycycline|mesh-list
43756839|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43756840|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756841|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
43756842|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43756843|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43574069|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43574070|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43574071|NCT03520595|Analgesics|analgesics|mesh-ancestor
43574072|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
43574073|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572467|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
43572468|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572469|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572470|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572471|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
43751232|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43751233|NCT02499861|Protective Agents|protective agents|mesh-ancestor
43751234|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574074|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574075|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574076|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574077|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43574078|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574079|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574080|NCT03520543|Clonidine|clonidine|mesh-list
43574081|NCT03520543|Yohimbine|yohimbine|mesh-list
43574082|NCT03520543|Analgesics|analgesics|mesh-ancestor
43574083|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
43574084|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574085|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574086|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43574087|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
43756844|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43756845|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43756846|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43756847|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43756848|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
43756905|NCT02462889|Growth Substances|growth substances|mesh-ancestor
43756906|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756907|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
43756908|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756909|NCT02463019|Tenofovir|tenofovir|mesh-list
43756926|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756927|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756928|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43756929|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43756930|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756931|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43756933|NCT02462941|Analgesics|analgesics|mesh-ancestor
43756934|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
43756935|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756936|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756937|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43756938|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
43756939|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43756940|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
43756941|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
43756942|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756943|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574088|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
43574089|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43574090|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43574091|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43574092|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574093|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574094|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574096|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43574097|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43574098|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43574099|NCT03520543|Urological Agents|urological agents|mesh-ancestor
43574100|NCT03520478|Bicalutamide|bicalutamide|mesh-list
43574101|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
43751235|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43751236|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
43751237|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43751238|NCT02499861|Estrogens|estrogens|mesh-ancestor
43751239|NCT02499861|Hormones|hormones|mesh-ancestor
43751240|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751241|NCT02499822|Ramipril|ramipril|mesh-list
43751242|NCT02499822|Nifedipine|nifedipine|mesh-list
43751243|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43751244|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
43751245|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836329|NCT04982354|Fludarabine|fludarabine|mesh-list
43751246|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574102|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
43574103|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574104|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574115|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43574117|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
43574118|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574119|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
43574120|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43574121|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43756944|NCT02462915|Lidocaine|lidocaine|mesh-list
43756945|NCT02462915|Fentanyl|fentanyl|mesh-list
43756946|NCT02462915|Propofol|propofol|mesh-list
43756947|NCT02462915|Cisatracurium|cisatracurium|mesh-list
43756948|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
43756949|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
43756950|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756951|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756952|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
43756953|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756954|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43756955|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43756956|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43756957|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756958|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756959|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43756960|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43756961|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
43756962|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756963|NCT02462915|Narcotics|narcotics|mesh-ancestor
43756964|NCT02462915|Analgesics|analgesics|mesh-ancestor
43756965|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43756966|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43756967|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43756968|NCT02462837|Mirabegron|mirabegron|mesh-list
43756969|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43756970|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43756971|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756972|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756973|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756974|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756975|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837035|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43751247|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43751248|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43751249|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43751250|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43751251|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751252|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
43751253|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
43837036|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837037|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
43837038|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43837039|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43837040|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43837041|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
43837042|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837043|NCT04936685|Vaccines|vaccines|mesh-list
43837044|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
43837045|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837046|NCT04935931|Naltrexone|naltrexone|mesh-list
43837047|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43837048|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43837084|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43837085|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43837086|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
43837087|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756977|NCT02462525|Dexamethasone|dexamethasone|mesh-list
43756978|NCT02462525|Pomalidomide|pomalidomide|mesh-list
43756979|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756980|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
43756981|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
43756982|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756983|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756984|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756985|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
43756987|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43756988|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43756989|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756990|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
43756991|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43756992|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43756993|NCT02462525|Growth Substances|growth substances|mesh-ancestor
43756994|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
43756995|NCT02462577|Morphine|morphine|mesh-list
43756996|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756997|NCT02462577|Narcotics|narcotics|mesh-ancestor
43756998|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756999|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757000|NCT02462577|Analgesics|analgesics|mesh-ancestor
43757015|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757016|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43757017|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43757018|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
43757019|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
43757020|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757021|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43757022|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43757023|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757024|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757025|NCT02462499|Eplerenone|eplerenone|mesh-list
43757026|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43757027|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
43757051|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757052|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43757053|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43757054|NCT02462304|Growth Substances|growth substances|mesh-ancestor
43757055|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757056|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
43757057|NCT02462317|Baclofen|baclofen|mesh-list
43757058|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43757059|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43757060|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43757061|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757062|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43757063|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757064|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43757065|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
43757066|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
43757067|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757068|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757069|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43757070|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43757071|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
43757072|NCT02462109|Lorazepam|lorazepam|mesh-list
43757073|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
43757074|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
43757075|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
43757076|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757077|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757079|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43757080|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757081|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43757082|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43757083|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574123|NCT03520257|Apatinib|apatinib|mesh-list
43574124|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574125|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43574126|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574127|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574128|NCT03520062|Liraglutide|liraglutide|mesh-list
43574129|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43757085|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
43757086|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757087|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757088|NCT02462161|Insulin|insulin|mesh-list
43757089|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43757090|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
43757091|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
43757092|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43757093|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43757094|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757095|NCT02462174|Ketamine|ketamine|mesh-list
43757096|NCT02462174|Bupivacaine|bupivacaine|mesh-list
43757097|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
43757098|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
43757099|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757100|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757101|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
43757102|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757103|NCT02462174|Analgesics|analgesics|mesh-ancestor
43757104|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43757105|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43757106|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
43757107|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43757108|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43757109|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757110|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757111|NCT02462252|Cyclosporine|cyclosporine|mesh-list
43757112|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
43757113|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43757114|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43757115|NCT02462252|Cyclosporins|cyclosporins|mesh-list
43757116|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43757117|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757125|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757126|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43757127|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757128|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
43757129|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
43757130|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757131|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757132|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
43757133|NCT02462252|Hormones|hormones|mesh-ancestor
43757134|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757135|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43757136|NCT02462252|Protective Agents|protective agents|mesh-ancestor
43757137|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43757138|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757139|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
43757140|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
43757141|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757142|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757143|NCT02462265|Analgesics|analgesics|mesh-ancestor
43757144|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
43757145|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757146|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43574130|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574131|NCT03520062|Incretins|incretins|mesh-ancestor
43574132|NCT03520062|Hormones|hormones|mesh-ancestor
43574133|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574134|NCT03520049|Oseltamivir|oseltamivir|mesh-list
43574135|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
43574136|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574137|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574138|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574140|NCT03519776|Progestins|progestins|mesh-ancestor
43574141|NCT03519776|Hormones|hormones|mesh-ancestor
43704555|NCT04688814|Analgesics|analgesics|mesh-ancestor
43574147|NCT03519750|Protective Agents|protective agents|mesh-ancestor
43574148|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574149|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574150|NCT03519724|Neostigmine|neostigmine|mesh-list
43574151|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43574152|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574153|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574154|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
43574155|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574156|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574157|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43757147|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43757148|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757150|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
43757151|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43757152|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757153|NCT02462044|Trace Elements|trace elements|mesh-ancestor
43757154|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
43757155|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757156|NCT02461706|Cannabidiol|cannabidiol|mesh-list
43757157|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
43757158|NCT02461836|Gemcitabine|gemcitabine|mesh-list
43757159|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43757160|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
43757161|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757162|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757163|NCT02461836|Antiviral Agents|antiviral agents|mesh-ancestor
43757164|NCT02461836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757165|NCT02461836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757166|NCT02461836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757167|NCT02461836|Immunologic Factors|immunologic factors|mesh-ancestor
43757168|NCT02461836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757169|NCT02461888|Dexamethasone|dexamethasone|mesh-list
43757170|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
43757171|NCT02461888|Ixazomib|ixazomib|mesh-list
43757172|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757173|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
43757174|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757175|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757176|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43757177|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
43757179|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757192|NCT02461875|Cabergoline|cabergoline|mesh-list
43757193|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43757194|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43757195|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
43757196|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
43757197|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757198|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757199|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757200|NCT02461719|Cyclosporine|cyclosporine|mesh-list
43757201|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43757202|NCT02461719|Cyclosporins|cyclosporins|mesh-list
43561489|NCT02664558|Ubenimex|ubenimex|mesh-list
43757203|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757204|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757205|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757206|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
43757207|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757208|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
43757209|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757210|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757211|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757212|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43757225|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43757226|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43757232|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757233|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
43757234|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757235|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43757236|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43757237|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43757238|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43757239|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757240|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757241|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
43757242|NCT02461368|Hormones|hormones|mesh-ancestor
43757243|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757244|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757245|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
43757246|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757247|NCT02461186|Piperaquine|piperaquine|mesh-list
43757248|NCT02461186|Artenimol|artenimol|mesh-list
43757249|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
43757250|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43757251|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43757252|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574158|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
43574159|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574160|NCT03519633|Neostigmine|neostigmine|mesh-list
43574161|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43574162|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574163|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574164|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
43849066|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
43574165|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574166|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574167|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43574168|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
43574169|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574170|NCT03519542|Sunitinib|sunitinib|mesh-list
43574171|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574172|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43574173|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43751254|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43751255|NCT02499757|Nicotine|nicotine|mesh-list
43751256|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43751257|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
43751258|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751259|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751260|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43704401|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43574174|NCT03519542|Growth Substances|growth substances|mesh-ancestor
43574175|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574176|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
43574177|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43574178|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574179|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574180|NCT03519386|Travoprost|travoprost|mesh-list
43574181|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43574182|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43574183|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43574184|NCT03519152|Diclofenac|diclofenac|mesh-list
43574185|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43574186|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43574187|NCT03519152|Analgesics|analgesics|mesh-ancestor
43757262|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43757263|NCT02461056|Analgesics|analgesics|mesh-ancestor
43757264|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
43757265|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757266|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757267|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757268|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757269|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43757270|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757271|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757272|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43757273|NCT02461056|Narcotics|narcotics|mesh-ancestor
43757274|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757275|NCT02461121|Cyclosporine|cyclosporine|mesh-list
43757276|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
43757277|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
43757278|NCT02461121|Fludarabine|fludarabine|mesh-list
43757279|NCT02461121|Cyclosporins|cyclosporins|mesh-list
43561551|NCT02638805|Liraglutide|liraglutide|mesh-list
43757280|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43757281|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757282|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
43757283|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757284|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757285|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43757286|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
43757287|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574189|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574190|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574191|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757288|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757289|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43757290|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757291|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
43757292|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757293|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757294|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43757295|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43757296|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43757297|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
43757298|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43757299|NCT02461043|Paclitaxel|paclitaxel|mesh-list
43757300|NCT02461043|Cisplatin|cisplatin|mesh-list
43757301|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43757302|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757303|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
43572472|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572473|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572474|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572475|NCT00004895|Octreotide|octreotide|mesh-list
43572476|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43572477|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43572478|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572479|NCT00004584|Ritonavir|ritonavir|mesh-list
43572480|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43757304|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
43757305|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
43757306|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757307|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43757308|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757309|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757310|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
43757311|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757312|NCT02461030|Listerine|listerine|mesh-list
43757313|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
43757314|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
43847873|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
43757330|NCT02460510|Mannitol|mannitol|mesh-list
43757331|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43757332|NCT02460510|Diuretics|diuretics|mesh-ancestor
43757333|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
43757334|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757335|NCT02460627|Lidocaine|lidocaine|mesh-list
43757336|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
43574192|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574193|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43574194|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574195|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574196|NCT03519061|Budesonide|budesonide|mesh-list
43574207|NCT03519022|Cocaine|cocaine|mesh-list
43574208|NCT03519022|Methylphenidate|methylphenidate|mesh-list
43574209|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43574210|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574211|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43574212|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43574213|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43757350|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43757351|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43757369|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757370|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
43757372|NCT02460276|Rituximab|rituximab|mesh-list
43757373|NCT02460276|Lenalidomide|lenalidomide|mesh-list
43757374|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43757375|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757376|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
43757377|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757378|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757379|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43757380|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43757381|NCT02460276|Growth Substances|growth substances|mesh-ancestor
43757382|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
43757383|NCT02460432|Paclitaxel|paclitaxel|mesh-list
43757384|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43757385|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757386|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
43757387|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
43757388|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
43757389|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757390|NCT02460289|Minoxidil|minoxidil|mesh-list
43757391|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43757392|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
43757393|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43572481|NCT00004584|Saquinavir|saquinavir|mesh-list
43572482|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572483|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572484|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572485|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751261|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43751262|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
43751263|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751264|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751265|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43751266|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43704402|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
43757418|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43757419|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43757420|NCT02460341|Ondansetron|ondansetron|mesh-list
43757421|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
43757422|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
43757423|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757424|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757425|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757426|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
43757427|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757428|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43757429|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
43757465|NCT02460302|Progestins|progestins|mesh-ancestor
43757467|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757468|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757469|NCT02460068|Nivolumab|nivolumab|mesh-list
43757470|NCT02460068|Ipilimumab|ipilimumab|mesh-list
43757471|NCT02460068|Fotemustine|fotemustine|mesh-list
43757472|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43757473|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757474|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43757475|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757476|NCT02459977|Basiliximab|basiliximab|mesh-list
43757477|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757478|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
43574214|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574215|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
43574216|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574217|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
43574218|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
43574219|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574220|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
43574221|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574222|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43574223|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43574224|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43574225|NCT03518528|Estradiol|estradiol|mesh-list
43574226|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43574227|NCT03518528|Estrogens|estrogens|mesh-ancestor
43574228|NCT03518528|Hormones|hormones|mesh-ancestor
43574229|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574230|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574231|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43574232|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
43757487|NCT02460055|Dexamethasone|dexamethasone|mesh-list
43757488|NCT02460055|Fentanyl|fentanyl|mesh-list
43757489|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
43757490|NCT02460055|Ondansetron|ondansetron|mesh-list
43757491|NCT02460055|Propofol|propofol|mesh-list
43757492|NCT02460055|Sevoflurane|sevoflurane|mesh-list
43757493|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757494|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
43757495|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
43751267|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43751268|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
43751269|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751270|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751271|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43751272|NCT02499614|Crizotinib|crizotinib|mesh-list
43757496|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574267|NCT03517995|Sulforaphane|sulforaphane|mesh-list
43574268|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43574269|NCT03517995|Protective Agents|protective agents|mesh-ancestor
43574270|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574271|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574272|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
43574273|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43574274|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574275|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43574276|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
43574277|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43574278|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757505|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757506|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43757507|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
43757508|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
43757509|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43757510|NCT02460055|Narcotics|narcotics|mesh-ancestor
43757511|NCT02460055|Analgesics|analgesics|mesh-ancestor
43757512|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
43757513|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43757514|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43757515|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43757516|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
43757517|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757518|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43757519|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
43757520|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757521|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757522|NCT02460055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43757523|NCT02460055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43757524|NCT02460055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43757525|NCT02460055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43757526|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43757527|NCT02459782|Anesthetics|anesthetics|mesh-list
43757528|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757529|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757555|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
43757556|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757557|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757559|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757560|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757561|NCT02459756|Ascorbic Acid|ascorbic acid|mesh-list
43757562|NCT02459756|Citric Acid|citric acid|mesh-list
43757563|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
43757564|NCT02459756|Vitamins|vitamins|mesh-ancestor
43757565|NCT02459756|Micronutrients|micronutrients|mesh-ancestor
43757566|NCT02459756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757567|NCT02459756|Antioxidants|antioxidants|mesh-ancestor
43757568|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757569|NCT02459756|Protective Agents|protective agents|mesh-ancestor
43757570|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
43757571|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43757572|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
43757573|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
43757574|NCT02459574|Amiodarone|amiodarone|mesh-list
43757575|NCT02459574|Sotalol|sotalol|mesh-list
43757576|NCT02459574|Flecainide|flecainide|mesh-list
43757577|NCT02459574|Propafenone|propafenone|mesh-list
43757578|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43757579|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
43757580|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43757594|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43751273|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751274|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43751275|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751276|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751277|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
43757595|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43757596|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43757597|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
43757598|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
43757599|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757600|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43757601|NCT02459288|Clopidogrel|clopidogrel|mesh-list
43757602|NCT02459288|Ticagrelor|ticagrelor|mesh-list
43757603|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43757604|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43757605|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43757606|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43757607|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
43757608|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757609|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757610|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757611|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
43757612|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43757613|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757614|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43757624|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
43757625|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757626|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757627|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
43757628|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757629|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43757630|NCT02458742|Narcotics|narcotics|mesh-ancestor
43757631|NCT02458742|Analgesics|analgesics|mesh-ancestor
43757632|NCT02458755|Atorvastatin|atorvastatin|mesh-list
43757633|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43757634|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43757635|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43757636|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
43757637|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757638|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43757639|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43757640|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757642|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43757643|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
43757644|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757645|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43757646|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
43757647|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
43757648|NCT02458924|Vitamins|vitamins|mesh-ancestor
43757649|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
43757650|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757651|NCT02459158|Arbekacin|arbekacin|mesh-list
43757652|NCT02459158|Dibekacin|dibekacin|mesh-list
43574279|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757654|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757655|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43757656|NCT02458716|Leuprolide|leuprolide|mesh-list
43757658|NCT02458716|Androgens|androgens|mesh-list
43757659|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
43757660|NCT02458716|Hormones|hormones|mesh-ancestor
43757661|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757662|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757663|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43757664|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
43757665|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43757666|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43757667|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757668|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
43757669|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
43751278|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
43751279|NCT02499445|Sufentanil|sufentanil|mesh-list
43751280|NCT02499445|Remifentanil|remifentanil|mesh-list
43751281|NCT02499445|Propofol|propofol|mesh-list
43751282|NCT02499445|Sevoflurane|sevoflurane|mesh-list
43751283|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43751284|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751285|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751286|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43757670|NCT02458911|Paclitaxel|paclitaxel|mesh-list
43757671|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43757672|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574324|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43574326|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574328|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43574329|NCT03517683|Methamphetamine|methamphetamine|mesh-list
43574330|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43574331|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574332|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
43574333|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
43757759|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757760|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757761|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43757762|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757763|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
43757764|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757765|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43757766|NCT02458209|Bococizumab|bococizumab|mesh-list
43757767|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43757768|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43757769|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
43757770|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757771|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43757772|NCT02458183|Vaccines|vaccines|mesh-list
43757773|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
43757774|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757775|NCT02458274|Dimercaprol|dimercaprol|mesh-list
43574337|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574338|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574339|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43574340|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43574341|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574342|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43574344|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43574345|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43574346|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
43574347|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43574348|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43574349|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574350|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574351|NCT03517670|Protective Agents|protective agents|mesh-ancestor
43574352|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574353|NCT03517631|Busulfan|busulfan|mesh-list
43574354|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
43757776|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
43757777|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
43757778|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757779|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
43757780|NCT02458196|Prednisone|prednisone|mesh-list
43757781|NCT02458196|Prednisolone|prednisolone|mesh-list
43757782|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757783|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
43757784|NCT02458196|Hormones|hormones|mesh-ancestor
43757785|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757786|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757787|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43757788|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751287|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
43751288|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
43751289|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43751290|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43751291|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43751292|NCT02499445|Narcotics|narcotics|mesh-ancestor
43751293|NCT02499445|Analgesics|analgesics|mesh-ancestor
43572486|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572487|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572488|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572489|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
43572490|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757822|NCT02458079|Protective Agents|protective agents|mesh-ancestor
43757823|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757824|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
43757825|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43757826|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
43757827|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
43757829|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757830|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
43757831|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757832|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757833|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43757834|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
43757835|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757836|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757837|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43757838|NCT02457806|Phenylephrine|phenylephrine|mesh-list
43757839|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
43757840|NCT02457806|Tetracaine|tetracaine|mesh-list
43757841|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
43757842|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
43757843|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757844|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757845|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
43757846|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757847|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43757848|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43757849|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
43757850|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757851|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757852|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
43757853|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
43757854|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
43757855|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43757856|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
43757861|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43757863|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757864|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757865|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757866|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757867|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
43757868|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
43574358|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574359|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43574360|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574361|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43574362|NCT03517618|Leucovorin|leucovorin|mesh-list
43574363|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574364|NCT03517618|Antidotes|antidotes|mesh-ancestor
43574365|NCT03517618|Protective Agents|protective agents|mesh-ancestor
43574366|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
43574367|NCT03517618|Vitamins|vitamins|mesh-ancestor
43572491|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43572492|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43572493|NCT00004231|Leucovorin|leucovorin|mesh-list
43572494|NCT00004231|Interferons|interferons|mesh-list
43751294|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
43751295|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751296|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43836330|NCT04982354|Melphalan|melphalan|mesh-list
43836331|NCT04982354|Busulfan|busulfan|mesh-list
43836332|NCT04982354|Midostaurin|midostaurin|mesh-list
43574368|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
43574369|NCT03517462|Ivermectin|ivermectin|mesh-list
43574370|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43574371|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574372|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
43574373|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43574374|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43574375|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43574376|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574377|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574378|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
43574379|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574380|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574381|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43574382|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574383|NCT03517033|Nebivolol|nebivolol|mesh-list
43574384|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43574385|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
43574386|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43574387|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43757883|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757884|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43757885|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
43757886|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757887|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757888|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43757889|NCT02457442|Remifentanil|remifentanil|mesh-list
43757890|NCT02457442|Propofol|propofol|mesh-list
43757891|NCT02457442|Sevoflurane|sevoflurane|mesh-list
43757892|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43757893|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574395|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
43574396|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43574397|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43574398|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43574399|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574400|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574401|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574402|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574403|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43574404|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43574405|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43574406|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
43574407|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574408|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43574409|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43574410|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574412|NCT03516903|Methotrexate|methotrexate|mesh-list
43574413|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43574414|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
43574415|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43574416|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574417|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43574418|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
43574419|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574420|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574421|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
43574422|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757901|NCT02457442|Narcotics|narcotics|mesh-ancestor
43757902|NCT02457442|Analgesics|analgesics|mesh-ancestor
43757903|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
43757904|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757905|NCT02457312|Letrozole|letrozole|mesh-list
43757906|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757922|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757923|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
43757924|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43757925|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757926|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757927|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43757928|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43757929|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43757930|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43757931|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43574423|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43574424|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574425|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
43574426|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574427|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43574428|NCT03516903|Hematinics|hematinics|mesh-ancestor
43574429|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
43574430|NCT03516903|Vitamins|vitamins|mesh-ancestor
43574431|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
43574432|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
43757932|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43757933|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43757934|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43757935|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
43757936|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43837126|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43837127|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43837128|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837129|NCT04929379|Fenofibrate|fenofibrate|mesh-list
43837130|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43837131|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
43837132|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837133|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43837134|NCT04928222|Doxorubicin|doxorubicin|mesh-list
43837135|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43837136|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837137|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43757938|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
43757939|NCT02456961|Vitamins|vitamins|mesh-ancestor
43757940|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
43757941|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757942|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43757943|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757944|NCT02457130|Clopidogrel|clopidogrel|mesh-list
43757945|NCT02457130|Ticagrelor|ticagrelor|mesh-list
43757946|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43757947|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43757982|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
43757983|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757984|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757985|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43574433|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43574434|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574435|NCT03516747|Hormones|hormones|mesh-list
43574436|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
43574437|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574438|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574439|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43574440|NCT03516669|Amoxicillin|amoxicillin|mesh-list
43574441|NCT03516669|Clarithromycin|clarithromycin|mesh-list
43574442|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43574443|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574444|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43574445|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574446|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574447|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43574451|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
43574452|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43757986|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43757987|NCT02457026|Growth Substances|growth substances|mesh-ancestor
43757988|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
43757989|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757990|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43757991|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757993|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43757994|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757995|NCT02456844|Leucovorin|leucovorin|mesh-list
43757996|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
43757997|NCT02456844|Methotrexate|methotrexate|mesh-list
43757998|NCT02456844|Digoxin|digoxin|mesh-list
43757999|NCT02456844|Midazolam|midazolam|mesh-list
43758000|NCT02456844|Pravastatin|pravastatin|mesh-list
43758001|NCT02456844|Montelukast|montelukast|mesh-list
43758002|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43758003|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
43758004|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43758005|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758006|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43758007|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
43758008|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758009|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758010|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
43758011|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758012|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43758013|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758014|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
43758015|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758016|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43758017|NCT02456844|Antidotes|antidotes|mesh-ancestor
43758018|NCT02456844|Protective Agents|protective agents|mesh-ancestor
43758019|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
43758031|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
43758032|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
43758033|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758034|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43758035|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
43758036|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43758037|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
43758038|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758039|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43758040|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43758043|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43758044|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43758045|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43758046|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43758047|NCT02456844|Analgesics|analgesics|mesh-ancestor
43758048|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
43758049|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758050|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43758051|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43758052|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43758053|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43758055|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
43758056|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
43758057|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758058|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758059|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
43758073|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758074|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758075|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43758076|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43758077|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758078|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43758079|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43758080|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
43758081|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
43758082|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758083|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
43758084|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
43758085|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43758086|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
43574453|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43574454|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574455|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
43574457|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43574458|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574459|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43574460|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43574461|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574462|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574463|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574464|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574465|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43574466|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43574467|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574468|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574469|NCT03516630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43574470|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43574471|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574472|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574473|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
43574474|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43574475|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
43574476|NCT03516526|Natalizumab|natalizumab|mesh-list
43574477|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
43574478|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574479|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43574482|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574483|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43574485|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43574486|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
43574487|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
43574488|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43574489|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574490|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
43574491|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
43574492|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
43574493|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574494|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574495|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
43574496|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574497|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574498|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43758087|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43758088|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
43758089|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43758090|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758091|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43758092|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43758093|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43758094|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758095|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43758096|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43758097|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43758098|NCT02456701|Vemurafenib|vemurafenib|mesh-list
43758099|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758100|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43758101|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758102|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758103|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43758104|NCT02456558|Deferiprone|deferiprone|mesh-list
43758105|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43758106|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
43758107|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
43758108|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758109|NCT02456428|Insulin|insulin|mesh-list
43758110|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43758111|NCT02456428|Metformin|metformin|mesh-list
43758112|NCT02456428|Pioglitazone|pioglitazone|mesh-list
43758113|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43574510|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
43574511|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574512|NCT03515707|Etoposide|etoposide|mesh-list
43574513|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
43574514|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
43574515|NCT03515707|Busulfan|busulfan|mesh-list
43574516|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43758117|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
43758118|NCT02456428|Vildagliptin|vildagliptin|mesh-list
43758119|NCT02456428|Saxagliptin|saxagliptin|mesh-list
43758120|NCT02456428|Acarbose|acarbose|mesh-list
43758121|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43758122|NCT02456428|Repaglinide|repaglinide|mesh-list
43758123|NCT02456428|Gliclazide|gliclazide|mesh-list
43758124|NCT02456428|Glipizide|glipizide|mesh-list
43758125|NCT02456428|Biguanides|biguanides|mesh-list
43758126|NCT02456428|Voglibose|voglibose|mesh-list
43758127|NCT02456428|Tolbutamide|tolbutamide|mesh-list
43758128|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
43758129|NCT02456428|Nateglinide|nateglinide|mesh-list
43758130|NCT02456428|Miglitol|miglitol|mesh-list
43758131|NCT02456428|Troglitazone|troglitazone|mesh-list
43758132|NCT02456428|Meglitinide|meglitinide|mesh-list
43758133|NCT02456428|Acetohexamide|acetohexamide|mesh-list
43758134|NCT02456428|Phenformin|phenformin|mesh-list
43758135|NCT02456428|Buformin|buformin|mesh-list
43758136|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
43758137|NCT02456428|Gliquidone|gliquidone|mesh-list
43758138|NCT02456428|Carbutamide|carbutamide|mesh-list
43758139|NCT02456428|Tolazamide|tolazamide|mesh-list
43758140|NCT02456428|Glibornuride|glibornuride|mesh-list
43758141|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43758142|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
43758143|NCT02456428|Incretins|incretins|mesh-list
43758175|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758176|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758177|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43758178|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758181|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758182|NCT02456142|Morphine|morphine|mesh-list
43758183|NCT02456142|Bupivacaine|bupivacaine|mesh-list
43758184|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
43758185|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
43758186|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758187|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758188|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
43758189|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758190|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758191|NCT02456142|Narcotics|narcotics|mesh-ancestor
43758192|NCT02456142|Analgesics|analgesics|mesh-ancestor
43758193|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43836333|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836334|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836335|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43836336|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
43836337|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836338|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43836339|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
43836340|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43836341|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43758194|NCT02456194|Calcium|calcium|mesh-list
43758195|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43574517|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574518|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43574519|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43574520|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574528|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
43574529|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
43574530|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
43574531|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
43574532|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
43574534|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43574535|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574536|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43574537|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43574538|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574539|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574541|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574542|NCT03515577|Edetic Acid|edetic acid|mesh-list
43574543|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43574544|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
43574545|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
43574546|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574547|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
43574548|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43574549|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43574550|NCT03515538|Cisplatin|cisplatin|mesh-list
43574551|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574552|NCT03515382|Itraconazole|itraconazole|mesh-list
43574553|NCT03515382|Voriconazole|voriconazole|mesh-list
43574554|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
43574571|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43574573|NCT03515200|Dexamethasone|dexamethasone|mesh-list
43574574|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
43574575|NCT03515200|Doxorubicin|doxorubicin|mesh-list
43574576|NCT03515200|Methotrexate|methotrexate|mesh-list
43574577|NCT03515200|Bortezomib|bortezomib|mesh-list
43574578|NCT03515200|Dasatinib|dasatinib|mesh-list
43574579|NCT03515200|Palbociclib|palbociclib|mesh-list
43836342|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836343|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
43836344|NCT04981860|Povidone|povidone|mesh-list
43836345|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
43836346|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
43836347|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43836348|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836349|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43574580|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574581|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
43574582|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
43574583|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574584|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574585|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43574586|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
43574587|NCT03515200|Hormones|hormones|mesh-ancestor
43574588|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758204|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758211|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43758212|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758213|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
43758214|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758215|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758216|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43758217|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43758218|NCT02456116|Analgesics|analgesics|mesh-ancestor
43758219|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
43758220|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758221|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758222|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43758223|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758224|NCT02456025|Tacrolimus|tacrolimus|mesh-list
43758225|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758226|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
43758227|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758228|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43758229|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758232|NCT02455726|Oxycodone|oxycodone|mesh-list
43758233|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
43758234|NCT02455726|Analgesics|analgesics|mesh-ancestor
43758235|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
43758236|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758237|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758256|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758257|NCT02455869|Alendronate|alendronate|mesh-list
43758258|NCT02455869|Atorvastatin|atorvastatin|mesh-list
43758259|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43758260|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43758261|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
43758262|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758263|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43758264|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43758265|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836350|NCT04979611|Exenatide|exenatide|mesh-list
43836351|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43836352|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836353|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43836354|NCT04979611|Incretins|incretins|mesh-ancestor
43751297|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
43751299|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43751300|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758266|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43758267|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758268|NCT02455856|Itraconazole|itraconazole|mesh-list
43758269|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
43758270|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758271|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43758272|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43758273|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758274|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758305|NCT02455362|Analgesics|analgesics|mesh-ancestor
43758306|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
43758307|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837138|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43837139|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837140|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574589|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43574590|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574591|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43574592|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43574593|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43574594|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574595|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574596|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43574597|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
43574598|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43574599|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43574600|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
43574601|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
43574602|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43574603|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574604|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
43574605|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574606|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43574607|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
43574608|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574609|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43574610|NCT03515187|Bromides|bromides|mesh-list
43574611|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43574612|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43574613|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
43574614|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
43574615|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43574616|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
43574617|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574618|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
43574619|NCT03515187|Protective Agents|protective agents|mesh-ancestor
43574620|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
43574621|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
43574622|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574623|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43574624|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574625|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574626|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
43574627|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43574628|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43574629|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
43837145|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837147|NCT04926844|Midazolam|midazolam|mesh-list
43837148|NCT04926844|Levetiracetam|levetiracetam|mesh-list
43837149|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43837150|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43837151|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837152|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837153|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43837154|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43837155|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837156|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43837157|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
43837158|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
43837159|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
43837160|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
43837161|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837162|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837163|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
43837164|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
43837165|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43837166|NCT04926545|Fluorouracil|fluorouracil|mesh-list
43837167|NCT04926545|Irinotecan|irinotecan|mesh-list
43837168|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
43837169|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758316|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758317|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43758318|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43758319|NCT02455609|Analgesics|analgesics|mesh-ancestor
43758320|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43758321|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43758322|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43758323|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
43758324|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758325|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758326|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43758327|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43758328|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
43758329|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43758330|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43758331|NCT02455401|Remifentanil|remifentanil|mesh-list
43758332|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758333|NCT02455401|Narcotics|narcotics|mesh-ancestor
43758334|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758335|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758336|NCT02455401|Analgesics|analgesics|mesh-ancestor
43758337|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
43758338|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572495|NCT00004231|Cytarabine|cytarabine|mesh-list
43751315|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43751316|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
43751317|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751318|NCT02499341|Ketamine|ketamine|mesh-list
43751319|NCT02499341|Tramadol|tramadol|mesh-list
43574633|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
43574634|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574635|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574636|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43574637|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
43574638|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574639|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574640|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43574641|NCT03514810|Ketoprofen|ketoprofen|mesh-list
43574642|NCT03514810|Sertraline|sertraline|mesh-list
43574643|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
43574644|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574645|NCT03514810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43758339|NCT02455596|Interferons|interferons|mesh-list
43758340|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758341|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
43758342|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758344|NCT02455440|Sevoflurane|sevoflurane|mesh-list
43758345|NCT02455440|Esmolol|esmolol|mesh-list
43758346|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43758347|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758348|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758349|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43758350|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
43758351|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
43758352|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43758353|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43758354|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43574657|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574658|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574659|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43574660|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574661|NCT03514771|Valacyclovir|valacyclovir|mesh-list
43574662|NCT03514771|Isotretinoin|isotretinoin|mesh-list
43574663|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
43574664|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574665|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
43574666|NCT03514667|Curcumin|curcumin|mesh-list
43574667|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43574668|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43574669|NCT03514667|Analgesics|analgesics|mesh-ancestor
43574670|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
43574671|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574672|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574673|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574674|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574675|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574676|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574677|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574678|NCT03514576|Pasireotide|pasireotide|mesh-list
43574679|NCT03514576|Hormones|hormones|mesh-ancestor
43574680|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574681|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574682|NCT03514550|Propofol|propofol|mesh-list
43574685|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574686|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574687|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43574688|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
43574689|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
43574690|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43574691|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43574692|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43574693|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574694|NCT03514381|Doxorubicin|doxorubicin|mesh-list
43758373|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43751320|NCT02499341|Analgesics|analgesics|mesh-ancestor
43751321|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
43751322|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751323|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751324|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43751325|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43751326|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
43751327|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
43751328|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751329|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43751330|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43758374|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43758375|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758376|NCT02455245|Carboplatin|carboplatin|mesh-list
43758377|NCT02455245|Vincristine|vincristine|mesh-list
43758378|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758379|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43758380|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
43758381|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
43758382|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
43758383|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758384|NCT02454894|Lidocaine|lidocaine|mesh-list
43758385|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
43758386|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
43758387|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758393|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43758394|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43758395|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758396|NCT02455154|Letrozole|letrozole|mesh-list
43758397|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758406|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
43758407|NCT02455180|Vitamins|vitamins|mesh-ancestor
43758408|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
43758409|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758410|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
43758411|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758412|NCT02455180|Protective Agents|protective agents|mesh-ancestor
43758413|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
43758414|NCT02454881|Oxycodone|oxycodone|mesh-list
43758415|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43758416|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758417|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758418|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43758420|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
43758424|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43758438|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758439|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758440|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
43758441|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
43758442|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758443|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43758444|NCT02455115|Trace Elements|trace elements|mesh-ancestor
43758445|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
43758446|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
43758447|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43758448|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
43758449|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
43758450|NCT02455115|Antidotes|antidotes|mesh-ancestor
43758451|NCT02455115|Protective Agents|protective agents|mesh-ancestor
43758452|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43758453|NCT02455011|Volagidemab|volagidemab|mesh-list
43758454|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43758455|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562802|NCT01378676|Riluzole|riluzole|mesh-list
43758456|NCT02454868|Remifentanil|remifentanil|mesh-list
43758457|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758458|NCT02454868|Narcotics|narcotics|mesh-ancestor
43758459|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758460|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758461|NCT02454868|Analgesics|analgesics|mesh-ancestor
43758462|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
43758463|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758465|NCT02454764|Tenofovir|tenofovir|mesh-list
43758487|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43758488|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43758489|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
43758490|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
43758491|NCT02454712|Naltrexone|naltrexone|mesh-list
43758492|NCT02454712|Oxycodone|oxycodone|mesh-list
43758493|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758494|NCT02454712|Narcotics|narcotics|mesh-ancestor
43758495|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758496|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758497|NCT02454712|Analgesics|analgesics|mesh-ancestor
43758498|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
43758499|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758500|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43758501|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43758502|NCT02454491|Verapamil|verapamil|mesh-list
43758503|NCT02454491|Heparin|heparin|mesh-list
43758504|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
43574711|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
43574712|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43574713|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574715|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
43574716|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574717|NCT03513874|Metformin|metformin|mesh-list
43574719|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574720|NCT03513822|Midazolam|midazolam|mesh-list
43574721|NCT03513822|Ketamine|ketamine|mesh-list
43574722|NCT03513822|Analgesics|analgesics|mesh-ancestor
43574723|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
43574724|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574725|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574726|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43574727|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43574728|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
43574729|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
43574730|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574731|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43751331|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751332|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751333|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758511|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43758512|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758513|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
43758514|NCT02454504|Neostigmine|neostigmine|mesh-list
43758515|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43758516|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758517|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758518|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
43758519|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758520|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758521|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43758522|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
43574732|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43574733|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574734|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574735|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43574736|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43574737|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43574738|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43574739|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574740|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
43574741|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
43574742|NCT03513601|Rituximab|rituximab|mesh-list
43574743|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43574744|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574745|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
43574761|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574763|NCT03513484|Nintedanib|nintedanib|mesh-list
43574764|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43574765|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
43574766|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574767|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574768|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574769|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43574770|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43574771|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574772|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43574773|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574774|NCT03513432|Ethanol|ethanol|mesh-list
43574775|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43574776|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574777|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574778|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574779|NCT03513393|Velpatasvir|velpatasvir|mesh-list
43574780|NCT03513393|Omeprazole|omeprazole|mesh-list
43574781|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43574782|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43574783|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43574784|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758523|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758524|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43758526|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758527|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758528|NCT02454426|Vortioxetine|vortioxetine|mesh-list
43758529|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
43758530|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43758531|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43758532|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43758533|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758534|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758535|NCT02454426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43758536|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43758537|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43758538|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758539|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758540|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
43758541|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43758542|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43758543|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43758544|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43758545|NCT02454348|Vasopressins|vasopressins|mesh-list
43758546|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
43758547|NCT02454348|Norepinephrine|norepinephrine|mesh-list
43758548|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43758549|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43758550|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
43758551|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758567|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
43758568|NCT02454205|Bedaquiline|bedaquiline|mesh-list
43758569|NCT02454205|Ethionamide|ethionamide|mesh-list
43758570|NCT02454205|Kanamycin|kanamycin|mesh-list
43758571|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43758572|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758573|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43758574|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43758575|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758576|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574796|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
43574797|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574798|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43574799|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43574800|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574801|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574802|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574803|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43574804|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43574805|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
43574806|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43574810|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43574811|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43574812|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43574813|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43574814|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43574815|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43574816|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574817|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574818|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574819|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758593|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43758594|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43758595|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
43758596|NCT02454088|Hormones|hormones|mesh-ancestor
43574847|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43574848|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43574849|NCT03512860|Valproic Acid|valproic acid|mesh-list
43574850|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
43574851|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574852|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574853|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
43574854|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574855|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574856|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
43574857|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43574858|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574866|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
43574867|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574868|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43574869|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43574870|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43574871|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43574872|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43574873|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43574874|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43574875|NCT03512574|Pregabalin|pregabalin|mesh-list
43574876|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
43574878|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574880|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43758597|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758598|NCT02453867|Tacrolimus|tacrolimus|mesh-list
43758599|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758600|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
43758601|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758602|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43758603|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758604|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758605|NCT02453932|Donepezil|donepezil|mesh-list
43758606|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43758607|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562938|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43758608|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758609|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
43758610|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758611|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758612|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
43758613|NCT02453698|Methylphenidate|methylphenidate|mesh-list
43758614|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43758615|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758616|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43758617|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43574881|NCT03512574|Analgesics|analgesics|mesh-ancestor
43574882|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
43574883|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574884|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43574885|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43574886|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43574887|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574888|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574889|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574890|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
43574891|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43574892|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574893|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43574894|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43574895|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43574896|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574897|NCT03512548|Itraconazole|itraconazole|mesh-list
43574898|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
43574899|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574900|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43574901|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43574902|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574903|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574904|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43574905|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
43849069|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
43758618|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43758629|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
43758630|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758631|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758632|NCT02453893|Risperidone|risperidone|mesh-list
43758633|NCT02453893|Iloperidone|iloperidone|mesh-list
43758634|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43758635|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
43758636|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758637|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758638|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758639|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43758640|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43758641|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758642|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43758644|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
43758645|NCT02453776|Infliximab|infliximab|mesh-list
43758646|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
43758647|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43758648|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758649|NCT02453607|Infliximab|infliximab|mesh-list
43758650|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
43758651|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43758652|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43837174|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837175|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43837176|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43837177|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837178|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43837179|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
43837180|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837181|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43837182|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43837183|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43837184|NCT04925505|Anesthetics|anesthetics|mesh-list
43837185|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837186|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837187|NCT04925076|Ethanol|ethanol|mesh-list
43837188|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43837189|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837190|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837191|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837192|NCT04924257|Esketamine|esketamine|mesh-list
43837193|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
43837194|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837195|NCT04924062|Gemcitabine|gemcitabine|mesh-list
43837196|NCT04924062|Cisplatin|cisplatin|mesh-list
43837197|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
43837198|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837199|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43837200|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
43837201|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837202|NCT04924062|Antiviral Agents|antiviral agents|mesh-ancestor
43837203|NCT04924062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837204|NCT04924062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758653|NCT02453529|Nafithromycin|nafithromycin|mesh-list
43758654|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43758655|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574921|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574922|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574923|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574924|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43574925|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43758664|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758665|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
43758666|NCT02453802|Coagulants|coagulants|mesh-ancestor
43758667|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43758668|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
43758669|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43758670|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
43758671|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758672|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
43751334|NCT02499341|Narcotics|narcotics|mesh-ancestor
43751335|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
43751336|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751337|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751338|NCT02498977|Cyclosporine|cyclosporine|mesh-list
43751339|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
43751340|NCT02498977|Azathioprine|azathioprine|mesh-list
43751341|NCT02498977|Tacrolimus|tacrolimus|mesh-list
43751342|NCT02498977|Cyclosporins|cyclosporins|mesh-list
43751343|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43751344|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
43751345|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751346|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43751347|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751348|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751358|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
43758673|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
43758674|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43758675|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43758676|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43758677|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43758678|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758679|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758680|NCT02453516|Epinephrine|epinephrine|mesh-list
43758681|NCT02453516|Ropivacaine|ropivacaine|mesh-list
43758682|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
43758683|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
43758684|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758687|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758688|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43758689|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43758690|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
43758691|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758692|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758693|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43758698|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
43758699|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
43758700|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43758701|NCT02453503|Triamcinolone|triamcinolone|mesh-list
43758702|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43758703|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43758704|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43758705|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751359|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43751361|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43751362|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751363|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43751364|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751365|NCT02498860|Cisplatin|cisplatin|mesh-list
43751366|NCT02498860|Pemetrexed|pemetrexed|mesh-list
43751367|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751368|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758706|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
43758708|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758709|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758710|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758711|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
43758712|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758713|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758714|NCT02453490|Fluorouracil|fluorouracil|mesh-list
43758715|NCT02453490|Raltitrexed|raltitrexed|mesh-list
43758716|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
43758717|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758718|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43758719|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758720|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758721|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
43758722|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758723|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43758724|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758726|NCT02453464|Irinotecan|irinotecan|mesh-list
43758727|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43758728|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43758729|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758730|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758731|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758732|NCT02453464|Antidotes|antidotes|mesh-ancestor
43758733|NCT02453464|Protective Agents|protective agents|mesh-ancestor
43574926|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43758734|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758735|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
43758747|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758748|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43758749|NCT02453087|Rituximab|rituximab|mesh-list
43758750|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
43758751|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43574927|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43574928|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43574929|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43574930|NCT03511833|Ketamine|ketamine|mesh-list
43574931|NCT03511833|Morphine|morphine|mesh-list
43574932|NCT03511833|Analgesics|analgesics|mesh-ancestor
43574933|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
43574934|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574935|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574936|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43574938|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
43574939|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
43574940|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574941|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43574942|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43574943|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574944|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574945|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43574946|NCT03511833|Narcotics|narcotics|mesh-ancestor
43574947|NCT03511820|Amphotericin B|amphotericin b|mesh-list
43751369|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751370|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43704403|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574950|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43574951|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43574952|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574953|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43574954|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
43574955|NCT03511768|Octreotide|octreotide|mesh-list
43574956|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
43574957|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43574958|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43574959|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574960|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43574961|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574962|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
43574963|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574964|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574965|NCT03511703|Apatinib|apatinib|mesh-list
43758752|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758753|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
43758754|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758755|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758756|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
43758757|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43758758|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758760|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43758761|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43758762|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43758763|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758764|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758765|NCT02452970|Gemcitabine|gemcitabine|mesh-list
43758766|NCT02452970|Cisplatin|cisplatin|mesh-list
43758798|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758800|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43758801|NCT02452775|Poly ICLC|poly iclc|mesh-list
43758802|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43758803|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
43758804|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
43758805|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758806|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43758807|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
43758808|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43758810|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43758849|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758850|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758851|NCT02452450|Acetaminophen|acetaminophen|mesh-list
43758852|NCT02452450|Ibuprofen|ibuprofen|mesh-list
43758853|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43758854|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43758855|NCT02452450|Analgesics|analgesics|mesh-ancestor
43758856|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
43758857|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758858|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758859|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43758860|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758861|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43758862|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758863|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758864|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
43758865|NCT02452281|Ipilimumab|ipilimumab|mesh-list
43758872|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
43758873|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758874|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758875|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43758876|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43758877|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
43758878|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758879|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758889|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
43758890|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
43751371|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43751372|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
43751373|NCT02498496|Analgesics|analgesics|mesh-ancestor
43758891|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758893|NCT02452151|Infliximab|infliximab|mesh-list
43758894|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
43758895|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43758896|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758897|NCT02452177|Vitamin D|vitamin d|mesh-list
43758898|NCT02452177|Vitamins|vitamins|mesh-ancestor
43758899|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
43758900|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758901|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43758902|NCT02452255|Propranolol|propranolol|mesh-list
43758903|NCT02452255|Metoprolol|metoprolol|mesh-list
43758904|NCT02452255|Fenofibrate|fenofibrate|mesh-list
43758905|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43758906|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43758907|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
43758908|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758909|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758910|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758911|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758912|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43758913|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
43758914|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
43758915|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
43758916|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758917|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43758918|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43758919|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
43758920|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43758921|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43758922|NCT02452216|Hematinics|hematinics|mesh-ancestor
43758932|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758933|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43758934|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43758935|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43758936|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758937|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
43758938|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43758939|NCT02452099|Protective Agents|protective agents|mesh-ancestor
43758940|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758941|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43758943|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758944|NCT02451956|Paclitaxel|paclitaxel|mesh-list
43758945|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43758946|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758947|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
43758948|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
43758949|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
43758950|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758951|NCT02451865|Docetaxel|docetaxel|mesh-list
43758952|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759000|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759001|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43759002|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
43759003|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43759004|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43759006|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759007|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
43759008|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759009|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43759010|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759011|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
43759012|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759013|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43759018|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43759019|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43759020|NCT02451748|Analgesics|analgesics|mesh-ancestor
43759021|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
43751374|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
43751375|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751376|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751377|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
43751378|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751379|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43751380|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
43751381|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43751382|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43751383|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751384|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43751385|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
43830976|NCT05334277|Carboplatin|carboplatin|mesh-list
43759022|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759023|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
43759024|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43759025|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837205|NCT04924062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574975|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574976|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574977|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
43574978|NCT03511391|Nivolumab|nivolumab|mesh-list
43574979|NCT03511391|Atezolizumab|atezolizumab|mesh-list
43574980|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43574981|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43574982|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574983|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574984|NCT03511261|Curcumin|curcumin|mesh-list
43574985|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43574986|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43574987|NCT03511261|Analgesics|analgesics|mesh-ancestor
43574988|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
43759037|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759038|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759039|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
43759040|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759041|NCT02451579|Cetirizine|cetirizine|mesh-list
43759042|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
43759043|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43759044|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43759045|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43759046|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
43759047|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574995|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574996|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
43574997|NCT03511222|Nivolumab|nivolumab|mesh-list
43574998|NCT03511222|Vorolanib|vorolanib|mesh-list
43574999|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43575000|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575001|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43575002|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575003|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43575004|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575005|NCT03511183|Bevacizumab|bevacizumab|mesh-list
43575006|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43575007|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575008|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43575009|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43751386|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43751387|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
43751388|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43751389|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
43751390|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751391|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572496|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
43572497|NCT00004231|Aldesleukin|aldesleukin|mesh-list
43572498|NCT00004231|Prednisone|prednisone|mesh-list
43572499|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
43572500|NCT00004231|Busulfan|busulfan|mesh-list
43572501|NCT00004231|Doxorubicin|doxorubicin|mesh-list
43572502|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43575010|NCT03511183|Growth Substances|growth substances|mesh-ancestor
43575011|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575012|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
43575013|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43575014|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
43575015|NCT03510975|Coagulants|coagulants|mesh-ancestor
43575016|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43575017|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
43575018|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575019|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
43575020|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43575021|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575022|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
43575024|NCT03510871|Ipilimumab|ipilimumab|mesh-list
43575025|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43575026|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575027|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43575028|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575029|NCT03510793|Anesthetics|anesthetics|mesh-list
43575030|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759053|NCT02451475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43759054|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43759055|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43759056|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759057|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759058|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
43759059|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759060|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43759061|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
43759062|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43759063|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43759064|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43759065|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759084|NCT02451293|Melatonin|melatonin|mesh-list
43759085|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
43575031|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575032|NCT03510611|Ensartinib|ensartinib|mesh-list
43759086|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759087|NCT02451293|Protective Agents|protective agents|mesh-ancestor
43759088|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759089|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759091|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43759092|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
43759093|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759094|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43563464|NCT01235754|Hormones|hormones|mesh-ancestor
43759095|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43759096|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
43759097|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759098|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759099|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43759100|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43759101|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43759103|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759104|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759105|NCT02450994|Dexamethasone|dexamethasone|mesh-list
43759106|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759107|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
43759108|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
43759109|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759110|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759111|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43759112|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
43759113|NCT02450994|Hormones|hormones|mesh-ancestor
43759114|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759115|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43759136|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759137|NCT02451098|Atorvastatin|atorvastatin|mesh-list
43759138|NCT02451098|Ezetimibe|ezetimibe|mesh-list
43759139|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43759140|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43759141|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
43759142|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759143|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43759144|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43759145|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575033|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575034|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43575035|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575036|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575037|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43575038|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43575039|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575040|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575041|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575042|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575043|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575044|NCT03510533|Autoantibodies|autoantibodies|mesh-list
43575045|NCT03510533|alpha-MSH|alpha-msh|mesh-list
43575046|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
43575047|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575048|NCT03510533|Hormones|hormones|mesh-ancestor
43575049|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575050|NCT03510416|Apatinib|apatinib|mesh-list
43575051|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759147|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43759148|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759241|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759242|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43759243|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759244|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759245|NCT02450084|Fentanyl|fentanyl|mesh-list
43759246|NCT02450084|Ropivacaine|ropivacaine|mesh-list
43759247|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
43759248|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
43759249|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759250|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759251|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
43759279|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43759280|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759282|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43759385|NCT02449655|Paclitaxel|paclitaxel|mesh-list
43759386|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43759482|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43759483|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43759484|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759485|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759486|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
43759487|NCT02449252|Hormones|hormones|mesh-ancestor
43759501|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759502|NCT02449278|Prednisone|prednisone|mesh-list
43759503|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
43759504|NCT02449278|Doxorubicin|doxorubicin|mesh-list
43759505|NCT02449278|Vincristine|vincristine|mesh-list
43759506|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759507|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
43759508|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759509|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759510|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43759511|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
43759512|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759513|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759514|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43759515|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43759516|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43759517|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43759518|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759552|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43759553|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
43575067|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43575068|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43575069|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575070|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575071|NCT03510338|Urological Agents|urological agents|mesh-ancestor
43575072|NCT03510325|Olanzapine|olanzapine|mesh-list
43575073|NCT03510325|Risperidone|risperidone|mesh-list
43575074|NCT03510325|Aripiprazole|aripiprazole|mesh-list
43575075|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43575076|NCT03510325|Amisulpride|amisulpride|mesh-list
43575077|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43575078|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
43575079|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575080|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575081|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575082|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43575083|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43575084|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575085|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43575086|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43575087|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
43759579|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759580|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43759582|NCT02448316|Hormones|hormones|mesh-ancestor
43759583|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759584|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43759585|NCT02448316|Protective Agents|protective agents|mesh-ancestor
43759586|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43759587|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759589|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759590|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759592|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759593|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759594|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759595|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759596|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759597|NCT02448251|Abivertinib|abivertinib|mesh-list
43759754|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759755|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43759756|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43759758|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759759|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43759766|NCT02447380|Docetaxel|docetaxel|mesh-list
43759767|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759768|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759769|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759770|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759771|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759772|NCT02447315|Pilocarpine|pilocarpine|mesh-list
43759773|NCT02447315|Miotics|miotics|mesh-ancestor
43759774|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
43759775|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759776|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575164|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
43575165|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575166|NCT03509688|Entecavir|entecavir|mesh-list
43575167|NCT03509688|Resveratrol|resveratrol|mesh-list
43575168|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
43575169|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575170|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
43575171|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575172|NCT03509688|Protective Agents|protective agents|mesh-ancestor
43575173|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575174|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575175|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43575176|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
43575177|NCT03509662|Thiamine|thiamine|mesh-list
43575179|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
43575180|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575181|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
43759780|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759781|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759782|NCT02447224|Metronidazole|metronidazole|mesh-list
43759783|NCT02447224|Ertapenem|ertapenem|mesh-list
43759784|NCT02447224|Cefdinir|cefdinir|mesh-list
43759785|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759786|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43759787|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43759788|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43759789|NCT02447211|Doxepin|doxepin|mesh-list
43759790|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43759791|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43759792|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759793|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759794|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43759795|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
43759796|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43759797|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
43759798|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
43759799|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759800|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759801|NCT02447185|Triamcinolone|triamcinolone|mesh-list
43759802|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43759803|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43759804|NCT02447185|Ranibizumab|ranibizumab|mesh-list
43759805|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43759806|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43759807|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43759808|NCT02447185|Growth Substances|growth substances|mesh-ancestor
43759809|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575182|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575183|NCT03509662|Protective Agents|protective agents|mesh-ancestor
43759875|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759877|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43759878|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759879|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43759880|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759881|NCT02446730|Clopidogrel|clopidogrel|mesh-list
43759882|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43759886|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
43759887|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759888|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759889|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759890|NCT02446652|Paclitaxel|paclitaxel|mesh-list
43759891|NCT02446652|Carboplatin|carboplatin|mesh-list
43759892|NCT02446652|Hydralazine|hydralazine|mesh-list
43759893|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43759894|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575196|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575197|NCT03509298|Antibodies|antibodies|mesh-list
43575198|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43575199|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
43575200|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575201|NCT03509285|Cenobamate|cenobamate|mesh-list
43575202|NCT03509285|Alprazolam|alprazolam|mesh-list
43575203|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43575204|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575205|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575206|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43575207|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43575208|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43575209|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
43575210|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
43575211|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575212|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575213|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
43575214|NCT03509246|Doxorubicin|doxorubicin|mesh-list
43575215|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43575216|NCT03509246|Bortezomib|bortezomib|mesh-list
43575217|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43575218|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575219|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43575220|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43575221|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575222|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575223|NCT03509168|Misoprostol|misoprostol|mesh-list
43575224|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43575225|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
43575226|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43575227|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575228|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43575229|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43575230|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
43575231|NCT03509142|Sirolimus|sirolimus|mesh-list
43575232|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43575233|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575234|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43575235|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759895|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759896|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759897|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759898|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759899|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43759900|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
43759901|NCT02446782|Clindamycin|clindamycin|mesh-list
43759902|NCT02446782|Cefazolin|cefazolin|mesh-list
43759903|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43759904|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759905|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43759906|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564315|NCT01098435|ALKS-33|alks-33|mesh-list
43759907|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759908|NCT02446795|Sunitinib|sunitinib|mesh-list
43759909|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759910|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43759911|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43759912|NCT02446795|Growth Substances|growth substances|mesh-ancestor
43759913|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759914|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
43759930|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759932|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43759933|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759934|NCT02446548|Losartan|losartan|mesh-list
43759935|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43759936|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43751392|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43751393|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
43751394|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43751396|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751397|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751398|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43751399|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
43751400|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
43751401|NCT02498535|Protective Agents|protective agents|mesh-ancestor
43751402|NCT02498457|Calcium|calcium|mesh-list
43751403|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43759937|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43759938|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43759939|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759941|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
43759942|NCT02446431|Bevacizumab|bevacizumab|mesh-list
43759943|NCT02446431|Valproic Acid|valproic acid|mesh-list
43759944|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759945|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
43759946|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759947|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759948|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43575326|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
43575327|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43575328|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43575329|NCT03508440|Prednisone|prednisone|mesh-list
43575330|NCT03508440|Prednisolone|prednisolone|mesh-list
43575331|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575332|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
43575333|NCT03508440|Hormones|hormones|mesh-ancestor
43575334|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575335|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575336|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43575337|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575338|NCT03508102|Remifentanil|remifentanil|mesh-list
43575339|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43575340|NCT03508102|Narcotics|narcotics|mesh-ancestor
43575341|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575342|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575343|NCT03508102|Analgesics|analgesics|mesh-ancestor
43575344|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
43575345|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575346|NCT03507842|Cytarabine|cytarabine|mesh-list
43575347|NCT03507842|Daunorubicin|daunorubicin|mesh-list
43575348|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43575349|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
43760071|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43760072|NCT02445599|Dipyrone|dipyrone|mesh-list
43760073|NCT02445599|Diclofenac|diclofenac|mesh-list
43760074|NCT02445599|Atropine|atropine|mesh-list
43760075|NCT02445599|Fentanyl|fentanyl|mesh-list
43760076|NCT02445599|Midazolam|midazolam|mesh-list
43760077|NCT02445599|Tramadol|tramadol|mesh-list
43760120|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
43760121|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
43760122|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43760123|NCT02445716|Androgens|androgens|mesh-ancestor
43575416|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
43575417|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43575418|NCT03507556|Protective Agents|protective agents|mesh-ancestor
43575419|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575420|NCT03507465|Capecitabine|capecitabine|mesh-list
43575421|NCT03507465|Letrozole|letrozole|mesh-list
43575422|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43575423|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
43751404|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751405|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
43575424|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575425|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575426|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43575427|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43575428|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575429|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43575430|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
43575431|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575432|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575434|NCT03507426|Analgesics|analgesics|mesh-ancestor
43575435|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
43575436|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575437|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575438|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43575439|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43575440|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
43575481|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575482|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575483|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43575484|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
43575485|NCT03507244|Hormones|hormones|mesh-ancestor
43575486|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575487|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43575488|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575489|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575490|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575491|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43575492|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43760175|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760176|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43760177|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760178|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43760179|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43760180|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43760181|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
43760182|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
43760183|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
43760185|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
43760186|NCT02445066|Vitamins|vitamins|mesh-ancestor
43760187|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
43760188|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760189|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43760190|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43760191|NCT02444949|Cisplatin|cisplatin|mesh-list
43760192|NCT02444949|Endostar protein|endostar protein|mesh-list
43760193|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760194|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43760195|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43575493|NCT03507166|Trastuzumab|trastuzumab|mesh-list
43575494|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43575495|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575496|NCT03507127|Varenicline|varenicline|mesh-list
43575497|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43760198|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
43760200|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43760201|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760202|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760203|NCT02444767|Bimatoprost|bimatoprost|mesh-list
43564602|NCT01012895|Interferons|interferons|mesh-list
43760204|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43760205|NCT02444897|Fentanyl|fentanyl|mesh-list
43760206|NCT02444897|Nefopam|nefopam|mesh-list
43760207|NCT02444897|Ramosetron|ramosetron|mesh-list
43760208|NCT02444897|Ropivacaine|ropivacaine|mesh-list
43760209|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
43760210|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
43760211|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760212|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760213|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
43760214|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751406|NCT02498509|Levocabastine|levocabastine|mesh-list
43751407|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751408|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
43760215|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43760216|NCT02444897|Narcotics|narcotics|mesh-ancestor
43760217|NCT02444897|Analgesics|analgesics|mesh-ancestor
43760246|NCT02444507|Esomeprazole|esomeprazole|mesh-list
43760247|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43760248|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760249|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43760250|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760251|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760252|NCT02444481|Polymyxins|polymyxins|mesh-list
43760253|NCT02444481|Neomycin|neomycin|mesh-list
43760254|NCT02444481|Nystatin|nystatin|mesh-list
43760255|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43760256|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760257|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43760258|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760259|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760261|NCT02444481|Ionophores|ionophores|mesh-ancestor
43760262|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760266|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43760267|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760269|NCT02444559|Ropivacaine|ropivacaine|mesh-list
43760270|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
43760271|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
43760272|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760273|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760274|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
43760275|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760276|NCT02444559|Analgesics|analgesics|mesh-ancestor
43760277|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43760278|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
43564660|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
43760279|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
43760280|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43760281|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43760282|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43760283|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760284|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760285|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760286|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
43575583|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
43575584|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575585|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575586|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575587|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43575588|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43837323|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
43837324|NCT04915248|Bortezomib|bortezomib|mesh-list
43837325|NCT04915248|Daratumumab|daratumumab|mesh-list
43837326|NCT04915248|BB 1101|bb 1101|mesh-list
43837327|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43837328|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837329|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
43837330|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
43837331|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837332|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837333|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837334|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
43837335|NCT04915248|Hormones|hormones|mesh-ancestor
43837336|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837337|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43575589|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575590|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575591|NCT03506620|Ropivacaine|ropivacaine|mesh-list
43575592|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
43575593|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
43575594|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575595|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575685|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575686|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43575687|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
43575688|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43575689|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
43575690|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
43575691|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837346|NCT04914676|Cytarabine|cytarabine|mesh-list
43837347|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43837348|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
43837349|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837350|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837351|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
43837352|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837353|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837354|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
43837355|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837356|NCT04914195|Leuprolide|leuprolide|mesh-list
43837357|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43760294|NCT03608163|Diazoxide|diazoxide|mesh-list
43760295|NCT03608163|Naloxone|naloxone|mesh-list
43760296|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43760297|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760298|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
43760299|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760300|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43760301|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
43760302|NCT03512197|Midostaurin|midostaurin|mesh-list
43760303|NCT03512197|Staurosporine|staurosporine|mesh-list
43760304|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760305|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43760306|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760307|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760308|NCT03471611|Lenograstim|lenograstim|mesh-list
43760309|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760310|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
43760311|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760312|NCT03388788|CGP 12177|cgp 12177|mesh-list
43760353|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760354|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43760355|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
43760356|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760357|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760358|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43760359|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43760360|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
43760361|NCT03099486|Leucovorin|leucovorin|mesh-list
43760362|NCT03099486|Antidotes|antidotes|mesh-ancestor
43760363|NCT03099486|Protective Agents|protective agents|mesh-ancestor
43760364|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575706|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575707|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
43575708|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43575709|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43575761|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
43575762|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575763|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575764|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
43760365|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
43760366|NCT03099486|Vitamins|vitamins|mesh-ancestor
43760367|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
43575777|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575778|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575779|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575781|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
43575782|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
43575783|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575784|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575785|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
43575786|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575787|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
43575788|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43751409|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43751410|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43751411|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43751412|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
43751413|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
43751414|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751415|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751416|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751417|NCT02498301|Rifaximin|rifaximin|mesh-list
43575789|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43575790|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
43575791|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575792|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43575793|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43575794|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43575795|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760407|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
43760408|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760409|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760410|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760411|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43760412|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43760413|NCT02532257|Growth Substances|growth substances|mesh-ancestor
43760414|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
43760415|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
43760416|NCT02317783|Flutemetamol|flutemetamol|mesh-list
43760417|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
43760418|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760419|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
43760420|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575855|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575856|NCT03504345|Progesterone|progesterone|mesh-list
43575857|NCT03504345|Progestins|progestins|mesh-ancestor
43575858|NCT03504345|Hormones|hormones|mesh-ancestor
43575859|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575860|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575861|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
43575862|NCT03504280|Vitamin D|vitamin d|mesh-list
43575863|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43575864|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575865|NCT03504280|Vitamins|vitamins|mesh-ancestor
43575866|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
43575867|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43575868|NCT03504202|Trimetazidine|trimetazidine|mesh-list
43575869|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
43575872|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43575875|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
43575889|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43575891|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
43575892|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575893|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575894|NCT03503994|Beclomethasone|beclomethasone|mesh-list
43575895|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575896|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
43575897|NCT03503994|Hormones|hormones|mesh-ancestor
43575898|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751418|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43849062|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
43572503|NCT00004231|Methotrexate|methotrexate|mesh-list
43572504|NCT00004231|Vincristine|vincristine|mesh-list
43572505|NCT00004231|Teniposide|teniposide|mesh-list
43572506|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
43572507|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572508|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
43572509|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572512|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
43572513|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572514|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575899|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575900|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43575901|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
43575902|NCT03503786|Paclitaxel|paclitaxel|mesh-list
43575903|NCT03503786|Carboplatin|carboplatin|mesh-list
43575904|NCT03503786|Avelumab|avelumab|mesh-list
43575905|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43575906|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575907|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
43575908|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
43575909|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
43575910|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575911|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43575912|NCT03503604|Leucovorin|leucovorin|mesh-list
43575913|NCT03503604|Gemcitabine|gemcitabine|mesh-list
43575914|NCT03503604|Paclitaxel|paclitaxel|mesh-list
43575915|NCT03503604|Carboplatin|carboplatin|mesh-list
43575916|NCT03503604|Fluorouracil|fluorouracil|mesh-list
43575917|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
43575918|NCT03503604|Irinotecan|irinotecan|mesh-list
43575919|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43575920|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760437|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760438|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760439|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
43760440|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760441|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
43760442|NCT01336530|Oxethazaine|oxethazaine|mesh-list
43760454|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
43760455|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760456|NCT01194622|Fluticasone|fluticasone|mesh-list
43760459|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760460|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43760461|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
43760462|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575921|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
43575922|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
43575923|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
43575924|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575925|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43575926|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
43575927|NCT03503604|Antiviral Agents|antiviral agents|mesh-ancestor
43575928|NCT03503604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575929|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575930|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43575931|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
43575932|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575933|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43575934|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43575935|NCT03503604|Antidotes|antidotes|mesh-ancestor
43575936|NCT03503604|Protective Agents|protective agents|mesh-ancestor
43575937|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
43575938|NCT03503604|Vitamins|vitamins|mesh-ancestor
43572515|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572516|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43572517|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572518|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572519|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572520|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43572521|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
43751419|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575939|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
43575940|NCT03503227|Aspirin|aspirin|mesh-list
43575941|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
43575942|NCT03503227|Prednisolone|prednisolone|mesh-list
43575943|NCT03503227|Salicylates|salicylates|mesh-list
43575944|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575945|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
43575946|NCT03503227|Hormones|hormones|mesh-ancestor
43575947|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760463|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760464|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43760465|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
43760466|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
43760467|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43760468|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43760469|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760470|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760471|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43760472|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43760473|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
43760474|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
43760475|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760476|NCT01190852|Fluticasone|fluticasone|mesh-list
43760477|NCT01190852|Azelastine|azelastine|mesh-list
43760478|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760479|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43760480|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
43760481|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760487|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43760488|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760489|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760490|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43760491|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43760493|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
43760507|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760508|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760509|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760510|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43760512|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760513|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43760514|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
43760517|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43760518|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760519|NCT00777127|Analgesics|analgesics|mesh-ancestor
43760520|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
43760521|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760522|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760523|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575948|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575949|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43575960|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43575961|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43575962|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575963|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575964|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43575965|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43575966|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43575968|NCT03503201|Chromium|chromium|mesh-list
43575969|NCT03503201|Trace Elements|trace elements|mesh-ancestor
43575970|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
43575971|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575972|NCT03503136|Cisplatin|cisplatin|mesh-list
43575973|NCT03503136|Docetaxel|docetaxel|mesh-list
43575974|NCT03503136|Fluorouracil|fluorouracil|mesh-list
43575975|NCT03503136|Capecitabine|capecitabine|mesh-list
43575976|NCT03503136|Nedaplatin|nedaplatin|mesh-list
43575977|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575978|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
43575979|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
43575980|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
43575981|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575982|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
43575983|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43575984|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43575985|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
43575986|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575987|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43575988|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575989|NCT03502889|Ropivacaine|ropivacaine|mesh-list
43575990|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
43575991|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
43575992|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575993|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575994|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
43575995|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575996|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
43760524|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760525|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43760526|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760527|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760528|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760529|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
43760535|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760536|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575997|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43575998|NCT03502642|Morphine|morphine|mesh-list
43575999|NCT03502642|Ropivacaine|ropivacaine|mesh-list
43576000|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
43576001|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576002|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576003|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43576004|NCT03502642|Narcotics|narcotics|mesh-ancestor
43576005|NCT03502642|Analgesics|analgesics|mesh-ancestor
43576006|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
43576007|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576008|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
43576009|NCT03502551|Ketamine|ketamine|mesh-list
43576010|NCT03502551|Analgesics|analgesics|mesh-ancestor
43576011|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
43576012|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576013|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576014|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43576015|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43576016|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
43576017|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
43576018|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576019|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43576020|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43576021|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576022|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576023|NCT03502434|Petrolatum|petrolatum|mesh-list
43576024|NCT03502434|Emollients|emollients|mesh-ancestor
43576025|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
43576026|NCT03502421|Ketamine|ketamine|mesh-list
43576027|NCT03502421|Analgesics|analgesics|mesh-ancestor
43576028|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
43576029|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576030|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576031|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43576032|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43830977|NCT05334277|Pemetrexed|pemetrexed|mesh-list
43830978|NCT05334277|Aflutinib|aflutinib|mesh-list
43830979|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830980|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830981|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43830982|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43830983|NCT05334277|Growth Substances|growth substances|mesh-ancestor
43830984|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830985|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
43576033|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
43576034|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
43576035|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576036|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43576037|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43576038|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576039|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576040|NCT03502395|Lidocaine|lidocaine|mesh-list
43576041|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
43576042|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
43576043|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760538|NCT00591227|Insulin|insulin|mesh-list
43760539|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43760540|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
43760541|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
43760542|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43760543|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760544|NCT00492999|Leucovorin|leucovorin|mesh-list
43760545|NCT00492999|Dexamethasone|dexamethasone|mesh-list
43760546|NCT00492999|Fluorouracil|fluorouracil|mesh-list
43760547|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
43760548|NCT00492999|Irinotecan|irinotecan|mesh-list
43760549|NCT00492999|Floxuridine|floxuridine|mesh-list
43760550|NCT00492999|Calcium|calcium|mesh-list
43760551|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
43760552|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760553|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
43760554|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
43760555|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760556|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760562|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760563|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43760564|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
43760565|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760566|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43751420|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751421|NCT02498288|Isotretinoin|isotretinoin|mesh-list
43751422|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
43751423|NCT02498171|Fentanyl|fentanyl|mesh-list
43751424|NCT02498171|Morphine|morphine|mesh-list
43751425|NCT02498171|Bupivacaine|bupivacaine|mesh-list
43751426|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
43760567|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760568|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
43760569|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43760570|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43760571|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760572|NCT00492999|Antidotes|antidotes|mesh-ancestor
43760573|NCT00492999|Protective Agents|protective agents|mesh-ancestor
43760574|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
43576045|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
43576046|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576047|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43760576|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
43760577|NCT00408473|Flecainide|flecainide|mesh-list
43760578|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43760579|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43760580|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43760581|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760582|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576048|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43576049|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43576050|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576051|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576052|NCT03502356|Azithromycin|azithromycin|mesh-list
43576053|NCT03502356|Cefazolin|cefazolin|mesh-list
43576054|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43576055|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576056|NCT03502343|Gemcitabine|gemcitabine|mesh-list
43576057|NCT03502343|Paclitaxel|paclitaxel|mesh-list
43576058|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43576059|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576060|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
43576061|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
43576062|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
43576063|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576064|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43576065|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
43576066|NCT03502343|Antiviral Agents|antiviral agents|mesh-ancestor
43576067|NCT03502343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576068|NCT03502343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576069|NCT03502343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43576070|NCT03502343|Immunologic Factors|immunologic factors|mesh-ancestor
43576071|NCT03502343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576072|NCT03502135|Phenylephrine|phenylephrine|mesh-list
43576073|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
43576074|NCT03502135|Tetracaine|tetracaine|mesh-list
43576075|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
43576076|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
43576077|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576078|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576079|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
43576080|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576081|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43576082|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43576083|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
43576084|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576085|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576086|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
43576087|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
43576088|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
43576097|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43576099|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576100|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43576101|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43751427|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
43751428|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751429|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751430|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
43751431|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751432|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43751433|NCT02498171|Narcotics|narcotics|mesh-ancestor
43751434|NCT02498171|Analgesics|analgesics|mesh-ancestor
43751435|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43751436|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43751437|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
43751438|NCT02498145|Nicotine|nicotine|mesh-list
43751439|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43751440|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
43751441|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751442|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576102|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576103|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576104|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43760583|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
43760584|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
43760585|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760586|NCT00328601|Protective Agents|protective agents|mesh-ancestor
43760587|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760588|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
43760589|NCT00328601|Vitamins|vitamins|mesh-ancestor
43760590|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
43760591|NCT00294320|Imiquimod|imiquimod|mesh-list
43760592|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760593|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
43760594|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760595|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760596|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
43760597|NCT00189319|Flecainide|flecainide|mesh-list
43760598|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43576105|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43576106|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43576107|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576108|NCT03501680|Insulin|insulin|mesh-list
43576109|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43576110|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576111|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
43576112|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576113|NCT03501459|Rituximab|rituximab|mesh-list
43576114|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43576115|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576116|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
43576117|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576118|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576119|NCT03501433|Niacinamide|niacinamide|mesh-list
43576121|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
43576122|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
43576123|NCT03501433|Vitamins|vitamins|mesh-ancestor
43576124|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
43576125|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576126|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43576127|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
43576128|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576129|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43576130|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
43576131|NCT03501251|Albendazole|albendazole|mesh-list
43576132|NCT03501251|Moxidectin|moxidectin|mesh-list
43751443|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43751444|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43751445|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
43751446|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43572522|NCT00004231|Hormones|hormones|mesh-ancestor
43572523|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43572524|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43572525|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43572526|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
43572527|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43572528|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43572529|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
43576133|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
43576134|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43576135|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576136|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
43576137|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43576138|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43576139|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
43576140|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
43576141|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
43576142|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760607|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760608|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
43760610|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760611|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
43760612|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760613|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760614|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
43760615|NCT00189254|Imiquimod|imiquimod|mesh-list
43760616|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760619|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760620|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
43760622|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760623|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
43760624|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760625|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760626|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
43760627|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
43760628|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760644|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43760645|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43760646|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43760647|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760648|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760649|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
43760650|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760651|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760652|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43760653|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760654|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
43760655|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760656|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
43760657|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760658|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760659|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43760660|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
43760661|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760662|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760663|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43760665|NCT02444260|Midazolam|midazolam|mesh-list
43576155|NCT03500900|Vildagliptin|vildagliptin|mesh-list
43576156|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43576157|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760678|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760679|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760680|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
43760681|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
43760682|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760683|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43760684|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43760685|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43576158|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43576159|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
43576160|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576161|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576162|NCT03500874|Leucovorin|leucovorin|mesh-list
43576163|NCT03500874|Fluorouracil|fluorouracil|mesh-list
43576164|NCT03500874|Floxuridine|floxuridine|mesh-list
43576165|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
43576166|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
43576167|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576168|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43576170|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43576172|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576173|NCT03500874|Antidotes|antidotes|mesh-ancestor
43576174|NCT03500874|Protective Agents|protective agents|mesh-ancestor
43576175|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
43576177|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
43576178|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
43576179|NCT03500848|Sirolimus|sirolimus|mesh-list
43576180|NCT03500848|Tacrolimus|tacrolimus|mesh-list
43576181|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43576182|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
43576183|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576184|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43576185|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576186|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576187|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43576188|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576189|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43576190|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
43576191|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43576192|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576193|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
43576195|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43576196|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
43576197|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576198|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576199|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43576200|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
43576201|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43576202|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
43576203|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576204|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576205|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43576206|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
43576207|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
43576208|NCT03500783|Protective Agents|protective agents|mesh-ancestor
43576209|NCT03500653|Curcumin|curcumin|mesh-list
43576210|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43576211|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43576212|NCT03500653|Analgesics|analgesics|mesh-ancestor
43576213|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
43576214|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760686|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760687|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
43760688|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760689|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
43760690|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760691|NCT02443727|Oxytocin|oxytocin|mesh-list
43760692|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
43760693|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43572530|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
43572531|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43572532|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572533|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
43572534|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760694|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760695|NCT02443818|Sirolimus|sirolimus|mesh-list
43760696|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43760697|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760698|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43760699|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760700|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
43760701|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760702|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
43760703|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760704|NCT02444013|Folic Acid|folic acid|mesh-list
43760705|NCT02444013|Uric Acid|uric acid|mesh-list
43576215|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576216|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43576217|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576218|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576219|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576220|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576221|NCT03500445|Dexamethasone|dexamethasone|mesh-list
43576222|NCT03500445|Lenalidomide|lenalidomide|mesh-list
43576223|NCT03500445|Daratumumab|daratumumab|mesh-list
43576224|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43576225|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
43576226|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
43576227|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576228|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576229|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43576230|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
43576231|NCT03500445|Hormones|hormones|mesh-ancestor
43576232|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43576233|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43576235|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
43576236|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43576237|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43576238|NCT03500445|Growth Substances|growth substances|mesh-ancestor
43576239|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
43576240|NCT03500432|Lidocaine|lidocaine|mesh-list
43576241|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
43576242|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
43576243|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576251|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576253|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43576254|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576255|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43576256|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576257|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
43576258|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760707|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
43760708|NCT02444013|Vitamins|vitamins|mesh-ancestor
43760709|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
43760710|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576265|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576267|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
43576268|NCT03500133|Cisplatin|cisplatin|mesh-list
43576269|NCT03500133|Etoposide|etoposide|mesh-list
43576270|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576271|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43576272|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
43576273|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576274|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
43576275|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576276|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43576277|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
43576278|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576279|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43576280|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572535|NCT00004231|Antidotes|antidotes|mesh-ancestor
43572536|NCT00004231|Protective Agents|protective agents|mesh-ancestor
43572537|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
43572538|NCT00004231|Vitamins|vitamins|mesh-ancestor
43572539|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
43572540|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43572541|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
43572542|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
43572543|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
43576281|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43576282|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576284|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
43576285|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
43576286|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576287|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43576288|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
43576289|NCT03500133|Hormones|hormones|mesh-ancestor
43576290|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43576291|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43576292|NCT03500133|Protective Agents|protective agents|mesh-ancestor
43576293|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
43576294|NCT03500120|Captopril|captopril|mesh-list
43576295|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43576296|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
43576297|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576298|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576299|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43576300|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43576301|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
43760722|NCT02443844|Urological Agents|urological agents|mesh-ancestor
43837358|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
43576337|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43576338|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
43576339|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43576340|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
43576341|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576342|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43576343|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
43576344|NCT03499730|Midazolam|midazolam|mesh-list
43576345|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43576346|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43576347|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576348|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576349|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43576350|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43576352|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43576353|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
43576355|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
43576356|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
43576357|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576358|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576359|NCT03499639|Ritonavir|ritonavir|mesh-list
43576360|NCT03499639|Ribavirin|ribavirin|mesh-list
43576361|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43576362|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43576363|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
43576364|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576365|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576366|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43576367|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43576368|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
43576369|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576370|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43576371|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43576372|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
43576373|NCT03499457|Amoxicillin|amoxicillin|mesh-list
43576374|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43751447|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751448|NCT02497911|Bupivacaine|bupivacaine|mesh-list
43751449|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
43751450|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
43751451|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751452|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751453|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
43576375|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576376|NCT03499444|Rucaparib|rucaparib|mesh-list
43576377|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43760723|NCT02443922|Metformin|metformin|mesh-list
43760724|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43760725|NCT02443922|Glimepiride|glimepiride|mesh-list
43760726|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43760727|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760728|NCT02443922|Incretins|incretins|mesh-ancestor
43760729|NCT02443922|Hormones|hormones|mesh-ancestor
43760730|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760731|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43760732|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
43760733|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760734|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760735|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43576416|NCT03499106|Itraconazole|itraconazole|mesh-list
43576417|NCT03499106|Praliciguat|praliciguat|mesh-list
43576418|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
43576419|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576420|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43576421|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43576422|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576423|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576424|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43576425|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
43576426|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43576427|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576428|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43576429|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43576430|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
43576431|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43576433|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
43576434|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
43576435|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576436|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
43576458|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
43760736|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760737|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
43760738|NCT02443714|Insulin|insulin|mesh-list
43760739|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43760740|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
43760741|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43760742|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760743|NCT02443545|Deferiprone|deferiprone|mesh-list
43760744|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43760745|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
43760746|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
43760747|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760748|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
43760749|NCT02443285|Cefotaxime|cefotaxime|mesh-list
43760750|NCT02443285|Cefoxitin|cefoxitin|mesh-list
43760751|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43760752|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760753|NCT02443246|Vitamin D|vitamin d|mesh-list
43760754|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
43760755|NCT02443246|Vitamins|vitamins|mesh-ancestor
43760756|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
43760757|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760758|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43576459|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43576460|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576461|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43576462|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43576463|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
43576464|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576465|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43576466|NCT03498456|Amoxicillin|amoxicillin|mesh-list
43576467|NCT03498456|Clarithromycin|clarithromycin|mesh-list
43576470|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43576471|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576472|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43576473|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576474|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576475|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43576476|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43576477|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43576478|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43576480|NCT03498417|Antibodies|antibodies|mesh-list
43576481|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
43576482|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576483|NCT03498326|Gemcitabine|gemcitabine|mesh-list
43576484|NCT03498326|Celecoxib|celecoxib|mesh-list
43576485|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43576486|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
43576487|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576488|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576489|NCT03498326|Antiviral Agents|antiviral agents|mesh-ancestor
43576490|NCT03498326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576491|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576492|NCT03498326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670820|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43670821|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43670822|NCT05424393|Analgesics|analgesics|mesh-ancestor
43670823|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
43670824|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670825|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670826|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670827|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670828|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43670829|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670830|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
43670832|NCT05423834|Entecavir|entecavir|mesh-list
43670833|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
43670834|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670835|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43670836|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43670837|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670838|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670839|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43670840|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43670841|NCT05423821|Anesthetics|anesthetics|mesh-list
43670842|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670843|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670844|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43670845|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43670846|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670847|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670848|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
43670849|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670850|NCT05423197|Panitumumab|panitumumab|mesh-list
43576493|NCT03498326|Immunologic Factors|immunologic factors|mesh-ancestor
43576494|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576495|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43576496|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43576497|NCT03498326|Analgesics|analgesics|mesh-ancestor
43576498|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
43576499|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576500|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43576501|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576502|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43670851|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670852|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670853|NCT05423132|Ropivacaine|ropivacaine|mesh-list
43670854|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
43670855|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
43670856|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670857|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670858|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
43576522|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576524|NCT03498235|Sevoflurane|sevoflurane|mesh-list
43576525|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43576526|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576527|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576528|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43576529|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
43576530|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
43576531|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43576532|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43576533|NCT03498222|Carboplatin|carboplatin|mesh-list
43576534|NCT03498222|Pemetrexed|pemetrexed|mesh-list
43576535|NCT03498222|Atezolizumab|atezolizumab|mesh-list
43576536|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576537|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576538|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576539|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43576540|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43576541|NCT03498170|Itraconazole|itraconazole|mesh-list
43576542|NCT03498170|Acumapimod|acumapimod|mesh-list
43576543|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
43576544|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576545|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43576546|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43576547|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670866|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670882|NCT05421962|Analgesics|analgesics|mesh-ancestor
43670883|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
43670884|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670885|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670886|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43670887|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43670888|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
43670889|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
43670890|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576548|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576549|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43576550|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
43576551|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43576552|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849072|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576553|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43576554|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43576555|NCT03498118|Bupivacaine|bupivacaine|mesh-list
43576556|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
43576557|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
43576558|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576559|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576560|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
43576561|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576562|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
43576563|NCT03498092|Bupivacaine|bupivacaine|mesh-list
43576564|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
43576565|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
43576566|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576567|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576568|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
43670891|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43670892|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43670893|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670894|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670895|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43670896|NCT05421962|Narcotics|narcotics|mesh-ancestor
43576569|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576570|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43576571|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43576572|NCT03498092|Analgesics|analgesics|mesh-ancestor
43576573|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43576579|NCT03497988|Oxytocin|oxytocin|mesh-list
43576580|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
43576581|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43576582|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576583|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
43576584|NCT03497923|Analgesics|analgesics|mesh-ancestor
43576585|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
43576586|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576587|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576589|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576590|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43576591|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
43576592|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43576593|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576594|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576595|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43576596|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
43576597|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43576598|NCT03497715|Ibuprofen|ibuprofen|mesh-list
43576599|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43576600|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43576601|NCT03497715|Analgesics|analgesics|mesh-ancestor
43576602|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
43576603|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576604|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576605|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43576606|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576607|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43576608|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576609|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576610|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
43576611|NCT03497702|Docetaxel|docetaxel|mesh-list
43576612|NCT03497702|Doxorubicin|doxorubicin|mesh-list
43576613|NCT03497702|Letrozole|letrozole|mesh-list
43576614|NCT03497702|Leuprolide|leuprolide|mesh-list
43576615|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43576616|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
43576617|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576618|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576619|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43576620|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
43576621|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576622|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576623|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43576624|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
43576625|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
43576626|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
43576627|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43576628|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43576629|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43576630|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670897|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43670898|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
43670899|NCT05420805|Butyric Acid|butyric acid|mesh-list
43670900|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
43670901|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
43670902|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43670903|NCT05420805|Protective Agents|protective agents|mesh-ancestor
43670904|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670905|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
43670906|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
43670907|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670908|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670909|NCT05420350|Lamotrigine|lamotrigine|mesh-list
43670910|NCT05420350|Bupropion|bupropion|mesh-list
43576656|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576658|NCT03497351|Urapidil|urapidil|mesh-list
43576714|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576715|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576716|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
43576717|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576718|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43576719|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43576720|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576721|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576722|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
43576723|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576724|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670937|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43670938|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43670939|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43670940|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43670942|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
43670943|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670944|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670945|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670946|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670947|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43670948|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43670949|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670950|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43670951|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670952|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
43670953|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43670954|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
43670955|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43670956|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
43670957|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43670958|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43576726|NCT03496519|Trabectedin|trabectedin|mesh-list
43576727|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43576728|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43576729|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576730|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
43576731|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576732|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43576733|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
43576734|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576735|NCT03496506|Selexipag|selexipag|mesh-list
43576736|NCT03496506|Clopidogrel|clopidogrel|mesh-list
43576737|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43576738|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43576739|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43576740|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43670966|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43670967|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670968|NCT05392699|Interleukin-12|interleukin-12|mesh-list
43670969|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43670970|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
43670971|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670972|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43576752|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576753|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
43576754|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43576755|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43576756|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576757|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43576758|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43751454|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751455|NCT02498015|Ribavirin|ribavirin|mesh-list
43751456|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
43751457|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751458|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
43576759|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43576760|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576761|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576762|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
43576763|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43576764|NCT03496389|Narcotics|narcotics|mesh-ancestor
43576765|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43576766|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
43576767|NCT03496246|Vitamin D|vitamin d|mesh-list
43576768|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43576769|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
43576770|NCT03496246|Calcifediol|calcifediol|mesh-list
43576771|NCT03496246|Calcium|calcium|mesh-list
43576772|NCT03496246|Vitamins|vitamins|mesh-ancestor
43576773|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
43576774|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576775|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43576776|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43576777|NCT03496233|Grazoprevir|grazoprevir|mesh-list
43576778|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43576779|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
43576780|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576781|NCT03495804|Mannitol|mannitol|mesh-list
43576782|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43576783|NCT03495804|Diuretics|diuretics|mesh-ancestor
43576784|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
43576786|NCT03495765|Ranibizumab|ranibizumab|mesh-list
43576787|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43576802|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576803|NCT03495466|Anesthetics|anesthetics|mesh-list
43576804|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576805|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576806|NCT03495206|Edaravone|edaravone|mesh-list
43576807|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43576808|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
43576809|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576810|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43576811|NCT03495206|Protective Agents|protective agents|mesh-ancestor
43576812|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576813|NCT03495063|Caffeine|caffeine|mesh-list
43576814|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43576815|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576816|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43576817|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576818|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576819|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43576820|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43576821|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
43576822|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576823|NCT03495024|Varenicline|varenicline|mesh-list
43576824|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43576825|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43576826|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
43576827|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576828|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576832|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576833|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43576834|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576835|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576836|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
43576837|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43576838|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43576839|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576840|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43576841|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43751459|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751460|NCT02498002|Lidocaine|lidocaine|mesh-list
43751461|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
43751462|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
43751464|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751465|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
43751466|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751467|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43751468|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43576842|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576843|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576844|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576845|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43576846|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
43576847|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43576848|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827110|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827111|NCT05491785|Analgesics|analgesics|mesh-ancestor
43827112|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
43827113|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827114|NCT05491720|Risperidone|risperidone|mesh-list
43827115|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43827116|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
43827117|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827118|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827119|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827120|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43827121|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43827122|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827123|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43827124|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43827125|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
43670977|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
43670978|NCT05387408|Narcotics|narcotics|mesh-ancestor
43670979|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576849|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43576850|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43576851|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43576852|NCT03494686|Anesthetics|anesthetics|mesh-list
43576853|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576854|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576855|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
43576856|NCT03494517|Analgesics|analgesics|mesh-ancestor
43576869|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43576871|NCT03494426|Tramadol|tramadol|mesh-list
43576872|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
43576873|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
43576874|NCT03494426|Analgesics|analgesics|mesh-ancestor
43576875|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
43576876|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576877|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576878|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
43576879|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43576880|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576881|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576882|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43576883|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43576884|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43576885|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576886|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43576887|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43576888|NCT03494426|Narcotics|narcotics|mesh-ancestor
43576889|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
43576890|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
43576891|NCT03494387|Antioxidants|antioxidants|mesh-list
43751469|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43751470|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43751471|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751472|NCT02497833|Tretinoin|tretinoin|mesh-list
43572544|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572545|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572546|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
43572547|NCT00004230|Captopril|captopril|mesh-list
43572548|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572549|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
43572550|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572551|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830986|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576892|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
43576893|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576894|NCT03494387|Expectorants|expectorants|mesh-ancestor
43670990|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670992|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
43670993|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43670994|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670995|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670996|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43670997|NCT05376761|Analgesics|analgesics|mesh-ancestor
43670998|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
43670999|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671000|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43671001|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43671002|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43671003|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
43671004|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671005|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671006|NCT05349448|Triamcinolone|triamcinolone|mesh-list
43671007|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43671008|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43671009|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
43671022|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671023|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671024|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43671025|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
43671026|NCT05349448|Hormones|hormones|mesh-ancestor
43671027|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43671028|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671029|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
43671030|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671031|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
43671032|NCT05349383|Antibodies|antibodies|mesh-list
43671033|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
43671034|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
43671035|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
43671036|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671037|NCT05321043|Riboflavin|riboflavin|mesh-list
43671038|NCT05321043|Vitamins|vitamins|mesh-ancestor
43671039|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
43671040|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671041|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
43671042|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43671043|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
43671044|NCT05289492|Dexamethasone|dexamethasone|mesh-list
43671045|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43671046|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
43671047|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
43671048|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572552|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572553|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
43572554|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572555|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572556|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572557|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43572558|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572559|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572560|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43572561|NCT00004182|Irinotecan|irinotecan|mesh-list
43572562|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43572563|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43751473|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751474|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
43751475|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
43671049|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671050|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43671051|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
43671052|NCT05289492|Hormones|hormones|mesh-ancestor
43576916|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576918|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576919|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
43576920|NCT03493841|Vitamins|vitamins|mesh-ancestor
43576921|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
43576922|NCT03493568|Dolutegravir|dolutegravir|mesh-list
43849073|NCT03965845|Palbociclib|palbociclib|mesh-list
43576924|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43576925|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43576926|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576927|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576928|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43576929|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43576930|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
43576931|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576932|NCT03493503|Albuterol|albuterol|mesh-list
43576933|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43576934|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
43576935|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576936|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576948|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43576949|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43576950|NCT03493490|Analgesics|analgesics|mesh-ancestor
43576951|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
43576952|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671062|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
43671063|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671064|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43671065|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43671066|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671067|NCT05233228|Nicotine|nicotine|mesh-list
43671068|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43671069|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
43671070|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576954|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751476|NCT02497820|Aspirin|aspirin|mesh-list
43751477|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43751478|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43751479|NCT02497820|Analgesics|analgesics|mesh-ancestor
43751480|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
43751481|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751482|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751483|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751484|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751485|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43751486|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43576955|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576956|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43576957|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576958|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576960|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43576961|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43576962|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576963|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576964|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43576965|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576966|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
43576967|NCT03493269|Midazolam|midazolam|mesh-list
43576968|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43576969|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43576970|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671088|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43671089|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671090|NCT05219409|Incretins|incretins|mesh-ancestor
43671091|NCT05219409|Hormones|hormones|mesh-ancestor
43671092|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43671093|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43671094|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
43671095|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671096|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671097|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
43671098|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43671099|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671100|NCT05184192|Gabapentin|gabapentin|mesh-list
43671101|NCT05184192|Analgesics|analgesics|mesh-ancestor
43671102|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
43671103|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671104|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671105|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
43671106|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43671107|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43671141|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43671142|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
43671143|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671144|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671146|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43671147|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43827126|NCT05491694|Paclitaxel|paclitaxel|mesh-list
43671148|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43671149|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43671150|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
43671151|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671152|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751487|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751488|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43751489|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43671153|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671154|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43671155|NCT05125796|Acetaminophen|acetaminophen|mesh-list
43671156|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43671157|NCT05125796|Ketoprofen|ketoprofen|mesh-list
43671158|NCT05125796|Lidocaine|lidocaine|mesh-list
43671159|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
43671160|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
43671161|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671162|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671163|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
43671164|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671165|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43671175|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671176|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43671177|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671179|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671180|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43671181|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671182|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827127|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
43827128|NCT05491694|Carboplatin|carboplatin|mesh-list
43827129|NCT05491694|Epirubicin|epirubicin|mesh-list
43827130|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43827131|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827132|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
43827133|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
43827134|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
43827135|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827136|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827137|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
43827138|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827139|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827140|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43827141|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
43827142|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43827143|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43827144|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43827145|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43827146|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827147|NCT05491512|Cisplatin|cisplatin|mesh-list
43827148|NCT05491512|Carboplatin|carboplatin|mesh-list
43827152|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827161|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43827162|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
43827163|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43827164|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
43827165|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827166|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827167|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
43671184|NCT05096117|Analgesics|analgesics|mesh-ancestor
43671185|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
43671186|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671187|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671188|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
43671189|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
43671190|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671191|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671192|NCT05054023|Piroxicam|piroxicam|mesh-list
43671193|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43671194|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43671195|NCT05054023|Analgesics|analgesics|mesh-ancestor
43671196|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
43671197|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671198|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671199|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43671200|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671201|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43671202|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671203|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671204|NCT05053737|Atezolizumab|atezolizumab|mesh-list
43671223|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671224|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
43671225|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671226|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671227|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43671228|NCT05004259|Daratumumab|daratumumab|mesh-list
43671229|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671230|NCT04958122|Penicillins|penicillins|mesh-list
43671231|NCT04958122|Cefixime|cefixime|mesh-list
43671232|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43671233|NCT04958122|Penicillin G|penicillin g|mesh-list
43671234|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
43671235|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43671236|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671237|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
43671238|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671239|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
43671240|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
43671241|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
43671242|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43671243|NCT04934228|Clonidine|clonidine|mesh-list
43671244|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43671245|NCT04934228|Diuretics|diuretics|mesh-ancestor
43671246|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
43671247|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671248|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43671249|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43671250|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671251|NCT04934228|Analgesics|analgesics|mesh-ancestor
43671252|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
43671253|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671254|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
43671255|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
43671256|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43671257|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43671258|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43671259|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
43576971|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671260|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671261|NCT04881929|Docetaxel|docetaxel|mesh-list
43671262|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671273|NCT04871607|Etoposide|etoposide|mesh-list
43671274|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
43671275|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
43671276|NCT04871607|Carmustine|carmustine|mesh-list
43671277|NCT04871607|Basiliximab|basiliximab|mesh-list
43671278|NCT04871607|Lenograstim|lenograstim|mesh-list
43671279|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43671280|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671281|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43671282|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43671283|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671284|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671285|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43671286|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
43671287|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
43671288|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671307|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
43671308|NCT04864431|Vitamins|vitamins|mesh-ancestor
43671309|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
43671310|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671311|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43671312|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43671314|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
43671315|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671316|NCT04833959|Panitumumab|panitumumab|mesh-list
43671317|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671318|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671319|NCT04798287|Adalimumab|adalimumab|mesh-list
43671320|NCT04798287|Etanercept|etanercept|mesh-list
43671321|NCT04798287|Golimumab|golimumab|mesh-list
43671322|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43671323|NCT04798287|Infliximab|infliximab|mesh-list
43671324|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
43671325|NCT04798287|Tofacitinib|tofacitinib|mesh-list
43671326|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43671327|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671328|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
43671329|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43671330|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43671331|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43671332|NCT04798287|Analgesics|analgesics|mesh-ancestor
43671333|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
43671334|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671335|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827182|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43827183|NCT05491187|Fentanyl|fentanyl|mesh-list
43827184|NCT05491187|Bupivacaine|bupivacaine|mesh-list
43827185|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
43827186|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
43827187|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827188|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827189|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
43751505|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43751506|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
43751507|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43751508|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
43751509|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751510|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751511|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
43836355|NCT04979611|Hormones|hormones|mesh-ancestor
43836356|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836357|NCT04979520|Brodalumab|brodalumab|mesh-list
43836358|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
43836359|NCT04979442|Trabectedin|trabectedin|mesh-list
43836360|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43836361|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
43836362|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836363|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836364|NCT04979065|Vitamin D|vitamin d|mesh-list
43836365|NCT04979065|Vitamins|vitamins|mesh-ancestor
43836366|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
43836367|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836399|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836400|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43836401|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43836402|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
43836403|NCT04974281|Lenvatinib|lenvatinib|mesh-list
43836404|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836405|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836406|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751512|NCT02497547|Oxytocin|oxytocin|mesh-list
43751513|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
43751514|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43751515|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751516|NCT02497508|Nivolumab|nivolumab|mesh-list
43827190|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827191|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43827192|NCT05491187|Narcotics|narcotics|mesh-ancestor
43671344|NCT04731844|Curcumin|curcumin|mesh-list
43671345|NCT04731844|Piperine|piperine|mesh-list
43671346|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43671348|NCT04731844|Analgesics|analgesics|mesh-ancestor
43751517|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43751518|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751519|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43751520|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751521|NCT02497313|Metformin|metformin|mesh-list
43751522|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
43751523|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43751524|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751525|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43751526|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751527|NCT02497378|Dexamethasone|dexamethasone|mesh-list
43751528|NCT02497378|Bortezomib|bortezomib|mesh-list
43751529|NCT02497378|Daratumumab|daratumumab|mesh-list
43751530|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751531|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
43751532|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
43751533|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751534|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751535|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751536|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
43751537|NCT02497378|Hormones|hormones|mesh-ancestor
43751538|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751539|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43751540|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751541|NCT02497326|Heparin|heparin|mesh-list
43751542|NCT02497326|Tramadol|tramadol|mesh-list
43751543|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
43751544|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43751545|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43751546|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751547|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43751548|NCT02497326|Narcotics|narcotics|mesh-ancestor
43751549|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751556|NCT02497118|Endostatins|endostatins|mesh-list
43751557|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751558|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43751559|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
43751560|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
43751561|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
43751562|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751563|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43751564|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43751565|NCT02497118|Growth Substances|growth substances|mesh-ancestor
43751566|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751567|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
43751568|NCT02497222|RNS60|rns60|mesh-list
43751569|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43751570|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43751571|NCT02497222|Analgesics|analgesics|mesh-ancestor
43751572|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
43751575|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751580|NCT02497157|Fluorouracil|fluorouracil|mesh-list
43751581|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
43751582|NCT02497157|Irinotecan|irinotecan|mesh-list
43751583|NCT02497157|Calcium|calcium|mesh-list
43751584|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
43751585|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43751586|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751587|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43751588|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43751589|NCT02497157|Growth Substances|growth substances|mesh-ancestor
43751590|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751608|NCT02497365|Besifloxacin|besifloxacin|mesh-list
43751609|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43751610|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751611|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572564|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572565|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572566|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671349|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
43671350|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671351|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671352|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43671353|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671354|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671355|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671356|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671357|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43671358|NCT04725812|Eculizumab|eculizumab|mesh-list
43671373|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671374|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671375|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43671376|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671377|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43671382|NCT04683614|Norepinephrine|norepinephrine|mesh-list
43671383|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43671384|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43671385|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
43671386|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671387|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671388|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671389|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
43671390|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
43671391|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671392|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43671393|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
43671394|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
43671425|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43671426|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43671427|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
43671428|NCT04632316|Fludarabine|fludarabine|mesh-list
43671429|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671430|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
43671431|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671432|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671433|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671434|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
43576976|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
43576977|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
43576978|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
43576979|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
43576980|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576981|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576982|NCT03493087|Vitamin K|vitamin k|mesh-list
43576983|NCT03493087|Vitamins|vitamins|mesh-ancestor
43576984|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
43576985|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576986|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43576987|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43576988|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576990|NCT03493087|Coagulants|coagulants|mesh-ancestor
43576991|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
43576992|NCT03493061|Irinotecan|irinotecan|mesh-list
43671453|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43671454|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572567|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
43572568|NCT00004181|Busulfan|busulfan|mesh-list
43572569|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572570|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
43572571|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572572|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572573|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572574|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
43671455|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671456|NCT04587947|Valsartan|valsartan|mesh-list
43671457|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43671458|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43671459|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43671460|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43671461|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671462|NCT04569877|Molgramostim|molgramostim|mesh-list
43671463|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43671464|NCT04569877|Sargramostim|sargramostim|mesh-list
43671465|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671466|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
43671467|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671476|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43671477|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671478|NCT04522167|Aflibercept|aflibercept|mesh-list
43671501|NCT04485273|Anesthetics|anesthetics|mesh-list
43671502|NCT04485273|Sevoflurane|sevoflurane|mesh-list
43671503|NCT04485273|Bupivacaine|bupivacaine|mesh-list
43671504|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
43671505|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43671506|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671507|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671508|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43671509|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43671510|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
43671511|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
43671512|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671513|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
43671514|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671515|NCT04465643|Nivolumab|nivolumab|mesh-list
43671516|NCT04465643|Ipilimumab|ipilimumab|mesh-list
43671517|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671518|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671519|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43671520|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671521|NCT04465487|Cemiplimab|cemiplimab|mesh-list
43671522|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671523|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671524|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
43671525|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
43671526|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43671527|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43671528|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671529|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671530|NCT04447989|Urological Agents|urological agents|mesh-ancestor
43671531|NCT04447768|Venetoclax|venetoclax|mesh-list
43671532|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
43671533|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671534|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671535|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
43671537|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671538|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572575|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572576|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751612|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43751613|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751614|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751615|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751616|NCT02497079|Formaldehyde|formaldehyde|mesh-list
43751617|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
43751618|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751619|NCT02497053|Pemetrexed|pemetrexed|mesh-list
43751620|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671539|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671540|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43671541|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
43671542|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671543|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671544|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671545|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
43671546|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827193|NCT05491187|Analgesics|analgesics|mesh-ancestor
43827200|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827201|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43827202|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43827203|NCT05490953|Protective Agents|protective agents|mesh-ancestor
43827204|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827205|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
43827206|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43827207|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
43827208|NCT05490888|Terlipressin|terlipressin|mesh-list
43827209|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43576993|NCT03493061|Floxuridine|floxuridine|mesh-list
43576994|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576995|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43576996|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43576997|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576998|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576999|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43577000|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
43827210|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43827211|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
43827212|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
43827231|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827232|NCT05490342|Antibodies|antibodies|mesh-list
43827233|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
43827234|NCT05490342|Paraproteins|paraproteins|mesh-list
43827235|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
43827236|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827237|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
43827238|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43827239|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43751621|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751622|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751623|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43751624|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43751625|NCT02496988|Temozolomide|temozolomide|mesh-list
43751626|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43751627|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
43671595|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
43671596|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43671597|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
43671598|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671599|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671600|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43671601|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
43671602|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
43671603|NCT04306393|Protective Agents|protective agents|mesh-ancestor
43671605|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43671606|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
43671607|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671608|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671609|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43671610|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43671611|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
43671612|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671613|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671614|NCT04230187|Leucovorin|leucovorin|mesh-list
43671615|NCT04230187|Bevacizumab|bevacizumab|mesh-list
43671616|NCT04230187|Fluorouracil|fluorouracil|mesh-list
43671617|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
43671618|NCT04230187|Irinotecan|irinotecan|mesh-list
43671619|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
43671620|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671644|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671645|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671646|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671647|NCT04173364|Ropivacaine|ropivacaine|mesh-list
43671648|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43671649|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
43671650|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
43671651|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671652|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671653|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
43671668|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43671669|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
43671670|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43671671|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671672|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671673|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43671674|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43671675|NCT04152980|Protective Agents|protective agents|mesh-ancestor
43671676|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671677|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
43671678|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43671679|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
43671680|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
43671681|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43671682|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671683|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671684|NCT04111315|Dipyrone|dipyrone|mesh-list
43671685|NCT04111315|Ibuprofen|ibuprofen|mesh-list
43671686|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43671687|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43671688|NCT04111315|Analgesics|analgesics|mesh-ancestor
43671689|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
43671690|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671691|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671692|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43671693|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671694|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43671695|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671696|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671697|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
43671708|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671710|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671711|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
43671712|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671731|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43671732|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671755|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671757|NCT03850535|Daunorubicin|daunorubicin|mesh-list
43671758|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43671759|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
43671760|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671761|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671762|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
43671763|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671764|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671765|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
43671766|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671767|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43671768|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43671769|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43671770|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671771|NCT03850301|Etifoxine|etifoxine|mesh-list
43671772|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43671773|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43671774|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671775|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671776|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43827240|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827241|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
43827242|NCT05490160|Coagulants|coagulants|mesh-ancestor
43827243|NCT05490095|Everolimus|everolimus|mesh-list
43827244|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827245|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827246|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
43827247|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827248|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
43827249|NCT05490082|Mirabegron|mirabegron|mesh-list
43827250|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43827251|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43671799|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43671800|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43671801|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671802|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671803|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43671804|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43671823|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43671824|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43671826|NCT03653000|Anesthetics|anesthetics|mesh-list
43671827|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
43671828|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671829|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671830|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
43671831|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671833|NCT03639389|Analgesics|analgesics|mesh-list
43671834|NCT03639389|Bupivacaine|bupivacaine|mesh-list
43671835|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
43671836|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
43827261|NCT05489952|Iron|iron|mesh-list
43671837|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671838|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671839|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
43671842|NCT03639389|Narcotics|narcotics|mesh-ancestor
43671862|NCT03570983|Etoposide|etoposide|mesh-list
43671863|NCT03570983|Melphalan|melphalan|mesh-list
43671864|NCT03570983|Carmustine|carmustine|mesh-list
43671865|NCT03570983|Allopurinol|allopurinol|mesh-list
43671866|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43671867|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671868|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43671869|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43671870|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671871|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671881|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43671882|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
43671883|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671884|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43671886|NCT03570983|Protective Agents|protective agents|mesh-ancestor
43671887|NCT03540758|Niacin|niacin|mesh-list
43577003|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
43577004|NCT03493048|Irinotecan|irinotecan|mesh-list
43577005|NCT03493048|Cetuximab|cetuximab|mesh-list
43577006|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
43577007|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577008|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43577009|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577010|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43577011|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
43577012|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577013|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43577014|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43577015|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577016|NCT03493048|Antidotes|antidotes|mesh-ancestor
43577017|NCT03493048|Protective Agents|protective agents|mesh-ancestor
43671888|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
43671889|NCT03540758|Niacinamide|niacinamide|mesh-list
43671890|NCT03540758|Diazoxide|diazoxide|mesh-list
43671891|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43671892|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
43671893|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671894|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43671895|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
43671896|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
43671897|NCT03540758|Vitamins|vitamins|mesh-ancestor
43671898|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
43671899|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671900|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43671901|NCT03478488|Gemcitabine|gemcitabine|mesh-list
43671902|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
43671903|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43671904|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
43671905|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671906|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671907|NCT03478488|Antiviral Agents|antiviral agents|mesh-ancestor
43671908|NCT03478488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671909|NCT03478488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671910|NCT03478488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671911|NCT03478488|Immunologic Factors|immunologic factors|mesh-ancestor
43671912|NCT03478488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671913|NCT03430882|Paclitaxel|paclitaxel|mesh-list
43671914|NCT03430882|Carboplatin|carboplatin|mesh-list
43671917|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671918|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
43671919|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
43671920|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
43671921|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671923|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671924|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671928|NCT03374254|Leucovorin|leucovorin|mesh-list
43671929|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
43671930|NCT03374254|Fluorouracil|fluorouracil|mesh-list
43577018|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
43671947|NCT03374254|Vitamins|vitamins|mesh-ancestor
43671948|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
43671949|NCT03312738|Everolimus|everolimus|mesh-list
43671950|NCT03312738|Exemestane|exemestane|mesh-list
43671951|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671952|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671953|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
43671954|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671955|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43671956|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43671957|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671958|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671959|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43671960|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
43671961|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43671962|NCT03303339|Cytarabine|cytarabine|mesh-list
43671963|NCT03303339|Decitabine|decitabine|mesh-list
43671964|NCT03303339|Onvansertib|onvansertib|mesh-list
43671965|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43671972|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
43671973|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671974|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671975|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43671976|NCT03299946|Nivolumab|nivolumab|mesh-list
43671977|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671978|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671979|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43671980|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671981|NCT03291886|Exemestane|exemestane|mesh-list
43671982|NCT03291886|Entinostat|entinostat|mesh-list
43671983|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671984|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43671985|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43671986|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671987|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671988|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43671989|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
43672000|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672001|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577023|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577024|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577025|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43577026|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577027|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577028|NCT03492970|Melatonin|melatonin|mesh-list
43577029|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
43577030|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577031|NCT03492970|Protective Agents|protective agents|mesh-ancestor
43577032|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577033|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577034|NCT03492931|Ticagrelor|ticagrelor|mesh-list
43672002|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43672003|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
43672004|NCT03252808|Antiviral Agents|antiviral agents|mesh-ancestor
43672005|NCT03252808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672006|NCT03252808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672007|NCT03252808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672008|NCT03252808|Immunologic Factors|immunologic factors|mesh-ancestor
43672009|NCT03252808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672010|NCT03235505|Nicotine|nicotine|mesh-list
43672011|NCT03235505|Varenicline|varenicline|mesh-list
43672012|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43672013|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
43672014|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672015|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577035|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43751628|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751629|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751630|NCT02496962|Atorvastatin|atorvastatin|mesh-list
43751631|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43751632|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43751633|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
43751634|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577036|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43577037|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43577038|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43577039|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
43577040|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577041|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577042|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577043|NCT03492866|Gentamicins|gentamicins|mesh-list
43577044|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577045|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577046|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43577047|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577048|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577049|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
43577050|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43577051|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43577052|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577053|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
43577054|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
43577055|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43577056|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
43577057|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43577058|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
43577059|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577081|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577083|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577084|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43577085|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43577086|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577087|NCT03492593|Provitamins|provitamins|mesh-ancestor
43577088|NCT03492593|Vitamins|vitamins|mesh-ancestor
43577089|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
43577090|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
43577091|NCT03492580|Empagliflozin|empagliflozin|mesh-list
43577092|NCT03492580|Canagliflozin|canagliflozin|mesh-list
43577093|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
43577094|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43577131|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577132|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672027|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
43672028|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43672029|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
43672030|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
43672031|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672032|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672033|NCT03187379|Bupivacaine|bupivacaine|mesh-list
43672035|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
43672036|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672037|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672038|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
43672039|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672040|NCT03184090|Palbociclib|palbociclib|mesh-list
43672041|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751635|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43751636|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43751637|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751638|NCT02496975|Cyclosporine|cyclosporine|mesh-list
43751639|NCT02496975|Cyclosporins|cyclosporins|mesh-list
43751640|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751641|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751642|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849063|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43572577|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572579|NCT00004175|Docetaxel|docetaxel|mesh-list
43572580|NCT00004175|Doxorubicin|doxorubicin|mesh-list
43572581|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43572589|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572590|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572591|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
43572592|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672042|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43672043|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672044|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672046|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672047|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672048|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43672049|NCT03182231|Incretins|incretins|mesh-ancestor
43672050|NCT03182231|Hormones|hormones|mesh-ancestor
43672051|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577133|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43577134|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577135|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
43572593|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
43751643|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
43751644|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751645|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
43751646|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751647|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
43751648|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751649|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43751650|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43751652|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751653|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751654|NCT02496910|Amlodipine|amlodipine|mesh-list
43751655|NCT02496910|Telmisartan|telmisartan|mesh-list
43751656|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
43751657|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43751658|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43751659|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43751660|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43751661|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751662|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43751663|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751664|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
43751665|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43751666|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43751667|NCT02496910|Diuretics|diuretics|mesh-ancestor
43751673|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751675|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43751676|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43751677|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751678|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
43751679|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751680|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
43751681|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43751682|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751683|NCT02496715|Fluticasone|fluticasone|mesh-list
43751684|NCT02496715|Xhance|xhance|mesh-list
43751685|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43751686|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751687|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43751688|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
43751689|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751690|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751691|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43577136|NCT03492255|Hormones|hormones|mesh-ancestor
43751693|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
43751694|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43751699|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751700|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751701|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
43751702|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43751703|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751704|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751705|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43751706|NCT02496650|Analgesics|analgesics|mesh-ancestor
43751707|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
43751708|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751709|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43751710|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43751711|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43751712|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
43751713|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751714|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751715|NCT02496494|Tacrolimus|tacrolimus|mesh-list
43751716|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43751717|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
43577137|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577138|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43577139|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43577140|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43577141|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
43577142|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577143|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577144|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577145|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
43751718|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751719|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43751720|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751721|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751722|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
43751723|NCT02496377|Glycine|glycine|mesh-list
43751724|NCT02496377|Hematinics|hematinics|mesh-ancestor
43751725|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
43751726|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751727|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751744|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751745|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
43751746|NCT02496299|Hormones|hormones|mesh-ancestor
43751747|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751748|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43751749|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751750|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
43751752|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751753|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
43751754|NCT02496286|Bevacizumab|bevacizumab|mesh-list
43751755|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43751756|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751757|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43751758|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43751759|NCT02496286|Growth Substances|growth substances|mesh-ancestor
43751760|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751761|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
43751765|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751766|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751767|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43751768|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43751769|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751770|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751771|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751772|NCT02496078|Asunaprevir|asunaprevir|mesh-list
43751773|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
43751774|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751775|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751776|NCT02495922|Dexamethasone|dexamethasone|mesh-list
43577146|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
43577147|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577148|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577149|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43577150|NCT03492255|Protective Agents|protective agents|mesh-ancestor
43577151|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43577152|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577153|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577155|NCT03492138|Ixazomib|ixazomib|mesh-list
43577156|NCT03492138|TIC10 compound|tic10 compound|mesh-list
43672052|NCT03182192|Exenatide|exenatide|mesh-list
43672053|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672054|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672055|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43672056|NCT03182192|Incretins|incretins|mesh-ancestor
43672057|NCT03182192|Hormones|hormones|mesh-ancestor
43672068|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672069|NCT03149770|Naloxone|naloxone|mesh-list
43577157|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577158|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
43577159|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
43577160|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577161|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577162|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577163|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
43577164|NCT03492138|Hormones|hormones|mesh-ancestor
43577165|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577166|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43577167|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577168|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
43577169|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577170|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577171|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
43577172|NCT03492047|Paclitaxel|paclitaxel|mesh-list
43577173|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43577174|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43577175|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577176|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
43751777|NCT02495922|Lenalidomide|lenalidomide|mesh-list
43751778|NCT02495922|Bortezomib|bortezomib|mesh-list
43751779|NCT02495922|Elotuzumab|elotuzumab|mesh-list
43751785|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751786|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
43751787|NCT02495922|Hormones|hormones|mesh-ancestor
43751788|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751789|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43751790|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577177|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
43577178|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
43577179|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577180|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
43577181|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577182|NCT03492047|Expectorants|expectorants|mesh-ancestor
43577183|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
43577184|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43577185|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
43577186|NCT03492047|Protective Agents|protective agents|mesh-ancestor
43577187|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577188|NCT03492047|Antidotes|antidotes|mesh-ancestor
43577189|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
43577190|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
43577191|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577192|NCT03491969|Protective Agents|protective agents|mesh-ancestor
43672070|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43672071|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672072|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
43672073|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672074|NCT03098589|Lenalidomide|lenalidomide|mesh-list
43672075|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
43672076|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672077|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43672078|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43672079|NCT03098589|Growth Substances|growth substances|mesh-ancestor
43672080|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
43672081|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672083|NCT03026517|Trametinib|trametinib|mesh-list
43751791|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
43751792|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43751793|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43751794|NCT02495922|Growth Substances|growth substances|mesh-ancestor
43751795|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
43751796|NCT02495688|Anesthetics|anesthetics|mesh-list
43751797|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751798|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836407|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836408|NCT04973800|Simvastatin|simvastatin|mesh-list
43836409|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43836410|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43836411|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
43751858|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43751859|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751860|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751861|NCT02495181|Aflibercept|aflibercept|mesh-list
43751862|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43751863|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43751864|NCT02495181|Growth Substances|growth substances|mesh-ancestor
43751865|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751866|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
43751867|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751868|NCT02495324|Valsartan|valsartan|mesh-list
43751869|NCT02495324|Olmesartan|olmesartan|mesh-list
43751870|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43751871|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43751872|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43751873|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43555492|NCT03562468|Niacin|niacin|mesh-list
43751874|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751903|NCT02495415|Protective Agents|protective agents|mesh-ancestor
43751904|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751906|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
43672084|NCT03026517|Dabrafenib|dabrafenib|mesh-list
43672085|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672086|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43672087|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672088|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672089|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672090|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672092|NCT02964884|L 647318|l 647318|mesh-list
43672093|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
43672094|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43672095|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43672096|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
43672097|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672098|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43672116|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43672117|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43672118|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43672119|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43672120|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
43672121|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672122|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672123|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
43672124|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
43672125|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672127|NCT02827435|Rocuronium|rocuronium|mesh-list
43672128|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
43672129|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43672130|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43672131|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43672132|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672133|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672134|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
43672135|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43672136|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43672137|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672138|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
43672139|NCT02797119|Coagulants|coagulants|mesh-ancestor
43751907|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
43555541|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
43836416|NCT04972656|Ambrisentan|ambrisentan|mesh-list
43751908|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751909|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751910|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
43751911|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751912|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43751913|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
43751914|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751915|NCT02494830|Ketamine|ketamine|mesh-list
43751916|NCT02494830|Analgesics|analgesics|mesh-ancestor
43751917|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
43751918|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751919|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572594|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43572595|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572596|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572597|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751926|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43751927|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751928|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751929|NCT02494804|Temozolomide|temozolomide|mesh-list
43751930|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43751931|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
43751932|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751933|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751934|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
43751935|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751936|NCT02494895|Aspirin|aspirin|mesh-list
43751937|NCT02494895|Ticagrelor|ticagrelor|mesh-list
43751938|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43751939|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43751940|NCT02494895|Analgesics|analgesics|mesh-ancestor
43751941|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
43751942|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751943|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751944|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751952|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
43751966|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43751967|NCT02494856|Analgesics|analgesics|mesh-ancestor
43751968|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
43751969|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577193|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577195|NCT03491969|Vitamins|vitamins|mesh-ancestor
43577196|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
43577197|NCT03491904|Fasinumab|fasinumab|mesh-list
43577198|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43577199|NCT03491904|Analgesics|analgesics|mesh-ancestor
43577200|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
43577201|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577202|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577203|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
43577204|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43577205|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
43577206|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577207|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
43577208|NCT03491761|Protective Agents|protective agents|mesh-ancestor
43577209|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
43577210|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
43577211|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577212|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577213|NCT03491709|Cetuximab|cetuximab|mesh-list
43577214|NCT03491709|Antibodies|antibodies|mesh-list
43577215|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43846856|NCT04166669|Itraconazole|itraconazole|mesh-list
43672140|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43751970|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751971|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751972|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751973|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
43751974|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43751975|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
43751976|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751977|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
43751978|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43751979|NCT02494687|Domperidone|domperidone|mesh-list
43751980|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
43751981|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
43751982|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751983|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751984|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751985|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43751986|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
43751987|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751988|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751989|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43751990|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
43751991|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
43751992|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43751993|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751994|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43751997|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752007|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752008|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752009|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672141|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
43672142|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672143|NCT02710643|Ofatumumab|ofatumumab|mesh-list
43672144|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827262|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43752010|NCT02494466|Montelukast|montelukast|mesh-list
43752011|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43752012|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
43752013|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43752014|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
43752015|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752016|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752017|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43752018|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43752019|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752020|NCT02494349|Tamsulosin|tamsulosin|mesh-list
43752021|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
43752022|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43752023|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43752024|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43752025|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
43752026|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752027|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752028|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752029|NCT02494349|Urological Agents|urological agents|mesh-ancestor
43752030|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43752031|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43752052|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43752053|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
43572609|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572610|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572612|NCT00004171|Busulfan|busulfan|mesh-list
43572613|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572614|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
43572615|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572616|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572617|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572618|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
43572619|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572620|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572621|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572622|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
43572623|NCT00004169|Carboplatin|carboplatin|mesh-list
43572624|NCT00004169|Etoposide|etoposide|mesh-list
43572625|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572626|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
43572627|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572628|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572629|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572630|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
43827263|NCT05489952|Trace Elements|trace elements|mesh-ancestor
43827264|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
43827265|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827266|NCT05489952|Hematinics|hematinics|mesh-ancestor
43827267|NCT05489939|Salicylates|salicylates|mesh-list
43827268|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
43827269|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43827270|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827271|NCT05489939|Analgesics|analgesics|mesh-ancestor
43827272|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
43827273|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827274|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577219|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577220|NCT03491696|Metyrapone|metyrapone|mesh-list
43577221|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
43572631|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572632|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572633|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572634|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43572635|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43572636|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43572637|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572638|NCT00004166|Amifostine|amifostine|mesh-list
43572639|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43572640|NCT00004166|Protective Agents|protective agents|mesh-ancestor
43572641|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572642|NCT00004165|Melphalan|melphalan|mesh-list
43836418|NCT04972253|Infigratinib|infigratinib|mesh-list
43555721|NCT03560336|Liraglutide|liraglutide|mesh-list
43752072|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43752073|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752074|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752075|NCT02493959|Incretins|incretins|mesh-ancestor
43752076|NCT02493959|Hormones|hormones|mesh-ancestor
43752077|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752078|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43752079|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
43752201|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
43752202|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752203|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43752204|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43752205|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43752206|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43752207|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752235|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752253|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43752254|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752338|NCT02491697|Capecitabine|capecitabine|mesh-list
43752339|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43752340|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
43752341|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752342|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752343|NCT02491749|Anesthetics|anesthetics|mesh-list
43752344|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752364|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43752365|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
43752366|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752367|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752368|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43752369|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
43752370|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
43752371|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43752372|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43752431|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43752432|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752466|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43752467|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43752468|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
43752469|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752470|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752471|NCT02490982|Teriflunomide|teriflunomide|mesh-list
43752473|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752658|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
43752659|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43752660|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43752661|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43752662|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752678|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
43752679|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752680|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752681|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43752736|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
43752737|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752738|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43752739|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43752740|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
43752741|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
43752742|NCT02488889|Ethanol|ethanol|mesh-list
43752743|NCT02488889|Varenicline|varenicline|mesh-list
43572749|NCT00002240|Stavudine|stavudine|mesh-list
43572750|NCT00002240|Didanosine|didanosine|mesh-list
43572751|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572752|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572753|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572754|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572755|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572756|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572757|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572758|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
43572759|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572760|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
43572761|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43572762|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572763|NCT00002224|Nelfinavir|nelfinavir|mesh-list
43577222|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577223|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577224|NCT03491579|Cytarabine|cytarabine|mesh-list
43577225|NCT03491579|Cladribine|cladribine|mesh-list
43827289|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43752745|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752746|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752747|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752748|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43752749|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43752750|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
43752751|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752752|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752753|NCT02488902|Mefloquine|mefloquine|mesh-list
43752754|NCT02488902|Tafenoquine|tafenoquine|mesh-list
43752755|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
43752756|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43752757|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43752758|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752759|NCT02488993|Rifaximin|rifaximin|mesh-list
43752760|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43752761|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752762|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43752763|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
43827290|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43827291|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
43827292|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827293|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827294|NCT05489887|Ceritinib|ceritinib|mesh-list
43827295|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827296|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43827297|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827298|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827299|NCT05489848|Paclitaxel|paclitaxel|mesh-list
43827300|NCT05489848|Cisplatin|cisplatin|mesh-list
43752764|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43752765|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
43752766|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
43752767|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752768|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752769|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752770|NCT02489097|Analgesics|analgesics|mesh-ancestor
43752771|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
43752772|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752773|NCT02488694|Pemetrexed|pemetrexed|mesh-list
43752774|NCT02488694|Afatinib|afatinib|mesh-list
43752775|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752776|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752777|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752778|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43827302|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43827303|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827304|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
43827305|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
43827306|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
43827307|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827308|NCT05489796|Ketorolac|ketorolac|mesh-list
43827309|NCT05489796|Fentanyl|fentanyl|mesh-list
43827310|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43827311|NCT05489796|Narcotics|narcotics|mesh-ancestor
43827319|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
43827320|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
43672145|NCT02675959|Defibrotide|defibrotide|mesh-list
43672146|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43672147|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43672148|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672149|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43672150|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
43672151|NCT02650986|Decitabine|decitabine|mesh-list
43672152|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672153|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
43672154|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672155|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43577237|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577238|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577239|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577240|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43577241|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43577242|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577243|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
43577244|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
43752779|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43556502|NCT03552315|Chromium|chromium|mesh-list
43752780|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43752781|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
43752782|NCT02488473|Ropivacaine|ropivacaine|mesh-list
43752783|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43752784|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752785|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752786|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752791|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43752792|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43752793|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
43752794|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752795|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752796|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
43572764|NCT00002224|Stavudine|stavudine|mesh-list
43572765|NCT00002224|Didanosine|didanosine|mesh-list
43572766|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572767|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572768|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
43577245|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
43577246|NCT03491475|Ajmaline|ajmaline|mesh-list
43577247|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43577248|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43577249|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43577250|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577251|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672166|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672167|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43672168|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43672169|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672170|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672171|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43672172|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
43572769|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572770|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572771|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572772|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572773|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
43572774|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572775|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
43572776|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43572777|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572778|NCT00002207|Stavudine|stavudine|mesh-list
43572779|NCT00002207|Didanosine|didanosine|mesh-list
43572780|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
43752798|NCT02488512|Edotreotide|edotreotide|mesh-list
43752799|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43752800|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752801|NCT02488564|Metformin|metformin|mesh-list
43752802|NCT02488564|Docetaxel|docetaxel|mesh-list
43752803|NCT02488564|Doxorubicin|doxorubicin|mesh-list
43752804|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43752805|NCT02488564|Trastuzumab|trastuzumab|mesh-list
43752806|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752807|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752808|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672173|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672174|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672175|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43577252|NCT03491410|Aspirin|aspirin|mesh-list
43577253|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43577254|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43577255|NCT03491410|Analgesics|analgesics|mesh-ancestor
43752809|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
43752810|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
43752811|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
43752812|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752813|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43752814|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43752815|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43752816|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752817|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43752818|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
43752819|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
43752820|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752821|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752822|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43577256|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
43577257|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577272|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577273|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
43577274|NCT03491098|Prednisolone|prednisolone|mesh-list
43577275|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43577276|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
43577277|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43577278|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
43577279|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43577280|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
43577281|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577282|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
43577283|NCT03491098|Hormones|hormones|mesh-ancestor
43577284|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577285|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577286|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43577287|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577288|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
43577289|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
43577291|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577292|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43577293|NCT03491098|Protective Agents|protective agents|mesh-ancestor
43577294|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
43577295|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43577296|NCT03491085|Amoxicillin|amoxicillin|mesh-list
43577297|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
43577298|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
43577299|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43577300|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577301|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577302|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43577303|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672178|NCT02572141|Capecitabine|capecitabine|mesh-list
43672179|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
43672180|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
43672181|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
43672182|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752823|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
43752824|NCT02488603|Tamoxifen|tamoxifen|mesh-list
43752825|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43572793|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43572794|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572795|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43572796|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43572797|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43572798|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
43572799|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572800|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43572801|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43572802|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572803|NCT03532464|Azithromycin|azithromycin|mesh-list
43572804|NCT03532464|Doxycycline|doxycycline|mesh-list
43572805|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43572806|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572807|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
43572808|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43752826|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
43672183|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43672184|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672185|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672186|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
43672187|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672188|NCT02572141|Antidotes|antidotes|mesh-ancestor
43672189|NCT02572141|Protective Agents|protective agents|mesh-ancestor
43672190|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
43672191|NCT02572141|Vitamins|vitamins|mesh-ancestor
43672192|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
43672193|NCT02521363|Taxane|taxane|mesh-list
43672204|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672206|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43672207|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43672208|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672209|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672210|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43752827|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752828|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752829|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43752830|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752831|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43752832|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43752833|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43752835|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
43752836|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
43752837|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43752838|NCT02488538|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43752839|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43672211|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
43577304|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577306|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43577307|NCT03491072|Narcotics|narcotics|mesh-ancestor
43577308|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577309|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577310|NCT03491072|Analgesics|analgesics|mesh-ancestor
43577311|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
43672212|NCT02466867|Naftifine|naftifine|mesh-list
43672213|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
43672214|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672215|NCT02465606|Triamcinolone|triamcinolone|mesh-list
43672216|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43672217|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43672218|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
43672219|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43672220|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672221|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
43672222|NCT02465606|Hormones|hormones|mesh-ancestor
43672223|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672224|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672225|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43577312|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577313|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43577314|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43577315|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
43577316|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
43577317|NCT03490994|Warfarin|warfarin|mesh-list
43577318|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
43577319|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
43577320|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43752840|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43752841|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752842|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752843|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
43752844|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752845|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43752846|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
43752847|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43577321|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
43577322|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43577323|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
43577324|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577325|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577326|NCT03490708|Tranilast|tranilast|mesh-list
43577327|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43577328|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43577329|NCT03490708|Analgesics|analgesics|mesh-ancestor
43577330|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
43577331|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577332|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577333|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577334|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43577335|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43577336|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577337|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577341|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
43577342|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577343|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43577344|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43577345|NCT03490617|Misoprostol|misoprostol|mesh-list
43577346|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43577347|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
43577348|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43577349|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577350|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43577351|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577352|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
43577353|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
43577354|NCT03490539|Azathioprine|azathioprine|mesh-list
43577355|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43577356|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577357|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43577358|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
43577359|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43672226|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
43672227|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752848|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43752849|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43836540|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
43836541|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
43836542|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
43836543|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836544|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836545|NCT04966585|Posaconazole|posaconazole|mesh-list
43836546|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
43836547|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836548|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43836549|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43836550|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43836551|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43836552|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43836553|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836554|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836555|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43836556|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
43836557|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672228|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672229|NCT02462811|Acetaminophen|acetaminophen|mesh-list
43672230|NCT02462811|Promethazine|promethazine|mesh-list
43672231|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
43672232|NCT02462811|Hydrocodone|hydrocodone|mesh-list
43672233|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43672234|NCT02462811|Analgesics|analgesics|mesh-ancestor
43836558|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836559|NCT04965701|Osimertinib|osimertinib|mesh-list
43836560|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836561|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836562|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836563|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836564|NCT04965181|Nicotine|nicotine|mesh-list
43836565|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43836566|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
43836567|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836568|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836569|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43836570|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43572809|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43572810|NCT03532178|Rocuronium|rocuronium|mesh-list
43572811|NCT03532178|Succinylcholine|succinylcholine|mesh-list
43572812|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43572813|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43572814|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43572815|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572816|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672235|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
43672236|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672237|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672238|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
43672239|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43672240|NCT02462811|Narcotics|narcotics|mesh-ancestor
43672241|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672242|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
43672243|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
43672244|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
43572817|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43572818|NCT03532087|Denosumab|denosumab|mesh-list
43836571|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
43836572|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836573|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836574|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
43836575|NCT04965116|Progestins|progestins|mesh-list
43836576|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43836577|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836579|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836580|NCT04965064|Capecitabine|capecitabine|mesh-list
43836581|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43836582|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
43836583|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836584|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836585|NCT04964934|Letrozole|letrozole|mesh-list
43836586|NCT04964934|Palbociclib|palbociclib|mesh-list
43836587|NCT04964934|Anastrozole|anastrozole|mesh-list
43836588|NCT04964934|Hormones|hormones|mesh-list
43836589|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43836590|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672245|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672246|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43672247|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
43577360|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577361|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577362|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577363|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
43577378|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577380|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43577381|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577382|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577383|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
43577384|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577385|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577386|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
43577387|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577388|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
43577389|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43577390|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577391|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43577392|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43577393|NCT03490487|Analgesics|analgesics|mesh-ancestor
43577394|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
43577395|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43577396|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43836591|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836592|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836593|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43752859|NCT02488642|Isosorbide|isosorbide|mesh-list
43752860|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43752861|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43752862|NCT02488642|Misoprostol|misoprostol|mesh-list
43752863|NCT02488642|Oxytocin|oxytocin|mesh-list
43752864|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
43752865|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43752866|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752867|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43572819|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43572820|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572821|NCT03532035|Brincidofovir|brincidofovir|mesh-list
43572822|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
43572823|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572824|NCT03531970|Dexamethasone|dexamethasone|mesh-list
43572825|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
43572826|NCT03531970|Lidocaine|lidocaine|mesh-list
43572827|NCT03531970|Epinephrine|epinephrine|mesh-list
43572828|NCT03531970|BB 1101|bb 1101|mesh-list
43572829|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752868|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
43752869|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43752870|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43752871|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43752872|NCT02488642|Diuretics|diuretics|mesh-ancestor
43577397|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43577398|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43577399|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43577400|NCT03490396|Povidone|povidone|mesh-list
43577401|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
43577402|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43672266|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
43672267|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752873|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
43752874|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
43752875|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43752876|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752877|NCT02488486|Remifentanil|remifentanil|mesh-list
43752878|NCT02488486|Propofol|propofol|mesh-list
43752879|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43752880|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752881|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752882|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43752883|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
43752884|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
43672268|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672269|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672270|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
43672271|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672272|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672273|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
43672274|NCT02437136|Entinostat|entinostat|mesh-list
43672275|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672278|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672294|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43672295|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
43672296|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672297|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43672298|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672299|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43672300|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672301|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43672302|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672303|NCT02413827|Ipilimumab|ipilimumab|mesh-list
43672304|NCT02413827|Poly ICLC|poly iclc|mesh-list
43672305|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43672306|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672307|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672308|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43672309|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672310|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
43752885|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43752886|NCT02488486|Narcotics|narcotics|mesh-ancestor
43752887|NCT02488486|Analgesics|analgesics|mesh-ancestor
43672311|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
43672312|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672313|NCT02389985|Paclitaxel|paclitaxel|mesh-list
43672314|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43672316|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
43672344|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43672345|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672357|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672359|NCT02341989|Carboplatin|carboplatin|mesh-list
43672360|NCT02341989|Etoposide|etoposide|mesh-list
43672361|NCT02341989|Bleomycin|bleomycin|mesh-list
43672362|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577406|NCT03490396|Protective Agents|protective agents|mesh-ancestor
43577407|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
43577408|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
43577410|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577411|NCT03490123|Azithromycin|azithromycin|mesh-list
43577412|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577413|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577414|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
43577415|NCT03490097|Simvastatin|simvastatin|mesh-list
43577416|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43577417|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43577418|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
43577419|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577420|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43577421|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43577422|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577424|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577425|NCT03490019|Metformin|metformin|mesh-list
43577426|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43577429|NCT03489928|Dinoprostone|dinoprostone|mesh-list
43577430|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43577431|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
43577432|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43577433|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577434|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43577435|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577436|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
43577437|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43577438|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43577439|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577440|NCT03489837|Dipropizine|dipropizine|mesh-list
43577441|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
43577442|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
43577443|NCT03489798|Alprostadil|alprostadil|mesh-list
43577444|NCT03489798|Misoprostol|misoprostol|mesh-list
43672363|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43672364|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43672365|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43672366|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672367|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672368|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43672369|NCT02339129|Ibuprofen|ibuprofen|mesh-list
43672370|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43672371|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43577479|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43577480|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43577481|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43577483|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577484|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577485|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577486|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43577487|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43577488|NCT03489395|Edoxaban|edoxaban|mesh-list
43577489|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43577490|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
43577491|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43577492|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
43577493|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577519|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43577520|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577521|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577522|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43577523|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43577524|NCT03489161|Buprenorphine|buprenorphine|mesh-list
43577525|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43577526|NCT03489161|Narcotics|narcotics|mesh-ancestor
43577527|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577528|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577529|NCT03489161|Analgesics|analgesics|mesh-ancestor
43577530|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
43577531|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577532|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43577533|NCT03489044|Levetiracetam|levetiracetam|mesh-list
43577534|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
43577535|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
43577536|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
43577537|NCT03489005|Zamicastat|zamicastat|mesh-list
43577538|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577539|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577540|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43577541|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43577569|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
43577570|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577571|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577572|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
43577573|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
43577574|NCT03488485|Ledipasvir|ledipasvir|mesh-list
43577575|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577576|NCT03488316|Calcium|calcium|mesh-list
43672379|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672380|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556714|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752888|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
43752889|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752890|NCT02488057|Liraglutide|liraglutide|mesh-list
43752891|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752892|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752893|NCT02488057|Incretins|incretins|mesh-ancestor
43752905|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43752906|NCT02488291|Narcotics|narcotics|mesh-ancestor
43752907|NCT02488291|Analgesics|analgesics|mesh-ancestor
43752908|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43752909|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43752910|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
43752911|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43752912|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43752913|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43752914|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43752915|NCT02487953|Nicotine|nicotine|mesh-list
43752916|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43752917|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
43752918|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752919|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752920|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43672381|NCT02339064|Apomorphine|apomorphine|mesh-list
43672382|NCT02339064|Emetics|emetics|mesh-ancestor
43672383|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672384|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
43672385|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672386|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43672387|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
43672388|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
43672389|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672390|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577577|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43577578|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577579|NCT03488186|Lansoprazole|lansoprazole|mesh-list
43752921|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43752922|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
43752923|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752924|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752925|NCT02487914|Lidocaine|lidocaine|mesh-list
43752926|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
43752927|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
43752928|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752929|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577580|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
43577581|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43577582|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577583|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43577584|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577585|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577586|NCT03488173|Lansoprazole|lansoprazole|mesh-list
43577587|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
43577588|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43577589|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577590|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43577591|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577592|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577593|NCT03488147|Esomeprazole|esomeprazole|mesh-list
43577594|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43577595|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577596|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43577597|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577598|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577599|NCT03487939|Fluorouracil|fluorouracil|mesh-list
43577600|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
43577601|NCT03487939|Irinotecan|irinotecan|mesh-list
43577602|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
43577603|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577604|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43577605|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577606|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43577608|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577609|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43577610|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43577611|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577612|NCT03487874|Ropivacaine|ropivacaine|mesh-list
43577613|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
43577614|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
43577615|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577616|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577617|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
43577618|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577619|NCT03487809|Budesonide|budesonide|mesh-list
43577620|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577621|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43577622|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
43577623|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672399|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672400|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43672401|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672403|NCT02333643|Furosemide|furosemide|mesh-list
43672404|NCT02333643|Diuretics|diuretics|mesh-ancestor
43672405|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
43672406|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672407|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43672408|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43672409|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672410|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43752930|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
43752931|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752932|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43752933|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43752934|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43752935|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43752937|NCT02487680|Chromium|chromium|mesh-list
43752947|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43752948|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43752949|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752950|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752951|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43752952|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43752953|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
43752954|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752955|NCT02487732|Ticagrelor|ticagrelor|mesh-list
43752956|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43752957|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43672411|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43672412|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577629|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577630|NCT03487783|Aripiprazole|aripiprazole|mesh-list
43577631|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43577632|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
43577633|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43577634|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43577635|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43577636|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577637|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577638|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
43577639|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
43577640|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577641|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577642|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43577643|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43577644|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
43577645|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43577646|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43577647|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43577648|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43577649|NCT03487770|Aripiprazole|aripiprazole|mesh-list
43577650|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43577651|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
43577652|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43577653|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43577654|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43577655|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672413|NCT02333643|Protective Agents|protective agents|mesh-ancestor
43672414|NCT02331134|Lenograstim|lenograstim|mesh-list
43672415|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43672416|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
43672417|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672418|NCT02326454|Talaporfin|talaporfin|mesh-list
43752958|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43752959|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43752960|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43752961|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
43752962|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752963|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752965|NCT02487823|Bicalutamide|bicalutamide|mesh-list
43752966|NCT02487823|Buserelin|buserelin|mesh-list
43752967|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
43752968|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
43752969|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672419|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672424|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43672425|NCT02324985|Analgesics|analgesics|mesh-ancestor
43672426|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
43672427|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672428|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672429|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672430|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672431|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43672432|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672433|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577656|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577657|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
43577658|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
43577659|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577660|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577661|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43577662|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43577663|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
43577664|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43577665|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43572830|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
43572831|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
43572832|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572833|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572834|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43572835|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
43572836|NCT03531970|Hormones|hormones|mesh-ancestor
43572837|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43572838|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43572839|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577666|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43577667|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43577670|NCT03487562|Lansoprazole|lansoprazole|mesh-list
43577671|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
43577672|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577673|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577674|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43577675|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577676|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577677|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43577678|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43577679|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43577680|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577681|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43577683|NCT03487406|Ticagrelor|ticagrelor|mesh-list
43577684|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43577685|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43577686|NCT03487406|Analgesics|analgesics|mesh-ancestor
43577687|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
43577688|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577689|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672434|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
43672435|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672436|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672437|NCT02320708|Acetaminophen|acetaminophen|mesh-list
43672438|NCT02320708|Ibuprofen|ibuprofen|mesh-list
43672439|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43672440|NCT02320708|Analgesics|analgesics|mesh-ancestor
43672441|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
43672442|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672443|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672444|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
43672445|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43672446|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672447|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672448|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43672449|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672450|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672451|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43672452|NCT02309671|Hormones|hormones|mesh-ancestor
43672453|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672454|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672455|NCT02306291|Cytarabine|cytarabine|mesh-list
43672456|NCT02306291|Etoposide|etoposide|mesh-list
43672457|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
43672458|NCT02306291|Idarubicin|idarubicin|mesh-list
43672462|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43672463|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577690|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577691|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43577692|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43577693|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43577694|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577695|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43572840|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572841|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572842|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572843|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
43572844|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
43572853|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
43572854|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43572855|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43572856|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43572857|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43572858|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
43572859|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
43572860|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
43572861|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43572862|NCT03531931|Apatinib|apatinib|mesh-list
43572863|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572864|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43752970|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752971|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752972|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43752973|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
43752974|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43752975|NCT02487719|Teferrol|teferrol|mesh-list
43752976|NCT02487719|Hematinics|hematinics|mesh-ancestor
43752977|NCT02487433|Tofacitinib|tofacitinib|mesh-list
43752978|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43752979|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752980|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752981|NCT02487407|Simendan|simendan|mesh-list
43752982|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43752983|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
43577696|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43577697|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577698|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
43577699|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43577700|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43577701|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43577702|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
43577703|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577704|NCT03487354|Misoprostol|misoprostol|mesh-list
43672464|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672465|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43672466|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
43672467|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
43752984|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43752985|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43752986|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752987|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752988|NCT02487407|Protective Agents|protective agents|mesh-ancestor
43752989|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752990|NCT02487381|Dronabinol|dronabinol|mesh-list
43752991|NCT02487381|Cannabidiol|cannabidiol|mesh-list
43752992|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
43752993|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
43752994|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752995|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43752996|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752997|NCT02487381|Analgesics|analgesics|mesh-ancestor
43752998|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
43752999|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753000|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43753001|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43753002|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753003|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753004|NCT02487381|Hormones|hormones|mesh-ancestor
43753033|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43753034|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43753035|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43753036|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
43753037|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43753045|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43753046|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
43753047|NCT02487212|Hormones|hormones|mesh-ancestor
43753048|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753049|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753050|NCT02487212|Emollients|emollients|mesh-ancestor
43753051|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
43753052|NCT02487069|Cyclosporine|cyclosporine|mesh-list
43753053|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
43753054|NCT02487069|Methotrexate|methotrexate|mesh-list
43753055|NCT02487069|Cyclosporins|cyclosporins|mesh-list
43753056|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43672468|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672469|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672470|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
43672471|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672472|NCT02306291|Analgesics|analgesics|mesh-ancestor
43672473|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
43672474|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672475|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43672476|NCT02302079|Ranibizumab|ranibizumab|mesh-list
43672477|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43672478|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43672479|NCT02302079|Growth Substances|growth substances|mesh-ancestor
43672480|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672481|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
43672482|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672483|NCT02301234|Celecoxib|celecoxib|mesh-list
43672484|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43577705|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43577706|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
43577707|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43577708|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577709|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43577710|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577711|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
43577712|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43753057|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43753058|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
43753059|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43753060|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753061|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43753062|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
43753063|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753064|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753065|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
43753066|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753067|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43753068|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43753069|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
43753070|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43753071|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43753072|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
43753073|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753074|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43753075|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43753079|NCT02487082|Melatonin|melatonin|mesh-list
43753088|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
43753089|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753090|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
43753091|NCT02486822|Oxytocin|oxytocin|mesh-list
43753092|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
43753093|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43753094|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753095|NCT02486848|Minoxidil|minoxidil|mesh-list
43753096|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43753097|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43753098|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753099|NCT02486926|Remifentanil|remifentanil|mesh-list
43577713|NCT03487211|Citalopram|citalopram|mesh-list
43577714|NCT03487211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43577715|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43577716|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577717|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577718|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577719|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
43577720|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577721|NCT03487211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43577722|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
43577723|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43753100|NCT02486926|Alfentanil|alfentanil|mesh-list
43753101|NCT02486926|Thiopental|thiopental|mesh-list
43753102|NCT02486926|Sevoflurane|sevoflurane|mesh-list
43753103|NCT02486926|Rocuronium|rocuronium|mesh-list
43753104|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43753105|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43753106|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
43753107|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
43753108|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753109|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753110|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43753111|NCT02486926|Narcotics|narcotics|mesh-ancestor
43753112|NCT02486926|Analgesics|analgesics|mesh-ancestor
43753113|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
43753114|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753115|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43572869|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577724|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577725|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43577726|NCT03487211|Analgesics|analgesics|mesh-ancestor
43577728|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
43577729|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
43577730|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
43577731|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577732|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577733|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577734|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
43577736|NCT03487172|Mannitol|mannitol|mesh-list
43577737|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43672485|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43672486|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43672487|NCT02301234|Analgesics|analgesics|mesh-ancestor
43672488|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
43672489|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672490|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672491|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672492|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672493|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43672494|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43672495|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672496|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672497|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
43672498|NCT02300142|Vaccines|vaccines|mesh-list
43672499|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
43672500|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672501|NCT02296645|Ethanol|ethanol|mesh-list
43577738|NCT03487172|Diuretics|diuretics|mesh-ancestor
43577739|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
43577740|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577741|NCT03487133|Dexamethasone|dexamethasone|mesh-list
43577742|NCT03487133|Bortezomib|bortezomib|mesh-list
43577743|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577744|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
43572870|NCT03531749|Protective Agents|protective agents|mesh-ancestor
43572871|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572872|NCT03531749|Vitamins|vitamins|mesh-ancestor
43572873|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
43572874|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43572875|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43572876|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43753116|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43753117|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43753118|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43753119|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
43753120|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43753121|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
43753122|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
43753123|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753124|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753125|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43753126|NCT02486744|Hormones|hormones|mesh-ancestor
43577745|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
43577746|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577747|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577748|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577749|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
43577750|NCT03487133|Hormones|hormones|mesh-ancestor
43577751|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577752|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43577753|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577754|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
43577755|NCT03487107|Yimitasvir|yimitasvir|mesh-list
43577756|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
43577757|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577758|NCT03487042|Bimatoprost|bimatoprost|mesh-list
43577759|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43577760|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43577761|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43577762|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
43577763|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43577764|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43577765|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
43577766|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577767|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577768|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577769|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
43577770|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
43577771|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577772|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
43577773|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43577774|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
43577775|NCT03487003|Bromides|bromides|mesh-list
43577776|NCT03487003|Rocuronium|rocuronium|mesh-list
43577777|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
43577778|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43577779|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43672502|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
43672503|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43672504|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43753127|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753128|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753129|NCT02486432|Levodopa|levodopa|mesh-list
43753130|NCT02486432|Carbidopa|carbidopa|mesh-list
43753131|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43753132|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43753133|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43753134|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
43753135|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753136|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672505|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672506|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672507|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672508|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
43672509|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672510|NCT02295865|Toreforant|toreforant|mesh-list
43672511|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
43672512|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
43672513|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672514|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672515|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827323|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827324|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827325|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43827326|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827327|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577780|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43577781|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577782|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577783|NCT03486925|Oxytocin|oxytocin|mesh-list
43577784|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
43577785|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43577786|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577787|NCT03486626|Metformin|metformin|mesh-list
43577788|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43577789|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577790|NCT03486561|Ranolazine|ranolazine|mesh-list
43577791|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43577792|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577793|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672529|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
43753137|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753138|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43753139|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753140|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43753141|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
43753142|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
43672530|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672531|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672532|NCT02255409|Vaccines|vaccines|mesh-list
43672533|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
43672534|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672535|NCT02252835|Colchicine|colchicine|mesh-list
43672536|NCT02252835|Febuxostat|febuxostat|mesh-list
43672537|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
43672538|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672539|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
43672540|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672541|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672542|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672543|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672549|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672550|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43672551|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43672552|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43672553|NCT02224235|Aspirin|aspirin|mesh-list
43672554|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43672555|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43672556|NCT02224235|Analgesics|analgesics|mesh-ancestor
43672557|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
43672558|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672559|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672560|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672561|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672562|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43672563|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43672564|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672565|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43672566|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43672567|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672568|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
43672569|NCT02221232|Ethanol|ethanol|mesh-list
43577794|NCT03486548|Dexamethasone|dexamethasone|mesh-list
43577795|NCT03486548|Lidocaine|lidocaine|mesh-list
43577796|NCT03486548|Bupivacaine|bupivacaine|mesh-list
43577797|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577798|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
43577799|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
43577800|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577801|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577802|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577803|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
43577804|NCT03486548|Hormones|hormones|mesh-ancestor
43577840|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577841|NCT03486184|Cystatins|cystatins|mesh-list
43577842|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43577843|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
43577844|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577845|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577846|NCT03486119|Nivolumab|nivolumab|mesh-list
43577847|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43577848|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577849|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43577850|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577851|NCT03486106|Propofol|propofol|mesh-list
43577852|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43577853|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577854|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577855|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43577856|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
43577857|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
43577858|NCT03486080|Lenograstim|lenograstim|mesh-list
43672584|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672586|NCT02206100|Enoxaparin|enoxaparin|mesh-list
43672587|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
43672588|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43672589|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43672590|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672591|NCT02206087|Heparin|heparin|mesh-list
43672592|NCT02206087|Calcium heparin|calcium heparin|mesh-list
43672593|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
43672594|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43577863|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43577864|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43577865|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
43577866|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577867|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577868|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43577869|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43577870|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
43577871|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577872|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43577873|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43577874|NCT03485703|Azithromycin|azithromycin|mesh-list
43577875|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577876|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577877|NCT03485625|Acetaminophen|acetaminophen|mesh-list
43577878|NCT03485625|Ketorolac|ketorolac|mesh-list
43577879|NCT03485625|Lidocaine|lidocaine|mesh-list
43577880|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
43577881|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
43577882|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577883|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577884|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
43577885|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577886|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43577887|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43577888|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43672595|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43672596|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672597|NCT02205528|Metformin|metformin|mesh-list
43672610|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672611|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556977|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
43753143|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
43753154|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753155|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43753156|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43753157|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
43753158|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753159|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43753160|NCT02486549|Bupivacaine|bupivacaine|mesh-list
43753161|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
43753162|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
43753163|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753164|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753165|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
43753166|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753167|NCT02486601|Paclitaxel|paclitaxel|mesh-list
43753168|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43753169|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753170|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
43753171|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
43753213|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43753214|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
43753215|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753216|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753217|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43753218|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43753219|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
43753220|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753221|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43753222|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43753223|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43753224|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43753225|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43753226|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43753227|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
43753228|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
43753229|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753230|NCT02486055|Vitamins|vitamins|mesh-ancestor
43753232|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
43753249|NCT02486276|Protective Agents|protective agents|mesh-ancestor
43753250|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43753251|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43753252|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753253|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43753254|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43753255|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43753256|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
43753257|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753258|NCT02485990|Olaparib|olaparib|mesh-list
43753259|NCT02485990|Tremelimumab|tremelimumab|mesh-list
43753260|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43753261|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672612|NCT02200380|Plerixafor|plerixafor|mesh-list
43672613|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43672614|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43672615|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
43672616|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672617|NCT02187302|Bevacizumab|bevacizumab|mesh-list
43753262|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753263|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753264|NCT02485821|Misoprostol|misoprostol|mesh-list
43753265|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43753266|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43753267|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43753268|NCT02485821|Estradiol|estradiol|mesh-list
43753269|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43753270|NCT02485821|Estrogens|estrogens|mesh-ancestor
43753271|NCT02485821|Hormones|hormones|mesh-ancestor
43753272|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753273|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753274|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43753275|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
43753276|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43753277|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43753278|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43753291|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
43572886|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43753307|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43672618|NCT02187302|Sunitinib|sunitinib|mesh-list
43672619|NCT02187302|Everolimus|everolimus|mesh-list
43672620|NCT02187302|Sorafenib|sorafenib|mesh-list
43672621|NCT02187302|Axitinib|axitinib|mesh-list
43672622|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672623|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672624|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43672625|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43577889|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577890|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577891|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43577892|NCT03485625|Analgesics|analgesics|mesh-ancestor
43577893|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
43577894|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43577895|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577896|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43577897|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43577898|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577900|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43577901|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
43577902|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
43577903|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672626|NCT02187302|Growth Substances|growth substances|mesh-ancestor
43753308|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43753309|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
43753310|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753311|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43753314|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43753315|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
43753316|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
43753317|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753329|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753330|NCT02485444|Oxytocin|oxytocin|mesh-list
43753331|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
43753332|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43753333|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753334|NCT02485340|Isosorbide|isosorbide|mesh-list
43753335|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43753336|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43753337|NCT02485340|Sumatriptan|sumatriptan|mesh-list
43753338|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43753339|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43753340|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43753341|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
43753342|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753343|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753344|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753360|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
43753361|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753362|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753363|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43753364|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
43753365|NCT02485249|Hormones|hormones|mesh-ancestor
43753366|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753372|NCT02485145|Diclofenac|diclofenac|mesh-list
43753378|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753379|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753380|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
43753381|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753382|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43557176|NCT03545711|Irinotecan|irinotecan|mesh-list
43753383|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43753384|NCT02485145|Analgesics|analgesics|mesh-ancestor
43557254|NCT03544723|Nivolumab|nivolumab|mesh-list
43753427|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753428|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43753429|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
43753430|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
43753431|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753432|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753433|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43753434|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43753442|NCT02485080|Simeprevir|simeprevir|mesh-list
43753443|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
43753444|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753445|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
43753446|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753447|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753448|NCT02485106|Rifaximin|rifaximin|mesh-list
43753480|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753481|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
43753482|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
43753483|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
43753517|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43753518|NCT02484170|Diuretics|diuretics|mesh-ancestor
43753527|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
43753528|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43753529|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753530|NCT02484261|Bortezomib|bortezomib|mesh-list
43753561|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43753562|NCT02483715|Rabeprazole|rabeprazole|mesh-list
43753563|NCT02483715|Bismuth|bismuth|mesh-list
43753564|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43753565|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753566|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
43753567|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43753568|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43753569|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43753570|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43753571|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753572|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753573|NCT02483715|Antacids|antacids|mesh-ancestor
43753574|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43753575|NCT02483793|Tamsulosin|tamsulosin|mesh-list
43753576|NCT02483793|Oxybutynin|oxybutynin|mesh-list
43753577|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43753578|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43753579|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43753580|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
43753581|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753582|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753583|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753584|NCT02483793|Urological Agents|urological agents|mesh-ancestor
43753603|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43753604|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
43753605|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43753606|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43753607|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43753608|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753699|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
43753700|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753701|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753702|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43753703|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43753704|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43753705|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43753706|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753707|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43753708|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43753709|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753710|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
43753711|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43753712|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
43753713|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43753733|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43753734|NCT02483221|Narcotics|narcotics|mesh-ancestor
43753735|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753736|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753757|NCT02483026|Vitamin D|vitamin d|mesh-list
43753758|NCT02483026|Vitamins|vitamins|mesh-list
43753759|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
43753760|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753761|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43753762|NCT02483104|Paclitaxel|paclitaxel|mesh-list
43753763|NCT02483104|Carboplatin|carboplatin|mesh-list
43753764|NCT02483104|Veliparib|veliparib|mesh-list
43753765|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43753766|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753767|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
43753768|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
43753769|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
43753770|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753771|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43753772|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753773|NCT02482740|Tamoxifen|tamoxifen|mesh-list
43753795|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
43753796|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753797|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753798|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43753799|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572970|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
43572971|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43572972|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572984|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43572985|NCT03530462|Antibodies|antibodies|mesh-list
43572986|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
43753867|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753868|NCT02482155|Ibuprofen|ibuprofen|mesh-list
43753880|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
43572997|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43572998|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573000|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
43573002|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573051|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573052|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847853|NCT04073316|Warfarin|warfarin|mesh-list
43754035|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
43754036|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
43754037|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
43573072|NCT03530085|Fludarabine|fludarabine|mesh-list
43573073|NCT03530085|Busulfan|busulfan|mesh-list
43573074|NCT03530085|Decitabine|decitabine|mesh-list
43573075|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573076|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43573077|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
43573078|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573079|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43573080|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
43573086|NCT03530033|Lidocaine|lidocaine|mesh-list
43754104|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
43754107|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
43754172|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43754173|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43573115|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43573116|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
43573117|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573118|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573119|NCT03530007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43573120|NCT03530007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43573121|NCT03530007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754187|NCT02479815|Micronutrients|micronutrients|mesh-list
43754258|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43754348|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
43754349|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754350|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754351|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
43754352|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43754353|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754356|NCT02479178|Docetaxel|docetaxel|mesh-list
43754456|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43573314|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43754610|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43754611|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43754612|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
43573340|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43573341|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573342|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754613|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43754614|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43754615|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754616|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43754617|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754619|NCT02477501|Ephedrine|ephedrine|mesh-list
43754620|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43754621|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43754622|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
43754623|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754624|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558578|NCT03532711|Antidotes|antidotes|mesh-ancestor
43573347|NCT03528785|Vitamins|vitamins|mesh-ancestor
43754651|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43573383|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43573384|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43573385|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43573386|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
43754652|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754653|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43754654|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
43754662|NCT02477397|Hormones|hormones|mesh-ancestor
43754671|NCT02477267|Buprenorphine|buprenorphine|mesh-list
43754673|NCT02477267|Naloxone|naloxone|mesh-list
43754734|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754735|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754736|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
43754737|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754738|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43754781|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43754782|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43754783|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754796|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43754797|NCT02476981|Analgesics|analgesics|mesh-ancestor
43754844|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754845|NCT02476773|Antacids|antacids|mesh-ancestor
43754846|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754847|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754848|NCT02476708|Curcumin|curcumin|mesh-list
43754849|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43754850|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43754852|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
43754853|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754881|NCT02476760|Miglitol|miglitol|mesh-list
43754882|NCT02476760|Troglitazone|troglitazone|mesh-list
43754883|NCT02476760|Meglitinide|meglitinide|mesh-list
43754884|NCT02476760|Acetohexamide|acetohexamide|mesh-list
43754885|NCT02476760|Phenformin|phenformin|mesh-list
43754956|NCT02475876|Clindamycin|clindamycin|mesh-list
43754957|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
43754958|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
43754959|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43754960|NCT02475876|Trimethoprim|trimethoprim|mesh-list
43754961|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
43754962|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43754963|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754964|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43754965|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754966|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754967|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43754968|NCT02475876|Renal Agents|renal agents|mesh-ancestor
43754969|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
43754970|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43754971|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43754972|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43754973|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43754974|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43754975|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43754976|NCT02475863|Warfarin|warfarin|mesh-list
43754977|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
43754978|NCT02475915|Tenofovir|tenofovir|mesh-list
43754980|NCT02475915|Efavirenz|efavirenz|mesh-list
43755012|NCT02475824|Meperidine|meperidine|mesh-list
43755013|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
43755014|NCT02475824|Propofol|propofol|mesh-list
43755015|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43755016|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755017|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755018|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43755019|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
43755020|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
43755050|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755145|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755146|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43755147|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43755160|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755161|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43755162|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755163|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755164|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
43755165|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43755166|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755167|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43755168|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43755169|NCT02475317|Volixibat|volixibat|mesh-list
43755170|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43755171|NCT02474953|Curcumin|curcumin|mesh-list
43755172|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43755173|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43755174|NCT02474953|Analgesics|analgesics|mesh-ancestor
43755175|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
43755176|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755177|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755178|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43755179|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43755180|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755181|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755182|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755183|NCT02474914|Octreotide|octreotide|mesh-list
43755184|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755185|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43755186|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755187|NCT02475057|Hormones|hormones|mesh-list
43755188|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43755191|NCT02474667|Mitogens|mitogens|mesh-list
43672627|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672628|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
43672629|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672630|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
43755204|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
43755206|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43755282|NCT02474290|Sorafenib|sorafenib|mesh-list
43755283|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755285|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755286|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755287|NCT02474212|Enoxaparin|enoxaparin|mesh-list
43755288|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
43755289|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43755290|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43755291|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836803|NCT04947254|Cortisone|cortisone|mesh-list
43836804|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
43836805|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
43836806|NCT04947254|Niraparib|niraparib|mesh-list
43836807|NCT04947254|Hormones|hormones|mesh-list
43836808|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43755322|NCT02474134|Interferons|interferons|mesh-list
43755323|NCT02474134|Interferon-beta|interferon-beta|mesh-list
43755324|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
43755325|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755326|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
43755327|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755328|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
43755329|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755330|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43755331|NCT02474186|Paclitaxel|paclitaxel|mesh-list
43755332|NCT02474186|Docetaxel|docetaxel|mesh-list
43755333|NCT02474186|Capecitabine|capecitabine|mesh-list
43755334|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43755335|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755336|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
43755337|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
43755338|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
43755339|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755340|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43755341|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
43755342|NCT02473900|Oseltamivir|oseltamivir|mesh-list
43755343|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
43755344|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755347|NCT02473887|Ondansetron|ondansetron|mesh-list
43755366|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755367|NCT02473809|Incretins|incretins|mesh-ancestor
43755368|NCT02473809|Hormones|hormones|mesh-ancestor
43755369|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755370|NCT02473562|Varenicline|varenicline|mesh-list
43755371|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43755372|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43755373|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
43755374|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755375|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755376|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755458|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43755459|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
43755460|NCT02473263|Norepinephrine|norepinephrine|mesh-list
43755461|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43755462|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43755463|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43755464|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
43755465|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755466|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755467|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755468|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
43755501|NCT02473198|Morphine|morphine|mesh-list
43755550|NCT02472691|Lenalidomide|lenalidomide|mesh-list
43755551|NCT02472691|Azacitidine|azacitidine|mesh-list
43755552|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
43755553|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755554|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43755555|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43755556|NCT02472691|Growth Substances|growth substances|mesh-ancestor
43755557|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
43755558|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755559|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43755560|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
43755562|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755602|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755603|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755604|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
43755605|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573550|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43573551|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573552|NCT03526315|Fluorides|fluorides|mesh-list
43573553|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
43573554|NCT03526315|Protective Agents|protective agents|mesh-ancestor
43573555|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573556|NCT03526276|Fluorides|fluorides|mesh-list
43573557|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
43573581|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43573582|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43573583|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43573584|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43573589|NCT03525925|Nivolumab|nivolumab|mesh-list
43755705|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
43755706|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755707|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755708|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
43755709|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755710|NCT02472275|Protective Agents|protective agents|mesh-ancestor
43755711|NCT02472275|Vitamins|vitamins|mesh-ancestor
43755712|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
43755718|NCT02472236|Digoxin|digoxin|mesh-list
43559838|NCT03180684|Imiquimod|imiquimod|mesh-list
43755757|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43573671|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
43573672|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43573673|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
43573674|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43573675|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573676|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573677|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573678|NCT03524950|Analgesics|analgesics|mesh-ancestor
43573679|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
43755812|NCT02470923|Nicotine|nicotine|mesh-list
43755866|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43755867|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43755868|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
43755869|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836869|NCT04944095|Antibodies|antibodies|mesh-list
43755870|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755871|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43755873|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
43755901|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43755904|NCT02470546|Metformin|metformin|mesh-list
43573686|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573687|NCT03524937|Melatonin|melatonin|mesh-list
43573688|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
43755964|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43755966|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
43755967|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755968|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755969|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755970|NCT02469545|Citalopram|citalopram|mesh-list
43755971|NCT02469545|Sertraline|sertraline|mesh-list
43755972|NCT02469545|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43755973|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43755974|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43755975|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755976|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755977|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
43755978|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755979|NCT02469545|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43756005|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43756006|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43756007|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43756008|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756009|NCT02468908|Molgramostim|molgramostim|mesh-list
43756010|NCT02468908|Sargramostim|sargramostim|mesh-list
43756011|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
43756012|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573807|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43573808|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573809|NCT03523221|Dexamethasone|dexamethasone|mesh-list
43573810|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573811|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
43573812|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
43573813|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573814|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573816|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
43573856|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573857|NCT03522649|Leucovorin|leucovorin|mesh-list
43573858|NCT03522649|Fluorouracil|fluorouracil|mesh-list
43573859|NCT03522649|Irinotecan|irinotecan|mesh-list
43573860|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
43573861|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573862|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43573863|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573864|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43573865|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
43573866|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573870|NCT03522649|Antidotes|antidotes|mesh-ancestor
43756113|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
43756114|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43756115|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
43756116|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756117|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756119|NCT02468167|Polidocanol|polidocanol|mesh-list
43756120|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43756121|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43756122|NCT02467907|Paclitaxel|paclitaxel|mesh-list
43756123|NCT02467907|Bevacizumab|bevacizumab|mesh-list
43756124|NCT02467907|Carboplatin|carboplatin|mesh-list
43756125|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43756126|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756127|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
43756191|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
43756192|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
43756193|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756194|NCT02467595|Narcotics|narcotics|mesh-ancestor
43756195|NCT02467595|Analgesics|analgesics|mesh-ancestor
43756196|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
43756197|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573877|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
43573878|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573879|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
43573880|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
43756203|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43756204|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43756205|NCT02467543|Ethanol|ethanol|mesh-list
43756206|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43756207|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756208|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756239|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756240|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756261|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
43756283|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43756284|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
43756285|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43756286|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43756287|NCT02467673|Progestins|progestins|mesh-ancestor
43756288|NCT02467023|Lidocaine|lidocaine|mesh-list
43756289|NCT02467023|Fentanyl|fentanyl|mesh-list
43756290|NCT02467023|Midazolam|midazolam|mesh-list
43756291|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
43756292|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
43756293|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756294|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756295|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
43756296|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756297|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43756298|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43756299|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43756327|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43756328|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
43756329|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756330|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756331|NCT02466997|Tacrolimus|tacrolimus|mesh-list
43756332|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43756333|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
43756334|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756403|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
43756404|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
43756405|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43756512|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574063|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43574064|NCT03520985|Growth Substances|growth substances|mesh-ancestor
43574065|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
43574066|NCT03520946|Ramucirumab|ramucirumab|mesh-list
43756571|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
43756572|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756573|NCT02465801|Lenograstim|lenograstim|mesh-list
43756574|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43756575|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
43756576|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756577|NCT02465645|Carvedilol|carvedilol|mesh-list
43756578|NCT02465645|Simvastatin|simvastatin|mesh-list
43756579|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43756580|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43756627|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43756628|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756629|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756631|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
43756632|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
43756638|NCT02465255|Ketorolac|ketorolac|mesh-list
43756651|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756652|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756653|NCT02465255|Narcotics|narcotics|mesh-ancestor
43756654|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756655|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43756656|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43756657|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43756658|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
43756659|NCT02464722|Epinephrine|epinephrine|mesh-list
43756660|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
43756661|NCT02464722|Remifentanil|remifentanil|mesh-list
43756662|NCT02464722|Propofol|propofol|mesh-list
43756663|NCT02464722|Rocuronium|rocuronium|mesh-list
43756723|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756724|NCT02464683|Vitamin D|vitamin d|mesh-list
43756725|NCT02464683|Vitamins|vitamins|mesh-ancestor
43756726|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
43756727|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836958|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756728|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43756730|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43756731|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756732|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
43756733|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
43756734|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
43756735|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836959|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836988|NCT04939272|Venetoclax|venetoclax|mesh-list
43837016|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43837017|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837025|NCT04937699|Analgesics|analgesics|mesh-ancestor
43756736|NCT02464228|Tipifarnib|tipifarnib|mesh-list
43756737|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756738|NCT02464462|Vitamin D|vitamin d|mesh-list
43756739|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
43756740|NCT02464462|Calcium|calcium|mesh-list
43756741|NCT02464462|Vitamins|vitamins|mesh-ancestor
43756742|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
43756743|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756744|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43756745|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43756746|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
43756747|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43756748|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756749|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
43756750|NCT02463929|Promethazine|promethazine|mesh-list
43756751|NCT02463929|Ketamine|ketamine|mesh-list
43756752|NCT02463929|Bupivacaine|bupivacaine|mesh-list
43756753|NCT02463929|Sevoflurane|sevoflurane|mesh-list
43756760|NCT02463929|Analgesics|analgesics|mesh-ancestor
43756795|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43756796|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756797|NCT02463747|Vancomycin|vancomycin|mesh-list
43756798|NCT02463747|Meropenem|meropenem|mesh-list
43756799|NCT02463747|Tazobactam|tazobactam|mesh-list
43756800|NCT02463747|Piperacillin|piperacillin|mesh-list
43756801|NCT02463747|Ceftazidime|ceftazidime|mesh-list
43756849|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43756850|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43756851|NCT02463383|Ibuprofen|ibuprofen|mesh-list
43756852|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43756853|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43756854|NCT02463383|Analgesics|analgesics|mesh-ancestor
43756855|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
43756856|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756857|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756858|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756859|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43756860|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43756861|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756862|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756863|NCT02463513|Vitamins|vitamins|mesh-list
43756864|NCT02463513|Riboflavin|riboflavin|mesh-list
43756865|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
43756866|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
43756867|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756868|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43756869|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
43756870|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43756871|NCT02463318|Melatonin|melatonin|mesh-list
43756872|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
43756873|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756874|NCT02463318|Protective Agents|protective agents|mesh-ancestor
43756875|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756876|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756877|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43756878|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756879|NCT02463110|Sertraline|sertraline|mesh-list
43756883|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43756884|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43756885|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756887|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
43756888|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756889|NCT02462772|Cabotegravir|cabotegravir|mesh-list
43756890|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43756891|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43756892|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43756893|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43756894|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43756895|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43756896|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756897|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756898|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43756899|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43756900|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
43756901|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756902|NCT02462889|Aflibercept|aflibercept|mesh-list
43756903|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43756904|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43574105|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574106|NCT03520439|Mifepristone|mifepristone|mesh-list
43574107|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43574108|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
43574109|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43574110|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574111|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43574112|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43574113|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43574114|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
43574116|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43837049|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837050|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
43837051|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837052|NCT04935112|Pantoprazole|pantoprazole|mesh-list
43837053|NCT04935112|Famotidine|famotidine|mesh-list
43837054|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43837055|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837056|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43837057|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837058|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837059|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43837060|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
43837061|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
43837062|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837063|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837064|NCT04934904|Ropivacaine|ropivacaine|mesh-list
43837065|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
43837066|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
43837078|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837079|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
43837080|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43837081|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
43837082|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
43837083|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43757001|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
43757002|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574122|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43757003|NCT02462447|Choline|choline|mesh-list
43757004|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
43757005|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43757006|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
43757007|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757008|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757009|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43757010|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
43757011|NCT02462681|Ketamine|ketamine|mesh-list
43757012|NCT02462681|Analgesics|analgesics|mesh-ancestor
43757013|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
43757014|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757084|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
43574142|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574143|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574144|NCT03519750|Melatonin|melatonin|mesh-list
43574145|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
43574146|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757149|NCT02462044|Iodine|iodine|mesh-list
43757213|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43757215|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
43757216|NCT02461667|Alendronate|alendronate|mesh-list
43757217|NCT02461667|Metformin|metformin|mesh-list
43757218|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43757219|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757220|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43757221|NCT02461329|Polygeline|polygeline|mesh-list
43757222|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
43757223|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
43757224|NCT02461368|Triamcinolone|triamcinolone|mesh-list
43757227|NCT02461368|Lidocaine|lidocaine|mesh-list
43574188|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
43757253|NCT02461004|Ezetimibe|ezetimibe|mesh-list
43757254|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43757255|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43757256|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
43757257|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757258|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43757259|NCT02461056|Ibuprofen|ibuprofen|mesh-list
43757260|NCT02461056|Hydromorphone|hydromorphone|mesh-list
43757261|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43757315|NCT02461030|Protective Agents|protective agents|mesh-ancestor
43757318|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837094|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837095|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43837096|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
43837097|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
43837098|NCT04934072|Denosumab|denosumab|mesh-list
43837099|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43837100|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837101|NCT04933526|Dasatinib|dasatinib|mesh-list
43837102|NCT04933526|HH-GV-678|hh-gv-678|mesh-list
43837103|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837104|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43837105|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837106|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847867|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847868|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847869|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847870|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847871|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757337|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
43757338|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757339|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757340|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
43757341|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757342|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43757343|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43757344|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43757345|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43757346|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757347|NCT02460692|Dronabinol|dronabinol|mesh-list
43757348|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
43757349|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757371|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
43757430|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757431|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757432|NCT02460341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43757433|NCT02460341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43757434|NCT02460341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757435|NCT02460341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43757436|NCT02460341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43757437|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
43757438|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43757439|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43757440|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43757441|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43757442|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757443|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
43757444|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757445|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757448|NCT02460133|Ritonavir|ritonavir|mesh-list
43757463|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757464|NCT02460302|Progesterone|progesterone|mesh-list
43574233|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43574234|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43574235|NCT03518502|Sorafenib|sorafenib|mesh-list
43574236|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574237|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43849067|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574238|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574239|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574240|NCT03518489|Lappaconitine|lappaconitine|mesh-list
43574241|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43574242|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574243|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43574244|NCT03518489|Analgesics|analgesics|mesh-ancestor
43574245|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
43574246|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574247|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574248|NCT03518320|Gemcitabine|gemcitabine|mesh-list
43574249|NCT03518320|Nivolumab|nivolumab|mesh-list
43574250|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43574251|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
43574252|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574253|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574254|NCT03518320|Antiviral Agents|antiviral agents|mesh-ancestor
43574255|NCT03518320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757479|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757480|NCT02459938|Glucagon|glucagon|mesh-list
43757481|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43757482|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757483|NCT02459938|Hormones|hormones|mesh-ancestor
43757484|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757485|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757486|NCT02459938|Incretins|incretins|mesh-ancestor
43757497|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757498|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757499|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
43757500|NCT02460055|Hormones|hormones|mesh-ancestor
43757501|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757502|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43757503|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757504|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43574256|NCT03518320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574257|NCT03518320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574258|NCT03518320|Immunologic Factors|immunologic factors|mesh-ancestor
43574260|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43574261|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43574262|NCT03518021|Naloxone|naloxone|mesh-list
43574263|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43574264|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574265|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
43574266|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757530|NCT02460016|Ziresovir|ziresovir|mesh-list
43757531|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
43757532|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757533|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
43757534|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
43757535|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
43757536|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757537|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757549|NCT02459509|Analgesics|analgesics|mesh-ancestor
43757550|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
43757551|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757552|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43757553|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43757554|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43757558|NCT02459613|Annexin A5|annexin a5|mesh-list
43757615|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757616|NCT02458963|Menotropins|menotropins|mesh-list
43757617|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43757618|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
43757619|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43757620|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837121|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43837122|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
43837123|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
43837124|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
43837125|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43561940|NCT01594216|Exemestane|exemestane|mesh-list
43757621|NCT02458742|Morphine|morphine|mesh-list
43757622|NCT02458742|Bupivacaine|bupivacaine|mesh-list
43757623|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
43757641|NCT02458924|Niacin|niacin|mesh-list
43757673|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
43757674|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
43757675|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
43757676|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757677|NCT02458781|Metronidazole|metronidazole|mesh-list
43757678|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
43757693|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
43757702|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43757703|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
43757704|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757705|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
43757706|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
43757707|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43757708|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43757709|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43757710|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43757711|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757712|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757713|NCT02458547|Bupivacaine|bupivacaine|mesh-list
43757714|NCT02458547|Propofol|propofol|mesh-list
43757715|NCT02458547|Desflurane|desflurane|mesh-list
43757716|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
43757717|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
43757718|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757719|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757720|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
43757721|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672631|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43757722|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43757723|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43574280|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574281|NCT03517943|Loratadine|loratadine|mesh-list
43574282|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
43574283|NCT03517943|Ephedrine|ephedrine|mesh-list
43574284|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
43574285|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
43574287|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43574289|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
43574290|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
43574291|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574292|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574293|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574294|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43574295|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
43574296|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574297|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43574298|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
43574299|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
43574300|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43574301|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43574302|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
43574303|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574304|NCT03517930|Loratadine|loratadine|mesh-list
43574305|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
43574306|NCT03517930|Ephedrine|ephedrine|mesh-list
43574307|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
43574308|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
43574309|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43757724|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
43757725|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43757726|NCT02458625|Iron|iron|mesh-list
43757727|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43757728|NCT02458625|Trace Elements|trace elements|mesh-ancestor
43757729|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
43672632|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672633|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672635|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43757730|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757731|NCT02458625|Hematinics|hematinics|mesh-ancestor
43757732|NCT02458482|Albuterol|albuterol|mesh-list
43757733|NCT02458482|Ipratropium|ipratropium|mesh-list
43757734|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43757735|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
43757736|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757737|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757738|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43757739|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
43757740|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
43757741|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43757742|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43757743|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43757744|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43757745|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
43757746|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757747|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574310|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43574311|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43574312|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
43574313|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
43574314|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574315|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574316|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574317|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43574318|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
43574319|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574320|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43574321|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
43574322|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
43574323|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43574325|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
43574334|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574336|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757748|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43757749|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
43757750|NCT02458339|Methotrexate|methotrexate|mesh-list
43757751|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43757752|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
43757753|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43757754|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757755|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43757756|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
43757757|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757758|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757789|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43757790|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43757791|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
43757792|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43757793|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757794|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757795|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757796|NCT02458157|Furosemide|furosemide|mesh-list
43757797|NCT02458157|Diuretics|diuretics|mesh-ancestor
43757798|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
43757799|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757800|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43757811|NCT02458118|Secretin|secretin|mesh-list
43757869|NCT02457507|Vitamins|vitamins|mesh-ancestor
43757870|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
43757871|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757872|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
43757873|NCT02457507|Hematinics|hematinics|mesh-ancestor
43757874|NCT02457286|Metformin|metformin|mesh-list
43757875|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43757876|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757877|NCT02457351|Itraconazole|itraconazole|mesh-list
43757878|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
43757879|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757880|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43757881|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43757882|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574355|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574356|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574357|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
43757894|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757895|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43757896|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
43757897|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
43757898|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43757899|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43757900|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43574388|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43574389|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
43574390|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574391|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574392|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574393|NCT03517020|Nebivolol|nebivolol|mesh-list
43574394|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43574411|NCT03516903|Folic Acid|folic acid|mesh-list
43757907|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43757908|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43757909|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757910|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757911|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43757912|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
43757913|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757914|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757916|NCT02457208|Isoniazid|isoniazid|mesh-list
43757917|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
43757918|NCT02457208|Ethambutol|ethambutol|mesh-list
43757919|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43757920|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
43757921|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43757948|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43757949|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43757950|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
43757951|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757952|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757953|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757961|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757962|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
43757963|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757964|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43757965|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43757966|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
43757967|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757968|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757969|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43757970|NCT02457026|Triamcinolone|triamcinolone|mesh-list
43757971|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43757972|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43757973|NCT02457026|Aflibercept|aflibercept|mesh-list
43757974|NCT02457026|Verteporfin|verteporfin|mesh-list
43757976|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43757977|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
43757978|NCT02457026|Hormones|hormones|mesh-ancestor
43757979|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757980|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757981|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574448|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43574449|NCT03516656|Heparin|heparin|mesh-list
43574450|NCT03516656|Calcium heparin|calcium heparin|mesh-list
43758114|NCT02456428|Liraglutide|liraglutide|mesh-list
43758115|NCT02456428|Exenatide|exenatide|mesh-list
43574499|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
43574500|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43574501|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43574502|NCT03515772|Darunavir|darunavir|mesh-list
43574503|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43574504|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43574505|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
43574506|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574507|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574508|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43574509|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43574521|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574522|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
43574523|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574524|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
43574525|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574526|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43574527|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43574533|NCT03515668|Methylphenidate|methylphenidate|mesh-list
43562543|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758196|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758197|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758198|NCT02456129|Itraconazole|itraconazole|mesh-list
43758199|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
43758200|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758201|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43758202|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43758203|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758210|NCT02456207|Rituximab|rituximab|mesh-list
43758275|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43758276|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
43758277|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758278|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758279|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43758280|NCT02455921|Atropine|atropine|mesh-list
43758281|NCT02455921|Neostigmine|neostigmine|mesh-list
43758299|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43758300|NCT02455362|Morphine|morphine|mesh-list
43758301|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758302|NCT02455362|Narcotics|narcotics|mesh-ancestor
43758303|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758304|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574630|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574631|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
43574632|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837141|NCT04927975|Upadacitinib|upadacitinib|mesh-list
43837142|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43837143|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43837144|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837146|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574646|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43574647|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574648|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574649|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574650|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
43574651|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574652|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43574653|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43574654|NCT03514810|Analgesics|analgesics|mesh-ancestor
43574655|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
43574656|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758343|NCT02455440|Propofol|propofol|mesh-list
43574695|NCT03514381|Ifosfamide|ifosfamide|mesh-list
43574696|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43574697|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574698|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43574699|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43574700|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574701|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574702|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43758355|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43758356|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43758357|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
43758358|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758359|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758360|NCT02455271|Eszopiclone|eszopiclone|mesh-list
43758361|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43758362|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758363|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758364|NCT02455232|Lidocaine|lidocaine|mesh-list
43758365|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
43758366|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
43758367|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758368|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758369|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
43758370|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758371|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758372|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43758398|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43758399|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43758400|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758401|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758402|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43758403|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
43758404|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758405|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758505|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43758506|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43758507|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758508|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758509|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43758510|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574703|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
43574704|NCT03514342|Ropivacaine|ropivacaine|mesh-list
43574705|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
43574706|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
43574707|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574708|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574709|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
43574710|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574714|NCT03514030|Antibodies|antibodies|mesh-list
43574746|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574747|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574748|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
43574749|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43574750|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574751|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
43574752|NCT03513549|Loxapine|loxapine|mesh-list
43574753|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43574754|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43574755|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574756|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758552|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574786|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
43574787|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574788|NCT03513276|Epinephrine|epinephrine|mesh-list
43574789|NCT03513276|Racepinephrine|racepinephrine|mesh-list
43574790|NCT03513276|Ropivacaine|ropivacaine|mesh-list
43574791|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
43574792|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
43574793|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
43574794|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574795|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758553|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758555|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
43758556|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758557|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43758558|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
43758559|NCT02454348|Coagulants|coagulants|mesh-ancestor
43758560|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43758561|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
43758562|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
43758563|NCT02454205|Levofloxacin|levofloxacin|mesh-list
43758564|NCT02454205|Ofloxacin|ofloxacin|mesh-list
43758565|NCT02454205|Isoniazid|isoniazid|mesh-list
43758566|NCT02454205|Linezolid|linezolid|mesh-list
43574820|NCT03513055|Insulin|insulin|mesh-list
43574821|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43574822|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574823|NCT03512990|Bupivacaine|bupivacaine|mesh-list
43574824|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
43758577|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758578|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43758579|NCT02454205|Renal Agents|renal agents|mesh-ancestor
43758580|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43758581|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43758582|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
43758583|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43758584|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43758585|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
43758586|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43758587|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43758588|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
43758589|NCT02454088|Triamcinolone|triamcinolone|mesh-list
43758590|NCT02454088|Calcium|calcium|mesh-list
43758591|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43758592|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574859|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43574860|NCT03512834|Paclitaxel|paclitaxel|mesh-list
43574861|NCT03512834|Avelumab|avelumab|mesh-list
43574862|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43574863|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574864|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
43758619|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758621|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758622|NCT02453659|Nicotine|nicotine|mesh-list
43758623|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43758624|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
43758625|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758626|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758627|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43758628|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43574906|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574907|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574908|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43574910|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43574911|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574912|NCT03512171|Amphetamine|amphetamine|mesh-list
43574913|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
43574914|NCT03512171|Fallypride|fallypride|mesh-list
43574915|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43574916|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574917|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
43574918|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
43574919|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574920|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
43847874|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
43758660|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
43758661|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
43758662|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43758663|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43758725|NCT02453464|Leucovorin|leucovorin|mesh-list
43758736|NCT02453464|Vitamins|vitamins|mesh-ancestor
43758737|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
43758738|NCT02453425|Norepinephrine|norepinephrine|mesh-list
43758739|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43758740|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43758741|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
43758742|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758743|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758744|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758745|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
43758746|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
43758767|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758768|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43758769|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
43758770|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758771|NCT02452970|Antiviral Agents|antiviral agents|mesh-ancestor
43758772|NCT02452970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758773|NCT02452970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758774|NCT02452970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758775|NCT02452970|Immunologic Factors|immunologic factors|mesh-ancestor
43758776|NCT02452970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758777|NCT02452918|Oritavancin|oritavancin|mesh-list
43758778|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43758779|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758780|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
43758781|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43758782|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43758783|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
43758784|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758794|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758795|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43758796|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
43758797|NCT02453009|Hormones|hormones|mesh-ancestor
43758799|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758866|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43758867|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758868|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43758869|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758870|NCT02452125|Nicotine|nicotine|mesh-list
43758871|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43758880|NCT02452307|Imiquimod|imiquimod|mesh-list
43758953|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
43758954|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
43758955|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
43758956|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758979|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758980|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43758981|NCT02451852|Osimertinib|osimertinib|mesh-list
43758982|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758983|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43758984|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758985|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758986|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
43758987|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
43758988|NCT02451748|Prednisone|prednisone|mesh-list
43758989|NCT02451748|Triamcinolone|triamcinolone|mesh-list
43758990|NCT02451748|Naproxen|naproxen|mesh-list
43758991|NCT02451748|Methotrexate|methotrexate|mesh-list
43758992|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
43758993|NCT02451748|Leflunomide|leflunomide|mesh-list
43758994|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43758995|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
43758996|NCT02451748|Hormones|hormones|mesh-ancestor
43758997|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758998|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758999|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43759005|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
43837206|NCT04924062|Immunologic Factors|immunologic factors|mesh-ancestor
43837207|NCT04924062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837208|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43837209|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43837210|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43837211|NCT04923867|Estradiol|estradiol|mesh-list
43759026|NCT02451527|Digoxin|digoxin|mesh-list
43759027|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43759028|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43759029|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759030|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759031|NCT02451527|Protective Agents|protective agents|mesh-ancestor
43759032|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759033|NCT02451605|Analgesics|analgesics|mesh-list
43759034|NCT02451605|Ropivacaine|ropivacaine|mesh-list
43759036|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
43574966|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574967|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43574968|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574969|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574970|NCT03511560|Tacrolimus|tacrolimus|mesh-list
43574971|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43574972|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
43574973|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574974|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43759048|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759049|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759050|NCT02451475|Amitriptyline|amitriptyline|mesh-list
43759051|NCT02451475|Paroxetine|paroxetine|mesh-list
43759052|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43574989|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574990|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574991|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574992|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574993|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43574994|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759066|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43759067|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43759068|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43759069|NCT02451475|Analgesics|analgesics|mesh-ancestor
43759070|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
43759071|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759072|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43759073|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
43759074|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
43759075|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43759076|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759077|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43759078|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
43759079|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43759080|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43759081|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43759082|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759083|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759119|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759120|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43759121|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43759122|NCT02450981|Growth Substances|growth substances|mesh-ancestor
43759123|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759124|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
43759125|NCT02450968|Dexamethasone|dexamethasone|mesh-list
43759126|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759127|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
43759128|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
43759129|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759130|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759131|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43759132|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
43759134|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759135|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43759149|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759150|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
43759151|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759152|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759153|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
43759154|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43759155|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43759156|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
43759157|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759158|NCT02450838|Antacids|antacids|mesh-ancestor
43759159|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759160|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43759161|NCT02450773|Furosemide|furosemide|mesh-list
43759162|NCT02450773|Diuretics|diuretics|mesh-ancestor
43759163|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
43759164|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759165|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43759166|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43759167|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759168|NCT02450877|Azacitidine|azacitidine|mesh-list
43759169|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43759170|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
43759171|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759172|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759173|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759174|NCT02450682|Warfarin|warfarin|mesh-list
43759175|NCT02450682|Apixaban|apixaban|mesh-list
43759176|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
43759177|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43759183|NCT02450656|Docetaxel|docetaxel|mesh-list
43704556|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
43672636|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43672637|NCT02179151|Growth Substances|growth substances|mesh-ancestor
43672638|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672639|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
43672640|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672641|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43672642|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43759189|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759190|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43759191|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759192|NCT02450513|Adalimumab|adalimumab|mesh-list
43759193|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759194|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759195|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43759196|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
43759197|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43759198|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43759199|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759200|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759201|NCT02450188|Urological Agents|urological agents|mesh-ancestor
43759202|NCT02450214|Ketamine|ketamine|mesh-list
43759203|NCT02450214|Analgesics|analgesics|mesh-ancestor
43759204|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
43759205|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759206|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759207|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43759208|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43759209|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
43759210|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
43759211|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759212|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43759213|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43759235|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
43759236|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759237|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43759238|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
43759239|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43759240|NCT02450149|Sorafenib|sorafenib|mesh-list
43759252|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759253|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43759254|NCT02450084|Narcotics|narcotics|mesh-ancestor
43759255|NCT02450084|Analgesics|analgesics|mesh-ancestor
43759256|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43759257|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43759258|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
43759259|NCT02450045|Bupivacaine|bupivacaine|mesh-list
43759260|NCT02450045|Ropivacaine|ropivacaine|mesh-list
43759261|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
43759262|NCT02450045|Anesthetics|anesthetics|mesh-list
43759263|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759264|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759265|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
43759266|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759267|NCT02449954|Ketorolac|ketorolac|mesh-list
43759268|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43759269|NCT02449954|Morphine|morphine|mesh-list
43575052|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43575053|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575054|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575055|NCT03510351|Tazobactam|tazobactam|mesh-list
43575056|NCT03510351|Ceftolozane|ceftolozane|mesh-list
43575057|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
43575058|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43759270|NCT02449954|Tramadol|tramadol|mesh-list
43759271|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43759272|NCT02449954|Narcotics|narcotics|mesh-ancestor
43759273|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759274|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759275|NCT02449954|Analgesics|analgesics|mesh-ancestor
43759276|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
43759277|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759278|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43759281|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759283|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759284|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837212|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43837213|NCT04923867|Estrogens|estrogens|mesh-ancestor
43837214|NCT04923867|Hormones|hormones|mesh-ancestor
43837215|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837216|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837217|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43837218|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
43837219|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43837220|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43837221|NCT04923594|Mazindol|mazindol|mesh-list
43837222|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43672643|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
43672644|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672645|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43672646|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672647|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43577918|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
43577919|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577920|NCT03485404|Hematinics|hematinics|mesh-ancestor
43577921|NCT03485300|Warfarin|warfarin|mesh-list
43577922|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
43577923|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43577924|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43577925|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577926|NCT03485118|Rituximab|rituximab|mesh-list
43577927|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43577928|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577929|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
43577930|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577931|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43577932|NCT03485092|Empagliflozin|empagliflozin|mesh-list
43672650|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672651|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
43672652|NCT02160665|Tazarotene|tazarotene|mesh-list
43672653|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672654|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
43672655|NCT02158585|Lamotrigine|lamotrigine|mesh-list
43672656|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
43672657|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43672658|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43672659|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672660|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43672661|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672662|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43672663|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43672664|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672665|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672666|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43672667|NCT02153502|Quinidine|quinidine|mesh-list
43672668|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
43672669|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
43672670|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
43672671|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
43672672|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43672673|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43672674|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672675|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672676|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837223|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837224|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43837225|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43837226|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43837227|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837237|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43837238|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837239|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
43837240|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
43837241|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
43837242|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837243|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
43837244|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43837245|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
43847875|NCT04070833|Vitamins|vitamins|mesh-list
43759285|NCT02449941|Rabeprazole|rabeprazole|mesh-list
43759286|NCT02449941|Pantoprazole|pantoprazole|mesh-list
43577933|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43577934|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577935|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43577936|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577938|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43577944|NCT03484845|Trace Elements|trace elements|mesh-ancestor
43577945|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
43577946|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577947|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43577948|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
43577949|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
43577950|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
43577951|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672677|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43672678|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43672679|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
43672680|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43672681|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
43672682|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43672683|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43672684|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672685|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672686|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43672687|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43672688|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
43672689|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43672690|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43672691|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43672692|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43672693|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43672695|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
43672696|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672697|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
43672698|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672699|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672700|NCT02137343|Cisplatin|cisplatin|mesh-list
43672701|NCT02137343|Capecitabine|capecitabine|mesh-list
43672702|NCT02137343|Rilotumumab|rilotumumab|mesh-list
43672703|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759287|NCT02449941|Lansoprazole|lansoprazole|mesh-list
43759288|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
43759289|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43759290|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43759291|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43759292|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759293|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759294|NCT02449811|Amlodipine|amlodipine|mesh-list
43759295|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43759296|NCT02449811|Olmesartan|olmesartan|mesh-list
43759297|NCT02449811|Perindopril|perindopril|mesh-list
43672704|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43672705|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
43672706|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672707|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672708|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43577952|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577953|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
43577954|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577955|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43577956|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
43577957|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43577958|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577959|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577960|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
43672710|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672711|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672712|NCT02130687|Incretins|incretins|mesh-ancestor
43672713|NCT02130687|Hormones|hormones|mesh-ancestor
43672714|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672715|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43672716|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
43672717|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672718|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672719|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
43672720|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
43672721|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672722|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43672723|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43672724|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577976|NCT03484611|Cetrorelix|cetrorelix|mesh-list
43577977|NCT03484611|Menotropins|menotropins|mesh-list
43577978|NCT03484611|Progesterone|progesterone|mesh-list
43577979|NCT03484611|Progestins|progestins|mesh-ancestor
43577980|NCT03484611|Hormones|hormones|mesh-ancestor
43577981|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577982|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577983|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43577984|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43577985|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
43577986|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
43577987|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
43759298|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43759299|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43759300|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43759301|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759302|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43759303|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759304|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
43759305|NCT02449811|Diuretics|diuretics|mesh-ancestor
43759306|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
43759307|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43759308|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43759316|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
43577988|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
43577989|NCT03484507|Prednisolone|prednisolone|mesh-list
43577990|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43577991|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
43672729|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672730|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43672731|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
43672732|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577992|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43577993|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
43577994|NCT03484507|Povidone|povidone|mesh-list
43577995|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43577996|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
43577997|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577998|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
43577999|NCT03484507|Hormones|hormones|mesh-ancestor
43578000|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578001|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578002|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578003|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578004|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
43578005|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
43578006|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578007|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578011|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578012|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
43578013|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
43578014|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
43578015|NCT03484416|Vitamin D|vitamin d|mesh-list
43578016|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
43578017|NCT03484416|Calcium|calcium|mesh-list
43578018|NCT03484416|Vitamins|vitamins|mesh-ancestor
43578019|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
43578020|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672733|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672734|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672735|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672736|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43759317|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759318|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43759319|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43759320|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759321|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759323|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43759324|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
43759325|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43759327|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
43759328|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43759329|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
43759330|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759331|NCT02449538|Everolimus|everolimus|mesh-list
43672737|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672738|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
43672739|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672740|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43672741|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
43672742|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672743|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672744|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43672745|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43672746|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43672747|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
43672748|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672749|NCT02116998|Antacids|antacids|mesh-ancestor
43672750|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672751|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43672752|NCT02114060|Vaccines|vaccines|mesh-list
43672753|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
43672754|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672755|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
43672756|NCT02110368|Testosterone|testosterone|mesh-list
43672757|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
43672758|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
43672759|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43672760|NCT02110368|Androgens|androgens|mesh-ancestor
43672761|NCT02110368|Hormones|hormones|mesh-ancestor
43672765|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672780|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
43672781|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43672782|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672783|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43672784|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43672785|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672786|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672787|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672788|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43672789|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43672790|NCT02104050|Dapansutrile|dapansutrile|mesh-list
43672791|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672792|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
43578021|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43578022|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43759332|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759333|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759334|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
43759335|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759336|NCT02449564|Sirolimus|sirolimus|mesh-list
43759337|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43759338|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759339|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43759340|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759341|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
43759342|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759343|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
43759366|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43759367|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759368|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759369|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759370|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759371|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759372|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759373|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
43759374|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759375|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759376|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43759377|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
43759378|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43759379|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
43759380|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43759381|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43759382|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43759383|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43759384|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759387|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43759388|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759389|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759390|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759391|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759392|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759393|NCT02449486|Ropivacaine|ropivacaine|mesh-list
43759394|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
43759395|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
43759408|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43759409|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
43759410|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759411|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759412|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43759413|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43759414|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43759415|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43759416|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759417|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759418|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
43759419|NCT02449265|Hormones|hormones|mesh-ancestor
43759420|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759421|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43759422|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43759423|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759424|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759425|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759426|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
43578023|NCT03484416|Antacids|antacids|mesh-ancestor
43578024|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578025|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578026|NCT03484260|Testosterone|testosterone|mesh-list
43759427|NCT02449187|Metformin|metformin|mesh-list
43759428|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43759429|NCT02449187|Calcium|calcium|mesh-list
43759459|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
43759460|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43759461|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43759462|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
43759463|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759464|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759465|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
43759466|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43759467|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759469|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
43759470|NCT02449252|Doxorubicin|doxorubicin|mesh-list
43759471|NCT02449252|Vincristine|vincristine|mesh-list
43759472|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759473|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
43759474|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759475|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759476|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43759477|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
43759478|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759479|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759480|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43759481|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43759519|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759520|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
43759521|NCT02449278|Hormones|hormones|mesh-ancestor
43759522|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759523|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43759524|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43759525|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759526|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759527|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759528|NCT02448797|Vinorelbine|vinorelbine|mesh-list
43759529|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43759530|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575059|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575060|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43575061|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575062|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578027|NCT03484260|Androgens|androgens|mesh-ancestor
43578028|NCT03484260|Hormones|hormones|mesh-ancestor
43578029|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578030|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578031|NCT03484221|Fluorouracil|fluorouracil|mesh-list
43578032|NCT03484221|Capecitabine|capecitabine|mesh-list
43578033|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
43578034|NCT03484221|Irinotecan|irinotecan|mesh-list
43578035|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
43578036|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578037|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43578039|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43578040|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
43578042|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43578043|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43578044|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578046|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
43578047|NCT03484195|Irinotecan|irinotecan|mesh-list
43578048|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
43578049|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578050|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43578051|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578052|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43578053|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
43578054|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578055|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43578056|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43578057|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578058|NCT03484091|Hylan|hylan|mesh-list
43578059|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
43578060|NCT03484091|Protective Agents|protective agents|mesh-ancestor
43578061|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578062|NCT03483948|Azacitidine|azacitidine|mesh-list
43578063|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43578064|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
43575063|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43575064|NCT03510351|Renal Agents|renal agents|mesh-ancestor
43575065|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
43575066|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
43759532|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759533|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759534|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759536|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43759537|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759538|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759539|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
43759540|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759541|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759542|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
43759543|NCT02448901|Edoxaban|edoxaban|mesh-list
43759544|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43759545|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
43759546|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43759547|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
43759548|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759549|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759550|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
43759551|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
43575088|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
43575089|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
43575090|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575091|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43575092|NCT03510325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43759554|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759555|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
43759556|NCT02448407|Protective Agents|protective agents|mesh-ancestor
43759557|NCT02448550|Heparin|heparin|mesh-list
43759558|NCT02448550|Calcium heparin|calcium heparin|mesh-list
43759559|NCT02448550|Bivalirudin|bivalirudin|mesh-list
43759560|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
43759561|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43759562|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43759563|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759564|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
43759565|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43759566|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
43759567|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759568|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43759569|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
43759570|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43759571|NCT02448316|Prednisolone|prednisolone|mesh-list
43759572|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
43759573|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43759574|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
43759575|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759576|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
43759577|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
43759578|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759581|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
43759598|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43759599|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759600|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759601|NCT02448199|Meloxicam|meloxicam|mesh-list
43759602|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
43759603|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43759604|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43759605|NCT02448199|Analgesics|analgesics|mesh-ancestor
43759606|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
43759607|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759608|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759609|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759610|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43759611|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43759612|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759613|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837246|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837247|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837248|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43837249|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
43837250|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43837251|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
43837252|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837253|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837254|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43837255|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
43837256|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
43578065|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578066|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578067|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578069|NCT03483870|Granisetron|granisetron|mesh-list
43672793|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672794|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43672795|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672796|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672797|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43672798|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
43672799|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672800|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672801|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
43672802|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672803|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672804|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43578070|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43837258|NCT04920565|Polymyxins|polymyxins|mesh-list
43837261|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837262|NCT04920539|Dronabinol|dronabinol|mesh-list
43837263|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
43837264|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837265|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837266|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43837267|NCT04920539|Analgesics|analgesics|mesh-ancestor
43837268|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
43837269|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837270|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43837271|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43837272|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837273|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837274|NCT04920539|Hormones|hormones|mesh-ancestor
43837275|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837276|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
43837277|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
43837278|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43837279|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
43837280|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837281|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837282|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
43837283|NCT04917861|Vaccines|vaccines|mesh-list
43837284|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
43837285|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837286|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
43578071|NCT03483870|Narcotics|narcotics|mesh-ancestor
43578072|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578073|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578074|NCT03483870|Analgesics|analgesics|mesh-ancestor
43578075|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
43578076|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578077|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
43578078|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
43578079|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578080|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43578081|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
43578082|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578083|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578084|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
43578085|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578086|NCT03483753|Vasopressins|vasopressins|mesh-list
43578087|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
43578088|NCT03483753|Norepinephrine|norepinephrine|mesh-list
43578089|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43578090|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43578091|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
43578092|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837287|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43837288|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43837289|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43759628|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759629|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
43759630|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759631|NCT02447939|Trametinib|trametinib|mesh-list
43759632|NCT02447939|Dabrafenib|dabrafenib|mesh-list
43759633|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759634|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43759635|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759636|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759637|NCT02447809|Aspirin|aspirin|mesh-list
43759638|NCT02447809|Clopidogrel|clopidogrel|mesh-list
43759639|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43759640|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43759641|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43759642|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43759643|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
43759644|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759645|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759646|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759647|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43759648|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43759649|NCT02447809|Analgesics|analgesics|mesh-ancestor
43759650|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
43759651|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759652|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759653|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759654|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43578093|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578094|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578095|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
43578096|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
43578097|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578098|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43578099|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
43578100|NCT03483753|Coagulants|coagulants|mesh-ancestor
43578101|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43578104|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43578105|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759655|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43759656|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43759671|NCT02447705|Telbivudine|telbivudine|mesh-list
43759672|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
43759673|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759674|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43759675|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759676|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759677|NCT02447835|Olanzapine|olanzapine|mesh-list
43759678|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
43759679|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
43759680|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759681|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759682|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43759683|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43759684|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43578106|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578107|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43578108|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43578109|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578110|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578111|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43578113|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578114|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578115|NCT03483415|Morphine|morphine|mesh-list
43578116|NCT03483415|Bupivacaine|bupivacaine|mesh-list
43578117|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
43672805|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43672806|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43672807|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
43672808|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
43672809|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43672810|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672811|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672812|NCT02092935|Vancomycin|vancomycin|mesh-list
43672813|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43672814|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672815|NCT02092922|Filanesib|filanesib|mesh-list
43672816|NCT02092922|Lenograstim|lenograstim|mesh-list
43672817|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43672818|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
43672819|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672820|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672821|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672822|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672823|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672824|NCT02092454|Benzocaine|benzocaine|mesh-list
43672825|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
43672826|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
43672827|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672828|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672829|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
43672830|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672831|NCT02092077|Hormones|hormones|mesh-list
43672832|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759685|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759686|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43759687|NCT02447835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43759688|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43847876|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
43759689|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43759690|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672833|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672834|NCT02083289|Latanoprost|latanoprost|mesh-list
43672835|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43672836|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43672837|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
43672838|NCT02081300|Testosterone|testosterone|mesh-list
43672839|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
43578118|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
43672840|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
43672841|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43672843|NCT02081300|Hormones|hormones|mesh-ancestor
43672844|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672845|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672846|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43672847|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672848|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
43672849|NCT02081118|Exenatide|exenatide|mesh-list
43672850|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672851|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672852|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43672853|NCT02081118|Incretins|incretins|mesh-ancestor
43672854|NCT02081118|Hormones|hormones|mesh-ancestor
43578119|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578120|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578121|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
43578122|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578123|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43578124|NCT03483415|Narcotics|narcotics|mesh-ancestor
43578127|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43578128|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578129|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578130|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578131|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
43578137|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578138|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578167|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578168|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578169|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
43578170|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43578171|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43578172|NCT03483142|Misoprostol|misoprostol|mesh-list
43578173|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43578174|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
43578175|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43578176|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578177|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43578178|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578179|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
43578181|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43578182|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
43578183|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
43578184|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578185|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578186|NCT03482752|Molgramostim|molgramostim|mesh-list
43578187|NCT03482752|Sargramostim|sargramostim|mesh-list
43578188|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759691|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759692|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
43759693|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
43759694|NCT02447796|Propofol|propofol|mesh-list
43759695|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43759696|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759697|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759698|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43759699|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
43759712|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43759713|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
43759714|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759715|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759716|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759717|NCT02447679|Tegafur|tegafur|mesh-list
43759718|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43759719|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
43759720|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759721|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759722|NCT02447601|Simvastatin|simvastatin|mesh-list
43759726|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759727|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43759728|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43759729|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759730|NCT02447393|Cetirizine|cetirizine|mesh-list
43759731|NCT02447393|Levocetirizine|levocetirizine|mesh-list
43759732|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43759733|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43759734|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43759735|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
43759736|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
43759737|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672855|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672857|NCT02077881|Paclitaxel|paclitaxel|mesh-list
43672858|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43672859|NCT02077881|Tryptophan|tryptophan|mesh-list
43672860|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43672861|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672862|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
43672863|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672864|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672865|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759738|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759739|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759740|NCT02447510|Mitogens|mitogens|mesh-list
43759741|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
43575093|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43575094|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43575095|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
43575101|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43575102|NCT03510221|Antioxidants|antioxidants|mesh-list
43575103|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575104|NCT03510221|Protective Agents|protective agents|mesh-ancestor
43575105|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575106|NCT03510013|Anesthetics|anesthetics|mesh-list
43575107|NCT03510013|Sevoflurane|sevoflurane|mesh-list
43575108|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
43575109|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759742|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759743|NCT02447289|Midazolam|midazolam|mesh-list
43759744|NCT02447289|Ketamine|ketamine|mesh-list
43759745|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43759746|NCT02447289|Analgesics|analgesics|mesh-ancestor
43759747|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
43759748|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759749|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759750|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43759751|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43759752|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
43759753|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
43759757|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759760|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43759761|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43564191|NCT01114308|Buprenorphine|buprenorphine|mesh-list
43575110|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575111|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43575112|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
43575113|NCT03510000|Empagliflozin|empagliflozin|mesh-list
43575114|NCT03510000|Pancrelipase|pancrelipase|mesh-list
43575115|NCT03510000|Hormones|hormones|mesh-list
43575116|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575117|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575118|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43575119|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575120|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43575121|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43575122|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
43575123|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43575124|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43575125|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575126|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43575127|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43575129|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575130|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575131|NCT03509831|Irsogladine|irsogladine|mesh-list
43575132|NCT03509831|Nizatidine|nizatidine|mesh-list
43575133|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575134|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43575135|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43759762|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43759763|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43759764|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
43759777|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43759778|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43759779|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575136|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43575137|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
43575138|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
43575139|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575140|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575141|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575142|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43575143|NCT03509831|Protective Agents|protective agents|mesh-ancestor
43575144|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43575145|NCT03509740|Acetaminophen|acetaminophen|mesh-list
43575146|NCT03509740|Tramadol|tramadol|mesh-list
43575147|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43575148|NCT03509740|Analgesics|analgesics|mesh-ancestor
43672866|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43672867|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
43672868|NCT02077881|Antiviral Agents|antiviral agents|mesh-ancestor
43672869|NCT02077881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672870|NCT02077881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672871|NCT02077881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672872|NCT02077881|Immunologic Factors|immunologic factors|mesh-ancestor
43672873|NCT02077881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672874|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43672875|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
43672876|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672877|NCT02074007|Benzocaine|benzocaine|mesh-list
43672878|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672879|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
43672880|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
43672881|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672882|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
43672883|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672884|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
43672885|NCT02073123|Nivolumab|nivolumab|mesh-list
43672886|NCT02073123|Ipilimumab|ipilimumab|mesh-list
43672887|NCT02073123|Tryptophan|tryptophan|mesh-list
43672888|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43578195|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578196|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
43578197|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43578198|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43575149|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
43575150|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575151|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575152|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
43575153|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43575154|NCT03509740|Narcotics|narcotics|mesh-ancestor
43575155|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575156|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
43575157|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
43575158|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575159|NCT03509714|Protective Agents|protective agents|mesh-ancestor
43575160|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575161|NCT03509714|Vitamins|vitamins|mesh-ancestor
43575162|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
43575184|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
43575185|NCT03509545|Torsemide|torsemide|mesh-list
43575186|NCT03509545|Furosemide|furosemide|mesh-list
43575187|NCT03509545|Diuretics|diuretics|mesh-ancestor
43575188|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
43575189|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575190|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43575191|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43575192|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575193|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43575194|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
43575195|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43759810|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
43759811|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578199|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672889|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672890|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43672891|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578202|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43578203|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578204|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43578205|NCT03482492|Acetaminophen|acetaminophen|mesh-list
43578207|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578208|NCT03482492|Analgesics|analgesics|mesh-ancestor
43578209|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
43578210|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578211|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578212|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
43578213|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43578214|NCT03482492|Narcotics|narcotics|mesh-ancestor
43578215|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578216|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43578217|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43578218|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578219|NCT03482440|Analgesics|analgesics|mesh-ancestor
43578220|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
43578221|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578222|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578223|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43578224|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43578225|NCT03482362|Vinorelbine|vinorelbine|mesh-list
43578226|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43578227|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578228|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
43578229|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
43578230|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
43578231|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578232|NCT03482232|Acetaminophen|acetaminophen|mesh-list
43578253|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43578254|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
43672909|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672910|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43827330|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43827331|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827332|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827333|NCT05489692|Leucovorin|leucovorin|mesh-list
43827334|NCT05489692|Fluorouracil|fluorouracil|mesh-list
43759812|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43759813|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
43759814|NCT02447185|Hormones|hormones|mesh-ancestor
43759815|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759816|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759817|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
43759818|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759819|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759820|NCT02446977|Riboflavin|riboflavin|mesh-list
43759821|NCT02446977|Vitamins|vitamins|mesh-ancestor
43759822|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
43759823|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759824|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
43759825|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43759826|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
43759827|NCT02447016|Tenofovir|tenofovir|mesh-list
43759828|NCT02447016|Emtricitabine|emtricitabine|mesh-list
43827335|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
43827336|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43827337|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
43827338|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827339|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43827340|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827341|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827342|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
43827343|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827344|NCT05489692|Antidotes|antidotes|mesh-ancestor
43827345|NCT05489692|Protective Agents|protective agents|mesh-ancestor
43827346|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
43827347|NCT05489692|Vitamins|vitamins|mesh-ancestor
43827348|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
43827349|NCT05489666|Vitamin D|vitamin d|mesh-list
43578256|NCT03482180|Calcium|calcium|mesh-list
43578257|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43578258|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578259|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43578260|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43578261|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
43578262|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578263|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43578264|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43578265|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578266|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43578267|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578268|NCT03482024|Tirzepatide|tirzepatide|mesh-list
43578269|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43578270|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578271|NCT03482024|Incretins|incretins|mesh-ancestor
43578273|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578274|NCT03481998|Letrozole|letrozole|mesh-list
43578275|NCT03481998|Fulvestrant|fulvestrant|mesh-list
43578276|NCT03481998|Anastrozole|anastrozole|mesh-list
43578277|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578278|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43578279|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43578280|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578281|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578282|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43849075|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43564256|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
43564257|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43564258|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43564259|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43759829|NCT02447016|Efavirenz|efavirenz|mesh-list
43759830|NCT02447016|Rilpivirine|rilpivirine|mesh-list
43759831|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
43759832|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759833|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43564260|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43759834|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43759835|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759836|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759837|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43759838|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43759839|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43759840|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43759842|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43578283|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
43578284|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578285|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578286|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578287|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43827350|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
43827351|NCT05489666|Vitamins|vitamins|mesh-ancestor
43827352|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
43827353|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827354|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43827355|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43827356|NCT05489601|Oxycodone|oxycodone|mesh-list
43827357|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43827358|NCT05489601|Narcotics|narcotics|mesh-ancestor
43827359|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827360|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827361|NCT05489601|Analgesics|analgesics|mesh-ancestor
43827362|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
43827363|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827364|NCT05489406|Dolutegravir|dolutegravir|mesh-list
43827365|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43827368|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827369|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43827370|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43827371|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
43827372|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827373|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
43827374|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43827375|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43827401|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
43827402|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827403|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672916|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43672919|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759843|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43759844|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43759845|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
43759846|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
43759847|NCT02447055|Melphalan|melphalan|mesh-list
43759848|NCT02447055|Fludarabine|fludarabine|mesh-list
43759849|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
43759850|NCT02447055|Tacrolimus|tacrolimus|mesh-list
43759851|NCT02447055|Lenograstim|lenograstim|mesh-list
43759852|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759853|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
43759854|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759855|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759856|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43759857|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
43759858|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759859|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759860|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43759861|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43759862|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
43759863|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43759864|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759865|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43759866|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43759867|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43759868|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
43759869|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43759870|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759871|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43759872|NCT02447094|Plasminogen|plasminogen|mesh-list
43759873|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43759874|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43759876|NCT02446860|Nivolumab|nivolumab|mesh-list
43759883|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43759884|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43759885|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43759915|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43759916|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759917|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759918|NCT02446574|Paclitaxel|paclitaxel|mesh-list
43759919|NCT02446574|Cisplatin|cisplatin|mesh-list
43759920|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43759921|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759922|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759923|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759924|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
43575236|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
43575237|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43575238|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
43575239|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575240|NCT03508999|Metronidazole|metronidazole|mesh-list
43575241|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575242|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43575243|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43575244|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43575245|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
43575246|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43575247|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43575248|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43575249|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43759925|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759927|NCT02446704|Olaparib|olaparib|mesh-list
43759928|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43759929|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
43759931|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759949|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
43759950|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759951|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759952|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43759953|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43759954|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43759955|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43759956|NCT02446431|Growth Substances|growth substances|mesh-ancestor
43759957|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
43672920|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43672921|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672922|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672923|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672924|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
43672925|NCT02064426|Hematinics|hematinics|mesh-ancestor
43672926|NCT02063997|Colchicine|colchicine|mesh-list
43672927|NCT02063997|Allopurinol|allopurinol|mesh-list
43672928|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
43672929|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672930|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
43672931|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672932|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672933|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672934|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578289|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43578290|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578291|NCT03481790|Folic Acid|folic acid|mesh-list
43578292|NCT03481790|Lactoferrin|lactoferrin|mesh-list
43578293|NCT03481790|Vitamins|vitamins|mesh-ancestor
43578294|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
43578295|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578296|NCT03481790|Hematinics|hematinics|mesh-ancestor
43578297|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
43578298|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578299|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
43578300|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
43578301|NCT03481517|Bupivacaine|bupivacaine|mesh-list
43578302|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
43578303|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
43578304|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578305|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578306|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
43578307|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578308|NCT03481400|Calcitonin|calcitonin|mesh-list
43578309|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
43578310|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43578311|NCT03481400|Katacalcin|katacalcin|mesh-list
43578312|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43578313|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578314|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43578315|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
43578316|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
43578317|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578318|NCT03480997|Bromides|bromides|mesh-list
43578319|NCT03480997|Albuterol|albuterol|mesh-list
43578320|NCT03480997|Ipratropium|ipratropium|mesh-list
43578321|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
43672935|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
43672936|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672937|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43672938|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
43672939|NCT02063997|Protective Agents|protective agents|mesh-ancestor
43672940|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672941|NCT02063685|Prednisone|prednisone|mesh-list
43672942|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
43672943|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43672944|NCT02063685|Rituximab|rituximab|mesh-list
43672945|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43672946|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672947|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
43672948|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672949|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43578322|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43578323|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
43578324|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578325|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578326|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43578327|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
43578328|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
43578329|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43578330|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43578331|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43578333|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
43578334|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578335|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578336|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43578337|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
43578338|NCT03480958|Morphine|morphine|mesh-list
43578339|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43578340|NCT03480958|Narcotics|narcotics|mesh-ancestor
43578341|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578342|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578343|NCT03480958|Analgesics|analgesics|mesh-ancestor
43578344|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
43578345|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578346|NCT03480945|Nitroprusside|nitroprusside|mesh-list
43578347|NCT03480945|Serotonin|serotonin|mesh-list
43578348|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43578349|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
43578350|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578351|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578352|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578353|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43578354|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
43578355|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43578356|NCT03480906|Latanoprost|latanoprost|mesh-list
43578357|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43578358|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43578359|NCT03480867|Temozolomide|temozolomide|mesh-list
43849076|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578360|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43578361|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
43578362|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578363|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578364|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
43672950|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43672951|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
43672952|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672953|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672954|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43672955|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672956|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672957|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
43672958|NCT02063685|Hormones|hormones|mesh-ancestor
43672959|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672960|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43672961|NCT02063295|CKD732|ckd732|mesh-list
43672962|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43672963|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43672964|NCT02063295|Growth Substances|growth substances|mesh-ancestor
43759958|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43759959|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759960|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43759961|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
43759962|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
43759963|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759964|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
43759965|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759966|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
43759967|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43759968|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759969|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43759970|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43759971|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43759972|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672965|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672966|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
43672967|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672968|NCT02061761|Nivolumab|nivolumab|mesh-list
43672969|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672970|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672971|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43672972|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672973|NCT02058420|Tocotrienols|tocotrienols|mesh-list
43672974|NCT02058420|Vitamin E|vitamin e|mesh-list
43672975|NCT02058420|Tocopherols|tocopherols|mesh-list
43672976|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
43672977|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672978|NCT02058420|Protective Agents|protective agents|mesh-ancestor
43672979|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672980|NCT02058420|Vitamins|vitamins|mesh-ancestor
43578367|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578368|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578369|NCT03480789|Analgesics|analgesics|mesh-ancestor
43672985|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43672987|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672988|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
43672989|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672990|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672991|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672992|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672993|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
43672994|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
43672995|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672996|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672997|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43672998|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
43672999|NCT02057380|Hormones|hormones|mesh-ancestor
43578370|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
43578371|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578372|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43578373|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43578374|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43578375|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
43578376|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578377|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578378|NCT03480646|Prednisone|prednisone|mesh-list
43608243|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43608244|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759973|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
43759974|NCT02446353|Megestrol|megestrol|mesh-list
43759975|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43759976|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759977|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
43759978|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43759979|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564391|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759980|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43759981|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43759982|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43578379|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
43578380|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43578381|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
43578382|NCT03480646|Hormones|hormones|mesh-ancestor
43578383|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578384|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578385|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578386|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578387|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578388|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578389|NCT03480607|Dexamethasone|dexamethasone|mesh-list
43578390|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
43578391|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43578392|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
43578393|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
43578394|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578395|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578396|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578397|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
43578398|NCT03480607|Hormones|hormones|mesh-ancestor
43578399|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578400|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578401|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578402|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43578403|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578404|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578406|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
43578407|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43578408|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43578409|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43673000|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673001|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43673002|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673003|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673008|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
43673009|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673010|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673011|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43673012|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43673013|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43673014|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673015|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578410|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
43578411|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575250|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575251|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575252|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575253|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575255|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575256|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43575257|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43575258|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43575259|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43575260|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43575261|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43575262|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43575263|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
43575264|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575265|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575266|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575267|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43578412|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578413|NCT03480568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43578414|NCT03480568|Immunologic Factors|immunologic factors|mesh-ancestor
43578415|NCT03480568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578416|NCT03480516|Fluorides|fluorides|mesh-list
43578417|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
43578418|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
43578419|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
43578420|NCT03480516|Protective Agents|protective agents|mesh-ancestor
43578421|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578422|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
43578423|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
43578424|NCT03480360|Fludarabine|fludarabine|mesh-list
43578425|NCT03480360|Tacrolimus|tacrolimus|mesh-list
43578426|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43578427|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
43578428|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578429|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43578430|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43578432|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578433|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578434|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43578435|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43578436|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578437|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43575268|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43575269|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575270|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43575271|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575272|NCT03508817|Atropine|atropine|mesh-list
43575273|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43575274|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43575275|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43759983|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
43759984|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43759985|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43759986|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43578438|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43578439|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
43578440|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43578441|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578442|NCT03480321|Cilostazol|cilostazol|mesh-list
43578443|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43578444|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
43578445|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578446|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578447|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43578448|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
43578449|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43673017|NCT02057172|Exenatide|exenatide|mesh-list
43673018|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43673019|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673020|NCT02057172|Incretins|incretins|mesh-ancestor
43673021|NCT02057172|Hormones|hormones|mesh-ancestor
43673022|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673023|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43673024|NCT02052778|Futibatinib|futibatinib|mesh-list
43673025|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673026|NCT02052648|Bevacizumab|bevacizumab|mesh-list
43673027|NCT02052648|Temozolomide|temozolomide|mesh-list
43673028|NCT02052648|Tryptophan|tryptophan|mesh-list
43673029|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43673030|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578450|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43578451|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578452|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43578453|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
43759987|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
43759988|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43759989|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43759990|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759991|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
43759992|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
43759993|NCT02446301|Nalbuphine|nalbuphine|mesh-list
43759994|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43759995|NCT02446301|Narcotics|narcotics|mesh-ancestor
43759996|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759997|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759998|NCT02446301|Analgesics|analgesics|mesh-ancestor
43759999|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
43760000|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760001|NCT02445976|Seviteronel|seviteronel|mesh-list
43760002|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760003|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43760004|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760005|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760006|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
43760007|NCT02445989|NuvaRing|nuvaring|mesh-list
43760008|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43760009|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760010|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43760011|NCT02446002|Lofexidine|lofexidine|mesh-list
43760012|NCT02446002|Clonidine|clonidine|mesh-list
43760013|NCT02446002|Naltrexone|naltrexone|mesh-list
43760014|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43760015|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43578454|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43578455|NCT03480321|Protective Agents|protective agents|mesh-ancestor
43578456|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43578464|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
43578465|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578466|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578467|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578468|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
43578469|NCT03480308|Hormones|hormones|mesh-ancestor
43578470|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578471|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578472|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578473|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
43578474|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
43760016|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760017|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
43760023|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760024|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760025|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760026|NCT02446002|Analgesics|analgesics|mesh-ancestor
43760027|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
43760028|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
43837291|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837292|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
43837293|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837294|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837295|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43837296|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847877|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847878|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43847879|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43847881|NCT04069936|Tadalafil|tadalafil|mesh-list
43847882|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847883|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578475|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578476|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
43578477|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43578479|NCT03480308|Analgesics|analgesics|mesh-ancestor
43578480|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43578481|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43578482|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
43578483|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
43578484|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43578485|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
43578486|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578487|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
43578488|NCT03480295|Protective Agents|protective agents|mesh-ancestor
43578490|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43578491|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578492|NCT03480165|Parecoxib|parecoxib|mesh-list
43578493|NCT03480165|Ropivacaine|ropivacaine|mesh-list
43578494|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
43578495|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
43578496|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578497|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578498|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
43578499|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578500|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43578501|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43673031|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673032|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43673033|NCT02052648|Growth Substances|growth substances|mesh-ancestor
43673034|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673035|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673036|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43673037|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
43847884|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43847885|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847886|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
43847887|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43847888|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43847889|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847890|NCT04069936|Urological Agents|urological agents|mesh-ancestor
43847891|NCT04069273|Paclitaxel|paclitaxel|mesh-list
43847892|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
43847893|NCT04069273|Ramucirumab|ramucirumab|mesh-list
43847894|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847895|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847896|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
43575276|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43575277|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43575278|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
43575279|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575280|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575281|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43575282|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
43575283|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
43673038|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673039|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43673040|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
43673041|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43673042|NCT02050828|Ranibizumab|ranibizumab|mesh-list
43578502|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578503|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578504|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43578505|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578506|NCT03480165|Analgesics|analgesics|mesh-ancestor
43578507|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43578508|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43578509|NCT03480100|Xylometazoline|xylometazoline|mesh-list
43578510|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
43578511|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43578512|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
43578513|NCT03479996|Bupivacaine|bupivacaine|mesh-list
43578514|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
43578515|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
43578516|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673246|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43673247|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43673248|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673376|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673378|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
43673379|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673381|NCT01917383|Latanoprost|latanoprost|mesh-list
43673382|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43673383|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43575284|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
43760030|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43760031|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43760032|NCT02445898|Prednisolone|prednisolone|mesh-list
43760033|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
43760034|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43760035|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
43760036|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760037|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
43760038|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
43760039|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760040|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760041|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760042|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
43760043|NCT02445898|Hormones|hormones|mesh-ancestor
43760044|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760045|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43760046|NCT02445898|Protective Agents|protective agents|mesh-ancestor
43760047|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43760048|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760049|NCT02445872|Dexamethasone|dexamethasone|mesh-list
43760050|NCT02445872|Aprepitant|aprepitant|mesh-list
43760051|NCT02445872|Palonosetron|palonosetron|mesh-list
43760052|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760053|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
43575285|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43575286|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43575287|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575288|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575289|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575290|NCT03508804|Lidocaine|lidocaine|mesh-list
43575291|NCT03508804|Prilocaine|prilocaine|mesh-list
43575292|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43575293|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
43673384|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
43673385|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673386|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673387|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673388|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43673430|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673431|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43673433|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43673434|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
43575294|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
43575295|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575296|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575297|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
43575298|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575299|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43575300|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43575301|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43575302|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43575303|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575304|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43575305|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
43575306|NCT03508635|Prednisone|prednisone|mesh-list
43575307|NCT03508635|Cortisone|cortisone|mesh-list
43575308|NCT03508635|Mifepristone|mifepristone|mesh-list
43575309|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575310|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
43575311|NCT03508635|Hormones|hormones|mesh-ancestor
43760054|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
43760055|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760056|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760057|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760058|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
43673435|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673436|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
43673437|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673438|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
43673439|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
43673440|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673441|NCT01902381|Protective Agents|protective agents|mesh-ancestor
43673471|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43673543|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673544|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
43673545|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43673546|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43673547|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579482|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579483|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43579484|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43579485|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
43579486|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579487|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43579488|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
43673574|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673575|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673576|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43673577|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43673578|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
43760059|NCT02445872|Hormones|hormones|mesh-ancestor
43760060|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760061|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43760062|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760063|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43760064|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760065|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760066|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43760067|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43760068|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
43760069|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
43760070|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43575312|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575313|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575315|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575319|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43575321|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43575322|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
43575323|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43575324|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43575325|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
43760078|NCT02445599|Nalbuphine|nalbuphine|mesh-list
43760079|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43760080|NCT02445599|Narcotics|narcotics|mesh-ancestor
43760081|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760082|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760083|NCT02445599|Analgesics|analgesics|mesh-ancestor
43760084|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
43760085|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760086|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43760087|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43760088|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
43760089|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
43760090|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43760091|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43760092|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43760093|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43673579|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673582|NCT01818921|CKD732|ckd732|mesh-list
43673585|NCT01818921|Growth Substances|growth substances|mesh-ancestor
43673586|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673587|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673588|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673589|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
43673590|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43673591|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43673592|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43673593|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673594|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673595|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
43673596|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673597|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673598|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43673599|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673600|NCT01811576|Hormones|hormones|mesh-list
43673601|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673602|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673603|NCT01811498|Bevacizumab|bevacizumab|mesh-list
43673604|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43673605|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673606|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673607|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43673608|NCT01811498|Growth Substances|growth substances|mesh-ancestor
43673609|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673610|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673611|NCT01810575|Alprostadil|alprostadil|mesh-list
43673612|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43673613|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
43673614|NCT01810575|Urological Agents|urological agents|mesh-ancestor
43579492|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
43579493|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
43579494|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579495|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
43579496|NCT03470480|Methamphetamine|methamphetamine|mesh-list
43760094|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
43760095|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
43760096|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760097|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760098|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43760099|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760100|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760101|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760102|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43564522|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
43575350|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575351|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575352|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
43575353|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575354|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43575355|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
43575356|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575357|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43575358|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43575359|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43575360|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760104|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43760105|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43760107|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43760108|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
43760109|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
43760110|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
43760111|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43760112|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43760113|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
43760114|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
43760115|NCT02445703|Vaccines|vaccines|mesh-list
43760116|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
43760117|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760118|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
43760119|NCT02445716|Testosterone|testosterone|mesh-list
43760124|NCT02445716|Hormones|hormones|mesh-ancestor
43760125|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760126|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575361|NCT03507829|Insulin|insulin|mesh-list
43575362|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43575363|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
43575364|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
43575365|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
43575366|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
43575367|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43579497|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43579498|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579499|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
43579500|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
43579501|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579502|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
43579503|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579674|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43579753|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43579754|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579810|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579812|NCT05390255|Omalizumab|omalizumab|mesh-list
43579813|NCT05390255|Hormones|hormones|mesh-list
43579814|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579815|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579816|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579817|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
43579818|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43579819|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43579927|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
43579928|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
43579929|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579930|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579931|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43579932|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
43579934|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
43579935|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579936|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43575368|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575369|NCT03507751|Meropenem|meropenem|mesh-list
43575370|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43575371|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575372|NCT03507634|Lidocaine|lidocaine|mesh-list
43575373|NCT03507634|Fentanyl|fentanyl|mesh-list
43575374|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
43575375|NCT03507634|Remifentanil|remifentanil|mesh-list
43575376|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
43575377|NCT03507634|Anesthetics|anesthetics|mesh-list
43575378|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
43575379|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575380|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575381|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
43575382|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575383|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43575384|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43575385|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43575386|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579937|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43579938|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579939|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579940|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43579941|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
43579942|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579943|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579944|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43579946|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
43579947|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579948|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579950|NCT05236231|Macitentan|macitentan|mesh-list
43579951|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
43579952|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43579953|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43579954|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579955|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579956|NCT05236231|Urological Agents|urological agents|mesh-ancestor
43579957|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43579958|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43579959|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43579960|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43579961|NCT05165290|Latanoprost|latanoprost|mesh-list
43579962|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43579963|NCT05133674|Tamoxifen|tamoxifen|mesh-list
43579964|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43579965|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
43579966|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673830|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43673831|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43673832|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43673833|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43575396|NCT03507634|Narcotics|narcotics|mesh-ancestor
43575398|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43575399|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
43575400|NCT03507556|Metronidazole|metronidazole|mesh-list
43575401|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
43575402|NCT03507556|Minocycline|minocycline|mesh-list
43575403|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
43575404|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575405|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43575406|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43575407|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43575408|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43575409|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43575410|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575411|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575412|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575413|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43575414|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43575415|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
43760127|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43760128|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760129|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
43760131|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760133|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
43760135|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
43760136|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
43760137|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760138|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43760139|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760140|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43760141|NCT02445352|Ezetimibe|ezetimibe|mesh-list
43760142|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43760143|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43760144|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
43760145|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760146|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43673834|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43673835|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43673836|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43673837|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
43673838|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43673839|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43673840|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
43673841|NCT01756339|Solithromycin|solithromycin|mesh-list
43673842|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43673843|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579967|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579968|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43579971|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43579972|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43579973|NCT05131867|Nimodipine|nimodipine|mesh-list
43579974|NCT05131867|Milrinone|milrinone|mesh-list
43579975|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43579976|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43579977|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
43579978|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43579979|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43579980|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579981|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579982|NCT05131867|Protective Agents|protective agents|mesh-ancestor
43579983|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579984|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43579985|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43579986|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579987|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43579989|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43579990|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43579991|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
43579992|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579993|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575441|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
43575442|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575443|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43575444|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43575445|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575446|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575447|NCT03507387|Phenylephrine|phenylephrine|mesh-list
43575448|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
43575449|NCT03507387|Bupivacaine|bupivacaine|mesh-list
43575450|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
43575451|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
43575452|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575454|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
43575455|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575456|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43575457|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
43579994|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579995|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43579996|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43579997|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
43579998|NCT05012787|Vaccines|vaccines|mesh-list
43579999|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
43580000|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
43580001|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580002|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43580003|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
43580004|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
43849083|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580005|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580006|NCT05009901|Protective Agents|protective agents|mesh-ancestor
43580007|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580008|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
43580009|NCT05009901|Vitamins|vitamins|mesh-ancestor
43673844|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43673845|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43673846|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673847|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673848|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673849|NCT01749969|Dexamethasone|dexamethasone|mesh-list
43673850|NCT01749969|Lenalidomide|lenalidomide|mesh-list
43673851|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43673852|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
43673853|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
43673854|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673855|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673856|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43673857|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
43673858|NCT01749969|Hormones|hormones|mesh-ancestor
43673859|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673860|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43673861|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673862|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
43673863|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43580010|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
43580011|NCT04936399|Nivolumab|nivolumab|mesh-list
43580012|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43575458|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
43575459|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
43575460|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43575461|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
43575462|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
43575463|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43575464|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43575465|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43575466|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
43575467|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575468|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575469|NCT03507387|Protective Agents|protective agents|mesh-ancestor
43575470|NCT03507348|Rituximab|rituximab|mesh-list
43760147|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43760148|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760149|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43760151|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760152|NCT02445404|Dexamethasone|dexamethasone|mesh-list
43760153|NCT02445404|Prednisone|prednisone|mesh-list
43760154|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
43760155|NCT02445404|Ifosfamide|ifosfamide|mesh-list
43760156|NCT02445404|Carboplatin|carboplatin|mesh-list
43760157|NCT02445404|Etoposide|etoposide|mesh-list
43760158|NCT02445404|Vincristine|vincristine|mesh-list
43760159|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760160|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
43760161|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760162|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760163|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580013|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580014|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43580015|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580016|NCT04928183|Nitroprusside|nitroprusside|mesh-list
43580017|NCT04928183|Phenylephrine|phenylephrine|mesh-list
43580018|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
43580019|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
43580020|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43580023|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580024|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580025|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
43580026|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43580027|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
43580028|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
43580029|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43580030|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43580031|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43580032|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
43580033|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760164|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
43760165|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760166|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760167|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43760168|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760169|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
43760170|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
43760171|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760172|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760173|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
43575471|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43575472|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575473|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
43575474|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575475|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43575477|NCT03507244|Pemetrexed|pemetrexed|mesh-list
43575478|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575479|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
43575480|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
43575498|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43575499|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575500|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575501|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575502|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575503|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
43575504|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43575505|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43575506|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
43575507|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43575508|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575509|NCT03506919|Allopurinol|allopurinol|mesh-list
43575510|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
43575511|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575512|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575513|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
43575514|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43575515|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43575516|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
43575517|NCT03506919|Protective Agents|protective agents|mesh-ancestor
43575518|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575519|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
43575520|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43575521|NCT03506841|Protective Agents|protective agents|mesh-ancestor
43575522|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575523|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
43575524|NCT03506828|Phenol|phenol|mesh-list
43760196|NCT02444949|Growth Substances|growth substances|mesh-ancestor
43760197|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760218|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43760219|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43760220|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
43760221|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
43760222|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
43760223|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760224|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43760225|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
43760226|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575525|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43575526|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575527|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
43575543|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
43575544|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43575545|NCT03506802|Lenograstim|lenograstim|mesh-list
43575546|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43575547|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
43575548|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575549|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43575550|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43575551|NCT03506802|Growth Substances|growth substances|mesh-ancestor
43575552|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
43575553|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575554|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580034|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580035|NCT04928183|Protective Agents|protective agents|mesh-ancestor
43580036|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
43580037|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
43580038|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43580039|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
43580040|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43580041|NCT04923659|Nimodipine|nimodipine|mesh-list
43580042|NCT04923659|Carbamazepine|carbamazepine|mesh-list
43580043|NCT04923659|Lorazepam|lorazepam|mesh-list
43580044|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
43580045|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
43673864|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43673865|NCT01749969|Growth Substances|growth substances|mesh-ancestor
43673866|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673867|NCT01746836|Ponatinib|ponatinib|mesh-list
43673868|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673869|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673870|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673871|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673872|NCT01741155|Docetaxel|docetaxel|mesh-list
43673873|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673874|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
43673875|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
43673876|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
43673877|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673878|NCT01737905|Epinephrine|epinephrine|mesh-list
43673879|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43673880|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43673881|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760227|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760228|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760229|NCT02444611|Vaccines|vaccines|mesh-list
43760230|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
43760231|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
43760232|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760233|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760234|NCT02444637|Rivastigmine|rivastigmine|mesh-list
43760235|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43760236|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760237|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760238|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
43760239|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760240|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760241|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43760242|NCT02444637|Protective Agents|protective agents|mesh-ancestor
43760243|NCT02444585|Denosumab|denosumab|mesh-list
43760244|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43760245|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760288|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760289|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760290|NCT03808025|Analgesics|analgesics|mesh-ancestor
43760291|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
43575555|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
43575556|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575557|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43575558|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43575559|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43575560|NCT03506802|Analgesics|analgesics|mesh-ancestor
43673882|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673883|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673884|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673885|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43673886|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43673887|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
43673888|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673889|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43673890|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
43580046|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
43580047|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43580048|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43580049|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580050|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580051|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580053|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
43580054|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
43580055|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580056|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580057|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43580058|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580059|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43580060|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43580061|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43580062|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
43580065|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43673891|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
43673892|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
43673893|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43673894|NCT01737892|Epinephrine|epinephrine|mesh-list
43673895|NCT01737892|Racepinephrine|racepinephrine|mesh-list
43673896|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
43673898|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43673899|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
43673900|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673901|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580066|NCT04923659|Analgesics|analgesics|mesh-ancestor
43580067|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
43580068|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43580069|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43580070|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43580071|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43580072|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43575561|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
43575562|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575563|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43575564|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43575565|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
43575566|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575567|NCT03506789|Dexamethasone|dexamethasone|mesh-list
43575568|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575569|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
43575570|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
43575571|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575572|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575573|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43575574|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
43575575|NCT03506789|Hormones|hormones|mesh-ancestor
43760292|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837297|NCT04916548|Ketamine|ketamine|mesh-list
43837298|NCT04916548|Analgesics|analgesics|mesh-ancestor
43837299|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
43837300|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837301|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837302|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43837303|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43837304|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
43837305|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
43837306|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580073|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43580074|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43580075|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
43837307|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43837308|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43837309|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837310|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837311|NCT04916327|Antioxidants|antioxidants|mesh-list
43837312|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837313|NCT04916327|Protective Agents|protective agents|mesh-ancestor
43837314|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837315|NCT04915950|APD791|apd791|mesh-list
43837316|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43837317|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43837318|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
43837319|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837321|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837322|NCT04915248|Dexamethasone|dexamethasone|mesh-list
43575576|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575577|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43575578|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575579|NCT03506763|Diclofenac|diclofenac|mesh-list
43575580|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43575581|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43575582|NCT03506763|Analgesics|analgesics|mesh-ancestor
43575596|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
43575597|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575598|NCT03506542|Mitomycins|mitomycins|mesh-list
43575599|NCT03506542|Mitomycin|mitomycin|mesh-list
43575600|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43575601|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575602|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
43575603|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575604|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43575605|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575606|NCT03506516|Ethanol|ethanol|mesh-list
43575607|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43575608|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575609|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575610|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575611|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
43575612|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43575613|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
43575614|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
43575615|NCT03506399|Estradiol|estradiol|mesh-list
43575616|NCT03506399|Estrogens|estrogens|mesh-ancestor
43575617|NCT03506399|Hormones|hormones|mesh-ancestor
43575618|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575619|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575620|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43575621|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43575622|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43575623|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43580076|NCT04862650|Paclitaxel|paclitaxel|mesh-list
43580077|NCT04862650|Carboplatin|carboplatin|mesh-list
43580078|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43580079|NCT04862650|Cemiplimab|cemiplimab|mesh-list
43580080|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43580081|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580082|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
43580083|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
43580084|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
43580085|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580086|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580088|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
43575624|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43575625|NCT03506256|Norfloxacin|norfloxacin|mesh-list
43575626|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43575627|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575628|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43575629|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43575630|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575631|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575632|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837338|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837339|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
43837340|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580089|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580090|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580091|NCT04807972|Folfirinox|folfirinox|mesh-list
43580092|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580093|NCT04742777|Sirolimus|sirolimus|mesh-list
43580094|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43580095|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580096|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43580097|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580098|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
43580099|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580100|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
43580101|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580102|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43580103|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43580104|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580105|NCT04642261|Empagliflozin|empagliflozin|mesh-list
43580106|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43580107|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580108|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43580109|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580110|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
43580111|NCT04614636|Fludarabine|fludarabine|mesh-list
43580112|NCT04614636|Daratumumab|daratumumab|mesh-list
43580113|NCT04614636|Elotuzumab|elotuzumab|mesh-list
43580114|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837341|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837342|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
43837343|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
43837344|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43837345|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575633|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43575634|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43575636|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
43575637|NCT03506178|Menthol|menthol|mesh-list
43575638|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
43575639|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
43575640|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43575641|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43575642|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
43575643|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575644|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575645|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575646|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
43575647|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
43575648|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575649|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
43575650|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43575651|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
43575652|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43580115|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
43580116|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580117|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580118|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43673903|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43673904|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43673905|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
43673906|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673907|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43673908|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
43673909|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
43673910|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
43673911|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43673913|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43673914|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
43580120|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580121|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580122|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43580123|NCT04602533|Durvalumab|durvalumab|mesh-list
43580124|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580125|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580137|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580139|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
43580140|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575653|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
43575654|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43849071|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43575655|NCT03506178|Protective Agents|protective agents|mesh-ancestor
43575657|NCT03506061|Elexacaftor|elexacaftor|mesh-list
43575658|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43575659|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43575660|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575661|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43575662|NCT03506009|Argatroban|argatroban|mesh-list
43575663|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43575664|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43580141|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
43580142|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580143|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580144|NCT04421339|Melatonin|melatonin|mesh-list
43580145|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
43580146|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580147|NCT04421339|Protective Agents|protective agents|mesh-ancestor
43580148|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580149|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580150|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
43580151|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43580152|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43580153|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580154|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
43580155|NCT04347122|Coagulants|coagulants|mesh-ancestor
43580156|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
43580157|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43580158|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
43580159|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580160|NCT04311489|Ularitide|ularitide|mesh-list
43580161|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43580162|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
43580163|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580164|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580165|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43580166|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
43580167|NCT04311489|Diuretics|diuretics|mesh-ancestor
43580168|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
43580169|NCT04308304|Donepezil|donepezil|mesh-list
43673915|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43673916|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
43673917|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673918|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673919|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43673920|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43846898|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43673921|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673923|NCT01719016|Analgesics|analgesics|mesh-ancestor
43673924|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
43673925|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673926|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673927|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43673928|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
43673929|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43580170|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43580171|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580172|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580173|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
43580175|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575665|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575667|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43575668|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
43575669|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575670|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
43575671|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43575672|NCT03505788|Acetazolamide|acetazolamide|mesh-list
43575673|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
43575674|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43575675|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575676|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575677|NCT03505788|Diuretics|diuretics|mesh-ancestor
43575678|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
43575679|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575680|NCT03505736|Adenosine|adenosine|mesh-list
43575681|NCT03505736|Regadenoson|regadenoson|mesh-list
43575682|NCT03505736|Analgesics|analgesics|mesh-ancestor
43575683|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
43575684|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575692|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575693|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43575694|NCT03505528|Paclitaxel|paclitaxel|mesh-list
43575695|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43575696|NCT03505528|Phenelzine|phenelzine|mesh-list
43575697|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43575698|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575699|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
43575700|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
43575701|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
43575702|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575703|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
43575704|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43575705|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43760313|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43760314|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43760315|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760316|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760317|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760318|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760319|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43760320|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43760321|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
43580176|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
43580177|NCT04280848|Temozolomide|temozolomide|mesh-list
43580178|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580179|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
43580180|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580181|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580182|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
43580183|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43580184|NCT04211272|Macitentan|macitentan|mesh-list
43580185|NCT04211272|Riociguat|riociguat|mesh-list
43580186|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43580187|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43580188|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
43580189|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580190|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43580196|NCT04211272|Urological Agents|urological agents|mesh-ancestor
43580197|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43580198|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43580199|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43580200|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
43580201|NCT04201964|Tenecteplase|tenecteplase|mesh-list
43580202|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43580203|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43580204|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580205|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
43580206|NCT04155203|Mupirocin|mupirocin|mesh-list
43580207|NCT04155203|Calcium|calcium|mesh-list
43760322|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43760323|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
43760324|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43760325|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760326|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760327|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43760328|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760329|NCT03365908|Ropivacaine|ropivacaine|mesh-list
43760330|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
43760331|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
43760332|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760333|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760334|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
43760335|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760336|NCT03295240|Rituximab|rituximab|mesh-list
43760337|NCT03295240|Venetoclax|venetoclax|mesh-list
43760338|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43760339|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43760340|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760341|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
43760342|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760343|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760344|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43760345|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
43760346|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760347|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
43760351|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
43760352|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575710|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575711|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
43575712|NCT03505502|Coagulants|coagulants|mesh-ancestor
43575713|NCT03505489|Mannitol|mannitol|mesh-list
43575714|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
43575715|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43575716|NCT03505489|Diuretics|diuretics|mesh-ancestor
43575717|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
43575718|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575719|NCT03505489|Miotics|miotics|mesh-ancestor
43575720|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
43575721|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575722|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43575723|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43575724|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
43575725|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43575726|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43575727|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575728|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575729|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575730|NCT03505411|Melatonin|melatonin|mesh-list
43575731|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
43575732|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575733|NCT03505411|Protective Agents|protective agents|mesh-ancestor
43575734|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575735|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43575737|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43575738|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575739|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575740|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575757|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
43575758|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43575759|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575760|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43760368|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43760369|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43760370|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
43760371|NCT03017820|Iodine|iodine|mesh-list
43760372|NCT03017820|Interferons|interferons|mesh-list
43760373|NCT03017820|Interferon-beta|interferon-beta|mesh-list
43760374|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
43760375|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760376|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
43760377|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760378|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760379|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43760380|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
43760381|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760382|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760383|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43575765|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575766|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43575767|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43575768|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
43575769|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43575770|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43575771|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575772|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
43575773|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43575774|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575775|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43575776|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43575780|NCT03504865|Bupivacaine|bupivacaine|mesh-list
43575796|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43575797|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575798|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43575799|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575800|NCT03504566|Empagliflozin|empagliflozin|mesh-list
43575801|NCT03504566|Linagliptin|linagliptin|mesh-list
43760384|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
43760385|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760386|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43760387|NCT03017820|Trace Elements|trace elements|mesh-ancestor
43760388|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
43760389|NCT02600897|Rituximab|rituximab|mesh-list
43760390|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
43760391|NCT02600897|Lenalidomide|lenalidomide|mesh-list
43760392|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43760393|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760394|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
43575802|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
43575803|NCT03504566|Telmisartan|telmisartan|mesh-list
43575804|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43575805|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673930|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
43673931|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
43673932|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673933|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673934|NCT01718158|Ribavirin|ribavirin|mesh-list
43673935|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43673936|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
43673937|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673938|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
43673939|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673940|NCT01718145|Ribavirin|ribavirin|mesh-list
43673941|NCT01718145|Asunaprevir|asunaprevir|mesh-list
43673942|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
43673943|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673944|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
43673945|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673946|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
43673947|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673948|NCT01714739|Nivolumab|nivolumab|mesh-list
43673949|NCT01714739|Ipilimumab|ipilimumab|mesh-list
43673950|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
43673951|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43673952|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673953|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43673954|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673955|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
43673956|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580208|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43580209|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580210|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43580211|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43575807|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575808|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43575809|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43575810|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43575811|NCT03504566|Incretins|incretins|mesh-ancestor
43575812|NCT03504566|Hormones|hormones|mesh-ancestor
43575813|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575814|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43575815|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
43575816|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575817|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
43575818|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43575819|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
43575820|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43575821|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43575822|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43575823|NCT03504527|Budesonide|budesonide|mesh-list
43575824|NCT03504527|Bromides|bromides|mesh-list
43575825|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
43575826|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43575827|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43575829|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575830|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575831|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43575832|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
43575833|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
43575834|NCT03504527|Hormones|hormones|mesh-ancestor
43575835|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43575836|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
43575837|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43580212|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580213|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43580214|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580215|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580216|NCT04099836|Bevacizumab|bevacizumab|mesh-list
43580217|NCT04099836|Atezolizumab|atezolizumab|mesh-list
43580218|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580219|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580220|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43580222|NCT04099836|Growth Substances|growth substances|mesh-ancestor
43580223|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580224|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
43580226|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43580227|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43575838|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
43575839|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575840|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575841|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
43575842|NCT03504475|Paroxetine|paroxetine|mesh-list
43575843|NCT03504475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43575844|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43673957|NCT01712451|Fluticasone|fluticasone|mesh-list
43673959|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43673960|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43673961|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43673962|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
43673963|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673974|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673975|NCT01712217|Crizotinib|crizotinib|mesh-list
43673976|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673977|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673978|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673979|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673980|NCT01709214|Oxycodone|oxycodone|mesh-list
43673981|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43673982|NCT01709214|Narcotics|narcotics|mesh-ancestor
43673983|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674007|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43674008|NCT01698281|Dexamethasone|dexamethasone|mesh-list
43674009|NCT01698281|Doxorubicin|doxorubicin|mesh-list
43674010|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43674011|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
43674012|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
43674013|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674014|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674015|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43674016|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
43674017|NCT01698281|Hormones|hormones|mesh-ancestor
43674018|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674019|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43674020|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674021|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43674022|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43674023|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43580228|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580229|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849084|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43580230|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43580232|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580233|NCT04073615|Trifluridine|trifluridine|mesh-list
43580234|NCT04073615|Apatinib|apatinib|mesh-list
43580235|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580236|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580237|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580238|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580239|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
43580240|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
43580241|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580242|NCT04072042|Apatinib|apatinib|mesh-list
43580243|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580244|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580245|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580246|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580247|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
43580248|NCT03912831|Fludarabine|fludarabine|mesh-list
43580249|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580250|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
43580252|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580253|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580254|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
43704626|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43575845|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43575846|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575847|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575848|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
43575849|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575850|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43575851|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
43575852|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43575853|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43575854|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43760395|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760396|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760397|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43760398|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43760399|NCT02600897|Growth Substances|growth substances|mesh-ancestor
43760400|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
43760401|NCT02532257|Rituximab|rituximab|mesh-list
43760402|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43760403|NCT02532257|Lenalidomide|lenalidomide|mesh-list
43760404|NCT02532257|Antibodies|antibodies|mesh-list
43760405|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
43760406|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43575876|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575877|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575879|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760422|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43760423|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
43760424|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760425|NCT01453179|Diclofenac|diclofenac|mesh-list
43760426|NCT01453179|Imiquimod|imiquimod|mesh-list
43760427|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43760428|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760429|NCT01453179|Analgesics|analgesics|mesh-ancestor
43760430|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
43760431|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760432|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674025|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674026|NCT01697072|Cisplatin|cisplatin|mesh-list
43674027|NCT01697072|Capecitabine|capecitabine|mesh-list
43674028|NCT01697072|Epirubicin|epirubicin|mesh-list
43674029|NCT01697072|Rilotumumab|rilotumumab|mesh-list
43674030|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674031|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43674032|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
43674033|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674034|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43674035|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43674036|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43674037|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674038|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43674039|NCT01696435|Vitamin D|vitamin d|mesh-list
43674040|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
43674041|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
43674042|NCT01696435|Vitamins|vitamins|mesh-list
43674043|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
43674044|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674045|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43580265|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43580266|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43580267|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760433|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760434|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760435|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43760436|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575880|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43575881|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43575882|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
43575883|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43575884|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575885|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575886|NCT03504046|Pancrelipase|pancrelipase|mesh-list
43575887|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43575888|NCT03504033|Desflurane|desflurane|mesh-list
43575890|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
43760443|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43760444|NCT01336530|Antacids|antacids|mesh-list
43760445|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
43760446|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760447|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
43760448|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760449|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760450|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760451|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
43760452|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
43760453|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760482|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760483|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43760484|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
43760485|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
43760486|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43760530|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760531|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
43760532|NCT00761371|Imiquimod|imiquimod|mesh-list
43760533|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760534|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
43760537|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
43760557|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760558|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
43760559|NCT00492999|Hormones|hormones|mesh-ancestor
43760560|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760561|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43576089|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43576090|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
43576091|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43576092|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
43576093|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43576094|NCT03502135|Protective Agents|protective agents|mesh-ancestor
43576095|NCT03502005|Tenofovir|tenofovir|mesh-list
43576096|NCT03502005|Emtricitabine|emtricitabine|mesh-list
43576098|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
43576143|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576144|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
43576145|NCT03501212|Anesthetics|anesthetics|mesh-list
43576146|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
43576147|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576148|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576149|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
43576150|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576151|NCT03501056|Antibodies|antibodies|mesh-list
43760599|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43760600|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43760601|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760602|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760603|NCT00189293|Imiquimod|imiquimod|mesh-list
43760604|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43760605|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
43760606|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760609|NCT00189267|Imiquimod|imiquimod|mesh-list
43760666|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43760667|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43760668|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760669|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760670|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43760671|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43760672|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43760673|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43760674|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
43760675|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
43760676|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
43576152|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43576153|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
43576154|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760711|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
43760712|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760713|NCT02444013|Protective Agents|protective agents|mesh-ancestor
43760714|NCT02443844|Tamsulosin|tamsulosin|mesh-list
43760715|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43760716|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43760717|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43760718|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760719|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760720|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760721|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576259|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
43576260|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576261|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43576262|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
43576263|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576264|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837359|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43837360|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837361|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43837362|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576302|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43576303|NCT03499886|Ketamine|ketamine|mesh-list
43576304|NCT03499886|Analgesics|analgesics|mesh-ancestor
43576305|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
43576306|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576307|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576308|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43576309|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43576310|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
43576313|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43576314|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43576315|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576316|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576317|NCT03499743|Celecoxib|celecoxib|mesh-list
43576318|NCT03499743|Scopolamine|scopolamine|mesh-list
43576319|NCT03499743|Bromides|bromides|mesh-list
43576320|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43576321|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43576322|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43580268|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43580270|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580271|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43580272|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43580273|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
43580274|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580275|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580276|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43580277|NCT03530995|Itraconazole|itraconazole|mesh-list
43580278|NCT03530995|Rifampin|rifampin|mesh-list
43580279|NCT03530995|Omeprazole|omeprazole|mesh-list
43580280|NCT03530995|Rabeprazole|rabeprazole|mesh-list
43580281|NCT03530995|Belumosudil|belumosudil|mesh-list
43580282|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43580283|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580284|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43576323|NCT03499743|Analgesics|analgesics|mesh-ancestor
43576324|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
43576325|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576326|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576327|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43576328|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576329|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43576330|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43576331|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576332|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576334|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43576335|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
43576336|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
43576378|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576379|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576380|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576381|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
43576382|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43576383|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
43576384|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43576405|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576406|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576407|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576408|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
43576409|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576410|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43576411|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
43576412|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43576413|NCT03499132|Anesthetics|anesthetics|mesh-list
43576414|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576415|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837363|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43576437|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576438|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576439|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576440|NCT03498820|Remifentanil|remifentanil|mesh-list
43576441|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43576442|NCT03498820|Narcotics|narcotics|mesh-ancestor
43576443|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576444|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576445|NCT03498820|Analgesics|analgesics|mesh-ancestor
43576446|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
43576447|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576448|NCT03498703|Azathioprine|azathioprine|mesh-list
43576449|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
43576450|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576451|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43576452|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576453|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43576454|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
43576455|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576456|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576457|NCT03498534|Isoniazid|isoniazid|mesh-list
43576468|NCT03498456|Lansoprazole|lansoprazole|mesh-list
43576469|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
43670859|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670861|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670862|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
43670863|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670864|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43670865|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576503|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43576504|NCT03498261|Gabapentin|gabapentin|mesh-list
43576505|NCT03498261|Analgesics|analgesics|mesh-ancestor
43576506|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
43576507|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576508|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576509|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
43576510|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43576511|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43576512|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576513|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43576514|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43576515|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43576516|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576517|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576520|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43576521|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
43576523|NCT03498235|Propofol|propofol|mesh-list
43670867|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
43670868|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670869|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670870|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43670871|NCT05422885|Dasatinib|dasatinib|mesh-list
43670872|NCT05422885|Quercetin|quercetin|mesh-list
43670873|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670874|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43670875|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670876|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670877|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
43670878|NCT05422885|Protective Agents|protective agents|mesh-ancestor
43670879|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670880|NCT05421962|Fentanyl|fentanyl|mesh-list
43670881|NCT05421962|Ketamine|ketamine|mesh-list
43576574|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43576575|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43576576|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
43576577|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576578|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670911|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43670912|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
43670913|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43670914|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43670915|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43670916|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43670917|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576631|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43576632|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43576633|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43576634|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
43576635|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43576636|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43576637|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
43576638|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43576639|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43576640|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43576641|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43576642|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43576643|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43576644|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43576645|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
43576646|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576647|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576648|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576649|NCT03497364|Bupivacaine|bupivacaine|mesh-list
43576650|NCT03497364|Ropivacaine|ropivacaine|mesh-list
43576651|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
43576652|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
43576653|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576654|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576655|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
43576657|NCT03497351|Nicardipine|nicardipine|mesh-list
43576682|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576683|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43576684|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670918|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
43670919|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670920|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670921|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43670922|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43670923|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670924|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
43670925|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43670926|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43670927|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43670928|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43670929|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670930|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43670931|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
43670933|NCT05419583|Warfarin|warfarin|mesh-list
43670934|NCT05419583|Apixaban|apixaban|mesh-list
43576685|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43576686|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
43576687|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
43576688|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43576689|NCT03496831|Adalimumab|adalimumab|mesh-list
43576690|NCT03496831|Etanercept|etanercept|mesh-list
43576691|NCT03496831|Golimumab|golimumab|mesh-list
43576692|NCT03496831|Abatacept|abatacept|mesh-list
43576693|NCT03496831|Infliximab|infliximab|mesh-list
43576694|NCT03496831|Ustekinumab|ustekinumab|mesh-list
43576695|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576696|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
43576697|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576698|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43576699|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43576700|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
43576701|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43576702|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43576703|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43576704|NCT03496831|Analgesics|analgesics|mesh-ancestor
43576705|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
43576706|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576707|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43576708|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43576709|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576710|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43576711|NCT03496740|Bupivacaine|bupivacaine|mesh-list
43576712|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
43576713|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
43670941|NCT05419583|Analgesics|analgesics|mesh-ancestor
43576741|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
43576742|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576743|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576744|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576745|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43576746|NCT03496389|Acetaminophen|acetaminophen|mesh-list
43576747|NCT03496389|Gabapentin|gabapentin|mesh-list
43576748|NCT03496389|Tramadol|tramadol|mesh-list
43576749|NCT03496389|Analgesics|analgesics|mesh-ancestor
43576750|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
43576751|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670960|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43670961|NCT05400031|Propolis|propolis|mesh-list
43670962|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670963|NCT05393674|Nivolumab|nivolumab|mesh-list
43670964|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670965|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576788|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43576789|NCT03495765|Growth Substances|growth substances|mesh-ancestor
43576790|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576791|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
43576792|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576793|NCT03495739|Dabigatran|dabigatran|mesh-list
43576794|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
43576796|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
43576797|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576798|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576799|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
43576800|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43670973|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43670975|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
43670976|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827103|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43827104|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827105|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827106|NCT05491785|Oxycodone|oxycodone|mesh-list
43827107|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43827108|NCT05491785|Narcotics|narcotics|mesh-ancestor
43827109|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576801|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43576829|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576830|NCT03494972|Tetracycline|tetracycline|mesh-list
43576831|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43576895|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
43576896|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43670980|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670981|NCT05387408|Analgesics|analgesics|mesh-ancestor
43670982|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
43670983|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670984|NCT05386576|Venetoclax|venetoclax|mesh-list
43670985|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670986|NCT05379790|Irinotecan|irinotecan|mesh-list
43670987|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43670988|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43670989|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670991|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576897|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576898|NCT03494387|Protective Agents|protective agents|mesh-ancestor
43576899|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576900|NCT03494387|Vitamins|vitamins|mesh-ancestor
43576901|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
43576903|NCT03494257|Brinzolamide|brinzolamide|mesh-list
43576904|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43576905|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43576906|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43576907|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43576908|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
43576909|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576910|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576911|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576912|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43576913|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43576914|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
43576915|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
43671053|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43671054|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43671055|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671056|NCT05265052|Oxycodone|oxycodone|mesh-list
43671057|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43671058|NCT05265052|Narcotics|narcotics|mesh-ancestor
43671059|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671060|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671061|NCT05265052|Analgesics|analgesics|mesh-ancestor
43576937|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43576938|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
43576939|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
43576940|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43576941|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43576942|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43576943|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43576944|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
43576945|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576946|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576947|NCT03493490|Diclofenac|diclofenac|mesh-list
43671071|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671072|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43671073|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43671074|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
43671075|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671076|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671077|NCT05223478|Phentolamine|phentolamine|mesh-list
43671078|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43671079|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43671080|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43671081|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43671082|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
43671083|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671084|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671085|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671086|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43576953|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671108|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671109|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43671110|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43671114|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
43671136|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43671137|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671138|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671139|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43671140|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43671145|NCT05134974|Phentolamine|phentolamine|mesh-list
43827149|NCT05491512|Fluorouracil|fluorouracil|mesh-list
43827150|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827151|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
43671263|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
43671264|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
43671265|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
43671266|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671267|NCT04881032|Temozolomide|temozolomide|mesh-list
43671268|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671269|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
43671270|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671271|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671272|NCT04871607|Cytarabine|cytarabine|mesh-list
43671336|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671337|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
43671338|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43671339|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671340|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671341|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
43671342|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
43827178|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43827179|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827180|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827181|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43671435|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671436|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671437|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43671439|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
43671440|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671441|NCT04622865|Protective Agents|protective agents|mesh-ancestor
43671442|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671443|NCT04615910|Exenatide|exenatide|mesh-list
43671444|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43671445|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671446|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43671447|NCT04615910|Incretins|incretins|mesh-ancestor
43671448|NCT04615910|Hormones|hormones|mesh-ancestor
43671449|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43671450|NCT04609397|Hemay005|hemay005|mesh-list
43671451|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
43671452|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43576972|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43576973|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43576974|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43576975|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43671468|NCT04546633|Lumefantrine|lumefantrine|mesh-list
43671469|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
43671470|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43671471|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43671472|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671473|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
43671474|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43671475|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671547|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671548|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
43671549|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43671550|NCT04401176|Lidocaine|lidocaine|mesh-list
43671551|NCT04401176|Heparin|heparin|mesh-list
43671561|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43671562|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671563|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
43671564|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43671565|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43671567|NCT04395079|Ipilimumab|ipilimumab|mesh-list
43671568|NCT04395079|Tremelimumab|tremelimumab|mesh-list
43671569|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
43671570|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43671571|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
43671572|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671573|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671574|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
43671575|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671576|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43671577|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827194|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43827195|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43827196|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
43827197|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
43827198|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43827199|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827213|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
43827214|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
43827215|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827216|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
43827217|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827218|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827219|NCT05490719|Cisplatin|cisplatin|mesh-list
43827220|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827221|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
43827222|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
43827223|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43827224|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43827225|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827226|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827227|NCT05490680|Urological Agents|urological agents|mesh-ancestor
43827228|NCT05490485|Cisplatin|cisplatin|mesh-list
43827229|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827230|NCT05490407|Carboplatin|carboplatin|mesh-list
43671621|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671622|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43671623|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43671624|NCT04230187|Growth Substances|growth substances|mesh-ancestor
43671625|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671626|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
43671627|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
43671628|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671629|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43671630|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43577002|NCT03493048|Fluorouracil|fluorouracil|mesh-list
43671633|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43671634|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671635|NCT04230187|Antidotes|antidotes|mesh-ancestor
43671636|NCT04230187|Protective Agents|protective agents|mesh-ancestor
43671637|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
43671638|NCT04230187|Vitamins|vitamins|mesh-ancestor
43671639|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
43671640|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
43671641|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43671642|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
43671643|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
43671654|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671655|NCT04171453|Pregabalin|pregabalin|mesh-list
43671656|NCT04171453|Analgesics|analgesics|mesh-ancestor
43671657|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
43671658|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671659|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671660|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
43671661|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43671713|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671714|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43671715|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671716|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43671717|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
43671718|NCT04024761|Fludarabine|fludarabine|mesh-list
43671719|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671720|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
43671721|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671722|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671723|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671724|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
43671725|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671726|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671727|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43671728|NCT03993132|Empagliflozin|empagliflozin|mesh-list
43671729|NCT03993132|Glucagon|glucagon|mesh-list
43671730|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43671756|NCT03850535|Cytarabine|cytarabine|mesh-list
43827257|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43827258|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43827259|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43827260|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846836|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846837|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846838|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43846839|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
43846840|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43846841|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43846842|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43846843|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43846844|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43846845|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846847|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846848|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846849|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846850|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846852|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
43846853|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
43846854|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846855|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848945|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848946|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848949|NCT03976362|Paclitaxel|paclitaxel|mesh-list
43671790|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43671791|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671792|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
43671793|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671794|NCT03685500|Emtricitabine|emtricitabine|mesh-list
43671795|NCT03685500|Darunavir|darunavir|mesh-list
43671796|NCT03685500|Cobicistat|cobicistat|mesh-list
43671797|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
43671798|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671805|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43671806|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43671807|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
43671808|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43671809|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43671810|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43671811|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
43671812|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671813|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43671814|NCT03678350|Trioxsalen|trioxsalen|mesh-list
43671815|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671816|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
43671817|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43671818|NCT03654053|Simvastatin|simvastatin|mesh-list
43671819|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43671820|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43671821|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
43671822|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671825|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671872|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43671873|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
43671874|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
43671875|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671876|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671877|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
43671878|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671879|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671880|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
43671885|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
43577019|NCT03493048|Vitamins|vitamins|mesh-ancestor
43577020|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
43577021|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671931|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
43671932|NCT03374254|Irinotecan|irinotecan|mesh-list
43671933|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671934|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671935|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671936|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
43671937|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671938|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43671939|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671940|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
43671941|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43671942|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43671943|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671944|NCT03374254|Antidotes|antidotes|mesh-ancestor
43671945|NCT03374254|Protective Agents|protective agents|mesh-ancestor
43671946|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
43671990|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43671991|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671992|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43671993|NCT03252808|Gemcitabine|gemcitabine|mesh-list
43671994|NCT03252808|Paclitaxel|paclitaxel|mesh-list
43671995|NCT03252808|Tegafur|tegafur|mesh-list
43671996|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43671997|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671998|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
43671999|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
43577060|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577061|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43577062|NCT03492736|Melatonin|melatonin|mesh-list
43577064|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577066|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577067|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577068|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
43577069|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43577070|NCT03492710|Antibodies|antibodies|mesh-list
43577071|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
43577072|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577073|NCT03492632|Hormones|hormones|mesh-list
43577074|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577075|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577076|NCT03492593|Beta Carotene|beta carotene|mesh-list
43577077|NCT03492593|Lycopene|lycopene|mesh-list
43577078|NCT03492593|Carotenoids|carotenoids|mesh-list
43577079|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672016|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43672017|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43672018|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
43672019|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672020|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672021|NCT03191461|Adenosine|adenosine|mesh-list
43672022|NCT03191461|Analgesics|analgesics|mesh-ancestor
43672023|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
43672024|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672025|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672026|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43577080|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
43577082|NCT03492593|Protective Agents|protective agents|mesh-ancestor
43577095|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43577096|NCT03492580|Glucagon|glucagon|mesh-list
43577097|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43577098|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577099|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43577100|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577101|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577102|NCT03492580|Hormones|hormones|mesh-ancestor
43577103|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577104|NCT03492580|Incretins|incretins|mesh-ancestor
43577105|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
43577106|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577107|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43577108|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43577109|NCT03492489|Cemiplimab|cemiplimab|mesh-list
43577110|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43577111|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577112|NCT03492385|Ticagrelor|ticagrelor|mesh-list
43577113|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43577114|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43577115|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43577116|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43577117|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
43577118|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577119|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580285|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580286|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580287|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
43580288|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580289|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43674046|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43674052|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674053|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
43674054|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43674055|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674056|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674057|NCT01691846|Metformin|metformin|mesh-list
43674058|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43674059|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674060|NCT01669980|Vancomycin|vancomycin|mesh-list
43674061|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
43580290|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43580291|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43580292|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
43580293|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43580294|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577120|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577121|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
43577122|NCT03492255|Prednisone|prednisone|mesh-list
43577123|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
43577124|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
43577125|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43577126|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
43577127|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577128|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43577129|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43577130|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
43672058|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672059|NCT03160846|Milrinone|milrinone|mesh-list
43672060|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43672061|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43672062|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
43672063|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43672064|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43672065|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672066|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672067|NCT03160846|Protective Agents|protective agents|mesh-ancestor
43672091|NCT02964884|Lovastatin|lovastatin|mesh-list
43827275|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827276|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827277|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43827278|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827279|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827280|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
43827281|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43827282|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827283|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827284|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827285|NCT05489900|Analgesics|analgesics|mesh-ancestor
43827286|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
43827287|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827288|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43577216|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
43577218|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672156|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43672157|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
43672158|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672159|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672160|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43672161|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43672162|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
43672163|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672164|NCT02623751|Exemestane|exemestane|mesh-list
43672165|NCT02623751|Entinostat|entinostat|mesh-list
43577226|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43577227|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
43577228|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577229|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577230|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
43577231|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577232|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43577233|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
43577234|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577235|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
43577236|NCT03491527|Pemetrexed|pemetrexed|mesh-list
43577258|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577259|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577260|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43577261|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43577262|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43577263|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577264|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43577265|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43577266|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577267|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
43577268|NCT03491371|Apatinib|apatinib|mesh-list
43577269|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577270|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43577271|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672194|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672195|NCT02470039|Insulin|insulin|mesh-list
43672196|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43672197|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
43672198|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672199|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672200|NCT02469155|Risperidone|risperidone|mesh-list
43672201|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43672202|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
43672203|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672205|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577338|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43577339|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43577340|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
43577403|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
43577404|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577405|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
43672248|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
43672249|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672250|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672251|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43672252|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43672253|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43672254|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
43672255|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
43672256|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
43672257|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
43672258|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43672260|NCT02458014|Blinatumomab|blinatumomab|mesh-list
43672261|NCT02458014|Antibodies|antibodies|mesh-list
43672262|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
43672263|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43672264|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
43672265|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43672346|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672347|NCT02365649|Upadacitinib|upadacitinib|mesh-list
43672348|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43672349|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43672350|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672351|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672352|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672353|NCT02342249|Oseltamivir|oseltamivir|mesh-list
43672354|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
43672355|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672356|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672358|NCT02341989|Cisplatin|cisplatin|mesh-list
43577445|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43577446|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
43577447|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43577448|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577449|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43577450|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577451|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
43580295|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43580296|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43580297|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
43580298|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43580299|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
43580300|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43580301|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43580302|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43580303|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43580304|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43580305|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43580306|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43580307|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580308|NCT03442972|Teduglutide|teduglutide|mesh-list
43580309|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580310|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43674062|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43674063|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43674064|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674065|NCT01666977|Carboplatin|carboplatin|mesh-list
43577452|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43577453|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
43577454|NCT03489798|Urological Agents|urological agents|mesh-ancestor
43577456|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43577457|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577458|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
43577459|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43577460|NCT03489629|Minocycline|minocycline|mesh-list
43577461|NCT03489629|Trimethoprim|trimethoprim|mesh-list
43577462|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
43577463|NCT03489629|Mupirocin|mupirocin|mesh-list
43577464|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43577465|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43577466|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577467|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
43577468|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
43577469|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577470|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43577471|NCT03489629|Renal Agents|renal agents|mesh-ancestor
43577472|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
43577473|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43577474|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43577475|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43577476|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577477|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577478|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43577482|NCT03489616|Pemetrexed|pemetrexed|mesh-list
43577494|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577495|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
43577496|NCT03489317|Metformin|metformin|mesh-list
43577497|NCT03489317|Amlodipine|amlodipine|mesh-list
43577498|NCT03489317|Simvastatin|simvastatin|mesh-list
43577499|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43577500|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577501|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43577502|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43577503|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577504|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577505|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43577506|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
43577507|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43577508|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43577509|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
43577510|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43577511|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43577513|NCT03489265|Eluxadoline|eluxadoline|mesh-list
43577514|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43577516|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
43577517|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577518|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43577542|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577543|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577544|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577545|NCT03488888|Bupivacaine|bupivacaine|mesh-list
43577546|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
43577547|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
43577548|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672372|NCT02339129|Analgesics|analgesics|mesh-ancestor
43672373|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
43672374|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672375|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672376|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672377|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43672378|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43577549|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577550|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
43577551|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577552|NCT03488810|Hormones|hormones|mesh-list
43577553|NCT03488810|Androgens|androgens|mesh-list
43577554|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
43577555|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
43577556|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577557|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577558|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
43577559|NCT03488719|Metoprolol|metoprolol|mesh-list
43577560|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43577561|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43577562|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
43577563|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
43674066|NCT01666977|Pemetrexed|pemetrexed|mesh-list
43674067|NCT01666977|Trebananib|trebananib|mesh-list
43577564|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577565|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577566|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43577567|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43577624|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577625|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43577626|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
43577627|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
43577628|NCT03487809|Hormones|hormones|mesh-ancestor
43672391|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43672392|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
43672393|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672394|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43672395|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672396|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
43672397|NCT02335918|Nivolumab|nivolumab|mesh-list
43672398|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672402|NCT02333643|Digoxin|digoxin|mesh-list
43672420|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43672421|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672422|NCT02324985|Ibuprofen|ibuprofen|mesh-list
43672423|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43672459|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43672460|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672461|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43577735|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
43672516|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43672517|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
43672518|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672519|NCT02282215|Lenograstim|lenograstim|mesh-list
43672520|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43672521|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
43672522|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827321|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43827322|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827328|NCT05489731|Osimertinib|osimertinib|mesh-list
43672523|NCT02257983|Ubiquinone|ubiquinone|mesh-list
43672524|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
43672525|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672526|NCT02257619|Docetaxel|docetaxel|mesh-list
43672527|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672528|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
43577859|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43577860|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
43577861|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577862|NCT03485846|Ritonavir|ritonavir|mesh-list
43672570|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
43672571|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43672572|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43672573|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672574|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672575|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672576|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
43672577|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
43672578|NCT02207257|Edoxaban|edoxaban|mesh-list
43672579|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43672580|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
43672581|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43672582|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
43672583|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672585|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
43672598|NCT02205528|Liraglutide|liraglutide|mesh-list
43672599|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672600|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672601|NCT02205528|Incretins|incretins|mesh-ancestor
43672602|NCT02205528|Hormones|hormones|mesh-ancestor
43672603|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672604|NCT02204345|Paclitaxel|paclitaxel|mesh-list
43672605|NCT02204345|Carboplatin|carboplatin|mesh-list
43672606|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43672607|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672608|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
43672609|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672648|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672649|NCT02160678|Tazarotene|tazarotene|mesh-list
43577904|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577905|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43577907|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43577908|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
43577909|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577910|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577911|NCT03485456|Tobramycin|tobramycin|mesh-list
43577912|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43577913|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43577915|NCT03485404|Folic Acid|folic acid|mesh-list
43577916|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
43577917|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
43577939|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
43577940|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577941|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
43577942|NCT03484845|Lactoferrin|lactoferrin|mesh-list
43577943|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43672694|NCT02138630|Capsaicin|capsaicin|mesh-list
43672725|NCT02125266|Methotrexate|methotrexate|mesh-list
43672726|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43672727|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
43672728|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43577961|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43577962|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577963|NCT03484650|Lidocaine|lidocaine|mesh-list
43577964|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
43577965|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
43577966|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577967|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577968|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
43577969|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577970|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43577971|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43577972|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43577973|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577974|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577975|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43578008|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43578009|NCT03484507|Protective Agents|protective agents|mesh-ancestor
43578010|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43578041|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578045|NCT03484195|Fluorouracil|fluorouracil|mesh-list
43578112|NCT03483545|Hormones|hormones|mesh-ancestor
43578132|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43578134|NCT03483350|Granisetron|granisetron|mesh-list
43849074|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578135|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43578136|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43578180|NCT03482960|Xenon|xenon|mesh-list
43672892|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43672893|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
43672894|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672895|NCT02072954|Asenapine|asenapine|mesh-list
43672896|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43672897|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43672898|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672899|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672900|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672901|NCT02072863|Prednisone|prednisone|mesh-list
43672902|NCT02072863|Melphalan|melphalan|mesh-list
43672903|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43672904|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
43672905|NCT02072863|Hormones|hormones|mesh-ancestor
43672906|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672907|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672908|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578200|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43578201|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43578206|NCT03482492|Tramadol|tramadol|mesh-list
43578233|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43578234|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43578235|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
43578236|NCT03482232|Ibuprofen|ibuprofen|mesh-list
43578237|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43578238|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43578239|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
43578240|NCT03482232|Expectorants|expectorants|mesh-list
43578241|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
43578242|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578243|NCT03482232|Analgesics|analgesics|mesh-ancestor
43578244|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
43578245|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578246|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578247|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43578248|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43578249|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578250|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578251|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
43578252|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
43672911|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
43672912|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578255|NCT03482180|Atorvastatin|atorvastatin|mesh-list
43827366|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43827367|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672981|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
43672982|NCT02057380|Dexamethasone|dexamethasone|mesh-list
43672983|NCT02057380|Paclitaxel|paclitaxel|mesh-list
43672984|NCT02057380|Bortezomib|bortezomib|mesh-list
43578365|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43578366|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673004|NCT02057315|Ketoprofen|ketoprofen|mesh-list
43673005|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43673006|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43673007|NCT02057315|Analgesics|analgesics|mesh-ancestor
43578457|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43578458|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578459|NCT03480308|Dexamethasone|dexamethasone|mesh-list
43578460|NCT03480308|Fentanyl|fentanyl|mesh-list
43578461|NCT03480308|Bupivacaine|bupivacaine|mesh-list
43578462|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43578463|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
43578517|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578518|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
43578519|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578520|NCT03479918|Prednisone|prednisone|mesh-list
43578521|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
43578522|NCT03479918|Doxorubicin|doxorubicin|mesh-list
43578523|NCT03479918|Etoposide|etoposide|mesh-list
43578524|NCT03479918|Vincristine|vincristine|mesh-list
43578525|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43578526|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
43578527|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578528|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43578529|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43578530|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
43578531|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578532|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578533|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43578534|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43578535|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43578536|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43578537|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578538|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43578539|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43578540|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
43578542|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674068|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674069|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674070|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578543|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578544|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
43578545|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
43578546|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
43578547|NCT03479879|Misoprostol|misoprostol|mesh-list
43578548|NCT03479879|Estradiol|estradiol|mesh-list
43673043|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673044|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43673045|NCT02050828|Growth Substances|growth substances|mesh-ancestor
43673046|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673047|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673048|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673049|NCT02047214|Bevacizumab|bevacizumab|mesh-list
43578549|NCT03479879|Estrogens|estrogens|mesh-ancestor
43578550|NCT03479879|Hormones|hormones|mesh-ancestor
43578551|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578552|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674071|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43674072|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43674073|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43674074|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43674075|NCT01666977|Growth Substances|growth substances|mesh-ancestor
43580311|NCT03442972|Protective Agents|protective agents|mesh-ancestor
43580312|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580313|NCT03440216|Meropenem|meropenem|mesh-list
43580314|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
43580315|NCT03440216|Temocillin|temocillin|mesh-list
43580316|NCT03440216|Penicillins|penicillins|mesh-list
43580317|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43580318|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580319|NCT03428126|Durvalumab|durvalumab|mesh-list
43580320|NCT03428126|Trametinib|trametinib|mesh-list
43580321|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580322|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580323|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580324|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580325|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580326|NCT03425292|Bevacizumab|bevacizumab|mesh-list
43578554|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43578555|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
43578556|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43578557|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578558|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
43578559|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43578560|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
43578561|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43578562|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578563|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
43578564|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43578565|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578566|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578567|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43580327|NCT03425292|Nivolumab|nivolumab|mesh-list
43580328|NCT03425292|Ipilimumab|ipilimumab|mesh-list
43580329|NCT03425292|Temozolomide|temozolomide|mesh-list
43580330|NCT03425292|Lomustine|lomustine|mesh-list
43580331|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580332|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580333|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43580334|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43580335|NCT03425292|Growth Substances|growth substances|mesh-ancestor
43580336|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580337|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
43580338|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43580339|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580340|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580341|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
43580342|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
43580344|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580345|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580347|NCT03367988|Analgesics|analgesics|mesh-ancestor
43580348|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
43580349|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580350|NCT03343431|Tenofovir|tenofovir|mesh-list
43580351|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
43580352|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580353|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43580354|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43580355|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580356|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580357|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43580358|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43580359|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
43578568|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
43578569|NCT03479411|Itraconazole|itraconazole|mesh-list
43578570|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43578571|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
43578572|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578573|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43578574|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43578575|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578576|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578577|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43578578|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
43578579|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578580|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578581|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43578582|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43674076|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674077|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
43674078|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43674079|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
43674080|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674081|NCT01661634|Ularitide|ularitide|mesh-list
43674082|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43674083|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
43674084|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674085|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674086|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43674087|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
43674088|NCT01661634|Diuretics|diuretics|mesh-ancestor
43674089|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
43674090|NCT01661166|Fesoterodine|fesoterodine|mesh-list
43674091|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43674092|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43674093|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
43674094|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580360|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580361|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580362|NCT03247712|Nivolumab|nivolumab|mesh-list
43578583|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43578584|NCT03479320|Lidocaine|lidocaine|mesh-list
43578585|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
43578586|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
43578588|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578589|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
43578590|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578591|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43578592|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43578593|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43578594|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43578595|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578596|NCT03479086|Topiramate|topiramate|mesh-list
43580363|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580364|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580365|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43580366|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580367|NCT03237611|Dexamethasone|dexamethasone|mesh-list
43580368|NCT03237611|Ondansetron|ondansetron|mesh-list
43580369|NCT03237611|Aprepitant|aprepitant|mesh-list
43580370|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
43580371|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43580372|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
43580373|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
43580374|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580375|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580376|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580377|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
43580378|NCT03237611|Hormones|hormones|mesh-ancestor
43849085|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43580379|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43580380|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43580381|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580382|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
43580383|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
43580384|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43580385|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
43580386|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580387|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580388|NCT03237611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43580393|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43580394|NCT03234491|Insulin|insulin|mesh-list
43580395|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43580396|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43674095|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674096|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674097|NCT01661166|Urological Agents|urological agents|mesh-ancestor
43578597|NCT03479086|Naltrexone|naltrexone|mesh-list
43578598|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43578600|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578601|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
43578602|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578603|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
43578604|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43578605|NCT03478709|Norepinephrine|norepinephrine|mesh-list
43578606|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43578607|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43578608|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
43578609|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673050|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43673051|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673052|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673053|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43673054|NCT02047214|Growth Substances|growth substances|mesh-ancestor
43674098|NCT01660633|Melphalan|melphalan|mesh-list
43674099|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43674100|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
43674101|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674102|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674103|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43674104|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43674105|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
43674106|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580397|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580398|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43580399|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43580400|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43580401|NCT03229408|Analgesics|analgesics|mesh-ancestor
43580402|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
43580403|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580404|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580405|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43580406|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580407|NCT03225417|Sirolimus|sirolimus|mesh-list
43580408|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
43580409|NCT03225417|Ixazomib|ixazomib|mesh-list
43580410|NCT03225417|Tacrolimus|tacrolimus|mesh-list
43580411|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43673055|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673056|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673057|NCT02046694|Allopurinol|allopurinol|mesh-list
43673058|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
43673059|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673060|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673061|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
43673062|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43673063|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43673064|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
43673065|NCT02046694|Protective Agents|protective agents|mesh-ancestor
43673066|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580412|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580413|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
43580414|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580415|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580416|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580418|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580419|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580420|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43580421|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43580422|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580423|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43580424|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580425|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43580426|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
43580427|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
43580428|NCT03188172|Dexamethasone|dexamethasone|mesh-list
43580429|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
43580430|NCT03188172|Melphalan|melphalan|mesh-list
43580431|NCT03188172|Lenalidomide|lenalidomide|mesh-list
43580432|NCT03188172|Bortezomib|bortezomib|mesh-list
43580433|NCT03188172|Daratumumab|daratumumab|mesh-list
43580434|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580435|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
43580436|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580437|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580438|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580439|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
43580440|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580441|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580442|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43580443|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43580444|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
43580445|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
43674107|NCT01658826|Valacyclovir|valacyclovir|mesh-list
43674108|NCT01658826|Pritelivir|pritelivir|mesh-list
43674109|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
43674110|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674111|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674112|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674119|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674121|NCT01652482|Fluorouracil|fluorouracil|mesh-list
43674122|NCT01652482|Irinotecan|irinotecan|mesh-list
43674123|NCT01652482|Cetuximab|cetuximab|mesh-list
43674124|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
43674125|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674126|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43674127|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674128|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43674129|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
43578610|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578611|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578612|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
43578613|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
43578614|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578615|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43578616|NCT03478605|Dexamethasone|dexamethasone|mesh-list
43578617|NCT03478605|Ondansetron|ondansetron|mesh-list
43578618|NCT03478605|Olanzapine|olanzapine|mesh-list
43578619|NCT03478605|Aprepitant|aprepitant|mesh-list
43578620|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43674130|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674131|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43674132|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43674133|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580446|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580447|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580448|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
43580449|NCT03188172|Hormones|hormones|mesh-ancestor
43580450|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43580451|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43580452|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43580453|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43580454|NCT03188172|Growth Substances|growth substances|mesh-ancestor
43849086|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580455|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
43580456|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
43580457|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43580458|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43580459|NCT02889159|Imiquimod|imiquimod|mesh-list
43580460|NCT02889159|Histamine|histamine|mesh-list
43580461|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
43580462|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43580463|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
43580464|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580465|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580466|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
43674134|NCT01652482|Antidotes|antidotes|mesh-ancestor
43674135|NCT01652482|Protective Agents|protective agents|mesh-ancestor
43674136|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
43674137|NCT01652482|Vitamins|vitamins|mesh-ancestor
43674138|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
43674139|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43674140|NCT01651871|Cetirizine|cetirizine|mesh-list
43674141|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43674142|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43674143|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43674144|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
43674145|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
43578621|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
43578622|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
43578623|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578624|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578625|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578626|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
43578627|NCT03478605|Hormones|hormones|mesh-ancestor
43578629|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578630|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578631|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
43578632|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
43578633|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43578634|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
43578635|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578636|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578637|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43578638|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43578639|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578640|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43578641|NCT03478605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43578642|NCT03478605|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43578643|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43578644|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43578645|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43674146|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578646|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43578647|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
43578648|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578651|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43578652|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578653|NCT03478475|Vitamins|vitamins|mesh-ancestor
43578654|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
43578655|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43578656|NCT03478436|Doxycycline|doxycycline|mesh-list
43674147|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674148|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674149|NCT01643226|Riboflavin|riboflavin|mesh-list
43674150|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43674151|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
43674152|NCT01643226|Vitamins|vitamins|mesh-ancestor
43674153|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
43674154|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674155|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43674156|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
43674157|NCT01640080|Esketamine|esketamine|mesh-list
43674158|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
43674159|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43674160|NCT01632228|Bevacizumab|bevacizumab|mesh-list
43674161|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43674162|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674165|NCT01632228|Growth Substances|growth substances|mesh-ancestor
43674182|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674193|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43674194|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674195|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
43674196|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
43674197|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
43578657|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43578658|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578659|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
43578660|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43578661|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43578662|NCT03478423|Oxycodone|oxycodone|mesh-list
43578663|NCT03478423|Hydromorphone|hydromorphone|mesh-list
43578664|NCT03478423|Codeine|codeine|mesh-list
43578665|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43578666|NCT03478423|Narcotics|narcotics|mesh-ancestor
43578667|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578668|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578669|NCT03478423|Analgesics|analgesics|mesh-ancestor
43578670|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
43578671|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578672|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
43674198|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827466|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43827467|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
43827468|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827469|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43827470|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
43827471|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827472|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827473|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43827474|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43827475|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43580467|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
43580468|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
43580469|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580470|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580471|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
43580472|NCT02874144|Fluticasone|fluticasone|mesh-list
43580473|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43580474|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
43580475|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43580476|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43580477|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
43580478|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580479|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580480|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43580481|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
43580482|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43580483|NCT02835534|Plasminogen|plasminogen|mesh-list
43578673|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
43578674|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
43578675|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578676|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
43578677|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
43827476|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
43827477|NCT05488106|Riboflavin|riboflavin|mesh-list
43827478|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
43827479|NCT05488106|Vitamins|vitamins|mesh-ancestor
43580484|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43580485|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43580486|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580487|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
43580488|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43580489|NCT02620306|Losartan|losartan|mesh-list
43580490|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43580491|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43580503|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580505|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580507|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580508|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
43580517|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580518|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580519|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
43580526|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43580527|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43580528|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43580529|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580531|NCT02186847|Paclitaxel|paclitaxel|mesh-list
43580532|NCT02186847|Carboplatin|carboplatin|mesh-list
43580533|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43580534|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580535|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
43580536|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
43580537|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
43580538|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580539|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43580540|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580541|NCT02101034|Cetuximab|cetuximab|mesh-list
43580542|NCT02101034|Palbociclib|palbociclib|mesh-list
43580543|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580544|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580545|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580546|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580547|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580548|NCT01968590|Vitamin D|vitamin d|mesh-list
43580549|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
43580550|NCT01968590|Vitamins|vitamins|mesh-ancestor
43580551|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
43580552|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580553|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43608245|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43578678|NCT03478306|Melatonin|melatonin|mesh-list
43578679|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
43578680|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578681|NCT03478306|Protective Agents|protective agents|mesh-ancestor
43578682|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578683|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578684|NCT03478280|Brodalumab|brodalumab|mesh-list
43580554|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43580555|NCT01938261|Acetaminophen|acetaminophen|mesh-list
43580558|NCT01938261|Analgesics|analgesics|mesh-ancestor
43580559|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
43580560|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580561|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580562|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
43580563|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43580564|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43580565|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580566|NCT01709981|Colchicine|colchicine|mesh-list
43580567|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
43580568|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580569|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
43580570|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
43580571|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
43580572|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580573|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580574|NCT01553032|Cetuximab|cetuximab|mesh-list
43580575|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43580576|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580577|NCT00753532|Vitamin E|vitamin e|mesh-list
43580578|NCT00753532|Tocopherols|tocopherols|mesh-list
43580579|NCT00753532|Tocotrienols|tocotrienols|mesh-list
43580580|NCT00753532|Tocovid|tocovid|mesh-list
43580581|NCT00753532|Vitamins|vitamins|mesh-ancestor
43580582|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
43580583|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580593|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580594|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43580595|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43580596|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43580597|NCT03468595|Listerine|listerine|mesh-list
43580598|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43580599|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580600|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
43580601|NCT03468478|Sirolimus|sirolimus|mesh-list
43580602|NCT03468478|Everolimus|everolimus|mesh-list
43580603|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580604|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580605|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
43580606|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580607|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43580608|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43580610|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43580611|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580612|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580613|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580614|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
43580615|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
43580616|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43580617|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43580618|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
43580619|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578685|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
43578686|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
43578687|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
43578688|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
43578689|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43578690|NCT03478150|Protective Agents|protective agents|mesh-ancestor
43578691|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578692|NCT03478111|Methotrexate|methotrexate|mesh-list
43578693|NCT03478111|Infliximab|infliximab|mesh-list
43578694|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43578695|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
43578696|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43578697|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578698|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43578699|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
43578700|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578701|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578702|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
43578704|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43578705|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43578706|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
43578707|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43578708|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43578709|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578710|NCT03478033|Rifampin|rifampin|mesh-list
43578711|NCT03478033|Rifabutin|rifabutin|mesh-list
43578712|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43578713|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
43578714|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43578715|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578716|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
43578717|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43578718|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578719|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578720|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43578721|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43578722|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43578723|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43578724|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43578726|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
43578727|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
43580620|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580621|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580622|NCT03468465|Urological Agents|urological agents|mesh-ancestor
43580623|NCT03468439|Phenol|phenol|mesh-list
43580624|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43580625|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580626|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
43580627|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43580628|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43580629|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43580630|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43580632|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43580633|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580634|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580635|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580636|NCT03468348|Analgesics|analgesics|mesh-ancestor
43580637|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
43580638|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580639|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
43580640|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43580641|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
43580642|NCT03468296|Aflibercept|aflibercept|mesh-list
43580643|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43580644|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43578728|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43578729|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43578730|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578731|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43578732|NCT03477994|Clonidine|clonidine|mesh-list
43578733|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
43578734|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43578735|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578736|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578738|NCT03477994|Analgesics|analgesics|mesh-ancestor
43580645|NCT03468296|Growth Substances|growth substances|mesh-ancestor
43580646|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580647|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
43580648|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580670|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
43580671|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580672|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
43580673|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43580674|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580675|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580676|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43580677|NCT03468062|Analgesics|analgesics|mesh-ancestor
43580678|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
43580679|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580680|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43580681|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43580682|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43580683|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
43580684|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580685|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580686|NCT03468023|Calpastatin|calpastatin|mesh-list
43674199|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
43674200|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
43580707|NCT03467438|Polaprezinc|polaprezinc|mesh-list
43580708|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43674280|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
43674281|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674333|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43674334|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
43580723|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580724|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580725|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43580726|NCT03467178|Gemcitabine|gemcitabine|mesh-list
43580727|NCT03467178|Paclitaxel|paclitaxel|mesh-list
43580728|NCT03467178|Carboplatin|carboplatin|mesh-list
43580729|NCT03467178|Doxorubicin|doxorubicin|mesh-list
43580730|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43580731|NCT03467178|Decitabine|decitabine|mesh-list
43580732|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43580733|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580734|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
43580735|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
43580736|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
43580737|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580738|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43580739|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
43580740|NCT03467178|Antiviral Agents|antiviral agents|mesh-ancestor
43580741|NCT03467178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580742|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580793|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
43580794|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580795|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43580796|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43580797|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43580798|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
43580799|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580800|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580802|NCT03466567|Probenecid|probenecid|mesh-list
43580803|NCT03466567|Cyclosporins|cyclosporins|mesh-list
43580804|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580805|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580806|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580807|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
43580808|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580809|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
43580810|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580811|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
43580812|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580813|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43580814|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
43580815|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
43580816|NCT03466567|Renal Agents|renal agents|mesh-ancestor
43580817|NCT03466528|Thiamine|thiamine|mesh-list
43580818|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
43580819|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
43580820|NCT03466528|Vitamins|vitamins|mesh-ancestor
43580821|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
43580822|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580823|NCT03466528|Analgesics|analgesics|mesh-ancestor
43580824|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
43580825|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580826|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
43580852|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43580853|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
43580913|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43580914|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580915|NCT03465488|Albendazole|albendazole|mesh-list
43580916|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
43580917|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43580918|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580919|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
43580920|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43580921|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43580922|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
43580923|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
43580924|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
43580925|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580926|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674439|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674440|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674441|NCT02893553|Urological Agents|urological agents|mesh-ancestor
43674442|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
43674479|NCT02893371|Fluoxetine|fluoxetine|mesh-list
43674480|NCT02893371|Paroxetine|paroxetine|mesh-list
43674481|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43674482|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43674483|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
43674484|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43674485|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
43674486|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674487|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674488|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674489|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43674490|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43674491|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674492|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43674493|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43674494|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
43674495|NCT02893371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43674496|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43674497|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43674498|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43674499|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
43674500|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43674501|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
43674541|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43674543|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43674544|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43674545|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674546|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43674547|NCT02893384|Anesthetics|anesthetics|mesh-list
43674548|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
43674549|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674550|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580958|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580959|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580960|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43580961|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43581044|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581045|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43581046|NCT03464305|Aspirin|aspirin|mesh-list
43581047|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43581048|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581049|NCT03464305|Analgesics|analgesics|mesh-ancestor
43581050|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
43581051|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581052|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581053|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581054|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43581055|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43581056|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43581222|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43581223|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581225|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43581226|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43581227|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674628|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674629|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43674630|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43674631|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674632|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
43578739|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
43578740|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578741|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43578742|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43674633|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674634|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43674635|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674636|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827502|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827503|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
43827505|NCT05487885|Analgesics|analgesics|mesh-ancestor
43581325|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581326|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581327|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43581328|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
43581329|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581330|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
43581331|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581332|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
43581333|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43674710|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43674711|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581360|NCT03461081|Telmisartan|telmisartan|mesh-list
43581361|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43581362|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
43581363|NCT03461081|Atorvastatin|atorvastatin|mesh-list
43581364|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43581365|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43581366|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
43581367|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581368|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43581369|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43581370|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581545|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43581546|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43581547|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43581548|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581549|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43581550|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43581551|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43578743|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43578744|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
43578745|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578746|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578747|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43578748|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
43578749|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
43578750|NCT03477955|Silicon|silicon|mesh-list
43578751|NCT03477955|Trace Elements|trace elements|mesh-ancestor
43578752|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
43674753|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
43674754|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43674755|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
43674756|NCT02890238|Citric Acid|citric acid|mesh-list
43674757|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
43674758|NCT02890238|Clomiphene|clomiphene|mesh-list
43674759|NCT02890238|Enclomiphene|enclomiphene|mesh-list
43674760|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
43581600|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43581601|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581603|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
43581604|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43581605|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581606|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43674922|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43581936|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581937|NCT04754035|Venetoclax|venetoclax|mesh-list
43581938|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581939|NCT04642404|Cannabidiol|cannabidiol|mesh-list
43581940|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
43581941|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
43581942|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43581943|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
43581944|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581945|NCT04628429|Erenumab|erenumab|mesh-list
43581946|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43581947|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581948|NCT04628429|Analgesics|analgesics|mesh-ancestor
43581950|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581951|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581952|NCT04614714|Niacinamide|niacinamide|mesh-list
43581953|NCT04614714|Niacin|niacin|mesh-list
43581954|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
43581955|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
43673067|NCT02046395|Amlodipine|amlodipine|mesh-list
43673068|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43673069|NCT02046395|Hydralazine|hydralazine|mesh-list
43673070|NCT02046395|Terazosin|terazosin|mesh-list
43673071|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43673072|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43673073|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673074|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673075|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43673076|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673077|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
43673078|NCT02046395|Diuretics|diuretics|mesh-ancestor
43673079|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
43673083|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43673110|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
43673111|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
43581956|NCT04614714|Vitamins|vitamins|mesh-ancestor
43581957|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
43674985|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674986|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43674988|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43674989|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
43674990|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674991|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674992|NCT02888561|Protective Agents|protective agents|mesh-ancestor
43674993|NCT02888444|Varenicline|varenicline|mesh-list
43674994|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43674995|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43674996|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
43674997|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674998|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674999|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675000|NCT02888054|Allopurinol|allopurinol|mesh-list
43675141|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43675142|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43675143|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43675144|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673112|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673113|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673114|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
43673115|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673116|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43673117|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43673118|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
43673119|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43673120|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43673121|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43673122|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43673123|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673124|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43673125|NCT02026349|Favipiravir|favipiravir|mesh-list
43673126|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
43673127|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673128|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
43578753|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578754|NCT03477929|Cetrorelix|cetrorelix|mesh-list
43578755|NCT03477929|Ganirelix|ganirelix|mesh-list
43578756|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
43578757|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578758|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578759|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43578760|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
43578761|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43578762|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43675145|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578763|NCT03477864|Ipilimumab|ipilimumab|mesh-list
43578764|NCT03477864|Cemiplimab|cemiplimab|mesh-list
43578765|NCT03477864|Antibodies|antibodies|mesh-list
43578766|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
43578767|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43578768|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
43578769|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578770|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578771|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43578772|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578774|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43578775|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43578776|NCT03477448|Bleomycin|bleomycin|mesh-list
43578777|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43578778|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578792|NCT03477344|Analgesics|analgesics|mesh-ancestor
43578793|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
43675146|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
43675147|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675148|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675149|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43675150|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675151|NCT02886897|Antibodies|antibodies|mesh-list
43675152|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
43675153|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704656|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43675243|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675245|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43675246|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675247|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
43675252|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43675254|NCT02885441|Analgesics|analgesics|mesh-ancestor
43582274|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582275|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43582276|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
43582277|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43582278|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582279|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43582280|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
43582281|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
43582282|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582283|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
43578794|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578795|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43578796|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43578797|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43578798|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
43578799|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578800|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578801|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43673130|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43673131|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43673132|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673133|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673134|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673135|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43673136|NCT02019589|Progesterone|progesterone|mesh-list
43673137|NCT02019589|Progestins|progestins|mesh-ancestor
43673138|NCT02019589|Hormones|hormones|mesh-ancestor
43673139|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673140|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675255|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
43675256|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675350|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675351|NCT02884986|Etoricoxib|etoricoxib|mesh-list
43675352|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43675353|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43675354|NCT02884986|Analgesics|analgesics|mesh-ancestor
43675355|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
43675356|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675357|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675358|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675369|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827558|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827559|NCT05487742|Analgesics|analgesics|mesh-ancestor
43827560|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
43673141|NCT02018926|Azacitidine|azacitidine|mesh-list
43673142|NCT02018926|Mocetinostat|mocetinostat|mesh-list
43578802|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578803|NCT03477266|Mosapride|mosapride|mesh-list
43578804|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578805|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43578806|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
43578807|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578808|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578809|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578811|NCT03477136|Vitamins|vitamins|mesh-ancestor
43827561|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827563|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43675393|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675394|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
43675395|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43675396|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43675397|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43675398|NCT02884713|Renal Agents|renal agents|mesh-ancestor
43675399|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43675400|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43675401|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675402|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43675403|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43675404|NCT02884388|Anesthetics|anesthetics|mesh-list
43675405|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675406|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675407|NCT02884440|Ropivacaine|ropivacaine|mesh-list
43675408|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
43675409|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675410|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675411|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
43675412|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
43675413|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675414|NCT02884635|Methotrexate|methotrexate|mesh-list
43582316|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582317|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
43582318|NCT02168140|Protective Agents|protective agents|mesh-ancestor
43582319|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582361|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582362|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582363|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582364|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582365|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582387|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43582388|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
43582389|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582390|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578812|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
43578813|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578814|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43578815|NCT03477110|Temozolomide|temozolomide|mesh-list
43578816|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43578817|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
43578818|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578819|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578820|NCT03476941|Clindamycin|clindamycin|mesh-list
43578821|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
43578822|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
43578823|NCT03476941|Gentamicins|gentamicins|mesh-list
43578824|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43578825|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578826|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43578827|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578828|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578829|NCT03476772|Nalbuphine|nalbuphine|mesh-list
43578830|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43578831|NCT03476772|Narcotics|narcotics|mesh-ancestor
43582391|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582392|NCT01166633|Atorvastatin|atorvastatin|mesh-list
43582393|NCT01166633|Pitavastatin|pitavastatin|mesh-list
43582394|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43582395|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43582396|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
43582397|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582398|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43582399|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43675469|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
43675471|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
43675473|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43675474|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675475|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43675476|NCT02884180|Dexamethasone|dexamethasone|mesh-list
43675477|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675478|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
43578832|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578833|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578834|NCT03476772|Analgesics|analgesics|mesh-ancestor
43578835|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
43578836|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578837|NCT03476616|Valsartan|valsartan|mesh-list
43578838|NCT03476616|Eplerenone|eplerenone|mesh-list
43578839|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43675479|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
43675480|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675481|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675482|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43675483|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
43675484|NCT02884180|Hormones|hormones|mesh-ancestor
43675485|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675486|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43675487|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675488|NCT02883647|Tenofovir|tenofovir|mesh-list
43675489|NCT02883647|Entecavir|entecavir|mesh-list
43675490|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
43675491|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675492|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43675493|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43582493|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582494|NCT03449173|Sunitinib|sunitinib|mesh-list
43582495|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582496|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43582497|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43582498|NCT03449173|Growth Substances|growth substances|mesh-ancestor
43582499|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582500|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
43582501|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43582502|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582503|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582504|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43582505|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
43582506|NCT03449082|Coagulants|coagulants|mesh-ancestor
43582507|NCT03449056|Albuterol|albuterol|mesh-list
43582508|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43582509|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
43582510|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582511|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582512|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43582513|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
43582514|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
43582515|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43582516|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43582517|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43675512|NCT02883569|Analgesics|analgesics|mesh-ancestor
43582525|NCT03448835|Atezolizumab|atezolizumab|mesh-list
43582526|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582527|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582528|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582529|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582530|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582531|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43582532|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
43582533|NCT03448770|Lactulose|lactulose|mesh-list
43582534|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582535|NCT03448744|Entecavir|entecavir|mesh-list
43582536|NCT03448744|Thymalfasin|thymalfasin|mesh-list
43582537|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
43582538|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582539|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43582540|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
43582541|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582542|NCT03448731|Doxycycline|doxycycline|mesh-list
43582543|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43582544|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578840|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43578842|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578843|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43578844|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
43578845|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578846|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578847|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43673143|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673144|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
43673145|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582545|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
43582546|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43582547|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43582548|NCT03448705|Vaccines|vaccines|mesh-list
43582549|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
43582550|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582551|NCT03448640|Tropicamide|tropicamide|mesh-list
43582552|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
43582553|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
43582554|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582555|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582556|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43582557|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43582558|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
43582559|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582560|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582561|NCT03448588|Selenium|selenium|mesh-list
43582562|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
43582563|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582564|NCT03448588|Protective Agents|protective agents|mesh-ancestor
43582565|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582566|NCT03448588|Trace Elements|trace elements|mesh-ancestor
43582567|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
43582568|NCT03448549|Capecitabine|capecitabine|mesh-list
43582569|NCT03448549|Tegafur|tegafur|mesh-list
43675538|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675539|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582572|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
43582573|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582574|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582576|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
43582577|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673146|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673147|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673148|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43673150|NCT02014649|Zanamivir|zanamivir|mesh-list
43673151|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
43673152|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673153|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673154|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673155|NCT02014142|Latanoprost|latanoprost|mesh-list
43673156|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43673157|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43673158|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
43673159|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
43673160|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
43673161|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673162|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673163|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
43673164|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582578|NCT03448094|Protective Agents|protective agents|mesh-ancestor
43582579|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582580|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582581|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43582582|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
43582583|NCT03447925|Salicylates|salicylates|mesh-list
43582584|NCT03447925|Petrolatum|petrolatum|mesh-list
43582585|NCT03447925|Emollients|emollients|mesh-ancestor
43582587|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43582588|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43582590|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
43582591|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582592|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673165|NCT02009579|Nintedanib|nintedanib|mesh-list
43673166|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673167|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673168|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673169|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673170|NCT02008344|Favipiravir|favipiravir|mesh-list
43673171|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
43673172|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673173|NCT01999764|Retinol acetate|retinol acetate|mesh-list
43673174|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43673175|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
43673176|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673177|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43673178|NCT01999764|Protective Agents|protective agents|mesh-ancestor
43582593|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582594|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43582595|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43582596|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582597|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582598|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582599|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
43582600|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
43582601|NCT03447873|Lamivudine|lamivudine|mesh-list
43582602|NCT03447873|Cobicistat|cobicistat|mesh-list
43582603|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43582604|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43582605|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582606|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582607|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
43582608|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582609|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43582610|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43582611|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43582612|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43675540|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
43675541|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675542|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43675555|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675556|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43675557|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
43675558|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675559|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675560|NCT02883192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43675561|NCT02883192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43675562|NCT02883192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673179|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578848|NCT03476616|Diuretics|diuretics|mesh-ancestor
43673180|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
43673181|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43673182|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673183|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43673184|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
43673185|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43673186|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673187|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673188|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673189|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
43673190|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673191|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673192|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673193|NCT01998035|Azacitidine|azacitidine|mesh-list
43673194|NCT01998035|Romidepsin|romidepsin|mesh-list
43673195|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673196|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
43673197|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673198|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673199|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673200|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43673201|NCT01993641|Azacitidine|azacitidine|mesh-list
43675563|NCT02883192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43675564|NCT02883192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43675565|NCT02883439|Fluticasone|fluticasone|mesh-list
43675566|NCT02883439|Xhance|xhance|mesh-list
43675567|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675568|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43675569|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
43675570|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675571|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675572|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43675573|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
43675574|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675575|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43675576|NCT02883426|Vaccines|vaccines|mesh-list
43582664|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43582665|NCT03446937|BB 1101|bb 1101|mesh-list
43582667|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
43582668|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
43673202|NCT01993641|Decitabine|decitabine|mesh-list
43673203|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673204|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
43673205|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673206|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673207|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673208|NCT01989429|Vitamin D|vitamin d|mesh-list
43673209|NCT01989429|Vitamins|vitamins|mesh-ancestor
43673210|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
43578849|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
43578851|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43578852|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578853|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578854|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43578855|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43578856|NCT03476564|Protective Agents|protective agents|mesh-ancestor
43578857|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578858|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
43582669|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582670|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582671|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582672|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
43582673|NCT03446937|Hormones|hormones|mesh-ancestor
43582674|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582675|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43582676|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582677|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43582678|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
43582679|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
43582680|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582681|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578859|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43673211|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673212|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43673213|NCT01989325|Dexamethasone|dexamethasone|mesh-list
43673214|NCT01989325|Filanesib|filanesib|mesh-list
43673215|NCT01989325|Lenograstim|lenograstim|mesh-list
43673216|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
43673217|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43673218|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
43673219|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
43673220|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673221|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673222|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43673223|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
43673225|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673226|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43673227|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673228|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43673229|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
43673230|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
43582682|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
43582683|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43582684|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582685|NCT03446872|Leucovorin|leucovorin|mesh-list
43582686|NCT03446872|Fluorouracil|fluorouracil|mesh-list
43582687|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
43675577|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
43675578|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675579|NCT02883114|Itraconazole|itraconazole|mesh-list
43675580|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
43675581|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675582|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43675583|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43673231|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578860|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
43578861|NCT03476356|Clomiphene|clomiphene|mesh-list
43578862|NCT03476356|Enclomiphene|enclomiphene|mesh-list
43578863|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
43578864|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43578865|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
43578866|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578867|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578868|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43578869|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
43675584|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675585|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675586|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43675587|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
43675588|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675589|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675590|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43827574|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
43827575|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827576|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
43827577|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
43827578|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827579|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827580|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43827581|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
43827582|NCT05487521|Hormones|hormones|mesh-ancestor
43675596|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43675597|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675598|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675599|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43675600|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675601|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675602|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
43675603|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675604|NCT02882828|Tacrolimus|tacrolimus|mesh-list
43675605|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43675606|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
43675607|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675608|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43675609|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675610|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675611|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43675612|NCT02882984|Gefitinib|gefitinib|mesh-list
43675613|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675614|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43675615|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578870|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43578871|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43578872|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43578873|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
43578874|NCT03476174|Interleukin-2|interleukin-2|mesh-list
43578875|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43578876|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578877|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578878|NCT03476174|Analgesics|analgesics|mesh-ancestor
43578879|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
43578880|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578881|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578882|NCT03476083|Tenofovir|tenofovir|mesh-list
43578883|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
43578884|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578885|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43578886|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43578887|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578888|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578889|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43578890|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43578891|NCT03476044|Selenium|selenium|mesh-list
43578892|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
43673232|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673233|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
43673234|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
43673236|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43673237|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
43673238|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673239|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43673240|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
43673241|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43673243|NCT01978366|Halofuginone|halofuginone|mesh-list
43673244|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673245|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
43673249|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43673250|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673251|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673252|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673253|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43578893|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578894|NCT03476044|Protective Agents|protective agents|mesh-ancestor
43578895|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675616|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675617|NCT02882789|Delpazolid|delpazolid|mesh-list
43675618|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
43675619|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43675620|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675621|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43675622|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675624|NCT02882737|Glucagon|glucagon|mesh-list
43675636|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675637|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43675638|NCT02882308|Cisplatin|cisplatin|mesh-list
43675639|NCT02882308|Durvalumab|durvalumab|mesh-list
43675640|NCT02882308|Olaparib|olaparib|mesh-list
43675641|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675642|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43675643|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43675644|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675645|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675646|NCT02882581|Metformin|metformin|mesh-list
43675647|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675648|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675649|NCT02882347|Somatostatin|somatostatin|mesh-list
43675650|NCT02882347|Hormones|hormones|mesh-ancestor
43675651|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675652|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675653|NCT02882477|Metformin|metformin|mesh-list
43675654|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43582689|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43582690|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582691|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582692|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
43582693|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582695|NCT03446872|Protective Agents|protective agents|mesh-ancestor
43675656|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43675657|NCT02882477|Deferiprone|deferiprone|mesh-list
43675658|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675659|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675660|NCT02882477|Incretins|incretins|mesh-ancestor
43675661|NCT02882477|Hormones|hormones|mesh-ancestor
43675662|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675663|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43675664|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
43675665|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675666|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675667|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
43675668|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675669|NCT02882477|Expectorants|expectorants|mesh-ancestor
43578896|NCT03476044|Trace Elements|trace elements|mesh-ancestor
43578897|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
43578898|NCT03475862|Oxycodone|oxycodone|mesh-list
43578899|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43578900|NCT03475862|Narcotics|narcotics|mesh-ancestor
43578901|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578902|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578903|NCT03475862|Analgesics|analgesics|mesh-ancestor
43578904|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
43578905|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578906|NCT03475810|Midazolam|midazolam|mesh-list
43578907|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43578908|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43578909|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578910|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578911|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43578912|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43578913|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43578914|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43578915|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
43578916|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
43578917|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
43578918|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
43578919|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578920|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673254|NCT01978366|Growth Substances|growth substances|mesh-ancestor
43673255|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675670|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
43675671|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43673256|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673257|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
43673258|NCT01975818|Hematinics|hematinics|mesh-ancestor
43673259|NCT01975610|Spebrutinib|spebrutinib|mesh-list
43673260|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673261|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673262|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673263|NCT01973049|Ribavirin|ribavirin|mesh-list
43673264|NCT01973049|Asunaprevir|asunaprevir|mesh-list
43673265|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
43673266|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673267|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
43673268|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673269|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
43673270|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675672|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
43675673|NCT02882477|Protective Agents|protective agents|mesh-ancestor
43675674|NCT02882477|Antidotes|antidotes|mesh-ancestor
43675675|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43675676|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
43675677|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
43675678|NCT02882425|Selexipag|selexipag|mesh-list
43675679|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43675680|NCT02882451|Ascorbic Acid|ascorbic acid|mesh-list
43675681|NCT02882451|Pinaverium|pinaverium|mesh-list
43675682|NCT02882451|Bromides|bromides|mesh-list
43675683|NCT02882451|Vitamins|vitamins|mesh-ancestor
43675684|NCT02882451|Micronutrients|micronutrients|mesh-ancestor
43675685|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675686|NCT02882451|Antioxidants|antioxidants|mesh-ancestor
43675687|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675688|NCT02882451|Protective Agents|protective agents|mesh-ancestor
43675689|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
43675690|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43675695|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675697|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675699|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675700|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675701|NCT02882594|Anesthetics|anesthetics|mesh-list
43675702|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675703|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675704|NCT02882100|Vaccines|vaccines|mesh-list
43675705|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
43673271|NCT01972854|Riboflavin|riboflavin|mesh-list
43673272|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43673273|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
43673274|NCT01972854|Vitamins|vitamins|mesh-ancestor
43673275|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
43673276|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673277|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43578921|NCT03475758|Goserelin|goserelin|mesh-list
43578922|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43578923|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578924|NCT03475693|Acetaminophen|acetaminophen|mesh-list
43578925|NCT03475693|Ondansetron|ondansetron|mesh-list
43578926|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
43578927|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578928|NCT03475693|Analgesics|analgesics|mesh-ancestor
43578929|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
43578930|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578931|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578932|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
43578933|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
43578934|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
43578935|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578936|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
43578937|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
43578938|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43578939|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
43578940|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578941|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578942|NCT03475693|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43578943|NCT03475693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43578944|NCT03475693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675706|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675707|NCT02882113|Tacrolimus|tacrolimus|mesh-list
43578945|NCT03475693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43578946|NCT03475693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43578947|NCT03475693|Antacids|antacids|mesh-ancestor
43578948|NCT03475680|Gentamicins|gentamicins|mesh-list
43578949|NCT03475680|Ornidazole|ornidazole|mesh-list
43578950|NCT03475680|Sennosides|sennosides|mesh-list
43578951|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43578952|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673278|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
43582698|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
43582699|NCT03446638|Cytarabine|cytarabine|mesh-list
43582700|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43582701|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
43582702|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582703|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582704|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
43582705|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582706|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582707|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
43582708|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582709|NCT03446625|Resveratrol|resveratrol|mesh-list
43582710|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
43582711|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582713|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582714|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582716|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
43582717|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
43582718|NCT03446599|Methylene Blue|methylene blue|mesh-list
43582719|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582720|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582721|NCT03446599|Hematinics|hematinics|mesh-ancestor
43582722|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
43582723|NCT03446599|Vitamins|vitamins|mesh-ancestor
43582724|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
43582725|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582727|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43582728|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582729|NCT03446534|Amoxicillin|amoxicillin|mesh-list
43582730|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43582731|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582732|NCT03446495|Trabectedin|trabectedin|mesh-list
43582733|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43582734|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
43582735|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582736|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582737|NCT03446443|Metronidazole|metronidazole|mesh-list
43582738|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582739|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43582740|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43582741|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43582742|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43582743|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43675708|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43675709|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
43675710|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675711|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43675712|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675713|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675715|NCT02882217|Glutarimide|glutarimide|mesh-list
43675716|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
43582753|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
43582754|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
43582755|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
43582756|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673279|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
43673280|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673281|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673282|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673283|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
43673284|NCT01968733|Solithromycin|solithromycin|mesh-list
43673285|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43673286|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673287|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43673288|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43673289|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673290|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673291|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673292|NCT01967810|Bevacizumab|bevacizumab|mesh-list
43673293|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43673294|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673295|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673296|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43673297|NCT01967810|Growth Substances|growth substances|mesh-ancestor
43578953|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43578954|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582757|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582758|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
43582759|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582760|NCT03445702|Metformin|metformin|mesh-list
43578955|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578956|NCT03475680|Laxatives|laxatives|mesh-ancestor
43578957|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578958|NCT03475680|Amebicides|amebicides|mesh-ancestor
43578959|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43578960|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43578961|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43578962|NCT03475628|Daratumumab|daratumumab|mesh-list
43578963|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578964|NCT03475615|Paclitaxel|paclitaxel|mesh-list
43578965|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
43578966|NCT03475615|Tegafur|tegafur|mesh-list
43578967|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43578968|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578969|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582761|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43582762|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582763|NCT03445624|Infliximab|infliximab|mesh-list
43582764|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
43582765|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582766|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43582767|NCT03445611|Lidocaine|lidocaine|mesh-list
43582768|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43582769|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
43582770|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
43582771|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582772|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582773|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
43582774|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582775|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43582776|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43582777|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43582778|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43582779|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582780|NCT03445468|Vaccines|vaccines|mesh-list
43582781|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
43582782|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582783|NCT03445286|Fluorides|fluorides|mesh-list
43582784|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
43582785|NCT03445286|Protective Agents|protective agents|mesh-ancestor
43582786|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582787|NCT03445182|Anesthetics|anesthetics|mesh-list
43582788|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582789|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582790|NCT03445104|Huperzine A|huperzine a|mesh-list
43582791|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43582795|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608246|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
43578970|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
43578971|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
43578972|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578973|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43578974|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
43578975|NCT03475589|Apatinib|apatinib|mesh-list
43578976|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578977|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43578978|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578979|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578980|NCT03475524|Metformin|metformin|mesh-list
43582796|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582797|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43582798|NCT03445104|Protective Agents|protective agents|mesh-ancestor
43582799|NCT03445078|Selenium|selenium|mesh-list
43582800|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
43675718|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675719|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675720|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675721|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43675722|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675723|NCT02881866|Furosemide|furosemide|mesh-list
43675724|NCT02881866|Diuretics|diuretics|mesh-ancestor
43675725|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
43675726|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675727|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43675728|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675732|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
43675733|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43675734|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
43675735|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43578981|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43578982|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578983|NCT03475459|Melatonin|melatonin|mesh-list
43578984|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
43578985|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578986|NCT03475459|Protective Agents|protective agents|mesh-ancestor
43578987|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578988|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578989|NCT03475407|Dexamethasone|dexamethasone|mesh-list
43578990|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
43578991|NCT03475407|BB 1101|bb 1101|mesh-list
43578992|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43578993|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
43578995|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578996|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578997|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578998|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
43578999|NCT03475407|Hormones|hormones|mesh-ancestor
43579000|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579001|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43579002|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579003|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
43579004|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579005|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579006|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
43579007|NCT03475225|Vitamin D|vitamin d|mesh-list
43579008|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43579009|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579010|NCT03475225|Vitamins|vitamins|mesh-ancestor
43579011|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
43675736|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675737|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43675738|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43675739|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43675740|NCT02882126|Treprostinil|treprostinil|mesh-list
43675741|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43675742|NCT02882230|Dolutegravir|dolutegravir|mesh-list
43675743|NCT02882230|Rilpivirine|rilpivirine|mesh-list
43579013|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
43579014|NCT03475160|Citric Acid|citric acid|mesh-list
43579015|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
43579016|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
43579017|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43579018|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
43579019|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
43579020|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579021|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
43579022|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43579023|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43579024|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579025|NCT03475160|Urological Agents|urological agents|mesh-ancestor
43673298|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675744|NCT02882230|Elvitegravir|elvitegravir|mesh-list
43675745|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43582801|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582802|NCT03445078|Protective Agents|protective agents|mesh-ancestor
43582803|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582804|NCT03445078|Trace Elements|trace elements|mesh-ancestor
43582805|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
43582806|NCT03444831|Buspirone|buspirone|mesh-list
43582807|NCT03444831|Omeprazole|omeprazole|mesh-list
43582808|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43582809|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582810|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43582811|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582812|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582813|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43582814|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43582815|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582816|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582817|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43675747|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608247|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
43673299|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673300|NCT01964989|Vaccines|vaccines|mesh-list
43673301|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
43673302|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673303|NCT01963208|Ganaxolone|ganaxolone|mesh-list
43673304|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
43673305|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673306|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673307|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673308|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
43673309|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
43673310|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43673311|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43673312|NCT01959282|Niacinamide|niacinamide|mesh-list
43673313|NCT01959282|Peficitinib|peficitinib|mesh-list
43673314|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673315|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673316|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673317|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
43673318|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673319|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
43673320|NCT01959282|Vitamins|vitamins|mesh-ancestor
43673321|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
43673322|NCT01956812|Gemcitabine|gemcitabine|mesh-list
43673323|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673324|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
43673325|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673326|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673327|NCT01956812|Antiviral Agents|antiviral agents|mesh-ancestor
43673337|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
43673338|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675748|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675749|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43673339|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673340|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
43673341|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673342|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43673343|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43673344|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
43673345|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579026|NCT03475121|Topotecan|topotecan|mesh-list
43579027|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43579028|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43579029|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579030|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579031|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579032|NCT03475017|Curcumin|curcumin|mesh-list
43579033|NCT03475017|Piperine|piperine|mesh-list
43579034|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43579035|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43579036|NCT03475017|Analgesics|analgesics|mesh-ancestor
43579037|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
43579038|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579039|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579040|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579041|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43579042|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579043|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579044|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675750|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43675751|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
43579045|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43579047|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43579048|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43579049|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579050|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579051|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43579052|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43579053|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43579054|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43579055|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
43579056|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
43579057|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
43579058|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
43579059|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579060|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579061|NCT03474614|Propranolol|propranolol|mesh-list
43675752|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675753|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43675754|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43675755|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
43675756|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
43675757|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675758|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43675759|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675760|NCT02881762|Maraviroc|maraviroc|mesh-list
43675761|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43582818|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43582819|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
43582820|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582821|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43582822|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
43582823|NCT03444649|Cytarabine|cytarabine|mesh-list
43582824|NCT03444649|Daunorubicin|daunorubicin|mesh-list
43582825|NCT03444649|Idarubicin|idarubicin|mesh-list
43582826|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43582827|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
43582828|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582829|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582830|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
43582831|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582832|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582833|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
43579062|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43579063|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43579064|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
43579065|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579066|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579067|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579068|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43579081|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579082|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43579083|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43582834|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582835|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43582836|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43582837|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43582838|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582839|NCT03444636|Fentanyl|fentanyl|mesh-list
43582840|NCT03444636|Bupivacaine|bupivacaine|mesh-list
43582841|NCT03444636|Ropivacaine|ropivacaine|mesh-list
43582843|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
43582844|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582845|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582846|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
43582847|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582848|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43582849|NCT03444636|Narcotics|narcotics|mesh-ancestor
43582850|NCT03444636|Analgesics|analgesics|mesh-ancestor
43582851|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43582852|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43582853|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
43582854|NCT03444519|Mannitol|mannitol|mesh-list
43582855|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43582856|NCT03444519|Diuretics|diuretics|mesh-ancestor
43582857|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
43582858|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582859|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43582860|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43675762|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43675763|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675764|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43675765|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43675766|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
43675767|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675768|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43675769|NCT02882087|Methotrexate|methotrexate|mesh-list
43675770|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43675771|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
43675772|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43675773|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675774|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675775|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
43608248|NCT03197480|Aflibercept|aflibercept|mesh-list
43579084|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579086|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43579087|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
43673346|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673347|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
43673348|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
43673349|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
43673350|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43673351|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
43673352|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43673353|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
43673354|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43675776|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675777|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675778|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675779|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675780|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43675781|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43675782|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
43675783|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675784|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43675785|NCT02881346|Betamethasone|betamethasone|mesh-list
43675786|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
43675787|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43675788|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
43675789|NCT02881346|Calcipotriene|calcipotriene|mesh-list
43675790|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43582861|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43582862|NCT03444506|Analgesics|analgesics|mesh-ancestor
43582863|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
43582864|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582865|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582866|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582867|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43582868|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43582869|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43582870|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43582871|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
43582873|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582874|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582875|NCT03444467|Glucagon|glucagon|mesh-list
43675791|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675793|NCT02881346|Hormones|hormones|mesh-ancestor
43675794|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675795|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675796|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43675797|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
43673355|NCT01952990|Protective Agents|protective agents|mesh-ancestor
43827404|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827405|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43827406|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827407|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827408|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43827409|NCT05488925|Narcotics|narcotics|mesh-ancestor
43827410|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827411|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
43827412|NCT05488925|Protective Agents|protective agents|mesh-ancestor
43827414|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
43579088|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579089|NCT03474237|Hormones|hormones|mesh-list
43579090|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579091|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579092|NCT03474198|Levofloxacin|levofloxacin|mesh-list
43579093|NCT03474198|Rifampin|rifampin|mesh-list
43579094|NCT03474198|Isoniazid|isoniazid|mesh-list
43579095|NCT03474198|Linezolid|linezolid|mesh-list
43579096|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
43579097|NCT03474198|Ethambutol|ethambutol|mesh-list
43579098|NCT03474198|Rifapentine|rifapentine|mesh-list
43675798|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675799|NCT02881528|Metformin|metformin|mesh-list
43675800|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675801|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827595|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
43827596|NCT05487508|Hormones|hormones|mesh-ancestor
43827608|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827609|NCT05487443|Antiviral Agents|antiviral agents|mesh-ancestor
43827610|NCT05487443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827611|NCT05487443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579099|NCT03474198|Bedaquiline|bedaquiline|mesh-list
43579100|NCT03474198|Clofazimine|clofazimine|mesh-list
43579101|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43579102|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579103|NCT03474198|Renal Agents|renal agents|mesh-ancestor
43579104|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43579106|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43579107|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579108|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579109|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579110|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43579111|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43827612|NCT05487443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827613|NCT05487443|Immunologic Factors|immunologic factors|mesh-ancestor
43827614|NCT05487443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827616|NCT05487391|Vinorelbine|vinorelbine|mesh-list
43582876|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582877|NCT03444467|Hormones|hormones|mesh-ancestor
43582878|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582879|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582880|NCT03444402|Esomeprazole|esomeprazole|mesh-list
43582881|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43582882|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582883|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43827617|NCT05487391|Cisplatin|cisplatin|mesh-list
43827618|NCT05487391|Carboplatin|carboplatin|mesh-list
43827619|NCT05487391|Pemetrexed|pemetrexed|mesh-list
43827620|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43827621|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827622|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
43827623|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
43827624|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
43827625|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827626|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827627|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43827628|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43827629|NCT05487300|Levodopa|levodopa|mesh-list
43582884|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582885|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582886|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
43582888|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582890|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
43582891|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43582892|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582893|NCT03444246|Trace Elements|trace elements|mesh-ancestor
43582894|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
43582895|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582896|NCT03444142|Exenatide|exenatide|mesh-list
43582897|NCT03444142|Dulaglutide|dulaglutide|mesh-list
43579112|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43579113|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
43849077|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579114|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
43579115|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43579116|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43579117|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43579118|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43827415|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43827416|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827417|NCT05488899|Trace Elements|trace elements|mesh-ancestor
43827418|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
43827419|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827420|NCT05488860|Triamcinolone|triamcinolone|mesh-list
43582898|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43582899|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582900|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43582901|NCT03444142|Incretins|incretins|mesh-ancestor
43582902|NCT03444142|Hormones|hormones|mesh-ancestor
43582903|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582904|NCT03444025|Goserelin|goserelin|mesh-list
43582905|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43582906|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582907|NCT03444012|Ticagrelor|ticagrelor|mesh-list
43582908|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43827630|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43827631|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43827633|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827634|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827635|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827636|NCT05487261|Valsartan|valsartan|mesh-list
43827637|NCT05487261|Enalapril|enalapril|mesh-list
43827638|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43827639|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43827640|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43827641|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43827642|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827643|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43675818|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675819|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827421|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43827422|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43827423|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43827424|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
43827425|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43827426|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827427|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
43827428|NCT05488860|Hormones|hormones|mesh-ancestor
43704624|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675820|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43675821|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43675822|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
43675823|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675824|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675825|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43675826|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
43675827|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43675828|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675829|NCT02881177|Oxytocin|oxytocin|mesh-list
43675830|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
43675832|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675834|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43675835|NCT02881125|Nortriptyline|nortriptyline|mesh-list
43675836|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43675837|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582922|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582923|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
43582924|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582925|NCT03443960|Amitriptyline|amitriptyline|mesh-list
43582926|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
43582927|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43582928|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
43582929|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43582930|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43582931|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582932|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43582933|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582934|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43582936|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43582937|NCT03443960|Analgesics|analgesics|mesh-ancestor
43582938|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
43582939|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43582940|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43582941|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43582943|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
43582944|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582945|NCT03443921|Paclitaxel|paclitaxel|mesh-list
43582946|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43582947|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582948|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582949|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582950|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582951|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849087|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582952|NCT03443843|Fluticasone|fluticasone|mesh-list
43675838|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
43827429|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827430|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827431|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827432|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
43827433|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827434|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827435|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675839|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
43675840|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
43675841|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675842|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43675843|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
43675844|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43675845|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43675846|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43675847|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675848|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
43675849|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675850|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675851|NCT02880787|Rocuronium|rocuronium|mesh-list
43675852|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43675853|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43675854|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43675855|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675856|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675857|NCT02880800|Morphine|morphine|mesh-list
43675858|NCT02880800|Hydromorphone|hydromorphone|mesh-list
43675859|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43675860|NCT02880800|Narcotics|narcotics|mesh-ancestor
43675861|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675862|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675863|NCT02880800|Analgesics|analgesics|mesh-ancestor
43675864|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
43675865|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675866|NCT02880462|Sulforaphane|sulforaphane|mesh-list
43675867|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43675868|NCT02880462|Protective Agents|protective agents|mesh-ancestor
43675869|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675870|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675871|NCT02880410|Temozolomide|temozolomide|mesh-list
43675872|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43582954|NCT03443843|Loratadine|loratadine|mesh-list
43582955|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
43582956|NCT03443843|Ephedrine|ephedrine|mesh-list
43675873|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
43675874|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675875|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675876|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
43675877|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43675878|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675879|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43675880|NCT02880280|Menotropins|menotropins|mesh-list
43675881|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43675882|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827436|NCT05488522|Bevacizumab|bevacizumab|mesh-list
43579119|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43579120|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43579121|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43579122|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43579123|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43579124|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
43579125|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43579126|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43579127|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579128|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
43579130|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43579131|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579132|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
43579133|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
43579134|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43579135|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43675883|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43675884|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
43675885|NCT02879955|Acarbose|acarbose|mesh-list
43675886|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43675887|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675888|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675889|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675893|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
43675894|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
43675895|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675896|NCT02879981|Trimethoprim|trimethoprim|mesh-list
43675897|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
43675898|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
43675899|NCT02879981|Guaifenesin|guaifenesin|mesh-list
43579136|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579137|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43579138|NCT03473964|Hormones|hormones|mesh-ancestor
43579139|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579140|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579141|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
43579142|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43579143|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579144|NCT03473626|Alicaforsen|alicaforsen|mesh-list
43579145|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43579146|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43579147|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
43579148|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827437|NCT05488522|Atezolizumab|atezolizumab|mesh-list
43675900|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
43675901|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43675902|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675903|NCT02879981|Renal Agents|renal agents|mesh-ancestor
43582957|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582958|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43582959|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
43582960|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582961|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582962|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43582963|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
43582964|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675905|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43675906|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43675907|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43675908|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675909|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675910|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43675911|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43675912|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43675913|NCT02879981|Expectorants|expectorants|mesh-ancestor
43675914|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
43675915|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43675916|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43675917|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
43675918|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675919|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675920|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
43675921|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43675922|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
43675923|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
43827438|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43827439|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827440|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673356|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43673357|NCT01941836|Ezetimibe|ezetimibe|mesh-list
43579149|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
43579150|NCT03473613|Cabergoline|cabergoline|mesh-list
43579151|NCT03473613|Calcium|calcium|mesh-list
43579152|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43579153|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675924|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675925|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
43675926|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43675927|NCT02880007|Cisplatin|cisplatin|mesh-list
43675955|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675956|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43675957|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
43675958|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675959|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675960|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43675961|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675962|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43675963|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43675965|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
43675966|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
43675967|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675968|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675969|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
43675970|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675971|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
43675972|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43675973|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675974|NCT02879513|Paclitaxel|paclitaxel|mesh-list
43675975|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
43675976|NCT02879513|Cisplatin|cisplatin|mesh-list
43675977|NCT02879513|Epirubicin|epirubicin|mesh-list
43675978|NCT02879513|Fluorouracil|fluorouracil|mesh-list
43675979|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43675980|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675981|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
43675982|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
43675983|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
43675984|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675986|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
43675987|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675996|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
43675997|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675998|NCT02879643|Vincristine|vincristine|mesh-list
43675999|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43676000|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676001|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
43676002|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
43579154|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43579155|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43579156|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43579157|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
43579158|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
43579159|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579160|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579161|NCT03473600|Triamcinolone|triamcinolone|mesh-list
43579162|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43579163|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43579164|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43579165|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579166|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
43579167|NCT03473600|Hormones|hormones|mesh-ancestor
43676003|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
43676004|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827646|NCT05487001|Dexamethasone|dexamethasone|mesh-list
43827647|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827648|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
43827649|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
43827650|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827651|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827652|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582965|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43582966|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
43582967|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43582968|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43582969|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
43582970|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
43582971|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582972|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582973|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
43582974|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43582975|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43582976|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
43582977|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
43582978|NCT03443778|Dexamethasone|dexamethasone|mesh-list
43582979|NCT03443778|Bupivacaine|bupivacaine|mesh-list
43582980|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582981|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
43582982|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
43582983|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582984|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582985|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582986|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
43582987|NCT03443778|Hormones|hormones|mesh-ancestor
43579168|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579169|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579170|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43579171|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
43579172|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579173|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579174|NCT03473431|Ketamine|ketamine|mesh-list
43579175|NCT03473431|Analgesics|analgesics|mesh-ancestor
43579176|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
43579177|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579178|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579179|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43582988|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582989|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43582990|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582991|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
43582992|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
43582993|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582994|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
43582995|NCT03443765|Vitamin D|vitamin d|mesh-list
43582996|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
43582997|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43582998|NCT03443765|Antibodies|antibodies|mesh-list
43582999|NCT03443765|Vitamins|vitamins|mesh-ancestor
43583000|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
43583001|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583002|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43583003|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
43583004|NCT03443726|Epinephrine|epinephrine|mesh-list
43583005|NCT03443726|Carticaine|carticaine|mesh-list
43583006|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43583007|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43827653|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
43827655|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827656|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827657|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827658|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
43827659|NCT05486949|Itraconazole|itraconazole|mesh-list
43827660|NCT05486949|Carbamazepine|carbamazepine|mesh-list
43827661|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
43827662|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827663|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43827664|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43827665|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676035|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43676036|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43676037|NCT02879097|Growth Substances|growth substances|mesh-ancestor
43579180|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43579181|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
43579182|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
43579183|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579184|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43579185|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43849078|NCT03964051|Omalizumab|omalizumab|mesh-list
43849079|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43579186|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579187|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579188|NCT03473418|Ketoconazole|ketoconazole|mesh-list
43579189|NCT03473418|Terconazole|terconazole|mesh-list
43579190|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
43579191|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579192|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43579193|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43579194|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579195|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579196|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43579197|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
43579198|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579200|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43579202|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43579203|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
43579204|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579205|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579206|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43579207|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
43579208|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43579209|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
43676038|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673358|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43673359|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43673360|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
43673361|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673362|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43579210|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579211|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579212|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43579213|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
43579214|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
43579216|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43579217|NCT03473210|Erythromycin|erythromycin|mesh-list
43579219|NCT03473210|Dexamethasone|dexamethasone|mesh-list
43676039|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
43676040|NCT02879006|Omalizumab|omalizumab|mesh-list
43676041|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43676042|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43676043|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
43676044|NCT02878837|Midazolam|midazolam|mesh-list
43676045|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
43676046|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43676047|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676048|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676049|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676050|NCT02878837|Analgesics|analgesics|mesh-ancestor
43676051|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
43676052|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676053|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43676054|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43676055|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43676056|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
43676057|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676058|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676059|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43676072|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676073|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676075|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43676076|NCT02878863|Peoniflorin|peoniflorin|mesh-list
43676077|NCT02878863|Silymarin|silymarin|mesh-list
43676078|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
43676079|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676080|NCT02878863|Protective Agents|protective agents|mesh-ancestor
43676081|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676082|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43676083|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43579220|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579221|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
43579222|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
43579223|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579224|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579225|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43579226|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
43579227|NCT03473210|Hormones|hormones|mesh-ancestor
43579228|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579229|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43579230|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579231|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579232|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676084|NCT02878863|Analgesics|analgesics|mesh-ancestor
43676085|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
43676086|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676087|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676088|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676089|NCT02878772|Aspirin|aspirin|mesh-list
43676090|NCT02878772|Vinpocetine|vinpocetine|mesh-list
43676091|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43676092|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676093|NCT02878772|Analgesics|analgesics|mesh-ancestor
43676094|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
43676095|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676096|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676097|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676098|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676099|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43676100|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43676101|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676102|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43676103|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43676104|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579233|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579234|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43579235|NCT03473132|Thrombin|thrombin|mesh-list
43579236|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
43579237|NCT03473132|Coagulants|coagulants|mesh-ancestor
43579238|NCT03473093|Pregabalin|pregabalin|mesh-list
43579239|NCT03473093|Morphine|morphine|mesh-list
43579240|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43579241|NCT03473093|Narcotics|narcotics|mesh-ancestor
43579242|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579243|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579244|NCT03473093|Analgesics|analgesics|mesh-ancestor
43579245|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
43579246|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579247|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
43676106|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43676107|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
43676110|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
43676111|NCT02878564|Praziquantel|praziquantel|mesh-list
43676112|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
43676113|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43676114|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676115|NCT02878512|Anesthetics|anesthetics|mesh-list
43676116|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676117|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676118|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
43676119|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43676120|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676121|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676122|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676123|NCT02878707|Analgesics|analgesics|mesh-ancestor
43676124|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
43583010|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583011|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583012|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43583013|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43583015|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583016|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43583019|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
43583020|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43583021|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
43583022|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
43583023|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583024|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
43583025|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43583026|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43583027|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849088|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43579248|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43579249|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579250|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579251|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43579252|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43579253|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43579254|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43579255|NCT03472976|Imiquimod|imiquimod|mesh-list
43579256|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43579257|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
43583028|NCT03443570|Rituximab|rituximab|mesh-list
43583029|NCT03443570|Bortezomib|bortezomib|mesh-list
43583030|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43583031|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583036|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583037|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583038|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43583039|NCT03443518|Narcotics|narcotics|mesh-ancestor
43583040|NCT03443518|Analgesics|analgesics|mesh-ancestor
43583041|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
43583042|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583044|NCT03443492|Gemcitabine|gemcitabine|mesh-list
43583045|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
43583046|NCT03443492|Irinotecan|irinotecan|mesh-list
43583047|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
43583048|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43583049|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
43583050|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583051|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583052|NCT03443492|Antiviral Agents|antiviral agents|mesh-ancestor
43583053|NCT03443492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676125|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676126|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43676127|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43676128|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43676129|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
43676130|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676131|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676132|NCT02878681|Ranibizumab|ranibizumab|mesh-list
43676133|NCT02878681|Aflibercept|aflibercept|mesh-list
43676134|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43676135|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43676136|NCT02878681|Growth Substances|growth substances|mesh-ancestor
43676137|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676138|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
43676139|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676140|NCT02878421|Nicotine|nicotine|mesh-list
43676141|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43676142|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
43676143|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676144|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676145|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43676146|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43676147|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
43579258|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579259|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579260|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
43579261|NCT03472963|Darunavir|darunavir|mesh-list
43579262|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43579263|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43579264|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43579265|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
43579266|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579267|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579268|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43579269|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43579270|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
43579271|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579272|NCT03472950|Ranolazine|ranolazine|mesh-list
43579273|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43579274|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673363|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673364|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43673365|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673366|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
43673367|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43673368|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43673369|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43673370|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673371|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673372|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
43673373|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673374|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673375|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43673389|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43673390|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43673391|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43673392|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
43673393|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43673394|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43673395|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43673396|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
43579275|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579276|NCT03472846|Teriparatide|teriparatide|mesh-list
43579277|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43579278|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579279|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43673397|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673398|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
43673399|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673400|NCT01909427|Methotrexate|methotrexate|mesh-list
43673401|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43673402|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
43673403|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43673404|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673405|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673406|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
43673407|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673408|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673409|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
43676148|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579280|NCT03472677|Capsaicin|capsaicin|mesh-list
43579281|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
43579282|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
43579283|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
43579284|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579285|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579287|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
43579288|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43579289|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43579290|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579291|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579292|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43579293|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43579294|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
43579295|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579296|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579297|NCT03472508|Folic Acid|folic acid|mesh-list
43579298|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
43579299|NCT03472508|Enalapril|enalapril|mesh-list
43579300|NCT03472508|Enalaprilat|enalaprilat|mesh-list
43579301|NCT03472508|Hematinics|hematinics|mesh-ancestor
43579302|NCT03472508|Vitamins|vitamins|mesh-ancestor
43676149|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676150|NCT02878538|Deferiprone|deferiprone|mesh-list
43676151|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43676152|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
43676153|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
43676154|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676155|NCT02878200|Piperaquine|piperaquine|mesh-list
43676171|NCT02878265|Zinc|zinc|mesh-list
43676172|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
43676173|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
43676174|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676175|NCT02878265|Trace Elements|trace elements|mesh-ancestor
43676176|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
43579303|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
43579304|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579305|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579306|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579307|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43579308|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
43579309|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43579310|NCT03472456|Eugenol|eugenol|mesh-list
43579311|NCT03472456|Carticaine|carticaine|mesh-list
43579312|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
43579313|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
43579314|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579315|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579316|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
43579317|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579318|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579319|NCT03472378|Celecoxib|celecoxib|mesh-list
43579321|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43579323|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
43579324|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579325|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579326|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579327|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43579328|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43673411|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43673412|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673413|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
43673414|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43673415|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43676177|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673416|NCT01908738|Lidocaine|lidocaine|mesh-list
43673417|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
43673418|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
43673419|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673420|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579329|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43579330|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579331|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579332|NCT03472339|Diclofenac|diclofenac|mesh-list
43579333|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43676178|NCT02878265|Protective Agents|protective agents|mesh-ancestor
43676179|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43676180|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676181|NCT02878161|Prednisone|prednisone|mesh-list
43676182|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
43676183|NCT02878161|Adalimumab|adalimumab|mesh-list
43676184|NCT02878161|Etanercept|etanercept|mesh-list
43676185|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43676186|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43676187|NCT02878161|Methotrexate|methotrexate|mesh-list
43676188|NCT02878161|Infliximab|infliximab|mesh-list
43676189|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
43676190|NCT02878161|Leflunomide|leflunomide|mesh-list
43676191|NCT02878161|Hormones|hormones|mesh-ancestor
43676192|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43583056|NCT03443492|Immunologic Factors|immunologic factors|mesh-ancestor
43583057|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583058|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43583059|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43583060|NCT03443492|Antidotes|antidotes|mesh-ancestor
43583061|NCT03443492|Protective Agents|protective agents|mesh-ancestor
43583062|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
43583063|NCT03443492|Vitamins|vitamins|mesh-ancestor
43583064|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
43583065|NCT03443271|Bupivacaine|bupivacaine|mesh-list
43583066|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
43583067|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
43583068|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583069|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583070|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
43583071|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583072|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
43583073|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43583074|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
43583075|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583076|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583077|NCT03443141|Vitamin E|vitamin e|mesh-list
43583078|NCT03443141|Vitamins|vitamins|mesh-ancestor
43583079|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
43583080|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583081|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
43676194|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43676195|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676196|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43676197|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
43676198|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43579334|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43579335|NCT03472339|Analgesics|analgesics|mesh-ancestor
43579336|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
43579337|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579338|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579339|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579340|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43579341|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43579342|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579343|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579344|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
43579345|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43579346|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43579347|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43579357|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43579358|NCT03472144|Levofloxacin|levofloxacin|mesh-list
43579359|NCT03472144|Ofloxacin|ofloxacin|mesh-list
43579360|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43579361|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579362|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
43579363|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43579364|NCT03472144|Renal Agents|renal agents|mesh-ancestor
43579365|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43579366|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43579367|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676199|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43676200|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
43579368|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579369|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579370|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43579371|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43579372|NCT03471988|Voriconazole|voriconazole|mesh-list
43579373|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
43579374|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579375|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43579376|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43579377|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579378|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579379|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43579380|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
43579381|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579382|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579383|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43579384|NCT03471819|Serotonin|serotonin|mesh-list
43579385|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43579386|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
43673421|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
43673422|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673423|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43673424|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43673425|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43673426|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673427|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673429|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43673432|NCT01903954|Ribavirin|ribavirin|mesh-list
43673472|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673473|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579387|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579388|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579389|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579390|NCT03471585|Dronabinol|dronabinol|mesh-list
43579391|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
43579392|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579393|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43579394|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43579395|NCT03471585|Analgesics|analgesics|mesh-ancestor
43676201|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676202|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
43676203|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676204|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43676205|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43676206|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
43676207|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676208|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43676209|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
43676210|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
43676211|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676212|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676213|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43676214|NCT02878161|Protective Agents|protective agents|mesh-ancestor
43676215|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676216|NCT02878161|Analgesics|analgesics|mesh-ancestor
43579396|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
43579397|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579398|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43579399|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43579400|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579401|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579402|NCT03471585|Hormones|hormones|mesh-ancestor
43579403|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579404|NCT03471559|Cannabidiol|cannabidiol|mesh-list
43579405|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
43579406|NCT03471455|Itraconazole|itraconazole|mesh-list
43579407|NCT03471455|Terbinafine|terbinafine|mesh-list
43579408|NCT03471455|Isotretinoin|isotretinoin|mesh-list
43579409|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
43579412|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43676217|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
43676218|NCT02878018|Hormones|hormones|mesh-list
43676220|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43676221|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43676222|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676223|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583082|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583083|NCT03443141|Protective Agents|protective agents|mesh-ancestor
43583084|NCT03443037|Amantadine|amantadine|mesh-list
43583085|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43583086|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43583087|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
43583088|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583089|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
43583090|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583091|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583092|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583098|NCT03442621|Cortisone|cortisone|mesh-list
43676224|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676225|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583113|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43583114|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
43583115|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
43583116|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579413|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579414|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579415|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43579416|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
43579417|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579418|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579419|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43579420|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
43579421|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
43579422|NCT03471351|Tenalisib|tenalisib|mesh-list
43583117|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583118|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
43583119|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583120|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43583121|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43583122|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43583123|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43583124|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583125|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43583126|NCT03441815|Histamine|histamine|mesh-list
43583127|NCT03441815|Glutarimide|glutarimide|mesh-list
43583128|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
43583129|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
43583130|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583131|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583132|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583133|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43583134|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583135|NCT03441529|Tazobactam|tazobactam|mesh-list
43583136|NCT03441529|Piperacillin|piperacillin|mesh-list
43583137|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43583138|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43583139|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583140|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43583148|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
43583149|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583150|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583151|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579423|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43579424|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579425|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
43579426|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579427|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579429|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43579430|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673474|NCT01873703|Azacitidine|azacitidine|mesh-list
43673475|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673476|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
43673477|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673478|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673479|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673480|NCT01871415|Metformin|metformin|mesh-list
43673481|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43673482|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673483|NCT01870505|Letrozole|letrozole|mesh-list
43673484|NCT01870505|Exemestane|exemestane|mesh-list
43673485|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673486|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43673487|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43673488|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579431|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
43579432|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
43579433|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579434|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
43579435|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579436|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579437|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
43579438|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43583152|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43583153|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43583154|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
43583155|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583156|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43583157|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
43579439|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43579440|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579441|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43579442|NCT03471117|Pioglitazone|pioglitazone|mesh-list
43579443|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43579444|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579445|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
43579446|NCT03471039|Growth Substances|growth substances|mesh-ancestor
43579447|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579448|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
43579449|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579450|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579451|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43579452|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
43579453|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579454|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43579455|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
43579456|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43579457|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43579458|NCT03470649|Hematinics|hematinics|mesh-ancestor
43579459|NCT03470610|Estradiol|estradiol|mesh-list
43579460|NCT03470610|Progesterone|progesterone|mesh-list
43579461|NCT03470610|Estrogens|estrogens|mesh-ancestor
43579462|NCT03470610|Hormones|hormones|mesh-ancestor
43673489|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673490|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43673491|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
43673492|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673493|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673494|NCT01866930|Interferons|interferons|mesh-list
43673495|NCT01866930|Ribavirin|ribavirin|mesh-list
43673496|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673497|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
43673498|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673499|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
43673500|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583158|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
43673501|NCT01862224|Methotrexate|methotrexate|mesh-list
43673502|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43673503|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
43673504|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43673505|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673506|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673507|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
43673508|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673509|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583159|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
43583160|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43583161|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43583162|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43583163|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43583164|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43583166|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43583167|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43583168|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
43583169|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43583170|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43583171|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43583172|NCT03441373|Histamine|histamine|mesh-list
43583173|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
43583174|NCT03441373|Glutarimide|glutarimide|mesh-list
43583175|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
43583176|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
43583177|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583178|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583179|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583180|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43583181|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583182|NCT03441217|Scopolamine|scopolamine|mesh-list
43583183|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43583184|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43583185|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
43583186|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
43583187|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583188|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583214|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43583215|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583216|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43583218|NCT03440502|Anesthetics|anesthetics|mesh-list
43583219|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583220|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583221|NCT03440359|Letrozole|letrozole|mesh-list
43583222|NCT03440359|Progesterone|progesterone|mesh-list
43583223|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583224|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43583225|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43583226|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673510|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
43673511|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673512|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43673513|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673514|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
43579463|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579464|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579465|NCT03470610|Progestins|progestins|mesh-ancestor
43583227|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583228|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43583229|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
43583230|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43583231|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583232|NCT03440359|Progestins|progestins|mesh-ancestor
43583233|NCT03440359|Hormones|hormones|mesh-ancestor
43676250|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
43676251|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676252|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676254|NCT02877771|Insulin|insulin|mesh-list
43676255|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43676256|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676257|NCT02877537|Albuterol|albuterol|mesh-list
43583234|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43583235|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
43583236|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
43583237|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43583238|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
43676258|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43676259|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
43676260|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676263|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
43676264|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
43676265|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43676266|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43676267|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43676268|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43676269|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
43676270|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676271|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676272|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
43676273|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43676274|NCT02877511|Protective Agents|protective agents|mesh-ancestor
43676275|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676276|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
43676278|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
43676279|NCT02877641|Vitamins|vitamins|mesh-list
43676280|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
43676284|NCT02877238|Sevoflurane|sevoflurane|mesh-list
43676310|NCT02876770|Melatonin|melatonin|mesh-list
43676311|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
43676312|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676313|NCT02876770|Protective Agents|protective agents|mesh-ancestor
43676314|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676315|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676316|NCT02876822|Vitamin D|vitamin d|mesh-list
43676317|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
43676318|NCT02876822|Vitamins|vitamins|mesh-ancestor
43676319|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
43676320|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676321|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43579466|NCT03470597|Iodine|iodine|mesh-list
43579467|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43579468|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579469|NCT03470597|Trace Elements|trace elements|mesh-ancestor
43579470|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
43579471|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579472|NCT03470532|Epinephrine|epinephrine|mesh-list
43579473|NCT03470532|Racepinephrine|racepinephrine|mesh-list
43579474|NCT03470532|Mepivacaine|mepivacaine|mesh-list
43579475|NCT03470532|Carticaine|carticaine|mesh-list
43579476|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
43579477|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43579478|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43579479|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
43676322|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43676323|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
43676324|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43676325|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
43676326|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43676327|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
43676328|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676329|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676330|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
43676331|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
43676332|NCT02876978|Fludarabine|fludarabine|mesh-list
43676333|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43676334|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
43676335|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676336|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676337|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43676338|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
43676339|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676340|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676341|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43676342|NCT02876679|Cyclosporine|cyclosporine|mesh-list
43583239|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583240|NCT03440268|Expectorants|expectorants|mesh-ancestor
43583241|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
43583242|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43583244|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583245|NCT03440268|Protective Agents|protective agents|mesh-ancestor
43583246|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583247|NCT03440268|Antidotes|antidotes|mesh-ancestor
43583248|NCT03440177|Ramipril|ramipril|mesh-list
43676343|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
43676344|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
43676345|NCT02876679|Cyclosporins|cyclosporins|mesh-list
43676346|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43676347|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43676348|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
43676349|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579480|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849080|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43579481|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673515|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43673516|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43673517|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43673518|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43673519|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
43673520|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673521|NCT01859962|Ribavirin|ribavirin|mesh-list
43673522|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
43673523|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673524|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
43673525|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673526|NCT01858883|Gemcitabine|gemcitabine|mesh-list
43673527|NCT01858883|Paclitaxel|paclitaxel|mesh-list
43673528|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43673529|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673530|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
43673531|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
43673532|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
43673533|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673534|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673535|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
43673536|NCT01858883|Antiviral Agents|antiviral agents|mesh-ancestor
43673537|NCT01858883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673538|NCT01858883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673539|NCT01858883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673540|NCT01858883|Immunologic Factors|immunologic factors|mesh-ancestor
43673541|NCT01858883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673542|NCT01847573|Halofuginone|halofuginone|mesh-list
43579489|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
43579490|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
43579491|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43673548|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43673549|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673550|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673551|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673552|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43673553|NCT01847573|Growth Substances|growth substances|mesh-ancestor
43673554|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673555|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
43673556|NCT01846481|Cocaine|cocaine|mesh-list
43673557|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
43673558|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
43673559|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673560|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673561|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
43676350|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676351|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43676352|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
43676353|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676354|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676364|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43676368|NCT02876549|Chloroquine|chloroquine|mesh-list
43676377|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43676378|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676379|NCT02876432|Analgesics|analgesics|mesh-ancestor
43676380|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
43676381|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676382|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583249|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43583250|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
43583251|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583252|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673562|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673563|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43673564|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43673565|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43673566|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673567|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673568|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
43673569|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673570|NCT01825980|Ritonavir|ritonavir|mesh-list
43673571|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43673572|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43673573|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
43673621|NCT01804829|Antibodies|antibodies|mesh-list
43673622|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
43673623|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43673624|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43673625|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
43673626|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
43673627|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673628|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43673629|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43673630|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
43673631|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579504|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579505|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
43579506|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43579507|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43579508|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579509|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43579510|NCT03470454|Linagliptin|linagliptin|mesh-list
43579511|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43583253|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43583254|NCT03440034|Pioglitazone|pioglitazone|mesh-list
43583255|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43583256|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583257|NCT03439943|Lixisenatide|lixisenatide|mesh-list
43849089|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
43583258|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43583259|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583261|NCT03439787|Bupivacaine|bupivacaine|mesh-list
43583262|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
43583263|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
43583264|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583265|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583266|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
43583267|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583268|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43583269|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43579512|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579513|NCT03470454|Incretins|incretins|mesh-ancestor
43579514|NCT03470454|Hormones|hormones|mesh-ancestor
43579515|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579516|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43579517|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
43579518|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579519|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579520|NCT03470363|Sufentanil|sufentanil|mesh-list
43579521|NCT03470363|Bupivacaine|bupivacaine|mesh-list
43579522|NCT03470363|Sevoflurane|sevoflurane|mesh-list
43579523|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
43579524|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
43579525|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579526|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579527|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
43583270|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
43583271|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583272|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583273|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43583274|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43583275|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
43583276|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43583277|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
43583278|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
43583279|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
43583280|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43583281|NCT03439709|Lanreotide|lanreotide|mesh-list
43583282|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583283|NCT03439501|Avelumab|avelumab|mesh-list
43583284|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43583285|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583287|NCT03439358|Analgesics|analgesics|mesh-ancestor
43676383|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676384|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676385|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43676386|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676387|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676388|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
43676389|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43676390|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
43579528|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579529|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43579530|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43579531|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
43579532|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43579533|NCT03470363|Narcotics|narcotics|mesh-ancestor
43673632|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673633|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43673634|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
43676393|NCT02876276|Protective Agents|protective agents|mesh-ancestor
43676395|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
43676396|NCT02876354|Vitamins|vitamins|mesh-ancestor
43676397|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
43676398|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676399|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43676400|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43676401|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676402|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
43676403|NCT02876354|Coagulants|coagulants|mesh-ancestor
43676404|NCT02876224|Bevacizumab|bevacizumab|mesh-list
43676405|NCT02876224|Atezolizumab|atezolizumab|mesh-list
43676406|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43676407|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676408|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43676409|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43676410|NCT02876224|Growth Substances|growth substances|mesh-ancestor
43676411|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676412|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
43676413|NCT02876250|Cyclosporine|cyclosporine|mesh-list
43676428|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43676429|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
43676430|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676431|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43676432|NCT02876484|Cathartics|cathartics|mesh-ancestor
43676433|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676434|NCT02876094|Celecoxib|celecoxib|mesh-list
43676435|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43676436|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676437|NCT02876094|Analgesics|analgesics|mesh-ancestor
43676438|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
43676439|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676440|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676441|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676442|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676443|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43676444|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43676445|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676446|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676447|NCT02876081|Afatinib|afatinib|mesh-list
43583289|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583290|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583291|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
43583292|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583293|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43583294|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
43846857|NCT04166669|Rifampin|rifampin|mesh-list
43673635|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43673636|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43673637|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43673638|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
43673639|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673640|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673641|NCT01789736|Travoprost|travoprost|mesh-list
43673642|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43673643|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43673644|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43673645|NCT01785771|Exenatide|exenatide|mesh-list
43673646|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43673647|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673648|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43673649|NCT01785771|Incretins|incretins|mesh-ancestor
43673650|NCT01785771|Hormones|hormones|mesh-ancestor
43673651|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673652|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
43579534|NCT03470363|Analgesics|analgesics|mesh-ancestor
43579535|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43579536|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43579538|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43579539|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
43579540|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579541|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579542|NCT03470337|Wobenzym|wobenzym|mesh-list
43579543|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43579544|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
43579545|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579546|NCT03470103|Aflibercept|aflibercept|mesh-list
43579547|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43579548|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43579549|NCT03470103|Growth Substances|growth substances|mesh-ancestor
43583295|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43579550|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579551|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
43579552|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579553|NCT03470077|Nalbuphine|nalbuphine|mesh-list
43579554|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579555|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579559|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
43579560|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579562|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
43579563|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579564|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
43579565|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43579566|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43579567|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673653|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43673654|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
43673655|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673656|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673657|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43673658|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
43673659|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
43673660|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43673661|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
43583296|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673662|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579568|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
43579569|NCT03469947|Coagulants|coagulants|mesh-ancestor
43579570|NCT03469895|Idelalisib|idelalisib|mesh-list
43579571|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579572|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579573|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579574|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43579575|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43579576|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
43579577|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43579578|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579579|NCT03469700|Anesthetics|anesthetics|mesh-list
43579580|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579581|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579582|NCT03469583|Entecavir|entecavir|mesh-list
43579583|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
43579584|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579585|NCT03469557|Cisplatin|cisplatin|mesh-list
43579586|NCT03469557|Capecitabine|capecitabine|mesh-list
43579587|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
43579588|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579589|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43583297|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583298|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43583299|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
43583300|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43583301|NCT03438955|Telmisartan|telmisartan|mesh-list
43583302|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43583303|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43583304|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43579590|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
43579591|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579592|NCT03469544|Hormones|hormones|mesh-list
43579593|NCT03469544|Antibodies|antibodies|mesh-list
43579594|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579595|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579596|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
43579597|NCT03469531|Cisplatin|cisplatin|mesh-list
43579598|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
43579599|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579600|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43579601|NCT03469375|Folfirinox|folfirinox|mesh-list
43579602|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579603|NCT03469323|Succinylcholine|succinylcholine|mesh-list
43579604|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43579606|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43579607|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579608|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579609|NCT03469310|Acetaminophen|acetaminophen|mesh-list
43579611|NCT03469310|Codeine|codeine|mesh-list
43579612|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43579613|NCT03469310|Analgesics|analgesics|mesh-ancestor
43579614|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
43579615|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579616|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579617|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
43579618|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43579619|NCT03469310|Narcotics|narcotics|mesh-ancestor
43583305|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583306|NCT03438942|Folic Acid|folic acid|mesh-list
43583307|NCT03438942|Hematinics|hematinics|mesh-ancestor
43579620|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579621|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
43579622|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
43583308|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
43583309|NCT03438942|Vitamins|vitamins|mesh-ancestor
43583310|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
43583311|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583312|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
43583313|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43583314|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583315|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
43583319|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583320|NCT03438773|Tacrolimus|tacrolimus|mesh-list
43583321|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43583322|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
43676448|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583324|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43583325|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583326|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583327|NCT03438708|Axitinib|axitinib|mesh-list
43583328|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583329|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43583330|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583331|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583332|NCT03438604|Donepezil|donepezil|mesh-list
43583333|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43583334|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583335|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583337|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583338|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583339|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
43583340|NCT03438344|Vaccines|vaccines|mesh-list
43583341|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
43583342|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583343|NCT03438253|Anesthetics|anesthetics|mesh-list
43583344|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583345|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583346|NCT03438240|Fentanyl|fentanyl|mesh-list
43583347|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
43583348|NCT03438240|Bupivacaine|bupivacaine|mesh-list
43583349|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
43583350|NCT03438240|Anesthetics|anesthetics|mesh-list
43583351|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
43583352|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583353|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583354|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
43583355|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583356|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43583357|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43583358|NCT03438240|Analgesics|analgesics|mesh-ancestor
43583359|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43583360|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43583362|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
43583363|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583364|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583365|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43583366|NCT03438240|Narcotics|narcotics|mesh-ancestor
43583367|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43583368|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43583369|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
43583370|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
43583371|NCT03438227|Dextrans|dextrans|mesh-list
43583372|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
43583373|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
43583374|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
43583375|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
43583376|NCT03438227|Hematinics|hematinics|mesh-ancestor
43583377|NCT03438214|Vancomycin|vancomycin|mesh-list
43583378|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43583379|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583380|NCT03437980|Propofol|propofol|mesh-list
43583381|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43583382|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583383|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579623|NCT03469271|Calcitriol|calcitriol|mesh-list
43579624|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43673663|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673664|NCT01784874|Vaccines|vaccines|mesh-list
43673665|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
43673666|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673667|NCT01782729|Tacrolimus|tacrolimus|mesh-list
43673668|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673669|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
43673670|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673671|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43673672|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579625|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43579626|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579627|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43579628|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579630|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43579631|NCT03469271|Vitamins|vitamins|mesh-ancestor
43579632|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
43579633|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43579634|NCT03469167|Epinephrine|epinephrine|mesh-list
43579635|NCT03469167|CEGP-003|cegp-003|mesh-list
43579636|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43579637|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43579638|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
43579639|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579640|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579641|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579642|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43579643|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43579644|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
43583384|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43583385|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
43583386|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
43583387|NCT03437902|Vitamins|vitamins|mesh-list
43583388|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
43579645|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579646|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43579647|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
43579648|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
43579649|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
43579650|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43579651|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
43579652|NCT03469167|Coagulants|coagulants|mesh-ancestor
43579653|NCT03469128|Sertraline|sertraline|mesh-list
43579654|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
43579655|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43579656|NCT03469128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43579657|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43579658|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579659|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579660|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579661|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
43579662|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579663|NCT03469089|Ketamine|ketamine|mesh-list
43579664|NCT03469089|Modafinil|modafinil|mesh-list
43579665|NCT03469089|Analgesics|analgesics|mesh-ancestor
43579666|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
43579667|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579668|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579669|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43579670|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43579671|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
43579673|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673673|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673674|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
43673675|NCT01780844|Prednisone|prednisone|mesh-list
43673676|NCT01780844|Tacrolimus|tacrolimus|mesh-list
43673677|NCT01780844|Basiliximab|basiliximab|mesh-list
43673678|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43673679|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
43673680|NCT01780844|Hormones|hormones|mesh-ancestor
43673681|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579675|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43579676|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579677|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579678|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43579679|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43579680|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43579681|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43579682|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
43579683|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579684|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43579685|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579686|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579687|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43579688|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
43579689|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579690|NCT03468946|Caffeine|caffeine|mesh-list
43579691|NCT03468946|Citric Acid|citric acid|mesh-list
43579692|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43579693|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673682|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827676|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43827679|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
43827680|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673683|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43673684|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673685|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673686|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
43673687|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43673688|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673689|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673690|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43673691|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43673692|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
43673693|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43673694|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827441|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43827442|NCT05488522|Growth Substances|growth substances|mesh-ancestor
43827443|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827444|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
43827446|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
43827447|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43827448|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827449|NCT05488405|Mesalamine|mesalamine|mesh-list
43827450|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43827451|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827452|NCT05488405|Analgesics|analgesics|mesh-ancestor
43827453|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
43827454|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827455|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827456|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827457|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827681|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43827458|NCT05488327|Lenalidomide|lenalidomide|mesh-list
43846863|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846864|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43846865|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
43846866|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846867|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846868|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43846869|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43846870|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
43846871|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43827682|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43827683|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43827684|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43827685|NCT05486884|Benzocaine|benzocaine|mesh-list
43827686|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
43827687|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
43827688|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827689|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827690|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
43827691|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827692|NCT05486819|Propofol|propofol|mesh-list
43827693|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43827694|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827695|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827696|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43827697|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
43827698|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
43827699|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43583389|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
43583390|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583391|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
43583392|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583394|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
43583395|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
43583396|NCT03437824|Vitamins|vitamins|mesh-ancestor
43583397|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
43583398|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583399|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
43583400|NCT03437824|Hematinics|hematinics|mesh-ancestor
43583401|NCT03437785|Ethanol|ethanol|mesh-list
43583402|NCT03437785|Rebamipide|rebamipide|mesh-list
43583403|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43583404|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583405|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583406|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583407|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43583408|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43583409|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
43583410|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583411|NCT03437785|Protective Agents|protective agents|mesh-ancestor
43583412|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583413|NCT03437707|Acetaminophen|acetaminophen|mesh-list
43583415|NCT03437707|Morphine|morphine|mesh-list
43846872|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
43846873|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43846874|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43846875|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43846876|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43846877|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43846878|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43846879|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43846888|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
43846889|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
43846890|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846891|NCT04165239|Protective Agents|protective agents|mesh-ancestor
43846892|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579694|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43579695|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579696|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579697|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43579698|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43579699|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
43846893|NCT04161989|Progesterone|progesterone|mesh-list
43846894|NCT04161989|Progestins|progestins|mesh-ancestor
43846895|NCT04161989|Hormones|hormones|mesh-ancestor
43846896|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846897|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583416|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43583417|NCT03437707|Narcotics|narcotics|mesh-ancestor
43673696|NCT01780428|Promethazine|promethazine|mesh-list
43673697|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
43673698|NCT01780428|Hydrocodone|hydrocodone|mesh-list
43673699|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43673700|NCT01780428|Analgesics|analgesics|mesh-ancestor
43673701|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
43579700|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579722|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
43579723|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43579724|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43579725|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43579726|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579727|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43579728|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
43579729|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579730|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579731|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43579732|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
43579733|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
43579736|NCT03468790|Hormones|hormones|mesh-ancestor
43579737|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579738|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43579739|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43579740|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43579741|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
43579742|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579743|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579744|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
43579745|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43579746|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
43579747|NCT03468777|Lansoprazole|lansoprazole|mesh-list
43579748|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
43579749|NCT03468777|Ranitidine|ranitidine|mesh-list
43579750|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43579751|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43579752|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43579755|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579756|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43579757|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
43579759|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579760|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579762|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
43579763|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579764|NCT05390905|Tramadol|tramadol|mesh-list
43579765|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43579766|NCT05390905|Narcotics|narcotics|mesh-ancestor
43579767|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579768|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579769|NCT05390905|Analgesics|analgesics|mesh-ancestor
43579770|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
43579771|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579772|NCT05390749|Rituximab|rituximab|mesh-list
43579773|NCT05390749|Methotrexate|methotrexate|mesh-list
43579774|NCT05390749|Pomalidomide|pomalidomide|mesh-list
43673702|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673703|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673704|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
43673705|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43673706|NCT01780428|Narcotics|narcotics|mesh-ancestor
43673707|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673708|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
43673709|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
43673710|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
43673711|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
43673712|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43673713|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
43673714|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
43673715|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673716|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673717|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43673718|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43673719|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43673720|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
43673721|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
43673722|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
43673723|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
43673724|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43673725|NCT01779947|Estradiol|estradiol|mesh-list
43673726|NCT01779947|Estrogens|estrogens|mesh-ancestor
43673727|NCT01779947|Hormones|hormones|mesh-ancestor
43673728|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43673729|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673730|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43673731|NCT01779453|Atorvastatin|atorvastatin|mesh-list
43673732|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43673733|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43673734|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
43579775|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43579776|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579777|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
43579778|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579779|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43579780|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43579781|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
43827700|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673735|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673736|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43673737|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43673738|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673739|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43673740|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673742|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43673743|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43673744|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
43673745|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673746|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673747|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673748|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
43673749|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43673750|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43827701|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827702|NCT05486481|Dexamethasone|dexamethasone|mesh-list
43676452|NCT02876146|Albendazole|albendazole|mesh-list
43676453|NCT02876146|Benzimidazole|benzimidazole|mesh-list
43676454|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
43676455|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43676456|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676457|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
43676458|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43676459|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43676460|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
43676461|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
43676462|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
43676463|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676464|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676465|NCT02875756|Ivermectin|ivermectin|mesh-list
43676466|NCT02875756|Selamectin|selamectin|mesh-list
43676467|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43676468|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676469|NCT02875743|Posaconazole|posaconazole|mesh-list
43676470|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
43676473|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43676474|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43676475|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43676476|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43676480|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
43673751|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43673752|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673753|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673754|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
43673755|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673756|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673757|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43673758|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673759|NCT01774578|Gemcitabine|gemcitabine|mesh-list
43673760|NCT01774578|Docetaxel|docetaxel|mesh-list
43673761|NCT01774578|Pemetrexed|pemetrexed|mesh-list
43673762|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43673763|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
43673764|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673765|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673773|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
43673774|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
43673775|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43673776|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43673777|NCT01773928|Vaccines|vaccines|mesh-list
43673778|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
43673779|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673780|NCT01773785|Docetaxel|docetaxel|mesh-list
43673781|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673782|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
43673783|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
43673784|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
43676481|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676490|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43673785|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673786|NCT01768975|Dapansutrile|dapansutrile|mesh-list
43673787|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43579782|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43849081|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
43579783|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43579784|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
43579785|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579786|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
43579787|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579788|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43579789|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43579790|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43579791|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43579792|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43579793|NCT05390749|Growth Substances|growth substances|mesh-ancestor
43579794|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
43579796|NCT05390736|Vitamins|vitamins|mesh-ancestor
43579797|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
43579798|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579799|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43579800|NCT05390710|Paclitaxel|paclitaxel|mesh-list
43579801|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43579802|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43579803|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579804|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
43579805|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
43579806|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
43579807|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579808|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43579809|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
43579811|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
43579820|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
43579821|NCT05390203|Testosterone|testosterone|mesh-list
43579822|NCT05390203|Androgens|androgens|mesh-ancestor
43579823|NCT05390203|Hormones|hormones|mesh-ancestor
43579824|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579825|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579826|NCT05390073|Hormones|hormones|mesh-list
43579827|NCT05390073|Mitogens|mitogens|mesh-list
43673789|NCT01758458|Aldesleukin|aldesleukin|mesh-list
43673790|NCT01758458|Interferon-beta|interferon-beta|mesh-list
43676492|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43676493|NCT02875886|Diuretics|diuretics|mesh-ancestor
43676494|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
43676495|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676496|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43676497|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43676498|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676499|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43676500|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43676501|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43676502|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43676503|NCT02875873|Methamphetamine|methamphetamine|mesh-list
43583418|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583419|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583420|NCT03437707|Analgesics|analgesics|mesh-ancestor
43583421|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
43583422|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583423|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43583424|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43583425|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583426|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43583427|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43583428|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583429|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583430|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
43583431|NCT03437655|Eugenol|eugenol|mesh-list
43583432|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
43583433|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
43583434|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
43583435|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43583436|NCT03437655|Protective Agents|protective agents|mesh-ancestor
43583437|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583438|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583439|NCT03437629|Calcium|calcium|mesh-list
43583440|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43583441|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583442|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
43583443|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
43583444|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43673791|NCT01758458|Interleukin-2|interleukin-2|mesh-list
43673792|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673793|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
43673794|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673795|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43673796|NCT01758458|Analgesics|analgesics|mesh-ancestor
43673797|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
43673798|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673799|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583445|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43583446|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
43583447|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583448|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583449|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583450|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43583451|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
43583452|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583453|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583454|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583455|NCT03437460|Ibuprofen|ibuprofen|mesh-list
43583456|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583457|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43583458|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676504|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
43676505|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43676506|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676507|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
43676508|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
43676509|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676510|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
43676511|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43704659|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43676514|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43676515|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43676516|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43676517|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43676518|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43676519|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43676520|NCT02875457|Cisplatin|cisplatin|mesh-list
43676521|NCT02875457|Etoposide|etoposide|mesh-list
43676522|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
43676523|NCT02875457|Apatinib|apatinib|mesh-list
43676524|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676525|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43676526|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43676527|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43676528|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676529|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583459|NCT03437460|Analgesics|analgesics|mesh-ancestor
43583460|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
43583461|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583462|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583463|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43583464|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43583465|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583466|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583469|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
43673800|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43673801|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43673802|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
43673803|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43579828|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579829|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579830|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
43579831|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579834|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579835|NCT05389943|Vitamin D|vitamin d|mesh-list
43579836|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
43579837|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
43579838|NCT05389943|Vitamins|vitamins|mesh-list
43579839|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
43583470|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43583471|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43583472|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583473|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583474|NCT03437226|Protective Agents|protective agents|mesh-ancestor
43583475|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583476|NCT03437213|Anesthetics|anesthetics|mesh-list
43583477|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676530|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43676531|NCT02875587|Cabergoline|cabergoline|mesh-list
43676532|NCT02875587|Calcium|calcium|mesh-list
43676533|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43676534|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676535|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43676536|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43676537|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
43676538|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
43676539|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676540|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676541|NCT02875717|Aspirin|aspirin|mesh-list
43676542|NCT02875717|Heparin|heparin|mesh-list
43676543|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43676544|NCT02875717|Tinzaparin|tinzaparin|mesh-list
43676545|NCT02875717|Dalteparin|dalteparin|mesh-list
43676546|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
43676547|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43676548|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43676549|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676550|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43676551|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676552|NCT02875717|Analgesics|analgesics|mesh-ancestor
43676553|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
43579840|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579841|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43579842|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43579843|NCT05389930|Ethanol|ethanol|mesh-list
43579844|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43579845|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579846|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579847|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579848|NCT05389514|Gemcitabine|gemcitabine|mesh-list
43579849|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
43579850|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
43579851|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43579852|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
43579853|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579854|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43579855|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43579856|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
43849082|NCT03962647|Letrozole|letrozole|mesh-list
43583478|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583479|NCT03437200|Nivolumab|nivolumab|mesh-list
43583480|NCT03437200|Ipilimumab|ipilimumab|mesh-list
43583481|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43583482|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583483|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43583484|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583485|NCT03437187|Analgesics|analgesics|mesh-list
43583486|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583487|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
43583488|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583489|NCT03437070|Doxorubicin|doxorubicin|mesh-list
43583490|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43583498|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583499|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43583500|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
43583501|NCT03437057|Aspirin|aspirin|mesh-list
43583502|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43583503|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43579857|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579858|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579859|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43579860|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43579862|NCT05389514|Antiviral Agents|antiviral agents|mesh-ancestor
43579863|NCT05389514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579864|NCT05389514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579865|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43579866|NCT05389176|Esmolol|esmolol|mesh-list
43579867|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43579868|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43579869|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43579870|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
43579871|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579872|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673804|NCT01756924|Vancomycin|vancomycin|mesh-list
43673805|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
43673806|NCT01756924|Levofloxacin|levofloxacin|mesh-list
43673807|NCT01756924|Rifampin|rifampin|mesh-list
43673808|NCT01756924|Cefazolin|cefazolin|mesh-list
43673809|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
43673810|NCT01756924|Linezolid|linezolid|mesh-list
43676554|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676555|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676556|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676557|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676558|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43676559|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43676560|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676561|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
43673811|NCT01756924|Daptomycin|daptomycin|mesh-list
43673812|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43673813|NCT01756924|Oxacillin|oxacillin|mesh-list
43673814|NCT01756924|Nafcillin|nafcillin|mesh-list
43673815|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
43673816|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673817|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43579873|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579874|NCT05389150|Pregabalin|pregabalin|mesh-list
43579875|NCT05389150|Tramadol|tramadol|mesh-list
43579876|NCT05389150|Analgesics|analgesics|mesh-ancestor
43579877|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
43676562|NCT02875262|Deferoxamine|deferoxamine|mesh-list
43676563|NCT02875262|Siderophores|siderophores|mesh-ancestor
43676564|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43676565|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
43676566|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
43676567|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676568|NCT02875093|Cytarabine|cytarabine|mesh-list
43676569|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43676570|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
43676571|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676572|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676573|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
43676574|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676575|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43676576|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
43676577|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676578|NCT02875288|Bupivacaine|bupivacaine|mesh-list
43676579|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
43583504|NCT03437057|Analgesics|analgesics|mesh-ancestor
43583505|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
43583506|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583507|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583508|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583509|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43583510|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43583511|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43583512|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583513|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43583514|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43583515|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583516|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
43583517|NCT03436836|Lidocaine|lidocaine|mesh-list
43583518|NCT03436836|Nalbuphine|nalbuphine|mesh-list
43583519|NCT03436836|Bupivacaine|bupivacaine|mesh-list
43583520|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
43583521|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
43583522|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583523|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583524|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
43583525|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583526|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43676580|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
43676581|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579878|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579879|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579880|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
43579881|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43579882|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579883|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579884|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43579885|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43579886|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43579887|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579888|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43579889|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43579890|NCT05389150|Narcotics|narcotics|mesh-ancestor
43579891|NCT05382806|Flumazenil|flumazenil|mesh-list
43579892|NCT05382806|Antidotes|antidotes|mesh-ancestor
43579893|NCT05382806|Protective Agents|protective agents|mesh-ancestor
43579894|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579895|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
43579896|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
43579897|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579898|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579899|NCT05345691|Denosumab|denosumab|mesh-list
43579900|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43676582|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676583|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
43676584|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676585|NCT02875015|Lidocaine|lidocaine|mesh-list
43579901|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579902|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
43579903|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43579904|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43579908|NCT05307770|Melatonin|melatonin|mesh-list
43579909|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
43579910|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579911|NCT05307770|Protective Agents|protective agents|mesh-ancestor
43579912|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579913|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579914|NCT05303805|Sevoflurane|sevoflurane|mesh-list
43579915|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43579916|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43579917|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
43676586|NCT02875015|Bupivacaine|bupivacaine|mesh-list
43583528|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43583529|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43583530|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583531|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43583532|NCT03436836|Narcotics|narcotics|mesh-ancestor
43583533|NCT03436836|Analgesics|analgesics|mesh-ancestor
43583534|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43583535|NCT03436719|Metronidazole|metronidazole|mesh-list
43583536|NCT03436719|Erythromycin|erythromycin|mesh-list
43583537|NCT03436719|Cefoperazone|cefoperazone|mesh-list
43583538|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43583539|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583540|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
43583543|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43583544|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43583545|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583546|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583547|NCT03436693|Canagliflozin|canagliflozin|mesh-list
43583548|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43583549|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583550|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43583551|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583552|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
43583553|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43583554|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583555|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583556|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43583557|NCT03436472|Analgesics|analgesics|mesh-ancestor
43583558|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
43583559|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583560|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43579918|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
43579919|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579920|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579921|NCT05295212|Atezolizumab|atezolizumab|mesh-list
43579922|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579923|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
43579925|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579926|NCT05282706|Peppermint oil|peppermint oil|mesh-list
43673818|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
43673819|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43673820|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43673821|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583561|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43583562|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43583563|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
43583564|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583565|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583566|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
43583567|NCT03436303|Progestins|progestins|mesh-ancestor
43583569|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43583583|NCT03436225|Hormones|hormones|mesh-ancestor
43583584|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43583585|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43583586|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583587|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
43583588|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583589|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583590|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43583591|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43583592|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
43583593|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
43583594|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43583595|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43583596|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43583597|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43583598|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
43583599|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583600|NCT03436173|Fluoxetine|fluoxetine|mesh-list
43583601|NCT03436173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43583602|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43583603|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43583604|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583605|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583606|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
43583607|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583608|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43583609|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
43583610|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43583633|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43673822|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673823|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673824|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43673825|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43673826|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43673827|NCT01756924|Renal Agents|renal agents|mesh-ancestor
43673828|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
43673829|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43579949|NCT05236231|Tadalafil|tadalafil|mesh-list
43579969|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43579970|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43580021|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
43580022|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
43673897|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43580126|NCT04594915|Edoxaban|edoxaban|mesh-list
43580135|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43580136|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43580138|NCT04481919|Diuretics|diuretics|mesh-list
43580191|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43580192|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580193|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
43580194|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43580195|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43673958|NCT01712451|Xhance|xhance|mesh-list
43673964|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673965|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43673966|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
43673967|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
43673968|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43673969|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43673970|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43673971|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43673972|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
43673973|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580255|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580256|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580257|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43580258|NCT03910621|Miglustat|miglustat|mesh-list
43580259|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580260|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580261|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43580262|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43580263|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
43580264|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674024|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674047|NCT01694277|Sunitinib|sunitinib|mesh-list
43674048|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674049|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43674050|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43674051|NCT01694277|Growth Substances|growth substances|mesh-ancestor
43580389|NCT03237611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43580390|NCT03237611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580392|NCT03237611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43674113|NCT01658501|Metformin|metformin|mesh-list
43674114|NCT01658501|Liraglutide|liraglutide|mesh-list
43674115|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43674117|NCT01658501|Incretins|incretins|mesh-ancestor
43674118|NCT01658501|Hormones|hormones|mesh-ancestor
43674120|NCT01652482|Leucovorin|leucovorin|mesh-list
43674183|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43674184|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43674185|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
43674186|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674187|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43674188|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43674189|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
43674190|NCT01566240|Paclitaxel|paclitaxel|mesh-list
43674191|NCT01566240|Cisplatin|cisplatin|mesh-list
43674192|NCT01566240|Carboplatin|carboplatin|mesh-list
43580509|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
43580510|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580511|NCT02457221|Prednisone|prednisone|mesh-list
43580512|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
43580513|NCT02457221|Tacrolimus|tacrolimus|mesh-list
43580514|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580515|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
43580516|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580585|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580586|NCT00753532|Protective Agents|protective agents|mesh-ancestor
43580587|NCT00003857|Tamoxifen|tamoxifen|mesh-list
43580588|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43580589|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
43580590|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43580591|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580592|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43580649|NCT03468231|Leucovorin|leucovorin|mesh-list
43580650|NCT03468231|Fluorouracil|fluorouracil|mesh-list
43580653|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
43580654|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580655|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43580656|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580657|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580658|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
43580659|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580660|NCT03468231|Antidotes|antidotes|mesh-ancestor
43580661|NCT03468231|Protective Agents|protective agents|mesh-ancestor
43580662|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
43580663|NCT03468231|Vitamins|vitamins|mesh-ancestor
43580664|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
43580665|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580666|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580667|NCT03468140|Eculizumab|eculizumab|mesh-list
43580668|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43580669|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43674202|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43674203|NCT01563731|Simvastatin|simvastatin|mesh-list
43674204|NCT01563731|Pravastatin|pravastatin|mesh-list
43674205|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43674206|NCT01563731|Diuretics|diuretics|mesh-list
43674207|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43674208|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43674209|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43674210|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
43674211|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43674212|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674213|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43674214|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43674215|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
43674216|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580687|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43580688|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
43580689|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580690|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580691|NCT03468010|Paclitaxel|paclitaxel|mesh-list
43580692|NCT03468010|Cisplatin|cisplatin|mesh-list
43580693|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43580694|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580695|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
43580696|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
43580697|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
43580698|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580699|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43580700|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
43580701|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580702|NCT03467893|Antacids|antacids|mesh-list
43580703|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580704|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580705|NCT03467620|Cannabidiol|cannabidiol|mesh-list
43580706|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
43580709|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580710|NCT03467334|Simethicone|simethicone|mesh-list
43580711|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
43580712|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580713|NCT03467334|Emollients|emollients|mesh-ancestor
43580714|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
43580715|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
43580716|NCT03467256|Fludarabine|fludarabine|mesh-list
43580717|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580718|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
43580719|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580720|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580721|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580722|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
43674217|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43674218|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43674219|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
43674220|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
43827480|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
43674221|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43674222|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
43674223|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674224|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43674225|NCT01516346|Hydralazine|hydralazine|mesh-list
43674226|NCT01516346|Isosorbide|isosorbide|mesh-list
43674227|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43674228|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43674229|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43674230|NCT01516346|Diuretics|diuretics|mesh-ancestor
43674231|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
43674232|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674233|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
43674275|NCT00712582|Carboplatin|carboplatin|mesh-list
43674276|NCT00712582|Etoposide|etoposide|mesh-list
43674277|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
43674278|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
43674279|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43674282|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43674283|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43674284|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
43674285|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674286|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674287|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43674288|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43674289|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43674290|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43674291|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43674292|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674293|NCT00712582|Analgesics|analgesics|mesh-ancestor
43674294|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
43674295|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846899|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43674323|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
43674324|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43674325|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
43674326|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674327|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674328|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
43674329|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43674330|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
43674331|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43674332|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43580743|NCT03467178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580744|NCT03467178|Immunologic Factors|immunologic factors|mesh-ancestor
43580745|NCT03467178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580746|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43580747|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43580748|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43580749|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
43580750|NCT03467022|Vitamins|vitamins|mesh-ancestor
43580751|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
43580752|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580753|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
43580754|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580755|NCT03467022|Protective Agents|protective agents|mesh-ancestor
43580756|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43580757|NCT03466983|Hematinics|hematinics|mesh-ancestor
43580758|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
43580760|NCT03466775|Antibodies|antibodies|mesh-list
43580761|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
43580762|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
43580763|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580764|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43580765|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43580766|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
43580767|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580768|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580769|NCT03466749|Paclitaxel|paclitaxel|mesh-list
43580770|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43580771|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580772|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
43580773|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
43580774|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
43674335|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43674336|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674337|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43674338|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43583634|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
43583635|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
43674339|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43674340|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43674341|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674343|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43674344|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43674345|NCT02894268|Doxycycline|doxycycline|mesh-list
43674346|NCT02894268|Furazolidone|furazolidone|mesh-list
43674347|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43674348|NCT02894268|Esomeprazole|esomeprazole|mesh-list
43674349|NCT02894268|Bismuth|bismuth|mesh-list
43674350|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674351|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43674352|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43674353|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43674354|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674355|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674356|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
43674357|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43674358|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43674359|NCT02894268|Antacids|antacids|mesh-ancestor
43674360|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43674361|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43674362|NCT02894268|Renal Agents|renal agents|mesh-ancestor
43674363|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43674364|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43674365|NCT02893618|Diazoxide|diazoxide|mesh-list
43674366|NCT02893618|Choline|choline|mesh-list
43674367|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
43674368|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43674369|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
43674370|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674372|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43674373|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
43674374|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43674375|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
43674376|NCT02893722|Oxytocin|oxytocin|mesh-list
43674377|NCT02893722|Atosiban|atosiban|mesh-list
43674378|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
43583636|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43583637|NCT03435900|Metronidazole|metronidazole|mesh-list
43674379|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43674380|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674381|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
43674382|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674383|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
43674384|NCT02893709|Omeprazole|omeprazole|mesh-list
43674385|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43674386|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43674387|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43674388|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674389|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580775|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580776|NCT03466736|Flutemetamol|flutemetamol|mesh-list
43580777|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43580778|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580779|NCT03466645|Vancomycin|vancomycin|mesh-list
43580780|NCT03466645|Cefazolin|cefazolin|mesh-list
43580781|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43580782|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580791|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43580801|NCT03466567|Cyclosporine|cyclosporine|mesh-list
43674391|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43674392|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43674393|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43674394|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674395|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43674396|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674397|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
43674398|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43674399|NCT02893332|Gefitinib|gefitinib|mesh-list
43580827|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580828|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43580829|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
43580830|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43580831|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43580832|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580833|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43580834|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
43580835|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43580836|NCT03466502|Vancomycin|vancomycin|mesh-list
43580837|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43580838|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580839|NCT03466437|Methamphetamine|methamphetamine|mesh-list
43580840|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43580841|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580842|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
43580843|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
43580844|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580845|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
43580846|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580847|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580848|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
43580849|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43580850|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43580851|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43580854|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580855|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580857|NCT03466333|Enalaprilat|enalaprilat|mesh-list
43580858|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580859|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580860|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43580861|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
43580862|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43580863|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
43580864|NCT03466320|Fludarabine|fludarabine|mesh-list
43580865|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580866|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
43580867|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580868|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43580869|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43580870|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
43580871|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580872|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580873|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43580874|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
43580875|NCT03466242|Ketamine|ketamine|mesh-list
43580876|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43580877|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580878|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580879|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43674400|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674403|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674406|NCT02893280|Streptokinase|streptokinase|mesh-list
43674407|NCT02893280|Clopidogrel|clopidogrel|mesh-list
43674408|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43674409|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43674410|NCT02893280|Analgesics|analgesics|mesh-ancestor
43583638|NCT03435900|Fosfomycin|fosfomycin|mesh-list
43583639|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43674411|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
43674412|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674413|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674414|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43674415|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43674416|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43674417|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43674418|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580880|NCT03466242|Analgesics|analgesics|mesh-ancestor
43580881|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
43580882|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43580883|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43580884|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43580885|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43580886|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
43580887|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580888|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580889|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43580890|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43580891|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
43580892|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
43580893|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43580894|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43580895|NCT03466216|Octreotide|octreotide|mesh-list
43580896|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580897|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43580898|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580899|NCT03466021|Liraglutide|liraglutide|mesh-list
43580900|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43580901|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580902|NCT03466021|Incretins|incretins|mesh-ancestor
43580903|NCT03466021|Hormones|hormones|mesh-ancestor
43580904|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43580905|NCT03465969|Tacrolimus|tacrolimus|mesh-list
43580906|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580907|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
43580908|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580909|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43580910|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580911|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674419|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43674420|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43674421|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674422|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
43674423|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43674424|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43674425|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43674426|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
43674427|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674428|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
43674429|NCT02893553|Midodrine|midodrine|mesh-list
43674430|NCT02893553|Bromides|bromides|mesh-list
43674431|NCT02893553|Mirabegron|mirabegron|mesh-list
43674432|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43674433|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
43580912|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43580928|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
43580929|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580930|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580931|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43580932|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43580933|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
43580934|NCT03465410|Tacrolimus|tacrolimus|mesh-list
43580935|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580936|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
43580937|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580938|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43580939|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580940|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580941|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43580942|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
43580943|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580944|NCT03465345|Metformin|metformin|mesh-list
43580945|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
43580946|NCT03465345|Procyanidin|procyanidin|mesh-list
43580947|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43580948|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580949|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
43580950|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580951|NCT03465345|Protective Agents|protective agents|mesh-ancestor
43580952|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43580953|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43580954|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43580955|NCT03465202|Capecitabine|capecitabine|mesh-list
43580956|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43580957|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
43674434|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43674435|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43674436|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43674437|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
43674438|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674443|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
43674444|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674445|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43674446|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43674447|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43674448|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43674449|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674450|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
43674451|NCT02893540|Capecitabine|capecitabine|mesh-list
43674452|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43674453|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
43674454|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674455|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674456|NCT02893371|Lamotrigine|lamotrigine|mesh-list
43674457|NCT02893371|Carbamazepine|carbamazepine|mesh-list
43674458|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
43674459|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43674460|NCT02893371|Valproic Acid|valproic acid|mesh-list
43674461|NCT02893371|Haloperidol|haloperidol|mesh-list
43674462|NCT02893371|Olanzapine|olanzapine|mesh-list
43674463|NCT02893371|Risperidone|risperidone|mesh-list
43674464|NCT02893371|Aripiprazole|aripiprazole|mesh-list
43674465|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43674466|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43674467|NCT02893371|Ziprasidone|ziprasidone|mesh-list
43674468|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43674469|NCT02893371|Clozapine|clozapine|mesh-list
43674478|NCT02893371|Sertraline|sertraline|mesh-list
43674502|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674503|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
43674504|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43674505|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43674506|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43674508|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674520|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43674521|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43674522|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
43674523|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43674524|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
43674525|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
43674526|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43674527|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43674528|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43674529|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43674530|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
43674531|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43674532|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43674533|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43674534|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43674535|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
43674536|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43674537|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43674538|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43674539|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43674540|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43674542|NCT02893176|Macitentan|macitentan|mesh-list
43674551|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
43674552|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674553|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
43674554|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
43674555|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
43674556|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674557|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674559|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674560|NCT02893488|Lamivudine|lamivudine|mesh-list
43674561|NCT02893488|Dolutegravir|dolutegravir|mesh-list
43674562|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43674563|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43674564|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674565|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674566|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
43674567|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674568|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43674569|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43674570|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43674571|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43674572|NCT02893254|Adalimumab|adalimumab|mesh-list
43674573|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43674574|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827481|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827482|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43580962|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580963|NCT03465085|Heparin|heparin|mesh-list
43580964|NCT03465085|Calcium heparin|calcium heparin|mesh-list
43580965|NCT03465085|Streptokinase|streptokinase|mesh-list
43580966|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
43580967|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43583640|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583641|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
43580968|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43580969|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580970|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
43580971|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580972|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580973|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580974|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580975|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
43580976|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43580977|NCT03464968|Leucovorin|leucovorin|mesh-list
43580978|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
43580979|NCT03464968|Irinotecan|irinotecan|mesh-list
43580980|NCT03464968|Fluorouracil|fluorouracil|mesh-list
43580981|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
43580982|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580983|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43827483|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
43827484|NCT05488067|Atorvastatin|atorvastatin|mesh-list
43827485|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43827486|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43827487|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
43827488|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827489|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43827490|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43583642|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43583643|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43827491|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827492|NCT05487963|Tofacitinib|tofacitinib|mesh-list
43827493|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827494|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43827495|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827496|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
43827497|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43827498|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
43827499|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43827500|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
43827501|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580984|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43580985|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580986|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580988|NCT03464968|Protective Agents|protective agents|mesh-ancestor
43583644|NCT03435744|Simvastatin|simvastatin|mesh-list
43583645|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43583646|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43676602|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676605|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676606|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43676607|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676608|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676609|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
43676610|NCT02874989|Protective Agents|protective agents|mesh-ancestor
43676611|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676612|NCT02874963|Ethanol|ethanol|mesh-list
43676613|NCT02874963|Listerine|listerine|mesh-list
43676614|NCT02874963|Thymol|thymol|mesh-list
43676624|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
43676625|NCT02874963|Protective Agents|protective agents|mesh-ancestor
43676626|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43676627|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676628|NCT02874963|Analgesics|analgesics|mesh-ancestor
43676629|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
43676630|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676631|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676640|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
43676641|NCT02874768|Propofol|propofol|mesh-list
43676642|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43676643|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676644|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676645|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43676646|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
43676647|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
43676648|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43580989|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580990|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
43580991|NCT03464968|Vitamins|vitamins|mesh-ancestor
43580992|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
43580993|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
43580994|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43580995|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43580996|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
43580997|NCT03464864|Treprostinil|treprostinil|mesh-list
43580998|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43580999|NCT03464682|Atorvastatin|atorvastatin|mesh-list
43581000|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43581001|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43581002|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
43581003|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581004|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43581005|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43581006|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581007|NCT03464656|Antioxidants|antioxidants|mesh-list
43581008|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581009|NCT03464656|Protective Agents|protective agents|mesh-ancestor
43581010|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581012|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43581013|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581014|NCT03464552|Analgesics|analgesics|mesh-ancestor
43581015|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
43581016|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581017|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581018|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581019|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43674576|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674577|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43674578|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43676649|NCT02874768|Analgesics|analgesics|mesh-ancestor
43676650|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
43676651|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674579|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
43674580|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674582|NCT02892916|Analgesics|analgesics|mesh-ancestor
43674583|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
43674584|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674585|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674586|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43581020|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43581021|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43581022|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581023|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581024|NCT03464539|Chitosan|chitosan|mesh-list
43581025|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43581026|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43581027|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
43581028|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581029|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43581030|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
43581031|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
43581032|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
43581033|NCT03464539|Coagulants|coagulants|mesh-ancestor
43581034|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43581035|NCT03464435|Tobramycin|tobramycin|mesh-list
43581036|NCT03464435|Tacrolimus|tacrolimus|mesh-list
43581037|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43581038|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
43581039|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581040|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43581041|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581042|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581043|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43581057|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581058|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43581059|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43581060|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581061|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
43581062|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43581069|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581072|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
43581073|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581074|NCT03463967|Protective Agents|protective agents|mesh-ancestor
43581075|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581076|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43581077|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43674587|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43674588|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
43674590|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674591|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43674592|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43674593|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674594|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674595|NCT02892942|Cetrorelix|cetrorelix|mesh-list
43674596|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43674597|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
43674598|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43674599|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674600|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
43581078|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581079|NCT03463733|Temozolomide|temozolomide|mesh-list
43581080|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
43581081|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43581082|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
43581083|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581084|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581085|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
43676652|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43676653|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43581087|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43581088|NCT03463642|Vitamin D|vitamin d|mesh-list
43581089|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
43581090|NCT03463642|Mineral Oil|mineral oil|mesh-list
43581091|NCT03463642|Vitamins|vitamins|mesh-ancestor
43581092|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
43581093|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581094|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43581095|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43581096|NCT03463642|Emollients|emollients|mesh-ancestor
43581097|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
43581098|NCT03463564|Insulin|insulin|mesh-list
43581099|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43581100|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43581101|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676654|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43676655|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
43676656|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676657|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676658|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43676659|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
43676660|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676661|NCT02874690|Methylphenidate|methylphenidate|mesh-list
43676662|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43676663|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676664|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43676665|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43676666|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43676667|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676668|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
43676669|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676670|NCT02874807|Empagliflozin|empagliflozin|mesh-list
43583647|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
43583648|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583649|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43583650|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43583651|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583652|NCT03435666|Capecitabine|capecitabine|mesh-list
43583653|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43583654|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
43676671|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43676672|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581107|NCT03463382|Bupivacaine|bupivacaine|mesh-list
43581108|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
43581109|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
43581110|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581111|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581112|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
43581113|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581114|NCT03463317|Aspirin|aspirin|mesh-list
43581115|NCT03463317|Warfarin|warfarin|mesh-list
43581116|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
43581117|NCT03463317|Dabigatran|dabigatran|mesh-list
43581118|NCT03463317|Apixaban|apixaban|mesh-list
43581119|NCT03463317|Edoxaban|edoxaban|mesh-list
43581120|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
43581121|NCT03463317|Clopidogrel|clopidogrel|mesh-list
43581122|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43581123|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43581124|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43581125|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43581126|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
43581127|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674601|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676673|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43676674|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676675|NCT02874729|Dimercaprol|dimercaprol|mesh-list
43676676|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
43676677|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
43704660|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43676680|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43676681|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43676682|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43676683|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
43674602|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43674603|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
43674604|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674605|NCT02892357|Omeprazole|omeprazole|mesh-list
43674606|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43674607|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43581128|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581129|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581130|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
43581131|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43581132|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
43581133|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43581134|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
43581135|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581136|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43581137|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581138|NCT03463317|Analgesics|analgesics|mesh-ancestor
43581139|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
43676684|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676685|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676686|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676687|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
43676688|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43676689|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676690|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676691|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676692|NCT02874378|Analgesics|analgesics|mesh-ancestor
43676693|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
43676694|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676695|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43676696|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43676697|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43676698|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
43676699|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581140|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581141|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581142|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43581143|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43581144|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43581145|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43581146|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
43581147|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43581148|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
43581149|NCT03463252|Progesterone|progesterone|mesh-list
43581150|NCT03463252|Progestins|progestins|mesh-ancestor
43581151|NCT03463252|Hormones|hormones|mesh-ancestor
43581152|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581153|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581154|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43581155|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43581156|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43581157|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
43581158|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43581159|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43581160|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43581161|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43581162|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43581163|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581164|NCT03463083|Fentanyl|fentanyl|mesh-list
43581165|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
43676701|NCT02874326|Octreotide|octreotide|mesh-list
43827710|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581166|NCT03463083|Bupivacaine|bupivacaine|mesh-list
43581167|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
43581178|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43581179|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
43581180|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581181|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581182|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43581183|NCT03463083|Narcotics|narcotics|mesh-ancestor
43581184|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43581185|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43581186|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
43581187|NCT03463070|Misoprostol|misoprostol|mesh-list
43581188|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43581189|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
43581190|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43674610|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674611|NCT02892318|Atezolizumab|atezolizumab|mesh-list
43674612|NCT02892318|Guadecitabine|guadecitabine|mesh-list
43674613|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674615|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43674616|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43674617|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674618|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674619|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
43674620|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674621|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674622|NCT02891980|Vaccines|vaccines|mesh-list
43674623|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
43674624|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674625|NCT02891785|Antipain|antipain|mesh-list
43674626|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
43674627|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581191|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581192|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43581193|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43581194|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
43581195|NCT03463044|Nangibotide|nangibotide|mesh-list
43581196|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581197|NCT03463005|Propolis|propolis|mesh-list
43581198|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581199|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
43581200|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
43581201|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581202|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43581203|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43581204|NCT03462836|Lidocaine|lidocaine|mesh-list
43581205|NCT03462836|Ketamine|ketamine|mesh-list
43581206|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
43581207|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
43581208|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581209|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581210|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
43581211|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581212|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43581213|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43581214|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43581215|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43581216|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581217|NCT03462836|Analgesics|analgesics|mesh-ancestor
43581218|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43581219|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43581220|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
43581221|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43581224|NCT03462810|Cabotegravir|cabotegravir|mesh-list
43827506|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
43827507|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827508|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674637|NCT02891161|Durvalumab|durvalumab|mesh-list
43674638|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43674639|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674640|NCT02891278|Cytarabine|cytarabine|mesh-list
43674641|NCT02891278|Sertraline|sertraline|mesh-list
43674642|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43674643|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
43674644|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674645|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674646|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
43674647|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674648|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43674649|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
43674650|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674655|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43674656|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674657|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
43674658|NCT02891018|Paclitaxel|paclitaxel|mesh-list
43674659|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43674664|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
43674665|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674666|NCT02891083|Paclitaxel|paclitaxel|mesh-list
43674667|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43674668|NCT02891083|Cisplatin|cisplatin|mesh-list
43827711|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43827713|NCT05486481|Hormones|hormones|mesh-ancestor
43827714|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827715|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827716|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674669|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43674670|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674671|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
43674672|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
43674673|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
43674674|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674675|NCT02891005|Paclitaxel|paclitaxel|mesh-list
43581228|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581229|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43581230|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43581231|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
43581232|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581234|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
43581235|NCT03462446|Vitamins|vitamins|mesh-ancestor
43581236|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
43581237|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581238|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43581239|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
43827717|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
43846900|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846901|NCT04161430|Incretins|incretins|mesh-ancestor
43846902|NCT04161430|Hormones|hormones|mesh-ancestor
43846903|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846904|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43583655|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583656|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583657|NCT03435302|Cisplatin|cisplatin|mesh-list
43583658|NCT03435302|Temozolomide|temozolomide|mesh-list
43583659|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583660|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43583661|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
43583662|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583663|NCT03435289|Gemcitabine|gemcitabine|mesh-list
43583664|NCT03435289|Paclitaxel|paclitaxel|mesh-list
43583665|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43583666|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43583668|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
43583669|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
43581240|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43581241|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
43581242|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581243|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581244|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
43581245|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43581246|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43581247|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
43581248|NCT03462446|Coagulants|coagulants|mesh-ancestor
43581249|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
43581250|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43581251|NCT03462212|Paclitaxel|paclitaxel|mesh-list
43581252|NCT03462212|Bevacizumab|bevacizumab|mesh-list
43581253|NCT03462212|Carboplatin|carboplatin|mesh-list
43581254|NCT03462212|Rucaparib|rucaparib|mesh-list
43581255|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43581256|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581257|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
43581258|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
43581259|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
43581260|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581261|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581262|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43583670|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
43583671|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583672|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43583673|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
43583674|NCT03435289|Antiviral Agents|antiviral agents|mesh-ancestor
43674676|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43674677|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674678|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
43674679|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
43674680|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
43674681|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674682|NCT02890875|Ethanol|ethanol|mesh-list
43674683|NCT02890875|Heparin|heparin|mesh-list
43674684|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
43674685|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43674686|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43674687|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674688|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43674689|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674690|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674691|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674692|NCT02890719|Ribavirin|ribavirin|mesh-list
43674693|NCT02890719|Grazoprevir|grazoprevir|mesh-list
43581263|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43581264|NCT03462212|Growth Substances|growth substances|mesh-ancestor
43581265|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581266|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
43581268|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581269|NCT03462173|Yimitasvir|yimitasvir|mesh-list
43581270|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
43581271|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581272|NCT03461783|Charcoal|charcoal|mesh-list
43583675|NCT03435289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581273|NCT03461783|Antidotes|antidotes|mesh-ancestor
43581274|NCT03461783|Protective Agents|protective agents|mesh-ancestor
43581275|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581276|NCT03461718|Fentanyl|fentanyl|mesh-list
43581277|NCT03461718|Midazolam|midazolam|mesh-list
43581278|NCT03461718|Ketamine|ketamine|mesh-list
43581279|NCT03461718|Analgesics|analgesics|mesh-ancestor
43581280|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
43581281|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581282|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581283|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43581284|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43581285|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
43581286|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
43581287|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581288|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43581289|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43581290|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581291|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581292|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43581293|NCT03461718|Narcotics|narcotics|mesh-ancestor
43674694|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
43674695|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674696|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
43674697|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674698|NCT02890745|Empagliflozin|empagliflozin|mesh-list
43674699|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43674700|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674701|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43674702|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674703|NCT02890771|Turmeric extract|turmeric extract|mesh-list
43674704|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
43674705|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674706|NCT02890771|Protective Agents|protective agents|mesh-ancestor
43674707|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583676|NCT03435289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583677|NCT03435289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43674708|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
43674709|NCT02890823|Vitamin D|vitamin d|mesh-list
43581294|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43581295|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43581296|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43581297|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43581298|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43581299|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
43581300|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
43581301|NCT03461627|Fluticasone|fluticasone|mesh-list
43581302|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43581303|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43581304|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581305|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43581306|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
43581307|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581308|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581309|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43581311|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
43581312|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43581313|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43581314|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43581315|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43581316|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
43581317|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581318|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581319|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
43581320|NCT03461627|Hormones|hormones|mesh-ancestor
43581321|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581322|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
43581323|NCT03461575|Cyclosporine|cyclosporine|mesh-list
43581324|NCT03461575|Cyclosporins|cyclosporins|mesh-list
43674713|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
43674714|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43674715|NCT02890602|Prednisolone|prednisolone|mesh-list
43674716|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
43674717|NCT02890602|Vincristine|vincristine|mesh-list
43674718|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
43581334|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43581335|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
43581336|NCT03461328|Analgesics|analgesics|mesh-ancestor
43581337|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
43581338|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581339|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581340|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
43581341|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581342|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43581343|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
43581344|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43581345|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43581346|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581347|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43581348|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
43581349|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43581350|NCT03461302|Coal Tar|coal tar|mesh-list
43581351|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
43581352|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
43581353|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
43581354|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43581355|NCT03461185|Growth Substances|growth substances|mesh-ancestor
43581356|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581357|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
43581358|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581359|NCT03461081|Amlodipine|amlodipine|mesh-list
43581371|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43581372|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43581373|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43581374|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43581375|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581376|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
43581377|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43581378|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43581379|NCT03460964|Pilocarpine|pilocarpine|mesh-list
43581380|NCT03460964|Miotics|miotics|mesh-ancestor
43581381|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
43581382|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581383|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581384|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43581385|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43581386|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
43581387|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674720|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
43674721|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674722|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43674723|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43674724|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
43674725|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583678|NCT03435289|Immunologic Factors|immunologic factors|mesh-ancestor
43583679|NCT03435289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583680|NCT03435133|Ticagrelor|ticagrelor|mesh-list
43583681|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43583682|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43583683|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43583684|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43583685|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43583686|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
43583687|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674726|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674727|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43674728|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43674729|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
43581388|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581389|NCT03460860|Tocopherols|tocopherols|mesh-list
43581391|NCT03460860|Tocotrienols|tocotrienols|mesh-list
43581392|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
43581393|NCT03460860|Lycopene|lycopene|mesh-list
43581394|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
43581395|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581396|NCT03460860|Protective Agents|protective agents|mesh-ancestor
43581397|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581398|NCT03460860|Vitamins|vitamins|mesh-ancestor
43581399|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
43583688|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583689|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583690|NCT03435094|Alendronate|alendronate|mesh-list
43583695|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
43583696|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
43583697|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583698|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583699|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
43583700|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583701|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43846905|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
43846906|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846907|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846908|NCT04161066|Psilocybin|psilocybin|mesh-list
43846909|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
43846910|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846911|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43846912|NCT04160546|Aspirin|aspirin|mesh-list
43846913|NCT04160546|Ponatinib|ponatinib|mesh-list
43846914|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43846915|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43846916|NCT04160546|Analgesics|analgesics|mesh-ancestor
43846917|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
43583702|NCT03434951|Narcotics|narcotics|mesh-ancestor
43581400|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581401|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43581402|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43581403|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581404|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
43581405|NCT03460808|Atorvastatin|atorvastatin|mesh-list
43581406|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43581407|NCT03460808|Danazol|danazol|mesh-list
43581408|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43581409|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43581410|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
43581411|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581412|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43581413|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43583703|NCT03434951|Analgesics|analgesics|mesh-ancestor
43583704|NCT03434782|Listerine|listerine|mesh-list
43583705|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43583706|NCT03434782|Fluorides|fluorides|mesh-list
43583707|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
43583708|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
43583709|NCT03434782|Protective Agents|protective agents|mesh-ancestor
43583710|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583711|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43583712|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583713|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
43583714|NCT03434704|Clotrimazole|clotrimazole|mesh-list
43583715|NCT03434704|Miconazole|miconazole|mesh-list
43583716|NCT03434704|Fludarabine|fludarabine|mesh-list
43583717|NCT03434704|Thiotepa|thiotepa|mesh-list
43583718|NCT03434704|Treosulfan|treosulfan|mesh-list
43583719|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583720|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583721|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43583722|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
43583723|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583724|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43583725|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
43583726|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43583727|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583728|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43583729|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43583730|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43583731|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583732|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43583733|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
43583734|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581414|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581415|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
43581416|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581417|NCT03460808|Expectorants|expectorants|mesh-ancestor
43581418|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
43581419|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43581420|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
43581421|NCT03460808|Protective Agents|protective agents|mesh-ancestor
43581422|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581423|NCT03460808|Antidotes|antidotes|mesh-ancestor
43581424|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43581425|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
43581426|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581427|NCT03460782|Ipilimumab|ipilimumab|mesh-list
43581428|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581429|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581430|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43581431|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581432|NCT03460743|Vaccines|vaccines|mesh-list
43581433|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
43581434|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
43581435|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581436|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
43581437|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43581438|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
43674730|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
43674731|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
43674732|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43674733|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
43674734|NCT02890602|Hormones|hormones|mesh-ancestor
43674735|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43583735|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43674736|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43674737|NCT02890602|Hematinics|hematinics|mesh-ancestor
43674738|NCT02890589|Chromium|chromium|mesh-list
43674739|NCT02890589|Everolimus|everolimus|mesh-list
43674740|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674741|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43674742|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
43674743|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674744|NCT02890589|Trace Elements|trace elements|mesh-ancestor
43581439|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581440|NCT03460678|Pemetrexed|pemetrexed|mesh-list
43581441|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43581442|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581443|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581444|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581445|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43581446|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43581447|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43581448|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
43581449|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
43583736|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43583737|NCT03434691|Remifentanil|remifentanil|mesh-list
43583738|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43846918|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846919|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846920|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846921|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846922|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43846923|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43846924|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846925|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43846926|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43846928|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
43846929|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581450|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43581451|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43581452|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581453|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581454|NCT03460470|Urological Agents|urological agents|mesh-ancestor
43581456|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
43581457|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581458|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43581459|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581460|NCT03460275|Osimertinib|osimertinib|mesh-list
43581473|NCT03460041|Bupivacaine|bupivacaine|mesh-list
43581474|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
43581475|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
43581476|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581477|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581478|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
43581479|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581480|NCT03460041|Analgesics|analgesics|mesh-ancestor
43581481|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43581482|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
43581483|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43581484|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43581485|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581486|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43581487|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
43581488|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43581489|NCT03460002|Vaccines|vaccines|mesh-list
43581490|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
43581491|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581492|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
43581493|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43581494|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43581495|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581496|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43674746|NCT02890173|Eplerenone|eplerenone|mesh-list
43674747|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43674748|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
43674749|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674750|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674751|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43581497|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581498|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581499|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
43581500|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43581501|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581502|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43581503|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581504|NCT03457467|Apatinib|apatinib|mesh-list
43581505|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581506|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43581507|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581508|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581509|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
43581510|NCT03456570|Progestins|progestins|mesh-ancestor
43581511|NCT03456570|Hormones|hormones|mesh-ancestor
43581512|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581513|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581514|NCT03455426|Letrozole|letrozole|mesh-list
43581515|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581516|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43581517|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43581519|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581520|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43581521|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
43581522|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581523|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581525|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43581526|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581527|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
43581528|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43581529|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43581530|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
43581531|NCT03453892|Nivolumab|nivolumab|mesh-list
43581532|NCT03453892|Ipilimumab|ipilimumab|mesh-list
43581533|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581534|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581535|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43581536|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581537|NCT03453723|Lidocaine|lidocaine|mesh-list
43581538|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
43581539|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
43581540|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581541|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581542|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
43581543|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581544|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43674761|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
43674762|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43674763|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
43674764|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
43674765|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674766|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
43674767|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43674768|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43674769|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674770|NCT02890238|Urological Agents|urological agents|mesh-ancestor
43674771|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43674772|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
43674773|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674774|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674775|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43581552|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846930|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846931|NCT04160117|Colchicine|colchicine|mesh-list
43846932|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
43583741|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583743|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
43583744|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583745|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43583746|NCT03434613|Ezetimibe|ezetimibe|mesh-list
43583747|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43583748|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43583749|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
43583750|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583751|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43583752|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43583753|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583754|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
43583755|NCT03434340|Dexamethasone|dexamethasone|mesh-list
43583756|NCT03434340|Granisetron|granisetron|mesh-list
43583757|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583758|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
43583759|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
43583760|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581553|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
43581554|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581555|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581556|NCT03453541|Ketorolac|ketorolac|mesh-list
43581557|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43581558|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43581559|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581560|NCT03453541|Analgesics|analgesics|mesh-ancestor
43581561|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
43581562|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581563|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581564|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581565|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43581566|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43581567|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581568|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581569|NCT03453190|Apremilast|apremilast|mesh-list
43581570|NCT03453190|Clobetasol|clobetasol|mesh-list
43581571|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43581572|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581573|NCT03453190|Analgesics|analgesics|mesh-ancestor
43581574|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
43581575|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581576|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581577|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581578|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43581579|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43674776|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
43674777|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43674778|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43674779|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43674780|NCT02890511|Paclitaxel|paclitaxel|mesh-list
43583761|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674781|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43674782|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674783|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
43674784|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
43674785|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
43674786|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674787|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
43674788|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43674789|NCT02890277|Chitosan|chitosan|mesh-list
43674790|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43674791|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43674792|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
43674793|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674794|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43674795|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
43674796|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
43674797|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
43674798|NCT02890277|Coagulants|coagulants|mesh-ancestor
43674799|NCT02890186|Remifentanil|remifentanil|mesh-list
43674800|NCT02890186|Propofol|propofol|mesh-list
43674801|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43674802|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674803|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674804|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43674805|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
43674806|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
43674807|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43583762|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43674808|NCT02890186|Narcotics|narcotics|mesh-ancestor
43674809|NCT02890186|Analgesics|analgesics|mesh-ancestor
43674810|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
43581580|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43581581|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581582|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581583|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
43581584|NCT03453190|Hormones|hormones|mesh-ancestor
43581585|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581586|NCT03452553|Doxorubicin|doxorubicin|mesh-list
43674811|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674813|NCT02890199|Bupivacaine|bupivacaine|mesh-list
43674814|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
43674815|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
43583763|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
43583765|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43583766|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43583767|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583768|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43583769|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
43583770|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583771|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583772|NCT03434275|Meloxicam|meloxicam|mesh-list
43583773|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43583774|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43583775|NCT03434275|Analgesics|analgesics|mesh-ancestor
43583776|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
43583789|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
43583790|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583791|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583792|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583793|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43583794|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43583795|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583796|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583797|NCT03434106|Dextrans|dextrans|mesh-list
43583798|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
43676706|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
43676707|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43676708|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43676709|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676710|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676711|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676712|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676713|NCT02874248|Drospirenone|drospirenone|mesh-list
43674816|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674817|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674818|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
43674819|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674820|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43674821|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43674822|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43674823|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43674824|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674825|NCT02890082|Tamoxifen|tamoxifen|mesh-list
43674826|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43674827|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
43674828|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674829|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674830|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43674831|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674832|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43674833|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43674834|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43674835|NCT02890368|Interferons|interferons|mesh-list
43674836|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43674837|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43674838|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
43674839|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674840|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
43581587|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43581588|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581589|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43581590|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43581591|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581592|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581594|NCT03452475|Artemether|artemether|mesh-list
43581595|NCT03452475|Piperaquine|piperaquine|mesh-list
43581597|NCT03452475|Mefloquine|mefloquine|mesh-list
43581598|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
43674841|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674842|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43674843|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
43674844|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674845|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674846|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
43674847|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43674848|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674849|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
43674850|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43674851|NCT02889692|Gefitinib|gefitinib|mesh-list
43674852|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674853|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43674854|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674855|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674856|NCT02889822|Alprostadil|alprostadil|mesh-list
43674857|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43674858|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
43674859|NCT02889822|Urological Agents|urological agents|mesh-ancestor
43674860|NCT02889653|Anticoagulants|anticoagulants|mesh-list
43827509|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43827510|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43827511|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
43674861|NCT02889549|Clopidogrel|clopidogrel|mesh-list
43674862|NCT02889549|Ticagrelor|ticagrelor|mesh-list
43674863|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43674864|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43674865|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43674866|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43674867|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
43674868|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674869|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581599|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43581602|NCT03451734|Metformin|metformin|mesh-list
43581607|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674870|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674872|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
43674873|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674874|NCT02889432|Protective Agents|protective agents|mesh-ancestor
43674875|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674876|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674877|NCT02889497|Vaccines|vaccines|mesh-list
43674878|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
43674881|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
43674882|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674883|NCT02889081|Vitamin D|vitamin d|mesh-list
43674884|NCT02889081|Vitamins|vitamins|mesh-ancestor
43674885|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
43581608|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43581609|NCT03451396|Lifitegrast|lifitegrast|mesh-list
43581610|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43581611|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43581612|NCT03451266|Ascorbic Acid|ascorbic acid|mesh-list
43581613|NCT03451266|Vitamins|vitamins|mesh-ancestor
43581614|NCT03451266|Micronutrients|micronutrients|mesh-ancestor
43581615|NCT03451266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581616|NCT03451266|Antioxidants|antioxidants|mesh-ancestor
43581617|NCT03451266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676714|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43676715|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
43827718|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43676716|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581618|NCT03451266|Protective Agents|protective agents|mesh-ancestor
43581619|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
43581620|NCT03451227|Remifentanil|remifentanil|mesh-list
43581621|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43581622|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581623|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581624|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581625|NCT03451227|Analgesics|analgesics|mesh-ancestor
43581626|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
43581627|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581628|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43581629|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43581630|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43581631|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
43581632|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581633|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581634|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43581635|NCT03451227|Narcotics|narcotics|mesh-ancestor
43581636|NCT05322499|Paclitaxel|paclitaxel|mesh-list
43581637|NCT05322499|Docetaxel|docetaxel|mesh-list
43581638|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43581639|NCT05322499|Irinotecan|irinotecan|mesh-list
43581640|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43581641|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581642|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
43581643|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
43581644|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
43676717|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581645|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581646|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43581647|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43581648|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581649|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
43581650|NCT05322330|Fludarabine|fludarabine|mesh-list
43581651|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43581652|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
43674886|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674887|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43674888|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
43674889|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43674890|NCT02888990|Dasatinib|dasatinib|mesh-list
43674891|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674892|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43674893|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674894|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674895|NCT02888899|Loperamide|loperamide|mesh-list
43581653|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676718|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43676719|NCT02874248|Diuretics|diuretics|mesh-ancestor
43676720|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
43676721|NCT02873650|Dabrafenib|dabrafenib|mesh-list
43676722|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676723|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43676724|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676725|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676726|NCT02873559|Testosterone|testosterone|mesh-list
43676727|NCT02873559|Androgens|androgens|mesh-ancestor
43676728|NCT02873559|Hormones|hormones|mesh-ancestor
43676729|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676730|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676731|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43676732|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676733|NCT02873871|Hemostatics|hemostatics|mesh-list
43581654|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43581655|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43581656|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
43581657|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581658|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581659|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43581660|NCT05322265|Epinephrine|epinephrine|mesh-list
43581661|NCT05322265|Racepinephrine|racepinephrine|mesh-list
43581662|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
43581663|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43581664|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43581665|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
43581666|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581667|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581669|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43581670|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43581673|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43581674|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
43581676|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
43581677|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43581678|NCT05322252|Misoprostol|misoprostol|mesh-list
43581679|NCT05322252|Mifepristone|mifepristone|mesh-list
43581680|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43581681|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
43581682|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43581683|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581684|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43581685|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676734|NCT02873871|Coagulants|coagulants|mesh-ancestor
43676735|NCT02873273|Dexamethasone|dexamethasone|mesh-list
43581686|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
43581687|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43581688|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43581689|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43581690|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43581691|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
43581692|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43581693|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43581694|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
43581695|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581696|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
43581697|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43581698|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43581699|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
43581700|NCT05322187|Lenvatinib|lenvatinib|mesh-list
43581701|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43581702|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581703|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581704|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43581705|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581706|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674896|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
43674897|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
43674898|NCT02888899|Psyllium|psyllium|mesh-list
43674899|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43674900|NCT02888899|Cathartics|cathartics|mesh-ancestor
43674901|NCT02889003|Pioglitazone|pioglitazone|mesh-list
43676736|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676737|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
43674902|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43674903|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674904|NCT02888730|Tobramycin|tobramycin|mesh-list
43674905|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43674906|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581707|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43581708|NCT05321524|Cathartics|cathartics|mesh-ancestor
43581709|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43581710|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43581711|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43581712|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43581713|NCT05321511|Hormones|hormones|mesh-ancestor
43581714|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581715|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581716|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
43581717|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43581718|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
43581719|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43581720|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43581721|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43581722|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581723|NCT05321329|Capecitabine|capecitabine|mesh-list
43581724|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43581725|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
43581726|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581727|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581728|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
43581729|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43581730|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581731|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581732|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581733|NCT05321121|Analgesics|analgesics|mesh-ancestor
43676738|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
43676739|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581734|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
43581735|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581736|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43581737|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43581738|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43581739|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
43581740|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581746|NCT05320757|Olaparib|olaparib|mesh-list
43581747|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43581748|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581749|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581750|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581751|NCT05320640|Decitabine|decitabine|mesh-list
43581752|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43581753|NCT05320640|Antibodies|antibodies|mesh-list
43581754|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
43581755|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581756|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43581757|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
43581758|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581759|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581760|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581761|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
43581762|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581763|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674907|NCT02888652|Clopidogrel|clopidogrel|mesh-list
43676740|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583799|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
43583800|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
43676741|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676743|NCT02873273|Hormones|hormones|mesh-ancestor
43704661|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43676748|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676749|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
43676750|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43676752|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
43674908|NCT02888652|Ticagrelor|ticagrelor|mesh-list
43674909|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43581764|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
43581765|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581766|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43581767|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581768|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581769|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43581770|NCT05306704|Calcifediol|calcifediol|mesh-list
43581771|NCT05306704|Vitamins|vitamins|mesh-ancestor
43581772|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
43581773|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581774|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43581775|NCT05303311|Dexamethasone|dexamethasone|mesh-list
43581776|NCT05303311|Meperidine|meperidine|mesh-list
43581777|NCT05303311|Bupivacaine|bupivacaine|mesh-list
43581778|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581779|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
43581780|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
43581781|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676753|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
43676754|NCT02873364|Vitamins|vitamins|mesh-list
43676755|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
43676756|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676757|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43676758|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43676759|NCT02873351|Levodopa|levodopa|mesh-list
43676760|NCT02873351|Carbidopa|carbidopa|mesh-list
43581782|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581783|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43581784|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
43581785|NCT05303311|Hormones|hormones|mesh-ancestor
43581786|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581787|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43581788|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581789|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
43581790|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
43581791|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581792|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
43581793|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43581794|NCT05303311|Narcotics|narcotics|mesh-ancestor
43581795|NCT05303311|Analgesics|analgesics|mesh-ancestor
43581796|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43581797|NCT05283161|Dronabinol|dronabinol|mesh-list
43581798|NCT05283161|Cannabidiol|cannabidiol|mesh-list
43581799|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
43581800|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
43581801|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581802|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43581803|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581804|NCT05283161|Analgesics|analgesics|mesh-ancestor
43581805|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
43674910|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43674911|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43674912|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43674913|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
43674914|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674915|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674916|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674917|NCT02888574|Oxytocin|oxytocin|mesh-list
43674918|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
43674919|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43674920|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674921|NCT02888301|Clofarabine|clofarabine|mesh-list
43674923|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
43674924|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674925|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674926|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
43674927|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43674928|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43674929|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43581806|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581807|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43581808|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43581809|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581810|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581811|NCT05283161|Hormones|hormones|mesh-ancestor
43581814|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581815|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
43581816|NCT05278858|Hormones|hormones|mesh-ancestor
43581817|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581818|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581819|NCT05260528|Cytarabine|cytarabine|mesh-list
43581820|NCT05260528|Idarubicin|idarubicin|mesh-list
43581821|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43581822|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
43581823|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676761|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43581824|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581825|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
43581826|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581827|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43581828|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
43581829|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581830|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43581831|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43581832|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43581833|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581834|NCT05211635|Vitamin D|vitamin d|mesh-list
43581835|NCT05211635|Vitamins|vitamins|mesh-ancestor
43581836|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
43581837|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581838|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43581839|NCT05202145|Cyclosporine|cyclosporine|mesh-list
43674930|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43674931|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674932|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
43674933|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674934|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674935|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43674936|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674937|NCT02888327|Oseltamivir|oseltamivir|mesh-list
43674939|NCT02888327|Midazolam|midazolam|mesh-list
43674940|NCT02888327|Pitavastatin|pitavastatin|mesh-list
43674941|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43674943|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674944|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674945|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43674946|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43674947|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43674948|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43674949|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
43674950|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
43674951|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
43676762|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43674952|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
43674953|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581840|NCT05202145|Tacrolimus|tacrolimus|mesh-list
43581841|NCT05202145|Cyclosporins|cyclosporins|mesh-list
43581842|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43581843|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
43581844|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581845|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43581846|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581847|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581848|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
43581849|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581850|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
43581851|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43581853|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43581854|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43581855|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581856|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581857|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43581858|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
43581859|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581860|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581861|NCT05045378|Midazolam|midazolam|mesh-list
43676763|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43583801|NCT03434054|Losartan|losartan|mesh-list
43583802|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43583803|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43583804|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43581862|NCT05045378|Ketamine|ketamine|mesh-list
43581863|NCT05045378|Analgesics|analgesics|mesh-ancestor
43581864|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
43581865|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581866|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581867|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43581868|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43581869|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
43581870|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
43674954|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674955|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43674956|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43674957|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674958|NCT02888327|Protective Agents|protective agents|mesh-ancestor
43674959|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
43674960|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674961|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43674962|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43674963|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43674964|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
43674965|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43674966|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
43674967|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43674968|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674969|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674970|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581871|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581872|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43583805|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43583806|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581873|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43581874|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581875|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581876|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43581877|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43581878|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43581879|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43581880|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43581881|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
43581882|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
43581883|NCT04984889|Protein C|protein c|mesh-list
43581884|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
43581887|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581888|NCT04966481|Cetuximab|cetuximab|mesh-list
43581889|NCT04966481|Palbociclib|palbociclib|mesh-list
43581890|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581891|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581892|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43581894|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581895|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43581896|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43581897|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
43583807|NCT03433976|Anesthetics|anesthetics|mesh-list
43583808|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583809|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583810|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43583811|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43581898|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581899|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581900|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43581901|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
43581902|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
43581903|NCT04946630|Hormones|hormones|mesh-ancestor
43581904|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581905|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
43581906|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
43581907|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581908|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581909|NCT04796363|Anesthetics|anesthetics|mesh-list
43581910|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43674971|NCT02888275|Analgesics|analgesics|mesh-ancestor
43674972|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
43674973|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674974|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43674975|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43674976|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43674977|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
43674978|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674979|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674980|NCT02888561|Dobutamine|dobutamine|mesh-list
43674981|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43674982|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
43674983|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
43674984|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581911|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581912|NCT04768166|Miglustat|miglustat|mesh-list
43581913|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581914|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581915|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43583812|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43581916|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43581917|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
43581918|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581919|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43581920|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43581921|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581922|NCT04760041|Midazolam|midazolam|mesh-list
43581923|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43581924|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43581925|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581926|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581927|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43581928|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43581929|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43581930|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43581931|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
43581932|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
43581933|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
43581934|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
43581935|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675001|NCT02888054|Lesinurad|lesinurad|mesh-list
43675002|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
43675003|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675004|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675005|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
43675006|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675007|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43675008|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
43675009|NCT02888054|Protective Agents|protective agents|mesh-ancestor
43581958|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581959|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43581961|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581962|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43581963|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
43581964|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
43581965|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581966|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581968|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43581969|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
43581970|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581971|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
43581972|NCT04557527|Protective Agents|protective agents|mesh-ancestor
43581973|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
43581974|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43581975|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581976|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581977|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43581978|NCT04430699|Cisplatin|cisplatin|mesh-list
43581979|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
43581980|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675010|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675011|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
43675012|NCT02888054|Renal Agents|renal agents|mesh-ancestor
43675013|NCT02888392|Psyllium|psyllium|mesh-list
43675014|NCT02888392|Cathartics|cathartics|mesh-ancestor
43675015|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43675016|NCT02888223|Factor VIII|factor viii|mesh-list
43675017|NCT02888223|Coagulants|coagulants|mesh-ancestor
43675018|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
43675019|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43675020|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43675021|NCT02887976|Prednisolone|prednisolone|mesh-list
43675022|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
43675023|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
43675024|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43581981|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581982|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
43581983|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43581984|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
43581985|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581986|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581987|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43581989|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43581990|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
43581991|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581992|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581993|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43581994|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
43581995|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
43581996|NCT04383002|Protective Agents|protective agents|mesh-ancestor
43581997|NCT04375228|Rituximab|rituximab|mesh-list
43583813|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581998|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43581999|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582000|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
43582001|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582002|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43582003|NCT04370145|Meropenem|meropenem|mesh-list
43582004|NCT04370145|Tinidazole|tinidazole|mesh-list
43582005|NCT04370145|Teicoplanin|teicoplanin|mesh-list
43582006|NCT04370145|Sulperazone|sulperazone|mesh-list
43582007|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43582008|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582009|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
43582010|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582011|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43582012|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43582013|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43582014|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43582015|NCT04370145|Renal Agents|renal agents|mesh-ancestor
43582016|NCT04368429|Vaccines|vaccines|mesh-list
43582017|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
43582018|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583814|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583825|NCT03433586|Aspirin|aspirin|mesh-list
43583826|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43583827|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43583828|NCT03433586|Analgesics|analgesics|mesh-ancestor
43583829|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
43583830|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583831|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583832|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583833|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43583834|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43583835|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43583836|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582019|NCT04366908|Calcifediol|calcifediol|mesh-list
43582020|NCT04366908|Vitamins|vitamins|mesh-ancestor
43582021|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
43582022|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582023|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43582024|NCT04358003|Coal Tar|coal tar|mesh-list
43582025|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
43582026|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
43582027|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
43582028|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43582029|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43675025|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
43675026|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675027|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
43675028|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
43675029|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675030|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675031|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43675032|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
43675033|NCT02887976|Hormones|hormones|mesh-ancestor
43675034|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675035|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43675036|NCT02887976|Protective Agents|protective agents|mesh-ancestor
43583837|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43676765|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676766|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676767|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676768|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43676769|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582030|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582031|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
43582032|NCT04311073|Coagulants|coagulants|mesh-ancestor
43582033|NCT04283890|Nivolumab|nivolumab|mesh-list
43582034|NCT04283890|Ipilimumab|ipilimumab|mesh-list
43582035|NCT04283890|Melphalan|melphalan|mesh-list
43582036|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43582038|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43582039|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582040|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43582041|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
43582042|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43582043|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582044|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
43582045|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582046|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43582047|NCT04238143|Complement Factor H|complement factor h|mesh-list
43582048|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43582049|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582050|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
43582051|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582052|NCT04221087|Dexamethasone|dexamethasone|mesh-list
43582053|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582054|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
43582055|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
43582056|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582057|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676770|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43582058|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582059|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
43582061|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582062|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43582063|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582064|NCT04179032|Belimumab|belimumab|mesh-list
43582065|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582066|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
43582067|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582068|NCT04169100|Prednisone|prednisone|mesh-list
43582069|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582070|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
43582071|NCT04169100|Hormones|hormones|mesh-ancestor
43582072|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582073|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582074|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43582075|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582076|NCT04155840|Rituximab|rituximab|mesh-list
43582077|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43676771|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
43583839|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583840|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
43583841|NCT03433534|Nivolumab|nivolumab|mesh-list
43583842|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43583843|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583844|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43583845|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582078|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43582079|NCT04155840|Antibodies|antibodies|mesh-list
43582080|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
43582081|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43675037|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43675038|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675039|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43675040|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675041|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675042|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
43675043|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43827513|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827514|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43583846|NCT03433378|Tretinoin|tretinoin|mesh-list
43583847|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583848|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
43583849|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
43583850|NCT03433352|Methimazole|methimazole|mesh-list
43583851|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
43583852|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
43583853|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
43583856|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
43583857|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583858|NCT03433326|Grazoprevir|grazoprevir|mesh-list
43583859|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43583860|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
43583861|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583862|NCT03433235|Edoxaban|edoxaban|mesh-list
43583863|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43583864|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
43583865|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43583866|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
43583867|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583868|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583869|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
43583870|NCT03433222|Coal Tar|coal tar|mesh-list
43583871|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
43827515|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43827516|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827517|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827518|NCT05487807|Nicotine|nicotine|mesh-list
43827519|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43827520|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
43582082|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
43582083|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582084|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582085|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43582086|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43582087|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
43582088|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582089|NCT04119453|Apatinib|apatinib|mesh-list
43582090|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582091|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43582092|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582093|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582094|NCT04060628|Docetaxel|docetaxel|mesh-list
43582095|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582096|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
43583872|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
43583873|NCT03433196|Atorvastatin|atorvastatin|mesh-list
43583874|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43583875|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43583876|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
43583877|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583904|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
43583905|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583906|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583907|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582097|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582098|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582099|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582100|NCT04037072|Mitomycins|mitomycins|mesh-list
43582101|NCT04037072|Mitomycin|mitomycin|mesh-list
43582102|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43582103|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582104|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
43582105|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582106|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43582107|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582108|NCT04019873|Lamivudine|lamivudine|mesh-list
43582109|NCT04019873|Rilpivirine|rilpivirine|mesh-list
43582110|NCT04019873|Dolutegravir|dolutegravir|mesh-list
43582111|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43582112|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43582114|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582116|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582117|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43582118|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43582119|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43582120|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43582121|NCT03819088|Zinc|zinc|mesh-list
43827521|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827522|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827523|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43827524|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43827525|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
43827526|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583908|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
43827527|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827528|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
43827529|NCT05487794|Testosterone|testosterone|mesh-list
43827530|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
43827531|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
43827532|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43827533|NCT05487794|Androgens|androgens|mesh-ancestor
43827534|NCT05487794|Hormones|hormones|mesh-ancestor
43827535|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827536|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827537|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827538|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827539|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
43827540|NCT05487755|Tadalafil|tadalafil|mesh-list
43827541|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
43582122|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
43582123|NCT03819088|Trace Elements|trace elements|mesh-ancestor
43582124|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
43582125|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582126|NCT03819088|Astringents|astringents|mesh-ancestor
43582127|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
43582128|NCT03756311|Paclitaxel|paclitaxel|mesh-list
43582129|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43582130|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43582131|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582132|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582133|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582134|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582135|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582136|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43583909|NCT03433001|Hormones|hormones|mesh-ancestor
43583910|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582137|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43582138|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582139|NCT03707028|Paclitaxel|paclitaxel|mesh-list
43582140|NCT03707028|Apatinib|apatinib|mesh-list
43582141|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43582142|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582143|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582144|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582145|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582146|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582147|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43582148|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582149|NCT03634228|Cytarabine|cytarabine|mesh-list
43582150|NCT03634228|Venetoclax|venetoclax|mesh-list
43582151|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43582152|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
43675044|NCT02887807|Cyclosporine|cyclosporine|mesh-list
43675045|NCT02887807|Cyclosporins|cyclosporins|mesh-list
43675046|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675047|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675048|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43675049|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
43675050|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675051|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
43675052|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583911|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43675053|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675054|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675055|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43675056|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
43675057|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43675058|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675059|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675060|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675061|NCT02887573|Mosapride|mosapride|mesh-list
43675062|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675063|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43675064|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43675065|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
43675066|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675067|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675068|NCT02887534|Tizanidine|tizanidine|mesh-list
43675069|NCT02887534|Analgesics|analgesics|mesh-ancestor
43675070|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
43675071|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675072|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675073|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
43675074|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43675075|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43675077|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
43675085|NCT02887443|Idebenone|idebenone|mesh-list
43675086|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43675087|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43675088|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675089|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675090|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43675091|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43583912|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583913|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
43582153|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582154|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582155|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
43582156|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582157|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582158|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
43582159|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582160|NCT03507452|BAY 2287411|bay 2287411|mesh-list
43582161|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43582162|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582163|NCT03499704|Metformin|metformin|mesh-list
43582164|NCT03499704|Pioglitazone|pioglitazone|mesh-list
43582165|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
43582166|NCT03499704|Alogliptin|alogliptin|mesh-list
43582167|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43582168|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582169|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43582170|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582171|NCT03499704|Incretins|incretins|mesh-ancestor
43582172|NCT03499704|Hormones|hormones|mesh-ancestor
43582173|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582174|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43582175|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
43583914|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43583915|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43582176|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582177|NCT03443869|Acyclovir|acyclovir|mesh-list
43582178|NCT03443869|Valganciclovir|valganciclovir|mesh-list
43582179|NCT03443869|Letermovir|letermovir|mesh-list
43582180|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
43582181|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582182|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43582183|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582184|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582185|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582186|NCT03248531|Adalimumab|adalimumab|mesh-list
43582187|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582188|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43582189|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43582190|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43582191|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582192|NCT03245918|Aprepitant|aprepitant|mesh-list
43582193|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
43582194|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
43582195|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
43582196|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582197|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582198|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43583916|NCT03433001|Growth Substances|growth substances|mesh-ancestor
43583917|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
43583918|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
43583919|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676772|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
43676773|NCT02873091|Sufentanil|sufentanil|mesh-list
43676774|NCT02873091|Ropivacaine|ropivacaine|mesh-list
43582199|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43582200|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582201|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582203|NCT03205605|Oxybutynin|oxybutynin|mesh-list
43582204|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
43582205|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
43582206|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582207|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582208|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43582209|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43582210|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
43582211|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582212|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582213|NCT03205605|Urological Agents|urological agents|mesh-ancestor
43675092|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43675093|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43675094|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
43675095|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
43675096|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
43675097|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
43675098|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675099|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675100|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
43675101|NCT02887443|Protective Agents|protective agents|mesh-ancestor
43675102|NCT02887365|Tegafur|tegafur|mesh-list
43675103|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675104|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
43675105|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675106|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675107|NCT02887625|Insulin|insulin|mesh-list
43675108|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
43675109|NCT02887625|Pioglitazone|pioglitazone|mesh-list
43675110|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
43675111|NCT02887625|Exenatide|exenatide|mesh-list
43675112|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675113|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675114|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43676775|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
43675115|NCT02887625|Incretins|incretins|mesh-ancestor
43675116|NCT02887625|Hormones|hormones|mesh-ancestor
43675117|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675118|NCT02887222|Bupivacaine|bupivacaine|mesh-list
43675119|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
43675120|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
43675121|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675122|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675123|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
43675124|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675125|NCT02887313|Leucovorin|leucovorin|mesh-list
43675126|NCT02887313|Fluorouracil|fluorouracil|mesh-list
43675127|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
43582214|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43582215|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582216|NCT03205605|Renal Agents|renal agents|mesh-ancestor
43582217|NCT03119584|Linaclotide|linaclotide|mesh-list
43582218|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43582219|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
43675129|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675130|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675131|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675132|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43675133|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
43675134|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675135|NCT02887313|Antidotes|antidotes|mesh-ancestor
43675136|NCT02887313|Protective Agents|protective agents|mesh-ancestor
43675137|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
43675138|NCT02887313|Vitamins|vitamins|mesh-ancestor
43675139|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
43675140|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
43582220|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582221|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582222|NCT03019588|Paclitaxel|paclitaxel|mesh-list
43582223|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
43582224|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43582225|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582226|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582227|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582228|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582229|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582230|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43582231|NCT02951377|Dexamethasone|dexamethasone|mesh-list
43582232|NCT02951377|Lidocaine|lidocaine|mesh-list
43582233|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582234|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
43582235|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
43582236|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582237|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582238|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582239|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
43582240|NCT02951377|Hormones|hormones|mesh-ancestor
43675155|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43675156|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675157|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
43675158|NCT02886429|Bupivacaine|bupivacaine|mesh-list
43675159|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
43675160|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
43675161|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675162|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676776|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
43675163|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
43675164|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675165|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43675166|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43675167|NCT02886429|Analgesics|analgesics|mesh-ancestor
43675168|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43675169|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43675170|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43675171|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
43675172|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675173|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675175|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
43675176|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675177|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
43675178|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43704658|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
43676777|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676778|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676779|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
43676780|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676781|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43676782|NCT02873091|Narcotics|narcotics|mesh-ancestor
43583920|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583921|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
43583922|NCT03432975|Povidone|povidone|mesh-list
43583923|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
43583924|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
43583925|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43675203|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43675204|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583926|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583927|NCT03432923|Benzocaine|benzocaine|mesh-list
43583928|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
43583930|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583931|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583932|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
43583933|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583936|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43583937|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583938|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43583939|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43583940|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583941|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583942|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583943|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43583961|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43583962|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583963|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583964|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43583965|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43583966|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
43583967|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675219|NCT02885961|Dabigatran|dabigatran|mesh-list
43675220|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
43675221|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43675222|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
43675223|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582241|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582242|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43582243|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582244|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
43582245|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
43582246|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582247|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
43582248|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43582249|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43582250|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43582251|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43582252|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582253|NCT02811523|Doxorubicin|doxorubicin|mesh-list
43582254|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43582255|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582256|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43582257|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43582258|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582259|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582260|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43582261|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43582262|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583968|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
43583969|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583970|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43583971|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43583972|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43582264|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582265|NCT02366494|Docetaxel|docetaxel|mesh-list
43582266|NCT02366494|Leuprolide|leuprolide|mesh-list
43582267|NCT02366494|Goserelin|goserelin|mesh-list
43582268|NCT02366494|Bicalutamide|bicalutamide|mesh-list
43582269|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43582270|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582271|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582272|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582273|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
43675224|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675225|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
43675227|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43675228|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675229|NCT02885909|Insulin|insulin|mesh-list
43675230|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675231|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675232|NCT02885740|Adenosine|adenosine|mesh-list
43675233|NCT02885740|Analgesics|analgesics|mesh-ancestor
43675234|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
43675235|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675236|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675237|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43675238|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
43675239|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43675240|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
43675241|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
43675242|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675244|NCT02885948|Naloxone|naloxone|mesh-list
43675257|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675258|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675259|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675260|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43675261|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675262|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675263|NCT02885688|Insulin|insulin|mesh-list
43675264|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675265|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675266|NCT02885597|Methotrexate|methotrexate|mesh-list
43675267|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43675268|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
43675269|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43675270|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675271|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675272|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
43675273|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675274|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675275|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675276|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675298|NCT02885454|Drospirenone|drospirenone|mesh-list
43675299|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43675300|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43675301|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43675302|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43675303|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43675304|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
43675305|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43675306|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675307|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43675308|NCT02885454|Estrogens|estrogens|mesh-ancestor
43675309|NCT02885454|Hormones|hormones|mesh-ancestor
43583973|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
43583974|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676784|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43675310|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675311|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43675312|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
43675313|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43675314|NCT02885454|Diuretics|diuretics|mesh-ancestor
43675315|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
43675316|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
43675317|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675318|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
43675319|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675320|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675321|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
43675322|NCT02885168|Phenylephrine|phenylephrine|mesh-list
43675323|NCT02885168|Protein C|protein c|mesh-list
43675324|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
43675325|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43675326|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
43675327|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
43582284|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43582285|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
43582286|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43582287|NCT02262923|Metoclopramide|metoclopramide|mesh-list
43582288|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
43582289|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
43582290|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582291|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582292|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582293|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43582294|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43582295|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
43582296|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582297|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582298|NCT02234323|Factor VIII|factor viii|mesh-list
43675328|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675329|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675330|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
43676785|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43676786|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
43675331|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43675332|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
43675333|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
43675334|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43675335|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43675336|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43675337|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
43675338|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675339|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675340|NCT02885168|Protective Agents|protective agents|mesh-ancestor
43675341|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
43675342|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43675343|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43675344|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675346|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43675347|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43675348|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675349|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
43675371|NCT02884596|Serotonin|serotonin|mesh-list
43675372|NCT02884596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43675373|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43675374|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
43675375|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675376|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675377|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675378|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43675379|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675380|NCT02884817|Listerine|listerine|mesh-list
43675381|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43675382|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827551|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827552|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43827553|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
43827554|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
43827555|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43827556|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827557|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675415|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43675416|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
43675417|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43675418|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675419|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675420|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
43675421|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675422|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582299|NCT02234323|Coagulants|coagulants|mesh-ancestor
43582300|NCT02194595|Insulin|insulin|mesh-list
43582301|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43582302|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
43582303|NCT02194595|Exenatide|exenatide|mesh-list
43582304|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
43582305|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43582306|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582307|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43582308|NCT02194595|Incretins|incretins|mesh-ancestor
43582310|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582312|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43675423|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675424|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675425|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43675426|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43675427|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
43675428|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675429|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43675430|NCT02884479|Docetaxel|docetaxel|mesh-list
43675431|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675432|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
43675433|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
43675434|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582313|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43582314|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
43582315|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582320|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
43582321|NCT02168140|Vitamins|vitamins|mesh-ancestor
43582322|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
43582323|NCT02099188|Leucovorin|leucovorin|mesh-list
43582324|NCT02099188|Cisplatin|cisplatin|mesh-list
43582325|NCT02099188|Docetaxel|docetaxel|mesh-list
43582326|NCT02099188|Fluorouracil|fluorouracil|mesh-list
43582327|NCT02099188|Etoposide|etoposide|mesh-list
43582328|NCT02099188|Doxorubicin|doxorubicin|mesh-list
43582329|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43582330|NCT02099188|Ifosfamide|ifosfamide|mesh-list
43582331|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582332|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
43582333|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
43582334|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
43582335|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582336|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
43582337|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43582338|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582339|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
43582341|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43582342|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43582343|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43582344|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582345|NCT02099188|Antidotes|antidotes|mesh-ancestor
43582346|NCT02099188|Protective Agents|protective agents|mesh-ancestor
43582347|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
43582349|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
43582350|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43582351|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43582352|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
43582354|NCT02099175|Cisplatin|cisplatin|mesh-list
43582355|NCT02099175|Docetaxel|docetaxel|mesh-list
43582356|NCT02099175|Fluorouracil|fluorouracil|mesh-list
43582357|NCT02099175|Etoposide|etoposide|mesh-list
43582358|NCT02099175|Doxorubicin|doxorubicin|mesh-list
43582359|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43582360|NCT02099175|Ifosfamide|ifosfamide|mesh-list
43582366|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
43582367|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675435|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675437|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43675438|NCT02884310|Narcotics|narcotics|mesh-ancestor
43675439|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675440|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675441|NCT02884310|Analgesics|analgesics|mesh-ancestor
43675442|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
43675443|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675444|NCT02884050|Topiramate|topiramate|mesh-list
43675445|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
43675451|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
43582368|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43582369|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
43582370|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582371|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43582372|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43582373|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43582374|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582375|NCT02099175|Antidotes|antidotes|mesh-ancestor
43582376|NCT02099175|Protective Agents|protective agents|mesh-ancestor
43582377|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
43582378|NCT02099175|Vitamins|vitamins|mesh-ancestor
43582379|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
43582380|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43582381|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43582382|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
43582383|NCT02087826|Metformin|metformin|mesh-list
43582384|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43582385|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582386|NCT01333046|Azacitidine|azacitidine|mesh-list
43582400|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582401|NCT00872950|Amifampridine|amifampridine|mesh-list
43582402|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43675452|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43675453|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675454|NCT02884128|Leucovorin|leucovorin|mesh-list
43675455|NCT02884128|Fluorouracil|fluorouracil|mesh-list
43675456|NCT02884128|Irinotecan|irinotecan|mesh-list
43675457|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
43675458|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675459|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675460|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675461|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43675462|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
43675463|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675464|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43675465|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43675466|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675467|NCT02884128|Antidotes|antidotes|mesh-ancestor
43675468|NCT02884128|Protective Agents|protective agents|mesh-ancestor
43582403|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582404|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582405|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43582406|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43582407|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582408|NCT00493896|Enoxaparin|enoxaparin|mesh-list
43582409|NCT00493896|PENTA|penta|mesh-list
43582410|NCT00493896|Fondaparinux|fondaparinux|mesh-list
43582411|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
43582412|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43582413|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43582414|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582415|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43582424|NCT03449940|Analgesics|analgesics|mesh-list
43582425|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
43582427|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582428|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582429|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
43582430|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582431|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43582432|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43582433|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43582434|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43582435|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582436|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582437|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43582438|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43582439|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582440|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43582441|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43582442|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582443|NCT03449836|Fluticasone|fluticasone|mesh-list
43582444|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
43582445|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582446|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43582447|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
43582448|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582449|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582450|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43675472|NCT02884037|Rifaximin|rifaximin|mesh-list
43675494|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675495|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582451|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
43582452|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
43582453|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43582454|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
43582455|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43582456|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43582457|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43582458|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582459|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
43582460|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582461|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43582462|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582463|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582464|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
43582465|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582466|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582467|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43582468|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
43582469|NCT03449693|Antacids|antacids|mesh-ancestor
43582470|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582471|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582472|NCT03449654|Liraglutide|liraglutide|mesh-list
43582473|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675497|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43675498|NCT02883595|Thymalfasin|thymalfasin|mesh-list
43675499|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43675500|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
43675501|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675502|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
43675503|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43675504|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675505|NCT02883569|Ibuprofen|ibuprofen|mesh-list
43676787|NCT02873065|Amoxicillin|amoxicillin|mesh-list
43676788|NCT02873065|Clarithromycin|clarithromycin|mesh-list
43676789|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
43675506|NCT02883569|Aceclofenac|aceclofenac|mesh-list
43675507|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43675508|NCT02883569|Tramadol|tramadol|mesh-list
43675509|NCT02883569|Codeine|codeine|mesh-list
43675510|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43675511|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43582474|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582475|NCT03449654|Incretins|incretins|mesh-ancestor
43582476|NCT03449654|Hormones|hormones|mesh-ancestor
43582477|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582478|NCT03449537|Caseins|caseins|mesh-list
43582479|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
43582480|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
43582481|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582483|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43582484|NCT03449251|Verapamil|verapamil|mesh-list
43582485|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
43582486|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43582487|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43582488|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43582489|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582490|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43582491|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582492|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
43675513|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
43675514|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675515|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675516|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675517|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675518|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43675519|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675520|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675521|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43675522|NCT02883569|Narcotics|narcotics|mesh-ancestor
43582518|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43582519|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
43582520|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582521|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582522|NCT03448835|Docetaxel|docetaxel|mesh-list
43582524|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
43582570|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
43582571|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43675523|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675524|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
43675525|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
43675527|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
43675528|NCT02883478|Vitamins|vitamins|mesh-ancestor
43675529|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
43675530|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675531|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43675532|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675533|NCT02883179|Lidocaine|lidocaine|mesh-list
43675534|NCT02883179|Prilocaine|prilocaine|mesh-list
43675535|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43675536|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
43675537|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
43675543|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43675544|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43675545|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675546|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675547|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43675549|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
43675550|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
43582613|NCT03447691|Remifentanil|remifentanil|mesh-list
43582614|NCT03447691|Anesthetics|anesthetics|mesh-list
43582615|NCT03447691|Propofol|propofol|mesh-list
43582616|NCT03447691|Desflurane|desflurane|mesh-list
43582617|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582618|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582619|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43582620|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43582621|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
43582622|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43582623|NCT03447691|Narcotics|narcotics|mesh-ancestor
43582624|NCT03447691|Analgesics|analgesics|mesh-ancestor
43582625|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
43582626|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43582627|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43582628|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
43582629|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43582630|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582631|NCT03447470|Nivolumab|nivolumab|mesh-list
43582632|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43582633|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582634|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43582635|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582636|NCT03447184|Androgens|androgens|mesh-list
43582637|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43582638|NCT03447184|Hormones|hormones|mesh-ancestor
43582639|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676790|NCT02873065|Bismuth|bismuth|mesh-list
43676791|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582640|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582641|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43582642|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582643|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582644|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43582645|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
43582646|NCT03447093|Methimazole|methimazole|mesh-list
43582647|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
43582648|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
43582650|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43582652|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
43582653|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582654|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43582655|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
43582656|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582657|NCT03446937|Dexamethasone|dexamethasone|mesh-list
43582658|NCT03446937|Betamethasone|betamethasone|mesh-list
43582659|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
43582660|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43582661|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
43582662|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
43582663|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43675551|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675552|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675553|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43582666|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675628|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43675629|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675630|NCT02882737|Incretins|incretins|mesh-ancestor
43675631|NCT02882555|Capsaicin|capsaicin|mesh-list
43675632|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
43675633|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
43675634|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
43675635|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675691|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675692|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43582696|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
43582697|NCT03446872|Vitamins|vitamins|mesh-ancestor
43675693|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
43675694|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
43675698|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
43675717|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
43582744|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582745|NCT03445897|Miltefosine|miltefosine|mesh-list
43582746|NCT03445897|Pentamidine|pentamidine|mesh-list
43582747|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
43582748|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582749|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582750|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43582751|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43582752|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43675729|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675730|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
43675731|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43582842|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
43827597|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827598|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827599|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827600|NCT05487469|Thymalfasin|thymalfasin|mesh-list
43827601|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43827602|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
43827603|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827604|NCT05487443|Gemcitabine|gemcitabine|mesh-list
43827605|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43827606|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
43827607|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827615|NCT05487391|Paclitaxel|paclitaxel|mesh-list
43582909|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43582910|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43582911|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43582912|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
43582913|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43582914|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582915|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582916|NCT03443999|Sirolimus|sirolimus|mesh-list
43582917|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43582918|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43582919|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43582920|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582921|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
43827632|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
43582935|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675890|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675891|NCT02880033|Deferiprone|deferiprone|mesh-list
43675892|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43675985|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43676005|NCT02879721|Candesartan|candesartan|mesh-list
43676006|NCT02879721|Enalapril|enalapril|mesh-list
43676007|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43676008|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43676009|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43676010|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676011|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43676031|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
43676032|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
43676033|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676034|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43676060|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43676061|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43676062|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43583032|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
43583033|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583034|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43583035|NCT03443518|Remifentanil|remifentanil|mesh-list
43676193|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583054|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583055|NCT03443492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43676226|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
43676227|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
43676228|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676229|NCT02878031|Amoxicillin|amoxicillin|mesh-list
43676230|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43676231|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676232|NCT02878122|Carboplatin|carboplatin|mesh-list
43676233|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676234|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43676235|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43676236|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43676237|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
43583099|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583100|NCT03442491|Hemostatics|hemostatics|mesh-list
43583101|NCT03442491|Coagulants|coagulants|mesh-ancestor
43583102|NCT03442283|Vitamins|vitamins|mesh-list
43583103|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
43583104|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583106|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43583107|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43583108|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583109|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
43583110|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
43583111|NCT03441841|Lidocaine|lidocaine|mesh-list
43583112|NCT03441841|Prilocaine|prilocaine|mesh-list
43583141|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583142|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583145|NCT03441412|Ticagrelor|ticagrelor|mesh-list
43583146|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43676238|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676239|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676240|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676241|NCT02877901|Urological Agents|urological agents|mesh-ancestor
43676243|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
43676244|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
43676245|NCT02877888|Protective Agents|protective agents|mesh-ancestor
43676246|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827666|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827667|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43827668|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
43583147|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43583189|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43583190|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
43583191|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43583192|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
43583193|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583194|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827669|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827670|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827671|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43827672|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
43827673|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
43676248|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
43676249|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
43583195|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43583196|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
43583197|NCT03441035|Anesthetics|anesthetics|mesh-list
43583198|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583199|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583200|NCT03440996|Listerine|listerine|mesh-list
43676792|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43676793|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676794|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43676795|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676796|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43676797|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43676799|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676800|NCT02873065|Diuretics|diuretics|mesh-ancestor
43676801|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
43676802|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583201|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
43583202|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
43583203|NCT03440996|Protective Agents|protective agents|mesh-ancestor
43583204|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583205|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43583206|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43583207|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43583208|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43583209|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583210|NCT03440515|Prednisone|prednisone|mesh-list
43583212|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
43583213|NCT03440515|Hormones|hormones|mesh-ancestor
43583217|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676261|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676262|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43676355|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43676356|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676357|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
43676358|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676359|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
43676360|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43676361|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43676362|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43676363|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
43676391|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676392|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
43676449|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43676450|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676451|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827674|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43827675|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583323|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827677|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827678|NCT05486949|Analgesics|analgesics|mesh-ancestor
43676477|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676478|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676479|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43676512|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676513|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
43583491|NCT03437070|Trabectedin|trabectedin|mesh-list
43583492|NCT03437070|Olaratumab|olaratumab|mesh-list
43583493|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43583494|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583495|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43583496|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43583497|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676589|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676590|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676591|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
43676592|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676593|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43676594|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43676595|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43676596|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43676597|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676598|NCT02875002|Belinostat|belinostat|mesh-list
43676599|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676600|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43676601|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583527|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43583570|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583572|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
43583573|NCT03436225|Budesonide|budesonide|mesh-list
43583574|NCT03436225|Albuterol|albuterol|mesh-list
43583575|NCT03436225|BB 1101|bb 1101|mesh-list
43583576|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583577|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
43583578|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
43583579|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583580|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583581|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43583582|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
43676615|NCT02874963|Eucalyptol|eucalyptol|mesh-list
43676616|NCT02874963|Salicylates|salicylates|mesh-list
43676617|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
43676618|NCT02874963|Menthol|menthol|mesh-list
43676619|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43676620|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676621|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827703|NCT05486481|Venetoclax|venetoclax|mesh-list
43676622|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676623|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
43676678|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676679|NCT02874820|Idazoxan|idazoxan|mesh-list
43583692|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583693|NCT03434951|Morphine|morphine|mesh-list
43583694|NCT03434951|Bupivacaine|bupivacaine|mesh-list
43846933|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846934|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
43846935|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
43846936|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
43846937|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846938|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846939|NCT04157036|Ibuprofen|ibuprofen|mesh-list
43846940|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
43583739|NCT03434691|Narcotics|narcotics|mesh-ancestor
43583740|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583742|NCT03434691|Analgesics|analgesics|mesh-ancestor
43676705|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
43583777|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583778|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583779|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583780|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43583781|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43583782|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43583783|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583784|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583786|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43583787|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676744|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676745|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43676746|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676747|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
43676751|NCT02873364|Vitamin D|vitamin d|mesh-list
43583854|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43583855|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583944|NCT03432871|Niacinamide|niacinamide|mesh-list
43583945|NCT03432871|Niacin|niacin|mesh-list
43583946|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
43583947|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
43583948|NCT03432871|Vitamins|vitamins|mesh-ancestor
43583949|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
43583950|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583951|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43583952|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
43583953|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583954|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43583955|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
43583956|NCT03432793|Itraconazole|itraconazole|mesh-list
43583957|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
43583958|NCT03432793|Caffeine|caffeine|mesh-list
43583959|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43583960|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676803|NCT02873065|Expectorants|expectorants|mesh-ancestor
43676804|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
43676805|NCT02872818|Metformin|metformin|mesh-list
43676806|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43676807|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43676808|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43676809|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
43676810|NCT02872818|Estradiol|estradiol|mesh-list
43676811|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43676812|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43676813|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676814|NCT02872818|Estrogens|estrogens|mesh-ancestor
43676817|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43676818|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
43583975|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43583976|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43583977|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43583978|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676819|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43676820|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43676821|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43676822|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43584030|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676823|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43676824|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43676825|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43583979|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43583980|NCT03432793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43583981|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43583982|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43583983|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
43583984|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43583985|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
43583986|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43583987|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43583988|NCT03432780|Docetaxel|docetaxel|mesh-list
43676883|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
43676884|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
43676885|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43676886|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
43676887|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583989|NCT03432780|Hormones|hormones|mesh-list
43583990|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583991|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
43583992|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
43583993|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
43583994|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583995|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43584089|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
43583996|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583997|NCT03432767|Chrysarobin|chrysarobin|mesh-list
43583998|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43583999|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584000|NCT03432767|Analgesics|analgesics|mesh-ancestor
43584001|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
43676943|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
43584002|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584003|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584004|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43584005|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43584006|NCT03432728|Anesthetics|anesthetics|mesh-list
43584313|NCT03430466|Fulvestrant|fulvestrant|mesh-list
43584007|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584008|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584009|NCT03432689|Cycloserine|cycloserine|mesh-list
43584010|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43677012|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
43584011|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584012|NCT03432689|Renal Agents|renal agents|mesh-ancestor
43584013|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43584014|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
43584015|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43584016|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
43584017|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584018|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
43584019|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43584020|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584021|NCT03432663|Amiodarone|amiodarone|mesh-list
43584022|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43584023|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
43584024|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43584025|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43584026|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584373|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
43584374|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584375|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584376|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43584377|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43584378|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43584379|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584381|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43584027|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43584028|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43584029|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43584031|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43584032|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43676828|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43676829|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43676830|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43676831|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676832|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
43676833|NCT02873026|Hormones|hormones|mesh-ancestor
43676834|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676835|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676836|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43584420|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584421|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
43584422|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
43584423|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43676837|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
43676838|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676839|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676840|NCT02872584|Prednisone|prednisone|mesh-list
43676841|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676842|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
43676843|NCT02872584|Hormones|hormones|mesh-ancestor
43676844|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676845|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676846|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43676847|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676848|NCT02872597|Dexamethasone|dexamethasone|mesh-list
43676849|NCT02872597|Prednisone|prednisone|mesh-list
43676850|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
43676851|NCT02872597|Prednisolone|prednisolone|mesh-list
43676852|NCT02872597|Albuterol|albuterol|mesh-list
43676853|NCT02872597|Ipratropium|ipratropium|mesh-list
43676854|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676855|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
43676856|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
43676857|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676858|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676859|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676860|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
43676861|NCT02872597|Hormones|hormones|mesh-ancestor
43584034|NCT03432637|Anesthetics|anesthetics|mesh-list
43584035|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676862|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676863|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43676864|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676865|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584525|NCT03428256|Anesthetics|anesthetics|mesh-list
43676866|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43676867|NCT02872597|Protective Agents|protective agents|mesh-ancestor
43676868|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43676869|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43676870|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
43676871|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
43676872|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43676873|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43676874|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43677179|NCT02870036|Growth Substances|growth substances|mesh-ancestor
43676875|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43676876|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
43676877|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676878|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43676879|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
43676880|NCT02872649|Warfarin|warfarin|mesh-list
43676881|NCT02872649|Dabigatran|dabigatran|mesh-list
43676882|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
43676888|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676889|NCT02872389|Sevoflurane|sevoflurane|mesh-list
43677226|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677227|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677228|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43677264|NCT02869035|Citalopram|citalopram|mesh-list
43677269|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827730|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43827731|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827732|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584037|NCT03432598|Gemcitabine|gemcitabine|mesh-list
43584038|NCT03432598|Paclitaxel|paclitaxel|mesh-list
43584039|NCT03432598|Etoposide|etoposide|mesh-list
43584040|NCT03432598|Cisplatin|cisplatin|mesh-list
43584041|NCT03432598|Carboplatin|carboplatin|mesh-list
43584042|NCT03432598|Pemetrexed|pemetrexed|mesh-list
43584043|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43584044|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584045|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
43584046|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
43677346|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677347|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
43584047|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
43584048|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584049|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43584050|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
43584051|NCT03432598|Antiviral Agents|antiviral agents|mesh-ancestor
43584052|NCT03432598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584053|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584054|NCT03432598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43584055|NCT03432598|Immunologic Factors|immunologic factors|mesh-ancestor
43584056|NCT03432598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584057|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43584058|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43584059|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43584060|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43584061|NCT03432572|Riboflavin|riboflavin|mesh-list
43584062|NCT03432572|Thiamine|thiamine|mesh-list
43677410|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677411|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
43677412|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
43677413|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677414|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584933|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
43584934|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584935|NCT03424928|Thalidomide|thalidomide|mesh-list
43584936|NCT03424928|Pomalidomide|pomalidomide|mesh-list
43584937|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
43584938|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584939|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43584940|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43584941|NCT03424928|Growth Substances|growth substances|mesh-ancestor
43584942|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
43584943|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584944|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43584945|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
43584946|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43584947|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584948|NCT03424889|Xylometazoline|xylometazoline|mesh-list
43584949|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
43584950|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43584951|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
43584952|NCT03424876|Sunitinib|sunitinib|mesh-list
43584953|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
43584063|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
43584064|NCT03432572|Vitamins|vitamins|mesh-ancestor
43584065|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
43584066|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584067|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43584068|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
43584069|NCT03432468|Valsartan|valsartan|mesh-list
43584070|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43584071|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43584072|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43584073|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584074|NCT03432442|Ivermectin|ivermectin|mesh-list
43584962|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584963|NCT03424759|Osimertinib|osimertinib|mesh-list
43584964|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584965|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43584966|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584967|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584968|NCT03424746|Edetic Acid|edetic acid|mesh-list
43584969|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
43584970|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
43584971|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43584972|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
43584973|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
43584974|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584975|NCT03424746|Antidotes|antidotes|mesh-ancestor
43584976|NCT03424746|Protective Agents|protective agents|mesh-ancestor
43584977|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584978|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43584979|NCT03424733|Acetaminophen|acetaminophen|mesh-list
43584980|NCT03424733|Interferons|interferons|mesh-list
43584981|NCT03424733|Interferon-beta|interferon-beta|mesh-list
43677416|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
43677417|NCT02867904|Hormones|hormones|mesh-ancestor
43677418|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677419|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43677420|NCT02867904|Protective Agents|protective agents|mesh-ancestor
43677421|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43677422|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584075|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43584076|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584077|NCT03432312|Nicotine|nicotine|mesh-list
43584078|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43677562|NCT02867293|Anesthetics|anesthetics|mesh-list
43677563|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677564|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677565|NCT02867306|Methotrexate|methotrexate|mesh-list
43677566|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43677567|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
43677568|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43677569|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677570|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43584079|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
43584080|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584081|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584082|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43677582|NCT02867397|Epirubicin|epirubicin|mesh-list
43584083|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43584084|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
43584085|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584086|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584088|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43584090|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584091|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584092|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43827734|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827735|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43827736|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677716|NCT02866448|Aspirin|aspirin|mesh-list
43827737|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827738|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43827739|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43827740|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827741|NCT05485766|Paclitaxel|paclitaxel|mesh-list
43827742|NCT05485766|Carboplatin|carboplatin|mesh-list
43827743|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
43584093|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43584094|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
43584095|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584096|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584097|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43584098|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43584099|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43584100|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43584101|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584102|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584103|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584104|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
43584105|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43584106|NCT03432195|Donepezil|donepezil|mesh-list
43584107|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43584108|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584109|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584110|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
43584111|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584112|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584113|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
43584114|NCT03431974|Aminopterin|aminopterin|mesh-list
43584115|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43584116|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585430|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43585431|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
43677833|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677834|NCT02865629|Antidotes|antidotes|mesh-ancestor
43677835|NCT02865681|Letrozole|letrozole|mesh-list
43677836|NCT02865681|Clomiphene|clomiphene|mesh-list
43677837|NCT02865681|Enclomiphene|enclomiphene|mesh-list
43677838|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
43677839|NCT02865681|Menotropins|menotropins|mesh-list
43677840|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677841|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677842|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43584117|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584118|NCT03431961|Triamcinolone|triamcinolone|mesh-list
43584119|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43584120|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43584121|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43584122|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43584123|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
43584124|NCT03431961|Hormones|hormones|mesh-ancestor
43585598|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
43584125|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827744|NCT05485766|Olaparib|olaparib|mesh-list
43827745|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43827746|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827747|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
43827748|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
43827749|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
43585660|NCT03419624|Metformin|metformin|mesh-list
43827750|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676897|NCT02872272|Amikacin|amikacin|mesh-list
43676898|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43676899|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676900|NCT02872428|Valproic Acid|valproic acid|mesh-list
43676901|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
43676902|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676903|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676904|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
43677891|NCT02865356|Cyclosporine|cyclosporine|mesh-list
43677892|NCT02865356|Cyclosporins|cyclosporins|mesh-list
43677893|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677894|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677895|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677925|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
43677926|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43677927|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43677928|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677929|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43676905|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676906|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676907|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
43676908|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43676909|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676910|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43676911|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
43676912|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676913|NCT02871869|Buformin|buformin|mesh-list
43676914|NCT02871869|Prednisone|prednisone|mesh-list
43676915|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
43585742|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43585743|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585744|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43585745|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
43585746|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
43585747|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
43585748|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585750|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585752|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585753|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585754|NCT03418506|Lobeline|lobeline|mesh-list
43585755|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43585756|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
43585757|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585758|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585759|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43585760|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43585761|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
43585762|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585764|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
43676916|NCT02871869|Rituximab|rituximab|mesh-list
43676917|NCT02871869|Epirubicin|epirubicin|mesh-list
43676918|NCT02871869|Vindesine|vindesine|mesh-list
43676919|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43676920|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
43676921|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676934|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43676935|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43676936|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43676937|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585788|NCT03417921|Gemcitabine|gemcitabine|mesh-list
43585789|NCT03417921|Paclitaxel|paclitaxel|mesh-list
43585804|NCT03417700|Vitamin D|vitamin d|mesh-list
43676938|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43676939|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
43676940|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
43584126|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584127|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43584128|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
43584137|NCT03431909|Analgesics|analgesics|mesh-ancestor
43584138|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
43584139|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584140|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584141|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43584142|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43584143|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43584144|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43584145|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584146|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43584147|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43584148|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584149|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
43584159|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584160|NCT03431909|Coagulants|coagulants|mesh-ancestor
43584161|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
43584162|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
43584163|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43584164|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
43584165|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43584166|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43584167|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584168|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
43584169|NCT03431805|Coagulants|coagulants|mesh-ancestor
43584170|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
43584171|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43584172|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584173|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
43584174|NCT03431714|Artesunate|artesunate|mesh-list
43584175|NCT03431714|Piperaquine|piperaquine|mesh-list
43584176|NCT03431714|Amodiaquine|amodiaquine|mesh-list
43584177|NCT03431714|Artenimol|artenimol|mesh-list
43584178|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
43584179|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43584180|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43584181|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584182|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584183|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
43584184|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
43584185|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43584186|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
43584187|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43584188|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
43584189|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584190|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43584191|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
43584192|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
43584193|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43584194|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584195|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43584196|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43584197|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676941|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
43676942|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43676944|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
43676945|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43676946|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
43676947|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676948|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584198|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584199|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585970|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
43584200|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43584201|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43584204|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584205|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
43584206|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43584207|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43584208|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584209|NCT03431649|Urological Agents|urological agents|mesh-ancestor
43584210|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43584211|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
43584212|NCT03431623|Hematinics|hematinics|mesh-ancestor
43584213|NCT03431597|Micronutrients|micronutrients|mesh-list
43584214|NCT03431597|Trace Elements|trace elements|mesh-list
43584215|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584216|NCT03431558|Lactoferrin|lactoferrin|mesh-list
43584217|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584218|NCT03431285|Ketamine|ketamine|mesh-list
43584219|NCT03431285|Morphine|morphine|mesh-list
43584221|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
43584222|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584223|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584224|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43584225|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43584226|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
43584227|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
43584228|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584229|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43584230|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43584231|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584232|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584233|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43584234|NCT03431285|Narcotics|narcotics|mesh-ancestor
43584235|NCT03431272|Lifitegrast|lifitegrast|mesh-list
43584236|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43584237|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43584238|NCT03431142|Aspirin|aspirin|mesh-list
43584239|NCT03431142|Clopidogrel|clopidogrel|mesh-list
43584240|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43584241|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584242|NCT03431142|Analgesics|analgesics|mesh-ancestor
43584243|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
43676949|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43678128|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
43678129|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678130|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
43678131|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43586051|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
43586052|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678132|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
43678133|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
43678134|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
43678135|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
43678136|NCT02863406|Dimercaprol|dimercaprol|mesh-list
43676950|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
43676951|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
43676952|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43676953|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
43676954|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676955|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676956|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43676957|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43584244|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584245|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584246|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43584247|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43584248|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43584249|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43584250|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584251|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43584252|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43584253|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584254|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
43584255|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43584256|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43584258|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
43584259|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584260|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
43584261|NCT03431077|Giapreza|giapreza|mesh-list
43584262|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
43584263|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43584264|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43584265|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
43584266|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584267|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584268|NCT03430817|Amantadine|amantadine|mesh-list
43584269|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43584270|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43584271|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43584272|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
43584273|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584274|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
43584275|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584276|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584277|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584278|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584279|NCT03430817|Analgesics|analgesics|mesh-ancestor
43584280|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
43678287|NCT02862769|Lidocaine|lidocaine|mesh-list
43584281|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584282|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
43584283|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43584284|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43584285|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584286|NCT03430609|Hormones|hormones|mesh-list
43584287|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676959|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43676960|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
43676961|NCT02871661|Amitriptyline|amitriptyline|mesh-list
43676962|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43676963|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
43676964|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43676965|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43676966|NCT02871661|Analgesics|analgesics|mesh-ancestor
43678331|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
43676967|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
43676968|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676969|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676970|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43676971|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43676972|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43676973|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676974|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
43584288|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584289|NCT03430544|Cariprazine|cariprazine|mesh-list
43584290|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43584291|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43584292|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584293|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584294|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43584295|NCT03430518|Durvalumab|durvalumab|mesh-list
43584296|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43584297|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584298|NCT03430505|Albuterol|albuterol|mesh-list
43846982|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
43584299|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43584300|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
43584301|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584302|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584303|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43584304|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
43584305|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
43584306|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43584307|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43584308|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43584309|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43584310|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
43584311|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678401|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
43678402|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
43678409|NCT02861716|Analgesics|analgesics|mesh-ancestor
43584312|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584314|NCT03430466|Tremelimumab|tremelimumab|mesh-list
43584315|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43584316|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584317|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43584318|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43584319|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
43584320|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43584321|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584322|NCT03430362|Scopolamine|scopolamine|mesh-list
43584323|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43584324|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43584325|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
43584326|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
43676975|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676976|NCT02871986|Estrogens|estrogens|mesh-list
43676977|NCT02871986|Hormones|hormones|mesh-ancestor
43676978|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676979|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676980|NCT02871713|Morphine|morphine|mesh-list
43676981|NCT02871713|Ropivacaine|ropivacaine|mesh-list
43676982|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43676983|NCT02871713|Narcotics|narcotics|mesh-ancestor
43586408|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
43586409|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43586434|NCT03411369|Vitamins|vitamins|mesh-list
43676984|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676985|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676986|NCT02871713|Analgesics|analgesics|mesh-ancestor
43676987|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
43676988|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676989|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
43676990|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
43676991|NCT02871765|Warfarin|warfarin|mesh-list
43676992|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
43676993|NCT02872038|Cefazolin|cefazolin|mesh-list
43676994|NCT02872038|Ceftazidime|ceftazidime|mesh-list
43676995|NCT02872038|Cefepime|cefepime|mesh-list
43676996|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43676997|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676998|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
43676999|NCT02871648|Eplerenone|eplerenone|mesh-list
43677000|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43677001|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
43677002|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677003|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584327|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584328|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584329|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43584330|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
43584331|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43584332|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
43584333|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584334|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584335|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43586573|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
43586574|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584336|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
43584337|NCT03430297|Dacarbazine|dacarbazine|mesh-list
43584338|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43584339|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
43584340|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584341|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584342|NCT03430180|Naloxone|naloxone|mesh-list
43584343|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43584344|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584345|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
43677004|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43677005|NCT02871648|Diuretics|diuretics|mesh-ancestor
43677006|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
43677007|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43677008|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677009|NCT02871323|Durvalumab|durvalumab|mesh-list
43677010|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
43677011|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43677013|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43677014|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677015|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
43677016|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677017|NCT02871518|Cisplatin|cisplatin|mesh-list
43677018|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677019|NCT02871505|Penicillins|penicillins|mesh-list
43677020|NCT02871505|Penicillin G|penicillin g|mesh-list
43677021|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43677022|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
43677023|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43677024|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677025|NCT02871349|Propranolol|propranolol|mesh-list
43677026|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43677027|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43677028|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
43677029|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677030|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677031|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677032|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43677033|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43677034|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
43677035|NCT02871193|Dexamethasone|dexamethasone|mesh-list
43677036|NCT02871193|Ropivacaine|ropivacaine|mesh-list
43678543|NCT02860819|Carboplatin|carboplatin|mesh-list
43677037|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677047|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677048|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
43677049|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
43677050|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677051|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
43677052|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
43677053|NCT02870907|Thiotepa|thiotepa|mesh-list
43677054|NCT02870907|Carboplatin|carboplatin|mesh-list
43677055|NCT02870907|Etoposide|etoposide|mesh-list
43677056|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
43677057|NCT02870907|Vincristine|vincristine|mesh-list
43677058|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677059|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
43677060|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677061|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677062|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43677063|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
43677064|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677065|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677066|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43677067|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43584346|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584347|NCT03430024|Estrogens|estrogens|mesh-list
43584348|NCT03430024|Hormones|hormones|mesh-ancestor
43584349|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43584350|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584351|NCT03429998|Evolocumab|evolocumab|mesh-list
43584352|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43584353|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43584354|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43584355|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
43584356|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584357|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43584358|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
43584359|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584360|NCT03429972|Paclitaxel|paclitaxel|mesh-list
43584361|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43584362|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584363|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
43584364|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
43584365|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
43586724|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
43586725|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
43586726|NCT03401619|Vitamin D|vitamin d|mesh-list
43586727|NCT03401619|Calcitonin|calcitonin|mesh-list
43586729|NCT03401619|Diphosphonates|diphosphonates|mesh-list
43586739|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43586740|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586741|NCT03401177|Analgesics|analgesics|mesh-ancestor
43586742|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
43584366|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584367|NCT03429738|Ibuprofen|ibuprofen|mesh-list
43584368|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
43584372|NCT03429738|Analgesics|analgesics|mesh-ancestor
43584380|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584382|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
43677068|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43677070|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677071|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
43677072|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
43584383|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43584384|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
43584385|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
43584386|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43584387|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43584388|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
43584389|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
43584390|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584391|NCT03429621|Simethicone|simethicone|mesh-list
43584392|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
43584393|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584394|NCT03429621|Emollients|emollients|mesh-ancestor
43584395|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
43584396|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
43584397|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584398|NCT03429400|Morphine|morphine|mesh-list
43584399|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43584400|NCT03429400|Narcotics|narcotics|mesh-ancestor
43584401|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584402|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584403|NCT03429400|Analgesics|analgesics|mesh-ancestor
43584404|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
43584405|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584406|NCT03429309|Propofol|propofol|mesh-list
43584407|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43584408|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584409|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584410|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43584411|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
43584412|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
43584413|NCT03429179|Butorphanol|butorphanol|mesh-list
43584414|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43584415|NCT03429179|Narcotics|narcotics|mesh-ancestor
43584416|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584417|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584418|NCT03429179|Analgesics|analgesics|mesh-ancestor
43584419|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
43584424|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
43586823|NCT03399474|Lidocaine|lidocaine|mesh-list
43584425|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43584426|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43584427|NCT03429101|Trastuzumab|trastuzumab|mesh-list
43584428|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43584429|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43584431|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
43584432|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
43584433|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
43584434|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584435|NCT03429075|Citalopram|citalopram|mesh-list
43584436|NCT03429075|Psilocybin|psilocybin|mesh-list
43584437|NCT03429075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43584438|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43584439|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43584440|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584460|NCT03428880|Analgesics|analgesics|mesh-ancestor
43584461|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
43584462|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584463|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
43584464|NCT03428685|Progestins|progestins|mesh-ancestor
43584465|NCT03428685|Hormones|hormones|mesh-ancestor
43584466|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43584467|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584468|NCT03428633|Morphine|morphine|mesh-list
43584469|NCT03428633|Ropivacaine|ropivacaine|mesh-list
43584470|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43584471|NCT03428633|Narcotics|narcotics|mesh-ancestor
43584472|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584473|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584474|NCT03428633|Analgesics|analgesics|mesh-ancestor
43584475|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
43584476|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584477|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
43584478|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
43584479|NCT03428607|Olaparib|olaparib|mesh-list
43584480|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43584481|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584482|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584483|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584484|NCT03428568|Clarithromycin|clarithromycin|mesh-list
43584485|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43584486|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677073|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
43677075|NCT02870634|Trace Elements|trace elements|mesh-ancestor
43677076|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
43677077|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677078|NCT02870478|Atropine|atropine|mesh-list
43677079|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43677080|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43677081|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43677082|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43677083|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43677084|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
43677085|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586943|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43677086|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677087|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43677088|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
43677089|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
43677090|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
43677091|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43677092|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43677093|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
43677094|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677095|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677096|NCT02870673|Triamcinolone|triamcinolone|mesh-list
43677097|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43677098|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43677099|NCT02870673|Lidocaine|lidocaine|mesh-list
43677100|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43677101|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677102|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
43677103|NCT02870673|Hormones|hormones|mesh-ancestor
43584487|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43584488|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584489|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584490|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43584491|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43584492|NCT03428529|Fluorouracil|fluorouracil|mesh-list
43584493|NCT03428529|Capecitabine|capecitabine|mesh-list
43584495|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584496|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43584497|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584498|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43584499|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
43584510|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677104|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677105|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677106|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677107|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
43677108|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677109|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677110|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
43677112|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677113|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
43677114|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677115|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43677116|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43677117|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43677118|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43827751|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43827752|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43587065|NCT03397914|Polymyxins|polymyxins|mesh-list
43587068|NCT03397888|Betrixaban|betrixaban|mesh-list
43827753|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827754|NCT05485571|Methotrexate|methotrexate|mesh-list
43827755|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43827756|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
43827757|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43584511|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43584512|NCT03428425|Paclitaxel|paclitaxel|mesh-list
43584513|NCT03428425|Apatinib|apatinib|mesh-list
43584514|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43584515|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584516|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
43584517|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
43584518|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
43584519|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584520|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43584521|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584522|NCT03428282|Anesthetics|anesthetics|mesh-list
43584523|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584524|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584526|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584527|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584528|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
43584529|NCT03428191|Remifentanil|remifentanil|mesh-list
43584530|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43584531|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584532|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584533|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584534|NCT03428191|Analgesics|analgesics|mesh-ancestor
43584535|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
43827758|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827759|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43827760|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
43827761|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827762|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587096|NCT03397706|Valganciclovir|valganciclovir|mesh-list
43587100|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43587101|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587102|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
43587103|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43587104|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587106|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587107|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43587108|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43587109|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587110|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587111|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43587112|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
43587113|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587114|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587115|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43587116|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43587117|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827763|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
43827764|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827765|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43827766|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827767|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
43827768|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827769|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43827770|NCT05485519|Midazolam|midazolam|mesh-list
43584536|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584537|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43584538|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43584539|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43584541|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584542|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584543|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43584544|NCT03428191|Narcotics|narcotics|mesh-ancestor
43584545|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
43584546|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
43584547|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584548|NCT03428139|Protective Agents|protective agents|mesh-ancestor
43584549|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584550|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
43584551|NCT03428139|Vitamins|vitamins|mesh-ancestor
43584552|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
43584553|NCT03428022|Apatinib|apatinib|mesh-list
43584554|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584555|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43584556|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584557|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584558|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
43584559|NCT03427944|Calcium|calcium|mesh-list
43584560|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43587118|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43587119|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43587120|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43587121|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587122|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
43587123|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587125|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43587126|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43587127|NCT03397264|Growth Substances|growth substances|mesh-ancestor
43587128|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587129|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
43587130|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587131|NCT03397199|Apatinib|apatinib|mesh-list
43587132|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587133|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43587134|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587135|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584561|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584562|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
43584563|NCT03427944|Coagulants|coagulants|mesh-ancestor
43584565|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
43584566|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
43584568|NCT03427632|Protective Agents|protective agents|mesh-ancestor
43584569|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584570|NCT03427554|Tretinoin|tretinoin|mesh-list
43584571|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584572|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
43587142|NCT03397173|Azacitidine|azacitidine|mesh-list
43587143|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43587144|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
43587145|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587146|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587147|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587148|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
43587149|NCT03397173|Protective Agents|protective agents|mesh-ancestor
43587150|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587151|NCT03397173|Vitamins|vitamins|mesh-ancestor
43587152|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
43587153|NCT03397082|Lidocaine|lidocaine|mesh-list
43587154|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
43587155|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
43587156|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587157|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587158|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
43587159|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584573|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
43584574|NCT03427502|Epinephrine|epinephrine|mesh-list
43584575|NCT03427502|Bupivacaine|bupivacaine|mesh-list
43584576|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
43584577|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
43584578|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584579|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584580|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
43584581|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584582|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43584583|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43584584|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
43584585|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827771|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
43827772|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43827773|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827774|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827775|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587198|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43587199|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587200|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587201|NCT03396523|Losartan|losartan|mesh-list
43587202|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43587203|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43587204|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43587205|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43587207|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
43587225|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43587226|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587227|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
43587228|NCT03396380|Vitamin D|vitamin d|mesh-list
43587229|NCT03396380|Citric Acid|citric acid|mesh-list
43587230|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
43587231|NCT03396380|Clomiphene|clomiphene|mesh-list
43587232|NCT03396380|Enclomiphene|enclomiphene|mesh-list
43587233|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
43827776|NCT05485519|Analgesics|analgesics|mesh-ancestor
43827777|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
43827778|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827779|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43827780|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43827781|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43827782|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587234|NCT03396380|Calcium|calcium|mesh-list
43827783|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827784|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827785|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43827786|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43827787|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43827788|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43827789|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43827790|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
43827791|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
43584586|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587235|NCT03396380|Vitamins|vitamins|mesh-ancestor
43587236|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
43587237|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587238|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43587239|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43587261|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587262|NCT03396250|Analgesics|analgesics|mesh-ancestor
43587263|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
43587264|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587265|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587266|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587268|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
43587269|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43587270|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584587|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43584588|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43584589|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
43584590|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43584591|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
43584592|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
43584593|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
43584594|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43584595|NCT03427437|Epinephrine|epinephrine|mesh-list
43584596|NCT03427437|Racepinephrine|racepinephrine|mesh-list
43584598|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
43584599|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
43584600|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
43584601|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584602|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584603|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
43584604|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584605|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43587271|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678757|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678758|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678759|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
43678760|NCT02858804|Hormones|hormones|mesh-ancestor
43678761|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678762|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43678763|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43584606|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43678764|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43584607|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
43584608|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584609|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584610|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43584611|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43584612|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
43584613|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43584614|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
43678765|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43584615|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
43584616|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
43678766|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587272|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43587273|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43827792|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
43827793|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
43827794|NCT05485272|Fluorides|fluorides|mesh-list
43827795|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
43827796|NCT05485272|Protective Agents|protective agents|mesh-ancestor
43827797|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827798|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
43827799|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
43827800|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827801|NCT05485259|Protective Agents|protective agents|mesh-ancestor
43827802|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827803|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
43827804|NCT05485259|Vitamins|vitamins|mesh-ancestor
43827805|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
43584617|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43584618|NCT03427385|Ropivacaine|ropivacaine|mesh-list
43584619|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
43584620|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
43584621|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584622|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584623|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
43584624|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584625|NCT03427359|Cisplatin|cisplatin|mesh-list
43584626|NCT03427359|Capecitabine|capecitabine|mesh-list
43584627|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584628|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43584629|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
43584630|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584631|NCT03427242|Apatinib|apatinib|mesh-list
43584632|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584633|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43584634|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584635|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584636|NCT03427229|Vancomycin|vancomycin|mesh-list
43584637|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43584638|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584639|NCT03427216|Diazepam|diazepam|mesh-list
43584640|NCT03427216|Baclofen|baclofen|mesh-list
43584641|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43584642|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587290|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
43584644|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584645|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43584646|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
43584647|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
43584648|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584649|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584650|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43584651|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
43584652|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
43584653|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
43584654|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43584655|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43584656|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584657|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43584658|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43584659|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43584660|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43584661|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
43584662|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
43584663|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
43584664|NCT03427086|Biotin|biotin|mesh-list
43584665|NCT03427086|Vitamins|vitamins|mesh-ancestor
43584666|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
43584667|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584668|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
43827806|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
43677119|NCT02870361|Insulin|insulin|mesh-list
43677120|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43677121|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677122|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43677123|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43677124|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43677125|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678779|NCT02858804|Growth Substances|growth substances|mesh-ancestor
43677126|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677127|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
43677128|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677129|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43677130|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43677131|NCT02870231|Liraglutide|liraglutide|mesh-list
43677132|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43677133|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677134|NCT02870231|Incretins|incretins|mesh-ancestor
43677135|NCT02870231|Hormones|hormones|mesh-ancestor
43584669|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
43584670|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584671|NCT03426982|Heparin|heparin|mesh-list
43584672|NCT03426982|Calcium heparin|calcium heparin|mesh-list
43584673|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
43584674|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43584675|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43584676|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584677|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
43584678|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
43584679|NCT03426969|Melphalan|melphalan|mesh-list
43584680|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
43584681|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43584682|NCT03426969|Fludarabine|fludarabine|mesh-list
43584683|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
43584684|NCT03426969|Tacrolimus|tacrolimus|mesh-list
43584685|NCT03426969|Lenograstim|lenograstim|mesh-list
43584686|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43584687|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
43584688|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584689|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43584690|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43587368|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43587388|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587389|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43587390|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
43587391|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
43587392|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43587393|NCT03395093|Narcotics|narcotics|mesh-ancestor
43587394|NCT03395093|Analgesics|analgesics|mesh-ancestor
43587395|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
43587396|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587397|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43584691|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
43584692|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584693|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584694|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43584695|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43584696|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
43584697|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43584698|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584699|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43584700|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43584701|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43584702|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
43677136|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677137|NCT02869984|Ramosetron|ramosetron|mesh-list
43677138|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
43677139|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
43677140|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677141|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677142|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43677143|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43677144|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
43677145|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677146|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677147|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
43677148|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677149|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
43677150|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
43677151|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
43677152|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677153|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677154|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
43677155|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677156|NCT02870036|Leucovorin|leucovorin|mesh-list
43677157|NCT02870036|Thalidomide|thalidomide|mesh-list
43677158|NCT02870036|Fluorouracil|fluorouracil|mesh-list
43677159|NCT02870036|Calcium|calcium|mesh-list
43677160|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
43677161|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43677162|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677163|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
43677164|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584703|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43584704|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584705|NCT03426956|Canagliflozin|canagliflozin|mesh-list
43584706|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43584707|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584708|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43584709|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584710|NCT03426761|Vancomycin|vancomycin|mesh-list
43584711|NCT03426761|Cefazolin|cefazolin|mesh-list
43584712|NCT03426761|Daptomycin|daptomycin|mesh-list
43584713|NCT03426761|Dalbavancin|dalbavancin|mesh-list
43827942|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43584714|NCT03426761|Nafcillin|nafcillin|mesh-list
43827943|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
43827945|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827946|NCT05484193|Progesterone|progesterone|mesh-list
43827947|NCT05484193|Progestins|progestins|mesh-ancestor
43827948|NCT05484193|Hormones|hormones|mesh-ancestor
43827949|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827950|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827951|NCT05484154|Protein C|protein c|mesh-list
43827952|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
43827953|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43827954|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43827955|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827956|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43678785|NCT02858258|Rituximab|rituximab|mesh-list
43678786|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43587398|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43587399|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43587400|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43587401|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
43587402|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
43587403|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587404|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587405|NCT03395028|Lenograstim|lenograstim|mesh-list
43587406|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43584715|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43584716|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584717|NCT03426592|Vitamin D|vitamin d|mesh-list
43584718|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
43584719|NCT03426592|Vitamins|vitamins|mesh-ancestor
43584720|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
43677165|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43677166|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677167|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677168|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
43677169|NCT02870036|Antidotes|antidotes|mesh-ancestor
43677170|NCT02870036|Protective Agents|protective agents|mesh-ancestor
43677171|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
43677172|NCT02870036|Vitamins|vitamins|mesh-ancestor
43677173|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
43677174|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
43677175|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43677176|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677177|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43677178|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43584721|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584735|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584736|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43584737|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584738|NCT03426527|Analgesics|analgesics|mesh-ancestor
43584739|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
43584740|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584741|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43584742|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43584743|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43584744|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
43584745|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584746|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584747|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
43584748|NCT03426462|Propofol|propofol|mesh-list
43584749|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43584750|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584751|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584752|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43584753|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
43584754|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
43584755|NCT03426202|Modafinil|modafinil|mesh-list
43584756|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43584757|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584758|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43584759|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43584760|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43584761|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584762|NCT03426176|Oxytocin|oxytocin|mesh-list
43584763|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
43584764|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43584765|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584766|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43584767|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43584768|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587407|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
43584769|NCT03426085|Liraglutide|liraglutide|mesh-list
43584770|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43584771|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584772|NCT03426085|Incretins|incretins|mesh-ancestor
43584773|NCT03426085|Hormones|hormones|mesh-ancestor
43584774|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43584775|NCT03426033|Warfarin|warfarin|mesh-list
43584776|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
43584777|NCT03426020|Midazolam|midazolam|mesh-list
43584778|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43584779|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43584780|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677180|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
43677181|NCT02869815|Methylene Blue|methylene blue|mesh-list
43677182|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677183|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677184|NCT02869763|Ethanol|ethanol|mesh-list
43677185|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43677186|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677187|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677188|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677189|NCT02869672|Vaccines|vaccines|mesh-list
43677190|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
43677191|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677192|NCT02869347|Complement C1s|complement c1s|mesh-list
43677193|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43677194|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43677195|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
43677196|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677197|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43677198|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677199|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
43584781|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584782|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43584783|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43584805|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43584806|NCT03425929|Oxytocin|oxytocin|mesh-list
43584807|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
43584808|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43584809|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584810|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
43584811|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
43584812|NCT03425747|Calcium|calcium|mesh-list
43584813|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43584814|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584815|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43678816|NCT02858206|Nedaplatin|nedaplatin|mesh-list
43678817|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43584816|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584817|NCT03425747|Antacids|antacids|mesh-ancestor
43584818|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43584819|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
43584820|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43584821|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584822|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584823|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584824|NCT03425734|Analgesics|analgesics|mesh-ancestor
43584825|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
43584826|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584827|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43584828|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43584829|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43677200|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43677201|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677202|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
43677203|NCT02869204|Ascorbic Acid|ascorbic acid|mesh-list
43677204|NCT02869204|Vitamins|vitamins|mesh-ancestor
43678839|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678840|NCT02857712|Axitinib|axitinib|mesh-list
43678843|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677205|NCT02869204|Micronutrients|micronutrients|mesh-ancestor
43677206|NCT02869204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677207|NCT02869204|Antioxidants|antioxidants|mesh-ancestor
43677208|NCT02869204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677209|NCT02869204|Protective Agents|protective agents|mesh-ancestor
43677210|NCT02869321|Fentanyl|fentanyl|mesh-list
43677211|NCT02869321|Morphine|morphine|mesh-list
43677212|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43677213|NCT02869321|Narcotics|narcotics|mesh-ancestor
43677214|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677215|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677216|NCT02869321|Analgesics|analgesics|mesh-ancestor
43677217|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
43677218|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677219|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43677220|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43677221|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
43677222|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
43677223|NCT02869165|Estrogens|estrogens|mesh-list
43677224|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43677225|NCT02869165|Hormones|hormones|mesh-ancestor
43677229|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43584832|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584833|NCT03425708|Febuxostat|febuxostat|mesh-list
43584834|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
43584835|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43584836|NCT03425669|Methylphenidate|methylphenidate|mesh-list
43584837|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43678888|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584838|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584840|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43584841|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43584842|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584843|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
43584844|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677230|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677231|NCT02869100|Listerine|listerine|mesh-list
43677232|NCT02869100|Fluorides|fluorides|mesh-list
43677233|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
43677234|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
43677235|NCT02869100|Protective Agents|protective agents|mesh-ancestor
43677236|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677237|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43677238|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677239|NCT02868944|Sufentanil|sufentanil|mesh-list
43677240|NCT02868944|Morphine|morphine|mesh-list
43677241|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
43677242|NCT02868944|Anesthetics|anesthetics|mesh-list
43677243|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
43677244|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43677245|NCT02868944|Narcotics|narcotics|mesh-ancestor
43677246|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677247|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677248|NCT02868944|Analgesics|analgesics|mesh-ancestor
43587641|NCT03393949|Hormones|hormones|mesh-ancestor
43677249|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
43677250|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677251|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43584845|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
43584847|NCT03425656|Doxorubicin|doxorubicin|mesh-list
43584848|NCT03425656|Trastuzumab|trastuzumab|mesh-list
43584849|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43584850|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
43584851|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584852|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43584853|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43584854|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
43584855|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584857|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43584858|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
43677252|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43677253|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
43677254|NCT02868931|Insulin|insulin|mesh-list
43677255|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43677256|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677257|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
43677258|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43587678|NCT03393715|Perindopril|perindopril|mesh-list
43677259|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
43677260|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677261|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
43677262|NCT02868749|Protective Agents|protective agents|mesh-ancestor
43677263|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43677265|NCT02869035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43677266|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43677267|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43677268|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677270|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
43677271|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677272|NCT02869035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43677273|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
43677274|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43584859|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
43584860|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
43584861|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43584862|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43584863|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43584864|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584865|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43584866|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
43584867|NCT03425617|Olodaterol|olodaterol|mesh-list
43584868|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43584869|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
43584870|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584871|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584872|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43584873|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
43584874|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
43584875|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43584876|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
43584877|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584878|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584879|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43584880|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43584881|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43584882|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584883|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584884|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43584885|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43677275|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677276|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43677278|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
43677279|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
43677280|NCT02868996|Kallikreins|kallikreins|mesh-list
43677281|NCT02868996|Coagulants|coagulants|mesh-ancestor
43677282|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
43677283|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
43677284|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43677285|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677286|NCT02868814|Pregabalin|pregabalin|mesh-list
43587792|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587796|NCT03393117|Analgesics|analgesics|mesh-ancestor
43677287|NCT02868814|Analgesics|analgesics|mesh-ancestor
43677288|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
43677289|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677290|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677291|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
43677292|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43677293|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43677294|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677329|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
43677331|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
43677332|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677333|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43677334|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43677335|NCT02868606|Insulin|insulin|mesh-list
43677336|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43677337|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43677338|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677339|NCT02868385|Praziquantel|praziquantel|mesh-list
43677340|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
43677341|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43677342|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677343|NCT02868632|Durvalumab|durvalumab|mesh-list
43677344|NCT02868632|Tremelimumab|tremelimumab|mesh-list
43677345|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43587813|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43587814|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
43587815|NCT03392961|Insulin|insulin|mesh-list
43587816|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43587817|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587818|NCT03392909|Gentamicins|gentamicins|mesh-list
43587819|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43587820|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587821|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43587822|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587823|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587824|NCT03392792|Plasminogen|plasminogen|mesh-list
43587825|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43587826|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43587827|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43587828|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587829|NCT03392740|Lisinopril|lisinopril|mesh-list
43587830|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43587831|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
43587832|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587833|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587834|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43587835|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43587836|NCT03392740|Protective Agents|protective agents|mesh-ancestor
43677348|NCT02868372|Povidone|povidone|mesh-list
43677387|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
43677388|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
43677389|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43677390|NCT02867930|Analgesics|analgesics|mesh-ancestor
43677391|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
43677392|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677393|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43677394|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43677395|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43677396|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
43677397|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677398|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677399|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43677400|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43584886|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43584887|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
43584888|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584889|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584890|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43587840|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
43587841|NCT03392623|Tretinoin|tretinoin|mesh-list
43587842|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
43587843|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587844|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
43587845|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
43587846|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43587847|NCT03392623|Protective Agents|protective agents|mesh-ancestor
43587848|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587849|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
43587850|NCT03392623|Vitamins|vitamins|mesh-ancestor
43587851|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
43587852|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43587853|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
43587854|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587855|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43587856|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
43587857|NCT03392571|Gemcitabine|gemcitabine|mesh-list
43587858|NCT03392571|Paclitaxel|paclitaxel|mesh-list
43587859|NCT03392571|Cisplatin|cisplatin|mesh-list
43587860|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43587861|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587862|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
43584891|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43584892|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
43584893|NCT03425474|Propofol|propofol|mesh-list
43584894|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43584895|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584896|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584897|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43584898|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
43584899|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
43584900|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43584901|NCT03425461|Nivolumab|nivolumab|mesh-list
43584902|NCT03425461|Ipilimumab|ipilimumab|mesh-list
43584903|NCT03425461|Antibodies|antibodies|mesh-list
43584904|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
43584905|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43584906|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
43584907|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584908|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584909|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43584920|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584921|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584922|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
43584923|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584924|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43584925|NCT03425162|Narcotics|narcotics|mesh-ancestor
43584926|NCT03425162|Analgesics|analgesics|mesh-ancestor
43584927|NCT03425084|Morphine|morphine|mesh-list
43584928|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43584929|NCT03425084|Narcotics|narcotics|mesh-ancestor
43584930|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584931|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584932|NCT03425084|Analgesics|analgesics|mesh-ancestor
43587887|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43587888|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587889|NCT03392051|Clopidogrel|clopidogrel|mesh-list
43587890|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43587891|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43679010|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
43679011|NCT02857062|Emollients|emollients|mesh-list
43679012|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
43679013|NCT02857166|Antibodies|antibodies|mesh-list
43679014|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43679015|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
43679016|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679017|NCT02856932|Methamphetamine|methamphetamine|mesh-list
43679018|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43679019|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679020|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
43679021|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
43679022|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679027|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43679028|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43679029|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43677401|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43677402|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
43679030|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43679031|NCT02856867|Leucovorin|leucovorin|mesh-list
43677403|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43677404|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43677405|NCT02867904|Prednisolone|prednisolone|mesh-list
43677406|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
43679032|NCT02856867|Fluorouracil|fluorouracil|mesh-list
43679033|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
43677407|NCT02867904|Bupivacaine|bupivacaine|mesh-list
43677408|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43677409|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
43584954|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43584955|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43584956|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43584957|NCT03424876|Growth Substances|growth substances|mesh-ancestor
43679034|NCT02856867|Nintedanib|nintedanib|mesh-list
43679035|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
43584958|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584959|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
43584960|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43584961|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677423|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
43677424|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
43677425|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677426|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
43677427|NCT02867878|Adenosine|adenosine|mesh-list
43677428|NCT02867878|Analgesics|analgesics|mesh-ancestor
43677429|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
43677430|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677431|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677432|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43677433|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
43677434|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43677435|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
43677436|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
43677437|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677438|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677439|NCT02867917|Psyllium|psyllium|mesh-list
43677440|NCT02867917|Cathartics|cathartics|mesh-ancestor
43677441|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43679036|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677442|NCT02867566|Rituximab|rituximab|mesh-list
43677443|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43677444|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677445|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
43677446|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677447|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677448|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
43677449|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677454|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677455|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677456|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43677457|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43677458|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43677459|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
43677460|NCT02867553|Rituximab|rituximab|mesh-list
43677461|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43677462|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677463|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
43677464|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677465|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677466|NCT02867800|Acetaminophen|acetaminophen|mesh-list
43677467|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
43587913|NCT03391934|Antidotes|antidotes|mesh-ancestor
43677468|NCT02867800|Promethazine|promethazine|mesh-list
43677469|NCT02867800|Cyclosporine|cyclosporine|mesh-list
43677470|NCT02867800|Sirolimus|sirolimus|mesh-list
43677471|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
43677472|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
43677473|NCT02867800|Methotrexate|methotrexate|mesh-list
43584982|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
43584983|NCT03424733|Prednisone|prednisone|mesh-list
43584984|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43584985|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
43584986|NCT03424733|Hormones|hormones|mesh-ancestor
43584987|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43584988|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584989|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43584990|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585002|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43585003|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43585004|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585005|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43585006|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585007|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43585008|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43585009|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585010|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
43585011|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
43585012|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
43585013|NCT03424629|Methotrexate|methotrexate|mesh-list
43585014|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43585015|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
43585017|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585018|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43585019|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
43587954|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
43585020|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585021|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585022|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
43585023|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585024|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43585025|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585026|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
43585027|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677474|NCT02867800|Fludarabine|fludarabine|mesh-list
43677475|NCT02867800|Melphalan|melphalan|mesh-list
43677476|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
43677477|NCT02867800|Abatacept|abatacept|mesh-list
43677478|NCT02867800|Thiotepa|thiotepa|mesh-list
43677479|NCT02867800|Meperidine|meperidine|mesh-list
43677480|NCT02867800|Tacrolimus|tacrolimus|mesh-list
43677481|NCT02867800|Cyclosporins|cyclosporins|mesh-list
43677482|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
43677483|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43677484|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
43677485|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43677486|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677487|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43677488|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
43677489|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677490|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677491|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
43677492|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677493|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43585028|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43585029|NCT03424473|Tucatinib|tucatinib|mesh-list
43585030|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679066|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43679067|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43585031|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43588020|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
43585032|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585033|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585034|NCT03424408|Aspirin|aspirin|mesh-list
43588021|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43679074|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
43679075|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43679076|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
43679077|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43679078|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43679079|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43827957|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827958|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827959|NCT05483894|Atorvastatin|atorvastatin|mesh-list
43827960|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43585035|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43585036|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585037|NCT03424408|Analgesics|analgesics|mesh-ancestor
43585038|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
43585039|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827961|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43827962|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
43827963|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588022|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588023|NCT03391050|Dabrafenib|dabrafenib|mesh-list
43588024|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588025|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43588026|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588027|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588028|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
43588029|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43585040|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585041|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585042|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585043|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43585044|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43585045|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585046|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43585047|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43585048|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585049|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
43585050|NCT03424356|Fentanyl|fentanyl|mesh-list
43585051|NCT03424356|Narcotics|narcotics|mesh-list
43585052|NCT03424356|Analgesics|analgesics|mesh-list
43585053|NCT03424356|Bromides|bromides|mesh-list
43585054|NCT03424356|Propofol|propofol|mesh-list
43585055|NCT03424356|Rocuronium|rocuronium|mesh-list
43585056|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43585057|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585058|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585059|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43588032|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43588033|NCT03390972|Analgesics|analgesics|mesh-ancestor
43588034|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
43588035|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585060|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
43585062|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43585063|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
43585064|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585065|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43677494|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677495|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
43677496|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677497|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43677498|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43677500|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677501|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43677503|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
43677504|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677505|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
43677506|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43677507|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43677508|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
43677509|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43677556|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43677557|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43677558|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677559|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677560|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43677561|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677571|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
43585066|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
43585067|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43585068|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43585069|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43585070|NCT03424291|Apatinib|apatinib|mesh-list
43585071|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585072|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43585073|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585074|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585075|NCT03424226|Acetazolamide|acetazolamide|mesh-list
43585076|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
43585077|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43585078|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585079|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588065|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827966|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585080|NCT03424226|Diuretics|diuretics|mesh-ancestor
43585081|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
43585082|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585083|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
43585084|NCT03424135|Promethazine|promethazine|mesh-list
43585085|NCT03424135|Naproxen|naproxen|mesh-list
43585086|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43585087|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585088|NCT03424135|Analgesics|analgesics|mesh-ancestor
43585089|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
43585090|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585091|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585092|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585093|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585094|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
43585095|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43585096|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585097|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585098|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43585099|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43585100|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585101|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
43585102|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
43585103|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
43585104|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
43585105|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43585106|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43677572|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677573|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677574|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
43677575|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677576|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43677577|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677578|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
43677579|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43679119|NCT02856568|Cisplatin|cisplatin|mesh-list
43677580|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43677581|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
43677583|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677584|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43679129|NCT02856568|Immunologic Factors|immunologic factors|mesh-ancestor
43588143|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43588144|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43588145|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43588147|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43588148|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588149|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
43588150|NCT03390374|Ionophores|ionophores|mesh-ancestor
43588151|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43588152|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677585|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43588153|NCT03390062|Apatinib|apatinib|mesh-list
43677586|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43677587|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677588|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827807|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43827808|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43588154|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588155|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43588156|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588157|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827809|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43827810|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43827811|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827812|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
43827813|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827814|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827815|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43827816|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827817|NCT05485103|Glycerol|glycerol|mesh-list
43827818|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43827819|NCT05485103|Protective Agents|protective agents|mesh-ancestor
43827820|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827821|NCT05485064|Fentanyl|fentanyl|mesh-list
43677593|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677594|NCT02867124|Naltrexone|naltrexone|mesh-list
43677595|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43677596|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43677597|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677598|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
43588158|NCT03390036|Triamcinolone|triamcinolone|mesh-list
43588159|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43588160|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43588161|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43588164|NCT03390036|Hormones|hormones|mesh-ancestor
43588167|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677599|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677600|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
43677601|NCT02867332|Interleukin-2|interleukin-2|mesh-list
43677602|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588168|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
43588169|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588170|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588171|NCT03389958|Copper|copper|mesh-list
43588172|NCT03389958|Trace Elements|trace elements|mesh-ancestor
43588173|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
43588174|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588175|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43677603|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
43588176|NCT03389776|Anesthetics|anesthetics|mesh-list
43677604|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677605|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677606|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43677607|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
43677608|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677609|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585107|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
43585108|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
43585109|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585110|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43585111|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
43585112|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
43585113|NCT03423849|Gemcitabine|gemcitabine|mesh-list
43585114|NCT03423849|Cisplatin|cisplatin|mesh-list
43585115|NCT03423849|Capecitabine|capecitabine|mesh-list
43585116|NCT03423849|Vinorelbine|vinorelbine|mesh-list
43585117|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585118|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43585119|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
43585120|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585121|NCT03423849|Antiviral Agents|antiviral agents|mesh-ancestor
43585122|NCT03423849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585123|NCT03423849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585124|NCT03423849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585125|NCT03423849|Immunologic Factors|immunologic factors|mesh-ancestor
43585126|NCT03423849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585127|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43585128|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
43585129|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
43585130|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
43585132|NCT03423823|Aflibercept|aflibercept|mesh-list
43585133|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585135|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43585136|NCT03423823|Growth Substances|growth substances|mesh-ancestor
43585137|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585138|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
43585139|NCT03423810|Hydralazine|hydralazine|mesh-list
43585140|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43585141|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
43585142|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43585143|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
43585144|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43585145|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
43585146|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585147|NCT03423667|Expectorants|expectorants|mesh-ancestor
43585148|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
43585149|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43585150|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
43677611|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43677612|NCT02867332|Analgesics|analgesics|mesh-ancestor
43677613|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
43677614|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677615|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
43677616|NCT02867345|Interleukin-2|interleukin-2|mesh-list
43677617|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677618|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
43677619|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677620|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677621|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43677622|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
43677623|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588199|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679130|NCT02856568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679131|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43679132|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
43588200|NCT03389490|Insulin|insulin|mesh-list
43588201|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43588202|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
43588203|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
43588204|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
43588205|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
43588206|NCT03389490|Protamines|protamines|mesh-list
43588231|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43588232|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
43588233|NCT03389295|Cisplatin|cisplatin|mesh-list
43588234|NCT03389295|Docetaxel|docetaxel|mesh-list
43588235|NCT03389295|Fluorouracil|fluorouracil|mesh-list
43677624|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677625|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43677626|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585151|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585152|NCT03423667|Protective Agents|protective agents|mesh-ancestor
43585153|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585154|NCT03423667|Antidotes|antidotes|mesh-ancestor
43585155|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43588236|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585156|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43585157|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585158|NCT03423472|Vitamin A|vitamin a|mesh-list
43585159|NCT03423472|Vitamins|vitamins|mesh-ancestor
43588237|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
43588238|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
43588239|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
43588240|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588241|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
43588242|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43585160|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
43585161|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585162|NCT03423329|Ibuprofen|ibuprofen|mesh-list
43585163|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43585164|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585165|NCT03423329|Analgesics|analgesics|mesh-ancestor
43585166|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
43585167|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585168|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585169|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588243|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585170|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585171|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43585172|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585173|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585174|NCT03423225|Tacrolimus|tacrolimus|mesh-list
43585175|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585176|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
43585177|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585178|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43588244|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
43585179|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585180|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585181|NCT03423030|Macozinone|macozinone|mesh-list
43585182|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
43585183|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43585184|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585185|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
43585186|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43585187|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585188|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585189|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585190|NCT03422978|Analgesics|analgesics|mesh-ancestor
43677627|NCT02867345|Analgesics|analgesics|mesh-ancestor
43677628|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
43677629|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677630|NCT02866903|Bevacizumab|bevacizumab|mesh-list
43677631|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
43677632|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43677633|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679141|NCT02856178|Caspofungin|caspofungin|mesh-list
43677634|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43677635|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43677636|NCT02866903|Growth Substances|growth substances|mesh-ancestor
43677637|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677638|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
43677639|NCT02867046|Dexamethasone|dexamethasone|mesh-list
43677640|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677641|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
43677642|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
43677643|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588309|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679144|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677644|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677645|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43677646|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
43677647|NCT02867046|Hormones|hormones|mesh-ancestor
43677648|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677649|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43677650|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677651|NCT02867020|Prednisone|prednisone|mesh-list
43677652|NCT02867020|Goserelin|goserelin|mesh-list
43585191|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
43585192|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585193|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43585194|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43585195|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43585196|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
43585197|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585198|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585199|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
43585200|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
43585201|NCT03422887|Nalbuphine|nalbuphine|mesh-list
43585202|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43585204|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585205|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585206|NCT03422887|Analgesics|analgesics|mesh-ancestor
43585207|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
43585208|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585225|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43585226|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
43585227|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585228|NCT03422796|Cilostazol|cilostazol|mesh-list
43585229|NCT03422796|Sumatriptan|sumatriptan|mesh-list
43585230|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43677653|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677654|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
43677655|NCT02867020|Hormones|hormones|mesh-ancestor
43677656|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677657|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677658|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43677659|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677660|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
43677661|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677662|NCT02866955|Tamoxifen|tamoxifen|mesh-list
43677663|NCT02866955|Estramustine|estramustine|mesh-list
43677664|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43677665|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
43677666|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677667|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677668|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43677669|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677670|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43677671|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43677672|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43677673|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43677674|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
43677675|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677676|NCT02866786|Metformin|metformin|mesh-list
43677677|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
43585231|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
43585232|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585233|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585234|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43585235|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
43585236|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43585237|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43588466|NCT03387644|Analgesics|analgesics|mesh-ancestor
43585238|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585239|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43585240|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
43585241|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43585242|NCT03422796|Protective Agents|protective agents|mesh-ancestor
43585243|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43585244|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43585245|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585246|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43585247|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43585248|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43585249|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
43585250|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585251|NCT03422640|Apremilast|apremilast|mesh-list
43677678|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43677679|NCT02866786|Estradiol|estradiol|mesh-list
43677680|NCT02866786|Cyproterone|cyproterone|mesh-list
43677681|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43677682|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677683|NCT02866786|Estrogens|estrogens|mesh-ancestor
43677684|NCT02866786|Hormones|hormones|mesh-ancestor
43677685|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677686|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43677687|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
43677688|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43677689|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43677690|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43677691|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43677692|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
43677694|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677695|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43679261|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43679262|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
43679263|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43679264|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679265|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43588505|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
43588506|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
43588507|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
43588508|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588509|NCT03387566|Growth Substances|growth substances|mesh-ancestor
43588510|NCT03387241|Fluticasone|fluticasone|mesh-list
43588511|NCT03387241|Xhance|xhance|mesh-list
43588512|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
43588513|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43588514|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43677696|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
43677697|NCT02866409|Bupivacaine|bupivacaine|mesh-list
43677698|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
43677699|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
43677700|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677701|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677702|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
43588515|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588516|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43588517|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
43677703|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677704|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43677705|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43677706|NCT02866409|Analgesics|analgesics|mesh-ancestor
43677707|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43677708|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43677709|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43677710|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
43585252|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43585253|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585254|NCT03422640|Analgesics|analgesics|mesh-ancestor
43585255|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
43585256|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585257|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585258|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585259|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585260|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43677711|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677712|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677714|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
43677715|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677717|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43677718|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43677719|NCT02866448|Analgesics|analgesics|mesh-ancestor
43677720|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
43677721|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677722|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677723|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598893|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
43677724|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677725|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43677726|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43585261|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43585262|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585263|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585264|NCT03422575|Etoricoxib|etoricoxib|mesh-list
43585265|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43585266|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585267|NCT03422575|Analgesics|analgesics|mesh-ancestor
43585278|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585279|NCT03422445|Temozolomide|temozolomide|mesh-list
43585280|NCT03422445|Apatinib|apatinib|mesh-list
43585281|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43585282|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
43585283|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585284|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585285|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43585286|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585287|NCT03422419|Heparin|heparin|mesh-list
43585288|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
43585289|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43585290|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43585291|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585292|NCT03422406|Iodine|iodine|mesh-list
43585293|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43585294|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585295|NCT03422406|Trace Elements|trace elements|mesh-ancestor
43585296|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
43585297|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585298|NCT03422393|Venetoclax|venetoclax|mesh-list
43585299|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585300|NCT03422315|Propofol|propofol|mesh-list
43585301|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43585302|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585303|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585304|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43585305|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
43585306|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
43585307|NCT03422289|Folic Acid|folic acid|mesh-list
43585308|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
43585309|NCT03422289|Inositol|inositol|mesh-list
43585310|NCT03422289|Hematinics|hematinics|mesh-ancestor
43585311|NCT03422289|Vitamins|vitamins|mesh-ancestor
43677727|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677728|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43677729|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43677730|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677732|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
43677733|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677734|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
43677735|NCT02866435|Protective Agents|protective agents|mesh-ancestor
43677736|NCT02866370|Paclitaxel|paclitaxel|mesh-list
43585312|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
43585313|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585314|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
43585315|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43585316|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585317|NCT03422055|Fucoidan|fucoidan|mesh-list
43585318|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43585319|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43585320|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
43585321|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585322|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43585323|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43585324|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585325|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
43585326|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43585327|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43585328|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585329|NCT03421990|Anesthetics|anesthetics|mesh-list
43585330|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585331|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585332|NCT03421860|Phenylephrine|phenylephrine|mesh-list
43585333|NCT03421860|Epinephrine|epinephrine|mesh-list
43585334|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
43585335|NCT03421860|Ephedrine|ephedrine|mesh-list
43585338|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43585339|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43585340|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
43585341|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585342|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585343|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585344|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43585345|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43585346|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
43585347|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588606|NCT03386838|Cetuximab|cetuximab|mesh-list
43588607|NCT03386838|Linrodostat|linrodostat|mesh-list
43585348|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43585349|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
43585350|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
43585351|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
43585352|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43585353|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
43585354|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43585355|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
43585356|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
43585357|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43585358|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
43585359|NCT03421860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43585360|NCT03421860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43585361|NCT03421860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585362|NCT03421860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43585363|NCT03421860|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43585364|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43585365|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
43585366|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43585367|NCT03421860|Protective Agents|protective agents|mesh-ancestor
43677737|NCT02866370|Carboplatin|carboplatin|mesh-list
43677738|NCT02866370|Doxorubicin|doxorubicin|mesh-list
43677740|NCT02866370|Topotecan|topotecan|mesh-list
43677741|NCT02866370|Nintedanib|nintedanib|mesh-list
43677742|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43677743|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677744|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
43677745|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
43677746|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
43677747|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677748|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43677749|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43677750|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43677751|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677752|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43677753|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43677754|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43588683|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43588684|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43588685|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677755|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43677756|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
43677757|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677758|NCT02866396|Pregabalin|pregabalin|mesh-list
43677759|NCT02866396|Analgesics|analgesics|mesh-ancestor
43677760|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
43677761|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677762|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585368|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43585369|NCT03421821|Ropivacaine|ropivacaine|mesh-list
43585370|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
43588686|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588687|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588694|NCT03386149|Loxoprofen|loxoprofen|mesh-list
43585371|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
43585372|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585373|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585374|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
43585375|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585376|NCT03421743|Molgramostim|molgramostim|mesh-list
43585377|NCT03421743|Sargramostim|sargramostim|mesh-list
43585378|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585379|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
43585380|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585381|NCT03421717|Chitosan|chitosan|mesh-list
43585382|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43585383|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43585384|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
43585385|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585386|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43585387|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
43585388|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
43585389|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
43585390|NCT03421717|Coagulants|coagulants|mesh-ancestor
43585391|NCT03421496|Cannabidiol|cannabidiol|mesh-list
43677764|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43677765|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43677766|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677767|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43677768|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43677769|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43677770|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677771|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43677772|NCT02866136|Carboplatin|carboplatin|mesh-list
43677773|NCT02866136|Etoposide|etoposide|mesh-list
43677774|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
43677775|NCT02866136|Melphalan|melphalan|mesh-list
43677776|NCT02866136|Vincristine|vincristine|mesh-list
43677777|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677778|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43677779|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43677780|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43677781|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677782|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677783|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43677784|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
43677785|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43588723|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
43677786|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43677787|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
43677788|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677789|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
43677790|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
43677791|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
43677792|NCT02865824|Aspirin|aspirin|mesh-list
43677793|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43588755|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588756|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
43588757|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677794|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585392|NCT03421496|Vigabatrin|vigabatrin|mesh-list
43585393|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
43588758|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588759|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
43588760|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43588761|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588762|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43588765|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43588766|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
43588767|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585394|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585395|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585396|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
43588768|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588769|NCT03385382|Dexamethasone|dexamethasone|mesh-list
43588770|NCT03385382|Ranibizumab|ranibizumab|mesh-list
43588771|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588772|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
43588773|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
43588774|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588775|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588776|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43585397|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585398|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585399|NCT03421366|Posaconazole|posaconazole|mesh-list
43585400|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
43585401|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677795|NCT02865824|Analgesics|analgesics|mesh-ancestor
43677796|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
43677797|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677798|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677799|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677800|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677801|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43677802|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43588777|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
43679317|NCT02854761|Vitamin D|vitamin d|mesh-list
43679319|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
43679320|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679321|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43679322|NCT02854748|Empagliflozin|empagliflozin|mesh-list
43679323|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43679324|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679325|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43679326|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679327|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43679328|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43679329|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43677803|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677804|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43677805|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43677806|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677807|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
43677808|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
43677809|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43677810|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679330|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679331|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
43677811|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43677812|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43679332|NCT02854722|Vitamin D|vitamin d|mesh-list
43677813|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43677814|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43677816|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
43677817|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677818|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
43585402|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43585403|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43585404|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43585405|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43585406|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43585407|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585408|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585409|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43585410|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
43585411|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43585412|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585414|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
43585415|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585416|NCT03421314|Protective Agents|protective agents|mesh-ancestor
43585417|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585418|NCT03421314|Trace Elements|trace elements|mesh-ancestor
43585419|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
43585420|NCT03421275|Fentanyl|fentanyl|mesh-list
43585421|NCT03421275|Esketamine|esketamine|mesh-list
43585422|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43585423|NCT03421275|Narcotics|narcotics|mesh-ancestor
43585424|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585425|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585426|NCT03421275|Analgesics|analgesics|mesh-ancestor
43585427|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
43585428|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585429|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43677819|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43677820|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677821|NCT02865733|Treprostinil|treprostinil|mesh-list
43677822|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43677823|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
43677824|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43677825|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
43677826|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677827|NCT02865629|Expectorants|expectorants|mesh-ancestor
43677828|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
43677829|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43677830|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
43677831|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677832|NCT02865629|Protective Agents|protective agents|mesh-ancestor
43677843|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43677844|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677845|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43677846|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
43677847|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677848|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677849|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43588781|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677850|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
43677851|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43677852|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43677853|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43677854|NCT02865642|Citalopram|citalopram|mesh-list
43585432|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
43585433|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
43585434|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43585435|NCT03421119|Insulin|insulin|mesh-list
43585436|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43585437|NCT03421119|Metformin|metformin|mesh-list
43585438|NCT03421119|Liraglutide|liraglutide|mesh-list
43585439|NCT03421119|Secretagogues|secretagogues|mesh-list
43585440|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43585441|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585442|NCT03421119|Incretins|incretins|mesh-ancestor
43585444|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43585445|NCT03421002|Micafungin|micafungin|mesh-list
43585446|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
43585447|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585448|NCT03420937|Atropine|atropine|mesh-list
43585449|NCT03420937|Neostigmine|neostigmine|mesh-list
43585450|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43585451|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43677855|NCT02865642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43677856|NCT02865642|Serotonin|serotonin|mesh-list
43677857|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43677858|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43677859|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677860|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677861|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
43677862|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677863|NCT02865642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43677864|NCT02865642|Antidepressive Agents|antidepressive agents|mesh-ancestor
43677865|NCT02865642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43677866|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43827824|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827825|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827826|NCT05485064|Analgesics|analgesics|mesh-ancestor
43827827|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
43827828|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827829|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43827830|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43827831|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
43827832|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
43588859|NCT03384862|Hematinics|hematinics|mesh-ancestor
43827833|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
43588860|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
43588861|NCT03384524|Metoprolol|metoprolol|mesh-list
43588862|NCT03384524|Bromocriptine|bromocriptine|mesh-list
43588863|NCT03384524|Tamsulosin|tamsulosin|mesh-list
43588864|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43588865|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43588866|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
43588867|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
43827834|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43827835|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43827836|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827837|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
43585452|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43585453|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
43585468|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43585469|NCT03420911|Midazolam|midazolam|mesh-list
43585470|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43588868|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588869|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588870|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43588871|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43588872|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43588873|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
43588874|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588875|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588876|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43588877|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43585471|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43585472|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585473|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585474|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43585475|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43585476|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43585477|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43585478|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
43585479|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
43585480|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
43585481|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
43585482|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585483|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585484|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43585485|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827838|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
43827839|NCT05484817|Hormones|hormones|mesh-list
43827840|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827841|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827842|NCT05484687|Anesthetics|anesthetics|mesh-list
43827843|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827844|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827845|NCT05484648|Dexamethasone|dexamethasone|mesh-list
43827846|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
43827847|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827848|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
43827849|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
43585486|NCT03420911|Analgesics|analgesics|mesh-ancestor
43585487|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
43585488|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585489|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585490|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585492|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
43585493|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
43585494|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585495|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585511|NCT03420703|Morphine|morphine|mesh-list
43585512|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43585513|NCT03420703|Narcotics|narcotics|mesh-ancestor
43585514|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588885|NCT03384511|Apatinib|apatinib|mesh-list
43588886|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588887|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43588888|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588889|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679339|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679341|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43585515|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679390|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43679391|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
43679392|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679393|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679394|NCT02854072|Antiviral Agents|antiviral agents|mesh-ancestor
43679395|NCT02854072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679396|NCT02854072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679397|NCT02854072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585516|NCT03420703|Analgesics|analgesics|mesh-ancestor
43585539|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43585540|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
43585541|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43585542|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
43585543|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
43585544|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585545|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585546|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585547|NCT03420586|Analgesics|analgesics|mesh-ancestor
43585548|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
43585549|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585550|NCT03420534|Iloperidone|iloperidone|mesh-list
43585551|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43585552|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43585553|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585554|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585555|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43585556|NCT03420469|Bupropion|bupropion|mesh-list
43585557|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43585558|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
43585559|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43585560|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43585561|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43585562|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43585563|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585564|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
43585565|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585566|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585567|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43585568|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43585569|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585570|NCT03420378|Vitamin D|vitamin d|mesh-list
43827850|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827851|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827852|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43827853|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
43827854|NCT05484648|Hormones|hormones|mesh-ancestor
43827855|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827856|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827857|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827858|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43827859|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827860|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827861|NCT05484648|Analgesics|analgesics|mesh-ancestor
43827862|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
43827863|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43827864|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43827865|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43827866|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
43827867|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827868|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827869|NCT05484583|Cisplatin|cisplatin|mesh-list
43827870|NCT05484583|Carboplatin|carboplatin|mesh-list
43827871|NCT05484583|Etoposide|etoposide|mesh-list
43827872|NCT05484583|Durvalumab|durvalumab|mesh-list
43585571|NCT03420378|Vitamins|vitamins|mesh-ancestor
43585572|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
43585573|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585574|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43585575|NCT03420313|Buprenorphine|buprenorphine|mesh-list
43679415|NCT02853526|Warfarin|warfarin|mesh-list
43585576|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43585577|NCT03420313|Naloxone|naloxone|mesh-list
43585578|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43585579|NCT03420313|Narcotics|narcotics|mesh-ancestor
43585580|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585581|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585582|NCT03420313|Analgesics|analgesics|mesh-ancestor
43585583|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
43585584|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585585|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43585586|NCT03420144|Hormones|hormones|mesh-list
43585587|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43585588|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585589|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
43585590|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43585591|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585592|NCT03419975|Latanoprost|latanoprost|mesh-list
43585593|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43585594|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43585595|NCT03419949|Pregabalin|pregabalin|mesh-list
43585596|NCT03419949|Lamotrigine|lamotrigine|mesh-list
43585597|NCT03419949|Analgesics|analgesics|mesh-ancestor
43585599|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827873|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43827874|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827875|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43827876|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43827877|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43827878|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827879|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827880|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43827881|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
43827882|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827883|NCT05484557|Enoxaparin|enoxaparin|mesh-list
43585600|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585601|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
43585602|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43585603|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43585604|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585605|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43588985|NCT03383367|TEMPO|tempo|mesh-list
43589031|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589033|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589034|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589035|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43589038|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585606|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43585607|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43585608|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585609|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43585610|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43585611|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43585613|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
43585614|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
43585615|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43585616|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
43585617|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
43585618|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585619|NCT03419910|Cyclosporine|cyclosporine|mesh-list
43585620|NCT03419910|BMS-986165|bms-986165|mesh-list
43585621|NCT03419910|Cyclosporins|cyclosporins|mesh-list
43585622|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585623|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585624|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585625|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
43585626|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585627|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
43585628|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585630|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585631|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43585632|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43585634|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43585635|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585636|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
43585637|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585638|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43585639|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43585640|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
43585641|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585642|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43585643|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43585652|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585653|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585654|NCT03419715|Bimatoprost|bimatoprost|mesh-list
43585655|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43585656|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43827884|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
43827885|NCT05484557|Apixaban|apixaban|mesh-list
43827886|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
43827887|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43827888|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43827889|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827890|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43827891|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
43677868|NCT02865668|Canagliflozin|canagliflozin|mesh-list
43677869|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43677870|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677871|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43585657|NCT03419650|Hormones|hormones|mesh-ancestor
43639138|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585658|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589060|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585659|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585661|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
43585662|NCT03419624|Exenatide|exenatide|mesh-list
43585663|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43585664|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585665|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43585666|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585667|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43585668|NCT03419624|Incretins|incretins|mesh-ancestor
43585669|NCT03419624|Hormones|hormones|mesh-ancestor
43585670|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43585671|NCT03419559|Durvalumab|durvalumab|mesh-list
43585672|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43585673|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585674|NCT03419494|Doxorubicin|doxorubicin|mesh-list
43585675|NCT03419494|Daunorubicin|daunorubicin|mesh-list
43585676|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43585678|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585679|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43585680|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43585681|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585682|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585683|NCT03419442|Docetaxel|docetaxel|mesh-list
43585684|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585685|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
43585686|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
43585687|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
43585688|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585689|NCT03419429|Simvastatin|simvastatin|mesh-list
43585690|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43585691|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43585692|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
43585693|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585694|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43585695|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43585696|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585697|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
43585698|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43585699|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585700|NCT03418974|Atorvastatin|atorvastatin|mesh-list
43585701|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43585702|NCT03418974|Pitavastatin|pitavastatin|mesh-list
43585703|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43585704|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43585705|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
43585706|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585707|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43677872|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677874|NCT02865564|Ampicillin|ampicillin|mesh-list
43677875|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43677876|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677877|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43677878|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677879|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677880|NCT02865616|Vancomycin|vancomycin|mesh-list
43677881|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43677882|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677883|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
43677884|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
43677885|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677886|NCT02865460|Vitamins|vitamins|mesh-ancestor
43677887|NCT02865369|Asunaprevir|asunaprevir|mesh-list
43677888|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
43677889|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677890|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677930|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43677931|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677932|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677933|NCT02865005|Dapsone|dapsone|mesh-list
43677934|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677935|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
43677936|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43677937|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43677938|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43677939|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677940|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677941|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
43677942|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43677943|NCT02864927|Vaccines|vaccines|mesh-list
43677944|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
43585708|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43585709|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585710|NCT03418935|Niacinamide|niacinamide|mesh-list
43585714|NCT03418935|Vitamins|vitamins|mesh-ancestor
43585715|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
43589183|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
43589208|NCT03381664|Quinidine|quinidine|mesh-list
43585716|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585717|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43585718|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
43585719|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585720|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43585721|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
43585722|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43585723|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43585724|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585725|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43585726|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43585727|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
43585728|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43585729|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585730|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43585731|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43585732|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43585733|NCT03418610|Azelaic acid|azelaic acid|mesh-list
43585734|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585735|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
43585736|NCT03418597|Anesthetics|anesthetics|mesh-list
43585737|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585738|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585739|NCT03418558|Trastuzumab|trastuzumab|mesh-list
43585740|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43585741|NCT03418558|Maytansine|maytansine|mesh-list
43585763|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585765|NCT03418337|Lansoprazole|lansoprazole|mesh-list
43585766|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
43585767|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43585768|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43585769|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43585770|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585771|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585772|NCT03418246|Calcium|calcium|mesh-list
43585773|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43585774|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585775|NCT03418090|Xenon|xenon|mesh-list
43585776|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43585777|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
43585778|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
43585779|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585780|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585781|NCT03417947|Vitamin D|vitamin d|mesh-list
43585782|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
43585783|NCT03417947|Vitamins|vitamins|mesh-ancestor
43585784|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
43585785|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585787|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43585790|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43679498|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
43679499|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679500|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679501|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43679502|NCT02852681|Diuretics|diuretics|mesh-ancestor
43679503|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
43679504|NCT02852694|Adalimumab|adalimumab|mesh-list
43679505|NCT02852694|Methotrexate|methotrexate|mesh-list
43679506|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
43679507|NCT02852694|Azathioprine|azathioprine|mesh-list
43585791|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585792|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
43585793|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
43585794|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
43585795|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585796|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43585797|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
43585798|NCT03417921|Antiviral Agents|antiviral agents|mesh-ancestor
43585799|NCT03417921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585800|NCT03417921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585801|NCT03417921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585802|NCT03417921|Immunologic Factors|immunologic factors|mesh-ancestor
43585803|NCT03417921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585805|NCT03417700|Vitamins|vitamins|mesh-ancestor
43679533|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
43679534|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679535|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679536|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679537|NCT02852577|Clonazepam|clonazepam|mesh-list
43679538|NCT02852577|Paroxetine|paroxetine|mesh-list
43679539|NCT02852577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43679540|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43679541|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43679543|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585806|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
43585807|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585808|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43585809|NCT03417648|Vitamin E|vitamin e|mesh-list
43585810|NCT03417648|Vitamins|vitamins|mesh-ancestor
43585811|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
43585812|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585813|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
43585814|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585815|NCT03417648|Protective Agents|protective agents|mesh-ancestor
43585816|NCT03417518|Propofol|propofol|mesh-list
43585817|NCT03417518|Desflurane|desflurane|mesh-list
43585818|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43585819|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585820|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585821|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43585822|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
43585823|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
43585824|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43585825|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43585826|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43677945|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677946|NCT02864849|Capecitabine|capecitabine|mesh-list
43677947|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
43677948|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43677949|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
43677950|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677951|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589343|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677953|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43677954|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43677955|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43677956|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
43677957|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
43677958|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677959|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677960|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677961|NCT02864758|Vitamin K|vitamin k|mesh-list
43677962|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
43677963|NCT02864758|Dabigatran|dabigatran|mesh-list
43677964|NCT02864758|Vitamins|vitamins|mesh-ancestor
43677965|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
43585828|NCT03417427|Decitabine|decitabine|mesh-list
43585829|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43585830|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
43585831|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585832|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585833|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
43585834|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585835|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585836|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
43585837|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589425|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
43585838|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589426|NCT03380039|Fludarabine|fludarabine|mesh-list
43589427|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43589428|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
43589429|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589430|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43589431|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43589432|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
43585839|NCT03417388|Aspirin|aspirin|mesh-list
43585840|NCT03417388|Losartan|losartan|mesh-list
43585841|NCT03417388|Lisinopril|lisinopril|mesh-list
43589433|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589434|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589435|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43585842|NCT03417388|Atorvastatin|atorvastatin|mesh-list
43585843|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43585844|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43589436|NCT03379987|Morphine|morphine|mesh-list
43589437|NCT03379987|Bupivacaine|bupivacaine|mesh-list
43585845|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585846|NCT03417388|Analgesics|analgesics|mesh-ancestor
43585847|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
43585848|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585849|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677966|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677967|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43677968|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
43589438|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
43677969|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43677970|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
43589440|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677971|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677972|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677973|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
43677974|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43677975|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43677976|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
43677977|NCT02864758|Coagulants|coagulants|mesh-ancestor
43677978|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
43677979|NCT02864784|Calcium|calcium|mesh-list
43677980|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43677981|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677982|NCT02864784|Antacids|antacids|mesh-ancestor
43677983|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677984|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43677985|NCT02864602|Dexamethasone|dexamethasone|mesh-list
43677986|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
43677987|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43677988|NCT02864602|BB 1101|bb 1101|mesh-list
43677989|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677991|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
43677992|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677993|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677994|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43677995|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
43677996|NCT02864602|Hormones|hormones|mesh-ancestor
43677997|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677998|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43678009|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678010|NCT02864550|Doxycycline|doxycycline|mesh-list
43678011|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43678012|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678013|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
43678014|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43678015|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43678016|NCT02864264|Interferons|interferons|mesh-list
43678017|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
43585850|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585851|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585852|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43585853|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43585854|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585855|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43585856|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43585857|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585858|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
43585859|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43679588|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589473|NCT03379103|Propofol|propofol|mesh-list
43585860|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43585861|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
43585862|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43585864|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43585865|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43585866|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43585867|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43585868|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43585869|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
43585870|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43585871|NCT03417388|Protective Agents|protective agents|mesh-ancestor
43585872|NCT03417206|Remifentanil|remifentanil|mesh-list
43585873|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43585874|NCT03417206|Narcotics|narcotics|mesh-ancestor
43585875|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585876|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585877|NCT03417206|Analgesics|analgesics|mesh-ancestor
43585878|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
43585879|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585880|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
43585881|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43585882|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585883|NCT03417037|Nivolumab|nivolumab|mesh-list
43585884|NCT03417037|Linrodostat|linrodostat|mesh-list
43585885|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43585886|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585887|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43585888|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585889|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585890|NCT03416777|Tocopherols|tocopherols|mesh-list
43585891|NCT03416777|Vitamin E|vitamin e|mesh-list
43585892|NCT03416777|Tocotrienols|tocotrienols|mesh-list
43585893|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
43585894|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
43585895|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585896|NCT03416777|Protective Agents|protective agents|mesh-ancestor
43589494|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585897|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585898|NCT03416777|Vitamins|vitamins|mesh-ancestor
43585899|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
43585900|NCT03416569|Prazosin|prazosin|mesh-list
43585901|NCT03416569|Nicotine|nicotine|mesh-list
43585902|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43585903|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
43585904|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585905|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585907|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43585908|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
43585909|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678018|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678020|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678021|NCT02864199|Ribavirin|ribavirin|mesh-list
43678022|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43678023|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
43678024|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678025|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
43678026|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678027|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
43678028|NCT02863861|Ketamine|ketamine|mesh-list
43678029|NCT02863861|Propofol|propofol|mesh-list
43678030|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43585910|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585911|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43585912|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43585913|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43585914|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43585915|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
43585916|NCT03416517|Irinotecan|irinotecan|mesh-list
43585917|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43585918|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43585919|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585920|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585921|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585922|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
43585923|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
43585924|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585925|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
43585926|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43585927|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585928|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43585929|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585930|NCT03416231|Docetaxel|docetaxel|mesh-list
43585931|NCT03416231|Apatinib|apatinib|mesh-list
43585932|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585933|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
43585934|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
43585935|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
43639139|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585936|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585937|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43585947|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43585948|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43585949|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585951|NCT03415802|Tegafur|tegafur|mesh-list
43585952|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43585953|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585954|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
43585955|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
43585956|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
43585957|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585958|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43585959|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
43585960|NCT03415763|Leucovorin|leucovorin|mesh-list
43585961|NCT03415763|Capecitabine|capecitabine|mesh-list
43585962|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
43585963|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43585964|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
43585965|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585966|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585967|NCT03415763|Antidotes|antidotes|mesh-ancestor
43678031|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678032|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678033|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43678034|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
43678035|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
43678036|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43678037|NCT02863861|Analgesics|analgesics|mesh-ancestor
43678038|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
43678039|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678040|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43678041|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43678042|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43678043|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678044|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678045|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678046|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43678047|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43678048|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43678049|NCT02864095|Epinephrine|epinephrine|mesh-list
43585968|NCT03415763|Protective Agents|protective agents|mesh-ancestor
43585969|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679652|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585971|NCT03415763|Vitamins|vitamins|mesh-ancestor
43585972|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
43585973|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
43585974|NCT03415750|Everolimus|everolimus|mesh-list
43585975|NCT03415750|Tacrolimus|tacrolimus|mesh-list
43585976|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43585977|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
43585978|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585979|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43585980|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585981|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585982|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585983|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43585984|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43585985|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
43585986|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43585987|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585988|NCT03415711|Mesalamine|mesalamine|mesh-list
43585989|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43585990|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585991|NCT03415711|Analgesics|analgesics|mesh-ancestor
43585992|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
43585993|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585994|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585995|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585996|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585997|NCT03415646|Morphine|morphine|mesh-list
43585998|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43585999|NCT03415646|Narcotics|narcotics|mesh-ancestor
43586000|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586001|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586002|NCT03415646|Analgesics|analgesics|mesh-ancestor
43586003|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
43589617|NCT03378297|Analgesics|analgesics|mesh-ancestor
43678050|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
43678051|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43678052|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43678053|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678054|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
43678056|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43678057|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43678058|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678059|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678060|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678062|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43678063|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
43678064|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678065|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43678066|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
43678067|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
43678068|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
43678069|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43678070|NCT02863835|Albuterol|albuterol|mesh-list
43678071|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43678072|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
43678073|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678074|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678075|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43678076|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
43678077|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
43678078|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43678079|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43678080|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43678081|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43678082|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586004|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586006|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43586007|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43589644|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43589646|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586009|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586010|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586011|NCT03415594|Incretins|incretins|mesh-ancestor
43586012|NCT03415555|Acetaminophen|acetaminophen|mesh-list
43586013|NCT03415555|Oxycodone|oxycodone|mesh-list
43678083|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678084|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678085|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
43678086|NCT02863913|Interleukin-2|interleukin-2|mesh-list
43678087|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678088|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
43678089|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678090|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43678091|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43678092|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
43678093|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678094|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678095|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43678096|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43678097|NCT02863913|Analgesics|analgesics|mesh-ancestor
43678098|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
43678099|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586014|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586015|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586016|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586017|NCT03415555|Analgesics|analgesics|mesh-ancestor
43586018|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
43586019|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586020|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
43586022|NCT03415555|Narcotics|narcotics|mesh-ancestor
43586023|NCT03415477|Denosumab|denosumab|mesh-list
43586024|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43586025|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586026|NCT03415386|Anticoagulants|anticoagulants|mesh-list
43586027|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43586028|NCT03415269|Ambroxol|ambroxol|mesh-list
43586029|NCT03415269|Expectorants|expectorants|mesh-ancestor
43589700|NCT03377400|Cisplatin|cisplatin|mesh-list
43586030|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
43586031|NCT03415191|Ketamine|ketamine|mesh-list
43586032|NCT03415191|Analgesics|analgesics|mesh-ancestor
43586033|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
43586034|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586035|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586036|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43586037|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43586038|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
43586039|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
43586040|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589713|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586041|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43586042|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43586043|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586044|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586045|NCT03415087|Fentanyl|fentanyl|mesh-list
43586046|NCT03415087|Bupivacaine|bupivacaine|mesh-list
43589714|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43589715|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
43589716|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589717|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589726|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
43589727|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589728|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43679690|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43586047|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586048|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
43586049|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586050|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678100|NCT02863614|Ibuprofen|ibuprofen|mesh-list
43678101|NCT02863614|Lorazepam|lorazepam|mesh-list
43678102|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43678103|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43678104|NCT02863614|Analgesics|analgesics|mesh-ancestor
43678105|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
43678106|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678107|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678108|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678109|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43678110|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43678111|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679692|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
43678112|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678113|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
43678114|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
43678115|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
43678116|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678117|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43678118|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678119|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43678120|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43678121|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43678122|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
43678123|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
43678124|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827892|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43827893|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
43827894|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827895|NCT05484505|Nicotine|nicotine|mesh-list
43827896|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43827897|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
43678125|NCT02863809|Riboflavin|riboflavin|mesh-list
43678126|NCT02863809|Dextrans|dextrans|mesh-list
43678127|NCT02863809|Vitamins|vitamins|mesh-ancestor
43678137|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
43678138|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
43678139|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678140|NCT02863367|Gemcitabine|gemcitabine|mesh-list
43678141|NCT02863367|Apatinib|apatinib|mesh-list
43678142|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678143|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
43678144|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678145|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678146|NCT02863367|Antiviral Agents|antiviral agents|mesh-ancestor
43678147|NCT02863367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678148|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678149|NCT02863367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678150|NCT02863367|Immunologic Factors|immunologic factors|mesh-ancestor
43589736|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589737|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589772|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589773|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589774|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43589775|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
43589776|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
43589777|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43678151|NCT02863367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678152|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589778|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
43678153|NCT02863679|Tetracaine|tetracaine|mesh-list
43589779|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678154|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
43678155|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
43678156|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678157|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678158|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
43678159|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678160|NCT02863705|Timolol|timolol|mesh-list
43678179|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678180|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678181|NCT02863471|Antiviral Agents|antiviral agents|mesh-ancestor
43678182|NCT02863471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678183|NCT02863471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678184|NCT02863471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678185|NCT02863471|Immunologic Factors|immunologic factors|mesh-ancestor
43678186|NCT02863471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678188|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43678189|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43678190|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678191|NCT02862977|Ketoprofen|ketoprofen|mesh-list
43678192|NCT02862977|Amitriptyline|amitriptyline|mesh-list
43678193|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
43678194|NCT02862977|Caffeine|caffeine|mesh-list
43678195|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43678196|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678197|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43678198|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678199|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678200|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43678202|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
43678203|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586053|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43589780|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589781|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
43589782|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43589783|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43589789|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586054|NCT03415087|Narcotics|narcotics|mesh-ancestor
43586055|NCT03415087|Analgesics|analgesics|mesh-ancestor
43586056|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43586057|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43586058|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
43586059|NCT03414931|Sertraline|sertraline|mesh-list
43586060|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
43586061|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43586062|NCT03414931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43586063|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43586064|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586065|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586066|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586067|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
43586068|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586069|NCT03414918|Clarithromycin|clarithromycin|mesh-list
43586070|NCT03414918|Roxithromycin|roxithromycin|mesh-list
43586071|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43586072|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586073|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43586074|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678204|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43678205|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43678206|NCT02862977|Analgesics|analgesics|mesh-ancestor
43678207|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
43678208|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678209|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678210|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43678211|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43678212|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43678213|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
43678214|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43678215|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43589790|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589791|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
43589792|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43589793|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589794|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43589795|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43589796|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
43589797|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589798|NCT03376789|MYL-1501D|myl-1501d|mesh-list
43589799|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43589800|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589801|NCT03376737|Pemetrexed|pemetrexed|mesh-list
43589802|NCT03376737|Apatinib|apatinib|mesh-list
43589803|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589804|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589805|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589806|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43589807|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43678216|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43678217|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43678218|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678219|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43678220|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43678221|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43678222|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586075|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586076|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43586077|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43586078|NCT03414892|Globalagliatin|globalagliatin|mesh-list
43586079|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
43586080|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586082|NCT03414879|Ketamine|ketamine|mesh-list
43586083|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586084|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
43586085|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586086|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586087|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
43586088|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586089|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43586090|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43586091|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43586092|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43639140|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43586093|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586094|NCT03414879|Analgesics|analgesics|mesh-ancestor
43586095|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43586096|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43586097|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
43586098|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43586099|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43586100|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679706|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679707|NCT02850887|Anesthetics|anesthetics|mesh-list
43679708|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679709|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679710|NCT02850913|Doxycycline|doxycycline|mesh-list
43679711|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43679712|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679713|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
43589808|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589809|NCT03376594|Loratadine|loratadine|mesh-list
43589810|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
43589811|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586101|NCT03414840|Atorvastatin|atorvastatin|mesh-list
43586102|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43586103|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43586104|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
43586105|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586106|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43586107|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43678224|NCT02863120|Ropivacaine|ropivacaine|mesh-list
43678225|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
43678226|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
43678227|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678228|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678229|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
43678230|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678231|NCT02863185|Atorvastatin|atorvastatin|mesh-list
43678232|NCT02863185|Pitavastatin|pitavastatin|mesh-list
43678233|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43678234|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43586108|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586109|NCT03414814|Osimertinib|osimertinib|mesh-list
43586110|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586111|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43586112|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586113|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586115|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586116|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43586117|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586118|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586119|NCT03414333|Hormones|hormones|mesh-list
43586120|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586121|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679733|NCT05382923|Melatonin|melatonin|mesh-list
43586122|NCT03414164|Procyanidin|procyanidin|mesh-list
43586123|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
43679767|NCT05382351|Entecavir|entecavir|mesh-list
43679768|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
43679769|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679770|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43679771|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43828018|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828019|NCT05482451|Nivolumab|nivolumab|mesh-list
43828020|NCT05482451|Tretinoin|tretinoin|mesh-list
43828021|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43828022|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828023|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43586124|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586125|NCT03414164|Protective Agents|protective agents|mesh-ancestor
43586126|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586127|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
43586128|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43586129|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43586130|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586131|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
43586132|NCT03413891|Coagulants|coagulants|mesh-ancestor
43586133|NCT03413722|Everolimus|everolimus|mesh-list
43586134|NCT03413722|Tacrolimus|tacrolimus|mesh-list
43586135|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43586136|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
43586137|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586138|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43586139|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586140|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586141|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586142|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
43586143|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43586144|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586145|NCT03413436|Cisplatin|cisplatin|mesh-list
43586146|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586147|NCT03413410|Metoprolol|metoprolol|mesh-list
43586148|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43586149|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43586150|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
43586151|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
43586152|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586153|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586154|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43586155|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43586156|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43586157|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586158|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678235|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
43678236|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678237|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43678239|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678240|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43678241|NCT02862665|Hematinics|hematinics|mesh-ancestor
43678242|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43678243|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43678244|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
43678245|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43679777|NCT05382182|Hormones|hormones|mesh-ancestor
43679778|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678246|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
43678247|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43679822|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43679823|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
43678248|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678249|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43678250|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43678251|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678252|NCT02862873|Ondansetron|ondansetron|mesh-list
43678253|NCT02862873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679824|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679825|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679826|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43679827|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
43679828|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
43679829|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43679830|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43679831|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
43679832|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679833|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43679834|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43679835|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679836|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
43589930|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
43589932|NCT03375632|Renal Agents|renal agents|mesh-ancestor
43589933|NCT03375593|Acetaminophen|acetaminophen|mesh-list
43589934|NCT03375593|Ibuprofen|ibuprofen|mesh-list
43589935|NCT03375593|Oxycodone|oxycodone|mesh-list
43678254|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678255|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
43678256|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
43678257|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589936|NCT03375593|Hydrocodone|hydrocodone|mesh-list
43589937|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43589938|NCT03375593|Analgesics|analgesics|mesh-ancestor
43589939|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
43678258|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678259|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
43678260|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
43678261|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43678262|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
43678263|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678264|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678265|NCT02862873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43586159|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586160|NCT03413371|Acetaminophen|acetaminophen|mesh-list
43586162|NCT03413371|Bupivacaine|bupivacaine|mesh-list
43586163|NCT03413371|Ropivacaine|ropivacaine|mesh-list
43599880|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
43589940|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589941|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589942|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
43589943|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43589944|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43589945|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43589946|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43589947|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589948|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589949|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43589950|NCT03375593|Narcotics|narcotics|mesh-ancestor
43589951|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589952|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
43589953|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
43589954|NCT03375580|Metformin|metformin|mesh-list
43589955|NCT03375580|Simvastatin|simvastatin|mesh-list
43589956|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43586164|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586165|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
43586166|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586167|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586168|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
43586169|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678266|NCT02862873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43589957|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589958|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43589959|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43589960|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
43589961|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678267|NCT02862873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43678268|NCT02862873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43678269|NCT02862691|Acetaminophen|acetaminophen|mesh-list
43678270|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43678272|NCT02862691|Analgesics|analgesics|mesh-list
43678273|NCT02862691|Bupivacaine|bupivacaine|mesh-list
43678274|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
43678275|NCT02862691|Anesthetics|anesthetics|mesh-list
43678276|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678277|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678278|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
43678279|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678280|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43678281|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
43678282|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43678283|NCT02862691|Narcotics|narcotics|mesh-ancestor
43678284|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43678285|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678286|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43678288|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
43679837|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
43679838|NCT05381168|Calcium|calcium|mesh-list
43679839|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43679840|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678289|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
43678290|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678291|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678292|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
43678293|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679841|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43679842|NCT05381168|Antacids|antacids|mesh-ancestor
43679843|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679844|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43679845|NCT05381038|Paclitaxel|paclitaxel|mesh-list
43679846|NCT05381038|Docetaxel|docetaxel|mesh-list
43678294|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43678295|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43678296|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43678297|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43678298|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586170|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43679847|NCT05381038|Irinotecan|irinotecan|mesh-list
43589962|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43849093|NCT03962465|Prednisone|prednisone|mesh-list
43589963|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43589964|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589965|NCT03375515|Hydromorphone|hydromorphone|mesh-list
43589966|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43589967|NCT03375515|Narcotics|narcotics|mesh-ancestor
43586171|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43586172|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43586173|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586174|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586175|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586176|NCT03413371|Analgesics|analgesics|mesh-ancestor
43586177|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
43586178|NCT03413358|Cisplatin|cisplatin|mesh-list
43678299|NCT02862483|Tadalafil|tadalafil|mesh-list
43678300|NCT02862483|Tamsulosin|tamsulosin|mesh-list
43678301|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
43678302|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43678303|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43678304|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678305|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678306|NCT02862483|Urological Agents|urological agents|mesh-ancestor
43678307|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43589979|NCT03375424|Vedolizumab|vedolizumab|mesh-list
43589980|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43589981|NCT03375398|PAZ320|paz320|mesh-list
43589982|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43589983|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589984|NCT03375138|Abatacept|abatacept|mesh-list
43589985|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43678308|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43678309|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43678310|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678311|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678312|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678313|NCT02862509|Budesonide|budesonide|mesh-list
43678314|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678315|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43678316|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
43678317|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678318|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678319|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43678320|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
43678321|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
43678322|NCT02862509|Hormones|hormones|mesh-ancestor
43678323|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678324|NCT02862145|Dexamethasone|dexamethasone|mesh-list
43678325|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678326|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
43678327|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
43678328|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678329|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678330|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43586179|NCT03413358|Carboplatin|carboplatin|mesh-list
43586180|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678332|NCT02862145|Hormones|hormones|mesh-ancestor
43678333|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678334|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43678335|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678336|NCT02862327|Dexamethasone|dexamethasone|mesh-list
43678337|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
43678338|NCT02862327|Ropivacaine|ropivacaine|mesh-list
43678339|NCT02862327|BB 1101|bb 1101|mesh-list
43678340|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678341|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
43589987|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678342|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
43678343|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678344|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678345|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678346|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
43678347|NCT02862327|Hormones|hormones|mesh-ancestor
43586181|NCT03413319|Tilavonemab|tilavonemab|mesh-list
43586182|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
43586183|NCT03413150|Amiodarone|amiodarone|mesh-list
43586184|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43586185|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
43586186|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43586187|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586188|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678348|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678349|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43678350|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678351|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
43678352|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678353|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590023|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43679848|NCT05381038|Azacitidine|azacitidine|mesh-list
43679849|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43590024|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43590025|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590026|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590027|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43590028|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43590029|NCT03374670|Aflibercept|aflibercept|mesh-list
43590030|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43590031|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43590032|NCT03374670|Growth Substances|growth substances|mesh-ancestor
43590033|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590034|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
43590035|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590036|NCT03374540|Vitamin K|vitamin k|mesh-list
43590037|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
43590038|NCT03374540|Vitamins|vitamins|mesh-ancestor
43590039|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
43678354|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
43590040|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590041|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43590042|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
43590043|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43590044|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
43590045|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590046|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590047|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
43590048|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43590049|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43590050|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
43590051|NCT03374540|Coagulants|coagulants|mesh-ancestor
43590052|NCT03374514|Dexamethasone|dexamethasone|mesh-list
43590053|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590054|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
43590055|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
43590056|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590057|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590058|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678355|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
43678356|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678357|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
43678358|NCT02862015|Gemcitabine|gemcitabine|mesh-list
43678359|NCT02862015|Folfirinox|folfirinox|mesh-list
43678360|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678361|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
43590059|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
43590060|NCT03374514|Hormones|hormones|mesh-ancestor
43590061|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590068|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590069|NCT03374345|Mitogens|mitogens|mesh-ancestor
43586189|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43586190|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43586191|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43586192|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586193|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43586194|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43586195|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43586196|NCT03413059|Triamcinolone|triamcinolone|mesh-list
43586197|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43586198|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43586199|NCT03413059|Morphine|morphine|mesh-list
43586200|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43586201|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43586202|NCT03413059|Narcotics|narcotics|mesh-ancestor
43586203|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586204|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590070|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
43586206|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
43590071|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590072|NCT03374306|Atropine|atropine|mesh-list
43590073|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
43590074|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43590075|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43590076|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43590077|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
43590078|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590079|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590080|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43590081|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590082|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
43590083|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
43590084|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43590085|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43586207|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586208|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586209|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
43586210|NCT03413059|Hormones|hormones|mesh-ancestor
43586211|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586212|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43586213|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
43586214|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586215|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586216|NCT03413020|Amoxicillin|amoxicillin|mesh-list
43586217|NCT03413020|Metronidazole|metronidazole|mesh-list
43586218|NCT03413020|Clarithromycin|clarithromycin|mesh-list
43586219|NCT03413020|Levofloxacin|levofloxacin|mesh-list
43586220|NCT03413020|Ofloxacin|ofloxacin|mesh-list
43586221|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
43586222|NCT03413020|Esomeprazole|esomeprazole|mesh-list
43586223|NCT03413020|Bismuth|bismuth|mesh-list
43586224|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586225|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43586226|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586227|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43586228|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43586229|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43586236|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43586237|NCT03413020|Renal Agents|renal agents|mesh-ancestor
43586238|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43586239|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43586240|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586241|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43678362|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678363|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678364|NCT02862015|Antiviral Agents|antiviral agents|mesh-ancestor
43678365|NCT02862015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678366|NCT02862015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678367|NCT02862015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678368|NCT02862015|Immunologic Factors|immunologic factors|mesh-ancestor
43678369|NCT02862015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678370|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
43678371|NCT02861976|Narcotics|narcotics|mesh-ancestor
43678372|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678373|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678374|NCT02861976|Analgesics|analgesics|mesh-ancestor
43678375|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
43590086|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
43590087|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590088|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590089|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43590090|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43590091|NCT03374293|Antibodies|antibodies|mesh-list
43590092|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
43590093|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678376|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590094|NCT03374280|Cisplatin|cisplatin|mesh-list
43590095|NCT03374280|Pemetrexed|pemetrexed|mesh-list
43827898|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827899|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827900|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43827901|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43827902|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
43827903|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827904|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827905|NCT05484466|Entecavir|entecavir|mesh-list
43827906|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
43827907|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846950|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
43846951|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846952|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846970|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846971|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
43846972|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
43846973|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846974|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846975|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43846976|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
43590096|NCT03374280|Gefitinib|gefitinib|mesh-list
43846977|NCT04156581|Hormones|hormones|mesh-ancestor
43846978|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846979|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43846980|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846981|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
43846983|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846984|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
43846985|NCT04155411|Dasatinib|dasatinib|mesh-list
43846986|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846987|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43678377|NCT02861859|Olanzapine|olanzapine|mesh-list
43590097|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590098|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590099|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590100|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43590101|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43590102|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43590103|NCT03374228|Linrodostat|linrodostat|mesh-list
43590104|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590105|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590107|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43590108|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43590109|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43590110|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43586243|NCT03413020|Diuretics|diuretics|mesh-ancestor
43586244|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
43586245|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586246|NCT03413020|Expectorants|expectorants|mesh-ancestor
43586247|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
43586248|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
43586249|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
43586250|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586251|NCT03412994|Apatinib|apatinib|mesh-list
43586252|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586253|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43586254|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586255|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586257|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
43586258|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586259|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586260|NCT03412682|Budesonide|budesonide|mesh-list
43586261|NCT03412682|Mesalamine|mesalamine|mesh-list
43586262|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586263|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43586264|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
43586265|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586266|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586267|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43586268|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
43586269|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
43586270|NCT03412682|Hormones|hormones|mesh-ancestor
43586271|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586272|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43586273|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586274|NCT03412682|Analgesics|analgesics|mesh-ancestor
43586275|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
43586276|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586277|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
43586278|NCT03412552|Analgesics|analgesics|mesh-ancestor
43678378|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
43678379|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
43678380|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678381|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678382|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678383|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43678384|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43590111|NCT03374007|Antibodies|antibodies|mesh-list
43590112|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
43590113|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43590114|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
43678385|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678386|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43678387|NCT02861859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43678388|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43678389|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43678390|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678391|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678392|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
43590115|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590116|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590117|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43590118|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43590119|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590120|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
43590121|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43590122|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590123|NCT03373903|Everolimus|everolimus|mesh-list
43590124|NCT03373903|Dactolisib|dactolisib|mesh-list
43590125|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590126|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43590127|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
43590128|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590129|NCT03373864|Anesthetics|anesthetics|mesh-list
43678393|NCT02861482|Oxytocin|oxytocin|mesh-list
43678394|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
43678395|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
43678396|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43678397|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678398|NCT02861716|Fentanyl|fentanyl|mesh-list
43678399|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
43678400|NCT02861716|Bupivacaine|bupivacaine|mesh-list
43678403|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678404|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678405|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
43678406|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678407|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43678408|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586279|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
43586280|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586281|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586282|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
43586283|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586284|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43586285|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
43586286|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43586287|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586288|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678410|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43678411|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43599881|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
43678412|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43678413|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678414|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678415|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678416|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43678417|NCT02861716|Narcotics|narcotics|mesh-ancestor
43678418|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43678419|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43678420|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
43678422|NCT02861690|Nedaplatin|nedaplatin|mesh-list
43678423|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43678424|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590130|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590131|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590137|NCT03373825|Analgesics|analgesics|mesh-ancestor
43590138|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
43590139|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590140|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43590141|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43590142|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
43590143|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
43678425|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
43678426|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
43678427|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
43590144|NCT03373708|Tamoxifen|tamoxifen|mesh-list
43590145|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
43590146|NCT03373708|Docetaxel|docetaxel|mesh-list
43590147|NCT03373708|Letrozole|letrozole|mesh-list
43590148|NCT03373708|Epirubicin|epirubicin|mesh-list
43679850|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679851|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
43679852|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
43679853|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
43679854|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679855|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43679856|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43679857|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679858|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678428|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678429|NCT02861261|Promethazine|promethazine|mesh-list
43678430|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
43678431|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
43678432|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
43678433|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43678434|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
43678435|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
43586289|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43586290|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
43586291|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43586292|NCT03412526|Fludarabine|fludarabine|mesh-list
43679859|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
43679860|NCT05380986|Apatinib|apatinib|mesh-list
43679861|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586293|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586294|NCT03412513|Mirabegron|mirabegron|mesh-list
43679862|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43590149|NCT03373708|Goserelin|goserelin|mesh-list
43590150|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43590151|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
43590152|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590153|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590154|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43590155|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
43590156|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590157|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586295|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43586296|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43586297|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43586302|NCT03412513|Urological Agents|urological agents|mesh-ancestor
43586303|NCT03412500|Vancomycin|vancomycin|mesh-list
43586304|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43586305|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586306|NCT03412474|Acetaminophen|acetaminophen|mesh-list
43586307|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
43586308|NCT03412474|Bupivacaine|bupivacaine|mesh-list
43586309|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586310|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
43586311|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586312|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586313|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
43678436|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678437|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678438|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678439|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43678440|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43678441|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43678442|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678443|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
43678444|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
43678445|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
43678446|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678447|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
43678448|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
43678449|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678450|NCT02861222|Doxorubicin|doxorubicin|mesh-list
43678451|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43827908|NCT05484401|Ibuprofen|ibuprofen|mesh-list
43678452|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678453|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43586314|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586315|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43586316|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586317|NCT03412474|Analgesics|analgesics|mesh-ancestor
43586318|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43586319|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43586320|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43586321|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586322|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586323|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586324|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
43586325|NCT03412409|Cytarabine|cytarabine|mesh-list
43586326|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
43586327|NCT03412409|Busulfan|busulfan|mesh-list
43586328|NCT03412409|Semustine|semustine|mesh-list
43586329|NCT03412409|Fludarabine|fludarabine|mesh-list
43590158|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43590159|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
43590160|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
43590161|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
43586332|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
43590162|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43590163|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43586333|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586334|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586335|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43586336|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
43586337|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586338|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586339|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43586340|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43586341|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
43586342|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
43586343|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586344|NCT03412305|Amoxicillin|amoxicillin|mesh-list
43590164|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590165|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43590166|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
43590167|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590168|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43590169|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43590170|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43586345|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43586346|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586347|NCT03412071|Metronidazole|metronidazole|mesh-list
43586348|NCT03412071|Clindamycin|clindamycin|mesh-list
43586349|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
43678454|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43678455|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678456|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678458|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43678459|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43678460|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678461|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678462|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678463|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678464|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43678465|NCT02861105|Enoxaparin|enoxaparin|mesh-list
43678466|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43586350|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
43586351|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43586352|NCT03412071|Tinidazole|tinidazole|mesh-list
43586353|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586354|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43586355|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43586356|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43586357|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43586358|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586359|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586360|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43586361|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
43586362|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43586363|NCT03412006|Fulacimstat|fulacimstat|mesh-list
43586364|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590171|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43590172|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43590173|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43590174|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43590176|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
43590177|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590179|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43590180|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
43590181|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590182|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590183|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43590184|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590185|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
43590186|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43590187|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43590188|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43590189|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43590190|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
43590191|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586365|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586366|NCT03411967|Docetaxel|docetaxel|mesh-list
43586367|NCT03411967|Apatinib|apatinib|mesh-list
43586368|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586369|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
43586370|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
43586371|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
43586372|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586373|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43586374|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586376|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43586377|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43586378|NCT03411941|Growth Substances|growth substances|mesh-ancestor
43586379|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586380|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
43586381|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586383|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43586384|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586385|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586386|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43586387|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
43586388|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586389|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586390|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
43586391|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
43586392|NCT03411798|Methotrexate|methotrexate|mesh-list
43586393|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43586394|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
43586395|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43586396|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590192|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679863|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679864|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679865|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
43679866|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43679867|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43679868|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679869|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
43679870|NCT05380960|Coagulants|coagulants|mesh-ancestor
43679871|NCT05380934|Methotrexate|methotrexate|mesh-list
43679872|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43679873|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
43679874|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43679875|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679876|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43679877|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
43586397|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678467|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
43678468|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43678469|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43678470|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678471|NCT02860936|Lenvatinib|lenvatinib|mesh-list
43678472|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678473|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43678474|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678475|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678476|NCT02860949|Ketorolac|ketorolac|mesh-list
43678477|NCT02860949|Epinephrine|epinephrine|mesh-list
43678478|NCT02860949|Morphine|morphine|mesh-list
43678479|NCT02860949|Bupivacaine|bupivacaine|mesh-list
43678480|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586398|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
43586399|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586400|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586401|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586402|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586403|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43586404|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43586405|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
43586406|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586407|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43586410|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43586411|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586412|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43586413|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586414|NCT03411798|Analgesics|analgesics|mesh-ancestor
43586415|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
43586416|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586417|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586418|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43586419|NCT03411551|Anesthetics|anesthetics|mesh-list
43586420|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586421|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586422|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
43586423|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43586424|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586425|NCT03411434|Methylphenidate|methylphenidate|mesh-list
43586426|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43586427|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586428|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43586429|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43586430|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586431|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586432|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
43586433|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586435|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
43586436|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586437|NCT03411330|Lidocaine|lidocaine|mesh-list
43586438|NCT03411330|Bupivacaine|bupivacaine|mesh-list
43586439|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586440|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
43586441|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586442|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586443|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
43678481|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
43678482|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678483|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678484|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
43678485|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679908|NCT05380479|Mirtazapine|mirtazapine|mesh-list
43678486|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43678487|NCT02860949|Narcotics|narcotics|mesh-ancestor
43678488|NCT02860949|Analgesics|analgesics|mesh-ancestor
43678489|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43678490|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43678491|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586454|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586455|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586456|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590279|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
43590280|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
43590281|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43586457|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586458|NCT03411252|Urological Agents|urological agents|mesh-ancestor
43586459|NCT03411161|Paclitaxel|paclitaxel|mesh-list
43586460|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43586461|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43586462|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586463|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
43586464|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
43586465|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
43586466|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586467|NCT03411109|Hydromorphone|hydromorphone|mesh-list
43586468|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43586469|NCT03411109|Narcotics|narcotics|mesh-ancestor
43586470|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586471|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586472|NCT03411109|Analgesics|analgesics|mesh-ancestor
43586473|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
43586474|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586475|NCT03411096|Ropivacaine|ropivacaine|mesh-list
43586476|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586477|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
43586478|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586479|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586480|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
43586481|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586482|NCT03410836|Lidocaine|lidocaine|mesh-list
43586483|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586484|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
43586485|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586486|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586487|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
43586488|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586489|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43828049|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
43828050|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828051|NCT05482074|Olaparib|olaparib|mesh-list
43828052|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43828053|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590305|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43586490|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43586491|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43586492|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586493|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586494|NCT03410784|Paclitaxel|paclitaxel|mesh-list
43586495|NCT03410784|Carboplatin|carboplatin|mesh-list
43586496|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
43586497|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43586498|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586499|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
43586500|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
43586501|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
43586502|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586503|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43678492|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678493|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678494|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43678495|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43678497|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43678498|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
43678499|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
43678500|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
43678501|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43678502|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43678503|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43678504|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586504|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43586505|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586507|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
43586508|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586509|NCT03410524|Emollients|emollients|mesh-ancestor
43586510|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586511|NCT03410511|Nicotine|nicotine|mesh-list
43586512|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43586513|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
43590335|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590336|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
43590337|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590338|NCT03372239|Tryptophan|tryptophan|mesh-list
43590339|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43590340|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
43590341|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43590342|NCT03372200|Febuxostat|febuxostat|mesh-list
43590343|NCT03372200|Dotinurad|dotinurad|mesh-list
43590344|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
43586514|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586515|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586516|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43586517|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43586518|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
43586519|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586520|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586521|NCT03410212|Ketorolac|ketorolac|mesh-list
43586522|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43586523|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43586524|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586525|NCT03410212|Analgesics|analgesics|mesh-ancestor
43586526|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
43586527|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586528|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586529|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586530|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586531|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43586532|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586533|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586534|NCT03409237|Mannitol|mannitol|mesh-list
43586535|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43586536|NCT03409237|Diuretics|diuretics|mesh-ancestor
43586537|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
43586538|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586539|NCT03408847|Beclomethasone|beclomethasone|mesh-list
43586540|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586541|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
43586542|NCT03408847|Hormones|hormones|mesh-ancestor
43586543|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586544|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586545|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43586546|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
43586547|NCT03408756|Methotrexate|methotrexate|mesh-list
43586548|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43586549|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
43586550|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43586551|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586552|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678506|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43678507|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678508|NCT02860923|Exenatide|exenatide|mesh-list
43678509|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43678510|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678511|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43678512|NCT02860923|Incretins|incretins|mesh-ancestor
43678513|NCT02860923|Hormones|hormones|mesh-ancestor
43590353|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
43590361|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
43590362|NCT03371992|Nivolumab|nivolumab|mesh-list
43828054|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828055|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828056|NCT05481970|Dexamethasone|dexamethasone|mesh-list
43828058|NCT05481970|Fentanyl|fentanyl|mesh-list
43828059|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
43828060|NCT05481970|Ketamine|ketamine|mesh-list
43828061|NCT05481970|Propofol|propofol|mesh-list
43828062|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678514|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678515|NCT02861040|Vincristine|vincristine|mesh-list
43678516|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43586553|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
43586554|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586555|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586556|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586557|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586558|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43586559|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43586560|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
43586561|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586562|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43586563|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43586564|NCT03408405|Hormones|hormones|mesh-ancestor
43586565|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586566|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586567|NCT03408093|Interferons|interferons|mesh-list
43586568|NCT03408093|Interferon-beta|interferon-beta|mesh-list
43586569|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
43586570|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586571|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
43586572|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586575|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43586576|NCT03407521|Isosorbide|isosorbide|mesh-list
43586577|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43586578|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43586580|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43586581|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
43586582|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43586583|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586584|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43586585|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43586586|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
43586587|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43586588|NCT03407521|Diuretics|diuretics|mesh-ancestor
43586589|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
43586590|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
43586591|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43586592|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586593|NCT03407027|Triamcinolone|triamcinolone|mesh-list
43586594|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43586595|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43586596|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43586597|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586598|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
43586599|NCT03407027|Hormones|hormones|mesh-ancestor
43586600|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586601|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586602|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43586603|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
43586604|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678517|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678519|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
43678520|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
43828063|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
43678521|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678522|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
43678523|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
43678524|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
43678525|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43678526|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43678527|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678528|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586605|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586606|NCT03406988|Nifedipine|nifedipine|mesh-list
43586607|NCT03406988|Iloprost|iloprost|mesh-list
43586608|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43586609|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828064|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
43586610|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586611|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43586612|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586613|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
43586614|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
43586615|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43586616|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43586617|NCT03406832|Nitroprusside|nitroprusside|mesh-list
43586618|NCT03406832|Tirofiban|tirofiban|mesh-list
43586619|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43586620|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
43586621|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43586622|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586623|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43586624|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43586625|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43586626|NCT03406819|Nitroprusside|nitroprusside|mesh-list
43586627|NCT03406819|Tirofiban|tirofiban|mesh-list
43586628|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43586629|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
43586630|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43586631|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586632|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43586633|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43586634|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43586635|NCT03405974|Aspirin|aspirin|mesh-list
43586636|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43679985|NCT05379322|Adalimumab|adalimumab|mesh-list
43679986|NCT05379322|Etanercept|etanercept|mesh-list
43679987|NCT05379322|Golimumab|golimumab|mesh-list
43586637|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586638|NCT03405974|Analgesics|analgesics|mesh-ancestor
43586639|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
43586640|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586641|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586642|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586643|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586644|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43586645|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43586646|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586647|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43586648|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43586649|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678529|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678531|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43678532|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43678533|NCT02860858|Growth Substances|growth substances|mesh-ancestor
43678534|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678535|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
43678536|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678537|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43678538|NCT02860897|Estrogens|estrogens|mesh-ancestor
43678539|NCT02860897|Hormones|hormones|mesh-ancestor
43678540|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678541|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678542|NCT02860819|Gemcitabine|gemcitabine|mesh-list
43678544|NCT02860819|Veliparib|veliparib|mesh-list
43678545|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678546|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678547|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
43678548|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678549|NCT02860819|Antiviral Agents|antiviral agents|mesh-ancestor
43678550|NCT02860819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678551|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678552|NCT02860819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680013|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43678553|NCT02860819|Immunologic Factors|immunologic factors|mesh-ancestor
43678554|NCT02860819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586650|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
43586652|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43586655|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43586656|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586657|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586658|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586659|NCT03404804|Amoxicillin|amoxicillin|mesh-list
43586660|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43586661|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586662|NCT03404739|Ceftazidime|ceftazidime|mesh-list
43586663|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43586664|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586665|NCT03404544|Carbetocin|carbetocin|mesh-list
43586666|NCT03404544|Oxytocin|oxytocin|mesh-list
43586667|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
43586668|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43586669|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586670|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
43586671|NCT03404310|Astringents|astringents|mesh-ancestor
43586672|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586673|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586674|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
43586675|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
43586676|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
43678555|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43678556|NCT02860663|Vitamin D|vitamin d|mesh-list
43678557|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
43678558|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
43678559|NCT02860663|Vitamins|vitamins|mesh-list
43678560|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
43678561|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678562|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43678563|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43678564|NCT02860624|Esomeprazole|esomeprazole|mesh-list
43678566|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678567|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43678568|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678569|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678570|NCT02860494|Everolimus|everolimus|mesh-list
43678571|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586677|NCT03403842|Sufentanil|sufentanil|mesh-list
43586678|NCT03403842|Morphine|morphine|mesh-list
43586679|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43586680|NCT03403842|Narcotics|narcotics|mesh-ancestor
43586681|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586682|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586683|NCT03403842|Analgesics|analgesics|mesh-ancestor
43586684|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
43586685|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586686|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43586687|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43586688|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
43586689|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
43586690|NCT03403023|Cyclosporine|cyclosporine|mesh-list
43586691|NCT03403023|Cyclosporins|cyclosporins|mesh-list
43586692|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586693|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586694|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43586695|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
43586696|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586697|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
43586698|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586699|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586700|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586701|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43586702|NCT03401736|Midazolam|midazolam|mesh-list
43586703|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
43586704|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43586705|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586706|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586707|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586708|NCT03401736|Analgesics|analgesics|mesh-ancestor
43586709|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
43586710|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586711|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43590529|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
43586712|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43586713|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43586714|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586715|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586716|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680033|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43680034|NCT05379049|Analgesics|analgesics|mesh-ancestor
43680035|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
43680036|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680037|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680038|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680039|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
43586717|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43680040|NCT05378932|Melatonin|melatonin|mesh-list
43680041|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
43680042|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680043|NCT05378932|Protective Agents|protective agents|mesh-ancestor
43680044|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590558|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
43590559|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590560|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43590561|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43590562|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849094|NCT03962465|Methotrexate|methotrexate|mesh-list
43849095|NCT03962465|Vincristine|vincristine|mesh-list
43849096|NCT03962465|Daunorubicin|daunorubicin|mesh-list
43678572|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678573|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
43678574|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678575|NCT02860234|Capecitabine|capecitabine|mesh-list
43678576|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
43678577|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678578|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
43678579|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678580|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678581|NCT02860299|Heparin|heparin|mesh-list
43678582|NCT02860299|Calcium heparin|calcium heparin|mesh-list
43678583|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
43678584|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678585|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43678586|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43827909|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43827910|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586718|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43586719|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43586720|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43586721|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43586722|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
43586723|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
43586743|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586744|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586745|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586746|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586747|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
43586748|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43586749|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590563|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590564|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43590565|NCT03370627|Antibodies|antibodies|mesh-list
43590566|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
43590567|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590568|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
43590569|NCT03370601|Azathioprine|azathioprine|mesh-list
43590570|NCT03370601|Infliximab|infliximab|mesh-list
43590571|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586750|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586751|NCT03399955|Amphotericin B|amphotericin b|mesh-list
43586752|NCT03399955|Paromomycin|paromomycin|mesh-list
43586753|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43586754|NCT03399955|Miltefosine|miltefosine|mesh-list
43586755|NCT03399955|Amebicides|amebicides|mesh-ancestor
43590572|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43586756|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43586757|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43590573|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590574|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
43590575|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590576|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43590577|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590578|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43590579|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
43590584|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43590585|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586758|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586759|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43586760|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
43586761|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586762|NCT03399903|Mesalamine|mesalamine|mesh-list
43586763|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43586764|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586765|NCT03399903|Analgesics|analgesics|mesh-ancestor
43586766|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
43586767|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590586|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590587|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43590588|NCT03370588|Analgesics|analgesics|mesh-ancestor
43586768|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586769|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827911|NCT05484401|Analgesics|analgesics|mesh-ancestor
43827912|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
43827913|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827914|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827915|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827916|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827917|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43678587|NCT02860117|Ketamine|ketamine|mesh-list
43678588|NCT02860117|Analgesics|analgesics|mesh-ancestor
43678589|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
43678590|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678591|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678592|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43678593|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43678594|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
43678595|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
43586770|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586771|NCT03399708|Apremilast|apremilast|mesh-list
43586772|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43586773|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586774|NCT03399708|Analgesics|analgesics|mesh-ancestor
43586775|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
43586776|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586777|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586778|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586779|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586780|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43586781|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43586782|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586783|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586784|NCT03399669|Gefitinib|gefitinib|mesh-list
43586785|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586786|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43586788|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586789|NCT03399643|Atezolizumab|atezolizumab|mesh-list
43586790|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586791|NCT03399604|Treprostinil|treprostinil|mesh-list
43590589|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
43586792|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43590617|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590618|NCT03370367|Tretinoin|tretinoin|mesh-list
43590619|NCT03370367|Isotretinoin|isotretinoin|mesh-list
43590620|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590621|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
43590622|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
43590623|NCT03370328|Peppermint oil|peppermint oil|mesh-list
43590624|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
43586793|NCT03399526|Calcitriol|calcitriol|mesh-list
43586794|NCT03399526|Betamethasone|betamethasone|mesh-list
43586795|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
43586796|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43586797|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
43586803|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
43678596|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678597|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43678598|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43678599|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678600|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678601|NCT02860221|Epinephrine|epinephrine|mesh-list
43678602|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
43678603|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43678604|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43678605|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678606|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
43678607|NCT02860221|Coagulants|coagulants|mesh-ancestor
43678608|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43678609|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43678610|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678611|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586804|NCT03399526|Hormones|hormones|mesh-ancestor
43586805|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586807|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43586808|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
43586809|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586810|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43586811|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43586812|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586813|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590625|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
43590626|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590629|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
43586814|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43586815|NCT03399526|Vitamins|vitamins|mesh-ancestor
43680065|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43680066|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680067|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43680068|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43680069|NCT05378867|Growth Substances|growth substances|mesh-ancestor
43680070|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590648|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590649|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
43590650|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590660|NCT03369847|Budesonide|budesonide|mesh-list
43590661|NCT03369847|Beclomethasone|beclomethasone|mesh-list
43599988|NCT03284177|Calcium|calcium|mesh-list
43586816|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
43586817|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43586818|NCT03399487|Ceritinib|ceritinib|mesh-list
43639141|NCT03555578|Leuprolide|leuprolide|mesh-list
43586819|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586820|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43586821|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586822|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586824|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
43586825|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586826|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
43586827|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586828|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586829|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
43586830|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586831|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43586832|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43586833|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43586834|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586835|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586836|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43586837|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586838|NCT03399474|Analgesics|analgesics|mesh-ancestor
43586839|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43586840|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43586841|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43586842|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586843|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586844|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
43678612|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678613|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43678614|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43678615|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
43678616|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678617|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43678618|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
43678620|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
43678621|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43678622|NCT02859792|Riluzole|riluzole|mesh-list
43678623|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
43678624|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43678625|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43678626|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586845|NCT03399448|Fludarabine|fludarabine|mesh-list
43586846|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43586847|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
43586848|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586849|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43586850|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43586851|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
43586852|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586853|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586854|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43586855|NCT03399435|Epinephrine|epinephrine|mesh-list
43586856|NCT03399435|Racepinephrine|racepinephrine|mesh-list
43586857|NCT03399435|Bupivacaine|bupivacaine|mesh-list
43586858|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
43586859|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
43586860|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
43586861|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
43586862|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586863|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586864|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
43586865|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586866|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43586867|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43586868|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586869|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586871|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43586872|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43586873|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
43586874|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43586875|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
43586876|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
43586877|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
43586879|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43586880|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43586881|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43586882|NCT03399201|Anesthetics|anesthetics|mesh-list
43586883|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43586884|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586885|NCT03399110|Capecitabine|capecitabine|mesh-list
43586886|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
43586887|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43586888|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
43586889|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586890|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586891|NCT03399032|Caspofungin|caspofungin|mesh-list
43586892|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
43678627|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678628|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678629|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43678630|NCT02859792|Protective Agents|protective agents|mesh-ancestor
43678631|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
43678632|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43678633|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
43678634|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678635|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43678636|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43678637|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43678638|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
43678639|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678640|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43678641|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43678642|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678643|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
43678644|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43678645|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43678646|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43678647|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678648|NCT02859571|Oxytocin|oxytocin|mesh-list
43678649|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
43586893|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43586894|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586895|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586896|NCT03399019|Midazolam|midazolam|mesh-list
43586897|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
43586898|NCT03399019|Propofol|propofol|mesh-list
43586899|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43586900|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590662|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590663|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43590664|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
43590665|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590666|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590667|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43590668|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590669|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
43586901|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586902|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43586903|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
43586904|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
43586905|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586906|NCT03399019|Analgesics|analgesics|mesh-ancestor
43586907|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
43586908|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586909|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43586910|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43586911|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43586912|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586913|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586914|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586915|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43586916|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43586917|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43586918|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43586919|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
43678650|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43678651|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678652|NCT02859285|Estradiol|estradiol|mesh-list
43678653|NCT02859285|Estrogens|estrogens|mesh-ancestor
43678654|NCT02859285|Hormones|hormones|mesh-ancestor
43678655|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678656|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678657|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43678658|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43678659|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43678660|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43678661|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
43678662|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678663|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43678664|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43678665|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678666|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43586920|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
43586921|NCT03398993|Clomiphene|clomiphene|mesh-list
43586922|NCT03398993|Enclomiphene|enclomiphene|mesh-list
43586923|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
43586924|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43586925|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43586926|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
43586927|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586928|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586929|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43586930|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
43586931|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43586932|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43586933|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43586934|NCT03398941|Octreotide|octreotide|mesh-list
43586935|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43586936|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43586937|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586938|NCT03398876|Nicotine|nicotine|mesh-list
43586939|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43586940|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
43590670|NCT03369847|Hormones|hormones|mesh-ancestor
43590671|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590672|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43590673|NCT03369808|Vaccines|vaccines|mesh-list
43590674|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
43586941|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586942|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586944|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43586945|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
43586947|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586948|NCT03398837|Dronabinol|dronabinol|mesh-list
43586949|NCT03398837|Lenabasum|lenabasum|mesh-list
43586950|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43590675|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590676|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43590677|NCT03369808|Antacids|antacids|mesh-ancestor
43590678|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590679|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590680|NCT03369795|Methotrexate|methotrexate|mesh-list
43590681|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43590682|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
43590683|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43590684|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590685|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43590686|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
43590687|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586951|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43586952|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586953|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586955|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678667|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43678668|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43678669|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43678670|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43678671|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678672|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678673|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678674|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
43678676|NCT02859259|Fostemsavir|fostemsavir|mesh-list
43678677|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43678678|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43678679|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
43678680|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678681|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43590697|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43590698|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43590699|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43590700|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590701|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590702|NCT03369574|Reslizumab|reslizumab|mesh-list
43590703|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43590704|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590705|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
43590706|NCT03369379|Vitamins|vitamins|mesh-ancestor
43678682|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43678683|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678684|NCT02859077|Gemcitabine|gemcitabine|mesh-list
43678685|NCT02859077|Carboplatin|carboplatin|mesh-list
43678686|NCT02859077|Pemetrexed|pemetrexed|mesh-list
43586956|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586957|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
43586958|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43586959|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43586960|NCT03398837|Analgesics|analgesics|mesh-ancestor
43586961|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
43586962|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586963|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43586964|NCT03398811|Etonogestrel|etonogestrel|mesh-list
43586965|NCT03398811|Desogestrel|desogestrel|mesh-list
43590707|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
43590708|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590709|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43586966|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
43586967|NCT03398811|Progesterone|progesterone|mesh-list
43586968|NCT03398811|Progestins|progestins|mesh-ancestor
43586969|NCT03398811|Hormones|hormones|mesh-ancestor
43586970|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43586971|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586972|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43586973|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
43586974|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43586975|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43586976|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43586977|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43586978|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43586979|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43586980|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43586981|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586982|NCT03398785|Epinephrine|epinephrine|mesh-list
43586983|NCT03398785|Racepinephrine|racepinephrine|mesh-list
43586984|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
43586985|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43586986|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43586987|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586988|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678687|NCT02859077|Gefitinib|gefitinib|mesh-list
43678688|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678689|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678690|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
43678691|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678692|NCT02859077|Antiviral Agents|antiviral agents|mesh-ancestor
43678693|NCT02859077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678694|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678695|NCT02859077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678696|NCT02859077|Immunologic Factors|immunologic factors|mesh-ancestor
43678697|NCT02859077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678698|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43678699|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43678700|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43678701|NCT02858843|Ivacaftor|ivacaftor|mesh-list
43586989|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586990|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586991|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43586992|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43586993|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
43590710|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43590711|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
43586994|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586995|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43586996|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
43586997|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
43586998|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
43586999|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43587000|NCT03398759|Butorphanol|butorphanol|mesh-list
43587001|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43587002|NCT03398759|Narcotics|narcotics|mesh-ancestor
43587003|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587004|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587005|NCT03398759|Analgesics|analgesics|mesh-ancestor
43587006|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
43587007|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587008|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
43587009|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
43587010|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43587011|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
43587012|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43587013|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587014|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43587015|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587016|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
43587017|NCT03398473|Hematinics|hematinics|mesh-ancestor
43587018|NCT03398434|Apixaban|apixaban|mesh-list
43587019|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43587020|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
43587021|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43587022|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
43587023|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587024|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587025|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
43587026|NCT03398122|Apatinib|apatinib|mesh-list
43587027|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587028|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43587029|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587030|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587031|NCT03398083|Alprazolam|alprazolam|mesh-list
43587032|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43587033|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678702|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43678703|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43678704|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678706|NCT02858817|Proguanil|proguanil|mesh-list
43678707|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
43678708|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678709|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
43678710|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43678711|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43678712|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678713|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678714|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
43678715|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
43587034|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587035|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43587036|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43587037|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43587038|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
43587039|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
43587040|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587041|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587042|NCT03398044|Dexamethasone|dexamethasone|mesh-list
43587043|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587044|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
43587045|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
43587046|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587047|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587048|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43587049|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
43587050|NCT03398044|Hormones|hormones|mesh-ancestor
43587051|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587052|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43587053|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587054|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
43587055|NCT03398031|Antacids|antacids|mesh-ancestor
43587056|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587057|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43587058|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43587059|NCT03398018|Hormones|hormones|mesh-ancestor
43587060|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587061|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590830|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
43590831|NCT03368131|Trastuzumab|trastuzumab|mesh-list
43590832|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43590833|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
43590834|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590835|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590836|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43590837|NCT03367728|Ropivacaine|ropivacaine|mesh-list
43590838|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
43590839|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
43590840|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590841|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590842|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
43590843|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590844|NCT03367676|Docetaxel|docetaxel|mesh-list
43587062|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
43587063|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43587064|NCT03397914|Colistin|colistin|mesh-list
43587066|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43587067|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587069|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43587070|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
43587071|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43587072|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
43587073|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587074|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587075|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
43587076|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
43587077|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
43587078|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
43678716|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678718|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
43678719|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678720|NCT02858622|Fentanyl|fentanyl|mesh-list
43678721|NCT02858622|Meperidine|meperidine|mesh-list
43678722|NCT02858622|Bupivacaine|bupivacaine|mesh-list
43828111|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43678723|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
43678724|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
43678725|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678726|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678727|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
43678728|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678729|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43678730|NCT02858622|Narcotics|narcotics|mesh-ancestor
43678731|NCT02858622|Analgesics|analgesics|mesh-ancestor
43590969|NCT03366480|Paclitaxel|paclitaxel|mesh-list
43590970|NCT03366480|Carboplatin|carboplatin|mesh-list
43678732|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43678733|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43678734|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
43678735|NCT02858804|Cytarabine|cytarabine|mesh-list
43587080|NCT03397875|Protective Agents|protective agents|mesh-ancestor
43587081|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587082|NCT03397862|Donepezil|donepezil|mesh-list
43587083|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43587084|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587085|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587086|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
43587087|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587088|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587089|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
43587090|NCT03397797|Rocuronium|rocuronium|mesh-list
43587091|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43591033|NCT03365817|Narcotics|narcotics|mesh-ancestor
43591036|NCT03365817|Analgesics|analgesics|mesh-ancestor
43587092|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43587093|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43587094|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587095|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587136|NCT03397186|Trabectedin|trabectedin|mesh-list
43587137|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43587138|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
43587139|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587140|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587141|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
43587160|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43587161|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43587162|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43587163|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680220|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
43587164|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587165|NCT03397069|Midazolam|midazolam|mesh-list
43587166|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43587167|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43587168|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587176|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
43587177|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
43587178|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587179|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587181|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43587182|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43587183|NCT03396861|Growth Substances|growth substances|mesh-ancestor
43587184|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587185|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
43587186|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587187|NCT03396601|Ketamine|ketamine|mesh-list
43587188|NCT03396601|Analgesics|analgesics|mesh-ancestor
43587189|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
43587190|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587191|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587192|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43587193|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43587195|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
43587196|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587197|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43587206|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587208|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43587209|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587210|NCT03396484|Methyldopa|methyldopa|mesh-list
43587211|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43587212|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
43587213|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
43587214|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587215|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587216|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43587217|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43587218|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43587219|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587220|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587221|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587223|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
43678736|NCT02858804|Thalidomide|thalidomide|mesh-list
43678737|NCT02858804|Dexamethasone|dexamethasone|mesh-list
43678738|NCT02858804|Prednisone|prednisone|mesh-list
43678739|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
43678740|NCT02858804|Rituximab|rituximab|mesh-list
43678741|NCT02858804|Doxorubicin|doxorubicin|mesh-list
43678742|NCT02858804|Etoposide|etoposide|mesh-list
43678743|NCT02858804|Vincristine|vincristine|mesh-list
43678744|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678745|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
43678746|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678747|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827918|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678748|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43678749|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
43678750|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678751|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678752|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43678753|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43678754|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43680274|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
43680275|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
43680276|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680283|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
43591153|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591154|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591155|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591156|NCT03364764|Sirolimus|sirolimus|mesh-list
43591157|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43591158|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591159|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43591160|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678755|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
43678756|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
43587224|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43587274|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587275|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
43587276|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
43587277|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
43587278|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
43587279|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43587280|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43587281|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
43587282|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
43587283|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587284|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43587285|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
43587286|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
43587287|NCT03396107|Dexamethasone|dexamethasone|mesh-list
43587288|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587289|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
43587291|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587292|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587293|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43587294|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
43587295|NCT03396107|Hormones|hormones|mesh-ancestor
43587296|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591175|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591176|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591177|NCT03364530|Antiviral Agents|antiviral agents|mesh-ancestor
43591178|NCT03364530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591179|NCT03364530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591206|NCT03364075|Serotonin|serotonin|mesh-list
43591207|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43591208|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43591209|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43591210|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591211|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591212|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591214|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
43591215|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587297|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43587298|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587299|NCT03395977|Febuxostat|febuxostat|mesh-list
43587300|NCT03395977|Rasburicase|rasburicase|mesh-list
43587301|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
43587302|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43587303|NCT03395951|Diuretics|diuretics|mesh-list
43587304|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
43587305|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587306|NCT03395873|Decitabine|decitabine|mesh-list
43587307|NCT03395873|Avelumab|avelumab|mesh-list
43587308|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43591241|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591242|NCT03363867|Bevacizumab|bevacizumab|mesh-list
43591243|NCT03363867|Atezolizumab|atezolizumab|mesh-list
43591244|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43591246|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43591247|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43591248|NCT03363867|Growth Substances|growth substances|mesh-ancestor
43591249|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591250|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
43591251|NCT03363815|Vitamin K|vitamin k|mesh-list
43591252|NCT03363815|Metformin|metformin|mesh-list
43591253|NCT03363815|Nintedanib|nintedanib|mesh-list
43587309|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
43587310|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587311|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587312|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587313|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43587314|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43587315|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
43587316|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43587317|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43587318|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43587319|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
43587320|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43587321|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587322|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43587323|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43587324|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43587325|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43587326|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678767|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43678768|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678769|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
43678770|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
43678771|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678772|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
43591295|NCT03363659|Copper|copper|mesh-list
43678773|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
43678774|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
43678775|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
43678776|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43678777|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43678778|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43678780|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
43587327|NCT03395730|Oxytocin|oxytocin|mesh-list
43587328|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
43587329|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43587330|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587332|NCT03395665|Progesterone|progesterone|mesh-list
43587333|NCT03395665|Estrogens|estrogens|mesh-ancestor
43587334|NCT03395665|Hormones|hormones|mesh-ancestor
43587335|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587336|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587337|NCT03395665|Progestins|progestins|mesh-ancestor
43587338|NCT03395574|Terlipressin|terlipressin|mesh-list
43587339|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43587340|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43587341|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43587342|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43587343|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43587345|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587346|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43587347|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43587348|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587349|NCT03395262|Caffeine|caffeine|mesh-list
43587350|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43587351|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587352|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43587353|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587354|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591337|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
43587355|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43587356|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43587357|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
43587358|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587359|NCT03395223|Methylene Blue|methylene blue|mesh-list
43587360|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587361|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587362|NCT03395171|Vitamin D|vitamin d|mesh-list
43587363|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
43587364|NCT03395171|Vitamins|vitamins|mesh-ancestor
43680326|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43680327|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680330|NCT05122481|Vitamins|vitamins|mesh-ancestor
43587365|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
43587366|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587367|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43587369|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
43587371|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587375|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587376|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43587377|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
43587378|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43678781|NCT02858505|Iron|iron|mesh-list
43678782|NCT02858505|Trace Elements|trace elements|mesh-ancestor
43678783|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
43678784|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827919|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827920|NCT05484375|Capecitabine|capecitabine|mesh-list
43827921|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43827922|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
43827923|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827924|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827925|NCT05484349|Clonidine|clonidine|mesh-list
43827926|NCT05484349|Tizanidine|tizanidine|mesh-list
43827927|NCT05484349|Analgesics|analgesics|mesh-ancestor
43827928|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
43827929|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827930|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827931|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
43827932|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43827933|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43591401|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43591413|NCT03362788|Vitamin K|vitamin k|mesh-list
43827934|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
43827935|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
43827936|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43827937|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43827938|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43827939|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
43827940|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827941|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587379|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587380|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43587381|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587382|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587383|NCT03395093|Fentanyl|fentanyl|mesh-list
43587384|NCT03395093|Midazolam|midazolam|mesh-list
43587385|NCT03395093|Propofol|propofol|mesh-list
43587386|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43587387|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587408|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587410|NCT03395002|Xhance|xhance|mesh-list
43587411|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
43587412|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43587413|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591434|NCT03362684|Cetuximab|cetuximab|mesh-list
43587414|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43587415|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
43587416|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587417|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587418|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43587419|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
43587420|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
43587421|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43587422|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
43587423|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43587424|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
43587425|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587426|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587427|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43587428|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43587429|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43587430|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587431|NCT03394989|Fluticasone|fluticasone|mesh-list
43587433|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43587434|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43587435|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587436|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43587437|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
43587438|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678787|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678788|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
43678789|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678790|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43678792|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43678793|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43678794|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43678795|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678796|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
43678797|NCT02858297|Hormones|hormones|mesh-ancestor
43591469|NCT03362216|Analgesics|analgesics|mesh-ancestor
43678798|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678799|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678800|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678801|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
43678802|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587439|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587440|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43587441|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
43587442|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
43587443|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43587444|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43587445|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43587447|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587448|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587449|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587450|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
43587452|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587453|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
43587454|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43587455|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43587456|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43587457|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587458|NCT03394833|Polygeline|polygeline|mesh-list
43591497|NCT03362008|Varenicline|varenicline|mesh-list
43587459|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
43587460|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
43587461|NCT03394820|Dexamethasone|dexamethasone|mesh-list
43587462|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587463|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
43587464|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
43587465|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587466|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587467|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43587468|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
43587469|NCT03394820|Hormones|hormones|mesh-ancestor
43587470|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587471|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43587472|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587473|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
43587474|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
43587475|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
43587476|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587477|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587478|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
43587479|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587480|NCT03394729|Propolis|propolis|mesh-list
43678803|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678805|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43678806|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678807|NCT02858193|Expectorants|expectorants|mesh-ancestor
43678808|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
43678809|NCT02858024|Dapivirine|dapivirine|mesh-list
43678810|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43678811|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43678812|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
43678813|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680429|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
43591588|NCT03360955|Anesthetics|anesthetics|mesh-list
43678814|NCT02858206|Paclitaxel|paclitaxel|mesh-list
43678815|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
43678818|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678819|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
43678820|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
43678821|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
43678822|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678823|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43678824|NCT02857959|Penicillins|penicillins|mesh-list
43678825|NCT02857959|Penicillin G|penicillin g|mesh-list
43587481|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587482|NCT03394586|Golimumab|golimumab|mesh-list
43587483|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43587484|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587485|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43587486|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
43587487|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587488|NCT03394573|Aflibercept|aflibercept|mesh-list
43680434|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587489|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43587490|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43587491|NCT03394573|Growth Substances|growth substances|mesh-ancestor
43587492|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587493|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
43587494|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587495|NCT03394430|Midazolam|midazolam|mesh-list
43587496|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
43587497|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43587498|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587499|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587500|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587501|NCT03394430|Analgesics|analgesics|mesh-ancestor
43587502|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
43587503|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587504|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43587505|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43587506|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43587507|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587508|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678826|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43678827|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
43678828|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43678829|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678830|NCT02857946|Linagliptin|linagliptin|mesh-list
43678831|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43678832|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678833|NCT02857946|Incretins|incretins|mesh-ancestor
43680445|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43678835|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678836|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43678837|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
43678838|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678841|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678842|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43678844|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678845|NCT02857920|Bevacizumab|bevacizumab|mesh-list
43678846|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43678847|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678848|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43678849|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43678850|NCT02857920|Growth Substances|growth substances|mesh-ancestor
43678851|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678852|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
43678853|NCT02857829|Caffeine|caffeine|mesh-list
43678854|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43587509|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587510|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43587511|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43587512|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43587513|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591712|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43591713|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
43591714|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591715|NCT03359694|Docetaxel|docetaxel|mesh-list
43591716|NCT03359694|Doxorubicin|doxorubicin|mesh-list
43591717|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43680465|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680466|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680467|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680468|NCT04982614|Vaccines|vaccines|mesh-list
43680469|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
43680470|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680471|NCT04979780|Heparin|heparin|mesh-list
43680472|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43680473|NCT04979780|Tinzaparin|tinzaparin|mesh-list
43680474|NCT04979780|Dalteparin|dalteparin|mesh-list
43680475|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
43680476|NCT04979780|Anticoagulants|anticoagulants|mesh-list
43587514|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43587515|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
43587516|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
43587517|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
43587518|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
43591718|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591719|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
43591720|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
43591721|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
43591722|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591723|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43591724|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43591725|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43591733|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43587519|NCT03394287|Apatinib|apatinib|mesh-list
43591734|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43587540|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587541|NCT03394196|Ritonavir|ritonavir|mesh-list
43587542|NCT03394196|Lopinavir|lopinavir|mesh-list
43678855|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678856|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43678857|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678858|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678859|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43591735|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
43591736|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43591737|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591738|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43678860|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43678861|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
43678862|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678863|NCT02857842|Prednisolone|prednisolone|mesh-list
43678864|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678865|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
43591739|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43587543|NCT03394196|Darunavir|darunavir|mesh-list
43587544|NCT03394196|Tenofovir|tenofovir|mesh-list
43587545|NCT03394196|Lamivudine|lamivudine|mesh-list
43591740|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
43591741|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
43591742|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43591743|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
43591744|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
43587546|NCT03394196|Zidovudine|zidovudine|mesh-list
43587547|NCT03394196|Emtricitabine|emtricitabine|mesh-list
43587548|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
43587549|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43587550|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43587551|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
43587552|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591746|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
43587553|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587554|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43587555|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43587556|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
43587557|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587558|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43587559|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43587560|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43587561|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43587562|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
43587563|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43587564|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43587565|NCT03394144|Durvalumab|durvalumab|mesh-list
43587566|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43587567|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587568|NCT03394131|Insulin|insulin|mesh-list
43587569|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43680504|NCT04951323|Vaccines|vaccines|mesh-list
43587570|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43587571|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587572|NCT03394118|Osimertinib|osimertinib|mesh-list
43587573|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587574|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43587575|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587576|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587577|NCT03394105|Docetaxel|docetaxel|mesh-list
43587578|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587579|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
43587580|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
43587581|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
43587582|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587583|NCT03394001|Ketorolac|ketorolac|mesh-list
43587584|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43587585|NCT03394001|Lidocaine|lidocaine|mesh-list
43587586|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
43587587|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
43587588|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587589|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587590|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
43587591|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587592|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43678867|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678868|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678869|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43678870|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678871|NCT02857777|Esketamine|esketamine|mesh-list
43678872|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
43678873|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43678874|NCT02857686|Anesthetics|anesthetics|mesh-list
43678875|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678876|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678878|NCT02857582|Vancomycin|vancomycin|mesh-list
43678879|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678880|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43678881|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43678882|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43678883|NCT02857569|Nivolumab|nivolumab|mesh-list
43678884|NCT02857569|Ipilimumab|ipilimumab|mesh-list
43678885|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43678886|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678887|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43678889|NCT02857491|Ranibizumab|ranibizumab|mesh-list
43678890|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43678891|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43678892|NCT02857491|Growth Substances|growth substances|mesh-ancestor
43587593|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43587594|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43587595|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43587596|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587597|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43587598|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587599|NCT03394001|Analgesics|analgesics|mesh-ancestor
43591907|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
43587600|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587601|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43587602|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43587603|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587604|NCT03393988|Fentanyl|fentanyl|mesh-list
43587605|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
43587606|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
43587607|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43591936|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
43587608|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587609|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587610|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587611|NCT03393988|Analgesics|analgesics|mesh-ancestor
43587612|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
43678893|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678894|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
43678895|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678896|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43678897|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
43678898|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43678899|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678900|NCT02857309|Hormones|hormones|mesh-ancestor
43678901|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678902|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678903|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
43678904|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43678905|NCT02857309|Diuretics|diuretics|mesh-ancestor
43678906|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
43592016|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43592017|NCT03357055|Ketamine|ketamine|mesh-list
43592018|NCT03357055|Analgesics|analgesics|mesh-ancestor
43592019|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
43592020|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592021|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678907|NCT02857465|Dexamethasone|dexamethasone|mesh-list
43587613|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587614|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43587615|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43587616|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43587617|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587618|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587619|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587620|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43587621|NCT03393988|Narcotics|narcotics|mesh-ancestor
43587622|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43587623|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43587624|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
43587625|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
43587626|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
43587627|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
43587628|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43587629|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43587630|NCT03393949|Prednisolone|prednisolone|mesh-list
43587631|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
43587632|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43587633|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
43587634|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587635|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
43587636|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
43587637|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587638|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587639|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43587640|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
43587642|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587643|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43587644|NCT03393949|Protective Agents|protective agents|mesh-ancestor
43587645|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43587646|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587647|NCT03393858|Antibodies|antibodies|mesh-list
43587648|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
43587649|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587650|NCT03393819|Ethanol|ethanol|mesh-list
43587651|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
43587653|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587654|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587655|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587656|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
43587657|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43678908|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
43678909|NCT02857465|Sufentanil|sufentanil|mesh-list
43678910|NCT02857465|Dsuvia|dsuvia|mesh-list
43678911|NCT02857465|Ropivacaine|ropivacaine|mesh-list
43678912|NCT02857465|BB 1101|bb 1101|mesh-list
43678913|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43678914|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
43678915|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
43678916|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678917|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678918|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43678919|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
43678920|NCT02857465|Hormones|hormones|mesh-ancestor
43678921|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43678922|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43678923|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678924|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
43678925|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678926|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678927|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
43587659|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587660|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587661|NCT03393767|Ranibizumab|ranibizumab|mesh-list
43587662|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43587663|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43587664|NCT03393767|Growth Substances|growth substances|mesh-ancestor
43587665|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587666|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
43587667|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587668|NCT03393728|Propranolol|propranolol|mesh-list
43587669|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43587670|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43587671|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587672|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592234|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43592235|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592236|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592237|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
43592238|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43592254|NCT03355027|Ezetimibe|ezetimibe|mesh-list
43587673|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587674|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587675|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43587676|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43587677|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
43587679|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43587680|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
43587681|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587682|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587683|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43587684|NCT03393702|Gabapentin|gabapentin|mesh-list
43587685|NCT03393702|Analgesics|analgesics|mesh-ancestor
43587686|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
43587687|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587688|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587689|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
43587690|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43587691|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43587692|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587693|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43678929|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678930|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
43678931|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43678932|NCT02857465|Narcotics|narcotics|mesh-ancestor
43678933|NCT02857465|Analgesics|analgesics|mesh-ancestor
43678934|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43678935|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43678936|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
43678937|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43678938|NCT02857218|Hematinics|hematinics|mesh-ancestor
43678939|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43678940|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43680648|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680649|NCT04796220|Antiviral Agents|antiviral agents|mesh-ancestor
43680650|NCT04796220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43678941|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43678942|NCT02857244|Modafinil|modafinil|mesh-list
43678943|NCT02857244|Donepezil|donepezil|mesh-list
43678944|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43678945|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43678946|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43678947|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678948|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678949|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678950|NCT02857244|Analgesics|analgesics|mesh-ancestor
43678951|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
43678952|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678953|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
43678954|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43678955|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
43678956|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43678957|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678958|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
43678959|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
43678960|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43587694|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43828220|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
43828221|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828222|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828223|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43828224|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828225|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828226|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828227|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
43828228|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828229|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43828230|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43828231|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828232|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828233|NCT05480072|Hormones|hormones|mesh-ancestor
43828234|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592329|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43592330|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43592331|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
43592341|NCT03354117|Meloxicam|meloxicam|mesh-list
43592342|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
43592343|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43592344|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587695|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43587696|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587697|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587698|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
43587699|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
43587700|NCT03393572|Nalbuphine|nalbuphine|mesh-list
43587701|NCT03393572|Bupivacaine|bupivacaine|mesh-list
43587702|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
43678961|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43678962|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43678963|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43678964|NCT02857361|Ketamine|ketamine|mesh-list
43678965|NCT02857361|Analgesics|analgesics|mesh-ancestor
43678966|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
43678967|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678968|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678969|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43678970|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43678971|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
43678972|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
43678973|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678974|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43592345|NCT03354117|Analgesics|analgesics|mesh-ancestor
43592346|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
43592347|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592348|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592349|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592350|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592351|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43592352|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43592353|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592354|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678976|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678977|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587703|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
43587704|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587705|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587706|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
43587707|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587708|NCT03393572|Analgesics|analgesics|mesh-ancestor
43587709|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43587711|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43587712|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43587713|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587714|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43587715|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
43587716|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43587717|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43587718|NCT03393572|Narcotics|narcotics|mesh-ancestor
43587720|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587721|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43587722|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592389|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592390|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43592391|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43592392|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43592393|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43592394|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
43592395|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
43592396|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
43592397|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
43592398|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592399|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592421|NCT03353857|Hormones|hormones|mesh-ancestor
43587723|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587724|NCT03393481|Enoxaparin|enoxaparin|mesh-list
43587725|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
43587728|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587730|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
43587731|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587732|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
43587733|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43587734|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587735|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587736|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587737|NCT03393403|Analgesics|analgesics|mesh-ancestor
43680677|NCT04747912|Dexamethasone|dexamethasone|mesh-list
43680678|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
43680679|NCT04747912|Methotrexate|methotrexate|mesh-list
43680680|NCT04747912|Vincristine|vincristine|mesh-list
43680681|NCT04747912|Dasatinib|dasatinib|mesh-list
43680682|NCT04747912|Ponatinib|ponatinib|mesh-list
43680683|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43680684|NCT04747912|BB 1101|bb 1101|mesh-list
43680686|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
43587738|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
43587739|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587740|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43587741|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43587742|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43587743|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678978|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43678979|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43678980|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43678981|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43587744|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587745|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587746|NCT03393377|Valsartan|valsartan|mesh-list
43587747|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43587748|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43587749|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43587750|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587751|NCT03393364|Ketorolac|ketorolac|mesh-list
43587752|NCT03393364|Oxycodone|oxycodone|mesh-list
43587753|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43587754|NCT03393364|Narcotics|narcotics|mesh-ancestor
43587755|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587756|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587757|NCT03393364|Analgesics|analgesics|mesh-ancestor
43587758|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
43587759|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587760|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43587761|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587762|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587763|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43587764|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43587765|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587766|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587767|NCT03393325|Tadalafil|tadalafil|mesh-list
43587768|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
43587769|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43592552|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43592553|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587770|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43587771|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587772|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587773|NCT03393325|Urological Agents|urological agents|mesh-ancestor
43587775|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587776|NCT03393247|Azathioprine|azathioprine|mesh-list
43587777|NCT03393247|Infliximab|infliximab|mesh-list
43587778|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
43587779|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43587780|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849106|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43849107|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
43680769|NCT04666948|Vancomycin|vancomycin|mesh-list
43680770|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43592600|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
43592601|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592602|NCT03351517|Tapentadol|tapentadol|mesh-list
43592607|NCT03351517|Analgesics|analgesics|mesh-ancestor
43592608|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
43592609|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592614|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587781|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
43587782|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587783|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43587784|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587785|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43587786|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
43587787|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587788|NCT03393117|Narcotics|narcotics|mesh-list
43587789|NCT03393117|Bupivacaine|bupivacaine|mesh-list
43587790|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
43587791|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
43587793|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587794|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
43587795|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587797|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43587798|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43587799|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43587800|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587801|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587802|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43587803|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43587804|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43587805|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43587806|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587807|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587808|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678983|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678984|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678985|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678986|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678987|NCT02856854|Cocaine|cocaine|mesh-list
43592724|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43592725|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43592726|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592727|NCT03350191|Exenatide|exenatide|mesh-list
43592728|NCT03350191|Glucagon|glucagon|mesh-list
43592729|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43592730|NCT03350191|Hormones|hormones|mesh-ancestor
43592731|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592732|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592733|NCT03350191|Incretins|incretins|mesh-ancestor
43592734|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43678988|NCT02856854|Oxazepam|oxazepam|mesh-list
43678989|NCT02856854|Metyrapone|metyrapone|mesh-list
43678990|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
43678991|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
43678992|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678993|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678994|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
43678995|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43678996|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43678997|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43678998|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43678999|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43679000|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679001|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
43679002|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679003|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
43679004|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679005|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43679006|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43679007|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43679008|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43679009|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
43587809|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43587810|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43587811|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
43587812|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43587837|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587838|NCT03392623|Niacinamide|niacinamide|mesh-list
43587839|NCT03392623|Niacin|niacin|mesh-list
43587863|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
43587864|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
43587865|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587866|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43587867|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
43587868|NCT03392571|Antiviral Agents|antiviral agents|mesh-ancestor
43587869|NCT03392571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592781|NCT03349619|Protective Agents|protective agents|mesh-ancestor
43592782|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592783|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592784|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43592785|NCT03349606|Amphetamine|amphetamine|mesh-list
43592786|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
43592787|NCT03349606|FLB 457|flb 457|mesh-list
43592788|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43592789|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592790|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
43587870|NCT03392571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587871|NCT03392571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43587872|NCT03392571|Immunologic Factors|immunologic factors|mesh-ancestor
43587873|NCT03392571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679037|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43679038|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679039|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43679040|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
43679041|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679042|NCT02856867|Antidotes|antidotes|mesh-ancestor
43679043|NCT02856867|Protective Agents|protective agents|mesh-ancestor
43587892|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43587893|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43592791|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
43592792|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592793|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
43592794|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592795|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592796|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
43592797|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43592798|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43592799|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680771|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680772|NCT04666649|Venetoclax|venetoclax|mesh-list
43680773|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680774|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
43592801|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43587894|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
43587895|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587896|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587897|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587898|NCT03391934|Leucovorin|leucovorin|mesh-list
43587899|NCT03391934|Fluorouracil|fluorouracil|mesh-list
43587900|NCT03391934|Irinotecan|irinotecan|mesh-list
43587901|NCT03391934|Cetuximab|cetuximab|mesh-list
43587902|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587903|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
43587904|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587905|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43587906|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587907|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43587908|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
43587909|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43587910|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43587911|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587912|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43587914|NCT03391934|Protective Agents|protective agents|mesh-ancestor
43587915|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
43587916|NCT03391934|Vitamins|vitamins|mesh-ancestor
43587917|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
43587918|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
43587919|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43587920|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
43680785|NCT04646187|Infliximab|infliximab|mesh-list
43587921|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587922|NCT03391856|Expectorants|expectorants|mesh-ancestor
43587923|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
43587924|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43587925|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
43587926|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587927|NCT03391856|Protective Agents|protective agents|mesh-ancestor
43587928|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587929|NCT03391856|Antidotes|antidotes|mesh-ancestor
43587930|NCT03391843|Cetuximab|cetuximab|mesh-list
43587931|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
43587932|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43587933|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587934|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
43679044|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
43679045|NCT02856867|Vitamins|vitamins|mesh-ancestor
43679046|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
43679047|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43679048|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679049|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
43679050|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679051|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
43679052|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
43679053|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
43679054|NCT02857153|Urapidil|urapidil|mesh-list
43679055|NCT02857153|Phenylephrine|phenylephrine|mesh-list
43679056|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
43587935|NCT03391830|Atorvastatin|atorvastatin|mesh-list
43587936|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43587938|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
43680826|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43587939|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587940|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43587941|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43587942|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587943|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
43587944|NCT03391830|Protective Agents|protective agents|mesh-ancestor
43587945|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587946|NCT03391830|Vitamins|vitamins|mesh-ancestor
43587947|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
43587948|NCT03391700|Rocuronium|rocuronium|mesh-list
43587949|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43587950|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43587951|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43587952|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587953|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587955|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43587956|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587957|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587958|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587959|NCT03391609|Analgesics|analgesics|mesh-ancestor
43587960|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
43587961|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587962|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43587963|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43587964|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43587965|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
43587966|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587967|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587968|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43587969|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43587970|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587971|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587972|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43587973|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43587974|NCT03391570|Analgesics|analgesics|mesh-ancestor
43587975|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
43587976|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587977|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587978|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587979|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43587980|NCT03391427|Lidocaine|lidocaine|mesh-list
43587981|NCT03391427|Ketamine|ketamine|mesh-list
43587982|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
43587983|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
43587984|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43587985|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679057|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43679058|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
43679059|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
43679060|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679061|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679062|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
43679063|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43679064|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
43679065|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
43679068|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43679069|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
43679070|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679071|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679072|NCT02857153|Protective Agents|protective agents|mesh-ancestor
43679073|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43587986|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
43587987|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587988|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43587989|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43587990|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43587991|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43587992|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587993|NCT03391427|Analgesics|analgesics|mesh-ancestor
43587994|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43680851|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43587995|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43587996|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
43587997|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43587998|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43587999|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588000|NCT03391245|Vitamin D|vitamin d|mesh-list
43588001|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43588002|NCT03391245|Calcifediol|calcifediol|mesh-list
43588003|NCT03391245|Vitamins|vitamins|mesh-ancestor
43588004|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
43588005|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588006|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43588007|NCT03391219|Bevacizumab|bevacizumab|mesh-list
43588008|NCT03391219|Fasudil|fasudil|mesh-list
43588009|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588011|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43592953|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
43588012|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43588013|NCT03391219|Growth Substances|growth substances|mesh-ancestor
43588014|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588015|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
43588016|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43588017|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43588018|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588019|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43588030|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588031|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588036|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43588037|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43588038|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43588039|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
43588040|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588041|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588042|NCT03390790|Lidocaine|lidocaine|mesh-list
43588043|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
43588044|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
43588045|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588046|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588047|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
43588048|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588049|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43588050|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43588051|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43588052|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43588053|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588054|NCT03390738|Nivolumab|nivolumab|mesh-list
43588055|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588056|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588057|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43588058|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588059|NCT03390712|Risperidone|risperidone|mesh-list
43588060|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43588061|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
43588062|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43588063|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
43588064|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588066|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827964|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43827965|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43679081|NCT02856789|Coagulants|coagulants|mesh-ancestor
43679082|NCT02856724|Dinoprostone|dinoprostone|mesh-list
43679083|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
43679084|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43679085|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679086|NCT02856776|Vitamin D|vitamin d|mesh-list
43679087|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
43679088|NCT02856776|Vitamins|vitamins|mesh-ancestor
43679089|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
43679090|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679091|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43588067|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43588068|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588069|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43588070|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43588071|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
43588072|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43588073|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43588074|NCT03390673|Bevacizumab|bevacizumab|mesh-list
43588075|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588076|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588077|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43588078|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43588079|NCT03390673|Growth Substances|growth substances|mesh-ancestor
43588080|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588106|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588107|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588108|NCT03390465|Amlodipine|amlodipine|mesh-list
43588109|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43588110|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43588111|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43588112|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43588113|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588114|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43588115|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588116|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
43588117|NCT03390465|Diuretics|diuretics|mesh-ancestor
43588118|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
43588119|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43588121|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
43588122|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
43588123|NCT03390387|Bortezomib|bortezomib|mesh-list
43588124|NCT03390387|Daunorubicin|daunorubicin|mesh-list
43588125|NCT03390387|Idarubicin|idarubicin|mesh-list
43588126|NCT03390387|BB 1101|bb 1101|mesh-list
43588127|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588128|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
43588129|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
43588130|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588131|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588132|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43588133|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
43588134|NCT03390387|Hormones|hormones|mesh-ancestor
43588135|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588136|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43588137|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679092|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43679093|NCT02856750|Gabapentin|gabapentin|mesh-list
43593139|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43680917|NCT04384562|Nicotine|nicotine|mesh-list
43680918|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43680919|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
43680920|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680921|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680922|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43680923|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43601483|NCT03263299|Aspirin|aspirin|mesh-list
43679094|NCT02856750|Analgesics|analgesics|mesh-ancestor
43679095|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
43679096|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679097|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679098|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
43679099|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43679100|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43679101|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679102|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43679103|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43679104|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43679105|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679106|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679107|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
43679108|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
43679109|NCT02856685|Analgesics|analgesics|mesh-ancestor
43679110|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
43593140|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593141|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593142|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43593143|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
43593144|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593145|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593146|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43593147|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43593148|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
43593149|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593150|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
43593151|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43593152|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43593153|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43593154|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43680924|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
43680925|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680926|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679111|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679112|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679113|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679114|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43679115|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43679116|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679117|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679118|NCT02856568|Gemcitabine|gemcitabine|mesh-list
43679121|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679122|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43679123|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
43593165|NCT03346681|Expectorants|expectorants|mesh-ancestor
43593166|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
43679124|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588138|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
43588139|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588140|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588141|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43588142|NCT03390387|Protective Agents|protective agents|mesh-ancestor
43679125|NCT02856568|Antiviral Agents|antiviral agents|mesh-ancestor
43679126|NCT02856568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679127|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679128|NCT02856568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588162|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588163|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
43588165|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588166|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588177|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588178|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588179|NCT03389763|Remifentanil|remifentanil|mesh-list
43588180|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43588181|NCT03389763|Narcotics|narcotics|mesh-ancestor
43588182|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588183|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588184|NCT03389763|Analgesics|analgesics|mesh-ancestor
43588185|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
43588186|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588187|NCT03389672|Anesthetics|anesthetics|mesh-list
43588188|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588189|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588190|NCT03389659|Vitamin D|vitamin d|mesh-list
43588191|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
43588192|NCT03389659|Vitamins|vitamins|mesh-ancestor
43588193|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
43588194|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588195|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43588196|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43588197|NCT03389607|Anesthetics|anesthetics|mesh-list
43588198|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588207|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43588208|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588209|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
43588210|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588211|NCT03389490|Coagulants|coagulants|mesh-ancestor
43588212|NCT03389451|Edetic Acid|edetic acid|mesh-list
43588213|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43588214|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
43588215|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
43593277|NCT03346083|Betrixaban|betrixaban|mesh-list
43593278|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43593279|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
43593293|NCT03345966|Antibodies|antibodies|mesh-list
43593303|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
43593304|NCT03345797|Testosterone|testosterone|mesh-list
43588216|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588217|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
43588218|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43588219|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43588220|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43588221|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
43588222|NCT03389412|Coagulants|coagulants|mesh-ancestor
43588223|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43588224|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
43588225|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588227|NCT03389321|Riociguat|riociguat|mesh-list
43588228|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43588229|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43593305|NCT03345797|Androgens|androgens|mesh-ancestor
43593311|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43593312|NCT03345667|Growth Substances|growth substances|mesh-ancestor
43588230|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593313|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593314|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
43593315|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593316|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43593317|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593318|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593319|NCT03345498|Entecavir|entecavir|mesh-list
43593320|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
43593321|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588245|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588246|NCT03389256|Apatinib|apatinib|mesh-list
43588247|NCT03389256|Gefitinib|gefitinib|mesh-list
43588248|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588249|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43588250|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588251|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588252|NCT03389191|Acyclovir|acyclovir|mesh-list
43588253|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
43679133|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679134|NCT02856503|Vitamin D|vitamin d|mesh-list
43679135|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
43593322|NCT03345303|Bortezomib|bortezomib|mesh-list
43593323|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593324|NCT03345147|Vitamins|vitamins|mesh-list
43593325|NCT03345147|Vitamin A|vitamin a|mesh-list
43593326|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
43593327|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
43593328|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593329|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
43593331|NCT03345147|Protective Agents|protective agents|mesh-ancestor
43679136|NCT02856503|Vitamins|vitamins|mesh-ancestor
43679137|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
43679138|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679139|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43679140|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43679142|NCT02856178|Olorofim|olorofim|mesh-list
43679143|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
43588254|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588255|NCT03389139|Anesthetics|anesthetics|mesh-list
43588256|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588257|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588258|NCT03389126|Avelumab|avelumab|mesh-list
43588259|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588260|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588261|NCT03389087|Etoposide|etoposide|mesh-list
43588262|NCT03389087|Apatinib|apatinib|mesh-list
43588263|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43588264|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588265|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43588266|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43588267|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588268|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588269|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43588270|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
43588271|NCT03389061|Velpatasvir|velpatasvir|mesh-list
43588272|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43588273|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
43588274|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588275|NCT03388970|Vitamin K|vitamin k|mesh-list
43588276|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
43588277|NCT03388970|Vitamins|vitamins|mesh-ancestor
43588278|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
43588279|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588280|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43588281|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43593337|NCT03345095|Temozolomide|temozolomide|mesh-list
43593338|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43588282|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588284|NCT03388970|Coagulants|coagulants|mesh-ancestor
43588285|NCT03388957|Propranolol|propranolol|mesh-list
43588286|NCT03388957|Midazolam|midazolam|mesh-list
43588287|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43588288|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43588289|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588290|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588291|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43588292|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43588293|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43588294|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43588295|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
43588296|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
43588297|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
43588298|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
43588299|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588300|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588301|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43588302|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43588303|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
43588304|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43588305|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43588306|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
43588307|NCT03388892|Paclitaxel|paclitaxel|mesh-list
43588308|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43679145|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679146|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679147|NCT02856542|Betamethasone|betamethasone|mesh-list
43679148|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
43679149|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43679150|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
43679151|NCT02856542|Calcipotriene|calcipotriene|mesh-list
43679152|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43679153|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679154|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
43679155|NCT02856542|Hormones|hormones|mesh-ancestor
43679156|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679157|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679158|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43828301|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43679159|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
43679160|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
43679161|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
43679162|NCT02856425|Nintedanib|nintedanib|mesh-list
43588310|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
43588311|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
43588312|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
43588313|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588314|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
43588315|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588316|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
43588317|NCT03388853|Doxofylline|doxofylline|mesh-list
43588318|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43588319|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
43588320|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588321|NCT03388853|Expectorants|expectorants|mesh-ancestor
43588322|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
43588323|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43588324|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
43588325|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588326|NCT03388853|Protective Agents|protective agents|mesh-ancestor
43588327|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588328|NCT03388853|Antidotes|antidotes|mesh-ancestor
43588329|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
43588330|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43588331|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
43588332|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588333|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43588334|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43588335|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588336|NCT03388827|Misoprostol|misoprostol|mesh-list
43588337|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43588338|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
43588339|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43588340|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588341|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43588342|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43588343|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
43593472|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
43593473|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593474|NCT03343873|Midazolam|midazolam|mesh-list
43593475|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
43593476|NCT03343873|Propofol|propofol|mesh-list
43593477|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43593478|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593479|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593480|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43593481|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
43593482|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
43593483|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43593484|NCT03343873|Analgesics|analgesics|mesh-ancestor
43593485|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
43593486|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593487|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43593488|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43681011|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43681013|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
43588344|NCT03388814|Bupivacaine|bupivacaine|mesh-list
43679163|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43679164|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679165|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43679166|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679167|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679168|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43679169|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679170|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43679171|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
43679172|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43679173|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
43679174|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43588345|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
43588346|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
43588347|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588348|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588349|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
43588350|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588351|NCT03388697|Insulin|insulin|mesh-list
43588352|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43588353|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588354|NCT03388671|Bupivacaine|bupivacaine|mesh-list
43588355|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
43588356|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
43588357|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588358|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588359|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
43588360|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588361|NCT03388580|Dimercaprol|dimercaprol|mesh-list
43588379|NCT03388463|Omeprazole|omeprazole|mesh-list
43588380|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43588381|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43588382|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43588383|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588384|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588385|NCT03388372|Temozolomide|temozolomide|mesh-list
43593504|NCT03343678|Venetoclax|venetoclax|mesh-list
43593505|NCT03343678|BI 836826|bi 836826|mesh-list
43593506|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593507|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43593508|NCT03343665|Nivolumab|nivolumab|mesh-list
43593509|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43593510|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593511|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43681019|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43681020|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43681021|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43681022|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681023|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593512|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593513|NCT03343652|Nivolumab|nivolumab|mesh-list
43588386|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
43588387|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43588388|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
43588389|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588390|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588391|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588393|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43588394|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
43588395|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
43588396|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588397|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
43588398|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43588399|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43588400|NCT03388151|Midazolam|midazolam|mesh-list
43588401|NCT03388151|Propofol|propofol|mesh-list
43588402|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43588403|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588404|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588405|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43588406|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
43588407|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
43588408|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43588409|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43588410|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43588411|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43679175|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679176|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43679177|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43679178|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679179|NCT02856230|Paclitaxel|paclitaxel|mesh-list
43679180|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43679181|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679182|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
43679183|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
43679184|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
43593526|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
43679185|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679186|NCT02856087|Remifentanil|remifentanil|mesh-list
43679187|NCT02856087|Naloxone|naloxone|mesh-list
43679188|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43588412|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
43588413|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
43588414|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588415|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588416|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
43588417|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43588418|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43588427|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
43588428|NCT03387956|Hormones|hormones|mesh-ancestor
43588429|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588430|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43588431|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588432|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43588433|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43588434|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43588435|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43588436|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
43588437|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
43588438|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
43588439|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43593547|NCT03343444|Ledipasvir|ledipasvir|mesh-list
43588440|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43588441|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
43588442|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588443|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588444|NCT03387943|Cisplatin|cisplatin|mesh-list
43588445|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588446|NCT03387904|Irinotecan|irinotecan|mesh-list
43588447|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43588448|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43588449|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588450|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588451|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588452|NCT03387826|Ticagrelor|ticagrelor|mesh-list
43588453|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43588454|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43588455|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43588456|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43588457|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43588458|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
43588459|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588460|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588461|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588463|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43588464|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679189|NCT02856087|Narcotics|narcotics|mesh-ancestor
43679190|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679191|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679192|NCT02856087|Analgesics|analgesics|mesh-ancestor
43593611|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593612|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43593629|NCT03342170|Thrombin|thrombin|mesh-list
43593666|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593667|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43681051|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43681052|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43679193|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
43679194|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679195|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43679196|NCT02855632|Hormones|hormones|mesh-list
43679197|NCT02855632|Progesterone|progesterone|mesh-list
43679198|NCT02855632|Lenograstim|lenograstim|mesh-list
43679199|NCT02855632|Estrogens|estrogens|mesh-list
43679200|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679201|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679202|NCT02855632|Progestins|progestins|mesh-ancestor
43679203|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43679204|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
43679205|NCT02855684|Insulin|insulin|mesh-list
43679206|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43679207|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
43679208|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43679209|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679210|NCT02855866|Acetaminophen|acetaminophen|mesh-list
43679211|NCT02855866|Dexamethasone|dexamethasone|mesh-list
43679212|NCT02855866|Cortisone|cortisone|mesh-list
43679213|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
43679214|NCT02855866|BB 1101|bb 1101|mesh-list
43679215|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679216|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
43679217|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
43679218|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679219|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679220|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43679221|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
43679222|NCT02855866|Hormones|hormones|mesh-ancestor
43679223|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679224|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43679227|NCT02855866|Analgesics|analgesics|mesh-ancestor
43679231|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679232|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679233|NCT02855788|Leucovorin|leucovorin|mesh-list
43679234|NCT02855788|Paclitaxel|paclitaxel|mesh-list
43679235|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
43679236|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43679237|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679238|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
43679239|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
43679240|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
43679241|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679242|NCT02855788|Antidotes|antidotes|mesh-ancestor
43679243|NCT02855788|Protective Agents|protective agents|mesh-ancestor
43679244|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593725|NCT03341234|Bupivacaine|bupivacaine|mesh-list
43679245|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
43679246|NCT02855788|Vitamins|vitamins|mesh-ancestor
43679247|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
43679248|NCT02855502|Prednisolone|prednisolone|mesh-list
43679249|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679250|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
43679251|NCT02855502|Hormones|hormones|mesh-ancestor
43679252|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679253|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679254|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43679255|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588467|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
43588468|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588469|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588470|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
43588471|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43588472|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43588473|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588474|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43588475|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43588476|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43588477|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588478|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43681091|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
43681102|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
43681103|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43588479|NCT03387631|Lumefantrine|lumefantrine|mesh-list
43588480|NCT03387631|Artemether|artemether|mesh-list
43588481|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43588482|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
43588483|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43588484|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43588485|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588486|NCT03387592|Leucovorin|leucovorin|mesh-list
43588499|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
43588500|NCT03387592|Antidotes|antidotes|mesh-ancestor
43588501|NCT03387592|Protective Agents|protective agents|mesh-ancestor
43588502|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
43588503|NCT03387592|Vitamins|vitamins|mesh-ancestor
43588504|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
43679256|NCT02855515|Anesthetics|anesthetics|mesh-list
43679257|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679258|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679259|NCT02855346|Dapivirine|dapivirine|mesh-list
43679260|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
43598892|NCT03295760|Ubiquinone|ubiquinone|mesh-list
43588518|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588519|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588520|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43588521|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
43588522|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
43588523|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43588524|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43588525|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43588526|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43588527|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
43588528|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593765|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
43681123|NCT04156087|Tremelimumab|tremelimumab|mesh-list
43681124|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43681125|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
43681126|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681128|NCT04156087|Antiviral Agents|antiviral agents|mesh-ancestor
43588529|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588530|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
43588531|NCT03387241|Hormones|hormones|mesh-ancestor
43588532|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588533|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
43588535|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43588536|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43588537|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43588538|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43588539|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588540|NCT03387111|Leucovorin|leucovorin|mesh-list
43588541|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
43588542|NCT03387111|Bevacizumab|bevacizumab|mesh-list
43588543|NCT03387111|Fluorouracil|fluorouracil|mesh-list
43588544|NCT03387111|Capecitabine|capecitabine|mesh-list
43588545|NCT03387111|Cetuximab|cetuximab|mesh-list
43588546|NCT03387111|Avelumab|avelumab|mesh-list
43588547|NCT03387111|Necitumumab|necitumumab|mesh-list
43588548|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588549|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588550|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588551|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
43588556|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43588557|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588558|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43588559|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43593809|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43593810|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
43588560|NCT03387111|Growth Substances|growth substances|mesh-ancestor
43588561|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
43588562|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
43588563|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43588565|NCT03387111|Protective Agents|protective agents|mesh-ancestor
43679266|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43679267|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43679268|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43679269|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43679270|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
43679271|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679272|NCT02855307|Insulin|insulin|mesh-list
43679273|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43679274|NCT02855307|Hormones|hormones|mesh-list
43679275|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43588566|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
43588567|NCT03387111|Vitamins|vitamins|mesh-ancestor
43588568|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
43588569|NCT03387098|Leucovorin|leucovorin|mesh-list
43588570|NCT03387098|Paclitaxel|paclitaxel|mesh-list
43588571|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
43588572|NCT03387098|Bevacizumab|bevacizumab|mesh-list
43588573|NCT03387098|Fluorouracil|fluorouracil|mesh-list
43588574|NCT03387098|Capecitabine|capecitabine|mesh-list
43588575|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
43588576|NCT03387098|Avelumab|avelumab|mesh-list
43588577|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43588578|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588579|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
43588580|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
43588581|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
43588582|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588583|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588584|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
43588585|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588586|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588587|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43588588|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
43588589|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43588590|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588591|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43588592|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43588593|NCT03387098|Growth Substances|growth substances|mesh-ancestor
43588594|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
43588595|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
43588596|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43588597|NCT03387098|Antidotes|antidotes|mesh-ancestor
43588598|NCT03387098|Protective Agents|protective agents|mesh-ancestor
43588599|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
43588600|NCT03387098|Vitamins|vitamins|mesh-ancestor
43588601|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
43588602|NCT03386838|Cisplatin|cisplatin|mesh-list
43588603|NCT03386838|Carboplatin|carboplatin|mesh-list
43588604|NCT03386838|Fluorouracil|fluorouracil|mesh-list
43681141|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43588605|NCT03386838|Nivolumab|nivolumab|mesh-list
43588608|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588609|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
43588610|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588611|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43588612|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588613|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
43588614|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588615|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588616|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43588617|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588618|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
43588619|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43588620|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43588621|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588622|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
43593924|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593925|NCT03339427|Vitamin D|vitamin d|mesh-list
43588623|NCT03386656|Coagulants|coagulants|mesh-ancestor
43588624|NCT03386643|Clobetasol|clobetasol|mesh-list
43588625|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588635|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
43679276|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679277|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679278|NCT02855294|Drospirenone|drospirenone|mesh-list
43679279|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43679280|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
43679281|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679282|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828324|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828325|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43679283|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43679284|NCT02855294|Diuretics|diuretics|mesh-ancestor
43679285|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
43679286|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
43679287|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588636|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588637|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588638|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
43588639|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588640|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43588641|NCT03386630|Narcotics|narcotics|mesh-ancestor
43588642|NCT03386630|Analgesics|analgesics|mesh-ancestor
43588643|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43588644|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43588645|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
43588646|NCT03386591|Naloxone|naloxone|mesh-list
43588647|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43588648|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588649|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
43588650|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588651|NCT03386565|Lidocaine|lidocaine|mesh-list
43847015|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43594038|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43594039|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43594049|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594051|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
43594052|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594053|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43588652|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43588653|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
43588654|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
43588655|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588656|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588657|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
43588658|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588659|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43588660|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43588661|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43588662|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43588663|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588664|NCT03386318|Oxycodone|oxycodone|mesh-list
43588665|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43588666|NCT03386318|Narcotics|narcotics|mesh-ancestor
43588667|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588668|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588669|NCT03386318|Analgesics|analgesics|mesh-ancestor
43588670|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
43588671|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588672|NCT03386305|Tacrolimus|tacrolimus|mesh-list
43588673|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588674|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
43588675|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588676|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43588677|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588678|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588679|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
43588680|NCT03386279|Abrocitinib|abrocitinib|mesh-list
43588681|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43679288|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679289|NCT02855138|Isotretinoin|isotretinoin|mesh-list
43679290|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
43679291|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
43679292|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43679293|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
43679294|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679295|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
43679296|NCT02855073|Protective Agents|protective agents|mesh-ancestor
43679297|NCT02854995|Triamcinolone|triamcinolone|mesh-list
43679298|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679299|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
43679300|NCT02854995|Hormones|hormones|mesh-ancestor
43679301|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679302|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588682|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598894|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
43588688|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43588689|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43588690|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588691|NCT03386201|Methylene Blue|methylene blue|mesh-list
43588692|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588693|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588700|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594054|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43594055|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43594056|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
43594057|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594058|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594059|NCT03337529|Ascorbic Acid|ascorbic acid|mesh-list
43594060|NCT03337529|Vitamins|vitamins|mesh-ancestor
43594061|NCT03337529|Micronutrients|micronutrients|mesh-ancestor
43588701|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588703|NCT03386071|Trametinib|trametinib|mesh-list
43588704|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588705|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43588706|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588707|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588708|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
43588709|NCT03385967|Ropivacaine|ropivacaine|mesh-list
43588710|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43588711|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588712|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588713|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43588715|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
43588716|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588717|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43588718|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43588719|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43588720|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
43588721|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588722|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588724|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
43588725|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43588726|NCT03385863|Poractant alfa|poractant alfa|mesh-list
43588727|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
43588728|NCT03385668|Pirfenidone|pirfenidone|mesh-list
43588729|NCT03385668|Analgesics|analgesics|mesh-ancestor
43588730|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
43588731|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588732|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679303|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
43679304|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43679305|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679306|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594062|NCT03337529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594063|NCT03337529|Antioxidants|antioxidants|mesh-ancestor
43679307|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43679309|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
43679310|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679311|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43679312|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43679313|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43679314|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
43679315|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681197|NCT03954366|Rucaparib|rucaparib|mesh-list
43681198|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43588733|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43588734|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43588735|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588736|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588737|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588738|NCT03385551|Estradiol|estradiol|mesh-list
43588739|NCT03385551|Estrogens|estrogens|mesh-ancestor
43588740|NCT03385551|Hormones|hormones|mesh-ancestor
43588741|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588742|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588743|NCT03385538|Clopidogrel|clopidogrel|mesh-list
43588744|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43588745|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43588746|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43588747|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43588748|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
43588749|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588750|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588751|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588752|NCT03385525|Valproic Acid|valproic acid|mesh-list
43588753|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
43588754|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599274|NCT03291821|Hormones|hormones|mesh-ancestor
43588779|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588780|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43679316|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679318|NCT02854761|Vitamins|vitamins|mesh-ancestor
43588782|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43588783|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43588784|NCT03385382|Growth Substances|growth substances|mesh-ancestor
43588785|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
43681216|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588786|NCT03385356|Vitamin D|vitamin d|mesh-list
43588787|NCT03385356|Vitamins|vitamins|mesh-ancestor
43681217|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
43681218|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
43681219|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
43681220|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588788|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
43588789|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588790|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43588791|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
43588792|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
43588793|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588794|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
43588795|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588796|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588797|NCT03385161|Ethanol|ethanol|mesh-list
43588798|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
43588799|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43681221|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43681222|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
43681223|NCT03943667|Antiviral Agents|antiviral agents|mesh-ancestor
43681224|NCT03943667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681225|NCT03943667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681226|NCT03943667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681227|NCT03943667|Immunologic Factors|immunologic factors|mesh-ancestor
43681228|NCT03943667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681229|NCT03923725|Artesunate|artesunate|mesh-list
43681230|NCT03923725|Lumefantrine|lumefantrine|mesh-list
43681232|NCT03923725|Piperaquine|piperaquine|mesh-list
43681233|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43681234|NCT03923725|Amodiaquine|amodiaquine|mesh-list
43681235|NCT03923725|Mefloquine|mefloquine|mesh-list
43681236|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
43594209|NCT03336125|Vitamin D|vitamin d|mesh-list
43594210|NCT03336125|Vitamins|vitamins|mesh-ancestor
43594211|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
43588800|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43588801|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43588802|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43588803|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588804|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
43588805|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588806|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594215|NCT03335956|Prednisone|prednisone|mesh-list
43588807|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43588808|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588809|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588810|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43588811|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588812|NCT03385135|Allopurinol|allopurinol|mesh-list
43588813|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
43588814|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588815|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588816|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
43588817|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588818|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43588819|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
43679333|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
43679334|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
43679335|NCT02854722|Vitamins|vitamins|mesh-list
43679336|NCT02854722|Calcium|calcium|mesh-list
43679337|NCT02854722|Deferasirox|deferasirox|mesh-list
43679338|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
43588820|NCT03385135|Protective Agents|protective agents|mesh-ancestor
43588821|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588822|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
43588823|NCT03385096|Melphalan|melphalan|mesh-list
43588824|NCT03385096|Busulfan|busulfan|mesh-list
43588825|NCT03385096|Etoposide|etoposide|mesh-list
43588827|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
43588828|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588829|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588830|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43588831|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
43588832|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594218|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
43588833|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588834|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43588835|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43588836|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43588844|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588845|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588846|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
43588847|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43588848|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588849|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588850|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43588851|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594254|NCT03335527|Analgesics|analgesics|mesh-ancestor
43594263|NCT03335501|Pancrelipase|pancrelipase|mesh-list
43588852|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588854|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
43588855|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
43588856|NCT03384862|Vitamins|vitamins|mesh-ancestor
43588857|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
43588858|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588878|NCT03384524|Urological Agents|urological agents|mesh-ancestor
43588879|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43588880|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43588881|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
43588882|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588883|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
43588884|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
43679340|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43679342|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43679343|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
43679344|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
43679345|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679346|NCT02854787|Phenylephrine|phenylephrine|mesh-list
43679347|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
43679348|NCT02854787|Norepinephrine|norepinephrine|mesh-list
43679349|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43679350|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
43679351|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
43679352|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679353|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679354|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
43679355|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43679356|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
43679357|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
43679358|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43679359|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43679360|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43679361|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
43679362|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679364|NCT02854787|Protective Agents|protective agents|mesh-ancestor
43679373|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679374|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679375|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43679376|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
43679377|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
43679378|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43679379|NCT02853864|Analgesics|analgesics|mesh-ancestor
43679380|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
43679381|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679382|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43679383|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43679384|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43679385|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
43679386|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679387|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679388|NCT02854072|Gemcitabine|gemcitabine|mesh-list
43679389|NCT02854072|Capecitabine|capecitabine|mesh-list
43679398|NCT02854072|Immunologic Factors|immunologic factors|mesh-ancestor
43679399|NCT02854072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679400|NCT02853799|Insulin|insulin|mesh-list
43679401|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43679402|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679403|NCT02853630|Metformin|metformin|mesh-list
43679404|NCT02853630|Vildagliptin|vildagliptin|mesh-list
43679405|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43588890|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
43588891|NCT03384277|Rituximab|rituximab|mesh-list
43588892|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588893|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
43588894|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588895|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588896|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43588897|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
43679406|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679407|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43679408|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
43679409|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681281|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681282|NCT03839914|Vancomycin|vancomycin|mesh-list
43681283|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43681284|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681285|NCT03832972|Estrogens|estrogens|mesh-list
43681286|NCT03832972|Hormones|hormones|mesh-ancestor
43681287|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681288|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828345|NCT05478382|Pregabalin|pregabalin|mesh-list
43828346|NCT05478382|Analgesics|analgesics|mesh-ancestor
43828347|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
43828348|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828349|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828350|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
43828351|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43828352|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828353|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828354|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43679410|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679411|NCT02853539|Denosumab|denosumab|mesh-list
43679412|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43679413|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679414|NCT02853526|Propranolol|propranolol|mesh-list
43679416|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
43679417|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43679418|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43679419|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
43679420|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679421|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588898|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588899|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588900|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43588901|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588902|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43588904|NCT03384238|Antibodies|antibodies|mesh-list
43588905|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
43588911|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43588913|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43588914|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588915|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
43588916|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43588917|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588918|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588919|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43681289|NCT03770338|Teriparatide|teriparatide|mesh-list
43681290|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43681291|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681292|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43594449|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594450|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594451|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43681293|NCT03755791|Sorafenib|sorafenib|mesh-list
43681294|NCT03755791|Atezolizumab|atezolizumab|mesh-list
43681295|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681296|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43681297|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681299|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43588920|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43588921|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43588922|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43588923|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43588924|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43588925|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
43588926|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43588927|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
43588928|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588929|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
43588930|NCT03384095|Protective Agents|protective agents|mesh-ancestor
43588931|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43588932|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43588933|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43588934|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
43588935|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588936|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588937|NCT03383822|Insulin|insulin|mesh-list
43588938|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43588939|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43599365|NCT03290846|Hormones|hormones|mesh-ancestor
43588940|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588941|NCT03383744|Vitamin A|vitamin a|mesh-list
43588942|NCT03383744|Vitamins|vitamins|mesh-ancestor
43588943|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
43588944|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679422|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679423|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43679424|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43679425|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
43679426|NCT02853552|Misoprostol|misoprostol|mesh-list
43679427|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43679428|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
43679429|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43679430|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679431|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43679432|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43679433|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
43827967|NCT05483647|Anesthetics|anesthetics|mesh-list
43588946|NCT03383406|Methotrexate|methotrexate|mesh-list
43588947|NCT03383406|Etoposide|etoposide|mesh-list
43588948|NCT03383406|Ifosfamide|ifosfamide|mesh-list
43588949|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43588950|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
43588951|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43588952|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588953|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43588954|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
43588955|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588956|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588957|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
43588958|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588959|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43588960|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588961|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
43588962|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588963|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43588964|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43588965|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43588966|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43588967|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
43588968|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588969|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43588970|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
43588971|NCT03383393|Adenosine|adenosine|mesh-list
43588972|NCT03383393|Eptifibatide|eptifibatide|mesh-list
43588973|NCT03383393|Analgesics|analgesics|mesh-ancestor
43588974|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
43588975|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588979|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43588981|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
43588982|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588983|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588984|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43588986|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
43588987|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588988|NCT03383367|Protective Agents|protective agents|mesh-ancestor
43588989|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588991|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43588992|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
43588993|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43588994|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
43588995|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43588996|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43588997|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
43588998|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588999|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
43827968|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827969|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827970|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
43827971|NCT05483439|Carboplatin|carboplatin|mesh-list
43827972|NCT05483439|Docetaxel|docetaxel|mesh-list
43679434|NCT02853253|SMOFlipid|smoflipid|mesh-list
43679435|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43594604|NCT03332602|Protective Agents|protective agents|mesh-ancestor
43594638|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
43679436|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43679437|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43679438|NCT02853370|Rituximab|rituximab|mesh-list
43679439|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43594639|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43594640|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
43594641|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
43594642|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594643|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43594644|NCT03332329|Entecavir|entecavir|mesh-list
43594645|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43679440|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43679441|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589000|NCT03383328|Hormones|hormones|mesh-ancestor
43589001|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589002|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589003|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43589004|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589005|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
43589006|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
43589007|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589008|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43589009|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43589010|NCT03383328|Protective Agents|protective agents|mesh-ancestor
43589011|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43589012|NCT03383328|Analgesics|analgesics|mesh-ancestor
43589013|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
43589014|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43589015|NCT03383315|Tramadol|tramadol|mesh-list
43589016|NCT03383315|Metoclopramide|metoclopramide|mesh-list
43589017|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43589018|NCT03383315|Narcotics|narcotics|mesh-ancestor
43589019|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589020|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589021|NCT03383315|Analgesics|analgesics|mesh-ancestor
43589022|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
43589023|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589024|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
43589025|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
43589026|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43589027|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43589028|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43594672|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594673|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
43594674|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
43594675|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594676|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681325|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43589030|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589036|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589037|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43589039|NCT03383237|Apatinib|apatinib|mesh-list
43589040|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589041|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589042|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589043|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589044|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43589045|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
43589046|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
43589052|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43589053|NCT03383185|Hormones|hormones|mesh-ancestor
43679442|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
43679443|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679444|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43679445|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43679446|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
43679447|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679448|NCT02853578|Budesonide|budesonide|mesh-list
43679449|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679450|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43679451|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
43679452|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679453|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589054|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589055|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43589056|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43589057|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43589058|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43589059|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43589061|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43589062|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589063|NCT03383094|Cisplatin|cisplatin|mesh-list
43589064|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
43589065|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589066|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589067|NCT03383068|Metformin|metformin|mesh-list
43589068|NCT03383068|Exenatide|exenatide|mesh-list
43589069|NCT03383068|Acarbose|acarbose|mesh-list
43589070|NCT03383068|Orlistat|orlistat|mesh-list
43589071|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43589072|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589073|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43589074|NCT03383068|Incretins|incretins|mesh-ancestor
43589075|NCT03383068|Hormones|hormones|mesh-ancestor
43589076|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589077|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43589078|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589079|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589080|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43589081|NCT03383003|Amoxicillin|amoxicillin|mesh-list
43589082|NCT03383003|Metronidazole|metronidazole|mesh-list
43589083|NCT03383003|Clarithromycin|clarithromycin|mesh-list
43589084|NCT03383003|Esomeprazole|esomeprazole|mesh-list
43589085|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43589086|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589087|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43589088|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43589089|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43589090|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43589091|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43589092|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589093|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589094|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43589095|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43589096|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43589098|NCT03382886|Nivolumab|nivolumab|mesh-list
43589099|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589100|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589101|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43589102|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43589103|NCT03382886|Growth Substances|growth substances|mesh-ancestor
43679454|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43679455|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
43679457|NCT02853578|Hormones|hormones|mesh-ancestor
43679458|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679459|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
43679460|NCT02853136|BI 409306|bi 409306|mesh-list
43679461|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43679462|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43679463|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679464|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679465|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43679466|NCT02853136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43679467|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43679468|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43679469|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679470|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679471|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
43679472|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43679473|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
43679474|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43589104|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589105|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
43589106|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43589107|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589108|NCT03382756|Choline|choline|mesh-list
43589109|NCT03382756|Atorvastatin|atorvastatin|mesh-list
43589110|NCT03382756|Fenofibrate|fenofibrate|mesh-list
43589111|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43589112|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43589113|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
43589114|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589115|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43589116|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43589124|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589125|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589126|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
43594797|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589127|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589128|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43589129|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43589130|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43589131|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43589132|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589133|NCT03382717|Amorolfine|amorolfine|mesh-list
43589134|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
43594798|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
43594799|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594800|NCT03330782|Remifentanil|remifentanil|mesh-list
43594801|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43594802|NCT03330782|Narcotics|narcotics|mesh-ancestor
43594803|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594804|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594805|NCT03330782|Analgesics|analgesics|mesh-ancestor
43594806|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
43594807|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594808|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
43594809|NCT03330717|Anesthetics|anesthetics|mesh-list
43594810|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594811|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594812|NCT03330613|Anesthetics|anesthetics|mesh-list
43594813|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594814|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594815|NCT03330223|Clopidogrel|clopidogrel|mesh-list
43589135|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589136|NCT03382600|Cisplatin|cisplatin|mesh-list
43849090|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589137|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
43589138|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
43679475|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43679476|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679477|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43594816|NCT03330223|Ticagrelor|ticagrelor|mesh-list
43594825|NCT03330171|Vaccines|vaccines|mesh-list
43679478|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43589139|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589140|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589141|NCT03382587|Aflibercept|aflibercept|mesh-list
43589142|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43589143|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43589144|NCT03382587|Growth Substances|growth substances|mesh-ancestor
43594826|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
43594827|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681337|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681338|NCT03730194|Protective Agents|protective agents|mesh-ancestor
43681339|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681340|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681341|NCT03718130|Vaccines|vaccines|mesh-list
43681342|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
43681343|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681344|NCT03672500|Epinephrine|epinephrine|mesh-list
43681345|NCT03672500|Bupivacaine|bupivacaine|mesh-list
43681346|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
43681347|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
43681348|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681349|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594828|NCT03330132|Vaccines|vaccines|mesh-list
43589145|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589146|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
43589147|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589148|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
43589149|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43589151|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
43589152|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589153|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589154|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589155|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
43589156|NCT03382314|Vitamin D|vitamin d|mesh-list
43589157|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
43589158|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43589159|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589160|NCT03382314|Vitamins|vitamins|mesh-ancestor
43589161|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
43589162|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43589163|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43589164|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43589165|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
43589166|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589167|NCT03382275|Iron|iron|mesh-list
43589168|NCT03382275|Ferric maltol|ferric maltol|mesh-list
43589169|NCT03382275|Trace Elements|trace elements|mesh-ancestor
43589170|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
43589171|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589172|NCT03382275|Hematinics|hematinics|mesh-ancestor
43589173|NCT03381859|Grazoprevir|grazoprevir|mesh-list
43589174|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43589175|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
43589176|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589177|NCT03381833|Hepcidins|hepcidins|mesh-list
43589178|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589179|NCT03381781|Cytarabine|cytarabine|mesh-list
43589180|NCT03381781|Decitabine|decitabine|mesh-list
43589181|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
43589182|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43589184|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589185|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589186|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
43589196|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43589197|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
43589198|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589199|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589200|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589202|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43589203|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43589204|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
43589205|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589206|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589207|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589209|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
43589210|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
43589211|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
43589212|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43589213|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43589214|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679479|NCT02853071|Estramustine|estramustine|mesh-list
43679480|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43679481|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
43679482|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679483|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679484|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43679485|NCT02852837|Daratumumab|daratumumab|mesh-list
43679486|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594843|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594844|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43679487|NCT02852798|Docetaxel|docetaxel|mesh-list
43679488|NCT02852798|Apatinib|apatinib|mesh-list
43679489|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679490|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
43589215|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589216|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589217|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43589218|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43589219|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
43589220|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43589221|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
43589222|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43589223|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43594872|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43589224|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589225|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589226|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43589227|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43589228|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
43589229|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43589230|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43589231|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43589232|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43594873|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
43589233|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43589234|NCT03381599|Lenograstim|lenograstim|mesh-list
43589235|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43589236|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
43589237|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589238|NCT03381495|Sufentanil|sufentanil|mesh-list
43589239|NCT03381495|Ropivacaine|ropivacaine|mesh-list
43589240|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589241|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
43589242|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589243|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589244|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
43589245|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589246|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43589247|NCT03381495|Narcotics|narcotics|mesh-ancestor
43589248|NCT03381495|Analgesics|analgesics|mesh-ancestor
43589249|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43589250|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43589259|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589260|NCT03381352|Capecitabine|capecitabine|mesh-list
43594921|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
43589261|NCT03381352|Mitomycins|mitomycins|mesh-list
43589262|NCT03381352|Mitomycin|mitomycin|mesh-list
43589263|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43589264|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
43589265|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589266|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589267|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43589268|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
43589269|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43589270|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589271|NCT03381118|Cytarabine|cytarabine|mesh-list
43594964|NCT03329183|Irinotecan|irinotecan|mesh-list
43594965|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43594966|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43589272|NCT03381118|Nivolumab|nivolumab|mesh-list
43679492|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
43594967|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679493|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679494|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43679495|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679496|NCT02852681|Drospirenone|drospirenone|mesh-list
43679497|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43679508|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43679509|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
43679510|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43589273|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589274|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595000|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
43595001|NCT03328728|Protective Agents|protective agents|mesh-ancestor
43595002|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595003|NCT03328533|Phenylephrine|phenylephrine|mesh-list
43595004|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
43595005|NCT03328533|Norepinephrine|norepinephrine|mesh-list
43595006|NCT03328533|Bupivacaine|bupivacaine|mesh-list
43595007|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589275|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43589276|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589277|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43589278|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
43589279|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
43589280|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589281|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43589282|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
43589283|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589284|NCT03381066|Cisplatin|cisplatin|mesh-list
43589285|NCT03381066|Pemetrexed|pemetrexed|mesh-list
43589286|NCT03381066|Vinorelbine|vinorelbine|mesh-list
43589287|NCT03381066|Gefitinib|gefitinib|mesh-list
43589288|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589289|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589290|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589291|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43589292|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43589293|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43589294|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
43589295|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
43589296|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
43589297|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589298|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
43589299|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589300|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589301|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589302|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679542|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679544|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
43679545|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679546|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43679547|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
43679548|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43679549|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43681383|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
43681385|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43679550|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43679551|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589303|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
43589304|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43595043|NCT03328312|Atropine|atropine|mesh-list
43589305|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
43589306|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589307|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
43589308|NCT03381040|Protective Agents|protective agents|mesh-ancestor
43589309|NCT03380975|Montelukast|montelukast|mesh-list
43589310|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43589311|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
43589312|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43589313|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
43589314|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589315|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589316|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43589317|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43589326|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589328|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
43589329|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43589330|NCT03380936|Antibodies|antibodies|mesh-list
43589331|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
43595110|NCT03327727|VL-2397|vl-2397|mesh-list
43589332|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43589333|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43589334|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
43589335|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589336|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43589337|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589338|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589339|NCT03380871|Carboplatin|carboplatin|mesh-list
43589340|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
43589341|NCT03380871|Pemetrexed|pemetrexed|mesh-list
43589342|NCT03380871|Poly ICLC|poly iclc|mesh-list
43589344|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589345|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679552|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
43679553|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
43679554|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
43679555|NCT02852083|Pioglitazone|pioglitazone|mesh-list
43679556|NCT02852083|Clarithromycin|clarithromycin|mesh-list
43679557|NCT02852083|Nivolumab|nivolumab|mesh-list
43679558|NCT02852083|Treosulfan|treosulfan|mesh-list
43679559|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43679560|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679561|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43679562|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679563|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43679564|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679565|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43595171|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43589346|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589347|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43589348|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43589349|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
43589350|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
43589351|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589352|NCT03380728|Ibogaine|ibogaine|mesh-list
43589353|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
43589354|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589355|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43589356|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43589357|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43589358|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589359|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589360|NCT03380689|Bevacizumab|bevacizumab|mesh-list
43589361|NCT03380689|Irinotecan|irinotecan|mesh-list
43589362|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589363|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589364|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43589365|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43589366|NCT03380689|Growth Substances|growth substances|mesh-ancestor
43589367|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589368|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
43589369|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43589370|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43589371|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589372|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589373|NCT03380533|Buprenorphine|buprenorphine|mesh-list
43589374|NCT03380533|Tramadol|tramadol|mesh-list
43589375|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43589376|NCT03380533|Narcotics|narcotics|mesh-ancestor
43589377|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589378|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589379|NCT03380533|Analgesics|analgesics|mesh-ancestor
43589380|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
43589381|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681443|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
43589382|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43589383|NCT03380468|Cisplatin|cisplatin|mesh-list
43589384|NCT03380468|Pemetrexed|pemetrexed|mesh-list
43589385|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589386|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589395|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589396|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43589397|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43589398|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
43589399|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
43679566|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679567|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43679568|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595326|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679569|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43679570|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43679571|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43679572|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
43679573|NCT02852239|Dabrafenib|dabrafenib|mesh-list
43679574|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679575|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43679576|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679577|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679578|NCT02852122|Choline|choline|mesh-list
43589400|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589401|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43589402|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43595389|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595485|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43589403|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589404|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589405|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
43589406|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43589407|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
43589408|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43589409|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589410|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43589411|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43589412|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589413|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589414|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589415|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43589416|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43589417|NCT03380325|Iloprost|iloprost|mesh-list
43589418|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43589419|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
43589420|NCT03380130|Nivolumab|nivolumab|mesh-list
43589421|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589422|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589423|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43589424|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589441|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681543|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589442|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
43589443|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589444|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43589445|NCT03379987|Narcotics|narcotics|mesh-ancestor
43589446|NCT03379987|Analgesics|analgesics|mesh-ancestor
43589447|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43679579|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
43679580|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43679581|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
43679582|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679583|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43679584|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43679585|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
43679587|NCT02852382|Bupivacaine|bupivacaine|mesh-list
43679589|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
43679590|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589448|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
43589449|NCT03379974|Coagulants|coagulants|mesh-ancestor
43589450|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43589451|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
43589452|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589454|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43589464|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43589465|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43589466|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
43589467|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589468|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589469|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589470|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43589471|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43589472|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
43589474|NCT03379103|Sevoflurane|sevoflurane|mesh-list
43589475|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43589476|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589477|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589478|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43589479|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
43589480|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
43589481|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43589482|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43589483|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
43589484|NCT03379012|Sunitinib|sunitinib|mesh-list
43849123|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
43589485|NCT03379012|Testosterone|testosterone|mesh-list
43589486|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
43589487|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
43589488|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43589489|NCT03379012|Androgens|androgens|mesh-ancestor
43589490|NCT03379012|Hormones|hormones|mesh-ancestor
43589491|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589492|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589493|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43589495|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
43595632|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595633|NCT03323671|Analgesics|analgesics|mesh-ancestor
43595634|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
43589496|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43589497|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43595635|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595636|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595637|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595638|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43589498|NCT03379012|Growth Substances|growth substances|mesh-ancestor
43589499|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
43589500|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589501|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589502|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589503|NCT03378960|Omeprazole|omeprazole|mesh-list
43589504|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43589505|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43589506|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43589507|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679592|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
43679593|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679594|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43679595|NCT02852382|Narcotics|narcotics|mesh-ancestor
43679596|NCT02852382|Analgesics|analgesics|mesh-ancestor
43679597|NCT02851888|Ropivacaine|ropivacaine|mesh-list
43679598|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
43679599|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679600|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679601|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
43679602|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
43589508|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595639|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43589509|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
43589510|NCT03378791|Trace Elements|trace elements|mesh-ancestor
43589511|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
43589512|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589514|NCT03378726|Trace Elements|trace elements|mesh-list
43589515|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589516|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
43589517|NCT03378713|Testosterone|testosterone|mesh-list
43589518|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
43589519|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
43681607|NCT03302728|Lenalidomide|lenalidomide|mesh-list
43681608|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43681609|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
43681619|NCT03299660|Avelumab|avelumab|mesh-list
43589520|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43589521|NCT03378713|Androgens|androgens|mesh-ancestor
43589532|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589533|NCT03378674|Analgesics|analgesics|mesh-ancestor
43589534|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
43589535|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589536|NCT03378661|Benzonidazole|benzonidazole|mesh-list
43589537|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43589538|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
43589539|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589540|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43589541|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43589542|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43589543|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589544|NCT03378648|Bromides|bromides|mesh-list
43589545|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
43589546|NCT03378427|Doxycycline|doxycycline|mesh-list
43589547|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
43589548|NCT03378427|Levofloxacin|levofloxacin|mesh-list
43589549|NCT03378427|Ofloxacin|ofloxacin|mesh-list
43589550|NCT03378427|Minocycline|minocycline|mesh-list
43589551|NCT03378427|Rifampin|rifampin|mesh-list
43589552|NCT03378427|Clindamycin|clindamycin|mesh-list
43589553|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43589554|NCT03378427|Tedizolid|tedizolid|mesh-list
43589555|NCT03378427|Teicoplanin|teicoplanin|mesh-list
43589556|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
43595698|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595700|NCT03323372|Fluorides|fluorides|mesh-list
43595701|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
43595702|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
43595703|NCT03323372|Protective Agents|protective agents|mesh-ancestor
43595704|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595705|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43595706|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595708|NCT03323047|Dexamethasone|dexamethasone|mesh-list
43595709|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
43595710|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43595711|NCT03323047|BB 1101|bb 1101|mesh-list
43595712|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595713|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
43595714|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
43595715|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589557|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
43589558|NCT03378427|Trimethoprim|trimethoprim|mesh-list
43589559|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
43589560|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43589561|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589562|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
43589563|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43589564|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43589565|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43589566|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43589568|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589569|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589570|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43679603|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679604|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
43679605|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
43679606|NCT02851914|Serotonin|serotonin|mesh-list
43679607|NCT02851914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43679608|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43679609|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43679610|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
43679611|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595743|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595744|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43595745|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
43595746|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43595747|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43595748|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595749|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43595750|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
43595751|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43595753|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
43681634|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43681635|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43681636|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681637|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681638|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
43681639|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679612|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679613|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679614|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43679615|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43679616|NCT02852070|Dimercaprol|dimercaprol|mesh-list
43679617|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
43679618|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
43679619|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679620|NCT02851745|Linagliptin|linagliptin|mesh-list
43679621|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43679622|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827999|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828000|NCT05482763|Itraconazole|itraconazole|mesh-list
43828001|NCT05482763|Terbinafine|terbinafine|mesh-list
43828002|NCT05482763|Ciclopirox|ciclopirox|mesh-list
43828003|NCT05482763|Amorolfine|amorolfine|mesh-list
43828004|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
43828005|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828006|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43828007|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43828008|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828009|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681640|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828010|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43828011|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
43828012|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828013|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828014|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43846988|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846989|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679646|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
43679647|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679648|NCT02851433|Anesthetics|anesthetics|mesh-list
43679649|NCT02851433|Propofol|propofol|mesh-list
43679650|NCT02851433|Sevoflurane|sevoflurane|mesh-list
43679651|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679653|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43679654|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43679655|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
43595806|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
43679656|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43679657|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43679658|NCT02851095|Metformin|metformin|mesh-list
43679659|NCT02851095|Canagliflozin|canagliflozin|mesh-list
43679660|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43589571|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43849091|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589572|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43589573|NCT03378427|Renal Agents|renal agents|mesh-ancestor
43589574|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43589575|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
43589576|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
43589577|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43589578|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43589579|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43589580|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43589581|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43589582|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43589583|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43589584|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43589585|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43589586|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43589596|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589597|NCT03378310|Linrodostat|linrodostat|mesh-list
43589598|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589599|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589600|NCT03378297|Aspirin|aspirin|mesh-list
43589601|NCT03378297|Metformin|metformin|mesh-list
43589602|NCT03378297|Letrozole|letrozole|mesh-list
43589603|NCT03378297|Olaparib|olaparib|mesh-list
43589604|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43589605|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589606|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589607|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43589608|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43589609|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589610|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589611|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43589612|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
43595895|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595896|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589613|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589614|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43589615|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43589616|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43589618|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
43589619|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679661|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679662|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43679663|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679664|NCT02851394|Tramadol|tramadol|mesh-list
43679665|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
43679666|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43679667|NCT02851394|Narcotics|narcotics|mesh-ancestor
43679668|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679669|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679670|NCT02851394|Analgesics|analgesics|mesh-ancestor
43679671|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
43679672|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589620|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43589621|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43589622|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43589623|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43589624|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43589625|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43589626|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
43589627|NCT03377907|Lidocaine|lidocaine|mesh-list
43589628|NCT03377907|Ketamine|ketamine|mesh-list
43681729|NCT03043729|Vitamins|vitamins|mesh-ancestor
43589629|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589630|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
43589631|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589632|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589633|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
43589634|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589635|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43589636|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43589637|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43589638|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43589639|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589640|NCT03377907|Analgesics|analgesics|mesh-ancestor
43589641|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43589642|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43589643|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
43589645|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43589647|NCT03377842|Leucovorin|leucovorin|mesh-list
43596025|NCT03320538|Rabeprazole|rabeprazole|mesh-list
43596026|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43589648|NCT03377842|Apatinib|apatinib|mesh-list
43589649|NCT03377842|Fluorouracil|fluorouracil|mesh-list
43589650|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
43589651|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589660|NCT03377842|Antidotes|antidotes|mesh-ancestor
43589661|NCT03377842|Protective Agents|protective agents|mesh-ancestor
43589662|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
43589663|NCT03377842|Vitamins|vitamins|mesh-ancestor
43589664|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
43589665|NCT03377725|Decitabine|decitabine|mesh-list
43589667|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43589668|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
43589669|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589670|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589671|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589672|NCT03377608|Tenofovir|tenofovir|mesh-list
43589673|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43589674|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
43589675|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
43596062|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43681805|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
43589676|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589677|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43589678|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43679673|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
43679674|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
43679675|NCT02851303|Morphine|morphine|mesh-list
43679676|NCT02851303|Methadone|methadone|mesh-list
43679677|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43679678|NCT02851303|Narcotics|narcotics|mesh-ancestor
43679679|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679680|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679681|NCT02851303|Analgesics|analgesics|mesh-ancestor
43679682|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
43679683|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679684|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
43679685|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
43679686|NCT02851212|Metformin|metformin|mesh-list
43679687|NCT02851212|Canagliflozin|canagliflozin|mesh-list
43679688|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43679689|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589679|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589680|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589681|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43589682|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43589683|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43828394|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
43828398|NCT05478083|Leuprolide|leuprolide|mesh-list
43589684|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
43589685|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43589686|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589687|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43589688|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43589689|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43589690|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589691|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43589692|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43589693|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43589694|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43589695|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
43589696|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
43589697|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589698|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589699|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589701|NCT03377400|Durvalumab|durvalumab|mesh-list
43589702|NCT03377400|Tremelimumab|tremelimumab|mesh-list
43589703|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589704|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589705|NCT03377348|Triamcinolone|triamcinolone|mesh-list
43589706|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43589707|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43589708|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43589709|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43589710|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
43589711|NCT03377348|Hormones|hormones|mesh-ancestor
43589712|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679691|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679693|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43679694|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596136|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679695|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
43679696|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
43679697|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43679698|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43679699|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679700|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679701|NCT02850718|Urological Agents|urological agents|mesh-ancestor
43679702|NCT02850744|Temozolomide|temozolomide|mesh-list
43679703|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43589729|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
43589730|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
43589731|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43589732|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43589733|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
43589734|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589735|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589738|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43589739|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589740|NCT03377218|Iodine|iodine|mesh-list
43589741|NCT03377218|Selenium|selenium|mesh-list
43589742|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
43589743|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43589744|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589745|NCT03377218|Trace Elements|trace elements|mesh-ancestor
43589746|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
43589747|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589748|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
43589749|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589750|NCT03377218|Protective Agents|protective agents|mesh-ancestor
43589751|NCT03377101|Fulvestrant|fulvestrant|mesh-list
43589752|NCT03377101|Palbociclib|palbociclib|mesh-list
43589753|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43589754|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589755|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43596196|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43596197|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43596198|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
43596199|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596200|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43596201|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43596202|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43596204|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
43596205|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596206|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43596207|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
43596208|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596216|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43596217|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43596218|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
43589756|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43589757|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
43589758|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589759|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589760|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589761|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589762|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589763|NCT03376958|Apatinib|apatinib|mesh-list
43589764|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589765|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589766|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589767|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589768|NCT03376932|Albuterol|albuterol|mesh-list
43589769|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
43589770|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43589771|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
43679704|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
43679705|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589812|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43849092|NCT03962465|Cytarabine|cytarabine|mesh-list
43589813|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43589814|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43589815|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
43589816|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
43596219|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589817|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589818|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589819|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589820|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
43589821|NCT03376555|Acetylcholine|acetylcholine|mesh-list
43589822|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
43589823|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43589824|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
43589825|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589826|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589827|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589828|NCT03376529|Tazobactam|tazobactam|mesh-list
43589829|NCT03376529|Piperacillin|piperacillin|mesh-list
43589830|NCT03376529|Ceftazidime|ceftazidime|mesh-list
43589831|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43589832|NCT03376529|Aztreonam|aztreonam|mesh-list
43589833|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43589834|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589835|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43589836|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589837|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589838|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43589839|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43589840|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589841|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596239|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43596240|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43681842|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681843|NCT02640222|Vitamin K|vitamin k|mesh-list
43681844|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
43681845|NCT02640222|Apixaban|apixaban|mesh-list
43681846|NCT02640222|Dabigatran|dabigatran|mesh-list
43681847|NCT02640222|Vitamins|vitamins|mesh-ancestor
43589842|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43589843|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43589844|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589845|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
43589846|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589847|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43589848|NCT03376243|Emollients|emollients|mesh-list
43589849|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
43589850|NCT03376191|Apatinib|apatinib|mesh-list
43589851|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589855|NCT03376178|Lidocaine|lidocaine|mesh-list
43589856|NCT03376178|Ropivacaine|ropivacaine|mesh-list
43681848|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
43681849|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589857|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589858|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
43589859|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589860|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589861|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
43589862|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589863|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43589864|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43589865|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43681875|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
43589866|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43589867|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589868|NCT03376139|Zonisamide|zonisamide|mesh-list
43589869|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
43589870|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43589871|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43679714|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43679715|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43679716|NCT02850848|Entecavir|entecavir|mesh-list
43681907|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681908|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43681909|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43681910|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
43679717|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
43679718|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679719|NCT05383131|Pirfenidone|pirfenidone|mesh-list
43679720|NCT05383131|Nintedanib|nintedanib|mesh-list
43679721|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679722|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43679723|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679724|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679725|NCT05383131|Analgesics|analgesics|mesh-ancestor
43679726|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
43679727|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679728|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679729|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43679730|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43679731|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679732|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596361|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43596362|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
43596363|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43596364|NCT03318159|Posaconazole|posaconazole|mesh-list
43596365|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
43596366|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596367|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43596368|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43596369|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43596370|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43596371|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43596372|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681929|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
43681930|NCT02555839|Bortezomib|bortezomib|mesh-list
43679734|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
43679735|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679736|NCT05382923|Protective Agents|protective agents|mesh-ancestor
43679737|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589872|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589873|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43589874|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589875|NCT03376048|Ropivacaine|ropivacaine|mesh-list
43589876|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589877|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
43589878|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589879|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589880|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
43589881|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589882|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43589883|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
43589884|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43589885|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
43589886|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
43589887|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596397|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589888|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589889|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
43589890|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43589891|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43589892|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
43589893|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589894|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679738|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679740|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43679741|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679742|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43679744|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
43679745|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43679746|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43679747|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679748|NCT05382390|Cytarabine|cytarabine|mesh-list
43679749|NCT05382390|Decitabine|decitabine|mesh-list
43679750|NCT05382390|Aclarubicin|aclarubicin|mesh-list
43679751|NCT05382390|Lenograstim|lenograstim|mesh-list
43679752|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43679753|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
43679754|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679755|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679756|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
43679757|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679758|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43679759|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
43679760|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679761|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43679762|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679763|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43679764|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43679765|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43679766|NCT05382351|Tenofovir|tenofovir|mesh-list
43828024|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828025|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
43828026|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
43828027|NCT05482373|Oleuropein|oleuropein|mesh-list
43828028|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828029|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43828030|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
43828031|NCT05482295|Vaccines|vaccines|mesh-list
43828032|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
43828033|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828034|NCT05482282|Vaccines|vaccines|mesh-list
43828035|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
43828036|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828037|NCT05482256|Listerine|listerine|mesh-list
43681972|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43828038|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
43828039|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
43828040|NCT05482256|Protective Agents|protective agents|mesh-ancestor
43828041|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828042|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43828043|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679776|NCT05382182|Androgens|androgens|mesh-list
43679780|NCT05382143|Atosiban|atosiban|mesh-list
43679796|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
43679797|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679798|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679799|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679800|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43679801|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
43679802|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
43679803|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43679804|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43679805|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679806|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679807|NCT05381389|Bupivacaine|bupivacaine|mesh-list
43679808|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
43679809|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
43679810|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679811|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679812|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
43596499|NCT03317197|Epinephrine|epinephrine|mesh-list
43596500|NCT03317197|Racepinephrine|racepinephrine|mesh-list
43682003|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
43679813|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679814|NCT05381363|Interferons|interferons|mesh-list
43679815|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589895|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
43589896|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589897|NCT03375671|Midazolam|midazolam|mesh-list
43589898|NCT03375671|Ketamine|ketamine|mesh-list
43589899|NCT03375671|Haloperidol|haloperidol|mesh-list
43589900|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
43589901|NCT03375671|Analgesics|analgesics|mesh-ancestor
43589902|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
43589903|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589904|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589905|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43589906|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43589907|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
43589908|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
43589909|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589910|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43682028|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682029|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682030|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43682031|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
43682032|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682033|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589911|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43589912|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43589913|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589914|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43589915|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43589916|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43589917|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43589918|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43589919|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
43589920|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
43589921|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
43589922|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
43589926|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
43589927|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43589928|NCT03375632|Dotinurad|dotinurad|mesh-list
43589929|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
43679816|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
43679817|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679818|NCT05381207|Fluticasone|fluticasone|mesh-list
43679819|NCT05381207|Xhance|xhance|mesh-list
43679820|NCT05381207|Montelukast|montelukast|mesh-list
43679821|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43589968|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589969|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589970|NCT03375515|Analgesics|analgesics|mesh-ancestor
43589971|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
43589972|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589973|NCT03375463|Tirzepatide|tirzepatide|mesh-list
43589974|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43589975|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589976|NCT03375463|Incretins|incretins|mesh-ancestor
43589978|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589986|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589988|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43589989|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
43589990|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589991|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43589992|NCT03375112|Bupivacaine|bupivacaine|mesh-list
43589993|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589994|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
43589995|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590007|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
43590008|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43590009|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590010|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43596589|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
43590011|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
43590012|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43590013|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590014|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
43590015|NCT03374722|Narcotics|narcotics|mesh-ancestor
43590016|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590017|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590018|NCT03374722|Analgesics|analgesics|mesh-ancestor
43590019|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
43590020|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590021|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
43590022|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
43590106|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43679878|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679879|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679880|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
43679881|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679882|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43679883|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43679884|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
43679885|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43679886|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43679887|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
43596641|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596642|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596643|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43596644|NCT03316339|Analgesics|analgesics|mesh-ancestor
43679888|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679889|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679909|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
43679910|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43679911|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43679912|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
43679913|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
43679914|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679915|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679916|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679917|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43679918|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43679919|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590193|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
43590194|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43590195|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43590196|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43590197|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43590198|NCT03373305|Lenalidomide|lenalidomide|mesh-list
43590199|NCT03373305|Piperidine|piperidine|mesh-list
43590200|NCT03373305|Antibodies|antibodies|mesh-list
43590201|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
43590202|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43590203|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
43590204|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
43590213|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590214|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43590215|NCT03373266|Anesthetics|anesthetics|mesh-list
43590216|NCT03373266|Sevoflurane|sevoflurane|mesh-list
43590217|NCT03373266|Isoflurane|isoflurane|mesh-list
43590218|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590219|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590220|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43590221|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43590222|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
43590223|NCT03373227|Tacrolimus|tacrolimus|mesh-list
43590224|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43590225|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
43590226|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590227|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43590228|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590229|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590231|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43590232|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590233|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590235|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43590236|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590237|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43590238|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590239|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590240|NCT03372837|Rituximab|rituximab|mesh-list
43590241|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43590242|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590243|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
43590244|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590245|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590246|NCT03372785|Aspirin|aspirin|mesh-list
43590247|NCT03372785|Metoprolol|metoprolol|mesh-list
43590248|NCT03372785|Clopidogrel|clopidogrel|mesh-list
43590249|NCT03372785|Ticagrelor|ticagrelor|mesh-list
43590250|NCT03372785|Atorvastatin|atorvastatin|mesh-list
43590251|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43596691|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43596692|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43596693|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596694|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596698|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596699|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596700|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596701|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596702|NCT03315533|Analgesics|analgesics|mesh-ancestor
43596703|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
43596704|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596705|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
43596706|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43596707|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
43590252|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43679920|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43679922|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43679923|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
43679924|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43679925|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43679926|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
43679927|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43679928|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43679929|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43679930|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43679940|NCT05380245|Clarithromycin|clarithromycin|mesh-list
43679970|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43679971|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
43679972|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679973|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43679974|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43596708|NCT03315520|Cytarabine|cytarabine|mesh-list
43596710|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43596711|NCT03315520|Etoposide|etoposide|mesh-list
43596712|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596713|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
43679975|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
43679976|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679977|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679978|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43679979|NCT05379530|Anesthetics|anesthetics|mesh-list
43679980|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590253|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43590254|NCT03372785|Analgesics|analgesics|mesh-ancestor
43590255|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
43590256|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590257|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590258|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590259|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590260|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43590261|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43590262|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590263|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43590264|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43590265|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590266|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
43590267|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43590268|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43590269|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
43590270|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43590271|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43590276|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590277|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43590278|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43590282|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43590283|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43590284|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
43590285|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
43590286|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590287|NCT03372486|Bupivacaine|bupivacaine|mesh-list
43590288|NCT03372486|Naloxone|naloxone|mesh-list
43590289|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
43590290|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
43596747|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
43596748|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596749|NCT03315338|Prednisone|prednisone|mesh-list
43596750|NCT03315338|Cortisone|cortisone|mesh-list
43596751|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596752|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
43596753|NCT03315338|Hormones|hormones|mesh-ancestor
43596754|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596755|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596756|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596757|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596758|NCT03315312|Fluorides|fluorides|mesh-list
43596759|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
43596763|NCT03315091|Adavosertib|adavosertib|mesh-list
43590291|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590292|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590293|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
43590294|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590295|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43590296|NCT03372473|Loratadine|loratadine|mesh-list
43596771|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590297|NCT03372473|Montelukast|montelukast|mesh-list
43590298|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43590299|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590300|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43590301|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
43590302|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590303|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590304|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43679981|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679982|NCT05379478|Antibodies|antibodies|mesh-list
43679983|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
43679984|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828044|NCT05482113|Bupivacaine|bupivacaine|mesh-list
43828045|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
43828046|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
43828047|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828048|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590306|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590307|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
43590309|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43590310|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43590311|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43590312|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
43590313|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
43590314|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590315|NCT03372447|Thiamine|thiamine|mesh-list
43590316|NCT03372447|Pyridoxine|pyridoxine|mesh-list
43590318|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
43590319|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
43590320|NCT03372447|Vitamins|vitamins|mesh-ancestor
43590321|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
43590322|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596772|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43596776|NCT03315052|Prednisone|prednisone|mesh-list
43596796|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43590323|NCT03372447|Hematinics|hematinics|mesh-ancestor
43590324|NCT03372304|Ropivacaine|ropivacaine|mesh-list
43590325|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
43596797|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
43596798|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596799|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43596800|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
43596801|NCT03315000|Fluticasone|fluticasone|mesh-list
43596803|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596804|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43596805|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
43596806|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596807|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596808|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43596809|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590326|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
43590327|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590328|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596810|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
43596811|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43596813|NCT03314792|Tapentadol|tapentadol|mesh-list
43596814|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43590329|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
43590330|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590331|NCT03372265|Ropivacaine|ropivacaine|mesh-list
43590332|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
43590333|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
43590334|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590355|NCT03372109|Turmeric extract|turmeric extract|mesh-list
43590356|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43590357|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590358|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
43590359|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590360|NCT03372109|Protective Agents|protective agents|mesh-ancestor
43828065|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828066|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828067|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43828068|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
43590363|NCT03371992|Atezolizumab|atezolizumab|mesh-list
43590364|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43590365|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590366|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43590367|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590368|NCT03371953|Atracurium|atracurium|mesh-list
43590369|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
43596815|NCT03314792|Narcotics|narcotics|mesh-ancestor
43590370|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43590371|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43590372|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43590373|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590374|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590375|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43590376|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43590377|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
43590378|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590379|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590380|NCT03371862|Liraglutide|liraglutide|mesh-list
43590381|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43590382|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590383|NCT03371862|Incretins|incretins|mesh-ancestor
43590384|NCT03371862|Hormones|hormones|mesh-ancestor
43590385|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590386|NCT03371849|Montelukast|montelukast|mesh-list
43590387|NCT03371849|Levocetirizine|levocetirizine|mesh-list
43590388|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43590389|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590390|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43590392|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596825|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
43596826|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590393|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590394|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43590395|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43590396|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590397|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43590398|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43590399|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
43596868|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
43596869|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
43590400|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
43590401|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590402|NCT03371797|Amlodipine|amlodipine|mesh-list
43590403|NCT03371797|Valsartan|valsartan|mesh-list
43590404|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43590405|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43590406|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590407|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828069|NCT05481970|Hormones|hormones|mesh-ancestor
43828070|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828071|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828072|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828073|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828074|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
43828075|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
43828076|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679988|NCT05379322|Upadacitinib|upadacitinib|mesh-list
43679989|NCT05379322|Tofacitinib|tofacitinib|mesh-list
43679990|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43679991|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596928|NCT03313869|Trace Elements|trace elements|mesh-ancestor
43679992|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43679993|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43679994|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43679995|NCT05379322|Analgesics|analgesics|mesh-ancestor
43679996|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
43679997|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679998|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679999|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680000|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596967|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
43596968|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43596969|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596970|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596971|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43596972|NCT03313479|Analgesics|analgesics|mesh-ancestor
43596973|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
43596974|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596975|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43596976|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43596977|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43596978|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
43596979|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596980|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596981|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
43596982|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43596983|NCT03313414|Velpatasvir|velpatasvir|mesh-list
43596984|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
43596985|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596986|NCT03313401|Aflibercept|aflibercept|mesh-list
43596987|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43596988|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43596989|NCT03313401|Growth Substances|growth substances|mesh-ancestor
43680001|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
43680002|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680003|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590408|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43590409|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590410|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
43590412|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43590413|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
43590414|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590415|NCT03371589|Dexamethasone|dexamethasone|mesh-list
43590416|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590417|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
43590418|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
43590419|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590420|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590421|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590422|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
43590423|NCT03371589|Hormones|hormones|mesh-ancestor
43590424|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590425|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43590426|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680004|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680005|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43680006|NCT05379283|Lidocaine|lidocaine|mesh-list
43680007|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
43680008|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
43680009|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680011|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
43680012|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680014|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43680015|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43590427|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43590428|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43590429|NCT03371550|Cisplatin|cisplatin|mesh-list
43590430|NCT03371550|Docetaxel|docetaxel|mesh-list
43682184|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43682185|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682186|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590431|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590432|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
43590433|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
43590434|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
43590435|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590436|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
43590437|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43590438|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43590439|NCT03371498|Prednisolone|prednisolone|mesh-list
43590440|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
43682187|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
43682188|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43682189|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590441|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43590442|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
43590443|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590444|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
43682190|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590445|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
43590446|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590447|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590448|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590449|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
43590450|NCT03371498|Hormones|hormones|mesh-ancestor
43590451|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590452|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43590453|NCT03371498|Protective Agents|protective agents|mesh-ancestor
43590454|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43590455|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590456|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43590457|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43590458|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590459|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590460|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43590461|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590462|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590463|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
43590464|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590465|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
43590466|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43590467|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590469|NCT03371173|Hematinics|hematinics|mesh-ancestor
43590470|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
43590471|NCT03371095|Infliximab|infliximab|mesh-list
43590472|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43590473|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
43680016|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680017|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680018|NCT05379257|Furosemide|furosemide|mesh-list
43680019|NCT05379257|Diuretics|diuretics|mesh-ancestor
43680020|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
43680021|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597043|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
43597044|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680022|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43680023|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680024|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680025|NCT05379049|Adalimumab|adalimumab|mesh-list
43680026|NCT05379049|Etanercept|etanercept|mesh-list
43680027|NCT05379049|Infliximab|infliximab|mesh-list
43680028|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43680029|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680030|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
43590474|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590475|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590476|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43590477|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
43590478|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590479|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590480|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43590481|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
43590482|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590483|NCT03371069|Methylphenidate|methylphenidate|mesh-list
43590526|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
43590527|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590528|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590530|NCT03370835|Protective Agents|protective agents|mesh-ancestor
43590531|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43590532|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682269|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
43682270|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682271|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43682272|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
43682273|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682274|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682275|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43682276|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
43597062|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43597063|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597064|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597065|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
43597066|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597067|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597068|NCT03312179|Incretins|incretins|mesh-list
43597069|NCT03312179|Hormones|hormones|mesh-ancestor
43597070|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597071|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590533|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43590534|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
43590535|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43590536|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43590537|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
43590538|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
43590539|NCT03370705|Captopril|captopril|mesh-list
43590540|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43590541|NCT03370705|Atorvastatin|atorvastatin|mesh-list
43590542|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43590543|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43590544|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43590545|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
43590546|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590547|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43590548|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43597082|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43597083|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
43597084|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43597085|NCT03311984|Dalteparin|dalteparin|mesh-list
43597086|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
43597087|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43597088|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43597089|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597090|NCT03311971|Methamphetamine|methamphetamine|mesh-list
43597091|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43597092|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597093|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
43597095|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597096|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
43590549|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590550|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
43590551|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43590552|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
43590553|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43590554|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43590555|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43590556|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590557|NCT03370705|Analgesics|analgesics|mesh-ancestor
43680031|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680032|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43590590|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590591|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43590592|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43590593|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43590594|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
43590595|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590596|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590597|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
43590598|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43590599|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590600|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590601|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43590602|NCT03370562|Analgesics|analgesics|mesh-ancestor
43590603|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
43680045|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680046|NCT05378919|Folic Acid|folic acid|mesh-list
43680047|NCT05378919|Leucovorin|leucovorin|mesh-list
43680048|NCT05378919|Fluorouracil|fluorouracil|mesh-list
43680049|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
43680050|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
43680051|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
43680052|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680053|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43680054|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597144|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597146|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43597147|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
43597148|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597149|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43680055|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680056|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
43680057|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680058|NCT05378919|Hematinics|hematinics|mesh-ancestor
43680059|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
43680060|NCT05378919|Vitamins|vitamins|mesh-ancestor
43597173|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43597174|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43590604|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590605|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43597238|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43590606|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43590607|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43590608|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
43590609|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590610|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590611|NCT03370380|Aflibercept|aflibercept|mesh-list
43590612|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43590613|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43597239|NCT03310606|Lactams|lactams|mesh-list
43597240|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597242|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
43597243|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
43597244|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597245|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597246|NCT03310372|Temozolomide|temozolomide|mesh-list
43597247|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43597248|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
43597249|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597250|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597251|NCT03310333|Dinoprostone|dinoprostone|mesh-list
43597252|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
43597263|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
43590614|NCT03370380|Growth Substances|growth substances|mesh-ancestor
43590615|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590616|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
43597264|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43597265|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43597266|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43597267|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597268|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
43590627|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590628|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590630|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
43590631|NCT03370159|Docetaxel|docetaxel|mesh-list
43590632|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590633|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
43590634|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
43590635|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
43590636|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590637|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
43590638|NCT03370159|Protective Agents|protective agents|mesh-ancestor
43590639|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590640|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
43590641|NCT03370159|Vitamins|vitamins|mesh-ancestor
43590642|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
43590643|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
43590644|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43597269|NCT03310060|Coagulants|coagulants|mesh-ancestor
43590645|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43590646|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43590647|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680062|NCT05378919|Antidotes|antidotes|mesh-ancestor
43680063|NCT05378919|Protective Agents|protective agents|mesh-ancestor
43680064|NCT05378867|Bevacizumab|bevacizumab|mesh-list
43590688|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590689|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
43590690|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590691|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43590692|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43590693|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
43590694|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590695|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43590696|NCT03369782|Rocuronium|rocuronium|mesh-list
43680071|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
43680072|NCT05378711|Fluoxetine|fluoxetine|mesh-list
43680073|NCT05378711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43680074|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43680075|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680076|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680077|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680078|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
43680079|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680080|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43597282|NCT03309865|Vedolizumab|vedolizumab|mesh-list
43680081|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
43680082|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43680083|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43680084|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43680085|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680086|NCT05378646|Interferons|interferons|mesh-list
43590712|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
43590713|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43590714|NCT03369262|Atosiban|atosiban|mesh-list
43590715|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
43590716|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590722|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590723|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43590724|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
43590725|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590726|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590727|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43590728|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43590729|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590730|NCT03369093|Amoxicillin|amoxicillin|mesh-list
43590731|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43590732|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43590734|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43590735|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43590736|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590737|NCT03369015|Amphetamine|amphetamine|mesh-list
43590738|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
43590739|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43590740|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590741|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
43590742|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
43590743|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590744|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
43590745|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590746|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590747|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
43590748|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43590749|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43682377|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43682378|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43682379|NCT02848768|Growth Substances|growth substances|mesh-ancestor
43682380|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597359|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
43597360|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597361|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590750|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590751|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43590752|NCT03369002|Seladelpar|seladelpar|mesh-list
43590753|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43680087|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
43680088|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597362|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43597363|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
43597364|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43680089|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
43680090|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680091|NCT05378555|Ketamine|ketamine|mesh-list
43680092|NCT05378555|Analgesics|analgesics|mesh-ancestor
43680093|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
43680094|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680095|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597365|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43597366|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43680096|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43680097|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43680098|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
43680099|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
43680100|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680101|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43680102|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43680103|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680104|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680105|NCT05378503|Topiramate|topiramate|mesh-list
43680106|NCT05378503|Phentermine|phentermine|mesh-list
43680107|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
43680108|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43680109|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597413|NCT03308890|Entecavir|entecavir|mesh-list
43680110|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43680111|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
43680112|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43680113|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
43680114|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
43680115|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680116|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
43680117|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590754|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
43590755|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590756|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43590757|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43590758|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590759|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
43590760|NCT03368794|Narcotics|narcotics|mesh-ancestor
43590761|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590762|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590763|NCT03368794|Analgesics|analgesics|mesh-ancestor
43590764|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
43680118|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680119|NCT05378191|Vaccines|vaccines|mesh-list
43680120|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
43680121|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680122|NCT05377788|Lazertinib|lazertinib|mesh-list
43680123|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43682425|NCT02848417|Curcumin|curcumin|mesh-list
43680124|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680125|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680126|NCT05372380|Atorvastatin|atorvastatin|mesh-list
43680127|NCT05372380|Ezetimibe|ezetimibe|mesh-list
43680128|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43680129|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43680130|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
43597492|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597493|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
43680131|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680132|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43680133|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43680134|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680135|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
43682451|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43682452|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682453|NCT02848339|Aspirin|aspirin|mesh-list
43682454|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43682455|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682456|NCT02848339|Analgesics|analgesics|mesh-ancestor
43682457|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
43682458|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682460|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43680137|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680138|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680139|NCT05345717|Abatacept|abatacept|mesh-list
43680140|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
43680141|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43680142|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680143|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680144|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680145|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
43680146|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680147|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680148|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
43680149|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680150|NCT05336968|Triamcinolone|triamcinolone|mesh-list
43680151|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43680152|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43680153|NCT05336968|Ketorolac|ketorolac|mesh-list
43680154|NCT05336968|Ropivacaine|ropivacaine|mesh-list
43590765|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590766|NCT03368547|Edetic Acid|edetic acid|mesh-list
43680155|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43680156|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
43680157|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
43680158|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680159|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680160|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
43680161|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680162|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43680163|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
43680164|NCT05336968|Hormones|hormones|mesh-ancestor
43639142|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43680165|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680166|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680167|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
43590767|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43590768|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
43590769|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
43590770|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590771|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
43590772|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43590773|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43590774|NCT03368430|Melatonin|melatonin|mesh-list
43590775|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
43590776|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590777|NCT03368430|Protective Agents|protective agents|mesh-ancestor
43590778|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590779|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590780|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43590781|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43590782|NCT03368391|Lidocaine|lidocaine|mesh-list
43590783|NCT03368391|Phenylephrine|phenylephrine|mesh-list
43590784|NCT03368391|Epinephrine|epinephrine|mesh-list
43590785|NCT03368391|Racepinephrine|racepinephrine|mesh-list
43590786|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
43590801|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43597587|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43597588|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43597589|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
43597590|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597606|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590802|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43590803|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
43590804|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590805|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43590806|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43590807|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
43590808|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43590809|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
43590810|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
43590811|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
43590812|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43590813|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
43590814|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43590815|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43590816|NCT03368391|Protective Agents|protective agents|mesh-ancestor
43590817|NCT03368352|Melatonin|melatonin|mesh-list
43590818|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
43590819|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590820|NCT03368352|Protective Agents|protective agents|mesh-ancestor
43590821|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590822|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590823|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
43590824|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590825|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
43590826|NCT03368274|Hormones|hormones|mesh-ancestor
43590827|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590828|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590829|NCT03368131|Capecitabine|capecitabine|mesh-list
43680168|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680169|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680170|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43680171|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43680173|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43597607|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43597608|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
43597609|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597610|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43597611|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597612|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43597613|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597614|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
43597615|NCT03307148|Gemcitabine|gemcitabine|mesh-list
43597616|NCT03307148|Paclitaxel|paclitaxel|mesh-list
43680174|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43680175|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43680176|NCT05332444|Amoxicillin|amoxicillin|mesh-list
43680177|NCT05332444|Metronidazole|metronidazole|mesh-list
43680178|NCT05332444|Clarithromycin|clarithromycin|mesh-list
43680179|NCT05332444|Levofloxacin|levofloxacin|mesh-list
43680180|NCT05332444|Tetracycline|tetracycline|mesh-list
43680181|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43680182|NCT05332444|Rabeprazole|rabeprazole|mesh-list
43680183|NCT05332444|Bismuth|bismuth|mesh-list
43590845|NCT03367676|Trastuzumab|trastuzumab|mesh-list
43590861|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
43590862|NCT03367585|Vitamins|vitamins|mesh-ancestor
43590863|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
43590864|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590865|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43590866|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43590867|NCT03367494|Bromides|bromides|mesh-list
43590868|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
43590869|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
43590870|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43590871|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590872|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
43682479|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43682480|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43682481|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
43682482|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682483|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682484|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
43682485|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
43682486|NCT02848287|Ropivacaine|ropivacaine|mesh-list
43682487|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
43682488|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
43597626|NCT03307148|Antiviral Agents|antiviral agents|mesh-ancestor
43597627|NCT03307148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597628|NCT03307148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597629|NCT03307148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43597630|NCT03307148|Immunologic Factors|immunologic factors|mesh-ancestor
43597643|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43597644|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597645|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43597646|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
43590873|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43597647|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
43597648|NCT03306836|Heparin|heparin|mesh-list
43597649|NCT03306836|Calcium heparin|calcium heparin|mesh-list
43597650|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
43597651|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43590874|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590875|NCT03367195|Omeprazole|omeprazole|mesh-list
43590876|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43590877|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590878|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43590879|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590880|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590881|NCT03367182|Paclitaxel|paclitaxel|mesh-list
43590882|NCT03367182|Bevacizumab|bevacizumab|mesh-list
43590883|NCT03367182|Doxorubicin|doxorubicin|mesh-list
43590884|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43590885|NCT03367182|Topotecan|topotecan|mesh-list
43590886|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43590887|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597652|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43597659|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597661|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
43597662|NCT03306732|Vitamins|vitamins|mesh-ancestor
43597663|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
43597664|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590888|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
43597665|NCT03306667|Dotinurad|dotinurad|mesh-list
43597666|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
43597667|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
43597668|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590889|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
43590890|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
43590891|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680185|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680186|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
43680187|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43680188|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43680189|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43680190|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680191|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680192|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43597669|NCT03306667|Renal Agents|renal agents|mesh-ancestor
43597670|NCT03306602|Z 350|z 350|mesh-list
43597671|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43680193|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43680194|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43680195|NCT05332444|Renal Agents|renal agents|mesh-ancestor
43590892|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43590893|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43590894|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43590895|NCT03367182|Growth Substances|growth substances|mesh-ancestor
43590896|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590897|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
43590898|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43590899|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43597678|NCT03306550|Aspirin|aspirin|mesh-list
43590900|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43590901|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590902|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43590903|NCT03367143|Carboplatin|carboplatin|mesh-list
43590904|NCT03367143|Etoposide|etoposide|mesh-list
43590905|NCT03367143|Lenalidomide|lenalidomide|mesh-list
43590916|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43590917|NCT03367143|Growth Substances|growth substances|mesh-ancestor
43590918|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
43590919|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43590920|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
43590921|NCT03366883|Paclitaxel|paclitaxel|mesh-list
43590922|NCT03366883|Cisplatin|cisplatin|mesh-list
43680196|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43680197|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43680198|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597723|NCT03306368|Analgesics|analgesics|mesh-ancestor
43680199|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43680200|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43680201|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680202|NCT05332444|Antacids|antacids|mesh-ancestor
43680203|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
43680204|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680205|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
43680206|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
43680207|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
43680208|NCT05303909|Gentamicins|gentamicins|mesh-list
43680209|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43680210|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680211|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43680212|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680213|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828077|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
43828078|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43828079|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43828080|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43828081|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828082|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43828083|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43828084|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
43828085|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828086|NCT05481970|Analgesics|analgesics|mesh-ancestor
43828087|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43828088|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43828089|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43828090|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
43828091|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828092|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43828099|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
43828100|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43828101|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43828102|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43828103|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597743|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828104|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828105|NCT05481957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43828106|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43828107|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828108|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828109|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828110|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
43590923|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43590924|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590925|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
43590926|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
43590927|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
43590928|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590929|NCT03366597|Sevoflurane|sevoflurane|mesh-list
43590930|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43590931|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43590932|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
43590933|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
43590934|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849097|NCT03962465|Pegaspargase|pegaspargase|mesh-list
43590935|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590936|NCT03366584|Vitamin D|vitamin d|mesh-list
43590937|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
43590938|NCT03366584|Beta Carotene|beta carotene|mesh-list
43590940|NCT03366584|Dexamethasone|dexamethasone|mesh-list
43590941|NCT03366584|Carotenoids|carotenoids|mesh-list
43590942|NCT03366584|Picolinic acid|picolinic acid|mesh-list
43590943|NCT03366584|Vitamins|vitamins|mesh-ancestor
43590944|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
43590945|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590946|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590947|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
43590948|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
43590949|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590950|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590951|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
43590952|NCT03366584|Hormones|hormones|mesh-ancestor
43590953|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590954|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43590955|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590956|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43597881|NCT03303677|Trimethoprim|trimethoprim|mesh-list
43597882|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
43590957|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43590958|NCT03366584|Trace Elements|trace elements|mesh-ancestor
43590959|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
43590960|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590961|NCT03366584|Protective Agents|protective agents|mesh-ancestor
43590962|NCT03366584|Provitamins|provitamins|mesh-ancestor
43590963|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43597883|NCT03303677|Budesonide|budesonide|mesh-list
43597884|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590964|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
43590965|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
43590966|NCT03366571|Entecavir|entecavir|mesh-list
43590967|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
43590968|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828112|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43828113|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43828114|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43828115|NCT05481723|Norepinephrine|norepinephrine|mesh-list
43828116|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43828117|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43828118|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
43828119|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828120|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639143|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
43590971|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43590979|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
43590980|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43590981|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590982|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43590983|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590985|NCT03366246|Lidocaine|lidocaine|mesh-list
43590986|NCT03366246|Prilocaine|prilocaine|mesh-list
43590987|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43590988|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
43590989|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
43590990|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590991|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590992|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
43597892|NCT03303677|Hormones|hormones|mesh-ancestor
43682594|NCT02846909|Hormones|hormones|mesh-ancestor
43590993|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590994|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43590995|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43590996|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43590997|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590998|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590999|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43591000|NCT03366064|Pemetrexed|pemetrexed|mesh-list
43591001|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591002|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591003|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591004|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43591005|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43591006|NCT03366025|Progesterone|progesterone|mesh-list
43591007|NCT03366025|Progestins|progestins|mesh-ancestor
43591008|NCT03366025|Hormones|hormones|mesh-ancestor
43682595|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591009|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591010|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591011|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
43591012|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
43591013|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43591014|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43591015|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591016|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
43591017|NCT03365999|Coagulants|coagulants|mesh-ancestor
43591019|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43591020|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682602|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591021|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43682603|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682604|NCT02847286|Dapivirine|dapivirine|mesh-list
43682605|NCT02847286|Clotrimazole|clotrimazole|mesh-list
43682606|NCT02847286|Miconazole|miconazole|mesh-list
43682607|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43682608|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43597967|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597968|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597969|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43597970|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597971|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43597972|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43597973|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
43597974|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597989|NCT03302845|Omeprazole|omeprazole|mesh-list
43591022|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591023|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
43591024|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43591025|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
43591026|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591027|NCT03365817|Fentanyl|fentanyl|mesh-list
43591028|NCT03365817|Morphine|morphine|mesh-list
43591029|NCT03365817|Oxycodone|oxycodone|mesh-list
43591030|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
43591031|NCT03365817|Tramadol|tramadol|mesh-list
43591032|NCT03365817|Methadone|methadone|mesh-list
43828121|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828122|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
43828123|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
43828124|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828125|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43828127|NCT05481684|Progestins|progestins|mesh-ancestor
43828128|NCT05481684|Hormones|hormones|mesh-ancestor
43828129|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828130|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598011|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
43828131|NCT05481645|Paclitaxel|paclitaxel|mesh-list
43828132|NCT05481645|Carboplatin|carboplatin|mesh-list
43591034|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591035|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591037|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
43591038|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591039|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43591040|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43591045|NCT03365765|Fluorouracil|fluorouracil|mesh-list
43591046|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
43591047|NCT03365765|Apatinib|apatinib|mesh-list
43591048|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
43591049|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591050|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43591051|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591052|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43591053|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
43591054|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591055|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43591056|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591057|NCT03365726|Dobutamine|dobutamine|mesh-list
43591058|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43591059|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
43591060|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
43591061|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591062|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591063|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43591064|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43591065|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43591066|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
43591067|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591068|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591069|NCT03365726|Protective Agents|protective agents|mesh-ancestor
43591070|NCT03365479|Iloprost|iloprost|mesh-list
43591071|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43591072|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
43591073|NCT03365466|Aspirin|aspirin|mesh-list
43591074|NCT03365466|Heparin|heparin|mesh-list
43598071|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
43598072|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
43598073|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43598074|NCT03302364|Risperidone|risperidone|mesh-list
43591075|NCT03365466|Calcium heparin|calcium heparin|mesh-list
43591076|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43591077|NCT03365466|Tinzaparin|tinzaparin|mesh-list
43591078|NCT03365466|Dalteparin|dalteparin|mesh-list
43591079|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43591080|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43591081|NCT03365466|Analgesics|analgesics|mesh-ancestor
43591082|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
43591083|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591084|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591085|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591086|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43591087|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43591088|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43828133|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43680214|NCT05293964|Palbociclib|palbociclib|mesh-list
43680215|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680216|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680217|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680218|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680219|NCT05265806|Oxytocin|oxytocin|mesh-list
43680221|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43680222|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680223|NCT05261594|Caffeine|caffeine|mesh-list
43680224|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43680225|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680226|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43680227|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591089|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591090|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43591091|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43591092|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598075|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43591093|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
43591094|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
43591095|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
43591096|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43591097|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
43591098|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591099|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
43591100|NCT03365388|Protective Agents|protective agents|mesh-ancestor
43591101|NCT03365336|Oseltamivir|oseltamivir|mesh-list
43591102|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
43591103|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591104|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591105|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591106|NCT03365141|Triamcinolone|triamcinolone|mesh-list
43591107|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43591108|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43591109|NCT03365141|Tacrolimus|tacrolimus|mesh-list
43591110|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43591111|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43591112|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
43591113|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591123|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43591124|NCT03365115|Narcotics|narcotics|mesh-ancestor
43591125|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591126|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591127|NCT03365115|Analgesics|analgesics|mesh-ancestor
43591128|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
43591129|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591130|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43591131|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43591132|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
43591133|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
43591135|NCT03364998|Coagulants|coagulants|mesh-ancestor
43591136|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
43591137|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43591138|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680228|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680229|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43680230|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43680231|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
43680232|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680233|NCT05220020|Lenvatinib|lenvatinib|mesh-list
43680234|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680235|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680236|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680237|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680238|NCT05199038|Octreotide|octreotide|mesh-list
43680239|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680240|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43680241|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680242|NCT05191862|Cilostazol|cilostazol|mesh-list
43680243|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43680244|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
43680245|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680246|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680247|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43680248|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
43680249|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43680250|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43680251|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680252|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43680253|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
43680254|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43682655|NCT02846831|Insulin|insulin|mesh-list
43680255|NCT05191862|Protective Agents|protective agents|mesh-ancestor
43591139|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43591140|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591141|NCT03364842|Furosemide|furosemide|mesh-list
43591142|NCT03364842|Diuretics|diuretics|mesh-ancestor
43591143|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
43591144|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591145|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43591146|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43591147|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591148|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
43591149|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43591150|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43591151|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43591152|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
43680256|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43598207|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680257|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43680259|NCT05190432|Taxifolin|taxifolin|mesh-list
43680260|NCT05190432|Ergothioneine|ergothioneine|mesh-list
43680261|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
43680262|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680263|NCT05190432|Protective Agents|protective agents|mesh-ancestor
43680264|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680265|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43680266|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43680267|NCT05190432|Analgesics|analgesics|mesh-ancestor
43680268|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
43680269|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680270|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43680271|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680272|NCT05180968|Dronabinol|dronabinol|mesh-list
43680273|NCT05180968|Nabilone|nabilone|mesh-list
43591161|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
43591162|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43591163|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
43591164|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591165|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
43591166|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43591167|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43849098|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43591168|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591169|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
43591170|NCT03364569|Coagulants|coagulants|mesh-ancestor
43591171|NCT03364530|Gemcitabine|gemcitabine|mesh-list
43591172|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
43591173|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43591174|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
43591216|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
43591217|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591218|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
43591219|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43591220|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43591221|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
43591222|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43591223|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43591224|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
43591225|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43591226|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
43591227|NCT03363984|Midazolam|midazolam|mesh-list
43591228|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43591229|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43591230|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591231|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591236|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
43591237|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
43591238|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
43591239|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
43591240|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591254|NCT03363815|Digoxin|digoxin|mesh-list
43591255|NCT03363815|Midazolam|midazolam|mesh-list
43591256|NCT03363815|Omeprazole|omeprazole|mesh-list
43591257|NCT03363815|Warfarin|warfarin|mesh-list
43591258|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43591259|NCT03363815|Vitamins|vitamins|mesh-ancestor
43591260|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
43591261|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591262|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43591263|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43591264|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43598243|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598244|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591265|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591266|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43591267|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43591268|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591269|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43591270|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
43591271|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
43591272|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
43591273|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
43591274|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682691|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682692|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
43682693|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43682694|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682695|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682696|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43682697|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43682698|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43682699|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43682700|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43682701|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43682702|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
43682703|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43682704|NCT02846506|Metformin|metformin|mesh-list
43682705|NCT02846506|Canagliflozin|canagliflozin|mesh-list
43591275|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680289|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680290|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680291|NCT05180968|Hormones|hormones|mesh-ancestor
43680292|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680293|NCT05165771|Tofacitinib|tofacitinib|mesh-list
43591276|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43591277|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43591278|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
43682746|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43682747|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43682748|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43682749|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
43682750|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682751|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682752|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
43682753|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43682754|NCT02846142|Estradiol|estradiol|mesh-list
43682755|NCT02846142|Estrogens|estrogens|mesh-ancestor
43682756|NCT02846142|Hormones|hormones|mesh-ancestor
43682757|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682758|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682759|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43682760|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
43682761|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43682762|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43682763|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43682764|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43682766|NCT02846025|Folic Acid|folic acid|mesh-list
43591279|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43591280|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43591281|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591282|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
43591283|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43591284|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43591285|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43591286|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43591287|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43591288|NCT03363815|Protective Agents|protective agents|mesh-ancestor
43591289|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43591290|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43591291|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
43591292|NCT03363815|Coagulants|coagulants|mesh-ancestor
43591293|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591294|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43682793|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
43682794|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682795|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682796|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43682797|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43682798|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43682799|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43682800|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
43682801|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682802|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43682803|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
43682804|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43682805|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682806|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682807|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682808|NCT02845661|Analgesics|analgesics|mesh-ancestor
43682810|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682811|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43682812|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43682814|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
43591296|NCT03363659|Temozolomide|temozolomide|mesh-list
43591297|NCT03363659|Disulfiram|disulfiram|mesh-list
43591298|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43591299|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
43591300|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591301|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591302|NCT03363659|Trace Elements|trace elements|mesh-ancestor
43591303|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
43591304|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591305|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43591306|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43591307|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591320|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591321|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591322|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
43591323|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591324|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43591325|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43591326|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43591327|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680294|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680296|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680297|NCT05158374|Aspirin|aspirin|mesh-list
43680298|NCT05158374|Metformin|metformin|mesh-list
43680299|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43680300|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680301|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43682820|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
43682821|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682822|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43682823|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682824|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43682825|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
43682826|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682828|NCT02845908|Protective Agents|protective agents|mesh-ancestor
43682829|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
43682830|NCT02845908|Vitamins|vitamins|mesh-ancestor
43682831|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
43682832|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
43682833|NCT02845999|Fludarabine|fludarabine|mesh-list
43680302|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43680303|NCT05158374|Analgesics|analgesics|mesh-ancestor
43680304|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
43680305|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680306|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43680307|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680308|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43680309|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43680310|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680311|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43680312|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43591328|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591329|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43591330|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43591331|NCT03363425|Analgesics|analgesics|mesh-ancestor
43591332|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43591333|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43591334|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43591335|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
43682892|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43682893|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682894|NCT02845388|Estrogens|estrogens|mesh-ancestor
43682895|NCT02845388|Hormones|hormones|mesh-ancestor
43591336|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591338|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43591339|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591340|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43591341|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43591342|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591343|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591344|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591345|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
43591346|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591347|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
43591348|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
43591349|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
43591350|NCT03363191|Fluticasone|fluticasone|mesh-list
43591352|NCT03363191|Albuterol|albuterol|mesh-list
43591353|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591354|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43591355|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
43682941|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
43682942|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43682943|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43682944|NCT02845024|Doxycycline|doxycycline|mesh-list
43682945|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43682946|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591356|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682999|NCT02844530|Epratuzumab|epratuzumab|mesh-list
43591357|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591358|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43828509|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591359|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
43591360|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
43591361|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43591362|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
43591363|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43680313|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680316|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43680317|NCT05153174|Protective Agents|protective agents|mesh-ancestor
43680318|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680319|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680320|NCT05151328|Plecanatide|plecanatide|mesh-list
43680321|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43680322|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
43680323|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680324|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680325|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43680328|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
43680329|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
43680331|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
43680332|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680333|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
43680334|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680335|NCT05122481|Protective Agents|protective agents|mesh-ancestor
43680336|NCT05121909|Listerine|listerine|mesh-list
43680337|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43680338|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
43680339|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
43591364|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43591365|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43591366|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43828510|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43591367|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
43591368|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591369|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591370|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
43591371|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43591380|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591381|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683027|NCT02844322|Rituximab|rituximab|mesh-list
43683028|NCT02844322|Bortezomib|bortezomib|mesh-list
43683029|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43683030|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683031|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
43683032|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683034|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
43683035|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43683036|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683037|NCT02844309|Thalidomide|thalidomide|mesh-list
43683038|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43591382|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
43591383|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591384|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43591385|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43591386|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43591387|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43591388|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591389|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
43591390|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43591391|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680340|NCT05121909|Protective Agents|protective agents|mesh-ancestor
43680341|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680342|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680343|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
43680344|NCT05115136|Promethazine|promethazine|mesh-list
43680345|NCT05115136|Doxepin|doxepin|mesh-list
43680346|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43680347|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43680348|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680349|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680350|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
43680352|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
43680353|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680354|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
43680355|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
43680356|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680357|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43680358|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
43680359|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
43680360|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591392|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43591393|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43591394|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683039|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
43683040|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683041|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
43591395|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591396|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591397|NCT03362814|Ritonavir|ritonavir|mesh-list
43591398|NCT03362814|Ribavirin|ribavirin|mesh-list
43591399|NCT03362814|Lactams|lactams|mesh-list
43591400|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43591402|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
43591403|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591404|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591405|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43591406|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43591407|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
43683077|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683078|NCT05242718|Hormones|hormones|mesh-ancestor
43591408|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591409|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43591410|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43683156|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591411|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
43591412|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43591414|NCT03362788|Anticoagulants|anticoagulants|mesh-list
43591415|NCT03362788|Vitamins|vitamins|mesh-ancestor
43591416|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
43591417|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591418|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43591419|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43591420|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591421|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
43591422|NCT03362788|Coagulants|coagulants|mesh-ancestor
43591423|NCT03362775|Propofol|propofol|mesh-list
43591424|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43680361|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680362|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43680363|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
43680364|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
43680365|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43680366|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
43680367|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43828134|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828135|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
43683157|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43683158|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43683159|NCT05040880|Telmisartan|telmisartan|mesh-list
43683160|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43683161|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43683162|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43683163|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683164|NCT05007509|Vaccines|vaccines|mesh-list
43683165|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
43683166|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828511|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43828513|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43828514|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828515|NCT05476679|Analgesics|analgesics|mesh-ancestor
43828136|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
43828137|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
43828138|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828139|NCT05481619|Vedolizumab|vedolizumab|mesh-list
43828140|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43828141|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43828142|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43828143|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828144|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
43828145|NCT05481281|Ketamine|ketamine|mesh-list
43680369|NCT05101629|Lenvatinib|lenvatinib|mesh-list
43680370|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43591425|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591426|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591427|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43591428|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
43591429|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
43591430|NCT03362736|Ustekinumab|ustekinumab|mesh-list
43591431|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
43591432|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43591433|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591435|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43591436|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591437|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43591438|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591444|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43591446|NCT03362281|Clarithromycin|clarithromycin|mesh-list
43683170|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
43683171|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43683172|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
43683173|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43683174|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
43683175|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683176|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683177|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
43683178|NCT04918810|Docetaxel|docetaxel|mesh-list
43683179|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591447|NCT03362281|Omeprazole|omeprazole|mesh-list
43591448|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43591449|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591450|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43591451|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43591452|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43591453|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591454|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591455|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43591456|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43591457|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43591458|NCT03362268|Omeprazole|omeprazole|mesh-list
43591459|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43591460|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43591461|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43680371|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680372|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680373|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680374|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627449|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
43680376|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680377|NCT05065736|Clofarabine|clofarabine|mesh-list
43680378|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43680379|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
43680380|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680381|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680382|NCT05052541|Dronabinol|dronabinol|mesh-list
43680383|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
43680384|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680385|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43680386|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43680387|NCT05052541|Analgesics|analgesics|mesh-ancestor
43680388|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
43680389|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680390|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43591462|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591463|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591464|NCT03362216|Diclofenac|diclofenac|mesh-list
43591465|NCT03362216|Salicylates|salicylates|mesh-list
43591466|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
43591467|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43591468|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43591470|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
43591471|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591472|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591473|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591475|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43591476|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591477|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591478|NCT03362073|Ketamine|ketamine|mesh-list
43591479|NCT03362073|Analgesics|analgesics|mesh-ancestor
43591480|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
43591481|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591482|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591483|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43683234|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43683235|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
43683236|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683237|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43627513|NCT03072485|Sirolimus|sirolimus|mesh-list
43627514|NCT03072485|Diclofenac|diclofenac|mesh-list
43627515|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43627516|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591484|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43591485|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
43591486|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
43591487|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591488|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43591489|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43591490|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591491|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627559|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627560|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43627561|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
43627562|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43627563|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43849440|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627564|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43627565|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627566|NCT03072394|Lidocaine|lidocaine|mesh-list
43627567|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
43627568|NCT03072394|Anesthetics|anesthetics|mesh-list
43627569|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627570|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627575|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43627576|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627577|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627578|NCT03072329|Bupivacaine|bupivacaine|mesh-list
43627579|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627580|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
43627581|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683266|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
43683267|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43683268|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43683269|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
43683270|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683271|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683272|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683273|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43591492|NCT03362047|Macitentan|macitentan|mesh-list
43591493|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43591494|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43680391|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43680392|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680393|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683274|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43683275|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
43683276|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680395|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680396|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
43680397|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43680398|NCT05026203|Midazolam|midazolam|mesh-list
43680399|NCT05026203|Ketamine|ketamine|mesh-list
43680400|NCT05026203|Analgesics|analgesics|mesh-ancestor
43680401|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
43680402|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680403|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591495|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591496|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43683277|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43591498|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43683278|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
43591499|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43591500|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
43591501|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591502|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591503|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591504|NCT03361878|Metformin|metformin|mesh-list
43591505|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43591506|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591507|NCT03361800|Entinostat|entinostat|mesh-list
43591508|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627582|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627583|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
43627584|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627585|NCT03072082|Aspirin|aspirin|mesh-list
43627586|NCT03072082|Metoprolol|metoprolol|mesh-list
43627587|NCT03072082|Isosorbide|isosorbide|mesh-list
43627588|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43627589|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43627590|NCT03072082|Trimetazidine|trimetazidine|mesh-list
43627591|NCT03072082|Clopidogrel|clopidogrel|mesh-list
43627592|NCT03072082|Atorvastatin|atorvastatin|mesh-list
43627593|NCT03072082|Calcium|calcium|mesh-list
43627597|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627605|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627606|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43627607|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43627608|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627609|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
43627610|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43627611|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43627612|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
43627613|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43627614|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43627615|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43627616|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43627617|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43627618|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
43627619|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627620|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43627621|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43627622|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
43627623|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
43602902|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
43591510|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591511|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591513|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
43591514|NCT03361774|Protective Agents|protective agents|mesh-ancestor
43591515|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591516|NCT03361709|Dexamethasone|dexamethasone|mesh-list
43591517|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591518|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
43591520|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591521|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591522|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43591523|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
43591524|NCT03361709|Hormones|hormones|mesh-ancestor
43591525|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591526|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43591527|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591528|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
43591529|NCT03361618|Astringents|astringents|mesh-ancestor
43591530|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591531|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
43591532|NCT03361397|Lidocaine|lidocaine|mesh-list
43591533|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
43591534|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
43591535|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591536|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591537|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
43591538|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591539|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43591540|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43591541|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43591542|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43600137|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
43680404|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43680405|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43680406|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
43680407|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
43680408|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680409|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43680410|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43627625|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43680411|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680412|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680413|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43680414|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43680415|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43680416|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43680417|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591543|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591545|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43591546|NCT03361319|Nintedanib|nintedanib|mesh-list
43591547|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43591548|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591549|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
43591550|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
43591551|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
43591552|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591553|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43591554|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591555|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43591556|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43591557|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
43591558|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591559|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591560|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591561|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
43591562|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43591563|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43591564|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
43683297|NCT04481308|Narcotics|narcotics|mesh-ancestor
43849443|NCT03928015|Analgesics|analgesics|mesh-list
43591565|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591566|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591567|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591568|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43591569|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43591570|NCT03361124|Oxytocin|oxytocin|mesh-list
43591571|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
43591572|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43591573|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591574|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
43591575|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43591576|NCT03361098|Exenatide|exenatide|mesh-list
43591577|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591578|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43591579|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591580|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43591584|NCT03360981|Incretins|incretins|mesh-list
43591585|NCT03360981|Hormones|hormones|mesh-ancestor
43591586|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680418|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
43680419|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
43680420|NCT05019534|Cetuximab|cetuximab|mesh-list
43680421|NCT05019534|Vemurafenib|vemurafenib|mesh-list
43680422|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43680423|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680424|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680425|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680426|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680427|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
43680428|NCT05013463|Indapamide|indapamide|mesh-list
43680430|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43591587|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591589|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591590|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591591|NCT03360760|Cisplatin|cisplatin|mesh-list
43591592|NCT03360760|Doxorubicin|doxorubicin|mesh-list
43591593|NCT03360760|Methotrexate|methotrexate|mesh-list
43591594|NCT03360760|Ifosfamide|ifosfamide|mesh-list
43591595|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
43591596|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627752|NCT03071731|Bromides|bromides|mesh-list
43591597|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43591598|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43591599|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43591600|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591601|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591602|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43591603|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
43591604|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43591605|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591606|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43591607|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
43591608|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
43591609|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43591610|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43591611|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
43591612|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43591613|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43591614|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43591615|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
43849099|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591617|NCT03360734|Panitumumab|panitumumab|mesh-list
43591618|NCT03360734|Necitumumab|necitumumab|mesh-list
43591619|NCT03360734|Antibodies|antibodies|mesh-list
43627799|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627800|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627801|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43627802|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627803|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591620|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
43591621|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591622|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43591623|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591624|NCT03360682|Tenofovir|tenofovir|mesh-list
43591625|NCT03360682|Lamivudine|lamivudine|mesh-list
43591626|NCT03360682|Emtricitabine|emtricitabine|mesh-list
43591627|NCT03360682|Dolutegravir|dolutegravir|mesh-list
43591628|NCT03360682|Abacavir|abacavir|mesh-list
43591629|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
43591630|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591631|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43591632|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43591633|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680431|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43680432|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680433|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680435|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680436|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43680437|NCT05013463|Diuretics|diuretics|mesh-ancestor
43680438|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
43680439|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680440|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43680441|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627861|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43627862|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627863|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
43627864|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43627865|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43627866|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627867|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
43627868|NCT03070847|Coagulants|coagulants|mesh-ancestor
43627869|NCT03070665|Norepinephrine|norepinephrine|mesh-list
43627870|NCT03070665|Ephedrine|ephedrine|mesh-list
43627871|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43627872|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43627873|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
43680442|NCT05001152|Ozanimod|ozanimod|mesh-list
43591634|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591635|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43627874|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627875|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627876|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627877|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
43591636|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43591637|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43591638|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43591640|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43591641|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591642|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
43591643|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
43591644|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
43591645|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591646|NCT03360266|Listerine|listerine|mesh-list
43591647|NCT03360266|Fluorides|fluorides|mesh-list
43591648|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
43591649|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
43591650|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
43591651|NCT03360266|Protective Agents|protective agents|mesh-ancestor
43591652|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591653|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43591654|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591661|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43591662|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43591663|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591664|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43591665|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
43591666|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
43591667|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
43591668|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
43591669|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591670|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591671|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
43591672|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
43683420|NCT04191421|Siltuximab|siltuximab|mesh-list
43627890|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591673|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43591674|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43591675|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591676|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
43591677|NCT03360045|Coagulants|coagulants|mesh-ancestor
43591678|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43591679|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43591680|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591681|NCT03359876|Warfarin|warfarin|mesh-list
43591682|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
43591683|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
43591684|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43591685|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
43591686|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43591687|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
43680443|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43680444|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680446|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
43680447|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828525|NCT05476380|Paclitaxel|paclitaxel|mesh-list
43680448|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
43680449|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43680450|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
43680451|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680452|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680453|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43680454|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
43680455|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43680456|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
43680457|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680458|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680459|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43680460|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
43680461|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
43680462|NCT04996667|Protective Agents|protective agents|mesh-ancestor
43680463|NCT04992156|Palbociclib|palbociclib|mesh-list
43591688|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591689|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591690|NCT03359837|Insulin|insulin|mesh-list
43591691|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43591692|NCT03359837|Metformin|metformin|mesh-list
43591693|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
43591694|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
43591695|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
43591696|NCT03359837|Acarbose|acarbose|mesh-list
43591697|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
43591698|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
43591700|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43591701|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591702|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43591703|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591704|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591705|NCT03359798|Narcotics|narcotics|mesh-list
43591706|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591707|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591708|NCT03359798|Analgesics|analgesics|mesh-ancestor
43591709|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
43591710|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591711|NCT03359746|Grazoprevir|grazoprevir|mesh-list
43600546|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
43680477|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43680478|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43680479|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680486|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43680487|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
43680488|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680489|NCT04964843|Expectorants|expectorants|mesh-ancestor
43680490|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
43680491|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43680492|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
43680493|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680494|NCT04964843|Protective Agents|protective agents|mesh-ancestor
43680495|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680496|NCT04964843|Antidotes|antidotes|mesh-ancestor
43680497|NCT04956705|Vitamin D|vitamin d|mesh-list
43680498|NCT04956705|Calcium|calcium|mesh-list
43680499|NCT04956705|Vitamins|vitamins|mesh-ancestor
43680500|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
43680501|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627982|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43627983|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
43828539|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43828540|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828541|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
43828544|NCT05476341|Bevacizumab|bevacizumab|mesh-list
43591745|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591747|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43591748|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
43591749|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639144|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43591750|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591751|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43591752|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
43591753|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
43591754|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43591755|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43591756|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591757|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
43591758|NCT03359525|Coagulants|coagulants|mesh-ancestor
43591759|NCT03359499|Trimebutine|trimebutine|mesh-list
43591760|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43591761|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
43591762|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
43591763|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591764|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591765|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43680502|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43680503|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43680505|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
43680506|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680507|NCT04945720|Durvalumab|durvalumab|mesh-list
43680508|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43680509|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43680510|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680511|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
43680512|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680513|NCT04932980|Aflibercept|aflibercept|mesh-list
43591766|NCT03359291|Macitentan|macitentan|mesh-list
43591767|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43591768|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43591769|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
43591770|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591771|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43591772|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43591773|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591774|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43591775|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43591776|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43591777|NCT03359070|Miconazole|miconazole|mesh-list
43591778|NCT03359070|Clotrimazole|clotrimazole|mesh-list
43591779|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
43591780|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591781|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43591782|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43591783|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591784|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591785|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43591786|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
43591787|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591788|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591789|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43591790|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43591791|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43591792|NCT03359057|Folic Acid|folic acid|mesh-list
43591793|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
43628014|NCT03069950|Antidotes|antidotes|mesh-ancestor
43591797|NCT03359057|Estrogens|estrogens|mesh-ancestor
43591798|NCT03359057|Hormones|hormones|mesh-ancestor
43591799|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591800|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591801|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43591802|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
43591803|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43591804|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43591805|NCT03359057|Hematinics|hematinics|mesh-ancestor
43591806|NCT03359057|Vitamins|vitamins|mesh-ancestor
43591807|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
43591808|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43591809|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43591810|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43591811|NCT03359018|Apatinib|apatinib|mesh-list
43591812|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591813|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43591814|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591815|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591816|NCT03358953|Nicotine|nicotine|mesh-list
43591817|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43628109|NCT03069183|Ropivacaine|ropivacaine|mesh-list
43628110|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628111|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
43628112|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628113|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628114|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
43628115|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628117|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
43628118|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
43628119|NCT03069248|Rituximab|rituximab|mesh-list
43628120|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43628121|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628122|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
43628123|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628124|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628125|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
43680514|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43680515|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43680516|NCT04932980|Growth Substances|growth substances|mesh-ancestor
43680517|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680518|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
43680519|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680521|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43680522|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680523|NCT04920682|Trace Elements|trace elements|mesh-ancestor
43680524|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
43680525|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680526|NCT04907721|Glucagon|glucagon|mesh-list
43680527|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43680528|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680529|NCT04907721|Hormones|hormones|mesh-ancestor
43591818|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
43591819|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591820|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591821|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43591822|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43591823|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
43591824|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591825|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591826|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
43591827|NCT03358888|Narcotics|narcotics|mesh-ancestor
43591828|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591829|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591830|NCT03358888|Analgesics|analgesics|mesh-ancestor
43591831|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
43591832|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591833|NCT03358719|Poly I-C|poly i-c|mesh-list
43591834|NCT03358719|Nivolumab|nivolumab|mesh-list
43591835|NCT03358719|Decitabine|decitabine|mesh-list
43591836|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43591837|NCT03358719|Poly ICLC|poly iclc|mesh-list
43591838|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43591839|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683453|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
43628131|NCT03068936|Cisplatin|cisplatin|mesh-list
43591840|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43591841|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591842|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43591843|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
43591844|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591845|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
43591846|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
43591847|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591848|NCT03358719|Laxatives|laxatives|mesh-ancestor
43591849|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43591850|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
43591851|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591852|NCT03358524|Vitamins|vitamins|mesh-list
43591853|NCT03358524|Vitamin E|vitamin e|mesh-list
43591854|NCT03358524|Tocopherols|tocopherols|mesh-list
43591855|NCT03358524|Tocotrienols|tocotrienols|mesh-list
43591856|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
43591857|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
43628196|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43628197|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628198|NCT03068065|Incretins|incretins|mesh-ancestor
43628199|NCT03068065|Hormones|hormones|mesh-ancestor
43628200|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628201|NCT03068234|Pirfenidone|pirfenidone|mesh-list
43628202|NCT03068234|Analgesics|analgesics|mesh-ancestor
43628203|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
43628204|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628205|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628206|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43628207|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43628208|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628209|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628210|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628211|NCT03068260|Acetaminophen|acetaminophen|mesh-list
43628212|NCT03068260|Ibuprofen|ibuprofen|mesh-list
43591858|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591859|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
43591860|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591861|NCT03358524|Protective Agents|protective agents|mesh-ancestor
43591862|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
43591863|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43680530|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680531|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680532|NCT04907721|Incretins|incretins|mesh-ancestor
43680533|NCT04907019|Rifampin|rifampin|mesh-list
43680534|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43680535|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
43680536|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43680537|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680538|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
43680539|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43680540|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628271|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
43628272|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628273|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43680541|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680542|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43680543|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43680544|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43680545|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43680546|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43680547|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43828146|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43591864|NCT03358277|Methylphenidate|methylphenidate|mesh-list
43591865|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591866|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
43591867|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628329|NCT03067753|Protective Agents|protective agents|mesh-ancestor
43628330|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43591868|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591872|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43591873|NCT03358212|Denosumab|denosumab|mesh-list
43591874|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43591875|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591876|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
43591877|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43591878|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43591879|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43591880|NCT03358082|Tacrolimus|tacrolimus|mesh-list
43591881|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43591882|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
43628331|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628332|NCT03067792|Leucovorin|leucovorin|mesh-list
43628333|NCT03067792|Cisplatin|cisplatin|mesh-list
43628334|NCT03067792|Docetaxel|docetaxel|mesh-list
43628335|NCT03067792|Fluorouracil|fluorouracil|mesh-list
43628336|NCT03067792|Irinotecan|irinotecan|mesh-list
43628337|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628338|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
43628339|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
43628340|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
43628342|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
43628370|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43628371|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
43628372|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43628373|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43628374|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628375|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43628376|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43628377|NCT03067727|Dinoprostone|dinoprostone|mesh-list
43628378|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
43628379|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628380|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628381|NCT03067103|Ketamine|ketamine|mesh-list
43628382|NCT03067103|Tramadol|tramadol|mesh-list
43628383|NCT03067103|Analgesics|analgesics|mesh-ancestor
43628384|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
43628385|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591883|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591884|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43591885|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591886|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591887|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591888|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
43591889|NCT03358017|Atorvastatin|atorvastatin|mesh-list
43591890|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43591891|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43591892|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
43591893|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591894|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43591895|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43828147|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828148|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828149|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828150|NCT05481281|Analgesics|analgesics|mesh-ancestor
43828151|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
43828152|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828153|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43828154|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43828155|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43828156|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
43828157|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828158|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828159|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43828160|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43828161|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
43828162|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
43828163|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43828164|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43828165|NCT05480631|Mitogens|mitogens|mesh-list
43828166|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
43828167|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847011|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
43847012|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847013|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847014|NCT04149470|Omeprazole|omeprazole|mesh-list
43680548|NCT04879134|Apomorphine|apomorphine|mesh-list
43680549|NCT04879134|Emetics|emetics|mesh-ancestor
43683500|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
43683501|NCT03721406|Ropivacaine|ropivacaine|mesh-list
43683502|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
43680550|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680551|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
43680552|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591896|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591897|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43591898|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591899|NCT03358004|Capecitabine|capecitabine|mesh-list
43591901|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43591902|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
43591903|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591904|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591905|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43591906|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
43680553|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680554|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
43680555|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
43680556|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680557|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680559|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43680560|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43680561|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43680562|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
43680563|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680564|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680565|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680566|NCT04859660|Urological Agents|urological agents|mesh-ancestor
43680567|NCT04851613|Fulvestrant|fulvestrant|mesh-list
43683503|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
43683504|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683505|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683506|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
43683507|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683508|NCT03708549|Metformin|metformin|mesh-list
43683509|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43680568|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43680569|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680570|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43680571|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43680572|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
43680573|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680574|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680575|NCT04846829|Citalopram|citalopram|mesh-list
43680576|NCT04846829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43680577|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43680578|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43601481|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
43680579|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680580|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591908|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
43591909|NCT03357900|Remifentanil|remifentanil|mesh-list
43591910|NCT03357900|Propofol|propofol|mesh-list
43591911|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43591912|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591913|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591914|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43591915|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
43591916|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
43591917|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43591918|NCT03357900|Narcotics|narcotics|mesh-ancestor
43591919|NCT03357900|Analgesics|analgesics|mesh-ancestor
43680581|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
43680582|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680583|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43680584|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
43680585|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43628409|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
43680586|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
43680587|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680588|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
43680589|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
43680590|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680591|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
43680592|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43680593|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680594|NCT04831047|Phenylephrine|phenylephrine|mesh-list
43680595|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
43591920|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
43591921|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591922|NCT03357874|Clopidogrel|clopidogrel|mesh-list
43591923|NCT03357874|Ticagrelor|ticagrelor|mesh-list
43591924|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43591925|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43591926|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43591927|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43591928|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
43591929|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591930|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591931|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591933|NCT03357822|Tenofovir|tenofovir|mesh-list
43591934|NCT03357822|Entecavir|entecavir|mesh-list
43591935|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591937|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591938|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43591939|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43591940|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591960|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
43591961|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591962|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591963|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
43591964|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43591965|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591966|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591967|NCT03357718|Midazolam|midazolam|mesh-list
43591968|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
43591969|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43591970|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591971|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591972|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43591973|NCT03357718|Analgesics|analgesics|mesh-ancestor
43591974|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
43591975|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591976|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43591977|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43591978|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43591979|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
43591980|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591981|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680596|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43680597|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43680598|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43680599|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43680600|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
43680601|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680602|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628500|NCT03066466|Methotrexate|methotrexate|mesh-list
43628501|NCT03066466|Atorvastatin|atorvastatin|mesh-list
43628555|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628556|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43628557|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680603|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680604|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
43680605|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
43680606|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680607|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
43680608|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43680609|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
43591982|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43591983|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43591984|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43591985|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591986|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43628558|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591987|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
43591988|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
43591989|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
43591990|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
43591991|NCT03357653|Losartan|losartan|mesh-list
43591992|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43591993|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43592002|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43592003|NCT03357627|Venetoclax|venetoclax|mesh-list
43592004|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592005|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
43592006|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43592007|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
43592008|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592009|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
43592010|NCT03357575|Protective Agents|protective agents|mesh-ancestor
43592011|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43592012|NCT03357133|Tirofiban|tirofiban|mesh-list
43592013|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43592014|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43592015|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592022|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43592023|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43592024|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
43592025|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
43628585|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628586|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628587|NCT03065868|Clarithromycin|clarithromycin|mesh-list
43628588|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43628589|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628590|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43628591|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628592|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628603|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628605|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
43628606|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628607|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628608|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43628609|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43628610|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43628611|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43628613|NCT03065998|Opipramol|opipramol|mesh-list
43592026|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592027|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43592028|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43592029|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592030|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592031|NCT03356964|Hormones|hormones|mesh-list
43592032|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43592033|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680610|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43680611|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
43680612|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43680613|NCT04831047|Protective Agents|protective agents|mesh-ancestor
43680614|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
43680615|NCT04825496|Fludarabine|fludarabine|mesh-list
43680616|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680617|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
43680618|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680619|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680620|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43680621|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
43592034|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592035|NCT03356912|Prednisone|prednisone|mesh-list
43592036|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592037|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
43592038|NCT03356912|Hormones|hormones|mesh-ancestor
43592039|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592040|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628619|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
43592041|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43592042|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628622|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592043|NCT03356899|Bupivacaine|bupivacaine|mesh-list
43592044|NCT03356899|Anesthetics|anesthetics|mesh-list
43592045|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
43592046|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592047|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592048|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
43592049|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592050|NCT03356873|Vitamin D|vitamin d|mesh-list
43592051|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
43628623|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43628624|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
43592052|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
43592053|NCT03356873|Vitamins|vitamins|mesh-list
43592054|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
43592055|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592056|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43592057|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43592058|NCT03356769|Aspirin|aspirin|mesh-list
43592066|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592067|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592068|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43592069|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43592070|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849100|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
43592071|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43592072|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43592073|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592075|NCT03356600|Apatinib|apatinib|mesh-list
43592076|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592077|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43592078|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592079|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592080|NCT03356730|Vitamin D|vitamin d|mesh-list
43592081|NCT03356730|Vitamins|vitamins|mesh-ancestor
43628625|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43628626|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43628627|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43592082|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
43592083|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592084|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43592086|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
43592087|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592088|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
43592089|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
43680622|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680623|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680624|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43680625|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
43628629|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
43628642|NCT03065569|Bupivacaine|bupivacaine|mesh-list
43628643|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628644|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
43628645|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628646|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628647|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
43683589|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683590|NCT01934452|Sunitinib|sunitinib|mesh-list
43683591|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683592|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43683593|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43683594|NCT01934452|Growth Substances|growth substances|mesh-ancestor
43683595|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683596|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
43683597|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43683598|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683599|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683600|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43683601|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
43680626|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
43680627|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680628|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680629|NCT04811014|Buprenorphine|buprenorphine|mesh-list
43680630|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43680632|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43680633|NCT04811014|Narcotics|narcotics|mesh-ancestor
43680634|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680635|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680636|NCT04811014|Analgesics|analgesics|mesh-ancestor
43680637|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
43680638|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680639|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43592090|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
43592091|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592092|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43592093|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592094|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
43592095|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592096|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592097|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43592098|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
43592099|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592100|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
43592101|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43592102|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43592103|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592104|NCT03356353|Urological Agents|urological agents|mesh-ancestor
43592105|NCT03356158|Cetuximab|cetuximab|mesh-list
43592106|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43592107|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592108|NCT03356080|Cytarabine|cytarabine|mesh-list
43592109|NCT03356080|Decitabine|decitabine|mesh-list
43683602|NCT01773083|Heparin|heparin|mesh-list
43592110|NCT03356080|Tretinoin|tretinoin|mesh-list
43628648|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628649|NCT03065660|Mifepristone|mifepristone|mesh-list
43628650|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43628651|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
43628652|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628653|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628657|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
43628658|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43592111|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43592112|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
43628659|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43592113|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628660|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
43628661|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592114|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592115|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
43592116|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592117|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43592118|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
43592119|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592120|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592121|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
43592122|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
43592123|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43592124|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43592132|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
43592133|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680640|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
43680641|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43592134|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592135|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43592136|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592137|NCT03355768|Romidepsin|romidepsin|mesh-list
43592138|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43592139|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592140|NCT03355716|Fentanyl|fentanyl|mesh-list
43592141|NCT03355716|Ketamine|ketamine|mesh-list
43592142|NCT03355716|Morphine|morphine|mesh-list
43592143|NCT03355716|Bupivacaine|bupivacaine|mesh-list
43592144|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
43592145|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
43592146|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592147|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592148|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
43592149|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592150|NCT03355716|Analgesics|analgesics|mesh-ancestor
43592151|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43592152|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43592153|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
43592154|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43592155|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43592156|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592157|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592158|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43592159|NCT03355716|Narcotics|narcotics|mesh-ancestor
43601482|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
43592160|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43592161|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
43592162|NCT03355638|Aflibercept|aflibercept|mesh-list
43592163|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43592164|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43592165|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43592166|NCT03355638|Growth Substances|growth substances|mesh-ancestor
43592167|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592168|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
43592169|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592170|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43592171|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43592172|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43592173|NCT03355638|Analgesics|analgesics|mesh-ancestor
43592174|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
43592175|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592176|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592177|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592178|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
43592179|NCT03355612|Capecitabine|capecitabine|mesh-list
43592180|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
43592181|NCT03355612|Apatinib|apatinib|mesh-list
43592182|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43592183|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
43592184|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592185|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592186|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43592187|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628702|NCT03064633|Analgesics|analgesics|mesh-ancestor
43628705|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43592188|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
43592189|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43592190|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43592191|NCT03355482|Prednisolone|prednisolone|mesh-list
43592192|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
43592202|NCT03355482|Hormones|hormones|mesh-ancestor
43592203|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592204|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43592205|NCT03355482|Protective Agents|protective agents|mesh-ancestor
43592206|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43592207|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592208|NCT03355352|Sufentanil|sufentanil|mesh-list
43592209|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43592210|NCT03355352|Narcotics|narcotics|mesh-ancestor
43592211|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592212|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592213|NCT03355352|Analgesics|analgesics|mesh-ancestor
43592214|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
43680643|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680644|NCT04796220|Gemcitabine|gemcitabine|mesh-list
43592215|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592216|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43592217|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43592218|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
43592219|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
43683678|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592220|NCT03355300|Cannabidiol|cannabidiol|mesh-list
43592221|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
43592222|NCT03355248|Acetaminophen|acetaminophen|mesh-list
43592223|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43592224|NCT03355248|Oxycodone|oxycodone|mesh-list
43592225|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43592226|NCT03355248|Analgesics|analgesics|mesh-ancestor
43592227|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
43592228|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592229|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683679|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43683680|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
43683681|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683682|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683683|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43592230|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
43592231|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43592232|NCT03355248|Narcotics|narcotics|mesh-ancestor
43592233|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592239|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592240|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683684|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
43683685|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683686|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683688|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
43683689|NCT00816972|Oxybutynin|oxybutynin|mesh-list
43683690|NCT00816972|Desloratadine|desloratadine|mesh-list
43683691|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
43628804|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
43628805|NCT03063892|Coagulants|coagulants|mesh-ancestor
43628806|NCT03063905|Buprenorphine|buprenorphine|mesh-list
43628807|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43628808|NCT03063905|Narcotics|narcotics|mesh-ancestor
43628809|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628810|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628811|NCT03063905|Analgesics|analgesics|mesh-ancestor
43592241|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43592242|NCT03355053|Analgesics|analgesics|mesh-ancestor
43592243|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
43592244|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592245|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43592246|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43592247|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43592248|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
43592249|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592250|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592251|NCT03355027|Atorvastatin|atorvastatin|mesh-list
43592252|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43592253|NCT03355027|Simvastatin|simvastatin|mesh-list
43592255|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43592256|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43592257|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
43592258|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592259|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43592263|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43592264|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592265|NCT03354962|Nivolumab|nivolumab|mesh-list
43592266|NCT03354962|Ipilimumab|ipilimumab|mesh-list
43592267|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43592268|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592269|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43592270|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592271|NCT03354897|Torsemide|torsemide|mesh-list
43592272|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43592273|NCT03354897|Diuretics|diuretics|mesh-ancestor
43592274|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
43592275|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592276|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43592277|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43592278|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592279|NCT03354806|Analgesics|analgesics|mesh-list
43592280|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
43592281|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628812|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
43628813|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628814|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43628815|NCT03063710|Olaparib|olaparib|mesh-list
43592282|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592283|NCT03354624|Mitogens|mitogens|mesh-list
43592284|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
43592285|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592286|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
43592287|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43592288|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
43592289|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628850|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628851|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628852|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628853|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628854|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43628855|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43628856|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592290|NCT03354572|Expectorants|expectorants|mesh-ancestor
43592291|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
43592293|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
43592294|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592295|NCT03354572|Protective Agents|protective agents|mesh-ancestor
43592296|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592297|NCT03354572|Antidotes|antidotes|mesh-ancestor
43628857|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43628858|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43628859|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628860|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
43628861|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
43628862|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43683703|NCT00816972|Renal Agents|renal agents|mesh-ancestor
43683704|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683705|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683706|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683707|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
43683708|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
43683709|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683710|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683711|NCT00805324|Desloratadine|desloratadine|mesh-list
43683712|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683713|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683714|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683715|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683716|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683717|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43628863|NCT03063723|Ledipasvir|ledipasvir|mesh-list
43849101|NCT03962465|Hormones|hormones|mesh-ancestor
43628865|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628866|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
43628867|NCT03063671|Ketamine|ketamine|mesh-list
43628868|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43628869|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628870|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628871|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43592298|NCT03354494|Desogestrel|desogestrel|mesh-list
43592299|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43592300|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43592301|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43592302|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
43592303|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592304|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592305|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43628872|NCT03063671|Analgesics|analgesics|mesh-ancestor
43628873|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
43628874|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628875|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43592306|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43592307|NCT03354494|Progestins|progestins|mesh-ancestor
43592308|NCT03354494|Hormones|hormones|mesh-ancestor
43592309|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592310|NCT03354338|Amoxicillin|amoxicillin|mesh-list
43592311|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43592312|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592313|NCT03354312|Lidocaine|lidocaine|mesh-list
43592314|NCT03354312|Epinephrine|epinephrine|mesh-list
43592315|NCT03354312|Racepinephrine|racepinephrine|mesh-list
43592316|NCT03354312|Carticaine|carticaine|mesh-list
43592317|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
43592318|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
43592319|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
43592320|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592321|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592322|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
43592323|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592324|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43592325|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43592326|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43592327|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43592328|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680645|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43680646|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
43680647|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680651|NCT04796220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680652|NCT04796220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680653|NCT04796220|Immunologic Factors|immunologic factors|mesh-ancestor
43680654|NCT04796220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680655|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
43680656|NCT04782037|Calcium|calcium|mesh-list
43680657|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43680658|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680662|NCT04772001|Carboplatin|carboplatin|mesh-list
43680663|NCT04772001|Cisplatin|cisplatin|mesh-list
43680664|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680665|NCT04767698|Belimumab|belimumab|mesh-list
43828171|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828172|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43828173|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43828174|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
43828177|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43828178|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828179|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43828180|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828181|NCT05480293|Ranibizumab|ranibizumab|mesh-list
43828182|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43828183|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43828184|NCT05480293|Growth Substances|growth substances|mesh-ancestor
43828185|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828186|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
43828187|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828188|NCT05480280|Leucovorin|leucovorin|mesh-list
43828189|NCT05480280|Fluorouracil|fluorouracil|mesh-list
43828190|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
43828191|NCT05480280|Calcium|calcium|mesh-list
43828192|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
43828193|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43828194|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828195|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
43828196|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828197|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43828198|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828199|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43828200|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
43828201|NCT05480280|Antidotes|antidotes|mesh-ancestor
43828202|NCT05480280|Protective Agents|protective agents|mesh-ancestor
43828203|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
43828204|NCT05480280|Vitamins|vitamins|mesh-ancestor
43828205|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
43828206|NCT05480111|Anesthetics|anesthetics|mesh-list
43628876|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43828211|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43828212|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43828213|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43828214|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
43828215|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683743|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43828216|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828217|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628947|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
43628948|NCT03063307|Protective Agents|protective agents|mesh-ancestor
43628949|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828219|NCT05480072|Analgesics|analgesics|mesh-ancestor
43628951|NCT03063359|Morphine|morphine|mesh-list
43628952|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43592355|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43592356|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
43592357|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592358|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43592359|NCT03353948|Metformin|metformin|mesh-list
43592360|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43592361|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592362|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
43592363|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43592364|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
43592365|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592366|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
43592367|NCT03353909|Protective Agents|protective agents|mesh-ancestor
43592368|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43592369|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
43592370|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43592371|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
43592372|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592373|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592374|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43628953|NCT03063359|Narcotics|narcotics|mesh-ancestor
43628954|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628955|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628961|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
43592375|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43592376|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592378|NCT03353857|Dienogest|dienogest|mesh-list
43592379|NCT03353857|Drospirenone|drospirenone|mesh-list
43592380|NCT03353857|Midazolam|midazolam|mesh-list
43592381|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
43592382|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43592383|NCT03353857|Norethindrone|norethindrone|mesh-list
43592384|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
43592385|NCT03353857|Desogestrel|desogestrel|mesh-list
43592386|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43592387|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43592388|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592400|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43592404|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43592405|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43592406|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43592407|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
43592408|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43592409|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592410|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
43592411|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43629070|NCT03063060|Vitamin D|vitamin d|mesh-list
43629071|NCT03063060|Calcium|calcium|mesh-list
43592412|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592413|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43592414|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43592415|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43592416|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43592417|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43592418|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43592419|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43592422|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592423|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43592424|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
43592425|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43592426|NCT03353857|Diuretics|diuretics|mesh-ancestor
43592427|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
43592428|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43592429|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43592430|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592431|NCT03353857|Progestins|progestins|mesh-ancestor
43592432|NCT03353480|Azithromycin|azithromycin|mesh-list
43592433|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43680685|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629119|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43629129|NCT03061838|Rituximab|rituximab|mesh-list
43680687|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
43680688|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680689|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592434|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592435|NCT03353441|Glycine|glycine|mesh-list
43592436|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
43592437|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592438|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592440|NCT03353363|Bupivacaine|bupivacaine|mesh-list
43592441|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
43592442|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
43629162|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
43629163|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43592443|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592444|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592445|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
43592446|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592447|NCT03353324|Bevacizumab|bevacizumab|mesh-list
43592448|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43592449|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592450|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43592451|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43592452|NCT03353324|Growth Substances|growth substances|mesh-ancestor
43592453|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592454|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
43680690|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680691|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
43680693|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680694|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43680695|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680696|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
43680697|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680698|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680699|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43629207|NCT03061253|Nicotine|nicotine|mesh-list
43680700|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
43680701|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592455|NCT03353298|Allopurinol|allopurinol|mesh-list
43592456|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
43629232|NCT03061006|Warfarin|warfarin|mesh-list
43592457|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592458|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592459|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
43592460|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592461|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43592462|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
43592463|NCT03353298|Protective Agents|protective agents|mesh-ancestor
43592464|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592465|NCT03353103|Listerine|listerine|mesh-list
43592466|NCT03353103|Fluorides|fluorides|mesh-list
43592467|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
43592468|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
43592469|NCT03353103|Protective Agents|protective agents|mesh-ancestor
43592470|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592471|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43592478|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592479|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629348|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43629349|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43629350|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43629351|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
43629352|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592481|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592482|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592483|NCT03353025|Protective Agents|protective agents|mesh-ancestor
43592484|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
43592485|NCT03353012|Etonogestrel|etonogestrel|mesh-list
43592486|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43592487|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
43629354|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43592488|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592489|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592490|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43592491|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43592492|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43592493|NCT03352947|Trametinib|trametinib|mesh-list
43592494|NCT03352947|Dabrafenib|dabrafenib|mesh-list
43592495|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592496|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43592497|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592498|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592499|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
43592500|NCT03352895|Resveratrol|resveratrol|mesh-list
43592501|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
43592502|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592503|NCT03352895|Protective Agents|protective agents|mesh-ancestor
43592504|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592505|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592506|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43592507|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43629456|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592508|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629457|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629458|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629459|NCT03059615|Doxorubicin|doxorubicin|mesh-list
43629460|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43629461|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629462|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43629463|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43629464|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629465|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592509|NCT03352869|Metformin|metformin|mesh-list
43680702|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43680703|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
43680704|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
43680705|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43680706|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680707|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
43680708|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680709|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43680710|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43680711|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
43680712|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
43680713|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
43680714|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680715|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43680716|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43680717|NCT04746547|Dolutegravir|dolutegravir|mesh-list
43680718|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43680719|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43680720|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680721|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680722|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43680723|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43680724|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
43680725|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680726|NCT04738695|Antibodies|antibodies|mesh-list
43680727|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
43680728|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680729|NCT04713969|Pantoprazole|pantoprazole|mesh-list
43680730|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43592510|NCT03352869|Exenatide|exenatide|mesh-list
43629514|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43629515|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629516|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629517|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629518|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43629519|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43629520|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629521|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629523|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43629524|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43629525|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43629526|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
43629527|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629528|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629529|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629531|NCT03058939|Tamoxifen|tamoxifen|mesh-list
43592511|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43592512|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592513|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43592514|NCT03352869|Incretins|incretins|mesh-ancestor
43592515|NCT03352869|Hormones|hormones|mesh-ancestor
43592516|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592517|NCT03352843|Primaquine|primaquine|mesh-list
43592518|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
43592519|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43592520|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43592521|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592522|NCT03352700|Dyclonine|dyclonine|mesh-list
43592523|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
43592524|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
43592525|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680731|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680732|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43680733|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680734|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680736|NCT04706130|Primaquine|primaquine|mesh-list
43680737|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
43680738|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43680739|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43680740|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680741|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680742|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
43680743|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
43680744|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43680745|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
43680746|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
43680747|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
43680748|NCT04669782|Teriparatide|teriparatide|mesh-list
43629543|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43629544|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43629545|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43629546|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629547|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43629548|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
43629549|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629550|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629551|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43629552|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43629553|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43629557|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
43629558|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43629559|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629560|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43629562|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629563|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629564|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
43629565|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629566|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43683925|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
43683926|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683927|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683928|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683929|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683930|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
43680749|NCT04669782|Vitamin K|vitamin k|mesh-list
43680750|NCT04669782|Vitamins|vitamins|mesh-ancestor
43680751|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
43680752|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680753|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43680754|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43680755|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592526|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592527|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
43592528|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592529|NCT03352674|Insulin|insulin|mesh-list
43592530|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43592531|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
43592532|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43592533|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592534|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
43592535|NCT03352479|Narcotics|narcotics|mesh-ancestor
43592536|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629620|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43629621|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43629622|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
43683945|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683946|NCT00380523|Etoricoxib|etoricoxib|mesh-list
43683947|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43683948|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43683949|NCT00380523|Analgesics|analgesics|mesh-ancestor
43683950|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
43629623|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
43629624|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
43629625|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
43629626|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592537|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592538|NCT03352479|Analgesics|analgesics|mesh-ancestor
43592539|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
43592540|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592541|NCT03352362|Acetaminophen|acetaminophen|mesh-list
43592542|NCT03352362|Ibuprofen|ibuprofen|mesh-list
43592550|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592551|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629629|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43629630|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629631|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43629632|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629633|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43629634|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43629635|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43629636|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43592554|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592556|NCT03352349|Terlipressin|terlipressin|mesh-list
43592557|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43592558|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43592559|NCT03352128|Calcium|calcium|mesh-list
43592560|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43592561|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680756|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
43680757|NCT04669782|Coagulants|coagulants|mesh-ancestor
43680758|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43680759|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43680760|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43680761|NCT04669041|Ezetimibe|ezetimibe|mesh-list
43680762|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43680763|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43680764|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
43629641|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43680765|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680766|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43680767|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43680768|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592562|NCT03352115|Prednisolone|prednisolone|mesh-list
43592563|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592564|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
43592565|NCT03352115|Hormones|hormones|mesh-ancestor
43592566|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592567|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592568|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43592569|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592570|NCT03352076|Danazol|danazol|mesh-list
43592571|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43629740|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
43629741|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
43629742|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43629743|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43629744|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43592572|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
43592573|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592574|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592575|NCT03351842|Cisplatin|cisplatin|mesh-list
43592576|NCT03351842|Carboplatin|carboplatin|mesh-list
43592577|NCT03351842|Pemetrexed|pemetrexed|mesh-list
43592578|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592579|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592580|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592581|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43592582|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43592583|NCT03351751|PF-06372865|pf-06372865|mesh-list
43592584|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
43592585|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
43592586|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592587|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592588|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592589|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
43592590|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43592591|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43592592|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629745|NCT03057769|Analgesics|analgesics|mesh-ancestor
43629746|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
43629763|NCT03057483|Vaccines|vaccines|mesh-list
43592593|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
43592594|NCT03351686|Coagulants|coagulants|mesh-ancestor
43592595|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
43592596|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43592597|NCT03351569|Antibodies|antibodies|mesh-list
43592598|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
43592599|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43849102|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849103|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849104|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849105|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592610|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43592611|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43592612|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43592613|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592615|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592617|NCT03351361|Ipilimumab|ipilimumab|mesh-list
43592618|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43592619|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592620|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43592621|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592622|NCT03351322|Minoxidil|minoxidil|mesh-list
43592623|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43592624|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
43592625|NCT03351296|Bevacizumab|bevacizumab|mesh-list
43592626|NCT03351296|Capecitabine|capecitabine|mesh-list
43592627|NCT03351296|Temozolomide|temozolomide|mesh-list
43592628|NCT03351296|Streptozocin|streptozocin|mesh-list
43592629|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43592630|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592631|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43592632|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43592633|NCT03351296|Growth Substances|growth substances|mesh-ancestor
43592634|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592635|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
43592636|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43592638|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592639|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43592640|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
43592641|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43592642|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43592643|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43592644|NCT03351205|Estradiol|estradiol|mesh-list
43592645|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43592646|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
43592647|NCT03351205|Estrogens|estrogens|mesh-ancestor
43592648|NCT03351205|Hormones|hormones|mesh-ancestor
43592649|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592650|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592651|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43592652|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
43592653|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592655|NCT03351205|Progestins|progestins|mesh-ancestor
43592656|NCT03351062|Tamoxifen|tamoxifen|mesh-list
43592657|NCT03351062|Toremifene|toremifene|mesh-list
43592658|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43592659|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
43592660|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592661|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592662|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43592663|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592664|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43592665|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43592666|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43592667|NCT03350737|Heparin|heparin|mesh-list
43592668|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
43592669|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43592670|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43592671|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592672|NCT03350659|Midodrine|midodrine|mesh-list
43592681|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
43592682|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
43592683|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592684|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43592685|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43592686|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43592687|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43629864|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629865|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592688|NCT03350633|Azathioprine|azathioprine|mesh-list
43592689|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
43592690|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592691|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43592692|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592693|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43592694|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
43592695|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592696|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592697|NCT03350399|Mitogens|mitogens|mesh-list
43592698|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
43592699|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592700|NCT03350373|Dotinurad|dotinurad|mesh-list
43592701|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
43592702|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
43592703|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592704|NCT03350373|Renal Agents|renal agents|mesh-ancestor
43592705|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
43592706|NCT03350347|Hematinics|hematinics|mesh-ancestor
43592707|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43592708|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43592709|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43592710|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43592711|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592712|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592713|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592714|NCT03350334|Analgesics|analgesics|mesh-ancestor
43592715|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
43592716|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592717|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
43592718|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43592719|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
43592720|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
43592721|NCT03350321|Hematinics|hematinics|mesh-ancestor
43592722|NCT03350295|Nifurtimox|nifurtimox|mesh-list
43592723|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43592735|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43592736|NCT03350126|Nivolumab|nivolumab|mesh-list
43592737|NCT03350126|Ipilimumab|ipilimumab|mesh-list
43684062|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43629925|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
43629926|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
43629927|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43592738|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43592745|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43592746|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43592748|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592749|NCT03349866|Capecitabine|capecitabine|mesh-list
43592750|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
43592751|NCT03349866|Apatinib|apatinib|mesh-list
43592752|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43592753|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
43629992|NCT03056092|Ranibizumab|ranibizumab|mesh-list
43629993|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43629994|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43629995|NCT03056092|Growth Substances|growth substances|mesh-ancestor
43629999|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
43592754|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592755|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592756|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43592757|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592758|NCT03349840|Insulin|insulin|mesh-list
43592759|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43684098|NCT00156091|Olanzapine|olanzapine|mesh-list
43592760|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
43592761|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43592762|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592763|NCT03349827|Apatinib|apatinib|mesh-list
43592764|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592765|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43592766|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592767|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592768|NCT03349684|Metformin|metformin|mesh-list
43592769|NCT03349684|Acarbose|acarbose|mesh-list
43592770|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43592771|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630044|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43630045|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
43630046|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630047|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630048|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43630052|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630053|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43630054|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43630055|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43630056|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
43630057|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630058|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630060|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
43630061|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43630062|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684151|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684152|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684153|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684154|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684155|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684156|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630063|NCT03055507|Acetaminophen|acetaminophen|mesh-list
43630065|NCT03055507|Oxycodone|oxycodone|mesh-list
43630066|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43630067|NCT03055507|Analgesics|analgesics|mesh-ancestor
43630068|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
43630069|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630070|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630071|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
43630072|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43630073|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592772|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43592773|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592774|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592775|NCT03349658|Anesthetics|anesthetics|mesh-list
43592776|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592777|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592779|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
43592780|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592800|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43592802|NCT03349489|Insulin|insulin|mesh-list
43592803|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43592804|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43592805|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592806|NCT03349424|Somatostatin|somatostatin|mesh-list
43592807|NCT03349424|Hormones|hormones|mesh-ancestor
43630074|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630075|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43630076|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630077|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630078|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43630079|NCT03055507|Narcotics|narcotics|mesh-ancestor
43630080|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630081|NCT03055234|Treprostinil|treprostinil|mesh-list
43630082|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43592822|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592823|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43592824|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43592825|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43592826|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592827|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592828|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43592829|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
43592830|NCT03349216|Anesthetics|anesthetics|mesh-list
43592831|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592832|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592833|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
43592834|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43592835|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
43592836|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592837|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592838|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43592839|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
43592840|NCT03349177|Docetaxel|docetaxel|mesh-list
43592841|NCT03349177|Fluorouracil|fluorouracil|mesh-list
43592842|NCT03349177|Epirubicin|epirubicin|mesh-list
43592843|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43592844|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
43592845|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592846|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592847|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43592848|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
43592849|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592850|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630083|NCT03055312|Bicalutamide|bicalutamide|mesh-list
43592851|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43592852|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
43592853|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
43630084|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
43592854|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
43680775|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680776|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
43680777|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680778|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680779|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43630085|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
43630086|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630087|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630088|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630089|NCT03055442|Inositol|inositol|mesh-list
43630090|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
43630091|NCT03055442|Vitamins|vitamins|mesh-ancestor
43630093|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630094|NCT03055091|Sorbitol|sorbitol|mesh-list
43630095|NCT03055091|Cathartics|cathartics|mesh-ancestor
43630096|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630097|NCT03054948|SMOFlipid|smoflipid|mesh-list
43630098|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43630099|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43630100|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43680780|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
43680781|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680782|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680783|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43680786|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43680787|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680788|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
43680789|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680790|NCT04643093|Ezetimibe|ezetimibe|mesh-list
43680791|NCT04643093|Pitavastatin|pitavastatin|mesh-list
43680792|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43680793|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43680794|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
43680795|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680796|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43680797|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43680798|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680799|NCT04636255|Calcium|calcium|mesh-list
43680800|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43680801|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680802|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
43680803|NCT04636086|Vitamin D|vitamin d|mesh-list
43680804|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43680805|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680806|NCT04636086|Vitamins|vitamins|mesh-ancestor
43680807|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
43680808|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43680816|NCT04612920|Ibuprofen|ibuprofen|mesh-list
43680817|NCT04612920|Oxycodone|oxycodone|mesh-list
43680818|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43680819|NCT04612920|Analgesics|analgesics|mesh-ancestor
43680820|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
43630101|NCT03054662|Hemostatics|hemostatics|mesh-list
43680821|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680822|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680823|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
43680824|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43680825|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43680827|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43680828|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680829|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680830|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43630102|NCT03054662|Coagulants|coagulants|mesh-ancestor
43630103|NCT03054610|Betamethasone|betamethasone|mesh-list
43630104|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
43680831|NCT04612920|Narcotics|narcotics|mesh-ancestor
43680832|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680833|NCT04597099|Flutamide|flutamide|mesh-list
43680834|NCT04597099|Estradiol|estradiol|mesh-list
43680835|NCT04597099|Progesterone|progesterone|mesh-list
43680836|NCT04597099|Estrogens|estrogens|mesh-ancestor
43680837|NCT04597099|Hormones|hormones|mesh-ancestor
43680838|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43680839|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680840|NCT04597099|Progestins|progestins|mesh-ancestor
43680841|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
43680842|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
43680843|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43592855|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
43630105|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43630106|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
43630107|NCT03054610|Ropivacaine|ropivacaine|mesh-list
43630108|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
43630109|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43630110|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
43592856|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43630111|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43630112|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43630113|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
43592857|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43592858|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43592859|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43592860|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592862|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
43592863|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
43630114|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
43630115|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630116|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630117|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
43630118|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630122|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
43592864|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684183|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43684184|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684185|NCT00132717|Atorvastatin|atorvastatin|mesh-list
43592865|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592866|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
43592867|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592868|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43592869|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43684186|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43684187|NCT00132717|Simvastatin|simvastatin|mesh-list
43684188|NCT00132717|Ezetimibe|ezetimibe|mesh-list
43592870|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43592877|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592878|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
43592879|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
43592881|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43680844|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828235|NCT05480007|Metformin|metformin|mesh-list
43828236|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43828237|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43684189|NCT00132717|Pravastatin|pravastatin|mesh-list
43684190|NCT00132717|Lovastatin|lovastatin|mesh-list
43684192|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
43684193|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43684194|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684195|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
43630136|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
43630137|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43828238|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828239|NCT05480007|Incretins|incretins|mesh-ancestor
43828240|NCT05480007|Hormones|hormones|mesh-ancestor
43828241|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828242|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43680845|NCT04577716|Listerine|listerine|mesh-list
43592882|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592883|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
43630138|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43630139|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43592884|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
43592885|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
43592886|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43592887|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43592888|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43592889|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43592890|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592891|NCT03348800|Anesthetics|anesthetics|mesh-list
43592892|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592893|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592895|NCT03348735|Pregabalin|pregabalin|mesh-list
43592896|NCT03348735|Capsaicin|capsaicin|mesh-list
43630140|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43630141|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630142|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
43630143|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630144|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630145|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43630146|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630147|NCT03054207|Clopidogrel|clopidogrel|mesh-list
43630148|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43630149|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43592897|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
43592898|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
43592899|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592900|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592901|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
43592902|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630150|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43630151|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43630152|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43630153|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
43630154|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630155|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630156|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592903|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43592904|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43592905|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43592906|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43592907|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592908|NCT03348735|Analgesics|analgesics|mesh-ancestor
43630157|NCT03054285|Levetiracetam|levetiracetam|mesh-list
43630158|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
43630159|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
43630160|NCT03054467|Amlodipine|amlodipine|mesh-list
43630161|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43592909|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
43592910|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43592911|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43592912|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43592913|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43592915|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
43592916|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
43592917|NCT03348696|Dexamethasone|dexamethasone|mesh-list
43592918|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
43592919|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43592920|NCT03348696|BB 1101|bb 1101|mesh-list
43592921|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592922|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
43592923|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
43592924|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592925|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592926|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43592927|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
43592928|NCT03348696|Hormones|hormones|mesh-ancestor
43592929|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592930|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43592931|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592932|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
43592933|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592934|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680846|NCT04577716|Fluorides|fluorides|mesh-list
43680847|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
43630162|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43630163|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43630164|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630165|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43630166|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630167|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
43630169|NCT03054168|Testosterone|testosterone|mesh-list
43630170|NCT03054168|Hormones|hormones|mesh-ancestor
43630171|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630172|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630173|NCT03054168|Androgens|androgens|mesh-ancestor
43630174|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43630176|NCT03054220|Tramadol|tramadol|mesh-list
43680848|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
43680849|NCT04577716|Protective Agents|protective agents|mesh-ancestor
43680850|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680852|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680853|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
43684201|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684202|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630186|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630187|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43680854|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
43680855|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680856|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
43680857|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592935|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
43592936|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
43592937|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
43592938|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592939|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592940|NCT03348462|Anthralin|anthralin|mesh-list
43592948|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
43592949|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592950|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43592951|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43592952|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
43592955|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43592956|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592957|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592958|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592959|NCT03348267|Caseins|caseins|mesh-list
43592960|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
43592961|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
43592962|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592963|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43592964|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43592965|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592966|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
43592967|NCT03348098|Paclitaxel|paclitaxel|mesh-list
43592968|NCT03348098|Apatinib|apatinib|mesh-list
43592969|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43849108|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592970|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592971|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
43592972|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
43592973|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
43592974|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592975|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43592976|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592977|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
43592978|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592980|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
43592981|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43592982|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43592983|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
43592984|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43592985|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
43592986|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592987|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592989|NCT03347968|Esmolol|esmolol|mesh-list
43592990|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
43592991|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43680858|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680860|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
43680861|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680862|NCT04547439|Protective Agents|protective agents|mesh-ancestor
43680863|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680864|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680865|NCT04543942|Ethanol|ethanol|mesh-list
43630188|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43630189|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680866|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43680867|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680868|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680869|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680870|NCT04522544|Durvalumab|durvalumab|mesh-list
43680871|NCT04522544|Tremelimumab|tremelimumab|mesh-list
43630203|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43630204|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43630206|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43630207|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43630208|NCT03054259|Prednisolone|prednisolone|mesh-list
43630209|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
43630210|NCT03054259|Rituximab|rituximab|mesh-list
43680872|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43680873|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680874|NCT04515134|Ubiquinone|ubiquinone|mesh-list
43680875|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
43680876|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
43680877|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592992|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43592993|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43592994|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
43592995|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592996|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592997|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592998|NCT03347916|Gabapentin|gabapentin|mesh-list
43592999|NCT03347916|Analgesics|analgesics|mesh-ancestor
43593000|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
43593001|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593002|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593003|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
43593004|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43593005|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43593006|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593007|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43593008|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43593035|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593036|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43593037|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43593038|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43593039|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43593040|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593041|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
43849109|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43849110|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
43849111|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849112|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
43849113|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849114|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43849115|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43630211|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43630212|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
43630213|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849116|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
43849117|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43680879|NCT04496063|Ustekinumab|ustekinumab|mesh-list
43630214|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630215|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
43680880|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
43680881|NCT04476550|Lenograstim|lenograstim|mesh-list
43680882|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43680883|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
43680884|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680885|NCT04449536|Mesna|mesna|mesh-list
43680886|NCT04449536|Protective Agents|protective agents|mesh-ancestor
43680887|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680888|NCT04435015|Camostat|camostat|mesh-list
43680889|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
43680890|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680891|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680892|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43680893|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43680894|NCT04414228|Anesthetics|anesthetics|mesh-list
43680895|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680896|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680897|NCT04413201|Osimertinib|osimertinib|mesh-list
43849118|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43593042|NCT03347591|Hemostatics|hemostatics|mesh-list
43593043|NCT03347591|Coagulants|coagulants|mesh-ancestor
43593044|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43593045|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
43593060|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593061|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593062|NCT03347526|Hormones|hormones|mesh-ancestor
43593063|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593064|NCT03347513|Glycine|glycine|mesh-list
43593065|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
43593066|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593067|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593068|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593069|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
43593070|NCT03347461|Dexamethasone|dexamethasone|mesh-list
43593071|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43593072|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
43593073|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
43593074|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593075|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593076|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43593077|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
43593078|NCT03347461|Hormones|hormones|mesh-ancestor
43593079|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593080|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43593081|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593082|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593083|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593084|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593085|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593086|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43593087|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43593088|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43593089|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43593091|NCT03347370|Interferon-beta|interferon-beta|mesh-list
43593092|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
43680898|NCT04413201|Afatinib|afatinib|mesh-list
43680899|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680900|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680901|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680902|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680903|NCT04407754|Inositol|inositol|mesh-list
43630219|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
43630220|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
43630221|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630222|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630223|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
43630224|NCT03054259|Hormones|hormones|mesh-ancestor
43630225|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630226|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43630227|NCT03054259|Protective Agents|protective agents|mesh-ancestor
43630228|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43630229|NCT03053739|Bosentan|bosentan|mesh-list
43630230|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
43630231|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
43680904|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
43680905|NCT04407754|Vitamins|vitamins|mesh-ancestor
43680906|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
43680907|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680908|NCT04404049|UB-421|ub-421|mesh-list
43680909|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43680910|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
43680911|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680912|NCT04395248|Anesthetics|anesthetics|mesh-list
43680913|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680914|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680915|NCT04384562|Methylphenidate|methylphenidate|mesh-list
43593093|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
43593094|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593095|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
43593096|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593097|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
43593098|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593099|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43593100|NCT03347357|Tacrolimus|tacrolimus|mesh-list
43593101|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43593102|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
43593103|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593104|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43593105|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593106|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593107|NCT03347344|Riluzole|riluzole|mesh-list
43593114|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43593115|NCT03347344|Protective Agents|protective agents|mesh-ancestor
43593116|NCT03347240|Baclofen|baclofen|mesh-list
43593117|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43593118|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593119|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43593120|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593121|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43593122|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
43593123|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
43593124|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593125|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593126|NCT03346993|Bupivacaine|bupivacaine|mesh-list
43593127|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
43593128|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
43593129|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593130|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593131|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
43593132|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593133|NCT03346837|Itraconazole|itraconazole|mesh-list
43593134|NCT03346837|Rifampin|rifampin|mesh-list
43593135|NCT03346837|Linrodostat|linrodostat|mesh-list
43593136|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
43593137|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593138|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43680927|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43680928|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43680929|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43680930|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43680931|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
43680932|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
43680933|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43593155|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43593156|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43593157|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43593158|NCT03346733|Psyllium|psyllium|mesh-list
43593159|NCT03346733|Cathartics|cathartics|mesh-ancestor
43593160|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43593161|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
43593162|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43593163|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
43593164|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593167|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43593168|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
43593169|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593170|NCT03346681|Protective Agents|protective agents|mesh-ancestor
43593171|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593172|NCT03346681|Antidotes|antidotes|mesh-ancestor
43593173|NCT03346642|Decitabine|decitabine|mesh-list
43593174|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43593177|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593178|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630240|NCT03053856|Cisplatin|cisplatin|mesh-list
43684225|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593179|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593180|NCT03346629|Misoprostol|misoprostol|mesh-list
43593181|NCT03346629|Mifepristone|mifepristone|mesh-list
43630263|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
43630264|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
43630265|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630266|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630267|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43630268|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43630269|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43630270|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630271|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
43630272|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
43630273|NCT03053947|Ketamine|ketamine|mesh-list
43630274|NCT03053947|Analgesics|analgesics|mesh-ancestor
43630275|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
43630276|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630277|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593182|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43593183|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
43593184|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43593185|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593186|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43593187|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43593188|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
43593189|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43593190|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43593191|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43593192|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43593193|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
43593194|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43630278|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43630279|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630280|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
43593195|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43593196|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
43680934|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43680935|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
43680936|NCT04338165|Evolocumab|evolocumab|mesh-list
43680937|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43680938|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43680939|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
43680940|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680941|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43828243|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
43593197|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630281|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
43593198|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
43593199|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43684228|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684229|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684230|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684231|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684233|NCT00093899|Ezetimibe|ezetimibe|mesh-list
43684234|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43593200|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43593201|NCT03346538|Edaravone|edaravone|mesh-list
43593202|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43593203|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
43593204|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684235|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684236|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
43684237|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684238|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684239|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43684240|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684241|NCT00092898|Ezetimibe|ezetimibe|mesh-list
43593205|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43593206|NCT03346538|Protective Agents|protective agents|mesh-ancestor
43593207|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593208|NCT03346525|Penicillins|penicillins|mesh-list
43593209|NCT03346525|Penicillin G|penicillin g|mesh-list
43593210|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43593211|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
43593212|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593213|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593214|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43593215|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43593216|NCT03346317|Estradiol|estradiol|mesh-list
43593217|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43684242|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43593218|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
43593219|NCT03346317|Estrogens|estrogens|mesh-ancestor
43593220|NCT03346317|Hormones|hormones|mesh-ancestor
43593221|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593222|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593223|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43593224|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
43593225|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43593226|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43593227|NCT03346317|Progestins|progestins|mesh-ancestor
43593228|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
43630287|NCT03053830|Ketamine|ketamine|mesh-list
43630300|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630301|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
43630302|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43593229|NCT03346226|Propofol|propofol|mesh-list
43593230|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43593231|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593232|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593233|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43593234|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
43593235|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
43593236|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43593237|NCT03346226|Analgesics|analgesics|mesh-ancestor
43593238|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
43593239|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593240|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43593241|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43593242|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43593243|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
43593244|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630303|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
43630304|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630305|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630306|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43630307|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
43630308|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43630310|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630311|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630312|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43630313|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
43630317|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43630318|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630319|NCT03053622|Mirikizumab|mirikizumab|mesh-list
43593245|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593247|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43593248|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
43593260|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593261|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43593262|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43593263|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
43828244|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828245|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630320|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43630321|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828246|NCT05479916|Caseins|caseins|mesh-list
43828247|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
43630322|NCT03053622|Analgesics|analgesics|mesh-ancestor
43684247|NCT00092820|Ezetimibe|ezetimibe|mesh-list
43828248|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
43828249|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828250|NCT05479747|Analgesics|analgesics|mesh-list
43828251|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
43828252|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828253|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684248|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43684249|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684250|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
43828254|NCT05479487|Apatinib|apatinib|mesh-list
43828255|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828256|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43828257|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828258|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828259|NCT05479448|Prednisone|prednisone|mesh-list
43593264|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593265|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43593266|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43593267|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593268|NCT03346096|Thiotepa|thiotepa|mesh-list
43593269|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43593270|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
43593271|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593272|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593273|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43593274|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43593275|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
43593276|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593280|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43593281|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
43593282|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593283|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593284|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
43593285|NCT03345992|Clarithromycin|clarithromycin|mesh-list
43593286|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593287|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593288|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43684251|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684252|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684253|NCT00092807|Ezetimibe|ezetimibe|mesh-list
43630340|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43630341|NCT03053505|Vancomycin|vancomycin|mesh-list
43630342|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
43630343|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43630344|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43630345|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43630346|NCT03053284|Pasireotide|pasireotide|mesh-list
43630347|NCT03053284|Hormones|hormones|mesh-ancestor
43630348|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630349|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593289|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593290|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630350|NCT03053219|Abivertinib|abivertinib|mesh-list
43684267|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43593291|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43593292|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43593294|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
43593295|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593296|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43593297|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43593298|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43593299|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593300|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43593301|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
43593302|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828260|NCT05479448|Hormones|hormones|mesh-list
43828261|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828262|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
43828263|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828264|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828265|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828266|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828267|NCT05479357|Oxytocin|oxytocin|mesh-list
43828268|NCT05479357|Carbetocin|carbetocin|mesh-list
43828269|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
43828270|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43593330|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593332|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43593333|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593334|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
43593335|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43593336|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593339|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
43593340|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593341|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593342|NCT03345004|Vitamin D|vitamin d|mesh-list
43593343|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
43593344|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
43593345|NCT03345004|Vitamins|vitamins|mesh-list
43593346|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
43593347|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593348|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43593349|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43593350|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
43593351|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43593352|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43593353|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43593354|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43593355|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593356|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
43593357|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593358|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593359|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43593360|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828271|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828272|NCT05479240|Capecitabine|capecitabine|mesh-list
43828273|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
43828274|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43828275|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
43828276|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828277|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828278|NCT05479214|Metformin|metformin|mesh-list
43828279|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43828280|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828281|NCT05479175|Ibuprofen|ibuprofen|mesh-list
43828282|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43828283|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684268|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684269|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684270|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684271|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684272|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684274|NCT00092768|Etoricoxib|etoricoxib|mesh-list
43684275|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684276|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684277|NCT00092768|Analgesics|analgesics|mesh-ancestor
43684278|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
43684279|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684280|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630351|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43630352|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630353|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630354|NCT03052998|Ivermectin|ivermectin|mesh-list
43630355|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
43630356|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43630357|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828284|NCT05479175|Analgesics|analgesics|mesh-ancestor
43828285|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
43593361|NCT03344822|Choline|choline|mesh-list
43593362|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43593363|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
43593364|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43593365|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
43593366|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593367|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43593368|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43593369|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
43593370|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43593371|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
43593372|NCT03344705|Fludarabine|fludarabine|mesh-list
43593373|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43593374|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
43593375|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593376|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630358|NCT03053167|Irinotecan|irinotecan|mesh-list
43630359|NCT03053167|Raltitrexed|raltitrexed|mesh-list
43630360|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43630361|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43630362|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630363|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630364|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630365|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43630366|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
43593384|NCT03344679|Bupivacaine|bupivacaine|mesh-list
43593385|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
43593386|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
43593387|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593388|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593389|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
43593390|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593391|NCT03344679|Analgesics|analgesics|mesh-ancestor
43593392|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43630367|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43630368|NCT03052673|Fentanyl|fentanyl|mesh-list
43630369|NCT03052673|Ketamine|ketamine|mesh-list
43630370|NCT03052673|Analgesics|analgesics|mesh-ancestor
43630371|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
43630372|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630373|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593393|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
43593394|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43593395|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43593396|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593397|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43593398|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
43593399|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43593400|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
43593401|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43593402|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
43593403|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
43593404|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593405|NCT03344627|Meropenem|meropenem|mesh-list
43593406|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593407|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593408|NCT03344614|Apatinib|apatinib|mesh-list
43593409|NCT03344614|Raltitrexed|raltitrexed|mesh-list
43593410|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593411|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43593412|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593413|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828286|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828287|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828288|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828289|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828290|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43828291|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828292|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828293|NCT05479123|Timolol|timolol|mesh-list
43828294|NCT05479123|Propranolol|propranolol|mesh-list
43828295|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43828296|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43828297|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
43828298|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828299|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828300|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828302|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43828303|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
43680943|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43680944|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680945|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
43680946|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
43680947|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
43680948|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680949|NCT04329442|Tenofovir|tenofovir|mesh-list
43680950|NCT04329442|Emtricitabine|emtricitabine|mesh-list
43680951|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
43680952|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680967|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
43680968|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43680969|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
43680970|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
43680971|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
43680972|NCT04308863|Coagulants|coagulants|mesh-ancestor
43680973|NCT04285580|Bimatoprost|bimatoprost|mesh-list
43680974|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43680975|NCT04280692|Lumefantrine|lumefantrine|mesh-list
43680976|NCT04280692|Artemether|artemether|mesh-list
43680977|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
43680978|NCT04280692|Piperaquine|piperaquine|mesh-list
43680979|NCT04280692|Primaquine|primaquine|mesh-list
43680980|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
43680981|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43680982|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43680983|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
43680984|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43680985|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43680986|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43680987|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43680988|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680989|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680990|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43680991|NCT04280692|Renal Agents|renal agents|mesh-ancestor
43680992|NCT04276298|Metronidazole|metronidazole|mesh-list
43680993|NCT04276298|Lidocaine|lidocaine|mesh-list
43680994|NCT04276298|Diltiazem|diltiazem|mesh-list
43680995|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
43680996|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
43680997|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680998|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680999|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
43681000|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681001|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43593414|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43593415|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
43593416|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43593417|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
43593418|NCT03344523|Hematinics|hematinics|mesh-ancestor
43593419|NCT03344445|Anesthetics|anesthetics|mesh-list
43593420|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681002|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43681003|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43681004|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681005|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681006|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681007|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43681008|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43681009|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43681010|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43593421|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593422|NCT03344393|Ketamine|ketamine|mesh-list
43593423|NCT03344393|Analgesics|analgesics|mesh-ancestor
43593424|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
43593425|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630374|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43630375|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630376|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
43630377|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
43630378|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630379|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43630380|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43630381|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630382|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630383|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43630384|NCT03052673|Narcotics|narcotics|mesh-ancestor
43630385|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43630386|NCT03052569|Agerafenib|agerafenib|mesh-list
43593426|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593427|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43593428|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43593429|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
43593430|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
43593431|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593432|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43593433|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43593434|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593435|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593436|NCT03344328|Bortezomib|bortezomib|mesh-list
43593438|NCT03344302|Oxytocin|oxytocin|mesh-list
43593439|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
43593440|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43593441|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593442|NCT03344094|Interferons|interferons|mesh-list
43593443|NCT03344094|Interferon-beta|interferon-beta|mesh-list
43593444|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
43593445|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593446|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
43593456|NCT03344042|Analgesics|analgesics|mesh-ancestor
43593457|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
43593458|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593459|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43593460|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43593461|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
43593462|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
43593463|NCT03344029|Vaccines|vaccines|mesh-list
43593464|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
43593465|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593466|NCT03344003|Factor VIII|factor viii|mesh-list
43593467|NCT03344003|Coagulants|coagulants|mesh-ancestor
43593468|NCT03343977|Docetaxel|docetaxel|mesh-list
43593469|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593470|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
43593471|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
43681012|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43681014|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
43681015|NCT04273880|Methylphenidate|methylphenidate|mesh-list
43681016|NCT04273880|Vitamins|vitamins|mesh-ancestor
43681017|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
43681018|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593489|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43593490|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
43593491|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593492|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593493|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43593494|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43593495|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43593496|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630387|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43630388|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630393|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630395|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43630396|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630397|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630398|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630399|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
43630400|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
43593497|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
43593498|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
43593499|NCT03343795|Progesterone|progesterone|mesh-list
43593500|NCT03343795|Progestins|progestins|mesh-ancestor
43593501|NCT03343795|Hormones|hormones|mesh-ancestor
43593502|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630401|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
43630402|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
43684281|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684282|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684283|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684284|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684285|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593503|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593514|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43593515|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684286|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684287|NCT00092755|Ibuprofen|ibuprofen|mesh-list
43684288|NCT00092755|Etoricoxib|etoricoxib|mesh-list
43684289|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684290|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43593525|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593527|NCT03343548|Analgesics|analgesics|mesh-ancestor
43593528|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
43593529|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593530|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593531|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
43593532|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593533|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43593534|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
43593535|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43593536|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43593537|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593538|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43593539|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
43593540|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43681024|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
43684291|NCT00092755|Analgesics|analgesics|mesh-ancestor
43684292|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
43684293|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681025|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681026|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
43681027|NCT04273880|Protective Agents|protective agents|mesh-ancestor
43681029|NCT04260412|Cathartics|cathartics|mesh-ancestor
43681030|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681031|NCT04257448|Gemcitabine|gemcitabine|mesh-list
43681032|NCT04257448|Paclitaxel|paclitaxel|mesh-list
43681033|NCT04257448|Lenalidomide|lenalidomide|mesh-list
43681034|NCT04257448|Azacitidine|azacitidine|mesh-list
43681035|NCT04257448|Durvalumab|durvalumab|mesh-list
43681036|NCT04257448|Romidepsin|romidepsin|mesh-list
43681037|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43681038|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681039|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
43681040|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
43593541|NCT03343509|Metronidazole|metronidazole|mesh-list
43593542|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593543|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593544|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43593545|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43593546|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
43593548|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
43593549|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593550|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43593551|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
43593552|NCT03343418|Coagulants|coagulants|mesh-ancestor
43593553|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43593554|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
43593555|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593556|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43593557|NCT03343366|Metronidazole|metronidazole|mesh-list
43593558|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593559|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43593560|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43593561|NCT03343002|Fentanyl|fentanyl|mesh-list
43593563|NCT03343002|Narcotics|narcotics|mesh-ancestor
43593564|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593565|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593566|NCT03343002|Analgesics|analgesics|mesh-ancestor
43593567|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
43593568|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684301|NCT00092742|Diclofenac|diclofenac|mesh-list
43684307|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684308|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684309|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684310|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684311|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684312|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684313|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593569|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43593570|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43593571|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
43593572|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
43593573|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
43593574|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43593575|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
43593576|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43593577|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593578|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43593579|NCT03342807|Insulin|insulin|mesh-list
43593580|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43593581|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593582|NCT03342651|Vitamin D|vitamin d|mesh-list
43593583|NCT03342651|Vitamins|vitamins|mesh-ancestor
43593584|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
43593585|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593607|NCT03342352|Nivolumab|nivolumab|mesh-list
43593608|NCT03342352|Cetuximab|cetuximab|mesh-list
43593609|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593610|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
43681041|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
43681042|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681043|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43681044|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
43681045|NCT04257448|Antiviral Agents|antiviral agents|mesh-ancestor
43681046|NCT04257448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681047|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681048|NCT04257448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681049|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
43681050|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601484|NCT03263299|Cabergoline|cabergoline|mesh-list
43593613|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43593614|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
43593615|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593616|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43593617|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43593618|NCT03342300|Doxorubicin|doxorubicin|mesh-list
43593619|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43593620|NCT03342300|Pirarubicin|pirarubicin|mesh-list
43593621|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43593622|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593623|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43593624|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43593625|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593626|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593627|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
43593628|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593630|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
43593631|NCT03342170|Coagulants|coagulants|mesh-ancestor
43593632|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
43593633|NCT03342079|Anesthetics|anesthetics|mesh-list
43593634|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
43593635|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593636|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593637|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
43593638|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593639|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43593640|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
43593653|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43593654|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
43684315|NCT00092729|Naproxen|naproxen|mesh-list
43684316|NCT00092729|Etoricoxib|etoricoxib|mesh-list
43684317|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43630428|NCT03052361|Ondansetron|ondansetron|mesh-list
43630429|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
43593655|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593656|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593658|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43593659|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
43593660|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593661|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43593662|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43593663|NCT03341845|Avelumab|avelumab|mesh-list
43593664|NCT03341845|Axitinib|axitinib|mesh-list
43593665|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681053|NCT04257448|Growth Substances|growth substances|mesh-ancestor
43681054|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
43681055|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681056|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43593668|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593669|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593670|NCT03341767|Clofazimine|clofazimine|mesh-list
43593671|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43593672|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
43593673|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593674|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593675|NCT03341741|Tobramycin|tobramycin|mesh-list
43593676|NCT03341741|Colistin|colistin|mesh-list
43593677|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593678|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593679|NCT03341494|Thalidomide|thalidomide|mesh-list
43593680|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43593681|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
43593682|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593683|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
43593684|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593685|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593686|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43593687|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43593688|NCT03341494|Growth Substances|growth substances|mesh-ancestor
43593689|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
43593690|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593691|NCT03341429|Liraglutide|liraglutide|mesh-list
43593692|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43593693|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593694|NCT03341429|Incretins|incretins|mesh-ancestor
43593696|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593697|NCT03341390|Aspirin|aspirin|mesh-list
43593698|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43593699|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43593700|NCT03341390|Analgesics|analgesics|mesh-ancestor
43593701|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
43593702|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593703|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593704|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43593705|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43593706|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43630430|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
43593716|NCT03341260|Analgesics|analgesics|mesh-ancestor
43593717|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
43593718|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593719|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593720|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43593721|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43593722|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43593723|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593724|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593726|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
43593727|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
43593728|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593729|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593730|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
43593731|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593732|NCT03341117|Aspirin|aspirin|mesh-list
43593733|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
43593734|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43593735|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43593736|NCT03341117|Analgesics|analgesics|mesh-ancestor
43630431|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630432|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630433|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630434|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
43630435|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
43630436|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43630437|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
43630438|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630439|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630440|NCT03052361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43630441|NCT03052361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630442|NCT03052361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630443|NCT03052361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630444|NCT03052361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43630445|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43630446|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43630447|NCT03051932|Acetaminophen|acetaminophen|mesh-list
43630448|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43630449|NCT03051932|Analgesics|analgesics|mesh-ancestor
43630450|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
43630451|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630452|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630453|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
43593737|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
43684318|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43681058|NCT04247867|Cathartics|cathartics|mesh-ancestor
43681059|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681060|NCT04238390|Meropenem|meropenem|mesh-list
43681061|NCT04238390|Tazobactam|tazobactam|mesh-list
43681062|NCT04238390|Ceftolozane|ceftolozane|mesh-list
43681063|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
43681064|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43684319|NCT00092729|Analgesics|analgesics|mesh-ancestor
43681065|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681066|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43681067|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681068|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681069|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43681070|NCT04238390|Renal Agents|renal agents|mesh-ancestor
43681071|NCT04236830|Fluorides|fluorides|mesh-list
43681072|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
43681073|NCT04236830|Protective Agents|protective agents|mesh-ancestor
43681074|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681075|NCT04232969|Exenatide|exenatide|mesh-list
43681076|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681077|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681078|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43681079|NCT04232969|Incretins|incretins|mesh-ancestor
43681080|NCT04232969|Hormones|hormones|mesh-ancestor
43681081|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681082|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
43681083|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43681084|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
43681085|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681086|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
43681087|NCT04219722|Protective Agents|protective agents|mesh-ancestor
43681088|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
43681089|NCT04210505|Povidone|povidone|mesh-list
43681090|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
43681104|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681105|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681106|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43681107|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
43681108|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43681110|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
43684320|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
43681111|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
43681112|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681113|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681114|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
43681115|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681116|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43681117|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43681118|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43684321|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684322|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684323|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684324|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684325|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
43684326|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684327|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684328|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684329|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684330|NCT00092703|Diclofenac|diclofenac|mesh-list
43684331|NCT00092703|Etoricoxib|etoricoxib|mesh-list
43681119|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681120|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681121|NCT04156087|Gemcitabine|gemcitabine|mesh-list
43681122|NCT04156087|Durvalumab|durvalumab|mesh-list
43593738|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593739|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593740|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684332|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684333|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684334|NCT00092703|Analgesics|analgesics|mesh-ancestor
43684335|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
43684336|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684337|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684338|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684339|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43593741|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43593742|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43593743|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43593744|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593745|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43593746|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43593747|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593748|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
43593749|NCT03341117|Antacids|antacids|mesh-ancestor
43593750|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43593751|NCT03341104|Bupivacaine|bupivacaine|mesh-list
43684340|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684341|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684343|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684356|NCT02844062|Fludarabine|fludarabine|mesh-list
43684357|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684358|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
43684359|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684360|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43593752|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
43593753|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
43593754|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593755|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593756|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
43593757|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593758|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
43593760|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593761|NCT03340779|Dobutamine|dobutamine|mesh-list
43593762|NCT03340779|Norepinephrine|norepinephrine|mesh-list
43593763|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43593764|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43681127|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681129|NCT04156087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593766|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593767|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593768|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593769|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
43593770|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
43593771|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593772|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43593773|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43593774|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43593785|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
43593787|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43593788|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43593789|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43593790|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
43593791|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
43593792|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593793|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593794|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593796|NCT03340701|Progestins|progestins|mesh-ancestor
43593798|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593799|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593800|NCT03340662|Itraconazole|itraconazole|mesh-list
43593801|NCT03340662|Rifampin|rifampin|mesh-list
43593802|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
43593803|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
43593804|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593805|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43593806|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43593807|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593808|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593811|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593812|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593813|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43593814|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43593815|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
43593816|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593817|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
43593818|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43593819|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43593820|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43593821|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43593822|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43593823|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43593824|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43681130|NCT04156087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681131|NCT04156087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681132|NCT04156087|Immunologic Factors|immunologic factors|mesh-ancestor
43681133|NCT04156087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681134|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681135|NCT04156074|Vitamin D|vitamin d|mesh-list
43681136|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
43681137|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
43681138|NCT04156074|Vitamins|vitamins|mesh-list
43593825|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43593826|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43593827|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593828|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43593829|NCT03340662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43684361|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43684362|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
43593830|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43593831|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43593832|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630508|NCT03051698|Metronidazole|metronidazole|mesh-list
43593833|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
43593834|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43593835|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
43630510|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
43593845|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43593846|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593847|NCT03340376|Doxorubicin|doxorubicin|mesh-list
43593848|NCT03340376|Atezolizumab|atezolizumab|mesh-list
43593849|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43593850|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593851|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43593852|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43593853|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593854|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593855|NCT03340168|Bisphenol A|bisphenol a|mesh-list
43593856|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43593857|NCT03340168|Estrogens|estrogens|mesh-ancestor
43593858|NCT03340168|Hormones|hormones|mesh-ancestor
43593859|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593860|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593861|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43593863|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593864|NCT03340168|Protective Agents|protective agents|mesh-ancestor
43593866|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43593867|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43630511|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43630512|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43630513|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43593868|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593869|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
43593870|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593871|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593872|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
43593873|NCT03339804|Doxorubicin|doxorubicin|mesh-list
43593874|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43593875|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
43593876|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593877|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43593878|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43593879|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
43593880|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593881|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593882|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43593883|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43593884|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43593885|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43681139|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
43681140|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601590|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681142|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43681143|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43681144|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681145|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43681146|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43681147|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681148|NCT04117763|Empagliflozin|empagliflozin|mesh-list
43681149|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43630531|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630532|NCT03051503|Analgesics|analgesics|mesh-ancestor
43630533|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
43630534|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630535|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43828630|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828631|NCT05475873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43828632|NCT05475873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43681150|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681151|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681152|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681153|NCT04117451|Propolis|propolis|mesh-list
43681154|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828304|NCT05479032|Amantadine|amantadine|mesh-list
43828305|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43828306|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43593886|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593887|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43593888|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43593889|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43593890|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
43593891|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593892|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43593893|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43593894|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593895|NCT03339700|Gemcitabine|gemcitabine|mesh-list
43593896|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
43593897|NCT03339700|Busulfan|busulfan|mesh-list
43593898|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43593899|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
43593900|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593905|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593906|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43593907|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43593908|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
43593909|NCT03339700|Antiviral Agents|antiviral agents|mesh-ancestor
43593910|NCT03339700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593911|NCT03339700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593912|NCT03339544|Celecoxib|celecoxib|mesh-list
43593913|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43593915|NCT03339544|Analgesics|analgesics|mesh-ancestor
43593916|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
43593917|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593918|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593919|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630565|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43593920|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43593921|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43593922|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43593923|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828307|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
43828308|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828309|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
43828310|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828311|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828312|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630595|NCT03050866|Histamine|histamine|mesh-list
43630596|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
43630597|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43630598|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
43630599|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
43630600|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630601|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828633|NCT05475873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828634|NCT05475873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43828635|NCT05475873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43828637|NCT05475665|Irbesartan|irbesartan|mesh-list
43828638|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43828639|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43828640|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828641|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828642|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43828643|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828644|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
43828645|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43828313|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828314|NCT05479032|Analgesics|analgesics|mesh-ancestor
43828315|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
43828316|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828317|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
43593926|NCT03339427|Vitamins|vitamins|mesh-ancestor
43593927|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
43593928|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593929|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43593930|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
43593931|NCT03339362|Bupivacaine|bupivacaine|mesh-list
43593932|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
43593933|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
43593934|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849120|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593935|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593936|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
43593937|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593938|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43593939|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
43593940|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
43593941|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43593942|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
43593943|NCT03339362|Hormones|hormones|mesh-ancestor
43593944|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593945|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43593946|NCT03339362|Protective Agents|protective agents|mesh-ancestor
43593947|NCT03339349|Enoxaparin|enoxaparin|mesh-list
43593948|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
43593949|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43593950|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43593951|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593952|NCT03339024|Oxytocin|oxytocin|mesh-list
43593953|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
43593954|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43593955|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593956|NCT03338426|Atorvastatin|atorvastatin|mesh-list
43593957|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43593958|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43593959|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
43593960|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828646|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43828647|NCT05475639|Diclofenac|diclofenac|mesh-list
43593961|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43630642|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
43630643|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
43630644|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630645|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630646|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630647|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
43593962|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43593963|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593964|NCT03338348|Azacitidine|azacitidine|mesh-list
43593965|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43593966|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
43593967|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593968|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593969|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630648|NCT03051022|Hormones|hormones|mesh-ancestor
43630649|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630650|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43593976|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43593977|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
43593978|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
43593979|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828318|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
43828319|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43828320|NCT05478954|Amodiaquine|amodiaquine|mesh-list
43828321|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
43828322|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43828323|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43828326|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828327|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828328|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43630651|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630652|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
43630653|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
43630654|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630655|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
43630656|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43630657|NCT03051022|Narcotics|narcotics|mesh-ancestor
43630658|NCT03051022|Analgesics|analgesics|mesh-ancestor
43630659|NCT03050710|Lidocaine|lidocaine|mesh-list
43828329|NCT05478954|Renal Agents|renal agents|mesh-ancestor
43828330|NCT05478785|Cisplatin|cisplatin|mesh-list
43828331|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828332|NCT05478772|Fluconazole|fluconazole|mesh-list
43828333|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
43828334|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593980|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43593981|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43593982|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593983|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593984|NCT03337932|Doxycycline|doxycycline|mesh-list
43593985|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43593986|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593987|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
43593988|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43593989|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43593990|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
43593991|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43593992|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593994|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43593995|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593996|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593997|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593998|NCT03337672|Midazolam|midazolam|mesh-list
43593999|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
43594000|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43594001|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594002|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594003|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594004|NCT03337672|Analgesics|analgesics|mesh-ancestor
43594005|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
43594006|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594007|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43594008|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43594010|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
43594011|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594012|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594013|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43594014|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43594015|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43594016|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43594017|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43594018|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
43594019|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
43594020|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
43594021|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
43594022|NCT03337607|Celecoxib|celecoxib|mesh-list
43828335|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43828336|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43828337|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828338|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828339|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43828340|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
43828341|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828342|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828343|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43828344|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43681155|NCT04096391|Analgesics|analgesics|mesh-list
43681156|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
43684457|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684458|NCT02842814|Hormones|hormones|mesh-ancestor
43684459|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43684460|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684461|NCT02842567|Vitamin E|vitamin e|mesh-list
43684462|NCT02842567|Tocopherols|tocopherols|mesh-list
43684463|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
43684464|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
43684465|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
43684466|NCT02842567|Vitamins|vitamins|mesh-ancestor
43684467|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
43684468|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684469|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
43684470|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684471|NCT02842567|Protective Agents|protective agents|mesh-ancestor
43684472|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684473|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43684474|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43684475|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
43684476|NCT02842580|Leucovorin|leucovorin|mesh-list
43681157|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681158|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681159|NCT04084106|Amoxicillin|amoxicillin|mesh-list
43681160|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
43681161|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
43681162|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43684532|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43684533|NCT02841982|Morphine|morphine|mesh-list
43684534|NCT02841982|Ropivacaine|ropivacaine|mesh-list
43684535|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43684536|NCT02841982|Narcotics|narcotics|mesh-ancestor
43684537|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684538|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684539|NCT02841982|Analgesics|analgesics|mesh-ancestor
43684540|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
43684541|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684542|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
43684543|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
43684544|NCT02841839|Fluorides|fluorides|mesh-list
43684545|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
43684546|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
43684547|NCT02841839|Protective Agents|protective agents|mesh-ancestor
43684548|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684549|NCT02841488|Fentanyl|fentanyl|mesh-list
43684550|NCT02841488|Ropivacaine|ropivacaine|mesh-list
43684551|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
43684552|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
43684553|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630707|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630708|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681163|NCT04084106|Penicillin V|penicillin v|mesh-list
43681164|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43681165|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681166|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681167|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681168|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43681169|NCT04083157|Imiquimod|imiquimod|mesh-list
43681170|NCT04083157|Vaccines|vaccines|mesh-list
43681171|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
43594023|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43594024|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43594025|NCT03337607|Eperisone|eperisone|mesh-list
43594026|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
43594027|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594028|NCT03337607|Analgesics|analgesics|mesh-ancestor
43594029|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
43594030|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594031|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594032|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594033|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43594034|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43630712|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43594035|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681172|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681173|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43681174|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681175|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
43681176|NCT04072341|Propolis|propolis|mesh-list
43681177|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681178|NCT04071821|Cetirizine|cetirizine|mesh-list
43630713|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630714|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630715|NCT03049930|Ketamine|ketamine|mesh-list
43630716|NCT03049930|Analgesics|analgesics|mesh-ancestor
43630717|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
43630718|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630719|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630720|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43630721|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630722|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
43630723|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
43630724|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684554|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684555|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
43684556|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684557|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43684558|NCT02841488|Narcotics|narcotics|mesh-ancestor
43684559|NCT02841488|Analgesics|analgesics|mesh-ancestor
43684560|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43684561|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43684562|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
43684563|NCT02841722|Lenograstim|lenograstim|mesh-list
43684564|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43681179|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43681180|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43681181|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43681182|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
43681183|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
43681184|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681185|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681186|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681187|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43681188|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
43681189|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594036|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594037|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
43594064|NCT03337529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594065|NCT03337529|Protective Agents|protective agents|mesh-ancestor
43594066|NCT03337503|Dronabinol|dronabinol|mesh-list
43594067|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
43684565|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
43684566|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684567|NCT02841579|Osimertinib|osimertinib|mesh-list
43684568|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684569|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43684570|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684571|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684572|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43684573|NCT02841774|Pravastatin|pravastatin|mesh-list
43684574|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43594068|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594069|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43594070|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594071|NCT03337503|Analgesics|analgesics|mesh-ancestor
43594072|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
43594074|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43594075|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43594076|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594077|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594078|NCT03337503|Hormones|hormones|mesh-ancestor
43594079|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594080|NCT03337373|Cisatracurium|cisatracurium|mesh-list
43594081|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43594082|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43681190|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
43681191|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
43681192|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43681193|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
43681194|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681195|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681196|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43681199|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
43681200|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
43681201|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43681202|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43681203|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
43594083|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594084|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594086|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594087|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594088|NCT03337191|Morphine|morphine|mesh-list
43594089|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
43594090|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43594091|NCT03337191|Narcotics|narcotics|mesh-ancestor
43594092|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594093|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594094|NCT03337191|Analgesics|analgesics|mesh-ancestor
43594095|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
43594096|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594097|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
43594098|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
43594099|NCT03337126|Metronidazole|metronidazole|mesh-list
43594100|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594101|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43594102|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43594103|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43594119|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594121|NCT03336840|Promethazine|promethazine|mesh-list
43594122|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
43594123|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43594124|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594125|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
43594126|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
43594127|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43594128|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
43594129|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
43594130|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594131|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594132|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43594133|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43594134|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43594135|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594136|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
43594137|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
43594138|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
43594139|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594140|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
43594141|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
43594142|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681204|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681205|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43681206|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43684575|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684576|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
43681207|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681208|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43681209|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684577|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684578|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684579|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43684580|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684581|NCT02841800|Phenobarbital|phenobarbital|mesh-list
43684582|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
43684583|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43684584|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684585|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684586|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43684587|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43684592|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43684593|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43684594|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43684595|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43684596|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43684597|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43828660|NCT05475613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43681211|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43594143|NCT03336814|Terlipressin|terlipressin|mesh-list
43594144|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43594145|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43594146|NCT03336801|Propofol|propofol|mesh-list
43594147|NCT03336801|Sevoflurane|sevoflurane|mesh-list
43594148|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43594149|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828661|NCT05475613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828662|NCT05475613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43828663|NCT05475613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594150|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594151|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43594152|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
43594153|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
43594154|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43594155|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43594156|NCT03336632|Cyclosporine|cyclosporine|mesh-list
43594157|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
43594158|NCT03336632|Cyclosporins|cyclosporins|mesh-list
43594159|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43594160|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
43594161|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594162|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594163|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43594176|NCT03336437|Estradiol|estradiol|mesh-list
43594177|NCT03336437|Estrogens|estrogens|mesh-ancestor
43594178|NCT03336437|Hormones|hormones|mesh-ancestor
43594179|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594180|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594181|NCT03336346|Efavirenz|efavirenz|mesh-list
43594182|NCT03336346|Dolutegravir|dolutegravir|mesh-list
43594183|NCT03336346|Etonogestrel|etonogestrel|mesh-list
43594184|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43594185|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43594186|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594187|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594188|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
43594189|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594190|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43594191|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43594192|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43594193|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43594194|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43594195|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43594196|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43594197|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43594198|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43594199|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43594200|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43594201|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
43594202|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43630768|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43594203|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594204|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43594205|NCT03336281|Ustekinumab|ustekinumab|mesh-list
43594206|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
43594207|NCT03336242|Cannabidiol|cannabidiol|mesh-list
43594208|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
43681212|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681213|NCT03943667|Gemcitabine|gemcitabine|mesh-list
43681214|NCT03943667|Paclitaxel|paclitaxel|mesh-list
43681215|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43594212|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630769|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43630770|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630771|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630772|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43630773|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630774|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630775|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630776|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
43594213|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43594214|NCT03335956|Pioglitazone|pioglitazone|mesh-list
43594216|NCT03335956|Cortisone|cortisone|mesh-list
43594217|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594219|NCT03335956|Hormones|hormones|mesh-ancestor
43594220|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594221|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594222|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43594223|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594224|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43594225|NCT03335904|Losartan|losartan|mesh-list
43594226|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43594227|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43594241|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43594242|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
43594243|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43594244|NCT03335579|Narcotics|narcotics|mesh-ancestor
43594245|NCT03335579|Analgesics|analgesics|mesh-ancestor
43594246|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
43594247|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594248|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43594249|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
43594250|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43594251|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681237|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43681238|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43681239|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681240|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681241|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
43681242|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
43681243|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43681244|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
43681245|NCT03922048|Bupivacaine|bupivacaine|mesh-list
43681246|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
43684627|NCT02841176|Golimumab|golimumab|mesh-list
43684628|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43681247|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
43681248|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681249|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681250|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
43681251|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681252|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
43681253|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43681254|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
43681255|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43681256|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
43681257|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630844|NCT03048214|Anesthetics|anesthetics|mesh-list
43684685|NCT02840526|Fentanyl|fentanyl|mesh-list
43684686|NCT02840526|Bupivacaine|bupivacaine|mesh-list
43684687|NCT02840526|Propofol|propofol|mesh-list
43684688|NCT02840526|Sevoflurane|sevoflurane|mesh-list
43684689|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
43684690|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
43684691|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684692|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684693|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
43594252|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594253|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594255|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
43594256|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594257|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43594258|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43594259|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43594260|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
43594261|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594262|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594264|NCT03335501|Hormones|hormones|mesh-list
43594265|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594266|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594267|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594268|NCT03335436|Gabapentin|gabapentin|mesh-list
43594269|NCT03335436|Analgesics|analgesics|mesh-ancestor
43594270|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
43594271|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594272|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594273|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
43594274|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43594275|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43594276|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594277|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43594278|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43594279|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43594280|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594281|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594282|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
43594283|NCT03335423|Metformin|metformin|mesh-list
43594284|NCT03335423|Codeine|codeine|mesh-list
43681258|NCT03865290|Ondansetron|ondansetron|mesh-list
43681259|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
43681260|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
43681261|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681262|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681263|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681264|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
43681265|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
43681266|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43681267|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
43681268|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681269|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681270|NCT03865290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43681271|NCT03865290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43594285|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43594286|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594287|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43594288|NCT03335423|Narcotics|narcotics|mesh-ancestor
43594351|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594352|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43684694|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684695|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43684696|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43684697|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
43684698|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43684699|NCT02840526|Narcotics|narcotics|mesh-ancestor
43684700|NCT02840526|Analgesics|analgesics|mesh-ancestor
43684701|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43684702|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684703|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
43684704|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43684705|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43684706|NCT02840409|Bevacizumab|bevacizumab|mesh-list
43594353|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43594354|NCT03335098|Growth Substances|growth substances|mesh-ancestor
43594355|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
43594356|NCT03335085|Oxytocin|oxytocin|mesh-list
43594357|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
43594358|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43594359|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594360|NCT03335072|Azithromycin|azithromycin|mesh-list
43594361|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43594362|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594363|NCT03335059|Mitomycins|mitomycins|mesh-list
43594364|NCT03335059|Mitomycin|mitomycin|mesh-list
43594365|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43594366|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594367|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
43594368|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594369|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43594370|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594371|NCT03335007|Aceclofenac|aceclofenac|mesh-list
43594372|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43594373|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594374|NCT03335007|Analgesics|analgesics|mesh-ancestor
43594375|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
43594376|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594431|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43594432|NCT03333824|Midazolam|midazolam|mesh-list
43594433|NCT03333824|Granisetron|granisetron|mesh-list
43594434|NCT03333824|Caffeine|caffeine|mesh-list
43594435|NCT03333824|Omeprazole|omeprazole|mesh-list
43594436|NCT03333824|Adavosertib|adavosertib|mesh-list
43594437|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43594438|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43594439|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594440|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594441|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43594442|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43594443|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43594444|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43594445|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
43594446|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
43594447|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
43594448|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
43681272|NCT03865290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681273|NCT03865290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43681274|NCT03865290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43681275|NCT03844815|Decitabine|decitabine|mesh-list
43681276|NCT03844815|Venetoclax|venetoclax|mesh-list
43681277|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43681278|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
43681279|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681280|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828355|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43681298|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681301|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43684707|NCT02840409|Vinblastine|vinblastine|mesh-list
43684708|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684709|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684710|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43684711|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43684712|NCT02840409|Growth Substances|growth substances|mesh-ancestor
43684713|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684714|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
43630845|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681302|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681303|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
43681304|NCT03739853|Adalimumab|adalimumab|mesh-list
43681305|NCT03739853|Methotrexate|methotrexate|mesh-list
43594452|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594453|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43594454|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594455|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43594460|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
43594461|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
43594462|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594463|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43594465|NCT03333603|Esomeprazole|esomeprazole|mesh-list
43594466|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43594467|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594468|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43594469|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594470|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594471|NCT03333525|Insulin|insulin|mesh-list
43594472|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43594473|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594474|NCT03333499|Trimetazidine|trimetazidine|mesh-list
43594475|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
43594476|NCT03333395|Heparin|heparin|mesh-list
43594477|NCT03333395|Albuterol|albuterol|mesh-list
43594479|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43594480|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43594481|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594482|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43594483|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
43594484|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594485|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594486|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43594487|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
43594488|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
43594489|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43594490|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43594491|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43594492|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43594493|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
43594494|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594495|NCT03333369|Levodopa|levodopa|mesh-list
43594496|NCT03333369|Benserazide|benserazide|mesh-list
43594497|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43594498|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43594499|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
43594500|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594501|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594502|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594503|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594504|NCT03333278|Vitamins|vitamins|mesh-list
43594505|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
43594506|NCT03333278|Thiamine|thiamine|mesh-list
43594507|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
43681306|NCT03739853|Leflunomide|leflunomide|mesh-list
43630846|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681307|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43681308|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
43681309|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43681310|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681311|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43681312|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
43601591|NCT03262961|Urological Agents|urological agents|mesh-ancestor
43681313|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594508|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43594509|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
43594510|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594511|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594512|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
43594513|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594514|NCT03333278|Protective Agents|protective agents|mesh-ancestor
43594515|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
43594517|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
43594518|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43594519|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43594520|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594521|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594522|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
43594523|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594524|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43594525|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43594526|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43594527|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43594529|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
43594530|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43594531|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
43594581|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
43594582|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594583|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43594584|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43594585|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594587|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
43630847|NCT03048110|Itraconazole|itraconazole|mesh-list
43630848|NCT03048110|Rifampin|rifampin|mesh-list
43630849|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
43630850|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43630851|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43630852|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43630853|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630854|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630855|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43630856|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
43630857|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630858|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684715|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43684716|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
43684717|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
43684718|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
43684719|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684720|NCT02840175|Adalimumab|adalimumab|mesh-list
43684721|NCT02840175|Etanercept|etanercept|mesh-list
43684722|NCT02840175|Abatacept|abatacept|mesh-list
43684723|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684724|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684725|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684726|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594588|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594589|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594590|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594591|NCT03332602|Vitamins|vitamins|mesh-list
43594592|NCT03332602|Folic Acid|folic acid|mesh-list
43594593|NCT03332602|Vitamin A|vitamin a|mesh-list
43594594|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
43684727|NCT02840175|Analgesics|analgesics|mesh-ancestor
43594595|NCT03332602|Fesoterodine|fesoterodine|mesh-list
43594596|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
43594597|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
43594598|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594599|NCT03332602|Hematinics|hematinics|mesh-ancestor
43594600|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
43594601|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43594602|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
43594603|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
43594605|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
43594606|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594607|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43594608|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594609|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43594610|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43594614|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
43594615|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684738|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
43594616|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
43594617|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594618|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594619|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43594620|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
43681314|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681315|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
43681316|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681317|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43681318|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681319|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
43681320|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43681321|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43681322|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43681323|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594621|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594622|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594623|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43594624|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
43594626|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43594627|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684748|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684749|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684750|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684751|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43684752|NCT02840006|Anesthetics|anesthetics|mesh-list
43684753|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684754|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684755|NCT02839928|Ketamine|ketamine|mesh-list
43684756|NCT02839928|Analgesics|analgesics|mesh-list
43684757|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43684758|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
43684759|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684760|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684766|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43684767|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43684768|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684769|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684770|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
43684771|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43684773|NCT02839941|Tacrolimus|tacrolimus|mesh-list
43684783|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43684784|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
43684785|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43630872|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43630873|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630886|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43630887|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630888|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43594628|NCT03332524|Analgesics|analgesics|mesh-ancestor
43594629|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
43594630|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594631|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594632|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594633|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594634|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43594635|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594636|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594637|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
43594646|NCT03332329|Molgramostim|molgramostim|mesh-list
43594647|NCT03332329|Vaccines|vaccines|mesh-list
43594648|NCT03332329|Sargramostim|sargramostim|mesh-list
43594649|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
43594650|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594651|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
43594652|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594653|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594654|NCT03332316|Dexamethasone|dexamethasone|mesh-list
43594655|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
43594656|NCT03332316|Ropivacaine|ropivacaine|mesh-list
43594657|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43594658|NCT03332316|BB 1101|bb 1101|mesh-list
43594659|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594660|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
43594661|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
43594662|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594663|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594664|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594665|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
43594666|NCT03332316|Hormones|hormones|mesh-ancestor
43594667|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594668|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43594669|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594670|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
43630889|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43630912|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43594671|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
43601592|NCT03262792|Andrographolide|andrographolide|mesh-list
43681324|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43681326|NCT03739853|Analgesics|analgesics|mesh-ancestor
43681327|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
43681328|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681329|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681330|NCT03734770|Progesterone|progesterone|mesh-list
43681331|NCT03734770|Progestins|progestins|mesh-ancestor
43594677|NCT03332225|Interferons|interferons|mesh-list
43594678|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
43594679|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43594680|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594681|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
43594682|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594683|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594685|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594686|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
43594697|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43594698|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594699|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
43594700|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594701|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684786|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684787|NCT02839941|Hormones|hormones|mesh-ancestor
43684788|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43684789|NCT02839694|Celecoxib|celecoxib|mesh-list
43684790|NCT02839694|Decitabine|decitabine|mesh-list
43684791|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
43684792|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684793|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684794|NCT02839694|Analgesics|analgesics|mesh-ancestor
43684795|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
43684796|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594702|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43684797|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684798|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684799|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684800|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684801|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684802|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684803|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684804|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43684805|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
43684806|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684807|NCT02839785|Ibuprofen|ibuprofen|mesh-list
43594703|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594705|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43594706|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594707|NCT03331770|Latanoprost|latanoprost|mesh-list
43594708|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43594709|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43594710|NCT03331692|Anesthetics|anesthetics|mesh-list
43594711|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594712|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594713|NCT03331523|Betamethasone|betamethasone|mesh-list
43594714|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
43594715|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43594716|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
43594717|NCT03331523|Calcipotriene|calcipotriene|mesh-list
43594718|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43594719|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594720|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
43594721|NCT03331523|Hormones|hormones|mesh-ancestor
43594722|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594723|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594724|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43594725|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
43594726|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
43594727|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
43594728|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43594729|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
43594730|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594731|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594732|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43594733|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
43594734|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43594735|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
43594736|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594737|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594738|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43594739|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
43594740|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
43594741|NCT03331445|Protective Agents|protective agents|mesh-ancestor
43594742|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
43594743|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
43594744|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594745|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43594746|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594748|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43681332|NCT03734770|Hormones|hormones|mesh-ancestor
43681333|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681334|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681335|NCT03730194|Melatonin|melatonin|mesh-list
43681336|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
43594749|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
43594750|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
43594751|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594752|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594762|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43594763|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594764|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594766|NCT03330990|Entrectinib|entrectinib|mesh-list
43594767|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43594768|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43594769|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594771|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43594772|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43594773|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43594774|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43594775|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
43594776|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
43594777|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
43594778|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
43594779|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594780|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594781|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43594782|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594783|NCT03330886|Atezolizumab|atezolizumab|mesh-list
43594784|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594785|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43594786|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43594787|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
43594788|NCT03330860|Hormones|hormones|mesh-ancestor
43594789|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594790|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594791|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594792|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594793|NCT03330808|Anesthetics|anesthetics|mesh-list
43594794|NCT03330808|Ropivacaine|ropivacaine|mesh-list
43594795|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594796|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594817|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43594818|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43594819|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43594820|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43594821|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
43594829|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
43594830|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
43594831|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594832|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
43594833|NCT03330106|Paclitaxel|paclitaxel|mesh-list
43594834|NCT03330106|Docetaxel|docetaxel|mesh-list
43594835|NCT03330106|Carboplatin|carboplatin|mesh-list
43594836|NCT03330106|Pevonedistat|pevonedistat|mesh-list
43594837|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43594838|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594839|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
43594840|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
43594841|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
43594842|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594845|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43594846|NCT03329898|Estradiol|estradiol|mesh-list
43594847|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43594848|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
43594849|NCT03329898|Estrogens|estrogens|mesh-ancestor
43594850|NCT03329898|Hormones|hormones|mesh-ancestor
43594851|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594852|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594853|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43594854|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
43594855|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43594856|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43594857|NCT03329898|Progestins|progestins|mesh-ancestor
43594858|NCT03329781|Curcumin|curcumin|mesh-list
43594859|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43594860|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43594861|NCT03329781|Analgesics|analgesics|mesh-ancestor
43594862|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
43594863|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594864|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594865|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594866|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594867|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594868|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594869|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594870|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43594871|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43594874|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594875|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43594876|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43681350|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
43681351|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681352|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43681353|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43681354|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
43681355|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594877|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594879|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43594880|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684827|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684828|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684829|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
43684830|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594881|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43684831|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43684832|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43684833|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43684834|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684835|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684836|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684837|NCT02839668|Analgesics|analgesics|mesh-ancestor
43684838|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
43684839|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43594882|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43594883|NCT03329547|Cefixime|cefixime|mesh-list
43594884|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43594885|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594886|NCT03329508|Pramipexole|pramipexole|mesh-list
43594887|NCT03329508|Rasagiline|rasagiline|mesh-list
43594888|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
43594889|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594890|NCT03329508|Protective Agents|protective agents|mesh-ancestor
43594891|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594892|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43594893|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43594894|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
43594898|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594899|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43594901|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
43594902|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
43594903|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594904|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594905|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
43594906|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684840|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43684841|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
43684842|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43594907|NCT03329443|Spironolactone|spironolactone|mesh-list
43594908|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43594909|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
43594910|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630918|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43630919|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630920|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43630921|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43630922|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43630923|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43630924|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
43630925|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630926|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630928|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43594911|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594912|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43630929|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43630930|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
43630931|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630932|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43630933|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43630934|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630936|NCT03047538|Perindopril|perindopril|mesh-list
43594913|NCT03329443|Diuretics|diuretics|mesh-ancestor
43594914|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
43594915|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
43594916|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
43594917|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594918|NCT03329339|Protective Agents|protective agents|mesh-ancestor
43594919|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594920|NCT03329339|Vitamins|vitamins|mesh-ancestor
43594922|NCT03329261|Clopidogrel|clopidogrel|mesh-list
43594923|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43594924|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43594925|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43594926|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43594927|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
43594928|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594929|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594930|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594931|NCT03329248|Leucovorin|leucovorin|mesh-list
43594932|NCT03329248|Paclitaxel|paclitaxel|mesh-list
43594933|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
43594934|NCT03329248|Bevacizumab|bevacizumab|mesh-list
43594935|NCT03329248|Fluorouracil|fluorouracil|mesh-list
43594936|NCT03329248|Capecitabine|capecitabine|mesh-list
43594937|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
43594938|NCT03329248|Avelumab|avelumab|mesh-list
43594939|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43594940|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594941|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
43594942|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
43594943|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
43681356|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681357|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43681358|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43681359|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
43681360|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43681361|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
43681362|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
43681363|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
43681364|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43681365|NCT03667820|Osimertinib|osimertinib|mesh-list
43681366|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681367|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43681368|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594944|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594945|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43594946|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
43594947|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594948|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594949|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43594950|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
43594951|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43594952|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43594953|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43594954|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43594955|NCT03329248|Growth Substances|growth substances|mesh-ancestor
43594956|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
43594957|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
43594958|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43594959|NCT03329248|Antidotes|antidotes|mesh-ancestor
43594960|NCT03329248|Protective Agents|protective agents|mesh-ancestor
43594961|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
43594962|NCT03329248|Vitamins|vitamins|mesh-ancestor
43594963|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
43595008|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
43595009|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595010|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595019|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
43595020|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43595021|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43595023|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
43595024|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595025|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595026|NCT03328533|Protective Agents|protective agents|mesh-ancestor
43595027|NCT03328494|Paclitaxel|paclitaxel|mesh-list
43595028|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43595029|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595030|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
43595031|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
43595032|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
43681369|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681371|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
43681372|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681373|NCT03654989|Treprostinil|treprostinil|mesh-list
43681374|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43681375|NCT03606694|Metformin|metformin|mesh-list
43681376|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681377|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681378|NCT03597776|Lidocaine|lidocaine|mesh-list
43681379|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
43681380|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
43681381|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681382|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681384|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681386|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43681387|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43681388|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681389|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681390|NCT03560882|Atorvastatin|atorvastatin|mesh-list
43681391|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43681392|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43681393|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
43681394|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681397|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681413|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43684875|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684876|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43681414|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
43681415|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681416|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681417|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
43681418|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681419|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43681420|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681421|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
43681422|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43681423|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43595033|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595034|NCT03328481|Anesthetics|anesthetics|mesh-list
43828678|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828679|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828680|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828681|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43828682|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43828683|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43828684|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43828685|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
43828686|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43828687|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
43828688|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
43630948|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43630950|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
43630951|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43630952|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
43630953|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
43595035|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595036|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595037|NCT03328364|Docetaxel|docetaxel|mesh-list
43595038|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595039|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
43595040|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
43595041|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
43595042|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595044|NCT03328312|Neostigmine|neostigmine|mesh-list
43595045|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43595046|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43595047|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43595048|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
43595049|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595050|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595051|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43595052|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
43595053|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
43595054|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
43595055|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43595056|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43595057|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
43595058|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595059|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595060|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43595061|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595062|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43595063|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
43595064|NCT03328299|Bupivacaine|bupivacaine|mesh-list
43595065|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
43595066|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
43595067|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595068|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595069|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
43595070|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828701|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
43828702|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828703|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828704|NCT05475080|Anticoagulants|anticoagulants|mesh-list
43828705|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43630977|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
43630978|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43630979|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630980|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630981|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630982|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43630983|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43595071|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43595072|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595073|NCT03328299|Analgesics|analgesics|mesh-ancestor
43595074|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43595075|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43595076|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43595077|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
43595082|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43595083|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681425|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
43681426|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681427|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681428|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43681429|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681430|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595084|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
43595085|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
43595086|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
43595087|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595088|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
43595089|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595090|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43595091|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595092|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595093|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
43595094|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43595095|NCT03327987|Vaccines|vaccines|mesh-list
43595096|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
43595097|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595098|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43595099|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43595100|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
43595101|NCT03327766|Calcifediol|calcifediol|mesh-list
43595102|NCT03327766|Vitamins|vitamins|mesh-ancestor
43595103|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
43595104|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595105|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43595106|NCT03327727|Voriconazole|voriconazole|mesh-list
43595107|NCT03327727|Amphotericin B|amphotericin b|mesh-list
43595108|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43595109|NCT03327727|Isavuconazole|isavuconazole|mesh-list
43595111|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
43595112|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595113|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43595114|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43595115|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595116|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595117|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43595118|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
43595119|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595120|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595121|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43595122|NCT03327727|Amebicides|amebicides|mesh-ancestor
43595123|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43595124|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43595125|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43595126|NCT03327701|Benralizumab|benralizumab|mesh-list
43595127|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43595128|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
43595129|NCT03327558|Mesalamine|mesalamine|mesh-list
43595130|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43630984|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630985|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630986|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
43595131|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595132|NCT03327558|Analgesics|analgesics|mesh-ancestor
43595133|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
43595134|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595135|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595136|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595137|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43595139|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43595140|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681431|NCT03522831|Albuterol|albuterol|mesh-list
43681432|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43681433|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
43681434|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681435|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681436|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43681437|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
43595141|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595142|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43595143|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43595144|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43595145|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
43595146|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
43595147|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595148|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631062|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
43631063|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631064|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631066|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631067|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43631068|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631069|NCT03046173|Mitogens|mitogens|mesh-list
43631070|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
43631071|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631072|NCT03046108|Triamcinolone|triamcinolone|mesh-list
43595157|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828706|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
43828707|NCT05474898|Analgesics|analgesics|mesh-ancestor
43828708|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
43828709|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828710|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828711|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
43828712|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828713|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43595158|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43595159|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43595160|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
43595161|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
43595162|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43595163|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595164|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595165|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595166|NCT03327389|Analgesics|analgesics|mesh-ancestor
43595167|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
43595168|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595169|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43595170|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43595172|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
43595173|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595174|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595175|NCT03327350|Anticoagulants|anticoagulants|mesh-list
43595176|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
43595177|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43595178|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43595179|NCT03327272|Prednisolone|prednisolone|mesh-list
43595180|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
43595181|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43595182|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
43828714|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
43595183|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847022|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43847023|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847024|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43631073|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43631074|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43631075|NCT03046108|Mepivacaine|mepivacaine|mesh-list
43631076|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43631077|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631078|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
43631079|NCT03046108|Hormones|hormones|mesh-ancestor
43631080|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631081|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631082|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631083|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
43595184|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
43595185|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
43595186|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595187|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595188|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43595189|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
43595190|NCT03327272|Hormones|hormones|mesh-ancestor
43595191|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595192|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43595193|NCT03327272|Protective Agents|protective agents|mesh-ancestor
43595194|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43595195|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595196|NCT03327168|Adenosine|adenosine|mesh-list
43595197|NCT03327168|Analgesics|analgesics|mesh-ancestor
43595198|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
43595199|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595200|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595201|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43595202|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
43595203|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43595204|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
43595205|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
43595206|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595207|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595208|NCT03327155|Tenofovir|tenofovir|mesh-list
43595209|NCT03327155|Emtricitabine|emtricitabine|mesh-list
43681438|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
43681439|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43681440|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43681441|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43681442|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43681444|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595210|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
43595211|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595212|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43595213|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43595214|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595215|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595216|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43595232|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43595233|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43595234|NCT03326960|Propofol|propofol|mesh-list
43595235|NCT03326960|Sevoflurane|sevoflurane|mesh-list
43595236|NCT03326960|Desflurane|desflurane|mesh-list
43595237|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43595238|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595239|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595240|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43595241|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
43595242|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
43595243|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43631085|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631086|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
43631087|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
43631088|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631089|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
43631090|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631091|NCT03046290|Lidocaine|lidocaine|mesh-list
43595244|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43595245|NCT03326752|Nivolumab|nivolumab|mesh-list
43631092|NCT03046290|Ropivacaine|ropivacaine|mesh-list
43631093|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
43631094|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
43631095|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631096|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631097|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
43631098|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631099|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43631101|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43595246|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43595247|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43595248|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595249|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595250|NCT03326674|Capecitabine|capecitabine|mesh-list
43595251|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43595252|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
43595253|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595254|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595255|NCT03326661|Clindamycin|clindamycin|mesh-list
43595256|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
43595257|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
43595258|NCT03326661|Penicillins|penicillins|mesh-list
43595259|NCT03326661|Penicillin V|penicillin v|mesh-list
43595260|NCT03326661|Metronidazole|metronidazole|mesh-list
43595261|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43595262|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595263|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43595264|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595265|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595266|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43595267|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43595268|NCT03326609|Ropivacaine|ropivacaine|mesh-list
43595269|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
43595270|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
43595271|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595272|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631102|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631103|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595273|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
43847025|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847026|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
43595274|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595275|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
43847027|NCT04147533|Dasatinib|dasatinib|mesh-list
43595285|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
43595286|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
43595287|NCT03326258|Immunotoxins|immunotoxins|mesh-list
43595288|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43595289|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
43595290|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595291|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43595292|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681445|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681446|NCT03504501|Lamotrigine|lamotrigine|mesh-list
43681448|NCT03504501|L 647318|l 647318|mesh-list
43681449|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
43681450|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
43681451|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43681452|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681453|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681454|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43681455|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681456|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43681457|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43595293|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43595294|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595295|NCT03326128|Bupropion|bupropion|mesh-list
43595296|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43595297|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
43595298|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43595299|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43595300|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43595301|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43595302|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595303|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
43631104|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
43631133|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631134|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43631135|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631136|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
43631137|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43631138|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631140|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43631141|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43631142|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631143|NCT03045770|Antidotes|antidotes|mesh-ancestor
43631144|NCT03045770|Protective Agents|protective agents|mesh-ancestor
43631145|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
43631146|NCT03045770|Vitamins|vitamins|mesh-ancestor
43595304|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595305|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595306|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43595307|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43595308|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595309|NCT03326102|Paclitaxel|paclitaxel|mesh-list
43595310|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43595311|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43595312|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595313|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
43595314|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
43595315|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
43595316|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595317|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
43595318|NCT03326050|Rifampin|rifampin|mesh-list
43595319|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
43595320|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43595321|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595322|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43595323|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43595324|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595325|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595327|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43595328|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43595329|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43595330|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
43595331|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
43595332|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43595333|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43595334|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43595335|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43595336|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43681458|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681459|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43681460|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43681461|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43681462|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43681463|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
43681464|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43681465|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43681466|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681467|NCT03494322|Cetuximab|cetuximab|mesh-list
43681468|NCT03494322|Avelumab|avelumab|mesh-list
43595337|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43631147|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
43631148|NCT03045627|Cytarabine|cytarabine|mesh-list
43595338|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43595339|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
43595340|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43595349|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
43595350|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595351|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595352|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
43631149|NCT03045627|Aclarubicin|aclarubicin|mesh-list
43631150|NCT03045627|Lenograstim|lenograstim|mesh-list
43631151|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43631152|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
43631153|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631154|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631155|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
43603977|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
43595353|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595355|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43595357|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43595358|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595359|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43595360|NCT03325790|Ebselen|ebselen|mesh-list
43595361|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43595362|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595363|NCT03325790|Analgesics|analgesics|mesh-ancestor
43595364|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
43595365|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595366|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595367|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595368|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43595369|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43595370|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43595371|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
43595372|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595373|NCT03325790|Protective Agents|protective agents|mesh-ancestor
43595374|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43595375|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595376|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43595377|NCT03325686|Vitamin D|vitamin d|mesh-list
43595378|NCT03325686|Vitamins|vitamins|mesh-ancestor
43595379|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
43595380|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595381|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43595382|NCT03325491|Acipimox|acipimox|mesh-list
43595383|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43595384|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
43595385|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595386|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43595387|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
43595388|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43595390|NCT03325413|Anesthetics|anesthetics|mesh-list
43595391|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595392|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681469|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681470|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681471|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
43681472|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681473|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681474|NCT03485274|Vortioxetine|vortioxetine|mesh-list
43681475|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
43681476|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43681477|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43681478|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43595393|NCT03325400|Fluorides|fluorides|mesh-list
43595394|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
43631156|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631157|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631158|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
43631159|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631160|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43631161|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43631162|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43631163|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43631164|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631165|NCT03045484|Oxycodone|oxycodone|mesh-list
43631166|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43631167|NCT03045484|Narcotics|narcotics|mesh-ancestor
43595395|NCT03325400|Protective Agents|protective agents|mesh-ancestor
43595396|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595397|NCT03325348|Labetalol|labetalol|mesh-list
43595398|NCT03325348|Nifedipine|nifedipine|mesh-list
43595399|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43595400|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43595401|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595402|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43595403|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595404|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
43595442|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631168|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631169|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595443|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43595444|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595453|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
43595454|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
43595455|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595456|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595457|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595458|NCT03324815|Morphine|morphine|mesh-list
43595459|NCT03324815|Methadone|methadone|mesh-list
43595460|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43595461|NCT03324815|Narcotics|narcotics|mesh-ancestor
43595462|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595463|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595464|NCT03324815|Analgesics|analgesics|mesh-ancestor
43595465|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
43595466|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595467|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
43595468|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
43595470|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43595471|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43595472|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595473|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
43595474|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43595475|NCT03324685|Estradiol|estradiol|mesh-list
43595476|NCT03324685|Estrogens|estrogens|mesh-ancestor
43595477|NCT03324685|Hormones|hormones|mesh-ancestor
43595478|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595479|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595480|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43595481|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
43595482|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43595483|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43595484|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43631170|NCT03045484|Analgesics|analgesics|mesh-ancestor
43595486|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43595487|NCT03324542|Ranibizumab|ranibizumab|mesh-list
43595488|NCT03324542|Aflibercept|aflibercept|mesh-list
43595489|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595490|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43595491|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43681479|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681480|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847032|NCT04146207|Prednisone|prednisone|mesh-list
43684886|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43684887|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684888|NCT02839239|Vitamin D|vitamin d|mesh-list
43684889|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
43684890|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
43684891|NCT02839239|Vitamins|vitamins|mesh-list
43684892|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
43684893|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684894|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43684895|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43684896|NCT02839213|Scopolamine|scopolamine|mesh-list
43684897|NCT02839213|Bromides|bromides|mesh-list
43684898|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43684899|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
43681481|NCT03485274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43681482|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43681483|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681484|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681485|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681486|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
43681487|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43681488|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43681489|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43681490|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43681492|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43681493|NCT03477396|Hormones|hormones|mesh-ancestor
43681494|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681495|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681496|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43681497|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684900|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43684901|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
43684902|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
43684903|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684904|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684905|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684906|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
43684907|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43681498|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681499|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43681500|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
43681501|NCT03464461|Ketorolac|ketorolac|mesh-list
43828366|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828367|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828368|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43828369|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
43828370|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
43684910|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684911|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43684912|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
43684913|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43684927|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43684928|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43684929|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684930|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828371|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
43828372|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43828373|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43828374|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
43828375|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828376|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828378|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
43828379|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
43681525|NCT03396926|Bevacizumab|bevacizumab|mesh-list
43681526|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43681527|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
43681528|NCT03396926|Capecitabine|capecitabine|mesh-list
43681529|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
43681531|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
43681532|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43681533|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
43681534|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681535|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43681536|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43681537|NCT03396926|Growth Substances|growth substances|mesh-ancestor
43681538|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681539|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
43681540|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
43681541|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43681542|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
43639145|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681553|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43681554|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
43681555|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681557|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
43681558|NCT03367572|Olanzapine|olanzapine|mesh-list
43681559|NCT03367572|Palonosetron|palonosetron|mesh-list
43681560|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
43681561|NCT03367572|Ichthammol|ichthammol|mesh-list
43681562|NCT03367572|BB 1101|bb 1101|mesh-list
43681563|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43681564|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
43595492|NCT03324542|Growth Substances|growth substances|mesh-ancestor
43595493|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595494|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
43684931|NCT02839122|Urological Agents|urological agents|mesh-ancestor
43595495|NCT03324503|Prednisone|prednisone|mesh-list
43595496|NCT03324503|Prednisolone|prednisolone|mesh-list
43595497|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43595498|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
43595499|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43595500|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
43595501|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43595502|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
43595503|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
43595504|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595505|NCT03324503|Hormones|hormones|mesh-ancestor
43595506|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595507|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595508|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43595509|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595510|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
43595511|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
43595512|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595513|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43595514|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43595515|NCT03324503|Protective Agents|protective agents|mesh-ancestor
43595516|NCT03324490|Fentanyl|fentanyl|mesh-list
43595523|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
43595524|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595525|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43595526|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595527|NCT03324490|Analgesics|analgesics|mesh-ancestor
43595528|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43595529|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43595530|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43595531|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
43595532|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595533|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595534|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43595535|NCT03324490|Narcotics|narcotics|mesh-ancestor
43595536|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43595537|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43595538|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
43595539|NCT03324425|Simvastatin|simvastatin|mesh-list
43595540|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43595541|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43595542|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
43595543|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595544|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43595545|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43595546|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595547|NCT03324334|Antibodies|antibodies|mesh-list
43595548|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
43681566|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681567|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681568|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681569|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
43681570|NCT03367572|Hormones|hormones|mesh-ancestor
43681571|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681572|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43681573|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681574|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43595549|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595550|NCT03324243|Cytarabine|cytarabine|mesh-list
43595551|NCT03324243|Fludarabine|fludarabine|mesh-list
43595552|NCT03324243|Crenolanib|crenolanib|mesh-list
43595553|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595554|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43595555|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
43684939|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43684992|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684993|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
43684994|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684995|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43684996|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43684997|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43684998|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684999|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685000|NCT02838719|Dexamethasone|dexamethasone|mesh-list
43685001|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
43685002|NCT02838719|BB 1101|bb 1101|mesh-list
43685003|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595556|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595557|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43595558|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
43595559|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595560|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
43595561|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595562|NCT03324139|Heparin|heparin|mesh-list
43595563|NCT03324139|Calcium heparin|calcium heparin|mesh-list
43595564|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43595565|NCT03324139|Tinzaparin|tinzaparin|mesh-list
43595566|NCT03324139|Dalteparin|dalteparin|mesh-list
43595567|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
43595568|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43595569|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43595570|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595571|NCT03324061|Fulvestrant|fulvestrant|mesh-list
43595572|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43595573|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595574|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43595575|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43595576|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
43595577|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595578|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595579|NCT03323710|Sunitinib|sunitinib|mesh-list
43595580|NCT03323710|Propranolol|propranolol|mesh-list
43595581|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595582|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43595583|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43595584|NCT03323710|Growth Substances|growth substances|mesh-ancestor
43595585|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595586|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
43595590|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43595591|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43595592|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
43595593|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595594|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43595595|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43595596|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
43595597|NCT03323697|Citalopram|citalopram|mesh-list
43595598|NCT03323697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43849121|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43849122|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
43849124|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
43595599|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43595600|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43595601|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681575|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43681576|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685004|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
43685005|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
43685006|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685007|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685008|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685009|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
43631171|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
43631172|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631173|NCT03045471|Prednisolone|prednisolone|mesh-list
43681577|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43681578|NCT03367572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43681579|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43681580|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681581|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681582|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681583|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
43681584|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
43681585|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681586|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43681587|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43681588|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
43595602|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595604|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595605|NCT03323697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43595606|NCT03323697|Antidepressive Agents|antidepressive agents|mesh-ancestor
43595607|NCT03323697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43595608|NCT03323684|Acetaminophen|acetaminophen|mesh-list
43595609|NCT03323684|Ketorolac|ketorolac|mesh-list
43595610|NCT03323684|Fentanyl|fentanyl|mesh-list
43595611|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43595612|NCT03323684|Narcotics|narcotics|mesh-ancestor
43595613|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595614|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595615|NCT03323684|Analgesics|analgesics|mesh-ancestor
43595616|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
43595617|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595618|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43595619|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43595620|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
43595621|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
43595622|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595623|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
43595624|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43595625|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595626|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43595627|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43595628|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595629|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595630|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
43595631|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43595640|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595641|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595642|NCT03323619|Anesthetics|anesthetics|mesh-list
43595643|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595644|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595645|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
43681589|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43681590|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
43681591|NCT03326310|Azacitidine|azacitidine|mesh-list
43681592|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43681593|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
43681594|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681595|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681596|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681597|NCT03314363|Trace Elements|trace elements|mesh-list
43631174|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43631175|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
43631176|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43631177|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
43631178|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
43631180|NCT03045471|Etoposide|etoposide|mesh-list
43631181|NCT03045471|Vincristine|vincristine|mesh-list
43631182|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43631183|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
43631184|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631185|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
43631186|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631187|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43631188|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43631189|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
43681598|NCT03314363|Micronutrients|micronutrients|mesh-list
43681599|NCT03314363|Citric Acid|citric acid|mesh-list
43681600|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
43681601|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681602|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
43681603|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43681604|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
43681605|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
43681606|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681610|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681611|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43681612|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43681613|NCT03302728|Growth Substances|growth substances|mesh-ancestor
43595646|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43595647|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595648|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595649|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595650|NCT03323593|Analgesics|analgesics|mesh-ancestor
43595651|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
43595652|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595653|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43595662|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
43595663|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595664|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595665|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
43595666|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849125|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43595667|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43595668|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43595669|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43595670|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43595671|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595672|NCT03323541|Lenograstim|lenograstim|mesh-list
43595673|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43681615|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681616|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681617|NCT03299660|Fluorouracil|fluorouracil|mesh-list
43681618|NCT03299660|Capecitabine|capecitabine|mesh-list
43681620|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
43681621|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681622|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43681623|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681624|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43595674|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
43595675|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595676|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43631190|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631197|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631198|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631199|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
43631200|NCT03045471|Hormones|hormones|mesh-ancestor
43595678|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
43595679|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
43595680|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595681|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595682|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
43595683|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595684|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43595685|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595686|NCT03323385|Meloxicam|meloxicam|mesh-list
43595687|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43595688|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595689|NCT03323385|Analgesics|analgesics|mesh-ancestor
43595690|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
43595691|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595692|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595693|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595694|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43595695|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43595696|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43595697|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595716|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595717|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43595718|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
43595719|NCT03323047|Hormones|hormones|mesh-ancestor
43595720|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595728|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
43595730|NCT03322969|Paclitaxel|paclitaxel|mesh-list
43595731|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43595732|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595733|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
43595734|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
43595735|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
43681625|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
43595736|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595737|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
43595738|NCT03322878|Analgesics|analgesics|mesh-ancestor
43595739|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
43595740|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631229|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43631230|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43631231|NCT03045185|Metronidazole|metronidazole|mesh-list
43595741|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631232|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
43631233|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631234|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43595742|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
43595754|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595755|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
43595756|NCT03322735|Fludarabine|fludarabine|mesh-list
43631235|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43631236|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43631237|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43631238|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43631239|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631240|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631241|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631242|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43631243|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43631244|NCT03045198|Azithromycin|azithromycin|mesh-list
43631245|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631246|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631247|NCT03045393|Maytansine|maytansine|mesh-list
43595757|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43595758|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
43595759|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595760|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43595761|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43595762|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
43595763|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595764|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595765|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43595767|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43595768|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595769|NCT03322631|Incretins|incretins|mesh-ancestor
43595770|NCT03322631|Hormones|hormones|mesh-ancestor
43595771|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595772|NCT03322488|Metronidazole|metronidazole|mesh-list
43595773|NCT03322488|Doxycycline|doxycycline|mesh-list
43595774|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
43595775|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595776|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43595777|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43595778|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43604213|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43681626|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681627|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43631248|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43681628|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
43681629|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681630|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681631|NCT03248167|Cannabidiol|cannabidiol|mesh-list
43681632|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
43681633|NCT03230604|Z 350|z 350|mesh-list
43681641|NCT03221036|Vedolizumab|vedolizumab|mesh-list
43681664|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681665|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43681666|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43681667|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681668|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
43631249|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631250|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
43631251|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
43631252|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
43631253|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631254|NCT03045133|Morphine|morphine|mesh-list
43631256|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43631257|NCT03045133|Narcotics|narcotics|mesh-ancestor
43631258|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631259|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631267|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43681669|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43631268|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43631269|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43631270|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
43631271|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631272|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631273|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685012|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43685013|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685015|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681670|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43681671|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43681672|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
43681673|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595779|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
43595780|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43595781|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43595782|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595783|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595784|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685017|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
43595785|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43595786|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43595787|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
43595788|NCT03322358|Promethazine|promethazine|mesh-list
43595794|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
43595795|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
43595796|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685018|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43685019|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
43685020|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685021|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595797|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
43685022|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595798|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
43685023|NCT02838589|Exenatide|exenatide|mesh-list
43685024|NCT02838589|Glucagon|glucagon|mesh-list
43595799|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43595800|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43685025|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43685026|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43685027|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685028|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43595801|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
43595802|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
43595803|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595804|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685029|NCT02838589|Incretins|incretins|mesh-ancestor
43685030|NCT02838589|Hormones|hormones|mesh-ancestor
43685031|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595805|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43595807|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
43595808|NCT03322150|Atropine|atropine|mesh-list
43595809|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
43595810|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43595811|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43685032|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685033|NCT02838576|Estrogens|estrogens|mesh-list
43595812|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43595813|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
43595814|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595815|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595816|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43595817|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
43595819|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
43595820|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43595821|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43595822|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
43595823|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685034|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43595824|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595825|NCT03322124|Octenidine|octenidine|mesh-list
43595826|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595827|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43595828|NCT03322098|Atropine|atropine|mesh-list
43631284|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43631285|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631286|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631287|NCT03044873|BMS-986165|bms-986165|mesh-list
43631288|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43631289|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43631290|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43631291|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
43595829|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
43595830|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43595831|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43595832|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43595833|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
43595834|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595835|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595836|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43595837|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
43595838|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
43681675|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43681676|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
43681677|NCT03153527|Hormones|hormones|mesh-ancestor
43681678|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681679|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681680|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43681681|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681682|NCT03141203|Romidepsin|romidepsin|mesh-list
43681683|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43681684|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681685|NCT03087773|Empagliflozin|empagliflozin|mesh-list
43681686|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43681687|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681688|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681689|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681690|NCT03082755|Gabapentin|gabapentin|mesh-list
43681691|NCT03082755|Analgesics|analgesics|mesh-ancestor
43681692|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
43631293|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43681693|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595839|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
43595840|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43595841|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43595842|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
43595843|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595844|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595845|NCT03321955|Ziconotide|ziconotide|mesh-list
43601868|NCT03260569|Protective Agents|protective agents|mesh-ancestor
43595846|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43595847|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43595848|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595849|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43595850|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595851|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43595852|NCT03321955|Protective Agents|protective agents|mesh-ancestor
43595853|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595854|NCT03321955|Analgesics|analgesics|mesh-ancestor
43595855|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
43595856|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595857|NCT03321903|Charcoal|charcoal|mesh-list
43595858|NCT03321903|Antidotes|antidotes|mesh-ancestor
43595859|NCT03321903|Protective Agents|protective agents|mesh-ancestor
43595868|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43595869|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43595870|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
43595871|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595872|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595873|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43595874|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595875|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
43595877|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595878|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43681694|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685061|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
43685062|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685063|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685065|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
43685089|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685090|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685091|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43685092|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
43685093|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685094|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685128|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685129|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
43685130|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685131|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43685132|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43685133|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
43685134|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43685135|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685136|NCT02837965|Doxycycline|doxycycline|mesh-list
43685137|NCT02837965|Prednisone|prednisone|mesh-list
43685138|NCT02837965|Methotrexate|methotrexate|mesh-list
43685139|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685140|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
43685141|NCT02837965|Hormones|hormones|mesh-ancestor
43685142|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685143|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681695|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
43681696|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43681697|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43681698|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681699|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43681700|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43681701|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43681702|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681703|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681704|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
43681705|NCT03068910|Spironolactone|spironolactone|mesh-list
43595879|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43595880|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
43595881|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43595882|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43595883|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
43595884|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
43595885|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595886|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43595887|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43595888|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43595889|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43595890|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43595892|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
43595893|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
43595894|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
43595897|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
43595898|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685144|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43685145|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595899|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43685155|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685156|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
43631294|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43631295|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631296|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
43595900|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43595901|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43595902|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43595903|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685157|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685158|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43685159|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43595904|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43595905|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
43595906|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
43595907|NCT03321825|Protective Agents|protective agents|mesh-ancestor
43685160|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685161|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
43685162|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43685163|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43685164|NCT02838173|Ropivacaine|ropivacaine|mesh-list
43685165|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
43685166|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
43685167|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685168|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685169|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
43595908|NCT03321773|Amoxicillin|amoxicillin|mesh-list
43595909|NCT03321773|Metronidazole|metronidazole|mesh-list
43595910|NCT03321773|Clarithromycin|clarithromycin|mesh-list
43595911|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43595912|NCT03321773|Pantoprazole|pantoprazole|mesh-list
43595913|NCT03321773|Bismuth|bismuth|mesh-list
43595914|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43595915|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595916|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43595917|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43595918|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43595919|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595920|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595921|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43595922|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43595923|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43595924|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43595925|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43595926|NCT03321773|Antacids|antacids|mesh-ancestor
43595932|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681706|NCT03068910|Progesterone|progesterone|mesh-list
43681707|NCT03068910|Progestins|progestins|mesh-ancestor
43681708|NCT03068910|Hormones|hormones|mesh-ancestor
43681709|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681710|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685170|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685171|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
43681711|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43681712|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
43681713|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43595933|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43595934|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43595935|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
43595936|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595937|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
43595938|NCT03321318|Vitamin D|vitamin d|mesh-list
43595939|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
43595940|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43595941|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595942|NCT03321318|Vitamins|vitamins|mesh-ancestor
43595943|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
43595944|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43595945|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43595946|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43595947|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
43595948|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43595949|NCT03321292|Aspirin|aspirin|mesh-list
43595950|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43595951|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595952|NCT03321292|Analgesics|analgesics|mesh-ancestor
43595953|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
43595954|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595955|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595956|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595957|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685217|NCT02837640|Levodopa|levodopa|mesh-list
43685248|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
43685249|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43685250|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685251|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685252|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
43595958|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43595959|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43595960|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595961|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43595962|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43595963|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595964|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
43595965|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43849126|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43595966|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
43685253|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685254|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685255|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
43685256|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685257|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43685258|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685259|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
43685260|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685261|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43685262|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
43685263|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43595967|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595968|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43595969|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43595970|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
43595971|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595972|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595973|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43595974|NCT03321110|Ubiquinone|ubiquinone|mesh-list
43595975|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
43595976|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
43595977|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595978|NCT03321110|Vitamins|vitamins|mesh-ancestor
43595979|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
43595980|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
43595981|NCT03320967|Coagulants|coagulants|mesh-ancestor
43595982|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43595983|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43595984|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
43595985|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595986|NCT03320928|Methotrexate|methotrexate|mesh-list
43685264|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
43685265|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43685266|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43685267|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685268|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
43685291|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43685292|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43685293|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685294|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43595987|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43681714|NCT03068910|Diuretics|diuretics|mesh-ancestor
43681715|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
43681716|NCT03059147|Nivolumab|nivolumab|mesh-list
43681717|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681718|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681719|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43681720|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681721|NCT03043729|Leucovorin|leucovorin|mesh-list
43681722|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
43681723|NCT03043729|Aflibercept|aflibercept|mesh-list
43681724|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681725|NCT03043729|Antidotes|antidotes|mesh-ancestor
43681726|NCT03043729|Protective Agents|protective agents|mesh-ancestor
43681727|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681728|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
43681730|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
43681731|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43681732|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43681733|NCT03043729|Growth Substances|growth substances|mesh-ancestor
43681734|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
43681735|NCT03043547|Leucovorin|leucovorin|mesh-list
43681736|NCT03043547|Antidotes|antidotes|mesh-ancestor
43681737|NCT03043547|Protective Agents|protective agents|mesh-ancestor
43681738|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681739|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
43681740|NCT03043547|Vitamins|vitamins|mesh-ancestor
43681741|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
43681742|NCT02992964|Nivolumab|nivolumab|mesh-list
43681743|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681763|NCT02890212|Protective Agents|protective agents|mesh-ancestor
43681764|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681765|NCT02890212|Trace Elements|trace elements|mesh-ancestor
43681766|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
43681767|NCT02873962|Bevacizumab|bevacizumab|mesh-list
43681768|NCT02873962|Nivolumab|nivolumab|mesh-list
43681769|NCT02873962|Rucaparib|rucaparib|mesh-list
43681770|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681771|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681772|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43681773|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43681774|NCT02873962|Growth Substances|growth substances|mesh-ancestor
43681775|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681776|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
43681777|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43681778|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681779|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43681780|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681781|NCT02823028|Nicotine|nicotine|mesh-list
43681782|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43595988|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
43595989|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43595990|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685295|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43685296|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685297|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
43685298|NCT02836977|Tegafur|tegafur|mesh-list
43685334|NCT02836821|Rifampin|rifampin|mesh-list
43685335|NCT02836821|Apatinib|apatinib|mesh-list
43685336|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685337|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43685338|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685339|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595991|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43595992|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
43595993|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595994|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596002|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
43596003|NCT03320915|Vitamin D|vitamin d|mesh-list
43596004|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43596005|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596006|NCT03320915|Vitamins|vitamins|mesh-ancestor
43596007|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
43596008|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43596009|NCT03320707|Daratumumab|daratumumab|mesh-list
43596010|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596011|NCT03320694|Insulin|insulin|mesh-list
43596012|NCT03320694|Metformin|metformin|mesh-list
43596013|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43596014|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
43596015|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43596016|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596017|NCT03320629|Apatinib|apatinib|mesh-list
43596018|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596019|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43596020|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596021|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596022|NCT03320603|Thrombin|thrombin|mesh-list
43596023|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
43596024|NCT03320603|Coagulants|coagulants|mesh-ancestor
43596027|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43596028|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43596029|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681783|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
43681784|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681785|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681786|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43681787|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43681788|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
43681789|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681790|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681791|NCT02821923|Erythritol|erythritol|mesh-list
43681792|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
43681793|NCT02794402|Exenatide|exenatide|mesh-list
43681794|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681795|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681796|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43681797|NCT02794402|Incretins|incretins|mesh-ancestor
43681798|NCT02794402|Hormones|hormones|mesh-ancestor
43681799|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681800|NCT02783092|Cannabidiol|cannabidiol|mesh-list
43681801|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
43681802|NCT02776917|Paclitaxel|paclitaxel|mesh-list
43596030|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685340|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43596031|NCT03320486|Ketoconazole|ketoconazole|mesh-list
43596032|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
43596033|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685341|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
43596034|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43596035|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43685342|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43685343|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685344|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
43685345|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43685346|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43685347|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43685348|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43685349|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43685350|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43685351|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43685352|NCT02836548|Vorinostat|vorinostat|mesh-list
43685353|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43685354|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685355|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685356|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685357|NCT02836743|Melatonin|melatonin|mesh-list
43685358|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
43596036|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596037|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596038|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43596039|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
43596040|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596041|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596042|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43596044|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596045|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
43596046|NCT03320460|Hormones|hormones|mesh-ancestor
43596047|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596048|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596049|NCT03320447|Lidocaine|lidocaine|mesh-list
43596051|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43596052|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43596053|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43596054|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
43596056|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596057|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596058|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
43596059|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596060|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43596061|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43681803|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43681804|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681806|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
43681807|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
43681808|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681809|NCT02768948|Losartan|losartan|mesh-list
43681810|NCT02768948|Telmisartan|telmisartan|mesh-list
43681811|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43681812|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43681813|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43685382|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685383|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685384|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685385|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43685386|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685387|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681814|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43681815|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828380|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828381|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828382|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828383|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828384|NCT05478291|Vitamin D|vitamin d|mesh-list
43828385|NCT05478291|Vitamins|vitamins|mesh-ancestor
43828386|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
43828387|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596063|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596069|NCT03320187|Dinoprostone|dinoprostone|mesh-list
43596070|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
43596071|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
43596072|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43596073|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596074|NCT03320174|Tafenoquine|tafenoquine|mesh-list
43596075|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
43596076|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43596077|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43596078|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596079|NCT03320109|Vitamin D|vitamin d|mesh-list
43596080|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
43596081|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
43596082|NCT03320109|Vitamins|vitamins|mesh-list
43596083|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
43596084|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596085|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43596086|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43596087|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
43596088|NCT03320031|Linagliptin|linagliptin|mesh-list
43596089|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43596090|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596091|NCT03320031|Incretins|incretins|mesh-ancestor
43596092|NCT03320031|Hormones|hormones|mesh-ancestor
43685388|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
43631307|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
43631308|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631309|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43631310|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43596093|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596094|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43596095|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
43828388|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43828389|NCT05478161|Fexofenadine|fexofenadine|mesh-list
43828390|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43828391|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43631311|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
43631312|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631313|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828392|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43828393|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
43828395|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828396|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828397|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828399|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43828400|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
43828401|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43828402|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596096|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596097|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596098|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
43596099|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596100|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596101|NCT03319823|Diuretics|diuretics|mesh-ancestor
43596102|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
43596103|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596104|NCT03319784|Triamcinolone|triamcinolone|mesh-list
43596105|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43596106|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43596107|NCT03319784|Ketorolac|ketorolac|mesh-list
43596108|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43631314|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43596109|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596110|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
43596111|NCT03319784|Hormones|hormones|mesh-ancestor
43596112|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596113|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596114|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596115|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
43596116|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596117|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596118|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43596119|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43596121|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
43596122|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596123|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596124|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43596125|NCT03319706|Olmesartan|olmesartan|mesh-list
43596126|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43596127|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43596128|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43596129|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43596130|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596131|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
43685423|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43685424|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43596132|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43596134|NCT03319563|Anesthetics|anesthetics|mesh-list
43596135|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
43596137|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828403|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828404|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828405|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
43828407|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
43828408|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828409|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
43828410|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828411|NCT05478044|Protective Agents|protective agents|mesh-ancestor
43828413|NCT05477797|Ixazomib|ixazomib|mesh-list
43828414|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
43828415|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596138|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43596139|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43596140|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
43596141|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596142|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596143|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43596144|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43596145|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
43596146|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596147|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43596148|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
43596149|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
43596150|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
43596151|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43596152|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
43685425|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596153|NCT03319550|Caseins|caseins|mesh-list
43685451|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43685452|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685453|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685454|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685455|NCT02836431|Analgesics|analgesics|mesh-ancestor
43685456|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
43685457|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685458|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43631322|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631323|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631324|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43631325|NCT03044665|Ezetimibe|ezetimibe|mesh-list
43631326|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43631349|NCT03044587|Vitamins|vitamins|mesh-ancestor
43631350|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
43596154|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
43596155|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
43596156|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596157|NCT03319498|Peppermint oil|peppermint oil|mesh-list
43596158|NCT03319498|Mineral Oil|mineral oil|mesh-list
43596159|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
43596160|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
43596161|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596162|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631351|NCT03044808|Lidocaine|lidocaine|mesh-list
43631352|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
43631353|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
43631354|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596163|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43596164|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
43596165|NCT03319498|Emollients|emollients|mesh-ancestor
43596166|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
43596167|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43596168|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43596169|NCT03319238|Ketamine|ketamine|mesh-list
43596170|NCT03319238|Analgesics|analgesics|mesh-ancestor
43596171|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
43596172|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596173|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596174|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43596175|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43596176|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
43596177|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
43596178|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596179|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43596180|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43596181|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596182|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596183|NCT03319121|Theophylline|theophylline|mesh-list
43596184|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
43596185|NCT03319121|Lansoprazole|lansoprazole|mesh-list
43631355|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631356|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
43631357|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631358|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43631359|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43631360|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43631361|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631362|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631363|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
43596186|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43596187|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
43828416|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43828417|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43828418|NCT05477797|Growth Substances|growth substances|mesh-ancestor
43828419|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
43828420|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828421|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
43828422|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828423|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828424|NCT05477615|Carboplatin|carboplatin|mesh-list
43828425|NCT05477615|Pemetrexed|pemetrexed|mesh-list
43596188|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596189|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596190|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43596191|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
43596192|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43596193|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596194|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596195|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
43596220|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596221|NCT03318887|Ribavirin|ribavirin|mesh-list
43596222|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
43596223|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
43596224|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596225|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
43596226|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596227|NCT03318835|Thalidomide|thalidomide|mesh-list
43596228|NCT03318835|Prednisone|prednisone|mesh-list
43596229|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
43596230|NCT03318835|Vincristine|vincristine|mesh-list
43596231|NCT03318835|Rituximab|rituximab|mesh-list
43596232|NCT03318835|Doxorubicin|doxorubicin|mesh-list
43596233|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596234|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
43596235|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596236|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
43596237|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43596238|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596241|NCT03318835|Growth Substances|growth substances|mesh-ancestor
43596242|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
43596243|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596244|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596245|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43596246|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
43596247|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596248|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43596249|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596250|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
43828427|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828428|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828429|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828431|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43828432|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43828433|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43828434|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
43828435|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828436|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43828437|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43828438|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
43828439|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681816|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
43681817|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43681818|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43681819|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681820|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681821|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43681822|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
43681823|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
43681824|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681825|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681826|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43681828|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43681829|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
43681830|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681831|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681832|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
43681833|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43681839|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681840|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681841|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43681850|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43681851|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
43681852|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43681853|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
43631364|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631365|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
43631366|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43631367|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43631368|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631369|NCT03044561|Urological Agents|urological agents|mesh-ancestor
43631371|NCT03044522|Narcotics|narcotics|mesh-ancestor
43631372|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631373|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631375|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
43631376|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631378|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43631379|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
43631380|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631381|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631403|NCT03044171|Listerine|listerine|mesh-list
43631404|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43631405|NCT03044171|Fluorides|fluorides|mesh-list
43681854|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681855|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681856|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
43681857|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43681858|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43681859|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
43681860|NCT02640222|Coagulants|coagulants|mesh-ancestor
43681861|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
43681862|NCT02630628|Tacrolimus|tacrolimus|mesh-list
43596251|NCT03318835|Hormones|hormones|mesh-ancestor
43596252|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596253|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596254|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43596255|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
43596256|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
43596257|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
43596258|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43631410|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43631411|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631412|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
43631413|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
43631414|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43631415|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43631416|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631417|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
43631418|NCT03044184|Coagulants|coagulants|mesh-ancestor
43631419|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
43631420|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43631421|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43631422|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631423|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43631424|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43631425|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596259|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43596260|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43596261|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43596262|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596263|NCT03318757|Bupivacaine|bupivacaine|mesh-list
43596264|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
43596265|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
43596266|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596267|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596268|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
43685543|NCT02835664|Niacin|niacin|mesh-list
43596269|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596271|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43685551|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685552|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43685553|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
43685554|NCT02835586|Paclitaxel|paclitaxel|mesh-list
43596272|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685555|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43596273|NCT03318744|Analgesics|analgesics|mesh-ancestor
43685556|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685573|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685574|NCT02835404|Nedaplatin|nedaplatin|mesh-list
43685575|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685576|NCT02835391|Surgiflo|surgiflo|mesh-list
43685577|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
43685578|NCT02835391|Coagulants|coagulants|mesh-ancestor
43685579|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
43685580|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43685581|NCT02835170|Antibodies|antibodies|mesh-list
43685582|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
43685583|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685584|NCT02835183|Insulin|insulin|mesh-list
43685585|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43596274|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
43596275|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596276|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596282|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43596283|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43596284|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596285|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
43681863|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681864|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
43681865|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681866|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43681867|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681868|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681869|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43681870|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681871|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43681872|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
43681873|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43681874|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681876|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43681877|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681878|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681879|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681880|NCT02603848|Ibuprofen|ibuprofen|mesh-list
43681881|NCT02603848|Morphine|morphine|mesh-list
43681882|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43681883|NCT02603848|Narcotics|narcotics|mesh-ancestor
43681884|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596286|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
43596287|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43685586|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596288|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596289|NCT03318718|Rocuronium|rocuronium|mesh-list
43596290|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596291|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43596292|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43596293|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43596294|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596295|NCT03318536|Granisetron|granisetron|mesh-list
43596296|NCT03318536|Serotonin|serotonin|mesh-list
43596297|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
43596298|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
43596299|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596300|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596301|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43596302|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43596303|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
43596304|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596305|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596306|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43596307|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
43596308|NCT03318471|Analgesics|analgesics|mesh-ancestor
43596309|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
43596310|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596311|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596312|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
43596313|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681885|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681886|NCT02603848|Analgesics|analgesics|mesh-ancestor
43681887|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
43681888|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681889|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43681890|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43681891|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43681892|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43681893|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43681894|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681895|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681896|NCT02586038|Thalidomide|thalidomide|mesh-list
43681897|NCT02586038|Dexamethasone|dexamethasone|mesh-list
43681898|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
43681900|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681901|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
43681902|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681903|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43681904|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43681905|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
43681906|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681911|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
43596314|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43596315|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
43596316|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43596317|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596318|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596319|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43596320|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
43596321|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43596322|NCT03318445|Irinotecan|irinotecan|mesh-list
43596323|NCT03318445|Rucaparib|rucaparib|mesh-list
43596324|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43596325|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43596326|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596327|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596328|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596329|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43596330|NCT03318419|Cytarabine|cytarabine|mesh-list
43596331|NCT03318419|Pegaspargase|pegaspargase|mesh-list
43596332|NCT03318419|Asparaginase|asparaginase|mesh-list
43596333|NCT03318419|Cladribine|cladribine|mesh-list
43681912|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681913|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681914|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
43681915|NCT02586038|Hormones|hormones|mesh-ancestor
43681916|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681917|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43681918|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
43681919|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43681920|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681921|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43681922|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43681923|NCT02586038|Growth Substances|growth substances|mesh-ancestor
43681924|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
43681925|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
43681926|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681927|NCT02555839|Thalidomide|thalidomide|mesh-list
43681928|NCT02555839|Dexamethasone|dexamethasone|mesh-list
43596334|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43596335|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
43596336|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596337|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596338|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
43596339|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596340|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596341|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
43596342|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596344|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43596345|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43596346|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43596353|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596354|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
43596355|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596356|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43596357|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
43596358|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43596359|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596360|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681931|NCT02555839|Pomalidomide|pomalidomide|mesh-list
43681932|NCT02555839|BB 1101|bb 1101|mesh-list
43681933|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43681934|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
43681935|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
43681936|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681937|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596373|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596374|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43596375|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
43596376|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596377|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596378|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43596379|NCT03318146|Latanoprost|latanoprost|mesh-list
43596380|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43596381|NCT03318029|Vitamin D|vitamin d|mesh-list
43596382|NCT03318029|Vitamins|vitamins|mesh-ancestor
43596383|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
43596384|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596385|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43596386|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
43596387|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596388|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
43596389|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596390|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596391|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43596392|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
43596393|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596394|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596395|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43596396|NCT03317912|Lidocaine|lidocaine|mesh-list
43596398|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
43685587|NCT02834676|Ethanol|ethanol|mesh-list
43685588|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43685589|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685590|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685591|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685592|NCT02834637|Vaccines|vaccines|mesh-list
43685593|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
43685594|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685595|NCT02834754|Vedolizumab|vedolizumab|mesh-list
43685597|NCT02834845|Sevoflurane|sevoflurane|mesh-list
43685627|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685628|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
43685629|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
43685630|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685631|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685632|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43596399|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596400|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596401|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
43681938|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681939|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
43681940|NCT02555839|Hormones|hormones|mesh-ancestor
43681941|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681942|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43681943|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681944|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
43681945|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681946|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681947|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
43681948|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43681949|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43681950|NCT02555839|Growth Substances|growth substances|mesh-ancestor
43681951|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
43681952|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681953|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
43681954|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43681955|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681956|NCT02535936|Anesthetics|anesthetics|mesh-list
43681957|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681958|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681959|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
43596402|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596403|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43596404|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43596405|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43596407|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596409|NCT03317847|Bromfenac|bromfenac|mesh-list
43596410|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43596411|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596412|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
43596416|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43596417|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
43596419|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596420|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596421|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596422|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43596423|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43596424|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43596425|NCT03317847|Analgesics|analgesics|mesh-ancestor
43596426|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
43596427|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596428|NCT03317730|Oxycodone|oxycodone|mesh-list
43596429|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43596430|NCT03317730|Narcotics|narcotics|mesh-ancestor
43596431|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596432|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681960|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43681961|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681962|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
43681963|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681964|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681965|NCT02389374|Chloroquine|chloroquine|mesh-list
43681966|NCT02389374|Lumefantrine|lumefantrine|mesh-list
43681967|NCT02389374|Artemether|artemether|mesh-list
43681968|NCT02389374|Primaquine|primaquine|mesh-list
43681969|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43681970|NCT02389374|Amebicides|amebicides|mesh-ancestor
43681971|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43596433|NCT03317730|Analgesics|analgesics|mesh-ancestor
43596434|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
43596435|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596436|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43596437|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43685633|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
43685634|NCT02834260|Hormones|hormones|mesh-ancestor
43596438|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685680|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43685681|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
43685682|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43685683|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
43685684|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685685|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685686|NCT02833766|Doxorubicin|doxorubicin|mesh-list
43631458|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631459|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631460|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43631461|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631462|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631465|NCT03043677|Adalimumab|adalimumab|mesh-list
43631466|NCT03043677|Golimumab|golimumab|mesh-list
43631467|NCT03043677|Infliximab|infliximab|mesh-list
43631468|NCT03043677|Ustekinumab|ustekinumab|mesh-list
43596439|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596440|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43596441|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596442|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596443|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
43596444|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596445|NCT03317652|Nitroprusside|nitroprusside|mesh-list
43596446|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43596447|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
43596448|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43596449|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596450|NCT03317600|Lidocaine|lidocaine|mesh-list
43596451|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
43596452|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
43596453|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596454|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596455|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
43596456|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596457|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43596458|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43596459|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43596460|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596461|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596462|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
43596463|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43596464|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43596465|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43596466|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596467|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596468|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
43596469|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596470|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596471|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43596472|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596473|NCT03317548|Progesterone|progesterone|mesh-list
43596474|NCT03317548|Progestins|progestins|mesh-ancestor
43596475|NCT03317548|Hormones|hormones|mesh-ancestor
43681973|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681974|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
43631469|NCT03043677|Vedolizumab|vedolizumab|mesh-list
43631470|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631471|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43631472|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
43631473|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43631474|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43631475|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631476|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
43685687|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43685688|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685689|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43685690|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43685691|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604622|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
43681975|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43681976|NCT02339532|Carboplatin|carboplatin|mesh-list
43681977|NCT02339532|Docetaxel|docetaxel|mesh-list
43681978|NCT02339532|Trastuzumab|trastuzumab|mesh-list
43681979|NCT02339532|Pertuzumab|pertuzumab|mesh-list
43681980|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681981|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
43681982|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
43681983|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
43681984|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681985|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681986|NCT02304809|Vemurafenib|vemurafenib|mesh-list
43681987|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681988|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43681989|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681990|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681991|NCT02131753|Cladribine|cladribine|mesh-list
43681992|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681993|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681994|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
43681995|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681996|NCT02122185|Metformin|metformin|mesh-list
43681997|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681998|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681999|NCT02087865|Donepezil|donepezil|mesh-list
43682000|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43682001|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596476|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596477|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596478|NCT03317327|Nivolumab|nivolumab|mesh-list
43596479|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43596480|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596481|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43596491|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43596492|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596493|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596495|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43596496|NCT03317210|Hematinics|hematinics|mesh-ancestor
43596497|NCT03317197|Vasopressins|vasopressins|mesh-list
43596498|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
43682002|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682004|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682006|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
43682007|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
43682008|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
43682009|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
43682010|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685692|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685694|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43682011|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682012|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
43682013|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682014|NCT01889199|Flutamide|flutamide|mesh-list
43682015|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
43682016|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
43682017|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682018|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682019|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43682020|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682021|NCT01868269|Dexamethasone|dexamethasone|mesh-list
43682022|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
43682023|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
43682024|NCT01868269|Rituximab|rituximab|mesh-list
43682025|NCT01868269|BB 1101|bb 1101|mesh-list
43682026|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596501|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
43596502|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43596503|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43596504|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
43596505|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596506|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596507|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596508|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43596509|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43596510|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
43596511|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596512|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43596513|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
43596514|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
43596515|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
43596516|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43596517|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
43596518|NCT03317197|Coagulants|coagulants|mesh-ancestor
43596519|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43596520|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
43596521|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
43596522|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
43682027|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
43682034|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43682035|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43682036|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682037|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
43682038|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
43682039|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682040|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682041|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
43682042|NCT01868269|Hormones|hormones|mesh-ancestor
43682043|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682044|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43682045|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
43682046|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682047|NCT01748448|Vitamin D|vitamin d|mesh-list
43682048|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
43682049|NCT01748448|Vitamins|vitamins|mesh-ancestor
43682050|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
43685695|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685696|NCT02833480|Fluticasone|fluticasone|mesh-list
43685697|NCT02833480|Budesonide|budesonide|mesh-list
43685698|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
43685699|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685700|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43682051|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682052|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43682053|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43682054|NCT01730313|Pyridoxine|pyridoxine|mesh-list
43682073|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682074|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43682075|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43682076|NCT01679119|Gemcitabine|gemcitabine|mesh-list
43682077|NCT01679119|Prednisolone|prednisolone|mesh-list
43682078|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
43682079|NCT01679119|Rituximab|rituximab|mesh-list
43682080|NCT01679119|Vincristine|vincristine|mesh-list
43682081|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43682082|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43682083|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
43631477|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631478|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43682084|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682085|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682086|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43682087|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
43682088|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682089|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685715|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682090|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43682091|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43685716|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685717|NCT02833506|Sirolimus|sirolimus|mesh-list
43685718|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43685719|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685720|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43685731|NCT02833701|Antibodies|antibodies|mesh-list
43596523|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43596524|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596525|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
43596526|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43596527|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596528|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596529|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43596530|NCT03317067|Analgesics|analgesics|mesh-ancestor
43596531|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
43596532|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596533|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43596534|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43596535|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43596536|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
43596537|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596538|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596539|NCT03317015|Fluticasone|fluticasone|mesh-list
43596540|NCT03317015|Triamcinolone|triamcinolone|mesh-list
43596541|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596542|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43596543|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
43596544|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596545|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596546|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43596547|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
43596548|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
43596549|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43596577|NCT03316690|Metformin|metformin|mesh-list
43596578|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43596579|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596580|NCT03316599|Gemcitabine|gemcitabine|mesh-list
43596581|NCT03316599|Paclitaxel|paclitaxel|mesh-list
43596582|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43596583|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682092|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43682094|NCT01679119|Antiviral Agents|antiviral agents|mesh-ancestor
43682095|NCT01679119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682096|NCT01679119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682097|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43682098|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
43682099|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
43682100|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
43682101|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682102|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
43682103|NCT01679119|Hormones|hormones|mesh-ancestor
43682104|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682105|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43682106|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43682107|NCT01478698|Plasminogen|plasminogen|mesh-list
43596584|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
43596585|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
43596586|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
43596587|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596588|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685750|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685752|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
43685753|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685754|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43685755|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43685756|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43685757|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
43685758|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685759|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685760|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
43685761|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43685762|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596590|NCT03316599|Antiviral Agents|antiviral agents|mesh-ancestor
43596591|NCT03316599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596592|NCT03316599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596593|NCT03316599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596594|NCT03316599|Immunologic Factors|immunologic factors|mesh-ancestor
43596610|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596611|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
43596612|NCT03316482|Leuprolide|leuprolide|mesh-list
43596613|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43596614|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
43685764|NCT02833584|Acetaminophen|acetaminophen|mesh-list
43596615|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43596616|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596617|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596618|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596619|NCT03316469|Clomiphene|clomiphene|mesh-list
43596620|NCT03316469|Enclomiphene|enclomiphene|mesh-list
43596621|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
43596622|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43596623|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
43596624|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596625|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596626|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43596627|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
43596628|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43596629|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43685817|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685818|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685819|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685820|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
43685821|NCT02833116|Hormones|hormones|mesh-ancestor
43685822|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685824|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685862|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
43685863|NCT02832778|Isoniazid|isoniazid|mesh-list
43685864|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
43685865|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685866|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43685867|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43685868|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631479|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43596630|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43596631|NCT03316352|Bupivacaine|bupivacaine|mesh-list
43596632|NCT03316352|Anesthetics|anesthetics|mesh-list
43596633|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
43596634|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596635|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596636|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
43596637|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596638|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
43596639|NCT03316339|Remifentanil|remifentanil|mesh-list
43596640|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43682108|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43682109|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43682110|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43682111|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682112|NCT01428089|Progesterone|progesterone|mesh-list
43682113|NCT01428089|Progestins|progestins|mesh-ancestor
43682114|NCT01428089|Hormones|hormones|mesh-ancestor
43682115|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682116|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682117|NCT01372254|Nicotine|nicotine|mesh-list
43682118|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43682119|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
43682120|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682121|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682122|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43682123|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43682124|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
43596645|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
43596646|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596647|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43596648|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43596649|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43596650|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
43596651|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596652|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596664|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
43596665|NCT03316313|Antibodies|antibodies|mesh-list
43596666|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
43596667|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
43596668|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596669|NCT03316066|Ropivacaine|ropivacaine|mesh-list
43596670|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
43596671|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
43596672|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596673|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596674|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
43596675|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596676|NCT03315923|Rituximab|rituximab|mesh-list
43596677|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
43596678|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
43596679|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43596680|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596681|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
43596682|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596683|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596684|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43596685|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596686|NCT03315845|Anesthetics|anesthetics|mesh-list
43596687|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596688|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596689|NCT03315676|Esomeprazole|esomeprazole|mesh-list
43596690|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43682125|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682126|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828440|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828441|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43828442|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43639146|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596695|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43596696|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43596697|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43601869|NCT03260556|Pirfenidone|pirfenidone|mesh-list
43596714|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596715|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596716|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43596717|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
43596725|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43596726|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
43596727|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
43596728|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596729|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
43596730|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
43596732|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43596733|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596734|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43596735|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596736|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596737|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43596738|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43596739|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
43596740|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596741|NCT03315364|Paclitaxel|paclitaxel|mesh-list
43596742|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43596743|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43596744|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596745|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
43685890|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685891|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
43685892|NCT02832999|Liraglutide|liraglutide|mesh-list
43596746|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
43601870|NCT03260556|Analgesics|analgesics|mesh-ancestor
43596760|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
43596761|NCT03315312|Protective Agents|protective agents|mesh-ancestor
43596762|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596764|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596765|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596766|NCT03315078|Busulfan|busulfan|mesh-list
43596767|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
43596768|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596769|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596770|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
43596773|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596774|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43596775|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
43596777|NCT03315052|Budesonide|budesonide|mesh-list
43596778|NCT03315052|Tacrolimus|tacrolimus|mesh-list
43596779|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596780|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
43596781|NCT03315052|Hormones|hormones|mesh-ancestor
43596782|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596783|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596784|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596789|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596790|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596791|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43596792|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43596793|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
43828443|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828444|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43828445|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828446|NCT05477004|Ketamine|ketamine|mesh-list
43828447|NCT05477004|Analgesics|analgesics|mesh-ancestor
43828448|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
43828449|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685893|NCT02832999|Vildagliptin|vildagliptin|mesh-list
43685897|NCT02832999|Hormones|hormones|mesh-ancestor
43828450|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828451|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43828452|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43828453|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
43828454|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
43596794|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43596795|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596816|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596817|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596818|NCT03314792|Analgesics|analgesics|mesh-ancestor
43596819|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
43596820|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596821|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43596822|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43596823|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596824|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596827|NCT03314740|Paclitaxel|paclitaxel|mesh-list
43596828|NCT03314740|Olaparib|olaparib|mesh-list
43596829|NCT03314740|Cediranib|cediranib|mesh-list
43596830|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43596831|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596832|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
43596833|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
43596834|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
43596835|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596836|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43596837|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596838|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43596839|NCT03314636|Dexamethasone|dexamethasone|mesh-list
43596840|NCT03314636|Lenalidomide|lenalidomide|mesh-list
43596841|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596842|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
43596843|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
43596844|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828455|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685905|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43828456|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43828457|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43828458|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828459|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828461|NCT05476991|Colchicine|colchicine|mesh-list
43682127|NCT01351766|Nicotine|nicotine|mesh-list
43682128|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43828734|NCT05472259|Leucovorin|leucovorin|mesh-list
43828735|NCT05472259|Fluorouracil|fluorouracil|mesh-list
43828736|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
43828737|NCT05472259|Irinotecan|irinotecan|mesh-list
43828738|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
43828739|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828740|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43828741|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828742|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43828743|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
43828744|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828745|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43828746|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43828747|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828748|NCT05472259|Antidotes|antidotes|mesh-ancestor
43828749|NCT05472259|Protective Agents|protective agents|mesh-ancestor
43828750|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
43828752|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
43828753|NCT05471947|Glycolic acid|glycolic acid|mesh-list
43828754|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
43828755|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
43828756|NCT05471661|PENTA|penta|mesh-list
43685923|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
43682129|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
43682130|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682131|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682132|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43682133|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43682134|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
43682135|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596845|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596846|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43596847|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
43596848|NCT03314636|Hormones|hormones|mesh-ancestor
43596849|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596850|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596851|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596852|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
43596853|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43596854|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43596855|NCT03314636|Growth Substances|growth substances|mesh-ancestor
43596856|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
43685924|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
43685925|NCT02832726|Vitamins|vitamins|mesh-ancestor
43685926|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
43596865|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
43596866|NCT03314298|Anastrozole|anastrozole|mesh-list
43596867|NCT03314298|Testosterone|testosterone|mesh-list
43596870|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43596871|NCT03314298|Androgens|androgens|mesh-ancestor
43596872|NCT03314298|Hormones|hormones|mesh-ancestor
43596873|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596874|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685927|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685928|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
43685929|NCT02832726|Hematinics|hematinics|mesh-ancestor
43685930|NCT02832635|Temozolomide|temozolomide|mesh-list
43685931|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43685932|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
43685933|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685942|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43596875|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596876|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596877|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
43596878|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43596879|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43596880|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596881|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596882|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43596883|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
43596884|NCT03314259|Tamsulosin|tamsulosin|mesh-list
43596885|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43596886|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43596887|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43596888|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
43596889|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682136|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682137|NCT01340430|Trastuzumab|trastuzumab|mesh-list
43682138|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43682139|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682140|NCT01199380|Nicotine|nicotine|mesh-list
43682141|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43682142|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
43682143|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682144|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682145|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43596890|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596891|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596892|NCT03314259|Urological Agents|urological agents|mesh-ancestor
43596893|NCT03314064|Dolutegravir|dolutegravir|mesh-list
43596894|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43596895|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43596896|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596897|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596898|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43596899|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43596900|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
43596901|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43596902|NCT03314025|Tamsulosin|tamsulosin|mesh-list
43596903|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43596904|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43596905|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43596906|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
43596907|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596908|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596909|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596910|NCT03314025|Urological Agents|urological agents|mesh-ancestor
43596911|NCT03313960|Insulin|insulin|mesh-list
43685943|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43685944|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
43685945|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685946|NCT02832596|Norepinephrine|norepinephrine|mesh-list
43685947|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43685948|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43685949|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
43685950|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685951|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604796|NCT03234699|Warfarin|warfarin|mesh-list
43596912|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43596913|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596914|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
43596915|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43596916|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
43596917|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596918|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
43596919|NCT03313934|Protective Agents|protective agents|mesh-ancestor
43596920|NCT03313869|Vitamin E|vitamin e|mesh-list
43596921|NCT03313869|Selenium|selenium|mesh-list
43596922|NCT03313869|Vitamins|vitamins|mesh-ancestor
43596926|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596929|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
43596930|NCT03313856|Antacids|antacids|mesh-ancestor
43596931|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596932|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43849127|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43596933|NCT03313791|Caseins|caseins|mesh-list
43596934|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
43596935|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
43596936|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596937|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
43596938|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43596939|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596940|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43596941|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596942|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43596943|NCT03313726|Hormones|hormones|mesh-ancestor
43596944|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682146|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43682147|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
43682148|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682149|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682150|NCT01064635|Letrozole|letrozole|mesh-list
43682151|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682152|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43682153|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43682154|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682155|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682156|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43682157|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
43596945|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596946|NCT03313661|Gliclazide|gliclazide|mesh-list
43596947|NCT03313661|Cabergoline|cabergoline|mesh-list
43596948|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43596949|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43596950|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
43596951|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
43596952|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596953|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596954|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596955|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43596957|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596958|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596959|NCT03313544|Nivolumab|nivolumab|mesh-list
43596960|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43596961|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596962|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43596963|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596964|NCT03313531|Thrombin|thrombin|mesh-list
43596965|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
43596966|NCT03313531|Coagulants|coagulants|mesh-ancestor
43596990|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596991|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
43596992|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597004|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43682158|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682159|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682160|NCT00930228|Flutamide|flutamide|mesh-list
43682161|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
43682162|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
43682163|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682164|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682165|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43682166|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682167|NCT00929006|Progesterone|progesterone|mesh-list
43682168|NCT00929006|Progestins|progestins|mesh-ancestor
43682169|NCT00929006|Hormones|hormones|mesh-ancestor
43682170|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682171|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682172|NCT00877214|Rituximab|rituximab|mesh-list
43682173|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43682174|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682175|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
43682176|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682177|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682178|NCT00810017|Trastuzumab|trastuzumab|mesh-list
43682179|NCT00810017|Etoposide|etoposide|mesh-list
43682180|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43682181|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597005|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597007|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597008|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597009|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
43597010|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
43597011|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597012|NCT03312777|Tramadol|tramadol|mesh-list
43597013|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43597014|NCT03312777|Narcotics|narcotics|mesh-ancestor
43597015|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597016|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597017|NCT03312777|Analgesics|analgesics|mesh-ancestor
43597018|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
43597019|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597020|NCT03312582|Metformin|metformin|mesh-list
43597021|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43597022|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597023|NCT03312530|Atezolizumab|atezolizumab|mesh-list
43597024|NCT03312530|Venetoclax|venetoclax|mesh-list
43597025|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597026|NCT03312478|Antibodies|antibodies|mesh-list
43597027|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597028|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
43597029|NCT03312426|Linrodostat|linrodostat|mesh-list
43597030|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682182|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43682183|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43602198|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
43682191|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
43682192|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682193|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682195|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
43682196|NCT00433420|Fluorouracil|fluorouracil|mesh-list
43682197|NCT00433420|Epirubicin|epirubicin|mesh-list
43682198|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43682199|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682200|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
43682201|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
43682202|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
43682203|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682204|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43597031|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597033|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43597034|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597035|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597036|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43597037|NCT03312413|Analgesics|analgesics|mesh-ancestor
43597038|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
43597039|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597040|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43597041|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43597042|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43597045|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597046|NCT03312335|Aldesleukin|aldesleukin|mesh-list
43597047|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597048|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43597049|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43597050|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
43597051|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597052|NCT03312283|Ranibizumab|ranibizumab|mesh-list
43597053|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43597054|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43597060|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43597061|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
43682205|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
43682206|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682207|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682208|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43682209|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
43682210|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43685957|NCT02832089|Carvedilol|carvedilol|mesh-list
43682211|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
43682212|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43682213|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43682214|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43682215|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43682216|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682218|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
43682219|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
43682220|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43682221|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43682222|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682223|NCT02850250|Cefuroxime|cefuroxime|mesh-list
43682224|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
43682225|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631602|NCT03043495|Hormones|hormones|mesh-ancestor
43631603|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631604|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43631605|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631606|NCT03043157|Rocuronium|rocuronium|mesh-list
43631607|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43631608|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43685958|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43685959|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43685960|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
43685961|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685962|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685963|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685964|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43685965|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
43685966|NCT02832089|Protective Agents|protective agents|mesh-ancestor
43685967|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43685968|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43685969|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43682226|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682227|NCT02850445|Olanzapine|olanzapine|mesh-list
43682228|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
43682229|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
43682230|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682231|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682232|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682233|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43682252|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682253|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682254|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43682255|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682256|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682257|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43682258|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43682259|NCT02850211|Narcotics|narcotics|mesh-ancestor
43682260|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682261|NCT02850289|Interferons|interferons|mesh-list
43682262|NCT02850289|Ribavirin|ribavirin|mesh-list
43682263|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682264|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
43682265|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682266|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
43682267|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682268|NCT02850484|Budesonide|budesonide|mesh-list
43597072|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43685970|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
43685971|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43685972|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43685973|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43685974|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685975|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685976|NCT02831972|Itraconazole|itraconazole|mesh-list
43685977|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
43685978|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685979|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43685980|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43597073|NCT03312153|Eusol|eusol|mesh-list
43597074|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
43597075|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597076|NCT03312140|Choline|choline|mesh-list
43597077|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
43597078|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43597079|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
43597080|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849128|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597081|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43597097|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597098|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597099|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
43597100|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43597101|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43597102|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597103|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43597104|NCT03311945|Lamivudine|lamivudine|mesh-list
43597105|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
43597106|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43597107|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43597108|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597109|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597110|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
43597111|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597112|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43597113|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43597114|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43597115|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43597116|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
43597117|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43597118|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
43597119|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597120|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
43597121|NCT03311906|Protective Agents|protective agents|mesh-ancestor
43597122|NCT03311789|Gemcitabine|gemcitabine|mesh-list
43597123|NCT03311789|Cisplatin|cisplatin|mesh-list
43597141|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597142|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597150|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43597151|NCT03311581|Propofol|propofol|mesh-list
43597152|NCT03311581|Sevoflurane|sevoflurane|mesh-list
43597153|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43597154|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597155|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597156|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43597158|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
43597159|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43597160|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43685981|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685982|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685983|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43685985|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685986|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685987|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43685989|NCT02831933|Nivolumab|nivolumab|mesh-list
43685990|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43685991|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597161|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
43597162|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597163|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597164|NCT03311516|Insulin|insulin|mesh-list
43597165|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43597166|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43597167|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597168|NCT03311464|Adalimumab|adalimumab|mesh-list
43685992|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43685993|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685994|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
43685995|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685996|NCT02831842|Bevacizumab|bevacizumab|mesh-list
43685997|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43682277|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
43685998|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682278|NCT02850484|Hormones|hormones|mesh-ancestor
43682279|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682280|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43682281|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43682282|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43682283|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
43597169|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43597170|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43597171|NCT03311425|Dexamethasone|dexamethasone|mesh-list
43597172|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
43602199|NCT03257514|Vitamins|vitamins|mesh-ancestor
43597175|NCT03311425|Prednisolone|prednisolone|mesh-list
43597176|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
43597177|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43597178|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
43597179|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43597180|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
43597181|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
43597182|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597183|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597192|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43597193|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43597194|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43597195|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597197|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
43597198|NCT03311321|Vitamin MK 7|vitamin mk 7|mesh-list
43597199|NCT03311321|Vitamins|vitamins|mesh-ancestor
43597200|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
43597201|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597202|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43597203|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43597204|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597205|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
43597206|NCT03311321|Coagulants|coagulants|mesh-ancestor
43597207|NCT03311178|Dobutamine|dobutamine|mesh-list
43597208|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43597209|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
43597210|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
43597211|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597212|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597213|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43597214|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43597215|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43597216|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
43597217|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597218|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597219|NCT03311178|Protective Agents|protective agents|mesh-ancestor
43597220|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43597221|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43597222|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597223|NCT03311022|Nefopam|nefopam|mesh-list
43597224|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43597225|NCT03311022|Analgesics|analgesics|mesh-ancestor
43597226|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
43682284|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682285|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682286|NCT02849873|Tazarotene|tazarotene|mesh-list
43682287|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
43682288|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
43682289|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
43682290|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43682291|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682292|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828462|NCT05476991|Ticagrelor|ticagrelor|mesh-list
43828463|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43597227|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597228|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597229|NCT03310762|Silicon|silicon|mesh-list
43597230|NCT03310762|Trace Elements|trace elements|mesh-ancestor
43597231|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
43597232|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597233|NCT03310749|Metformin|metformin|mesh-list
43597235|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597236|NCT03310736|Hepcidins|hepcidins|mesh-list
43597237|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597270|NCT03310047|Lidocaine|lidocaine|mesh-list
43597271|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
43597272|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
43597273|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597274|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597275|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
43597276|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597277|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43597278|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43597279|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43685999|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43686000|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43686001|NCT02831842|Growth Substances|growth substances|mesh-ancestor
43686002|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686003|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
43686004|NCT02831751|Vaccines|vaccines|mesh-list
43597280|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597281|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597283|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43597284|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
43597285|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43597286|NCT03309735|Progesterone|progesterone|mesh-list
43597287|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
43597288|NCT03309735|Progestins|progestins|mesh-ancestor
43597290|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597291|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828464|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828465|NCT05476991|Analgesics|analgesics|mesh-ancestor
43828466|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
43828467|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682293|NCT02849483|Ramosetron|ramosetron|mesh-list
43682294|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
43682295|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
43682296|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682297|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682298|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682299|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43682300|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
43682301|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682302|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597292|NCT03309709|Progesterone|progesterone|mesh-list
43597293|NCT03309709|Progestins|progestins|mesh-ancestor
43597294|NCT03309709|Hormones|hormones|mesh-ancestor
43597295|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597296|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597298|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43597299|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597300|NCT03309644|Trace Elements|trace elements|mesh-ancestor
43597301|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
43686040|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43686045|NCT02831205|Cobalt|cobalt|mesh-list
43597302|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597303|NCT03309618|Valsartan|valsartan|mesh-list
43597304|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43597305|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43597306|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43597307|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597308|NCT03309592|Ambrisentan|ambrisentan|mesh-list
43597309|NCT03309592|Tadalafil|tadalafil|mesh-list
43597310|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
43597311|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43597312|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43597313|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597314|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597315|NCT03309592|Urological Agents|urological agents|mesh-ancestor
43597316|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43597317|NCT03309566|Tenofovir|tenofovir|mesh-list
43597318|NCT03309566|Emtricitabine|emtricitabine|mesh-list
43597319|NCT03309566|Efavirenz|efavirenz|mesh-list
43597327|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43597328|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43597329|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43597330|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43597331|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43597332|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43597333|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43597334|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
43686069|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686071|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43686074|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
43686086|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686087|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686088|NCT02831101|Analgesics|analgesics|mesh-ancestor
43686089|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
43686090|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686091|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43686092|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43597335|NCT03309527|Promethazine|promethazine|mesh-list
43597336|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43597337|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43597338|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597339|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597340|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
43597341|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
43597342|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
43597343|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597344|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
43597345|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
43597346|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682304|NCT02849730|Analgesics|analgesics|mesh-list
43682305|NCT02849730|Ropivacaine|ropivacaine|mesh-list
43682306|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
43682307|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
43682308|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682309|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682310|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
43682311|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682312|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43682313|NCT02849730|Narcotics|narcotics|mesh-ancestor
43682314|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43682315|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43682316|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
43682317|NCT02849548|Suvorexant|suvorexant|mesh-list
43682318|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43682319|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43682320|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682321|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682322|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43682323|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682324|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682325|NCT02849236|Ropivacaine|ropivacaine|mesh-list
43682326|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
43682327|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
43682328|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631640|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43631641|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43631642|NCT03043027|Bupivacaine|bupivacaine|mesh-list
43631643|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
43631644|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
43631645|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631646|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631647|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
43631648|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631649|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43631650|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43631651|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631652|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
43631653|NCT03042871|Ranibizumab|ranibizumab|mesh-list
43631654|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43631655|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43631656|NCT03042871|Growth Substances|growth substances|mesh-ancestor
43631657|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631658|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
43631659|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631660|NCT03042546|Calcium|calcium|mesh-list
43604940|NCT03233152|Nivolumab|nivolumab|mesh-list
43682329|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682330|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
43682331|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682332|NCT02848963|Ketamine|ketamine|mesh-list
43682333|NCT02848963|Propofol|propofol|mesh-list
43682334|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43682335|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682336|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682337|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43682338|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
43682339|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
43682340|NCT02848963|Analgesics|analgesics|mesh-ancestor
43682341|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
43682342|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682343|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43682344|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43682345|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43682346|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682347|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682348|NCT02848937|Citric Acid|citric acid|mesh-list
43682349|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
43682350|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
43682351|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43682352|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
43682354|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682355|NCT02848950|Metformin|metformin|mesh-list
43682356|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682357|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682358|NCT02849132|Entecavir|entecavir|mesh-list
43682359|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
43682360|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682361|NCT02848612|Heparin|heparin|mesh-list
43682362|NCT02848612|Calcium heparin|calcium heparin|mesh-list
43682363|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
43682364|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43682365|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43682366|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631661|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43631662|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631663|NCT03042637|Tacrolimus|tacrolimus|mesh-list
43631665|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
43631666|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631667|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43631668|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686131|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43682367|NCT02848794|Irinotecan|irinotecan|mesh-list
43682368|NCT02848794|Apatinib|apatinib|mesh-list
43682369|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43682370|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43682371|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597347|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43597348|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
43597349|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
43597350|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597351|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597352|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43597353|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
43597354|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
43597355|NCT03309436|Clomiphene|clomiphene|mesh-list
43597356|NCT03309436|Enclomiphene|enclomiphene|mesh-list
43597357|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
43597358|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43682372|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682373|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682374|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43682375|NCT02848768|Sunitinib|sunitinib|mesh-list
43682376|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597367|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
43597368|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43597369|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597371|NCT03309215|Trace Elements|trace elements|mesh-ancestor
43597372|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
43597373|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597374|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43597375|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
43597376|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43597377|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43597378|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43597379|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
43597380|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43597381|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597382|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43597383|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43597384|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43597385|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43597394|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
43597395|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597396|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43597397|NCT03309163|Narcotics|narcotics|mesh-ancestor
43597398|NCT03309163|Analgesics|analgesics|mesh-ancestor
43597399|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
43597400|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
43597401|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
43597402|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43597403|NCT03309059|Protective Agents|protective agents|mesh-ancestor
43597404|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597405|NCT03308955|Tramadol|tramadol|mesh-list
43597406|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43597407|NCT03308955|Narcotics|narcotics|mesh-ancestor
43597408|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597409|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597410|NCT03308955|Analgesics|analgesics|mesh-ancestor
43686132|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43597411|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
43597412|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597414|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
43597415|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597416|NCT03308708|Norepinephrine|norepinephrine|mesh-list
43597417|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43597418|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43597419|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
43597420|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597421|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682381|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
43682382|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43682383|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682384|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686133|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43682385|NCT02848508|Metformin|metformin|mesh-list
43682386|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682387|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682388|NCT02848443|Trifluridine|trifluridine|mesh-list
43682389|NCT02848443|Bevacizumab|bevacizumab|mesh-list
43682390|NCT02848443|Nivolumab|nivolumab|mesh-list
43682391|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
43682392|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43682393|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682394|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43682395|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43682396|NCT02848443|Growth Substances|growth substances|mesh-ancestor
43682397|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682398|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
43682399|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43682400|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682401|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
43682402|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
43682403|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682404|NCT02848183|Cytarabine|cytarabine|mesh-list
43682405|NCT02848183|Etoposide|etoposide|mesh-list
43682406|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
43682407|NCT02848183|Idarubicin|idarubicin|mesh-list
43682408|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43597422|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597423|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
43597424|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
43597425|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597426|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43597427|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
43597428|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43597429|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597430|NCT03308643|Oxytocin|oxytocin|mesh-list
43597431|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
43597432|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43597433|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597434|NCT03308604|Cisplatin|cisplatin|mesh-list
43597435|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686134|NCT02830906|Ondansetron|ondansetron|mesh-list
43686135|NCT02830906|Ramosetron|ramosetron|mesh-list
43686136|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
43686148|NCT02830906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43686149|NCT02830906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686150|NCT02830906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43686151|NCT02830906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43597437|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43597438|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43597439|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597440|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
43597441|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
43597442|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
43597443|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682409|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682410|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43682411|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43682412|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682413|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682414|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43682415|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
43682416|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
43682417|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682418|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43682419|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
43682420|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682422|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
43682423|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682424|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43597444|NCT03308487|Vitamin D|vitamin d|mesh-list
43597445|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
43597446|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
43597447|NCT03308487|Vitamins|vitamins|mesh-list
43597448|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
43597449|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597450|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43597451|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43597452|NCT03308357|Infliximab|infliximab|mesh-list
43597453|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
43597454|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43597455|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43597456|NCT03308331|Nicotine|nicotine|mesh-list
43597457|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43597469|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597471|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43597472|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597473|NCT03308201|Letrozole|letrozole|mesh-list
43597474|NCT03308201|Fulvestrant|fulvestrant|mesh-list
43597475|NCT03308201|Exemestane|exemestane|mesh-list
43597476|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597477|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43597478|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43597479|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597480|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597481|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43597482|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
43597483|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597484|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597485|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43597486|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43597487|NCT03308149|Triamcinolone|triamcinolone|mesh-list
43597488|NCT03308149|Bupivacaine|bupivacaine|mesh-list
43597489|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
43597490|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
43597491|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597494|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597495|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682426|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43682427|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682428|NCT02848417|Analgesics|analgesics|mesh-ancestor
43682429|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
43682430|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682431|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682432|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682433|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682434|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682435|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682436|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682437|NCT02848209|Phenol|phenol|mesh-list
43682438|NCT02848209|Croton Oil|croton oil|mesh-list
43682439|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43682440|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682441|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
43682442|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43682443|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43597496|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
43597497|NCT03308149|Hormones|hormones|mesh-ancestor
43597498|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597499|NCT03308136|Lidocaine|lidocaine|mesh-list
43597500|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
43597501|NCT03308136|Anesthetics|anesthetics|mesh-list
43597502|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597503|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597504|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
43597505|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597506|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43597507|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43597508|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43597509|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597510|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597511|NCT03308084|Dexamethasone|dexamethasone|mesh-list
43597512|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
43597513|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43597514|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43597515|NCT03308084|Prednisolone|prednisolone|mesh-list
43597516|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
43597517|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43597518|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
43597519|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43597520|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
43597522|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597523|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597524|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43597525|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
43597526|NCT03308084|Hormones|hormones|mesh-ancestor
43597527|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597528|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43597529|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828767|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43828768|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828769|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43828770|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828771|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828772|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43828773|NCT05471544|Renal Agents|renal agents|mesh-ancestor
43828774|NCT05470673|Metronidazole|metronidazole|mesh-list
43828775|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828776|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43828777|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43828778|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43828779|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
43828780|NCT05470283|Fludarabine|fludarabine|mesh-list
43828781|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
43828783|NCT05470283|Acetazolamide|acetazolamide|mesh-list
43828784|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43828785|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
43828786|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597530|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43597531|NCT03308084|Protective Agents|protective agents|mesh-ancestor
43597533|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
43597534|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
43682444|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
43682445|NCT02848300|Bimatoprost|bimatoprost|mesh-list
43682446|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43682447|NCT02848170|Olmesartan|olmesartan|mesh-list
43682448|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43682449|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43682450|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43682459|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682461|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682462|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43682463|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43682464|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682465|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43682466|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43682467|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682468|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
43682469|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
43682470|NCT02848157|Ropivacaine|ropivacaine|mesh-list
43682471|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43682472|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597535|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597536|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43597537|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597538|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43597539|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
43828808|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
43828809|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597540|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597542|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43597543|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
43597544|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597545|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597546|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
43597547|NCT03307863|Topiramate|topiramate|mesh-list
43597548|NCT03307863|Carbamazepine|carbamazepine|mesh-list
43597549|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
43686161|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
43686162|NCT02831023|Piperaquine|piperaquine|mesh-list
43682473|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682474|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682475|NCT02848157|Analgesics|analgesics|mesh-ancestor
43682476|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
43682477|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686163|NCT02831023|Primaquine|primaquine|mesh-list
43686164|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
43686166|NCT02831023|Amodiaquine|amodiaquine|mesh-list
43686168|NCT02831023|Methylene Blue|methylene blue|mesh-list
43686169|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
43686170|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43686171|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43686172|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686173|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43686174|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686175|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686176|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43686177|NCT02831023|Renal Agents|renal agents|mesh-ancestor
43686178|NCT02830932|Vaccines|vaccines|mesh-list
43686179|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
43686180|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686181|NCT02830347|Amoxicillin|amoxicillin|mesh-list
43682478|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43597550|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43597551|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597552|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
43597553|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43597554|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597555|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43597556|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43597557|NCT03307863|Analgesics|analgesics|mesh-ancestor
43597558|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
43597559|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597560|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43597561|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597562|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686182|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43686183|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686184|NCT02830230|Azithromycin|azithromycin|mesh-list
43597563|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43597564|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43597565|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43597566|NCT03307720|Hormones|hormones|mesh-list
43597567|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597568|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597569|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43597570|NCT03307603|Nivolumab|nivolumab|mesh-list
43597571|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597572|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597573|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43597574|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597575|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
43597576|NCT03307590|Bupivacaine|bupivacaine|mesh-list
43597577|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
43597578|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
43597579|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597580|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597581|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
43597582|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597583|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43597584|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43597585|NCT03307590|Analgesics|analgesics|mesh-ancestor
43597586|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43597617|NCT03307148|Tretinoin|tretinoin|mesh-list
43597618|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43597619|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597620|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
43597621|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
43597622|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
43597623|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597624|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43597625|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
43597631|NCT03307148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597632|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
43597633|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
43597634|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
43597635|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43682489|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682490|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682491|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
43682492|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682493|NCT02847884|Infliximab|infliximab|mesh-list
43682494|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
43682495|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682496|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828468|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682497|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
43682498|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682499|NCT02847806|Insulin|insulin|mesh-list
43682500|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43682501|NCT02847806|Estradiol|estradiol|mesh-list
43597636|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43597637|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43597638|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597639|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597640|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
43597641|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597642|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597672|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43597673|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597674|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686196|NCT02830048|Glyburide|glyburide|mesh-list
43686197|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43597675|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
43597676|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597677|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597679|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43597680|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43597681|NCT03306550|Analgesics|analgesics|mesh-ancestor
43597682|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
43597683|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597684|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597685|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43597686|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43597687|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43597688|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43597689|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682502|NCT02847806|Testosterone|testosterone|mesh-list
43682503|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682504|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682505|NCT02847806|Estrogens|estrogens|mesh-ancestor
43682506|NCT02847806|Hormones|hormones|mesh-ancestor
43682507|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682508|NCT02847806|Androgens|androgens|mesh-ancestor
43682509|NCT02847702|Naproxen|naproxen|mesh-list
43682510|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43682511|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682512|NCT02847702|Analgesics|analgesics|mesh-ancestor
43682513|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
43682514|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682515|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682516|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682517|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682518|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
43682519|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43682520|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682521|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682522|NCT02847442|Levodopa|levodopa|mesh-list
43597690|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43597691|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43597692|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597693|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
43686198|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686199|NCT02830126|Anesthetics|anesthetics|mesh-list
43686200|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686201|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686202|NCT02829879|Listerine|listerine|mesh-list
43686203|NCT02829879|Fluorides|fluorides|mesh-list
43686204|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
43686205|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
43686206|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
43686207|NCT02829879|Protective Agents|protective agents|mesh-ancestor
43686208|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597694|NCT03306472|Letrozole|letrozole|mesh-list
43597695|NCT03306472|Megestrol|megestrol|mesh-list
43597696|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
43597697|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597698|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43597699|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43597700|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597701|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686209|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43686210|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686211|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
43686212|NCT02829957|Apixaban|apixaban|mesh-list
43597702|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43597703|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
43597704|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597705|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597706|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43597707|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43597708|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43597709|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
43597710|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43597711|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43597712|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43597713|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43597714|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
43597715|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43597716|NCT03306446|Adalimumab|adalimumab|mesh-list
43597720|NCT03306368|Narcotics|narcotics|mesh-ancestor
43597721|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597722|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682524|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
43682525|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
43682526|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43682527|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43682528|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
43682529|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682530|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682531|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682532|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43682533|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682534|NCT02847455|Rabeprazole|rabeprazole|mesh-list
43682535|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43682536|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682537|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43682538|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682539|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682540|NCT02847429|Crenolanib|crenolanib|mesh-list
43682541|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686213|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43631685|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43631686|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43631687|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43631688|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43686214|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
43686215|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43686216|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
43686217|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686218|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686219|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
43686221|NCT02830139|Capecitabine|capecitabine|mesh-list
43686222|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
43686223|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686224|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43686225|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
43686226|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682542|NCT02847403|Exenatide|exenatide|mesh-list
43682543|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682544|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682545|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43682546|NCT02847403|Incretins|incretins|mesh-ancestor
43682547|NCT02847403|Hormones|hormones|mesh-ancestor
43682548|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682549|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43682550|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43597724|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
43597725|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597726|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43597727|NCT03306290|Cefoxitin|cefoxitin|mesh-list
43597728|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597729|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
43597730|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43597731|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43597732|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43597733|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597734|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597735|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
43597736|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597737|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597738|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43597739|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597741|NCT03305978|Selamectin|selamectin|mesh-list
43597742|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43682551|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682552|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
43682553|NCT02847338|Amlodipine|amlodipine|mesh-list
43682554|NCT02847338|Lisinopril|lisinopril|mesh-list
43682555|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
43682556|NCT02847338|Amiloride|amiloride|mesh-list
43682557|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43682558|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43682559|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682560|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686227|NCT02829840|Azacitidine|azacitidine|mesh-list
43686228|NCT02829840|Ponatinib|ponatinib|mesh-list
43682561|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43682562|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597744|NCT03305536|Vitamin D|vitamin d|mesh-list
43597745|NCT03305536|Vitamins|vitamins|mesh-list
43597746|NCT03305536|Vitamin K|vitamin k|mesh-list
43597747|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
43597748|NCT03305536|Vitamin MK 7|vitamin mk 7|mesh-list
43597749|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
43597750|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597751|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43597752|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43597753|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43597754|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597755|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
43597756|NCT03305536|Coagulants|coagulants|mesh-ancestor
43597757|NCT03305510|Vitamin D|vitamin d|mesh-list
43597758|NCT03305510|Vitamins|vitamins|mesh-ancestor
43686229|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43686230|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
43686231|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597759|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
43597760|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597761|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43597762|NCT03305471|Sevelamer|sevelamer|mesh-list
43597763|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
43597764|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
43597765|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597766|NCT03305445|Nivolumab|nivolumab|mesh-list
43597767|NCT03305445|Ipilimumab|ipilimumab|mesh-list
43597768|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597769|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597770|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43597771|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597772|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
43597773|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
43597774|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43597775|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43597776|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597777|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597778|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597779|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43597780|NCT03305068|Celecoxib|celecoxib|mesh-list
43597781|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43597782|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43597783|NCT03305068|Analgesics|analgesics|mesh-ancestor
43686232|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597784|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
43597785|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597786|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597787|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43597788|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43597789|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43597790|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43597795|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43597796|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597797|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682563|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
43682564|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43682565|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
43686263|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686264|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
43686265|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43686266|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43686267|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686268|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
43686269|NCT02829346|Coagulants|coagulants|mesh-ancestor
43686270|NCT02829333|Anesthetics|anesthetics|mesh-list
43686271|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686272|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686273|NCT02829697|Ropivacaine|ropivacaine|mesh-list
43686274|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
43686275|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
43686276|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682566|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682567|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43682568|NCT02847338|Protective Agents|protective agents|mesh-ancestor
43682569|NCT02847338|Diuretics|diuretics|mesh-ancestor
43682570|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
43682571|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43682572|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43682574|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43682575|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43682576|NCT02847104|Insulin|insulin|mesh-list
43682577|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43682578|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682579|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682580|NCT02847013|Bupivacaine|bupivacaine|mesh-list
43597798|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
43597799|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
43597800|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597801|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597802|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
43597803|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43597804|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
43597805|NCT03304457|Olanzapine|olanzapine|mesh-list
43597806|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43597807|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
43597808|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
43597809|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597810|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597811|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43597812|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43597813|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43597814|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597815|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43597816|NCT03304457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43686277|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686278|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
43686279|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686280|NCT02829151|Aspirin|aspirin|mesh-list
43597817|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43597818|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597819|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597820|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597821|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
43597822|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43597823|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43597824|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43597825|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
43597826|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43597827|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43597828|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43597829|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43597830|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
43597831|NCT03304444|Bupivacaine|bupivacaine|mesh-list
43597832|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
43597833|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
43597834|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597835|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682581|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
43682582|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
43682583|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682584|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682585|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
43682586|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597836|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
43597837|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597838|NCT03304431|Lidocaine|lidocaine|mesh-list
43686281|NCT02829151|Cilostazol|cilostazol|mesh-list
43597839|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
43597841|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686311|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43686312|NCT02829177|Allopurinol|allopurinol|mesh-list
43686313|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
43686314|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686315|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686316|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
43686317|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686318|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43686319|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
43686320|NCT02829177|Protective Agents|protective agents|mesh-ancestor
43686321|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686322|NCT02829281|Triamcinolone|triamcinolone|mesh-list
43686323|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43631695|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
43597842|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597843|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
43597844|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597845|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43597846|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43597847|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43597848|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597849|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597850|NCT03304288|Rituximab|rituximab|mesh-list
43597851|NCT03304288|Tretinoin|tretinoin|mesh-list
43597852|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597853|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597854|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
43597855|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597856|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43597857|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
43597858|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
43597859|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43597860|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597869|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597871|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43597872|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597873|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43597874|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597875|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597877|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
43597878|NCT03303677|Gentamicins|gentamicins|mesh-list
43597879|NCT03303677|Mupirocin|mupirocin|mesh-list
43597880|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43597885|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43597886|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
43597887|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597888|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597889|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43597890|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
43597891|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
43597893|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597894|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597895|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43597896|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43597897|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597898|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597899|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597900|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43597901|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43597902|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43597903|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43597904|NCT03303677|Renal Agents|renal agents|mesh-ancestor
43597905|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
43597906|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43597907|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43682587|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
43682588|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682589|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682590|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43682591|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682592|NCT02846909|Progesterone|progesterone|mesh-list
43682593|NCT02846909|Progestins|progestins|mesh-ancestor
43682596|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682597|NCT02846935|Decitabine|decitabine|mesh-list
43682598|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
43682599|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43597908|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43597909|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43597910|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43597911|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
43597912|NCT03303651|Narcotics|narcotics|mesh-ancestor
43597913|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597914|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597915|NCT03303651|Analgesics|analgesics|mesh-ancestor
43597916|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
43597917|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597918|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
43597919|NCT03303573|Hematinics|hematinics|mesh-ancestor
43597920|NCT03303495|Leucovorin|leucovorin|mesh-list
43597921|NCT03303495|Bevacizumab|bevacizumab|mesh-list
43597922|NCT03303495|Fluorouracil|fluorouracil|mesh-list
43597923|NCT03303495|Irinotecan|irinotecan|mesh-list
43597924|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597925|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597926|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43597927|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43631711|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
43631712|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631713|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631714|NCT03042260|Trimethoprim|trimethoprim|mesh-list
43631715|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43828820|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828821|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828822|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597937|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43597938|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597939|NCT03303495|Antidotes|antidotes|mesh-ancestor
43597940|NCT03303495|Protective Agents|protective agents|mesh-ancestor
43597941|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
43597942|NCT03303495|Vitamins|vitamins|mesh-ancestor
43597943|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
43597944|NCT03303378|Melatonin|melatonin|mesh-list
43597945|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
43597946|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597947|NCT03303378|Protective Agents|protective agents|mesh-ancestor
43597948|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597949|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597950|NCT03303235|Methylergonovine|methylergonovine|mesh-list
43597951|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
43597952|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43597953|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597954|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
43597955|NCT03303209|Narcotics|narcotics|mesh-ancestor
43597956|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597957|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597958|NCT03303209|Analgesics|analgesics|mesh-ancestor
43597959|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
43597960|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597961|NCT03303053|Prednisolone|prednisolone|mesh-list
43597962|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
43597963|NCT03303053|Carbimazole|carbimazole|mesh-list
43597964|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43597965|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
43597966|NCT03303053|Hormones|hormones|mesh-ancestor
43682600|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
43682601|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597975|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43597976|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
43597977|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
43597978|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
43597979|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43597980|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43597981|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43597982|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43597983|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597984|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
43597985|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597986|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597987|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43597988|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849130|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43597990|NCT03302845|Famotidine|famotidine|mesh-list
43828823|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
43597991|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43597992|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43597996|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43597997|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
43597999|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598000|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598001|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
43598002|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43598003|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598004|NCT03302689|Ropivacaine|ropivacaine|mesh-list
43598005|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
43598006|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43598007|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
43598008|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
43602200|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
43598009|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598010|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598012|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598014|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
43598015|NCT03302650|Giapreza|giapreza|mesh-list
43598016|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
43598017|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43598018|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43598019|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
43598020|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682609|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
43598021|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598022|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598023|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
43598024|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
43598025|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598026|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43598027|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43598028|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
43598029|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598030|NCT03302585|Vitamin D|vitamin d|mesh-list
43598031|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
43598032|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
43598033|NCT03302585|Vitamins|vitamins|mesh-list
43598034|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
43598035|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598036|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43598037|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43598038|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
43598039|NCT03302403|Fludarabine|fludarabine|mesh-list
43598040|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43598041|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
43598042|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598043|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598044|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43598045|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
43598046|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598047|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598048|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43598049|NCT03302390|Lidocaine|lidocaine|mesh-list
43598050|NCT03302390|Epinephrine|epinephrine|mesh-list
43598051|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
43598052|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
43598053|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598054|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598055|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
43598056|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598057|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43598058|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43598059|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43598060|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598061|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682611|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43682612|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
43682613|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43682614|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43682615|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682616|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682617|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43682618|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
43828824|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43828825|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43828826|NCT05469893|Growth Substances|growth substances|mesh-ancestor
43682619|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682620|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682621|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43682622|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43682623|NCT02847000|Decitabine|decitabine|mesh-list
43682624|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
43682625|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43682626|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
43682627|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682629|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682630|NCT02847143|Oxytocin|oxytocin|mesh-list
43682631|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
43682632|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43682633|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598062|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43598063|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43598064|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
43849133|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849135|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849136|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849137|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43849138|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849139|NCT03957681|Brodalumab|brodalumab|mesh-list
43849140|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
43598066|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43598067|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43598068|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
43598069|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43598070|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
43598076|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
43598077|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598078|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598079|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598080|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43682635|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43682636|NCT02846857|Glucagon|glucagon|mesh-list
43682637|NCT02846857|Hormones|hormones|mesh-list
43682638|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682639|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682640|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682641|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682642|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43598081|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43598082|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598083|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43598084|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43598085|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
43598086|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
43598087|NCT03302351|Ketamine|ketamine|mesh-list
43849141|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
43849142|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849143|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849144|NCT03956797|Anesthetics|anesthetics|mesh-list
43849145|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849146|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849147|NCT03956056|Poly I-C|poly i-c|mesh-list
43849148|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43849149|NCT03956056|Poly ICLC|poly iclc|mesh-list
43849150|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
43849151|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
43598088|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43598089|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828827|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
43598090|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598091|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598092|NCT03302351|Analgesics|analgesics|mesh-ancestor
43598093|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
43598094|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598095|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43598096|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43598097|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43598098|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
43598099|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598100|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598101|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43598102|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43598103|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
43598104|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
43598105|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43598106|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43598107|NCT03302299|Pyridoxine|pyridoxine|mesh-list
43598108|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
43598109|NCT03302299|Isoniazid|isoniazid|mesh-list
43598110|NCT03302299|Vitamins|vitamins|mesh-ancestor
43598111|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
43598112|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598113|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
43598154|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43598156|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43598157|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
43598158|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598159|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598160|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43598161|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
43598162|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
43598163|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43598164|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
43598165|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598166|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598167|NCT03302039|Phenylephrine|phenylephrine|mesh-list
43598168|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
43598169|NCT03302039|Bupivacaine|bupivacaine|mesh-list
43682643|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43682644|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43682645|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682646|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682647|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682648|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682649|NCT02846701|Analgesics|analgesics|mesh-ancestor
43682650|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
43682651|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682652|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
43682653|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43682654|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
43682656|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43682657|NCT02846831|Hormones|hormones|mesh-list
43682658|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43598170|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
43828832|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43598171|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
43598172|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598173|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598174|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
43598175|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598176|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43598177|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
43598178|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
43598179|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
43598180|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43598181|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
43598189|NCT03302039|Protective Agents|protective agents|mesh-ancestor
43598190|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43598191|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
43598192|NCT03301974|Coagulants|coagulants|mesh-ancestor
43598193|NCT03301766|Lidocaine|lidocaine|mesh-list
43598194|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
43849153|NCT03956056|Laxatives|laxatives|mesh-ancestor
43598195|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
43598196|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598197|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598198|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
43598199|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598200|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43598201|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43598202|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43598203|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598204|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598205|NCT03301454|Paclitaxel|paclitaxel|mesh-list
43598206|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43598208|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
43598209|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
43598210|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
43598211|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598212|NCT03301350|Paclitaxel|paclitaxel|mesh-list
43598213|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
43598214|NCT03301350|Carboplatin|carboplatin|mesh-list
43598215|NCT03301350|Doxorubicin|doxorubicin|mesh-list
43598216|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43598217|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598218|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
43682659|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682660|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682662|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682663|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43682664|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682665|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682666|NCT02846493|Dexamethasone|dexamethasone|mesh-list
43682667|NCT02846493|Bromocriptine|bromocriptine|mesh-list
43682668|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682669|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
43682670|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
43631727|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43682671|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682672|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682673|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682674|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
43682675|NCT02846493|Hormones|hormones|mesh-ancestor
43682676|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631753|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631754|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43686348|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686349|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43686350|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686351|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682677|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43682678|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682679|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43682680|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43598219|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
43598220|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
43598221|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598222|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43598223|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
43598224|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598225|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598226|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43598227|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
43598228|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43598229|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43598230|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43598231|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43598232|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598233|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
43598234|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43598235|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598236|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
43598237|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43598238|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43598239|NCT03301233|Estradiol|estradiol|mesh-list
43598240|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43598241|NCT03301233|Estrogens|estrogens|mesh-ancestor
43598242|NCT03301233|Hormones|hormones|mesh-ancestor
43598245|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43682682|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
43682683|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
43682684|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682685|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682686|NCT02846519|Rifampin|rifampin|mesh-list
43682687|NCT02846519|Esketamine|esketamine|mesh-list
43682688|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43682689|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
43682690|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43682706|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682707|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682708|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43682709|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682710|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
43682711|NCT02846428|Docetaxel|docetaxel|mesh-list
43682712|NCT02846428|Fluorouracil|fluorouracil|mesh-list
43682721|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682722|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682723|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43682724|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
43682725|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
43682726|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
43682727|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
43682728|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43682729|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43682730|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43682731|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43682732|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682733|NCT02846155|Simethicone|simethicone|mesh-list
43682734|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
43631796|NCT03041948|Morphine|morphine|mesh-list
43682735|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682736|NCT02846155|Emollients|emollients|mesh-ancestor
43682737|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
43682738|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
43682739|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43598246|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
43598247|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43682740|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682742|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682743|NCT02846090|Analgesics|analgesics|mesh-ancestor
43682744|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
43682745|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682765|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43631797|NCT03041948|Remifentanil|remifentanil|mesh-list
43631798|NCT03041948|Ondansetron|ondansetron|mesh-list
43631799|NCT03041948|Propofol|propofol|mesh-list
43631800|NCT03041948|Sevoflurane|sevoflurane|mesh-list
43631801|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631802|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
43631803|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
43631804|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631805|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631806|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43631807|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
43631808|NCT03041948|Hormones|hormones|mesh-ancestor
43631809|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631810|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43631811|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631812|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43631813|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631814|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43631815|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
43631816|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
43631817|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43631818|NCT03041948|Narcotics|narcotics|mesh-ancestor
43631819|NCT03041948|Analgesics|analgesics|mesh-ancestor
43682767|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
43682768|NCT02846025|Antioxidants|antioxidants|mesh-list
43682769|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682770|NCT02846025|Protective Agents|protective agents|mesh-ancestor
43682771|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682772|NCT02846025|Hematinics|hematinics|mesh-ancestor
43682773|NCT02846025|Vitamins|vitamins|mesh-ancestor
43682774|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
43828469|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43682776|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682777|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43682778|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
43682779|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682780|NCT02845856|Cetuximab|cetuximab|mesh-list
43631820|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
43631821|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43631822|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
43631823|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43631824|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43631825|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
43682781|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43631826|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
43631827|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43682782|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631828|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
43682783|NCT02845843|Interferons|interferons|mesh-list
43682784|NCT02845843|Ritonavir|ritonavir|mesh-list
43682785|NCT02845843|Lopinavir|lopinavir|mesh-list
43682786|NCT02845843|Interferon-beta|interferon-beta|mesh-list
43682787|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
43682788|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682790|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682791|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43682792|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43631829|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686388|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686389|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
43686390|NCT02828163|Hormones|hormones|mesh-ancestor
43686391|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686392|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686393|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43686394|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
43686395|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682815|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682816|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682817|NCT02845908|Leucovorin|leucovorin|mesh-list
43682818|NCT02845908|Fluorouracil|fluorouracil|mesh-list
43682819|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
43682834|NCT02845999|Cetuximab|cetuximab|mesh-list
43682835|NCT02845999|Interleukin-2|interleukin-2|mesh-list
43682836|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43682837|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
43682838|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682839|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682840|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43682841|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
43682842|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682843|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682844|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43682845|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43682847|NCT02845999|Analgesics|analgesics|mesh-ancestor
43682871|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43682872|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
43682873|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
43682874|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
43682875|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682876|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682877|NCT02845713|Filaricides|filaricides|mesh-ancestor
43682878|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
43682879|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43682880|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682881|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
43682882|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43682883|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682884|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682885|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43682886|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43682887|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682888|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
43682889|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43682890|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43682896|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682897|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682898|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43682899|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
43682900|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43682901|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43682902|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
43682903|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43682904|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43686397|NCT02828176|Anesthetics|anesthetics|mesh-list
43682905|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682908|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
43682909|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
43682910|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43682911|NCT02845466|Growth Substances|growth substances|mesh-ancestor
43682912|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682913|NCT02845349|Vortioxetine|vortioxetine|mesh-list
43682914|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
43682915|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43682916|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43682917|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43682918|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682919|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682920|NCT02845349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43682921|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43682922|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682923|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682924|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682925|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
43682926|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43682927|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43682928|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43682929|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43682930|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43686416|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43686417|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682931|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
43682932|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43682933|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
43682934|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43682935|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682936|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43682937|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43682938|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43682939|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43682940|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43682947|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
43682948|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43682949|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43682950|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
43682952|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43682953|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682954|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682955|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682956|NCT02844894|Analgesics|analgesics|mesh-ancestor
43682957|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
43682958|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682959|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43682960|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43682961|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43682962|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
43682963|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682964|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682965|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43682966|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43682967|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43682968|NCT02844790|Insulin|insulin|mesh-list
43682969|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
43682970|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682971|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682972|NCT02844933|Cannabidiol|cannabidiol|mesh-list
43682973|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
43682974|NCT02844881|Apatinib|apatinib|mesh-list
43682975|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682976|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43682977|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682978|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682979|NCT02844712|beta-Lactams|beta-lactams|mesh-list
43682980|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43682981|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43682982|NCT02845050|Cisplatin|cisplatin|mesh-list
43682983|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682984|NCT02844621|Omeprazole|omeprazole|mesh-list
43682985|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43682986|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43682987|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43682988|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682989|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682990|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
43682991|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682992|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
43682993|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828470|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682994|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682995|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43682997|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43682998|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683000|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43683001|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43683002|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683003|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
43683004|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
43683005|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683006|NCT02844517|Pancrelipase|pancrelipase|mesh-list
43683007|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43683008|NCT02844634|Tenofovir|tenofovir|mesh-list
43683009|NCT02844634|Emtricitabine|emtricitabine|mesh-list
43683010|NCT02844634|Doxycycline|doxycycline|mesh-list
43683011|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
43683012|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683013|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43683014|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43683015|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683016|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683017|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43683018|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43683019|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43683020|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
43683021|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43683022|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43683024|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43683025|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683026|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43828471|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43828472|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43828473|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828474|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43828475|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43828476|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828477|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
43828478|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43828479|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43828480|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43828481|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
43828482|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828483|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
43828484|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
43828485|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
43828486|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
43828487|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828488|NCT05476952|Rocuronium|rocuronium|mesh-list
43828489|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43828490|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43828491|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43828492|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631881|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828493|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828494|NCT05476822|Antibodies|antibodies|mesh-list
43828495|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
43828496|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828497|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
43828498|NCT05476731|Clotrimazole|clotrimazole|mesh-list
43828499|NCT05476731|Miconazole|miconazole|mesh-list
43828500|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828501|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43828502|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43828503|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43828504|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828505|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828506|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43828507|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
43828508|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602224|NCT03257423|Ertapenem|ertapenem|mesh-list
43683042|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43683043|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683044|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43683045|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43683046|NCT02844309|Growth Substances|growth substances|mesh-ancestor
43683047|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
43683048|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683049|NCT05242926|Docetaxel|docetaxel|mesh-list
43683050|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631917|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43683051|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
43683052|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
43683053|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
43683054|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683055|NCT05242783|Terlipressin|terlipressin|mesh-list
43683056|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43683057|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43683058|NCT05242718|Palmidrol|palmidrol|mesh-list
43683059|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
43683060|NCT05242718|Curcumin|curcumin|mesh-list
43683061|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43683062|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43683063|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43683064|NCT05242718|Analgesics|analgesics|mesh-ancestor
43631949|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
43631950|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43631951|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
43631952|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
43631953|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631954|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43631955|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43631956|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43631957|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
43631958|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631959|NCT03040817|Esomeprazole|esomeprazole|mesh-list
43631960|NCT03040817|Mosapride|mosapride|mesh-list
43631961|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686473|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43686474|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686475|NCT02827747|Vitamin A|vitamin a|mesh-list
43686476|NCT02827747|Antioxidants|antioxidants|mesh-list
43686477|NCT02827747|Vitamins|vitamins|mesh-ancestor
43686478|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
43686479|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686480|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686481|NCT02827747|Protective Agents|protective agents|mesh-ancestor
43686482|NCT02827578|Tamsulosin|tamsulosin|mesh-list
43686483|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
43686484|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43686485|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43686486|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43686487|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
43686488|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686489|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683065|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
43683066|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683067|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683068|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683069|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43683070|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683071|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683072|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683073|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
43683074|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683075|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43683076|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43683079|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683080|NCT05242718|Expectorants|expectorants|mesh-ancestor
43683081|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
43683082|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43683083|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
43683084|NCT05242718|Protective Agents|protective agents|mesh-ancestor
43683085|NCT05242718|Antidotes|antidotes|mesh-ancestor
43683086|NCT05242419|Huperzine A|huperzine a|mesh-list
43683087|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43683088|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683090|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683108|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43683109|NCT05241912|Dobutamine|dobutamine|mesh-list
43683110|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43683111|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
43683112|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
43683113|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683114|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683115|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43683116|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43683117|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43683118|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
43683119|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683120|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686507|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686508|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43686509|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43686510|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686511|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683121|NCT05241912|Protective Agents|protective agents|mesh-ancestor
43683122|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43683123|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43683124|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683125|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
43683126|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43683127|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683128|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43683129|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683130|NCT05168462|Norepinephrine|norepinephrine|mesh-list
43683131|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43683132|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43683133|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
43683134|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683135|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683136|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683137|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
43683138|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
43683139|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683140|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43683141|NCT05104047|Lobeline|lobeline|mesh-list
43683142|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43683143|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
43683144|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683145|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683146|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43683147|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43683148|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
43686536|NCT02827136|Lidocaine|lidocaine|mesh-list
43683149|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683150|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683151|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
43683152|NCT05078502|Vitamin D|vitamin d|mesh-list
43683153|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
43683154|NCT05078502|Vitamins|vitamins|mesh-ancestor
43683155|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
43602572|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
43828516|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
43828517|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828518|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828519|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828520|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828521|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43828522|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43828523|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828524|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847016|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686560|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
43631962|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43631963|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606576|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
43847017|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43847018|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847019|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847020|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
43683168|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43683169|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683180|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
43683181|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
43683182|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
43683183|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683184|NCT04887402|Clomiphene|clomiphene|mesh-list
43683185|NCT04887402|Enclomiphene|enclomiphene|mesh-list
43683186|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
43683187|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43683188|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
43683189|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683190|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683191|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43683192|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
43683193|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43683194|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43683195|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43627433|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627434|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627435|NCT03072992|Analgesics|analgesics|mesh-ancestor
43627436|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
43627437|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627438|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627439|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627440|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627441|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627442|NCT03073265|Apixaban|apixaban|mesh-list
43627443|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43627444|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
43627445|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43627446|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
43627447|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627448|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627450|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43627451|NCT03073057|Budesonide|budesonide|mesh-list
43627452|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
43627453|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43627454|NCT03073057|Charcoal|charcoal|mesh-list
43627455|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631993|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631994|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
43631995|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43631996|NCT03040531|Estrogens|estrogens|mesh-ancestor
43631997|NCT03040531|Hormones|hormones|mesh-ancestor
43631998|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631999|NCT03040219|Folic Acid|folic acid|mesh-list
43632000|NCT03040219|Hematinics|hematinics|mesh-ancestor
43632001|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
43632002|NCT03040219|Vitamins|vitamins|mesh-ancestor
43632003|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
43632004|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632005|NCT03040401|Aldesleukin|aldesleukin|mesh-list
43632006|NCT03040401|Interleukin-2|interleukin-2|mesh-list
43632007|NCT03040401|Histamine|histamine|mesh-list
43632008|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
43632009|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632010|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43632011|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43632012|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
43632013|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632014|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43632015|NCT03040401|Analgesics|analgesics|mesh-ancestor
43627456|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43627457|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
43627458|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627459|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627460|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43627461|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
43627462|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
43627463|NCT03073057|Hormones|hormones|mesh-ancestor
43627464|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627465|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43627466|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43627467|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43627468|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
43627469|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627470|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627471|NCT03073057|Antidotes|antidotes|mesh-ancestor
43627472|NCT03073057|Protective Agents|protective agents|mesh-ancestor
43627473|NCT03073018|Fosinopril|fosinopril|mesh-list
43627474|NCT03073018|Pravastatin|pravastatin|mesh-list
43627475|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43627476|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43627477|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
43627478|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627479|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43627480|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43627481|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627482|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43686630|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
43627483|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
43627484|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43627485|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
43627486|NCT03073369|Vitamin D|vitamin d|mesh-list
43627487|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43627488|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627489|NCT03073369|Vitamins|vitamins|mesh-ancestor
43627490|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
43627491|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43627492|NCT03072849|Fluticasone|fluticasone|mesh-list
43627493|NCT03072849|Azithromycin|azithromycin|mesh-list
43627494|NCT03072849|Montelukast|montelukast|mesh-list
43627495|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683197|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
43683198|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683199|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
43683200|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683201|NCT04793490|Acetaminophen|acetaminophen|mesh-list
43683202|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43683203|NCT04793490|Analgesics|analgesics|mesh-ancestor
43683204|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
43683205|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686654|NCT02826174|Anesthetics|anesthetics|mesh-list
43683206|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683207|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
43683208|NCT04782700|Prednisone|prednisone|mesh-list
43683209|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683210|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
43683211|NCT04782700|Hormones|hormones|mesh-ancestor
43683212|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683213|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683214|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43683215|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683216|NCT04750005|Listerine|listerine|mesh-list
43683217|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43632058|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632060|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43632061|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632062|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
43632063|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
43632064|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43632065|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632066|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632067|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
43632068|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43632069|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632070|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632071|NCT03039842|Valproic Acid|valproic acid|mesh-list
43632072|NCT03039842|Memantine|memantine|mesh-list
43632073|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
43632074|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43632075|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43632077|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632078|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632079|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632080|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43632081|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43632082|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
43632083|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
43632084|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
43632085|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632086|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
43683218|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683219|NCT04748783|Listerine|listerine|mesh-list
43683220|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
43683221|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43683222|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43683223|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
43683224|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
43683225|NCT04748783|Protective Agents|protective agents|mesh-ancestor
43849436|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43849437|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43849438|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
43849439|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
43627496|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43627497|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
43627498|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627499|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632095|NCT03039608|Hormones|hormones|mesh-ancestor
43632096|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632097|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632098|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43632099|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632100|NCT03039491|Vaccines|vaccines|mesh-list
43627500|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43627501|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
43627505|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627506|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43627507|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
43627508|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627509|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43627510|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43627511|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683226|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683227|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43683228|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683229|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
43683230|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683231|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43683232|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
43683233|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602675|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
43627517|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43627518|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627519|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43627520|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627521|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
43627522|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43627523|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
43627524|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627525|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627526|NCT03072485|Analgesics|analgesics|mesh-ancestor
43627527|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
43627528|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627529|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627530|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627531|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43627532|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627533|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627534|NCT03072589|Regadenoson|regadenoson|mesh-list
43627535|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43627536|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43627537|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
43627538|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
43627539|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627540|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627541|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627542|NCT03072511|Nicotine|nicotine|mesh-list
43627543|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43627544|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
43627545|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627546|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627547|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43627548|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43627549|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
43627550|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627551|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627552|NCT03072264|Fluoxetine|fluoxetine|mesh-list
43627553|NCT03072264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43627554|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43627555|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627556|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627557|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627558|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
43683238|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683239|NCT04646655|Enoxaparin|enoxaparin|mesh-list
43683240|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
43683241|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43683242|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43627594|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43627595|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627596|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627598|NCT03072082|Analgesics|analgesics|mesh-ancestor
43627599|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
43627600|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627601|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627602|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627603|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43627604|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43627624|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43627626|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43627627|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
43627628|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43627629|NCT03072082|Diuretics|diuretics|mesh-ancestor
43683279|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
43683280|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
43683281|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43683283|NCT04545541|Calcium heparin|calcium heparin|mesh-list
43683284|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
43683285|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43683286|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43683287|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683288|NCT04481308|Fentanyl|fentanyl|mesh-list
43683289|NCT04481308|Propofol|propofol|mesh-list
43683290|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43683291|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683292|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683293|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43627630|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
43627631|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
43627632|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43627633|NCT03072290|Triamcinolone|triamcinolone|mesh-list
43627634|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43627635|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43627636|NCT03072290|Lidocaine|lidocaine|mesh-list
43627637|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43627638|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627639|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
43627640|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627652|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627653|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43632235|NCT03038321|Levofloxacin|levofloxacin|mesh-list
43632271|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
43632272|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
43632273|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632274|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632275|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
43632276|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632277|NCT03038256|Capecitabine|capecitabine|mesh-list
43632278|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43632279|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
43632280|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632281|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632283|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43632284|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
43632285|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632286|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
43632287|NCT03038334|Analgesics|analgesics|mesh-ancestor
43632288|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
43632289|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632290|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632291|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
43632292|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632293|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43632294|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
43627654|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
43627655|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627656|NCT03072121|Aspirin|aspirin|mesh-list
43627657|NCT03072121|Metoprolol|metoprolol|mesh-list
43627658|NCT03072121|Isosorbide|isosorbide|mesh-list
43627659|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43627660|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43627661|NCT03072121|Trimetazidine|trimetazidine|mesh-list
43627662|NCT03072121|Clopidogrel|clopidogrel|mesh-list
43627663|NCT03072121|Atorvastatin|atorvastatin|mesh-list
43627664|NCT03072121|Calcium|calcium|mesh-list
43627665|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43627666|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627667|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627668|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627669|NCT03072121|Analgesics|analgesics|mesh-ancestor
43627670|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
43627671|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627672|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627673|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627674|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43627675|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43627676|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627677|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43627678|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43627679|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627680|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
43627681|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43627682|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43627683|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
43627684|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43627685|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43683294|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
43632295|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43632296|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43632297|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686822|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43686823|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
43686824|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686825|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686826|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43686828|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43686829|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686830|NCT02824770|Tramadol|tramadol|mesh-list
43686831|NCT02824770|Bupivacaine|bupivacaine|mesh-list
43683295|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
43683296|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43683298|NCT04481308|Analgesics|analgesics|mesh-ancestor
43683299|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
43683300|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683301|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43683303|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43683304|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43683305|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683306|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627686|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43627687|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43627688|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43627689|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
43627690|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627691|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43627692|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43627693|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
43627694|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
43627695|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43627696|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43627697|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43627698|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
43627699|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43627700|NCT03072121|Diuretics|diuretics|mesh-ancestor
43627701|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
43627702|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
43627703|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43627704|NCT03072173|Xylometazoline|xylometazoline|mesh-list
43849444|NCT03928015|Dronabinol|dronabinol|mesh-list
43849445|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
43849446|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849447|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849448|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
43849449|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43849450|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43686854|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686855|NCT02824718|Teriparatide|teriparatide|mesh-list
43686856|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
43849451|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43849452|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43849453|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627714|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
43627716|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43627717|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
43627718|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627719|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627720|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
43627721|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627722|NCT03071822|Gemcitabine|gemcitabine|mesh-list
43632341|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43632342|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43632343|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
43632344|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632345|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632346|NCT03037736|Bevacizumab|bevacizumab|mesh-list
43632347|NCT03037736|Fluorouracil|fluorouracil|mesh-list
43686874|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686875|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43686876|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
43686877|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686878|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686880|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
43686882|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43627723|NCT03071822|Dexamethasone|dexamethasone|mesh-list
43627724|NCT03071822|Cisplatin|cisplatin|mesh-list
43627725|NCT03071822|Etoposide|etoposide|mesh-list
43627726|NCT03071822|Asparaginase|asparaginase|mesh-list
43627727|NCT03071822|Ifosfamide|ifosfamide|mesh-list
43627728|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627729|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
43627730|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
43828899|NCT05465226|Narcotics|narcotics|mesh-ancestor
43627731|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627732|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627733|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43683307|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43683308|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43683309|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43683310|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43683311|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
43683312|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
43683313|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
43683314|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
43683315|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683316|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683317|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43683318|NCT04452565|Dexamethasone|dexamethasone|mesh-list
43683319|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
43683320|NCT04452565|BB 1101|bb 1101|mesh-list
43683321|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683322|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
43683323|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
43683324|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683325|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683326|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43683327|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
43683328|NCT04452565|Hormones|hormones|mesh-ancestor
43683329|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683330|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43683331|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683332|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
43632399|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43632400|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43686935|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
43683333|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683334|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683335|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43683336|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43683337|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43683338|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43683339|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
43627734|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
43627735|NCT03071822|Hormones|hormones|mesh-ancestor
43627736|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627737|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43627738|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627739|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43627740|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
43627741|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627742|NCT03071822|Antiviral Agents|antiviral agents|mesh-ancestor
43683340|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683341|NCT04410328|Aspirin|aspirin|mesh-list
43683342|NCT04410328|Dipyridamole|dipyridamole|mesh-list
43683343|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43683344|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43683345|NCT04410328|Analgesics|analgesics|mesh-ancestor
43683346|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
43683347|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683348|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627743|NCT03071822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627744|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627745|NCT03071822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43627746|NCT03071822|Immunologic Factors|immunologic factors|mesh-ancestor
43627747|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43627748|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43627749|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43627750|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43627751|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
43627753|NCT03071731|Ipratropium|ipratropium|mesh-list
43627754|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
43627755|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
43627764|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
43627765|NCT03071575|Vaccines|vaccines|mesh-list
43627766|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
43627767|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627768|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
43627769|NCT03071549|Salicylates|salicylates|mesh-list
43627770|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627771|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
43627772|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
43627773|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
43627774|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627775|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627776|NCT03071549|Analgesics|analgesics|mesh-ancestor
43627777|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
43627778|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627779|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627780|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627781|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627782|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43627783|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627784|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627785|NCT03071770|Ivosidenib|ivosidenib|mesh-list
43627786|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627787|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627788|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627789|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
43627790|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
43627791|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43627792|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
43627793|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632427|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627794|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627795|NCT03071705|Metformin|metformin|mesh-list
43627796|NCT03071705|Gefitinib|gefitinib|mesh-list
43627797|NCT03071705|Afatinib|afatinib|mesh-list
43627798|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43627804|NCT03071289|Cisplatin|cisplatin|mesh-list
43627805|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627806|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
43627807|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
43627808|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
43683349|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683350|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43683351|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43683352|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43683353|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683354|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43683355|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43683356|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683358|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43683359|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
43683360|NCT04400474|Atezolizumab|atezolizumab|mesh-list
43683361|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683362|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
43683363|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43632432|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43632436|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683364|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43683365|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683366|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683367|NCT04375787|Atorvastatin|atorvastatin|mesh-list
43683368|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683369|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683370|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
43683371|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632473|NCT03036605|Hormones|hormones|mesh-ancestor
43683374|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632474|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632475|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43632476|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632477|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
43632478|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632479|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632480|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
43632481|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
43683375|NCT04345796|Empagliflozin|empagliflozin|mesh-list
43683376|NCT04345796|Carvedilol|carvedilol|mesh-list
43683377|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43683378|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683379|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43683380|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683381|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43683382|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43683383|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
43683384|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683385|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43683386|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
43683387|NCT04345796|Protective Agents|protective agents|mesh-ancestor
43683388|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43683389|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43683390|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43683391|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
43683392|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43683393|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43683395|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
43683396|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
43683397|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683398|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627809|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627810|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627811|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
43627812|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43627813|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
43627814|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43627815|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
43627816|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627817|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627818|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
43627819|NCT03071055|Ranibizumab|ranibizumab|mesh-list
43686981|NCT02823626|Diuretics|diuretics|mesh-ancestor
43627820|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43627821|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43627827|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43627828|NCT03071172|Progesterone|progesterone|mesh-list
43627829|NCT03071172|Hormones|hormones|mesh-ancestor
43627830|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627831|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627832|NCT03071172|Progestins|progestins|mesh-ancestor
43627833|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
43627834|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43627835|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
43627836|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43683399|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
43683400|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683401|NCT04280601|Vitamin D|vitamin d|mesh-list
43683402|NCT04280601|Vitamins|vitamins|mesh-ancestor
43683403|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
43683404|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683405|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43683406|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43683407|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43683408|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43683409|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627837|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43627838|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43627839|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627840|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
43627841|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43627842|NCT03071042|Docetaxel|docetaxel|mesh-list
43627843|NCT03071042|Apatinib|apatinib|mesh-list
43627844|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627845|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
43627846|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
43627847|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
43627848|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627849|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43627850|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627851|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43627852|NCT03071068|Antibodies|antibodies|mesh-list
43632549|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
43632550|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43632551|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43632552|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
43632553|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
43687040|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43687041|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687042|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687043|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632567|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627853|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
43632568|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632569|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
43632570|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632571|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43632572|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43632573|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
43627854|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43627855|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
43627856|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627857|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627858|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
43627859|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43627860|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43627878|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
43627879|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627880|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43627881|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43627882|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
43627883|NCT03070574|Mesalamine|mesalamine|mesh-list
43632574|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627884|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627885|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627886|NCT03070574|Analgesics|analgesics|mesh-ancestor
43627887|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
43632578|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
43683410|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683412|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683413|NCT04224584|Analgesics|analgesics|mesh-ancestor
43683414|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
43683415|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683416|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
43683417|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43683418|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
43683419|NCT04191421|Spartalizumab|spartalizumab|mesh-list
43683421|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43627888|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627889|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627891|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627892|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
43627900|NCT03070704|Hormones|hormones|mesh-ancestor
43627901|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627902|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43627903|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
43627904|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43627905|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627906|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43627907|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627908|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43632630|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632631|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43632632|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43632633|NCT05618912|Petrolatum|petrolatum|mesh-list
43632634|NCT05618912|Emollients|emollients|mesh-ancestor
43632635|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
43632636|NCT05618808|Enoxaparin|enoxaparin|mesh-list
43632637|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
43687095|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
43687096|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
43687097|NCT02822482|Cetuximab|cetuximab|mesh-list
43687098|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43687099|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687100|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43687101|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
43687102|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687103|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43687104|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43687105|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627909|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627910|NCT03070678|Analgesics|analgesics|mesh-ancestor
43627911|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
43828908|NCT05464173|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43828909|NCT05464173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43847036|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847037|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847038|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847039|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847040|NCT04142658|Warfarin|warfarin|mesh-list
43847041|NCT04142658|Apixaban|apixaban|mesh-list
43847042|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
43847043|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43847044|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
43847046|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
43627912|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627913|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627914|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627915|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43627916|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627917|NCT03070613|Lectins|lectins|mesh-list
43627918|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
43627919|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
43627920|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627921|NCT03070613|Coagulants|coagulants|mesh-ancestor
43627922|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43627923|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43627924|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627925|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43627926|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43627927|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627928|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627929|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
43627930|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627931|NCT03070379|Lidocaine|lidocaine|mesh-list
43627933|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
43627934|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627935|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627936|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
43627937|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627938|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43627939|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43683422|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683423|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828526|NCT05476380|Cisplatin|cisplatin|mesh-list
43828527|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847065|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828528|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828529|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
43828530|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
43828531|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
43828532|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828533|NCT05476354|Amlodipine|amlodipine|mesh-list
43828534|NCT05476354|Irbesartan|irbesartan|mesh-list
43828535|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43627940|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43627941|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627942|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627944|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
43627945|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
43627946|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627947|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43627948|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43627949|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627950|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627951|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43627952|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43627953|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
43627954|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43627955|NCT03070353|Dextrans|dextrans|mesh-list
43627956|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
43627957|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
43627958|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
43627959|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43627966|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43627967|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43627968|NCT03070054|Epinephrine|epinephrine|mesh-list
43627969|NCT03070054|Bupivacaine|bupivacaine|mesh-list
43627970|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627971|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
43627972|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627973|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627974|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
43627975|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627976|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43627977|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43627978|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
43627979|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627980|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627981|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43627984|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43627985|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
43627986|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
43627987|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
43627988|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43627989|NCT03069950|Leucovorin|leucovorin|mesh-list
43627990|NCT03069950|Dexamethasone|dexamethasone|mesh-list
43627991|NCT03069950|Fluorouracil|fluorouracil|mesh-list
43627992|NCT03069950|Irinotecan|irinotecan|mesh-list
43627993|NCT03069950|Panitumumab|panitumumab|mesh-list
43627994|NCT03069950|Floxuridine|floxuridine|mesh-list
43828536|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43828537|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828538|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828542|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43828543|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43828545|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43828546|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828547|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43828548|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43828549|NCT05476341|Growth Substances|growth substances|mesh-ancestor
43828550|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828551|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
43828552|NCT05476198|Anesthetics|anesthetics|mesh-list
43828553|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828554|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828555|NCT05476172|Dienogest|dienogest|mesh-list
43828556|NCT05476172|Norethindrone|norethindrone|mesh-list
43828557|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
43627995|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627996|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
43627997|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
43627998|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627999|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628000|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628001|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
43628002|NCT03069950|Hormones|hormones|mesh-ancestor
43628003|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628004|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43628005|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628006|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
43628007|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628008|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43628009|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43628010|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
43687136|NCT02822144|Narcotics|narcotics|mesh-ancestor
43687137|NCT02822144|Analgesics|analgesics|mesh-ancestor
43687152|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628011|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43687153|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687154|NCT02822157|Gemcitabine|gemcitabine|mesh-list
43687156|NCT02822157|Carboplatin|carboplatin|mesh-list
43687157|NCT02822157|Doxorubicin|doxorubicin|mesh-list
43687158|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43687159|NCT02822157|Topotecan|topotecan|mesh-list
43628012|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43628013|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628015|NCT03069950|Protective Agents|protective agents|mesh-ancestor
43628016|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
43628017|NCT03069950|Vitamins|vitamins|mesh-ancestor
43628018|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
43628019|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43628020|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43628021|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43628022|NCT03069781|Estradiol|estradiol|mesh-list
43828558|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43828559|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43828560|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43828561|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
43828562|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43828563|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828564|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43683424|NCT04073290|Rifaximin|rifaximin|mesh-list
43683425|NCT04073290|Lactulose|lactulose|mesh-list
43683426|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43628023|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43628024|NCT03069781|Estrogens|estrogens|mesh-ancestor
43628025|NCT03069781|Hormones|hormones|mesh-ancestor
43628026|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628027|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628028|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43628029|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
43628030|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628031|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43628038|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628040|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43628041|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43687160|NCT02822157|Olaparib|olaparib|mesh-list
43628042|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
43628043|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628044|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628046|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
43628047|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43628048|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43628049|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43628050|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628051|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628052|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
43628053|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628054|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628055|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43628056|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628058|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43628059|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43628060|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
43628061|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628062|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632749|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
43632750|NCT05617430|Vitamins|vitamins|mesh-ancestor
43632751|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
43632752|NCT05616923|Trametinib|trametinib|mesh-list
43632753|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632754|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43632755|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632756|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632757|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
43632758|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43632759|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
43632760|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632761|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687179|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43687180|NCT02821689|Pirfenidone|pirfenidone|mesh-list
43687181|NCT02821689|Analgesics|analgesics|mesh-ancestor
43687182|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
43632762|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43628063|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628064|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43628065|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
43628066|NCT03069339|Protective Agents|protective agents|mesh-ancestor
43628067|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43628068|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628069|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43628070|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
43628071|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43628072|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43628073|NCT03069001|Ribavirin|ribavirin|mesh-list
43628074|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
43628075|NCT03069001|Simeprevir|simeprevir|mesh-list
43628076|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
43628077|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628078|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
43628079|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628080|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
43628081|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628082|NCT03069027|Lidocaine|lidocaine|mesh-list
43683427|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683428|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43683429|NCT03998488|Psyllium|psyllium|mesh-list
43683430|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
43683431|NCT03998488|Cathartics|cathartics|mesh-ancestor
43683432|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43683433|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
43683434|NCT03987685|Topotecan|topotecan|mesh-list
43683435|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43683436|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43683437|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683438|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683439|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683440|NCT03936790|Fentanyl|fentanyl|mesh-list
43683441|NCT03936790|Ropivacaine|ropivacaine|mesh-list
43683442|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
43683443|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
43628083|NCT03069027|Epinephrine|epinephrine|mesh-list
43628084|NCT03069027|Racepinephrine|racepinephrine|mesh-list
43628085|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
43628086|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628087|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
43628088|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628089|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628090|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
43628091|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628092|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43628093|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43628094|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43628095|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628096|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628097|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43628098|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43628099|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
43628100|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628107|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
43628108|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43628126|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628127|NCT03068975|Alvimopan|alvimopan|mesh-list
43687183|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632763|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
43632764|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43632765|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
43687184|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687193|NCT02821533|Cisplatin|cisplatin|mesh-list
43628128|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628129|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43628130|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683444|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683445|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683446|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
43683447|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683448|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43683449|NCT03936790|Narcotics|narcotics|mesh-ancestor
43683450|NCT03936790|Analgesics|analgesics|mesh-ancestor
43683451|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43683452|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43628132|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628133|NCT03068832|Poly I-C|poly i-c|mesh-list
43628134|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43628135|NCT03068832|Poly ICLC|poly iclc|mesh-list
43628136|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
43628137|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
43628138|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628139|NCT03068832|Laxatives|laxatives|mesh-ancestor
43628140|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628141|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
43628142|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628143|NCT03069144|Calcitriol|calcitriol|mesh-list
43687233|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687234|NCT02821390|Analgesics|analgesics|mesh-ancestor
43687235|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
43687236|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687237|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687238|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687239|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687240|NCT02821312|DA-8010|da-8010|mesh-list
43628144|NCT03069144|Calcipotriene|calcipotriene|mesh-list
43628145|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
43628146|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43628147|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628148|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43628149|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628150|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628151|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43628152|NCT03069144|Vitamins|vitamins|mesh-ancestor
43628153|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
43628154|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43628155|NCT03068650|Rindopepimut|rindopepimut|mesh-list
43687241|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43628156|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43628157|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628158|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
43628160|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43628161|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628162|NCT03068533|Antacids|antacids|mesh-ancestor
43628163|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628164|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628165|NCT03068442|Flutemetamol|flutemetamol|mesh-list
43628166|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43628167|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628168|NCT03068429|Sertraline|sertraline|mesh-list
43628169|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
43628170|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43628171|NCT03068429|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43628172|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43628184|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628185|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628186|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628187|NCT03068247|Analgesics|analgesics|mesh-ancestor
43628188|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
43687319|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
43628190|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
43687320|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687321|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
43687322|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687323|NCT02820948|Protective Agents|protective agents|mesh-ancestor
43632805|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632806|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
43632807|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
43628191|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43628192|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
43628194|NCT03068065|Liraglutide|liraglutide|mesh-list
43628195|NCT03068065|Gliclazide|gliclazide|mesh-list
43632808|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
43632809|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632810|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
43687355|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43687356|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43687357|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
43683454|NCT03931057|Midazolam|midazolam|mesh-list
43683455|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43683456|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43683457|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683458|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683464|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
43687358|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687359|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687360|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
43687361|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43687362|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
43687363|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43687364|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687365|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43687366|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
43632811|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
43632812|NCT05616442|Vitamin E|vitamin e|mesh-list
43632813|NCT05616442|Ketotifen|ketotifen|mesh-list
43632814|NCT05616442|Vitamins|vitamins|mesh-ancestor
43628213|NCT03068260|Morphine|morphine|mesh-list
43628214|NCT03068260|Ropivacaine|ropivacaine|mesh-list
43628215|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43628216|NCT03068260|Narcotics|narcotics|mesh-ancestor
43628217|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628218|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628219|NCT03068260|Analgesics|analgesics|mesh-ancestor
43628220|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
43628221|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628222|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628223|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
43628224|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43628225|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
43628226|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43632818|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632820|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
43632821|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
43628227|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628228|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628229|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43628230|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628231|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632825|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632826|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43632827|NCT05616390|Bevacizumab|bevacizumab|mesh-list
43632828|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43632836|NCT05616364|Tramadol|tramadol|mesh-list
43628232|NCT03068208|Methylene Blue|methylene blue|mesh-list
43628233|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628234|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628235|NCT03067974|Ketamine|ketamine|mesh-list
43628269|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628270|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628274|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43628275|NCT03067896|Analgesics|analgesics|mesh-ancestor
43628276|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43828923|NCT05463341|Fentanyl|fentanyl|mesh-list
43828924|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43828925|NCT05463341|Narcotics|narcotics|mesh-ancestor
43828926|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828927|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628277|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43628278|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43628279|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
43628280|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628281|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628282|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43628283|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
43628284|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43628285|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628286|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43828928|NCT05463341|Analgesics|analgesics|mesh-ancestor
43828929|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
43828930|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828931|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43828932|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43828933|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
43828934|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
43628287|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
43628288|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628289|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
43628290|NCT03067740|Bupivacaine|bupivacaine|mesh-list
43628291|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628292|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
43628293|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628294|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628295|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
43628296|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628297|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43628298|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43628299|NCT03067740|Analgesics|analgesics|mesh-ancestor
43628300|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43628301|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43628302|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43628303|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
43628304|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628305|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628306|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
43628307|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
43628308|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628309|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
43628310|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628311|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628312|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
43628313|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43628314|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43628315|NCT03067753|Prednisolone|prednisolone|mesh-list
43628316|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
43828935|NCT05463094|Metformin|metformin|mesh-list
43828936|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43628317|NCT03067753|Hormones|hormones|mesh-list
43628318|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43628319|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
43628320|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628321|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628322|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43632866|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828941|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43828942|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43828943|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
43628328|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43628341|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628343|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43628346|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628347|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43628348|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43628349|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628350|NCT03067792|Antidotes|antidotes|mesh-ancestor
43628351|NCT03067792|Protective Agents|protective agents|mesh-ancestor
43628352|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
43628353|NCT03067792|Vitamins|vitamins|mesh-ancestor
43628354|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
43628355|NCT03067597|Dinoprostone|dinoprostone|mesh-list
43628356|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
43628357|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628358|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628359|NCT03067688|Amlodipine|amlodipine|mesh-list
43628360|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43628361|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43628362|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43828944|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828945|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828946|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43828947|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
43828948|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
43828950|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828951|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
43828952|NCT05458609|Naltrexone|naltrexone|mesh-list
43828953|NCT05458609|Lemborexant|lemborexant|mesh-list
43632867|NCT05615818|Gemcitabine|gemcitabine|mesh-list
43632868|NCT05615818|Cisplatin|cisplatin|mesh-list
43632869|NCT05615818|Trastuzumab|trastuzumab|mesh-list
43632870|NCT05615818|Niraparib|niraparib|mesh-list
43628363|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43628364|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628365|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628366|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43628367|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628368|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
43628369|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683510|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683511|NCT03673124|Letrozole|letrozole|mesh-list
43683512|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628386|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628387|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43628388|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43628389|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
43628390|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
43628391|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628392|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43628393|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43632891|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632892|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43632893|NCT05615727|Analgesics|analgesics|mesh-ancestor
43632894|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
43632895|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632896|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43632897|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43632898|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43632899|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
43632900|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632901|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632902|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43632903|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43632904|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
43632905|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
43632929|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43632930|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632931|NCT05614934|Clarithromycin|clarithromycin|mesh-list
43632932|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43632933|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632934|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43632935|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628394|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628403|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
43628404|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628405|NCT03067194|Celecoxib|celecoxib|mesh-list
43628406|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43628407|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43628408|NCT03067194|Analgesics|analgesics|mesh-ancestor
43628410|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628411|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628412|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628413|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628414|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43628415|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43628416|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683513|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43683514|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43683515|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683516|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683517|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43683518|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
43683519|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683520|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683521|NCT03635489|Paclitaxel|paclitaxel|mesh-list
43683522|NCT03635489|Bevacizumab|bevacizumab|mesh-list
43683523|NCT03635489|Carboplatin|carboplatin|mesh-list
43683524|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43683525|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683526|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
43683527|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
43683528|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
43683529|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683530|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43683531|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43687375|NCT02820558|Neurokinin A|neurokinin a|mesh-list
43683532|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43683533|NCT03635489|Growth Substances|growth substances|mesh-ancestor
43683534|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683535|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
43683536|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
43628417|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628418|NCT03067415|Latanoprost|latanoprost|mesh-list
43628419|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43628420|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43687376|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628421|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
43628422|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43628423|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43628424|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43628425|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628426|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628427|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
43628428|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628429|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628430|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43628431|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628432|NCT03066791|Curcumin|curcumin|mesh-list
43628433|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43628434|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828954|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43687377|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687378|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687379|NCT02820259|Tacrolimus|tacrolimus|mesh-list
43687380|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43687381|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
43687382|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687383|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43687384|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687385|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687386|NCT02820077|Hemostatics|hemostatics|mesh-list
43687387|NCT02820077|Coagulants|coagulants|mesh-ancestor
43687388|NCT02819999|Cisplatin|cisplatin|mesh-list
43687389|NCT02819999|Etoposide|etoposide|mesh-list
43687390|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687391|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43687392|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43628435|NCT03066791|Analgesics|analgesics|mesh-ancestor
43628436|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
43628437|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683538|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43683539|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683540|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
43683541|NCT03582293|Coagulants|coagulants|mesh-ancestor
43683542|NCT03574337|Neostigmine|neostigmine|mesh-list
43683543|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43683544|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683545|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683546|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683547|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683548|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683549|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43683551|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683553|NCT02721342|Irbesartan|irbesartan|mesh-list
43683554|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43683555|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
43683556|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683557|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683558|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43683559|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43683560|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43628438|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628439|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628440|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687415|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43628441|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628442|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628443|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628444|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
43628445|NCT03066817|Vitamin D|vitamin d|mesh-list
43628446|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43628447|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628448|NCT03066817|Vitamins|vitamins|mesh-ancestor
43628449|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
43628450|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43628451|NCT03066661|Entrectinib|entrectinib|mesh-list
43628452|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43628453|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628454|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628455|NCT03066700|Hemostatics|hemostatics|mesh-list
43628456|NCT03066700|Coagulants|coagulants|mesh-ancestor
43628457|NCT03066557|Apatinib|apatinib|mesh-list
43628458|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
43628459|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628460|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43628466|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683561|NCT02153645|Amantadine|amantadine|mesh-list
43683562|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43683563|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43683564|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
43683565|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683566|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
43683567|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683568|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683569|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683570|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687475|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687476|NCT02819375|Ketamine|ketamine|mesh-list
43687477|NCT02819375|Remifentanil|remifentanil|mesh-list
43687478|NCT02819375|Propofol|propofol|mesh-list
43683571|NCT02153645|Analgesics|analgesics|mesh-ancestor
43683572|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
43683573|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683574|NCT02153632|Amantadine|amantadine|mesh-list
43683575|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43628467|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628468|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43628469|NCT03066544|Dexamethasone|dexamethasone|mesh-list
43628470|NCT03066544|Ketorolac|ketorolac|mesh-list
43628471|NCT03066544|Naratriptan|naratriptan|mesh-list
43628472|NCT03066544|Bupivacaine|bupivacaine|mesh-list
43628473|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628474|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
43628475|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
43628476|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628477|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628478|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628479|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
43628481|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628482|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43628483|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628484|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628485|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
43628486|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628487|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
43628488|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43628489|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43628490|NCT03066544|Analgesics|analgesics|mesh-ancestor
43628491|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687493|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687512|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
43687513|NCT02818985|Hormones|hormones|mesh-ancestor
43687514|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687515|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43687516|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687517|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43687518|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687519|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687520|NCT02818985|Analgesics|analgesics|mesh-ancestor
43687521|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
43687522|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43687523|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43687524|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43687525|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
43687526|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632992|NCT05614440|Tramadol|tramadol|mesh-list
43632993|NCT05614440|Anesthetics|anesthetics|mesh-list
43632994|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
43628492|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43628493|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628494|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628495|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43628496|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43628497|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43628498|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
43628499|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628502|NCT03066466|Tacrolimus|tacrolimus|mesh-list
43628503|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43628504|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
43628505|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628506|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628507|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43628508|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
43628509|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628510|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628511|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
43628512|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683576|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43683578|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683579|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
43683580|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683581|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683582|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683583|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43683584|NCT02153632|Analgesics|analgesics|mesh-ancestor
43628513|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43628514|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43628515|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
43628516|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628517|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43628518|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43628519|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43628520|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43628521|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43628522|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43628523|NCT03066518|Melatonin|melatonin|mesh-list
43628524|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
43628525|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628526|NCT03066518|Protective Agents|protective agents|mesh-ancestor
43628527|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628528|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628529|NCT03066427|Sunitinib|sunitinib|mesh-list
43628539|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
43628540|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
43628541|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
43628542|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628543|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
43628544|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628545|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628546|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
43628547|NCT03066115|Ketorolac|ketorolac|mesh-list
43628548|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43628549|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43628550|NCT03066115|Analgesics|analgesics|mesh-ancestor
43628551|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
43628552|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628553|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628554|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628559|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
43628560|NCT03066115|Protective Agents|protective agents|mesh-ancestor
43628561|NCT03066115|Vitamins|vitamins|mesh-ancestor
43628562|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
43628563|NCT03066154|Ritonavir|ritonavir|mesh-list
43628564|NCT03066154|Docetaxel|docetaxel|mesh-list
43628565|NCT03066154|Androgens|androgens|mesh-list
43632995|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632996|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632997|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43632998|NCT05614440|Narcotics|narcotics|mesh-ancestor
43632999|NCT05614440|Analgesics|analgesics|mesh-ancestor
43633000|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
43633001|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633002|NCT05613894|177Lu-PSMA-617|177lu-psma-617|mesh-list
43633003|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43633004|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633005|NCT05613491|Insulin|insulin|mesh-list
43633006|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43633007|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43633008|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633009|NCT05613478|Apatinib|apatinib|mesh-list
43633014|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633015|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43633016|NCT05613478|Estrogens|estrogens|mesh-ancestor
43628566|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628567|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
43628568|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
43628569|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
43628570|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628571|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43628572|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43628573|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
43683585|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
43683586|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683587|NCT02013141|Telavancin|telavancin|mesh-list
43683588|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43628574|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628575|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43633017|NCT05613478|Hormones|hormones|mesh-ancestor
43849475|NCT03926130|Ustekinumab|ustekinumab|mesh-list
43628576|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43633018|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633019|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633020|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43633021|NCT05613361|Colistin|colistin|mesh-list
43633022|NCT05613361|Curcumin|curcumin|mesh-list
43633023|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43633024|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633025|NCT05613361|Analgesics|analgesics|mesh-ancestor
43633032|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633033|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633034|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43633035|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633036|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43633037|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
43633038|NCT05613335|Coagulants|coagulants|mesh-ancestor
43633039|NCT05613205|Vaccines|vaccines|mesh-list
43633040|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
43633041|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633042|NCT05613192|Vitamin D|vitamin d|mesh-list
43633044|NCT05613192|Vitamins|vitamins|mesh-ancestor
43628577|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
43628578|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628579|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43628580|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43628581|NCT03066154|Hormones|hormones|mesh-ancestor
43633061|NCT05613166|Everolimus|everolimus|mesh-list
43628582|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628583|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628584|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
43602903|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43628614|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43628615|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628616|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43628617|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628618|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43628620|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
43628621|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639147|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628628|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628630|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
43628631|NCT03065816|Antacids|antacids|mesh-ancestor
43628632|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628633|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628634|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
43687597|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633082|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633088|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
43628635|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43628636|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628637|NCT03065504|Turmeric extract|turmeric extract|mesh-list
43628638|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
43628639|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628640|NCT03065504|Protective Agents|protective agents|mesh-ancestor
43628641|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683603|NCT01773083|Calcium heparin|calcium heparin|mesh-list
43628662|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
43628663|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43687618|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628664|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43628666|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687619|NCT02818751|Citalopram|citalopram|mesh-list
43687620|NCT02818751|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43687621|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43687622|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687623|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687624|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687625|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
43628667|NCT03065309|Narcotics|narcotics|mesh-ancestor
43628668|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628669|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628670|NCT03065309|Analgesics|analgesics|mesh-ancestor
43628671|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
43687626|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849454|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849455|NCT03928015|Hormones|hormones|mesh-ancestor
43849456|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628672|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628673|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43628674|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43628675|NCT03064906|Pancrelipase|pancrelipase|mesh-list
43628676|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628677|NCT03064633|Dexamethasone|dexamethasone|mesh-list
43628678|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
43628679|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
43628680|NCT03064633|Bupivacaine|bupivacaine|mesh-list
43628681|NCT03064633|BB 1101|bb 1101|mesh-list
43628682|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628683|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
43628684|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
43628685|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628686|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849457|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43849458|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849459|NCT03926338|Celecoxib|celecoxib|mesh-list
43849460|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
43683604|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
43683605|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43683606|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43683607|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683608|NCT01723579|Estradiol|estradiol|mesh-list
43683609|NCT01723579|Estrogens|estrogens|mesh-ancestor
43683610|NCT01723579|Hormones|hormones|mesh-ancestor
43683611|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683612|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683613|NCT01689909|Zolpidem|zolpidem|mesh-list
43683614|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43683615|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43683616|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683617|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683618|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43683619|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
43683620|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
43683659|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683660|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683661|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683663|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683664|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683665|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683666|NCT00817076|Desloratadine|desloratadine|mesh-list
43683667|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683668|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
43849461|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43849462|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43849463|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849464|NCT03926338|Analgesics|analgesics|mesh-ancestor
43849465|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
43849466|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628687|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628688|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
43628689|NCT03064633|Hormones|hormones|mesh-ancestor
43628690|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628691|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43628692|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628693|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
43628694|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628695|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628696|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628697|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
43628698|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628699|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
43628700|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43628701|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633161|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
43687653|NCT02818491|BB 1101|bb 1101|mesh-list
43628703|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43687685|NCT02818270|Expectorants|expectorants|mesh-ancestor
43687686|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
43687687|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43687688|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
43687689|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687690|NCT02818270|Protective Agents|protective agents|mesh-ancestor
43687691|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687692|NCT02818270|Antidotes|antidotes|mesh-ancestor
43687693|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43687694|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
43687695|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687696|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43687697|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
43687698|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628704|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43628706|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
43628707|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628708|NCT03064542|Carbimazole|carbimazole|mesh-list
43628709|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
43628710|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
43628719|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
43628720|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
43628721|NCT03064191|Calcium|calcium|mesh-list
43628722|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43628723|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628724|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43628725|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43628726|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628727|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
43628728|NCT03064165|Epinephrine|epinephrine|mesh-list
43628729|NCT03064165|Bupivacaine|bupivacaine|mesh-list
43628730|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628731|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
43628732|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628733|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628734|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
43628735|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628736|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43628737|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43628738|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
43628739|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628740|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628741|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43628742|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43628743|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
43683669|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683670|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683671|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683672|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683673|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683674|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
43628744|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43628745|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
43628746|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
43628747|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
43628748|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43628749|NCT03064295|Adenosine|adenosine|mesh-list
43628750|NCT03064295|Regadenoson|regadenoson|mesh-list
43829659|NCT05414409|Metformin|metformin|mesh-list
43628751|NCT03064295|Analgesics|analgesics|mesh-ancestor
43628752|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
43628753|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628754|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628755|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43628756|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
43628757|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43628758|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
43628759|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
43628760|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628761|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628762|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43628763|NCT03064243|Apatinib|apatinib|mesh-list
43628764|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628765|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43628766|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628767|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628768|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
43628769|NCT03063983|Methotrexate|methotrexate|mesh-list
43628770|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43628771|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
43628772|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628773|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628774|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43628775|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
43628779|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43628780|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
43628781|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43628782|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43628783|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
43628784|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
43628785|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628786|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43633191|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
43687703|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687704|NCT02818387|Midazolam|midazolam|mesh-list
43687705|NCT02818387|Remifentanil|remifentanil|mesh-list
43687706|NCT02818387|Propofol|propofol|mesh-list
43687707|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43687708|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628787|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43628788|NCT03064035|Thrombin|thrombin|mesh-list
43628789|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
43628790|NCT03064035|Coagulants|coagulants|mesh-ancestor
43628791|NCT03063762|Bevacizumab|bevacizumab|mesh-list
43628792|NCT03063762|Atezolizumab|atezolizumab|mesh-list
43628793|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43628794|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628795|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43628796|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43628797|NCT03063762|Growth Substances|growth substances|mesh-ancestor
43628798|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628799|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
43628800|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
43628801|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43628802|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43628803|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683676|NCT00817050|Fluticasone|fluticasone|mesh-list
43683677|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
43628816|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43628817|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628818|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628819|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628820|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
43628821|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
43628822|NCT03063775|Coagulants|coagulants|mesh-ancestor
43628823|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
43628824|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
43628825|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628826|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43628827|NCT03063580|Rifampin|rifampin|mesh-list
43628828|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43628829|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
43628830|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43687709|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687710|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43628831|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628832|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
43628833|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43628834|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687739|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43687740|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43687741|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43628835|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628836|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43628837|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43687742|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43687744|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628838|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43687745|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
43687746|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687747|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687748|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
43687749|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687750|NCT02817932|Ranolazine|ranolazine|mesh-list
43687751|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43687752|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687753|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687754|NCT02818049|Dimercaprol|dimercaprol|mesh-list
43687755|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
43687756|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
43628839|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43628840|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43628841|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43628842|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43628843|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43628844|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628845|NCT03063541|Aspirin|aspirin|mesh-list
43683692|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
43683693|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683694|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683695|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43683696|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683697|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683698|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683699|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683700|NCT00816972|Urological Agents|urological agents|mesh-ancestor
43683701|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43683702|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639148|NCT03554473|Temozolomide|temozolomide|mesh-list
43687757|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687758|NCT02817750|Zolpidem|zolpidem|mesh-list
43687760|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43628864|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
43628877|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43628878|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
43628879|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849467|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628880|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633225|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
43633226|NCT05611593|Finasteride|finasteride|mesh-list
43633227|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43633228|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43633229|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633230|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633231|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
43633232|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628882|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43628883|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
43628884|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
43628885|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43628886|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43628887|NCT03063788|Copper|copper|mesh-list
43628888|NCT03063788|Trace Elements|trace elements|mesh-ancestor
43628889|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
43628890|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628891|NCT03063658|Acetaminophen|acetaminophen|mesh-list
43628892|NCT03063658|Ibuprofen|ibuprofen|mesh-list
43628893|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43628894|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633233|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633237|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633238|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
43633239|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
43633240|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
43633241|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687762|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687763|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43687764|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
43687765|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
43687766|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687767|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687768|NCT02817477|Ketamine|ketamine|mesh-list
43687769|NCT02817477|Morphine|morphine|mesh-list
43687770|NCT02817477|Analgesics|analgesics|mesh-ancestor
43687771|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
43687772|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687773|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687776|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
43683718|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683719|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683720|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
43683721|NCT00794794|Cetirizine|cetirizine|mesh-list
43683722|NCT00794794|Desloratadine|desloratadine|mesh-list
43683723|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683724|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683725|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683726|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683727|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
43683728|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683729|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683730|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683731|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683732|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683733|NCT00794378|Cetirizine|cetirizine|mesh-list
43683734|NCT00794378|Desloratadine|desloratadine|mesh-list
43683735|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683736|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683737|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683738|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683739|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
43683740|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683741|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683742|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683744|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
43687788|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43633264|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633265|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633266|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
43683745|NCT00789152|Levocetirizine|levocetirizine|mesh-list
43683746|NCT00789152|Desloratadine|desloratadine|mesh-list
43683748|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683764|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
43683765|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683766|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683767|NCT00783211|Fexofenadine|fexofenadine|mesh-list
43683768|NCT00783211|Desloratadine|desloratadine|mesh-list
43683769|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683770|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683771|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683772|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683773|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683774|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683775|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43628895|NCT03063658|Analgesics|analgesics|mesh-ancestor
43628896|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
43628897|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628898|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628899|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43628900|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43628901|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43628902|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628903|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628904|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
43628905|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43628906|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43628907|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43628908|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628909|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628910|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43628911|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628912|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628913|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
43628914|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633274|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
43633275|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43633276|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
43633277|NCT05611242|Cangrelor|cangrelor|mesh-list
43633278|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43633279|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43633280|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43633281|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43633282|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
43687845|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687846|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687847|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
43628921|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43628922|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
43628923|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
43628924|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43628925|NCT03063866|Narcotics|narcotics|mesh-ancestor
43687848|NCT02817360|Protective Agents|protective agents|mesh-ancestor
43687849|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43628926|NCT03063866|Analgesics|analgesics|mesh-ancestor
43628927|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
43628928|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628929|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43628932|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43628933|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
43628934|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
43628935|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628936|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628937|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43628938|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43628939|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628940|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628941|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
43628942|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628943|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628944|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43687850|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687852|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
43687866|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
43687867|NCT02816970|Vildagliptin|vildagliptin|mesh-list
43687868|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43687870|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43687871|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
43687872|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687873|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687874|NCT02817191|Tobramycin|tobramycin|mesh-list
43687875|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
43687876|NCT02817191|Dexamethasone|dexamethasone|mesh-list
43687877|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
43683776|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683777|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
43683778|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683779|NCT00783146|Fexofenadine|fexofenadine|mesh-list
43683780|NCT00783146|Desloratadine|desloratadine|mesh-list
43683781|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683782|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683783|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683784|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628945|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43628957|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
43628958|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628959|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43628960|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43628962|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
43628963|NCT03063190|Vitamin D|vitamin d|mesh-list
43628964|NCT03063190|Vitamins|vitamins|mesh-ancestor
43628965|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
43628966|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628967|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43628968|NCT03063242|Sargramostim|sargramostim|mesh-list
43628969|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
43628970|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628971|NCT03062839|Melatonin|melatonin|mesh-list
43628972|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
43628973|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628974|NCT03062839|Protective Agents|protective agents|mesh-ancestor
43628975|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628976|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628977|NCT03062800|Thalidomide|thalidomide|mesh-list
43628978|NCT03062800|Cisplatin|cisplatin|mesh-list
43628980|NCT03062800|Pemetrexed|pemetrexed|mesh-list
43687913|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687914|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43633283|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633284|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687915|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43687916|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687917|NCT02817100|Itraconazole|itraconazole|mesh-list
43687918|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
43687919|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687920|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43687921|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43687922|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687929|NCT02817113|Fluorouracil|fluorouracil|mesh-list
43628981|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628982|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628983|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628984|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43628985|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43628986|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43628987|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
43628992|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43628993|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43628994|NCT03062800|Growth Substances|growth substances|mesh-ancestor
43628995|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
43628996|NCT03062813|Entecavir|entecavir|mesh-list
43628997|NCT03062813|Tacrolimus|tacrolimus|mesh-list
43628998|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43628999|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
43629000|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629001|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43629002|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629003|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629004|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
43629005|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629006|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
43629007|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
43629008|NCT03062904|Miotics|miotics|mesh-ancestor
43629009|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
43683785|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683786|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683787|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683788|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683790|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683791|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
43683792|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683793|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683794|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43629010|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629011|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629012|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43629013|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43629014|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
43629015|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43629016|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43629017|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
43629018|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629019|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629020|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43629021|NCT03062787|Triamcinolone|triamcinolone|mesh-list
43629022|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43629023|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43629024|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
43629025|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43629026|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629027|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
43629028|NCT03062787|Hormones|hormones|mesh-ancestor
43629029|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629030|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629031|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43629032|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
43629033|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629034|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629035|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43629036|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
43629037|NCT03062787|Protective Agents|protective agents|mesh-ancestor
43629038|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
43629039|NCT03063073|Bupivacaine|bupivacaine|mesh-list
43629040|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
43629041|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
43629042|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629043|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629044|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
43629045|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629046|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43629047|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629048|NCT03063073|Analgesics|analgesics|mesh-ancestor
43829030|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847088|NCT04139304|Daratumumab|daratumumab|mesh-list
43847089|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
43847090|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43629049|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43629050|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43629051|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43629052|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
43629053|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629054|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629055|NCT03063112|Ethanol|ethanol|mesh-list
43629056|NCT03063112|Lidocaine|lidocaine|mesh-list
43629057|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
43847091|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
43847092|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629058|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
43629059|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629069|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683795|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
43847093|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847094|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43847095|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
43683796|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683797|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683798|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683799|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
43683800|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43683801|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43629072|NCT03063060|Vitamins|vitamins|mesh-ancestor
43629073|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
43629074|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629075|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43629076|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43629077|NCT03062644|Celecoxib|celecoxib|mesh-list
43629078|NCT03062644|Tramadol|tramadol|mesh-list
43629079|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43629080|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629081|NCT03062644|Analgesics|analgesics|mesh-ancestor
43629082|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
43629083|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629084|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629085|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847096|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847097|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847098|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43847117|NCT04139213|Naloxone|naloxone|mesh-list
43629086|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629087|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43629088|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43629089|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629090|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629091|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43629092|NCT03062644|Narcotics|narcotics|mesh-ancestor
43629093|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629094|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
43629095|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
43629096|NCT03062436|Protective Agents|protective agents|mesh-ancestor
43629097|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629098|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
43629099|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
43629100|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629101|NCT03062631|Amifampridine|amifampridine|mesh-list
43629102|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43629103|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629104|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629105|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43629106|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43629107|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629108|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
43629109|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629110|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
43629111|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629112|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629113|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43629114|NCT03062462|Clopidogrel|clopidogrel|mesh-list
43629115|NCT03062462|Ticagrelor|ticagrelor|mesh-list
43629116|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43629117|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43629118|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43629120|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
43629121|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629122|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688013|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
43688014|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43688015|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688016|NCT02815657|Valsartan|valsartan|mesh-list
43688017|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688018|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43688019|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43688020|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688021|NCT02815787|Glyburide|glyburide|mesh-list
43688022|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43688023|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688024|NCT02815722|Simvastatin|simvastatin|mesh-list
43688025|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43688026|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43688031|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688032|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43688033|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43629125|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43629126|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43629127|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629128|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
43629130|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43629131|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683802|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683803|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43683804|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43683806|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683807|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683808|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43683809|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
43683810|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43683811|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683812|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43629132|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
43629133|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629134|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629135|NCT03061981|Metformin|metformin|mesh-list
43629136|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43629137|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629138|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43629139|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629140|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
43629141|NCT03062163|Resveratrol|resveratrol|mesh-list
43629142|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
43629143|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629144|NCT03062163|Protective Agents|protective agents|mesh-ancestor
43629145|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629146|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629147|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43629148|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
43629149|NCT03062163|Vitamins|vitamins|mesh-ancestor
43629150|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
43629151|NCT03061734|Acetaminophen|acetaminophen|mesh-list
43629152|NCT03061734|Naltrexone|naltrexone|mesh-list
43629153|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629154|NCT03061734|Analgesics|analgesics|mesh-ancestor
43629155|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
43629156|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629157|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629158|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
43629159|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43629160|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43629161|NCT03062150|Cycloserine|cycloserine|mesh-list
43688045|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688046|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
43688047|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
43688048|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688049|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688050|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688051|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
43688052|NCT02815319|Hormones|hormones|mesh-ancestor
43688053|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688054|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43629164|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629165|NCT03062150|Renal Agents|renal agents|mesh-ancestor
43629166|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43629167|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
43629168|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43629169|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
43629170|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629171|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629172|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
43629173|NCT03061656|Melphalan|melphalan|mesh-list
43629174|NCT03061656|Thiotepa|thiotepa|mesh-list
43629175|NCT03061656|Carboplatin|carboplatin|mesh-list
43849468|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629176|NCT03061656|Etoposide|etoposide|mesh-list
43629177|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43629178|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
43629179|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629180|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629181|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43629182|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
43683813|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43683814|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43683816|NCT00751218|Desloratadine|desloratadine|mesh-list
43683817|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683818|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683819|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683820|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683821|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
43683822|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683823|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688055|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688056|NCT02815410|Levetiracetam|levetiracetam|mesh-list
43683824|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683825|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683826|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683827|NCT00751166|Cetirizine|cetirizine|mesh-list
43683828|NCT00751166|Desloratadine|desloratadine|mesh-list
43683829|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683830|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683831|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683832|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
43828583|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828584|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828585|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828586|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828587|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43828588|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43683851|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683852|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683853|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
43683854|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683855|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683856|NCT00704444|Ezetimibe|ezetimibe|mesh-list
43683857|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683858|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683859|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
43683860|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629183|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629184|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629185|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43629186|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43629187|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43629188|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43629189|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629190|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
43629191|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43629192|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43629193|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629194|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
43629195|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
43629196|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43629200|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629201|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629202|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43629203|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629205|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
43629206|NCT03061565|Hematinics|hematinics|mesh-ancestor
43629208|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43629209|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
43629210|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629211|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629212|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43629213|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43629214|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
43629215|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688123|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43688124|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43688125|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43688126|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688127|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688128|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
43688129|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688131|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43629216|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629217|NCT03061058|Cisplatin|cisplatin|mesh-list
43629218|NCT03061058|Docetaxel|docetaxel|mesh-list
43629219|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
43629220|NCT03061058|Irinotecan|irinotecan|mesh-list
43629221|NCT03061058|Pemetrexed|pemetrexed|mesh-list
43629222|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629223|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
43629224|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
43629225|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
43683861|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683862|NCT00653913|Ezetimibe|ezetimibe|mesh-list
43683863|NCT00653913|Pitavastatin|pitavastatin|mesh-list
43683864|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683865|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683866|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
43683867|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683868|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683869|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43683870|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683871|NCT00652431|Niacin|niacin|mesh-list
43683872|NCT00652431|Niacinamide|niacinamide|mesh-list
43683873|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
43683874|NCT00652431|Simvastatin|simvastatin|mesh-list
43688221|NCT02813135|Irinotecan|irinotecan|mesh-list
43688222|NCT02813135|Temozolomide|temozolomide|mesh-list
43688223|NCT02813135|Topotecan|topotecan|mesh-list
43688224|NCT02813135|Olaparib|olaparib|mesh-list
43688225|NCT02813135|Adavosertib|adavosertib|mesh-list
43688226|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688227|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43688228|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43688229|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688230|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43683875|NCT00652431|Ezetimibe|ezetimibe|mesh-list
43683876|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
43629226|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629227|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43629228|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43629229|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629230|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43629231|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43629233|NCT03061006|Dabigatran|dabigatran|mesh-list
43629234|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
43629235|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
43629236|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43629237|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
43629238|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629239|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629240|NCT03061227|Glucagon|glucagon|mesh-list
43629241|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629242|NCT03061227|Hormones|hormones|mesh-ancestor
43629243|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629244|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629246|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
43629247|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
43629248|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
43629249|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629250|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629251|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629252|NCT03061032|Ribavirin|ribavirin|mesh-list
43629253|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
43629254|NCT03061032|Ledipasvir|ledipasvir|mesh-list
43629255|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
43629256|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849469|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629257|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
43629258|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629259|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
43629260|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43629261|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43629262|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629263|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
43629264|NCT03060889|Coagulants|coagulants|mesh-ancestor
43629265|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
43629266|NCT03060603|Hematinics|hematinics|mesh-ancestor
43629267|NCT03060707|Bromides|bromides|mesh-list
43629268|NCT03060707|Rocuronium|rocuronium|mesh-list
43629269|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
43629270|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43683877|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683878|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683879|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
43683880|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683881|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683882|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43683883|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683884|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
43683885|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
43683886|NCT00652431|Vitamins|vitamins|mesh-ancestor
43683887|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
43683888|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683889|NCT00651378|Atorvastatin|atorvastatin|mesh-list
43683890|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43683891|NCT00651378|Ezetimibe|ezetimibe|mesh-list
43629271|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43629272|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43629276|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
43629277|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
43629278|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629279|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629280|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
43629281|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629282|NCT03060850|Abivertinib|abivertinib|mesh-list
43629283|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43629284|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629285|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629287|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43629289|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
43629290|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629291|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629292|NCT03060785|Tenofovir|tenofovir|mesh-list
43629293|NCT03060785|Emtricitabine|emtricitabine|mesh-list
43629294|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
43629295|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629296|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43629297|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43629298|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629299|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633332|NCT05610878|Curcumin|curcumin|mesh-list
43629300|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43629301|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43629302|NCT03060278|Nicotine|nicotine|mesh-list
43629303|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43629304|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
43629305|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629306|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629307|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43629308|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43629309|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
43629310|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629311|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629312|NCT03060304|Tamoxifen|tamoxifen|mesh-list
43629313|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43629314|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43629315|NCT03060304|Estradiol|estradiol|mesh-list
43629316|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43629317|NCT03060304|Estrogens|estrogens|mesh-ancestor
43629318|NCT03060304|Hormones|hormones|mesh-ancestor
43629319|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683892|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683893|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683894|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
43683895|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683896|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683897|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43683898|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683899|NCT00651274|Ezetimibe|ezetimibe|mesh-list
43683900|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43629320|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629321|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43629322|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
43629323|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43688317|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43688318|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688319|NCT02812719|Analgesics|analgesics|mesh-ancestor
43688320|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
43629324|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43629325|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43629326|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
43629327|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43629328|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629329|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43629330|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43629331|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43849470|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43629332|NCT03060265|Acetaminophen|acetaminophen|mesh-list
43629333|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629334|NCT03060265|Analgesics|analgesics|mesh-ancestor
43629335|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
43629336|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629337|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629338|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
43629339|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
43629340|NCT03060070|Ketamine|ketamine|mesh-list
43629341|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43629353|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629355|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43629356|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
43629357|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
43629358|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43629359|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43629361|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43688436|NCT02812043|Amorolfine|amorolfine|mesh-list
43688437|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
43633343|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633344|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43633345|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43633346|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629362|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629363|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629364|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43629365|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
43629366|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629367|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629368|NCT03059849|Adalimumab|adalimumab|mesh-list
43629369|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629370|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629371|NCT03060018|Oxitropium|oxitropium|mesh-list
43629372|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
43629373|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
43629374|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629375|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633347|NCT05701007|Docetaxel|docetaxel|mesh-list
43633348|NCT05701007|Goserelin|goserelin|mesh-list
43633349|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43633350|NCT05701007|Leuprolide|leuprolide|mesh-list
43629376|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
43629377|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43683901|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683902|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
43683903|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683904|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683905|NCT00650819|Simvastatin|simvastatin|mesh-list
43683906|NCT00650819|Ezetimibe|ezetimibe|mesh-list
43683907|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683908|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683909|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
43683910|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683911|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43629378|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43629379|NCT03059979|Prednisolone|prednisolone|mesh-list
43629380|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
43629381|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43629382|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
43629383|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629384|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
43629385|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
43629386|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629387|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629388|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629389|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
43629390|NCT03059979|Hormones|hormones|mesh-ancestor
43629391|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629392|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43629393|NCT03059979|Protective Agents|protective agents|mesh-ancestor
43629394|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43629395|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629396|NCT03060044|Fluticasone|fluticasone|mesh-list
43629397|NCT03060044|Xhance|xhance|mesh-list
43633372|NCT05700903|Leuprolide|leuprolide|mesh-list
43629398|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43629399|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43629400|NCT03060044|Charcoal|charcoal|mesh-list
43629401|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629402|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43629403|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
43629404|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629405|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629406|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43629407|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
43849471|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629408|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
43629409|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43629415|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629416|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
43629417|NCT03060044|Hormones|hormones|mesh-ancestor
43629418|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629419|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
43629420|NCT03060044|Antidotes|antidotes|mesh-ancestor
43629421|NCT03060044|Protective Agents|protective agents|mesh-ancestor
43629422|NCT03059719|Exenatide|exenatide|mesh-list
43629423|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43629424|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629425|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43629426|NCT03059719|Incretins|incretins|mesh-ancestor
43629427|NCT03059719|Hormones|hormones|mesh-ancestor
43629428|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629429|NCT03059862|Tryptophan|tryptophan|mesh-list
43629430|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43629431|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
43629432|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43688465|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
43629433|NCT03060031|Oxytocin|oxytocin|mesh-list
43683912|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43683913|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683914|NCT00423995|Loratadine|loratadine|mesh-list
43683915|NCT00423995|Montelukast|montelukast|mesh-list
43683916|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43683917|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
43688519|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43688520|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43688521|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688522|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688523|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688524|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688525|NCT02811289|Urological Agents|urological agents|mesh-ancestor
43683918|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43683919|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
43683920|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683921|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683922|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43683923|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43683924|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629434|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
43629435|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43629436|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629437|NCT03060005|Dextrans|dextrans|mesh-list
43629438|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
43629439|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
43629440|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
43629441|NCT03059667|Carboplatin|carboplatin|mesh-list
43629442|NCT03059667|Etoposide|etoposide|mesh-list
43629443|NCT03059667|Atezolizumab|atezolizumab|mesh-list
43629444|NCT03059667|Topotecan|topotecan|mesh-list
43629445|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629446|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43629447|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43629448|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43629449|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629450|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629451|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43629452|NCT03059563|Varenicline|varenicline|mesh-list
43629453|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43629454|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43629455|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
43629466|NCT03059277|Aflibercept|aflibercept|mesh-list
43629467|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43629468|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43629469|NCT03059277|Growth Substances|growth substances|mesh-ancestor
43633402|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633403|NCT05700695|Lactulose|lactulose|mesh-list
43633404|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43633405|NCT05700669|Olaparib|olaparib|mesh-list
43633406|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43633407|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629470|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629471|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
43629472|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629474|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
43629475|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
43629476|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43629477|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43629478|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
43629479|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629480|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629481|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629486|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43629487|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43629488|NCT03059303|Simeprevir|simeprevir|mesh-list
43629489|NCT03059303|Odalasvir|odalasvir|mesh-list
43629490|NCT03059303|Omeprazole|omeprazole|mesh-list
43629491|NCT03059303|Lansoprazole|lansoprazole|mesh-list
43629492|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
43629493|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43629494|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629495|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43629496|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629497|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633408|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633409|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633410|NCT05700656|Capecitabine|capecitabine|mesh-list
43633411|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43633412|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
43633413|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633414|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633415|NCT05700630|Vorinostat|vorinostat|mesh-list
43633416|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633417|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43633418|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633419|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633420|NCT05700617|Dobutamine|dobutamine|mesh-list
43688526|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43688527|NCT02811289|Protective Agents|protective agents|mesh-ancestor
43688528|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43688529|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43629498|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
43629499|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629500|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
43629501|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43629502|NCT03059537|Cathartics|cathartics|mesh-ancestor
43629503|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629504|NCT03059238|Celecoxib|celecoxib|mesh-list
43629505|NCT03059238|Parecoxib|parecoxib|mesh-list
43629506|NCT03059238|Oxycodone|oxycodone|mesh-list
43629507|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43629508|NCT03059238|Narcotics|narcotics|mesh-ancestor
43629509|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629510|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629511|NCT03059238|Analgesics|analgesics|mesh-ancestor
43629512|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
43629513|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629530|NCT03059134|Urological Agents|urological agents|mesh-ancestor
43629532|NCT03058939|Paclitaxel|paclitaxel|mesh-list
43629533|NCT03058939|Carboplatin|carboplatin|mesh-list
43629534|NCT03058939|Trastuzumab|trastuzumab|mesh-list
43629535|NCT03058939|Letrozole|letrozole|mesh-list
43629536|NCT03058939|Pertuzumab|pertuzumab|mesh-list
43629537|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43629538|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629540|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
43629541|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
43629542|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629567|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43633427|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43633428|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43633429|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43633430|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
43633431|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633432|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629568|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
43629569|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629570|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43629572|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43629573|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
43629574|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683931|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
43683932|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683933|NCT00380627|Etoricoxib|etoricoxib|mesh-list
43683934|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43683935|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43683936|NCT00380627|Analgesics|analgesics|mesh-ancestor
43683939|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683940|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683941|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43683942|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43683943|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43683944|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629575|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629576|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43629577|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
43629578|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
43629579|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43629580|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43629581|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43629582|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43629583|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
43629584|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829082|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43629585|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629586|NCT03058744|Clobetasol|clobetasol|mesh-list
43629587|NCT03058744|Halobetasol|halobetasol|mesh-list
43629588|NCT03058744|Tazarotene|tazarotene|mesh-list
43629589|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
43629590|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
43629591|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43629592|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629593|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
43629594|NCT03058744|Hormones|hormones|mesh-ancestor
43629595|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629596|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629597|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
43629598|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43629599|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629600|NCT03059056|Empagliflozin|empagliflozin|mesh-list
43629601|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43629602|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629603|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43629604|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629605|NCT03058666|Calfactant|calfactant|mesh-list
43629606|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43629607|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
43629608|NCT03058419|Midazolam|midazolam|mesh-list
43629609|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
43629610|NCT03058419|Caffeine|caffeine|mesh-list
43629611|NCT03058419|Bupropion|bupropion|mesh-list
43629612|NCT03058419|Omeprazole|omeprazole|mesh-list
43629613|NCT03058419|Warfarin|warfarin|mesh-list
43629614|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43629615|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43629616|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629617|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629618|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43629619|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43629637|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
43629638|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43629639|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
43629640|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43629642|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43629643|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
43629644|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43629645|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43629646|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
43629647|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
43629648|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43629649|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43629650|NCT03058536|Progesterone|progesterone|mesh-list
43629651|NCT03058536|Progestins|progestins|mesh-ancestor
43629653|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629654|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629655|NCT03058341|Propofol|propofol|mesh-list
43629656|NCT03058341|Sevoflurane|sevoflurane|mesh-list
43629657|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43633498|NCT05700253|Protective Agents|protective agents|mesh-ancestor
43633499|NCT05700214|Lidocaine|lidocaine|mesh-list
43633500|NCT05700214|Ropivacaine|ropivacaine|mesh-list
43633501|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
43633502|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
43633503|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633504|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633505|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
43633506|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633507|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43633508|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43633509|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43633510|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43629658|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629659|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629660|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43629661|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
43629662|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
43629663|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43629664|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43629665|NCT03058471|Methotrexate|methotrexate|mesh-list
43629666|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43629667|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
43629668|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43629669|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629670|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43629671|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
43629672|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629673|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629674|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
43629675|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629676|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43629677|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43629678|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
43629679|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629680|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43688606|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43633547|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
43629681|NCT03058263|Neostigmine|neostigmine|mesh-list
43629682|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43629683|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683951|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683952|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683953|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683954|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43683955|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43683956|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43683957|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683958|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683959|NCT00319995|Loratadine|loratadine|mesh-list
43683960|NCT00319995|Montelukast|montelukast|mesh-list
43683961|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43683962|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
43683963|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43683964|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
43629684|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629685|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
43629686|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629687|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629688|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43629689|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
43629690|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629691|NCT03058224|Acetaminophen|acetaminophen|mesh-list
43629692|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629693|NCT03058224|Analgesics|analgesics|mesh-ancestor
43629694|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
43629695|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629696|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629702|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43629703|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629704|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43629705|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
43629706|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
43629707|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633548|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
43633550|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43633571|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43633572|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43633573|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
43633574|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633575|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629708|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629710|NCT03058094|Pemetrexed|pemetrexed|mesh-list
43629711|NCT03058094|Abivertinib|abivertinib|mesh-list
43629712|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629713|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629714|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629715|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43629716|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43629717|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43629718|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
43629719|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
43629720|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43629721|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43629722|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629723|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43629724|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629725|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629726|NCT03057769|Indomethacin|indomethacin|mesh-list
43629727|NCT03057769|Epinephrine|epinephrine|mesh-list
43629728|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43629729|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43629730|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
43629731|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629732|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683965|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683966|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683967|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43683968|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43683969|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633576|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633578|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
43633582|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43633583|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
43633584|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43633585|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43688651|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688652|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
43688653|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688654|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688655|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43688656|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683970|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
43683971|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683972|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683973|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683974|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683975|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
43629733|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629734|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43629735|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43629736|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
43629737|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629738|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43629739|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
43629747|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629748|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629749|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
43629750|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
43629751|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43629752|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43629753|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629754|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43629755|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43629756|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629757|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
43629758|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43629760|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629761|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43629762|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629764|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
43688657|NCT02809781|Etanercept|etanercept|mesh-list
43688658|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43688659|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688660|NCT02809781|Analgesics|analgesics|mesh-ancestor
43688661|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
43688681|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688682|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43688683|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43688684|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
43688685|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43688686|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
43688687|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43688701|NCT02809937|Analgesics|analgesics|mesh-ancestor
43629765|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629766|NCT03057470|Insulin|insulin|mesh-list
43629767|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43629768|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43629776|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629777|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43629778|NCT03057574|Hormones|hormones|mesh-ancestor
43629779|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629780|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629781|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43629782|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
43629783|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
43629784|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629785|NCT03057145|Olaparib|olaparib|mesh-list
43629786|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43629787|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629788|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683976|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
43683977|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683978|NCT00311844|Desloratadine|desloratadine|mesh-list
43683979|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683980|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683981|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683982|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683983|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683984|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683985|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43683986|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683987|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
43683988|NCT00212836|Olanzapine|olanzapine|mesh-list
43683989|NCT00212836|Asenapine|asenapine|mesh-list
43683990|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
43683991|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
43683992|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683993|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683994|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43683995|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43683996|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43683997|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683998|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43683999|NCT00212836|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43684000|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43684001|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684002|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684003|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684020|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684021|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
43684022|NCT00212771|Olanzapine|olanzapine|mesh-list
43684023|NCT00212771|Asenapine|asenapine|mesh-list
43684024|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
43684025|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
43684026|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684027|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629789|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629790|NCT03057041|Fentanyl|fentanyl|mesh-list
43629791|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43629792|NCT03057041|Narcotics|narcotics|mesh-ancestor
43629793|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629794|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633635|NCT05699655|Apatinib|apatinib|mesh-list
43629795|NCT03057041|Analgesics|analgesics|mesh-ancestor
43629796|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
43629797|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629798|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43629799|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43629800|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
43629802|NCT03056846|Sulfalene|sulfalene|mesh-list
43629803|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629804|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43629805|NCT03056846|Renal Agents|renal agents|mesh-ancestor
43633655|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43688735|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43688736|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688737|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688738|NCT02809729|Cefazolin|cefazolin|mesh-list
43688739|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43688740|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688741|NCT02809573|Prednisone|prednisone|mesh-list
43688742|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
43688743|NCT02809573|Vincristine|vincristine|mesh-list
43688744|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43688745|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
43688746|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688747|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43688748|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43688749|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
43688750|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688751|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688755|NCT02809573|Hormones|hormones|mesh-ancestor
43688816|NCT02809079|Hormones|hormones|mesh-ancestor
43688817|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688818|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688819|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43688820|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688821|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43688822|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43688823|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
43688824|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43688825|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633658|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
43633659|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
43633660|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43633661|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633662|NCT05699356|Estrogens|estrogens|mesh-list
43633663|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43633664|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633665|NCT05699356|Hormones|hormones|mesh-ancestor
43633666|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633667|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43633668|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633669|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633670|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43629806|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
43629807|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43629808|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43629809|NCT03057015|Dexamethasone|dexamethasone|mesh-list
43629810|NCT03057015|Clonidine|clonidine|mesh-list
43629811|NCT03057015|Epinephrine|epinephrine|mesh-list
43629812|NCT03057015|Ropivacaine|ropivacaine|mesh-list
43629813|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629814|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
43629815|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
43629816|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629817|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629818|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629819|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
43629820|NCT03057015|Hormones|hormones|mesh-ancestor
43629821|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43629822|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43629823|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629824|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
43629825|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
43629826|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629827|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
43629828|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43629829|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43629830|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
43629831|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629832|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629833|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43629834|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43629835|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43629845|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
43629846|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629847|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43629848|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629849|NCT03056495|Vorinostat|vorinostat|mesh-list
43629850|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629851|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43629852|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629853|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629854|NCT03056625|Vitamin A|vitamin a|mesh-list
43629855|NCT03056625|Vitamins|vitamins|mesh-ancestor
43629856|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
43629857|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629858|NCT03056703|Aspirin|aspirin|mesh-list
43629859|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43629860|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684028|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684029|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43684030|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43684031|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684032|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43684033|NCT00212771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43633671|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
43633672|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43633683|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633685|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43633686|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633687|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
43633688|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43633689|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633690|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684034|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43684035|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684036|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629861|NCT03056703|Analgesics|analgesics|mesh-ancestor
43629862|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
43629863|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629867|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43629868|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43633720|NCT05698680|Prednisolone|prednisolone|mesh-list
43633721|NCT05698680|Colchicine|colchicine|mesh-list
43633722|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633723|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
43633724|NCT05698680|Hormones|hormones|mesh-ancestor
43688853|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688854|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629869|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629870|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43629871|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43629872|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629873|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
43629874|NCT03056482|Haloperidol|haloperidol|mesh-list
43629875|NCT03056482|Ondansetron|ondansetron|mesh-list
43629876|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
43629877|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
43629878|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
43629879|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629880|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629881|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629882|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
43629883|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
43629884|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43629885|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
43629886|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629887|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629888|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43629889|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43629890|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629891|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43629892|NCT03056482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43629893|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43629894|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
43688855|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688856|NCT02808741|Olorofim|olorofim|mesh-list
43688857|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
43688858|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688859|NCT02808728|Bupivacaine|bupivacaine|mesh-list
43629895|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43629896|NCT03056599|Gemcitabine|gemcitabine|mesh-list
43629897|NCT03056599|Interferons|interferons|mesh-list
43629898|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
43629899|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
43629900|NCT03056599|Aldesleukin|aldesleukin|mesh-list
43629901|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
43629902|NCT03056599|Docetaxel|docetaxel|mesh-list
43629903|NCT03056599|Doxorubicin|doxorubicin|mesh-list
43629904|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
43629905|NCT03056599|Nivolumab|nivolumab|mesh-list
43629906|NCT03056599|Bortezomib|bortezomib|mesh-list
43629907|NCT03056599|Ipilimumab|ipilimumab|mesh-list
43629915|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
43629916|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629917|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629918|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
43629919|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629920|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629921|NCT03056599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43629922|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
43629923|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629924|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
43684038|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
43684039|NCT00202904|Ezetimibe|ezetimibe|mesh-list
43684040|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43684041|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684042|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
43684043|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684044|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684045|NCT00157924|Atorvastatin|atorvastatin|mesh-list
43684046|NCT00157924|Simvastatin|simvastatin|mesh-list
43684047|NCT00157924|Ezetimibe|ezetimibe|mesh-list
43684048|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43684049|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684050|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
43633726|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688898|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688899|NCT02808091|Bortezomib|bortezomib|mesh-list
43688900|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688901|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
43633794|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43633795|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
43633796|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633797|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43633798|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43684051|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684052|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684053|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43684054|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684055|NCT00157911|Simvastatin|simvastatin|mesh-list
43684056|NCT00157911|Ezetimibe|ezetimibe|mesh-list
43684057|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43684058|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684059|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
43684060|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684061|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43633799|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
43633800|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629928|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43629929|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43633801|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633802|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43633803|NCT05697965|Vancomycin|vancomycin|mesh-list
43633814|NCT05697809|Hormones|hormones|mesh-ancestor
43629930|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43629931|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43629932|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43629933|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43629934|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43629935|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
43629936|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43629937|NCT03056391|Acetaminophen|acetaminophen|mesh-list
43629938|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629939|NCT03056391|Analgesics|analgesics|mesh-ancestor
43629940|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
43629941|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629942|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629943|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
43684063|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684066|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
43684067|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
43684068|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684069|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684070|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684071|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43629944|NCT03056274|Metformin|metformin|mesh-list
43629945|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43629946|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43629947|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629948|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43629949|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43629950|NCT03056118|Aspirin|aspirin|mesh-list
43629951|NCT03056118|Clopidogrel|clopidogrel|mesh-list
43688917|NCT02807909|Itraconazole|itraconazole|mesh-list
43688946|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688947|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688948|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43688950|NCT02807870|Methylphenidate|methylphenidate|mesh-list
43688951|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43688952|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688953|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43688954|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43688955|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688956|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688957|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
43688958|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688959|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43633845|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
43633846|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43688963|NCT02807610|Propofol|propofol|mesh-list
43629952|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43629953|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629954|NCT03056118|Analgesics|analgesics|mesh-ancestor
43629955|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
43629956|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629957|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629958|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43629959|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43629960|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43629961|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43629962|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629963|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43629964|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43629965|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43629966|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
43629967|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43629968|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43629969|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43629970|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
43629971|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629972|NCT03056079|Aflibercept|aflibercept|mesh-list
43629973|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43629974|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43629975|NCT03056079|Growth Substances|growth substances|mesh-ancestor
43629976|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629977|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
43629978|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629984|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43629985|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
43629986|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
43629987|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629988|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629989|NCT03056261|Anesthetics|anesthetics|mesh-list
43629990|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629991|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629996|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629997|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
43688965|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688966|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688967|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688968|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43629998|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630000|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
43630001|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43688969|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
43688970|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
43688971|NCT02807571|Anesthetics|anesthetics|mesh-list
43688972|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688973|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829089|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829090|NCT05450965|Onvansertib|onvansertib|mesh-list
43829091|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43829092|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829093|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829094|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
43829095|NCT05449392|Petrolatum|petrolatum|mesh-list
43829128|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43829129|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829130|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43829131|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829132|NCT05444036|Ketamine|ketamine|mesh-list
43829133|NCT05444036|Analgesics|analgesics|mesh-ancestor
43633861|NCT05697614|Analgesics|analgesics|mesh-ancestor
43633862|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
43633863|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633864|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43633865|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43633872|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633873|NCT05697471|Dienogest|dienogest|mesh-list
43633874|NCT05697471|Danazol|danazol|mesh-list
43688974|NCT02807441|Aspirin|aspirin|mesh-list
43688975|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43688976|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688977|NCT02807441|Analgesics|analgesics|mesh-ancestor
43688978|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
43688979|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688980|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688981|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688982|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43688983|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43630002|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630003|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630004|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
43684073|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684074|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43684075|NCT00156117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43688984|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43688985|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684076|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43684077|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684078|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684079|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684080|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
43684081|NCT00156104|Haloperidol|haloperidol|mesh-list
43684082|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
43684083|NCT00156104|Asenapine|asenapine|mesh-list
43684084|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
43684085|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
43684086|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684087|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630005|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630006|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630007|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630008|NCT03055663|Midazolam|midazolam|mesh-list
43630009|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43630010|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43630011|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630012|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630013|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43630014|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630015|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630016|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43633875|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43633876|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
43633877|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43633878|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633879|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43630017|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
43630019|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
43630020|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
43630021|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630022|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630024|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43630025|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630026|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630027|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
43630028|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630029|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630030|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
43630031|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43630032|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43630033|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43630034|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630035|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630036|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43630037|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43630038|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630039|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
43684088|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684089|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43684090|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43684091|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684092|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43684093|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43684094|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
43684095|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684096|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684097|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43684099|NCT00156091|Asenapine|asenapine|mesh-list
43684100|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
43684101|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
43684102|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684103|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684104|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684105|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43684106|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43684107|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684108|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43684109|NCT00156091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43684110|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43684111|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684112|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684113|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684114|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
43684115|NCT00142558|Indomethacin|indomethacin|mesh-list
43684116|NCT00142558|Etoricoxib|etoricoxib|mesh-list
43684117|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684118|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684119|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684120|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684121|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43630040|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630041|NCT03055793|Budesonide|budesonide|mesh-list
43630042|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
43630043|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684122|NCT00142558|Analgesics|analgesics|mesh-ancestor
43684123|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
43633880|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43684124|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684125|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684126|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
43684127|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
43684128|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43684129|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684130|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684131|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684132|NCT00140985|Losartan|losartan|mesh-list
43684133|NCT00140985|Amlodipine|amlodipine|mesh-list
43684134|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43684135|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43684136|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684137|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684138|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43684139|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684140|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
43684141|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43684142|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43684143|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43684144|NCT00140972|Diclofenac|diclofenac|mesh-list
43684145|NCT00140972|Etoricoxib|etoricoxib|mesh-list
43684146|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684147|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684148|NCT00140972|Analgesics|analgesics|mesh-ancestor
43684149|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
43684150|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630119|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43630120|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43630121|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630129|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
43630130|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43630131|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43630132|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
43630134|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43630135|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630175|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630177|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43630178|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
43630179|NCT03054220|Paroxetine|paroxetine|mesh-list
43630180|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43630181|NCT03054220|Narcotics|narcotics|mesh-ancestor
43630182|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630183|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630184|NCT03054220|Analgesics|analgesics|mesh-ancestor
43630185|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
43684196|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684197|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684198|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43684199|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684200|NCT00127179|Finasteride|finasteride|mesh-list
43639149|NCT03554473|Topotecan|topotecan|mesh-list
43630216|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630217|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633979|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
43633983|NCT05696886|Meperidine|meperidine|mesh-list
43630218|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630232|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43630233|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43630234|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630235|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630236|NCT03053739|Urological Agents|urological agents|mesh-ancestor
43630237|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43630238|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43630241|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
43630242|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43630243|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630244|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
43630245|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
43630246|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
43630247|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630248|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43630249|NCT03053869|Diazepam|diazepam|mesh-list
43630260|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43630261|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630262|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43684203|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43684204|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43634059|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684205|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684206|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
43684207|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43684208|NCT00127179|Urological Agents|urological agents|mesh-ancestor
43684209|NCT00110435|Atorvastatin|atorvastatin|mesh-list
43684210|NCT00110435|Simvastatin|simvastatin|mesh-list
43684211|NCT00110435|Ezetimibe|ezetimibe|mesh-list
43684212|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43684213|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684214|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
43684215|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684216|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684217|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43684218|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684219|NCT00095017|Etoricoxib|etoricoxib|mesh-list
43684220|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684221|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684223|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
43684224|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630282|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630283|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43630284|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43634105|NCT05695664|Ibuprofen|ibuprofen|mesh-list
43630285|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684226|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684227|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630286|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630288|NCT03053830|Analgesics|analgesics|mesh-ancestor
43630289|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
43630290|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630291|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630292|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43630293|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630294|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
43630295|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
43630296|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630297|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43630298|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43630299|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630323|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
43630324|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634125|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634126|NCT05695508|Dexamethasone|dexamethasone|mesh-list
43634127|NCT05695508|Lenalidomide|lenalidomide|mesh-list
43634128|NCT05695508|Bortezomib|bortezomib|mesh-list
43634129|NCT05695508|Daratumumab|daratumumab|mesh-list
43634130|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43634131|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
43634132|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
43634133|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634138|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634140|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634141|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
43634142|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43634143|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43634144|NCT05695508|Growth Substances|growth substances|mesh-ancestor
43634145|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
43689076|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43630325|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684243|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684245|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684246|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684254|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43684255|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43684256|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
43684257|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684258|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43684259|NCT00092781|Celecoxib|celecoxib|mesh-list
43684260|NCT00092781|Etoricoxib|etoricoxib|mesh-list
43684261|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684262|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684263|NCT00092781|Analgesics|analgesics|mesh-ancestor
43684264|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
43684265|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684266|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630326|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630327|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630328|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43630329|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630330|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
43630331|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
43630332|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
43630334|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
43630335|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
43630336|NCT03053414|Vitamins|vitamins|mesh-ancestor
43630337|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
43630338|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630339|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43684294|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684295|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684297|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684298|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684299|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684300|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684302|NCT00092742|Etoricoxib|etoricoxib|mesh-list
43684303|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43689112|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634170|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43634171|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684304|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43630403|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630404|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630405|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
43630406|NCT03052348|Betamethasone|betamethasone|mesh-list
43630407|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
43630408|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43630409|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
43630410|NCT03052348|Ether|ether|mesh-list
43630411|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43630412|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630413|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
43630414|NCT03052348|Hormones|hormones|mesh-ancestor
43630415|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630416|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630417|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43630418|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
43630419|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43630420|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
43630421|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
43630422|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630423|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43630424|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43630425|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43630426|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630427|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684305|NCT00092742|Analgesics|analgesics|mesh-ancestor
43684306|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
43684314|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43630454|NCT03051945|Ketamine|ketamine|mesh-list
43630455|NCT03051945|Analgesics|analgesics|mesh-ancestor
43630456|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
43630457|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630458|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630459|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43684363|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684364|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684365|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43684366|NCT02844114|Gemcitabine|gemcitabine|mesh-list
43684367|NCT02844114|Cisplatin|cisplatin|mesh-list
43684368|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684369|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43684370|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
43684371|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684372|NCT02844114|Antiviral Agents|antiviral agents|mesh-ancestor
43684373|NCT02844114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684374|NCT02844114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684375|NCT02844114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684376|NCT02844114|Immunologic Factors|immunologic factors|mesh-ancestor
43684377|NCT02844114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684378|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
43684379|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43684380|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684404|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43684405|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
43684406|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684407|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684408|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684409|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43828589|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828590|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43828591|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43828592|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634203|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634218|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634219|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43634225|NCT05692297|Denosumab|denosumab|mesh-list
43828594|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43630487|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630488|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43630489|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43630490|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43630491|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630492|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43630493|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43630494|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630496|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634233|NCT05691933|Analgesics|analgesics|mesh-ancestor
43634234|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
43634235|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630497|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630498|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43630499|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43630500|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630501|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43630502|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43630503|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630504|NCT03051529|Anesthetics|anesthetics|mesh-list
43630505|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630506|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630507|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43630514|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43630515|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43630516|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43630517|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630518|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630519|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630520|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43634236|NCT05691920|Fentanyl|fentanyl|mesh-list
43634237|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43630521|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43630522|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43630523|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43630524|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
43630525|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630527|NCT03051503|Morphine|morphine|mesh-list
43630528|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43630529|NCT03051503|Narcotics|narcotics|mesh-ancestor
43630530|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828595|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43828596|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43828597|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
43828598|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828599|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
43828600|NCT05476042|Hematinics|hematinics|mesh-ancestor
43828601|NCT05476003|Midazolam|midazolam|mesh-list
43828602|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43828603|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43828604|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828605|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828606|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43828607|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43828608|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43828609|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43828610|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
43828611|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
43828612|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
43828613|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
43828614|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603011|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
43630536|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630537|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
43630538|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
43630539|NCT03051451|Metformin|metformin|mesh-list
43630540|NCT03051451|Fluoxetine|fluoxetine|mesh-list
43630541|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43630542|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630543|NCT03051451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43630544|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43630545|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43630546|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630557|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43630559|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43630560|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630561|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
43630562|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
43630563|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
43630564|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828615|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828616|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43634256|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
43634261|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
43828617|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
43828618|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
43828620|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
43828621|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
43828622|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828623|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634291|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
43634292|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43634293|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
43634294|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43634295|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
43634296|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828624|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43828625|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
43828626|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
43828627|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43828628|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
43828629|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603510|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
43630566|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
43630567|NCT03051373|Antiviral Agents|antiviral agents|mesh-ancestor
43630568|NCT03051373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43630569|NCT03051373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630570|NCT03051373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43630571|NCT03051373|Immunologic Factors|immunologic factors|mesh-ancestor
43630572|NCT03051373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630573|NCT03051087|Ganirelix|ganirelix|mesh-list
43630574|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
43630575|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630576|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630577|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
43630578|NCT03051269|Calcium|calcium|mesh-list
43630579|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43630580|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630581|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43630582|NCT03051243|Insulin|insulin|mesh-list
43630583|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43630584|NCT03051243|Linagliptin|linagliptin|mesh-list
43630585|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43630586|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630587|NCT03051243|Incretins|incretins|mesh-ancestor
43630588|NCT03051243|Hormones|hormones|mesh-ancestor
43630589|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630590|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43630591|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
43630592|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630593|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630594|NCT03050866|Antiemetics|antiemetics|mesh-list
43828648|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43828649|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828650|NCT05475639|Analgesics|analgesics|mesh-ancestor
43828651|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
43828652|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828653|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828654|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828655|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828656|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43828657|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828658|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828659|NCT05475613|Lenvatinib|lenvatinib|mesh-list
43684410|NCT02843126|Trastuzumab|trastuzumab|mesh-list
43684411|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684412|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684413|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
43684423|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
43684424|NCT02842931|Doxorubicin|doxorubicin|mesh-list
43684425|NCT02842931|Etoposide|etoposide|mesh-list
43684426|NCT02842931|Vincristine|vincristine|mesh-list
43684427|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684428|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
43684429|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684430|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684431|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43630602|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630603|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
43630604|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630605|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630606|NCT03050905|Ritonavir|ritonavir|mesh-list
43630607|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43630608|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43630609|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
43630610|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689158|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630611|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630612|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43630621|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630622|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630623|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43630624|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43630625|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
43630626|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630627|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630628|NCT03050827|Urological Agents|urological agents|mesh-ancestor
43630629|NCT03050957|Menthol|menthol|mesh-list
43630630|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
43630631|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
43630632|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43630633|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
43630634|NCT03051009|Coagulants|coagulants|mesh-ancestor
43630635|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43630636|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
43689221|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43689222|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689223|NCT02805738|Tenofovir|tenofovir|mesh-list
43689224|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
43689225|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689226|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43689227|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43689228|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689229|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689231|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43689232|NCT02805920|Bupivacaine|bupivacaine|mesh-list
43689233|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
43689234|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
43689235|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689236|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689237|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
43689238|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829134|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
43829135|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829136|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829137|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43705520|NCT04594551|Vaccines|vaccines|mesh-list
43630637|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630638|NCT03051022|Dexamethasone|dexamethasone|mesh-list
43630639|NCT03051022|Morphine|morphine|mesh-list
43630640|NCT03051022|Bupivacaine|bupivacaine|mesh-list
43630641|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829138|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43829139|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
43829140|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
43829141|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829142|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43630660|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
43630661|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
43829143|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43829144|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829145|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829146|NCT05443555|Gabapentin|gabapentin|mesh-list
43829147|NCT05443555|Analgesics|analgesics|mesh-ancestor
43829148|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
43829149|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634300|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
43634301|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43630662|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630663|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630664|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
43630665|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630666|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43684433|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684434|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684435|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43684436|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43684437|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43684438|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43684439|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684440|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43684441|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684442|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
43684443|NCT02842931|Hormones|hormones|mesh-ancestor
43684444|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43684445|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43684446|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
43684447|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
43684448|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
43684449|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
43684450|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
43684451|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
43684452|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43684453|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43684454|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684455|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630667|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43630668|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43630669|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43630670|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630672|NCT03050437|Pemetrexed|pemetrexed|mesh-list
43630673|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630674|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630675|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630676|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43630677|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43630678|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43630679|NCT03050411|Apatinib|apatinib|mesh-list
43630680|NCT03050411|Gefitinib|gefitinib|mesh-list
43630681|NCT03050411|Osimertinib|osimertinib|mesh-list
43630695|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43630697|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630698|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630699|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630700|NCT03050177|Gefitinib|gefitinib|mesh-list
43630701|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630702|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43630703|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630704|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630705|NCT03050229|Empagliflozin|empagliflozin|mesh-list
43684456|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684477|NCT02842580|Bevacizumab|bevacizumab|mesh-list
43684478|NCT02842580|Capecitabine|capecitabine|mesh-list
43684479|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
43684480|NCT02842580|Irinotecan|irinotecan|mesh-list
43684481|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
43684483|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684495|NCT02842580|Antidotes|antidotes|mesh-ancestor
43684525|NCT02842125|Nivolumab|nivolumab|mesh-list
43684526|NCT02842125|Capecitabine|capecitabine|mesh-list
43684527|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684531|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689266|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
43689267|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689268|NCT02805556|Fostemsavir|fostemsavir|mesh-list
43630709|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630710|NCT03050164|Gefitinib|gefitinib|mesh-list
43630711|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630725|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43630726|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43630727|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630728|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630729|NCT03049878|Acetaminophen|acetaminophen|mesh-list
43630730|NCT03049878|Codeine|codeine|mesh-list
43630731|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43630732|NCT03049878|Analgesics|analgesics|mesh-ancestor
43630733|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
43630734|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630735|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630736|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
43630737|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43630738|NCT03049878|Narcotics|narcotics|mesh-ancestor
43630739|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630740|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
43630741|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
43630743|NCT03049163|Propoxycaine|propoxycaine|mesh-list
43630753|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43630754|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
43630755|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43630756|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43630757|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43630758|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630759|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630760|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43630761|NCT03049059|Hydroquinone|hydroquinone|mesh-list
43630762|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
43630763|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630764|NCT03049059|Protective Agents|protective agents|mesh-ancestor
43630765|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630766|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43630777|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
43634437|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630778|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
43630779|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
43630780|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630781|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630782|NCT03049267|Apremilast|apremilast|mesh-list
43630783|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43630784|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43630785|NCT03049267|Analgesics|analgesics|mesh-ancestor
43630786|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
43684599|NCT02841332|Bevacizumab|bevacizumab|mesh-list
43684600|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684601|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684602|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43684603|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43684604|NCT02841332|Growth Substances|growth substances|mesh-ancestor
43684605|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684606|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
43684607|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43684608|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43684609|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684610|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
43684612|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684613|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684614|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43684615|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684616|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
43689300|NCT02805049|Echinocandins|echinocandins|mesh-list
43689301|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
43689302|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689303|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689304|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689305|NCT02805231|Vitamin D|vitamin d|mesh-list
43684617|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
43684618|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43684619|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43684620|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684621|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43684622|NCT02841137|Progesterone|progesterone|mesh-list
43684623|NCT02841137|Progestins|progestins|mesh-ancestor
43684624|NCT02841137|Hormones|hormones|mesh-ancestor
43684625|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43684626|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684629|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684630|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684631|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
43684632|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684633|NCT02840929|Esomeprazole|esomeprazole|mesh-list
43684634|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43630787|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630788|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630789|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684635|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684636|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43684637|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684638|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684639|NCT02840708|Sargramostim|sargramostim|mesh-list
43684640|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
43684641|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684642|NCT02840539|Cytarabine|cytarabine|mesh-list
43689306|NCT02805231|Vitamins|vitamins|mesh-ancestor
43689307|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
43689310|NCT02805010|Abatacept|abatacept|mesh-list
43684643|NCT02840539|Dexamethasone|dexamethasone|mesh-list
43684644|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
43684645|NCT02840539|Bortezomib|bortezomib|mesh-list
43684646|NCT02840539|BB 1101|bb 1101|mesh-list
43684647|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684648|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
43684649|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
43684650|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684651|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630790|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630791|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43630792|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43634530|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634531|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43634532|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43634533|NCT05618613|Onapristone|onapristone|mesh-list
43634534|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634535|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43634536|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
43634537|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43634538|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634539|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
43634551|NCT05604170|Ganaxolone|ganaxolone|mesh-list
43634563|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
43630793|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630794|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630795|NCT03049046|Caffeic acid|caffeic acid|mesh-list
43630796|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
43630797|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630798|NCT03049046|Protective Agents|protective agents|mesh-ancestor
43630799|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630800|NCT03049085|Aspirin|aspirin|mesh-list
43630801|NCT03049085|Ascorbic Acid|ascorbic acid|mesh-list
43630802|NCT03049085|Vitamins|vitamins|mesh-ancestor
43630803|NCT03049085|Micronutrients|micronutrients|mesh-ancestor
43630804|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630805|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43630806|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43630807|NCT03049085|Analgesics|analgesics|mesh-ancestor
43630808|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
43630809|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630819|NCT03049085|Antioxidants|antioxidants|mesh-ancestor
43630820|NCT03049085|Protective Agents|protective agents|mesh-ancestor
43630822|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630823|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630824|NCT03048877|Apatinib|apatinib|mesh-list
43630825|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630826|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43630827|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630828|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630829|NCT03048942|Paclitaxel|paclitaxel|mesh-list
43630830|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43630831|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630832|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
43630833|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
43630834|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
43630835|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630836|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43630837|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684652|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684653|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
43684654|NCT02840539|Hormones|hormones|mesh-ancestor
43684655|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43684656|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43684657|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684658|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
43684659|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684660|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684661|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43684662|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
43684663|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
43684664|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689381|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
43689382|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
43634621|NCT05587673|Hormones|hormones|mesh-ancestor
43847146|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684665|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684666|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
43684667|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43684668|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
43684669|NCT02840240|Gabapentin|gabapentin|mesh-list
43684670|NCT02840240|Analgesics|analgesics|mesh-ancestor
43684671|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
43684672|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684673|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684674|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
43684675|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43684676|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43684677|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684678|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43684679|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43684680|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43684681|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684682|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684683|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
43684684|NCT02840526|Acetaminophen|acetaminophen|mesh-list
43630838|NCT03048474|Nivolumab|nivolumab|mesh-list
43630839|NCT03048474|Ipilimumab|ipilimumab|mesh-list
43630840|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43630841|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630842|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43630843|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630859|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43630860|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43630861|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
43630862|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43630863|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
43630864|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43630865|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43630866|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43630867|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43630868|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43630869|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43847148|NCT04136756|Daratumumab|daratumumab|mesh-list
43847149|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847150|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847151|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
43847152|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847153|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848954|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43848955|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848956|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
43848957|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
43848958|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
43848959|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634624|NCT05587673|Protective Agents|protective agents|mesh-ancestor
43634625|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43634626|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848960|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848961|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43848962|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848965|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
43848966|NCT03976323|Pemetrexed|pemetrexed|mesh-list
43848967|NCT03976323|Olaparib|olaparib|mesh-list
43848968|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689401|NCT02804126|Acetaminophen|acetaminophen|mesh-list
43689402|NCT02804126|Dipyrone|dipyrone|mesh-list
43689403|NCT02804126|Ketoprofen|ketoprofen|mesh-list
43689404|NCT02804126|Morphine|morphine|mesh-list
43689405|NCT02804126|Bupivacaine|bupivacaine|mesh-list
43689406|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
43689407|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
43630870|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43630871|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43684728|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
43684729|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684730|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684731|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684732|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684733|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
43684734|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43684735|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684736|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684739|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684740|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684741|NCT02840162|Analgesics|analgesics|mesh-ancestor
43684742|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
43684743|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684744|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684745|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684746|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684747|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684774|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
43684775|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684776|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
43684777|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684778|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43684779|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684780|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684781|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43684782|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689408|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689409|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689410|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
43689411|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689412|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43689413|NCT02804126|Narcotics|narcotics|mesh-ancestor
43689414|NCT02804126|Analgesics|analgesics|mesh-ancestor
43689415|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43689416|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
43689417|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43634659|NCT05576792|Ranibizumab|ranibizumab|mesh-list
43603659|NCT03244540|Ropivacaine|ropivacaine|mesh-list
43634660|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43634661|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43630890|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630892|NCT03048084|Levetiracetam|levetiracetam|mesh-list
43630893|NCT03048084|Valproic Acid|valproic acid|mesh-list
43630894|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
43630895|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
43630896|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630897|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630898|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
43630899|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630900|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630901|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
43630902|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630903|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630904|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630905|NCT03048136|Nivolumab|nivolumab|mesh-list
43630906|NCT03048136|Ipilimumab|ipilimumab|mesh-list
43630907|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43630908|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630909|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43630910|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630911|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
43684808|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684809|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684810|NCT02839785|Analgesics|analgesics|mesh-ancestor
43684811|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
43684812|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684813|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684814|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43684815|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684816|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43684817|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684818|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684819|NCT02839668|Acetaminophen|acetaminophen|mesh-list
43684826|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
43684843|NCT02839668|Narcotics|narcotics|mesh-ancestor
43684844|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43634662|NCT05576792|Growth Substances|growth substances|mesh-ancestor
43634663|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634674|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43634675|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43634676|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43634677|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
43634678|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634679|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634680|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
43634681|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43689423|NCT02803918|Metformin|metformin|mesh-list
43684845|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43684846|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
43684847|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43684848|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
43684849|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
43684850|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
43630913|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
43630914|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630915|NCT03048019|Tirofiban|tirofiban|mesh-list
43630916|NCT03048019|Cangrelor|cangrelor|mesh-list
43630917|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43684851|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43684852|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43684853|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
43689427|NCT02803944|Azithromycin|azithromycin|mesh-list
43689468|NCT02803788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43689469|NCT02803788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43689470|NCT02803502|Thrombin|thrombin|mesh-list
43689471|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
43689472|NCT02803502|Coagulants|coagulants|mesh-ancestor
43689473|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
43689474|NCT02803385|Anesthetics|anesthetics|mesh-list
43689493|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43689494|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43689496|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
43684854|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684855|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43684856|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684857|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43689497|NCT02802995|Coagulants|coagulants|mesh-ancestor
43684859|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684860|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689498|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
43689499|NCT02803073|Testosterone|testosterone|mesh-list
43689500|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
43689501|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
43689502|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43689503|NCT02803073|Androgens|androgens|mesh-ancestor
43689504|NCT02803073|Hormones|hormones|mesh-ancestor
43689505|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43689506|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689507|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43689508|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684861|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
43684862|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43684863|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684864|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43684865|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43684866|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684867|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684868|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684869|NCT02839356|Epinephrine|epinephrine|mesh-list
43684870|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43684871|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43684872|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
43684873|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689509|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
43684874|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828689|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
43828690|NCT05475444|Coagulants|coagulants|mesh-ancestor
43828691|NCT05475431|Bismuth|bismuth|mesh-list
43828692|NCT05475431|Antacids|antacids|mesh-ancestor
43828693|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828694|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689510|NCT02802748|Letrozole|letrozole|mesh-list
43689511|NCT02802748|Vinorelbine|vinorelbine|mesh-list
43689512|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689513|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43828695|NCT05475379|Vaccines|vaccines|mesh-list
43630937|NCT03047538|Atorvastatin|atorvastatin|mesh-list
43630938|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43630942|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43689514|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43630943|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43689515|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630944|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630945|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43630946|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43630947|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603660|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
43630954|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43630955|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43630956|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43634705|NCT05550909|Primaquine|primaquine|mesh-list
43634706|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43634707|NCT05550909|Amodiaquine|amodiaquine|mesh-list
43634718|NCT05548296|Gemcitabine|gemcitabine|mesh-list
43634719|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43630957|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43630958|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634720|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
43634729|NCT05546957|Aspirin|aspirin|mesh-list
43689531|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
43689532|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689533|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43689534|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43689585|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43689586|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689587|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43829163|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43829164|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829165|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43630959|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
43630960|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630961|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630962|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43630963|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630964|NCT03047733|Tacrolimus|tacrolimus|mesh-list
43630965|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43630966|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
43630967|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630968|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43630969|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630970|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630971|NCT03047278|Cetirizine|cetirizine|mesh-list
43630972|NCT03047278|Gabapentin|gabapentin|mesh-list
43630973|NCT03047278|Analgesics|analgesics|mesh-ancestor
43630974|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
43630975|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630976|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828696|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
43828697|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828698|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
43828699|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
43828700|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630987|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43630988|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43630989|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43630990|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
43630991|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
43630992|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
43630993|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43630994|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
43630995|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630996|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
43630997|NCT03047096|Protective Agents|protective agents|mesh-ancestor
43634809|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634810|NCT05494437|Gabapentin|gabapentin|mesh-list
43630998|NCT03046953|Avelumab|avelumab|mesh-list
43634811|NCT05494437|Nabilone|nabilone|mesh-list
43630999|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43631000|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631001|NCT03046979|Apatinib|apatinib|mesh-list
43634812|NCT05494437|Analgesics|analgesics|mesh-ancestor
43634813|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
43634814|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634815|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634816|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
43634817|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43634818|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43634819|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634820|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43631002|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631003|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43631005|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631007|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
43829174|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829176|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43829177|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43829178|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43829184|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
43631008|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
43631044|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
43631045|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631046|NCT03046901|Vancomycin|vancomycin|mesh-list
43631053|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631054|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631055|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43631056|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43631057|NCT03046511|Cefazolin|cefazolin|mesh-list
43631058|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631059|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631060|NCT03046719|Bupivacaine|bupivacaine|mesh-list
43631061|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
43828715|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43828716|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828717|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828718|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43828719|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
43828720|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43847021|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43603661|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
43631084|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847028|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847029|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847030|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847031|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631105|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43631106|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631107|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631108|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43631109|NCT03046238|Analgesics|analgesics|mesh-ancestor
43631110|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
43631111|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631112|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43631113|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43631114|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43631115|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
43631116|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631121|NCT03045770|Leucovorin|leucovorin|mesh-list
43631122|NCT03045770|Paclitaxel|paclitaxel|mesh-list
43631123|NCT03045770|Fluorouracil|fluorouracil|mesh-list
43631124|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
43631125|NCT03045770|Irinotecan|irinotecan|mesh-list
43631126|NCT03045770|Calcium|calcium|mesh-list
43631127|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
43631128|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43631129|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631130|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
43631131|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
43631132|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
43684908|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
43684909|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684932|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43829191|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829192|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
43829193|NCT05441592|Coagulants|coagulants|mesh-ancestor
43829194|NCT05441527|Muramidase|muramidase|mesh-list
43684933|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43684934|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
43684935|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43684936|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684937|NCT02839135|Scopolamine|scopolamine|mesh-list
43684938|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43684940|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
43684941|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
43684944|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684984|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684985|NCT02838940|Cefazolin|cefazolin|mesh-list
43684986|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43684987|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684988|NCT02838758|Lidocaine|lidocaine|mesh-list
43684989|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
43684990|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
43684991|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685011|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631201|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631202|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43631203|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
43631204|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
43631205|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631206|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43631207|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43631208|NCT03045471|Protective Agents|protective agents|mesh-ancestor
43631209|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
43631210|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
43631211|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
43631212|NCT03045510|Decitabine|decitabine|mesh-list
43631213|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43631214|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
43631215|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634857|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43634858|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
43634859|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
43634860|NCT05477823|Androgens|androgens|mesh-list
43634861|NCT05477823|Hormones|hormones|mesh-ancestor
43631216|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631217|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631218|NCT03045406|Dalteparin|dalteparin|mesh-list
43634871|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
43634872|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634873|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43634874|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43705944|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
43631219|NCT03045406|Tinzaparin|tinzaparin|mesh-list
43631220|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43631221|NCT03045406|Apixaban|apixaban|mesh-list
43631222|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43631223|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
43631224|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43631225|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
43631226|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631227|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631228|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
43685016|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685035|NCT02838576|Hormones|hormones|mesh-ancestor
43685036|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685037|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631275|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43631276|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43631277|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43631278|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
43631279|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631280|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631281|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631282|NCT03044912|Urological Agents|urological agents|mesh-ancestor
43631283|NCT03044964|Ranolazine|ranolazine|mesh-list
43631292|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685039|NCT02838472|Vitamins|vitamins|mesh-ancestor
43685040|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
43685041|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685042|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
43685043|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685044|NCT02838472|Protective Agents|protective agents|mesh-ancestor
43685045|NCT02838238|Capecitabine|capecitabine|mesh-list
43685046|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685047|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
43685048|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685049|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685050|NCT02838329|Ropivacaine|ropivacaine|mesh-list
43685051|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
43685052|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
43685053|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685054|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685055|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
43685056|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685057|NCT02838342|Interferons|interferons|mesh-list
43685058|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
43685059|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
43685060|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685095|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43685096|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
43685097|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
43689588|NCT02802215|Folic Acid|folic acid|mesh-list
43689589|NCT02802215|Metformin|metformin|mesh-list
43689590|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43689591|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689592|NCT02802215|Hematinics|hematinics|mesh-ancestor
43689593|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
43689594|NCT02802215|Vitamins|vitamins|mesh-ancestor
43689608|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43689609|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689610|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
43689611|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43689612|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43689613|NCT02802163|Growth Substances|growth substances|mesh-ancestor
43689614|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
43689615|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43689616|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689617|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689618|NCT02802072|Aspirin|aspirin|mesh-list
43689619|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43689620|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43689621|NCT02802072|Analgesics|analgesics|mesh-ancestor
43689622|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
43689623|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689624|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689626|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685098|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
43685099|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43685100|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43685101|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43685103|NCT02838264|Itraconazole|itraconazole|mesh-list
43685104|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
43685105|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685106|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43685107|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43685123|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685124|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685125|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
43685126|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685127|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43685146|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43685147|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
43685148|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43685149|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685150|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
43685151|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685152|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
43685153|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685154|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43685172|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634924|NCT05461053|Lidocaine|lidocaine|mesh-list
43828722|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43685174|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43685175|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685176|NCT02838030|Analgesics|analgesics|mesh-ancestor
43685177|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
43685178|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685179|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685180|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685181|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685182|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43685183|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43685184|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685185|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43685201|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685202|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685203|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
43685205|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685206|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43685207|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685208|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
43685209|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685210|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685211|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43685212|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685213|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685214|NCT02837614|Analgesics|analgesics|mesh-ancestor
43685215|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
43685216|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
43685218|NCT02837640|Carbidopa|carbidopa|mesh-list
43685219|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43685220|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43685221|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43685222|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
43685223|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685224|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685225|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685226|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43685227|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689746|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43689747|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43689748|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43689749|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847154|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
43689750|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43689751|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689752|NCT02801305|Emollients|emollients|mesh-ancestor
43689753|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
43689754|NCT02801227|Oxytocin|oxytocin|mesh-list
43689755|NCT02801227|Dinoprostone|dinoprostone|mesh-list
43689756|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
43689757|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43689758|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689759|NCT02801201|Midazolam|midazolam|mesh-list
43689760|NCT02801201|Bupivacaine|bupivacaine|mesh-list
43689761|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
43689762|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
43689763|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689764|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689765|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
43689766|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689767|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43689768|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43689769|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43685228|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43685246|NCT02837146|Methotrexate|methotrexate|mesh-list
43685247|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43685269|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685389|NCT02836483|Linezolid|linezolid|mesh-list
43685390|NCT02836483|Delpazolid|delpazolid|mesh-list
43685391|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
43685392|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43685393|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685394|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43685395|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685396|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685397|NCT02836171|Itraconazole|itraconazole|mesh-list
43685398|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43685399|NCT02836171|Apatinib|apatinib|mesh-list
43685400|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685401|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43685402|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685403|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685404|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
43685405|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631297|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43631299|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43631300|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631301|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43631302|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631303|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
43631304|NCT03044743|Fludarabine|fludarabine|mesh-list
43631305|NCT03044743|Interleukin-2|interleukin-2|mesh-list
43631306|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631315|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43631316|NCT03044743|Analgesics|analgesics|mesh-ancestor
43631317|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
43631318|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631319|NCT03044795|Veliparib|veliparib|mesh-list
43631320|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43631321|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689784|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
43689785|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689786|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43689787|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43689788|NCT02801188|Analgesics|analgesics|mesh-ancestor
43689789|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43689790|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43689791|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43689792|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
43689793|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689794|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689795|NCT02800902|Atorvastatin|atorvastatin|mesh-list
43689796|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43689797|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43689799|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
43685406|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43685407|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43685408|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43685409|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
43685410|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685411|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685412|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43685413|NCT02836288|Ketamine|ketamine|mesh-list
43685414|NCT02836288|Analgesics|analgesics|mesh-ancestor
43685415|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
43685416|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685417|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685418|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43685419|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43685420|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
43685421|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
43685422|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604322|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43685426|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685427|NCT02836184|Niacin|niacin|mesh-list
43685428|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
43685429|NCT02836184|Niacinamide|niacinamide|mesh-list
43685430|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
43685431|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685432|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43685433|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
43685435|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43828723|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828724|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43828725|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828726|NCT05472337|Colchicine|colchicine|mesh-list
43828727|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
43685450|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
43631407|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
43631408|NCT03044171|Protective Agents|protective agents|mesh-ancestor
43631409|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631426|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631427|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
43631428|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43631429|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43631430|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631431|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
43631432|NCT03044041|Coagulants|coagulants|mesh-ancestor
43631433|NCT03044093|Misoprostol|misoprostol|mesh-list
43631434|NCT03044093|Mifepristone|mifepristone|mesh-list
43631435|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43631436|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
43631437|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43631438|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631439|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43631440|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43631442|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43631443|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43631444|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43631445|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43631446|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
43631447|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43685460|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43685461|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
43685462|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635008|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
43689801|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43685463|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685464|NCT02835794|Azacitidine|azacitidine|mesh-list
43685465|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
43685494|NCT02836002|Piperaquine|piperaquine|mesh-list
43685495|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
43685496|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43685497|NCT02836002|Atovaquone|atovaquone|mesh-list
43685498|NCT02836002|Proguanil|proguanil|mesh-list
43685499|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
43685500|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
43685501|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43685502|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43685503|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685504|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43685505|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685506|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685507|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43685508|NCT02836002|Renal Agents|renal agents|mesh-ancestor
43685509|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
43685510|NCT02835742|Sargramostim|sargramostim|mesh-list
43685511|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
43685512|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685513|NCT02835729|Cytarabine|cytarabine|mesh-list
43685514|NCT02835729|Idarubicin|idarubicin|mesh-list
43685515|NCT02835729|Tryptophan|tryptophan|mesh-list
43685516|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685517|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
43685518|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635040|NCT05411237|Doxorubicin|doxorubicin|mesh-list
43685519|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685520|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
43685521|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685522|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685523|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
43685524|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685525|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43685526|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43631448|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43631449|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
43631450|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631452|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43631453|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43631454|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43631455|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43631456|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43631457|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43685527|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43685528|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685529|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43685530|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
43685531|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43685532|NCT02835716|Ustekinumab|ustekinumab|mesh-list
43685533|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
43685534|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
43685535|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685536|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685537|NCT02835469|Menotropins|menotropins|mesh-list
43685538|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43685539|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
43685540|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43685541|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685542|NCT02835664|Niacinamide|niacinamide|mesh-list
43685544|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
43685545|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
43685546|NCT02835664|Vitamins|vitamins|mesh-ancestor
43685547|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
43685548|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685549|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43685550|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
43685635|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685636|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43685637|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828728|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828729|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
43689905|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689906|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
43689907|NCT02800174|Clopidogrel|clopidogrel|mesh-list
43689908|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43689909|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689910|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689911|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43689912|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43689913|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43689914|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
43689915|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689916|NCT02800330|Esomeprazole|esomeprazole|mesh-list
43689917|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43689918|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689919|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43689920|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689921|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689922|NCT02799862|Paclitaxel|paclitaxel|mesh-list
43689923|NCT02799862|Carboplatin|carboplatin|mesh-list
43689924|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43689932|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689933|NCT02799888|Cyclosporine|cyclosporine|mesh-list
43689934|NCT02799888|Maraviroc|maraviroc|mesh-list
43689935|NCT02799888|Methotrexate|methotrexate|mesh-list
43689936|NCT02799888|Tacrolimus|tacrolimus|mesh-list
43689937|NCT02799888|Cyclosporins|cyclosporins|mesh-list
43689938|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43689939|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
43689940|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43689941|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689942|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43689943|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
43689944|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689945|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689946|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
43689947|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689948|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43828730|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
43828731|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
43847033|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685638|NCT02834286|Dexamethasone|dexamethasone|mesh-list
43685639|NCT02834286|Rituximab|rituximab|mesh-list
43685640|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43685641|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685642|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
43685643|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685644|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685645|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685646|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
43685647|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
43685648|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685649|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685650|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
43685651|NCT02834286|Hormones|hormones|mesh-ancestor
43685652|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685653|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43685654|NCT02834052|Poly I-C|poly i-c|mesh-list
43685655|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
43685656|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43685661|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
43685662|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685664|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685665|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
43685667|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
43685668|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43685669|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685670|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43685671|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43685672|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685673|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689962|NCT02800135|Furosemide|furosemide|mesh-list
43685674|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685675|NCT02833987|Warfarin|warfarin|mesh-list
43685676|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
43685677|NCT02833987|Dabigatran|dabigatran|mesh-list
43685678|NCT02833987|Apixaban|apixaban|mesh-list
43685679|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
43685701|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
43685702|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685703|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685704|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43685721|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685722|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
43685723|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685724|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
43685725|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685727|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
43685728|NCT02833701|Bevacizumab|bevacizumab|mesh-list
43685729|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43685730|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
43685732|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
43685733|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43685734|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
43685735|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685736|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43685737|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43685738|NCT02833701|Growth Substances|growth substances|mesh-ancestor
43685739|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685740|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
43685741|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
43685742|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
43685743|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685744|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
43685745|NCT02833701|Protective Agents|protective agents|mesh-ancestor
43685746|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
43685747|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43685748|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604623|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43689979|NCT02799797|Sufentanil|sufentanil|mesh-list
43689981|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43689982|NCT02799797|Narcotics|narcotics|mesh-ancestor
43685763|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
43685765|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685766|NCT02833584|Analgesics|analgesics|mesh-ancestor
43685767|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
43685768|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685770|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
43685806|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685808|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
43685809|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685810|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685811|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43685812|NCT02833116|Dexamethasone|dexamethasone|mesh-list
43685813|NCT02833116|Betamethasone|betamethasone|mesh-list
43690011|NCT02799589|Analgesics|analgesics|mesh-ancestor
43690031|NCT02799355|Ribavirin|ribavirin|mesh-list
43685814|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685815|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
43685816|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
43685869|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631480|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
43631481|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631482|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631483|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43631484|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43631485|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43631486|NCT03043989|Clarithromycin|clarithromycin|mesh-list
43631487|NCT03043989|Docetaxel|docetaxel|mesh-list
43631488|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631489|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
43631490|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
43631491|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
43631492|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631493|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631494|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631495|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43631496|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631497|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43631498|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43631499|NCT03043612|Doxazosin|doxazosin|mesh-list
43631500|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43631501|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43631502|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43631503|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43631504|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
43604624|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43604625|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43604626|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604627|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631505|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631506|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631507|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631508|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
43631509|NCT03043521|Lansoprazole|lansoprazole|mesh-list
43631510|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43631511|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43631512|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43631513|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631514|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631515|NCT03043430|Midazolam|midazolam|mesh-list
43631516|NCT03043430|Ketamine|ketamine|mesh-list
43631517|NCT03043430|Analgesics|analgesics|mesh-ancestor
43631518|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
43631519|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631520|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631521|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43631522|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43631523|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
43631524|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
43631525|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631526|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43631527|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43631528|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631529|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685870|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43685871|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43685872|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
43685873|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43685874|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43685875|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43685876|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43685877|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43685878|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43685879|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
43685880|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43685881|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43685882|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43685883|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43685884|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
43685885|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43685886|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
43685887|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43685888|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
43685889|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685894|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43685895|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685896|NCT02832999|Incretins|incretins|mesh-ancestor
43631530|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43631531|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43631532|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43631533|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43631534|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43631535|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
43631538|NCT03043248|Midazolam|midazolam|mesh-list
43631539|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43631540|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43631541|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631542|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631543|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43631544|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43631545|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43631546|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43631547|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
43631548|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
43631549|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
43631550|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
43631551|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685898|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685899|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43685900|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
43685901|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685902|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685903|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
43685904|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43685906|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
43685907|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43685908|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43685909|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685910|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
43685911|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685912|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685913|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43685914|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
43685915|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
43685916|NCT02832713|Protective Agents|protective agents|mesh-ancestor
43685917|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43685918|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685919|NCT02832700|Caseins|caseins|mesh-list
43829218|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43829219|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43829220|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
43829221|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829222|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829223|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829224|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43635322|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635324|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
43635325|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43635326|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635327|NCT05319730|Paclitaxel|paclitaxel|mesh-list
43685920|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
43685921|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
43685922|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828732|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631552|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631553|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43631554|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43631555|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631556|NCT03043248|Protective Agents|protective agents|mesh-ancestor
43631557|NCT03043326|Tenofovir|tenofovir|mesh-list
43631558|NCT03043326|Emtricitabine|emtricitabine|mesh-list
43635328|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
43635329|NCT05319730|Irinotecan|irinotecan|mesh-list
43635330|NCT05319730|Lenvatinib|lenvatinib|mesh-list
43631559|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
43631560|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631561|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43631562|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43631563|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631564|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631565|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43631566|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43631567|NCT03043482|Calcitriol|calcitriol|mesh-list
43631568|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43828733|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685952|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685953|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
43685954|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
43685955|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685956|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43631569|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631570|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43631571|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631572|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631573|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43631574|NCT03043482|Vitamins|vitamins|mesh-ancestor
43631575|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
43631576|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43631577|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
43631578|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43631579|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43631580|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43631581|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631582|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631583|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
43631584|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631585|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631586|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43631587|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631588|NCT03043443|Melatonin|melatonin|mesh-list
43631589|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
43631590|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631591|NCT03043443|Protective Agents|protective agents|mesh-ancestor
43631592|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631593|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631594|NCT03043495|Dexamethasone|dexamethasone|mesh-list
43631595|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631596|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
43631597|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
43631598|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631599|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631600|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43631601|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
43686041|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686043|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43635331|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
43686044|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686046|NCT02831205|Chromium|chromium|mesh-list
43686047|NCT02831205|Everolimus|everolimus|mesh-list
43686048|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686049|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43686050|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
43686051|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686052|NCT02831205|Trace Elements|trace elements|mesh-ancestor
43686053|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
43686054|NCT02831218|Aspirin|aspirin|mesh-list
43686055|NCT02831218|Clopidogrel|clopidogrel|mesh-list
43686056|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43686057|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43686058|NCT02831218|Analgesics|analgesics|mesh-ancestor
43686059|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
43686060|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686061|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686062|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686063|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686064|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43686065|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43686066|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686067|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43686068|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43686093|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
43686094|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
43686095|NCT02831088|Salicylates|salicylates|mesh-list
43686096|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43686097|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43686098|NCT02831088|Analgesics|analgesics|mesh-ancestor
43686099|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
43686100|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686101|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635358|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
43635359|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635360|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690100|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43690101|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43690102|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690103|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690104|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43690105|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43690106|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
43690107|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690108|NCT02798653|Progesterone|progesterone|mesh-list
43690109|NCT02798653|Progestins|progestins|mesh-ancestor
43690126|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686102|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686103|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686104|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43686105|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686106|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686107|NCT02831179|Capecitabine|capecitabine|mesh-list
43686108|NCT02831179|Temozolomide|temozolomide|mesh-list
43686109|NCT02831179|Veliparib|veliparib|mesh-list
43686110|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43686111|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
43631613|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43631614|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43631616|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631617|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43631618|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43631619|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631620|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
43631621|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43631622|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43631623|NCT03042936|Insulin|insulin|mesh-list
43631624|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43631625|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631626|NCT03042923|Mannitol|mannitol|mesh-list
43631627|NCT03042923|Lactulose|lactulose|mesh-list
43631628|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43631629|NCT03042923|Diuretics|diuretics|mesh-ancestor
43631630|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
43631631|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631632|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43631633|NCT03043001|Memantine|memantine|mesh-list
43686112|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686113|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686114|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43686115|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
43686116|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43686117|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686118|NCT02831231|Xanomeline|xanomeline|mesh-list
43686119|NCT02831231|Trospium chloride|trospium chloride|mesh-list
43686120|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
43686121|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
43690168|NCT02798172|Hormones|hormones|mesh-ancestor
43690169|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690170|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43690171|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
43690172|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690173|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690174|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
43690175|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43690176|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43690177|NCT02798068|Prednisolone|prednisolone|mesh-list
43690178|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
43690179|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43690192|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43690194|NCT02797704|Aflibercept|aflibercept|mesh-list
43686122|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686123|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686124|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43686125|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43686126|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
43686127|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686128|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686129|NCT02831231|Urological Agents|urological agents|mesh-ancestor
43686130|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43631634|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43631635|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43631636|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
43631637|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631638|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631639|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686137|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
43686138|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686139|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686140|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686141|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
43686142|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
43686143|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43686144|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
43686145|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686146|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686147|NCT02830906|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43686152|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
43686153|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
43686155|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43686156|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686157|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43635392|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690244|NCT02797977|Antiviral Agents|antiviral agents|mesh-ancestor
43686158|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686159|NCT02830789|Antacids|antacids|mesh-ancestor
43686160|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43828757|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
43631669|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631670|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
43631671|NCT03042429|Ifosfamide|ifosfamide|mesh-list
43631672|NCT03042429|Cisplatin|cisplatin|mesh-list
43631673|NCT03042429|Doxorubicin|doxorubicin|mesh-list
43631674|NCT03042429|Etoposide|etoposide|mesh-list
43631675|NCT03042429|Topotecan|topotecan|mesh-list
43631676|NCT03042429|Vindesine|vindesine|mesh-list
43631677|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631678|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
43631679|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631680|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43631681|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43828758|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43828759|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43828760|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828761|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
43828762|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
43828763|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43828764|NCT05471544|Amodiaquine|amodiaquine|mesh-list
43828765|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
43828766|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43828787|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828788|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43828789|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
43828802|NCT05470075|Tramadol|tramadol|mesh-list
43828803|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43828804|NCT05470075|Narcotics|narcotics|mesh-ancestor
43828805|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828806|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828807|NCT05470075|Analgesics|analgesics|mesh-ancestor
43686233|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686234|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43686235|NCT02829385|Apatinib|apatinib|mesh-list
43686236|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686237|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43686238|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686239|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686240|NCT02829424|Methotrexate|methotrexate|mesh-list
43686241|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43686242|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
43686243|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43686244|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686245|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43686255|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43686256|NCT02829359|Entecavir|entecavir|mesh-list
43686257|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
43686258|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686259|NCT02829372|Antibodies|antibodies|mesh-list
43686260|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43686261|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43686262|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
43604941|NCT03233152|Ipilimumab|ipilimumab|mesh-list
43686282|NCT02829151|Clopidogrel|clopidogrel|mesh-list
43686283|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43686284|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43686285|NCT02829151|Analgesics|analgesics|mesh-ancestor
43686286|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
43686287|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686288|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686289|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631689|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631690|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43631691|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43631692|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
43631693|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
43631694|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
43686290|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686291|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43686292|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43686293|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686294|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43686295|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43686296|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686297|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
43686298|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43686299|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43686300|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43686301|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
43686302|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686303|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43686304|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
43686305|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43686306|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
43686307|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
43686308|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43686309|NCT02829151|Protective Agents|protective agents|mesh-ancestor
43686310|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43631696|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43631697|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43686324|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43686325|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
43686326|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43690286|NCT02797340|Metformin|metformin|mesh-list
43690287|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690288|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690289|NCT02797145|Digoxin|digoxin|mesh-list
43686327|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43686328|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43686329|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43686330|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43686331|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686332|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
43686333|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686334|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686335|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686336|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
43686338|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686339|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43686340|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
43686341|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686342|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43686343|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828811|NCT05469893|Lenalidomide|lenalidomide|mesh-list
43828812|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828813|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
43828814|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
43828815|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828816|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828817|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43828818|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
43631699|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43631700|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631701|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43631702|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631703|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
43631705|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43631706|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631707|NCT03042325|Incretins|incretins|mesh-ancestor
43631708|NCT03042325|Hormones|hormones|mesh-ancestor
43631709|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631710|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43828828|NCT05469178|Carboplatin|carboplatin|mesh-list
43828829|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
43828830|NCT05469178|Pemetrexed|pemetrexed|mesh-list
43828831|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606153|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
43828833|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828834|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686344|NCT02829060|Gentamicins|gentamicins|mesh-list
43686345|NCT02829060|Ampicillin|ampicillin|mesh-list
43686346|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
43686347|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631716|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
43631717|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43631718|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631719|NCT03042260|Renal Agents|renal agents|mesh-ancestor
43631720|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
43631721|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43631722|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43631723|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43631724|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631725|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631726|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43631728|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43631729|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631730|NCT03042234|Insulin|insulin|mesh-list
43631731|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43631732|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43631733|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631734|NCT03041935|Acetaminophen|acetaminophen|mesh-list
43631735|NCT03041935|Dexamethasone|dexamethasone|mesh-list
43631736|NCT03041935|Ketorolac|ketorolac|mesh-list
43631737|NCT03041935|Morphine|morphine|mesh-list
43631738|NCT03041935|Remifentanil|remifentanil|mesh-list
43631739|NCT03041935|Ondansetron|ondansetron|mesh-list
43631740|NCT03041935|Propofol|propofol|mesh-list
43631742|NCT03041935|Sevoflurane|sevoflurane|mesh-list
43631743|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631744|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
43631745|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
43631746|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631747|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631748|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43631749|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
43631751|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631752|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43686352|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43686353|NCT02829060|Renal Agents|renal agents|mesh-ancestor
43686354|NCT02829008|Bevacizumab|bevacizumab|mesh-list
43686355|NCT02829008|Pemetrexed|pemetrexed|mesh-list
43686356|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43686357|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686358|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43686359|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43686360|NCT02829008|Growth Substances|growth substances|mesh-ancestor
43686361|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686362|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
43686363|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686364|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686366|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43686367|NCT02828384|Psyllium|psyllium|mesh-list
43686368|NCT02828384|Cathartics|cathartics|mesh-ancestor
43686369|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686370|NCT02828566|Ketamine|ketamine|mesh-list
43686371|NCT02828566|Analgesics|analgesics|mesh-ancestor
43686372|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
43686373|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686374|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686375|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43686376|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43686377|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
43631755|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631761|NCT03041935|Analgesics|analgesics|mesh-ancestor
43631762|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
43631763|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
43631764|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43631765|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
43631766|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43631767|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43631768|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
43631769|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
43631770|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43631771|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
43631772|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686378|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
43686379|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690308|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43690309|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43686380|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43686381|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43686382|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686383|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686384|NCT02828163|Triamcinolone|triamcinolone|mesh-list
43686385|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43686386|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43686387|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43631773|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631774|NCT03041935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43631775|NCT03041935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43631776|NCT03041935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43631777|NCT03041935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43631778|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43631779|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43631780|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43631782|NCT03042013|Naquotinib|naquotinib|mesh-list
43631783|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631784|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43631785|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631786|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631787|NCT03042000|Capecitabine|capecitabine|mesh-list
43631788|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
43631789|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43631790|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
43631791|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631792|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631793|NCT03041948|Acetaminophen|acetaminophen|mesh-list
43631794|NCT03041948|Dexamethasone|dexamethasone|mesh-list
43631795|NCT03041948|Ketorolac|ketorolac|mesh-list
43686396|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686398|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686399|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686400|NCT02828059|Ropivacaine|ropivacaine|mesh-list
43686401|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
43686402|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
43686403|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686404|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686405|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
43631830|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631837|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43631838|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631839|NCT03042182|Vaccines|vaccines|mesh-list
43631840|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
43631841|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631842|NCT03042091|Metronidazole|metronidazole|mesh-list
43631843|NCT03042091|Ethanol|ethanol|mesh-list
43631844|NCT03042091|Neomycin|neomycin|mesh-list
43631845|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631846|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631847|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43631848|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43631849|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43631850|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631851|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829249|NCT05438160|Coal Tar|coal tar|mesh-list
43631852|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43631853|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631854|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631855|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
43631856|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43631857|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631858|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631859|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
43631860|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631861|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631863|NCT03041779|Diclofenac|diclofenac|mesh-list
43631864|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43631865|NCT03041779|Analgesics|analgesics|mesh-ancestor
43631866|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
43631867|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631868|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631869|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
43631870|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43631871|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686406|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686408|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
43686409|NCT02828228|Vitamins|vitamins|mesh-ancestor
43686410|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
43686411|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686412|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43686413|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43686414|NCT02827903|Metformin|metformin|mesh-list
43686415|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43686418|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43686419|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43686420|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
43686421|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686422|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43686423|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43686424|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686425|NCT02828033|Rilonacept|rilonacept|mesh-list
43829280|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43829281|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
43829282|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829283|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
43829284|NCT05436652|Hormones|hormones|mesh-ancestor
43829285|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829286|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829287|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43829288|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686426|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686427|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43686428|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43686429|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686430|NCT02827890|Incretins|incretins|mesh-ancestor
43686431|NCT02827890|Hormones|hormones|mesh-ancestor
43686432|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686433|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43686434|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
43686435|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686436|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686437|NCT02827877|Copper|copper|mesh-list
43686438|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43686439|NCT02827877|Trastuzumab|trastuzumab|mesh-list
43686440|NCT02827877|Pertuzumab|pertuzumab|mesh-list
43686445|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686446|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686447|NCT02827877|Trace Elements|trace elements|mesh-ancestor
43686448|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
43686449|NCT02827643|Vitamin D|vitamin d|mesh-list
43686450|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
43686451|NCT02827643|Lamivudine|lamivudine|mesh-list
43686452|NCT02827643|Calcium|calcium|mesh-list
43686453|NCT02827643|Vitamins|vitamins|mesh-ancestor
43686454|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
43686455|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686456|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43829296|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43686457|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43686458|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43631872|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43631873|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43631874|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631875|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631876|NCT03041506|Lidocaine|lidocaine|mesh-list
43631877|NCT03041506|Midazolam|midazolam|mesh-list
43631878|NCT03041506|Ketamine|ketamine|mesh-list
43631879|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
43631880|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
43631882|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631883|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
43631884|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631885|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43631886|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43631887|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43631888|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631889|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631890|NCT03041506|Analgesics|analgesics|mesh-ancestor
43631891|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43631892|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43631893|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
43631894|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43631895|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43631896|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631897|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43631898|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43631899|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43690401|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43690402|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43690403|NCT02796183|Growth Substances|growth substances|mesh-ancestor
43631904|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
43631905|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43631906|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
43631907|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631908|NCT03041259|Protective Agents|protective agents|mesh-ancestor
43631909|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631910|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43631911|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631912|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43631914|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
43631915|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
43631916|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631918|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686459|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43686460|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686461|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686462|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
43686463|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686464|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43686465|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43686466|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43686467|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
43686468|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43686469|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
43686470|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43686471|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686472|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43631919|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
43631920|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631921|NCT03040934|Sirolimus|sirolimus|mesh-list
43631922|NCT03040934|Everolimus|everolimus|mesh-list
43631923|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631924|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631925|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
43690466|NCT02795572|Hydroxocobalamin|hydroxocobalamin|mesh-list
43635582|NCT05253651|Fluorouracil|fluorouracil|mesh-list
43635583|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
43635585|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
43635586|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635587|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635588|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43635589|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43631926|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631927|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631928|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631929|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43631930|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
43631931|NCT03040791|Nivolumab|nivolumab|mesh-list
43631932|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43631933|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631934|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43631935|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631936|NCT03040830|Progesterone|progesterone|mesh-list
43631937|NCT03040830|Progestins|progestins|mesh-ancestor
43631938|NCT03040830|Hormones|hormones|mesh-ancestor
43631939|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631940|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631941|NCT03040752|Nifedipine|nifedipine|mesh-list
43631942|NCT03040752|Ritodrine|ritodrine|mesh-list
43631943|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43631944|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631945|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631946|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43631947|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631948|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
43606575|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
43686512|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43686513|NCT02827487|Narcotics|narcotics|mesh-ancestor
43686514|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686515|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
43686516|NCT02827266|Hematinics|hematinics|mesh-ancestor
43828835|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43828836|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43828837|NCT05468957|Hemostatics|hemostatics|mesh-list
43828838|NCT05468957|Coagulants|coagulants|mesh-ancestor
43828839|NCT05468554|Metformin|metformin|mesh-list
43828840|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43828841|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828842|NCT05468138|Antibodies|antibodies|mesh-list
43828843|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
43828844|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828845|NCT05466734|Cilostazol|cilostazol|mesh-list
43828846|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43828879|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828880|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
43828881|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
43828882|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828883|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
43828884|NCT05466175|Prednisone|prednisone|mesh-list
43828885|NCT05466175|Vincristine|vincristine|mesh-list
43828886|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828887|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
43828888|NCT05466175|Hormones|hormones|mesh-ancestor
43828889|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828890|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828891|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43635590|NCT05253651|Growth Substances|growth substances|mesh-ancestor
43635591|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635592|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
43635593|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
43635594|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635595|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43635596|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635597|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
43635598|NCT05253651|Antidotes|antidotes|mesh-ancestor
43635599|NCT05253651|Protective Agents|protective agents|mesh-ancestor
43635600|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
43635601|NCT05253651|Vitamins|vitamins|mesh-ancestor
43635602|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
43635603|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43635604|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635606|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635607|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635608|NCT05232071|Empagliflozin|empagliflozin|mesh-list
43686517|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43686518|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
43686519|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
43686520|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43686521|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686522|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686523|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43686524|NCT02827942|Amoxicillin|amoxicillin|mesh-list
43686525|NCT02827942|Metronidazole|metronidazole|mesh-list
43686526|NCT02827942|Clarithromycin|clarithromycin|mesh-list
43686527|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43686528|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686529|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43686530|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43686531|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43686532|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686533|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686534|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43686535|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43686537|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
43686538|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
43686539|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686540|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686541|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
43686542|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686543|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43686544|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43686545|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43686546|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43686547|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686548|NCT02826902|Remifentanil|remifentanil|mesh-list
43686549|NCT02826902|Propofol|propofol|mesh-list
43686550|NCT02826902|Desflurane|desflurane|mesh-list
43686551|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43686552|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43635628|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635629|NCT05217342|Diuretics|diuretics|mesh-list
43635630|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
43635631|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635632|NCT05215418|Topiramate|topiramate|mesh-list
43635633|NCT05215418|Phentermine|phentermine|mesh-list
43635634|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
43635635|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43635648|NCT05210374|Copper|copper|mesh-list
43686553|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686554|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43686555|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
43686556|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
43686557|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43686558|NCT02826902|Narcotics|narcotics|mesh-ancestor
43686559|NCT02826902|Analgesics|analgesics|mesh-ancestor
43631964|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43631965|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631966|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43631967|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
43631968|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631969|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631970|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
43631971|NCT03040765|Denosumab|denosumab|mesh-list
43631972|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43631973|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631974|NCT03040635|Risdiplam|risdiplam|mesh-list
43631975|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43631976|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631977|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631978|NCT03040531|Vitamin D|vitamin d|mesh-list
43631979|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
43631980|NCT03040531|Alendronate|alendronate|mesh-list
43631981|NCT03040531|Genistein|genistein|mesh-list
43631982|NCT03040531|Calcium|calcium|mesh-list
43631983|NCT03040531|Vitamins|vitamins|mesh-ancestor
43631984|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
43631985|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631986|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43631987|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43631988|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43631989|NCT03040531|Protective Agents|protective agents|mesh-ancestor
43631990|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631991|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43631992|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686561|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686562|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43635661|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43635662|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43635663|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
43635664|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
43635665|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635666|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
43635667|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43635668|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635674|NCT05199285|Nivolumab|nivolumab|mesh-list
43686563|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
43686564|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43686565|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686566|NCT02826616|Trimetazidine|trimetazidine|mesh-list
43686567|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
43686568|NCT02826772|Androgens|androgens|mesh-list
43686569|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
43686570|NCT02826772|Hormones|hormones|mesh-ancestor
43686571|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686572|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686573|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
43686574|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
43686575|NCT02826876|Ropivacaine|ropivacaine|mesh-list
43686576|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
43686577|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
43686578|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686579|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686580|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
43686581|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686583|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43686584|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632016|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
43632017|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632018|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632019|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
43632020|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
43632021|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632022|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632023|NCT03040180|Bleomycin|bleomycin|mesh-list
43635715|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635716|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635717|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43635718|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43635719|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
43635720|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
43635721|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635722|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43635723|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
43635724|NCT05192889|Hormones|hormones|mesh-ancestor
43635725|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690501|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
43690502|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635726|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43635727|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43635728|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
43635729|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43635730|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43635731|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
43632024|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43632026|NCT03040167|Epinephrine|epinephrine|mesh-list
43632027|NCT03040167|Bupivacaine|bupivacaine|mesh-list
43686621|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686622|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43686623|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
43686624|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686625|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43686626|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
43686627|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
43686628|NCT02826343|Hormones|hormones|mesh-ancestor
43639150|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43686629|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686631|NCT02826252|Iloprost|iloprost|mesh-list
43686632|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43686633|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
43686634|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
43686635|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
43686636|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43686637|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
43686638|NCT02826070|Adefovir|adefovir|mesh-list
43686639|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43686640|NCT02826070|Telbivudine|telbivudine|mesh-list
43686641|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
43686642|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686643|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43686644|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43686645|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632028|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
43632029|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
43632030|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632031|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632032|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
43632033|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632034|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43632035|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43632036|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
43632037|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632038|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632039|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43632040|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43632041|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
43632045|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
43632046|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43632047|NCT03040193|Lidocaine|lidocaine|mesh-list
43632048|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
43632049|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
43632050|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632051|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632052|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
43632053|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686646|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686647|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
43686648|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
43686649|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686650|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686651|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43686652|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
43686653|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43686655|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686656|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686657|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
43686658|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43686659|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
43847157|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
43847158|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847159|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847160|NCT04134923|Corticosterone|corticosterone|mesh-list
43847161|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847162|NCT04134884|Talazoparib|talazoparib|mesh-list
43847164|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686660|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686661|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
43686662|NCT02826031|Protective Agents|protective agents|mesh-ancestor
43686663|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
43686664|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
43686665|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43686666|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43686667|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686668|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
43847169|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847170|NCT04133480|Cannabidiol|cannabidiol|mesh-list
43686669|NCT02825719|Coagulants|coagulants|mesh-ancestor
43686670|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43686671|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
43686672|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43847171|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
43847172|NCT04133376|Nicotine|nicotine|mesh-list
43847173|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43847174|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
43847175|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847176|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847177|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43847178|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43847179|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
43847180|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690530|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43690531|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43690532|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
43690533|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686673|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686674|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43828892|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828893|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43686684|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
43686685|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686686|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686687|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43686689|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686690|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43686691|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43686692|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43686693|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43686694|NCT02825797|Antibodies|antibodies|mesh-list
43686695|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
43686696|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43690538|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43690539|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686697|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
43686698|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686699|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686700|NCT02825394|Ecarin|ecarin|mesh-list
43686701|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43686702|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43686703|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686704|NCT02825147|Dexamethasone|dexamethasone|mesh-list
43686705|NCT02825147|Methotrexate|methotrexate|mesh-list
43686706|NCT02825147|Etoposide|etoposide|mesh-list
43686707|NCT02825147|Pegaspargase|pegaspargase|mesh-list
43632054|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43632055|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43632056|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43632057|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43829655|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43632087|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
43632088|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43632089|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632090|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43632091|NCT03039608|Prednisone|prednisone|mesh-list
43632092|NCT03039608|Triamcinolone|triamcinolone|mesh-list
43632093|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43632094|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
43632101|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43632102|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
43632103|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632104|NCT03039426|Diclofenac|diclofenac|mesh-list
43632105|NCT03039426|Bupivacaine|bupivacaine|mesh-list
43632106|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
43632107|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
43632108|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632109|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632110|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
43632111|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632112|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43632113|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43632114|NCT03039426|Analgesics|analgesics|mesh-ancestor
43632122|NCT03039205|Clopidogrel|clopidogrel|mesh-list
43632124|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43632125|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43632126|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43632127|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43632128|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
43632129|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686708|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686709|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
43686710|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
43686711|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686712|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686713|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686714|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
43686715|NCT02825147|Hormones|hormones|mesh-ancestor
43686716|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686717|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43686718|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686719|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43686720|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
43686721|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43686722|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43686723|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
43686725|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
43686753|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686754|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43686755|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
43686756|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43686757|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686758|NCT02825225|Anesthetics|anesthetics|mesh-list
43686759|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690586|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690587|NCT02794389|Protective Agents|protective agents|mesh-ancestor
43635787|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43635788|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43635789|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
43635790|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43635791|NCT05149898|Cannabidiol|cannabidiol|mesh-list
43635792|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
43635793|NCT05149638|Cosyntropin|cosyntropin|mesh-list
43635794|NCT05149638|Hormones|hormones|mesh-ancestor
43635795|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43635796|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635797|NCT05148026|Heparin|heparin|mesh-list
43635798|NCT05148026|Calcium heparin|calcium heparin|mesh-list
43686760|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686761|NCT02825186|Dexamethasone|dexamethasone|mesh-list
43686762|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686763|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
43686764|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
43686765|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686766|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686767|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686768|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
43686769|NCT02825186|Hormones|hormones|mesh-ancestor
43686770|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686771|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43686772|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686773|NCT02825095|Lidocaine|lidocaine|mesh-list
43686774|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
43686775|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
43686776|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686777|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686778|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
43686779|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686780|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43686781|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43686782|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43686783|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43632130|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632131|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632133|NCT03039257|Vitamins|vitamins|mesh-ancestor
43632134|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
43632135|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632136|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
43632137|NCT03038919|Testosterone|testosterone|mesh-list
43632138|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
43632139|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
43632140|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43632141|NCT03038919|Androgens|androgens|mesh-ancestor
43686784|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686786|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43686787|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686788|NCT02825121|Trace Elements|trace elements|mesh-ancestor
43686789|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
43686790|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686792|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43632142|NCT03038919|Hormones|hormones|mesh-ancestor
43632143|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632144|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632145|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43632146|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635799|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
43632147|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
43632148|NCT03039101|Montelukast|montelukast|mesh-list
43632149|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43632150|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
43632151|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43632152|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
43632153|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632154|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632155|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43632156|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43632157|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632158|NCT03038958|Prilocaine|prilocaine|mesh-list
43632159|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
43632160|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
43632161|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
43632162|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632163|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632164|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
43632165|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632166|NCT03039075|Metformin|metformin|mesh-list
43632167|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43632168|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632169|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43632170|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
43632171|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43632172|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
43632173|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43632174|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632175|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43632176|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43632177|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632178|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
43632179|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
43632180|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
43632181|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632182|NCT03038607|Aspirin|aspirin|mesh-list
43632183|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43632188|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632189|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43632190|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43632191|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43632192|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43632193|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632194|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43632195|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43632197|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
43632198|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
43632199|NCT03038516|Vitamin D|vitamin d|mesh-list
43632200|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43632201|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686793|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686794|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43686795|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686796|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686797|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43686798|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43686799|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
43686800|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686801|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
43686802|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43686803|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686804|NCT02825056|Morphine|morphine|mesh-list
43632203|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
43632204|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43632205|NCT03038477|Durvalumab|durvalumab|mesh-list
43632206|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43632207|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632208|NCT03038503|Terlipressin|terlipressin|mesh-list
43632209|NCT03038503|Methylene Blue|methylene blue|mesh-list
43632210|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632211|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632212|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43632213|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43632214|NCT03038451|Amlodipine|amlodipine|mesh-list
43632215|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43632216|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43632217|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43632218|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632219|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43632220|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632221|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
43632222|NCT03038243|Vaccines|vaccines|mesh-list
43632223|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
43632224|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632225|NCT03038295|Propranolol|propranolol|mesh-list
43632226|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43632227|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43632228|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
43632229|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632230|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632231|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632232|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43632233|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43632234|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
43635800|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
43635801|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43635802|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43635842|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635843|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632236|NCT03038321|Lornoxicam|lornoxicam|mesh-list
43632237|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43635844|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
43635845|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
43635846|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43635860|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43635861|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43635862|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43632238|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632239|NCT03038321|Renal Agents|renal agents|mesh-ancestor
43632240|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43632241|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43632242|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43632243|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632244|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632245|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635863|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635864|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635865|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43635866|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43635868|NCT05140525|Riociguat|riociguat|mesh-list
43635869|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43635870|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43635871|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632246|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43632247|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43632248|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43632249|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43686805|NCT02825056|Bupivacaine|bupivacaine|mesh-list
43686806|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
43686807|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
43686808|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686809|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686810|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
43686811|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686812|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43686813|NCT02825056|Narcotics|narcotics|mesh-ancestor
43686814|NCT02825056|Analgesics|analgesics|mesh-ancestor
43686815|NCT02824926|Ketoconazole|ketoconazole|mesh-list
43686816|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
43686817|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686818|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43686819|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43686820|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686821|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632250|NCT03038321|Analgesics|analgesics|mesh-ancestor
43632251|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
43632252|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632253|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632262|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632263|NCT03038282|Protective Agents|protective agents|mesh-ancestor
43635873|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
43632264|NCT03038217|Capecitabine|capecitabine|mesh-list
43632265|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
43632266|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43632267|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
43632268|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632270|NCT03038425|Ropivacaine|ropivacaine|mesh-list
43686832|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
43686833|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
43686834|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686835|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635874|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43635875|NCT05135650|Antibodies|antibodies|mesh-list
43635876|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
43635877|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43635878|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
43635879|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635880|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635881|NCT05132582|Trastuzumab|trastuzumab|mesh-list
43635882|NCT05132582|Pertuzumab|pertuzumab|mesh-list
43635883|NCT05132582|Tucatinib|tucatinib|mesh-list
43635884|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43690628|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
43690629|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690630|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690631|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43690632|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43690633|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
43690634|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690635|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690637|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43690638|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
43690639|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43686836|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
43686837|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686838|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43686839|NCT02824770|Narcotics|narcotics|mesh-ancestor
43686840|NCT02824770|Analgesics|analgesics|mesh-ancestor
43686841|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43686842|NCT02824536|Antibodies|antibodies|mesh-list
43686843|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
43686844|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43686845|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
43686846|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686847|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686848|NCT02824666|Fallypride|fallypride|mesh-list
43686849|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43686850|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43686851|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
43686852|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706533|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690640|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690641|NCT02793843|Dexamethasone|dexamethasone|mesh-list
43690642|NCT02793843|Ondansetron|ondansetron|mesh-list
43690643|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43635885|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635886|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43635887|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635888|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635890|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635891|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43686853|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632298|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43632299|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
43632300|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43632301|NCT03037970|Becaplermin|becaplermin|mesh-list
43632302|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
43632303|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
43632304|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43635892|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635893|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635894|NCT05126784|Denosumab|denosumab|mesh-list
43635895|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43632305|NCT03037970|Growth Substances|growth substances|mesh-ancestor
43607392|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43686857|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43686858|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
43686859|NCT02824718|Diuretics|diuretics|mesh-list
43686860|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
43686861|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43686862|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686863|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43686864|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
43686865|NCT02824718|Vitamins|vitamins|mesh-ancestor
43686866|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
43686867|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43686868|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686869|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43686870|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43686871|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686872|NCT02824874|Incretins|incretins|mesh-ancestor
43686873|NCT02824874|Hormones|hormones|mesh-ancestor
43632306|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632307|NCT03037944|Drospirenone|drospirenone|mesh-list
43632308|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
43632309|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43632310|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43632311|NCT03037944|Estradiol|estradiol|mesh-list
43632312|NCT03037944|Estrogens|estrogens|mesh-ancestor
43632313|NCT03037944|Hormones|hormones|mesh-ancestor
43632314|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632315|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632316|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43632317|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
43632318|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43632319|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43632320|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43632327|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
43632328|NCT03038048|Ranibizumab|ranibizumab|mesh-list
43632329|NCT03038048|Aflibercept|aflibercept|mesh-list
43632330|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43635896|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635897|NCT05122741|Aspirin|aspirin|mesh-list
43635898|NCT05122741|Clopidogrel|clopidogrel|mesh-list
43635899|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43635900|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43635901|NCT05122741|Analgesics|analgesics|mesh-ancestor
43635913|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
43635938|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635939|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
43635940|NCT05114590|Lixisenatide|lixisenatide|mesh-list
43635941|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43635942|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635943|NCT05112536|Paclitaxel|paclitaxel|mesh-list
43635944|NCT05112536|Carboplatin|carboplatin|mesh-list
43635945|NCT05112536|Doxorubicin|doxorubicin|mesh-list
43635946|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
43632331|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43635947|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43632332|NCT03038048|Growth Substances|growth substances|mesh-ancestor
43632333|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632334|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
43632335|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632336|NCT03037775|Nicotine|nicotine|mesh-list
43632337|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43632338|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
43632339|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632340|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686883|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
43686884|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43635948|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690658|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43686885|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686886|NCT02824458|Apatinib|apatinib|mesh-list
43686887|NCT02824458|Gefitinib|gefitinib|mesh-list
43686888|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686889|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43686890|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686891|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686892|NCT02824094|Crizotinib|crizotinib|mesh-list
43686893|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686894|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43686895|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686896|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686897|NCT02824315|Simeprevir|simeprevir|mesh-list
43686898|NCT02824315|Odalasvir|odalasvir|mesh-list
43686899|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
43686900|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686901|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
43686902|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686903|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686904|NCT02824406|Acetazolamide|acetazolamide|mesh-list
43686905|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
43686909|NCT02824406|Diuretics|diuretics|mesh-ancestor
43690659|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
43690660|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690661|NCT02793843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43690662|NCT02793843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43690663|NCT02793843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43690664|NCT02793843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43690665|NCT02793908|Progesterone|progesterone|mesh-list
43635949|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
43635950|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
43635951|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
43635952|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686910|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
43686911|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686912|NCT02824354|Nalmefene|nalmefene|mesh-list
43686913|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43686914|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686915|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
43686916|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828895|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
43828896|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
43828897|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828898|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
43828900|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828901|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828902|NCT05465226|Analgesics|analgesics|mesh-ancestor
43828903|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
43828904|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632348|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43632349|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632350|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43632351|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43632352|NCT03037736|Growth Substances|growth substances|mesh-ancestor
43632353|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632354|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
43632355|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
43632356|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828906|NCT05464173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828907|NCT05464173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686918|NCT02823977|Ketamine|ketamine|mesh-list
43686919|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43686920|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686921|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686922|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43686923|NCT02823977|Analgesics|analgesics|mesh-ancestor
43686924|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
43686925|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686926|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43686927|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43686928|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43686929|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
43632357|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43632358|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43632359|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
43632360|NCT03037892|Fentanyl|fentanyl|mesh-list
43632361|NCT03037892|Midazolam|midazolam|mesh-list
43632362|NCT03037892|Remifentanil|remifentanil|mesh-list
43632363|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43635953|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43635954|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43635955|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635956|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635957|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635958|NCT05111353|Poly ICLC|poly iclc|mesh-list
43635959|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
43635960|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
43635961|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635962|NCT05109728|Temozolomide|temozolomide|mesh-list
43635963|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43635964|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43635965|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43635966|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
43635967|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635968|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635969|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
43635970|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
43635971|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43635972|NCT05108428|Capecitabine|capecitabine|mesh-list
43632365|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632366|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632367|NCT03037892|Analgesics|analgesics|mesh-ancestor
43632368|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
43632369|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632370|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43632371|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43632372|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
43632373|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
43632374|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43635973|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43635974|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
43635975|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632375|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43632376|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43632377|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43632378|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
43632379|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
43632380|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632381|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632382|NCT03038009|Pantoprazole|pantoprazole|mesh-list
43632383|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43632384|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43632385|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43632386|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632387|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635977|NCT05105841|Venetoclax|venetoclax|mesh-list
43635978|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
43635979|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690666|NCT02793908|Progestins|progestins|mesh-ancestor
43690667|NCT02793908|Hormones|hormones|mesh-ancestor
43690668|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690669|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690670|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
43690672|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690673|NCT02793687|Protective Agents|protective agents|mesh-ancestor
43632388|NCT03037606|Rabeprazole|rabeprazole|mesh-list
43632389|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43632390|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43632393|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632394|NCT03037593|Vitamin D|vitamin d|mesh-list
43632395|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
43632396|NCT03037593|Vitamins|vitamins|mesh-ancestor
43632397|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
43632398|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607947|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
43632401|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
43632402|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43686930|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686931|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686932|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43686933|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43686934|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
43686936|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43686937|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43686938|NCT02823808|Glimepiride|glimepiride|mesh-list
43686939|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43686940|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43686941|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686942|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43686943|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
43686944|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43686945|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
43686946|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43632403|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43632404|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632405|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
43632406|NCT03037515|Coagulants|coagulants|mesh-ancestor
43632408|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43632409|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43632410|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43632411|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43632412|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
43632413|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632414|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43849473|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632415|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632416|NCT03036995|Apremilast|apremilast|mesh-list
43632417|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43632418|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43632420|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
43632421|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632422|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632423|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43632424|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43632425|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43632426|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43632428|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632429|NCT03036826|Meropenem|meropenem|mesh-list
43632430|NCT03036826|Tazobactam|tazobactam|mesh-list
43632431|NCT03036826|Piperacillin|piperacillin|mesh-list
43608331|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
43632433|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43632434|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632435|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43632437|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632438|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43686947|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
43686948|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686950|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
43686951|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
43686952|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
43686953|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
43686954|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686955|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686956|NCT02823912|Antacids|antacids|mesh-ancestor
43686957|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686958|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686959|NCT02823743|Aspirin|aspirin|mesh-list
43632439|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43632440|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43632441|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43632442|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632443|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632444|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632445|NCT03037073|Analgesics|analgesics|mesh-ancestor
43632446|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
43632447|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632448|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
43632449|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43632450|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
43632451|NCT03036891|Naloxegol|naloxegol|mesh-list
43632452|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43632453|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632454|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
43632455|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632456|NCT03036800|Liraglutide|liraglutide|mesh-list
43632457|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43632458|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632459|NCT03036800|Incretins|incretins|mesh-ancestor
43632460|NCT03036800|Hormones|hormones|mesh-ancestor
43635996|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43635997|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43635998|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
43632461|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632468|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
43632469|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632470|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632471|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43632472|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
43632482|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632483|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
43632484|NCT03036501|Risdiplam|risdiplam|mesh-list
43632485|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43632486|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632487|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632488|NCT03036514|Sufentanil|sufentanil|mesh-list
43632489|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43686960|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43686961|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43686962|NCT02823743|Analgesics|analgesics|mesh-ancestor
43686963|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
43686964|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686965|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686966|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686967|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686968|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43686969|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43686970|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686971|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43686972|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43686973|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686974|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
43686975|NCT02823626|Spironolactone|spironolactone|mesh-list
43686976|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43686977|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
43686978|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686979|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686980|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43686982|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
43686983|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
43686984|NCT02823925|Pamidronate|pamidronate|mesh-list
43686985|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43686986|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686987|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
43686988|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43686989|NCT02823496|Protective Agents|protective agents|mesh-ancestor
43686990|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686991|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
43632490|NCT03036514|Narcotics|narcotics|mesh-ancestor
43632491|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632492|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632493|NCT03036514|Analgesics|analgesics|mesh-ancestor
43632494|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
43632495|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632496|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43632497|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43686992|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
43686993|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43686994|NCT02823483|Protective Agents|protective agents|mesh-ancestor
43686995|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686996|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
43686997|NCT02823691|Metformin|metformin|mesh-list
43686998|NCT02823691|Lanreotide|lanreotide|mesh-list
43686999|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43687000|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687001|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687002|NCT02824042|Itraconazole|itraconazole|mesh-list
43687003|NCT02824042|Maytansine|maytansine|mesh-list
43687004|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
43687005|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687006|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43687007|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43632498|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
43632499|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
43632500|NCT03036644|Nicotine|nicotine|mesh-list
43632501|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43632502|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
43632503|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632504|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632505|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43632506|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43632507|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
43632508|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632509|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632510|NCT03036046|Fluconazole|fluconazole|mesh-list
43632511|NCT03036046|Posaconazole|posaconazole|mesh-list
43632512|NCT03036046|Olorofim|olorofim|mesh-list
43632513|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
43632514|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632515|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43632516|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43632517|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632518|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632519|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43632520|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
43632521|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632522|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632523|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43632524|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43632525|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43632526|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43632527|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43829333|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
43636042|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
43690749|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
43632528|NCT03036202|Epinephrine|epinephrine|mesh-list
43632529|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43632530|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43632531|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
43632537|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
43632538|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632539|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43632540|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
43632541|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
43632542|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
43632543|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43632544|NCT03036059|Ivermectin|ivermectin|mesh-list
43632545|NCT03036059|Albendazole|albendazole|mesh-list
43632546|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43687008|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687009|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687010|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43687011|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
43687012|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687013|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687014|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43687015|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43687016|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687017|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
43687018|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
43687019|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
43687020|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
43687021|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43687022|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687023|NCT02823236|Triamcinolone|triamcinolone|mesh-list
43687024|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43687025|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43687026|NCT02823236|Pirfenidone|pirfenidone|mesh-list
43687027|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43690804|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43687028|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687029|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
43687030|NCT02823236|Hormones|hormones|mesh-ancestor
43687031|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687032|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687033|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43687034|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
43687035|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687036|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687037|NCT02823236|Analgesics|analgesics|mesh-ancestor
43687038|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
43687039|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632547|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632548|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
43687044|NCT02823249|Erythritol|erythritol|mesh-list
43687045|NCT02823249|Tryptophan|tryptophan|mesh-list
43687046|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43687047|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
43687048|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43687049|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
43687050|NCT02823106|Verapamil|verapamil|mesh-list
43687051|NCT02823106|Choline|choline|mesh-list
43687052|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43687053|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
43687054|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43687055|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
43687056|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687057|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43687058|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43687059|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
43687060|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43687061|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43687062|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687063|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43690805|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
43690824|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43687064|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687065|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
43632554|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
43632555|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632556|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632557|NCT03036111|Trimebutine|trimebutine|mesh-list
43632558|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43632559|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
43690825|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43690826|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
43690827|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43690828|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
43690829|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690830|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
43690831|NCT02792673|Protective Agents|protective agents|mesh-ancestor
43690832|NCT02792621|Acipimox|acipimox|mesh-list
43632560|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
43636087|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
43636088|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632561|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632562|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632563|NCT03036085|Epinephrine|epinephrine|mesh-list
43632564|NCT03036085|Bupivacaine|bupivacaine|mesh-list
43632565|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
43632566|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
43829656|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632575|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632576|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43632577|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43632579|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43632580|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
43632581|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
43632582|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
43632583|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43632584|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
43632585|NCT03035838|Aprepitant|aprepitant|mesh-list
43632586|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
43632587|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
43632588|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632589|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632590|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43632591|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43632592|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636098|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
43632593|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632594|NCT03035656|Ropivacaine|ropivacaine|mesh-list
43632595|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
43632596|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
43632597|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632598|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632599|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
43632600|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632601|NCT03035695|Hemostatics|hemostatics|mesh-list
43632615|NCT05619315|Antacids|antacids|mesh-ancestor
43632616|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632617|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43632618|NCT05619315|Antidotes|antidotes|mesh-ancestor
43632619|NCT05619315|Protective Agents|protective agents|mesh-ancestor
43632620|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
43632621|NCT05618925|Rituximab|rituximab|mesh-list
43632622|NCT05618925|Fludarabine|fludarabine|mesh-list
43632623|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43632624|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
43632625|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632626|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687067|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43687068|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43687069|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43687070|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43687071|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
43687072|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687073|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687074|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687075|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43687076|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43687077|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43687078|NCT02822742|Latanoprost|latanoprost|mesh-list
43687079|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43687080|NCT02822937|Triazolam|triazolam|mesh-list
43687081|NCT02822937|Methylphenidate|methylphenidate|mesh-list
43636099|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636100|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687082|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43687083|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687084|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43687085|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43687086|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687087|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687088|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
43687089|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687090|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43687091|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43687092|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43636122|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636123|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636124|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43636126|NCT05042128|Paclitaxel|paclitaxel|mesh-list
43636127|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43636128|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636129|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
43636130|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
43636131|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
43636134|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
43687093|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687094|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43632627|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43632628|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
43632629|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828910|NCT05464173|Hormone Antagonists|hormone antagonists|mesh-ancestor
43828911|NCT05464173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828912|NCT05464173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847034|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
43847035|NCT04146207|Hormones|hormones|mesh-ancestor
43829657|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847066|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
43847067|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847068|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
43847069|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847070|NCT04139395|Citric Acid|citric acid|mesh-list
43847071|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
43847072|NCT04139395|Gallium citrate|gallium citrate|mesh-list
43847073|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
43847074|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43847075|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
43847076|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
43847077|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847078|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43847080|NCT04139304|Cortisone|cortisone|mesh-list
43847081|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
43632638|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43632639|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43632640|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632641|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43632642|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
43632643|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43632644|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
43632645|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43632646|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
43632647|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632648|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
43632649|NCT05618496|Protective Agents|protective agents|mesh-ancestor
43632650|NCT05618353|Colchicine|colchicine|mesh-list
43632651|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
43632652|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43632653|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
43632654|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
43632655|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690866|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43690867|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
43690868|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632656|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632657|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632658|NCT05618301|Natalizumab|natalizumab|mesh-list
43632659|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
43632660|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632661|NCT05618236|Atropine|atropine|mesh-list
43632662|NCT05618236|Neostigmine|neostigmine|mesh-list
43632663|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43636205|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636206|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
43636207|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636217|NCT05018585|Antacids|antacids|mesh-ancestor
43632664|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43632665|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43632666|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
43632667|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632668|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632670|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
43706889|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
43632672|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
43632673|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43632674|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43632675|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
43632676|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632677|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632678|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43632679|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632680|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43632681|NCT05618210|Anesthetics|anesthetics|mesh-list
43632682|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632683|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847082|NCT04139304|Doxorubicin|doxorubicin|mesh-list
43847083|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43847084|NCT04139304|Etoposide|etoposide|mesh-list
43847085|NCT04139304|Vincristine|vincristine|mesh-list
43687106|NCT02822131|Sevelamer|sevelamer|mesh-list
43687107|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
43687108|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
43687109|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687110|NCT02821897|Anesthetics|anesthetics|mesh-list
43687111|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687112|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687113|NCT02821858|Odalasvir|odalasvir|mesh-list
43687114|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
43687115|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687116|NCT02822144|Lidocaine|lidocaine|mesh-list
43687117|NCT02822144|Remifentanil|remifentanil|mesh-list
43687118|NCT02822144|Propofol|propofol|mesh-list
43687119|NCT02822144|Etomidate|etomidate|mesh-list
43687120|NCT02822144|Succinylcholine|succinylcholine|mesh-list
43687121|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
43687122|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
43687123|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687124|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687125|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
43687126|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687127|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43687129|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43687130|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43632684|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
43632685|NCT05617950|Salicylates|salicylates|mesh-list
43632686|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632687|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
43632688|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
43632689|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
43632690|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43632691|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43632692|NCT05617950|Analgesics|analgesics|mesh-ancestor
43632693|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
43632694|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632695|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636255|NCT05002127|Paclitaxel|paclitaxel|mesh-list
43636256|NCT05002127|Trastuzumab|trastuzumab|mesh-list
43636257|NCT05002127|Ramucirumab|ramucirumab|mesh-list
43636258|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43636259|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636260|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
43636261|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
43636262|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
43636263|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636264|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43690909|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43690910|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690911|NCT02791737|Coal Tar|coal tar|mesh-list
43690912|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
43690913|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
43690914|NCT02791815|Selexipag|selexipag|mesh-list
43632696|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43632697|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43632698|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43632699|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632700|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632701|NCT05617885|Leuprolide|leuprolide|mesh-list
43632702|NCT05617885|Goserelin|goserelin|mesh-list
43632703|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43687131|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687132|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43690915|NCT02791815|Midazolam|midazolam|mesh-list
43690916|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43687133|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43690917|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43690918|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687135|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687138|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43687139|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43687140|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43687141|NCT02822196|Lidocaine|lidocaine|mesh-list
43687142|NCT02822196|Bupivacaine|bupivacaine|mesh-list
43687143|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
43687144|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
43687145|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687146|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687147|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
43687148|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687149|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43690919|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690920|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43690921|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43690922|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43690923|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43687150|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43687151|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43632704|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43632705|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
43632706|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43632707|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632708|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43632709|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632710|NCT05617885|Hormones|hormones|mesh-ancestor
43632711|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632712|NCT05617872|Acetic Acid|acetic acid|mesh-list
43632713|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43632714|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632715|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
43632716|NCT05617729|Povidone|povidone|mesh-list
43632717|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
43632718|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
43849474|NCT03926130|Mirikizumab|mirikizumab|mesh-list
43632719|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43632720|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632722|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43632723|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632724|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632725|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43632726|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
43632727|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
43632728|NCT05617482|Anesthetics|anesthetics|mesh-list
43632729|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632730|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632731|NCT05617430|Leucovorin|leucovorin|mesh-list
43632732|NCT05617430|Bevacizumab|bevacizumab|mesh-list
43632733|NCT05617430|Fluorouracil|fluorouracil|mesh-list
43632734|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
43690924|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
43690925|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
43690926|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
43690927|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
43690928|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690929|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687161|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43687162|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687163|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
43687164|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
43687165|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
43687166|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687167|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43687168|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
43687169|NCT02822157|Antiviral Agents|antiviral agents|mesh-ancestor
43687170|NCT02822157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687171|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687172|NCT02822157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43687173|NCT02822157|Immunologic Factors|immunologic factors|mesh-ancestor
43687174|NCT02822157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687175|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43687176|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43687177|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43687178|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43632735|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43632736|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632737|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43632738|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43632739|NCT05617430|Growth Substances|growth substances|mesh-ancestor
43632740|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632741|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
43632742|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
43687185|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43687186|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687187|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687188|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687189|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687191|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43687192|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
43687194|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
43687195|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43687196|NCT02821468|Acetaminophen|acetaminophen|mesh-list
43687197|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43687198|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687199|NCT02821468|Analgesics|analgesics|mesh-ancestor
43687200|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
43687201|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687202|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687203|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
43687204|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43687205|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687206|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687207|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43687208|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687209|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687210|NCT02821676|Anesthetics|anesthetics|mesh-list
43687211|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687212|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687213|NCT02821559|Bevacizumab|bevacizumab|mesh-list
43687214|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
43687215|NCT02821559|Raltitrexed|raltitrexed|mesh-list
43687226|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43687227|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687229|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43687230|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
43687231|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43687232|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43687242|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43687243|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
43687244|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687245|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687246|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687247|NCT02821377|Furosemide|furosemide|mesh-list
43687248|NCT02821377|Diuretics|diuretics|mesh-ancestor
43687249|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
43687250|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687251|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43687252|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687253|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687254|NCT02820987|Meropenem|meropenem|mesh-list
43687255|NCT02820987|Tazobactam|tazobactam|mesh-list
43632766|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632767|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632768|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43632769|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
43829665|NCT05414084|Phenol|phenol|mesh-list
43632770|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
43632771|NCT05616910|Protective Agents|protective agents|mesh-ancestor
43632772|NCT05616754|Vaccines|vaccines|mesh-list
43632773|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
43632774|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632775|NCT05616624|Gemcitabine|gemcitabine|mesh-list
43632776|NCT05616624|Docetaxel|docetaxel|mesh-list
43632777|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43632778|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
43632779|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687256|NCT02820987|Piperacillin|piperacillin|mesh-list
43687257|NCT02820987|Cefepime|cefepime|mesh-list
43687258|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43687259|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43687260|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687261|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43687262|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687263|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687264|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
43687265|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43687266|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
43687267|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687268|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687269|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43687270|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
43687271|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43687272|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
43687273|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687274|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687275|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43687276|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
43687277|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
43687278|NCT02821156|Protective Agents|protective agents|mesh-ancestor
43687279|NCT02821169|Ropivacaine|ropivacaine|mesh-list
43687280|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
43687281|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
43687282|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687283|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687284|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
43687285|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687286|NCT02820935|Itraconazole|itraconazole|mesh-list
43687287|NCT02820935|Rifampin|rifampin|mesh-list
43687288|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
43687296|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687297|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687298|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43687299|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43687300|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
43690931|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
43690932|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43690933|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687301|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43687302|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
43690934|NCT02791243|Finasteride|finasteride|mesh-list
43690935|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43690936|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43690937|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636322|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636323|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43636324|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43636325|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
43636326|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687303|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43687304|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43687305|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43687306|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43687307|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43687308|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43687309|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43687310|NCT02821052|Insulin|insulin|mesh-list
43687311|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
43687312|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43687313|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687314|NCT02820948|Vitamins|vitamins|mesh-list
43687315|NCT02820948|Vitamin E|vitamin e|mesh-list
43687316|NCT02820948|Tocopherols|tocopherols|mesh-list
43687317|NCT02820948|Tocotrienols|tocotrienols|mesh-list
43687318|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
43687324|NCT02820922|Anesthetics|anesthetics|mesh-list
43687325|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687326|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687327|NCT02821247|Aflibercept|aflibercept|mesh-list
43687328|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43687329|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43687330|NCT02821247|Growth Substances|growth substances|mesh-ancestor
43687331|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687332|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
43687333|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687334|NCT02820883|Vaccines|vaccines|mesh-list
43687335|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
43687336|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687337|NCT02820688|Bupivacaine|bupivacaine|mesh-list
43687338|NCT02820688|Prilocaine|prilocaine|mesh-list
43636327|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
43636328|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
43636329|NCT04984980|Gemcitabine|gemcitabine|mesh-list
43636330|NCT04984980|Bevacizumab|bevacizumab|mesh-list
43636331|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
43636332|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43687339|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
43687340|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
43847086|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
43687341|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687342|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687343|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
43636350|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636351|NCT04979832|Metronidazole|metronidazole|mesh-list
43636352|NCT04979832|Fosfomycin|fosfomycin|mesh-list
43636353|NCT04979832|Molgramostim|molgramostim|mesh-list
43636354|NCT04979832|Sargramostim|sargramostim|mesh-list
43636355|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687344|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687346|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
43687347|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43687348|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687349|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687350|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687351|NCT02820610|Analgesics|analgesics|mesh-ancestor
43687352|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
43687353|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687354|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43632780|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632781|NCT05616624|Antiviral Agents|antiviral agents|mesh-ancestor
43632782|NCT05616624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632783|NCT05616624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632784|NCT05616624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43632785|NCT05616624|Immunologic Factors|immunologic factors|mesh-ancestor
43632786|NCT05616624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632787|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
43632788|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
43632789|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
43632790|NCT05616598|Ribavirin|ribavirin|mesh-list
43632791|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
43632792|NCT05616598|Simeprevir|simeprevir|mesh-list
43632793|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
43632794|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632795|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
43632796|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632797|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
43632798|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632799|NCT05616507|Fucoidan|fucoidan|mesh-list
43632800|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43632801|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43632802|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
43632803|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632804|NCT05616494|Docetaxel|docetaxel|mesh-list
43632822|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43632823|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
43632824|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
43632829|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632830|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43632831|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43632832|NCT05616390|Growth Substances|growth substances|mesh-ancestor
43632833|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632834|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
43632835|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
43632837|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43632838|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632839|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632840|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43632841|NCT05616364|Analgesics|analgesics|mesh-ancestor
43632842|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
43632843|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632844|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43636356|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43632845|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43636357|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43636358|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43632846|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43632847|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
43632848|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632849|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632850|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43632851|NCT05616364|Narcotics|narcotics|mesh-ancestor
43632852|NCT05616117|Vitamin D|vitamin d|mesh-list
43632853|NCT05616117|Vitamins|vitamins|mesh-list
43632854|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
43632855|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632856|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43632857|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43632858|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43632859|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43632860|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632861|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632862|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43687367|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43687368|NCT02820493|Vedolizumab|vedolizumab|mesh-list
43687369|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43687370|NCT02820441|Zopiclone|zopiclone|mesh-list
43687371|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43687372|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687373|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828913|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43828914|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43828915|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43828916|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828917|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828918|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43828919|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828920|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828921|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
43828922|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828937|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828938|NCT05459285|Dulaglutide|dulaglutide|mesh-list
43828939|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43828940|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632863|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43632864|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632865|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
43632871|NCT05615818|Ivosidenib|ivosidenib|mesh-list
43632872|NCT05615818|Futibatinib|futibatinib|mesh-list
43632873|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632874|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43632876|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632877|NCT05615818|Antiviral Agents|antiviral agents|mesh-ancestor
43632878|NCT05615818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632879|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632880|NCT05615818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43632881|NCT05615818|Immunologic Factors|immunologic factors|mesh-ancestor
43632882|NCT05615818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632883|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43632884|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43632885|NCT05615779|Levan|levan|mesh-list
43632886|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632887|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
43632906|NCT05615636|Lenalidomide|lenalidomide|mesh-list
43632907|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
43632908|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632909|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43632910|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43632911|NCT05615636|Growth Substances|growth substances|mesh-ancestor
43632912|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
43632913|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632914|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43632915|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632916|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632917|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43632918|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43632919|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632920|NCT05615012|Metformin|metformin|mesh-list
43632921|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43632922|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43632923|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632924|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43632925|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43632926|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
43632927|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632928|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43704721|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
43687393|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43687394|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687395|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687396|NCT02820025|Doxapram|doxapram|mesh-list
43687397|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43687398|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687399|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
43687400|NCT02820051|Lidocaine|lidocaine|mesh-list
43687401|NCT02820051|Midazolam|midazolam|mesh-list
43687402|NCT02820051|Nalbuphine|nalbuphine|mesh-list
43687403|NCT02820051|Propofol|propofol|mesh-list
43687404|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
43687405|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
43687406|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687407|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687414|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687416|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43687417|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
43687418|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43687419|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43687420|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43687421|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43687422|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
43687424|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687425|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687426|NCT02820051|Narcotics|narcotics|mesh-ancestor
43687427|NCT02820051|Analgesics|analgesics|mesh-ancestor
43687428|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43687429|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43687430|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43687431|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687432|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687433|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687434|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687435|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
43687436|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43687437|NCT02819661|Morphine|morphine|mesh-list
43687438|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687439|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687440|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687441|NCT02819661|Narcotics|narcotics|mesh-ancestor
43687442|NCT02819661|Analgesics|analgesics|mesh-ancestor
43687458|NCT02819414|Analgesics|analgesics|mesh-ancestor
43687459|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
43687460|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687461|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687462|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
43687463|NCT02819544|Ropivacaine|ropivacaine|mesh-list
43687464|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
43687465|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
43687466|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687467|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687468|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
43687469|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687470|NCT02819570|Ampicillin|ampicillin|mesh-list
43687471|NCT02819570|Cefuroxime|cefuroxime|mesh-list
43687472|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
43687473|NCT02819570|Roxithromycin|roxithromycin|mesh-list
43687474|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43687479|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43632936|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632937|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43632938|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43632939|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
43632940|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43632941|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632942|NCT05614765|Ezetimibe|ezetimibe|mesh-list
43632943|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43632944|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43632945|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
43632946|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632947|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43632948|NCT05614648|Clonidine|clonidine|mesh-list
43632949|NCT05614648|Analgesics|analgesics|mesh-ancestor
43632950|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
43632951|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632952|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632953|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43632954|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
43632955|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
43632956|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43632957|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43632958|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43632959|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
43632960|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632961|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632962|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43632964|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43687480|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687481|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687482|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43687483|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
43687484|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
43687485|NCT02819375|Analgesics|analgesics|mesh-ancestor
43687486|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
43687487|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687488|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43687489|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43687490|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43687491|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687492|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687494|NCT02819375|Narcotics|narcotics|mesh-ancestor
43687495|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
43687496|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43687497|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687498|NCT02819115|Vaccines|vaccines|mesh-list
43687499|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
43687500|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687501|NCT02819102|Berotralstat|berotralstat|mesh-list
43632970|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43632971|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43632972|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
43632973|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632974|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632976|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43632977|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43632978|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632979|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43632980|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
43632981|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
43632982|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
43632983|NCT05614518|Listerine|listerine|mesh-list
43632984|NCT05614518|Fluorides|fluorides|mesh-list
43632985|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
43632986|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
43632987|NCT05614518|Protective Agents|protective agents|mesh-ancestor
43632988|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632989|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43632990|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43632991|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43608249|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43608250|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43608251|NCT03197480|Growth Substances|growth substances|mesh-ancestor
43608252|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608253|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
43608254|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608255|NCT03197402|Caseins|caseins|mesh-list
43608256|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
43687503|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687504|NCT02818985|Dexamethasone|dexamethasone|mesh-list
43687505|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
43687506|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687507|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
43687508|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
43687509|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687510|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687511|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43633010|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
43633011|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828956|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687527|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687529|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
43687530|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687531|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
43687532|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43687533|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687534|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633012|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43633013|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704722|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633043|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
43633045|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
43633046|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633047|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43633048|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43633050|NCT05613179|Analgesics|analgesics|mesh-list
43633051|NCT05613179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43633052|NCT05613179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633053|NCT05613179|Sensory System Agents|sensory system agents|mesh-ancestor
43633054|NCT05613179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633055|NCT05613179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633056|NCT05613179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633057|NCT05613179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633058|NCT05613179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43633059|NCT05613179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633060|NCT05613179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633062|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633063|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43633064|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
43633065|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633066|NCT05613140|Valsartan|valsartan|mesh-list
43633067|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43633068|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43633069|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43633070|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43633071|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633072|NCT05613088|Paclitaxel|paclitaxel|mesh-list
43633073|NCT05613088|Doxorubicin|doxorubicin|mesh-list
43633074|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43633075|NCT05613088|Topotecan|topotecan|mesh-list
43633076|NCT05613088|Farletuzumab|farletuzumab|mesh-list
43633077|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43633078|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633079|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
43633080|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
43633081|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
43687535|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687536|NCT02819089|Analgesics|analgesics|mesh-ancestor
43687537|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
43687538|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690940|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687539|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43687540|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43687541|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43687542|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
43687543|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687544|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687545|NCT02818881|Methamphetamine|methamphetamine|mesh-list
43687546|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43687547|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687548|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
43687549|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
43687550|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687551|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
43687552|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687553|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687554|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
43687555|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43687556|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43687557|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687558|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43687580|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687581|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43690943|NCT02791373|Gemcitabine|gemcitabine|mesh-list
43687582|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43687583|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43687584|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
43687585|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
43687586|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
43687588|NCT02818803|Miconazole|miconazole|mesh-list
43687589|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687590|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
43687591|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43687592|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43687593|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687594|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687595|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43687596|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
43829658|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633083|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43633084|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43633085|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43633086|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633087|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43633089|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43633090|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633091|NCT05613062|Analgesics|analgesics|mesh-ancestor
43849476|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
43633092|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
43633095|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633096|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633097|NCT05612984|Aspirin|aspirin|mesh-list
43633098|NCT05612984|Folic Acid|folic acid|mesh-list
43633099|NCT05612984|Micronutrients|micronutrients|mesh-list
43633100|NCT05612984|Trace Elements|trace elements|mesh-list
43633101|NCT05612984|Calcium|calcium|mesh-list
43633102|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43633103|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633104|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43633105|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633106|NCT05612984|Analgesics|analgesics|mesh-ancestor
43633107|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
43633108|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633109|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633110|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633111|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43687598|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687599|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43687600|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43687601|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43687602|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43636362|NCT04975997|Dexamethasone|dexamethasone|mesh-list
43687603|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43687604|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43687605|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43687606|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43687607|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43687608|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43687609|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
43687610|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687611|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687612|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687613|NCT02818816|Laxatives|laxatives|mesh-ancestor
43687614|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43687615|NCT02818660|Cosyntropin|cosyntropin|mesh-list
43687616|NCT02818660|Hormones|hormones|mesh-ancestor
43687617|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633112|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43633113|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633114|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43633115|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43633116|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633117|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
43633118|NCT05612984|Hematinics|hematinics|mesh-ancestor
43633119|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
43633121|NCT05612880|Androgens|androgens|mesh-list
43633122|NCT05612880|Hormones|hormones|mesh-ancestor
43687627|NCT02818751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43687628|NCT02818751|Antidepressive Agents|antidepressive agents|mesh-ancestor
43687629|NCT02818751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43687630|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
43687631|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43687632|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687633|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687634|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687635|NCT02818621|Analgesics|analgesics|mesh-ancestor
43687636|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
43687637|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687638|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43687639|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43687640|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43687641|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
43687642|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687643|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687644|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
43687645|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43687646|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
43687647|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687648|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
43687649|NCT02818556|Protective Agents|protective agents|mesh-ancestor
43828957|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
43828958|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828959|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43828960|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828961|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633123|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633124|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633125|NCT05612867|Ascorbic Acid|ascorbic acid|mesh-list
43633127|NCT05612867|Micronutrients|micronutrients|mesh-ancestor
43633128|NCT05612867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633129|NCT05612867|Antioxidants|antioxidants|mesh-ancestor
43633130|NCT05612867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633131|NCT05612867|Protective Agents|protective agents|mesh-ancestor
43633132|NCT05612711|Dronabinol|dronabinol|mesh-list
43633133|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
43633134|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633135|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43633136|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633137|NCT05612711|Analgesics|analgesics|mesh-ancestor
43633138|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
43828962|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43828963|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43828964|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828966|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
43828967|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43828968|NCT05457868|Albuterol|albuterol|mesh-list
43828969|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43828970|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
43828971|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828972|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828973|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43828974|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
43828975|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
43828976|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43828977|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43828978|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43828979|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43828980|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
43828981|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828982|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828983|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43828984|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43828985|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43828986|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
43828987|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828988|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828989|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43828990|NCT05456490|Bupivacaine|bupivacaine|mesh-list
43828991|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
43828992|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
43828993|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828994|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633139|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633140|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43633141|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43633142|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633143|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633144|NCT05612711|Hormones|hormones|mesh-ancestor
43828995|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
43828996|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828997|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43828998|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43828999|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
43829000|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
43829001|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829002|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43829003|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43829004|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829005|NCT05454891|Insulin|insulin|mesh-list
43829006|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43829007|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43829008|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829009|NCT05454358|Letrozole|letrozole|mesh-list
43829010|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829011|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43690994|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690995|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43829012|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43829013|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829014|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829015|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43633145|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633146|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
43633147|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43633148|NCT05612607|Antibodies|antibodies|mesh-list
43633149|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
43633150|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633151|NCT05612594|Ertugliflozin|ertugliflozin|mesh-list
43633152|NCT05612594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43633153|NCT05612594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633154|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43633155|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633157|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43633158|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633159|NCT05612490|Furosemide|furosemide|mesh-list
43633160|NCT05612490|Diuretics|diuretics|mesh-ancestor
43633162|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633163|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43633164|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633165|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633170|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633172|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43633173|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
43633174|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633175|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633176|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43633177|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
43633178|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43633179|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
43829016|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
43847087|NCT04139304|Daunorubicin|daunorubicin|mesh-list
43687650|NCT02818491|Dexamethasone|dexamethasone|mesh-list
43687651|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
43687652|NCT02818491|Ropivacaine|ropivacaine|mesh-list
43687654|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687655|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
43687656|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
43687657|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687658|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687659|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43687660|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
43687661|NCT02818491|Hormones|hormones|mesh-ancestor
43687662|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687663|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43687664|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687665|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
43687666|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687667|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687668|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
43687669|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
43687670|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687671|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
43687672|NCT02818309|Lesogaberan|lesogaberan|mesh-list
43687673|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43687674|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43687675|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
43687676|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
43687677|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687678|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687679|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633180|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633181|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633182|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43633183|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
43633184|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
43633185|NCT05612074|Protective Agents|protective agents|mesh-ancestor
43633186|NCT05611879|Paclitaxel|paclitaxel|mesh-list
43633187|NCT05611879|Carboplatin|carboplatin|mesh-list
43633188|NCT05611879|Pemetrexed|pemetrexed|mesh-list
43633189|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43687680|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
43687681|NCT02818270|Albuterol|albuterol|mesh-list
43687682|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43687683|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
43687684|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687699|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43633190|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633192|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
43633193|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
43633194|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633195|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633196|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43633197|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43633198|NCT05611827|Quercetin|quercetin|mesh-list
43633199|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
43633200|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633201|NCT05611827|Protective Agents|protective agents|mesh-ancestor
43633202|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633203|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43633204|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43633205|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43633206|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633207|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633208|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633209|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633210|NCT05611749|Analgesics|analgesics|mesh-ancestor
43633211|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
43633212|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633213|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
43633214|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43633215|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
43633216|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43633217|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633218|NCT05611645|Bevacizumab|bevacizumab|mesh-list
43633219|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43633220|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633221|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43633222|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43633223|NCT05611645|Growth Substances|growth substances|mesh-ancestor
43687700|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43687701|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43687702|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
43687711|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
43687712|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
43687713|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43687714|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43687715|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43687716|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43687717|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
43687718|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
43687719|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687720|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687721|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687722|NCT02818387|Narcotics|narcotics|mesh-ancestor
43687723|NCT02818387|Analgesics|analgesics|mesh-ancestor
43687724|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
43687725|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687726|NCT02818348|Darunavir|darunavir|mesh-list
43687727|NCT02818348|Cobicistat|cobicistat|mesh-list
43687728|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43687729|NCT02818348|Etravirine|etravirine|mesh-list
43687731|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43687732|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
43687733|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687734|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687735|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43687736|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43829660|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43687759|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43687761|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633224|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687774|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43687775|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43687789|NCT02817503|Enalapril|enalapril|mesh-list
43687790|NCT02817503|Enalaprilat|enalaprilat|mesh-list
43687791|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43687792|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43687793|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687794|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687795|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43687796|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687797|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
43687798|NCT02817503|Diuretics|diuretics|mesh-ancestor
43687799|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
43687800|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43687801|NCT02817503|Hematinics|hematinics|mesh-ancestor
43687802|NCT02817503|Vitamins|vitamins|mesh-ancestor
43687803|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
43687804|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43687805|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
43687806|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687807|NCT02817321|Morphine|morphine|mesh-list
43687808|NCT02817321|Ropivacaine|ropivacaine|mesh-list
43687809|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687810|NCT02817321|Narcotics|narcotics|mesh-ancestor
43633242|NCT05611385|Amphetamine|amphetamine|mesh-list
43633243|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43633244|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633245|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
43633246|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
43633247|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633248|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
43633249|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633250|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633251|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
43633252|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43633253|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43633254|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633255|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43633256|NCT05611372|Rasagiline|rasagiline|mesh-list
43633257|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43633258|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691023|NCT02790450|Benzbromarone|benzbromarone|mesh-list
43633259|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633260|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43633261|NCT05611372|Protective Agents|protective agents|mesh-ancestor
43633262|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633263|NCT05611307|Hormones|hormones|mesh-list
43704723|NCT04313088|Eluxadoline|eluxadoline|mesh-list
43633267|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43687811|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687812|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687813|NCT02817321|Analgesics|analgesics|mesh-ancestor
43687814|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
43687815|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687816|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
43687817|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
43687818|NCT02817360|Losartan|losartan|mesh-list
43687819|NCT02817360|Valsartan|valsartan|mesh-list
43687820|NCT02817360|Carvedilol|carvedilol|mesh-list
43687821|NCT02817360|Candesartan|candesartan|mesh-list
43687822|NCT02817360|Ramipril|ramipril|mesh-list
43687823|NCT02817360|Enalapril|enalapril|mesh-list
43687824|NCT02817360|Lisinopril|lisinopril|mesh-list
43687825|NCT02817360|Irbesartan|irbesartan|mesh-list
43687826|NCT02817360|Nebivolol|nebivolol|mesh-list
43687827|NCT02817360|Bisoprolol|bisoprolol|mesh-list
43687828|NCT02817360|Perindopril|perindopril|mesh-list
43687829|NCT02817360|Captopril|captopril|mesh-list
43687830|NCT02817360|Quinapril|quinapril|mesh-list
43687831|NCT02817360|Trandolapril|trandolapril|mesh-list
43687832|NCT02817360|Fosinopril|fosinopril|mesh-list
43687833|NCT02817360|Eprosartan|eprosartan|mesh-list
43687834|NCT02817360|Zofenopril|zofenopril|mesh-list
43687835|NCT02817360|Spirapril|spirapril|mesh-list
43687836|NCT02817360|Cilazapril|cilazapril|mesh-list
43687837|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43687838|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43687839|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43687840|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43687841|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687842|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43687843|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43687844|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
43633268|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633269|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633270|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43633271|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43633272|NCT05611268|Protective Agents|protective agents|mesh-ancestor
43633273|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687851|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43687853|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43687854|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43687855|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43687856|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
43687857|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687858|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43687859|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43687860|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43687861|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43687862|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
43687863|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
43687864|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687865|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43687878|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43687879|NCT02817191|BB 1101|bb 1101|mesh-list
43687881|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687882|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
43687883|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
43691026|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43687884|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687885|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687886|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43687887|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
43687888|NCT02817191|Hormones|hormones|mesh-ancestor
43687889|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687890|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43687891|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687892|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
43687893|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687894|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687895|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43687896|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43687897|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687898|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43687899|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
43687900|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687901|NCT02817217|Valsartan|valsartan|mesh-list
43687902|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43687903|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43687904|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43687905|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687906|NCT02817256|Vitamins|vitamins|mesh-list
43687907|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
43687908|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687909|NCT02817243|Simvastatin|simvastatin|mesh-list
43687910|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43687911|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43687912|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
43829661|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687923|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687924|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43687925|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
43687926|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687927|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687928|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43687930|NCT02817113|Cetuximab|cetuximab|mesh-list
43687931|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
43687932|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687933|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43687934|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687935|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691044|NCT02790099|Morphine|morphine|mesh-list
43687936|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
43687937|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687938|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43687940|NCT02816905|Dexamethasone|dexamethasone|mesh-list
43687941|NCT02816905|Rimexolone|rimexolone|mesh-list
43687942|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687943|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
43829017|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829018|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829019|NCT05453955|Propofol|propofol|mesh-list
43829020|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43829021|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829022|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829023|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43829024|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
43829025|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
43829026|NCT05453799|Antibodies|antibodies|mesh-list
43829027|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
43829028|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43829029|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
43847099|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43847100|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43847101|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43847102|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847103|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847104|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
43847118|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43847119|NCT04139213|Narcotics|narcotics|mesh-ancestor
43847120|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43847121|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847122|NCT04139213|Analgesics|analgesics|mesh-ancestor
43847123|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
43687958|NCT02816853|Domperidone|domperidone|mesh-list
43687959|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43687960|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687961|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43687962|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43687963|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687964|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687965|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687966|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687967|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
43687968|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
43687969|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687970|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43687971|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43687972|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
43687973|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687974|NCT02816476|Daratumumab|daratumumab|mesh-list
43687975|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687976|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43687977|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
43687978|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43687979|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687993|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687994|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43687995|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43687996|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43687997|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
43687998|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43687999|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688000|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43688001|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43688002|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688003|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688004|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688005|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43688006|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43688007|NCT02816411|Caseins|caseins|mesh-list
43688008|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
43688009|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
43688010|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688011|NCT02815865|Oxytocin|oxytocin|mesh-list
43688012|NCT02815865|Dinoprostone|dinoprostone|mesh-list
43688034|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43688035|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688036|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688037|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43688038|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688039|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688040|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
43688041|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688042|NCT02816203|Hemostatics|hemostatics|mesh-list
43688043|NCT02816203|Coagulants|coagulants|mesh-ancestor
43688044|NCT02815319|Dexamethasone|dexamethasone|mesh-list
43688057|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
43688058|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
43688059|NCT02815475|Curcumin|curcumin|mesh-list
43633285|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633286|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
43633287|NCT05611229|Nivolumab|nivolumab|mesh-list
43633288|NCT05611229|Ipilimumab|ipilimumab|mesh-list
43633289|NCT05611229|Trametinib|trametinib|mesh-list
43633290|NCT05611229|Vemurafenib|vemurafenib|mesh-list
43633291|NCT05611229|Dabrafenib|dabrafenib|mesh-list
43633292|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43633293|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633294|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43633295|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633296|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43633297|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633298|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
43633299|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43633300|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
43688060|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43688061|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688062|NCT02815475|Analgesics|analgesics|mesh-ancestor
43688063|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
43688064|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688065|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688066|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688067|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43688068|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688069|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688070|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688071|NCT02815449|Iron|iron|mesh-list
43688072|NCT02815449|Trace Elements|trace elements|mesh-ancestor
43688073|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
43688074|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688075|NCT02815332|Minocycline|minocycline|mesh-list
43688076|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43688077|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688078|NCT02815189|Acetaminophen|acetaminophen|mesh-list
43688079|NCT02815189|Ibuprofen|ibuprofen|mesh-list
43688080|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688081|NCT02815189|Analgesics|analgesics|mesh-ancestor
43688082|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
43688083|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688084|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688085|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
43688109|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43688110|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
43688111|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43688112|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43688113|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688114|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688115|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
43688116|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
43688117|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43688118|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43688119|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43688120|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
43688121|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
43688122|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
43688130|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829032|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
43829050|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43829051|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43829052|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
43829053|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43829054|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
43829055|NCT05451849|Fludarabine|fludarabine|mesh-list
43829056|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43829057|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
43829058|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829059|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829060|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43829061|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
43829062|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829063|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688133|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43688134|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688135|NCT02815059|Prednisone|prednisone|mesh-list
43688136|NCT02815059|Dasatinib|dasatinib|mesh-list
43688137|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688138|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
43688139|NCT02815059|Hormones|hormones|mesh-ancestor
43688140|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688141|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688142|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43829662|NCT05414214|Anesthetics|anesthetics|mesh-list
43688143|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688144|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43688145|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633301|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633302|NCT05611086|Expectorants|expectorants|mesh-ancestor
43633303|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
43633304|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43633305|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
43688146|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688147|NCT02814500|Amlodipine|amlodipine|mesh-list
43688148|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43688149|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688150|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43688151|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688152|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688153|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43688154|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688155|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
43688156|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43688157|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43688158|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
43688159|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43688160|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43688161|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688162|NCT02814669|Atezolizumab|atezolizumab|mesh-list
43688163|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43688164|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688165|NCT02814461|Axitinib|axitinib|mesh-list
43688166|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688167|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43688168|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688169|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688194|NCT02813863|Metformin|metformin|mesh-list
43688195|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43688196|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688197|NCT02813356|Naloxegol|naloxegol|mesh-list
43688198|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43688199|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688200|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
43688201|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688202|NCT02813369|Naloxegol|naloxegol|mesh-list
43688203|NCT02813369|Laxatives|laxatives|mesh-list
43688204|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43688205|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688206|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
43688207|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688208|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688210|NCT02813382|Prilocaine|prilocaine|mesh-list
43688211|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
43688212|NCT02813382|Procaine|procaine|mesh-list
43688213|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
43688214|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
43688215|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688216|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688217|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
43688218|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688219|NCT02813135|Carboplatin|carboplatin|mesh-list
43688220|NCT02813135|Nivolumab|nivolumab|mesh-list
43633306|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633307|NCT05611086|Protective Agents|protective agents|mesh-ancestor
43633310|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
43633311|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633312|NCT05610969|Midazolam|midazolam|mesh-list
43633313|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43633314|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688231|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43688232|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688233|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43688234|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
43688235|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43688237|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
43688238|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688239|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43688240|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43688241|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
43688242|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43688243|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
43688244|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43688245|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688246|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43688247|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43688248|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688249|NCT02813018|Ropivacaine|ropivacaine|mesh-list
43688250|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
43688251|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
43688252|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688253|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688254|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
43688255|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688256|NCT02813148|Naloxegol|naloxegol|mesh-list
43688257|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43688258|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688259|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
43688260|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688261|NCT02813044|Anesthetics|anesthetics|mesh-list
43688262|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633315|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633316|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633317|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43633318|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43633319|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43633320|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43633321|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
43633323|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
43633324|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
43688263|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688264|NCT02812888|Propranolol|propranolol|mesh-list
43688265|NCT02812888|Methimazole|methimazole|mesh-list
43688266|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
43688267|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43688268|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43688269|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688270|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688271|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688272|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688273|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43688274|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688275|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
43688276|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
43688277|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
43688278|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688279|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
43829064|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43829065|NCT05451615|Abatacept|abatacept|mesh-list
43829066|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43829067|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43688280|NCT02812979|Albuterol|albuterol|mesh-list
43688281|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43688282|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
43688283|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688284|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688285|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43688286|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
43688287|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
43688288|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43688289|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43688290|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43633325|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633326|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633327|NCT05610956|Empagliflozin|empagliflozin|mesh-list
43633328|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43633329|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633330|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43633331|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633333|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43688291|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43688292|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688293|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688294|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688295|NCT02812940|Everolimus|everolimus|mesh-list
43688296|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688297|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43688298|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
43688299|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688300|NCT02812654|Doxorubicin|doxorubicin|mesh-list
43688301|NCT02812654|Ifosfamide|ifosfamide|mesh-list
43688302|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43688303|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688304|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43688305|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43688306|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688307|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688308|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43688309|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
43688310|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
43688311|NCT02812719|Salicylates|salicylates|mesh-list
43688312|NCT02812719|Glycolic acid|glycolic acid|mesh-list
43688313|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688314|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
43688315|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
43688316|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
43688321|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688322|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633334|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633335|NCT05610878|Analgesics|analgesics|mesh-ancestor
43633336|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
43633337|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633338|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633339|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633340|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633341|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633342|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691063|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691064|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43688323|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688324|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43688325|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43688326|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688327|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688328|NCT02812992|Gemcitabine|gemcitabine|mesh-list
43688329|NCT02812992|Paclitaxel|paclitaxel|mesh-list
43688330|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43688331|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688332|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
43688333|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
43688334|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
43688335|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688336|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43688337|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
43688338|NCT02812992|Antiviral Agents|antiviral agents|mesh-ancestor
43688339|NCT02812992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688340|NCT02812992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688341|NCT02812992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43688342|NCT02812992|Immunologic Factors|immunologic factors|mesh-ancestor
43688343|NCT02812992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688344|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
43688369|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688370|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688371|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
43688372|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688373|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43688374|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43688375|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43688376|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688377|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688378|NCT02812368|Clonidine|clonidine|mesh-list
43688379|NCT02812368|Analgesics|analgesics|mesh-ancestor
43688380|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
43688381|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688382|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688383|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688384|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
43688385|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
43688386|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43688387|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43688388|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43688389|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688390|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688391|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688392|NCT02812394|Levodopa|levodopa|mesh-list
43688393|NCT02812394|Carbidopa|carbidopa|mesh-list
43688394|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43688395|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43688396|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43688397|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
43688398|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688406|NCT02812199|Lidocaine|lidocaine|mesh-list
43688411|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
43688412|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688413|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688414|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
43688415|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688416|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43688417|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43688418|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43688419|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688420|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688421|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43688422|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43829666|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43688423|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688424|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688425|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43688426|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43688428|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43688429|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
43688430|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
43688431|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
43688432|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43688433|NCT02812147|Droxidopa|droxidopa|mesh-list
43688434|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43688435|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43633351|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633352|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
43633353|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
43633354|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
43633355|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633356|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43633357|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
43633358|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43633359|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
43633360|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43688438|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688439|NCT02811978|Dexamethasone|dexamethasone|mesh-list
43688440|NCT02811978|Bortezomib|bortezomib|mesh-list
43688441|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688442|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
43688443|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
43688444|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688445|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688446|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688447|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
43688448|NCT02811978|Hormones|hormones|mesh-ancestor
43688449|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688450|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43688451|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688452|NCT02812355|Heparin|heparin|mesh-list
43688453|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
43688454|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43688455|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43633361|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633362|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43633363|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43633364|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
43633365|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
43633366|NCT05700955|Temozolomide|temozolomide|mesh-list
43704823|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
43633367|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43633368|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633369|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43633370|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
43633371|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633373|NCT05700903|Goserelin|goserelin|mesh-list
43633374|NCT05700903|Flutamide|flutamide|mesh-list
43633375|NCT05700903|Bicalutamide|bicalutamide|mesh-list
43633376|NCT05700903|Hormones|hormones|mesh-list
43633377|NCT05700903|Androgens|androgens|mesh-list
43633378|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
43633379|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633380|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633381|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43633383|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43633384|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43633386|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
43633387|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
43633388|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43633389|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43633391|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43636445|NCT04910061|Niacinamide|niacinamide|mesh-list
43633392|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
43633393|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43633394|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633395|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43633396|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43633397|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43633398|NCT05700721|Niraparib|niraparib|mesh-list
43633399|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43633400|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633401|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688456|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688457|NCT02811731|Amlodipine|amlodipine|mesh-list
43688458|NCT02811731|Candesartan|candesartan|mesh-list
43688459|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688460|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43688461|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688462|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688463|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43688464|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688466|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43688467|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43688468|NCT02811809|Leuprolide|leuprolide|mesh-list
43688469|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43688470|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
43688471|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43688472|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688473|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43688474|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688475|NCT02811991|Acetaminophen|acetaminophen|mesh-list
43688476|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688477|NCT02811991|Analgesics|analgesics|mesh-ancestor
43688478|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
43688479|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688480|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688481|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
43688482|NCT02811692|Aflibercept|aflibercept|mesh-list
43688483|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43688484|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43688489|NCT02811627|Memantine|memantine|mesh-list
43688498|NCT02811497|Azacitidine|azacitidine|mesh-list
43688499|NCT02811497|Durvalumab|durvalumab|mesh-list
43688500|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43688502|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688503|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688504|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688505|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43688506|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
43688507|NCT02811484|Exenatide|exenatide|mesh-list
43688508|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43688509|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688510|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43688511|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688512|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43688513|NCT02811484|Incretins|incretins|mesh-ancestor
43688514|NCT02811484|Hormones|hormones|mesh-ancestor
43688515|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688516|NCT02811289|Mirabegron|mirabegron|mesh-list
43688517|NCT02811289|Glycerol|glycerol|mesh-list
43688518|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43704824|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
43633421|NCT05700617|Milrinone|milrinone|mesh-list
43633422|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43633423|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
43633424|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
43633425|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633426|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633433|NCT05700617|Protective Agents|protective agents|mesh-ancestor
43633434|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43633435|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
43633436|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43633437|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43633438|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633439|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43633440|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
43633441|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633442|NCT05700448|Gemcitabine|gemcitabine|mesh-list
43633443|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
43633444|NCT05700448|Pegaspargase|pegaspargase|mesh-list
43633445|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43633446|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
43633447|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633448|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633449|NCT05700448|Antiviral Agents|antiviral agents|mesh-ancestor
43633450|NCT05700448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633451|NCT05700448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633452|NCT05700448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43688530|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829068|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829069|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829070|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43829071|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
43829072|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829073|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829074|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43829075|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829076|NCT05451095|Ketamine|ketamine|mesh-list
43829077|NCT05451095|Analgesics|analgesics|mesh-ancestor
43829078|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
43829079|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829080|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829081|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43829083|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
43829084|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
43829085|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829086|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43688531|NCT02811341|Scopolamine|scopolamine|mesh-list
43688532|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43688533|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43688534|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
43688535|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
43688536|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688543|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688544|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43688545|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
43688546|NCT02811354|Osimertinib|osimertinib|mesh-list
43688547|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688548|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43688549|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688550|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688552|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
43688553|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
43688554|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688555|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688556|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688557|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43688558|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688559|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688560|NCT02811016|Budesonide|budesonide|mesh-list
43688561|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688562|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43688563|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
43688564|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688565|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688566|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43688567|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
43688568|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
43688569|NCT02811016|Hormones|hormones|mesh-ancestor
43688570|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688571|NCT02810808|Ranibizumab|ranibizumab|mesh-list
43688572|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43688573|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43688574|NCT02810808|Growth Substances|growth substances|mesh-ancestor
43633453|NCT05700448|Immunologic Factors|immunologic factors|mesh-ancestor
43633454|NCT05700448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633462|NCT05700344|Avelumab|avelumab|mesh-list
43633463|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43633464|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633465|NCT05700266|Aspirin|aspirin|mesh-list
43633466|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
43633467|NCT05700266|Clopidogrel|clopidogrel|mesh-list
43633468|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43688575|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688576|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
43688577|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688578|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43688579|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43688580|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688581|NCT02810782|Morphine|morphine|mesh-list
43688582|NCT02810782|Phenobarbital|phenobarbital|mesh-list
43688583|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
43688584|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43688585|NCT02810782|Narcotics|narcotics|mesh-ancestor
43688586|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688587|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688588|NCT02810782|Analgesics|analgesics|mesh-ancestor
43688589|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
43633469|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633470|NCT05700266|Analgesics|analgesics|mesh-ancestor
43633471|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
43633472|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633473|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633474|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633475|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633476|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43633477|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43633478|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633479|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43633480|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43633481|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633482|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
43633483|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43633484|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43633485|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43633486|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
43633487|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633488|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43633489|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
43633490|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43633491|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
43633492|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
43633493|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
43633494|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43633495|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
43633496|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633497|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
43633511|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633512|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
43633513|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688590|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688592|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688593|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43688594|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43688595|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688596|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688597|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
43688598|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
43688599|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43688600|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43688601|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43688602|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
43688603|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
43688604|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688605|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43688607|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43688608|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43688609|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
43688610|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
43688611|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688612|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633514|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633515|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633516|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633517|NCT05700045|Analgesics|analgesics|mesh-ancestor
43633518|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
43633519|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633520|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43633521|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43633522|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43633523|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
43633530|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43633531|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
43633532|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633533|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633535|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
43633536|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
43633537|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633538|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43633539|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43633540|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633541|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633542|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43633543|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
43688613|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688614|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688615|NCT02810899|Analgesics|analgesics|mesh-ancestor
43688616|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
43688617|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688618|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43688619|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43688630|NCT02810275|Folic Acid|folic acid|mesh-list
43688631|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
43688632|NCT02810275|Antidotes|antidotes|mesh-ancestor
43688633|NCT02810275|Protective Agents|protective agents|mesh-ancestor
43688634|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688635|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
43688636|NCT02810275|Vitamins|vitamins|mesh-ancestor
43688637|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
43633544|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633545|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633546|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43633549|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43633551|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633553|NCT05699876|Melatonin|melatonin|mesh-list
43633554|NCT05699876|Analgesics|analgesics|mesh-ancestor
43633555|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
43633556|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633557|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633558|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
43688638|NCT02810275|Hematinics|hematinics|mesh-ancestor
43688639|NCT02810483|Topiramate|topiramate|mesh-list
43688640|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
43688641|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43688642|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688643|NCT02810132|Metformin|metformin|mesh-list
43688644|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43688645|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688646|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
43688647|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43688648|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43688649|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43688650|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633559|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43633560|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43633561|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633562|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43633563|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43633564|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43633565|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633566|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633567|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
43633568|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
43633569|NCT05699876|Protective Agents|protective agents|mesh-ancestor
43633570|NCT05699824|Carvedilol|carvedilol|mesh-list
43688662|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688663|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688664|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688665|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43688666|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688667|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43688668|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
43688669|NCT02809768|Itraconazole|itraconazole|mesh-list
43688670|NCT02809768|Fluconazole|fluconazole|mesh-list
43688671|NCT02809768|Rifampin|rifampin|mesh-list
43688672|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
43688673|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688674|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43688675|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43688676|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688677|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633613|NCT05699746|Capecitabine|capecitabine|mesh-list
43633614|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
43633615|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43633616|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
43633617|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633618|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633619|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
43633620|NCT05699720|Analgesics|analgesics|mesh-ancestor
43633621|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
43633622|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633623|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633624|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
43633625|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633626|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43688678|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43688679|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
43688680|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688688|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43688689|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43688690|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43688691|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43691071|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691072|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
43691073|NCT02790177|Protective Agents|protective agents|mesh-ancestor
43691074|NCT02790164|Rocuronium|rocuronium|mesh-list
43691080|NCT02789969|Fentanyl|fentanyl|mesh-list
43688692|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43688693|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43688694|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43688695|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43688696|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
43688697|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688698|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688699|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688700|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688702|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
43688703|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688704|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43688705|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43688706|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43633628|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43633629|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633630|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633631|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43633632|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
43633633|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43633634|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
43633636|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688707|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688708|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688709|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688711|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43688712|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
43688713|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688714|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688715|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43688716|NCT02809963|Diuretics|diuretics|mesh-ancestor
43688717|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
43688718|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688719|NCT02809742|Ropivacaine|ropivacaine|mesh-list
43691096|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43688720|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
43688721|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
43688722|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688723|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688724|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
43688725|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688726|NCT02809755|Lidocaine|lidocaine|mesh-list
43688727|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
43688728|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
43688729|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688730|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688731|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
43688732|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688733|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43688734|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43633637|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43633638|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633639|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633640|NCT05699603|Fluorouracil|fluorouracil|mesh-list
43633641|NCT05699603|Calcipotriene|calcipotriene|mesh-list
43633642|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
43633643|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633644|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43633645|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633646|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43633647|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
43633648|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633654|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688752|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43688753|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688754|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
43688756|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688757|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43688758|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43688759|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
43688760|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
43688761|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
43688762|NCT02809378|Remifentanil|remifentanil|mesh-list
43688763|NCT02809378|Thiopental|thiopental|mesh-list
43688764|NCT02809378|Palonosetron|palonosetron|mesh-list
43688765|NCT02809378|Propofol|propofol|mesh-list
43688766|NCT02809378|Sevoflurane|sevoflurane|mesh-list
43688791|NCT02809404|Everolimus|everolimus|mesh-list
43688802|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
43688803|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688804|NCT02809469|Apixaban|apixaban|mesh-list
43688805|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43688806|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
43688807|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43688808|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
43688809|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688810|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688811|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
43688812|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
43688813|NCT02809079|Prednisone|prednisone|mesh-list
43688814|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636475|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
43636476|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688815|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
43633691|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
43633692|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633693|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688826|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688827|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688829|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43688830|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
43688831|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688832|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688833|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
43688834|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43688835|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688836|NCT02808949|Dapivirine|dapivirine|mesh-list
43688837|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43688838|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43688839|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
43688840|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688841|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
43688842|NCT02809066|Calcium|calcium|mesh-list
43688843|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43688844|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688845|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43688846|NCT02808767|Ticagrelor|ticagrelor|mesh-list
43688847|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43688848|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43688849|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43688850|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43688852|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
43688860|NCT02808728|Ropivacaine|ropivacaine|mesh-list
43688861|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
43688862|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
43688863|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688864|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688865|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
43688866|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688867|NCT02808676|Vitamin D|vitamin d|mesh-list
43688868|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
43688869|NCT02808676|Vitamins|vitamins|mesh-ancestor
43688870|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
43688871|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688872|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43688873|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43688875|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43688876|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43688877|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688878|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633725|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633727|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43633728|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633729|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
43633730|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633731|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
43633732|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
43633733|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
43633734|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633735|NCT05698524|Temozolomide|temozolomide|mesh-list
43633736|NCT05698524|Abexinostat|abexinostat|mesh-list
43633737|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43633738|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
43633739|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633766|NCT05698407|Narcotics|narcotics|mesh-ancestor
43633767|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43633768|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43633769|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
43633770|NCT05698394|Esketamine|esketamine|mesh-list
43633771|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
43633772|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43688879|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688880|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688881|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43688882|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688883|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
43688884|NCT02808533|Topiramate|topiramate|mesh-list
43688885|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
43688886|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43688887|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688888|NCT02808325|Polygeline|polygeline|mesh-list
43688889|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
43688890|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
43688891|NCT02808247|Ifosfamide|ifosfamide|mesh-list
43688892|NCT02808247|Nintedanib|nintedanib|mesh-list
43688893|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43688894|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
43688895|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688896|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688897|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43633804|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43633805|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633806|NCT05697809|Dexamethasone|dexamethasone|mesh-list
43633807|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633808|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
43633809|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
43633810|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633811|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633812|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43633813|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
43633815|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633816|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43633817|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633818|NCT05697783|Fentanyl|fentanyl|mesh-list
43633819|NCT05697783|Methadone|methadone|mesh-list
43633820|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43633821|NCT05697783|Narcotics|narcotics|mesh-ancestor
43633822|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688902|NCT02808065|Tacrolimus|tacrolimus|mesh-list
43636570|NCT04871529|Gemcitabine|gemcitabine|mesh-list
43688903|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43688904|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
43688905|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688906|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43688907|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688908|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688909|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43688910|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688911|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43688912|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
43688913|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43688914|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688915|NCT02808117|Micronutrients|micronutrients|mesh-list
43688916|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688918|NCT02807909|Diltiazem|diltiazem|mesh-list
43688919|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
43688920|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688921|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43688922|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43688923|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688924|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688925|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43688926|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
43688927|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43688928|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688929|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43633828|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43633829|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
43633831|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
43633832|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
43633833|NCT05697692|Heparin|heparin|mesh-list
43633834|NCT05697692|Calcium heparin|calcium heparin|mesh-list
43633835|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
43633836|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43633837|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43633838|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633839|NCT05697614|Lamotrigine|lamotrigine|mesh-list
43633840|NCT05697614|Carbamazepine|carbamazepine|mesh-list
43633841|NCT05697614|Phenytoin|phenytoin|mesh-list
43633842|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
43633843|NCT05697614|Valproic Acid|valproic acid|mesh-list
43633844|NCT05697614|Clobazam|clobazam|mesh-list
43688930|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688931|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43636576|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636578|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
43688932|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688933|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43688934|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
43688935|NCT02807922|Zopiclone|zopiclone|mesh-list
43688936|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688937|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688938|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688939|NCT02808104|Mazindol|mazindol|mesh-list
43688940|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43688941|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688942|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43688943|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43688944|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688945|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633847|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633848|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633849|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43633850|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633858|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633859|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
43633860|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43688960|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43688961|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43688962|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43688964|NCT02807610|Etomidate|etomidate|mesh-list
43633866|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43633867|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43633868|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43633869|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43633870|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
43633871|NCT05697510|Siltuximab|siltuximab|mesh-list
43633881|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43633882|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43633883|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
43633884|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633885|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43633886|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633887|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43633889|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43633890|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43633891|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
43688986|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43688987|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43688988|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688989|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
43688990|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
43688991|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
43688992|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688993|NCT02807415|Ivacaftor|ivacaftor|mesh-list
43633892|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633893|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43849482|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849483|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849484|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849485|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43849486|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43849487|NCT03924947|Pancrelipase|pancrelipase|mesh-list
43849488|NCT03924947|Pancreatin|pancreatin|mesh-list
43633909|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43633910|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633911|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43633912|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633913|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
43633914|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43633915|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633916|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633917|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43633918|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633919|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43633920|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
43633921|NCT05697016|Sivelestat|sivelestat|mesh-list
43633922|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43633923|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
43633924|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633925|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633926|NCT05697003|Fluticasone|fluticasone|mesh-list
43633937|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
43633938|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43633939|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43633940|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43633941|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43633942|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
43633943|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633944|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633945|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
43633946|NCT05697003|Hormones|hormones|mesh-ancestor
43633947|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633948|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
43633949|NCT05696977|Cyclosporine|cyclosporine|mesh-list
43633950|NCT05696977|Cyclosporins|cyclosporins|mesh-list
43633951|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633952|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633953|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43633954|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
43633955|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633956|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
43633957|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633958|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
43633959|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633960|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43633968|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43633969|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633970|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633971|NCT05696938|Niacinamide|niacinamide|mesh-list
43633973|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
43633974|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
43633975|NCT05696938|Vitamins|vitamins|mesh-ancestor
43633976|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
43633977|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688994|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43688995|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43636601|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636602|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
43636603|NCT04862468|Hormones|hormones|mesh-ancestor
43688996|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688997|NCT02807272|Tipifarnib|tipifarnib|mesh-list
43688998|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688999|NCT02807298|Lidocaine|lidocaine|mesh-list
43689000|NCT02807298|Epinephrine|epinephrine|mesh-list
43689001|NCT02807298|Carticaine|carticaine|mesh-list
43689002|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43689003|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43689004|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
43689005|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689006|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689007|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689008|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43689009|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43689010|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
43689011|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689012|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43689013|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
43689015|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
43689016|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43689017|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
43689018|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
43689019|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689020|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
43633978|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43633980|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633981|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43633982|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
43633984|NCT05696886|Tramadol|tramadol|mesh-list
43633985|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43633986|NCT05696886|Narcotics|narcotics|mesh-ancestor
43633987|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633988|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633989|NCT05696886|Analgesics|analgesics|mesh-ancestor
43633990|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
43633991|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633992|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43633993|NCT05696847|Tirzepatide|tirzepatide|mesh-list
43633994|NCT05696847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43633995|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633996|NCT05696847|Incretins|incretins|mesh-ancestor
43633997|NCT05696847|Hormones|hormones|mesh-ancestor
43633998|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43633999|NCT05696795|Abrocitinib|abrocitinib|mesh-list
43634000|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43689021|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43689022|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43689023|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43689024|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43689025|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
43689026|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689027|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829369|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829371|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
43689028|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43689029|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43689030|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634016|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43634018|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634019|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634020|NCT05696678|Morphine|morphine|mesh-list
43634021|NCT05696678|Ropivacaine|ropivacaine|mesh-list
43634022|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43634023|NCT05696678|Narcotics|narcotics|mesh-ancestor
43634024|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634025|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634026|NCT05696678|Analgesics|analgesics|mesh-ancestor
43634027|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
43634028|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634029|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
43634030|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
43634041|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634042|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634043|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
43634044|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634045|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43634046|NCT05696613|Hormones|hormones|mesh-ancestor
43634047|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634048|NCT05696574|Misoprostol|misoprostol|mesh-list
43634049|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43634050|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
43634051|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43634052|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634053|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43634054|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634055|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
43634056|NCT05696548|Nivolumab|nivolumab|mesh-list
43634057|NCT05696548|Lenvatinib|lenvatinib|mesh-list
43634058|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634060|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43634061|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634062|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43634063|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634064|NCT05696509|Anesthetics|anesthetics|mesh-list
43634065|NCT05696509|Propofol|propofol|mesh-list
43634066|NCT05696509|Sevoflurane|sevoflurane|mesh-list
43634067|NCT05696509|Isoflurane|isoflurane|mesh-list
43634068|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634069|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634079|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43691145|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43634081|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43634082|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634083|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43634084|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634085|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
43634086|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
43689031|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689032|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689033|NCT02806999|Insulin|insulin|mesh-list
43689034|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43689035|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43689036|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689037|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
43689038|NCT02807103|Rituximab|rituximab|mesh-list
43689039|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43689040|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
43689041|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689042|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43689043|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43689044|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
43689045|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689046|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689047|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43689048|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43689050|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689051|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634087|NCT05696236|Protective Agents|protective agents|mesh-ancestor
43634088|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634089|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
43634090|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43634091|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634092|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43634093|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43634094|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634095|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43634096|NCT05696093|Renal Agents|renal agents|mesh-ancestor
43634097|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
43634098|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43634099|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43634100|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43634101|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
43634102|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634103|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43634104|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43634106|NCT05695664|Ketorolac|ketorolac|mesh-list
43634107|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43634108|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43634109|NCT05695664|Analgesics|analgesics|mesh-ancestor
43634110|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
43634112|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634113|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43634114|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43634115|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43634116|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634117|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634118|NCT05695625|Anesthetics|anesthetics|mesh-list
43689053|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43689054|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
43689055|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689056|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689057|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
43691174|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691175|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43689058|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43689059|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689060|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689061|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43689062|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43689063|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43689064|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43689065|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43689066|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43689067|NCT02807051|Clarithromycin|clarithromycin|mesh-list
43689068|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689069|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689070|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43689071|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689072|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689073|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43689074|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43634119|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634120|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634121|NCT05695573|Cystatins|cystatins|mesh-list
43634122|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43634123|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
43634124|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689077|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689078|NCT02806791|Lenograstim|lenograstim|mesh-list
43689079|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43689080|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
43689081|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689082|NCT02806817|Bevacizumab|bevacizumab|mesh-list
43689083|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43689084|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689085|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43689086|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43689087|NCT02806817|Growth Substances|growth substances|mesh-ancestor
43689088|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689089|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
43689090|NCT02806804|Vaccines|vaccines|mesh-list
43689091|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
43689092|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689093|NCT02806648|Palbociclib|palbociclib|mesh-list
43691188|NCT02789475|Amlodipine|amlodipine|mesh-list
43689094|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689095|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43689096|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689097|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689098|NCT02806752|Triamcinolone|triamcinolone|mesh-list
43689099|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43689100|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43634146|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43634147|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
43634148|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634149|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43634150|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43634151|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
43634152|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634153|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634154|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43634155|NCT05695352|Meloxicam|meloxicam|mesh-list
43634156|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
43634157|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43634158|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
43634159|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43634160|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634161|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43634162|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43634164|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43634165|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43634166|NCT05695352|Analgesics|analgesics|mesh-ancestor
43634167|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
43634168|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634169|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689101|NCT02806752|Ranibizumab|ranibizumab|mesh-list
43689102|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43689103|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43689104|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43689105|NCT02806752|Growth Substances|growth substances|mesh-ancestor
43689106|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689107|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
43689108|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689109|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689110|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
43689111|NCT02806752|Hormones|hormones|mesh-ancestor
43634172|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43634173|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634174|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634175|NCT05695287|Propofol|propofol|mesh-list
43634176|NCT05695287|Sevoflurane|sevoflurane|mesh-list
43634177|NCT05695287|Isoflurane|isoflurane|mesh-list
43634178|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43634179|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634180|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634181|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43634182|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
43634183|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
43634184|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43634185|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43691221|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43849489|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634186|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43634187|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43634188|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634189|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
43634190|NCT05694936|Cetuximab|cetuximab|mesh-list
43634191|NCT05694936|Panitumumab|panitumumab|mesh-list
43634192|NCT05694936|Valproic Acid|valproic acid|mesh-list
43634193|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634194|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634195|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
43634196|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634197|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634198|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
43634199|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634200|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634201|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
43634202|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43634220|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
43634221|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43634223|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43634224|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634226|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43634227|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634228|NCT05691933|Morphine|morphine|mesh-list
43634229|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43634230|NCT05691933|Narcotics|narcotics|mesh-ancestor
43634231|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634232|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689113|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43689114|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
43689115|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689116|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689117|NCT02806596|Sevoflurane|sevoflurane|mesh-list
43689118|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43689119|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43689120|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
43689121|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
43689122|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689123|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689124|NCT02806492|Phenylephrine|phenylephrine|mesh-list
43689125|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
43689126|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43689127|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
43689128|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
43689129|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689130|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689131|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
43689132|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43689133|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
43689134|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
43689135|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43689136|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43691237|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691239|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
43691240|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43691241|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43691243|NCT02789202|Fluorides|fluorides|mesh-list
43689137|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43689138|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
43634238|NCT05691920|Narcotics|narcotics|mesh-ancestor
43634239|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634240|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634241|NCT05691920|Analgesics|analgesics|mesh-ancestor
43634242|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
43634243|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634244|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43689139|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689140|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689141|NCT02806492|Protective Agents|protective agents|mesh-ancestor
43689142|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43689143|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
43689144|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689145|NCT02806440|Naltrexone|naltrexone|mesh-list
43689146|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43689147|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43689148|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689149|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
43689150|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689151|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
43689152|NCT02806375|Busulfan|busulfan|mesh-list
43689153|NCT02806375|Fludarabine|fludarabine|mesh-list
43689154|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
43634245|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43634246|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
43634247|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
43634248|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
43634249|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43634250|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
43634251|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634252|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634253|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43634254|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
43634255|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43634257|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634258|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634259|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43634260|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
43634262|NCT05691426|Protective Agents|protective agents|mesh-ancestor
43634263|NCT05690503|Ketamine|ketamine|mesh-list
43634264|NCT05690503|Analgesics|analgesics|mesh-ancestor
43634265|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
43634278|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
43634279|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
43634280|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634281|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634282|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
43634283|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634284|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43634285|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43636621|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636637|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
43636638|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636639|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43636640|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43636641|NCT04847596|Ofatumumab|ofatumumab|mesh-list
43691257|NCT02789189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691258|NCT02789189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691259|NCT02789189|Immunologic Factors|immunologic factors|mesh-ancestor
43691260|NCT02789189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634286|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43634287|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43634288|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634289|NCT05687448|Warfarin|warfarin|mesh-list
43634290|NCT05687448|Apixaban|apixaban|mesh-list
43634297|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634298|NCT05681182|Amiodarone|amiodarone|mesh-list
43634299|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43689155|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43689157|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689159|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43689160|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
43689161|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689162|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689163|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43689164|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43689165|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
43689166|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
43689167|NCT02806349|Cathartics|cathartics|mesh-ancestor
43689168|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689169|NCT02806362|Ritonavir|ritonavir|mesh-list
43689170|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43689171|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43689172|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
43689173|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689174|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689175|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43689176|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43689177|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
43689178|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689179|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43689180|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43689181|NCT02806206|Prucalopride|prucalopride|mesh-list
43689182|NCT02806206|Laxatives|laxatives|mesh-ancestor
43689183|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689184|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43689185|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43689186|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
43689187|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689190|NCT02806141|Colistin|colistin|mesh-list
43689195|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
43689196|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
43691261|NCT02788864|Piperaquine|piperaquine|mesh-list
43691266|NCT02788851|Guanfacine|guanfacine|mesh-list
43689197|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43689198|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689199|NCT02806115|Acetic Acid|acetic acid|mesh-list
43689200|NCT02806115|Retinol acetate|retinol acetate|mesh-list
43689201|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689202|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689203|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43689204|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
43689205|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689206|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43689207|NCT02806115|Protective Agents|protective agents|mesh-ancestor
43689208|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689209|NCT02805946|Posaconazole|posaconazole|mesh-list
43689210|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
43689211|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689212|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43689213|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43689214|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43689215|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43689216|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43689217|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689218|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689219|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43689220|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
43704930|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
43634302|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43634303|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634304|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43634305|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43634306|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43634307|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634308|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43634309|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43634310|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43634311|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
43634312|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43634313|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43634314|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689239|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43689240|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43689241|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689243|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636642|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636643|NCT04843579|Clarithromycin|clarithromycin|mesh-list
43636644|NCT04843579|Dexamethasone|dexamethasone|mesh-list
43636645|NCT04843579|Pomalidomide|pomalidomide|mesh-list
43636646|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636647|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
43636648|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
43636649|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636650|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636651|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636652|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
43636653|NCT04843579|Hormones|hormones|mesh-ancestor
43689244|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
43689245|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689246|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43689247|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689248|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689249|NCT02805829|Trastuzumab|trastuzumab|mesh-list
43689250|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43689251|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689252|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
43689253|NCT02805725|Trabectedin|trabectedin|mesh-list
43689254|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43689255|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
43689256|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689257|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43689258|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43634315|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
43634316|NCT05672407|Coagulants|coagulants|mesh-ancestor
43634317|NCT05671900|Gemcitabine|gemcitabine|mesh-list
43634318|NCT05671900|Docetaxel|docetaxel|mesh-list
43634319|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43634320|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
43634321|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634322|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634323|NCT05671900|Antiviral Agents|antiviral agents|mesh-ancestor
43634324|NCT05671900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634325|NCT05671900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634338|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634340|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43634341|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634343|NCT05669742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43634344|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43634345|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43634346|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634347|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634348|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
43634349|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43634350|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43634351|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43634352|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
43634353|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43634354|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43634355|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43634356|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634357|NCT05657990|Tamsulosin|tamsulosin|mesh-list
43634358|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43634359|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43634360|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43634361|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
43634362|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689260|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689261|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689262|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43689263|NCT02805868|Siltuximab|siltuximab|mesh-list
43689264|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43689265|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634363|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634364|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634365|NCT05657990|Urological Agents|urological agents|mesh-ancestor
43634366|NCT05656248|Cytarabine|cytarabine|mesh-list
43634367|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
43634368|NCT05656248|Methotrexate|methotrexate|mesh-list
43634369|NCT05656248|Daunorubicin|daunorubicin|mesh-list
43634370|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43634371|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
43634372|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43634373|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634374|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43634375|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
43634376|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634377|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634378|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
43634379|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634380|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43634381|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43634382|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
43634383|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43634384|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43634385|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
43634386|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634395|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43634396|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
43634397|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634398|NCT05655949|Antiviral Agents|antiviral agents|mesh-ancestor
43634399|NCT05655949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634400|NCT05655949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634401|NCT05655949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43634402|NCT05655949|Immunologic Factors|immunologic factors|mesh-ancestor
43634403|NCT05655949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634404|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634405|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
43634406|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634419|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43634420|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634433|NCT05652205|Linaclotide|linaclotide|mesh-list
43634434|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43634435|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
43705521|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
43634436|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634439|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
43634440|NCT05649722|Treprostinil|treprostinil|mesh-list
43634441|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43634442|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43634443|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43689269|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43689270|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43689271|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
43689272|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636680|NCT04816643|Vaccines|vaccines|mesh-list
43689273|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43689274|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43689275|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689277|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
43689278|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43689279|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43634444|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634446|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43634447|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
43634448|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
43634449|NCT05645705|Protective Agents|protective agents|mesh-ancestor
43634450|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634451|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634452|NCT05643560|Factor VIII|factor viii|mesh-list
43634453|NCT05643560|Coagulants|coagulants|mesh-ancestor
43634454|NCT05643066|Ketamine|ketamine|mesh-list
43634455|NCT05643066|Propofol|propofol|mesh-list
43634456|NCT05643066|Esketamine|esketamine|mesh-list
43634457|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43634458|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634459|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634460|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43634461|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
43634462|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
43634463|NCT05643066|Analgesics|analgesics|mesh-ancestor
43634464|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
43634465|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634466|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43634467|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43634468|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43634469|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634470|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634471|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
43634472|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43634477|NCT05640245|Adalimumab|adalimumab|mesh-list
43634478|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43634479|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43634480|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
43634505|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
43634506|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634507|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634508|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43634509|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43634510|NCT05628883|Analgesics|analgesics|mesh-ancestor
43634511|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
43634512|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634514|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
43634515|NCT05627271|Natalizumab|natalizumab|mesh-list
43634516|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634517|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
43634518|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634519|NCT05620784|Furosemide|furosemide|mesh-list
43634520|NCT05620784|Diuretics|diuretics|mesh-list
43634521|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43634522|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
43689280|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689281|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
43689282|NCT02805426|Coagulants|coagulants|mesh-ancestor
43689283|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43689284|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
43689285|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43689286|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689287|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43689288|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689289|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
43689290|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
43689291|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43689292|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43689293|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
43689294|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689295|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691337|NCT02788292|Antidotes|antidotes|mesh-ancestor
43689296|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689297|NCT02805452|Urological Agents|urological agents|mesh-ancestor
43689298|NCT02805049|Caspofungin|caspofungin|mesh-list
43689299|NCT02805049|Micafungin|micafungin|mesh-list
43689308|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689309|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43689311|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43689312|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689313|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689314|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43634523|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634524|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43689315|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
43689316|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689317|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43689319|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43689320|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43689321|NCT02804815|Analgesics|analgesics|mesh-ancestor
43689322|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
43689323|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689324|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689325|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689326|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43689327|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43689328|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43689329|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689330|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43689331|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43689332|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689333|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
43634526|NCT05619289|Vitamin D|vitamin d|mesh-list
43634527|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
43634528|NCT05619289|Vitamins|vitamins|mesh-ancestor
43634529|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
43634540|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634552|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
43634553|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634564|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634565|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634566|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
43634567|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634568|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43634569|NCT05602038|Narcotics|narcotics|mesh-ancestor
43634570|NCT05602038|Analgesics|analgesics|mesh-ancestor
43634577|NCT05593328|Bevacizumab|bevacizumab|mesh-list
43634578|NCT05593328|Onvansertib|onvansertib|mesh-list
43634579|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634580|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634581|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43634582|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43689334|NCT02804841|Vitamin D|vitamin d|mesh-list
43689335|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
43689336|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
43689337|NCT02804841|Vitamins|vitamins|mesh-list
43689338|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
43689339|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689340|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43689341|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43689342|NCT02804711|Vaccines|vaccines|mesh-list
43689343|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
43689344|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689345|NCT02804776|Gefitinib|gefitinib|mesh-list
43689346|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689347|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43689348|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689349|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689350|NCT02804633|Acetaminophen|acetaminophen|mesh-list
43689351|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43689352|NCT02804633|Analgesics|analgesics|mesh-ancestor
43689353|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
43689354|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689355|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689356|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
43689357|NCT02804646|Cisplatin|cisplatin|mesh-list
43689358|NCT02804646|Carboplatin|carboplatin|mesh-list
43689359|NCT02804646|Pemetrexed|pemetrexed|mesh-list
43689360|NCT02804646|Endostatins|endostatins|mesh-list
43689361|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689362|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634583|NCT05593328|Growth Substances|growth substances|mesh-ancestor
43634584|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634585|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
43634586|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43634590|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
43634591|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634592|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43634593|NCT05590377|Daratumumab|daratumumab|mesh-list
43634594|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634595|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
43634596|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634597|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634598|NCT05589181|Buprenorphine|buprenorphine|mesh-list
43634599|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43634600|NCT05589181|Narcotics|narcotics|mesh-ancestor
43634601|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634602|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634603|NCT05589181|Analgesics|analgesics|mesh-ancestor
43689363|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689364|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43689365|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43689366|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43689367|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43689368|NCT02804646|Growth Substances|growth substances|mesh-ancestor
43689369|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689370|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
43689371|NCT02804490|Vitamin A|vitamin a|mesh-list
43689372|NCT02804490|Beta Carotene|beta carotene|mesh-list
43689373|NCT02804490|Provitamins|provitamins|mesh-list
43689374|NCT02804490|Carotenoids|carotenoids|mesh-list
43689375|NCT02804490|Vitamins|vitamins|mesh-ancestor
43689376|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
43689377|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689378|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
43689379|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689380|NCT02804490|Protective Agents|protective agents|mesh-ancestor
43689383|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689384|NCT02804360|Dexamethasone|dexamethasone|mesh-list
43689385|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
43689386|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689387|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
43689388|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
43689389|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634604|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
43634605|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634606|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43634607|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
43634608|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43634609|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43634610|NCT05587673|Prednisolone|prednisolone|mesh-list
43634611|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
43634612|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43634613|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
43634614|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43634615|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
43634616|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
43634617|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634618|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634619|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634620|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
43634622|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634623|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43689391|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689392|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
43689393|NCT02804360|Hormones|hormones|mesh-ancestor
43689394|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43689395|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43689396|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689397|NCT02804373|Oxytocin|oxytocin|mesh-list
43689398|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
43689399|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43689400|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829150|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829152|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43829153|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43829154|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829155|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43829156|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43829157|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43829158|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829159|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829160|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
43829161|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
43829162|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
43847125|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43847126|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43847127|NCT04138628|Atezolizumab|atezolizumab|mesh-list
43847128|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847129|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
43847130|NCT04138394|Vitamins|vitamins|mesh-ancestor
43847131|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
43847132|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847144|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43847145|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
43689418|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689419|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43689420|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43689421|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689422|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689424|NCT02803918|Lixisenatide|lixisenatide|mesh-list
43689425|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43689426|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689428|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689429|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689430|NCT02803892|Vildagliptin|vildagliptin|mesh-list
43689431|NCT02803892|Sirolimus|sirolimus|mesh-list
43689432|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689433|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689434|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43689435|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689437|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43689438|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
43689439|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689440|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43689441|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43689442|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
43689443|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689444|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634682|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
43634683|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634684|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
43634685|NCT05575063|Protective Agents|protective agents|mesh-ancestor
43634687|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43634688|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43634689|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
43634690|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634691|NCT05568745|Misoprostol|misoprostol|mesh-list
43634692|NCT05568745|Oxytocin|oxytocin|mesh-list
43634693|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
43634694|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43634695|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634696|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43634697|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
43634698|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43634699|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634700|NCT05566756|Ofatumumab|ofatumumab|mesh-list
43634701|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634702|NCT05550909|Artesunate|artesunate|mesh-list
43634703|NCT05550909|Lumefantrine|lumefantrine|mesh-list
43634704|NCT05550909|Artemether|artemether|mesh-list
43689445|NCT02803788|Dexamethasone|dexamethasone|mesh-list
43689446|NCT02803788|Ondansetron|ondansetron|mesh-list
43689447|NCT02803788|Ramosetron|ramosetron|mesh-list
43689448|NCT02803788|Antiemetics|antiemetics|mesh-list
43689449|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689450|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
43689451|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689452|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689453|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689454|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
43689455|NCT02803788|Hormones|hormones|mesh-ancestor
43689456|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43689457|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43689458|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689459|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
43689460|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
43689461|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43689462|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
43689463|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689464|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689465|NCT02803788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43689466|NCT02803788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43689467|NCT02803788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634721|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634722|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634723|NCT05548296|Antiviral Agents|antiviral agents|mesh-ancestor
43634724|NCT05548296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634725|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634726|NCT05548296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43634727|NCT05548296|Immunologic Factors|immunologic factors|mesh-ancestor
43634728|NCT05548296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634730|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
43634731|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43634732|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43634733|NCT05546957|Analgesics|analgesics|mesh-ancestor
43634734|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
43634735|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634736|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634737|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43634738|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43634739|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43634740|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43634748|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43634749|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
43634750|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
43634751|NCT05542407|Atezolizumab|atezolizumab|mesh-list
43634752|NCT05542407|TIC10 compound|tic10 compound|mesh-list
43689516|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689517|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43689518|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
43689519|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43689520|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689521|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43689522|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
43689523|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
43689524|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
43689525|NCT02802631|Minocycline|minocycline|mesh-list
43689526|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689527|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689528|NCT02802722|Vitamin D|vitamin d|mesh-list
43689529|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
43689530|NCT02802722|Vitamins|vitamins|mesh-ancestor
43689535|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43689536|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43689537|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689538|NCT02802644|Incretins|incretins|mesh-ancestor
43689539|NCT02802644|Hormones|hormones|mesh-ancestor
43689540|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43689541|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43689542|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
43634753|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634765|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634766|NCT05526586|Ethanol|ethanol|mesh-list
43634767|NCT05526586|Listerine|listerine|mesh-list
43634768|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43634769|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634770|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634771|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634779|NCT05520723|Loperamide|loperamide|mesh-list
43634780|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
43634781|NCT05520723|Lenograstim|lenograstim|mesh-list
43634782|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43634783|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
43689544|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689545|NCT02802683|Phenylephrine|phenylephrine|mesh-list
43689546|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
43689547|NCT02802683|Bupivacaine|bupivacaine|mesh-list
43689548|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
43689549|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
43689550|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
43689551|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689552|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689553|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
43689554|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689555|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43689556|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
43689557|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
43689558|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
43689559|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43689560|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
43689561|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
43689562|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43689563|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43689564|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43689565|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
43689566|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689567|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689568|NCT02802683|Protective Agents|protective agents|mesh-ancestor
43689569|NCT02802696|Furosemide|furosemide|mesh-list
43689570|NCT02802696|Diuretics|diuretics|mesh-ancestor
43689571|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
43689572|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689573|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43689574|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43689575|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634784|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634785|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634787|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
43634788|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634789|NCT05503030|Nintedanib|nintedanib|mesh-list
43634790|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689576|NCT02802605|Bemiparin|bemiparin|mesh-list
43689577|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
43689579|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
43689580|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
43689581|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689582|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689583|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689584|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43829166|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829167|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829168|NCT05442034|Mitogens|mitogens|mesh-list
43829169|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
43829170|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829171|NCT05441930|Levofloxacin|levofloxacin|mesh-list
43829172|NCT05441930|Ofloxacin|ofloxacin|mesh-list
43829173|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43634791|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43634792|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634793|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634794|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
43634795|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634796|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634797|NCT05501574|Tacrolimus|tacrolimus|mesh-list
43634798|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43634799|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
43634800|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634801|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43634802|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634803|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634804|NCT05498792|Nivolumab|nivolumab|mesh-list
43634805|NCT05498792|Ipilimumab|ipilimumab|mesh-list
43634806|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634807|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634808|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43829663|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829179|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829180|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829181|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829182|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43829183|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43829185|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43829186|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829187|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
43829188|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
43829189|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43829190|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43705848|NCT03555968|Analgesics|analgesics|mesh-ancestor
43829195|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829196|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43634821|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43634822|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43634823|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634824|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634825|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
43634826|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
43634827|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
43634828|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634839|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634840|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
43634841|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
43634842|NCT05487417|Minocycline|minocycline|mesh-list
43634843|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43634844|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634845|NCT05480306|Bevacizumab|bevacizumab|mesh-list
43634846|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634847|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634848|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43634849|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43634850|NCT05480306|Growth Substances|growth substances|mesh-ancestor
43634851|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634852|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
43634853|NCT05478174|Propofol|propofol|mesh-list
43634854|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43634855|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634856|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829197|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829198|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829199|NCT05439876|Melatonin|melatonin|mesh-list
43829200|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
43829201|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829202|NCT05439876|Protective Agents|protective agents|mesh-ancestor
43829203|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689625|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689627|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43689628|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43689629|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689630|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43689631|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43689632|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689633|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
43689634|NCT02802137|Timolol|timolol|mesh-list
43689635|NCT02802137|Dorzolamide|dorzolamide|mesh-list
43689636|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43689637|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43689638|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
43689639|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689640|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689641|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689642|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43689643|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43689644|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43689645|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689646|NCT02801799|Ropivacaine|ropivacaine|mesh-list
43689647|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
43689648|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
43689649|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689650|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689651|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
43689652|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634875|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43634876|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
43634877|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634878|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634879|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43634880|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43634881|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
43634882|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
43634883|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43634884|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43634885|NCT05471648|Pertuzumab|pertuzumab|mesh-list
43634886|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634887|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634898|NCT05469737|Azacitidine|azacitidine|mesh-list
43634899|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43634900|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
43634901|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634902|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634903|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634904|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
43634905|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634906|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634907|NCT05467475|Esomeprazole|esomeprazole|mesh-list
43634908|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43634909|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689653|NCT02801786|Tamoxifen|tamoxifen|mesh-list
43689654|NCT02801786|Lidocaine|lidocaine|mesh-list
43689655|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
43689656|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
43689657|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689658|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689659|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
43689660|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689661|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43689662|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43689663|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43689664|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43689665|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689666|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43689667|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
43689668|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634910|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43634911|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634912|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634913|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
43634925|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
43634926|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
43634927|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634928|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634929|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
43634930|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634931|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43634932|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43634933|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43634934|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43634935|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634936|NCT05455320|Dexamethasone|dexamethasone|mesh-list
43634937|NCT05455320|Daratumumab|daratumumab|mesh-list
43634938|NCT05455320|Pomalidomide|pomalidomide|mesh-list
43634939|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43634940|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
43634941|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
43634942|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634943|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634944|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634945|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
43634947|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634948|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43634949|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634950|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
43634951|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43634952|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43634953|NCT05455320|Growth Substances|growth substances|mesh-ancestor
43634954|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
43634955|NCT05450432|Ketamine|ketamine|mesh-list
43634956|NCT05450432|Esketamine|esketamine|mesh-list
43634958|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
43689669|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43689670|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689671|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43689672|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43689673|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43689674|NCT02801838|Morphine|morphine|mesh-list
43689675|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43689676|NCT02801838|Narcotics|narcotics|mesh-ancestor
43689677|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689678|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689679|NCT02801838|Analgesics|analgesics|mesh-ancestor
43689680|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
43689681|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689682|NCT02802098|Bevacizumab|bevacizumab|mesh-list
43689683|NCT02802098|Durvalumab|durvalumab|mesh-list
43689684|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43689685|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689686|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43689687|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43689688|NCT02802098|Growth Substances|growth substances|mesh-ancestor
43689689|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689690|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
43689691|NCT02801487|Cisplatin|cisplatin|mesh-list
43689692|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689693|NCT02801526|Amlodipine|amlodipine|mesh-list
43689694|NCT02801526|Candesartan|candesartan|mesh-list
43689695|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43689696|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43689697|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43689698|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689699|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43689700|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689701|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
43689702|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43634959|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634960|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634961|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43634962|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43689703|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43689705|NCT02801357|Buprenorphine|buprenorphine|mesh-list
43689706|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43689707|NCT02801357|Narcotics|narcotics|mesh-ancestor
43689708|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689709|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689710|NCT02801357|Analgesics|analgesics|mesh-ancestor
43689711|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
43689712|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689713|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43689714|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43689715|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43689716|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43689717|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43689718|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
43689719|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689720|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689721|NCT02801383|Interferons|interferons|mesh-list
43689722|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689723|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
43689724|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689725|NCT02801409|Anesthetics|anesthetics|mesh-list
43689726|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689727|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689728|NCT02801292|Ketamine|ketamine|mesh-list
43689729|NCT02801292|Analgesics|analgesics|mesh-ancestor
43689730|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
43689731|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689732|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689733|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43689734|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43689735|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
43689736|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
43689737|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689742|NCT02801305|Diltiazem|diltiazem|mesh-list
43689743|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
43689744|NCT02801305|Petrolatum|petrolatum|mesh-list
43689745|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
43689770|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43634963|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
43634964|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
43634965|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634966|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43634967|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43634968|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634969|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634970|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
43634971|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43634972|NCT05440942|Trametinib|trametinib|mesh-list
43634973|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634974|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43634975|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634976|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634977|NCT05438186|Liraglutide|liraglutide|mesh-list
43634978|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43634979|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634980|NCT05438186|Incretins|incretins|mesh-ancestor
43634987|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
43634988|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634989|NCT05426395|Hematinics|hematinics|mesh-ancestor
43634991|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43634992|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634993|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43634994|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634995|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
43634996|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43689771|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43689772|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43689773|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
43689774|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
43689775|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
43689776|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689777|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689778|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
43689779|NCT02801188|Bupivacaine|bupivacaine|mesh-list
43689780|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
43689781|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
43689782|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689783|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689798|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43689800|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634997|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
43634998|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634999|NCT05424016|Propranolol|propranolol|mesh-list
43635000|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43635001|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43635002|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
43635003|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635004|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635005|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635006|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43635007|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43689802|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43689803|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689804|NCT02801032|Tadalafil|tadalafil|mesh-list
43689805|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
43608257|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
43689806|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43608259|NCT03197298|Clopidogrel|clopidogrel|mesh-list
43689807|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43689808|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689809|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689810|NCT02801032|Urological Agents|urological agents|mesh-ancestor
43689811|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
43689812|NCT02800785|Metronidazole|metronidazole|mesh-list
43689813|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
43689814|NCT02800785|Levofloxacin|levofloxacin|mesh-list
43689815|NCT02800785|Cefazolin|cefazolin|mesh-list
43689816|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
43689817|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
43689818|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
43689819|NCT02800785|Cefuroxime|cefuroxime|mesh-list
43689820|NCT02800785|Ertapenem|ertapenem|mesh-list
43689821|NCT02800785|Tigecycline|tigecycline|mesh-list
43689822|NCT02800785|Cefotaxime|cefotaxime|mesh-list
43689823|NCT02800785|Cefoxitin|cefoxitin|mesh-list
43689824|NCT02800785|Ticarcillin|ticarcillin|mesh-list
43689825|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
43635009|NCT05421065|Ketamine|ketamine|mesh-list
43635010|NCT05421065|Psilocybin|psilocybin|mesh-list
43635011|NCT05421065|Analgesics|analgesics|mesh-ancestor
43635012|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
43635020|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43635021|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43635022|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635023|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635024|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
43635025|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43635033|NCT05412004|Tirzepatide|tirzepatide|mesh-list
43635034|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43635035|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635036|NCT05412004|Incretins|incretins|mesh-ancestor
43635037|NCT05412004|Hormones|hormones|mesh-ancestor
43635038|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43635041|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43635042|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43635043|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635044|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
43635045|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
43635046|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
43635047|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635048|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43635049|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43689826|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689827|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689828|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43689829|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43689830|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689831|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689832|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689833|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43689834|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43689835|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43689836|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43689837|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43689838|NCT02800785|Renal Agents|renal agents|mesh-ancestor
43689839|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43689840|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43689841|NCT02800889|Pixantrone|pixantrone|mesh-list
43689842|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43689843|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43689844|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689845|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689846|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689847|NCT02800447|Procarbazine|procarbazine|mesh-list
43689848|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635050|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635051|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635063|NCT05407441|Nivolumab|nivolumab|mesh-list
43635064|NCT05407441|Ipilimumab|ipilimumab|mesh-list
43635065|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635066|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635067|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43635068|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635069|NCT05392764|Empagliflozin|empagliflozin|mesh-list
43635070|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43635071|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635072|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43635073|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635074|NCT05391750|Venetoclax|venetoclax|mesh-list
43635075|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
43635157|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
43635158|NCT05383352|Vitamins|vitamins|mesh-ancestor
43635159|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
43635160|NCT05383352|Hematinics|hematinics|mesh-ancestor
43635161|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43689849|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
43689850|NCT02800408|Provitamins|provitamins|mesh-ancestor
43689851|NCT02800408|Vitamins|vitamins|mesh-ancestor
43689852|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
43689853|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689854|NCT02800772|Acetic Acid|acetic acid|mesh-list
43689855|NCT02800772|Retinol acetate|retinol acetate|mesh-list
43689856|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689857|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689858|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43689859|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
43689860|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689861|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43689862|NCT02800772|Protective Agents|protective agents|mesh-ancestor
43689863|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829204|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829205|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
43829206|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43689864|NCT02800590|Abp-700|abp-700|mesh-list
43689865|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43689866|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
43689867|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
43689868|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689869|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689870|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689871|NCT02800694|Fentanyl|fentanyl|mesh-list
43689872|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43689873|NCT02800694|Narcotics|narcotics|mesh-ancestor
43689874|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689875|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689893|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43689894|NCT02800252|Analgesics|analgesics|mesh-ancestor
43689895|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
43689896|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689897|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689898|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689899|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43689900|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43689901|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43689902|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689903|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43689904|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43689949|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43689950|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
43689951|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43689952|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43689953|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43689954|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
43689955|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689956|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43689961|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43689963|NCT02800135|Diuretics|diuretics|mesh-ancestor
43689964|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
43689965|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608270|NCT03197207|Salicylates|salicylates|mesh-list
43608271|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
43608272|NCT03197207|Menthol|menthol|mesh-list
43608273|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43608274|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608275|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
43608276|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
43608277|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43608278|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43608279|NCT03197207|Analgesics|analgesics|mesh-ancestor
43689966|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43608280|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
43689967|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43689969|NCT02799901|Nivolumab|nivolumab|mesh-list
43689973|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689974|NCT02800265|Sulforaphane|sulforaphane|mesh-list
43689975|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43689976|NCT02800265|Protective Agents|protective agents|mesh-ancestor
43689977|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689978|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689983|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689984|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689985|NCT02799797|Analgesics|analgesics|mesh-ancestor
43689986|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
43689987|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689988|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43689989|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43689990|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
43689991|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
43689992|NCT02799615|Infliximab|infliximab|mesh-list
43689993|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
43689994|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689995|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43689996|NCT02799758|Pitavastatin|pitavastatin|mesh-list
43689997|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43689998|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43689999|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43690000|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
43690001|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635183|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
43635184|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635185|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635186|NCT05375942|Infliximab|infliximab|mesh-list
43635187|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
43635188|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43635189|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43690002|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690003|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43690004|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
43690005|NCT02799589|Remifentanil|remifentanil|mesh-list
43690006|NCT02799589|Ropivacaine|ropivacaine|mesh-list
43690007|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43690008|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690009|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690010|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43690012|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
43690013|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690014|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43690015|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43690016|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43690017|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
43690018|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690019|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690020|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
43690021|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
43690022|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43690023|NCT02799589|Narcotics|narcotics|mesh-ancestor
43690024|NCT02799459|Anesthetics|anesthetics|mesh-list
43690025|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690026|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690028|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43690029|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
43690030|NCT02799355|Interferons|interferons|mesh-list
43690032|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
43635190|NCT05372614|Trastuzumab|trastuzumab|mesh-list
43635191|NCT05372614|Camptothecin|camptothecin|mesh-list
43635192|NCT05372614|Maleic acid|maleic acid|mesh-list
43635193|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
43635194|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635195|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635196|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635197|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635198|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43635199|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43635200|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635201|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
43635202|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635203|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
43635204|NCT05372224|Vitamin D|vitamin d|mesh-list
43690033|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690034|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
43690035|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690036|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
43690037|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690038|NCT02799498|Etanercept|etanercept|mesh-list
43690039|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43690040|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43690041|NCT02799498|Analgesics|analgesics|mesh-ancestor
43690042|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
43690043|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690044|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690045|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43690046|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43690047|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43690048|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690049|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
43690051|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
43690052|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690053|NCT02799238|Temozolomide|temozolomide|mesh-list
43690054|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43690055|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
43635205|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43635206|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635207|NCT05372224|Vitamins|vitamins|mesh-ancestor
43635208|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
43635209|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43635219|NCT05369832|Ozanimod|ozanimod|mesh-list
43635220|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43635221|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635222|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635223|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
43635224|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635225|NCT05359237|Vincristine|vincristine|mesh-list
43635226|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43635237|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635238|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635239|NCT05357612|Pimavanserin|pimavanserin|mesh-list
43635240|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43635251|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635253|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
43635254|NCT05352672|Cemiplimab|cemiplimab|mesh-list
43635255|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635256|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635286|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
43635287|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43635288|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43635289|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43635290|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43635291|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43635292|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
43635293|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43690056|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690057|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690058|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43690059|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43690060|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
43690062|NCT02799277|Androgens|androgens|mesh-ancestor
43690063|NCT02799277|Hormones|hormones|mesh-ancestor
43690064|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690065|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690066|NCT02799147|Fludarabine|fludarabine|mesh-list
43690067|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
43690068|NCT02799147|Busulfan|busulfan|mesh-list
43690069|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43690070|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690071|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43690072|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
43690073|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690074|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690075|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
43690076|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690077|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
43690078|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43635294|NCT05345899|Ascorbic Acid|ascorbic acid|mesh-list
43635295|NCT05345899|Vitamins|vitamins|mesh-ancestor
43635296|NCT05345899|Micronutrients|micronutrients|mesh-ancestor
43635297|NCT05345899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635298|NCT05345899|Antioxidants|antioxidants|mesh-ancestor
43635299|NCT05345899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635300|NCT05345899|Protective Agents|protective agents|mesh-ancestor
43635301|NCT05334485|Bromides|bromides|mesh-list
43635302|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43635303|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
43635304|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43635305|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635306|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635307|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
43635308|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635309|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635310|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
43635311|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
43635312|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635313|NCT05327439|Nicotine|nicotine|mesh-list
43635314|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43635315|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
43635316|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635317|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635318|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43635319|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43635320|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
43635321|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690079|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43690080|NCT02798913|Clopidogrel|clopidogrel|mesh-list
43690081|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43690082|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43690083|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43690084|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43690085|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
43690086|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690087|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690088|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829207|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43829208|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829209|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
43829210|NCT05439694|Coagulants|coagulants|mesh-ancestor
43829211|NCT05439460|Phenylephrine|phenylephrine|mesh-list
43829212|NCT05439460|Vasopressins|vasopressins|mesh-list
43829213|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
43829214|NCT05439460|Epinephrine|epinephrine|mesh-list
43829215|NCT05439460|Racepinephrine|racepinephrine|mesh-list
43829216|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
43829217|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
43635332|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43635333|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635338|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635339|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43635340|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635341|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635342|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
43829225|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43829226|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
43829227|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829228|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43829229|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
43829230|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
43829231|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
43829232|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43829233|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43829234|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
43829235|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43829236|NCT05439460|Protective Agents|protective agents|mesh-ancestor
43829237|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
43829238|NCT05439460|Coagulants|coagulants|mesh-ancestor
43829239|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43829240|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
43829241|NCT05439356|Colchicine|colchicine|mesh-list
43690089|NCT02798874|Clopidogrel|clopidogrel|mesh-list
43690090|NCT02798874|Ticagrelor|ticagrelor|mesh-list
43690091|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43690092|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43690093|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43690094|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43690095|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
43690096|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690097|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690098|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690099|NCT02799264|Cabotegravir|cabotegravir|mesh-list
43635343|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635344|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43635345|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
43635346|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43635347|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
43635348|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635349|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
43635350|NCT05316233|Protective Agents|protective agents|mesh-ancestor
43635351|NCT05316129|Hormones|hormones|mesh-list
43635352|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43635353|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43635354|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635355|NCT05312255|Propranolol|propranolol|mesh-list
43635356|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43635357|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
43690110|NCT02798653|Hormones|hormones|mesh-ancestor
43690111|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690112|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690113|NCT02798744|Empagliflozin|empagliflozin|mesh-list
43690114|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43690115|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690116|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690117|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690118|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
43690120|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690121|NCT02798510|Gemcitabine|gemcitabine|mesh-list
43690122|NCT02798510|Capecitabine|capecitabine|mesh-list
43690123|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43690124|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
43690125|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690127|NCT02798510|Antiviral Agents|antiviral agents|mesh-ancestor
43690128|NCT02798510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690129|NCT02798510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690130|NCT02798510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690131|NCT02798510|Immunologic Factors|immunologic factors|mesh-ancestor
43690132|NCT02798510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690133|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
43690134|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43690135|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690136|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690137|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690138|NCT02798367|Melatonin|melatonin|mesh-list
43690139|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
43690140|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690141|NCT02798367|Protective Agents|protective agents|mesh-ancestor
43690142|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690143|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690144|NCT02798250|Insulin|insulin|mesh-list
43690145|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43690146|NCT02798250|Glucagon|glucagon|mesh-list
43690147|NCT02798250|Hormones|hormones|mesh-list
43690148|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690149|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635361|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635362|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43635363|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43635364|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
43635365|NCT05312216|Durvalumab|durvalumab|mesh-list
43635366|NCT05312216|Lenvatinib|lenvatinib|mesh-list
43635367|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635368|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635369|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43635370|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635371|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635372|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
43635373|NCT05311540|Astringents|astringents|mesh-ancestor
43635374|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635375|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
43690150|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690151|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43690153|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43690154|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43690155|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690156|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
43690157|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690158|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
43690159|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43690160|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43690161|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690162|NCT02798159|Urological Agents|urological agents|mesh-ancestor
43690163|NCT02798172|Metformin|metformin|mesh-list
43690164|NCT02798172|Alogliptin|alogliptin|mesh-list
43690165|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690166|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690167|NCT02798172|Incretins|incretins|mesh-ancestor
43690193|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690195|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43690196|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43690197|NCT02797704|Growth Substances|growth substances|mesh-ancestor
43690198|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690199|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
43690200|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690201|NCT02797717|Prednisone|prednisone|mesh-list
43690202|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
43690203|NCT02797717|Dacarbazine|dacarbazine|mesh-list
43690204|NCT02797717|Doxorubicin|doxorubicin|mesh-list
43690205|NCT02797717|Etoposide|etoposide|mesh-list
43690206|NCT02797717|Vincristine|vincristine|mesh-list
43690207|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690208|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
43690209|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690210|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43690211|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43690212|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
43690213|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635387|NCT05307627|Naltrexone|naltrexone|mesh-list
43635388|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43635389|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43635390|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635391|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
43635393|NCT05303532|Durvalumab|durvalumab|mesh-list
43635394|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635396|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
43635397|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
43635398|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635399|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43635400|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635401|NCT05303064|Olanzapine|olanzapine|mesh-list
43635402|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
43635403|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
43635404|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690214|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690215|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43690216|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43690217|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43690218|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43690219|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690220|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43690221|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
43690222|NCT02797717|Hormones|hormones|mesh-ancestor
43690223|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690224|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43690225|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43690226|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
43690227|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
43690228|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690229|NCT02797860|Rocuronium|rocuronium|mesh-list
43690230|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43690231|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43690232|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43690233|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690234|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690235|NCT02797782|Antibodies|antibodies|mesh-list
43690236|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
43690237|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690238|NCT02797977|Gemcitabine|gemcitabine|mesh-list
43690239|NCT02797977|Cisplatin|cisplatin|mesh-list
43690240|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690241|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43690242|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
43690243|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690245|NCT02797977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690246|NCT02797977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635410|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43635411|NCT05303064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43635412|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43635413|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43635414|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690247|NCT02797977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690248|NCT02797977|Immunologic Factors|immunologic factors|mesh-ancestor
43690249|NCT02797977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690250|NCT02797587|Nicotine|nicotine|mesh-list
43690251|NCT02797587|Varenicline|varenicline|mesh-list
43690252|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43690253|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
43690254|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690255|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690256|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43690257|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43690258|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
43690259|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690260|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690262|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
43690263|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690264|NCT02797249|Aspirin|aspirin|mesh-list
43690265|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
43690266|NCT02797249|Salicylates|salicylates|mesh-list
43706423|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
43690267|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43690268|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43690269|NCT02797249|Analgesics|analgesics|mesh-ancestor
43690270|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
43635415|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635416|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
43635417|NCT05292664|Leucovorin|leucovorin|mesh-list
43635418|NCT05292664|Cytarabine|cytarabine|mesh-list
43635419|NCT05292664|Dexamethasone|dexamethasone|mesh-list
43635420|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
43635421|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
43635422|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43635423|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43635424|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43635425|NCT05292664|Cortisone|cortisone|mesh-list
43635426|NCT05292664|Doxorubicin|doxorubicin|mesh-list
43635427|NCT05292664|Methotrexate|methotrexate|mesh-list
43635428|NCT05292664|Vincristine|vincristine|mesh-list
43635429|NCT05292664|Azacitidine|azacitidine|mesh-list
43635430|NCT05292664|Venetoclax|venetoclax|mesh-list
43635431|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
43635432|NCT05292664|Razoxane|razoxane|mesh-list
43635433|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43635434|NCT05292664|BB 1101|bb 1101|mesh-list
43635435|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
43635436|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43635437|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
43635438|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
43635439|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635440|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635441|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43635442|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
43635443|NCT05292664|Hormones|hormones|mesh-ancestor
43635444|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43635445|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43635446|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690271|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690272|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690273|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43690275|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43690276|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43690277|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690278|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43690279|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43690280|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690281|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
43690282|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690283|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
43690284|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
43690285|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
43690290|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43690291|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43690292|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690293|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690294|NCT02797145|Protective Agents|protective agents|mesh-ancestor
43635447|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
43635448|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635449|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635450|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43635451|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43635452|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635453|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43635454|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
43635455|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43635456|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43635457|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
43635458|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
43635459|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43635460|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635461|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
43635462|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43635463|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43635464|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
43635465|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43635466|NCT05292664|Antidotes|antidotes|mesh-ancestor
43635467|NCT05292664|Protective Agents|protective agents|mesh-ancestor
43635468|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
43635469|NCT05292664|Vitamins|vitamins|mesh-ancestor
43635470|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
43635497|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43635498|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690295|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690296|NCT02797067|Indomethacin|indomethacin|mesh-list
43690297|NCT02797067|Glycerol|glycerol|mesh-list
43690298|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43690299|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43690300|NCT02797067|Analgesics|analgesics|mesh-ancestor
43690301|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
43690302|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690303|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690304|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43690305|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43690306|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
43690307|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
43690310|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690311|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690312|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43690313|NCT02797067|Protective Agents|protective agents|mesh-ancestor
43690314|NCT02797028|Allopurinol|allopurinol|mesh-list
43690315|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
43690316|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690317|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690318|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
43690319|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43690320|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43690321|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
43690322|NCT02797028|Protective Agents|protective agents|mesh-ancestor
43690323|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690324|NCT02797015|Ozanimod|ozanimod|mesh-list
43690325|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43690326|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690327|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690328|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
43690329|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690330|NCT02797041|Bortezomib|bortezomib|mesh-list
43690331|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690332|NCT02796794|Genistein|genistein|mesh-list
43690333|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43690334|NCT02796794|Protective Agents|protective agents|mesh-ancestor
43690335|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690336|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690337|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43690338|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690339|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690340|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
43690341|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43635499|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43635500|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
43635501|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635502|NCT05286814|Antiviral Agents|antiviral agents|mesh-ancestor
43635506|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
43690343|NCT02796794|Hormones|hormones|mesh-ancestor
43690344|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829242|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
43829243|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829244|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
43829245|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
43829246|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
43829247|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829248|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829250|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
43829251|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
43829252|NCT05436886|Gabapentin|gabapentin|mesh-list
43829253|NCT05436886|Analgesics|analgesics|mesh-ancestor
43829254|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
43829255|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829256|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829257|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
43829258|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43829259|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43829260|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829261|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43829262|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43829263|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43829264|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829265|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829266|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
43829267|NCT05436769|Clarithromycin|clarithromycin|mesh-list
43829268|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43635507|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43635508|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635509|NCT05286814|Antidotes|antidotes|mesh-ancestor
43635510|NCT05286814|Protective Agents|protective agents|mesh-ancestor
43691342|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43691343|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
43691344|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691345|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691346|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43691347|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
43829379|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691348|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43691349|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43635511|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
43635512|NCT05286814|Vitamins|vitamins|mesh-ancestor
43635513|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
43635514|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
43635515|NCT05286801|Atezolizumab|atezolizumab|mesh-list
43635516|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43635517|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43635519|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
43635520|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635521|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43635522|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829269|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829270|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43829271|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829272|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829273|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43829274|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43829275|NCT05436652|Prednisolone|prednisolone|mesh-list
43829276|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43829277|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
43829278|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43829279|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
43829289|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
43829290|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
43635523|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
43635524|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
43635525|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43635526|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43635527|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43635528|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635529|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635530|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
43635531|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635578|NCT05253651|Leucovorin|leucovorin|mesh-list
43635579|NCT05253651|Bevacizumab|bevacizumab|mesh-list
43635580|NCT05253651|Trastuzumab|trastuzumab|mesh-list
43829291|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829292|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43829293|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43829294|NCT05436652|Protective Agents|protective agents|mesh-ancestor
43829295|NCT05435768|Denosumab|denosumab|mesh-list
43829297|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829298|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43829299|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43829300|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
43829301|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
43829302|NCT05435547|Dexamethasone|dexamethasone|mesh-list
43829303|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829304|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
43829305|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
43829306|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829307|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690345|NCT02796833|SMOFlipid|smoflipid|mesh-list
43690346|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43690347|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43690348|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43690349|NCT02796950|Acipimox|acipimox|mesh-list
43690350|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43690351|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
43690352|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690353|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43690354|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43690355|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43690375|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43690376|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
43690377|NCT02796378|Ubiquinone|ubiquinone|mesh-list
43690378|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
43690379|NCT02796378|Simvastatin|simvastatin|mesh-list
43690380|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43690381|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43690382|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
43690383|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690384|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43690385|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43690386|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690387|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
43690388|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690389|NCT02796378|Vitamins|vitamins|mesh-ancestor
43690390|NCT02796157|Everolimus|everolimus|mesh-list
43690391|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690392|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690393|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
43690394|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690395|NCT02796196|Coal Tar|coal tar|mesh-list
43690396|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
43690397|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
43690398|NCT02796183|Bevacizumab|bevacizumab|mesh-list
43690399|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43690400|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690404|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690405|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
43690406|NCT02796105|Ganirelix|ganirelix|mesh-list
43690407|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
43690410|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43690420|NCT02795949|Cefuroxime|cefuroxime|mesh-list
43690421|NCT02795949|Ertapenem|ertapenem|mesh-list
43690422|NCT02795949|Cefepime|cefepime|mesh-list
43690423|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43690424|NCT02795949|Lactams|lactams|mesh-list
43690425|NCT02795949|Aztreonam|aztreonam|mesh-list
43690426|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43690427|NCT02795949|beta-Lactams|beta-lactams|mesh-list
43690428|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43690429|NCT02795949|Trimethoprim|trimethoprim|mesh-list
43690430|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
43690431|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690432|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
43690433|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43690434|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43690435|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690436|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690437|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690438|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43690439|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43690440|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43690441|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43690442|NCT02795949|Renal Agents|renal agents|mesh-ancestor
43690443|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
43690444|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43690445|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43690446|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43690447|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43690448|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43690449|NCT02795884|Cisplatin|cisplatin|mesh-list
43690450|NCT02795884|Pemetrexed|pemetrexed|mesh-list
43690451|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43690452|NCT02795884|Vinorelbine|vinorelbine|mesh-list
43690463|NCT02795572|Vitamin D|vitamin d|mesh-list
43690464|NCT02795572|Vitamins|vitamins|mesh-list
43690465|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
43690467|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
43690468|NCT02795572|Pyridoxal|pyridoxal|mesh-list
43690469|NCT02795572|Pyridoxine|pyridoxine|mesh-list
43690470|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
43690471|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
43690472|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690473|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43690474|NCT02795572|Hematinics|hematinics|mesh-ancestor
43690475|NCT02795754|Ritonavir|ritonavir|mesh-list
43690476|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
43690477|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43690478|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43690479|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
43690480|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690481|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690482|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43690483|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43690484|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
43690485|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690486|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43690487|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43690488|NCT02795546|Alendronate|alendronate|mesh-list
43690489|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43690490|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690491|NCT02795299|Folic Acid|folic acid|mesh-list
43690492|NCT02795299|Methotrexate|methotrexate|mesh-list
43690493|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43690494|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
43690495|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43690496|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690497|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43690498|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
43690499|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635581|NCT05253651|Cetuximab|cetuximab|mesh-list
43690500|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706531|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
43635609|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43635610|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635611|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43635612|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635613|NCT05226832|Triamcinolone|triamcinolone|mesh-list
43635614|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43635615|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
43635616|NCT05226832|Hormones|hormones|mesh-ancestor
43635617|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43635618|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635619|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
43635620|NCT05222529|Bromides|bromides|mesh-list
43635636|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635637|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43635638|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
43635639|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43635640|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
43635641|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
43635642|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635643|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
43635644|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635645|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635647|NCT05211947|Nootropic Agents|nootropic agents|mesh-ancestor
43635649|NCT05210374|Doxorubicin|doxorubicin|mesh-list
43635650|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43635651|NCT05210374|Disulfiram|disulfiram|mesh-list
43635652|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43635653|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635654|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43635655|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635656|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635657|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635658|NCT05210374|Trace Elements|trace elements|mesh-ancestor
43635659|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
43635660|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635669|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
43635670|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635671|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43635672|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635673|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635675|NCT05199285|Ipilimumab|ipilimumab|mesh-list
43635676|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635677|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635678|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43635679|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635682|NCT05198830|Durvalumab|durvalumab|mesh-list
43635683|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
43635684|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43635685|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
43635686|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635687|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635688|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635712|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43635713|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43635714|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
43635732|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
43635733|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635734|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43635735|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43635736|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43635737|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43635738|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635739|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
43635740|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690503|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43690504|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690505|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
43690506|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43690507|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43690508|NCT02795299|Hematinics|hematinics|mesh-ancestor
43690509|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
43690510|NCT02795299|Vitamins|vitamins|mesh-ancestor
43690511|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
43690512|NCT02795143|Isotretinoin|isotretinoin|mesh-list
43690513|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
43690514|NCT02795429|Spartalizumab|spartalizumab|mesh-list
43690515|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43690516|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690517|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690518|NCT02795039|Fulvestrant|fulvestrant|mesh-list
43690519|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43690520|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690521|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43690522|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43690523|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
43690524|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690525|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690526|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
43690527|NCT02794922|Vitamins|vitamins|mesh-ancestor
43690528|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
43635741|NCT05192889|Antidotes|antidotes|mesh-ancestor
43635742|NCT05192889|Protective Agents|protective agents|mesh-ancestor
43635743|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
43635744|NCT05192889|Vitamins|vitamins|mesh-ancestor
43635745|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
43635746|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
43635754|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635755|NCT05171777|Atezolizumab|atezolizumab|mesh-list
43635756|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635757|NCT05170204|Durvalumab|durvalumab|mesh-list
43635758|NCT05170204|Pralsetinib|pralsetinib|mesh-list
43635759|NCT05170204|Entrectinib|entrectinib|mesh-list
43635760|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635761|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635763|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635764|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635765|NCT05164653|Valsartan|valsartan|mesh-list
43635766|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
43635767|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43635768|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43635769|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43635770|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43635771|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43690529|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829308|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43829309|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
43829311|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829312|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43829313|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829314|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
43829315|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829316|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43829317|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43829318|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
43829319|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829320|NCT05434039|Diclofenac|diclofenac|mesh-list
43829321|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43829322|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43829323|NCT05434039|Analgesics|analgesics|mesh-ancestor
43829324|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
43829325|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829326|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829327|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829328|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829329|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43829330|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829331|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847155|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43847156|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690534|NCT02795065|Enoxaparin|enoxaparin|mesh-list
43690535|NCT02795065|Bemiparin|bemiparin|mesh-list
43690536|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
43690537|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43706532|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
43690540|NCT02794792|Metformin|metformin|mesh-list
43690541|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
43690542|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690543|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690544|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43690545|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690546|NCT02794779|Oxytocin|oxytocin|mesh-list
43690547|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
43690548|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43690549|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690562|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690563|NCT02794506|Propolis|propolis|mesh-list
43690564|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690565|NCT02794584|Sufentanil|sufentanil|mesh-list
43690566|NCT02794584|Dsuvia|dsuvia|mesh-list
43690567|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
43690568|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690569|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690570|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43690571|NCT02794584|Narcotics|narcotics|mesh-ancestor
43690572|NCT02794584|Analgesics|analgesics|mesh-ancestor
43690573|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
43690574|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690575|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43690576|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43690577|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
43690578|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
43690579|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43690580|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
43690581|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690582|NCT02794389|Expectorants|expectorants|mesh-ancestor
43690583|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
43690584|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43690585|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
43690588|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690589|NCT02794389|Antidotes|antidotes|mesh-ancestor
43690590|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
43690591|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690592|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
43690593|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690594|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43690595|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43690596|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
43690598|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690602|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43690603|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690604|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690605|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43690606|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
43690607|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
43690608|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43690609|NCT02793986|Analgesics|analgesics|mesh-ancestor
43690610|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
43690611|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690612|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43690613|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43690614|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43690615|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
43690616|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690617|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635772|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635773|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43635774|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
43635775|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635776|NCT05155293|Aflibercept|aflibercept|mesh-list
43635777|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43635785|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635803|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635804|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43635805|NCT05146739|Leucovorin|leucovorin|mesh-list
43635806|NCT05146739|Cytarabine|cytarabine|mesh-list
43635807|NCT05146739|Fludarabine|fludarabine|mesh-list
43635808|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635809|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43635810|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
43635811|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635812|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635813|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
43635814|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635815|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
43635816|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43635817|NCT05146739|Antidotes|antidotes|mesh-ancestor
43635818|NCT05146739|Protective Agents|protective agents|mesh-ancestor
43690618|NCT02794025|Esmolol|esmolol|mesh-list
43690619|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43690620|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43690621|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43690622|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
43690623|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690624|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690625|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690626|NCT02794220|Nicotine|nicotine|mesh-list
43690627|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43635819|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
43635820|NCT05146739|Vitamins|vitamins|mesh-ancestor
43635822|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43635823|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43635826|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635827|NCT05144009|Rituximab|rituximab|mesh-list
43635828|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43635829|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635830|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635831|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
43635832|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635833|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43635834|NCT05142696|Carboplatin|carboplatin|mesh-list
43635835|NCT05142696|Etoposide|etoposide|mesh-list
43635836|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43635837|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43635838|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635839|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43635840|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43635841|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635872|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43635902|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
43635903|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635904|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635905|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43635906|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43635907|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43635910|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43635911|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43690645|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
43690646|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690647|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690648|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43690649|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
43690650|NCT02793843|Hormones|hormones|mesh-ancestor
43690651|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690652|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43690653|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690654|NCT02793843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690655|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690656|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
43690657|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
43635914|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43635915|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43635916|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43635917|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
43635918|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635919|NCT05116189|Paclitaxel|paclitaxel|mesh-list
43635920|NCT05116189|Docetaxel|docetaxel|mesh-list
43635921|NCT05116189|Bevacizumab|bevacizumab|mesh-list
43635922|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
43635923|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43635924|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635925|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
43635926|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
43635927|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
43635928|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635929|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635930|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43635931|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43635932|NCT05116189|Growth Substances|growth substances|mesh-ancestor
43635933|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635934|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
43635935|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43635936|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
43635937|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43635976|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690674|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690675|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43690676|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43690677|NCT02793765|Docetaxel|docetaxel|mesh-list
43690678|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690679|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
43690680|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
43690681|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690682|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690683|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
43690684|NCT02793544|Sirolimus|sirolimus|mesh-list
43690685|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
43690686|NCT02793544|Busulfan|busulfan|mesh-list
43690687|NCT02793544|Fludarabine|fludarabine|mesh-list
43690688|NCT02793544|Mesna|mesna|mesh-list
43690689|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690690|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
43690691|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690692|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43635992|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
43635993|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
43635994|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635995|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635999|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636000|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636001|NCT05100017|Urological Agents|urological agents|mesh-ancestor
43636002|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43636003|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43636004|NCT05093517|Volagidemab|volagidemab|mesh-list
43636005|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43636006|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636007|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
43636008|NCT05092451|Fludarabine|fludarabine|mesh-list
43636009|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
43636010|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636011|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
43636012|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636013|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636014|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43636015|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
43690693|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43690694|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
43690695|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690696|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690697|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43690698|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43690699|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43690700|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
43690701|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43690702|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690703|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690704|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
43690705|NCT02793544|Protective Agents|protective agents|mesh-ancestor
43690706|NCT02793388|Primaquine|primaquine|mesh-list
43690707|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
43690708|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43690709|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43690710|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690711|NCT02793648|Vitamins|vitamins|mesh-list
43690712|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
43690713|NCT02793648|Vitamin E|vitamin e|mesh-list
43690714|NCT02793648|Tocopherols|tocopherols|mesh-list
43690715|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
43690716|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
43690717|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636016|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636017|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636018|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43636019|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636020|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
43636021|NCT05090085|Z 350|z 350|mesh-list
43636022|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43636023|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43636024|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636025|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636026|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
43636027|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636028|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636029|NCT05089734|Docetaxel|docetaxel|mesh-list
43636033|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
43636034|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636035|NCT05087992|Bevacizumab|bevacizumab|mesh-list
43636036|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636037|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636038|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43636039|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43636040|NCT05087992|Growth Substances|growth substances|mesh-ancestor
43636041|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690719|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690720|NCT02793648|Protective Agents|protective agents|mesh-ancestor
43690721|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
43690722|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43690723|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
43690724|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690725|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
43690726|NCT02793739|Protective Agents|protective agents|mesh-ancestor
43690727|NCT02793323|Anesthetics|anesthetics|mesh-list
43690728|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690729|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690730|NCT02793440|Cortivazol|cortivazol|mesh-list
43690731|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43690732|NCT02793505|Metformin|metformin|mesh-list
43690733|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690734|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690735|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43690736|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43690737|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690738|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
43829332|NCT05431725|Vaccines|vaccines|mesh-list
43636043|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43636049|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636050|NCT05086393|Analgesics|analgesics|mesh-ancestor
43636051|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
43636052|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636053|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
43636054|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43636055|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
43636056|NCT05074706|Antibodies|antibodies|mesh-list
43636057|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
43636058|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
43636059|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636064|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
43636065|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636066|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636067|NCT05065190|Nintedanib|nintedanib|mesh-list
43636068|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636069|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43636070|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636071|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636072|NCT05060549|Cariprazine|cariprazine|mesh-list
43636073|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43636074|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43636075|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829334|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829336|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829337|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
43829338|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
43829339|NCT05430308|Povidone|povidone|mesh-list
43690739|NCT02793466|Durvalumab|durvalumab|mesh-list
43690740|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43690741|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43690742|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690743|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
43690744|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690745|NCT02793219|Docetaxel|docetaxel|mesh-list
43690746|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690747|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
43690748|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
43690750|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690751|NCT02793050|Trabectedin|trabectedin|mesh-list
43690752|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43690753|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
43690754|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690755|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690756|NCT02793011|Dexamethasone|dexamethasone|mesh-list
43690757|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43690758|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
43690759|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
43690760|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690761|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690762|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43690763|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
43690764|NCT02793011|Hormones|hormones|mesh-ancestor
43690765|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690766|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43690774|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43690775|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43690776|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690777|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690779|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
43690780|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43690781|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
43690782|NCT02792712|Clopidogrel|clopidogrel|mesh-list
43690783|NCT02792712|Ticagrelor|ticagrelor|mesh-list
43690784|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43690785|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43690786|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43690787|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43690788|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
43690789|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690790|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690791|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690792|NCT02792946|Ambroxol|ambroxol|mesh-list
43690793|NCT02792946|Expectorants|expectorants|mesh-ancestor
43690794|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
43690795|NCT02792491|Prednisone|prednisone|mesh-list
43690796|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
43690797|NCT02792491|Rituximab|rituximab|mesh-list
43690798|NCT02792491|Doxorubicin|doxorubicin|mesh-list
43690799|NCT02792491|Vincristine|vincristine|mesh-list
43690800|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690801|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
43690802|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690803|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636076|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636077|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43636078|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
43636079|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
43636080|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636081|NCT05057806|Empagliflozin|empagliflozin|mesh-list
43636082|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43636083|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636084|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43636085|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636086|NCT05056402|Vaccines|vaccines|mesh-list
43690806|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690807|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690808|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43690809|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43690810|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43690811|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43690812|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43690813|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690814|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43690815|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
43690817|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690818|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43690819|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43690820|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
43690821|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
43690822|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690823|NCT02792803|Latanoprost|latanoprost|mesh-list
43636101|NCT05051735|Acetaminophen|acetaminophen|mesh-list
43636102|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43636103|NCT05051735|Analgesics|analgesics|mesh-ancestor
43636104|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
43690833|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43690834|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
43690835|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690836|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43690837|NCT02792426|Nicotine|nicotine|mesh-list
43690838|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43690839|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
43690840|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690841|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690842|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43690843|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43690844|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
43690845|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43690846|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690847|NCT02792400|Empagliflozin|empagliflozin|mesh-list
43690848|NCT02792400|Linagliptin|linagliptin|mesh-list
43690849|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43690850|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690851|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690852|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636105|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636106|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636107|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
43636108|NCT05048615|Itraconazole|itraconazole|mesh-list
43636109|NCT05048615|Azacitidine|azacitidine|mesh-list
43636110|NCT05048615|Venetoclax|venetoclax|mesh-list
43636111|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636119|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43636120|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43636132|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636133|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636135|NCT05042128|Antiviral Agents|antiviral agents|mesh-ancestor
43636136|NCT05042128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636137|NCT05042128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636138|NCT05042128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636139|NCT05042128|Immunologic Factors|immunologic factors|mesh-ancestor
43691350|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43636140|NCT05042128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636141|NCT05041335|Heparin|heparin|mesh-list
43636142|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
43690854|NCT02792400|Hormones|hormones|mesh-ancestor
43690855|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690856|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43690857|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
43690858|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690859|NCT02792335|Warfarin|warfarin|mesh-list
43690860|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
43690861|NCT02792335|Dabigatran|dabigatran|mesh-list
43690862|NCT02792335|Apixaban|apixaban|mesh-list
43690863|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
43690864|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43690865|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
43690869|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690870|NCT02792036|Carboplatin|carboplatin|mesh-list
43690871|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690872|NCT02792153|Estradiol|estradiol|mesh-list
43690873|NCT02792153|Estrogens|estrogens|mesh-ancestor
43690874|NCT02792153|Hormones|hormones|mesh-ancestor
43690875|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690876|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690877|NCT02791958|Ramipril|ramipril|mesh-list
43690878|NCT02791958|Atorvastatin|atorvastatin|mesh-list
43690879|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43636143|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43636144|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43636145|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636146|NCT05040360|Capecitabine|capecitabine|mesh-list
43636147|NCT05040360|Temozolomide|temozolomide|mesh-list
43636148|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636149|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
43636150|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636170|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43636171|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636172|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
43636173|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636174|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636175|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43636176|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636198|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43636199|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636200|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636201|NCT05020665|Cytarabine|cytarabine|mesh-list
43636202|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636203|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
43636204|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690880|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43690881|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
43690882|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690883|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43690884|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43690885|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690886|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43690887|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
43690888|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43690890|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43706888|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
43636208|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636209|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
43636210|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636211|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
43636213|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43636214|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43636215|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
43636216|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636219|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636220|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43636221|NCT05018585|Vitamins|vitamins|mesh-ancestor
43636222|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
43636223|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43636224|NCT05016310|Vitamin D|vitamin d|mesh-list
43849492|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636225|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
43636226|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
43636227|NCT05016310|Vitamins|vitamins|mesh-list
43636228|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
43636229|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636230|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43636231|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43636232|NCT05012371|Everolimus|everolimus|mesh-list
43636233|NCT05012371|Lenvatinib|lenvatinib|mesh-list
43636234|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636235|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636236|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
43636237|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636238|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43636239|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636240|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636241|NCT05009992|TIC10 compound|tic10 compound|mesh-list
43636242|NCT05009992|Dopamine|dopamine|mesh-list
43636243|NCT05009992|GDC-0084|gdc-0084|mesh-list
43636244|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43636245|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
43636246|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
43636247|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636248|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636249|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
43636250|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636251|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636252|NCT05009992|Protective Agents|protective agents|mesh-ancestor
43636253|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636254|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690892|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690893|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
43690894|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690895|NCT02791919|Cytarabine|cytarabine|mesh-list
43690896|NCT02791919|Fludarabine|fludarabine|mesh-list
43690897|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
43690898|NCT02791919|Lenograstim|lenograstim|mesh-list
43690899|NCT02791919|Adavosertib|adavosertib|mesh-list
43690900|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690901|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43690902|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
43690903|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690904|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690905|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
43690906|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690907|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
43690908|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690930|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43636265|NCT04999969|Gemcitabine|gemcitabine|mesh-list
43636266|NCT04999969|Paclitaxel|paclitaxel|mesh-list
43636267|NCT04999969|Durvalumab|durvalumab|mesh-list
43636268|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43636269|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636270|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
43636271|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
43636272|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
43636273|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636274|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636275|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
43636276|NCT04999969|Antiviral Agents|antiviral agents|mesh-ancestor
43636277|NCT04999969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636278|NCT04999969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636279|NCT04999969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636280|NCT04999969|Immunologic Factors|immunologic factors|mesh-ancestor
43636281|NCT04999969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636282|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636283|NCT04996134|Domperidone|domperidone|mesh-list
43636284|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
43636285|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
43636286|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636287|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636288|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636289|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43636290|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
43636291|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636319|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636321|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43829664|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636333|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636334|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43636335|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43636336|NCT04984980|Growth Substances|growth substances|mesh-ancestor
43636337|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636348|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
43636349|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690938|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690939|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
43690941|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690942|NCT02791243|Urological Agents|urological agents|mesh-ancestor
43829340|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43829341|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829342|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
43829343|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
43829344|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
43829345|NCT05430074|Calpastatin|calpastatin|mesh-list
43690944|NCT02791373|Vinorelbine|vinorelbine|mesh-list
43690945|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43690946|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
43690947|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690948|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690949|NCT02791373|Antiviral Agents|antiviral agents|mesh-ancestor
43690950|NCT02791373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690951|NCT02791373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690952|NCT02791373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690953|NCT02791373|Immunologic Factors|immunologic factors|mesh-ancestor
43690954|NCT02791373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690955|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43690956|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
43690957|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
43690958|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690960|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43690961|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
43690962|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690963|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
43690964|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690965|NCT02790957|Plerixafor|plerixafor|mesh-list
43690966|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43690967|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43690968|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
43636359|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
43636360|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690969|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690970|NCT02790996|Vancomycin|vancomycin|mesh-list
43690971|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43690972|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690973|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
43690974|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43690975|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690976|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690977|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690978|NCT02790840|Omeprazole|omeprazole|mesh-list
43690979|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43690980|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43690981|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43690982|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690983|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690984|NCT02790684|Firuglipel|firuglipel|mesh-list
43690985|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690986|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690987|NCT02790671|Firuglipel|firuglipel|mesh-list
43690988|NCT02790671|Itraconazole|itraconazole|mesh-list
43690989|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
43690990|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690991|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43690992|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43636361|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636363|NCT04975997|Bortezomib|bortezomib|mesh-list
43636364|NCT04975997|Daratumumab|daratumumab|mesh-list
43636365|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636366|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
43636367|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
43636368|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636369|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636370|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636371|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
43636372|NCT04975997|Hormones|hormones|mesh-ancestor
43636373|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636374|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43636375|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636376|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
43849494|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636385|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
43636386|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636387|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43636389|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43636390|NCT04937062|Protective Agents|protective agents|mesh-ancestor
43636391|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636392|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636393|NCT04936230|Atezolizumab|atezolizumab|mesh-list
43636394|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43636395|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636396|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
43690996|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
43690997|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690998|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690999|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43691000|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43691001|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
43691002|NCT02790580|Doxorubicin|doxorubicin|mesh-list
43691003|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43691004|NCT02790580|Sunitinib|sunitinib|mesh-list
43691005|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691006|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
43691007|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691008|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691009|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43691010|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
43691011|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691012|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691013|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43636397|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636398|NCT04933539|Dexamethasone|dexamethasone|mesh-list
43636399|NCT04933539|Daratumumab|daratumumab|mesh-list
43636400|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636401|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
43636402|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
43636403|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636404|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636405|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636406|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
43636407|NCT04933539|Hormones|hormones|mesh-ancestor
43636408|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636409|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43636410|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636417|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43636418|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43636419|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
43636420|NCT04924322|Enoxaparin|enoxaparin|mesh-list
43636421|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
43636422|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43636423|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43636424|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636425|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
43636426|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
43636427|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636428|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
43691014|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43691015|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43691016|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43691017|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691018|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43691019|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43829382|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
43691020|NCT02790580|Growth Substances|growth substances|mesh-ancestor
43691021|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
43691022|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43691024|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
43691025|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
43691027|NCT02790450|Renal Agents|renal agents|mesh-ancestor
43691028|NCT02790632|Nimodipine|nimodipine|mesh-list
43691029|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43691030|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43691031|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691032|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691033|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43691034|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691035|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
43691036|NCT02790528|Atorvastatin|atorvastatin|mesh-list
43691037|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43691038|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43691039|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
43691040|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691041|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43691042|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43691043|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691045|NCT02790099|Bupivacaine|bupivacaine|mesh-list
43691046|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691047|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
43636429|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636430|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636431|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43636432|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
43691048|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691049|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691050|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
43691051|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691052|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43691053|NCT02790099|Narcotics|narcotics|mesh-ancestor
43691054|NCT02790099|Analgesics|analgesics|mesh-ancestor
43691056|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43691057|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691058|NCT02790203|Analgesics|analgesics|mesh-ancestor
43691059|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
43691060|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691061|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691062|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43691065|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43691066|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691067|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691068|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
43636433|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636434|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636435|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43636436|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636447|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
43849495|NCT03921242|Metformin|metformin|mesh-list
43636448|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
43636449|NCT04910061|Vitamins|vitamins|mesh-ancestor
43636450|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
43636451|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636452|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43636453|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
43636454|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636455|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43691070|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
43706966|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691075|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43691076|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43691077|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43691078|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691079|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691081|NCT02789969|Hydromorphone|hydromorphone|mesh-list
43691082|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43691083|NCT02789969|Narcotics|narcotics|mesh-ancestor
43691084|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691085|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691086|NCT02789969|Analgesics|analgesics|mesh-ancestor
43691087|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
43691088|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691089|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43691090|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43691091|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
43691092|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
43691093|NCT02789982|Propranolol|propranolol|mesh-list
43691094|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
43691097|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691098|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691099|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691100|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43691101|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43691102|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
43691103|NCT02789865|Metronidazole|metronidazole|mesh-list
43691104|NCT02789865|Levofloxacin|levofloxacin|mesh-list
43691105|NCT02789865|Ofloxacin|ofloxacin|mesh-list
43691106|NCT02789865|Ertapenem|ertapenem|mesh-list
43691107|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691108|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43691109|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43691110|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43691111|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43691112|NCT02789865|Renal Agents|renal agents|mesh-ancestor
43691113|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43636456|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
43636457|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43636458|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43636459|NCT04907968|Carboplatin|carboplatin|mesh-list
43636460|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636461|NCT04903197|Lenalidomide|lenalidomide|mesh-list
43636462|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
43636463|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636464|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43636465|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43636466|NCT04903197|Growth Substances|growth substances|mesh-ancestor
43636467|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
43636468|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636469|NCT04900038|Lamivudine|lamivudine|mesh-list
43636470|NCT04900038|Dolutegravir|dolutegravir|mesh-list
43636471|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43636472|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43636473|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636474|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636477|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43636478|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43636479|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43636480|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43636481|NCT04898894|Cytarabine|cytarabine|mesh-list
43636482|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
43636483|NCT04898894|Methotrexate|methotrexate|mesh-list
43636484|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
43636485|NCT04898894|Fludarabine|fludarabine|mesh-list
43636486|NCT04898894|Venetoclax|venetoclax|mesh-list
43636487|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43636488|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
43636489|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43636490|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636491|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636492|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
43636493|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636551|NCT04887831|Immunologic Factors|immunologic factors|mesh-ancestor
43691114|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43691115|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691116|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691117|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691118|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43691119|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43691120|NCT02789930|Anesthetics|anesthetics|mesh-list
43691121|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691122|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829387|NCT05428215|Estradiol|estradiol|mesh-list
43691123|NCT02789813|Valproic Acid|valproic acid|mesh-list
43691124|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
43691125|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691126|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691127|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
43691128|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691129|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691130|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
43691131|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43691132|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691133|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43829346|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43829347|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
43829348|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829349|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829350|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
43636552|NCT04887831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636560|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636561|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43636562|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43636563|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43636564|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43636565|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636567|NCT04872400|Tobramycin|tobramycin|mesh-list
43636568|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43636569|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636571|NCT04871529|Carboplatin|carboplatin|mesh-list
43636572|NCT04871529|Avelumab|avelumab|mesh-list
43636573|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
43636574|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
43636575|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43636577|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636579|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829351|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43829352|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829353|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
43829354|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43829355|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829356|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43829357|NCT05429476|Plasminogen|plasminogen|mesh-list
43829358|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43829359|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43829360|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829361|NCT05429450|Triamcinolone|triamcinolone|mesh-list
43829362|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43829363|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43829364|NCT05429450|Methotrexate|methotrexate|mesh-list
43829365|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43829366|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43829367|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
43829368|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43636580|NCT04871529|Antiviral Agents|antiviral agents|mesh-ancestor
43636581|NCT04871529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636582|NCT04871529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636583|NCT04871529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636584|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
43636585|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636586|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636587|NCT04870424|Colchicine|colchicine|mesh-list
43636588|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
43636589|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636590|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
43636591|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
43636592|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
43636593|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636594|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636595|NCT04862468|Dexamethasone|dexamethasone|mesh-list
43636596|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636597|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
43636598|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
43636599|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636600|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707123|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43636604|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636605|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43636606|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636607|NCT04862338|Niacinamide|niacinamide|mesh-list
43636608|NCT04862338|Niacin|niacin|mesh-list
43636609|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
43636610|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
43636611|NCT04862338|Vitamins|vitamins|mesh-ancestor
43636612|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
43636613|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636614|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43636615|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
43636616|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636617|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43636618|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
43829370|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43829372|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829373|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829374|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
43829375|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829376|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43829377|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43829378|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
43691134|NCT02789592|Clonazepam|clonazepam|mesh-list
43691135|NCT02789592|Melatonin|melatonin|mesh-list
43691136|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
43691137|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691138|NCT02789592|Protective Agents|protective agents|mesh-ancestor
43691139|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691140|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691141|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
43691142|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
43691143|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
43691144|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691146|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43691147|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43691148|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43691149|NCT02789579|Levofloxacin|levofloxacin|mesh-list
43691150|NCT02789579|Ofloxacin|ofloxacin|mesh-list
43691151|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
43691152|NCT02789579|Cefuroxime|cefuroxime|mesh-list
43691153|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
43691154|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43691155|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691156|NCT02789579|Renal Agents|renal agents|mesh-ancestor
43691157|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43691158|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43691159|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43691160|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691163|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43691164|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43691165|NCT02789150|Norepinephrine|norepinephrine|mesh-list
43691166|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43691167|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43691168|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
43691169|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691170|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691171|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691172|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
43691173|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
43691176|NCT02789358|Adenosine|adenosine|mesh-list
43691177|NCT02789358|Analgesics|analgesics|mesh-ancestor
43691178|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
43691179|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691180|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691181|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43691182|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
43691183|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43691184|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
43691185|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
43691186|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691187|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691189|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43691190|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43691191|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43691192|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691193|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691194|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43691196|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
43691201|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43691202|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691204|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43691205|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
43691206|NCT02789332|Carboplatin|carboplatin|mesh-list
43691207|NCT02789332|Epirubicin|epirubicin|mesh-list
43691208|NCT02789332|Olaparib|olaparib|mesh-list
43691209|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43691210|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691211|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
43691212|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
43691213|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
43691214|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691215|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691216|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
43691217|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691218|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691219|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43691220|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
43691222|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43691223|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43691224|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43691225|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691226|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43691227|NCT02789397|Rituximab|rituximab|mesh-list
43691228|NCT02789397|Azathioprine|azathioprine|mesh-list
43691229|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43691230|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691231|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
43691232|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691233|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691234|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
43691235|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636619|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43636620|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
43691236|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43691242|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691244|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
43691245|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
43691246|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
43691247|NCT02789202|Protective Agents|protective agents|mesh-ancestor
43691248|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691249|NCT02789189|Gemcitabine|gemcitabine|mesh-list
43691250|NCT02789189|Nedaplatin|nedaplatin|mesh-list
43691251|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43691252|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
43691253|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691254|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691255|NCT02789189|Antiviral Agents|antiviral agents|mesh-ancestor
43691256|NCT02789189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691262|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
43691263|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43691264|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43691265|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691267|NCT02788851|Methylphenidate|methylphenidate|mesh-list
43691268|NCT02788851|Amphetamine|amphetamine|mesh-list
43691269|NCT02788851|Adderall|adderall|mesh-list
43691270|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
43691271|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43691272|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43691273|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691274|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43691275|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43691276|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691309|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43691310|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
43691311|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43691312|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691313|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43691314|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43691315|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
43691316|NCT02788643|Dimercaprol|dimercaprol|mesh-list
43691317|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
43691318|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
43691319|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691320|NCT02788240|Meropenem|meropenem|mesh-list
43691321|NCT02788240|Terlipressin|terlipressin|mesh-list
43691322|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43691323|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691324|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43636654|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636655|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43636656|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636657|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43636658|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636659|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43636660|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636661|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636662|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43636663|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43636664|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
43636665|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43636666|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43636667|NCT04843579|Growth Substances|growth substances|mesh-ancestor
43636668|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
43636669|NCT04840615|Ipilimumab|ipilimumab|mesh-list
43636670|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636671|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636672|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43636673|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636674|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43636675|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43636676|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636677|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
43636678|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636679|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636681|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
43691325|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43691326|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
43691327|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43691328|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
43691329|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691330|NCT02788292|Expectorants|expectorants|mesh-ancestor
43691331|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
43691332|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43691333|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
43608281|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608282|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691334|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691335|NCT02788292|Protective Agents|protective agents|mesh-ancestor
43691336|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691338|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43691339|NCT02787824|Hematinics|hematinics|mesh-ancestor
43691340|NCT02787967|Beclomethasone|beclomethasone|mesh-list
43691341|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
43691351|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
43691352|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691353|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691354|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829383|NCT05429450|Hormones|hormones|mesh-ancestor
43829384|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829385|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43829386|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43829388|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43829389|NCT05428215|Estrogens|estrogens|mesh-ancestor
43829390|NCT05428215|Hormones|hormones|mesh-ancestor
43829391|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829392|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829393|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43691437|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
43847182|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
43847183|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
43847184|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847185|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847186|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847187|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847188|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43847189|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
43847190|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847191|NCT04129151|Palbociclib|palbociclib|mesh-list
43847192|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847193|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847194|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847195|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847206|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847208|NCT04128176|Omalizumab|omalizumab|mesh-list
43847209|NCT04128176|Rituximab|rituximab|mesh-list
43847210|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847211|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847212|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
43847213|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847214|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847215|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43847216|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43847217|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
43847218|NCT04126681|Interferons|interferons|mesh-list
43847219|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
43847220|NCT04126681|Dasatinib|dasatinib|mesh-list
43691617|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43691618|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43691619|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
43691620|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691621|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691640|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691641|NCT02785757|Thrombin|thrombin|mesh-list
43691642|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
43691643|NCT02785757|Coagulants|coagulants|mesh-ancestor
43691644|NCT02785601|Trazodone|trazodone|mesh-list
43691645|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43691646|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43691647|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691648|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691649|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43691650|NCT02785601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43637051|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43637052|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43829394|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
43829395|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43829396|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43829397|NCT05427565|Caffeine|caffeine|mesh-list
43829398|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43707124|NCT02703090|Narcotics|narcotics|mesh-ancestor
43637053|NCT04697719|Analgesics|analgesics|mesh-ancestor
43637054|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
43637055|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637056|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637057|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43637058|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637059|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43691748|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
43637077|NCT04697628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637078|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637079|NCT04697628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637080|NCT04697628|Immunologic Factors|immunologic factors|mesh-ancestor
43637081|NCT04697628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637082|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43637083|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43637084|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43637085|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43637086|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637087|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
43637088|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
43637089|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
43637090|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637092|NCT04695340|Cathartics|cathartics|mesh-ancestor
43637093|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43637094|NCT04694586|Rifampin|rifampin|mesh-list
43637095|NCT04694586|Isoniazid|isoniazid|mesh-list
43637096|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
43637097|NCT04694586|Ethambutol|ethambutol|mesh-list
43637098|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43637099|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
43637100|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43691852|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43691853|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
43691854|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691855|NCT02784795|Antiviral Agents|antiviral agents|mesh-ancestor
43691856|NCT02784795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691857|NCT02784795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691858|NCT02784795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691859|NCT02784795|Immunologic Factors|immunologic factors|mesh-ancestor
43691860|NCT02784795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637106|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43637107|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43637108|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43637109|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43637110|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43637111|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43637112|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43637113|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43637114|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
43637115|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43637116|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43637117|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
43637118|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43637119|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637120|NCT04686799|Doxycycline|doxycycline|mesh-list
43637121|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43637122|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637123|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
43637124|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43637125|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43637133|NCT04677569|Azithromycin|azithromycin|mesh-list
43637134|NCT04677569|Amikacin|amikacin|mesh-list
43637135|NCT04677569|Ethambutol|ethambutol|mesh-list
43637136|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43637137|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637138|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
43637156|NCT04667663|Pomalidomide|pomalidomide|mesh-list
43637163|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637164|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637165|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43637166|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43637167|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
43637168|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
43691865|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691866|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691867|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43691868|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
43691869|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
43691870|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691871|NCT02784626|Analgesics|analgesics|mesh-ancestor
43691872|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
43691873|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691874|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43691875|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43691876|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43691877|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
43691878|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691879|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691880|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
43691881|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43691882|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691883|NCT02784457|Cetrorelix|cetrorelix|mesh-list
43691884|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43691885|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
43691886|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43691887|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691888|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
43637209|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637211|NCT04662710|Protective Agents|protective agents|mesh-ancestor
43637212|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637213|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
43637214|NCT04662710|Vitamins|vitamins|mesh-ancestor
43637215|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
43637216|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637217|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637244|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637245|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43637246|NCT04635735|Ipilimumab|ipilimumab|mesh-list
43637247|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43691916|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
43691917|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691918|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
43691919|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691920|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
43691921|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43691922|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43691923|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43691924|NCT02784340|Dexamethasone|dexamethasone|mesh-list
43637248|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637249|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43637250|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692077|NCT02783053|Metformin|metformin|mesh-list
43692078|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43692079|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692080|NCT02783144|Dexamethasone|dexamethasone|mesh-list
43692081|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
43692082|NCT02783144|BB 1101|bb 1101|mesh-list
43692083|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692084|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
43692085|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
43692086|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692087|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692088|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692089|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
43692090|NCT02783144|Hormones|hormones|mesh-ancestor
43692091|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692092|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43692093|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692135|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43829399|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829400|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43692136|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43692137|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692138|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43692139|NCT02783196|Liraglutide|liraglutide|mesh-list
43692140|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43637626|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637627|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43637628|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
43637629|NCT04529772|Hormones|hormones|mesh-ancestor
43637630|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637631|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637632|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637633|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
43637634|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
43637635|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
43637636|NCT04526899|Cemiplimab|cemiplimab|mesh-list
43637637|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637638|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637639|NCT04524455|Dexamethasone|dexamethasone|mesh-list
43637640|NCT04524455|Blinatumomab|blinatumomab|mesh-list
43637641|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43637642|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
43637643|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
43637644|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637645|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637646|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43637647|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
43637648|NCT04524455|Hormones|hormones|mesh-ancestor
43637649|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637650|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637651|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637652|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43692153|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
43692154|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43692185|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692187|NCT02782559|Urological Agents|urological agents|mesh-ancestor
43692192|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
43692193|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692194|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692195|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692196|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692197|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692198|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692199|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692201|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43692202|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692203|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637751|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43637752|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43637754|NCT04447027|Lenalidomide|lenalidomide|mesh-list
43637755|NCT04447027|Azacitidine|azacitidine|mesh-list
43637756|NCT04447027|Romidepsin|romidepsin|mesh-list
43637757|NCT04447027|Cc-486|cc-486|mesh-list
43637758|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43637759|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
43637760|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
43637761|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637762|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637763|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43637764|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
43637765|NCT04447027|Hormones|hormones|mesh-ancestor
43637766|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637767|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637768|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637769|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
43637770|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43829667|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637895|NCT04380636|Cisplatin|cisplatin|mesh-list
43637896|NCT04380636|Carboplatin|carboplatin|mesh-list
43637912|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43637913|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43829401|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829402|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829403|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43829404|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43829405|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
43829406|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829407|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
43636686|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43636687|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636688|NCT04812379|Aripiprazole|aripiprazole|mesh-list
43636689|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
43636690|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43636691|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43636692|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43636693|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43636694|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636695|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
43636696|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
43636697|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636698|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636699|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43636700|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43636701|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
43636702|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43636703|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43636704|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43636705|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43829408|NCT05427149|Analgesics|analgesics|mesh-ancestor
43829409|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
43829410|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829411|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637914|NCT04372628|Ritonavir|ritonavir|mesh-list
43637915|NCT04372628|Lopinavir|lopinavir|mesh-list
43637916|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43637917|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43692357|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43692358|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43692359|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692360|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
43692361|NCT02781597|Coagulants|coagulants|mesh-ancestor
43829412|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
43829413|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829414|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43829415|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
43829416|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43829417|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43829418|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829419|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43829420|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
43829421|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43829422|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
43829423|NCT05426434|Piperaquine|piperaquine|mesh-list
43829424|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
43829425|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43692362|NCT02781805|Alendronate|alendronate|mesh-list
43692363|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43692364|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692365|NCT02781493|Prucalopride|prucalopride|mesh-list
43692366|NCT02781493|Laxatives|laxatives|mesh-ancestor
43692367|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692368|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43692369|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43692370|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
43692371|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692372|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692373|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638011|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638012|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43638013|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43638014|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
43638015|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43638017|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638023|NCT04324463|Aspirin|aspirin|mesh-list
43638024|NCT04324463|Interferons|interferons|mesh-list
43638026|NCT04324463|Colchicine|colchicine|mesh-list
43638027|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
43638028|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638029|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
43638030|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638031|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43638032|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43638033|NCT04324463|Analgesics|analgesics|mesh-ancestor
43638163|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43638164|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43638165|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43638166|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43638191|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
43638192|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43638193|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692443|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
43692444|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
43692445|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
43692446|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692447|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43636706|NCT04810559|Antibodies|antibodies|mesh-list
43636707|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
43636708|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636709|NCT04799288|Teriflunomide|teriflunomide|mesh-list
43636710|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43636711|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43636712|NCT04799288|Analgesics|analgesics|mesh-ancestor
43636713|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
43636714|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829427|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
43829428|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43829429|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43829430|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829431|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43829432|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829433|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829434|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43829435|NCT05426434|Renal Agents|renal agents|mesh-ancestor
43691366|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43691367|NCT02788123|Pantoprazole|pantoprazole|mesh-list
43691368|NCT02788123|Bismuth|bismuth|mesh-list
43691369|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43692448|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692449|NCT02780479|Dexamethasone|dexamethasone|mesh-list
43692450|NCT02780479|Prednisone|prednisone|mesh-list
43692451|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692477|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692478|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
43692479|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43692480|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43692481|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692482|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
43692483|NCT02780245|Coagulants|coagulants|mesh-ancestor
43692484|NCT02780323|Celecoxib|celecoxib|mesh-list
43692485|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43692486|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692487|NCT02780323|Analgesics|analgesics|mesh-ancestor
43692488|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
43692489|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692490|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692491|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692556|NCT02779283|Vincristine|vincristine|mesh-list
43692557|NCT02779283|Sorafenib|sorafenib|mesh-list
43692558|NCT02779283|Sunitinib|sunitinib|mesh-list
43692559|NCT02779283|Dasatinib|dasatinib|mesh-list
43692560|NCT02779283|Idarubicin|idarubicin|mesh-list
43691370|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43691371|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43691372|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691373|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691374|NCT02788123|Antacids|antacids|mesh-ancestor
43691375|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691376|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43691377|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43691378|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691379|NCT02788058|Gefitinib|gefitinib|mesh-list
43691380|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691381|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43691382|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691383|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691384|NCT02787642|Olaparib|olaparib|mesh-list
43691385|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43636715|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636716|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636717|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636718|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636719|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
43636720|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
43636721|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636722|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636723|NCT04793958|Cetuximab|cetuximab|mesh-list
43636724|NCT04793958|Adagrasib|adagrasib|mesh-list
43636725|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636726|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636727|NCT04776252|Islatravir|islatravir|mesh-list
43636728|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
43692561|NCT02779283|Ponatinib|ponatinib|mesh-list
43692562|NCT02779283|Idelalisib|idelalisib|mesh-list
43692563|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43692564|NCT02779283|Antibodies|antibodies|mesh-list
43692565|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
43692566|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43692620|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
43692621|NCT02779283|Hematinics|hematinics|mesh-ancestor
43692622|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
43692623|NCT02779413|Insulin|insulin|mesh-list
43692624|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43707179|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
43692741|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43692742|NCT02779153|Hormones|hormones|mesh-ancestor
43829670|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43638394|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
43691387|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691388|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691389|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43691390|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691392|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43691393|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691394|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691395|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
43691396|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691397|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638395|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638396|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
43638397|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638398|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638399|NCT04165070|Paclitaxel|paclitaxel|mesh-list
43829517|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
43829518|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829519|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43829520|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43829522|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43829523|NCT05420337|Narcotics|narcotics|mesh-ancestor
43829524|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829525|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829526|NCT05420337|Analgesics|analgesics|mesh-ancestor
43829527|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
43829528|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829529|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
43829530|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43829531|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829532|NCT05419427|Denosumab|denosumab|mesh-list
43829533|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43692794|NCT02778308|Gemcitabine|gemcitabine|mesh-list
43692795|NCT02778308|Cisplatin|cisplatin|mesh-list
43692796|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692797|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43692798|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
43692799|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692800|NCT02778308|Antiviral Agents|antiviral agents|mesh-ancestor
43692801|NCT02778308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692802|NCT02778308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692803|NCT02778308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692804|NCT02778308|Immunologic Factors|immunologic factors|mesh-ancestor
43692805|NCT02778308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692806|NCT02778178|Clonidine|clonidine|mesh-list
43692807|NCT02778178|Ropivacaine|ropivacaine|mesh-list
43692808|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
43692809|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
43692830|NCT02777866|Bupivacaine|bupivacaine|mesh-list
43692831|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
43692832|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
43691398|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
43691399|NCT02787798|Valsartan|valsartan|mesh-list
43691400|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43691401|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43636729|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636730|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636731|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636732|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43692833|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692834|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692835|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
43692836|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638468|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638469|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
43638470|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638471|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638472|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43638473|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
43638474|NCT04109066|Paclitaxel|paclitaxel|mesh-list
43638475|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
43638476|NCT04109066|Nivolumab|nivolumab|mesh-list
43638542|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
43638543|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638544|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43638545|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43638546|NCT04071457|Growth Substances|growth substances|mesh-ancestor
43638547|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
43638548|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638549|NCT04058756|Spartalizumab|spartalizumab|mesh-list
43638550|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43638551|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638552|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638556|NCT04051619|Oxytocin|oxytocin|mesh-list
43638557|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
43638558|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43638559|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638560|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
43638563|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
43638564|NCT04047628|Natalizumab|natalizumab|mesh-list
43638565|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638566|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638567|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
43638568|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692894|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
43692895|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692896|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692897|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43692898|NCT02777671|Gliclazide|gliclazide|mesh-list
43692899|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43692900|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
43692901|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43692902|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43636733|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43636734|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43636735|NCT04776018|Daratumumab|daratumumab|mesh-list
43636736|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636737|NCT04775082|Liraglutide|liraglutide|mesh-list
43636738|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43636739|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636740|NCT04775082|Incretins|incretins|mesh-ancestor
43636741|NCT04775082|Hormones|hormones|mesh-ancestor
43636742|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636743|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
43636744|NCT04772222|Morphine|morphine|mesh-list
43636745|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43636746|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691402|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43691403|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43691404|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691405|NCT02787473|Cisplatin|cisplatin|mesh-list
43691406|NCT02787473|Docetaxel|docetaxel|mesh-list
43691407|NCT02787473|Pemetrexed|pemetrexed|mesh-list
43691408|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691409|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
43691410|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
43691411|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
43691412|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691413|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692903|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43692904|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692905|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43692906|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692908|NCT02777619|Propofol|propofol|mesh-list
43692909|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43692910|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43638569|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638570|NCT04026412|Nivolumab|nivolumab|mesh-list
43638571|NCT04026412|Ipilimumab|ipilimumab|mesh-list
43638572|NCT04026412|Durvalumab|durvalumab|mesh-list
43638573|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638574|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691414|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43691415|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43691416|NCT02787447|Gefitinib|gefitinib|mesh-list
43691417|NCT02787447|Thymalfasin|thymalfasin|mesh-list
43636747|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636748|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43636749|NCT04772222|Analgesics|analgesics|mesh-ancestor
43636750|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
43638575|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43638576|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638577|NCT04026113|Linaclotide|linaclotide|mesh-list
43638578|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43638579|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
43638580|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638581|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43638582|NCT04016805|Venetoclax|venetoclax|mesh-list
43638583|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
43638584|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638752|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43638754|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638755|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43638756|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
43638757|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
43638758|NCT03907852|Nivolumab|nivolumab|mesh-list
43638759|NCT03907852|Fludarabine|fludarabine|mesh-list
43638760|NCT03907852|Ipilimumab|ipilimumab|mesh-list
43638761|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638762|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
43638763|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638764|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638765|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43638766|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
43638767|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638768|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693159|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693160|NCT02776059|Prednisolone|prednisolone|mesh-list
43693161|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43693162|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
43693163|NCT02776059|Hormones|hormones|mesh-ancestor
43693164|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693165|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693166|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43693167|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693168|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
43693169|NCT02775734|Clomiphene|clomiphene|mesh-list
43693170|NCT02775734|Enclomiphene|enclomiphene|mesh-list
43693171|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
43693172|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43693173|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693174|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43693175|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
43693176|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693177|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693178|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43693179|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
43693180|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43693181|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43693182|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43693183|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
43693184|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693185|NCT02775734|Expectorants|expectorants|mesh-ancestor
43693186|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
43693187|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43693188|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
43693189|NCT02775734|Protective Agents|protective agents|mesh-ancestor
43693190|NCT02775734|Antidotes|antidotes|mesh-ancestor
43636751|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636762|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43636763|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636764|NCT04769206|Galantamine|galantamine|mesh-list
43636765|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43636766|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636767|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636768|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
43636769|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636770|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636771|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43636772|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
43636773|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636774|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
43636775|NCT04766996|Aspirin|aspirin|mesh-list
43636776|NCT04766996|Acetaminophen|acetaminophen|mesh-list
43636777|NCT04766996|Prednisone|prednisone|mesh-list
43636778|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43636779|NCT04766996|Meloxicam|meloxicam|mesh-list
43636780|NCT04766996|Diclofenac|diclofenac|mesh-list
43691419|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43691420|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691421|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691422|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43691423|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
43691424|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691425|NCT02787317|Heparin|heparin|mesh-list
43691426|NCT02787317|Bivalirudin|bivalirudin|mesh-list
43691427|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
43691428|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43691429|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43691430|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691431|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
43691432|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43691433|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
43691434|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691435|NCT02787356|Lidocaine|lidocaine|mesh-list
43691436|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691438|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691439|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691440|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
43691441|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691442|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43636781|NCT04766996|Lidocaine|lidocaine|mesh-list
43636782|NCT04766996|Pregabalin|pregabalin|mesh-list
43636783|NCT04766996|Tramadol|tramadol|mesh-list
43636784|NCT04766996|Bupivacaine|bupivacaine|mesh-list
43636785|NCT04766996|Propofol|propofol|mesh-list
43636786|NCT04766996|Omeprazole|omeprazole|mesh-list
43636787|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
43636788|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
43636789|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
43636790|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43636791|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636792|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
43636793|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636794|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43636795|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43636796|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43636797|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43636798|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693191|NCT02776397|Vitamin E|vitamin e|mesh-list
43693192|NCT02776397|Tocopherols|tocopherols|mesh-list
43693202|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693203|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43693204|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43693205|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693206|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693207|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43693208|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
43693209|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693210|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693211|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43693212|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
43693213|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43693214|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43693215|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43693216|NCT02775474|Fentanyl|fentanyl|mesh-list
43693217|NCT02775474|Methadone|methadone|mesh-list
43693218|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43693219|NCT02775474|Narcotics|narcotics|mesh-ancestor
43693220|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693237|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693238|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693240|NCT02775500|Apremilast|apremilast|mesh-list
43693241|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43693242|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43636799|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636800|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
43636801|NCT04766996|Hormones|hormones|mesh-ancestor
43691443|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43691444|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43691445|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691446|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691447|NCT02787278|Otaplimastat|otaplimastat|mesh-list
43691448|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43691449|NCT02787278|Protective Agents|protective agents|mesh-ancestor
43691450|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691451|NCT02786979|Aspirin|aspirin|mesh-list
43693243|NCT02775500|Analgesics|analgesics|mesh-ancestor
43693244|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
43693245|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693246|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693247|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43693248|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693249|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43693250|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43693251|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693252|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693253|NCT02775318|Bupivacaine|bupivacaine|mesh-list
43693254|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
43693255|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
43693256|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693257|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693258|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
43693259|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693260|NCT02775292|Aldesleukin|aldesleukin|mesh-list
43693261|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
43693262|NCT02775292|Nivolumab|nivolumab|mesh-list
43693263|NCT02775292|Fludarabine|fludarabine|mesh-list
43693264|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
43693265|NCT02775292|Interleukin-2|interleukin-2|mesh-list
43693266|NCT02775292|Vaccines|vaccines|mesh-list
43693267|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
43693268|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693269|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693270|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693271|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43693272|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
43693273|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693274|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693275|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43693276|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43693277|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43693278|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43693279|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
43693280|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43693281|NCT02775292|Analgesics|analgesics|mesh-ancestor
43693282|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
43693283|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693284|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43693285|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43693286|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
43693300|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
43693301|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693302|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
43693303|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
43693304|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693305|NCT02775266|Protective Agents|protective agents|mesh-ancestor
43693306|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691452|NCT02786979|Beraprost|beraprost|mesh-list
43691453|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43691454|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691455|NCT02786979|Analgesics|analgesics|mesh-ancestor
43691456|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
43691457|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691458|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691459|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43691460|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691461|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43691462|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43691463|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691464|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43691465|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43691466|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691467|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
43691468|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
43691469|NCT02787226|Bupivacaine|bupivacaine|mesh-list
43691470|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691471|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
43691472|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691473|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691474|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
43691476|NCT02787018|Dexamethasone|dexamethasone|mesh-list
43691484|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693307|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
43693309|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
43829596|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829597|NCT05415865|Lidocaine|lidocaine|mesh-list
43829598|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
43829599|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
43693311|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43693312|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693313|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
43693314|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43693315|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43693338|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43693339|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693340|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693341|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43693342|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43693343|NCT02774876|Insulin|insulin|mesh-list
43693344|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43693345|NCT02774876|Hormones|hormones|mesh-list
43693346|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43693347|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693348|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693349|NCT02774811|Bimatoprost|bimatoprost|mesh-list
43693350|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43691485|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
43691486|NCT02787018|Hormones|hormones|mesh-ancestor
43691487|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43691488|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43691489|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691490|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43691491|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691492|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691493|NCT02787018|Analgesics|analgesics|mesh-ancestor
43691494|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
43691495|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43691496|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43691497|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43691498|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
43691499|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691500|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691501|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691503|NCT02787031|Anesthetics|anesthetics|mesh-list
43691504|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691505|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691506|NCT02786992|Misoprostol|misoprostol|mesh-list
43691507|NCT02786992|Oxytocin|oxytocin|mesh-list
43691508|NCT02786992|Carbetocin|carbetocin|mesh-list
43691537|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691538|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
43691539|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691540|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691541|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43691542|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691544|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
43691545|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
43691546|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691547|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691548|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691549|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
43693351|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43691550|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43691551|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43691552|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43691553|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691554|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691555|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
43691556|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691557|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636802|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636803|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43636804|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636805|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43636806|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43636807|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
43636808|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43636809|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43636810|NCT04766996|Analgesics|analgesics|mesh-ancestor
43636811|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636812|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43636813|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43636814|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43636815|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43636816|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636817|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
43636818|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636819|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
43636820|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43636824|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43636825|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43693352|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43693353|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
43693354|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693355|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43693356|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43693357|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
43693358|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
43693359|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693360|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693362|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43693363|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693372|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43693373|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636826|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
43636827|NCT04766996|Coagulants|coagulants|mesh-ancestor
43636828|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43636829|NCT04766996|Narcotics|narcotics|mesh-ancestor
43636830|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43636831|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43636832|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43691558|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43691559|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691561|NCT02786641|Docetaxel|docetaxel|mesh-list
43691562|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691563|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
43691564|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
43691565|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
43691566|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691567|NCT02786446|Naproxen|naproxen|mesh-list
43691568|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43691569|NCT02786446|Lidocaine|lidocaine|mesh-list
43691570|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691571|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
43693374|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
43693375|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43693376|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43693377|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43693378|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
43693379|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693380|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43693381|NCT02774460|Protective Agents|protective agents|mesh-ancestor
43693382|NCT02774499|Methadone|methadone|mesh-list
43693383|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43638771|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43638773|NCT03907475|Paclitaxel|paclitaxel|mesh-list
43638774|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43638775|NCT03907475|Carboplatin|carboplatin|mesh-list
43638776|NCT03907475|Doxorubicin|doxorubicin|mesh-list
43638777|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43638778|NCT03907475|Capecitabine|capecitabine|mesh-list
43691572|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691573|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691574|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
43691575|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691576|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43691577|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43691578|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43691579|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691580|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691581|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691582|NCT02786446|Analgesics|analgesics|mesh-ancestor
43691583|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638779|NCT03907475|Durvalumab|durvalumab|mesh-list
43638780|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
43638781|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43638782|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
43638783|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43638784|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638785|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638786|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
43638787|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
43638788|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638789|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43638790|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
43638792|NCT03907475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638793|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638794|NCT03907475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693384|NCT02774499|Narcotics|narcotics|mesh-ancestor
43693385|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693386|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693387|NCT02774499|Analgesics|analgesics|mesh-ancestor
43693388|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
43693389|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693390|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
43693391|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
43693392|NCT02774525|Ethanol|ethanol|mesh-list
43693393|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43693394|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693395|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693396|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693397|NCT02774200|Apatinib|apatinib|mesh-list
43693398|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693399|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43691584|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691585|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
43691586|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43691587|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691588|NCT02786264|Fentanyl|fentanyl|mesh-list
43691589|NCT02786264|Midazolam|midazolam|mesh-list
43691590|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
43691591|NCT02786264|Propofol|propofol|mesh-list
43691592|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43636944|NCT04739761|Trastuzumab|trastuzumab|mesh-list
43636945|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636946|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636947|NCT04738292|Fulvestrant|fulvestrant|mesh-list
43636948|NCT04738292|Onapristone|onapristone|mesh-list
43636949|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43636950|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636951|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43636952|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43636953|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
43636954|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636955|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636956|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43636957|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
43636958|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43693400|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693401|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693402|NCT02774044|Beractant|beractant|mesh-list
43693403|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
43693404|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43693405|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
43693406|NCT02774187|Leucovorin|leucovorin|mesh-list
43693407|NCT02774187|Fluorouracil|fluorouracil|mesh-list
43638798|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43638799|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43638800|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638801|NCT03901469|Talazoparib|talazoparib|mesh-list
43638802|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43638803|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638804|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693416|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693417|NCT02774187|Antidotes|antidotes|mesh-ancestor
43693418|NCT02774187|Protective Agents|protective agents|mesh-ancestor
43693419|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
43693420|NCT02774187|Vitamins|vitamins|mesh-ancestor
43693421|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
43693422|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43693423|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693424|NCT02774291|Aldesleukin|aldesleukin|mesh-list
43693425|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
43693426|NCT02774291|Fludarabine|fludarabine|mesh-list
43693427|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
43636959|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43636960|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43636969|NCT04729322|Vancomycin|vancomycin|mesh-list
43636970|NCT04729322|Neomycin|neomycin|mesh-list
43636971|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
43636972|NCT04729322|Nivolumab|nivolumab|mesh-list
43636973|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636974|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636975|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43691593|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691594|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691596|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
43691597|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
43691598|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691599|NCT02786264|Analgesics|analgesics|mesh-ancestor
43691600|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
43691601|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691602|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43691603|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43691604|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43691605|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
43691606|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691607|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691608|NCT02786264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43691609|NCT02786264|Narcotics|narcotics|mesh-ancestor
43691610|NCT02786264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43691611|NCT02786264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43691612|NCT02786264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43691613|NCT02786264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43691614|NCT02786264|GABA Modulators|gaba modulators|mesh-ancestor
43691615|NCT02786264|GABA Agents|gaba agents|mesh-ancestor
43829436|NCT05426304|S 20098|s 20098|mesh-list
43636976|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693428|NCT02774291|Interleukin-2|interleukin-2|mesh-list
43693429|NCT02774291|Lenograstim|lenograstim|mesh-list
43693430|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693431|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
43693432|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693433|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636977|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636978|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43636979|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43636980|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43636981|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43636982|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636983|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43636984|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
43636985|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43636986|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636987|NCT04714112|Dexamethasone|dexamethasone|mesh-list
43636988|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
43636996|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636997|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
43636999|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637000|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637001|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637002|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
43829438|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829440|NCT05426031|Protamines|protamines|mesh-list
43829441|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
43829442|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829443|NCT05426031|Coagulants|coagulants|mesh-ancestor
43829444|NCT05424835|Capecitabine|capecitabine|mesh-list
43829445|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43829446|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
43829447|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829448|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847181|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847196|NCT04128501|Azacitidine|azacitidine|mesh-list
43847197|NCT04128501|Venetoclax|venetoclax|mesh-list
43637003|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637004|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637005|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
43637006|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637007|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637011|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637012|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43637013|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637014|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637018|NCT04704661|Trastuzumab|trastuzumab|mesh-list
43637019|NCT04704661|Camptothecin|camptothecin|mesh-list
43637020|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
43847198|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43847199|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
43847200|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847201|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847202|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847203|NCT04128436|Progesterone|progesterone|mesh-list
43847204|NCT04128436|Progestins|progestins|mesh-ancestor
43847205|NCT04128436|Hormones|hormones|mesh-ancestor
43847207|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691651|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43637021|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637022|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637023|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637024|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43637025|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43637026|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637027|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637028|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
43637029|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637030|NCT04702893|Nintedanib|nintedanib|mesh-list
43637031|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637032|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637033|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637034|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637035|NCT04701333|Cabergoline|cabergoline|mesh-list
43637036|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43637037|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43637038|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
43637039|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
43637040|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43637041|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637042|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637043|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
43637044|NCT04700072|Lenvatinib|lenvatinib|mesh-list
43637045|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637046|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637047|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637048|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637049|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637050|NCT04697719|Aspirin|aspirin|mesh-list
43637060|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43637061|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637062|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43637063|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43637065|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
43637066|NCT04697628|Gemcitabine|gemcitabine|mesh-list
43637067|NCT04697628|Irinotecan|irinotecan|mesh-list
43637073|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
43637074|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691652|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691653|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691654|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691655|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
43691656|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43691657|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
43691658|NCT02785705|Vaccines|vaccines|mesh-list
43691659|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
43691660|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691661|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
43691662|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
43691663|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43691664|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691665|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43691666|NCT02785666|Ribavirin|ribavirin|mesh-list
43691667|NCT02785666|Grazoprevir|grazoprevir|mesh-list
43691668|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43691669|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
43691670|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693434|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43693435|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
43693436|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693437|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693438|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43693439|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43693441|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43693442|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43693443|NCT02774291|Analgesics|analgesics|mesh-ancestor
43693444|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
43693445|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693446|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43693447|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43693448|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
43693449|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693450|NCT02774096|Xenon|xenon|mesh-list
43691671|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
43691672|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691673|NCT02785614|Trazodone|trazodone|mesh-list
43691674|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43691675|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43691676|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691677|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691678|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43691679|NCT02785614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43691680|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43691681|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691682|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691683|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691684|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
43691685|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43691686|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
43691687|NCT02785653|Sevoflurane|sevoflurane|mesh-list
43691688|NCT02785653|Rocuronium|rocuronium|mesh-list
43691689|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43691690|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43691691|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
43691692|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
43691693|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691694|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691695|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43693460|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638823|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43638824|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693469|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43691696|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43691697|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43691698|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691699|NCT02785718|Hemostatics|hemostatics|mesh-list
43691700|NCT02785718|Coagulants|coagulants|mesh-ancestor
43691701|NCT02785549|Acetaminophen|acetaminophen|mesh-list
43691702|NCT02785549|Amoxicillin|amoxicillin|mesh-list
43691703|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
43691704|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
43691705|NCT02785549|Ibuprofen|ibuprofen|mesh-list
43691706|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691707|NCT02785549|Analgesics|analgesics|mesh-ancestor
43691708|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
43691709|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691710|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691711|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
43691712|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43691713|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43691714|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691716|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691717|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691718|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43691719|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691720|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43691722|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691723|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
43691724|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691725|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691739|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43691740|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
43691741|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691742|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43691743|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691744|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691745|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
43691746|NCT02785146|Antidotes|antidotes|mesh-ancestor
43691747|NCT02785146|Protective Agents|protective agents|mesh-ancestor
43691749|NCT02785146|Vitamins|vitamins|mesh-ancestor
43691750|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
43691751|NCT02785393|Doxazosin|doxazosin|mesh-list
43691752|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43691753|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43691754|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43691755|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43691756|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
43691757|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691758|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691759|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691760|NCT02785276|Ropivacaine|ropivacaine|mesh-list
43691761|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691762|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
43691763|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691764|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691765|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
43693470|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693471|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693472|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43693473|NCT02773797|Analgesics|analgesics|mesh-ancestor
43693474|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
43693475|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693476|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43693477|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43693478|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43693479|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
43693480|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693481|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693482|NCT02773875|Pancrelipase|pancrelipase|mesh-list
43693483|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693484|NCT02773927|Metformin|metformin|mesh-list
43693485|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43693486|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693524|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693526|NCT02773316|Morphine|morphine|mesh-list
43693527|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43693528|NCT02773316|Narcotics|narcotics|mesh-ancestor
43693529|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693530|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693531|NCT02773316|Analgesics|analgesics|mesh-ancestor
43693532|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
43693533|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693534|NCT02773199|Bupivacaine|bupivacaine|mesh-list
43693535|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
43693536|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
43693537|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693538|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693539|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
43829603|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829605|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43829606|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43829607|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43829608|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829609|NCT05415709|Paclitaxel|paclitaxel|mesh-list
43829610|NCT05415709|Cisplatin|cisplatin|mesh-list
43829611|NCT05415709|Carboplatin|carboplatin|mesh-list
43829612|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43829613|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43829614|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829615|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
43829616|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
43829617|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
43829618|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829619|NCT05415462|Vaccines|vaccines|mesh-list
43829620|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
43829621|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847223|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847224|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
43847225|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847226|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847227|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847228|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847229|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
43847230|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43847231|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847232|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43847233|NCT04126200|Dexamethasone|dexamethasone|mesh-list
43847234|NCT04126200|Lenalidomide|lenalidomide|mesh-list
43847235|NCT04126200|Pomalidomide|pomalidomide|mesh-list
43638825|NCT03836040|Analgesics|analgesics|mesh-ancestor
43638826|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
43638827|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847236|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847237|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
43847238|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
43847239|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847240|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847241|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43847242|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
43847243|NCT04126200|Hormones|hormones|mesh-ancestor
43847244|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43691786|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691787|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691788|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
43691789|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691790|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43691791|NCT02785055|Narcotics|narcotics|mesh-ancestor
43691792|NCT02785055|Analgesics|analgesics|mesh-ancestor
43691793|NCT02785003|Acetaminophen|acetaminophen|mesh-list
43691794|NCT02785003|Ketamine|ketamine|mesh-list
43691795|NCT02785003|Morphine|morphine|mesh-list
43691796|NCT02785003|Narcotics|narcotics|mesh-list
43691797|NCT02785003|Alvimopan|alvimopan|mesh-list
43691798|NCT02785003|Analgesics|analgesics|mesh-ancestor
43691799|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
43691800|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691801|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691802|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43691803|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43691804|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
43691805|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
43691806|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691807|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43847245|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847246|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847247|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
43847248|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43847249|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43847250|NCT04126200|Growth Substances|growth substances|mesh-ancestor
43847251|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
43847252|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
43847253|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847254|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
43847255|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847256|NCT04124432|Nicotine|nicotine|mesh-list
43847257|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43638851|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638852|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
43693575|NCT02773472|Morphine|morphine|mesh-list
43693576|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43693577|NCT02773472|Narcotics|narcotics|mesh-ancestor
43693578|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693579|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693580|NCT02773472|Analgesics|analgesics|mesh-ancestor
43693581|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
43693582|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693583|NCT02773095|Lactitol|lactitol|mesh-list
43693584|NCT02773095|Cathartics|cathartics|mesh-ancestor
43693585|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693586|NCT02772926|Benphothiamine|benphothiamine|mesh-list
43693587|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43693588|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
43693589|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693590|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
43693591|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
43693592|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693593|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
43691808|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43691809|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691810|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691811|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43691812|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691813|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
43691814|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43691815|NCT02785068|Leucovorin|leucovorin|mesh-list
43691816|NCT02785068|Fluorouracil|fluorouracil|mesh-list
43691817|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
43691818|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691819|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43691820|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691821|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691822|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
43691825|NCT02785068|Protective Agents|protective agents|mesh-ancestor
43691826|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
43691827|NCT02785068|Vitamins|vitamins|mesh-ancestor
43691828|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
43691829|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43691830|NCT02784821|Gentamicins|gentamicins|mesh-list
43691831|NCT02784821|Ampicillin|ampicillin|mesh-list
43693594|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43693599|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
43693600|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829622|NCT05414877|Phenylephrine|phenylephrine|mesh-list
43693601|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43693602|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43693603|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43693604|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
43693605|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693606|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693608|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
43693609|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
43693610|NCT02773147|Hematinics|hematinics|mesh-ancestor
43693611|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
43693612|NCT02773147|Vitamins|vitamins|mesh-ancestor
43693613|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
43693614|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693615|NCT02772822|Rituximab|rituximab|mesh-list
43693616|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43693617|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693618|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
43693619|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693620|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693621|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43693622|NCT02772640|Ezetimibe|ezetimibe|mesh-list
43693623|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43693624|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43693625|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
43693626|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693627|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43693631|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
43693632|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
43693633|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691832|NCT02784821|Cefotaxime|cefotaxime|mesh-list
43691833|NCT02784821|Cefoxitin|cefoxitin|mesh-list
43691834|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43691835|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691836|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
43691837|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43691838|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691839|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691840|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
43691841|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43691842|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
43691843|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43691844|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
43691845|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691846|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691847|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
43691848|NCT02784795|Gemcitabine|gemcitabine|mesh-list
43691849|NCT02784795|Cisplatin|cisplatin|mesh-list
43691850|NCT02784795|Carboplatin|carboplatin|mesh-list
43691851|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637075|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637076|NCT04697628|Antiviral Agents|antiviral agents|mesh-ancestor
43637091|NCT04695340|Psyllium|psyllium|mesh-list
43691861|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
43691862|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
43691863|NCT02784626|Propofol|propofol|mesh-list
43691864|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43637101|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637102|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
43637103|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43637104|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637105|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691889|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637169|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637170|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43637171|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
43637172|NCT04667663|Hormones|hormones|mesh-ancestor
43637173|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693634|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
43693635|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693636|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43693637|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
43693638|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693639|NCT02772354|Metoprolol|metoprolol|mesh-list
43693640|NCT02772354|Verapamil|verapamil|mesh-list
43693641|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43693642|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43693643|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
43693644|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
43693645|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693646|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693647|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43638890|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638891|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43638909|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43638910|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638911|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638912|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638917|NCT03699540|Ethanol|ethanol|mesh-list
43638918|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43638919|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638920|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43638921|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638922|NCT03684811|Gemcitabine|gemcitabine|mesh-list
43638923|NCT03684811|Cisplatin|cisplatin|mesh-list
43638924|NCT03684811|Nivolumab|nivolumab|mesh-list
43638925|NCT03684811|Azacitidine|azacitidine|mesh-list
43638926|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638927|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43638928|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
43638929|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638930|NCT03684811|Antiviral Agents|antiviral agents|mesh-ancestor
43638931|NCT03684811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638932|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638933|NCT03684811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638934|NCT03684811|Immunologic Factors|immunologic factors|mesh-ancestor
43638935|NCT03684811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638936|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638937|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43693666|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693667|NCT02772601|Metoprolol|metoprolol|mesh-list
43693668|NCT02772601|Midazolam|midazolam|mesh-list
43693669|NCT02772601|Caffeine|caffeine|mesh-list
43693670|NCT02772601|Omeprazole|omeprazole|mesh-list
43693671|NCT02772601|Warfarin|warfarin|mesh-list
43693672|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43693673|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43693674|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693675|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693676|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43693677|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43693678|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43693679|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43638945|NCT03678025|Flutamide|flutamide|mesh-list
43638946|NCT03678025|Nilutamide|nilutamide|mesh-list
43638947|NCT03678025|Tryptophan|tryptophan|mesh-list
43638948|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638949|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638950|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
43638951|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
43637174|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637175|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43637176|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43637177|NCT04667663|Growth Substances|growth substances|mesh-ancestor
43637178|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
43637179|NCT04665739|Everolimus|everolimus|mesh-list
43637180|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43637181|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637182|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637183|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
43637184|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637185|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637186|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43637187|NCT04664361|Niacinamide|niacinamide|mesh-list
43637189|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
43637190|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
43637191|NCT04664361|Vitamins|vitamins|mesh-ancestor
43637192|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
43691890|NCT02784743|Ivermectin|ivermectin|mesh-list
43691891|NCT02784743|Albendazole|albendazole|mesh-list
43691892|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43691893|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691894|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
43691895|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
43691896|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43691897|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43691898|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
43691899|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
43691900|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
43691901|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691902|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691904|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638952|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638953|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638954|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
43693680|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
43693681|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
43693682|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
43693683|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
43693684|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829677|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43693703|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43693704|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
43693705|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43693706|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
43691905|NCT02784561|Cytarabine|cytarabine|mesh-list
43691906|NCT02784561|Fludarabine|fludarabine|mesh-list
43691907|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
43691908|NCT02784561|Busulfan|busulfan|mesh-list
43691909|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
43691910|NCT02784561|Lenograstim|lenograstim|mesh-list
43691911|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691912|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43691913|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
43691914|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637193|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637194|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43637195|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
43637196|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637197|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43637198|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
43637199|NCT04662710|Leucovorin|leucovorin|mesh-list
43637200|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
43637201|NCT04662710|Capecitabine|capecitabine|mesh-list
43637202|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
43637203|NCT04662710|Lenvatinib|lenvatinib|mesh-list
43637204|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
43637205|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637206|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637207|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43637208|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
43637210|NCT04662710|Antidotes|antidotes|mesh-ancestor
43637251|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
43637252|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43637338|NCT04616924|Clarithromycin|clarithromycin|mesh-list
43637339|NCT04616924|Rifabutin|rifabutin|mesh-list
43637340|NCT04616924|Clofazimine|clofazimine|mesh-list
43637341|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43637342|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637343|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43637344|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637345|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637346|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43637347|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43637348|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43637349|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
43637350|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43637351|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
43637352|NCT04616534|Gemcitabine|gemcitabine|mesh-list
43637353|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43637354|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
43637355|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637356|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637357|NCT04616534|Antiviral Agents|antiviral agents|mesh-ancestor
43637358|NCT04616534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637359|NCT04616534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637360|NCT04616534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637361|NCT04616534|Immunologic Factors|immunologic factors|mesh-ancestor
43637362|NCT04616534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693707|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693708|NCT02772107|Temozolomide|temozolomide|mesh-list
43693726|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43693727|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43693728|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
43693729|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
43693730|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693731|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43693732|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43693733|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693734|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693735|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43693736|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693737|NCT02772211|Renal Agents|renal agents|mesh-ancestor
43693738|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43693739|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
43693740|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43693741|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
43637363|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
43637364|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43637365|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637366|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637367|NCT04609020|Lidocaine|lidocaine|mesh-list
43637368|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
43637369|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
43637370|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43637371|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637373|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637374|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43637375|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43637376|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43637377|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691925|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
43693742|NCT02772120|Progesterone|progesterone|mesh-list
43693745|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693746|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693747|NCT02772029|Apatinib|apatinib|mesh-list
43693748|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693749|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43693750|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693751|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693753|NCT02771925|Analgesics|analgesics|mesh-ancestor
43638962|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
43638963|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
43638964|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
43638965|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43638966|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
43638967|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43638968|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43638969|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
43638970|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43638971|NCT03661320|Gemcitabine|gemcitabine|mesh-list
43638972|NCT03661320|Cisplatin|cisplatin|mesh-list
43638973|NCT03661320|Nivolumab|nivolumab|mesh-list
43638974|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638985|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43693758|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43693759|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43693760|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693761|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43693762|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43693763|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43693764|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693765|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693766|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
43693767|NCT02771860|Denosumab|denosumab|mesh-list
43693768|NCT02771860|Calcium|calcium|mesh-list
43693769|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43693770|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693771|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43693772|NCT02771782|Vaccines|vaccines|mesh-list
43693773|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
43693774|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
43693775|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693776|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43693777|NCT02771795|Trastuzumab|trastuzumab|mesh-list
43693788|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
43691926|NCT02784340|Bupivacaine|bupivacaine|mesh-list
43691927|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43691928|NCT02784340|BB 1101|bb 1101|mesh-list
43691929|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43691930|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
43691931|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
43691932|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691933|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691934|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693789|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693790|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693798|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43693799|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693800|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693801|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43693802|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
43693804|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43693805|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43693806|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43693807|NCT02771457|Infliximab|infliximab|mesh-list
43693808|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
43693809|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693810|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693811|NCT02771392|Tetracaine|tetracaine|mesh-list
43829636|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43829637|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43829638|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
43829639|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829640|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829641|NCT05414877|Protective Agents|protective agents|mesh-ancestor
43829642|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43829643|NCT05414838|Vitamin D|vitamin d|mesh-list
43829644|NCT05414838|Curcumin|curcumin|mesh-list
43829645|NCT05414838|Vitamins|vitamins|mesh-ancestor
43829646|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
43829647|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829648|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43829649|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43829650|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43829651|NCT05414838|Analgesics|analgesics|mesh-ancestor
43829652|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
43693827|NCT02771587|Ethanol|ethanol|mesh-list
43693828|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43693829|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693830|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693831|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693832|NCT02771704|Iodine|iodine|mesh-list
43693833|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
43693834|NCT02771704|Fluorides|fluorides|mesh-list
43693835|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
43693863|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693864|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43693865|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43693866|NCT02771743|Analgesics|analgesics|mesh-ancestor
43693867|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
43693868|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693869|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
43693870|NCT02771418|Anesthetics|anesthetics|mesh-list
43693871|NCT02771418|Propofol|propofol|mesh-list
43693872|NCT02771418|Sevoflurane|sevoflurane|mesh-list
43693873|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693874|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693875|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43693876|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43693877|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
43693878|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43693879|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43693880|NCT02771600|Anesthetics|anesthetics|mesh-list
43693881|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
43691935|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
43691936|NCT02784340|Hormones|hormones|mesh-ancestor
43691937|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43691938|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43691939|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691940|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
43691941|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691942|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691943|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691944|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
43691945|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691946|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
43829449|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43829450|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43829451|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829452|NCT05422092|Pioglitazone|pioglitazone|mesh-list
43829453|NCT05422092|Canagliflozin|canagliflozin|mesh-list
43829454|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43829455|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829456|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43829457|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637378|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637379|NCT04604704|Niacinamide|niacinamide|mesh-list
43637380|NCT04604704|Naltrexone|naltrexone|mesh-list
43637381|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43693882|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693883|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693884|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
43637382|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43637383|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637384|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
43637385|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637386|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
43637388|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
43637389|NCT04603911|Dexamethasone|dexamethasone|mesh-list
43637390|NCT04603911|Clonidine|clonidine|mesh-list
43637391|NCT04603911|Epinephrine|epinephrine|mesh-list
43637392|NCT04603911|Bupivacaine|bupivacaine|mesh-list
43637393|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43637394|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
43637395|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
43693919|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693920|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693921|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43693922|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43693923|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43693924|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43693925|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
43693926|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693927|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693928|NCT02770885|Dulaglutide|dulaglutide|mesh-list
43693929|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43693930|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693931|NCT02770651|Everolimus|everolimus|mesh-list
43693932|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693933|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693934|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
43693935|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693936|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
43693937|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43693938|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43693939|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693963|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693964|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43693965|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43693966|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43693967|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43639001|NCT03649724|Leuprolide|leuprolide|mesh-list
43639002|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43639003|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
43639004|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43639005|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639006|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43639007|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639008|NCT03646604|Upadacitinib|upadacitinib|mesh-list
43639009|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43639010|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43639012|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639013|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639014|NCT03641560|Androgens|androgens|mesh-list
43639015|NCT03641560|Hormones|hormones|mesh-ancestor
43639016|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639017|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637396|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637397|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637398|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43637399|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
43637400|NCT04603911|Hormones|hormones|mesh-ancestor
43637401|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637402|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637403|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693968|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693969|NCT02770404|Nafithromycin|nafithromycin|mesh-list
43693970|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43693971|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693972|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43693973|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693974|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693975|NCT02770508|Ritonavir|ritonavir|mesh-list
43693976|NCT02770508|Darunavir|darunavir|mesh-list
43693977|NCT02770508|Tenofovir|tenofovir|mesh-list
43693978|NCT02770508|Lamivudine|lamivudine|mesh-list
43693979|NCT02770508|Emtricitabine|emtricitabine|mesh-list
43639047|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43639048|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639050|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43639051|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43639052|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43639053|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
43639054|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639055|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639056|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639057|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
43639058|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
43639059|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639060|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43639061|NCT03618537|Dexamethasone|dexamethasone|mesh-list
43639062|NCT03618537|Ixazomib|ixazomib|mesh-list
43693995|NCT02770378|Minocycline|minocycline|mesh-list
43693997|NCT02770378|Temozolomide|temozolomide|mesh-list
43693998|NCT02770378|Auranofin|auranofin|mesh-list
43693999|NCT02770378|Captopril|captopril|mesh-list
43694000|NCT02770378|Disulfiram|disulfiram|mesh-list
43694001|NCT02770378|Aprepitant|aprepitant|mesh-list
43694002|NCT02770378|Sertraline|sertraline|mesh-list
43694003|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43694004|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43694005|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
43694006|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694007|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694008|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43694009|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43639066|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639067|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639068|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43639069|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
43639070|NCT03618537|Hormones|hormones|mesh-ancestor
43639071|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639072|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43639073|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639074|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
43639075|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639076|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639077|NCT03605901|Methadone|methadone|mesh-list
43639078|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43639079|NCT03605901|Narcotics|narcotics|mesh-ancestor
43694010|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
43694011|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694012|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43694013|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43637407|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
43637408|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43637409|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43637410|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
43637411|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43637412|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637413|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43637414|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43637415|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43637416|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
43694014|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43694015|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
43694016|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694017|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43694018|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694019|NCT02770378|Analgesics|analgesics|mesh-ancestor
43694020|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
43694060|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43694063|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
43694064|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694065|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694066|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694067|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
43694068|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694069|NCT02770274|Aspirin|aspirin|mesh-list
43694070|NCT02770274|Cilostazol|cilostazol|mesh-list
43694071|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43694072|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694073|NCT02770274|Analgesics|analgesics|mesh-ancestor
43639080|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43639081|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639082|NCT03605901|Analgesics|analgesics|mesh-ancestor
43694075|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694076|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694077|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694078|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694079|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43694080|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43694081|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694082|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43694083|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43694084|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694085|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
43694086|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43694087|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
43694088|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43694089|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
43694090|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
43694091|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43694092|NCT02770274|Protective Agents|protective agents|mesh-ancestor
43639099|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43639100|NCT03597581|Growth Substances|growth substances|mesh-ancestor
43639101|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639102|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
43639103|NCT03587662|Gemcitabine|gemcitabine|mesh-list
43639104|NCT03587662|Doxorubicin|doxorubicin|mesh-list
43639105|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43639106|NCT03587662|Daunorubicin|daunorubicin|mesh-list
43639108|NCT03587662|Glycine|glycine|mesh-list
43639109|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43639110|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
43639111|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639112|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639113|NCT03587662|Antiviral Agents|antiviral agents|mesh-ancestor
43639114|NCT03587662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639115|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639116|NCT03587662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639117|NCT03587662|Immunologic Factors|immunologic factors|mesh-ancestor
43639118|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639119|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43639120|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43639121|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43639122|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
43639123|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
43639161|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829683|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43829684|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829685|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829686|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
43829687|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43829688|NCT05413122|Nicotine|nicotine|mesh-list
43829689|NCT05413122|Varenicline|varenicline|mesh-list
43829690|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43829691|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
43829692|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829693|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829694|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43829695|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43829696|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
43829697|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829698|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829699|NCT05412875|Nicotine|nicotine|mesh-list
43829700|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43829701|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
43639172|NCT03519256|Nivolumab|nivolumab|mesh-list
43639173|NCT03519256|Linrodostat|linrodostat|mesh-list
43639174|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639175|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639176|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43639177|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639178|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639179|NCT03504644|Vincristine|vincristine|mesh-list
43639180|NCT03504644|Venetoclax|venetoclax|mesh-list
43639181|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43639182|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639183|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
43639184|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
43639185|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
43639186|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639187|NCT03485209|Cisplatin|cisplatin|mesh-list
43639188|NCT03485209|Carboplatin|carboplatin|mesh-list
43639189|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
43639190|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
43639191|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639192|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639194|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
43639195|NCT03478865|Vitamins|vitamins|mesh-ancestor
43639196|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
43639197|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639198|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
43691947|NCT02784327|Ropivacaine|ropivacaine|mesh-list
43691948|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691949|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
43691950|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691951|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691952|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
43691953|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691954|NCT02784223|Choline|choline|mesh-list
43691955|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
43639199|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639200|NCT03478865|Protective Agents|protective agents|mesh-ancestor
43694173|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
43694174|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694175|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694176|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694177|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694178|NCT02769494|Riboflavin|riboflavin|mesh-list
43694179|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
43694180|NCT02769494|Mesalamine|mesalamine|mesh-list
43694181|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
43694182|NCT02769494|Vitamins|vitamins|mesh-ancestor
43694183|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
43694184|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694186|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
43694187|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43694188|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694189|NCT02769494|Analgesics|analgesics|mesh-ancestor
43694202|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694203|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43694204|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694205|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694206|NCT02769325|Ketorolac|ketorolac|mesh-list
43694207|NCT02769325|Atropine|atropine|mesh-list
43694208|NCT02769325|Morphine|morphine|mesh-list
43639206|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43639207|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43639208|NCT03472092|Analgesics|analgesics|mesh-ancestor
43639209|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
43639210|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639211|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639212|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43639213|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43639214|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43639215|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639216|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
43639217|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639218|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
43639219|NCT03456843|Docetaxel|docetaxel|mesh-list
43639220|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
43639221|NCT03456843|Hormones|hormones|mesh-list
43639222|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43639223|NCT03456843|Androgens|androgens|mesh-list
43639224|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
43639225|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639226|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
43639227|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
43639228|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
43639229|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639230|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639231|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639233|NCT03456843|Protective Agents|protective agents|mesh-ancestor
43639234|NCT03456843|Vitamins|vitamins|mesh-ancestor
43691956|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43691957|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
43691958|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691966|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691967|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43691968|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43691969|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43691970|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
43691971|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691972|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691973|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
43691975|NCT02784054|Thiotepa|thiotepa|mesh-list
43691976|NCT02784054|Carboplatin|carboplatin|mesh-list
43691977|NCT02784054|Etoposide|etoposide|mesh-list
43691978|NCT02784054|Bleomycin|bleomycin|mesh-list
43691979|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43691980|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
43691981|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637417|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
43637418|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
43637419|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43637420|NCT04603911|Analgesics|analgesics|mesh-ancestor
43637421|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43637422|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
43637423|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43694210|NCT02769325|Sevoflurane|sevoflurane|mesh-list
43694211|NCT02769325|Rocuronium|rocuronium|mesh-list
43694212|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43694213|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694214|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694215|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43694216|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
43694217|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
43694218|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43694219|NCT02769325|Narcotics|narcotics|mesh-ancestor
43694220|NCT02769325|Analgesics|analgesics|mesh-ancestor
43694221|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
43694222|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694223|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43694224|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43694225|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43694235|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43694236|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43694237|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43694238|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
43694239|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43694240|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
43694241|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
43694242|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
43694243|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43694244|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43637424|NCT04591431|Nivolumab|nivolumab|mesh-list
43637425|NCT04591431|Trastuzumab|trastuzumab|mesh-list
43637426|NCT04591431|Ipilimumab|ipilimumab|mesh-list
43637427|NCT04591431|Pertuzumab|pertuzumab|mesh-list
43637428|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43637429|NCT04591431|Everolimus|everolimus|mesh-list
43637430|NCT04591431|Atezolizumab|atezolizumab|mesh-list
43637431|NCT04591431|Lapatinib|lapatinib|mesh-list
43637432|NCT04591431|Palbociclib|palbociclib|mesh-list
43637433|NCT04591431|Vemurafenib|vemurafenib|mesh-list
43637434|NCT04591431|Maytansine|maytansine|mesh-list
43637435|NCT04591431|Ponatinib|ponatinib|mesh-list
43637436|NCT04591431|Entrectinib|entrectinib|mesh-list
43637437|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637438|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637439|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43694245|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
43694246|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694247|NCT02769390|Clonidine|clonidine|mesh-list
43694248|NCT02769390|Diazepam|diazepam|mesh-list
43694249|NCT02769390|Analgesics|analgesics|mesh-ancestor
43694250|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
43694251|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694252|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694253|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43694254|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
43694255|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
43694256|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43694257|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43694258|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43639249|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639250|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43639251|NCT03429543|Empagliflozin|empagliflozin|mesh-list
43639252|NCT03429543|Linagliptin|linagliptin|mesh-list
43694273|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43694274|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
43694275|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
43694276|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
43694277|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
43694278|NCT02769286|Osimertinib|osimertinib|mesh-list
43694279|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694280|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43694281|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694282|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694283|NCT02769130|Losartan|losartan|mesh-list
43694284|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43694285|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43694286|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43694287|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43694288|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694289|NCT02769104|Docetaxel|docetaxel|mesh-list
43694290|NCT02769104|Letrozole|letrozole|mesh-list
43694291|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43694292|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694293|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
43694294|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
43694295|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
43639298|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639299|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639300|NCT03418961|Carvedilol|carvedilol|mesh-list
43639301|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43639302|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43639303|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
43637440|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637441|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637442|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
43637443|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637444|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637445|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637446|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637462|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
43637463|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637464|NCT04584853|Tamoxifen|tamoxifen|mesh-list
43637465|NCT04584853|Letrozole|letrozole|mesh-list
43637466|NCT04584853|Anastrozole|anastrozole|mesh-list
43637467|NCT04584853|Exemestane|exemestane|mesh-list
43637468|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637469|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43637470|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43637471|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639304|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639305|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639306|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639309|NCT03418961|Protective Agents|protective agents|mesh-ancestor
43639310|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43639311|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43639312|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43639313|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
43639314|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43694392|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694393|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43694394|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43694395|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43637472|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637473|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43637474|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
43637475|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637476|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637477|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637478|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43691982|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43691983|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43691984|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
43694396|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694397|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694398|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694399|NCT02768493|Ropivacaine|ropivacaine|mesh-list
43694400|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
43694401|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
43694402|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694403|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694404|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
43694405|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694406|NCT02768415|Apatinib|apatinib|mesh-list
43694407|NCT02768415|Vinorelbine|vinorelbine|mesh-list
43694408|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694409|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43694410|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829722|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43829723|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
43829724|NCT05411159|Anesthetics|anesthetics|mesh-list
43829725|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829726|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829727|NCT05411159|Narcotics|narcotics|mesh-ancestor
43829728|NCT05411159|Analgesics|analgesics|mesh-ancestor
43829729|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
43829730|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829731|NCT05411107|Iloprost|iloprost|mesh-list
43829732|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43829733|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
43829734|NCT05410860|Etripamil|etripamil|mesh-list
43829735|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43829737|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829739|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829740|NCT05410301|Bevacizumab|bevacizumab|mesh-list
43829741|NCT05410301|Lomustine|lomustine|mesh-list
43829742|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43829743|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829744|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43829745|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43829746|NCT05410301|Growth Substances|growth substances|mesh-ancestor
43829747|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829748|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
43829749|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43829750|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
43829751|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829752|NCT05408559|Sulforaphane|sulforaphane|mesh-list
43639451|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639453|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43639454|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
43639457|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43639458|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639459|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
43639460|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
43691985|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691986|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691987|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43691988|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43691989|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43691990|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43691991|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43691992|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43691994|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
43691995|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691996|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
43639461|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639462|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43639463|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
43639464|NCT03252600|Hormones|hormones|mesh-ancestor
43639465|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639466|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43694634|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
43694635|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694636|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43694637|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43694638|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694639|NCT02767401|Aspirin|aspirin|mesh-list
43694640|NCT02767401|Metoprolol|metoprolol|mesh-list
43694641|NCT02767401|Clopidogrel|clopidogrel|mesh-list
43694642|NCT02767401|Ticagrelor|ticagrelor|mesh-list
43694643|NCT02767401|Atorvastatin|atorvastatin|mesh-list
43694644|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43694649|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639467|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43639468|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43639469|NCT03252600|Growth Substances|growth substances|mesh-ancestor
43639470|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
43639471|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
43639472|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639473|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
43639474|NCT03244020|Aspirin|aspirin|mesh-list
43639475|NCT03244020|Enoxaparin|enoxaparin|mesh-list
43639482|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639484|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43639485|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43639486|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639487|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43639488|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43639489|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639490|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
43639491|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
43639492|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
43639493|NCT03233724|Decitabine|decitabine|mesh-list
43639494|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
43639495|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639496|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639497|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43639498|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
43639499|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639500|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639501|NCT03232424|Temozolomide|temozolomide|mesh-list
43639502|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43639503|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
43639504|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639505|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639506|NCT03215095|Durvalumab|durvalumab|mesh-list
43694650|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691997|NCT02783924|Vitamin D|vitamin d|mesh-list
43691998|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43691999|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692000|NCT02783924|Vitamins|vitamins|mesh-ancestor
43692001|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
43637479|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43637480|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43637502|NCT04570956|Tamoxifen|tamoxifen|mesh-list
43637503|NCT04570956|Afimoxifene|afimoxifene|mesh-list
43637504|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43637505|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
43637506|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637507|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637508|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637509|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637510|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43637511|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43637512|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43637517|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43637518|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637519|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707175|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694651|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694652|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694653|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43694654|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43694655|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694656|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43694657|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43694658|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694659|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
43694660|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43694661|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43694662|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
43694663|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43694664|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43694665|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43639507|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639508|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639510|NCT03214510|Hydromorphone|hydromorphone|mesh-list
43639511|NCT03214510|Bupivacaine|bupivacaine|mesh-list
43639512|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
43639513|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
43639514|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43639515|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639516|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
43639517|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639518|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43639519|NCT03214510|Narcotics|narcotics|mesh-ancestor
43639520|NCT03214510|Analgesics|analgesics|mesh-ancestor
43639521|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43637520|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637521|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637522|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637523|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637524|NCT04549051|Anesthetics|anesthetics|mesh-list
43637525|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
43637526|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43637527|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637528|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
43637529|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692002|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43692003|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
43692004|NCT02784015|Melphalan|melphalan|mesh-list
43692005|NCT02784015|Ifosfamide|ifosfamide|mesh-list
43692006|NCT02784015|Thiotepa|thiotepa|mesh-list
43692007|NCT02784015|Cisplatin|cisplatin|mesh-list
43692008|NCT02784015|Carboplatin|carboplatin|mesh-list
43639522|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43639523|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
43639524|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
43830586|NCT05354999|Caffeine|caffeine|mesh-list
43639553|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639555|NCT03192397|Sirolimus|sirolimus|mesh-list
43694666|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43694667|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43694668|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
43694669|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694670|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43694671|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43694672|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
43694673|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
43694674|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43694675|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43694676|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43694677|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694678|NCT02767154|Mannitol|mannitol|mesh-list
43694679|NCT02767154|Dextrans|dextrans|mesh-list
43694680|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43694681|NCT02767154|Diuretics|diuretics|mesh-ancestor
43694682|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
43694683|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694684|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
43694685|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
43694686|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
43694687|NCT02767102|Melatonin|melatonin|mesh-list
43694699|NCT02767479|Rabeprazole|rabeprazole|mesh-list
43694700|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43694701|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694702|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43694703|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694704|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694705|NCT02767089|Prednisone|prednisone|mesh-list
43694706|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694707|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
43694708|NCT02767089|Hormones|hormones|mesh-ancestor
43692009|NCT02784015|Doxorubicin|doxorubicin|mesh-list
43692010|NCT02784015|Etoposide|etoposide|mesh-list
43692011|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692013|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692015|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43692016|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
43692017|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692018|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692019|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43692020|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43692021|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43692022|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43692023|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692024|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43692025|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
43692026|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43692027|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
43692028|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692029|NCT02783989|Protective Agents|protective agents|mesh-ancestor
43692030|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692031|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
43692032|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
43692033|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692034|NCT02783937|Lenograstim|lenograstim|mesh-list
43692035|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43692036|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
43692043|NCT02783846|Analgesics|analgesics|mesh-ancestor
43692044|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
43692045|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692046|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43692047|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43829758|NCT05408026|Bortezomib|bortezomib|mesh-list
43700116|NCT02733458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639601|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
43694782|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694784|NCT02766803|Protective Agents|protective agents|mesh-ancestor
43694785|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694786|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43694787|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
43694788|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
43694789|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43694790|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43694791|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692048|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43692049|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
43692050|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692051|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692052|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
43692053|NCT02783378|Antacids|antacids|mesh-ancestor
43692054|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692055|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692056|NCT02783586|Bupivacaine|bupivacaine|mesh-list
43692057|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
43692058|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
43692059|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43637537|NCT04542070|Rilpivirine|rilpivirine|mesh-list
43637538|NCT04542070|Cabotegravir|cabotegravir|mesh-list
43637539|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43637540|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43637541|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637542|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637543|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
43637544|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694792|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694793|NCT02766725|Urological Agents|urological agents|mesh-ancestor
43694794|NCT02766647|Lenograstim|lenograstim|mesh-list
43694796|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
43639645|NCT03126968|Epinephrine|epinephrine|mesh-list
43639646|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43639647|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43639648|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
43639661|NCT03110562|Dexamethasone|dexamethasone|mesh-list
43639662|NCT03110562|Bortezomib|bortezomib|mesh-list
43639663|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639664|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
43639665|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
43639666|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639667|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639668|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43639669|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
43639670|NCT03110562|Hormones|hormones|mesh-ancestor
43639671|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639672|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43694952|NCT02765217|Amoxicillin|amoxicillin|mesh-list
43694953|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
43694954|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
43694955|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43694956|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43694957|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694958|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694959|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694960|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43694961|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
43637545|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43637546|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43637547|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43637548|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43637549|NCT04540211|Paclitaxel|paclitaxel|mesh-list
43637550|NCT04540211|Cisplatin|cisplatin|mesh-list
43637551|NCT04540211|Atezolizumab|atezolizumab|mesh-list
43637552|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43637553|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637554|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637555|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
43637556|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
43637557|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
43637558|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694962|NCT02765204|Saxagliptin|saxagliptin|mesh-list
43694965|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43694966|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694967|NCT02765204|Incretins|incretins|mesh-ancestor
43694968|NCT02765204|Hormones|hormones|mesh-ancestor
43694969|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694970|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43694971|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
43694972|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694973|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43694974|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43694976|NCT02765022|Hormones|hormones|mesh-ancestor
43694977|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694978|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694979|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639742|NCT03029351|Exenatide|exenatide|mesh-list
43639743|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43639744|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639745|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43639746|NCT03029351|Incretins|incretins|mesh-ancestor
43639747|NCT03029351|Hormones|hormones|mesh-ancestor
43639748|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639749|NCT03027388|LB100|lb100|mesh-list
43639750|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639751|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639752|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639753|NCT03026140|Celecoxib|celecoxib|mesh-list
43639754|NCT03026140|Nivolumab|nivolumab|mesh-list
43639755|NCT03026140|Ipilimumab|ipilimumab|mesh-list
43639756|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639757|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639758|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43639759|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639760|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43639761|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43639762|NCT03026140|Analgesics|analgesics|mesh-ancestor
43639775|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694983|NCT02765009|Bumetanide|bumetanide|mesh-list
43694984|NCT02765009|Diuretics|diuretics|mesh-list
43694985|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43694986|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
43694987|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694988|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43694989|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43694990|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694991|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43637559|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
43637560|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637561|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
43637562|NCT04539366|Fludarabine|fludarabine|mesh-list
43637563|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
43637564|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
43637565|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637566|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637567|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637568|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43637569|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
43637570|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637571|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692060|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692061|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
43692062|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692063|NCT02783638|Pregabalin|pregabalin|mesh-list
43692064|NCT02783638|Analgesics|analgesics|mesh-ancestor
43692065|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
43692066|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692067|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692068|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
43692069|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43692070|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43692071|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692072|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43692073|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43692074|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43692075|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694992|NCT02765126|Vaccines|vaccines|mesh-list
43694993|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
43694994|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694995|NCT02764619|Spironolactone|spironolactone|mesh-list
43694996|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43829846|NCT05404906|Azacitidine|azacitidine|mesh-list
43829847|NCT05404906|Venetoclax|venetoclax|mesh-list
43829848|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43829849|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
43829850|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829851|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829852|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847258|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
43637572|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43637573|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43637574|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
43637575|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
43637577|NCT04535401|Folic Acid|folic acid|mesh-list
43637578|NCT04535401|Fluorouracil|fluorouracil|mesh-list
43637579|NCT04535401|Irinotecan|irinotecan|mesh-list
43637580|NCT04535401|Camptothecin|camptothecin|mesh-list
43637581|NCT04535401|Calcium|calcium|mesh-list
43637582|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
43637583|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43637584|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707177|NCT02702622|Beta Carotene|beta carotene|mesh-list
43695051|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43695052|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695053|NCT02764125|Levodopa|levodopa|mesh-list
43695054|NCT02764125|Carbidopa|carbidopa|mesh-list
43695055|NCT02764125|Entacapone|entacapone|mesh-list
43695056|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43695057|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43695058|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
43639841|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
43639842|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
43639843|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
43639844|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639845|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639846|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
43639847|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639848|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639849|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43639850|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
43639851|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43639852|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43639853|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43639854|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43639855|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639856|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639857|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43639858|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
43639859|NCT02957097|Gabapentin|gabapentin|mesh-list
43639860|NCT02957097|Analgesics|analgesics|mesh-ancestor
43639861|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
43639862|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639863|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639864|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
43695059|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695122|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695123|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43695169|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43695170|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43695171|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
43695172|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695173|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43695174|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43695175|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
43695176|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
43695177|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639865|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43639866|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43639867|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43639868|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43639869|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43639870|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43637585|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43637586|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
43637591|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
43637592|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43637593|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43637594|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637595|NCT04535401|Antidotes|antidotes|mesh-ancestor
43637596|NCT04535401|Protective Agents|protective agents|mesh-ancestor
43637598|NCT04535401|Vitamins|vitamins|mesh-ancestor
43637599|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
43637600|NCT04535401|Hematinics|hematinics|mesh-ancestor
43637601|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637602|NCT04532645|Olaparib|olaparib|mesh-list
43637603|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43637604|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637605|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637606|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637607|NCT04529772|Prednisone|prednisone|mesh-list
43637608|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
43637609|NCT04529772|Rituximab|rituximab|mesh-list
43637610|NCT04529772|Doxorubicin|doxorubicin|mesh-list
43637611|NCT04529772|Vincristine|vincristine|mesh-list
43637612|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
43637613|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637614|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
43637615|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637616|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692076|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43692141|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692142|NCT02783196|Incretins|incretins|mesh-ancestor
43692143|NCT02783196|Hormones|hormones|mesh-ancestor
43692144|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692145|NCT02783222|Paclitaxel|paclitaxel|mesh-list
43692146|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43692147|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692148|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
43692149|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
43692150|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
43692151|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692152|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43637617|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43637618|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
43637619|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637620|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637621|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43637622|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637623|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43637624|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43637625|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43692155|NCT02782897|Antibodies|antibodies|mesh-list
43692156|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
43692157|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692159|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43692160|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692161|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43692162|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692163|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
43692164|NCT02782754|Carboplatin|carboplatin|mesh-list
43692165|NCT02782754|Etoposide|etoposide|mesh-list
43692166|NCT02782754|Bleomycin|bleomycin|mesh-list
43692167|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692168|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
43692169|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692170|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692171|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43692172|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
43692173|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692174|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692175|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43692176|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43692177|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43692178|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43692179|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692180|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43692181|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
43692182|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
43692183|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43692184|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43637653|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
43637654|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43637655|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43637656|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43637657|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43637660|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637661|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637662|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
43637663|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43637664|NCT04514302|Antibodies|antibodies|mesh-list
43637665|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
43637666|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637667|NCT04511013|Nivolumab|nivolumab|mesh-list
43637668|NCT04511013|Ipilimumab|ipilimumab|mesh-list
43637669|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637670|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637671|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43637673|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
43637674|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
43637675|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637676|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
43637677|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43637679|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
43637680|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
43637681|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637682|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637683|NCT04509674|Empagliflozin|empagliflozin|mesh-list
43637684|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43639871|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639891|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43639892|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
43639893|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43695300|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695301|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
43695302|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695303|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43695304|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43695305|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43695306|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43637685|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637686|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43637687|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637701|NCT04494412|Zanamivir|zanamivir|mesh-list
43637702|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
43637703|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637704|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637705|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637706|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
43695307|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829854|NCT05401916|Ibuprofen|ibuprofen|mesh-list
43829855|NCT05401916|Tramadol|tramadol|mesh-list
43829856|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43829857|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43829858|NCT05401916|Analgesics|analgesics|mesh-ancestor
43829859|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
43829860|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829861|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829862|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829863|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829864|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43829865|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637707|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43637708|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
43637709|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637710|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637711|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43637712|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
43637713|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43637714|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
43637715|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637716|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43637717|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43637718|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
43637719|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
43637720|NCT04476992|Protective Agents|protective agents|mesh-ancestor
43637723|NCT04471597|Bupivacaine|bupivacaine|mesh-list
43637724|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
43637725|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
43637726|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43637727|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637728|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
43637729|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43637730|NCT04460560|Terlipressin|terlipressin|mesh-list
43637731|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43637732|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43637733|NCT04447716|Rituximab|rituximab|mesh-list
43637771|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43637772|NCT04447027|Growth Substances|growth substances|mesh-ancestor
43637773|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
43637774|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43829866|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829867|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
43829868|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43829869|NCT05401916|Narcotics|narcotics|mesh-ancestor
43829870|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829871|NCT05401357|Bimatoprost|bimatoprost|mesh-list
43639909|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43639919|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639920|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639921|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639923|NCT02941926|Leuprolide|leuprolide|mesh-list
43639924|NCT02941926|Goserelin|goserelin|mesh-list
43639925|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639926|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43639927|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43639928|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639929|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639930|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43695334|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43695335|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
43695345|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695346|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
43695347|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
43695348|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
43695349|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695350|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43695351|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
43695352|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695353|NCT02762448|Asunaprevir|asunaprevir|mesh-list
43695354|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
43695355|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695356|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695357|NCT02762253|Riboflavin|riboflavin|mesh-list
43695358|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
43695359|NCT02762253|Vitamins|vitamins|mesh-ancestor
43695360|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
43695361|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695362|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43695363|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695364|NCT02762006|Durvalumab|durvalumab|mesh-list
43695365|NCT02762006|Tremelimumab|tremelimumab|mesh-list
43695366|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43695367|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695369|NCT02762123|Digoxin|digoxin|mesh-list
43639933|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639934|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43695370|NCT02762123|Midazolam|midazolam|mesh-list
43695371|NCT02762123|Omeprazole|omeprazole|mesh-list
43695372|NCT02762123|Montelukast|montelukast|mesh-list
43695373|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43695374|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43695375|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695376|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695377|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43695378|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43695379|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43695380|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43695381|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
43695382|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
43695383|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
43695384|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
43695385|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695386|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695387|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43695388|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695389|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43637775|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
43637776|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637777|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637778|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43695390|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695391|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43695392|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
43695393|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43695394|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639935|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
43639936|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43639937|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43639938|NCT02938520|Rilpivirine|rilpivirine|mesh-list
43695455|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
43695456|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43695457|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
43639970|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639971|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43639972|NCT02923128|Narcotics|narcotics|mesh-ancestor
43639973|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43640108|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43640109|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43640110|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
43640111|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640112|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43640113|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
43640114|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
43640115|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
43640116|NCT02865551|Anesthetics|anesthetics|mesh-list
43640117|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43640118|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640119|NCT02853500|Doxorubicin|doxorubicin|mesh-list
43640120|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640121|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695512|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
43700231|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43695563|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
43695564|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
43695565|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43695566|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695567|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
43695568|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
43695569|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695570|NCT02760823|Protective Agents|protective agents|mesh-ancestor
43695571|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695572|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
43695573|NCT02760823|Vitamins|vitamins|mesh-ancestor
43695574|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
43695575|NCT02760420|Amoxicillin|amoxicillin|mesh-list
43695576|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43695577|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695578|NCT02760342|Metformin|metformin|mesh-list
43695579|NCT02760342|Peficitinib|peficitinib|mesh-list
43695607|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43695608|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43695609|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43695610|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43695611|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695612|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43695615|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43695616|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43695617|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43695618|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
43637791|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
43637792|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43637817|NCT04428151|Docetaxel|docetaxel|mesh-list
43637818|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
43637819|NCT04428151|Capecitabine|capecitabine|mesh-list
43637820|NCT04428151|Cetuximab|cetuximab|mesh-list
43637822|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637824|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
43637825|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
43637826|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
43637827|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637828|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637829|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43637830|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
43637831|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637832|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637833|NCT04419272|Methylphenidate|methylphenidate|mesh-list
43637834|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43637835|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637836|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43637837|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43637838|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43637839|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637840|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
43637841|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43637842|NCT04417621|Trametinib|trametinib|mesh-list
43637849|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43637850|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43637851|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695619|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
43695620|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
43640234|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
43695650|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
43695652|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695653|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695654|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43637852|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43637853|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637854|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
43637856|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43637857|NCT04404283|Lenalidomide|lenalidomide|mesh-list
43637858|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637859|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637860|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
43695655|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695656|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
43640252|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640253|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640254|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640255|NCT02621021|Aldesleukin|aldesleukin|mesh-list
43640256|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
43640257|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
43640258|NCT02621021|Fludarabine|fludarabine|mesh-list
43640259|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640260|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
43640261|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640262|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640263|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43640264|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
43640279|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
43640280|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640281|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43640282|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43640283|NCT02576912|Analgesics|analgesics|mesh-ancestor
43640284|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
43640285|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640286|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43695657|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
43695658|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695659|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695660|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43695661|NCT02760316|Protective Agents|protective agents|mesh-ancestor
43695662|NCT02760472|SMOFlipid|smoflipid|mesh-list
43695663|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43695664|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43695665|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43695666|NCT02760381|Acetic Acid|acetic acid|mesh-list
43695667|NCT02760381|Retinol acetate|retinol acetate|mesh-list
43695668|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43695669|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695670|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43695671|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
43695672|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695673|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43695674|NCT02760381|Protective Agents|protective agents|mesh-ancestor
43695675|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695676|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
43695677|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43695678|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695679|NCT02760043|Dexamethasone|dexamethasone|mesh-list
43695680|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695681|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
43695682|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
43695683|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695684|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695685|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695686|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
43695687|NCT02760043|Hormones|hormones|mesh-ancestor
43640287|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43640288|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43637861|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637862|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637863|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43637864|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43637865|NCT04404283|Growth Substances|growth substances|mesh-ancestor
43637866|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
43637867|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
43637868|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43637869|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637870|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43637871|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637872|NCT04394858|Temozolomide|temozolomide|mesh-list
43637873|NCT04394858|Olaparib|olaparib|mesh-list
43637874|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43637875|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43637876|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
43637877|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637878|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637879|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637881|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
43637882|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43637883|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637884|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637885|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
43637886|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
43637894|NCT04380636|Etoposide|etoposide|mesh-list
43637918|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
43692204|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43692205|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
43692206|NCT02782273|Ketorolac|ketorolac|mesh-list
43692207|NCT02782273|Morphine|morphine|mesh-list
43692208|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43692209|NCT02782273|Narcotics|narcotics|mesh-ancestor
43692210|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692211|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692212|NCT02782273|Analgesics|analgesics|mesh-ancestor
43692213|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
43692214|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692215|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43692216|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692217|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692218|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692219|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692220|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692221|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640289|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640290|NCT02576912|Hormones|hormones|mesh-ancestor
43700232|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43695708|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43695709|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43695710|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695712|NCT02760030|Palbociclib|palbociclib|mesh-list
43695713|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43695714|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43695715|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695716|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43695717|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43695718|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
43695719|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695720|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640304|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43640305|NCT02481635|Gemcitabine|gemcitabine|mesh-list
43640306|NCT02481635|Paclitaxel|paclitaxel|mesh-list
43640307|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43692222|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43692223|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43692225|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692226|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692227|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43692228|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
43692229|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
43692231|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692232|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
43692233|NCT02782403|Axitinib|axitinib|mesh-list
43692234|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692235|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43692236|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692237|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692238|NCT02782481|Levodopa|levodopa|mesh-list
43692239|NCT02782481|Carbidopa|carbidopa|mesh-list
43692240|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43692241|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43692242|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43692243|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
43692244|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43640308|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640309|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
43640310|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
43640311|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
43695721|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43695722|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695723|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695724|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43695726|NCT02760095|Acetic Acid|acetic acid|mesh-list
43695727|NCT02760095|Retinol acetate|retinol acetate|mesh-list
43695728|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
43695729|NCT02760095|Vitamins|vitamins|mesh-ancestor
43695730|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
43695731|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695732|NCT02760095|Protective Agents|protective agents|mesh-ancestor
43695733|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43695734|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695735|NCT02760095|Astringents|astringents|mesh-ancestor
43695736|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695737|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43695787|NCT02759510|Protective Agents|protective agents|mesh-ancestor
43695788|NCT02759224|Irsogladine|irsogladine|mesh-list
43695789|NCT02759224|Lafutidine|lafutidine|mesh-list
43695790|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695791|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43695792|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695793|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43695802|NCT02759393|Lansoprazole|lansoprazole|mesh-list
43695804|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43695805|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695806|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43695807|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692245|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692246|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692247|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43692248|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692249|NCT02782286|Ketorolac|ketorolac|mesh-list
43692250|NCT02782286|Morphine|morphine|mesh-list
43692251|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43692252|NCT02782286|Narcotics|narcotics|mesh-ancestor
43692253|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692254|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692255|NCT02782286|Analgesics|analgesics|mesh-ancestor
43692256|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
43692257|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829459|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
43829460|NCT05422066|Rituximab|rituximab|mesh-list
43829461|NCT05422066|Doxorubicin|doxorubicin|mesh-list
43829462|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43829463|NCT05422066|Vincristine|vincristine|mesh-list
43829464|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43829465|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
43829466|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829467|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829468|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43829469|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
43829470|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829471|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829472|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43637919|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829668|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
43695808|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695809|NCT02759042|Leronlimab|leronlimab|mesh-list
43695810|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43695811|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43695812|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695813|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43695814|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43695815|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
43695816|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637920|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637921|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43637922|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43637923|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
43637924|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637925|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43637947|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43637948|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637949|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
43637950|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637951|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43695817|NCT02759107|Dulaglutide|dulaglutide|mesh-list
43695818|NCT02759107|Tirzepatide|tirzepatide|mesh-list
43695819|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43695820|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695821|NCT02759107|Incretins|incretins|mesh-ancestor
43695822|NCT02759107|Hormones|hormones|mesh-ancestor
43695823|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695831|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
43695832|NCT02758925|Cytarabine|cytarabine|mesh-list
43695833|NCT02758925|Rituximab|rituximab|mesh-list
43695834|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43695835|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43695836|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695837|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
43695838|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695839|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695840|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43695841|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
43695842|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695843|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
43695844|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695845|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695846|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43695847|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
43695848|NCT02758990|Vitamin D|vitamin d|mesh-list
43695849|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
43695850|NCT02758990|Vitamins|vitamins|mesh-list
43695851|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
43695852|NCT02758990|Vitamin E|vitamin e|mesh-list
43695853|NCT02758990|Tocopherols|tocopherols|mesh-list
43695854|NCT02758990|Vitamin A|vitamin a|mesh-list
43695855|NCT02758990|Niacinamide|niacinamide|mesh-list
43640312|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640313|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640314|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
43640315|NCT02481635|Antiviral Agents|antiviral agents|mesh-ancestor
43640316|NCT02481635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640317|NCT02481635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640318|NCT02481635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640319|NCT02481635|Immunologic Factors|immunologic factors|mesh-ancestor
43640320|NCT02481635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640321|NCT02470091|Denosumab|denosumab|mesh-list
43640322|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43637952|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637953|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637954|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
43637955|NCT04363801|Antidotes|antidotes|mesh-ancestor
43637956|NCT04363801|Protective Agents|protective agents|mesh-ancestor
43637957|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
43637959|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
43637960|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43637961|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637962|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
43637963|NCT04357587|Capecitabine|capecitabine|mesh-list
43637964|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637965|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637966|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43695856|NCT02758990|Niacin|niacin|mesh-list
43695857|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
43695858|NCT02758990|Pyridoxine|pyridoxine|mesh-list
43695859|NCT02758990|Pyridoxal|pyridoxal|mesh-list
43695860|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
43695861|NCT02758990|Caffeine|caffeine|mesh-list
43695862|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
43695863|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695864|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43701260|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
43695875|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695876|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
43695877|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43695878|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
43695879|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43695880|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
43695881|NCT02759198|Celecoxib|celecoxib|mesh-list
43695882|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43695883|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43695884|NCT02759198|Analgesics|analgesics|mesh-ancestor
43695885|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
43640323|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640324|NCT02467270|Ponatinib|ponatinib|mesh-list
43640325|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640326|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43640327|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640328|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640329|NCT02441660|Capsaicin|capsaicin|mesh-list
43640330|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
43640331|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
43640332|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
43640333|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640334|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640335|NCT02420613|Sirolimus|sirolimus|mesh-list
43640336|NCT02420613|Vorinostat|vorinostat|mesh-list
43640337|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43640339|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640340|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695886|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695887|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695888|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695889|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695890|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43695891|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43695892|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695893|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695894|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43695895|NCT02758873|Montelukast|montelukast|mesh-list
43637967|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
43637968|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637969|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43829473|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43829474|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43829475|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43829476|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43829477|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829478|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829479|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
43829481|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692265|NCT02782429|Ketamine|ketamine|mesh-list
43692266|NCT02782429|Analgesics|analgesics|mesh-ancestor
43692267|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
43692268|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692269|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692270|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43692271|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43692272|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
43692273|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
43692274|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695896|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43695897|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
43695898|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695899|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695900|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43695901|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
43695902|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43695903|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43695904|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43695905|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
43695906|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695907|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695908|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43695910|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695914|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43695915|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695916|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695917|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695918|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
43695919|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695920|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695921|NCT02758782|Celecoxib|celecoxib|mesh-list
43695922|NCT02758782|Golimumab|golimumab|mesh-list
43695923|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43695924|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43695925|NCT02758782|Analgesics|analgesics|mesh-ancestor
43637970|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43637971|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637977|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637979|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
43637980|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637981|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43637982|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
43637983|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43637984|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43637985|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
43637986|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43637987|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43695926|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
43695927|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695928|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695929|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695930|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695931|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43695932|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43695933|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695934|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695935|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43695936|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695937|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
43695938|NCT02758522|Insulin|insulin|mesh-list
43695939|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43640360|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640361|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43640362|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695947|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695948|NCT02758509|Interferons|interferons|mesh-list
43695949|NCT02758509|Ritonavir|ritonavir|mesh-list
43695950|NCT02758509|Ribavirin|ribavirin|mesh-list
43695951|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
43695952|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
43695953|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
43695954|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43695955|NCT02758509|Ledipasvir|ledipasvir|mesh-list
43695956|NCT02758509|Simeprevir|simeprevir|mesh-list
43695957|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43640391|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640392|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640393|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640394|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
43640395|NCT02385110|Hormones|hormones|mesh-ancestor
43640396|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640397|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640398|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640399|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43640400|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
43640401|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43640402|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640403|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
43640404|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640405|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
43640406|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640407|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43640408|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640409|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
43640410|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637988|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637989|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
43637990|NCT04348747|Vaccines|vaccines|mesh-list
43637991|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
43637992|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637993|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637994|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637995|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
43637996|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
43637997|NCT04339777|Busulfan|busulfan|mesh-list
43637998|NCT04339777|Fludarabine|fludarabine|mesh-list
43637999|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
43638000|NCT04339777|Tacrolimus|tacrolimus|mesh-list
43638001|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638002|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
43638003|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638004|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638005|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43692275|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43692276|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43829669|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43640411|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43640429|NCT02352948|Gemcitabine|gemcitabine|mesh-list
43640430|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43640431|NCT02352948|Durvalumab|durvalumab|mesh-list
43640432|NCT02352948|Vinorelbine|vinorelbine|mesh-list
43640433|NCT02352948|Tremelimumab|tremelimumab|mesh-list
43640434|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43640435|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640436|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
43695967|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43695968|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43695969|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43695970|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
43695971|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
43695972|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695974|NCT02758444|Trace Elements|trace elements|mesh-list
43695975|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695976|NCT02758340|Misoprostol|misoprostol|mesh-list
43695977|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43695978|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
43695979|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43695980|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695981|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43640447|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43640448|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
43640449|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
43640450|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
43640451|NCT02339740|Vitamins|vitamins|mesh-list
43640452|NCT02339740|Vitamin A|vitamin a|mesh-list
43640453|NCT02339740|Cytarabine|cytarabine|mesh-list
43640454|NCT02339740|Dexamethasone|dexamethasone|mesh-list
43640455|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
43640456|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
43640457|NCT02339740|Idarubicin|idarubicin|mesh-list
43640458|NCT02339740|Tretinoin|tretinoin|mesh-list
43640459|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
43640460|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
43692277|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692278|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692279|NCT02782221|Hormones|hormones|mesh-list
43692280|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692281|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692282|NCT02782208|Acipimox|acipimox|mesh-list
43692283|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43692284|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
43692285|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692286|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43692287|NCT02782182|Leucovorin|leucovorin|mesh-list
43692288|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
43692289|NCT02782182|Irinotecan|irinotecan|mesh-list
43692290|NCT02782182|Folfirinox|folfirinox|mesh-list
43692291|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692292|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43692293|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43692294|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692295|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692296|NCT02782182|Antidotes|antidotes|mesh-ancestor
43692297|NCT02782182|Protective Agents|protective agents|mesh-ancestor
43692298|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692299|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
43692300|NCT02782182|Vitamins|vitamins|mesh-ancestor
43692301|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
43692302|NCT02782078|Clindamycin|clindamycin|mesh-list
43692303|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
43692304|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
43692305|NCT02782078|Rifampin|rifampin|mesh-list
43692306|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43692307|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692308|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43692309|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638006|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
43638007|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638008|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640461|NCT02339740|BB 1101|bb 1101|mesh-list
43640462|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
43640463|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640464|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638009|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43638010|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43692310|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692311|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43692312|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
43692313|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
43692314|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43692315|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43692316|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43692317|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43692318|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43692319|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43692320|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43692321|NCT02782052|Bromides|bromides|mesh-list
43692322|NCT02782052|Albuterol|albuterol|mesh-list
43692323|NCT02782052|Ipratropium|ipratropium|mesh-list
43692324|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
43692325|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43692326|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
43692327|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692328|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692329|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43692330|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
43640465|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
43640466|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
43640467|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696031|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696033|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43696034|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
43696035|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696036|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43696037|NCT02758067|Risperidone|risperidone|mesh-list
43696038|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
43696039|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43696040|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
43696041|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696042|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640615|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640616|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
43640617|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640618|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
43640619|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640620|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43640621|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640622|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640623|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43640624|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43640625|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
43640635|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43692331|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
43692332|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43692333|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43692334|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43692335|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43692336|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
43692337|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692338|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692339|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43692340|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
43692341|NCT02781909|Ibuprofen|ibuprofen|mesh-list
43692342|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43692348|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692349|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692350|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692351|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692352|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692353|NCT02781766|Thrombin|thrombin|mesh-list
43692354|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
43692355|NCT02781766|Coagulants|coagulants|mesh-ancestor
43692356|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
43638034|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
43638035|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638036|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638037|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638038|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638039|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43638040|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43692374|NCT02781753|Interferons|interferons|mesh-list
43692375|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
43692376|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
43692377|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692378|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
43692379|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692380|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
43692381|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692382|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43692383|NCT02781779|Laxatives|laxatives|mesh-ancestor
43692384|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692385|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
43692386|NCT02781467|Fludarabine|fludarabine|mesh-list
43692387|NCT02781467|Interleukin-2|interleukin-2|mesh-list
43692388|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692389|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
43692390|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692391|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692393|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
43640636|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43640637|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640638|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
43640639|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640640|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696057|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43696058|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696059|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43696060|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696061|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696062|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43696063|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43696065|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696066|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696067|NCT02757534|Domperidone|domperidone|mesh-list
43696068|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
43696069|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
43696070|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696071|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696072|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696073|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43638041|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638042|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43638043|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43638044|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638045|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
43638046|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43638047|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
43696089|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43696090|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43696091|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
43696092|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696113|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43696114|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43696115|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
43696116|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696129|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696131|NCT02757365|Levofloxacin|levofloxacin|mesh-list
43696132|NCT02757365|Ofloxacin|ofloxacin|mesh-list
43696133|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43696134|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43696135|NCT02757365|Analgesics|analgesics|mesh-ancestor
43696136|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
43696137|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696138|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696139|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696140|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696141|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43696142|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43696143|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696144|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43696145|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43696146|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696147|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
43696148|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43696149|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696150|NCT02757365|Renal Agents|renal agents|mesh-ancestor
43696151|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43696152|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43696153|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43696154|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696155|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43696156|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43638122|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43638123|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43638145|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43638146|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43638147|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638149|NCT04285450|Coagulants|coagulants|mesh-ancestor
43638150|NCT04272801|Tamoxifen|tamoxifen|mesh-list
43638151|NCT04272801|Letrozole|letrozole|mesh-list
43638152|NCT04272801|Anastrozole|anastrozole|mesh-list
43638153|NCT04272801|Exemestane|exemestane|mesh-list
43638154|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638155|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43638156|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43638157|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692415|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
43692416|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692417|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43692418|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43638158|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638159|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43638160|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
43638161|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43638162|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638194|NCT04251169|Paclitaxel|paclitaxel|mesh-list
43638195|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
43638196|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43638197|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638198|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638199|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
43638200|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
43638201|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638202|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638203|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
43692419|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43692420|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
43692421|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692422|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692423|NCT02781064|Atorvastatin|atorvastatin|mesh-list
43692424|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43692425|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43692426|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
43847222|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
43692427|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692428|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43692429|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43692430|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692436|NCT02780882|Pasireotide|pasireotide|mesh-list
43692437|NCT02780882|Hormones|hormones|mesh-ancestor
43692438|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692439|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692440|NCT02780778|Docetaxel|docetaxel|mesh-list
43692441|NCT02780778|Apatinib|apatinib|mesh-list
43692442|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692452|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
43692453|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
43638204|NCT04246177|Lenvatinib|lenvatinib|mesh-list
43638205|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638206|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692454|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692455|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692456|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692457|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
43692458|NCT02780479|Hormones|hormones|mesh-ancestor
43692459|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692460|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43692461|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692462|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
43692463|NCT02780505|Vitamins|vitamins|mesh-ancestor
43692464|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
43692465|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692466|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
43692467|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692468|NCT02780505|Protective Agents|protective agents|mesh-ancestor
43829482|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43829483|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43829484|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
43829485|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
43829487|NCT05422027|Dexamethasone|dexamethasone|mesh-list
43692473|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43692474|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43692475|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692476|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
43692492|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692493|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43692494|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692495|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692496|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692497|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43692498|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43692499|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692500|NCT02779881|Caseins|caseins|mesh-list
43692501|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
43692502|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
43692503|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692504|NCT02779777|Tipifarnib|tipifarnib|mesh-list
43692514|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692515|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43692516|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43692517|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
43692518|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692519|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692521|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
43692522|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692523|NCT02779634|Vitamins|vitamins|mesh-ancestor
43692524|NCT02779348|Warfarin|warfarin|mesh-list
43692525|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
43692526|NCT02779608|Docetaxel|docetaxel|mesh-list
43692527|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692528|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
43692529|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
43692530|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
43707178|NCT02702622|Vitamins|vitamins|mesh-ancestor
43696157|NCT02757469|Drospirenone|drospirenone|mesh-list
43829940|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829941|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829943|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43829944|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829945|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829946|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43829947|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829948|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829949|NCT05398705|Cepharanthine|cepharanthine|mesh-list
43696185|NCT02757391|Aldesleukin|aldesleukin|mesh-list
43696186|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
43696187|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
43696188|NCT02757391|Interleukin-2|interleukin-2|mesh-list
43696189|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
43696190|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692531|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692532|NCT02779582|Progesterone|progesterone|mesh-list
43692533|NCT02779582|Progestins|progestins|mesh-ancestor
43692534|NCT02779582|Hormones|hormones|mesh-ancestor
43692535|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692536|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692537|NCT02779387|Goserelin|goserelin|mesh-list
43692538|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43692539|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692540|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
43692541|NCT02779283|Leucovorin|leucovorin|mesh-list
43696191|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696192|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696193|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43696194|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
43696195|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696196|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696197|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43696198|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696199|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43696200|NCT02757391|Analgesics|analgesics|mesh-ancestor
43696201|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
43696202|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696203|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43696204|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43696205|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
43696206|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696207|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
43696208|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43696230|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43696231|NCT02757144|Esomeprazole|esomeprazole|mesh-list
43696232|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43696233|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696234|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43696235|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696236|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696237|NCT02757248|Romidepsin|romidepsin|mesh-list
43696283|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696285|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43696286|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696307|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43696308|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696309|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696310|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43696311|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
43696313|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43696314|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
43696315|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
43640720|NCT02091960|Trastuzumab|trastuzumab|mesh-list
43640721|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640722|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640723|NCT02088541|Cytarabine|cytarabine|mesh-list
43640724|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
43640725|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640726|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
43640727|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640728|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696316|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
43696317|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696318|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
43696319|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696320|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692542|NCT02779283|Folic Acid|folic acid|mesh-list
43692543|NCT02779283|Cytarabine|cytarabine|mesh-list
43692544|NCT02779283|Dexamethasone|dexamethasone|mesh-list
43692545|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
43638207|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43638208|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638209|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638210|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
43638211|NCT04245839|Fludarabine|fludarabine|mesh-list
43638212|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638213|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
43638214|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638215|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696321|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43696322|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
43696323|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696324|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696325|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43696326|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640730|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640731|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640732|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
43640733|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640734|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
43640735|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640736|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43640738|NCT02031419|Spebrutinib|spebrutinib|mesh-list
43640739|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640740|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640741|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
43640742|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640743|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640744|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43640745|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640746|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640747|NCT02015013|Plerixafor|plerixafor|mesh-list
43640748|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43638221|NCT04235101|Trastuzumab|trastuzumab|mesh-list
43638223|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638224|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638225|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43638226|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638227|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638228|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
43638229|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43638230|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43638231|NCT04233164|Prednisolone|prednisolone|mesh-list
43638232|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
43638233|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43638234|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
43638235|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638236|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
43638237|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
43638238|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638239|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638240|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43638241|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
43638242|NCT04233164|Hormones|hormones|mesh-ancestor
43638243|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640749|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43640750|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
43638244|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43638245|NCT04233164|Protective Agents|protective agents|mesh-ancestor
43638246|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43638247|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638248|NCT04230980|Gabapentin|gabapentin|mesh-list
43638249|NCT04230980|Analgesics|analgesics|mesh-ancestor
43638250|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
43638251|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638252|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638253|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
43638254|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43638255|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43638256|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43638257|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43638258|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43638259|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43638260|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43638261|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638262|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
43638263|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
43638264|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
43638265|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43692546|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43692547|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43692548|NCT02779283|Prednisolone|prednisolone|mesh-list
43692549|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
43692550|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
43692551|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
43692552|NCT02779283|Rituximab|rituximab|mesh-list
43692553|NCT02779283|Doxorubicin|doxorubicin|mesh-list
43692554|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43692555|NCT02779283|Methotrexate|methotrexate|mesh-list
43692567|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43692568|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
43692569|NCT02779283|BB 1101|bb 1101|mesh-list
43692570|NCT02779283|Calcium|calcium|mesh-list
43692571|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
43692572|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692582|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
43692598|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43692599|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43692600|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
43692601|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
43692602|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43692603|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43692604|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
43692605|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638270|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638271|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638272|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43638273|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43638274|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
43638275|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
43638280|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638281|NCT04223856|Gemcitabine|gemcitabine|mesh-list
43638282|NCT04223856|Cisplatin|cisplatin|mesh-list
43638283|NCT04223856|Carboplatin|carboplatin|mesh-list
43638284|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
43638285|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638286|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43638287|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
43638288|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638293|NCT04223856|Immunologic Factors|immunologic factors|mesh-ancestor
43638294|NCT04223856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638295|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43692618|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43692619|NCT02779283|Growth Substances|growth substances|mesh-ancestor
43692625|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692640|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692642|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
43692643|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692644|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692645|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692646|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692647|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692648|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692649|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692650|NCT02779192|Ebselen|ebselen|mesh-list
43692651|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43692652|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692653|NCT02779192|Analgesics|analgesics|mesh-ancestor
43692654|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
43692655|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640751|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640752|NCT01970865|Crizotinib|crizotinib|mesh-list
43640753|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640754|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43640755|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640756|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640757|NCT01966263|Epinephrine|epinephrine|mesh-list
43640758|NCT01966263|Racepinephrine|racepinephrine|mesh-list
43640759|NCT01966263|Ropivacaine|ropivacaine|mesh-list
43640760|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
43640761|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
43640762|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
43696337|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
43696338|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43696339|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696341|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
43696343|NCT02756104|Vitamins|vitamins|mesh-ancestor
43696344|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
43696345|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696346|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43696347|NCT02756130|Carboplatin|carboplatin|mesh-list
43696348|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696349|NCT02756026|Micronutrients|micronutrients|mesh-list
43696350|NCT02756026|Trace Elements|trace elements|mesh-list
43696351|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692656|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692657|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692658|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692659|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43692660|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692661|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
43692662|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692663|NCT02779192|Protective Agents|protective agents|mesh-ancestor
43692664|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692665|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692666|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43692667|NCT02778906|Abatacept|abatacept|mesh-list
43692668|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43692669|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692670|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692671|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692672|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
43692673|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692674|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692676|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43707247|NCT02701673|Azacitidine|azacitidine|mesh-list
43696352|NCT02755753|Lansoprazole|lansoprazole|mesh-list
43696353|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
43696354|NCT02755753|Rebamipide|rebamipide|mesh-list
43696355|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43696356|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696357|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43696358|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696359|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696360|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
43696361|NCT02755753|Protective Agents|protective agents|mesh-ancestor
43696362|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696363|NCT02755714|Bromides|bromides|mesh-list
43696374|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696380|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43696382|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
43696383|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696384|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640763|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43640764|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640765|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
43640766|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640767|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43640768|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43640769|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
43640770|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43640771|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640779|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43692678|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692679|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692680|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692681|NCT02778828|Linezolid|linezolid|mesh-list
43692682|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43692683|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692684|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43692685|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692686|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692687|NCT02778789|Adalimumab|adalimumab|mesh-list
43692688|NCT02778789|Etanercept|etanercept|mesh-list
43640780|NCT01955460|Aldesleukin|aldesleukin|mesh-list
43640781|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
43640782|NCT01955460|Fludarabine|fludarabine|mesh-list
43640783|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
43640784|NCT01955460|Interleukin-2|interleukin-2|mesh-list
43640785|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640786|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
43640787|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640788|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640789|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43640790|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
43640791|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640792|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640793|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640794|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640795|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
43640796|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43640797|NCT01955460|Analgesics|analgesics|mesh-ancestor
43640798|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
43640799|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696385|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43696386|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43696387|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43640824|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696415|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
43696416|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696417|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
43696418|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
43696419|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43696420|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696421|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696422|NCT02755532|Bupivacaine|bupivacaine|mesh-list
43696423|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
43696424|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
43696425|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696426|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696427|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
43640877|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640878|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640879|NCT01745588|Clarithromycin|clarithromycin|mesh-list
43640880|NCT01745588|Dexamethasone|dexamethasone|mesh-list
43640881|NCT01745588|Pomalidomide|pomalidomide|mesh-list
43640882|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640883|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
43640884|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
43640885|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640886|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640887|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640888|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
43696502|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696503|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696504|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43640889|NCT01745588|Hormones|hormones|mesh-ancestor
43692689|NCT02778789|Golimumab|golimumab|mesh-list
43692690|NCT02778789|Infliximab|infliximab|mesh-list
43692691|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
43692692|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692693|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692694|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
43692695|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692696|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43692697|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692698|NCT02778789|Analgesics|analgesics|mesh-ancestor
43692699|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
43692700|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692701|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692702|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692703|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
43692704|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43692705|NCT02778958|Acetaminophen|acetaminophen|mesh-list
43638328|NCT04216329|Temozolomide|temozolomide|mesh-list
43638329|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43638330|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
43638331|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638332|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638339|NCT04206319|Fluorides|fluorides|mesh-list
43638340|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
43638341|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
43638342|NCT04206319|Protective Agents|protective agents|mesh-ancestor
43638343|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638344|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43638345|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638346|NCT04205630|Trastuzumab|trastuzumab|mesh-list
43638347|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43692706|NCT02778958|Ibuprofen|ibuprofen|mesh-list
43692707|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692708|NCT02778958|Analgesics|analgesics|mesh-ancestor
43640890|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640891|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640892|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640893|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43692709|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
43692710|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692711|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692712|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
43692713|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43692714|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692715|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692716|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692717|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692718|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692719|NCT02778971|Flutemetamol|flutemetamol|mesh-list
43692720|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43692721|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692722|NCT02778945|Rocuronium|rocuronium|mesh-list
43692723|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43692724|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43692725|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43692726|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638348|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638349|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
43638386|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43692727|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692728|NCT02778776|Metformin|metformin|mesh-list
43692729|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43692730|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692731|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
43692732|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43692733|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692734|NCT02778919|Leuprolide|leuprolide|mesh-list
43692735|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43692736|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
43692737|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43692738|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692739|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43692740|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692743|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692744|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692745|NCT02778893|Thalidomide|thalidomide|mesh-list
43692746|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692747|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
43692748|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692749|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
43692750|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43692751|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692752|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43692753|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43692754|NCT02778893|Growth Substances|growth substances|mesh-ancestor
43692755|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
43692756|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829516|NCT05421819|Calcium|calcium|mesh-list
43638387|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43638388|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638389|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638390|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
43638392|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43638393|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43829534|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829535|NCT05419011|Vaccines|vaccines|mesh-list
43829536|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
43829537|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829538|NCT05417971|Fludarabine|fludarabine|mesh-list
43829539|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829540|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43829541|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
43638400|NCT04165070|Carboplatin|carboplatin|mesh-list
43638401|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
43638402|NCT04165070|Pemetrexed|pemetrexed|mesh-list
43638403|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43638404|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638405|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638406|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
43638407|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
43638408|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638409|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638410|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638411|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43638412|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43829542|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
43829543|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829545|NCT05417386|Fluorouracil|fluorouracil|mesh-list
43829546|NCT05417386|Capecitabine|capecitabine|mesh-list
43829547|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
43829548|NCT05417386|Irinotecan|irinotecan|mesh-list
43829549|NCT05417386|Camptothecin|camptothecin|mesh-list
43829550|NCT05417386|Folfirinox|folfirinox|mesh-list
43829551|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
43640894|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640895|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43640896|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640897|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829552|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829553|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
43829554|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829555|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43638439|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43638440|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
43638441|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
43638442|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43638443|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43696506|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43696507|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43696508|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43696509|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
43696510|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638444|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43638445|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43638446|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638447|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43638448|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43638449|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43638450|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43638451|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43638452|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
43638453|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
43638454|NCT04115631|Cytarabine|cytarabine|mesh-list
43696511|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
43696512|NCT02754817|Liraglutide|liraglutide|mesh-list
43696513|NCT02754817|Xultophy|xultophy|mesh-list
43696514|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43696515|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696516|NCT02754817|Incretins|incretins|mesh-ancestor
43696517|NCT02754817|Hormones|hormones|mesh-ancestor
43696518|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696519|NCT02754960|Thalidomide|thalidomide|mesh-list
43696520|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696521|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
43696522|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696523|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
43696524|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43696525|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696526|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43696527|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43696528|NCT02754960|Growth Substances|growth substances|mesh-ancestor
43696529|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
43696530|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696531|NCT02755064|Erythromycin|erythromycin|mesh-list
43696532|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
43640898|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43640942|NCT01652092|Vidarabine|vidarabine|mesh-list
43640943|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
43640944|NCT01652092|Melphalan|melphalan|mesh-list
43640945|NCT01652092|Busulfan|busulfan|mesh-list
43640946|NCT01652092|Fludarabine|fludarabine|mesh-list
43640947|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
43640948|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
43640949|NCT01652092|Mesna|mesna|mesh-list
43640950|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640951|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
43640952|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640953|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640954|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43640955|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
43640956|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640957|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640958|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640959|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640960|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
43640961|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
43640962|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692757|NCT02778659|Zolpidem|zolpidem|mesh-list
43692758|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43692759|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43692760|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692761|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692762|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43692763|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
43692764|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
43692765|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692766|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692767|NCT02778594|Levodopa|levodopa|mesh-list
43692768|NCT02778594|Benserazide|benserazide|mesh-list
43692769|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43692770|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43692771|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
43692784|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692785|NCT02778360|Methylphenidate|methylphenidate|mesh-list
43692786|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43692787|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692788|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43692789|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43692790|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43692791|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692792|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
43692793|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692810|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692811|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692812|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
43692813|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692814|NCT02778178|Analgesics|analgesics|mesh-ancestor
43638455|NCT04115631|Rituximab|rituximab|mesh-list
43638456|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43638461|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43638462|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
43638463|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638464|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638465|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638466|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43638467|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
43692815|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43692816|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
43692817|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
43692818|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43692819|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43692820|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43692821|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
43692822|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692823|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692824|NCT02778191|Cisplatin|cisplatin|mesh-list
43692825|NCT02778191|Carboplatin|carboplatin|mesh-list
43692826|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692827|NCT02777814|Entecavir|entecavir|mesh-list
43692828|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
43692829|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638477|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43638478|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638479|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638480|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
43638481|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
43638482|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638483|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638484|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
43638485|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638486|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638487|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43638488|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
43638489|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43638490|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638491|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43638492|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43638493|NCT04108858|Trastuzumab|trastuzumab|mesh-list
43638494|NCT04108858|Pertuzumab|pertuzumab|mesh-list
43640963|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640964|NCT01652092|Protective Agents|protective agents|mesh-ancestor
43640965|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43640966|NCT01638533|Romidepsin|romidepsin|mesh-list
43640967|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640968|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640969|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640970|NCT01607905|Acetaminophen|acetaminophen|mesh-list
43640971|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43640972|NCT01607905|Analgesics|analgesics|mesh-ancestor
43696545|NCT02754726|Nivolumab|nivolumab|mesh-list
43696546|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43696547|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43696548|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696549|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
43696550|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
43696551|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
43696552|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696553|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43696554|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
43696555|NCT02754726|Antiviral Agents|antiviral agents|mesh-ancestor
43696556|NCT02754726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696557|NCT02754726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696558|NCT02754726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696559|NCT02754726|Immunologic Factors|immunologic factors|mesh-ancestor
43641001|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
43641002|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641003|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43641004|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43641005|NCT01553149|Growth Substances|growth substances|mesh-ancestor
43641006|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
43641007|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696560|NCT02754726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696561|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696562|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43696563|NCT02754739|Pravastatin|pravastatin|mesh-list
43638495|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43638496|NCT04108858|Antibodies|antibodies|mesh-list
43638497|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
43638498|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43638499|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
43692837|NCT02777801|Entecavir|entecavir|mesh-list
43692838|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
43692839|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692840|NCT02777788|Gemcitabine|gemcitabine|mesh-list
43692841|NCT02777788|Paclitaxel|paclitaxel|mesh-list
43692842|NCT02777788|Vinorelbine|vinorelbine|mesh-list
43692843|NCT02777788|Docetaxel|docetaxel|mesh-list
43692844|NCT02777788|Carboplatin|carboplatin|mesh-list
43692845|NCT02777788|Pemetrexed|pemetrexed|mesh-list
43692846|NCT02777788|Cisplatin|cisplatin|mesh-list
43692847|NCT02777788|Nedaplatin|nedaplatin|mesh-list
43692848|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43692849|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692850|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
43692851|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
43692852|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
43692853|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692854|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43692855|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
43692856|NCT02777788|Antiviral Agents|antiviral agents|mesh-ancestor
43692857|NCT02777788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692858|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692859|NCT02777788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692860|NCT02777788|Immunologic Factors|immunologic factors|mesh-ancestor
43692861|NCT02777788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692862|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43692863|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43692864|NCT02777736|Methotrexate|methotrexate|mesh-list
43692865|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43692866|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
43692867|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43696564|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43696565|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43696566|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
43641033|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641035|NCT01391962|Sunitinib|sunitinib|mesh-list
43641036|NCT01391962|Cediranib|cediranib|mesh-list
43641037|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638500|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638501|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638530|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638531|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
43638532|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638533|NCT04080739|Ropivacaine|ropivacaine|mesh-list
43638534|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
43638535|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
43638536|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43638537|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638538|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
43638539|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638540|NCT04071457|Lenalidomide|lenalidomide|mesh-list
43638541|NCT04071457|Daratumumab|daratumumab|mesh-list
43692868|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692869|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43692871|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692872|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692873|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
43692874|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692875|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43692876|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692877|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
43692878|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692879|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43692880|NCT02777710|Durvalumab|durvalumab|mesh-list
43692881|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43692882|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641038|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43641039|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43641040|NCT01391962|Growth Substances|growth substances|mesh-ancestor
43641041|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641042|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
43641043|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43641044|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641045|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641046|NCT01371981|Cytarabine|cytarabine|mesh-list
43641047|NCT01371981|Etoposide|etoposide|mesh-list
43641048|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
43641049|NCT01371981|Daunorubicin|daunorubicin|mesh-list
43641050|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
43641051|NCT01371981|Bortezomib|bortezomib|mesh-list
43641052|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
43641053|NCT01371981|Sorafenib|sorafenib|mesh-list
43641054|NCT01371981|Asparaginase|asparaginase|mesh-list
43692883|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
43692884|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43692885|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
43692886|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692887|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
43692888|NCT02777723|Protective Agents|protective agents|mesh-ancestor
43692889|NCT02777411|Vaccines|vaccines|mesh-list
43692890|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
43692891|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692892|NCT02777489|Perindopril|perindopril|mesh-list
43692893|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43638586|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
43638587|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43692911|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692912|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43692913|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
43692914|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
43692915|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692916|NCT02777619|Analgesics|analgesics|mesh-ancestor
43692917|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
43692918|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692919|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43692920|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43692921|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43692922|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
43692923|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692924|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692925|NCT02777320|Acetaminophen|acetaminophen|mesh-list
43692926|NCT02777320|Ibuprofen|ibuprofen|mesh-list
43692927|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43692928|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692929|NCT02777320|Analgesics|analgesics|mesh-ancestor
43692930|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
43829671|NCT05414006|Ketamine|ketamine|mesh-list
43641055|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43641056|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641057|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43641058|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43641059|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641060|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641061|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641062|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
43641063|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
43641093|NCT01352962|Growth Substances|growth substances|mesh-ancestor
43641094|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
43641095|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
43641096|NCT01351909|Veliparib|veliparib|mesh-list
43641097|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641098|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
43641099|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641100|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641101|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43641102|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
43849497|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43641103|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641104|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641105|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43641106|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43641107|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641108|NCT01351896|Lenalidomide|lenalidomide|mesh-list
43641109|NCT01351896|Vaccines|vaccines|mesh-list
43641110|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43692931|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692932|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692933|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692934|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641111|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
43641112|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641113|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43641114|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43641115|NCT01351896|Growth Substances|growth substances|mesh-ancestor
43641116|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
43641117|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641118|NCT01349959|Azacitidine|azacitidine|mesh-list
43641119|NCT01349959|Entinostat|entinostat|mesh-list
43641120|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43696581|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43696582|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43696583|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43696584|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
43696585|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696586|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696587|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641121|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641122|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
43641123|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641124|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641125|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641126|NCT01349881|Eflornithine|eflornithine|mesh-list
43641127|NCT01349881|Sulindac|sulindac|mesh-list
43641128|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641129|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43641144|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43641145|NCT01336140|Aminophylline|aminophylline|mesh-list
43641146|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43641148|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641149|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641150|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43641151|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
43696613|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43696614|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696615|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
43696616|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43696617|NCT02754102|Protective Agents|protective agents|mesh-ancestor
43696618|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696619|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
43696620|NCT02754258|Methylphenidate|methylphenidate|mesh-list
43696621|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43696622|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696623|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43696624|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43696625|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43696626|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696670|NCT02753738|Citalopram|citalopram|mesh-list
43696671|NCT02753738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43696677|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696678|NCT02753738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43696679|NCT02753738|Antidepressive Agents|antidepressive agents|mesh-ancestor
43696680|NCT02753738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43829993|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43829994|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
43829996|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
43829997|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
43829998|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829999|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830000|NCT05395091|Denosumab|denosumab|mesh-list
43830001|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43830002|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830003|NCT05395065|Listerine|listerine|mesh-list
43830004|NCT05395065|Fluorides|fluorides|mesh-list
43830005|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
43830006|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
43830007|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
43830008|NCT05395065|Protective Agents|protective agents|mesh-ancestor
43830009|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830010|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43830011|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830012|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43830013|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43830014|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830015|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
43847259|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847285|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847286|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847287|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43847288|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
43847289|NCT04123561|Hormones|hormones|mesh-ancestor
43696681|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43696682|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43696683|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43696684|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696685|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696686|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
43696687|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696688|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43696690|NCT02753712|Fluticasone|fluticasone|mesh-list
43696692|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
43696693|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696694|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43696695|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
43696696|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696697|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696698|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43696699|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
43696700|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
43696701|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43641294|NCT00977977|Cyclosporine|cyclosporine|mesh-list
43641295|NCT00977977|Rituximab|rituximab|mesh-list
43641296|NCT00977977|Cyclosporins|cyclosporins|mesh-list
43641303|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641304|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641305|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
43641306|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641307|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
43641308|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43641318|NCT00862433|Vitamin E|vitamin e|mesh-list
43641319|NCT00862433|Tocopherols|tocopherols|mesh-list
43641320|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
43641321|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
43641322|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641323|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
43696702|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43696703|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43696704|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43696705|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
43696706|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696707|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696709|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
43696710|NCT02753647|Rituximab|rituximab|mesh-list
43696711|NCT02753647|Doxorubicin|doxorubicin|mesh-list
43696712|NCT02753647|Vincristine|vincristine|mesh-list
43696713|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696714|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
43696715|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696716|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696717|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43696718|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
43696719|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696720|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696721|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43696722|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696723|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43696724|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43696725|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43696726|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641324|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641325|NCT00862433|Protective Agents|protective agents|mesh-ancestor
43641326|NCT00843037|Sunitinib|sunitinib|mesh-list
43641327|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641328|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43641329|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43641330|NCT00843037|Growth Substances|growth substances|mesh-ancestor
43641331|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641332|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
43641333|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43641334|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641335|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641336|NCT00602641|Thalidomide|thalidomide|mesh-list
43641337|NCT00602641|Prednisone|prednisone|mesh-list
43641338|NCT00602641|Cortisone|cortisone|mesh-list
43641339|NCT00602641|Lenalidomide|lenalidomide|mesh-list
43641340|NCT00602641|Melphalan|melphalan|mesh-list
43641341|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
43641342|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43641343|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641344|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
43641345|NCT00602641|Hormones|hormones|mesh-ancestor
43641346|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43701495|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43696743|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43696744|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641416|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641417|NCT00065676|Protective Agents|protective agents|mesh-ancestor
43641418|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641419|NCT00061568|Sirolimus|sirolimus|mesh-list
43641420|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
43641421|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43641422|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641423|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43641424|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641425|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
43641426|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641427|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
43641428|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641429|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43641430|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
43641431|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641432|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43641433|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641434|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641435|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
43641436|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
43641437|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43641438|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641439|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641440|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
43641441|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43641442|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641443|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641444|NCT00024622|Levodopa|levodopa|mesh-list
43641445|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43641446|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43641447|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
43641448|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641449|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641450|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641452|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641467|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43641468|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641469|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641470|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
43641471|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43641472|NCT00001481|Estradiol|estradiol|mesh-list
43641473|NCT00001481|Progesterone|progesterone|mesh-list
43641474|NCT00001481|Estrogens|estrogens|mesh-ancestor
43641475|NCT00001481|Hormones|hormones|mesh-ancestor
43641476|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43641477|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641478|NCT00001481|Progestins|progestins|mesh-ancestor
43641479|NCT00001379|Interferons|interferons|mesh-list
43696745|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
43696746|NCT02753309|Sirolimus|sirolimus|mesh-list
43696747|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43696748|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696749|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43696750|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696751|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
43696752|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696753|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
43696754|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696755|NCT02753140|Cisplatin|cisplatin|mesh-list
43696756|NCT02753140|Docetaxel|docetaxel|mesh-list
43696757|NCT02753140|Cetuximab|cetuximab|mesh-list
43696758|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696759|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
43696760|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
43696761|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
43696762|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696763|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696764|NCT02753114|Ketamine|ketamine|mesh-list
43696765|NCT02753114|Analgesics|analgesics|mesh-ancestor
43696766|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
43696767|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696768|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696769|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43696770|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43696771|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
43696772|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
43696773|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641480|NCT00001379|Rituximab|rituximab|mesh-list
43641481|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641482|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
43641483|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641484|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43641485|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
43641486|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641487|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641488|NCT00001337|Rituximab|rituximab|mesh-list
43641489|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43641490|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641491|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
43641492|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641493|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641494|NCT00001247|Sirolimus|sirolimus|mesh-list
43641495|NCT00001247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43641496|NCT00001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696774|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43696830|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
43696831|NCT02753166|Hormones|hormones|mesh-ancestor
43696832|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696833|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43696834|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696835|NCT02752828|Insulin|insulin|mesh-list
43696836|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43696837|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
43696838|NCT02752828|Lixisenatide|lixisenatide|mesh-list
43696839|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43696840|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696841|NCT02752763|Dextrans|dextrans|mesh-list
43696842|NCT02752763|Povidone|povidone|mesh-list
43696843|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43696844|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
43696845|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43696846|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
43696847|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
43696848|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
43696849|NCT02753062|Rituximab|rituximab|mesh-list
43696850|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43696851|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696852|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696853|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
43696854|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696855|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696856|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43696857|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
43696858|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696859|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
43696860|NCT02753088|Mannitol|mannitol|mesh-list
43696869|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696871|NCT02752646|Nepafenac|nepafenac|mesh-list
43696880|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43696881|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696882|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696883|NCT02752841|Vitamin D|vitamin d|mesh-list
43696884|NCT02752841|Vitamins|vitamins|mesh-ancestor
43696885|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
43696886|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696887|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43696905|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
43696907|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696908|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43696909|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43696910|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696911|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696912|NCT02752529|Tacrolimus|tacrolimus|mesh-list
43696913|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696914|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
43696915|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696916|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43696950|NCT02752308|Narcotics|narcotics|mesh-ancestor
43696951|NCT02752308|Analgesics|analgesics|mesh-ancestor
43696952|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43696953|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43696954|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
43696955|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43696956|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43696957|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
43696958|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696959|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696960|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43696961|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43696962|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
43696973|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43696978|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
43696979|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
43696980|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696981|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696982|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
43696983|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696984|NCT02752334|Analgesics|analgesics|mesh-ancestor
43696985|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43696986|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
43696987|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43696988|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43696989|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696990|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43696991|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
43696992|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43697003|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43697005|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43697006|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697007|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43697008|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43697009|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697010|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697011|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43697012|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
43697013|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
43697014|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
43697015|NCT02751840|Caffeine|caffeine|mesh-list
43697023|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
43697024|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830016|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
43830017|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43830018|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830019|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43830020|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830021|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43830022|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43830023|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830024|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
43830025|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43830026|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830027|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830028|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43697025|NCT02752477|Anesthetics|anesthetics|mesh-list
43697026|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
43697027|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697029|NCT02752412|Insulin|insulin|mesh-list
43697065|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697066|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697067|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
43697068|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697069|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43697070|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43697071|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43697072|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43697073|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697074|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
43697075|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43697076|NCT02751541|Protective Agents|protective agents|mesh-ancestor
43697077|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697078|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
43697079|NCT02751476|Disinfectants|disinfectants|mesh-list
43697080|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697081|NCT02751528|Vaccines|vaccines|mesh-list
43697082|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
43697083|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697084|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
43697118|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697120|NCT05429684|Capecitabine|capecitabine|mesh-list
43697121|NCT05429684|Trastuzumab|trastuzumab|mesh-list
43697122|NCT05429684|Everolimus|everolimus|mesh-list
43697123|NCT05429684|Letrozole|letrozole|mesh-list
43697124|NCT05429684|Palbociclib|palbociclib|mesh-list
43697125|NCT05429684|Pertuzumab|pertuzumab|mesh-list
43697126|NCT05429684|Antibodies|antibodies|mesh-list
43697127|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43697128|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697129|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
43697130|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
43697131|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
43697132|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697133|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
43697134|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697135|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43697136|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
43697137|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697138|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43697146|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43697147|NCT05429671|Gentamicins|gentamicins|mesh-list
43697148|NCT05429671|Tobramycin|tobramycin|mesh-list
43697149|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697161|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697162|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
43697163|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697164|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697165|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
43697166|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697167|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43697168|NCT05429567|Narcotics|narcotics|mesh-ancestor
43697169|NCT05429567|Analgesics|analgesics|mesh-ancestor
43697170|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43697171|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43697172|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
43697173|NCT05429554|Vildagliptin|vildagliptin|mesh-list
43697195|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697196|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43697198|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
43697199|NCT05428670|Rituximab|rituximab|mesh-list
43697200|NCT05428670|Lenalidomide|lenalidomide|mesh-list
43697201|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
43697202|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697203|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697204|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
43697205|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697206|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43697207|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43697208|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43697209|NCT05428670|Growth Substances|growth substances|mesh-ancestor
43697210|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
43697211|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43697212|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697213|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697214|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
43697215|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43697216|NCT05412056|Metformin|metformin|mesh-list
43697217|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697218|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697219|NCT05411978|Ubiquinone|ubiquinone|mesh-list
43697220|NCT05411978|Idebenone|idebenone|mesh-list
43697221|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
43697222|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697223|NCT05411978|Protective Agents|protective agents|mesh-ancestor
43697224|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697225|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
43830029|NCT05389852|Analgesics|analgesics|mesh-ancestor
43830030|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
43830031|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830032|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43830033|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43830034|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43830035|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
43830036|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700234|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43830038|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
43830039|NCT05388929|Methocarbamol|methocarbamol|mesh-list
43830040|NCT05388929|Narcotics|narcotics|mesh-ancestor
43830041|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830043|NCT05388929|Analgesics|analgesics|mesh-ancestor
43830044|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
43830045|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697226|NCT05318560|Lidocaine|lidocaine|mesh-list
43697227|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697228|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
43697229|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697238|NCT05289687|Daratumumab|daratumumab|mesh-list
43697255|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43697257|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697258|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697259|NCT05215873|Misoprostol|misoprostol|mesh-list
43697260|NCT05215873|Oxytocin|oxytocin|mesh-list
43697261|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
43697262|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43697263|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697264|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43697265|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
43697266|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43697267|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43697268|NCT05177484|Ferric maltol|ferric maltol|mesh-list
43697269|NCT05177484|Hematinics|hematinics|mesh-ancestor
43697270|NCT05168566|Maleic acid|maleic acid|mesh-list
43697271|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697272|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697273|NCT05112991|Lenvatinib|lenvatinib|mesh-list
43697274|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697275|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43697276|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697277|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697308|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697309|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
43697310|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697311|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697312|NCT04799626|Levofloxacin|levofloxacin|mesh-list
43697313|NCT04799626|Ofloxacin|ofloxacin|mesh-list
43697314|NCT04799626|Meropenem|meropenem|mesh-list
43697315|NCT04799626|Tazobactam|tazobactam|mesh-list
43697316|NCT04799626|Piperacillin|piperacillin|mesh-list
43697317|NCT04799626|Tigecycline|tigecycline|mesh-list
43697318|NCT04799626|Biapenem|biapenem|mesh-list
43697319|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43697320|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697321|NCT04799626|Renal Agents|renal agents|mesh-ancestor
43697322|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43697323|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43697324|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43697325|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697326|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697327|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697328|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43697329|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43697330|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43697331|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43697332|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43697333|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
43697334|NCT04788043|Magrolimab|magrolimab|mesh-list
43697335|NCT04788043|Antibodies|antibodies|mesh-list
43697357|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
43697358|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43697359|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697360|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697361|NCT04696445|Morphine|morphine|mesh-list
43697362|NCT04696445|Oxycodone|oxycodone|mesh-list
43697363|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43697364|NCT04696445|Narcotics|narcotics|mesh-ancestor
43697365|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697366|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697367|NCT04696445|Analgesics|analgesics|mesh-ancestor
43697368|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
43697369|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697371|NCT04529135|Remifentanil|remifentanil|mesh-list
43697372|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43697373|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697404|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43697405|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697406|NCT04278508|Progesterone|progesterone|mesh-list
43697407|NCT04278508|Progestins|progestins|mesh-ancestor
43697408|NCT04278508|Hormones|hormones|mesh-ancestor
43697409|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697410|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697411|NCT04278144|Nivolumab|nivolumab|mesh-list
43697412|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697413|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697414|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43697415|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697416|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43697417|NCT04264208|Bombesin|bombesin|mesh-list
43697418|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43697419|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697420|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697421|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697422|NCT04180813|Linagliptin|linagliptin|mesh-list
43697423|NCT04180813|Acarbose|acarbose|mesh-list
43697424|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697425|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697426|NCT04180813|Incretins|incretins|mesh-ancestor
43697427|NCT04180813|Hormones|hormones|mesh-ancestor
43697428|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697430|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
43692935|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692937|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692939|NCT02777229|Tenofovir|tenofovir|mesh-list
43692940|NCT02777229|Lamivudine|lamivudine|mesh-list
43830061|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
43697438|NCT04138875|Rituximab|rituximab|mesh-list
43697439|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43697440|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43697441|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697442|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697443|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
43697444|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697445|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43697446|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43697447|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
43697448|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697449|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
43697450|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697451|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697452|NCT04088500|Nivolumab|nivolumab|mesh-list
43697453|NCT04088500|Ipilimumab|ipilimumab|mesh-list
43697454|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697455|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697456|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43697457|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697458|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43697473|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
43697474|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
43697475|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697476|NCT03553446|Sevoflurane|sevoflurane|mesh-list
43697477|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43697478|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43697479|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
43697480|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
43697481|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697482|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697483|NCT03530189|Insulin|insulin|mesh-list
43697484|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697485|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697486|NCT03523273|Liraglutide|liraglutide|mesh-list
43697487|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697488|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697489|NCT03523273|Incretins|incretins|mesh-ancestor
43697490|NCT03523273|Hormones|hormones|mesh-ancestor
43697491|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697493|NCT03508570|Ipilimumab|ipilimumab|mesh-list
43697494|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697495|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697496|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43697497|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697499|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43697500|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697501|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
43697502|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43697503|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43697504|NCT03454529|Simvastatin|simvastatin|mesh-list
43697505|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43697506|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43697507|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
43697508|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697509|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43697510|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43697511|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697542|NCT03141034|Irinotecan|irinotecan|mesh-list
43697543|NCT03141034|Ramucirumab|ramucirumab|mesh-list
43697544|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43697545|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43697546|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697547|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697548|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697549|NCT03116126|Guanfacine|guanfacine|mesh-list
43692941|NCT02777229|Efavirenz|efavirenz|mesh-list
43692942|NCT02777229|Dolutegravir|dolutegravir|mesh-list
43697550|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43697551|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43697552|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43697553|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43697554|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
43697555|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697556|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697557|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697584|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
43697585|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697586|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697587|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
43697588|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697589|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43697590|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43697591|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
43697592|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43697593|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43697594|NCT02735239|Leucovorin|leucovorin|mesh-list
43697595|NCT02735239|Paclitaxel|paclitaxel|mesh-list
43697596|NCT02735239|Docetaxel|docetaxel|mesh-list
43697597|NCT02735239|Carboplatin|carboplatin|mesh-list
43697598|NCT02735239|Fluorouracil|fluorouracil|mesh-list
43697599|NCT02735239|Capecitabine|capecitabine|mesh-list
43697600|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
43697601|NCT02735239|Durvalumab|durvalumab|mesh-list
43697602|NCT02735239|Tremelimumab|tremelimumab|mesh-list
43697603|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43697604|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697605|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
43697606|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
43697607|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
43697608|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697609|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
43697610|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43697611|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43697612|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
43697613|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697614|NCT02735239|Antidotes|antidotes|mesh-ancestor
43697615|NCT02735239|Protective Agents|protective agents|mesh-ancestor
43697616|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
43697617|NCT02735239|Vitamins|vitamins|mesh-ancestor
43697618|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
43697619|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697620|NCT02655523|Dexamethasone|dexamethasone|mesh-list
43697621|NCT02655523|Triamcinolone|triamcinolone|mesh-list
43697622|NCT02655523|Bupivacaine|bupivacaine|mesh-list
43697623|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43697624|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
43697625|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
43697626|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697627|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697628|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43697629|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
43697644|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43697645|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697646|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
43697647|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
43697648|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
43697649|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697650|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697651|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697653|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
43697654|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697683|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
43697684|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43697685|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
43697686|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697687|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43697688|NCT02041234|Liraglutide|liraglutide|mesh-list
43697689|NCT02041234|Empagliflozin|empagliflozin|mesh-list
43697690|NCT02041234|Linagliptin|linagliptin|mesh-list
43697691|NCT02041234|Canagliflozin|canagliflozin|mesh-list
43697692|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43697693|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43697694|NCT02041234|Orlistat|orlistat|mesh-list
43697695|NCT02041234|Incretins|incretins|mesh-list
43697696|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697697|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697747|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
43697748|NCT00716066|Carmustine|carmustine|mesh-list
43697749|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
43697750|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43697751|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
43697752|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43697753|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43697754|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
43697755|NCT00716066|Hormones|hormones|mesh-ancestor
43697756|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697757|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697758|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43697759|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697760|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43697761|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43697762|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43697763|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697764|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697765|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43697766|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
43830067|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830068|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43830069|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
43830070|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43830071|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830072|NCT05385367|Anesthetics|anesthetics|mesh-list
43830073|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
43830074|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830075|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830076|NCT05384756|Sirolimus|sirolimus|mesh-list
43697831|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697832|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43697833|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43697834|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43697835|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43697836|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697837|NCT02750995|Azacitidine|azacitidine|mesh-list
43697838|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43697839|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
43697840|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697841|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697842|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697843|NCT02750748|Naltrexone|naltrexone|mesh-list
43697844|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43697845|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43697846|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697847|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
43697848|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697849|NCT02750696|Acetaminophen|acetaminophen|mesh-list
43697851|NCT02750696|Codeine|codeine|mesh-list
43697852|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43697853|NCT02750696|Analgesics|analgesics|mesh-ancestor
43697854|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
43697855|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697856|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697857|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
43697858|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43697889|NCT02750475|Protective Agents|protective agents|mesh-ancestor
43697890|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697891|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
43697892|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
43697893|NCT02750293|Vitamin D|vitamin d|mesh-list
43697894|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43697895|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697896|NCT02750293|Vitamins|vitamins|mesh-ancestor
43697897|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
43697898|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43697899|NCT02750254|Plerixafor|plerixafor|mesh-list
43697900|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
43697901|NCT02750254|Melphalan|melphalan|mesh-list
43697902|NCT02750254|Busulfan|busulfan|mesh-list
43697903|NCT02750254|Fludarabine|fludarabine|mesh-list
43697904|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
43697905|NCT02750254|Azacitidine|azacitidine|mesh-list
43697906|NCT02750254|Lenograstim|lenograstim|mesh-list
43697907|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43697908|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
43697909|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697910|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43697911|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43697912|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
43697913|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697914|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697915|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43697916|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43697917|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
43697918|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697919|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43697920|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43697921|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43697922|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
43697923|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697924|NCT02750202|Vaccines|vaccines|mesh-list
43697928|NCT02749994|Ezetimibe|ezetimibe|mesh-list
43697931|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
43697932|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697933|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43697934|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43697935|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697936|NCT02750137|Tetracaine|tetracaine|mesh-list
43697937|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697938|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
43697939|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697940|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697941|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
43697942|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697943|NCT02750059|Tenofovir|tenofovir|mesh-list
43697944|NCT02750059|Lamivudine|lamivudine|mesh-list
43697945|NCT02750059|Efavirenz|efavirenz|mesh-list
43697946|NCT02750059|Telmisartan|telmisartan|mesh-list
43697947|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
43697948|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697949|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43697950|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43697951|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697952|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697953|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43697954|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43697955|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43697956|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43697957|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43697958|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43697959|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43697960|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43697961|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43697962|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43697963|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43697964|NCT02749825|Goserelin|goserelin|mesh-list
43697965|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43697966|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43697967|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697968|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43697969|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697970|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
43697971|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43697972|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
43697983|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697984|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
43697985|NCT02749747|Sulpiride|sulpiride|mesh-list
43697986|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43697987|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43697988|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697989|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697990|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43697991|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43697992|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
43697993|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697994|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697995|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43697996|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
43697997|NCT02749578|Atorvastatin|atorvastatin|mesh-list
43697998|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43697999|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43698000|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
43698001|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698002|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43698003|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43698004|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698005|NCT02749656|Desoximetasone|desoximetasone|mesh-list
43698006|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698007|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
43698009|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698022|NCT02749292|Rituximab|rituximab|mesh-list
43698023|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43698024|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830107|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830108|NCT05383001|Durvalumab|durvalumab|mesh-list
43830109|NCT05383001|Tremelimumab|tremelimumab|mesh-list
43830133|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830134|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43830135|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43830136|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
43830137|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43830138|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43830139|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830140|NCT05382442|Antidotes|antidotes|mesh-ancestor
43698065|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43698066|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698067|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698068|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
43698069|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
43698071|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43698072|NCT02749032|Vildagliptin|vildagliptin|mesh-list
43698073|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698074|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698075|NCT02749032|Incretins|incretins|mesh-ancestor
43698076|NCT02749032|Hormones|hormones|mesh-ancestor
43698077|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698078|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43698079|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
43698080|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698113|NCT02749136|Gemcitabine|gemcitabine|mesh-list
43698115|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43698116|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
43698117|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698118|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698119|NCT02749136|Antiviral Agents|antiviral agents|mesh-ancestor
43698120|NCT02749136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698132|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43698133|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698134|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43698135|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43698136|NCT02748772|Growth Substances|growth substances|mesh-ancestor
43698137|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
43698138|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698139|NCT02748564|Aldesleukin|aldesleukin|mesh-list
43698140|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
43698141|NCT02748564|Interleukin-2|interleukin-2|mesh-list
43698142|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43698143|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698144|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698145|NCT02748564|Analgesics|analgesics|mesh-ancestor
43698146|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
43698147|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698148|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698150|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43698151|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
43698152|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698153|NCT02748265|Epoprostenol|epoprostenol|mesh-list
43698154|NCT02748265|Phenylephrine|phenylephrine|mesh-list
43698155|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
43698156|NCT02748265|Tezosentan|tezosentan|mesh-list
43698157|NCT02748265|Propofol|propofol|mesh-list
43698158|NCT02748265|Sevoflurane|sevoflurane|mesh-list
43698159|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43698160|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698161|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698162|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43698163|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
43698164|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
43698165|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43698180|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698182|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43698183|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
43698185|NCT02748304|Sorafenib|sorafenib|mesh-list
43698186|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43698187|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698188|NCT02748304|Analgesics|analgesics|mesh-ancestor
43698189|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
43698190|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698191|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698192|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698193|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698194|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43698195|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43698196|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698197|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43698198|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43698199|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698200|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
43698201|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698202|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43698203|NCT02748395|Triamcinolone|triamcinolone|mesh-list
43698204|NCT02748395|Lidocaine|lidocaine|mesh-list
43698205|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
43698206|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
43698207|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698215|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698216|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698217|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
43698218|NCT02748395|Hormones|hormones|mesh-ancestor
43698219|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698220|NCT02748330|Aspirin|aspirin|mesh-list
43698221|NCT02748330|Clopidogrel|clopidogrel|mesh-list
43698222|NCT02748330|Ticagrelor|ticagrelor|mesh-list
43698223|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43698224|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698225|NCT02748330|Analgesics|analgesics|mesh-ancestor
43698226|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
43698227|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698228|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698229|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698230|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698231|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43698232|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43698233|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698234|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43698235|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43698236|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698237|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
43698238|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43698239|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43698240|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43698241|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
43698242|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698244|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
43698245|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698247|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698248|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43698249|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698250|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698251|NCT02747940|Pregabalin|pregabalin|mesh-list
43698252|NCT02747940|Flunarizine|flunarizine|mesh-list
43698253|NCT02747940|Analgesics|analgesics|mesh-ancestor
43698254|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
43698255|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698256|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698257|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
43698258|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43698259|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698260|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698261|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43698262|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43698263|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43698264|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698265|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43698266|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43698267|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
43698268|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
43698269|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698270|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
43698271|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43698306|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698307|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43698309|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43698310|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43698311|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698312|NCT02747381|Vitamins|vitamins|mesh-ancestor
43698313|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
43830151|NCT05381948|Growth Substances|growth substances|mesh-ancestor
43830152|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830153|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
43830154|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830155|NCT05381909|Paclitaxel|paclitaxel|mesh-list
43698319|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43698320|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43698322|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43698323|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43698324|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698325|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
43698326|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698327|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698328|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
43698329|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698330|NCT02746783|Vaccines|vaccines|mesh-list
43698331|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
43698332|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698333|NCT02746250|Amitriptyline|amitriptyline|mesh-list
43698334|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
43698335|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
43698336|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43698337|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698338|NCT02746250|Analgesics|analgesics|mesh-ancestor
43698353|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
43698354|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43698355|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43698356|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698357|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43698358|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
43698359|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43698360|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
43698361|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698378|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698379|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698381|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698382|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43698383|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698384|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698386|NCT02745912|Naltrexone|naltrexone|mesh-list
43698387|NCT02745912|Bupropion|bupropion|mesh-list
43698388|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698389|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698390|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43698391|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43698392|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
43698393|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698394|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43698395|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
43698396|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43698397|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43698398|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43698399|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698400|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698401|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
43698402|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698403|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43698404|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43698405|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698406|NCT02745886|Metformin|metformin|mesh-list
43698407|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698408|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698409|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
43698410|NCT02745873|Vitamins|vitamins|mesh-ancestor
43698411|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
43698412|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698413|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
43698414|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698415|NCT02745873|Protective Agents|protective agents|mesh-ancestor
43830169|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
43830170|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43830171|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830172|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830174|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43830176|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43830177|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830178|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830179|NCT05380635|Hypericin|hypericin|mesh-list
43830180|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
43830181|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43830182|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830183|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
43830184|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830185|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830186|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830189|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830198|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43830199|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830201|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43830202|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
43830203|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830204|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43698424|NCT02745756|Vaccines|vaccines|mesh-list
43698425|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
43698426|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698427|NCT02745717|Cyclosporine|cyclosporine|mesh-list
43698428|NCT02745717|Cyclosporins|cyclosporins|mesh-list
43698429|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
43698430|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43698431|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698432|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698433|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698434|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
43698435|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698436|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
43698437|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698438|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
43698439|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698440|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43698441|NCT02745691|Gefitinib|gefitinib|mesh-list
43698442|NCT02745691|Crizotinib|crizotinib|mesh-list
43698443|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698444|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43698445|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698446|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698447|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
43698469|NCT02745093|Misoprostol|misoprostol|mesh-list
43698470|NCT02745093|Mifepristone|mifepristone|mesh-list
43698489|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43698491|NCT02744690|Mitomycin|mitomycin|mesh-list
43698492|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43698493|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698494|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
43698495|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698496|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43698497|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698498|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
43698499|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43698500|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698501|NCT02744716|Aspirin|aspirin|mesh-list
43698502|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43698503|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698504|NCT02744716|Analgesics|analgesics|mesh-ancestor
43698505|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
43698506|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698507|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698508|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698509|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698510|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43698511|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43698512|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698513|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43698514|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43698515|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698549|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698550|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698551|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698552|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43698553|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43698554|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698555|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43698556|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43698557|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698559|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43698560|NCT02744625|Propofol|propofol|mesh-list
43698561|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43698562|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698563|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698564|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43698565|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
43698566|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
43698567|NCT02744417|Bupropion|bupropion|mesh-list
43698568|NCT02744417|Nicotine|nicotine|mesh-list
43698583|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43698584|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698586|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43698587|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43698589|NCT02744339|Riociguat|riociguat|mesh-list
43698590|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
43700236|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
43698602|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698603|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43698604|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698605|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43698606|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43698607|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
43698608|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698609|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698610|NCT02744378|Clobetasol|clobetasol|mesh-list
43698611|NCT02744378|Tacrolimus|tacrolimus|mesh-list
43698612|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698613|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
43698614|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698615|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43698616|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698617|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698618|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698619|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
43698620|NCT02744378|Hormones|hormones|mesh-ancestor
43698621|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698622|NCT02744456|Losartan|losartan|mesh-list
43698623|NCT02744456|Amlodipine|amlodipine|mesh-list
43698624|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43698632|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43698633|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43698634|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43698635|NCT02744456|Diuretics|diuretics|mesh-ancestor
43849500|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849501|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
43698636|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
43698637|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43698668|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43698669|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43698670|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698671|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43698672|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43698673|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43698674|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
43698675|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698676|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698677|NCT02744196|Methotrexate|methotrexate|mesh-list
43698678|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698679|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
43698680|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698681|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698682|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43698683|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
43698684|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698685|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43698686|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
43698687|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698688|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
43698689|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698690|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43698691|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698692|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43698693|NCT02744131|Metformin|metformin|mesh-list
43698694|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
43698695|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
43698696|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
43698697|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43698698|NCT02744131|Estradiol|estradiol|mesh-list
43698699|NCT02744131|Cyproterone|cyproterone|mesh-list
43698709|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698710|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43830205|NCT05379179|Fentanyl|fentanyl|mesh-list
43830206|NCT05379179|Ketamine|ketamine|mesh-list
43830207|NCT05379179|Analgesics|analgesics|mesh-ancestor
43830208|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
43830209|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830210|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830211|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43698750|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43698751|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
43698752|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698753|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698754|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43698755|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43698756|NCT02743260|Protective Agents|protective agents|mesh-ancestor
43698757|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
43698758|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698759|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43698760|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43698761|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43698762|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43698792|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
43698793|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43698824|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43698825|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43698826|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43698827|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
43698828|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
43698829|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43698830|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
43698831|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43849503|NCT03920722|Rituximab|rituximab|mesh-list
43698846|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
43698847|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698848|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
43698863|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
43698864|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698865|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
43698866|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43698867|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
43698868|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43698870|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
43698871|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
43698872|NCT02742805|Vitamins|vitamins|mesh-list
43698873|NCT02742805|Omalizumab|omalizumab|mesh-list
43698874|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
43698875|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698876|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43698877|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43698878|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43698879|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43698880|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
43698882|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43698883|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
43830226|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
43698884|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43698886|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698887|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698888|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
43698889|NCT02742285|Lumefantrine|lumefantrine|mesh-list
43698894|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43698895|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698896|NCT02742480|Dabigatran|dabigatran|mesh-list
43698897|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
43698898|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
43698899|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43698900|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
43698901|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698902|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698903|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
43698904|NCT02742233|Saxagliptin|saxagliptin|mesh-list
43698905|NCT02742233|Incretins|incretins|mesh-ancestor
43698906|NCT02742233|Hormones|hormones|mesh-ancestor
43698907|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698908|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698909|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43698910|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
43698911|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698912|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698913|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698914|NCT02742467|Amlodipine|amlodipine|mesh-list
43698915|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43698916|NCT02742467|Perindopril|perindopril|mesh-list
43698917|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43698918|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43698953|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43698954|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43698955|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698956|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43698957|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
43698958|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698959|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43698960|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43698961|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43698963|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
43698964|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
43698965|NCT02742038|Protective Agents|protective agents|mesh-ancestor
43698966|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698967|NCT02741947|Levodopa|levodopa|mesh-list
43698968|NCT02741947|Benserazide|benserazide|mesh-list
43698969|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43698970|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43830266|NCT05376553|Cisplatin|cisplatin|mesh-list
43830267|NCT05376553|Docetaxel|docetaxel|mesh-list
43830268|NCT05376553|Cemiplimab|cemiplimab|mesh-list
43830280|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43830281|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
43830282|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698977|NCT02741960|Metformin|metformin|mesh-list
43698978|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698979|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698981|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43698982|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698983|NCT02741817|Analgesics|analgesics|mesh-ancestor
43698984|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
43698996|NCT02741856|Paclitaxel|paclitaxel|mesh-list
43698997|NCT02741856|Cisplatin|cisplatin|mesh-list
43698998|NCT02741856|Carboplatin|carboplatin|mesh-list
43698999|NCT02741856|Capecitabine|capecitabine|mesh-list
43699000|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43699001|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699002|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
43699003|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
43699004|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
43699005|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699007|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
43699028|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43699030|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43699031|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
43699032|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
43699033|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
43699034|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43699035|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
43699036|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43699052|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43699053|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699054|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699055|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43699056|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43699057|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43699094|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43699095|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699096|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699097|NCT02740829|Glucagon|glucagon|mesh-list
43699098|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43699099|NCT02740829|Hormones|hormones|mesh-ancestor
43699100|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699101|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699102|NCT02741063|Oxytocin|oxytocin|mesh-list
43699115|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43699116|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699117|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699118|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43699119|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
43699142|NCT02741024|Amodiaquine|amodiaquine|mesh-list
43699143|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
43699144|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43699145|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43699146|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699158|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43699160|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699161|NCT02740712|Vitamin K|vitamin k|mesh-list
43699162|NCT02740712|Rucaparib|rucaparib|mesh-list
43699163|NCT02740712|Digoxin|digoxin|mesh-list
43699164|NCT02740712|Midazolam|midazolam|mesh-list
43699165|NCT02740712|Caffeine|caffeine|mesh-list
43699166|NCT02740712|Omeprazole|omeprazole|mesh-list
43699167|NCT02740712|Warfarin|warfarin|mesh-list
43699168|NCT02740712|Vitamins|vitamins|mesh-ancestor
43699169|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
43699180|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
43699181|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
43699182|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699183|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699184|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
43699185|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43699192|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43699193|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
43699194|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43699195|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43699208|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699210|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
43699211|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43699212|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699213|NCT02740192|Bupivacaine|bupivacaine|mesh-list
43699214|NCT02740192|Ropivacaine|ropivacaine|mesh-list
43699215|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
43699216|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
43699217|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699218|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699219|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
43699220|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699221|NCT02740166|Propranolol|propranolol|mesh-list
43699222|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43699223|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43699224|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
43699225|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699226|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847290|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847304|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43847305|NCT04122443|Narcotics|narcotics|mesh-ancestor
43847306|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43847307|NCT04120961|Hirudins|hirudins|mesh-list
43847308|NCT04120961|Bivalirudin|bivalirudin|mesh-list
43847309|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
43847310|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43847311|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
43847312|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847313|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847314|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
43847315|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43847316|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43847318|NCT04117087|Ipilimumab|ipilimumab|mesh-list
43847319|NCT04117087|Poly ICLC|poly iclc|mesh-list
43699241|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43699242|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
43699243|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699245|NCT02739880|Protective Agents|protective agents|mesh-ancestor
43699246|NCT02739906|Insulin|insulin|mesh-list
43699259|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
43699260|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43699261|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
43699262|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699263|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43699264|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699265|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
43699266|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699267|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
43699268|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43699269|NCT02739711|Protective Agents|protective agents|mesh-ancestor
43699270|NCT02739672|Amlodipine|amlodipine|mesh-list
43699271|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43699272|NCT02739672|Telmisartan|telmisartan|mesh-list
43699273|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43699274|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43699275|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43699276|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43699277|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699278|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43699279|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699280|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
43699281|NCT02739672|Diuretics|diuretics|mesh-ancestor
43699282|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
43699283|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43849530|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
43699297|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
43699298|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699299|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43699300|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
43699301|NCT02739633|Antiviral Agents|antiviral agents|mesh-ancestor
43699302|NCT02739633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699303|NCT02739633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699304|NCT02739633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43699305|NCT02739633|Immunologic Factors|immunologic factors|mesh-ancestor
43699306|NCT02739633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699316|NCT02739516|Letrozole|letrozole|mesh-list
43699317|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43699318|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699319|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43699320|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43699321|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699322|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699323|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43699324|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
43699325|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699326|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699327|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43699328|NCT02739399|Phenylephrine|phenylephrine|mesh-list
43699329|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
43699338|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
43699339|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43699340|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43699341|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43699342|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
43699343|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699355|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
43699356|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699357|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699358|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43699359|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849504|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43699360|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43699361|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43699362|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699363|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699364|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
43699365|NCT02739061|Sertraline|sertraline|mesh-list
43699366|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
43699367|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43699368|NCT02739061|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43699369|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43699370|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43699371|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699372|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699373|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
43699374|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699375|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43699376|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43699377|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699378|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43699379|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43699380|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43699381|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699382|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43699383|NCT02738970|Trastuzumab|trastuzumab|mesh-list
43699384|NCT02738970|Pertuzumab|pertuzumab|mesh-list
43699385|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43699386|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699387|NCT02738918|Abatacept|abatacept|mesh-list
43699388|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43699389|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699390|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699391|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43699392|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
43699393|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699394|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43699395|NCT02738931|Lamivudine|lamivudine|mesh-list
43699396|NCT02738931|Dolutegravir|dolutegravir|mesh-list
43699397|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43699398|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43699399|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699400|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699401|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
43699411|NCT02738814|Propofol|propofol|mesh-list
43699412|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43699413|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699414|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699415|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43699416|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
43699417|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
43699418|NCT02739386|Ipilimumab|ipilimumab|mesh-list
43699433|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43699434|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
43699435|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699436|NCT02738502|Ritonavir|ritonavir|mesh-list
43699479|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43699480|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
43699481|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43830327|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
43830328|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830329|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43830330|NCT05368090|Epinephrine|epinephrine|mesh-list
43830331|NCT05368090|Racepinephrine|racepinephrine|mesh-list
43830332|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
43830333|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43830334|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43830335|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
43830336|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830337|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830338|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830339|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43830340|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43830341|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
43830342|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830343|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43830344|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
43830361|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830362|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830363|NCT05366933|Folic Acid|folic acid|mesh-list
43830364|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
43830365|NCT05366933|Vitamins|vitamins|mesh-ancestor
43830366|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
43830367|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830368|NCT05366933|Hematinics|hematinics|mesh-ancestor
43830369|NCT05366868|Metformin|metformin|mesh-list
43699518|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699519|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
43699520|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
43699521|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43699522|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
43699523|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699524|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43699525|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43699526|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43699569|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43699570|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43699571|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699580|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
43699581|NCT02737423|Vitamins|vitamins|mesh-ancestor
43699623|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43699625|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
43699626|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699627|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699628|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
43699629|NCT02737150|Anesthetics|anesthetics|mesh-list
43699630|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699631|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699632|NCT02737059|Codeine|codeine|mesh-list
43699633|NCT02737059|Naloxegol|naloxegol|mesh-list
43699634|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43699635|NCT02737059|Narcotics|narcotics|mesh-ancestor
43699636|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699637|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699638|NCT02737059|Analgesics|analgesics|mesh-ancestor
43699639|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
43699640|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699641|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
43699642|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
43699643|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43699644|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43699645|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43699646|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
43699647|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
43699648|NCT02736604|Anesthetics|anesthetics|mesh-list
43699649|NCT02736604|Sevoflurane|sevoflurane|mesh-list
43699650|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699651|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699652|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43699653|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43699654|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
43699655|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43699656|NCT02736604|Analgesics|analgesics|mesh-ancestor
43699659|NCT02736448|Capecitabine|capecitabine|mesh-list
43699665|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
43699666|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699667|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699668|NCT02736513|Osimertinib|osimertinib|mesh-list
43699669|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699670|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43699671|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699672|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699673|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43699692|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43699693|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
43699694|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699695|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
43699696|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43699697|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699699|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43699700|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
43699701|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699702|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43699703|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43699704|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43699705|NCT02736032|Estradiol|estradiol|mesh-list
43699706|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43699707|NCT02736032|Progesterone|progesterone|mesh-list
43699708|NCT02736032|Estrogens|estrogens|mesh-ancestor
43699709|NCT02736032|Hormones|hormones|mesh-ancestor
43699710|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699711|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699712|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43699713|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
43699714|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43699715|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43699716|NCT02736032|Progestins|progestins|mesh-ancestor
43699717|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
43699718|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43699719|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699720|NCT02736071|Celecoxib|celecoxib|mesh-list
43699721|NCT02736071|Tramadol|tramadol|mesh-list
43699722|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43699723|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43699724|NCT02736071|Analgesics|analgesics|mesh-ancestor
43699725|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
43699726|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699727|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699728|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43699729|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43699730|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43699731|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43699732|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699733|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699734|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43699735|NCT02736071|Narcotics|narcotics|mesh-ancestor
43699736|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699737|NCT02736123|Nivolumab|nivolumab|mesh-list
43830382|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830383|NCT05365451|Diuretics|diuretics|mesh-ancestor
43830384|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
43830385|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43830386|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43830387|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830388|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
43830389|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
43830390|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830391|NCT05365451|Renal Agents|renal agents|mesh-ancestor
43830392|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43830393|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43830394|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43830395|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
43699794|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43699795|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
43699796|NCT02735694|Cycloserine|cycloserine|mesh-list
43699797|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43699798|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699799|NCT02735694|Renal Agents|renal agents|mesh-ancestor
43699800|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43699801|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
43699802|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699803|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
43699804|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699805|NCT02735395|Amoxicillin|amoxicillin|mesh-list
43699806|NCT02735395|Metronidazole|metronidazole|mesh-list
43699807|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699808|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699809|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43699821|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699822|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43699823|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43699824|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699825|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699826|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
43699827|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
43699828|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43830396|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
43699840|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699841|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43699842|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
43699843|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699844|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699845|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43699847|NCT02735603|Naltrexone|naltrexone|mesh-list
43699848|NCT02735603|Bupropion|bupropion|mesh-list
43699941|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43699942|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43699943|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43699945|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
43699946|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43699947|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43699948|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43699949|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43699964|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699965|NCT02734407|Aflibercept|aflibercept|mesh-list
43699966|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43699967|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43699968|NCT02734407|Growth Substances|growth substances|mesh-ancestor
43699981|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
43699982|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699983|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43699984|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43699985|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
43699986|NCT02734069|Carboplatin|carboplatin|mesh-list
43699987|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699988|NCT02734186|Praziquantel|praziquantel|mesh-list
43699989|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
43699990|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43699991|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849507|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699992|NCT02734160|Durvalumab|durvalumab|mesh-list
43699993|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43699994|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830397|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830398|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43830399|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43830400|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830401|NCT05364645|Carboplatin|carboplatin|mesh-list
43830402|NCT05364645|Pemetrexed|pemetrexed|mesh-list
43830403|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830404|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830405|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830406|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43830407|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43830408|NCT05363670|Albuterol|albuterol|mesh-list
43830409|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43830410|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
43830411|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830412|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830413|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43830414|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
43830415|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
43830416|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43830417|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43830418|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43830419|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43830420|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
43830421|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830422|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830423|NCT05363631|Selenium|selenium|mesh-list
43830424|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
43830425|NCT05363631|Axitinib|axitinib|mesh-list
43830426|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830427|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830428|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43830438|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43830439|NCT05363267|Analgesics|analgesics|mesh-ancestor
43830440|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
43830441|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830442|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830443|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43830444|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830445|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830446|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830447|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830448|NCT05362474|Montelukast|montelukast|mesh-list
43830449|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43830450|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
43830451|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43830452|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
43830453|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699995|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
43699996|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43699997|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43699998|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699999|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
43700000|NCT02733952|Coagulants|coagulants|mesh-ancestor
43700001|NCT02733809|Sorafenib|sorafenib|mesh-list
43700002|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700003|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43700004|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700005|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700007|NCT02733640|Ranitidine|ranitidine|mesh-list
43700008|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43700009|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43700010|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700011|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43700012|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700013|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700014|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43700015|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
43700016|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
43700017|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700018|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700019|NCT02733835|Remifentanil|remifentanil|mesh-list
43700020|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43700021|NCT02733835|Narcotics|narcotics|mesh-ancestor
43700022|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700023|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700024|NCT02733835|Analgesics|analgesics|mesh-ancestor
43700025|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
43700026|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700027|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43700028|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43700029|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700030|NCT02733822|Naloxone|naloxone|mesh-list
43700031|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43700032|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700033|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
43700034|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700035|NCT02733679|Metformin|metformin|mesh-list
43700036|NCT02733679|Pioglitazone|pioglitazone|mesh-list
43700037|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43849531|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700135|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43700136|NCT02733237|Oxytocin|oxytocin|mesh-list
43700137|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
43700138|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43700139|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700140|NCT02733250|Paclitaxel|paclitaxel|mesh-list
43700141|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
43700142|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43700143|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700144|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
43700145|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
43700146|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
43700147|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700148|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43700149|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43700150|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
43700151|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
43700152|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700153|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43700154|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43700155|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700178|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700179|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700180|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700181|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
43700182|NCT02733380|Hormones|hormones|mesh-ancestor
43700183|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700184|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43700185|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700186|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43700187|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43700188|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43700189|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700190|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700191|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43700192|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
43700193|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
43700194|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
43700195|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43700196|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
43700197|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
43700198|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43700213|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700216|NCT02732795|Morphine|morphine|mesh-list
43700222|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
43700223|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700224|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43700225|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43700226|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43700227|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700228|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847339|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43847340|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847341|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
43847342|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847343|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700303|NCT02732132|Fentanyl|fentanyl|mesh-list
43700304|NCT02732132|Midazolam|midazolam|mesh-list
43700305|NCT02732132|Ketamine|ketamine|mesh-list
43700306|NCT02732132|Propofol|propofol|mesh-list
43700307|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43700308|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700309|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849521|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43849522|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43849523|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
43849524|NCT03919955|Urological Agents|urological agents|mesh-ancestor
43849525|NCT03919799|Belumosudil|belumosudil|mesh-list
43849526|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43849527|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849528|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849529|NCT03919292|Valproic Acid|valproic acid|mesh-list
43700315|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700317|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43700318|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43700319|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700320|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700321|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43700322|NCT02732132|Narcotics|narcotics|mesh-ancestor
43700323|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43700324|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43700325|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43700326|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43700327|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
43700328|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
43700329|NCT02732249|Metronidazole|metronidazole|mesh-list
43700330|NCT02732249|Clarithromycin|clarithromycin|mesh-list
43700331|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
43700332|NCT02732249|Esomeprazole|esomeprazole|mesh-list
43700334|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700335|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700336|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43700337|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43700338|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43700339|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43700340|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700341|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43700342|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700343|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43700344|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43700345|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43700346|NCT02732249|Antacids|antacids|mesh-ancestor
43700347|NCT02732249|Diuretics|diuretics|mesh-ancestor
43700348|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
43700349|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700350|NCT02732249|Expectorants|expectorants|mesh-ancestor
43700351|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
43700352|NCT02732314|Desonide|desonide|mesh-list
43700353|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700354|NCT02732093|Lidocaine|lidocaine|mesh-list
43700355|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
43700356|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
43700357|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700358|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700359|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
43700366|NCT02732236|Rituximab|rituximab|mesh-list
43700382|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
43700383|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43700384|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700385|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700386|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43700387|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
43700388|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43700389|NCT02731911|Dexamethasone|dexamethasone|mesh-list
43700390|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700416|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43700417|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
43700418|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
43700419|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43700420|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
43700421|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43700422|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43700423|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43700424|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43700425|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
43700538|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700539|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700540|NCT02730676|Menthol|menthol|mesh-list
43700541|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
43700542|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
43700543|NCT02730624|Tazobactam|tazobactam|mesh-list
43700544|NCT02730624|Piperacillin|piperacillin|mesh-list
43700545|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43700546|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43700547|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700548|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43700549|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700550|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700551|NCT02730481|Paclitaxel|paclitaxel|mesh-list
43700552|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43700553|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700554|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
43700555|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
43700556|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
43700557|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700558|NCT02730572|Methylphenidate|methylphenidate|mesh-list
43700559|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43700560|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700561|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43700562|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43700563|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700564|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700565|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
43700566|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700567|NCT02730442|Fluconazole|fluconazole|mesh-list
43700568|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
43700569|NCT02730442|Clotrimazole|clotrimazole|mesh-list
43700570|NCT02730442|Miconazole|miconazole|mesh-list
43700571|NCT02730442|Olorofim|olorofim|mesh-list
43700824|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
43700583|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43700584|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43700585|NCT02730364|Acetaminophen|acetaminophen|mesh-list
43700586|NCT02730364|Ascorbic Acid|ascorbic acid|mesh-list
43700587|NCT02730364|Pheniramine|pheniramine|mesh-list
43700588|NCT02730364|Phenylephrine|phenylephrine|mesh-list
43700599|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700600|NCT02730364|Protective Agents|protective agents|mesh-ancestor
43700601|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43700602|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
43700603|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
43700604|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
43700605|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43700606|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
43700607|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
43700608|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43700609|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43700610|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43700611|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
43700612|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700613|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
43700614|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
43700615|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43700616|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
43700645|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830491|NCT05359055|Rifampin|rifampin|mesh-list
43830492|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
43830493|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830494|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43830495|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43830496|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830497|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830503|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43830504|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
43830505|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43830506|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
43830507|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43830508|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43830537|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830538|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43830539|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43830540|NCT05357417|Growth Substances|growth substances|mesh-ancestor
43830541|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830542|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
43830543|NCT05356897|Trifluridine|trifluridine|mesh-list
43830544|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43830545|NCT05356897|Trastuzumab|trastuzumab|mesh-list
43830546|NCT05356897|Tucatinib|tucatinib|mesh-list
43830547|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43830548|NCT05356897|Antibodies|antibodies|mesh-list
43830549|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
43830550|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43830551|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
43830552|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830553|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700646|NCT02730091|Letrozole|letrozole|mesh-list
43700657|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700658|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43700659|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
43700660|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
43700661|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
43700662|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43700663|NCT02730026|Ketoprofen|ketoprofen|mesh-list
43700664|NCT02730026|Omeprazole|omeprazole|mesh-list
43700665|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43700666|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700667|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43700668|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700669|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700670|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43700671|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43700672|NCT02730026|Analgesics|analgesics|mesh-ancestor
43700673|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
43700674|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700675|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700676|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700677|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43700678|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43700679|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43700680|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43700681|NCT02729961|Ceritinib|ceritinib|mesh-list
43700682|NCT02729961|Antibodies|antibodies|mesh-list
43700683|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
43700684|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43700685|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
43700686|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
43700687|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700688|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700689|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43700690|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700691|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700692|NCT02729662|Tolvaptan|tolvaptan|mesh-list
43700693|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43700694|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700695|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
43700710|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43700711|NCT02729870|Laxatives|laxatives|mesh-ancestor
43700712|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700713|NCT02729805|Ketamine|ketamine|mesh-list
43700714|NCT02729805|Analgesics|analgesics|mesh-ancestor
43700755|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43700756|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
43700757|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700758|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700759|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43700760|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
43700761|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700762|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700763|NCT02729467|Itraconazole|itraconazole|mesh-list
43700764|NCT02729467|Rifampin|rifampin|mesh-list
43700765|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
43700766|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700767|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43700768|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43700769|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700770|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700771|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43700772|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
43700773|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700774|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700775|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43700776|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43700777|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
43700778|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43700779|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
43700780|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43700781|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43700812|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700813|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43700814|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43700815|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700816|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43700817|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
43700818|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700819|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43700820|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700822|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43700823|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
43700863|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43700864|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43700865|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700866|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43700867|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
43700868|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700869|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700870|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43700871|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43700872|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43700873|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43700884|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
43830557|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830558|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43830559|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830560|NCT05355974|Norepinephrine|norepinephrine|mesh-list
43830561|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
43830562|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43830563|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43830564|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
43830565|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830566|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830567|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830568|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
43830569|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
43830570|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830571|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43830572|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43830573|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43830574|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43830575|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43830576|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830577|NCT05355350|Meropenem|meropenem|mesh-list
43830578|NCT05355350|Tazobactam|tazobactam|mesh-list
43830579|NCT05355350|Piperacillin|piperacillin|mesh-list
43830580|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43830581|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43830582|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830583|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43830584|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830585|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700983|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700995|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
43700996|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700997|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
43700998|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700999|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43701000|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
43701001|NCT02727621|Propofol|propofol|mesh-list
43701002|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43701003|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701004|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701005|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43701006|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
43701007|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
43701008|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701009|NCT02727621|Analgesics|analgesics|mesh-ancestor
43701010|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
43701011|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701012|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43701013|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43701014|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43701015|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
43701016|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701017|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701018|NCT02727608|Eculizumab|eculizumab|mesh-list
43701019|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43701020|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701021|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
43701022|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701023|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
43701024|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
43701025|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
43701026|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43701027|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43701028|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701029|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701030|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701031|NCT02727504|Dobutamine|dobutamine|mesh-list
43701032|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43701033|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
43701034|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
43701073|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701076|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
43701077|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701078|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701079|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701080|NCT02726867|Lacosamide|lacosamide|mesh-list
43701081|NCT02726867|Ketamine|ketamine|mesh-list
43701082|NCT02726867|Levetiracetam|levetiracetam|mesh-list
43701083|NCT02726867|Phenobarbital|phenobarbital|mesh-list
43701084|NCT02726867|Analgesics|analgesics|mesh-ancestor
43701085|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
43701086|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701087|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849547|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701088|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43701089|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43701091|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
43701092|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701093|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43701094|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43701095|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701096|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701097|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
43701098|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
43701099|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43701100|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43701101|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701102|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43701103|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
43701104|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
43701105|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43701106|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43701118|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43701119|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701120|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701121|NCT02726828|Ketamine|ketamine|mesh-list
43701122|NCT02726828|Morphine|morphine|mesh-list
43701123|NCT02726828|Analgesics|analgesics|mesh-ancestor
43701132|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43701133|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43701134|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701135|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830594|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
43830629|NCT05352516|Denosumab|denosumab|mesh-list
43830630|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43830631|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830632|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43830633|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43701144|NCT02726555|Red yeast rice|red yeast rice|mesh-list
43701145|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43701146|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43701147|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
43701148|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701149|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43701150|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43701151|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701152|NCT02726490|Metformin|metformin|mesh-list
43701153|NCT02726490|Glyburide|glyburide|mesh-list
43701154|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43701155|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701156|NCT02726737|Lidocaine|lidocaine|mesh-list
43701157|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
43701158|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
43701159|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701160|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701161|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
43701162|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701163|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43701164|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43701165|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43701166|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701167|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701168|NCT02726646|Doxycycline|doxycycline|mesh-list
43701169|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43701170|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701171|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
43701172|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43701173|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43701174|NCT02726308|Dexamethasone|dexamethasone|mesh-list
43701175|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701176|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
43701177|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
43701207|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701208|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43701209|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43701211|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
43701212|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
43701265|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43701266|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
43701267|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43701268|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
43701269|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
43701270|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701271|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701272|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43701273|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
43701284|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
43701285|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43701286|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43701287|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
43701288|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
43701289|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
43701290|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701291|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701292|NCT02725359|Tizanidine|tizanidine|mesh-list
43701293|NCT02725359|Bupivacaine|bupivacaine|mesh-list
43701294|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
43701295|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
43849548|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43701308|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43701309|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
43701310|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701311|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701313|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43701314|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701315|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
43701316|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
43701317|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
43701318|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701319|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701320|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
43701321|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701322|NCT02725242|Budesonide|budesonide|mesh-list
43701323|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
43701324|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701325|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43701326|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
43701327|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701328|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701329|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43701330|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
43701331|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
43701332|NCT02725242|Hormones|hormones|mesh-ancestor
43701333|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43701334|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43701335|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43701336|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43701337|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
43701338|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701339|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701340|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
43701341|NCT02725164|Sevoflurane|sevoflurane|mesh-list
43701342|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43701343|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43701344|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
43701345|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
43701346|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701375|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701376|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
43701377|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701378|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43701379|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43701380|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
43701381|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43701382|NCT02725112|Pregabalin|pregabalin|mesh-list
43701383|NCT02725112|Analgesics|analgesics|mesh-ancestor
43701384|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
43830654|NCT05351346|Decitabine|decitabine|mesh-list
43830655|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43830656|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
43830657|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830658|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830659|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43830660|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
43830661|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830662|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830663|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43830664|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43701414|NCT02724618|Curcumin|curcumin|mesh-list
43701415|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43701416|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701431|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
43701432|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701433|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
43701434|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701435|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
43701436|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43701437|NCT02724358|Estrogens|estrogens|mesh-ancestor
43701438|NCT02724358|Hormones|hormones|mesh-ancestor
43701439|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43701440|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701441|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43701442|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701443|NCT02724202|Curcumin|curcumin|mesh-list
43701444|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43701445|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701446|NCT02724202|Analgesics|analgesics|mesh-ancestor
43701447|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
43701448|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701449|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701450|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701451|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701452|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701453|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701454|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701485|NCT02724293|Pregabalin|pregabalin|mesh-list
43701486|NCT02724293|Analgesics|analgesics|mesh-ancestor
43701487|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
43701488|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701489|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701490|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
43701491|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43701492|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701493|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701494|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43701513|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701514|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701515|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43701516|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43701517|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
43701518|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
43701519|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701520|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43701521|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43701522|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43701523|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701524|NCT02724163|Analgesics|analgesics|mesh-ancestor
43701525|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
43701526|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701527|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43701528|NCT02723981|Vitamins|vitamins|mesh-list
43701529|NCT02723981|Vitamin K|vitamin k|mesh-list
43701530|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
43701531|NCT02723981|Dabigatran|dabigatran|mesh-list
43701532|NCT02723981|Anticoagulants|anticoagulants|mesh-list
43701533|NCT02723981|Clopidogrel|clopidogrel|mesh-list
43701534|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
43701535|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701554|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43701555|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701556|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701557|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701558|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
43701559|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701560|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43701561|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
43701562|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43701563|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43701564|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43701565|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701566|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
43701567|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43701568|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701570|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43701571|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701572|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701573|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701574|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43701575|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43701576|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43701577|NCT02723838|Gemcitabine|gemcitabine|mesh-list
43701578|NCT02723838|Cisplatin|cisplatin|mesh-list
43701579|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701580|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43701581|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
43701582|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701583|NCT02723838|Antiviral Agents|antiviral agents|mesh-ancestor
43701584|NCT02723838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701585|NCT02723838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701586|NCT02723838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701587|NCT02723838|Immunologic Factors|immunologic factors|mesh-ancestor
43701588|NCT02723838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701590|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43701591|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
43701592|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
43701593|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701594|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701595|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
43701596|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43701597|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
43701598|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701599|NCT02723669|Expectorants|expectorants|mesh-ancestor
43701600|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
43701611|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701612|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701614|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
43701615|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43701616|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701617|NCT02723487|Bupivacaine|bupivacaine|mesh-list
43701618|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
43701643|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
43701644|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
43701645|NCT02723266|Protective Agents|protective agents|mesh-ancestor
43701647|NCT02723253|Raltitrexed|raltitrexed|mesh-list
43701649|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43701650|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
43701651|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701652|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43701653|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701654|NCT02723383|Baclofen|baclofen|mesh-list
43701655|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43701656|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701657|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43701658|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701659|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43701660|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
43701661|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
43701662|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701663|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701664|NCT02723435|Midostaurin|midostaurin|mesh-list
43701665|NCT02723435|Staurosporine|staurosporine|mesh-list
43701666|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701667|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43701668|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701669|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701679|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43701680|NCT02722811|Etanercept|etanercept|mesh-list
43701681|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43701682|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701683|NCT02722811|Analgesics|analgesics|mesh-ancestor
43701684|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
43701685|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701686|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701687|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701688|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701689|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43701690|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701691|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
43701692|NCT02722538|Gemcitabine|gemcitabine|mesh-list
43701693|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43701694|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
43701695|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701696|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701697|NCT02722538|Antiviral Agents|antiviral agents|mesh-ancestor
43701698|NCT02722538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701699|NCT02722538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701700|NCT02722538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701701|NCT02722538|Immunologic Factors|immunologic factors|mesh-ancestor
43701702|NCT02722538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701727|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
43701728|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43701729|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
43701731|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
43701734|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43701735|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701736|NCT02722772|Analgesics|analgesics|mesh-ancestor
43701737|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
43701738|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701739|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701740|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701741|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701742|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43701743|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701744|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
43701745|NCT02722733|Cytarabine|cytarabine|mesh-list
43701746|NCT02722733|Lenograstim|lenograstim|mesh-list
43701747|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43701748|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
43701749|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701750|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43701751|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
43701752|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701753|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701754|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
43701755|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701756|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701757|NCT02722694|Methotrexate|methotrexate|mesh-list
43701758|NCT02722694|Abatacept|abatacept|mesh-list
43701759|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43701760|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
43701761|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43701762|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701763|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43701764|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
43701765|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701766|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701767|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
43701768|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701769|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43701770|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701771|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
43701772|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701773|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43701774|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43701775|NCT02722603|Gabapentin|gabapentin|mesh-list
43701776|NCT02722603|Tramadol|tramadol|mesh-list
43701777|NCT02722603|Analgesics|analgesics|mesh-ancestor
43701778|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
43701779|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701780|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701781|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
43701782|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43701783|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43701784|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701785|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43701828|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
43701829|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701830|NCT02722369|Antiviral Agents|antiviral agents|mesh-ancestor
43701873|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701874|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
43701875|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701876|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43701877|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43701878|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43701879|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701882|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43701883|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701884|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43701885|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43701886|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43701887|NCT02721888|Liraglutide|liraglutide|mesh-list
43701888|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43701889|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701890|NCT02721888|Incretins|incretins|mesh-ancestor
43701891|NCT02721888|Hormones|hormones|mesh-ancestor
43701892|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43701893|NCT02721511|Furosemide|furosemide|mesh-list
43701907|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
43701908|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
43701909|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701910|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701911|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
43701928|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43701929|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701930|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
43701931|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43701932|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43701933|NCT02721043|Lenalidomide|lenalidomide|mesh-list
43701934|NCT02721043|Vaccines|vaccines|mesh-list
43701935|NCT02721043|Poly ICLC|poly iclc|mesh-list
43701936|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
43701937|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701938|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43701939|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43701940|NCT02721043|Growth Substances|growth substances|mesh-ancestor
43701941|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
43701942|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701943|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
43701944|NCT02721290|Ropivacaine|ropivacaine|mesh-list
43701945|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
43701946|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
43701947|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701948|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701949|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
43701950|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701951|NCT02721173|Clindamycin|clindamycin|mesh-list
43701952|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
43701953|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
43701954|NCT02721173|Adapalene|adapalene|mesh-list
43701955|NCT02721173|Tazarotene|tazarotene|mesh-list
43701956|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43701957|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701958|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43701959|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701960|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701961|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43701962|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701963|NCT02721173|Analgesics|analgesics|mesh-ancestor
43701964|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
43701965|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701966|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701967|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701980|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43701981|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701983|NCT02720991|Mifepristone|mifepristone|mesh-list
43701984|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43701985|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
43701986|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43849550|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
43701987|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701988|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43701989|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43701990|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
43702015|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702016|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702017|NCT02720926|Capecitabine|capecitabine|mesh-list
43702018|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
43702019|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702020|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
43702021|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702022|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702023|NCT02720965|Anesthetics|anesthetics|mesh-list
43702024|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
43702025|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702026|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702041|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702043|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43702044|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702045|NCT02720692|Analgesics|analgesics|mesh-ancestor
43702046|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
43702047|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702048|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702049|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702050|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43702051|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43702052|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43702053|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702054|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702055|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
43702056|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43702057|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702058|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702059|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702060|NCT02720705|Analgesics|analgesics|mesh-ancestor
43702061|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
43702087|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702088|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702090|NCT02720575|Vitamins|vitamins|mesh-ancestor
43702091|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
43702092|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702093|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43702094|NCT02720406|Ketamine|ketamine|mesh-list
43702095|NCT02720406|Analgesics|analgesics|mesh-ancestor
43702096|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
43702097|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702098|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702099|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43702100|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43702118|NCT02720367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702119|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
43702120|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
43702121|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702123|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43702124|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702125|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702126|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
43702127|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702128|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702130|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
43702131|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43702132|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702133|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43702134|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702135|NCT02719795|Ropivacaine|ropivacaine|mesh-list
43702136|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
43702137|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
43702139|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702140|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
43702141|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702142|NCT02719834|Acetaminophen|acetaminophen|mesh-list
43702143|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702144|NCT02719834|Analgesics|analgesics|mesh-ancestor
43702145|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
43702146|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702147|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702148|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
43702149|NCT02719808|Tenofovir|tenofovir|mesh-list
43702150|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
43702151|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702152|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43702153|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43702154|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702155|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702156|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43702157|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43702158|NCT02719574|Cytarabine|cytarabine|mesh-list
43702159|NCT02719574|Azacitidine|azacitidine|mesh-list
43702160|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702161|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
43702162|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702163|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702187|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43702188|NCT02719210|Diuretics|diuretics|mesh-ancestor
43702189|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
43702190|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830670|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
43830671|NCT05351346|Hormones|hormones|mesh-ancestor
43830684|NCT05350124|Vitamins|vitamins|mesh-list
43830685|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
43830686|NCT05350124|Vitamin E|vitamin e|mesh-list
43830687|NCT05350124|Tocopherols|tocopherols|mesh-list
43830688|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
43830689|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830690|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
43830691|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830692|NCT05350124|Protective Agents|protective agents|mesh-ancestor
43830693|NCT05350085|Midazolam|midazolam|mesh-list
43830694|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43830695|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43830696|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830697|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830698|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43830699|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43830700|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43702199|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702200|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
43702201|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
43702202|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
43702203|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702204|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43702205|NCT02718950|Liraglutide|liraglutide|mesh-list
43702206|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43702207|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702216|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43702218|NCT02718755|Cytarabine|cytarabine|mesh-list
43702219|NCT02718755|Fludarabine|fludarabine|mesh-list
43702220|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
43702221|NCT02718755|Asparaginase|asparaginase|mesh-list
43702226|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702227|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
43702228|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702229|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
43702230|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702231|NCT02718976|Lidocaine|lidocaine|mesh-list
43702232|NCT02718976|Epinephrine|epinephrine|mesh-list
43702233|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43702234|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
43702235|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
43702236|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702237|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702238|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
43702239|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702240|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43702241|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43702242|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43702243|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43702244|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702245|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43702246|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43849551|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702267|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43702268|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
43702269|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43702270|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43702271|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43702272|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
43702273|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702274|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702275|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702276|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43702277|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43702278|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43702279|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43702280|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43702281|NCT02718742|Paclitaxel|paclitaxel|mesh-list
43702282|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43702283|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43702284|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702285|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
43702286|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
43702287|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
43702288|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702289|NCT02718469|Vaccines|vaccines|mesh-list
43702290|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
43702291|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702292|NCT02718521|Isosorbide|isosorbide|mesh-list
43702293|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43702294|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43702295|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43702296|NCT02718521|Diuretics|diuretics|mesh-ancestor
43702326|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43702327|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43702328|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702350|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702351|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43702353|NCT02718079|Mannitol|mannitol|mesh-list
43702354|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43702355|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702356|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43702357|NCT02718079|Diuretics|diuretics|mesh-ancestor
43702358|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
43702359|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702360|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
43702361|NCT02718079|Expectorants|expectorants|mesh-ancestor
43702374|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702375|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
43702376|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702377|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702378|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43702404|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43702405|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702407|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
43702408|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702409|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43702410|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43702411|NCT02717871|Protective Agents|protective agents|mesh-ancestor
43702412|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43702413|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702414|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43702415|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43702416|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702417|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702418|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43702419|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43702420|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43702421|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43702422|NCT02717871|Renal Agents|renal agents|mesh-ancestor
43702423|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43702424|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43702425|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
43702426|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43702438|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702439|NCT02717819|Vitamin D|vitamin d|mesh-list
43702440|NCT02717819|Vitamins|vitamins|mesh-ancestor
43702441|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
43702442|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702453|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
43702454|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702455|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43702456|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43702457|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
43702458|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
43702459|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43702475|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702476|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
43702477|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43702479|NCT02717091|Paclitaxel|paclitaxel|mesh-list
43702480|NCT02717091|Folfirinox|folfirinox|mesh-list
43702488|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
43702492|NCT02717091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702493|NCT02717091|Immunologic Factors|immunologic factors|mesh-ancestor
43702494|NCT02717091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830715|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
43830716|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43830717|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
43830718|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830719|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830720|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
43830721|NCT05347212|Nivolumab|nivolumab|mesh-list
43830722|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830723|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830724|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43830725|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830726|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
43830727|NCT05347173|Nalbuphine|nalbuphine|mesh-list
43830728|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43830729|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830730|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830731|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43830732|NCT05347173|Analgesics|analgesics|mesh-ancestor
43830733|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
43830734|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830735|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43830736|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43830737|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43830738|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
43830745|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43830746|NCT05347069|Analgesics|analgesics|mesh-ancestor
43830747|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
43830748|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830749|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830750|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43830751|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830752|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43830753|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43830754|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830755|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43830756|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43830757|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702495|NCT02716961|Gemcitabine|gemcitabine|mesh-list
43702496|NCT02716961|Cisplatin|cisplatin|mesh-list
43702497|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702498|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702499|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
43702500|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702501|NCT02716961|Antiviral Agents|antiviral agents|mesh-ancestor
43702502|NCT02716961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702503|NCT02716961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702504|NCT02716961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702505|NCT02716961|Immunologic Factors|immunologic factors|mesh-ancestor
43702506|NCT02716961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702507|NCT02716857|Oxycodone|oxycodone|mesh-list
43702508|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43702509|NCT02716857|Narcotics|narcotics|mesh-ancestor
43702510|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702511|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702512|NCT02716857|Analgesics|analgesics|mesh-ancestor
43702513|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
43702514|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702515|NCT02716766|Capecitabine|capecitabine|mesh-list
43702516|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
43702517|NCT02716766|Sorafenib|sorafenib|mesh-list
43702518|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702519|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
43702520|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702521|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702522|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43702592|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702594|NCT02715869|Sevoflurane|sevoflurane|mesh-list
43702595|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43702596|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43702597|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
43702598|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
43702599|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702600|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702601|NCT02715687|Amiodarone|amiodarone|mesh-list
43702602|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43702603|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
43702604|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43702605|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43702606|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702607|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43702608|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43702609|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43702610|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702611|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43702612|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43702613|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43702614|NCT02715947|Methotrexate|methotrexate|mesh-list
43702615|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43702616|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
43702617|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43702618|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702619|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702620|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
43702621|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702622|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702623|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
43702624|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702625|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43702626|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702627|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
43702629|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43702630|NCT02715960|Vitamin A|vitamin a|mesh-list
43702631|NCT02715960|Tretinoin|tretinoin|mesh-list
43702632|NCT02715960|Acitretin|acitretin|mesh-list
43702633|NCT02715960|Vitamins|vitamins|mesh-ancestor
43702634|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
43702681|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702683|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43702684|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
43702685|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830759|NCT05346731|Dexamethasone|dexamethasone|mesh-list
43830760|NCT05346731|Ondansetron|ondansetron|mesh-list
43830761|NCT05346731|Olanzapine|olanzapine|mesh-list
43830762|NCT05346731|Aprepitant|aprepitant|mesh-list
43830763|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43830764|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
43830765|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
43830766|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830767|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830768|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43830769|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
43830770|NCT05346731|Hormones|hormones|mesh-ancestor
43830771|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43830772|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43830773|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830774|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
43830775|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
43830776|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43830777|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
43830778|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830779|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830780|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43830781|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43830782|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830783|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43830784|NCT05346731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43830785|NCT05346731|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43830786|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43830787|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43702690|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702707|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43702708|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43702709|NCT02715024|Tamsulosin|tamsulosin|mesh-list
43702710|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
43702711|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43702712|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43702713|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43702714|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
43702715|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702716|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702717|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702718|NCT02715024|Urological Agents|urological agents|mesh-ancestor
43702719|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43702720|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43702721|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
43702722|NCT02715193|Volagidemab|volagidemab|mesh-list
43702723|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43702724|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702725|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
43702726|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43702727|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702740|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
43702741|NCT02715232|Lynestrenol|lynestrenol|mesh-list
43702742|NCT02715232|Estradiol|estradiol|mesh-list
43702743|NCT02715232|Testosterone|testosterone|mesh-list
43702744|NCT02715232|Cyproterone|cyproterone|mesh-list
43702745|NCT02715232|Estrogens|estrogens|mesh-ancestor
43702746|NCT02715232|Hormones|hormones|mesh-ancestor
43702747|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702748|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702749|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43702750|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
43702751|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43702752|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43702753|NCT02715232|Androgens|androgens|mesh-ancestor
43702754|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43702755|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702756|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
43702757|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
43702758|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
43702928|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702929|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43702955|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702956|NCT02714075|Trace Elements|trace elements|mesh-ancestor
43702957|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
43702958|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702959|NCT02714075|Astringents|astringents|mesh-ancestor
43702960|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
43702961|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
43830829|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
43830830|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43830831|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
43830832|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830834|NCT05342194|Cisplatin|cisplatin|mesh-list
43830835|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
43830836|NCT05342194|Lenvatinib|lenvatinib|mesh-list
43847351|NCT04113616|Cytarabine|cytarabine|mesh-list
43702971|NCT02713763|Sunitinib|sunitinib|mesh-list
43702972|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702973|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43702974|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43702975|NCT02713763|Growth Substances|growth substances|mesh-ancestor
43702976|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702977|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
43702978|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43702979|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702980|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702981|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43702982|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43702983|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43702984|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702985|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702986|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43702987|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43702988|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43702989|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
43702990|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702991|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702992|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43702993|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43702994|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
43702995|NCT02713477|Insulin|insulin|mesh-list
43702996|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43702997|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
43702998|NCT02713477|Lixisenatide|lixisenatide|mesh-list
43702999|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43703000|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703001|NCT02713139|Metronidazole|metronidazole|mesh-list
43703002|NCT02713139|Clotrimazole|clotrimazole|mesh-list
43703004|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703005|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703006|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43703007|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43703109|NCT02712697|Prednisone|prednisone|mesh-list
43703057|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
43703058|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
43703059|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43703060|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703062|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
43703063|NCT02713087|Ephedrine|ephedrine|mesh-list
43703064|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43703065|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
43703066|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
43703067|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703068|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703070|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43703071|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
43703074|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43703075|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43703076|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
43703077|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703078|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703079|NCT02713087|Protective Agents|protective agents|mesh-ancestor
43703080|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43703081|NCT02712957|Naproxen|naproxen|mesh-list
43703082|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43703083|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703084|NCT02712957|Analgesics|analgesics|mesh-ancestor
43703085|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
43703086|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703087|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703088|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703089|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703090|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
43703091|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43703092|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703093|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703094|NCT02712944|Testosterone|testosterone|mesh-list
43703095|NCT02712944|Androgens|androgens|mesh-ancestor
43703096|NCT02712944|Hormones|hormones|mesh-ancestor
43703097|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703099|NCT02712866|Vedolizumab|vedolizumab|mesh-list
43703100|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703101|NCT02712619|Metformin|metformin|mesh-list
43703102|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43703103|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703104|NCT02712671|Interferons|interferons|mesh-list
43703105|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
43703106|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703107|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
43703108|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703165|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703167|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43703168|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43703169|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43703170|NCT02712346|Ambrisentan|ambrisentan|mesh-list
43703171|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43703172|NCT02712476|Furosemide|furosemide|mesh-list
43703173|NCT02712476|Mannitol|mannitol|mesh-list
43703174|NCT02712476|Diuretics|diuretics|mesh-ancestor
43703175|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
43703176|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703177|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43703192|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
43703193|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703194|NCT02712203|Vaccines|vaccines|mesh-list
43703195|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
43703196|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703197|NCT02712307|Penicillins|penicillins|mesh-list
43703198|NCT02712307|Penicillin V|penicillin v|mesh-list
43703199|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703200|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703201|NCT02711865|Antibodies|antibodies|mesh-list
43703202|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
43703203|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703204|NCT02711904|Remifentanil|remifentanil|mesh-list
43703205|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43703206|NCT02711904|Narcotics|narcotics|mesh-ancestor
43703207|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703208|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703209|NCT02711904|Analgesics|analgesics|mesh-ancestor
43703210|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
43703224|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43703225|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
43703226|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43703227|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43703228|NCT02711982|Prednisolone|prednisolone|mesh-list
43703229|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
43703230|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43703231|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
43703232|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703233|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
43703234|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
43703235|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703236|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703237|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703248|NCT02711917|Propofol|propofol|mesh-list
43703249|NCT02711917|Etomidate|etomidate|mesh-list
43703250|NCT02711917|Rocuronium|rocuronium|mesh-list
43703251|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43703252|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703253|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703254|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43703255|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
43703256|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
43703257|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43703258|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43703259|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43703260|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830837|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830858|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43830859|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43830860|NCT05341115|Leuprolide|leuprolide|mesh-list
43830861|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43830862|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
43830863|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43847352|NCT04113616|Decitabine|decitabine|mesh-list
43703261|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
43703262|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43703263|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43703264|NCT02711449|Prednisolone|prednisolone|mesh-list
43703265|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
43703266|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43703267|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
43703268|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703269|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
43703270|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
43703271|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703272|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703273|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703274|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
43608283|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703276|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703277|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43703278|NCT02711449|Protective Agents|protective agents|mesh-ancestor
43703302|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703303|NCT02711579|Celecoxib|celecoxib|mesh-list
43703304|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43703305|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703306|NCT02711579|Analgesics|analgesics|mesh-ancestor
43703307|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
43703308|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703309|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703310|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703311|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703401|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703402|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43703406|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43703407|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43703408|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43703409|NCT02711358|Indomethacin|indomethacin|mesh-list
43703410|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43703411|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703412|NCT02711358|Analgesics|analgesics|mesh-ancestor
43703413|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
43703414|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703415|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703416|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703417|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703418|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
43703419|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
43703420|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43703421|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43703422|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703423|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703424|NCT02711267|Acyclovir|acyclovir|mesh-list
43703425|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
43703426|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703427|NCT02711280|Propofol|propofol|mesh-list
43703428|NCT02711280|Sevoflurane|sevoflurane|mesh-list
43703429|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43703430|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703431|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703432|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43703433|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
43703434|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
43703435|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43703436|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43703437|NCT02711241|Dipyrone|dipyrone|mesh-list
43703438|NCT02711241|Papaverine|papaverine|mesh-list
43703445|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703446|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703447|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
43703448|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43703449|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703450|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703451|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
43703452|NCT02711241|Urological Agents|urological agents|mesh-ancestor
43703453|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
43703454|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43703455|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703457|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703458|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43703459|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703460|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703461|NCT02710877|Sufentanil|sufentanil|mesh-list
43703462|NCT02710877|Dsuvia|dsuvia|mesh-list
43703463|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
43703464|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43703465|NCT02710877|Narcotics|narcotics|mesh-ancestor
43703466|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703521|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703621|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43703622|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
43703623|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
43703624|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
43703625|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703626|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
43703628|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
43703629|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703630|NCT02709590|Diclofenac|diclofenac|mesh-list
43703631|NCT02709590|Lidocaine|lidocaine|mesh-list
43703632|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
43703633|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
43703634|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703635|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703636|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
43703637|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703639|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43703640|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43703641|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703642|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703643|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43703684|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
43703685|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703686|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43703687|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43703688|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43703689|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703690|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703691|NCT02709473|Remifentanil|remifentanil|mesh-list
43703692|NCT02709473|Propofol|propofol|mesh-list
43703693|NCT02709473|Rocuronium|rocuronium|mesh-list
43703694|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43703695|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703696|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703697|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43703698|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
43703699|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
43703700|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43703701|NCT02709473|Narcotics|narcotics|mesh-ancestor
43703702|NCT02709473|Analgesics|analgesics|mesh-ancestor
43703703|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
43703704|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703708|NCT02709187|Candesartan|candesartan|mesh-list
43703721|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
43703722|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43703723|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703724|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703725|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703726|NCT02709200|Analgesics|analgesics|mesh-ancestor
43703727|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
43703728|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703729|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43703730|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43703731|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43703732|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
43703733|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703734|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703735|NCT02709382|Tazobactam|tazobactam|mesh-list
43703736|NCT02709382|Cefepime|cefepime|mesh-list
43703737|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703738|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703739|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43703740|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703741|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703742|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
43703743|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43703744|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
43703745|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703746|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
43703747|NCT02709525|Protective Agents|protective agents|mesh-ancestor
43703748|NCT02708992|Azithromycin|azithromycin|mesh-list
43703749|NCT02708992|Cefixime|cefixime|mesh-list
43703750|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703751|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703752|NCT02709031|Cicletanine|cicletanine|mesh-list
43703755|NCT02709031|Diuretics|diuretics|mesh-ancestor
43703764|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
43703765|NCT02708693|Triamcinolone|triamcinolone|mesh-list
43703766|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43703767|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43703768|NCT02708693|Lidocaine|lidocaine|mesh-list
43703769|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43703770|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
43703771|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
43703772|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703773|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703774|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
43703775|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703776|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43703777|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43703778|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43703785|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43703786|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
43703787|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703789|NCT02708511|Trace Elements|trace elements|mesh-ancestor
43703790|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
43703791|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703792|NCT02708160|Fluorides|fluorides|mesh-list
43703793|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
43703794|NCT02708160|Protective Agents|protective agents|mesh-ancestor
43703795|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703796|NCT02708446|Misoprostol|misoprostol|mesh-list
43703797|NCT02708446|Mifepristone|mifepristone|mesh-list
43703798|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43703799|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
43703800|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43703801|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703802|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43703803|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703804|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
43703805|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43703806|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43703807|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43703808|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43703809|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
43703810|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43703811|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43703812|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
43703813|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703814|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
43703815|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43703816|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43703817|NCT02708251|Lidocaine|lidocaine|mesh-list
43703818|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
43703819|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
43703820|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
43703821|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703840|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
43703841|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703842|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
43703843|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43703844|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703845|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703846|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703847|NCT02707809|Analgesics|analgesics|mesh-ancestor
43703848|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
43703849|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703850|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43703851|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43703852|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43703853|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
43703854|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703855|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830885|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
43830886|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830896|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830897|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830898|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830899|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43830900|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43830901|NCT05339074|Ketamine|ketamine|mesh-list
43692943|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
43692944|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830902|NCT05339074|Analgesics|analgesics|mesh-ancestor
43830903|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
43830904|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830915|NCT05339022|Coal Tar|coal tar|mesh-list
43830916|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
43830917|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
43830918|NCT05338450|Clemastine|clemastine|mesh-list
43830919|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
43830920|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
43830921|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43830922|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
43703856|NCT02707900|Vorinostat|vorinostat|mesh-list
43703857|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703858|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43703881|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703882|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703883|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43703884|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43703886|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43703887|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
43703888|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43703889|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703890|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43703891|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703892|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
43703893|NCT02707458|Probucol|probucol|mesh-list
43703894|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43703895|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43703915|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43703916|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43703917|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43703918|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43703919|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
43703920|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703921|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703922|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703923|NCT02707393|Cyclosporine|cyclosporine|mesh-list
43703924|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
43703925|NCT02707393|Fludarabine|fludarabine|mesh-list
43703926|NCT02707393|Melphalan|melphalan|mesh-list
43703927|NCT02707393|Thiotepa|thiotepa|mesh-list
43703928|NCT02707393|Cyclosporins|cyclosporins|mesh-list
43703929|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
43703930|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830923|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
43703931|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703932|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43703933|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
43703934|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703935|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703936|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
43703937|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703938|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
43703939|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703940|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43703951|NCT02707575|Growth Substances|growth substances|mesh-ancestor
43703952|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703995|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703996|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43703997|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
43703998|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43703999|NCT02707081|Lidocaine|lidocaine|mesh-list
43704000|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
43704001|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
43704002|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704003|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704004|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
43704005|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704006|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43704007|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43704008|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43704009|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704017|NCT02707224|Candesartan|candesartan|mesh-list
43704018|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
43704019|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43704020|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43704021|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43704066|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43704068|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
43704069|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
43704070|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704071|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704072|NCT02706704|Adalimumab|adalimumab|mesh-list
43704073|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704074|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704075|NCT02706769|Acetaminophen|acetaminophen|mesh-list
43704076|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43704077|NCT02706769|Analgesics|analgesics|mesh-ancestor
43704078|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
43704079|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704080|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704081|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
43704082|NCT02706860|Atorvastatin|atorvastatin|mesh-list
43704083|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43704084|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43704085|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
43704086|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704087|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43704088|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43704089|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704090|NCT02706470|Cyclosporine|cyclosporine|mesh-list
43704091|NCT02706470|Cyclosporins|cyclosporins|mesh-list
43704092|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
43704093|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704094|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704095|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704096|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
43704097|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704098|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
43704105|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43704106|NCT02706535|Itraconazole|itraconazole|mesh-list
43704107|NCT02706535|Rifampin|rifampin|mesh-list
43704108|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
43704109|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704110|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43704111|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43704112|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704113|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704114|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43704115|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
43704116|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43704117|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704150|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704152|NCT05265442|Analgesics|analgesics|mesh-ancestor
43704153|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
43704154|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704170|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
43704171|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
43704172|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704173|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704174|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
43704175|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704176|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43704177|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
43704178|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704179|NCT05264493|Naloxone|naloxone|mesh-list
43704180|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43849558|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
43704188|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704189|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43704190|NCT05264077|Analgesics|analgesics|mesh-ancestor
43704191|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
43704205|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
43704206|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
43704207|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
43704208|NCT05263882|Gemcitabine|gemcitabine|mesh-list
43704209|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43692945|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43692946|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43692947|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692948|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692949|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43692950|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43692951|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43692952|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43704210|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
43704211|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704212|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704213|NCT05263882|Antiviral Agents|antiviral agents|mesh-ancestor
43704214|NCT05263882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704215|NCT05263882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704216|NCT05263882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704217|NCT05263882|Immunologic Factors|immunologic factors|mesh-ancestor
43704218|NCT05263882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704219|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43704220|NCT05263778|Ezetimibe|ezetimibe|mesh-list
43704221|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43704222|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43704223|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
43704224|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704241|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704242|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704243|NCT05260255|Vitamin D|vitamin d|mesh-list
43704244|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
43704245|NCT05260255|Vitamins|vitamins|mesh-ancestor
43704246|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
43704247|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704248|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43704249|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43704250|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
43830934|NCT05335993|Oregovomab|oregovomab|mesh-list
43830935|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43830936|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704275|NCT05225545|Trace Elements|trace elements|mesh-ancestor
43704276|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
43704277|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704278|NCT05222971|Durvalumab|durvalumab|mesh-list
43704279|NCT05222971|Olaparib|olaparib|mesh-list
43704280|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704281|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704282|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43704283|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704284|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704285|NCT05219487|Risdiplam|risdiplam|mesh-list
43704286|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43704287|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704288|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704289|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
43704290|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
43704291|NCT05207358|Rituximab|rituximab|mesh-list
43704292|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704293|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
43704308|NCT05201846|Insulin|insulin|mesh-list
43704312|NCT05194189|Ascorbic Acid|ascorbic acid|mesh-list
43704313|NCT05194189|Vitamins|vitamins|mesh-ancestor
43704314|NCT05194189|Micronutrients|micronutrients|mesh-ancestor
43704315|NCT05194189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704316|NCT05194189|Antioxidants|antioxidants|mesh-ancestor
43704317|NCT05194189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704318|NCT05194189|Protective Agents|protective agents|mesh-ancestor
43704319|NCT05181462|Gemcitabine|gemcitabine|mesh-list
43704320|NCT05181462|Carboplatin|carboplatin|mesh-list
43704321|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704322|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43704323|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
43704324|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704325|NCT05181462|Antiviral Agents|antiviral agents|mesh-ancestor
43704326|NCT05181462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704327|NCT05181462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704328|NCT05181462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704329|NCT05181462|Immunologic Factors|immunologic factors|mesh-ancestor
43704330|NCT05181462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704331|NCT05174598|Calcitriol|calcitriol|mesh-list
43704332|NCT05174598|Calcipotriene|calcipotriene|mesh-list
43704333|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
43704334|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43704335|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704336|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43704337|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704338|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704339|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43704379|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704380|NCT05044117|Capecitabine|capecitabine|mesh-list
43704381|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43704382|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
43704383|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704439|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704440|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704443|NCT04942067|Hormones|hormones|mesh-ancestor
43704444|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43704445|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43704446|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704447|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
43704448|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704449|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704450|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
43704451|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43704452|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43704453|NCT04942067|Growth Substances|growth substances|mesh-ancestor
43704454|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
43704455|NCT04931368|Rituximab|rituximab|mesh-list
43704456|NCT04931368|Methotrexate|methotrexate|mesh-list
43704457|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704458|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704459|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
43847391|NCT04112043|Niacinamide|niacinamide|mesh-list
43704460|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704461|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704462|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43704463|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
43704466|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
43830956|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43830957|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830958|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
43830959|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43830960|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
43830968|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
43830969|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830970|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830971|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43830972|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
43830973|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830974|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43830975|NCT05334277|Bevacizumab|bevacizumab|mesh-list
43830987|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830989|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43830990|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43830992|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
43830993|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43830994|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43830995|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
43830996|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830997|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830998|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830999|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43831000|NCT05332717|Ascorbic Acid|ascorbic acid|mesh-list
43831001|NCT05332717|Melatonin|melatonin|mesh-list
43831002|NCT05332717|Vitamins|vitamins|mesh-ancestor
43831003|NCT05332717|Micronutrients|micronutrients|mesh-ancestor
43831004|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831005|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
43847392|NCT04112043|Niacin|niacin|mesh-list
43704473|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
43704474|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704475|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
43704476|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704477|NCT04899791|Protective Agents|protective agents|mesh-ancestor
43704478|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704479|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43704480|NCT04882293|Atorvastatin|atorvastatin|mesh-list
43704481|NCT04882293|Fenofibrate|fenofibrate|mesh-list
43704482|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43704489|NCT04863248|Docetaxel|docetaxel|mesh-list
43704497|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43704498|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43704499|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
43704500|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704501|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43704502|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43704503|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704504|NCT04848714|Antivenins|antivenins|mesh-list
43704505|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
43704506|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704507|NCT04829422|Lazertinib|lazertinib|mesh-list
43704508|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43704509|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704510|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704511|NCT04800822|Cetuximab|cetuximab|mesh-list
43704512|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704513|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704514|NCT04789928|Gentamicins|gentamicins|mesh-list
43704515|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704516|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704517|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43704518|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704519|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704520|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43704521|NCT04747847|Atorvastatin|atorvastatin|mesh-list
43704522|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43704523|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43704524|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
43704525|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704539|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43704540|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
43704541|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
43704542|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704543|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43704544|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43704545|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43704546|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704547|NCT04705844|Adalimumab|adalimumab|mesh-list
43704548|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704549|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704550|NCT04688814|Morphine|morphine|mesh-list
43704551|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43704552|NCT04688814|Narcotics|narcotics|mesh-ancestor
43704553|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704565|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
43704566|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704567|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704568|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43704569|NCT04663555|Dexamethasone|dexamethasone|mesh-list
43704570|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704571|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
43704572|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
43704573|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704574|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704579|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43704580|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704581|NCT04649489|Bevacizumab|bevacizumab|mesh-list
43704582|NCT04649489|Atezolizumab|atezolizumab|mesh-list
43704583|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43704584|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704585|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704586|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43704587|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43704588|NCT04649489|Growth Substances|growth substances|mesh-ancestor
43704589|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704590|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
43704591|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
43704592|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
43704593|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704594|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704595|NCT04570644|Ibuprofen|ibuprofen|mesh-list
43704596|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
43704597|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43704598|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43704599|NCT04570644|Analgesics|analgesics|mesh-ancestor
43704600|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
43704601|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704602|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704603|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704604|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704605|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43704606|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704607|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704608|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43704609|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
43704610|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43704611|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
43704612|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43704613|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43704614|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
43704615|NCT04570085|Caffeine|caffeine|mesh-list
43704616|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43704617|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704618|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43704619|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704620|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704621|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43704622|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43704623|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
43831015|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43831016|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831017|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831019|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43831020|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43831021|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43831022|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
43831023|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
43831024|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831025|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
43831026|NCT05331664|Polymyxins|polymyxins|mesh-list
43831027|NCT05331664|Trimethoprim|trimethoprim|mesh-list
43831028|NCT05331664|Prednisolone|prednisolone|mesh-list
43831029|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
43831030|NCT05331664|Triamcinolone|triamcinolone|mesh-list
43831031|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43831032|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43831033|NCT05331664|Atropine|atropine|mesh-list
43831034|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43831035|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43831036|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831037|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
43831038|NCT05331664|Hormones|hormones|mesh-ancestor
43831039|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831040|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831041|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43831042|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831043|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
43831044|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831045|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43831046|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831047|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43831048|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43831049|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831050|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831051|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43831052|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
43831053|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43831054|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43831055|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43831056|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43831057|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831058|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
43831059|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43831060|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43831061|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43831062|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43831063|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
43831064|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
43831065|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
43831066|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43831067|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43831068|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
43831069|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831070|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43831071|NCT05331664|Renal Agents|renal agents|mesh-ancestor
43831072|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
43831073|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43831074|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43831075|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43831076|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43831077|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43704687|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
43704688|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704689|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704690|NCT04385303|Lorecivivint|lorecivivint|mesh-list
43704691|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704692|NCT04356339|Interferons|interferons|mesh-list
43704693|NCT04356339|Interferon-beta|interferon-beta|mesh-list
43704694|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
43704695|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704696|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
43704697|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704698|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
43704699|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704700|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43704701|NCT04353414|Bupivacaine|bupivacaine|mesh-list
43704702|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
43704703|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
43704704|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704705|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704710|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43704711|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43704712|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43704713|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
43704714|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43704715|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704716|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704718|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43704719|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43704720|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704724|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43704725|NCT04302896|Tenofovir|tenofovir|mesh-list
43704726|NCT04302896|Lamivudine|lamivudine|mesh-list
43704727|NCT04302896|Emtricitabine|emtricitabine|mesh-list
43704728|NCT04302896|Dolutegravir|dolutegravir|mesh-list
43704729|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43704730|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
43704731|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704732|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43704733|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43704734|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704735|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704736|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43704737|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43704738|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43704739|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43704740|NCT04298099|Ropivacaine|ropivacaine|mesh-list
43704741|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
43704742|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
43704752|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43704753|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43704754|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
43704755|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
43704756|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
43704757|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43704758|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43704759|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704760|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704761|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704762|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704763|NCT04246541|Acetaminophen|acetaminophen|mesh-list
43704764|NCT04246541|Ketorolac|ketorolac|mesh-list
43704765|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43704766|NCT04246541|Oxycodone|oxycodone|mesh-list
43704767|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43704768|NCT04246541|Analgesics|analgesics|mesh-ancestor
43704769|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
43704770|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704771|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704772|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
43704773|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43704774|NCT04246541|Narcotics|narcotics|mesh-ancestor
43704775|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704776|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43704777|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704778|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704779|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43704780|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704781|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704782|NCT04230681|Fentanyl|fentanyl|mesh-list
43704783|NCT04230681|Hydromorphone|hydromorphone|mesh-list
43704784|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43704785|NCT04230681|Narcotics|narcotics|mesh-ancestor
43704786|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704787|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704790|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704791|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43704792|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43704793|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
43704794|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
43704795|NCT04180943|Bupivacaine|bupivacaine|mesh-list
43704796|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
43704797|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
43704798|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704799|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704800|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
43704812|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43704813|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704814|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704815|NCT04120870|Ketamine|ketamine|mesh-list
43704816|NCT04120870|Etomidate|etomidate|mesh-list
43704817|NCT04120870|Analgesics|analgesics|mesh-ancestor
43704818|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
43704819|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704820|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704821|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43704822|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43704833|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43704834|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831078|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43831080|NCT05331573|Emetics|emetics|mesh-ancestor
43831081|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831082|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
43831083|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831084|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831085|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
43831086|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
43831087|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847393|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
43704835|NCT04050280|Cytarabine|cytarabine|mesh-list
43704836|NCT04050280|Cladribine|cladribine|mesh-list
43704837|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
43704838|NCT04050280|Lenograstim|lenograstim|mesh-list
43704839|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43704840|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
43704857|NCT03896685|Bedaquiline|bedaquiline|mesh-list
43704858|NCT03896685|Clofazimine|clofazimine|mesh-list
43704859|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704860|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704861|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43704862|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704863|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704864|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
43704865|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704866|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
43704867|NCT03868839|Telmisartan|telmisartan|mesh-list
43704868|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43704869|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43704870|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43704871|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704872|NCT03862495|Azithromycin|azithromycin|mesh-list
43704873|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704874|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704875|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
43704876|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704877|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704878|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43704879|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608284|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704880|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704882|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
43704883|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43704884|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43704885|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43704886|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
43704887|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43704888|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704889|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43704890|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43704891|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43704892|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704893|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
43704894|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43704895|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
43704905|NCT03792256|Cytarabine|cytarabine|mesh-list
43704927|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704928|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43704929|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43704934|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
43704935|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43704936|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704937|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
43704938|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704939|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43704941|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704942|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43704943|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
43704944|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
43704945|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
43704954|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704955|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43704956|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704957|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704958|NCT03769155|Nivolumab|nivolumab|mesh-list
43704959|NCT03769155|Ipilimumab|ipilimumab|mesh-list
43704960|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704961|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704962|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43704963|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704964|NCT03765788|Prednisolone|prednisolone|mesh-list
43704965|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704966|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
43704967|NCT03765788|Hormones|hormones|mesh-ancestor
43704968|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43704969|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704995|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43704996|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704997|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43704998|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
43704999|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705008|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43705009|NCT03685747|Vancomycin|vancomycin|mesh-list
43705010|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43705011|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705012|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
43705013|NCT03640949|Vasopressins|vasopressins|mesh-list
43705014|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
43705015|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705016|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
43705017|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
43705018|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705019|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705020|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43705021|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
43705022|NCT03640949|Hormones|hormones|mesh-ancestor
43705023|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705024|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43705025|NCT03640949|Protective Agents|protective agents|mesh-ancestor
43705026|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
43705027|NCT03640949|Coagulants|coagulants|mesh-ancestor
43705028|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43705029|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43705030|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
43705031|NCT03616886|Paclitaxel|paclitaxel|mesh-list
43705032|NCT03616886|Carboplatin|carboplatin|mesh-list
43705033|NCT03616886|Durvalumab|durvalumab|mesh-list
43705034|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43705035|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705036|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
43705041|NCT03615508|Phenylephrine|phenylephrine|mesh-list
43705042|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
43705043|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43705044|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
43705045|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
43705046|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705047|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705048|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
43705051|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
43705052|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43705053|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43705054|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43705055|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
43705056|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705057|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705058|NCT03615508|Protective Agents|protective agents|mesh-ancestor
43705061|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705062|NCT03609840|Thiotepa|thiotepa|mesh-list
43705063|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
43705064|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
43705065|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
43705066|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705067|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43705068|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43705069|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
43705070|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705071|NCT03606642|Clopidogrel|clopidogrel|mesh-list
43705072|NCT03606642|Ticagrelor|ticagrelor|mesh-list
43705073|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43705074|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705075|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705076|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43705077|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43705078|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43705079|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43705080|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
43705081|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705082|NCT03586687|Triamcinolone|triamcinolone|mesh-list
43705083|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705084|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
43705085|NCT03586687|Hormones|hormones|mesh-ancestor
43705086|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705087|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705088|NCT03570437|Paclitaxel|paclitaxel|mesh-list
43705089|NCT03570437|Olaparib|olaparib|mesh-list
43705090|NCT03570437|Cediranib|cediranib|mesh-list
43705091|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43705092|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705093|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
43705094|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
43705095|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
43705096|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705097|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43705098|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705099|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43705100|NCT03481660|Aflibercept|aflibercept|mesh-list
43705101|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43705102|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43705103|NCT03481660|Growth Substances|growth substances|mesh-ancestor
43705104|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705105|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
43705106|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705107|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
43705108|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43705109|NCT03369301|Antibodies|antibodies|mesh-list
43705113|NCT03342456|Doxycycline|doxycycline|mesh-list
43705114|NCT03342456|Furazolidone|furazolidone|mesh-list
43705115|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
43705116|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705117|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43705118|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705119|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
43705120|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43705121|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43705122|NCT03342456|Diuretics|diuretics|mesh-ancestor
43705123|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
43705124|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705125|NCT03342456|Expectorants|expectorants|mesh-ancestor
43705126|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
43705127|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43705128|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43705129|NCT03342456|Renal Agents|renal agents|mesh-ancestor
43705130|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43705131|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43705132|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831088|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831089|NCT05331521|Vincristine|vincristine|mesh-list
43831090|NCT05331521|Temozolomide|temozolomide|mesh-list
43831091|NCT05331521|Lomustine|lomustine|mesh-list
43831092|NCT05331521|Procarbazine|procarbazine|mesh-list
43831093|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43831094|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705145|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705146|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705148|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43705149|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43705150|NCT05345236|Growth Substances|growth substances|mesh-ancestor
43705151|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705152|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
43705153|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705154|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
43705155|NCT05345132|Nifedipine|nifedipine|mesh-list
43705156|NCT05345132|Analgesics|analgesics|mesh-ancestor
43705157|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
43705158|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705159|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705160|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
43705161|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705162|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43705163|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
43705164|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43705165|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705166|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705167|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43705169|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43705170|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
43705171|NCT05345119|Sirolimus|sirolimus|mesh-list
43705172|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
43705173|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43705174|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43705175|NCT05345119|Prednisolone|prednisolone|mesh-list
43705176|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
43705177|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43705178|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
43705179|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43705180|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705181|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43705182|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705183|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
43705184|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43705202|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705203|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
43705204|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
43705205|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
43705206|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705207|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43705208|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
43705209|NCT05344742|Analgesics|analgesics|mesh-ancestor
43705210|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
43705211|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705212|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705213|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43705214|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43705215|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705216|NCT05344443|Lemborexant|lemborexant|mesh-list
43705217|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43705218|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705219|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705220|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43705221|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43705222|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705223|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705228|NCT05343806|Nifedipine|nifedipine|mesh-list
43705229|NCT05343806|Analgesics|analgesics|mesh-ancestor
43705230|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
43705231|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849559|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705232|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705233|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
43705234|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705235|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43705236|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
43705237|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43705246|NCT05343702|Rocuronium|rocuronium|mesh-list
43705247|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43705248|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43705249|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43705250|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705251|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705252|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43705253|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
43705254|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43705255|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43705256|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705257|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705258|NCT05343637|Urological Agents|urological agents|mesh-ancestor
43705259|NCT05343546|Copper|copper|mesh-list
43705260|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
43705261|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43705262|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
43705263|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43705264|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705265|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43705266|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43705267|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43705268|NCT05343546|Trace Elements|trace elements|mesh-ancestor
43705269|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
43705270|NCT05343338|Sivelestat|sivelestat|mesh-list
43705271|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43705272|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
43705273|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705274|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705275|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43705276|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
43705277|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43705278|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43705279|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705280|NCT05343299|Lidocaine|lidocaine|mesh-list
43705281|NCT05343299|Ropivacaine|ropivacaine|mesh-list
43705282|NCT05343299|Anesthetics|anesthetics|mesh-list
43705283|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
43705284|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705285|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705286|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
43705287|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705288|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43705289|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43705310|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705311|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43705312|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43705313|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43705314|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
43705315|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705316|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705317|NCT05342857|Aflibercept|aflibercept|mesh-list
43705318|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43705319|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43705320|NCT05342857|Growth Substances|growth substances|mesh-ancestor
43705321|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705322|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
43705328|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43705329|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
43831106|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
43831107|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831108|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831109|NCT05330858|Rabeprazole|rabeprazole|mesh-list
43831110|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43831111|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831112|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43831113|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831114|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831115|NCT05329428|Vitamin D|vitamin d|mesh-list
43831116|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
43831117|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
43831118|NCT05329428|Vitamins|vitamins|mesh-list
43831119|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
43831120|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831121|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43831122|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43831123|NCT05329155|Heparin|heparin|mesh-list
43831124|NCT05329155|Calcium heparin|calcium heparin|mesh-list
43705333|NCT05278351|Cetuximab|cetuximab|mesh-list
43705334|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43705335|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43705336|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705337|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705338|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705339|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705340|NCT05268419|Ethanol|ethanol|mesh-list
43705341|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43705342|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705343|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705344|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705345|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43705346|NCT05267873|Vortioxetine|vortioxetine|mesh-list
43705347|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43849560|NCT03916068|Protective Agents|protective agents|mesh-ancestor
43705348|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43705349|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705350|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705351|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705352|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705353|NCT05267873|Analgesics|analgesics|mesh-ancestor
43705354|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
43705355|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705356|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
43705357|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43705358|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
43705359|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43705360|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43705361|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705362|NCT05267873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43705363|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
43705364|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43705365|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43705366|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43705367|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43705368|NCT05251233|Pantoprazole|pantoprazole|mesh-list
43705369|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43705370|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43705371|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43705372|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705373|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705374|NCT05244538|Remifentanil|remifentanil|mesh-list
43705376|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43705403|NCT05141682|Azacitidine|azacitidine|mesh-list
43705404|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43705405|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
43705407|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705408|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705409|NCT05136846|Paclitaxel|paclitaxel|mesh-list
43705410|NCT05136846|Carboplatin|carboplatin|mesh-list
43705411|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43705412|NCT05136846|Durvalumab|durvalumab|mesh-list
43705413|NCT05136846|Papaverine|papaverine|mesh-list
43705414|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
43705415|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43705416|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
43705417|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43705418|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705419|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
43705420|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
43705421|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
43705422|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705423|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705424|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
43705425|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705426|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43705428|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
43705429|NCT05136846|Urological Agents|urological agents|mesh-ancestor
43705431|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
43705432|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705433|NCT05042531|Azacitidine|azacitidine|mesh-list
43705434|NCT05042531|Dasatinib|dasatinib|mesh-list
43705435|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43705436|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
43705437|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705438|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705439|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705440|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43705441|NCT05042440|Factor VIII|factor viii|mesh-list
43705442|NCT05042440|BAX 855|bax 855|mesh-list
43705444|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43705445|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43705446|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705447|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705448|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43831125|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
43705449|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705450|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705451|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
43705452|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705453|NCT04891068|Azacitidine|azacitidine|mesh-list
43705454|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43705455|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
43705473|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43705474|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43705475|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705476|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
43705477|NCT04735861|Bevacizumab|bevacizumab|mesh-list
43705478|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705479|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705480|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43705481|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43705482|NCT04735861|Growth Substances|growth substances|mesh-ancestor
43705483|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705484|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
43705485|NCT04717700|Dexamethasone|dexamethasone|mesh-list
43705486|NCT04717700|Lenalidomide|lenalidomide|mesh-list
43705487|NCT04717700|Bortezomib|bortezomib|mesh-list
43705488|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705489|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
43705490|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
43705491|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705492|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705493|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43705494|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
43705495|NCT04717700|Hormones|hormones|mesh-ancestor
43705496|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705497|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43705498|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705499|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
43705500|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43705501|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43705502|NCT04717700|Growth Substances|growth substances|mesh-ancestor
43705503|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
43705504|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43705505|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43705506|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705507|NCT04686279|Tenofovir|tenofovir|mesh-list
43705508|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
43705509|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705510|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43705511|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43705512|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705513|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705514|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43705515|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43705516|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43705517|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
43705518|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
43705523|NCT04594551|Antibodies|antibodies|mesh-list
43705524|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
43705525|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705526|NCT04593680|Tenofovir|tenofovir|mesh-list
43705527|NCT04593680|Emtricitabine|emtricitabine|mesh-list
43705528|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
43705529|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705530|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43705531|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43705532|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705533|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705534|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43705535|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43705536|NCT04537208|Vaccines|vaccines|mesh-list
43705537|NCT04537208|Immunologic Factors|immunologic factors|mesh-ancestor
43705538|NCT04537208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705539|NCT04477759|Atezolizumab|atezolizumab|mesh-list
43831137|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831138|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
43831139|NCT05327686|Nivolumab|nivolumab|mesh-list
43831140|NCT05327686|Ipilimumab|ipilimumab|mesh-list
43831141|NCT05327686|Avelumab|avelumab|mesh-list
43831142|NCT05327686|Lenvatinib|lenvatinib|mesh-list
43831143|NCT05327686|Axitinib|axitinib|mesh-list
43831144|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43831145|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43831146|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831147|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43831148|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831149|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831150|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831151|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
43831152|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831153|NCT05327426|Vaccines|vaccines|mesh-list
43831154|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
43831155|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831156|NCT05327270|Nivolumab|nivolumab|mesh-list
43831157|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43831158|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831159|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43831160|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847394|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
43847395|NCT04112043|Vitamins|vitamins|mesh-ancestor
43847396|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
43847397|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847398|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43847399|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
43847400|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847401|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43847402|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
43847403|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43847404|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43847405|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
43847409|NCT04110301|Lenalidomide|lenalidomide|mesh-list
43847411|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43847412|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
43847413|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847414|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43847415|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43847416|NCT04110301|Growth Substances|growth substances|mesh-ancestor
43705541|NCT04461587|Pirfenidone|pirfenidone|mesh-list
43705542|NCT04461587|Analgesics|analgesics|mesh-ancestor
43705543|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
43705544|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705545|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705546|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43705547|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43705548|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705549|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43705550|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705551|NCT04457089|Simvastatin|simvastatin|mesh-list
43705552|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43705554|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
43705555|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705556|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43705566|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
43705567|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
43705573|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705574|NCT04349306|Rasburicase|rasburicase|mesh-list
43705575|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
43705576|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43705577|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
43705578|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
43705579|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43705580|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43705581|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705582|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705583|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705584|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43705585|NCT04229615|Apatinib|apatinib|mesh-list
43705586|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705587|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43705588|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705589|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705590|NCT04177693|Letrozole|letrozole|mesh-list
43705591|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43705592|NCT04177693|Clomiphene|clomiphene|mesh-list
43705593|NCT04177693|Enclomiphene|enclomiphene|mesh-list
43705594|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
43705595|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705596|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705597|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43705598|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43705599|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705600|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43705601|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
43705602|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705603|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705604|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43705605|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
43705606|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43705607|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43705613|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43705614|NCT04142086|Vaccines|vaccines|mesh-list
43705615|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
43705616|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705625|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43705626|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43705627|NCT04074187|Prednisolone|prednisolone|mesh-list
43705628|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
43705629|NCT04074187|Rituximab|rituximab|mesh-list
43705630|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43705631|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
43705632|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43705633|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705657|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43705658|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
43705659|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705660|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705661|NCT04003818|Teicoplanin|teicoplanin|mesh-list
43705662|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43705663|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705664|NCT03951142|Losartan|losartan|mesh-list
43705665|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43705666|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43705667|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43705668|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43705669|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705670|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
43705671|NCT03945591|Bortezomib|bortezomib|mesh-list
43705672|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43705673|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
43705674|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705675|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43705676|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43705677|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
43705678|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705679|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705680|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43705681|NCT03930446|Ethanol|ethanol|mesh-list
43705682|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43705683|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705684|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705685|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705686|NCT03916601|Insulin|insulin|mesh-list
43705687|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43705697|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705698|NCT03903016|Insulin|insulin|mesh-list
43705699|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43705700|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
43705701|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705702|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705703|NCT03822507|Cinacalcet|cinacalcet|mesh-list
43705704|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43705705|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705706|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43705707|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
43705708|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705709|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43705710|NCT03802487|Charcoal|charcoal|mesh-list
43705711|NCT03802487|Antidotes|antidotes|mesh-ancestor
43705712|NCT03802487|Protective Agents|protective agents|mesh-ancestor
43705714|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705715|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705716|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705717|NCT03800836|Paclitaxel|paclitaxel|mesh-list
43705718|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43705719|NCT03800836|Atezolizumab|atezolizumab|mesh-list
43705720|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43705721|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705722|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
43705723|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
43705724|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
43705725|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705726|NCT03794336|Aspirin|aspirin|mesh-list
43705739|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43705740|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43705741|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705742|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43705743|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43705744|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705753|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705754|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705755|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705756|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705757|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
43705758|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705759|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705760|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
43705761|NCT03767543|Lixisenatide|lixisenatide|mesh-list
43705762|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705763|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705764|NCT03761134|Metformin|metformin|mesh-list
43705765|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43705766|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705767|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705768|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705769|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705771|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705772|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705773|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43705774|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705775|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705776|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705777|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705778|NCT03743636|Niacinamide|niacinamide|mesh-list
43705779|NCT03743636|Niacin|niacin|mesh-list
43705780|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
43705781|NCT03743636|Resveratrol|resveratrol|mesh-list
43705782|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
43705783|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705784|NCT03743636|Protective Agents|protective agents|mesh-ancestor
43705785|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705786|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705787|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43705788|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
43705789|NCT03743636|Vitamins|vitamins|mesh-ancestor
43705791|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43705792|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
43705793|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43705794|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
43705796|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705797|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
43705798|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705799|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705800|NCT03681158|Valproic Acid|valproic acid|mesh-list
43705801|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
43705802|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705803|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705804|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
43705805|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705820|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
43705821|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705822|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43705823|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43705824|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
43705825|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705827|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43705828|NCT03664882|Fexofenadine|fexofenadine|mesh-list
43705829|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43705830|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43705831|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43705832|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
43705833|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
43705834|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705835|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705836|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705837|NCT03630809|Vaccines|vaccines|mesh-list
43705838|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
43705839|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831161|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
43831162|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
43831163|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831164|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831165|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831166|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
43831167|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
43831168|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
43831169|NCT05325853|Propoxycaine|propoxycaine|mesh-list
43831170|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
43831171|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
43831172|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831173|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831174|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
43831176|NCT05325775|SR 142801|sr 142801|mesh-list
43705840|NCT03583658|Ambroxol|ambroxol|mesh-list
43705841|NCT03583658|Expectorants|expectorants|mesh-ancestor
43705842|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
43705843|NCT03555968|Dronabinol|dronabinol|mesh-list
43705844|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
43705845|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705846|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43705847|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43705849|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
43705850|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705851|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43705852|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43705853|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705854|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705855|NCT03555968|Hormones|hormones|mesh-ancestor
43705856|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705857|NCT03529123|Insulin|insulin|mesh-list
43705858|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43705859|NCT03529123|Metformin|metformin|mesh-list
43705860|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
43705861|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
43705862|NCT03529123|Lixisenatide|lixisenatide|mesh-list
43705863|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705864|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705865|NCT03514732|Melatonin|melatonin|mesh-list
43705866|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
43705867|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705868|NCT03514732|Protective Agents|protective agents|mesh-ancestor
43705869|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705882|NCT03481959|Methylphenidate|methylphenidate|mesh-list
43705883|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43705884|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705885|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43705886|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43705887|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705888|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705889|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
43705890|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705891|NCT03479502|Doxycycline|doxycycline|mesh-list
43705892|NCT03479502|Prednisone|prednisone|mesh-list
43705893|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
43705894|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43705895|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43705896|NCT03479502|Prednisolone|prednisolone|mesh-list
43705897|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
43705898|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43705899|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
43705900|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705901|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
43705902|NCT03479502|Hormones|hormones|mesh-ancestor
43705903|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705904|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705905|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43705906|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705907|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
43705908|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
43705909|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705910|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43705911|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43705912|NCT03479502|Protective Agents|protective agents|mesh-ancestor
43705921|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705922|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705923|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705924|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
43705925|NCT03462017|Acetylcholine|acetylcholine|mesh-list
43705926|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
43705927|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43705928|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43705929|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705930|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705931|NCT03462017|Urological Agents|urological agents|mesh-ancestor
43705932|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43705933|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
43705934|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705935|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705936|NCT03436498|Insulin|insulin|mesh-list
43705937|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43705938|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
43705939|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
43705940|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43705941|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705942|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705943|NCT03435952|Doxycycline|doxycycline|mesh-list
43705945|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705946|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705947|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43705948|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705949|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
43705950|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43705951|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43705952|NCT03421652|Nivolumab|nivolumab|mesh-list
43705953|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705954|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705955|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43760760|NCT02443311|Betamethasone|betamethasone|mesh-list
43705957|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43705958|NCT03414723|Ramipril|ramipril|mesh-list
43705959|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43705960|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
43705961|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705962|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705963|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43705964|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705965|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705966|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705967|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
43705968|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705969|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705970|NCT03391193|Vaccines|vaccines|mesh-list
43705971|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
43705972|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705973|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43705974|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43705975|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43705976|NCT03387657|Diuretics|diuretics|mesh-ancestor
43705977|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
43705978|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705979|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43705980|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705981|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705982|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705983|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705984|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43705985|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43705986|NCT03332303|Estradiol|estradiol|mesh-list
43705987|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43705988|NCT03332303|Estrogens|estrogens|mesh-ancestor
43705989|NCT03332303|Hormones|hormones|mesh-ancestor
43760761|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
43705990|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705991|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705992|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43705993|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
43705994|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43705995|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43705996|NCT02964013|Cisplatin|cisplatin|mesh-list
43705997|NCT02964013|Carboplatin|carboplatin|mesh-list
43705998|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
43705999|NCT02964013|Etoposide|etoposide|mesh-list
43706000|NCT02964013|Pemetrexed|pemetrexed|mesh-list
43706001|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706002|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706003|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43706004|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43706005|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43706006|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706007|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706008|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43706009|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43706010|NCT02932618|Factor VIII|factor viii|mesh-list
43706011|NCT02932618|Coagulants|coagulants|mesh-ancestor
43706012|NCT02699840|Vaccines|vaccines|mesh-list
43706013|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
43706014|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706015|NCT02584426|Cefazolin|cefazolin|mesh-list
43706016|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43706045|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706047|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43706048|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706049|NCT02330926|Analgesics|analgesics|mesh-ancestor
43706050|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
43706051|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706052|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706053|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706054|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706055|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43706056|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706061|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43706063|NCT02078427|Coagulants|coagulants|mesh-ancestor
43706064|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43706065|NCT02046434|Glycerol|glycerol|mesh-list
43706066|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43706067|NCT02046434|Protective Agents|protective agents|mesh-ancestor
43706068|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706069|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706070|NCT01743651|Baclofen|baclofen|mesh-list
43706071|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43706072|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706073|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43706074|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706075|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43706076|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
43706077|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
43706078|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706079|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706080|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
43706081|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43706082|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
43706083|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706084|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706085|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43706086|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
43706087|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43706089|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706090|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706091|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43706092|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
43706093|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
43706094|NCT00848731|Protective Agents|protective agents|mesh-ancestor
43706095|NCT00627250|Amantadine|amantadine|mesh-list
43706096|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43706097|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43706098|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
43706099|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706100|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
43706101|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706102|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706104|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706105|NCT00627250|Analgesics|analgesics|mesh-ancestor
43706106|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
43706107|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706108|NCT00454285|Amoxicillin|amoxicillin|mesh-list
43706109|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43706110|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706111|NCT00405613|Aspirin|aspirin|mesh-list
43706112|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43706113|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706114|NCT00405613|Analgesics|analgesics|mesh-ancestor
43706115|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
43706116|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706117|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706118|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831193|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43831194|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43831195|NCT05324735|Protective Agents|protective agents|mesh-ancestor
43831196|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831197|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
43831198|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43831200|NCT05323617|Cyclosporine|cyclosporine|mesh-list
43831201|NCT05323617|Cyclosporins|cyclosporins|mesh-list
43831202|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43831203|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831204|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831205|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831206|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
43831207|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831208|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
43831209|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831210|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
43831211|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831212|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43831213|NCT05323487|Bumetanide|bumetanide|mesh-list
43831214|NCT05323487|Diuretics|diuretics|mesh-ancestor
43831215|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
43831216|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831217|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43706133|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706134|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706136|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43706137|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706138|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706139|NCT03169972|Factor VIII|factor viii|mesh-list
43706140|NCT03169972|BAX 855|bax 855|mesh-list
43706141|NCT03169972|Coagulants|coagulants|mesh-ancestor
43706142|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
43706143|NCT03096275|Hormones|hormones|mesh-ancestor
43706144|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706145|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706146|NCT03094052|Trastuzumab|trastuzumab|mesh-list
43706147|NCT03094052|Atropine|atropine|mesh-list
43706148|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
43706149|NCT03094052|Loperamide|loperamide|mesh-list
43706150|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
43706151|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
43706152|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706153|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706154|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43706155|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43706156|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43706157|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
43706158|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706159|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706160|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43706161|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
43706162|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
43706163|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
43706164|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43706165|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43706166|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
43706167|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706253|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
43706168|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706169|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43706170|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43706171|NCT03094052|Narcotics|narcotics|mesh-ancestor
43706172|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706173|NCT03094052|Analgesics|analgesics|mesh-ancestor
43706174|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
43706175|NCT03039036|Misoprostol|misoprostol|mesh-list
43706176|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43706177|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
43706178|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43706179|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706180|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43706181|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43706182|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
43706183|NCT02997605|Prednisone|prednisone|mesh-list
43706184|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
43706185|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
43706186|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706187|NCT02997605|Hormones|hormones|mesh-ancestor
43706188|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706189|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706190|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43706191|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706193|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43706194|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706195|NCT02988297|Analgesics|analgesics|mesh-ancestor
43706196|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
43706197|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706198|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706199|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706200|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706201|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43706211|NCT02803203|Growth Substances|growth substances|mesh-ancestor
43706212|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706213|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
43706214|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43706215|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706216|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706217|NCT02737436|Oxytocin|oxytocin|mesh-list
43706218|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
43706219|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43706220|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706221|NCT02643303|Durvalumab|durvalumab|mesh-list
43706222|NCT02643303|Tremelimumab|tremelimumab|mesh-list
43706223|NCT02643303|Poly ICLC|poly iclc|mesh-list
43706224|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706225|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706226|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
43706227|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
43706228|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706229|NCT02601586|Oxycodone|oxycodone|mesh-list
43706230|NCT02601586|Levodopa|levodopa|mesh-list
43706231|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43706232|NCT02601586|Narcotics|narcotics|mesh-ancestor
43706233|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706234|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706235|NCT02601586|Analgesics|analgesics|mesh-ancestor
43706236|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
43706237|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706238|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43706239|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43706240|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
43706241|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706242|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706243|NCT02549209|Paclitaxel|paclitaxel|mesh-list
43706244|NCT02549209|Carboplatin|carboplatin|mesh-list
43706245|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
43706246|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43706247|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706248|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
43706249|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
43706250|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
43706251|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706252|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706265|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
43706266|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706267|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706272|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706273|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
43706274|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43706275|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706276|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43706277|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706278|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706279|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706280|NCT02402660|Vitamin A|vitamin a|mesh-list
43706281|NCT02402660|Retinol acetate|retinol acetate|mesh-list
43706282|NCT02402660|Vitamins|vitamins|mesh-ancestor
43706283|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
43706284|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706285|NCT02402660|Protective Agents|protective agents|mesh-ancestor
43706286|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43706287|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706288|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43706289|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
43706290|NCT02313389|Rituximab|rituximab|mesh-list
43706291|NCT02313389|Methotrexate|methotrexate|mesh-list
43706292|NCT02313389|Temozolomide|temozolomide|mesh-list
43706293|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706294|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706295|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
43706296|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706297|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706298|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43706299|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
43706300|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43706301|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43706302|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
43706303|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706304|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
43706305|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706310|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
43706311|NCT02273375|Durvalumab|durvalumab|mesh-list
43706312|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706313|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706314|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43706315|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706316|NCT02145143|Vemurafenib|vemurafenib|mesh-list
43706317|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706318|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43706319|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706320|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706321|NCT02131493|Gemcitabine|gemcitabine|mesh-list
43706322|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43706323|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
43706324|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706325|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706326|NCT02131493|Antiviral Agents|antiviral agents|mesh-ancestor
43706328|NCT02131493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706329|NCT02131493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706330|NCT02131493|Immunologic Factors|immunologic factors|mesh-ancestor
43706331|NCT02131493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706332|NCT02096159|Trimethoprim|trimethoprim|mesh-list
43706333|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43706334|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
43706335|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43706336|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706337|NCT02096159|Renal Agents|renal agents|mesh-ancestor
43706338|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
43706339|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43706340|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43706341|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43706342|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706343|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706344|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43706345|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43706346|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43706347|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43706348|NCT01989598|Trametinib|trametinib|mesh-list
43706349|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706350|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43706351|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706352|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706353|NCT01939275|Copper|copper|mesh-list
43706354|NCT01939275|Trastuzumab|trastuzumab|mesh-list
43706355|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706356|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706357|NCT01939275|Trace Elements|trace elements|mesh-ancestor
43706358|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
43706359|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706360|NCT01831076|Tamoxifen|tamoxifen|mesh-list
43706361|NCT01831076|Exemestane|exemestane|mesh-list
43706362|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43706363|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
43706376|NCT01542021|Hormones|hormones|mesh-ancestor
43706377|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706378|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706379|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
43706380|NCT01455389|Promethazine|promethazine|mesh-list
43706381|NCT01455389|Dexamethasone|dexamethasone|mesh-list
43706382|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43706383|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706384|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
43706385|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
43706386|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706387|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706388|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43706389|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
43706390|NCT01455389|Hormones|hormones|mesh-ancestor
43706391|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706392|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43706393|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706394|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43706395|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706396|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706397|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43706398|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43706399|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706400|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
43706401|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
43706402|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
43706403|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43706404|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
43706405|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
43706406|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706416|NCT01203722|Sirolimus|sirolimus|mesh-list
43706417|NCT01203722|Fludarabine|fludarabine|mesh-list
43706418|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
43706419|NCT01203722|Tacrolimus|tacrolimus|mesh-list
43706420|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706421|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706422|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706424|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706425|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43706426|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706443|NCT01029717|Heparin|heparin|mesh-list
43706444|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706445|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43706446|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
43706447|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
43706448|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43706449|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43706450|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706451|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
43706452|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43706453|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706454|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43706455|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43706456|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43706457|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43706458|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43706459|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43706460|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43706461|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
43706462|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43706463|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
43706464|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706465|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706466|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706467|NCT00700076|Ketamine|ketamine|mesh-list
43706468|NCT00700076|Analgesics|analgesics|mesh-ancestor
43706469|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
43706470|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706471|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706472|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43706473|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43706474|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
43706475|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
43706476|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706477|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43706478|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43706479|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706480|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706481|NCT00482157|Vitamin D|vitamin d|mesh-list
43706482|NCT00482157|Calcitriol|calcitriol|mesh-list
43706483|NCT00482157|Vitamins|vitamins|mesh-ancestor
43706484|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
43706485|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706486|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43706504|NCT00193427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706505|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
43706506|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
43706507|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
43706508|NCT00193414|Gemcitabine|gemcitabine|mesh-list
43706509|NCT00193414|Pemetrexed|pemetrexed|mesh-list
43706510|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43706511|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
43706512|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706513|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706514|NCT00193414|Antiviral Agents|antiviral agents|mesh-ancestor
43706515|NCT00193414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706516|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706517|NCT00193414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706518|NCT00193414|Immunologic Factors|immunologic factors|mesh-ancestor
43706519|NCT00193414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706520|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43706521|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43706522|NCT00003042|Tamoxifen|tamoxifen|mesh-list
43706523|NCT00003042|Paclitaxel|paclitaxel|mesh-list
43706524|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
43706525|NCT00003042|Cisplatin|cisplatin|mesh-list
43706526|NCT00003042|Doxorubicin|doxorubicin|mesh-list
43706527|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43706528|NCT00003042|Melphalan|melphalan|mesh-list
43706529|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43706530|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706544|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43706545|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706546|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43706547|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
43706548|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706549|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43706550|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43706551|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43706552|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43706553|NCT02706158|Vitamin D|vitamin d|mesh-list
43706554|NCT02706158|Calcium|calcium|mesh-list
43706555|NCT02706158|Vitamins|vitamins|mesh-ancestor
43706556|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
43706557|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706558|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43706559|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43706560|NCT02706119|Insulin|insulin|mesh-list
43706561|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43706562|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
43706563|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43706564|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706565|NCT02705950|Baclofen|baclofen|mesh-list
43706566|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43706567|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706568|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43706569|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706570|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43706579|NCT02705872|Narcotics|narcotics|mesh-ancestor
43706582|NCT02705872|Analgesics|analgesics|mesh-ancestor
43706583|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
43706584|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706585|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43706586|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43706587|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
43706588|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
43706589|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
43706590|NCT02706054|Meloxicam|meloxicam|mesh-list
43706591|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43706592|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706593|NCT02706054|Analgesics|analgesics|mesh-ancestor
43706594|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
43706595|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706596|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706597|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706598|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706599|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43706600|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43706601|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706602|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706603|NCT02706015|Dipyrone|dipyrone|mesh-list
43706611|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43706612|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43706613|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
43706614|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706615|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43706616|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706617|NCT02706015|Analgesics|analgesics|mesh-ancestor
43706618|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
43706619|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706620|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706621|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706622|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
43706623|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43706624|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
43706625|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
43706626|NCT02705976|Warfarin|warfarin|mesh-list
43706627|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
43706628|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
43706629|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706630|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706631|NCT02705989|Branebrutinib|branebrutinib|mesh-list
43706632|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43706633|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831220|NCT05322538|Vitamin D|vitamin d|mesh-list
43831235|NCT05321875|Candesartan|candesartan|mesh-list
43831236|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43831237|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43831238|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43831239|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831240|NCT05321810|Warfarin|warfarin|mesh-list
43831241|NCT05321810|Apixaban|apixaban|mesh-list
43831242|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
43831243|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43831244|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
43831245|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43831246|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
43831247|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831248|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831249|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
43831250|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43831251|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706654|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706655|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43706656|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43706657|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43706658|NCT02705729|Methamphetamine|methamphetamine|mesh-list
43706659|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43706887|NCT02704520|Capecitabine|capecitabine|mesh-list
43706660|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706661|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
43706662|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
43706663|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706664|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
43706665|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706666|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706667|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
43706668|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43706669|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43706670|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43706671|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43706672|NCT02705534|Ribavirin|ribavirin|mesh-list
43706673|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
43706674|NCT02705534|Ledipasvir|ledipasvir|mesh-list
43706675|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
43706676|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706677|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
43706678|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706679|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43706680|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43706681|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43706682|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
43706683|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706684|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43706685|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43706686|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706687|NCT02705573|Mannitol|mannitol|mesh-list
43706688|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43706689|NCT02705573|Diuretics|diuretics|mesh-ancestor
43706690|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
43706691|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706692|NCT02705508|Gemcitabine|gemcitabine|mesh-list
43706693|NCT02705508|Etoposide|etoposide|mesh-list
43706694|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
43706695|NCT02705508|Pegaspargase|pegaspargase|mesh-list
43706696|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43706697|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
43706698|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706699|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706700|NCT02705508|Antiviral Agents|antiviral agents|mesh-ancestor
43706701|NCT02705508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706702|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706703|NCT02705508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706704|NCT02705508|Immunologic Factors|immunologic factors|mesh-ancestor
43706705|NCT02705508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706706|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43706707|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43706708|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43706709|NCT02705482|Durvalumab|durvalumab|mesh-list
43706710|NCT02705482|Tremelimumab|tremelimumab|mesh-list
43706711|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706712|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706713|NCT02705612|Cisplatin|cisplatin|mesh-list
43706714|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
43706715|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706716|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706717|NCT02705664|Amorolfine|amorolfine|mesh-list
43706718|NCT02705664|Bifonazole|bifonazole|mesh-list
43706719|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
43706720|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706733|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43706734|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43706735|NCT02705638|Growth Substances|growth substances|mesh-ancestor
43706736|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
43706737|NCT02705651|Somatostatin|somatostatin|mesh-list
43706738|NCT02705651|Hormones|hormones|mesh-ancestor
43706739|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706740|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706741|NCT02705287|Vitamin D|vitamin d|mesh-list
43706742|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
43706743|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
43706744|NCT02705287|Vitamins|vitamins|mesh-list
43706745|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
43706746|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706747|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43706748|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43706751|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706752|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43706753|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
43706755|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43706756|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706757|NCT02705274|Bevacizumab|bevacizumab|mesh-list
43706758|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706759|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706760|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43706761|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43706762|NCT02705274|Growth Substances|growth substances|mesh-ancestor
43706763|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706764|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
43706765|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43706766|NCT02705014|Hormones|hormones|mesh-list
43706767|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706768|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706769|NCT02704962|Olanzapine|olanzapine|mesh-list
43706770|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
43706771|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
43706796|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706797|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706798|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43706799|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706800|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706801|NCT02704923|Atropine|atropine|mesh-list
43706802|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43706803|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43706804|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43706805|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43706806|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43706807|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
43706808|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706812|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
43706813|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
43706814|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43706815|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43706816|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
43706817|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706818|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706820|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
43706821|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
43706822|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43706823|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
43706824|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43706825|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
43706826|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706827|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706828|NCT02704767|Apatinib|apatinib|mesh-list
43706829|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43706830|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706832|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706868|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706869|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
43706870|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43706871|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43706872|NCT02704494|Losartan|losartan|mesh-list
43706873|NCT02704494|Resveratrol|resveratrol|mesh-list
43706874|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43706875|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43706876|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43706877|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43706878|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706879|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
43706880|NCT02704494|Protective Agents|protective agents|mesh-ancestor
43706881|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706882|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706883|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43706884|NCT02704520|Leucovorin|leucovorin|mesh-list
43706885|NCT02704520|Folic Acid|folic acid|mesh-list
43706886|NCT02704520|Fluorouracil|fluorouracil|mesh-list
43706897|NCT02704520|Antidotes|antidotes|mesh-ancestor
43706898|NCT02704520|Protective Agents|protective agents|mesh-ancestor
43706899|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
43706900|NCT02704520|Vitamins|vitamins|mesh-ancestor
43706901|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
43706902|NCT02704520|Hematinics|hematinics|mesh-ancestor
43831270|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831271|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831272|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831273|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831275|NCT05318755|Androgens|androgens|mesh-ancestor
43831276|NCT05318755|Hormones|hormones|mesh-ancestor
43831277|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831278|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831279|NCT05318066|Norepinephrine|norepinephrine|mesh-list
43831280|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43831281|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43831282|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
43831283|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706903|NCT02704507|Triamcinolone|triamcinolone|mesh-list
43706905|NCT02704507|Emollients|emollients|mesh-list
43706906|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706907|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
43706908|NCT02704507|Hormones|hormones|mesh-ancestor
43706909|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706910|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706911|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706912|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
43706913|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
43706914|NCT02703857|Cefoxitin|cefoxitin|mesh-list
43706915|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43706916|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706917|NCT02704052|Enoxaparin|enoxaparin|mesh-list
43706918|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
43706919|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
43706920|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43706921|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43706922|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706923|NCT02703896|Esomeprazole|esomeprazole|mesh-list
43706924|NCT02703896|Omeprazole|omeprazole|mesh-list
43706925|NCT02703896|Pantoprazole|pantoprazole|mesh-list
43706926|NCT02703896|Lansoprazole|lansoprazole|mesh-list
43706927|NCT02703896|Famotidine|famotidine|mesh-list
43706928|NCT02703896|Ranitidine|ranitidine|mesh-list
43706929|NCT02703896|Cimetidine|cimetidine|mesh-list
43706930|NCT02703896|Nizatidine|nizatidine|mesh-list
43706955|NCT02703961|Cisplatin|cisplatin|mesh-list
43706956|NCT02703961|Docetaxel|docetaxel|mesh-list
43706957|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706958|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
43706959|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
43706960|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
43706961|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706962|NCT02703649|Letrozole|letrozole|mesh-list
43706963|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706964|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43706965|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43706968|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43706969|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
43706970|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706971|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706973|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706974|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43706975|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706976|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706977|NCT02703740|Lidocaine|lidocaine|mesh-list
43706978|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
43706979|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
43706980|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
43706981|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706982|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706983|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
43706984|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706985|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43706986|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43706987|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43706988|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43706989|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706990|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43706991|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
43706992|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
43706993|NCT02703740|Protective Agents|protective agents|mesh-ancestor
43706994|NCT02703363|Minocycline|minocycline|mesh-list
43706995|NCT02703363|Celecoxib|celecoxib|mesh-list
43706996|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43706997|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706998|NCT02703363|Analgesics|analgesics|mesh-ancestor
43706999|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
43707000|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707001|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707002|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707003|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707010|NCT02703376|Prednisone|prednisone|mesh-list
43707050|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43707051|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707052|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
43707053|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707054|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707055|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707056|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
43707057|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
43707058|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707059|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43707060|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
43707061|NCT02703272|Hormones|hormones|mesh-ancestor
43707062|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707063|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707064|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43707066|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43707067|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707106|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
43707107|NCT02702960|Hormones|hormones|mesh-ancestor
43707108|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707109|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707110|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43707111|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707112|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43707113|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43707114|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
43707115|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43707116|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707117|NCT02702960|Protective Agents|protective agents|mesh-ancestor
43707118|NCT02703051|Lenograstim|lenograstim|mesh-list
43707119|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43707120|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
43707121|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707122|NCT02703090|Remifentanil|remifentanil|mesh-list
43707152|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43707153|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
43707154|NCT02702674|Propranolol|propranolol|mesh-list
43707155|NCT02702674|Oxytocin|oxytocin|mesh-list
43707156|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
43707157|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43707158|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707159|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43707160|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43707161|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
43707162|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707163|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707164|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43707165|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43707166|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
43707167|NCT02702739|Ribavirin|ribavirin|mesh-list
43707168|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
43707169|NCT02702739|Simeprevir|simeprevir|mesh-list
43707170|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
43707171|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707172|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
43707173|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707174|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
43707180|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707181|NCT02702661|Anesthetics|anesthetics|mesh-list
43707182|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
43707183|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
43707184|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707185|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707186|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
43707187|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707189|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707190|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
43707191|NCT02702778|Hormones|hormones|mesh-ancestor
43707192|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707193|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707194|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707195|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707196|NCT02702206|Triamcinolone|triamcinolone|mesh-list
43707197|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
43707198|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707199|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
43707200|NCT02702206|Hormones|hormones|mesh-ancestor
43707201|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707202|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707203|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
43707204|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43707205|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
43707206|NCT02702206|Protective Agents|protective agents|mesh-ancestor
43831288|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831289|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43831291|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43831292|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831293|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
43831294|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43831295|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43831296|NCT05317624|Prednisolone|prednisolone|mesh-list
43831297|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
43831298|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43831299|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
43831300|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831301|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
43831302|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
43831303|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831304|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831305|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831306|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
43831307|NCT05317624|Hormones|hormones|mesh-ancestor
43831308|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831309|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43831310|NCT05317624|Protective Agents|protective agents|mesh-ancestor
43831311|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43831312|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847418|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707212|NCT02702349|Penicillins|penicillins|mesh-list
43707213|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43707214|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707215|NCT02702076|Apomorphine|apomorphine|mesh-list
43707216|NCT02702076|Emetics|emetics|mesh-ancestor
43707217|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707229|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
43707230|NCT02702128|Coagulants|coagulants|mesh-ancestor
43707231|NCT02701933|Ketamine|ketamine|mesh-list
43707232|NCT02701933|Analgesics|analgesics|mesh-ancestor
43707233|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
43707234|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707235|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707236|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43707237|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43707238|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
43707239|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
43707240|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707241|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43707242|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43707243|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707244|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707245|NCT02701673|Pyridoxine|pyridoxine|mesh-list
43707246|NCT02701673|Gemcitabine|gemcitabine|mesh-list
43707294|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707295|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43707296|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43707297|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43707298|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
43707299|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
43707300|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43707301|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43707302|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43707303|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43707304|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43707305|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43707306|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43707307|NCT02701348|Letrozole|letrozole|mesh-list
43707308|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43707309|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707310|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43707311|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707312|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707313|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43707314|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
43707317|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
43707320|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
43707321|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707322|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707323|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707324|NCT02701478|Analgesics|analgesics|mesh-ancestor
43707325|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
43707326|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707327|NCT02701517|Cyclosporine|cyclosporine|mesh-list
43707328|NCT02701517|Methotrexate|methotrexate|mesh-list
43707329|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
43707330|NCT02701517|Cyclosporins|cyclosporins|mesh-list
43707331|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43707332|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
43707333|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43707334|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707335|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43707336|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
43707337|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707338|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707339|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
43707340|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707370|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43707371|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707522|NCT02700087|Famotidine|famotidine|mesh-list
43707372|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707373|NCT02701127|Niacinamide|niacinamide|mesh-list
43707374|NCT02701127|Niacin|niacin|mesh-list
43707375|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
43707376|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
43707377|NCT02701127|Vitamins|vitamins|mesh-ancestor
43707378|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
43707379|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707380|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43707381|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
43707382|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707383|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43707384|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
43707385|NCT02701166|Bezafibrate|bezafibrate|mesh-list
43707386|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43707387|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
43707388|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707389|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43707390|NCT02700893|Atropine|atropine|mesh-list
43707391|NCT02700893|Sufentanil|sufentanil|mesh-list
43707392|NCT02700893|Propofol|propofol|mesh-list
43707393|NCT02700893|Atracurium|atracurium|mesh-list
43707394|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43707395|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707396|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707397|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43707398|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
43707399|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
43707400|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43707401|NCT02700893|Narcotics|narcotics|mesh-ancestor
43707402|NCT02700893|Analgesics|analgesics|mesh-ancestor
43707403|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
43707404|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707405|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43707406|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43707407|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43707408|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
43707409|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43707410|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
43707411|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
43707412|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
43707413|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43707414|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43707415|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
43707416|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707417|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707418|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43707419|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43707420|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43707421|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43707422|NCT02700906|Lidocaine|lidocaine|mesh-list
43638588|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707446|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43707447|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43707448|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707449|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707450|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
43707451|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707452|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43707453|NCT02700711|Analgesics|analgesics|mesh-ancestor
43707454|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
43707455|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707506|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
43707507|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43707508|NCT02700217|Narcotics|narcotics|mesh-ancestor
43707509|NCT02700217|Analgesics|analgesics|mesh-ancestor
43707510|NCT02701205|Etanercept|etanercept|mesh-list
43707511|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43707512|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707513|NCT02701205|Analgesics|analgesics|mesh-ancestor
43707514|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
43707515|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707516|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707517|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707518|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707519|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43707520|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43707521|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
43707527|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43707528|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
43707555|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707556|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43707557|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
43707558|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43707559|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707560|NCT02699723|Itraconazole|itraconazole|mesh-list
43707561|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
43707562|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
43707563|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847419|NCT04108676|Omeprazole|omeprazole|mesh-list
43707564|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43707565|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43707566|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707567|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707568|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43707569|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
43707570|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707571|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707572|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43707573|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707574|NCT02699645|Amlodipine|amlodipine|mesh-list
43707575|NCT02699645|Telmisartan|telmisartan|mesh-list
43707576|NCT02699645|Indapamide|indapamide|mesh-list
43707577|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43707578|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43707579|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707580|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707581|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43707582|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707583|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
43707585|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43707591|NCT02700022|Doxorubicin|doxorubicin|mesh-list
43707592|NCT02700022|Etoposide|etoposide|mesh-list
43707593|NCT02700022|Vincristine|vincristine|mesh-list
43707594|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43707595|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
43707596|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707597|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707598|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43707599|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
43707600|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707601|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707602|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43707603|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43707604|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43707605|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43707606|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707607|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707608|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
43707609|NCT02700022|Hormones|hormones|mesh-ancestor
43707610|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707611|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707612|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43707613|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
43707614|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
43707616|NCT02699658|Levofloxacin|levofloxacin|mesh-list
43707640|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707641|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43707642|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43707643|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43707644|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
43707645|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707646|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707647|NCT02699710|Folic Acid|folic acid|mesh-list
43707648|NCT02699710|Methotrexate|methotrexate|mesh-list
43707649|NCT02699710|Rabeprazole|rabeprazole|mesh-list
43707650|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43707651|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
43707652|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43707653|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707654|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43707656|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707657|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707658|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
43707659|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707660|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43707661|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43707662|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
43707663|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707664|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43707665|NCT02699710|Hematinics|hematinics|mesh-ancestor
43707666|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
43707667|NCT02699710|Vitamins|vitamins|mesh-ancestor
43707668|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
43707669|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43707670|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43707671|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43707672|NCT02699437|Antibodies|antibodies|mesh-list
43707673|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
43707674|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
43707675|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707676|NCT02699281|Palmidrol|palmidrol|mesh-list
43707677|NCT02699281|Analgesics|analgesics|mesh-ancestor
43707678|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
43707679|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707680|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707681|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43707682|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707683|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707684|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707685|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
43707686|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707687|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43707688|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43707689|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707690|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707691|NCT02699281|Hormones|hormones|mesh-ancestor
43707692|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707693|NCT02699385|Domperidone|domperidone|mesh-list
43707694|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
43707695|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
43707696|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707697|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707698|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43707699|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43707700|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
43707701|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707702|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707703|NCT02699528|Methylphenidate|methylphenidate|mesh-list
43707704|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43707705|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707706|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43707707|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43707708|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707709|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707710|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
43707711|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707712|NCT02699008|Clopidogrel|clopidogrel|mesh-list
43707713|NCT02699008|Ticagrelor|ticagrelor|mesh-list
43707714|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43707715|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43707716|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43707717|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43707718|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
43707719|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707720|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707721|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707722|NCT02699138|Trazodone|trazodone|mesh-list
43707723|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43707724|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43707725|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707733|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
43707734|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43707735|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
43707736|NCT02698982|Anesthetics|anesthetics|mesh-list
43707737|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707738|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707739|NCT02698969|Atropine|atropine|mesh-list
43707740|NCT02698969|Fentanyl|fentanyl|mesh-list
43707741|NCT02698969|Propofol|propofol|mesh-list
43707742|NCT02698969|Sevoflurane|sevoflurane|mesh-list
43707743|NCT02698969|Rocuronium|rocuronium|mesh-list
43707744|NCT02698969|Neostigmine|neostigmine|mesh-list
43707745|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43707746|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707747|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707748|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43707752|NCT02698969|Narcotics|narcotics|mesh-ancestor
43707753|NCT02698969|Analgesics|analgesics|mesh-ancestor
43707754|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
43707755|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707756|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43707757|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43707758|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43707759|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43707760|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43707761|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43707762|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43707763|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43707764|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
43707765|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43707766|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
43707767|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
43707768|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
43707769|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43707770|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43707771|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
43707772|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707773|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707774|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43707775|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707776|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43707777|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
43707778|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43707779|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707780|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707781|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707782|NCT02698930|Analgesics|analgesics|mesh-ancestor
43707783|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
43707784|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707831|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43707832|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43707833|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707834|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707835|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
43707836|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707837|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707838|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43707839|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43707840|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707841|NCT02698514|Sevoflurane|sevoflurane|mesh-list
43707843|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43707844|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43707845|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
43707846|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
43707847|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707848|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707849|NCT02698527|Lidocaine|lidocaine|mesh-list
43707850|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707851|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
43707852|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707853|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707856|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43707857|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43707869|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43707870|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707872|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
43707873|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707874|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707875|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707876|NCT02698748|Filaricides|filaricides|mesh-ancestor
43707877|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
43707878|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
43831317|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831318|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43831319|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43831320|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831321|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831322|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43831323|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
43831324|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831325|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831326|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43831327|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43831328|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43831329|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
43831330|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43831331|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43831332|NCT05316935|Estrogens|estrogens|mesh-ancestor
43831333|NCT05316935|Hormones|hormones|mesh-ancestor
43831334|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
43831335|NCT05316467|Megestrol|megestrol|mesh-list
43831336|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
43831337|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43831338|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43831339|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43831340|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
43831341|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43831342|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831343|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43831344|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43831345|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43831346|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831347|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
43831348|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43831349|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
43831350|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43831351|NCT05314998|Leucovorin|leucovorin|mesh-list
43831352|NCT05314998|Folic Acid|folic acid|mesh-list
43831353|NCT05314998|Gemcitabine|gemcitabine|mesh-list
43831354|NCT05314998|Fluorouracil|fluorouracil|mesh-list
43831355|NCT05314998|Capecitabine|capecitabine|mesh-list
43831356|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
43707892|NCT02698280|Nimustine|nimustine|mesh-list
43707893|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43707894|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707895|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43707896|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43707897|NCT02698280|Growth Substances|growth substances|mesh-ancestor
43707898|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707899|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
43707900|NCT02698124|Decitabine|decitabine|mesh-list
43707901|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43707902|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
43707903|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707904|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707905|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707906|NCT02698306|Dexamethasone|dexamethasone|mesh-list
43707907|NCT02698306|Diclofenac|diclofenac|mesh-list
43707918|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707919|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43707920|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707921|NCT02698306|Analgesics|analgesics|mesh-ancestor
43707935|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
43707936|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
43707937|NCT02698228|Morphine|morphine|mesh-list
43707938|NCT02698228|Bupivacaine|bupivacaine|mesh-list
43707939|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707940|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
43707941|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707942|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707953|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707954|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
43707955|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707956|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43707957|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43707958|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
43707959|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707960|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707961|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43707962|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43707963|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
43707964|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43707965|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
43707966|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
43707967|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
43707968|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43707969|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43707970|NCT02697851|Cobicistat|cobicistat|mesh-list
43707971|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
43707972|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43707973|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43707974|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
43707975|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43707986|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707987|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43707988|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43707989|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
43707990|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707991|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43707992|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43707993|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43707995|NCT02697851|Hormones|hormones|mesh-ancestor
43707996|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707997|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43707998|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
43707999|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43708000|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43708001|NCT02697877|Regadenoson|regadenoson|mesh-list
43708002|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43708003|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43708004|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
43708005|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
43708006|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708007|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708008|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708010|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43708011|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708012|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708013|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
43708014|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708015|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708016|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43708017|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
43708018|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708019|NCT02697838|Paclitaxel|paclitaxel|mesh-list
43708020|NCT02697838|Apatinib|apatinib|mesh-list
43708021|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43708022|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708023|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
43708024|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
43708025|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
43708026|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708027|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43708028|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708029|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
43708030|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43708031|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43708032|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43708033|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43708034|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708035|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
43708036|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708037|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708038|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43708049|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708051|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708052|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
43708053|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43708054|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43708055|NCT05324748|Prednisolone|prednisolone|mesh-list
43708056|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
43708057|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43708058|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
43708059|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708060|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
43708061|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
43708062|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708063|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708064|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43708065|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
43708066|NCT05324748|Hormones|hormones|mesh-ancestor
43708067|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43708068|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43708081|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708082|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708083|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708085|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43708086|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43708087|NCT05324592|Growth Substances|growth substances|mesh-ancestor
43708088|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708089|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
43708090|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708091|NCT05323981|Pertuzumab|pertuzumab|mesh-list
43708092|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43708093|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708094|NCT05323812|Edaravone|edaravone|mesh-list
43708095|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43708096|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
43708097|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708098|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43708099|NCT05323812|Protective Agents|protective agents|mesh-ancestor
43708100|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708101|NCT05323786|Anesthetics|anesthetics|mesh-list
43708102|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708103|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708104|NCT05323565|Dexamethasone|dexamethasone|mesh-list
43708105|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
43708107|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
43708108|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
43708109|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708110|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708111|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43708112|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
43708113|NCT05323565|Hormones|hormones|mesh-ancestor
43708114|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43708115|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708116|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708117|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708118|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43708119|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708120|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43708121|NCT05323565|Analgesics|analgesics|mesh-ancestor
43708122|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
43708123|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43708124|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43708125|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43708126|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
43708127|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708128|NCT05323422|Ketamine|ketamine|mesh-list
43708129|NCT05323422|Analgesics|analgesics|mesh-ancestor
43708130|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
43708131|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708132|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708136|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
43831409|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43831410|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43831411|NCT05314101|Growth Substances|growth substances|mesh-ancestor
43831412|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831413|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
43831414|NCT05313997|Diclofenac|diclofenac|mesh-list
43831415|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43831416|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43831417|NCT05313997|Analgesics|analgesics|mesh-ancestor
43831418|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
43831419|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831420|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708142|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
43708143|NCT05323201|Fludarabine|fludarabine|mesh-list
43708144|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708145|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
43708146|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708147|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708148|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43708149|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
43708150|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708151|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708152|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43708153|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
43708154|NCT05322889|Telmisartan|telmisartan|mesh-list
43708155|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43708156|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43708157|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43708158|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708159|NCT05322720|Paclitaxel|paclitaxel|mesh-list
43708160|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43708161|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43708162|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708163|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
43708164|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
43708165|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
43708211|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43708212|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43708213|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
43708214|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708215|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708216|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43708217|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43708218|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
43708220|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
43708221|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708222|NCT05300451|Daratumumab|daratumumab|mesh-list
43708223|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708224|NCT05295394|Lamivudine|lamivudine|mesh-list
43708225|NCT05295394|Dolutegravir|dolutegravir|mesh-list
43708226|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43708227|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43708228|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708229|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708233|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43708234|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43708235|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43708236|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
43708237|NCT05273632|Oxytocin|oxytocin|mesh-list
43708238|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
43708239|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43708241|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43708242|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43708243|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708244|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
43708245|NCT05273632|Coagulants|coagulants|mesh-ancestor
43708246|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
43708247|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43708248|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708249|NCT05228041|Benralizumab|benralizumab|mesh-list
43708250|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43708251|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
43708252|NCT05210062|Succinylcholine|succinylcholine|mesh-list
43708253|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43708254|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43708255|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43708256|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708257|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708258|NCT05182658|Empagliflozin|empagliflozin|mesh-list
43708259|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43708260|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708261|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43708262|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708263|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43708264|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43708265|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708266|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43708267|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
43708268|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708269|NCT05063656|Gabapentin|gabapentin|mesh-list
43708270|NCT05063656|Analgesics|analgesics|mesh-ancestor
43708271|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
43708275|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43708276|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708277|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708278|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43708279|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43708280|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43708281|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708282|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708283|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
43708285|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43708286|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708287|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43708288|NCT05048498|Azacitidine|azacitidine|mesh-list
43831423|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43831425|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831426|NCT05313620|Adalimumab|adalimumab|mesh-list
43831427|NCT05313620|Golimumab|golimumab|mesh-list
43831428|NCT05313620|Infliximab|infliximab|mesh-list
43831429|NCT05313620|Tofacitinib|tofacitinib|mesh-list
43831430|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831431|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831432|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
43831433|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831434|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831435|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831436|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831437|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43831438|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831439|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
43831440|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831441|NCT05313256|Lidocaine|lidocaine|mesh-list
43831442|NCT05313256|Epinephrine|epinephrine|mesh-list
43831443|NCT05313256|Racepinephrine|racepinephrine|mesh-list
43831444|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
43708359|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
43708360|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708361|NCT04937738|Antidotes|antidotes|mesh-ancestor
43708362|NCT04937738|Protective Agents|protective agents|mesh-ancestor
43708363|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
43708364|NCT04937738|Vitamins|vitamins|mesh-ancestor
43708439|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43708441|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708442|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708443|NCT04808531|Analgesics|analgesics|mesh-ancestor
43708444|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
43708445|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708463|NCT04734197|Betamethasone|betamethasone|mesh-list
43708464|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
43708465|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43708466|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
43708467|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43708468|NCT04734197|Lifitegrast|lifitegrast|mesh-list
43708469|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43708470|NCT04734197|Cyclosporins|cyclosporins|mesh-list
43708471|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43708472|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708718|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
43708480|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708481|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43708482|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708483|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
43708512|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708513|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708514|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708515|NCT04662515|Warfarin|warfarin|mesh-list
43708516|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
43708517|NCT04662515|Dabigatran|dabigatran|mesh-list
43708518|NCT04662515|Apixaban|apixaban|mesh-list
43708519|NCT04662515|Edoxaban|edoxaban|mesh-list
43708520|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
43708521|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43708522|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
43708523|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43708524|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
43708525|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708526|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708527|NCT04660097|Etoposide|etoposide|mesh-list
43708528|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
43708529|NCT04660097|Durvalumab|durvalumab|mesh-list
43708530|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43708531|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43708532|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708533|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43708534|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43708535|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708546|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
43708548|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
43708549|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
43708550|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708551|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708552|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
43708553|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708554|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43708555|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43708556|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43708557|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43708558|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708559|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43708560|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43708561|NCT04648540|Analgesics|analgesics|mesh-ancestor
43708562|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43708563|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43708564|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43708565|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
43708566|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708567|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43708568|NCT04648540|Narcotics|narcotics|mesh-ancestor
43708569|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43708570|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43708571|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
43708572|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
43708575|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43708576|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43708577|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708578|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43708719|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
43708606|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708630|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708631|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
43708632|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43708633|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43708634|NCT04397003|Durvalumab|durvalumab|mesh-list
43708635|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43708636|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708637|NCT04382885|Cariprazine|cariprazine|mesh-list
43708638|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43708639|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708640|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831458|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
43708641|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708642|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43708644|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43708645|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43708646|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708687|NCT04315350|Curcumin|curcumin|mesh-list
43708688|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708689|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
43708690|NCT04315350|Hormones|hormones|mesh-ancestor
43708691|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43708692|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708693|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708694|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708695|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708696|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43708697|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43708698|NCT04315350|Analgesics|analgesics|mesh-ancestor
43708699|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
43708700|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708701|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708702|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708703|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
43708704|NCT04314219|Methotrexate|methotrexate|mesh-list
43708705|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708706|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
43708709|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43708710|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
43708711|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708712|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708713|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43708714|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43708715|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
43708716|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43708717|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43708747|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708749|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708750|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708751|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708752|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43708753|NCT04160377|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43708754|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43708755|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43708756|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708757|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
43708758|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43708759|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
43708760|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43708761|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43708762|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43708763|NCT04147013|Celecoxib|celecoxib|mesh-list
43708764|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43708765|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43708766|NCT04147013|Analgesics|analgesics|mesh-ancestor
43708768|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708769|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708770|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708771|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708772|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43708773|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43708774|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708775|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708776|NCT04126070|Docetaxel|docetaxel|mesh-list
43708777|NCT04126070|Nivolumab|nivolumab|mesh-list
43708778|NCT04126070|Leuprolide|leuprolide|mesh-list
43708779|NCT04126070|Goserelin|goserelin|mesh-list
43708780|NCT04126070|Androgens|androgens|mesh-list
43708781|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708782|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
43708783|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
43708784|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
43708785|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708786|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43708787|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43708788|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43708789|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
43708790|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43708791|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708792|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708793|NCT04126070|Hormones|hormones|mesh-ancestor
43708794|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43708795|NCT04064697|Valganciclovir|valganciclovir|mesh-list
43708796|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
43708797|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708829|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43708830|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43709013|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
43831459|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831460|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43831461|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43831462|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
43708840|NCT03838263|Cisplatin|cisplatin|mesh-list
43708842|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708843|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43708844|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43708845|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708846|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
43708847|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43708848|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708849|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43708850|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708851|NCT03771651|Aspirin|aspirin|mesh-list
43708852|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43708853|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43708854|NCT03771651|Analgesics|analgesics|mesh-ancestor
43708855|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
43708856|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708857|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708858|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708896|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
43708897|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43708898|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
43708899|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708900|NCT03563560|Cytarabine|cytarabine|mesh-list
43708901|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
43708902|NCT03563560|Alvocidib|alvocidib|mesh-list
43708924|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43708925|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43708926|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43708927|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708928|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708930|NCT03548805|Mitomycin|mitomycin|mesh-list
43708931|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43708939|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43708940|NCT03535116|Analgesics|analgesics|mesh-ancestor
43708941|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
43708942|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708943|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708944|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708945|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708946|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43708947|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708948|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708949|NCT03471143|Betadex|betadex|mesh-list
43708950|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
43708951|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708952|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
43708953|NCT03434366|Ketamine|ketamine|mesh-list
43708954|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43708955|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708956|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708957|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43708958|NCT03434366|Analgesics|analgesics|mesh-ancestor
43708959|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
43708960|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708961|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43708963|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43708971|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43708972|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43708973|NCT03244059|Belimumab|belimumab|mesh-list
43708974|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708975|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
43708976|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708977|NCT03170960|Atezolizumab|atezolizumab|mesh-list
43708978|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708979|NCT03014648|Atezolizumab|atezolizumab|mesh-list
43708980|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708981|NCT02740335|Protein C|protein c|mesh-list
43708982|NCT02740335|Protein S|protein s|mesh-list
43708983|NCT02740335|Thrombin|thrombin|mesh-list
43708984|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
43708985|NCT02740335|Coagulants|coagulants|mesh-ancestor
43708986|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
43708987|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43708988|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43708989|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708990|NCT02692313|Epinephrine|epinephrine|mesh-list
43708991|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43708992|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43708993|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
43708994|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708995|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708996|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708997|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43708998|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43708999|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
43709000|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709006|NCT02666105|Exemestane|exemestane|mesh-list
43709007|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709008|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43709009|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43709010|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709011|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709012|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43709025|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709026|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
43709027|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43709028|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43709029|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709102|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709103|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
43709104|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
43709105|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
43709106|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709107|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43709108|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43709109|NCT02364713|Growth Substances|growth substances|mesh-ancestor
43709110|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709111|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
43709112|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
43709128|NCT02354898|Sorafenib|sorafenib|mesh-list
43709129|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709130|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43709131|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709132|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709133|NCT02347917|Cisplatin|cisplatin|mesh-list
43709134|NCT02347917|Pemetrexed|pemetrexed|mesh-list
43709135|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709136|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709137|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709138|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43709139|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43709140|NCT02303795|Warfarin|warfarin|mesh-list
43709141|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
43709142|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
43709143|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43709144|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
43709145|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43709146|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
43709147|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709148|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831484|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831485|NCT05311852|Hormones|hormones|mesh-ancestor
43831486|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831487|NCT05311436|Iron|iron|mesh-list
43831488|NCT05311436|Folic Acid|folic acid|mesh-list
43831489|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831490|NCT05311436|Trace Elements|trace elements|mesh-ancestor
43831539|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831540|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709149|NCT02167763|Copper|copper|mesh-list
43709150|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
43709151|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43709152|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709153|NCT02167763|Trace Elements|trace elements|mesh-ancestor
43709154|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
43709155|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43709156|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43709157|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43709158|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709159|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709160|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709220|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709221|NCT01858896|Incretins|incretins|mesh-ancestor
43709222|NCT01678027|Clarithromycin|clarithromycin|mesh-list
43709223|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43709224|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709225|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43709226|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709227|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709228|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43709229|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43709231|NCT01672255|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43709232|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43709233|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43709234|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709235|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709247|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709257|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43709259|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43709260|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43709261|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
43709262|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43709263|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43709264|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43709265|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709266|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709343|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709344|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709345|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709346|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43709347|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43709348|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709349|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709350|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43709351|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
43709352|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43709353|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43709354|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43709355|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709356|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43709357|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43709359|NCT00411138|Cisplatin|cisplatin|mesh-list
43709360|NCT00411138|Carboplatin|carboplatin|mesh-list
43709361|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43709362|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709363|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
43709364|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
43709365|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
43709366|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709367|NCT00286169|Amrubicin|amrubicin|mesh-list
43709368|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709369|NCT00188539|Anesthetics|anesthetics|mesh-list
43709370|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709371|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709372|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43709373|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43709374|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709375|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
43709376|NCT02697630|Entinostat|entinostat|mesh-list
43709377|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43709378|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709379|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43709380|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709381|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709382|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43709383|NCT02697162|Octenidine|octenidine|mesh-list
43709384|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709398|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709399|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43709400|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43709401|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709402|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709403|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
43709404|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
43709405|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709406|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709407|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43709408|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43709409|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
43709410|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43709411|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43709412|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43709413|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43709524|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709525|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43709526|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
43709527|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709528|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831541|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
43831542|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831543|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43831544|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43831545|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43831546|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43831547|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831548|NCT05306431|Biguanides|biguanides|mesh-list
43831549|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43831550|NCT05306431|Polihexanide|polihexanide|mesh-list
43831551|NCT05306431|Eusol|eusol|mesh-list
43831552|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
43831553|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831555|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831556|NCT05305989|Belumosudil|belumosudil|mesh-list
43831557|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831558|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709534|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709536|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709537|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
43709538|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43709539|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709540|NCT05367362|Minocycline|minocycline|mesh-list
43709541|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43709542|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709543|NCT05367284|Testosterone|testosterone|mesh-list
43709544|NCT05367284|Androgens|androgens|mesh-ancestor
43709553|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
43709554|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
43709555|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
43709556|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709557|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43709558|NCT05367063|Canagliflozin|canagliflozin|mesh-list
43709559|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43709560|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709561|NCT05367063|Incretins|incretins|mesh-ancestor
43709563|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709564|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43709565|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
43709566|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709567|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709568|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43709569|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43709570|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709571|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43709635|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709636|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43709637|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43709646|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43709647|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43709648|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
43709649|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709650|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43709651|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
43709652|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
43709653|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
43709654|NCT05212311|Coagulants|coagulants|mesh-ancestor
43709655|NCT05197192|Venetoclax|venetoclax|mesh-list
43709656|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
43709657|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
43709658|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709659|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43709660|NCT05194111|Valsartan|valsartan|mesh-list
43709663|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43709664|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43638589|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
43829672|NCT05414006|Esketamine|esketamine|mesh-list
43709665|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709667|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43709668|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709669|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709670|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709671|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
43709672|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709673|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43709675|NCT05160493|Ketamine|ketamine|mesh-list
43709676|NCT05160493|Esketamine|esketamine|mesh-list
43709677|NCT05160493|Analgesics|analgesics|mesh-ancestor
43709678|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
43709719|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709720|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43709730|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43709731|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43709732|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43709733|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43709734|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43709735|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709736|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
43709737|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
43709738|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43709739|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43709741|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831573|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
43831575|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831576|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
43831577|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
43831578|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831579|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831580|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831581|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
43831582|NCT05305404|Hormones|hormones|mesh-ancestor
43709822|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
43709847|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43709848|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
43709849|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709850|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43709851|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43709852|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43709853|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709854|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43709855|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
43709856|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43709857|NCT04962841|Protective Agents|protective agents|mesh-ancestor
43709858|NCT04908800|Itraconazole|itraconazole|mesh-list
43709859|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
43709860|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709861|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43709862|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43709863|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709864|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709865|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43709866|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
43709877|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709878|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
43709879|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43709880|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709881|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
43709882|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709884|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
43709885|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
43709886|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709887|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709918|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709919|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
43709964|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43709965|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709967|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709968|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
43709969|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709970|NCT04608448|Emollients|emollients|mesh-ancestor
43709971|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
43709972|NCT04599075|Insulin|insulin|mesh-list
43709973|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43709974|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43709975|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709993|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709994|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43709995|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
43709996|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709997|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709998|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43709999|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831591|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831592|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43847421|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43847422|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43847423|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847424|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847425|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
43847426|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
43847427|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847428|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
43847429|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847430|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847431|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
43847432|NCT04106219|Topotecan|topotecan|mesh-list
43847433|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710012|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
43710013|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
43710014|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
43710015|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710016|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710017|NCT04474938|Dexamethasone|dexamethasone|mesh-list
43710018|NCT04474938|Bortezomib|bortezomib|mesh-list
43710019|NCT04474938|Daratumumab|daratumumab|mesh-list
43710020|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710021|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
43710022|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
43710023|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710024|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710025|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43710026|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
43710027|NCT04474938|Hormones|hormones|mesh-ancestor
43710028|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710029|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43710030|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710031|NCT04468815|Esomeprazole|esomeprazole|mesh-list
43710032|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43710033|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43710154|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710155|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
43710156|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710157|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710158|NCT03967847|Ketorolac|ketorolac|mesh-list
43710159|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43710160|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43710161|NCT03967847|Analgesics|analgesics|mesh-ancestor
43710162|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
43710163|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710164|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710165|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710166|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710201|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710203|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
43710204|NCT03889743|Hormones|hormones|mesh-ancestor
43710205|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710206|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43710207|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710208|NCT03863587|Ramucirumab|ramucirumab|mesh-list
43710209|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710210|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43710211|NCT03854500|Tenecteplase|tenecteplase|mesh-list
43710212|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43710213|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43710214|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710215|NCT03847506|Amlodipine|amlodipine|mesh-list
43710216|NCT03847506|Candesartan|candesartan|mesh-list
43710217|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
43710258|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
43710259|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710260|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43710262|NCT03577704|Antiviral Agents|antiviral agents|mesh-ancestor
43710263|NCT03577704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710264|NCT03577704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710265|NCT03577704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710266|NCT03539822|Durvalumab|durvalumab|mesh-list
43710267|NCT03539822|Tremelimumab|tremelimumab|mesh-list
43710268|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43710269|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710270|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710271|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710272|NCT02744092|Enoxaparin|enoxaparin|mesh-list
43710273|NCT02744092|Dalteparin|dalteparin|mesh-list
43710274|NCT02744092|PENTA|penta|mesh-list
43710275|NCT02744092|Warfarin|warfarin|mesh-list
43710276|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
43710277|NCT02744092|Dabigatran|dabigatran|mesh-list
43710278|NCT02744092|Apixaban|apixaban|mesh-list
43710279|NCT02744092|Edoxaban|edoxaban|mesh-list
43710280|NCT02744092|Fondaparinux|fondaparinux|mesh-list
43710281|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
43710282|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43710283|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
43710284|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43710285|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
43710286|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710287|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710288|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43710289|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43831593|NCT05305066|Adalimumab|adalimumab|mesh-list
43831595|NCT05305066|Golimumab|golimumab|mesh-list
43831596|NCT05305066|Upadacitinib|upadacitinib|mesh-list
43831597|NCT05305066|Tofacitinib|tofacitinib|mesh-list
43831598|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831599|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831600|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43831601|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43831602|NCT05305066|Analgesics|analgesics|mesh-ancestor
43710290|NCT02580994|Carboplatin|carboplatin|mesh-list
43710339|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43710340|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
43710341|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43710342|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710343|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43710344|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
43710345|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710346|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710347|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710348|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710349|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43710351|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
43710352|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710353|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43710354|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
43710355|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710356|NCT02200978|Analgesics|analgesics|mesh-ancestor
43710357|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
43710358|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710359|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43710360|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43710414|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710415|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
43710416|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710417|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43710418|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
43710419|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710420|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43710421|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710450|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43710459|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
43710460|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43710461|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43710462|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710464|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710465|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
43710466|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710467|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710468|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
43710469|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710470|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43710471|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43710472|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43710473|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710474|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710477|NCT02696694|Hormones|hormones|mesh-ancestor
43710478|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710479|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710480|NCT02696941|Metformin|metformin|mesh-list
43710481|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43710482|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43710483|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710484|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710485|NCT02696954|Lumefantrine|lumefantrine|mesh-list
43710486|NCT02696954|Artemether|artemether|mesh-list
43710487|NCT02696954|Primaquine|primaquine|mesh-list
43710488|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43710489|NCT02696954|Amodiaquine|amodiaquine|mesh-list
43710490|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
43710491|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43710492|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43710512|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
43710513|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710514|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710515|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
43710516|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710543|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43710544|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710545|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43710546|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43710547|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
43710548|NCT02696512|Protective Agents|protective agents|mesh-ancestor
43710549|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
43710550|NCT02696512|Vitamins|vitamins|mesh-ancestor
43710551|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
43710552|NCT02696512|Antidotes|antidotes|mesh-ancestor
43710553|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
43710554|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
43710555|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710556|NCT02696577|Aspirin|aspirin|mesh-list
43710557|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43710558|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43710559|NCT02696577|Analgesics|analgesics|mesh-ancestor
43710560|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
43710561|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710562|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710563|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710564|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43644230|NCT04692077|Emtricitabine|emtricitabine|mesh-list
43644231|NCT04692077|Cabotegravir|cabotegravir|mesh-list
43644232|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
43644233|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644234|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43644235|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43644236|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644237|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846346|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846347|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846348|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846349|NCT04205409|Nivolumab|nivolumab|mesh-list
43846350|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846351|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846352|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43846353|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846354|NCT04204967|Fentanyl|fentanyl|mesh-list
43846355|NCT04204967|Remifentanil|remifentanil|mesh-list
43846356|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43846357|NCT04204967|Narcotics|narcotics|mesh-ancestor
43846358|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846359|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846360|NCT04204967|Analgesics|analgesics|mesh-ancestor
43846361|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
43846362|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846363|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43846364|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43846365|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
43846366|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
43846367|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43846368|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
43644256|NCT04680988|Gemcitabine|gemcitabine|mesh-list
43644257|NCT04680988|Paclitaxel|paclitaxel|mesh-list
43644258|NCT04680988|Pemetrexed|pemetrexed|mesh-list
43644259|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43644260|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43644261|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644262|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
43644279|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43644280|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644281|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
43644282|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43644284|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644285|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644286|NCT04677114|Analgesics|analgesics|mesh-ancestor
43644287|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
43644288|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644289|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43644290|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
43644291|NCT04666740|Olaparib|olaparib|mesh-list
43644292|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644293|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644294|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43644295|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644296|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644297|NCT04665856|Carboplatin|carboplatin|mesh-list
43644298|NCT04665856|Etoposide|etoposide|mesh-list
43644299|NCT04665856|Atezolizumab|atezolizumab|mesh-list
43644300|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644301|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43644303|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43644304|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644306|NCT04656652|Docetaxel|docetaxel|mesh-list
43644312|NCT04655170|Albuterol|albuterol|mesh-list
43644326|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644327|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644329|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43644330|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
43644331|NCT04651348|Antibodies|antibodies|mesh-list
43644332|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43644333|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
43644335|NCT04650087|Apixaban|apixaban|mesh-list
43644336|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43644337|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
43644338|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43644339|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
43644340|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644341|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644342|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
43644343|NCT04646356|Tacrolimus|tacrolimus|mesh-list
43644382|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644383|NCT04622735|Acetaminophen|acetaminophen|mesh-list
43644384|NCT04622735|Nefopam|nefopam|mesh-list
43644385|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43644386|NCT04622735|Analgesics|analgesics|mesh-ancestor
43644387|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
43644388|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644389|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644390|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
43644391|NCT04622319|Trastuzumab|trastuzumab|mesh-list
43644392|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43644393|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644394|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644395|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
43644396|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
43644397|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
43644398|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644399|NCT04614974|Famotidine|famotidine|mesh-list
43644400|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43644401|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43644402|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43644403|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
43644404|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
43644405|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644406|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644407|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644408|NCT04610671|Nivolumab|nivolumab|mesh-list
43644409|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644410|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644411|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43644412|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644413|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
43644414|NCT04610476|Prednisolone|prednisolone|mesh-list
43644415|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43644423|NCT04610476|Methotrexate|methotrexate|mesh-list
43644424|NCT04610476|Abatacept|abatacept|mesh-list
43644425|NCT04610476|Infliximab|infliximab|mesh-list
43644426|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
43644427|NCT04610476|Ustekinumab|ustekinumab|mesh-list
43644428|NCT04610476|Ixekizumab|ixekizumab|mesh-list
43644429|NCT04610476|Tofacitinib|tofacitinib|mesh-list
43644430|NCT04610476|Leflunomide|leflunomide|mesh-list
43644431|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43644432|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
43644433|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43644434|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
43644435|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43644487|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43644488|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644489|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644490|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
43644491|NCT04588311|Hematinics|hematinics|mesh-ancestor
43644492|NCT04584255|Niraparib|niraparib|mesh-list
43644494|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823937|NCT05517499|Hormones|hormones|mesh-ancestor
43823938|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823939|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43644535|NCT04577443|Adenosine|adenosine|mesh-list
43644536|NCT04577443|Analgesics|analgesics|mesh-ancestor
43644537|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
43644538|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644539|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644540|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43644541|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
43644542|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43644543|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
43644547|NCT04572763|Venetoclax|venetoclax|mesh-list
43644780|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43644781|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43644782|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644783|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
43644784|NCT04427618|Coagulants|coagulants|mesh-ancestor
43644785|NCT04421092|Lidocaine|lidocaine|mesh-list
43598277|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43598278|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598279|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
43598300|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43598301|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598302|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598303|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43598304|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
43598305|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598306|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598307|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43598308|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43598309|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
43598310|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43598311|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
43598312|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43598313|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43598314|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43598315|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43598316|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43598317|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43598318|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43598349|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43598350|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598351|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598352|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
43598353|NCT03300609|Leucovorin|leucovorin|mesh-list
43598354|NCT03300609|Folic Acid|folic acid|mesh-list
43598355|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
43598356|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
43598357|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43598358|NCT03300609|Panitumumab|panitumumab|mesh-list
43598359|NCT03300609|Fluorouracil|fluorouracil|mesh-list
43598360|NCT03300609|Capecitabine|capecitabine|mesh-list
43598361|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
43598362|NCT03300609|Antibodies|antibodies|mesh-list
43598363|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
43598364|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43598365|NCT03300609|Calcium|calcium|mesh-list
43598366|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
43598367|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
43598368|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598369|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598370|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43598371|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43598372|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
43598373|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598401|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598402|NCT03300089|Anesthetics|anesthetics|mesh-list
43598403|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598404|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598405|NCT03299998|Anesthetics|anesthetics|mesh-list
43598406|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598407|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598409|NCT03299842|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43598410|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43598411|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598412|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598413|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598414|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
43598415|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598416|NCT03299829|Trientine|trientine|mesh-list
43598417|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
43598418|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
43598419|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598420|NCT03299725|Bismuth|bismuth|mesh-list
43598421|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598422|NCT03299725|Antacids|antacids|mesh-ancestor
43598423|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43598424|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
43598425|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
43598426|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43598427|NCT03299712|Protective Agents|protective agents|mesh-ancestor
43598428|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598429|NCT03299621|Rocuronium|rocuronium|mesh-list
43598430|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43598431|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43598432|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43598433|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598438|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
43598439|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
43829673|NCT05414006|Analgesics|analgesics|mesh-ancestor
43829674|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
43598440|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598441|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598442|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
43598443|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598444|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43598445|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43598446|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598447|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598448|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
43598449|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43598450|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43598451|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43598452|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598453|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43598454|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43598455|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43598457|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
43598458|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598459|NCT03299387|Gentamicins|gentamicins|mesh-list
43598460|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
43598461|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43598462|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598484|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598485|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598486|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
43598488|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43598489|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598490|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43598491|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43598492|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598493|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598495|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43598503|NCT03298906|Ticlopidine|ticlopidine|mesh-list
43598547|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598548|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598549|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43598551|NCT03298646|Analgesics|analgesics|mesh-ancestor
43598552|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598553|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598554|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43598555|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598556|NCT03298581|Clobetasol|clobetasol|mesh-list
43598557|NCT03298581|Halobetasol|halobetasol|mesh-list
43598558|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43598560|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
43849156|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598561|NCT03298581|Hormones|hormones|mesh-ancestor
43598562|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598563|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598564|NCT03298542|Golimumab|golimumab|mesh-list
43598565|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43598566|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598567|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43598568|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
43598569|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598570|NCT03298516|Azacitidine|azacitidine|mesh-list
43598571|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43598572|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
43598592|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598593|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598594|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43598595|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43598596|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
43598597|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598598|NCT03298321|Azacitidine|azacitidine|mesh-list
43598599|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43598600|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
43608285|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43598601|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598602|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598603|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598604|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
43598605|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
43598606|NCT03298191|Ritodrine|ritodrine|mesh-list
43598607|NCT03298191|Calcium|calcium|mesh-list
43598609|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598648|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43598649|NCT03297879|Incretins|incretins|mesh-ancestor
43598650|NCT03297879|Hormones|hormones|mesh-ancestor
43598651|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598652|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
43598653|NCT03297502|Tacrolimus|tacrolimus|mesh-list
43598654|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43598655|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598656|NCT03297502|Analgesics|analgesics|mesh-ancestor
43598657|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
43598658|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598659|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598660|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598661|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598662|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
43598710|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849158|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598711|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598713|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43598714|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
43598715|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598716|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43598717|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43598718|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
43598719|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
43598720|NCT03296670|Alprostadil|alprostadil|mesh-list
43598721|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
43598722|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43598723|NCT03296670|Urological Agents|urological agents|mesh-ancestor
43598724|NCT03296657|Fluorides|fluorides|mesh-list
43598725|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
43598726|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
43598727|NCT03296657|Protective Agents|protective agents|mesh-ancestor
43598728|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598729|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
43598730|NCT03296579|Aminophylline|aminophylline|mesh-list
43598731|NCT03296579|Albuterol|albuterol|mesh-list
43598732|NCT03296579|Ipratropium|ipratropium|mesh-list
43598733|NCT03296579|Analgesics|analgesics|mesh-ancestor
43598734|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
43598735|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598736|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598737|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
43598738|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598739|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43598753|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43598754|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
43598755|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598756|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43598757|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
43598758|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43598759|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43598760|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598761|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43598762|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43598763|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
43598764|NCT03296579|Protective Agents|protective agents|mesh-ancestor
43598765|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43598766|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43598767|NCT03296488|Fentanyl|fentanyl|mesh-list
43598768|NCT03296488|Nalbuphine|nalbuphine|mesh-list
43598769|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43598770|NCT03296488|Narcotics|narcotics|mesh-ancestor
43598771|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598772|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598773|NCT03296488|Analgesics|analgesics|mesh-ancestor
43598774|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
43598775|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598776|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43598777|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43598778|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
43598779|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
43598804|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
43598805|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
43598806|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598807|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598808|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43598809|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
43598810|NCT03296189|Hormones|hormones|mesh-ancestor
43598811|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598812|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43598813|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598814|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
43598815|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
43598816|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598817|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
43598818|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
43598819|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598820|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598821|NCT03296137|Aldesleukin|aldesleukin|mesh-list
43598822|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
43598823|NCT03296137|Nivolumab|nivolumab|mesh-list
43598824|NCT03296137|Ipilimumab|ipilimumab|mesh-list
43598825|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
43598826|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43598827|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
43598828|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598829|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598853|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
43598854|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598855|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598856|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598857|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598858|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43598859|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598860|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598861|NCT03295955|Amoxicillin|amoxicillin|mesh-list
43849159|NCT03955042|Pemetrexed|pemetrexed|mesh-list
43598862|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
43598863|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
43849160|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598864|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43598865|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43598866|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598867|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43598869|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598870|NCT03295903|Cannabidiol|cannabidiol|mesh-list
43598889|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598890|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598891|NCT03295786|Protective Agents|protective agents|mesh-ancestor
43598895|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598897|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43598898|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43598899|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598900|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
43598901|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43598902|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598903|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
43598904|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
43598905|NCT03295383|Rituximab|rituximab|mesh-list
43598906|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43598907|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
43598908|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598909|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598910|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43598911|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
43598913|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598937|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43598938|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598939|NCT03294967|Vitamin E|vitamin e|mesh-list
43598940|NCT03294967|Caffeine|caffeine|mesh-list
43598941|NCT03294967|Vitamins|vitamins|mesh-ancestor
43598942|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
43598943|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598944|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43598945|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43598946|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598947|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598948|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43598949|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43598950|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
43598951|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598952|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
43598953|NCT03294967|Protective Agents|protective agents|mesh-ancestor
43598954|NCT03294798|Interferons|interferons|mesh-list
43598955|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
43598956|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
43598957|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43598958|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598959|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
43598960|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598961|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
43598962|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598963|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
43598964|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43598965|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598985|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43598986|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43598987|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43598988|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598989|NCT03294551|Vaccines|vaccines|mesh-list
43598990|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
43598991|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598992|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43598993|NCT03294525|Mirtazapine|mirtazapine|mesh-list
43598994|NCT03294525|Citalopram|citalopram|mesh-list
43598995|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
43598996|NCT03294525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43598997|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43598998|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598999|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599000|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599043|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
43599044|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599045|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599046|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43599047|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599048|NCT03294252|Leucovorin|leucovorin|mesh-list
43599049|NCT03294252|Folic Acid|folic acid|mesh-list
43599050|NCT03294252|Fluorouracil|fluorouracil|mesh-list
43599051|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
43599052|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
43599053|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
43599054|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599055|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43599056|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599057|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43599058|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
43599059|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599060|NCT03294252|Antidotes|antidotes|mesh-ancestor
43599061|NCT03294252|Protective Agents|protective agents|mesh-ancestor
43599062|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
43599063|NCT03294252|Vitamins|vitamins|mesh-ancestor
43599064|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
43599065|NCT03294252|Hematinics|hematinics|mesh-ancestor
43599066|NCT03294174|Ropivacaine|ropivacaine|mesh-list
43599067|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
43599068|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
43599077|NCT03294070|Amlodipine|amlodipine|mesh-list
43599096|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599097|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43599098|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43599099|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43599100|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
43599101|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599102|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599103|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43599104|NCT03293927|Narcotics|narcotics|mesh-ancestor
43599105|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43599106|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43599107|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
43599108|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
43599109|NCT03293641|Folic Acid|folic acid|mesh-list
43599110|NCT03293641|Penicillins|penicillins|mesh-list
43599111|NCT03293641|Penicillin V|penicillin v|mesh-list
43599112|NCT03293641|Proguanil|proguanil|mesh-list
43599113|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
43599114|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
43599115|NCT03293641|Hematinics|hematinics|mesh-ancestor
43599116|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
43599117|NCT03293641|Vitamins|vitamins|mesh-ancestor
43599118|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
43599119|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599120|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599121|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
43599127|NCT03293641|Astringents|astringents|mesh-ancestor
43599146|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43599147|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
43599148|NCT03293368|Triamcinolone|triamcinolone|mesh-list
43599149|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43599150|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43599151|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43599152|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43599153|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
43599155|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599156|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599157|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43599158|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
43599159|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599160|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599161|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
43599204|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599205|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
43599206|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
43599207|NCT03292822|Paclitaxel|paclitaxel|mesh-list
43599208|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43599209|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599210|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
43599211|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
43599212|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
43599213|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599214|NCT03292796|Bimatoprost|bimatoprost|mesh-list
43599215|NCT03292796|Latanoprost|latanoprost|mesh-list
43599216|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43599217|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43599218|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43599219|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
43599220|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
43599234|NCT03292731|Hormones|hormones|mesh-ancestor
43599266|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599267|NCT03291899|Folfirinox|folfirinox|mesh-list
43599268|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599269|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43599270|NCT03291821|Cetrorelix|cetrorelix|mesh-list
43599271|NCT03291821|Menotropins|menotropins|mesh-list
43599272|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43599273|NCT03291821|Ganirelix|ganirelix|mesh-list
43599275|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599276|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599278|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43599279|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
43599280|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43599281|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43599282|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43599283|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599284|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43599285|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
43599286|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
43599287|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
43599288|NCT03291457|Hormones|hormones|mesh-ancestor
43599289|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599290|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599291|NCT03291418|Naproxen|naproxen|mesh-list
43599292|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43599293|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43599294|NCT03291418|Analgesics|analgesics|mesh-ancestor
43599295|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
43599296|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599309|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43599310|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599311|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43599312|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599313|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599315|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43599316|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43599317|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43599318|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599319|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599320|NCT03291158|Minocycline|minocycline|mesh-list
43599321|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43599322|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599323|NCT03291145|Spironolactone|spironolactone|mesh-list
43599324|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43599325|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43599326|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
43599327|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599328|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599329|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43599330|NCT03291145|Diuretics|diuretics|mesh-ancestor
43599331|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
43599332|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43599333|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
43599334|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599335|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599336|NCT03291093|Flutemetamol|flutemetamol|mesh-list
43599337|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43599338|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599339|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
43599340|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43599346|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599347|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43599348|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43599349|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
43599351|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599352|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43599353|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43599354|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599355|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599356|NCT03290859|Propofol|propofol|mesh-list
43599357|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43599358|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599359|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599360|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43599361|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
43599362|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
43599363|NCT03290846|Secretin|secretin|mesh-list
43599364|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43599366|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599367|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599368|NCT03290820|Aspirin|aspirin|mesh-list
43599369|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43599370|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43599371|NCT03290820|Analgesics|analgesics|mesh-ancestor
43599372|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
43849181|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599373|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599388|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599389|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599390|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
43599391|NCT03290625|Ketamine|ketamine|mesh-list
43599392|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43599393|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599394|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599395|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43599396|NCT03290625|Analgesics|analgesics|mesh-ancestor
43599397|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
43599398|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599399|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43599400|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43599401|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43599402|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
43599403|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599404|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599405|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43599406|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43599407|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
43599408|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
43599409|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43599410|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43599411|NCT03290495|Ketamine|ketamine|mesh-list
43599412|NCT03290495|Analgesics|analgesics|mesh-ancestor
43599413|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
43599414|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599415|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599416|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43599417|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43599418|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
43599419|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
43599423|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599428|NCT03290456|Hormones|hormones|mesh-ancestor
43599429|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599430|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599431|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43599432|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599433|NCT03290430|Nicotine|nicotine|mesh-list
43599434|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43599435|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
43599436|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599437|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599438|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43599439|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43599440|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
43599441|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599442|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599443|NCT03290417|Vitamin D|vitamin d|mesh-list
43599444|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
43599445|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
43599446|NCT03290417|Vitamins|vitamins|mesh-list
43599447|NCT03290417|Curcumin|curcumin|mesh-list
43599448|NCT03290417|Turmeric extract|turmeric extract|mesh-list
43599449|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
43599450|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599451|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43599452|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43599453|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43599454|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43599455|NCT03290417|Analgesics|analgesics|mesh-ancestor
43599476|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
43599477|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599478|NCT03289871|Amorolfine|amorolfine|mesh-list
43599479|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
43599879|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
43599481|NCT03289819|Paclitaxel|paclitaxel|mesh-list
43599482|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43599483|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
43599484|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
43599485|NCT03289819|Epirubicin|epirubicin|mesh-list
43599486|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43599487|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599488|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
43599489|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
43599490|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
43599491|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599492|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43599493|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
43599494|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599495|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43599496|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43599497|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
43599498|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43599499|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43599500|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43599501|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43599502|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43599503|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599505|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43599521|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43599522|NCT03289559|Testosterone|testosterone|mesh-list
43599523|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43599524|NCT03289559|Androgens|androgens|mesh-ancestor
43599525|NCT03289559|Hormones|hormones|mesh-ancestor
43599526|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599527|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599528|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43599529|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599530|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599531|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43599532|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
43599533|NCT03289520|Clopidogrel|clopidogrel|mesh-list
43599534|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43599535|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43599536|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43599537|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43599538|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
43599539|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599540|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599541|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599542|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
43599543|NCT03289429|Atorvastatin|atorvastatin|mesh-list
43599544|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43599568|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599569|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599571|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
43599572|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
43599573|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43599574|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43599575|NCT03289338|Prednisolone|prednisolone|mesh-list
43599576|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
43599577|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43599578|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
43599579|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43599580|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
43599581|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
43599582|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599583|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599584|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43599585|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
43599586|NCT03289338|Hormones|hormones|mesh-ancestor
43599587|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599588|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43599589|NCT03289338|Protective Agents|protective agents|mesh-ancestor
43599590|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43599591|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599592|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43599593|NCT03289260|Imiquimod|imiquimod|mesh-list
43599599|NCT03289182|Rituximab|rituximab|mesh-list
43599615|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
43599616|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43599617|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43599618|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43599619|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599620|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599621|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
43599622|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
43599623|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599624|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599625|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43599626|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43599627|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
43599628|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43599629|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43599630|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43599631|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43599633|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43599634|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599635|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599636|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599637|NCT03288870|Docetaxel|docetaxel|mesh-list
43599638|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599639|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
43599640|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
43599641|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
43599642|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599643|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
43599644|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
43599648|NCT03288636|Ritonavir|ritonavir|mesh-list
43599656|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
43599657|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599658|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43599659|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43599660|NCT03288610|Vasopressins|vasopressins|mesh-list
43599661|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
43599662|NCT03288610|Coagulants|coagulants|mesh-ancestor
43599663|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43599664|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43599665|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
43599666|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599667|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43599668|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43599669|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599670|NCT03288532|Durvalumab|durvalumab|mesh-list
43599671|NCT03288532|Tremelimumab|tremelimumab|mesh-list
43599672|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43599673|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599674|NCT03288428|Morphine|morphine|mesh-list
43599675|NCT03288428|Nalbuphine|nalbuphine|mesh-list
43599676|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43599677|NCT03288428|Narcotics|narcotics|mesh-ancestor
43599678|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599679|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599680|NCT03288428|Analgesics|analgesics|mesh-ancestor
43599681|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
43599683|NCT03288402|Caffeine|caffeine|mesh-list
43599705|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
43599706|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599707|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599708|NCT03288077|Tryptophan|tryptophan|mesh-list
43599709|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43599710|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
43599711|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43599712|NCT03288051|Dobutamine|dobutamine|mesh-list
43599713|NCT03288051|Norepinephrine|norepinephrine|mesh-list
43599714|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43599715|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43599716|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
43599717|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599718|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599719|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599720|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
43599721|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
43599723|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43599724|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43599725|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43599726|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43599727|NCT03288051|Protective Agents|protective agents|mesh-ancestor
43599758|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599759|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
43599760|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
43599761|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599762|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599763|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43599764|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43599765|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
43599766|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43599767|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43599768|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43599769|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43599770|NCT03287388|Rocuronium|rocuronium|mesh-list
43599771|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43599772|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43599773|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43599774|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599775|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599776|NCT03287271|Paclitaxel|paclitaxel|mesh-list
43599777|NCT03287271|Carboplatin|carboplatin|mesh-list
43599779|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599811|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599813|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43599814|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599815|NCT03286803|Vaccines|vaccines|mesh-list
43599816|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
43599817|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599818|NCT03286764|Peppermint oil|peppermint oil|mesh-list
43599819|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
43599820|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
43599821|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599822|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599823|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43599824|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
43599825|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
43599826|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
43599828|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43599829|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599830|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43599832|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599833|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43599834|NCT03286582|Clobetasol|clobetasol|mesh-list
43599835|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43599836|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
43599837|NCT03286582|Hormones|hormones|mesh-ancestor
43599838|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599842|NCT03286296|Antibodies|antibodies|mesh-list
43599859|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599860|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599861|NCT03285802|Everolimus|everolimus|mesh-list
43599862|NCT03285802|Letrozole|letrozole|mesh-list
43599863|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599864|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43599865|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
43599866|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599867|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43599868|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43599869|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599870|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599871|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43599872|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
43599873|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599874|NCT03285607|Paclitaxel|paclitaxel|mesh-list
43599875|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
43599876|NCT03285607|Doxorubicin|doxorubicin|mesh-list
43599877|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43599878|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599882|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599883|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43599884|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
43599885|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599886|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43599887|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43599888|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
43599889|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43599890|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43608286|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599891|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43599892|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43599893|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599894|NCT03285568|Palbociclib|palbociclib|mesh-list
43599895|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599896|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43599898|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599899|NCT03285503|Aripiprazole|aripiprazole|mesh-list
43599900|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
43599901|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43599902|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43599903|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43599904|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599905|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599906|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
43599907|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
43599908|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599909|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599910|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43599911|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43599912|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
43599913|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43599914|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43599915|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43599916|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43599917|NCT03285360|Fluorides|fluorides|mesh-list
43599918|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
43599919|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
43599920|NCT03285360|Protective Agents|protective agents|mesh-ancestor
43599921|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599922|NCT03285165|Propofol|propofol|mesh-list
43599923|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43599924|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599925|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599928|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
43599940|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
43599941|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599942|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599943|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
43599944|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43599945|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
43599946|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43599947|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
43599948|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599949|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599950|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
43599951|NCT03284749|Copper|copper|mesh-list
43599952|NCT03284749|Trace Elements|trace elements|mesh-ancestor
43599953|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
43599954|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599955|NCT03284645|Tenofovir|tenofovir|mesh-list
43599956|NCT03284645|Lamivudine|lamivudine|mesh-list
43599957|NCT03284645|Zidovudine|zidovudine|mesh-list
43599958|NCT03284645|Efavirenz|efavirenz|mesh-list
43599959|NCT03284645|Abacavir|abacavir|mesh-list
43599960|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
43599961|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599962|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43599963|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43599964|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599965|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599966|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43599967|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43599968|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
43599975|NCT03284593|Azacitidine|azacitidine|mesh-list
43599986|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
43599987|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43599989|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43599990|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599991|NCT03284164|Tenofovir|tenofovir|mesh-list
43599992|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
43599993|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599994|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43599995|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43599996|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599997|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599998|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43599999|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43600000|NCT03283943|Durvalumab|durvalumab|mesh-list
43600001|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43600002|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600004|NCT03283800|Trace Elements|trace elements|mesh-ancestor
43600005|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
43600006|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600007|NCT03283410|Propofol|propofol|mesh-list
43600008|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43600009|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600010|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600011|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43600012|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
43600013|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
43600014|NCT03283202|Prednisone|prednisone|mesh-list
43600015|NCT03283202|Prednisolone|prednisolone|mesh-list
43600016|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
43600017|NCT03283202|Rituximab|rituximab|mesh-list
43600018|NCT03283202|Vincristine|vincristine|mesh-list
43600019|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43600020|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
43600021|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600025|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600027|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43600028|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43600029|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600030|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
43600031|NCT03283202|Hormones|hormones|mesh-ancestor
43600032|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600033|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43600034|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43600035|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
43600036|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
43600037|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
43600038|NCT03283176|Folic Acid|folic acid|mesh-list
43600039|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
43600040|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
43600041|NCT03283176|Vitamins|vitamins|mesh-ancestor
43600042|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
43600043|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600044|NCT03283176|Hematinics|hematinics|mesh-ancestor
43600045|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
43600046|NCT03283059|Donepezil|donepezil|mesh-list
43600047|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43600049|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600050|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
43600051|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600052|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600053|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
43600054|NCT03283046|Dexamethasone|dexamethasone|mesh-list
43600055|NCT03283046|Nivolumab|nivolumab|mesh-list
43600056|NCT03283046|Lenalidomide|lenalidomide|mesh-list
43600057|NCT03283046|Ipilimumab|ipilimumab|mesh-list
43600058|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600059|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
43600068|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600069|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43600070|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43600071|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600072|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
43600073|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43600074|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43600075|NCT03283046|Growth Substances|growth substances|mesh-ancestor
43600076|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
43600077|NCT03283020|Naltrexone|naltrexone|mesh-list
43600134|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
43600135|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600136|NCT03282188|Sargramostim|sargramostim|mesh-list
43600138|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600139|NCT03282162|Oxytocin|oxytocin|mesh-list
43600140|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
43600141|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43600142|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600143|NCT03282136|Incretins|incretins|mesh-list
43600144|NCT03282136|Hormones|hormones|mesh-ancestor
43600145|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600146|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600147|NCT03282110|Citalopram|citalopram|mesh-list
43600148|NCT03282110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43600149|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43600150|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43600151|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600152|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600153|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
43600154|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600155|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43600156|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
43600186|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
43600187|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600188|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600189|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
43600190|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43600191|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
43600192|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600193|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600194|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
43600195|NCT03281187|Testosterone|testosterone|mesh-list
43600196|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
43600197|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
43600198|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43600199|NCT03281187|Androgens|androgens|mesh-ancestor
43600200|NCT03281187|Hormones|hormones|mesh-ancestor
43600201|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600202|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600203|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43600204|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600206|NCT03280927|Efinaconazole|efinaconazole|mesh-list
43600207|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
43600211|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43600212|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
43600213|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600214|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43600215|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
43600216|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
43600217|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
43600218|NCT03280849|Coagulants|coagulants|mesh-ancestor
43600219|NCT03280667|Denosumab|denosumab|mesh-list
43600225|NCT03280641|Warfarin|warfarin|mesh-list
43600226|NCT03280641|Dabigatran|dabigatran|mesh-list
43600227|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
43600228|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
43600229|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43600230|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
43600231|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600232|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600233|NCT03280407|Leucovorin|leucovorin|mesh-list
43600234|NCT03280407|Capecitabine|capecitabine|mesh-list
43600235|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
43600236|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
43600237|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43600238|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
43600239|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600240|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600241|NCT03280407|Antidotes|antidotes|mesh-ancestor
43600242|NCT03280407|Protective Agents|protective agents|mesh-ancestor
43600243|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600244|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
43600245|NCT03280407|Vitamins|vitamins|mesh-ancestor
43600246|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
43600247|NCT03280342|Topiramate|topiramate|mesh-list
43600248|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
43600249|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43600250|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600251|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43600252|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
43600253|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43600254|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43600255|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43600256|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43600257|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600258|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
43600259|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600260|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600262|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600263|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43600264|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43600265|NCT03280316|Urological Agents|urological agents|mesh-ancestor
43600266|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43600267|NCT03280277|Hematinics|hematinics|mesh-ancestor
43600268|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43600269|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43600270|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
43600271|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43600272|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43600273|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600274|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
43600275|NCT03280212|Coagulants|coagulants|mesh-ancestor
43600276|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43600277|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43600278|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600279|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
43600281|NCT03280095|Codeine|codeine|mesh-list
43600282|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43600283|NCT03280095|Analgesics|analgesics|mesh-ancestor
43600284|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
43600285|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600287|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
43600313|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600314|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600315|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43600316|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
43600317|NCT03279679|Ropivacaine|ropivacaine|mesh-list
43600318|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
43600319|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
43600320|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600321|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600322|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
43600323|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600324|NCT03278483|Rifampin|rifampin|mesh-list
43600325|NCT03278483|Isoniazid|isoniazid|mesh-list
43600326|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43600327|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
43600328|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43600329|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600330|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
43600331|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43600332|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600333|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600334|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43600362|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43600364|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
43600365|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43600366|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43600367|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43600368|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43600369|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43600370|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43600371|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
43600372|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600373|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600374|NCT03277222|Insulin|insulin|mesh-list
43600375|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43600376|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600377|NCT03277001|Enoxaparin|enoxaparin|mesh-list
43600422|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600424|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43600425|NCT03273192|Adalimumab|adalimumab|mesh-list
43600426|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600427|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43600428|NCT03273088|Etanercept|etanercept|mesh-list
43600429|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43600430|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43600431|NCT03273088|Analgesics|analgesics|mesh-ancestor
43600432|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
43600433|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600434|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600435|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600436|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43600437|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43600438|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43600439|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
43600440|NCT03272711|Vortioxetine|vortioxetine|mesh-list
43600441|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
43600442|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43600443|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43600444|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43600445|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600446|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600447|NCT03272711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43600448|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43600449|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43600450|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600451|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600452|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
43600453|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43600454|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43600461|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600462|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600463|NCT05075512|Fulvestrant|fulvestrant|mesh-list
43600464|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43600465|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600466|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43600467|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43600468|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
43600469|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600470|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600471|NCT05075265|Methadone|methadone|mesh-list
43600472|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43600473|NCT05075265|Narcotics|narcotics|mesh-ancestor
43600474|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600475|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600476|NCT05075265|Analgesics|analgesics|mesh-ancestor
43600477|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
43600478|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600479|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
43600481|NCT05074966|Cetuximab|cetuximab|mesh-list
43600517|NCT05074589|Protective Agents|protective agents|mesh-ancestor
43600518|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
43600519|NCT05074589|Vitamins|vitamins|mesh-ancestor
43600520|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
43600521|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43600522|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600523|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
43600524|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600525|NCT05073965|Vitamin D|vitamin d|mesh-list
43600526|NCT05073965|Vitamins|vitamins|mesh-ancestor
43600527|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
43600528|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600529|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43600530|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
43600531|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43600532|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600533|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600534|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43600535|NCT05065775|Analgesics|analgesics|mesh-ancestor
43600536|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
43600537|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600538|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43600539|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43600540|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43600541|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
43600542|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600543|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600544|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
43600545|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43600548|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
43600549|NCT05045586|Protective Agents|protective agents|mesh-ancestor
43600550|NCT04962022|Ritonavir|ritonavir|mesh-list
43600559|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
43600560|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600561|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43600562|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43600563|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
43600564|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43600565|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43600566|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
43600567|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600568|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600569|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
43600570|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600571|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43600572|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600573|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600582|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43600584|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600585|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43600586|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43600587|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600589|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
43600591|NCT04877821|Epirubicin|epirubicin|mesh-list
43600592|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43600593|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600594|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
43600595|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
43600596|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
43600597|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600598|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43600599|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
43600600|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600601|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43600606|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43600607|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43600608|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600609|NCT04733560|Bupivacaine|bupivacaine|mesh-list
43600610|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
43600611|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
43600612|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600613|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600614|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
43600615|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600616|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43600617|NCT04669561|Lifitegrast|lifitegrast|mesh-list
43600618|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43600619|NCT04647383|Lemborexant|lemborexant|mesh-list
43600620|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43600621|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600622|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600623|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43600624|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43600625|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600626|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600627|NCT04630002|Ritonavir|ritonavir|mesh-list
43600628|NCT04630002|Darunavir|darunavir|mesh-list
43600629|NCT04630002|Etravirine|etravirine|mesh-list
43600630|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43600631|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43600632|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
43600633|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600634|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600635|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43600636|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43600637|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
43600648|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43600650|NCT04239040|Ipilimumab|ipilimumab|mesh-list
43600652|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
43600653|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600654|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43600655|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600656|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43600657|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600658|NCT03920527|Itraconazole|itraconazole|mesh-list
43600659|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
43600660|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600661|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43600662|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43600663|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600664|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600665|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43600666|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
43600668|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600702|NCT03536429|Acetazolamide|acetazolamide|mesh-list
43600703|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
43600704|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43600705|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600706|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600707|NCT03536429|Diuretics|diuretics|mesh-ancestor
43600708|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
43600709|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600710|NCT03529825|Rifaximin|rifaximin|mesh-list
43600711|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43600712|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600713|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43600714|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
43600715|NCT03475134|Nivolumab|nivolumab|mesh-list
43600716|NCT03475134|Fludarabine|fludarabine|mesh-list
43600763|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43600764|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43600766|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43600767|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600768|NCT03271749|Anesthetics|anesthetics|mesh-list
43600769|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600770|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600771|NCT03270839|Meclizine|meclizine|mesh-list
43600772|NCT03270839|Scopolamine|scopolamine|mesh-list
43600773|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43600774|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
43600775|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
43600776|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600777|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600778|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43600779|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
43600780|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43600781|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
43600782|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600820|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
43600822|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43600823|NCT03270033|BB 1101|bb 1101|mesh-list
43600824|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600825|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
43600826|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
43600827|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600828|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600829|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43600830|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
43600831|NCT03270033|Hormones|hormones|mesh-ancestor
43600832|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600833|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43600834|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600835|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
43600836|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600837|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600838|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43600839|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600840|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43600841|NCT03270033|Analgesics|analgesics|mesh-ancestor
43600842|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
43600843|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43600844|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43600845|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43600846|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
43600847|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600848|NCT03269916|Hormones|hormones|mesh-list
43601479|NCT03263624|Tazarotene|tazarotene|mesh-list
43600849|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43600850|NCT03269916|Estrogens|estrogens|mesh-list
43600851|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600852|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600859|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43600860|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600861|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
43600862|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
43600863|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600864|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
43600865|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600866|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600867|NCT03269955|Thrombin|thrombin|mesh-list
43600868|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
43600869|NCT03269955|Coagulants|coagulants|mesh-ancestor
43600870|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43600871|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43600872|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600873|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
43600874|NCT03269799|Ascorbic Acid|ascorbic acid|mesh-list
43600875|NCT03269799|Vitamins|vitamins|mesh-ancestor
43600876|NCT03269799|Micronutrients|micronutrients|mesh-ancestor
43600877|NCT03269799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600878|NCT03269799|Antioxidants|antioxidants|mesh-ancestor
43600879|NCT03269799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600880|NCT03269799|Protective Agents|protective agents|mesh-ancestor
43600881|NCT03269591|Diclofenac|diclofenac|mesh-list
43600882|NCT03269591|Progesterone|progesterone|mesh-list
43600883|NCT03269591|Progestins|progestins|mesh-ancestor
43600884|NCT03269591|Hormones|hormones|mesh-ancestor
43600885|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600907|NCT03269214|Phenytoin|phenytoin|mesh-list
43600909|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43600910|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43600911|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43600912|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600913|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43600914|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43600915|NCT03269279|Misoprostol|misoprostol|mesh-list
43600916|NCT03269279|Mifepristone|mifepristone|mesh-list
43600917|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43600918|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
43600919|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43600920|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600921|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43600922|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43600923|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
43600924|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43600925|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43600926|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43600927|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43600928|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
43600929|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43600930|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43600931|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
43600932|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600933|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
43600951|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43600952|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43600953|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
43600954|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600955|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600956|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43600957|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
43600958|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600959|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43600960|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43600961|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43600962|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600963|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
43601015|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601017|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601018|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43601019|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43601020|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43601021|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43601022|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601023|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43601024|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43601025|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
43601026|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601027|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43601028|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43601029|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
43601030|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43601031|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
43601032|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
43601033|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
43601034|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43601035|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43601036|NCT03268278|Narcotics|narcotics|mesh-ancestor
43601037|NCT03268278|Analgesics|analgesics|mesh-ancestor
43601038|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43601039|NCT03268226|Beclomethasone|beclomethasone|mesh-list
43601040|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
43601041|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
43601042|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43601043|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
43601044|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601045|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601046|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43601047|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
43601048|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43601049|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43601050|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43601051|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
43601052|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601053|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601054|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43601055|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43601056|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43601057|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
43601058|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601059|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
43601061|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601062|NCT03267771|Progesterone|progesterone|mesh-list
43601063|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
43601064|NCT03267771|Progestins|progestins|mesh-ancestor
43601066|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601067|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601068|NCT03267628|Morphine|morphine|mesh-list
43601069|NCT03267628|Anesthetics|anesthetics|mesh-list
43601070|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
43601071|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43601072|NCT03267628|Narcotics|narcotics|mesh-ancestor
43601073|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601074|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601075|NCT03267628|Analgesics|analgesics|mesh-ancestor
43601076|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
43601077|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601078|NCT03268018|Calcium|calcium|mesh-list
43601079|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43601080|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601081|NCT03267654|Apatinib|apatinib|mesh-list
43601094|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43601095|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
43601096|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601097|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601098|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43601099|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43601101|NCT03267316|Paclitaxel|paclitaxel|mesh-list
43601102|NCT03267316|Cisplatin|cisplatin|mesh-list
43601103|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43601104|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601105|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
43601106|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
43601107|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
43601108|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601109|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43601110|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
43601111|NCT03267316|Antiviral Agents|antiviral agents|mesh-ancestor
43601112|NCT03267316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601113|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601114|NCT03267316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43601115|NCT03267316|Immunologic Factors|immunologic factors|mesh-ancestor
43601116|NCT03267316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601117|NCT03267329|Telmisartan|telmisartan|mesh-list
43601118|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43601119|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43601120|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43601121|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601122|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43601123|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43601137|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601138|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
43601139|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601140|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601141|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
43601142|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601143|NCT03266926|Hormones|hormones|mesh-ancestor
43601144|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601145|NCT03266991|Isoniazid|isoniazid|mesh-list
43601146|NCT03266991|Rifapentine|rifapentine|mesh-list
43601147|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
43601148|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43601149|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601150|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43601151|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43601152|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
43601153|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601154|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43601155|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43601156|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
43601157|NCT03266731|Aspirin|aspirin|mesh-list
43601158|NCT03266731|Clopidogrel|clopidogrel|mesh-list
43601159|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43601160|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601161|NCT03266731|Analgesics|analgesics|mesh-ancestor
43601162|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
43601163|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601164|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601165|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601178|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601179|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43601180|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43601181|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601183|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43638590|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601184|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43601185|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601186|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
43601187|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601188|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601189|NCT03266601|Interferons|interferons|mesh-list
43601191|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601192|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
43601193|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601194|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
43601195|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601196|NCT03266393|Tacrolimus|tacrolimus|mesh-list
43601197|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43601198|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
43601199|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601228|NCT03266146|Protective Agents|protective agents|mesh-ancestor
43601229|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43601230|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601231|NCT03266445|Buprenorphine|buprenorphine|mesh-list
43601232|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43601233|NCT03266445|Naloxone|naloxone|mesh-list
43601234|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43601235|NCT03266445|Narcotics|narcotics|mesh-ancestor
43601480|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
43601236|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601237|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601238|NCT03266445|Analgesics|analgesics|mesh-ancestor
43601239|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
43601240|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601241|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43601242|NCT03265886|Bupivacaine|bupivacaine|mesh-list
43601243|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601244|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
43601245|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601246|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601247|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
43601248|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601249|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43601250|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43601251|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601252|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
43601278|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43601279|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
43601280|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601281|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601282|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43601283|NCT03265470|Narcotics|narcotics|mesh-ancestor
43601284|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43601285|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43601286|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
43601287|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
43601288|NCT03265899|Lactitol|lactitol|mesh-list
43601289|NCT03265899|Oxytocin|oxytocin|mesh-list
43601290|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
43601291|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43601292|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601293|NCT03265899|Cathartics|cathartics|mesh-ancestor
43601294|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43601296|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43601297|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
43601298|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
43601299|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601300|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601301|NCT03265002|Psyllium|psyllium|mesh-list
43601302|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
43601303|NCT03265002|Cathartics|cathartics|mesh-ancestor
43601304|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43601305|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
43601329|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43601330|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43601331|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43601332|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43601333|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601334|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
43601335|NCT03264638|Cyproterone|cyproterone|mesh-list
43601336|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
43601337|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
43601338|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
43601339|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601340|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601341|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601342|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43601343|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
43601344|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43601345|NCT03264651|Anastrozole|anastrozole|mesh-list
43601346|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43601347|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601348|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43601349|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43601350|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601356|NCT03264794|Gefitinib|gefitinib|mesh-list
43601376|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43601377|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601378|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
43601379|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601380|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601381|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
43601382|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601383|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43601384|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43601385|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43601386|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43601387|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601388|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43601390|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
43601391|NCT03264625|Vitamins|vitamins|mesh-ancestor
43601392|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
43601393|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601394|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43601395|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43601396|NCT03264547|Paclitaxel|paclitaxel|mesh-list
43601397|NCT03264547|Docetaxel|docetaxel|mesh-list
43601398|NCT03264547|Trastuzumab|trastuzumab|mesh-list
43601399|NCT03264547|Pertuzumab|pertuzumab|mesh-list
43601400|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43601401|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601402|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
43601403|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
43601422|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601424|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
43601425|NCT03264118|Coagulants|coagulants|mesh-ancestor
43601426|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
43601427|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601428|NCT03264274|Aflibercept|aflibercept|mesh-list
43601429|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43601430|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43601431|NCT03264274|Growth Substances|growth substances|mesh-ancestor
43601432|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601433|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
43601434|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601435|NCT03264079|Itraconazole|itraconazole|mesh-list
43601436|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
43601437|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601438|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43601439|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43601440|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601441|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601442|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43601443|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
43601444|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601445|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601446|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43601447|NCT03263741|Paclitaxel|paclitaxel|mesh-list
43601448|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43601449|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
43601450|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43601451|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601452|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
43601453|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
43601454|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
43601456|NCT03263962|Canrenone|canrenone|mesh-list
43601459|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601460|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601461|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43601462|NCT03263962|Diuretics|diuretics|mesh-ancestor
43601463|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
43601464|NCT03263871|Micronutrients|micronutrients|mesh-list
43601465|NCT03263871|Trace Elements|trace elements|mesh-list
43601466|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601468|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43601469|NCT03263689|Narcotics|narcotics|mesh-ancestor
43849184|NCT03950609|Lenvatinib|lenvatinib|mesh-list
43601470|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601471|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601472|NCT03263689|Analgesics|analgesics|mesh-ancestor
43601473|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
43601474|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601475|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
43601476|NCT03263715|Hormones|hormones|mesh-ancestor
43601477|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601478|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601485|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43601486|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601487|NCT03263299|Analgesics|analgesics|mesh-ancestor
43601488|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
43601489|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601503|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
43601504|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601505|NCT03263533|Vorinostat|vorinostat|mesh-list
43601506|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601507|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43601508|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601509|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601510|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
43601511|NCT03263520|Dexamethasone|dexamethasone|mesh-list
43601512|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
43601513|NCT03263520|Nandrolone|nandrolone|mesh-list
43601514|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
43601515|NCT03263520|BB 1101|bb 1101|mesh-list
43601516|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601517|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
43601518|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
43601519|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601520|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601521|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43601522|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
43601523|NCT03263520|Hormones|hormones|mesh-ancestor
43601524|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601525|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43601526|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601527|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
43601528|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601529|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601530|NCT03263520|Androgens|androgens|mesh-ancestor
43601548|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601549|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601550|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
43601551|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601552|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43601553|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43601554|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43601555|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43601556|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601558|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
43601559|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43601560|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43601561|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
43601562|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43601563|NCT03262948|Paclitaxel|paclitaxel|mesh-list
43601564|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43601565|NCT03262948|Carboplatin|carboplatin|mesh-list
43601566|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43601567|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601568|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
43601569|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
43601570|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
43601571|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601572|NCT03263065|Psyllium|psyllium|mesh-list
43601573|NCT03263065|Cathartics|cathartics|mesh-ancestor
43601574|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43601575|NCT03263052|Tacrolimus|tacrolimus|mesh-list
43601576|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43601577|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
43601578|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601579|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43601580|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601581|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601582|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
43601583|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43601584|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601585|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
43601586|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601587|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
43601588|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43601589|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43601593|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601594|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43601595|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601596|NCT03262792|Analgesics|analgesics|mesh-ancestor
43601597|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
43601598|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601599|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601600|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601601|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43601602|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43601603|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601604|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
43601605|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43601633|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43601634|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43601635|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43601636|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
43601637|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43601638|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601639|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601641|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43601642|NCT03262727|Norethindrone|norethindrone|mesh-list
43601643|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
43601644|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
43601646|NCT03262727|Estrogens|estrogens|mesh-ancestor
43601647|NCT03262727|Hormones|hormones|mesh-ancestor
43601648|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601687|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601688|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43601689|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43601690|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43601691|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
43601692|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601693|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601695|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43601696|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601697|NCT03262363|Analgesics|analgesics|mesh-ancestor
43601698|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
43601699|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601700|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601701|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601702|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601703|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601704|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601705|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601706|NCT03262376|Vitamins|vitamins|mesh-list
43601707|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
43601708|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601709|NCT03261635|Indomethacin|indomethacin|mesh-list
43601710|NCT03261635|Ranibizumab|ranibizumab|mesh-list
43638591|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638592|NCT04000529|Spartalizumab|spartalizumab|mesh-list
43638593|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43638594|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638595|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638596|NCT03999749|Nivolumab|nivolumab|mesh-list
43638597|NCT03999749|Ipilimumab|ipilimumab|mesh-list
43707248|NCT02701673|Melphalan|melphalan|mesh-list
43601711|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43601712|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43601713|NCT03261635|Growth Substances|growth substances|mesh-ancestor
43601714|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601731|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
43601732|NCT03261921|Bupivacaine|bupivacaine|mesh-list
43601733|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601734|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
43601735|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
43601736|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601737|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601738|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43601739|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
43601740|NCT03261921|Hormones|hormones|mesh-ancestor
43601741|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601742|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43601743|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601744|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601745|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
43601746|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601747|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
43601748|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43601749|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601750|NCT03261921|Analgesics|analgesics|mesh-ancestor
43601751|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43601752|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43601753|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43601754|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
43601755|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601756|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601757|NCT03261596|Mebendazole|mebendazole|mesh-list
43601758|NCT03261596|Piperazine|piperazine|mesh-list
43601759|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
43601760|NCT03261596|DMP 777|dmp 777|mesh-list
43601761|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
43601762|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
43601763|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43601764|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601765|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
43601771|NCT03261791|Apatinib|apatinib|mesh-list
43601772|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601773|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43601774|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601775|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601776|NCT03261284|Warfarin|warfarin|mesh-list
43601777|NCT03261284|Dabigatran|dabigatran|mesh-list
43601778|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
43601779|NCT03261284|Antithrombins|antithrombins|mesh-ancestor
43601780|NCT03261284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43601781|NCT03261284|Protease Inhibitors|protease inhibitors|mesh-ancestor
43601782|NCT03261284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601783|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601784|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
43601785|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43601786|NCT03261349|Ledipasvir|ledipasvir|mesh-list
43601787|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
43601788|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601789|NCT03261310|Acetaminophen|acetaminophen|mesh-list
43601790|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601791|NCT03261310|Analgesics|analgesics|mesh-ancestor
43601792|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
43601793|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601795|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
43601825|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
43601826|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601827|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601828|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43601829|NCT03261427|Pregabalin|pregabalin|mesh-list
43601830|NCT03261427|Analgesics|analgesics|mesh-ancestor
43601831|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
43601832|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601833|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601834|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
43601835|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43601836|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43601837|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601838|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43601839|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43601840|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43601841|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601842|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43601843|NCT03261115|Anesthetics|anesthetics|mesh-list
43601844|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601845|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601847|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43601848|NCT03260439|Narcotics|narcotics|mesh-ancestor
43601849|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601850|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601851|NCT03260439|Analgesics|analgesics|mesh-ancestor
43601852|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
43601853|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601854|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
43601855|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43601856|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
43601857|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601864|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601865|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43601866|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
43601871|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
43601872|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601873|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601874|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43601875|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601876|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601877|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601878|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601880|NCT03260283|Meperidine|meperidine|mesh-list
43601881|NCT03260283|Ropivacaine|ropivacaine|mesh-list
43601882|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601883|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
43601884|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601895|NCT03260166|Niacin|niacin|mesh-list
43601923|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601924|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
43601925|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601926|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601927|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
43601928|NCT03259529|Gemcitabine|gemcitabine|mesh-list
43601930|NCT03259529|Nivolumab|nivolumab|mesh-list
43601931|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43601932|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43601933|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601934|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
43601935|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601936|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601937|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43601938|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
43601939|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601940|NCT03259529|Antiviral Agents|antiviral agents|mesh-ancestor
43601941|NCT03259529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601942|NCT03259529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601943|NCT03259529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43601977|NCT03259672|Sevoflurane|sevoflurane|mesh-list
43601978|NCT03259672|Desflurane|desflurane|mesh-list
43601979|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43601980|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43601981|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
43601982|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
43601983|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601984|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601985|NCT03259607|Nicotine|nicotine|mesh-list
43601986|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43601987|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
43601988|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601989|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601990|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43601991|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43601992|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
43601993|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601994|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601995|NCT03259542|Itraconazole|itraconazole|mesh-list
43601996|NCT03259542|Mifepristone|mifepristone|mesh-list
43601997|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
43601998|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601999|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43602000|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43602001|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602002|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602003|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43602004|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
43602006|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602021|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43602022|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602023|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
43602024|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43602025|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43602026|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
43602027|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602029|NCT03258931|Midostaurin|midostaurin|mesh-list
43602030|NCT03258931|Crenolanib|crenolanib|mesh-list
43602031|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602032|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
43602033|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602034|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602036|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602037|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43602038|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
43602039|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602040|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602041|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602042|NCT03259243|Bupivacaine|bupivacaine|mesh-list
43602043|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
43602044|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
43602045|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602046|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602047|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
43602048|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602049|NCT03258684|Ascorbic Acid|ascorbic acid|mesh-list
43602050|NCT03258684|Thiamine|thiamine|mesh-list
43602051|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
43602052|NCT03258684|Vitamins|vitamins|mesh-ancestor
43602053|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
43602054|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602055|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43602060|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
43602061|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
43602062|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
43602063|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602064|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602065|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
43602066|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602067|NCT03258866|Rituximab|rituximab|mesh-list
43602068|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43602069|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602122|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43602123|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43602124|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
43602125|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602126|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
43602127|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43602128|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43602129|NCT03258476|Guanfacine|guanfacine|mesh-list
43602130|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43602131|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43602132|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43602133|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43602134|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
43602135|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602136|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602137|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602138|NCT03258294|Melatonin|melatonin|mesh-list
43602139|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
43602141|NCT03258294|Protective Agents|protective agents|mesh-ancestor
43602175|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602176|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602177|NCT03257852|Methotrexate|methotrexate|mesh-list
43602178|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43602179|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
43602180|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602181|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602182|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602183|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
43602184|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602185|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602186|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
43602187|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602188|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43602189|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43602190|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
43602191|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43602192|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43602193|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
43602194|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
43602195|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602196|NCT03257514|Protective Agents|protective agents|mesh-ancestor
43602197|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602225|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43602226|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602227|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43602228|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43602230|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602231|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602232|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43602233|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43602234|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43602235|NCT03257423|Renal Agents|renal agents|mesh-ancestor
43602236|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43602237|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43602238|NCT03257319|Morphine|morphine|mesh-list
43602284|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43602285|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
43602286|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
43602287|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602288|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602289|NCT03256721|Docetaxel|docetaxel|mesh-list
43602290|NCT03256721|Pemetrexed|pemetrexed|mesh-list
43602291|NCT03256721|Apatinib|apatinib|mesh-list
43602292|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602293|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
43602294|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
43602295|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
43638598|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638599|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638600|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43638601|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602350|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43602351|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602352|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
43602353|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602354|NCT03255330|Dipyrone|dipyrone|mesh-list
43602355|NCT03255330|Gabapentin|gabapentin|mesh-list
43602356|NCT03255330|Tramadol|tramadol|mesh-list
43602357|NCT03255330|Analgesics|analgesics|mesh-ancestor
43602358|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
43602359|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602360|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602361|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
43602362|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43602363|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43602365|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43602410|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43602411|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43602412|NCT03254810|Adalimumab|adalimumab|mesh-list
43602413|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43602414|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43602415|NCT03254927|Cetuximab|cetuximab|mesh-list
43602416|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43602417|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602418|NCT03255044|Atorvastatin|atorvastatin|mesh-list
43602419|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43602420|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43602421|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43602422|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
43602423|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602424|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43602425|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43602426|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602428|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
43602429|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
43602430|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43602431|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43602432|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602433|NCT03254784|BMS-986165|bms-986165|mesh-list
43602434|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
43602435|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602436|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602437|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602438|NCT03254628|Misoprostol|misoprostol|mesh-list
43602439|NCT03254628|Oxytocin|oxytocin|mesh-list
43602440|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
43602441|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602442|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602443|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43602444|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
43602571|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
43602451|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43602452|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43602453|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
43707249|NCT02701673|Busulfan|busulfan|mesh-list
43602454|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602455|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602456|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602457|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43602458|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43602459|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
43602460|NCT03254173|Mirtazapine|mirtazapine|mesh-list
43602461|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
43602462|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43602463|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43602464|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
43602465|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
43602466|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602467|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602468|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602469|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43602470|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43602471|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602472|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43602473|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43602474|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43602475|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
43602476|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43602480|NCT03254368|ZGN-1061|zgn-1061|mesh-list
43602495|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602496|NCT03253328|Expectorants|expectorants|mesh-ancestor
43602497|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
43602498|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43602499|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
43602500|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602501|NCT03253328|Protective Agents|protective agents|mesh-ancestor
43602502|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602503|NCT03253328|Antidotes|antidotes|mesh-ancestor
43602504|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43602505|NCT03253276|Cathartics|cathartics|mesh-ancestor
43602506|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43602508|NCT03253224|Analgesics|analgesics|mesh-ancestor
43602509|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
43602510|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602511|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602512|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
43602513|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602514|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43602515|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
43602516|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43602517|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43602518|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602520|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
43602545|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602546|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602547|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
43602548|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602549|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
43602550|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43602551|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602552|NCT03253107|Trastuzumab|trastuzumab|mesh-list
43602553|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43602554|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602556|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
43602557|NCT03252665|Alprostadil|alprostadil|mesh-list
43602558|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
43602559|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43602560|NCT03252665|Urological Agents|urological agents|mesh-ancestor
43602561|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43602562|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43602563|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
43602565|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
43602566|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602567|NCT03252457|Dexamethasone|dexamethasone|mesh-list
43602568|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
43602569|NCT03252457|Decitabine|decitabine|mesh-list
43602570|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43602573|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602574|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602575|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43602576|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
43602577|NCT03252457|Hormones|hormones|mesh-ancestor
43602578|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602591|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602592|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602593|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
43602594|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602595|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43602597|NCT03252496|Analgesics|analgesics|mesh-ancestor
43602598|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43602599|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43602600|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
43602601|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
43602602|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602603|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43602604|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
43602605|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
43602606|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43602607|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
43602608|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602609|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602610|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
43602611|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
43602612|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602613|NCT03252418|Protective Agents|protective agents|mesh-ancestor
43602614|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602615|NCT03252418|Vitamins|vitamins|mesh-ancestor
43602616|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
43602617|NCT03252561|Anesthetics|anesthetics|mesh-list
43602618|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
43602619|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602620|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602636|NCT03251690|Emtricitabine|emtricitabine|mesh-list
43602638|NCT03251690|Rilpivirine|rilpivirine|mesh-list
43602639|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
43602640|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602641|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43602642|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43602643|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602644|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602645|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43602646|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43602647|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43602648|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43602649|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43602650|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43602651|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43602652|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43602653|NCT03251859|Ticagrelor|ticagrelor|mesh-list
43602654|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43602655|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43602656|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43602657|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43602658|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
43602659|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602660|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602661|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602662|NCT03251768|Lenograstim|lenograstim|mesh-list
43602663|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43602664|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
43602665|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602666|NCT03251872|Olaparib|olaparib|mesh-list
43602667|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43602668|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602669|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602672|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43602673|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849186|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43692953|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43692954|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43707250|NCT02701673|Belinostat|belinostat|mesh-list
43602674|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602676|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602677|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602678|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
43602679|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
43602680|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
43602681|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43602682|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43602683|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602684|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
43602685|NCT03251469|Coagulants|coagulants|mesh-ancestor
43602686|NCT03251365|Gemcitabine|gemcitabine|mesh-list
43602687|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602688|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
43602689|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602690|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602691|NCT03251365|Antiviral Agents|antiviral agents|mesh-ancestor
43602692|NCT03251365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602693|NCT03251365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602694|NCT03251365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43602695|NCT03251365|Immunologic Factors|immunologic factors|mesh-ancestor
43602697|NCT03251417|Irinotecan|irinotecan|mesh-list
43602718|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
43602719|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602720|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43602721|NCT03251170|Fentanyl|fentanyl|mesh-list
43602722|NCT03251170|Midazolam|midazolam|mesh-list
43602723|NCT03251170|Ketamine|ketamine|mesh-list
43602724|NCT03251170|Analgesics|analgesics|mesh-ancestor
43602725|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
43602726|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602727|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602728|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43602729|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43602730|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
43602731|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
43602732|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602733|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43602734|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43602735|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602736|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602737|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43602738|NCT03251170|Narcotics|narcotics|mesh-ancestor
43602739|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43602740|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43602741|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43602742|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43602743|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43602744|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
43602745|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
43602746|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
43602747|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43602748|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602749|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602750|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43602761|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
43602762|NCT03250910|Velpatasvir|velpatasvir|mesh-list
43602763|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43602764|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
43602765|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692955|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43602766|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
43602767|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602768|NCT03250962|Decitabine|decitabine|mesh-list
43602769|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602770|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
43602771|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602772|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602773|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602774|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
43602775|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
43602776|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43602777|NCT03250520|Protective Agents|protective agents|mesh-ancestor
43602778|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602779|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
43602780|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43602781|NCT03250494|Dexamethasone|dexamethasone|mesh-list
43602782|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
43602783|NCT03250494|BB 1101|bb 1101|mesh-list
43602901|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602785|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
43602786|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
43602787|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602788|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602789|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43602790|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
43602791|NCT03250494|Hormones|hormones|mesh-ancestor
43602792|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602793|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43602802|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602803|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43602804|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
43602805|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
43602806|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43602807|NCT03250481|Narcotics|narcotics|mesh-ancestor
43602808|NCT03250481|Analgesics|analgesics|mesh-ancestor
43602809|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
43602810|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602811|NCT03250741|Rotigotine|rotigotine|mesh-list
43602812|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
43602813|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
43602814|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602815|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602816|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602817|NCT03250338|Cytarabine|cytarabine|mesh-list
43602818|NCT03250338|Fludarabine|fludarabine|mesh-list
43602819|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
43602820|NCT03250338|Idarubicin|idarubicin|mesh-list
43602821|NCT03250338|Crenolanib|crenolanib|mesh-list
43602822|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602823|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602824|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
43602825|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602826|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849187|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
43602827|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
43602828|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602829|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
43602830|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602831|NCT03250338|Analgesics|analgesics|mesh-ancestor
43602832|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
43602833|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602846|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
43602847|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602848|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
43602849|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602850|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
43602851|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43602852|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43602853|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
43602854|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602855|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602856|NCT03250039|Abrocitinib|abrocitinib|mesh-list
43602857|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602858|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602859|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692956|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43692957|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43692958|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43692960|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
43692961|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
43602860|NCT03250052|Linagliptin|linagliptin|mesh-list
43602861|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43602862|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602863|NCT03250052|Incretins|incretins|mesh-ancestor
43602864|NCT03250052|Hormones|hormones|mesh-ancestor
43602865|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602866|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43602867|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
43602868|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602869|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602894|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43602895|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602896|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43602897|NCT03249506|Hormones|hormones|mesh-ancestor
43602898|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602899|NCT03249506|Incretins|incretins|mesh-ancestor
43602900|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
43602904|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43602905|NCT03249402|Estradiol|estradiol|mesh-list
43602906|NCT03249402|Estrogens|estrogens|mesh-ancestor
43602907|NCT03249402|Hormones|hormones|mesh-ancestor
43602908|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602909|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602910|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43602911|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
43602912|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602913|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43602914|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43602915|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43602916|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43602917|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43602918|NCT03249662|Bupivacaine|bupivacaine|mesh-list
43602919|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
43602920|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
43602921|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602922|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602923|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
43602926|NCT03249311|Milnacipran|milnacipran|mesh-list
43602935|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
43602936|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602937|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
43602938|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43602939|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
43602940|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43602941|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43602942|NCT03249285|Perindopril|perindopril|mesh-list
43602943|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43602944|NCT03249285|Diuretics|diuretics|mesh-ancestor
43602945|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
43602946|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602947|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43602948|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43602949|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602950|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43602951|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
43602952|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602954|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43602955|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
43602956|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602957|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602958|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43707523|NCT02700087|Ranitidine|ranitidine|mesh-list
43707524|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43602959|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43602960|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
43602983|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43602984|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43602985|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43602986|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602987|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602988|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602990|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
43602991|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602992|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
43602993|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43602994|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
43602995|NCT03248856|Triamcinolone|triamcinolone|mesh-list
43602996|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43602997|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43602998|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43602999|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603000|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
43603001|NCT03248856|Hormones|hormones|mesh-ancestor
43603002|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603003|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603004|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43603005|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
43603006|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603007|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603008|NCT03249025|Lidocaine|lidocaine|mesh-list
43603009|NCT03249025|Ketamine|ketamine|mesh-list
43603010|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
43603013|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603014|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
43603015|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603021|NCT03249025|Analgesics|analgesics|mesh-ancestor
43603022|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43603023|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43603024|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
43603025|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43603026|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43603027|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603029|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43603030|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43603031|NCT03249038|Analgesics|analgesics|mesh-ancestor
43603032|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
43603033|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603083|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603084|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
43603085|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43603086|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43603088|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
43603089|NCT03248544|Vitamins|vitamins|mesh-ancestor
43603090|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
43603091|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603092|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43603093|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43603094|NCT03248973|Ampicillin|ampicillin|mesh-list
43603095|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43603096|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603097|NCT03248791|Phenylephrine|phenylephrine|mesh-list
43603098|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
43603099|NCT03248791|Norepinephrine|norepinephrine|mesh-list
43603100|NCT03248791|Bupivacaine|bupivacaine|mesh-list
43603101|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
43603102|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
43603107|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43603142|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
43603143|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
43603144|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603145|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43603146|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43603147|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692962|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692963|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
43692964|NCT02777073|Liraglutide|liraglutide|mesh-list
43692965|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43603148|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603149|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43603150|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603151|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
43603152|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43603153|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
43603155|NCT03248401|Cilostazol|cilostazol|mesh-list
43603156|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43603157|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43603158|NCT03248401|Analgesics|analgesics|mesh-ancestor
43603159|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
43603160|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603161|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603162|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603163|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43603164|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43603165|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43603166|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603167|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43603168|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43603169|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603170|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
43603171|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43603172|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
43603173|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43603184|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43603185|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603186|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
43603187|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
43603188|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
43603189|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603190|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43603191|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
43603192|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603193|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43603194|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43603195|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
43603196|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43603197|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43603198|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43603199|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43603200|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603201|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43603202|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43603211|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
43603239|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603240|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43603241|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603242|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603244|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43603245|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603246|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603247|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
43603248|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603249|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603250|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
43603251|NCT03247595|Bisacodyl|bisacodyl|mesh-list
43603252|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43603253|NCT03247595|Cathartics|cathartics|mesh-ancestor
43603254|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43603255|NCT03247595|Laxatives|laxatives|mesh-ancestor
43603256|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
43603257|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
43603258|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603259|NCT03247452|Protective Agents|protective agents|mesh-ancestor
43603291|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43603292|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
43603293|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603294|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43603295|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43603296|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603297|NCT03247296|Ribavirin|ribavirin|mesh-list
43603298|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
43603299|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
43603300|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603301|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
43603302|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603303|NCT03247257|Lidocaine|lidocaine|mesh-list
43603304|NCT03247257|Anesthetics|anesthetics|mesh-list
43603305|NCT03247257|Propofol|propofol|mesh-list
43603306|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
43603307|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603308|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603309|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
43603310|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603311|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43603312|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43603313|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43603314|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603315|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603338|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
43603339|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603340|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43603341|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603342|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
43603343|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
43603344|NCT03246776|Hormones|hormones|mesh-ancestor
43603345|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603346|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603347|NCT03246880|Tadalafil|tadalafil|mesh-list
43603348|NCT03246880|Tamsulosin|tamsulosin|mesh-list
43603349|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
43603350|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43603351|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43603352|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603353|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603354|NCT03246880|Urological Agents|urological agents|mesh-ancestor
43603355|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43603356|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43603357|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43603358|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
43603359|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603360|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603361|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43603362|NCT03246555|Perindopril|perindopril|mesh-list
43603363|NCT03246555|Indapamide|indapamide|mesh-list
43603364|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43603384|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
43603385|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43603386|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
43603387|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603388|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603389|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43603390|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
43603391|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
43603392|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43603393|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
43603394|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603395|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603396|NCT03246386|Posaconazole|posaconazole|mesh-list
43603397|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
43603398|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603399|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43603400|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43603401|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43603402|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43603403|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43603404|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603405|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707525|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43603406|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43603407|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
43603408|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603409|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603410|NCT03246451|Metformin|metformin|mesh-list
43603431|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
43603432|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
43603433|NCT03245853|Vitamins|vitamins|mesh-ancestor
43603434|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
43603435|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603436|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43603437|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
43603438|NCT03245970|Atenolol|atenolol|mesh-list
43603439|NCT03245970|Labetalol|labetalol|mesh-list
43603440|NCT03245970|Nifedipine|nifedipine|mesh-list
43603441|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43603442|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603443|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603444|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43603445|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603446|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
43603490|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603491|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
43603492|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
43603493|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603494|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603495|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43603497|NCT03245671|Hormones|hormones|mesh-ancestor
43603498|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603499|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43603500|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603501|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
43603502|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603503|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603504|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43603505|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
43603506|NCT03245515|Branebrutinib|branebrutinib|mesh-list
43603507|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43603508|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603509|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603512|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43603513|NCT03245424|Ivosidenib|ivosidenib|mesh-list
43603514|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603541|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603542|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603543|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43603544|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603545|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43603546|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603547|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
43603548|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
43603549|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603550|NCT03245281|Diuretics|diuretics|mesh-list
43603551|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
43603552|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603553|NCT03245190|Chiauranib|chiauranib|mesh-list
43603554|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603555|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43603556|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603557|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603558|NCT03245346|Anesthetics|anesthetics|mesh-list
43603559|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603560|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603561|NCT03244956|Trametinib|trametinib|mesh-list
43603562|NCT03244956|Dabrafenib|dabrafenib|mesh-list
43603563|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603564|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43603565|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638651|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
43603590|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43603591|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603592|NCT03244488|Mecamylamine|mecamylamine|mesh-list
43603593|NCT03244488|Scopolamine|scopolamine|mesh-list
43603594|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43603595|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43603596|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
43603597|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
43603598|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603599|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603600|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43603601|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
43603602|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43603603|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
43603604|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603605|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603606|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43603607|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
43603608|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43603609|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43603610|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43603611|NCT03244319|Warfarin|warfarin|mesh-list
43603612|NCT03244319|Edoxaban|edoxaban|mesh-list
43603613|NCT03244319|Anticoagulants|anticoagulants|mesh-list
43603614|NCT03244319|Coagulants|coagulants|mesh-list
43603615|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43603616|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
43603617|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43603618|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
43603638|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603640|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43603641|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
43603642|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603643|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603644|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43603645|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
43603646|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603647|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603648|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
43603649|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603650|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43603651|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43603652|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
43603653|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43603654|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43603655|NCT03244540|Acetaminophen|acetaminophen|mesh-list
43603656|NCT03244540|Dipyrone|dipyrone|mesh-list
43603657|NCT03244540|Ketoprofen|ketoprofen|mesh-list
43603658|NCT03244540|Bupivacaine|bupivacaine|mesh-list
43603663|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603664|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
43603665|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603666|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43603667|NCT03244540|Analgesics|analgesics|mesh-ancestor
43603668|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
43603681|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603682|NCT03243864|Ceftazidime|ceftazidime|mesh-list
43603683|NCT03243864|Avibactam|avibactam|mesh-list
43603684|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
43603685|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43603686|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603687|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43638652|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638653|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638654|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43638655|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43638656|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43638657|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
43638658|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43638659|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638660|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638661|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
43638662|NCT03972657|Cemiplimab|cemiplimab|mesh-list
43638663|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43603688|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603689|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603690|NCT03243851|Metformin|metformin|mesh-list
43603691|NCT03243851|Temozolomide|temozolomide|mesh-list
43603692|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43603693|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603694|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43603695|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
43603696|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603697|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603698|NCT03243500|Lidocaine|lidocaine|mesh-list
43603699|NCT03243500|Bupivacaine|bupivacaine|mesh-list
43603700|NCT03243500|Atracurium|atracurium|mesh-list
43603701|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
43603702|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
43603703|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603704|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603705|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
43603706|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603707|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43603742|NCT03243032|Ibuprofen|ibuprofen|mesh-list
43603743|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43603744|NCT03243032|Anesthetics|anesthetics|mesh-list
43603745|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
43603746|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603747|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603748|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43603749|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43603750|NCT03243032|Analgesics|analgesics|mesh-ancestor
43603751|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
43603752|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603753|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43603754|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43603755|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603756|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603758|NCT03242993|Hematinics|hematinics|mesh-ancestor
43603759|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
43603760|NCT03242993|Vitamins|vitamins|mesh-ancestor
43603761|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
43603762|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603763|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
43603764|NCT03242967|Hematinics|hematinics|mesh-ancestor
43603765|NCT03243006|Acetaminophen|acetaminophen|mesh-list
43603766|NCT03243006|Tramadol|tramadol|mesh-list
43603767|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43603768|NCT03243006|Analgesics|analgesics|mesh-ancestor
43603769|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
43603770|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603789|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43603790|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
43603791|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603792|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43603793|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43603794|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
43603795|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603796|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603797|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43603798|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603799|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
43603800|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
43603801|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603802|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43603803|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
43603804|NCT03242460|Hormones|hormones|mesh-ancestor
43603805|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603806|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43603807|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43603808|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43603809|NCT03242460|Growth Substances|growth substances|mesh-ancestor
43603810|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
43603811|NCT03242499|Lovastatin|lovastatin|mesh-list
43603812|NCT03242499|L 647318|l 647318|mesh-list
43603837|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603838|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43603840|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
43603841|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43603842|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
43603843|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43603844|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
43603845|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603846|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603847|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
43603848|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
43603849|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603850|NCT03242239|Trastuzumab|trastuzumab|mesh-list
43603851|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43603852|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603853|NCT03241875|Pregabalin|pregabalin|mesh-list
43603854|NCT03241875|Gabapentin|gabapentin|mesh-list
43603855|NCT03241875|Analgesics|analgesics|mesh-ancestor
43603856|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
43603892|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603893|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
43603894|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43603895|NCT03241784|Interleukin-2|interleukin-2|mesh-list
43603896|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603897|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43603898|NCT03241784|Analgesics|analgesics|mesh-ancestor
43603899|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
43603900|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603901|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603903|NCT03242096|Paclitaxel|paclitaxel|mesh-list
43603904|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43603905|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603906|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
43603907|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
43603908|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
43603909|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603948|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43603949|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43603952|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603953|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
43603954|NCT03241563|Hormones|hormones|mesh-ancestor
43638664|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638665|NCT03965234|Cisplatin|cisplatin|mesh-list
43638666|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638667|NCT03964090|Cytarabine|cytarabine|mesh-list
43638668|NCT03964090|Isavuconazole|isavuconazole|mesh-list
43638669|NCT03964090|Methotrexate|methotrexate|mesh-list
43638670|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43638671|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
43638672|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603955|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603956|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603957|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43603958|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43603959|NCT03241745|Nivolumab|nivolumab|mesh-list
43603960|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43603961|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603962|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43603963|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603964|NCT03241602|Lidocaine|lidocaine|mesh-list
43603965|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
43603966|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
43603967|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603968|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603969|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
43603970|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603971|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43603972|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43603973|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43603974|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603975|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603976|NCT03241641|Tenofovir|tenofovir|mesh-list
43603979|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43603980|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43603987|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603989|NCT03241407|Fluorides|fluorides|mesh-list
43603990|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
43603991|NCT03241407|Protective Agents|protective agents|mesh-ancestor
43603992|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603993|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43603994|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603995|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43603996|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43603997|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
43603998|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603999|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43604000|NCT03241706|Glucagon|glucagon|mesh-list
43604001|NCT03241706|Somatostatin|somatostatin|mesh-list
43604002|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604003|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604004|NCT03241706|Hormones|hormones|mesh-ancestor
43604005|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604006|NCT03241381|Vitamin D|vitamin d|mesh-list
43604007|NCT03241381|Vitamins|vitamins|mesh-ancestor
43604008|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
43604041|NCT03240939|Tadalafil|tadalafil|mesh-list
43604042|NCT03240939|Dutasteride|dutasteride|mesh-list
43604043|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
43604044|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43604045|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43604046|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604047|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604048|NCT03240939|Urological Agents|urological agents|mesh-ancestor
43604049|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43638673|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638674|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43638675|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
43638676|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638677|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638678|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
43638679|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604050|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43604051|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
43604052|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604053|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604054|NCT03240783|Dexamethasone|dexamethasone|mesh-list
43604055|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
43604056|NCT03240783|Betamethasone|betamethasone|mesh-list
43604057|NCT03240783|BB 1101|bb 1101|mesh-list
43604058|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43604059|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
43604060|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
43604061|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604062|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604063|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604064|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
43604065|NCT03240783|Hormones|hormones|mesh-ancestor
43604066|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604067|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43604074|NCT03240471|Calpastatin|calpastatin|mesh-list
43604086|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
43604087|NCT03240120|Tinzaparin|tinzaparin|mesh-list
43604088|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43604089|NCT03240120|Dalteparin|dalteparin|mesh-list
43604090|NCT03240120|Dabigatran|dabigatran|mesh-list
43604091|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
43604092|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43604093|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
43604094|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604095|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604096|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
43604097|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43849189|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43604098|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43604099|NCT03240055|Etomidate|etomidate|mesh-list
43604100|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
43604101|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604102|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604103|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43604104|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43604105|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
43604106|NCT03239691|ACT-709478|act-709478|mesh-list
43604107|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43604108|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43604109|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604110|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43604111|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604113|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43604114|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
43604115|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604116|NCT03239743|Midazolam|midazolam|mesh-list
43604117|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43604118|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43638680|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43692966|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692967|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43692968|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692969|NCT02777073|Incretins|incretins|mesh-ancestor
43692970|NCT02777073|Hormones|hormones|mesh-ancestor
43692971|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43692972|NCT02776956|Atorvastatin|atorvastatin|mesh-list
43604119|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604120|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604121|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43604123|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43604124|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43604125|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
43604126|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
43604127|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
43604128|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
43604129|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604130|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604132|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43604133|NCT03239821|Narcotics|narcotics|mesh-ancestor
43604134|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604135|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604136|NCT03239821|Analgesics|analgesics|mesh-ancestor
43604137|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
43604138|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604139|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
43604140|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
43604141|NCT03239964|Dexamethasone|dexamethasone|mesh-list
43604142|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43604143|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
43604144|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
43604145|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604146|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604147|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604148|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
43604149|NCT03239964|Hormones|hormones|mesh-ancestor
43604150|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604151|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43604152|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604153|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
43604154|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604155|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43604156|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604158|NCT03239600|Methotrexate|methotrexate|mesh-list
43604163|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43604165|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604166|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604167|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
43604168|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604169|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43604170|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43604171|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
43604172|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43604173|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43604174|NCT03239327|Alprostadil|alprostadil|mesh-list
43604175|NCT03239327|Misoprostol|misoprostol|mesh-list
43604176|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43604177|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
43604178|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43604179|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604180|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43604181|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604182|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
43604183|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43604184|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
43604185|NCT03239327|Urological Agents|urological agents|mesh-ancestor
43604186|NCT03239314|Dexamethasone|dexamethasone|mesh-list
43604187|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43604188|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43604189|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
43604211|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
43604212|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43604214|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43604215|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43604216|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604217|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
43604218|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604219|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604220|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43604221|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604222|NCT03238703|Tamoxifen|tamoxifen|mesh-list
43604223|NCT03238703|Toremifene|toremifene|mesh-list
43604224|NCT03238703|Letrozole|letrozole|mesh-list
43604225|NCT03238703|Anastrozole|anastrozole|mesh-list
43604226|NCT03238703|Exemestane|exemestane|mesh-list
43604227|NCT03238703|Citric Acid|citric acid|mesh-list
43604228|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
43604229|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
43604230|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43604231|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
43604232|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
43604233|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604234|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604235|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43604236|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43604237|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604260|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43604261|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43604262|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43604263|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43604264|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
43604265|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604266|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604267|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43604268|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
43604269|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
43604270|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43604271|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43604272|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43604273|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43604274|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
43604275|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604276|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604277|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
43604278|NCT03238482|Hormones|hormones|mesh-ancestor
43604279|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604280|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
43604281|NCT03238560|Montelukast|montelukast|mesh-list
43604282|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43604283|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
43692973|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43692974|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43692975|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
43692976|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692977|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43692978|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43604284|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43604285|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
43604286|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604287|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604300|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43604301|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
43604302|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43604303|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604305|NCT03238131|Albendazole|albendazole|mesh-list
43604306|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43604307|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604308|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
43604309|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
43604310|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43604311|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43604312|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
43604313|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
43604314|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
43604315|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604316|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604317|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
43604318|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43604319|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
43604320|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849190|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604321|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43604324|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43604350|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
43604351|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43604352|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43604353|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
43604354|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43604355|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
43604356|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604357|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
43604358|NCT03238183|Protective Agents|protective agents|mesh-ancestor
43604359|NCT03237637|Propranolol|propranolol|mesh-list
43604360|NCT03237637|Atenolol|atenolol|mesh-list
43604361|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43604362|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43604363|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
43604364|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604365|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604366|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604374|NCT03237715|Bilirubin|bilirubin|mesh-list
43604409|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43604410|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
43604411|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
43692979|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692980|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
43692981|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43692982|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
43692983|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692984|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
43692985|NCT02776943|Protective Agents|protective agents|mesh-ancestor
43692986|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43692987|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43604412|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604413|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43604414|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
43604415|NCT03237533|Ionophores|ionophores|mesh-ancestor
43604416|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43604417|NCT03237312|Hormones|hormones|mesh-list
43604418|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604419|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604420|NCT03237507|Paclitaxel|paclitaxel|mesh-list
43604421|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
43604422|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43604423|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604424|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
43604425|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
43604426|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
43604427|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604428|NCT03237416|Midazolam|midazolam|mesh-list
43604429|NCT03237416|Dabigatran|dabigatran|mesh-list
43604430|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43604431|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43604463|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604464|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604465|NCT03237260|Vedolizumab|vedolizumab|mesh-list
43604466|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604467|NCT03236818|Bosentan|bosentan|mesh-list
43604468|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
43604469|NCT03236818|Tadalafil|tadalafil|mesh-list
43604470|NCT03236818|Macitentan|macitentan|mesh-list
43604471|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
43604472|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43604473|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43604474|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604475|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604476|NCT03236818|Urological Agents|urological agents|mesh-ancestor
43604477|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43604478|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43604479|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43604480|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43604481|NCT03236974|Fulvestrant|fulvestrant|mesh-list
43604482|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43692988|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43638681|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638682|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
43692989|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692990|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692991|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
43692992|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43692993|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43692994|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43692996|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
43692997|NCT02776891|Gallium citrate|gallium citrate|mesh-list
43692998|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
43692999|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43693000|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
43693001|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
43693002|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693003|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43693004|NCT02776722|Tagatose|tagatose|mesh-list
43693005|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43693006|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
43693007|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
43693008|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693009|NCT02776813|Rituximab|rituximab|mesh-list
43604483|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604484|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43604485|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43604486|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
43604487|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604488|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604489|NCT03236883|Gemcitabine|gemcitabine|mesh-list
43604509|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604510|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604511|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43604512|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43604513|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43604514|NCT03236961|Renal Agents|renal agents|mesh-ancestor
43604515|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43604516|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43604518|NCT03236610|Entecavir|entecavir|mesh-list
43604519|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
43604520|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604521|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43604522|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43604523|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604524|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604525|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43604526|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43604527|NCT03236649|Sorafenib|sorafenib|mesh-list
43693010|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43693011|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693012|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
43693013|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693014|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829556|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829557|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638683|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638684|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43638685|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
43638686|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638687|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
43604528|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604529|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43604530|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604531|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604532|NCT03236740|Metformin|metformin|mesh-list
43604533|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43604534|NCT03236740|Estradiol|estradiol|mesh-list
43604557|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
43604558|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604559|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604560|NCT03236987|Azithromycin|azithromycin|mesh-list
43604561|NCT03236987|Clarithromycin|clarithromycin|mesh-list
43604562|NCT03236987|Rifampin|rifampin|mesh-list
43604563|NCT03236987|Ethambutol|ethambutol|mesh-list
43604564|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604565|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604566|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43604567|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604568|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604569|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43604570|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43604571|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43604572|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
43604573|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
43604574|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43604575|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43604576|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43604577|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43604578|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43604579|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43604580|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43604581|NCT03236493|PF-06700841|pf-06700841|mesh-list
43604582|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43604583|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604584|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604585|NCT03236584|Tenofovir|tenofovir|mesh-list
43604586|NCT03236584|Lamivudine|lamivudine|mesh-list
43604587|NCT03236584|Adefovir|adefovir|mesh-list
43604588|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
43604596|NCT03236623|Menthol|menthol|mesh-list
43604598|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
43604599|NCT03236233|PC-786|pc-786|mesh-list
43604600|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
43604601|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604603|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604604|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
43604605|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43604606|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
43604607|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604608|NCT03236220|Expectorants|expectorants|mesh-ancestor
43604609|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
43604610|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43604611|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
43604612|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604613|NCT03236220|Protective Agents|protective agents|mesh-ancestor
43604614|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604615|NCT03236220|Antidotes|antidotes|mesh-ancestor
43604616|NCT03235947|Trimethoprim|trimethoprim|mesh-list
43604617|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
43604618|NCT03235947|Fosfomycin|fosfomycin|mesh-list
43604619|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43604620|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604621|NCT03235947|Renal Agents|renal agents|mesh-ancestor
43604628|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43604629|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43604632|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
43604638|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604639|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
43604640|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
43604641|NCT03235973|Fludarabine|fludarabine|mesh-list
43604642|NCT03235973|Busulfan|busulfan|mesh-list
43604643|NCT03235973|Cladribine|cladribine|mesh-list
43604644|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604645|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604646|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43604647|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
43604648|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604649|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
43604650|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43604651|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43604652|NCT03235869|Durvalumab|durvalumab|mesh-list
43604653|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43604654|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604655|NCT03235609|Fentanyl|fentanyl|mesh-list
43604656|NCT03235609|Ketamine|ketamine|mesh-list
43604657|NCT03235609|Analgesics|analgesics|mesh-ancestor
43604658|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
43604659|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604660|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604661|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43604662|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43604663|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
43604664|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
43604686|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
43604687|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604688|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604689|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43604690|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43604691|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
43604692|NCT03235700|Nicorandil|nicorandil|mesh-list
43604693|NCT03235700|Adenosine|adenosine|mesh-list
43604694|NCT03235700|Analgesics|analgesics|mesh-ancestor
43604695|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
43604696|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604697|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604698|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43604699|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
43849191|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849192|NCT03950427|Bupropion|bupropion|mesh-list
43849193|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43604700|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43604701|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
43604702|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
43604703|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604706|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
43604737|NCT03234816|Bupivacaine|bupivacaine|mesh-list
43604738|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
43604739|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
43604740|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604741|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604742|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
43604743|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604744|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43604745|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43604746|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
43604747|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604748|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604749|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
43604750|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
43604751|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43604752|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43604753|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
43604754|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604756|NCT03234842|Carboplatin|carboplatin|mesh-list
43604757|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43604791|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604792|NCT03234699|Midazolam|midazolam|mesh-list
43604793|NCT03234699|Cenobamate|cenobamate|mesh-list
43604794|NCT03234699|Bupropion|bupropion|mesh-list
43604795|NCT03234699|Omeprazole|omeprazole|mesh-list
43604797|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43604798|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43604799|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604800|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604801|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43604802|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43604803|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43604804|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43604805|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
43604806|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
43604807|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
43604808|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
43604809|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604810|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604811|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
43604812|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43604813|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604814|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43604815|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604816|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43604817|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
43604818|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43604821|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
43604838|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604839|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43604840|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604841|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
43604842|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43604843|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604844|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604845|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43604847|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
43604848|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604849|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43604850|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43604851|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43604852|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
43604853|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604854|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604855|NCT03234296|Metronidazole|metronidazole|mesh-list
43604856|NCT03234296|Levofloxacin|levofloxacin|mesh-list
43604857|NCT03234296|Ertapenem|ertapenem|mesh-list
43604858|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604859|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604860|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43604861|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43638688|NCT03954041|Glyburide|glyburide|mesh-list
43638689|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43638690|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638691|NCT03950674|Folic Acid|folic acid|mesh-list
43638692|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
43638693|NCT03950674|Hydroxocobalamin|hydroxocobalamin|mesh-list
43638694|NCT03950674|Dexamethasone|dexamethasone|mesh-list
43638695|NCT03950674|Carboplatin|carboplatin|mesh-list
43638696|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
43604862|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43604863|NCT03234296|Renal Agents|renal agents|mesh-ancestor
43604864|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43604865|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43604866|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604867|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604868|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604869|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43604870|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43604871|NCT03234387|Acetylcholine|acetylcholine|mesh-list
43604877|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604878|NCT03234062|Choline|choline|mesh-list
43604879|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
43604880|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43604881|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
43604882|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604883|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604884|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43604885|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
43604886|NCT03233932|Leuprolide|leuprolide|mesh-list
43604887|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43604888|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
43604889|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43604890|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604893|NCT03233880|Azithromycin|azithromycin|mesh-list
43604937|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604938|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43604939|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43604942|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43604943|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43604944|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604945|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43604946|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604947|NCT03233035|Ketamine|ketamine|mesh-list
43604948|NCT03233035|Analgesics|analgesics|mesh-ancestor
43604949|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
43604950|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604951|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604952|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43604953|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43604954|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
43604955|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
43604956|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604957|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43604958|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43604959|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604960|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604961|NCT03232957|Morphine|morphine|mesh-list
43604962|NCT03232957|Bupivacaine|bupivacaine|mesh-list
43604963|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
43604964|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
43604965|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604966|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604967|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
43604968|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604969|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43604970|NCT03232957|Narcotics|narcotics|mesh-ancestor
43604976|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
43604977|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43604978|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43604979|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43604980|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604981|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604982|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
43604983|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
43604984|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604985|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604986|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43604987|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43604988|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
43605039|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43605040|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
43605042|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605043|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43605044|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43605045|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43605046|NCT03232307|Growth Substances|growth substances|mesh-ancestor
43605047|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
43605048|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
43605049|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605050|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605051|NCT03232216|Vitamin D|vitamin d|mesh-list
43605052|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
43605053|NCT03232216|Vitamins|vitamins|mesh-ancestor
43605054|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
43605055|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605056|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43605057|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43605058|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43605059|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43605060|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605061|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605089|NCT03232021|Analgesics|analgesics|mesh-ancestor
43605090|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
43605091|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605092|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605093|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
43605094|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43605095|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605096|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605245|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
43605097|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43605098|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43605099|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43605100|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605101|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43605102|NCT03232112|Exenatide|exenatide|mesh-list
43638697|NCT03950674|Pemetrexed|pemetrexed|mesh-list
43638698|NCT03950674|Vitamins|vitamins|mesh-ancestor
43638699|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
43638700|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638701|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638702|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
43638703|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
43638704|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829558|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
43829559|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43829560|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43829561|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829562|NCT05417386|Antidotes|antidotes|mesh-ancestor
43605103|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43605104|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605105|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43605106|NCT03232112|Incretins|incretins|mesh-ancestor
43605107|NCT03232112|Hormones|hormones|mesh-ancestor
43605108|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605109|NCT03231813|Emollients|emollients|mesh-list
43605110|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
43605111|NCT03231683|Ketamine|ketamine|mesh-list
43605112|NCT03231683|Remifentanil|remifentanil|mesh-list
43605113|NCT03231683|Propofol|propofol|mesh-list
43605114|NCT03231683|Esketamine|esketamine|mesh-list
43605115|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43605116|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605117|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605118|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43605119|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
43605120|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
43605121|NCT03231683|Analgesics|analgesics|mesh-ancestor
43605122|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
43605123|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605124|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43605127|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605128|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605129|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43605130|NCT03231683|Narcotics|narcotics|mesh-ancestor
43605131|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
43605132|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43605133|NCT03231436|Bupivacaine|bupivacaine|mesh-list
43605134|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
43605135|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
43605136|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605137|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605138|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
43605139|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605140|NCT03231176|Capecitabine|capecitabine|mesh-list
43605141|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43605142|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
43605143|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605183|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605184|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
43605185|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
43605186|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43605187|NCT03230630|Melatonin|melatonin|mesh-list
43605188|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
43605189|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605190|NCT03230630|Protective Agents|protective agents|mesh-ancestor
43605191|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605192|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605193|NCT03230734|Docetaxel|docetaxel|mesh-list
43605194|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829563|NCT05417386|Protective Agents|protective agents|mesh-ancestor
43829564|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
43829565|NCT05417386|Vitamins|vitamins|mesh-ancestor
43829566|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
43829567|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43829568|NCT05416476|Anisodine|anisodine|mesh-list
43829569|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43829570|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43829571|NCT05416476|Analgesics|analgesics|mesh-ancestor
43605195|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
43605196|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
43605197|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
43605198|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605199|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
43605200|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43605201|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
43605202|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43605203|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605204|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43605205|NCT03230474|Morphine|morphine|mesh-list
43605206|NCT03230474|Naloxone|naloxone|mesh-list
43605236|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43605237|NCT03229954|Hematinics|hematinics|mesh-ancestor
43605238|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
43605239|NCT03229746|Vincristine|vincristine|mesh-list
43605240|NCT03229746|Azathioprine|azathioprine|mesh-list
43605241|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43605242|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605243|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
43605244|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
43605246|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605247|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
43605248|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43605249|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43605250|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605251|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605252|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605253|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
43605254|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43605255|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43605256|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
43605257|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605259|NCT03229668|Analgesics|analgesics|mesh-ancestor
43605260|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
43605261|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605262|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605263|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
43605264|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43605265|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605266|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605267|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43605268|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43605269|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43605270|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605276|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
43605277|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605278|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43605279|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43829572|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
43829573|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829574|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829575|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829576|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829577|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
43829578|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
43829579|NCT05416229|Psilocybin|psilocybin|mesh-list
43829580|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
43829581|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829582|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43829583|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43605280|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605281|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605282|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43605283|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
43605284|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605285|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605286|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43605287|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43605288|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43605290|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
43605291|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43605292|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605293|NCT03230136|Anesthetics|anesthetics|mesh-list
43605294|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605295|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605325|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43605327|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605328|NCT03229096|Apatinib|apatinib|mesh-list
43829584|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43829585|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829586|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43829587|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43829588|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43829589|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829590|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
43829591|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693018|NCT02776878|Dasatinib|dasatinib|mesh-list
43693019|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693020|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43693021|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693022|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693023|NCT02776865|Lidocaine|lidocaine|mesh-list
43693024|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
43693025|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
43693026|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605329|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605330|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43605331|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605332|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605333|NCT03229148|Anesthetics|anesthetics|mesh-list
43605334|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605387|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43605388|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605389|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605390|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605391|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
43605392|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605393|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43605394|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
43605395|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43605396|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43605397|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43605398|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605399|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43605400|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
43605401|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
43605402|NCT03228667|Nivolumab|nivolumab|mesh-list
43605403|NCT03228667|Durvalumab|durvalumab|mesh-list
43605404|NCT03228667|Avelumab|avelumab|mesh-list
43605405|NCT03228667|Atezolizumab|atezolizumab|mesh-list
43605617|NCT03227016|Veliparib|veliparib|mesh-list
43605442|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43605443|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605444|NCT03228862|Vitamins|vitamins|mesh-ancestor
43605445|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
43605446|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43605447|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
43605448|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605449|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43605450|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605451|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605452|NCT03228238|Vitamins|vitamins|mesh-list
43605453|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
43605454|NCT03228238|Vitamin E|vitamin e|mesh-list
43605455|NCT03228238|Tocopherols|tocopherols|mesh-list
43605456|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
43605457|NCT03228238|Atorvastatin|atorvastatin|mesh-list
43605468|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
43605501|NCT03228108|Renal Agents|renal agents|mesh-ancestor
43605502|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
43605503|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43605504|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43605505|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43605506|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43605507|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43605508|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43605509|NCT03228030|Thiamine|thiamine|mesh-list
43605510|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
43605511|NCT03228030|Vitamins|vitamins|mesh-ancestor
43605512|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
43605513|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605514|NCT03227900|Lidocaine|lidocaine|mesh-list
43605515|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
43605516|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
43605517|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605518|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605519|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
43605520|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605521|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43849195|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43605522|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43605523|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43605550|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43605551|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43605552|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605553|NCT03227705|Progesterone|progesterone|mesh-list
43605554|NCT03227705|Progestins|progestins|mesh-ancestor
43605555|NCT03227705|Hormones|hormones|mesh-ancestor
43605556|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605557|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605558|NCT03227653|Ritonavir|ritonavir|mesh-list
43605559|NCT03227653|Lopinavir|lopinavir|mesh-list
43605560|NCT03227653|Nevirapine|nevirapine|mesh-list
43605561|NCT03227653|Efavirenz|efavirenz|mesh-list
43605562|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43605563|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43605564|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
43605565|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605566|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605567|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43605568|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43605569|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
43605570|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605585|NCT03227419|Abatacept|abatacept|mesh-list
43605602|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43605604|NCT03227432|Hormones|hormones|mesh-ancestor
43605605|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605606|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43605607|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605608|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43605609|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43605610|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605611|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
43605612|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43605613|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43605614|NCT03227432|Growth Substances|growth substances|mesh-ancestor
43605615|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
43605616|NCT03227016|Topotecan|topotecan|mesh-list
43605618|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43605619|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43605620|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43605621|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605622|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605623|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605624|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
43605625|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605626|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43605627|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605628|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
43605629|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
43605630|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605631|NCT03226431|Protective Agents|protective agents|mesh-ancestor
43605632|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605633|NCT03226431|Vitamins|vitamins|mesh-ancestor
43605641|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605642|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605643|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
43605644|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605645|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605646|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43605647|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43605648|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605650|NCT03226340|Amlodipine|amlodipine|mesh-list
43605651|NCT03226340|Telmisartan|telmisartan|mesh-list
43605652|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
43605653|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43605654|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43605655|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605656|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605657|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43605658|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605659|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
43605660|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43605694|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605695|NCT03225963|Temozolomide|temozolomide|mesh-list
43605696|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43605697|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
43605698|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605699|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605700|NCT03225924|Prednisone|prednisone|mesh-list
43605701|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
43605702|NCT03225924|Rituximab|rituximab|mesh-list
43605703|NCT03225924|Doxorubicin|doxorubicin|mesh-list
43605704|NCT03225924|Vincristine|vincristine|mesh-list
43605705|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43605706|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
43605707|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605708|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605709|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43605710|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
43605711|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605712|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605713|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43605714|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43605715|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43605718|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605746|NCT03225950|Antibodies|antibodies|mesh-list
43605747|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
43605748|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605749|NCT03225690|Morphine|morphine|mesh-list
43605750|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43605751|NCT03225690|Narcotics|narcotics|mesh-ancestor
43605752|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605753|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605754|NCT03225690|Analgesics|analgesics|mesh-ancestor
43605755|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
43605756|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605757|NCT03225781|Bleomycin|bleomycin|mesh-list
43605758|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43605759|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605760|NCT03225456|Oxytocin|oxytocin|mesh-list
43605761|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
43606152|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43605763|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605764|NCT03225352|Aspirin|aspirin|mesh-list
43605765|NCT03225352|Ibuprofen|ibuprofen|mesh-list
43605766|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43605768|NCT03225352|Analgesics|analgesics|mesh-ancestor
43605801|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605802|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43605803|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43605804|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605805|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
43605806|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43605807|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43605808|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43605809|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
43605810|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605811|NCT03224637|Acetaminophen|acetaminophen|mesh-list
43605812|NCT03224637|Ketorolac|ketorolac|mesh-list
43605813|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43605814|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605815|NCT03224637|Analgesics|analgesics|mesh-ancestor
43605816|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
43605817|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605818|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605819|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
43605820|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43605821|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849196|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43849197|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43605822|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605823|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43605824|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605825|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605826|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
43605827|NCT03224572|Vitamins|vitamins|mesh-ancestor
43605828|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
43605829|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605831|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605832|NCT03224572|Protective Agents|protective agents|mesh-ancestor
43605833|NCT03224871|Aldesleukin|aldesleukin|mesh-list
43605834|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
43605835|NCT03224871|Nivolumab|nivolumab|mesh-list
43605836|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43605837|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849198|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849199|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849200|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
43849201|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849202|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849203|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43849204|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43849205|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849206|NCT03949855|Rituximab|rituximab|mesh-list
43849207|NCT03949855|Belimumab|belimumab|mesh-list
43605875|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43605876|NCT03224039|Narcotics|narcotics|mesh-ancestor
43605877|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605878|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605879|NCT03224039|Analgesics|analgesics|mesh-ancestor
43605880|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
43605881|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605882|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43605883|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43605884|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
43605885|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
43605886|NCT03224416|Ethanol|ethanol|mesh-list
43605887|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43605888|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605889|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605890|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605891|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
43849210|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
43849211|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605919|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43605920|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605921|NCT03223519|Analgesics|analgesics|mesh-ancestor
43605922|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
43605923|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605924|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605925|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605926|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43605927|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605928|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605929|NCT03223519|Antioxidants|antioxidants|mesh-ancestor
43605930|NCT03223519|Protective Agents|protective agents|mesh-ancestor
43605931|NCT03223402|Lamivudine|lamivudine|mesh-list
43605932|NCT03223402|Nevirapine|nevirapine|mesh-list
43605933|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43605934|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43605935|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605978|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43605979|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
43605980|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43605981|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605982|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605983|NCT03222518|Acetaminophen|acetaminophen|mesh-list
43605984|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43605985|NCT03222518|Piroxicam|piroxicam|mesh-list
43605986|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605987|NCT03222518|Analgesics|analgesics|mesh-ancestor
43605988|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
43605989|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605990|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605991|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
43605992|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605993|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605994|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43605995|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606033|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43606034|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606035|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43606036|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
43606037|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606038|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43606039|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43606040|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606041|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606044|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606045|NCT03222089|Antidotes|antidotes|mesh-ancestor
43606046|NCT03222089|Protective Agents|protective agents|mesh-ancestor
43606047|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
43606048|NCT03222089|Vitamins|vitamins|mesh-ancestor
43606049|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
43606050|NCT03222310|Itraconazole|itraconazole|mesh-list
43606051|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
43606052|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606053|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43693027|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693028|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
43693029|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693030|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43693031|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43693032|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43693033|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43693034|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693035|NCT02776540|Aspirin|aspirin|mesh-list
43693036|NCT02776540|Clopidogrel|clopidogrel|mesh-list
43693037|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43693038|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43693039|NCT02776540|Analgesics|analgesics|mesh-ancestor
43693040|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
43693041|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693042|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693043|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638705|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606054|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43606055|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606062|NCT03222167|Grazoprevir|grazoprevir|mesh-list
43606086|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
43606087|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606088|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606090|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43606091|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606092|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606093|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43606094|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43606095|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43606096|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606097|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43606098|NCT03221881|Docetaxel|docetaxel|mesh-list
43606099|NCT03221881|Doxorubicin|doxorubicin|mesh-list
43606145|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606146|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606147|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606148|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43606149|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606150|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
43606151|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43606154|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606155|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606156|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606157|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
43606158|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
43606159|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606160|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
43606161|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43606162|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
43606163|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43638714|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43638715|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43638716|NCT03950674|Hematinics|hematinics|mesh-ancestor
43638717|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
43638718|NCT03950076|Edoxaban|edoxaban|mesh-list
43638719|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43638720|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
43638721|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43638722|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
43638723|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638724|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638725|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
43606164|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
43606165|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606166|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
43606167|NCT03221634|Daratumumab|daratumumab|mesh-list
43606168|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43606169|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606170|NCT03221166|Thalidomide|thalidomide|mesh-list
43606171|NCT03221166|Infliximab|infliximab|mesh-list
43606172|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
43606173|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606174|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606191|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
43606192|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43606194|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606195|NCT03221231|Protective Agents|protective agents|mesh-ancestor
43606196|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606197|NCT03221231|Antidotes|antidotes|mesh-ancestor
43606198|NCT03221621|Adalimumab|adalimumab|mesh-list
43606199|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606200|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606201|NCT03221023|Vancomycin|vancomycin|mesh-list
43606202|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43606203|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606204|NCT03220932|Bevacizumab|bevacizumab|mesh-list
43638726|NCT03937219|Nivolumab|nivolumab|mesh-list
43638727|NCT03937219|Ipilimumab|ipilimumab|mesh-list
43638728|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638729|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638730|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43638731|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638732|NCT03930953|Rituximab|rituximab|mesh-list
43638733|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
43693044|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693045|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43693046|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43606205|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43606206|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606207|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43606208|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43606209|NCT03220932|Growth Substances|growth substances|mesh-ancestor
43606226|NCT03220841|Adalimumab|adalimumab|mesh-list
43606247|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606248|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606249|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43606250|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43606251|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606252|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43606253|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43606254|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
43606255|NCT03220789|Methamphetamine|methamphetamine|mesh-list
43606256|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43606257|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606258|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
43606259|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
43606260|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606261|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
43606262|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606263|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606264|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606265|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43606301|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606302|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606303|NCT03220425|Insulin|insulin|mesh-list
43606304|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43606305|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
43606306|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
43606307|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
43606308|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
43606309|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43606310|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606311|NCT03220542|Amoxicillin|amoxicillin|mesh-list
43606312|NCT03220542|Clarithromycin|clarithromycin|mesh-list
43606313|NCT03220542|Sulforaphane|sulforaphane|mesh-list
43606314|NCT03220542|Esomeprazole|esomeprazole|mesh-list
43606315|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43606316|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606317|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43606318|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606319|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43606320|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606321|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606322|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43606323|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43606324|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43606325|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43606326|NCT03220542|Protective Agents|protective agents|mesh-ancestor
43606327|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606328|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606346|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43606347|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43606348|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606349|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606350|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43606351|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43606352|NCT03220464|Interferons|interferons|mesh-list
43606353|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
43606355|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
43606413|NCT03219008|Bupropion|bupropion|mesh-list
43606414|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
43606415|NCT03219008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43606416|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43606417|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606418|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606419|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606420|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
43606421|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606422|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43606423|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
43606424|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43606425|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43606427|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606471|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606472|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43606473|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606474|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606475|NCT03215602|Pyrantel|pyrantel|mesh-list
43606476|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
43606477|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
43606478|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
43606479|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43606480|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606481|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43606482|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43606483|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43606484|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606485|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606486|NCT03214653|Propofol|propofol|mesh-list
43606487|NCT03214653|Sevoflurane|sevoflurane|mesh-list
43606488|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43606489|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606490|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606523|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606525|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43606526|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606527|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43606528|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606529|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606530|NCT03213548|Daminozide|daminozide|mesh-list
43606531|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
43606532|NCT03213548|Growth Substances|growth substances|mesh-ancestor
43606533|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606534|NCT03212677|Iron|iron|mesh-list
43606535|NCT03212677|Trace Elements|trace elements|mesh-ancestor
43606536|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
43606538|NCT03212950|Insulin|insulin|mesh-list
43606569|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606570|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606571|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43606572|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606573|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
43693047|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693048|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43693049|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43693050|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693052|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43693053|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43693054|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43606574|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43606577|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43606579|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
43606580|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606581|NCT03210766|Nabilone|nabilone|mesh-list
43606582|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
43606583|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
43606613|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
43606614|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606615|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606616|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43606617|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43606618|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
43606619|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606620|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606621|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
43606622|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43606623|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43606624|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606674|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606675|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43606676|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
43606677|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43606678|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43606679|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
43606680|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606681|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
43606682|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
43606683|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
43606684|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
43606685|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
43606686|NCT03209115|Calcium|calcium|mesh-list
43606688|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606734|NCT03208972|Menotropins|menotropins|mesh-list
43606735|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43606736|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606737|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43606738|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
43849254|NCT03945604|Apatinib|apatinib|mesh-list
43606739|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
43606740|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43606741|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
43606742|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606743|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606744|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43606745|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
43606746|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43606747|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
43606748|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606749|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606750|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43606751|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
43606752|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
43606753|NCT03208764|Protective Agents|protective agents|mesh-ancestor
43606754|NCT03208894|Furosemide|furosemide|mesh-list
43606755|NCT03208894|Diuretics|diuretics|mesh-ancestor
43606756|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
43606757|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606761|NCT03208712|Atezolizumab|atezolizumab|mesh-list
43606781|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606782|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43606783|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606784|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43606785|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
43606786|NCT03208452|Analgesics|analgesics|mesh-ancestor
43606787|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
43606788|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606789|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606790|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
43606791|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606792|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43606793|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
43606794|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43606795|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606796|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606798|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
43606799|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43606800|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43606801|NCT03208465|Empagliflozin|empagliflozin|mesh-list
43606802|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43606803|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606804|NCT03208465|Incretins|incretins|mesh-ancestor
43606805|NCT03208465|Hormones|hormones|mesh-ancestor
43606806|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43606807|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43606822|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
43606823|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606824|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
43606825|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43606826|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606827|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43606828|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43606829|NCT03208413|Growth Substances|growth substances|mesh-ancestor
43606830|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
43606831|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606833|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43606834|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43606866|NCT03208101|Vaccines|vaccines|mesh-list
43606886|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
43606887|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606888|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43606889|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
43606890|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849257|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606892|NCT03207334|Midostaurin|midostaurin|mesh-list
43606893|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43606894|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
43606895|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606896|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606897|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
43606898|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606899|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43606900|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
43606901|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606902|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43606903|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606904|NCT03207165|Dobutamine|dobutamine|mesh-list
43606905|NCT03207165|Milrinone|milrinone|mesh-list
43606939|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606940|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43606941|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43606942|NCT03206957|Growth Substances|growth substances|mesh-ancestor
43606943|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606944|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
43606945|NCT03206944|Aspirin|aspirin|mesh-list
43606946|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43606947|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606948|NCT03206944|Analgesics|analgesics|mesh-ancestor
43606949|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
43606960|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
43607002|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43607003|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
43607004|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
43607005|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43607006|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43607007|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43607008|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
43607009|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607010|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
43607011|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
43607012|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
43607013|NCT03206723|Hydrocodone|hydrocodone|mesh-list
43607014|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43607015|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43607016|NCT03206723|Narcotics|narcotics|mesh-ancestor
43607017|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607018|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607019|NCT03206723|Analgesics|analgesics|mesh-ancestor
43607020|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
43607021|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607022|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
43607023|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
43607024|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43607025|NCT03206658|Spironolactone|spironolactone|mesh-list
43607026|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43607051|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
43607052|NCT03206177|Paclitaxel|paclitaxel|mesh-list
43607053|NCT03206177|Carboplatin|carboplatin|mesh-list
43607054|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43607055|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607056|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
43607057|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
43607058|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
43607059|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607060|NCT03206255|Vaccines|vaccines|mesh-list
43607061|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
43607062|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607063|NCT03206411|Hormones|hormones|mesh-list
43607064|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607065|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607066|NCT03206320|Lidocaine|lidocaine|mesh-list
43607067|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
43607068|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
43607069|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607070|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607071|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
43607072|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607073|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43607074|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43607075|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43607076|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607077|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607078|NCT03206021|Carboplatin|carboplatin|mesh-list
43607096|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607097|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43607098|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
43607099|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43607100|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43607101|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43607102|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607103|NCT03205228|Flupenthixol|flupenthixol|mesh-list
43693055|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
43693056|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693057|NCT02776527|Apatinib|apatinib|mesh-list
43693058|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693059|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43693060|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693061|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693062|NCT02776163|Cisplatin|cisplatin|mesh-list
43693063|NCT02776163|Docetaxel|docetaxel|mesh-list
43693064|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693065|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
43693066|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
43693067|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
43829675|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607104|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
43607106|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43607107|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43607108|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43607109|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607110|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607111|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43607112|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43607113|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607114|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607115|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43607116|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43607117|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
43607118|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607120|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43607121|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607122|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607123|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607124|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
43607125|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43607126|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43607127|NCT03204929|Copper|copper|mesh-list
43607139|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
43607140|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607141|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607143|NCT03204760|Prednisolone|prednisolone|mesh-list
43607144|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607145|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
43607146|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
43607147|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607148|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607390|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
43607149|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43607150|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
43607151|NCT03204760|Hormones|hormones|mesh-ancestor
43607152|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607153|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43607154|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607155|NCT03204877|Melatonin|melatonin|mesh-list
43607156|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
43607157|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607158|NCT03204877|Protective Agents|protective agents|mesh-ancestor
43607159|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607160|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607161|NCT03204799|Metformin|metformin|mesh-list
43607162|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43607163|NCT03204799|Ezetimibe|ezetimibe|mesh-list
43607164|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43607165|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607166|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43607186|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
43607187|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43607188|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43607189|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43607190|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43607191|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43607192|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
43607193|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
43607195|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43607196|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43607197|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607198|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607199|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43607200|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43607201|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43607202|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43607203|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
43607205|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
43607206|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
43607242|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43607243|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607244|NCT03203967|Morphine|morphine|mesh-list
43607245|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43607246|NCT03203967|Narcotics|narcotics|mesh-ancestor
43607247|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607248|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607249|NCT03203967|Analgesics|analgesics|mesh-ancestor
43607250|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
43607251|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607252|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
43607253|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43607254|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607255|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607256|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43607257|NCT03204006|Analgesics|analgesics|mesh-ancestor
43607258|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
43607259|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607260|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43607261|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43607262|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43607263|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
43607264|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607265|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607267|NCT03204032|Temozolomide|temozolomide|mesh-list
43607292|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
43607293|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607294|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43607295|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43607296|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
43607298|NCT03204058|Metformin|metformin|mesh-list
43607299|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43607300|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43607301|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607302|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43607303|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43607304|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
43607391|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43607305|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607306|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43607307|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43607309|NCT03204071|Metformin|metformin|mesh-list
43607310|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43607311|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607312|NCT03204019|Thalidomide|thalidomide|mesh-list
43607313|NCT03204019|Temozolomide|temozolomide|mesh-list
43607314|NCT03204019|Tegafur|tegafur|mesh-list
43693068|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693069|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
43693070|NCT02776202|Sirolimus|sirolimus|mesh-list
43693071|NCT02776202|Fludarabine|fludarabine|mesh-list
43693072|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
43693073|NCT02776202|Melphalan|melphalan|mesh-list
43693074|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693075|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43607315|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43607316|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
43607317|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607318|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607319|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607320|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
43607321|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607322|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
43607323|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43607324|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607325|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43607332|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607333|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
43607334|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607335|NCT03203746|Protective Agents|protective agents|mesh-ancestor
43607336|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607337|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43607338|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43607339|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607341|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
43607342|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43607343|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
43607344|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607345|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43607346|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43607347|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
43607349|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607350|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607351|NCT03203304|Nivolumab|nivolumab|mesh-list
43607352|NCT03203304|Ipilimumab|ipilimumab|mesh-list
43607353|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43607354|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607355|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43607356|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607357|NCT03203590|Carboplatin|carboplatin|mesh-list
43607358|NCT03203590|Vinorelbine|vinorelbine|mesh-list
43607359|NCT03203590|Gefitinib|gefitinib|mesh-list
43607360|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607361|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43607362|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
43607363|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
43607364|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
43607365|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607366|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43607367|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607370|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43607371|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607373|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
43607374|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
43607375|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607377|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
43607378|NCT03203408|Protective Agents|protective agents|mesh-ancestor
43607379|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607380|NCT03203317|Insulin|insulin|mesh-list
43607381|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43607382|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607383|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
43607384|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
43607385|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43607386|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
43607387|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607388|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607389|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
43607393|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43607394|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607395|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607396|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
43607397|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607399|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43607416|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607417|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607419|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
43607420|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43607421|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
43607422|NCT03203031|Anesthetics|anesthetics|mesh-list
43607423|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607424|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607425|NCT03203070|Dipyrone|dipyrone|mesh-list
43607426|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43607427|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43607428|NCT03203070|Analgesics|analgesics|mesh-ancestor
43607429|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
43607430|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607431|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607432|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607433|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43607434|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
43607435|NCT03202875|Insulin|insulin|mesh-list
43607436|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43607437|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
43607438|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
43607439|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43607440|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43607441|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607442|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
43607443|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607444|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
43607445|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607446|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43607447|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43607448|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
43607449|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607457|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
43607458|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607459|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607460|NCT03202784|Berotralstat|berotralstat|mesh-list
43607461|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607462|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607463|NCT03202758|Durvalumab|durvalumab|mesh-list
43607464|NCT03202758|Tremelimumab|tremelimumab|mesh-list
43693076|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
43693077|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693078|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638734|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638735|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638736|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
43638737|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693079|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
43693080|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693081|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43693082|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43693083|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
43693084|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43693085|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693086|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693087|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
43693088|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43693089|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
43693090|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43693092|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
43693093|NCT02776189|Propofol|propofol|mesh-list
43693094|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43693095|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607465|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43607466|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607467|NCT03202563|Metformin|metformin|mesh-list
43607468|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
43607469|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43607470|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607471|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43607472|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607473|NCT03202615|Lactoferrin|lactoferrin|mesh-list
43607474|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607475|NCT03202459|Pregabalin|pregabalin|mesh-list
43607476|NCT03202459|Gabapentin|gabapentin|mesh-list
43607477|NCT03202459|Analgesics|analgesics|mesh-ancestor
43607478|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
43607479|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607480|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607481|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
43607503|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
43607504|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693096|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693097|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43693098|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
43693099|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
43693100|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43693101|NCT02776189|Analgesics|analgesics|mesh-ancestor
43693102|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
43693103|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607505|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
43607506|NCT03202446|Chitosan|chitosan|mesh-list
43607507|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607508|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
43607509|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607510|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43607511|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43607512|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
43607513|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607514|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607515|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43607516|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43607517|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43607518|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
43607519|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43607520|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
43607521|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
43607522|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
43607523|NCT03202446|Coagulants|coagulants|mesh-ancestor
43607524|NCT03202186|Progesterone|progesterone|mesh-list
43607525|NCT03202186|Progestins|progestins|mesh-ancestor
43607527|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607529|NCT03202316|Atezolizumab|atezolizumab|mesh-list
43607553|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607554|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607555|NCT03201796|Levofloxacin|levofloxacin|mesh-list
43607556|NCT03201796|Ofloxacin|ofloxacin|mesh-list
43607557|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
43607558|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43607559|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607560|NCT03201796|Renal Agents|renal agents|mesh-ancestor
43607561|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43607562|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43607563|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43607564|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607565|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607567|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43607568|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43607569|NCT03201770|Artesunate|artesunate|mesh-list
43607570|NCT03201770|Pyronaridine|pyronaridine|mesh-list
43607571|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
43607572|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43607573|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43607574|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607609|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
43607610|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607611|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607612|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43607614|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
43607615|NCT03201601|Vitamins|vitamins|mesh-ancestor
43607616|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
43607617|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693104|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43693105|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43693106|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43693107|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
43693108|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693109|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693110|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43693111|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43693112|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43638738|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638739|NCT03922880|Nivolumab|nivolumab|mesh-list
43638740|NCT03922880|Ipilimumab|ipilimumab|mesh-list
43638741|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638742|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638743|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43693113|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43693114|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
43693115|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
43693116|NCT02776137|Docetaxel|docetaxel|mesh-list
43693117|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693118|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
43693119|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
43693120|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
43829676|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607618|NCT03201380|Choline|choline|mesh-list
43607619|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
43607620|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43607621|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
43607622|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607623|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693121|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693122|NCT02776228|Brotizolam|brotizolam|mesh-list
43693123|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43708069|NCT05324748|Protective Agents|protective agents|mesh-ancestor
43607624|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43607625|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
43607626|NCT03201159|Pentamidine|pentamidine|mesh-list
43607627|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
43607628|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607629|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43607630|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43607631|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43607632|NCT03201146|Cisplatin|cisplatin|mesh-list
43607633|NCT03201146|Carboplatin|carboplatin|mesh-list
43607634|NCT03201146|Pemetrexed|pemetrexed|mesh-list
43607635|NCT03201146|Apatinib|apatinib|mesh-list
43607653|NCT03200938|Zinc|zinc|mesh-list
43607661|NCT03200938|Protective Agents|protective agents|mesh-ancestor
43607662|NCT03200821|Gemcitabine|gemcitabine|mesh-list
43607663|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43607664|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
43607665|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607666|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607667|NCT03200821|Antiviral Agents|antiviral agents|mesh-ancestor
43607668|NCT03200821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607669|NCT03200821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607670|NCT03200821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607671|NCT03200821|Immunologic Factors|immunologic factors|mesh-ancestor
43607672|NCT03200821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607673|NCT03200782|Empagliflozin|empagliflozin|mesh-list
43607674|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43607675|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43607676|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607677|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43607678|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607679|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43607681|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
43607682|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607683|NCT03200886|Triamcinolone|triamcinolone|mesh-list
43607684|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43607685|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43607686|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43607687|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607688|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
43607689|NCT03200886|Hormones|hormones|mesh-ancestor
43607691|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607706|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607707|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43607709|NCT03200600|Hormones|hormones|mesh-ancestor
43607710|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607711|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43607712|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607713|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
43607714|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607715|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607716|NCT03200600|Analgesics|analgesics|mesh-ancestor
43607717|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
43607718|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43607719|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43607720|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43607721|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43607723|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
43607724|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43607725|NCT03200561|Antibodies|antibodies|mesh-list
43607726|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607727|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
43607728|NCT03200561|Hormones|hormones|mesh-ancestor
43607729|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607730|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607731|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43607732|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607733|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
43607734|NCT03200613|Heparin|heparin|mesh-list
43607735|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43607736|NCT03200613|Tinzaparin|tinzaparin|mesh-list
43607737|NCT03200613|Dalteparin|dalteparin|mesh-list
43607738|NCT03200613|Apixaban|apixaban|mesh-list
43607739|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
43607740|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43607748|NCT03200392|Chromium|chromium|mesh-list
43607749|NCT03200392|Trace Elements|trace elements|mesh-ancestor
43607750|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
43607751|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607753|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43607754|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607755|NCT03200197|Menthol|menthol|mesh-list
43607756|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
43607757|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
43607758|NCT03200210|Febuxostat|febuxostat|mesh-list
43607759|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
43607760|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43607761|NCT03200080|Amphetamine|amphetamine|mesh-list
43607762|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
43607763|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43607764|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607765|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
43607799|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607800|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43607801|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43607802|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
43607803|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607804|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607805|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43607806|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43607807|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43607808|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
43607809|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43607810|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607811|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607812|NCT03199976|Fluticasone|fluticasone|mesh-list
43607813|NCT03199976|Xhance|xhance|mesh-list
43607814|NCT03199976|Bromides|bromides|mesh-list
43607815|NCT03199976|Albuterol|albuterol|mesh-list
43607816|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
43607817|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607818|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43607855|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43607856|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43607857|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43607858|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43607859|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43607860|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43607861|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43607862|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43849267|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43607863|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43607864|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43607865|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
43607866|NCT03199950|Haloperidol|haloperidol|mesh-list
43607867|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
43607868|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
43607869|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
43607870|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607871|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607872|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43607873|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43607874|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43607875|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607876|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43607877|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43607878|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
43607879|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607880|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607881|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43607882|NCT03199677|Apatinib|apatinib|mesh-list
43607883|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607884|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43607885|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607887|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43607894|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43607895|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607896|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
43607897|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43607898|NCT03199820|Dinoprostone|dinoprostone|mesh-list
43607899|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
43607900|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43607901|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607902|NCT03199339|Midazolam|midazolam|mesh-list
43607903|NCT03199339|Bupropion|bupropion|mesh-list
43607904|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43607905|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43607906|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607907|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607908|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43607909|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43607910|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43607911|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43607912|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
43607913|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
43607914|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
43607915|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
43607916|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607917|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607918|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43607919|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
43607920|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43607921|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43607941|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
43607943|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607944|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43607945|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607946|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43607949|NCT03199430|Protective Agents|protective agents|mesh-ancestor
43607950|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607951|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43607952|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43607953|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607954|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43607955|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
43607956|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43607957|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43607958|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43607959|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607960|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607961|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
43607962|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607963|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607964|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43607965|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607966|NCT03199521|Thrombin|thrombin|mesh-list
43607967|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
43607968|NCT03199521|Coagulants|coagulants|mesh-ancestor
43607969|NCT03199170|Morphine|morphine|mesh-list
43607970|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43607971|NCT03199170|Narcotics|narcotics|mesh-ancestor
43607983|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
43607984|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607985|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43607986|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43607987|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
43607988|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
43607990|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
43607991|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
43607992|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607993|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607994|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
43607995|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607996|NCT03198637|Cisatracurium|cisatracurium|mesh-list
43607997|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43607998|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43607999|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608000|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608001|NCT03198819|Cefotaxime|cefotaxime|mesh-list
43608002|NCT03198819|Cefoxitin|cefoxitin|mesh-list
43608003|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43608004|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608005|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
43608006|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43608007|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43608008|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43608009|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608010|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608011|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
43608012|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608013|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608026|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608028|NCT03198403|Bupivacaine|bupivacaine|mesh-list
43608029|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
43608030|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
43608031|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608032|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608033|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
43608034|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608035|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43608092|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43608093|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
43608094|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
43608095|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608096|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43608097|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43608098|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693124|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693125|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693126|NCT02776436|Dexamethasone|dexamethasone|mesh-list
43693127|NCT02776436|Prednisone|prednisone|mesh-list
43693128|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43693134|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
43693136|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693137|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608099|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608100|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43608101|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43608102|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43608103|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43608104|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43608105|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
43608106|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43608107|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608108|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43608109|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43608110|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43608111|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608112|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608114|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43608115|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43608116|NCT03197779|Analgesics|analgesics|mesh-ancestor
43608117|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
43608118|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608119|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608120|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608121|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608122|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43608123|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43608124|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608127|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608128|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
43608129|NCT03197818|Budesonide|budesonide|mesh-list
43608130|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
43608131|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608132|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43608133|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
43693138|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693139|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
43693140|NCT02775773|Oxytocin|oxytocin|mesh-list
43693141|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
43693142|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43693143|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693144|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43693145|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43693146|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693147|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
43693148|NCT02775773|Coagulants|coagulants|mesh-ancestor
43693149|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43693150|NCT02775968|Azithromycin|azithromycin|mesh-list
43693151|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
43693152|NCT02775968|Erythromycin|erythromycin|mesh-list
43693153|NCT02775968|Cephalosporins|cephalosporins|mesh-list
43693154|NCT02775968|Cefamandole|cefamandole|mesh-list
43693155|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608134|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608135|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608136|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43608137|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
43608138|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
43608139|NCT03197818|Hormones|hormones|mesh-ancestor
43608140|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608141|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43608142|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43608143|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43608144|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
43608145|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608146|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608147|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
43608148|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608149|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608150|NCT03197623|Alendronate|alendronate|mesh-list
43608151|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43608177|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43608178|NCT03197571|Growth Substances|growth substances|mesh-ancestor
43608179|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
43608180|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
43608181|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43608182|NCT03197571|Antidotes|antidotes|mesh-ancestor
43608183|NCT03197571|Protective Agents|protective agents|mesh-ancestor
43608184|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
43608185|NCT03197571|Vitamins|vitamins|mesh-ancestor
43608186|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
43608187|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608188|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43693156|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693157|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43638744|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638745|NCT03919071|Trametinib|trametinib|mesh-list
43638746|NCT03919071|Dabrafenib|dabrafenib|mesh-list
43638747|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
43638748|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638749|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43638750|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638751|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638753|NCT03919071|Protective Agents|protective agents|mesh-ancestor
43693193|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
43693194|NCT02776397|Vitamins|vitamins|mesh-ancestor
43638769|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43638770|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43693196|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693197|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
43693198|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693199|NCT02776397|Protective Agents|protective agents|mesh-ancestor
43693200|NCT02775877|Letrozole|letrozole|mesh-list
43693201|NCT02775877|Clomiphene|clomiphene|mesh-list
43693227|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
43693228|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
43693229|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
43693230|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
43693231|NCT02775539|Mirabegron|mirabegron|mesh-list
43693232|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43693233|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43693234|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43693235|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
43693236|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693287|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693288|NCT02775370|Apatinib|apatinib|mesh-list
43693289|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693290|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43693291|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693292|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693293|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
43693294|NCT02775227|Pasireotide|pasireotide|mesh-list
43693295|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43693296|NCT02775227|Hormones|hormones|mesh-ancestor
43693297|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693298|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693299|NCT02775110|Natalizumab|natalizumab|mesh-list
43693308|NCT02775266|Vitamins|vitamins|mesh-ancestor
43693364|NCT02774460|Amlodipine|amlodipine|mesh-list
43693365|NCT02774460|Candesartan|candesartan|mesh-list
43693366|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
43693367|NCT02774460|Lisinopril|lisinopril|mesh-list
43693368|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43693369|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43693370|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43693371|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693408|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
43693409|NCT02774187|Sorafenib|sorafenib|mesh-list
43693410|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
43693411|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693412|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43693413|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693414|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693415|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
43638795|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
43638796|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638797|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43693461|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
43638805|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638806|NCT03879109|Folfirinox|folfirinox|mesh-list
43638807|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638808|NCT03866239|Atezolizumab|atezolizumab|mesh-list
43638809|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
43638810|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638811|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638812|NCT03860987|Prednisone|prednisone|mesh-list
43638813|NCT03860987|Goserelin|goserelin|mesh-list
43638814|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43638815|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
43638816|NCT03860987|Hormones|hormones|mesh-ancestor
43638817|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43638819|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43693462|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693463|NCT02774005|Idebenone|idebenone|mesh-list
43693464|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
43693465|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693466|NCT02774005|Protective Agents|protective agents|mesh-ancestor
43693467|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693468|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
43638820|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638821|NCT03836040|Erenumab|erenumab|mesh-list
43638822|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43693540|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693541|NCT02773550|Prednisone|prednisone|mesh-list
43693542|NCT02773550|Bortezomib|bortezomib|mesh-list
43693543|NCT02773550|Melphalan|melphalan|mesh-list
43693544|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43693545|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
43693546|NCT02773550|Hormones|hormones|mesh-ancestor
43693548|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829601|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829604|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43638828|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638829|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
43638830|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43638831|NCT03825874|Amikacin|amikacin|mesh-list
43638832|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638839|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
43638840|NCT03810911|Hematinics|hematinics|mesh-ancestor
43638847|NCT03796195|Bupivacaine|bupivacaine|mesh-list
43638848|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
43638849|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
43693595|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693596|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693597|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43638853|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638869|NCT03789240|Rituximab|rituximab|mesh-list
43638870|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638871|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638872|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
43638873|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638874|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638875|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
43638876|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43638877|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43693598|NCT02773017|Analgesics|analgesics|mesh-ancestor
43693607|NCT02773147|Pyridoxine|pyridoxine|mesh-list
43638878|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638879|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
43638880|NCT03780894|Coagulants|coagulants|mesh-ancestor
43638881|NCT03748095|Tazobactam|tazobactam|mesh-list
43638882|NCT03748095|Piperacillin|piperacillin|mesh-list
43638883|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43638884|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638885|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43638886|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638887|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638888|NCT03742414|Fluticasone|fluticasone|mesh-list
43693628|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43693629|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693630|NCT02772744|Ribavirin|ribavirin|mesh-list
43638938|NCT03678025|Prednisone|prednisone|mesh-list
43638939|NCT03678025|Cortisone|cortisone|mesh-list
43638940|NCT03678025|Docetaxel|docetaxel|mesh-list
43638941|NCT03678025|Leuprolide|leuprolide|mesh-list
43638942|NCT03678025|Goserelin|goserelin|mesh-list
43638944|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43693648|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43693649|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43693650|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
43693651|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693652|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693653|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43693654|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43693655|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43693656|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
43693657|NCT02772419|Benralizumab|benralizumab|mesh-list
43693658|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43693659|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
43693660|NCT02772497|Aflibercept|aflibercept|mesh-list
43693661|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43693662|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43693663|NCT02772497|Growth Substances|growth substances|mesh-ancestor
43693664|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693665|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
43693685|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693686|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
43693687|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43693688|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693689|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43693690|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693691|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43693692|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43693693|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43693694|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43693695|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
43693696|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43693697|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43693698|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
43693699|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
43693700|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693701|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43693702|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43638955|NCT03678025|Hormones|hormones|mesh-ancestor
43638956|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43638957|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638958|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43638959|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43638960|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
43638961|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43693743|NCT02772120|Progestins|progestins|mesh-ancestor
43693744|NCT02772120|Hormones|hormones|mesh-ancestor
43693754|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
43693755|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693756|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693757|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
43638975|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43638976|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
43638977|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638978|NCT03661320|Antiviral Agents|antiviral agents|mesh-ancestor
43638979|NCT03661320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638980|NCT03661320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638981|NCT03661320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638982|NCT03661320|Immunologic Factors|immunologic factors|mesh-ancestor
43638983|NCT03661320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638984|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43693791|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43693792|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
43693793|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
43693794|NCT02771717|Hormones|hormones|mesh-ancestor
43693795|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693796|NCT02771912|Propofol|propofol|mesh-list
43693797|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43693803|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
43693885|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693886|NCT02771405|Ribavirin|ribavirin|mesh-list
43693887|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
43693888|NCT02771405|Simeprevir|simeprevir|mesh-list
43693889|NCT02771405|Ledipasvir|ledipasvir|mesh-list
43693913|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43693914|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693915|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693917|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
43693918|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
43693940|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43693944|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693945|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43693946|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
43693947|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43693948|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693949|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43693950|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43693951|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43693952|NCT02770794|Infliximab|infliximab|mesh-list
43693953|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
43693954|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693955|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693956|NCT02770690|Lidocaine|lidocaine|mesh-list
43693957|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
43693958|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
43693959|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
43693960|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693961|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693962|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
43639019|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639020|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639021|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43639022|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639023|NCT03634839|Nicotine|nicotine|mesh-list
43639024|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43639025|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
43639026|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639027|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639028|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43639029|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43639030|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
43639031|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43639032|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639033|NCT03629171|Cytarabine|cytarabine|mesh-list
43639034|NCT03629171|Daunorubicin|daunorubicin|mesh-list
43639035|NCT03629171|Venetoclax|venetoclax|mesh-list
43639036|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43639037|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
43639038|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639039|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639040|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
43639041|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639042|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639043|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
43639044|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639045|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43639046|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43639049|NCT03626454|Norepinephrine|norepinephrine|mesh-list
43639063|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639064|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
43639065|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
43693980|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43693981|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43693982|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
43693983|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693984|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693985|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43693987|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
43693988|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693989|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43693990|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43693991|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43693992|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43693993|NCT02770378|Ritonavir|ritonavir|mesh-list
43693994|NCT02770378|Itraconazole|itraconazole|mesh-list
43693996|NCT02770378|Celecoxib|celecoxib|mesh-list
43694021|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694022|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694023|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694024|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694025|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43694026|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43694027|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
43694028|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43694029|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43694030|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
43694031|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694032|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
43694033|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43694034|NCT02770378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43694035|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43694036|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43694037|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694053|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
43694054|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694055|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43694056|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43694057|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694058|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43694059|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43694062|NCT02770430|Basiliximab|basiliximab|mesh-list
43639083|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
43639084|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639085|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
43639086|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
43639087|NCT03602859|Niraparib|niraparib|mesh-list
43639088|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43639089|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639090|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639091|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639093|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639095|NCT03597581|Bevacizumab|bevacizumab|mesh-list
43639096|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639097|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639098|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43694074|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
43639152|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639153|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639154|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43639155|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43639156|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639157|NCT03521154|Osimertinib|osimertinib|mesh-list
43639158|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639159|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43639160|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639201|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43639202|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639203|NCT03472092|Amitriptyline|amitriptyline|mesh-list
43639204|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43639205|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
43829702|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829703|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829704|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43829705|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43829706|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
43829707|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829708|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829709|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
43829710|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829711|NCT05411965|Pioglitazone|pioglitazone|mesh-list
43829712|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
43829713|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43829714|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829715|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43829716|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829717|NCT05411484|Doxycycline|doxycycline|mesh-list
43829718|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43694166|NCT02769884|Pancrelipase|pancrelipase|mesh-list
43694167|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694168|NCT02769793|Levodopa|levodopa|mesh-list
43694169|NCT02769793|Benserazide|benserazide|mesh-list
43694170|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43694171|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43694172|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43694190|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
43694191|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694192|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694193|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694194|NCT02769572|Diclofenac|diclofenac|mesh-list
43694195|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43694196|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694197|NCT02769572|Analgesics|analgesics|mesh-ancestor
43694198|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
43694199|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694200|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694201|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639235|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
43639236|NCT03456843|Estrogens|estrogens|mesh-ancestor
43639244|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639245|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639246|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43639247|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
43639248|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694227|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694228|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694229|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43694230|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694231|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694232|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43694233|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43694234|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43639253|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43639254|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639255|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43639256|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694259|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694260|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694261|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694262|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43694263|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
43694264|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
43694265|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694266|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43694267|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694268|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43694269|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43694270|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43694271|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43694272|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43694296|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694297|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43694298|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694299|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43639257|NCT03429543|Incretins|incretins|mesh-ancestor
43639259|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639260|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43639261|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
43639262|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639264|NCT03428958|Bevacizumab|bevacizumab|mesh-list
43639265|NCT03428958|Cetuximab|cetuximab|mesh-list
43639266|NCT03428958|Panitumumab|panitumumab|mesh-list
43608287|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608288|NCT03197740|Donepezil|donepezil|mesh-list
43608289|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43608290|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608291|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608292|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
43608293|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608294|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608295|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
43608296|NCT03197233|Vitamin D|vitamin d|mesh-list
43608297|NCT03197233|Vitamins|vitamins|mesh-list
43608298|NCT03197233|Vitamin A|vitamin a|mesh-list
43608299|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
43608315|NCT03197077|Hormones|hormones|mesh-ancestor
43608316|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608317|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43608318|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43608319|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43608320|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43608321|NCT03197077|Progestins|progestins|mesh-ancestor
43608322|NCT03196869|Cisplatin|cisplatin|mesh-list
43608323|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608324|NCT03196921|Amphotericin B|amphotericin b|mesh-list
43608325|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43608326|NCT03196921|Amebicides|amebicides|mesh-ancestor
43608327|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43608328|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43608329|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608330|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43608373|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608374|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
43608375|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608376|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43608377|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43608378|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43608379|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608380|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608381|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608382|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
43608383|NCT03196817|Hormones|hormones|mesh-ancestor
43608384|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608385|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43608386|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
43608387|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
43849290|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849291|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
43608397|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608398|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43608399|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608400|NCT03196648|Fluorides|fluorides|mesh-list
43608401|NCT03196648|Antioxidants|antioxidants|mesh-list
43608402|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
43608403|NCT03196648|Protective Agents|protective agents|mesh-ancestor
43608404|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608405|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608406|NCT03196466|Topiramate|topiramate|mesh-list
43608407|NCT03196466|Pregabalin|pregabalin|mesh-list
43608408|NCT03196466|Lamotrigine|lamotrigine|mesh-list
43608409|NCT03196466|Zonisamide|zonisamide|mesh-list
43608410|NCT03196466|Lacosamide|lacosamide|mesh-list
43608411|NCT03196466|Carbamazepine|carbamazepine|mesh-list
43608412|NCT03196466|Phenytoin|phenytoin|mesh-list
43608413|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
43608414|NCT03196466|Rufinamide|rufinamide|mesh-list
43608415|NCT03196466|Cannabidiol|cannabidiol|mesh-list
43608416|NCT03196466|Levetiracetam|levetiracetam|mesh-list
43608417|NCT03196466|Valproic Acid|valproic acid|mesh-list
43608418|NCT03196466|Brivaracetam|brivaracetam|mesh-list
43608419|NCT03196466|Phenobarbital|phenobarbital|mesh-list
43608420|NCT03196466|Clobazam|clobazam|mesh-list
43608421|NCT03196466|Ethosuximide|ethosuximide|mesh-list
43608422|NCT03196466|Stiripentol|stiripentol|mesh-list
43608423|NCT03196466|Tiagabine|tiagabine|mesh-list
43608424|NCT03196466|Primidone|primidone|mesh-list
43608425|NCT03196466|Felbamate|felbamate|mesh-list
43608426|NCT03196466|Analgesics|analgesics|mesh-ancestor
43608430|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
43608445|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849292|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43608446|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
43608447|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43608448|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43608449|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43608450|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43608451|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43608452|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43608453|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43608454|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43608455|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
43608456|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43608457|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43608458|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
43608459|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
43608460|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43608462|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608463|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608464|NCT03196479|Ketamine|ketamine|mesh-list
43608465|NCT03196479|Propofol|propofol|mesh-list
43608466|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43608467|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608468|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608469|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43608470|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
43608471|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
43608472|NCT03196479|Analgesics|analgesics|mesh-ancestor
43608473|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
43608474|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608475|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43608476|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43608484|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43608485|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43608486|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
43608487|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
43608488|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608489|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608490|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608491|NCT03196362|Metformin|metformin|mesh-list
43608492|NCT03196362|Pioglitazone|pioglitazone|mesh-list
43608493|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43608494|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608495|NCT03196154|Insulin|insulin|mesh-list
43608496|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43608497|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608498|NCT03195634|Carvedilol|carvedilol|mesh-list
43608499|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43608500|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43608501|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
43608502|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608503|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608504|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608505|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43608506|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
43608507|NCT03195634|Protective Agents|protective agents|mesh-ancestor
43608508|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43608509|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608510|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43608511|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
43608529|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608530|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43608531|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43608532|NCT03195569|Growth Substances|growth substances|mesh-ancestor
43608533|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608534|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
43608535|NCT03195946|Midazolam|midazolam|mesh-list
43608536|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43608537|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43608538|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608539|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608540|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43608541|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43608542|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43608543|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43608544|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
43608545|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
43608546|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
43608547|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
43608549|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608550|NCT03195673|Terazosin|terazosin|mesh-list
43608551|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43608552|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43608580|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608581|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43608583|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608584|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608585|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43608684|NCT03195023|Protective Agents|protective agents|mesh-ancestor
43608586|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608587|NCT03195413|Lidocaine|lidocaine|mesh-list
43608588|NCT03195413|Epinephrine|epinephrine|mesh-list
43608589|NCT03195413|Racepinephrine|racepinephrine|mesh-list
43608590|NCT03195413|Bupivacaine|bupivacaine|mesh-list
43608591|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
43608592|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
43608593|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
43608594|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849293|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
43849295|NCT03944356|Trametinib|trametinib|mesh-list
43849296|NCT03944356|Dabrafenib|dabrafenib|mesh-list
43849297|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849298|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43608595|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608596|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
43608597|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608598|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43608599|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43608624|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608625|NCT03195257|Incretins|incretins|mesh-ancestor
43608626|NCT03195049|Bilirubin|bilirubin|mesh-list
43608627|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
43608628|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608629|NCT03195049|Protective Agents|protective agents|mesh-ancestor
43608630|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608631|NCT03195153|Allopurinol|allopurinol|mesh-list
43608632|NCT03195153|Atorvastatin|atorvastatin|mesh-list
43608633|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43608634|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43608635|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
43608636|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608637|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43608638|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43608639|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608640|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
43608641|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608642|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43608643|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
43608644|NCT03195153|Protective Agents|protective agents|mesh-ancestor
43608645|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608646|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43608647|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43608648|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608649|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43608650|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43608651|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608652|NCT03195309|Fentanyl|fentanyl|mesh-list
43608653|NCT03195309|Ropivacaine|ropivacaine|mesh-list
43608654|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
43608655|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
43608656|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608657|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608658|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
43608659|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849299|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608662|NCT03195309|Analgesics|analgesics|mesh-ancestor
43608664|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43608665|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
43608666|NCT03195023|Amlodipine|amlodipine|mesh-list
43608667|NCT03195023|Lisinopril|lisinopril|mesh-list
43608668|NCT03195023|Lercanidipine|lercanidipine|mesh-list
43608669|NCT03195023|Furosemide|furosemide|mesh-list
43608670|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43608671|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43608672|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43608673|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43608674|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608675|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608676|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43608677|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608678|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
43608679|NCT03195023|Diuretics|diuretics|mesh-ancestor
43608680|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
43608681|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43608682|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
43608683|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43608687|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43608688|NCT03194815|Antibodies|antibodies|mesh-list
43608689|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
43608690|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43608696|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
43608709|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608710|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
43608711|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608712|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43608713|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43608714|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43608715|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
43608716|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
43608717|NCT03194685|FF-10101|ff-10101|mesh-list
43608718|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43608719|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608720|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608721|NCT03194724|Vitamin A|vitamin a|mesh-list
43608722|NCT03194724|Vitamins|vitamins|mesh-ancestor
43608723|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
43608724|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608725|NCT03194633|Nifedipine|nifedipine|mesh-list
43608726|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43608727|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608728|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608729|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43608730|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608731|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
43608732|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
43608733|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43608734|NCT03194659|Choline|choline|mesh-list
43608735|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
43608736|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43608737|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
43608738|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608739|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43608740|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43608742|NCT03194594|Dexamethasone|dexamethasone|mesh-list
43608743|NCT03194594|Ketamine|ketamine|mesh-list
43608752|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608753|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608754|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608755|NCT03194594|Analgesics|analgesics|mesh-ancestor
43608756|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
43608757|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43608758|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43608759|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
43608760|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
43608761|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608762|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43608763|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43608764|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608765|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608766|NCT03194555|Acetaminophen|acetaminophen|mesh-list
43608767|NCT03194555|Naltrexone|naltrexone|mesh-list
43608768|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43608769|NCT03194555|Analgesics|analgesics|mesh-ancestor
43608770|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
43608771|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608772|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608773|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
43608774|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43608775|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43608776|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
43608777|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
43608778|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608781|NCT03194204|Doxycycline|doxycycline|mesh-list
43608799|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608800|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608801|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43608802|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
43608803|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
43608804|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43608805|NCT03193749|Amiodarone|amiodarone|mesh-list
43608806|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43608807|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
43608808|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43608809|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608810|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608811|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43608812|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43608813|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43608814|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608815|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43608816|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43608817|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43608819|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
43608820|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
43608821|NCT03193944|Vitamins|vitamins|mesh-list
43608851|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608852|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
43608853|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
43608854|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608855|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43608856|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
43608857|NCT03193788|Hormones|hormones|mesh-ancestor
43608858|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608859|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608860|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608861|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608862|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608863|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43608864|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43608865|NCT03193788|Hematinics|hematinics|mesh-ancestor
43608866|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
43608867|NCT03193723|Anesthetics|anesthetics|mesh-list
43608868|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608869|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608870|NCT03193710|Remifentanil|remifentanil|mesh-list
43608871|NCT03193710|Propofol|propofol|mesh-list
43608872|NCT03193710|Sevoflurane|sevoflurane|mesh-list
43608873|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43608874|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608904|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43608905|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
43608906|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608907|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608908|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
43608909|NCT03193424|Docetaxel|docetaxel|mesh-list
43608910|NCT03193424|Apatinib|apatinib|mesh-list
43608911|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608912|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
43608913|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
43608914|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
43608915|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608916|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43608917|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608918|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
43608919|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43608920|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43608960|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43608961|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608962|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608963|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608964|NCT03193606|Fluorides|fluorides|mesh-list
43849300|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608965|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
43608966|NCT03193606|Protective Agents|protective agents|mesh-ancestor
43608967|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608968|NCT03193203|Etanercept|etanercept|mesh-list
43608969|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43608970|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43608971|NCT03193203|Analgesics|analgesics|mesh-ancestor
43608972|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
43608973|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608974|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608975|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608976|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608977|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43608978|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43608979|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
43608994|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43608995|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608996|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608997|NCT03193112|S 20098|s 20098|mesh-list
43608998|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43608999|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609000|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609001|NCT03192969|Abatacept|abatacept|mesh-list
43609002|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
43609003|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43609004|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609007|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
43609008|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609009|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609010|NCT03192969|Hormones|hormones|mesh-ancestor
43609011|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43609012|NCT03192566|Acetaminophen|acetaminophen|mesh-list
43609013|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609014|NCT03192566|Analgesics|analgesics|mesh-ancestor
43609015|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
43609016|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609017|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609018|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
43609019|NCT03192618|Leucovorin|leucovorin|mesh-list
43609022|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
43609023|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43609024|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609025|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609026|NCT03192618|Antidotes|antidotes|mesh-ancestor
43609027|NCT03192618|Protective Agents|protective agents|mesh-ancestor
43609028|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
43609029|NCT03192618|Vitamins|vitamins|mesh-ancestor
43609030|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
43609031|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43609032|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43609033|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43609034|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
43609035|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609036|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43609037|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43609038|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609039|NCT03192657|Basiliximab|basiliximab|mesh-list
43609040|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43609041|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609042|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
43609043|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609044|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609046|NCT03192644|Leucovorin|leucovorin|mesh-list
43609073|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43609074|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609075|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
43609076|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
43609077|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43609078|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43609079|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609080|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609081|NCT03192709|Urological Agents|urological agents|mesh-ancestor
43609082|NCT03192449|Albendazole|albendazole|mesh-list
43609083|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
43609084|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43609085|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609086|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
43609087|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43609088|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43609089|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
43609090|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
43609091|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
43609096|NCT03192371|Vaccines|vaccines|mesh-list
43609128|NCT03192059|Vitamin D|vitamin d|mesh-list
43609129|NCT03192059|Curcumin|curcumin|mesh-list
43609130|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
43609131|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
43609132|NCT03192059|Lansoprazole|lansoprazole|mesh-list
43609133|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
43609134|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609135|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
43609137|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609138|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43609139|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
43609140|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609141|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609142|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43609143|NCT03192059|Vitamins|vitamins|mesh-ancestor
43609144|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
43609145|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43609185|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609186|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
43609187|NCT03191903|Hormones|hormones|mesh-ancestor
43609188|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43609189|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609190|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609191|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
43609192|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609193|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609194|NCT03191721|Triclosan|triclosan|mesh-list
43609195|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
43609196|NCT03191721|Fluorides|fluorides|mesh-list
43609197|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
43609198|NCT03191721|Protective Agents|protective agents|mesh-ancestor
43609199|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609200|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43609201|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43609202|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43609241|NCT03190798|Canagliflozin|canagliflozin|mesh-list
43609242|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43609243|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609244|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43609245|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609246|NCT03190681|Methylphenidate|methylphenidate|mesh-list
43609247|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43609248|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609249|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43609250|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43609251|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609252|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609253|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
43609254|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609255|NCT03190733|Fludarabine|fludarabine|mesh-list
43609256|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609257|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
43609258|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
43609259|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609294|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43609295|NCT03190642|Protective Agents|protective agents|mesh-ancestor
43609296|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43609297|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609298|NCT03190616|Apatinib|apatinib|mesh-list
43609299|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609300|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43609301|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609302|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609303|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43609304|NCT03190447|Laxatives|laxatives|mesh-ancestor
43609358|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43609359|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609361|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
43609362|NCT03189069|Dabigatran|dabigatran|mesh-list
43609363|NCT03189069|Apixaban|apixaban|mesh-list
43609364|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
43609365|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43609366|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
43609367|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43609368|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
43609369|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609370|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609371|NCT03189329|Lidocaine|lidocaine|mesh-list
43609372|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
43609373|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
43609374|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
43609375|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609376|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609377|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
43609378|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609379|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43609380|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43609381|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43609382|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609383|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609384|NCT03188978|Atorvastatin|atorvastatin|mesh-list
43609385|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43609386|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43609387|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
43609388|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609389|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43609390|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43609391|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609399|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
43609400|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609401|NCT03188445|Protective Agents|protective agents|mesh-ancestor
43609402|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609404|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
43609405|NCT03188445|Trace Elements|trace elements|mesh-ancestor
43609406|NCT03188445|Hematinics|hematinics|mesh-ancestor
43609407|NCT03188471|Aspirin|aspirin|mesh-list
43609408|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609409|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609410|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609411|NCT03188471|Analgesics|analgesics|mesh-ancestor
43609412|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
43609413|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609414|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609415|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609416|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43609417|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43609418|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609419|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43609420|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609421|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609422|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
43609423|NCT03188510|Mirikizumab|mirikizumab|mesh-list
43609424|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609425|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609426|NCT03188510|Analgesics|analgesics|mesh-ancestor
43609427|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
43609431|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609445|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43609446|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
43609447|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609448|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609449|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43609450|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43609451|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43609452|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43609459|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43609460|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43609461|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
43609462|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
43609464|NCT03188289|Chitosan|chitosan|mesh-list
43609465|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
43609466|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43609467|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
43609468|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609469|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
43609470|NCT03188289|Protective Agents|protective agents|mesh-ancestor
43609471|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43609472|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43609473|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
43849321|NCT03941496|Azacitidine|azacitidine|mesh-list
43849322|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43849323|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
43849324|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849325|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849326|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849327|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
43849328|NCT03941262|Avelumab|avelumab|mesh-list
43849329|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849330|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849331|NCT03939182|Abexinostat|abexinostat|mesh-list
43849332|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43849333|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849334|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609474|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609475|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43609476|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
43609477|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
43609478|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
43609479|NCT03188289|Coagulants|coagulants|mesh-ancestor
43609480|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
43609481|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43609482|NCT03188276|Ledipasvir|ledipasvir|mesh-list
43609483|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
43609491|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609492|NCT03187912|Riboflavin|riboflavin|mesh-list
43609493|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
43609494|NCT03187912|Vitamins|vitamins|mesh-ancestor
43609495|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
43609496|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609497|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43609498|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
43609499|NCT03187899|Ropivacaine|ropivacaine|mesh-list
43609500|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
43609501|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
43609502|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609503|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609504|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
43609505|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609507|NCT03187795|Oxybutynin|oxybutynin|mesh-list
43609508|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43609509|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43609510|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43609511|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
43609512|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609513|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609514|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609515|NCT03187795|Urological Agents|urological agents|mesh-ancestor
43609541|NCT03187548|Calcium|calcium|mesh-list
43609542|NCT03187548|Caseins|caseins|mesh-list
43609543|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43609544|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609545|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
43609546|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
43609547|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609548|NCT03187457|Metronidazole|metronidazole|mesh-list
43609549|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609550|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43609551|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43609552|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43609553|NCT03187093|Vortioxetine|vortioxetine|mesh-list
43609554|NCT03187093|Citalopram|citalopram|mesh-list
43609555|NCT03187093|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43609556|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43609557|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609558|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609559|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609560|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
43609561|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609562|NCT03187093|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43609563|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
43609564|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43609565|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43609566|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43609567|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609568|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43609569|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43609570|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43609571|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43609574|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43609575|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
43609578|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43609579|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609580|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
43609581|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609583|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
43609584|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
43609585|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609586|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609587|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
43609588|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609589|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43609590|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43609591|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43609592|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609593|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609594|NCT03187496|Midazolam|midazolam|mesh-list
43609595|NCT03187496|Caffeine|caffeine|mesh-list
43609596|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43609597|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43609598|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43609599|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609600|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609601|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43609602|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43609603|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43609604|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43609605|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
43609606|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
43609621|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
43609623|NCT03187015|Midazolam|midazolam|mesh-list
43609624|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43609625|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43609626|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609627|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609628|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43609629|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43609630|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43609631|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43609632|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
43609633|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
43609634|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
43609635|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
43609636|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609637|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609638|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609639|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43609640|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609641|NCT03186742|Eplerenone|eplerenone|mesh-list
43609642|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43609643|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
43609647|NCT03186742|Diuretics|diuretics|mesh-ancestor
43609673|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43609674|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43609675|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
43609676|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43609677|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609678|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
43609679|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43609680|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609681|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849338|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849339|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43849340|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43849341|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43849343|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609682|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43609683|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43609684|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43609685|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43609686|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43609719|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43609720|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609721|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43609722|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43609723|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43609724|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609725|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
43609726|NCT03186131|Vitamin D|vitamin d|mesh-list
43609727|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
43609728|NCT03186131|Vitamins|vitamins|mesh-ancestor
43609729|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
43609730|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609731|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43609732|NCT03186040|Lacosamide|lacosamide|mesh-list
43609733|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
43609734|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43609735|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43609736|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609737|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609738|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43609739|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43609740|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43609741|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609742|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609743|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
43609744|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609745|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609746|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43609747|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609749|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609750|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609751|NCT03185871|Analgesics|analgesics|mesh-ancestor
43609760|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609761|NCT03185988|Trastuzumab|trastuzumab|mesh-list
43609762|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43609763|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609764|NCT03185845|Warfarin|warfarin|mesh-list
43609765|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
43609766|NCT03185611|Rifaximin|rifaximin|mesh-list
43609767|NCT03185611|Azathioprine|azathioprine|mesh-list
43609768|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43609769|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609770|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43609771|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
43609772|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609773|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43609774|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609775|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609776|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
43609777|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609778|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609779|NCT03185624|Rifaximin|rifaximin|mesh-list
43609780|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43609781|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609782|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43609783|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
43609784|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
43609785|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609786|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609787|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609788|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43609789|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
43609790|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609803|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
43609804|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609805|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609806|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
43609807|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609808|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43609810|NCT03185403|Analgesics|analgesics|mesh-ancestor
43609811|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43609812|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43609813|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
43609911|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609912|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609913|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609914|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609915|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43609916|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43609917|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609918|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43609919|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609920|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609922|NCT03184649|Acetaminophen|acetaminophen|mesh-list
43609923|NCT03184649|Ibuprofen|ibuprofen|mesh-list
43609924|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609925|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609926|NCT03184649|Analgesics|analgesics|mesh-ancestor
43609927|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
43609928|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609929|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609930|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609931|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609932|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609933|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609934|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609952|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609953|NCT03184493|Analgesics|analgesics|mesh-ancestor
43609954|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
43609955|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609956|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609957|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609958|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43609959|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609960|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609961|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609962|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43609963|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43609964|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43609965|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609966|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609967|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43609968|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609969|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609970|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
43609971|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609972|NCT03184766|Ibuprofen|ibuprofen|mesh-list
43609973|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
43610003|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
43610004|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
43610005|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610007|NCT03183739|Analgesics|analgesics|mesh-ancestor
43610008|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
43610009|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610010|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610011|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
43610012|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
43610013|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610014|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610015|NCT03183752|Metformin|metformin|mesh-list
43610069|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610070|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43610071|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
43610072|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43610073|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610074|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610075|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43610076|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43610077|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43610078|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
43610079|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
43610080|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610081|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43610082|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43610232|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
43610083|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610085|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
43610086|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
43610087|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610088|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610089|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610090|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43610091|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43610092|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610093|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43610094|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43610095|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
43610096|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610097|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610098|NCT03183492|Vaccines|vaccines|mesh-list
43610099|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
43610100|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610109|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610110|NCT03182803|Antibodies|antibodies|mesh-list
43610111|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
43610112|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610113|NCT03183024|Benralizumab|benralizumab|mesh-list
43610114|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43610115|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
43610116|NCT03182855|Ticagrelor|ticagrelor|mesh-list
43610117|NCT03182855|Cangrelor|cangrelor|mesh-list
43610118|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43610119|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43610120|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43610122|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
43610123|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610124|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610125|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610126|NCT03182634|Olaparib|olaparib|mesh-list
43610127|NCT03182634|Fulvestrant|fulvestrant|mesh-list
43610138|NCT03182595|Acetaminophen|acetaminophen|mesh-list
43610165|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610166|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43610167|NCT03182296|Incretins|incretins|mesh-ancestor
43610168|NCT03182296|Hormones|hormones|mesh-ancestor
43610169|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610170|NCT03182257|ONO-7579|ono-7579|mesh-list
43610171|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43610172|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610173|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610174|NCT03182374|Hylan|hylan|mesh-list
43610175|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
43610177|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610178|NCT03182322|Insulin|insulin|mesh-list
43610179|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43610180|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610181|NCT03181919|Letrozole|letrozole|mesh-list
43610182|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610183|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43610184|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43610185|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610187|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43610214|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43610215|NCT03181880|Bromides|bromides|mesh-list
43610216|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
43610217|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43610218|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
43610219|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610220|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610221|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43610222|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
43610223|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43610224|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43610225|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43610226|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
43610227|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610228|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610229|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
43610230|NCT03182114|Bupivacaine|bupivacaine|mesh-list
43610231|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
43610233|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610234|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610236|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610237|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43610238|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
43610239|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610240|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43610241|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
43610242|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610243|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610244|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43610245|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43610246|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43610254|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610255|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610256|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43610257|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
43610258|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43610259|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
43610260|NCT03181464|Lidocaine|lidocaine|mesh-list
43610261|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
43610262|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
43610263|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610264|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610265|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
43610275|NCT03181360|Tenecteplase|tenecteplase|mesh-list
43610314|NCT03180879|Analgesics|analgesics|mesh-ancestor
43610315|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
43610316|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610317|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610318|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610319|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43610320|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43610321|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610322|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610323|NCT03180944|Lugol's solution|lugol's solution|mesh-list
43610324|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43610325|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
43610326|NCT03180944|Coagulants|coagulants|mesh-ancestor
43610327|NCT03180775|Glycine|glycine|mesh-list
43610328|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
43610329|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610330|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610331|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610332|NCT03180723|Cyclosporine|cyclosporine|mesh-list
43610333|NCT03180723|Rituximab|rituximab|mesh-list
43610334|NCT03180723|Cyclosporins|cyclosporins|mesh-list
43610335|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43610336|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610337|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
43610338|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610339|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43610340|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849346|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
43610348|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43610349|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610350|NCT03180476|Apatinib|apatinib|mesh-list
43610351|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610352|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43610353|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610354|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610355|NCT03180632|Lorazepam|lorazepam|mesh-list
43610356|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
43610357|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
43610358|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
43610359|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610360|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610361|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610362|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43610363|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610364|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43610365|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43610366|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43610397|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610398|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610399|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43610401|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610402|NCT03180359|Vaccines|vaccines|mesh-list
43849359|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610403|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
43610404|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610405|NCT03180125|Lidocaine|lidocaine|mesh-list
43610406|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
43610407|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
43610408|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
43610409|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610410|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610411|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
43610430|NCT03180281|Hormones|hormones|mesh-ancestor
43610450|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610451|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43610453|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
43610454|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
43610455|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
43610456|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43610457|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43610458|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610459|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610460|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610461|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43610462|NCT03180099|Bupivacaine|bupivacaine|mesh-list
43610463|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
43610464|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
43610465|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610466|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610467|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
43610468|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610469|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
43610470|NCT03179839|Sertraline|sertraline|mesh-list
43610471|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
43610472|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43610473|NCT03179839|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43610474|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43610475|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43610476|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610477|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610478|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
43610479|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610492|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610493|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
43610494|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43610495|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
43610496|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
43610497|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
43610498|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43610499|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610500|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
43610501|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43610502|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
43610503|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
43610504|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43610505|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
43610506|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
43610507|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43610508|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610509|NCT03179293|Propofol|propofol|mesh-list
43610510|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43610511|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610512|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610513|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43610514|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
43610515|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
43610516|NCT03179280|Insulin|insulin|mesh-list
43610517|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
43610518|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43610519|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610520|NCT03178994|Ketoconazole|ketoconazole|mesh-list
43610521|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
43610523|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43610524|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43610525|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610526|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610532|NCT03179254|Metformin|metformin|mesh-list
43610533|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43610534|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610535|NCT03178708|Amantadine|amantadine|mesh-list
43610536|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43610537|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43610538|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
43610539|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610540|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
43610541|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610542|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610543|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610544|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43610545|NCT03178708|Analgesics|analgesics|mesh-ancestor
43610546|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
43610547|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610548|NCT03178955|Etanercept|etanercept|mesh-list
43610549|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43610550|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43610551|NCT03178955|Analgesics|analgesics|mesh-ancestor
43849360|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43849361|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849362|NCT03934814|Rituximab|rituximab|mesh-list
43610577|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43610579|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
43610580|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610581|NCT03178747|Methylene Blue|methylene blue|mesh-list
43610582|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610583|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610584|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
43610585|NCT03178591|Vildagliptin|vildagliptin|mesh-list
43610586|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43610587|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610588|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43610589|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610590|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43610591|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
43610592|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610593|NCT03178292|Levofloxacin|levofloxacin|mesh-list
43610594|NCT03178292|Ofloxacin|ofloxacin|mesh-list
43610595|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43610596|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610597|NCT03178292|Renal Agents|renal agents|mesh-ancestor
43610598|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43610601|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610628|NCT03178539|Analgesics|analgesics|mesh-ancestor
43610629|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
43610630|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610631|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610632|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610633|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43610634|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43610635|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610636|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610637|NCT03178500|Clomiphene|clomiphene|mesh-list
43610638|NCT03178500|Enclomiphene|enclomiphene|mesh-list
43610639|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
43610640|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43610641|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
43610642|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610643|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610644|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43610645|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
43610646|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43610647|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43610648|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43610649|NCT03178526|Lovastatin|lovastatin|mesh-list
43610650|NCT03178526|L 647318|l 647318|mesh-list
43610651|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
43610652|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43610653|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43610654|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
43610655|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610656|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43610657|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43610658|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610673|NCT03178084|Maraviroc|maraviroc|mesh-list
43610674|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43610675|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43610676|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610677|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610678|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
43610679|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610680|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43610681|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43610682|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
43610683|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43610684|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43610685|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43610686|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43610687|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43610688|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43610689|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43610690|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43610691|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43610692|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
43610694|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
43610723|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610724|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43610725|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43610726|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
43610727|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
43610728|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43610729|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
43610730|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
43610731|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43610732|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43610733|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43610734|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
43610735|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610785|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610786|NCT03177317|Dexamethasone|dexamethasone|mesh-list
43610787|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610788|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
43610789|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
43610790|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610791|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610792|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610793|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
43610794|NCT03177317|Hormones|hormones|mesh-ancestor
43610795|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610796|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43610797|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610798|NCT03177239|Nivolumab|nivolumab|mesh-list
43610799|NCT03177239|Ipilimumab|ipilimumab|mesh-list
43610800|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43610801|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610802|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43610803|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610804|NCT03176849|Vitamin D|vitamin d|mesh-list
43610805|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
43610806|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
43610807|NCT03176849|Vitamins|vitamins|mesh-list
43610808|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
43610809|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610810|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43610812|NCT03177109|Fluorides|fluorides|mesh-list
43610834|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43610835|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43610836|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43610837|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
43610838|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610963|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43610839|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610840|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610841|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
43610842|NCT03177070|Methylene Blue|methylene blue|mesh-list
43610843|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610844|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610845|NCT03176628|Niacinamide|niacinamide|mesh-list
43610846|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
43610848|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
43610849|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610850|NCT03176524|Glucagon|glucagon|mesh-list
43610851|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43610852|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610853|NCT03176524|Hormones|hormones|mesh-ancestor
43610854|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610855|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610856|NCT03176524|Incretins|incretins|mesh-ancestor
43610884|NCT03176537|Hormones|hormones|mesh-ancestor
43610885|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610886|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610887|NCT03176212|Milk fat globule|milk fat globule|mesh-list
43610888|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610889|NCT03176121|Oxycodone|oxycodone|mesh-list
43610890|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43610891|NCT03176121|Narcotics|narcotics|mesh-ancestor
43610892|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610893|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610894|NCT03176121|Analgesics|analgesics|mesh-ancestor
43610895|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
43610896|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610897|NCT03176199|Oxycodone|oxycodone|mesh-list
43610898|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43610899|NCT03176199|Narcotics|narcotics|mesh-ancestor
43610900|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610901|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610902|NCT03176199|Analgesics|analgesics|mesh-ancestor
43610903|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
43610904|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610905|NCT03176186|Xenon|xenon|mesh-list
43610906|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43610907|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
43610908|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
43610909|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610910|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610911|NCT03175939|Cisplatin|cisplatin|mesh-list
43610932|NCT03175679|Tegafur|tegafur|mesh-list
43610933|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610934|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43610935|NCT03175679|Analgesics|analgesics|mesh-ancestor
43610936|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
43610937|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610938|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610939|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43610940|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
43610941|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610942|NCT03175666|Leucovorin|leucovorin|mesh-list
43610943|NCT03175666|Paclitaxel|paclitaxel|mesh-list
43610944|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
43610945|NCT03175666|Bevacizumab|bevacizumab|mesh-list
43610946|NCT03175666|Cisplatin|cisplatin|mesh-list
43610947|NCT03175666|Fluorouracil|fluorouracil|mesh-list
43610948|NCT03175666|Capecitabine|capecitabine|mesh-list
43610949|NCT03175666|Avelumab|avelumab|mesh-list
43610950|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43610951|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610952|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
43610953|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
43610954|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
43610955|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610956|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43610957|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
43610958|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610959|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43610960|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43610961|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
43610962|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43610964|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43610965|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43610966|NCT03175666|Growth Substances|growth substances|mesh-ancestor
43610974|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
43610976|NCT03175705|Tegafur|tegafur|mesh-list
43610977|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610978|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43610979|NCT03175705|Analgesics|analgesics|mesh-ancestor
43610980|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
43610981|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610982|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610983|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43610984|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
43610985|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610986|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43610987|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43610988|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43610989|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
43610990|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610991|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43610992|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43610993|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610994|NCT03175653|Oxycodone|oxycodone|mesh-list
43610995|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43610996|NCT03175653|Narcotics|narcotics|mesh-ancestor
43610997|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610998|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610999|NCT03175653|Analgesics|analgesics|mesh-ancestor
43611000|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
43611001|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611002|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
43611003|NCT03175341|Vitamins|vitamins|mesh-ancestor
43611004|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
43611005|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611006|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
43611007|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611009|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
43611012|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611013|NCT03175042|Chrysarobin|chrysarobin|mesh-list
43611014|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43611015|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611016|NCT03175042|Analgesics|analgesics|mesh-ancestor
43611017|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
43611018|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611019|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611020|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611021|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611022|NCT03175081|Ropivacaine|ropivacaine|mesh-list
43611023|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
43611024|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
43611025|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611026|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611027|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
43611028|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611029|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
43611030|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43611031|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43611032|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
43611033|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611034|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43611035|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43611036|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611038|NCT03175016|Irinotecan|irinotecan|mesh-list
43611060|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43611061|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43611062|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611063|NCT03174795|Meropenem|meropenem|mesh-list
43611064|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43611065|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611066|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43611067|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43611068|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611069|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43611070|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611120|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611122|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611123|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611124|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
43611125|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611127|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
43611128|NCT03174080|Protective Agents|protective agents|mesh-ancestor
43611129|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611131|NCT03174236|Gentamicins|gentamicins|mesh-list
43611132|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
43611133|NCT03174236|Penicillins|penicillins|mesh-list
43611134|NCT03174236|Penicillin G|penicillin g|mesh-list
43611135|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43611136|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
43611137|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611138|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43611139|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43611140|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43611141|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43611142|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611143|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611144|NCT03174288|Spironolactone|spironolactone|mesh-list
43611145|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43611146|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
43611147|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611148|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611149|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43611150|NCT03174288|Diuretics|diuretics|mesh-ancestor
43611151|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
43611164|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
43611165|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43611166|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43611167|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43611168|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
43611169|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611170|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611171|NCT03174041|Itraconazole|itraconazole|mesh-list
43611172|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43611173|NCT03174041|Midazolam|midazolam|mesh-list
43611174|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43611175|NCT03174041|Simvastatin|simvastatin|mesh-list
43611224|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611225|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43611227|NCT03173235|Vitamins|vitamins|mesh-ancestor
43611229|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611230|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43611231|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43611232|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43611233|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43611234|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43611235|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43611236|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
43611237|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611238|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611239|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611240|NCT03173339|Remifentanil|remifentanil|mesh-list
43611241|NCT03173339|Sevoflurane|sevoflurane|mesh-list
43611242|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43611243|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43611244|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
43611245|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
43611246|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611280|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611281|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43611282|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43611283|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
43611284|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43611285|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43611286|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43611287|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43611288|NCT03172988|Dexamethasone|dexamethasone|mesh-list
43611289|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
43611368|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611370|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43611371|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
43611372|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43611373|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43611374|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43611375|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43849365|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611376|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43611377|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
43611378|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43611379|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611380|NCT03172234|Amantadine|amantadine|mesh-list
43611381|NCT03172234|Gabapentin|gabapentin|mesh-list
43611382|NCT03172234|Analgesics|analgesics|mesh-ancestor
43611383|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
43611384|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611385|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611386|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
43611387|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43611388|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43611411|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611412|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43611413|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611414|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
43611415|NCT03171987|Lidocaine|lidocaine|mesh-list
43611416|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
43611417|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
43611418|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611419|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611420|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
43611421|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611422|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43611423|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43611424|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43611425|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43611426|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611427|NCT03171987|Analgesics|analgesics|mesh-ancestor
43611428|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43611429|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611430|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611431|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611432|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43611433|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611434|NCT03172052|Streptokinase|streptokinase|mesh-list
43611435|NCT03172052|Mesna|mesna|mesh-list
43611436|NCT03172052|Protective Agents|protective agents|mesh-ancestor
43611437|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611454|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611456|NCT03171818|Hematinics|hematinics|mesh-ancestor
43611457|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
43611458|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
43611459|NCT03171831|Busulfan|busulfan|mesh-list
43611460|NCT03171831|Methotrexate|methotrexate|mesh-list
43611461|NCT03171831|Fludarabine|fludarabine|mesh-list
43611462|NCT03171831|Tacrolimus|tacrolimus|mesh-list
43611463|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
43611464|NCT03171831|Basiliximab|basiliximab|mesh-list
43611465|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611466|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
43611467|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611468|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611469|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43611470|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
43611471|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611472|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611473|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43611474|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43611475|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
43611476|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43611477|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43611478|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
43611479|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
43611481|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43611482|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43611483|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43611484|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43611485|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43611486|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
43611499|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611501|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
43611502|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43611503|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43611504|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611505|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611506|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611507|NCT03171740|Analgesics|analgesics|mesh-ancestor
43611508|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
43611509|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611510|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43611511|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43611512|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43611513|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
43611514|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611515|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611516|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43611517|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43611518|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43611519|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43611520|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43611521|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
43611523|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
43611524|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
43611525|NCT03171584|Itraconazole|itraconazole|mesh-list
43611526|NCT03171584|Fluconazole|fluconazole|mesh-list
43611527|NCT03171584|Terbinafine|terbinafine|mesh-list
43611528|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
43611529|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611530|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43611531|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43611532|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611533|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611534|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43611538|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43611539|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43611540|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43611543|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43611544|NCT03171610|Narcotics|narcotics|mesh-ancestor
43611545|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611546|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611547|NCT03171610|Analgesics|analgesics|mesh-ancestor
43611548|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
43611549|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611550|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43611551|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43611552|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
43611553|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
43611554|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
43611555|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43611556|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
43611557|NCT03171389|Ponatinib|ponatinib|mesh-list
43611558|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611559|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43611560|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611561|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611562|NCT03171090|Anesthetics|anesthetics|mesh-list
43611563|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
43611564|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611565|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611566|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
43611567|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611568|NCT03170895|Sorafenib|sorafenib|mesh-list
43611569|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
43611570|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611571|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43611572|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611573|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611575|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43611577|NCT03171220|Fludarabine|fludarabine|mesh-list
43611578|NCT03171220|Interleukin-2|interleukin-2|mesh-list
43611579|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611580|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
43611581|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611582|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611583|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43611584|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
43611586|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611587|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43611588|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611589|NCT03171220|Analgesics|analgesics|mesh-ancestor
43611590|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
43611591|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611592|NCT03170713|Ibuprofen|ibuprofen|mesh-list
43611593|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43611594|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43611595|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611596|NCT03170713|Analgesics|analgesics|mesh-ancestor
43611597|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
43611598|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611599|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611605|NCT03170596|Tazarotene|tazarotene|mesh-list
43611622|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611623|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43611624|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611625|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611626|NCT03170739|Dopamine|dopamine|mesh-list
43611627|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
43611628|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43611629|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611630|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611631|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611632|NCT03170739|Analgesics|analgesics|mesh-ancestor
43611633|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
43611634|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611635|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43611636|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43611637|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43611638|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
43611639|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611640|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611641|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43611642|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
43611643|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
43611644|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
43611645|NCT03170739|Protective Agents|protective agents|mesh-ancestor
43611646|NCT03170310|Apatinib|apatinib|mesh-list
43611647|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611648|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43611649|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611650|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611651|NCT03170323|Cyclosporine|cyclosporine|mesh-list
43611652|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
43611653|NCT03170323|Cyclosporins|cyclosporins|mesh-list
43611654|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611663|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43611664|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43611665|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611666|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43611667|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
43611668|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43611670|NCT03170336|Amiloride|amiloride|mesh-list
43611671|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43611672|NCT03170336|Diuretics|diuretics|mesh-ancestor
43611673|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
43611674|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849367|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611677|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611678|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43611679|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43612083|NCT03168035|NC-4016|nc-4016|mesh-list
43611680|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43611681|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43611683|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611684|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611685|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43611686|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43611687|NCT03170284|Growth Substances|growth substances|mesh-ancestor
43611688|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611689|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
43611691|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
43611692|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
43611693|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611694|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611695|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
43611696|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611697|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43611698|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43611699|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43611700|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43611701|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611702|NCT03170115|Aspirin|aspirin|mesh-list
43611703|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43611704|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611705|NCT03170115|Analgesics|analgesics|mesh-ancestor
43611706|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
43611707|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611708|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611709|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611710|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611711|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43611712|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43611713|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611714|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43611715|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43611716|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611717|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
43611718|NCT03169959|Metformin|metformin|mesh-list
43611719|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
43611720|NCT03169959|Saxagliptin|saxagliptin|mesh-list
43611721|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43611725|NCT03169959|Incretins|incretins|mesh-ancestor
43611740|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611741|NCT03169764|Leucovorin|leucovorin|mesh-list
43611742|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
43611743|NCT03169764|Bevacizumab|bevacizumab|mesh-list
43611744|NCT03169764|Fluorouracil|fluorouracil|mesh-list
43611745|NCT03169764|Capecitabine|capecitabine|mesh-list
43611746|NCT03169764|Nivolumab|nivolumab|mesh-list
43611747|NCT03169764|Cetuximab|cetuximab|mesh-list
43611748|NCT03169764|Fulvestrant|fulvestrant|mesh-list
43611750|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611751|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611752|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611753|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
43611754|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611755|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611756|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43611757|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
43611758|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43611759|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611760|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43611761|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43611762|NCT03169764|Growth Substances|growth substances|mesh-ancestor
43611763|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
43611764|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
43611765|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43611766|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43611767|NCT03169764|Antidotes|antidotes|mesh-ancestor
43611791|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611792|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43611793|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
43611794|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43611795|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611796|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43611798|NCT03169738|Growth Substances|growth substances|mesh-ancestor
43611799|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
43611800|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
43611801|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43611802|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43611804|NCT03169738|Protective Agents|protective agents|mesh-ancestor
43611805|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
43611806|NCT03169738|Vitamins|vitamins|mesh-ancestor
43611807|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
43611808|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43611809|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43611810|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43611811|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
43611812|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611813|NCT03169725|Vaccines|vaccines|mesh-list
43611814|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
43611815|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611816|NCT03170479|Vitamin D|vitamin d|mesh-list
43611817|NCT03170479|Vitamins|vitamins|mesh-ancestor
43611818|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
43611819|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611837|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
43611838|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
43611839|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611840|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611841|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
43611842|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611843|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611844|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43611845|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
43611846|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43611847|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611848|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43611849|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43611850|NCT03169790|Growth Substances|growth substances|mesh-ancestor
43611851|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
43611852|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
43611853|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43611854|NCT03169790|Antidotes|antidotes|mesh-ancestor
43611855|NCT03169790|Protective Agents|protective agents|mesh-ancestor
43611856|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
43611857|NCT03169790|Vitamins|vitamins|mesh-ancestor
43611858|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
43611859|NCT03169660|Aflibercept|aflibercept|mesh-list
43611860|NCT03169660|Mitogens|mitogens|mesh-list
43611861|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
43611862|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
43611863|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611864|NCT03169660|Growth Substances|growth substances|mesh-ancestor
43611886|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43611887|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
43611888|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43611889|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611890|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43611891|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43611892|NCT03169777|Growth Substances|growth substances|mesh-ancestor
43611893|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
43611894|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
43611895|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43611896|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43611897|NCT03169777|Antidotes|antidotes|mesh-ancestor
43611898|NCT03169777|Protective Agents|protective agents|mesh-ancestor
43611899|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
43611900|NCT03169777|Vitamins|vitamins|mesh-ancestor
43611901|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
43611902|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43611903|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43611904|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43611905|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
43611939|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43611940|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43611941|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
43611942|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611943|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611945|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43611946|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
43611947|NCT03169426|Protective Agents|protective agents|mesh-ancestor
43611948|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43611949|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43611950|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43611951|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
43611952|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43611953|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43611954|NCT03169569|Hemostatics|hemostatics|mesh-list
43611955|NCT03169569|Coagulants|coagulants|mesh-ancestor
43611956|NCT03169413|Adenosine|adenosine|mesh-list
43611957|NCT03169413|Analgesics|analgesics|mesh-ancestor
43611958|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
43611959|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611960|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611961|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43611962|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
43611968|NCT03169335|Paclitaxel|paclitaxel|mesh-list
43611987|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43611988|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43611990|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611991|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611992|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611993|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43611994|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43611995|NCT03169114|Amikacin|amikacin|mesh-list
43611996|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43611997|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611998|NCT03169127|Ibuprofen|ibuprofen|mesh-list
43611999|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43612000|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43612001|NCT03169127|Analgesics|analgesics|mesh-ancestor
43612002|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
43612003|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612004|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612005|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612006|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43612007|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43612008|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612009|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612010|NCT03168958|Methadone|methadone|mesh-list
43612011|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43612012|NCT03168958|Narcotics|narcotics|mesh-ancestor
43612013|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612014|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612015|NCT03168958|Analgesics|analgesics|mesh-ancestor
43612016|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
43612017|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612029|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612030|NCT03168828|Urological Agents|urological agents|mesh-ancestor
43612031|NCT03168698|Oxytocin|oxytocin|mesh-list
43612032|NCT03168698|Carbetocin|carbetocin|mesh-list
43612033|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
43612034|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43612035|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612036|NCT03168594|Cisplatin|cisplatin|mesh-list
43612037|NCT03168594|Irinotecan|irinotecan|mesh-list
43612038|NCT03168594|Etoposide|etoposide|mesh-list
43612039|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612040|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43612041|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43612042|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612043|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612044|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43612045|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43612046|NCT03168568|Valsartan|valsartan|mesh-list
43612047|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43612048|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43612049|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43849369|NCT03933631|Ofloxacin|ofloxacin|mesh-list
43612081|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43612082|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43612086|NCT03168100|Lenalidomide|lenalidomide|mesh-list
43612087|NCT03168100|Bortezomib|bortezomib|mesh-list
43612088|NCT03168100|Elotuzumab|elotuzumab|mesh-list
43612089|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612090|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
43612091|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
43612092|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612093|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612094|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43612095|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
43612096|NCT03168100|Hormones|hormones|mesh-ancestor
43612097|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43612098|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43612099|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612100|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
43612101|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43612102|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43612103|NCT03168100|Growth Substances|growth substances|mesh-ancestor
43612104|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
43612105|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
43612106|NCT03167918|Metformin|metformin|mesh-list
43612107|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
43612108|NCT03167918|Calcium|calcium|mesh-list
43612130|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612132|NCT03167333|Protective Agents|protective agents|mesh-ancestor
43612133|NCT03167372|Imidacloprid|imidacloprid|mesh-list
43612134|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
43612135|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612136|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612137|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612138|NCT03167385|Apatinib|apatinib|mesh-list
43612139|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612140|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43612141|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612142|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612143|NCT03167268|Lycopene|lycopene|mesh-list
43612144|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612146|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612147|NCT03167268|Protective Agents|protective agents|mesh-ancestor
43612148|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612149|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43612187|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612188|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612189|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
43612190|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612191|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43612192|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43612193|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
43612194|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43612195|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612196|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43612197|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43612198|NCT03167164|Growth Substances|growth substances|mesh-ancestor
43612199|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
43612200|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
43612201|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43612202|NCT03167164|Antidotes|antidotes|mesh-ancestor
43612203|NCT03167164|Protective Agents|protective agents|mesh-ancestor
43612204|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
43612205|NCT03167164|Vitamins|vitamins|mesh-ancestor
43612206|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
43612207|NCT03166891|Chiauranib|chiauranib|mesh-list
43612208|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612209|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43612210|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612211|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612212|NCT03167112|Leucovorin|leucovorin|mesh-list
43612213|NCT03167112|Fluorouracil|fluorouracil|mesh-list
43612235|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612236|NCT03167034|Diuretics|diuretics|mesh-ancestor
43612237|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
43612238|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612239|NCT03167177|Leucovorin|leucovorin|mesh-list
43612246|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612247|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612248|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612249|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
43612250|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612251|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43612252|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43612253|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
43612254|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43612255|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612256|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43612257|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43612258|NCT03167177|Growth Substances|growth substances|mesh-ancestor
43612259|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
43612260|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
43612261|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43612262|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43612263|NCT03167177|Antidotes|antidotes|mesh-ancestor
43612264|NCT03167177|Protective Agents|protective agents|mesh-ancestor
43612265|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
43612266|NCT03167177|Vitamins|vitamins|mesh-ancestor
43612267|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
43612268|NCT03166644|Sufentanil|sufentanil|mesh-list
43612278|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
43612279|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
43612280|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
43612281|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43612282|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
43612283|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612284|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
43612285|NCT03166865|Protective Agents|protective agents|mesh-ancestor
43612286|NCT03166787|Ascorbic Acid|ascorbic acid|mesh-list
43612287|NCT03166787|Tadalafil|tadalafil|mesh-list
43612288|NCT03166787|Charcoal|charcoal|mesh-list
43612289|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
43612290|NCT03166787|Vitamins|vitamins|mesh-ancestor
43612291|NCT03166787|Micronutrients|micronutrients|mesh-ancestor
43612292|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612293|NCT03166787|Antioxidants|antioxidants|mesh-ancestor
43612294|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612295|NCT03166787|Protective Agents|protective agents|mesh-ancestor
43612296|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
43612297|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43612298|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43612299|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612300|NCT03166787|Urological Agents|urological agents|mesh-ancestor
43612302|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
43612303|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
43612304|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612305|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
43612306|NCT03166254|Vaccines|vaccines|mesh-list
43612332|NCT03166397|Nivolumab|nivolumab|mesh-list
43612333|NCT03166397|Fludarabine|fludarabine|mesh-list
43612334|NCT03166397|Ipilimumab|ipilimumab|mesh-list
43612335|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612336|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
43612337|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612338|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43612339|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43612340|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
43612341|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612342|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612343|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43612344|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612345|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43612346|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
43612347|NCT03166527|Antibodies|antibodies|mesh-list
43612348|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
43612349|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43612350|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43612351|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
43612352|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612353|NCT03166111|Lidocaine|lidocaine|mesh-list
43612354|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
43612355|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
43612356|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612357|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612358|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
43612536|NCT03165409|Nivolumab|nivolumab|mesh-list
43612360|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43612361|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43612362|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43612363|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612364|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612371|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
43612372|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612373|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
43612374|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43612375|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612376|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
43612377|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
43612378|NCT03165929|Analgesics|analgesics|mesh-ancestor
43612379|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
43612380|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612382|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43612383|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43612432|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612433|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612435|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612436|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43612437|NCT03165383|Narcotics|narcotics|mesh-ancestor
43612438|NCT03165383|Analgesics|analgesics|mesh-ancestor
43612439|NCT03165591|Vaccines|vaccines|mesh-list
43612440|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
43612441|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612442|NCT03165500|Midazolam|midazolam|mesh-list
43612443|NCT03165500|Diazepam|diazepam|mesh-list
43612444|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
43612445|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43612446|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43612447|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612448|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612449|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43612450|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43612451|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43612452|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43612453|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
43612454|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
43612455|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
43612456|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
43612457|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612483|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43612484|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612485|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43612486|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43612487|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43612488|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612489|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612490|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43612491|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43612492|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43612493|NCT03165123|Azithromycin|azithromycin|mesh-list
43612494|NCT03165123|Dexamethasone|dexamethasone|mesh-list
43612495|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612496|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
43612497|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
43612498|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612499|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612500|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43612501|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
43612502|NCT03165123|Hormones|hormones|mesh-ancestor
43612503|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43612504|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43612505|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612506|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43612507|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612508|NCT03165240|Eplerenone|eplerenone|mesh-list
43612531|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612532|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612533|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43612534|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612535|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43612538|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612539|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612540|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43612541|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612542|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
43612543|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43612544|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612545|NCT03164694|Carboplatin|carboplatin|mesh-list
43612547|NCT03164694|Apatinib|apatinib|mesh-list
43612548|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612549|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612550|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612551|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43612552|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43612553|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43612554|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
43612555|NCT03164590|Ketamine|ketamine|mesh-list
43612556|NCT03164590|Bupivacaine|bupivacaine|mesh-list
43612558|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
43612579|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
43612580|NCT03164512|Cannabidiol|cannabidiol|mesh-list
43612581|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
43612582|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
43612583|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43612584|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
43612585|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612586|NCT03164421|Expectorants|expectorants|mesh-ancestor
43612587|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
43612588|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43612589|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
43612590|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612591|NCT03164421|Protective Agents|protective agents|mesh-ancestor
43612592|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612593|NCT03164421|Antidotes|antidotes|mesh-ancestor
43612594|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
43612596|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
43612597|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612598|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612599|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
43612600|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612601|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43612602|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
43612603|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43612604|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612605|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612629|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612630|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43612631|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43612632|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612633|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612634|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612635|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612636|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
43612637|NCT03164109|Protective Agents|protective agents|mesh-ancestor
43612638|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
43612639|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43612640|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612641|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612642|NCT03163914|Phenylephrine|phenylephrine|mesh-list
43612643|NCT03163914|Epinephrine|epinephrine|mesh-list
43612645|NCT03163914|Norepinephrine|norepinephrine|mesh-list
43612646|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43612647|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43612648|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
43612649|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612650|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612681|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43612682|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43612683|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612684|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612685|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43612686|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43612687|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612688|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
43612689|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43612691|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612692|NCT03164161|Endorphins|endorphins|mesh-list
43612693|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612694|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612695|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612696|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
43612697|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
43612698|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612699|NCT03163966|Methotrexate|methotrexate|mesh-list
43612700|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43612701|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
43612702|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43612703|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612704|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43612729|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43612730|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43612731|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43612732|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43612733|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43612734|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43612735|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
43612736|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43612737|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43612738|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
43612739|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43612740|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612741|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612742|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43612744|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
43612745|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612746|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43612747|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43612748|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43612749|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
43612751|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612752|NCT03163420|Diclofenac|diclofenac|mesh-list
43612753|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43612754|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43612774|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612775|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43612776|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43612778|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612779|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43612780|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612781|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612782|NCT03163576|Niacin|niacin|mesh-list
43612783|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43612784|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
43612785|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612786|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43612787|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
43612788|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
43612789|NCT03163576|Vitamins|vitamins|mesh-ancestor
43612790|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
43612791|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612792|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
43612793|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
43612794|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612795|NCT03163173|Protective Agents|protective agents|mesh-ancestor
43612796|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612797|NCT03163212|Lactoferrin|lactoferrin|mesh-list
43612798|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612801|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612802|NCT03162861|Anesthetics|anesthetics|mesh-list
43612819|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43612820|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
43612821|NCT03162653|Protective Agents|protective agents|mesh-ancestor
43612822|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612823|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43612824|NCT03162653|Diuretics|diuretics|mesh-ancestor
43612825|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
43612826|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
43612827|NCT03162588|Hematinics|hematinics|mesh-ancestor
43612828|NCT03162406|Vitamin D|vitamin d|mesh-list
43612832|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612833|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43612834|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43612835|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
43612836|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43612837|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612838|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43612839|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43612840|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612841|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612842|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612843|NCT03162562|Oregovomab|oregovomab|mesh-list
43612872|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43612873|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43612875|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
43612876|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612877|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612878|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43612879|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43612880|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43612881|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
43612882|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612883|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612884|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43612885|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612886|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43612887|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43612888|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43612890|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43849371|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
43612891|NCT03161977|Diuretics|diuretics|mesh-ancestor
43612892|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
43612903|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612904|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612905|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
43612906|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43612907|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612908|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612909|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43612911|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43612916|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
43612921|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43612922|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43612923|NCT03161457|Rituximab|rituximab|mesh-list
43612924|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612925|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612926|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
43612927|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612928|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43612929|NCT03161340|Sirolimus|sirolimus|mesh-list
43612930|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43612931|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612932|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43612933|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612934|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
43612935|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612936|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
43612937|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612938|NCT03161210|Anesthetics|anesthetics|mesh-list
43612939|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612940|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612941|NCT03161574|Fluorouracil|fluorouracil|mesh-list
43612942|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
43612943|NCT03161574|Irinotecan|irinotecan|mesh-list
43612944|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
43612945|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612946|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43612947|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612948|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612949|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
43612950|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612951|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43612952|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43612973|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43612974|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43612975|NCT03161041|Growth Substances|growth substances|mesh-ancestor
43612976|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612977|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
43612978|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
43612979|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612980|NCT03161106|Lactulose|lactulose|mesh-list
43612981|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43612982|NCT03160807|Levofloxacin|levofloxacin|mesh-list
43612983|NCT03160807|Ofloxacin|ofloxacin|mesh-list
43612984|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43612985|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612986|NCT03160807|Renal Agents|renal agents|mesh-ancestor
43612987|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43612988|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43612989|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43612990|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612991|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612992|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612993|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43612994|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43612995|NCT03160729|Dexamethasone|dexamethasone|mesh-list
43612996|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612997|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
43612998|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
43612999|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613000|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613001|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43613002|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
43613004|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613005|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613006|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613007|NCT03160404|Zolpidem|zolpidem|mesh-list
43613008|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43613011|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613012|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43613013|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
43613014|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
43613015|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613016|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613017|NCT05676931|Docetaxel|docetaxel|mesh-list
43613018|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613019|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613020|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613021|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613022|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613023|NCT05676749|Aldesleukin|aldesleukin|mesh-list
43613024|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
43613025|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613026|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613027|NCT05676749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43613028|NCT05676749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43613029|NCT05676749|Antiviral Agents|antiviral agents|mesh-ancestor
43613030|NCT05676749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613031|NCT05676645|Lumefantrine|lumefantrine|mesh-list
43613032|NCT05676645|Artemether|artemether|mesh-list
43613033|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43613034|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
43613035|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43613036|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43613037|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613038|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
43613039|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
43613040|NCT05676463|Hormones|hormones|mesh-list
43613041|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43849372|NCT03933631|Pilocarpine|pilocarpine|mesh-list
43613042|NCT05676463|Androgens|androgens|mesh-list
43613043|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
43613048|NCT05676463|Protective Agents|protective agents|mesh-ancestor
43613055|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
43613056|NCT05676294|Olanzapine|olanzapine|mesh-list
43613057|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
43613058|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
43613059|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613060|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613061|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43613062|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43613069|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613070|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613071|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
43613072|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
43613073|NCT05676216|Promethazine|promethazine|mesh-list
43613074|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43613075|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43613076|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613077|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613078|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
43613103|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43613104|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613105|NCT05675813|Azacitidine|azacitidine|mesh-list
43613106|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43613107|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
43613108|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613109|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613110|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613112|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
43613113|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613114|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43613115|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43613116|NCT05675787|Atorvastatin|atorvastatin|mesh-list
43613117|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
43613118|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43613119|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43613121|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613122|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43613123|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43613124|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613125|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43613126|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43613127|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43613128|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
43613129|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43613130|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613131|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43613132|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43613146|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613147|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43613148|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
43613154|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
43613155|NCT05675410|Prednisone|prednisone|mesh-list
43613156|NCT05675410|Prednisolone|prednisolone|mesh-list
43613157|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43613158|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
43613159|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43613160|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
43613161|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
43613162|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43613163|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43613164|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43613165|NCT05675410|Cortisone|cortisone|mesh-list
43613166|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
43613167|NCT05675410|Dacarbazine|dacarbazine|mesh-list
43613168|NCT05675410|Doxorubicin|doxorubicin|mesh-list
43613169|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43613170|NCT05675410|Nivolumab|nivolumab|mesh-list
43613171|NCT05675410|Etoposide|etoposide|mesh-list
43613172|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
43613173|NCT05675410|Vincristine|vincristine|mesh-list
43613174|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43613175|NCT05675410|Bleomycin|bleomycin|mesh-list
43613176|NCT05675410|Vinblastine|vinblastine|mesh-list
43613177|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
43613195|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613197|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43613198|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43613199|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43613200|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613201|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43613202|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
43613203|NCT05675410|Hormones|hormones|mesh-ancestor
43613204|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613205|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613206|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43613207|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43613208|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613209|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613210|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613211|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
43613212|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
43613213|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613214|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43613215|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43613216|NCT05675410|Protective Agents|protective agents|mesh-ancestor
43613217|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43613218|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
43613219|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
43613220|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
43613221|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
43613222|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613244|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
43613245|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613246|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613247|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
43613248|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43613249|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43613250|NCT05675319|Growth Substances|growth substances|mesh-ancestor
43613251|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
43613252|NCT05675098|Methylphenidate|methylphenidate|mesh-list
43613253|NCT05675098|Modafinil|modafinil|mesh-list
43613254|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43613255|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613256|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43613257|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43613258|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43613259|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613260|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
43613261|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613262|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43613263|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43613264|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43613265|NCT05675033|Bevacizumab|bevacizumab|mesh-list
43613266|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613267|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613268|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43613269|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43613270|NCT05675033|Growth Substances|growth substances|mesh-ancestor
43613271|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613272|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
43613273|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
43613274|NCT05674877|Ketamine|ketamine|mesh-list
43613275|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
43613276|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43613277|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613278|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613281|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
43613282|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613283|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43613284|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43613285|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43613286|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
43613287|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613288|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613289|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43613290|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43613291|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
43613293|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43613294|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43613296|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
43613297|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43613298|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613299|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613300|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43613301|NCT05672225|Analgesics|analgesics|mesh-ancestor
43613302|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
43613303|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613304|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43613305|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43613306|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43613307|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
43613308|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613309|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613310|NCT05672212|Sufentanil|sufentanil|mesh-list
43613311|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43613312|NCT05672212|Narcotics|narcotics|mesh-ancestor
43613322|NCT05671510|Docetaxel|docetaxel|mesh-list
43613323|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613324|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613325|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613326|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613327|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613328|NCT05668026|Venetoclax|venetoclax|mesh-list
43613329|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613330|NCT05667454|Atropine|atropine|mesh-list
43613331|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43613332|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43613333|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43613334|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
43613335|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613336|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613337|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43613338|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
43613340|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
43613341|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43613342|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43613395|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613396|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43613397|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43613398|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613399|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43613400|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43613401|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613402|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
43613408|NCT05630859|Vaccines|vaccines|mesh-list
43613411|NCT05630183|Gemcitabine|gemcitabine|mesh-list
43613412|NCT05630183|Paclitaxel|paclitaxel|mesh-list
43613413|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43613414|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613415|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613416|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613417|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613418|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613419|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43849373|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43613420|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
43613428|NCT05580250|Simvastatin|simvastatin|mesh-list
43613429|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43613430|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613431|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43613432|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43613433|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
43613434|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613435|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43613436|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43613437|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613438|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43613439|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43613440|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613441|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
43613466|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
43613471|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43613472|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43613473|NCT05539729|Vancomycin|vancomycin|mesh-list
43613474|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43613475|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613488|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613489|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43613490|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613491|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43613492|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613493|NCT05482789|Exenatide|exenatide|mesh-list
43613494|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43613495|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613496|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43613497|NCT05482789|Incretins|incretins|mesh-ancestor
43613498|NCT05482789|Hormones|hormones|mesh-ancestor
43613499|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613517|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43613518|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613519|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
43613520|NCT05443425|Leflunomide|leflunomide|mesh-list
43613521|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613522|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613523|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613524|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
43613525|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613526|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43613527|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43613528|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
43613529|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43613530|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
43613531|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613532|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613533|NCT05420636|Paclitaxel|paclitaxel|mesh-list
43613534|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43613535|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613537|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613538|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613539|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613540|NCT05415215|Trastuzumab|trastuzumab|mesh-list
43613541|NCT05415215|Pertuzumab|pertuzumab|mesh-list
43613542|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43613543|NCT05415215|Maytansine|maytansine|mesh-list
43613544|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613545|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613563|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43613564|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43613565|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43613566|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
43613567|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613568|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613569|NCT05363319|Cemiplimab|cemiplimab|mesh-list
43613570|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613578|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613579|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613580|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
43613581|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613582|NCT05343013|Trifluridine|trifluridine|mesh-list
43613583|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
43613584|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613585|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
43613586|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613587|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
43613588|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613589|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613590|NCT05304585|Dactinomycin|dactinomycin|mesh-list
43613591|NCT05304585|Cactinomycin|cactinomycin|mesh-list
43613592|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
43613593|NCT05304585|Vincristine|vincristine|mesh-list
43613594|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613595|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
43613596|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613597|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613598|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43613608|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613609|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43613610|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43613612|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43613613|NCT05298085|Oxytocin|oxytocin|mesh-list
43613614|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
43613615|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43613616|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613617|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43613618|NCT05283395|Latanoprost|latanoprost|mesh-list
43613619|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43613620|NCT05254639|Donepezil|donepezil|mesh-list
43613621|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43613622|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613623|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613624|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
43613625|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613626|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613627|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
43613628|NCT05251129|Atorvastatin|atorvastatin|mesh-list
43613629|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43613630|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43613631|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
43613632|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613658|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613659|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613660|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613661|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613662|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613663|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613664|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
43613665|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613666|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613667|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43613668|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
43613669|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43613670|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43613671|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43613672|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43613673|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613675|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43613676|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
43613677|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
43613678|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613679|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
43613680|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43613681|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43613682|NCT05171647|Gemcitabine|gemcitabine|mesh-list
43613683|NCT05171647|Rituximab|rituximab|mesh-list
43613684|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
43613691|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
43613706|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613708|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43613709|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
43613710|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43613711|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613712|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613713|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613714|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43613715|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43613716|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
43613717|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613718|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613719|NCT05075980|Cisplatin|cisplatin|mesh-list
43613720|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613721|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43613722|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
43613733|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613734|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43613735|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43613736|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613737|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613738|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43613739|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
43613740|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613742|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43613744|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613745|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613746|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613761|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613762|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613763|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613764|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613765|NCT04967196|Nivolumab|nivolumab|mesh-list
43613766|NCT04967196|Ipilimumab|ipilimumab|mesh-list
43613767|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613768|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613769|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43613770|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613771|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43613772|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43613773|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43613774|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613775|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613776|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43613777|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43613778|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613779|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
43613780|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613781|NCT04932096|Melatonin|melatonin|mesh-list
43613782|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
43613783|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613784|NCT04932096|Protective Agents|protective agents|mesh-ancestor
43613785|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613786|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613787|NCT04927780|Leucovorin|leucovorin|mesh-list
43613802|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43613803|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613805|NCT04927780|Protective Agents|protective agents|mesh-ancestor
43613806|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
43613807|NCT04927780|Vitamins|vitamins|mesh-ancestor
43613808|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
43613810|NCT04895735|Pemetrexed|pemetrexed|mesh-list
43613811|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613812|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613813|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613814|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613815|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43613816|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43613817|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
43613818|NCT04892277|Fludarabine|fludarabine|mesh-list
43613819|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613820|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
43613821|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613822|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613823|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43613824|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
43613825|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613826|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613827|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43613828|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
43613852|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43613853|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
43613854|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613855|NCT04861584|Antiviral Agents|antiviral agents|mesh-ancestor
43613856|NCT04861584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613857|NCT04861584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613859|NCT04861584|Immunologic Factors|immunologic factors|mesh-ancestor
43613860|NCT04861584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613861|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
43613862|NCT04828486|Futibatinib|futibatinib|mesh-list
43613863|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613864|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613865|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
43613866|NCT04809766|Fludarabine|fludarabine|mesh-list
43613867|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613868|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
43613869|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613870|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613871|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43613872|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
43849374|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
43613873|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613874|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613875|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43613876|NCT04797780|Azacitidine|azacitidine|mesh-list
43613877|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43613878|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
43613879|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613880|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613881|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613882|NCT04787471|Riboflavin|riboflavin|mesh-list
43613895|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
43613896|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
43613897|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613898|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613899|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43613900|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
43613901|NCT04764942|Hormones|hormones|mesh-ancestor
43613902|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613903|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613904|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613905|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
43613906|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613907|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613908|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
43613909|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43613910|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43613911|NCT04764942|Growth Substances|growth substances|mesh-ancestor
43613912|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
43613913|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
43613914|NCT04743505|Osimertinib|osimertinib|mesh-list
43613915|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613916|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43613917|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613918|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613944|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43613945|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
43613946|NCT04669678|Etonogestrel|etonogestrel|mesh-list
43613947|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43613948|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43849375|NCT03933631|Hormones|hormones|mesh-ancestor
43613949|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43613950|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
43613951|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43613952|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613953|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43613954|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43613955|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43613956|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613957|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613958|NCT04665570|Metformin|metformin|mesh-list
43613959|NCT04665570|Acarbose|acarbose|mesh-list
43613960|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43613961|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613962|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43613963|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613964|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613965|NCT04628338|Interferons|interferons|mesh-list
43613966|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
43613967|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613994|NCT04553692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613996|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613997|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
43613998|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613999|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
43614000|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
43614001|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43614002|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43614003|NCT04553692|Antidotes|antidotes|mesh-ancestor
43614011|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43614012|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614013|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
43614014|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
43614015|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
43614016|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614017|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614024|NCT04540133|Dexamethasone|dexamethasone|mesh-list
43614047|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43614048|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614049|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614050|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614052|NCT04483960|Enoxaparin|enoxaparin|mesh-list
43614053|NCT04483960|Dalteparin|dalteparin|mesh-list
43614054|NCT04483960|Tinzaparin|tinzaparin|mesh-list
43614055|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43614056|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
43614057|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43614058|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43614059|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614060|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43614061|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43614062|NCT04483960|Analgesics|analgesics|mesh-ancestor
43614063|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
43614064|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614065|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614066|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614067|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614068|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
43614069|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614070|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43614071|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43614072|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43614073|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614074|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
43614075|NCT04404439|Topiramate|topiramate|mesh-list
43614076|NCT04404439|Verapamil|verapamil|mesh-list
43614092|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43614093|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614094|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43614095|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43614096|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43614097|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
43614098|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43614099|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43614100|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
43614103|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614156|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43614157|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43614158|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
43614159|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614160|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43614161|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43614162|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43614163|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
43614164|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43614165|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43614166|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43614167|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43614168|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
43614169|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
43614170|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
43614171|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
43614172|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614173|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
43614174|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614176|NCT04360941|Avelumab|avelumab|mesh-list
43614177|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614178|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43614179|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614180|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614181|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614191|NCT04301661|Tenofovir|tenofovir|mesh-list
43614205|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
43614206|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614207|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614208|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
43614209|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614210|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43614211|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614212|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614213|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
43614214|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
43614215|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43614216|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
43614217|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614218|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
43614219|NCT04262336|Protective Agents|protective agents|mesh-ancestor
43614220|NCT04262336|Antidotes|antidotes|mesh-ancestor
43614221|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
43614222|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614223|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
43614224|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43614225|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614226|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
43614227|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
43614228|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
43614229|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614230|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614231|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43614232|NCT04210427|Laxatives|laxatives|mesh-ancestor
43614233|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614250|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
43614251|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614252|NCT04190433|Carvedilol|carvedilol|mesh-list
43614253|NCT04190433|Lisinopril|lisinopril|mesh-list
43614254|NCT04190433|Spironolactone|spironolactone|mesh-list
43614256|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43614257|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
43614258|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614259|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614260|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43614261|NCT04190433|Diuretics|diuretics|mesh-ancestor
43614262|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
43614263|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43614264|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43614265|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
43614266|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43614267|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614268|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43614269|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
43614270|NCT04190433|Protective Agents|protective agents|mesh-ancestor
43614303|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43614304|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43614305|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614306|NCT04182633|Laxatives|laxatives|mesh-ancestor
43614307|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614308|NCT04175431|Prednisone|prednisone|mesh-list
43614309|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
43614310|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614311|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
43614312|NCT04175431|Hormones|hormones|mesh-ancestor
43614313|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614314|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614315|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614316|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614317|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43614318|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614319|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614320|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
43614321|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43614322|NCT04173507|Avelumab|avelumab|mesh-list
43614323|NCT04173507|Talazoparib|talazoparib|mesh-list
43614324|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43614325|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614326|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614327|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43614328|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614329|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614331|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614333|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43614334|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614335|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614336|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614337|NCT04132427|Vancomycin|vancomycin|mesh-list
43614342|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43614343|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
43614344|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
43614345|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614346|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43614347|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614348|NCT04132427|Cathartics|cathartics|mesh-ancestor
43614349|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614350|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
43614351|NCT04098068|Antibodies|antibodies|mesh-list
43614352|NCT04098068|Immunologic Factors|immunologic factors|mesh-ancestor
43614353|NCT04098068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614354|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614355|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614356|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
43614357|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614358|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614359|NCT04072445|Trifluridine|trifluridine|mesh-list
43614360|NCT04072445|Irinotecan|irinotecan|mesh-list
43614361|NCT04072445|Camptothecin|camptothecin|mesh-list
43614362|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43614363|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43614364|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614365|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614366|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614367|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43614368|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
43614369|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
43614370|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614372|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43614373|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
43614385|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614386|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614387|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614388|NCT04027309|Midostaurin|midostaurin|mesh-list
43614389|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614390|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43614391|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614392|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614393|NCT04015180|Aflibercept|aflibercept|mesh-list
43614394|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43614395|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43614396|NCT04015180|Growth Substances|growth substances|mesh-ancestor
43614397|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614398|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
43614399|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614400|NCT04008797|Lenvatinib|lenvatinib|mesh-list
43614401|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614402|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43614403|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614404|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614405|NCT03959891|Letrozole|letrozole|mesh-list
43614406|NCT03959891|Fulvestrant|fulvestrant|mesh-list
43614407|NCT03959891|Palbociclib|palbociclib|mesh-list
43614408|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43614409|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614434|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614435|NCT03923270|Durvalumab|durvalumab|mesh-list
43614436|NCT03923270|Olaparib|olaparib|mesh-list
43614437|NCT03923270|Tremelimumab|tremelimumab|mesh-list
43614438|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43614439|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614440|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614441|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43614442|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614443|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614444|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
43614445|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614446|NCT03922542|Riboflavin|riboflavin|mesh-list
43614447|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
43614450|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614451|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43614452|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
43614453|NCT03878095|Olaparib|olaparib|mesh-list
43614454|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43614455|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614456|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614457|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614485|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614486|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614487|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43614488|NCT03773237|SMOFlipid|smoflipid|mesh-list
43614489|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43614490|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43614491|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43614492|NCT03765983|Trastuzumab|trastuzumab|mesh-list
43614493|NCT03765983|GDC-0084|gdc-0084|mesh-list
43614494|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614495|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614496|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614497|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614498|NCT03715946|Nivolumab|nivolumab|mesh-list
43614499|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614500|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614501|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43614502|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614503|NCT03672773|Temozolomide|temozolomide|mesh-list
43614504|NCT03672773|Talazoparib|talazoparib|mesh-list
43614505|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43614506|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
43614507|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614508|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614509|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43614510|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614511|NCT03671018|Rituximab|rituximab|mesh-list
43614512|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614527|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614528|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43614529|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614531|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614532|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614533|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43614534|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614535|NCT03603509|Vaccines|vaccines|mesh-list
43614536|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
43614537|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614538|NCT03601455|Durvalumab|durvalumab|mesh-list
43614539|NCT03601455|Ipilimumab|ipilimumab|mesh-list
43614540|NCT03601455|Tremelimumab|tremelimumab|mesh-list
43614541|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
43614542|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43614543|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
43614544|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614545|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614546|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
43614547|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614549|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614551|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614552|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
43614553|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614554|NCT03586999|Nivolumab|nivolumab|mesh-list
43614577|NCT03506360|Dexamethasone|dexamethasone|mesh-list
43614578|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
43614580|NCT03506360|Ixazomib|ixazomib|mesh-list
43614581|NCT03506360|Ichthammol|ichthammol|mesh-list
43614582|NCT03506360|BB 1101|bb 1101|mesh-list
43614583|NCT03506360|Glycine|glycine|mesh-list
43614584|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614585|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
43614586|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
43614587|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614588|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614589|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614590|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
43614591|NCT03506360|Hormones|hormones|mesh-ancestor
43614592|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614593|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614594|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614595|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
43614596|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614597|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614598|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614599|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
43614633|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43614634|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614635|NCT03359863|Pirfenidone|pirfenidone|mesh-list
43614636|NCT03359863|Analgesics|analgesics|mesh-ancestor
43614637|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
43614638|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614639|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614640|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43614641|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43614642|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614643|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614644|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614645|NCT03344159|Spironolactone|spironolactone|mesh-list
43614646|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43614647|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
43614648|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614649|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614650|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43614651|NCT03344159|Diuretics|diuretics|mesh-ancestor
43614652|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
43614653|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
43614654|NCT03324113|Promethazine|promethazine|mesh-list
43614655|NCT03324113|Dexamethasone|dexamethasone|mesh-list
43614656|NCT03324113|Naphazoline|naphazoline|mesh-list
43614657|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43614659|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
43614682|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
43614683|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
43614684|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43614685|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43614686|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
43614687|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
43614688|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43614689|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
43614690|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
43614692|NCT03323476|Rituximab|rituximab|mesh-list
43614693|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43614694|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614695|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614696|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
43614697|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614698|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614699|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43614700|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43614701|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
43614702|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43614703|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614704|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614734|NCT03240861|Aldesleukin|aldesleukin|mesh-list
43614735|NCT03240861|Plerixafor|plerixafor|mesh-list
43614736|NCT03240861|Fludarabine|fludarabine|mesh-list
43614737|NCT03240861|Busulfan|busulfan|mesh-list
43614738|NCT03240861|Interleukin-2|interleukin-2|mesh-list
43614739|NCT03240861|Lenograstim|lenograstim|mesh-list
43614740|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614741|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614742|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614743|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
43614744|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614745|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43614746|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
43614747|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43614748|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43614749|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43614750|NCT03240861|Analgesics|analgesics|mesh-ancestor
43614751|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
43614752|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614753|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43614754|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43614755|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
43614756|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614757|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43614758|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43614759|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614785|NCT02958917|Analgesics|analgesics|mesh-ancestor
43614786|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
43614787|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614788|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614789|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43614790|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43614791|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614792|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614793|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614794|NCT02937818|Carboplatin|carboplatin|mesh-list
43614795|NCT02937818|Durvalumab|durvalumab|mesh-list
43614796|NCT02937818|Olaparib|olaparib|mesh-list
43614797|NCT02937818|Tremelimumab|tremelimumab|mesh-list
43614798|NCT02937818|Adavosertib|adavosertib|mesh-list
43614799|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614800|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614801|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43614802|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614803|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614804|NCT02881086|Cytarabine|cytarabine|mesh-list
43614805|NCT02881086|Dexamethasone|dexamethasone|mesh-list
43614806|NCT02881086|Prednisolone|prednisolone|mesh-list
43614807|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
43614808|NCT02881086|Rituximab|rituximab|mesh-list
43614809|NCT02881086|Methotrexate|methotrexate|mesh-list
43614810|NCT02881086|Fludarabine|fludarabine|mesh-list
43614811|NCT02881086|Vincristine|vincristine|mesh-list
43614812|NCT02881086|Doxorubicin|doxorubicin|mesh-list
43614813|NCT02881086|Daunorubicin|daunorubicin|mesh-list
43614814|NCT02881086|Asparaginase|asparaginase|mesh-list
43614815|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
43614816|NCT02881086|Idarubicin|idarubicin|mesh-list
43614817|NCT02881086|Pegaspargase|pegaspargase|mesh-list
43614819|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614831|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
43614832|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614833|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614834|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
43614835|NCT02881086|Hormones|hormones|mesh-ancestor
43614836|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614837|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614838|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43614839|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
43614840|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43614841|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43614842|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
43614843|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
43614844|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614845|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43614846|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43614847|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
43614848|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614849|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43614850|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
43614851|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
43614852|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
43614853|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43614854|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43614855|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43614856|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
43614857|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43614858|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
43614859|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43614860|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614861|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43614862|NCT02794571|Paclitaxel|paclitaxel|mesh-list
43614863|NCT02794571|Etoposide|etoposide|mesh-list
43614864|NCT02794571|Bevacizumab|bevacizumab|mesh-list
43614871|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43614872|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614873|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
43614874|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
43614876|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614877|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614878|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43614879|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43614880|NCT02794571|Growth Substances|growth substances|mesh-ancestor
43614881|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614882|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
43614883|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43614885|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43614886|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43614887|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614888|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43614889|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43614890|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
43614891|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43614892|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43614923|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614924|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614925|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43614926|NCT02453620|Nivolumab|nivolumab|mesh-list
43614927|NCT02453620|Ipilimumab|ipilimumab|mesh-list
43614928|NCT02453620|Entinostat|entinostat|mesh-list
43614929|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43614930|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614931|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614932|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43614933|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614934|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614935|NCT02453282|Gemcitabine|gemcitabine|mesh-list
43614936|NCT02453282|Paclitaxel|paclitaxel|mesh-list
43614937|NCT02453282|Cisplatin|cisplatin|mesh-list
43614938|NCT02453282|Carboplatin|carboplatin|mesh-list
43614939|NCT02453282|Pemetrexed|pemetrexed|mesh-list
43614940|NCT02453282|Durvalumab|durvalumab|mesh-list
43614941|NCT02453282|Tremelimumab|tremelimumab|mesh-list
43849376|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614943|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43614944|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614945|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
43614946|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
43614947|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
43614948|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614949|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43614950|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
43614951|NCT02453282|Antiviral Agents|antiviral agents|mesh-ancestor
43614952|NCT02453282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614953|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614954|NCT02453282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614967|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614968|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614969|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43614970|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43614971|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
43614972|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614973|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43614974|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43614975|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43614976|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43614977|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43614978|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43614979|NCT02299141|Nintedanib|nintedanib|mesh-list
43614980|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614981|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43614982|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614983|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614984|NCT02205047|Cisplatin|cisplatin|mesh-list
43614985|NCT02205047|Fluorouracil|fluorouracil|mesh-list
43614986|NCT02205047|Capecitabine|capecitabine|mesh-list
43614987|NCT02205047|Trastuzumab|trastuzumab|mesh-list
43614988|NCT02205047|Pertuzumab|pertuzumab|mesh-list
43614989|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614990|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
43614991|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614992|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43615154|NCT03160248|Apremilast|apremilast|mesh-list
43614993|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614994|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
43614995|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614996|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614997|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
43614998|NCT02037126|Promethazine|promethazine|mesh-list
43615009|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
43615010|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615011|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43615012|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
43615013|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
43615014|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615015|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615016|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43615017|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
43615018|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
43615019|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
43615020|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43615022|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
43615023|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849377|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849378|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849379|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849380|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
43849381|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849382|NCT03933631|Miotics|miotics|mesh-ancestor
43615053|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43615054|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43615055|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
43615056|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615057|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615058|NCT01572506|Biotin|biotin|mesh-list
43615059|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
43615060|NCT01572506|Vitamins|vitamins|mesh-ancestor
43615061|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
43615062|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615063|NCT01345851|Paclitaxel|paclitaxel|mesh-list
43615064|NCT01345851|Carboplatin|carboplatin|mesh-list
43615065|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43615066|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615067|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
43615068|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
43615069|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
43615070|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615071|NCT00773695|Paclitaxel|paclitaxel|mesh-list
43615072|NCT00773695|Docetaxel|docetaxel|mesh-list
43615073|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
43615074|NCT00773695|Bevacizumab|bevacizumab|mesh-list
43615075|NCT00773695|Fluorouracil|fluorouracil|mesh-list
43615076|NCT00773695|Epirubicin|epirubicin|mesh-list
43615077|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43615078|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43615079|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615103|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43615104|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43615105|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43615106|NCT00735748|Tramadol|tramadol|mesh-list
43615107|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43615108|NCT00735748|Narcotics|narcotics|mesh-ancestor
43615109|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615110|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615111|NCT00735748|Analgesics|analgesics|mesh-ancestor
43615112|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
43615113|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615114|NCT00014443|Thalidomide|thalidomide|mesh-list
43615115|NCT00014443|Topotecan|topotecan|mesh-list
43615116|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43615117|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43615118|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615119|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615120|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615121|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615122|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
43615123|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615124|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
43615125|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43615126|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615127|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43615156|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615157|NCT03160248|Analgesics|analgesics|mesh-ancestor
43615158|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
43615159|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615160|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615161|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615162|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615163|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43615164|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43615165|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615166|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615167|NCT03160001|Niclosamide|niclosamide|mesh-list
43615168|NCT03160001|Etanercept|etanercept|mesh-list
43615169|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615170|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615171|NCT03160001|Analgesics|analgesics|mesh-ancestor
43615172|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
43615173|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615174|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615175|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615176|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615177|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615178|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615179|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
43615180|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
43615181|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43615182|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
43615183|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43615184|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615185|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
43615186|NCT03160040|Minocycline|minocycline|mesh-list
43615196|NCT03159741|Glucagon|glucagon|mesh-list
43615197|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43615198|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615199|NCT03159741|Hormones|hormones|mesh-ancestor
43615200|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43615201|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615202|NCT03159741|Incretins|incretins|mesh-ancestor
43615203|NCT03159845|Levofloxacin|levofloxacin|mesh-list
43615204|NCT03159845|Ofloxacin|ofloxacin|mesh-list
43615205|NCT03159845|Fluconazole|fluconazole|mesh-list
43615206|NCT03159845|Acyclovir|acyclovir|mesh-list
43615207|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
43615208|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43615209|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615210|NCT03159845|Renal Agents|renal agents|mesh-ancestor
43615211|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43615212|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43615213|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43615214|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615215|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615216|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615217|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43615218|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43615219|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
43615220|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43615221|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43615222|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
43615223|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43615224|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615225|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43615226|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43615227|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
43615228|NCT03159845|Astringents|astringents|mesh-ancestor
43615238|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615239|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615241|NCT03158168|Astringents|astringents|mesh-ancestor
43615242|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615243|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
43615244|NCT03157804|Plerixafor|plerixafor|mesh-list
43615245|NCT03157804|Lenograstim|lenograstim|mesh-list
43615246|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43615247|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
43615248|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615249|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43615250|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43615251|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
43615252|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615253|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
43615254|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615255|NCT03157414|Empagliflozin|empagliflozin|mesh-list
43615256|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43615257|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615258|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43615259|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615260|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
43615261|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43615262|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
43615263|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615264|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
43615265|NCT03157193|Protective Agents|protective agents|mesh-ancestor
43615266|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
43615267|NCT03156062|Salicylates|salicylates|mesh-list
43615282|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615283|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
43615285|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43615286|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615287|NCT03155477|Vitamins|vitamins|mesh-ancestor
43615288|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
43615289|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43615290|NCT03154385|Rituximab|rituximab|mesh-list
43615291|NCT03154385|Belimumab|belimumab|mesh-list
43615292|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615293|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615294|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
43615295|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615296|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615297|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615298|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43615299|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
43615300|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43615301|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43615302|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43615303|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
43615304|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43615305|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615306|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43615307|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43615310|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615330|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615331|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
43615332|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615333|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
43615334|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615335|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
43615336|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615337|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43615338|NCT03149939|Febuxostat|febuxostat|mesh-list
43615339|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
43615340|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615341|NCT03149913|Paclitaxel|paclitaxel|mesh-list
43615342|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43615343|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615344|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
43615345|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
43615346|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
43615347|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615348|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43615349|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615350|NCT03149783|Ropivacaine|ropivacaine|mesh-list
43615351|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
43615352|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
43615353|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615380|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615381|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615382|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
43615383|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615549|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43615384|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43615385|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
43615387|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43615388|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43615389|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615390|NCT03149588|Propofol|propofol|mesh-list
43615391|NCT03149588|Sevoflurane|sevoflurane|mesh-list
43615392|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43615393|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615394|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615395|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43615396|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
43615397|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
43615398|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43615399|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43615434|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43615435|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
43615436|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615437|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615438|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
43615439|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615440|NCT03148990|Vaccines|vaccines|mesh-list
43615441|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
43615442|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615443|NCT03149159|Nivolumab|nivolumab|mesh-list
43615444|NCT03149159|Ipilimumab|ipilimumab|mesh-list
43615445|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615446|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615447|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43615448|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615449|NCT03149120|Nivolumab|nivolumab|mesh-list
43615450|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615451|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615452|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43615453|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615454|NCT03149250|Hemostatics|hemostatics|mesh-list
43615455|NCT03149250|Coagulants|coagulants|mesh-ancestor
43615456|NCT03148717|Misoprostol|misoprostol|mesh-list
43615457|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43615458|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
43615459|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43615460|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615463|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
43615481|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615483|NCT03148574|Misoprostol|misoprostol|mesh-list
43615484|NCT03148574|Oxytocin|oxytocin|mesh-list
43615485|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
43615486|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43615487|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615488|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43615489|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
43615490|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43615491|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615492|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
43615493|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
43615494|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43615495|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615496|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615497|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
43615498|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43615499|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615535|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615536|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
43615537|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615538|NCT03148522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43615539|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
43615540|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43615541|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615542|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43615543|NCT03148522|Analgesics|analgesics|mesh-ancestor
43615544|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
43615545|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
43615546|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43615547|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
43615548|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
43615551|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615552|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43615592|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
43615593|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
43615594|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615596|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
43615597|NCT03147859|Vedolizumab|vedolizumab|mesh-list
43615598|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615599|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
43615600|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43615601|NCT03147677|Irbesartan|irbesartan|mesh-list
43615602|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43615603|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43615604|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43615605|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615606|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43615607|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615609|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
43849387|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849388|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43615639|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615640|NCT03147092|Losartan|losartan|mesh-list
43615641|NCT03147092|Atenolol|atenolol|mesh-list
43615642|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43615643|NCT03147092|Clonidine|clonidine|mesh-list
43615644|NCT03147092|Captopril|captopril|mesh-list
43615645|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43615646|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43615647|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43615648|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43615649|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615650|NCT03147092|Diuretics|diuretics|mesh-ancestor
43615651|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
43615652|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615653|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43615654|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43615655|NCT03147092|Analgesics|analgesics|mesh-ancestor
43615656|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
43615657|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615658|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
43615659|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
43615660|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43615661|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43615662|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43615663|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
43615664|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615665|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43615666|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43615667|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43615668|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43615669|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
43615670|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615671|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43615672|NCT03147196|Bicalutamide|bicalutamide|mesh-list
43615673|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
43615674|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
43615675|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43615677|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615680|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43615681|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43615682|NCT03146858|Enoxaparin|enoxaparin|mesh-list
43615683|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
43615684|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43615685|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43615686|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615687|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
43615688|NCT03146793|Antidotes|antidotes|mesh-ancestor
43615689|NCT03146793|Protective Agents|protective agents|mesh-ancestor
43615690|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615691|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
43615692|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615693|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
43615694|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43615695|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615696|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
43615725|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
43615726|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615727|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615728|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43615730|NCT03146689|Capsaicin|capsaicin|mesh-list
43615731|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615732|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615733|NCT03146689|Analgesics|analgesics|mesh-ancestor
43615734|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
43615735|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615736|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615737|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615738|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615739|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43615740|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615741|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615742|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
43615743|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
43615744|NCT03146481|Aceclofenac|aceclofenac|mesh-list
43615745|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615746|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615747|NCT03146481|Analgesics|analgesics|mesh-ancestor
43615753|NCT03146468|Nivolumab|nivolumab|mesh-list
43615776|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615777|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615778|NCT03146247|Analgesics|analgesics|mesh-ancestor
43615779|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
43615780|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615781|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615782|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615783|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615784|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43615785|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43615786|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615787|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615788|NCT03146000|Meloxicam|meloxicam|mesh-list
43615789|NCT03146000|Lidocaine|lidocaine|mesh-list
43615790|NCT03146000|Prilocaine|prilocaine|mesh-list
43615791|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43615792|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
43615793|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
43615794|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615795|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615796|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
43615797|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615798|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43615799|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43615800|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43615801|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43615802|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615822|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43615823|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615824|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615826|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43615827|NCT03146052|Simethicone|simethicone|mesh-list
43615828|NCT03146052|Bisacodyl|bisacodyl|mesh-list
43615829|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615830|NCT03146052|Cathartics|cathartics|mesh-ancestor
43615831|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615832|NCT03146052|Laxatives|laxatives|mesh-ancestor
43615833|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
43615834|NCT03146052|Emollients|emollients|mesh-ancestor
43615835|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
43615836|NCT03145649|Insulin|insulin|mesh-list
43615837|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43615838|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615839|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
43615840|NCT03145714|Anesthetics|anesthetics|mesh-list
43615841|NCT03145714|Propofol|propofol|mesh-list
43615842|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615843|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615844|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43615846|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
43615873|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615874|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43615875|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
43615877|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43615878|NCT03145623|Grazoprevir|grazoprevir|mesh-list
43615879|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43615880|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
43615881|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615882|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
43615883|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615884|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615885|NCT03145896|Vitamin D|vitamin d|mesh-list
43615886|NCT03145896|Vitamins|vitamins|mesh-ancestor
43615887|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
43615888|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615889|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43615890|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
43615891|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615892|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615894|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43615895|NCT03145272|Narcotics|narcotics|mesh-ancestor
43615896|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615897|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615898|NCT03145272|Analgesics|analgesics|mesh-ancestor
43615924|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
43615925|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615926|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615927|NCT05254899|Antiviral Agents|antiviral agents|mesh-ancestor
43615928|NCT05254899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615929|NCT05254899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615930|NCT05254899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615931|NCT05254665|Docetaxel|docetaxel|mesh-list
43615932|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615933|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
43615934|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
43615935|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
43615936|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615937|NCT05254652|Pregabalin|pregabalin|mesh-list
43615938|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43615939|NCT05254652|Analgesics|analgesics|mesh-ancestor
43615940|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
43615941|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615942|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615943|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
43615944|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43615945|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43615974|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
43615975|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
43615976|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43615977|NCT05253781|Aspirin|aspirin|mesh-list
43615978|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615979|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615980|NCT05253781|Analgesics|analgesics|mesh-ancestor
43615982|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615983|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615984|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615985|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615986|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43615987|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43615988|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615989|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43615990|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43615991|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615992|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
43615993|NCT05253768|Glycerol|glycerol|mesh-list
43615994|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43615995|NCT05253768|Protective Agents|protective agents|mesh-ancestor
43615996|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615997|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43615998|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615999|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
43616000|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
43616027|NCT05012865|Axitinib|axitinib|mesh-list
43616134|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
43616028|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616029|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616030|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43616031|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616032|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616033|NCT04935476|Dapsone|dapsone|mesh-list
43616034|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616035|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
43616036|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43616037|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43616038|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43616039|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616040|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616041|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
43616042|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43616043|NCT04930107|Fluconazole|fluconazole|mesh-list
43616044|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
43616045|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616046|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43616047|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43616048|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616076|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43616077|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43616078|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
43616079|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616080|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616081|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43616082|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
43616083|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616084|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616085|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43616086|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43616087|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43616088|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43616089|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616090|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616091|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
43616092|NCT04850495|Hormones|hormones|mesh-ancestor
43616093|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616094|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43616095|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43616096|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
43616097|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
43616098|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616099|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43616100|NCT04824274|Fentanyl|fentanyl|mesh-list
43616101|NCT04824274|Morphine|morphine|mesh-list
43616102|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43616103|NCT04824274|Narcotics|narcotics|mesh-ancestor
43616104|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616105|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616106|NCT04824274|Analgesics|analgesics|mesh-ancestor
43616107|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
43616108|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616109|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43616110|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43616113|NCT04771923|Epinephrine|epinephrine|mesh-list
43616114|NCT04771923|Racepinephrine|racepinephrine|mesh-list
43616115|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
43616116|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
43616117|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43616118|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43616119|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616121|NCT04771923|Coagulants|coagulants|mesh-ancestor
43616122|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43616123|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43616124|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616125|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616126|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616127|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43616128|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43616129|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
43616130|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616131|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43616132|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
43616135|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43616168|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43616169|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616170|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43616171|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43616172|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616173|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
43616174|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43616175|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43616176|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43616177|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
43616178|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616179|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
43616181|NCT04688203|Analgesics|analgesics|mesh-ancestor
43616182|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
43616183|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616184|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616185|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
43616186|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616187|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43616188|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
43616189|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43616190|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43616191|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616192|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43616193|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
43616194|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43616195|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43616196|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43616197|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616198|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616199|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43616200|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
43616208|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
43616209|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616210|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43616211|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43616212|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616213|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616214|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43616215|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43616216|NCT04630938|Lidocaine|lidocaine|mesh-list
43616217|NCT04630938|Morphine|morphine|mesh-list
43616218|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
43616219|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
43616220|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616221|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616222|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
43616223|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616224|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43616225|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43616226|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43616227|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43616228|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616229|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43616230|NCT04630938|Narcotics|narcotics|mesh-ancestor
43616231|NCT04630938|Analgesics|analgesics|mesh-ancestor
43616232|NCT04624451|Dalbavancin|dalbavancin|mesh-list
43616233|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43616234|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616252|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616253|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616254|NCT04509973|Dexamethasone|dexamethasone|mesh-list
43616255|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616256|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
43616257|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
43616258|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616259|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616260|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43616261|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
43616263|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616264|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43616265|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616267|NCT04469959|Carbidopa|carbidopa|mesh-list
43616268|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43616269|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43616270|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43616271|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
43616272|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616273|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616274|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616275|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43616276|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616277|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43849393|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43616278|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
43616279|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
43616281|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
43616294|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616295|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43616296|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43616297|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43616298|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43616299|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43616300|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
43616301|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
43616302|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
43616303|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
43616304|NCT04352608|Vaccines|vaccines|mesh-list
43616305|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
43616306|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616307|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
43616308|NCT04346108|Antibodies|antibodies|mesh-list
43616309|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
43616310|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43616311|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43616312|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
43616313|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
43616314|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616315|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
43616316|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43616317|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43616318|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616319|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
43616320|NCT04233749|Coagulants|coagulants|mesh-ancestor
43616321|NCT04210180|Varenicline|varenicline|mesh-list
43616322|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43616323|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43616324|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
43616325|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616326|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616327|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616328|NCT04175886|Tofacitinib|tofacitinib|mesh-list
43616329|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43616330|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616334|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616335|NCT04031729|Analgesics|analgesics|mesh-ancestor
43616336|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
43616337|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616338|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616339|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616340|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616341|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43616342|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43616343|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616344|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43616345|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43616346|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616347|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
43616348|NCT03977363|Anticoagulants|anticoagulants|mesh-list
43616349|NCT03651206|Niraparib|niraparib|mesh-list
43616350|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43616351|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616352|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616353|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616354|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
43616355|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43616357|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616358|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616359|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43616360|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
43616361|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43616362|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43616363|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43616364|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616365|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616366|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616374|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616375|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616376|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43616377|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616378|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43616379|NCT03107871|Valganciclovir|valganciclovir|mesh-list
43616380|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
43616381|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616382|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
43616383|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43616384|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
43616385|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616386|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616387|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43616388|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
43616389|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
43616390|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43616391|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
43616392|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616393|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616395|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616396|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43616397|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
43616399|NCT03064113|Ipratropium|ipratropium|mesh-list
43616420|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
43616421|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616422|NCT02919683|Nivolumab|nivolumab|mesh-list
43616423|NCT02919683|Ipilimumab|ipilimumab|mesh-list
43616424|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616425|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616426|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43849394|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616427|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616428|NCT02890459|Denatonium|denatonium|mesh-list
43616429|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
43616430|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616431|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
43616432|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616433|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
43616434|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616435|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
43616436|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43616437|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616438|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43616439|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43616440|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616441|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616442|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616443|NCT02797275|Albuterol|albuterol|mesh-list
43616444|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43616445|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
43616446|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616447|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616448|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43616449|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
43616450|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
43616451|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43616452|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43616453|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43616455|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616456|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616457|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616458|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
43616460|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43616461|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616462|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43616463|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43616464|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616465|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616466|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616467|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43616468|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43616469|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43616470|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43616471|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43616472|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616473|NCT02669173|Bevacizumab|bevacizumab|mesh-list
43616505|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616506|NCT02586831|Exenatide|exenatide|mesh-list
43616507|NCT02586831|Aldesleukin|aldesleukin|mesh-list
43616508|NCT02586831|Adalimumab|adalimumab|mesh-list
43616509|NCT02586831|Interleukin-2|interleukin-2|mesh-list
43616510|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
43616511|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43616512|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616513|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616514|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616515|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616517|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
43616518|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616519|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616520|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43616521|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43616522|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
43616523|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616524|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43616525|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43616526|NCT02586831|Incretins|incretins|mesh-ancestor
43616527|NCT02586831|Hormones|hormones|mesh-ancestor
43616528|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616529|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
43616530|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43616540|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
43616554|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616555|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
43616556|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
43616557|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616558|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616559|NCT02129751|Bupropion|bupropion|mesh-list
43616560|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43616561|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
43616562|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43616563|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43616564|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43616565|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43616566|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616567|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
43616568|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616569|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616570|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43616571|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43616572|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616573|NCT01959633|Interferons|interferons|mesh-list
43616574|NCT01959633|Vemurafenib|vemurafenib|mesh-list
43616575|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616576|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
43616577|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616578|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43616579|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616580|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616581|NCT01936688|Etanercept|etanercept|mesh-list
43616582|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43616583|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616584|NCT01936688|Analgesics|analgesics|mesh-ancestor
43616594|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616596|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616597|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43616599|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616600|NCT01767675|Carboplatin|carboplatin|mesh-list
43616601|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616602|NCT00970866|Folic Acid|folic acid|mesh-list
43616603|NCT00970866|Micronutrients|micronutrients|mesh-list
43616604|NCT00970866|Trace Elements|trace elements|mesh-list
43616605|NCT00970866|Hematinics|hematinics|mesh-ancestor
43616606|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
43616607|NCT00970866|Vitamins|vitamins|mesh-ancestor
43616608|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616609|NCT00799396|Aspirin|aspirin|mesh-list
43616610|NCT00799396|Clopidogrel|clopidogrel|mesh-list
43616611|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43616612|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616613|NCT00799396|Analgesics|analgesics|mesh-ancestor
43616614|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
43616615|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616616|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616617|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616618|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616619|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43616620|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43616621|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616622|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43616623|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43616624|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616625|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
43616626|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43616627|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43616628|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43616629|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
43616635|NCT00069238|Vincristine|vincristine|mesh-list
43616636|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
43616637|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43616638|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
43616639|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616640|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616641|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43616642|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
43616643|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616644|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616645|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43616646|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43616647|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43616648|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43616649|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616650|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616651|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
43616653|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616690|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616691|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43616692|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616693|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616694|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
43616695|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616696|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616697|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43616698|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43616699|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616700|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
43616701|NCT03145025|Hormones|hormones|mesh-ancestor
43616702|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616703|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616704|NCT03144947|Docetaxel|docetaxel|mesh-list
43616705|NCT03144947|Trastuzumab|trastuzumab|mesh-list
43616706|NCT03144947|Pertuzumab|pertuzumab|mesh-list
43616707|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616708|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
43616709|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
43616710|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616711|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616712|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616714|NCT03144596|Alfuzosin|alfuzosin|mesh-list
43616715|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43616716|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43616717|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43616718|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616719|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616720|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616732|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616734|NCT03144778|Ipilimumab|ipilimumab|mesh-list
43616735|NCT03144778|Tremelimumab|tremelimumab|mesh-list
43616736|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
43616737|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43616738|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
43616739|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616740|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616741|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
43616742|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616743|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43616744|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616745|NCT03144843|Apatinib|apatinib|mesh-list
43616746|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616747|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43616748|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616749|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616750|NCT03144713|Terlipressin|terlipressin|mesh-list
43616751|NCT03144713|Midodrine|midodrine|mesh-list
43616752|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
43616753|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
43616754|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616755|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616756|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43616757|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43616758|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43616759|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43616760|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616761|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616763|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43616776|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616777|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616778|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616779|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616780|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616781|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616782|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616783|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
43616784|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616785|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616786|NCT03144453|Atropine|atropine|mesh-list
43616787|NCT03144453|Neostigmine|neostigmine|mesh-list
43616788|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43616789|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43616790|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43616791|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
43616792|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616793|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616794|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43616795|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
43616796|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
43616797|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
43616798|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43616799|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43616800|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
43616801|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616802|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616803|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43616804|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616805|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43616806|NCT03144401|Misoprostol|misoprostol|mesh-list
43616807|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43616808|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
43616817|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616818|NCT03144128|Vitamin D|vitamin d|mesh-list
43616819|NCT03144128|Vitamins|vitamins|mesh-ancestor
43616820|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
43616821|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616822|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43616824|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616826|NCT03143946|Vitamins|vitamins|mesh-list
43616827|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
43616828|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616829|NCT03143933|Fentanyl|fentanyl|mesh-list
43616830|NCT03143933|Propofol|propofol|mesh-list
43616831|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43616832|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616833|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616834|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43616835|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
43616836|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
43616837|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43616838|NCT03143933|Narcotics|narcotics|mesh-ancestor
43616839|NCT03143933|Analgesics|analgesics|mesh-ancestor
43616840|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
43616841|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616842|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43616869|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
43616870|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616871|NCT03143738|Anesthetics|anesthetics|mesh-list
43616872|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616873|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616874|NCT03143452|Lidocaine|lidocaine|mesh-list
43616875|NCT03143452|Tetracaine|tetracaine|mesh-list
43616877|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
43616878|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
43616879|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616880|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616881|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
43616882|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616883|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43616884|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43616885|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43616886|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43616887|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616888|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43616889|NCT03143465|Calcitonin|calcitonin|mesh-list
43616923|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616924|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616925|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616926|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43616927|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43616928|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43616929|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43616931|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
43616932|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
43616933|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
43616934|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
43616935|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43616936|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616938|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43616939|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616940|NCT03143036|Thalidomide|thalidomide|mesh-list
43616941|NCT03143036|Dexamethasone|dexamethasone|mesh-list
43616942|NCT03143036|Daratumumab|daratumumab|mesh-list
43616943|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43616944|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
43616945|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
43616946|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616947|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616948|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43616949|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
43616950|NCT03143036|Hormones|hormones|mesh-ancestor
43616951|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616952|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43616953|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616955|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
43616968|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43616969|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43616970|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43616971|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
43616972|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616973|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616974|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43616975|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
43616976|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43616977|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616978|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616979|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616980|NCT03143010|Analgesics|analgesics|mesh-ancestor
43616981|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
43616982|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616983|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43616984|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43616985|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43616986|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616987|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616988|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616989|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43616990|NCT03142776|Clarithromycin|clarithromycin|mesh-list
43616991|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617014|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43617016|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43617017|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617018|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
43617019|NCT03142763|Choline|choline|mesh-list
43617020|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
43617021|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43617022|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
43617023|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617025|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43617026|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
43617027|NCT03142620|Vitamin D|vitamin d|mesh-list
43617028|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
43617029|NCT03142620|Amoxicillin|amoxicillin|mesh-list
43617030|NCT03142620|Clarithromycin|clarithromycin|mesh-list
43617031|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
43617032|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43617033|NCT03142620|Esomeprazole|esomeprazole|mesh-list
43617034|NCT03142620|Vitamins|vitamins|mesh-ancestor
43617035|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
43617036|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617037|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43617038|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43617039|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617040|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617041|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43617042|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617043|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43617044|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617045|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617046|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43617047|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43617048|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43617049|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43617056|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
43617057|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617058|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43617059|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43617061|NCT03142516|Folic Acid|folic acid|mesh-list
43617062|NCT03142516|Fluorouracil|fluorouracil|mesh-list
43617063|NCT03142516|Irinotecan|irinotecan|mesh-list
43617064|NCT03142516|Panitumumab|panitumumab|mesh-list
43617065|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
43617066|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
43617067|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617068|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43617069|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617070|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617071|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
43617072|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617073|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43617074|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43617075|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617076|NCT03142516|Antidotes|antidotes|mesh-ancestor
43617077|NCT03142516|Protective Agents|protective agents|mesh-ancestor
43617078|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
43617079|NCT03142516|Vitamins|vitamins|mesh-ancestor
43617080|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
43617081|NCT03142516|Hematinics|hematinics|mesh-ancestor
43617082|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43617083|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
43617084|NCT03142165|Promethazine|promethazine|mesh-list
43617085|NCT03142165|Famotidine|famotidine|mesh-list
43617105|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43617106|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43617107|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43617108|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43617109|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43617110|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617111|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617112|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
43617113|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617114|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43617115|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43617117|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43617118|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
43617120|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43617121|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43617122|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617124|NCT03141827|Insulin|insulin|mesh-list
43617160|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617161|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617162|NCT03141645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43617163|NCT03141645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43617164|NCT03141645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617165|NCT03141645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43617166|NCT03141645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43617167|NCT03141918|Curcumin|curcumin|mesh-list
43617168|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43617169|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43617170|NCT03141918|Analgesics|analgesics|mesh-ancestor
43617171|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
43617172|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617173|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617174|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43617175|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617176|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617177|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617178|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617180|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43617181|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617183|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
43617184|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
43617185|NCT03141593|Vitamins|vitamins|mesh-list
43617186|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
43617187|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617188|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43617189|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43617190|NCT03141398|Pancrelipase|pancrelipase|mesh-list
43617192|NCT03141268|Lactulose|lactulose|mesh-list
43617204|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43617205|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617206|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617207|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617208|NCT03140982|Propofol|propofol|mesh-list
43617209|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43617210|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617211|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617212|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43617213|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
43617214|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
43617215|NCT03140956|Levodopa|levodopa|mesh-list
43617216|NCT03140956|Carbidopa|carbidopa|mesh-list
43617217|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43617218|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43617220|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617221|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617222|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617223|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43617224|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617225|NCT03140943|Thalidomide|thalidomide|mesh-list
43617226|NCT03140943|Dexamethasone|dexamethasone|mesh-list
43617227|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43617228|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
43617230|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617231|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617232|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617233|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
43617234|NCT03140943|Hormones|hormones|mesh-ancestor
43617235|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617236|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43617237|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617238|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617243|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43617244|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43617245|NCT03140943|Growth Substances|growth substances|mesh-ancestor
43617246|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
43617247|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
43617248|NCT03140553|Carboplatin|carboplatin|mesh-list
43617249|NCT03140553|Docetaxel|docetaxel|mesh-list
43617250|NCT03140553|Trastuzumab|trastuzumab|mesh-list
43617251|NCT03140553|Epirubicin|epirubicin|mesh-list
43617252|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617254|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617255|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617256|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43617257|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
43617258|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617259|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617260|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43617261|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
43617262|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
43617263|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
43617264|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43617265|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43617266|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43617267|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43617293|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43617294|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617295|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43617296|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617297|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
43617298|NCT03140449|Calcitriol|calcitriol|mesh-list
43617299|NCT03140449|Sirolimus|sirolimus|mesh-list
43617300|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617301|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617302|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43617303|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617304|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
43617305|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617306|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
43617307|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617308|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43617309|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43617310|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43617311|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617313|NCT03140449|Vitamins|vitamins|mesh-ancestor
43617314|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
43617315|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43617316|NCT03140709|Oxytocin|oxytocin|mesh-list
43617317|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
43617344|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
43617345|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617346|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43617347|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43617348|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43617349|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43617350|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617351|NCT03140332|Sorafenib|sorafenib|mesh-list
43617352|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617353|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43617354|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617355|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617356|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
43617357|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
43617358|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43617359|NCT03140397|Estrogens|estrogens|mesh-ancestor
43617360|NCT03140397|Hormones|hormones|mesh-ancestor
43617516|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617361|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617362|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617363|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
43617364|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
43617365|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617366|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
43617367|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617378|NCT03139708|Phenylephrine|phenylephrine|mesh-list
43617392|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43617393|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
43617394|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617395|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617396|NCT03139708|Protective Agents|protective agents|mesh-ancestor
43617397|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43617398|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43617399|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43617400|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43617401|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
43617403|NCT03140033|Ranitidine|ranitidine|mesh-list
43617404|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43617405|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43617406|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
43617407|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43617408|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617409|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43617410|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617411|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
43617412|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43617413|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
43617414|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
43617415|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617416|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617417|NCT03139474|Hormones|hormones|mesh-list
43617443|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617444|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43617445|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617446|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617447|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43617448|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43617449|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43617450|NCT03139253|Renal Agents|renal agents|mesh-ancestor
43617451|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43617452|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43617453|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617454|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43617455|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43617456|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43617457|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43617458|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43617459|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43617460|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
43617461|NCT03139591|Dexamethasone|dexamethasone|mesh-list
43617462|NCT03139591|Lidocaine|lidocaine|mesh-list
43617470|NCT03139591|Hormones|hormones|mesh-ancestor
43617495|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
43617496|NCT03139422|Coagulants|coagulants|mesh-ancestor
43617497|NCT03139513|Vemurafenib|vemurafenib|mesh-list
43617498|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617499|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43617500|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617501|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617502|NCT03139565|Vaccines|vaccines|mesh-list
43617503|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
43617504|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617505|NCT03139305|Glucagon|glucagon|mesh-list
43617506|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43617507|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617508|NCT03139305|Hormones|hormones|mesh-ancestor
43617509|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617510|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617511|NCT03139305|Incretins|incretins|mesh-ancestor
43617512|NCT03139500|Midazolam|midazolam|mesh-list
43617513|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43617514|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43617515|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617549|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617550|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617551|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
43617552|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617554|NCT03138785|Voriconazole|voriconazole|mesh-list
43617555|NCT03138785|Levofloxacin|levofloxacin|mesh-list
43617556|NCT03138785|Ofloxacin|ofloxacin|mesh-list
43617557|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
43617558|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617559|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43617560|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43617561|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617562|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617563|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43617564|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
43617565|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617566|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617567|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43617568|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43617569|NCT03138785|Renal Agents|renal agents|mesh-ancestor
43617570|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617571|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43617572|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43617573|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617574|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43617575|NCT03138616|Vitamin D|vitamin d|mesh-list
43617576|NCT03138616|Vitamins|vitamins|mesh-ancestor
43617577|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
43617578|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617579|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43617580|NCT03138499|Nivolumab|nivolumab|mesh-list
43617590|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
43617591|NCT03138356|Saxagliptin|saxagliptin|mesh-list
43617592|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43617593|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617594|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43617595|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617596|NCT03138356|Incretins|incretins|mesh-ancestor
43617597|NCT03138356|Hormones|hormones|mesh-ancestor
43617598|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617599|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43617600|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
43617601|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617602|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43617603|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43617604|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617605|NCT03138031|Ethanol|ethanol|mesh-list
43617606|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43617607|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617608|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617609|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617642|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617643|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617644|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43617646|NCT03137134|Esomeprazole|esomeprazole|mesh-list
43617647|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43617648|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617649|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43617650|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617651|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617652|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617653|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43617654|NCT03137368|Tamoxifen|tamoxifen|mesh-list
43617655|NCT03137368|Exemestane|exemestane|mesh-list
43617656|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43617657|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
43617658|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617659|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617660|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43617661|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617662|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43617663|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43617664|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43617665|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43617666|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43617667|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617668|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617669|NCT03137290|Neostigmine|neostigmine|mesh-list
43617670|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43617671|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617672|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617673|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
43617674|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617680|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43617681|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617682|NCT03137030|Acetaminophen|acetaminophen|mesh-list
43617683|NCT03137030|Hydrocodone|hydrocodone|mesh-list
43617684|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43617685|NCT03137030|Analgesics|analgesics|mesh-ancestor
43617686|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
43617687|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617688|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617689|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
43617690|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43617691|NCT03137030|Narcotics|narcotics|mesh-ancestor
43617692|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617693|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
43617694|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
43617695|NCT03137017|Acetaminophen|acetaminophen|mesh-list
43617696|NCT03137017|Hydrocodone|hydrocodone|mesh-list
43617697|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43617698|NCT03137017|Analgesics|analgesics|mesh-ancestor
43617699|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
43617700|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617701|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617703|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43617704|NCT03137017|Narcotics|narcotics|mesh-ancestor
43617705|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617706|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
43617707|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
43617708|NCT03137082|Guanfacine|guanfacine|mesh-list
43617709|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43617710|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43617726|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43617727|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43617728|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43617729|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617730|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43617731|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43617732|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43617733|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617734|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
43617735|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
43617736|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43617738|NCT03136705|Niacin|niacin|mesh-list
43617739|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
43617740|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
43617741|NCT03136705|Vitamins|vitamins|mesh-ancestor
43617742|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
43617743|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617744|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43617745|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
43617746|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617747|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43617748|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
43617749|NCT03136796|Meropenem|meropenem|mesh-list
43617750|NCT03136796|Piperacillin|piperacillin|mesh-list
43617751|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617752|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617753|NCT03136510|Apixaban|apixaban|mesh-list
43617754|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43617755|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
43617770|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617771|NCT03136237|Cyclosporine|cyclosporine|mesh-list
43617772|NCT03136237|Digoxin|digoxin|mesh-list
43617773|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43617774|NCT03136237|Cyclosporins|cyclosporins|mesh-list
43617775|NCT03136237|Berotralstat|berotralstat|mesh-list
43617776|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617777|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617779|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
43617780|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617781|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
43617782|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617783|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
43617787|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43617788|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
43617789|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43617790|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43617791|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43617792|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43617793|NCT03136237|Protective Agents|protective agents|mesh-ancestor
43617795|NCT03136406|Paclitaxel|paclitaxel|mesh-list
43617796|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
43617797|NCT03136406|Bevacizumab|bevacizumab|mesh-list
43617798|NCT03136406|Fluorouracil|fluorouracil|mesh-list
43617799|NCT03136406|Capecitabine|capecitabine|mesh-list
43617800|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
43617801|NCT03136406|Avelumab|avelumab|mesh-list
43617802|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43617803|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617804|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
43617805|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
43617806|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
43617807|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617808|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617809|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
43617810|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617811|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617812|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43617813|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
43617814|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43617815|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43617816|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43617817|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43617818|NCT03136406|Growth Substances|growth substances|mesh-ancestor
43617819|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
43617820|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
43617821|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43617822|NCT03136406|Antidotes|antidotes|mesh-ancestor
43617823|NCT03136406|Protective Agents|protective agents|mesh-ancestor
43617824|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
43617825|NCT03136406|Vitamins|vitamins|mesh-ancestor
43617826|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
43617827|NCT03135977|Etoposide|etoposide|mesh-list
43617828|NCT03135977|Apatinib|apatinib|mesh-list
43617829|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43617830|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617831|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43617832|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43617833|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617834|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617859|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617860|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617861|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43617862|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
43617864|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43617865|NCT03135795|Analgesics|analgesics|mesh-ancestor
43617866|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
43617867|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617868|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43617869|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43617870|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43617871|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
43617872|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617873|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617874|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
43617875|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43617876|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
43617877|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
43617878|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43617879|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43617880|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43617883|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43617884|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43617885|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43617886|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43617887|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43617903|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
43617904|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617905|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617906|NCT03135769|Avelumab|avelumab|mesh-list
43617907|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43617908|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617909|NCT03135340|Anesthetics|anesthetics|mesh-list
43617910|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617911|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617912|NCT03135171|Trastuzumab|trastuzumab|mesh-list
43617913|NCT03135171|Pertuzumab|pertuzumab|mesh-list
43617914|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43617915|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617916|NCT03135184|Coal Tar|coal tar|mesh-list
43617917|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
43617918|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
43617919|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
43617920|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43617921|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617922|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43617923|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617924|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617925|NCT03135106|Itraconazole|itraconazole|mesh-list
43617926|NCT03135106|Fluconazole|fluconazole|mesh-list
43617927|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
43617928|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849396|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43617929|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43617930|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43617931|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617932|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617933|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43617934|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
43617938|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43617939|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43617940|NCT03134872|Carboplatin|carboplatin|mesh-list
43617941|NCT03134872|Pemetrexed|pemetrexed|mesh-list
43617942|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617943|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617944|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617945|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43617946|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43617947|NCT03134677|Bupivacaine|bupivacaine|mesh-list
43617948|NCT03134677|Sevoflurane|sevoflurane|mesh-list
43617949|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
43617950|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
43617951|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617952|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617953|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
43617954|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617955|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43617956|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43617957|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
43617958|NCT03134729|Ropivacaine|ropivacaine|mesh-list
43617959|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
43617960|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
43617961|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617987|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617988|NCT03134443|Andrographolide|andrographolide|mesh-list
43617989|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43617990|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43617991|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43617992|NCT03134443|Analgesics|analgesics|mesh-ancestor
43617993|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
43617994|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617995|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617996|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617997|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43617998|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43617999|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618000|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
43618001|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43618002|NCT03134612|Lidocaine|lidocaine|mesh-list
43618003|NCT03134612|Ondansetron|ondansetron|mesh-list
43618004|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
43849397|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
43618005|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
43618006|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618007|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618008|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
43618009|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618010|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43618012|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43618036|NCT03134417|Vitamin D|vitamin d|mesh-list
43618037|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
43618038|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
43618039|NCT03134417|Vitamins|vitamins|mesh-list
43618040|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
43618041|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618042|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43618043|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43618044|NCT03134378|Amoxicillin|amoxicillin|mesh-list
43618045|NCT03134378|Clarithromycin|clarithromycin|mesh-list
43618046|NCT03134378|Rabeprazole|rabeprazole|mesh-list
43618047|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618048|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618049|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43618050|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618051|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618052|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43618053|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43618054|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43618055|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618056|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43618091|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43618092|NCT03133845|Narcotics|narcotics|mesh-ancestor
43618093|NCT03133845|Analgesics|analgesics|mesh-ancestor
43618094|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
43618095|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618096|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43618097|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43618098|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43618099|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43618100|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
43618101|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
43618102|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618103|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618104|NCT03133897|Dexamethasone|dexamethasone|mesh-list
43618105|NCT03133897|Prednisone|prednisone|mesh-list
43618106|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618107|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
43618108|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
43618109|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618110|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618111|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618112|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
43618113|NCT03133897|Hormones|hormones|mesh-ancestor
43618114|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43618115|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43618116|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618117|NCT03133923|Vaccines|vaccines|mesh-list
43618118|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
43618119|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618120|NCT03134001|Analgesics|analgesics|mesh-list
43618121|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
43618122|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618123|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618124|NCT03133780|Midazolam|midazolam|mesh-list
43618125|NCT03133780|Ketamine|ketamine|mesh-list
43618126|NCT03133780|Analgesics|analgesics|mesh-ancestor
43618132|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
43618133|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
43618134|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618135|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43618136|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43618138|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618139|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43618140|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43618141|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43618142|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43618143|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43618144|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
43618145|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
43618146|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
43618147|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618148|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618149|NCT03133234|Osimertinib|osimertinib|mesh-list
43618150|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618151|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618152|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618153|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618154|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
43618155|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849398|NCT03932643|TIC10 compound|tic10 compound|mesh-list
43618156|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
43618157|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43618159|NCT03133312|Povidone|povidone|mesh-list
43618160|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43618161|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618162|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
43618163|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
43618164|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
43618165|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
43618166|NCT03133195|Vitamin D|vitamin d|mesh-list
43618167|NCT03133195|Teriparatide|teriparatide|mesh-list
43618168|NCT03133195|Calcium|calcium|mesh-list
43618169|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
43618170|NCT03133195|Vitamins|vitamins|mesh-ancestor
43618171|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
43618173|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43618174|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43618175|NCT03133299|Vitamin D|vitamin d|mesh-list
43618176|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
43618177|NCT03133299|Vitamins|vitamins|mesh-ancestor
43618178|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
43618179|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618180|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43618181|NCT03133299|Hormones|hormones|mesh-ancestor
43618182|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43618183|NCT03132688|Propofol|propofol|mesh-list
43618184|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43618185|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618186|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618187|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43618188|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
43618189|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
43618190|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43618191|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43618192|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43618193|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43618194|NCT03132623|Andrographolide|andrographolide|mesh-list
43618195|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618196|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43618197|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618199|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
43618220|NCT03132610|Andrographolide|andrographolide|mesh-list
43618221|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618222|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43618223|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618224|NCT03132610|Analgesics|analgesics|mesh-ancestor
43618225|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
43618226|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618227|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618228|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43618229|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43618230|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43618231|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618232|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
43618233|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43618235|NCT03132701|Analgesics|analgesics|mesh-ancestor
43618236|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
43618237|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618238|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618239|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
43618241|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43618242|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
43618243|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43618244|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43618245|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618246|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43618247|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
43618248|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43618249|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
43618250|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
43618251|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43618252|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
43618262|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
43618263|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618265|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43618266|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618267|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43618268|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618269|NCT03132519|Remifentanil|remifentanil|mesh-list
43618270|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43618271|NCT03132519|Narcotics|narcotics|mesh-ancestor
43618272|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618273|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618274|NCT03132519|Analgesics|analgesics|mesh-ancestor
43618275|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
43618276|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618277|NCT03132233|Calcium|calcium|mesh-list
43618278|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43618279|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618280|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
43618317|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
43618318|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618319|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618320|NCT03132181|Empagliflozin|empagliflozin|mesh-list
43618321|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43618322|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618324|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618325|NCT03132103|Vitamin D|vitamin d|mesh-list
43618326|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
43618327|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
43618328|NCT03132103|Vitamins|vitamins|mesh-list
43618329|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
43618330|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618331|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43618332|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43618333|NCT03132168|Anesthetics|anesthetics|mesh-list
43618334|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618335|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618336|NCT03132025|Capecitabine|capecitabine|mesh-list
43618337|NCT03132025|Apatinib|apatinib|mesh-list
43618338|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43618339|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
43618340|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618341|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618342|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618343|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618363|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618364|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
43618366|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43618367|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43618368|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43618369|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43618370|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618371|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
43618372|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618373|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618374|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43618375|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618376|NCT03131843|Ethanol|ethanol|mesh-list
43618377|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43618378|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618379|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618380|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618382|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
43618383|NCT03131973|Methotrexate|methotrexate|mesh-list
43618384|NCT03131973|Digoxin|digoxin|mesh-list
43618385|NCT03131973|Midazolam|midazolam|mesh-list
43618386|NCT03131973|Caffeine|caffeine|mesh-list
43618387|NCT03131973|Omeprazole|omeprazole|mesh-list
43618388|NCT03131973|Pravastatin|pravastatin|mesh-list
43618389|NCT03131973|Montelukast|montelukast|mesh-list
43618390|NCT03131973|Branebrutinib|branebrutinib|mesh-list
43618391|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43618392|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
43618393|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43618394|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618395|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43618396|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
43618397|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618398|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618399|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
43618400|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618402|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43618403|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
43618404|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43618405|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43618406|NCT03131973|Antidotes|antidotes|mesh-ancestor
43618407|NCT03131973|Protective Agents|protective agents|mesh-ancestor
43618408|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
43618410|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
43618411|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43618412|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43618413|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618414|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43618415|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43618416|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43618417|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43618418|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
43618419|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
43618420|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
43618421|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
43618422|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618423|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43618424|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618425|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43618426|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43618427|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43618428|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43618448|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618449|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618450|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43618451|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618452|NCT03131882|Triamcinolone|triamcinolone|mesh-list
43618453|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43618454|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43618455|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
43618456|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43618457|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618458|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
43618459|NCT03131882|Hormones|hormones|mesh-ancestor
43618460|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43618461|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618462|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43618463|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
43618464|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618465|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618466|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43618503|NCT03131050|Citalopram|citalopram|mesh-list
43618504|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43618505|NCT03131050|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43618506|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43618507|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43618508|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618509|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618510|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
43618511|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618512|NCT03131050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43618513|NCT03131050|Antidepressive Agents|antidepressive agents|mesh-ancestor
43618514|NCT03131050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43618515|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
43618516|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
43618517|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618518|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43618519|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43618520|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
43618521|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43618522|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
43618523|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618524|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
43618525|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43618526|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618527|NCT03131037|Valacyclovir|valacyclovir|mesh-list
43618528|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
43618529|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618531|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618532|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618533|NCT03130855|Carticaine|carticaine|mesh-list
43618535|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
43618548|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43618549|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43618550|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
43618551|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
43618552|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
43618553|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
43618554|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618555|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618556|NCT03130829|Fucoidan|fucoidan|mesh-list
43618557|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43618558|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618559|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
43618560|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618561|NCT03130764|Durvalumab|durvalumab|mesh-list
43618562|NCT03130764|Tremelimumab|tremelimumab|mesh-list
43618563|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43618564|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618565|NCT03130504|Progesterone|progesterone|mesh-list
43618566|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43618567|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
43618568|NCT03130504|Progestins|progestins|mesh-ancestor
43618569|NCT03130504|Hormones|hormones|mesh-ancestor
43618570|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43618571|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618572|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43618573|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
43618574|NCT03130634|Silymarin|silymarin|mesh-list
43618575|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
43618576|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618577|NCT03130634|Protective Agents|protective agents|mesh-ancestor
43618578|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618579|NCT03130556|Rabeprazole|rabeprazole|mesh-list
43618580|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43618581|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618582|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43618589|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
43618590|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618591|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618592|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43618593|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43618594|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43618595|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618596|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618597|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43618598|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43618599|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43618600|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618602|NCT03130426|Insulin|insulin|mesh-list
43618603|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43618604|NCT03130426|Metformin|metformin|mesh-list
43618605|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
43618606|NCT03130426|Lixisenatide|lixisenatide|mesh-list
43618607|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43618608|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618609|NCT03130582|Etoposide|etoposide|mesh-list
43618610|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43618611|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618612|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43618613|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43618614|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618615|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618616|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
43618636|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43618637|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43618638|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618639|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
43618640|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618641|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618642|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
43618643|NCT03130179|Nicotine|nicotine|mesh-list
43618644|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43618645|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
43618646|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618647|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618648|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43618649|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43618650|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
43618651|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618652|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618653|NCT03130010|Nefopam|nefopam|mesh-list
43618654|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618655|NCT03130010|Analgesics|analgesics|mesh-ancestor
43618669|NCT03130153|Aspirin|aspirin|mesh-list
43618688|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
43618689|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
43618690|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
43618691|NCT03130114|Azithromycin|azithromycin|mesh-list
43618692|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618693|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618695|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618696|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618697|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618698|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618699|NCT03130101|Insulin|insulin|mesh-list
43618700|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43618701|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618703|NCT03129646|Miltefosine|miltefosine|mesh-list
43618704|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
43618705|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618706|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618707|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43618708|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43618709|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
43618710|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618711|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
43618712|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43618713|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
43618714|NCT03129594|Glucagon|glucagon|mesh-list
43618715|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43618716|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618739|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618740|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618741|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
43618742|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
43618743|NCT03129555|Apixaban|apixaban|mesh-list
43618744|NCT03129555|Edoxaban|edoxaban|mesh-list
43618745|NCT03129555|Dabigatran|dabigatran|mesh-list
43618746|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43618747|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
43618748|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43618749|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
43618750|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618751|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618752|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
43618753|NCT03129542|Midodrine|midodrine|mesh-list
43618754|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
43618755|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
43618756|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618757|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618796|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43618797|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618798|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43618799|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618801|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
43620381|NCT04631029|Carboplatin|carboplatin|mesh-list
43618803|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618804|NCT03128216|Bupivacaine|bupivacaine|mesh-list
43618805|NCT03128216|Ropivacaine|ropivacaine|mesh-list
43618806|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
43618807|NCT03128216|Anesthetics|anesthetics|mesh-list
43618808|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618809|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618810|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
43618811|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618813|NCT03128346|Acetaminophen|acetaminophen|mesh-list
43618814|NCT03128346|Fentanyl|fentanyl|mesh-list
43618815|NCT03128346|Hydromorphone|hydromorphone|mesh-list
43618816|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43618817|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618818|NCT03128346|Analgesics|analgesics|mesh-ancestor
43618819|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
43618820|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618847|NCT03127800|Analgesics|analgesics|mesh-ancestor
43618853|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43618854|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
43618855|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43618856|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
43618857|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
43618858|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618859|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618860|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618861|NCT03127371|Analgesics|analgesics|mesh-ancestor
43618862|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
43618863|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618864|NCT03127449|Aflutinib|aflutinib|mesh-list
43618865|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618866|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618867|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618868|NCT03127137|Triamcinolone|triamcinolone|mesh-list
43618869|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43618870|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43618871|NCT03127137|Lidocaine|lidocaine|mesh-list
43618872|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43618873|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
43618874|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
43618875|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618876|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618877|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
43618878|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618879|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43618880|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43618881|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43618882|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43618883|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618884|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618886|NCT03127137|Hormones|hormones|mesh-ancestor
43618887|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43618888|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43618889|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
43618890|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618891|NCT03127319|Docetaxel|docetaxel|mesh-list
43618892|NCT03127319|Apatinib|apatinib|mesh-list
43618893|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618894|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
43618895|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
43618896|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
43618897|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618898|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618899|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618900|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43618901|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43618906|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43618908|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618909|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
43618910|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618911|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43618912|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43618913|NCT03127124|Leucovorin|leucovorin|mesh-list
43618922|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618924|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618925|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43618926|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
43618927|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43618928|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43618929|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43618930|NCT03127124|Growth Substances|growth substances|mesh-ancestor
43618931|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
43618932|NCT03127124|Antidotes|antidotes|mesh-ancestor
43618933|NCT03127124|Protective Agents|protective agents|mesh-ancestor
43618934|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
43618935|NCT03127124|Vitamins|vitamins|mesh-ancestor
43618936|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
43618937|NCT03127046|Aceclofenac|aceclofenac|mesh-list
43618938|NCT03127046|Diclofenac|diclofenac|mesh-list
43618939|NCT03127046|Esomeprazole|esomeprazole|mesh-list
43618940|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43618941|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618942|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43618943|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618944|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618945|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43618946|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618947|NCT03127046|Analgesics|analgesics|mesh-ancestor
43618948|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
43618949|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618969|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43618970|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
43618971|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618972|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618973|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43618974|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43618975|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
43618977|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43618978|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43618979|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618980|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618981|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43618982|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43618983|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43618984|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43849401|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849402|NCT03930771|Capecitabine|capecitabine|mesh-list
43618985|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
43618986|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
43618987|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
43618988|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
43618989|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618999|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619000|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43619001|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619003|NCT03126721|Midazolam|midazolam|mesh-list
43619004|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43619005|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43619006|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619007|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619008|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43619053|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43619054|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619055|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43619056|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619058|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43619059|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
43619060|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43619061|NCT03126188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43619062|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43619063|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619064|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619065|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619066|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
43619067|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619068|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43619108|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619109|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43619111|NCT03126097|Hormones|hormones|mesh-ancestor
43619112|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619113|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43619114|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
43619115|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43619116|NCT03126097|Diuretics|diuretics|mesh-ancestor
43619117|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
43619118|NCT03126071|Bevacizumab|bevacizumab|mesh-list
43619119|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
43619170|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619171|NCT03125486|Belimumab|belimumab|mesh-list
43619172|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619173|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
43619174|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619175|NCT03125473|Vaccines|vaccines|mesh-list
43619176|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
43619177|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619178|NCT03125187|Heparin|heparin|mesh-list
43619179|NCT03125187|Calcium heparin|calcium heparin|mesh-list
43619180|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
43619181|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43619182|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43619183|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619184|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43619185|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
43619186|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619187|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
43619188|NCT03124680|Narcotics|narcotics|mesh-ancestor
43619189|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619190|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619191|NCT03124680|Analgesics|analgesics|mesh-ancestor
43619192|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
43619193|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619194|NCT03124524|Dienogest|dienogest|mesh-list
43619195|NCT03124524|Drospirenone|drospirenone|mesh-list
43619196|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43619197|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43619198|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43619199|NCT03124524|Estradiol|estradiol|mesh-list
43619218|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619219|NCT03124420|Amoxicillin|amoxicillin|mesh-list
43619220|NCT03124420|Clarithromycin|clarithromycin|mesh-list
43619221|NCT03124420|Lansoprazole|lansoprazole|mesh-list
43619222|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
43619223|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43619224|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619225|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43619226|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619227|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619228|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43619229|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43619280|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
43849403|NCT03930771|Temozolomide|temozolomide|mesh-list
43619281|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43849404|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619282|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43619283|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43619284|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619285|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
43619286|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
43619287|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
43619288|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619289|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
43619292|NCT03123744|Palbociclib|palbociclib|mesh-list
43619335|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619337|NCT03123445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619338|NCT03123445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619339|NCT03123445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619340|NCT03123445|Immunologic Factors|immunologic factors|mesh-ancestor
43619341|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619342|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43619343|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43619344|NCT03123445|Growth Substances|growth substances|mesh-ancestor
43619345|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
43619346|NCT03123276|Gemcitabine|gemcitabine|mesh-list
43619347|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
43619348|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619349|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
43619351|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619394|NCT03122730|Epoprostenol|epoprostenol|mesh-list
43619395|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43619396|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43619397|NCT03122756|Dexamethasone|dexamethasone|mesh-list
43619398|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43619399|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
43619400|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
43619401|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619402|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619462|NCT03121963|Hydrocodone|hydrocodone|mesh-list
43619463|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619464|NCT03121963|Analgesics|analgesics|mesh-ancestor
43619465|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
43619466|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619467|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619468|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
43619469|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43619470|NCT03121963|Narcotics|narcotics|mesh-ancestor
43619471|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619472|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43619473|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43619474|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43619475|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43619476|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43619477|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619478|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619479|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
43619480|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43619481|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43619482|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43619515|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619516|NCT03122314|Acetaminophen|acetaminophen|mesh-list
43619517|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43619518|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619519|NCT03122314|Analgesics|analgesics|mesh-ancestor
43619520|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
43619521|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619522|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619523|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
43619578|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619580|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
43619584|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
43619586|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43619587|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619588|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43619589|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619590|NCT03121313|Tegafur|tegafur|mesh-list
43619595|NCT03121352|Paclitaxel|paclitaxel|mesh-list
43619640|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43619641|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
43619642|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619643|NCT03121222|Protective Agents|protective agents|mesh-ancestor
43619644|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619645|NCT03121222|Antidotes|antidotes|mesh-ancestor
43619646|NCT03120962|Famciclovir|famciclovir|mesh-list
43619647|NCT03120962|Oxycodone|oxycodone|mesh-list
43619648|NCT03120962|Gabapentin|gabapentin|mesh-list
43619649|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43619650|NCT03120962|Narcotics|narcotics|mesh-ancestor
43619651|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619652|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619653|NCT03120962|Analgesics|analgesics|mesh-ancestor
43619687|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43619688|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43619689|NCT03120923|Lidocaine|lidocaine|mesh-list
43619690|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43619691|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
43619692|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
43619693|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619694|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619695|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
43619696|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619697|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43619698|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43619699|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43619700|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619704|NCT03120923|Hormones|hormones|mesh-ancestor
43619748|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
43619749|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43619750|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
43619751|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43619752|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619753|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
43619754|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619755|NCT03120468|Expectorants|expectorants|mesh-ancestor
43619756|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
43619757|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43619758|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
43619759|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619760|NCT03120468|Protective Agents|protective agents|mesh-ancestor
43619761|NCT03120468|Antidotes|antidotes|mesh-ancestor
43619762|NCT03120715|Heparin|heparin|mesh-list
43619763|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43619764|NCT03120715|Tinzaparin|tinzaparin|mesh-list
43619765|NCT03120715|Dalteparin|dalteparin|mesh-list
43619801|NCT03120663|Amoxicillin|amoxicillin|mesh-list
43619802|NCT03120663|Clindamycin|clindamycin|mesh-list
43619803|NCT03120663|Meropenem|meropenem|mesh-list
43619804|NCT03120663|Tazobactam|tazobactam|mesh-list
43619805|NCT03120663|Piperacillin|piperacillin|mesh-list
43619806|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
43619807|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
43619808|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43619809|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43619811|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619812|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43619814|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619815|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43619816|NCT03120273|Lansoprazole|lansoprazole|mesh-list
43619817|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
43619818|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43619819|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43619837|NCT05465330|Propofol|propofol|mesh-list
43619858|NCT05464979|Midazolam|midazolam|mesh-list
43619859|NCT05464979|Ketamine|ketamine|mesh-list
43619860|NCT05464979|Esketamine|esketamine|mesh-list
43619861|NCT05464979|Analgesics|analgesics|mesh-ancestor
43619862|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
43619863|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619864|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619865|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43619866|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43619867|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
43619868|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
43619869|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619870|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43619871|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43619872|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619873|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619874|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43619875|NCT05464979|Narcotics|narcotics|mesh-ancestor
43619876|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43619877|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43619878|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43619879|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43619880|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43619881|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
43619882|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
43619883|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
43619884|NCT05464966|Insulin|insulin|mesh-list
43619885|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43619886|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619887|NCT05464953|Triamcinolone|triamcinolone|mesh-list
43619903|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619904|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619905|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
43619906|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619907|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43619908|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43619909|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43619910|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619911|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619913|NCT05464745|Indapamide|indapamide|mesh-list
43619914|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43619915|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
43619916|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619917|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619918|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43619919|NCT05464745|Diuretics|diuretics|mesh-ancestor
43619920|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
43619921|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619924|NCT05464615|Amoxicillin|amoxicillin|mesh-list
43619955|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619957|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43619958|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619959|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619960|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
43619961|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43619962|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43619963|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43619964|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620016|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43620017|NCT05463588|Methamphetamine|methamphetamine|mesh-list
43620018|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43620019|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620020|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
43620021|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
43620022|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620086|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
43620087|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620088|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43620089|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43620090|NCT05461339|Growth Substances|growth substances|mesh-ancestor
43620091|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
43620092|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620093|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
43620094|NCT05460338|Vitamin D|vitamin d|mesh-list
43620095|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43620096|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620097|NCT05460338|Vitamins|vitamins|mesh-ancestor
43620098|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
43620099|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43620100|NCT05456269|Cytarabine|cytarabine|mesh-list
43620101|NCT05456269|Decitabine|decitabine|mesh-list
43620102|NCT05456269|Bisantrene|bisantrene|mesh-list
43620103|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43620145|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
43620146|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
43620147|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43620148|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620149|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
43620150|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620151|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
43620152|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620153|NCT05373225|Acetic Acid|acetic acid|mesh-list
43620154|NCT05373225|Retinol acetate|retinol acetate|mesh-list
43620155|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43620163|NCT05341323|Ketamine|ketamine|mesh-list
43620210|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620211|NCT05272826|Dexamethasone|dexamethasone|mesh-list
43620212|NCT05272826|Bortezomib|bortezomib|mesh-list
43620213|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43620214|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
43620215|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
43620216|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620217|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620218|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43620219|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
43620220|NCT05272826|Hormones|hormones|mesh-ancestor
43620221|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43620222|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43620224|NCT05265650|Nivolumab|nivolumab|mesh-list
43620225|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620226|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620227|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43620228|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620270|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
43620271|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620272|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43620273|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43620274|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43620275|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
43620276|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620277|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620278|NCT04975919|Decitabine|decitabine|mesh-list
43620279|NCT04975919|Venetoclax|venetoclax|mesh-list
43620280|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43620281|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
43620282|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620283|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620284|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620285|NCT04965506|Dulaglutide|dulaglutide|mesh-list
43620286|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43620287|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620288|NCT04964024|Antibodies|antibodies|mesh-list
43620289|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
43620290|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620291|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
43620292|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43620293|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620294|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
43620295|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
43620296|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43620297|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43620298|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43620299|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620301|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
43620313|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620314|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43620317|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43620318|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43620319|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620320|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
43620321|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
43620322|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620323|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
43620324|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43620325|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620326|NCT04791475|Analgesics|analgesics|mesh-ancestor
43620327|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43620328|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43620329|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43620330|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
43620331|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620332|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620333|NCT04780568|Osimertinib|osimertinib|mesh-list
43620334|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620335|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43620366|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
43620367|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620368|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
43620369|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43620370|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
43620371|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620372|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43620373|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
43620374|NCT04665531|Ropivacaine|ropivacaine|mesh-list
43620375|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
43620376|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
43620377|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620378|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620379|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
43620380|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620390|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43620391|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43620392|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43620393|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620394|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620395|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
43620396|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620410|NCT04527055|Metronidazole|metronidazole|mesh-list
43620411|NCT04527055|Tetracycline|tetracycline|mesh-list
43620412|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43620413|NCT04527055|Esomeprazole|esomeprazole|mesh-list
43620414|NCT04527055|Bismuth|bismuth|mesh-list
43620415|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620416|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43620417|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43620418|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43620419|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43620420|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43620421|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43620422|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620423|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620424|NCT04527055|Antacids|antacids|mesh-ancestor
43620425|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43620426|NCT04491695|Tirofiban|tirofiban|mesh-list
43620427|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43620428|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43620429|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620430|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43620431|NCT04491084|Antibodies|antibodies|mesh-list
43620432|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
43620433|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
43620434|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620435|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43620436|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43620437|NCT04491084|Protective Agents|protective agents|mesh-ancestor
43620438|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
43620439|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43620457|NCT04335201|Defibrotide|defibrotide|mesh-list
43620458|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43620459|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43620460|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620461|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43620462|NCT04328714|Interferons|interferons|mesh-list
43620463|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
43849414|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
43620464|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620465|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
43620466|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620468|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43620469|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43620470|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
43620471|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620472|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620473|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620474|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
43620475|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43620476|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43620477|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43620478|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43620479|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620480|NCT04307329|Trastuzumab|trastuzumab|mesh-list
43620481|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620482|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620483|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
43620484|NCT04267120|Lenvatinib|lenvatinib|mesh-list
43620485|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620486|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620487|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43620488|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620497|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620498|NCT04239339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43620499|NCT04239339|Antidepressive Agents|antidepressive agents|mesh-ancestor
43620500|NCT04239339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43620502|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43620503|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620504|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620505|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43620506|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620507|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
43620508|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
43620509|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43620556|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43620557|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
43620558|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620559|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620560|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43620561|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43620562|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43620563|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43620564|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43620565|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
43620566|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
43620567|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
43620568|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
43620569|NCT03988205|Cytarabine|cytarabine|mesh-list
43620570|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43620571|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
43620572|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620573|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620574|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
43620575|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620577|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
43620613|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43620614|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620615|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
43620616|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
43620617|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
43620618|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620619|NCT03934905|Sulforaphane|sulforaphane|mesh-list
43620620|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43620621|NCT03934905|Protective Agents|protective agents|mesh-ancestor
43620622|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620623|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620627|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620628|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620629|NCT03928275|Analgesics|analgesics|mesh-ancestor
43620630|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
43620631|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620632|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620633|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43620634|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43620635|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
43620636|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620637|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43620638|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
43620639|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
43620640|NCT03919526|Fludarabine|fludarabine|mesh-list
43620641|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43620642|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
43620643|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620644|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43620645|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43620646|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
43620647|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620648|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620649|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43620650|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
43620651|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43620652|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620653|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620655|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43620656|NCT03798080|Metformin|metformin|mesh-list
43620657|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
43620658|NCT03798080|Lixisenatide|lixisenatide|mesh-list
43620659|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43620660|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620661|NCT03798054|Insulin|insulin|mesh-list
43620662|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43620663|NCT03798054|Metformin|metformin|mesh-list
43620666|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43620668|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620669|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620670|NCT03778372|Methadone|methadone|mesh-list
43620671|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43620672|NCT03778372|Narcotics|narcotics|mesh-ancestor
43620673|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620674|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620675|NCT03778372|Analgesics|analgesics|mesh-ancestor
43620676|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
43620699|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
43620700|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43620701|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
43620702|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43620703|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43620704|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
43620705|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
43620706|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620707|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620708|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43620709|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
43620711|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43620712|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43620713|NCT03511625|Protective Agents|protective agents|mesh-ancestor
43620714|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43620715|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620716|NCT03377049|Acetazolamide|acetazolamide|mesh-list
43620717|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
43620721|NCT03377049|Diuretics|diuretics|mesh-ancestor
43620755|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620756|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620757|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43620758|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43620759|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43620760|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43620761|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620762|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43620763|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43620764|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620766|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43620768|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43620769|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
43620770|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
43620771|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
43620772|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43620773|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
43620774|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620812|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43620813|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43620814|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
43620815|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
43620816|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620817|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43620818|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620819|NCT02314559|Propofol|propofol|mesh-list
43620820|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43620821|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620822|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620823|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43620824|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
43620825|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
43620826|NCT02189798|Imidacloprid|imidacloprid|mesh-list
43620827|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
43620828|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620829|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620830|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620831|NCT02167945|Ritonavir|ritonavir|mesh-list
43620832|NCT02167945|Ribavirin|ribavirin|mesh-list
43620833|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43620834|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43620835|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
43620836|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620837|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620861|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
43620862|NCT01552434|Antibodies|antibodies|mesh-list
43620863|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
43620864|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43620865|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
43620866|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620867|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43620868|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43620869|NCT01552434|Growth Substances|growth substances|mesh-ancestor
43620870|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620871|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
43620872|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
43620873|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43620874|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620875|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43620876|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
43620877|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43620878|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620879|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
43620880|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620881|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
43620882|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620883|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
43620884|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43620885|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620886|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43620887|NCT01236547|Paclitaxel|paclitaxel|mesh-list
43620888|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43620889|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43620890|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620891|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
43620892|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
43620893|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
43620895|NCT01204684|Poly ICLC|poly iclc|mesh-list
43620904|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620905|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43620906|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43620907|NCT01191697|Growth Substances|growth substances|mesh-ancestor
43620908|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620909|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
43620910|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43620911|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
43620912|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620913|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
43620914|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43620915|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849415|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620916|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620917|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43620918|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620919|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43620920|NCT00238420|Paclitaxel|paclitaxel|mesh-list
43620921|NCT00238420|Trastuzumab|trastuzumab|mesh-list
43620922|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43620925|NCT00238420|Antibodies|antibodies|mesh-list
43620955|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
43620956|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620957|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620958|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43620959|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43620960|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
43620961|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
43620962|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43620963|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43620964|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43620965|NCT03120234|Narcotics|narcotics|mesh-ancestor
43620966|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43620967|NCT03119857|Docetaxel|docetaxel|mesh-list
43620968|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
43620969|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620970|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
43620971|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
43620972|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
43620973|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621009|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43621011|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621012|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43621013|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
43621014|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621015|NCT03119454|Betamethasone|betamethasone|mesh-list
43621016|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
43621017|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43621018|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
43621019|NCT03119454|Hormones|hormones|mesh-ancestor
43621020|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621021|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621062|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621063|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43621065|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43621066|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621067|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621068|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43621069|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43621070|NCT03119324|Nimesulide|nimesulide|mesh-list
43621071|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43621072|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621073|NCT03119324|Analgesics|analgesics|mesh-ancestor
43621074|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
43621075|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621076|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621077|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43621078|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43621079|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43621080|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621117|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43621118|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621119|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621120|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43621121|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
43621122|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
43621123|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43621124|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43621125|NCT03118336|Empagliflozin|empagliflozin|mesh-list
43621126|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43621127|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621128|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43621129|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621130|NCT03118167|Antioxidants|antioxidants|mesh-list
43621131|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621132|NCT03118167|Protective Agents|protective agents|mesh-ancestor
43621133|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621134|NCT03118037|Zaleplon|zaleplon|mesh-list
43621135|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
43621170|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
43621171|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621172|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43621173|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43621174|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43621175|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
43621176|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621177|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621178|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43621179|NCT03117790|Narcotics|narcotics|mesh-ancestor
43621180|NCT03117894|Acetaminophen|acetaminophen|mesh-list
43621181|NCT03117894|Etoricoxib|etoricoxib|mesh-list
43621182|NCT03117894|Morphine|morphine|mesh-list
43621183|NCT03117894|Remifentanil|remifentanil|mesh-list
43621184|NCT03117894|Ondansetron|ondansetron|mesh-list
43621185|NCT03117894|Propofol|propofol|mesh-list
43621186|NCT03117894|Ropivacaine|ropivacaine|mesh-list
43621187|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43621191|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
43621228|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621230|NCT03117998|Volagidemab|volagidemab|mesh-list
43621231|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43621880|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
43621232|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621234|NCT03117595|Morphine|morphine|mesh-list
43621235|NCT03117595|Bupivacaine|bupivacaine|mesh-list
43621236|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
43621237|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
43621238|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621239|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621240|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
43621242|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43621290|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
43621291|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621292|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43621293|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43621294|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43621295|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43621296|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621297|NCT03116971|Cisplatin|cisplatin|mesh-list
43621298|NCT03116971|Etoposide|etoposide|mesh-list
43621299|NCT03116971|Peposertib|peposertib|mesh-list
43621300|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621301|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43621302|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43621303|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43621304|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621305|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621345|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
43621346|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43621347|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43621348|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43621349|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43621350|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43621351|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43621352|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43621353|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43621354|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
43621355|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43621356|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43621357|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
43621358|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621359|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
43621360|NCT03116776|Protective Agents|protective agents|mesh-ancestor
43621361|NCT03116737|Benzocaine|benzocaine|mesh-list
43621402|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43621403|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43621404|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621405|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621406|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621407|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43621409|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43621410|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43621411|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43621412|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43621413|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621414|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43621415|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621460|NCT03116087|Androgens|androgens|mesh-ancestor
43621462|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621463|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621464|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43621465|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621466|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
43621467|NCT03116308|Opicapone|opicapone|mesh-list
43621468|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43621469|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621470|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621471|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43621472|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43621473|NCT03116282|Ethanol|ethanol|mesh-list
43621474|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43621475|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621476|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621478|NCT03116295|Opicapone|opicapone|mesh-list
43621479|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43621480|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621481|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621482|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43621483|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43621484|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
43621490|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43621491|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621493|NCT03115736|Tenofovir|tenofovir|mesh-list
43621504|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
43621505|NCT03115775|Vitamins|vitamins|mesh-list
43621506|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
43621507|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621508|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43621509|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43621510|NCT03115489|Ketamine|ketamine|mesh-list
43621511|NCT03115489|Propofol|propofol|mesh-list
43621512|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43621513|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621514|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621515|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43621516|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
43621517|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
43621518|NCT03115489|Analgesics|analgesics|mesh-ancestor
43621519|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
43621520|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621521|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43621522|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43621523|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43621524|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621525|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621526|NCT03115762|Bevacizumab|bevacizumab|mesh-list
43621527|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43621528|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621529|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43621530|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43621531|NCT03115762|Growth Substances|growth substances|mesh-ancestor
43621532|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621533|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
43621534|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43621535|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
43621536|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43621537|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
43621538|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43621539|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621540|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43621541|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43621542|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621543|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43621544|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43621545|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621546|NCT03115619|Pirfenidone|pirfenidone|mesh-list
43621547|NCT03115619|Analgesics|analgesics|mesh-ancestor
43621548|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
43621549|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621550|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621556|NCT03115255|Ranibizumab|ranibizumab|mesh-list
43621593|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621594|NCT03115099|Incretins|incretins|mesh-ancestor
43621595|NCT03115099|Hormones|hormones|mesh-ancestor
43621596|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621597|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43621598|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
43621599|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621600|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621601|NCT03114813|Carvedilol|carvedilol|mesh-list
43621602|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43621603|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43621604|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
43621605|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621606|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621607|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621608|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43621610|NCT03114813|Protective Agents|protective agents|mesh-ancestor
43621611|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43621612|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43621613|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43621614|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
43621615|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43621641|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621642|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
43621643|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
43621644|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621645|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
43621646|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621647|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621648|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
43621649|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43621650|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43621651|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43621652|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43621653|NCT03114215|Biotin|biotin|mesh-list
43621654|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
43621655|NCT03114215|Vitamins|vitamins|mesh-ancestor
43621656|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
43621657|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621658|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43621659|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
43621660|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43621661|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
43621662|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621663|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
43621693|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43621694|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621695|NCT03113344|Amoxicillin|amoxicillin|mesh-list
43621696|NCT03113344|Azithromycin|azithromycin|mesh-list
43621697|NCT03113344|Meropenem|meropenem|mesh-list
43621698|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
43621699|NCT03113344|Penicillins|penicillins|mesh-list
43621700|NCT03113344|Imipenem|imipenem|mesh-list
43621701|NCT03113344|Erythromycin|erythromycin|mesh-list
43621702|NCT03113344|Ceftazidime|ceftazidime|mesh-list
43621703|NCT03113344|Ampicillin|ampicillin|mesh-list
43621704|NCT03113344|Cephalosporins|cephalosporins|mesh-list
43621705|NCT03113344|Acyclovir|acyclovir|mesh-list
43621706|NCT03113344|Ganciclovir|ganciclovir|mesh-list
43621707|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
43621708|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43621709|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621710|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621711|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621712|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43621713|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43621714|NCT03113084|Heparin|heparin|mesh-list
43621715|NCT03113084|Calcium heparin|calcium heparin|mesh-list
43621716|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
43621717|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43621718|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43621719|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621720|NCT03113266|Antibodies|antibodies|mesh-list
43621721|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43621722|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
43621723|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621724|NCT03113019|Vaccines|vaccines|mesh-list
43621725|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
43621726|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621737|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43621738|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43621739|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621740|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621741|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43621742|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
43621743|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
43621744|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621745|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43621746|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
43621747|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621749|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
43621750|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43621751|NCT03112889|Valproic Acid|valproic acid|mesh-list
43621752|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
43621753|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621754|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621755|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
43621757|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621758|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
43621759|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43621760|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621784|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621785|NCT03112577|Fluticasone|fluticasone|mesh-list
43621786|NCT03112577|Xhance|xhance|mesh-list
43621787|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43621788|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43621789|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
43621790|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621791|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621792|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43621793|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
43621794|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
43621795|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43621796|NCT03112538|Insulin|insulin|mesh-list
43621797|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43621798|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43621799|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621800|NCT03112785|Cimetidine|cimetidine|mesh-list
43621801|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43621802|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43621804|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
43621805|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
43621806|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621807|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621808|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621809|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43621810|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43621811|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621812|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
43621831|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43621833|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621834|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621835|NCT03112564|Analgesics|analgesics|mesh-ancestor
43621836|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
43621837|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621838|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43621839|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43621840|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
43621841|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
43621842|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43621843|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43621844|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43621845|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43621846|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43621847|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
43621848|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43621849|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
43621850|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43621851|NCT03112148|Tofacitinib|tofacitinib|mesh-list
43621852|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43621853|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621854|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621855|NCT03112187|Iron|iron|mesh-list
43621856|NCT03112187|Trace Elements|trace elements|mesh-ancestor
43621857|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
43621858|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621859|NCT03112135|Epinephrine|epinephrine|mesh-list
43621860|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
43849419|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849420|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43621876|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
43621877|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
43621878|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
43621879|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43621881|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621882|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
43621883|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
43621884|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
43621886|NCT03112382|Vitamin A|vitamin a|mesh-list
43621887|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
43621888|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
43621889|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621890|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
43621891|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621892|NCT03112382|Protective Agents|protective agents|mesh-ancestor
43621893|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43621894|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621895|NCT03112226|Estradiol|estradiol|mesh-list
43621896|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
43621897|NCT03112226|Estrogens|estrogens|mesh-ancestor
43621898|NCT03112226|Hormones|hormones|mesh-ancestor
43621899|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621900|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621920|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43621921|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43621922|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43621923|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
43621924|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621925|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43621926|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43621927|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621928|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621929|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43621930|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43621931|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43621932|NCT03112031|Amebicides|amebicides|mesh-ancestor
43621933|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43621934|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43621935|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43621936|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
43621937|NCT03111901|Interleukin-2|interleukin-2|mesh-list
43621938|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43621941|NCT03111901|Analgesics|analgesics|mesh-ancestor
43621972|NCT03111810|Protective Agents|protective agents|mesh-ancestor
43621973|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
43621976|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43621977|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43621978|NCT03111511|Betadex|betadex|mesh-list
43621979|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43621980|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43621981|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621982|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621983|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43621984|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43621985|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43621986|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43621987|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
43621988|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
43621989|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
43621990|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
43621991|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621992|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621993|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43621994|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43621995|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43621996|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
43621997|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43622021|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622023|NCT03111420|Ticagrelor|ticagrelor|mesh-list
43622024|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43622025|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43622026|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43622027|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43622028|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43622029|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
43622030|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622141|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
43622142|NCT03110640|Fludarabine|fludarabine|mesh-list
43622143|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43622144|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
43622170|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43622171|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622172|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622173|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622174|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622175|NCT03110172|Analgesics|analgesics|mesh-ancestor
43622176|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
43622177|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622178|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
43622179|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43622180|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
43622181|NCT03109886|Maleic acid|maleic acid|mesh-list
43622182|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622183|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622184|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
43622185|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43622186|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43622187|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43622189|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43622190|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43622191|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622192|NCT03110198|Analgesics|analgesics|mesh-ancestor
43622193|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
43622194|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622195|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622196|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622197|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43622198|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43622199|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
43622200|NCT03109977|Pertuzumab|pertuzumab|mesh-list
43622201|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43622202|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622211|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
43622212|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622213|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622214|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622215|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
43622216|NCT03109691|Hormones|hormones|mesh-ancestor
43622217|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43622218|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43622219|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622220|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622221|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
43622222|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622223|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
43622224|NCT03109730|Tenofovir|tenofovir|mesh-list
43622225|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43622226|NCT03109730|Entecavir|entecavir|mesh-list
43622227|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
43622228|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622229|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43622230|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43622231|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622232|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622233|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43622234|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43622235|NCT03109756|Gaboxadol|gaboxadol|mesh-list
43622236|NCT03109756|Analgesics|analgesics|mesh-ancestor
43622237|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
43622248|NCT03109600|Vaccines|vaccines|mesh-list
43622258|NCT03109392|Lidocaine|lidocaine|mesh-list
43622259|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622260|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
43622261|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622262|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622263|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
43622264|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622265|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43622266|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43622267|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43622268|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622269|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622271|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
43622272|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
43622273|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622274|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622275|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43622276|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43622277|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
43622278|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622279|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622280|NCT03109379|Urological Agents|urological agents|mesh-ancestor
43622281|NCT03109080|Olaparib|olaparib|mesh-list
43622283|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43622284|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622285|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622286|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622287|NCT03109080|Analgesics|analgesics|mesh-ancestor
43622288|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
43622289|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622291|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43622298|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43622299|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622300|NCT03109119|Propofol|propofol|mesh-list
43622301|NCT03109119|Sevoflurane|sevoflurane|mesh-list
43622302|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43622303|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622304|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622305|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43622306|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
43622307|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
43622308|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43622309|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43622310|NCT03109314|Donepezil|donepezil|mesh-list
43622311|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43622312|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622313|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622314|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
43622315|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622316|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622317|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
43622318|NCT03108846|Citalopram|citalopram|mesh-list
43622319|NCT03108846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43622320|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43622321|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622322|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622323|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622324|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
43622325|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622342|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622343|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43622345|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43622346|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43622347|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622348|NCT03108963|Metformin|metformin|mesh-list
43622349|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43622350|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622351|NCT03108989|Neostigmine|neostigmine|mesh-list
43622352|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43622353|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622354|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622355|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
43622356|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622357|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622358|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43622359|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
43622360|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622361|NCT03108872|Anticoagulants|anticoagulants|mesh-list
43622362|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43622363|NCT03108690|Meropenem|meropenem|mesh-list
43622364|NCT03108690|Tazobactam|tazobactam|mesh-list
43622542|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43622544|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
43622545|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622546|NCT03107702|Protective Agents|protective agents|mesh-ancestor
43622547|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622596|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43622597|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43622598|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43622600|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
43622601|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43622602|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
43622603|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
43622604|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622605|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622606|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622607|NCT03107078|Hormones|hormones|mesh-ancestor
43622608|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43622658|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622659|NCT03106818|Analgesics|analgesics|mesh-ancestor
43622660|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43622661|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43622662|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622663|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43622664|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622665|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622666|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43622667|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
43622668|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43622684|NCT03106623|Mirabegron|mirabegron|mesh-list
43622720|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622721|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622722|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
43622723|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622742|NCT03106363|Ethanol|ethanol|mesh-list
43622743|NCT03106363|Dronabinol|dronabinol|mesh-list
43622744|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43622745|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622746|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622747|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622748|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
43622749|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43622750|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622751|NCT03106363|Analgesics|analgesics|mesh-ancestor
43622763|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622764|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622765|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
43622766|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622768|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43622769|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
43622770|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43622771|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622772|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43622773|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622823|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43622824|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
43622825|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622826|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
43622827|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43622828|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43622829|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
43622830|NCT03105791|Narcotics|narcotics|mesh-ancestor
43622831|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622832|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622833|NCT03105791|Analgesics|analgesics|mesh-ancestor
43622834|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
43622835|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622836|NCT03105674|Anesthetics|anesthetics|mesh-list
43622837|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
43622842|NCT03105765|Ketamine|ketamine|mesh-list
43622882|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622883|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
43622884|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622885|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43622934|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622935|NCT03105375|Omeprazole|omeprazole|mesh-list
43622936|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43622937|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622938|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43622939|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622940|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622942|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43622983|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43622984|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
43622985|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
43622986|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622987|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622988|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
43622989|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622990|NCT05376904|Ropivacaine|ropivacaine|mesh-list
43622991|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622993|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622994|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622995|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
43622997|NCT05376865|Vitamin D|vitamin d|mesh-list
43623050|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43623051|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
43623052|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623053|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623054|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623055|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43623056|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43623057|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
43623058|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623059|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623060|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
43623061|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43623063|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623064|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43623138|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623139|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623140|NCT05350917|Maleic acid|maleic acid|mesh-list
43623141|NCT05350917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623142|NCT05350917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849423|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623143|NCT05338866|Capecitabine|capecitabine|mesh-list
43623203|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
43623204|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
43623205|NCT05164081|Gentamicins|gentamicins|mesh-list
43623206|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43623207|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623208|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
43623209|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43623210|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623211|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623212|NCT05135845|Spartalizumab|spartalizumab|mesh-list
43623213|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43623214|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623215|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623216|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
43623217|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623218|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43623219|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43623220|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43623221|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623222|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623223|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623224|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623225|NCT05115123|Analgesics|analgesics|mesh-ancestor
43623246|NCT04966676|Nivolumab|nivolumab|mesh-list
43623251|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623252|NCT04930458|Listerine|listerine|mesh-list
43623253|NCT04930458|Calcium|calcium|mesh-list
43623254|NCT04930458|Fluorides|fluorides|mesh-list
43623255|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
43623309|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43623310|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623311|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623312|NCT04674254|Bevacizumab|bevacizumab|mesh-list
43623313|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623314|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623315|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43623316|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43623317|NCT04674254|Growth Substances|growth substances|mesh-ancestor
43623318|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623319|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
43623320|NCT04670471|Remifentanil|remifentanil|mesh-list
43623322|NCT04670471|Narcotics|narcotics|mesh-ancestor
43623333|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43623334|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623335|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
43623336|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
43623337|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
43623338|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623339|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43623340|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
43623341|NCT04669197|Antiviral Agents|antiviral agents|mesh-ancestor
43623342|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623343|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623344|NCT04669197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43623345|NCT04669197|Immunologic Factors|immunologic factors|mesh-ancestor
43623346|NCT04669197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623347|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
43623348|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43623349|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43623350|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623352|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
43623353|NCT04644016|Fludarabine|fludarabine|mesh-list
43623354|NCT04644016|Busulfan|busulfan|mesh-list
43623355|NCT04644016|Clofarabine|clofarabine|mesh-list
43623356|NCT04644016|Cyclosporins|cyclosporins|mesh-list
43623357|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623358|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43623359|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
43623360|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623361|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43623362|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
43623363|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623364|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623365|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
43623366|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623367|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
43623368|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623373|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623374|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
43623375|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43623376|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43623378|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
43623379|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43623380|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43623381|NCT04636671|Prednisolone|prednisolone|mesh-list
43623382|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
43623383|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43623384|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
43623385|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43623386|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
43623387|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
43623388|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623389|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623390|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43623391|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
43623392|NCT04636671|Hormones|hormones|mesh-ancestor
43623393|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43623394|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43623395|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623396|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43623397|NCT04636671|Protective Agents|protective agents|mesh-ancestor
43623398|NCT04632589|Losartan|losartan|mesh-list
43623399|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43623400|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43623401|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43623402|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43623403|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623404|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
43623406|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43623407|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623408|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
43623411|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43623412|NCT04585841|Cannabidiol|cannabidiol|mesh-list
43623413|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
43623414|NCT04581447|Metformin|metformin|mesh-list
43623415|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43623416|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623417|NCT04574479|Morphine|morphine|mesh-list
43623418|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43623419|NCT04574479|Narcotics|narcotics|mesh-ancestor
43623420|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623421|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623422|NCT04574479|Analgesics|analgesics|mesh-ancestor
43623423|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
43623424|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623425|NCT04551040|Terazosin|terazosin|mesh-list
43623426|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43623427|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43623428|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43623429|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
43623430|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623431|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623465|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43623466|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623467|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
43623468|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623469|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
43623470|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
43623471|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
43623472|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623474|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43623475|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
43623476|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43623477|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623478|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43623479|NCT04423211|Leuprolide|leuprolide|mesh-list
43623480|NCT04423211|Goserelin|goserelin|mesh-list
43623481|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43623482|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
43623483|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43623484|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623485|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43623486|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623487|NCT04368364|Morphine|morphine|mesh-list
43623488|NCT04368364|Bupivacaine|bupivacaine|mesh-list
43623489|NCT04368364|Ropivacaine|ropivacaine|mesh-list
43623490|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623491|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
43623492|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623493|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623494|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
43623495|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623496|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43623497|NCT04368364|Narcotics|narcotics|mesh-ancestor
43623498|NCT04368364|Analgesics|analgesics|mesh-ancestor
43623509|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623510|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43623511|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43623512|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623513|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623514|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623515|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43623516|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43623517|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
43623518|NCT04318678|Rituximab|rituximab|mesh-list
43623519|NCT04318678|Fludarabine|fludarabine|mesh-list
43623520|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43623521|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
43623522|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623523|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623525|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
43623526|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623527|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623528|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43623529|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623530|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
43623531|NCT04303000|Naloxone|naloxone|mesh-list
43623557|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
43623558|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43623559|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
43623560|NCT04299113|Vinorelbine|vinorelbine|mesh-list
43623561|NCT04299113|Mocetinostat|mocetinostat|mesh-list
43623562|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43623563|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623564|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
43623565|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
43623566|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
43623567|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623568|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43623569|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623571|NCT04221880|Bupivacaine|bupivacaine|mesh-list
43623572|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43623573|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623574|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
43623575|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623576|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623577|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
43623578|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623579|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43623580|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43623581|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43623582|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623583|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623585|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
43623586|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43623587|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43623588|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623589|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
43623590|NCT04189588|Promethazine|promethazine|mesh-list
43623591|NCT04189588|Cetirizine|cetirizine|mesh-list
43623599|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623600|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623601|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
43623602|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623603|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623604|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43623605|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43623606|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623607|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623608|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
43623609|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
43623610|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623611|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
43623612|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
43623613|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43623614|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43623615|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
43623616|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
43623617|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623618|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43623619|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
43623620|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
43623621|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43623622|NCT04181008|Amiloride|amiloride|mesh-list
43623623|NCT04181008|Diuretics|diuretics|mesh-ancestor
43623624|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
43623625|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623626|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43623643|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
43623644|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623645|NCT04175470|Protective Agents|protective agents|mesh-ancestor
43623646|NCT04175470|Vitamins|vitamins|mesh-ancestor
43623691|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623692|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43623693|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
43623694|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623695|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623696|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
43623697|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623698|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43623699|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43623700|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
43623701|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623702|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43623703|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43623704|NCT03994731|Analgesics|analgesics|mesh-ancestor
43623705|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
43623706|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623707|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
43623708|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43623709|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
43623710|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
43623711|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43623712|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
43623723|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43623724|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
43623725|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
43623726|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623728|NCT03971708|Ropivacaine|ropivacaine|mesh-list
43623729|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623730|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
43623731|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623732|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623733|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
43623734|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623735|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43623736|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43623737|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43623738|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623739|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623741|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43849428|NCT03928314|Paclitaxel|paclitaxel|mesh-list
43623742|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623744|NCT03965728|Midazolam|midazolam|mesh-list
43623745|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43623746|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
43623747|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43623748|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623749|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43623750|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
43623751|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623752|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623753|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
43623754|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623755|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43623764|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43623765|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43623766|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43623767|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
43623769|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
43623770|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
43623771|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623772|NCT03963895|Thrombin|thrombin|mesh-list
43623773|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
43623774|NCT03963895|Coagulants|coagulants|mesh-ancestor
43623775|NCT03956446|Doxycycline|doxycycline|mesh-list
43623776|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623777|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623781|NCT03955172|Everolimus|everolimus|mesh-list
43623829|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623830|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43623831|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43623832|NCT03818061|Growth Substances|growth substances|mesh-ancestor
43623833|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623834|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
43623836|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
43623837|NCT03734744|Vitamins|vitamins|mesh-ancestor
43623838|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
43623839|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623840|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43623841|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43623842|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43623844|NCT03576716|Vitamins|vitamins|mesh-ancestor
43623845|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
43623846|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623847|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43623848|NCT03436862|Nivolumab|nivolumab|mesh-list
43623849|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623850|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623851|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43623852|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623853|NCT03367819|Cemiplimab|cemiplimab|mesh-list
43623854|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623855|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623856|NCT03343197|Ivosidenib|ivosidenib|mesh-list
43623857|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623858|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623859|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623860|NCT03177746|Tadalafil|tadalafil|mesh-list
43623867|NCT03077620|Suvorexant|suvorexant|mesh-list
43623872|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43623873|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623874|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623875|NCT02980276|Metformin|metformin|mesh-list
43623876|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43623877|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623878|NCT02871843|Temozolomide|temozolomide|mesh-list
43623879|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43623880|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
43623881|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623882|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623883|NCT02848131|Dasatinib|dasatinib|mesh-list
43623884|NCT02848131|Quercetin|quercetin|mesh-list
43623885|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623886|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43623887|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623888|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623889|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
43623890|NCT02848131|Protective Agents|protective agents|mesh-ancestor
43623891|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623892|NCT02801097|Irinotecan|irinotecan|mesh-list
43623893|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43623894|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43623895|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623896|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623897|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623900|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
43623915|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623917|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43623918|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43623920|NCT02536794|Ipilimumab|ipilimumab|mesh-list
43623921|NCT02536794|Tremelimumab|tremelimumab|mesh-list
43623922|NCT02536794|Antibodies|antibodies|mesh-list
43623923|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
43623924|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43623925|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
43623926|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623927|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623928|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43623929|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623930|NCT02506517|Afatinib|afatinib|mesh-list
43623931|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623932|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43623933|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623934|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623935|NCT02402842|Cisplatin|cisplatin|mesh-list
43623936|NCT02402842|Docetaxel|docetaxel|mesh-list
43623937|NCT02402842|Fluorouracil|fluorouracil|mesh-list
43623938|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623939|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
43623940|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
43623941|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
43623942|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623943|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
43623944|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43623945|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43623948|NCT02398656|Tenecteplase|tenecteplase|mesh-list
43623961|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43623962|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
43623963|NCT02375295|Trimethoprim|trimethoprim|mesh-list
43623964|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623965|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623966|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43623967|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43623968|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623969|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623970|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623971|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43623972|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43623973|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43623974|NCT02375295|Renal Agents|renal agents|mesh-ancestor
43623975|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
43623976|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43623977|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43623978|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43623979|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43623980|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43623981|NCT02124187|Nicotine|nicotine|mesh-list
43623982|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43623983|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
43623984|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623985|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623986|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43623987|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43624004|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624005|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43624006|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43624007|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
43624008|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624009|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624010|NCT01936857|Buprenorphine|buprenorphine|mesh-list
43624011|NCT01936857|Methadone|methadone|mesh-list
43624012|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43624013|NCT01936857|Naloxone|naloxone|mesh-list
43624014|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43624015|NCT01936857|Narcotics|narcotics|mesh-ancestor
43624016|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624017|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624018|NCT01936857|Analgesics|analgesics|mesh-ancestor
43624019|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
43624020|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624021|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43624022|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
43624023|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
43624024|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
43624025|NCT01903330|Bevacizumab|bevacizumab|mesh-list
43624026|NCT01903330|Sargramostim|sargramostim|mesh-list
43624042|NCT01735461|Calcium|calcium|mesh-list
43624056|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43624057|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624058|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43624059|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624060|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624061|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
43624062|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43624063|NCT01595841|Sirolimus|sirolimus|mesh-list
43624064|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43624065|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624066|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43624067|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624068|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
43624069|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624070|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
43624071|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624072|NCT05405049|Lidocaine|lidocaine|mesh-list
43624073|NCT05405049|Fentanyl|fentanyl|mesh-list
43624074|NCT05405049|Morphine|morphine|mesh-list
43624075|NCT05405049|Bupivacaine|bupivacaine|mesh-list
43624161|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624162|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
43624163|NCT05403099|Protective Agents|protective agents|mesh-ancestor
43624181|NCT05403047|Tenofovir|tenofovir|mesh-list
43624215|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624216|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624217|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
43624218|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624219|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
43624220|NCT05301517|Hematinics|hematinics|mesh-ancestor
43624221|NCT05279963|Amitriptyline|amitriptyline|mesh-list
43624222|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43624223|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
43624224|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43624225|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43624226|NCT05279963|Analgesics|analgesics|mesh-ancestor
43624227|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
43624228|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624229|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624230|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43624231|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43624232|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43624233|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624234|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
43624235|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624236|NCT05258110|Midazolam|midazolam|mesh-list
43624237|NCT05258110|BI 425809|bi 425809|mesh-list
43624238|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43624239|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43624266|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43624267|NCT05137262|Methotrexate|methotrexate|mesh-list
43624268|NCT05137262|Durvalumab|durvalumab|mesh-list
43624269|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
43624270|NCT05137262|Vinblastine|vinblastine|mesh-list
43624271|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624272|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43624273|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43624274|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624275|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624276|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624277|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43624278|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
43624279|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43624280|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624281|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43624282|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
43624283|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
43624284|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43624285|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624286|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
43624287|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624288|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43624289|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624290|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43624291|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
43624292|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624293|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43624294|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624295|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624296|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
43624297|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
43624298|NCT05118620|Bupivacaine|bupivacaine|mesh-list
43624304|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624305|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
43624306|NCT05080790|Interleukin-2|interleukin-2|mesh-list
43624307|NCT05080790|Dinutuximab|dinutuximab|mesh-list
43624308|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624309|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43624310|NCT05080790|Analgesics|analgesics|mesh-ancestor
43624311|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
43624312|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624313|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624314|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43624315|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43624316|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43624317|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624318|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624319|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43624320|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43624321|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624322|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
43624323|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624324|NCT05012254|Paclitaxel|paclitaxel|mesh-list
43624325|NCT05012254|Cisplatin|cisplatin|mesh-list
43624326|NCT05012254|Carboplatin|carboplatin|mesh-list
43624327|NCT05012254|Nivolumab|nivolumab|mesh-list
43624328|NCT05012254|Pemetrexed|pemetrexed|mesh-list
43624329|NCT05012254|Ipilimumab|ipilimumab|mesh-list
43624330|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624331|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624332|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624333|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
43624334|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
43624335|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624336|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624337|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43624339|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43624340|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43624343|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43624344|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43624345|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624346|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624347|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43624348|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43624349|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43624350|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43624351|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
43624353|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
43624354|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
43624355|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624356|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624357|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43624358|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43624359|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
43624360|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624361|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43624362|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43624363|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
43624364|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624365|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43624366|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43624367|NCT04966507|Listerine|listerine|mesh-list
43624368|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43624369|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624370|NCT04949113|Nivolumab|nivolumab|mesh-list
43624371|NCT04949113|Ipilimumab|ipilimumab|mesh-list
43624372|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624373|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624374|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43624375|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624376|NCT04913610|Ivermectin|ivermectin|mesh-list
43624377|NCT04913610|Albendazole|albendazole|mesh-list
43624383|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43624384|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624385|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
43624386|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
43624387|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624388|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624389|NCT04812002|Bevacizumab|bevacizumab|mesh-list
43624390|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43624391|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624392|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624393|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43624394|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43624395|NCT04812002|Growth Substances|growth substances|mesh-ancestor
43624396|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624397|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
43624398|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624399|NCT04779216|Alendronate|alendronate|mesh-list
43624400|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43624401|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624403|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
43624404|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624433|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624434|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
43624435|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
43624436|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43624437|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43624442|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624443|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624445|NCT04475991|Favipiravir|favipiravir|mesh-list
43624446|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43624447|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43624448|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624449|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43624450|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43624451|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
43624452|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624453|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43624454|NCT04437225|Glycolic acid|glycolic acid|mesh-list
43624455|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
43624456|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
43624457|NCT04419389|Rituximab|rituximab|mesh-list
43624458|NCT04419389|Venetoclax|venetoclax|mesh-list
43624459|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
43624460|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624461|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624462|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
43624463|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624464|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624465|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43624466|NCT04387071|Antibodies|antibodies|mesh-list
43624467|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
43624468|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43624469|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
43624470|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624471|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624473|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624474|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624475|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
43624476|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43624477|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
43624478|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624479|NCT04314713|Scopolamine|scopolamine|mesh-list
43624480|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43624481|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43624482|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
43624483|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
43624484|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624485|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624486|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43624487|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
43624488|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43624489|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
43624490|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624491|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624492|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43624494|NCT04113109|Icatibant|icatibant|mesh-list
43624495|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43624496|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43624497|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624498|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43624499|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43624500|NCT04113109|Analgesics|analgesics|mesh-ancestor
43624501|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
43624502|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624506|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43624507|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43624508|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43624509|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624510|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
43624511|NCT04090697|Oxandrolone|oxandrolone|mesh-list
43624512|NCT04090697|Androgens|androgens|mesh-ancestor
43624579|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43624580|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624581|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624582|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43624583|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43624584|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43624585|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43624586|NCT03892044|Nivolumab|nivolumab|mesh-list
43624587|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624588|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624589|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43624590|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624591|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
43624592|NCT03882060|Hematinics|hematinics|mesh-ancestor
43624593|NCT03844997|Palbociclib|palbociclib|mesh-list
43624594|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624595|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43624596|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624597|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624598|NCT03790397|Osimertinib|osimertinib|mesh-list
43624599|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624600|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43624601|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624602|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624611|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624612|NCT03738878|Incretins|incretins|mesh-ancestor
43624613|NCT03738878|Hormones|hormones|mesh-ancestor
43624614|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624615|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43624616|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
43624617|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624618|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624619|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43624620|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43624621|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43624622|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
43624623|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43624624|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624625|NCT03710460|Metformin|metformin|mesh-list
43624626|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
43624627|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43624628|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624629|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43624630|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624663|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624664|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
43624665|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
43624666|NCT03337087|Leucovorin|leucovorin|mesh-list
43624667|NCT03337087|Folic Acid|folic acid|mesh-list
43624668|NCT03337087|Fluorouracil|fluorouracil|mesh-list
43624669|NCT03337087|Irinotecan|irinotecan|mesh-list
43624670|NCT03337087|Rucaparib|rucaparib|mesh-list
43624671|NCT03337087|Calcium|calcium|mesh-list
43624672|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
43624673|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43624674|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624675|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43624676|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
43624677|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624678|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43624679|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624680|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624721|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43624723|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
43624724|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624725|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624726|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43624727|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624728|NCT02900976|Rituximab|rituximab|mesh-list
43624729|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43624730|NCT02900976|Antibodies|antibodies|mesh-list
43624731|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
43624732|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43624733|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
43624734|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624735|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624736|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624737|NCT02735057|Paclitaxel|paclitaxel|mesh-list
43624738|NCT02735057|Carboplatin|carboplatin|mesh-list
43624739|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624740|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624741|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624742|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
43624743|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
43624744|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624745|NCT02720185|Dasatinib|dasatinib|mesh-list
43624746|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624747|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43624748|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624749|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624750|NCT02714894|Clozapine|clozapine|mesh-list
43624751|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43624752|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
43624753|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624764|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43624765|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43624766|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43624767|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624768|NCT02684461|Paclitaxel|paclitaxel|mesh-list
43624769|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
43624770|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624771|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624772|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624773|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
43624774|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
43624775|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624776|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624777|NCT02639650|Dactinomycin|dactinomycin|mesh-list
43624778|NCT02639650|Paclitaxel|paclitaxel|mesh-list
43624779|NCT02639650|Etoposide|etoposide|mesh-list
43624780|NCT02639650|Vincristine|vincristine|mesh-list
43624781|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
43624782|NCT02639650|Cisplatin|cisplatin|mesh-list
43624783|NCT02639650|Carboplatin|carboplatin|mesh-list
43624784|NCT02639650|Methotrexate|methotrexate|mesh-list
43624785|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624786|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624787|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624788|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
43624789|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
43624790|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624791|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624792|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
43624793|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624794|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624795|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43624807|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43624808|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624809|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43624810|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624811|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43624812|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43624814|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624815|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624816|NCT02514031|Gemcitabine|gemcitabine|mesh-list
43624817|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
43624818|NCT02514031|Paclitaxel|paclitaxel|mesh-list
43624819|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624820|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624821|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624822|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
43624823|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
43624824|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624825|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43624862|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624863|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43624864|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
43624865|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624866|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624872|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43624873|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
43624874|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43624875|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43624876|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624877|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43624878|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624879|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43624880|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624881|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43624882|NCT00495508|Analgesics|analgesics|mesh-ancestor
43624883|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
43624884|NCT01554046|Methylphenidate|methylphenidate|mesh-list
43624885|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43624886|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624887|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43624888|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43624911|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624912|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624913|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43624914|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43624915|NCT01295944|Growth Substances|growth substances|mesh-ancestor
43624916|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624917|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
43624918|NCT01285557|Cisplatin|cisplatin|mesh-list
43624919|NCT01285557|Fluorouracil|fluorouracil|mesh-list
43624920|NCT01285557|Tegafur|tegafur|mesh-list
43624922|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
43624923|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624924|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43624925|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624926|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
43624927|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624928|NCT01228331|Cytarabine|cytarabine|mesh-list
43624929|NCT01228331|Dexamethasone|dexamethasone|mesh-list
43624930|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
43624931|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
43624932|NCT01228331|Doxorubicin|doxorubicin|mesh-list
43624933|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43624934|NCT01228331|Methotrexate|methotrexate|mesh-list
43624935|NCT01228331|Etoposide|etoposide|mesh-list
43624936|NCT01228331|Vincristine|vincristine|mesh-list
43624964|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624965|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624966|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43624967|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
43624968|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43624969|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43624970|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
43624971|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
43624972|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43624973|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43624974|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624975|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
43624976|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624977|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
43624978|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
43624979|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
43624980|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43624981|NCT01228331|Protective Agents|protective agents|mesh-ancestor
43624982|NCT01171937|Risperidone|risperidone|mesh-list
43624983|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43625015|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625016|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
43625017|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625018|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43625019|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43625020|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43625021|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43625022|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43625023|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43625024|NCT00887783|Vinorelbine|vinorelbine|mesh-list
43625025|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43625026|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625027|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
43625030|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625032|NCT00790218|Analgesics|analgesics|mesh-ancestor
43625033|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
43625034|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625035|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625036|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43625037|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
43625038|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43625039|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
43625040|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
43625041|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625042|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625043|NCT00583778|Ipratropium|ipratropium|mesh-list
43625044|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43625053|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625055|NCT00432094|Etoposide|etoposide|mesh-list
43625056|NCT00432094|Carboplatin|carboplatin|mesh-list
43625057|NCT00432094|Ifosfamide|ifosfamide|mesh-list
43625058|NCT00432094|Thiotepa|thiotepa|mesh-list
43625059|NCT00432094|Mesna|mesna|mesh-list
43625060|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43625061|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625062|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
43625063|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
43625064|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
43625065|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625066|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43625067|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43625068|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625069|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
43625070|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625071|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43625112|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625113|NCT03104959|Protective Agents|protective agents|mesh-ancestor
43625114|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625115|NCT03104959|Antidotes|antidotes|mesh-ancestor
43625116|NCT03104998|Ubiquinone|ubiquinone|mesh-list
43625117|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
43625118|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
43625119|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625120|NCT03104998|Vitamins|vitamins|mesh-ancestor
43625121|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43625122|NCT03104855|Calcifediol|calcifediol|mesh-list
43625123|NCT03104855|Vitamins|vitamins|mesh-ancestor
43625124|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
43625125|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625126|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43625127|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43625128|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43625129|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625130|NCT03104634|Bromides|bromides|mesh-list
43625131|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
43625132|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43625133|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
43625166|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43625167|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43625168|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
43625169|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
43625170|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625171|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43625172|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43625173|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625174|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625176|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43625177|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
43625178|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
43625179|NCT03104010|Hormones|hormones|mesh-list
43625180|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625181|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625182|NCT03103893|Sirolimus|sirolimus|mesh-list
43625183|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43625184|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625185|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43625186|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625187|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
43625188|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625190|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625191|NCT03104036|Mesalamine|mesalamine|mesh-list
43625192|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43625193|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43625194|NCT03104036|Analgesics|analgesics|mesh-ancestor
43625195|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
43625196|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625197|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625198|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625208|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43625209|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43625210|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
43625211|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625212|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625213|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625214|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
43625216|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625217|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
43625218|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625219|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625220|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43625221|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
43625222|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625223|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625224|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43625225|NCT03103412|Tofacitinib|tofacitinib|mesh-list
43625226|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43625227|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625228|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625229|NCT03103568|Tolbutamide|tolbutamide|mesh-list
43625230|NCT03103568|Metoprolol|metoprolol|mesh-list
43625231|NCT03103568|Furosemide|furosemide|mesh-list
43625232|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
43625233|NCT03103568|Nitisinone|nitisinone|mesh-list
43625234|NCT03103568|Diuretics|diuretics|mesh-ancestor
43625235|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
43625236|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625237|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43625238|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43625239|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625240|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43625241|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43625246|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43625247|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43625248|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
43625249|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625250|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43625251|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625252|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43625253|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43625254|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43625255|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
43625256|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625257|NCT03103646|Itraconazole|itraconazole|mesh-list
43625258|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43625259|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
43625260|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625261|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43625262|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43625263|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625264|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625265|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43625266|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
43625267|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625268|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625269|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43625270|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
43625271|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43625272|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625273|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
43625274|NCT03103399|Levodopa|levodopa|mesh-list
43625275|NCT03103399|Carbidopa|carbidopa|mesh-list
43625276|NCT03103399|Entacapone|entacapone|mesh-list
43625277|NCT03103399|Benserazide|benserazide|mesh-list
43625279|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
43625284|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625285|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625286|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625287|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43625288|NCT03103334|Methotrexate|methotrexate|mesh-list
43625289|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43625290|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
43625291|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43625292|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625293|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43625295|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625296|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625297|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
43625298|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625299|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43625300|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625301|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
43625302|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625303|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43625304|NCT03103152|Aspirin|aspirin|mesh-list
43625305|NCT03103152|Vitamin D|vitamin d|mesh-list
43625334|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625335|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
43625336|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43625337|NCT03103009|Pasireotide|pasireotide|mesh-list
43625338|NCT03103009|Hormones|hormones|mesh-ancestor
43625339|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625340|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625341|NCT03103022|Acetaminophen|acetaminophen|mesh-list
43625342|NCT03103022|Ibuprofen|ibuprofen|mesh-list
43625343|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43625344|NCT03103022|Analgesics|analgesics|mesh-ancestor
43625345|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
43625346|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625347|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625348|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
43625349|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43625350|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625351|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625352|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43625353|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625354|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625356|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
43625357|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625358|NCT03102801|Insulin|insulin|mesh-list
43625359|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43625360|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43625383|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625384|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625385|NCT03102398|Urological Agents|urological agents|mesh-ancestor
43625386|NCT03101995|Gemcitabine|gemcitabine|mesh-list
43625387|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43625388|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
43625389|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625390|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625391|NCT03101995|Antiviral Agents|antiviral agents|mesh-ancestor
43625392|NCT03101995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625393|NCT03101995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625394|NCT03101995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625395|NCT03101995|Immunologic Factors|immunologic factors|mesh-ancestor
43625396|NCT03101995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625398|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625399|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43625400|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43625401|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625402|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
43625403|NCT03102021|Hematinics|hematinics|mesh-ancestor
43625404|NCT03101800|Azathioprine|azathioprine|mesh-list
43625405|NCT03101800|Allopurinol|allopurinol|mesh-list
43625406|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
43625407|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625408|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625411|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43625412|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
43625413|NCT03101800|Protective Agents|protective agents|mesh-ancestor
43625452|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43625454|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
43625455|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
43625456|NCT03101709|Fludarabine|fludarabine|mesh-list
43625457|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625459|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625460|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625461|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43625470|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625471|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43625472|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43625473|NCT03101280|Atezolizumab|atezolizumab|mesh-list
43625474|NCT03101280|Rucaparib|rucaparib|mesh-list
43625475|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625476|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43625477|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625478|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625479|NCT03101644|Darunavir|darunavir|mesh-list
43625480|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43625481|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43625482|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
43625483|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625484|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625485|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43625486|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43625487|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
43625488|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625489|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43625490|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43625491|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625492|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
43625493|NCT03100955|Cisplatin|cisplatin|mesh-list
43625494|NCT03100955|Etoposide|etoposide|mesh-list
43625495|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
43625496|NCT03100955|Apatinib|apatinib|mesh-list
43625497|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625498|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43625499|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43625500|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43625501|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625502|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625503|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43625504|NCT03101137|Dexamethasone|dexamethasone|mesh-list
43625505|NCT03101137|Bupivacaine|bupivacaine|mesh-list
43625506|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625507|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
43625508|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
43625509|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625523|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43625524|NCT03101085|Estrogens|estrogens|mesh-ancestor
43625525|NCT03101085|Hormones|hormones|mesh-ancestor
43625526|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625527|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625528|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
43625529|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43625530|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43625531|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625532|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
43625533|NCT03101124|Coagulants|coagulants|mesh-ancestor
43625534|NCT03100994|Bupivacaine|bupivacaine|mesh-list
43625535|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
43625536|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
43625537|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625538|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625539|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
43625540|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625541|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
43625543|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
43625544|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43625546|NCT03100877|Lenograstim|lenograstim|mesh-list
43625547|NCT03100877|Mitogens|mitogens|mesh-list
43625548|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625549|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
43625950|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
43625550|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625551|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625552|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43625553|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
43625554|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625555|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625556|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43625557|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43625558|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43625559|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43625560|NCT03100877|Growth Substances|growth substances|mesh-ancestor
43625561|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
43625562|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
43625564|NCT03100604|Desflurane|desflurane|mesh-list
43625565|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43625566|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43625567|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
43625609|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625611|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625612|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625613|NCT03100019|Resveratrol|resveratrol|mesh-list
43625614|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
43625615|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625616|NCT03100019|Protective Agents|protective agents|mesh-ancestor
43625617|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625618|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625619|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43625620|NCT03100071|Apixaban|apixaban|mesh-list
43625621|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43625622|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
43625623|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43625624|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
43625625|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625626|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625627|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
43625628|NCT03099720|Ropivacaine|ropivacaine|mesh-list
43625629|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
43625630|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
43625631|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625632|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625633|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
43625634|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625635|NCT03099759|Vitamin D|vitamin d|mesh-list
43625636|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
43625637|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
43625638|NCT03099759|Vitamins|vitamins|mesh-ancestor
43625639|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
43625640|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625641|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43625642|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43625643|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
43625644|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
43625645|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625646|NCT03099824|Protective Agents|protective agents|mesh-ancestor
43625647|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625648|NCT03099785|Rifamycins|rifamycins|mesh-list
43625649|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
43625650|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43625651|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625652|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625653|NCT03099590|Puerarin|puerarin|mesh-list
43625654|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
43625677|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
43625678|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625711|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625712|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43625714|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43625715|NCT03099213|Ramipril|ramipril|mesh-list
43625716|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43625717|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
43625718|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625719|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625720|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43625721|NCT03098875|Remifentanil|remifentanil|mesh-list
43625722|NCT03098875|Propofol|propofol|mesh-list
43625723|NCT03098875|Sevoflurane|sevoflurane|mesh-list
43625725|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625726|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625727|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43625728|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
43625729|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
43625730|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43625731|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43625734|NCT03098875|Analgesics|analgesics|mesh-ancestor
43625735|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
43625736|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625738|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43625739|NCT03099031|Dalteparin|dalteparin|mesh-list
43625740|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
43625741|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43625742|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43625743|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625744|NCT03098888|Dimercaprol|dimercaprol|mesh-list
43625745|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
43625746|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
43625747|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625748|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43625749|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43625750|NCT03098823|Prednisone|prednisone|mesh-list
43625751|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625752|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
43625753|NCT03098823|Hormones|hormones|mesh-ancestor
43625754|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625755|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625756|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43625757|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625758|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
43625759|NCT03098810|Astringents|astringents|mesh-ancestor
43625760|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625761|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
43625762|NCT03098680|Verapamil|verapamil|mesh-list
43625763|NCT03098680|Nicardipine|nicardipine|mesh-list
43625764|NCT03098680|Phentolamine|phentolamine|mesh-list
43625765|NCT03098680|Phenylephrine|phenylephrine|mesh-list
43625766|NCT03098680|Dobutamine|dobutamine|mesh-list
43625767|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
43625768|NCT03098680|Albuterol|albuterol|mesh-list
43625769|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43625770|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
43625771|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625772|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625773|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43625774|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
43625775|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
43625776|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43625777|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43625778|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43625779|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43849430|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625780|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
43625781|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625782|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625783|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43625784|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
43625785|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
43625786|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43625787|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
43625805|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43625806|NCT03098407|Narcotics|narcotics|mesh-ancestor
43625807|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625808|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625809|NCT03098407|Analgesics|analgesics|mesh-ancestor
43625810|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
43625811|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625812|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43625813|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
43625814|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
43625815|NCT03098368|Rotigotine|rotigotine|mesh-list
43625816|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
43625817|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
43625818|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625951|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
43625819|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625820|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625821|NCT03098342|Amorolfine|amorolfine|mesh-list
43625822|NCT03098342|Methylene Blue|methylene blue|mesh-list
43625823|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625824|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625825|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
43625826|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625827|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
43625828|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43625829|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43625830|NCT03098225|Prednisolone|prednisolone|mesh-list
43625831|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
43625832|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43625833|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
43625834|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625835|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
43625879|NCT03097601|Sunitinib|sunitinib|mesh-list
43625880|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625881|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43625882|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43625883|NCT03097601|Growth Substances|growth substances|mesh-ancestor
43625884|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625885|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
43625886|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43625887|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625888|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625889|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
43625890|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43625891|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
43625892|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625893|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625894|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43625895|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
43625896|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
43625897|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43625898|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
43625899|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625900|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625902|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43625903|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
43625904|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625905|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625906|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43625908|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
43625909|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625910|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625911|NCT03097406|Imidacloprid|imidacloprid|mesh-list
43625912|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
43625913|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625914|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625915|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625916|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43625917|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
43625918|NCT03097120|Estrogens|estrogens|mesh-list
43625919|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43625920|NCT03097120|Hormones|hormones|mesh-ancestor
43625921|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625924|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43625935|NCT03097211|Resveratrol|resveratrol|mesh-list
43625936|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43625937|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43625938|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43625939|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
43625940|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625941|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625942|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625943|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
43625944|NCT03097211|Protective Agents|protective agents|mesh-ancestor
43625945|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625946|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43625947|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43625948|NCT03097198|Tropicamide|tropicamide|mesh-list
43625949|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43625952|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625953|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625954|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43625955|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43625956|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
43625957|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625958|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625959|NCT03097003|Apremilast|apremilast|mesh-list
43625960|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43625961|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43625962|NCT03097003|Analgesics|analgesics|mesh-ancestor
43625963|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
43625964|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625965|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625966|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625967|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625968|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43625969|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43625970|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625971|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625972|NCT03096990|Apremilast|apremilast|mesh-list
43625973|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43625974|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43625975|NCT03096990|Analgesics|analgesics|mesh-ancestor
43625976|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
43625977|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625978|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625979|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625980|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625981|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43625988|NCT03096756|Protective Agents|protective agents|mesh-ancestor
43625989|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625991|NCT03096704|Vitamins|vitamins|mesh-ancestor
43625992|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
43625993|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625994|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43625995|NCT03096470|Anesthetics|anesthetics|mesh-list
43625996|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625997|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625998|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
43625999|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626000|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
43626001|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
43626002|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626003|NCT03096327|Montelukast|montelukast|mesh-list
43626004|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43626005|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
43626006|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43626007|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
43626008|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626009|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626010|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43626011|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43626012|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626013|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
43626014|NCT03096340|Irinotecan|irinotecan|mesh-list
43626015|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43626016|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626017|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43626018|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43626019|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626020|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626021|NCT03096392|Insulin|insulin|mesh-list
43626022|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43626023|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
43626024|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626025|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626026|NCT03096522|Phenytoin|phenytoin|mesh-list
43626027|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
43626028|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43626029|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43626030|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43626031|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626032|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43626033|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43626036|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43626037|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626038|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43626039|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43626061|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
43626062|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626063|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
43626064|NCT03096028|Hematinics|hematinics|mesh-ancestor
43626065|NCT03095547|Cyclosporine|cyclosporine|mesh-list
43626066|NCT03095547|Posaconazole|posaconazole|mesh-list
43626067|NCT03095547|Olorofim|olorofim|mesh-list
43626068|NCT03095547|Pantoprazole|pantoprazole|mesh-list
43626069|NCT03095547|Tacrolimus|tacrolimus|mesh-list
43626070|NCT03095547|Cyclosporins|cyclosporins|mesh-list
43626071|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43626072|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
43626073|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626074|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43626075|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626076|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626077|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
43626078|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626079|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626080|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43626081|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43626082|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626083|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43626084|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43626085|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43626086|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43626087|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43626088|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43626089|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43626090|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
43626091|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626092|NCT03095703|Sirolimus|sirolimus|mesh-list
43626093|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43626094|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626095|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43626096|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626097|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
43626098|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43626099|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
43626100|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626101|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
43626102|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43626103|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626104|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626105|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43626106|NCT03095469|Analgesics|analgesics|mesh-ancestor
43626107|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
43626108|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626109|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43626110|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43626111|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43626112|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
43626113|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626114|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626115|NCT03095404|Lidocaine|lidocaine|mesh-list
43626116|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43626117|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
43626118|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
43626119|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626120|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626121|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
43626124|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43626125|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43626126|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43626127|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626128|NCT03095144|Anesthetics|anesthetics|mesh-list
43626129|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626130|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626254|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
43626133|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43626134|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626135|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
43626136|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
43626137|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
43626138|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626139|NCT03095222|Ketamine|ketamine|mesh-list
43626140|NCT03095222|Analgesics|analgesics|mesh-ancestor
43626141|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
43626142|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626143|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626144|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43626145|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43626146|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
43626147|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
43626148|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626149|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43626150|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43626151|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626152|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626153|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
43626154|NCT03095378|Tetracycline|tetracycline|mesh-list
43626155|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43626157|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
43626158|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43626159|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626160|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626161|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
43626162|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43626163|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
43626164|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
43626165|NCT03095326|Zinc|zinc|mesh-list
43626166|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
43626167|NCT03095326|Vaccines|vaccines|mesh-list
43626168|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
43626169|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626170|NCT03095326|Trace Elements|trace elements|mesh-ancestor
43626171|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
43626172|NCT03095326|Astringents|astringents|mesh-ancestor
43626173|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626174|NCT03095235|Riboflavin|riboflavin|mesh-list
43626175|NCT03095235|Vitamins|vitamins|mesh-ancestor
43626176|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
43626177|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626178|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
43626179|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43626180|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626181|NCT03095105|Resveratrol|resveratrol|mesh-list
43626182|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
43626184|NCT03095105|Protective Agents|protective agents|mesh-ancestor
43626207|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43626208|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626209|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
43626218|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
43626219|NCT03094663|Cefazolin|cefazolin|mesh-list
43626220|NCT03094663|Dexamethasone|dexamethasone|mesh-list
43626221|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
43626222|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
43626223|NCT03094663|Epinephrine|epinephrine|mesh-list
43626224|NCT03094663|Bupivacaine|bupivacaine|mesh-list
43626225|NCT03094663|BB 1101|bb 1101|mesh-list
43626226|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626227|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
43626228|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
43626229|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626230|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626231|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626232|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
43626233|NCT03094663|Hormones|hormones|mesh-ancestor
43626234|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626235|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43626236|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626237|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
43626238|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626249|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626250|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43626251|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43626252|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43626253|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
43626256|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43626257|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43626258|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626259|NCT03094481|Epinephrine|epinephrine|mesh-list
43626260|NCT03094481|Bupivacaine|bupivacaine|mesh-list
43626261|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
43626262|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
43626263|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626264|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626265|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
43626266|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626267|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43626268|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43626269|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
43626270|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626293|NCT03094468|Terbinafine|terbinafine|mesh-list
43626294|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
43626295|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626296|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626297|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626298|NCT03094507|Dolutegravir|dolutegravir|mesh-list
43626299|NCT03094507|Darunavir|darunavir|mesh-list
43626300|NCT03094507|Cobicistat|cobicistat|mesh-list
43626301|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43626302|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43626303|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626304|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626305|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43626306|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43626307|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
43626308|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626314|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43626315|NCT03094182|Hematinics|hematinics|mesh-ancestor
43626316|NCT03094442|Dexamethasone|dexamethasone|mesh-list
43626317|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626318|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
43626319|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
43626320|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626321|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626322|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626323|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
43626324|NCT03094442|Hormones|hormones|mesh-ancestor
43626325|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626326|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43626327|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626328|NCT03094156|Resveratrol|resveratrol|mesh-list
43626329|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43626330|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
43626331|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626332|NCT03094156|Protective Agents|protective agents|mesh-ancestor
43626333|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626334|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626335|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43626336|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
43626337|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626338|NCT03093805|Calcipotriene|calcipotriene|mesh-list
43626339|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626340|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43626341|NCT03093883|Hematinics|hematinics|mesh-ancestor
43626342|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
43626343|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
43626344|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
43626345|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43626346|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43626347|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626348|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626349|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
43626350|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43626351|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
43626352|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626353|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
43626354|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43626355|NCT03093545|Antibodies|antibodies|mesh-list
43626357|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626358|NCT03093597|Petrolatum|petrolatum|mesh-list
43626359|NCT03093597|Emollients|emollients|mesh-ancestor
43626360|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626361|NCT03093129|Artesunate|artesunate|mesh-list
43626366|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626367|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
43626368|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
43626369|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43626370|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
43626371|NCT03093389|Resveratrol|resveratrol|mesh-list
43626372|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
43626373|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626374|NCT03093389|Protective Agents|protective agents|mesh-ancestor
43626375|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626376|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626377|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43626378|NCT03093090|Furosemide|furosemide|mesh-list
43626379|NCT03093090|Diuretics|diuretics|mesh-ancestor
43626380|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
43626381|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626382|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43626383|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43626384|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626386|NCT03093168|Fludarabine|fludarabine|mesh-list
43626387|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43626388|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
43626389|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626390|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43626391|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43626392|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
43626393|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626394|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626395|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43626396|NCT03093103|Empagliflozin|empagliflozin|mesh-list
43626399|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626405|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43626406|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626407|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
43626408|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
43626409|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
43626410|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626411|NCT03092908|Acetic Acid|acetic acid|mesh-list
43626412|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43626413|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626414|NCT03092765|Quetmolimab|quetmolimab|mesh-list
43626415|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43626416|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43626417|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626418|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43626419|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
43626420|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626421|NCT03092310|Pancrelipase|pancrelipase|mesh-list
43626422|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626423|NCT03092193|Naproxen|naproxen|mesh-list
43626424|NCT03092193|Esomeprazole|esomeprazole|mesh-list
43626425|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43626426|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626432|NCT03092193|Analgesics|analgesics|mesh-ancestor
43626433|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
43626434|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626435|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626436|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626437|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43626438|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
43626439|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43626440|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43626441|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43626442|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
43626443|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626444|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43626445|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43626446|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626447|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626448|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43626449|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43626450|NCT03092466|Ropivacaine|ropivacaine|mesh-list
43626453|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626454|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626456|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626457|NCT03092076|Ticagrelor|ticagrelor|mesh-list
43626458|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43626459|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43626460|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43626461|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43626462|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
43626463|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626464|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626465|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626466|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
43626467|NCT03091894|Propofol|propofol|mesh-list
43626468|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43626469|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626470|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626471|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43626472|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
43626473|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
43626474|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43626475|NCT03091894|Analgesics|analgesics|mesh-ancestor
43626476|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
43626477|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626479|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43626480|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43626481|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
43626482|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626483|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626484|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43626485|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43626486|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
43626487|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626488|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43626489|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43626490|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
43626491|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
43626492|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626493|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626494|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43626495|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
43626496|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
43626497|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626498|NCT03091712|Insulin|insulin|mesh-list
43626499|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626500|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626501|NCT03091699|Nicotine|nicotine|mesh-list
43626502|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43626503|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
43626504|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626505|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626506|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43626507|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43626508|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
43626509|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626510|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626511|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43626512|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626513|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626514|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
43626515|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626516|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626517|NCT03091569|Vitamin K|vitamin k|mesh-list
43626518|NCT03091569|Vitamins|vitamins|mesh-ancestor
43626519|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
43626520|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626521|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43626522|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43626529|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43626530|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43626531|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
43626533|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626534|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43626535|NCT03091595|Estrogens|estrogens|mesh-ancestor
43626536|NCT03091595|Hormones|hormones|mesh-ancestor
43626537|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626546|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43626547|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
43626548|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626549|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626550|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43626551|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
43626552|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
43626553|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43626554|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43626555|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43626556|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43626557|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
43626558|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626559|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626560|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
43626561|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43626562|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626563|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626564|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43626565|NCT03091166|Analgesics|analgesics|mesh-ancestor
43626566|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
43626567|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626568|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43626569|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43626570|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43626571|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
43626576|NCT03091075|Hormones|hormones|mesh-ancestor
43626609|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43626610|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
43626611|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626612|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626613|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626614|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43626615|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43626616|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626617|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43626618|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43626619|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
43626620|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
43626621|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
43626622|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43626623|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43626624|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43626625|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43626626|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
43626627|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43626628|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626629|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626630|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43626631|NCT03090516|Donepezil|donepezil|mesh-list
43626632|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43626633|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626634|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626635|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
43626636|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626637|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626638|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
43626639|NCT03090269|Methylphenidate|methylphenidate|mesh-list
43626640|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43626641|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626642|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43626643|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43626644|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43626645|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626647|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626649|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43626650|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43626651|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
43626652|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
43626653|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626654|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626655|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626656|NCT03090048|Vitamin A|vitamin a|mesh-list
43626657|NCT03090048|Azithromycin|azithromycin|mesh-list
43626658|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
43626659|NCT03090048|Vitamins|vitamins|mesh-ancestor
43626660|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
43626661|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626662|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43626663|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626664|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
43626665|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626687|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626689|NCT03088072|Warfarin|warfarin|mesh-list
43626690|NCT03088072|Edoxaban|edoxaban|mesh-list
43626691|NCT03088072|Clopidogrel|clopidogrel|mesh-list
43626692|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43626693|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43626694|NCT03088072|Analgesics|analgesics|mesh-ancestor
43626695|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
43626696|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626697|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626698|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626699|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43626700|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43626701|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43626702|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626703|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43626704|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43626705|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626706|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
43626707|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43626708|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43626709|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43626739|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
43626740|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626741|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43626742|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626757|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43626758|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43626759|NCT03085784|Growth Substances|growth substances|mesh-ancestor
43626760|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626761|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
43626762|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626763|NCT03085849|Durvalumab|durvalumab|mesh-list
43626764|NCT03085849|Tremelimumab|tremelimumab|mesh-list
43626765|NCT03085849|Guadecitabine|guadecitabine|mesh-list
43626766|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43626767|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626768|NCT03084783|Dexamethasone|dexamethasone|mesh-list
43626769|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626770|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
43626771|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
43626772|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626773|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626774|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626775|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
43626777|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626778|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43626779|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626780|NCT03081923|Durvalumab|durvalumab|mesh-list
43626781|NCT03081923|Tremelimumab|tremelimumab|mesh-list
43626782|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43626783|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626784|NCT03081949|Selenium|selenium|mesh-list
43626785|NCT03081949|Selenious Acid|selenious acid|mesh-list
43626786|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
43626787|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
43626788|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626789|NCT03081949|Protective Agents|protective agents|mesh-ancestor
43626790|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626792|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
43626793|NCT03081676|Glimepiride|glimepiride|mesh-list
43626794|NCT03081676|Glucagon|glucagon|mesh-list
43626795|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
43626796|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43626797|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43626798|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626804|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626805|NCT03081676|Incretins|incretins|mesh-ancestor
43626806|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
43626807|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
43626808|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626809|NCT03080480|Pioglitazone|pioglitazone|mesh-list
43626810|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626811|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626812|NCT03079973|Calcipotriene|calcipotriene|mesh-list
43626813|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626814|NCT03079830|Pirinitramide|pirinitramide|mesh-list
43626815|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43626816|NCT03079830|Narcotics|narcotics|mesh-ancestor
43626817|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626818|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626819|NCT03079830|Analgesics|analgesics|mesh-ancestor
43626820|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
43626821|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626822|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43626823|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626824|NCT03079895|Nicotine|nicotine|mesh-list
43626825|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43626826|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
43626827|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626828|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626829|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43626830|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43626831|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
43626832|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626833|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626834|NCT03079687|Olaparib|olaparib|mesh-list
43626835|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43626836|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626837|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626838|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626839|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
43626840|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43626841|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43626842|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43626843|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43626848|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43626849|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626850|NCT03079453|Dexamethasone|dexamethasone|mesh-list
43626851|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626852|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
43626853|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
43626854|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626855|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626856|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626857|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
43626859|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626860|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43626861|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626862|NCT03079388|Azithromycin|azithromycin|mesh-list
43626863|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
43626864|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
43626865|NCT03079388|Albendazole|albendazole|mesh-list
43626866|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43626867|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43626868|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626869|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
43626870|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43626871|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43626872|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43626873|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626874|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627066|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626875|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43626876|NCT03079388|Renal Agents|renal agents|mesh-ancestor
43626877|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
43626878|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
43626879|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43626880|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
43626881|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
43626882|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
43626883|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626884|NCT03079544|Asparaginase|asparaginase|mesh-list
43626885|NCT03079544|Pegaspargase|pegaspargase|mesh-list
43626886|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626887|NCT03079505|Dasatinib|dasatinib|mesh-list
43626888|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626889|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43626890|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626891|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626892|NCT03079219|Dexamethasone|dexamethasone|mesh-list
43626901|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
43626902|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626903|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626904|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626905|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
43626907|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626908|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43626909|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626910|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
43626911|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626913|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
43626914|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626915|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43626916|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
43626917|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626918|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43626919|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43626920|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626921|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43626922|NCT03079219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43626923|NCT03079219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43626924|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43626925|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43626926|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43626927|NCT03079271|Benzocaine|benzocaine|mesh-list
43626928|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
43626929|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
43626930|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626931|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626932|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
43626934|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
43626935|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43626936|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
43626937|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626938|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626939|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43626940|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
43626941|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43626942|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
43626943|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626944|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626945|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43626946|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
43626947|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
43626948|NCT03078933|Protective Agents|protective agents|mesh-ancestor
43626949|NCT03078829|Leuprolide|leuprolide|mesh-list
43626950|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43626951|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
43626952|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43626953|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626954|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43626955|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626956|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
43626957|NCT03079050|Lansoprazole|lansoprazole|mesh-list
43626958|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43626959|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626960|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43626961|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626962|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626963|NCT03079076|Bupivacaine|bupivacaine|mesh-list
43626964|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
43626970|NCT03079141|Eplerenone|eplerenone|mesh-list
43849434|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626974|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626975|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43626977|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
43626978|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43626979|NCT03079115|Atorvastatin|atorvastatin|mesh-list
43626980|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43626981|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43626982|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
43626983|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627000|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43627001|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
43627002|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627003|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627004|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627005|NCT03078777|Fexofenadine|fexofenadine|mesh-list
43627006|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43627007|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43627008|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43627009|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
43627010|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
43627011|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627012|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627013|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627014|NCT03078374|Warfarin|warfarin|mesh-list
43627015|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
43627016|NCT03078309|Cannabidiol|cannabidiol|mesh-list
43627017|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
43627018|NCT03078569|Testosterone|testosterone|mesh-list
43627019|NCT03078569|Androgens|androgens|mesh-ancestor
43627020|NCT03078569|Hormones|hormones|mesh-ancestor
43627021|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627022|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627023|NCT03078257|Aspirin|aspirin|mesh-list
43627024|NCT03078257|Tirofiban|tirofiban|mesh-list
43627025|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
43627026|NCT03078257|Clopidogrel|clopidogrel|mesh-list
43627027|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627028|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627029|NCT03078257|Analgesics|analgesics|mesh-ancestor
43627030|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
43627031|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627032|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627033|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627034|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627035|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43627036|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43627041|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
43627042|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43627043|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43627044|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43627045|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
43627046|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627047|NCT03078231|Mydriatics|mydriatics|mesh-list
43627048|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
43627049|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627050|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627051|NCT03078062|Dexamethasone|dexamethasone|mesh-list
43627052|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627054|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
43627055|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627056|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627057|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43627058|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
43627059|NCT03078062|Hormones|hormones|mesh-ancestor
43627060|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627061|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43627062|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627063|NCT03078101|Empagliflozin|empagliflozin|mesh-list
43627064|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43627065|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627067|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627068|NCT03077633|Progesterone|progesterone|mesh-list
43627069|NCT03077633|Progestins|progestins|mesh-ancestor
43627070|NCT03077633|Hormones|hormones|mesh-ancestor
43627071|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627072|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627073|NCT03077581|Anesthetics|anesthetics|mesh-list
43627074|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627075|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627076|NCT03077828|Carboplatin|carboplatin|mesh-list
43627077|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
43627078|NCT03077828|Etoposide|etoposide|mesh-list
43627079|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
43627080|NCT03077828|Ifosfamide|ifosfamide|mesh-list
43627081|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
43627082|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
43627083|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627084|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43627085|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43627091|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
43627092|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
43627093|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
43627094|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
43627095|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
43627096|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
43627108|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43627109|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
43627110|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627111|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627112|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43627113|NCT03077503|Narcotics|narcotics|mesh-ancestor
43627114|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43627115|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43627116|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
43627117|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
43627118|NCT03077516|Meloxicam|meloxicam|mesh-list
43627119|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627120|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627121|NCT03077516|Analgesics|analgesics|mesh-ancestor
43627122|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
43627123|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627126|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627127|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43627128|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43627129|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627130|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627131|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43627132|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43627133|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43627134|NCT03077555|Estradiol|estradiol|mesh-list
43627135|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43627136|NCT03077555|Estrogens|estrogens|mesh-ancestor
43627137|NCT03077555|Hormones|hormones|mesh-ancestor
43627138|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627139|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627140|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43627141|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
43627142|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43627143|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43627144|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43627145|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43627146|NCT03077217|Rifaximin|rifaximin|mesh-list
43627147|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43627148|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627149|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43627150|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
43627151|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43627152|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
43627154|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
43627168|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43627169|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627170|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627171|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43627172|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627173|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627174|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
43627177|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
43627178|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627179|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627180|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
43627181|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627182|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43627183|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
43627184|NCT03076684|Protective Agents|protective agents|mesh-ancestor
43627185|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627186|NCT03076151|Tacrolimus|tacrolimus|mesh-list
43627187|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43627188|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
43627189|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627190|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43627191|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627192|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627225|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627226|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627227|NCT03075657|Haloperidol|haloperidol|mesh-list
43627228|NCT03075657|Risperidone|risperidone|mesh-list
43627229|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
43627230|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43627231|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
43627232|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627233|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627234|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627235|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43627236|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43627237|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627238|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43627239|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43627240|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
43627241|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
43627242|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
43627243|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627244|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43627245|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43627246|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43627247|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43627248|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43627249|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627250|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627251|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
43627252|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627253|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627254|NCT03075358|Lidocaine|lidocaine|mesh-list
43627255|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627256|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
43627257|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627259|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
43627260|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627261|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43627262|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43627263|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43627264|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627265|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627266|NCT03074942|Reslizumab|reslizumab|mesh-list
43627267|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43627268|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
43627269|NCT03074968|Benzydamine|benzydamine|mesh-list
43627270|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627271|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
43627272|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
43627273|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627316|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627317|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
43627318|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627319|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
43627320|NCT03074786|Tenofovir|tenofovir|mesh-list
43627321|NCT03074786|Emtricitabine|emtricitabine|mesh-list
43627322|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43627323|NCT03074786|Dapivirine|dapivirine|mesh-list
43627326|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43627327|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43627328|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627329|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627330|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43627332|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
43627367|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627368|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
43627369|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627370|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627371|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
43627372|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627373|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43627374|NCT03074136|Eusol|eusol|mesh-list
43627375|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
43627376|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627377|NCT03073850|Anticoagulants|anticoagulants|mesh-list
43627378|NCT03073850|Edoxaban|edoxaban|mesh-list
43627379|NCT03073850|Clopidogrel|clopidogrel|mesh-list
43627380|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627381|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627382|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43627383|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627384|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43627385|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43627386|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43627387|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
43627388|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627389|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43627390|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
43627391|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43627392|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
43627393|NCT03073863|Atorvastatin|atorvastatin|mesh-list
43627394|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43627395|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43627396|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
43627397|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627406|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
43627407|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627408|NCT03073408|Propofol|propofol|mesh-list
43627409|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43627410|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627411|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627412|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43627413|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
43627414|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
43627415|NCT03073317|Mitogens|mitogens|mesh-list
43627416|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
43627417|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760769|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760770|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760771|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43760772|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
43760773|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43760774|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760775|NCT02443311|Analgesics|analgesics|mesh-ancestor
43760776|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
43760777|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760778|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760779|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
43760780|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760781|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
43760782|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43760783|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760784|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760785|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43760786|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43760787|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43760788|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760789|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760790|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760792|NCT02443194|Analgesics|analgesics|mesh-ancestor
43760793|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
43760794|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760795|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
43760796|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43760811|NCT02443142|Ibuprofen|ibuprofen|mesh-list
43760812|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760813|NCT02443142|Analgesics|analgesics|mesh-ancestor
43760814|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
43760815|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760816|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760817|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
43760818|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43760819|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760820|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760821|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43760822|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760823|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760824|NCT02442921|Colchicine|colchicine|mesh-list
43760825|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
43760826|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760827|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
43760828|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
43760829|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
43760848|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760850|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
43760851|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43760852|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
43760853|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43760854|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43760855|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760856|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43760857|NCT02442817|Linagliptin|linagliptin|mesh-list
43760858|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43760859|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760860|NCT02442817|Incretins|incretins|mesh-ancestor
43760861|NCT02442817|Hormones|hormones|mesh-ancestor
43760862|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760863|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43760864|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
43760865|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760866|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760867|NCT02442674|Tolvaptan|tolvaptan|mesh-list
43760868|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43760869|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760870|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
43760871|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760872|NCT02442648|Rituximab|rituximab|mesh-list
43760873|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43760874|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760887|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
43760888|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43760889|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760890|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
43760891|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
43760892|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
43760893|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760894|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
43760895|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43760896|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43760897|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
43760898|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760899|NCT02442739|Ketamine|ketamine|mesh-list
43760900|NCT02442739|Analgesics|analgesics|mesh-ancestor
43760901|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
43760902|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760903|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760904|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43760905|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43760906|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
43760907|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
43761033|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
43760908|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760911|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760912|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760913|NCT02442453|Turmeric extract|turmeric extract|mesh-list
43760914|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
43760915|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760916|NCT02442453|Protective Agents|protective agents|mesh-ancestor
43760917|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760918|NCT02442531|Docetaxel|docetaxel|mesh-list
43760919|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760920|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
43760921|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
43760922|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
43760923|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760925|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43760926|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43760927|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43760928|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760929|NCT02442440|Anisodamine|anisodamine|mesh-list
43760930|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43760931|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43760932|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760933|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760934|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760935|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760936|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43760937|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43760938|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760939|NCT02442440|Analgesics|analgesics|mesh-ancestor
43760940|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
43760941|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760942|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760943|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760944|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43565390|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
43760945|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760947|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
43760948|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
43760949|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43760950|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
43760951|NCT02442440|Protective Agents|protective agents|mesh-ancestor
43760952|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
43760953|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
43760954|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43760955|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43760956|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760957|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760958|NCT02442492|Urological Agents|urological agents|mesh-ancestor
43760959|NCT02442063|Paclitaxel|paclitaxel|mesh-list
43760960|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43760961|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43760962|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760963|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
43760964|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
43760965|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
43760966|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760967|NCT02442427|Palivizumab|palivizumab|mesh-list
43760968|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
43760969|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760970|NCT02442128|Fentanyl|fentanyl|mesh-list
43760971|NCT02442128|Propofol|propofol|mesh-list
43760972|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43760973|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760974|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760975|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43760976|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
43760977|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
43760978|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43760979|NCT02442128|Narcotics|narcotics|mesh-ancestor
43760980|NCT02442128|Analgesics|analgesics|mesh-ancestor
43760981|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
43760982|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760983|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43837364|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
43837365|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43837366|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837367|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
43837368|NCT04913025|Nivolumab|nivolumab|mesh-list
43837369|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43837370|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837371|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43837372|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837373|NCT04912921|Palmidrol|palmidrol|mesh-list
43837374|NCT04912921|Analgesics|analgesics|mesh-ancestor
43837375|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
43837376|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837377|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837378|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43837379|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43837380|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837381|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43837382|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
43837383|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837384|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43837385|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43837386|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837387|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837388|NCT04912921|Hormones|hormones|mesh-ancestor
43837389|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837390|NCT04912765|Nivolumab|nivolumab|mesh-list
43837391|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43837392|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837393|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43837394|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837395|NCT04912427|Dexamethasone|dexamethasone|mesh-list
43837396|NCT04912427|Bortezomib|bortezomib|mesh-list
43837397|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837398|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
43837399|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
43837400|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760984|NCT02441933|Carboplatin|carboplatin|mesh-list
43760986|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760987|NCT02441907|Aflibercept|aflibercept|mesh-list
43760988|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43760989|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43760990|NCT02441907|Growth Substances|growth substances|mesh-ancestor
43760991|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760992|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
43760993|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760994|NCT02441842|Atenolol|atenolol|mesh-list
43760995|NCT02441842|Lisinopril|lisinopril|mesh-list
43760996|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43760997|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
43760998|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760999|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761000|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43761001|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43761002|NCT02441842|Protective Agents|protective agents|mesh-ancestor
43761009|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43761010|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43761011|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
43761012|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761013|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
43761014|NCT02441894|Promethazine|promethazine|mesh-list
43761015|NCT02441894|Dexamethasone|dexamethasone|mesh-list
43761016|NCT02441894|Prednisolone|prednisolone|mesh-list
43761017|NCT02441894|Ondansetron|ondansetron|mesh-list
43761018|NCT02441894|Metoclopramide|metoclopramide|mesh-list
43761019|NCT02441894|Granisetron|granisetron|mesh-list
43761021|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
43761022|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761023|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
43761024|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
43761025|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761026|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761027|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761028|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
43761029|NCT02441894|Hormones|hormones|mesh-ancestor
43761030|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761031|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43761032|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761036|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
43761042|NCT02441894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43761043|NCT02441894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43761044|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43761045|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43761046|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
43761047|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
43761048|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
43761049|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43761050|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
43761051|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
43761052|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43761053|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43761054|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43761055|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
43761056|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43761057|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43761059|NCT02441673|Meperidine|meperidine|mesh-list
43761060|NCT02441673|Tramadol|tramadol|mesh-list
43761061|NCT02441673|Nefopam|nefopam|mesh-list
43761062|NCT02441673|Metoclopramide|metoclopramide|mesh-list
43761063|NCT02441673|Ranitidine|ranitidine|mesh-list
43761064|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43761066|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
43761067|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43761068|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761069|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43761070|NCT02441673|Narcotics|narcotics|mesh-ancestor
43761071|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761072|NCT02441673|Analgesics|analgesics|mesh-ancestor
43761073|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
43761074|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761075|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
43761076|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
43761077|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761078|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43761079|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43761080|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
43761081|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761082|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761083|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43761084|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
43761085|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43761086|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
43761087|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43761088|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43761089|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
43761090|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
43761091|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43761092|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761093|NCT02441803|Cytarabine|cytarabine|mesh-list
43761094|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
43761095|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
43761096|NCT02441803|Busulfan|busulfan|mesh-list
43761097|NCT02441803|Fludarabine|fludarabine|mesh-list
43761098|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
43761099|NCT02441803|Decitabine|decitabine|mesh-list
43761100|NCT02441803|Idarubicin|idarubicin|mesh-list
43761101|NCT02441803|Clofarabine|clofarabine|mesh-list
43761102|NCT02441803|Tacrolimus|tacrolimus|mesh-list
43761103|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
43761104|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43761105|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43761106|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
43761107|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761108|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761109|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43761110|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
43761111|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761112|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761113|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43761114|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43761115|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
43761116|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
43761117|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761118|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43761119|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761130|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761132|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761133|NCT02441465|Vemurafenib|vemurafenib|mesh-list
43761134|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761135|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43761136|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761137|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761138|NCT02441530|Vitamin D|vitamin d|mesh-list
43761139|NCT02441530|Vitamins|vitamins|mesh-list
43761140|NCT02441530|Vitamin E|vitamin e|mesh-list
43761141|NCT02441530|Ibuprofen|ibuprofen|mesh-list
43761142|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
43761143|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761144|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43761145|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43761146|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761147|NCT02441530|Analgesics|analgesics|mesh-ancestor
43761148|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
43761149|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761150|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761151|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761152|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43761153|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761154|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761155|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
43761156|NCT02441530|Protective Agents|protective agents|mesh-ancestor
43761157|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
43761158|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43761159|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
43761160|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43761161|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
43761162|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761163|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761164|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43761165|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
43761166|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761167|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761168|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43761169|NCT02441075|Ethanol|ethanol|mesh-list
43761170|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43761171|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761172|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761173|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761174|NCT02440880|Dexamethasone|dexamethasone|mesh-list
43761175|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
43761176|NCT02440880|BB 1101|bb 1101|mesh-list
43761177|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761178|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
43761179|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
43761180|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761181|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761182|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761183|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
43761184|NCT02440880|Hormones|hormones|mesh-ancestor
43761185|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761186|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43761187|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761188|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
43761189|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761190|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761198|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43761199|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43761200|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43761201|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
43761202|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761203|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43761204|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761205|NCT02440958|Folfirinox|folfirinox|mesh-list
43761206|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761207|NCT02440841|Itraconazole|itraconazole|mesh-list
43761208|NCT02440841|Rifampin|rifampin|mesh-list
43761209|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
43761210|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761211|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43761212|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43761213|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761214|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761215|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43761216|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
43761217|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761218|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761219|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43761220|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43761221|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
43761222|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43761223|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
43761224|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43761225|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43761226|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43761227|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43761228|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43761229|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43761230|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43761232|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43761233|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761238|NCT02440399|Diclofenac|diclofenac|mesh-list
43761239|NCT02440399|Morphine|morphine|mesh-list
43761240|NCT02440399|Oxycodone|oxycodone|mesh-list
43761241|NCT02440399|Tramadol|tramadol|mesh-list
43761242|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43761243|NCT02440399|Narcotics|narcotics|mesh-ancestor
43761244|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761245|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761246|NCT02440399|Analgesics|analgesics|mesh-ancestor
43761247|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
43761248|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761249|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761250|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
43761251|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43761252|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761253|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761254|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43761255|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761256|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761257|NCT02440243|Vaccines|vaccines|mesh-list
43761258|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
43761259|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761260|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
43761261|NCT02440256|Narcotics|narcotics|mesh-ancestor
43761262|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761263|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837410|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837411|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
43565754|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
43761267|NCT02440100|Midazolam|midazolam|mesh-list
43761268|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43761269|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43761270|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761271|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761272|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43761273|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43761274|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43761275|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43761276|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
43761278|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
43761279|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
43761280|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761281|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761282|NCT02439944|Nicotine|nicotine|mesh-list
43761283|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43761284|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
43761285|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761286|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761287|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43761288|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43761289|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
43761290|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761291|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761292|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
43761293|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43761294|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761295|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761296|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761297|NCT02439905|Analgesics|analgesics|mesh-ancestor
43761298|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
43761299|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761300|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43761301|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43761302|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43761303|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
43761304|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761305|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761306|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
43761307|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43761317|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761318|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761319|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
43761320|NCT02439866|Hormones|hormones|mesh-ancestor
43761321|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761322|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43761323|NCT02439866|Protective Agents|protective agents|mesh-ancestor
43761324|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43761325|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761326|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43761327|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
43761328|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43761329|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
43761330|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761331|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
43761332|NCT02439788|Fludarabine|fludarabine|mesh-list
43761333|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43761334|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
43761335|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761336|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761337|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43761338|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
43761339|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761340|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761341|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43761342|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
43761343|NCT02439697|Hematinics|hematinics|mesh-ancestor
43761344|NCT02439632|Levofloxacin|levofloxacin|mesh-list
43761345|NCT02439632|Ofloxacin|ofloxacin|mesh-list
43761346|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
43761347|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
43761348|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43761349|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761350|NCT02439632|Renal Agents|renal agents|mesh-ancestor
43761351|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43761352|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43761354|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761355|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761356|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761357|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43761358|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43761359|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43761360|NCT02439489|Carboplatin|carboplatin|mesh-list
43761361|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761362|NCT02439190|Aspirin|aspirin|mesh-list
43761363|NCT02439190|Clopidogrel|clopidogrel|mesh-list
43761364|NCT02439190|BMS-986120|bms-986120|mesh-list
43761365|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43761366|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761367|NCT02439190|Analgesics|analgesics|mesh-ancestor
43761368|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
43761369|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761370|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761371|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761372|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761373|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43761374|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43761375|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761376|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43761377|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43761378|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761379|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
43761380|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43761381|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43761382|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43761383|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
43761384|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761386|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761387|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43761388|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761390|NCT02439125|Eltoprazine|eltoprazine|mesh-list
43761403|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761404|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
43761405|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43761406|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761407|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761408|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43761409|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761410|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761411|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43761412|NCT02439034|Narcotics|narcotics|mesh-ancestor
43761413|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43565902|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761414|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
43761415|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
43761416|NCT02438982|Rituximab|rituximab|mesh-list
43761417|NCT02438982|Tacrolimus|tacrolimus|mesh-list
43761418|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43761419|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43761420|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761421|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
43761422|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761423|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761424|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43761425|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761426|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761427|NCT02438709|Etoricoxib|etoricoxib|mesh-list
43761428|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43761429|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43761430|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761431|NCT02438709|Analgesics|analgesics|mesh-ancestor
43761432|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
43761433|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761435|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761442|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761443|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761444|NCT02438683|BI 409306|bi 409306|mesh-list
43761445|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43761447|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761449|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
43761450|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
43761451|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761452|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761453|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
43761454|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761455|NCT02438657|Lidocaine|lidocaine|mesh-list
43761456|NCT02438657|Epinephrine|epinephrine|mesh-list
43761457|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
43761458|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
43761459|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761460|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761461|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
43761462|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761463|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43761464|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43761465|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43761466|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43761467|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761468|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43761469|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43761470|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
43761471|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761472|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43761473|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43761482|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761483|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43761484|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43761485|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761486|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761487|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
43761488|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43761489|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43837412|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
43761490|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761491|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
43761492|NCT02438566|Coagulants|coagulants|mesh-ancestor
43761493|NCT02438345|Leronlimab|leronlimab|mesh-list
43761494|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43761495|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43761496|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761497|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43761498|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43837438|NCT04908449|Bupivacaine|bupivacaine|mesh-list
43837439|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
43837440|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
43837441|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837442|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837443|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
43837444|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837445|NCT04908176|Midazolam|midazolam|mesh-list
43837446|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43837447|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43837448|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837449|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837451|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43837452|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837453|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43837454|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
43837455|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
43837456|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
43837457|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
43837458|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837459|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837460|NCT04906382|Paclitaxel|paclitaxel|mesh-list
43761512|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
43761513|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43761514|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
43761515|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761516|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761517|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
43761518|NCT02437825|Octreotide|octreotide|mesh-list
43761520|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43761521|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761522|NCT02438072|Fexofenadine|fexofenadine|mesh-list
43761523|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
43761524|NCT02438072|Midazolam|midazolam|mesh-list
43761525|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
43761526|NCT02438072|Caffeine|caffeine|mesh-list
43761527|NCT02438072|Bupropion|bupropion|mesh-list
43761528|NCT02438072|Omeprazole|omeprazole|mesh-list
43761529|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43761530|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43761531|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761532|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761533|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43761534|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43761535|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43761536|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43761537|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
43761538|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
43761539|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
43761540|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
43761541|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761542|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761543|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43761544|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761555|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43761556|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43761557|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
43761558|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43761559|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43761560|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
43761561|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
43761562|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43761563|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43761564|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43761576|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43761578|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43761579|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761580|NCT02437812|Metformin|metformin|mesh-list
43761581|NCT02437812|Paclitaxel|paclitaxel|mesh-list
43761582|NCT02437812|Carboplatin|carboplatin|mesh-list
43761583|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43761584|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761585|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
43761586|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
43761587|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
43761588|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761589|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43761590|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761591|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
43761592|NCT02437955|Trace Elements|trace elements|mesh-ancestor
43761593|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
43761594|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761595|NCT02437461|Triamcinolone|triamcinolone|mesh-list
43761596|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43761597|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43761598|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43761599|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761600|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
43761601|NCT02437461|Hormones|hormones|mesh-ancestor
43761602|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761603|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761604|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43761605|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
43761606|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761607|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761608|NCT02437721|Folic Acid|folic acid|mesh-list
43761609|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
43761610|NCT02437721|Hematinics|hematinics|mesh-ancestor
43761611|NCT02437721|Vitamins|vitamins|mesh-ancestor
43761612|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
43761613|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761614|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
43761627|NCT02437045|Piperacillin|piperacillin|mesh-list
43761628|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43761629|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43761630|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761631|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43761632|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761633|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761634|NCT02436993|Paclitaxel|paclitaxel|mesh-list
43761635|NCT02436993|Bevacizumab|bevacizumab|mesh-list
43761636|NCT02436993|Carboplatin|carboplatin|mesh-list
43761637|NCT02436993|Trastuzumab|trastuzumab|mesh-list
43761638|NCT02436993|Pertuzumab|pertuzumab|mesh-list
43761639|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43761640|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761641|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
43761642|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
43761643|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
43761644|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761645|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43761646|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43761647|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43761648|NCT02436993|Growth Substances|growth substances|mesh-ancestor
43761649|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761650|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
43761651|NCT02436980|Midazolam|midazolam|mesh-list
43761652|NCT02436980|Tramadol|tramadol|mesh-list
43761653|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43847897|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
43761654|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43761655|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761656|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761657|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43761658|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43761659|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43761660|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43761661|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
43761662|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
43761664|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
43761665|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761666|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761667|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43761668|NCT02436980|Narcotics|narcotics|mesh-ancestor
43761669|NCT02436980|Analgesics|analgesics|mesh-ancestor
43761670|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
43761671|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761672|NCT02437032|Menotropins|menotropins|mesh-list
43761673|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43761674|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
43761675|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43761676|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761677|NCT02436928|Vaccines|vaccines|mesh-list
43761678|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
43761679|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761680|NCT02436902|Sorafenib|sorafenib|mesh-list
43761681|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
43761682|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761683|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43761684|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761685|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761686|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43761687|NCT02436902|Estrogens|estrogens|mesh-ancestor
43761688|NCT02436902|Hormones|hormones|mesh-ancestor
43761689|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761705|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761706|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761707|NCT02436798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43761708|NCT02436798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43761709|NCT02436798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761710|NCT02436798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43761711|NCT02436798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43761712|NCT02436694|Dexamethasone|dexamethasone|mesh-list
43761713|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
43761714|NCT02436694|Ropivacaine|ropivacaine|mesh-list
43761715|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
43761716|NCT02436694|Anesthetics|anesthetics|mesh-list
43761717|NCT02436694|BB 1101|bb 1101|mesh-list
43761718|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761719|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
43761720|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
43762012|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
43566261|NCT00835614|Cefprozil|cefprozil|mesh-list
43761724|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
43761725|NCT02436694|Hormones|hormones|mesh-ancestor
43847898|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
43761734|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
43761749|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761750|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761751|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43761752|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761754|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43761755|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
43761756|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761757|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761758|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43761759|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
43761760|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43761761|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
43761762|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761763|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761779|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43761780|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
43761781|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43761782|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
43761783|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
43761784|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761785|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43761786|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
43761787|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761788|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761789|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43761790|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
43761791|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43761792|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43761793|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43761794|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43761795|NCT02436083|Cefuroxime|cefuroxime|mesh-list
43761796|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
43761797|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761798|NCT02436044|Leucovorin|leucovorin|mesh-list
43761799|NCT02436044|Fluorouracil|fluorouracil|mesh-list
43761800|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
43761801|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
43761802|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
43761803|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761804|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43761805|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761806|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43761807|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
43761808|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761809|NCT02436044|Antidotes|antidotes|mesh-ancestor
43761810|NCT02436044|Protective Agents|protective agents|mesh-ancestor
43761822|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43761823|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
43761824|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761825|NCT02435927|Antidotes|antidotes|mesh-ancestor
43761826|NCT02435927|Protective Agents|protective agents|mesh-ancestor
43761827|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
43761828|NCT02435927|Vitamins|vitamins|mesh-ancestor
43761829|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
43761830|NCT02435797|Nicorandil|nicorandil|mesh-list
43761831|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43761832|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43761833|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
43761834|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
43761835|NCT02435797|Vitamins|vitamins|mesh-ancestor
43761836|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
43761837|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761838|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
43761839|NCT02435771|Vitamin D|vitamin d|mesh-list
43761840|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43761841|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566409|NCT00834873|Carvedilol|carvedilol|mesh-list
43761843|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
43761844|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43761845|NCT02435732|Heparin|heparin|mesh-list
43761846|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
43761847|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43761848|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43761858|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761859|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43761861|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43761862|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43761863|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761864|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761865|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
43761866|NCT02435563|Ritonavir|ritonavir|mesh-list
43761867|NCT02435563|Ticagrelor|ticagrelor|mesh-list
43761868|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43761869|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43761870|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
43761871|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761872|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761873|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43761874|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43761875|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
43761876|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761877|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43761878|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43761879|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43761880|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43761881|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43761882|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43761883|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
43761884|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761885|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761886|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
43761887|NCT02435537|Morphine|morphine|mesh-list
43761888|NCT02435537|Bupivacaine|bupivacaine|mesh-list
43761889|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
43761896|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761897|NCT02435537|Analgesics|analgesics|mesh-ancestor
43761898|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43761899|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43761900|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43761901|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
43761902|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761903|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761904|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43761905|NCT02435537|Narcotics|narcotics|mesh-ancestor
43761906|NCT02435459|Calcium|calcium|mesh-list
43761907|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43761908|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761909|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
43761910|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43761911|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761912|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43761913|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
43761914|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43761915|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761916|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761917|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761918|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
43761919|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
43761920|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43761921|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43761930|NCT02435186|Paclitaxel|paclitaxel|mesh-list
43761931|NCT02435186|Cisplatin|cisplatin|mesh-list
43761932|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43761933|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761934|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
43761935|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
43761936|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
43761937|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761938|NCT02435108|Crizotinib|crizotinib|mesh-list
43761939|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761940|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43761941|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761942|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761944|NCT02434952|Primaquine|primaquine|mesh-list
43761945|NCT02434952|Artenimol|artenimol|mesh-list
43761946|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
43761947|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43761948|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43761949|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761950|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
43761951|NCT02434861|Digoxin|digoxin|mesh-list
43761952|NCT02434861|Rolapitant|rolapitant|mesh-list
43761953|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43761954|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43761955|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761956|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761957|NCT02434861|Protective Agents|protective agents|mesh-ancestor
43761958|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761959|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761960|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43761961|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761962|NCT02434861|Analgesics|analgesics|mesh-ancestor
43761963|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
43761964|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761971|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43761972|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43761973|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761974|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
43761975|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761976|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761977|NCT02434822|Vaccines|vaccines|mesh-list
43761978|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
43761979|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837508|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837509|NCT04905251|Misoprostol|misoprostol|mesh-list
43837510|NCT04905251|Mifepristone|mifepristone|mesh-list
43837511|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43837512|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
43837513|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43837514|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837515|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43837516|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837517|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
43837518|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43837519|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43837520|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43837521|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43837522|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
43837523|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43837524|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43761980|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43761981|NCT02434757|Hormones|hormones|mesh-ancestor
43761982|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761983|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761992|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761994|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
43761995|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761996|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
43761997|NCT02434614|Cisplatin|cisplatin|mesh-list
43761998|NCT02434614|Docetaxel|docetaxel|mesh-list
43761999|NCT02434614|Fluorouracil|fluorouracil|mesh-list
43762000|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762001|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
43762002|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
43762003|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
43762004|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762005|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
43762006|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43762007|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762008|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
43762009|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762010|NCT02433860|Nicotine|nicotine|mesh-list
43762011|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43762013|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762014|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762015|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43762016|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43762017|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
43762018|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762019|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762021|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762022|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43762023|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
43762024|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762025|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762026|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762028|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43762029|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762030|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762031|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
43762032|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762033|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762034|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43762035|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
43762036|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762037|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
43762038|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43762039|NCT02433899|Dexamethasone|dexamethasone|mesh-list
43762040|NCT02433899|Epinephrine|epinephrine|mesh-list
43762041|NCT02433899|Mepivacaine|mepivacaine|mesh-list
43762042|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762043|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
43762044|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
43762045|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762046|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762047|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762048|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
43762049|NCT02433899|Hormones|hormones|mesh-ancestor
43762050|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762051|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43762052|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762053|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43762061|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762062|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43762063|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43762064|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43762065|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
43762066|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
43762067|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
43762068|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43762069|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
43762070|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
43762071|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762072|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
43762073|NCT02434029|Budesonide|budesonide|mesh-list
43762074|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762075|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43762076|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
43762077|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762078|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762079|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43762080|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
43762081|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
43762082|NCT02434029|Hormones|hormones|mesh-ancestor
43762083|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762084|NCT02433925|Resveratrol|resveratrol|mesh-list
43762085|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
43762086|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762087|NCT02433925|Protective Agents|protective agents|mesh-ancestor
43762088|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762089|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762090|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43762091|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43762092|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43762093|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43762094|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762095|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762096|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43762098|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43762099|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
43762100|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762101|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762102|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43762103|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43762104|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
43762105|NCT02433652|Vaccines|vaccines|mesh-list
43762106|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
43762107|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762108|NCT02433626|Cisplatin|cisplatin|mesh-list
43762109|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762110|NCT02433587|Aspirin|aspirin|mesh-list
43762111|NCT02433587|Clopidogrel|clopidogrel|mesh-list
43762112|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43762113|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43762114|NCT02433587|Analgesics|analgesics|mesh-ancestor
43762115|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
43762116|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762117|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762118|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762119|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43762122|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762123|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43762124|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43762125|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762126|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
43762127|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43762128|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43762129|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43762130|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
43762131|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762132|NCT02433704|Cefazolin|cefazolin|mesh-list
43762133|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43762134|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762135|NCT02433457|Omeprazole|omeprazole|mesh-list
43762136|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43762137|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762138|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43762139|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762140|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762141|NCT02433535|Simvastatin|simvastatin|mesh-list
43762142|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43762143|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43762144|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
43762145|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762146|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43762147|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43762148|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762149|NCT02433522|Rituximab|rituximab|mesh-list
43762150|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43762151|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762152|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
43762153|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762154|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43762155|NCT02433418|Diclofenac|diclofenac|mesh-list
43762156|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43762157|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43762158|NCT02433418|Analgesics|analgesics|mesh-ancestor
43762159|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
43762160|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762161|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762162|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762163|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43762164|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43762165|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762166|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762167|NCT02433314|Brexanolone|brexanolone|mesh-list
43762168|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
43762169|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762170|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762171|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762235|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762236|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762237|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43762239|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
43762240|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43762241|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
43762242|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762243|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762244|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
43762245|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762246|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762247|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
43762248|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762249|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43762250|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43762251|NCT02433041|Ketamine|ketamine|mesh-list
43762252|NCT02433041|Haloperidol|haloperidol|mesh-list
43762253|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
43762254|NCT02433041|Analgesics|analgesics|mesh-ancestor
43762255|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
43762256|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762257|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762258|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43762259|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43762260|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
43762261|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
43762262|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762263|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43762264|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43762265|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762266|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762267|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
43762268|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
43762269|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762270|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43762303|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762304|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762305|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
43762313|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762315|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
43762316|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43762317|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
43762318|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762319|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762320|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43762321|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
43762322|NCT02432534|Atorvastatin|atorvastatin|mesh-list
43762323|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43762324|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43762325|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
43762326|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762327|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43762328|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43762329|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762330|NCT02432612|Nabiximols|nabiximols|mesh-list
43762331|NCT02432612|Analgesics|analgesics|mesh-ancestor
43762332|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
43762333|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762334|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762335|NCT02432677|Remifentanil|remifentanil|mesh-list
43762347|NCT02432651|Growth Substances|growth substances|mesh-ancestor
43762348|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762349|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
43762350|NCT02433795|Rituximab|rituximab|mesh-list
43762351|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43762352|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43762353|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762354|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
43762355|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762356|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43762357|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43762358|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
43762359|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762360|NCT02432664|Midazolam|midazolam|mesh-list
43762361|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43762362|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43762363|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762364|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762365|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43762366|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43762368|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43762369|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
43762370|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
43762371|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
43762372|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
43762373|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762374|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762375|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
43762376|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43762377|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762378|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43762379|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
43762380|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43762381|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762382|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837527|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
43762383|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762384|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43762385|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43762386|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
43762387|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762388|NCT02432365|Paclitaxel|paclitaxel|mesh-list
43762389|NCT02432365|Cisplatin|cisplatin|mesh-list
43762390|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43762391|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762392|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
43762393|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
43762394|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
43762395|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762396|NCT02432053|Tacrolimus|tacrolimus|mesh-list
43762397|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762398|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
43762399|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762400|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43762401|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762402|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762403|NCT02432027|Betamethasone|betamethasone|mesh-list
43762404|NCT02432027|Calcipotriene|calcipotriene|mesh-list
43762405|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762406|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
43762407|NCT02432027|Hormones|hormones|mesh-ancestor
43762408|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762409|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762410|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43762411|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
43762412|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
43762413|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
43762414|NCT02432261|ST 1435|st 1435|mesh-list
43762415|NCT02432261|Testosterone|testosterone|mesh-list
43762416|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
43762417|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
43762418|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43762419|NCT02432261|Androgens|androgens|mesh-ancestor
43762420|NCT02432261|Hormones|hormones|mesh-ancestor
43762425|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
43762426|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43762427|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
43762428|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43762429|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43762430|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
43762431|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43762432|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43762433|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
43762434|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762435|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762436|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762437|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
43762438|NCT02431988|Fludarabine|fludarabine|mesh-list
43762439|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762440|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
43762441|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762442|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43762443|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43762444|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
43762445|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762446|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762449|NCT02431975|Lopinavir|lopinavir|mesh-list
43762450|NCT02431975|Lamivudine|lamivudine|mesh-list
43762451|NCT02431975|Zidovudine|zidovudine|mesh-list
43762452|NCT02431975|Nevirapine|nevirapine|mesh-list
43762453|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43762454|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43762455|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
43762456|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762457|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762458|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43762459|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43762460|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
43762461|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762462|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43762463|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43762464|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43762465|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43762466|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
43762467|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43762468|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43762469|NCT02431936|Prazosin|prazosin|mesh-list
43762470|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43762471|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43762472|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43762473|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43762474|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
43762475|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762476|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762477|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762478|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43762479|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43762480|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762481|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43762482|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762483|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762484|NCT02431728|Melatonin|melatonin|mesh-list
43762485|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
43762486|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762487|NCT02431728|Protective Agents|protective agents|mesh-ancestor
43762488|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762489|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762490|NCT02431663|Ketamine|ketamine|mesh-list
43762491|NCT02431663|Analgesics|analgesics|mesh-ancestor
43762492|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
43762498|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
43762499|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762500|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43762501|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43762502|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762503|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762504|NCT02431429|Miltefosine|miltefosine|mesh-list
43762506|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762507|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762509|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43762510|NCT02431416|Hormones|hormones|mesh-list
43762511|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762512|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762513|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
43762514|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762515|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43762516|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762517|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762518|NCT02431325|Teduglutide|teduglutide|mesh-list
43762519|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762520|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43762521|NCT02431325|Protective Agents|protective agents|mesh-ancestor
43762522|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762523|NCT02431286|Dexamethasone|dexamethasone|mesh-list
43762524|NCT02431286|Aprepitant|aprepitant|mesh-list
43762525|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762526|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
43762527|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
43762528|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762529|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762530|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762531|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
43762532|NCT02431286|Hormones|hormones|mesh-ancestor
43762535|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762536|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43762537|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762538|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762540|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43762541|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43762542|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762543|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43762544|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762545|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
43762546|NCT02431208|Dexamethasone|dexamethasone|mesh-list
43762547|NCT02431208|Lenalidomide|lenalidomide|mesh-list
43762548|NCT02431208|Atezolizumab|atezolizumab|mesh-list
43762549|NCT02431208|Daratumumab|daratumumab|mesh-list
43762550|NCT02431208|Pomalidomide|pomalidomide|mesh-list
43762551|NCT02431208|Antibodies|antibodies|mesh-list
43762552|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43762553|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
43762554|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762555|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762556|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
43762557|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
43762558|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762559|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762560|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
43762562|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762563|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43762564|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762565|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43762566|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43762567|NCT02431208|Growth Substances|growth substances|mesh-ancestor
43762568|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
43762569|NCT02431143|Miltefosine|miltefosine|mesh-list
43762574|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43762576|NCT02431013|Simvastatin|simvastatin|mesh-list
43762577|NCT02431013|Pravastatin|pravastatin|mesh-list
43762578|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43762579|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43762580|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
43762581|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762582|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43762583|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43762584|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762585|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43762586|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
43762587|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762588|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762589|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43762590|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
43762591|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43762592|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43762593|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43762594|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
43762595|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43762596|NCT02431013|Protective Agents|protective agents|mesh-ancestor
43762597|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43762598|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43762599|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43762600|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762601|NCT02431065|Ropivacaine|ropivacaine|mesh-list
43762602|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
43762603|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
43762604|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762605|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762606|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
43762607|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762608|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
43837528|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43837529|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43763145|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
43837531|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43837532|NCT04904341|Protective Agents|protective agents|mesh-ancestor
43837533|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837534|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
43837535|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43837536|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43837537|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847899|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847900|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847902|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43847903|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43847904|NCT04069156|Analgesics|analgesics|mesh-ancestor
43847905|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
43847906|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847907|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847908|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847909|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847910|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43847911|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43847912|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847913|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43847914|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43847915|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847916|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
43847917|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
43847918|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43847936|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43847937|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
43847938|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43847939|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
43847940|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847941|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847942|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43847943|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43847944|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
43847945|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
43847946|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847947|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847948|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847949|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
43847950|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
43847951|NCT04065555|Cetuximab|cetuximab|mesh-list
43847952|NCT04065555|Avelumab|avelumab|mesh-list
43847953|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43847954|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43567253|NCT00760539|Timolol|timolol|mesh-list
43847955|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847956|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
43762613|NCT02430714|Lenvatinib|lenvatinib|mesh-list
43762614|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762615|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43762616|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762617|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762618|NCT02430896|Methylphenidate|methylphenidate|mesh-list
43762619|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43762620|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43762621|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762622|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43762623|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43762624|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43762625|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762626|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
43762627|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762628|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43762629|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
43762630|NCT02430545|Rifampin|rifampin|mesh-list
43762631|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43762632|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
43762633|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43762634|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762635|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
43762636|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43762637|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763146|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
43762638|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762639|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43762640|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43762641|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43762642|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43762643|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43762644|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43762645|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
43762646|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43762647|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43762648|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43762649|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
43762650|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762651|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762652|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762654|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
43762655|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762656|NCT02430298|Protective Agents|protective agents|mesh-ancestor
43762657|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762658|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762659|NCT02430259|Isoniazid|isoniazid|mesh-list
43762660|NCT02430259|Rifapentine|rifapentine|mesh-list
43762661|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
43762662|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43762663|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762664|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43762665|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43762666|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
43762667|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762668|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43762669|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43762670|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
43762671|NCT02430194|Interferons|interferons|mesh-list
43762672|NCT02430194|Ritonavir|ritonavir|mesh-list
43762673|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
43762674|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
43762675|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43762676|NCT02430194|Lonafarnib|lonafarnib|mesh-list
43762677|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762678|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
43762679|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762680|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43762681|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43762682|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
43762683|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762684|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762685|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43762686|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43762687|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43762688|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43762689|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
43762690|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762691|NCT02430350|Edaravone|edaravone|mesh-list
43762692|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43762693|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
43762694|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762695|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43762696|NCT02430350|Protective Agents|protective agents|mesh-ancestor
43762697|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762698|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
43762699|NCT02430363|Dactolisib|dactolisib|mesh-list
43762700|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43762701|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762702|NCT02429973|Gemcitabine|gemcitabine|mesh-list
43762703|NCT02429973|Sirolimus|sirolimus|mesh-list
43762704|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43762705|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
43762706|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762707|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762718|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43762720|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762721|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762722|NCT02429960|Analgesics|analgesics|mesh-ancestor
43762723|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
43762724|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762726|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
43762727|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762728|NCT02429921|Protective Agents|protective agents|mesh-ancestor
43762729|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762730|NCT02429921|Trace Elements|trace elements|mesh-ancestor
43762731|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
43762732|NCT02429804|Listerine|listerine|mesh-list
43762733|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
43762734|NCT02429804|Fluorides|fluorides|mesh-list
43762735|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
43762736|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43762737|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
43762738|NCT02429804|Protective Agents|protective agents|mesh-ancestor
43762739|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762740|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43762752|NCT02429700|Bleomycin|bleomycin|mesh-list
43762753|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43762754|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762755|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
43762756|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
43762757|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
43762758|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762759|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43762760|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43762761|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762762|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43762763|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
43762764|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43762765|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43762766|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
43762767|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762768|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762769|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762770|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
43762771|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
43762772|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762773|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
43762774|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43762775|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
43762776|NCT02429817|Edetic Acid|edetic acid|mesh-list
43762777|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
43762778|NCT02429817|Antidotes|antidotes|mesh-ancestor
43762779|NCT02429817|Protective Agents|protective agents|mesh-ancestor
43762780|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762781|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
43762782|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
43762783|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762784|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43762785|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
43762786|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43762787|NCT02429882|Brodalumab|brodalumab|mesh-list
43762788|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
43762789|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
43762790|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43762791|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
43762792|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762793|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762794|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43762795|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
43762796|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43762797|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43762798|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43762799|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
43762800|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762801|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762802|NCT02429687|Paclitaxel|paclitaxel|mesh-list
43762803|NCT02429687|Etoposide|etoposide|mesh-list
43762804|NCT02429687|Cisplatin|cisplatin|mesh-list
43762805|NCT02429687|Carboplatin|carboplatin|mesh-list
43762806|NCT02429687|Bleomycin|bleomycin|mesh-list
43762807|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43762808|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762809|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
43762810|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
43762811|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
43762812|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762814|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43762815|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762816|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43762817|NCT02429622|Paclitaxel|paclitaxel|mesh-list
43762818|NCT02429622|Nedaplatin|nedaplatin|mesh-list
43762819|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43762820|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762821|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
43762822|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
43762823|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
43762824|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762825|NCT02429596|Lamotrigine|lamotrigine|mesh-list
43762826|NCT02429596|Carbamazepine|carbamazepine|mesh-list
43762827|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
43762828|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43762829|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43762830|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762831|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43762832|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762833|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43762834|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43762835|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762836|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43762837|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43762838|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
43762839|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43762840|NCT02429596|Analgesics|analgesics|mesh-ancestor
43762841|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
43762842|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762843|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43762846|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43762847|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762848|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762849|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762851|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
43762852|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762853|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
43762854|NCT02429193|Hormones|hormones|mesh-ancestor
43762855|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762856|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762857|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43762858|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762859|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43762860|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762861|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762862|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
43762863|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43762864|NCT02429271|Clopidogrel|clopidogrel|mesh-list
43762865|NCT02429271|Ticagrelor|ticagrelor|mesh-list
43762866|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43762867|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43762868|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43762869|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43762870|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
43762871|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762872|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762873|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762874|NCT02429466|Guadecitabine|guadecitabine|mesh-list
43762875|NCT02429466|Azacitidine|azacitidine|mesh-list
43762876|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762877|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43762878|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
43762879|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762880|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762881|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43762882|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
43762883|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762894|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43762895|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
43762896|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762897|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762898|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
43762899|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43762900|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762902|NCT02429232|Linagliptin|linagliptin|mesh-list
43762903|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43762904|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762905|NCT02429232|Incretins|incretins|mesh-ancestor
43762906|NCT02429232|Hormones|hormones|mesh-ancestor
43762907|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762908|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43762909|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
43762910|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762911|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762912|NCT02429323|Sevoflurane|sevoflurane|mesh-list
43762913|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43762914|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43762915|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
43762916|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
43762917|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837546|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43837548|NCT04903509|Hormones|hormones|mesh-ancestor
43837549|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837550|NCT04903470|Bisacodyl|bisacodyl|mesh-list
43837551|NCT04903470|Cathartics|cathartics|mesh-ancestor
43837552|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837553|NCT04903470|Laxatives|laxatives|mesh-ancestor
43837554|NCT04903119|Trametinib|trametinib|mesh-list
43837555|NCT04903119|Dabrafenib|dabrafenib|mesh-list
43837556|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837557|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43837558|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837559|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837560|NCT04903002|Oxytocin|oxytocin|mesh-list
43837561|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
43837562|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43837563|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837564|NCT04902729|Oxytocin|oxytocin|mesh-list
43837565|NCT04902729|Carbetocin|carbetocin|mesh-list
43837566|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
43837567|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43837569|NCT04902625|Naltrexone|naltrexone|mesh-list
43762962|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762963|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43762964|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
43762965|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762966|NCT02428764|Antiviral Agents|antiviral agents|mesh-ancestor
43762967|NCT02428764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762968|NCT02428764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762969|NCT02428764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762970|NCT02428764|Immunologic Factors|immunologic factors|mesh-ancestor
43762971|NCT02428764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762972|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43762973|NCT02428933|Bromocriptine|bromocriptine|mesh-list
43762974|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43762975|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43762976|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
43762977|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762978|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762979|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
43762980|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
43762981|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762982|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762984|NCT02428777|Tramadol|tramadol|mesh-list
43762985|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43762986|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43762987|NCT02428777|Analgesics|analgesics|mesh-ancestor
43762988|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
43762997|NCT02428777|Narcotics|narcotics|mesh-ancestor
43763008|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763009|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43763010|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
43763011|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
43763012|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43763014|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43763015|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43763016|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43763017|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763018|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763019|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
43763020|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763068|NCT02428543|Ponatinib|ponatinib|mesh-list
43763069|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43763070|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
43763071|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763072|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763073|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
43763074|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763075|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763076|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
43763077|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763078|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43763079|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763080|NCT02428439|Lamotrigine|lamotrigine|mesh-list
43763081|NCT02428439|Bupropion|bupropion|mesh-list
43763082|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43763083|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
43763084|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43763085|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43763086|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43763087|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763088|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763089|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
43763090|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763091|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763092|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43763093|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43763094|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763095|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
43763096|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43763097|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43763098|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43763099|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43763112|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763113|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763114|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43763115|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43763116|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
43763117|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43763118|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43763119|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763121|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
43763122|NCT02428322|Vitamins|vitamins|mesh-ancestor
43763123|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
43763124|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763125|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43763126|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43763127|NCT02428257|Ephedrine|ephedrine|mesh-list
43763128|NCT02428257|Bupivacaine|bupivacaine|mesh-list
43763129|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
43763130|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
43763131|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763132|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763133|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
43763134|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763135|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43763136|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
43763137|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
43763138|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43763139|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
43763140|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763141|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763142|NCT02428283|Remifentanil|remifentanil|mesh-list
43763143|NCT02428283|Ropivacaine|ropivacaine|mesh-list
43763144|NCT02428283|Sevoflurane|sevoflurane|mesh-list
43763182|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
43763183|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43763184|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
43763185|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43763186|NCT02428062|Protective Agents|protective agents|mesh-ancestor
43763187|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43763188|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
43763189|NCT02427932|Gentamicins|gentamicins|mesh-list
43763190|NCT02427932|Ampicillin|ampicillin|mesh-list
43763191|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43763192|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763193|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43763194|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763195|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763196|NCT02427893|Vemurafenib|vemurafenib|mesh-list
43763197|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763198|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43763199|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763200|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763201|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43763202|NCT02427880|Furosemide|furosemide|mesh-list
43763203|NCT02427880|Acetazolamide|acetazolamide|mesh-list
43763204|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43763205|NCT02427880|Diuretics|diuretics|mesh-ancestor
43763206|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
43763207|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763208|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43763209|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763210|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763211|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43763212|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
43763213|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43763214|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763215|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43763216|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763217|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763219|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763220|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763221|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763223|NCT02427334|Fluoxetine|fluoxetine|mesh-list
43763224|NCT02427334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43763225|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43763227|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763228|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763229|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
43763230|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763231|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43763232|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
43763233|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43763234|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43763235|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43763236|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763237|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43763238|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
43763239|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763240|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43763241|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43763242|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43763259|NCT02427412|Coagulants|coagulants|mesh-ancestor
43763260|NCT02427386|Estradiol|estradiol|mesh-list
43763261|NCT02427386|Estrogens|estrogens|mesh-list
43763262|NCT02427386|Hormones|hormones|mesh-ancestor
43763263|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763264|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837576|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43837577|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
43837578|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837579|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43837580|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43837581|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43837582|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837583|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
43763285|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
43763286|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
43763287|NCT02426840|Vitamins|vitamins|mesh-list
43763288|NCT02426840|Calcium|calcium|mesh-list
43763289|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
43763290|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763291|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43763292|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43763293|NCT02426905|Trientine|trientine|mesh-list
43763294|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
43763295|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
43763296|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763297|NCT02426866|Efavirenz|efavirenz|mesh-list
43763298|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43763299|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43763300|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763301|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763302|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
43763303|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763304|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43763305|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43763306|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43763307|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43763308|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43763309|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43763310|NCT02426697|Fentanyl|fentanyl|mesh-list
43763311|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43763312|NCT02426697|Narcotics|narcotics|mesh-ancestor
43763313|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763314|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763315|NCT02426697|Analgesics|analgesics|mesh-ancestor
43763316|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
43763325|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43763326|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43763327|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763328|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763329|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763331|NCT02426723|Lenalidomide|lenalidomide|mesh-list
43763332|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43763333|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
43763335|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568032|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
43763336|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763337|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763338|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
43763340|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763342|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763365|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43763367|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
43763368|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
43763369|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
43763370|NCT02426619|Protective Agents|protective agents|mesh-ancestor
43763371|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763372|NCT02426463|Oxycodone|oxycodone|mesh-list
43763373|NCT02426463|Propofol|propofol|mesh-list
43763374|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43763375|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763376|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763377|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43763378|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
43763379|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
43763380|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43763381|NCT02426463|Narcotics|narcotics|mesh-ancestor
43763382|NCT02426463|Analgesics|analgesics|mesh-ancestor
43763383|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
43763384|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763385|NCT02426294|Pioglitazone|pioglitazone|mesh-list
43763386|NCT02426294|Glimepiride|glimepiride|mesh-list
43763387|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43763388|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763389|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43763390|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763391|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
43763392|NCT02426450|Leucovorin|leucovorin|mesh-list
43763393|NCT02426450|Fluorouracil|fluorouracil|mesh-list
43763394|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
43763395|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
43763396|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763397|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43763398|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763399|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763400|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
43763414|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
43763415|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763416|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43763418|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763419|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
43763420|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763421|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763422|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43763424|NCT02426177|Nifedipine|nifedipine|mesh-list
43763425|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43763426|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763427|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763428|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43763429|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763430|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
43763431|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
43763432|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763433|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43763434|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43763435|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
43763436|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763437|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43763438|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
43763439|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
43763440|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763441|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43763459|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763460|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
43763462|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763463|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43763464|NCT02426164|Protective Agents|protective agents|mesh-ancestor
43763467|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
43763468|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763469|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763470|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43763471|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43763472|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43763473|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
43763474|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
43763475|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
43763476|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43763477|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
43763478|NCT02426099|Spironolactone|spironolactone|mesh-list
43763479|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43763480|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
43763481|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763482|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763483|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43763484|NCT02426099|Diuretics|diuretics|mesh-ancestor
43763485|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
43763486|NCT02426060|Warfarin|warfarin|mesh-list
43763487|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
43763488|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43763489|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
43763539|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
43763540|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763541|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763542|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43763543|NCT02425722|Linaclotide|linaclotide|mesh-list
43763544|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43763545|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
43763546|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763547|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763548|NCT02425774|Prucalopride|prucalopride|mesh-list
43763549|NCT02425774|Laxatives|laxatives|mesh-ancestor
43763550|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763551|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43763552|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43763553|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
43763554|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763555|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763556|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763557|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
43763558|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763560|NCT02425709|Tramadol|tramadol|mesh-list
43763561|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43763562|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43763563|NCT02425709|Analgesics|analgesics|mesh-ancestor
43763564|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
43763565|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763566|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763567|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43763568|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43763569|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43763570|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763571|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763572|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43763573|NCT02425709|Narcotics|narcotics|mesh-ancestor
43763574|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763578|NCT02425605|Sorafenib|sorafenib|mesh-list
43837615|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43837616|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43837617|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837618|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837619|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837620|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43837621|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
43837622|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43837623|NCT04899492|Nicotine|nicotine|mesh-list
43837624|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43837625|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
43837626|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837627|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837628|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43837629|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43837630|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
43837631|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837632|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837633|NCT04898374|Gemcitabine|gemcitabine|mesh-list
43837634|NCT04898374|Cisplatin|cisplatin|mesh-list
43837635|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837636|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43837637|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
43837638|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837639|NCT04898374|Antiviral Agents|antiviral agents|mesh-ancestor
43837640|NCT04898374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837641|NCT04898374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837642|NCT04898374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837643|NCT04898374|Immunologic Factors|immunologic factors|mesh-ancestor
43837644|NCT04898374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837645|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
43837646|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
43837647|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837648|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
43837649|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43837651|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837652|NCT04898114|Urological Agents|urological agents|mesh-ancestor
43837653|NCT04898114|Analgesics|analgesics|mesh-ancestor
43763584|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
43763585|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763586|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
43763587|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763588|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763589|NCT02426112|Azithromycin|azithromycin|mesh-list
43763590|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43763591|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763592|NCT02425865|Golimumab|golimumab|mesh-list
43763593|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43763594|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43763595|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763596|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
43763597|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763598|NCT02425462|Dienogest|dienogest|mesh-list
43763599|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43763600|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
43763601|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763602|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763603|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43763604|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43763615|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43763616|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
43763617|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763618|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763619|NCT02425137|Antiviral Agents|antiviral agents|mesh-ancestor
43763620|NCT02425137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763621|NCT02425137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763622|NCT02425137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763623|NCT02425137|Immunologic Factors|immunologic factors|mesh-ancestor
43763624|NCT02425137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763625|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
43763626|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43763627|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43763628|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43763629|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43763630|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763631|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763632|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
43763633|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763634|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763635|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43763636|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763637|NCT02425202|Ketamine|ketamine|mesh-list
43763638|NCT02425202|Analgesics|analgesics|mesh-ancestor
43763639|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
43763640|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763722|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
43763642|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43763643|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43763644|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
43763646|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763647|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43763648|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43763650|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763651|NCT02425254|Acetaminophen|acetaminophen|mesh-list
43763652|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43763653|NCT02425254|Analgesics|analgesics|mesh-ancestor
43763654|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
43763655|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763656|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763657|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
43763658|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43763659|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43763660|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763661|NCT02424552|Vitamin D|vitamin d|mesh-list
43763662|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
43763663|NCT02424552|Vitamins|vitamins|mesh-ancestor
43763664|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
43763665|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763666|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43763667|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43763673|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
43763674|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43763675|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43763676|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763677|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43763678|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43763679|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43763680|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763681|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763682|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
43763683|NCT02424318|Topiramate|topiramate|mesh-list
43763684|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
43763685|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43763686|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763687|NCT02424214|Ionophores|ionophores|mesh-list
43763688|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763689|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763690|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
43763691|NCT02424201|Misoprostol|misoprostol|mesh-list
43763692|NCT02424201|Vitamins|vitamins|mesh-ancestor
43763693|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
43763694|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763695|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43763696|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
43763697|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763698|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43763699|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763700|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
43763701|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
43763702|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763703|NCT02424201|Protective Agents|protective agents|mesh-ancestor
43763704|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
43763707|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43763708|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763709|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43763710|NCT02424461|Renal Agents|renal agents|mesh-ancestor
43763711|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43763712|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43763713|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763714|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763715|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763716|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43763717|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43763718|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
43763719|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43763720|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43763721|NCT02424435|Prednisolone|prednisolone|mesh-list
43763723|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43763724|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
43763725|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43763726|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
43763727|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
43763728|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763729|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763730|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763741|NCT02424136|Antibodies|antibodies|mesh-list
43763742|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
43763743|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763744|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43763745|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
43763746|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763747|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43763748|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
43763749|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43763750|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
43763751|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763752|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763753|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43763754|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
43763755|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
43763756|NCT02424136|Protective Agents|protective agents|mesh-ancestor
43763757|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
43763758|NCT02423928|Ipilimumab|ipilimumab|mesh-list
43763759|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763760|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
43763761|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763762|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43763763|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43763764|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
43763771|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
43763772|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763773|NCT02424071|Protective Agents|protective agents|mesh-ancestor
43763774|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763775|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763776|NCT02423954|Sirolimus|sirolimus|mesh-list
43763777|NCT02423954|Capecitabine|capecitabine|mesh-list
43763778|NCT02423954|Nivolumab|nivolumab|mesh-list
43763779|NCT02423954|Irinotecan|irinotecan|mesh-list
43763780|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43763781|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
43763782|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763783|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763784|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43763785|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43763786|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43763787|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43763788|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763789|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43763790|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763791|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43763792|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
43763793|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763794|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
43763795|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763796|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
43763797|NCT02423915|Sirolimus|sirolimus|mesh-list
43763798|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
43763799|NCT02423915|Rituximab|rituximab|mesh-list
43763800|NCT02423915|Fludarabine|fludarabine|mesh-list
43763801|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
43763802|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763803|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
43763804|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763805|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43763806|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43763810|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43763811|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43763812|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43763813|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
43763814|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763815|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43763816|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43763817|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
43763818|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43763819|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763820|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
43763821|NCT02424045|Dexamethasone|dexamethasone|mesh-list
43763822|NCT02424045|Carboplatin|carboplatin|mesh-list
43763823|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43763824|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43763825|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
43763826|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
43763827|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763828|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763829|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763830|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
43763832|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763833|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763834|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763835|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43763836|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
43763837|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763838|NCT02423837|Rituximab|rituximab|mesh-list
43763839|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43763840|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43763841|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763842|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
43763843|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763844|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43763845|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43763847|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763849|NCT02423863|Nivolumab|nivolumab|mesh-list
43763850|NCT02423863|Durvalumab|durvalumab|mesh-list
43763851|NCT02423863|Cemiplimab|cemiplimab|mesh-list
43763852|NCT02423863|Atezolizumab|atezolizumab|mesh-list
43763853|NCT02423863|Poly ICLC|poly iclc|mesh-list
43763854|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43763855|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763856|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43763857|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763858|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
43763859|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
43763860|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837654|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
43837655|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837656|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837657|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
43837658|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837659|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43837660|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
43837661|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43837662|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43837663|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43837664|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
43837665|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763863|NCT02423811|Vitamins|vitamins|mesh-ancestor
43763864|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
43763865|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763866|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
43763867|NCT02423759|Gentamicins|gentamicins|mesh-list
43763868|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43763869|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763870|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43763871|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43763872|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763873|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763874|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763875|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43763876|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43763877|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43763878|NCT02423694|Dexetimide|dexetimide|mesh-list
43763879|NCT02423694|Citalopram|citalopram|mesh-list
43763880|NCT02423694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43763881|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43763882|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763883|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763884|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763887|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43763888|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
43763889|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43763890|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43763891|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43763892|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
43763893|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
43763894|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763895|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43763896|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43763897|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
43763898|NCT02423590|Gemcitabine|gemcitabine|mesh-list
43763899|NCT02423590|Carboplatin|carboplatin|mesh-list
43763900|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763901|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43763902|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
43763903|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763904|NCT02423590|Antiviral Agents|antiviral agents|mesh-ancestor
43763905|NCT02423590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763906|NCT02423590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763907|NCT02423590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763908|NCT02423590|Immunologic Factors|immunologic factors|mesh-ancestor
43763909|NCT02423590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763910|NCT02423642|Heparin|heparin|mesh-list
43763911|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
43763912|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763913|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43763914|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43763915|NCT02423603|Paclitaxel|paclitaxel|mesh-list
43763916|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43763917|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763918|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
43763919|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
43763920|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
43763949|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763950|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763951|NCT02423239|Gemcitabine|gemcitabine|mesh-list
43763952|NCT02423239|Paclitaxel|paclitaxel|mesh-list
43763953|NCT02423239|Sorafenib|sorafenib|mesh-list
43763955|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43763956|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763957|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
43763958|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
43763959|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
43763960|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763961|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43763962|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
43763963|NCT02423239|Antiviral Agents|antiviral agents|mesh-ancestor
43763964|NCT02423239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763965|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763966|NCT02423239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763967|NCT02423239|Immunologic Factors|immunologic factors|mesh-ancestor
43763968|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763969|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43763970|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43763971|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
43763972|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
43763973|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763981|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
43763982|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
43763983|NCT02422784|Vitamins|vitamins|mesh-list
43763984|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
43764000|NCT02422966|Acetaminophen|acetaminophen|mesh-list
43764001|NCT02422966|Ibuprofen|ibuprofen|mesh-list
43764002|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764003|NCT02422966|Analgesics|analgesics|mesh-ancestor
43764004|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
43764005|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764006|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764007|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
43764008|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43764009|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764010|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43568762|NCT00595699|Citalopram|citalopram|mesh-list
43764011|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43764013|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764014|NCT02422953|Micronutrients|micronutrients|mesh-list
43764015|NCT02422953|Trace Elements|trace elements|mesh-list
43764016|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764017|NCT02422888|Ticagrelor|ticagrelor|mesh-list
43764018|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43764019|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43764020|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43764021|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43764022|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43764023|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
43764024|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764025|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764026|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764027|NCT02422823|Epinephrine|epinephrine|mesh-list
43764028|NCT02422823|Carticaine|carticaine|mesh-list
43764029|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43764030|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43764031|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
43764032|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764033|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764034|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764035|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43764036|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43764037|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
43764038|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764039|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43764040|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
43764041|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
43764042|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
43764043|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43764044|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
43764045|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
43764046|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764047|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
43764048|NCT02423096|Haloperidol|haloperidol|mesh-list
43764049|NCT02423096|Olanzapine|olanzapine|mesh-list
43764050|NCT02423096|Risperidone|risperidone|mesh-list
43764051|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43764052|NCT02423096|Sulpiride|sulpiride|mesh-list
43764053|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43764054|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
43764055|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764056|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764057|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764058|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43764059|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43764060|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764061|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43764062|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43764064|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
43764065|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
43764066|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764067|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43764068|NCT02423096|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43764069|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43764070|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43764071|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
43764072|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43764073|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43764074|NCT02423018|Pregabalin|pregabalin|mesh-list
43764075|NCT02423018|Analgesics|analgesics|mesh-ancestor
43764076|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
43764077|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764078|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764079|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
43764080|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43764081|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43764082|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764083|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43764084|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43764085|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43764086|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764087|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43764088|NCT02422563|Paclitaxel|paclitaxel|mesh-list
43764105|NCT02422706|Doxycycline|doxycycline|mesh-list
43764106|NCT02422706|Omeprazole|omeprazole|mesh-list
43764107|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764108|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43764109|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43764110|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43764111|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43764128|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764129|NCT02422485|Analgesics|analgesics|mesh-ancestor
43764130|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
43764131|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764132|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764133|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764134|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764135|NCT02422589|Ceritinib|ceritinib|mesh-list
43764136|NCT02422589|Midazolam|midazolam|mesh-list
43764137|NCT02422589|Warfarin|warfarin|mesh-list
43764138|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43764139|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43764140|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764141|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764142|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43764143|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43764144|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43764145|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43764146|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
43764147|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
43764148|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
43764149|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
43764150|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764151|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764152|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
43764153|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764154|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43764155|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764156|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
43764157|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43764158|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
43764159|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43764160|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
43764161|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764162|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764163|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
43764164|NCT02422654|Eliglustat|eliglustat|mesh-list
43764165|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764166|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764167|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
43764168|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43764169|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43764170|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764171|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
43764172|NCT02422056|Coagulants|coagulants|mesh-ancestor
43764204|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
43764205|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764206|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764207|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43764208|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43764210|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
43764211|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764212|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43764213|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43764214|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764215|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764216|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
43764217|NCT02421926|Dasatinib|dasatinib|mesh-list
43764218|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764219|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43764220|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764221|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764222|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
43764223|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
43764224|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43764225|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43764226|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764227|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764228|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764229|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764278|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43764279|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43764280|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764281|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
43764282|NCT02421029|Edetic Acid|edetic acid|mesh-list
43764283|NCT02421029|Calcium|calcium|mesh-list
43764284|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
43764285|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43764286|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764287|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43764288|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
43764289|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43764290|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
43764291|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
43764292|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764293|NCT02421029|Antidotes|antidotes|mesh-ancestor
43764294|NCT02421029|Protective Agents|protective agents|mesh-ancestor
43764295|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43764296|NCT02423083|Guanabenz|guanabenz|mesh-list
43764297|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43764298|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43764299|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43764300|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43764301|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
43764302|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764303|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764304|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764305|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43764306|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43764307|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43764308|NCT02420834|Laxatives|laxatives|mesh-ancestor
43764309|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43764310|NCT02420665|Acetic Acid|acetic acid|mesh-list
43764311|NCT02420665|Proflavine|proflavine|mesh-list
43764312|NCT02420665|Retinol acetate|retinol acetate|mesh-list
43764318|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43764319|NCT02420665|Protective Agents|protective agents|mesh-ancestor
43764320|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764321|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43764322|NCT02420782|Itraconazole|itraconazole|mesh-list
43764323|NCT02420782|Midazolam|midazolam|mesh-list
43764324|NCT02420782|Pilocarpine|pilocarpine|mesh-list
43764325|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43764326|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43764327|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764328|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764329|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43764330|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43764331|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43764332|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43764333|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
43764334|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
43764335|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
43764336|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
43764337|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764338|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764339|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
43764340|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764341|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43764342|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43764343|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764344|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43764345|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
43764346|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764347|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43764349|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
43764350|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764351|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43764352|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43764353|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
43764358|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43764359|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764361|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
43764362|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764363|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764364|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764365|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43764366|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43764367|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764368|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43764369|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43764370|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764371|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
43764375|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764376|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43764377|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
43764378|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764379|NCT02420509|Antidotes|antidotes|mesh-ancestor
43764380|NCT02420509|Protective Agents|protective agents|mesh-ancestor
43764381|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
43764382|NCT02420509|Vitamins|vitamins|mesh-ancestor
43764383|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
43764384|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43764385|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43764386|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43764387|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
43764388|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43764389|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764390|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43764391|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764393|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
43764394|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764395|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43764396|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
43764397|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43764398|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
43764399|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764400|NCT02420418|Expectorants|expectorants|mesh-ancestor
43764401|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
43764402|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43764403|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
43764404|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764405|NCT02420418|Protective Agents|protective agents|mesh-ancestor
43764406|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764407|NCT02420418|Antidotes|antidotes|mesh-ancestor
43764408|NCT02420171|Insulin|insulin|mesh-list
43764409|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43764410|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764411|NCT02420132|Ranibizumab|ranibizumab|mesh-list
43764412|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43764413|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43764414|NCT02420132|Growth Substances|growth substances|mesh-ancestor
43764415|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764416|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
43764417|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764419|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
43764420|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837716|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837717|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837718|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43837719|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837720|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569218|NCT00542633|Insulin|insulin|mesh-list
43764421|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
43764422|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43764425|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764426|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764427|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764428|NCT02420002|Analgesics|analgesics|mesh-ancestor
43764429|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
43764430|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764432|NCT02419729|Hormones|hormones|mesh-ancestor
43764433|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764434|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764435|NCT02419651|Diclofenac|diclofenac|mesh-list
43764436|NCT02419651|Tramadol|tramadol|mesh-list
43764437|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43764438|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764439|NCT02419651|Analgesics|analgesics|mesh-ancestor
43764440|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
43764441|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764442|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764443|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764444|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764445|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43764446|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764448|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43764449|NCT02419651|Narcotics|narcotics|mesh-ancestor
43764450|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764451|NCT02419820|Aspirin|aspirin|mesh-list
43764452|NCT02419820|Clopidogrel|clopidogrel|mesh-list
43764453|NCT02419820|APD791|apd791|mesh-list
43764454|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43764455|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764456|NCT02419820|Analgesics|analgesics|mesh-ancestor
43764457|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
43764458|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764459|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764460|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764461|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764462|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43764463|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43764464|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764465|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43764466|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43764467|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764468|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
43764469|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43764470|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43764471|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43764472|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
43764473|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764474|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43764475|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43764476|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
43764477|NCT02419534|Diltiazem|diltiazem|mesh-list
43764478|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43764479|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43764480|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43764481|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764482|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43764483|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764484|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
43764485|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43764486|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
43764487|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43764488|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
43764489|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764490|NCT02419443|Gabapentin|gabapentin|mesh-list
43764491|NCT02419443|Analgesics|analgesics|mesh-ancestor
43764492|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
43764493|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764494|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764495|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
43764496|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43764497|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43764498|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764499|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43764500|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43764501|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43764502|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764503|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764504|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
43764505|NCT02419859|Insulin|insulin|mesh-list
43764506|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43764507|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43764508|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764509|NCT02419352|Atropine|atropine|mesh-list
43764510|NCT02419352|Neostigmine|neostigmine|mesh-list
43764511|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43764512|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43764513|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43764515|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764516|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764518|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
43764519|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
43764520|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
43764521|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43764532|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
43764533|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764534|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764535|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
43764537|NCT02419118|Dexamethasone|dexamethasone|mesh-list
43764546|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
43764548|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764549|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43764550|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764551|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
43764552|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43764555|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
43764557|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
43764558|NCT02419105|Testosterone|testosterone|mesh-list
43764559|NCT02419105|Vitamins|vitamins|mesh-ancestor
43764560|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
43764561|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764562|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43764563|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43764564|NCT02419105|Androgens|androgens|mesh-ancestor
43764565|NCT02419105|Hormones|hormones|mesh-ancestor
43764566|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764567|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
43764568|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43764569|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
43569374|NCT00528333|Cytarabine|cytarabine|mesh-list
43764570|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764571|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764572|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43764573|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
43764574|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764575|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764576|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43764577|NCT02419235|Ethanol|ethanol|mesh-list
43764578|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43764579|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764580|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764581|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764582|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
43764583|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43764584|NCT02418988|Estrogens|estrogens|mesh-ancestor
43764585|NCT02418988|Hormones|hormones|mesh-ancestor
43764586|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764587|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764588|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43764589|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764590|NCT02418572|Testosterone|testosterone|mesh-list
43764591|NCT02418572|Androgens|androgens|mesh-ancestor
43764592|NCT02418572|Hormones|hormones|mesh-ancestor
43764593|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764594|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764595|NCT02418702|Ketamine|ketamine|mesh-list
43764596|NCT02418702|Analgesics|analgesics|mesh-ancestor
43764597|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
43764735|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43764616|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764617|NCT02418624|Carboplatin|carboplatin|mesh-list
43764618|NCT02418624|Olaparib|olaparib|mesh-list
43764619|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764620|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43764621|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764623|NCT02418533|Menotropins|menotropins|mesh-list
43837726|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
43837727|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837728|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837729|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837730|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
43837731|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
43837732|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43837733|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
43837734|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837735|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837736|NCT04891484|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43837737|NCT04891484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43837738|NCT04891484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837739|NCT04891484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837740|NCT04891484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43837741|NCT04889664|Ketamine|ketamine|mesh-list
43837742|NCT04889664|Analgesics|analgesics|mesh-ancestor
43837743|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
43837744|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837745|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837746|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43837748|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
43837749|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
43764643|NCT02417883|Furosemide|furosemide|mesh-list
43764644|NCT02417883|Diuretics|diuretics|mesh-ancestor
43764645|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
43764646|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764647|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43764648|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43764650|NCT02417896|Spironolactone|spironolactone|mesh-list
43764661|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764662|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764663|NCT02418078|Anesthetics|anesthetics|mesh-list
43764664|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764665|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764666|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
43764667|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43764668|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
43764669|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764670|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
43764671|NCT02417610|Protective Agents|protective agents|mesh-ancestor
43764673|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43764674|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764675|NCT02417506|Analgesics|analgesics|mesh-ancestor
43764676|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
43764677|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764678|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764679|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764680|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764681|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43764682|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764683|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764684|NCT02417493|Epinephrine|epinephrine|mesh-list
43764685|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43764686|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43764687|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
43764688|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764689|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764704|NCT02417467|Nicotine|nicotine|mesh-list
43764705|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43764706|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
43764707|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764708|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764709|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43764710|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43764711|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
43764712|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764713|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764714|NCT02417389|Alendronate|alendronate|mesh-list
43764715|NCT02417389|Cinacalcet|cinacalcet|mesh-list
43764716|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43764717|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764718|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43764719|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43764720|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
43764721|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764722|NCT02417090|Metformin|metformin|mesh-list
43764723|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43764724|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764725|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43764726|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43764727|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43764728|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764729|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764730|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43764731|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43764732|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764733|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
43764734|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764737|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43764739|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
43764744|NCT02417298|Analgesics|analgesics|mesh-ancestor
43764745|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
43764746|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764747|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764748|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43764749|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43764750|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
43764751|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
43764752|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764753|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43764754|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43764755|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764756|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764757|NCT02417207|Entecavir|entecavir|mesh-list
43764758|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
43764759|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764760|NCT02416999|Bevacizumab|bevacizumab|mesh-list
43764761|NCT02416999|Temozolomide|temozolomide|mesh-list
43764762|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43764763|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764764|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43764765|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43764766|NCT02416999|Growth Substances|growth substances|mesh-ancestor
43764767|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764793|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764795|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43764796|NCT02416752|Narcotics|narcotics|mesh-ancestor
43764797|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764798|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764799|NCT02416752|Analgesics|analgesics|mesh-ancestor
43764800|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
43764801|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764802|NCT02416765|Glucagon|glucagon|mesh-list
43764803|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764804|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43764805|NCT02416765|Hormones|hormones|mesh-ancestor
43764806|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764807|NCT02416804|Buprenorphine|buprenorphine|mesh-list
43764808|NCT02416804|Tramadol|tramadol|mesh-list
43764809|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43764810|NCT02416804|Narcotics|narcotics|mesh-ancestor
43764811|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764812|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764813|NCT02416804|Analgesics|analgesics|mesh-ancestor
43764814|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
43764815|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764816|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43764817|NCT02416687|Etonogestrel|etonogestrel|mesh-list
43764818|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43764819|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
43764820|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43764821|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764822|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43764823|NCT02416869|Dexamethasone|dexamethasone|mesh-list
43764824|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
43764825|NCT02416869|BB 1101|bb 1101|mesh-list
43764826|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764827|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
43764834|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764836|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764837|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
43764838|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764839|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764840|NCT02416739|Niacinamide|niacinamide|mesh-list
43764841|NCT02416739|Niacin|niacin|mesh-list
43764842|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
43764843|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
43764844|NCT02416739|Vitamins|vitamins|mesh-ancestor
43764845|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
43764849|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764850|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43764852|NCT02416583|Oxytocin|oxytocin|mesh-list
43764853|NCT02416583|Dinoprostone|dinoprostone|mesh-list
43764854|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
43765139|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43764855|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43764856|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764857|NCT02416427|Atorvastatin|atorvastatin|mesh-list
43764858|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43764859|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43764860|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
43764861|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764862|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43764863|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43764864|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764865|NCT02416388|Cytarabine|cytarabine|mesh-list
43764866|NCT02416388|Cyclosporine|cyclosporine|mesh-list
43569695|NCT00485563|Analgesics|analgesics|mesh-ancestor
43764867|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
43764868|NCT02416388|Dexamethasone|dexamethasone|mesh-list
43764869|NCT02416388|Methotrexate|methotrexate|mesh-list
43764870|NCT02416388|Daunorubicin|daunorubicin|mesh-list
43764871|NCT02416388|Venetoclax|venetoclax|mesh-list
43764872|NCT02416388|Idarubicin|idarubicin|mesh-list
43764873|NCT02416388|Cyclosporins|cyclosporins|mesh-list
43764874|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764875|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
43764876|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
43764877|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764878|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764879|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43764880|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
43764881|NCT02416388|Hormones|hormones|mesh-ancestor
43764882|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764883|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43764884|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764885|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43764886|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
43764887|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43764888|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43764889|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
43764890|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764891|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
43764892|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764893|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43764894|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43764895|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
43764896|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764897|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43764898|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
43764899|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764900|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
43764901|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43764902|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43764903|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43764911|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43764912|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764913|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764914|NCT02416271|Vitamin D|vitamin d|mesh-list
43764915|NCT02416271|Alendronate|alendronate|mesh-list
43764916|NCT02416271|Teriparatide|teriparatide|mesh-list
43764917|NCT02416271|Calcium|calcium|mesh-list
43764918|NCT02416271|Vitamins|vitamins|mesh-ancestor
43764919|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
43764920|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764921|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43764922|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43764923|NCT02416531|Clobetasol|clobetasol|mesh-list
43764924|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764925|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
43764926|NCT02416531|Hormones|hormones|mesh-ancestor
43764927|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764928|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837750|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837751|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43837752|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43837753|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837754|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837755|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
43837756|NCT04889118|Lenvatinib|lenvatinib|mesh-list
43837757|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43837758|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837759|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43837760|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837761|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847957|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847958|NCT04065399|Cobicistat|cobicistat|mesh-list
43847959|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43764930|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
43764931|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43764932|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
43764933|NCT02416258|Calcipotriene|calcipotriene|mesh-list
43764934|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43764935|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764936|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
43764937|NCT02416258|Hormones|hormones|mesh-ancestor
43764938|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764939|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764940|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43764941|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
43764942|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
43764943|NCT02416245|Micronutrients|micronutrients|mesh-list
43764944|NCT02416245|Trace Elements|trace elements|mesh-list
43764945|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764946|NCT02416570|Clarithromycin|clarithromycin|mesh-list
43764947|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43764948|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764949|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43764950|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764951|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764952|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43764953|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43764954|NCT02416141|Tramadol|tramadol|mesh-list
43764955|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43764956|NCT02416141|Narcotics|narcotics|mesh-ancestor
43764957|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764958|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764959|NCT02416141|Analgesics|analgesics|mesh-ancestor
43764960|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
43764961|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764962|NCT02416167|Dotinurad|dotinurad|mesh-list
43764963|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
43764972|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764973|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764974|NCT02416115|Analgesics|analgesics|mesh-ancestor
43764975|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
43764976|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764977|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43764978|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
43764979|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
43764980|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43764981|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43764982|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
43764983|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764984|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764985|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
43764986|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43764987|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764988|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764989|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764990|NCT02416063|Analgesics|analgesics|mesh-ancestor
43764991|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
43764992|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764993|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43764994|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43764995|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43764996|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
43764997|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764998|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764999|NCT02416128|Prednisolone|prednisolone|mesh-list
43765000|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43765001|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
43765002|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43765003|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
43765004|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43765005|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
43765016|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43765017|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43765018|NCT02416128|Protective Agents|protective agents|mesh-ancestor
43765019|NCT02415985|Lopinavir|lopinavir|mesh-list
43765020|NCT02415985|Rifabutin|rifabutin|mesh-list
43765021|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43765022|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43765023|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
43765024|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765025|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765026|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43765027|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43765028|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
43765029|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765030|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43765031|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43765032|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43765033|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43765034|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
43765035|NCT02415920|Oxytocin|oxytocin|mesh-list
43765036|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
43765037|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43765038|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765039|NCT02415829|Capecitabine|capecitabine|mesh-list
43765040|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
43765041|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43765053|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43765054|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
43765055|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765056|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765057|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765058|NCT02415777|Riboflavin|riboflavin|mesh-list
43765059|NCT02415777|Thiamine|thiamine|mesh-list
43765060|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43765061|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
43765062|NCT02415777|Vitamins|vitamins|mesh-ancestor
43765063|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
43765064|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765065|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43765066|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
43765067|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43765068|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43765069|NCT02415569|Bisacodyl|bisacodyl|mesh-list
43765070|NCT02415569|Cathartics|cathartics|mesh-ancestor
43765071|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43765072|NCT02415569|Laxatives|laxatives|mesh-ancestor
43765073|NCT02415699|Leucovorin|leucovorin|mesh-list
43765074|NCT02415699|Fluorouracil|fluorouracil|mesh-list
43765075|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
43765076|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
43765077|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765078|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43765079|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765080|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765081|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
43765116|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765119|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43765120|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
43765121|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765122|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765123|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43765124|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43765125|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
43765126|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765127|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765128|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
43765129|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
43765130|NCT02415257|Gentamicins|gentamicins|mesh-list
43765131|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43765132|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765133|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43765134|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765135|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765136|NCT02415179|Fluticasone|fluticasone|mesh-list
43765137|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
43765138|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
43765140|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43765141|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765142|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43765143|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
43765162|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765163|NCT02415114|Protective Agents|protective agents|mesh-ancestor
43765164|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765165|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765166|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43765167|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
43765168|NCT02414919|Etonogestrel|etonogestrel|mesh-list
43765169|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43765170|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
43765171|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43765172|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765173|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43765174|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43765175|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43765177|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43765178|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43765179|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765180|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
43765181|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
43765182|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
43765183|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765185|NCT02414880|Neostigmine|neostigmine|mesh-list
43765186|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43765187|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43765188|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43765189|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765190|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765191|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43765192|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765193|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765194|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
43765195|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765196|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43765197|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
43765201|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765202|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
43765203|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765204|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
43765205|NCT02414945|Fludarabine|fludarabine|mesh-list
43765206|NCT02414945|Interleukin-2|interleukin-2|mesh-list
43765207|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765208|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
43765209|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765210|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43765211|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43765212|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
43765213|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765214|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765215|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43765216|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43765217|NCT02414945|Analgesics|analgesics|mesh-ancestor
43765218|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
43765219|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765221|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43765222|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765223|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765224|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
43765225|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765226|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765227|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
43765228|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
43765229|NCT02414802|Heparin|heparin|mesh-list
43765230|NCT02414802|Calcium heparin|calcium heparin|mesh-list
43765246|NCT02414555|Phenylephrine|phenylephrine|mesh-list
43765247|NCT02414555|Norepinephrine|norepinephrine|mesh-list
43765248|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43765249|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43765250|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
43765251|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
43765252|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766258|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43765253|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765254|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
43765255|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
43765256|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
43765257|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43765258|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43765259|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43765260|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
43765261|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765262|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765263|NCT02414555|Protective Agents|protective agents|mesh-ancestor
43765264|NCT02414568|Prednisone|prednisone|mesh-list
43765265|NCT02414568|Doxorubicin|doxorubicin|mesh-list
43765266|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43765267|NCT02414568|Vinblastine|vinblastine|mesh-list
43765268|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43765269|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765270|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43765271|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43765272|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765273|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765274|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765275|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
43765276|NCT02414568|Hormones|hormones|mesh-ancestor
43765277|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43765289|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43765290|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765291|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765292|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765293|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43765294|NCT02414581|Ethanol|ethanol|mesh-list
43765295|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
43765296|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43765297|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43765298|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765299|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765300|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765301|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
43765302|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
43765303|NCT02414529|Vitamin D|vitamin d|mesh-list
43765304|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
43765305|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
43765306|NCT02414529|Vitamins|vitamins|mesh-list
43765307|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
43765308|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765309|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43765310|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43765311|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
43765313|NCT02414490|Antibodies|antibodies|mesh-list
43765314|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
43765315|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43765316|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
43765317|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765318|NCT02414685|Paclitaxel|paclitaxel|mesh-list
43765319|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43765320|NCT02414685|Cisplatin|cisplatin|mesh-list
43765321|NCT02414685|Ifosfamide|ifosfamide|mesh-list
43765322|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
43765323|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43570155|NCT00437112|Insulin|insulin|mesh-list
43765330|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
43765331|NCT02414451|Propranolol|propranolol|mesh-list
43765332|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43765333|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43765334|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
43765335|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765336|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765337|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765338|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43765339|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43765340|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
43837762|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
43837763|NCT04887870|Nivolumab|nivolumab|mesh-list
43837764|NCT04887870|Ipilimumab|ipilimumab|mesh-list
43837765|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43837766|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837767|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43837768|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837770|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
43837771|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837772|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
43837773|NCT04887506|Hormones|hormones|mesh-ancestor
43837774|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837775|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837776|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43837777|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837797|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43837799|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
43837800|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837801|NCT04884802|Phenylephrine|phenylephrine|mesh-list
43837802|NCT04884802|Norepinephrine|norepinephrine|mesh-list
43837803|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43837804|NCT04884802|Propofol|propofol|mesh-list
43837805|NCT04884802|Etomidate|etomidate|mesh-list
43837806|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43837807|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837808|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837809|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43837810|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
43837811|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
43837812|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43837813|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
43837814|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
43837815|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837816|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
43837817|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
43837818|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
43765341|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
43765342|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43765343|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43765344|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43765345|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43765369|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
43765370|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765371|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765372|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
43765373|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765374|NCT02414165|Flucytosine|flucytosine|mesh-list
43765375|NCT02414165|Bevacizumab|bevacizumab|mesh-list
43765376|NCT02414165|Temozolomide|temozolomide|mesh-list
43765377|NCT02414165|Lomustine|lomustine|mesh-list
43765378|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43765379|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765381|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43765382|NCT02414165|Growth Substances|growth substances|mesh-ancestor
43765383|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765384|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
43765385|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43765386|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
43765387|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765388|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
43765389|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765390|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
43765391|NCT02414009|Leucovorin|leucovorin|mesh-list
43765392|NCT02414009|Fluorouracil|fluorouracil|mesh-list
43765393|NCT02414009|Capecitabine|capecitabine|mesh-list
43765394|NCT02414009|Irinotecan|irinotecan|mesh-list
43765395|NCT02414009|Temozolomide|temozolomide|mesh-list
43765396|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
43765397|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765398|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43765399|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765400|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765401|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
43765402|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765403|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43765404|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43765405|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765406|NCT02414009|Antidotes|antidotes|mesh-ancestor
43765407|NCT02414009|Protective Agents|protective agents|mesh-ancestor
43765408|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
43765409|NCT02414009|Vitamins|vitamins|mesh-ancestor
43765410|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
43765411|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43765412|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
43765414|NCT02413853|Bevacizumab|bevacizumab|mesh-list
43765415|NCT02413853|Fluorouracil|fluorouracil|mesh-list
43765416|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
43765417|NCT02413853|Calcium|calcium|mesh-list
43765418|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
43765419|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43765420|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765421|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43765422|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43765423|NCT02413853|Growth Substances|growth substances|mesh-ancestor
43765424|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765425|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
43765426|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43765427|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
43765428|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765429|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43765430|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765431|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
43765432|NCT02413853|Antidotes|antidotes|mesh-ancestor
43765433|NCT02413853|Protective Agents|protective agents|mesh-ancestor
43765434|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
43765435|NCT02413853|Vitamins|vitamins|mesh-ancestor
43765444|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43765445|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
43765446|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
43765447|NCT02413281|Buprenorphine|buprenorphine|mesh-list
43765448|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43765449|NCT02413281|Narcotics|narcotics|mesh-ancestor
43765450|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765451|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765452|NCT02413281|Analgesics|analgesics|mesh-ancestor
43765453|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
43765454|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765455|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43765456|NCT02413515|Nifedipine|nifedipine|mesh-list
43765457|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43765458|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43765459|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765460|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43765461|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765462|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
43765463|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
43765464|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43765465|NCT02413554|Rivastigmine|rivastigmine|mesh-list
43765466|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43765467|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765468|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765469|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
43765494|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
43765495|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765496|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43765497|NCT02412930|Narcotics|narcotics|mesh-ancestor
43765498|NCT02412930|Analgesics|analgesics|mesh-ancestor
43765499|NCT02413021|Cytarabine|cytarabine|mesh-list
43765500|NCT02413021|Deferasirox|deferasirox|mesh-list
43765501|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43765502|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
43765503|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765504|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765505|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
43765506|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765507|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765508|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
43765509|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765510|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43765511|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
43765512|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
43765513|NCT02412917|Valacyclovir|valacyclovir|mesh-list
43765514|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
43765515|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765516|NCT02412904|Menotropins|menotropins|mesh-list
43765517|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43765518|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
43765519|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43765562|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43837819|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43837820|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43837821|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43837822|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
43837823|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837824|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837825|NCT04884802|Protective Agents|protective agents|mesh-ancestor
43837826|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
43837827|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43765563|NCT02412345|Alprostadil|alprostadil|mesh-list
43765575|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765576|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765577|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43765578|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
43765579|NCT02412059|Prednisolone|prednisolone|mesh-list
43765580|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43765588|NCT02412059|Hormones|hormones|mesh-ancestor
43765589|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43765590|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765591|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43765598|NCT02412059|Protective Agents|protective agents|mesh-ancestor
43765599|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
43765600|NCT02412150|Remifentanil|remifentanil|mesh-list
43765601|NCT02412150|Desflurane|desflurane|mesh-list
43765602|NCT02412150|Anesthetics|anesthetics|mesh-list
43765603|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
43765604|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43765605|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765606|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765607|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43765608|NCT02412150|Analgesics|analgesics|mesh-ancestor
43765609|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
43765610|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765611|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43765612|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43765613|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43765614|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
43765615|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765616|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765617|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43765618|NCT02412150|Narcotics|narcotics|mesh-ancestor
43765619|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
43765620|NCT02412189|Norepinephrine|norepinephrine|mesh-list
43765621|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43765622|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43765623|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
43765624|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765625|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765626|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765627|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
43765628|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
43765629|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765630|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43765631|NCT02411942|Adapalene|adapalene|mesh-list
43765633|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43765638|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765639|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43765640|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
43765641|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
43765642|NCT02411955|Tazarotene|tazarotene|mesh-list
43765643|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
43765644|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
43765645|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
43765646|NCT02411955|Vitamins|vitamins|mesh-ancestor
43765647|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
43765648|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765649|NCT02412085|Golimumab|golimumab|mesh-list
43765650|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43765651|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765652|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765653|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
43765654|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765655|NCT02412033|Misoprostol|misoprostol|mesh-list
43765656|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43765657|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
43765658|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43765659|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765660|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43765661|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43765662|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
43765663|NCT02411994|Artesunate|artesunate|mesh-list
43765664|NCT02411994|Lumefantrine|lumefantrine|mesh-list
43765665|NCT02411994|Artemether|artemether|mesh-list
43765688|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43765689|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765690|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43765691|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43765692|NCT02411903|Clopidogrel|clopidogrel|mesh-list
43765693|NCT02411903|Atorvastatin|atorvastatin|mesh-list
43765694|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43765695|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43765696|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43765697|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
43765698|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765699|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43765700|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43765701|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765702|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43765703|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43765704|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43765705|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43765706|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
43765707|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765708|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765709|NCT02411786|Molgramostim|molgramostim|mesh-list
43765710|NCT02411786|Sargramostim|sargramostim|mesh-list
43765711|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
43765714|NCT02411825|Metformin|metformin|mesh-list
43765735|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
43765736|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43765737|NCT02411149|Narcotics|narcotics|mesh-ancestor
43765738|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765739|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765740|NCT02411149|Analgesics|analgesics|mesh-ancestor
43765741|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
43765742|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765743|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
43765744|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
43765745|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43765746|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43765747|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
43765748|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765749|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765750|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43765751|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43765752|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
43765753|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43765754|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
43765755|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
43765756|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
43765757|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43765758|NCT02411630|Tenofovir|tenofovir|mesh-list
43765759|NCT02411630|Emtricitabine|emtricitabine|mesh-list
43765760|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
43765761|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765762|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43765763|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43765764|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765765|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765766|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43765767|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43765768|NCT02411318|Ethanol|ethanol|mesh-list
43765769|NCT02411318|Caffeine|caffeine|mesh-list
43765775|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43765776|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43765777|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
43765778|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765779|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43765780|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765781|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765782|NCT02411175|Ethanol|ethanol|mesh-list
43765783|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43765784|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765785|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765786|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765787|NCT02411331|Ethanol|ethanol|mesh-list
43765788|NCT02411331|Enoxaparin|enoxaparin|mesh-list
43765789|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
43765790|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43765791|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43765792|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765799|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765800|NCT02410863|Trametinib|trametinib|mesh-list
43765801|NCT02410863|Dabrafenib|dabrafenib|mesh-list
43765802|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765803|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43765804|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765805|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765806|NCT02410759|Carbetocin|carbetocin|mesh-list
43765807|NCT02410759|Ergonovine|ergonovine|mesh-list
43570703|NCT00389155|Gemcitabine|gemcitabine|mesh-list
43765808|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
43765809|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43765810|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765811|NCT02410694|Thalidomide|thalidomide|mesh-list
43765812|NCT02410694|Dexamethasone|dexamethasone|mesh-list
43765813|NCT02410694|Ixazomib|ixazomib|mesh-list
43765814|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765815|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
43765816|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
43765817|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765818|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765819|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43765820|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
43765821|NCT02410694|Hormones|hormones|mesh-ancestor
43765822|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43765823|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43765824|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765825|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765826|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
43765827|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
43765828|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43765829|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765830|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43765831|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43765832|NCT02410694|Growth Substances|growth substances|mesh-ancestor
43765833|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
43765834|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
43765835|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765836|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765837|NCT02410746|Ibuprofen|ibuprofen|mesh-list
43765838|NCT02410746|Morphine|morphine|mesh-list
43765839|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
43765840|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43765841|NCT02410746|Narcotics|narcotics|mesh-ancestor
43765842|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765843|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765844|NCT02410746|Analgesics|analgesics|mesh-ancestor
43765845|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
43765846|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765847|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43765848|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43765849|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765850|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43765851|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43765852|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765853|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765854|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
43765855|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
43765856|NCT02410590|Atropine|atropine|mesh-list
43765857|NCT02410590|Rocuronium|rocuronium|mesh-list
43765858|NCT02410590|Cisatracurium|cisatracurium|mesh-list
43765859|NCT02410590|Succinylcholine|succinylcholine|mesh-list
43765860|NCT02410590|Neostigmine|neostigmine|mesh-list
43765861|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43765862|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43765887|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
43765888|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43765889|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765890|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43765891|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
43765892|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837829|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837830|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
43837831|NCT04883892|Protective Agents|protective agents|mesh-ancestor
43837832|NCT04883645|Imiquimod|imiquimod|mesh-list
43837833|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43837834|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
43837835|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837836|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837837|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
43837838|NCT04883528|Valsartan|valsartan|mesh-list
43837839|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43837840|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43837841|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43837842|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43837843|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837844|NCT04883281|Paclitaxel|paclitaxel|mesh-list
43837845|NCT04883281|Cisplatin|cisplatin|mesh-list
43837846|NCT04883281|Carboplatin|carboplatin|mesh-list
43837847|NCT04883281|Cetuximab|cetuximab|mesh-list
43837848|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43837849|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837851|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
43837852|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
43837853|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837854|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43837882|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
43837892|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43837893|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
43837894|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
43837895|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837896|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
43837897|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765893|NCT02410460|Lidocaine|lidocaine|mesh-list
43765894|NCT02410460|Clonidine|clonidine|mesh-list
43765895|NCT02410460|Midazolam|midazolam|mesh-list
43765896|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
43765897|NCT02410460|Scopolamine|scopolamine|mesh-list
43765898|NCT02410460|Ketamine|ketamine|mesh-list
43765899|NCT02410460|Ondansetron|ondansetron|mesh-list
43765900|NCT02410460|Metoclopramide|metoclopramide|mesh-list
43765901|NCT02410460|Bupivacaine|bupivacaine|mesh-list
43765902|NCT02410460|Propofol|propofol|mesh-list
43765903|NCT02410460|Sevoflurane|sevoflurane|mesh-list
43765904|NCT02410460|Desflurane|desflurane|mesh-list
43765905|NCT02410460|Famotidine|famotidine|mesh-list
43765906|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43765907|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
43765908|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
43765909|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765910|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765911|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
43765912|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765913|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43765914|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43765915|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43765916|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43765917|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765918|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43765919|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43765920|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
43765921|NCT02410460|Analgesics|analgesics|mesh-ancestor
43765922|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43765931|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
43765932|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43765933|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43765934|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
43765935|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
43765936|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43765937|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
43765938|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
43765939|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43765941|NCT02410460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43765942|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43765943|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
43765944|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43765945|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43765946|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43765947|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
43765948|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43765949|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43765950|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
43765951|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43765952|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43765953|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
43765954|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43765955|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43765956|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
43765957|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
43765958|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
43765959|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
43765960|NCT02410226|Anesthetics|anesthetics|mesh-list
43765978|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
43765979|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765980|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43765981|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
43765982|NCT02410096|Miotics|miotics|mesh-ancestor
43765983|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
43765984|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765985|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765986|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43765987|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43765988|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
43765989|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43765990|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43765991|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
43765992|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765993|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765994|NCT02410083|Aspirin|aspirin|mesh-list
43765995|NCT02410083|Clopidogrel|clopidogrel|mesh-list
43765996|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43765997|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43765998|NCT02410083|Analgesics|analgesics|mesh-ancestor
43765999|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
43766000|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766001|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766002|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766003|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766004|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43766005|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43766006|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766007|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766008|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43766009|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766010|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
43766011|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43766015|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766016|NCT02410005|Calcitriol|calcitriol|mesh-list
43766017|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43766018|NCT02410005|Losartan|losartan|mesh-list
43766019|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43766020|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43766021|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43766022|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43766023|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766024|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43766025|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766026|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43766027|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43766028|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43766029|NCT02410005|Vitamins|vitamins|mesh-ancestor
43766030|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
43766031|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43766032|NCT02410135|Mirabegron|mirabegron|mesh-list
43766033|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43766044|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766045|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
43766046|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43766047|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766048|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766049|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43766053|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766055|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43766056|NCT02409498|Bupivacaine|bupivacaine|mesh-list
43766057|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
43766058|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
43766059|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766060|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766061|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
43766062|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766063|NCT02409537|Resveratrol|resveratrol|mesh-list
43766064|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
43766065|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766066|NCT02409537|Protective Agents|protective agents|mesh-ancestor
43766067|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766068|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766069|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766070|NCT02409407|Alprostadil|alprostadil|mesh-list
43766071|NCT02409407|Misoprostol|misoprostol|mesh-list
43766072|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43766073|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
43766074|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43766075|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766076|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43766077|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766078|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
43766079|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766080|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
43571068|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766092|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766093|NCT02409433|Lacosamide|lacosamide|mesh-list
43766094|NCT02409433|Phenytoin|phenytoin|mesh-list
43766095|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
43766096|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43766097|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43766098|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43766116|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43766260|NCT02408419|Bupivacaine|bupivacaine|mesh-list
43766117|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43766118|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43766119|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43766121|NCT02409199|Apatinib|apatinib|mesh-list
43766122|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766123|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
43766124|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
43766125|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
43766126|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766127|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43766128|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766129|NCT02409147|Nystatin|nystatin|mesh-list
43766130|NCT02409147|Prednisone|prednisone|mesh-list
43766131|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
43766132|NCT02409147|Basiliximab|basiliximab|mesh-list
43766133|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766134|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
43766135|NCT02409147|Hormones|hormones|mesh-ancestor
43766136|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766137|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766138|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766139|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766140|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766141|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43766142|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
43766143|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43766144|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766145|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
43766146|NCT02409147|Ionophores|ionophores|mesh-ancestor
43766147|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43766148|NCT02409186|Paclitaxel|paclitaxel|mesh-list
43766149|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43766151|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
43766152|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43766153|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766154|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
43766155|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
43766156|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
43766157|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766158|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43766159|NCT02408978|Naproxen|naproxen|mesh-list
43766160|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43766161|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43766162|NCT02408978|Analgesics|analgesics|mesh-ancestor
43766163|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
43766164|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766165|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766166|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766167|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766168|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
43766169|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43766170|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766171|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766172|NCT02408679|Vitamin D|vitamin d|mesh-list
43766173|NCT02408679|Vitamins|vitamins|mesh-ancestor
43766174|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
43766175|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766176|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43766177|NCT02408705|Acetaminophen|acetaminophen|mesh-list
43766178|NCT02408705|Liraglutide|liraglutide|mesh-list
43766179|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43766180|NCT02408705|Analgesics|analgesics|mesh-ancestor
43766181|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
43766182|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766193|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766194|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43766195|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43766196|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766197|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766198|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766199|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
43766200|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43766201|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766259|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837898|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837899|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
43837900|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43837902|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
43837903|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837904|NCT04880876|Eluxadoline|eluxadoline|mesh-list
43837905|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837906|NCT04880863|Docetaxel|docetaxel|mesh-list
43837907|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
43837908|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837909|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
43837910|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
43837911|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
43837912|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837913|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43837914|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
43837915|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43837916|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43837918|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
43837934|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43837935|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766202|NCT02408926|Vaccines|vaccines|mesh-list
43766203|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
43766204|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766205|NCT02408562|Becaplermin|becaplermin|mesh-list
43766206|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
43766207|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
43766208|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43766209|NCT02408562|Growth Substances|growth substances|mesh-ancestor
43766210|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766211|NCT02408393|Ropivacaine|ropivacaine|mesh-list
43766212|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
43766213|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
43766214|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766215|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766216|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
43766217|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766218|NCT02408354|Glycerol|glycerol|mesh-list
43766219|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43766220|NCT02408354|Protective Agents|protective agents|mesh-ancestor
43766221|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766222|NCT02408185|Colistin|colistin|mesh-list
43766223|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43766225|NCT02408302|Midazolam|midazolam|mesh-list
43766226|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43766227|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43766228|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766229|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766230|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43766231|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43766232|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43766233|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43766234|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
43766235|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
43766236|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
43766237|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
43766238|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766239|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766240|NCT02408328|Caffeine|caffeine|mesh-list
43766241|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
43766242|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766243|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43766244|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766245|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43766246|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766247|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43766248|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43766249|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
43766250|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766251|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
43766252|NCT02408289|Procyanidin|procyanidin|mesh-list
43766253|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
43766254|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766255|NCT02408289|Protective Agents|protective agents|mesh-ancestor
43766256|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766257|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43766263|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766264|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766265|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
43766266|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766267|NCT02408172|Metoprolol|metoprolol|mesh-list
43766268|NCT02408172|Amlodipine|amlodipine|mesh-list
43766269|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43766270|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43766271|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43766272|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766273|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43766274|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766275|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
43766276|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43766277|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
43766278|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
43766279|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766280|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43766281|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43766282|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43766283|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
43766284|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766285|NCT02408146|Celecoxib|celecoxib|mesh-list
43766286|NCT02408146|Parecoxib|parecoxib|mesh-list
43766287|NCT02408146|Fentanyl|fentanyl|mesh-list
43766288|NCT02408146|Ondansetron|ondansetron|mesh-list
43766289|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43766290|NCT02408146|Narcotics|narcotics|mesh-ancestor
43766291|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766292|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766293|NCT02408146|Analgesics|analgesics|mesh-ancestor
43766294|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
43766295|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766296|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43766302|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43766303|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766304|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766305|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43766306|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43766307|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766309|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
43766310|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766311|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
43766312|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
43766313|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43766314|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
43766315|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766316|NCT02408146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43766317|NCT02408146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43766318|NCT02408146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43766319|NCT02408146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43766320|NCT02407899|Vitamin D|vitamin d|mesh-list
43766321|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
43766322|NCT02407899|Insulin|insulin|mesh-list
43766323|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43766324|NCT02407899|Metformin|metformin|mesh-list
43766325|NCT02407899|Saxagliptin|saxagliptin|mesh-list
43766326|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43766327|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43766328|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766329|NCT02407899|Vitamins|vitamins|mesh-ancestor
43766330|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
43766331|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43766332|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43766333|NCT02407899|Incretins|incretins|mesh-ancestor
43766334|NCT02407899|Hormones|hormones|mesh-ancestor
43766335|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766336|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
43766337|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766339|NCT02408042|Rituximab|rituximab|mesh-list
43766343|NCT02408042|Etoposide|etoposide|mesh-list
43766344|NCT02408042|Ifosfamide|ifosfamide|mesh-list
43766345|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43766346|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766347|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
43766348|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766349|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766350|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43766351|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43766352|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43766353|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766354|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766355|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43766356|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
43766357|NCT02408003|Simendan|simendan|mesh-list
43766358|NCT02408003|Milrinone|milrinone|mesh-list
43766359|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43766360|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
43766361|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43766362|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43766363|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766364|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766365|NCT02408003|Protective Agents|protective agents|mesh-ancestor
43766366|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766367|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766368|NCT02407821|Citalopram|citalopram|mesh-list
43766369|NCT02407821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43766370|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43766371|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43766372|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766373|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766374|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
43766375|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766385|NCT02407782|Ivermectin|ivermectin|mesh-list
43766386|NCT02407782|Permethrin|permethrin|mesh-list
43766387|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43766388|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766389|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766390|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766391|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43766392|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
43766393|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766394|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43766395|NCT02407600|Aprepitant|aprepitant|mesh-list
43766396|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
43766397|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
43766398|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
43766399|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766400|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766401|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766402|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43766403|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766404|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766405|NCT02407626|Propofol|propofol|mesh-list
43766406|NCT02407626|Sevoflurane|sevoflurane|mesh-list
43766407|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43766408|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766409|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766410|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43766411|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
43766412|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
43766413|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766414|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43766415|NCT02407392|Acetic Acid|acetic acid|mesh-list
43766416|NCT02407392|Retinol acetate|retinol acetate|mesh-list
43766417|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43766418|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766425|NCT02407366|Carboplatin|carboplatin|mesh-list
43766426|NCT02407366|Pemetrexed|pemetrexed|mesh-list
43766427|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766428|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766429|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766430|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43766431|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43766432|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43766434|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
43766435|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43766436|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766437|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43766438|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766439|NCT02407548|Vitamin E|vitamin e|mesh-list
43766440|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
43766441|NCT02407548|Ubiquinone|ubiquinone|mesh-list
43766442|NCT02407548|Vitamins|vitamins|mesh-ancestor
43766475|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43766476|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43766477|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43766478|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
43766479|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766480|NCT02407080|Interferons|interferons|mesh-list
43766481|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
43766482|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
43766483|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43766484|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766485|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
43766486|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766487|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
43766488|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766489|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43766490|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43766491|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766492|NCT02406950|Incretins|incretins|mesh-ancestor
43766493|NCT02406950|Hormones|hormones|mesh-ancestor
43766494|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837937|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
43766510|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766517|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43766518|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766519|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43766520|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
43766522|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766529|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766530|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43766531|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766532|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766533|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43766534|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
43766535|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43766536|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43766537|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
43766538|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766540|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43766541|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43766542|NCT02406690|Estradiol|estradiol|mesh-list
43766543|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43766544|NCT02406690|Progesterone|progesterone|mesh-list
43766545|NCT02406690|Estrogens|estrogens|mesh-ancestor
43766546|NCT02406690|Hormones|hormones|mesh-ancestor
43766547|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766548|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766549|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43766550|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
43766551|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43766552|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43766553|NCT02406690|Progestins|progestins|mesh-ancestor
43766558|NCT02406703|Mepivacaine|mepivacaine|mesh-list
43766579|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
43766580|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
43766581|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766582|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766583|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
43766584|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766585|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766586|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43571578|NCT00254904|Gemcitabine|gemcitabine|mesh-list
43766587|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
43766588|NCT02406183|Ipilimumab|ipilimumab|mesh-list
43766589|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43766590|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766591|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43766592|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766593|NCT02406144|Dexamethasone|dexamethasone|mesh-list
43766594|NCT02406144|Lenalidomide|lenalidomide|mesh-list
43766595|NCT02406144|Ixazomib|ixazomib|mesh-list
43766596|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766597|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
43766630|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766631|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43766632|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766633|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766634|NCT02405910|Gemcitabine|gemcitabine|mesh-list
43766635|NCT02405910|Paclitaxel|paclitaxel|mesh-list
43766636|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43766637|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766638|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
43766639|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
43766640|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
43766641|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837956|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766642|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43766643|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
43766644|NCT02405910|Antiviral Agents|antiviral agents|mesh-ancestor
43766645|NCT02405910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766646|NCT02405910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766647|NCT02405910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43766648|NCT02405910|Immunologic Factors|immunologic factors|mesh-ancestor
43766649|NCT02405910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766651|NCT02406066|Metyrapone|metyrapone|mesh-list
43766652|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
43766653|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766654|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766655|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43766656|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766657|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766658|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43766659|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43766660|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43766661|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
43571662|NCT00231257|Sirolimus|sirolimus|mesh-list
43766662|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
43766663|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766664|NCT02406092|Prednisone|prednisone|mesh-list
43766665|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
43766666|NCT02406092|Rituximab|rituximab|mesh-list
43766667|NCT02406092|Doxorubicin|doxorubicin|mesh-list
43766668|NCT02406092|Fludarabine|fludarabine|mesh-list
43766669|NCT02406092|Vincristine|vincristine|mesh-list
43766670|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43766671|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
43766672|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766673|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766674|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43766675|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
43766676|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766677|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766678|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43766679|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43766680|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43766681|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43766682|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43766683|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766684|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766685|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
43766686|NCT02406092|Hormones|hormones|mesh-ancestor
43766687|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766688|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766689|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43766690|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
43766691|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
43766692|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
43766693|NCT02405988|Remifentanil|remifentanil|mesh-list
43766694|NCT02405988|Naloxone|naloxone|mesh-list
43766695|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43766698|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766699|NCT02405988|Analgesics|analgesics|mesh-ancestor
43766700|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
43766701|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766702|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43766703|NCT02406053|Antioxidants|antioxidants|mesh-list
43766704|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766705|NCT02406053|Protective Agents|protective agents|mesh-ancestor
43766706|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766707|NCT02405858|Prednisolone|prednisolone|mesh-list
43766708|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
43766709|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766710|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
43766711|NCT02405858|Hormones|hormones|mesh-ancestor
43766712|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766713|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766714|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766715|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766716|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43766717|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837957|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43766718|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766719|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
43766748|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766749|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43766750|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43766751|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766752|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766753|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
43766754|NCT02405689|Remifentanil|remifentanil|mesh-list
43766755|NCT02405689|Sevoflurane|sevoflurane|mesh-list
43766756|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43766757|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766758|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766759|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43766760|NCT02405689|Analgesics|analgesics|mesh-ancestor
43766761|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
43766762|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766763|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43766764|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43766765|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43766766|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
43766767|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766768|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766769|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766770|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43766771|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
43766772|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
43766773|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43766774|NCT02405689|Narcotics|narcotics|mesh-ancestor
43766775|NCT02405364|Dexamethasone|dexamethasone|mesh-list
43766776|NCT02405364|Lenalidomide|lenalidomide|mesh-list
43766777|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766778|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
43766779|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
43766780|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766789|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43766790|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43766791|NCT02405364|Growth Substances|growth substances|mesh-ancestor
43766792|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
43766793|NCT02405156|Letrozole|letrozole|mesh-list
43766794|NCT02405156|Misoprostol|misoprostol|mesh-list
43766795|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766796|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43766797|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43766798|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766799|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766800|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43766801|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
43766802|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766803|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766804|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43766805|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
43766806|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43766807|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43766808|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766810|NCT02405130|Epinephrine|epinephrine|mesh-list
43571804|NCT00135369|Lamivudine|lamivudine|mesh-list
43766811|NCT02405130|Racepinephrine|racepinephrine|mesh-list
43766812|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
43766813|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43766814|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43766815|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
43766816|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766817|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766818|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837947|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43837948|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
43837949|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837950|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837951|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
43837952|NCT04877613|Fludarabine|fludarabine|mesh-list
43837953|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837954|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
43837955|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837959|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837960|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837961|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43837962|NCT04877587|Gemcitabine|gemcitabine|mesh-list
43837963|NCT04877587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837964|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43837965|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
43837966|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837967|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837968|NCT04877587|Antiviral Agents|antiviral agents|mesh-ancestor
43837969|NCT04877587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837970|NCT04877587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837971|NCT04877587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837972|NCT04877587|Immunologic Factors|immunologic factors|mesh-ancestor
43837973|NCT04877275|Dexamethasone|dexamethasone|mesh-list
43837993|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837994|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43837995|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43837996|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43837997|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43837998|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837999|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
43838000|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43838001|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43766828|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
43766829|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43766830|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766831|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43766832|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766833|NCT02404844|Tamoxifen|tamoxifen|mesh-list
43766834|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43766835|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
43766836|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766837|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766838|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766839|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766840|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43766841|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43766842|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43766844|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43766845|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43766846|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766847|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766848|NCT02405013|Ribavirin|ribavirin|mesh-list
43766859|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766860|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
43766861|NCT02404454|Protective Agents|protective agents|mesh-ancestor
43766862|NCT02404337|Betaine|betaine|mesh-list
43766863|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766864|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
43766865|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43766866|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
43766867|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766868|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43766869|NCT02404376|Exenatide|exenatide|mesh-list
43766870|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43766871|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766872|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43766873|NCT02404376|Incretins|incretins|mesh-ancestor
43766874|NCT02404376|Hormones|hormones|mesh-ancestor
43766875|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766876|NCT02404623|Vitamin D|vitamin d|mesh-list
43766877|NCT02404623|Vitamins|vitamins|mesh-ancestor
43766878|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
43766879|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766880|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43766881|NCT02404363|Clopidogrel|clopidogrel|mesh-list
43766882|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766883|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43766884|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43766885|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43766886|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
43766887|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767680|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766888|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766889|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766891|NCT02404519|Vitamin K|vitamin k|mesh-list
43766892|NCT02404519|Vitamin MK 7|vitamin mk 7|mesh-list
43766893|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43766894|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43766897|NCT02404519|Coagulants|coagulants|mesh-ancestor
43766898|NCT02404519|Vitamins|vitamins|mesh-ancestor
43766899|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
43766900|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766901|NCT02404259|Ritonavir|ritonavir|mesh-list
43766902|NCT02404259|Lopinavir|lopinavir|mesh-list
43766903|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43766904|NCT02404259|Tenofovir|tenofovir|mesh-list
43766905|NCT02404259|Efavirenz|efavirenz|mesh-list
43766906|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43766907|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43766908|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
43766909|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766910|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766911|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43766912|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43766913|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
43766914|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766915|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43766916|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43766917|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43766923|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43766925|NCT02404142|Curare|curare|mesh-list
43766926|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43766927|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43766928|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43766929|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766930|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766931|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43766935|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766936|NCT02404077|Clonidine|clonidine|mesh-list
43766937|NCT02404077|Analgesics|analgesics|mesh-ancestor
43766938|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
43766939|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766940|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766941|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43766942|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
43766943|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
43766944|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43766945|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43766946|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43766947|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
43766948|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766949|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766950|NCT02404233|Darunavir|darunavir|mesh-list
43766951|NCT02404233|Cobicistat|cobicistat|mesh-list
43766952|NCT02404233|Rilpivirine|rilpivirine|mesh-list
43766953|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43766954|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43766955|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43766956|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
43766957|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766958|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766959|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43766960|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43766961|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
43766962|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766963|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43766964|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43766965|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43766966|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43766967|NCT02404064|Metronidazole|metronidazole|mesh-list
43766968|NCT02404064|Cefotaxime|cefotaxime|mesh-list
43766969|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766970|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43766971|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43766972|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43766973|NCT02404038|NuvaRing|nuvaring|mesh-list
43767681|NCT02400281|Analgesics|analgesics|mesh-ancestor
43766975|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43766976|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
43766977|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43766978|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766984|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
43766987|NCT02404051|Everolimus|everolimus|mesh-list
43767014|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767015|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767016|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
43767017|NCT02403856|Hormones|hormones|mesh-ancestor
43767018|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767019|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43767020|NCT02403856|Protective Agents|protective agents|mesh-ancestor
43767021|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43767022|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767023|NCT02403804|Betaine|betaine|mesh-list
43767024|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767025|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
43767026|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43767027|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
43767028|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767029|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43767030|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
43767031|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43767032|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43767033|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767034|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
43767035|NCT02403596|Coagulants|coagulants|mesh-ancestor
43767036|NCT02403544|Capecitabine|capecitabine|mesh-list
43767037|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
43767038|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43767039|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
43767040|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767041|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767064|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767066|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43767067|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43767068|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43767069|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767070|NCT02403687|Analgesics|analgesics|mesh-ancestor
43767071|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43767072|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43767073|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
43767074|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43767075|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43767076|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767077|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
43767078|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43767079|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43767080|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43767081|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
43767082|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43767083|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43767084|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767085|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767086|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43767087|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767088|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43767089|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
43767090|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
43767091|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43767092|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43767093|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43767094|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
43767095|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
43767096|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43767097|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43767098|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43767099|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
43767100|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43767101|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43767102|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
43767110|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43767111|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43767112|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
43767115|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
43767116|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767117|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43767118|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
43767119|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767120|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767121|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43767122|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
43767123|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
43767124|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43767125|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43767126|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43767127|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43767128|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
43767129|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767130|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767131|NCT02403648|Glucagon|glucagon|mesh-list
43767132|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43767133|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767134|NCT02403648|Hormones|hormones|mesh-ancestor
43767135|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767136|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767137|NCT02403648|Incretins|incretins|mesh-ancestor
43767138|NCT02403531|Cisplatin|cisplatin|mesh-list
43767139|NCT02403531|Docetaxel|docetaxel|mesh-list
43767140|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767141|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
43767142|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
43767143|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
43767144|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767145|NCT02403349|Atenolol|atenolol|mesh-list
43767146|NCT02403349|Valsartan|valsartan|mesh-list
43767147|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43767148|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43767150|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767151|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43767152|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
43767153|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
43767154|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767155|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767156|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43767157|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43767158|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43767159|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
43767160|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767161|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
43767162|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43767163|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
43767164|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43767166|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43767167|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43767168|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43838002|NCT04876534|Prednisolone|prednisolone|mesh-list
43838003|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
43767186|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767187|NCT02403128|Aflibercept|aflibercept|mesh-list
43767188|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43767189|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43767190|NCT02403128|Growth Substances|growth substances|mesh-ancestor
43767191|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767192|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
43767193|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767194|NCT02403063|Neostigmine|neostigmine|mesh-list
43767195|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43767196|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767197|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767198|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
43767199|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767200|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767201|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43767202|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
43767203|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767204|NCT02403037|Dexamethasone|dexamethasone|mesh-list
43767205|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
43767206|NCT02403037|Antiemetics|antiemetics|mesh-list
43767208|NCT02403037|BB 1101|bb 1101|mesh-list
43767209|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767210|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
43767211|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767212|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767213|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767214|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
43767215|NCT02403037|Hormones|hormones|mesh-ancestor
43767216|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767217|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43767218|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767228|NCT02402972|Protective Agents|protective agents|mesh-ancestor
43767229|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767230|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
43767231|NCT02402972|Vitamins|vitamins|mesh-ancestor
43767232|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
43767233|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43767234|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
43767235|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767236|NCT02402868|Ketamine|ketamine|mesh-list
43767237|NCT02402868|Analgesics|analgesics|mesh-ancestor
43767238|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
43767239|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767240|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767241|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43767242|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43572308|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43767243|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
43767247|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43767285|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43767286|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
43767287|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
43767288|NCT02402595|Itraconazole|itraconazole|mesh-list
43767289|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
43767290|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767291|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43767292|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43767293|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767294|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767295|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43767296|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
43767297|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767298|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767299|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43767300|NCT02402491|Aspirin|aspirin|mesh-list
43767301|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
43767303|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43767304|NCT02402491|Analgesics|analgesics|mesh-ancestor
43767305|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
43767306|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767307|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767308|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767309|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767310|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43767311|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43767312|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767313|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43767314|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43767315|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767326|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
43767327|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767328|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767329|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43767330|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
43767331|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
43767332|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43767333|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43767334|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767335|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767336|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43767337|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43767338|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
43767339|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
43767340|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767341|NCT02402400|Ticagrelor|ticagrelor|mesh-list
43767342|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43767343|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43767344|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43767345|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43767346|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
43767347|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767348|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767350|NCT02402413|Androgens|androgens|mesh-list
43767375|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767376|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43767377|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767378|NCT02402543|Analgesics|analgesics|mesh-ancestor
43767379|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
43767380|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43767381|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43767382|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
43767383|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
43767384|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767385|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43767386|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43767387|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767388|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767389|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43767390|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
43767391|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
43767392|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43767393|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43767394|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43767395|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
43767396|NCT02402348|Metformin|metformin|mesh-list
43767397|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43767398|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767424|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767425|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43767426|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43767427|NCT02401971|Growth Substances|growth substances|mesh-ancestor
43767428|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
43767429|NCT02401880|Empagliflozin|empagliflozin|mesh-list
43767430|NCT02401880|Linagliptin|linagliptin|mesh-list
43767431|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43767432|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767433|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43767434|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767435|NCT02401880|Incretins|incretins|mesh-ancestor
43767436|NCT02401880|Hormones|hormones|mesh-ancestor
43767437|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767438|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43767439|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
43767440|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767441|NCT02401828|Dolutegravir|dolutegravir|mesh-list
43767442|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43767443|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43767444|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767445|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767446|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43767447|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43767448|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
43767449|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767450|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43767451|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
43767470|NCT02401425|Misoprostol|misoprostol|mesh-list
43767471|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767472|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43767473|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43767474|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767475|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767476|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43767477|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
43767478|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767479|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767480|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43767481|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
43767482|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43767483|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43767484|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767485|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
43767486|NCT02401269|Aspirin|aspirin|mesh-list
43767487|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43767488|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43767489|NCT02401269|Analgesics|analgesics|mesh-ancestor
43767490|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
43767491|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767492|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767493|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767494|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767495|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43767516|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767517|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
43767518|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767519|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43767520|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43767521|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43767522|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
43767523|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767524|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43767525|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767526|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
43767527|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
43767528|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
43767529|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43767530|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767531|NCT02401139|Ketamine|ketamine|mesh-list
43767532|NCT02401139|Analgesics|analgesics|mesh-ancestor
43767533|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
43767534|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767535|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767536|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43767537|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43767538|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
43767565|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43767566|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43767568|NCT02400645|Bupivacaine|bupivacaine|mesh-list
43767569|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
43767570|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
43767571|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767572|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767573|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
43767574|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767575|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43767576|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43767578|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767579|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767580|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43767581|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767582|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767583|NCT02400866|Olanzapine|olanzapine|mesh-list
43767584|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
43767585|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
43767586|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767587|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767588|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767589|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43767590|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43767591|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767592|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43767603|NCT02400788|Sorafenib|sorafenib|mesh-list
43767611|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
43767612|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43767613|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
43767614|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43572686|NCT00002429|Lamivudine|lamivudine|mesh-list
43767615|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767616|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43767617|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43767618|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767619|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43767620|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43767621|NCT02400801|Estrogens|estrogens|mesh-ancestor
43767622|NCT02400801|Hormones|hormones|mesh-ancestor
43767623|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767624|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43767625|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
43767626|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
43767627|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43767628|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43767629|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43767630|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43767631|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767632|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
43767633|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767634|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767635|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43767636|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767637|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43767653|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43767654|NCT02400385|Growth Substances|growth substances|mesh-ancestor
43767655|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767656|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
43767657|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43767658|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767660|NCT02400281|Fludarabine|fludarabine|mesh-list
43767661|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
43767662|NCT02400281|Etoposide|etoposide|mesh-list
43767663|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
43767664|NCT02400281|Azacitidine|azacitidine|mesh-list
43767665|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
43767666|NCT02400281|Idarubicin|idarubicin|mesh-list
43767667|NCT02400281|Crenolanib|crenolanib|mesh-list
43767668|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767669|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43767670|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
43767671|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767672|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43767673|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
43767674|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767675|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
43767676|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767677|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43767678|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43767679|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43767734|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43767735|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
43767738|NCT02399566|Pemetrexed|pemetrexed|mesh-list
43767740|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767742|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767743|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43767744|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43767745|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43767746|NCT02399592|Bevacizumab|bevacizumab|mesh-list
43767835|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
43767747|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43767748|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767749|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43767750|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43767751|NCT02399592|Growth Substances|growth substances|mesh-ancestor
43767754|NCT02399657|Dexamethasone|dexamethasone|mesh-list
43838021|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838022|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838024|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43838025|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847960|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43847961|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
43847962|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847963|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43847964|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43847965|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847966|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847967|NCT04063267|Nicotine|nicotine|mesh-list
43847968|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43847969|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
43847970|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847971|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847972|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43847973|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43847974|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
43847975|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847976|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847977|NCT04062123|Fentanyl|fentanyl|mesh-list
43847978|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
43847979|NCT04062123|Propofol|propofol|mesh-list
43847980|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43847981|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43847985|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
43767778|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767779|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767780|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767781|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767783|NCT02399397|Midazolam|midazolam|mesh-list
43767784|NCT02399397|Anesthetics|anesthetics|mesh-list
43767785|NCT02399397|Propofol|propofol|mesh-list
43767786|NCT02399397|Rocuronium|rocuronium|mesh-list
43767787|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767788|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767789|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43767790|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43767791|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
43767792|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43767793|NCT02399397|Narcotics|narcotics|mesh-ancestor
43767794|NCT02399397|Analgesics|analgesics|mesh-ancestor
43767795|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
43767796|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767797|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43767798|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43767799|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43767800|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43767801|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
43767802|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
43767803|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767804|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767805|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43767806|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43767807|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43767822|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
43767823|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767824|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43767825|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43767826|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43767827|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43767828|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
43767829|NCT02399137|Gemcitabine|gemcitabine|mesh-list
43767830|NCT02399137|Paclitaxel|paclitaxel|mesh-list
43767831|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43767832|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767833|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
43767834|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
43767836|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767837|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43767838|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
43767839|NCT02399137|Antiviral Agents|antiviral agents|mesh-ancestor
43767840|NCT02399137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767841|NCT02399137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767842|NCT02399137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43767843|NCT02399137|Immunologic Factors|immunologic factors|mesh-ancestor
43767844|NCT02399137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767845|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
43767846|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
43767847|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43767848|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
43767849|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43767850|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767851|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
43767852|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
43767853|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767854|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767855|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767856|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
43767862|NCT02398929|Bisoprolol|bisoprolol|mesh-list
43767863|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43767864|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
43767865|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
43767866|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767867|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767868|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43767869|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43767870|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43767871|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
43767872|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767873|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767874|NCT02398838|Misoprostol|misoprostol|mesh-list
43767875|NCT02398838|Mifepristone|mifepristone|mesh-list
43767876|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43767877|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
43767878|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43767879|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767880|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43767881|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767882|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
43767883|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43767884|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43767885|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43767886|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43767887|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
43767888|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43767889|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43767890|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
43767891|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767892|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
43767893|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43767894|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43767895|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
43767896|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
43767898|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767900|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
43767901|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767902|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767903|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
43767904|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767905|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43767906|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
43767910|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767911|NCT02398630|Hormones|hormones|mesh-list
43767912|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767913|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767914|NCT02398487|Nicotine|nicotine|mesh-list
43767915|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43767916|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
43767917|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767918|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767919|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43767941|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43767942|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767943|NCT02398474|Ropivacaine|ropivacaine|mesh-list
43767944|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
43767945|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
43767946|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767947|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767948|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
43767949|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767950|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
43573103|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
43767951|NCT02398539|Triamcinolone|triamcinolone|mesh-list
43767952|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767953|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
43767954|NCT02398539|Hormones|hormones|mesh-ancestor
43767955|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767956|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767957|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43767958|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767959|NCT02398201|Bezafibrate|bezafibrate|mesh-list
43767960|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43767961|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
43767962|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767963|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43767981|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767982|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43767983|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43767984|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767985|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767986|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43767987|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43767988|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43767989|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43767990|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43767991|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
43767992|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
43767993|NCT02397928|Cisplatin|cisplatin|mesh-list
43767994|NCT02397928|Carboplatin|carboplatin|mesh-list
43767995|NCT02397928|Pemetrexed|pemetrexed|mesh-list
43767996|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767997|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767998|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767999|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43768000|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43838026|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
43838027|NCT04875585|Lenvatinib|lenvatinib|mesh-list
43838028|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838029|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838030|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43838031|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838032|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838033|NCT04875364|Eszopiclone|eszopiclone|mesh-list
43838034|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43838035|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838036|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838037|NCT04875026|Fluorouracil|fluorouracil|mesh-list
43838044|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838045|NCT04874025|Palbociclib|palbociclib|mesh-list
43838046|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838047|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43838048|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838049|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838050|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
43573137|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
43768001|NCT02397772|Albendazole|albendazole|mesh-list
43768002|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
43768003|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43768004|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768005|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
43768006|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43768007|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43768008|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
43768009|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
43768010|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
43768011|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768050|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43768051|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
43768052|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
43768053|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
43768054|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43768055|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43768056|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
43768057|NCT02397603|Bupivacaine|bupivacaine|mesh-list
43768058|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
43768059|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
43768060|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768061|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768062|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
43768063|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768064|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43768065|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43768066|NCT02397603|Analgesics|analgesics|mesh-ancestor
43768067|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43768068|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43768069|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43768070|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
43768071|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768072|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768073|NCT02397395|Simeprevir|simeprevir|mesh-list
43768075|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768076|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
43768077|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768078|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768079|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43768092|NCT02397538|Amlodipine|amlodipine|mesh-list
43768093|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43768094|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43768095|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43768096|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43768097|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768098|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43768099|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768100|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
43768101|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43768102|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43768103|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
43768104|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43768105|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43768106|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768107|NCT02397486|Vitamin E|vitamin e|mesh-list
43768108|NCT02397486|Cisplatin|cisplatin|mesh-list
43768109|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
43768110|NCT02397486|Vitamins|vitamins|mesh-ancestor
43768112|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768113|NCT02397486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768114|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
43768115|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768123|NCT02397590|Atorvastatin|atorvastatin|mesh-list
43768143|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768144|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768145|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43768146|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43768148|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768149|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573292|NCT03528967|Aspirin|aspirin|mesh-list
43768150|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43768151|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
43768152|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43768153|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43768154|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43768155|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
43768156|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768157|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768158|NCT02397330|Morphine|morphine|mesh-list
43768159|NCT02397330|Bupivacaine|bupivacaine|mesh-list
43768160|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
43768161|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
43768162|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768163|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768164|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
43768165|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768166|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43768167|NCT02397330|Narcotics|narcotics|mesh-ancestor
43768168|NCT02397330|Analgesics|analgesics|mesh-ancestor
43768169|NCT02396979|Methadone|methadone|mesh-list
43768170|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43768171|NCT02396979|Narcotics|narcotics|mesh-ancestor
43768172|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768173|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768174|NCT02396979|Analgesics|analgesics|mesh-ancestor
43768175|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
43768176|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768178|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
43768179|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
43768180|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768181|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
43768182|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
43768183|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
43768184|NCT02397213|Cyclosporine|cyclosporine|mesh-list
43768185|NCT02397213|Cyclosporins|cyclosporins|mesh-list
43768186|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768187|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768188|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43768189|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
43768190|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768210|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768211|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43768212|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43768213|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768214|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768215|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43768216|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
43768221|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
43768227|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43768228|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768229|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
43768230|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
43768231|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
43768232|NCT02396433|Carboplatin|carboplatin|mesh-list
43768233|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43768234|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768235|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768236|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768237|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
43768238|NCT02396030|Analgesics|analgesics|mesh-ancestor
43768239|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
43768240|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768241|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768242|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
43768244|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43768261|NCT02396043|Dexamethasone|dexamethasone|mesh-list
43768262|NCT02396043|Prednisone|prednisone|mesh-list
43768263|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
43768264|NCT02396043|Methotrexate|methotrexate|mesh-list
43768265|NCT02396043|Vincristine|vincristine|mesh-list
43768266|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
43768267|NCT02396043|Pegaspargase|pegaspargase|mesh-list
43768268|NCT02396043|Asparaginase|asparaginase|mesh-list
43768269|NCT02396043|Pirarubicin|pirarubicin|mesh-list
43768270|NCT02396043|Doxorubicin|doxorubicin|mesh-list
43768271|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43768272|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
43768273|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768274|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43768275|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43768276|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
43768277|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768278|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768279|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43768293|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43768302|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
43768303|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
43768304|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43768305|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43768306|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43768307|NCT02395783|Melatonin|melatonin|mesh-list
43768308|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
43768309|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768310|NCT02395783|Protective Agents|protective agents|mesh-ancestor
43768311|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768312|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768313|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
43768314|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43768315|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768316|NCT02395926|Choline|choline|mesh-list
43768317|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
43768318|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43768319|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
43768320|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768321|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768322|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43768323|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
43768324|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43768325|NCT02395952|Laxatives|laxatives|mesh-ancestor
43768326|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768327|NCT02395744|Paclitaxel|paclitaxel|mesh-list
43768328|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43768329|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768330|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
43768331|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
43768332|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
43768371|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43768372|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
43768373|NCT02394847|Propofol|propofol|mesh-list
43768374|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43768375|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768376|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768377|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43768378|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
43768379|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
43768380|NCT02395068|Irinotecan|irinotecan|mesh-list
43768381|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
43768382|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43768383|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43768384|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768385|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768386|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768387|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43768388|NCT02395016|Gemcitabine|gemcitabine|mesh-list
43768389|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
43768390|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43768391|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
43768416|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768417|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43768418|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768420|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768421|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43768422|NCT02394470|Protective Agents|protective agents|mesh-ancestor
43768423|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768425|NCT02394496|Lapatinib|lapatinib|mesh-list
43768426|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43768427|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43768428|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768429|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43768430|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43768431|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
43768432|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43768433|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768434|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43768435|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768436|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768437|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43768438|NCT02394483|Olorofim|olorofim|mesh-list
43768439|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
43768440|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768441|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
43768442|NCT02394418|Propofol|propofol|mesh-list
43768470|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768471|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768473|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43768476|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
43768477|NCT02394197|Primaquine|primaquine|mesh-list
43768478|NCT02394197|Amebicides|amebicides|mesh-ancestor
43768479|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43768480|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43768481|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768482|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
43768483|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43768484|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43768485|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43768486|NCT02394197|Analgesics|analgesics|mesh-ancestor
43768487|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
43768488|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768489|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838074|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
43768491|NCT02394197|Filaricides|filaricides|mesh-ancestor
43768492|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
43768493|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
43768494|NCT02394119|Rituximab|rituximab|mesh-list
43768495|NCT02394119|Ofatumumab|ofatumumab|mesh-list
43768496|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43768497|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838114|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
43838115|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
43838116|NCT04870866|Vitamins|vitamins|mesh-ancestor
43838117|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
43838118|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838119|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43838120|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
43768503|NCT02394015|Doxorubicin|doxorubicin|mesh-list
43768504|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43768505|NCT02394015|Trabectedin|trabectedin|mesh-list
43768506|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43768507|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768508|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43768509|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43768510|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768511|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768512|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43768513|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
43768514|NCT02393846|Ketoprofen|ketoprofen|mesh-list
43768515|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43768516|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43768517|NCT02393846|Analgesics|analgesics|mesh-ancestor
43768518|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
43768519|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768520|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768521|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43768522|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43768523|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43768524|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768525|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768526|NCT02394093|Aspirin|aspirin|mesh-list
43768527|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43768528|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43768529|NCT02394093|Analgesics|analgesics|mesh-ancestor
43768530|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
43768531|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768547|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
43768548|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
43768549|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
43768550|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768551|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43768552|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43768553|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43768554|NCT02393898|Growth Substances|growth substances|mesh-ancestor
43768555|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768593|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43768594|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43768595|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43768596|NCT02393599|Cocaine|cocaine|mesh-list
43768597|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
43768598|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
43768599|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768600|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768601|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
43768602|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768603|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43768604|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43768605|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43768606|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43768607|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768608|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
43768609|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768610|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
43768611|NCT02393482|Vitamin D|vitamin d|mesh-list
43768612|NCT02393482|Leuprolide|leuprolide|mesh-list
43768613|NCT02393482|Tibolone|tibolone|mesh-list
43768615|NCT02393482|Hormones|hormones|mesh-list
43768616|NCT02393482|Estradiol|estradiol|mesh-list
43768617|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43768618|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768619|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43768620|NCT02393482|Estrogens|estrogens|mesh-ancestor
43768621|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768622|NCT02393482|Antacids|antacids|mesh-ancestor
43768623|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768624|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768625|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43768626|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
43768627|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43768628|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768630|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
43768631|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43768632|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43768633|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
43768635|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
43768636|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43768637|NCT02393573|Metformin|metformin|mesh-list
43768638|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43768639|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768640|NCT02393586|Amoxicillin|amoxicillin|mesh-list
43768641|NCT02393586|Rifampin|rifampin|mesh-list
43768642|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43768643|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
43768644|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
43768645|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43768646|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768647|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43768648|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
43768649|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
43768650|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43768651|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768652|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768653|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43768654|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43768655|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43768656|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43768660|NCT02393456|Oxytocin|oxytocin|mesh-list
43768668|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43768669|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43768670|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
43768671|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768672|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768674|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43768675|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768676|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
43768677|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768678|NCT02393430|Protective Agents|protective agents|mesh-ancestor
43768679|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768680|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768681|NCT02393443|Oxytocin|oxytocin|mesh-list
43768682|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
43768683|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768684|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768685|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
43768686|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43768687|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43768688|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768689|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
43768690|NCT02393300|Coagulants|coagulants|mesh-ancestor
43768691|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
43768721|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768722|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
43768723|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43768724|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43768725|NCT02392780|Prednisolone|prednisolone|mesh-list
43768726|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
43768727|NCT02392780|Cannabidiol|cannabidiol|mesh-list
43768728|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43768729|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
43768730|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43768731|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43768732|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
43768733|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
43768734|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768735|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768736|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768737|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
43768739|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43768740|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43768741|NCT02392780|Protective Agents|protective agents|mesh-ancestor
43768742|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43768743|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768744|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
43768745|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768746|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768747|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
43768748|NCT02393066|Propofol|propofol|mesh-list
43768749|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43768750|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768751|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768752|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43768753|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
43768754|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
43768755|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43768756|NCT02393066|Analgesics|analgesics|mesh-ancestor
43768757|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
43768759|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43768760|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43768761|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43768762|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
43768772|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768774|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43768775|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
43768776|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768777|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43768813|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838149|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
43838150|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43838151|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838152|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43838153|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838154|NCT04868838|Daratumumab|daratumumab|mesh-list
43838155|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838156|NCT04868045|Hormones|hormones|mesh-list
43838157|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
43838158|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838159|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838160|NCT04866108|Capecitabine|capecitabine|mesh-list
43838161|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43838162|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
43838163|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768830|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768831|NCT02392156|Factor VIII|factor viii|mesh-list
43768832|NCT02392156|Coagulants|coagulants|mesh-ancestor
43768833|NCT02392169|Methylphenidate|methylphenidate|mesh-list
43768834|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43768835|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768836|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43768837|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43768838|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43768839|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768840|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
43768841|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768843|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43768844|NCT02391844|Narcotics|narcotics|mesh-ancestor
43768845|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768846|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768847|NCT02391844|Analgesics|analgesics|mesh-ancestor
43768848|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
43768849|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768850|NCT02391883|Clopidogrel|clopidogrel|mesh-list
43768851|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43768852|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43768853|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43768854|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43768855|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
43768856|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768859|NCT02391805|Tenofovir|tenofovir|mesh-list
43768875|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
43768876|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
43768877|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768878|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43768879|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
43768881|NCT02391662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768882|NCT02391662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768883|NCT02391662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43768884|NCT02391662|Immunologic Factors|immunologic factors|mesh-ancestor
43768885|NCT02391662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768886|NCT02391688|Fexofenadine|fexofenadine|mesh-list
43768887|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
43768888|NCT02391688|Midazolam|midazolam|mesh-list
43768889|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
43768890|NCT02391688|Caffeine|caffeine|mesh-list
43768891|NCT02391688|Bupropion|bupropion|mesh-list
43768892|NCT02391688|Omeprazole|omeprazole|mesh-list
43768893|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43768894|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43768895|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768896|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768897|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43768898|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43768899|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43768900|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43768901|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
43768902|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
43768903|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
43768904|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
43768905|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768906|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768907|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43768908|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768909|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43768916|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43768917|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
43768918|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43768919|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43768920|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43768921|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
43768922|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43768923|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43768924|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
43768925|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
43768926|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43768927|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43768928|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43768929|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43768930|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43768931|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
43768932|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
43768933|NCT02391688|Analgesics|analgesics|mesh-ancestor
43768934|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
43768935|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768936|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43768937|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43768938|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43768939|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43768940|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43768941|NCT02391636|Oxytocin|oxytocin|mesh-list
43768942|NCT02391636|Carbetocin|carbetocin|mesh-list
43768943|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
43768944|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768945|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768946|NCT02391480|Venetoclax|venetoclax|mesh-list
43768947|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768948|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43768956|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
43768957|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
43768958|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
43768959|NCT02391142|Lidocaine|lidocaine|mesh-list
43768960|NCT02391142|Ropivacaine|ropivacaine|mesh-list
43768961|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
43768962|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
43768963|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768964|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768965|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
43768966|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768967|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43768968|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43768969|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43769217|NCT02389179|Vitamins|vitamins|mesh-ancestor
43768979|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768980|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768981|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768982|NCT02390882|Urological Agents|urological agents|mesh-ancestor
43768983|NCT02390700|Golimumab|golimumab|mesh-list
43768984|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43768985|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43768999|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769000|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769002|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769003|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
43769005|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
43769006|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769007|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43769008|NCT02390739|Aldesleukin|aldesleukin|mesh-list
43769009|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
43769010|NCT02390739|Fludarabine|fludarabine|mesh-list
43769011|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769012|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
43769013|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769014|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769015|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43769016|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
43769017|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769018|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769019|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43769020|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43769021|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43769022|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
43769023|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769024|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
43769025|NCT02390843|Topotecan|topotecan|mesh-list
43769026|NCT02390843|Simvastatin|simvastatin|mesh-list
43769027|NCT02390843|Lenograstim|lenograstim|mesh-list
43769056|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769057|NCT02390817|Neostigmine|neostigmine|mesh-list
43769058|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43769059|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769060|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769061|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
43769062|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769218|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
43769063|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769064|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43769066|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769067|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43769068|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769069|NCT02390505|Ascorbic Acid|ascorbic acid|mesh-list
43769070|NCT02390505|Vitamins|vitamins|mesh-ancestor
43769071|NCT02390505|Micronutrients|micronutrients|mesh-ancestor
43769072|NCT02390505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769073|NCT02390505|Antioxidants|antioxidants|mesh-ancestor
43769074|NCT02390505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769075|NCT02390505|Protective Agents|protective agents|mesh-ancestor
43838164|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838165|NCT04865237|Remdesivir|remdesivir|mesh-list
43574327|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43838166|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
43769077|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769078|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
43769079|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769080|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769081|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
43769082|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769083|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43769084|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43769085|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43769086|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
43769093|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769094|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769095|NCT02390310|Lidocaine|lidocaine|mesh-list
43769096|NCT02390310|Prilocaine|prilocaine|mesh-list
43769097|NCT02390310|Anesthetics|anesthetics|mesh-list
43769098|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769099|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769100|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769101|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
43769102|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769103|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43769104|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43769105|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43769106|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769107|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769108|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
43769109|NCT02390102|Hematinics|hematinics|mesh-ancestor
43769110|NCT02390089|Capsaicin|capsaicin|mesh-list
43769111|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
43769112|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
43769113|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
43769114|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769115|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769116|NCT02389842|Palbociclib|palbociclib|mesh-list
43769117|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769118|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43769119|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769121|NCT02389972|Dasatinib|dasatinib|mesh-list
43769126|NCT02389751|Paclitaxel|paclitaxel|mesh-list
43769139|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43769140|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
43769141|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769142|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43769143|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43769144|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769145|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
43769146|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769147|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
43769148|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769149|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769150|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43769151|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
43769152|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769153|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769154|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43769155|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43769156|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43769189|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769190|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769191|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
43769192|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
43769193|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43769194|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
43769195|NCT02389426|Bosentan|bosentan|mesh-list
43769196|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43769197|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43769198|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769199|NCT02389348|Artefenomel|artefenomel|mesh-list
43769200|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
43769201|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43769202|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43769203|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769210|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43769211|NCT02389231|Analgesics|analgesics|mesh-ancestor
43769212|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
43769213|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769214|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769215|NCT02389179|Vitamin D|vitamin d|mesh-list
43769216|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
43769219|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769220|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43769221|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43769222|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43769223|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
43769224|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769225|NCT02388750|Palonosetron|palonosetron|mesh-list
43769226|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
43769227|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
43769228|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769229|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769230|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43769231|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43769232|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43769233|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
43769234|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769235|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769236|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
43574484|NCT03515798|Paclitaxel|paclitaxel|mesh-list
43769237|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769238|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
43769254|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43769255|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43769256|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769257|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769258|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43769259|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43769260|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43769261|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43769262|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43769263|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43769264|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43769265|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838167|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838168|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
43838169|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838170|NCT04865159|Tipifarnib|tipifarnib|mesh-list
43838171|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838172|NCT04864444|Piperaquine|piperaquine|mesh-list
43838173|NCT04864444|Primaquine|primaquine|mesh-list
43838174|NCT04864444|Artenimol|artenimol|mesh-list
43838175|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
43838176|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43838177|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43838178|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838179|NCT04864210|Bupivacaine|bupivacaine|mesh-list
43838181|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
43847995|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847996|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43847997|NCT04062123|Narcotics|narcotics|mesh-ancestor
43847998|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43847999|NCT04061980|Nivolumab|nivolumab|mesh-list
43848000|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848001|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848002|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43848003|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848004|NCT04061239|Cytarabine|cytarabine|mesh-list
43848005|NCT04061239|Azacitidine|azacitidine|mesh-list
43769266|NCT02388516|Vitamin D|vitamin d|mesh-list
43769267|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
43769268|NCT02388516|Vitamins|vitamins|mesh-ancestor
43769269|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
43769270|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769271|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43769272|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43769273|NCT02388477|Doxycycline|doxycycline|mesh-list
43769274|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43769275|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769276|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
43769277|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43769278|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43769279|NCT02388373|Fluticasone|fluticasone|mesh-list
43769280|NCT02388373|Xhance|xhance|mesh-list
43769281|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
43769282|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43769283|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43769284|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43769313|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
43769314|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769315|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43769316|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43769317|NCT02387931|Vitamin D|vitamin d|mesh-list
43769318|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
43769319|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
43769320|NCT02387931|Vitamins|vitamins|mesh-list
43769321|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
43769349|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43769350|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
43769351|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43769352|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43769353|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769354|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43769355|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43769376|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769377|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
43769378|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43769379|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769391|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769392|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769393|NCT02387450|Urological Agents|urological agents|mesh-ancestor
43769395|NCT02387086|Thalidomide|thalidomide|mesh-list
43769396|NCT02387086|Gefitinib|gefitinib|mesh-list
43769397|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43769398|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43769399|NCT02387086|Analgesics|analgesics|mesh-ancestor
43769400|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
43769401|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769404|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769421|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769422|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43769423|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
43769425|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769426|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43769427|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43769428|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769429|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769430|NCT02387060|Fentanyl|fentanyl|mesh-list
43769431|NCT02387060|Bupivacaine|bupivacaine|mesh-list
43769432|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769433|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
43769434|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769435|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769436|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
43769437|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769438|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43838209|NCT04859946|Thiotepa|thiotepa|mesh-list
43838210|NCT04859946|Fludarabine|fludarabine|mesh-list
43838211|NCT04859946|Tacrolimus|tacrolimus|mesh-list
43838212|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838213|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
43838214|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838215|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838216|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43838217|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
43838218|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838219|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838220|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43838221|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43838222|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838223|NCT04859465|Doxorubicin|doxorubicin|mesh-list
43838224|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43838225|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43838226|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43769470|NCT02386358|Benzonidazole|benzonidazole|mesh-list
43769509|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43769510|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769511|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769512|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43769534|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769535|NCT02386449|Cathartics|cathartics|mesh-ancestor
43769536|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43769537|NCT02386449|Laxatives|laxatives|mesh-ancestor
43769538|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
43769539|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43769540|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
43769541|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
43769542|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769544|NCT02386566|Natalizumab|natalizumab|mesh-list
43769545|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
43769546|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769548|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43769549|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43769550|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43769551|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769552|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
43769568|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43769569|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
43769570|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43769571|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43769572|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43769573|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
43769574|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
43769575|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769576|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43769577|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43769578|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
43769579|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43769580|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
43769581|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
43769582|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
43769584|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
43769585|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769586|NCT02386111|Sunitinib|sunitinib|mesh-list
43769587|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769588|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43769589|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43769621|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769622|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
43769623|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
43769624|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43769625|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
43769626|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769627|NCT02386059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43769628|NCT02386059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43769629|NCT02386059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769630|NCT02386059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43769631|NCT02386059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43769633|NCT02386072|Oxybutynin|oxybutynin|mesh-list
43769634|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
43769645|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769646|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43769669|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769670|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
43769671|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769672|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769673|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
43769674|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769675|NCT02385500|Fesoterodine|fesoterodine|mesh-list
43769676|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43769677|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43769678|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
43769679|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769680|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769681|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769682|NCT02385500|Urological Agents|urological agents|mesh-ancestor
43769683|NCT02385474|Fluorides|fluorides|mesh-list
43769705|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43769707|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769708|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43769709|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769710|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43769711|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43769712|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
43769713|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43769714|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43769715|NCT02385422|Propranolol|propranolol|mesh-list
43769716|NCT02385422|Carvedilol|carvedilol|mesh-list
43769717|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43769718|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43769719|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
43769720|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769721|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769722|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769723|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43769724|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43769725|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
43769726|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
43769727|NCT02385422|Protective Agents|protective agents|mesh-ancestor
43769728|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43769729|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769730|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43769731|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43769735|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769736|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
43769737|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769738|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769739|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
43769740|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769741|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43769742|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43769743|NCT02385435|Analgesics|analgesics|mesh-ancestor
43769744|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43769745|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43769746|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43769747|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
43769748|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769749|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769750|NCT02385396|Folic Acid|folic acid|mesh-list
43769751|NCT02385396|Inositol|inositol|mesh-list
43769752|NCT02385396|Hematinics|hematinics|mesh-ancestor
43769753|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
43769754|NCT02385396|Vitamins|vitamins|mesh-ancestor
43769755|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
43769756|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769757|NCT02385266|Cycloserine|cycloserine|mesh-list
43769758|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43769759|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769760|NCT02385266|Renal Agents|renal agents|mesh-ancestor
43769761|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43769762|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
43769763|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43769764|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
43769765|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769766|NCT02385305|Anesthetics|anesthetics|mesh-list
43769780|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769781|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769782|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769783|NCT02385227|Nicotine|nicotine|mesh-list
43769784|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43769785|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
43769786|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769787|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769788|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43769789|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43769790|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
43769791|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769792|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769793|NCT02385188|Acetaminophen|acetaminophen|mesh-list
43769794|NCT02385188|Imiquimod|imiquimod|mesh-list
43769795|NCT02385188|Lidocaine|lidocaine|mesh-list
43769796|NCT02385188|Petrolatum|petrolatum|mesh-list
43769797|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769798|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
43769799|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769800|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769801|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
43769802|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769803|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43769804|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43769805|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43769806|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769807|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769808|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43769809|NCT02385188|Analgesics|analgesics|mesh-ancestor
43769810|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
43769811|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43769812|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
43769813|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769814|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
43769819|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43769821|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43769822|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
43769823|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769824|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769828|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
43769829|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769830|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838227|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838228|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43838229|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43838230|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838231|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838232|NCT04859062|Lidocaine|lidocaine|mesh-list
43838233|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
43838234|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
43838235|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838236|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838237|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
43838238|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838239|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43838240|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43769835|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769836|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769837|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
43769838|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769839|NCT02384954|Rituximab|rituximab|mesh-list
43769840|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43769841|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769842|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
43769843|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769844|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769845|NCT02384967|Darunavir|darunavir|mesh-list
43769846|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43769847|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43769848|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
43769849|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769850|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769851|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43769852|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43769853|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
43769854|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769855|NCT02384876|Ephedrine|ephedrine|mesh-list
43769856|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
43769857|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43769858|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43769859|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769860|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
43769861|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
43769862|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769882|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43769883|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43769884|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43769885|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769886|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43769887|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769888|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769889|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
43769890|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43769891|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769893|NCT02384746|Ixazomib|ixazomib|mesh-list
43769894|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43769895|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769896|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43769897|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43769898|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
43769899|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769900|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769901|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
43769902|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575254|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43769903|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769904|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
43769905|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43769906|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769907|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769922|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43769923|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769924|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769925|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43769926|NCT02384512|Protective Agents|protective agents|mesh-ancestor
43769927|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769929|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43769930|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43769931|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769932|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
43769933|NCT02384135|Coagulants|coagulants|mesh-ancestor
43769934|NCT02384122|Octreotide|octreotide|mesh-list
43769935|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43769936|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43769937|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769938|NCT02383901|Methotrexate|methotrexate|mesh-list
43769939|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43769940|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
43769944|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
43769957|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769958|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769959|NCT02383888|BI 425809|bi 425809|mesh-list
43769960|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
43769961|NCT02383927|Tipifarnib|tipifarnib|mesh-list
43769962|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769963|NCT02384187|Gabapentin|gabapentin|mesh-list
43769964|NCT02384187|Analgesics|analgesics|mesh-ancestor
43769965|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
43769966|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769967|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769968|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
43769969|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43769970|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43769971|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769972|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43769973|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43769974|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43769975|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769978|NCT02383771|Aspirin|aspirin|mesh-list
43770012|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
43770112|NCT02382328|Protective Agents|protective agents|mesh-ancestor
43770017|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
43770018|NCT02383212|Carboplatin|carboplatin|mesh-list
43770019|NCT02383212|Pemetrexed|pemetrexed|mesh-list
43770020|NCT02383212|Cemiplimab|cemiplimab|mesh-list
43770021|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43770022|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770023|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
43770024|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
43770025|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
43770026|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770027|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770028|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
43770029|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770030|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770031|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43770032|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
43770033|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43770034|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770035|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43770036|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43770037|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43770038|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
43770039|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43838269|NCT04856761|Tegafur|tegafur|mesh-list
43838270|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43838271|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
43770051|NCT02382757|Insulin|insulin|mesh-list
43770052|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43770053|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43770054|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770055|NCT02382653|Piroxicam|piroxicam|mesh-list
43770056|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43770057|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43770058|NCT02382653|Analgesics|analgesics|mesh-ancestor
43770059|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
43770060|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770061|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770062|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770063|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770064|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43770065|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770066|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770067|NCT02382679|Vitamins|vitamins|mesh-list
43770087|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770088|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43770089|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
43770090|NCT02382263|Antiviral Agents|antiviral agents|mesh-ancestor
43770091|NCT02382263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770092|NCT02382263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770093|NCT02382263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770094|NCT02382263|Immunologic Factors|immunologic factors|mesh-ancestor
43770095|NCT02382263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770096|NCT02382354|Remifentanil|remifentanil|mesh-list
43770097|NCT02382354|Propofol|propofol|mesh-list
43770098|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43770099|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770100|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770101|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43770102|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
43770103|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
43770104|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43770105|NCT02382354|Narcotics|narcotics|mesh-ancestor
43770106|NCT02382354|Analgesics|analgesics|mesh-ancestor
43770107|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
43770108|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770109|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
43770110|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
43770111|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770139|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43770141|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
43770142|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770144|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43770155|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770156|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770157|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
43770158|NCT02382146|Hormones|hormones|mesh-ancestor
43770159|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770160|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43770161|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770162|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
43770163|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770164|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770185|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770186|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770187|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
43770188|NCT02382068|Hormones|hormones|mesh-ancestor
43770189|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770190|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43770191|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770192|NCT02382094|Bicalutamide|bicalutamide|mesh-list
43770193|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
43770194|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
43770195|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770196|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770197|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770198|NCT02382029|Clonazepam|clonazepam|mesh-list
43770199|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
43770200|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
43770201|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
43770202|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770203|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770204|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770205|NCT02381899|Rituximab|rituximab|mesh-list
43770206|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43770207|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43770208|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770209|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
43770210|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770211|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770212|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43770213|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
43770214|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770215|NCT02381600|Vitamin D|vitamin d|mesh-list
43770216|NCT02381600|Vitamins|vitamins|mesh-ancestor
43770217|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
43770220|NCT02381717|Morphine|morphine|mesh-list
43770226|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
43770227|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770228|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43770229|NCT02381717|Narcotics|narcotics|mesh-ancestor
43770230|NCT02381717|Analgesics|analgesics|mesh-ancestor
43770231|NCT02381730|Aflibercept|aflibercept|mesh-list
43770232|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43770233|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43770234|NCT02381730|Growth Substances|growth substances|mesh-ancestor
43770235|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770236|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
43770237|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770238|NCT02381548|Belinostat|belinostat|mesh-list
43770239|NCT02381548|Adavosertib|adavosertib|mesh-list
43770240|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770241|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770242|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770243|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43770244|NCT02381249|Octreotide|octreotide|mesh-list
43770245|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770246|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43770327|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
43770252|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838288|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838289|NCT04854551|Naltrexone|naltrexone|mesh-list
43838290|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43838291|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43838292|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838293|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
43838294|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838295|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
43838296|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43838297|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
43838298|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838299|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
43838300|NCT04853589|Protective Agents|protective agents|mesh-ancestor
43838301|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43838302|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43838303|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838304|NCT04853355|Spironolactone|spironolactone|mesh-list
43838305|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43838306|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
43838307|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838308|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838309|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43838310|NCT04853355|Diuretics|diuretics|mesh-ancestor
43838311|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
43838312|NCT04852068|Vaccines|vaccines|mesh-list
43838313|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
43838314|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838315|NCT04850937|Esketamine|esketamine|mesh-list
43838316|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
43838317|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43838318|NCT04848792|Sulforaphane|sulforaphane|mesh-list
43770265|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43770266|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
43770267|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770268|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770269|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43770270|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
43770271|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43770272|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43770273|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43770274|NCT02381470|Amoxicillin|amoxicillin|mesh-list
43770275|NCT02381470|Rifampin|rifampin|mesh-list
43770276|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43770278|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
43770279|NCT02381470|Cefadroxil|cefadroxil|mesh-list
43770280|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43770281|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770284|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
43770313|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770314|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43770315|NCT02381080|Voriconazole|voriconazole|mesh-list
43770316|NCT02381080|Erythromycin|erythromycin|mesh-list
43770317|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
43770318|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43770319|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
43770320|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
43770321|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770322|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43770323|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43770324|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770325|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770326|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43770328|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770329|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770330|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43770331|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43770332|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770333|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43770351|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770352|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770353|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43770354|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
43770355|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43770356|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43770357|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43770358|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
43770359|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43770360|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770361|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
43770362|NCT02380625|Azithromycin|azithromycin|mesh-list
43770363|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43770364|NCT02380625|Sunitinib|sunitinib|mesh-list
43770365|NCT02380625|Irbesartan|irbesartan|mesh-list
43770366|NCT02380625|Atorvastatin|atorvastatin|mesh-list
43770367|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43770368|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43770369|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
43770370|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770371|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43770372|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43770373|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770374|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770375|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43770376|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43770377|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770378|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43770379|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43770386|NCT02380521|Exenatide|exenatide|mesh-list
43770394|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770396|NCT02380417|Ropivacaine|ropivacaine|mesh-list
43770397|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
43770398|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
43770399|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770400|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770401|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
43770402|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770403|NCT02380313|Prednisone|prednisone|mesh-list
43770404|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770405|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
43770406|NCT02380313|Hormones|hormones|mesh-ancestor
43770407|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770408|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770409|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43770410|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770411|NCT02380352|Amoxicillin|amoxicillin|mesh-list
43770412|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43770413|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770414|NCT02380131|Capecitabine|capecitabine|mesh-list
43770415|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
43770416|NCT02380131|Trastuzumab|trastuzumab|mesh-list
43770417|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43770418|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
43770419|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770420|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770421|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43770422|NCT02380118|Midazolam|midazolam|mesh-list
43770423|NCT02380118|Haloperidol|haloperidol|mesh-list
43770424|NCT02380118|Olanzapine|olanzapine|mesh-list
43770439|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770440|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
43770441|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
43770442|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770443|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770444|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43770445|NCT02380118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43770446|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43770447|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43770448|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
43770449|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43770450|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
43770451|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43770452|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43770453|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43770454|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43770455|NCT02380001|Analgesics|analgesics|mesh-ancestor
43770456|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
43770457|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770458|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770459|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770460|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770461|NCT02379754|Gentamicins|gentamicins|mesh-list
43770462|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43770463|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770464|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43770465|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770466|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770468|NCT02380053|Bisoprolol|bisoprolol|mesh-list
43770469|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43770473|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770474|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43770476|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43770477|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
43770478|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770479|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770480|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43770482|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
43770483|NCT02379793|Mineral Oil|mineral oil|mesh-list
43770484|NCT02379793|Emollients|emollients|mesh-ancestor
43770485|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
43770486|NCT02379767|Harmine|harmine|mesh-list
43770487|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
43770488|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770489|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43770490|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43770491|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770492|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838320|NCT04848792|Protective Agents|protective agents|mesh-ancestor
43838321|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838322|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838323|NCT04848688|Ivermectin|ivermectin|mesh-list
43838324|NCT04848688|Moxidectin|moxidectin|mesh-list
43838325|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43838326|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838328|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
43838329|NCT04848584|Vaccines|vaccines|mesh-list
43838330|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
43838331|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848007|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43848008|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
43848009|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848010|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848011|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
43848012|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848013|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848014|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
43848015|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848016|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848017|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43848018|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43848019|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43848020|NCT04060849|Ethanol|ethanol|mesh-list
43848021|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43848022|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43848023|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848024|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848025|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770501|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770503|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
43770504|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
43770505|NCT02379663|Enoxaparin|enoxaparin|mesh-list
43770506|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
43770507|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43770510|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
43770511|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770512|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770513|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
43770514|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43770515|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43770516|NCT02379546|Desflurane|desflurane|mesh-list
43770517|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43770518|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
43770519|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
43770520|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770521|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770522|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
43770523|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
43770524|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43770525|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43770552|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770553|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
43770554|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770555|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770556|NCT02379026|Vitamin D|vitamin d|mesh-list
43770557|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
43770558|NCT02379026|Vitamins|vitamins|mesh-ancestor
43770559|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
43770560|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770561|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43770562|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43770563|NCT02379156|Midodrine|midodrine|mesh-list
43770564|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
43770565|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
43770566|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770567|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770568|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43770569|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43770570|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43770571|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43770572|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
43770573|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770574|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770575|NCT02378623|Apixaban|apixaban|mesh-list
43770576|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43770577|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
43770578|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43770579|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
43770580|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770581|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770596|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770598|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
43770599|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43770600|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43770601|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770602|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770603|NCT02378649|Urological Agents|urological agents|mesh-ancestor
43770604|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43770605|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770606|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770607|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770608|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43770609|NCT02378415|Ketamine|ketamine|mesh-list
43770610|NCT02378415|Analgesics|analgesics|mesh-ancestor
43770611|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
43770612|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770613|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770614|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43770615|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43770616|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
43770617|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
43770618|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770619|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43770620|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43770621|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770622|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770643|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770644|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
43770645|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770646|NCT02378389|Docetaxel|docetaxel|mesh-list
43770647|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770648|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
43770649|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
43770650|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
43770651|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770652|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
43770653|NCT02378129|Methamphetamine|methamphetamine|mesh-list
43770654|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43770655|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770656|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
43770657|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
43770658|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770659|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
43770660|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770661|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770662|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
43770663|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43770678|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838333|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43838334|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43838335|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
43838336|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43838337|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838338|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838339|NCT04848116|Nivolumab|nivolumab|mesh-list
43838340|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838341|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838342|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43838343|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838346|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43838347|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43838348|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
43838349|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838350|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43838351|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43838352|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838354|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
43838355|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
43838380|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43838381|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43838382|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838383|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43838384|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
43838385|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
43838386|NCT04844216|Protective Agents|protective agents|mesh-ancestor
43838387|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
43838388|NCT04844164|Vitamin D|vitamin d|mesh-list
43838389|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43838390|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838391|NCT04844164|Vitamins|vitamins|mesh-ancestor
43838392|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
43838393|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43838394|NCT04844099|Piperaquine|piperaquine|mesh-list
43838395|NCT04844099|Artenimol|artenimol|mesh-list
43838396|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
43838397|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43838398|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43838399|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838400|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
43838402|NCT04843917|Antibodies|antibodies|mesh-list
43770712|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43770713|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43770714|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43770715|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43770716|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770717|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43770718|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770719|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
43770720|NCT02377661|Diuretics|diuretics|mesh-ancestor
43770721|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
43770722|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43770723|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43770724|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43770726|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
43770727|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770728|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770729|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770730|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43770731|NCT02377388|Saxagliptin|saxagliptin|mesh-list
43770732|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43770733|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770734|NCT02377388|Incretins|incretins|mesh-ancestor
43770735|NCT02377388|Hormones|hormones|mesh-ancestor
43770736|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770737|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43770738|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
43770741|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
43770754|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43770755|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770757|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
43770758|NCT02377180|Capsaicin|capsaicin|mesh-list
43770759|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770760|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770761|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
43770762|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770763|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
43770764|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
43770765|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
43770766|NCT02377076|Calcium|calcium|mesh-list
43770767|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43770768|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770769|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43770770|NCT02376972|Rifaximin|rifaximin|mesh-list
43770789|NCT02376478|Etanercept|etanercept|mesh-list
43770790|NCT02376478|Methotrexate|methotrexate|mesh-list
43770798|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43770799|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
43770800|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770801|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770802|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
43770803|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770804|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770805|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
43770806|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770807|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43770808|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770809|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770814|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770815|NCT02376478|Hematinics|hematinics|mesh-ancestor
43770816|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
43770817|NCT02376478|Vitamins|vitamins|mesh-ancestor
43770818|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
43770854|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770855|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770856|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
43770857|NCT02376088|Methimazole|methimazole|mesh-list
43770858|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
43770859|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
43770867|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770868|NCT02376192|Phenylephrine|phenylephrine|mesh-list
43770876|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
43770877|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770878|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43770879|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
43770880|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
43770881|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
43770882|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43770883|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
43770884|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
43770885|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43770886|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43770887|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43770888|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
43770889|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770890|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770891|NCT02376192|Protective Agents|protective agents|mesh-ancestor
43770892|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43770893|NCT02376049|Betamethasone|betamethasone|mesh-list
43770894|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
43770895|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43770896|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
43770897|NCT02376049|Clobetasol|clobetasol|mesh-list
43770898|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
43770899|NCT02376049|Emollients|emollients|mesh-list
43770900|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43770901|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770902|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
43770903|NCT02376049|Hormones|hormones|mesh-ancestor
43770904|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770905|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770906|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43770907|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
43770908|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43770909|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43770910|NCT02376049|Analgesics|analgesics|mesh-ancestor
43770915|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770916|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
43770917|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43770918|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770919|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770920|NCT02376205|Bupivacaine|bupivacaine|mesh-list
43770921|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43770922|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
43770923|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
43770924|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770925|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770926|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
43770927|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838405|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838408|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
43838409|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
43838410|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
43838411|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770928|NCT02376075|Linagliptin|linagliptin|mesh-list
43770929|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43770930|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770931|NCT02376075|Incretins|incretins|mesh-ancestor
43770933|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770934|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43770942|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43770943|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770944|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
43770945|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770946|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770947|NCT02375880|Gemcitabine|gemcitabine|mesh-list
43770948|NCT02375880|Cisplatin|cisplatin|mesh-list
43770949|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770950|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43770951|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
43770952|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770953|NCT02375880|Antiviral Agents|antiviral agents|mesh-ancestor
43770954|NCT02375880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770955|NCT02375880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770956|NCT02375880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770957|NCT02375880|Immunologic Factors|immunologic factors|mesh-ancestor
43770958|NCT02375880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770959|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
43770960|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43770961|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43770962|NCT02375867|Prednisolone|prednisolone|mesh-list
43770963|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
43770964|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43770965|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
43770966|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770967|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
43770968|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
43770969|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770970|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770971|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770972|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
43770973|NCT02375867|Hormones|hormones|mesh-ancestor
43770974|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770976|NCT02375867|Protective Agents|protective agents|mesh-ancestor
43770984|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43770985|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770987|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770988|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43770989|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770990|NCT02375503|Vitamin D|vitamin d|mesh-list
43770991|NCT02375503|Calcium|calcium|mesh-list
43770992|NCT02375503|Vitamins|vitamins|mesh-ancestor
43770993|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
43770994|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770995|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43770996|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43770997|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
43770998|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43770999|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771000|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771001|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771002|NCT02375243|Analgesics|analgesics|mesh-ancestor
43771003|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
43771004|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771005|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43771006|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43771007|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43771008|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
43771009|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771010|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771011|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
43771012|NCT02375217|Neostigmine|neostigmine|mesh-list
43771013|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43771014|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771015|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771016|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
43771017|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771020|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
43771021|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771022|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43771023|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43771024|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43771025|NCT02375139|Metformin|metformin|mesh-list
43771026|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771027|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771028|NCT02375191|Fentanyl|fentanyl|mesh-list
43771029|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
43771030|NCT02375191|Ropivacaine|ropivacaine|mesh-list
43771031|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43771032|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771033|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771034|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771035|NCT02375191|Analgesics|analgesics|mesh-ancestor
43771036|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
43771037|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771038|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43771039|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43771040|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43771041|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
43771042|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771043|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771044|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771045|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
43771046|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43771047|NCT02375191|Narcotics|narcotics|mesh-ancestor
43771069|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771070|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
43771071|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43771072|NCT02375100|Narcotics|narcotics|mesh-ancestor
43771073|NCT02375022|Endostar protein|endostar protein|mesh-list
43771074|NCT02375022|Endostatins|endostatins|mesh-list
43771075|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43771076|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43771077|NCT02375022|Growth Substances|growth substances|mesh-ancestor
43771078|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771079|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
43771080|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771081|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
43771082|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43771084|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
43771085|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
43771086|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771087|NCT02374931|Estradiol|estradiol|mesh-list
43771088|NCT02374931|Estrogens|estrogens|mesh-ancestor
43771089|NCT02374931|Hormones|hormones|mesh-ancestor
43771090|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771091|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771092|NCT02374632|Octreotide|octreotide|mesh-list
43771093|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771094|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43771095|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771096|NCT02374645|Gefitinib|gefitinib|mesh-list
43771097|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771098|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43771099|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771100|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771101|NCT02374489|Ceritinib|ceritinib|mesh-list
43771102|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771103|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43771104|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771105|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771110|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771111|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
43771112|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838412|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838413|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43838414|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43838415|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838427|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838428|NCT04841343|Triamcinolone|triamcinolone|mesh-list
43838429|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838430|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
43838431|NCT04841343|Hormones|hormones|mesh-ancestor
43838432|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838433|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838434|NCT04841265|Vitamin D|vitamin d|mesh-list
43838435|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
43838436|NCT04841265|Vitamins|vitamins|mesh-ancestor
43838437|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
43838438|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771113|NCT02374567|Topiramate|topiramate|mesh-list
43771114|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
43771115|NCT02374567|Promethazine|promethazine|mesh-list
43771116|NCT02374567|Pregabalin|pregabalin|mesh-list
43771117|NCT02374567|Lamotrigine|lamotrigine|mesh-list
43771128|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43771129|NCT02374567|Amitriptyline|amitriptyline|mesh-list
43771130|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
43771131|NCT02374567|Levetiracetam|levetiracetam|mesh-list
43771132|NCT02374567|Valproic Acid|valproic acid|mesh-list
43771133|NCT02374567|Lorazepam|lorazepam|mesh-list
43771134|NCT02374567|Clonazepam|clonazepam|mesh-list
43771135|NCT02374567|Phenobarbital|phenobarbital|mesh-list
43771136|NCT02374567|Clobazam|clobazam|mesh-list
43771137|NCT02374567|Zaleplon|zaleplon|mesh-list
43771138|NCT02374567|Nitrazepam|nitrazepam|mesh-list
43771140|NCT02374567|Memantine|memantine|mesh-list
43771141|NCT02374567|Biperiden|biperiden|mesh-list
43771142|NCT02374567|Haloperidol|haloperidol|mesh-list
43771143|NCT02374567|Pimozide|pimozide|mesh-list
43771144|NCT02374567|Olanzapine|olanzapine|mesh-list
43771145|NCT02374567|Zolpidem|zolpidem|mesh-list
43771146|NCT02374567|Alprazolam|alprazolam|mesh-list
43771147|NCT02374567|Zopiclone|zopiclone|mesh-list
43771148|NCT02374567|S 20098|s 20098|mesh-list
43771149|NCT02374567|Doxepin|doxepin|mesh-list
43771150|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
43771151|NCT02374567|Oxazepam|oxazepam|mesh-list
43771152|NCT02374567|Temazepam|temazepam|mesh-list
43771153|NCT02374567|Brotizolam|brotizolam|mesh-list
43771154|NCT02374567|Lormetazepam|lormetazepam|mesh-list
43771155|NCT02374567|Flurazepam|flurazepam|mesh-list
43771156|NCT02374567|Mirtazapine|mirtazapine|mesh-list
43771157|NCT02374567|Buspirone|buspirone|mesh-list
43771158|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
43771159|NCT02374567|Trazodone|trazodone|mesh-list
43771160|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
43771161|NCT02374567|Bromazepam|bromazepam|mesh-list
43771162|NCT02374567|Risperidone|risperidone|mesh-list
43771163|NCT02374567|Melatonin|melatonin|mesh-list
43771164|NCT02374567|Aripiprazole|aripiprazole|mesh-list
43771165|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43771166|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43771167|NCT02374567|Ziprasidone|ziprasidone|mesh-list
43771208|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43771209|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848037|NCT04060342|Antiviral Agents|antiviral agents|mesh-ancestor
43771210|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771227|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43771228|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43771229|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43771230|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
43771231|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43771232|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
43771233|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43771234|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43771235|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
43771237|NCT02374567|Protective Agents|protective agents|mesh-ancestor
43771251|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43771252|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43771253|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43771254|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771255|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
43771256|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43771257|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43771258|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43771259|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43771260|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43771261|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43771262|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
43771263|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771264|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43771265|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43771266|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771267|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43771268|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
43771269|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
43771270|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43771271|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
43771272|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
43771273|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43771274|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
43771298|NCT02374047|Atorvastatin|atorvastatin|mesh-list
43771299|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43771300|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43771301|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
43771319|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771320|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
43771321|NCT02374008|Hormones|hormones|mesh-ancestor
43771322|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771323|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43771324|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771325|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771326|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771327|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771328|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
43771329|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771330|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
43771331|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43771332|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771333|NCT02374008|Analgesics|analgesics|mesh-ancestor
43771334|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771335|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43771336|NCT02373735|Mannitol|mannitol|mesh-list
43771337|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43771338|NCT02373735|Diuretics|diuretics|mesh-ancestor
43771339|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
43771340|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771341|NCT02373449|Ketamine|ketamine|mesh-list
43771342|NCT02373449|Analgesics|analgesics|mesh-ancestor
43771343|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
43771344|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771345|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771346|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43771347|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43771348|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
43771349|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
43771350|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771351|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43771352|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43771353|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771354|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771355|NCT02373722|Petrolatum|petrolatum|mesh-list
43771356|NCT02373722|Mineral Oil|mineral oil|mesh-list
43771357|NCT02373722|Emollients|emollients|mesh-ancestor
43771358|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
43771359|NCT02373514|Acetaminophen|acetaminophen|mesh-list
43771360|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43771361|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771366|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
43771367|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43771368|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771369|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771370|NCT02373384|Allopurinol|allopurinol|mesh-list
43771371|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
43771372|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771373|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
43771374|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771375|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
43771376|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771377|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43771378|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
43771379|NCT02373384|Protective Agents|protective agents|mesh-ancestor
43771380|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771381|NCT02373384|Diuretics|diuretics|mesh-ancestor
43771382|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
43771383|NCT02373384|Expectorants|expectorants|mesh-ancestor
43771384|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
43771385|NCT02373579|Methotrexate|methotrexate|mesh-list
43771386|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43771387|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
43771388|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43771389|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771390|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43771391|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
43771392|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771393|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771394|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
43771395|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771396|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43771397|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43771398|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
43771401|NCT02373410|Bupivacaine|bupivacaine|mesh-list
43771403|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
43771404|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771405|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771406|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
43771407|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771409|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
43771410|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43771411|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43771412|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771413|NCT02373215|Nalbuphine|nalbuphine|mesh-list
43771414|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43771415|NCT02373215|Narcotics|narcotics|mesh-ancestor
43771416|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771417|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771418|NCT02373215|Analgesics|analgesics|mesh-ancestor
43771419|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
43771420|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771421|NCT02373254|Acetaminophen|acetaminophen|mesh-list
43771422|NCT02373254|Ibuprofen|ibuprofen|mesh-list
43771423|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43771425|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771426|NCT02373254|Analgesics|analgesics|mesh-ancestor
43771427|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
43771428|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771429|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771430|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
43771440|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
43771441|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
43771442|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43771443|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43771444|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771465|NCT02373280|Esomeprazole|esomeprazole|mesh-list
43771466|NCT02373280|Bismuth|bismuth|mesh-list
43771467|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43771468|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43771469|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771470|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43771471|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43771472|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771473|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771474|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771475|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43771476|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
43771477|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43771478|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771479|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43771480|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43771481|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43771482|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43771484|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43771485|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771486|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43771487|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43771488|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43771489|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43771490|NCT02373280|Antacids|antacids|mesh-ancestor
43771491|NCT02372942|Progesterone|progesterone|mesh-list
43771492|NCT02372942|Progestins|progestins|mesh-ancestor
43771493|NCT02372942|Hormones|hormones|mesh-ancestor
43771496|NCT02373163|Amlodipine|amlodipine|mesh-list
43771508|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43771509|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43771510|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43771511|NCT02372903|Palmidrol|palmidrol|mesh-list
43771512|NCT02372903|Analgesics|analgesics|mesh-ancestor
43771513|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
43771514|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771515|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771516|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43771517|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771518|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838440|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43838441|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
43838442|NCT04841148|Palbociclib|palbociclib|mesh-list
43838443|NCT04841148|Avelumab|avelumab|mesh-list
43838444|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
43838445|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43838446|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43838447|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838449|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838451|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838452|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43838453|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43771550|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43771551|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
43771552|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771553|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43771554|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43771555|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771556|NCT02372591|Buprenorphine|buprenorphine|mesh-list
43771557|NCT02372591|Hydromorphone|hydromorphone|mesh-list
43771558|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43771559|NCT02372591|Narcotics|narcotics|mesh-ancestor
43771560|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771561|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771562|NCT02372591|Analgesics|analgesics|mesh-ancestor
43771563|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
43771564|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771565|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43771566|NCT02372786|Lidocaine|lidocaine|mesh-list
43771567|NCT02372786|Tetracaine|tetracaine|mesh-list
43771568|NCT02372786|Prilocaine|prilocaine|mesh-list
43771569|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771570|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
43771571|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771572|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771573|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
43771574|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771575|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43771576|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43771577|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43771578|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43771579|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771580|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
43771587|NCT02372669|Chitosan|chitosan|mesh-list
43771592|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43771593|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
43771594|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
43771595|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
43771596|NCT02372669|Coagulants|coagulants|mesh-ancestor
43771597|NCT02372760|Lidocaine|lidocaine|mesh-list
43771598|NCT02372760|Anesthetics|anesthetics|mesh-list
43771599|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771600|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771601|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771602|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
43771603|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771604|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43771605|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43771606|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43771607|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43771608|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771609|NCT02372461|Amoxicillin|amoxicillin|mesh-list
43771610|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43771611|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771629|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
43771630|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771631|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771632|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771633|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43771635|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43771636|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771637|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43771638|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771639|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771640|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43771641|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43771642|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
43771643|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771644|NCT02372240|Dexamethasone|dexamethasone|mesh-list
43771645|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771650|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771651|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
43771652|NCT02372240|Hormones|hormones|mesh-ancestor
43771653|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771654|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43771655|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771656|NCT02372188|Caffeine|caffeine|mesh-list
43771657|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43771658|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771659|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43771660|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771661|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771662|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43771663|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43771664|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
43771665|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771666|NCT02372292|Furosemide|furosemide|mesh-list
43771667|NCT02372292|Diuretics|diuretics|mesh-ancestor
43771668|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
43771669|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771670|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43771671|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43771672|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771673|NCT02372318|Nalmefene|nalmefene|mesh-list
43771674|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43771685|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43771686|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771687|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771688|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43771689|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
43771690|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771691|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771692|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
43771693|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43771694|NCT02372149|Antibodies|antibodies|mesh-list
43771695|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
43771696|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43771697|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
43771698|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771699|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
43771700|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43771701|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
43771702|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771703|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771718|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43771719|NCT02371577|Growth Substances|growth substances|mesh-ancestor
43771720|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
43771721|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771722|NCT02371603|Pioglitazone|pioglitazone|mesh-list
43771723|NCT02371603|Trimethoprim|trimethoprim|mesh-list
43771724|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43771725|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43771726|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43771727|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
43771728|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771729|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43771730|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43771731|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771732|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771733|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771734|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43771735|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771736|NCT02371603|Renal Agents|renal agents|mesh-ancestor
43771737|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
43771738|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43771739|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43771740|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43771741|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43771819|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771751|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
43771752|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771753|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43771754|NCT02371473|Acetazolamide|acetazolamide|mesh-list
43771755|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
43771756|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43771757|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771758|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771759|NCT02371473|Diuretics|diuretics|mesh-ancestor
43771760|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
43771761|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771762|NCT02371421|Allopurinol|allopurinol|mesh-list
43771763|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
43771764|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771765|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771769|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
43771770|NCT02371421|Protective Agents|protective agents|mesh-ancestor
43771771|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771773|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
43771774|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
43771775|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771776|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
43771777|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771778|NCT02371226|Insulin|insulin|mesh-list
43771779|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43771780|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771781|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771782|NCT02371304|Capecitabine|capecitabine|mesh-list
43771783|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43771784|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
43771785|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771786|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771787|NCT02371096|Rituximab|rituximab|mesh-list
43771788|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43771789|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771790|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
43771791|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771792|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771793|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
43771794|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
43771795|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771796|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771797|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771798|NCT02371148|Rituximab|rituximab|mesh-list
43771799|NCT02371148|Bortezomib|bortezomib|mesh-list
43838493|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43838494|NCT04837924|Narcotics|narcotics|mesh-ancestor
43838495|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838496|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
43838497|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
43838498|NCT04837014|Acetaminophen|acetaminophen|mesh-list
43838499|NCT04837014|Naproxen|naproxen|mesh-list
43838500|NCT04837014|Hydromorphone|hydromorphone|mesh-list
43838501|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43838502|NCT04837014|Analgesics|analgesics|mesh-ancestor
43838503|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
43838504|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838505|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577409|NCT03490279|Lactoferrin|lactoferrin|mesh-list
43771809|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
43771810|NCT02370862|Neostigmine|neostigmine|mesh-list
43771811|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43771812|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771813|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771814|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
43771815|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771816|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771817|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43771818|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
43771836|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43771837|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771839|NCT02370745|Insulin|insulin|mesh-list
43771840|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43771841|NCT02370745|Incretins|incretins|mesh-list
43771842|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771843|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771844|NCT02370745|Hormones|hormones|mesh-ancestor
43771845|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771846|NCT02370758|Valganciclovir|valganciclovir|mesh-list
43771847|NCT02370758|Ganciclovir|ganciclovir|mesh-list
43771848|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43771849|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
43771850|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771851|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43771852|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771853|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771854|NCT02370849|Cisplatin|cisplatin|mesh-list
43771855|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
43771856|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771857|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43771858|NCT02370550|Cyclosporine|cyclosporine|mesh-list
43771859|NCT02370550|Prednisone|prednisone|mesh-list
43771860|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
43771861|NCT02370550|Calcium|calcium|mesh-list
43771862|NCT02370550|Cyclosporins|cyclosporins|mesh-list
43771863|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43771864|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771865|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771866|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
43771867|NCT02370550|Hormones|hormones|mesh-ancestor
43771868|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771869|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43771870|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771871|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771872|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771873|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43771874|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
43771875|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
43771876|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771877|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
43771878|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771879|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43771880|NCT02370550|Antacids|antacids|mesh-ancestor
43771881|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771882|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
43771883|NCT02370433|Neostigmine|neostigmine|mesh-list
43771884|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43771885|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771886|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771887|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
43771888|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771889|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771890|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43771891|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
43771893|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43771932|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771933|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43771934|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771935|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43771936|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
43771937|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771938|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43771939|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
43771940|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43771941|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771942|NCT02369822|Ascorbic Acid|ascorbic acid|mesh-list
43771943|NCT02369822|Vitamins|vitamins|mesh-ancestor
43771944|NCT02369822|Micronutrients|micronutrients|mesh-ancestor
43771945|NCT02369822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771947|NCT02369822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771948|NCT02369822|Protective Agents|protective agents|mesh-ancestor
43771949|NCT02369549|Curcumin|curcumin|mesh-list
43771950|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43771951|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771952|NCT02369549|Analgesics|analgesics|mesh-ancestor
43771953|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
43771954|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771955|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771956|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771957|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771958|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771959|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771961|NCT02369523|Bupivacaine|bupivacaine|mesh-list
43771962|NCT02369523|Ropivacaine|ropivacaine|mesh-list
43771963|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771964|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
43771965|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771966|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771967|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
43771968|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771969|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
43771970|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43771971|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
43771972|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771973|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
43771974|NCT02369380|Protective Agents|protective agents|mesh-ancestor
43771975|NCT02369133|Acetaminophen|acetaminophen|mesh-list
43771976|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771978|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
43771979|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771980|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771981|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
43771982|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43772015|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43838506|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
43838507|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43838508|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838509|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838510|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
43838511|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43838512|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838513|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838514|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43838515|NCT04837014|Narcotics|narcotics|mesh-ancestor
43838516|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838517|NCT04836962|Dexamethasone|dexamethasone|mesh-list
43838518|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838519|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
43838520|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
43838521|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838522|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838523|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43838524|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
43838525|NCT04836962|Hormones|hormones|mesh-ancestor
43838526|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838527|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43838528|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838529|NCT04836780|Dexamethasone|dexamethasone|mesh-list
43838530|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838531|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
43838532|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
43838533|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838534|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838535|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772024|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43772025|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772026|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43772027|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
43772028|NCT02368730|Coagulants|coagulants|mesh-ancestor
43772029|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43772030|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
43772031|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772032|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43772033|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43772034|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
43772043|NCT02368795|Isosorbide|isosorbide|mesh-list
43772044|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43772045|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43772046|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43772047|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772048|NCT02368795|Analgesics|analgesics|mesh-ancestor
43772049|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
43772050|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772051|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772052|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772053|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772054|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
43772055|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
43772056|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43772061|NCT02368795|Diuretics|diuretics|mesh-ancestor
43772066|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43772067|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772068|NCT02368717|Analgesics|analgesics|mesh-ancestor
43772069|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
43772070|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772071|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772072|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772073|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772074|NCT02368743|Mesalamine|mesalamine|mesh-list
43772075|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43772076|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772077|NCT02368743|Analgesics|analgesics|mesh-ancestor
43772078|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
43772079|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772080|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772081|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772118|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
43772119|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772120|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
43772121|NCT02368561|Protective Agents|protective agents|mesh-ancestor
43772122|NCT02368288|Entecavir|entecavir|mesh-list
43772123|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
43772124|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772125|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
43772126|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
43772127|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43772128|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
43772129|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772130|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772132|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
43772133|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43772134|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
43772135|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772136|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772137|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43772138|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
43772139|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
43772140|NCT02368171|Protective Agents|protective agents|mesh-ancestor
43772141|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
43772142|NCT02368054|Epinephrine|epinephrine|mesh-list
43772167|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772169|NCT02368015|Cefazolin|cefazolin|mesh-list
43772170|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43772171|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772172|NCT02368197|Paclitaxel|paclitaxel|mesh-list
43772173|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43772174|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772175|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
43772176|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
43772177|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
43772178|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772179|NCT02368249|Terlipressin|terlipressin|mesh-list
43772180|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43772181|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43772182|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
43772183|NCT02367937|Midazolam|midazolam|mesh-list
43772184|NCT02367937|Omeprazole|omeprazole|mesh-list
43772185|NCT02367937|Simvastatin|simvastatin|mesh-list
43772186|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43772187|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43772188|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772189|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772190|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43772191|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43772192|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43772193|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43772194|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
43772195|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
43772196|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
43772213|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772214|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772215|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772216|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43772217|NCT02367924|Trabectedin|trabectedin|mesh-list
43772218|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43772219|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
43772220|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772221|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772222|NCT02367807|Tenofovir|tenofovir|mesh-list
43772223|NCT02367807|Emtricitabine|emtricitabine|mesh-list
43772224|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
43772225|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772226|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43772227|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43772228|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772229|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772230|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43772231|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43772233|NCT02367755|Propofol|propofol|mesh-list
43772234|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43772235|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772236|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772237|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43772238|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
43772239|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
43772240|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
43772241|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
43772242|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
43772243|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772244|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772245|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43772246|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43772247|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43772248|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
43772261|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
43772262|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772263|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
43772264|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
43772265|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772266|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772267|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772268|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
43772269|NCT02367560|Hormones|hormones|mesh-ancestor
43772270|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772271|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43772272|NCT02367560|Protective Agents|protective agents|mesh-ancestor
43772273|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43772274|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772275|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43772276|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43772277|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43772279|NCT02367196|Rituximab|rituximab|mesh-list
43772285|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43772286|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43772287|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43772288|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43772289|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772290|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772291|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772292|NCT02367404|Analgesics|analgesics|mesh-ancestor
43772293|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
43772294|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772295|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
43838540|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838541|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
43838542|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
43838543|NCT04836637|Calcium|calcium|mesh-list
43838544|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43838545|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838546|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43838547|NCT04836637|Antacids|antacids|mesh-ancestor
43838548|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838549|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43838550|NCT04835870|Prednisone|prednisone|mesh-list
43838551|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
43838552|NCT04835870|Rituximab|rituximab|mesh-list
43838553|NCT04835870|Doxorubicin|doxorubicin|mesh-list
43838554|NCT04835870|Vincristine|vincristine|mesh-list
43838555|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
43838556|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838557|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
43838558|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838565|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838566|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43838567|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43838568|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43838570|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838571|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
43838572|NCT04835870|Hormones|hormones|mesh-ancestor
43838573|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772298|NCT02367248|Deferoxamine|deferoxamine|mesh-list
43772299|NCT02367248|Siderophores|siderophores|mesh-ancestor
43772300|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43772301|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
43772303|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772304|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
43772305|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43772306|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
43772307|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43772308|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
43772309|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772310|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772311|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
43772312|NCT02367053|Glucagon|glucagon|mesh-list
43772313|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772314|NCT02367053|Hormones|hormones|mesh-ancestor
43772315|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772318|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
43772320|NCT02366884|Miconazole|miconazole|mesh-list
43772321|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
43772322|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772323|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43772324|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43772325|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43772326|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772327|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772328|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43772329|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
43772330|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772331|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772332|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43772333|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43772334|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43772335|NCT02366975|Testosterone|testosterone|mesh-list
43772336|NCT02366975|Androgens|androgens|mesh-ancestor
43772337|NCT02366975|Hormones|hormones|mesh-ancestor
43772338|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772339|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772340|NCT02367118|Prednisone|prednisone|mesh-list
43772341|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772342|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
43772365|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43772366|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
43772367|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43772368|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
43772369|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772370|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
43772371|NCT02366676|Protective Agents|protective agents|mesh-ancestor
43772373|NCT02366585|Cyclosporins|cyclosporins|mesh-list
43772374|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772375|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772376|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43772377|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
43772378|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772379|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
43772380|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772381|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
43772382|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772383|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43772384|NCT02366481|Vitamins|vitamins|mesh-list
43772385|NCT02366481|Vitamin K|vitamin k|mesh-list
43772386|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
43772387|NCT02366481|Vitamin MK 7|vitamin mk 7|mesh-list
43772388|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
43772389|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772390|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43772391|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43772392|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772393|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
43772394|NCT02366481|Coagulants|coagulants|mesh-ancestor
43772395|NCT02366247|Adefovir|adefovir|mesh-list
43772396|NCT02366247|Thymalfasin|thymalfasin|mesh-list
43772397|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
43772406|NCT02366377|Metformin|metformin|mesh-list
43772413|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772415|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
43772416|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
43772417|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772418|NCT02366299|Analgesics|analgesics|mesh-ancestor
43772419|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
43772588|NCT02365493|Floxacillin|floxacillin|mesh-list
43772427|NCT02366065|Acetaminophen|acetaminophen|mesh-list
43772428|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772429|NCT02366065|Analgesics|analgesics|mesh-ancestor
43772430|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
43772431|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772432|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772433|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
43772434|NCT02366208|Adefovir|adefovir|mesh-list
43772435|NCT02366208|Thymalfasin|thymalfasin|mesh-list
43772436|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
43772437|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772438|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43772439|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43772440|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772441|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772442|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43772443|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
43772444|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772445|NCT02365909|Bupivacaine|bupivacaine|mesh-list
43772446|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
43772447|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
43772448|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772449|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772450|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
43772451|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772452|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
43772453|NCT02365857|Bupivacaine|bupivacaine|mesh-list
43772454|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
43772455|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
43772456|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772457|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772458|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
43772459|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772460|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43772468|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772470|NCT02365935|Cisplatin|cisplatin|mesh-list
43772471|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43772472|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772473|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
43772474|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
43772475|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
43772476|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772477|NCT02365675|Petrolatum|petrolatum|mesh-list
43772478|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43772479|NCT02365675|Laxatives|laxatives|mesh-ancestor
43772480|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772481|NCT02365675|Emollients|emollients|mesh-ancestor
43772482|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
43772483|NCT02365571|Itraconazole|itraconazole|mesh-list
43772484|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
43772485|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772486|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43772487|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43772488|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772489|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772490|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43772491|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
43772492|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772493|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772494|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43772495|NCT02365740|Insulin|insulin|mesh-list
43772496|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43772497|NCT02365740|Hormones|hormones|mesh-list
43772498|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43772499|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772500|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772501|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
43772502|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43772503|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
43772504|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772505|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772506|NCT02365727|Clonidine|clonidine|mesh-list
43772507|NCT02365727|Epinephrine|epinephrine|mesh-list
43772508|NCT02365727|Bupivacaine|bupivacaine|mesh-list
43772509|NCT02365727|Ropivacaine|ropivacaine|mesh-list
43772510|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
43772511|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
43772512|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772513|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772514|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
43772515|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772516|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43772517|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43772518|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
43772519|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772520|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772521|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43772522|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43772523|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
43772524|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43772525|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
43772526|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
43772527|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
43772528|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43772539|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43772540|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772541|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
43772542|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
43772543|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
43772544|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772545|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
43772546|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43772547|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43772548|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
43772549|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772550|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43772551|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43772552|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43772553|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772554|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772555|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43772556|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
43772557|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43772559|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
43772560|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
43772561|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43772562|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772564|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43772565|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43772566|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43772567|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772568|NCT02365155|Vitamin D|vitamin d|mesh-list
43772569|NCT02365155|Vitamins|vitamins|mesh-list
43772570|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
43772571|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772572|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43772579|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43772580|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772581|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
43772582|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43772583|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
43772584|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772585|NCT02365493|Cefazolin|cefazolin|mesh-list
43772586|NCT02365493|Lactams|lactams|mesh-list
43772587|NCT02365493|beta-Lactams|beta-lactams|mesh-list
43838576|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
43838577|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
43838578|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
43838581|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838583|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
43838584|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
43838586|NCT04834310|Cephalexin|cephalexin|mesh-list
43838587|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838588|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838589|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43838590|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838591|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838592|NCT04833582|Gemcitabine|gemcitabine|mesh-list
43838593|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43838594|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
43772600|NCT02365181|Ropivacaine|ropivacaine|mesh-list
43772601|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
43772602|NCT02365181|Anesthetics|anesthetics|mesh-list
43772603|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772604|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772605|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
43772606|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772607|NCT02364986|Interferons|interferons|mesh-list
43772608|NCT02364986|Interferon-beta|interferon-beta|mesh-list
43772609|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
43772610|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772611|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
43772612|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772613|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
43772614|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772615|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43772616|NCT02364934|Propofol|propofol|mesh-list
43772617|NCT02364934|Sevoflurane|sevoflurane|mesh-list
43772618|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43772619|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772620|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772621|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43772622|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
43772623|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
43772624|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43772625|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43772626|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
43772627|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
43772628|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43772629|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43772630|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772631|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772632|NCT02364882|Urological Agents|urological agents|mesh-ancestor
43772633|NCT02364804|Aprepitant|aprepitant|mesh-list
43772634|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
43772635|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
43772636|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772637|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772638|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772639|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43772640|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772641|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772642|NCT02365012|Midodrine|midodrine|mesh-list
43772651|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
43772652|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772653|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772654|NCT02364765|Remifentanil|remifentanil|mesh-list
43772655|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43772657|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772658|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772659|NCT02364765|Analgesics|analgesics|mesh-ancestor
43772660|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
43772661|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772662|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
43772663|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772664|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43772665|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772666|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772667|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
43772668|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772669|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772670|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43772672|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43772673|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772675|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
43772676|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772677|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772678|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772679|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772680|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772681|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43772682|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
43772683|NCT02364752|Diuretics|diuretics|mesh-list
43772684|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43772685|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
43772687|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43772688|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772689|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
43772690|NCT02364609|Afatinib|afatinib|mesh-list
43772691|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43772692|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772693|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43772694|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772695|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772696|NCT02364583|Primaquine|primaquine|mesh-list
43772697|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
43772698|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43772699|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43772747|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
43772748|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772750|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
43772751|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
43772752|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772753|NCT02363829|Nelfinavir|nelfinavir|mesh-list
43772754|NCT02363829|Cisplatin|cisplatin|mesh-list
43772755|NCT02363829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772756|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43772757|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43838602|NCT04833582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838603|NCT04833114|Carboplatin|carboplatin|mesh-list
43838604|NCT04833114|Etoposide|etoposide|mesh-list
43838605|NCT04833114|Rituximab|rituximab|mesh-list
43838606|NCT04833114|Ifosfamide|ifosfamide|mesh-list
43838607|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838608|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43838609|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43838610|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43838611|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838612|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772806|NCT02363400|Epirubicin|epirubicin|mesh-list
43772807|NCT02363400|Mitomycins|mitomycins|mesh-list
43772808|NCT02363400|Mitomycin|mitomycin|mesh-list
43772809|NCT02363400|Tegafur|tegafur|mesh-list
43772810|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772811|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43772812|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43772854|NCT02362958|Lapatinib|lapatinib|mesh-list
43772855|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43772856|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
43772857|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772858|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772859|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43772860|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
43772861|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
43772909|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43772910|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43772911|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772912|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772913|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43772914|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772915|NCT02362581|Factor VIII|factor viii|mesh-list
43772916|NCT02362581|Coagulants|coagulants|mesh-ancestor
43772917|NCT02362308|Eplerenone|eplerenone|mesh-list
43772918|NCT02362308|Spironolactone|spironolactone|mesh-list
43772919|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43772975|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772976|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43772977|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
43772978|NCT02362165|Dexamethasone|dexamethasone|mesh-list
43772979|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
43772980|NCT02362165|Doxorubicin|doxorubicin|mesh-list
43772981|NCT02362165|Bortezomib|bortezomib|mesh-list
43772982|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43772983|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
43772984|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772985|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772986|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43772987|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
43772988|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772989|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772990|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43772991|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772992|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
43772993|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
43773042|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43773043|NCT02361645|Ketorolac|ketorolac|mesh-list
43773044|NCT02361645|Indomethacin|indomethacin|mesh-list
43773045|NCT02361645|Nepafenac|nepafenac|mesh-list
43773046|NCT02361645|Bromfenac|bromfenac|mesh-list
43773047|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43773048|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43773049|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43773050|NCT02361645|Analgesics|analgesics|mesh-ancestor
43773051|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
43773052|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773053|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773054|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773055|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773056|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43773057|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773058|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773059|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
43773060|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
43773061|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773062|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43838618|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
43773100|NCT02361619|Midazolam|midazolam|mesh-list
43773101|NCT02361619|Caffeine|caffeine|mesh-list
43773102|NCT02361619|Esomeprazole|esomeprazole|mesh-list
43773103|NCT02361619|Dabigatran|dabigatran|mesh-list
43773104|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43773105|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43773106|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773107|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773108|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43773109|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43773110|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43773111|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43773112|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
43773113|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
43773114|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
43773115|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
43773162|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773163|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773164|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43773165|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773166|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
43773167|NCT02361112|Capecitabine|capecitabine|mesh-list
43773168|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43773169|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
43773170|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773171|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773228|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773230|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
43773231|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43773232|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43773233|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43773234|NCT02360709|Sirolimus|sirolimus|mesh-list
43773235|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43773236|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773237|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43773238|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773239|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
43773240|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773241|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
43838630|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838631|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43838632|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
43838633|NCT04832269|Hormones|hormones|mesh-ancestor
43838634|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838635|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43838636|NCT04832269|Protective Agents|protective agents|mesh-ancestor
43838637|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43838638|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838639|NCT04832100|Pregabalin|pregabalin|mesh-list
43838640|NCT04832100|Imipramine|imipramine|mesh-list
43838641|NCT04832100|Analgesics|analgesics|mesh-ancestor
43838642|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
43838643|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838644|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838645|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
43838646|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43838647|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43773353|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773354|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43773355|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773356|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773357|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43773358|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43773359|NCT02359617|Insulin|insulin|mesh-list
43773360|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43773361|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773362|NCT02359292|Charcoal|charcoal|mesh-list
43773363|NCT02359292|Antidotes|antidotes|mesh-ancestor
43773364|NCT02359292|Protective Agents|protective agents|mesh-ancestor
43773365|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773366|NCT02359214|Vitamin D|vitamin d|mesh-list
43773367|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
43773368|NCT02359214|Vitamins|vitamins|mesh-ancestor
43773369|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
43773370|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773371|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43773373|NCT02359370|Lidocaine|lidocaine|mesh-list
43773407|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43773408|NCT02359331|Tetracycline|tetracycline|mesh-list
43773409|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
43773410|NCT02359331|Bismuth|bismuth|mesh-list
43773411|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43773412|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43773413|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43773414|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773415|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773416|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773417|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43773474|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43773476|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
43773477|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773478|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773479|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
43773480|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43773481|NCT02358850|Narcotics|narcotics|mesh-ancestor
43773524|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43773525|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
43773526|NCT02359162|Antiviral Agents|antiviral agents|mesh-ancestor
43773527|NCT02359162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773528|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773529|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43773530|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43773531|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43773532|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773533|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
43773534|NCT02359162|Hormones|hormones|mesh-ancestor
43773535|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773536|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43773537|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43773583|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43773585|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43773586|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773587|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43773588|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
43773589|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
43773590|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
43773591|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
43773592|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773593|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43773594|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
43773595|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
43773649|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43773650|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838651|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43838652|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848066|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43848067|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43848068|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848070|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848071|NCT04053712|Hormones|hormones|mesh-ancestor
43848072|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848073|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848074|NCT04051957|Isosorbide|isosorbide|mesh-list
43848075|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43848076|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43848077|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43848078|NCT04051957|Diuretics|diuretics|mesh-ancestor
43848079|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
43773674|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43773675|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43773676|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43773677|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773678|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773679|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
43773680|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
43773681|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773682|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773683|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43773684|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43773685|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
43773686|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43773687|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43773688|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43773689|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43773690|NCT02357849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43773691|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43773692|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43773693|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43773694|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43773695|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43773696|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773697|NCT02357693|Aprepitant|aprepitant|mesh-list
43773715|NCT02357524|Oritavancin|oritavancin|mesh-list
43773716|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43773717|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773718|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43773720|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
43773721|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43773722|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
43773723|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773724|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773725|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43773726|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773727|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43773728|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
43773729|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43773730|NCT02357615|Nifedipine|nifedipine|mesh-list
43773731|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43773732|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43773733|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773734|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43773735|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773736|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
43773737|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
43773738|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773739|NCT02357602|Tenofovir|tenofovir|mesh-list
43773758|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
43773760|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
43773761|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773762|NCT02357303|Protective Agents|protective agents|mesh-ancestor
43773763|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773764|NCT02357303|Antidotes|antidotes|mesh-ancestor
43773765|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
43773766|NCT02357303|Emollients|emollients|mesh-ancestor
43773767|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
43773768|NCT02357277|Budesonide|budesonide|mesh-list
43773769|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773770|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43773771|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
43773772|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773773|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773774|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43773775|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
43773776|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
43773777|NCT02357277|Hormones|hormones|mesh-ancestor
43773778|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773779|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
43773780|NCT02357407|Ofloxacin|ofloxacin|mesh-list
43773781|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43773782|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773783|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43773784|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43773785|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773786|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773787|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773788|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43773819|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773820|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773821|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43773823|NCT02357004|Protective Agents|protective agents|mesh-ancestor
43773824|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43773825|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43773826|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43773827|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
43773828|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43773829|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43773830|NCT02357004|Diuretics|diuretics|mesh-ancestor
43773831|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
43773832|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43773833|NCT02357069|Etanercept|etanercept|mesh-list
43773865|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43773866|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43773867|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773868|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773869|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
43773870|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43773871|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
43773872|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773873|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773874|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43773875|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
43773876|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43773878|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773879|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773880|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43773881|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
43773882|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
43773883|NCT02356835|Protective Agents|protective agents|mesh-ancestor
43773884|NCT02356445|Methotrexate|methotrexate|mesh-list
43773885|NCT02356445|Azathioprine|azathioprine|mesh-list
43773886|NCT02356445|Infliximab|infliximab|mesh-list
43773887|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43773888|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
43773889|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773890|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773891|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43773892|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
43773893|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773909|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773910|NCT02356679|Ethanol|ethanol|mesh-list
43773911|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43773912|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773913|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773914|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773915|NCT02356146|Tacrolimus|tacrolimus|mesh-list
43773916|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773917|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
43773918|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773919|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43773920|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773921|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773922|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43773923|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43773924|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
43773925|NCT02356419|Hematinics|hematinics|mesh-ancestor
43773926|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43773927|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43838660|NCT04831736|Ketamine|ketamine|mesh-list
43838661|NCT04831736|Analgesics|analgesics|mesh-ancestor
43838662|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
43838663|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838664|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838665|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43838666|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43838667|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
43838668|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
43838669|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838670|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43838671|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43838672|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773932|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43773933|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773934|NCT02355704|Atorvastatin|atorvastatin|mesh-list
43773935|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43773936|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43773937|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
43773938|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773939|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43773940|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43773941|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773942|NCT02355678|Acetaminophen|acetaminophen|mesh-list
43773943|NCT02355678|Dexamethasone|dexamethasone|mesh-list
43773944|NCT02355678|Propacetamol|propacetamol|mesh-list
43773945|NCT02355678|Tramadol|tramadol|mesh-list
43773946|NCT02355678|Anesthetics|anesthetics|mesh-list
43773947|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
43773948|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773949|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
43773950|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
43773951|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773952|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773953|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773954|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
43773982|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43773983|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43773984|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773986|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
43773987|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43773988|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
43773989|NCT02355639|Clobetasol|clobetasol|mesh-list
43773990|NCT02355639|Petrolatum|petrolatum|mesh-list
43773991|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43773992|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773993|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
43773994|NCT02355639|Hormones|hormones|mesh-ancestor
43773995|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773996|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773997|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43773998|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
43773999|NCT02355639|Emollients|emollients|mesh-ancestor
43774000|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
43774001|NCT02355509|Acarbose|acarbose|mesh-list
43774002|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43774003|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774021|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774022|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774023|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774024|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43774025|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43774026|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43774027|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774028|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774029|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
43774030|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
43774031|NCT02355197|Vitamins|vitamins|mesh-ancestor
43774032|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
43774033|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774035|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774036|NCT02355197|Protective Agents|protective agents|mesh-ancestor
43774037|NCT02355119|Gemcitabine|gemcitabine|mesh-list
43774038|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43774039|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
43774040|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774041|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774042|NCT02355119|Antiviral Agents|antiviral agents|mesh-ancestor
43774043|NCT02355119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774044|NCT02355119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774072|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774073|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774074|NCT02354807|Mirabegron|mirabegron|mesh-list
43774075|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43774076|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43774077|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43774078|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
43774079|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774080|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774081|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774082|NCT02354807|Urological Agents|urological agents|mesh-ancestor
43774083|NCT02354937|Cabotegravir|cabotegravir|mesh-list
43774084|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43774085|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43774086|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774087|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774088|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43774089|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43774090|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
43774091|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774092|NCT02354950|Cabotegravir|cabotegravir|mesh-list
43774093|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43774094|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43774095|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774096|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774097|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43774098|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43774099|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
43774100|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774101|NCT02354872|Nicotine|nicotine|mesh-list
43774102|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43774103|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
43774104|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774113|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
43774114|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774115|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774116|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43774117|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43774118|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
43774119|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774120|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774121|NCT02354612|Bevacizumab|bevacizumab|mesh-list
43774122|NCT02354612|Capecitabine|capecitabine|mesh-list
43774123|NCT02354612|Axitinib|axitinib|mesh-list
43774124|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43774125|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774126|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43774127|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43774128|NCT02354612|Growth Substances|growth substances|mesh-ancestor
43774129|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774130|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
43774131|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43774132|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
43774133|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774134|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43774135|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774136|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
43774137|NCT02354547|Topotecan|topotecan|mesh-list
43774162|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43774163|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774164|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774165|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43774166|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774167|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774169|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
43774174|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774175|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43774176|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774177|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774178|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774179|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43774180|NCT02354170|Mifepristone|mifepristone|mesh-list
43774181|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43838691|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
43838692|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43838693|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838694|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838695|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43838696|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43838697|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43838698|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43838699|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43838700|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43838701|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43838702|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43838703|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
43838704|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43838705|NCT04829760|Psyllium|psyllium|mesh-list
43838706|NCT04829760|Cathartics|cathartics|mesh-ancestor
43838707|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43838708|NCT04827446|Methamphetamine|methamphetamine|mesh-list
43838709|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43838710|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838711|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
43838712|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
43838713|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838714|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
43838715|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43838716|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838717|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
43838718|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43838719|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43838720|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43838721|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43838722|NCT04825275|Posaconazole|posaconazole|mesh-list
43838728|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43838729|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43838730|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838731|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838732|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43838733|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
43848084|NCT04051320|Leuprolide|leuprolide|mesh-list
43774196|NCT02353949|Flutemetamol|flutemetamol|mesh-list
43774197|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43774198|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774199|NCT02354027|Metformin|metformin|mesh-list
43774200|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43774201|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774202|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43774203|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43774204|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774205|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774206|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774207|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43774208|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43774209|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43774210|NCT02354053|Triumeq|triumeq|mesh-list
43774211|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43774218|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774231|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774232|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774233|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774235|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
43774236|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
43774237|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774238|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774239|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
43774240|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774241|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43774242|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43774243|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774244|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
43774245|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774246|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43774247|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774248|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774249|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774250|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774251|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774252|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43774253|NCT02353676|Bupivacaine|bupivacaine|mesh-list
43774254|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
43774255|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
43774256|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774257|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774260|NCT02353494|Piperaquine|piperaquine|mesh-list
43774274|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774276|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
43774277|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43774278|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43774279|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
43774280|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774281|NCT02353325|Urological Agents|urological agents|mesh-ancestor
43774282|NCT02353260|Cisplatin|cisplatin|mesh-list
43774283|NCT02353260|Docetaxel|docetaxel|mesh-list
43774284|NCT02353260|Fluorouracil|fluorouracil|mesh-list
43774285|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774286|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
43774287|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
43774288|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
43774289|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774290|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
43774291|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43774292|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43774293|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
43774294|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774295|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
43774296|NCT02353182|Remifentanil|remifentanil|mesh-list
43774297|NCT02353182|Bupivacaine|bupivacaine|mesh-list
43774298|NCT02353182|Ropivacaine|ropivacaine|mesh-list
43774299|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
43774300|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
43774301|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774302|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774303|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
43774304|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774305|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43774306|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43774307|NCT02353182|Analgesics|analgesics|mesh-ancestor
43774308|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43774341|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
43774342|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43774343|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43774344|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774345|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774346|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
43774347|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
43774348|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43774349|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
43774350|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
43774351|NCT02352987|Salicylates|salicylates|mesh-list
43774352|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774353|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
43774354|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
43774355|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
43774356|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43774357|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43774358|NCT02352987|Analgesics|analgesics|mesh-ancestor
43774359|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
43774360|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774361|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774362|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774363|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43774364|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43774373|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774374|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43774375|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43774376|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43774377|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774378|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774379|NCT02352545|Montelukast|montelukast|mesh-list
43774380|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43774381|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
43774382|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43774383|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774384|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774385|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774386|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43774387|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43774388|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774389|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43774390|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43774391|NCT02352597|Clomiphene|clomiphene|mesh-list
43774392|NCT02352597|Enclomiphene|enclomiphene|mesh-list
43774393|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
43774394|NCT02352597|Estradiol|estradiol|mesh-list
43774395|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43774396|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
43774420|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43774421|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774422|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43774424|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43774425|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43774426|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774427|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774428|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774429|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43774430|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43774431|NCT02352402|Ticagrelor|ticagrelor|mesh-list
43774432|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43774433|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43774434|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43774435|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43774436|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
43774437|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774438|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774439|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838734|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838735|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838736|NCT04824638|Vaccines|vaccines|mesh-list
43838737|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
43838738|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838739|NCT04824092|Prednisone|prednisone|mesh-list
43774444|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774445|NCT02352168|Budesonide|budesonide|mesh-list
43774446|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774447|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43774448|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
43774449|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774450|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774451|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43774452|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
43774453|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
43774454|NCT02352168|Hormones|hormones|mesh-ancestor
43774455|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774456|NCT02352051|Methylphenidate|methylphenidate|mesh-list
43774457|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43774458|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43774459|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774460|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43774461|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43774462|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774463|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774464|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
43774465|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774466|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43774467|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
43774490|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
43774491|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
43774492|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
43774493|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43774495|NCT02351895|Trace Elements|trace elements|mesh-ancestor
43774496|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
43774497|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774498|NCT02351882|Nabilone|nabilone|mesh-list
43774499|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
43774500|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
43774501|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774502|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774503|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774504|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43774505|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43774506|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774507|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43774508|NCT02352311|Tadalafil|tadalafil|mesh-list
43774509|NCT02352311|Dutasteride|dutasteride|mesh-list
43774510|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
43774511|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43774512|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43774513|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774514|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774515|NCT02352311|Urological Agents|urological agents|mesh-ancestor
43774516|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43774517|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43774518|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774519|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774536|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774537|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43774538|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43774539|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774540|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774541|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43774542|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43774543|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43774544|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43774545|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43774546|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43774547|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43774548|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43774549|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774550|NCT02351869|Midazolam|midazolam|mesh-list
43774551|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
43774552|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43774553|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43774554|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774555|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774556|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43774557|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43774558|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43774559|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43774560|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
43774561|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
43774562|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
43774563|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
43774564|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774565|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774566|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43774567|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43774568|NCT02351869|Analgesics|analgesics|mesh-ancestor
43774569|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
43774570|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774571|NCT02351765|Cisplatin|cisplatin|mesh-list
43774573|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
43774574|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
43774575|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43774576|NCT02351687|Albendazole|albendazole|mesh-list
43774577|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
43774578|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43774579|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43774580|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774581|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43774582|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774583|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774584|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43774585|NCT02351687|Renal Agents|renal agents|mesh-ancestor
43774586|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
43580506|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774587|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
43774588|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43774589|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
43774590|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
43774591|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
43774592|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774593|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
43774594|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
43774595|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43774596|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43774597|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774598|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774599|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774600|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43774601|NCT02351622|Dexamethasone|dexamethasone|mesh-list
43774602|NCT02351622|Caffeic acid|caffeic acid|mesh-list
43774603|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774604|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
43774605|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
43774613|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774614|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
43774615|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774616|NCT02351622|Protective Agents|protective agents|mesh-ancestor
43774617|NCT02351804|Dexamethasone|dexamethasone|mesh-list
43774618|NCT02351804|Ropivacaine|ropivacaine|mesh-list
43774619|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774620|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
43774621|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
43774622|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774623|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774624|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774625|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
43774626|NCT02351804|Hormones|hormones|mesh-ancestor
43774627|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774628|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43774629|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774630|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
43774631|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
43774632|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580584|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
43774633|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
43774635|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
43774636|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
43774637|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774638|NCT02351232|Liraglutide|liraglutide|mesh-list
43774639|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43774640|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774641|NCT02351232|Incretins|incretins|mesh-ancestor
43774642|NCT02351232|Hormones|hormones|mesh-ancestor
43774643|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774644|NCT02351427|Bortezomib|bortezomib|mesh-list
43774645|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774646|NCT02351310|Betamethasone|betamethasone|mesh-list
43774647|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774648|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
43774649|NCT02351310|Hormones|hormones|mesh-ancestor
43774650|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774651|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774652|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43774682|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774683|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43774684|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
43774685|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43774686|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774687|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774689|NCT02350725|Diuretics|diuretics|mesh-ancestor
43774690|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
43774691|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774692|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43774693|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774694|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774695|NCT02350959|Atorvastatin|atorvastatin|mesh-list
43774696|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43774697|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43774698|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
43774699|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774700|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43774701|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43774702|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774703|NCT02350985|Propranolol|propranolol|mesh-list
43774704|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43774705|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43774706|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43774707|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
43774708|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774720|NCT02350946|Oxytocin|oxytocin|mesh-list
43774726|NCT02350712|Cetuximab|cetuximab|mesh-list
43774727|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774728|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43774729|NCT02350439|Adenosine|adenosine|mesh-list
43774730|NCT02350439|Analgesics|analgesics|mesh-ancestor
43774731|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
43774732|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774733|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774734|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43774735|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
43774736|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43774737|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
43774738|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
43774739|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774740|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774741|NCT02350686|Capecitabine|capecitabine|mesh-list
43774742|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
43774743|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43774744|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
43774745|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774746|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774747|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
43774748|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43774749|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43774750|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
43774751|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774752|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774753|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774754|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
43774755|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
43774756|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774757|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
43774758|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43774767|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
43774768|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774769|NCT02350335|Nicotine|nicotine|mesh-list
43774770|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43774771|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
43774772|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774773|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774774|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43774775|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43774776|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
43774777|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774778|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838754|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838755|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43838756|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43774779|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43774780|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43774781|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774782|NCT02350530|Bevacizumab|bevacizumab|mesh-list
43774783|NCT02350530|Fluorouracil|fluorouracil|mesh-list
43774784|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
43774785|NCT02350530|Irinotecan|irinotecan|mesh-list
43774786|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43774787|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774788|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43774789|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43774790|NCT02350530|Growth Substances|growth substances|mesh-ancestor
43774810|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43774811|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43774812|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774813|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43774814|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43774815|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774817|NCT02350517|Paclitaxel|paclitaxel|mesh-list
43774818|NCT02350517|Endostar protein|endostar protein|mesh-list
43774819|NCT02350517|Endostatins|endostatins|mesh-list
43774820|NCT02350517|Nedaplatin|nedaplatin|mesh-list
43774821|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43774822|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774823|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
43774824|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
43774825|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
43774826|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774827|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43774828|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43774829|NCT02350517|Growth Substances|growth substances|mesh-ancestor
43774830|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774831|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
43774832|NCT02350400|Irinotecan|irinotecan|mesh-list
43774833|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43774834|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43774835|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774840|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43774841|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774842|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
43774843|NCT02350179|Coagulants|coagulants|mesh-ancestor
43774844|NCT02350231|Progesterone|progesterone|mesh-list
43774845|NCT02350231|Progestins|progestins|mesh-ancestor
43774846|NCT02350231|Hormones|hormones|mesh-ancestor
43774847|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774848|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774849|NCT02350218|Alprostadil|alprostadil|mesh-list
43774850|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43774851|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
43774852|NCT02350218|Urological Agents|urological agents|mesh-ancestor
43774853|NCT02349919|Procaterol|procaterol|mesh-list
43774854|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43774855|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
43774856|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774857|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774858|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43774859|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
43774860|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
43774861|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43774862|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43774863|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43774864|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
43774865|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774866|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774867|NCT02350023|Betamethasone|betamethasone|mesh-list
43774887|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43774888|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774889|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43774890|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43774891|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774892|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774894|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
43774895|NCT02349763|BB 1101|bb 1101|mesh-list
43774896|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774897|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
43774898|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
43774899|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774900|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774901|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774902|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
43774903|NCT02349763|Hormones|hormones|mesh-ancestor
43774904|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774905|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43774906|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774907|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
43774908|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580856|NCT03466333|Enalapril|enalapril|mesh-list
43774909|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848085|NCT04051320|Estradiol|estradiol|mesh-list
43774910|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43774912|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774913|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774914|NCT02349841|Amoxicillin|amoxicillin|mesh-list
43774915|NCT02349841|Meropenem|meropenem|mesh-list
43774916|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
43774917|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
43774918|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43774936|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774937|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43774938|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43774939|NCT02349516|Growth Substances|growth substances|mesh-ancestor
43774940|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
43774941|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43774942|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43774943|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43774944|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43774945|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
43774947|NCT02349399|Cyproterone|cyproterone|mesh-list
43774948|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
43774949|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43774950|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43774951|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43774952|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
43774972|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43774973|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43774974|NCT02349607|Analgesics|analgesics|mesh-ancestor
43774975|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
43774976|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774977|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774978|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774979|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43774980|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43774981|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774982|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774983|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
43774984|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43774985|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774986|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43774987|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43774988|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43774989|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774990|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43774991|NCT02349282|Vitamin D|vitamin d|mesh-list
43774992|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
43774993|NCT02349282|Calcifediol|calcifediol|mesh-list
43774994|NCT02349282|Vitamins|vitamins|mesh-ancestor
43774995|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
43774996|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774997|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43774998|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43774999|NCT02349243|Entacapone|entacapone|mesh-list
43775000|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43775001|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43775005|NCT02349204|Zaleplon|zaleplon|mesh-list
43775015|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
43775017|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
43775018|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775019|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43775020|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
43775021|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43775022|NCT02348905|Hormones|hormones|mesh-ancestor
43775023|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775024|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775025|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43775026|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43775027|NCT02349113|Estrogens|estrogens|mesh-list
43775028|NCT02349113|Estradiol|estradiol|mesh-list
43838773|NCT04824053|Caseins|caseins|mesh-list
43838774|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
43838775|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838776|NCT04824053|Protective Agents|protective agents|mesh-ancestor
43838777|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838778|NCT04824053|Trace Elements|trace elements|mesh-ancestor
43838779|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
43838780|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
43838781|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
43838782|NCT04821778|Paclitaxel|paclitaxel|mesh-list
43838783|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
43838784|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43838785|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838786|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
43838787|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
43838788|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
43838789|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838790|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838791|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43838792|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43838793|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43838794|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838795|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
43838796|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43838797|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838799|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838800|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581011|NCT03464552|Celecoxib|celecoxib|mesh-list
43775037|NCT02348788|Chloroquine|chloroquine|mesh-list
43775038|NCT02348788|Lumefantrine|lumefantrine|mesh-list
43775054|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775055|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775056|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
43775057|NCT02348528|Hormones|hormones|mesh-ancestor
43775058|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775059|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775060|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775061|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
43775062|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43775063|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43775064|NCT02348528|Growth Substances|growth substances|mesh-ancestor
43775065|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
43775066|NCT02348463|Clindamycin|clindamycin|mesh-list
43775067|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
43775068|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
43775069|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43775070|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775071|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43775072|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775073|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775074|NCT02348255|Bevacizumab|bevacizumab|mesh-list
43775075|NCT02348255|Carmustine|carmustine|mesh-list
43775076|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43775077|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775078|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43775079|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43775080|NCT02348255|Growth Substances|growth substances|mesh-ancestor
43775081|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775082|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
43775083|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43775084|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
43775096|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43775097|NCT02348333|Dotinurad|dotinurad|mesh-list
43775098|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
43775099|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
43775100|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775101|NCT02348333|Renal Agents|renal agents|mesh-ancestor
43775102|NCT02348307|Dotinurad|dotinurad|mesh-list
43775103|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
43775104|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
43775105|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775106|NCT02348307|Renal Agents|renal agents|mesh-ancestor
43775107|NCT02348424|Solithromycin|solithromycin|mesh-list
43775108|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43775109|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775110|NCT02348450|Cisplatin|cisplatin|mesh-list
43775111|NCT02348450|Irinotecan|irinotecan|mesh-list
43775112|NCT02348450|Etoposide|etoposide|mesh-list
43775113|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775114|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43775115|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43775116|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775117|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775118|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43775119|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43775120|NCT02348372|Glycine|glycine|mesh-list
43775121|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
43775122|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775123|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775124|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775125|NCT02348281|Bicalutamide|bicalutamide|mesh-list
43775126|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
43775127|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775128|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775140|NCT02348190|Heparin|heparin|mesh-list
43775141|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
43775142|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43775143|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43775144|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775145|NCT02348177|Ritonavir|ritonavir|mesh-list
43775146|NCT02348177|Lopinavir|lopinavir|mesh-list
43775147|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43775148|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43775149|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
43775150|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775151|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775152|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43775153|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43775154|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
43775155|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775366|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775162|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775163|NCT02348125|Protective Agents|protective agents|mesh-ancestor
43775164|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775165|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
43775166|NCT02348125|Vitamins|vitamins|mesh-ancestor
43775167|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
43775168|NCT02347878|Aprepitant|aprepitant|mesh-list
43775169|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
43775170|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
43775171|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775172|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775173|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775182|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43775183|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775185|NCT02347501|Hormones|hormones|mesh-ancestor
43775186|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775187|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43775188|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
43775189|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775190|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775191|NCT02347839|Gefitinib|gefitinib|mesh-list
43775192|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775193|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43775194|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775195|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775197|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
43775198|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775199|NCT02347319|Protective Agents|protective agents|mesh-ancestor
43775200|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775201|NCT02347358|Plasminogen|plasminogen|mesh-list
43775202|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43775203|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43775204|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43775205|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775206|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
43775218|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43775219|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43775220|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
43775221|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775222|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775223|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775224|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
43775225|NCT02347059|Protective Agents|protective agents|mesh-ancestor
43775226|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43775227|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
43775228|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
43775229|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775230|NCT02347033|Sertraline|sertraline|mesh-list
43775231|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
43775232|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43775233|NCT02347033|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43775234|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43775235|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775236|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775237|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775238|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
43775239|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775240|NCT02346890|Sevelamer|sevelamer|mesh-list
43775241|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
43775242|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
43775243|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775439|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
43775253|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775254|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775255|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43775256|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
43775257|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43775258|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
43775259|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
43775260|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
43775261|NCT02346539|Nicotine|nicotine|mesh-list
43775262|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43775263|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
43775264|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775265|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775266|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43775267|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43775268|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
43775269|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775270|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775271|NCT02346578|Flutamide|flutamide|mesh-list
43775278|NCT02346201|Methylphenidate|methylphenidate|mesh-list
43775306|NCT02346110|Epinephrine|epinephrine|mesh-list
43775307|NCT02346110|Racepinephrine|racepinephrine|mesh-list
43775308|NCT02346110|Bupivacaine|bupivacaine|mesh-list
43775309|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
43775310|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775311|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
43775312|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
43775313|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775314|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775315|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775316|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
43775317|NCT02346110|Hormones|hormones|mesh-ancestor
43775318|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775319|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775320|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775321|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
43775322|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
43775323|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775324|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
43775325|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43775326|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43775327|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
43775328|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775329|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775330|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43775331|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43775332|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43775333|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
43775334|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
43775335|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
43775336|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43775337|NCT02346084|Maraviroc|maraviroc|mesh-list
43775338|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43775339|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43775341|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43775346|NCT02345902|Haloperidol|haloperidol|mesh-list
43775347|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
43775348|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
43775349|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
43775350|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775351|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775352|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775353|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43775354|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43775355|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775356|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43775357|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43775358|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
43775359|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775360|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775361|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43775362|NCT02345837|Clomiphene|clomiphene|mesh-list
43775363|NCT02345837|Enclomiphene|enclomiphene|mesh-list
43775364|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
43775365|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43775378|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581390|NCT03460860|Vitamin E|vitamin e|mesh-list
43775383|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43775384|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
43775385|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775386|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775387|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43775388|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
43775389|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43775390|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43775391|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43775392|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
43775393|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775394|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775395|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775396|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
43775398|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775399|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
43775400|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
43775401|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43775402|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43775403|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775411|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
43775412|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775413|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43775414|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775415|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43775416|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
43775417|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775418|NCT02345746|Antidotes|antidotes|mesh-ancestor
43775419|NCT02345746|Protective Agents|protective agents|mesh-ancestor
43775420|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
43775422|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
43775423|NCT02345746|Hematinics|hematinics|mesh-ancestor
43775424|NCT02345707|Cabotegravir|cabotegravir|mesh-list
43775425|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43775426|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43775427|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775428|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775429|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43775430|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43775431|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
43775432|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775433|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
43775434|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43775435|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
43775436|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775437|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775438|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43775452|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43775453|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775454|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775455|NCT02345304|Digoxin|digoxin|mesh-list
43775456|NCT02345304|Midazolam|midazolam|mesh-list
43775457|NCT02345304|Omeprazole|omeprazole|mesh-list
43775458|NCT02345304|Warfarin|warfarin|mesh-list
43775459|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43775460|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43775461|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775462|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775463|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43775464|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43775465|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43775466|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43775467|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
43775468|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
43775469|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
43775470|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
43775471|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775472|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775473|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
43775474|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43775475|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775476|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43775477|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775478|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43775479|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43775480|NCT02345304|Protective Agents|protective agents|mesh-ancestor
43775481|NCT02345343|Apixaban|apixaban|mesh-list
43775487|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775489|NCT02345590|Eplerenone|eplerenone|mesh-list
43775490|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43775491|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775492|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775493|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775494|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43775495|NCT02345590|Diuretics|diuretics|mesh-ancestor
43775496|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
43775497|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43775498|NCT02345239|Pantoprazole|pantoprazole|mesh-list
43775499|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43775500|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775501|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43775502|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775503|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775504|NCT02345148|Esketamine|esketamine|mesh-list
43775505|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
43775509|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775510|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775511|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775512|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43775513|NCT02345044|Diuretics|diuretics|mesh-ancestor
43775514|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
43775515|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43775516|NCT02345213|Donepezil|donepezil|mesh-list
43775517|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43775518|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775519|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775520|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
43775521|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775522|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775523|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
43775524|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
43775525|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43775526|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775527|NCT02345187|Micronutrients|micronutrients|mesh-list
43775528|NCT02345187|Trace Elements|trace elements|mesh-list
43775529|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775530|NCT02344940|Tamoxifen|tamoxifen|mesh-list
43775531|NCT02344940|Toremifene|toremifene|mesh-list
43775532|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43775536|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775537|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775538|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43775539|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43775540|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43775541|NCT02344888|Folic Acid|folic acid|mesh-list
43775542|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
43775543|NCT02344888|Prednisolone|prednisolone|mesh-list
43775544|NCT02344888|Citric Acid|citric acid|mesh-list
43775545|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
43775546|NCT02344888|Clomiphene|clomiphene|mesh-list
43775547|NCT02344888|Enclomiphene|enclomiphene|mesh-list
43775548|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
43775549|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
43775550|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43775551|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
43775552|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
43775553|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775554|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775555|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
43775556|NCT02344888|Hormones|hormones|mesh-ancestor
43775557|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775558|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775559|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775560|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775561|NCT02344888|Hematinics|hematinics|mesh-ancestor
43775562|NCT02344888|Vitamins|vitamins|mesh-ancestor
43775563|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
43775564|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43775571|NCT02344862|Dotinurad|dotinurad|mesh-list
43775572|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
43775573|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
43775574|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775575|NCT02344862|Renal Agents|renal agents|mesh-ancestor
43775576|NCT02344875|Dotinurad|dotinurad|mesh-list
43775577|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
43775578|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
43775579|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775580|NCT02344875|Renal Agents|renal agents|mesh-ancestor
43775581|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43775582|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
43775583|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43775584|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43775585|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775586|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775593|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43775594|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775595|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
43775596|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775597|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43775598|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775599|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43775621|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43775622|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775623|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775624|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43775625|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775626|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775627|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43775628|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
43775629|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43775630|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775631|NCT02344784|Methylphenidate|methylphenidate|mesh-list
43775632|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43775633|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775634|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43775635|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43775636|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775637|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775638|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
43775639|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775641|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
43775671|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775672|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775673|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775674|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
43775675|NCT02344732|Hormones|hormones|mesh-ancestor
43775676|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775677|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775678|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775679|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43775680|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43775681|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775682|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43775683|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775684|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775685|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
43775686|NCT02344264|Ropivacaine|ropivacaine|mesh-list
43775687|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
43775688|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
43775689|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775690|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775699|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775700|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775703|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43775704|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775705|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
43775706|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
43775707|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
43775708|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775709|NCT02343926|Metformin|metformin|mesh-list
43775710|NCT02343926|Vildagliptin|vildagliptin|mesh-list
43775711|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43775712|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775713|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43775714|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
43775760|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
43775761|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775762|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775763|NCT02343679|Ceritinib|ceritinib|mesh-list
43775764|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775765|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43775766|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775767|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775768|NCT02343432|Triamcinolone|triamcinolone|mesh-list
43775769|NCT02343432|Bupivacaine|bupivacaine|mesh-list
43775770|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
43775779|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775781|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43775782|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775783|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775784|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775785|NCT02343536|Prednisone|prednisone|mesh-list
43775786|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
43775787|NCT02343536|Rituximab|rituximab|mesh-list
43775807|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
43775808|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
43775809|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43775810|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
43775811|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775812|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
43775813|NCT02343419|Miotics|miotics|mesh-ancestor
43775814|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
43775815|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775816|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775817|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43775818|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43775819|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
43775820|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43775821|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43775822|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
43775823|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775824|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775825|NCT02343614|Celecoxib|celecoxib|mesh-list
43775827|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43775862|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43775863|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43775864|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
43775865|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43775866|NCT02342977|Lacosamide|lacosamide|mesh-list
43775867|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
43775904|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775905|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43775906|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775907|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775908|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775909|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43775910|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
43775911|NCT02342600|Trametinib|trametinib|mesh-list
43775948|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
43775949|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
43775950|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775951|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775952|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43775953|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
43775954|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775955|NCT02342145|Cyclosporine|cyclosporine|mesh-list
43775956|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
43775957|NCT02342145|Methotrexate|methotrexate|mesh-list
43775958|NCT02342145|Cyclosporins|cyclosporins|mesh-list
43775959|NCT02342145|Basiliximab|basiliximab|mesh-list
43775960|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43775961|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
43775962|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43775965|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
43776008|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43776009|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
43776010|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776011|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776012|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43776013|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776014|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
43776015|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43776016|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43776017|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43776018|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43776019|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
43776020|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43776021|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43776022|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
43776023|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776062|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776063|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776064|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776065|NCT02341703|Metformin|metformin|mesh-list
43776066|NCT02341703|Pioglitazone|pioglitazone|mesh-list
43776067|NCT02341703|Letrozole|letrozole|mesh-list
43776068|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43776069|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776070|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776071|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43776072|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43776073|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776074|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776075|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43776076|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
43776077|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776078|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
43776079|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
43776112|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43776113|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43776114|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43776115|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
43776116|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776117|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43776118|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
43776119|NCT02341547|Hematinics|hematinics|mesh-ancestor
43776120|NCT02341352|Fluorides|fluorides|mesh-list
43776121|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
43776122|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
43776123|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43776124|NCT02341352|Antibodies|antibodies|mesh-list
43776125|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
43776126|NCT02341352|Protective Agents|protective agents|mesh-ancestor
43776127|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776128|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
43776129|NCT02341365|Vitamin D|vitamin d|mesh-list
43776130|NCT02341365|Vitamins|vitamins|mesh-ancestor
43776131|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
43776132|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776133|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43838830|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838831|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43838832|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43838833|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43838834|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43838835|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838836|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
43838837|NCT04817826|Durvalumab|durvalumab|mesh-list
43838838|NCT04817826|Tremelimumab|tremelimumab|mesh-list
43838839|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838840|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838841|NCT04816682|Silymarin|silymarin|mesh-list
43838842|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
43848090|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848091|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43848092|NCT04051320|Progestins|progestins|mesh-ancestor
43848093|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43848094|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
43776134|NCT02341209|Doxycycline|doxycycline|mesh-list
43776135|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43776136|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776137|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
43776138|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43776139|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43776140|NCT02341300|Iron|iron|mesh-list
43776141|NCT02341300|Trace Elements|trace elements|mesh-ancestor
43776142|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
43776143|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776144|NCT02341274|Tacrolimus|tacrolimus|mesh-list
43776145|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776146|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
43776147|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776148|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43776149|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776150|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776151|NCT02341105|Amiodarone|amiodarone|mesh-list
43776152|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43776153|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
43776154|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43776155|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43776156|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776157|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43776158|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43776159|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43776161|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43776162|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43776163|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43776167|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776168|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776169|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
43776170|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776171|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
43776172|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43776173|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43776174|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
43776175|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776176|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776177|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776178|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
43776179|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
43776180|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776181|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
43776182|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43776183|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
43776184|NCT02340936|Lenalidomide|lenalidomide|mesh-list
43776185|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
43776186|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776187|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43776188|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43776189|NCT02340936|Growth Substances|growth substances|mesh-ancestor
43776216|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43776217|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776218|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43776220|NCT02340481|Loperamide|loperamide|mesh-list
43776221|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
43776222|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776223|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
43776224|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776225|NCT02340481|Emollients|emollients|mesh-ancestor
43776226|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
43776227|NCT02340611|Olaparib|olaparib|mesh-list
43776228|NCT02340611|Cediranib|cediranib|mesh-list
43776229|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43776230|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776231|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776232|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776233|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43776234|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
43776235|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43776236|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43776237|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776238|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776239|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776240|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
43776241|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43776242|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43776243|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
43776244|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776245|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776246|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776259|NCT02340117|Paclitaxel|paclitaxel|mesh-list
43776260|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43776261|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43776262|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776263|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
43776264|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
43776265|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
43776266|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776267|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43776269|NCT02340117|Antiviral Agents|antiviral agents|mesh-ancestor
43776270|NCT02340117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776271|NCT02340117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776272|NCT02340117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776273|NCT02340117|Immunologic Factors|immunologic factors|mesh-ancestor
43776274|NCT02340117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776276|NCT02340182|Vancomycin|vancomycin|mesh-list
43776277|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
43776278|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776325|NCT02339662|Amitriptyline|amitriptyline|mesh-list
43776326|NCT02339662|Analgesics|analgesics|mesh-ancestor
43776327|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
43776328|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776329|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776330|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
43776331|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43776332|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43776333|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776334|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43776357|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776358|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43776359|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43776360|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
43776361|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43776362|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43776363|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43776364|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43838847|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838848|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43776467|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
43776392|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43776393|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43776394|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
43776395|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776396|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43776397|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
43776398|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
43776399|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776400|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43776401|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43776402|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43776403|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43776404|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
43776405|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43776406|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776407|NCT02339324|Interferons|interferons|mesh-list
43776408|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
43776409|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
43776424|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776425|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776426|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43776427|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776428|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776429|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
43776430|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
43776431|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776432|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
43776433|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43776434|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43776435|NCT02339142|Prednisolone|prednisolone|mesh-list
43776436|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
43776437|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43776438|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
43776439|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776441|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
43776442|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776443|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776444|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776445|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
43776446|NCT02339142|Hormones|hormones|mesh-ancestor
43776447|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776448|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43776449|NCT02339142|Protective Agents|protective agents|mesh-ancestor
43776450|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43776451|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776452|NCT02339116|Bevacizumab|bevacizumab|mesh-list
43776453|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
43776454|NCT02339116|Irinotecan|irinotecan|mesh-list
43776455|NCT02339116|Fluorouracil|fluorouracil|mesh-list
43776456|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43776457|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776469|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776471|NCT02338934|Vitamin D|vitamin d|mesh-list
43776472|NCT02338934|Cinacalcet|cinacalcet|mesh-list
43776473|NCT02338934|Vitamins|vitamins|mesh-ancestor
43776474|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
43776475|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776476|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43776477|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43776478|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43776479|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
43776480|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776481|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
43776482|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776483|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43776484|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43776485|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776486|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776487|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
43776488|NCT02338830|Progesterone|progesterone|mesh-list
43776489|NCT02338830|Progestins|progestins|mesh-ancestor
43776490|NCT02338830|Hormones|hormones|mesh-ancestor
43776491|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776492|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776493|NCT02338687|Calcium|calcium|mesh-list
43776494|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43776495|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776496|NCT02338674|Tenofovir|tenofovir|mesh-list
43776497|NCT02338674|Telbivudine|telbivudine|mesh-list
43776498|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
43776499|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776500|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43776501|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43776502|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776504|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43776505|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43776507|NCT02338518|Etoposide|etoposide|mesh-list
43776508|NCT02338518|Epirubicin|epirubicin|mesh-list
43776509|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776510|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43776511|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43776512|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43776513|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776514|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776515|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43776516|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43776517|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43776518|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776519|NCT02338544|Adapalene|adapalene|mesh-list
43776520|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43776521|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
43776522|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43776523|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43776524|NCT02338544|Analgesics|analgesics|mesh-ancestor
43776525|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
43776526|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776527|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776528|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776529|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776550|NCT02338310|Letrozole|letrozole|mesh-list
43776551|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43776552|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776553|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43776554|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776555|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776556|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43776557|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
43776558|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776559|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776560|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43776561|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
43776562|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776567|NCT02338245|Capecitabine|capecitabine|mesh-list
43776568|NCT02338245|Lapatinib|lapatinib|mesh-list
43776569|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43776570|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
43776571|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776572|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776573|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43776574|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776575|NCT02338206|Hormones|hormones|mesh-list
43776576|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776577|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776578|NCT02338011|Gefitinib|gefitinib|mesh-list
43776579|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776580|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43776581|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776583|NCT02338115|Paclitaxel|paclitaxel|mesh-list
43776588|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
43776589|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776590|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
43776591|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776592|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43776593|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43776594|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
43776595|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776596|NCT02337855|Antacids|antacids|mesh-ancestor
43776597|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776598|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776599|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
43776600|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
43776601|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43776602|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43776603|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776604|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776605|NCT02337881|Urological Agents|urological agents|mesh-ancestor
43776606|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
43776607|NCT02337972|Povidone|povidone|mesh-list
43776608|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
43776609|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
43776610|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43776611|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776612|NCT02337712|Cisplatin|cisplatin|mesh-list
43776613|NCT02337712|Etoposide|etoposide|mesh-list
43838851|NCT04814615|Daratumumab|daratumumab|mesh-list
43838866|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838867|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838868|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838869|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838870|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43838871|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838872|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838873|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43838874|NCT04813991|Narcotics|narcotics|mesh-ancestor
43838875|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838877|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838878|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838879|NCT04810598|Venetoclax|venetoclax|mesh-list
43838880|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838881|NCT04810546|Lactoferrin|lactoferrin|mesh-list
43838882|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838883|NCT04809974|Niacinamide|niacinamide|mesh-list
43838884|NCT04809974|Vitamins|vitamins|mesh-ancestor
43838885|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
43838886|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838887|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
43838888|NCT04809311|Insulin|insulin|mesh-list
43838889|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43838890|NCT04809311|Glucagon|glucagon|mesh-list
43776620|NCT02337426|Temozolomide|temozolomide|mesh-list
43776621|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43776622|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43776623|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
43776624|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776635|NCT02337257|Vitamin D|vitamin d|mesh-list
43776636|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
43776637|NCT02337257|Vitamins|vitamins|mesh-ancestor
43776638|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
43776639|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776640|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43776641|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43776642|NCT02337231|Borage oil|borage oil|mesh-list
43776643|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776644|NCT02337322|Ritonavir|ritonavir|mesh-list
43776645|NCT02337322|Darunavir|darunavir|mesh-list
43776646|NCT02337322|Dolutegravir|dolutegravir|mesh-list
43776647|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43776648|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43776649|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
43776650|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776651|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776652|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43776653|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43776654|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
43776655|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776656|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43776657|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43776658|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43776659|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43776660|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
43776661|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43776662|NCT02337192|Curcumin|curcumin|mesh-list
43776684|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776685|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
43776686|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776687|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43776688|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43776689|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
43776690|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43776691|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
43776692|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776693|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
43776694|NCT02337166|Protective Agents|protective agents|mesh-ancestor
43776695|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
43776696|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776697|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776698|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
43776699|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43776700|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776701|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43776703|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776704|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
43776705|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776706|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43776707|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776708|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776709|NCT02336984|Trastuzumab|trastuzumab|mesh-list
43776710|NCT02336984|Pertuzumab|pertuzumab|mesh-list
43776711|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43776712|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776713|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43776714|NCT02336906|Laxatives|laxatives|mesh-ancestor
43776715|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776716|NCT02336854|Tacrolimus|tacrolimus|mesh-list
43776717|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776726|NCT02336659|Incretins|incretins|mesh-ancestor
43776727|NCT02336659|Hormones|hormones|mesh-ancestor
43776728|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776729|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43776730|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
43776731|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776732|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776733|NCT02336633|Resveratrol|resveratrol|mesh-list
43776734|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
43776735|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776736|NCT02336633|Protective Agents|protective agents|mesh-ancestor
43776737|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776738|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776786|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43776787|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776789|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
43776790|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776791|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776792|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
43776793|NCT02336386|Hormones|hormones|mesh-ancestor
43776794|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776795|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43776796|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776797|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43776798|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43776799|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43776800|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
43776801|NCT02336048|Chlorambucil|chlorambucil|mesh-list
43776802|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43776803|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776804|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43776805|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
43776807|NCT02336152|Anesthetics|anesthetics|mesh-list
43776827|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776828|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43776829|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43776830|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
43776831|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43776832|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43776833|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43776834|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43776835|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43776836|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
43776837|NCT02336139|Velpatasvir|velpatasvir|mesh-list
43776838|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
43776839|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838891|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43838892|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43838893|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838894|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776840|NCT02335736|Cetrorelix|cetrorelix|mesh-list
43776841|NCT02335736|Hormones|hormones|mesh-list
43776842|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
43776843|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776844|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776845|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43776872|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43776873|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776874|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43776875|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
43777644|NCT02330796|Protective Agents|protective agents|mesh-ancestor
43776936|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
43776937|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776938|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776939|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43776940|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43776941|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43776942|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43776943|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776945|NCT02334904|Aripiprazole|aripiprazole|mesh-list
43776946|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43776947|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
43776948|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776949|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776950|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776951|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43776952|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43776953|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776954|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43776955|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43776956|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
43776957|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
43583105|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
43776977|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776978|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
43776979|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
43776980|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776981|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776982|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776984|NCT02334475|Hormones|hormones|mesh-ancestor
43776985|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776986|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43776987|NCT02334475|Protective Agents|protective agents|mesh-ancestor
43776988|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43776989|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776990|NCT02334605|Capsaicin|capsaicin|mesh-list
43776991|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
43776992|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
43776993|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
43776994|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776995|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776996|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
43776997|NCT02334488|Everolimus|everolimus|mesh-list
43776998|NCT02334488|Tacrolimus|tacrolimus|mesh-list
43776999|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777000|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
43777001|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777002|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43777003|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777004|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777005|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777006|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43777007|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43777008|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
43777019|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
43777020|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777021|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777022|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43777023|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43777024|NCT02334631|Simethicone|simethicone|mesh-list
43777025|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
43777026|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777027|NCT02334631|Emollients|emollients|mesh-ancestor
43777028|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
43777029|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43777030|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43777031|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
43777032|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777034|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777035|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777036|NCT02334254|Warfarin|warfarin|mesh-list
43777037|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
43777038|NCT02334254|Clopidogrel|clopidogrel|mesh-list
43777039|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43777040|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43777041|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43777042|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43777043|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
43777044|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777045|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777046|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777047|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
43777048|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43777049|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
43777050|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43777051|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
43777060|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777061|NCT02334176|Lidocaine|lidocaine|mesh-list
43777062|NCT02334176|Epinephrine|epinephrine|mesh-list
43777063|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
43777064|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
43777065|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777066|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777067|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
43777068|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777069|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43777070|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43777071|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43777072|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43777073|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777074|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43777075|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43777076|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
43777077|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777078|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43777079|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43777080|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
43777081|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43777082|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
43777083|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
43777084|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
43777108|NCT02334046|Analgesics|analgesics|mesh-ancestor
43583211|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777109|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
43777110|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777111|NCT02333890|Chloroquine|chloroquine|mesh-list
43777112|NCT02333890|Amebicides|amebicides|mesh-ancestor
43777113|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43777114|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43777115|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777116|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
43777117|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777118|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
43777119|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43777120|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
43777121|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43777122|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
43777123|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777124|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777125|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
43777127|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43777164|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43777165|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43777166|NCT02333565|Everolimus|everolimus|mesh-list
43777167|NCT02333565|Octreotide|octreotide|mesh-list
43777168|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777169|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777170|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
43777171|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777172|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777173|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43777174|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
43777175|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43777176|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777177|NCT02333513|Vincristine|vincristine|mesh-list
43777178|NCT02333513|Lomustine|lomustine|mesh-list
43777179|NCT02333513|Procarbazine|procarbazine|mesh-list
43777180|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43777181|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777182|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
43777183|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
43777184|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
43583286|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
43777185|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777186|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43777187|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
43777188|NCT02333253|Cetrorelix|cetrorelix|mesh-list
43777189|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43777190|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
43777191|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43777192|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777193|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
43777194|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777195|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
43777197|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
43777204|NCT02333188|Calcium|calcium|mesh-list
43777205|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
43777206|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43777207|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777208|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
43777209|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
43777210|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
43777211|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777212|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43777213|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777214|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
43777215|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43777227|NCT02332941|Rituximab|rituximab|mesh-list
43777228|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43777229|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777230|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
43777231|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777232|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777233|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
43777234|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777248|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43777249|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43777250|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777251|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
43777252|NCT02333058|Treosulfan|treosulfan|mesh-list
43777253|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43777254|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
43777255|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777256|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777257|NCT02332954|Vortioxetine|vortioxetine|mesh-list
43777258|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
43777259|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43777260|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43777261|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43777262|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583361|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43777263|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777264|NCT02332954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43777265|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43777266|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43777267|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777268|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777269|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
43777270|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43777271|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43777272|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43777273|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43777274|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
43777277|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777308|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777309|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777310|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
43777312|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777313|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43777314|NCT02332603|Protective Agents|protective agents|mesh-ancestor
43777315|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43777316|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777317|NCT02332447|Naloxone|naloxone|mesh-list
43777318|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43777319|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777320|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
43777321|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777322|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
43777323|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43777324|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43777325|NCT02332629|Prednisolone|prednisolone|mesh-list
43777326|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
43777327|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43777328|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
43777329|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777330|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
43777331|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
43777332|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777333|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777334|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777335|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
43777336|NCT02332629|Hormones|hormones|mesh-ancestor
43777337|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777338|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43777352|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777353|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777354|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777355|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
43777356|NCT02332616|Hormones|hormones|mesh-ancestor
43777357|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777358|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43777359|NCT02332616|Protective Agents|protective agents|mesh-ancestor
43777360|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43777361|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777362|NCT02332174|Rufinamide|rufinamide|mesh-list
43777363|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
43777364|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43777365|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43777366|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43777367|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777368|NCT02332135|Vitamin D|vitamin d|mesh-list
43777369|NCT02332135|Vitamins|vitamins|mesh-ancestor
43777370|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
43777371|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777372|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43777373|NCT02332356|Adalimumab|adalimumab|mesh-list
43777374|NCT02332356|Azathioprine|azathioprine|mesh-list
43777375|NCT02332356|Infliximab|infliximab|mesh-list
43777376|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777377|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777378|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
43777379|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777380|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
43838906|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
43838907|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43838908|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43838909|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838910|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43838911|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
43838912|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43838913|NCT04808882|Tinzaparin|tinzaparin|mesh-list
43838914|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43838915|NCT04808882|Dalteparin|dalteparin|mesh-list
43838916|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
43838917|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43838918|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43838919|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838920|NCT04807816|Gemcitabine|gemcitabine|mesh-list
43838921|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43838922|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
43838923|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838924|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838925|NCT04807816|Antiviral Agents|antiviral agents|mesh-ancestor
43838926|NCT04807816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838927|NCT04807816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838928|NCT04807816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838929|NCT04807816|Immunologic Factors|immunologic factors|mesh-ancestor
43838930|NCT04807816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838931|NCT04807517|Buspirone|buspirone|mesh-list
43838932|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43838933|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43838934|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838935|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838936|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43838946|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43838947|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838948|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
43838949|NCT04804072|Narcotics|narcotics|mesh-ancestor
43777387|NCT02332057|Diclofenac|diclofenac|mesh-list
43777388|NCT02332057|Lidocaine|lidocaine|mesh-list
43777389|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
43777390|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
43777391|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777392|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777393|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
43777394|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777395|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43777396|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43777397|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43777398|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43777399|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777400|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43777401|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43777402|NCT02332057|Analgesics|analgesics|mesh-ancestor
43777403|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777404|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777405|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43777406|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777428|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
43777429|NCT02331823|Ethambutol|ethambutol|mesh-list
43777430|NCT02331823|Rifabutin|rifabutin|mesh-list
43777431|NCT02331823|Streptomycin|streptomycin|mesh-list
43777432|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43777433|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777434|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43777435|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43777436|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777437|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777438|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777439|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43777440|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
43777441|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43777442|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43777443|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
43777444|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43777445|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43777446|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
43777447|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43777448|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43777449|NCT02331862|Prednisolone|prednisolone|mesh-list
43777450|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
43777465|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777466|NCT02331927|Aflibercept|aflibercept|mesh-list
43777467|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43777468|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43777469|NCT02331927|Growth Substances|growth substances|mesh-ancestor
43777470|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777471|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
43777472|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777473|NCT02332005|Choline|choline|mesh-list
43777474|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
43777475|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43777476|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
43777477|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777478|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777479|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43777480|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
43777481|NCT02331706|Interferons|interferons|mesh-list
43777482|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
43777483|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
43777484|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777485|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
43777486|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777487|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
43777520|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777521|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777522|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43777523|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43777524|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777525|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43777526|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43777527|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777528|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
43777529|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43777530|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43777531|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43777532|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
43777533|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777534|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
43777535|NCT02331563|Bupivacaine|bupivacaine|mesh-list
43777536|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
43777537|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
43777538|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777539|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777540|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
43777541|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777542|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43777543|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43777544|NCT02331563|Analgesics|analgesics|mesh-ancestor
43777545|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43777546|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43777547|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43777548|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
43777549|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777550|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777551|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43777560|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777561|NCT02330991|Temozolomide|temozolomide|mesh-list
43777562|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43777563|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
43777564|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777565|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777566|NCT02331173|Dorzolamide|dorzolamide|mesh-list
43777567|NCT02331173|Brinzolamide|brinzolamide|mesh-list
43777568|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43777569|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777570|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777571|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43777572|NCT02331030|Ropivacaine|ropivacaine|mesh-list
43777573|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
43777574|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
43777580|NCT02331251|Paclitaxel|paclitaxel|mesh-list
43777620|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43777621|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43777622|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
43777623|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43777624|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
43777625|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43777626|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43777627|NCT02330796|Bucillamine|bucillamine|mesh-list
43777629|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
43777630|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777631|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
43777632|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
43777633|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
43777634|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777635|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777636|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43777637|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43777638|NCT02330796|Analgesics|analgesics|mesh-ancestor
43777639|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
43777640|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777641|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777642|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777643|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
43777664|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43777665|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43777666|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43777668|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777688|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838950|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838951|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838952|NCT04804072|Analgesics|analgesics|mesh-ancestor
43838953|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
43838954|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838955|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43838956|NCT04803734|Albuterol|albuterol|mesh-list
43838957|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43838958|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
43838959|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838960|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838961|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43838962|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
43838963|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
43838964|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43838965|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43838966|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43838967|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43838968|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
43838969|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43838970|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838971|NCT04803201|Prednisone|prednisone|mesh-list
43838972|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
43838973|NCT04803201|Doxorubicin|doxorubicin|mesh-list
43838974|NCT04803201|Etoposide|etoposide|mesh-list
43838975|NCT04803201|Vincristine|vincristine|mesh-list
43838976|NCT04803201|Azacitidine|azacitidine|mesh-list
43838977|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838978|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
43838979|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838992|NCT04803201|Hormones|hormones|mesh-ancestor
43838993|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838994|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43838995|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43838996|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
43838997|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
43777689|NCT02330367|Abivertinib|abivertinib|mesh-list
43777690|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43777691|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777957|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43777692|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777693|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43777694|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43777695|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43777696|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43777697|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777698|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777699|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777700|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
43777701|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43777703|NCT02330380|Etanercept|etanercept|mesh-list
43777704|NCT02330380|Methotrexate|methotrexate|mesh-list
43777705|NCT02330380|Ustekinumab|ustekinumab|mesh-list
43777706|NCT02330380|Acitretin|acitretin|mesh-list
43777707|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43777708|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
43777709|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43777710|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777711|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43777726|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
43777727|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777728|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777729|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
43777730|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43777732|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43777733|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777734|NCT02330406|Incretins|incretins|mesh-ancestor
43777735|NCT02330406|Hormones|hormones|mesh-ancestor
43777736|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777737|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43777738|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
43777739|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777740|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777741|NCT02330302|Ropivacaine|ropivacaine|mesh-list
43777742|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
43777743|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
43777744|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777745|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777746|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
43777747|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777748|NCT02330419|Naltrexone|naltrexone|mesh-list
43777749|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43777750|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43777751|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777752|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
43777753|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777754|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
43777755|NCT02330120|Propofol|propofol|mesh-list
43777756|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43777757|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777758|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777759|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43777765|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777766|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43777767|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43777768|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43777769|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
43777770|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777771|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777772|NCT02330029|Pinaverium|pinaverium|mesh-list
43777773|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43777774|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43777775|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777776|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43777777|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777778|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
43777779|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
43777780|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777781|NCT02330068|Citalopram|citalopram|mesh-list
43777782|NCT02330068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43777783|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43777784|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43777786|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777787|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
43777812|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777813|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
43777814|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43777815|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43777816|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777817|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
43777818|NCT02329756|Coagulants|coagulants|mesh-ancestor
43777819|NCT02329535|Progesterone|progesterone|mesh-list
43777820|NCT02329535|Progestins|progestins|mesh-ancestor
43777822|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777823|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777824|NCT02329405|Rifampin|rifampin|mesh-list
43777825|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43777826|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
43777827|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43777828|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777829|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
43777830|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43777831|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777832|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777833|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43777862|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777863|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
43777864|NCT02329132|Ranibizumab|ranibizumab|mesh-list
43777865|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43777866|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43777867|NCT02329132|Growth Substances|growth substances|mesh-ancestor
43777868|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777869|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
43777870|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777871|NCT02328950|Cytarabine|cytarabine|mesh-list
43777872|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
43777873|NCT02328950|Busulfan|busulfan|mesh-list
43777874|NCT02328950|Fludarabine|fludarabine|mesh-list
43777875|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777876|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
43777877|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777878|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777879|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43777880|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
43777881|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777882|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777883|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43777884|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43777885|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
43777886|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
43777887|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777888|NCT02328729|Epinephrine|epinephrine|mesh-list
43777889|NCT02328729|Racepinephrine|racepinephrine|mesh-list
43777890|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
43777891|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43777892|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43777893|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
43777894|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777895|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777896|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777897|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43777899|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
43777901|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43777902|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
43777904|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
43777905|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43777906|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
43777907|NCT02328963|Everolimus|everolimus|mesh-list
43777908|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777909|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777910|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
43777911|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777912|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43777913|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43777915|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43777924|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777925|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838998|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
43838999|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43839000|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
43839001|NCT04802408|Listerine|listerine|mesh-list
43839002|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
43839003|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43839004|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839005|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
43839006|NCT04802408|Protective Agents|protective agents|mesh-ancestor
43839017|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43839018|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839019|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43839020|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839021|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839023|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
43839024|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43839025|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839026|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839027|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43839028|NCT04801589|Analgesics|analgesics|mesh-ancestor
43839029|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
43839030|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839031|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43777929|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
43777930|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777931|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
43777932|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777933|NCT02328521|Nicorandil|nicorandil|mesh-list
43777934|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43777935|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43777936|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
43777937|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
43777938|NCT02328521|Vitamins|vitamins|mesh-ancestor
43777939|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
43777940|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777941|NCT02328469|Doxycycline|doxycycline|mesh-list
43777942|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
43777943|NCT02328469|Acyclovir|acyclovir|mesh-list
43777944|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43777945|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777946|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
43777947|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43777948|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43777949|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
43777950|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43777951|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43777952|NCT02328495|Misoprostol|misoprostol|mesh-list
43777953|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43777954|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
43777955|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43777956|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777958|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777959|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
43777960|NCT02328183|Polymyxins|polymyxins|mesh-list
43777961|NCT02328183|Polymyxin B|polymyxin b|mesh-list
43777962|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43777963|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777964|NCT02328053|Voriconazole|voriconazole|mesh-list
43777965|NCT02328053|Natamycin|natamycin|mesh-list
43777972|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777973|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777974|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43777975|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
43777976|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777977|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777978|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43777979|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43777980|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43777981|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43777983|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
43777984|NCT02328079|Prednisolone|prednisolone|mesh-list
43777985|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43777986|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
43777987|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43777988|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
43777989|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43777990|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
43777991|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777992|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
43777993|NCT02328079|Hormones|hormones|mesh-ancestor
43777994|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777998|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
43778021|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
43778022|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778023|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778024|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
43778025|NCT02328118|Hormones|hormones|mesh-ancestor
43778026|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778027|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43778028|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
43778029|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778030|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778031|NCT02328443|Itraconazole|itraconazole|mesh-list
43778032|NCT02328443|Rifampin|rifampin|mesh-list
43778033|NCT02328443|Midazolam|midazolam|mesh-list
43778034|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43778035|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43778036|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778037|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778038|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43778039|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43778040|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43778041|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43778042|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
43778043|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
43778044|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
43778045|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
43778046|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778047|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778048|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
43778049|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778050|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43778051|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43778052|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778053|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43778054|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
43778061|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43778062|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43778063|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43778064|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43778065|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43778066|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43778067|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43778068|NCT02328144|Metronidazole|metronidazole|mesh-list
43778069|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778070|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43778084|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778085|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43778086|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43778087|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778088|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778089|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43778090|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43778091|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
43778092|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43778093|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43778101|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778102|NCT02327624|Clopidogrel|clopidogrel|mesh-list
43778103|NCT02327624|Ticagrelor|ticagrelor|mesh-list
43778104|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43778105|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43778106|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43778107|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43778108|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
43778109|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778110|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778111|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778112|NCT02327936|Fesoterodine|fesoterodine|mesh-list
43778113|NCT02327936|Oxybutynin|oxybutynin|mesh-list
43778114|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43778115|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43778117|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778118|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778119|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778120|NCT02327936|Urological Agents|urological agents|mesh-ancestor
43778121|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
43778122|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
43778123|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778125|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
43778132|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778133|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43778134|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
43778135|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
43778136|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778137|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43778138|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43778139|NCT02327754|FYX-051|fyx-051|mesh-list
43778140|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778141|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778142|NCT02327689|Emtricitabine|emtricitabine|mesh-list
43778143|NCT02327689|Adefovir|adefovir|mesh-list
43778144|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43778145|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
43778146|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778147|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43778148|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43778149|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778150|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778151|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43778152|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43778153|NCT02327923|Ketorolac|ketorolac|mesh-list
43778154|NCT02327923|Lidocaine|lidocaine|mesh-list
43778188|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43778190|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
43778191|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43778192|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
43778193|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778194|NCT02327923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43778195|NCT02327923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43778196|NCT02327923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43778197|NCT02327923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43778198|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43778199|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778200|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778201|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43778202|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778203|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43778204|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43778205|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
43778206|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
43778207|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
43778208|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43778209|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43778210|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
43778211|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43778212|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43778213|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43778214|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43778215|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43778216|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
43778235|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778236|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43778237|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43778238|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778239|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778240|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43778241|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43778242|NCT02327338|Ibuprofen|ibuprofen|mesh-list
43778243|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43778244|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778245|NCT02327338|Analgesics|analgesics|mesh-ancestor
43778246|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
43778247|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778248|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778249|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778279|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43778280|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778282|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
43778283|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778284|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778285|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778286|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778287|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43778288|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778289|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778290|NCT02327247|Felodipine|felodipine|mesh-list
43778291|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43778292|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43778293|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43778294|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778295|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778296|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43778297|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778298|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839032|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43839033|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43839034|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
43839035|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839036|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839037|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43839038|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43839039|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43839040|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43839041|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43839042|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
43839043|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
43839044|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
43839045|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
43584564|NCT03427801|Hematinics|hematinics|mesh-list
43778300|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43778301|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778302|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778303|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778304|NCT02327156|Analgesics|analgesics|mesh-ancestor
43778305|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
43778306|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778307|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43778308|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43778309|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43778310|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
43778311|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778312|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778313|NCT02327000|Pregabalin|pregabalin|mesh-list
43778314|NCT02327000|Analgesics|analgesics|mesh-ancestor
43778315|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
43778316|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778317|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778318|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
43778325|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778326|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43778328|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43778329|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43778330|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778332|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
43778333|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
43778334|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43778335|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
43778336|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43778337|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778338|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43778339|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43778340|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43778341|NCT02326987|Pregabalin|pregabalin|mesh-list
43778342|NCT02326987|Analgesics|analgesics|mesh-ancestor
43778343|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
43778344|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778345|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778346|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
43778347|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43778348|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778349|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778372|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778373|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778374|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43778375|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43778376|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778377|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43778378|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43778379|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778381|NCT02326727|Fentanyl|fentanyl|mesh-list
43778382|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
43778384|NCT02326727|Ropivacaine|ropivacaine|mesh-list
43778385|NCT02326727|Isoflurane|isoflurane|mesh-list
43778386|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43778387|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778388|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778389|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43778390|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
43778391|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
43778392|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
43778393|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
43778394|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778395|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43778396|NCT02326727|Narcotics|narcotics|mesh-ancestor
43778397|NCT02326727|Analgesics|analgesics|mesh-ancestor
43778398|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43778399|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43778400|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778401|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43778402|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43778403|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43778404|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778405|NCT02326441|KX2-361|kx2-361|mesh-list
43778406|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43778407|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778413|NCT02326584|Cytarabine|cytarabine|mesh-list
43778414|NCT02326584|Daunorubicin|daunorubicin|mesh-list
43778415|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43778416|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
43778417|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778418|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778419|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
43778420|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778421|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43778422|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
43778423|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778424|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43778425|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43778466|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43778467|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
43778468|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43778469|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778470|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43778471|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43778472|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778473|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778477|NCT02326194|Vaccines|vaccines|mesh-list
43778529|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43778530|NCT05076773|Narcotics|narcotics|mesh-ancestor
43778531|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778532|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778533|NCT05076773|Analgesics|analgesics|mesh-ancestor
43778534|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
43778535|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778536|NCT05076695|Trastuzumab|trastuzumab|mesh-list
43778537|NCT05076695|Fulvestrant|fulvestrant|mesh-list
43778538|NCT05076695|Palbociclib|palbociclib|mesh-list
43778539|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43778540|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778541|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43778542|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43778543|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43778544|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
43778545|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778546|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778547|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43778548|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778549|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778550|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
43778551|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43778552|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
43778553|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778554|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
43778555|NCT05076526|Protective Agents|protective agents|mesh-ancestor
43778556|NCT05076474|Orlistat|orlistat|mesh-list
43778582|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778583|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43778584|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43778585|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839048|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839050|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43839051|NCT04799431|Poly ICLC|poly iclc|mesh-list
43839052|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
43839053|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
43839054|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839055|NCT04799431|Laxatives|laxatives|mesh-ancestor
43778587|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
43778588|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778589|NCT05034809|Protective Agents|protective agents|mesh-ancestor
43778590|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778591|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778592|NCT04993924|Cetrorelix|cetrorelix|mesh-list
43778593|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43778594|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
43778595|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43778596|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778597|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
43778598|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778599|NCT04893785|Temozolomide|temozolomide|mesh-list
43778600|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43778601|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
43778602|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778603|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778604|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
43778605|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43778606|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43778607|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778608|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
43778609|NCT04803591|Coagulants|coagulants|mesh-ancestor
43778610|NCT04696822|Epinephrine|epinephrine|mesh-list
43778611|NCT04696822|Racepinephrine|racepinephrine|mesh-list
43778612|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
43778613|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43778614|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43778616|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778617|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778618|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778619|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43778620|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43778621|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
43778622|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778623|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43778624|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
43778625|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
43778626|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
43778627|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43778628|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43778629|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778630|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778631|NCT04501861|Vasopressins|vasopressins|mesh-list
43778632|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
43778633|NCT04501861|Norepinephrine|norepinephrine|mesh-list
43778634|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43778686|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
43778687|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778688|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778689|NCT04342078|Vitamin D|vitamin d|mesh-list
43778690|NCT04342078|Vitamins|vitamins|mesh-ancestor
43778708|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778709|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778711|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778712|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43778713|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43778714|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43778715|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778730|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43778731|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778732|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778733|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43778734|NCT03978767|Narcotics|narcotics|mesh-ancestor
43778735|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778736|NCT03838692|Ponatinib|ponatinib|mesh-list
43778737|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778738|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43778739|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778740|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778741|NCT03774186|Pancrelipase|pancrelipase|mesh-list
43778742|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43778743|NCT03739268|Sevelamer|sevelamer|mesh-list
43778744|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
43778745|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
43778746|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778747|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43778748|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778749|NCT03576443|Idelalisib|idelalisib|mesh-list
43778750|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778751|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778752|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778753|NCT03505944|Venetoclax|venetoclax|mesh-list
43778754|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778755|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
43778756|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43778757|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43778758|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778759|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
43778760|NCT03353259|Coagulants|coagulants|mesh-ancestor
43778761|NCT02913495|Progesterone|progesterone|mesh-list
43778762|NCT02913495|Progestins|progestins|mesh-ancestor
43778770|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778783|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778784|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778785|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
43778837|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
43778838|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778839|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778840|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839059|NCT04799262|Prednisone|prednisone|mesh-list
43839060|NCT04799262|Tofacitinib|tofacitinib|mesh-list
43839061|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839062|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
43839063|NCT04799262|Hormones|hormones|mesh-ancestor
43839064|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778841|NCT05080348|Ropivacaine|ropivacaine|mesh-list
43778842|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
43778843|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
43778844|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778845|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778846|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
43778847|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778848|NCT05080140|Ezetimibe|ezetimibe|mesh-list
43778849|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43778850|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43778851|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
43778852|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778853|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43778882|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778883|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43778884|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43778885|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
43778887|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778888|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43778889|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43778890|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778891|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778892|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43778893|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43778894|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43778895|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43778896|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43778897|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
43778898|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
43778899|NCT05079022|Aflutinib|aflutinib|mesh-list
43778900|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43778901|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778902|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778903|NCT05078788|Triamcinolone|triamcinolone|mesh-list
43778904|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778905|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
43778932|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43778933|NCT05078255|Incretins|incretins|mesh-ancestor
43778934|NCT05078255|Hormones|hormones|mesh-ancestor
43778935|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778936|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778937|NCT05078177|Rituximab|rituximab|mesh-list
43778938|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43779009|NCT05068141|Paclitaxel|paclitaxel|mesh-list
43779010|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43839080|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839081|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43839082|NCT04798482|Analgesics|analgesics|mesh-ancestor
43839083|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
43839084|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839085|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43839086|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43839087|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43839088|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
43839089|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839090|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839091|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
43839092|NCT04798469|Testosterone|testosterone|mesh-list
43839093|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
43839094|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
43839095|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43839096|NCT04798469|Androgens|androgens|mesh-ancestor
43839097|NCT04798469|Hormones|hormones|mesh-ancestor
43839098|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839099|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839100|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839101|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839102|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
43839103|NCT04798027|Vaccines|vaccines|mesh-list
43839104|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
43839105|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839106|NCT04798001|Vaccines|vaccines|mesh-list
43839107|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
43839108|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839109|NCT04797325|Prednisolone|prednisolone|mesh-list
43839110|NCT04797325|Infliximab|infliximab|mesh-list
43779034|NCT05021562|Niraparib|niraparib|mesh-list
43779035|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43779036|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779037|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779042|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
43779043|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
43779044|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43779531|NCT03252626|Alprostadil|alprostadil|mesh-list
43779045|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779046|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779047|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43779048|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779049|NCT04996199|Analgesics|analgesics|mesh-ancestor
43779050|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
43779051|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779052|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43779053|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43779054|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779055|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43779056|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43779057|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43779058|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43779059|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779093|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779094|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
43779095|NCT04926454|Bupivacaine|bupivacaine|mesh-list
43779096|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
43779097|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
43779098|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779099|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779100|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
43779101|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779102|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43779103|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779104|NCT04926454|Analgesics|analgesics|mesh-ancestor
43779105|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43779106|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43779107|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43779108|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
43779109|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779110|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779112|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43779113|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779114|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
43779115|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779116|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43779117|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43779118|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43779119|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
43779120|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779121|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43779122|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43779123|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779124|NCT04822376|Ansuvimab|ansuvimab|mesh-list
43779125|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
43779126|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779132|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43779133|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43779134|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779135|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
43779136|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779137|NCT04797312|Sufentanil|sufentanil|mesh-list
43779138|NCT04797312|Remifentanil|remifentanil|mesh-list
43779139|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
43779140|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
43779141|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779142|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779143|NCT04797312|Narcotics|narcotics|mesh-ancestor
43779144|NCT04797312|Analgesics|analgesics|mesh-ancestor
43779145|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
43779146|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779147|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43779148|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43779149|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
43779150|NCT04735263|Atorvastatin|atorvastatin|mesh-list
43779151|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43779152|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43779153|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
43779154|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779186|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779202|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
43779203|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779204|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43779205|NCT04654429|Ondansetron|ondansetron|mesh-list
43779206|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
43779207|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
43779208|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779209|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779210|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43779230|NCT04551911|Vitamins|vitamins|mesh-ancestor
43839126|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839127|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839128|NCT04797286|Urological Agents|urological agents|mesh-ancestor
43839130|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
43839131|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839132|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43839133|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43839134|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839135|NCT04796012|Irinotecan|irinotecan|mesh-list
43839136|NCT04796012|Vincristine|vincristine|mesh-list
43839137|NCT04796012|Temozolomide|temozolomide|mesh-list
43779271|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779272|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43779273|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
43779274|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779275|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779276|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43779277|NCT04149990|Valsartan|valsartan|mesh-list
43779278|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43779279|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43779280|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43779281|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43779282|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779283|NCT04022967|Ritonavir|ritonavir|mesh-list
43779284|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43779285|NCT04022967|Tenofovir|tenofovir|mesh-list
43779286|NCT04022967|Lamivudine|lamivudine|mesh-list
43779287|NCT04022967|Dolutegravir|dolutegravir|mesh-list
43779288|NCT04022967|Efavirenz|efavirenz|mesh-list
43779289|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43779325|NCT03971474|Antiviral Agents|antiviral agents|mesh-ancestor
43779326|NCT03971474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779327|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779378|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
43779379|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43779380|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
43779381|NCT03821610|Melphalan|melphalan|mesh-list
43779382|NCT03821610|Fludarabine|fludarabine|mesh-list
43779383|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
43779384|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779385|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
43779387|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779424|NCT03733418|Vitamins|vitamins|mesh-ancestor
43779425|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
43779426|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779427|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43779428|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43779494|NCT03473574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779495|NCT03473574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779496|NCT03473574|Immunologic Factors|immunologic factors|mesh-ancestor
43779497|NCT03473574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779498|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839170|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
43839171|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
43839172|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839173|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839174|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
43839175|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839176|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43839177|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839178|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
43839179|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43839180|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43839181|NCT04794569|Tinzaparin|tinzaparin|mesh-list
43839182|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43839183|NCT04794569|Dalteparin|dalteparin|mesh-list
43839184|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
43839185|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43839186|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
43839187|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43839188|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
43839189|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839190|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839191|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
43779514|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779515|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779516|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
43779517|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43779518|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779519|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779520|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779521|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43779522|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43779523|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779524|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
43779525|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43779526|NCT03316274|Nivolumab|nivolumab|mesh-list
43779527|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43779528|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779529|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43779530|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779579|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43779580|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43779581|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43779582|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779583|NCT02654080|Vaccines|vaccines|mesh-list
43779584|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
43779585|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779586|NCT02618148|Estrogens|estrogens|mesh-list
43779587|NCT02618148|Hormones|hormones|mesh-ancestor
43779588|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43779620|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779621|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
43779636|NCT05082142|Coagulants|coagulants|mesh-ancestor
43779637|NCT05081986|Cycloserine|cycloserine|mesh-list
43779638|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43779639|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779640|NCT05081986|Renal Agents|renal agents|mesh-ancestor
43779641|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43779642|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
43779643|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779644|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
43779645|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779646|NCT05081765|Olaparib|olaparib|mesh-list
43779647|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43779648|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779649|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779650|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779651|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
43779652|NCT05081687|Irinotecan|irinotecan|mesh-list
43779653|NCT05081687|Folfirinox|folfirinox|mesh-list
43779654|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779655|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43779656|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43779657|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779659|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
43779660|NCT05081674|Nivolumab|nivolumab|mesh-list
43779661|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43779662|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43779663|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779664|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43779665|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779666|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43779667|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779668|NCT05080985|Bupivacaine|bupivacaine|mesh-list
43779669|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
43779677|NCT05080803|Aflibercept|aflibercept|mesh-list
43779678|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43779679|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779680|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43779681|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43779682|NCT05080803|Growth Substances|growth substances|mesh-ancestor
43779683|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779684|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
43779685|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
43779686|NCT05062278|Vinblastine|vinblastine|mesh-list
43779687|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779688|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
43779689|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779690|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779691|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43779692|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43779693|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
43779694|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
43779695|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
43779697|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43779698|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779699|NCT04997174|Analgesics|analgesics|mesh-ancestor
43779700|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
43779701|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779702|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779703|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779704|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779705|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43779706|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43779707|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779720|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779721|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779722|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43779723|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779724|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779725|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43779726|NCT04976387|Narcotics|narcotics|mesh-ancestor
43779727|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779728|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
43779729|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
43839196|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
43839197|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839198|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
43839199|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
43839200|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839202|NCT04793906|Trace Elements|trace elements|mesh-ancestor
43839203|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
43779737|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779738|NCT04895488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43779739|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43779740|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43779741|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779742|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779743|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
43779744|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43779745|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43779746|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43779747|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43779748|NCT04585724|Palbociclib|palbociclib|mesh-list
43779749|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779784|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779785|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779786|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
43779787|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43779788|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779789|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779790|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43779791|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43779792|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43779793|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43779794|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43779795|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43779796|NCT04423601|Itraconazole|itraconazole|mesh-list
43779797|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
43779798|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779799|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43779800|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43779801|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779803|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43779824|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779825|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779826|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
43779827|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
43779828|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
43779829|NCT03832647|Salicylates|salicylates|mesh-list
43779830|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779831|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
43779832|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
43779833|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
43779834|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43779835|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779836|NCT03832647|Analgesics|analgesics|mesh-ancestor
43779837|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
43779838|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779839|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779840|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779841|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779842|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43779843|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779844|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779846|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
43779847|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
43779855|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43779856|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43779857|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43779858|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
43779861|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43779862|NCT03778671|Narcotics|narcotics|mesh-ancestor
43779863|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43779864|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43779865|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
43779866|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
43779867|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
43779868|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
43779869|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779870|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779871|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43779872|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43779873|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779874|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779875|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779876|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43779877|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43779878|NCT03563066|Benralizumab|benralizumab|mesh-list
43779879|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43779880|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
43779881|NCT03558789|Lactoferrin|lactoferrin|mesh-list
43779882|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779883|NCT03495921|Irinotecan|irinotecan|mesh-list
43779884|NCT03495921|Camptothecin|camptothecin|mesh-list
43779885|NCT03495921|Temozolomide|temozolomide|mesh-list
43779886|NCT03495921|Immunologic Factors|immunologic factors|mesh-list
43779887|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43779896|NCT03317223|Amoxicillin|amoxicillin|mesh-list
43779910|NCT02983006|DS-8273a|ds-8273a|mesh-list
43779911|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43779912|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779913|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43779914|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779915|NCT02936687|Ambrisentan|ambrisentan|mesh-list
43779916|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43779971|NCT05084001|Fluorides|fluorides|mesh-list
43779972|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
43779973|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
43779974|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
43779975|NCT05084001|Protective Agents|protective agents|mesh-ancestor
43779976|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779977|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43779978|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839237|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839238|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43839239|NCT04789837|Protective Agents|protective agents|mesh-ancestor
43839240|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43839241|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43839243|NCT04789668|Atezolizumab|atezolizumab|mesh-list
43839296|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839297|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839298|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
43839299|NCT04786964|Hormones|hormones|mesh-ancestor
43839300|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839301|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839302|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779979|NCT05083793|Pregabalin|pregabalin|mesh-list
43779980|NCT05083793|Analgesics|analgesics|mesh-ancestor
43779981|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
43779982|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779983|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779984|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
43779985|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43779986|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43779987|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779988|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43779989|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43779990|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43780026|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
43780027|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43780028|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43780029|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
43780030|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780031|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780032|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43780033|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
43780034|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
43780035|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43780036|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
43780037|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780038|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780039|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43780040|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43780041|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43780042|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
43780044|NCT05083247|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43780045|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43780046|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
43780047|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780048|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780049|NCT05083247|Antiviral Agents|antiviral agents|mesh-ancestor
43780050|NCT05083247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780051|NCT05083247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780052|NCT05083247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43780053|NCT05083247|Immunologic Factors|immunologic factors|mesh-ancestor
43780054|NCT05083247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780056|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
43780057|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
43780058|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780059|NCT05083013|Chrysarobin|chrysarobin|mesh-list
43780067|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43780068|NCT05082974|Varenicline|varenicline|mesh-list
43780069|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43780070|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43780071|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
43780072|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780073|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780074|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780075|NCT05082896|Anesthetics|anesthetics|mesh-list
43780076|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780077|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780078|NCT05082753|Ivermectin|ivermectin|mesh-list
43780079|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43780080|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780081|NCT05082662|Diclofenac|diclofenac|mesh-list
43780082|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43780083|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43780084|NCT05082662|Analgesics|analgesics|mesh-ancestor
43780085|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
43780086|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780087|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780088|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43780120|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780121|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43780122|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43780123|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43780124|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780125|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43780126|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43780127|NCT05049902|Antacids|antacids|mesh-ancestor
43780128|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43780129|NCT05049902|Diuretics|diuretics|mesh-ancestor
43780144|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780146|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780147|NCT04962230|Ritonavir|ritonavir|mesh-list
43780148|NCT04962230|Carbamazepine|carbamazepine|mesh-list
43780166|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43780167|NCT04962230|Analgesics|analgesics|mesh-ancestor
43780241|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780242|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43780243|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43780244|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
43780245|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43780246|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43839311|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43839313|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
43839314|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839315|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839316|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839317|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43839318|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43839319|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43839320|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839321|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839322|NCT04785638|Bupivacaine|bupivacaine|mesh-list
43839323|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
43839324|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
43839325|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839326|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839327|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
43839328|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848133|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
43848134|NCT04046744|Anesthetics|anesthetics|mesh-list
43848135|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848144|NCT04046549|Abatacept|abatacept|mesh-list
43848166|NCT04044222|Carboplatin|carboplatin|mesh-list
43848167|NCT04044222|Etoposide|etoposide|mesh-list
43848168|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
43848169|NCT04044222|Ifosfamide|ifosfamide|mesh-list
43848170|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
43848171|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848172|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43780255|NCT05393414|Acetaminophen|acetaminophen|mesh-list
43780256|NCT05393414|Ketorolac|ketorolac|mesh-list
43780257|NCT05393414|Morphine|morphine|mesh-list
43780258|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
43780259|NCT05393414|Narcotics|narcotics|mesh-ancestor
43780260|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780261|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780262|NCT05393414|Analgesics|analgesics|mesh-ancestor
43780263|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
43780264|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780304|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
43780305|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43780306|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780307|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780308|NCT05392166|Calcium|calcium|mesh-list
43780309|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43780310|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780311|NCT05392101|Deferasirox|deferasirox|mesh-list
43780312|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43780313|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
43780314|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
43780315|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780316|NCT05392075|Vaccines|vaccines|mesh-list
43780317|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
43780318|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780319|NCT05391867|Sorafenib|sorafenib|mesh-list
43780320|NCT05391867|Lenvatinib|lenvatinib|mesh-list
43780321|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780322|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43780347|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43780348|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43780349|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43780350|NCT05386524|Bevacizumab|bevacizumab|mesh-list
43780351|NCT05386524|Doxorubicin|doxorubicin|mesh-list
43780352|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43780353|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780354|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780355|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43780356|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43780357|NCT05386524|Growth Substances|growth substances|mesh-ancestor
43780358|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780359|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
43780360|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43780361|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43780362|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43780363|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780365|NCT05385562|Triamcinolone|triamcinolone|mesh-list
43780401|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43780402|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43780403|NCT05325502|Mannitol|mannitol|mesh-list
43780409|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839338|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43839340|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
43839341|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780467|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780468|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43780469|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43780470|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780471|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780472|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43780473|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43780474|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43780475|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43780476|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43780477|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
43780478|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
43780479|NCT05022563|Warfarin|warfarin|mesh-list
43780480|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
43780481|NCT05022563|Dabigatran|dabigatran|mesh-list
43780482|NCT05022563|Apixaban|apixaban|mesh-list
43780483|NCT05022563|Anticoagulants|anticoagulants|mesh-list
43780484|NCT05022563|Edoxaban|edoxaban|mesh-list
43780485|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43780486|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
43780487|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43780488|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
43780489|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780492|NCT05005728|Olaparib|olaparib|mesh-list
43780521|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780522|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780523|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
43780524|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43780525|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43780526|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780527|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
43780528|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780529|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839378|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
43839379|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839380|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839381|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
43839382|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839383|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
43839384|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43839385|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839386|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
43839387|NCT04780269|Dinoprostone|dinoprostone|mesh-list
43839388|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
43839389|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43839390|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839391|NCT04779320|Vedolizumab|vedolizumab|mesh-list
43839392|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43780574|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780575|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43780576|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780577|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
43780578|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43780579|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
43780580|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780581|NCT04508634|Metformin|metformin|mesh-list
43780582|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43780583|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780584|NCT04470128|Fentanyl|fentanyl|mesh-list
43780585|NCT04470128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43780586|NCT04470128|Narcotics|narcotics|mesh-ancestor
43780587|NCT04470128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780588|NCT04470128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780589|NCT04470128|Analgesics|analgesics|mesh-ancestor
43780590|NCT04470128|Sensory System Agents|sensory system agents|mesh-ancestor
43780591|NCT04470128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780592|NCT04470128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43780593|NCT04470128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43780594|NCT04470128|Anesthetics, General|anesthetics, general|mesh-ancestor
43780595|NCT04470128|Anesthetics|anesthetics|mesh-ancestor
43780596|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43780597|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
43780598|NCT04351230|Trastuzumab|trastuzumab|mesh-list
43780599|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43780600|NCT04351230|Maytansine|maytansine|mesh-list
43780611|NCT04278092|Paclitaxel|paclitaxel|mesh-list
43780617|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
43780618|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780619|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780620|NCT04262479|Vitamin D|vitamin d|mesh-list
43780621|NCT04262479|Vitamins|vitamins|mesh-ancestor
43780622|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
43780623|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780624|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43780625|NCT04262024|Cabergoline|cabergoline|mesh-list
43780626|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43780681|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780682|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43780683|NCT03909074|Vaccines|vaccines|mesh-list
43780684|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
43780685|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780686|NCT03907540|Belumosudil|belumosudil|mesh-list
43780687|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43780688|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780689|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780690|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
43780691|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43780692|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
43780693|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780694|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
43780695|NCT03906877|Protective Agents|protective agents|mesh-ancestor
43780696|NCT03904108|Ramucirumab|ramucirumab|mesh-list
43780697|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780698|NCT03899961|Oxytocin|oxytocin|mesh-list
43780699|NCT03899961|Carbetocin|carbetocin|mesh-list
43780700|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
43780703|NCT03880539|Vancomycin|vancomycin|mesh-list
43780766|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43780767|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780768|NCT03285763|Atezolizumab|atezolizumab|mesh-list
43780769|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780770|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43780771|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43780772|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
43780773|NCT03196427|Vedolizumab|vedolizumab|mesh-list
43780774|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43780775|NCT03193853|Paclitaxel|paclitaxel|mesh-list
43780776|NCT03193853|Cisplatin|cisplatin|mesh-list
43780777|NCT03193853|Serabelisib|serabelisib|mesh-list
43780778|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43780779|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780780|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
43780847|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780849|NCT02624596|Ketamine|ketamine|mesh-list
43780850|NCT02624596|Analgesics|analgesics|mesh-ancestor
43780851|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
43780852|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780853|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780854|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43780855|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43780856|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
43780857|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
43780858|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780859|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43780860|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43780861|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780862|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780863|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43780864|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43780865|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43780866|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43780867|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43780868|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
43780869|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
43780870|NCT02322099|Alendronate|alendronate|mesh-list
43780894|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780895|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43780897|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
43780898|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780899|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43780900|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43780901|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43780902|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
43780903|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780904|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780906|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
43780907|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780908|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
43780909|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43780914|NCT02037529|Paclitaxel|paclitaxel|mesh-list
43780954|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43780955|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43780956|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780957|NCT01794793|Cabergoline|cabergoline|mesh-list
43780958|NCT01794793|Pasireotide|pasireotide|mesh-list
43780959|NCT01794793|Somatostatin|somatostatin|mesh-list
43780960|NCT01794793|Hormones|hormones|mesh-ancestor
43780961|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43780962|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780963|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43780964|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43780965|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
43780966|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
43780967|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780968|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780969|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
43780970|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43780971|NCT01398319|Ethanol|ethanol|mesh-list
43780972|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43780973|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780974|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780975|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780976|NCT01305889|Sertraline|sertraline|mesh-list
43780977|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
43780978|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43780979|NCT01305889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43780980|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43780981|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43781001|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
43781002|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781003|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
43781004|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43781005|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
43781006|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
43781007|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43839466|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839467|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781023|NCT04406415|Analgesics|analgesics|mesh-ancestor
43781092|NCT03441139|Analgesics|analgesics|mesh-list
43781093|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
43781094|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781095|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781096|NCT03359460|Lenalidomide|lenalidomide|mesh-list
43781097|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
43781098|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781099|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43781100|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43781101|NCT03359460|Growth Substances|growth substances|mesh-ancestor
43781102|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
43781103|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781104|NCT03227263|Bevacizumab|bevacizumab|mesh-list
43781105|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43781106|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781107|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43781121|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781122|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781135|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43781136|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43781137|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43781138|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
43781139|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781141|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43781142|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781202|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781203|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43781204|NCT05087693|Albuterol|albuterol|mesh-list
43781205|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43781206|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
43781207|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781208|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781209|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43781210|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
43781211|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
43781212|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781213|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43781214|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43781215|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43781216|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781217|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781218|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781219|NCT05087368|Vaccines|vaccines|mesh-list
43781220|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
43781221|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839468|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839469|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
43839470|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839480|NCT04770623|Docetaxel|docetaxel|mesh-list
43839499|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43839500|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
43839501|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839502|NCT04767711|Prednisolone|prednisolone|mesh-list
43839503|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839504|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
43839505|NCT04767711|Hormones|hormones|mesh-ancestor
43839506|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839507|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839508|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839509|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839510|NCT04767217|Lumefantrine|lumefantrine|mesh-list
43839511|NCT04767217|Artemether|artemether|mesh-list
43781222|NCT05087134|Choline|choline|mesh-list
43781223|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
43781224|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43781225|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
43781282|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
43781283|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781284|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781285|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43781286|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
43781287|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
43781288|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43781289|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43781290|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43781291|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43781292|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781293|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781294|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781295|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
43781296|NCT05085587|Hormones|hormones|mesh-ancestor
43781297|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781298|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
43781299|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
43781300|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43781301|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43781302|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43781303|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43781304|NCT05085106|Analgesics|analgesics|mesh-ancestor
43781305|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
43781306|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781307|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781308|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781309|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781310|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
43781311|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
43781312|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43781322|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781323|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
43781324|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781325|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
43781326|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43781327|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781328|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781329|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43781331|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
43781332|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781333|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43781334|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43781335|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43781336|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781337|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781338|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781339|NCT05073939|Oxytocin|oxytocin|mesh-list
43781340|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
43781341|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781343|NCT05068206|Bevacizumab|bevacizumab|mesh-list
43781375|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
43781376|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781377|NCT05020392|Vidarabine|vidarabine|mesh-list
43781378|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
43781379|NCT05020392|Fludarabine|fludarabine|mesh-list
43781380|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
43781381|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43781382|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
43781383|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781384|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781385|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43781386|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
43781387|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781388|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781389|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43781390|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43781391|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
43781392|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
43781393|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781394|NCT05013242|Goserelin|goserelin|mesh-list
43781395|NCT05013242|Dienogest|dienogest|mesh-list
43781396|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43781416|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
43781417|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839512|NCT04767217|Piperaquine|piperaquine|mesh-list
43839513|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43839514|NCT04767217|Artenimol|artenimol|mesh-list
43839515|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
43839516|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43839517|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43839518|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839519|NCT04767113|Heparin|heparin|mesh-list
43839520|NCT04767113|Calcium heparin|calcium heparin|mesh-list
43839521|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
43839522|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43839523|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43839524|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839574|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
43848192|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43781454|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43781455|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
43781456|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
43781457|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781458|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781459|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
43781460|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43781461|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781462|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43781463|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781464|NCT04726098|Dexamethasone|dexamethasone|mesh-list
43781593|NCT04405063|Paclitaxel|paclitaxel|mesh-list
43781594|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43781595|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781596|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781597|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781628|NCT04122196|Analgesics|analgesics|mesh-ancestor
43781629|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
43781630|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781631|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781632|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
43781633|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43781634|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43781635|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781636|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43781637|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43781638|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43781639|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781640|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43781642|NCT04021381|Cathartics|cathartics|mesh-ancestor
43781643|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781644|NCT03898154|Dexamethasone|dexamethasone|mesh-list
43781645|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
43781648|NCT03898154|Prednisolone|prednisolone|mesh-list
43781721|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
43781722|NCT03113994|Vitamin D|vitamin d|mesh-list
43781723|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
43781724|NCT03113994|Ubiquinone|ubiquinone|mesh-list
43781725|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
43781726|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43781727|NCT03113994|Calcium|calcium|mesh-list
43781728|NCT03113994|Vitamins|vitamins|mesh-ancestor
43781729|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
43781730|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781731|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43781732|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43781733|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43781734|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43781735|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
43781736|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781737|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43781738|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43781739|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781740|NCT03113994|Antacids|antacids|mesh-ancestor
43781741|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781742|NCT02960568|Primaquine|primaquine|mesh-list
43781743|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
43781745|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43781746|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781747|NCT02864004|Apomorphine|apomorphine|mesh-list
43781752|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781753|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
43781754|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
43781755|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839602|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43839603|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43839604|NCT04757740|Prednisolone|prednisolone|mesh-list
43839605|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
43839606|NCT04757740|Lidocaine|lidocaine|mesh-list
43839607|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43839608|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
43839609|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
43839610|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
43839611|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839612|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839666|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43839667|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43839668|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
43781757|NCT02834403|Aspirin|aspirin|mesh-list
43781758|NCT02834403|Docetaxel|docetaxel|mesh-list
43781759|NCT02834403|Amlodipine|amlodipine|mesh-list
43781760|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
43781761|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781762|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781763|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781764|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781765|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781766|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43781767|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43781768|NCT02834403|Analgesics|analgesics|mesh-ancestor
43781816|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
43781817|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43781818|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43781819|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43781820|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43781821|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781822|NCT05090449|Diuretics|diuretics|mesh-ancestor
43781823|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
43781824|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781825|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43781871|NCT05089383|Hormones|hormones|mesh-ancestor
43781872|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781873|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781874|NCT05089344|Clomiphene|clomiphene|mesh-list
43781875|NCT05089344|Enclomiphene|enclomiphene|mesh-list
43781876|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
43781877|NCT05089344|Hormones|hormones|mesh-list
43781878|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781937|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781938|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781939|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781940|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781941|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43781942|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
43781943|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781944|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
43781945|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43781946|NCT05043077|Phenylephrine|phenylephrine|mesh-list
43781947|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
43781948|NCT05043077|Tropicamide|tropicamide|mesh-list
43781949|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43781950|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
43781951|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
43781952|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781953|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781954|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
43781955|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43781956|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
43781957|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
43781958|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43781969|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43781970|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43781971|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
43781972|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
43781976|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43781977|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
43781978|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781979|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781980|NCT04908592|Dexamethasone|dexamethasone|mesh-list
43781981|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781982|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
43781983|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
43781984|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781985|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848213|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848214|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848215|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
43848216|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43848220|NCT04040439|Analgesics|analgesics|mesh-ancestor
43589121|NCT03382743|Lidocaine|lidocaine|mesh-list
43782045|NCT04536194|Norepinephrine|norepinephrine|mesh-list
43782046|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43782086|NCT04089150|Fluorouracil|fluorouracil|mesh-list
43782087|NCT04089150|Capecitabine|capecitabine|mesh-list
43782088|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
43782089|NCT04089150|Irinotecan|irinotecan|mesh-list
43782090|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43782091|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782092|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
43782093|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
43782094|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
43782095|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782096|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43782097|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
43782098|NCT04089150|Antiviral Agents|antiviral agents|mesh-ancestor
43782099|NCT04089150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782100|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782101|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782102|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
43782103|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782104|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43782105|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43782106|NCT04089150|Antidotes|antidotes|mesh-ancestor
43782107|NCT04089150|Protective Agents|protective agents|mesh-ancestor
43782141|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43782142|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
43782143|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43782144|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43782145|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43782146|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43782147|NCT02339766|Morphine|morphine|mesh-list
43782148|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43782165|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782166|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782167|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
43782168|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43782169|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
43782170|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782171|NCT05091359|Calcium|calcium|mesh-list
43782172|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43589327|NCT03380936|Tacrolimus|tacrolimus|mesh-list
43782222|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782223|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
43782224|NCT05091008|Ledipasvir|ledipasvir|mesh-list
43782225|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43782226|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
43782227|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782228|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
43782229|NCT05090761|Buprenorphine|buprenorphine|mesh-list
43782230|NCT05090761|Bupivacaine|bupivacaine|mesh-list
43782231|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43782232|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
43782233|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
43782234|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782235|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782236|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
43782237|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782238|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43782239|NCT05090761|Narcotics|narcotics|mesh-ancestor
43782240|NCT05090761|Analgesics|analgesics|mesh-ancestor
43782272|NCT05077839|Trifluridine|trifluridine|mesh-list
43782273|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
43782274|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782275|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
43782276|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782277|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
43782278|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43782279|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
43782280|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43782281|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
43782282|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782283|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782284|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
43782285|NCT05077085|Vancomycin|vancomycin|mesh-list
43782286|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43782287|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782332|NCT04710199|Maraviroc|maraviroc|mesh-list
43782333|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43782334|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43782335|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782336|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43782337|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43782338|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
43782339|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782340|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43782364|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782365|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43782366|NCT04526652|Analgesics|analgesics|mesh-ancestor
43782367|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
43782368|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782371|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43782431|NCT03393468|Dapivirine|dapivirine|mesh-list
43782432|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43782433|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43782434|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
43782435|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782436|NCT03073525|Atezolizumab|atezolizumab|mesh-list
43782437|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782438|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43782439|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43782440|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
43782441|NCT02563015|Vitamin D|vitamin d|mesh-list
43782442|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
43782443|NCT02563015|Vitamins|vitamins|mesh-ancestor
43782490|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782491|NCT05093478|Lidocaine|lidocaine|mesh-list
43782492|NCT05093478|Capsaicin|capsaicin|mesh-list
43782493|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
43782494|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
43839795|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
43839796|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43839797|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43839798|NCT04749810|Eculizumab|eculizumab|mesh-list
43839799|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43839800|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43839801|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
43839802|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782514|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
43782515|NCT05092945|Niacinamide|niacinamide|mesh-list
43782516|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43782517|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
43782518|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782519|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43782520|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
43782521|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
43782522|NCT05092945|Vitamins|vitamins|mesh-ancestor
43782523|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
43782524|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782525|NCT05089526|Lidocaine|lidocaine|mesh-list
43782526|NCT05089526|Fentanyl|fentanyl|mesh-list
43782527|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
43782528|NCT05089526|Ketamine|ketamine|mesh-list
43782529|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
43782530|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
43782531|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782532|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782533|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
43782554|NCT05089526|Narcotics|narcotics|mesh-ancestor
43782555|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43782556|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
43782557|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43782558|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782559|NCT05022810|Acetaminophen|acetaminophen|mesh-list
43782560|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43782561|NCT05022810|Analgesics|analgesics|mesh-ancestor
43782562|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
43782563|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782569|NCT04885816|Sirolimus|sirolimus|mesh-list
43782570|NCT04885816|Everolimus|everolimus|mesh-list
43782571|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782572|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782573|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
43782574|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782575|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43782576|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782577|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43782578|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
43782579|NCT04865614|Sevoflurane|sevoflurane|mesh-list
43782580|NCT04865614|Etomidate|etomidate|mesh-list
43782581|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43782582|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43782583|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
43782626|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782627|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43782628|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782629|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782630|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43782631|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43782641|NCT04504240|Famotidine|famotidine|mesh-list
43839810|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43839811|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839812|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839813|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43839814|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
43839815|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839817|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43782731|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
43782732|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782733|NCT03688828|Expectorants|expectorants|mesh-ancestor
43782734|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782735|NCT03643822|Dexamethasone|dexamethasone|mesh-list
43782736|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
43782737|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
43782738|NCT03643822|BB 1101|bb 1101|mesh-list
43782739|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43782740|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
43782741|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
43782742|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782744|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43782779|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782780|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43782781|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
43782782|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43782783|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43782784|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
43782785|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782786|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
43782787|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782788|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43782789|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782790|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
43782791|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782792|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43782794|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782795|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782796|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782797|NCT03329378|Paclitaxel|paclitaxel|mesh-list
43782798|NCT03329378|Docetaxel|docetaxel|mesh-list
43782799|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43782800|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
43782832|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782833|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782834|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
43782835|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43782836|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43782837|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
43782838|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782839|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782840|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782841|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
43782889|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782891|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
43782892|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
43782893|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782894|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782895|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
43782896|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782897|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43782898|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43782899|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43782900|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43839873|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43839874|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
43839875|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43839876|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
43839877|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839878|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43839879|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43782938|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43782939|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
43782940|NCT05095259|Insulin|insulin|mesh-list
43782941|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43782942|NCT05095259|Epinephrine|epinephrine|mesh-list
43782943|NCT05095259|Glucagon|glucagon|mesh-list
43782944|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43782945|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782946|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43782947|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43782948|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
43782949|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782950|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782961|NCT05095259|Hormones|hormones|mesh-ancestor
43783000|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783001|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
43783002|NCT05057481|Rituximab|rituximab|mesh-list
43783003|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783004|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783005|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
43783006|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783007|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43783008|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43783009|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43783010|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
43783011|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43783012|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783013|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783059|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43590308|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
43783060|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
43783061|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783062|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783118|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43783119|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43783120|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
43783121|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
43783122|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
43783123|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783124|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
43783125|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
43783126|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783127|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43783128|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
43783129|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
43783130|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783131|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43783132|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
43783133|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
43783134|NCT03856619|Teriflunomide|teriflunomide|mesh-list
43783175|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
43783176|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783177|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783178|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
43783179|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
43783180|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783181|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
43783182|NCT03636165|Hormones|hormones|mesh-ancestor
43783183|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783184|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43783185|NCT03636165|Protective Agents|protective agents|mesh-ancestor
43783186|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43783187|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783188|NCT03521037|Rucaparib|rucaparib|mesh-list
43783189|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43783190|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783191|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783192|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783193|NCT03422094|Nivolumab|nivolumab|mesh-list
43783194|NCT03422094|Ipilimumab|ipilimumab|mesh-list
43783195|NCT03422094|Poly ICLC|poly iclc|mesh-list
43783196|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783197|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783198|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43783199|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783200|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
43783201|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
43783202|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783203|NCT03046862|Gemcitabine|gemcitabine|mesh-list
43783204|NCT03046862|Cisplatin|cisplatin|mesh-list
43783219|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43783220|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43783221|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783222|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
43783223|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783224|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
43783233|NCT02758431|Hormones|hormones|mesh-ancestor
43783234|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783235|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783236|NCT02758431|Androgens|androgens|mesh-ancestor
43783237|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43783238|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783239|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
43783240|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43783241|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783273|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783275|NCT05097911|Bevacizumab|bevacizumab|mesh-list
43783276|NCT05097911|Atezolizumab|atezolizumab|mesh-list
43783277|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783278|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783279|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43783280|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43783281|NCT05097911|Growth Substances|growth substances|mesh-ancestor
43783282|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783283|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
43783284|NCT05097781|Antibodies|antibodies|mesh-list
43783285|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
43783286|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
43783287|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783288|NCT05097508|Bromides|bromides|mesh-list
43783289|NCT05097508|Rocuronium|rocuronium|mesh-list
43783290|NCT05097508|Atracurium|atracurium|mesh-list
43783291|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
43783292|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43783293|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43783294|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43783295|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783296|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783297|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43783298|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43783302|NCT05097365|Folic Acid|folic acid|mesh-list
43783323|NCT05097209|Gemcitabine|gemcitabine|mesh-list
43783324|NCT05097209|Cisplatin|cisplatin|mesh-list
43783325|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783326|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43783327|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
43783328|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783329|NCT05097209|Antiviral Agents|antiviral agents|mesh-ancestor
43783330|NCT05097209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783331|NCT05097209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783332|NCT05097209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43783333|NCT05097209|Immunologic Factors|immunologic factors|mesh-ancestor
43783386|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43783387|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783388|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783389|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43783391|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
43783392|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43783393|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783394|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783395|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783396|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43783397|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
43783398|NCT04912791|Anesthetics|anesthetics|mesh-list
43783399|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783400|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783401|NCT04908293|Listerine|listerine|mesh-list
43783402|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
43783403|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
43783404|NCT04908293|Protective Agents|protective agents|mesh-ancestor
43783405|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839929|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
43839930|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839931|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839932|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839933|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43839934|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43839935|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839936|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
43839937|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43839938|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
43839939|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839940|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43839941|NCT04740697|Tamoxifen|tamoxifen|mesh-list
43839942|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43839943|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
43839944|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839945|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839946|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839947|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839948|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43839949|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43839950|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43839951|NCT04740593|Methamphetamine|methamphetamine|mesh-list
43839952|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43839953|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839959|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783415|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
43783416|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783417|NCT04796636|Protective Agents|protective agents|mesh-ancestor
43783448|NCT04523935|Diazepam|diazepam|mesh-list
43783449|NCT04523935|Gabapentin|gabapentin|mesh-list
43783450|NCT04523935|Amitriptyline|amitriptyline|mesh-list
43783451|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
43783452|NCT04523935|Clonazepam|clonazepam|mesh-list
43783453|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
43783454|NCT04523935|Baclofen|baclofen|mesh-list
43783455|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
43783456|NCT04523935|Analgesics|analgesics|mesh-ancestor
43783457|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
43783509|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43783510|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43783511|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783512|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783513|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783514|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43783515|NCT04389775|Glucagon|glucagon|mesh-list
43783516|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43783517|NCT04389775|Incretins|incretins|mesh-ancestor
43783518|NCT04389775|Hormones|hormones|mesh-ancestor
43783522|NCT04345887|Spironolactone|spironolactone|mesh-list
43839990|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43839991|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
43839992|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
43839993|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839994|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839995|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
43839996|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
43839997|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839998|NCT04735354|Valsartan|valsartan|mesh-list
43783600|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783601|NCT03847181|Vitamin K|vitamin k|mesh-list
43783602|NCT03847181|Warfarin|warfarin|mesh-list
43783603|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
43783604|NCT03847181|Apixaban|apixaban|mesh-list
43783605|NCT03847181|Anticoagulants|anticoagulants|mesh-list
43783606|NCT03847181|Vitamins|vitamins|mesh-ancestor
43783607|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
43783608|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783609|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43783610|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
43783611|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43783612|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
43783613|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783614|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783615|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43783616|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43783617|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
43783618|NCT03847181|Coagulants|coagulants|mesh-ancestor
43783619|NCT03608436|Bromides|bromides|mesh-list
43783620|NCT03608436|Rocuronium|rocuronium|mesh-list
43783621|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
43783622|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43783643|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783644|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43783645|NCT03412188|Protective Agents|protective agents|mesh-ancestor
43783646|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43783648|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43783649|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43783650|NCT03079999|Analgesics|analgesics|mesh-ancestor
43783651|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
43783652|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783653|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783654|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783655|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43783656|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43783657|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43783658|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783659|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43783660|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43783661|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783662|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
43783663|NCT02958709|Rifampin|rifampin|mesh-list
43783664|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43783665|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
43783666|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43783667|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783668|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
43783684|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43783700|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783701|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
43783702|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783707|NCT02595060|Molgramostim|molgramostim|mesh-list
43783710|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
43783711|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783724|NCT05101005|Sirolimus|sirolimus|mesh-list
43783725|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43783726|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783727|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43783728|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783729|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
43783730|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43783731|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
43783732|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840006|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840007|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43840008|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43840009|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840010|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840011|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43840026|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840027|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
43840028|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840029|NCT04732208|Mydriatics|mydriatics|mesh-list
43840030|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
43591134|NCT03364998|Factor VIII|factor viii|mesh-list
43783734|NCT05100719|Simethicone|simethicone|mesh-list
43783735|NCT05100719|Citric Acid|citric acid|mesh-list
43783736|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
43783737|NCT05100719|Alverine|alverine|mesh-list
43783738|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
43783739|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43783740|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
43783741|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
43783742|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783789|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783790|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43783791|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43783792|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783793|NCT05100186|Dexamethasone|dexamethasone|mesh-list
43783794|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783795|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
43783796|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
43783797|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783798|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783799|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783800|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
43783801|NCT05100186|Hormones|hormones|mesh-ancestor
43783802|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783803|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43783804|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783841|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43783842|NCT05092165|Methylene Blue|methylene blue|mesh-list
43783843|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783844|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783846|NCT05092152|Esketamine|esketamine|mesh-list
43783847|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43783848|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783849|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783850|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43783851|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
43783852|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
43783855|NCT05087615|Ondansetron|ondansetron|mesh-list
43783892|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
43783893|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783895|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
43783896|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783897|NCT04730232|Paclitaxel|paclitaxel|mesh-list
43783898|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43783899|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783900|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
43783901|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
43783915|NCT04602117|Paclitaxel|paclitaxel|mesh-list
43783919|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783920|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
43783921|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
43783922|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
43783923|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783924|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783925|NCT04540848|Bupivacaine|bupivacaine|mesh-list
43783926|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
43783927|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
43783928|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783929|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783930|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
43783931|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783932|NCT04531592|Valproic Acid|valproic acid|mesh-list
43783933|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
43783934|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783935|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783936|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
43783937|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783938|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783939|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
43783940|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43783941|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783942|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43783943|NCT04531579|Valproic Acid|valproic acid|mesh-list
43783944|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43783945|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
43783946|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783947|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783949|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783950|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783951|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
43783952|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43783953|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783958|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783959|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783960|NCT04510584|Bevacizumab|bevacizumab|mesh-list
43783961|NCT04510584|Atezolizumab|atezolizumab|mesh-list
43783962|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783963|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783964|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43783965|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43783966|NCT04510584|Growth Substances|growth substances|mesh-ancestor
43783967|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783968|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
43783970|NCT04379024|Estrogens|estrogens|mesh-list
43783971|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43783972|NCT04379024|Hormones|hormones|mesh-ancestor
43783973|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783974|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783975|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43783976|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43783977|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
43783978|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43783979|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43783980|NCT04272008|Estradiol|estradiol|mesh-list
43783981|NCT04272008|Estrogens|estrogens|mesh-ancestor
43783982|NCT04272008|Hormones|hormones|mesh-ancestor
43783983|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783984|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783985|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43783986|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
43783987|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43783988|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43840031|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840032|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840033|NCT04732065|Dopamine|dopamine|mesh-list
43840034|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43840035|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
43840036|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
43840037|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840038|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840039|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
43840040|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840041|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840042|NCT04732065|Protective Agents|protective agents|mesh-ancestor
43840043|NCT04731558|Enoxaparin|enoxaparin|mesh-list
43840044|NCT04731558|Dalteparin|dalteparin|mesh-list
43840045|NCT04731558|Tinzaparin|tinzaparin|mesh-list
43840046|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43840047|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
43840048|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43784019|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784020|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784021|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43784022|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
43784023|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784024|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
43784025|NCT03237819|Analgesics|analgesics|mesh-ancestor
43784026|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
43784027|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784028|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784029|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
43784030|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784031|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43784032|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
43784033|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43784034|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43784035|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784036|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43784037|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
43784038|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43784039|NCT03139916|Temozolomide|temozolomide|mesh-list
43784040|NCT03139916|Bavituximab|bavituximab|mesh-list
43784041|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43784042|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
43784043|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784044|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784045|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784046|NCT02951130|Milrinone|milrinone|mesh-list
43784047|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43784086|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784087|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784088|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43784089|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
43784090|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
43784091|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43784092|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
43784093|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784094|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784095|NCT05102448|Methotrexate|methotrexate|mesh-list
43784096|NCT05102448|Tofacitinib|tofacitinib|mesh-list
43784097|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43784137|NCT05102396|Renal Agents|renal agents|mesh-ancestor
43784138|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
43784139|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43784140|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784141|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784142|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43784143|NCT05102058|Analgesics|analgesics|mesh-ancestor
43784144|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
43784145|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784146|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43784199|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43784200|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
43784201|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43784202|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
43784203|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
43784204|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
43784205|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43784206|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
43784207|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43784208|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784209|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43784210|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
43784211|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43784212|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784213|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784214|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784274|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784275|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
43784276|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43784277|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43784278|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43784279|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43784280|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43784281|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43784282|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43784283|NCT04560634|Norepinephrine|norepinephrine|mesh-list
43784284|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43784290|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
43784335|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840088|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43784346|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43784347|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784348|NCT03383224|Nicotine|nicotine|mesh-list
43784350|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
43784351|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784352|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784353|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43784354|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43784355|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
43784356|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784357|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784358|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
43784359|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784360|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
43784361|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43784362|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43784363|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784364|NCT03229512|Urological Agents|urological agents|mesh-ancestor
43784365|NCT03033914|Doxorubicin|doxorubicin|mesh-list
43784366|NCT03033914|Bleomycin|bleomycin|mesh-list
43784367|NCT03033914|Nivolumab|nivolumab|mesh-list
43784368|NCT03033914|Dacarbazine|dacarbazine|mesh-list
43784369|NCT03033914|Vinblastine|vinblastine|mesh-list
43784370|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43784371|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784372|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43784373|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43784374|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784375|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784376|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784377|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43784378|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43784384|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
43784385|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
43784386|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43784387|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43784388|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784389|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784390|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784391|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784393|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43784404|NCT02733614|SRX246|srx246|mesh-list
43784443|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784512|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
43784513|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784514|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43784515|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784516|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43784517|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784518|NCT05103098|Misoprostol|misoprostol|mesh-list
43784519|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43784520|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
43784521|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43784522|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784523|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43784524|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43784525|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
43784526|NCT05103020|Bevacizumab|bevacizumab|mesh-list
43784527|NCT05103020|Cetuximab|cetuximab|mesh-list
43784528|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
43784529|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784530|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784531|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43784532|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43784533|NCT05103020|Growth Substances|growth substances|mesh-ancestor
43784534|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784535|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
43784536|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
43784537|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43784538|NCT05103007|Estrogens|estrogens|mesh-ancestor
43784539|NCT05103007|Hormones|hormones|mesh-ancestor
43784540|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784549|NCT05092555|Coagulants|coagulants|mesh-ancestor
43784550|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
43784551|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43784552|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43784553|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784554|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
43784555|NCT05087199|Coagulants|coagulants|mesh-ancestor
43784557|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43784558|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784559|NCT05048134|Trametinib|trametinib|mesh-list
43784560|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784561|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43784562|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784564|NCT05019846|Bicalutamide|bicalutamide|mesh-list
43784585|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43784586|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784587|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784588|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43784589|NCT04976374|Analgesics|analgesics|mesh-ancestor
43784590|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
43784591|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784592|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43784903|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784593|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43784594|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43784595|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
43784596|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784597|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784598|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
43784599|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43784600|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43784601|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43784602|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43784603|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43784604|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
43639267|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
43639268|NCT03428958|Irinotecan|irinotecan|mesh-list
43639269|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
43639270|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639271|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639272|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43639273|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43639275|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639276|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
43639277|NCT03428958|Antidotes|antidotes|mesh-ancestor
43639278|NCT03428958|Protective Agents|protective agents|mesh-ancestor
43639279|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
43639280|NCT03428958|Vitamins|vitamins|mesh-ancestor
43639281|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
43639282|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43639283|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43784606|NCT04949412|Vitamins|vitamins|mesh-ancestor
43784607|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
43784608|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784609|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43840133|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
43840134|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840135|NCT04730037|Warfarin|warfarin|mesh-list
43840136|NCT04730037|Edoxaban|edoxaban|mesh-list
43840137|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
43840138|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43840139|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
43840140|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43840141|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
43840142|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840143|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840148|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
43840149|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840150|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840151|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43840152|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
43840153|NCT04729114|Hormones|hormones|mesh-ancestor
43840154|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840155|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43840156|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840157|NCT04729023|Temazepam|temazepam|mesh-list
43784610|NCT04834063|Selenium|selenium|mesh-list
43784611|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
43784612|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784613|NCT04834063|Protective Agents|protective agents|mesh-ancestor
43784614|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784615|NCT04834063|Trace Elements|trace elements|mesh-ancestor
43784616|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
43784617|NCT04794205|Caryophyllene|caryophyllene|mesh-list
43784618|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43784657|NCT04655222|Interferon-beta|interferon-beta|mesh-list
43784658|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784659|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
43784660|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784661|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
43784662|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784664|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43784665|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43784666|NCT04552327|Analgesics|analgesics|mesh-ancestor
43784667|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
43784668|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784669|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639284|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639285|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639286|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
43639287|NCT03426891|Temozolomide|temozolomide|mesh-list
43639288|NCT03426891|Vorinostat|vorinostat|mesh-list
43639289|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43694300|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
43694301|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694302|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694304|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43694305|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43694306|NCT02769169|Growth Substances|growth substances|mesh-ancestor
43694307|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694308|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
43694309|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694311|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43694312|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43694313|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43694314|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694315|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
43639290|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639291|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639292|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43639293|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
43639294|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639295|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639296|NCT03422822|Abrocitinib|abrocitinib|mesh-list
43639297|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43639315|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43639317|NCT03414684|Nivolumab|nivolumab|mesh-list
43639318|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639319|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639320|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43639321|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639323|NCT03414658|Avelumab|avelumab|mesh-list
43639324|NCT03414658|Vinorelbine|vinorelbine|mesh-list
43639325|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784670|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43784671|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784672|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43784673|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784674|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784675|NCT04519905|Paclitaxel|paclitaxel|mesh-list
43784716|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784717|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
43784718|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
43784719|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784720|NCT04279535|Protective Agents|protective agents|mesh-ancestor
43784721|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784722|NCT04279535|Vitamins|vitamins|mesh-ancestor
43784723|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
43784724|NCT04150770|Infliximab|infliximab|mesh-list
43784725|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
43784726|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43784771|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784772|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43784773|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784774|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43784775|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784776|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
43784778|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43784779|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784780|NCT05106400|Lidocaine|lidocaine|mesh-list
43784781|NCT05106400|Menthol|menthol|mesh-list
43784782|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
43784783|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
43784784|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784785|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784786|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
43784787|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784788|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43840176|NCT04726592|Ketoprofen|ketoprofen|mesh-list
43840177|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
43784810|NCT05106023|Temozolomide|temozolomide|mesh-list
43784811|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43784812|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
43784813|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784814|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784815|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
43784816|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43784817|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43784818|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784819|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43784820|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784821|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
43784822|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784823|NCT05105412|Gemcitabine|gemcitabine|mesh-list
43784824|NCT05105412|Lenalidomide|lenalidomide|mesh-list
43784825|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43784826|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
43784827|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784828|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784860|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639326|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639327|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43639328|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
43639329|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
43639330|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
43639331|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639332|NCT03399552|Avelumab|avelumab|mesh-list
43639333|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639334|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694316|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43694317|NCT02768961|Ledipasvir|ledipasvir|mesh-list
43694318|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
43694319|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694320|NCT02769013|Praziquantel|praziquantel|mesh-list
43694321|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
43694322|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43694323|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694324|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
43694325|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43694326|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694327|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694328|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694329|NCT02768688|Analgesics|analgesics|mesh-ancestor
43694330|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
43694331|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784861|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43784862|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
43784863|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
43784864|NCT05105009|Furosemide|furosemide|mesh-list
43784865|NCT05105009|Diuretics|diuretics|mesh-ancestor
43784866|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
43784867|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784868|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43784869|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43784870|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784871|NCT05104931|Piroxicam|piroxicam|mesh-list
43784872|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43784873|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43784874|NCT05104931|Analgesics|analgesics|mesh-ancestor
43784875|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
43784876|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784877|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784878|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43784879|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784880|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43784881|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784882|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784883|NCT05104788|Cisplatin|cisplatin|mesh-list
43784885|NCT05104788|Pemetrexed|pemetrexed|mesh-list
43784886|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694332|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43694333|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43694334|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43694335|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694336|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694337|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694338|NCT02768805|Vaccines|vaccines|mesh-list
43694339|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
43694340|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694341|NCT02768649|Risperidone|risperidone|mesh-list
43694342|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43694343|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
43694344|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694345|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694346|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694347|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43694348|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43639335|NCT03388632|Nivolumab|nivolumab|mesh-list
43639336|NCT03388632|Ipilimumab|ipilimumab|mesh-list
43784887|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784888|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784889|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43784890|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43784891|NCT05104437|Vaccines|vaccines|mesh-list
43784892|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
43784893|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784901|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784902|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43784917|NCT05076786|Cisplatin|cisplatin|mesh-list
43784918|NCT05076786|Carboplatin|carboplatin|mesh-list
43784919|NCT05076786|Etoposide|etoposide|mesh-list
43784920|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784921|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43784922|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43784923|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43784924|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784925|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784926|NCT05068752|Sorafenib|sorafenib|mesh-list
43784927|NCT05068752|Vemurafenib|vemurafenib|mesh-list
43784928|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784929|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43784931|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784932|NCT04777422|Defibrotide|defibrotide|mesh-list
43784933|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43784934|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43784935|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784936|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43784937|NCT04642950|Sargramostim|sargramostim|mesh-list
43784938|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
43840178|NCT04726592|Metoclopramide|metoclopramide|mesh-list
43840205|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43840206|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43840207|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840208|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840209|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639337|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639338|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639339|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43694349|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694350|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43694351|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43694352|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
43694353|NCT02768545|Ezetimibe|ezetimibe|mesh-list
43694354|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43694355|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43694356|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
43694357|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694358|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43694359|NCT02768532|Vedolizumab|vedolizumab|mesh-list
43694360|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694361|NCT02768519|OTS167|ots167|mesh-list
43694362|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43694363|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694364|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694365|NCT02769078|Warfarin|warfarin|mesh-list
43694366|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
43694367|NCT02769078|Dabigatran|dabigatran|mesh-list
43694368|NCT02769078|Apixaban|apixaban|mesh-list
43694369|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
43694370|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43694371|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
43694372|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43694373|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
43694374|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694375|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694376|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
43694377|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43694378|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694379|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43848261|NCT04037254|Niraparib|niraparib|mesh-list
43848262|NCT04037254|Hormones|hormones|mesh-list
43848263|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43848264|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43848265|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848266|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848267|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43694380|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43694381|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43639340|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639341|NCT03386929|Palbociclib|palbociclib|mesh-list
43639342|NCT03386929|Avelumab|avelumab|mesh-list
43639343|NCT03386929|Axitinib|axitinib|mesh-list
43639344|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639354|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
43639355|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694382|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694384|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694385|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
43694386|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43694387|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694388|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694389|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694390|NCT02768610|Analgesics|analgesics|mesh-ancestor
43694391|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
43694411|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694412|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43694413|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
43694414|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
43694421|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694422|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694424|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43694425|NCT02768571|Protective Agents|protective agents|mesh-ancestor
43694426|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694427|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
43694428|NCT02768376|Fentanyl|fentanyl|mesh-list
43694429|NCT02768376|Bupivacaine|bupivacaine|mesh-list
43694430|NCT02768376|Anesthetics|anesthetics|mesh-list
43694431|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
43694432|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694433|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694434|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
43694435|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694437|NCT02768376|Narcotics|narcotics|mesh-ancestor
43694438|NCT02768376|Analgesics|analgesics|mesh-ancestor
43848268|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848269|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848270|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848271|NCT04037176|Omalizumab|omalizumab|mesh-list
43848272|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43848273|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43848274|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
43784944|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
43784945|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43784946|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43784947|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784954|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784955|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43784957|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
43784958|NCT04434001|Coagulants|coagulants|mesh-ancestor
43784960|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
43784961|NCT04426591|Vitamins|vitamins|mesh-ancestor
43784962|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
43784963|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784964|NCT04374240|Tretazicar|tretazicar|mesh-list
43784965|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784966|NCT04230746|Trimethoprim|trimethoprim|mesh-list
43784967|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43784968|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
43784969|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43784970|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784972|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
43784973|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43784974|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43784975|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43784976|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784978|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43694439|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43694440|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43694441|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
43694442|NCT02768363|Valacyclovir|valacyclovir|mesh-list
43694443|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
43694444|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694445|NCT02768077|Melatonin|melatonin|mesh-list
43694446|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
43694447|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694448|NCT02768077|Protective Agents|protective agents|mesh-ancestor
43694449|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694450|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784986|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784987|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43784988|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43784989|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43784990|NCT03691311|Denosumab|denosumab|mesh-list
43784991|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43784992|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784993|NCT03690453|Ivermectin|ivermectin|mesh-list
43784994|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43784995|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784996|NCT03572413|Bromides|bromides|mesh-list
43784997|NCT03572413|Rocuronium|rocuronium|mesh-list
43784998|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
43784999|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43639366|NCT03361306|Elotuzumab|elotuzumab|mesh-list
43639367|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639368|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43639369|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
43639370|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43639371|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
43639372|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639374|NCT03347708|Protective Agents|protective agents|mesh-ancestor
43639375|NCT03341689|Psilocybin|psilocybin|mesh-list
43639376|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
43639377|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639378|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43639379|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
43639380|NCT03333486|Fludarabine|fludarabine|mesh-list
43694451|NCT02768389|Bevacizumab|bevacizumab|mesh-list
43694452|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785000|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43785001|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43785002|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785003|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785004|NCT03219775|Nivolumab|nivolumab|mesh-list
43785005|NCT03219775|Ipilimumab|ipilimumab|mesh-list
43592637|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
43785006|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785007|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785010|NCT03164564|Tenofovir|tenofovir|mesh-list
43785027|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43785028|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43785029|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785030|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785032|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
43785033|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43785034|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
43694453|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694488|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694490|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694491|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
43694492|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694493|NCT02767999|Fluoxetine|fluoxetine|mesh-list
43694494|NCT02767999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43694495|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43694496|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43694497|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694498|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694499|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
43694500|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694501|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43694502|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
43694503|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43694504|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43694505|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43694506|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829719|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829720|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
43829721|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43829753|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43829754|NCT05408559|Protective Agents|protective agents|mesh-ancestor
43829755|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829756|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639381|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
43639382|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694523|NCT02767635|Triamcinolone|triamcinolone|mesh-list
43694524|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43694525|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43694526|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43694527|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43694528|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43694529|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43694530|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694531|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694532|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43694533|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43694534|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694535|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
43639383|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
43700114|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
43785035|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
43785036|NCT02660281|Melphalan|melphalan|mesh-list
43785037|NCT02660281|Busulfan|busulfan|mesh-list
43785038|NCT02660281|Thiotepa|thiotepa|mesh-list
43785039|NCT02660281|Fludarabine|fludarabine|mesh-list
43785040|NCT02660281|Mesna|mesna|mesh-list
43785041|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43785042|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
43785043|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785044|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785045|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43785046|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
43785047|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639384|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639385|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639386|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43639388|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639389|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639390|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43639391|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43639392|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
43639393|NCT03315026|Siltuximab|siltuximab|mesh-list
43639394|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639396|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639397|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43639398|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639399|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639400|NCT03312400|Danazol|danazol|mesh-list
43639403|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639404|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639406|NCT03299049|Cabotegravir|cabotegravir|mesh-list
43639407|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43639408|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43639409|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639410|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639411|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
43639412|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639413|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43639414|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43639415|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43639416|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43639417|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
43639418|NCT03290079|Lenvatinib|lenvatinib|mesh-list
43639419|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639420|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639421|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43694536|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785048|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785049|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43694537|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694538|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
43694539|NCT02767635|Hormones|hormones|mesh-ancestor
43694540|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694541|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694542|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
43694543|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694544|NCT02767596|Lixisenatide|lixisenatide|mesh-list
43694545|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43694546|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694547|NCT02767752|Gemcitabine|gemcitabine|mesh-list
43694548|NCT02767752|Capecitabine|capecitabine|mesh-list
43694549|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43694550|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
43694551|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694552|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694553|NCT02767752|Antiviral Agents|antiviral agents|mesh-ancestor
43694554|NCT02767752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694555|NCT02767752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639423|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639424|NCT03284957|Everolimus|everolimus|mesh-list
43639425|NCT03284957|Palbociclib|palbociclib|mesh-list
43639426|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639427|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639428|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
43639429|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639430|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43785050|NCT02660281|Protective Agents|protective agents|mesh-ancestor
43785051|NCT02571530|Trastuzumab|trastuzumab|mesh-list
43785052|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785053|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785054|NCT02438995|Cetuximab|cetuximab|mesh-list
43785055|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785056|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785057|NCT05108389|Hemostatics|hemostatics|mesh-list
43785058|NCT05108389|Coagulants|coagulants|mesh-ancestor
43785059|NCT05108350|Metformin|metformin|mesh-list
43785060|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43785061|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785062|NCT05108220|Cannabidiol|cannabidiol|mesh-list
43785070|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43785071|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43785072|NCT05107921|Analgesics|analgesics|mesh-ancestor
43785073|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
43785074|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639431|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639432|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639433|NCT03283878|Cefazolin|cefazolin|mesh-list
43639434|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43639435|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639436|NCT03258593|Durvalumab|durvalumab|mesh-list
43639437|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639438|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639439|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43639440|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
43639441|NCT03255174|Coagulants|coagulants|mesh-ancestor
43639442|NCT03252600|Dexamethasone|dexamethasone|mesh-list
43639443|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
43639444|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
43639445|NCT03252600|Lenalidomide|lenalidomide|mesh-list
43639447|NCT03252600|Ichthammol|ichthammol|mesh-list
43639448|NCT03252600|BB 1101|bb 1101|mesh-list
43639449|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694557|NCT02767752|Immunologic Factors|immunologic factors|mesh-ancestor
43694558|NCT02767752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694559|NCT02767713|Dexamethasone|dexamethasone|mesh-list
43694560|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694561|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
43694562|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
43694563|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694564|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694565|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694566|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
43694567|NCT02767713|Hormones|hormones|mesh-ancestor
43700115|NCT02733458|Antiviral Agents|antiviral agents|mesh-ancestor
43785075|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785076|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43785077|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785078|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43785079|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43785080|NCT05107375|Vaccines|vaccines|mesh-list
43785081|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
43785082|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785083|NCT05107063|Pravastatin|pravastatin|mesh-list
43785084|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43785085|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43785086|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
43785087|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785088|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43840210|NCT04725201|Heparin|heparin|mesh-list
43785089|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43785090|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840211|NCT04725201|Calcium heparin|calcium heparin|mesh-list
43840212|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
43840213|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43840214|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43694568|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694569|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43694570|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694571|NCT02767674|Gemcitabine|gemcitabine|mesh-list
43694572|NCT02767674|Prednisone|prednisone|mesh-list
43694573|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
43694574|NCT02767674|Rituximab|rituximab|mesh-list
43694575|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
43694576|NCT02767674|Epirubicin|epirubicin|mesh-list
43694577|NCT02767674|Vindesine|vindesine|mesh-list
43694578|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694579|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
43694580|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694581|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694604|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
43694605|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
43694606|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43694607|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43694608|NCT02767245|Thiamine|thiamine|mesh-list
43840215|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840216|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
43840217|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
43840218|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
43840219|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840220|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840221|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43840222|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43840223|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
43840224|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
43840227|NCT04724629|Aldesleukin|aldesleukin|mesh-list
43840228|NCT04724629|Colchicine|colchicine|mesh-list
43840229|NCT04724629|Ixekizumab|ixekizumab|mesh-list
43840230|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840231|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43840232|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43840233|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
43840234|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840235|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
43840236|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840237|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
43840238|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
43840239|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
43840240|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840241|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
43840242|NCT04723862|Spironolactone|spironolactone|mesh-list
43840243|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43840244|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
43840245|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840246|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840247|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43840248|NCT04723862|Diuretics|diuretics|mesh-ancestor
43840249|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
43840250|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
43840251|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43840252|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43840253|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
43840281|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840282|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840283|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
43694609|NCT02767245|Vitamins|vitamins|mesh-ancestor
43694610|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
43694611|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694612|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
43694613|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43694614|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43694615|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43694616|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
43694617|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694618|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43694619|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43694620|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694621|NCT02767375|Fluorouracil|fluorouracil|mesh-list
43694622|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
43694623|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
43694624|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694625|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43694626|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694627|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694628|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
43694629|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694630|NCT02767362|Atorvastatin|atorvastatin|mesh-list
43694631|NCT02767362|Ezetimibe|ezetimibe|mesh-list
43694632|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43639450|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
43639452|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694645|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43694646|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694647|NCT02767401|Analgesics|analgesics|mesh-ancestor
43694648|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
43639526|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43639527|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
43639528|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639529|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639530|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639531|NCT03206073|Durvalumab|durvalumab|mesh-list
43639532|NCT03206073|Tremelimumab|tremelimumab|mesh-list
43639533|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639534|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639535|NCT03199885|Paclitaxel|paclitaxel|mesh-list
43639536|NCT03199885|Docetaxel|docetaxel|mesh-list
43639537|NCT03199885|Trastuzumab|trastuzumab|mesh-list
43639538|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43639539|NCT03199885|Atezolizumab|atezolizumab|mesh-list
43639540|NCT03199885|Pertuzumab|pertuzumab|mesh-list
43639541|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43639542|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43639543|NCT03199885|Antibodies|antibodies|mesh-list
43639544|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
43639545|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43639551|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639554|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
43694709|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694710|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694711|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43694712|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694713|NCT02767219|Dexamethasone|dexamethasone|mesh-list
43694714|NCT02767219|Bevacizumab|bevacizumab|mesh-list
43694715|NCT02767219|Fluorouracil|fluorouracil|mesh-list
43694716|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43694717|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694718|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43694719|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43694720|NCT02767219|Growth Substances|growth substances|mesh-ancestor
43694721|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694722|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
43694723|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694724|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
43694725|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
43694726|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694727|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694728|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
43694729|NCT02767219|Hormones|hormones|mesh-ancestor
43639556|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
43639557|NCT03192397|Melphalan|melphalan|mesh-list
43639558|NCT03192397|Fludarabine|fludarabine|mesh-list
43639559|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
43639560|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639561|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
43639562|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639563|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694730|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592778|NCT03349619|Resveratrol|resveratrol|mesh-list
43785091|NCT05106803|Amoxicillin|amoxicillin|mesh-list
43785092|NCT05106803|Vancomycin|vancomycin|mesh-list
43785093|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
43785094|NCT05106803|Clindamycin|clindamycin|mesh-list
43785095|NCT05106803|Gentamicins|gentamicins|mesh-list
43785096|NCT05106803|Tetracycline|tetracycline|mesh-list
43785097|NCT05106803|Penicillins|penicillins|mesh-list
43785098|NCT05106803|Erythromycin|erythromycin|mesh-list
43785099|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
43785100|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
43785101|NCT05106803|Ampicillin|ampicillin|mesh-list
43785102|NCT05106803|Cefepime|cefepime|mesh-list
43785103|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43785104|NCT05106803|Norfloxacin|norfloxacin|mesh-list
43785105|NCT05106803|Oxacillin|oxacillin|mesh-list
43694732|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
43694733|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694734|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43694735|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694736|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
43694737|NCT02767076|Anesthetics|anesthetics|mesh-list
43694738|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694739|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694740|NCT02767063|Pioglitazone|pioglitazone|mesh-list
43694741|NCT02767063|Avelumab|avelumab|mesh-list
43694742|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43694743|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694744|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43694745|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694746|NCT02766764|Hormones|hormones|mesh-list
43700117|NCT02733458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43785106|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
43785107|NCT05106803|Trimethoprim|trimethoprim|mesh-list
43785127|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785128|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43785129|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
43785130|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43785131|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
43785132|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785133|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
43785134|NCT05106751|Protective Agents|protective agents|mesh-ancestor
43785135|NCT05106712|Vitamin D|vitamin d|mesh-list
43785136|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
43785137|NCT05106712|Letrozole|letrozole|mesh-list
43785138|NCT05106712|Clomiphene|clomiphene|mesh-list
43785139|NCT05106712|Enclomiphene|enclomiphene|mesh-list
43785140|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
43785141|NCT05106712|Vitamins|vitamins|mesh-ancestor
43785142|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
43785143|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785144|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43785145|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785227|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
43785228|NCT04537286|Paclitaxel|paclitaxel|mesh-list
43785229|NCT04537286|Cisplatin|cisplatin|mesh-list
43785230|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43785231|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785232|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
43785233|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
43785234|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
43694747|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694748|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694749|NCT02766855|Cysteamine|cysteamine|mesh-list
43694750|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
43694751|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694752|NCT02767024|Nitroprusside|nitroprusside|mesh-list
43694753|NCT02767024|Dobutamine|dobutamine|mesh-list
43694754|NCT02767024|Furosemide|furosemide|mesh-list
43639564|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43639565|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
43639566|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639567|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639568|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43639569|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43785235|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785236|NCT04486625|Aztreonam|aztreonam|mesh-list
43785237|NCT04486625|Avibactam|avibactam|mesh-list
43785238|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43785239|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785240|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43785241|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785271|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43785272|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43785273|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
43785274|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785275|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785276|NCT03701711|Lenalidomide|lenalidomide|mesh-list
43785277|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
43785278|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785279|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43785280|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43785281|NCT03701711|Growth Substances|growth substances|mesh-ancestor
43785282|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
43785283|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785284|NCT03596073|Calcipotriene|calcipotriene|mesh-list
43785285|NCT03596073|Petrolatum|petrolatum|mesh-list
43785286|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
43785287|NCT03596073|Emollients|emollients|mesh-ancestor
43785288|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43785294|NCT03579914|Metoprolol|metoprolol|mesh-list
43785328|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43785329|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43785330|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43785331|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43785332|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
43785334|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
43785335|NCT03198559|Vorinostat|vorinostat|mesh-list
43785336|NCT03198559|Disulfiram|disulfiram|mesh-list
43785337|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785338|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43785339|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785340|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840340|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593090|NCT03347370|Interferons|interferons|mesh-list
43840341|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840342|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840343|NCT04711109|Denosumab|denosumab|mesh-list
43840344|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43785343|NCT03179943|Atezolizumab|atezolizumab|mesh-list
43785344|NCT03179943|Guadecitabine|guadecitabine|mesh-list
43785345|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639570|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
43639571|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43639572|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43639573|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
43639574|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43639575|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639576|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639577|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
43639578|NCT03190941|Aldesleukin|aldesleukin|mesh-list
43639579|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
43639580|NCT03190941|Fludarabine|fludarabine|mesh-list
43639581|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639582|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
43639583|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639584|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639585|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43694756|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
43694757|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694758|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43694759|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43694760|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694761|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43694762|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
43694763|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
43694764|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694765|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43694766|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43694767|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43785346|NCT03129113|Metformin|metformin|mesh-list
43785347|NCT03129113|Maraviroc|maraviroc|mesh-list
43785348|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43785349|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785350|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43785351|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43785352|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785353|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43785354|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43785355|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
43785356|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785358|NCT02982668|Metoclopramide|metoclopramide|mesh-list
43785373|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
43785374|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785375|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43785376|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43785377|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785378|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694768|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694769|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694770|NCT02767024|Protective Agents|protective agents|mesh-ancestor
43694771|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43694772|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
43694773|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43694774|NCT02766803|Resveratrol|resveratrol|mesh-list
43694775|NCT02766803|Simvastatin|simvastatin|mesh-list
43694776|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43694777|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43694778|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
43694779|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694780|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43694781|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43639586|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
43639587|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639588|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639589|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43639590|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43639591|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43639592|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
43639593|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639594|NCT03173950|Nivolumab|nivolumab|mesh-list
43639595|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639596|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639597|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43639598|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639599|NCT03142893|Ketoconazole|ketoconazole|mesh-list
43639600|NCT03142893|Dexamethasone|dexamethasone|mesh-list
43639602|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
43694797|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694798|NCT02766634|Lenograstim|lenograstim|mesh-list
43694799|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43694800|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
43694801|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694802|NCT02766439|Etanercept|etanercept|mesh-list
43694803|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43694804|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694805|NCT02766439|Analgesics|analgesics|mesh-ancestor
43639603|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43639604|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43639605|NCT03142893|Hormones|hormones|mesh-list
43639606|NCT03142893|Cosyntropin|cosyntropin|mesh-list
43639607|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43639608|NCT03142893|BB 1101|bb 1101|mesh-list
43639609|NCT03142893|Ganirelix|ganirelix|mesh-list
43639610|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639611|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
43639612|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
43639613|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639614|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639615|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43639616|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
43639618|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43639619|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639620|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
43639621|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785379|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43785380|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
43785381|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43785382|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785383|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43785384|NCT02684227|Paclitaxel|paclitaxel|mesh-list
43785385|NCT02684227|Carboplatin|carboplatin|mesh-list
43785386|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43639622|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639623|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
43639624|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639625|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43639626|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43639627|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43639628|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639629|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43639630|NCT03141684|Bevacizumab|bevacizumab|mesh-list
43639631|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43639632|NCT03141684|Atezolizumab|atezolizumab|mesh-list
43694806|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
43694807|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785387|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43785388|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785389|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
43785390|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
43785391|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
43785392|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785393|NCT02682641|Rituximab|rituximab|mesh-list
43785394|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785395|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785396|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
43785397|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785398|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785399|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
43785417|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43785418|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785420|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
43785421|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785422|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785423|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43785424|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43785425|NCT05110118|Growth Substances|growth substances|mesh-ancestor
43785426|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785427|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
43785428|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43785429|NCT05109650|Antibodies|antibodies|mesh-list
43785430|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
43785431|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
43785432|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785433|NCT05109585|Antibodies|antibodies|mesh-list
43785434|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
43785488|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
43785489|NCT05109299|Protective Agents|protective agents|mesh-ancestor
43785490|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593246|NCT03346200|Tamoxifen|tamoxifen|mesh-list
43785537|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785538|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785540|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785541|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43785542|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785543|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785544|NCT04595864|Leucovorin|leucovorin|mesh-list
43785545|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
43785546|NCT04595864|Calcium|calcium|mesh-list
43785547|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
43785548|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43848293|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848294|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43694808|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694809|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694810|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694811|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694812|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694813|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
43694814|NCT02766192|Ketamine|ketamine|mesh-list
43694815|NCT02766192|Analgesics|analgesics|mesh-ancestor
43694816|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
43694817|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694818|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694819|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43694820|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43694821|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
43694822|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
43694823|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694824|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43694825|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43694826|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694827|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694828|NCT02766270|Temozolomide|temozolomide|mesh-list
43694829|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43694830|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
43694831|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694832|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694833|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
43694834|NCT02766556|Ropivacaine|ropivacaine|mesh-list
43694835|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43694836|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694837|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694838|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694839|NCT02766556|Analgesics|analgesics|mesh-ancestor
43694840|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
43639633|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
43639634|NCT03141684|Antibodies|antibodies|mesh-list
43848295|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43848296|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848297|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
43848298|NCT04036188|Hormones|hormones|mesh-ancestor
43639635|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
43694841|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694842|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43694843|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43694844|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43694845|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694846|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694847|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694848|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
43694849|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
43694850|NCT02766348|Gemcitabine|gemcitabine|mesh-list
43694851|NCT02766348|Cisplatin|cisplatin|mesh-list
43694852|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43694853|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
43694854|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694855|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694856|NCT02766348|Antiviral Agents|antiviral agents|mesh-ancestor
43694857|NCT02766348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694858|NCT02766348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694859|NCT02766348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43694860|NCT02766348|Immunologic Factors|immunologic factors|mesh-ancestor
43694861|NCT02766348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694862|NCT02766322|Ethanol|ethanol|mesh-list
43694863|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43694864|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694865|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694866|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694867|NCT02766257|Anesthetics|anesthetics|mesh-list
43694868|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829759|NCT05408026|Daratumumab|daratumumab|mesh-list
43829773|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43829774|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43848299|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848300|NCT04035278|Vaccines|vaccines|mesh-list
43848301|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
43848302|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848303|NCT04033575|Listerine|listerine|mesh-list
43848304|NCT04033575|Fluorides|fluorides|mesh-list
43848305|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
43848306|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
43848307|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
43848308|NCT04033575|Protective Agents|protective agents|mesh-ancestor
43848309|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829775|NCT05408026|Growth Substances|growth substances|mesh-ancestor
43829776|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
43829777|NCT05407194|Ascorbic Acid|ascorbic acid|mesh-list
43829778|NCT05407194|Vitamins|vitamins|mesh-ancestor
43829779|NCT05407194|Micronutrients|micronutrients|mesh-ancestor
43829780|NCT05407194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829781|NCT05407194|Antioxidants|antioxidants|mesh-ancestor
43829782|NCT05407194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829783|NCT05407194|Protective Agents|protective agents|mesh-ancestor
43829784|NCT05406999|Prednisolone|prednisolone|mesh-list
43829785|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
43829786|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43829787|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829788|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
43829789|NCT05406999|Hormones|hormones|mesh-ancestor
43829790|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829791|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829792|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43829793|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829794|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43829795|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829796|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829797|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
43829798|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43829799|NCT05406726|Palmidrol|palmidrol|mesh-list
43829800|NCT05406726|Analgesics|analgesics|mesh-ancestor
43829801|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
43639636|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43639637|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
43639638|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639639|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43639640|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43639641|NCT03141684|Growth Substances|growth substances|mesh-ancestor
43639642|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639643|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
43639644|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
43639649|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849496|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43639650|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829802|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829803|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829804|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43829805|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43829806|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829807|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829808|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
43829809|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829810|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43829811|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43829812|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829813|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829814|NCT05406726|Hormones|hormones|mesh-ancestor
43848310|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43848311|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848315|NCT04032119|Epinephrine|epinephrine|mesh-list
43849007|NCT03973489|Methamphetamine|methamphetamine|mesh-list
43849008|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43849009|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849010|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
43849011|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
43849012|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785556|NCT04583462|Metformin|metformin|mesh-list
43785557|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43785558|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785559|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
43785560|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43785561|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43785562|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785563|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
43785564|NCT04555343|Coagulants|coagulants|mesh-ancestor
43785565|NCT04464408|Favipiravir|favipiravir|mesh-list
43785579|NCT04383119|Gemcitabine|gemcitabine|mesh-list
43785580|NCT04383119|Trabectedin|trabectedin|mesh-list
43785581|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43785582|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
43785595|NCT04339218|Pemetrexed|pemetrexed|mesh-list
43785596|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785597|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785598|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785599|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785600|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43785601|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43785602|NCT04309877|Theophylline|theophylline|mesh-list
43785603|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43785604|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
43785605|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785606|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785607|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43785608|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
43829815|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829816|NCT05406479|Bedaquiline|bedaquiline|mesh-list
43829817|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
43829818|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43639651|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639652|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43639653|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43639654|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
43639655|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639656|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43639657|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
43639659|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
43639660|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43785609|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43785610|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785611|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785612|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
43785613|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43785614|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43785615|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
43785616|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785617|NCT04305548|Trabectedin|trabectedin|mesh-list
43785618|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43785619|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
43785620|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785621|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785622|NCT04121299|Amlodipine|amlodipine|mesh-list
43785623|NCT04121299|Carvedilol|carvedilol|mesh-list
43785635|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
43785636|NCT04121299|Protective Agents|protective agents|mesh-ancestor
43785637|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43785638|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43785639|NCT04097912|Aspirin|aspirin|mesh-list
43785640|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43785641|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43785642|NCT04097912|Analgesics|analgesics|mesh-ancestor
43785643|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
43785644|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785645|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785646|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694870|NCT02766140|Docetaxel|docetaxel|mesh-list
43639673|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639674|NCT03104842|Dexamethasone|dexamethasone|mesh-list
43639675|NCT03104842|Lenalidomide|lenalidomide|mesh-list
43639676|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639677|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
43639678|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
43639679|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639680|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639681|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43639682|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
43639683|NCT03104842|Hormones|hormones|mesh-ancestor
43639684|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639685|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43639686|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639687|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
43639688|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43639689|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43639694|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
43639695|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
43639696|NCT03077542|Pentostatin|pentostatin|mesh-list
43694871|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694872|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
43694873|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
43694874|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
43694875|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694876|NCT02766036|Propolis|propolis|mesh-list
43694877|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694878|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
43694879|NCT02765971|Cathartics|cathartics|mesh-ancestor
43694880|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694881|NCT02765815|Ketorolac|ketorolac|mesh-list
43694882|NCT02765815|Epinephrine|epinephrine|mesh-list
43694883|NCT02765815|Racepinephrine|racepinephrine|mesh-list
43694884|NCT02765815|Morphine|morphine|mesh-list
43694885|NCT02765815|Bupivacaine|bupivacaine|mesh-list
43694886|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
43785647|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785648|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43785649|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43785650|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694887|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
43694888|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
43694889|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694890|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694892|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694893|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43694894|NCT02765815|Narcotics|narcotics|mesh-ancestor
43694895|NCT02765815|Analgesics|analgesics|mesh-ancestor
43694896|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43639697|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639698|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
43639699|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639700|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639701|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43639702|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
43639703|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639704|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639705|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43639706|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43639707|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639708|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43639709|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
43639710|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639711|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
43639712|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639713|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43639714|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43639715|NCT03076554|Avelumab|avelumab|mesh-list
43639716|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639717|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639718|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
43639719|NCT03073785|Fluorouracil|fluorouracil|mesh-list
43639720|NCT03073785|Capecitabine|capecitabine|mesh-list
43694897|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43785651|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43785654|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
43785675|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785676|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785677|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694898|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694899|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694900|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694901|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43694902|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43694903|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
43694904|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43694905|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
43694906|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
43694907|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
43694908|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43694909|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43694910|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43694911|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694912|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694913|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43694914|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694915|NCT02765633|Cangrelor|cangrelor|mesh-list
43694916|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43694917|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43694918|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43694919|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43694920|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
43694921|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694922|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694923|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694924|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
43694925|NCT02765594|Valsartan|valsartan|mesh-list
43694926|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43694927|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43639721|NCT03073785|Imidazole|imidazole|mesh-list
43639722|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
43639723|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639724|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43639727|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
43639728|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639729|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43694928|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43694929|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694930|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
43694931|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43694932|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43694933|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694934|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694935|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43694937|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43694938|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694939|NCT02765373|Letrozole|letrozole|mesh-list
43694940|NCT02765373|Anastrozole|anastrozole|mesh-list
43694941|NCT02765373|Exemestane|exemestane|mesh-list
43694942|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694943|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43694944|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43694945|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694946|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694947|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43694948|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
43694949|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694950|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694951|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43694980|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694981|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43694982|NCT02765009|Furosemide|furosemide|mesh-list
43639730|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639732|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43639733|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43639734|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639735|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
43639736|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
43639737|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
43639738|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639739|NCT03051516|Vaccines|vaccines|mesh-list
43639740|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
43639741|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694997|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
43694998|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694999|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695000|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43695001|NCT02764619|Diuretics|diuretics|mesh-ancestor
43695002|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
43695003|NCT02764515|Methotrexate|methotrexate|mesh-list
43695004|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43695005|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
43695006|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43695007|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695008|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43695009|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
43695010|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695011|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695012|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695013|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639776|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639777|NCT03004183|Valacyclovir|valacyclovir|mesh-list
43639778|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
43639779|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639780|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785722|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785723|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785724|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43785725|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785726|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43785727|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785728|NCT03517735|Remifentanil|remifentanil|mesh-list
43785730|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43785731|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785732|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785733|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43785734|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
43785735|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
43785736|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43785737|NCT03517735|Narcotics|narcotics|mesh-ancestor
43785738|NCT03517735|Analgesics|analgesics|mesh-ancestor
43785739|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
43785740|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785741|NCT03400501|Insulin|insulin|mesh-list
43785742|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43785743|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
43785744|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43785745|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785746|NCT02991807|Everolimus|everolimus|mesh-list
43785747|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785748|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43785749|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
43785750|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785751|NCT02944799|Vitamin D|vitamin d|mesh-list
43785752|NCT02944799|Alendronate|alendronate|mesh-list
43785754|NCT02944799|Vitamins|vitamins|mesh-ancestor
43639781|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
43639782|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695014|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43695015|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695016|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
43695017|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695018|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43695019|NCT02764736|Atorvastatin|atorvastatin|mesh-list
43695020|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43695021|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43695022|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
43695023|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695024|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43695025|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43695026|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695027|NCT02764723|Bupivacaine|bupivacaine|mesh-list
43695028|NCT02764723|Ropivacaine|ropivacaine|mesh-list
43695029|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
43695030|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
43700229|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
43785755|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
43785756|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785763|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43785764|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785765|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
43785766|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785767|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785768|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43785769|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785770|NCT02633293|Treprostinil|treprostinil|mesh-list
43785771|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43785772|NCT02570672|Metformin|metformin|mesh-list
43785773|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43785774|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785775|NCT05112471|Erythritol|erythritol|mesh-list
43785776|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
43785777|NCT05111860|Bevacizumab|bevacizumab|mesh-list
43785778|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785779|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785780|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43785781|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43785782|NCT05111860|Growth Substances|growth substances|mesh-ancestor
43785783|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785784|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
43785785|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43785786|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
43785787|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840370|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
43840371|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43840372|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
43840373|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840374|NCT04701034|Prednisolone|prednisolone|mesh-list
43840375|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
43840376|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43840377|NCT04701034|Antibodies|antibodies|mesh-list
43840378|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
43840379|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43695031|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695032|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695033|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
43695034|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695035|NCT02764710|Amoxicillin|amoxicillin|mesh-list
43695036|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
43695037|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
43695038|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43695039|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43695040|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695041|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43695042|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695043|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695045|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43695046|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695047|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
43695048|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43840380|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840381|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
43840382|NCT04701034|Hormones|hormones|mesh-ancestor
43785826|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
43785827|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43785828|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43785829|NCT05110469|Narcotics|narcotics|mesh-ancestor
43785830|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43785852|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
43785853|NCT05101356|Vaccines|vaccines|mesh-list
43785854|NCT05101356|Sargramostim|sargramostim|mesh-list
43785855|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
43785880|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785881|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785884|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43785885|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43785887|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785888|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
43785889|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43785890|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43785891|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
43785892|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785893|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43785894|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
43785895|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
43785896|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
43785897|NCT05079802|Coagulants|coagulants|mesh-ancestor
43785898|NCT04974879|Osimertinib|osimertinib|mesh-list
43785899|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695049|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43829819|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829820|NCT05405725|Denosumab|denosumab|mesh-list
43829821|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43829822|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829823|NCT05405309|Olaparib|olaparib|mesh-list
43829824|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43829825|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829826|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829827|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829828|NCT05404945|Doxorubicin|doxorubicin|mesh-list
43829829|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
43829830|NCT05404945|Dacarbazine|dacarbazine|mesh-list
43829831|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43829832|NCT05404945|Vinblastine|vinblastine|mesh-list
43829833|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43829834|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785900|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43785901|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785902|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785903|NCT04910230|Niacinamide|niacinamide|mesh-list
43593759|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
43785904|NCT04910230|Niacin|niacin|mesh-list
43785905|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
43829835|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43829836|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43829837|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829838|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639835|NCT02957968|Carboplatin|carboplatin|mesh-list
43639836|NCT02957968|Doxorubicin|doxorubicin|mesh-list
43639837|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
43639838|NCT02957968|Decitabine|decitabine|mesh-list
43639839|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43639840|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829839|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43829840|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43829841|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
43829842|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43829843|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
43829844|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
43829845|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
43695060|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695061|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695062|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43695063|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695064|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43695065|NCT02764281|Dexamethasone|dexamethasone|mesh-list
43695066|NCT02764281|Methotrexate|methotrexate|mesh-list
43695067|NCT02764281|Etoposide|etoposide|mesh-list
43695068|NCT02764281|Pegaspargase|pegaspargase|mesh-list
43695069|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695070|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
43695071|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
43695072|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695073|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695074|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695075|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
43695076|NCT02764281|Hormones|hormones|mesh-ancestor
43695077|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695078|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43695079|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695080|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695081|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695108|NCT02763969|Ustekinumab|ustekinumab|mesh-list
43695109|NCT02763969|Famotidine|famotidine|mesh-list
43695110|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695111|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
43695112|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695113|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
43695114|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695115|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695116|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43695117|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695118|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43695119|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
43695120|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
43695121|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785906|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
43695124|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695125|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695126|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
43695127|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695128|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695129|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43695130|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695131|NCT02763722|Emollients|emollients|mesh-list
43695132|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695134|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
43695136|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695137|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695152|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43695153|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
43695154|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695155|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
43695156|NCT02763761|Hormones|hormones|mesh-ancestor
43695157|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695158|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695159|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43695160|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695161|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
43695162|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
43695163|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695164|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695165|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43695166|NCT02763761|Protective Agents|protective agents|mesh-ancestor
43695167|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695168|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639872|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639873|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
43639874|NCT02954081|Apremilast|apremilast|mesh-list
43639875|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43639876|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43639877|NCT02954081|Analgesics|analgesics|mesh-ancestor
43639878|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
43639882|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639883|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43639884|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43639885|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639886|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639887|NCT02953457|Durvalumab|durvalumab|mesh-list
43639888|NCT02953457|Ipilimumab|ipilimumab|mesh-list
43639889|NCT02953457|Olaparib|olaparib|mesh-list
43695178|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695179|NCT02764008|Bupivacaine|bupivacaine|mesh-list
43695180|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
43695181|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
43695182|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695183|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695184|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
43695185|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695186|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
43695187|NCT02763475|Fludarabine|fludarabine|mesh-list
43695188|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695189|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
43695190|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695191|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695192|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43695193|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
43695194|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695195|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695196|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43785928|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
43785929|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785930|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785931|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785932|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
43785934|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695197|NCT02762955|Adalimumab|adalimumab|mesh-list
43695198|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695199|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695200|NCT02763098|Remifentanil|remifentanil|mesh-list
43695201|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43695202|NCT02763098|Narcotics|narcotics|mesh-ancestor
43695227|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695228|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43695229|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695230|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695232|NCT02763007|Alogliptin|alogliptin|mesh-list
43695233|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43695234|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695235|NCT02763007|Incretins|incretins|mesh-ancestor
43695236|NCT02763007|Hormones|hormones|mesh-ancestor
43695237|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695238|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43695239|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
43695240|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695241|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695242|NCT02762838|Folic Acid|folic acid|mesh-list
43695243|NCT02762838|Methotrexate|methotrexate|mesh-list
43695244|NCT02762838|Infliximab|infliximab|mesh-list
43695245|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43695246|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
43695247|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43695248|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695249|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43695250|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
43695251|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695252|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695253|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
43639890|NCT02953457|Tremelimumab|tremelimumab|mesh-list
43639894|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
43639895|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639896|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639897|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
43639898|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639899|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639900|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639901|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43639902|NCT02942355|Palbociclib|palbociclib|mesh-list
43639903|NCT02942355|Anastrozole|anastrozole|mesh-list
43695254|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695255|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43695256|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695257|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
43695258|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695259|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43695260|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695262|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
43695263|NCT02762838|Vitamins|vitamins|mesh-ancestor
43695264|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
43695265|NCT02762851|Vaccines|vaccines|mesh-list
43695266|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
43695267|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695268|NCT02762812|Infliximab|infliximab|mesh-list
43785935|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43785936|NCT04685772|Protective Agents|protective agents|mesh-ancestor
43785937|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43785938|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785939|NCT04674345|Sorafenib|sorafenib|mesh-list
43785940|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785941|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43785942|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785943|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785944|NCT04615936|Methylene Blue|methylene blue|mesh-list
43785945|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785946|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785947|NCT04461028|Dexamethasone|dexamethasone|mesh-list
43785948|NCT04461028|Bupivacaine|bupivacaine|mesh-list
43785949|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43785950|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
43785951|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
43785952|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785953|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785954|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785955|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
43785956|NCT04461028|Hormones|hormones|mesh-ancestor
43785957|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43785958|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43785959|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785960|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
43785961|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
43785962|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785963|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
43695269|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695270|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695271|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695272|NCT02762864|Clopidogrel|clopidogrel|mesh-list
43695273|NCT02762864|Ticagrelor|ticagrelor|mesh-list
43695274|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829853|NCT05401916|Acetaminophen|acetaminophen|mesh-list
43695275|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695276|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43695277|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43695278|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43695279|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43695280|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
43695281|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695282|NCT02762890|Iodine|iodine|mesh-list
43695283|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43695284|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695285|NCT02762890|Trace Elements|trace elements|mesh-ancestor
43695294|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695295|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
43695296|NCT02762656|Lidocaine|lidocaine|mesh-list
43695297|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
43695298|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
43695299|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43639910|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43639911|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43639912|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639913|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639914|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639915|NCT02942290|Azacitidine|azacitidine|mesh-list
43639916|NCT02942290|Venetoclax|venetoclax|mesh-list
43639917|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43829872|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43829873|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43829874|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43829875|NCT05401279|Gemcitabine|gemcitabine|mesh-list
43829876|NCT05401279|Cisplatin|cisplatin|mesh-list
43829877|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829878|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43829879|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
43829880|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829881|NCT05401279|Antiviral Agents|antiviral agents|mesh-ancestor
43829882|NCT05401279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695308|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43695309|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43695310|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
43695311|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695312|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639918|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
43639931|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639932|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695313|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43695314|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43695315|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43695317|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
43695318|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695319|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43695320|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43695321|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695322|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695323|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43695324|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43695325|NCT02762591|Pimavanserin|pimavanserin|mesh-list
43695326|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43695327|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43695328|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43695329|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43695330|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695331|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695332|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43695333|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43695336|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695337|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695338|NCT02762344|Heparin|heparin|mesh-list
43695339|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
43695340|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43695341|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43695342|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695343|NCT02762474|Paclitaxel|paclitaxel|mesh-list
43695344|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43639939|NCT02938520|Cabotegravir|cabotegravir|mesh-list
43639940|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43639941|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43639942|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639943|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639944|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
43639945|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43639946|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43639947|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43639948|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43639949|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43639959|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43639960|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639961|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43639962|NCT02923128|Analgesics|analgesics|mesh-ancestor
43639963|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
43639964|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639965|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43639966|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43639967|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43639968|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
43639969|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695395|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695396|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43695397|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43695398|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43695399|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43695400|NCT02762123|Protective Agents|protective agents|mesh-ancestor
43695402|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
43695403|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695404|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43695405|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43785967|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785968|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43785969|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43785970|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
43785971|NCT04367909|Carboplatin|carboplatin|mesh-list
43785972|NCT04367909|Docetaxel|docetaxel|mesh-list
43785973|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
43785974|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695406|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695407|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695408|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43695409|NCT02761512|Lansoprazole|lansoprazole|mesh-list
43695410|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
43695411|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43695413|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43695414|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695415|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695416|NCT02761486|Aspirin|aspirin|mesh-list
43695417|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43695418|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43695419|NCT02761486|Analgesics|analgesics|mesh-ancestor
43695420|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
43695421|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695422|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695431|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
43695440|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695441|NCT02761577|Protective Agents|protective agents|mesh-ancestor
43695442|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695443|NCT02761577|Antidotes|antidotes|mesh-ancestor
43695444|NCT02761161|Mianserin|mianserin|mesh-list
43695445|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43695446|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43695447|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
43695448|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695449|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695450|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695451|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43695452|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
43695453|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
43695454|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43639974|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43639975|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
43639976|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
43639977|NCT02913482|Risdiplam|risdiplam|mesh-list
43639978|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43639979|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639980|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785975|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
43785976|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
43785977|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
43786029|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786488|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
43786145|NCT03272464|Trametinib|trametinib|mesh-list
43786146|NCT03272464|Dabrafenib|dabrafenib|mesh-list
43786147|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786148|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43786149|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786150|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786151|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
43786152|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786153|NCT05116228|Rituximab|rituximab|mesh-list
43786154|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786155|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786156|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
43786157|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786158|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786159|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
43786160|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43786161|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786185|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
43786776|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43840394|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43840396|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
43840397|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840398|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43840399|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43840402|NCT04700839|Metformin|metformin|mesh-list
43786221|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43786222|NCT05113628|Methylene Blue|methylene blue|mesh-list
43786223|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786224|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786225|NCT05113511|Bevacizumab|bevacizumab|mesh-list
43786226|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786227|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640005|NCT02904954|Durvalumab|durvalumab|mesh-list
43640006|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43640007|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640008|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640009|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
43640010|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640011|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43640012|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
43640013|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786228|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43786229|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43786230|NCT05113511|Growth Substances|growth substances|mesh-ancestor
43786231|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786232|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
43786233|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43786234|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43786235|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43786236|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43786237|NCT05112692|Cetrorelix|cetrorelix|mesh-list
43786238|NCT05112692|Menotropins|menotropins|mesh-list
43786239|NCT05112692|Estradiol|estradiol|mesh-list
43786240|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43786241|NCT05112692|Progesterone|progesterone|mesh-list
43786242|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
43786243|NCT05112692|Estrogens|estrogens|mesh-ancestor
43786244|NCT05112692|Hormones|hormones|mesh-ancestor
43786246|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786272|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786273|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
43786274|NCT05102669|Antibodies|antibodies|mesh-list
43786275|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
43786276|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786277|NCT05091242|Clonidine|clonidine|mesh-list
43786278|NCT05091242|Analgesics|analgesics|mesh-ancestor
43786279|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
43786280|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786281|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786282|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43786283|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
43786284|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
43786285|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43786286|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43786287|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43786288|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786289|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786290|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786291|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
43786292|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43786293|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786777|NCT00659126|Hematinics|hematinics|mesh-ancestor
43786294|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43786295|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43786296|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786299|NCT05068336|Anesthetics|anesthetics|mesh-list
43786323|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786324|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786325|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
43786326|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786327|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43786328|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43786329|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
43786330|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786331|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43786332|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840441|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840442|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43840443|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43840444|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43840445|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
43840446|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
43840447|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840449|NCT04697602|Colchicine|colchicine|mesh-list
43786349|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43786350|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43786351|NCT04765787|Acetaminophen|acetaminophen|mesh-list
43786352|NCT04765787|Orphenadrine|orphenadrine|mesh-list
43786353|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786354|NCT04765787|Analgesics|analgesics|mesh-ancestor
43786355|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
43786356|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786357|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786358|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
43786359|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43786360|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43786361|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43786362|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43786363|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
43786364|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
43786365|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43786366|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43786367|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
43786368|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786369|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786370|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
43786371|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43786372|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786373|NCT04756791|Anesthetics|anesthetics|mesh-list
43786399|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
43786400|NCT04557215|Rifaximin|rifaximin|mesh-list
43786401|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43786402|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
43786403|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786404|NCT04557215|Expectorants|expectorants|mesh-ancestor
43786405|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
43786406|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43786407|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
43786408|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786468|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43786469|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
43786470|NCT04418895|Antidotes|antidotes|mesh-ancestor
43786471|NCT04418895|Protective Agents|protective agents|mesh-ancestor
43786472|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
43786473|NCT04418895|Vitamins|vitamins|mesh-ancestor
43786474|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
43786475|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43786476|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43786477|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43786478|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
43786479|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786480|NCT04376281|Norepinephrine|norepinephrine|mesh-list
43786481|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43786482|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43786483|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786484|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786485|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786486|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786487|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
43640014|NCT02891538|Protective Agents|protective agents|mesh-ancestor
43640015|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640016|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43640017|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43640018|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640019|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43640020|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
43640021|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
43640022|NCT02880293|Melphalan|melphalan|mesh-list
43640023|NCT02880293|Thiotepa|thiotepa|mesh-list
43640024|NCT02880293|Fludarabine|fludarabine|mesh-list
43640025|NCT02880293|Tacrolimus|tacrolimus|mesh-list
43640026|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640027|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
43640028|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840461|NCT04696029|Eflornithine|eflornithine|mesh-list
43840462|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840463|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43840464|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43840465|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43786541|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43786542|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786543|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43786544|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43786545|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43786546|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786547|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43786548|NCT03875638|Levetiracetam|levetiracetam|mesh-list
43786549|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
43786550|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
43786551|NCT03874234|GSK3186899|gsk3186899|mesh-list
43786552|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43786553|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786554|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786599|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43786601|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
43786602|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786603|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786604|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
43786605|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43786606|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
43786607|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786608|NCT03069300|Expectorants|expectorants|mesh-ancestor
43786609|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
43786610|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43786611|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
43786612|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786613|NCT03069300|Protective Agents|protective agents|mesh-ancestor
43786614|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786615|NCT03069300|Antidotes|antidotes|mesh-ancestor
43786616|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
43786617|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43786618|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786619|NCT02936388|Cisplatin|cisplatin|mesh-list
43786620|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786621|NCT02893241|Cafedrine|cafedrine|mesh-list
43695458|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43695459|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43695460|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43695461|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43695462|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43695463|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43695464|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
43695465|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43640029|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640030|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43640059|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
43640061|NCT02877303|Cortisone|cortisone|mesh-list
43640062|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
43640063|NCT02877303|Rituximab|rituximab|mesh-list
43640064|NCT02877303|Doxorubicin|doxorubicin|mesh-list
43640065|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43640066|NCT02877303|Methotrexate|methotrexate|mesh-list
43640067|NCT02877303|Vincristine|vincristine|mesh-list
43640068|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
43640070|NCT02877303|Blinatumomab|blinatumomab|mesh-list
43786622|NCT02893241|Theodrenaline|theodrenaline|mesh-list
43786623|NCT02893241|Ephedrine|ephedrine|mesh-list
43786624|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43786625|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786626|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
43786649|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43786650|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43786651|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786652|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43786653|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
43786654|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786655|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786656|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43786667|NCT02680561|Hormones|hormones|mesh-ancestor
43786713|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786714|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43786715|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
43786716|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
43786718|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786775|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43786788|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786789|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
43786790|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43786791|NCT05117957|Sorafenib|sorafenib|mesh-list
43786792|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640071|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43640072|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43640073|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
43640074|NCT02877303|Antibodies|antibodies|mesh-list
43640075|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
43640076|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43695466|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695467|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695468|NCT02761395|Deferasirox|deferasirox|mesh-list
43695469|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43695470|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
43695471|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
43695472|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695473|NCT02761317|Bisacodyl|bisacodyl|mesh-list
43695474|NCT02761317|Cathartics|cathartics|mesh-ancestor
43695475|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695476|NCT02761317|Laxatives|laxatives|mesh-ancestor
43695477|NCT02761070|Bevacizumab|bevacizumab|mesh-list
43786793|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43786794|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786795|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786796|NCT05117125|Heparin|heparin|mesh-list
43786797|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
43786798|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43786799|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43786800|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786801|NCT05117021|Bupivacaine|bupivacaine|mesh-list
43786802|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
43786821|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
43786822|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786823|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
43786824|NCT05116462|Gemcitabine|gemcitabine|mesh-list
43786826|NCT05116462|Docetaxel|docetaxel|mesh-list
43786827|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43786828|NCT05116462|Cisplatin|cisplatin|mesh-list
43786829|NCT05116462|Carboplatin|carboplatin|mesh-list
43786830|NCT05116462|Pemetrexed|pemetrexed|mesh-list
43786831|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43786889|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786890|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
43786891|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786903|NCT05002530|Vitamin D|vitamin d|mesh-list
43786959|NCT04585061|Lidocaine|lidocaine|mesh-list
43786960|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
43786961|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
43786962|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786963|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786964|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
43786965|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787025|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43787026|NCT04014803|Aspirin|aspirin|mesh-list
43787027|NCT04014803|Clopidogrel|clopidogrel|mesh-list
43787028|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43787029|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43787030|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43840506|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
43840507|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840508|NCT04691804|Prednisone|prednisone|mesh-list
43840509|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
43840510|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695478|NCT02761070|Temozolomide|temozolomide|mesh-list
43695479|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43695480|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695481|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43695482|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43695483|NCT02761070|Growth Substances|growth substances|mesh-ancestor
43695484|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695485|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
43695486|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43695487|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
43700230|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840511|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
43840512|NCT04691804|Hormones|hormones|mesh-ancestor
43840513|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840514|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840515|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43840522|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
43787116|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43787117|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787118|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43787140|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787191|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787192|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787194|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43787203|NCT05025163|Fluorides|fluorides|mesh-list
43787260|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43787261|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43787262|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
43787263|NCT04594382|Narcotics|narcotics|mesh-ancestor
43787266|NCT04594382|Analgesics|analgesics|mesh-ancestor
43787317|NCT03874494|Aripiprazole|aripiprazole|mesh-list
43787318|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
43787319|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
43787320|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43787321|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43787364|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787365|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43787366|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43787367|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
43787368|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787369|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787371|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43787372|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43787373|NCT02578394|Prednisolone|prednisolone|mesh-list
43787374|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
43787375|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43787376|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43787377|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
43787378|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787379|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
43787380|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
43787381|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787382|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787383|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787384|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
43787385|NCT02578394|Hormones|hormones|mesh-ancestor
43787386|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787387|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43787419|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787420|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787421|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787422|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43787423|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43695488|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695490|NCT02760888|Tramadol|tramadol|mesh-list
43640077|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43640078|NCT02877303|BB 1101|bb 1101|mesh-list
43640079|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640080|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
43640081|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640082|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640083|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43640084|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
43640085|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640086|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640089|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
43640090|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
43640091|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640092|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640093|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
43640094|NCT02877303|Hormones|hormones|mesh-ancestor
43695491|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43695492|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43695493|NCT02760888|Analgesics|analgesics|mesh-ancestor
43695494|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
43695495|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695496|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787425|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43787474|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43787475|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787476|NCT05120622|Tremelimumab|tremelimumab|mesh-list
43787477|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787478|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
43787479|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43787480|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43787481|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787484|NCT05119712|Terbinafine|terbinafine|mesh-list
43787542|NCT04995874|Trace Elements|trace elements|mesh-list
43787543|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787544|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
43787545|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43787546|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787547|NCT04814745|Morphine|morphine|mesh-list
43787548|NCT04814745|Tramadol|tramadol|mesh-list
43787549|NCT04814745|Ropivacaine|ropivacaine|mesh-list
43787550|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43787551|NCT04814745|Narcotics|narcotics|mesh-ancestor
43787552|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840572|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840573|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43840574|NCT04683965|Bevacizumab|bevacizumab|mesh-list
43695497|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695498|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695499|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43695500|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695501|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695502|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43695503|NCT02760888|Narcotics|narcotics|mesh-ancestor
43695504|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695505|NCT02761291|Gemcitabine|gemcitabine|mesh-list
43695506|NCT02761291|Valganciclovir|valganciclovir|mesh-list
43695507|NCT02761291|Valproic Acid|valproic acid|mesh-list
43695508|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43695509|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
43695510|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695511|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640095|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640096|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640097|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
43640098|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640099|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640100|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43640101|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43640102|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43640103|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
43640104|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43640105|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640106|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
43640107|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695513|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695514|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695515|NCT02761291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695516|NCT02761291|Immunologic Factors|immunologic factors|mesh-ancestor
43695517|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695518|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
43695519|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
43695520|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695521|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
43695522|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43695523|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695524|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43695525|NCT02760992|Baclofen|baclofen|mesh-list
43695526|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43695527|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695528|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43695529|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695530|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43695531|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
43695532|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
43787616|NCT04497870|Peppermint oil|peppermint oil|mesh-list
43787617|NCT04497870|Menthol|menthol|mesh-list
43787618|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
43787619|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
43787620|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
43787621|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
43787622|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787677|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43787678|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787679|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787680|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
43787681|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
43787682|NCT03225547|Mifepristone|mifepristone|mesh-list
43787747|NCT02969837|Elotuzumab|elotuzumab|mesh-list
43787748|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787749|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
43787750|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
43787751|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787752|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787753|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787754|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
43787755|NCT02969837|Hormones|hormones|mesh-ancestor
43787756|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787757|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43787758|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787759|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
43787860|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
43840576|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43840577|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840578|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43840579|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43787919|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787921|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43787922|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43787923|NCT05111717|Desflurane|desflurane|mesh-list
43787924|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43787925|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
43695533|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695534|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695535|NCT02760953|Epirubicin|epirubicin|mesh-list
43695536|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43695537|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695538|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43695539|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43695540|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695541|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829883|NCT05401279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829884|NCT05401279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43829885|NCT05401279|Immunologic Factors|immunologic factors|mesh-ancestor
43829886|NCT05401279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829887|NCT05401214|Prednisone|prednisone|mesh-list
43829888|NCT05401214|Prednisolone|prednisolone|mesh-list
43829894|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829895|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829896|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43829897|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829898|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43829899|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695542|NCT02760979|Denosumab|denosumab|mesh-list
43695543|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43695544|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695545|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
43695546|NCT02760901|Cisplatin|cisplatin|mesh-list
43787926|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
43787927|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787928|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787929|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43787930|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
43787984|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43787985|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
43787986|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787987|NCT05229276|Bone wax|bone wax|mesh-list
43787988|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
43787989|NCT05229276|Coagulants|coagulants|mesh-ancestor
43788047|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
43788048|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
43788049|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788050|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788051|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
43788052|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788053|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43788113|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788114|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43788115|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788116|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695547|NCT02760901|Mannitol|mannitol|mesh-list
43695548|NCT02760901|Acetazolamide|acetazolamide|mesh-list
43695549|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43695550|NCT02760901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695551|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
43695552|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695553|NCT02760901|Expectorants|expectorants|mesh-ancestor
43695554|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
43640122|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43640123|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43640124|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640125|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640126|NCT02847624|Tolvaptan|tolvaptan|mesh-list
43640127|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43640128|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640129|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
43640130|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640137|NCT02830724|Aldesleukin|aldesleukin|mesh-list
43640138|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
43640139|NCT02830724|Fludarabine|fludarabine|mesh-list
43640140|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640141|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
43640142|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640143|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640144|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43788117|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43788118|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43788119|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43788120|NCT05035186|Renal Agents|renal agents|mesh-ancestor
43788121|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43788122|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43788123|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788124|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43788125|NCT04987099|Choline|choline|mesh-list
43788126|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
43788163|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
43788164|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788165|NCT04441762|Ketorolac|ketorolac|mesh-list
43788174|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788175|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43788176|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788177|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788178|NCT04412694|Dexamethasone|dexamethasone|mesh-list
43788179|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
43788180|NCT04412694|BB 1101|bb 1101|mesh-list
43640145|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
43640146|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640147|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640148|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640149|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43640150|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43640151|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
43640152|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640153|NCT02784210|Prednisone|prednisone|mesh-list
43640154|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
43640155|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43640156|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43640157|NCT02784210|Prednisolone|prednisolone|mesh-list
43695555|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43695556|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
43695557|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695558|NCT02760901|Protective Agents|protective agents|mesh-ancestor
43695559|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695560|NCT02760901|Antidotes|antidotes|mesh-ancestor
43695561|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43695562|NCT02760901|Diuretics|diuretics|mesh-ancestor
43640158|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
43640159|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43640172|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43640173|NCT02784210|Protective Agents|protective agents|mesh-ancestor
43640174|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
43640175|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43640176|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
43640177|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640178|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640179|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43640180|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
43640181|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43640182|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
43640183|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640184|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43640185|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43640186|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
43640187|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
43640188|NCT02725372|Protective Agents|protective agents|mesh-ancestor
43640189|NCT02723955|Gemcitabine|gemcitabine|mesh-list
43640191|NCT02723955|Docetaxel|docetaxel|mesh-list
43640192|NCT02723955|Cisplatin|cisplatin|mesh-list
43640193|NCT02723955|Carboplatin|carboplatin|mesh-list
43640194|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
43640195|NCT02723955|Fluorouracil|fluorouracil|mesh-list
43640196|NCT02723955|Pemetrexed|pemetrexed|mesh-list
43640197|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43640198|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640199|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
43640200|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
43640201|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
43640202|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640203|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640204|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
43640205|NCT02723955|Antiviral Agents|antiviral agents|mesh-ancestor
43640206|NCT02723955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640207|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640208|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43788181|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788182|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
43695621|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43695622|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43695625|NCT02760355|Ledipasvir|ledipasvir|mesh-list
43695626|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
43695627|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695628|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
43695629|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695630|NCT02760459|Dexamethasone|dexamethasone|mesh-list
43695631|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695632|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
43695633|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
43695634|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695635|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695636|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695637|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
43695638|NCT02760459|Hormones|hormones|mesh-ancestor
43640209|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
43640210|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640211|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640212|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43640213|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43640214|NCT02710097|Ethanol|ethanol|mesh-list
43640215|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43640216|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640217|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43640218|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640219|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43640221|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640222|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43640226|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
43640227|NCT02629120|Busulfan|busulfan|mesh-list
43640228|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
43640229|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640230|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
43640231|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640232|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640233|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43640235|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640236|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640237|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640238|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43640240|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640241|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
43640242|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640243|NCT02628704|Dexamethasone|dexamethasone|mesh-list
43640244|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640245|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
43640246|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
43640247|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640248|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640249|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640250|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
43640251|NCT02628704|Hormones|hormones|mesh-ancestor
43695639|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695640|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43695641|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695642|NCT02760316|Prednisolone|prednisolone|mesh-list
43695643|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43695644|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
43695645|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43695646|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
43695647|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43695648|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
43695649|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695651|NCT02760316|Hormones|hormones|mesh-ancestor
43640265|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640266|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640267|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640268|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640269|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43640270|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43640271|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
43640272|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640273|NCT02607722|Nintedanib|nintedanib|mesh-list
43640274|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640275|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43640276|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640277|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640278|NCT02576912|Dronabinol|dronabinol|mesh-list
43640291|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640292|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43640293|NCT02511028|Hematinics|hematinics|mesh-ancestor
43640294|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43640300|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640301|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43640303|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700233|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
43788183|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
43788184|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788185|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788215|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43788216|NCT04200248|Aflibercept|aflibercept|mesh-list
43788217|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43788218|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43788219|NCT04200248|Growth Substances|growth substances|mesh-ancestor
43788220|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788221|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
43788222|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788223|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
43788282|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43788283|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43788284|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
43788285|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43788286|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43788287|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
43788289|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43788290|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43788291|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
43788354|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43788355|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
43788356|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43788357|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788358|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43788359|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43788360|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788361|NCT03598270|Gemcitabine|gemcitabine|mesh-list
43788362|NCT03598270|Paclitaxel|paclitaxel|mesh-list
43788363|NCT03598270|Carboplatin|carboplatin|mesh-list
43788364|NCT03598270|Doxorubicin|doxorubicin|mesh-list
43788365|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43788366|NCT03598270|Atezolizumab|atezolizumab|mesh-list
43788367|NCT03598270|Niraparib|niraparib|mesh-list
43788368|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43788370|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788415|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43788416|NCT03554707|Growth Substances|growth substances|mesh-ancestor
43788417|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788418|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
43788419|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43788420|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43788440|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788441|NCT03321019|Capsaicin|capsaicin|mesh-list
43788442|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
43788443|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
43788444|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
43788445|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788446|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788447|NCT03317613|Capsaicin|capsaicin|mesh-list
43788448|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
43788462|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43788464|NCT03186404|Atorvastatin|atorvastatin|mesh-list
43788465|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43788466|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43788467|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
43695688|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695689|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43695690|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695691|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
43695692|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43695694|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
43695695|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695696|NCT02760121|Acetazolamide|acetazolamide|mesh-list
43695697|NCT02760121|Methazolamide|methazolamide|mesh-list
43695698|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
43695699|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43695700|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695701|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695702|NCT02760121|Diuretics|diuretics|mesh-ancestor
43695703|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
43695704|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695705|NCT02759991|Vaccines|vaccines|mesh-list
43695706|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
43695707|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695711|NCT02760030|Fulvestrant|fulvestrant|mesh-list
43695738|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
43695739|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43695740|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695741|NCT02759926|Quinine|quinine|mesh-list
43695742|NCT02759926|Denatonium|denatonium|mesh-list
43695743|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
43695744|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43695745|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43695746|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695747|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43695748|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695749|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43695750|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695751|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43695752|NCT02759926|Analgesics|analgesics|mesh-ancestor
43695753|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
43695754|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
43695755|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695756|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
43695762|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43695763|NCT02759614|Growth Substances|growth substances|mesh-ancestor
43695764|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695765|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
43695766|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43788468|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788484|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
43788485|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43788486|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43788487|NCT03076164|Trametinib|trametinib|mesh-list
43788488|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788489|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43788490|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788492|NCT03073070|Biotin|biotin|mesh-list
43788567|NCT01057121|Lenalidomide|lenalidomide|mesh-list
43788568|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
43788569|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788570|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43788571|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43788572|NCT01057121|Growth Substances|growth substances|mesh-ancestor
43788573|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
43788574|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788575|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
43788576|NCT00961792|Promethazine|promethazine|mesh-list
43788577|NCT00961792|Ethanol|ethanol|mesh-list
43788578|NCT00961792|Caffeine|caffeine|mesh-list
43788579|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43788580|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788581|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43788582|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788584|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43788585|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43788623|NCT00698022|Risperidone|risperidone|mesh-list
43788624|NCT00698022|Mifepristone|mifepristone|mesh-list
43695767|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695768|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695769|NCT02759510|Phenylephrine|phenylephrine|mesh-list
43695770|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
43695771|NCT02759510|Norepinephrine|norepinephrine|mesh-list
43695772|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43695773|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
43695774|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
43695775|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695776|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695777|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
43695778|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43695779|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
43695780|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
43695781|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43695782|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43695783|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43695784|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
43695785|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695786|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829900|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829901|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
43829902|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43829903|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43829904|NCT05400863|Metformin|metformin|mesh-list
43829905|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43829906|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829910|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43695824|NCT02758951|Bevacizumab|bevacizumab|mesh-list
43695825|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43695826|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695827|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43695828|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43695829|NCT02758951|Growth Substances|growth substances|mesh-ancestor
43695830|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695865|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43695866|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
43695867|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695868|NCT02758990|Protective Agents|protective agents|mesh-ancestor
43695869|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43695870|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43695871|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695872|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43695873|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43695874|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
43640341|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
43640342|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640343|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
43640344|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640345|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43640346|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640347|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640348|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
43640349|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640350|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640351|NCT02404870|Canagliflozin|canagliflozin|mesh-list
43640352|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43640353|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640354|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43640355|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640356|NCT02397720|Nivolumab|nivolumab|mesh-list
43640357|NCT02397720|Ipilimumab|ipilimumab|mesh-list
43640358|NCT02397720|Azacitidine|azacitidine|mesh-list
43640359|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43695911|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43695912|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43695913|NCT02758769|Abatacept|abatacept|mesh-list
43640363|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640364|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
43640365|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640381|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43640382|NCT02389543|Growth Substances|growth substances|mesh-ancestor
43640383|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
43640384|NCT02385110|Dexamethasone|dexamethasone|mesh-list
43640385|NCT02385110|Methotrexate|methotrexate|mesh-list
43640386|NCT02385110|Etoposide|etoposide|mesh-list
43640387|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
43640388|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640389|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
43640390|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
43695940|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43695941|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695942|NCT02758691|Insulin|insulin|mesh-list
43695943|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43695944|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695945|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
43695946|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640437|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640438|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640442|NCT02352948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640443|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
43640444|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640445|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43640446|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43695958|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695959|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
43695960|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695961|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43695962|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43695963|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
43695964|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695965|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695966|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43695982|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695984|NCT02758249|Propofol|propofol|mesh-list
43695985|NCT02758249|Sevoflurane|sevoflurane|mesh-list
43695986|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43695987|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695988|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695989|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43695990|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
43695991|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
43695992|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43695993|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43695994|NCT02758366|Doxorubicin|doxorubicin|mesh-list
43695995|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43695996|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695997|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43695998|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43695999|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696000|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696001|NCT02758405|Fentanyl|fentanyl|mesh-list
43696002|NCT02758405|Bupivacaine|bupivacaine|mesh-list
43696003|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
43696004|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
43701261|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788625|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43788626|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
43788627|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788628|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788629|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788630|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43788631|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43788633|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43788689|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43788690|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43788691|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788692|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43788693|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43788694|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43788759|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788796|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788799|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
43788800|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788801|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788802|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43788803|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43788804|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43788805|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788810|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
43788858|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788859|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43788860|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43788861|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43788862|NCT04347616|Aldesleukin|aldesleukin|mesh-list
43696005|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696006|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696007|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
43696008|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696009|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43696010|NCT02758405|Narcotics|narcotics|mesh-ancestor
43696011|NCT02758405|Analgesics|analgesics|mesh-ancestor
43696012|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43696013|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43696014|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
43696015|NCT02758470|Acetazolamide|acetazolamide|mesh-list
43696016|NCT02758470|Methazolamide|methazolamide|mesh-list
43640468|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640469|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
43640470|NCT02339740|Hormones|hormones|mesh-ancestor
43640471|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640472|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640474|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
43696017|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
43696018|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43696019|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696020|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696021|NCT02758470|Diuretics|diuretics|mesh-ancestor
43696022|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
43696023|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696024|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43696025|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43696026|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
43696027|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43696028|NCT02758327|Laxatives|laxatives|mesh-ancestor
43696029|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696030|NCT02758015|Betaine|betaine|mesh-list
43696032|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
43696043|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696044|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43696045|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43696046|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696047|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43640475|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640476|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640477|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640478|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
43640479|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
43640480|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640481|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640482|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
43640483|NCT02339740|Analgesics|analgesics|mesh-ancestor
43640484|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
43640485|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43640486|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43696048|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43696049|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
43696050|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
43696051|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43696052|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43696053|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788863|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788864|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43788865|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43788866|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
43788867|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788868|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
43788869|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43788870|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43788871|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
43640487|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640488|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
43640489|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
43640517|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43640518|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
43640519|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
43640520|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43640521|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43640522|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43640523|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
43640524|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43640525|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640526|NCT02211755|Bortezomib|bortezomib|mesh-list
43640527|NCT02211755|Clofarabine|clofarabine|mesh-list
43788872|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788873|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43788874|NCT04209868|Bupivacaine|bupivacaine|mesh-list
43788917|NCT03704610|Infliximab|infliximab|mesh-list
43788918|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
43788919|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43788920|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788921|NCT03662815|Molgramostim|molgramostim|mesh-list
43788922|NCT03662815|Sargramostim|sargramostim|mesh-list
43788923|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
43788924|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788925|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788926|NCT03645148|Molgramostim|molgramostim|mesh-list
43788927|NCT03645148|Sargramostim|sargramostim|mesh-list
43788928|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
43788929|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788930|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788931|NCT03612921|Amantadine|amantadine|mesh-list
43788932|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43788933|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43788986|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43788987|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43788988|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
43788989|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43788990|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640528|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640529|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640530|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
43640531|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640561|NCT02181738|Nivolumab|nivolumab|mesh-list
43640562|NCT02181738|Dacarbazine|dacarbazine|mesh-list
43640563|NCT02181738|Vinblastine|vinblastine|mesh-list
43640564|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640565|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640566|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43640567|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43640568|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640569|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640591|NCT02143414|Prednisone|prednisone|mesh-list
43640592|NCT02143414|Cortisone|cortisone|mesh-list
43696054|NCT02757703|Terlipressin|terlipressin|mesh-list
43696055|NCT02757703|Pantoprazole|pantoprazole|mesh-list
43696056|NCT02757703|Somatostatin|somatostatin|mesh-list
43640593|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43640594|NCT02143414|Methotrexate|methotrexate|mesh-list
43640595|NCT02143414|Vincristine|vincristine|mesh-list
43640596|NCT02143414|Dasatinib|dasatinib|mesh-list
43640597|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
43640598|NCT02143414|Blinatumomab|blinatumomab|mesh-list
43640599|NCT02143414|Antibodies|antibodies|mesh-list
43640600|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
43640601|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43788991|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
43788992|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
43788993|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788994|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788995|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43640602|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
43640603|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43640604|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
43640605|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640606|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640607|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640608|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
43640609|NCT02143414|Hormones|hormones|mesh-ancestor
43640610|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640611|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640612|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43640613|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
43640614|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43696064|NCT02757703|Hormones|hormones|mesh-ancestor
43696093|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696094|NCT02757209|Fluticasone|fluticasone|mesh-list
43696095|NCT02757209|Xhance|xhance|mesh-list
43696096|NCT02757209|Budesonide|budesonide|mesh-list
43696097|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
43696098|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43696099|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43696100|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696101|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43696102|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
43696103|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696104|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696105|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43696106|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
43696107|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
43696108|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43696109|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
43696110|NCT02757209|Hormones|hormones|mesh-ancestor
43696111|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696112|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43696130|NCT02757365|Aspirin|aspirin|mesh-list
43696158|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43696159|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43696160|NCT02757469|Estradiol|estradiol|mesh-list
43696161|NCT02757469|Estrogens|estrogens|mesh-ancestor
43696162|NCT02757469|Hormones|hormones|mesh-ancestor
43696163|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696164|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696165|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43696166|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
43696167|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43696168|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43696169|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43696170|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43696171|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43696172|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
43696173|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43696174|NCT02757469|Diuretics|diuretics|mesh-ancestor
43696175|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
43696176|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43696177|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43696178|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696179|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696180|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43696181|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43829914|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829915|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829916|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829917|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43829918|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
43829919|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43829920|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829921|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43788996|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788997|NCT02829502|Exenatide|exenatide|mesh-list
43788998|NCT02829502|Glucagon|glucagon|mesh-list
43788999|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43789000|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789001|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789002|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43789003|NCT02829502|Incretins|incretins|mesh-ancestor
43829922|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43829923|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43829925|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829926|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829927|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
43829928|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43829929|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
43829930|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43829931|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
43829932|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829933|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829934|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
43829935|NCT05398874|Acetaminophen|acetaminophen|mesh-list
43829936|NCT05398874|Diclofenac|diclofenac|mesh-list
43829937|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43829938|NCT05398874|Analgesics|analgesics|mesh-ancestor
43829939|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
43829942|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
43696238|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43696239|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696240|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
43696241|NCT02757443|Anesthetics|anesthetics|mesh-list
43696242|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696243|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696244|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43696245|NCT02757443|Protective Agents|protective agents|mesh-ancestor
43696246|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
43696247|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696248|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
43696249|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
43696250|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
43696251|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
43696252|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696253|NCT02757066|Melatonin|melatonin|mesh-list
43696254|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
43696255|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696256|NCT02757066|Protective Agents|protective agents|mesh-ancestor
43696257|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696258|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696259|NCT02757079|Melatonin|melatonin|mesh-list
43696260|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
43696261|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696263|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696264|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696265|NCT02756598|Sufentanil|sufentanil|mesh-list
43696266|NCT02756598|Dsuvia|dsuvia|mesh-list
43696267|NCT02756598|Propofol|propofol|mesh-list
43696276|NCT02756598|Analgesics|analgesics|mesh-ancestor
43696277|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
43696278|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696279|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43696280|NCT02756728|Melphalan|melphalan|mesh-list
43696281|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43696282|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
43696284|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696287|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
43696288|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696290|NCT02756663|Panobinostat|panobinostat|mesh-list
43696291|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696292|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
43696293|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
43696294|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696295|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696296|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696297|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
43696298|NCT02756663|Hormones|hormones|mesh-ancestor
43696299|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696300|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43696301|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696302|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43696303|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696304|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696305|NCT02756715|Propofol|propofol|mesh-list
43696306|NCT02756715|Desflurane|desflurane|mesh-list
43696312|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
43696327|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
43696328|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43696329|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43696330|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696331|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696332|NCT02756312|Anesthetics|anesthetics|mesh-list
43696333|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696334|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696335|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
43696336|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43640729|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
43696364|NCT02755714|Ipratropium|ipratropium|mesh-list
43696365|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
43696366|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43696367|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
43696368|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696369|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696370|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43696371|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
43696372|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43696373|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
43789004|NCT02829502|Hormones|hormones|mesh-ancestor
43696388|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
43696389|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696390|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696391|NCT02756000|Protective Agents|protective agents|mesh-ancestor
43696392|NCT02755857|Itraconazole|itraconazole|mesh-list
43696393|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
43696394|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696395|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43696396|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43696397|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696398|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696399|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43696400|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
43696401|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696402|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696403|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43696404|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
43696405|NCT02755545|Adapalene|adapalene|mesh-list
43696406|NCT02755545|Salicylates|salicylates|mesh-list
43640800|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43640816|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640817|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
43640818|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
43640819|NCT01861106|Busulfan|busulfan|mesh-list
43640820|NCT01861106|Fludarabine|fludarabine|mesh-list
43640821|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
43640822|NCT01861106|Tacrolimus|tacrolimus|mesh-list
43640823|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43696428|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829950|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43829951|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43829952|NCT05398705|Analgesics|analgesics|mesh-ancestor
43640825|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
43640826|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640827|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640828|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43640829|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
43640830|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640831|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640832|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640833|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640834|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
43640835|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43640836|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640837|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640838|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43640839|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
43640840|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43640841|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640842|NCT01853826|Afatinib|afatinib|mesh-list
43640843|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640845|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640846|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640847|NCT01842386|Rituximab|rituximab|mesh-list
43640851|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640852|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640868|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
43640869|NCT01746849|Thiotepa|thiotepa|mesh-list
43789005|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789006|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43789007|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
43789008|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
43789035|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789036|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
43789037|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789038|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
43789039|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43789040|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
43789041|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43840644|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
43840645|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43640870|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640871|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
43640872|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640873|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43640874|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43829954|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829955|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829956|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829957|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43829958|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43829959|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829960|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43829961|NCT05398705|Protective Agents|protective agents|mesh-ancestor
43829962|NCT05397964|Calcium|calcium|mesh-list
43840646|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
43840647|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
43840648|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840649|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840650|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840651|NCT04681469|Niraparib|niraparib|mesh-list
43840652|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43840653|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789044|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
43789105|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43789106|NCT05124353|Protective Agents|protective agents|mesh-ancestor
43789107|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789108|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
43789109|NCT05124314|Misoprostol|misoprostol|mesh-list
43789110|NCT05124314|Mifepristone|mifepristone|mesh-list
43789111|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43789112|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
43789113|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43789114|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789115|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43789116|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43789117|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
43597289|NCT03309735|Hormones|hormones|mesh-ancestor
43789118|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43789119|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43789120|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43789121|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43789122|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
43789123|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43789124|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43789125|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
43789126|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789127|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
43789128|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43789151|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789152|NCT05123053|Amifampridine|amifampridine|mesh-list
43789153|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43789154|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789155|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789156|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43789157|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789158|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789159|NCT05122780|Acetylcholine|acetylcholine|mesh-list
43789160|NCT05122780|Anticoagulants|anticoagulants|mesh-list
43829963|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43829964|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829965|NCT05397886|Propofol|propofol|mesh-list
43829966|NCT05397886|Flumazenil|flumazenil|mesh-list
43829967|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43829968|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829969|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829970|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43829971|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
43829972|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
43829973|NCT05397886|Antidotes|antidotes|mesh-ancestor
43829974|NCT05397886|Protective Agents|protective agents|mesh-ancestor
43829975|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
43829976|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
43829977|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829978|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829979|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
43829980|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43829981|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
43829982|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829983|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829984|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640875|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
43640876|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829985|NCT05395104|Midazolam|midazolam|mesh-list
43829986|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43829987|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43829988|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829989|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829990|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43829991|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43829992|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43696429|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
43696430|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43696431|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
43696432|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696433|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
43696434|NCT02755376|Protective Agents|protective agents|mesh-ancestor
43696435|NCT02755298|Acetazolamide|acetazolamide|mesh-list
43696436|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
43696437|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43696438|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696439|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696440|NCT02755298|Diuretics|diuretics|mesh-ancestor
43696441|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
43696442|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696443|NCT02755311|Cisplatin|cisplatin|mesh-list
43696444|NCT02755311|Carboplatin|carboplatin|mesh-list
43696445|NCT02755311|Fluorouracil|fluorouracil|mesh-list
43696446|NCT02755311|Epirubicin|epirubicin|mesh-list
43696447|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
43696473|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43696474|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
43696475|NCT02754882|Paclitaxel|paclitaxel|mesh-list
43696476|NCT02754882|Bevacizumab|bevacizumab|mesh-list
43696477|NCT02754882|Carboplatin|carboplatin|mesh-list
43696478|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43696479|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696480|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
43696481|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
43696482|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
43696483|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789161|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43696484|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696485|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43696486|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43696487|NCT02754882|Growth Substances|growth substances|mesh-ancestor
43696488|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696489|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
43696490|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
43696491|NCT02754765|Levofloxacin|levofloxacin|mesh-list
43696492|NCT02754765|Ofloxacin|ofloxacin|mesh-list
43696493|NCT02754765|Linezolid|linezolid|mesh-list
43696494|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
43696495|NCT02754765|Bedaquiline|bedaquiline|mesh-list
43696496|NCT02754765|Clofazimine|clofazimine|mesh-list
43696497|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43696498|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696499|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43696500|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43696501|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640899|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43640900|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
43640901|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43640902|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43640903|NCT01745588|Growth Substances|growth substances|mesh-ancestor
43640904|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
43640905|NCT01729455|Belimumab|belimumab|mesh-list
43640906|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640907|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
43640908|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640909|NCT01728259|Dexamethasone|dexamethasone|mesh-list
43640910|NCT01728259|Bortezomib|bortezomib|mesh-list
43640911|NCT01728259|Pomalidomide|pomalidomide|mesh-list
43640912|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640913|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
43640914|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
43640915|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640916|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640917|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696533|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43696534|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
43696535|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
43696536|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43696537|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696538|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696539|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43696540|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696541|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696542|NCT02754726|Gemcitabine|gemcitabine|mesh-list
43696543|NCT02754726|Paclitaxel|paclitaxel|mesh-list
43696544|NCT02754726|Cisplatin|cisplatin|mesh-list
43640918|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
43640919|NCT01728259|Hormones|hormones|mesh-ancestor
43640920|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640921|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640922|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789162|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43789163|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43640923|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
43640924|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43640925|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43640926|NCT01728259|Growth Substances|growth substances|mesh-ancestor
43640927|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
43640928|NCT01660971|Gemcitabine|gemcitabine|mesh-list
43640929|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43640930|NCT01660971|Dasatinib|dasatinib|mesh-list
43640931|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640932|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
43640933|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640938|NCT01660971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640939|NCT01660971|Immunologic Factors|immunologic factors|mesh-ancestor
43640940|NCT01660971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640941|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43640973|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
43640974|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640975|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640976|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
43640977|NCT01602666|Carboplatin|carboplatin|mesh-list
43640978|NCT01602666|Etoposide|etoposide|mesh-list
43640979|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
43640980|NCT01602666|Ifosfamide|ifosfamide|mesh-list
43640981|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
43640982|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
43640983|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640984|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43640985|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43640986|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43640987|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640988|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640989|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43640990|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
43640991|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
43640992|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
43640993|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
43640994|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
43640995|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
43640996|NCT01554956|Plasminogen|plasminogen|mesh-list
43640997|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43640998|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43640999|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641000|NCT01553149|Lenalidomide|lenalidomide|mesh-list
43696567|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696568|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43696569|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43641023|NCT01500551|Tofacitinib|tofacitinib|mesh-list
43641024|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43641025|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641026|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641027|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
43641028|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
43641029|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43641030|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43641031|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641032|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641034|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641064|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641065|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641066|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
43641067|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641068|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43641069|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43641070|NCT01371981|Analgesics|analgesics|mesh-ancestor
43641071|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
43641072|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696570|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696571|NCT02754583|Azithromycin|azithromycin|mesh-list
43696572|NCT02754583|Tetracycline|tetracycline|mesh-list
43696573|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43696574|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696575|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43696576|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696577|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696578|NCT02754596|Timolol|timolol|mesh-list
43696579|NCT02754596|Travoprost|travoprost|mesh-list
43696580|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43641073|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
43641074|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
43641075|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
43641076|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
43641081|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641082|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641083|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
43641084|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789164|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
43789165|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789167|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789209|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789210|NCT04921189|Protective Agents|protective agents|mesh-ancestor
43789211|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789212|NCT04921189|Vitamins|vitamins|mesh-ancestor
43789213|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
43789214|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
43789215|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840661|NCT04678895|Naltrexone|naltrexone|mesh-list
43840662|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43840663|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43840664|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840665|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
43641085|NCT01352962|Antiviral Agents|antiviral agents|mesh-ancestor
43641086|NCT01352962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641087|NCT01352962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641088|NCT01352962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641089|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
43641090|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641091|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43641092|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43641152|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43641153|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43641154|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641155|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641156|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43641157|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43641158|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
43641159|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641160|NCT01336140|Protective Agents|protective agents|mesh-ancestor
43696588|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43696589|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43696590|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
43696591|NCT02754687|Nandrolone|nandrolone|mesh-list
43840666|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840667|NCT04678362|Avelumab|avelumab|mesh-list
43840668|NCT04678362|Talazoparib|talazoparib|mesh-list
43840669|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43840670|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840671|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43840672|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840673|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840674|NCT04678154|Vancomycin|vancomycin|mesh-list
43840675|NCT04678154|Tobramycin|tobramycin|mesh-list
43840676|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43840678|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
43840679|NCT04678050|Ketamine|ketamine|mesh-list
43840680|NCT04678050|Propofol|propofol|mesh-list
43840681|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43840682|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840683|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840684|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43840685|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
43840686|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
43840687|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43840696|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840698|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43840699|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43840700|NCT04677387|Naloxone|naloxone|mesh-list
43840701|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43840702|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840703|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
43840704|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840705|NCT04676204|Teriflunomide|teriflunomide|mesh-list
43840706|NCT04676204|Cladribine|cladribine|mesh-list
43840707|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43840708|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43840709|NCT04676204|Ozanimod|ozanimod|mesh-list
43840710|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597436|NCT03308552|Paclitaxel|paclitaxel|mesh-list
43840711|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43789217|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43789254|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789255|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789256|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789258|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789259|NCT04595994|Gemcitabine|gemcitabine|mesh-list
43789260|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43789261|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
43789262|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789263|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789315|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789316|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696592|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
43696593|NCT02754687|Androgens|androgens|mesh-ancestor
43696594|NCT02754687|Hormones|hormones|mesh-ancestor
43696595|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696596|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696597|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
43696598|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43696599|NCT02754362|Bevacizumab|bevacizumab|mesh-list
43696600|NCT02754362|Poly ICLC|poly iclc|mesh-list
43641193|NCT01281176|Paclitaxel|paclitaxel|mesh-list
43641194|NCT01281176|Carboplatin|carboplatin|mesh-list
43696601|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
43696602|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
43696603|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696604|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696605|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43696606|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43696607|NCT02754362|Growth Substances|growth substances|mesh-ancestor
43696608|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696609|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
43696610|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
43696611|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
43696612|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43696627|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
43696628|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696629|NCT02753803|Pioglitazone|pioglitazone|mesh-list
43696630|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43696631|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696633|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43696634|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696635|NCT02754180|Gemcitabine|gemcitabine|mesh-list
43696638|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696639|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696640|NCT02754180|Antiviral Agents|antiviral agents|mesh-ancestor
43696641|NCT02754180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696642|NCT02754180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696643|NCT02754180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696644|NCT02754180|Immunologic Factors|immunologic factors|mesh-ancestor
43696645|NCT02754180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696647|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43696648|NCT02753725|Narcotics|narcotics|mesh-ancestor
43696649|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696650|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696651|NCT02753725|Analgesics|analgesics|mesh-ancestor
43696652|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
43696653|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696654|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43696655|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43696656|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
43789317|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43789318|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43789319|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789320|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789321|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641220|NCT01174121|Aldesleukin|aldesleukin|mesh-list
43641221|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
43641222|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
43641223|NCT01174121|Fludarabine|fludarabine|mesh-list
43641226|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641227|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641228|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43641229|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
43641230|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641231|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641232|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43641233|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43641234|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43641235|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43641236|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
43641237|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641238|NCT01125228|Interferons|interferons|mesh-list
43641239|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
43641240|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
43641241|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641242|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
43789323|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
43789324|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789325|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43789326|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43789327|NCT04234022|Growth Substances|growth substances|mesh-ancestor
43641243|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641244|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
43641245|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641246|NCT01054196|Lenalidomide|lenalidomide|mesh-list
43641247|NCT01054196|Melphalan|melphalan|mesh-list
43641248|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
43641249|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641250|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43641251|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43641259|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641260|NCT00980460|Sirolimus|sirolimus|mesh-list
43789328|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
43789329|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789330|NCT04165993|Docetaxel|docetaxel|mesh-list
43789331|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789332|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
43789333|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
43789334|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
43789335|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789336|NCT03984045|Lidocaine|lidocaine|mesh-list
43789337|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
43789338|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
43789365|NCT03930602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43789366|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43789367|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789368|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789369|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789370|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
43789371|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43789372|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
43789373|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43789374|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43789375|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789376|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43789423|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43641261|NCT00980460|Cisplatin|cisplatin|mesh-list
43641262|NCT00980460|Doxorubicin|doxorubicin|mesh-list
43641263|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43641264|NCT00980460|Fluorouracil|fluorouracil|mesh-list
43641265|NCT00980460|Irinotecan|irinotecan|mesh-list
43641266|NCT00980460|Vincristine|vincristine|mesh-list
43641267|NCT00980460|Camptothecin|camptothecin|mesh-list
43641268|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
43641269|NCT00980460|Razoxane|razoxane|mesh-list
43641270|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
43641271|NCT00980460|Liver Extracts|liver extracts|mesh-list
43641272|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789424|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789425|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43789426|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43789475|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789476|NCT01611116|Sirolimus|sirolimus|mesh-list
43789477|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43789478|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789479|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43789480|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789481|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
43789482|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43789483|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
43789484|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840712|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
43840713|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840714|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43840715|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840716|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
43840717|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43840718|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43840719|NCT04676204|Analgesics|analgesics|mesh-ancestor
43840724|NCT04675931|Artesunate|artesunate|mesh-list
43789498|NCT05128292|Protective Agents|protective agents|mesh-ancestor
43789499|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789500|NCT05128292|Trace Elements|trace elements|mesh-ancestor
43789501|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
43789502|NCT05128175|Levodopa|levodopa|mesh-list
43789503|NCT05128175|Carbidopa|carbidopa|mesh-list
43789504|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43789505|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43789516|NCT05128162|Psilocybin|psilocybin|mesh-list
43789537|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
43789538|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789539|NCT05127369|Fluoxetine|fluoxetine|mesh-list
43789540|NCT05127369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43789541|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43789542|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789543|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789544|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789545|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
43789546|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789547|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43789548|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
43789549|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43789550|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43789551|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43789552|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789553|NCT05126901|Ferric maltol|ferric maltol|mesh-list
43789554|NCT05126901|Hematinics|hematinics|mesh-ancestor
43789555|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
43789562|NCT05126602|Vitamin D|vitamin d|mesh-list
43789592|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789593|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641273|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43641274|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43641275|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43641276|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641277|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641278|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
43641279|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641280|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641281|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
43641282|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641283|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43641284|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43641285|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
43641286|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
43641287|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
43641288|NCT00980460|Hematinics|hematinics|mesh-ancestor
43641289|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43641290|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641291|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
43641292|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43641293|NCT00980460|Protective Agents|protective agents|mesh-ancestor
43789594|NCT05125627|Progesterone|progesterone|mesh-list
43789595|NCT05125627|Progestins|progestins|mesh-ancestor
43789596|NCT05125627|Hormones|hormones|mesh-ancestor
43789597|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789598|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789599|NCT05125588|Meloxicam|meloxicam|mesh-list
43789600|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43789601|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43789602|NCT05125588|Analgesics|analgesics|mesh-ancestor
43789603|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
43789604|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789605|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789606|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43789607|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43789608|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43789609|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43789610|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789611|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789612|NCT05125575|Metformin|metformin|mesh-list
43789644|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789645|NCT05125042|Amiodarone|amiodarone|mesh-list
43789646|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43789647|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
43789648|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43789649|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43696658|NCT02753764|Prednisone|prednisone|mesh-list
43696660|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696661|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
43696662|NCT02753764|Hormones|hormones|mesh-ancestor
43696663|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696664|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696665|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43696666|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696667|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43696668|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696669|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696689|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43696691|NCT02753712|Xhance|xhance|mesh-list
43641347|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696727|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696728|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
43696730|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696731|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43696732|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43696733|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
43696734|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
43696735|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
43696736|NCT02753426|Doxycycline|doxycycline|mesh-list
43641348|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43641349|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641350|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
43641351|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43641352|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43641353|NCT00602641|Growth Substances|growth substances|mesh-ancestor
43641354|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
43641355|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43641356|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
43641357|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641359|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641361|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43641362|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789650|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789651|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43789652|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43789653|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43641388|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43641389|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
43641390|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641391|NCT00494234|Olaparib|olaparib|mesh-list
43641392|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43641393|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641394|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641395|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641396|NCT00493298|Natalizumab|natalizumab|mesh-list
43641397|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
43641414|NCT00065676|Quercetin|quercetin|mesh-list
43641415|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
43696737|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43696738|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696739|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
43696740|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43696741|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43696742|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
43641453|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
43641454|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43641455|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641456|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
43641457|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
43641459|NCT00001521|Flutamide|flutamide|mesh-list
43641460|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641461|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43641466|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
43641509|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43641511|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696786|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43696787|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
43696788|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
43696789|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
43696790|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
43696791|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696792|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696793|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
43696794|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43696795|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696796|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696797|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43696798|NCT02753205|Analgesics|analgesics|mesh-ancestor
43696799|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
43696888|NCT02752503|Nalmefene|nalmefene|mesh-list
43696889|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43696890|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696891|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
43696892|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696893|NCT02752555|Antioxidants|antioxidants|mesh-list
43696894|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696895|NCT02752555|Protective Agents|protective agents|mesh-ancestor
43696896|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696897|NCT02752724|Ketamine|ketamine|mesh-list
43696898|NCT02752724|Methohexital|methohexital|mesh-list
43696899|NCT02752724|Analgesics|analgesics|mesh-ancestor
43696900|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
43696901|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696902|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696903|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43696904|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43696906|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
43696974|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696975|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43696976|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
43696977|NCT02752334|Bupivacaine|bupivacaine|mesh-list
43697085|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43697086|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697087|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697088|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697089|NCT02751294|Tafenoquine|tafenoquine|mesh-list
43697090|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
43697091|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43697092|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43697093|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697094|NCT02751307|Metformin|metformin|mesh-list
43697095|NCT02751307|Clozapine|clozapine|mesh-list
43697096|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697104|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697105|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43697106|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
43697107|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
43697108|NCT05429775|Budesonide|budesonide|mesh-list
43697109|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43697110|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43697111|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
43697112|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697113|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697114|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43697115|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
43697116|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
43697117|NCT05429775|Hormones|hormones|mesh-ancestor
43697119|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43697150|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43697151|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697152|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697153|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
43697154|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43697155|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43697156|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697157|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
43697158|NCT05429580|Coagulants|coagulants|mesh-ancestor
43697159|NCT05429567|Fentanyl|fentanyl|mesh-list
43697160|NCT05429567|Bupivacaine|bupivacaine|mesh-list
43830037|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697370|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
43697498|NCT03465774|Doxycycline|doxycycline|mesh-list
43697630|NCT02655523|Hormones|hormones|mesh-ancestor
43697631|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697633|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697634|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697635|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
43697636|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697637|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
43697638|NCT02644291|Mebendazole|mebendazole|mesh-list
43697639|NCT02644291|Piperazine|piperazine|mesh-list
43697640|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
43697641|NCT02644291|DMP 777|dmp 777|mesh-list
43697642|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
43697643|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
43697652|NCT02499562|Entecavir|entecavir|mesh-list
43697795|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43697796|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
43697797|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697798|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830062|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830063|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43830064|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830065|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830066|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43697973|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43697974|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
43697975|NCT02749890|Lixisenatide|lixisenatide|mesh-list
43697976|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43697977|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697978|NCT02750163|Acetaminophen|acetaminophen|mesh-list
43697979|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43697980|NCT02750163|Analgesics|analgesics|mesh-ancestor
43697981|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
43697982|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698025|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
43698026|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698027|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698028|NCT02749409|Parecoxib|parecoxib|mesh-list
43698029|NCT02749409|Morphine|morphine|mesh-list
43698030|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43830098|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830099|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43830100|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43830101|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
43830102|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
43830103|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43830104|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43830105|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43830106|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
43830110|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830111|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830112|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
43830113|NCT05382650|Antibodies|antibodies|mesh-list
43830114|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
43830115|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43830116|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43830117|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
43830118|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830119|NCT05382442|Leucovorin|leucovorin|mesh-list
43830120|NCT05382442|Bevacizumab|bevacizumab|mesh-list
43830121|NCT05382442|Fluorouracil|fluorouracil|mesh-list
43830122|NCT05382442|Capecitabine|capecitabine|mesh-list
43830123|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
43830124|NCT05382442|Irinotecan|irinotecan|mesh-list
43830125|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830126|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830127|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43830128|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43830129|NCT05382442|Growth Substances|growth substances|mesh-ancestor
43830130|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830131|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
43830132|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
43830141|NCT05382442|Protective Agents|protective agents|mesh-ancestor
43830142|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
43830143|NCT05382442|Vitamins|vitamins|mesh-ancestor
43830144|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
43830145|NCT05382104|Maribavir|maribavir|mesh-list
43830146|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
43830147|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830148|NCT05381948|Aflibercept|aflibercept|mesh-list
43830149|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43830150|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43698045|NCT02749396|Interferons|interferons|mesh-list
43698046|NCT02749396|Interferon-beta|interferon-beta|mesh-list
43698047|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
43698048|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
43698049|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698050|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
43698051|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698052|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
43698053|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698054|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43698056|NCT02749123|Menthol|menthol|mesh-list
43698057|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
43698058|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
43698059|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698060|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698061|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
43698062|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698063|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43698064|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43698081|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698082|NCT02749162|Acetaminophen|acetaminophen|mesh-list
43698083|NCT02749162|Dexamethasone|dexamethasone|mesh-list
43698084|NCT02749162|Lidocaine|lidocaine|mesh-list
43698085|NCT02749162|Morphine|morphine|mesh-list
43698086|NCT02749162|Ropivacaine|ropivacaine|mesh-list
43698087|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43698088|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698089|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
43698090|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
43698091|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698092|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698093|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43698094|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
43698095|NCT02749162|Hormones|hormones|mesh-ancestor
43698096|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698097|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43698098|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698099|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
43698100|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
43698101|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789654|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789655|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43789656|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43789657|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43789658|NCT05124951|Cisplatin|cisplatin|mesh-list
43789659|NCT05124951|Carboplatin|carboplatin|mesh-list
43789660|NCT05124951|Etoposide|etoposide|mesh-list
43789661|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
43789662|NCT05124951|Ifosfamide|ifosfamide|mesh-list
43789663|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789664|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43789665|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43789666|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43698103|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43698104|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43698105|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43698106|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698107|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698108|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43698109|NCT02749162|Narcotics|narcotics|mesh-ancestor
43698110|NCT02749162|Analgesics|analgesics|mesh-ancestor
43698111|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698112|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
43698114|NCT02749136|Folfirinox|folfirinox|mesh-list
43698121|NCT02749136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698122|NCT02749136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698123|NCT02749136|Immunologic Factors|immunologic factors|mesh-ancestor
43698124|NCT02749136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698125|NCT02748772|Thalidomide|thalidomide|mesh-list
43698126|NCT02748772|Endostar protein|endostar protein|mesh-list
43698127|NCT02748772|Endostatins|endostatins|mesh-list
43698128|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698129|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
43698130|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698131|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
43698166|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43698167|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43698168|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
43698169|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
43698170|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698171|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
43698172|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43698173|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
43698174|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
43698175|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43698176|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43698177|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43698178|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
43698179|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698181|NCT02748265|Protective Agents|protective agents|mesh-ancestor
43698208|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698209|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
43698210|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698211|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43698212|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43698213|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43698214|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849499|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698272|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698273|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43698274|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
43698275|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698276|NCT02747823|Bevacizumab|bevacizumab|mesh-list
43698277|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43698278|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698279|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43698280|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43698281|NCT02747823|Growth Substances|growth substances|mesh-ancestor
43698282|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698283|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
43698284|NCT02747511|Haloperidol|haloperidol|mesh-list
43698285|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
43698286|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
43700235|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43789667|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698287|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
43698288|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698289|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698290|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43698291|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43698292|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43698293|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698294|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43698295|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43698296|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
43698297|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698298|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698299|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43698300|NCT02747537|Irinotecan|irinotecan|mesh-list
43698301|NCT02747537|Sorafenib|sorafenib|mesh-list
43698302|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43698303|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43698304|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698305|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698308|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
43830156|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43830157|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830158|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
43830159|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
43830160|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
43830161|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698315|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43698316|NCT02747316|Trace Elements|trace elements|mesh-ancestor
43698317|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
43698318|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698321|NCT02746744|Rituximab|rituximab|mesh-list
43698362|NCT02746276|Metronidazole|metronidazole|mesh-list
43698363|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
43698364|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698365|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43698366|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43698367|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43698368|NCT02746380|Adalimumab|adalimumab|mesh-list
43698369|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698370|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698371|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
43698372|NCT02745990|Hematinics|hematinics|mesh-ancestor
43698373|NCT02745925|Ibuprofen|ibuprofen|mesh-list
43698374|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43698375|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698376|NCT02745925|Analgesics|analgesics|mesh-ancestor
43698377|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
43698380|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698416|NCT02745860|Selexipag|selexipag|mesh-list
43698417|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43698418|NCT02745639|Capecitabine|capecitabine|mesh-list
43698419|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
43698420|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43698421|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
43698422|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698423|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830162|NCT05381753|Sunitinib|sunitinib|mesh-list
43830163|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
43830164|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830165|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43830166|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43830167|NCT05381753|Growth Substances|growth substances|mesh-ancestor
43830168|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830173|NCT05380947|Rabeprazole|rabeprazole|mesh-list
43830190|NCT05380024|Ensartinib|ensartinib|mesh-list
43830191|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830192|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43830193|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830194|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830195|NCT05379686|Glucagon|glucagon|mesh-list
43830196|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43830197|NCT05379686|Hormones|hormones|mesh-ancestor
43830200|NCT05379491|Linaclotide|linaclotide|mesh-list
43698448|NCT02745561|Endostatins|endostatins|mesh-list
43698449|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698450|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43698451|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43698452|NCT02745561|Growth Substances|growth substances|mesh-ancestor
43698453|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698454|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
43698455|NCT02745522|Oxytocin|oxytocin|mesh-list
43698456|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
43698457|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698458|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698459|NCT02745769|Ramucirumab|ramucirumab|mesh-list
43698460|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698461|NCT02745470|Lixisenatide|lixisenatide|mesh-list
43698462|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698463|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698464|NCT02745431|Oxytocin|oxytocin|mesh-list
43698465|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
43698466|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698467|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698468|NCT02745054|Anticoagulants|anticoagulants|mesh-list
43698471|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43698472|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
43698473|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698474|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698475|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43698476|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43698477|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
43698478|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43698479|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43698480|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43698481|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43698482|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
43698483|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43698484|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43698485|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
43698486|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698487|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
43698488|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43698490|NCT02744690|Mitomycins|mitomycins|mesh-list
43698516|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
43698518|NCT02744768|Blinatumomab|blinatumomab|mesh-list
43698519|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698520|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43698521|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698522|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698524|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43698525|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43698526|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43698527|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698528|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698529|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43698530|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789668|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789669|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43789670|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
43789671|NCT05124938|Hormones|hormones|mesh-list
43789672|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789673|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789674|NCT05124730|Metformin|metformin|mesh-list
43789675|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789676|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789681|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789682|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43789683|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
43789684|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789685|NCT05115591|Anesthetics|anesthetics|mesh-list
43789686|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789687|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789688|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
43789689|NCT05109949|Empagliflozin|empagliflozin|mesh-list
43789690|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43789691|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698538|NCT02744638|Metronidazole|metronidazole|mesh-list
43698539|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698540|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43698541|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43698542|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43698543|NCT02744937|Aspirin|aspirin|mesh-list
43698544|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43698545|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698546|NCT02744937|Analgesics|analgesics|mesh-ancestor
43698547|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
43698548|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698558|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
43698569|NCT02744417|Varenicline|varenicline|mesh-list
43698570|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43698571|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
43698572|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698573|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698574|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43698575|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43698576|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
43698577|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698578|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698579|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43698580|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
43698581|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43698582|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43698588|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698591|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698592|NCT02744508|Dexamethasone|dexamethasone|mesh-list
43698593|NCT02744508|Palonosetron|palonosetron|mesh-list
43698594|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698595|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
43698596|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
43698597|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698598|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698599|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43698600|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
43698601|NCT02744508|Hormones|hormones|mesh-ancestor
43698625|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43698626|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43698627|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698628|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698629|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43698630|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698631|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
43698638|NCT02744222|Interferons|interferons|mesh-list
43698639|NCT02744222|Interferon-beta|interferon-beta|mesh-list
43698640|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
43698662|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
43698663|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43698665|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
43698666|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698667|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43698700|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698701|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698702|NCT02744131|Estrogens|estrogens|mesh-ancestor
43698703|NCT02744131|Hormones|hormones|mesh-ancestor
43698704|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698705|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698706|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43698707|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
43698708|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
43698763|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43698764|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
43698765|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43698766|NCT02743182|Interferons|interferons|mesh-list
43698767|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
43698768|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
43698769|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43698770|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698771|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
43698772|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698773|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
43698774|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698775|NCT02743429|Dinutuximab|dinutuximab|mesh-list
43698776|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849502|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698788|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698789|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43698790|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698791|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43698849|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43698850|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698852|NCT02742675|Goserelin|goserelin|mesh-list
43698853|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43698854|NCT02742675|Flutamide|flutamide|mesh-list
43698855|NCT02742675|Bicalutamide|bicalutamide|mesh-list
43698856|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43698857|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
43698858|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698859|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698860|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43698861|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698862|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
43698869|NCT02742805|Vitamin D|vitamin d|mesh-list
43698919|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698944|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698945|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698946|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43698947|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
43698948|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698949|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698950|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43698951|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
43698952|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43698962|NCT02742038|Fluorides|fluorides|mesh-list
43698985|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698986|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698987|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698988|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698989|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43698990|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43698991|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698992|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43698993|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43698994|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698995|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
43699120|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699121|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699122|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
43699123|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43699124|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
43699125|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43699126|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43699127|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43699128|NCT02740803|Listerine|listerine|mesh-list
43699129|NCT02740803|Fluorides|fluorides|mesh-list
43699130|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
43699131|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
43699132|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
43699133|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
43699134|NCT02740803|Protective Agents|protective agents|mesh-ancestor
43699135|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699136|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43699137|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699138|NCT02741024|Artesunate|artesunate|mesh-list
43699139|NCT02741024|Lumefantrine|lumefantrine|mesh-list
43699140|NCT02741024|Artemether|artemether|mesh-list
43699141|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43699147|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699148|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
43699149|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
43699150|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43699151|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
43699152|NCT02740647|Amoxicillin|amoxicillin|mesh-list
43699153|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
43699154|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
43699155|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43699156|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699157|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699159|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699227|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699228|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43699229|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43830289|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
43830291|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830292|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830293|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
43830294|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830295|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43830296|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43830297|NCT05370417|Fluorides|fluorides|mesh-list
43830298|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
43830299|NCT05370417|Protective Agents|protective agents|mesh-ancestor
43830300|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699284|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43699285|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43699286|NCT02739685|Everolimus|everolimus|mesh-list
43699287|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699288|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43699289|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
43699291|NCT02739633|Gemcitabine|gemcitabine|mesh-list
43699295|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
43699296|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
43699344|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699345|NCT02739399|Protective Agents|protective agents|mesh-ancestor
43699346|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43699347|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699348|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43699349|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699350|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699351|NCT02739204|Celecoxib|celecoxib|mesh-list
43699352|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43699353|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43699354|NCT02739204|Analgesics|analgesics|mesh-ancestor
43699402|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699403|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43699404|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43699405|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43699406|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43699407|NCT02738905|Rifaximin|rifaximin|mesh-list
43699408|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699409|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699410|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43699528|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699529|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43699530|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
43699531|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43699532|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
43699533|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43699534|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699567|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699568|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43699674|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43699675|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699676|NCT02736435|Leuprolide|leuprolide|mesh-list
43699677|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43699678|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
43699679|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43699690|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43699691|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
43699765|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43789692|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789693|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789694|NCT05104918|Vortioxetine|vortioxetine|mesh-list
43789695|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43789696|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43789737|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789738|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43789739|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43789740|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
43789741|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
43789742|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
43789743|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789744|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789745|NCT04979910|Ixekizumab|ixekizumab|mesh-list
43789746|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
43789747|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
43789748|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43789749|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789750|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789751|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598013|NCT03302650|Norepinephrine|norepinephrine|mesh-list
43789794|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43789795|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789796|NCT04874831|Avelumab|avelumab|mesh-list
43789797|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789798|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789799|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43789800|NCT04846218|Progesterone|progesterone|mesh-list
43789853|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43789854|NCT04722601|Azacitidine|azacitidine|mesh-list
43789855|NCT04722601|Venetoclax|venetoclax|mesh-list
43789856|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
43789857|NCT04722601|Cc-486|cc-486|mesh-list
43789858|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43789859|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
43789860|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789861|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789862|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789863|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43699780|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43699782|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43699783|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699784|NCT02735590|Isoniazid|isoniazid|mesh-list
43699785|NCT02735590|Rifapentine|rifapentine|mesh-list
43699786|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
43699787|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699788|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699789|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43699790|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43699791|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
43699792|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699793|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43699849|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699850|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699851|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43699898|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699899|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699901|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
43699940|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830429|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830430|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830431|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
43830432|NCT05363631|Protective Agents|protective agents|mesh-ancestor
43830433|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830435|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
43830436|NCT05363267|Curcumin|curcumin|mesh-list
43830437|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43700038|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700039|NCT02733874|Betamethasone|betamethasone|mesh-list
43700040|NCT02733874|Clobetasol|clobetasol|mesh-list
43700041|NCT02733874|Calcipotriene|calcipotriene|mesh-list
43700042|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700043|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
43700044|NCT02733874|Hormones|hormones|mesh-ancestor
43700045|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700046|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700047|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43700048|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
43700049|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
43700059|NCT02733705|Narcotics|narcotics|mesh-ancestor
43700060|NCT02733705|Analgesics|analgesics|mesh-ancestor
43789864|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
43789865|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43789866|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789867|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789868|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43789869|NCT04700514|Analgesics|analgesics|mesh-ancestor
43789870|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
43789873|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43789909|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
43789910|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789911|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43789912|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
43789913|NCT04617067|Antiviral Agents|antiviral agents|mesh-ancestor
43789914|NCT04617067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789915|NCT04617067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789916|NCT04617067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43789917|NCT04617067|Immunologic Factors|immunologic factors|mesh-ancestor
43789918|NCT04617067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789919|NCT04584567|Doxycycline|doxycycline|mesh-list
43789920|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43789921|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789922|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
43789923|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43789924|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43789925|NCT04576325|Voriconazole|voriconazole|mesh-list
43789926|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
43789927|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789928|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43789929|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43789930|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789931|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789932|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43789933|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
43789934|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789935|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789937|NCT04572828|Naproxen|naproxen|mesh-list
43789953|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789954|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43840747|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
43840748|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
43840749|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
43840750|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840751|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43840752|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840753|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840754|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840755|NCT04673175|Tazobactam|tazobactam|mesh-list
43840756|NCT04673175|Ceftolozane|ceftolozane|mesh-list
43840757|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
43840758|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43840759|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789992|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43789993|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789994|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43789995|NCT04264663|Renal Agents|renal agents|mesh-ancestor
43789996|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43789997|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43789998|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43789999|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43790000|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790001|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790002|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
43790003|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43790004|NCT04256434|Nalbuphine|nalbuphine|mesh-list
43790005|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43790006|NCT04256434|Narcotics|narcotics|mesh-ancestor
43790007|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790008|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790009|NCT04256434|Analgesics|analgesics|mesh-ancestor
43790010|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
43790011|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790012|NCT04185012|Benralizumab|benralizumab|mesh-list
43790013|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43790014|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
43790015|NCT04139655|Colchicine|colchicine|mesh-list
43790024|NCT04122287|Ofloxacin|ofloxacin|mesh-list
43790041|NCT04030000|Paclitaxel|paclitaxel|mesh-list
43790042|NCT04030000|Carboplatin|carboplatin|mesh-list
43790043|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43790044|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790045|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790046|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
43790047|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
43790048|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790049|NCT04028115|Ixazomib|ixazomib|mesh-list
43790050|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790051|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
43790052|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790053|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790054|NCT03927443|Bimatoprost|bimatoprost|mesh-list
43790055|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43790056|NCT03913247|Metronidazole|metronidazole|mesh-list
43790065|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
43790068|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790125|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43790126|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43790127|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790128|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790129|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790130|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790131|NCT03131726|Simvastatin|simvastatin|mesh-list
43790132|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43790133|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43790134|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
43790135|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790136|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43598408|NCT03299842|Fenfluramine|fenfluramine|mesh-list
43790137|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43790138|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790140|NCT03023462|Oxycodone|oxycodone|mesh-list
43790141|NCT03023462|Ondansetron|ondansetron|mesh-list
43790142|NCT03023462|Ropivacaine|ropivacaine|mesh-list
43790184|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790318|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
43840763|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43840764|NCT04673175|Renal Agents|renal agents|mesh-ancestor
43840765|NCT04672941|Bromides|bromides|mesh-list
43840766|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
43840767|NCT04672941|Olodaterol|olodaterol|mesh-list
43840768|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43840769|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
43840770|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840771|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840772|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43840773|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
43840774|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
43840775|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43840776|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
43840777|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840778|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840779|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
43840780|NCT04672395|Vaccines|vaccines|mesh-list
43840781|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
43840782|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
43840783|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840784|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43840785|NCT04672005|Leucovorin|leucovorin|mesh-list
43840786|NCT04672005|Gemcitabine|gemcitabine|mesh-list
43840787|NCT04672005|Paclitaxel|paclitaxel|mesh-list
43598487|NCT03299036|Doxorubicin|doxorubicin|mesh-list
43840788|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43840789|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
43840790|NCT04672005|Irinotecan|irinotecan|mesh-list
43840791|NCT04672005|Folfirinox|folfirinox|mesh-list
43840792|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43790185|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
43790186|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43790187|NCT02730325|Antibodies|antibodies|mesh-list
43790188|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
43790192|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790193|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43790195|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790196|NCT02512692|Antiviral Agents|antiviral agents|mesh-ancestor
43790197|NCT02512692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790198|NCT02512692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790199|NCT02512692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790200|NCT02512692|Immunologic Factors|immunologic factors|mesh-ancestor
43790201|NCT02512692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790202|NCT02432404|NuvaRing|nuvaring|mesh-list
43790203|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43790204|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
43790205|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43790206|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790252|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
43790253|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790254|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
43790255|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790256|NCT00700791|Protective Agents|protective agents|mesh-ancestor
43790257|NCT00280202|Dimercaprol|dimercaprol|mesh-list
43790258|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
43790259|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
43790260|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790261|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
43790262|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43790263|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790264|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43790265|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
43790266|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43790267|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790308|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790309|NCT05128721|Vaccines|vaccines|mesh-list
43790310|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
43790311|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790312|NCT05128630|Durvalumab|durvalumab|mesh-list
43790313|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790314|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790315|NCT05097794|Indapamide|indapamide|mesh-list
43790316|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43790317|NCT05097794|Diuretics|diuretics|mesh-ancestor
43790331|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
43790332|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790333|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
43790334|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
43790359|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43790360|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790361|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43790362|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790363|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840793|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840794|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
43840795|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
43840796|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
43840797|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840798|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43840799|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
43840800|NCT04672005|Antiviral Agents|antiviral agents|mesh-ancestor
43840801|NCT04672005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840802|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840803|NCT04672005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43840804|NCT04672005|Immunologic Factors|immunologic factors|mesh-ancestor
43840805|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840806|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43840807|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43840808|NCT04672005|Antidotes|antidotes|mesh-ancestor
43840809|NCT04672005|Protective Agents|protective agents|mesh-ancestor
43840811|NCT04672005|Vitamins|vitamins|mesh-ancestor
43840839|NCT04669171|Growth Substances|growth substances|mesh-ancestor
43840840|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
43840841|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43790364|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43790365|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790366|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790367|NCT04405674|Paclitaxel|paclitaxel|mesh-list
43790368|NCT04405674|Bevacizumab|bevacizumab|mesh-list
43790369|NCT04405674|Carboplatin|carboplatin|mesh-list
43790370|NCT04405674|Pemetrexed|pemetrexed|mesh-list
43790371|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43790372|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790373|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790374|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
43790375|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
43790376|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790409|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43790410|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43790411|NCT04227314|Analgesics|analgesics|mesh-ancestor
43790412|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
43790413|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790414|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790415|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790416|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790417|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43790418|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43790419|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790420|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790421|NCT04223648|Nivolumab|nivolumab|mesh-list
43790422|NCT04223648|Ipilimumab|ipilimumab|mesh-list
43790423|NCT04223648|Durvalumab|durvalumab|mesh-list
43790424|NCT04223648|Tremelimumab|tremelimumab|mesh-list
43790425|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790426|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790427|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43790428|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790429|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
43790430|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
43790431|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43790439|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43790441|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
43790442|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790443|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790444|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
43790445|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
43790446|NCT04094675|Sirolimus|sirolimus|mesh-list
43790447|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43790448|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790449|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43790450|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790451|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
43790452|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790453|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
43790454|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790455|NCT04076748|Sufentanil|sufentanil|mesh-list
43790456|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43790457|NCT04076748|Narcotics|narcotics|mesh-ancestor
43790458|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790459|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790460|NCT04076748|Analgesics|analgesics|mesh-ancestor
43790461|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
43790462|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790463|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43790464|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43790465|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
43790466|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
43790467|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
43790468|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43790486|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
43790487|NCT04047862|Pemetrexed|pemetrexed|mesh-list
43790488|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43790489|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790656|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790657|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790658|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43790659|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43790660|NCT02010606|Growth Substances|growth substances|mesh-ancestor
43790661|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790662|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
43790663|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43790664|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
43790665|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790748|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790749|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
43790750|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
43790751|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790753|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43790754|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790755|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
43790756|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43790757|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43790758|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43790759|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790760|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790761|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
43790762|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43790763|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43790764|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
43790765|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790766|NCT05131295|Antacids|antacids|mesh-ancestor
43790767|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790768|NCT05130684|Paclitaxel|paclitaxel|mesh-list
43790769|NCT05130684|Cisplatin|cisplatin|mesh-list
43790770|NCT05130684|Nivolumab|nivolumab|mesh-list
43790771|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43790772|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790773|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790774|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
43790775|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
43790776|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599183|NCT03293004|Vitamins|vitamins|mesh-list
43790806|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43790807|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43790808|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790821|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790822|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43790823|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
43790824|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43790825|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
43790826|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43790827|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790828|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43790829|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790830|NCT04968899|Dexamethasone|dexamethasone|mesh-list
43790831|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
43790832|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43790833|NCT04968899|Antibodies|antibodies|mesh-list
43790834|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
43790835|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43790836|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790837|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
43790838|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
43840860|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
43840861|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840862|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840863|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
43840864|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43790863|NCT04691505|Methotrexate|methotrexate|mesh-list
43790864|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43790887|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790888|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790889|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
43790890|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790891|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790892|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790894|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
43790895|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790896|NCT04353128|Protective Agents|protective agents|mesh-ancestor
43790897|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790898|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790899|NCT04325880|Tamsulosin|tamsulosin|mesh-list
43790900|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
43790901|NCT04325880|Mirabegron|mirabegron|mesh-list
43790902|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43790903|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43790939|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43790940|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43790941|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
43790956|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790958|NCT03520231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790959|NCT03520231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790960|NCT03520231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791015|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791017|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43791018|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43791019|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791020|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43791022|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
43791023|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791024|NCT01308190|Capecitabine|capecitabine|mesh-list
43791025|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43791026|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
43791027|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791028|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791029|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
43791030|NCT01210768|Doxorubicin|doxorubicin|mesh-list
43791031|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43791033|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791034|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
43791035|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791036|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43791037|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43791038|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
43791039|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791040|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791041|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43791042|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43791043|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43791044|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43791045|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791046|NCT00719225|Abatacept|abatacept|mesh-list
43791047|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43791048|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791049|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791050|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791051|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
43791052|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791053|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43791064|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43791065|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43791066|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791067|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791068|NCT05134337|Itraconazole|itraconazole|mesh-list
43791069|NCT05134337|Rifampin|rifampin|mesh-list
43791070|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
43791071|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791072|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43791073|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43791074|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791075|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791076|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43791077|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
43791078|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791079|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791080|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43791081|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43791082|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
43791083|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43599465|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
43840869|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43840870|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840871|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43840872|NCT04666701|Ketorolac|ketorolac|mesh-list
43840873|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43840874|NCT04666701|Scopolamine|scopolamine|mesh-list
43840875|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43840876|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43840877|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43840878|NCT04666701|Analgesics|analgesics|mesh-ancestor
43840879|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
43840880|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840881|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840882|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840883|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840884|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43840898|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
43840899|NCT04666129|Docetaxel|docetaxel|mesh-list
43840900|NCT04666129|Relugolix|relugolix|mesh-list
43840901|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840902|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
43840903|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
43840904|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
43791139|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791140|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43791141|NCT05133635|Protective Agents|protective agents|mesh-ancestor
43791142|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43791143|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791144|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
43791145|NCT05133258|Dexamethasone|dexamethasone|mesh-list
43791146|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791147|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
43791148|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
43791149|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791150|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791151|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43791152|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
43791153|NCT05133258|Hormones|hormones|mesh-ancestor
43791154|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791155|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43791156|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791157|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43791165|NCT05133050|Ramipril|ramipril|mesh-list
43791166|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43791167|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
43791168|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791169|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791171|NCT05132777|Osimertinib|osimertinib|mesh-list
43791172|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791173|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43791174|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791175|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791176|NCT05132712|Losartan|losartan|mesh-list
43791181|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791182|NCT05132413|Bevacizumab|bevacizumab|mesh-list
43791183|NCT05132413|Cisplatin|cisplatin|mesh-list
43791184|NCT05132413|Carboplatin|carboplatin|mesh-list
43791185|NCT05132413|Pemetrexed|pemetrexed|mesh-list
43791186|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791187|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791188|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43791189|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43791190|NCT05132413|Growth Substances|growth substances|mesh-ancestor
43791191|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791192|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
43791193|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791194|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791206|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43791207|NCT05132270|Growth Substances|growth substances|mesh-ancestor
43791208|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
43791209|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791210|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
43791211|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791212|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791213|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43791214|NCT05129176|Metronidazole|metronidazole|mesh-list
43791215|NCT05129176|Levofloxacin|levofloxacin|mesh-list
43791216|NCT05129176|Ofloxacin|ofloxacin|mesh-list
43791217|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791218|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43791219|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43791269|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
43791270|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
43791271|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791272|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791273|NCT05027360|Nitroprusside|nitroprusside|mesh-list
43791274|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43791275|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
43791303|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791304|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791305|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43791306|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43791307|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43791308|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43791309|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
43791310|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
43791311|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
43791312|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
43791313|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791314|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791315|NCT04605796|Bevacizumab|bevacizumab|mesh-list
43791316|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791317|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791318|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43791319|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43791320|NCT04605796|Growth Substances|growth substances|mesh-ancestor
43791321|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791322|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
43840906|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840907|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
43840909|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840910|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840911|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43840912|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
43840913|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
43840914|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840915|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43840916|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43840917|NCT04666129|Protective Agents|protective agents|mesh-ancestor
43840918|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
43840919|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
43791347|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
43791348|NCT04215120|Hematinics|hematinics|mesh-ancestor
43791349|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
43791350|NCT04012957|Hematinics|hematinics|mesh-ancestor
43791351|NCT03883581|Quinidine|quinidine|mesh-list
43791352|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
43791353|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
43791354|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
43791355|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791356|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43791357|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43791358|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791378|NCT03854578|Citalopram|citalopram|mesh-list
43791388|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43791389|NCT03512119|Ivacaftor|ivacaftor|mesh-list
43791390|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43791391|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43791392|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791393|NCT03450772|Pancrelipase|pancrelipase|mesh-list
43791394|NCT03450772|Pancreatin|pancreatin|mesh-list
43791395|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43791396|NCT03445728|Nicorandil|nicorandil|mesh-list
43599827|NCT03286673|Calcium|calcium|mesh-list
43791397|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43791398|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43791399|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
43791400|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
43791401|NCT03445728|Vitamins|vitamins|mesh-ancestor
43791402|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
43791403|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791404|NCT03424460|Hemostatics|hemostatics|mesh-list
43791405|NCT03424460|Coagulants|coagulants|mesh-ancestor
43791406|NCT03278691|Ketorolac|ketorolac|mesh-list
43791407|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43791408|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43791409|NCT03278691|Analgesics|analgesics|mesh-ancestor
43791410|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
43791411|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791412|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791413|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791414|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43791415|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43791416|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791417|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791418|NCT02959619|Ensartinib|ensartinib|mesh-list
43791419|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791420|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43791448|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791449|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791450|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791453|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791455|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43791456|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
43791457|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791458|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791459|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43791483|NCT05136521|Trazodone|trazodone|mesh-list
43791484|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43791485|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43791486|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791487|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791488|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43791489|NCT05136521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43791490|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43791491|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43791492|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791493|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791494|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
43791495|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43791496|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
43791497|NCT05136508|Propofol|propofol|mesh-list
43791498|NCT05136508|Sevoflurane|sevoflurane|mesh-list
43791499|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43791500|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791501|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791502|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43791503|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
43791504|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
43791505|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43791506|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43840920|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43840921|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
43840922|NCT04666051|Coagulants|coagulants|mesh-ancestor
43791551|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43791554|NCT05135013|Progestins|progestins|mesh-ancestor
43791555|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43791557|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43791558|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
43791559|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
43791560|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791561|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791562|NCT05134519|Trastuzumab|trastuzumab|mesh-list
43791563|NCT05134519|Antibodies|antibodies|mesh-list
43791577|NCT05122169|Povidone|povidone|mesh-list
43791578|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43791579|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791580|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
43791581|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
43791582|NCT05122169|Trace Elements|trace elements|mesh-ancestor
43791583|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
43791584|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791605|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43791632|NCT05002192|Eucalyptol|eucalyptol|mesh-list
43791633|NCT05002192|Ambroxol|ambroxol|mesh-list
43791634|NCT05002192|Expectorants|expectorants|mesh-list
43791635|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791636|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791637|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
43791638|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
43791639|NCT05002192|Protective Agents|protective agents|mesh-ancestor
43791640|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791641|NCT04973020|Efavirenz|efavirenz|mesh-list
43791642|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43791643|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43791644|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791645|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791646|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
43791647|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791648|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43791649|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43791650|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43791658|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43791659|NCT04955249|Analgesics|analgesics|mesh-ancestor
43791660|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
43791661|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791662|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43791663|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43791664|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43791665|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791666|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791667|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791669|NCT04886453|Anesthetics|anesthetics|mesh-list
43791670|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791671|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791672|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43791673|NCT04886453|Narcotics|narcotics|mesh-ancestor
43791674|NCT04886453|Analgesics|analgesics|mesh-ancestor
43791683|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791684|NCT04849832|Urological Agents|urological agents|mesh-ancestor
43791687|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791688|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791689|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43791690|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791691|NCT04702464|Fluconazole|fluconazole|mesh-list
43791701|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791702|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43791703|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43791704|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
43791705|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
43791706|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43791707|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43791708|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791709|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791710|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791711|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840942|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43840943|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43848409|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848410|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43848411|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
43848412|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848413|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848414|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43848415|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43848416|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848417|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43848418|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43848419|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43848420|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
43848421|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43848422|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848423|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43848425|NCT04021043|Ipilimumab|ipilimumab|mesh-list
43848426|NCT04021043|Antibodies|antibodies|mesh-list
43848427|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
43848439|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
43848440|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848441|NCT04018937|Fludarabine|fludarabine|mesh-list
43848442|NCT04018937|Melphalan|melphalan|mesh-list
43848443|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
43848444|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848445|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848446|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848447|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
43848448|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848449|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43848450|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
43848451|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43848452|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848453|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43791712|NCT04644705|Niclosamide|niclosamide|mesh-list
43791713|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
43791714|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43791715|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
43791716|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43791717|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791718|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
43791719|NCT04637555|Valsartan|valsartan|mesh-list
43791720|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43791721|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43791722|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43791723|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43791724|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791725|NCT04607122|Landiolol|landiolol|mesh-list
43791726|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43791727|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43791736|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
43791737|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
43791738|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791739|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791740|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
43791741|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43791742|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
43791743|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791744|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43791745|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43791746|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43791747|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791748|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791749|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791750|NCT04576663|Protective Agents|protective agents|mesh-ancestor
43791751|NCT04556357|Phenylephrine|phenylephrine|mesh-list
43791752|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
43791753|NCT04556357|Norepinephrine|norepinephrine|mesh-list
43791754|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43791755|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43791756|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
43700061|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
43700062|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700063|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43700064|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
43700065|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43700066|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43700067|NCT02733510|Prednisolone|prednisolone|mesh-list
43700068|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
43700069|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43700070|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
43791757|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
43791758|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791771|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43791773|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791774|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791775|NCT04553939|Antiviral Agents|antiviral agents|mesh-ancestor
43791776|NCT04553939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791777|NCT04553939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791778|NCT04553939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791779|NCT04553939|Immunologic Factors|immunologic factors|mesh-ancestor
43791780|NCT04553939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791781|NCT04501939|Venetoclax|venetoclax|mesh-list
43791782|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791783|NCT04468425|Tofacitinib|tofacitinib|mesh-list
43791784|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791785|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43791786|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791788|NCT04400695|Vinorelbine|vinorelbine|mesh-list
43791789|NCT04400695|Docetaxel|docetaxel|mesh-list
43791790|NCT04400695|Capecitabine|capecitabine|mesh-list
43791791|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43791792|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791793|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
43791794|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
43791795|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
43791796|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791797|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43791798|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
43791799|NCT04359329|Estradiol|estradiol|mesh-list
43791800|NCT04359329|Estrogens|estrogens|mesh-ancestor
43791801|NCT04359329|Hormones|hormones|mesh-ancestor
43791802|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791803|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791804|NCT04328506|Vorolanib|vorolanib|mesh-list
43791805|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43791806|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791807|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791808|NCT04287855|Dexamethasone|dexamethasone|mesh-list
43791809|NCT04287855|Pomalidomide|pomalidomide|mesh-list
43791810|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791811|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
43791812|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
43791813|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791814|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791815|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43791816|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
43791817|NCT04287855|Hormones|hormones|mesh-ancestor
43791818|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791819|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43791820|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791821|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
43791825|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
43791826|NCT04264897|Metformin|metformin|mesh-list
43791827|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43791828|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791829|NCT04246060|Cysteamine|cysteamine|mesh-list
43791830|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
43791831|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791832|NCT04203875|Abatacept|abatacept|mesh-list
43791833|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43791834|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791835|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791836|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791837|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
43791849|NCT03909217|Dexetimide|dexetimide|mesh-list
43791850|NCT03909217|Citalopram|citalopram|mesh-list
43791851|NCT03909217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43791852|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43791853|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43791854|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791863|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
43791864|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
43791865|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791866|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43791867|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43791868|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
43791889|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791890|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43791891|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791892|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43791893|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43791894|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43791895|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791896|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791897|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791898|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791899|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
43791900|NCT03627858|Hormones|hormones|mesh-ancestor
43791901|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791902|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43791903|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43791904|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43791905|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
43791906|NCT03370172|Factor VIII|factor viii|mesh-list
43791907|NCT03370172|Coagulants|coagulants|mesh-ancestor
43840945|NCT04662086|Camostat|camostat|mesh-list
43840946|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
43840947|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840948|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840949|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43840950|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43840951|NCT04661683|Charcoal|charcoal|mesh-list
43840952|NCT04661683|Antidotes|antidotes|mesh-ancestor
43840953|NCT04661683|Protective Agents|protective agents|mesh-ancestor
43840954|NCT04661683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840955|NCT04661397|Tenofovir|tenofovir|mesh-list
43840956|NCT04661397|Emtricitabine|emtricitabine|mesh-list
43840957|NCT04661397|Darunavir|darunavir|mesh-list
43840958|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43840959|NCT04661397|Cobicistat|cobicistat|mesh-list
43840960|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43840962|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
43840963|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840964|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43840965|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43840966|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848454|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43791908|NCT03159000|Lidocaine|lidocaine|mesh-list
43791909|NCT03159000|Bupivacaine|bupivacaine|mesh-list
43791910|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
43791911|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
43791929|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43791930|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791932|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43791933|NCT02951364|Ledipasvir|ledipasvir|mesh-list
43791934|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
43791935|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791936|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
43791937|NCT02889237|Vitamin D|vitamin d|mesh-list
43791938|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
43791939|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
43791940|NCT02889237|Vitamins|vitamins|mesh-list
43791941|NCT02889237|Calcium|calcium|mesh-list
43791942|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
43791943|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791944|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43791945|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43791946|NCT02856438|Dexamethasone|dexamethasone|mesh-list
43791947|NCT02856438|Lenalidomide|lenalidomide|mesh-list
43791948|NCT02856438|Elotuzumab|elotuzumab|mesh-list
43791949|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791950|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
43791951|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
43791952|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791957|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791958|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43791959|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791961|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43791962|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43791963|NCT02856438|Growth Substances|growth substances|mesh-ancestor
43791964|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
43791965|NCT02808182|Niacin|niacin|mesh-list
43791966|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
43791967|NCT02808182|Niacinamide|niacinamide|mesh-list
43791968|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43791969|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
43791970|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791971|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43791972|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
43791973|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
43791974|NCT02808182|Vitamins|vitamins|mesh-ancestor
43791975|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
43791976|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791977|NCT02689167|Sunitinib|sunitinib|mesh-list
43791978|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791979|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43791980|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43791981|NCT02689167|Growth Substances|growth substances|mesh-ancestor
43791982|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791983|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
43791984|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43791998|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791999|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792000|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43792001|NCT02535221|Epirubicin|epirubicin|mesh-list
43792002|NCT02535221|Goserelin|goserelin|mesh-list
43792003|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43792004|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792005|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43792012|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792013|NCT02525796|Eplerenone|eplerenone|mesh-list
43792014|NCT02525796|Amiloride|amiloride|mesh-list
43792015|NCT02525796|Cinacalcet|cinacalcet|mesh-list
43792016|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43792017|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
43792018|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43792019|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792020|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43792021|NCT02525796|Diuretics|diuretics|mesh-ancestor
43792022|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
43792023|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43792024|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43792029|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792030|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43792031|NCT01669915|Vitamin D|vitamin d|mesh-list
43792032|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
43792033|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
43792034|NCT01669915|Vitamins|vitamins|mesh-list
43792035|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
43792036|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792037|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43792038|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43792039|NCT01503489|Norepinephrine|norepinephrine|mesh-list
43600588|NCT04877821|Paclitaxel|paclitaxel|mesh-list
43792046|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
43792047|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792048|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792049|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792050|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
43792051|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
43792052|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792053|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43792054|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43792055|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43792056|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
43792057|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43792058|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43792060|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43792061|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792062|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
43792063|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
43792064|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
43792065|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792066|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
43792067|NCT00000587|Hematinics|hematinics|mesh-ancestor
43792068|NCT05138146|Doxorubicin|doxorubicin|mesh-list
43792077|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43792079|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
43792080|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792081|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43792082|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
43792083|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43792084|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43792085|NCT05137522|Prednisolone|prednisolone|mesh-list
43792086|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
43792087|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43792088|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
43792089|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43792090|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
43792091|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
43792092|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792093|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792094|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792097|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43792099|NCT05137522|Protective Agents|protective agents|mesh-ancestor
43792100|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43792101|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792103|NCT05137288|Ondansetron|ondansetron|mesh-list
43792104|NCT05137288|Bupivacaine|bupivacaine|mesh-list
43792105|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
43792106|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
43792107|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792108|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792109|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
43792110|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792111|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
43792112|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
43792113|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792114|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
43792115|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
43792116|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43792117|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
43792118|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792119|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792120|NCT05137288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43792125|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43792126|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43792127|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43792128|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
43792130|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
43792131|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43792132|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43792133|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792134|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
43792135|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43792136|NCT05137184|Fentanyl|fentanyl|mesh-list
43792137|NCT05137184|Morphine|morphine|mesh-list
43792138|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
43792139|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43792140|NCT05137184|Narcotics|narcotics|mesh-ancestor
43792163|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43792164|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43792165|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792166|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792167|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792168|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792169|NCT05135715|Trastuzumab|trastuzumab|mesh-list
43792170|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792171|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792172|NCT05135182|Metronidazole|metronidazole|mesh-list
43792173|NCT05135182|Furazolidone|furazolidone|mesh-list
43792174|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792175|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43792176|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43792177|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43792178|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43792179|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43792180|NCT05135182|Renal Agents|renal agents|mesh-ancestor
43792181|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43792182|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43792198|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792199|NCT05125978|Dipyrone|dipyrone|mesh-list
43792200|NCT05125978|Tramadol|tramadol|mesh-list
43792201|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43792202|NCT05125978|Narcotics|narcotics|mesh-ancestor
43792203|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792204|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792205|NCT05125978|Analgesics|analgesics|mesh-ancestor
43792206|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
43792207|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792208|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43792209|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43792210|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43792211|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792212|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
43792213|NCT05125185|Insulin|insulin|mesh-list
43792214|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43792215|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840974|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43840975|NCT04659278|Peppermint oil|peppermint oil|mesh-list
43840976|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
43840977|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
43840978|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840979|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840980|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43840981|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
43840982|NCT04659044|Rituximab|rituximab|mesh-list
43840983|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43840984|NCT04659044|Venetoclax|venetoclax|mesh-list
43840985|NCT04659044|Antibodies|antibodies|mesh-list
43840986|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
43840987|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43840988|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
43841001|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
43841002|NCT04658927|Hormones|hormones|mesh-ancestor
43841003|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43841004|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43841005|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841006|NCT04658836|Triamcinolone|triamcinolone|mesh-list
43841007|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43841008|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43841009|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43841010|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841011|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
43841012|NCT04658836|Hormones|hormones|mesh-ancestor
43841013|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43841014|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841015|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43841016|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
43841019|NCT04658160|Imidacloprid|imidacloprid|mesh-list
43841020|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792216|NCT05306002|Antioxidants|antioxidants|mesh-list
43792217|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792218|NCT05306002|Protective Agents|protective agents|mesh-ancestor
43792219|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792220|NCT05305898|Metformin|metformin|mesh-list
43792221|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43792222|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792223|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43792224|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43792225|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792226|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792227|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43792228|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43792229|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792230|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792231|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792232|NCT05305287|Pioglitazone|pioglitazone|mesh-list
43792233|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43792234|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792249|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43792250|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
43792251|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792252|NCT05305131|Antiviral Agents|antiviral agents|mesh-ancestor
43792253|NCT05305131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792254|NCT05305131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792255|NCT05305131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43792256|NCT05305131|Immunologic Factors|immunologic factors|mesh-ancestor
43792257|NCT05304845|Aspirin|aspirin|mesh-list
43792258|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43792259|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43792260|NCT05304845|Analgesics|analgesics|mesh-ancestor
43792261|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
43792262|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792263|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792264|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43792265|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792266|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43792267|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43792277|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43792278|NCT05304598|Analgesics|analgesics|mesh-ancestor
43792279|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
43792288|NCT05304559|Esketamine|esketamine|mesh-list
43792289|NCT05304559|Analgesics|analgesics|mesh-ancestor
43792290|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
43792291|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792292|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792293|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43792294|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43792295|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
43792296|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
43792306|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792308|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
43792309|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792310|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
43792311|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43792312|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792314|NCT05304169|Leuprolide|leuprolide|mesh-list
43792330|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43792331|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
43792332|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43792333|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
43792334|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792335|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792336|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
43792337|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43792338|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43792339|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43792340|NCT05303688|Analgesics|analgesics|mesh-ancestor
43792341|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
43792342|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792343|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792344|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43792345|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792346|NCT05303597|Lidocaine|lidocaine|mesh-list
43792347|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
43792348|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
43792349|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792350|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792351|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
43792352|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792353|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43792354|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43792355|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43792356|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43793104|NCT04460352|Protective Agents|protective agents|mesh-ancestor
43792364|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792365|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43792366|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
43792367|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43792368|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792369|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792370|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792371|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43792372|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43792373|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
43792374|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792375|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792376|NCT05303259|Bevacizumab|bevacizumab|mesh-list
43792377|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792378|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792379|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43792380|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43792381|NCT05303259|Growth Substances|growth substances|mesh-ancestor
43792383|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
43792412|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
43792413|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
43792414|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792415|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841021|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841022|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841023|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841024|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
43841025|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43841026|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43841027|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841028|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
43841029|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
43841030|NCT04656041|Paclitaxel|paclitaxel|mesh-list
43841031|NCT04656041|Carboplatin|carboplatin|mesh-list
43841032|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43841033|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841034|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
43841035|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
43841036|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
43841037|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841038|NCT04655482|Aflibercept|aflibercept|mesh-list
43841039|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43841040|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43841041|NCT04655482|Growth Substances|growth substances|mesh-ancestor
43792432|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43792433|NCT05302531|Trimethoprim|trimethoprim|mesh-list
43792434|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
43792435|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43792436|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792437|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43792438|NCT05302531|Renal Agents|renal agents|mesh-ancestor
43792439|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43792440|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43792441|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792442|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792443|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792444|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43792445|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43792446|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
43792447|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43792448|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43792449|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43792450|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43792451|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43792452|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43792453|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
43792454|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43792456|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
43792457|NCT05302232|Lidocaine|lidocaine|mesh-list
43792458|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43792459|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
43792460|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
43792461|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
43792462|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792463|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792464|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
43792465|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792466|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43792467|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43792476|NCT05302232|Hormones|hormones|mesh-ancestor
43792477|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43792478|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43792479|NCT05302232|Protective Agents|protective agents|mesh-ancestor
43792480|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43792481|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792482|NCT05301660|Nicotine|nicotine|mesh-list
43792483|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43792484|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
43792485|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792486|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792487|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43792488|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43792489|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792490|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792491|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792492|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
43792493|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43792494|NCT05287984|Rituximab|rituximab|mesh-list
43792495|NCT05287984|Fludarabine|fludarabine|mesh-list
43792496|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
43792497|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43792498|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
43792499|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792500|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792501|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43792502|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
43792503|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792504|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792507|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43792509|NCT05287308|Paclitaxel|paclitaxel|mesh-list
43792510|NCT05287308|Docetaxel|docetaxel|mesh-list
43792511|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43792512|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
43792513|NCT05287308|Doxorubicin|doxorubicin|mesh-list
43792514|NCT05287308|Epirubicin|epirubicin|mesh-list
43792515|NCT05287308|Pirarubicin|pirarubicin|mesh-list
43792516|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43792517|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792518|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
43792519|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
43792520|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
43792521|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792522|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43792542|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
43792543|NCT05284656|Hematinics|hematinics|mesh-ancestor
43792544|NCT05284656|Vitamins|vitamins|mesh-ancestor
43792545|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
43792546|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792547|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43792548|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792549|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792555|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
43792556|NCT05284474|Mitogens|mitogens|mesh-list
43792557|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
43792558|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792559|NCT05283356|Ticagrelor|ticagrelor|mesh-list
43792560|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43792561|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43792562|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43792563|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43792564|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
43792565|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792568|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
43792590|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792591|NCT05265507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43792592|NCT05265507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43792593|NCT05265507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792594|NCT05265507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43792595|NCT05265507|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43792596|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43792597|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43792598|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43792599|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792600|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
43792601|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792602|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792603|NCT05245006|Antibodies|antibodies|mesh-list
43792604|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
43601254|NCT03265782|Ibuprofen|ibuprofen|mesh-list
43792605|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
43792606|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792607|NCT05243186|Methylphenidate|methylphenidate|mesh-list
43792608|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43792609|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792610|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43792611|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43792612|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43792613|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792614|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
43792615|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792617|NCT05229055|Analgesics|analgesics|mesh-ancestor
43792618|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
43792619|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792620|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792621|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43792622|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43792623|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
43792624|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
43792633|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43792634|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792635|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43792636|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43792637|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43792638|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
43792639|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43792640|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43792641|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
43792642|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43792643|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
43792644|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43792645|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43792646|NCT05205499|Sirolimus|sirolimus|mesh-list
43792647|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43792648|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792649|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43792650|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792651|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
43792652|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43792653|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
43792654|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841092|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43841093|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43841094|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
43841095|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841096|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43841097|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43841098|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841099|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792656|NCT05192798|Bevacizumab|bevacizumab|mesh-list
43792657|NCT05192798|Apatinib|apatinib|mesh-list
43792658|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43792659|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43792660|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792661|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
43792662|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
43792663|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
43792664|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792665|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792666|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43792667|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43792668|NCT05192798|Growth Substances|growth substances|mesh-ancestor
43792669|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792670|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
43792671|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43792672|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792673|NCT05191225|Rituximab|rituximab|mesh-list
43792674|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792675|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792676|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
43792677|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792678|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792679|NCT05185167|Propofol|propofol|mesh-list
43792680|NCT05185167|Anesthetics|anesthetics|mesh-list
43792681|NCT05185167|Desflurane|desflurane|mesh-list
43792682|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
43792683|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43792699|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792700|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792701|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43792702|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
43792703|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43792704|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43792705|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43792706|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43792707|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792709|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
43792710|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
43792711|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792712|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792713|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
43792714|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792715|NCT05118945|Insulin|insulin|mesh-list
43792716|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43792717|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43792718|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792719|NCT05108649|Nicotine|nicotine|mesh-list
43792720|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43792721|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
43792722|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792723|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792724|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43792725|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43792726|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792727|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792729|NCT05099913|Flupenthixol|flupenthixol|mesh-list
43792744|NCT05097274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792745|NCT05097274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43792746|NCT05097274|Nootropic Agents|nootropic agents|mesh-ancestor
43792747|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
43792748|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792749|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792750|NCT05044962|Rilpivirine|rilpivirine|mesh-list
43792751|NCT05044962|Cabotegravir|cabotegravir|mesh-list
43792752|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43792753|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
43792754|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
43792755|NCT05044962|Etonogestrel|etonogestrel|mesh-list
43792756|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43792757|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
43792758|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43792759|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792766|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792767|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43792768|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43792769|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792770|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792772|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792773|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43792774|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43792775|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43792776|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43792777|NCT05043714|Nivolumab|nivolumab|mesh-list
43792778|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792779|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792780|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43792781|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792782|NCT05019222|Anesthetics|anesthetics|mesh-list
43792783|NCT05019222|Sevoflurane|sevoflurane|mesh-list
43792784|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792785|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792786|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43792787|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43792788|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
43792789|NCT05010148|Lidocaine|lidocaine|mesh-list
43792790|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
43792791|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
43792792|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792793|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792794|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
43792795|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792796|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43792797|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43792799|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43792800|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792802|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43792803|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792804|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
43792805|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43792806|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43841114|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841115|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43841116|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841117|NCT04652076|Paclitaxel|paclitaxel|mesh-list
43841118|NCT04652076|Carboplatin|carboplatin|mesh-list
43841119|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
43841120|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43841121|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841122|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
43841123|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
43841124|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
43841125|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841126|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841127|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
43841128|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43841129|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43841130|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841131|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
43841132|NCT04650698|Coagulants|coagulants|mesh-ancestor
43841133|NCT04650282|Lidocaine|lidocaine|mesh-list
43841134|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
43841135|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
43841136|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792809|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
43792814|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43792815|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
43792816|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792817|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792818|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43792819|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
43792821|NCT04951986|Ofloxacin|ofloxacin|mesh-list
43792822|NCT04951986|Rifampin|rifampin|mesh-list
43792823|NCT04951986|Isoniazid|isoniazid|mesh-list
43792824|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
43792825|NCT04951986|Ethambutol|ethambutol|mesh-list
43792826|NCT04951986|Prednisone|prednisone|mesh-list
43792827|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43792828|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
43792829|NCT04951986|Hormones|hormones|mesh-ancestor
43792830|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43792831|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792832|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43792833|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792834|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43792835|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792836|NCT04951986|Renal Agents|renal agents|mesh-ancestor
43792837|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43792838|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43792839|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43792840|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792841|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792842|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43792843|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43792844|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43792845|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
43792846|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
43792847|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43792848|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43792849|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43792910|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792911|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43792912|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43792914|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
43792915|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792916|NCT04800393|Propofol|propofol|mesh-list
43792917|NCT04800393|Sevoflurane|sevoflurane|mesh-list
43792918|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43792919|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792920|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792921|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43792931|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
43792932|NCT04734028|Clopidogrel|clopidogrel|mesh-list
43792933|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792934|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792935|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43792936|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43792937|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43792938|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43792939|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
43792940|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841143|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841144|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841145|NCT04649476|Cisplatin|cisplatin|mesh-list
43841146|NCT04649476|Docetaxel|docetaxel|mesh-list
43841147|NCT04649476|Fluorouracil|fluorouracil|mesh-list
43792945|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792946|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43792947|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43792948|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792949|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792954|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
43792955|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792956|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43792957|NCT04698057|Amoxicillin|amoxicillin|mesh-list
43792958|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
43792959|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
43792960|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
43792961|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43792962|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43792973|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43792974|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
43792975|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792976|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792977|NCT04684589|Tadalafil|tadalafil|mesh-list
43792978|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
43792979|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43792980|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43792981|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792982|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792983|NCT04684589|Urological Agents|urological agents|mesh-ancestor
43792984|NCT04682834|Probenecid|probenecid|mesh-list
43792985|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
43792986|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
43792987|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792988|NCT04682834|Renal Agents|renal agents|mesh-ancestor
43792989|NCT04682743|Acetaminophen|acetaminophen|mesh-list
43792990|NCT04682743|Ondansetron|ondansetron|mesh-list
43792991|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43792992|NCT04682743|Analgesics|analgesics|mesh-ancestor
43792993|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
43792994|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792995|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792996|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
43792997|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
43792998|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
43792999|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43793000|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
43793001|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
43793002|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43793003|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
43793004|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793005|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793006|NCT04682743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43793007|NCT04682743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43793008|NCT04682743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793009|NCT04682743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43793010|NCT04682743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43793011|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
43793012|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43793013|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793014|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793015|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43793029|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793031|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793032|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793033|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793034|NCT04566991|Deferoxamine|deferoxamine|mesh-list
43793035|NCT04566991|Siderophores|siderophores|mesh-ancestor
43793036|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43793038|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
43793039|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793040|NCT04560595|Caffeine|caffeine|mesh-list
43793041|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43793042|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793043|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43793044|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793045|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841207|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43841208|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43848464|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848465|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43848466|NCT04017650|Nivolumab|nivolumab|mesh-list
43848467|NCT04017650|Cetuximab|cetuximab|mesh-list
43848468|NCT04017650|Antibodies|antibodies|mesh-list
43848469|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
43848470|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43848471|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
43848472|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848473|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848474|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43848475|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848476|NCT04017013|Lidocaine|lidocaine|mesh-list
43848478|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
43848484|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43848485|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43793081|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
43793082|NCT04499196|Hormones|hormones|mesh-ancestor
43793083|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43793084|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793085|NCT04460352|Leucovorin|leucovorin|mesh-list
43793086|NCT04460352|Paclitaxel|paclitaxel|mesh-list
43793087|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43793088|NCT04460352|Carboplatin|carboplatin|mesh-list
43793089|NCT04460352|Fluorouracil|fluorouracil|mesh-list
43793090|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
43793091|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
43793092|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43793093|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793094|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
43793095|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
43793096|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
43793097|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793102|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
43793103|NCT04460352|Antidotes|antidotes|mesh-ancestor
43793168|NCT04259645|Bupivacaine|bupivacaine|mesh-list
43793169|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
43793170|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
43793171|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793172|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793173|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
43793174|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793175|NCT04258150|Nivolumab|nivolumab|mesh-list
43793176|NCT04258150|Ipilimumab|ipilimumab|mesh-list
43793177|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793178|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793179|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43793180|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793181|NCT04250493|Insulin|insulin|mesh-list
43793182|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793183|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793184|NCT04227756|Psilocybin|psilocybin|mesh-list
43793185|NCT04227756|Mescaline|mescaline|mesh-list
43793186|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
43793187|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793188|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43793189|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43793190|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
43793191|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793192|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841214|NCT04644029|Tenofovir|tenofovir|mesh-list
43841215|NCT04644029|Emtricitabine|emtricitabine|mesh-list
43841216|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43841217|NCT04644029|Islatravir|islatravir|mesh-list
43841218|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
43841219|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841220|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43841221|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43841222|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841223|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841224|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43841225|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43841226|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43841227|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43841228|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841229|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43841230|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841231|NCT04642469|Durvalumab|durvalumab|mesh-list
43841232|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841233|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841234|NCT04641871|Irinotecan|irinotecan|mesh-list
43841235|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43841236|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43841237|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841238|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841239|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841240|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
43841241|NCT04641728|Olaparib|olaparib|mesh-list
43841242|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841243|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793193|NCT04201873|Poly I-C|poly i-c|mesh-list
43793194|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
43793195|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43793196|NCT04201873|Vaccines|vaccines|mesh-list
43793197|NCT04201873|Poly ICLC|poly iclc|mesh-list
43793198|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
43793200|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793201|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793202|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
43793204|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43793205|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
43793206|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793207|NCT04163900|Gemcitabine|gemcitabine|mesh-list
43793208|NCT04163900|Cisplatin|cisplatin|mesh-list
43793209|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793210|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793211|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
43793212|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793213|NCT04163900|Antiviral Agents|antiviral agents|mesh-ancestor
43793214|NCT04163900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793215|NCT04163900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793216|NCT04163900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793217|NCT04163900|Immunologic Factors|immunologic factors|mesh-ancestor
43793218|NCT04163900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793219|NCT04147221|Imipenem|imipenem|mesh-list
43793220|NCT04147221|Relebactam|relebactam|mesh-list
43793228|NCT04140968|Hormones|hormones|mesh-ancestor
43793229|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43793230|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793231|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
43793232|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
43793233|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43793234|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43793235|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793236|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793237|NCT04110444|Urological Agents|urological agents|mesh-ancestor
43793238|NCT04108039|Cetrorelix|cetrorelix|mesh-list
43793239|NCT04108039|Progesterone|progesterone|mesh-list
43793240|NCT04108039|Ganirelix|ganirelix|mesh-list
43793241|NCT04108039|Progestins|progestins|mesh-ancestor
43793242|NCT04108039|Hormones|hormones|mesh-ancestor
43793243|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43793244|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793245|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
43793246|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43793247|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
43793248|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43793249|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
43793250|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43793251|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793252|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
43793253|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43793254|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43793255|NCT04090710|Nivolumab|nivolumab|mesh-list
43793256|NCT04090710|Ipilimumab|ipilimumab|mesh-list
43793257|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793258|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793259|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43793260|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793261|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
43793262|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43793265|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
43793306|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43793307|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43793308|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793309|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793311|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793312|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43793313|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
43793314|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43793315|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43793316|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43793317|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793318|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43793319|NCT05431413|Protective Agents|protective agents|mesh-ancestor
43793320|NCT05431283|Tofacitinib|tofacitinib|mesh-list
43793321|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43793322|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793331|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
43793332|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43793333|NCT05431062|Bupivacaine|bupivacaine|mesh-list
43793334|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
43793335|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
43793336|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793337|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793339|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793340|NCT05431049|Anesthetics|anesthetics|mesh-list
43793341|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793342|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793343|NCT05431023|Lactoferrin|lactoferrin|mesh-list
43602171|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
43793344|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793345|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43793346|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43793347|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793348|NCT05430802|Pemetrexed|pemetrexed|mesh-list
43793349|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793350|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793351|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793352|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43793353|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43793354|NCT05430711|Dinoprostone|dinoprostone|mesh-list
43793356|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43793357|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793358|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
43793359|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43841244|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43841245|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841272|NCT04641195|Trace Elements|trace elements|mesh-ancestor
43841273|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
43841274|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841275|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43841276|NCT04641026|Protective Agents|protective agents|mesh-ancestor
43841277|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841278|NCT04639414|Empagliflozin|empagliflozin|mesh-list
43841279|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43841280|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841281|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793377|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
43793378|NCT05430087|Curcumin|curcumin|mesh-list
43793379|NCT05430087|Piperine|piperine|mesh-list
43793380|NCT05430087|Vitamins|vitamins|mesh-ancestor
43793381|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
43793382|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793383|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43793384|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43793385|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43793386|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43793387|NCT05430087|Analgesics|analgesics|mesh-ancestor
43793388|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
43793389|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793390|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43793392|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793393|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793394|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793395|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43793397|NCT05426252|Abatacept|abatacept|mesh-list
43793398|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43793399|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793400|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43793401|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793402|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
43793403|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793404|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
43793405|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793406|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43793407|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793409|NCT05422664|Lacosamide|lacosamide|mesh-list
43793419|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
43793420|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
43793421|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793422|NCT05391074|Vitamins|vitamins|mesh-list
43793423|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
43793424|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793426|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793427|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793428|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
43793429|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793430|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793431|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
43793432|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793433|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793434|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43602303|NCT03256864|Everolimus|everolimus|mesh-list
43793435|NCT05357833|Hematinics|hematinics|mesh-ancestor
43793436|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43793437|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43793438|NCT05353764|Ropivacaine|ropivacaine|mesh-list
43793439|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
43793440|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
43793441|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793442|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793443|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
43793444|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793445|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
43793446|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43793447|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793448|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793449|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43793461|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793463|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793464|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793465|NCT05258851|Ceftazidime|ceftazidime|mesh-list
43793466|NCT05258851|Colistin|colistin|mesh-list
43793467|NCT05258851|Avibactam|avibactam|mesh-list
43793468|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
43793469|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43793470|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793471|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43793472|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793473|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793474|NCT05253573|Nicotine|nicotine|mesh-list
43793475|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43793476|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
43793477|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793478|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793479|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43793480|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43793481|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
43793482|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793483|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793484|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
43793485|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43793486|NCT05245734|Antibodies|antibodies|mesh-list
43793487|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
43793488|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43793495|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793496|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43793497|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43793498|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
43793499|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793500|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793501|NCT05233722|Sirolimus|sirolimus|mesh-list
43793502|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793503|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43793504|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793505|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43793506|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793507|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
43793508|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793509|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
43793510|NCT05211570|Azacitidine|azacitidine|mesh-list
43793511|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793512|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
43793513|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793514|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793515|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793516|NCT05188313|Paclitaxel|paclitaxel|mesh-list
43793517|NCT05188313|Carboplatin|carboplatin|mesh-list
43793518|NCT05188313|Trastuzumab|trastuzumab|mesh-list
43793519|NCT05188313|Pertuzumab|pertuzumab|mesh-list
43793520|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43793521|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793522|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
43793523|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
43793524|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
43793525|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793526|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793527|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
43793528|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43793529|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43793530|NCT05150704|Prednisolone|prednisolone|mesh-list
43793531|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
43793532|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43793533|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
43793534|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43793535|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
43793536|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
43793537|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793538|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793539|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43793540|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
43793541|NCT05150704|Hormones|hormones|mesh-ancestor
43793542|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43793543|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43793551|NCT04954599|Atezolizumab|atezolizumab|mesh-list
43793552|NCT04954599|Durvalumab|durvalumab|mesh-list
43793553|NCT04954599|Avelumab|avelumab|mesh-list
43793554|NCT04954599|Cemiplimab|cemiplimab|mesh-list
43793555|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43793556|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793557|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793558|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793559|NCT04941573|Xenon|xenon|mesh-list
43793564|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793565|NCT04916691|Ropivacaine|ropivacaine|mesh-list
43793566|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
43793567|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
43793568|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793569|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793570|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
43793584|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43793585|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43793586|NCT04880785|Lamivudine|lamivudine|mesh-list
43793587|NCT04880785|Dolutegravir|dolutegravir|mesh-list
43793588|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43793589|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43793595|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43793596|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43793597|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43793625|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793626|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793627|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
43793628|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793629|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793630|NCT04786340|Pirenzepine|pirenzepine|mesh-list
43793631|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43793632|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43793633|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43793634|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43793635|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43793636|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
43793637|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793638|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793639|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841282|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841283|NCT04638400|Simvastatin|simvastatin|mesh-list
43841308|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841310|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841311|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841312|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
43841313|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43841314|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
43793642|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
43841330|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841331|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841332|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43841333|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
43841334|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602564|NCT03252665|Vitamins|vitamins|mesh-ancestor
43793641|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43793652|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43793653|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43793654|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43793655|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793656|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
43793657|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793658|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
43793659|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43793660|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43793662|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
43793663|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43793664|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
43793665|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43793666|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
43793667|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
43793668|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793669|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793684|NCT04335968|Protective Agents|protective agents|mesh-ancestor
43793685|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793686|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793687|NCT04283604|Methylphenidate|methylphenidate|mesh-list
43793688|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43793689|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793690|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43793691|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43793692|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43793693|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793694|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
43793695|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793703|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793704|NCT04214834|Morphine|morphine|mesh-list
43793705|NCT04214834|Methadone|methadone|mesh-list
43793706|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43793707|NCT04214834|Narcotics|narcotics|mesh-ancestor
43793708|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793709|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793710|NCT04214834|Analgesics|analgesics|mesh-ancestor
43793711|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
43793712|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793713|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
43793714|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
43793716|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793717|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
43793718|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793719|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43793720|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793721|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793745|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43793747|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793786|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
43793792|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43793793|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
43793794|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43793795|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
43793796|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793797|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793798|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
43793800|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43793801|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43793806|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793807|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43793808|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43793809|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793810|NCT03465592|Nivolumab|nivolumab|mesh-list
43793811|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793812|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793813|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43793814|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793815|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
43793816|NCT03283150|Remifentanil|remifentanil|mesh-list
43793817|NCT03283150|Propofol|propofol|mesh-list
43793823|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
43793824|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43793825|NCT03283150|Analgesics|analgesics|mesh-ancestor
43793826|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
43793827|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793828|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43793829|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43793830|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43793831|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
43793832|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793833|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793834|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43793835|NCT03283150|Narcotics|narcotics|mesh-ancestor
43793836|NCT03263936|Cytarabine|cytarabine|mesh-list
43793837|NCT03263936|Fludarabine|fludarabine|mesh-list
43793838|NCT03263936|Decitabine|decitabine|mesh-list
43793839|NCT03263936|Vorinostat|vorinostat|mesh-list
43793840|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793841|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793842|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
43793843|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793844|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793845|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
43793846|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793847|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
43793848|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793849|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793851|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
43793852|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43793853|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43793854|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793868|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43793869|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793870|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793871|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43793872|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
43793873|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793874|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43793875|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
43793876|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
43841336|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43841337|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43841339|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
43841340|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841375|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848486|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43848487|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848488|NCT04015739|Bevacizumab|bevacizumab|mesh-list
43848489|NCT04015739|Durvalumab|durvalumab|mesh-list
43848490|NCT04015739|Olaparib|olaparib|mesh-list
43793878|NCT02888041|Dinoprostone|dinoprostone|mesh-list
43793879|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
43793880|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43793881|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793882|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
43793883|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793884|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793885|NCT02867267|Thymalfasin|thymalfasin|mesh-list
43793886|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43793887|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
43793888|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793889|NCT02854696|Insulin|insulin|mesh-list
43793890|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793891|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793892|NCT02782468|Azacitidine|azacitidine|mesh-list
43793893|NCT02782468|Pevonedistat|pevonedistat|mesh-list
43793894|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793895|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
43793914|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
43793915|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793916|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
43793917|NCT02501096|Lenvatinib|lenvatinib|mesh-list
43793918|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793919|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793920|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43793921|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793922|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793923|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43793924|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
43793925|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793926|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
43793927|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793928|NCT02028364|Everolimus|everolimus|mesh-list
43793929|NCT02028364|Exemestane|exemestane|mesh-list
43793930|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793939|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
43793940|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602953|NCT03249428|Nicotine|nicotine|mesh-list
43793941|NCT01125371|Ethanol|ethanol|mesh-list
43793942|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43793943|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793944|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793945|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793946|NCT01003028|Remifentanil|remifentanil|mesh-list
43793947|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43793948|NCT01003028|Narcotics|narcotics|mesh-ancestor
43793949|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793950|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793951|NCT01003028|Analgesics|analgesics|mesh-ancestor
43793952|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
43793953|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793954|NCT00136435|Leucovorin|leucovorin|mesh-list
43793955|NCT00136435|Cytarabine|cytarabine|mesh-list
43793956|NCT00136435|Dexamethasone|dexamethasone|mesh-list
43793957|NCT00136435|Prednisone|prednisone|mesh-list
43793958|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
43793959|NCT00136435|Doxorubicin|doxorubicin|mesh-list
43793960|NCT00136435|Methotrexate|methotrexate|mesh-list
43793961|NCT00136435|Vincristine|vincristine|mesh-list
43793962|NCT00136435|Asparaginase|asparaginase|mesh-list
43793963|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
43793964|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43793965|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
43793966|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
43793967|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793968|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793969|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43793970|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
43793971|NCT00136435|Hormones|hormones|mesh-ancestor
43793972|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43793973|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43793974|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793975|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43793989|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43793990|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43794004|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43794005|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
43794006|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794007|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794008|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794009|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43794010|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43794011|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
43794012|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43794013|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43794014|NCT04039347|Cyclosporine|cyclosporine|mesh-list
43794015|NCT04039347|Cyclosporins|cyclosporins|mesh-list
43602989|NCT03249168|Analgesics|analgesics|mesh-ancestor
43794016|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794017|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794018|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794019|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
43794020|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794021|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
43794022|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794023|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794024|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794025|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43794027|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
43794028|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43794029|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
43794030|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43794031|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43794032|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794033|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43794034|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794038|NCT03990766|Theophylline|theophylline|mesh-list
43794039|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43794040|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
43794041|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794042|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794043|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43794044|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
43794045|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43794046|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794047|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794048|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
43794049|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43794050|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43794051|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
43794053|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
43794054|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
43794055|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794056|NCT03954327|Tenofovir|tenofovir|mesh-list
43794057|NCT03954327|Emtricitabine|emtricitabine|mesh-list
43794058|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
43794059|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
43794060|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794061|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43794062|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43794063|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794064|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794065|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43794066|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43794067|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43794068|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43794069|NCT03942120|Ustekinumab|ustekinumab|mesh-list
43794070|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794071|NCT03938831|Fentanyl|fentanyl|mesh-list
43794072|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
43794073|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43794074|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794075|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794076|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43794077|NCT03938831|Analgesics|analgesics|mesh-ancestor
43794078|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
43794079|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794120|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
43794121|NCT03864094|Remifentanil|remifentanil|mesh-list
43794123|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43794124|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794125|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794126|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43794127|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
43794128|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
43794129|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43794130|NCT03864094|Narcotics|narcotics|mesh-ancestor
43794131|NCT03864094|Analgesics|analgesics|mesh-ancestor
43794132|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
43794133|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794134|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43794135|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
43794136|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
43794137|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
43794138|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43794139|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
43794140|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
43794141|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43794142|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43794143|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43794172|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43794173|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794174|NCT03841058|Abaloparatide|abaloparatide|mesh-list
43794175|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43794176|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841377|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
43841398|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841400|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43841401|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841402|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841403|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
43841404|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43841405|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
43841406|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43841407|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43841408|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43841409|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43841410|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841411|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841412|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
43841413|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841437|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43841439|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841440|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841441|NCT04619979|Anesthetics|anesthetics|mesh-list
43841442|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841443|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841444|NCT04618744|Insulin|insulin|mesh-list
43841445|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43841446|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43603208|NCT03247972|Evolocumab|evolocumab|mesh-list
43794177|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
43794178|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
43794179|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794190|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
43794191|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794193|NCT03810105|Olaparib|olaparib|mesh-list
43794194|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794195|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794196|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43794197|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794198|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794199|NCT03806751|Acetazolamide|acetazolamide|mesh-list
43794208|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43794210|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794225|NCT03750786|Vitamins|vitamins|mesh-ancestor
43794226|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
43794227|NCT03748966|Calcitriol|calcitriol|mesh-list
43794243|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794244|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794245|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794246|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
43794247|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794248|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
43794249|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794250|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794251|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841452|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43794261|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794262|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794267|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794268|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794269|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43794270|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794271|NCT03643744|Celecoxib|celecoxib|mesh-list
43794293|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43794294|NCT03595150|Analgesics|analgesics|mesh-ancestor
43794304|NCT03594175|Reteplase|reteplase|mesh-list
43841447|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841448|NCT04617002|TIC10 compound|tic10 compound|mesh-list
43841449|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841450|NCT04616963|Tenofovir|tenofovir|mesh-list
43841451|NCT04616963|Emtricitabine|emtricitabine|mesh-list
43841462|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43841463|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43841464|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841465|NCT04614311|Triamcinolone|triamcinolone|mesh-list
43841466|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43841467|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43841468|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43841469|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841470|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
43841471|NCT04614311|Hormones|hormones|mesh-ancestor
43794328|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794329|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794330|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43794331|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43794332|NCT03451370|Growth Substances|growth substances|mesh-ancestor
43794346|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794347|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794348|NCT03376659|Bevacizumab|bevacizumab|mesh-list
43794349|NCT03376659|Durvalumab|durvalumab|mesh-list
43794350|NCT03376659|Capecitabine|capecitabine|mesh-list
43794351|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794352|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794353|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43794354|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43794355|NCT03376659|Growth Substances|growth substances|mesh-ancestor
43794356|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794357|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
43794358|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794359|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
43794360|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794361|NCT03324932|Denosumab|denosumab|mesh-list
43794362|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43794363|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794364|NCT03322215|Capecitabine|capecitabine|mesh-list
43794365|NCT03322215|Fulvestrant|fulvestrant|mesh-list
43794366|NCT03322215|Palbociclib|palbociclib|mesh-list
43794367|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794368|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
43794369|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794370|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794371|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43794386|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794387|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794388|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43794389|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794390|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
43794391|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43794392|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43794393|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
43794394|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
43794395|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794396|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794397|NCT03290560|Kallikreins|kallikreins|mesh-list
43794398|NCT03290560|Coagulants|coagulants|mesh-ancestor
43794399|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
43794400|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
43794401|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43794402|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794403|NCT03235986|Poractant alfa|poractant alfa|mesh-list
43794404|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43794405|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
43794406|NCT03199547|Azithromycin|azithromycin|mesh-list
43794407|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43794420|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
43794428|NCT03161223|Romidepsin|romidepsin|mesh-list
43794447|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43794458|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794459|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43794460|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
43794462|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794463|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43794464|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794465|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
43794466|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43794485|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43794486|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43794487|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
43794488|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794489|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794490|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
43794491|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43794492|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
43794500|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
43794501|NCT02996305|Gaboxadol|gaboxadol|mesh-list
43794502|NCT02996305|Analgesics|analgesics|mesh-ancestor
43794503|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
43794504|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794505|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794506|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
43794507|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
43794508|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
43794509|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794510|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794511|NCT02976753|Factor VIII|factor viii|mesh-list
43794512|NCT02976753|Coagulants|coagulants|mesh-ancestor
43794513|NCT02912988|Letrozole|letrozole|mesh-list
43794514|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794515|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43794516|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43794517|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794518|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794519|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43794520|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
43794521|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794522|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794523|NCT02854488|Ipilimumab|ipilimumab|mesh-list
43794525|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794526|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43794539|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43794540|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
43794541|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
43794542|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794543|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794544|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43794545|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43794546|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
43794547|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794548|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794550|NCT02809820|Protective Agents|protective agents|mesh-ancestor
43794551|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43794552|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43794553|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43794554|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
43794555|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43794556|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43794557|NCT02804022|Morphine|morphine|mesh-list
43794558|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43794559|NCT02804022|Narcotics|narcotics|mesh-ancestor
43794560|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794561|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794562|NCT02804022|Analgesics|analgesics|mesh-ancestor
43794563|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
43794564|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794565|NCT02786498|Vitamin D|vitamin d|mesh-list
43794581|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
43794582|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794583|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794584|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
43794585|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794586|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794587|NCT02597660|Hormones|hormones|mesh-list
43794588|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794589|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794601|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794602|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43794603|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794604|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794606|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794607|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43794608|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
43794609|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794610|NCT02592707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43794611|NCT02592707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43794612|NCT02592707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794613|NCT02592707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43794614|NCT02592707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43794615|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
43794616|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
43794617|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
43794618|NCT02499003|Pixantrone|pixantrone|mesh-list
43794619|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794620|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794633|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43794640|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43794641|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794642|NCT02439385|Curcumin|curcumin|mesh-list
43794643|NCT02439385|Bevacizumab|bevacizumab|mesh-list
43794644|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794645|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794646|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43794647|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43794648|NCT02439385|Growth Substances|growth substances|mesh-ancestor
43794649|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794650|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
43794651|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43794652|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43794653|NCT02439385|Analgesics|analgesics|mesh-ancestor
43794654|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
43794655|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794656|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794657|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794658|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794659|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794660|NCT02419664|Edotreotide|edotreotide|mesh-list
43794661|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43794662|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794689|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43794690|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794691|NCT02021006|Amoxicillin|amoxicillin|mesh-list
43794692|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
43794693|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
43794694|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43794695|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
43794697|NCT02021006|Trimethoprim|trimethoprim|mesh-list
43794698|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
43794699|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43794700|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794701|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43794702|NCT02021006|Renal Agents|renal agents|mesh-ancestor
43794703|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
43794704|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43794705|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43794706|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43794707|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794717|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794719|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43794720|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
43794721|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794722|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794723|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43794724|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43794725|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43794726|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794727|NCT01876953|Cytarabine|cytarabine|mesh-list
43794728|NCT01876953|Dasatinib|dasatinib|mesh-list
43794729|NCT01876953|Idarubicin|idarubicin|mesh-list
43794730|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794731|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
43794767|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794768|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794769|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794770|NCT01551472|Vitamin E|vitamin e|mesh-list
43794771|NCT01551472|Vitamins|vitamins|mesh-ancestor
43794772|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
43794773|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794774|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
43794775|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794776|NCT01551472|Protective Agents|protective agents|mesh-ancestor
43794777|NCT01506973|Gemcitabine|gemcitabine|mesh-list
43794778|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
43794779|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43794780|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794781|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
43794782|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794783|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794784|NCT01506973|Antiviral Agents|antiviral agents|mesh-ancestor
43794785|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794786|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794787|NCT01506973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794788|NCT01506973|Immunologic Factors|immunologic factors|mesh-ancestor
43794789|NCT01506973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794790|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
43849584|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794800|NCT01347970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794801|NCT01347970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43794802|NCT01347970|Antioxidants|antioxidants|mesh-ancestor
43794803|NCT01347970|Protective Agents|protective agents|mesh-ancestor
43794804|NCT01347970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43794805|NCT01347970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43794806|NCT01347970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43794807|NCT01347970|Vasodilator Agents|vasodilator agents|mesh-ancestor
43794808|NCT01347970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43794835|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
43794836|NCT00540995|Busulfan|busulfan|mesh-list
43794837|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43794838|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794839|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43794840|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43794841|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794842|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794843|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
43794844|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794849|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
43794850|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794851|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
43794852|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
43794853|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
43794854|NCT00484471|Valproic Acid|valproic acid|mesh-list
43794855|NCT00484471|Aripiprazole|aripiprazole|mesh-list
43794856|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
43794857|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43794858|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43794859|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43794860|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794861|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794862|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
43794863|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
43794864|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794865|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794866|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43794867|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43794868|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
43794869|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43794870|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43794871|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43794872|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43794873|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
43794874|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794875|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
43794876|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
43794877|NCT00015002|Betamethasone|betamethasone|mesh-list
43794878|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794879|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
43794880|NCT00015002|Hormones|hormones|mesh-ancestor
43794881|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794882|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794883|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43794884|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
43794886|NCT05105139|Coal Tar|coal tar|mesh-list
43794887|NCT05105139|Allantoin|allantoin|mesh-list
43794888|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43794889|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794890|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43794891|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43794892|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
43794893|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794894|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43794895|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
43794896|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794897|NCT05103215|Lidocaine|lidocaine|mesh-list
43794898|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
43794899|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
43794900|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794901|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794902|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
43794903|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794904|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43794905|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43794909|NCT05042700|Melatonin|melatonin|mesh-list
43841496|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
43841497|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841498|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841499|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
43841500|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841501|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43841502|NCT04613830|Narcotics|narcotics|mesh-ancestor
43841503|NCT04613830|Analgesics|analgesics|mesh-ancestor
43841504|NCT04613453|Midazolam|midazolam|mesh-list
43841505|NCT04613453|Ketamine|ketamine|mesh-list
43841506|NCT04613453|Analgesics|analgesics|mesh-ancestor
43841507|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
43841508|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848494|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43848495|NCT04015739|Growth Substances|growth substances|mesh-ancestor
43848496|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794920|NCT05015608|Carboplatin|carboplatin|mesh-list
43794921|NCT05015608|Pemetrexed|pemetrexed|mesh-list
43794922|NCT05015608|Osimertinib|osimertinib|mesh-list
43794923|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794924|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794925|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794926|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43794927|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43794935|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43794936|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43794937|NCT05001555|Analgesics|analgesics|mesh-ancestor
43794938|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
43794939|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794940|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794941|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794942|NCT04968158|Acetaminophen|acetaminophen|mesh-list
43794943|NCT04968158|Etoricoxib|etoricoxib|mesh-list
43794955|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794956|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794957|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43794958|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43794966|NCT04771637|Analgesics|analgesics|mesh-ancestor
43794967|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
43794968|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794969|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43794970|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43794971|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43794972|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
43794973|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794974|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794975|NCT04737343|Azathioprine|azathioprine|mesh-list
43794976|NCT04737343|Leflunomide|leflunomide|mesh-list
43794977|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
43794978|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794979|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794980|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794981|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794982|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
43794983|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794984|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794985|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794986|NCT04563338|Bevacizumab|bevacizumab|mesh-list
43794987|NCT04563338|Atezolizumab|atezolizumab|mesh-list
43794988|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794989|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795014|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43795015|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
43795016|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
43795029|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43795030|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43795031|NCT05244837|Paclitaxel|paclitaxel|mesh-list
43795032|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43795033|NCT05244837|Carboplatin|carboplatin|mesh-list
43795034|NCT05244837|Pemetrexed|pemetrexed|mesh-list
43795035|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43795036|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795037|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
43795038|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
43795039|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
43795040|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795041|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795042|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43795043|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43795044|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
43795045|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
43795046|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43795047|NCT05244811|Progestins|progestins|mesh-list
43795048|NCT05244811|Estradiol|estradiol|mesh-list
43795049|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43795050|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795059|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
43795060|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
43795061|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795062|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795063|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43795064|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43795065|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43795068|NCT05244577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43795069|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43795070|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43795071|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795072|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795073|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
43795074|NCT05244200|Insulin|insulin|mesh-list
43795075|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43795076|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841526|NCT04609865|Lidocaine|lidocaine|mesh-list
43841527|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
43841528|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
43841529|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841530|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841531|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
43841532|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841533|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43841534|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43841535|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43841536|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841537|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841538|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
43841539|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43841540|NCT04609761|Antibodies|antibodies|mesh-list
43841541|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
43841542|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43841543|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
43841544|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841545|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43841546|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841547|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43841548|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
43841549|NCT04608630|Denosumab|denosumab|mesh-list
43841550|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43841551|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841552|NCT04605731|Durvalumab|durvalumab|mesh-list
43841553|NCT04605731|Ipilimumab|ipilimumab|mesh-list
43841554|NCT04605731|Tremelimumab|tremelimumab|mesh-list
43795119|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795120|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43795121|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795122|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
43795123|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795124|NCT05213650|Methamphetamine|methamphetamine|mesh-list
43795125|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43795126|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795127|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
43795128|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
43795148|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43795149|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795150|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43795151|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43795152|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43795154|NCT05196945|Diuretics|diuretics|mesh-ancestor
43795155|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
43795156|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795157|NCT05196945|Expectorants|expectorants|mesh-ancestor
43795167|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
43795168|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795169|NCT05155007|Cyclosporine|cyclosporine|mesh-list
43795170|NCT05155007|Cyclosporins|cyclosporins|mesh-list
43795171|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795172|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795173|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795174|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
43795175|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795176|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
43795177|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795178|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795179|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43795180|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43795181|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43795182|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
43795203|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
43795204|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
43795205|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795206|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795207|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43795208|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
43795209|NCT04799015|Hormones|hormones|mesh-ancestor
43795210|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43795211|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43795212|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795213|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43795214|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43795215|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
43795216|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795217|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795218|NCT04701593|Triamcinolone|triamcinolone|mesh-list
43795219|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43795220|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43795221|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43795222|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795223|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
43795224|NCT04701593|Hormones|hormones|mesh-ancestor
43795225|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43795226|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795227|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795228|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
43795229|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795230|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795231|NCT04611529|Ibuprofen|ibuprofen|mesh-list
43795232|NCT04611529|Diclofenac|diclofenac|mesh-list
43795233|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43795234|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43795235|NCT04611529|Analgesics|analgesics|mesh-ancestor
43795236|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
43795237|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795238|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795239|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795240|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43795241|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43795242|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795262|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795263|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795272|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
43795273|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795274|NCT04424862|Cyclosporine|cyclosporine|mesh-list
43795275|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
43795276|NCT04424862|Prednisone|prednisone|mesh-list
43795277|NCT04424862|Cyclosporins|cyclosporins|mesh-list
43795278|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795279|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
43795280|NCT04424862|Hormones|hormones|mesh-ancestor
43795281|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43795282|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795283|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43795284|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795285|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795286|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795287|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795288|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
43795289|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
43795290|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795291|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795301|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849587|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795303|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
43795304|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795305|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
43795306|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795307|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
43795308|NCT04298229|Diuretics|diuretics|mesh-list
43795309|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43795310|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795311|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43604452|NCT03237624|Chitosan|chitosan|mesh-list
43795312|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795313|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
43795314|NCT04268849|Ascorbic Acid|ascorbic acid|mesh-list
43841563|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841566|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
43841567|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
43841568|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841569|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43841570|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43841571|NCT04605393|Analgesics|analgesics|mesh-ancestor
43841572|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
43841579|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43841581|NCT04603508|Empagliflozin|empagliflozin|mesh-list
43841582|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43841583|NCT04603508|Calcium|calcium|mesh-list
43841584|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43841585|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841586|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43841587|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43841588|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43841589|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
43841590|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841591|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43841592|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43841593|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841594|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43795329|NCT04133532|Metoprolol|metoprolol|mesh-list
43795330|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43795331|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43795332|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
43795333|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
43795334|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795335|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795336|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43849588|NCT03909412|Dexamethasone|dexamethasone|mesh-list
43849589|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
43795353|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
43795354|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43795355|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43795356|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43795357|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43795358|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795359|NCT03962855|Ifetroban|ifetroban|mesh-list
43795360|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43795361|NCT03940326|Levetiracetam|levetiracetam|mesh-list
43795362|NCT03940326|Valproic Acid|valproic acid|mesh-list
43795363|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
43795381|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795382|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795383|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795384|NCT03884452|Atorvastatin|atorvastatin|mesh-list
43795385|NCT03884452|Simvastatin|simvastatin|mesh-list
43795386|NCT03884452|Ezetimibe|ezetimibe|mesh-list
43795387|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795388|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795389|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
43795390|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795391|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795392|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795393|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795394|NCT03882996|Atorvastatin|atorvastatin|mesh-list
43795395|NCT03882996|Ezetimibe|ezetimibe|mesh-list
43795396|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795418|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795419|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
43795420|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795421|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795422|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795423|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795424|NCT03867188|Bupivacaine|bupivacaine|mesh-list
43795425|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
43795426|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
43795427|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43795428|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795429|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
43795430|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795431|NCT03867110|Atorvastatin|atorvastatin|mesh-list
43795435|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
43795436|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795437|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795439|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795471|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
43795472|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
43795473|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
43795474|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795491|NCT03466801|Hormones|hormones|mesh-ancestor
43795492|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43795493|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795494|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43795495|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795496|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
43795497|NCT03466450|Temozolomide|temozolomide|mesh-list
43795498|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43795499|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
43795500|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795501|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795502|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
43795503|NCT03449888|Calcium|calcium|mesh-list
43795504|NCT03449888|Regadenoson|regadenoson|mesh-list
43795523|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795524|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43795525|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
43795526|NCT03415854|Antiviral Agents|antiviral agents|mesh-ancestor
43795527|NCT03415854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795528|NCT03415854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795529|NCT03415854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795530|NCT03415854|Immunologic Factors|immunologic factors|mesh-ancestor
43795540|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43795541|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795542|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43795543|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795544|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
43795545|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795546|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
43795547|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795577|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43795578|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795579|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795580|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
43795587|NCT03221400|Hematinics|hematinics|mesh-ancestor
43795610|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
43795611|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795612|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795614|NCT03136809|Trace Elements|trace elements|mesh-ancestor
43795615|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
43795646|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43795647|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795648|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795650|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795651|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795652|NCT02178436|Gemcitabine|gemcitabine|mesh-list
43795653|NCT02178436|Paclitaxel|paclitaxel|mesh-list
43795654|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43795665|NCT02178436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795666|NCT02178436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795667|NCT02178436|Immunologic Factors|immunologic factors|mesh-ancestor
43795668|NCT02178436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795669|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43795670|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795672|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43795673|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
43795674|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795675|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43795676|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43795677|NCT02086604|Growth Substances|growth substances|mesh-ancestor
43795678|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
43795679|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795680|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841617|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841618|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841619|NCT04602221|Lamotrigine|lamotrigine|mesh-list
43841633|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43841635|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
43841636|NCT04601402|Avelumab|avelumab|mesh-list
43841637|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841638|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841639|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43841652|NCT04600336|Urological Agents|urological agents|mesh-ancestor
43841653|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
43841654|NCT04599868|Analgesics|analgesics|mesh-ancestor
43841655|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
43841656|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841657|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841658|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
43841659|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841660|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43841661|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
43841662|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43841663|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841664|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795683|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795684|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43795685|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
43795686|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795687|NCT01554410|Antiviral Agents|antiviral agents|mesh-ancestor
43795688|NCT01554410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795689|NCT01554410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795690|NCT01554410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795691|NCT01554410|Immunologic Factors|immunologic factors|mesh-ancestor
43795692|NCT01554410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795693|NCT01499888|Sirolimus|sirolimus|mesh-list
43795694|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
43795695|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43795696|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795697|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43795698|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795699|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
43795738|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795739|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795740|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795741|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
43795742|NCT00795158|Desloratadine|desloratadine|mesh-list
43795743|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795744|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795745|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795746|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795810|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
43795764|NCT00794768|Fexofenadine|fexofenadine|mesh-list
43795765|NCT00794768|Desloratadine|desloratadine|mesh-list
43795766|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795767|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795768|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795769|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795770|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795771|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795772|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795773|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795774|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
43795775|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795776|NCT00794599|Cetirizine|cetirizine|mesh-list
43795777|NCT00794599|Desloratadine|desloratadine|mesh-list
43795778|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795779|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795787|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795788|NCT00794495|Cetirizine|cetirizine|mesh-list
43795789|NCT00794495|Desloratadine|desloratadine|mesh-list
43795790|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795791|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795792|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795793|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795794|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
43795795|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795796|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795797|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795798|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795799|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795800|NCT00794248|Fexofenadine|fexofenadine|mesh-list
43795801|NCT00794248|Desloratadine|desloratadine|mesh-list
43795802|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795803|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795804|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795805|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795806|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795807|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795808|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795809|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795843|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795844|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795845|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795846|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795847|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795848|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795849|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795850|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795854|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795855|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43795856|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
43795857|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795858|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795859|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43795860|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
43795861|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795862|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795863|NCT00757562|Desloratadine|desloratadine|mesh-list
43795864|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795865|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795866|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795922|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795923|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795924|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43795925|NCT00651144|Ezetimibe|ezetimibe|mesh-list
43795926|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795927|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795928|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
43795929|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795930|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795931|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795932|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795933|NCT00651014|Ezetimibe|ezetimibe|mesh-list
43795934|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795935|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795936|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
43795937|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795938|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795939|NCT00650689|Atorvastatin|atorvastatin|mesh-list
43795940|NCT00650689|Ezetimibe|ezetimibe|mesh-list
43795941|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795942|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795943|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
43795944|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795945|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43841687|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43795946|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795947|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795948|NCT00650663|Simvastatin|simvastatin|mesh-list
43795949|NCT00650663|Ezetimibe|ezetimibe|mesh-list
43795950|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795951|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795952|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
43795953|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795954|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795955|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795956|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795970|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795971|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43849602|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
43795972|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795973|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795975|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795976|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795977|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43795978|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43795979|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795980|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
43795981|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43795982|NCT00396175|Urological Agents|urological agents|mesh-ancestor
43795983|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
43796020|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796022|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796023|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796024|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43796025|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
43796026|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796027|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
43796029|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796030|NCT04046900|Metronidazole|metronidazole|mesh-list
43796031|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796032|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796033|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43796034|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43796035|NCT03991832|Durvalumab|durvalumab|mesh-list
43796036|NCT03991832|Olaparib|olaparib|mesh-list
43796037|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43796038|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796039|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43796040|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796051|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
43796052|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796053|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796054|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
43796055|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
43796056|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43796095|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43796096|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796098|NCT03782350|Coagulants|coagulants|mesh-ancestor
43796099|NCT03636256|Docetaxel|docetaxel|mesh-list
43796100|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796101|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
43796102|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
43796103|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
43796104|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796105|NCT03559400|Gentamicins|gentamicins|mesh-list
43796106|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796107|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796108|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43796109|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796110|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796111|NCT03519984|Cytarabine|cytarabine|mesh-list
43796112|NCT03519984|Vincristine|vincristine|mesh-list
43796113|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43796114|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
43796115|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796116|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796118|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796119|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43796120|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
43796121|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796122|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43796123|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
43796124|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
43796125|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
43796126|NCT03287778|Pyridoxine|pyridoxine|mesh-list
43796127|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
43796128|NCT03287778|Vitamins|vitamins|mesh-ancestor
43796129|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
43796130|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796131|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
43796137|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796138|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43796139|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
43796140|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796141|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796142|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43796143|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841688|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
43841689|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841690|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841691|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841693|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
43841694|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841695|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43841696|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43841697|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
43841698|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43841709|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43841710|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796144|NCT02716948|Nivolumab|nivolumab|mesh-list
43796145|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43796146|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796147|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43796148|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796149|NCT01641107|Ponatinib|ponatinib|mesh-list
43796150|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796151|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43796152|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796153|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796154|NCT00054964|Albuterol|albuterol|mesh-list
43796155|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43796156|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
43796157|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796158|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796159|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43796160|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
43796161|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
43796162|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43796163|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43796164|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43796165|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43796166|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
43796167|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796177|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
43796178|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43796179|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
43796180|NCT05073094|Esmolol|esmolol|mesh-list
43796181|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43796182|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43796183|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43796184|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
43796185|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796186|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796187|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796188|NCT05073029|Vitamin D|vitamin d|mesh-list
43796189|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
43796190|NCT05073029|Vitamins|vitamins|mesh-ancestor
43796191|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
43796192|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796193|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43796194|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43796195|NCT05072938|Nizatidine|nizatidine|mesh-list
43796196|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43796197|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43796198|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43796199|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
43796226|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43796227|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796228|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
43796229|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796230|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796231|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43796232|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796233|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
43796234|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43796235|NCT05072691|Antibodies|antibodies|mesh-list
43796236|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
43796237|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796238|NCT03363893|Fulvestrant|fulvestrant|mesh-list
43796239|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43796240|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796241|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43796242|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43796243|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796244|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796245|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796246|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43796247|NCT05072405|Simvastatin|simvastatin|mesh-list
43796248|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43796249|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43796250|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
43796251|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796252|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43796253|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43796254|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796255|NCT05072249|Naloxone|naloxone|mesh-list
43796266|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796267|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43796268|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796269|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796271|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43796272|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796283|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
43796284|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43796285|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43796286|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796287|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43796288|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43796289|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43796290|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796291|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43796292|NCT05070520|Lumefantrine|lumefantrine|mesh-list
43796293|NCT05070520|Artemether|artemether|mesh-list
43796294|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43796295|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
43796296|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43796309|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796310|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
43796311|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
43796312|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796313|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796314|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43796315|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
43796316|NCT05070468|Hormones|hormones|mesh-ancestor
43796320|NCT05070598|Paclitaxel|paclitaxel|mesh-list
43796331|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43796332|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43796333|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796334|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796335|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43796336|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43796337|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43796338|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43796339|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
43796340|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
43796341|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
43796342|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
43796343|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796344|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796345|NCT05070221|Axitinib|axitinib|mesh-list
43796346|NCT05070221|Antibodies|antibodies|mesh-list
43841732|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43848497|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
43848498|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43848499|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848500|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796454|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848517|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796357|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
43796366|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796367|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43796368|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43796369|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
43796370|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796371|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
43796372|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43796380|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
43796381|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43796382|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43796384|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43796385|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
43796386|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
43796387|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
43796388|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796389|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796390|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43796391|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43796392|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796393|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43796394|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43796395|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43796396|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43796397|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43796398|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43796399|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
43796400|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
43796401|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
43796402|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
43796403|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796404|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796416|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796417|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43796418|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43796419|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43796420|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43796421|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43796422|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43796445|NCT05067530|Carboplatin|carboplatin|mesh-list
43796446|NCT05067530|Palbociclib|palbociclib|mesh-list
43796447|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43796448|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796449|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
43796450|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
43796451|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
43796452|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796453|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43796474|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43796475|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796476|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796477|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796478|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
43796479|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796480|NCT05066802|Folfirinox|folfirinox|mesh-list
43796481|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796482|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43796483|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796484|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796485|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
43796509|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796511|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796512|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841733|NCT04594239|Lidocaine|lidocaine|mesh-list
43841734|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
43841735|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
43841736|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
43841737|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841738|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841739|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
43841754|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43841755|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43841756|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841757|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796515|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796516|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43796517|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43796518|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43796519|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43796520|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43796521|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796522|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796523|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43796524|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796525|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796526|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796527|NCT05065905|Interferons|interferons|mesh-list
43796528|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
43796529|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796530|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
43796531|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796532|NCT05066035|Neostigmine|neostigmine|mesh-list
43796533|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43796534|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796535|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796536|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
43796537|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796538|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796539|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43796540|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
43796541|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796542|NCT05065164|Denosumab|denosumab|mesh-list
43796543|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43796544|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796545|NCT05065177|Vaccines|vaccines|mesh-list
43796546|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
43796547|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796548|NCT05063838|Anesthetics|anesthetics|mesh-list
43796549|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796550|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796551|NCT05063578|Lidocaine|lidocaine|mesh-list
43796552|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
43796553|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
43796554|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796555|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796556|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
43796557|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796558|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43796559|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43796560|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43796561|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43796562|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796563|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
43796565|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43796566|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796567|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
43796568|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796569|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796570|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43796571|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43796572|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
43796573|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796574|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796575|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796576|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796578|NCT05063422|Polymyxins|polymyxins|mesh-list
43796579|NCT05063422|Polymyxin B|polymyxin b|mesh-list
43796580|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43796581|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43796582|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796583|NCT05063422|Renal Agents|renal agents|mesh-ancestor
43796584|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
43796585|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43796586|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43841758|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796587|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43796588|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796636|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43796602|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796603|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43796604|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796605|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796606|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796607|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43796609|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
43796610|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796611|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43796612|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43796613|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796614|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796615|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43796616|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43796617|NCT05062681|Dexamethasone|dexamethasone|mesh-list
43796618|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
43796619|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43796620|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43796621|NCT05062681|Prednisolone|prednisolone|mesh-list
43796622|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
43796623|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43796624|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
43796625|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796626|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
43796627|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
43796628|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796629|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796630|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43796631|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
43796632|NCT05062681|Hormones|hormones|mesh-ancestor
43796633|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796634|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43796635|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796659|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
43796660|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
43796661|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796662|NCT05062304|Fluticasone|fluticasone|mesh-list
43796663|NCT05062304|Xhance|xhance|mesh-list
43796664|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796665|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43796666|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
43796667|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796668|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796669|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43796670|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
43796671|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
43796672|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43796689|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43796690|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43796691|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
43796692|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43796693|NCT05061732|Renal Agents|renal agents|mesh-ancestor
43796694|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43796695|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43796696|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796697|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43796698|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43796699|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43796700|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43796701|NCT05061732|Antacids|antacids|mesh-ancestor
43796702|NCT05061732|Diuretics|diuretics|mesh-ancestor
43796703|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
43796704|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796705|NCT05061732|Expectorants|expectorants|mesh-ancestor
43796706|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
43841760|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841761|NCT04594018|Urological Agents|urological agents|mesh-ancestor
43841762|NCT04593329|Dipyrone|dipyrone|mesh-list
43841763|NCT04593329|Tramadol|tramadol|mesh-list
43841764|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43841765|NCT04593329|Narcotics|narcotics|mesh-ancestor
43841766|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841767|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841768|NCT04593329|Analgesics|analgesics|mesh-ancestor
43841772|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43841773|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841774|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841775|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
43841776|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
43841777|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841778|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841779|NCT04592016|Diclofenac|diclofenac|mesh-list
43796718|NCT05060822|Pirfenidone|pirfenidone|mesh-list
43796719|NCT05060822|Analgesics|analgesics|mesh-ancestor
43796720|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
43796772|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
43796729|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
43796730|NCT05060809|Vitamins|vitamins|mesh-ancestor
43796731|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
43796732|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796733|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43796734|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43796735|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796737|NCT05060809|Coagulants|coagulants|mesh-ancestor
43796738|NCT05060588|Valsartan|valsartan|mesh-list
43796739|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43796740|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43796741|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43796742|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43796743|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796744|NCT05060419|Meropenem|meropenem|mesh-list
43796745|NCT05060419|Tazobactam|tazobactam|mesh-list
43796746|NCT05060419|Piperacillin|piperacillin|mesh-list
43796747|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43796748|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796749|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796750|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43796751|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796752|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796753|NCT05060198|Lumefantrine|lumefantrine|mesh-list
43796754|NCT05060198|Artemether|artemether|mesh-list
43796755|NCT05060198|Piperaquine|piperaquine|mesh-list
43796756|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43796757|NCT05060198|Artenimol|artenimol|mesh-list
43796758|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
43796759|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43796760|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43796761|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796762|NCT05059782|Coal Tar|coal tar|mesh-list
43796763|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
43796764|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
43796766|NCT05059418|Capsaicin|capsaicin|mesh-list
43796767|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
43796768|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
43796769|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
43796770|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796771|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796783|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
43796784|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
43796785|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43796786|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43796787|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796788|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796789|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43796790|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796791|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796792|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796793|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43796794|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43796795|NCT05058677|Lidocaine|lidocaine|mesh-list
43796796|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
43796816|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796817|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
43796818|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796819|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43796820|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43796821|NCT05058755|Growth Substances|growth substances|mesh-ancestor
43796822|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
43796823|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43796824|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
43796826|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43796827|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43796828|NCT05058209|Betamethasone|betamethasone|mesh-list
43796829|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
43796838|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796839|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796840|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43796841|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
43796842|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796843|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796844|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43796845|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
43796847|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796848|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796849|NCT05057663|Fluorouracil|fluorouracil|mesh-list
43796850|NCT05057663|Bleomycin|bleomycin|mesh-list
43796851|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
43796852|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796853|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43796854|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796855|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43796856|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
43796857|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796858|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43796859|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
43796860|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43796861|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43796862|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43796872|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841781|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43841782|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43841783|NCT04592016|Analgesics|analgesics|mesh-ancestor
43841784|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
43841785|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841786|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841787|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841788|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841789|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43841790|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841791|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841792|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
43841793|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
43841794|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
43841795|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841796|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841797|NCT04590495|Cannabidiol|cannabidiol|mesh-list
43841798|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
43841799|NCT04590404|Nicotine|nicotine|mesh-list
43841800|NCT04590404|Varenicline|varenicline|mesh-list
43841801|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43841802|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
43841803|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841804|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841805|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43841806|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43841807|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
43841808|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841809|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841811|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841812|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841813|NCT04589754|Ifosfamide|ifosfamide|mesh-list
43841814|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841815|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841816|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43841817|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
43841818|NCT04588792|Furosemide|furosemide|mesh-list
43841819|NCT04588792|Diuretics|diuretics|mesh-ancestor
43796873|NCT05056896|Aspirin|aspirin|mesh-list
43796874|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
43796875|NCT05056896|Salicylates|salicylates|mesh-list
43796876|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43796877|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43796878|NCT05056896|Analgesics|analgesics|mesh-ancestor
43796879|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
43796880|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796881|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796882|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796883|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796884|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43796885|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43796886|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796893|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
43796894|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
43796895|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
43796896|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796898|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
43796899|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796900|NCT05056337|Lenvatinib|lenvatinib|mesh-list
43796911|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796912|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796932|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43796933|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43796934|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
43796935|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796936|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43796937|NCT05054322|Fluticasone|fluticasone|mesh-list
43796938|NCT05054322|Xhance|xhance|mesh-list
43796939|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796940|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43796941|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
43796942|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796943|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796944|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43606392|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
43841827|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
43841828|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
43841829|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43841830|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43841831|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841832|NCT04588233|Melatonin|melatonin|mesh-list
43841833|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
43841834|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841835|NCT04588233|Protective Agents|protective agents|mesh-ancestor
43841836|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841837|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841838|NCT04587128|Irinotecan|irinotecan|mesh-list
43841839|NCT04587128|Cetuximab|cetuximab|mesh-list
43841840|NCT04587128|Panitumumab|panitumumab|mesh-list
43841841|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43841842|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43841843|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841844|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841845|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841846|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841847|NCT04587089|Anti-Infective Agents|anti-infective agents|mesh-list
43841861|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43841862|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43796976|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
43796977|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796978|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796979|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796980|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796981|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43796982|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796983|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796984|NCT05053386|Epirubicin|epirubicin|mesh-list
43796985|NCT05053386|Idarubicin|idarubicin|mesh-list
43796986|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43796987|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796988|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43796989|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43796990|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796991|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796992|NCT05052879|Tadalafil|tadalafil|mesh-list
43796993|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
43796994|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43796995|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43796996|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796997|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796998|NCT05052879|Urological Agents|urological agents|mesh-ancestor
43797002|NCT05052515|Micronutrients|micronutrients|mesh-ancestor
43797003|NCT05052515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797004|NCT05052515|Antioxidants|antioxidants|mesh-ancestor
43797005|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797006|NCT05052515|Protective Agents|protective agents|mesh-ancestor
43797007|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
43797008|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43797009|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
43797010|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797011|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43797012|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
43797013|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43797014|NCT05052619|Cefmetazole|cefmetazole|mesh-list
43797015|NCT05052619|Sulperazone|sulperazone|mesh-list
43797016|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797017|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43797018|NCT05052619|Renal Agents|renal agents|mesh-ancestor
43797019|NCT05052437|Capecitabine|capecitabine|mesh-list
43797020|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43797021|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
43797022|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797023|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797024|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
43797025|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43797026|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797027|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
43797028|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
43797029|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43797030|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
43797031|NCT05052814|Calcium|calcium|mesh-list
43797032|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43797033|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797034|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43797035|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797036|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
43797037|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
43797038|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
43797039|NCT05052008|Erenumab|erenumab|mesh-list
43797040|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43797041|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797042|NCT05052008|Analgesics|analgesics|mesh-ancestor
43797043|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
43797044|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797045|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797046|NCT05052359|Lectins|lectins|mesh-list
43797059|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
43797060|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43797061|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43797062|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797063|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797064|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797065|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43797066|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
43797067|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797068|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43797069|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43797070|NCT05051137|Analgesics|analgesics|mesh-ancestor
43797103|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
43797104|NCT05050357|Norethindrone|norethindrone|mesh-list
43797105|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
43797106|NCT05050357|Progestins|progestins|mesh-list
43797107|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43797108|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43797109|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43797110|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
43797111|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43797131|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43797132|NCT05050448|Analgesics|analgesics|mesh-ancestor
43797133|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
43797134|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797135|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797136|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797139|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797140|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841865|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43841866|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43841867|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43841868|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43841869|NCT04583618|Vaccines|vaccines|mesh-list
43841870|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43841871|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
43841872|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841873|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43841874|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
43841875|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841876|NCT04581603|Topiramate|topiramate|mesh-list
43841877|NCT04581603|Anticonvulsants|anticonvulsants|mesh-ancestor
43841878|NCT04581603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43841879|NCT04581603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841880|NCT04581395|Rocuronium|rocuronium|mesh-list
43841881|NCT04581395|Succinylcholine|succinylcholine|mesh-list
43841882|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43841883|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43841884|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43841885|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841886|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841887|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43848537|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
43848538|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848539|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43848540|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43797422|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43797166|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797169|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797170|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797171|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
43797172|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
43797173|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797174|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797175|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
43797176|NCT05049473|Hormones|hormones|mesh-ancestor
43797177|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797178|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43797179|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43797180|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43797181|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43797182|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797183|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43797184|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
43797185|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43797186|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43797187|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
43797188|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
43797189|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43797190|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43797191|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43797192|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
43797193|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797194|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
43797195|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
43797196|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
43797197|NCT05049681|Apatinib|apatinib|mesh-list
43797198|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797199|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43797201|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797203|NCT05048914|Dipyrone|dipyrone|mesh-list
43797204|NCT05048914|Ibuprofen|ibuprofen|mesh-list
43797205|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43797206|NCT05048914|Analgesics|analgesics|mesh-ancestor
43797207|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
43797208|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797209|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797210|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
43797211|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43797212|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797213|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43797214|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43797215|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797216|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797217|NCT05048940|Vaccines|vaccines|mesh-list
43797218|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
43797220|NCT05048901|Lanreotide|lanreotide|mesh-list
43797221|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797222|NCT05048511|Vitamin D|vitamin d|mesh-list
43797223|NCT05048511|Vitamins|vitamins|mesh-ancestor
43797224|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
43797225|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797226|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43797227|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
43606764|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
43797228|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43797229|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797230|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797231|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797232|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
43797233|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43797234|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43797235|NCT05047874|Prednisolone|prednisolone|mesh-list
43797236|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
43797237|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43797238|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
43797239|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797240|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
43797241|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
43797242|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797243|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797244|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797245|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
43797246|NCT05047874|Hormones|hormones|mesh-ancestor
43797247|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797248|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43797249|NCT05047874|Protective Agents|protective agents|mesh-ancestor
43797252|NCT05047848|Fulvestrant|fulvestrant|mesh-list
43797260|NCT05047991|Leucovorin|leucovorin|mesh-list
43797261|NCT05047991|Gemcitabine|gemcitabine|mesh-list
43797262|NCT05047991|Paclitaxel|paclitaxel|mesh-list
43797263|NCT05047991|Fluorouracil|fluorouracil|mesh-list
43797264|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
43797265|NCT05047991|Irinotecan|irinotecan|mesh-list
43797266|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43797267|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797268|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
43797269|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
43797270|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
43797271|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797272|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43797273|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
43797274|NCT05047991|Antiviral Agents|antiviral agents|mesh-ancestor
43797275|NCT05047991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797276|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797277|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43797278|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
43797279|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797280|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43797281|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43797282|NCT05047991|Antidotes|antidotes|mesh-ancestor
43797283|NCT05047991|Protective Agents|protective agents|mesh-ancestor
43797284|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
43797285|NCT05047991|Vitamins|vitamins|mesh-ancestor
43797286|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
43797287|NCT05047978|Caseins|caseins|mesh-list
43797288|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
43797289|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
43797290|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797291|NCT05047328|Inolimomab|inolimomab|mesh-list
43797292|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43797293|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
43797303|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
43797304|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797305|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43797306|NCT05047211|Dextrans|dextrans|mesh-list
43797307|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
43797308|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
43797309|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
43797310|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
43797312|NCT05046860|Dalbavancin|dalbavancin|mesh-list
43797313|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43797314|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797315|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
43797316|NCT05047055|Rifampin|rifampin|mesh-list
43797317|NCT05047055|Isoniazid|isoniazid|mesh-list
43797318|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
43797319|NCT05047055|Ethambutol|ethambutol|mesh-list
43797320|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43797321|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797322|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43797323|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43797324|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797325|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797326|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797327|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43797328|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
43797329|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
43797330|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43797331|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43797332|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43797333|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43797334|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43797348|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797349|NCT05046041|Misoprostol|misoprostol|mesh-list
43797350|NCT05046041|Mifepristone|mifepristone|mesh-list
43797351|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43797352|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
43797353|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43797373|NCT05045651|Cimetidine|cimetidine|mesh-list
43797384|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841897|NCT04578756|Cariprazine|cariprazine|mesh-list
43841907|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43841908|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841909|NCT04574947|Lidocaine|lidocaine|mesh-list
43841910|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
43841911|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
43841912|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841913|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841914|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
43841915|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841916|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43841917|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43841918|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43841919|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841920|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841921|NCT04573478|Atrasentan|atrasentan|mesh-list
43841922|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841923|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43841924|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43841925|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841927|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43841928|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
43797406|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43797407|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43797408|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
43797410|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43797411|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43797412|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
43797413|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43797414|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43797415|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43797416|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43797417|NCT05045274|Analgesics|analgesics|mesh-ancestor
43797418|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
43797419|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797420|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797421|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797510|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
43797511|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
43797512|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
43797513|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797514|NCT05043350|Loratadine|loratadine|mesh-list
43797515|NCT05043350|Famotidine|famotidine|mesh-list
43797516|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43797517|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797518|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43797519|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
43797520|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
43797521|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797522|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797523|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797524|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
43797525|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
43797526|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43797527|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43797528|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43797529|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43797530|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43797531|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797532|NCT05043233|Methimazole|methimazole|mesh-list
43797533|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
43797534|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
43797535|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797536|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797537|NCT05043129|Vaccines|vaccines|mesh-list
43797538|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
43797539|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797540|NCT05043142|Antibodies|antibodies|mesh-list
43797541|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
43797542|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797543|NCT05042817|Sufentanil|sufentanil|mesh-list
43797544|NCT05042817|Morphine|morphine|mesh-list
43797545|NCT05042817|Prilocaine|prilocaine|mesh-list
43797546|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43797547|NCT05042817|Narcotics|narcotics|mesh-ancestor
43797548|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797549|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797550|NCT05042817|Analgesics|analgesics|mesh-ancestor
43797551|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
43797552|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797553|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43797554|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43797555|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
43797556|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
43797557|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
43797558|NCT05042635|Ixekizumab|ixekizumab|mesh-list
43797559|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
43841929|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43797561|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797562|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43797563|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797564|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797565|NCT05042271|Meropenem|meropenem|mesh-list
43797566|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43797567|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797568|NCT05042245|Silymarin|silymarin|mesh-list
43797569|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
43797592|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43797593|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
43797594|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
43797595|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
43797596|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
43797597|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797598|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797599|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
43797600|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
43797601|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43797602|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797603|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797604|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797605|NCT05041582|Citalopram|citalopram|mesh-list
43797606|NCT05041582|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43797651|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
43797652|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797653|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797670|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43797671|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797672|NCT05039580|Dexamethasone|dexamethasone|mesh-list
43797674|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43797675|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
43797676|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797677|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797678|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
43797679|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
43797680|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797681|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797682|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
43797684|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797685|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43797686|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797687|NCT05039606|Cisplatin|cisplatin|mesh-list
43797688|NCT05039606|Nedaplatin|nedaplatin|mesh-list
43797689|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841946|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43841947|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841948|NCT04570839|Nivolumab|nivolumab|mesh-list
43841949|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849604|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43849605|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
43841950|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841951|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43841952|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841953|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
43841954|NCT04569461|Androgens|androgens|mesh-list
43841955|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841956|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841957|NCT04569461|Hormones|hormones|mesh-ancestor
43841958|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43841959|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841960|NCT04567784|Cannabidiol|cannabidiol|mesh-list
43841961|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
43841962|NCT04567420|Fulvestrant|fulvestrant|mesh-list
43841963|NCT04567420|Palbociclib|palbociclib|mesh-list
43841964|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43797690|NCT05038969|Esomeprazole|esomeprazole|mesh-list
43797691|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43797692|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797693|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43797694|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797695|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797696|NCT05038605|Metronidazole|metronidazole|mesh-list
43797697|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797698|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43797729|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
43797730|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797731|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43797732|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43797733|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43797734|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
43797735|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797736|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797737|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
43797739|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
43797740|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797741|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
43607372|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
43797742|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43797744|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
43797745|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43797746|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
43797747|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
43797748|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
43797749|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797750|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797751|NCT05038059|Acetic Acid|acetic acid|mesh-list
43797752|NCT05038059|Retinol acetate|retinol acetate|mesh-list
43797753|NCT05038059|Ethylene|ethylene|mesh-list
43797754|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43797755|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797756|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43797757|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
43797758|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797759|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43797760|NCT05038059|Protective Agents|protective agents|mesh-ancestor
43797761|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797762|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
43797763|NCT05038059|Growth Substances|growth substances|mesh-ancestor
43797765|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43797766|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797767|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43797768|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797769|NCT05037253|Vitamin D|vitamin d|mesh-list
43797772|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797773|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43797774|NCT05037240|Quercetin|quercetin|mesh-list
43797775|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
43797776|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797777|NCT05037240|Protective Agents|protective agents|mesh-ancestor
43797778|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797779|NCT05037006|Anesthetics|anesthetics|mesh-list
43797780|NCT05037006|Sevoflurane|sevoflurane|mesh-list
43797781|NCT05037006|Neostigmine|neostigmine|mesh-list
43797782|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797783|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797784|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43797785|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43797786|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
43797787|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43797788|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797789|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797790|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
43797791|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797792|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43797793|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
43797794|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797795|NCT05036824|Tinzaparin|tinzaparin|mesh-list
43797796|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43797797|NCT05036824|Dalteparin|dalteparin|mesh-list
43797798|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
43797799|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43797800|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43797817|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797818|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
43797820|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
43797821|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797822|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
43797823|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
43797824|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797825|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43797826|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
43797827|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
43797828|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797829|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797830|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43797831|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
43797832|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
43797833|NCT05035745|Talazoparib|talazoparib|mesh-list
43797834|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43797835|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797836|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797837|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797838|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43797839|NCT05035849|Acarbose|acarbose|mesh-list
43797840|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43797841|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797842|NCT05035849|Incretins|incretins|mesh-ancestor
43797843|NCT05035849|Hormones|hormones|mesh-ancestor
43797844|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797845|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43797846|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
43797847|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797874|NCT05035381|Vitamins|vitamins|mesh-ancestor
43797875|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
43797876|NCT05035498|Phenylephrine|phenylephrine|mesh-list
43797877|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
43797878|NCT05035498|Norepinephrine|norepinephrine|mesh-list
43797879|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43797880|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43797881|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
43797882|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
43797883|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797884|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797885|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
43797886|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
43797887|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
43797888|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43797899|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43797900|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
43797901|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
43797911|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797912|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797913|NCT05035485|Protective Agents|protective agents|mesh-ancestor
43797915|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
43797916|NCT05035472|Norepinephrine|norepinephrine|mesh-list
43797917|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43797918|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43797919|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
43797920|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
43797921|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797932|NCT05035472|Protective Agents|protective agents|mesh-ancestor
43797933|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
43797934|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43849606|NCT03909412|Hormones|hormones|mesh-ancestor
43797935|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
43797936|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797937|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
43797938|NCT05034965|Protective Agents|protective agents|mesh-ancestor
43797939|NCT05035069|Propofol|propofol|mesh-list
43797940|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43797941|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797942|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797943|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43797944|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
43797945|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
43797946|NCT05035147|Gemcitabine|gemcitabine|mesh-list
43797948|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43797949|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43797950|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797951|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
43797952|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
43797953|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
43797954|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797955|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43797956|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
43797970|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797971|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797972|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
43797973|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797974|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43797975|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43797980|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797981|NCT05034133|Cisplatin|cisplatin|mesh-list
43797982|NCT05034133|Etoposide|etoposide|mesh-list
43797983|NCT05034133|Durvalumab|durvalumab|mesh-list
43797984|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797985|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43797986|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43797987|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43797988|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797989|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797990|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797991|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
43797992|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43797993|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
43797994|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43797995|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
43797996|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797997|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797998|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
43797999|NCT05033574|Hormones|hormones|mesh-list
43798000|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798001|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798002|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
43798003|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
43798010|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798011|NCT05033106|Bevacizumab|bevacizumab|mesh-list
43798012|NCT05033106|Ranibizumab|ranibizumab|mesh-list
43798013|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43798014|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798015|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43798016|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43798017|NCT05033106|Growth Substances|growth substances|mesh-ancestor
43841975|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43841976|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841977|NCT04567108|Benzocaine|benzocaine|mesh-list
43841978|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
43841979|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
43841980|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841981|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841982|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
43841983|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841984|NCT04565301|Dexamethasone|dexamethasone|mesh-list
43841985|NCT04565301|Neostigmine|neostigmine|mesh-list
43841986|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841987|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
43841988|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
43841989|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841990|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841991|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43841992|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
43841993|NCT04565301|Hormones|hormones|mesh-ancestor
43841994|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43841995|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43607696|NCT03200600|Dexamethasone|dexamethasone|mesh-list
43798052|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43798053|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43798055|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798056|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43798057|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798058|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
43798059|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798060|NCT05032118|Ketamine|ketamine|mesh-list
43798061|NCT05032118|Propofol|propofol|mesh-list
43798062|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43798063|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798064|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798071|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43798072|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43798073|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43798074|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798075|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798076|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
43798077|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43798078|NCT05031689|Protective Agents|protective agents|mesh-ancestor
43798079|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798080|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
43798081|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
43798082|NCT05031676|Anesthetics|anesthetics|mesh-list
43798083|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798084|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798085|NCT05031676|Narcotics|narcotics|mesh-ancestor
43798086|NCT05031676|Analgesics|analgesics|mesh-ancestor
43798087|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
43798088|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798089|NCT05031234|Morphine|morphine|mesh-list
43798090|NCT05031234|Anesthetics|anesthetics|mesh-list
43798091|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798092|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798093|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43798094|NCT05031234|Narcotics|narcotics|mesh-ancestor
43798095|NCT05031234|Analgesics|analgesics|mesh-ancestor
43798096|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
43798097|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798098|NCT05031143|Triamcinolone|triamcinolone|mesh-list
43798099|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43798100|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43798101|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43798102|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798103|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
43798104|NCT05031143|Hormones|hormones|mesh-ancestor
43798105|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798106|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798107|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798108|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
43798109|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798110|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798111|NCT05030545|Eplerenone|eplerenone|mesh-list
43798112|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43798113|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
43798114|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
43798155|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798156|NCT05029297|Capsaicin|capsaicin|mesh-list
43798157|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
43798158|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
43798159|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
43798160|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798161|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798162|NCT05029037|Ascorbic Acid|ascorbic acid|mesh-list
43798163|NCT05029037|Vitamins|vitamins|mesh-ancestor
43798164|NCT05029037|Micronutrients|micronutrients|mesh-ancestor
43798165|NCT05029037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798166|NCT05029037|Antioxidants|antioxidants|mesh-ancestor
43798167|NCT05029037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798168|NCT05029037|Protective Agents|protective agents|mesh-ancestor
43798169|NCT05028907|Tocopherols|tocopherols|mesh-list
43798170|NCT05028907|Vitamin E|vitamin e|mesh-list
43798171|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
43798172|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
43798173|NCT05028907|Dexamethasone|dexamethasone|mesh-list
43798174|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
43798175|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
43798176|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43798177|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
43798178|NCT05028907|BB 1101|bb 1101|mesh-list
43798179|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798191|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
43798192|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
43798193|NCT05028907|Protective Agents|protective agents|mesh-ancestor
43798194|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
43798195|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798196|NCT05028907|Vitamins|vitamins|mesh-ancestor
43798197|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
43798198|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
43798199|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798200|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43798201|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841996|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841997|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43841998|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841999|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842000|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
43842001|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842002|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43842003|NCT04564846|Insulin|insulin|mesh-list
43842004|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43842020|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842021|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
43842022|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848543|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848544|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848546|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848547|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848548|NCT04009109|Dexamethasone|dexamethasone|mesh-list
43848549|NCT04009109|Lenalidomide|lenalidomide|mesh-list
43848550|NCT04009109|Daratumumab|daratumumab|mesh-list
43848551|NCT04009109|Ixazomib|ixazomib|mesh-list
43848552|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848553|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
43848554|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
43848555|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848556|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798220|NCT05028049|Sufentanil|sufentanil|mesh-list
43798221|NCT05028049|Remifentanil|remifentanil|mesh-list
43798222|NCT05028049|Dsuvia|dsuvia|mesh-list
43798223|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43798224|NCT05028049|Narcotics|narcotics|mesh-ancestor
43798225|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798226|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798227|NCT05028049|Analgesics|analgesics|mesh-ancestor
43798228|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
43798229|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798230|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43798231|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43798232|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
43798233|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
43798234|NCT05028140|Pioglitazone|pioglitazone|mesh-list
43798235|NCT05028140|Empagliflozin|empagliflozin|mesh-list
43798236|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43798237|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798249|NCT05027126|Vitamins|vitamins|mesh-ancestor
43798250|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
43798251|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798252|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43798253|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43798254|NCT05027126|Analgesics|analgesics|mesh-ancestor
43798255|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
43798256|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798257|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798258|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43798259|NCT05027126|Hematinics|hematinics|mesh-ancestor
43798260|NCT05027386|Irinotecan|irinotecan|mesh-list
43798261|NCT05027386|Temozolomide|temozolomide|mesh-list
43798262|NCT05027386|Apatinib|apatinib|mesh-list
43798263|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43798264|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43798265|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798266|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798267|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798268|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43798269|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
43798270|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43798271|NCT05027191|Sevoflurane|sevoflurane|mesh-list
43798272|NCT05027191|Desflurane|desflurane|mesh-list
43798273|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43798274|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43798275|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
43798276|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
43798277|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798278|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798279|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43798329|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
43798330|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798331|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798332|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43842023|NCT04561180|Dexamethasone|dexamethasone|mesh-list
43842024|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842025|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
43842026|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
43842027|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842028|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842029|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43842030|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
43842031|NCT04561180|Hormones|hormones|mesh-ancestor
43842032|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43842033|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43842034|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842035|NCT04560686|Atezolizumab|atezolizumab|mesh-list
43842036|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842037|NCT04559607|Apatinib|apatinib|mesh-list
43842038|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842039|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43842040|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842041|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842042|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
43842043|NCT04558736|Fludarabine|fludarabine|mesh-list
43842044|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
43842045|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43842046|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842047|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
43842048|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842050|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43842051|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
43842052|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842053|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842054|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43842056|NCT04555577|Peposertib|peposertib|mesh-list
43798362|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43798363|NCT05024825|Analgesics|analgesics|mesh-ancestor
43798364|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
43798365|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798366|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798367|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
43798368|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43798369|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798370|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43798371|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43798372|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798373|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798374|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
43798375|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43798376|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43798377|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798378|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43798379|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43798380|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43798381|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798382|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
43798383|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43798384|NCT05024825|Narcotics|narcotics|mesh-ancestor
43798385|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
43798405|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798406|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798408|NCT05024526|Edaravone|edaravone|mesh-list
43798409|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43798410|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
43798411|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798412|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43798413|NCT05024526|Protective Agents|protective agents|mesh-ancestor
43798414|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798415|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43798416|NCT05024565|Lactams|lactams|mesh-list
43798417|NCT05024565|beta-Lactams|beta-lactams|mesh-list
43798418|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798419|NCT05024357|Dasatinib|dasatinib|mesh-list
43798420|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798421|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43798422|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798423|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798424|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
43798425|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43798426|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798427|NCT05023915|Dexamethasone|dexamethasone|mesh-list
43798428|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
43798429|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798430|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
43798431|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
43798432|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798433|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798434|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43798435|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
43798436|NCT05023915|Hormones|hormones|mesh-ancestor
43798437|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798438|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43798439|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798440|NCT05023941|Acetazolamide|acetazolamide|mesh-list
43798441|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
43798442|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43798443|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798444|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798445|NCT05023941|Diuretics|diuretics|mesh-ancestor
43798446|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
43798447|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798448|NCT05024266|Paclitaxel|paclitaxel|mesh-list
43798449|NCT05024266|Carboplatin|carboplatin|mesh-list
43798450|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43798477|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798480|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
43798482|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43798483|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798484|NCT05023304|Prednisolone|prednisolone|mesh-list
43798485|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798486|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
43798487|NCT05023304|Hormones|hormones|mesh-ancestor
43798488|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798489|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798490|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43798491|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798492|NCT05023759|Cannabidiol|cannabidiol|mesh-list
43798493|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
43798494|NCT05023577|Metronidazole|metronidazole|mesh-list
43798495|NCT05023577|Clarithromycin|clarithromycin|mesh-list
43798496|NCT05023577|Levofloxacin|levofloxacin|mesh-list
43798497|NCT05023577|Ofloxacin|ofloxacin|mesh-list
43798498|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
43798499|NCT05023577|Rabeprazole|rabeprazole|mesh-list
43798500|NCT05023577|Bismuth|bismuth|mesh-list
43798501|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798502|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798503|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43798519|NCT05023577|Antacids|antacids|mesh-ancestor
43798531|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43798532|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43798533|NCT05022030|Cetuximab|cetuximab|mesh-list
43798534|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43798535|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842063|NCT04554485|Blinatumomab|blinatumomab|mesh-list
43842064|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842065|NCT04553770|Trastuzumab|trastuzumab|mesh-list
43842066|NCT04553770|Anastrozole|anastrozole|mesh-list
43842067|NCT04553770|Camptothecin|camptothecin|mesh-list
43842068|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
43842069|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43842070|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842071|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43842072|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43842073|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43842074|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842075|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842076|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43842077|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
43798539|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43798540|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
43798541|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798542|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798543|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43798544|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
43798545|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
43798546|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43798547|NCT05022186|Cannabidiol|cannabidiol|mesh-list
43798548|NCT05022186|Tramiprosate|tramiprosate|mesh-list
43798549|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
43798550|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
43798551|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
43798552|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798553|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798554|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798555|NCT05021770|Thiotepa|thiotepa|mesh-list
43798556|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43798557|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
43798558|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798559|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798560|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43798561|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798562|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
43798563|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798564|NCT05021588|Anticoagulants|anticoagulants|mesh-list
43798565|NCT05021406|Carvedilol|carvedilol|mesh-list
43798566|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43798567|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43798568|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
43798570|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798571|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798572|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43798573|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
43798574|NCT05021406|Protective Agents|protective agents|mesh-ancestor
43798575|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43798579|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43798580|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43798581|NCT05021731|Rifampin|rifampin|mesh-list
43798582|NCT05021731|Rifapentine|rifapentine|mesh-list
43798583|NCT05021731|Isoniazid|isoniazid|mesh-list
43798584|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43798585|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
43798586|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43798587|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798588|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
43798589|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43798590|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798591|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798592|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43798593|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43798594|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43798595|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43798596|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43798597|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43798598|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43798599|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43798600|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
43798601|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43798602|NCT05021276|Basiliximab|basiliximab|mesh-list
43798603|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798604|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
43798605|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798606|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
43798607|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798608|NCT05020964|Trastuzumab|trastuzumab|mesh-list
43798609|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43798610|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798611|NCT05020704|Empagliflozin|empagliflozin|mesh-list
43798612|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43798613|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798614|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43798615|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798616|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
43798617|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
43798618|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798619|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798620|NCT05019586|Amoxicillin|amoxicillin|mesh-list
43798621|NCT05019586|Clarithromycin|clarithromycin|mesh-list
43798622|NCT05019586|Levofloxacin|levofloxacin|mesh-list
43798623|NCT05019586|Ofloxacin|ofloxacin|mesh-list
43798624|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43798625|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798626|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43798627|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798628|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798629|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43798630|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43798631|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43798632|NCT05019586|Renal Agents|renal agents|mesh-ancestor
43798637|NCT05019690|Paclitaxel|paclitaxel|mesh-list
43798660|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798661|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798662|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43798663|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43798664|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43798665|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
43798666|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43798667|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43798668|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43798669|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798670|NCT05018923|Antacids|antacids|mesh-ancestor
43842111|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
43842112|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842113|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43842114|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43842115|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842116|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43842118|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43842119|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43842120|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
43842121|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842122|NCT04552223|Nivolumab|nivolumab|mesh-list
43842123|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43842124|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842125|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43842126|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842127|NCT04551222|Probenecid|probenecid|mesh-list
43842128|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
43842129|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
43842130|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842131|NCT04551222|Renal Agents|renal agents|mesh-ancestor
43842132|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
43842133|NCT04550832|Bedaquiline|bedaquiline|mesh-list
43842134|NCT04550832|Delpazolid|delpazolid|mesh-list
43842135|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43842136|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842137|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43798706|NCT05018637|Teriparatide|teriparatide|mesh-list
43798707|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43798708|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798709|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43798710|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
43798711|NCT05018364|Hematinics|hematinics|mesh-ancestor
43798712|NCT05018182|Leucovorin|leucovorin|mesh-list
43798713|NCT05018182|Folic Acid|folic acid|mesh-list
43798714|NCT05018182|Fluorouracil|fluorouracil|mesh-list
43798715|NCT05018182|Capecitabine|capecitabine|mesh-list
43798716|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
43798717|NCT05018182|Irinotecan|irinotecan|mesh-list
43798718|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
43798719|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
43798720|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798721|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43798722|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798723|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798724|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
43798725|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798726|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43798727|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43798728|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798730|NCT05018182|Protective Agents|protective agents|mesh-ancestor
43798731|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
43798732|NCT05018182|Vitamins|vitamins|mesh-ancestor
43798736|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798738|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43798739|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43798740|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
43798741|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43798742|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
43798743|NCT05017454|Valproic Acid|valproic acid|mesh-list
43798744|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798745|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
43798748|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798749|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798750|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
43798751|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798752|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798753|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
43798754|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43798755|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798756|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43798758|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
43798759|NCT05017311|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43798760|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43798761|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43798762|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798763|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798764|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
43798765|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798766|NCT05017311|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43798767|NCT05017311|Antidepressive Agents|antidepressive agents|mesh-ancestor
43798768|NCT05017311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43798769|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
43798770|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
43798771|NCT05017428|Niacinamide|niacinamide|mesh-list
43798772|NCT05017428|Niacin|niacin|mesh-list
43798773|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
43798774|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
43798775|NCT05017428|Vitamins|vitamins|mesh-ancestor
43798776|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
43798777|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798803|NCT05016128|Analgesics|analgesics|mesh-ancestor
43798804|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
43798805|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798806|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798807|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43798808|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43798809|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
43798810|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
43798811|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798812|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43798813|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43798814|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798815|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798816|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
43798817|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43798818|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
43798819|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43798820|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43798821|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798822|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43798823|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43798824|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798825|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798852|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798853|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798854|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43798855|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798856|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43798857|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43798858|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43798859|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
43798860|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
43798861|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
43798872|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43798873|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43798874|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
43798875|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798876|NCT05016349|Protective Agents|protective agents|mesh-ancestor
43798877|NCT05016349|Vitamins|vitamins|mesh-ancestor
43798878|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
43798879|NCT05016180|Ropivacaine|ropivacaine|mesh-list
43798880|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
43798881|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
43798882|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798883|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798884|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
43798890|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798891|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
43798892|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798893|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43798894|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43798895|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
43798896|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43798897|NCT05015907|Ropivacaine|ropivacaine|mesh-list
43798898|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
43798899|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
43798900|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798901|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798902|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
43798903|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798904|NCT05015595|Memantine|memantine|mesh-list
43798905|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43798906|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43798907|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
43798908|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798909|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798910|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798911|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43798912|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43799094|NCT05013164|Leucovorin|leucovorin|mesh-list
43798941|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43798942|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43798943|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
43798944|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798945|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798946|NCT05015829|Protective Agents|protective agents|mesh-ancestor
43798948|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43798949|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798950|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798951|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43798952|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
43798953|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
43798954|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
43798955|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43798956|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43798962|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
43798963|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
43798964|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798965|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798966|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
43798967|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798968|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798969|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
43798970|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
43798971|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43798972|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
43798973|NCT05015322|Hormones|hormones|mesh-ancestor
43798974|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798975|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43798976|NCT05015322|Protective Agents|protective agents|mesh-ancestor
43798977|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43798978|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798979|NCT05014711|Fentanyl|fentanyl|mesh-list
43798980|NCT05014711|Remifentanil|remifentanil|mesh-list
43798981|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43798982|NCT05014711|Narcotics|narcotics|mesh-ancestor
43798983|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798984|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798985|NCT05014711|Analgesics|analgesics|mesh-ancestor
43798986|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
43798987|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798988|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43798989|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43798990|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
43798991|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
43798992|NCT05014685|Amoxicillin|amoxicillin|mesh-list
43798993|NCT05014685|Metronidazole|metronidazole|mesh-list
43798994|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
43798995|NCT05014685|Rabeprazole|rabeprazole|mesh-list
43798996|NCT05014685|Bismuth|bismuth|mesh-list
43798997|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798998|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43798999|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799000|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43799001|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43799002|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43799003|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799004|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43799005|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799006|NCT05014685|Antacids|antacids|mesh-ancestor
43799007|NCT05014685|Diuretics|diuretics|mesh-ancestor
43799008|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
43799009|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799010|NCT05014685|Expectorants|expectorants|mesh-ancestor
43799011|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
43799012|NCT05014906|Minocycline|minocycline|mesh-list
43799013|NCT05014906|Azelaic acid|azelaic acid|mesh-list
43799095|NCT05013164|Folic Acid|folic acid|mesh-list
43799022|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799023|NCT05014490|Etoricoxib|etoricoxib|mesh-list
43799024|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43799025|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43799026|NCT05014490|Analgesics|analgesics|mesh-ancestor
43799027|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
43799028|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799029|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799030|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799031|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43799032|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43799033|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43799034|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799035|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799036|NCT05014581|Norepinephrine|norepinephrine|mesh-list
43799037|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43799038|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43799039|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799040|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799041|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799042|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799043|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
43799044|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
43799045|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799046|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43799047|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43799048|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43799049|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
43799050|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799051|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
43799052|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43799053|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799054|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43799056|NCT05014373|Favipiravir|favipiravir|mesh-list
43799071|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799072|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43799073|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43799074|NCT05013697|Paclitaxel|paclitaxel|mesh-list
43799075|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43799076|NCT05013697|Cisplatin|cisplatin|mesh-list
43799077|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43799078|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799079|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
43799080|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
43799081|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
43799082|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799083|NCT05013060|Butyric Acid|butyric acid|mesh-list
43799084|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
43799085|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
43799086|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799087|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799088|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799089|NCT05013112|Metformin|metformin|mesh-list
43799090|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43799091|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43799092|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799093|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799099|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799100|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
43799102|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
43799103|NCT05013164|Hematinics|hematinics|mesh-ancestor
43799115|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43799116|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799117|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
43799118|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
43799119|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
43799120|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799121|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
43799122|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
43799123|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43799124|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799125|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799126|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43799127|NCT05013320|Analgesics|analgesics|mesh-ancestor
43799128|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
43799129|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799130|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43799131|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43799132|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43799133|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799134|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799135|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799136|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43799137|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43799138|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43799139|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
43799140|NCT05012137|Ropivacaine|ropivacaine|mesh-list
43799141|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
43799142|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
43799143|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799144|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799145|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
43799146|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799147|NCT05012033|Prednisolone|prednisolone|mesh-list
43799148|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799149|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
43799150|NCT05012033|Hormones|hormones|mesh-ancestor
43799151|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799152|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799153|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799154|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799156|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43799157|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43799158|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43799159|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43799160|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799161|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799162|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43799163|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43799164|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43799165|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43799166|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799167|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799168|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799169|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43799170|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43799171|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
43799172|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43799173|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43799174|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
43799175|NCT05010538|Sarecycline|sarecycline|mesh-list
43799176|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43799177|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799178|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
43799179|NCT05010499|Bupivacaine|bupivacaine|mesh-list
43799180|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
43799181|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
43799182|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
43799183|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799184|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799253|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799254|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
43799255|NCT05008523|Narcotics|narcotics|mesh-ancestor
43799256|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799257|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799258|NCT05008523|Analgesics|analgesics|mesh-ancestor
43799259|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
43799260|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799261|NCT05008679|Oseltamivir|oseltamivir|mesh-list
43799262|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
43799263|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799264|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799265|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799267|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43799268|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
43799269|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799270|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799271|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799272|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
43799297|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799298|NCT05008029|Anesthetics|anesthetics|mesh-list
43799299|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799300|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799301|NCT05008068|Simvastatin|simvastatin|mesh-list
43799302|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43799303|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43799304|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
43799305|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799306|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43799307|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43799308|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799309|NCT05008263|Liver Extracts|liver extracts|mesh-list
43799310|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
43799311|NCT05008263|Hematinics|hematinics|mesh-ancestor
43799313|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799314|NCT05008237|Cisplatin|cisplatin|mesh-list
43799315|NCT05008237|Docetaxel|docetaxel|mesh-list
43799316|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799317|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
43799318|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
43799319|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
43799320|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842148|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799321|NCT05008250|Metoprolol|metoprolol|mesh-list
43799322|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43799323|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43799324|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
43799325|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
43799326|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799327|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799328|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43799329|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43799331|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799332|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799333|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799334|NCT05007678|Leflunomide|leflunomide|mesh-list
43799335|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799336|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799337|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799338|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
43799339|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799340|NCT05007587|Leucovorin|leucovorin|mesh-list
43799341|NCT05007587|Fluorouracil|fluorouracil|mesh-list
43799342|NCT05007587|Raltitrexed|raltitrexed|mesh-list
43799343|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
43799344|NCT05007587|Lenvatinib|lenvatinib|mesh-list
43799345|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
43799346|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799347|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43799348|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799349|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799350|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
43799351|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799366|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799368|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43799369|NCT05006911|Phenylephrine|phenylephrine|mesh-list
43799370|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
43799371|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
43799372|NCT05006911|Pilocarpine|pilocarpine|mesh-list
43799373|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43799374|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
43799375|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799376|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
43799377|NCT05006911|Protective Agents|protective agents|mesh-ancestor
43799378|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43799379|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43799380|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43799381|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43799382|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799383|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799384|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799385|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
43799398|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43799399|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43799400|NCT05006911|Analgesics|analgesics|mesh-ancestor
43799401|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
43799402|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799403|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43799404|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43799405|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
43799406|NCT05006898|Pilocarpine|pilocarpine|mesh-list
43799407|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43799408|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43799409|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43799410|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43799411|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799412|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799413|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799414|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799442|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799444|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
43799445|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799446|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799447|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799448|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
43799449|NCT05006469|Hormones|hormones|mesh-ancestor
43799450|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799451|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799452|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799453|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799454|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799455|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43799456|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43799457|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43799458|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43799459|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
43799460|NCT05006664|Prednisone|prednisone|mesh-list
43799461|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
43799462|NCT05006664|Doxorubicin|doxorubicin|mesh-list
43799463|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43799464|NCT05006664|Etoposide|etoposide|mesh-list
43799465|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
43799466|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43799467|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799476|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43799477|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43799478|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43799479|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799480|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799482|NCT05006664|Hormones|hormones|mesh-ancestor
43799483|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799484|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799537|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43799538|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
43799539|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43799540|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43799541|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799542|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43799543|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
43799544|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43799545|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
43799546|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43799547|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799548|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799549|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43799551|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
43799552|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799553|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43799554|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43799560|NCT05005637|Prednisone|prednisone|mesh-list
43799561|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799562|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
43799563|NCT05005637|Hormones|hormones|mesh-ancestor
43799564|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799565|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799566|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799567|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799568|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43799569|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799570|NCT05005741|Dulaglutide|dulaglutide|mesh-list
43799571|NCT05005741|Glucagon|glucagon|mesh-list
43799572|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43799573|NCT05005741|Incretins|incretins|mesh-ancestor
43799574|NCT05005741|Hormones|hormones|mesh-ancestor
43799575|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799577|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799578|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43799579|NCT05004909|Tretinoin|tretinoin|mesh-list
43799580|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799581|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
43799582|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
43799583|NCT05004753|Artemisinins|artemisinins|mesh-list
43799584|NCT05004753|Artemisinin|artemisinin|mesh-list
43799585|NCT05004753|Dexamethasone|dexamethasone|mesh-list
43799586|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799587|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
43799588|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
43799609|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799610|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43799611|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43799612|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43799613|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799614|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799615|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799616|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43799617|NCT05004519|Narcotics|narcotics|mesh-ancestor
43842150|NCT04549311|Amoxicillin|amoxicillin|mesh-list
43842151|NCT04549311|Metronidazole|metronidazole|mesh-list
43842152|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
43842153|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
43842154|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
43842155|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43842156|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43799618|NCT05004545|Propofol|propofol|mesh-list
43799619|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43799620|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799621|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799622|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43799623|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
43799624|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
43799625|NCT05004207|Lactulose|lactulose|mesh-list
43799626|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799627|NCT05004142|Letrozole|letrozole|mesh-list
43799628|NCT05004142|Fulvestrant|fulvestrant|mesh-list
43799629|NCT05004142|Goserelin|goserelin|mesh-list
43799630|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799631|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43799632|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43799633|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799638|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799639|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799640|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43799641|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
43799642|NCT05003765|Buprenorphine|buprenorphine|mesh-list
43799643|NCT05003765|Bupivacaine|bupivacaine|mesh-list
43799644|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43799645|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
43799646|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
43799669|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799670|NCT05003648|Pramipexole|pramipexole|mesh-list
43799671|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
43799672|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799673|NCT05003648|Protective Agents|protective agents|mesh-ancestor
43799674|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799675|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43799683|NCT05003596|Prednisolone|prednisolone|mesh-list
43799696|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799697|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43799705|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799706|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43799707|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799708|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799710|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
43799711|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
43799712|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799713|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799714|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
43799715|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799716|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43799730|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
43799731|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799732|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
43799733|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
43799734|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799741|NCT05002517|Protective Agents|protective agents|mesh-ancestor
43799742|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799743|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799744|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
43799745|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43799746|NCT05002270|Cetuximab|cetuximab|mesh-list
43799747|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43799748|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799749|NCT05002361|Dexamethasone|dexamethasone|mesh-list
43799750|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799755|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799756|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
43799758|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799759|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799760|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799761|NCT05002686|Paclitaxel|paclitaxel|mesh-list
43799762|NCT05002686|Capecitabine|capecitabine|mesh-list
43799763|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
43799764|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43799765|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799766|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
43609582|NCT03187392|Lidocaine|lidocaine|mesh-list
43799767|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
43799768|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
43799769|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799770|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43799771|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
43799772|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43799773|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43799774|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43799775|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799776|NCT05002101|Zinc|zinc|mesh-list
43799777|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
43799778|NCT05002101|Trace Elements|trace elements|mesh-ancestor
43799779|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
43799780|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799781|NCT05002101|Astringents|astringents|mesh-ancestor
43799782|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
43799802|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799803|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799804|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43799805|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43799830|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43799832|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43799844|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
43799845|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43799846|NCT05001243|Miotics|miotics|mesh-ancestor
43799847|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43799848|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43799849|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
43799850|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43799851|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43799852|NCT05001243|Analgesics|analgesics|mesh-ancestor
43799853|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
43799854|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799855|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43799856|NCT05001061|Misoprostol|misoprostol|mesh-list
43799857|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43799858|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
43799859|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43799860|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799861|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43799862|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799863|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
43799864|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
43799865|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43799866|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842157|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842158|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
43799868|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799869|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
43799870|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799871|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43799872|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799873|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799874|NCT05000892|Paclitaxel|paclitaxel|mesh-list
43799875|NCT05000892|Carboplatin|carboplatin|mesh-list
43799876|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43799877|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799878|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
43799879|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
43799880|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
43799881|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799882|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
43799883|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799884|NCT05000086|Diphosphonates|diphosphonates|mesh-list
43799885|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
43799886|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43799887|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799888|NCT05000281|Ibuprofen|ibuprofen|mesh-list
43799889|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43799890|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43799891|NCT05000281|Analgesics|analgesics|mesh-ancestor
43799892|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
43799893|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799894|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799900|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
43799910|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
43799911|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799912|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799913|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799914|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
43799915|NCT04999878|Hormones|hormones|mesh-ancestor
43799916|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799917|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799918|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799919|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43799920|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
43799921|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799922|NCT04999878|Antiviral Agents|antiviral agents|mesh-ancestor
43799969|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43799970|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43799971|NCT04998903|Dimercaprol|dimercaprol|mesh-list
43799972|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
43799973|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
43799974|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799975|NCT04999137|Vitamins|vitamins|mesh-list
43800003|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800004|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800006|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800007|NCT04998344|Vaccines|vaccines|mesh-list
43800008|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
43800009|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800010|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43800011|NCT04998253|Propofol|propofol|mesh-list
43800012|NCT04998253|Sevoflurane|sevoflurane|mesh-list
43800013|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43800014|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800015|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800016|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43800017|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
43800018|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
43800019|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43800020|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43800021|NCT04998500|Hormones|hormones|mesh-list
43800022|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800023|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800024|NCT04998214|Thrombin|thrombin|mesh-list
43800025|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
43800026|NCT04998214|Coagulants|coagulants|mesh-ancestor
43800027|NCT04997967|Ketamine|ketamine|mesh-list
43800028|NCT04997967|Propofol|propofol|mesh-list
43800030|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800031|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800032|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43800033|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
43800034|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
43800035|NCT04997967|Analgesics|analgesics|mesh-ancestor
43800036|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
43800037|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800038|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43800039|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43800048|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800049|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43800050|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43800051|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43800052|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800053|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43800054|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43800072|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43800073|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43800074|NCT04997798|Trastuzumab|trastuzumab|mesh-list
43800075|NCT04997798|Letrozole|letrozole|mesh-list
43800076|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800077|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800078|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43800079|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43800080|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800081|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800082|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43800083|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
43800084|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800085|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842161|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43842162|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43842163|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842164|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842165|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842166|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43842167|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43842168|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43842169|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
43842170|NCT04548661|Povidone|povidone|mesh-list
43842171|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
43842172|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
43842173|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43842174|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842185|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43842186|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
43842187|NCT04547842|Hormones|hormones|mesh-ancestor
43842188|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43609937|NCT03184480|Xhance|xhance|mesh-list
43800087|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
43800088|NCT04997564|Velpatasvir|velpatasvir|mesh-list
43800089|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43800090|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
43800091|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800092|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43800093|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43800094|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800095|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800096|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43800097|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43800098|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43800099|NCT04997525|Estradiol|estradiol|mesh-list
43800100|NCT04997525|Progesterone|progesterone|mesh-list
43800101|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43800102|NCT04997525|Estrogens|estrogens|mesh-ancestor
43800103|NCT04997525|Hormones|hormones|mesh-ancestor
43800104|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800105|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800106|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43800107|NCT04997525|Progestins|progestins|mesh-ancestor
43800108|NCT04996979|Ropivacaine|ropivacaine|mesh-list
43800109|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
43800110|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
43800111|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800112|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800113|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
43800114|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800115|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
43800116|NCT04997291|Razoxane|razoxane|mesh-list
43800117|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800118|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43800119|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43800120|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43800121|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800169|NCT04996160|Palbociclib|palbociclib|mesh-list
43800170|NCT04996160|BB 1101|bb 1101|mesh-list
43800171|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800172|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
43800173|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
43800174|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800175|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800176|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800177|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
43800178|NCT04996160|Hormones|hormones|mesh-ancestor
43800179|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800180|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43800181|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800182|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
43800183|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800184|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800185|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43800186|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43800187|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43800188|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43800189|NCT04995354|Mitogens|mitogens|mesh-list
43800190|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
43800192|NCT04995133|Colistin|colistin|mesh-list
43800209|NCT04995016|Axitinib|axitinib|mesh-list
43800210|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800211|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800212|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43800213|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800214|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800215|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
43800216|NCT04994860|Zamicastat|zamicastat|mesh-list
43800217|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
43800231|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43842189|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43842190|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842191|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
43842192|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43842193|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43842194|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
43842195|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
43842196|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842198|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43842199|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43842200|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842201|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43842202|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43842203|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43842204|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
43842205|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43842206|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43842207|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
43842208|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43842209|NCT04546672|Neostigmine|neostigmine|mesh-list
43842210|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43842211|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842212|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842213|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
43842214|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842216|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43842217|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
43842218|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842219|NCT04546425|Vaccines|vaccines|mesh-list
43842220|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43842221|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
43800232|NCT04994314|Fluorides|fluorides|mesh-list
43800233|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800234|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
43800235|NCT04994314|Protective Agents|protective agents|mesh-ancestor
43800236|NCT04994262|Menthol|menthol|mesh-list
43800237|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
43800238|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
43800239|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
43800240|NCT04994574|Olodaterol|olodaterol|mesh-list
43800241|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43800242|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
43800243|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800244|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800245|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43800246|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
43800247|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
43800248|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43800249|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
43800250|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800251|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800252|NCT04994236|Leucovorin|leucovorin|mesh-list
43800253|NCT04994236|Fluorouracil|fluorouracil|mesh-list
43800254|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
43800255|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
43800256|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800257|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43800258|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800259|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43800260|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
43800261|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800263|NCT04994236|Protective Agents|protective agents|mesh-ancestor
43800264|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
43800265|NCT04994236|Vitamins|vitamins|mesh-ancestor
43800266|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
43800267|NCT04994119|Warfarin|warfarin|mesh-list
43800268|NCT04994119|Zamicastat|zamicastat|mesh-list
43800269|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
43800270|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800271|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800272|NCT04993222|Amphotericin B|amphotericin b|mesh-list
43800273|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43800274|NCT04993222|Amebicides|amebicides|mesh-ancestor
43800275|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43800276|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43800277|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800278|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43800279|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
43800280|NCT04993014|Trastuzumab|trastuzumab|mesh-list
43800281|NCT04993014|Pertuzumab|pertuzumab|mesh-list
43800282|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800283|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800284|NCT04993040|Paclitaxel|paclitaxel|mesh-list
43800311|NCT04992481|Protective Agents|protective agents|mesh-ancestor
43800312|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800313|NCT04992182|Vaccines|vaccines|mesh-list
43800314|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
43800315|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800316|NCT04992143|Sorafenib|sorafenib|mesh-list
43800317|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800318|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43800319|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800320|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800321|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
43800322|NCT04991584|Amoxicillin|amoxicillin|mesh-list
43800323|NCT04991584|Levofloxacin|levofloxacin|mesh-list
43800324|NCT04991584|Ofloxacin|ofloxacin|mesh-list
43800325|NCT04991584|Tetracycline|tetracycline|mesh-list
43800326|NCT04991584|Furazolidone|furazolidone|mesh-list
43800365|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43800366|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43800367|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43800368|NCT04991181|Zamicastat|zamicastat|mesh-list
43800369|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800370|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842222|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848557|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848558|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
43848559|NCT04009109|Hormones|hormones|mesh-ancestor
43848560|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848572|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43848573|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43848574|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
43848575|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
43848576|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848577|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848578|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848579|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
43848580|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43848581|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
43848582|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848583|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848584|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43848585|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
43848600|NCT04007224|Oxytocin|oxytocin|mesh-list
43800378|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
43800379|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43800380|NCT04991064|Protective Agents|protective agents|mesh-ancestor
43800381|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800395|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800396|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43800397|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43800398|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
43800399|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
43800400|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43800401|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43800402|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43800403|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43800404|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
43800405|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
43800406|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800407|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800408|NCT04991194|Zamicastat|zamicastat|mesh-list
43800409|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800410|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800421|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
43800422|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800423|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800424|NCT04990830|Heparin|heparin|mesh-list
43800425|NCT04990830|Enoxaparin|enoxaparin|mesh-list
43800426|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43800427|NCT04990830|Tinzaparin|tinzaparin|mesh-list
43800428|NCT04990830|Dalteparin|dalteparin|mesh-list
43800429|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
43800430|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
43800431|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43800432|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43800433|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800434|NCT04990713|Ropivacaine|ropivacaine|mesh-list
43800435|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
43800436|NCT04990713|Anesthetics|anesthetics|mesh-list
43800437|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800482|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800483|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800484|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
43800485|NCT04989400|Misoprostol|misoprostol|mesh-list
43800486|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
43800487|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43800488|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
43800540|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43800541|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
43800542|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800543|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800544|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800545|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
43800546|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43800547|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
43800548|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800549|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800550|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43800551|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
43800552|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43800553|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
43800554|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800555|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800556|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43800557|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
43800558|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
43800568|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800569|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800570|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
43800571|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800572|NCT04988789|Paclitaxel|paclitaxel|mesh-list
43800573|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43800574|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800575|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
43800576|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
43800577|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
43800578|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800579|NCT04988607|Bevacizumab|bevacizumab|mesh-list
43800580|NCT04988607|Osimertinib|osimertinib|mesh-list
43800581|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800582|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800583|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43800584|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43800585|NCT04988607|Growth Substances|growth substances|mesh-ancestor
43842247|NCT04542200|Antibodies|antibodies|mesh-list
43842268|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842269|NCT04539951|Memantine|memantine|mesh-list
43842270|NCT04539951|Aripiprazole|aripiprazole|mesh-list
43842271|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
43842272|NCT04539951|Sertraline|sertraline|mesh-list
43842273|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43842278|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842279|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842280|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
43842281|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
43842282|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842283|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842284|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43842285|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43842286|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
43842287|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43842288|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43842289|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43842290|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43842291|NCT04539951|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43842292|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43842293|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43842294|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43800607|NCT04988048|Vaccines|vaccines|mesh-list
43800608|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
43800634|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800635|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
43800636|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
43800637|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800638|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800639|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43800640|NCT04987450|Protective Agents|protective agents|mesh-ancestor
43800642|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800643|NCT04987567|Protective Agents|protective agents|mesh-ancestor
43800644|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800645|NCT04987554|Immunoferon|immunoferon|mesh-list
43800646|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43800647|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
43800648|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800649|NCT04987242|Rasburicase|rasburicase|mesh-list
43800650|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
43800651|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43800652|NCT04986982|Opicapone|opicapone|mesh-list
43800653|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43800654|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800655|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800656|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43800657|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43800658|NCT04986995|Opicapone|opicapone|mesh-list
43800659|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43800660|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800661|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800662|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43800685|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800686|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43800688|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
43800689|NCT04986254|Tazobactam|tazobactam|mesh-list
43800690|NCT04986254|Piperacillin|piperacillin|mesh-list
43800691|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43800692|NCT04986254|Penicillin G|penicillin g|mesh-list
43800693|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43800694|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
43800695|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800696|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43800697|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800698|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800699|NCT04986319|Vitamin D|vitamin d|mesh-list
43800700|NCT04986319|Vitamins|vitamins|mesh-ancestor
43800701|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
43800702|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800703|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43800704|NCT04986098|Paclitaxel|paclitaxel|mesh-list
43800705|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43800706|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800707|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
43800708|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
43800709|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
43800742|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800743|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43800744|NCT04985669|Prucalopride|prucalopride|mesh-list
43800745|NCT04985669|Laxatives|laxatives|mesh-ancestor
43800746|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800747|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43800748|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43800749|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
43800750|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800751|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800752|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842295|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43842296|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43842297|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43842298|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43842299|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43842300|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43842301|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43842302|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43842303|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842304|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43842305|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
43842306|NCT04539808|Leucovorin|leucovorin|mesh-list
43842328|NCT04539808|Antidotes|antidotes|mesh-ancestor
43842329|NCT04539808|Protective Agents|protective agents|mesh-ancestor
43842330|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
43842331|NCT04539808|Vitamins|vitamins|mesh-ancestor
43842332|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
43842333|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43842334|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43842335|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43842336|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43842337|NCT04539808|Hematinics|hematinics|mesh-ancestor
43800757|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800758|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800761|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43800774|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
43800775|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800776|NCT04984577|Edaravone|edaravone|mesh-list
43800777|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43800778|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
43800779|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800780|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43800781|NCT04984577|Protective Agents|protective agents|mesh-ancestor
43800782|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800783|NCT04983836|Anesthetics|anesthetics|mesh-list
43800784|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800785|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800786|NCT04983849|Metronidazole|metronidazole|mesh-list
43800787|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800788|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43800789|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43800790|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43800791|NCT04983550|Doxorubicin|doxorubicin|mesh-list
43800792|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43800793|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43800794|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800795|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43800796|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43800797|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800798|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800799|NCT04983524|Propolis|propolis|mesh-list
43800800|NCT04983524|Calcium|calcium|mesh-list
43800801|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43800802|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800803|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800804|NCT04983615|Fentanyl|fentanyl|mesh-list
43800805|NCT04983615|Midazolam|midazolam|mesh-list
43800806|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43800807|NCT04983615|Narcotics|narcotics|mesh-ancestor
43800883|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43800851|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800852|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800853|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800854|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
43800856|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800857|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43800858|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800859|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43800860|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
43800861|NCT04982900|Aflutinib|aflutinib|mesh-list
43800862|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43800863|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800864|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800865|NCT04982913|Oseltamivir|oseltamivir|mesh-list
43800866|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
43800867|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800868|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800869|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800870|NCT05635955|Propofol|propofol|mesh-list
43800871|NCT05635955|Esketamine|esketamine|mesh-list
43800872|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43800873|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800874|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800875|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43800876|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
43800877|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
43800878|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
43800879|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43800881|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800882|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
43800885|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800887|NCT05635916|Bupivacaine|bupivacaine|mesh-list
43800888|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
43800889|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
43800890|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800891|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800892|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
43800894|NCT05635903|Diazepam|diazepam|mesh-list
43800895|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43800896|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
43800897|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
43800898|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
43800899|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800900|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800901|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800902|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43800903|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800904|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43800905|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43800906|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43800907|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43800908|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43800909|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43800910|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
43800911|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
43800912|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
43800913|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
43800914|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800915|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800916|NCT05635877|Esmolol|esmolol|mesh-list
43800917|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43800918|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43800919|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43842360|NCT04533841|Propranolol|propranolol|mesh-list
43842361|NCT04533841|Misoprostol|misoprostol|mesh-list
43842362|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43842363|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
43842364|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43842365|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842366|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43842367|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43842368|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
43842369|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43842370|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43842371|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
43842372|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800945|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43800946|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43800947|NCT05635357|Letrozole|letrozole|mesh-list
43800948|NCT05635357|Anastrozole|anastrozole|mesh-list
43800949|NCT05635357|Exemestane|exemestane|mesh-list
43800950|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800951|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43800952|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43800953|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800954|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800955|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43800956|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
43800957|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800958|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800959|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43800960|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
43800961|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800962|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800963|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43800964|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43800965|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800966|NCT05635227|Dexamethasone|dexamethasone|mesh-list
43800967|NCT05635227|Olanzapine|olanzapine|mesh-list
43800968|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43800982|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800983|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43800984|NCT05635227|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43800985|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43800998|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800999|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801000|NCT05635071|Nintedanib|nintedanib|mesh-list
43801001|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801002|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43801003|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801004|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801005|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
43801006|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43801007|NCT05634824|Antibodies|antibodies|mesh-list
43801008|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
43801009|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43801010|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
43801011|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801012|NCT05634759|Azithromycin|azithromycin|mesh-list
43801013|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43801014|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801015|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
43801016|NCT05634577|Mitotane|mitotane|mesh-list
43801017|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801018|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801019|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43801020|NCT05634525|Adagrasib|adagrasib|mesh-list
43801021|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801022|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
43801023|NCT05634473|Miotics|miotics|mesh-ancestor
43801024|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
43801025|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801026|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801035|NCT05634174|Mirabegron|mirabegron|mesh-list
43801037|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43801038|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43801039|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
43801040|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801041|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801042|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801043|NCT05634174|Urological Agents|urological agents|mesh-ancestor
43801044|NCT05633420|Artesunate|artesunate|mesh-list
43801045|NCT05633420|Pyronaridine|pyronaridine|mesh-list
43801046|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
43801047|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43801048|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43801049|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801050|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801051|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
43801052|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
43801053|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43801054|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
43801055|NCT05629702|Temozolomide|temozolomide|mesh-list
43801058|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
43848604|NCT04007055|Ticagrelor|ticagrelor|mesh-list
43801059|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801060|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801061|NCT05629702|Analgesics|analgesics|mesh-ancestor
43801072|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801073|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801074|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43801075|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43801076|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801077|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801078|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
43801079|NCT05624359|Ropivacaine|ropivacaine|mesh-list
43801080|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
43801081|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
43801082|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801083|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801084|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
43801085|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801086|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43801087|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43801088|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801089|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801090|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43801091|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43801092|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801093|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
43801094|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801095|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43801096|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801097|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842373|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842374|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43842377|NCT04533646|Insulin|insulin|mesh-list
43842393|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842394|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43842395|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842397|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
43842398|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43842399|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842400|NCT04530838|Vaccines|vaccines|mesh-list
43842401|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43842402|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
43842403|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842404|NCT04530630|Emtricitabine|emtricitabine|mesh-list
43842405|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
43842406|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611226|NCT03173235|Vitamin D|vitamin d|mesh-list
43801098|NCT05551104|Labetalol|labetalol|mesh-list
43801099|NCT05551104|Nifedipine|nifedipine|mesh-list
43801100|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43801101|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43801102|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801103|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43801104|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801105|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
43801106|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
43801107|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43801108|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43801109|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43801110|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
43801130|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801131|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
43801132|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43801133|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801134|NCT05492123|Cisplatin|cisplatin|mesh-list
43801135|NCT05492123|Nivolumab|nivolumab|mesh-list
43801136|NCT05492123|Ipilimumab|ipilimumab|mesh-list
43801137|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801138|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801148|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
43801149|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
43801150|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43801178|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43801179|NCT05474560|Allopurinol|allopurinol|mesh-list
43801180|NCT05474560|Febuxostat|febuxostat|mesh-list
43801181|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
43801182|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801183|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801184|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
43801185|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43801186|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43801187|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
43801188|NCT05474560|Protective Agents|protective agents|mesh-ancestor
43801189|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801210|NCT05458479|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43801211|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43801212|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43801213|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801214|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801215|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
43801216|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801217|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43801218|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
43801219|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43801220|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43801221|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43801222|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801228|NCT05438043|Dexamethasone|dexamethasone|mesh-list
43801229|NCT05438043|Lenalidomide|lenalidomide|mesh-list
43801230|NCT05438043|Daratumumab|daratumumab|mesh-list
43801231|NCT05438043|Pomalidomide|pomalidomide|mesh-list
43801232|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801233|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
43801234|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
43801235|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801236|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801237|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43801238|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
43801239|NCT05438043|Hormones|hormones|mesh-ancestor
43801275|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801277|NCT05371886|Analgesics|analgesics|mesh-ancestor
43801278|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
43801279|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801280|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43801281|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43801282|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43801283|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43801284|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43801285|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43801286|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
43801287|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
43801288|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
43801289|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
43801290|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801291|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801292|NCT05359861|Bevacizumab|bevacizumab|mesh-list
43801293|NCT05359861|Atezolizumab|atezolizumab|mesh-list
43801294|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801295|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801296|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43801304|NCT05331144|Losartan|losartan|mesh-list
43801305|NCT05331144|Amlodipine|amlodipine|mesh-list
43801306|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
43801307|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
43801308|NCT05331144|Giapreza|giapreza|mesh-list
43801309|NCT05331144|Calcium|calcium|mesh-list
43801310|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43801311|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
43801312|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43801313|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801314|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43801319|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43842419|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842420|NCT04530539|Protective Agents|protective agents|mesh-ancestor
43842421|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842422|NCT04530487|Cyclosporine|cyclosporine|mesh-list
43842423|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
43842424|NCT04530487|Fludarabine|fludarabine|mesh-list
43842425|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
43842426|NCT04530487|Etoposide|etoposide|mesh-list
43842427|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
43842428|NCT04530487|Melphalan|melphalan|mesh-list
43842429|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
43842430|NCT04530487|Thiotepa|thiotepa|mesh-list
43842431|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
43842432|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43842433|NCT04530487|Tacrolimus|tacrolimus|mesh-list
43842434|NCT04530487|Cyclosporins|cyclosporins|mesh-list
43842435|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
43842436|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43842437|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
43842438|NCT04530487|Antibodies|antibodies|mesh-list
43842439|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
43842440|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43842441|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43842442|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842443|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43842444|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
43842445|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842446|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842447|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
43842448|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842449|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43842450|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43842451|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43842452|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842453|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43842454|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
43842455|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842456|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
43842457|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842458|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43842459|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43842460|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
43842461|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43842462|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43842463|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
43842465|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
43842466|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
43842467|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
43842468|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
43842470|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43842471|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842472|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842473|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842474|NCT04529538|Vaccines|vaccines|mesh-list
43842475|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
43842476|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848605|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43801331|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43801332|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
43801333|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801335|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43801336|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
43801337|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801338|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801339|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43801340|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43801341|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43801342|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43801343|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801356|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43801357|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801358|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
43801360|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801361|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801363|NCT05214911|Prednisolone|prednisolone|mesh-list
43801364|NCT05214911|Desloratadine|desloratadine|mesh-list
43801365|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801366|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
43801367|NCT05214911|Hormones|hormones|mesh-ancestor
43801368|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801369|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801370|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43801371|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801372|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43801373|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
43801374|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801375|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801376|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43801377|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43801378|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
43801380|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
43801381|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
43801382|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43801383|NCT05208047|Sunitinib|sunitinib|mesh-list
43801384|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801385|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43801386|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43801387|NCT05208047|Growth Substances|growth substances|mesh-ancestor
43801388|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801389|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801390|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43801391|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801392|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801398|NCT05137054|Lenalidomide|lenalidomide|mesh-list
43801399|NCT05137054|Pomalidomide|pomalidomide|mesh-list
43801400|NCT05137054|Bortezomib|bortezomib|mesh-list
43801401|NCT05137054|Daratumumab|daratumumab|mesh-list
43801402|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
43801403|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801404|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43801405|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43801406|NCT05137054|Growth Substances|growth substances|mesh-ancestor
43801407|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801408|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801409|NCT05133531|Ravulizumab|ravulizumab|mesh-list
43801411|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43801412|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
43801413|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801415|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801416|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801448|NCT05004116|Temozolomide|temozolomide|mesh-list
43801449|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43801450|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43801451|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801452|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801453|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801454|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43801455|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
43801456|NCT04995003|Cyclophosphamide|cyclophosphamide|mesh-list
43801457|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
43801458|NCT04995003|Nivolumab|nivolumab|mesh-list
43801459|NCT04995003|Fludarabine|fludarabine|mesh-list
43801460|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43801461|NCT04995003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43801462|NCT04995003|Immunologic Factors|immunologic factors|mesh-ancestor
43801463|NCT04995003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801464|NCT04995003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43801465|NCT04995003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43801466|NCT04995003|Alkylating Agents|alkylating agents|mesh-ancestor
43801467|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801468|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801469|NCT04995003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43801470|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801474|NCT04977830|Xenon|xenon|mesh-list
43801475|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43801476|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
43801477|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
43801478|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801479|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801480|NCT04972292|Dipyrone|dipyrone|mesh-list
43801481|NCT04972292|Codeine|codeine|mesh-list
43801482|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43801483|NCT04972292|Narcotics|narcotics|mesh-ancestor
43801484|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801485|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801486|NCT04972292|Analgesics|analgesics|mesh-ancestor
43801487|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
43801499|NCT04943900|Nivolumab|nivolumab|mesh-list
43801500|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801501|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801502|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43801503|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801504|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
43801552|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
43801553|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801554|NCT04794699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43801555|NCT04794699|Antimetabolites|antimetabolites|mesh-ancestor
43801556|NCT04794699|Antiviral Agents|antiviral agents|mesh-ancestor
43801557|NCT04794699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801558|NCT04794699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801559|NCT04794699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43801560|NCT04794699|Immunologic Factors|immunologic factors|mesh-ancestor
43801561|NCT04794699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801562|NCT04794699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43801563|NCT04794699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43801564|NCT04782687|Dexamethasone|dexamethasone|mesh-list
43801565|NCT04782687|Lenalidomide|lenalidomide|mesh-list
43801566|NCT04782687|Daratumumab|daratumumab|mesh-list
43801567|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801568|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
43801569|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
43801570|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801571|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801577|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801578|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
43801579|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43801580|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43801581|NCT04782687|Growth Substances|growth substances|mesh-ancestor
43801582|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801583|NCT04721548|Minoxidil|minoxidil|mesh-list
43801584|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43801590|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801591|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43801592|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
43801593|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801594|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801595|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43801596|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
43801597|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
43801598|NCT04705727|Hormones|hormones|mesh-ancestor
43801599|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801600|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43801601|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43801602|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43801603|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
43801604|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801605|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801606|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
43801607|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
43801608|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43801609|NCT04699058|Antibodies|antibodies|mesh-list
43801610|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
43801611|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842477|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
43842478|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842480|NCT04528173|Fentanyl|fentanyl|mesh-list
43842481|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
43842482|NCT04528173|Morphine|morphine|mesh-list
43842483|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43842484|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842485|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842486|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43842487|NCT04528173|Analgesics|analgesics|mesh-ancestor
43842488|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
43842489|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842492|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43842493|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
43842494|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842495|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842496|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43842497|NCT04528173|Narcotics|narcotics|mesh-ancestor
43842498|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43842499|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43842500|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
43842501|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
43842502|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43842503|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842504|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842505|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43842506|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842507|NCT04528108|Hemostatics|hemostatics|mesh-list
43842508|NCT04528108|Coagulants|coagulants|mesh-ancestor
43842509|NCT04527432|Antibodies|antibodies|mesh-list
43842510|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
43842511|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842512|NCT04527393|Morphine|morphine|mesh-list
43842513|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43842514|NCT04527393|Narcotics|narcotics|mesh-ancestor
43842515|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842516|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842517|NCT04527393|Analgesics|analgesics|mesh-ancestor
43842518|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
43842519|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842520|NCT04525638|Nivolumab|nivolumab|mesh-list
43801615|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801616|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
43801617|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801618|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43801619|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43801620|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43801621|NCT04680052|Growth Substances|growth substances|mesh-ancestor
43801622|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801623|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
43801624|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801625|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801628|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43801629|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43801630|NCT04626128|Growth Substances|growth substances|mesh-ancestor
43801631|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801632|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801633|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801634|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43801635|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801636|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801637|NCT04573920|Atrasentan|atrasentan|mesh-list
43801638|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801639|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43801640|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43801641|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801642|NCT04552197|Tofacitinib|tofacitinib|mesh-list
43801643|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43801644|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801645|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801646|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
43801648|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
43801649|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43801650|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43801651|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801652|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43801653|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801654|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43801655|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801656|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43801657|NCT04459273|FAPI-46|fapi-46|mesh-list
43801658|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43801659|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801660|NCT04459078|Apatinib|apatinib|mesh-list
43801661|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43801662|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801663|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43801664|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801665|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801666|NCT04439357|Trametinib|trametinib|mesh-list
43801667|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
43801668|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801669|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43801670|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801671|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801673|NCT04439357|Protective Agents|protective agents|mesh-ancestor
43801674|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801675|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43801676|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
43801677|NCT04436796|Pancrelipase|pancrelipase|mesh-list
43801678|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43801679|NCT04419519|Venetoclax|venetoclax|mesh-list
43801680|NCT04419519|Antibodies|antibodies|mesh-list
43801681|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43801682|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
43801683|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801684|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801685|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43801686|NCT04401553|Vancomycin|vancomycin|mesh-list
43801687|NCT04401553|Cephalosporins|cephalosporins|mesh-list
43801688|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801689|NCT04384484|Gemcitabine|gemcitabine|mesh-list
43801690|NCT04384484|Rituximab|rituximab|mesh-list
43801691|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43801692|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
43801693|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801694|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801695|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
43801696|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801697|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43801698|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43801699|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
43801700|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801701|NCT04384484|Antiviral Agents|antiviral agents|mesh-ancestor
43801702|NCT04384484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801703|NCT04384484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801704|NCT04384484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43801705|NCT04374630|Paclitaxel|paclitaxel|mesh-list
43801712|NCT04364802|Iodine|iodine|mesh-list
43801713|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
43801714|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
43801715|NCT04364802|Povidone|povidone|mesh-list
43801716|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43801717|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801718|NCT04364802|Trace Elements|trace elements|mesh-ancestor
43801719|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
43801720|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801721|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
43801722|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
43801723|NCT04271189|Metformin|metformin|mesh-list
43801724|NCT04271189|Pioglitazone|pioglitazone|mesh-list
43801725|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43801726|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43801727|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801728|NCT04271189|Incretins|incretins|mesh-ancestor
43801729|NCT04271189|Hormones|hormones|mesh-ancestor
43801730|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801731|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43801732|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
43801733|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801734|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801735|NCT04233190|Budesonide|budesonide|mesh-list
43801736|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
43801737|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43801738|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
43801739|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801740|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801741|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43801751|NCT04233190|Hormones|hormones|mesh-ancestor
43801755|NCT04225598|Narcotics|narcotics|mesh-ancestor
43801756|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801757|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801758|NCT04225598|Analgesics|analgesics|mesh-ancestor
43801759|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
43801760|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801761|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43801762|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
43801763|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43801764|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801765|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801766|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43801767|NCT04206059|Analgesics|analgesics|mesh-ancestor
43801768|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
43801769|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801770|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43801771|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43801772|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43801773|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
43801774|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801775|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801776|NCT04181736|Guanfacine|guanfacine|mesh-list
43801777|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43801778|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43801779|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43801780|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43801781|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
43801782|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801783|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801784|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801785|NCT04179162|Gemcitabine|gemcitabine|mesh-list
43801786|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
43801826|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
43801827|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43801828|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801829|NCT04147494|Edetic Acid|edetic acid|mesh-list
43801830|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43801831|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43801833|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
43801834|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
43801835|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801836|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
43801837|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43801838|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43801839|NCT04132817|Paclitaxel|paclitaxel|mesh-list
43801840|NCT04132817|Nivolumab|nivolumab|mesh-list
43801841|NCT04132817|Ipilimumab|ipilimumab|mesh-list
43801842|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43801843|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801844|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
43801845|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
43801846|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
43801847|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801848|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801849|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43801850|NCT04118387|Acetazolamide|acetazolamide|mesh-list
43801851|NCT04118387|Zolpidem|zolpidem|mesh-list
43801852|NCT04118387|Buspirone|buspirone|mesh-list
43801854|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43801855|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801856|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801857|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43801859|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
43801860|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801861|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801862|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
43801863|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43801864|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801865|NCT04118387|Diuretics|diuretics|mesh-ancestor
43801866|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
43801867|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43801868|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43801869|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43801870|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43801871|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
43801872|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43801873|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
43801874|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801875|NCT04060394|Prednisone|prednisone|mesh-list
43801876|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801877|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
43801878|NCT04060394|Hormones|hormones|mesh-ancestor
43801879|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801985|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801986|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802020|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43802021|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43802022|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
43802023|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802024|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802025|NCT03582488|Corticosterone|corticosterone|mesh-list
43802026|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802027|NCT03576612|Valacyclovir|valacyclovir|mesh-list
43802028|NCT03576612|Acyclovir|acyclovir|mesh-list
43802029|NCT03576612|Nivolumab|nivolumab|mesh-list
43802030|NCT03576612|Temozolomide|temozolomide|mesh-list
43802031|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802032|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802033|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43802034|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802035|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43802036|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
43802037|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
43802038|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802050|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43802051|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802052|NCT03424525|Renal Agents|renal agents|mesh-ancestor
43802053|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
43802054|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43802065|NCT03337698|Carboplatin|carboplatin|mesh-list
43802067|NCT03337698|Pemetrexed|pemetrexed|mesh-list
43802068|NCT03337698|Atezolizumab|atezolizumab|mesh-list
43802087|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
43802089|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43802090|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43802091|NCT03337698|Incretins|incretins|mesh-ancestor
43802093|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802094|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43802095|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
43802096|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43802097|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43802098|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43802099|NCT03246906|Cyclosporine|cyclosporine|mesh-list
43802100|NCT03246906|Sirolimus|sirolimus|mesh-list
43802101|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
43802102|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
43802103|NCT03246906|Cyclosporins|cyclosporins|mesh-list
43802104|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802105|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
43802106|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802107|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43802108|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43802109|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
43802110|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802111|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802112|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43802113|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802114|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
43802115|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802130|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802131|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802132|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
43802134|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
43802135|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43802136|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802137|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43612389|NCT03165825|Dexamethasone|dexamethasone|mesh-list
43802139|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43802140|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43802141|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43802142|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802143|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43802144|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43802145|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
43802146|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802147|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802148|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
43802150|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802151|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
43802152|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802154|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43802155|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
43802156|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802157|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802158|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43802159|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
43802160|NCT03030378|Interleukin-12|interleukin-12|mesh-list
43802161|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802162|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802163|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43802164|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
43802172|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802173|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
43802174|NCT02935634|Nivolumab|nivolumab|mesh-list
43802175|NCT02935634|Ipilimumab|ipilimumab|mesh-list
43802176|NCT02935634|Rucaparib|rucaparib|mesh-list
43802177|NCT02935634|Linrodostat|linrodostat|mesh-list
43802178|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802179|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802180|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43802181|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802182|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43802183|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802184|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
43802185|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43802186|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43802197|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802211|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802212|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
43802213|NCT02633059|Hormones|hormones|mesh-ancestor
43802214|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802215|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802216|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802217|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802218|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
43802219|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802220|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
43802221|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
43802222|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802223|NCT02595424|Cisplatin|cisplatin|mesh-list
43802224|NCT02595424|Carboplatin|carboplatin|mesh-list
43802225|NCT02595424|Capecitabine|capecitabine|mesh-list
43802236|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43802237|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
43802238|NCT02575794|Masoprocol|masoprocol|mesh-list
43802239|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
43802241|NCT02575794|Protective Agents|protective agents|mesh-ancestor
43802284|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43802285|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43802286|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842524|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43842525|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842526|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43842527|NCT04525014|Irinotecan|irinotecan|mesh-list
43842528|NCT04525014|Temozolomide|temozolomide|mesh-list
43842529|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43842530|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43842531|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842532|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842533|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842534|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43842535|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
43842536|NCT04524611|Ustekinumab|ustekinumab|mesh-list
43842537|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43842538|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
43612546|NCT03164694|Pemetrexed|pemetrexed|mesh-list
43802287|NCT02252887|Gemcitabine|gemcitabine|mesh-list
43802288|NCT02252887|Trastuzumab|trastuzumab|mesh-list
43802289|NCT02252887|Pertuzumab|pertuzumab|mesh-list
43802290|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802337|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
43802338|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43802339|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43802340|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802341|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
43802342|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
43802343|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
43802344|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802345|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802346|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
43802347|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802363|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802364|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
43802365|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802366|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43802367|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43802368|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
43802369|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802370|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802371|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43802372|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802373|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
43802374|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43802375|NCT01697527|Analgesics|analgesics|mesh-ancestor
43802376|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
43802377|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802378|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43802379|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43802380|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
43802381|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802382|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43802383|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
43802384|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802385|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
43802386|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802387|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43802388|NCT01309672|Prednisone|prednisone|mesh-list
43802389|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
43802390|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802391|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
43802392|NCT01309672|Hormones|hormones|mesh-ancestor
43802393|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802394|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802395|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802396|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802397|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43802398|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802399|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802420|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43802421|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
43802422|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
43802427|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802428|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43802429|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43802430|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802431|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802432|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43802433|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
43802434|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802435|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802436|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
43802437|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802438|NCT04982549|Paclitaxel|paclitaxel|mesh-list
43802439|NCT04982549|Cisplatin|cisplatin|mesh-list
43802440|NCT04982549|Carboplatin|carboplatin|mesh-list
43802441|NCT04982549|Pemetrexed|pemetrexed|mesh-list
43802442|NCT04982549|Durvalumab|durvalumab|mesh-list
43802443|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43802444|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802445|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
43802446|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
43802447|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
43802448|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802449|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802450|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43802451|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43802452|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802453|NCT04982016|Methamphetamine|methamphetamine|mesh-list
43802454|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43802455|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802456|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
43802457|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
43802458|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802459|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
43802460|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802523|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
43802471|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802472|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802473|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43802474|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802475|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43802500|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43802501|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802503|NCT04981743|Vitamins|vitamins|mesh-ancestor
43802504|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
43802505|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802506|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43802507|NCT04981457|Misoprostol|misoprostol|mesh-list
43802508|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43802509|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
43802510|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43802511|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802512|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43802513|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802514|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
43802515|NCT04981327|Apixaban|apixaban|mesh-list
43802516|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43802517|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
43802518|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43802519|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
43802520|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802521|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802522|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
43802528|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802529|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802531|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43802532|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
43802533|NCT04981704|Itraconazole|itraconazole|mesh-list
43802534|NCT04981704|Phenytoin|phenytoin|mesh-list
43802535|NCT04981704|Paroxetine|paroxetine|mesh-list
43802536|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
43802537|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802538|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43802539|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43802540|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802541|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802542|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43802543|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
43802544|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43842539|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
43802549|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43802550|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802551|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
43802552|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43802553|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
43802554|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43802555|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43802556|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
43802557|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43802559|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43802560|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43802561|NCT04982211|Propranolol|propranolol|mesh-list
43802562|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43802563|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43802564|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
43802565|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802566|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802567|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802568|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43802569|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43802570|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
43802571|NCT04981093|Dexamethasone|dexamethasone|mesh-list
43802572|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
43802573|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802574|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
43802575|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
43802576|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802577|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802578|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802579|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
43802580|NCT04981093|Hormones|hormones|mesh-ancestor
43802581|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802582|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802583|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842540|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842541|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
43842542|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43842543|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842544|NCT04522739|Spironolactone|spironolactone|mesh-list
43842545|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43842546|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
43842547|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43842548|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842549|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43842550|NCT04522739|Diuretics|diuretics|mesh-ancestor
43842551|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
43842552|NCT04522622|Teriparatide|teriparatide|mesh-list
43842553|NCT04522622|Listerine|listerine|mesh-list
43842554|NCT04522622|Fluorides|fluorides|mesh-list
43842555|NCT04522622|Sodium Fluoride|sodium fluoride|mesh-list
43842556|NCT04522622|Cariostatic Agents|cariostatic agents|mesh-ancestor
43842561|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43842562|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43842564|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43842565|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43842566|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842567|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
43802594|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43802596|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
43802597|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43802598|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802599|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43802606|NCT04980105|Prednisolone|prednisolone|mesh-list
43802663|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
43802664|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
43802665|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802666|NCT04979884|Cyclosporine|cyclosporine|mesh-list
43802667|NCT04979884|Interleukin-2|interleukin-2|mesh-list
43802668|NCT04979884|Cyclosporins|cyclosporins|mesh-list
43802670|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802672|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
43802673|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802674|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
43802675|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802676|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
43802677|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43802678|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43802679|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802680|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43802681|NCT04979884|Analgesics|analgesics|mesh-ancestor
43802702|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
43802703|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802704|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43802705|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43802706|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43802707|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43802708|NCT04979273|Epinephrine|epinephrine|mesh-list
43802709|NCT04979273|Racepinephrine|racepinephrine|mesh-list
43802710|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
43802711|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43802712|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43802713|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
43802714|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802715|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802716|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802717|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43802718|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43802719|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
43802720|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802721|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43802722|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
43802723|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
43802724|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
43802731|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
43802732|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
43802733|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802734|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802735|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802736|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43802738|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43802739|NCT04979091|Hormones|hormones|mesh-list
43802740|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802741|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802742|NCT04978688|Relugolix|relugolix|mesh-list
43802743|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
43802744|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
43802745|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802746|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802747|NCT04978597|Opicapone|opicapone|mesh-list
43802748|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43802749|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802750|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802751|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43802752|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43802753|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43802754|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43802755|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43802756|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802757|NCT04977960|Canrenone|canrenone|mesh-list
43802758|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
43802759|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43802760|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
43802761|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802762|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802763|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43802764|NCT04977960|Diuretics|diuretics|mesh-ancestor
43802765|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
43802766|NCT04978155|Anesthetics|anesthetics|mesh-list
43802767|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43802768|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802769|NCT04977778|Fluorides|fluorides|mesh-list
43802794|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842574|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43842575|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842576|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842577|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
43842578|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43842579|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842580|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
43842581|NCT04520074|Cisplatin|cisplatin|mesh-list
43842582|NCT04520074|Carboplatin|carboplatin|mesh-list
43842583|NCT04520074|Etoposide|etoposide|mesh-list
43842584|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842585|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
43842586|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842587|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842588|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43842589|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
43802795|NCT04977661|Vitamin E|vitamin e|mesh-list
43802796|NCT04977661|Tocopherols|tocopherols|mesh-list
43802797|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
43802798|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
43802799|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43802800|NCT04977661|Vitamins|vitamins|mesh-ancestor
43802826|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802828|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
43802829|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
43802830|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802831|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802832|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43802833|NCT04977427|Protective Agents|protective agents|mesh-ancestor
43802834|NCT04977336|Acetaminophen|acetaminophen|mesh-list
43802847|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802848|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802849|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
43802850|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802851|NCT04977401|Glycerol|glycerol|mesh-list
43802914|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
43802915|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43802916|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802917|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
43802918|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43802919|NCT04975932|Estrogens|estrogens|mesh-ancestor
43802920|NCT04975932|Hormones|hormones|mesh-ancestor
43802921|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802922|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802923|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802924|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802925|NCT04975971|Dexamethasone|dexamethasone|mesh-list
43802926|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802927|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
43802928|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
43802929|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802930|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802931|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802932|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
43802933|NCT04975971|Hormones|hormones|mesh-ancestor
43802934|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802935|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802936|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802937|NCT04975724|Citalopram|citalopram|mesh-list
43802938|NCT04975724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43802939|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43802940|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43802941|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802942|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802943|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
43802944|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802945|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43802946|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
43802947|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43802948|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
43802949|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43802950|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
43802951|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802952|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
43802953|NCT04975373|Protective Agents|protective agents|mesh-ancestor
43802964|NCT04975022|Insulin|insulin|mesh-list
43802965|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43802966|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802967|NCT04975074|Iron|iron|mesh-list
43802968|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
43802969|NCT04975074|Trace Elements|trace elements|mesh-ancestor
43802970|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
43802971|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802972|NCT04975074|Hematinics|hematinics|mesh-ancestor
43802979|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802980|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43802981|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
43802982|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
43802983|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802985|NCT04974944|Bevacizumab|bevacizumab|mesh-list
43802986|NCT04974944|Cisplatin|cisplatin|mesh-list
43802987|NCT04974944|Carboplatin|carboplatin|mesh-list
43802988|NCT04974944|Apatinib|apatinib|mesh-list
43802989|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43802990|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802991|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
43802992|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
43802993|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
43802994|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802995|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802996|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43802998|NCT04974944|Growth Substances|growth substances|mesh-ancestor
43802999|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803000|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
43803001|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803002|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803003|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43803004|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
43803005|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842590|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842591|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842592|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43842593|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43842594|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43842595|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43842596|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842597|NCT04518306|Amlodipine|amlodipine|mesh-list
43842598|NCT04518306|Telmisartan|telmisartan|mesh-list
43842599|NCT04518306|Indapamide|indapamide|mesh-list
43842600|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43842601|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43842612|NCT04518293|Amlodipine|amlodipine|mesh-list
43842613|NCT04518293|Telmisartan|telmisartan|mesh-list
43842614|NCT04518293|Indapamide|indapamide|mesh-list
43842615|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43842616|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43842617|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43842619|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43842620|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842621|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842622|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43842623|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43842624|NCT04518293|Diuretics|diuretics|mesh-ancestor
43842625|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
43842626|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43842627|NCT04518280|Capecitabine|capecitabine|mesh-list
43842628|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
43842629|NCT04518280|Antibodies|antibodies|mesh-list
43842630|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
43842631|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842632|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43842633|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
43842634|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842635|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842636|NCT04517747|Ramucirumab|ramucirumab|mesh-list
43842637|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842638|NCT04517110|Pregabalin|pregabalin|mesh-list
43842639|NCT04517110|Analgesics|analgesics|mesh-ancestor
43842640|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
43842641|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842642|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842643|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
43842644|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43842645|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43842646|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842647|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43842648|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43842649|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43803023|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
43803024|NCT04973904|Paclitaxel|paclitaxel|mesh-list
43803025|NCT04973904|Bevacizumab|bevacizumab|mesh-list
43803026|NCT04973904|Cisplatin|cisplatin|mesh-list
43803027|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43803028|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803029|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
43803030|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
43803031|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
43803032|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803033|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803034|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43803035|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43803036|NCT04973904|Growth Substances|growth substances|mesh-ancestor
43803037|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803038|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
43803039|NCT04973462|Oseltamivir|oseltamivir|mesh-list
43803040|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
43803041|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803042|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803043|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803044|NCT04973722|Denosumab|denosumab|mesh-list
43803045|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43803046|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803049|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803050|NCT04973033|Tofacitinib|tofacitinib|mesh-list
43803051|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803052|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803053|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803054|NCT04973319|Trastuzumab|trastuzumab|mesh-list
43803055|NCT04973319|Pertuzumab|pertuzumab|mesh-list
43803056|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803057|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803058|NCT04972942|Daratumumab|daratumumab|mesh-list
43803059|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803060|NCT04973293|Bevacizumab|bevacizumab|mesh-list
43803061|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803062|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803063|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43803064|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43803065|NCT04973293|Growth Substances|growth substances|mesh-ancestor
43803077|NCT04972045|Curcumin|curcumin|mesh-list
43803078|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43803079|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803080|NCT04972045|Analgesics|analgesics|mesh-ancestor
43803088|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803089|NCT04971759|Fentanyl|fentanyl|mesh-list
43803090|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
43803091|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
43803092|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43803093|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803094|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803095|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803096|NCT04971759|Analgesics|analgesics|mesh-ancestor
43803097|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
43803098|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803099|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43803100|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43803101|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43803102|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
43803103|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803104|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803105|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43803106|NCT04971759|Narcotics|narcotics|mesh-ancestor
43803107|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43803108|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43803109|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
43803110|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
43803111|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
43803112|NCT04971382|Curcumin|curcumin|mesh-list
43803113|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43803114|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803115|NCT04971382|Analgesics|analgesics|mesh-ancestor
43803116|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
43803117|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803118|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803119|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803120|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43803121|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803123|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803124|NCT04971577|Simvastatin|simvastatin|mesh-list
43803125|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43803126|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43803127|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
43803141|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43803142|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803143|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803144|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
43803145|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842659|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
43842660|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842705|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842706|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43803151|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43803152|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
43803153|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43803154|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803155|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43803156|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
43803157|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803158|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803159|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
43803160|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803161|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43803162|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43803163|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
43803164|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43803165|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43803166|NCT04970719|Remdesivir|remdesivir|mesh-list
43803167|NCT04970719|Dexamethasone|dexamethasone|mesh-list
43803168|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43803169|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803170|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
43803171|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
43803172|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803173|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803174|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43803175|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
43803176|NCT04970719|Hormones|hormones|mesh-ancestor
43803177|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43803178|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43803179|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803180|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
43803181|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803182|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
43803208|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803209|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43803210|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803211|NCT04970251|Aflibercept|aflibercept|mesh-list
43803212|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43803219|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
43803220|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803221|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803222|NCT04970303|Methylphenidate|methylphenidate|mesh-list
43803223|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43613674|NCT05176223|Edetic Acid|edetic acid|mesh-list
43803224|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803225|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43803226|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43803227|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803228|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803229|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
43803230|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803231|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43803232|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43803233|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43803265|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43803266|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
43803267|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
43803268|NCT04970043|Pemetrexed|pemetrexed|mesh-list
43803269|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803270|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803271|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803272|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43803273|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43803274|NCT04969263|Vaccines|vaccines|mesh-list
43803275|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
43803276|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803277|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
43803278|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43803279|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43803280|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
43803281|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803282|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803283|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803284|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
43803285|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
43803287|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803288|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803289|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
43803290|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803291|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43803292|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803293|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803294|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
43803295|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842707|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803296|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803297|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
43803305|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803306|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43803307|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43803309|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
43803310|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803311|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803312|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
43803313|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
43803314|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43803315|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43803316|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43803317|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
43803318|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803319|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803320|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43803321|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
43803322|NCT04968132|Narcotics|narcotics|mesh-ancestor
43803323|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803324|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842715|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43842716|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43842717|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842718|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43842719|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
43842746|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
43842747|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842748|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43842749|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842750|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842751|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
43842752|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842753|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43842754|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43842755|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842756|NCT04513951|Antidotes|antidotes|mesh-ancestor
43842757|NCT04513951|Protective Agents|protective agents|mesh-ancestor
43842758|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
43842760|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
43842761|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43842762|NCT04513808|Anesthetics|anesthetics|mesh-list
43842763|NCT04513808|Propofol|propofol|mesh-list
43842772|NCT04513652|Carticaine|carticaine|mesh-list
43842773|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
43842774|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
43842775|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842776|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842777|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
43842778|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842779|NCT04513639|Dexamethasone|dexamethasone|mesh-list
43842780|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
43613839|NCT04869943|Exemestane|exemestane|mesh-list
43842781|NCT04513639|Daratumumab|daratumumab|mesh-list
43842782|NCT04513639|BB 1101|bb 1101|mesh-list
43842783|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43803329|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803330|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803331|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803332|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803333|NCT04967859|Gentamicins|gentamicins|mesh-list
43803334|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43803335|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803336|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43803337|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803338|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803339|NCT04967469|Calcitriol|calcitriol|mesh-list
43803340|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
43803342|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43803415|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803416|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803417|NCT04966234|Posaconazole|posaconazole|mesh-list
43803418|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
43803419|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803420|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43803438|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803439|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43803441|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803442|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803443|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803444|NCT04965545|Copper|copper|mesh-list
43803445|NCT04965545|Trace Elements|trace elements|mesh-ancestor
43803446|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
43803447|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803448|NCT04965532|Anesthetics|anesthetics|mesh-list
43803449|NCT04965532|Propofol|propofol|mesh-list
43803450|NCT04965532|Sevoflurane|sevoflurane|mesh-list
43803451|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803452|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803453|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43803454|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43803455|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
43849608|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849609|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43849610|NCT03908892|Tetracycline|tetracycline|mesh-list
43849611|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43849612|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849613|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43849614|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849615|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849616|NCT03907046|Aspirin|aspirin|mesh-list
43849617|NCT03907046|Apixaban|apixaban|mesh-list
43849618|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43848645|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43848646|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848647|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
43848648|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
43848649|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
43848650|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848651|NCT04004611|Mirikizumab|mirikizumab|mesh-list
43848652|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43848653|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803476|NCT04965324|Anesthetics|anesthetics|mesh-list
43803477|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803478|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803479|NCT04965051|Insulin|insulin|mesh-list
43803480|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43803481|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
43803482|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43803483|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803484|NCT04964869|Epinephrine|epinephrine|mesh-list
43803485|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43803486|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43803487|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
43803488|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803489|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803490|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803491|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43803492|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43803493|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
43803494|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803495|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43803496|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
43803497|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
43803498|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
43803499|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43803500|NCT04964583|Azithromycin|azithromycin|mesh-list
43803501|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
43803502|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43803529|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803530|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43803531|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
43803532|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
43803533|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43803534|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43803535|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803536|NCT04964219|Ketamine|ketamine|mesh-list
43803537|NCT04964219|Esketamine|esketamine|mesh-list
43803538|NCT04964219|Analgesics|analgesics|mesh-ancestor
43803539|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
43803540|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803541|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803542|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43803543|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43803544|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
43803546|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803547|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43803548|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43803549|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803550|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803551|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
43803553|NCT04963998|Copper|copper|mesh-list
43803554|NCT04963998|Trace Elements|trace elements|mesh-ancestor
43803555|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
43803556|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803557|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43803558|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803559|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803560|NCT04963881|Antibodies|antibodies|mesh-list
43803561|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
43803593|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43803594|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43803595|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43803596|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43803597|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803598|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43803599|NCT04963088|Capecitabine|capecitabine|mesh-list
43803600|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
43803601|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43803602|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
43803603|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803604|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803605|NCT04962672|Anesthetics|anesthetics|mesh-list
43803606|NCT04962672|Propofol|propofol|mesh-list
43803607|NCT04962672|Sevoflurane|sevoflurane|mesh-list
43803608|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803609|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803610|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43803611|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43803612|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
43803613|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43803614|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43803615|NCT04962958|Leucovorin|leucovorin|mesh-list
43803616|NCT04962958|Fluorouracil|fluorouracil|mesh-list
43803617|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
43803618|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
43803619|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803620|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43803621|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803622|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43803623|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
43803624|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803625|NCT04962958|Antidotes|antidotes|mesh-ancestor
43803626|NCT04962958|Protective Agents|protective agents|mesh-ancestor
43803627|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
43803629|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
43803630|NCT04962425|Trastuzumab|trastuzumab|mesh-list
43803631|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803632|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803633|NCT04962451|Ticagrelor|ticagrelor|mesh-list
43803634|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43803635|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43803636|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43803637|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43803638|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
43803639|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803640|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803641|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803642|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43803643|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43803644|NCT04962386|Hormones|hormones|mesh-list
43803645|NCT04962386|Estradiol|estradiol|mesh-list
43842820|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842821|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43842822|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
43842823|NCT04510285|Trastuzumab|trastuzumab|mesh-list
43842824|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43842825|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842826|NCT04510194|Metformin|metformin|mesh-list
43842827|NCT04510194|Ivermectin|ivermectin|mesh-list
43842828|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
43842829|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43842830|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842831|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43803680|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
43803695|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
43803696|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803697|NCT04961268|Acetaminophen|acetaminophen|mesh-list
43803698|NCT04961268|Ibuprofen|ibuprofen|mesh-list
43803699|NCT04961268|Tramadol|tramadol|mesh-list
43803701|NCT04961268|Analgesics|analgesics|mesh-ancestor
43803776|NCT04959409|Tetracaine|tetracaine|mesh-list
43614548|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43803777|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
43803803|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43803804|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
43803805|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
43803806|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43803807|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43803808|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
43803809|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43803817|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803819|NCT04957212|Carboplatin|carboplatin|mesh-list
43803820|NCT04957212|Docetaxel|docetaxel|mesh-list
43803821|NCT04957212|Trastuzumab|trastuzumab|mesh-list
43803822|NCT04957212|Pertuzumab|pertuzumab|mesh-list
43803823|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803824|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
43803825|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
43803826|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
43803827|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803828|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803829|NCT04956419|Fluconazole|fluconazole|mesh-list
43803830|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
43803831|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803832|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43803833|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43803834|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803835|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803836|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43803838|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43803839|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803840|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43803841|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43842921|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842922|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43842923|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43842924|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842925|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842927|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43842928|NCT04500613|Dexamethasone|dexamethasone|mesh-list
43842929|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
43614550|NCT03591380|Belimumab|belimumab|mesh-list
43803843|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
43803844|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803845|NCT04956094|Protective Agents|protective agents|mesh-ancestor
43803846|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803847|NCT04955834|Insulin|insulin|mesh-list
43803848|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43803849|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849624|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803850|NCT04955262|Nivolumab|nivolumab|mesh-list
43803851|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803852|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803853|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43803909|NCT04952571|Bevacizumab|bevacizumab|mesh-list
43803854|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803855|NCT04954560|Losartan|losartan|mesh-list
43803856|NCT04954560|Eprosartan|eprosartan|mesh-list
43803857|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43803858|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43803859|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43803860|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43803861|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803862|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
43803863|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43803864|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803865|NCT04953741|Fluticasone|fluticasone|mesh-list
43803866|NCT04953741|Xhance|xhance|mesh-list
43803867|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803868|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43803869|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
43803870|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803871|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803872|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43803873|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
43803874|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
43803875|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43803876|NCT04954014|Bevacizumab|bevacizumab|mesh-list
43803877|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803878|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803879|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43803880|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43803881|NCT04954014|Growth Substances|growth substances|mesh-ancestor
43803882|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803883|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
43803884|NCT04954040|Azithromycin|azithromycin|mesh-list
43803885|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
43803886|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43803887|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803888|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
43803889|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43803890|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43803891|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803892|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803893|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842930|NCT04500613|Bupivacaine|bupivacaine|mesh-list
43842931|NCT04500613|BB 1101|bb 1101|mesh-list
43842932|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842933|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
43842934|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
43842935|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842936|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842937|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43842938|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
43842939|NCT04500613|Hormones|hormones|mesh-ancestor
43842940|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43842941|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43842942|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842943|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
43842944|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842945|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842946|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
43842947|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
43842948|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842949|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
43842950|NCT04500548|Nivolumab|nivolumab|mesh-list
43803895|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43803896|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803897|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
43803898|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
43803899|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
43803900|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803901|NCT04952792|Apixaban|apixaban|mesh-list
43803902|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43803903|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
43803904|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43803905|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
43803906|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803907|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803908|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
43803910|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803911|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803912|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43803913|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43803914|NCT04952571|Growth Substances|growth substances|mesh-ancestor
43803915|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803916|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
43803918|NCT04952194|Carbidopa|carbidopa|mesh-list
43803919|NCT04952194|Entacapone|entacapone|mesh-list
43803946|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
43803947|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803948|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43803949|NCT04952129|Selenium|selenium|mesh-list
43803950|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
43803951|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
43803952|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803953|NCT04952129|Protective Agents|protective agents|mesh-ancestor
43803954|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803955|NCT04952129|Trace Elements|trace elements|mesh-ancestor
43803956|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
43803957|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43803958|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803959|NCT04952051|Folic Acid|folic acid|mesh-list
43804007|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804008|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804009|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
43804010|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804012|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43804013|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804014|NCT04951726|Neostigmine|neostigmine|mesh-list
43804015|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43804016|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804017|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804018|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
43804019|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804020|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804021|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43804022|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
43804023|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804024|NCT04951349|Petrolatum|petrolatum|mesh-list
43804025|NCT04951349|Emollients|emollients|mesh-ancestor
43804026|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
43804027|NCT04951167|Norepinephrine|norepinephrine|mesh-list
43804028|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43804029|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43804030|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
43804031|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804032|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804033|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804034|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
43804035|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
43804036|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804037|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43842953|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842955|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842957|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43842958|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842959|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43614779|NCT03029702|Glyburide|glyburide|mesh-list
43804038|NCT04950933|Riluzole|riluzole|mesh-list
43804039|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
43804040|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43804041|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43804042|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804043|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804044|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804045|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43804046|NCT04950933|Protective Agents|protective agents|mesh-ancestor
43804047|NCT04951128|Anesthetics|anesthetics|mesh-list
43804048|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
43804049|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
43804050|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804051|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804052|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43804053|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43804054|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804055|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
43804056|NCT04951128|Coagulants|coagulants|mesh-ancestor
43804057|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
43804058|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804059|NCT04951232|Cinepazide|cinepazide|mesh-list
43804060|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
43804061|NCT04950569|Simendan|simendan|mesh-list
43804062|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43804063|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
43804064|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43804066|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804067|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804068|NCT04950569|Protective Agents|protective agents|mesh-ancestor
43804069|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804070|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
43804071|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804072|NCT04950205|Sevoflurane|sevoflurane|mesh-list
43804073|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43804074|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43804075|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
43804076|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
43804077|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804078|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804079|NCT04950049|Dexamethasone|dexamethasone|mesh-list
43804080|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
43804081|NCT04950049|BB 1101|bb 1101|mesh-list
43804082|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804083|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
43804084|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
43804085|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804086|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804087|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804088|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
43804089|NCT04950049|Hormones|hormones|mesh-ancestor
43804090|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804091|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43804092|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804093|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
43804094|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804095|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804096|NCT04950400|Apatinib|apatinib|mesh-list
43804097|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804098|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43804099|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804100|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804101|NCT04950530|Emtricitabine|emtricitabine|mesh-list
43804103|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804104|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43804105|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43804106|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804107|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804119|NCT04948788|Gemcitabine|gemcitabine|mesh-list
43804120|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
43804121|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43804122|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
43804123|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804124|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804125|NCT04948788|Antiviral Agents|antiviral agents|mesh-ancestor
43804126|NCT04948788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804127|NCT04948788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804128|NCT04948788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43804129|NCT04948788|Immunologic Factors|immunologic factors|mesh-ancestor
43804130|NCT04948788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804131|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
43804132|NCT04948957|Esmolol|esmolol|mesh-list
43804133|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
43804134|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43804135|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43804136|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43804137|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
43804138|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804139|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804140|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804150|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804151|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
43804152|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804154|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
43804155|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43804165|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804166|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43804167|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804168|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804169|NCT04948385|Propofol|propofol|mesh-list
43804170|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43804171|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804172|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804173|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43804174|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
43842960|NCT04499859|Ezetimibe|ezetimibe|mesh-list
43842961|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43842962|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43842963|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
43842964|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842965|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43842966|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43842967|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842968|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
43842969|NCT04499495|Mesalamine|mesalamine|mesh-list
43842970|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43842971|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43804176|NCT04948372|Terlipressin|terlipressin|mesh-list
43804177|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43804178|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43804179|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43804180|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804181|NCT04948164|Naproxen|naproxen|mesh-list
43804182|NCT04948164|Sumatriptan|sumatriptan|mesh-list
43804183|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43804184|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43804185|NCT04948164|Analgesics|analgesics|mesh-ancestor
43804186|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
43804187|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804188|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804189|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804190|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804191|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
43804192|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43804193|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804195|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43804202|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43804229|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
43804231|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43804232|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
43804233|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
43804234|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804235|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804236|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804237|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
43804238|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43804239|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
43804240|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804583|NCT04943653|Capecitabine|capecitabine|mesh-list
43804241|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804243|NCT04947267|Epinephrine|epinephrine|mesh-list
43804244|NCT04947267|Mepivacaine|mepivacaine|mesh-list
43804245|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43804246|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43804247|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
43804248|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804249|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804250|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804252|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43804253|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
43804254|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804255|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43804256|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
43804257|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
43804258|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
43804307|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
43804308|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
43804309|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804310|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43804311|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804312|NCT04947241|Gemcitabine|gemcitabine|mesh-list
43804313|NCT04947241|Cisplatin|cisplatin|mesh-list
43804314|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43804315|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804316|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43804317|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
43804318|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804319|NCT04947241|Antiviral Agents|antiviral agents|mesh-ancestor
43804320|NCT04947241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804321|NCT04947241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804322|NCT04947241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43804323|NCT04947241|Immunologic Factors|immunologic factors|mesh-ancestor
43804324|NCT04947241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804325|NCT04946825|Nicotine|nicotine|mesh-list
43804326|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43804327|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
43804328|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804329|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804330|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43804331|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43804332|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
43804333|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804334|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804335|NCT04946734|Aspirin|aspirin|mesh-list
43804336|NCT04946734|Clopidogrel|clopidogrel|mesh-list
43804337|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43804338|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43804339|NCT04946734|Analgesics|analgesics|mesh-ancestor
43804340|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
43804341|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804342|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804447|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43804448|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43804449|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43804450|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43804451|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43804452|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43804453|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43804454|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43804455|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
43804456|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804457|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804458|NCT04945577|Vitamin D|vitamin d|mesh-list
43804473|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43804474|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804476|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
43804477|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804478|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
43804479|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804480|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804481|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
43804483|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43804484|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804485|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43842972|NCT04499495|Analgesics|analgesics|mesh-ancestor
43842973|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
43842974|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842975|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842976|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842977|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842978|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
43842979|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43842980|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842982|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842983|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
43842984|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842986|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842987|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842989|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43842990|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842991|NCT04495088|Leucovorin|leucovorin|mesh-list
43842992|NCT04495088|Folic Acid|folic acid|mesh-list
43842993|NCT04495088|Capecitabine|capecitabine|mesh-list
43842994|NCT04495088|Fluorouracil|fluorouracil|mesh-list
43842995|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
43842996|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
43842997|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43842998|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
43842999|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843000|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843001|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843002|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
43843003|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804528|NCT04944381|Vaccines|vaccines|mesh-list
43804529|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
43804530|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804531|NCT04944602|Omalizumab|omalizumab|mesh-list
43804532|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43804533|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43804534|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
43804535|NCT04944524|Methotrexate|methotrexate|mesh-list
43804539|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43804540|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804541|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43804542|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
43804543|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804544|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804545|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
43804546|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804547|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43804548|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43804549|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
43804550|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804551|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43804552|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43804553|NCT04943952|Asparaginase|asparaginase|mesh-list
43804554|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804555|NCT04944069|Bevacizumab|bevacizumab|mesh-list
43804556|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43804557|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804558|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43615361|NCT03149432|Gabapentin|gabapentin|mesh-list
43804559|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43804560|NCT04944069|Growth Substances|growth substances|mesh-ancestor
43804561|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804562|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
43804563|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
43804574|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804576|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43804577|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804578|NCT04943588|Antibodies|antibodies|mesh-list
43804579|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
43804580|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
43804581|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804582|NCT04943653|Paclitaxel|paclitaxel|mesh-list
43804603|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43804604|NCT04943237|Analgesics|analgesics|mesh-ancestor
43804605|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
43804606|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804607|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804608|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804609|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804610|NCT04943029|Paclitaxel|paclitaxel|mesh-list
43804611|NCT04943029|Carboplatin|carboplatin|mesh-list
43804612|NCT04943029|Pemetrexed|pemetrexed|mesh-list
43804613|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43804614|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804615|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
43804616|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
43804617|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
43804618|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804619|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804620|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43804621|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43804622|NCT04942899|Capecitabine|capecitabine|mesh-list
43804624|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43804625|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
43804626|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804627|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804628|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43804629|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43804681|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804682|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43804683|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43804684|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43804685|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804709|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43804710|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
43804711|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804712|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804713|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43804714|NCT04942769|Selenium|selenium|mesh-list
43804715|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
43804716|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804717|NCT04942769|Protective Agents|protective agents|mesh-ancestor
43804734|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843004|NCT04495088|Antidotes|antidotes|mesh-ancestor
43843005|NCT04495088|Protective Agents|protective agents|mesh-ancestor
43804751|NCT04942002|Hormones|hormones|mesh-ancestor
43804793|NCT04941131|Povidone|povidone|mesh-list
43804794|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43804795|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804796|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
43804797|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
43804798|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
43804799|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
43804800|NCT04941118|Anesthetics|anesthetics|mesh-list
43804801|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
43804802|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804803|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804804|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
43804805|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804806|NCT04940689|Lidocaine|lidocaine|mesh-list
43804807|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
43804808|NCT04940689|Remifentanil|remifentanil|mesh-list
43804809|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
43804810|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
43804811|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804812|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804813|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
43804814|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804815|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43804821|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43804822|NCT04940689|Analgesics|analgesics|mesh-ancestor
43804823|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43615623|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
43804824|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43804836|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43804837|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804838|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43804839|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43804840|NCT04940546|Growth Substances|growth substances|mesh-ancestor
43804841|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804842|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
43804843|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43804844|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
43804845|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804846|NCT04940273|Remifentanil|remifentanil|mesh-list
43804847|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43804848|NCT04940273|Narcotics|narcotics|mesh-ancestor
43849625|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43805026|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
43804938|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804939|NCT04938297|Rituximab|rituximab|mesh-list
43804940|NCT04938297|Lenalidomide|lenalidomide|mesh-list
43804941|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
43804942|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43804943|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804944|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
43804945|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804946|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804947|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43804948|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43804949|NCT04938297|Growth Substances|growth substances|mesh-ancestor
43804950|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
43804951|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43804952|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804953|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804954|NCT04938011|Progesterone|progesterone|mesh-list
43804955|NCT04938011|Progestins|progestins|mesh-ancestor
43804956|NCT04938011|Hormones|hormones|mesh-ancestor
43804957|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804958|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615857|NCT03145610|Triclosan|triclosan|mesh-list
43804979|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804980|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43804981|NCT04938037|Protective Agents|protective agents|mesh-ancestor
43804982|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43804983|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804984|NCT04937946|Fentanyl|fentanyl|mesh-list
43804985|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43804986|NCT04937946|Narcotics|narcotics|mesh-ancestor
43804987|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804988|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804989|NCT04937946|Analgesics|analgesics|mesh-ancestor
43804990|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
43804991|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804993|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43804994|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
43804995|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
43804996|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
43804997|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43804998|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43804999|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43805000|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805001|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805002|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
43805003|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805004|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805005|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43805020|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43805021|NCT04937673|Cisplatin|cisplatin|mesh-list
43805022|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43805023|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805024|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
43805025|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
43805027|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805029|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43805030|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805031|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43805032|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805033|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805034|NCT04937569|Ivermectin|ivermectin|mesh-list
43805035|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43805036|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805037|NCT04937634|Melphalan|melphalan|mesh-list
43805038|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43805039|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
43805040|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805041|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805042|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43805043|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805044|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
43805045|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805046|NCT04937140|Antibodies|antibodies|mesh-list
43805047|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
43805048|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805049|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
43805050|NCT04937101|Codeine|codeine|mesh-list
43805051|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43805052|NCT04937101|Narcotics|narcotics|mesh-ancestor
43615893|NCT03145272|Oxycodone|oxycodone|mesh-list
43805053|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805054|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805055|NCT04937101|Analgesics|analgesics|mesh-ancestor
43805056|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
43805057|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805058|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
43805059|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
43805060|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
43805061|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
43805062|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43805063|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
43805064|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
43805065|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805066|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805067|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43805068|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43805069|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43805070|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43805071|NCT04936711|Bupivacaine|bupivacaine|mesh-list
43805072|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
43805073|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
43805074|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805075|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805076|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
43805077|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805078|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
43805084|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805085|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
43805086|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805087|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43805088|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43805089|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
43805090|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43805095|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805096|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
43805097|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805098|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43805099|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805100|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805101|NCT04936295|Fulvestrant|fulvestrant|mesh-list
43805102|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43805103|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805104|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43805105|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43805106|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
43805107|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805108|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805123|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627425|NCT03072992|Curcumin|curcumin|mesh-list
43805125|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805126|NCT04936126|Protective Agents|protective agents|mesh-ancestor
43805127|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43805128|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43805129|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
43805131|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805132|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
43805133|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805134|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43805135|NCT04936126|Analgesics|analgesics|mesh-ancestor
43805136|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
43805137|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805138|NCT04935788|Caseins|caseins|mesh-list
43805139|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
43805140|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
43843027|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843028|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43843029|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43843030|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843031|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43843032|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43843033|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43843034|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
43843035|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43843036|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843037|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43843038|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43843039|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843040|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843041|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
43843042|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43843043|NCT04491643|Megestrol|megestrol|mesh-list
43843044|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
43843045|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43843046|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43843047|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43843048|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
43843049|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843050|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43843051|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43843052|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843053|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43843054|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43843055|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43843056|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
43843057|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43843058|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843059|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43843060|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43843061|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843062|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843063|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
43843064|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43843065|NCT04491383|Tocovid|tocovid|mesh-list
43843066|NCT04491383|Vitamins|vitamins|mesh-ancestor
43843067|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
43805213|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
43805214|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
43805215|NCT04934618|Irinotecan|irinotecan|mesh-list
43805216|NCT04934618|Apatinib|apatinib|mesh-list
43805217|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43805218|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43805219|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805220|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805221|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805222|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43805223|NCT04934514|Gemcitabine|gemcitabine|mesh-list
43805224|NCT04934514|Cisplatin|cisplatin|mesh-list
43805225|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805226|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43805227|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
43805228|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805230|NCT04934514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805231|NCT04934514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805232|NCT04934514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805233|NCT04934514|Immunologic Factors|immunologic factors|mesh-ancestor
43805249|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805250|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805251|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805252|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
43805253|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
43805254|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805255|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43805256|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43805257|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
43805258|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43805259|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805260|NCT04933864|Methylene Blue|methylene blue|mesh-list
43805261|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805262|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805263|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43805264|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805265|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
43805266|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
43805267|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43805268|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43805269|NCT04933292|Prednisolone|prednisolone|mesh-list
43805270|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
43805271|NCT04933292|Azathioprine|azathioprine|mesh-list
43805272|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43805274|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43805275|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805276|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43805277|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
43805278|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43805279|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805280|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805281|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805282|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43805283|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
43805284|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
43805285|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805286|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805287|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43805288|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
43805289|NCT04933292|Hormones|hormones|mesh-ancestor
43805290|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805291|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43805292|NCT04933292|Protective Agents|protective agents|mesh-ancestor
43805293|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43805294|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
43805295|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43805296|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805297|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
43805298|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43805299|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
43805300|NCT04933084|Narcotics|narcotics|mesh-ancestor
43805301|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805302|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805303|NCT04933084|Analgesics|analgesics|mesh-ancestor
43805304|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
43805305|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805306|NCT04933279|Iodine|iodine|mesh-list
43805307|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
43805308|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43805309|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805310|NCT04933279|Trace Elements|trace elements|mesh-ancestor
43805311|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
43805312|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805313|NCT04932564|Leflunomide|leflunomide|mesh-list
43805314|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805315|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805316|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805318|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805319|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
43805320|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43805321|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843101|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843102|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
43843104|NCT04487652|Vitamins|vitamins|mesh-ancestor
43843105|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
43843106|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843107|NCT04486911|Letrozole|letrozole|mesh-list
43843108|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805334|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43805335|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
43805336|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805337|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805339|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
43805340|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
43805392|NCT04931121|Protective Agents|protective agents|mesh-ancestor
43805393|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805395|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43805396|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805397|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805398|NCT04930627|Empagliflozin|empagliflozin|mesh-list
43805399|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43805400|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805401|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43805402|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805403|NCT04930471|Metformin|metformin|mesh-list
43805404|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43805405|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805406|NCT04930211|Dexamethasone|dexamethasone|mesh-list
43805407|NCT04930211|Lidocaine|lidocaine|mesh-list
43805435|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805436|NCT04929652|Irinotecan|irinotecan|mesh-list
43805437|NCT04929652|Molgramostim|molgramostim|mesh-list
43805438|NCT04929652|Sargramostim|sargramostim|mesh-list
43805439|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43805440|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43805441|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805442|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805443|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805444|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
43805445|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805446|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
43805447|NCT04929626|Albuterol|albuterol|mesh-list
43805448|NCT04929626|Analgesics|analgesics|mesh-ancestor
43805449|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
43805450|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805451|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805452|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
43805453|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805454|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43805455|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
43805456|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43805457|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805458|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805459|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43805460|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
43805461|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43805462|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43616417|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
43805465|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
43805466|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43805467|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43805468|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43805469|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805470|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843130|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
43843131|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
43843132|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43843133|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
43843134|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
43843135|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
43843136|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843137|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43843138|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843139|NCT04484337|Cabotegravir|cabotegravir|mesh-list
43843140|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43843141|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43843142|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43843143|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43843144|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843145|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843146|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43843147|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43843148|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
43843149|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843150|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43843151|NCT04484337|Analgesics|analgesics|mesh-ancestor
43843152|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
43843153|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843154|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843155|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43843162|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843164|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
43843165|NCT04483739|Lenalidomide|lenalidomide|mesh-list
43843166|NCT04483739|BB 1101|bb 1101|mesh-list
43843167|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843168|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
43843169|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
43843170|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843171|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843172|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43843173|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
43843174|NCT04483739|Hormones|hormones|mesh-ancestor
43843175|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843176|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843177|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843178|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
43843179|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843180|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843181|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
43805516|NCT04928066|Hormones|hormones|mesh-ancestor
43805517|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805591|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805593|NCT04926753|Fluorouracil|fluorouracil|mesh-list
43805594|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805595|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
43805596|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805597|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43805598|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805599|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
43805612|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805613|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843199|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843200|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43843201|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843202|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843203|NCT04478266|Letrozole|letrozole|mesh-list
43843204|NCT04478266|Palbociclib|palbociclib|mesh-list
43843205|NCT04478266|Goserelin|goserelin|mesh-list
43616652|NCT00069238|Hormones|hormones|mesh-ancestor
43805614|NCT04925973|Tofacitinib|tofacitinib|mesh-list
43805617|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805619|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43805620|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805621|NCT04925141|Dasatinib|dasatinib|mesh-list
43805622|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805623|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43805624|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805625|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805626|NCT04925063|Metformin|metformin|mesh-list
43805627|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43805628|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805629|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43805630|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43805631|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43805652|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43805653|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43805654|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805655|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805656|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805657|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43805658|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43805659|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43805661|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805662|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805663|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43805664|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
43805665|NCT04922996|Calcium|calcium|mesh-list
43805666|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43805667|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805668|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
43805669|NCT04922996|Coagulants|coagulants|mesh-ancestor
43805670|NCT04923113|Amoxicillin|amoxicillin|mesh-list
43805671|NCT04923113|Minocycline|minocycline|mesh-list
43805672|NCT04923113|Rabeprazole|rabeprazole|mesh-list
43805673|NCT04923113|Bismuth|bismuth|mesh-list
43805674|NCT04923113|Antibodies|antibodies|mesh-list
43805675|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
43805676|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805677|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43805678|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843216|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843218|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
43843219|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43843220|NCT04478084|Antibodies|antibodies|mesh-list
43843221|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
43843222|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843223|NCT04475224|Mitogens|mitogens|mesh-list
43843224|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
43843225|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843226|NCT04474600|Propofol|propofol|mesh-list
43843227|NCT04474600|Desflurane|desflurane|mesh-list
43843228|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43848684|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848685|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
43848686|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848687|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848688|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43848689|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
43848690|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848691|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848694|NCT04002297|Rituximab|rituximab|mesh-list
43805715|NCT04922008|Capecitabine|capecitabine|mesh-list
43805716|NCT04922008|Trastuzumab|trastuzumab|mesh-list
43805717|NCT04922008|Vinorelbine|vinorelbine|mesh-list
43805718|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43805719|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
43805720|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805721|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805722|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43805723|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43805756|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43805757|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43805758|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
43805759|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805760|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43805788|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
43805789|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
43805790|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
43805792|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
43805793|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805794|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43805796|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805797|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43805798|NCT04921124|Teriparatide|teriparatide|mesh-list
43805799|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43805800|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805801|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43805802|NCT04921046|Lidocaine|lidocaine|mesh-list
43805803|NCT04921046|Midazolam|midazolam|mesh-list
43805804|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43805805|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43805806|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805811|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43805812|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
43805813|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
43805814|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
43805815|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
43805816|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805817|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805818|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
43805819|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
43805820|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805821|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43805822|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43805823|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43805824|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805842|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805843|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805844|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
43805845|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805846|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43805847|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43805867|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43805868|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805869|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805871|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43805872|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
43805873|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805874|NCT04920448|Expectorants|expectorants|mesh-ancestor
43805875|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
43805876|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43805877|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
43805878|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805879|NCT04920448|Protective Agents|protective agents|mesh-ancestor
43805880|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805881|NCT04920448|Antidotes|antidotes|mesh-ancestor
43805882|NCT04920500|Cytarabine|cytarabine|mesh-list
43805883|NCT04920500|Daunorubicin|daunorubicin|mesh-list
43805884|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43805885|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
43805886|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805887|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805888|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
43805889|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805890|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805901|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805902|NCT04919252|Vedolizumab|vedolizumab|mesh-list
43805911|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
43805912|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805913|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43805914|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43805963|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43805964|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43805965|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43805966|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805967|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43805968|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43805969|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805970|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
43805971|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
43805972|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
43805973|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43805975|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805976|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
43805977|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43805978|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
43805979|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805980|NCT04918719|Expectorants|expectorants|mesh-ancestor
43805981|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
43805982|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43805983|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
43805984|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805985|NCT04918719|Protective Agents|protective agents|mesh-ancestor
43805986|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805987|NCT04918719|Antidotes|antidotes|mesh-ancestor
43805988|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
43805989|NCT04918563|Acetylcholine|acetylcholine|mesh-list
43805990|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
43805991|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43805992|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
43805993|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805994|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805995|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806005|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806007|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43806008|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43806009|NCT04918953|Prednisolone|prednisolone|mesh-list
43806010|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
43806011|NCT04918953|Budesonide|budesonide|mesh-list
43806012|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43806013|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
43806014|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806015|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
43806016|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
43806110|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806111|NCT04917250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806112|NCT04917250|Immunologic Factors|immunologic factors|mesh-ancestor
43806113|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43806114|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43806115|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43843269|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843270|NCT04470843|Diuretics|diuretics|mesh-ancestor
43843271|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
43843272|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843273|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
43843274|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43806132|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806133|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
43806134|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43806135|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806136|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806137|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43806138|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43806139|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43806140|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43806141|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43806142|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43806143|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43806144|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43806145|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
43806146|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43806147|NCT04916821|Propolis|propolis|mesh-list
43806148|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806149|NCT04916522|Colchicine|colchicine|mesh-list
43806206|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806208|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
43806296|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806297|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43806298|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
43806299|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43806300|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806301|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
43806302|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43806303|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43806304|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43806305|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43806306|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43806307|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43806308|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43806309|NCT04914936|Antacids|antacids|mesh-ancestor
43806310|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806311|NCT04914390|Paclitaxel|paclitaxel|mesh-list
43806312|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43806313|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806314|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
43806315|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
43806316|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
43806317|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806318|NCT04914598|Cisplatin|cisplatin|mesh-list
43806400|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806401|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43806402|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
43806403|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806404|NCT04912271|Dexamethasone|dexamethasone|mesh-list
43806406|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
43806407|NCT04912271|Palonosetron|palonosetron|mesh-list
43806428|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43806429|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
43806430|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806431|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806432|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
43806433|NCT04912258|Irinotecan|irinotecan|mesh-list
43806434|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43806435|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43806436|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806437|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806438|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806439|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43806440|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
43806441|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806442|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
43806443|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43806444|NCT04912128|Growth Substances|growth substances|mesh-ancestor
43806445|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806446|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
43806447|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806448|NCT04911959|Lenvatinib|lenvatinib|mesh-list
43806449|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806450|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43617613|NCT03137615|Anesthetics|anesthetics|mesh-list
43843280|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
43806457|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806458|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
43806459|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43806460|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
43806461|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806462|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806463|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43806465|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
43843281|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
43843282|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843283|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843284|NCT04467905|Etripamil|etripamil|mesh-list
43843285|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43843286|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43843287|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843288|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43843289|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843290|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
43843291|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
43843292|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43843293|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43843294|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843332|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43843333|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43843334|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43843335|NCT04463615|Leflunomide|leflunomide|mesh-list
43843336|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843337|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843338|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843339|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
43843340|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843341|NCT04463030|Vitamins|vitamins|mesh-list
43843342|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
43843343|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
43843344|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806466|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
43806467|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43806468|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43806469|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806470|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
43806471|NCT04911413|Coagulants|coagulants|mesh-ancestor
43806472|NCT04911244|Dimercaprol|dimercaprol|mesh-list
43806473|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
43806474|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
43806475|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806476|NCT04910477|Atropine|atropine|mesh-list
43806477|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
43806478|NCT04910477|Neostigmine|neostigmine|mesh-list
43806479|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43806480|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806481|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806482|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43806483|NCT04910477|Analgesics|analgesics|mesh-ancestor
43806484|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
43806485|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806486|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43806487|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43806488|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43806489|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
43806490|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806491|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806492|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43806493|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43806494|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43806495|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
43806496|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43806497|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
43806498|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
43806499|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
43806500|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43806501|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43806502|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
43806503|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43806504|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806505|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43806506|NCT04910347|Nivolumab|nivolumab|mesh-list
43806507|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43806508|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806509|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43806510|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806511|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43806512|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806513|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
43806514|NCT04910594|Hematinics|hematinics|mesh-ancestor
43806515|NCT04910126|Doxorubicin|doxorubicin|mesh-list
43806516|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43806517|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43806518|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806519|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43806520|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43806564|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806566|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806567|NCT04909775|Gemcitabine|gemcitabine|mesh-list
43806568|NCT04909775|Cisplatin|cisplatin|mesh-list
43806569|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806570|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43806571|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
43806572|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806573|NCT04909775|Antiviral Agents|antiviral agents|mesh-ancestor
43806587|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43806588|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43806589|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43806590|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806591|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43806592|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43806593|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806594|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
43806595|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
43806596|NCT04909255|Mirabegron|mirabegron|mesh-list
43806597|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43806598|NCT04909255|Oxybutynin|oxybutynin|mesh-list
43806599|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43806600|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43806601|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
43806602|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806603|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806604|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806605|NCT04909255|Urological Agents|urological agents|mesh-ancestor
43806606|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43806607|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43806608|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43806609|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
43806610|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
43806611|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
43806612|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806621|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806622|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
43806623|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43843378|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43806684|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
43806685|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43806686|NCT04907474|Tropicamide|tropicamide|mesh-list
43806687|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43806688|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43806689|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
43806690|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
43806691|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806692|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806693|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
43806694|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43806695|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
43806696|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
43806697|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43806698|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43806699|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43806700|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
43806734|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806736|NCT04907344|Carboplatin|carboplatin|mesh-list
43806737|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43806738|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806739|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
43806740|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
43806741|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
43806742|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806743|NCT04906876|Gemcitabine|gemcitabine|mesh-list
43806744|NCT04906876|Docetaxel|docetaxel|mesh-list
43806745|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43806746|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
43806747|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806748|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806749|NCT04906876|Antiviral Agents|antiviral agents|mesh-ancestor
43806750|NCT04906876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806751|NCT04906876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806761|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43806762|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806763|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806764|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43806765|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
43806766|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
43806767|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43806768|NCT04906772|Analgesics|analgesics|mesh-ancestor
43806769|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
43806770|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806771|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43806781|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43806782|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43806783|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43806784|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
43806785|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806786|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806787|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806788|NCT04906915|Ketamine|ketamine|mesh-list
43806789|NCT04906915|Analgesics|analgesics|mesh-ancestor
43806790|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
43806791|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806792|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806793|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43806794|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43806795|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
43806797|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806798|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43806799|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43806800|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806801|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806803|NCT04906317|Dezocine|dezocine|mesh-list
43806804|NCT04906317|Propofol|propofol|mesh-list
43806831|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
43806832|NCT04906304|Cyclosporine|cyclosporine|mesh-list
43806834|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806835|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806836|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
43806837|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806838|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43806849|NCT04906083|Mitogens|mitogens|mesh-list
43806862|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806863|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
43806864|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806865|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806866|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43806867|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
43806868|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806869|NCT04905667|Trastuzumab|trastuzumab|mesh-list
43806870|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43806871|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806872|NCT04905563|Acetaminophen|acetaminophen|mesh-list
43806873|NCT04905563|Ibuprofen|ibuprofen|mesh-list
43806874|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43806875|NCT04905563|Hydrocodone|hydrocodone|mesh-list
43806876|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43806877|NCT04905563|Analgesics|analgesics|mesh-ancestor
43806878|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
43806879|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806880|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806881|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
43843432|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843433|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
43843434|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
43843435|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843436|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43843437|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843438|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
43843440|NCT04456699|Protective Agents|protective agents|mesh-ancestor
43843441|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
43843442|NCT04456699|Vitamins|vitamins|mesh-ancestor
43843443|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
43843457|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843458|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
43843459|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843460|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848721|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848722|NCT04001413|Durvalumab|durvalumab|mesh-list
43848723|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848724|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848725|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43848726|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
43848727|NCT03999216|Diuretics|diuretics|mesh-list
43848728|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43848729|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
43848730|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
43806893|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
43806894|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806895|NCT04905147|Mosapride|mosapride|mesh-list
43806896|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806910|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43806911|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
43806912|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806913|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806914|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43806915|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43806916|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43806917|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
43806918|NCT04904406|Lamivudine|lamivudine|mesh-list
43806919|NCT04904406|Abacavir|abacavir|mesh-list
43806920|NCT04904406|Dolutegravir|dolutegravir|mesh-list
43806922|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43806923|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806924|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806925|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
43806926|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806927|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43806928|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43806929|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43806930|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43806931|NCT04903847|Tenofovir|tenofovir|mesh-list
43806932|NCT04903847|Lamivudine|lamivudine|mesh-list
43806933|NCT04903847|Dolutegravir|dolutegravir|mesh-list
43806934|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
43806935|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806936|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43806937|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43806938|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806939|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806940|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43806941|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43806951|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43806952|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806953|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
43806954|NCT04903743|Bupivacaine|bupivacaine|mesh-list
43806955|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
43806956|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
43806957|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806958|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806959|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
43806960|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806961|NCT04903743|Analgesics|analgesics|mesh-ancestor
43806962|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43806963|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
43806964|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43806965|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43618302|NCT03132376|Caseins|caseins|mesh-list
43806966|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806967|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43806968|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
43806969|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43806970|NCT04903678|Melphalan|melphalan|mesh-list
43806971|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43806972|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
43806973|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806974|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806975|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43806976|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806977|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
43806978|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806979|NCT04903366|Timolol|timolol|mesh-list
43806984|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806985|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806986|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43806987|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43806989|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
43806990|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
43806991|NCT04903275|Protective Agents|protective agents|mesh-ancestor
43806992|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806993|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
43806994|NCT04903054|Prednisone|prednisone|mesh-list
43806995|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
43806996|NCT04903054|Tacrolimus|tacrolimus|mesh-list
43806997|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
43806998|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43806999|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807000|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
43807001|NCT04903054|Hormones|hormones|mesh-ancestor
43807002|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807003|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807004|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43807005|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807006|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807007|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
43807021|NCT04903054|Protective Agents|protective agents|mesh-ancestor
43807023|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
43807051|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807052|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43807053|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807054|NCT04902261|Gemcitabine|gemcitabine|mesh-list
43807055|NCT04902261|Paclitaxel|paclitaxel|mesh-list
43807056|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43807057|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807058|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
43807059|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
43807060|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
43807061|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807062|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43807063|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
43807064|NCT04902261|Antiviral Agents|antiviral agents|mesh-ancestor
43807065|NCT04902261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843466|NCT04452461|Gemcitabine|gemcitabine|mesh-list
43843467|NCT04452461|Paclitaxel|paclitaxel|mesh-list
43843468|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
43843469|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43843470|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843471|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
43843475|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43843476|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
43843477|NCT04452461|Antiviral Agents|antiviral agents|mesh-ancestor
43843478|NCT04452461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843479|NCT04452461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843480|NCT04452461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843481|NCT04452461|Immunologic Factors|immunologic factors|mesh-ancestor
43843482|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843483|NCT04452461|Antidotes|antidotes|mesh-ancestor
43843484|NCT04452461|Protective Agents|protective agents|mesh-ancestor
43843485|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
43843486|NCT04452461|Vitamins|vitamins|mesh-ancestor
43843487|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
43843488|NCT04450953|Eplerenone|eplerenone|mesh-list
43843489|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43843490|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
43843491|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807112|NCT04901923|Itraconazole|itraconazole|mesh-list
43807113|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
43807114|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
43807115|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807116|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43807117|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43807118|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807119|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807120|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43807121|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
43807122|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807123|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807124|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43807125|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807126|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43807127|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43807128|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807130|NCT04901663|Clarithromycin|clarithromycin|mesh-list
43807131|NCT04901663|Omeprazole|omeprazole|mesh-list
43807146|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
43807147|NCT04901117|Bismuth|bismuth|mesh-list
43807148|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807149|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807150|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807151|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43807152|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43807153|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43807154|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807155|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43807156|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43807158|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807159|NCT04901117|Diuretics|diuretics|mesh-ancestor
43807160|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
43807161|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807162|NCT04901117|Expectorants|expectorants|mesh-ancestor
43807163|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
43807164|NCT04901065|Lidocaine|lidocaine|mesh-list
43807165|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
43807166|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
43807167|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807168|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807169|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
43807170|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807171|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43807172|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43807173|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43807174|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43807175|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807176|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
43807177|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43807178|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43807194|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43807195|NCT04900948|Protective Agents|protective agents|mesh-ancestor
43807196|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43807198|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43807199|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807200|NCT04900948|Analgesics|analgesics|mesh-ancestor
43807201|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
43807202|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43807203|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
43807213|NCT04900532|Tocotrienols|tocotrienols|mesh-list
43807214|NCT04900532|Vitamin E|vitamin e|mesh-list
43807215|NCT04900532|Tocopherols|tocopherols|mesh-list
43807216|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
43807217|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807218|NCT04900532|Protective Agents|protective agents|mesh-ancestor
43807219|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807220|NCT04900532|Vitamins|vitamins|mesh-ancestor
43807221|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
43807222|NCT04900415|Vitamin A|vitamin a|mesh-list
43807223|NCT04900415|Vitamins|vitamins|mesh-ancestor
43807224|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
43807225|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807226|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
43807227|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43807228|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807229|NCT04900571|Renal Agents|renal agents|mesh-ancestor
43807230|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807231|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
43807232|NCT04900766|Analgesics|analgesics|mesh-ancestor
43807233|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
43807234|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807235|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807236|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807237|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43807238|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43807239|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807240|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807241|NCT04900311|Paclitaxel|paclitaxel|mesh-list
43807245|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43807247|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
43807248|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
43807249|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
43807250|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807251|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43807252|NCT04900155|Atorvastatin|atorvastatin|mesh-list
43807253|NCT04900155|Ezetimibe|ezetimibe|mesh-list
43807254|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43807255|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43807256|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
43807257|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807258|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43807259|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43807260|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807261|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
43807262|NCT04900129|Diclofenac|diclofenac|mesh-list
43807263|NCT04900129|Salicylates|salicylates|mesh-list
43807264|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
43807265|NCT04900129|Menthol|menthol|mesh-list
43807266|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43807267|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43807268|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807269|NCT04900129|Analgesics|analgesics|mesh-ancestor
43807270|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
43807271|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807272|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807273|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807274|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43807275|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43807276|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807277|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807278|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
43807279|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
43807280|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
43807281|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807338|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618702|NCT03129646|Paromomycin|paromomycin|mesh-list
43807340|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807341|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43807355|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
43807356|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43807357|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43807358|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43807389|NCT04898946|Vaccines|vaccines|mesh-list
43807390|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
43807391|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807392|NCT04899050|Cannabidiol|cannabidiol|mesh-list
43807393|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
43807394|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
43618800|NCT03128242|Oxytocin|oxytocin|mesh-list
43807395|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43807396|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807397|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
43807398|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
43807399|NCT04898751|Nivolumab|nivolumab|mesh-list
43807400|NCT04898751|Ipilimumab|ipilimumab|mesh-list
43807401|NCT04898751|Durvalumab|durvalumab|mesh-list
43807402|NCT04898751|Avelumab|avelumab|mesh-list
43807403|NCT04898751|Cemiplimab|cemiplimab|mesh-list
43807404|NCT04898751|Atezolizumab|atezolizumab|mesh-list
43807405|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43807406|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43807407|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807408|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843492|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843493|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43843494|NCT04450953|Diuretics|diuretics|mesh-ancestor
43843495|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
43843496|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43843497|NCT04450199|Vitamin D|vitamin d|mesh-list
43843498|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
43843499|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
43843500|NCT04450199|Vitamins|vitamins|mesh-list
43843501|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
43843502|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843503|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43843504|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43843505|NCT04448392|Valacyclovir|valacyclovir|mesh-list
43843506|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
43843507|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843508|NCT04447911|Empagliflozin|empagliflozin|mesh-list
43843509|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43843510|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843511|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43843512|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843513|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
43843514|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43843515|NCT04447352|Leucovorin|leucovorin|mesh-list
43843516|NCT04447352|Cisplatin|cisplatin|mesh-list
43843546|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43843547|NCT04444830|Analgesics|analgesics|mesh-ancestor
43843548|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
43843549|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843550|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843551|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843552|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43843553|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43843554|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843555|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807409|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
43807410|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43807411|NCT04898907|Mitogens|mitogens|mesh-list
43807412|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807413|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807414|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43807415|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43807416|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807417|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807418|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807419|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43807420|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
43807421|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43807422|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807446|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43807447|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43807448|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807449|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
43807450|NCT04898712|Coagulants|coagulants|mesh-ancestor
43807451|NCT04898387|Timolol|timolol|mesh-list
43807452|NCT04898387|Bimatoprost|bimatoprost|mesh-list
43807453|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43807454|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43807455|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
43807456|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807457|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807458|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807459|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43807460|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43807461|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
43807462|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807463|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43807464|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43807465|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
43807466|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807467|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
43807468|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
43807469|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807470|NCT04898023|Protective Agents|protective agents|mesh-ancestor
43807471|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807472|NCT04898023|Vitamins|vitamins|mesh-ancestor
43807473|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
43807474|NCT04898504|Floxuridine|floxuridine|mesh-list
43807475|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43807490|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
43807491|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43807492|NCT04897971|Antibodies|antibodies|mesh-list
43807493|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
43807494|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807495|NCT04897958|Leuprolide|leuprolide|mesh-list
43807496|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43807497|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
43807498|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43807499|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807500|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43807501|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807502|NCT04897854|Folfirinox|folfirinox|mesh-list
43807503|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807504|NCT04897737|Tenofovir|tenofovir|mesh-list
43807505|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
43807506|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807507|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43807508|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43807509|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807510|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807529|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43807530|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
43807531|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807532|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807533|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807534|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43807535|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
43807536|NCT04897269|Progesterone|progesterone|mesh-list
43807537|NCT04897269|Progestins|progestins|mesh-ancestor
43807538|NCT04897269|Hormones|hormones|mesh-ancestor
43807539|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807540|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807541|NCT04896359|Ascorbic Acid|ascorbic acid|mesh-list
43807542|NCT04896359|Vitamins|vitamins|mesh-ancestor
43807543|NCT04896359|Micronutrients|micronutrients|mesh-ancestor
43807544|NCT04896359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807545|NCT04896359|Antioxidants|antioxidants|mesh-ancestor
43807546|NCT04896359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807547|NCT04896359|Protective Agents|protective agents|mesh-ancestor
43807548|NCT04896177|Sirolimus|sirolimus|mesh-list
43807549|NCT04896177|Paclitaxel|paclitaxel|mesh-list
43807550|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43807551|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807552|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
43807553|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
43807554|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
43807555|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618997|NCT03126656|Hormones|hormones|mesh-ancestor
43807562|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807564|NCT04896125|Latanoprost|latanoprost|mesh-list
43807565|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43807566|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43807567|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43807569|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43807570|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807571|NCT04896164|Analgesics|analgesics|mesh-ancestor
43807572|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
43807573|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807574|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807575|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807576|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43807577|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807578|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807579|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843556|NCT04443673|Glycine|glycine|mesh-list
43843557|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
43843558|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843559|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843560|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843561|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
43619057|NCT03126188|Sertraline|sertraline|mesh-list
43807581|NCT04895657|Piperacillin|piperacillin|mesh-list
43807582|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43807583|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807584|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807585|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43807586|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807594|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43807595|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807596|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43807598|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807599|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807600|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
43807601|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807602|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43807603|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807604|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
43807749|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807750|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
43807751|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43807752|NCT04892511|Nitroprusside|nitroprusside|mesh-list
43807753|NCT04892511|Labetalol|labetalol|mesh-list
43807754|NCT04892511|Urapidil|urapidil|mesh-list
43807755|NCT04892511|Phenylephrine|phenylephrine|mesh-list
43807756|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43807757|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
43807758|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
43807759|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807760|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807761|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
43807762|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43807763|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
43807992|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
43807765|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43807766|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43807773|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
43807774|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43807775|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43807776|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43807777|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43807778|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43807779|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43807780|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
43843573|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843574|NCT04440371|Betamethasone|betamethasone|mesh-list
43843575|NCT04440371|Calcipotriene|calcipotriene|mesh-list
43843576|NCT04440371|Tacrolimus|tacrolimus|mesh-list
43843577|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843578|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
43843579|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843580|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43843588|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
43843590|NCT04440176|Vaccines|vaccines|mesh-list
43843591|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
43843592|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843593|NCT04439318|Trametinib|trametinib|mesh-list
43843594|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
43843595|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843596|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43843597|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843598|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843622|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807782|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43807783|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43807784|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807785|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807786|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43807787|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43807788|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
43807789|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807790|NCT04892563|Morphine|morphine|mesh-list
43807791|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43807792|NCT04892563|Narcotics|narcotics|mesh-ancestor
43807793|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807794|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807795|NCT04892563|Analgesics|analgesics|mesh-ancestor
43807796|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
43807797|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807798|NCT04892212|Sirolimus|sirolimus|mesh-list
43807799|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807800|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807801|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43807802|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807828|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807829|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43807830|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807831|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807832|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
43807833|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
43807834|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807835|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807836|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43807837|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43807838|NCT04891744|Growth Substances|growth substances|mesh-ancestor
43807839|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
43807840|NCT04891900|Capecitabine|capecitabine|mesh-list
43807841|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
43807842|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43807843|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43807844|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
43807845|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807846|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807847|NCT04891588|Timolol|timolol|mesh-list
43807848|NCT04891588|Latanoprost|latanoprost|mesh-list
43807849|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43807850|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43807851|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43807866|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
43807867|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43807868|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807869|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43807870|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807871|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
43807872|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
43807873|NCT04891458|Anesthetics|anesthetics|mesh-list
43807875|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807876|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807877|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43807878|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43807879|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
43807880|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807881|NCT04891458|Analgesics|analgesics|mesh-ancestor
43807882|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
43807883|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807884|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43807885|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43807886|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43807887|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
43807888|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807889|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807890|NCT04891211|Vitamin D|vitamin d|mesh-list
43807906|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807907|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
43807908|NCT04890626|Hormones|hormones|mesh-ancestor
43807909|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807910|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43807911|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807912|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
43807913|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807914|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807915|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
43807916|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807917|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43807918|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43807981|NCT04889768|Antibodies|antibodies|mesh-list
43807982|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
43807983|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807984|NCT04889781|Dexamethasone|dexamethasone|mesh-list
43807985|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
43807986|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807987|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
43807988|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
43807989|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807990|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807991|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808083|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
43808084|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
43808085|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808086|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808087|NCT04887818|Lidocaine|lidocaine|mesh-list
43808088|NCT04887818|Diltiazem|diltiazem|mesh-list
43808089|NCT04887818|Nifedipine|nifedipine|mesh-list
43808090|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
43808126|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
43808127|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808128|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43808129|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43808130|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43808131|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808132|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808133|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808134|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
43808135|NCT04887844|Hormones|hormones|mesh-ancestor
43843672|NCT04436913|Protective Agents|protective agents|mesh-ancestor
43843673|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843674|NCT04436250|Ketamine|ketamine|mesh-list
43843675|NCT04436250|Esketamine|esketamine|mesh-list
43843676|NCT04436250|Analgesics|analgesics|mesh-ancestor
43843677|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
43843678|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843679|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843680|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43843681|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43843682|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
43843683|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
43843684|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843685|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43843686|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43843687|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843688|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843689|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
43843690|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43843691|NCT04436107|Lenalidomide|lenalidomide|mesh-list
43808205|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808220|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
43808221|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808238|NCT04885803|Vitamin D|vitamin d|mesh-list
43808239|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
43808240|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
43808241|NCT04885803|Vitamins|vitamins|mesh-list
43808242|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
43808243|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808244|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43808245|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43808246|NCT04885270|Cisplatin|cisplatin|mesh-list
43808247|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808248|NCT04885426|Metformin|metformin|mesh-list
43808249|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43808250|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808251|NCT04885413|Niraparib|niraparib|mesh-list
43808252|NCT04885413|Antibodies|antibodies|mesh-list
43808253|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
43808254|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808255|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43808256|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808257|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808258|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808259|NCT04885153|Fenofibrate|fenofibrate|mesh-list
43808260|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43808261|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
43808262|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808263|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43808269|NCT04884906|Paclitaxel|paclitaxel|mesh-list
43843701|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808286|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43808288|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
43808289|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
43808290|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
43808291|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808292|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808293|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
43808294|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
43808295|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
43808296|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808297|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808298|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43808299|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43808300|NCT04884919|Chitosan|chitosan|mesh-list
43808301|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43808302|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43808303|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
43808304|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808305|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43808306|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
43808307|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
43808308|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
43808309|NCT04884919|Coagulants|coagulants|mesh-ancestor
43808310|NCT04885049|Racecadotril|racecadotril|mesh-list
43808311|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
43808312|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808313|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
43808314|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808315|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808316|NCT04884503|Clonazepam|clonazepam|mesh-list
43808317|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
43808318|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
43808319|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
43808320|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808322|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808328|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43808329|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808330|NCT04884490|Renal Agents|renal agents|mesh-ancestor
43808331|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43808332|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
43808333|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43808334|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43843702|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843704|NCT04434664|Amlodipine|amlodipine|mesh-list
43843705|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43843706|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43843707|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43843708|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843709|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43843710|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843711|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
43843712|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43843713|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
43843714|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
43843715|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843716|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43843717|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43843718|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43848736|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848737|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43808336|NCT04884282|Nivolumab|nivolumab|mesh-list
43808337|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808338|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
43808339|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
43808340|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808341|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808342|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808343|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43808344|NCT04883996|Pilocarpine|pilocarpine|mesh-list
43808345|NCT04883996|Miotics|miotics|mesh-ancestor
43808346|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
43808347|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808348|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808349|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43808350|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43808351|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
43808352|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808353|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808354|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
43808355|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43808356|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
43808357|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43808358|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808359|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
43808360|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
43808361|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43808362|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
43808363|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808364|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
43808365|NCT04884464|Protective Agents|protective agents|mesh-ancestor
43808366|NCT04883736|Tretinoin|tretinoin|mesh-list
43808368|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
43808374|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
43808382|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43808383|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43808384|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808385|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808386|NCT04882826|Urological Agents|urological agents|mesh-ancestor
43808437|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808438|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808439|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
43808441|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808442|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43808443|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43808444|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
43808445|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808446|NCT04882163|Antiviral Agents|antiviral agents|mesh-ancestor
43808447|NCT04882163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808448|NCT04882163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808449|NCT04882163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808450|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43808451|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43808452|NCT04882163|Growth Substances|growth substances|mesh-ancestor
43808453|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
43808454|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43808455|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
43808456|NCT04881942|Menthol|menthol|mesh-list
43808457|NCT04881942|Nicotine|nicotine|mesh-list
43808458|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43808459|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
43808460|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808461|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808462|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43808463|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43808464|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
43808465|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808466|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808467|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
43808468|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
43808469|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
43808470|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808471|NCT04881747|Lasmiditan|lasmiditan|mesh-list
43808472|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43808473|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
43808474|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808475|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808476|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808477|NCT04881474|Ibuprofen|ibuprofen|mesh-list
43808478|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43808479|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43808480|NCT04881474|Analgesics|analgesics|mesh-ancestor
43808481|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
43843733|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843734|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
43843735|NCT04429893|Bupivacaine|bupivacaine|mesh-list
43843736|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
43843737|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
43843738|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843739|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843740|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
43843741|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843742|NCT04429893|Analgesics|analgesics|mesh-ancestor
43843743|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43843744|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
43843745|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43843746|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43843747|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843748|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43843749|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
43843750|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43843752|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43843753|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
43843754|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843755|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843756|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43843757|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
43843758|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43620114|NCT05451550|Anesthetics|anesthetics|mesh-list
43808500|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
43808501|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43808502|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808503|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43808504|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808512|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43808513|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808514|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43808515|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808516|NCT04880746|Cladribine|cladribine|mesh-list
43808517|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808518|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808519|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
43808520|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808521|NCT04880811|Afatinib|afatinib|mesh-list
43808522|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808523|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43808524|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808525|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808526|NCT04879446|Mitogens|mitogens|mesh-list
43808527|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808528|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808529|NCT04879511|Metformin|metformin|mesh-list
43808530|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43808531|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808532|NCT04879420|Teriparatide|teriparatide|mesh-list
43808533|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
43808534|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43808535|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808536|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43808537|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43808538|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808539|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808540|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43808541|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43808542|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43808543|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808544|NCT04879407|Warfarin|warfarin|mesh-list
43808545|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
43808550|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
43808551|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808552|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808553|NCT04879004|Ropivacaine|ropivacaine|mesh-list
43808554|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
43808555|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
43808556|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808557|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808558|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
43808559|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808560|NCT04878926|Midazolam|midazolam|mesh-list
43808561|NCT04878926|Propofol|propofol|mesh-list
43808562|NCT04878926|Anesthetics|anesthetics|mesh-list
43808563|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
43808564|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43808565|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808566|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808567|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43808568|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
43808569|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43808570|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43808600|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43808601|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808602|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808603|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808604|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43808605|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43808606|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43808608|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43808609|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43808610|NCT04878835|Ranibizumab|ranibizumab|mesh-list
43808611|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43808612|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43808613|NCT04878835|Growth Substances|growth substances|mesh-ancestor
43808614|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808630|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43808631|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808633|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
43808634|NCT04878497|Dabigatran|dabigatran|mesh-list
43808635|NCT04878497|Apixaban|apixaban|mesh-list
43808636|NCT04878497|Edoxaban|edoxaban|mesh-list
43808637|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
43808638|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43808640|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43808641|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
43808642|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808643|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843759|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843760|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843761|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43843762|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
43843764|NCT04429347|Tizanidine|tizanidine|mesh-list
43843765|NCT04429347|Analgesics|analgesics|mesh-ancestor
43843766|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
43843767|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843768|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843769|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
43843770|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43843771|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43843772|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843773|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43843775|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43843793|NCT04428008|Thymalfasin|thymalfasin|mesh-list
43808644|NCT04878016|Carboplatin|carboplatin|mesh-list
43808646|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808647|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43808648|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43808649|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43808650|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808651|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808652|NCT05257993|Gemcitabine|gemcitabine|mesh-list
43808653|NCT05257993|Paclitaxel|paclitaxel|mesh-list
43808654|NCT05257993|Folfirinox|folfirinox|mesh-list
43808655|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43808656|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808657|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
43808658|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
43808659|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808660|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808661|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43808662|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
43808663|NCT05257993|Antiviral Agents|antiviral agents|mesh-ancestor
43808664|NCT05257993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808665|NCT05257993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808666|NCT05257993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808667|NCT05257993|Immunologic Factors|immunologic factors|mesh-ancestor
43808668|NCT05257993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808669|NCT05257902|Choline|choline|mesh-list
43808670|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
43808690|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
43808691|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808692|NCT05257291|Protective Agents|protective agents|mesh-ancestor
43808693|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808694|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808695|NCT05256953|Anesthetics|anesthetics|mesh-list
43808696|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808697|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808698|NCT05256758|Fenofibrate|fenofibrate|mesh-list
43808699|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43808700|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
43808701|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808750|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
43808751|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808752|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808753|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808754|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808755|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43808756|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808757|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808758|NCT05255913|Fluorides|fluorides|mesh-list
43808759|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
43808760|NCT05255913|Protective Agents|protective agents|mesh-ancestor
43808761|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808762|NCT05255848|Heparin|heparin|mesh-list
43808763|NCT05255848|Calcium heparin|calcium heparin|mesh-list
43808764|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
43808765|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43808769|NCT05231941|Ropivacaine|ropivacaine|mesh-list
43808770|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
43808771|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
43808772|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808773|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808774|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
43808775|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808776|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43808777|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43620467|NCT04318704|Ifenprodil|ifenprodil|mesh-list
43808778|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43808779|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808780|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808781|NCT05216575|Almitrine|almitrine|mesh-list
43808782|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
43808783|NCT05214417|Ketamine|ketamine|mesh-list
43808784|NCT05214417|Analgesics|analgesics|mesh-ancestor
43808785|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
43808786|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808787|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808788|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43808789|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43808790|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
43808791|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
43808792|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808793|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43808794|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43808795|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808796|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808797|NCT05205252|Dexamethasone|dexamethasone|mesh-list
43808798|NCT05205252|Lenalidomide|lenalidomide|mesh-list
43808799|NCT05205252|Daratumumab|daratumumab|mesh-list
43808800|NCT05205252|Pomalidomide|pomalidomide|mesh-list
43808801|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
43808802|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43808803|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808804|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
43808805|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
43808806|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808807|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808808|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808809|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
43808810|NCT05205252|Hormones|hormones|mesh-ancestor
43808811|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808817|NCT05205252|Growth Substances|growth substances|mesh-ancestor
43808818|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
43843794|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43843795|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
43843796|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843798|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43843799|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43843800|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43843801|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
43843802|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
43843803|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843804|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
43843805|NCT04425655|Fludarabine|fludarabine|mesh-list
43843806|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843807|NCT04425382|Ritonavir|ritonavir|mesh-list
43843808|NCT04425382|Lopinavir|lopinavir|mesh-list
43843809|NCT04425382|Darunavir|darunavir|mesh-list
43843810|NCT04425382|Cobicistat|cobicistat|mesh-list
43843811|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43843812|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43843813|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43843814|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
43843815|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808835|NCT05028608|Carbamazepine|carbamazepine|mesh-list
43808836|NCT05028608|Midazolam|midazolam|mesh-list
43808837|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43843848|NCT04424654|Androgens|androgens|mesh-ancestor
43808838|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43808839|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808840|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808841|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43808842|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43808843|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43808844|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43808845|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
43808846|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
43808847|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
43808848|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
43808849|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808850|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808851|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
43808893|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808894|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
43808895|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808896|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43808897|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43808898|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43808899|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808900|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808901|NCT04550195|Famotidine|famotidine|mesh-list
43808902|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43808903|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808904|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43808905|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
43808906|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
43808907|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808908|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808909|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808910|NCT04537962|Listerine|listerine|mesh-list
43808911|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
43808912|NCT04537962|Fluorides|fluorides|mesh-list
43808913|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
43808914|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
43808915|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
43808916|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
43808917|NCT04537962|Protective Agents|protective agents|mesh-ancestor
43808918|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808919|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43808920|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808921|NCT04525391|Durvalumab|durvalumab|mesh-list
43808922|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808938|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
43808940|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808941|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
43808942|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808943|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808944|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43808945|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
43808946|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808947|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808948|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43808949|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43808950|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43808951|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43808952|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808953|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43808954|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808955|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43808956|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
43808957|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43808958|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43808959|NCT04469530|Analgesics|analgesics|mesh-ancestor
43808960|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
43808961|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808962|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808965|NCT04425291|Vaccines|vaccines|mesh-list
43808985|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808986|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808987|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43808988|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808989|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43808993|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43808994|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
43808995|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43808996|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
43808997|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
43808998|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808999|NCT04371445|Dexamethasone|dexamethasone|mesh-list
43809000|NCT04371445|Prednisolone|prednisolone|mesh-list
43809001|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43809002|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
43809003|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43809004|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
43809005|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43848738|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43809015|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809016|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43809018|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43809019|NCT04371445|Protective Agents|protective agents|mesh-ancestor
43809020|NCT04337073|Propofol|propofol|mesh-list
43809021|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43809022|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809023|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809024|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43809025|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
43809026|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
43809068|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43809069|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809070|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809071|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809073|NCT03871049|Bupivacaine|bupivacaine|mesh-list
43809074|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809075|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
43809076|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
43809077|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809078|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809079|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809080|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
43809081|NCT03871049|Hormones|hormones|mesh-ancestor
43809082|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809083|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43809084|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809085|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
43809086|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
43620784|NCT02425891|Paclitaxel|paclitaxel|mesh-list
43809087|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809088|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
43809089|NCT03849625|Aspirin|aspirin|mesh-list
43809090|NCT03849625|Acetaminophen|acetaminophen|mesh-list
43809091|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43809092|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809093|NCT03849625|Analgesics|analgesics|mesh-ancestor
43809094|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
43809097|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843832|NCT04425070|Antiviral Agents|antiviral agents|mesh-ancestor
43843833|NCT04425070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843834|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843835|NCT04425070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843836|NCT04425070|Immunologic Factors|immunologic factors|mesh-ancestor
43843837|NCT04425070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843838|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43843839|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43843840|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43843841|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43843842|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
43843843|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
43843844|NCT04424654|Testosterone|testosterone|mesh-list
43843845|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
43843846|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
43843847|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43843850|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843851|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843852|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843853|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843854|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
43843855|NCT04423731|Leucovorin|leucovorin|mesh-list
43843856|NCT04423731|Gemcitabine|gemcitabine|mesh-list
43843857|NCT04423731|Paclitaxel|paclitaxel|mesh-list
43843858|NCT04423731|Fluorouracil|fluorouracil|mesh-list
43843859|NCT04423731|Folfirinox|folfirinox|mesh-list
43843860|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43843861|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843862|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
43843863|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
43843864|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
43843865|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843866|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43843872|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
43843873|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843874|NCT04423731|Antidotes|antidotes|mesh-ancestor
43843875|NCT04423731|Protective Agents|protective agents|mesh-ancestor
43843876|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
43843877|NCT04423731|Vitamins|vitamins|mesh-ancestor
43843878|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
43843879|NCT04421820|Leucovorin|leucovorin|mesh-list
43843880|NCT04421820|Fluorouracil|fluorouracil|mesh-list
43843881|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
43843882|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
43843883|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809112|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809113|NCT03612973|Insulin|insulin|mesh-list
43809114|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43809115|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809116|NCT03589014|Propranolol|propranolol|mesh-list
43809117|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43809159|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43809160|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
43809161|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809163|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
43809164|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43809165|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
43809166|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809167|NCT03154580|Protective Agents|protective agents|mesh-ancestor
43809168|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809169|NCT03154580|Antidotes|antidotes|mesh-ancestor
43809170|NCT03123978|Niclosamide|niclosamide|mesh-list
43809171|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
43809172|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43809173|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
43809174|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43809175|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809176|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
43809177|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43809178|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809179|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43809180|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809181|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809182|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
43809183|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43809184|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43809185|NCT01838174|Prednisolone|prednisolone|mesh-list
43809186|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
43809187|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43809188|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
43809189|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809190|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
43809191|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
43809192|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809193|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809194|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809195|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
43809196|NCT01838174|Hormones|hormones|mesh-ancestor
43809197|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809198|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43809199|NCT01838174|Protective Agents|protective agents|mesh-ancestor
43809200|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43809201|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809213|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809214|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43809215|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43809216|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43809217|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
43809218|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809219|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809220|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
43809221|NCT00566618|Dasatinib|dasatinib|mesh-list
43809228|NCT04877626|Artesunate|artesunate|mesh-list
43809247|NCT04877509|Protective Agents|protective agents|mesh-ancestor
43809248|NCT04877509|Trace Elements|trace elements|mesh-ancestor
43809249|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43809250|NCT04877210|Insulin|insulin|mesh-list
43809251|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43809252|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43809253|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809254|NCT04877106|Metformin|metformin|mesh-list
43809255|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43809256|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43809257|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809259|NCT04877106|Hormones|hormones|mesh-ancestor
43809260|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809261|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43809262|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
43809263|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809265|NCT04876716|Voriconazole|voriconazole|mesh-list
43809286|NCT04876859|Anesthetics|anesthetics|mesh-list
43809287|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809288|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809289|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
43809290|NCT04876807|Omeprazole|omeprazole|mesh-list
43809291|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43809292|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809293|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43809294|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809295|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809296|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809297|NCT04876313|Paclitaxel|paclitaxel|mesh-list
43809298|NCT04876313|Nivolumab|nivolumab|mesh-list
43809299|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43809300|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809301|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
43809302|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
43809303|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
43809304|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809305|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43809306|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43809307|NCT04876755|TEMPO|tempo|mesh-list
43809308|NCT04876755|TEMPOL-H|tempol-h|mesh-list
43809309|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
43809310|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809311|NCT04876755|Protective Agents|protective agents|mesh-ancestor
43809312|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809313|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43809314|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
43809315|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
43809316|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
43809317|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809318|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43809319|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
43809320|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
43809321|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809324|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43809325|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
43809326|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43809327|NCT04876521|Olanzapine|olanzapine|mesh-list
43809328|NCT04876521|Amisulpride|amisulpride|mesh-list
43809329|NCT04876521|Fluoxetine|fluoxetine|mesh-list
43809330|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
43809331|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
43809332|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809333|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809334|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809335|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43809336|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43809337|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809338|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43809339|NCT04876521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43809340|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43809341|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43809342|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809343|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809344|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
43809345|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43809346|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
43809347|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43809348|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43809349|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809350|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43809351|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
43809352|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
43809353|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809355|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809356|NCT04876261|Protective Agents|protective agents|mesh-ancestor
43809357|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809358|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43843884|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43843885|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843886|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843887|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
43843888|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843889|NCT04421820|Antidotes|antidotes|mesh-ancestor
43843890|NCT04421820|Protective Agents|protective agents|mesh-ancestor
43843891|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
43843892|NCT04421820|Vitamins|vitamins|mesh-ancestor
43843893|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
43843894|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
43843895|NCT04421196|Analgesics|analgesics|mesh-list
43843896|NCT04421196|Narcotics|narcotics|mesh-ancestor
43843897|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843898|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843899|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
43843900|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843901|NCT04419181|Carboplatin|carboplatin|mesh-list
43843902|NCT04419181|Docetaxel|docetaxel|mesh-list
43843903|NCT04419181|Trastuzumab|trastuzumab|mesh-list
43843904|NCT04419181|Pertuzumab|pertuzumab|mesh-list
43843905|NCT04419181|Maytansine|maytansine|mesh-list
43843906|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43843907|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843908|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
43843909|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
43843910|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
43843911|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843912|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843913|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43843914|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43843919|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843920|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843921|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43843922|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
43843923|NCT04418999|Hormones|hormones|mesh-ancestor
43843924|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809731|NCT04871269|Analgesics|analgesics|mesh-ancestor
43809360|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43809361|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
43809362|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809363|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43809364|NCT04875702|Allopurinol|allopurinol|mesh-list
43809365|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
43809366|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809367|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809368|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
43809369|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809370|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43809371|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
43809372|NCT04875702|Protective Agents|protective agents|mesh-ancestor
43809373|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809374|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43809375|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
43809376|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809377|NCT04875611|Nivolumab|nivolumab|mesh-list
43809378|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43809379|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809382|NCT04874844|Antibodies|antibodies|mesh-list
43809384|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
43809385|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809386|NCT04875039|Dexamethasone|dexamethasone|mesh-list
43809387|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
43809388|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
43809389|NCT04875039|BB 1101|bb 1101|mesh-list
43809390|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809391|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
43809392|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
43809393|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809394|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809395|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809396|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
43809397|NCT04875039|Hormones|hormones|mesh-ancestor
43809398|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809399|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43809400|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809401|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
43809402|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809403|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809404|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43809405|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809406|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809407|NCT04875039|Analgesics|analgesics|mesh-ancestor
43809408|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
43809409|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43809410|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43809411|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43809412|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
43809413|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809414|NCT04874688|Provitamins|provitamins|mesh-list
43809415|NCT04874688|Beta Carotene|beta carotene|mesh-list
43809416|NCT04874688|Vitamins|vitamins|mesh-ancestor
43809417|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
43809418|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809419|NCT04874675|Acetaminophen|acetaminophen|mesh-list
43809424|NCT04874675|Analgesics|analgesics|mesh-ancestor
43809425|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
43809426|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809428|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
43809429|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43809430|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809431|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809432|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43809433|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809434|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809435|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43809436|NCT04874675|Narcotics|narcotics|mesh-ancestor
43809437|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809438|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
43809439|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
43809440|NCT04874506|TEMPO|tempo|mesh-list
43809441|NCT04874506|TEMPOL-H|tempol-h|mesh-list
43809442|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
43809443|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809444|NCT04874506|Protective Agents|protective agents|mesh-ancestor
43809445|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809446|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43809447|NCT04874246|Vasopressins|vasopressins|mesh-list
43809448|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
43809449|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
43809458|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
43809459|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43809460|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
43809461|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809462|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809463|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
43809464|NCT04873531|Neostigmine|neostigmine|mesh-list
43809465|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43809466|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809467|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809468|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
43809469|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809470|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809471|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43809472|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
43809473|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809474|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
43809475|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
43809476|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809477|NCT04873440|Manganese|manganese|mesh-list
43809478|NCT04873440|Trace Elements|trace elements|mesh-ancestor
43809479|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
43809480|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809481|NCT04873479|Ketamine|ketamine|mesh-list
43809482|NCT04873479|Esketamine|esketamine|mesh-list
43809483|NCT04873479|Analgesics|analgesics|mesh-ancestor
43809484|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
43809485|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809486|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809487|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43809488|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43809489|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
43809490|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
43809491|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809499|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809500|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43809501|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
43809502|NCT04873284|Dexamethasone|dexamethasone|mesh-list
43809503|NCT04873284|Aprepitant|aprepitant|mesh-list
43809504|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
43809505|NCT04873284|Granisetron|granisetron|mesh-list
43809506|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809507|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
43809508|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
43809509|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809510|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809511|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809512|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
43809513|NCT04873284|Hormones|hormones|mesh-ancestor
43809514|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809515|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43809516|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809517|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43809518|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809519|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809520|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43809521|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
43809522|NCT04873102|Danazol|danazol|mesh-list
43809523|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43809524|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
43809526|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809547|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
43809548|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
43809549|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
43809550|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809551|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43809552|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
43809553|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809554|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809555|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43809556|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
43809557|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43809558|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43809559|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43809560|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43809561|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843932|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
43843933|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843934|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
43843935|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809585|NCT04872634|Cetuximab|cetuximab|mesh-list
43809586|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43809587|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809588|NCT04872270|Caffeine|caffeine|mesh-list
43809589|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43809590|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809591|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43809592|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809594|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43809595|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43809596|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
43809597|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809598|NCT04872192|Anesthetics|anesthetics|mesh-list
43809599|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809600|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809601|NCT04872231|Voriconazole|voriconazole|mesh-list
43809602|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
43809603|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809604|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43809605|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43809606|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809607|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809608|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43809609|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
43809610|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809611|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809612|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43809627|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43809628|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43809629|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809630|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43809631|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43809632|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809634|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43809635|NCT04872283|Narcotics|narcotics|mesh-ancestor
43621461|NCT03116087|Hormones|hormones|mesh-ancestor
43809636|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809637|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
43809638|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43809639|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
43809640|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43809641|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809642|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43809643|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43809644|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43809645|NCT04872322|Ropivacaine|ropivacaine|mesh-list
43809669|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809670|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43809671|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43809673|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43809674|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809675|NCT04871802|Analgesics|analgesics|mesh-ancestor
43809676|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
43809677|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809678|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809679|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809680|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809681|NCT04871633|Azithromycin|azithromycin|mesh-list
43809682|NCT04871633|Remdesivir|remdesivir|mesh-list
43809683|NCT04871633|Dexamethasone|dexamethasone|mesh-list
43809684|NCT04871633|Prednisolone|prednisolone|mesh-list
43809685|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43809686|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809687|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
43809688|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
43809689|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809690|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809691|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809692|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
43809693|NCT04871633|Hormones|hormones|mesh-ancestor
43809702|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
43809723|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43809724|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43809725|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
43809726|NCT04871269|Dronabinol|dronabinol|mesh-list
43809727|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
43809728|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809729|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43809730|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809742|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43809743|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809744|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809745|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43809746|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43809747|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809748|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
43809767|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809769|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43809770|NCT04870489|Isotretinoin|isotretinoin|mesh-list
43809771|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
43809772|NCT04870541|Nefopam|nefopam|mesh-list
43809773|NCT04870541|Ondansetron|ondansetron|mesh-list
43809774|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
43809775|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
43809776|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809777|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809778|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809779|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
43809780|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
43809781|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43809782|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
43809783|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809784|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809785|NCT04870541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43809786|NCT04870541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43809787|NCT04870541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809788|NCT04870541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43809789|NCT04870541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43809790|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809791|NCT04870541|Analgesics|analgesics|mesh-ancestor
43809792|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
43809793|NCT04870502|Clomiphene|clomiphene|mesh-list
43809794|NCT04870502|Enclomiphene|enclomiphene|mesh-list
43809795|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
43809796|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43809797|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
43809798|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809799|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809801|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
43809809|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809810|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43809811|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809812|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809813|NCT04870060|Curcumin|curcumin|mesh-list
43809814|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43809815|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809817|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
43809818|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809819|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809820|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809821|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809822|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809823|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809824|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809825|NCT04870073|Mannitol|mannitol|mesh-list
43809826|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43809827|NCT04870073|Diuretics|diuretics|mesh-ancestor
43843952|NCT04416451|Rituximab|rituximab|mesh-list
43843961|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43843962|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43843963|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843964|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843965|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843966|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43843969|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43843970|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843971|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843972|NCT04413266|Curcumin|curcumin|mesh-list
43843973|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43843974|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43843975|NCT04413266|Analgesics|analgesics|mesh-ancestor
43843976|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
43843977|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843978|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843979|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843980|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43843981|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843982|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843983|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843984|NCT04413123|Nivolumab|nivolumab|mesh-list
43843985|NCT04413123|Ipilimumab|ipilimumab|mesh-list
43843986|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843987|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843988|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43848754|NCT03997968|Antiviral Agents|antiviral agents|mesh-ancestor
43848755|NCT03997968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848756|NCT03997968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809830|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
43809831|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809833|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809834|NCT04869579|Selenium|selenium|mesh-list
43809835|NCT04869579|Selenious Acid|selenious acid|mesh-list
43809836|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
43809837|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809838|NCT04869579|Protective Agents|protective agents|mesh-ancestor
43809839|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809840|NCT04869579|Trace Elements|trace elements|mesh-ancestor
43809841|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
43809842|NCT04869709|Betamethasone|betamethasone|mesh-list
43809843|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
43809844|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43809845|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
43809846|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43809847|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809848|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
43809849|NCT04869709|Hormones|hormones|mesh-ancestor
43809850|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809851|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809852|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43809853|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
43809854|NCT04869176|Caffeine|caffeine|mesh-list
43809866|NCT04869046|Ibuprofen|ibuprofen|mesh-list
43809875|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809876|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809877|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43809878|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809879|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809880|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
43809881|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
43809882|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809883|NCT04868903|Vitamin D|vitamin d|mesh-list
43809884|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
43809885|NCT04868903|Vitamins|vitamins|mesh-ancestor
43809886|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
43809887|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809888|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43809889|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43809891|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43809892|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809893|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43809894|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
43809895|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43809896|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809897|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809898|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809899|NCT04868552|Naloxone|naloxone|mesh-list
43809900|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43809901|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809902|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
43809903|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809921|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809922|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43809923|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43809924|NCT04868227|Vitamin D|vitamin d|mesh-list
43809925|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
43809926|NCT04868227|Vitamins|vitamins|mesh-ancestor
43809927|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
43809928|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809929|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43809930|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43809931|NCT04868019|Fenofibrate|fenofibrate|mesh-list
43809932|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43809933|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
43809934|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809935|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43809936|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
43809937|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
43809938|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43809939|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809940|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43809941|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43809942|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809943|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809944|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809945|NCT04868253|Oxazepam|oxazepam|mesh-list
43809946|NCT04868253|Metyrapone|metyrapone|mesh-list
43809947|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
43809948|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809949|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809950|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43809951|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809952|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809953|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43809954|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43809962|NCT04868058|Ropivacaine|ropivacaine|mesh-list
43809963|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
43809964|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
43809965|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809966|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809967|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
43809968|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809969|NCT04867720|Everolimus|everolimus|mesh-list
43809970|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809971|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43809972|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
43809973|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809974|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
43809975|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809976|NCT04867226|Colchicine|colchicine|mesh-list
43809977|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
43809978|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809979|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
43809980|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
43809981|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
43809982|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809983|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809984|NCT04867252|Inositol|inositol|mesh-list
43809985|NCT04867252|Metformin|metformin|mesh-list
43809986|NCT04867252|Pioglitazone|pioglitazone|mesh-list
43809987|NCT04867252|Resveratrol|resveratrol|mesh-list
43809988|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43809989|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809990|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
43810025|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43844000|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844015|NCT04411836|Tafenoquine|tafenoquine|mesh-list
43844016|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
43844017|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43844018|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43844019|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844020|NCT04411758|Propolis|propolis|mesh-list
43844021|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809998|NCT04866498|Analgesics|analgesics|mesh-list
43809999|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
43810000|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810001|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810002|NCT04866654|Nivolumab|nivolumab|mesh-list
43810003|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810009|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43810010|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43810011|NCT04866355|Analgesics|analgesics|mesh-ancestor
43810012|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
43810013|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810014|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810015|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810016|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43810017|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43810018|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810019|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810020|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43810021|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
43810022|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
43810023|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43810024|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
43810029|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
43810030|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810031|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810032|NCT04865900|Antibodies|antibodies|mesh-list
43810033|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
43810034|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810035|NCT04865848|Anesthetics|anesthetics|mesh-list
43810056|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43810057|NCT04865510|Heparin|heparin|mesh-list
43810058|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
43810059|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810060|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43810061|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43810062|NCT04865211|Bupivacaine|bupivacaine|mesh-list
43810063|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
43810064|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
43810065|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810066|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810067|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
43810068|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810069|NCT04865445|Midazolam|midazolam|mesh-list
43810070|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43810071|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43810072|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810073|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810074|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43810075|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43810076|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43810077|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43810078|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
43810079|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
43810080|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
43810081|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
43810082|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810083|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810084|NCT04865250|Paclitaxel|paclitaxel|mesh-list
43810085|NCT04865250|Carboplatin|carboplatin|mesh-list
43810086|NCT04865250|Atezolizumab|atezolizumab|mesh-list
43810087|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43810088|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810097|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
43810098|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810099|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810100|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810101|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43810102|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
43810103|NCT04865562|Testosterone|testosterone|mesh-list
43810104|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
43810105|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
43810106|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43810107|NCT04865562|Androgens|androgens|mesh-ancestor
43810108|NCT04865562|Hormones|hormones|mesh-ancestor
43810109|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810110|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810111|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43810112|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810113|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
43810114|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
43810115|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43810116|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43810117|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810118|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
43810119|NCT04865380|Coagulants|coagulants|mesh-ancestor
43810120|NCT04865185|Ethanol|ethanol|mesh-list
43810121|NCT04865185|Lidocaine|lidocaine|mesh-list
43810122|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43810128|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
43810129|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810130|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43810131|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43810132|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43810133|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43844041|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
43810134|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810136|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43810137|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810138|NCT04864782|Paclitaxel|paclitaxel|mesh-list
43810139|NCT04864782|Cisplatin|cisplatin|mesh-list
43810140|NCT04864782|Carboplatin|carboplatin|mesh-list
43810141|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43810142|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810143|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
43810144|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
43810145|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
43810146|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622033|NCT03111433|Ubiquinone|ubiquinone|mesh-list
43810147|NCT04864717|Doxycycline|doxycycline|mesh-list
43810148|NCT04864717|Isotretinoin|isotretinoin|mesh-list
43810149|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43810150|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810151|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
43810152|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43810153|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43810154|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
43810155|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43810156|NCT04864379|Molgramostim|molgramostim|mesh-list
43810157|NCT04864379|Sargramostim|sargramostim|mesh-list
43810158|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810159|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810160|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
43810161|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810162|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
43810163|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43810164|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
43810165|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810166|NCT04864314|Protective Agents|protective agents|mesh-ancestor
43810169|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
43810170|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810171|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43810172|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43810173|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810174|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810175|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43810176|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43810178|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
43810179|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810180|NCT04864509|Protective Agents|protective agents|mesh-ancestor
43810181|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810182|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810183|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
43810184|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43810185|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
43810186|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810187|NCT04864496|Expectorants|expectorants|mesh-ancestor
43810188|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
43810189|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43810190|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
43810191|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810192|NCT04864496|Protective Agents|protective agents|mesh-ancestor
43810193|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810194|NCT04864496|Antidotes|antidotes|mesh-ancestor
43844022|NCT04411654|Sirolimus|sirolimus|mesh-list
43844023|NCT04411654|Prednisone|prednisone|mesh-list
43844024|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
43844025|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43844026|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43844027|NCT04411654|Prednisolone|prednisolone|mesh-list
43844028|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
43844029|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43844030|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
43844031|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844032|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
43844034|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844035|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844036|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43844037|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844038|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43844039|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844040|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43810254|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
43810255|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810256|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43810257|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810258|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810259|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
43810260|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810261|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810262|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43810264|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810265|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43810266|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43810267|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
43810268|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810269|NCT04862845|Pregabalin|pregabalin|mesh-list
43810270|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43810271|NCT04862845|Analgesics|analgesics|mesh-ancestor
43810272|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
43810273|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810274|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810275|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
43810276|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43810277|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43810278|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627431|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
43810279|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43810281|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43810282|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810283|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43810284|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43810285|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43810286|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810287|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
43810288|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
43810289|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
43810290|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810291|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43810292|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810293|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810294|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
43810295|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810296|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810297|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43810299|NCT04862377|Poractant alfa|poractant alfa|mesh-list
43810300|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810301|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43810302|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
43810303|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810304|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810305|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43844054|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
43844055|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844056|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844057|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844058|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844069|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844070|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844071|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
43844072|NCT04410653|Afatinib|afatinib|mesh-list
43844075|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844076|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844077|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
43844078|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43844079|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844080|NCT04409002|Niraparib|niraparib|mesh-list
43844081|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43844082|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844083|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844084|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844085|NCT04408560|Acetaminophen|acetaminophen|mesh-list
43844086|NCT04408560|Analgesics|analgesics|mesh-list
43844087|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844088|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
43844089|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844090|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844091|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
43844092|NCT04407650|Metformin|metformin|mesh-list
43844093|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43844094|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43844095|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844096|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43844097|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43844098|NCT04407390|Niacinamide|niacinamide|mesh-list
43810340|NCT04860856|Ropivacaine|ropivacaine|mesh-list
43810341|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
43810342|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
43810343|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810344|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810345|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
43810346|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810347|NCT04861207|Cladribine|cladribine|mesh-list
43810348|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810349|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43810350|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
43810351|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810352|NCT04860531|Betamethasone|betamethasone|mesh-list
43810353|NCT04860531|Lidocaine|lidocaine|mesh-list
43810354|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
43810355|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
43810356|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810357|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810358|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
43810359|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810360|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43810361|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43810362|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43810392|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810393|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810394|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43810395|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43810413|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810415|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810416|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43810435|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810446|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43810447|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810449|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43810450|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
43810451|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810452|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810453|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810454|NCT04859569|Denosumab|denosumab|mesh-list
43810455|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43810456|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810457|NCT04859530|Lugol's solution|lugol's solution|mesh-list
43810458|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
43810459|NCT04859530|Coagulants|coagulants|mesh-ancestor
43810460|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
43810461|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43810462|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810463|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810464|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43810465|NCT04859283|Analgesics|analgesics|mesh-ancestor
43810466|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
43810467|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810468|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43810549|NCT04858087|Artemether|artemether|mesh-list
43810470|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43810471|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
43810472|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810474|NCT04859452|Metformin|metformin|mesh-list
43810492|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
43810493|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810494|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810495|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
43810496|NCT04859322|Glucagon|glucagon|mesh-list
43810497|NCT04859322|Somatostatin|somatostatin|mesh-list
43810498|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810499|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43810500|NCT04859322|Hormones|hormones|mesh-ancestor
43810501|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810502|NCT04859244|Remdesivir|remdesivir|mesh-list
43810503|NCT04859244|GS-441524|gs-441524|mesh-list
43810504|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
43810505|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810506|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
43810507|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810508|NCT04858997|Palbociclib|palbociclib|mesh-list
43810509|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810510|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43810512|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810513|NCT04858841|Levetiracetam|levetiracetam|mesh-list
43810514|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
43810515|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
43810516|NCT04858529|Carboplatin|carboplatin|mesh-list
43810517|NCT04858529|Docetaxel|docetaxel|mesh-list
43810518|NCT04858529|Trastuzumab|trastuzumab|mesh-list
43810519|NCT04858529|Pertuzumab|pertuzumab|mesh-list
43810520|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810521|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
43810522|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
43810523|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
43810524|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810525|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844104|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844105|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43844106|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
43844110|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
43844111|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43844112|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
43844113|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
43844114|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844115|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844116|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844117|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844118|NCT04406649|Analgesics|analgesics|mesh-ancestor
43844119|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
43844120|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844121|NCT04406389|Heparin|heparin|mesh-list
43844122|NCT04406389|Calcium heparin|calcium heparin|mesh-list
43844123|NCT04406389|Enoxaparin|enoxaparin|mesh-list
43844124|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
43844125|NCT04406389|Argatroban|argatroban|mesh-list
43844126|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
43844135|NCT04405596|Ambroxol|ambroxol|mesh-list
43810531|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43810532|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810533|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810534|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43810535|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43810536|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43810537|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
43810538|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810539|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810540|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
43810541|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
43810542|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43810543|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43810544|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810545|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810546|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810547|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43810548|NCT04858087|Lumefantrine|lumefantrine|mesh-list
43810550|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43810551|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
43810552|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43810553|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43810554|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810555|NCT04858048|Anesthetics|anesthetics|mesh-list
43810556|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810557|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810558|NCT04857801|Teduglutide|teduglutide|mesh-list
43810577|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
43810578|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
43810579|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810580|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43810581|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43810582|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810583|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810584|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43810585|NCT04857177|Ranibizumab|ranibizumab|mesh-list
43810586|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43810587|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43810588|NCT04857177|Growth Substances|growth substances|mesh-ancestor
43810589|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810590|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
43810591|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810592|NCT04856852|Iodine|iodine|mesh-list
43810593|NCT04856852|Temozolomide|temozolomide|mesh-list
43810594|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43810595|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
43810596|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810597|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810598|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43810599|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810626|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43810627|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810628|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43810629|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43810630|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810631|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810632|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810633|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43810634|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
43810635|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
43810636|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43810637|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43810638|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43810639|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43810640|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43810641|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43810642|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43810644|NCT04856371|Fulvestrant|fulvestrant|mesh-list
43810645|NCT04856371|Palbociclib|palbociclib|mesh-list
43810646|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810647|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43810648|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43810649|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810650|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810651|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43810652|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
43810653|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810654|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810655|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43810656|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43810665|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810666|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810667|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
43810668|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810669|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43810670|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
43810671|NCT04856098|Bromides|bromides|mesh-list
43810672|NCT04856098|Maleic acid|maleic acid|mesh-list
43810673|NCT04856098|Charcoal|charcoal|mesh-list
43810674|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
43810675|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810698|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43810699|NCT04855968|Analgesics|analgesics|mesh-list
43810700|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
43810701|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810702|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810703|NCT04856124|Ketamine|ketamine|mesh-list
43810704|NCT04856124|Esketamine|esketamine|mesh-list
43810705|NCT04856124|Analgesics|analgesics|mesh-ancestor
43810706|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
43810707|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810708|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810709|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43810710|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43810711|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
43810712|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
43810713|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810714|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43810715|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43810716|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810717|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810718|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
43810719|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43810720|NCT04855279|Listerine|listerine|mesh-list
43810721|NCT04855279|Fluorides|fluorides|mesh-list
43810722|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
43810723|NCT04855279|Glycerol|glycerol|mesh-list
43810724|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
43810725|NCT04855279|Protective Agents|protective agents|mesh-ancestor
43623473|NCT04463693|Etonogestrel|etonogestrel|mesh-list
43810726|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810727|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43810728|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844168|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844170|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
43844171|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
43844172|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
43844173|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844174|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844175|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43844176|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43844178|NCT04398537|Hormones|hormones|mesh-ancestor
43844179|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844180|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844181|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844182|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844183|NCT04397991|Furosemide|furosemide|mesh-list
43844184|NCT04397991|Diuretics|diuretics|mesh-ancestor
43844185|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
43844186|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844187|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43844188|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43844189|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844190|NCT04397679|Chloroquine|chloroquine|mesh-list
43844191|NCT04397679|Temozolomide|temozolomide|mesh-list
43844192|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43810730|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43810731|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43810732|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810733|NCT04855110|Warfarin|warfarin|mesh-list
43810735|NCT04854759|Amantadine|amantadine|mesh-list
43810746|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
43810747|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810748|NCT04854668|Bevacizumab|bevacizumab|mesh-list
43810749|NCT04854668|Capecitabine|capecitabine|mesh-list
43810750|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
43810751|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810752|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810753|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43810754|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43810755|NCT04854668|Growth Substances|growth substances|mesh-ancestor
43810756|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810757|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
43810758|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43810759|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
43810760|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810762|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43810763|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810764|NCT04854577|Anesthetics|anesthetics|mesh-list
43810765|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810766|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810767|NCT04854538|Budesonide|budesonide|mesh-list
43810768|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810769|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43810770|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
43810771|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810772|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810773|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43810776|NCT04854538|Hormones|hormones|mesh-ancestor
43810792|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43810793|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
43810795|NCT04853758|Valsartan|valsartan|mesh-list
43810796|NCT04853758|Enalapril|enalapril|mesh-list
43810797|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43810798|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43810799|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43810803|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810805|NCT04853797|Calcium|calcium|mesh-list
43810806|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43810807|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810808|NCT04853615|Empagliflozin|empagliflozin|mesh-list
43844208|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810817|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
43810818|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43810819|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
43810820|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
43810821|NCT04853524|Tenofovir|tenofovir|mesh-list
43810822|NCT04853524|Emtricitabine|emtricitabine|mesh-list
43810823|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
43810824|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
43810825|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810826|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43810827|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43810828|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810829|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810830|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43810831|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43810833|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810834|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810835|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
43810836|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
43810837|NCT04853069|Estradiol|estradiol|mesh-list
43810838|NCT04853069|Estrogens|estrogens|mesh-ancestor
43810839|NCT04853069|Hormones|hormones|mesh-ancestor
43810840|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810841|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810855|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43810856|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
43810857|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810858|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43810859|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43810860|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43810861|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
43844194|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844195|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844197|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43844198|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43844199|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844200|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
43844201|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844202|NCT04397107|Aldesleukin|aldesleukin|mesh-list
43844203|NCT04397107|Interleukin-2|interleukin-2|mesh-list
43844204|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844205|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844206|NCT04397107|Analgesics|analgesics|mesh-ancestor
43844207|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
43811306|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
43844212|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
43844213|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844214|NCT04395222|Fludarabine|fludarabine|mesh-list
43844216|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
43844217|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43844218|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844219|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844220|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844221|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
43844222|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844223|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43844224|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
43844225|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43844226|NCT04394663|Omeprazole|omeprazole|mesh-list
43844227|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43844228|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43844229|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43844230|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844231|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848757|NCT03997968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848758|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43848759|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
43848760|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
43848761|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848762|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43848763|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848764|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848765|NCT03997786|Etanercept|etanercept|mesh-list
43848766|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43848767|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43848768|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43848769|NCT03997786|Analgesics|analgesics|mesh-ancestor
43848770|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
43810866|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
43810867|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810883|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810884|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43810885|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43810886|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810887|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810888|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43810889|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
43810890|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810891|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810892|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43810893|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43810894|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43810895|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43810896|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43810897|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43810899|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43810900|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43810901|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810902|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43810903|NCT04851392|Dronabinol|dronabinol|mesh-list
43810904|NCT04851392|Cannabidiol|cannabidiol|mesh-list
43810905|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
43810906|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
43810907|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810908|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43810909|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43810910|NCT04851392|Analgesics|analgesics|mesh-ancestor
43810911|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
43810912|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810913|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43810914|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43810915|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810948|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43810950|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
43810951|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810952|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43810953|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43810954|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810955|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810956|NCT04851132|Durvalumab|durvalumab|mesh-list
43810957|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810958|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810959|NCT04850885|Dexamethasone|dexamethasone|mesh-list
43810960|NCT04850885|Lidocaine|lidocaine|mesh-list
43810961|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810997|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43810999|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811000|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811001|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811002|NCT04850404|Ropivacaine|ropivacaine|mesh-list
43811003|NCT04850404|Rocuronium|rocuronium|mesh-list
43811004|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
43811005|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
43811006|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811007|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811008|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
43811009|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811010|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43811011|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43811012|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43811014|NCT04850417|Clopidogrel|clopidogrel|mesh-list
43811015|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43811016|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43811017|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43811018|NCT04850417|Analgesics|analgesics|mesh-ancestor
43811019|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
43811020|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811030|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
43811046|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43811047|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
43811048|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43811049|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811050|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
43811051|NCT04850040|Apatinib|apatinib|mesh-list
43811066|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811074|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43811075|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43811076|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
43811077|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43811078|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43811079|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43811080|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43811081|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43811082|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
43811083|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811084|NCT04849845|Insulin|insulin|mesh-list
43811085|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43811086|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43811087|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811088|NCT04849858|Bupivacaine|bupivacaine|mesh-list
43811089|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
43811090|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
43811091|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811092|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811095|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
43811129|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811130|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811131|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811132|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
43811133|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43811134|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43811135|NCT04849026|Clozapine|clozapine|mesh-list
43844250|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43844251|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
43844253|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844255|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
43844256|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844257|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844258|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43844259|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
43844260|NCT04393207|Hormones|hormones|mesh-ancestor
43844261|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844262|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43844263|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844264|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
43844265|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844266|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844269|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844270|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
43844271|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43844272|NCT04393207|Protective Agents|protective agents|mesh-ancestor
43844273|NCT04392102|Niraparib|niraparib|mesh-list
43844274|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43844275|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844276|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844277|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844278|NCT04392011|Midazolam|midazolam|mesh-list
43844279|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
43844280|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43844281|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43844282|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844283|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811159|NCT04848974|Cytarabine|cytarabine|mesh-list
43811160|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
43811161|NCT04848974|Cladribine|cladribine|mesh-list
43811162|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43811163|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
43811165|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811166|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
43811167|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811168|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811169|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
43811170|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811171|NCT04848467|Vaccines|vaccines|mesh-list
43811172|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
43811174|NCT04848259|Dexamethasone|dexamethasone|mesh-list
43811189|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811190|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811191|NCT04848246|Bupropion|bupropion|mesh-list
43811192|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43811193|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
43811194|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43811195|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43811196|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43811197|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43811198|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811199|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
43811200|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811201|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811202|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43811203|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43811204|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811205|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
43811206|NCT04848181|Finasteride|finasteride|mesh-list
43811207|NCT04848181|Cyproterone|cyproterone|mesh-list
43811221|NCT04847791|Lactoferrin|lactoferrin|mesh-list
43811240|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43811241|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43811242|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811243|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
43811244|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43811245|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43811246|NCT04847687|Prednisolone|prednisolone|mesh-list
43811247|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
43811248|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43811249|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
43811250|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811251|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
43811252|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
43811253|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811254|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811255|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811256|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
43811257|NCT04847687|Hormones|hormones|mesh-ancestor
43811258|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811259|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43811260|NCT04847687|Protective Agents|protective agents|mesh-ancestor
43811261|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43811262|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811263|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43811264|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
43811265|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43811289|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811290|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43811291|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43811292|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43811293|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811294|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43811295|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43811296|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43811297|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811298|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
43811299|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
43811300|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
43811301|NCT04846673|Pregabalin|pregabalin|mesh-list
43811302|NCT04846673|Analgesics|analgesics|mesh-ancestor
43811303|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
43811304|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811305|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811316|NCT04846673|Protective Agents|protective agents|mesh-ancestor
43811317|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
43811318|NCT04846673|Vitamins|vitamins|mesh-ancestor
43811319|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
43811320|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
43811321|NCT04846621|Calcium|calcium|mesh-list
43811326|NCT04846634|Gemcitabine|gemcitabine|mesh-list
43811328|NCT04846634|Docetaxel|docetaxel|mesh-list
43811329|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43811330|NCT04846634|Cisplatin|cisplatin|mesh-list
43811331|NCT04846634|Carboplatin|carboplatin|mesh-list
43811332|NCT04846634|Pemetrexed|pemetrexed|mesh-list
43811333|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43811334|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811335|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811336|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811337|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811338|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844285|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43811339|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43811340|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
43844304|NCT04387942|Analgesics|analgesics|mesh-ancestor
43844305|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
43844306|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844307|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844308|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43844309|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43844310|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
43844311|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844312|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
43844313|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
43844314|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844315|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
43844316|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844317|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844318|NCT04387227|Carboplatin|carboplatin|mesh-list
43844319|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
43844320|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844321|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844322|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
43844323|NCT04387084|Nivolumab|nivolumab|mesh-list
43844324|NCT04387084|Durvalumab|durvalumab|mesh-list
43844325|NCT04387084|Avelumab|avelumab|mesh-list
43844326|NCT04387084|Cemiplimab|cemiplimab|mesh-list
43844327|NCT04387084|Atezolizumab|atezolizumab|mesh-list
43811374|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811376|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43811378|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43811379|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43811380|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811381|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43811382|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43811383|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43811384|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811385|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43811386|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43811387|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43811388|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
43811389|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43811390|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43811391|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811392|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
43811429|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811430|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811431|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
43811432|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43811433|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
43811434|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811435|NCT04844333|Anesthetics|anesthetics|mesh-list
43811436|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811437|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811438|NCT04843982|Esketamine|esketamine|mesh-list
43811439|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
43811440|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43811441|NCT04843943|Bevacizumab|bevacizumab|mesh-list
43811442|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43811443|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811444|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43811445|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43811447|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811448|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
43811449|NCT04843839|Nepafenac|nepafenac|mesh-list
43811450|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43811451|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43811452|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
43811453|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43811454|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43811455|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43811456|NCT04843839|Analgesics|analgesics|mesh-ancestor
43811457|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
43811458|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811459|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811460|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811461|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811462|NCT04843839|Laxatives|laxatives|mesh-ancestor
43811463|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811464|NCT04843553|Niacinamide|niacinamide|mesh-list
43811465|NCT04843553|Niacin|niacin|mesh-list
43811469|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811470|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
43811471|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43811472|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
43811473|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811474|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43811475|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
43811476|NCT04843449|Itraconazole|itraconazole|mesh-list
43811477|NCT04843449|Rifampin|rifampin|mesh-list
43811478|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
43811479|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811480|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43811489|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43811490|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
43811491|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43811492|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
43811493|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43811494|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43811495|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43811496|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43811497|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43811498|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43811499|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43811500|NCT04843644|Propolis|propolis|mesh-list
43811507|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811508|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811509|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811510|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811511|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811512|NCT04842825|Cetrorelix|cetrorelix|mesh-list
43811513|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43811514|NCT04842825|Hormones|hormones|mesh-ancestor
43811515|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811516|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623727|NCT03971708|Lidocaine|lidocaine|mesh-list
43811517|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43811518|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
43811519|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43811520|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
43844332|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844333|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43844334|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844335|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
43844336|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844337|NCT04386317|Terazosin|terazosin|mesh-list
43844338|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43844339|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43844340|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43844341|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
43844342|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844343|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844344|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844345|NCT04386317|Urological Agents|urological agents|mesh-ancestor
43844346|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
43844347|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
43844358|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43844359|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43844360|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
43844361|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43844362|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43844363|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811529|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811530|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811531|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811532|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811533|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811534|NCT04842968|Methylene Blue|methylene blue|mesh-list
43811535|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811536|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811537|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
43811538|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43811539|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
43811552|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43811553|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
43811554|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811555|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811556|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43811557|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43811558|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811559|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
43811560|NCT04842487|Hormones|hormones|mesh-ancestor
43811561|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811562|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43811563|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43811564|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811565|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811566|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811567|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43811568|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43811569|NCT04842487|Growth Substances|growth substances|mesh-ancestor
43811570|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
43811571|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43811572|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43811573|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43811574|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811580|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811581|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
43811595|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811596|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43811597|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
43811598|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43811600|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811601|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811602|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43811603|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
43811604|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
43811605|NCT04842331|Protective Agents|protective agents|mesh-ancestor
43811606|NCT04841980|Rifaximin|rifaximin|mesh-list
43811607|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43811608|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811609|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811610|NCT04841720|Metformin|metformin|mesh-list
43811611|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43811612|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811613|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
43811614|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43811615|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811616|NCT04841096|Metformin|metformin|mesh-list
43811617|NCT04841096|Glimepiride|glimepiride|mesh-list
43811618|NCT04841096|Vildagliptin|vildagliptin|mesh-list
43811619|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43811620|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811621|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43811644|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811645|NCT04840550|Lansoprazole|lansoprazole|mesh-list
43811646|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
43811647|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43811648|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811649|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43811650|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811651|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811652|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
43811653|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43811654|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811655|NCT04840745|Leuprolide|leuprolide|mesh-list
43811656|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43811657|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
43811658|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43811659|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811660|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43811661|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811662|NCT04840290|Paclitaxel|paclitaxel|mesh-list
43811663|NCT04840290|Cisplatin|cisplatin|mesh-list
43811664|NCT04840290|Carboplatin|carboplatin|mesh-list
43811665|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43811666|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811667|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811668|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811669|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811670|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623916|NCT02620046|Vedolizumab|vedolizumab|mesh-list
43844364|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
43811671|NCT04839913|Antibodies|antibodies|mesh-list
43811672|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
43811673|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811674|NCT04839666|Propofol|propofol|mesh-list
43811675|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43811676|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811677|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811678|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43811679|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
43811680|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
43811681|NCT04839731|Fluorouracil|fluorouracil|mesh-list
43811682|NCT04839731|Calcipotriene|calcipotriene|mesh-list
43811683|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
43811684|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811689|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811690|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
43811691|NCT04839653|Vancomycin|vancomycin|mesh-list
43811692|NCT04839653|Gentamicins|gentamicins|mesh-list
43811693|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
43811694|NCT04839653|Polymyxins|polymyxins|mesh-list
43811695|NCT04839653|Cefotaxime|cefotaxime|mesh-list
43811696|NCT04839653|Cefoxitin|cefoxitin|mesh-list
43811697|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43811698|NCT04839653|Polymyxin B|polymyxin b|mesh-list
43811699|NCT04839653|Amphotericin B|amphotericin b|mesh-list
43811700|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43811701|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811702|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43811703|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811704|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811705|NCT04839653|Amebicides|amebicides|mesh-ancestor
43811706|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43811707|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43811708|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
43811728|NCT04839445|Anesthetics|anesthetics|mesh-list
43811729|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811730|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811731|NCT04839224|Phenylephrine|phenylephrine|mesh-list
43811732|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
43811733|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43811734|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
43811735|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
43811736|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811737|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811738|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
43811739|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43811740|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
43811741|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
43811742|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43811743|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43811744|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43811745|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
43623991|NCT02096354|Irinotecan|irinotecan|mesh-list
43811746|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811747|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811748|NCT04839224|Protective Agents|protective agents|mesh-ancestor
43811749|NCT04839471|Afatinib|afatinib|mesh-list
43811750|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811751|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43811752|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811753|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811754|NCT04839198|Nicotine|nicotine|mesh-list
43811755|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43811756|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
43811757|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811758|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811759|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43811760|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43811764|NCT04839237|Metformin|metformin|mesh-list
43811767|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811768|NCT04839237|Incretins|incretins|mesh-ancestor
43811769|NCT04839237|Hormones|hormones|mesh-ancestor
43811770|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811771|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
43811772|NCT04838704|Methotrexate|methotrexate|mesh-list
43811773|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43811774|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
43811775|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43811776|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811777|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43811778|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
43811779|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811780|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811789|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43811790|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
43811791|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43811792|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811793|NCT04838665|Phenylephrine|phenylephrine|mesh-list
43811794|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
43811795|NCT04838665|Tropicamide|tropicamide|mesh-list
43811807|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43811808|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43811809|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
43811810|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811811|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811812|NCT04838665|Protective Agents|protective agents|mesh-ancestor
43811813|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43811814|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43811815|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
43811816|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
43811818|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811819|NCT04838145|Ribavirin|ribavirin|mesh-list
43811820|NCT04838145|Pleconaril|pleconaril|mesh-list
43811821|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
43811822|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811823|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
43811824|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811825|NCT04838132|Ropivacaine|ropivacaine|mesh-list
43811826|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
43811827|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
43811828|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811829|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811830|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
43811831|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811832|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43811833|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43811834|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811835|NCT04838080|Vaccines|vaccines|mesh-list
43811853|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
43811854|NCT04837664|Ionophores|ionophores|mesh-ancestor
43811855|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43811856|NCT04837651|Antibodies|antibodies|mesh-list
43811857|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
43811871|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43811872|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
43811873|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
43811874|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811875|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43811877|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844392|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43844393|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
43844394|NCT04383743|Methotrexate|methotrexate|mesh-list
43844395|NCT04383743|Daunorubicin|daunorubicin|mesh-list
43844396|NCT04383743|Vinblastine|vinblastine|mesh-list
43844397|NCT04383743|Lenograstim|lenograstim|mesh-list
43844398|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844399|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43844400|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43844401|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43844402|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844403|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844404|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844405|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43844406|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
43844407|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43844408|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844409|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43844410|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
43844411|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
43844412|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43844413|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844414|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
43844415|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844416|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43844417|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43811881|NCT04837261|Propranolol|propranolol|mesh-list
43811883|NCT04837261|Flecainide|flecainide|mesh-list
43811885|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43811896|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43811897|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43811899|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43811900|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43811901|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43811902|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43811903|NCT04836806|Cetirizine|cetirizine|mesh-list
43811904|NCT04836806|Famotidine|famotidine|mesh-list
43811905|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43811906|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811907|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43811908|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
43811909|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
43811910|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811911|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811912|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811913|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43811914|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43811915|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43811917|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43811918|NCT04836728|Carboplatin|carboplatin|mesh-list
43811919|NCT04836728|Pemetrexed|pemetrexed|mesh-list
43811920|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43811921|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43811922|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811923|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811924|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811925|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811926|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811927|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811928|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43811930|NCT04836819|Lidocaine|lidocaine|mesh-list
43811931|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
43811932|NCT04836819|Ketamine|ketamine|mesh-list
43811933|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
43811934|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
43811935|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811936|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811937|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
43811938|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811939|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43811940|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43811941|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43811942|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43811943|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811944|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43811945|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43811946|NCT04836819|Analgesics|analgesics|mesh-ancestor
43811947|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43811948|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43811949|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43811950|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
43811951|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811952|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43811953|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43811954|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
43811955|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43811956|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43811957|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
43811958|NCT04836507|Fludarabine|fludarabine|mesh-list
43811975|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
43811976|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
43811977|NCT04836078|Coagulants|coagulants|mesh-ancestor
43811978|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
43811979|NCT04836156|Carboplatin|carboplatin|mesh-list
43811980|NCT04836156|Docetaxel|docetaxel|mesh-list
43811981|NCT04836156|Epirubicin|epirubicin|mesh-list
43811982|NCT04836156|Phenobarbital|phenobarbital|mesh-list
43811983|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811984|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
43811985|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811986|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811987|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43811988|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
43811989|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811990|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811991|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43811992|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811993|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811994|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811999|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
43812000|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43812001|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812002|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43812003|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43812004|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812005|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
43812007|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43812008|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43812009|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43812010|NCT04836143|Mitogens|mitogens|mesh-list
43812011|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
43812013|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812014|NCT04836143|Growth Substances|growth substances|mesh-ancestor
43812015|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812016|NCT04836299|Ivermectin|ivermectin|mesh-list
43812017|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43812018|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812019|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43812020|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
43812021|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812022|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812023|NCT04835922|Anesthetics|anesthetics|mesh-list
43812024|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812025|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812026|NCT04835896|Paclitaxel|paclitaxel|mesh-list
43812027|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43812028|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812029|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
43812030|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
43812033|NCT04835350|Pancrelipase|pancrelipase|mesh-list
43812068|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43812070|NCT04835064|Antiviral Agents|antiviral agents|mesh-ancestor
43812071|NCT04835064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812072|NCT04835064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812073|NCT04835064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812074|NCT04835064|Immunologic Factors|immunologic factors|mesh-ancestor
43812075|NCT04835064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812076|NCT04835116|Acetaminophen|acetaminophen|mesh-list
43812077|NCT04835116|Tramadol|tramadol|mesh-list
43812078|NCT04835116|Analgesics|analgesics|mesh-list
43812079|NCT04835116|Orphenadrine|orphenadrine|mesh-list
43812080|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
43812081|NCT04835116|Bupivacaine|bupivacaine|mesh-list
43812082|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
43812083|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
43812084|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812085|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812086|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
43812087|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812088|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43812089|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
43812090|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43812091|NCT04835116|Narcotics|narcotics|mesh-ancestor
43812092|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43812093|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43812094|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43812095|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43812096|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
43812097|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
43812098|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43812099|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43812100|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
43812101|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812102|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812103|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
43812104|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43812105|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812152|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43812155|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
43812156|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812157|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812158|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43812159|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812160|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844418|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43844419|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
43844420|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
43844421|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
43844422|NCT04383574|Vaccines|vaccines|mesh-list
43844423|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
43844424|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844425|NCT04382664|Nivolumab|nivolumab|mesh-list
43844426|NCT04382664|Ipilimumab|ipilimumab|mesh-list
43844427|NCT04382664|Sargramostim|sargramostim|mesh-list
43844428|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812162|NCT04834427|Esketamine|esketamine|mesh-list
43812163|NCT04834427|Analgesics|analgesics|mesh-ancestor
43812164|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
43812165|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812166|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812167|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43812168|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43812169|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
43812170|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
43812171|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812172|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43812173|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43812174|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812175|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812176|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
43812177|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43812178|NCT04834375|Dexamethasone|dexamethasone|mesh-list
43812179|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
43812181|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812182|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
43812183|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
43812184|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812185|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812186|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812187|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
43812188|NCT04834375|Hormones|hormones|mesh-ancestor
43812189|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812207|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
43812208|NCT04833738|Hormones|hormones|mesh-ancestor
43812209|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812212|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
43812279|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43812280|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43812281|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844498|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
43812283|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812284|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812285|NCT04833296|Ropivacaine|ropivacaine|mesh-list
43812286|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
43812287|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
43812288|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812289|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812290|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
43812291|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812292|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
43812293|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43812294|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
43812295|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43812296|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812297|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43812298|NCT04832880|Remdesivir|remdesivir|mesh-list
43812299|NCT04832880|Dexamethasone|dexamethasone|mesh-list
43812300|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812301|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
43812302|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
43812303|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812304|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812305|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812306|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
43812307|NCT04832880|Hormones|hormones|mesh-ancestor
43812308|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812309|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43812320|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812321|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812322|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43812323|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43812324|NCT04832776|Growth Substances|growth substances|mesh-ancestor
43812325|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812326|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
43812327|NCT04832399|Natalizumab|natalizumab|mesh-list
43812328|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
43812329|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812330|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
43812331|NCT04832204|Apatinib|apatinib|mesh-list
43812332|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812333|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43812334|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812335|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844461|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844462|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844463|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
43844464|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844465|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844466|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43844467|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
43844468|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844469|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
43844470|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844471|NCT04379635|Paclitaxel|paclitaxel|mesh-list
43844472|NCT04379635|Cisplatin|cisplatin|mesh-list
43844473|NCT04379635|Carboplatin|carboplatin|mesh-list
43844474|NCT04379635|Pemetrexed|pemetrexed|mesh-list
43844475|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43844476|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844477|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
43844478|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
43844486|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844487|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844488|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844489|NCT04375813|Sirolimus|sirolimus|mesh-list
43844490|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43844491|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844492|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43844493|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844494|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
43844495|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844496|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
43844497|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844500|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844501|NCT04374474|Budesonide|budesonide|mesh-list
43844502|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844503|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43844504|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
43844505|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844506|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844507|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43844508|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
43844509|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
43844510|NCT04374474|Hormones|hormones|mesh-ancestor
43844511|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844512|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43812336|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43812337|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43812339|NCT04831528|Bevacizumab|bevacizumab|mesh-list
43812353|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812354|NCT04831255|Triamcinolone|triamcinolone|mesh-list
43812355|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43812356|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43812357|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43812358|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812359|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
43812360|NCT04831255|Hormones|hormones|mesh-ancestor
43812361|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812362|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812363|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812364|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
43812365|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812366|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812367|NCT04831294|Cannabidiol|cannabidiol|mesh-list
43812368|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
43812369|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
43812370|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43812371|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43812372|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812373|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
43812374|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
43812375|NCT04830878|Methotrexate|methotrexate|mesh-list
43812376|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43812377|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
43812378|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43812379|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812380|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43812381|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
43812382|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812383|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812384|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
43812385|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812386|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43812387|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812390|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43812392|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43812393|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43812394|NCT04830579|Analgesics|analgesics|mesh-ancestor
43812395|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
43812396|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812397|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812398|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812399|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43812400|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43812401|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43812402|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812403|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812404|NCT04831099|Testosterone|testosterone|mesh-list
43812405|NCT04831099|Androgens|androgens|mesh-ancestor
43812406|NCT04831099|Hormones|hormones|mesh-ancestor
43812407|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812408|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812409|NCT04831229|Menthol|menthol|mesh-list
43812410|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
43812411|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
43812447|NCT04829435|Rasburicase|rasburicase|mesh-list
43812448|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
43812449|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43812450|NCT04829487|Vitamin D|vitamin d|mesh-list
43812451|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
43812452|NCT04829487|Vitamins|vitamins|mesh-ancestor
43812458|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43812459|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43812460|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812461|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
43812462|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848791|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
43812499|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812500|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
43812501|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
43812502|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812503|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812504|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812505|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
43812506|NCT04828525|Hormones|hormones|mesh-ancestor
43812507|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812508|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43812509|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812510|NCT04828642|Vitamins|vitamins|mesh-list
43812511|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
43812512|NCT04828642|Vitamin E|vitamin e|mesh-list
43812513|NCT04828642|Tocopherols|tocopherols|mesh-list
43812514|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
43812515|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812516|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
43812517|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812518|NCT04828642|Protective Agents|protective agents|mesh-ancestor
43812519|NCT04828564|Ribavirin|ribavirin|mesh-list
43812520|NCT04828564|Favipiravir|favipiravir|mesh-list
43812521|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
43812522|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812523|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
43812524|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812525|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
43812526|NCT04827966|Listerine|listerine|mesh-list
43812527|NCT04827966|Calcium|calcium|mesh-list
43812528|NCT04827966|Fluorides|fluorides|mesh-list
43812529|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
43812541|NCT04828395|Paclitaxel|paclitaxel|mesh-list
43812542|NCT04828395|Etoposide|etoposide|mesh-list
43812543|NCT04828395|Cisplatin|cisplatin|mesh-list
43812544|NCT04828395|Carboplatin|carboplatin|mesh-list
43812545|NCT04828395|Pemetrexed|pemetrexed|mesh-list
43812546|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43812547|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812548|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
43812549|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
43812550|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812551|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812552|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43812554|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812555|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43812556|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43812557|NCT04827667|Dimercaprol|dimercaprol|mesh-list
43812558|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
43812559|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
43812560|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812561|NCT04827784|Anesthetics|anesthetics|mesh-list
43812562|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
43812563|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812564|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812565|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
43812566|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812567|NCT04827134|Triumeq|triumeq|mesh-list
43812568|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43812569|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43812570|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
43812571|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812586|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
43812587|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43812589|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
43812590|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43812591|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43812592|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812593|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812594|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43812595|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43812596|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812597|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
43812598|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812599|NCT04826679|Paclitaxel|paclitaxel|mesh-list
43812600|NCT04826679|Cisplatin|cisplatin|mesh-list
43812601|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43812602|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812603|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
43812604|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
43812605|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812606|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812607|NCT04826198|Olaparib|olaparib|mesh-list
43812608|NCT04826198|Niraparib|niraparib|mesh-list
43812609|NCT04826198|Rucaparib|rucaparib|mesh-list
43812610|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43812611|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812612|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812613|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812614|NCT04826562|Lamivudine|lamivudine|mesh-list
43812615|NCT04826562|Dolutegravir|dolutegravir|mesh-list
43812616|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43812617|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43812618|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812619|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812620|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
43812624|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43812625|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43812626|NCT04826406|Apatinib|apatinib|mesh-list
43812627|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812628|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43812629|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812630|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812631|NCT04826432|Pasireotide|pasireotide|mesh-list
43812632|NCT04826432|Hormones|hormones|mesh-ancestor
43812633|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812634|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812635|NCT04826497|Nicorandil|nicorandil|mesh-list
43812636|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43812637|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43812638|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
43812639|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
43812640|NCT04826497|Vitamins|vitamins|mesh-ancestor
43812641|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
43812642|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812643|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
43812644|NCT04826510|Perospirone|perospirone|mesh-list
43812645|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
43812648|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812649|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
43625076|NCT00416351|Clofarabine|clofarabine|mesh-list
43812651|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812652|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812653|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43812654|NCT04825938|Paclitaxel|paclitaxel|mesh-list
43812655|NCT04825938|Carboplatin|carboplatin|mesh-list
43812656|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43812657|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812658|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
43812659|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
43812660|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812661|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812662|NCT04826016|Paclitaxel|paclitaxel|mesh-list
43812663|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43812664|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812665|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
43812666|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
43812667|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812668|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812669|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43812670|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
43812671|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812672|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812673|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43812674|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844521|NCT04368403|Brodalumab|brodalumab|mesh-list
43844522|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
43844523|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
43844524|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43844525|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844526|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844527|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43844528|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43844529|NCT04367935|Protective Agents|protective agents|mesh-ancestor
43844530|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844531|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
43844532|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43844533|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
43844534|NCT04367168|Colchicine|colchicine|mesh-list
43844535|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
43844536|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844537|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
43844538|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
43844539|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
43844540|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844541|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844542|NCT04365933|Interferons|interferons|mesh-list
43844543|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
43844544|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
43844545|NCT04365933|Entecavir|entecavir|mesh-list
43844546|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43844547|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844548|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
43844549|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844550|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
43844551|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844552|NCT04364230|Poly ICLC|poly iclc|mesh-list
43844553|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
43844554|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844555|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
43844556|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
43844557|NCT04363164|Testosterone|testosterone|mesh-list
43844558|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
43844559|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
43844560|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43844561|NCT04363164|Androgens|androgens|mesh-ancestor
43844562|NCT04363164|Hormones|hormones|mesh-ancestor
43844563|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844564|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844565|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43844566|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844567|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
43844568|NCT04362839|Nivolumab|nivolumab|mesh-list
43844569|NCT04362839|Ipilimumab|ipilimumab|mesh-list
43813001|NCT04820439|Mitogens|mitogens|mesh-list
43812697|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812698|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43812699|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43812700|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812701|NCT04824937|Talazoparib|talazoparib|mesh-list
43812702|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43812703|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812704|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812705|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812706|NCT04824612|Triamcinolone|triamcinolone|mesh-list
43812707|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43812708|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43812709|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43812710|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812711|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
43812713|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812714|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812715|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812716|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
43812725|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43812726|NCT04824404|Narcotics|narcotics|mesh-ancestor
43812727|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812728|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812729|NCT04824404|Analgesics|analgesics|mesh-ancestor
43812730|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
43812731|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812732|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43812733|NCT04824261|Clotrimazole|clotrimazole|mesh-list
43812734|NCT04824261|Miconazole|miconazole|mesh-list
43812735|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43812736|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812737|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
43812738|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43812739|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43812740|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812741|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812750|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812752|NCT04823390|Midazolam|midazolam|mesh-list
43812753|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43812754|NCT04823390|Narcotics|narcotics|mesh-ancestor
43812755|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812756|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812758|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
43812759|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812760|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43812761|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43812762|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
43812763|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
43812764|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43812765|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43812766|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43812767|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43812768|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
43812769|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
43812770|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812771|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812772|NCT04823403|Nivolumab|nivolumab|mesh-list
43812773|NCT04823403|Ipilimumab|ipilimumab|mesh-list
43812774|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812775|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812776|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43812777|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812778|NCT04823260|Niacinamide|niacinamide|mesh-list
43812779|NCT04823260|Niacin|niacin|mesh-list
43812780|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
43812781|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
43812796|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812797|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812798|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812799|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43812800|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43812801|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43812802|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812803|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812804|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812805|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
43812806|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
43812807|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43812808|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844614|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844615|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
43844616|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844617|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
43844618|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43844619|NCT04357795|Cyclosporine|cyclosporine|mesh-list
43844620|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43844621|NCT04357795|Cyclosporins|cyclosporins|mesh-list
43844622|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844623|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844624|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844625|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
43844626|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844627|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
43844628|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844629|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
43844630|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844635|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844636|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844637|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43844638|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43844639|NCT04356729|Growth Substances|growth substances|mesh-ancestor
43844640|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844641|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
43625355|NCT03102658|Micafungin|micafungin|mesh-list
43812815|NCT04822649|Analgesics|analgesics|mesh-ancestor
43812816|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
43812817|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812818|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812819|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43812820|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
43812821|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43812822|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
43812823|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
43812824|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813002|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
43812833|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812834|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
43812835|NCT04822064|Ketamine|ketamine|mesh-list
43812836|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
43812837|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43812838|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812839|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812840|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43812841|NCT04822064|Analgesics|analgesics|mesh-ancestor
43812842|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
43812843|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812844|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43625431|NCT03101579|Folic Acid|folic acid|mesh-list
43812847|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
43812848|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812849|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812850|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43812851|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43812852|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
43812878|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812880|NCT04822090|Antibodies|antibodies|mesh-list
43812881|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
43812882|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43812883|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43812884|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
43812885|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812886|NCT04821843|Paclitaxel|paclitaxel|mesh-list
43812887|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
43812888|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43812889|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812890|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
43812891|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
43812892|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812893|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812894|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812895|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
43812896|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812897|NCT04821765|Paclitaxel|paclitaxel|mesh-list
43812898|NCT04821765|Cisplatin|cisplatin|mesh-list
43812899|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43812900|NCT04821765|Antibodies|antibodies|mesh-list
43812901|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43812902|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812903|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
43812904|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
43812905|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812906|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812907|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
43812908|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812909|NCT04821323|Indomethacin|indomethacin|mesh-list
43812911|NCT04821323|Lactulose|lactulose|mesh-list
43812921|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812922|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625466|NCT03101319|Vitamin D|vitamin d|mesh-list
43812923|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
43812924|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
43812925|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43812926|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43812927|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812928|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812929|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812930|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
43812931|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43812932|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
43812933|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812934|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
43812935|NCT04821804|Protective Agents|protective agents|mesh-ancestor
43812936|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43812937|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812938|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812939|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
43812940|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812941|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812942|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
43812943|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43812944|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
43812945|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43812946|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812947|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43812964|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812965|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
43812966|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43812967|NCT04821193|Disinfectants|disinfectants|mesh-list
43812968|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43812969|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43812970|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812971|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
43812972|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
43812973|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
43812974|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
43812975|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812976|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43812977|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
43812978|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
43812979|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812980|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812981|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812982|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43812983|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
43812984|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43812985|NCT04820933|Tenofovir|tenofovir|mesh-list
43812986|NCT04820933|Emtricitabine|emtricitabine|mesh-list
43812987|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
43812988|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812989|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43812990|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43812991|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812992|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812993|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43812994|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43812995|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
43812996|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43625542|NCT03100877|Melphalan|melphalan|mesh-list
43812997|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812998|NCT04820439|Pertuzumab|pertuzumab|mesh-list
43812999|NCT04820439|Antibodies|antibodies|mesh-list
43813000|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43813016|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43813017|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
43813018|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43813019|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813020|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43813021|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43813022|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813023|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813024|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813026|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43813027|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813028|NCT04819776|Iloperidone|iloperidone|mesh-list
43813029|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43844651|NCT04354428|Folic Acid|folic acid|mesh-list
43844652|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
43813034|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
43813035|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43813036|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813037|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813038|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813039|NCT04820101|Analgesics|analgesics|mesh-ancestor
43813040|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
43813041|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813042|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43813043|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43813044|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43813045|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
43813046|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813047|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813048|NCT04819867|Propolis|propolis|mesh-list
43813049|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813050|NCT04819503|Anesthetics|anesthetics|mesh-list
43813051|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813052|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813194|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43813195|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43813196|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43813197|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
43813198|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
43813199|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813201|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43813202|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
43813203|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813204|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43813205|NCT04817527|Protective Agents|protective agents|mesh-ancestor
43813206|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813207|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43813208|NCT04817202|Antibodies|antibodies|mesh-list
43813209|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
43813210|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43813211|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
43849636|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
43813212|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813213|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813214|NCT04816968|Vancomycin|vancomycin|mesh-list
43813215|NCT04816968|Meropenem|meropenem|mesh-list
43813216|NCT04816968|Tazobactam|tazobactam|mesh-list
43813217|NCT04816968|Piperacillin|piperacillin|mesh-list
43813218|NCT04816968|Cefepime|cefepime|mesh-list
43813219|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43813220|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43813221|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813222|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43813223|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813224|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813225|NCT04816838|Osimertinib|osimertinib|mesh-list
43813226|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813227|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43813236|NCT04816461|Artenimol|artenimol|mesh-list
43813237|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
43813238|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43813239|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43813240|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813241|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43813243|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
43813244|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43813245|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43813246|NCT04816253|Prednisolone|prednisolone|mesh-list
43813247|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
43813248|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43813249|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
43813250|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
43813251|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813252|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
43813253|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
43813254|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813255|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813256|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813257|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
43813258|NCT04816253|Hormones|hormones|mesh-ancestor
43813259|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813260|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43813261|NCT04816253|Protective Agents|protective agents|mesh-ancestor
43813279|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813281|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
43813282|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
43813283|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813284|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813285|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43813286|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43813287|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43813288|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43813289|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
43813290|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813291|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813292|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
43813293|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43813294|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813295|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813296|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813297|NCT04815265|Analgesics|analgesics|mesh-ancestor
43813298|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
43813299|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813300|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43813301|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43813302|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43813303|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
43813304|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813305|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813306|NCT04815408|Paclitaxel|paclitaxel|mesh-list
43813307|NCT04815408|Carboplatin|carboplatin|mesh-list
43813308|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43813309|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43813310|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813311|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
43813312|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
43813313|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
43813314|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813315|NCT04815395|Oxytocin|oxytocin|mesh-list
43813316|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
43813317|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43813318|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813335|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
43813336|NCT04814303|Morphine|morphine|mesh-list
43813337|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43813338|NCT04814303|Narcotics|narcotics|mesh-ancestor
43813339|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813340|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813341|NCT04814303|Analgesics|analgesics|mesh-ancestor
43813342|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
43813343|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813344|NCT04814511|Permethrin|permethrin|mesh-list
43813345|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813346|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813347|NCT04814485|Paclitaxel|paclitaxel|mesh-list
43813348|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43844684|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
43844685|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844686|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844687|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844688|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844689|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43844690|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43844691|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844692|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43844693|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43844694|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844695|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
43844709|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844710|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
43844711|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43844712|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844713|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844714|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813355|NCT04814043|Lenvatinib|lenvatinib|mesh-list
43813356|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43813357|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813358|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43813359|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813360|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813361|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43813362|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813363|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813365|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43813366|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43813367|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
43813368|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813369|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43813370|NCT04813913|Bevacizumab|bevacizumab|mesh-list
43813371|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43813372|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813373|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43813374|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43813375|NCT04813913|Growth Substances|growth substances|mesh-ancestor
43813376|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813377|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
43813378|NCT04813952|Sevoflurane|sevoflurane|mesh-list
43813379|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43813380|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43813381|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
43813382|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
43813406|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
43813407|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43813408|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43813409|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43813410|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
43813411|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43813412|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
43813413|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43813414|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
43813415|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
43813416|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813417|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813418|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813419|NCT04813874|Analgesics|analgesics|mesh-ancestor
43813420|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
43813448|NCT04813653|Cyclosporine|cyclosporine|mesh-list
43813449|NCT04813653|Dexamethasone|dexamethasone|mesh-list
43813450|NCT04813653|Cyclosporins|cyclosporins|mesh-list
43813451|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813452|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
43813453|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
43813454|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813455|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813456|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813457|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
43844715|NCT04346290|Analgesics|analgesics|mesh-ancestor
43813459|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813460|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43813461|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813462|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813463|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813464|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43813465|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
43813466|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
43813467|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844717|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844718|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43844719|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43844721|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
43844722|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844723|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844724|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
43844725|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
43844726|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
43844727|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844728|NCT04344717|Apixaban|apixaban|mesh-list
43844729|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43844730|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
43844731|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43844732|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
43844733|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844734|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813515|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
43813516|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813517|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43813518|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43813519|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
43813520|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43813521|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43813522|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
43813523|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
43813524|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813525|NCT04811326|Latanoprost|latanoprost|mesh-list
43813526|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43813529|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
43813530|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
43813531|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813532|NCT04811209|Analgesics|analgesics|mesh-list
43813533|NCT04811209|Anesthetics|anesthetics|mesh-list
43813534|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813535|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813536|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
43813537|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813538|NCT04811313|Bupivacaine|bupivacaine|mesh-list
43813539|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
43813540|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
43813541|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
43813542|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813543|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813544|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
43813545|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813546|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43813547|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43813548|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813549|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
43813550|NCT04811313|Coagulants|coagulants|mesh-ancestor
43813551|NCT04811001|Osimertinib|osimertinib|mesh-list
43813552|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813553|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43813554|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813555|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813557|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43813558|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43813559|NCT04810819|Prednisolone|prednisolone|mesh-list
43813560|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
43813561|NCT04810819|Dyphylline|dyphylline|mesh-list
43813562|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43813563|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
43813564|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813565|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
43813566|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
43813567|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813568|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813569|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813570|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
43813571|NCT04810819|Hormones|hormones|mesh-ancestor
43813572|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813573|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43813574|NCT04810819|Protective Agents|protective agents|mesh-ancestor
43813575|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43813576|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813577|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43813578|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43813579|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
43813581|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813608|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43813609|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813650|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43813651|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43813652|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813653|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813654|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43813655|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
43813656|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813657|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813658|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43813660|NCT04809532|Bupivacaine|bupivacaine|mesh-list
43813661|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
43813662|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
43813663|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813664|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813665|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
43813666|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813667|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43813668|NCT04809532|Narcotics|narcotics|mesh-ancestor
43813669|NCT04809532|Analgesics|analgesics|mesh-ancestor
43813670|NCT04809142|Gemcitabine|gemcitabine|mesh-list
43813671|NCT04809142|Capecitabine|capecitabine|mesh-list
43813672|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
43813673|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43813674|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
43813675|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813676|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813688|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813689|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813690|NCT04808739|Adalimumab|adalimumab|mesh-list
43813691|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813692|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43813693|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
43813694|NCT04808856|Hormones|hormones|mesh-list
43813695|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43813696|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43813697|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
43813698|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813699|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813700|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813701|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
43813702|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
43813703|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813704|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813705|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
43813706|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43813707|NCT04808856|Protective Agents|protective agents|mesh-ancestor
43813708|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813709|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813711|NCT04808648|Rifampin|rifampin|mesh-list
43813723|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43813724|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
43813725|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43813727|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43813728|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43813729|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43813730|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43813746|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43813747|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43813748|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813749|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
43813750|NCT04808791|Trifluridine|trifluridine|mesh-list
43813751|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
43813752|NCT04808791|Irinotecan|irinotecan|mesh-list
43813753|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813754|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43813778|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813779|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813781|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43813782|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43813783|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813784|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43813787|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43813788|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43813789|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
43813790|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813806|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
43813807|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813808|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813809|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43813810|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
43813811|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
43813812|NCT04807413|Protective Agents|protective agents|mesh-ancestor
43813813|NCT04807543|Castor Oil|castor oil|mesh-list
43813814|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43813815|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
43813816|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43813817|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
43813818|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813819|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813820|NCT04807543|Progestins|progestins|mesh-ancestor
43813821|NCT04807543|Hormones|hormones|mesh-ancestor
43813822|NCT04807543|Cathartics|cathartics|mesh-ancestor
43813823|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813824|NCT04807140|Paclitaxel|paclitaxel|mesh-list
43813825|NCT04807140|Carboplatin|carboplatin|mesh-list
43813826|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43813827|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813828|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
43813829|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
43813830|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
43813831|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813832|NCT04807309|Danazol|danazol|mesh-list
43813833|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43813834|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
43813835|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813836|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813837|NCT04807166|Paclitaxel|paclitaxel|mesh-list
43813838|NCT04807166|Carboplatin|carboplatin|mesh-list
43813839|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43813840|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813841|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
43813842|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
43813843|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
43813844|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813845|NCT04807335|Sufentanil|sufentanil|mesh-list
43813846|NCT04807335|Ketamine|ketamine|mesh-list
43813847|NCT04807335|Analgesics|analgesics|mesh-ancestor
43813848|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
43813849|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813850|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813851|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43813852|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43813853|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
43813854|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
43813855|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813856|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43813877|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813878|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
43813879|NCT04807127|Durvalumab|durvalumab|mesh-list
43813880|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43813881|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43813882|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813883|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813884|NCT04806945|Paclitaxel|paclitaxel|mesh-list
43813885|NCT04806945|Cisplatin|cisplatin|mesh-list
43813886|NCT04806945|Carboplatin|carboplatin|mesh-list
43813887|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43813888|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813889|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
43813890|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
43813891|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
43813892|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813893|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
43813894|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43813919|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813920|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813921|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43813922|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43813923|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43813924|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43813925|NCT04806438|Lidocaine|lidocaine|mesh-list
43813926|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
43813927|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
43813928|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813929|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813930|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
43813931|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813932|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43844748|NCT04340141|Leucovorin|leucovorin|mesh-list
43813933|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43813934|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43813935|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43813936|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813937|NCT04806230|Mirtazapine|mirtazapine|mesh-list
43813938|NCT04806230|Citalopram|citalopram|mesh-list
43813939|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43813940|NCT04806230|Sertraline|sertraline|mesh-list
43813941|NCT04806230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43813942|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43813943|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43813944|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813945|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813946|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
43813947|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813948|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43844750|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
43844751|NCT04340141|Irinotecan|irinotecan|mesh-list
43844752|NCT04340141|Calcium|calcium|mesh-list
43844753|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
43844754|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43844755|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844756|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
43844757|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844758|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43844759|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844760|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844761|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
43844762|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43844763|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43844764|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844765|NCT04340141|Antidotes|antidotes|mesh-ancestor
43844766|NCT04340141|Protective Agents|protective agents|mesh-ancestor
43844767|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
43844791|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43813965|NCT04805775|Propofol|propofol|mesh-list
43813966|NCT04805775|Desflurane|desflurane|mesh-list
43813967|NCT04805775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43813968|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813969|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813970|NCT04805775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43813971|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
43813972|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
43813973|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43813974|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43813975|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
43813976|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813977|NCT04805957|Sulforaphane|sulforaphane|mesh-list
43813978|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43813979|NCT04805957|Protective Agents|protective agents|mesh-ancestor
43813980|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813981|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813982|NCT04805827|Gabapentin|gabapentin|mesh-list
43813983|NCT04805827|Analgesics|analgesics|mesh-ancestor
43813984|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
43813985|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813986|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813987|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
43813988|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43813989|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43813990|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813991|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43813992|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43813993|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43813994|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813995|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813996|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
43814048|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814049|NCT04804267|Linaclotide|linaclotide|mesh-list
43814074|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43814075|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
43814076|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814077|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43814078|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814079|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814080|NCT04803162|Omeprazole|omeprazole|mesh-list
43814081|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43814082|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814083|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43814084|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814085|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814086|NCT04803175|Valsartan|valsartan|mesh-list
43814087|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43814088|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43814089|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43814090|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43814091|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814092|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
43844797|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43844798|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844799|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
43844806|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43844807|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43844808|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43844809|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844810|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844811|NCT04337970|Axitinib|axitinib|mesh-list
43844812|NCT04337970|Talazoparib|talazoparib|mesh-list
43844813|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814105|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
43814106|NCT04802967|Gabapentin|gabapentin|mesh-list
43814107|NCT04802967|Analgesics|analgesics|mesh-ancestor
43814108|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
43814109|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814110|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814111|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
43814112|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43814113|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43814114|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814137|NCT04802785|Domperidone|domperidone|mesh-list
43814138|NCT04802785|Melatonin|melatonin|mesh-list
43814139|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43814140|NCT04802785|Simethicone|simethicone|mesh-list
43814141|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
43814142|NCT04802785|Citric Acid|citric acid|mesh-list
43814143|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
43814144|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
43814145|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43814146|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
43814147|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
43814148|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814149|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
43814150|NCT04802785|Protective Agents|protective agents|mesh-ancestor
43814151|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814152|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814153|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43814154|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43814155|NCT04802785|Analgesics|analgesics|mesh-ancestor
43814156|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
43814157|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814158|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814159|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814160|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43814161|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43814162|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43814163|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43814164|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814186|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
43814187|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
43814188|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814189|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43814190|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
43814191|NCT04802980|Antiviral Agents|antiviral agents|mesh-ancestor
43814192|NCT04802980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814193|NCT04802980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814194|NCT04802980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43814195|NCT04802980|Immunologic Factors|immunologic factors|mesh-ancestor
43814196|NCT04802980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814198|NCT04802122|Sevoflurane|sevoflurane|mesh-list
43849637|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
43814286|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43814287|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43814288|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43814289|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43814290|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814291|NCT04799847|Catumaxomab|catumaxomab|mesh-list
43814292|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814293|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43814294|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
43814297|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
43814298|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814299|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814300|NCT04799925|Febuxostat|febuxostat|mesh-list
43814301|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
43814302|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814303|NCT04799743|Resveratrol|resveratrol|mesh-list
43814304|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
43814305|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814306|NCT04799743|Protective Agents|protective agents|mesh-ancestor
43814307|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814308|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814309|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43814310|NCT04799639|Paclitaxel|paclitaxel|mesh-list
43814311|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43814312|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814313|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
43814314|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
43814315|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
43814316|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814317|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43814319|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814323|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
43814324|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814325|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814326|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43814327|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43814328|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
43814329|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814330|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43814331|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43814341|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814342|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
43814343|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814344|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43814345|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43814346|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
43814347|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814348|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814349|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43814350|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43814351|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
43814352|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43814353|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
43814354|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
43814355|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
43814356|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43814357|NCT04798703|Paclitaxel|paclitaxel|mesh-list
43814358|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
43814359|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43814360|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814361|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
43814362|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
43814363|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
43814364|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814365|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43814366|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
43814367|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814368|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
43814369|NCT04798703|Protective Agents|protective agents|mesh-ancestor
43814370|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
43814371|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814372|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
43814373|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
43814374|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
43814375|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43814376|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
43814377|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814378|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
43814379|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43814380|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
43814381|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814382|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
43848830|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814422|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814424|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43814425|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43814426|NCT04797793|Analgesics|analgesics|mesh-ancestor
43814427|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
43814428|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814429|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814430|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814431|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814432|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
43814433|NCT04797338|Nafarelin|nafarelin|mesh-list
43814434|NCT04797338|Progesterone|progesterone|mesh-list
43814435|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43814436|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
43814437|NCT04797338|Estradiol|estradiol|mesh-list
43814438|NCT04797338|Progestins|progestins|mesh-ancestor
43814439|NCT04797338|Hormones|hormones|mesh-ancestor
43814440|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814441|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814442|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43814443|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
43814444|NCT04797338|Estrogens|estrogens|mesh-ancestor
43814445|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43814447|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
43814468|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
43814469|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814470|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814471|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43814472|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
43814473|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814474|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814475|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43814476|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
43814477|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
43814478|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844828|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43844829|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43844830|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844831|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43844832|NCT04331652|Anesthetics|anesthetics|mesh-list
43844833|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844834|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844835|NCT04331639|Vitamin D|vitamin d|mesh-list
43844836|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
43844837|NCT04331639|Vitamins|vitamins|mesh-ancestor
43844838|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
43844839|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844840|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43814498|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43814499|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814500|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43814511|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814512|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814513|NCT04794738|Morphine|morphine|mesh-list
43814514|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43814515|NCT04794738|Narcotics|narcotics|mesh-ancestor
43814516|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814517|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814518|NCT04794738|Analgesics|analgesics|mesh-ancestor
43814519|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
43814520|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814521|NCT04794426|Fluorides|fluorides|mesh-list
43814522|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
43814547|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814548|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43814549|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43814550|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814552|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814553|NCT04794049|Lactulose|lactulose|mesh-list
43814554|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814555|NCT04794127|Pioglitazone|pioglitazone|mesh-list
43814556|NCT04794127|Trabectedin|trabectedin|mesh-list
43814569|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43844865|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844866|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43844867|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844868|NCT04329806|Amlodipine|amlodipine|mesh-list
43844869|NCT04329806|Moxonidine|moxonidine|mesh-list
43844870|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43844871|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43844872|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43844873|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844874|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43844875|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844876|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
43844877|NCT04329624|Simendan|simendan|mesh-list
43844878|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43844879|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
43844880|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43844881|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43844882|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844883|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844884|NCT04329624|Protective Agents|protective agents|mesh-ancestor
43844885|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844887|NCT04329065|Trastuzumab|trastuzumab|mesh-list
43844888|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43844889|NCT04329065|Pertuzumab|pertuzumab|mesh-list
43844890|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43844891|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43844893|NCT04329065|Antibodies|antibodies|mesh-list
43844894|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
43844895|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43844896|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
43844897|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
43844898|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844899|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43844900|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844901|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
43844902|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
43844903|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
43844904|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844905|NCT04327206|Vaccines|vaccines|mesh-list
43844906|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
43844907|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
43844908|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844909|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43814570|NCT04793256|Listerine|listerine|mesh-list
43814571|NCT04793256|Fluorides|fluorides|mesh-list
43814572|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
43814573|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
43814574|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
43814575|NCT04793256|Protective Agents|protective agents|mesh-ancestor
43814585|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43814587|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814588|NCT04793152|Vancomycin|vancomycin|mesh-list
43814589|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43814590|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814591|NCT04793022|Anesthetics|anesthetics|mesh-list
43814592|NCT04793022|Propofol|propofol|mesh-list
43814593|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814594|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814595|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43814596|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43814597|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
43814598|NCT04792723|Aspirin|aspirin|mesh-list
43814599|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43814600|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43814601|NCT04792723|Analgesics|analgesics|mesh-ancestor
43814602|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
43814603|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814604|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814605|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814606|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814607|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43814608|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43814609|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814610|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43814611|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43814612|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814630|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814631|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814632|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43814633|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43814634|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814635|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814636|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43814637|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43814638|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814639|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
43814640|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814641|NCT04792333|Firibastat|firibastat|mesh-list
43814642|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43814643|NCT04792138|Phenobarbital|phenobarbital|mesh-list
43814644|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
43814645|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43844910|NCT04326283|Trametinib|trametinib|mesh-list
43814646|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814647|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814648|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43814649|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43814650|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814651|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814653|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
43814654|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43814655|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43814656|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43814657|NCT04792515|Apatinib|apatinib|mesh-list
43814658|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814659|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43814660|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814661|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814662|NCT04792034|Cocaine|cocaine|mesh-list
43814663|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
43814664|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
43814665|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814666|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814667|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
43814668|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814669|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43814670|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43814671|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43814672|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43814679|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814680|NCT04791345|Dexamethasone|dexamethasone|mesh-list
43814681|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
43814696|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814697|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
43814698|NCT04791345|Hormones|hormones|mesh-ancestor
43814699|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814700|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43814701|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814702|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
43814703|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814704|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814705|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43814706|NCT04791345|Protective Agents|protective agents|mesh-ancestor
43814707|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43814708|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
43814731|NCT04791202|Protective Agents|protective agents|mesh-ancestor
43814732|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43814733|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814734|NCT04790838|Fluticasone|fluticasone|mesh-list
43814736|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43814737|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43814738|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814739|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43814740|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
43814741|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814742|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814743|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43814744|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
43814745|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
43814746|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43814747|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43814748|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43814749|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43814750|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
43814751|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814752|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814753|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
43814754|NCT04790838|Hormones|hormones|mesh-ancestor
43814755|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844918|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43844919|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844920|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844921|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43844922|NCT04326283|Protective Agents|protective agents|mesh-ancestor
43844923|NCT04325503|Levodopa|levodopa|mesh-list
43844924|NCT04325503|Carbidopa|carbidopa|mesh-list
43844925|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43844926|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43844927|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
43844928|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844929|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844930|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844931|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43844932|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814769|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
43814770|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
43814771|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
43814772|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43814773|NCT04790383|Protective Agents|protective agents|mesh-ancestor
43814774|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815809|NCT03267121|Apatinib|apatinib|mesh-list
43814787|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
43814788|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
43814789|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814790|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814796|NCT04790448|Vemurafenib|vemurafenib|mesh-list
43814797|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43814798|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43814799|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814800|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814801|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814802|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43814803|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43814804|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43814805|NCT04790331|Verapamil|verapamil|mesh-list
43814806|NCT04790331|Diltiazem|diltiazem|mesh-list
43814807|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43814808|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43814809|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43814810|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814811|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43814813|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
43814814|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43814815|NCT04790136|Cannabidiol|cannabidiol|mesh-list
43814816|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
43814817|NCT04789941|Irinotecan|irinotecan|mesh-list
43814818|NCT04789941|Cisplatin|cisplatin|mesh-list
43814819|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43814820|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43814821|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814822|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814823|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814824|NCT04789915|Memantine|memantine|mesh-list
43814825|NCT04789915|Amisulpride|amisulpride|mesh-list
43814826|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43814827|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43814828|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
43814829|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814831|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814833|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43814834|NCT04789915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43814835|NCT04789915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43814836|NCT04789915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814837|NCT04789915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43814838|NCT04789915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43814839|NCT04789915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43814840|NCT04789915|Antidepressive Agents|antidepressive agents|mesh-ancestor
43814841|NCT04789005|Phenylephrine|phenylephrine|mesh-list
43814842|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
43814843|NCT04789005|Norepinephrine|norepinephrine|mesh-list
43814844|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43814845|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
43814846|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
43814847|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814848|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814849|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
43814850|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43814851|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
43627715|NCT03071679|Imiquimod|imiquimod|mesh-list
43814852|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
43814853|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43814854|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43814855|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43814856|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
43814857|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814858|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814859|NCT04789005|Protective Agents|protective agents|mesh-ancestor
43814860|NCT04788979|Melatonin|melatonin|mesh-list
43814861|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
43814862|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814863|NCT04788979|Protective Agents|protective agents|mesh-ancestor
43814864|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814865|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814866|NCT04788654|Acetaminophen|acetaminophen|mesh-list
43814867|NCT04788654|Dexamethasone|dexamethasone|mesh-list
43814871|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
43814872|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814873|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814874|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814875|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
43814876|NCT04788654|Hormones|hormones|mesh-ancestor
43814877|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814878|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43814879|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814880|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43814881|NCT04788654|Analgesics|analgesics|mesh-ancestor
43814882|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
43814883|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
43814884|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43814885|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814886|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43814887|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43814888|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814889|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814891|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
43814892|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
43814893|NCT04788355|Apixaban|apixaban|mesh-list
43814894|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
43814895|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43814896|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43814897|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814898|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814899|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814900|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814901|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43814902|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
43814903|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43814904|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
43814905|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
43814906|NCT04788381|Bevacizumab|bevacizumab|mesh-list
43814909|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43814910|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43814911|NCT04788381|Growth Substances|growth substances|mesh-ancestor
43814912|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814913|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
43814914|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
43814915|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43814916|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814917|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
43814918|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43814919|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43814920|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814921|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
43814922|NCT04788121|Coagulants|coagulants|mesh-ancestor
43814969|NCT04786327|Protective Agents|protective agents|mesh-ancestor
43814970|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814971|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43814973|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
43814974|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
43814975|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814976|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814977|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
43814978|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814979|NCT04785716|Niraparib|niraparib|mesh-list
43814980|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43814996|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814997|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43814998|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43814999|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43815000|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
43815001|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815002|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43815003|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
43815004|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
43815005|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815006|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43815007|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43815008|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43815009|NCT04785755|Protective Agents|protective agents|mesh-ancestor
43815010|NCT04786002|Busulfan|busulfan|mesh-list
43815011|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
43815012|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815013|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815014|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
43815015|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815016|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43815017|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815018|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43815019|NCT04785911|Antiemetics|antiemetics|mesh-list
43815020|NCT04785911|Histamine|histamine|mesh-list
43815021|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
43815022|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
43815023|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815024|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815025|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815027|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815810|NCT03267121|Tegafur|tegafur|mesh-list
43815042|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815043|NCT04785183|Protective Agents|protective agents|mesh-ancestor
43815044|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844972|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844973|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844974|NCT04316013|Lidocaine|lidocaine|mesh-list
43844975|NCT04316013|Propofol|propofol|mesh-list
43844976|NCT04316013|Sevoflurane|sevoflurane|mesh-list
43844977|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
43844978|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
43844979|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844980|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844981|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
43844982|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844983|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43844984|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43844985|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43844986|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43844987|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844988|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43844989|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43844990|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
43844991|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43844992|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43848831|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849038|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849039|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815060|NCT04785118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43815061|NCT04785118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43815062|NCT04785118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815063|NCT04785118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43815064|NCT04785118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43815065|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43815066|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
43815067|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43815068|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
43815069|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43815070|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
43815071|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
43815072|NCT04785222|Bupivacaine|bupivacaine|mesh-list
43815073|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
43815074|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
43815075|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815076|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815077|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
43815078|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815079|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43815080|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43815081|NCT04785222|Analgesics|analgesics|mesh-ancestor
43815082|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43815083|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43815084|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43815085|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
43815086|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815087|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815088|NCT04784988|BAX 855|bax 855|mesh-list
43815089|NCT04784988|Coagulants|coagulants|mesh-ancestor
43815090|NCT04784728|Lidocaine|lidocaine|mesh-list
43815091|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
43815092|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
43815093|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815094|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815100|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43815101|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815103|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
43815104|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43815105|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815106|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43815107|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815108|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815109|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
43815110|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43815111|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
43815112|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815113|NCT04784481|Ivermectin|ivermectin|mesh-list
43815114|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43815115|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815116|NCT05473234|Amoxicillin|amoxicillin|mesh-list
43815117|NCT05473234|Azithromycin|azithromycin|mesh-list
43815118|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43815119|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628045|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815120|NCT05472948|Capecitabine|capecitabine|mesh-list
43844993|NCT04315558|Bromides|bromides|mesh-list
43815121|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43815122|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
43815123|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815124|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815125|NCT05472896|Epirubicin|epirubicin|mesh-list
43815126|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43815127|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815130|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815142|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815143|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815144|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43815145|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
43815146|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43815147|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
43815148|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
43815149|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815150|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815152|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815153|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815154|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43815155|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815156|NCT05471609|Levodopa|levodopa|mesh-list
43815157|NCT05471609|Carbidopa|carbidopa|mesh-list
43815158|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43815159|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43815160|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
43815161|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815870|NCT02848820|Gentamicins|gentamicins|mesh-list
43845015|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43845016|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
43845017|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845018|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845019|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43845020|NCT04314375|Budesonide|budesonide|mesh-list
43845021|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845022|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43815166|NCT05471531|Vaccines|vaccines|mesh-list
43815167|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43815168|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
43815169|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815170|NCT05469243|Hallucinogens|hallucinogens|mesh-list
43815171|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815172|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43815173|NCT05466318|Gemcitabine|gemcitabine|mesh-list
43815174|NCT05466318|Cytarabine|cytarabine|mesh-list
43815175|NCT05466318|Etoposide|etoposide|mesh-list
43815176|NCT05466318|Melphalan|melphalan|mesh-list
43815177|NCT05466318|Busulfan|busulfan|mesh-list
43815178|NCT05466318|Carmustine|carmustine|mesh-list
43815179|NCT05466318|Cladribine|cladribine|mesh-list
43815180|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43815181|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
43815182|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815183|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815184|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
43815185|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815186|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815187|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815196|NCT05461820|Methimazole|methimazole|mesh-list
43815200|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815201|NCT05453253|Vaccines|vaccines|mesh-list
43815202|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
43815203|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815204|NCT05445791|Metformin|metformin|mesh-list
43815205|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43815206|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815207|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
43815208|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815209|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815210|NCT05328388|Lycopene|lycopene|mesh-list
43815211|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43815212|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
43815213|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815214|NCT05328388|Protective Agents|protective agents|mesh-ancestor
43815215|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815216|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43815217|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43815218|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815219|NCT05281614|Etanercept|etanercept|mesh-list
43815224|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
43815225|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815226|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815227|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43815284|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43815285|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
43815286|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
43815287|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43815288|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43815289|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43815290|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43815291|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
43815292|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815293|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845023|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
43845024|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845025|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845026|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43815294|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
43815295|NCT05013632|Remdesivir|remdesivir|mesh-list
43815296|NCT05013632|Antibodies|antibodies|mesh-list
43815297|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43815298|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
43815299|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815300|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815301|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
43815302|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815303|NCT04988035|Remdesivir|remdesivir|mesh-list
43815304|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
43815330|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
43815331|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815332|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
43815333|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
43815334|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
43815335|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815336|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815337|NCT04762771|Colchicine|colchicine|mesh-list
43815338|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
43815339|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815396|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
43815397|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43815398|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43815399|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43815400|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43815408|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43815409|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
43815410|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815411|NCT04481035|Expectorants|expectorants|mesh-ancestor
43815412|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
43815413|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43815414|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
43815415|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815416|NCT04481035|Protective Agents|protective agents|mesh-ancestor
43815417|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815418|NCT04481035|Antidotes|antidotes|mesh-ancestor
43815419|NCT04462952|Adavosertib|adavosertib|mesh-list
43815420|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815421|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815422|NCT04429022|Acetaminophen|acetaminophen|mesh-list
43815424|NCT04429022|Ketorolac|ketorolac|mesh-list
43815425|NCT04429022|Oxycodone|oxycodone|mesh-list
43815426|NCT04429022|Gabapentin|gabapentin|mesh-list
43815427|NCT04429022|Hydromorphone|hydromorphone|mesh-list
43815428|NCT04429022|Ropivacaine|ropivacaine|mesh-list
43815429|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
43815430|NCT04429022|Anesthetics|anesthetics|mesh-list
43815431|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815432|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815433|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
43816053|NCT00988364|Simvastatin|simvastatin|mesh-list
43815441|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43815442|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815443|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43815444|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43815445|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815446|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815447|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
43815448|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43815449|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43815450|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43815451|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43815452|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43815453|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815454|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
43815455|NCT04389411|Montelukast|montelukast|mesh-list
43815456|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43815457|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
43815458|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43815459|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
43815460|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43815461|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815462|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43815463|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43815464|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845027|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
43845028|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
43845030|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845031|NCT04311671|Ivermectin|ivermectin|mesh-list
43845032|NCT04311671|Moxidectin|moxidectin|mesh-list
43845033|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43845034|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845035|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
43845036|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
43845037|NCT04311411|Liraglutide|liraglutide|mesh-list
43845038|NCT04311411|Tirzepatide|tirzepatide|mesh-list
43845039|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845040|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845041|NCT04311411|Incretins|incretins|mesh-ancestor
43845042|NCT04311411|Hormones|hormones|mesh-ancestor
43845043|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845044|NCT04310930|Azithromycin|azithromycin|mesh-list
43845045|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
43845046|NCT04310930|Clarithromycin|clarithromycin|mesh-list
43845047|NCT04310930|Doxycycline|doxycycline|mesh-list
43845048|NCT04310930|Linezolid|linezolid|mesh-list
43845049|NCT04310930|Imipenem|imipenem|mesh-list
43845050|NCT04310930|Amikacin|amikacin|mesh-list
43845051|NCT04310930|Ethambutol|ethambutol|mesh-list
43845052|NCT04310930|Rifabutin|rifabutin|mesh-list
43845053|NCT04310930|Tigecycline|tigecycline|mesh-list
43845054|NCT04310930|Bedaquiline|bedaquiline|mesh-list
43845055|NCT04310930|Clofazimine|clofazimine|mesh-list
43845056|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43845057|NCT04310930|Cefoxitin|cefoxitin|mesh-list
43845062|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845066|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43845067|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43845068|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
43845069|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43845070|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43845071|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
43845072|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43845073|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845074|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
43845075|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43845077|NCT04310397|Trametinib|trametinib|mesh-list
43845078|NCT04310397|Dabrafenib|dabrafenib|mesh-list
43845079|NCT04310397|Spartalizumab|spartalizumab|mesh-list
43815465|NCT04153435|Calcium|calcium|mesh-list
43815466|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43815467|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815468|NCT04091126|Dexamethasone|dexamethasone|mesh-list
43815469|NCT04091126|Lenalidomide|lenalidomide|mesh-list
43815470|NCT04091126|Bortezomib|bortezomib|mesh-list
43815471|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43815472|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
43815478|NCT04091126|Hormones|hormones|mesh-ancestor
43815479|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43815480|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43815481|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815482|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
43815483|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43815484|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43815485|NCT04091126|Growth Substances|growth substances|mesh-ancestor
43815486|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
43815487|NCT04085458|Factor VIII|factor viii|mesh-list
43815488|NCT04085458|Coagulants|coagulants|mesh-ancestor
43815489|NCT04026776|Allopurinol|allopurinol|mesh-list
43815490|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
43815491|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815492|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815493|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
43815494|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815495|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43815496|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
43815497|NCT04026776|Protective Agents|protective agents|mesh-ancestor
43815498|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815499|NCT04023019|Thrombin|thrombin|mesh-list
43815500|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
43815501|NCT04023019|Coagulants|coagulants|mesh-ancestor
43815502|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43815503|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43815530|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
43815531|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815532|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
43815533|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815534|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
43815535|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815536|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815537|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
43815538|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43815539|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
43815540|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815541|NCT03900988|Expectorants|expectorants|mesh-ancestor
43815542|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
43815543|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43815544|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
43815545|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815546|NCT03900988|Protective Agents|protective agents|mesh-ancestor
43815547|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815548|NCT03900988|Antidotes|antidotes|mesh-ancestor
43815549|NCT03843853|Bevacizumab|bevacizumab|mesh-list
43815550|NCT03843853|Pemetrexed|pemetrexed|mesh-list
43815551|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815552|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815553|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43815554|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43815555|NCT03843853|Growth Substances|growth substances|mesh-ancestor
43815556|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815557|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
43815563|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
43815564|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815565|NCT03819517|Protective Agents|protective agents|mesh-ancestor
43815566|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815567|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815568|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43815569|NCT03794388|Pregabalin|pregabalin|mesh-list
43815570|NCT03794388|Capsaicin|capsaicin|mesh-list
43815571|NCT03794388|Analgesics|analgesics|mesh-ancestor
43815572|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
43815579|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43815580|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43815581|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43815582|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815583|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43815584|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
43815585|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
43815586|NCT03714958|Trametinib|trametinib|mesh-list
43815587|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815588|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43815589|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815590|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815591|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43815594|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
43815607|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
43815608|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815609|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43815610|NCT03548428|Atezolizumab|atezolizumab|mesh-list
43815611|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815612|NCT03535298|Interferons|interferons|mesh-list
43815613|NCT03535298|Interferon-beta|interferon-beta|mesh-list
43815614|NCT03535298|Teriflunomide|teriflunomide|mesh-list
43815615|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
43815616|NCT03535298|Ofatumumab|ofatumumab|mesh-list
43815617|NCT03535298|Cladribine|cladribine|mesh-list
43815618|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
43815619|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43815620|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
43815621|NCT03535298|Natalizumab|natalizumab|mesh-list
43815622|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43815623|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
43815624|NCT03535298|Ozanimod|ozanimod|mesh-list
43815625|NCT03535298|Ponesimod|ponesimod|mesh-list
43815628|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815629|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
43815630|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815631|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815632|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
43815633|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815634|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815635|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43815636|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815637|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
43815638|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43815639|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43815640|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43815641|NCT03535298|Analgesics|analgesics|mesh-ancestor
43815642|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
43815643|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815644|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43815645|NCT03526185|Nivolumab|nivolumab|mesh-list
43815646|NCT03526185|Ipilimumab|ipilimumab|mesh-list
43815647|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815648|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815649|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43815650|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815651|NCT03511118|Metformin|metformin|mesh-list
43815652|NCT03511118|Topiramate|topiramate|mesh-list
43815653|NCT03511118|Azithromycin|azithromycin|mesh-list
43815654|NCT03511118|Doxycycline|doxycycline|mesh-list
43815655|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
43815656|NCT03511118|Levofloxacin|levofloxacin|mesh-list
43815657|NCT03511118|Clindamycin|clindamycin|mesh-list
43815658|NCT03511118|Valganciclovir|valganciclovir|mesh-list
43815659|NCT03511118|Remdesivir|remdesivir|mesh-list
43815660|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
43815661|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43815662|NCT03511118|Verapamil|verapamil|mesh-list
43815663|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43815664|NCT03511118|Labetalol|labetalol|mesh-list
43815665|NCT03511118|Nifedipine|nifedipine|mesh-list
43815666|NCT03511118|Furosemide|furosemide|mesh-list
43815667|NCT03511118|Sumatriptan|sumatriptan|mesh-list
43815668|NCT03511118|Oxycodone|oxycodone|mesh-list
43815669|NCT03511118|Gabapentin|gabapentin|mesh-list
43815670|NCT03511118|Ondansetron|ondansetron|mesh-list
43815671|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
43815672|NCT03511118|Trazodone|trazodone|mesh-list
43815673|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
43815674|NCT03511118|Methylphenidate|methylphenidate|mesh-list
43815675|NCT03511118|Citalopram|citalopram|mesh-list
43815676|NCT03511118|Sertraline|sertraline|mesh-list
43815677|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43815678|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
43815682|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43815683|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43815684|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
43815685|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815686|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43815687|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43815688|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815689|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43815690|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815691|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43815692|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43815743|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43815744|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43815745|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43815747|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
43815748|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43815749|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815750|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43815751|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43815752|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43815753|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
43815754|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43815755|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43815756|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43815757|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43815758|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
43815759|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
43815760|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43815761|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43815762|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43815763|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43815764|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43815765|NCT03497689|Treprostinil|treprostinil|mesh-list
43815766|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43815767|NCT03358706|Vitamin K|vitamin k|mesh-list
43815768|NCT03358706|Midazolam|midazolam|mesh-list
43815769|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
43815770|NCT03358706|Caffeine|caffeine|mesh-list
43815771|NCT03358706|Ustekinumab|ustekinumab|mesh-list
43815772|NCT03358706|Omeprazole|omeprazole|mesh-list
43815773|NCT03358706|Warfarin|warfarin|mesh-list
43815789|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815790|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
43815791|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43815792|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815793|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43815794|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815795|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43815796|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43815797|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43815798|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43815799|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
43815800|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
43815801|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43815802|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43815803|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
43815804|NCT03358706|Coagulants|coagulants|mesh-ancestor
43815805|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
43815806|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
43815807|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43815808|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43815811|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815812|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43815813|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815815|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43815838|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43815840|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815841|NCT02885974|Antiviral Agents|antiviral agents|mesh-ancestor
43815842|NCT02885974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815843|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815844|NCT02885974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815845|NCT02885974|Immunologic Factors|immunologic factors|mesh-ancestor
43815846|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815847|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43815848|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43815849|NCT02885974|Analgesics|analgesics|mesh-ancestor
43815850|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
43815851|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815852|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43815853|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815854|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43815855|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43845080|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845081|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43845082|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845083|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845084|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43845085|NCT04307550|Ethanol|ethanol|mesh-list
43845086|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43845087|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845088|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845089|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845090|NCT04307511|Aspirin|aspirin|mesh-list
43845091|NCT04307511|Ticagrelor|ticagrelor|mesh-list
43845092|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43845103|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43845104|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43845105|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845107|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43845108|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43845109|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43845110|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
43845111|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845112|NCT04307238|Anesthetics|anesthetics|mesh-list
43845113|NCT04307238|Propofol|propofol|mesh-list
43845114|NCT04307238|Sevoflurane|sevoflurane|mesh-list
43845115|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845116|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845117|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43845118|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43845119|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
43845120|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43845121|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43845122|NCT04305002|Exenatide|exenatide|mesh-list
43845123|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845124|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845125|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43845126|NCT04305002|Incretins|incretins|mesh-ancestor
43845127|NCT04305002|Hormones|hormones|mesh-ancestor
43845128|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845129|NCT04303689|Colchicine|colchicine|mesh-list
43845130|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
43845131|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845132|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
43845133|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
43845134|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
43815860|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815861|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43815862|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43815863|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43815864|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43815865|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43815866|NCT02866643|Progestins|progestins|mesh-ancestor
43815868|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43815869|NCT02848820|Amoxicillin|amoxicillin|mesh-list
43815871|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43815872|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
43815873|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
43815874|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43815875|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815876|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43815877|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815878|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815879|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43815880|NCT02835079|Tamoxifen|tamoxifen|mesh-list
43815881|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43815882|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
43815883|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43815884|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815885|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43815886|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815887|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43815888|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43815889|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43815890|NCT02790515|Sirolimus|sirolimus|mesh-list
43815891|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
43815892|NCT02790515|Melphalan|melphalan|mesh-list
43815894|NCT02790515|Thiotepa|thiotepa|mesh-list
43815901|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815902|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
43815903|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815904|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815905|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43815906|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
43815907|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815908|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815909|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43815910|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815911|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43815912|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815913|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43815914|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815915|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43815916|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
43815917|NCT02730923|Anastrozole|anastrozole|mesh-list
43815918|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43815919|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815920|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43815921|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43815922|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815923|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815924|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43815925|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
43815926|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43815927|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815929|NCT02715609|Temozolomide|temozolomide|mesh-list
43628979|NCT03062800|Carboplatin|carboplatin|mesh-list
43815930|NCT02715609|Disulfiram|disulfiram|mesh-list
43815932|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
43815939|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43815940|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815941|NCT02678052|Vedolizumab|vedolizumab|mesh-list
43815942|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815943|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
43815944|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43815945|NCT02572791|Mupirocin|mupirocin|mesh-list
43815946|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43815947|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815948|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
43815949|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
43815950|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43815951|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43815952|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815953|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815954|NCT02531906|Oxycodone|oxycodone|mesh-list
43815955|NCT02531906|Methadone|methadone|mesh-list
43815956|NCT02531906|Gabapentin|gabapentin|mesh-list
43815957|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43815958|NCT02531906|Narcotics|narcotics|mesh-ancestor
43815959|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815982|NCT02414724|Gemcitabine|gemcitabine|mesh-list
43815995|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815997|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
43815998|NCT02412228|Ixazomib|ixazomib|mesh-list
43815999|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816000|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
43816001|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816002|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43816003|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43816004|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
43816005|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816006|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816007|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43816008|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816009|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
43816010|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
43816011|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816012|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43816013|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
43816014|NCT02412228|Hormones|hormones|mesh-ancestor
43816015|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816016|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43816017|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
43816018|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816019|NCT02227940|Gemcitabine|gemcitabine|mesh-list
43816020|NCT02227940|Paclitaxel|paclitaxel|mesh-list
43816021|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43816022|NCT02227940|Cisplatin|cisplatin|mesh-list
43816023|NCT02227940|Ceritinib|ceritinib|mesh-list
43816042|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816043|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816044|NCT01828710|Folic Acid|folic acid|mesh-list
43816045|NCT01828710|Inositol|inositol|mesh-list
43816046|NCT01828710|Hematinics|hematinics|mesh-ancestor
43816047|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
43816048|NCT01828710|Vitamins|vitamins|mesh-ancestor
43816049|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
43816050|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816052|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816055|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
43816056|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43816057|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43816058|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
43816059|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816060|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43816061|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43816062|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816063|NCT00347412|Paclitaxel|paclitaxel|mesh-list
43816064|NCT00347412|Carboplatin|carboplatin|mesh-list
43816065|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43816066|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816067|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816068|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
43816069|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
43816070|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816071|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43816072|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
43816073|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43816074|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816075|NCT05475054|Liver Extracts|liver extracts|mesh-list
43816076|NCT05475054|Hematinics|hematinics|mesh-ancestor
43816077|NCT05475041|Liver Extracts|liver extracts|mesh-list
43816085|NCT05474937|Sevoflurane|sevoflurane|mesh-list
43816086|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43816087|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816088|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816089|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43816090|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
43816091|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
43816092|NCT05474937|Analgesics|analgesics|mesh-ancestor
43816093|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
43816094|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816095|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43816096|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43816097|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43816098|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816099|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816100|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43816101|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43816102|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43816103|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43816104|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
43816105|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
43816106|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43816107|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43816108|NCT05474924|Prednisolone|prednisolone|mesh-list
43816109|NCT05474924|Budesonide|budesonide|mesh-list
43816110|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816111|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
43816112|NCT05474924|Hormones|hormones|mesh-ancestor
43816113|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816114|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816115|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43816116|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816123|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
43816124|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816125|NCT05474729|Minocycline|minocycline|mesh-list
43816126|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43816127|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816128|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43816129|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43816130|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43816131|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43816132|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43816133|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43816134|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43816135|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
43816136|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816137|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816138|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816139|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
43816140|NCT05474690|Carboplatin|carboplatin|mesh-list
43816141|NCT05474690|Docetaxel|docetaxel|mesh-list
43816142|NCT05474690|Trastuzumab|trastuzumab|mesh-list
43816143|NCT05474690|Epirubicin|epirubicin|mesh-list
43816145|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816146|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
43816147|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816148|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43816149|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43816150|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
43816151|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816152|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816153|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43816154|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816155|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
43816156|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
43816157|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816161|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816163|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
43816164|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816165|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816166|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43816167|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43845148|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845149|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845150|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845151|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43845152|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43845153|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845154|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845155|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43845156|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
43845157|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845158|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43845159|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43845160|NCT04300049|Glucagon|glucagon|mesh-list
43845161|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43845162|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43845163|NCT04300049|Hormones|hormones|mesh-ancestor
43845164|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845165|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845166|NCT04300049|Incretins|incretins|mesh-ancestor
43845167|NCT04299867|Metronidazole|metronidazole|mesh-list
43845168|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845171|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43629245|NCT03061136|Clonazepam|clonazepam|mesh-list
43816169|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43816170|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43816171|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43816172|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43816173|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
43816174|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816175|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816176|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816177|NCT05474001|Fentanyl|fentanyl|mesh-list
43816178|NCT05474001|Bupivacaine|bupivacaine|mesh-list
43816179|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
43816180|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
43816181|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816182|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816183|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
43816184|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816185|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43816186|NCT05474001|Narcotics|narcotics|mesh-ancestor
43816187|NCT05474001|Analgesics|analgesics|mesh-ancestor
43816219|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
43816220|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
43816221|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43816222|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43816223|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43816224|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43816225|NCT05468892|Trifluridine|trifluridine|mesh-list
43816226|NCT05468892|Panitumumab|panitumumab|mesh-list
43816227|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816228|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816229|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
43816230|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816249|NCT05455294|Navitoclax|navitoclax|mesh-list
43816250|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43816251|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
43816252|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816253|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816254|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816255|NCT05442567|Vedolizumab|vedolizumab|mesh-list
43816256|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43816289|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43816290|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43816291|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816292|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816293|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
43816294|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816295|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43816296|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
43816297|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43816298|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43816299|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43816300|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816301|NCT05304273|Letrozole|letrozole|mesh-list
43816302|NCT05304273|Misoprostol|misoprostol|mesh-list
43816303|NCT05304273|Mifepristone|mifepristone|mesh-list
43816304|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816305|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43816306|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43816307|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816316|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43816317|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43816319|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43816320|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43816344|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
43816345|NCT05195177|Histamine|histamine|mesh-list
43816346|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
43816347|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43816348|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816349|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816350|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
43816351|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816352|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
43816353|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
43816354|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816355|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816356|NCT05187377|Hormones|hormones|mesh-list
43816357|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816358|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816359|NCT05184842|Decitabine|decitabine|mesh-list
43816360|NCT05184842|Venetoclax|venetoclax|mesh-list
43816361|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43816362|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
43816363|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816364|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816365|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816366|NCT05170919|Olanzapine|olanzapine|mesh-list
43816367|NCT05170919|Mirtazapine|mirtazapine|mesh-list
43816368|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
43816369|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
43816370|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816371|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816372|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43816374|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43816375|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816376|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43816377|NCT05170919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43816378|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43816379|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43816380|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816381|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816382|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
43816383|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
43816384|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43816385|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
43816386|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
43816387|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43816388|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43816389|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43816390|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43816391|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
43816392|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43816393|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43816394|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43816395|NCT05168813|Vaccines|vaccines|mesh-list
43816396|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
43816397|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816398|NCT05151263|Salicylates|salicylates|mesh-list
43816399|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43816400|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43816401|NCT05151263|Analgesics|analgesics|mesh-ancestor
43816402|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
43816403|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816404|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816410|NCT05054179|Ropivacaine|ropivacaine|mesh-list
43816412|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
43629522|NCT03059134|Mirabegron|mirabegron|mesh-list
43816413|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
43816414|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816415|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816416|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
43816417|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816418|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
43816420|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
43816421|NCT05040568|Cetuximab|cetuximab|mesh-list
43816422|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816423|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
43816424|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816425|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43816426|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43816427|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
43816428|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816429|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816430|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43816431|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43816432|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
43816433|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816434|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
43816435|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43816436|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43816437|NCT04976868|Analgesics|analgesics|mesh-ancestor
43816438|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
43816439|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816440|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816441|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816442|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43816443|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
43816444|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816445|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
43816446|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43816447|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816448|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816449|NCT04976036|Nintedanib|nintedanib|mesh-list
43816450|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816451|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816452|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816453|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816454|NCT04928664|Bupivacaine|bupivacaine|mesh-list
43816455|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
43816456|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
43816457|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816458|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816459|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
43816460|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816461|NCT04926324|Niraparib|niraparib|mesh-list
43816462|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43816463|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816464|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816465|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816466|NCT04870359|Prednisolone|prednisolone|mesh-list
43816467|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43816468|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816469|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
43816471|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816472|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816473|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43816474|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816475|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
43816476|NCT04790032|Cangrelor|cangrelor|mesh-list
43816477|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43816478|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43816479|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43816480|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43816481|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
43816482|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816484|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816485|NCT04789057|Atorvastatin|atorvastatin|mesh-list
43816486|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43816487|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43816488|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
43816489|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816490|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43816501|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
43816502|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
43816503|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816504|NCT04773366|Cytarabine|cytarabine|mesh-list
43816505|NCT04773366|Prednisone|prednisone|mesh-list
43816506|NCT04773366|Vincristine|vincristine|mesh-list
43816507|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
43816508|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816509|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
43816510|NCT04773366|Hormones|hormones|mesh-ancestor
43816511|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816512|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816513|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43816514|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816515|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43816516|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
43816517|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816518|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
43816519|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816520|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816521|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
43816522|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43816523|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816524|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
43816525|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
43816526|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43816527|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816528|NCT04759274|Diuretics|diuretics|mesh-list
43816529|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
43816530|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816531|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
43816532|NCT04748224|Bupivacaine|bupivacaine|mesh-list
43816533|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
43816534|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
43816535|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816536|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816537|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
43816538|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816539|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43816540|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43816541|NCT04748224|Analgesics|analgesics|mesh-ancestor
43816542|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43816543|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43816544|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43816545|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
43816546|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816548|NCT04733963|Bevacizumab|bevacizumab|mesh-list
43816560|NCT04716413|Dsuvia|dsuvia|mesh-list
43845197|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43845198|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845199|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845200|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
43845201|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43845202|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
43845203|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
43845204|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
43845205|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
43816591|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43816592|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43816593|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816594|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816595|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
43816596|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43816597|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816598|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
43816599|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816600|NCT04562597|Expectorants|expectorants|mesh-ancestor
43816601|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
43816602|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43816603|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
43816604|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816605|NCT04562597|Protective Agents|protective agents|mesh-ancestor
43816606|NCT04562597|Antidotes|antidotes|mesh-ancestor
43816607|NCT04434560|Nivolumab|nivolumab|mesh-list
43816608|NCT04434560|Ipilimumab|ipilimumab|mesh-list
43816609|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816610|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816611|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43816612|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816613|NCT04428086|Metformin|metformin|mesh-list
43816616|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43816617|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816618|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43816619|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43816620|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
43816621|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816622|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43816623|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43816624|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816625|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816626|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816627|NCT04426409|Ofloxacin|ofloxacin|mesh-list
43816628|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43816629|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816630|NCT04426409|Renal Agents|renal agents|mesh-ancestor
43816631|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43816632|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43816633|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43816634|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816635|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816636|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816668|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
43816669|NCT04373603|Protective Agents|protective agents|mesh-ancestor
43816670|NCT04355858|Paclitaxel|paclitaxel|mesh-list
43816671|NCT04355858|Capecitabine|capecitabine|mesh-list
43816672|NCT04355858|Everolimus|everolimus|mesh-list
43816673|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43816674|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816675|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816676|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
43816677|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
43816678|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816679|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43816680|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
43816681|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816682|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
43816683|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816684|NCT04334863|Tyrphostins|tyrphostins|mesh-list
43816685|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816686|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816687|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816688|NCT04333706|Capecitabine|capecitabine|mesh-list
43816689|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43816690|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
43816691|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816692|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816693|NCT04331002|Triamcinolone|triamcinolone|mesh-list
43816717|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43816718|NCT04278755|Estradiol|estradiol|mesh-list
43816719|NCT04278755|Estrogens|estrogens|mesh-ancestor
43816720|NCT04278755|Hormones|hormones|mesh-ancestor
43816721|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816722|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816723|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43816784|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
43816785|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
43816786|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816787|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816788|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
43816789|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43816790|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
43816791|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
43816792|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43816793|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43816794|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43816795|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
43845206|NCT04295850|Aspirin|aspirin|mesh-list
43845207|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43845208|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43845209|NCT04295850|Analgesics|analgesics|mesh-ancestor
43845210|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
43845211|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845212|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845213|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845214|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845215|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43845216|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43845217|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845218|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43816951|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816952|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43816953|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43816954|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816955|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
43816956|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
43816957|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816958|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
43817010|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817011|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43817012|NCT02521415|Narcotics|narcotics|mesh-ancestor
43817013|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43817014|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817015|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
43817016|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43817017|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817018|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817019|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43817020|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817021|NCT02494882|Dexamethasone|dexamethasone|mesh-list
43817022|NCT02494882|Dasatinib|dasatinib|mesh-list
43817023|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817024|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
43817025|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
43817026|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817027|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817028|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817029|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
43817030|NCT02494882|Hormones|hormones|mesh-ancestor
43817031|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43817032|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43817033|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817034|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43817035|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817103|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43817104|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43817105|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
43817106|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817107|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
43817108|NCT01752491|Temozolomide|temozolomide|mesh-list
43817109|NCT01752491|Vitamins|vitamins|mesh-ancestor
43817110|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
43817111|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817112|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43817113|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
43817114|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817115|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817116|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
43817117|NCT01752491|Protective Agents|protective agents|mesh-ancestor
43817118|NCT01730638|Histamine|histamine|mesh-list
43817211|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43817212|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43817213|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43817214|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43817215|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817216|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43817217|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
43817218|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43817219|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43817220|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
43817265|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43817266|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43817267|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817268|NCT05558176|Urological Agents|urological agents|mesh-ancestor
43817269|NCT05558150|Aceclofenac|aceclofenac|mesh-list
43817270|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43817271|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817272|NCT05558150|Analgesics|analgesics|mesh-ancestor
43817273|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
43817274|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817275|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817277|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817328|NCT05557578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43817329|NCT05557578|Immunologic Factors|immunologic factors|mesh-ancestor
43817330|NCT05557578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817331|NCT05557344|Acetaminophen|acetaminophen|mesh-list
43817332|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817333|NCT05557344|Analgesics|analgesics|mesh-ancestor
43817334|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
43817335|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817378|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43817379|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
43817380|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
43817381|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43817382|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43817383|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43817384|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817385|NCT05556200|Apatinib|apatinib|mesh-list
43817386|NCT05556200|Antibodies|antibodies|mesh-list
43817387|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43817388|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
43817389|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817390|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817391|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43817392|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817393|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817394|NCT05556122|Betamethasone|betamethasone|mesh-list
43817395|NCT05556122|Ropivacaine|ropivacaine|mesh-list
43817435|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817444|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43630706|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43817479|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43817481|NCT05555147|Ropivacaine|ropivacaine|mesh-list
43817513|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817514|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
43817515|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43817516|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
43817517|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43817518|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43817519|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43817520|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
43845281|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845283|NCT04292743|Protective Agents|protective agents|mesh-ancestor
43845284|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
43845285|NCT04292743|Vitamins|vitamins|mesh-ancestor
43845286|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
43845287|NCT04292223|Pimavanserin|pimavanserin|mesh-list
43845288|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43845289|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43845290|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43845291|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43845292|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845293|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845294|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43845295|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43817579|NCT05554185|Analgesics|analgesics|mesh-ancestor
43817580|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
43817581|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817582|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817583|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817584|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817585|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43817586|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43817587|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817588|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43630891|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
43817617|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817618|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817619|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43817621|NCT05553717|Protective Agents|protective agents|mesh-ancestor
43817622|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43817623|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43817624|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43817625|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
43817626|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43817684|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43817685|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
43817686|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817687|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43817739|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817740|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
43817741|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
43817742|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
43817743|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817745|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
43817746|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
43817747|NCT05552729|Vitamins|vitamins|mesh-list
43817748|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
43817749|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817750|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43817751|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43817752|NCT05552651|Paclitaxel|paclitaxel|mesh-list
43817753|NCT05552651|Carboplatin|carboplatin|mesh-list
43817754|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43817755|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43817756|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817757|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
43817758|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
43817759|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
43817760|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817761|NCT05552586|Melatonin|melatonin|mesh-list
43817765|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817766|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817767|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
43817768|NCT05552391|Ketamine|ketamine|mesh-list
43817769|NCT05552391|Bupivacaine|bupivacaine|mesh-list
43817770|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
43817771|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
43817772|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817773|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817778|NCT05552391|Analgesics|analgesics|mesh-ancestor
43845355|NCT04283500|Buprenorphine|buprenorphine|mesh-list
43845356|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43817811|NCT05551767|Cisplatin|cisplatin|mesh-list
43817812|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
43817813|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817814|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43817815|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43817816|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43817817|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817818|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43817819|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43817820|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43817823|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817824|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
43817825|NCT05551624|Atorvastatin|atorvastatin|mesh-list
43817826|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43817827|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43817828|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43817829|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
43817830|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817831|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43817832|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43817833|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817834|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
43817835|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817836|NCT05551624|Expectorants|expectorants|mesh-ancestor
43817837|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
43817854|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817855|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43817856|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43817857|NCT05551247|Growth Substances|growth substances|mesh-ancestor
43817858|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817859|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
43817861|NCT05551221|Silodosin|silodosin|mesh-list
43817870|NCT05551208|Bevacizumab|bevacizumab|mesh-list
43817918|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43817919|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43817920|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817922|NCT05550402|Albuterol|albuterol|mesh-list
43817923|NCT05550402|Ipratropium|ipratropium|mesh-list
43817924|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
43817925|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43817926|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
43817927|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817928|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817929|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43817930|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
43817931|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
43817932|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43817933|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43817934|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43817935|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43817936|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
43817937|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817938|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817939|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43817940|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
43817941|NCT05550246|Oxybutynin|oxybutynin|mesh-list
43817942|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43817943|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43817966|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817967|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43817968|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43817969|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817970|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817971|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43817972|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
43817973|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817974|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
43817975|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43817976|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817977|NCT05550025|Apatinib|apatinib|mesh-list
43845393|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43845394|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845395|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
43845396|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
43845397|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
43845398|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817994|NCT05549778|Polaprezinc|polaprezinc|mesh-list
43817995|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43817996|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817997|NCT05549752|Amiodarone|amiodarone|mesh-list
43818108|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818109|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43818110|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43818111|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818113|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818114|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818115|NCT05548985|Midodrine|midodrine|mesh-list
43818116|NCT05548985|Metoclopramide|metoclopramide|mesh-list
43818117|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
43818118|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
43818119|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818120|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818121|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43818122|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43818123|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43818124|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
43818125|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818126|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818127|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
43818128|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43818129|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43818130|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43818131|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43818132|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
43818133|NCT05548465|Sufentanil|sufentanil|mesh-list
43818134|NCT05548465|Remifentanil|remifentanil|mesh-list
43818135|NCT05548465|Dsuvia|dsuvia|mesh-list
43818136|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43818137|NCT05548465|Narcotics|narcotics|mesh-ancestor
43818145|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
43818146|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
43818148|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43818149|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43818150|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818151|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
43818152|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
43818153|NCT05548348|Aflutinib|aflutinib|mesh-list
43818154|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43818155|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818156|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818157|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43818158|NCT05548283|Lactams|lactams|mesh-list
43818159|NCT05548283|beta-Lactams|beta-lactams|mesh-list
43818160|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818161|NCT05548270|Scopolamine|scopolamine|mesh-list
43845423|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
43845424|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43845425|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43845427|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43845428|NCT04279054|Narcotics|narcotics|mesh-ancestor
43845429|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845430|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818188|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
43818189|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818190|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818191|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818192|NCT05547685|Methylene Blue|methylene blue|mesh-list
43818193|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818194|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818195|NCT05547659|Acetaminophen|acetaminophen|mesh-list
43818197|NCT05547659|Pregabalin|pregabalin|mesh-list
43818198|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818199|NCT05547659|Analgesics|analgesics|mesh-ancestor
43818200|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
43818211|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818212|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43818213|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43818214|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818215|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818216|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43818217|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43818218|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818219|NCT05547516|Gemcitabine|gemcitabine|mesh-list
43818221|NCT05547516|Mitomycins|mitomycins|mesh-list
43818222|NCT05547516|Mitomycin|mitomycin|mesh-list
43818223|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43818224|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
43818225|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818226|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818227|NCT05547516|Antiviral Agents|antiviral agents|mesh-ancestor
43818228|NCT05547516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818229|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818230|NCT05547516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43818231|NCT05547516|Immunologic Factors|immunologic factors|mesh-ancestor
43818232|NCT05547516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818233|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43818234|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43818235|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43818236|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
43818237|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43818243|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
43818244|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818251|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43818252|NCT05546879|Growth Substances|growth substances|mesh-ancestor
43818253|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818254|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
43818255|NCT05546866|Osimertinib|osimertinib|mesh-list
43818256|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818257|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43818258|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818259|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818260|NCT05546853|Leucovorin|leucovorin|mesh-list
43818261|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
43818380|NCT05545670|Protective Agents|protective agents|mesh-ancestor
43818341|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
43818342|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
43818343|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818344|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818345|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43818346|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
43818347|NCT05546060|Hormones|hormones|mesh-ancestor
43818348|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818349|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43818350|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818351|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43818352|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43818353|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43818354|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818355|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818356|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
43818357|NCT05545969|Lenvatinib|lenvatinib|mesh-list
43818358|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818359|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818360|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43818361|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818362|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818363|NCT05545800|Insulin|insulin|mesh-list
43818364|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43818365|NCT05545800|Metformin|metformin|mesh-list
43631704|NCT03042325|Alogliptin|alogliptin|mesh-list
43818366|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
43818368|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43818370|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43818371|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845440|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845441|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
43845442|NCT04277845|Dexamethasone|dexamethasone|mesh-list
43845443|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
43845444|NCT04277845|Lenalidomide|lenalidomide|mesh-list
43845445|NCT04277845|Bortezomib|bortezomib|mesh-list
43845446|NCT04277845|BB 1101|bb 1101|mesh-list
43845447|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845448|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
43845449|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
43845450|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845451|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845452|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43845453|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
43845454|NCT04277845|Hormones|hormones|mesh-ancestor
43845455|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845456|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43845495|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
43845496|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43845497|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43845498|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845499|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
43845500|NCT04274335|Coagulants|coagulants|mesh-ancestor
43848835|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848836|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43848837|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43848838|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848839|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848840|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43848841|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43631781|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818372|NCT05545670|Allopurinol|allopurinol|mesh-list
43818373|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
43818374|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818375|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818376|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
43818377|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818378|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43818379|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
43818388|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818389|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43818390|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
43818392|NCT05545475|Heparin|heparin|mesh-list
43818393|NCT05545475|Enoxaparin|enoxaparin|mesh-list
43818394|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43818395|NCT05545475|Tinzaparin|tinzaparin|mesh-list
43818396|NCT05545475|Dalteparin|dalteparin|mesh-list
43818397|NCT05545475|Nadroparin|nadroparin|mesh-list
43818398|NCT05545475|Warfarin|warfarin|mesh-list
43818399|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
43818400|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43818401|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43818402|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818403|NCT05545462|Doxycycline|doxycycline|mesh-list
43818404|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43818405|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818406|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
43818407|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43818408|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43818409|NCT05545436|Capecitabine|capecitabine|mesh-list
43818410|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
43818411|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43818412|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
43818413|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818414|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818415|NCT05545397|Propofol|propofol|mesh-list
43818421|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
43818445|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43818446|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43818448|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
43818449|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43818450|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43818451|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
43818452|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818453|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43818454|NCT05544968|Antibodies|antibodies|mesh-list
43818455|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43818456|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
43818457|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818458|NCT05544812|Cetuximab|cetuximab|mesh-list
43818459|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818460|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818461|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
43818462|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43818463|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
43818464|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818465|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
43818466|NCT05544695|Protective Agents|protective agents|mesh-ancestor
43818467|NCT05544656|Tolperisone|tolperisone|mesh-list
43818468|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43818469|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818470|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43818471|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818472|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43818490|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818491|NCT05543837|Capsaicin|capsaicin|mesh-list
43818492|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
43818493|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
43818494|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
43818495|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845507|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845508|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43845509|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845510|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43845511|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43845512|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845513|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43845514|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43845515|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845516|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
43845517|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845518|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
43845519|NCT04273607|Heparin|heparin|mesh-list
43845520|NCT04273607|Calcium heparin|calcium heparin|mesh-list
43845521|NCT04273607|Enoxaparin|enoxaparin|mesh-list
43845522|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
43845523|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43845524|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43845525|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845526|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
43845527|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43845528|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
43845529|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43845530|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
43845531|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845532|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845533|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
43845534|NCT04272021|Methylphenidate|methylphenidate|mesh-list
43845535|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43845536|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845537|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43845538|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43845539|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43845540|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845541|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
43845542|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845544|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43845545|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818547|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43818548|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818549|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43818550|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
43818551|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818552|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818553|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
43818554|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818555|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43818556|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43818615|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818616|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818617|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43818618|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43818620|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43818621|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818622|NCT05542394|Analgesics|analgesics|mesh-ancestor
43818623|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
43818624|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818625|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818626|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818627|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818628|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818629|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818630|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818631|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43818632|NCT05542381|Nepafenac|nepafenac|mesh-list
43818633|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43818634|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
43818635|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43632132|NCT03039257|Vitamin A|vitamin a|mesh-list
43818636|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43818637|NCT05542381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43818638|NCT05542381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818639|NCT05542381|Analgesics|analgesics|mesh-ancestor
43818640|NCT05542381|Sensory System Agents|sensory system agents|mesh-ancestor
43818641|NCT05542381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818642|NCT05542381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818643|NCT05542381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818644|NCT05542381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818645|NCT05542147|Fenofibrate|fenofibrate|mesh-list
43818646|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43818647|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
43818648|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845561|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845562|NCT04266249|Paclitaxel|paclitaxel|mesh-list
43845563|NCT04266249|Maytansine|maytansine|mesh-list
43845564|NCT04266249|Docetaxel|docetaxel|mesh-list
43845565|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43845566|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43845567|NCT04266249|Trastuzumab|trastuzumab|mesh-list
43845568|NCT04266249|Pertuzumab|pertuzumab|mesh-list
43845569|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43845570|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43845571|NCT04266249|Antibodies|antibodies|mesh-list
43845575|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43845576|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845577|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
43845578|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
43845579|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
43845580|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845581|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
43845582|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845583|NCT04266236|Ropivacaine|ropivacaine|mesh-list
43845584|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
43845585|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845586|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845587|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
43818665|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
43818666|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
43818667|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818668|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818669|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
43818670|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818671|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43818672|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43818673|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43818674|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818675|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818676|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
43818677|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818678|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818680|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818681|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43818682|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
43818683|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818684|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818685|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43818686|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
43818687|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
43818689|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818690|NCT05541276|Melatonin|melatonin|mesh-list
43818691|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
43818692|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818693|NCT05541276|Protective Agents|protective agents|mesh-ancestor
43818694|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818695|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818705|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43818706|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43818707|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818708|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818709|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43818710|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818711|NCT05541185|Analgesics|analgesics|mesh-ancestor
43818712|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818713|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818714|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
43818715|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43818716|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818717|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
43818718|NCT05541172|Testosterone|testosterone|mesh-list
43818719|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
43818720|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
43818721|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43818723|NCT05541172|Hormones|hormones|mesh-ancestor
43818763|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818764|NCT05540600|Protective Agents|protective agents|mesh-ancestor
43818765|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818766|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43818767|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
43818768|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
43818769|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818770|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43818771|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43818772|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43818773|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
43818795|NCT05540431|Protective Agents|protective agents|mesh-ancestor
43818796|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818797|NCT05540288|Nalmefene|nalmefene|mesh-list
43818798|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43818799|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818800|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
43818803|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818804|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818805|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43818806|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43818807|NCT05540275|Growth Substances|growth substances|mesh-ancestor
43818808|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818809|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
43818810|NCT05540145|Paclitaxel|paclitaxel|mesh-list
43818811|NCT05540145|Antibodies|antibodies|mesh-list
43818812|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43818813|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818814|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
43818815|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
43845644|NCT04262843|Lenograstim|lenograstim|mesh-list
43845645|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845646|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
43632407|NCT03037372|Atorvastatin|atorvastatin|mesh-list
43845647|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845648|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845649|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43845650|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
43818833|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43818834|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818835|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818853|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818855|NCT05538988|Cemiplimab|cemiplimab|mesh-list
43818856|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818857|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818858|NCT05538702|Menthol|menthol|mesh-list
43818859|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
43818860|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
43818861|NCT05538507|Memantine|memantine|mesh-list
43818862|NCT05538507|Donepezil|donepezil|mesh-list
43818875|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
43818876|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43818877|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818878|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43818879|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
43818880|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43818881|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818882|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818883|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818884|NCT05538026|Mesalamine|mesalamine|mesh-list
43818895|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43818896|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43818897|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
43818898|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818899|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818900|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43818901|NCT05537584|Bupropion|bupropion|mesh-list
43818902|NCT05537584|Sertraline|sertraline|mesh-list
43818903|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43818904|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
43818905|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43818906|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43818907|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43845689|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43845690|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845692|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43845693|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845694|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845695|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43845696|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845697|NCT04261075|Durvalumab|durvalumab|mesh-list
43845698|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819017|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819018|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43819019|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43819020|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819021|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
43819022|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819023|NCT05536414|Citalopram|citalopram|mesh-list
43819024|NCT05536414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43819025|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43819026|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43819027|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819028|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819053|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43819054|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43819055|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
43819056|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819057|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819058|NCT05536193|Metformin|metformin|mesh-list
43819059|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
43819060|NCT05536193|Salicylates|salicylates|mesh-list
43819061|NCT05536193|Mitogens|mitogens|mesh-list
43819062|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43819063|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819064|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
43819065|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819066|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819067|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
43819068|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
43819069|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
43819070|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43819071|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43819072|NCT05536193|Analgesics|analgesics|mesh-ancestor
43819073|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
43819074|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819075|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819076|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819077|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43819078|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819079|NCT05536128|Olaparib|olaparib|mesh-list
43819100|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819101|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819103|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
43819153|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43819155|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819156|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819157|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43819158|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
43819159|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
43819160|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43819161|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819162|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
43819163|NCT05535738|Hormones|hormones|mesh-ancestor
43819164|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819165|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819166|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
43819167|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819168|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819169|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43819170|NCT05535725|Vancomycin|vancomycin|mesh-list
43819171|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43819172|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819173|NCT05535569|Paclitaxel|paclitaxel|mesh-list
43819174|NCT05535569|Nivolumab|nivolumab|mesh-list
43819175|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43819176|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819177|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
43845719|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
43845720|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845729|NCT04256213|Nivolumab|nivolumab|mesh-list
43845730|NCT04256213|Ipilimumab|ipilimumab|mesh-list
43845731|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845732|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845733|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43845734|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848843|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
43848844|NCT03985514|Tazobactam|tazobactam|mesh-list
43848845|NCT03985514|Piperacillin|piperacillin|mesh-list
43848846|NCT03985514|Metronidazole|metronidazole|mesh-list
43848847|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43848856|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43848857|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43848858|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43848859|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43848860|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43848861|NCT03984097|Dexamethasone|dexamethasone|mesh-list
43848862|NCT03984097|Lenalidomide|lenalidomide|mesh-list
43848863|NCT03984097|Bortezomib|bortezomib|mesh-list
43848864|NCT03984097|Pomalidomide|pomalidomide|mesh-list
43848865|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848866|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
43848867|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
43848868|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848869|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848870|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43819217|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
43819218|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
43819219|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819221|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819222|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43819223|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819224|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819226|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43819236|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819237|NCT05591560|Itraconazole|itraconazole|mesh-list
43819238|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
43819239|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819240|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43819241|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43819242|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819243|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819244|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43819245|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
43819249|NCT05591417|Dexamethasone|dexamethasone|mesh-list
43819299|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819300|NCT05589792|Diuretics|diuretics|mesh-ancestor
43819301|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
43819302|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819303|NCT05588934|Caffeine|caffeine|mesh-list
43819304|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43819305|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819306|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43819307|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819308|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819309|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43845780|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43845781|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845783|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
43845784|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845785|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
43819588|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43845794|NCT04248452|Fluorouracil|fluorouracil|mesh-list
43845795|NCT04248452|Capecitabine|capecitabine|mesh-list
43845796|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
43845797|NCT04248452|Calcium|calcium|mesh-list
43819313|NCT05586737|Rituximab|rituximab|mesh-list
43819314|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819315|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819316|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
43819317|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819318|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819319|NCT05579223|Hydromorphone|hydromorphone|mesh-list
43819320|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43819321|NCT05579223|Narcotics|narcotics|mesh-ancestor
43819322|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819323|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819324|NCT05579223|Analgesics|analgesics|mesh-ancestor
43819336|NCT05576272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819338|NCT05576272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819339|NCT05576116|Pancrelipase|pancrelipase|mesh-list
43819340|NCT05576116|Pancreatin|pancreatin|mesh-list
43819341|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43819342|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
43819343|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43819344|NCT05517668|Fomepizole|fomepizole|mesh-list
43819345|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
43819346|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819347|NCT05517668|Expectorants|expectorants|mesh-ancestor
43819348|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
43819349|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43819400|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819401|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845798|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
43819402|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819403|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
43819404|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
43819405|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819406|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43819407|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43819408|NCT05461261|Protective Agents|protective agents|mesh-ancestor
43819409|NCT05413330|Triamcinolone|triamcinolone|mesh-list
43819410|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43819411|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43819412|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43819413|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819414|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
43819415|NCT05413330|Hormones|hormones|mesh-ancestor
43819416|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819417|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819418|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819419|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
43819420|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819421|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819422|NCT05396833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43819423|NCT05396833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819424|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819426|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
43819427|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43819441|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43819442|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43819443|NCT05328414|Prednisolone|prednisolone|mesh-list
43819444|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819445|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
43819446|NCT05328414|Hormones|hormones|mesh-ancestor
43819447|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819448|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819449|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819450|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819451|NCT05242029|Psilocybin|psilocybin|mesh-list
43819452|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
43819453|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819454|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43819455|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
43819456|NCT05201638|Calcium|calcium|mesh-list
43819457|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43819458|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819459|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43819460|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
43819461|NCT05182073|Fludarabine|fludarabine|mesh-list
43819462|NCT05182073|Daratumumab|daratumumab|mesh-list
43819463|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43819464|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819465|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
43819466|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819467|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819468|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43819469|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
43819470|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819471|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819472|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43819473|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43819484|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819485|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43819486|NCT05128773|Tamoxifen|tamoxifen|mesh-list
43819487|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43819496|NCT05116241|Vaccines|vaccines|mesh-list
43819524|NCT05038735|Fulvestrant|fulvestrant|mesh-list
43819525|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819526|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819527|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43819528|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43819529|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
43819530|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819531|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845799|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43845800|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845801|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43845802|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
43845803|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845804|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845805|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845806|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845807|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
43845808|NCT04248452|Antidotes|antidotes|mesh-ancestor
43845809|NCT04248452|Protective Agents|protective agents|mesh-ancestor
43845810|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
43845811|NCT04248452|Vitamins|vitamins|mesh-ancestor
43845812|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
43845813|NCT04248452|Hematinics|hematinics|mesh-ancestor
43845814|NCT04247126|Gemcitabine|gemcitabine|mesh-list
43845815|NCT04247126|Paclitaxel|paclitaxel|mesh-list
43845816|NCT04247126|Fulvestrant|fulvestrant|mesh-list
43845817|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43845818|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845819|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
43845820|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
43845821|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
43845822|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845823|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845825|NCT04247126|Antiviral Agents|antiviral agents|mesh-ancestor
43845827|NCT04247126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845828|NCT04247126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845829|NCT04247126|Immunologic Factors|immunologic factors|mesh-ancestor
43845830|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845831|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43845832|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43845833|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43845834|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
43845835|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845836|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
43845837|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
43845838|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43845839|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43845840|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845841|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
43845842|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845843|NCT04246151|Vancomycin|vancomycin|mesh-list
43845844|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845845|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845846|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43845847|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43845848|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845849|NCT04243837|Pirfenidone|pirfenidone|mesh-list
43845850|NCT04243837|Analgesics|analgesics|mesh-ancestor
43845851|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
43845852|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845853|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845854|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43845855|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43845856|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845857|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845858|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845859|NCT04242173|Cemiplimab|cemiplimab|mesh-list
43819534|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43819535|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819536|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
43819537|NCT05007262|Coagulants|coagulants|mesh-ancestor
43819538|NCT04991025|Gemcitabine|gemcitabine|mesh-list
43819539|NCT04991025|Cisplatin|cisplatin|mesh-list
43819540|NCT04991025|Carboplatin|carboplatin|mesh-list
43819541|NCT04991025|Nivolumab|nivolumab|mesh-list
43819542|NCT04991025|Pemetrexed|pemetrexed|mesh-list
43819543|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
43819544|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819545|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819546|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
43819547|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819548|NCT04991025|Antiviral Agents|antiviral agents|mesh-ancestor
43819549|NCT04991025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819550|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819551|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819552|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
43819553|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819554|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819555|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43819556|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43819557|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43819558|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819559|NCT04990388|Acetaminophen|acetaminophen|mesh-list
43819560|NCT04990388|Antipyretics|antipyretics|mesh-list
43819561|NCT04990388|Cetirizine|cetirizine|mesh-list
43819562|NCT04990388|Ibuprofen|ibuprofen|mesh-list
43819563|NCT04990388|Famotidine|famotidine|mesh-list
43819564|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43819565|NCT04990388|Analgesics|analgesics|mesh-ancestor
43819566|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
43819567|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819568|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819569|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43819575|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43819587|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43819591|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819592|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
43819593|NCT04677855|Hormones|hormones|mesh-ancestor
43819594|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819595|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819596|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819597|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819598|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43819606|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
43819607|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819608|NCT04616560|Trastuzumab|trastuzumab|mesh-list
43819609|NCT04616560|Camptothecin|camptothecin|mesh-list
43819610|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
43819611|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819612|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819613|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43819614|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43819615|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43819616|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819617|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819618|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
43819619|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819620|NCT04605094|Benralizumab|benralizumab|mesh-list
43819621|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43819622|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
43819649|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819650|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
43819651|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819652|NCT04445519|Latanoprost|latanoprost|mesh-list
43819653|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43819654|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43819656|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
43819657|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43819658|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43819659|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43819660|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819661|NCT04331067|Paclitaxel|paclitaxel|mesh-list
43819662|NCT04331067|Carboplatin|carboplatin|mesh-list
43819663|NCT04331067|Nivolumab|nivolumab|mesh-list
43819664|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43819665|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819666|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
43819667|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
43819668|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
43819669|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819670|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819671|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43819672|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
43819673|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43819674|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819675|NCT04129398|Letermovir|letermovir|mesh-list
43819677|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819697|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819698|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819699|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43819700|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43819701|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
43819702|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43819703|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43819704|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
43819705|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43819706|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43819707|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819708|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
43845864|NCT04241640|Analgesics|analgesics|mesh-ancestor
43845865|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
43819757|NCT03861702|Irinotecan|irinotecan|mesh-list
43819758|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43819759|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43819760|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819761|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819762|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819763|NCT03784677|SOR-C13|sor-c13|mesh-list
43819764|NCT03784677|Calcium|calcium|mesh-list
43819765|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43819766|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819767|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819768|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43819769|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43819770|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819772|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43819776|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
43819806|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819807|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819808|NCT03631199|Paclitaxel|paclitaxel|mesh-list
43819809|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43819810|NCT03631199|Cisplatin|cisplatin|mesh-list
43819811|NCT03631199|Carboplatin|carboplatin|mesh-list
43819812|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
43819813|NCT03631199|Pemetrexed|pemetrexed|mesh-list
43819814|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43819815|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43819816|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819817|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
43819818|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
43819819|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
43819820|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819821|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819822|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819823|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43819824|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43819829|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819832|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819833|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43819834|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819835|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819836|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
43819837|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819838|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819839|NCT03265574|Enalapril|enalapril|mesh-list
43819840|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43819841|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
43819842|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819843|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819844|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43819845|NCT03203850|Deferasirox|deferasirox|mesh-list
43819846|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43819847|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
43819848|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
43819849|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819850|NCT03194906|Memantine|memantine|mesh-list
43819851|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43819852|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43819853|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
43819854|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819855|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819856|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819857|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43819858|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43819859|NCT03097068|Ranibizumab|ranibizumab|mesh-list
43819860|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43819861|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43819862|NCT03097068|Growth Substances|growth substances|mesh-ancestor
43819863|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819864|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
43819865|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819866|NCT02983578|Durvalumab|durvalumab|mesh-list
43819867|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
43819868|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43819869|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
43819870|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819871|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819885|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819886|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43819887|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819998|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819888|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819890|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43819891|NCT02942095|Ixazomib|ixazomib|mesh-list
43819892|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819893|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43819894|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819895|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819896|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
43819897|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
43819898|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819899|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819900|NCT02767804|Crizotinib|crizotinib|mesh-list
43819901|NCT02767804|Ensartinib|ensartinib|mesh-list
43819902|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819903|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43819904|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819905|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819906|NCT02520154|Paclitaxel|paclitaxel|mesh-list
43819937|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819938|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
43819939|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
43819940|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
43819941|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819942|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
43819943|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
43819944|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43819945|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43819946|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
43819947|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
43819948|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819949|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819953|NCT01801072|Levetiracetam|levetiracetam|mesh-list
43819954|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
43819955|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
43819956|NCT01582269|Lomustine|lomustine|mesh-list
43819957|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43819958|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
43819959|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819960|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819961|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
43819962|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43819963|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819964|NCT00748618|Vitamin D|vitamin d|mesh-list
43819965|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
43819966|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
43819967|NCT00748618|Vitamins|vitamins|mesh-list
43819968|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
43819969|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819970|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43819971|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43819972|NCT00082706|Leucovorin|leucovorin|mesh-list
43819973|NCT00082706|Gemcitabine|gemcitabine|mesh-list
43819975|NCT00082706|Fluorouracil|fluorouracil|mesh-list
43819976|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819977|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819978|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
43819979|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819980|NCT00082706|Antiviral Agents|antiviral agents|mesh-ancestor
43819981|NCT00082706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819982|NCT00082706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819983|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819984|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
43819985|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819986|NCT00082706|Antidotes|antidotes|mesh-ancestor
43819987|NCT00082706|Protective Agents|protective agents|mesh-ancestor
43819988|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
43819989|NCT00082706|Vitamins|vitamins|mesh-ancestor
43819990|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
43819991|NCT05535231|Curcumin|curcumin|mesh-list
43819992|NCT05535231|Turmeric extract|turmeric extract|mesh-list
43819993|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43819994|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43819995|NCT05535231|Analgesics|analgesics|mesh-ancestor
43819996|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
43819997|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820026|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820027|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820028|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43820032|NCT05679102|Atorvastatin|atorvastatin|mesh-list
43820033|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43820034|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43820035|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
43820036|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820037|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43820038|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43820039|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820040|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43820041|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43820042|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820043|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43820044|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820045|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
43820046|NCT05679050|Folfirinox|folfirinox|mesh-list
43820047|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820048|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
43820049|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
43820050|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820051|NCT05679037|Protective Agents|protective agents|mesh-ancestor
43820052|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820053|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
43820054|NCT05679037|Vitamins|vitamins|mesh-ancestor
43820055|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
43820056|NCT05679024|Apixaban|apixaban|mesh-list
43820057|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43820058|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
43820059|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43820060|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
43820061|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820062|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820063|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
43820064|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
43820065|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
43820066|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820068|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
43820069|NCT05678933|Vincristine|vincristine|mesh-list
43820070|NCT05678933|Azacitidine|azacitidine|mesh-list
43820071|NCT05678933|Epirubicin|epirubicin|mesh-list
43820072|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43820073|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
43820074|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820075|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43820076|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43820077|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
43820078|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820079|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820080|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43820081|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820082|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
43820083|NCT05678933|Hormones|hormones|mesh-ancestor
43820084|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43820085|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43820086|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43820087|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
43820088|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
43820089|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
43820090|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43820091|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
43820092|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820093|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43845867|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845868|NCT04241549|Azacitidine|azacitidine|mesh-list
43845869|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845870|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
43845871|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845872|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845873|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845874|NCT04240821|Theophylline|theophylline|mesh-list
43633972|NCT05696938|Niacin|niacin|mesh-list
43820137|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
43820138|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820141|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43820142|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43820143|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820207|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43820208|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43820209|NCT05677945|Simvastatin|simvastatin|mesh-list
43820210|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820211|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
43820212|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43820213|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43820214|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
43820215|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820216|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43820217|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43820218|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820219|NCT05677698|Peppermint oil|peppermint oil|mesh-list
43820220|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
43820221|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
43820222|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820223|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820224|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43820225|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
43820226|NCT05677633|Sargramostim|sargramostim|mesh-list
43820227|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
43820228|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820229|NCT05677620|Propofol|propofol|mesh-list
43820230|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43820231|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820232|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820233|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43820234|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
43820235|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
43820236|NCT05677555|Colchicine|colchicine|mesh-list
43820237|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
43820238|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43820239|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
43820240|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
43820241|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
43820242|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820243|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820245|NCT05677490|Leucovorin|leucovorin|mesh-list
43820246|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
43820247|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
43820248|NCT05677490|Fluorouracil|fluorouracil|mesh-list
43820249|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
43820250|NCT05677490|Nivolumab|nivolumab|mesh-list
43820251|NCT05677490|Irinotecan|irinotecan|mesh-list
43820252|NCT05677490|Calcium|calcium|mesh-list
43820253|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
43820254|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43820255|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820256|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43820257|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
43820258|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820259|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43820271|NCT05677490|Vitamins|vitamins|mesh-ancestor
43845897|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
43845899|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
43845900|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845901|NCT04238416|Lactulose|lactulose|mesh-list
43845902|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848894|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848895|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43848896|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848897|NCT03981744|Ustekinumab|ustekinumab|mesh-list
43848898|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
43848899|NCT03980925|Carboplatin|carboplatin|mesh-list
43848900|NCT03980925|Nivolumab|nivolumab|mesh-list
43848901|NCT03980925|Etoposide|etoposide|mesh-list
43848902|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848903|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848904|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43848905|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848906|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43820315|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43820316|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820317|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820318|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43820319|NCT05674253|Analgesics|analgesics|mesh-ancestor
43820320|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
43820321|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820322|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43820329|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43820330|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43820331|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43820332|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820333|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820334|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43820335|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820336|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820337|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
43820338|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820339|NCT05664659|Misoprostol|misoprostol|mesh-list
43820340|NCT05664659|Oxytocin|oxytocin|mesh-list
43820341|NCT05664659|Carbetocin|carbetocin|mesh-list
43820342|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
43820343|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43820344|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820345|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43820346|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
43820347|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43820348|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43820349|NCT05663658|Morphine|morphine|mesh-list
43820350|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43820351|NCT05663658|Narcotics|narcotics|mesh-ancestor
43820352|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820353|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820354|NCT05663658|Analgesics|analgesics|mesh-ancestor
43820355|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
43820356|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820357|NCT05663073|Amlodipine|amlodipine|mesh-list
43820358|NCT05663073|Irbesartan|irbesartan|mesh-list
43820359|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43820360|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43820361|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820369|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43820370|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820372|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
43820373|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820374|NCT05631730|Metoprolol|metoprolol|mesh-list
43820375|NCT05631730|Flecainide|flecainide|mesh-list
43820376|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43820377|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43820378|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
43820379|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
43820380|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820414|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
43820415|NCT05614115|Empagliflozin|empagliflozin|mesh-list
43820416|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43820417|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820418|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43820419|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820421|NCT05613842|Bombesin|bombesin|mesh-list
43820422|NCT05613842|Trace Elements|trace elements|mesh-ancestor
43820423|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
43820424|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820425|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820426|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820457|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
43820517|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820518|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820519|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43820521|NCT05575427|Ofloxacin|ofloxacin|mesh-list
43820522|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43820523|NCT05575427|Minocycline|minocycline|mesh-list
43820524|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43820525|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820526|NCT05575427|Renal Agents|renal agents|mesh-ancestor
43820527|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845908|NCT04233892|Estrogens|estrogens|mesh-list
43845909|NCT04233892|Hormones|hormones|mesh-ancestor
43845910|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845911|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845912|NCT04230759|Fluorouracil|fluorouracil|mesh-list
43845913|NCT04230759|Durvalumab|durvalumab|mesh-list
43845914|NCT04230759|Mitomycins|mitomycins|mesh-list
43845915|NCT04230759|Mitomycin|mitomycin|mesh-list
43845916|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43845917|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
43845918|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845919|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845920|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845921|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845922|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
43845923|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845924|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845925|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43845926|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
43845927|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43845928|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845929|NCT04230148|Triclabendazole|triclabendazole|mesh-list
43845930|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43845931|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
43845932|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43845933|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820575|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
43820576|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820577|NCT05450822|Lamotrigine|lamotrigine|mesh-list
43820578|NCT05450822|Levetiracetam|levetiracetam|mesh-list
43820579|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
43820580|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
43820581|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43820582|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820591|NCT05428007|Nivolumab|nivolumab|mesh-list
43820592|NCT05428007|Ipilimumab|ipilimumab|mesh-list
43820593|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43820594|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820595|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43820596|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820597|NCT05414032|Cetuximab|cetuximab|mesh-list
43820598|NCT05414032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43820599|NCT05414032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820605|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820606|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43820607|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
43820608|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
43820610|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43820611|NCT05402293|Lidocaine|lidocaine|mesh-list
43820612|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
43820613|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
43820614|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820615|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820616|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
43820617|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820618|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43820619|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43820620|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43820621|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820622|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820623|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
43820625|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43820626|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
43820627|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820628|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820629|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43820630|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
43820631|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
43820632|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43820633|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
43820634|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820635|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820636|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
43820637|NCT05390307|Liraglutide|liraglutide|mesh-list
43820638|NCT05390307|Glucagon|glucagon|mesh-list
43820639|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43820640|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43820641|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820642|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43820643|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820644|NCT05390307|Incretins|incretins|mesh-ancestor
43820645|NCT05390307|Hormones|hormones|mesh-ancestor
43820646|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43820647|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43820648|NCT05381974|Psilocybin|psilocybin|mesh-list
43820649|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
43820650|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820651|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43820652|NCT05375929|Abrocitinib|abrocitinib|mesh-list
43820653|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43820654|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820662|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43820663|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820664|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820665|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43820666|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43820667|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43820668|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43820669|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43820670|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43820672|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
43820673|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43820674|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
43820675|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820676|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820677|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43820678|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
43820685|NCT05362318|Nicotine|nicotine|mesh-list
43820715|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820716|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
43820717|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43820718|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820719|NCT05327556|Epinephrine|epinephrine|mesh-list
43820720|NCT05327556|Racepinephrine|racepinephrine|mesh-list
43820721|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
43820722|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43820723|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43820724|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
43820725|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820726|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820727|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820728|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43820729|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43820730|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
43820731|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820732|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43820733|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
43820734|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
43820735|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
43820736|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43820737|NCT05322954|Psilocybin|psilocybin|mesh-list
43820738|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
43820739|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820740|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43820741|NCT05319249|Talazoparib|talazoparib|mesh-list
43820764|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
43820765|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43820766|NCT05298696|Cilostazol|cilostazol|mesh-list
43820767|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43820768|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
43820769|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820770|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820771|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43820772|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
43820773|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43820774|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43820775|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820824|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43820825|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820826|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43820827|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820828|NCT05252416|Carboplatin|carboplatin|mesh-list
43820829|NCT05252416|Fulvestrant|fulvestrant|mesh-list
43820830|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820831|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43820832|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43820833|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43820834|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
43820835|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43820836|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820837|NCT05243329|Psilocybin|psilocybin|mesh-list
43820838|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
43820839|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820840|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43845934|NCT04229381|Coal Tar|coal tar|mesh-list
43845935|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
43845936|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
43845937|NCT04229004|Gemcitabine|gemcitabine|mesh-list
43845938|NCT04229004|Paclitaxel|paclitaxel|mesh-list
43845939|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43845940|NCT04229004|Spartalizumab|spartalizumab|mesh-list
43820846|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820847|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820849|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
43820850|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820851|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43820852|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43820853|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43820854|NCT05169060|Analgesics|analgesics|mesh-ancestor
43820855|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
43820856|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820857|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820858|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820859|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43820860|NCT05162742|Colchicine|colchicine|mesh-list
43820861|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
43820862|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43820863|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
43820864|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
43820865|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
43820866|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820867|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820868|NCT05147662|Factor VIII|factor viii|mesh-list
43820869|NCT05147662|Coagulants|coagulants|mesh-ancestor
43820897|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
43820898|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820900|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820901|NCT05123365|Antidotes|antidotes|mesh-ancestor
43820902|NCT05120349|Osimertinib|osimertinib|mesh-list
43820903|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820904|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43820905|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820966|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820967|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820968|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43820969|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43820970|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
43820971|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820972|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820973|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43820974|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43820975|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
43820976|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820977|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43820978|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43820979|NCT05041907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43820980|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43820981|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820982|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820983|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
43820984|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43820985|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
43820986|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43820987|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43820988|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43820989|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
43820990|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
43820991|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43820992|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820993|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43820994|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820995|NCT04988074|Cemiplimab|cemiplimab|mesh-list
43820996|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43820997|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820998|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
43821000|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821002|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
43821003|NCT04973163|Midazolam|midazolam|mesh-list
43821004|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43821005|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43821006|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821007|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821008|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43821009|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43821010|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43821011|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43821012|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
43821014|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
43821015|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
43821016|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821060|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43821061|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
43821062|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43821063|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821064|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821065|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
43821481|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
43821066|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821067|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821068|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
43821069|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846012|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
43846013|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43846014|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43846015|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846016|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
43846017|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846018|NCT04224987|Azithromycin|azithromycin|mesh-list
43846019|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43846020|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846021|NCT04224740|Cisplatin|cisplatin|mesh-list
43846022|NCT04224740|Carboplatin|carboplatin|mesh-list
43846024|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821118|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821119|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821120|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821121|NCT04785820|Nivolumab|nivolumab|mesh-list
43821122|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821123|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821124|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43821125|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821126|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43821127|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43821128|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43821129|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821130|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821131|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
43821132|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821133|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43821175|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43821176|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
43821177|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43821178|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821179|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
43821180|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821181|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
43821182|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821183|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43821184|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821185|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43821186|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43821187|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43821188|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43821189|NCT04609046|Growth Substances|growth substances|mesh-ancestor
43821190|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
43821191|NCT04597268|Midazolam|midazolam|mesh-list
43821192|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
43821193|NCT04597268|Ketamine|ketamine|mesh-list
43821194|NCT04597268|Propofol|propofol|mesh-list
43821195|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43821196|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821197|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821198|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43821199|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
43821200|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
43821201|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43821202|NCT04597268|Analgesics|analgesics|mesh-ancestor
43821203|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
43821204|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821205|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43821206|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43821207|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43821215|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43821216|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43821217|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43821218|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
43821219|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
43821220|NCT04559581|Nintedanib|nintedanib|mesh-list
43821221|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821222|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821223|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821224|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821226|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821227|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821229|NCT04541017|Magrolimab|magrolimab|mesh-list
43821278|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821279|NCT04503668|Dexamethasone|dexamethasone|mesh-list
43821280|NCT04503668|Ondansetron|ondansetron|mesh-list
43821281|NCT04503668|Olanzapine|olanzapine|mesh-list
43821282|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
43821283|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
43821284|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
43821285|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43821286|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
43821287|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
43821288|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821289|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821290|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43821291|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
43821292|NCT04503668|Hormones|hormones|mesh-ancestor
43821293|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821294|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43821295|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821296|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
43821297|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
43821298|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43821299|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
43821300|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821301|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821302|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43821303|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43821304|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821305|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43821306|NCT04503668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43821307|NCT04503668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43821308|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43821309|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43821310|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43821311|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
43821312|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
43821315|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821316|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821317|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
43821318|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821319|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821320|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43821322|NCT04480554|Buprenorphine|buprenorphine|mesh-list
43821323|NCT04480554|Methadone|methadone|mesh-list
43821324|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43821325|NCT04480554|Naloxone|naloxone|mesh-list
43821326|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43821327|NCT04480554|Narcotics|narcotics|mesh-ancestor
43821328|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821329|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821330|NCT04480554|Analgesics|analgesics|mesh-ancestor
43821331|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
43821332|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821333|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43821334|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43821335|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
43821336|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
43821337|NCT04464980|Naltrexone|naltrexone|mesh-list
43821338|NCT04464980|Buprenorphine|buprenorphine|mesh-list
43821339|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43821340|NCT04464980|Narcotics|narcotics|mesh-ancestor
43821341|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821342|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821343|NCT04464980|Analgesics|analgesics|mesh-ancestor
43821344|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
43821345|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821347|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43821348|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43821349|NCT04457258|FAPI-46|fapi-46|mesh-list
43821350|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43821678|NCT03571633|Paclitaxel|paclitaxel|mesh-list
43821354|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821355|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821356|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821358|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
43821359|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821360|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
43821361|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846032|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43846033|NCT04222023|Antibodies|antibodies|mesh-list
43846034|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
43846035|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43846036|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
43846037|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821386|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821387|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821388|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43821389|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821390|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
43821391|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821393|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43821394|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821395|NCT04336982|Azacitidine|azacitidine|mesh-list
43821396|NCT04336982|Venetoclax|venetoclax|mesh-list
43821397|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821398|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
43821399|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821400|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821401|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821402|NCT04325217|Nintedanib|nintedanib|mesh-list
43821403|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821442|NCT04231214|Olodaterol|olodaterol|mesh-list
43821443|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43821444|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
43821445|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821446|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821447|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43821448|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
43821449|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
43821450|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43821451|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
43821452|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821453|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821454|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
43821455|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821456|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
43821457|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821458|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821459|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43821460|NCT04212364|Naloxone|naloxone|mesh-list
43821461|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43821462|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821463|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
43821464|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821465|NCT04209114|Nivolumab|nivolumab|mesh-list
43821466|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821467|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821468|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43821469|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821470|NCT04206787|Afatinib|afatinib|mesh-list
43821471|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821472|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821473|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821474|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821475|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
43821477|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43821478|NCT04177433|Prednisolone|prednisolone|mesh-list
43821479|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
43821480|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43821482|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43821483|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
43821484|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
43821485|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821486|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821487|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43821488|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
43821489|NCT04177433|Hormones|hormones|mesh-ancestor
43821490|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821491|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43821492|NCT04177433|Protective Agents|protective agents|mesh-ancestor
43821493|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43821494|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821495|NCT04159155|Paclitaxel|paclitaxel|mesh-list
43821496|NCT04159155|Cisplatin|cisplatin|mesh-list
43821497|NCT04159155|Carboplatin|carboplatin|mesh-list
43821498|NCT04159155|Niraparib|niraparib|mesh-list
43821499|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821500|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821501|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821502|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821525|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821526|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43821527|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821528|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821530|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821531|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821532|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821533|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821534|NCT04097730|Riboflavin|riboflavin|mesh-list
43821535|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
43821536|NCT04097730|Difluprednate|difluprednate|mesh-list
43821537|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43821611|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43821613|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821614|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821615|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43821616|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
43821617|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43821618|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43821619|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821620|NCT03787680|Olaparib|olaparib|mesh-list
43821621|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43821622|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821623|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821624|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846049|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
43846050|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43846051|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43846052|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821627|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821628|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
43821629|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821630|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821631|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
43821632|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821633|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821634|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
43821635|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821636|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43821637|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43821638|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43821639|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821640|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43821641|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821642|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821644|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821645|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821646|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821647|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821648|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
43821660|NCT03595124|Nivolumab|nivolumab|mesh-list
43821677|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821680|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821681|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821682|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821683|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821684|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821685|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821686|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821742|NCT03547973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821744|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821745|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821746|NCT03534323|Venetoclax|venetoclax|mesh-list
43821747|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821748|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
43821749|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821750|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821751|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
43821752|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43821753|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821754|NCT03496779|Gemcitabine|gemcitabine|mesh-list
43821755|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43821756|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43821757|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821758|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
43821759|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821760|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821761|NCT03496779|Antiviral Agents|antiviral agents|mesh-ancestor
43821762|NCT03496779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821763|NCT03496779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821764|NCT03496779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821765|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
43821766|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821767|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821788|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43821789|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821790|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
43821791|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821793|NCT03458260|Etoposide|etoposide|mesh-list
43821794|NCT03458260|Ifosfamide|ifosfamide|mesh-list
43821795|NCT03458260|Pixantrone|pixantrone|mesh-list
43821796|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821797|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821798|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
43821799|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821800|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43821801|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821802|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43821803|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43821804|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821849|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821850|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821851|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43821852|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43821853|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821854|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821855|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821856|NCT03363464|Empagliflozin|empagliflozin|mesh-list
43821857|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43821858|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43821859|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821860|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43821861|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821862|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
43821863|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821864|NCT03323658|Bexarotene|bexarotene|mesh-list
43821865|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821866|NCT03276468|Atezolizumab|atezolizumab|mesh-list
43821867|NCT03276468|Venetoclax|venetoclax|mesh-list
43821868|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
43821869|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821870|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821871|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
43821872|NCT03199053|Saxagliptin|saxagliptin|mesh-list
43821873|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43821874|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821876|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821878|NCT03199053|Hormones|hormones|mesh-ancestor
43821879|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821880|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43821881|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
43821882|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821884|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43821885|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
43821886|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43821887|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821888|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
43821889|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43821890|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43821891|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821892|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821893|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821894|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821896|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43821897|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
43821898|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821900|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43821901|NCT03170206|Palbociclib|palbociclib|mesh-list
43821902|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821903|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821904|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821905|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821908|NCT03151811|Melphalan|melphalan|mesh-list
43821935|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43821936|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43821937|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821938|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821939|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43821940|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
43821941|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821942|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821943|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43821944|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43821945|NCT03081689|Paclitaxel|paclitaxel|mesh-list
43821946|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43821947|NCT03081689|Carboplatin|carboplatin|mesh-list
43821948|NCT03081689|Nivolumab|nivolumab|mesh-list
43821949|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821950|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821951|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821952|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821953|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821954|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821955|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821956|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43821957|NCT03065062|Palbociclib|palbociclib|mesh-list
43821958|NCT03065062|Gedatolisib|gedatolisib|mesh-list
43821959|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821960|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821961|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821962|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821963|NCT03054896|Venetoclax|venetoclax|mesh-list
43821964|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821965|NCT03043872|Cisplatin|cisplatin|mesh-list
43821966|NCT03043872|Carboplatin|carboplatin|mesh-list
43821967|NCT03043872|Etoposide|etoposide|mesh-list
43821968|NCT03043872|Durvalumab|durvalumab|mesh-list
43821969|NCT03043872|Tremelimumab|tremelimumab|mesh-list
43821970|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821971|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821972|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43821974|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821975|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821976|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821977|NCT03025880|Gemcitabine|gemcitabine|mesh-list
43821978|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
43821979|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821980|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
43821981|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821982|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822033|NCT02889523|Vincristine|vincristine|mesh-list
43822034|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822035|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
43822036|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822037|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822038|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822039|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
43822040|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822092|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43822093|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43822094|NCT02733042|Growth Substances|growth substances|mesh-ancestor
43822095|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
43822096|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822097|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
43822099|NCT02689440|Venetoclax|venetoclax|mesh-list
43822100|NCT02689440|Dasatinib|dasatinib|mesh-list
43822101|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822102|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43822103|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822104|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822105|NCT02688712|Fluorouracil|fluorouracil|mesh-list
43822106|NCT02688712|Capecitabine|capecitabine|mesh-list
43822107|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
43822108|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822109|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822110|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822111|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822112|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
43822113|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822114|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
43822115|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822116|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822117|NCT02632721|Decitabine|decitabine|mesh-list
43822118|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822119|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
43822120|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822121|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822122|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822123|NCT02581982|Paclitaxel|paclitaxel|mesh-list
43822124|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
43822125|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43822126|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43822131|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822132|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822133|NCT02467582|Aspirin|aspirin|mesh-list
43822134|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43822135|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43822136|NCT02467582|Analgesics|analgesics|mesh-ancestor
43822137|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
43822138|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822139|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822140|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822141|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636212|NCT05018585|Vitamin D|vitamin d|mesh-list
43822143|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43822144|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822145|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43822146|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43822147|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822148|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
43822149|NCT02431897|Estrogens|estrogens|mesh-list
43822150|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43822151|NCT02431897|Hormones|hormones|mesh-ancestor
43822152|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822153|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822154|NCT02426658|Pemetrexed|pemetrexed|mesh-list
43822155|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822156|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822177|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43822178|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822179|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822180|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
43822181|NCT02303119|Rituximab|rituximab|mesh-list
43822183|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822184|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
43822185|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822186|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822187|NCT02206984|Tamoxifen|tamoxifen|mesh-list
43822188|NCT02206984|Fulvestrant|fulvestrant|mesh-list
43822189|NCT02206984|Anastrozole|anastrozole|mesh-list
43822190|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43822191|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
43822193|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822234|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822235|NCT01856478|Methotrexate|methotrexate|mesh-list
43822236|NCT01856478|Afatinib|afatinib|mesh-list
43822246|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822247|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43822248|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822249|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
43822250|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822251|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43822252|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43822253|NCT01796002|Romidepsin|romidepsin|mesh-list
43822254|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43822255|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822256|NCT01772472|Trastuzumab|trastuzumab|mesh-list
43822257|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43822258|NCT01772472|Maytansine|maytansine|mesh-list
43822259|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822260|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822261|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43822262|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
43822263|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
43822264|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
43822265|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822266|NCT01640587|Artesunate|artesunate|mesh-list
43822267|NCT01640587|Piperaquine|piperaquine|mesh-list
43822268|NCT01640587|Artenimol|artenimol|mesh-list
43822269|NCT01640587|Mefloquine|mefloquine|mesh-list
43822270|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
43822271|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43822272|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43822273|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822274|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822275|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
43822276|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
43822277|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43822278|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
43822279|NCT01610713|Nabiximols|nabiximols|mesh-list
43822280|NCT01610713|Analgesics|analgesics|mesh-ancestor
43822281|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
43822282|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822283|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822284|NCT01610687|Nabiximols|nabiximols|mesh-list
43822285|NCT01610687|Analgesics|analgesics|mesh-ancestor
43822286|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
43822287|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822288|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822289|NCT01606202|Nabiximols|nabiximols|mesh-list
43822290|NCT01606202|Analgesics|analgesics|mesh-ancestor
43822294|NCT01606189|Nabiximols|nabiximols|mesh-list
43822295|NCT01606189|Analgesics|analgesics|mesh-ancestor
43822296|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
43822297|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822298|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822299|NCT01606176|Nabiximols|nabiximols|mesh-list
43822300|NCT01606176|Analgesics|analgesics|mesh-ancestor
43822301|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
43822311|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
43822312|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
43822313|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822314|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822315|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43822316|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
43822317|NCT01553214|Hormones|hormones|mesh-ancestor
43822318|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822319|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43822320|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822321|NCT01512888|Busulfan|busulfan|mesh-list
43822322|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
43822323|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822324|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822325|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
43822326|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822327|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822328|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822329|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43822330|NCT01465100|Liver Extracts|liver extracts|mesh-list
43822331|NCT01465100|Hematinics|hematinics|mesh-ancestor
43822332|NCT01441947|Fulvestrant|fulvestrant|mesh-list
43822333|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43822334|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822335|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43822336|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43822337|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
43822338|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822339|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822340|NCT01396408|Sirolimus|sirolimus|mesh-list
43822342|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822343|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43822344|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43822345|NCT01396408|Growth Substances|growth substances|mesh-ancestor
43822346|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822347|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
43822348|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43822349|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822350|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822405|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822406|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822407|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
43822408|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822409|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43822410|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822421|NCT00352027|Etoposide|etoposide|mesh-list
43822422|NCT00352027|Vincristine|vincristine|mesh-list
43822423|NCT00352027|Bleomycin|bleomycin|mesh-list
43822424|NCT00352027|Vinblastine|vinblastine|mesh-list
43822425|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822426|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
43822427|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822428|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822429|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822430|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
43822431|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822432|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822433|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43822434|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43822435|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43822436|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43822437|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822438|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822439|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
43822440|NCT00352027|Hormones|hormones|mesh-ancestor
43822441|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636510|NCT04894643|Gemcitabine|gemcitabine|mesh-list
43822442|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43822443|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43822444|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
43822445|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
43822446|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
43846091|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43846092|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43846093|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43846094|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43846095|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43846096|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43846097|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
43846098|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
43846099|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
43846100|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
43846101|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846103|NCT04216693|Digoxin|digoxin|mesh-list
43846105|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43846106|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846107|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846109|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846110|NCT04216524|Cytarabine|cytarabine|mesh-list
43846111|NCT04216524|Dexamethasone|dexamethasone|mesh-list
43846112|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
43846113|NCT04216524|Prednisone|prednisone|mesh-list
43846114|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
43846115|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43846116|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43846117|NCT04216524|Prednisolone|prednisolone|mesh-list
43846118|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
43846119|NCT04216524|Cortisone|cortisone|mesh-list
43846120|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
43846121|NCT04216524|Rituximab|rituximab|mesh-list
43846122|NCT04216524|Doxorubicin|doxorubicin|mesh-list
43846123|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43846124|NCT04216524|Methotrexate|methotrexate|mesh-list
43846125|NCT04216524|Vincristine|vincristine|mesh-list
43846126|NCT04216524|Daunorubicin|daunorubicin|mesh-list
43846127|NCT04216524|Venetoclax|venetoclax|mesh-list
43846128|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
43846129|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43846130|NCT04216524|Antibodies|antibodies|mesh-list
43846131|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
43846132|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43846133|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43846134|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
43846135|NCT04216524|BB 1101|bb 1101|mesh-list
43846136|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846137|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
43846138|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846139|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846140|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43846141|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
43846149|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43846150|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
43846151|NCT04216524|Hormones|hormones|mesh-ancestor
43846152|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846153|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43846154|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
43846155|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846156|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43846157|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43846158|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43846159|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43846160|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
43846161|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43846162|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43846163|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
43846164|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
43822447|NCT05535075|Vancomycin|vancomycin|mesh-list
43822448|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822449|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822450|NCT05535036|Dexamethasone|dexamethasone|mesh-list
43822451|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822452|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
43822453|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
43822454|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822455|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822456|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43822457|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
43822458|NCT05535036|Hormones|hormones|mesh-ancestor
43822459|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822460|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43822461|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822462|NCT05535023|Cemiplimab|cemiplimab|mesh-list
43822463|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822464|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822465|NCT05534802|Urinastatin|urinastatin|mesh-list
43822466|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43822469|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822470|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822471|NCT05534750|Linezolid|linezolid|mesh-list
43822472|NCT05534750|Tedizolid|tedizolid|mesh-list
43822473|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
43822474|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822475|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822476|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43822477|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822478|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822481|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822482|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43822483|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
43822484|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822485|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822486|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43822487|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
43822488|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
43822489|NCT05534685|Hormones|hormones|mesh-ancestor
43822490|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822491|NCT05534672|Sirolimus|sirolimus|mesh-list
43822492|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822493|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822500|NCT05534620|Fludarabine|fludarabine|mesh-list
43822518|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
43822519|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43822520|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43822521|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822522|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822523|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43822524|NCT05534230|Analgesics|analgesics|mesh-ancestor
43822525|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
43822526|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822527|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43822528|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43822529|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43822530|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
43822531|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822532|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822534|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822535|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822536|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43822537|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822538|NCT05533892|Lenvatinib|lenvatinib|mesh-list
43822539|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
43822540|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822541|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43822542|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822543|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822544|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43822545|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
43822546|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822547|NCT05533684|Gabapentin|gabapentin|mesh-list
43822548|NCT05533684|Analgesics|analgesics|mesh-ancestor
43822549|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
43822550|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822551|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822555|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822556|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43822557|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43822558|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43822559|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822560|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822561|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
43822562|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43822563|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822564|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822565|NCT05533606|Lactams|lactams|mesh-list
43822566|NCT05533606|beta-Lactams|beta-lactams|mesh-list
43822567|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822568|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822569|NCT05533255|Z 350|z 350|mesh-list
43822570|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43822571|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43822572|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822573|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822574|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
43822576|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822587|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822588|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822589|NCT05533073|Analgesics|analgesics|mesh-ancestor
43822590|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
43822591|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822601|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43822602|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
43822603|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43822604|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
43822605|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822606|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822607|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
43822608|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
43822609|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
43822611|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822612|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822613|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
43822614|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822615|NCT05532501|Oxytocin|oxytocin|mesh-list
43822616|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
43822692|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43822693|NCT05532254|Aripiprazole|aripiprazole|mesh-list
43822694|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
43822695|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43822696|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43822697|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43822698|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822699|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822700|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
43822701|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
43822702|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822703|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822704|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43822705|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43822706|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
43822707|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43822708|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43822709|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43822716|NCT05532215|Oxytocin|oxytocin|mesh-list
43822747|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822748|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822749|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
43822750|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822752|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
43822753|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43822754|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43822755|NCT05532072|Prednisolone|prednisolone|mesh-list
43822756|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
43822757|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43822758|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
43822759|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822760|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822761|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43822762|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822763|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
43822764|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822765|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
43822766|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822767|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822768|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
43822769|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
43822770|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822771|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43822772|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
43822773|NCT05532072|Hormones|hormones|mesh-ancestor
43822774|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822775|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43822776|NCT05532072|Protective Agents|protective agents|mesh-ancestor
43822777|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43822778|NCT05532059|Gemcitabine|gemcitabine|mesh-list
43822779|NCT05532059|Cisplatin|cisplatin|mesh-list
43822780|NCT05532059|Lenvatinib|lenvatinib|mesh-list
43822781|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822782|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822783|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
43822784|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822785|NCT05532059|Antiviral Agents|antiviral agents|mesh-ancestor
43822786|NCT05532059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822787|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822788|NCT05532059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822789|NCT05532059|Immunologic Factors|immunologic factors|mesh-ancestor
43822790|NCT05532059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822791|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43822792|NCT05532020|Diazoxide|diazoxide|mesh-list
43822793|NCT05532020|Choline|choline|mesh-list
43822794|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
43822795|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43822796|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
43822797|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822798|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636968|NCT04729322|Metronidazole|metronidazole|mesh-list
43822799|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43822800|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
43822801|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43822802|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
43822803|NCT05531994|Montelukast|montelukast|mesh-list
43822804|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43822805|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
43822806|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43822807|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
43822808|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822831|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43822832|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43822833|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43822834|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822835|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
43822836|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822837|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822838|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43822839|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43822840|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822841|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43822842|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43822843|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822844|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
43822845|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43822846|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43822847|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
43822848|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43822849|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43822850|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43822851|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43822852|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
43822853|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43822854|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43822855|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846185|NCT04215848|Hormones|hormones|mesh-ancestor
43846186|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846187|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43846188|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43846189|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43846190|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846191|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846192|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846194|NCT04215146|Avelumab|avelumab|mesh-list
43846196|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846197|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
43846198|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
43846199|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
43846200|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822856|NCT05531435|Anesthetics|anesthetics|mesh-list
43822857|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
43822858|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822859|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822860|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
43822861|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822862|NCT05531422|Fentanyl|fentanyl|mesh-list
43822863|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43822864|NCT05531422|Narcotics|narcotics|mesh-ancestor
43822865|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822866|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822867|NCT05531422|Analgesics|analgesics|mesh-ancestor
43822868|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
43822869|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822870|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43822871|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43822872|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
43822873|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
43822874|NCT05531383|Memantine|memantine|mesh-list
43822875|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43822876|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43822877|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
43822878|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822883|NCT05531344|Tamsulosin|tamsulosin|mesh-list
43822885|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43822886|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43822887|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
43822888|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822889|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822890|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822891|NCT05531344|Urological Agents|urological agents|mesh-ancestor
43822892|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
43822893|NCT05531266|Hormones|hormones|mesh-ancestor
43822894|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822895|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822896|NCT05531123|Gemcitabine|gemcitabine|mesh-list
43822897|NCT05531123|Cisplatin|cisplatin|mesh-list
43822898|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822899|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822900|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
43822901|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822902|NCT05531123|Antiviral Agents|antiviral agents|mesh-ancestor
43822903|NCT05531123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822904|NCT05531123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822905|NCT05531123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822906|NCT05531123|Immunologic Factors|immunologic factors|mesh-ancestor
43822907|NCT05531123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822908|NCT05531058|Vaccines|vaccines|mesh-list
43822909|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
43822910|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822911|NCT05530954|Calcium|calcium|mesh-list
43822912|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43822913|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822914|NCT05530811|Dexamethasone|dexamethasone|mesh-list
43822915|NCT05530811|Bupivacaine|bupivacaine|mesh-list
43822928|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
43822929|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822931|NCT05530785|Bevacizumab|bevacizumab|mesh-list
43822932|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822933|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822934|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43822935|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43822936|NCT05530785|Growth Substances|growth substances|mesh-ancestor
43822937|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822938|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
43822939|NCT05530655|Lisinopril|lisinopril|mesh-list
43822940|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43822941|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
43822942|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822943|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822944|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43822945|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43822946|NCT05530655|Protective Agents|protective agents|mesh-ancestor
43822947|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822948|NCT05530395|Testosterone|testosterone|mesh-list
43822949|NCT05530395|Androgens|androgens|mesh-ancestor
43822950|NCT05530395|Hormones|hormones|mesh-ancestor
43822951|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822952|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822953|NCT05530252|Minocycline|minocycline|mesh-list
43822954|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43822955|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
43822956|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43822961|NCT05530122|Infliximab|infliximab|mesh-list
43822969|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822970|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
43822971|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822973|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822974|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
43822975|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43822976|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822977|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43822978|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43822979|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43822980|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822981|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
43822982|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822983|NCT05529888|Isotretinoin|isotretinoin|mesh-list
43822984|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
43822985|NCT05529875|Propofol|propofol|mesh-list
43822986|NCT05529875|Sevoflurane|sevoflurane|mesh-list
43822987|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43822988|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822989|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822990|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43822991|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
43822992|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
43822993|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43822994|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43822995|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43822996|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
43822997|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822998|NCT05529667|Paclitaxel|paclitaxel|mesh-list
43822999|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43823000|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823001|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
43823002|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
43823003|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
43823004|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823006|NCT05529355|Endostar protein|endostar protein|mesh-list
43823007|NCT05529355|Endostatins|endostatins|mesh-list
43823008|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43823009|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
43823010|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823011|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823012|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43823013|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43823014|NCT05529355|Growth Substances|growth substances|mesh-ancestor
43823015|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823016|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
43823017|NCT05529290|Acetaminophen|acetaminophen|mesh-list
43823018|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43823019|NCT05529290|Ketoprofen|ketoprofen|mesh-list
43823020|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43823021|NCT05529290|Analgesics|analgesics|mesh-ancestor
43823022|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
43823023|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823024|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823025|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
43823026|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43823027|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823028|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823041|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823043|NCT05529082|Narcotics|narcotics|mesh-ancestor
43823044|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823045|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823046|NCT05529082|Analgesics|analgesics|mesh-ancestor
43823047|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
43823048|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823049|NCT05529056|Atropine|atropine|mesh-list
43823050|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43823051|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43823052|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43823053|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
43823054|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823077|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823078|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43637303|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
43823079|NCT05528718|Midazolam|midazolam|mesh-list
43823081|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43823082|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43823083|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823084|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823085|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43823086|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43823087|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43823088|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43823089|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
43823090|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
43823091|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
43823092|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
43823093|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823095|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43823132|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823133|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823134|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43823135|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43823136|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823138|NCT05528146|Cathartics|cathartics|mesh-ancestor
43823139|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823140|NCT05527912|Rituximab|rituximab|mesh-list
43823141|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
43823142|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43823143|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823144|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
43823145|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823146|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823147|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43823148|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823149|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823150|NCT05527808|Carboplatin|carboplatin|mesh-list
43823151|NCT05527808|Pemetrexed|pemetrexed|mesh-list
43823152|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823153|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823154|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823155|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43823156|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43823157|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
43823158|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43823159|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43823160|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
43823161|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823162|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823163|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823164|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
43823171|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43823172|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846201|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846202|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
43846203|NCT04214886|Fludarabine|fludarabine|mesh-list
43846204|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846205|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
43846206|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846207|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846208|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43846209|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
43846210|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846211|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846213|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43846214|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43846215|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
43846216|NCT04214678|Hormones|hormones|mesh-ancestor
43846217|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846218|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846219|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846220|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846221|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43846222|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43846223|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846224|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
43823228|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823230|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
43823231|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
43823232|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823233|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43823234|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823235|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823236|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
43823237|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823238|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
43823239|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823240|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43823241|NCT05526911|Tenofovir|tenofovir|mesh-list
43823242|NCT05526911|Lamivudine|lamivudine|mesh-list
43823243|NCT05526911|Dolutegravir|dolutegravir|mesh-list
43823244|NCT05526911|Digoxin|digoxin|mesh-list
43823245|NCT05526911|Midazolam|midazolam|mesh-list
43823286|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823287|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823289|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43823290|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823291|NCT05526469|Bupivacaine|bupivacaine|mesh-list
43823292|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
43823293|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
43823294|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823295|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823296|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
43823297|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823298|NCT05526118|Tenofovir|tenofovir|mesh-list
43823299|NCT05526118|Emtricitabine|emtricitabine|mesh-list
43823300|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43823301|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
43823302|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823303|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43823304|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43823305|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823306|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823307|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43823308|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43823309|NCT05525767|Bevacizumab|bevacizumab|mesh-list
43823310|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43823311|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823312|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43823313|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43823314|NCT05525767|Growth Substances|growth substances|mesh-ancestor
43823315|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823316|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
43823318|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
43823319|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637576|NCT04535401|Leucovorin|leucovorin|mesh-list
43823320|NCT05525481|Tamoxifen|tamoxifen|mesh-list
43823321|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43823322|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
43823323|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823324|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823325|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43823326|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823327|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43823328|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43823329|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43823334|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823335|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823336|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43823337|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
43823338|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
43823339|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43823340|NCT05525351|Analgesics|analgesics|mesh-ancestor
43823341|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
43823342|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823343|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43823344|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43823367|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43823368|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823369|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43823370|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43823371|NCT05525234|Growth Substances|growth substances|mesh-ancestor
43823372|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
43823373|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823374|NCT05525156|Aspirin|aspirin|mesh-list
43823375|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43823376|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43823377|NCT05525156|Analgesics|analgesics|mesh-ancestor
43823378|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
43823379|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823380|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823381|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823382|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823383|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43823384|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43823385|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823386|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43823387|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43823388|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823389|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
43823401|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
43823402|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823403|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43823404|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823405|NCT05524857|Decitabine|decitabine|mesh-list
43823406|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43823407|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
43823408|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823409|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823410|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823411|NCT05524519|Antidepressive Agents|antidepressive agents|mesh-list
43823412|NCT05524519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43823413|NCT05524259|Folic Acid|folic acid|mesh-list
43823414|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
43823415|NCT05524259|Inositol|inositol|mesh-list
43823416|NCT05524259|Hematinics|hematinics|mesh-ancestor
43823417|NCT05524259|Vitamins|vitamins|mesh-ancestor
43823418|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
43823421|NCT05523986|Vitamin D|vitamin d|mesh-list
43846256|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846257|NCT04207931|Fluocinonide|fluocinonide|mesh-list
43846258|NCT04207931|Triamcinolone|triamcinolone|mesh-list
43846259|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43846260|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43846261|NCT04207931|Betamethasone|betamethasone|mesh-list
43846262|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
43846263|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43846264|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
43846265|NCT04207931|Clobetasol|clobetasol|mesh-list
43846266|NCT04207931|Minoxidil|minoxidil|mesh-list
43846267|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43846268|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43846269|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846270|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
43846271|NCT04207931|Hormones|hormones|mesh-ancestor
43846272|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846273|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823444|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43823445|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
43823446|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
43846292|NCT04205968|Leucovorin|leucovorin|mesh-list
43823447|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823448|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43823495|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
43823496|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823498|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823499|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823501|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43823502|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823503|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823504|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823505|NCT05522465|Dexamethasone|dexamethasone|mesh-list
43823506|NCT05522465|Prednisone|prednisone|mesh-list
43823507|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823508|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
43823509|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
43823510|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823511|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823512|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823513|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
43823514|NCT05522465|Hormones|hormones|mesh-ancestor
43823515|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823516|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43823517|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823518|NCT05522361|Risdiplam|risdiplam|mesh-list
43823519|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43823520|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823521|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823522|NCT05522270|Mitogens|mitogens|mesh-list
43823523|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
43823525|NCT05522231|Everolimus|everolimus|mesh-list
43823527|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823528|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823529|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
43823530|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823531|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43823532|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823533|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823534|NCT05522192|Venetoclax|venetoclax|mesh-list
43823535|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
43823536|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823537|NCT05522192|Analgesics|analgesics|mesh-ancestor
43823538|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
43823539|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823540|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823541|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43823542|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43823543|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823544|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823545|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43823546|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43823557|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823558|NCT05521828|Progestins|progestins|mesh-ancestor
43823559|NCT05521763|Vaccines|vaccines|mesh-list
43823560|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
43823561|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846274|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846275|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
43846276|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846277|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846278|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43846279|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
43846280|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43846281|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
43846282|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43846283|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43846284|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846285|NCT04205994|Tolcapone|tolcapone|mesh-list
43846286|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43846287|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43846288|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43846289|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846290|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846291|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
43846301|NCT04205968|Antibodies|antibodies|mesh-list
43846302|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
43846303|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43637880|NCT04391569|Ganaxolone|ganaxolone|mesh-list
43641512|NCT05610800|Exenatide|exenatide|mesh-list
43641513|NCT05610800|Nicotine|nicotine|mesh-list
43641514|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43641515|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
43641516|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641517|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641518|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43641519|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43641520|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
43641521|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641522|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641523|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43641524|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43641525|NCT05610800|Incretins|incretins|mesh-ancestor
43641526|NCT05610800|Hormones|hormones|mesh-ancestor
43641527|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43641565|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43641566|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641567|NCT05610085|Levetiracetam|levetiracetam|mesh-list
43641568|NCT05610085|Phenobarbital|phenobarbital|mesh-list
43641569|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
43641570|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
43641571|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43641572|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641574|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43641575|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43641576|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641625|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
43641626|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43641627|NCT05579769|Cyclosporine|cyclosporine|mesh-list
43641628|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
43641629|NCT05579769|Busulfan|busulfan|mesh-list
43641630|NCT05579769|Thiotepa|thiotepa|mesh-list
43641631|NCT05579769|Methotrexate|methotrexate|mesh-list
43641632|NCT05579769|Fludarabine|fludarabine|mesh-list
43641633|NCT05579769|Cyclosporins|cyclosporins|mesh-list
43641634|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
43641635|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43641636|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641637|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
43641638|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641639|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641640|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43641641|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
43641642|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641643|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641644|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43641645|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43641646|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
43641647|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43641648|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641649|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
43641650|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
43641651|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641652|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43641653|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43641654|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
43641655|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641656|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43641657|NCT05579730|Ketotifen|ketotifen|mesh-list
43641658|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43641659|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43641660|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43638025|NCT04324463|Interferon-beta|interferon-beta|mesh-list
43641661|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43641662|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43641663|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43641664|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43641665|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
43641666|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641667|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641668|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641670|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
43641671|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43641672|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
43641673|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
43641674|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43641675|NCT05577364|Prednisone|prednisone|mesh-list
43641676|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
43641677|NCT05577364|Doxorubicin|doxorubicin|mesh-list
43641678|NCT05577364|Vincristine|vincristine|mesh-list
43641679|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641683|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43641684|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
43641685|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641686|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641687|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43641688|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43641689|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43641690|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43641691|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641692|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641694|NCT05577364|Hormones|hormones|mesh-ancestor
43641706|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641707|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641708|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
43641709|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641710|NCT05575999|Analgesics|analgesics|mesh-ancestor
43641711|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43641712|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43641713|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
43641714|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43641715|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43641716|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641717|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641719|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43823567|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43823568|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823569|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43823570|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823571|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823572|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43823573|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43823574|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
43823575|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823577|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43823578|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823579|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43823580|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823581|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823582|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43823583|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43823584|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
43823585|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823586|NCT05521152|Norepinephrine|norepinephrine|mesh-list
43823587|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43823588|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43823589|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
43823590|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823591|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823592|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823593|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
43823594|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
43823595|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823596|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43823597|NCT05521048|Doxycycline|doxycycline|mesh-list
43823598|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43823599|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823600|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
43823601|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43823602|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43823603|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
43823604|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
43823605|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823606|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43641764|NCT05564611|Omalizumab|omalizumab|mesh-list
43641765|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43641787|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641788|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
43641789|NCT05564403|Antidotes|antidotes|mesh-ancestor
43641790|NCT05564403|Protective Agents|protective agents|mesh-ancestor
43641791|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
43641792|NCT05564403|Vitamins|vitamins|mesh-ancestor
43641793|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
43641794|NCT05564403|Hematinics|hematinics|mesh-ancestor
43641795|NCT05564221|Omalizumab|omalizumab|mesh-list
43641796|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43641797|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43641798|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
43641799|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
43641800|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43641801|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43641802|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641803|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
43641804|NCT05562609|Coagulants|coagulants|mesh-ancestor
43641805|NCT05561309|Ropivacaine|ropivacaine|mesh-list
43641806|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
43641825|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641826|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641827|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641828|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43641829|NCT05557812|Eugenol|eugenol|mesh-list
43641830|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
43641831|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
43641832|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
43641833|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
43641834|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43641835|NCT05557812|Protective Agents|protective agents|mesh-ancestor
43641836|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641837|NCT05557812|Hematinics|hematinics|mesh-ancestor
43641838|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641852|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641853|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43641854|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43641855|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43641911|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43641912|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43641913|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43641915|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43641916|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43641917|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641918|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638338|NCT04206319|Listerine|listerine|mesh-list
43641919|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
43641920|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
43641921|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641922|NCT05554367|Palbociclib|palbociclib|mesh-list
43641923|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641924|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43641925|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641926|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641927|NCT05554354|Fulvestrant|fulvestrant|mesh-list
43641928|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43641929|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641930|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43641931|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43641932|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
43641933|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43641934|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641935|NCT05554341|Paclitaxel|paclitaxel|mesh-list
43641936|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43641937|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43641938|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641939|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
43641940|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
43641941|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
43641942|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641999|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642000|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
43642001|NCT05527314|Fentanyl|fentanyl|mesh-list
43642002|NCT05527314|Remifentanil|remifentanil|mesh-list
43642003|NCT05527314|Sevoflurane|sevoflurane|mesh-list
43642004|NCT05527314|Cisatracurium|cisatracurium|mesh-list
43642005|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43642006|NCT05527314|Narcotics|narcotics|mesh-ancestor
43642007|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642008|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642009|NCT05527314|Analgesics|analgesics|mesh-ancestor
43642010|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
43642011|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642012|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43642013|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642014|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
43642015|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
43642016|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43642017|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43642018|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43642019|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43642020|NCT05523440|Bevacizumab|bevacizumab|mesh-list
43642037|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642038|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823609|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823610|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823611|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823612|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43823613|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
43823614|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43823615|NCT05520892|Antibodies|antibodies|mesh-list
43823616|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
43823617|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43823618|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
43823619|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823620|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43823621|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823622|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823623|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43823624|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823625|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823626|NCT05520658|Fluorouracil|fluorouracil|mesh-list
43823627|NCT05520658|Digoxin|digoxin|mesh-list
43823628|NCT05520658|Furosemide|furosemide|mesh-list
43642060|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
43642061|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642062|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642063|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43642064|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
43642066|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642067|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43642068|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642069|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
43642070|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642071|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642072|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642073|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
43642074|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
43642076|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642077|NCT05511870|Etripamil|etripamil|mesh-list
43642078|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43642079|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43642080|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642081|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43642082|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642083|NCT05511779|Brincidofovir|brincidofovir|mesh-list
43642084|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
43642085|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642086|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
43642087|NCT05511415|Oxytocin|oxytocin|mesh-list
43642088|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43642103|NCT05509933|Budesonide|budesonide|mesh-list
43642104|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43642105|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43642106|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
43642107|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642108|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642109|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43642110|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
43642111|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
43642112|NCT05509933|Hormones|hormones|mesh-ancestor
43642113|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642114|NCT05509647|Heparin|heparin|mesh-list
43642115|NCT05509647|Calcium heparin|calcium heparin|mesh-list
43642116|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
43642117|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43642118|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43642119|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642120|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43642121|NCT05507476|Epinephrine|epinephrine|mesh-list
43642122|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43642123|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43642124|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642125|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642126|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642154|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43642155|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43642156|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43642157|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642158|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642159|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642160|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
43642161|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642162|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642163|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
43642164|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642165|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642166|NCT05493475|Fentanyl|fentanyl|mesh-list
43642167|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43642168|NCT05493475|Narcotics|narcotics|mesh-ancestor
43642212|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
43642213|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642214|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642215|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642216|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43642217|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43642218|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642219|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642220|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43642221|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
43642222|NCT05478863|Caffeine|caffeine|mesh-list
43642223|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43642224|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642225|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43642226|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642227|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642228|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43642229|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43642230|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
43642231|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642239|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43642240|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
43642241|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
43642242|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642243|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642244|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43642245|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
43642253|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43642254|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
43642255|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642256|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
43642257|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642258|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43642259|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43642260|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
43642261|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846306|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
43642262|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43642263|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
43642264|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642265|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43642266|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
43642267|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
43642268|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
43642269|NCT05474040|Morphine|morphine|mesh-list
43642270|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43642271|NCT05474040|Narcotics|narcotics|mesh-ancestor
43642272|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642273|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642274|NCT05474040|Analgesics|analgesics|mesh-ancestor
43642275|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
43642276|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642278|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
43823655|NCT05520073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823656|NCT05520073|Antioxidants|antioxidants|mesh-ancestor
43823657|NCT05520073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823658|NCT05520073|Protective Agents|protective agents|mesh-ancestor
43823659|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
43823660|NCT05520021|Nifedipine|nifedipine|mesh-list
43823661|NCT05520021|Analgesics|analgesics|mesh-ancestor
43823662|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
43823663|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823664|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823665|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
43823666|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823667|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43823668|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
43823669|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43823670|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43823671|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823672|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43642304|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642305|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642306|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
43642307|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43642308|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642309|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642310|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43642311|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43642313|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43642314|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642315|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43642316|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642317|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642318|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43642319|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43642320|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
43642321|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642322|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
43642323|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43642356|NCT05440968|Analgesics|analgesics|mesh-ancestor
43642357|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
43823680|NCT05519670|Niraparib|niraparib|mesh-list
43638889|NCT03742414|Xhance|xhance|mesh-list
43642358|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642360|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43642361|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43642362|NCT05438758|Ketamine|ketamine|mesh-list
43642363|NCT05438758|Esketamine|esketamine|mesh-list
43642364|NCT05438758|Analgesics|analgesics|mesh-ancestor
43642365|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
43642366|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642367|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642368|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43642369|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642370|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
43642371|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
43642372|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642373|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43642374|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43642375|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642376|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642377|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
43642378|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642379|NCT05438394|Melphalan|melphalan|mesh-list
43642380|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43642381|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
43642382|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642383|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642384|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43642385|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43642386|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
43642387|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642388|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
43642389|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43642393|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43642394|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43642395|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
43642396|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
43642397|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642398|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642399|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43642400|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
43642401|NCT05438277|Hormones|hormones|mesh-ancestor
43642402|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642403|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43642404|NCT05438277|Protective Agents|protective agents|mesh-ancestor
43642405|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43642406|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
43642407|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642408|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642409|NCT05432466|Celiprolol|celiprolol|mesh-list
43642410|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43642411|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43642412|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
43642413|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
43642414|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642415|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642416|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
43642417|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43642418|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43642419|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43642420|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642421|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642422|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642423|NCT05430828|Evolocumab|evolocumab|mesh-list
43642424|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43642429|NCT05430048|Bisoprolol|bisoprolol|mesh-list
43642435|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642436|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43642437|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43642438|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43642439|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642440|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642441|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642442|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
43642443|NCT05430048|Coagulants|coagulants|mesh-ancestor
43642448|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642449|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43642450|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642451|NCT05428150|Pirfenidone|pirfenidone|mesh-list
43642452|NCT05428150|Analgesics|analgesics|mesh-ancestor
43642453|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
43642454|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642455|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642456|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43642457|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43642458|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43642459|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43642460|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642461|NCT05427474|Propranolol|propranolol|mesh-list
43642462|NCT05427474|Gabapentin|gabapentin|mesh-list
43642463|NCT05427474|Analgesics|analgesics|mesh-ancestor
43642464|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
43642465|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642466|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642475|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642476|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
43642477|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43642478|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43642479|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642480|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43642481|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43642482|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
43642484|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
43642485|NCT05422612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43642486|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43642487|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43642488|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642489|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642490|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
43642491|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642492|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43642493|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
43642494|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642495|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43642496|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43642497|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642498|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43823683|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823684|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823685|NCT05519592|Ropivacaine|ropivacaine|mesh-list
43823686|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
43823687|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
43823688|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823689|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823690|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
43823691|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823692|NCT05519579|Methotrexate|methotrexate|mesh-list
43823693|NCT05519579|Blinatumomab|blinatumomab|mesh-list
43823694|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43823695|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
43823696|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43823697|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823698|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43823699|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
43823700|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823701|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823702|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823703|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823704|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43823705|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823706|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
43823707|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823708|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43823709|NCT05519514|Budesonide|budesonide|mesh-list
43823728|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823730|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
43823732|NCT05519254|Lactoferrin|lactoferrin|mesh-list
43823733|NCT05519254|Muramidase|muramidase|mesh-list
43823734|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823735|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
43823736|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823737|NCT05519111|Dronabinol|dronabinol|mesh-list
43823738|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
43823739|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823740|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43639094|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642520|NCT05409872|Vitamin D|vitamin d|mesh-list
43642521|NCT05409872|Vitamins|vitamins|mesh-list
43642522|NCT05409872|Inositol|inositol|mesh-list
43642523|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
43642524|NCT05409872|Pyridoxal|pyridoxal|mesh-list
43642525|NCT05409872|Pyridoxine|pyridoxine|mesh-list
43642526|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43642527|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
43642528|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642529|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43642530|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
43642531|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
43642532|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642533|NCT05409872|Protective Agents|protective agents|mesh-ancestor
43642534|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43642535|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43642536|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642537|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43642538|NCT05408403|Anesthetics|anesthetics|mesh-list
43642539|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642540|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642541|NCT05406583|Dolutegravir|dolutegravir|mesh-list
43642542|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43642549|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642551|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642552|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43642553|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642554|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642555|NCT05402111|Olanzapine|olanzapine|mesh-list
43642556|NCT05402111|Risperidone|risperidone|mesh-list
43642557|NCT05402111|Aripiprazole|aripiprazole|mesh-list
43642558|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43642559|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
43642560|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43642561|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
43642562|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642563|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642564|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642565|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43642566|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642567|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642568|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43642569|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
43642570|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
43642571|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
43642572|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642573|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43642574|NCT05402111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43642575|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43642576|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43642577|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
43642578|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
43642579|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43642580|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43642581|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43642582|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43642583|NCT05398913|Rimonabant|rimonabant|mesh-list
43642584|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43642586|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43642587|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642588|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642589|NCT05398913|Hormones|hormones|mesh-ancestor
43642590|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643122|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642591|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642592|NCT05396859|Decitabine|decitabine|mesh-list
43642593|NCT05396859|Entrectinib|entrectinib|mesh-list
43642594|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43642595|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
43642596|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642597|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642598|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642599|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43642600|NCT05395494|Cycloserine|cycloserine|mesh-list
43642601|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43642602|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642603|NCT05395494|Renal Agents|renal agents|mesh-ancestor
43642604|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43642605|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
43642606|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43642607|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
43642608|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642609|NCT05392530|Macitentan|macitentan|mesh-list
43642610|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43642611|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43642612|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642613|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43642614|NCT05391828|Cimetidine|cimetidine|mesh-list
43642615|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43642616|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43642624|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43642625|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642626|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
43642627|NCT05387759|Aticaprant|aticaprant|mesh-list
43642628|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43642629|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642630|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43642631|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43642632|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642633|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642634|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642635|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642636|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43642637|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
43642638|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642639|NCT05384938|Benralizumab|benralizumab|mesh-list
43642640|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43642641|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
43642642|NCT05384847|Hormones|hormones|mesh-list
43642643|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642644|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642645|NCT05382364|Tucatinib|tucatinib|mesh-list
43642646|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642647|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43642648|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642649|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642650|NCT05381597|Fluorouracil|fluorouracil|mesh-list
43642651|NCT05381597|Calcipotriene|calcipotriene|mesh-list
43642652|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
43642653|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642654|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43642655|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642656|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43642657|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
43642663|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642664|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
43642665|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
43642666|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
43642667|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639258|NCT03429543|Hormones|hormones|mesh-ancestor
43642668|NCT05346666|Midazolam|midazolam|mesh-list
43642669|NCT05346666|Phenobarbital|phenobarbital|mesh-list
43642670|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43642671|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43642672|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642673|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642674|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43642679|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
43643125|NCT05190705|Dexamethasone|dexamethasone|mesh-list
43642723|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43642724|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43823741|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43823742|NCT05519111|Analgesics|analgesics|mesh-ancestor
43823743|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
43823744|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823745|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43823746|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43823747|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823748|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823749|NCT05519111|Hormones|hormones|mesh-ancestor
43823750|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823751|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
43823752|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43823753|NCT05519072|Cephalexin|cephalexin|mesh-list
43823754|NCT05519072|Fosfomycin|fosfomycin|mesh-list
43823755|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
43823756|NCT05519072|Trimethoprim|trimethoprim|mesh-list
43639322|NCT03414658|Trastuzumab|trastuzumab|mesh-list
43642725|NCT05340309|Atezolizumab|atezolizumab|mesh-list
43642726|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43642727|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642728|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
43642729|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642730|NCT05335317|Hormones|hormones|mesh-list
43642731|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642732|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642733|NCT05330754|Caffeine|caffeine|mesh-list
43642734|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43642735|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642736|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43642737|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642738|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642739|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43642743|NCT05329779|Pregnanolone|pregnanolone|mesh-list
43642744|NCT05329779|Brexanolone|brexanolone|mesh-list
43642796|NCT05323552|Curare|curare|mesh-list
43642817|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642818|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43642819|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43642820|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642821|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642822|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
43642823|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642824|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
43642882|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
43642883|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642884|NCT05284019|Erenumab|erenumab|mesh-list
43642885|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43642886|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43642887|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43642888|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642889|NCT05284019|Analgesics|analgesics|mesh-ancestor
43642890|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
43642891|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642892|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642893|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43642894|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43642895|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43642898|NCT05283304|Buprenorphine|buprenorphine|mesh-list
43642942|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642943|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43642944|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43642945|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
43823758|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43823759|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823760|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43823761|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43642958|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642959|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43642960|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642961|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
43642962|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
43642964|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
43642965|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43642966|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43642967|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43642968|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43642970|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
43643000|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643001|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643002|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43643003|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43643004|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43643005|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
43643006|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643007|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643008|NCT05221021|Urological Agents|urological agents|mesh-ancestor
43643039|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643040|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43643041|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43643042|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
43643043|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43643044|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43643046|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
43643047|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643048|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43643049|NCT05219799|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43643050|NCT05219799|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43643051|NCT05219799|Cholinergic Agents|cholinergic agents|mesh-ancestor
43643052|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43643053|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43643054|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43643055|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
43643056|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43643057|NCT05219799|Protective Agents|protective agents|mesh-ancestor
43643058|NCT05218915|Dulaglutide|dulaglutide|mesh-list
43643059|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43643060|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643061|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
43643062|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43643063|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643066|NCT05215158|Analgesics|analgesics|mesh-ancestor
43643068|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643069|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43643070|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43643071|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43643072|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
43643073|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643074|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643075|NCT05197842|Prednisone|prednisone|mesh-list
43643076|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
43643077|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
43643078|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43643079|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
43643080|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643081|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43643082|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43643083|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
43643084|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643085|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643086|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43643087|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643088|NCT05197842|Hormones|hormones|mesh-ancestor
43643089|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643090|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43643091|NCT05195918|Pirfenidone|pirfenidone|mesh-list
43643115|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43643116|NCT05195034|Analgesics|analgesics|mesh-ancestor
43643117|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
43643118|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643119|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43643120|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43643121|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43643183|NCT05178862|Fluconazole|fluconazole|mesh-list
43643184|NCT05178862|Caspofungin|caspofungin|mesh-list
43643185|NCT05178862|Micafungin|micafungin|mesh-list
43643186|NCT05178862|Anidulafungin|anidulafungin|mesh-list
43643187|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
43643188|NCT05178862|Echinocandins|echinocandins|mesh-list
43643189|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
43643190|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643191|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43643192|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43643193|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643194|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643195|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43643196|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
43643197|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643198|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643199|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43643200|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43643201|NCT05178550|Heparin|heparin|mesh-list
43643202|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
43643203|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43643204|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43643205|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643206|NCT05173298|Bevacizumab|bevacizumab|mesh-list
43643207|NCT05173298|Atezolizumab|atezolizumab|mesh-list
43643208|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643209|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643210|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43643211|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43643212|NCT05173298|Growth Substances|growth substances|mesh-ancestor
43643213|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643221|NCT05168657|Pancrelipase|pancrelipase|mesh-list
43643222|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643223|NCT05168202|Azacitidine|azacitidine|mesh-list
43643224|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43643225|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
43643226|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643227|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643228|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643229|NCT05165641|Anesthetics|anesthetics|mesh-list
43643230|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643231|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823762|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823763|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823764|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823770|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43823771|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43823772|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43823773|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43643233|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643234|NCT05156606|Testosterone|testosterone|mesh-list
43643235|NCT05156606|Androgens|androgens|mesh-ancestor
43643236|NCT05156606|Hormones|hormones|mesh-ancestor
43643237|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643238|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643239|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
43643240|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
43643241|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643249|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43643250|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43643251|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43643252|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43643253|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
43643254|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43643255|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43643261|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
43643262|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43643263|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643264|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
43643265|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43643266|NCT05134792|Antibodies|antibodies|mesh-list
43643267|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
43643270|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643272|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43643273|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643274|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
43643275|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43643276|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643277|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
43643278|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
43643279|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643280|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643281|NCT05126966|Ranibizumab|ranibizumab|mesh-list
43643282|NCT05126966|Aflibercept|aflibercept|mesh-list
43643287|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
43643288|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643289|NCT05119166|Niacinamide|niacinamide|mesh-list
43643290|NCT05119166|Niacin|niacin|mesh-list
43643291|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
43643292|NCT05119166|Azithromycin|azithromycin|mesh-list
43643293|NCT05119166|Vitamins|vitamins|mesh-ancestor
43643294|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
43643295|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643296|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43643297|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643298|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
43643299|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43643300|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
43643301|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643302|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43643303|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
43643304|NCT05112952|Lazertinib|lazertinib|mesh-list
43643305|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643306|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643307|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643309|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
43643310|NCT05099471|Rituximab|rituximab|mesh-list
43643311|NCT05099471|Venetoclax|venetoclax|mesh-list
43643312|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43643313|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
43643314|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643315|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43643316|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43643317|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
43643318|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643319|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643333|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643334|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643335|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643336|NCT05095207|Bicalutamide|bicalutamide|mesh-list
43643337|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
43643338|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
43643339|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643340|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643341|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643343|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
43643344|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643345|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643346|NCT05087862|Anesthetics|anesthetics|mesh-list
43643347|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
43643348|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643349|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643350|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
43643351|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643352|NCT05083312|Fluticasone|fluticasone|mesh-list
43643354|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643355|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43643356|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
43643357|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643358|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643359|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43643360|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
43823786|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43823787|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43823788|NCT05518994|Growth Substances|growth substances|mesh-ancestor
43643367|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43643372|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43643373|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643374|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43643375|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43643376|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
43643377|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43643379|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643380|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643381|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643382|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643383|NCT05070104|Bevacizumab|bevacizumab|mesh-list
43643384|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643385|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643386|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43643387|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43643388|NCT05070104|Growth Substances|growth substances|mesh-ancestor
43643389|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643390|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
43643391|NCT05065554|Rituximab|rituximab|mesh-list
43643392|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
43643393|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643398|NCT05060965|Nicotine|nicotine|mesh-list
43643410|NCT05057845|Lenvatinib|lenvatinib|mesh-list
43643411|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643412|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643413|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643482|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43643483|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43643484|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43643485|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
43643486|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43643487|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43643488|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
43643489|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643490|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643491|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643493|NCT05018221|Vitamin K|vitamin k|mesh-list
43643494|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
43643495|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
43643496|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
43643497|NCT05018221|Citric Acid|citric acid|mesh-list
43643498|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
43643499|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
43643500|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643501|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
43643502|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43643503|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
43643504|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
43643505|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643506|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43643507|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43643508|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
43643509|NCT05018221|Coagulants|coagulants|mesh-ancestor
43643510|NCT05018221|Antidotes|antidotes|mesh-ancestor
43643511|NCT05018221|Protective Agents|protective agents|mesh-ancestor
43643512|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
43643513|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
43643529|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43643530|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643531|NCT05010681|Lenvatinib|lenvatinib|mesh-list
43643532|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643533|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643534|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643535|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643536|NCT05010668|Lenvatinib|lenvatinib|mesh-list
43643537|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643538|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643539|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643540|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643541|NCT04984200|Mydriatics|mydriatics|mesh-list
43643542|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
43643543|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643544|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643545|NCT04981509|Listerine|listerine|mesh-list
43643546|NCT04981509|Bevacizumab|bevacizumab|mesh-list
43643547|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43643550|NCT04981509|Antibodies|antibodies|mesh-list
43643551|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
43643552|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43643553|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
43643554|NCT04981509|Fluorides|fluorides|mesh-list
43643555|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
43643556|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643557|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43643558|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43643567|NCT04974398|Gemcitabine|gemcitabine|mesh-list
43643575|NCT04974398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643576|NCT04974398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43643577|NCT04974398|Immunologic Factors|immunologic factors|mesh-ancestor
43643578|NCT04974398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823789|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823790|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
43823791|NCT05518929|Propofol|propofol|mesh-list
43823792|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43823793|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823794|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823795|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43823796|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
43823797|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
43823798|NCT05518812|Carboprost|carboprost|mesh-list
43823799|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
43823800|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43823801|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
43823802|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43640239|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823803|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823804|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
43823805|NCT05518799|Midazolam|midazolam|mesh-list
43643579|NCT04968951|Metronidazole|metronidazole|mesh-list
43643580|NCT04968951|Vancomycin|vancomycin|mesh-list
43643581|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643582|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43643583|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43643584|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43643585|NCT04961632|Tamoxifen|tamoxifen|mesh-list
43643586|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43643587|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
43643588|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643589|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643590|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43643591|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643592|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43643593|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43643596|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43643597|NCT04959812|Narcotics|narcotics|mesh-ancestor
43643598|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643599|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643600|NCT04959812|Analgesics|analgesics|mesh-ancestor
43643601|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
43643602|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643603|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43643604|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43643605|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
43643606|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
43643607|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
43643608|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43643609|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643610|NCT04957758|Varenicline|varenicline|mesh-list
43643611|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43643612|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43643613|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
43643614|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643615|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643616|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643617|NCT04949633|Oxytocin|oxytocin|mesh-list
43643618|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
43643619|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43643621|NCT04948749|Sirolimus|sirolimus|mesh-list
43643646|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43643647|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643648|NCT04943848|Trace Elements|trace elements|mesh-ancestor
43643649|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
43643652|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643653|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
43643654|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43643655|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
43643656|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
43643657|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643658|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643659|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643660|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43643661|NCT04940390|Analgesics|analgesics|mesh-ancestor
43643662|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
43643663|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643665|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43643666|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643667|NCT04939662|Bevacizumab|bevacizumab|mesh-list
43643668|NCT04939662|Olaparib|olaparib|mesh-list
43643669|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643670|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643671|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43643672|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43643673|NCT04939662|Growth Substances|growth substances|mesh-ancestor
43643674|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643675|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
43643676|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43643677|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643678|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643679|NCT04939649|Midazolam|midazolam|mesh-list
43643680|NCT04939649|Ketamine|ketamine|mesh-list
43643681|NCT04939649|Analgesics|analgesics|mesh-ancestor
43643687|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
43643688|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
43643689|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643690|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43643691|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43643692|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643693|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643694|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43643695|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43643696|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43643697|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43643698|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43643751|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
43643752|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643753|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643754|NCT04912856|Ezogabine|ezogabine|mesh-list
43643755|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
43643756|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43643757|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643758|NCT04912596|Albuterol|albuterol|mesh-list
43643759|NCT04912596|Procaterol|procaterol|mesh-list
43643760|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
43643761|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43643762|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
43643763|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643823|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643824|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
43643826|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643827|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43643828|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643829|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
43643830|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43643831|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43643832|NCT04891809|Growth Substances|growth substances|mesh-ancestor
43643833|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
43823806|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43823807|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43823808|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823809|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823810|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43823811|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43823812|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43823813|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43823814|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
43823815|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
43823816|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
43823818|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823819|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823820|NCT05518578|Huperzine A|huperzine a|mesh-list
43823821|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43823822|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823823|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823824|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
43823825|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823838|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823839|NCT05518500|Vaccines|vaccines|mesh-list
43823840|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
43823841|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823842|NCT05518409|Donepezil|donepezil|mesh-list
43823843|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43823844|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823845|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823846|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
43823847|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823848|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823849|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
43823850|NCT05518383|Cytarabine|cytarabine|mesh-list
43823851|NCT05518383|Dexamethasone|dexamethasone|mesh-list
43823852|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
43823853|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
43640560|NCT02181738|Doxorubicin|doxorubicin|mesh-list
43643834|NCT04887857|Azacitidine|azacitidine|mesh-list
43643835|NCT04887857|Venetoclax|venetoclax|mesh-list
43643836|NCT04887857|Cc-486|cc-486|mesh-list
43643837|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43643838|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
43643839|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643840|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643841|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643842|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
43643843|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43643844|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643845|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43643846|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643847|NCT04882241|Leucovorin|leucovorin|mesh-list
43643848|NCT04882241|Cisplatin|cisplatin|mesh-list
43643849|NCT04882241|Docetaxel|docetaxel|mesh-list
43643850|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
43643851|NCT04882241|Fluorouracil|fluorouracil|mesh-list
43643852|NCT04882241|Capecitabine|capecitabine|mesh-list
43643859|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643860|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
43643861|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43643862|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43643863|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
43643864|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643865|NCT04882241|Antidotes|antidotes|mesh-ancestor
43643866|NCT04882241|Protective Agents|protective agents|mesh-ancestor
43643867|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
43643868|NCT04882241|Vitamins|vitamins|mesh-ancestor
43643870|NCT04880577|Tenofovir|tenofovir|mesh-list
43643927|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43643928|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643929|NCT04838743|Xultophy|xultophy|mesh-list
43643930|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43643931|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643932|NCT04838743|Incretins|incretins|mesh-ancestor
43643933|NCT04838743|Hormones|hormones|mesh-ancestor
43643934|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643935|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43643936|NCT04836429|Trioxsalen|trioxsalen|mesh-list
43643937|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643938|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
43643939|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43643940|NCT04834024|Antibodies|antibodies|mesh-list
43643941|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43643942|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
43643943|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643944|NCT04831892|Isosorbide|isosorbide|mesh-list
43643945|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43643946|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43643947|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43643948|NCT04831892|Diuretics|diuretics|mesh-ancestor
43643983|NCT04814875|Carboplatin|carboplatin|mesh-list
43643984|NCT04814875|Doxorubicin|doxorubicin|mesh-list
43643985|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43643986|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643987|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43643988|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43643989|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43643990|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643991|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643992|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
43643993|NCT04812535|Vilobelimab|vilobelimab|mesh-list
43643994|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643995|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643996|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43643997|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43643998|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
43643999|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644000|NCT04792645|Memantine|memantine|mesh-list
43644001|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43644002|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43644003|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
43644004|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644005|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644006|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644007|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43644008|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43644009|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43644010|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43644011|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823855|NCT05518383|Ifosfamide|ifosfamide|mesh-list
43823856|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
43823857|NCT05518383|Doxorubicin|doxorubicin|mesh-list
43823869|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823870|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43823871|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
43823872|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823873|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823874|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43823875|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823876|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
43823877|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
43823878|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823879|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823880|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
43823882|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823883|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43823884|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
43823885|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823886|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43823887|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43823907|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
43644025|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644026|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43644027|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644028|NCT04779645|Volagidemab|volagidemab|mesh-list
43644029|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43644030|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644031|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43644032|NCT04778358|Hormones|hormones|mesh-ancestor
43644033|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644034|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644035|NCT04772313|Methotrexate|methotrexate|mesh-list
43644036|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43644037|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
43644038|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43644039|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644040|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644041|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
43644042|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644043|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644044|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
43644045|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644046|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43644047|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644048|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
43644070|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43644071|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43644072|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43644073|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644074|NCT04768296|Topotecan|topotecan|mesh-list
43644075|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43644076|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43644077|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644078|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644079|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644080|NCT04759144|Insulin|insulin|mesh-list
43644081|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43644082|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
43644083|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
43644125|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
43644126|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644127|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644128|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644129|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644130|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
43644131|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644132|NCT04739670|Gemcitabine|gemcitabine|mesh-list
43644133|NCT04739670|Bevacizumab|bevacizumab|mesh-list
43644134|NCT04739670|Carboplatin|carboplatin|mesh-list
43644135|NCT04739670|Atezolizumab|atezolizumab|mesh-list
43644136|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644137|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644138|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43644198|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644199|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644200|NCT04720612|Omalizumab|omalizumab|mesh-list
43644201|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43850665|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43850666|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43850667|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
43850668|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
43851081|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536723|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536724|NCT04291521|Ketamine|ketamine|mesh-list
43536725|NCT04291521|Propofol|propofol|mesh-list
43536726|NCT04291521|Etomidate|etomidate|mesh-list
43536727|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43536728|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43536729|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536783|NCT04042077|Linezolid|linezolid|mesh-list
43536784|NCT04042077|Piperacillin|piperacillin|mesh-list
43536786|NCT04042077|Tigecycline|tigecycline|mesh-list
43536852|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43536853|NCT03738852|Insulin|insulin|mesh-list
43536854|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43536855|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536856|NCT03738397|Upadacitinib|upadacitinib|mesh-list
43536857|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43536858|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
43536859|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536860|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43536866|NCT03705845|Vitamin E|vitamin e|mesh-list
43536918|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43536919|NCT03568630|Chrysarobin|chrysarobin|mesh-list
43536920|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43536921|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43536922|NCT03568630|Analgesics|analgesics|mesh-ancestor
43536923|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
43536924|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536928|NCT03520491|Nivolumab|nivolumab|mesh-list
43536987|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43536988|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
43536989|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536990|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536991|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43536992|NCT03039673|Interleukin-2|interleukin-2|mesh-list
43536993|NCT03039673|Riluzole|riluzole|mesh-list
43536994|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536995|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43537053|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
43537054|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537055|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43537126|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43537127|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537128|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537129|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43537130|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43537132|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537133|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537134|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43537135|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43537136|NCT02372630|Linagliptin|linagliptin|mesh-list
43537137|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43537186|NCT05693077|Vancomycin|vancomycin|mesh-list
43537187|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43537188|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537189|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
43537190|NCT05692999|Pemetrexed|pemetrexed|mesh-list
43537191|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537192|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537193|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537194|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537195|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43537196|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43537197|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43537250|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43537251|NCT05692804|Protein S|protein s|mesh-list
43537252|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
43537395|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537475|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537476|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537478|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537479|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537548|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
43537549|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537550|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43537551|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
43537552|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
43537619|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537620|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537621|NCT05446870|Paclitaxel|paclitaxel|mesh-list
43537622|NCT05446870|Docetaxel|docetaxel|mesh-list
43537623|NCT05446870|Bevacizumab|bevacizumab|mesh-list
43537624|NCT05446870|Carboplatin|carboplatin|mesh-list
43537625|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
43537626|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43537627|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537628|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
43537685|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
43537686|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537687|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537688|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43537689|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537690|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43537691|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43537696|NCT05406401|Hormones|hormones|mesh-ancestor
43537759|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537761|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537764|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537842|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537843|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
43537844|NCT05276973|Paclitaxel|paclitaxel|mesh-list
43537845|NCT05276973|Carboplatin|carboplatin|mesh-list
43537846|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43537847|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43537848|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537849|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
43537912|NCT05211895|Durvalumab|durvalumab|mesh-list
43540967|NCT02131597|Azacitidine|azacitidine|mesh-list
43537913|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537914|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537983|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
43537984|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537985|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43537986|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537987|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537988|NCT05151744|Ranibizumab|ranibizumab|mesh-list
43537989|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43537990|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43537991|NCT05151744|Growth Substances|growth substances|mesh-ancestor
43537992|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537993|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
43537994|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537995|NCT05151731|Ranibizumab|ranibizumab|mesh-list
43538043|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538044|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538045|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43538046|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43538047|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43538048|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
43538049|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
43538050|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538051|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538108|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538109|NCT05053126|Pregabalin|pregabalin|mesh-list
43538110|NCT05053126|Oxycodone|oxycodone|mesh-list
43538111|NCT05053126|Analgesics|analgesics|mesh-ancestor
43538112|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
43538113|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538114|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538115|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
43538116|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43538117|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43538118|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538119|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43538125|NCT05053126|Narcotics|narcotics|mesh-ancestor
43538170|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538171|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538173|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
43538174|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538175|NCT04999020|Ravulizumab|ravulizumab|mesh-list
43538176|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43538177|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538184|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538248|NCT04924101|Lenvatinib|lenvatinib|mesh-list
43538249|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538250|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538321|NCT04847453|Ixazomib|ixazomib|mesh-list
43538322|NCT04847453|Ichthammol|ichthammol|mesh-list
43538323|NCT04847453|BB 1101|bb 1101|mesh-list
43538324|NCT04847453|Glycine|glycine|mesh-list
43538325|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538326|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
43538327|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
43538331|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
43538388|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43538389|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
43538390|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538391|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538394|NCT04812548|Venetoclax|venetoclax|mesh-list
43538460|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538461|NCT04762979|Fulvestrant|fulvestrant|mesh-list
43538462|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43538463|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43538464|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538465|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43538466|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43538467|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
43538525|NCT04716946|Durvalumab|durvalumab|mesh-list
43538526|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538527|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538528|NCT04711252|Palbociclib|palbociclib|mesh-list
43538529|NCT04711252|Anastrozole|anastrozole|mesh-list
43538530|NCT04711252|Hormones|hormones|mesh-list
43538531|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43538600|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538601|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43538603|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538604|NCT04584112|Paclitaxel|paclitaxel|mesh-list
43538651|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538652|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43538653|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538654|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43538724|NCT04396821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538725|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538726|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43538728|NCT04339062|Prednisone|prednisone|mesh-list
43538729|NCT04339062|Everolimus|everolimus|mesh-list
43538730|NCT04339062|Cemiplimab|cemiplimab|mesh-list
43538731|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538863|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538864|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538934|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
43538935|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43538936|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43538937|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
43539007|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539126|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539127|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539128|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
43539129|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43539130|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539131|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43539205|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
43539206|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539208|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539209|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43539210|NCT03565991|Avelumab|avelumab|mesh-list
43539276|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539277|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539278|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
43539279|NCT03393845|Fulvestrant|fulvestrant|mesh-list
43539352|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43539353|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43539354|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
43539355|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539356|NCT03281369|Antidotes|antidotes|mesh-ancestor
43539357|NCT03281369|Protective Agents|protective agents|mesh-ancestor
43539358|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
43539359|NCT03281369|Vitamins|vitamins|mesh-ancestor
43539360|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
43539361|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43539362|NCT03281369|Incretins|incretins|mesh-ancestor
43539363|NCT03281369|Hormones|hormones|mesh-ancestor
43539364|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539365|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43539366|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
43539412|NCT03182244|Fludarabine|fludarabine|mesh-list
43539413|NCT03182244|Etoposide|etoposide|mesh-list
43539414|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
43539415|NCT03182244|Lenograstim|lenograstim|mesh-list
43539416|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539417|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43539418|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
43539419|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539479|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539480|NCT02879136|Methylphenidate|methylphenidate|mesh-list
43539552|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43539553|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43539554|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539556|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539557|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539558|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539559|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539561|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43539562|NCT02584478|Carboplatin|carboplatin|mesh-list
43539563|NCT02584478|Doxorubicin|doxorubicin|mesh-list
43539613|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43539614|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43539615|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
43539616|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539617|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539618|NCT02032810|Ipilimumab|ipilimumab|mesh-list
43539619|NCT02032810|Panobinostat|panobinostat|mesh-list
43539683|NCT00092222|Rituximab|rituximab|mesh-list
43539684|NCT00092222|Doxorubicin|doxorubicin|mesh-list
43539685|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43539686|NCT00092222|Etoposide|etoposide|mesh-list
43539687|NCT00092222|Vincristine|vincristine|mesh-list
43539688|NCT00092222|Bortezomib|bortezomib|mesh-list
43539689|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43539690|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
43539691|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539692|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43539693|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43539694|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
43539705|NCT00092222|Hormones|hormones|mesh-ancestor
43539748|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43539751|NCT01415674|Afatinib|afatinib|mesh-list
43539819|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539820|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43539821|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539822|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43539823|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43539824|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43539825|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
43539826|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
43539827|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539828|NCT00972738|Loratadine|loratadine|mesh-list
43539829|NCT00972738|Montelukast|montelukast|mesh-list
43539876|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43539877|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539878|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
43539879|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
43539880|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43539884|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
43539942|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539943|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539944|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539945|NCT00898677|Sumatriptan|sumatriptan|mesh-list
43539946|NCT00898677|Rizatriptan|rizatriptan|mesh-list
43540008|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540010|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
43540011|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540012|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540013|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540014|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43540073|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540074|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43540075|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
43540076|NCT00641771|Vitamin D|vitamin d|mesh-list
43540077|NCT00641771|Alendronate|alendronate|mesh-list
43540078|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43540079|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540080|NCT00641771|Vitamins|vitamins|mesh-ancestor
43540081|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
43540082|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540083|NCT00616967|Paclitaxel|paclitaxel|mesh-list
43540085|NCT00616967|Carboplatin|carboplatin|mesh-list
43540133|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540134|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540135|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
43540136|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
43540137|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43540138|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
43540201|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43540202|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
43540203|NCT00395408|Hormones|hormones|mesh-ancestor
43540204|NCT00394069|Montelukast|montelukast|mesh-list
43540205|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540206|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540207|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540208|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540263|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540267|NCT00140946|Montelukast|montelukast|mesh-list
43540329|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540330|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540331|NCT00092118|Montelukast|montelukast|mesh-list
43540332|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540333|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540334|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540341|NCT00092105|Montelukast|montelukast|mesh-list
43540395|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
43540396|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540397|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43540398|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540464|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540466|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43540467|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540537|NCT05169866|Nifekalant|nifekalant|mesh-list
43540538|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43540539|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
43540540|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43540541|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43540542|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540543|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43540544|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43540603|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
43540604|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540605|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540606|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43540607|NCT05072704|Narcotics|narcotics|mesh-ancestor
43540608|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43540609|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43540610|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
43540692|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
43540693|NCT04787692|Narcotics|narcotics|mesh-ancestor
43540694|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43540695|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540762|NCT04104178|Clindamycin|clindamycin|mesh-list
43540763|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
43540764|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
43540765|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43540766|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540767|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43540768|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540770|NCT03918915|Atropine|atropine|mesh-list
43540786|NCT03882918|Gaboxadol|gaboxadol|mesh-list
43540827|NCT03772353|Fulvestrant|fulvestrant|mesh-list
43540828|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43540829|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540830|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43540831|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540832|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540833|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43540834|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540893|NCT02668783|Ibuprofen|ibuprofen|mesh-list
43540894|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43540895|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43540896|NCT02668783|Etonogestrel|etonogestrel|mesh-list
43540897|NCT02668783|Estradiol|estradiol|mesh-list
43540898|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43540963|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540964|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43540965|NCT02275546|Progestins|progestins|mesh-ancestor
43540966|NCT02131597|Guadecitabine|guadecitabine|mesh-list
43540968|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540969|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43540970|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
43540971|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540972|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540973|NCT02077166|Rituximab|rituximab|mesh-list
43540974|NCT02077166|Lenalidomide|lenalidomide|mesh-list
43540975|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43540986|NCT02027935|Ipilimumab|ipilimumab|mesh-list
43541027|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541028|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541097|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43541098|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43541099|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43541100|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
43541101|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
43541103|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43541104|NCT01267812|Rituximab|rituximab|mesh-list
43541105|NCT01267812|Bortezomib|bortezomib|mesh-list
43541112|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
43541160|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43541161|NCT00920361|Hormones|hormones|mesh-ancestor
43541162|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541163|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541164|NCT00886691|Bevacizumab|bevacizumab|mesh-list
43541165|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43541166|NCT00886691|Everolimus|everolimus|mesh-list
43541228|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541229|NCT00541684|Atenolol|atenolol|mesh-list
43541230|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
43541231|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541299|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541300|NCT05576597|Butyric Acid|butyric acid|mesh-list
43541301|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
43541302|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
43541303|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541304|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541305|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541306|NCT05576038|Tryptophan|tryptophan|mesh-list
43541309|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43541365|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
43541441|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43541442|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43541443|NCT05464628|Atorvastatin|atorvastatin|mesh-list
43541444|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43541445|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43541446|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
43541447|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541450|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541507|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43541508|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541509|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
43541510|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
43541511|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
43541512|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541575|NCT05295173|Plasminogen|plasminogen|mesh-list
43541576|NCT05295173|Reteplase|reteplase|mesh-list
43541577|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43541580|NCT05289349|Propofol|propofol|mesh-list
43541648|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43541649|NCT05093608|Growth Substances|growth substances|mesh-ancestor
43541650|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541651|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
43541652|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
43541653|NCT04971720|Valsartan|valsartan|mesh-list
43541654|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43541655|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43541714|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43541715|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43541716|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541717|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
43541718|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43541719|NCT04774237|Carbachol|carbachol|mesh-list
43541720|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43541729|NCT04774237|Miotics|miotics|mesh-ancestor
43541782|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
43541787|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43541854|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541855|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43541856|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
43541858|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541925|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541927|NCT03320434|Hormones|hormones|mesh-ancestor
43541928|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541929|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43541994|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541995|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43541996|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
43541997|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
43541998|NCT02843074|Dexamethasone|dexamethasone|mesh-list
43541999|NCT02843074|Lenalidomide|lenalidomide|mesh-list
43542065|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542066|NCT02117700|Expectorants|expectorants|mesh-ancestor
43542067|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
43542140|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542142|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43542143|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
43542146|NCT00143182|Olanzapine|olanzapine|mesh-list
43542209|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542210|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43542212|NCT03704753|Ropivacaine|ropivacaine|mesh-list
43542282|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542283|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542284|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
43542355|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
43542357|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
43542358|NCT03702985|Capecitabine|capecitabine|mesh-list
43542359|NCT03702985|Irinotecan|irinotecan|mesh-list
43542360|NCT03702985|Amifostine|amifostine|mesh-list
43542361|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43542362|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
43542363|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542364|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542365|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43542366|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43542367|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542368|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43542369|NCT03702985|Protective Agents|protective agents|mesh-ancestor
43542416|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542417|NCT03702738|Protective Agents|protective agents|mesh-ancestor
43542418|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542419|NCT03702738|Antidotes|antidotes|mesh-ancestor
43542420|NCT03702647|Ropivacaine|ropivacaine|mesh-list
43542421|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
43542423|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542424|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542425|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
43542426|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542427|NCT03702621|Bupivacaine|bupivacaine|mesh-list
43542428|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
43542429|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
43542430|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542434|NCT03702582|Warfarin|warfarin|mesh-list
43542476|NCT03702400|Norepinephrine|norepinephrine|mesh-list
43542477|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43542478|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
43542479|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
43542480|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542481|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542482|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
43542493|NCT03702387|Anesthetics|anesthetics|mesh-list
43542543|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43542544|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
43542545|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
43542546|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542547|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542548|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43542549|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43542611|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542612|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542613|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542614|NCT03701321|Dexamethasone|dexamethasone|mesh-list
43542615|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
43542621|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542623|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
43542624|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542625|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542673|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43542674|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542675|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542676|NCT03700801|Insulin|insulin|mesh-list
43542677|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43542678|NCT03700801|Metformin|metformin|mesh-list
43542679|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
43542680|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
43542681|NCT03700801|Saxagliptin|saxagliptin|mesh-list
43542742|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43542744|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43542745|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542746|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43542747|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43542813|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542814|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
43542815|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542883|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43542884|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542885|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542886|NCT03699215|Protective Agents|protective agents|mesh-ancestor
43542888|NCT03699202|Ziresovir|ziresovir|mesh-list
43542954|NCT03698682|Ofloxacin|ofloxacin|mesh-list
43542955|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43542956|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542957|NCT03698682|Renal Agents|renal agents|mesh-ancestor
43542958|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43542959|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43542960|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43542961|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542962|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542963|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542964|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43542966|NCT03698630|Dexamethasone|dexamethasone|mesh-list
43543015|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543016|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
43543017|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
43543018|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
43543019|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
43543020|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543021|NCT03698474|Analgesics|analgesics|mesh-ancestor
43543025|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
43543085|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543155|NCT03697564|Immunologic Factors|immunologic factors|mesh-ancestor
43543156|NCT03697564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543157|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543158|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43543159|NCT03697265|Pregnanolone|pregnanolone|mesh-list
43543160|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
43543161|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543162|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543163|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
43543164|NCT03697239|Gemcitabine|gemcitabine|mesh-list
43543220|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43543221|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543222|NCT03696901|Dalbavancin|dalbavancin|mesh-list
43543223|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43543224|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543225|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
43543226|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
43543227|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43543228|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543229|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543230|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
43543258|NCT03696290|Aztreonam|aztreonam|mesh-list
43543281|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543282|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543283|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
43543284|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543285|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
43543286|NCT03695952|Nivolumab|nivolumab|mesh-list
43543287|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43543288|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543346|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543347|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
43543348|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543349|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43543350|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
43543351|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43543352|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43543353|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543355|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
43543410|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
43543411|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543412|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543413|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543414|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543415|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43543416|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543417|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543418|NCT03694535|Mitomycins|mitomycins|mesh-list
43543419|NCT03694535|Mitomycin|mitomycin|mesh-list
43543420|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43543421|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543422|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
43543425|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543471|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43543472|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
43543473|NCT03693872|Protective Agents|protective agents|mesh-ancestor
43543474|NCT03693833|Cannabidiol|cannabidiol|mesh-list
43543475|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
43543544|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
43543545|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543616|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43543618|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543619|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43543687|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
43543688|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
43543689|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
43543690|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43543691|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
43543692|NCT03691896|Vitamin D|vitamin d|mesh-list
43543693|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543754|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43543756|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43543757|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
43543758|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43543759|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
43543761|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
43543824|NCT03690739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543825|NCT03690739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543826|NCT03690739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543827|NCT03690739|Immunologic Factors|immunologic factors|mesh-ancestor
43543828|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43543829|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
43543830|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
43543831|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43543892|NCT03690323|Immunologic Factors|immunologic factors|mesh-ancestor
43543893|NCT03690323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543894|NCT03690167|Mitogens|mitogens|mesh-list
43543895|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
43543896|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543897|NCT03690115|Ponatinib|ponatinib|mesh-list
43543898|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543899|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43543961|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43543962|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43543963|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543964|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
43543965|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43543966|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
43543967|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43543968|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43543969|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543970|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43543971|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43543972|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543974|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43544020|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544021|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
43544022|NCT03688464|Promethazine|promethazine|mesh-list
43544093|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544096|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
43544167|NCT03686878|Lifitegrast|lifitegrast|mesh-list
43544168|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43544169|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43544170|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
43544171|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43544172|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43544173|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544174|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
43544238|NCT03685409|Metformin|metformin|mesh-list
43544311|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43544312|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544386|NCT03682952|Beraprost|beraprost|mesh-list
43544387|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43544388|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
43544389|NCT03682952|Urological Agents|urological agents|mesh-ancestor
43544390|NCT03682939|Vaccines|vaccines|mesh-list
43544391|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
43544392|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544393|NCT03682718|Misoprostol|misoprostol|mesh-list
43544400|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
43544456|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544458|NCT03682172|Glucagon|glucagon|mesh-list
43544459|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43544460|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43544461|NCT03682172|Hormones|hormones|mesh-ancestor
43544462|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43544526|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43544527|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43544528|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43544529|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544530|NCT03680716|Ropivacaine|ropivacaine|mesh-list
43544531|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
43544532|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
43544533|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544534|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544535|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
43544536|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544537|NCT03680638|Allopurinol|allopurinol|mesh-list
43544539|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
43544540|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544541|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544542|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
43544543|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43544544|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43544545|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
43544581|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
43544582|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43544583|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
43544584|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544657|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43544658|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43544659|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
43544730|NCT03679052|Mirtazapine|mirtazapine|mesh-list
43544731|NCT03679052|Analgesics|analgesics|mesh-ancestor
43544732|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
43544733|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544734|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544735|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43544736|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
43544737|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
43544738|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43544739|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43544795|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544797|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43544798|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43544799|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43544804|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544861|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
43544862|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544863|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544864|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43544865|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43544866|NCT03678012|Hematinics|hematinics|mesh-ancestor
43544867|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43544868|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43544869|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43544870|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544871|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
43544872|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43544873|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
43544874|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544875|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
43544876|NCT03677895|Protective Agents|protective agents|mesh-ancestor
43544877|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
43544922|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43544923|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43544924|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43544925|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544927|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43544928|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
43544929|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544933|NCT03676985|Antibodies|antibodies|mesh-list
43544988|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
43544989|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43544990|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43544991|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43544992|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43544993|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
43544994|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544995|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545056|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
43545057|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545058|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
43545059|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43545129|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
43545130|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43545131|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43545132|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
43545133|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43545135|NCT03675191|Phentermine|phentermine|mesh-list
43545136|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545196|NCT03674411|Lenograstim|lenograstim|mesh-list
43545197|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43545198|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
43545199|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545200|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545201|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43545202|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
43545203|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545259|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
43545260|NCT03674151|Povidone|povidone|mesh-list
43545261|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
43545266|NCT03674099|Prednisolone|prednisolone|mesh-list
43545335|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
43545338|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43545409|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545410|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43545411|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43545412|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
43545481|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545482|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545483|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43545484|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545485|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43545486|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43545503|NCT03671161|Insulin|insulin|mesh-list
43545549|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43545550|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43545551|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
43545552|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545554|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43545555|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
43545556|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
43545616|NCT03670043|Cathartics|cathartics|mesh-ancestor
43545617|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43545618|NCT03669783|Dactinomycin|dactinomycin|mesh-list
43545619|NCT03669783|Carboplatin|carboplatin|mesh-list
43545620|NCT03669783|Doxorubicin|doxorubicin|mesh-list
43545621|NCT03669783|Etoposide|etoposide|mesh-list
43545690|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
43545691|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545692|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545764|NCT03668860|BB 1101|bb 1101|mesh-list
43545765|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545766|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
43545767|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
43545838|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43545839|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43545840|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
43545841|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545909|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43545910|NCT03667066|Clopidogrel|clopidogrel|mesh-list
43545911|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43545912|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43545914|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43545978|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
43546048|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43546049|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546050|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43546051|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546052|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
43546119|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546120|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43546121|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43546122|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
43546123|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546130|NCT03665428|Bismuth|bismuth|mesh-list
43546187|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43546188|NCT03664440|Nevirapine|nevirapine|mesh-list
43546189|NCT03664440|Rilpivirine|rilpivirine|mesh-list
43546190|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43546191|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43546192|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546253|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43546254|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43546324|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546325|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43546326|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546327|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
43546394|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
43546395|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43546468|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43546469|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43546470|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43546471|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43546472|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546473|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546474|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
43546475|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546476|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546477|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
43546478|NCT03661775|Analgesics|analgesics|mesh-ancestor
43546479|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
43546480|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546481|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546482|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
43546483|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546484|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43546485|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
43546486|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43546487|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546488|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546518|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546519|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546520|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43546586|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43546587|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
43546588|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
43546589|NCT03660306|Anesthetics|anesthetics|mesh-list
43546590|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546591|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546592|NCT03660306|Narcotics|narcotics|mesh-ancestor
43546593|NCT03660306|Analgesics|analgesics|mesh-ancestor
43546594|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
43546652|NCT03659292|Anesthetics|anesthetics|mesh-list
43546653|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43546654|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546655|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
43546656|NCT03659162|Clotrimazole|clotrimazole|mesh-list
43546657|NCT03659162|Miconazole|miconazole|mesh-list
43546658|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546659|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43546718|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43546719|NCT03658746|Amoxicillin|amoxicillin|mesh-list
43546795|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43546796|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546797|NCT03658473|Naproxen|naproxen|mesh-list
43546798|NCT03658473|Rabeprazole|rabeprazole|mesh-list
43546799|NCT03658473|Rebamipide|rebamipide|mesh-list
43546800|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43546801|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43546802|NCT03658473|Analgesics|analgesics|mesh-ancestor
43546803|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
43546804|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546805|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546806|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546807|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546857|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43546858|NCT03658317|Uric Acid|uric acid|mesh-list
43546859|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
43546861|NCT03658317|Protective Agents|protective agents|mesh-ancestor
43547001|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43547002|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
43547003|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
43547004|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547005|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547006|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43547007|NCT03657212|Zolpidem|zolpidem|mesh-list
43547008|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43547009|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43547066|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43547067|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43547142|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43547143|NCT03656172|Chrysarobin|chrysarobin|mesh-list
43547144|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547145|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547146|NCT03656172|Analgesics|analgesics|mesh-ancestor
43547147|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
43547148|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547149|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547150|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547151|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547153|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
43547154|NCT03656094|Pemetrexed|pemetrexed|mesh-list
43547155|NCT03656094|Vinorelbine|vinorelbine|mesh-list
43547156|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547157|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
43547166|NCT03656042|Lenograstim|lenograstim|mesh-list
43547200|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547201|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43547202|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43547203|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
43547204|NCT03655665|Ofloxacin|ofloxacin|mesh-list
43547205|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43547206|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43547216|NCT03655535|PAZ320|paz320|mesh-list
43547266|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547267|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43547268|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43547269|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
43547270|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547272|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
43547273|NCT03654144|Dienogest|dienogest|mesh-list
43547406|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43547412|NCT03652493|Carboplatin|carboplatin|mesh-list
43547479|NCT03652116|Narcotics|narcotics|mesh-ancestor
43547480|NCT03652116|Analgesics|analgesics|mesh-ancestor
43547481|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43547482|NCT03652103|Bupivacaine|bupivacaine|mesh-list
43547483|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
43547484|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
43547485|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43547551|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547552|NCT03651557|Analgesics|analgesics|mesh-ancestor
43547553|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
43547554|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547555|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547556|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547557|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43547558|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43547620|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43547621|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547622|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43547623|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547624|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547625|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43547626|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43547627|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43547628|NCT03650361|Adapalene|adapalene|mesh-list
43547629|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547630|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547685|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547686|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
43547687|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
43547688|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
43547689|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547690|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43547691|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43547751|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547752|NCT03649165|Acetaminophen|acetaminophen|mesh-list
43547753|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43547754|NCT03649165|Analgesics|analgesics|mesh-ancestor
43547755|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
43547822|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
43547823|NCT03648528|Vitamin D|vitamin d|mesh-list
43547824|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43547826|NCT03648528|Vitamins|vitamins|mesh-ancestor
43547827|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
43547828|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43547829|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43547830|NCT03648333|Niacin|niacin|mesh-list
43547831|NCT03648333|Amlodipine|amlodipine|mesh-list
43547832|NCT03648333|Valsartan|valsartan|mesh-list
43547833|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
43547834|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43547835|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43547836|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43547837|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547838|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43547882|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43547883|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43547884|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547953|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43547954|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43547955|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
43547956|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
43547957|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43547958|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548022|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548023|NCT03646526|Amitriptyline|amitriptyline|mesh-list
43548024|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43548082|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43548083|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43548084|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548085|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548086|NCT03646006|Bupivacaine|bupivacaine|mesh-list
43548087|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
43548152|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548407|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548409|NCT03642353|Listerine|listerine|mesh-list
43548410|NCT03642353|Triclosan|triclosan|mesh-list
43548411|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
43548470|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548471|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
43548472|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43548473|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43548474|NCT03641456|Growth Substances|growth substances|mesh-ancestor
43548475|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
43548477|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
43548478|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548479|NCT03641404|Protective Agents|protective agents|mesh-ancestor
43548480|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548481|NCT03641053|Iodine|iodine|mesh-list
43548482|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
43548483|NCT03641053|Povidone|povidone|mesh-list
43548484|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43548485|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548486|NCT03641053|Trace Elements|trace elements|mesh-ancestor
43548487|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
43548488|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548489|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
43548490|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
43548491|NCT03640728|Tenofovir|tenofovir|mesh-list
43548492|NCT03640728|Entecavir|entecavir|mesh-list
43548523|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
43548524|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548525|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43548526|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43548536|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548537|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43548538|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43548539|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43548540|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43548541|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43548542|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
43548543|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
43548545|NCT03640403|Piperaquine|piperaquine|mesh-list
43548546|NCT03640403|Amodiaquine|amodiaquine|mesh-list
43548547|NCT03640403|Artenimol|artenimol|mesh-list
43548548|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
43548549|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43548550|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43548551|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548552|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548612|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548613|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43548614|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43548615|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548616|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548617|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43548618|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548619|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
43548620|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
43548622|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43548623|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43548625|NCT03640221|Diuretics|diuretics|mesh-ancestor
43548673|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548674|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43548675|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548676|NCT03639571|Ibuprofen|ibuprofen|mesh-list
43548677|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43548678|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548679|NCT03639571|Analgesics|analgesics|mesh-ancestor
43548680|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
43548681|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548682|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548683|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548684|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43548734|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548735|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43548736|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548738|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43548739|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43548740|NCT03639467|Gemcitabine|gemcitabine|mesh-list
43548742|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548743|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43548790|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
43548791|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548865|NCT03638310|Gentamicins|gentamicins|mesh-list
43548866|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43548937|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548938|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
43548939|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548940|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43548941|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43548942|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43548943|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43548944|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548945|NCT03637400|Doxycycline|doxycycline|mesh-list
43548946|NCT03637400|Trimethoprim|trimethoprim|mesh-list
43548947|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
43548948|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43548949|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548950|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
43548951|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43548952|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43548953|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43548954|NCT03637400|Renal Agents|renal agents|mesh-ancestor
43548993|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43548994|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
43549017|NCT03636685|Paclitaxel|paclitaxel|mesh-list
43549065|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549066|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43549067|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549068|NCT03636308|Gemcitabine|gemcitabine|mesh-list
43549069|NCT03636308|Paclitaxel|paclitaxel|mesh-list
43549070|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43549071|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43549072|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549073|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
43549074|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
43549075|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
43549125|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43549126|NCT03635684|Analgesics|analgesics|mesh-ancestor
43549127|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
43549128|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549129|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549130|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
43549131|NCT03635411|Niacinamide|niacinamide|mesh-list
43549133|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
43549134|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
43549135|NCT03635411|Vitamins|vitamins|mesh-ancestor
43549136|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
43549175|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549176|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549177|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549383|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549384|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43549385|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549430|NCT03632876|Protective Agents|protective agents|mesh-ancestor
43549431|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549432|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43549433|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549434|NCT03632876|Vitamins|vitamins|mesh-ancestor
43549435|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
43549436|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
43549437|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43549438|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43549440|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
43549496|NCT03632590|Antacids|antacids|mesh-ancestor
43549497|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43549566|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549567|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549568|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43549569|NCT03632161|Analgesics|analgesics|mesh-ancestor
43549570|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43549571|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43549583|NCT03631953|Trametinib|trametinib|mesh-list
43549634|NCT03631836|Bevacizumab|bevacizumab|mesh-list
43549635|NCT03631836|Antibodies|antibodies|mesh-list
43549636|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43549637|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43549638|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549639|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43549640|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43549641|NCT03631836|Growth Substances|growth substances|mesh-ancestor
43549642|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549697|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549698|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
43549699|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549700|NCT03630796|Sevoflurane|sevoflurane|mesh-list
43549701|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43549702|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43549703|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
43549704|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
43549707|NCT03630614|Nicotine|nicotine|mesh-list
43549763|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43549764|NCT03629639|Metformin|metformin|mesh-list
43549838|NCT03629262|Narcotics|narcotics|mesh-ancestor
43549839|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43549912|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549913|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43549914|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43549915|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
43549987|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43549988|NCT03626753|Analgesics|analgesics|mesh-ancestor
43549989|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
43549990|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549991|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549992|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
43549993|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43549994|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43549995|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43549996|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43549997|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549998|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550050|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
43550051|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550052|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43550053|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43550054|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
43550055|NCT03626259|Losartan|losartan|mesh-list
43550056|NCT03626259|Amlodipine|amlodipine|mesh-list
43550057|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43550058|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43550059|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550060|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550061|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43550062|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550113|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550116|NCT03625739|Renal Agents|renal agents|mesh-ancestor
43550185|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550186|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43550187|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43550188|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43550189|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550252|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43550253|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43550254|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
43550255|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43550318|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43550319|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550320|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550321|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43550322|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
43550323|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550324|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550327|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43550328|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550329|NCT03624205|Paclitaxel|paclitaxel|mesh-list
43550380|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43550381|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43550383|NCT03623711|Bupropion|bupropion|mesh-list
43550384|NCT03623711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43550385|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43550386|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550387|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550448|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550449|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43550450|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
43550451|NCT03623087|Hormones|hormones|mesh-ancestor
43550452|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550453|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43550454|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550455|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43550456|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
43550457|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550510|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43550517|NCT03622502|Narcotics|narcotics|mesh-ancestor
43550583|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43550584|NCT03622047|Narcotics|narcotics|mesh-ancestor
43550585|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43550655|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43550656|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550659|NCT03621046|Zolpidem|zolpidem|mesh-list
43550726|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43550727|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43550728|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550729|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43550730|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43550731|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550732|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
43550733|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43550738|NCT03620591|Lidocaine|lidocaine|mesh-list
43550790|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550791|NCT03620461|Antiviral Agents|antiviral agents|mesh-ancestor
43550792|NCT03620461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43550793|NCT03620461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550794|NCT03620461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43550795|NCT03620461|Immunologic Factors|immunologic factors|mesh-ancestor
43550796|NCT03620461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550797|NCT03620435|Atezolizumab|atezolizumab|mesh-list
43550798|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550799|NCT03620422|Mannitol|mannitol|mesh-list
43550855|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
43550856|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550857|NCT03619824|Gemcitabine|gemcitabine|mesh-list
43550858|NCT03619824|Cisplatin|cisplatin|mesh-list
43550859|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550860|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43550861|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
43550928|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550929|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551001|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43551003|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
43551004|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
43551005|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551006|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
43551007|NCT03618173|Dexamethasone|dexamethasone|mesh-list
43551008|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
43551009|NCT03618173|BB 1101|bb 1101|mesh-list
43551010|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551011|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
43551012|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
43551013|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551014|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551064|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551065|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43551066|NCT03617484|Bortezomib|bortezomib|mesh-list
43551067|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551138|NCT03616808|Coagulants|coagulants|mesh-ancestor
43551139|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
43551140|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43551142|NCT03616691|Atezolizumab|atezolizumab|mesh-list
43551143|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43551144|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43551145|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551146|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43551147|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43551148|NCT03616691|Growth Substances|growth substances|mesh-ancestor
43551149|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551152|NCT03616639|Morphine|morphine|mesh-list
43551201|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43551202|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551203|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551204|NCT03616288|Thiamine|thiamine|mesh-list
43551205|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
43551206|NCT03616288|Vitamins|vitamins|mesh-ancestor
43551207|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
43551208|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551209|NCT03616262|Lidocaine|lidocaine|mesh-list
43551210|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
43551211|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
43551221|NCT03616236|Buprenorphine|buprenorphine|mesh-list
43551267|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551340|NCT03614273|Epinephrine|epinephrine|mesh-list
43551341|NCT03614273|Racepinephrine|racepinephrine|mesh-list
43551342|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
43551343|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43551344|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43551345|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551346|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551347|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551348|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551349|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43551350|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43551397|NCT03613857|Ticagrelor|ticagrelor|mesh-list
43551398|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43551399|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43551400|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43551401|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43551402|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
43551403|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551406|NCT03613792|Fentanyl|fentanyl|mesh-list
43551464|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551465|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43551466|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551468|NCT03613428|Vincristine|vincristine|mesh-list
43551469|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551470|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
43551471|NCT03613428|Hormones|hormones|mesh-ancestor
43551472|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551473|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551474|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43551475|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551476|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43551477|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
43551478|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
43551525|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43551526|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43551527|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551528|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551587|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
43551588|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
43551589|NCT03612323|Piroxicam|piroxicam|mesh-list
43551590|NCT03612323|Carticaine|carticaine|mesh-list
43551661|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551662|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551663|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
43551664|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551665|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551666|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43551667|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43551720|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43551721|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43551723|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
43553464|NCT03582605|Amoxicillin|amoxicillin|mesh-list
43551792|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551793|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
43551794|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551795|NCT03610230|Iron|iron|mesh-list
43551796|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43551797|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43551798|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
43551799|NCT03610230|Trace Elements|trace elements|mesh-ancestor
43551800|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
43551801|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551802|NCT03610230|Hematinics|hematinics|mesh-ancestor
43551803|NCT03610178|Insulin|insulin|mesh-list
43551809|NCT03610139|Vitamins|vitamins|mesh-ancestor
43551860|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43551861|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43551862|NCT03609827|Melphalan|melphalan|mesh-list
43551863|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43551864|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
43551865|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551866|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551867|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43551868|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43551869|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
43551870|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551871|NCT03609814|Fludarabine|fludarabine|mesh-list
43551872|NCT03609814|Clofarabine|clofarabine|mesh-list
43551873|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551874|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43551875|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
43551918|NCT03609294|Hormones|hormones|mesh-ancestor
43551919|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551920|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43551921|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
43551922|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551923|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551924|NCT03609190|Ketamine|ketamine|mesh-list
43551925|NCT03609190|Analgesics|analgesics|mesh-ancestor
43551926|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
43551979|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
43551980|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
43551981|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551982|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551983|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551984|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
43551985|NCT03608501|Hormones|hormones|mesh-ancestor
43551986|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551987|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43552040|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552041|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
43552042|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43552043|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
43552044|NCT03608046|Irinotecan|irinotecan|mesh-list
43552045|NCT03608046|Cetuximab|cetuximab|mesh-list
43552048|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43552078|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552079|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43552080|NCT03607851|Lacosamide|lacosamide|mesh-list
43552081|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
43552082|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43552083|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43552084|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552086|NCT03607734|Amoxicillin|amoxicillin|mesh-list
43552146|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
43552147|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
43552148|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
43552149|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552150|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552151|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
43552152|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552212|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552213|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552214|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
43552215|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552216|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43552217|NCT03606902|Narcotics|narcotics|mesh-ancestor
43552218|NCT03606902|Analgesics|analgesics|mesh-ancestor
43552219|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43552221|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
43552277|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
43552278|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552279|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552280|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43552281|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
43552282|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
43552283|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43552284|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
43552285|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552286|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552287|NCT03606369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43552288|NCT03606369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43552289|NCT03606369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552290|NCT03606369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43552291|NCT03606369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43552294|NCT03606174|Nivolumab|nivolumab|mesh-list
43552335|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
43552336|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552337|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
43552338|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43552339|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
43552340|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43552341|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
43552342|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552343|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552344|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
43552345|NCT03605199|Denosumab|denosumab|mesh-list
43552346|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43552347|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552348|NCT03605173|Vitamin D|vitamin d|mesh-list
43552349|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
43552350|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
43552381|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552382|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
43552383|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43552385|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552393|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552443|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43552444|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43552445|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552446|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552447|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43552448|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43552449|NCT03604003|Losartan|losartan|mesh-list
43552450|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43552451|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43552452|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43552453|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43552514|NCT03603548|Tacrolimus|tacrolimus|mesh-list
43552566|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552567|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43552568|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
43552569|NCT03603119|Hormones|hormones|mesh-ancestor
43552570|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552571|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43552572|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552573|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43552635|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43552636|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
43552637|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552638|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43552706|NCT03602287|Lidocaine|lidocaine|mesh-list
43552707|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
43552708|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
43552709|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552710|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552711|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
43552712|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552713|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43552714|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43552715|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43552716|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552718|NCT03602248|Methamphetamine|methamphetamine|mesh-list
43552767|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552768|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552769|NCT03602014|Droxidopa|droxidopa|mesh-list
43552839|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552840|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43552841|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
43552843|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552845|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43552847|NCT03601624|Growth Substances|growth substances|mesh-ancestor
43552911|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552912|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552913|NCT03600974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43552916|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
43552983|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43552984|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552985|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552986|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43552987|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
43552988|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
43552989|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43552990|NCT03600727|Analgesics|analgesics|mesh-ancestor
43552995|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43553049|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553050|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553051|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43553120|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553121|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43553122|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43553123|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
43553124|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43553125|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
43553126|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
43553127|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
43553128|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43553129|NCT03597945|Analgesics|analgesics|mesh-ancestor
43553130|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
43553135|NCT03597815|Aflibercept|aflibercept|mesh-list
43553183|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43553184|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553185|NCT03594513|Dipyrone|dipyrone|mesh-list
43553186|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
43553187|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43553188|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553189|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
43553190|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43553191|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43553251|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43553252|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553253|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
43553254|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43553255|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43553256|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553257|NCT03590626|Dulaglutide|dulaglutide|mesh-list
43553258|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43553259|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553263|NCT03590275|Folfirinox|folfirinox|mesh-list
43553392|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
43553393|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
43553394|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
43553395|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553396|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
43553397|NCT03584893|Provitamins|provitamins|mesh-ancestor
43553398|NCT03584893|Vitamins|vitamins|mesh-ancestor
43553399|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
43553457|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43553458|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553459|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43553460|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553461|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43553462|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43553463|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43553465|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43553466|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553467|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43553468|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43553469|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43553470|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553514|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
43553515|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553516|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553517|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553518|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43553519|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43553520|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43553521|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553523|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553580|NCT03579836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553581|NCT03579836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553582|NCT03579836|Immunologic Factors|immunologic factors|mesh-ancestor
43553583|NCT03579836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553584|NCT03579823|Adalimumab|adalimumab|mesh-list
43553585|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553586|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43553588|NCT03579784|Durvalumab|durvalumab|mesh-list
43553589|NCT03579784|Olaparib|olaparib|mesh-list
43553590|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43553599|NCT03579758|Gemcitabine|gemcitabine|mesh-list
43553647|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
43553798|NCT03577743|Growth Substances|growth substances|mesh-ancestor
43553799|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553873|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43553874|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553875|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
43553889|NCT03576794|Hormones|hormones|mesh-ancestor
43553944|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553955|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
43554019|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554020|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554021|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
43554023|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554024|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
43554025|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
43554026|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
43554028|NCT03576053|Serotonin|serotonin|mesh-list
43554029|NCT03576053|Histamine|histamine|mesh-list
43554030|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554031|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
43554052|NCT03575637|Olanzapine|olanzapine|mesh-list
43554083|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43554084|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43554085|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43554086|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43554087|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554088|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
43554089|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43554090|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554091|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
43554092|NCT03575247|Hormones|hormones|mesh-ancestor
43554093|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554094|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554095|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
43554096|NCT03575234|Nivolumab|nivolumab|mesh-list
43554143|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554146|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
43554147|NCT03574649|Cisplatin|cisplatin|mesh-list
43554215|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554216|NCT03573986|Bevacizumab|bevacizumab|mesh-list
43554217|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43554286|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554287|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554288|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43554289|NCT03573050|Protective Agents|protective agents|mesh-ancestor
43554290|NCT03573037|Anticoagulants|anticoagulants|mesh-list
43554358|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43554359|NCT03572517|Narcotics|narcotics|mesh-ancestor
43554586|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43554587|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554588|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
43554589|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
43554591|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43554592|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43554593|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
43554656|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
43554657|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554658|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554659|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
43554660|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43554661|NCT03570281|Enoxaparin|enoxaparin|mesh-list
43554662|NCT03570281|Edoxaban|edoxaban|mesh-list
43554663|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
43554664|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43554665|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43554666|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554668|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
43554719|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554721|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
43554794|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
43554795|NCT03568474|Protective Agents|protective agents|mesh-ancestor
43554796|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554797|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43554798|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
43554864|NCT03567629|Antidotes|antidotes|mesh-ancestor
43554940|NCT03566576|Pemetrexed|pemetrexed|mesh-list
43554941|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554942|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
43554943|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
43554944|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
43554945|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554946|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554947|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43554948|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43554949|NCT03566394|Gabapentin|gabapentin|mesh-list
43555003|NCT03566303|Warfarin|warfarin|mesh-list
43555078|NCT03565302|Terbutaline|terbutaline|mesh-list
43555081|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
43555228|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555229|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
43555230|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
43555231|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555232|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555233|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555234|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
43555235|NCT03564106|Hormones|hormones|mesh-ancestor
43555236|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555238|NCT03564106|Protective Agents|protective agents|mesh-ancestor
43555239|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43555240|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555241|NCT03563963|Lidocaine|lidocaine|mesh-list
43555242|NCT03563963|Ropivacaine|ropivacaine|mesh-list
43555243|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43555244|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
43555287|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555288|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43555289|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
43555290|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555291|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555293|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43555356|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
43555357|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43555359|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43555360|NCT03563170|Antidotes|antidotes|mesh-ancestor
43555363|NCT03563170|Vitamins|vitamins|mesh-ancestor
43555429|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43555506|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555579|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555580|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555657|NCT03560804|Olmesartan|olmesartan|mesh-list
43555797|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
43555798|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555870|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43555871|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
43555872|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555873|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555874|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555875|NCT03558295|Anticoagulants|anticoagulants|mesh-list
43555941|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555942|NCT03557255|Protective Agents|protective agents|mesh-ancestor
43555943|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556015|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
43556017|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
43556018|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
43556019|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556020|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556021|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
43556053|NCT03556098|Hormones|hormones|mesh-list
43556083|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556084|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43556085|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43556086|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556093|NCT03555526|Amoxicillin|amoxicillin|mesh-list
43556154|NCT03555136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43556155|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43556228|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43556229|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556230|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43556231|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43556232|NCT03554447|Protective Agents|protective agents|mesh-ancestor
43556298|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556300|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43556301|NCT03553628|Propolis|propolis|mesh-list
43556302|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43556303|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556304|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
43556305|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
43556306|NCT03553615|Ivermectin|ivermectin|mesh-list
43556307|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43556308|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556309|NCT03553537|Prednisone|prednisone|mesh-list
43556363|NCT03553238|Cytarabine|cytarabine|mesh-list
43556364|NCT03553238|Dexamethasone|dexamethasone|mesh-list
43556365|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
43556366|NCT03553238|Methotrexate|methotrexate|mesh-list
43556367|NCT03553238|Etoposide|etoposide|mesh-list
43556368|NCT03553238|Vincristine|vincristine|mesh-list
43556369|NCT03553238|Doxorubicin|doxorubicin|mesh-list
43556370|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
43556371|NCT03553238|Idarubicin|idarubicin|mesh-list
43556372|NCT03553238|Pegaspargase|pegaspargase|mesh-list
43556373|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43556374|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
43556430|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556431|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556432|NCT03553082|Propofol|propofol|mesh-list
43556433|NCT03553082|Sevoflurane|sevoflurane|mesh-list
43556434|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43556435|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556436|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556437|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43556438|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
43556496|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43556497|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
43556498|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556499|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556500|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
43556501|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43556503|NCT03552315|Trace Elements|trace elements|mesh-ancestor
43556504|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
43556565|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556566|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
43556567|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43556568|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43556569|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556570|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
43556571|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
43556572|NCT03551548|Spironolactone|spironolactone|mesh-list
43556573|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43556630|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556631|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556632|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43556633|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43556699|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556700|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556702|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556704|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43556705|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43556767|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
43556769|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
43556770|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
43556771|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43556772|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556773|NCT03549689|Tenofovir|tenofovir|mesh-list
43556774|NCT03549689|Lamivudine|lamivudine|mesh-list
43556775|NCT03549689|Dolutegravir|dolutegravir|mesh-list
43556786|NCT03549663|Prednisone|prednisone|mesh-list
43556835|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43556836|NCT03549312|Elvitegravir|elvitegravir|mesh-list
43556837|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
43556838|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556839|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43556840|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43556841|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556842|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556843|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43556897|NCT03548818|Interferons|interferons|mesh-list
43556898|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
43556899|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556900|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
43556901|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556902|NCT03548714|Ethanol|ethanol|mesh-list
43556903|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43556904|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556905|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556968|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
43556969|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43556970|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43556971|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43556972|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
43556974|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43557037|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557038|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557039|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43557041|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
43557042|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
43557043|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557044|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43557045|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557047|NCT03547219|Citalopram|citalopram|mesh-list
43557100|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43557101|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43557102|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
43557103|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
43557104|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43557105|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43557106|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557107|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
43557108|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557109|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557110|NCT03546855|Apatinib|apatinib|mesh-list
43557111|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557112|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43557113|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557114|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557115|NCT03546803|Protective Agents|protective agents|mesh-list
43557116|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557117|NCT03546634|Vaccines|vaccines|mesh-list
43557118|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
43557119|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557120|NCT03546530|Interferons|interferons|mesh-list
43557121|NCT03546530|Resveratrol|resveratrol|mesh-list
43557122|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557123|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
43557150|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43557151|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43557152|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557219|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43557220|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558352|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43557221|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43557222|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557223|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557224|NCT03544996|Insulin|insulin|mesh-list
43557225|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43557226|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557227|NCT03544827|Atropine|atropine|mesh-list
43557228|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43557229|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43557230|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43557231|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
43557232|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557233|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557234|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43557235|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
43557236|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
43557237|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
43557238|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43557239|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43557240|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
43557241|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557242|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557243|NCT03544814|Cisplatin|cisplatin|mesh-list
43557269|NCT03544125|Olaparib|olaparib|mesh-list
43557270|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43557271|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
43557272|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43557273|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
43557274|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43557276|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
43557277|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557278|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557279|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557280|NCT03544073|Leuprolide|leuprolide|mesh-list
43557281|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43557282|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
43557283|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557284|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557285|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43557286|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557287|NCT03544047|Paclitaxel|paclitaxel|mesh-list
43557288|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43557289|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557290|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
43557291|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
43557292|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
43557293|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557294|NCT03543826|Rocuronium|rocuronium|mesh-list
43557295|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43557296|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43557297|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43557298|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557299|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557300|NCT03543774|Simvastatin|simvastatin|mesh-list
43557301|NCT03543774|Ezetimibe|ezetimibe|mesh-list
43557303|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43557310|NCT03543683|Aspirin|aspirin|mesh-list
43557311|NCT03543683|Osimertinib|osimertinib|mesh-list
43557312|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43557313|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43557315|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
43557316|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557378|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557379|NCT03542825|Iron|iron|mesh-list
43557380|NCT03542825|Lactoferrin|lactoferrin|mesh-list
43557381|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
43557382|NCT03542825|Trace Elements|trace elements|mesh-ancestor
43557383|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
43557384|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557385|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557386|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
43557444|NCT03542279|Hormones|hormones|mesh-ancestor
43557445|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557446|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557447|NCT03542240|Curcumin|curcumin|mesh-list
43558413|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
43557448|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43557449|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43557450|NCT03542240|Analgesics|analgesics|mesh-ancestor
43557451|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
43557509|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557510|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557511|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43557512|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557513|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
43557514|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
43557515|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557575|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43557576|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43557577|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557579|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43557648|NCT03540225|Progesterone|progesterone|mesh-list
43557649|NCT03540225|Progestins|progestins|mesh-ancestor
43557650|NCT03540225|Hormones|hormones|mesh-ancestor
43557653|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
43557723|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
43557724|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
43557725|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
43557797|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43557798|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
43557799|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
43557800|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557801|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43557802|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43557803|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
43557804|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43557805|NCT03538691|Analgesics|analgesics|mesh-ancestor
43557806|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
43557807|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
43557861|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557862|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557863|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43557864|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43557865|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43557867|NCT03537612|Morphine|morphine|mesh-list
43557868|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43557869|NCT03537612|Narcotics|narcotics|mesh-ancestor
43557927|NCT03537287|Progesterone|progesterone|mesh-list
43557928|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
43557929|NCT03537287|Progestins|progestins|mesh-ancestor
43557930|NCT03537287|Hormones|hormones|mesh-ancestor
43557933|NCT03537196|Ribavirin|ribavirin|mesh-list
43558000|NCT03536780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558001|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43558002|NCT03536741|Anesthetics|anesthetics|mesh-list
43558067|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558068|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43558069|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43558070|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558139|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
43558140|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558141|NCT03535662|Itraconazole|itraconazole|mesh-list
43558142|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
43558143|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558144|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43558145|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43558146|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558147|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558148|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43558149|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
43558151|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558199|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558272|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558273|NCT03534973|Caffeine|caffeine|mesh-list
43558284|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
43558345|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558346|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43558347|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558348|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558349|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
43558350|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
43558415|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43558416|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558417|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43558418|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558419|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558420|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43558421|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43558422|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
43558424|NCT03533387|Ibudilast|ibudilast|mesh-list
43558476|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43558477|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558478|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
43558479|NCT03533127|Bevacizumab|bevacizumab|mesh-list
43558480|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43558481|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558482|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43558483|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43558484|NCT03533127|Growth Substances|growth substances|mesh-ancestor
43558485|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558486|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
43558538|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43558540|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
43558541|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558542|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558543|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43558549|NCT03532763|Tocotrienols|tocotrienols|mesh-list
43558609|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
43558610|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558611|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558612|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
43558613|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558614|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43558615|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43558616|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
43558617|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43558618|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43558620|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43558621|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558622|NCT05262608|Olaparib|olaparib|mesh-list
43558623|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43558624|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558625|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558628|NCT05262465|Venetoclax|venetoclax|mesh-list
43558665|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558666|NCT05261997|Metformin|metformin|mesh-list
43558667|NCT05261997|Acarbose|acarbose|mesh-list
43558668|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43558734|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558735|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558736|NCT05175001|Betamethasone|betamethasone|mesh-list
43558737|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
43558738|NCT05175001|Ropivacaine|ropivacaine|mesh-list
43558739|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
43558740|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
43558741|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558746|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
43558798|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43558799|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558800|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558801|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43558802|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
43558803|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43558804|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558805|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558814|NCT05055713|Somatostatin|somatostatin|mesh-list
43558863|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558864|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43558865|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558866|NCT04907071|Coal Tar|coal tar|mesh-list
43558867|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
43558868|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
43558869|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
43558870|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43558872|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558873|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
43558928|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
43558929|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558930|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43558931|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43558932|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558933|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558934|NCT04554693|Metronidazole|metronidazole|mesh-list
43558935|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558936|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43558937|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43558938|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43558939|NCT04544202|Trametinib|trametinib|mesh-list
43558992|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558993|NCT04500899|Phenylephrine|phenylephrine|mesh-list
43558994|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43558995|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
43558996|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
43558997|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558998|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558999|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
43559000|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43559001|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
43559002|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
43559003|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43559005|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43559055|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559056|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
43559057|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559058|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
43559059|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559060|NCT04378114|Acetaminophen|acetaminophen|mesh-list
43559061|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559062|NCT04378114|Analgesics|analgesics|mesh-ancestor
43559063|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
43559064|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559120|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559121|NCT04174612|Cytarabine|cytarabine|mesh-list
43559122|NCT04174612|Daunorubicin|daunorubicin|mesh-list
43559123|NCT04174612|Midostaurin|midostaurin|mesh-list
43559124|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43559190|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559191|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43559192|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559193|NCT04104685|Analgesics|analgesics|mesh-ancestor
43559194|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
43559195|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559196|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559258|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43559259|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
43559260|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559261|NCT03935958|Curcumin|curcumin|mesh-list
43559262|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43559263|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559264|NCT03935958|Analgesics|analgesics|mesh-ancestor
43559265|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
43559266|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559322|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
43559323|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43559324|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43559325|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43559326|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559327|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559381|NCT03818828|Iodine|iodine|mesh-list
43559391|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
43559392|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
43559393|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559394|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43559395|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43559396|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43559402|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
43559456|NCT03737123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559457|NCT03737123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559458|NCT03737123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43559459|NCT03737123|Immunologic Factors|immunologic factors|mesh-ancestor
43559527|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559528|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43559529|NCT03691974|Fasinumab|fasinumab|mesh-list
43559531|NCT03691974|Analgesics|analgesics|mesh-ancestor
43559599|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559600|NCT03635996|Etripamil|etripamil|mesh-list
43559601|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43559606|NCT03626545|Docetaxel|docetaxel|mesh-list
43559669|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43559670|NCT03542669|Doxorubicin|doxorubicin|mesh-list
43559671|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43559672|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559673|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43559674|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43559675|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559676|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559677|NCT03541655|Celecoxib|celecoxib|mesh-list
43559678|NCT03541655|Bupivacaine|bupivacaine|mesh-list
43559679|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
43559680|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
43559681|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43559683|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
43559731|NCT03412890|Norethindrone|norethindrone|mesh-list
43559732|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
43559733|NCT03412890|Estradiol|estradiol|mesh-list
43559734|NCT03412890|Relugolix|relugolix|mesh-list
43559735|NCT03412890|Estrogens|estrogens|mesh-ancestor
43559736|NCT03412890|Hormones|hormones|mesh-ancestor
43559804|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559805|NCT03228394|Ganaxolone|ganaxolone|mesh-list
43559806|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
43559807|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559808|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559809|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559810|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
43559811|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
43559814|NCT03198728|Hormones|hormones|mesh-ancestor
43559872|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43559873|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43559874|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43559875|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559876|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559877|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
43559878|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559879|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559880|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43559881|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559882|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43559883|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43559884|NCT03123783|Nivolumab|nivolumab|mesh-list
43559885|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43559889|NCT03118570|Vitamin D|vitamin d|mesh-list
43559934|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559935|NCT05563480|Antiviral Agents|antiviral agents|mesh-ancestor
43559936|NCT05563480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559937|NCT05563480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559938|NCT05563480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43559939|NCT05563480|Immunologic Factors|immunologic factors|mesh-ancestor
43559940|NCT05563480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559941|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43559942|NCT05546398|Ezetimibe|ezetimibe|mesh-list
43559943|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43559944|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43559945|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
43559946|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559947|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43559948|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559949|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43559951|NCT05542849|Acarbose|acarbose|mesh-list
43559991|NCT05411094|Olaparib|olaparib|mesh-list
43559992|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43559993|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
43559994|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43559995|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
43559996|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560002|NCT05370885|Vancomycin|vancomycin|mesh-list
43560062|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43560063|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43560130|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
43560131|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560132|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560133|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
43560134|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560135|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560136|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
43560137|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43560270|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
43560271|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
43560272|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
43560273|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560275|NCT05039177|Palbociclib|palbociclib|mesh-list
43560276|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560277|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560335|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43560336|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43560337|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560338|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560339|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
43560340|NCT04858009|Paclitaxel|paclitaxel|mesh-list
43560341|NCT04858009|Cisplatin|cisplatin|mesh-list
43560342|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43560343|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43560344|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560345|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
43560398|NCT04685135|Adagrasib|adagrasib|mesh-list
43560399|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560400|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
43560401|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
43560402|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
43560403|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560404|NCT04669288|Azithromycin|azithromycin|mesh-list
43560405|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43560406|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560464|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43560465|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560466|NCT04534153|Fexofenadine|fexofenadine|mesh-list
43560467|NCT04534153|Terfenadine|terfenadine|mesh-list
43560468|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43560469|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43560470|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43560471|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
43560531|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
43560532|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560533|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560534|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
43560540|NCT04385290|Cytarabine|cytarabine|mesh-list
43560603|NCT04106414|Linrodostat|linrodostat|mesh-list
43560604|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560605|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560606|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43560607|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560608|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560609|NCT04076761|Trifluridine|trifluridine|mesh-list
43560610|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
43560611|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560667|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560668|NCT03796884|Linaclotide|linaclotide|mesh-list
43560669|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43560670|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
43560671|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560672|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560673|NCT03793478|Cytarabine|cytarabine|mesh-list
43560674|NCT03793478|Fludarabine|fludarabine|mesh-list
43560675|NCT03793478|Etoposide|etoposide|mesh-list
43560676|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560677|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560678|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
43560679|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560680|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560681|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
43560682|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560683|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43560684|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43560685|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43560686|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560687|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
43560688|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560689|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
43560690|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560691|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560692|NCT03752918|Niacin|niacin|mesh-list
43560693|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
43560694|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43560695|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43560696|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
43560697|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560698|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43560699|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
43560700|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
43560701|NCT03752918|Vitamins|vitamins|mesh-ancestor
43560707|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560708|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43560709|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43560710|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43560711|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
43560712|NCT03736265|Carvedilol|carvedilol|mesh-list
43560713|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43560714|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43560715|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
43560716|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560717|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560718|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560719|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43560720|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
43560721|NCT03736265|Protective Agents|protective agents|mesh-ancestor
43560722|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43560723|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43560724|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43560725|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
43560726|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43560727|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43560729|NCT03735966|Docetaxel|docetaxel|mesh-list
43560730|NCT03735966|Trastuzumab|trastuzumab|mesh-list
43560731|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560737|NCT03679650|Decitabine|decitabine|mesh-list
43560757|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560758|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560759|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43560760|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560761|NCT03379428|Trastuzumab|trastuzumab|mesh-list
43560762|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560763|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560764|NCT03345173|Ketamine|ketamine|mesh-list
43560765|NCT03345173|Analgesics|analgesics|mesh-ancestor
43560766|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
43560767|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560772|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
43560819|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43560820|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560821|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560823|NCT03184870|Gemcitabine|gemcitabine|mesh-list
43560824|NCT03184870|Paclitaxel|paclitaxel|mesh-list
43560825|NCT03184870|Fluorouracil|fluorouracil|mesh-list
43560826|NCT03184870|Nivolumab|nivolumab|mesh-list
43560891|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43560892|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560893|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
43560894|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
43560895|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560896|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560900|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43560958|NCT02903368|Leuprolide|leuprolide|mesh-list
43560959|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
43560960|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560961|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
43560962|NCT02903368|Hormones|hormones|mesh-ancestor
43560963|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43560964|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560968|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
43561024|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43561025|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561026|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43561027|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561028|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561030|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43561032|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43561091|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561092|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
43561093|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
43561094|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
43561096|NCT02175173|Rufinamide|rufinamide|mesh-list
43561314|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43561315|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
43561316|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561317|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561318|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43561319|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
43561320|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43561321|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561322|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43561323|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43561375|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561376|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
43561377|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
43561520|NCT02654990|Bortezomib|bortezomib|mesh-list
43561521|NCT02654990|Panobinostat|panobinostat|mesh-list
43561599|NCT02609048|Seladelpar|seladelpar|mesh-list
43561673|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561674|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43561675|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561676|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561677|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
43561678|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43561679|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43561680|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43561681|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561682|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561734|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561735|NCT02553343|Vaccines|vaccines|mesh-list
43561736|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
43561738|NCT02547818|Ibuprofen|ibuprofen|mesh-list
43561810|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
43561881|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
43561882|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561883|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43561884|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
43561885|NCT01621243|Antiviral Agents|antiviral agents|mesh-ancestor
43561886|NCT01621243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561887|NCT01621243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561949|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562026|NCT01577173|Cetuximab|cetuximab|mesh-list
43562028|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562183|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43562250|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562251|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562252|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562253|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43562254|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43562255|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43562256|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43562257|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43562318|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43562319|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43562320|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562604|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43562605|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43562606|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562607|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43562608|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43562609|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43562622|NCT01418222|Leucovorin|leucovorin|mesh-list
43562663|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
43562664|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43562665|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562666|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43562735|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43562811|NCT01377662|Methylphenidate|methylphenidate|mesh-list
43562812|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43562883|NCT01365195|Analgesics|analgesics|mesh-ancestor
43562884|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
43562885|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562886|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562887|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43562889|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
43562890|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
43562891|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43562892|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43562893|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43562894|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562895|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562896|NCT01361802|Ambroxol|ambroxol|mesh-list
43562897|NCT01361802|Expectorants|expectorants|mesh-ancestor
43562898|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
43562899|NCT01360853|Gemcitabine|gemcitabine|mesh-list
43562900|NCT01360853|ON 01910|on 01910|mesh-list
43562901|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43562902|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
43562903|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562904|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562937|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43562945|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
43563307|NCT01280565|Dacarbazine|dacarbazine|mesh-list
43563376|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563377|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563378|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563379|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43563438|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43563439|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
43563440|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563441|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563442|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43563443|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
43563444|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
43563445|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43563580|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
43563582|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
43563583|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563584|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
43563585|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563586|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
43563587|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563589|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
43563591|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563645|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563646|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
43563647|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563648|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43563649|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43563650|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43563651|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43563652|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563653|NCT01205048|Lidocaine|lidocaine|mesh-list
43563654|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
43563706|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43563707|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43563708|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563709|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
43563710|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43563711|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563712|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43563713|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43563714|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563715|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563716|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563717|NCT01194960|Docetaxel|docetaxel|mesh-list
43563718|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563767|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43563768|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43563769|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43563771|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43563772|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
43563773|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563786|NCT01188187|Prednisone|prednisone|mesh-list
43563835|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563836|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563837|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563838|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43563839|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43563840|NCT01175785|Cyclosporine|cyclosporine|mesh-list
43563841|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
43563842|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
43563843|NCT01175785|Fludarabine|fludarabine|mesh-list
43563845|NCT01175785|Cyclosporins|cyclosporins|mesh-list
43563892|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43563959|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43563960|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563961|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
43563962|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
43563963|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
43563964|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563965|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43563966|NCT01159249|Vildagliptin|vildagliptin|mesh-list
43564022|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564023|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
43564024|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564025|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564026|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
43564027|NCT01133990|Leucovorin|leucovorin|mesh-list
43564028|NCT01133990|Bevacizumab|bevacizumab|mesh-list
43564029|NCT01133990|Fluorouracil|fluorouracil|mesh-list
43564030|NCT01133990|Irinotecan|irinotecan|mesh-list
43564031|NCT01133990|Calcium|calcium|mesh-list
43564032|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
43564097|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
43564098|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564099|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43564100|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
43564101|NCT01129648|Protective Agents|protective agents|mesh-ancestor
43564102|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564171|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564172|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43564173|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564174|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
43564175|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564176|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43564177|NCT01116141|Hematinics|hematinics|mesh-ancestor
43564178|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
43564180|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
43564237|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43564239|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43564368|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564369|NCT01074294|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
43564370|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564372|NCT01072981|Fluorouracil|fluorouracil|mesh-list
43564373|NCT01072981|Pancrelipase|pancrelipase|mesh-list
43564374|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
43564375|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564376|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
43564385|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
43564434|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43564435|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43564436|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43564718|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564719|NCT01001338|Allopurinol|allopurinol|mesh-list
43564720|NCT01001338|Lesinurad|lesinurad|mesh-list
43564721|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
43564722|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564723|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564777|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564778|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43564779|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564780|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564781|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564782|NCT00992563|Ranibizumab|ranibizumab|mesh-list
43564783|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43564784|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43564785|NCT00992563|Growth Substances|growth substances|mesh-ancestor
43564789|NCT00991172|Fasinumab|fasinumab|mesh-list
43564840|NCT00979251|Oseltamivir|oseltamivir|mesh-list
43564841|NCT00979251|Amantadine|amantadine|mesh-list
43564842|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
43564843|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564844|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564845|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564846|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43564847|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43564848|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
43564849|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564850|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564851|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564852|NCT00979251|Analgesics|analgesics|mesh-ancestor
43564904|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
43564905|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43564906|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43564907|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43564908|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43564909|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564910|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
43564911|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564912|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564913|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43564914|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564969|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43564970|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
43564971|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
43564972|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43564973|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43564974|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43564975|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
43564976|NCT00959036|Methotrexate|methotrexate|mesh-list
43564977|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43565034|NCT00948961|Poly I-C|poly i-c|mesh-list
43565035|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43565036|NCT00948961|Poly ICLC|poly iclc|mesh-list
43565037|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
43565038|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
43565039|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565040|NCT00948961|Laxatives|laxatives|mesh-ancestor
43565041|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565042|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
43565043|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565101|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
43565102|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565103|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565104|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565105|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43565106|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43565107|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565108|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565167|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43565169|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565170|NCT00938652|Antiviral Agents|antiviral agents|mesh-ancestor
43565171|NCT00938652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565172|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565173|NCT00938652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43565174|NCT00938652|Immunologic Factors|immunologic factors|mesh-ancestor
43565175|NCT00938652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565176|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43565230|NCT00934180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43565231|NCT00929968|Fluticasone|fluticasone|mesh-list
43565232|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565233|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43565234|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
43565235|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565236|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565237|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43565238|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
43565241|NCT00928590|Timolol|timolol|mesh-list
43565295|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43565296|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43565297|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
43565298|NCT00920985|Gestodene|gestodene|mesh-list
43565299|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
43565300|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43565301|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565302|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43565303|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43565304|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43565305|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43565306|NCT00920985|Progestins|progestins|mesh-ancestor
43565307|NCT00920985|Hormones|hormones|mesh-ancestor
43565308|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43565309|NCT00920764|Atrasentan|atrasentan|mesh-list
43565310|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565311|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43565353|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565354|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43565355|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
43565356|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565357|NCT00911963|Ribavirin|ribavirin|mesh-list
43565358|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43565359|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
43565360|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565361|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
43565362|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565363|NCT00911443|Interferons|interferons|mesh-list
43565364|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
43565416|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43565417|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565418|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565419|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565421|NCT00906334|Glycine|glycine|mesh-list
43565422|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565423|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43565424|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565425|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565426|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
43565427|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565428|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565479|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43565480|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
43565481|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565482|NCT00900783|Valacyclovir|valacyclovir|mesh-list
43565483|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
43565484|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565485|NCT00894868|Vildagliptin|vildagliptin|mesh-list
43565486|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565487|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565488|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43565489|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
43565490|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565543|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43565544|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43565545|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43565546|NCT00890305|Pidilizumab|pidilizumab|mesh-list
43565547|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43565548|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565549|NCT00890149|Ondansetron|ondansetron|mesh-list
43565550|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
43565551|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
43565552|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43565553|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565604|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565605|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43565606|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565607|NCT00884715|Octreotide|octreotide|mesh-list
43565608|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43565612|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43565613|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43565617|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
43565664|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43565665|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
43565666|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565668|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43565669|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565670|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565671|NCT00875108|Insulin|insulin|mesh-list
43565672|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43565673|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43565674|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565732|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
43565733|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
43565734|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43565735|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
43565736|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43565737|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565738|NCT00870688|Valproic Acid|valproic acid|mesh-list
43565739|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
43565740|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565741|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565742|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
43565796|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43565797|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43565798|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
43565799|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565800|NCT00863369|Antiviral Agents|antiviral agents|mesh-ancestor
43565801|NCT00863369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565802|NCT00863369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565804|NCT00862524|Gemcitabine|gemcitabine|mesh-list
43565805|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43565806|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
43565807|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565808|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565809|NCT00862524|Antiviral Agents|antiviral agents|mesh-ancestor
43565810|NCT00862524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565811|NCT00862524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565856|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43565857|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565858|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
43565859|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
43565860|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
43565861|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565862|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
43565863|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43565864|NCT00854945|ON 01910|on 01910|mesh-list
43565865|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43565924|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
43565932|NCT00849576|Insulin|insulin|mesh-list
43565993|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43565995|NCT00841542|Amlodipine|amlodipine|mesh-list
43565996|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43565997|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43565998|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43565999|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566000|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566886|NCT00814294|Insulin|insulin|mesh-list
43566001|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566053|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43566054|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43566056|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566057|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566058|NCT00840216|Clarithromycin|clarithromycin|mesh-list
43566059|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566060|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566118|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566119|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566120|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566122|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43566123|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
43566124|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566125|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566126|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43566127|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
43566128|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43566129|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43566130|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566131|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43566132|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
43566133|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43566134|NCT00838630|Protective Agents|protective agents|mesh-ancestor
43566135|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43566136|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43566137|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566138|NCT00838279|Lamotrigine|lamotrigine|mesh-list
43566139|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
43566140|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43566141|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566142|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566143|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566164|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
43566165|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
43566166|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566167|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566168|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43566169|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566170|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566172|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566173|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566179|NCT00836472|Metformin|metformin|mesh-list
43566228|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
43566229|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
43566230|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566300|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566301|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566302|NCT00835484|Cefdinir|cefdinir|mesh-list
43566303|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566304|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566305|NCT00835406|Alendronate|alendronate|mesh-list
43566306|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43566369|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566370|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43566371|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566373|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566437|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43566438|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
43566439|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43566440|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43566441|NCT00834756|Azithromycin|azithromycin|mesh-list
43566444|NCT00834743|Metformin|metformin|mesh-list
43566508|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566509|NCT00834431|Famciclovir|famciclovir|mesh-list
43566510|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
43566511|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43566512|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43566513|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566514|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566515|NCT00834418|Leflunomide|leflunomide|mesh-list
43566516|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566885|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566517|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566519|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
43566520|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566521|NCT00834405|Leflunomide|leflunomide|mesh-list
43566522|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566523|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566524|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43566525|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
43566526|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566527|NCT00834340|Glimepiride|glimepiride|mesh-list
43566528|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43566529|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566530|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566531|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43566532|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
43566533|NCT00834275|Cefadroxil|cefadroxil|mesh-list
43566534|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43566545|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43566551|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
43566552|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566553|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566554|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566555|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43566556|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43566557|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43566558|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43566559|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43566614|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43566615|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
43566617|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43566618|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
43566619|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43566620|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
43566621|NCT00833495|Hormones|hormones|mesh-ancestor
43566622|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43566623|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566680|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
43566681|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
43566682|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43566683|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43566684|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43566685|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43566748|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43566749|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566750|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43566751|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43566752|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43566753|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566754|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
43566755|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566757|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43566762|NCT00829504|Ropinirole|ropinirole|mesh-list
43566809|NCT00821249|Filanesib|filanesib|mesh-list
43566810|NCT00821249|Lenograstim|lenograstim|mesh-list
43566811|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43566812|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
43566813|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
43566814|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566815|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566816|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43566817|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
43566818|NCT00821249|Hormones|hormones|mesh-ancestor
43566874|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43566875|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43566876|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
43566878|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566879|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566880|NCT00817362|Trastuzumab|trastuzumab|mesh-list
43566881|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43566882|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43566883|NCT00814372|Metformin|metformin|mesh-list
43566884|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43566933|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566934|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43566935|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
43566936|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43566937|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43566938|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43566939|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
43566940|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566941|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43566942|NCT00807612|Paclitaxel|paclitaxel|mesh-list
43566943|NCT00807612|Carboplatin|carboplatin|mesh-list
43566944|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43566998|NCT00796289|Hormones|hormones|mesh-list
43566999|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43567000|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
43567001|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43567002|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
43567003|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
43567004|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567005|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567006|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567007|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43567008|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
43567009|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43567010|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
43567011|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43567014|NCT00794677|Ezetimibe|ezetimibe|mesh-list
43567056|NCT00789633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43567057|NCT00789633|Immunologic Factors|immunologic factors|mesh-ancestor
43567058|NCT00789633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567059|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
43567061|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43567062|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43567063|NCT00788541|Growth Substances|growth substances|mesh-ancestor
43567064|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567124|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43567125|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567127|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
43567128|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567129|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43567130|NCT00772343|Vaccines|vaccines|mesh-list
43567131|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
43567190|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567191|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43567192|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
43567193|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567194|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567195|NCT00765804|Dexamethasone|dexamethasone|mesh-list
43567196|NCT00765804|Citric Acid|citric acid|mesh-list
43567197|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
43567198|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43567199|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43567200|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43567201|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567254|NCT00760539|Travoprost|travoprost|mesh-list
43567255|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43567256|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43567257|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43567258|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43567259|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
43567260|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567261|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567262|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567263|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43567264|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43567265|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43567266|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567267|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567268|NCT00760344|Incretins|incretins|mesh-ancestor
43567269|NCT00760344|Hormones|hormones|mesh-ancestor
43567270|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567275|NCT00759135|Finasteride|finasteride|mesh-list
43567308|NCT00758563|Triclosan|triclosan|mesh-list
43567309|NCT00758563|Fluorides|fluorides|mesh-list
43567310|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
43570575|NCT00394199|Xhance|xhance|mesh-list
43567312|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567313|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43567314|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567315|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43567374|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567375|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
43567376|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43567377|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567378|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43567379|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567380|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
43567440|NCT00750243|Naproxen|naproxen|mesh-list
43567441|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43567442|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43567443|NCT00750243|Analgesics|analgesics|mesh-ancestor
43567444|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
43567445|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567446|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567447|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43567448|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43567449|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
43567450|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43567501|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43567502|NCT00744926|Incretins|incretins|mesh-ancestor
43567503|NCT00744926|Hormones|hormones|mesh-ancestor
43567504|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567505|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567506|NCT00744367|Metformin|metformin|mesh-list
43567507|NCT00744367|Pioglitazone|pioglitazone|mesh-list
43567508|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43567509|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567568|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
43567569|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567570|NCT00734461|Naltrexone|naltrexone|mesh-list
43567571|NCT00734461|Oxycodone|oxycodone|mesh-list
43567572|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43567573|NCT00734461|Narcotics|narcotics|mesh-ancestor
43849046|NCT03970382|Aldesleukin|aldesleukin|mesh-list
43567574|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43567575|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567576|NCT00734461|Analgesics|analgesics|mesh-ancestor
43567577|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
43567578|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567579|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43567581|NCT00734435|Zonisamide|zonisamide|mesh-list
43567629|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567630|NCT00728351|Metformin|metformin|mesh-list
43567631|NCT00728351|Vildagliptin|vildagliptin|mesh-list
43567632|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43567633|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567634|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43567635|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
43567636|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567637|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567638|NCT00728091|Satavaptan|satavaptan|mesh-list
43567639|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43567640|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567641|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
43567688|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567689|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567690|NCT00722358|Asunaprevir|asunaprevir|mesh-list
43567691|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
43567692|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567693|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567694|NCT00721760|Enoxaparin|enoxaparin|mesh-list
43567695|NCT00721760|Semuloparin|semuloparin|mesh-list
43567696|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
43567697|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
43567698|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43567699|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43567700|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567701|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43567702|NCT00721695|Mydriatics|mydriatics|mesh-list
43567703|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
43567749|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43567750|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43567751|NCT00713518|Growth Substances|growth substances|mesh-ancestor
43567752|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567753|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
43567754|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567755|NCT00713401|Esmolol|esmolol|mesh-list
43567756|NCT00713401|Tecadenoson|tecadenoson|mesh-list
43567757|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43567758|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43567759|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43567767|NCT00712699|Adderall|adderall|mesh-list
43567813|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567814|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43567815|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43567816|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
43567817|NCT00708292|Hormones|hormones|mesh-ancestor
43567818|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43567819|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567821|NCT00698789|Metformin|metformin|mesh-list
43567880|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43567881|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567882|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
43567883|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
43567884|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
43567885|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
43567886|NCT00692445|Mecamylamine|mecamylamine|mesh-list
43567888|NCT00692445|Citalopram|citalopram|mesh-list
43567889|NCT00692445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43567890|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43567945|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43567946|NCT00687882|Anticoagulants|anticoagulants|mesh-list
43567947|NCT00687687|Paclitaxel|paclitaxel|mesh-list
43567948|NCT00687687|Carboplatin|carboplatin|mesh-list
43567949|NCT00687687|Iniparib|iniparib|mesh-list
43567950|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43567951|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43567952|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
43567953|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
43567954|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
43567955|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567956|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43567957|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567959|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568007|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568008|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43568009|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
43568010|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568011|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568012|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
43568013|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568014|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43568015|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43568016|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
43568070|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43568071|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43568072|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568141|NCT00672386|Metformin|metformin|mesh-list
43568142|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43568143|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568144|NCT00670033|Travoprost|travoprost|mesh-list
43568145|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43568146|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43568147|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43568148|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
43568149|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43568150|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43568205|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568206|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568207|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43568208|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43568209|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43568210|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568211|NCT00662597|Paclitaxel|paclitaxel|mesh-list
43568212|NCT00662597|Carboplatin|carboplatin|mesh-list
43568213|NCT00662597|Vadimezan|vadimezan|mesh-list
43571079|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
43568214|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43568267|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568268|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568269|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
43568270|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568271|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43568272|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568273|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568276|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568330|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568331|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
43568332|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568404|NCT00643383|Narcotics|narcotics|mesh-ancestor
43568405|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43568406|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43568407|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43568408|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
43568409|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568410|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568411|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43568412|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
43568413|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
43568416|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
43568464|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43568465|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568466|NCT00626704|Doxorubicin|doxorubicin|mesh-list
43568468|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43568469|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568470|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43568471|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43568472|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568474|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43568530|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43568531|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
43568532|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43568533|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43568534|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43568535|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43568536|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568596|NCT00615251|Progestins|progestins|mesh-ancestor
43568597|NCT00615251|Hormones|hormones|mesh-ancestor
43568598|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43568599|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568600|NCT00614601|Vaccines|vaccines|mesh-list
43568601|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
43568602|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568603|NCT00613002|Testosterone|testosterone|mesh-list
43568604|NCT00613002|Androgens|androgens|mesh-ancestor
43568605|NCT00613002|Hormones|hormones|mesh-ancestor
43568608|NCT00612820|Fluticasone|fluticasone|mesh-list
43568656|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43568657|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43568659|NCT00609323|Tetracaine|tetracaine|mesh-list
43568660|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
43568661|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
43568662|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43568663|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568721|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43568722|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
43568723|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568724|NCT00602602|Antiviral Agents|antiviral agents|mesh-ancestor
43568725|NCT00602602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568726|NCT00602602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568727|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43568729|NCT00602329|Leucovorin|leucovorin|mesh-list
43568791|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568792|NCT00589823|Analgesics|analgesics|mesh-ancestor
43568793|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
43568794|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568795|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43568796|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43568797|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
43568798|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
43568799|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43568800|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43568857|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43568858|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43568927|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568928|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
43568929|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568930|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568931|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43568932|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568934|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43568992|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568993|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43568994|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
43568995|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568996|NCT00570752|Atorvastatin|atorvastatin|mesh-list
43568997|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43568998|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43569056|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569057|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
43569058|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43569059|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
43569060|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569061|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
43569062|NCT00562497|Prednisone|prednisone|mesh-list
43569063|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
43569064|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569065|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
43569066|NCT00562497|Hormones|hormones|mesh-ancestor
43569067|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569068|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569069|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43569070|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569113|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
43569114|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43569115|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43569116|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569181|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569182|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43569183|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43569184|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
43569185|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43569186|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43569187|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
43569188|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
43569189|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569190|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43569191|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43569202|NCT00543582|Azacitidine|azacitidine|mesh-list
43569245|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43569246|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
43569247|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569248|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569249|NCT00539721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43569250|NCT00539721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43569251|NCT00539721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569252|NCT00539721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43569253|NCT00539721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43569254|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43569307|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43569308|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43569309|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
43569310|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569313|NCT00532038|Ketoprofen|ketoprofen|mesh-list
43569378|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569379|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569380|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
43569381|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569382|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569383|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
43569384|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569385|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43569386|NCT00526227|Clotrimazole|clotrimazole|mesh-list
43569387|NCT00526227|Miconazole|miconazole|mesh-list
43569388|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43569439|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43569440|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569441|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43569442|NCT00520923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43569443|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43569444|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569446|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569506|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569508|NCT00508989|Acetylcholine|acetylcholine|mesh-list
43569509|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43569510|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
43569574|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43569575|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
43569576|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569577|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569578|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569579|NCT00495131|Interferons|interferons|mesh-list
43569580|NCT00495131|Ribavirin|ribavirin|mesh-list
43569581|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
43569640|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43569641|NCT00488267|Analgesics|analgesics|mesh-ancestor
43569642|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
43569643|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569644|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569645|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569646|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43569648|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569650|NCT00486512|Aspirin|aspirin|mesh-list
43569709|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569710|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43569711|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
43569712|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569713|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569714|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43569715|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43569716|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
43569717|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43569718|NCT00483977|Oxycodone|oxycodone|mesh-list
43569719|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43569720|NCT00483977|Narcotics|narcotics|mesh-ancestor
43569721|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43569722|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569723|NCT00483977|Analgesics|analgesics|mesh-ancestor
43569724|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
43569725|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569726|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
43569727|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43569728|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
43569729|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569730|NCT00481325|Citalopram|citalopram|mesh-list
43569731|NCT00481325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43569732|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43569733|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43569735|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569755|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
43569757|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43569758|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569759|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569760|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43569761|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43569762|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
43569773|NCT00468442|Sirolimus|sirolimus|mesh-list
43569825|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569826|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
43569828|NCT00468039|Vildagliptin|vildagliptin|mesh-list
43569829|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43569830|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569831|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43569893|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43569894|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
43569895|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569896|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43569897|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569898|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43569899|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43569900|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569901|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43569902|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569903|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
43569904|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43569905|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43569951|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43569952|NCT00460941|Incretins|incretins|mesh-ancestor
43569953|NCT00460941|Hormones|hormones|mesh-ancestor
43569954|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43569955|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43569957|NCT00460317|Carboplatin|carboplatin|mesh-list
43569958|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
43569967|NCT00459745|Fenofibrate|fenofibrate|mesh-list
43570019|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570020|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570021|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43570022|NCT00455156|ST 1435|st 1435|mesh-list
43570023|NCT00455156|Estradiol|estradiol|mesh-list
43570090|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
43570091|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43570160|NCT00436683|Sevelamer|sevelamer|mesh-list
43570161|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
43570236|NCT00434226|Growth Substances|growth substances|mesh-ancestor
43570237|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570309|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43570310|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43570311|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
43570312|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570313|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570314|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570315|NCT00425100|Urological Agents|urological agents|mesh-ancestor
43570316|NCT00424697|Lorazepam|lorazepam|mesh-list
43570317|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
43570318|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
43570319|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
43570320|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570321|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570351|NCT00417118|Citalopram|citalopram|mesh-list
43570368|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570369|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
43570371|NCT00415142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43570372|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43570373|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570374|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570375|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570376|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
43570377|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570378|NCT00415142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43570379|NCT00415142|Antidepressive Agents|antidepressive agents|mesh-ancestor
43570430|NCT00411242|S 20098|s 20098|mesh-list
43570431|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43570432|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570433|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570434|NCT00411099|S 20098|s 20098|mesh-list
43570501|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43570502|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
43570503|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570504|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570505|NCT00401570|Antiviral Agents|antiviral agents|mesh-ancestor
43570506|NCT00401570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570507|NCT00401570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570508|NCT00401570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570509|NCT00401570|Immunologic Factors|immunologic factors|mesh-ancestor
43570515|NCT00401388|Allopurinol|allopurinol|mesh-list
43570567|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570568|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570569|NCT00394563|Tanezumab|tanezumab|mesh-list
43570570|NCT00394563|Analgesics|analgesics|mesh-ancestor
43570571|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
43570572|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570573|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570574|NCT00394199|Fluticasone|fluticasone|mesh-list
43570635|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570636|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43570637|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
43570638|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
43570639|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43570640|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43570641|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43570642|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43570701|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570702|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43570704|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43570705|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
43570706|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570707|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570708|NCT00389155|Antiviral Agents|antiviral agents|mesh-ancestor
43570709|NCT00389155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570710|NCT00389155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570711|NCT00389155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570712|NCT00389155|Immunologic Factors|immunologic factors|mesh-ancestor
43570713|NCT00389155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570716|NCT00388960|Amrubicin|amrubicin|mesh-list
43570717|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570718|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43570719|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43570721|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570759|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43570760|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570761|NCT00383578|Metformin|metformin|mesh-list
43570762|NCT00383578|Vildagliptin|vildagliptin|mesh-list
43570763|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43570764|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570765|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43570766|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
43570767|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570768|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570769|NCT00383513|Epratuzumab|epratuzumab|mesh-list
43570770|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570771|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570820|NCT00375791|Dexamethasone|dexamethasone|mesh-list
43570821|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570822|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
43570823|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
43570824|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570825|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570826|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43570827|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
43570829|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570885|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570886|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
43570887|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
43570888|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
43570889|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570890|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570891|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43570892|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43570893|NCT00369070|Growth Substances|growth substances|mesh-ancestor
43570949|NCT00364247|Analgesics|analgesics|mesh-ancestor
43570950|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
43570951|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570952|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43570953|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43570954|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570955|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570956|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
43571012|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
43571014|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571015|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571016|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
43571017|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
43571018|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
43571019|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571020|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43571069|NCT00345618|Biotin|biotin|mesh-list
43571080|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43571081|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571082|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571083|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
43571085|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
43571086|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571087|NCT00344045|Acetaminophen|acetaminophen|mesh-list
43571088|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43571148|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571150|NCT00330369|Darusentan|darusentan|mesh-list
43571219|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571220|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571221|NCT00320203|Growth Substances|growth substances|mesh-ancestor
43571294|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571295|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
43571296|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
43571297|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
43571298|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571299|NCT00313222|Bosentan|bosentan|mesh-list
43571300|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43571301|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43571303|NCT00313196|Bosentan|bosentan|mesh-list
43571361|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571362|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
43571363|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571364|NCT00305188|Antidotes|antidotes|mesh-ancestor
43571365|NCT00305188|Protective Agents|protective agents|mesh-ancestor
43571366|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
43571367|NCT00305188|Vitamins|vitamins|mesh-ancestor
43571368|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
43571369|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43571370|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43571371|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
43571372|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571373|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
43571423|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571424|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43571426|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571427|NCT00297089|Pemetrexed|pemetrexed|mesh-list
43571428|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571429|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571430|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571431|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43571432|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571433|NCT00292396|Antibodies|antibodies|mesh-list
43571434|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43571435|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
43571437|NCT00289640|Ipilimumab|ipilimumab|mesh-list
43571482|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571483|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
43571484|NCT00267592|Temozolomide|temozolomide|mesh-list
43571485|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43571486|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
43571487|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571488|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571489|NCT00267280|Atorvastatin|atorvastatin|mesh-list
43571490|NCT00267280|Simvastatin|simvastatin|mesh-list
43571491|NCT00267280|Torcetrapib|torcetrapib|mesh-list
43571492|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43571493|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43571494|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
43571495|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571542|NCT00260078|Darunavir|darunavir|mesh-list
43571543|NCT00260078|Tenofovir|tenofovir|mesh-list
43571544|NCT00260078|Nevirapine|nevirapine|mesh-list
43571545|NCT00260078|Efavirenz|efavirenz|mesh-list
43571546|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43571547|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43571548|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571549|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571609|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571611|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43571612|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
43571613|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43571614|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571615|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571680|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
43571681|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43571686|NCT00228176|Rimonabant|rimonabant|mesh-list
43571750|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571751|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571752|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571754|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43571755|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43571756|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
43571757|NCT00138762|Atorvastatin|atorvastatin|mesh-list
43571758|NCT00138762|Torcetrapib|torcetrapib|mesh-list
43571759|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43571816|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43571817|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43571818|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43571819|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43571820|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43571821|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
43571883|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571884|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571885|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571886|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
43571887|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571890|NCT00120042|Misoprostol|misoprostol|mesh-list
43571951|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43571952|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43571953|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43571954|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43571955|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43571956|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43571957|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43571958|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43572017|NCT00095550|Diuretics|diuretics|mesh-ancestor
43572018|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
43572019|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572020|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43572021|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43572022|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572023|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43572024|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43572025|NCT00095394|Irbesartan|irbesartan|mesh-list
43572026|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43572027|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43572028|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43572029|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572030|NCT00095290|Ramipril|ramipril|mesh-list
43572031|NCT00095290|Irbesartan|irbesartan|mesh-list
43572073|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572074|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43572075|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43572076|NCT00073866|Analgesics|analgesics|mesh-ancestor
43572077|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
43572078|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572079|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572080|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43572081|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572082|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43572083|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43572084|NCT00071461|Bosentan|bosentan|mesh-list
43572085|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43572086|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43572087|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572088|NCT00070590|Bosentan|bosentan|mesh-list
43572089|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43572090|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43572091|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572127|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
43572128|NCT00058266|Genistein|genistein|mesh-list
43572129|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43572130|NCT00058266|Protective Agents|protective agents|mesh-ancestor
43572131|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572132|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572133|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43572134|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572135|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572191|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43572192|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
43572194|NCT00052598|Interleukin-2|interleukin-2|mesh-list
43572195|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572196|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43572197|NCT00052598|Analgesics|analgesics|mesh-ancestor
43572201|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572264|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572266|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572267|NCT00028301|Ritonavir|ritonavir|mesh-list
43572268|NCT00028301|Lopinavir|lopinavir|mesh-list
43572269|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43572270|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572271|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572272|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572273|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572274|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572275|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572276|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572277|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
43572278|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572279|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43572280|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43572281|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43572282|NCT00028067|Nelfinavir|nelfinavir|mesh-list
43572283|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572284|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572285|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572286|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572287|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572288|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572289|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572290|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
43572291|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572313|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43572314|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43572315|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
43572316|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
43572317|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572318|NCT00005788|Aldesleukin|aldesleukin|mesh-list
43572319|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572324|NCT00005608|Leucovorin|leucovorin|mesh-list
43572381|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
43572382|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572383|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572384|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572385|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
43572386|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572387|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572447|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43572448|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572449|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
43572450|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572451|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43572452|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572453|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
43572454|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
43572455|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572456|NCT00004897|Antidotes|antidotes|mesh-ancestor
43572457|NCT00004897|Protective Agents|protective agents|mesh-ancestor
43572458|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
43572459|NCT00004897|Vitamins|vitamins|mesh-ancestor
43572510|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572511|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572582|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572583|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
43572584|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572585|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572586|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572587|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
43572588|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572648|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572649|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43572650|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572652|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572653|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
43572654|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572655|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572656|NCT00004096|Carboplatin|carboplatin|mesh-list
43572716|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572717|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
43572718|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43572719|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43572720|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
43572723|NCT00002371|Stavudine|stavudine|mesh-list
43572724|NCT00002371|Indinavir|indinavir|mesh-list
43572725|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43572726|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572727|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572728|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572781|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572782|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43572783|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43572784|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43572785|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
43572786|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43572787|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43572788|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43572789|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
43572791|NCT03532620|Pitavastatin|pitavastatin|mesh-list
43572792|NCT03532620|Calcium|calcium|mesh-list
43572845|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43572846|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
43572847|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43572848|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43572849|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43572850|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43572851|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43572852|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43572913|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572914|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
43572915|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572917|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
43572918|NCT03531281|Etoposide|etoposide|mesh-list
43572919|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
43572920|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
43572921|NCT03531281|Tacrolimus|tacrolimus|mesh-list
43572922|NCT03531281|Mitogens|mitogens|mesh-list
43572923|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572924|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
43572925|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572926|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572927|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572928|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
43572930|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43572973|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
43572974|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572975|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43572976|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43572977|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43572978|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43572979|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572980|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
43572981|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
43572982|NCT03530462|Rituximab|rituximab|mesh-list
43572983|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
43573035|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573036|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
43573037|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573108|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
43573109|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
43573110|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573111|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573112|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43573179|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573180|NCT03529331|Analgesics|analgesics|mesh-ancestor
43573181|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
43573182|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573183|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573184|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
43573185|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
43573186|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
43573187|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573188|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573189|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573245|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43573246|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573247|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43573248|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573249|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
43573250|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43573251|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
43573252|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573253|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43573254|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43573255|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43573256|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
43573257|NCT03529097|Dipyrone|dipyrone|mesh-list
43573258|NCT03529097|Diclofenac|diclofenac|mesh-list
43573259|NCT03529097|Morphine|morphine|mesh-list
43573260|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43573261|NCT03529097|Narcotics|narcotics|mesh-ancestor
43573262|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573263|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573264|NCT03529097|Analgesics|analgesics|mesh-ancestor
43573265|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
43573266|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573267|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573297|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
43573298|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573299|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573300|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573301|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573302|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43573303|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43573304|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573305|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43573308|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
43573363|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573364|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573365|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43573366|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43573367|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
43573368|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43573369|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573370|NCT03528616|Protective Agents|protective agents|mesh-ancestor
43573371|NCT03528616|Analgesics|analgesics|mesh-ancestor
43573372|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
43573373|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573374|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43573375|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
43573376|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
43573377|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43573378|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43573379|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43573418|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
43573419|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573493|NCT03527251|Ipilimumab|ipilimumab|mesh-list
43573494|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43573495|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573496|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43573497|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573498|NCT03527134|Amantadine|amantadine|mesh-list
43573499|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43573500|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43573501|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
43573503|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
43573511|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
43573558|NCT03526276|Protective Agents|protective agents|mesh-ancestor
43573559|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573560|NCT03526224|Teriflunomide|teriflunomide|mesh-list
43573563|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43573564|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
43573565|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573566|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573567|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573569|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
43573570|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573571|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573572|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573573|NCT03526159|Gentamicins|gentamicins|mesh-list
43573574|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43573575|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573576|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43573577|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573578|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573580|NCT03526042|Enalapril|enalapril|mesh-list
43573596|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
43573597|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573598|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573599|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43573600|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43573601|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
43573603|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573604|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43573605|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43573606|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573607|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573608|NCT03525821|Ketamine|ketamine|mesh-list
43573609|NCT03525821|Analgesics|analgesics|mesh-ancestor
43573610|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
43573611|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573654|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
43573655|NCT03525522|Hormones|hormones|mesh-ancestor
43573656|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43573657|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573658|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43573659|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
43573660|NCT03525509|Morphine|morphine|mesh-list
43573661|NCT03525509|Methadone|methadone|mesh-list
43573662|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43573663|NCT03525509|Narcotics|narcotics|mesh-ancestor
43573720|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
43573721|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573722|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573723|NCT03524274|Antibodies|antibodies|mesh-list
43573724|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43573725|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
43573726|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573727|NCT03524261|Antibodies|antibodies|mesh-list
43573728|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43573787|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
43573788|NCT03523650|Propranolol|propranolol|mesh-list
43573789|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43573790|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43573791|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
43573792|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573793|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573794|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573797|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
43573798|NCT03523572|Nivolumab|nivolumab|mesh-list
43573850|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573851|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43573852|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43573924|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43573925|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573926|NCT03521960|Buspirone|buspirone|mesh-list
43573927|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43573928|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43573929|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573930|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573931|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43573932|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43573933|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
43573934|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583892|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
43573935|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573936|NCT03521895|Aflibercept|aflibercept|mesh-list
43573937|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43573938|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43573939|NCT03521895|Growth Substances|growth substances|mesh-ancestor
43573940|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573941|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
43573942|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573943|NCT03521726|Amoxicillin|amoxicillin|mesh-list
43573944|NCT03521726|Rabeprazole|rabeprazole|mesh-list
43573977|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574036|NCT03521024|Ether|ether|mesh-list
43574052|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
43574053|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574197|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574198|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43574199|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
43574200|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574201|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574202|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43574203|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
43574204|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
43574205|NCT03519061|Hormones|hormones|mesh-ancestor
43574206|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574259|NCT03518320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574335|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
43574343|NCT03517670|Milrinone|milrinone|mesh-list
43574555|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43574556|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43574557|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43574559|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574560|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43574561|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
43574562|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43574563|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574564|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43574565|NCT03515369|Liver Extracts|liver extracts|mesh-list
43574566|NCT03515369|Hematinics|hematinics|mesh-ancestor
43574567|NCT03515213|Fenofibrate|fenofibrate|mesh-list
43574568|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43574569|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
43574570|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574572|NCT03515200|Cytarabine|cytarabine|mesh-list
43574683|NCT03514550|Sevoflurane|sevoflurane|mesh-list
43574684|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43574757|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43849068|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574758|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43574759|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
43574760|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574762|NCT03513484|Azacitidine|azacitidine|mesh-list
43574825|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
43574826|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43574827|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574828|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
43574829|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574830|NCT03512873|Tranilast|tranilast|mesh-list
43574831|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43574832|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43574833|NCT03512873|Analgesics|analgesics|mesh-ancestor
43574834|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
43574835|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43574836|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574837|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574838|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43574839|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43574840|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43574841|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574842|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43574843|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43574844|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
43574845|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
43574846|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43574877|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43574879|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43574948|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43575096|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
43575097|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43575098|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43575099|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43575100|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43575316|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43575317|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
43575318|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43575320|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43575387|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575389|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43575391|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43575392|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43575393|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43575394|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
43575395|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575453|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575528|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43575529|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43575530|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
43575531|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43575532|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
43575533|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43575534|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
43575535|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575536|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575537|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
43575538|NCT03506802|Aldesleukin|aldesleukin|mesh-list
43575539|NCT03506802|Plerixafor|plerixafor|mesh-list
43575540|NCT03506802|Lenalidomide|lenalidomide|mesh-list
43575541|NCT03506802|Melphalan|melphalan|mesh-list
43575542|NCT03506802|Interleukin-2|interleukin-2|mesh-list
43575741|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43575742|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575743|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43575744|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
43575745|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575746|NCT03505151|BI 409306|bi 409306|mesh-list
43575747|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43575748|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575749|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575750|NCT03505047|Copper|copper|mesh-list
43575751|NCT03505047|Trace Elements|trace elements|mesh-ancestor
43575752|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
43575753|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43575754|NCT03505008|Adalimumab|adalimumab|mesh-list
43575755|NCT03505008|Methotrexate|methotrexate|mesh-list
43575756|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43575874|NCT03504072|Analgesics|analgesics|mesh-ancestor
43575950|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43575951|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43575952|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43575953|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
43575954|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
43575955|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
43575956|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43575957|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43575958|NCT03503227|Analgesics|analgesics|mesh-ancestor
43575959|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
43575967|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
43576169|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576171|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
43576244|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576245|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
43576246|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576247|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43576248|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43576249|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43576250|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576312|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576385|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576386|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43576387|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43576388|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43576389|NCT03499223|Ranibizumab|ranibizumab|mesh-list
43576390|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43576391|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43576392|NCT03499223|Growth Substances|growth substances|mesh-ancestor
43576393|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576394|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
43576395|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576396|NCT03499184|Metronidazole|metronidazole|mesh-list
43576397|NCT03499184|Amoxicillin|amoxicillin|mesh-list
43576398|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43576399|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43576400|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43576401|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43576403|NCT03499171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43576404|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43576518|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
43576659|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43576660|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43576661|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576662|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576663|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43576664|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576665|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
43576666|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43576667|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
43576668|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576669|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43576670|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43576671|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43576672|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
43576673|NCT03496870|Levodopa|levodopa|mesh-list
43576674|NCT03496870|Carbidopa|carbidopa|mesh-list
43576675|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43576676|NCT03496870|Opicapone|opicapone|mesh-list
43576677|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43576678|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43576679|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
43576680|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43576681|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576785|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576857|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
43576858|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43576859|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43576860|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
43576861|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43576862|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43576863|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
43576864|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43576865|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43576866|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43576867|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43576868|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
43576870|NCT03494426|Pregabalin|pregabalin|mesh-list
43576917|NCT03493841|Protective Agents|protective agents|mesh-ancestor
43576989|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
43577065|NCT03492736|Protective Agents|protective agents|mesh-ancestor
43577217|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577290|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43577305|NCT03491072|Fentanyl|fentanyl|mesh-list
43577364|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43577365|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43577366|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
43577367|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577368|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43577369|NCT03490487|Prednisolone|prednisolone|mesh-list
43577370|NCT03490487|Carbamazepine|carbamazepine|mesh-list
43577371|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
43577372|NCT03490487|Levetiracetam|levetiracetam|mesh-list
43577373|NCT03490487|Valproic Acid|valproic acid|mesh-list
43577374|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
43577375|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43577376|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
43577377|NCT03490487|Hormones|hormones|mesh-ancestor
43577379|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577727|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
43577805|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577806|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43577807|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577808|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
43577810|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43577811|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
43577812|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43577813|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43577814|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43577815|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577816|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577817|NCT03486509|Afatinib|afatinib|mesh-list
43577818|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577819|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43577820|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577821|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577822|NCT03486496|Gefitinib|gefitinib|mesh-list
43577823|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577824|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43577825|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577826|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577827|NCT03486457|Tofacitinib|tofacitinib|mesh-list
43577828|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43577829|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577830|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577832|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43577833|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
43577834|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43577835|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43577836|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577837|NCT03486236|Ivacaftor|ivacaftor|mesh-list
43577838|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43577839|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43577914|NCT03485404|Vitamins|vitamins|mesh-list
43578068|NCT03483870|Morphine|morphine|mesh-list
43578139|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43578140|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43578141|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43578142|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43578143|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
43578144|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
43578145|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
43578146|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
43578147|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43578148|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578149|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
43578150|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
43578151|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578152|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43578153|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43578154|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
43578155|NCT03483207|Heparin|heparin|mesh-list
43578156|NCT03483207|Warfarin|warfarin|mesh-list
43578157|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
43578158|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43578159|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43578160|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578161|NCT03483181|Enoxaparin|enoxaparin|mesh-list
43578162|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
43578163|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43578164|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
43578165|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43578166|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
43578189|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
43578190|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578191|NCT03482544|Pregabalin|pregabalin|mesh-list
43578192|NCT03482544|Analgesics|analgesics|mesh-ancestor
43578193|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
43578194|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578272|NCT03482024|Hormones|hormones|mesh-ancestor
43578405|NCT03480607|Analgesics|analgesics|mesh-ancestor
43578478|NCT03480308|Narcotics|narcotics|mesh-ancestor
43578553|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43578628|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43578703|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578779|NCT03477422|Meropenem|meropenem|mesh-list
43578780|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
43578781|NCT03477422|Sulbactam|sulbactam|mesh-list
43578782|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43578783|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43578784|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43578785|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578786|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578787|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
43578788|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43578789|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43578790|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43578791|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578841|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43578994|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
43579069|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43579070|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
43579071|NCT03474601|Hormones|hormones|mesh-list
43579072|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43579073|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579074|NCT03474510|Bupivacaine|bupivacaine|mesh-list
43579075|NCT03474510|Ropivacaine|ropivacaine|mesh-list
43579076|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
43579077|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
43579078|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43579079|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579080|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
43579085|NCT03474263|Antibodies|antibodies|mesh-list
43579129|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43579199|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579201|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
43579348|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43579349|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579350|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
43579351|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579352|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579353|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43579354|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43579355|NCT03472170|Lactoferrin|lactoferrin|mesh-list
43579356|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579410|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579411|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43579556|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43579557|NCT03470077|Narcotics|narcotics|mesh-ancestor
43579558|NCT03470077|Analgesics|analgesics|mesh-ancestor
43579561|NCT03470038|Mitogens|mitogens|mesh-list
43579629|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579701|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
43579702|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43579703|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
43579704|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
43579705|NCT03468907|Tenofovir|tenofovir|mesh-list
43579706|NCT03468907|Telbivudine|telbivudine|mesh-list
43579707|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
43579708|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579709|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43579710|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43579711|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579712|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579713|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43579714|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43579716|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
43579717|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43579718|NCT03468790|Fluticasone|fluticasone|mesh-list
43579719|NCT03468790|Xhance|xhance|mesh-list
43579720|NCT03468790|Budesonide|budesonide|mesh-list
43579721|NCT03468790|Albuterol|albuterol|mesh-list
43579758|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
43579761|NCT05391360|Entecavir|entecavir|mesh-list
43579832|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43579833|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43579905|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579906|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
43579907|NCT05323149|Coagulants|coagulants|mesh-ancestor
43579988|NCT05085782|Propranolol|propranolol|mesh-list
43580127|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43580128|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
43580129|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43580130|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
43580131|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580132|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580133|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
43580269|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
43580343|NCT03367988|Anesthetics|anesthetics|mesh-list
43580346|NCT03367988|Narcotics|narcotics|mesh-ancestor
43580417|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
43580492|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43580493|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43580494|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580496|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580497|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43580498|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580499|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580500|NCT02611830|Vedolizumab|vedolizumab|mesh-list
43580501|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43580502|NCT02611817|Vedolizumab|vedolizumab|mesh-list
43580504|NCT02557139|Belumosudil|belumosudil|mesh-list
43580556|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43580557|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43580631|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43580783|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
43580785|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43580786|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43580787|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580788|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43580789|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
43580790|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
43580792|NCT03466632|Analgesics|analgesics|mesh-ancestor
43581086|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581169|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581170|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581171|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
43581172|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581173|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43581174|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43581175|NCT03463083|Analgesics|analgesics|mesh-ancestor
43581176|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43581177|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43581310|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
43581461|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43581462|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43581463|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581464|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581466|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43581467|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43581468|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581469|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43581470|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
43581471|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
43581472|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
43581596|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43581671|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
43581672|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43581741|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581743|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43581744|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
43581745|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581812|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43581813|NCT05278858|Triamcinolone|triamcinolone|mesh-list
43581852|NCT05184335|RP5063|rp5063|mesh-list
43581885|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43581886|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43581960|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
43582037|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43582340|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582416|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
43582417|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43582418|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
43582419|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582420|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43582421|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
43582422|NCT03449940|Diclofenac|diclofenac|mesh-list
43582423|NCT03449940|Lidocaine|lidocaine|mesh-list
43582715|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43582793|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582794|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
43582942|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583017|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
43583018|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
43583093|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43583094|NCT03443037|Analgesics|analgesics|mesh-ancestor
43583095|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
43583096|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583097|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43583165|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
43583243|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
43583316|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43583317|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43583318|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
43583393|NCT03437902|Protective Agents|protective agents|mesh-ancestor
43583467|NCT03437226|Simendan|simendan|mesh-list
43583468|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43583541|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43583542|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43583611|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43583612|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43583613|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583614|NCT03436121|Midazolam|midazolam|mesh-list
43583616|NCT03436121|Analgesics|analgesics|mesh-ancestor
43583617|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
43583618|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583619|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583620|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43583621|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43583622|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
43583623|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
43583624|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583625|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43583626|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43583627|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583628|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583629|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43583630|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43583631|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43583632|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43583667|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43583815|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43583816|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43583817|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583818|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
43583819|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583820|NCT03433807|Idebenone|idebenone|mesh-list
43583821|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
43583822|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583823|NCT03433807|Protective Agents|protective agents|mesh-ancestor
43583824|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583878|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43583879|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43583880|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43583881|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
43583882|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43583883|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43583884|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583886|NCT03433144|Coagulants|coagulants|mesh-ancestor
43583887|NCT03433092|Carotenoids|carotenoids|mesh-list
43583888|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
43583889|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43583890|NCT03433092|Protective Agents|protective agents|mesh-ancestor
43583891|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583895|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43583896|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43583897|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
43583898|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43583899|NCT03433001|Dexamethasone|dexamethasone|mesh-list
43583900|NCT03433001|Lenalidomide|lenalidomide|mesh-list
43583901|NCT03433001|Ixazomib|ixazomib|mesh-list
43583902|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43583903|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
43583934|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
43584150|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43584151|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43584152|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
43584153|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43584154|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43584155|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43584156|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43584158|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
43584220|NCT03431285|Analgesics|analgesics|mesh-ancestor
43584369|NCT03429738|Ephedrine|ephedrine|mesh-list
43584370|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43584371|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584441|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584443|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584444|NCT03429075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43584445|NCT03429075|Antidepressive Agents|antidepressive agents|mesh-ancestor
43584446|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43584447|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
43584448|NCT03429010|Anesthetics|anesthetics|mesh-list
43584449|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584450|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584451|NCT03428906|Oxytocin|oxytocin|mesh-list
43584452|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
43584453|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43584454|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584455|NCT03428880|Morphine|morphine|mesh-list
43584456|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43584457|NCT03428880|Narcotics|narcotics|mesh-ancestor
43584458|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584500|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584501|NCT03428503|Acetaminophen|acetaminophen|mesh-list
43584502|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43584503|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584504|NCT03428503|Analgesics|analgesics|mesh-ancestor
43584505|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
43584506|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584507|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584508|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
43584509|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43584567|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43584643|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43584722|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43584723|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43584724|NCT03426553|Riboflavin|riboflavin|mesh-list
43584725|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
43584726|NCT03426553|Vitamins|vitamins|mesh-ancestor
43584727|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
43584728|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584729|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43584730|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
43584731|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
43584732|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
43584733|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
43584734|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584784|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43584785|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43584786|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
43584787|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
43584788|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
43584789|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
43584790|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43584791|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584792|NCT03425994|Emtricitabine|emtricitabine|mesh-list
43584793|NCT03425994|Cobicistat|cobicistat|mesh-list
43584794|NCT03425994|Elvitegravir|elvitegravir|mesh-list
43584795|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
43584796|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43585649|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
43584797|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43584798|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43584799|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584800|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584801|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43584802|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43584803|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43584804|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43584839|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43584991|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
43584992|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43584993|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43584994|NCT03424733|Analgesics|analgesics|mesh-ancestor
43584995|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
43584996|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43584997|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
43584998|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
43584999|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43585000|NCT03424707|Eperisone|eperisone|mesh-list
43585001|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
43585061|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
43585134|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43585209|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43585210|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43585211|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585212|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585213|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43585214|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585215|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585216|NCT03422874|Nelfinavir|nelfinavir|mesh-list
43585217|NCT03422874|Ixazomib|ixazomib|mesh-list
43585218|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585219|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
43585220|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585221|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585222|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43585223|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43585268|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
43585269|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585270|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585271|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43585272|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43585273|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43585274|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43585275|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585276|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585336|NCT03421860|Norepinephrine|norepinephrine|mesh-list
43585337|NCT03421860|Ondansetron|ondansetron|mesh-list
43585413|NCT03421314|Selenium|selenium|mesh-list
43585517|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
43585518|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585519|NCT03420638|Epinephrine|epinephrine|mesh-list
43585520|NCT03420638|Bupivacaine|bupivacaine|mesh-list
43585521|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
43585522|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
43585523|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43585524|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585525|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
43585526|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585527|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43585528|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43585529|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
43585530|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585531|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585532|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43585533|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43585534|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
43585535|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43585536|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
43585537|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
43585538|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
43585644|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
43585645|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
43585646|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585647|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585650|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585651|NCT03419767|Protective Agents|protective agents|mesh-ancestor
43585711|NCT03418935|Niacin|niacin|mesh-list
43585712|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
43585713|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
43585786|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43585863|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43585938|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585939|NCT03416062|Niacinamide|niacinamide|mesh-list
43585940|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
43585941|NCT03416062|Vitamins|vitamins|mesh-ancestor
43585942|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
43585943|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585944|NCT03415906|Valsartan|valsartan|mesh-list
43585945|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43585946|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43585950|NCT03415802|Paclitaxel|paclitaxel|mesh-list
43586008|NCT03415594|Hormones|hormones|mesh-ancestor
43586081|NCT03414879|Lidocaine|lidocaine|mesh-list
43586230|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43586231|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43586232|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586233|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43586234|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43586235|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43586242|NCT03413020|Antacids|antacids|mesh-ancestor
43586298|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
43586299|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43586300|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586301|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586382|NCT03411850|Abatacept|abatacept|mesh-list
43586444|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43586445|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43586446|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43586447|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43586448|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43586449|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586450|NCT03411252|Mirabegron|mirabegron|mesh-list
43586451|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43586452|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43586453|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43586579|NCT03407521|Misoprostol|misoprostol|mesh-list
43586653|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43586654|NCT03404947|Ethanol|ethanol|mesh-list
43586730|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43586732|NCT03401619|Vitamins|vitamins|mesh-ancestor
43586733|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
43586734|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586735|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43586736|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43586737|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
43586738|NCT03401177|Naproxen|naproxen|mesh-list
43586799|NCT03399526|Prednicarbate|prednicarbate|mesh-list
43586800|NCT03399526|Calcipotriene|calcipotriene|mesh-list
43586801|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43586802|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43586870|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586946|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43587097|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
43587098|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587099|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
43587169|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587170|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43587171|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43587172|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43587173|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43587174|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
43587241|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43587242|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
43587243|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
43587244|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587245|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43587246|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
43587247|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587248|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43587250|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43587251|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43587252|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43587253|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
43587255|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43587256|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587257|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
43587258|NCT03396250|Promethazine|promethazine|mesh-list
43587260|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43587372|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
43587373|NCT03395132|Hormones|hormones|mesh-ancestor
43587374|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587446|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43587451|NCT03394989|Hormones|hormones|mesh-ancestor
43587520|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587521|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43587522|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587523|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587524|NCT03394222|Budesonide|budesonide|mesh-list
43587525|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43587526|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43587527|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
43587528|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43587529|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587530|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43587531|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
43587532|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
43587533|NCT03394222|Hormones|hormones|mesh-ancestor
43587534|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587535|NCT03394209|Oseltamivir|oseltamivir|mesh-list
43587536|NCT03394209|Favipiravir|favipiravir|mesh-list
43587537|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
43587538|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43587539|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43587652|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43587726|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43587727|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43587729|NCT03393416|Antibodies|antibodies|mesh-list
43587874|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
43587875|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
43587876|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43587877|NCT03392311|Calcipotriene|calcipotriene|mesh-list
43587878|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
43587879|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43587880|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
43587881|NCT03392272|Coagulants|coagulants|mesh-ancestor
43587882|NCT03392103|Raltitrexed|raltitrexed|mesh-list
43587883|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43587884|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
43587885|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587886|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43587937|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43588010|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588081|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
43588083|NCT03390608|Estrogens|estrogens|mesh-list
43588084|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588085|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588086|NCT03390608|Hormones|hormones|mesh-ancestor
43588087|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588088|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588089|NCT03390595|Gemcitabine|gemcitabine|mesh-list
43588090|NCT03390595|Carboplatin|carboplatin|mesh-list
43588091|NCT03390595|Avelumab|avelumab|mesh-list
43588092|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588093|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43588094|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
43588095|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588096|NCT03390595|Antiviral Agents|antiviral agents|mesh-ancestor
43588097|NCT03390595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43588098|NCT03390595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588099|NCT03390595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588100|NCT03390595|Immunologic Factors|immunologic factors|mesh-ancestor
43588101|NCT03390595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588102|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43588103|NCT03390582|Methimazole|methimazole|mesh-list
43588364|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588365|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
43588366|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43588367|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43588368|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588369|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43588371|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
43588372|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588373|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43588374|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43588375|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43588376|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
43588377|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588378|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588419|NCT03387956|Dexamethasone|dexamethasone|mesh-list
43588420|NCT03387956|Atropine|atropine|mesh-list
43588421|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43588422|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
43588423|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
43588424|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588425|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588426|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43588487|NCT03387592|Fluorouracil|fluorouracil|mesh-list
43588488|NCT03387592|Capecitabine|capecitabine|mesh-list
43588489|NCT03387592|Temozolomide|temozolomide|mesh-list
43588490|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
43588491|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
43588492|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43588493|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43588494|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588495|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588496|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
43588497|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588498|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43588552|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588553|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588554|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43588555|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
43588564|NCT03387111|Antidotes|antidotes|mesh-ancestor
43588626|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
43588627|NCT03386643|Hormones|hormones|mesh-ancestor
43588628|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43588629|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588630|NCT03386630|Sufentanil|sufentanil|mesh-list
43588631|NCT03386630|Morphine|morphine|mesh-list
43588633|NCT03386630|Bupivacaine|bupivacaine|mesh-list
43588634|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
43588695|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43588696|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43588697|NCT03386149|Analgesics|analgesics|mesh-ancestor
43588698|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
43588699|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588702|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43588763|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43588764|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43588837|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43588838|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43588839|NCT03385057|Acetaminophen|acetaminophen|mesh-list
43588840|NCT03385057|Ibuprofen|ibuprofen|mesh-list
43588841|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43588842|NCT03385057|Analgesics|analgesics|mesh-ancestor
43588843|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
43588906|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43588907|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
43588908|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588909|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43588912|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
43588976|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43588977|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43588978|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
43588980|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
43589047|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
43589048|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43589049|NCT03383185|Progestins|progestins|mesh-list
43589050|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43589051|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589117|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589118|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
43589119|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43589122|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
43589123|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
43589150|NCT03382431|PC-786|pc-786|mesh-list
43589188|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43589189|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
43589190|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589191|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589192|NCT03381755|Ticagrelor|ticagrelor|mesh-list
43589193|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43589194|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43589195|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43589201|NCT03381703|YH12852|yh12852|mesh-list
43589251|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
43589252|NCT03381482|Anesthetics|anesthetics|mesh-list
43589253|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589254|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589255|NCT03381430|Gefitinib|gefitinib|mesh-list
43589256|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589257|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589258|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589318|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589319|NCT03380949|Remifentanil|remifentanil|mesh-list
43589320|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
43589321|NCT03380949|Narcotics|narcotics|mesh-ancestor
43589322|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589324|NCT03380949|Analgesics|analgesics|mesh-ancestor
43589325|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
43589387|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589388|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43589389|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43589390|NCT03380442|Ketamine|ketamine|mesh-list
43589391|NCT03380442|Psilocybin|psilocybin|mesh-list
43589392|NCT03380442|Analgesics|analgesics|mesh-ancestor
43589393|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
43589394|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589455|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589456|NCT03379779|Dimercaprol|dimercaprol|mesh-list
43589457|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
43589458|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
43589459|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589460|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
43589461|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43589462|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589463|NCT03379181|Propranolol|propranolol|mesh-list
43589522|NCT03378713|Hormones|hormones|mesh-ancestor
43589523|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43589524|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589525|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43589526|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589527|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
43589528|NCT03378674|Remifentanil|remifentanil|mesh-list
43589529|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43589530|NCT03378674|Narcotics|narcotics|mesh-ancestor
43589531|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589587|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43589589|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589590|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43589591|NCT03378323|Anesthetics|anesthetics|mesh-list
43589592|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
43589593|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43589594|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589595|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
43589652|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589653|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589654|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589656|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43589657|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43589658|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
43589659|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589719|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
43589720|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43592201|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
43589721|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589722|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43589723|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589724|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43589725|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
43589784|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43589785|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43589786|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
43589787|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
43589788|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43589852|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589853|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589854|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589923|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43589925|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43589998|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589999|NCT03375034|Clonazepam|clonazepam|mesh-list
43590000|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
43590001|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
43590002|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
43590003|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590004|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590005|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590006|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
43590062|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43590063|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590064|NCT03374501|PAZ320|paz320|mesh-list
43590065|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43590066|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590067|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
43590132|NCT03373825|Fentanyl|fentanyl|mesh-list
43590133|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43590134|NCT03373825|Narcotics|narcotics|mesh-ancestor
43590135|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590136|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590205|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590206|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590207|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43590208|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43590209|NCT03373305|Growth Substances|growth substances|mesh-ancestor
43590210|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
43590211|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43590212|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590272|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43590273|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43590275|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
43590345|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590346|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
43590347|NCT03372200|Renal Agents|renal agents|mesh-ancestor
43590348|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
43590349|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43590350|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43590351|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43590352|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
43590411|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43590484|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43590485|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590486|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43590487|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43590488|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590489|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590490|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
43590491|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43590492|NCT03371043|Analgesics|analgesics|mesh-list
43590493|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
43590494|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590495|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590496|NCT03370848|Aspirin|aspirin|mesh-list
43590497|NCT03370848|Psyllium|psyllium|mesh-list
43590498|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43590499|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43590500|NCT03370848|Analgesics|analgesics|mesh-ancestor
43590501|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
43590502|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590506|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43590507|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43590508|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590509|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43590510|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43590511|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590513|NCT03370848|Cathartics|cathartics|mesh-ancestor
43590514|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590515|NCT03370835|Metoprolol|metoprolol|mesh-list
43590516|NCT03370835|Carvedilol|carvedilol|mesh-list
43590517|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43590518|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43590519|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
43590520|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
43590521|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590522|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590523|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43590524|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43590525|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43590580|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590581|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43590582|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590651|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590652|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43590653|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590654|NCT03369964|Atezolizumab|atezolizumab|mesh-list
43590655|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
43590656|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590657|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43590658|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43590659|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
43590717|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590718|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
43590719|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43590721|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43590733|NCT03369067|Insulin|insulin|mesh-list
43590787|NCT03368391|Tetracaine|tetracaine|mesh-list
43590788|NCT03368391|Mepivacaine|mepivacaine|mesh-list
43590789|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
43590790|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
43590791|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
43590792|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43590793|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590794|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
43590795|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43590796|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43590797|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43590798|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43590799|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43590800|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590847|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
43590848|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
43590849|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
43590850|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590851|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43590852|NCT03367663|Prednisone|prednisone|mesh-list
43590853|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590854|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
43590855|NCT03367663|Hormones|hormones|mesh-ancestor
43590856|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43590857|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590858|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43590859|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590860|NCT03367585|Vitamin D|vitamin d|mesh-list
43590906|NCT03367143|Ifosfamide|ifosfamide|mesh-list
43590907|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590908|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43590909|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43590910|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43590911|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43590912|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590913|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
43590914|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590915|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43590972|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43590973|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
43590974|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
43590975|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
43590976|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590977|NCT03366259|Misoprostol|misoprostol|mesh-list
43590978|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43590984|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
43591041|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
43591043|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
43591044|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
43591114|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43591115|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591116|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591117|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43591118|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
43591119|NCT03365141|Hormones|hormones|mesh-ancestor
43591120|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591121|NCT03365115|Fentanyl|fentanyl|mesh-list
43591122|NCT03365115|Morphine|morphine|mesh-list
43591180|NCT03364530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43591182|NCT03364530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591183|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
43591184|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43591185|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
43591186|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591187|NCT03364218|Expectorants|expectorants|mesh-ancestor
43591188|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
43591189|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43591190|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
43591191|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591192|NCT03364218|Protective Agents|protective agents|mesh-ancestor
43591193|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591194|NCT03364218|Antidotes|antidotes|mesh-ancestor
43591196|NCT03364088|Anesthetics|anesthetics|mesh-list
43591197|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591198|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591199|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43591200|NCT03364088|Narcotics|narcotics|mesh-ancestor
43591201|NCT03364088|Analgesics|analgesics|mesh-ancestor
43591202|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
43591203|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43591204|NCT03364075|Propranolol|propranolol|mesh-list
43591205|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43591232|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43591233|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43591234|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591235|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43591309|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
43591310|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
43591311|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43591312|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43591313|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591314|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43591315|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591316|NCT03363425|Lidocaine|lidocaine|mesh-list
43591317|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
43591318|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
43591319|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
43591351|NCT03363191|Xhance|xhance|mesh-list
43591372|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43591373|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591374|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
43591375|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591376|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591378|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
43591379|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
43591439|NCT03362411|Linrodostat|linrodostat|mesh-list
43591440|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593452|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43591441|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591442|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43591443|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591509|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43591512|NCT03361774|Fluorides|fluorides|mesh-list
43591581|NCT03361098|Incretins|incretins|mesh-ancestor
43591582|NCT03361098|Hormones|hormones|mesh-ancestor
43591583|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591655|NCT03360123|Midazolam|midazolam|mesh-list
43591656|NCT03360123|Triazolam|triazolam|mesh-list
43591657|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43591658|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43591659|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43591660|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591726|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591727|NCT03359681|Metformin|metformin|mesh-list
43591728|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43591729|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591730|NCT03359655|Scopolamine|scopolamine|mesh-list
43591731|NCT03359655|Bromides|bromides|mesh-list
43591732|NCT03359655|Misoprostol|misoprostol|mesh-list
43591794|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
43591795|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43591869|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43591870|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43591871|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43591941|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591942|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43591943|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43591944|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43591945|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43591946|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43591947|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43591948|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591949|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591950|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591951|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
43591952|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43591953|NCT03357757|Avelumab|avelumab|mesh-list
43591954|NCT03357757|Valproic Acid|valproic acid|mesh-list
43591955|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43591956|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591957|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
43591958|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591959|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591994|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43591995|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43591996|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43591997|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
43591998|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
43591999|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43592000|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592001|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592060|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43592061|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43592062|NCT03356769|Analgesics|analgesics|mesh-ancestor
43592063|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
43592064|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592065|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592125|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592128|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43592129|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43592130|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43592131|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592193|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43592194|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
43592195|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592196|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
43592197|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
43592198|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592199|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592200|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43592260|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43592261|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592332|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592333|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43592334|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43592335|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
43592336|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43592337|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
43592339|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
43592340|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43592401|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
43592402|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43592403|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43592420|NCT03353857|Estrogens|estrogens|mesh-ancestor
43592472|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592473|NCT03353025|Dopamine|dopamine|mesh-list
43592474|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
43592475|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43592476|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
43592477|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
43592480|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
43592544|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43592545|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43592546|NCT03352362|Analgesics|analgesics|mesh-ancestor
43592547|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
43592548|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43592549|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592555|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
43592603|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43592604|NCT03351517|Narcotics|narcotics|mesh-ancestor
43592605|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592606|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592616|NCT03351361|Nivolumab|nivolumab|mesh-list
43592674|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43592675|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43592676|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43592677|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592678|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
43592679|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43592680|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592739|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592740|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43592741|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592743|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43592744|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592747|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592808|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592809|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592810|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43592812|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592813|NCT03349346|Rituximab|rituximab|mesh-list
43592814|NCT03349346|Carboplatin|carboplatin|mesh-list
43592815|NCT03349346|Etoposide|etoposide|mesh-list
43592816|NCT03349346|Ifosfamide|ifosfamide|mesh-list
43592817|NCT03349346|Idelalisib|idelalisib|mesh-list
43592818|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43592819|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592821|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592871|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43592872|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43592873|NCT03349008|Entecavir|entecavir|mesh-list
43592874|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
43592875|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
43592876|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43592880|NCT03348917|Povidone|povidone|mesh-list
43592941|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
43592942|NCT03348423|Fentanyl|fentanyl|mesh-list
43592943|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43592944|NCT03348423|Narcotics|narcotics|mesh-ancestor
43592945|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43592946|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592947|NCT03348423|Analgesics|analgesics|mesh-ancestor
43592954|NCT03348371|Ethanol|ethanol|mesh-list
43593009|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43593010|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593011|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593012|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
43593013|NCT03347890|Liraglutide|liraglutide|mesh-list
43593014|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43593015|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593016|NCT03347890|Incretins|incretins|mesh-ancestor
43593018|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593019|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
43593020|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43593021|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593022|NCT03347760|Octreotide|octreotide|mesh-list
43593023|NCT03347760|Edotreotide|edotreotide|mesh-list
43593024|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43593025|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593026|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43593027|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43593028|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593029|NCT03347721|Lidocaine|lidocaine|mesh-list
43593030|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
43593031|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
43593032|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593033|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593034|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
43593046|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593047|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43593048|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593049|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
43593050|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593051|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
43593052|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43593053|NCT03347591|Protective Agents|protective agents|mesh-ancestor
43593054|NCT03347526|Vigabatrin|vigabatrin|mesh-list
43593055|NCT03347526|Cosyntropin|cosyntropin|mesh-list
43593056|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
43593057|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593058|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593059|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
43593108|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
43593109|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43593110|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43593111|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593112|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593113|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593176|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
43593249|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593250|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593251|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43593252|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593253|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43593254|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43849119|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
43593255|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43593256|NCT03346187|Atorvastatin|atorvastatin|mesh-list
43593257|NCT03346187|Fenofibrate|fenofibrate|mesh-list
43593258|NCT03346187|Calcium|calcium|mesh-list
43593259|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43593306|NCT03345797|Hormones|hormones|mesh-ancestor
43593307|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593308|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593309|NCT03345667|Ranibizumab|ranibizumab|mesh-list
43593310|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43593377|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43593378|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
43593379|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593380|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593381|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43593382|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
43593383|NCT03344679|Adenosine|adenosine|mesh-list
43593447|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593448|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
43593449|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593450|NCT03344042|Fentanyl|fentanyl|mesh-list
43593451|NCT03344042|Sufentanil|sufentanil|mesh-list
43593454|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593455|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593517|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43593518|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593519|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43593521|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
43593522|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593523|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43593524|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593586|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43593587|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
43593588|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
43593589|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593590|NCT03342599|Protective Agents|protective agents|mesh-ancestor
43593591|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593592|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
43593593|NCT03342599|Vitamins|vitamins|mesh-ancestor
43593594|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
43593595|NCT03342443|Memantine|memantine|mesh-list
43593596|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43593597|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43593598|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
43593599|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43593600|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593601|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593602|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43593603|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43593604|NCT03342352|Cisplatin|cisplatin|mesh-list
43593605|NCT03342352|Carboplatin|carboplatin|mesh-list
43593606|NCT03342352|Fluorouracil|fluorouracil|mesh-list
43593641|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43593642|NCT03342079|Analgesics|analgesics|mesh-ancestor
43593643|NCT03342040|Bupivacaine|bupivacaine|mesh-list
43593644|NCT03342040|Ropivacaine|ropivacaine|mesh-list
43593645|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
43593646|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
43593647|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43593648|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593649|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
43593650|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593652|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43593657|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43593707|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43593708|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593709|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43593710|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43593711|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43593713|NCT03341260|Diclofenac|diclofenac|mesh-list
43593714|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43593775|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43593776|NCT03340779|Protective Agents|protective agents|mesh-ancestor
43593778|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43593779|NCT03340753|Hormones|hormones|mesh-ancestor
43593780|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43593781|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593782|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
43593783|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43593784|NCT03340753|Diuretics|diuretics|mesh-ancestor
43593786|NCT03340740|Cetirizine|cetirizine|mesh-list
43593836|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43593837|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43593838|NCT03340597|Olorofim|olorofim|mesh-list
43593839|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
43593840|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593841|NCT03340558|Atezolizumab|atezolizumab|mesh-list
43593842|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43593843|NCT03340493|Tenecteplase|tenecteplase|mesh-list
43593844|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43593901|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43593902|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43593903|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
43593904|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43593971|NCT03338205|Analgesics|analgesics|mesh-ancestor
43593972|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
43593973|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43593974|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593975|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43593993|NCT03337828|Ethanol|ethanol|mesh-list
43594040|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43594042|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43594043|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
43594044|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
43594045|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
43594046|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43594047|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594048|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594050|NCT03337581|Analgesics|analgesics|mesh-ancestor
43594104|NCT03337035|Oxytocin|oxytocin|mesh-list
43594105|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
43594106|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43594107|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594108|NCT03336970|Calcium|calcium|mesh-list
43594109|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43594110|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594111|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
43594112|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594113|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
43594114|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43594115|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594116|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
43594117|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43594118|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594120|NCT03336840|Metformin|metformin|mesh-list
43594164|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
43594165|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594166|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594167|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43594168|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594169|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
43594170|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594171|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
43594172|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43594174|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
43594175|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594228|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43594229|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43594230|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594231|NCT03335826|Anesthetics|anesthetics|mesh-list
43594232|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594233|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594234|NCT03335579|Sufentanil|sufentanil|mesh-list
43594235|NCT03335579|Remifentanil|remifentanil|mesh-list
43594236|NCT03335579|Propofol|propofol|mesh-list
43594237|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
43594238|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594239|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594240|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43594290|NCT03335423|Analgesics|analgesics|mesh-ancestor
43594291|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
43594292|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594293|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
43594294|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
43594295|NCT03335293|Epinephrine|epinephrine|mesh-list
43594296|NCT03335293|Racepinephrine|racepinephrine|mesh-list
43594297|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
43594298|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43594299|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43594300|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
43594301|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594302|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594303|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594304|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43594305|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43594306|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
43594307|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594308|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43594309|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
43594310|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
43594311|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
43594312|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43594313|NCT03335241|Doxorubicin|doxorubicin|mesh-list
43594331|NCT03335124|Protective Agents|protective agents|mesh-ancestor
43594332|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
43594333|NCT03335098|Thalidomide|thalidomide|mesh-list
43594334|NCT03335098|Dexamethasone|dexamethasone|mesh-list
43594335|NCT03335098|Bortezomib|bortezomib|mesh-list
43594336|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594337|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
43594338|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
43594339|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594340|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594341|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594342|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
43594343|NCT03335098|Hormones|hormones|mesh-ancestor
43594344|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594345|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43594346|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594347|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43594348|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
43594349|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
43594350|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43594377|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594378|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594379|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594380|NCT03334981|Buprenorphine|buprenorphine|mesh-list
43594381|NCT03334981|Methadone|methadone|mesh-list
43594382|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43594383|NCT03334981|Narcotics|narcotics|mesh-ancestor
43594384|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594385|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594387|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
43594388|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594389|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43594390|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
43594391|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
43594392|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43594393|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43594394|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594395|NCT03334838|Nifurtimox|nifurtimox|mesh-list
43594396|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43594397|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43594398|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43594399|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594400|NCT03334591|Apatinib|apatinib|mesh-list
43594401|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594402|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43594403|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594404|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594412|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594414|NCT03334487|Dexamethasone|dexamethasone|mesh-list
43594415|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594416|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
43594417|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
43594418|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594419|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594420|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594421|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
43594422|NCT03334487|Hormones|hormones|mesh-ancestor
43594423|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594424|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43594425|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594426|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43594427|NCT03334136|Calcifediol|calcifediol|mesh-list
43594428|NCT03334136|Vitamins|vitamins|mesh-ancestor
43594429|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
43594430|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594456|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43594457|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43594458|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43594459|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
43594532|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594533|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594534|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43594535|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
43594536|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43594537|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43594538|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43594539|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
43594540|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594541|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594542|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
43594544|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43594545|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
43594546|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594547|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594548|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43594549|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43594550|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
43594551|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594552|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594553|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
43594554|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43594555|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594556|NCT03332888|Rituximab|rituximab|mesh-list
43594557|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43594560|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594561|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43594562|NCT03332732|Metronidazole|metronidazole|mesh-list
43594563|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594564|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43594565|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43594566|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43594567|NCT03332719|Etanercept|etanercept|mesh-list
43594568|NCT03332719|Methotrexate|methotrexate|mesh-list
43594569|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43594570|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
43594571|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43594572|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594573|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43594574|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
43594575|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594576|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594577|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
43594578|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594579|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43594580|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43594586|NCT03332719|Analgesics|analgesics|mesh-ancestor
43594611|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
43594612|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594613|NCT03332602|Urological Agents|urological agents|mesh-ancestor
43594687|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
43594688|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43594689|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594690|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43594691|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594692|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594694|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43594695|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43594696|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43594704|NCT03331861|Metformin|metformin|mesh-list
43594754|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43594755|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43594756|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43594757|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
43594758|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
43594759|NCT03331211|Dasatinib|dasatinib|mesh-list
43594760|NCT03331211|Ponatinib|ponatinib|mesh-list
43594761|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594822|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594823|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594824|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594895|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
43594896|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43594897|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43594900|NCT03329456|Ropivacaine|ropivacaine|mesh-list
43594968|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594969|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594970|NCT03329118|Simvastatin|simvastatin|mesh-list
43594971|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43594972|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43594973|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
43594974|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594975|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43594976|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43594977|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594978|NCT03328975|Dexamethasone|dexamethasone|mesh-list
43594979|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594980|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
43594981|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
43594982|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43594983|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594984|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43594985|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
43594987|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43594988|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43594989|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594991|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43594992|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
43594993|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594994|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594995|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43594996|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43594997|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
43594998|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595011|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
43595012|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595013|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43595014|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
43595015|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
43595016|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
43595017|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43595018|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
43595022|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43595078|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595079|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595080|NCT03328234|Paclitaxel|paclitaxel|mesh-list
43595081|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43595150|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43595151|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595152|NCT03327454|Analgesics|analgesics|mesh-ancestor
43595153|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
43595154|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595155|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595156|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43595217|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43595218|NCT03327116|Methotrexate|methotrexate|mesh-list
43595219|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43595220|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
43595221|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43595222|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595223|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43595224|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
43595225|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595226|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595227|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
43595228|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595229|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43595230|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43595231|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
43595276|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43595277|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43595278|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595279|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
43595280|NCT03326596|Coagulants|coagulants|mesh-ancestor
43595283|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
43595284|NCT03326258|Antibodies|antibodies|mesh-list
43595342|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43595343|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595344|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43595345|NCT03325803|Lidocaine|lidocaine|mesh-list
43595346|NCT03325803|Prilocaine|prilocaine|mesh-list
43595347|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43595348|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
43595406|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43595407|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43595408|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43595409|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
43595410|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595411|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43595412|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
43595413|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
43595414|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595415|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43595416|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43595417|NCT03325335|Midazolam|midazolam|mesh-list
43595418|NCT03325335|Remifentanil|remifentanil|mesh-list
43595419|NCT03325335|Propofol|propofol|mesh-list
43595420|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43595421|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595422|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595423|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43595424|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
43595426|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43595427|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43595428|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43595429|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43595430|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
43595431|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
43595432|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595433|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595434|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43595435|NCT03325335|Narcotics|narcotics|mesh-ancestor
43595436|NCT03325335|Analgesics|analgesics|mesh-ancestor
43595437|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
43595438|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595439|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
43595440|NCT03325270|Trace Elements|trace elements|mesh-ancestor
43595441|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
43595447|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43595448|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595449|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
43595450|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
43595451|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
43595452|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43595517|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
43595519|NCT03324490|Anesthetics|anesthetics|mesh-list
43595520|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
43595521|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595522|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595587|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43595588|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595589|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595654|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43595655|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43595656|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
43595657|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595658|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595659|NCT03323567|Lidocaine|lidocaine|mesh-list
43595660|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43595661|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
43595721|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43595722|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43595723|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
43595724|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595725|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595726|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43595727|NCT03323047|Analgesics|analgesics|mesh-ancestor
43595729|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
43595789|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43595790|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43595791|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43595792|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595793|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
43595860|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595861|NCT03321890|Prednisone|prednisone|mesh-list
43595862|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
43595863|NCT03321890|Methotrexate|methotrexate|mesh-list
43595864|NCT03321890|Etoposide|etoposide|mesh-list
43595865|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43595866|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
43595867|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595876|NCT03321890|Hormones|hormones|mesh-ancestor
43595928|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43595929|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595930|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43595931|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595995|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
43595996|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43595997|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43595998|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43595999|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
43596000|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596001|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43596064|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596065|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43596067|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43596068|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
43596209|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596211|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
43596212|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
43596213|NCT03319043|Hormones|hormones|mesh-ancestor
43596214|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596215|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43596278|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596279|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43596280|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43596281|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596347|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43596348|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596349|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
43596350|NCT03318211|Analgesics|analgesics|mesh-ancestor
43596351|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
43596352|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596413|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
43596414|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596415|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596418|NCT03317847|Hormones|hormones|mesh-ancestor
43596482|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596484|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
43596485|NCT03317275|Protective Agents|protective agents|mesh-ancestor
43596486|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596487|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43596490|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43596550|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
43596551|NCT03317015|Hormones|hormones|mesh-ancestor
43596552|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596553|NCT03316963|Neostigmine|neostigmine|mesh-list
43596554|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43596555|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596556|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596557|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
43596558|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596559|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596560|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43596561|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
43596562|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596563|NCT03316898|Memantine|memantine|mesh-list
43596564|NCT03316898|Donepezil|donepezil|mesh-list
43596565|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43596566|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596567|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596568|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
43596569|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596570|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596571|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
43596572|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43596573|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43596574|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
43596575|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43596576|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43596595|NCT03316599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596596|NCT03316534|Aspirin|aspirin|mesh-list
43596597|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43596598|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43596599|NCT03316534|Analgesics|analgesics|mesh-ancestor
43596600|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
43596601|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43596602|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596603|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43596604|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43596605|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43596606|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43596607|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596608|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43596609|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43596653|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43596655|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
43596656|NCT03316326|Irinotecan|irinotecan|mesh-list
43596657|NCT03316326|Tegafur|tegafur|mesh-list
43596658|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596659|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43596660|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43596661|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596662|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596663|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43596718|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596719|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596720|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43596721|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43596722|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43596723|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43596724|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596785|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43596786|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43596787|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
43596788|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43596857|NCT03314493|Spironolactone|spironolactone|mesh-list
43596858|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43596859|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
43596860|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596861|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596862|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43596863|NCT03314493|Diuretics|diuretics|mesh-ancestor
43596864|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
43596923|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
43596924|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596927|NCT03313869|Protective Agents|protective agents|mesh-ancestor
43596993|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43596994|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
43596995|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
43596996|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43596997|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596998|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
43596999|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597000|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43597001|NCT03313323|Ipilimumab|ipilimumab|mesh-list
43597002|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597003|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597006|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
43597055|NCT03312283|Growth Substances|growth substances|mesh-ancestor
43597056|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597057|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
43597058|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597059|NCT03312244|Bromides|bromides|mesh-list
43597124|NCT03311789|Nivolumab|nivolumab|mesh-list
43597125|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43597126|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597127|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43597128|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
43597129|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597130|NCT03311789|Antiviral Agents|antiviral agents|mesh-ancestor
43597131|NCT03311789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597132|NCT03311789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597133|NCT03311789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43597134|NCT03311789|Immunologic Factors|immunologic factors|mesh-ancestor
43597135|NCT03311789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597136|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597137|NCT03311750|Panitumumab|panitumumab|mesh-list
43597138|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597139|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597140|NCT03311737|Anesthetics|anesthetics|mesh-list
43597145|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597184|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43597185|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
43597186|NCT03311425|Hormones|hormones|mesh-ancestor
43597187|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43597188|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43597189|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597190|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43597191|NCT03311425|Protective Agents|protective agents|mesh-ancestor
43597196|NCT03311321|Vitamin K|vitamin k|mesh-list
43597253|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43598254|NCT03301233|Urological Agents|urological agents|mesh-ancestor
43597257|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
43597258|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597259|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43597260|NCT03310073|Vaccines|vaccines|mesh-list
43597261|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
43597262|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597297|NCT03309644|Iodine|iodine|mesh-list
43597320|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
43597321|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43597322|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43597323|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43597324|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597325|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597326|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43597388|NCT03309163|Hydromorphone|hydromorphone|mesh-list
43597389|NCT03309163|Ropivacaine|ropivacaine|mesh-list
43597390|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
43597391|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
43597392|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597393|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597458|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
43597459|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43597460|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597461|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43597462|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43597463|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
43597464|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43597465|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597466|NCT03308253|Vancomycin|vancomycin|mesh-list
43597467|NCT03308253|Tobramycin|tobramycin|mesh-list
43597468|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43597470|NCT03308214|Imipenem|imipenem|mesh-list
43597521|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
43597591|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597592|NCT03307551|Propofol|propofol|mesh-list
43597593|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43597594|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43597595|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597596|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43597597|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
43597598|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
43597599|NCT03307512|Insulin|insulin|mesh-list
43597600|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43597601|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
43597602|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43597603|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597604|NCT03307213|Sirolimus|sirolimus|mesh-list
43597605|NCT03307213|Umirolimus|umirolimus|mesh-list
43597653|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597655|NCT03306745|Hematinics|hematinics|mesh-ancestor
43597656|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
43597657|NCT03306745|Vitamins|vitamins|mesh-ancestor
43597658|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
43597660|NCT03306732|Thiamine|thiamine|mesh-list
43597718|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43597719|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
43597791|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597792|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597793|NCT03304652|Zaleplon|zaleplon|mesh-list
43597794|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
43597861|NCT03304093|Nivolumab|nivolumab|mesh-list
43597862|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43597863|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597864|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43597865|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597866|NCT03303976|Vaccines|vaccines|mesh-list
43597867|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43597868|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
43597870|NCT03303924|Sulbactam|sulbactam|mesh-list
43597928|NCT03303495|Growth Substances|growth substances|mesh-ancestor
43597929|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597930|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
43597931|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
43597993|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43597994|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43597995|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597998|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
43598065|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849131|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43849132|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849134|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
43598114|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
43598115|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43598116|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598117|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43598119|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
43849152|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598120|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598121|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43598122|NCT03302221|Ropivacaine|ropivacaine|mesh-list
43598123|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
43598124|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598125|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598126|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
43598127|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
43598128|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598129|NCT03302208|Pregabalin|pregabalin|mesh-list
43598130|NCT03302208|Analgesics|analgesics|mesh-ancestor
43598131|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
43598132|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598133|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598134|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
43598135|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43598136|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598137|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598138|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43598139|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43598140|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43598141|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598142|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43598143|NCT03302182|Ritonavir|ritonavir|mesh-list
43598144|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43598145|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43598146|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
43598147|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598148|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598149|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43598150|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43598151|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
43598152|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598153|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43598182|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
43598183|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43598184|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43598185|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43598186|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
43598187|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598188|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598248|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43598249|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
43598250|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43598251|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43598252|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598253|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627648|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627649|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627650|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
43627705|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
43627706|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43627707|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
43627709|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43627710|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627711|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
43627712|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627713|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849441|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849442|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627756|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
43627757|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627758|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627759|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43627760|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
43627761|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627762|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627763|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43627822|NCT03071055|Growth Substances|growth substances|mesh-ancestor
43627823|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627824|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
43627825|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627826|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43627893|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43627894|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627896|NCT03070704|Xultophy|xultophy|mesh-list
43627898|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627899|NCT03070704|Incretins|incretins|mesh-ancestor
43627960|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
43627961|NCT03070275|Coagulants|coagulants|mesh-ancestor
43627962|NCT03070028|Phenol|phenol|mesh-list
43627963|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43627964|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627965|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
43628033|NCT03069820|Docetaxel|docetaxel|mesh-list
43628034|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628035|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
43628036|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
43628037|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
43628039|NCT03069768|Varenicline|varenicline|mesh-list
43628101|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43628102|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43628103|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
43628104|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43628105|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
43628106|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
43628173|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628174|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628175|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628176|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
43628177|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628178|NCT03068351|Daratumumab|daratumumab|mesh-list
43628179|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628180|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43628181|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43628182|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43628183|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628236|NCT03067974|Analgesics|analgesics|mesh-ancestor
43628237|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
43628238|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628239|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628241|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43628242|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
43628243|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
43628244|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628245|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43628246|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43628247|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43628248|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628249|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
43628250|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43628251|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628252|NCT03067883|Ritonavir|ritonavir|mesh-list
43628253|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43628254|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43628255|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
43628256|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628257|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628258|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43628259|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43628261|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628262|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43628263|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43628264|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
43628265|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
43628266|NCT03067896|Bupivacaine|bupivacaine|mesh-list
43628267|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628268|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
43628323|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
43628324|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
43628325|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628326|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43628327|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
43628395|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628396|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43628397|NCT03067103|Narcotics|narcotics|mesh-ancestor
43628398|NCT03067168|Bupivacaine|bupivacaine|mesh-list
43628399|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
43628400|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
43628401|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628402|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628461|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628462|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628463|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43628464|NCT03066557|Estrogens|estrogens|mesh-ancestor
43628465|NCT03066557|Hormones|hormones|mesh-ancestor
43628530|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628531|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43628532|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43628533|NCT03066427|Growth Substances|growth substances|mesh-ancestor
43628534|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628535|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
43628536|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43628537|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628538|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628593|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43628594|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43628595|NCT03066011|Voriconazole|voriconazole|mesh-list
43628596|NCT03066011|Posaconazole|posaconazole|mesh-list
43628597|NCT03066011|Isavuconazole|isavuconazole|mesh-list
43628598|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
43628599|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628600|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43628601|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43628602|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628604|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43628654|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43628655|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43628656|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43628665|NCT03065309|Remifentanil|remifentanil|mesh-list
43628711|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43628712|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628714|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43628715|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43628716|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628717|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
43628718|NCT03064282|Urological Agents|urological agents|mesh-ancestor
43628776|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43628777|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43628778|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43628846|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43628847|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43628848|NCT03063541|Analgesics|analgesics|mesh-ancestor
43628849|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
43628915|NCT03063866|Fentanyl|fentanyl|mesh-list
43628916|NCT03063866|Midazolam|midazolam|mesh-list
43628917|NCT03063866|Propofol|propofol|mesh-list
43628918|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43628919|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43628920|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628988|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628989|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
43628990|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43628991|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629060|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629061|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
43629062|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629063|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43629064|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43629065|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43629066|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43629067|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629068|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43629123|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629124|NCT03062319|Anticoagulants|anticoagulants|mesh-list
43629198|NCT03061604|Octreotide|octreotide|mesh-list
43629199|NCT03061604|Hemostatics|hemostatics|mesh-list
43629204|NCT03061604|Coagulants|coagulants|mesh-ancestor
43629273|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629274|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629275|NCT03060681|Bupivacaine|bupivacaine|mesh-list
43629286|NCT03060798|Desflurane|desflurane|mesh-list
43629342|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629343|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629344|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629346|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
43629347|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629410|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43629411|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43629412|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43629413|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
43629414|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629482|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43629483|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
43629484|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
43629485|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43629554|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43629556|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43629571|NCT03059017|Albuterol|albuterol|mesh-list
43629627|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629628|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
43629697|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
43629698|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
43629699|NCT03058237|Baclofen|baclofen|mesh-list
43629700|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43629701|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629769|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629770|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
43629772|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43629773|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629774|NCT03057314|Antacids|antacids|mesh-ancestor
43629775|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629836|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
43629837|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
43629838|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
43629839|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43629840|NCT03057015|Analgesics|analgesics|mesh-ancestor
43629841|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43629842|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
43629843|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43629844|NCT03056924|Vaccines|vaccines|mesh-list
43629908|NCT03056599|Atezolizumab|atezolizumab|mesh-list
43629909|NCT03056599|Durvalumab|durvalumab|mesh-list
43629910|NCT03056599|Avelumab|avelumab|mesh-list
43629911|NCT03056599|Trabectedin|trabectedin|mesh-list
43629912|NCT03056599|Olaratumab|olaratumab|mesh-list
43629913|NCT03056599|Entrectinib|entrectinib|mesh-list
43629914|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43629980|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43629981|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43629982|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43629983|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630049|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
43630051|NCT03055793|Hormones|hormones|mesh-ancestor
43630059|NCT03055546|Oxytocin|oxytocin|mesh-list
43630124|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630125|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
43630126|NCT03054610|Hormones|hormones|mesh-ancestor
43630127|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630128|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43630133|NCT03054532|Durvalumab|durvalumab|mesh-list
43630190|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630191|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630192|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
43630193|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630194|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
43630195|NCT03054220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43630196|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
43630197|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43630198|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43630199|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43630200|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630201|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
43630202|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
43630205|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
43630250|NCT03053869|Lorazepam|lorazepam|mesh-list
43630251|NCT03053869|Alprazolam|alprazolam|mesh-list
43630252|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
43630253|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
43630254|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
43630255|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630256|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630257|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630258|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43630259|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630315|NCT03053388|Protective Agents|protective agents|mesh-ancestor
43630389|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630391|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43630392|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43630394|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630460|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43630461|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
43630463|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630464|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43630466|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630467|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630468|NCT03051906|Cetuximab|cetuximab|mesh-list
43630469|NCT03051906|Durvalumab|durvalumab|mesh-list
43630470|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43630471|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630472|NCT03051841|Dexamethasone|dexamethasone|mesh-list
43630473|NCT03051841|Bortezomib|bortezomib|mesh-list
43630474|NCT03051841|CKD-581|ckd-581|mesh-list
43630475|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630476|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
43630477|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
43630478|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630479|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630480|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43630481|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
43630482|NCT03051841|Hormones|hormones|mesh-ancestor
43630483|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43630484|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43630485|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630486|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630547|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43630548|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
43630549|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43630550|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
43630551|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43630552|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43630553|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43630554|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630558|NCT03051373|Cisplatin|cisplatin|mesh-list
43630613|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43630614|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
43630615|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43630616|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43630617|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43630618|NCT03050827|Oxybutynin|oxybutynin|mesh-list
43630619|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
43630620|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
43630682|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630683|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43630684|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630685|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630686|NCT03050554|Avelumab|avelumab|mesh-list
43630687|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43630688|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630689|NCT03050086|Minocycline|minocycline|mesh-list
43630690|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43630691|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43630692|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
43630693|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43630694|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43630696|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
43630745|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43630746|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630747|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
43630748|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
43630749|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630750|NCT03049176|Tenofovir|tenofovir|mesh-list
43630751|NCT03049176|Emtricitabine|emtricitabine|mesh-list
43630752|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43630810|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630813|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43630814|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630815|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43630816|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43630817|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630875|NCT03047837|Metformin|metformin|mesh-list
43630876|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43630877|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630878|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43630879|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43630880|NCT03047837|Analgesics|analgesics|mesh-ancestor
43630881|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
43630882|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43630883|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630884|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630885|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43630939|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43630940|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
43630941|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631009|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631010|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631012|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631013|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43631014|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43631015|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43631016|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43631017|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631018|NCT03047109|Phenylephrine|phenylephrine|mesh-list
43631019|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
43631020|NCT03047109|Ephedrine|ephedrine|mesh-list
43631021|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43631022|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
43631023|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
43631024|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631025|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631026|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
43631027|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43631028|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
43631029|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
43631030|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43631031|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43631032|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43631033|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
43631034|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631035|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631036|NCT03047109|Protective Agents|protective agents|mesh-ancestor
43631037|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43631038|NCT03047265|Paclitaxel|paclitaxel|mesh-list
43631039|NCT03047265|Cisplatin|cisplatin|mesh-list
43631040|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43631041|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631042|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
43631043|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
43631047|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631048|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631049|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43631050|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
43631051|NCT03046758|Metronidazole|metronidazole|mesh-list
43631052|NCT03046758|Fosfomycin|fosfomycin|mesh-list
43631117|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631119|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43631120|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631191|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631192|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43631194|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43631195|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43631196|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43631261|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
43631262|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631263|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
43631264|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
43631265|NCT03045016|Prazosin|prazosin|mesh-list
43631266|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43631274|NCT03044912|Mirabegron|mirabegron|mesh-list
43631338|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
43631339|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631340|NCT03044587|Antiviral Agents|antiviral agents|mesh-ancestor
43631341|NCT03044587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631342|NCT03044587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631343|NCT03044587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631344|NCT03044587|Immunologic Factors|immunologic factors|mesh-ancestor
43631345|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631346|NCT03044587|Antidotes|antidotes|mesh-ancestor
43631347|NCT03044587|Protective Agents|protective agents|mesh-ancestor
43631348|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
43631382|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43631383|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
43631384|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
43631385|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43631386|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43631387|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43631388|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43631389|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
43631390|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631391|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631392|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
43631393|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43631394|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43631395|NCT03044366|Anesthetics|anesthetics|mesh-list
43631396|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43631397|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631398|NCT03044379|Dapivirine|dapivirine|mesh-list
43631399|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43631400|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43631401|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
43631402|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43631463|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
43631464|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43631536|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
43631609|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43631610|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43631611|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631612|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43631615|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
43631683|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631684|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631698|NCT03042377|Calcium|calcium|mesh-list
43631756|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43631757|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
43631758|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
43631835|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43631836|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43631900|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43631901|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43631902|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
43631903|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
43631913|NCT03041012|Romidepsin|romidepsin|mesh-list
43849472|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632042|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43632043|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
43632044|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
43632115|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43632116|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43632117|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43632118|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632119|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632120|NCT03039478|Erythritol|erythritol|mesh-list
43632123|NCT03039205|Ticagrelor|ticagrelor|mesh-list
43632185|NCT03038607|Analgesics|analgesics|mesh-ancestor
43632186|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
43632187|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632254|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43632255|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43632256|NCT03038282|Chromium|chromium|mesh-list
43632257|NCT03038282|Chromous chloride|chromous chloride|mesh-list
43632258|NCT03038282|Trace Elements|trace elements|mesh-ancestor
43632259|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
43632260|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632261|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
43632282|NCT03038230|Antibodies|antibodies|mesh-list
43632321|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43632322|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43632323|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43632324|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
43632325|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43632326|NCT03037944|Diuretics|diuretics|mesh-ancestor
43632391|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43632392|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632462|NCT03036605|Dexamethasone|dexamethasone|mesh-list
43632463|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
43632464|NCT03036605|Bupivacaine|bupivacaine|mesh-list
43632465|NCT03036605|BB 1101|bb 1101|mesh-list
43632466|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43632467|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
43632532|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43632533|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632534|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632535|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43632536|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43632602|NCT03035695|Coagulants|coagulants|mesh-ancestor
43632603|NCT05619341|Psyllium|psyllium|mesh-list
43632604|NCT05619341|Cathartics|cathartics|mesh-ancestor
43632605|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43632606|NCT05619328|Vitamins|vitamins|mesh-list
43632607|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
43632608|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
43632609|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632610|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
43632611|NCT05619315|Calcium|calcium|mesh-list
43632612|NCT05619315|Charcoal|charcoal|mesh-list
43632613|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43632614|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632669|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43632671|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
43632743|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43632744|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43632745|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43632746|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
43632747|NCT05617430|Antidotes|antidotes|mesh-ancestor
43632748|NCT05617430|Protective Agents|protective agents|mesh-ancestor
43633027|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633028|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633029|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633030|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43633031|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633093|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633094|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633166|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43633167|NCT05612451|Calcium|calcium|mesh-list
43633168|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43633169|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633234|NCT05611593|Urological Agents|urological agents|mesh-ancestor
43633236|NCT05611463|Docetaxel|docetaxel|mesh-list
43633308|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633382|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
43633385|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633524|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633525|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633526|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43633527|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43633528|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633529|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633534|NCT05699993|Itraconazole|itraconazole|mesh-list
43633579|NCT05699824|Protective Agents|protective agents|mesh-ancestor
43633580|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43633581|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633650|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
43633651|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
43633652|NCT05699473|Calcium|calcium|mesh-list
43633653|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43633656|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
43633740|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43633741|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43633742|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633743|NCT05698511|Psilocybin|psilocybin|mesh-list
43633744|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
43633745|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633746|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43633747|NCT05698407|Sufentanil|sufentanil|mesh-list
43633851|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43633852|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43633853|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633854|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43633855|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43633856|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633857|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
43633927|NCT05697003|Xhance|xhance|mesh-list
43633928|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43633929|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43633930|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43633931|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43633932|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
43633933|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633934|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633935|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43633936|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
43634001|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634002|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634003|NCT05696782|Durvalumab|durvalumab|mesh-list
43634004|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43634005|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634006|NCT05696691|Ketamine|ketamine|mesh-list
43634007|NCT05696691|Analgesics|analgesics|mesh-ancestor
43634008|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
43634009|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634010|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634011|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43634012|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43634013|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
43634014|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
43634015|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634017|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43634070|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43634071|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43634072|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
43634073|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43634074|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43634075|NCT05696431|Fluorides|fluorides|mesh-list
43634076|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
43634077|NCT05696431|Protective Agents|protective agents|mesh-ancestor
43634078|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634080|NCT05696366|Volagidemab|volagidemab|mesh-list
43634134|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634135|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43634136|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
43634139|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43634204|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43634205|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
43634207|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
43634208|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
43634209|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634210|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634211|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
43634212|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634213|NCT05694897|Analgesics|analgesics|mesh-ancestor
43634214|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43634215|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
43634216|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43634217|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43634222|NCT05694819|Goserelin|goserelin|mesh-list
43634266|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634267|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634268|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43634269|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43634270|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
43634271|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
43634272|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43634273|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43634274|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43634275|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634276|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634277|NCT05690087|Lidocaine|lidocaine|mesh-list
43634327|NCT05671900|Immunologic Factors|immunologic factors|mesh-ancestor
43634328|NCT05671900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634329|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
43634330|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
43634331|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
43634332|NCT05669742|Empagliflozin|empagliflozin|mesh-list
43634333|NCT05669742|Olanzapine|olanzapine|mesh-list
43634334|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
43849490|NCT03923699|Anesthetics|anesthetics|mesh-list
43634336|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634337|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634339|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43634387|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43634388|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43634389|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43634390|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43634391|NCT05655949|Gemcitabine|gemcitabine|mesh-list
43634392|NCT05655949|Cisplatin|cisplatin|mesh-list
43634393|NCT05655949|Durvalumab|durvalumab|mesh-list
43634394|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634438|NCT05651711|KHK4083|khk4083|mesh-list
43634488|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634497|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
43634498|NCT05628883|Fludarabine|fludarabine|mesh-list
43634499|NCT05628883|Interleukin-2|interleukin-2|mesh-list
43634500|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43634501|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
43634502|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634503|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43634504|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43634587|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634588|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634589|NCT05592379|Psilocybin|psilocybin|mesh-list
43634664|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
43634665|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634666|NCT05575219|Clonidine|clonidine|mesh-list
43634667|NCT05575219|Analgesics|analgesics|mesh-ancestor
43634668|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
43634669|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634670|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634672|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
43634673|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
43634741|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634742|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43634743|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43634744|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634745|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
43634746|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43634747|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
43634829|NCT05487456|Menthol|menthol|mesh-list
43634830|NCT05487456|Nicotine|nicotine|mesh-list
43634831|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43634832|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
43634833|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634834|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634835|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43634836|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43634837|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
43634838|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43634914|NCT05467462|Oxytocin|oxytocin|mesh-list
43634915|NCT05467462|Carbetocin|carbetocin|mesh-list
43634916|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
43634917|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43634918|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634919|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43634920|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43634921|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634922|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
43634923|NCT05467462|Coagulants|coagulants|mesh-ancestor
43634981|NCT05438186|Hormones|hormones|mesh-ancestor
43634982|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634983|NCT05426395|Vitamins|vitamins|mesh-list
43634984|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
43634985|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
43634986|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
43634990|NCT05425056|Sirolimus|sirolimus|mesh-list
43635076|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
43635077|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
43635078|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635079|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635080|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
43635081|NCT05389995|Methamphetamine|methamphetamine|mesh-list
43635082|NCT05389995|Citric Acid|citric acid|mesh-list
43635083|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
43635084|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
43635085|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43635086|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
43635087|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
43635155|NCT05383352|Antidotes|antidotes|mesh-ancestor
43635156|NCT05383352|Protective Agents|protective agents|mesh-ancestor
43635227|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635228|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
43635229|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
43635230|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
43635231|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635232|NCT05357989|Phenserine|phenserine|mesh-list
43635233|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43635234|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635235|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635236|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
43635334|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
43635335|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
43635336|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
43635337|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635405|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635406|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43635407|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43635408|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43635409|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43635503|NCT05286814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43635504|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635505|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635621|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
43635622|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43635623|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43635624|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43635625|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
43635626|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635627|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635689|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43635690|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43635691|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635692|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
43635693|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635694|NCT05192889|Leucovorin|leucovorin|mesh-list
43635695|NCT05192889|Cytarabine|cytarabine|mesh-list
43635696|NCT05192889|Dexamethasone|dexamethasone|mesh-list
43635697|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
43635698|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
43635709|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635710|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
43635711|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635747|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
43635748|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
43635749|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43635750|NCT05182385|Venetoclax|venetoclax|mesh-list
43635751|NCT05182385|Blinatumomab|blinatumomab|mesh-list
43635752|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635753|NCT05172245|Cisplatin|cisplatin|mesh-list
43635824|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635825|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
43635908|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43635909|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635912|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635980|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43635982|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43635983|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43635984|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43635985|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635986|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
43635987|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635988|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
43635989|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635990|NCT05100017|Methocarbamol|methocarbamol|mesh-list
43635991|NCT05100017|Oxybutynin|oxybutynin|mesh-list
43636044|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43636045|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43636046|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43636047|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636048|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636112|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
43636113|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636117|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636118|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43636121|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
43636218|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636292|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636293|NCT04991480|Niraparib|niraparib|mesh-list
43636294|NCT04991480|Talazoparib|talazoparib|mesh-list
43636295|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43636296|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636297|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636298|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636299|NCT04989946|Nivolumab|nivolumab|mesh-list
43636300|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849493|NCT03922997|Atezolizumab|atezolizumab|mesh-list
43636301|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636302|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43636303|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636304|NCT04989283|Paclitaxel|paclitaxel|mesh-list
43636305|NCT04989283|Etoposide|etoposide|mesh-list
43636306|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
43636307|NCT04989283|Cisplatin|cisplatin|mesh-list
43636308|NCT04989283|Carboplatin|carboplatin|mesh-list
43636309|NCT04989283|Pemetrexed|pemetrexed|mesh-list
43636310|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43636311|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
43636312|NCT04989283|Atezolizumab|atezolizumab|mesh-list
43636313|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43636314|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43636315|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636316|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
43636317|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
43636318|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
43636320|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43636338|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
43636339|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636340|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
43636341|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636342|NCT04984980|Antiviral Agents|antiviral agents|mesh-ancestor
43636343|NCT04984980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636344|NCT04984980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636345|NCT04984980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636346|NCT04984980|Immunologic Factors|immunologic factors|mesh-ancestor
43636494|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636495|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
43636496|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636497|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43636498|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636499|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
43636500|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43636501|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43636502|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
43636503|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636504|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636505|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
43636507|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
43636508|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636509|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636511|NCT04894643|Paclitaxel|paclitaxel|mesh-list
43636512|NCT04894643|Capecitabine|capecitabine|mesh-list
43636513|NCT04894643|Pancrelipase|pancrelipase|mesh-list
43636514|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43636515|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636516|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
43636517|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
43636518|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
43636519|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636520|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636521|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
43636522|NCT04894643|Antiviral Agents|antiviral agents|mesh-ancestor
43636523|NCT04894643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636524|NCT04894643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636525|NCT04894643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636526|NCT04894643|Immunologic Factors|immunologic factors|mesh-ancestor
43636527|NCT04894643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636528|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636550|NCT04887831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43636553|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636554|NCT04886232|Lidocaine|lidocaine|mesh-list
43636555|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
43636556|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
43636557|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43636558|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636559|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
43636566|NCT04872400|Vancomycin|vancomycin|mesh-list
43636622|NCT04858776|Dexamethasone|dexamethasone|mesh-list
43636623|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636624|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
43636625|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
43636626|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636627|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636628|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43636629|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
43636630|NCT04858776|Hormones|hormones|mesh-ancestor
43636631|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43636632|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43636633|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636634|NCT04847947|Vitamin D|vitamin d|mesh-list
43636635|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
43636636|NCT04847947|Vitamins|vitamins|mesh-ancestor
43636682|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636683|NCT04814940|Menotropins|menotropins|mesh-list
43636684|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43636685|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
43636752|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43636753|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43636754|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43636755|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
43636757|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636758|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43636760|NCT04770532|Insulin|insulin|mesh-list
43636761|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43636821|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43636822|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43636823|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43636993|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
43636994|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636995|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637068|NCT04697628|Pemetrexed|pemetrexed|mesh-list
43637157|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637158|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
43637159|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637160|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637161|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43637162|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
43637253|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
43637254|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637255|NCT04632069|Expectorants|expectorants|mesh-ancestor
43637256|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
43637257|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43637258|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
43637259|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637260|NCT04632069|Protective Agents|protective agents|mesh-ancestor
43637261|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637262|NCT04632069|Antidotes|antidotes|mesh-ancestor
43637263|NCT04630171|Anesthetics|anesthetics|mesh-list
43637264|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43637265|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637313|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637314|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637315|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637316|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637317|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
43637318|NCT04624204|Etoposide|etoposide|mesh-list
43637319|NCT04624204|Olaparib|olaparib|mesh-list
43637320|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637321|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637322|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637323|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43637324|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43637325|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637326|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637327|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43637328|NCT04619095|Psyllium|psyllium|mesh-list
43637329|NCT04619095|Cathartics|cathartics|mesh-ancestor
43637330|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43637331|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
43637332|NCT04617938|Narcotics|narcotics|mesh-ancestor
43637333|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43637334|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637335|NCT04617938|Analgesics|analgesics|mesh-ancestor
43637336|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
43637404|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
43637405|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
43637406|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43637513|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
43637514|NCT04566133|Trametinib|trametinib|mesh-list
43637515|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
43637516|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43637587|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637588|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43637589|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637590|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637658|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637659|NCT04515472|Hormones|hormones|mesh-list
43637734|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43637736|NCT04447716|Venetoclax|venetoclax|mesh-list
43637737|NCT04447716|Piperidine|piperidine|mesh-list
43637738|NCT04447716|Antibodies|antibodies|mesh-list
43637739|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
43637740|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43637741|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
43637742|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637743|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637744|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637745|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43637746|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43637747|NCT04447716|Growth Substances|growth substances|mesh-ancestor
43637748|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
43637749|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637750|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43637753|NCT04447027|Dexamethasone|dexamethasone|mesh-list
43637793|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43637801|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637802|NCT04440280|Protective Agents|protective agents|mesh-ancestor
43637803|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637804|NCT04440280|Antidotes|antidotes|mesh-ancestor
43637805|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43637806|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
43637807|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637808|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43637809|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
43637810|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43637811|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637812|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43637813|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43637814|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43637815|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
43637816|NCT04428151|Paclitaxel|paclitaxel|mesh-list
43637843|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637844|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637845|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637846|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637855|NCT04404283|Rituximab|rituximab|mesh-list
43637926|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43637942|NCT04363801|Fluorouracil|fluorouracil|mesh-list
43637943|NCT04363801|Capecitabine|capecitabine|mesh-list
43637944|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
43637945|NCT04363801|Calcium|calcium|mesh-list
43637946|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
43638016|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638216|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43638217|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
43638218|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638219|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638220|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43638289|NCT04223856|Antiviral Agents|antiviral agents|mesh-ancestor
43638290|NCT04223856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638291|NCT04223856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638292|NCT04223856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638374|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43638375|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43638376|NCT04176705|Lidocaine|lidocaine|mesh-list
43638377|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43638391|NCT04176705|Hormones|hormones|mesh-ancestor
43638457|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43638458|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
43638459|NCT04115631|Antibodies|antibodies|mesh-list
43638460|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
43638561|NCT04047628|Ofatumumab|ofatumumab|mesh-list
43638562|NCT04047628|Cladribine|cladribine|mesh-list
43638641|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
43638643|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
43638644|NCT03983850|Busulfan|busulfan|mesh-list
43638645|NCT03983850|Fludarabine|fludarabine|mesh-list
43638646|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638647|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
43638648|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638649|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638650|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43638707|NCT03950674|Hormones|hormones|mesh-ancestor
43638708|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43638709|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43638710|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638711|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638712|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638713|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638772|NCT03907475|Gemcitabine|gemcitabine|mesh-list
43638850|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43639092|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
43639402|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639405|NCT03299049|Rilpivirine|rilpivirine|mesh-list
43639476|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43639477|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43639479|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
43639480|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639481|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639483|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639546|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43639547|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639548|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
43639549|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
43639550|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
43639552|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
43639617|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43639690|NCT03104842|Growth Substances|growth substances|mesh-ancestor
43639691|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
43639692|NCT03077542|Sirolimus|sirolimus|mesh-list
43639693|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
43639763|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
43639764|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639765|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639766|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639767|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639768|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43639769|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43639770|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639771|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
43639772|NCT03007537|Hematinics|hematinics|mesh-ancestor
43639773|NCT03004443|Infliximab|infliximab|mesh-list
43639774|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
43639833|NCT02957968|Paclitaxel|paclitaxel|mesh-list
43639834|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
43639904|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639905|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43639906|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639907|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639908|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640087|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640088|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640160|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
43640161|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640162|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
43640163|NCT02784210|Hormones|hormones|mesh-ancestor
43640164|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640165|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640166|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640167|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640168|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
43640169|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
43640170|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640171|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640190|NCT02723955|Paclitaxel|paclitaxel|mesh-list
43640223|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640224|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640225|NCT02629120|Sirolimus|sirolimus|mesh-list
43640296|NCT02484404|Durvalumab|durvalumab|mesh-list
43640297|NCT02484404|Olaparib|olaparib|mesh-list
43640298|NCT02484404|Cediranib|cediranib|mesh-list
43640299|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640302|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640366|NCT02389543|Dexamethasone|dexamethasone|mesh-list
43640367|NCT02389543|Lenalidomide|lenalidomide|mesh-list
43640368|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640379|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
43640380|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43640440|NCT02352948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640573|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
43640574|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43640575|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
43640576|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
43640577|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
43640580|NCT02170090|Capecitabine|capecitabine|mesh-list
43640581|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640582|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43640583|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
43640584|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640585|NCT02170090|Antiviral Agents|antiviral agents|mesh-ancestor
43640586|NCT02170090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640587|NCT02170090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640588|NCT02170090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43640589|NCT02170090|Immunologic Factors|immunologic factors|mesh-ancestor
43640590|NCT02170090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640626|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
43640627|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
43640628|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43640629|NCT02120807|Cisplatin|cisplatin|mesh-list
43640630|NCT02120807|Pemetrexed|pemetrexed|mesh-list
43640631|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
43640632|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640633|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640634|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640772|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43640773|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43640774|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
43640775|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43640776|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
43640778|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
43640848|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640849|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640850|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
43640934|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640935|NCT01660971|Antiviral Agents|antiviral agents|mesh-ancestor
43640936|NCT01660971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640937|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641077|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
43641078|NCT01352962|Gemcitabine|gemcitabine|mesh-list
43641079|NCT01352962|Carboplatin|carboplatin|mesh-list
43641080|NCT01352962|Lenalidomide|lenalidomide|mesh-list
43641147|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
43641224|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641225|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
43641297|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43641298|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641299|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
43641300|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641301|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641302|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641317|NCT00862433|Vitamins|vitamins|mesh-list
43641462|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43641463|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641464|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700071|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700074|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700075|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700076|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700077|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
43700078|NCT02733510|Hormones|hormones|mesh-ancestor
43700079|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700080|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43700081|NCT02733510|Protective Agents|protective agents|mesh-ancestor
43700082|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43700083|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700084|NCT02733471|Lidocaine|lidocaine|mesh-list
43700085|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
43700086|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
43700087|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700088|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700089|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
43700090|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700091|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43700092|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43700093|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43700094|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700095|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700109|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43700110|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700112|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700113|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43700126|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700127|NCT02733107|Etoposide|etoposide|mesh-list
43700128|NCT02733107|Apatinib|apatinib|mesh-list
43700129|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43700130|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700131|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43700132|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43700133|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700134|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830488|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830489|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847334|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847335|NCT04115878|Oxybutynin|oxybutynin|mesh-list
43847336|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43847337|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43847338|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43849532|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849533|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
43700311|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
43700312|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
43700313|NCT02732132|Analgesics|analgesics|mesh-ancestor
43700314|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
43700316|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43700524|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700525|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43700527|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43700528|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43700529|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
43700530|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700531|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43700532|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43700533|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700534|NCT02730533|Esomeprazole|esomeprazole|mesh-list
43700535|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43700536|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700537|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43700576|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700577|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43700578|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
43700579|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700580|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700581|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43700582|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43830500|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43830501|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830502|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43700726|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700727|NCT02729935|Parecoxib|parecoxib|mesh-list
43700741|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43700742|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43700743|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43700745|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
43700746|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700747|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700748|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700749|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43700750|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43700751|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700752|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700753|NCT02729441|Ramipril|ramipril|mesh-list
43700754|NCT02729441|Perindopril|perindopril|mesh-list
43700825|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700826|NCT02728518|Amikacin|amikacin|mesh-list
43700827|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43700828|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700829|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
43700852|NCT02728622|Tamoxifen|tamoxifen|mesh-list
43700853|NCT02728622|Paclitaxel|paclitaxel|mesh-list
43700854|NCT02728622|Doxorubicin|doxorubicin|mesh-list
43700855|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43700856|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43700857|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700858|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
43700859|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
43700860|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
43700861|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700862|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43700874|NCT02728687|Mannitol|mannitol|mesh-list
43700966|NCT02727881|Squalamine|squalamine|mesh-list
43700967|NCT02727881|Ranibizumab|ranibizumab|mesh-list
43700968|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43700969|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43700970|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43700971|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43700972|NCT02727881|Growth Substances|growth substances|mesh-ancestor
43700973|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700974|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
43700975|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700976|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43700977|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700978|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43700979|NCT02727881|Protective Agents|protective agents|mesh-ancestor
43700980|NCT02727738|Selenium|selenium|mesh-list
43700981|NCT02727738|Methimazole|methimazole|mesh-list
43700982|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
43700984|NCT02727738|Protective Agents|protective agents|mesh-ancestor
43701048|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701050|NCT02727296|Sevoflurane|sevoflurane|mesh-list
43701051|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43701052|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701053|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701054|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43701055|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
43701056|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
43701057|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43701072|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701075|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
43830603|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830604|NCT05353933|Pantoprazole|pantoprazole|mesh-list
43830605|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43830606|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43830607|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43830608|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830626|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43830627|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
43830628|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
43701262|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701263|NCT02725398|Scopolamine|scopolamine|mesh-list
43701264|NCT02725398|Bromides|bromides|mesh-list
43701390|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701412|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
43701413|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43830645|NCT05351593|Growth Substances|growth substances|mesh-ancestor
43830646|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
43830647|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830648|NCT05351346|Prednisone|prednisone|mesh-list
43830649|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
43830650|NCT05351346|Rituximab|rituximab|mesh-list
43830651|NCT05351346|Doxorubicin|doxorubicin|mesh-list
43830652|NCT05351346|Vincristine|vincristine|mesh-list
43830653|NCT05351346|Lenalidomide|lenalidomide|mesh-list
43701631|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701632|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43701633|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
43701634|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701635|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43701636|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43701637|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43701638|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
43701639|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701640|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701641|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701642|NCT02723279|Urological Agents|urological agents|mesh-ancestor
43701720|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43701721|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43701722|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
43701723|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701724|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701725|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43701726|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43701849|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43701850|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
43701851|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701867|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43701868|NCT02722096|Lidocaine|lidocaine|mesh-list
43701869|NCT02722096|Ropivacaine|ropivacaine|mesh-list
43701870|NCT02722096|Anesthetics|anesthetics|mesh-list
43701871|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
43701872|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701881|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
43701897|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43701898|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701899|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701900|NCT02721420|Piperaquine|piperaquine|mesh-list
43701901|NCT02721420|Artenimol|artenimol|mesh-list
43701902|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
43701903|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43701904|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43701905|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701906|NCT02721368|Lidocaine|lidocaine|mesh-list
43701996|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43702004|NCT02720822|Laxatives|laxatives|mesh-list
43702005|NCT02720822|Cathartics|cathartics|mesh-list
43702006|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43702007|NCT02720822|Narcotics|narcotics|mesh-ancestor
43702008|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702009|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702010|NCT02720822|Analgesics|analgesics|mesh-ancestor
43702011|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
43702012|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702013|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43702014|NCT02720770|Hormones|hormones|mesh-list
43702104|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43702105|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43702106|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702107|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702108|NCT02720367|Gemcitabine|gemcitabine|mesh-list
43702109|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702110|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
43702111|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702112|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702113|NCT02720367|Antiviral Agents|antiviral agents|mesh-ancestor
43702114|NCT02720367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702115|NCT02720367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702116|NCT02720367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702117|NCT02720367|Immunologic Factors|immunologic factors|mesh-ancestor
43702173|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702174|NCT02719418|Tinzaparin|tinzaparin|mesh-list
43702175|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43702176|NCT02719418|Dalteparin|dalteparin|mesh-list
43702177|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
43702178|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43702185|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702186|NCT02719210|Mannitol|mannitol|mesh-list
43702225|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702396|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
43702397|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
43702398|NCT02717871|Mydriatics|mydriatics|mesh-list
43702399|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702400|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
43702401|NCT02717871|Hormones|hormones|mesh-ancestor
43702402|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702403|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702406|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
43702478|NCT02717091|Gemcitabine|gemcitabine|mesh-list
43702574|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702575|NCT02716142|Misoprostol|misoprostol|mesh-list
43702586|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43702587|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702588|NCT02716090|Analgesics|analgesics|mesh-ancestor
43702589|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
43702590|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702591|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702593|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43702682|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43702916|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702917|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43702918|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
43702919|NCT02713841|Insulin|insulin|mesh-list
43702920|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43702921|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
43702922|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43702923|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702924|NCT02713893|Econazole|econazole|mesh-list
43702925|NCT02713893|Benzydamine|benzydamine|mesh-list
43702926|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702927|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
43703013|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703014|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43703015|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
43703016|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703017|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703018|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43703019|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43703052|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703053|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43703054|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43703055|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
43703056|NCT02713074|Povidone|povidone|mesh-list
43703061|NCT02713087|Phenylephrine|phenylephrine|mesh-list
43703124|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703125|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43703126|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
43703127|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
43703128|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
43703129|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43703130|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43703131|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43703166|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703240|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703241|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43703242|NCT02711982|Protective Agents|protective agents|mesh-ancestor
43703243|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43703244|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703245|NCT02711891|Loperamide|loperamide|mesh-list
43703246|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
43703247|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703392|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43703393|NCT02711215|Analgesics|analgesics|mesh-ancestor
43703394|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
43703395|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
43703396|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43703397|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
43703398|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
43703399|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43703400|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43830878|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830879|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830880|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43830881|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
43830883|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43703610|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703611|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703627|NCT02709668|Vitamins|vitamins|mesh-ancestor
43703780|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703781|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703782|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
43703783|NCT02708693|Hormones|hormones|mesh-ancestor
43703784|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43830905|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830906|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43830907|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43830908|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
43830909|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
43830910|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830911|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43830912|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43830913|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830914|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703962|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703963|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43703964|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
43703965|NCT02707328|Antiviral Agents|antiviral agents|mesh-ancestor
43703966|NCT02707328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703967|NCT02707328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703968|NCT02707328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43703969|NCT02707328|Immunologic Factors|immunologic factors|mesh-ancestor
43703970|NCT02707328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703971|NCT02707315|Gemcitabine|gemcitabine|mesh-list
43703972|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43703973|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
43703974|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703975|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703976|NCT02707315|Antiviral Agents|antiviral agents|mesh-ancestor
43703987|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703988|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43703989|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43703990|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
43703991|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
43703992|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703993|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703994|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43704023|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704024|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43704025|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43704026|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704053|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
43704054|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
43704064|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704065|NCT02707016|Sevoflurane|sevoflurane|mesh-list
43704067|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43704143|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
43704144|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43704145|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43704146|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704147|NCT05265442|Methadone|methadone|mesh-list
43704148|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43704149|NCT05265442|Narcotics|narcotics|mesh-ancestor
43704151|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704255|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704256|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704257|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
43704268|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
43704269|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704270|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43704271|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704272|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830933|NCT05335993|Niraparib|niraparib|mesh-list
43704404|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704405|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43704406|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43704407|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43704408|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43704409|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
43704410|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43704411|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43704425|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43704426|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43704441|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43830991|NCT05333549|Istradefylline|istradefylline|mesh-list
43704557|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704558|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
43704559|NCT04678336|Fludarabine|fludarabine|mesh-list
43704560|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704561|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
43704562|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704563|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704564|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43704662|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831006|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831012|NCT05332561|Olaparib|olaparib|mesh-list
43831013|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43831014|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831018|NCT05332067|Omalizumab|omalizumab|mesh-list
43704670|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
43704671|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704672|NCT04470674|Carboplatin|carboplatin|mesh-list
43704673|NCT04470674|Pemetrexed|pemetrexed|mesh-list
43704674|NCT04470674|Durvalumab|durvalumab|mesh-list
43704675|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704676|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704677|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704678|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43704679|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43704680|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704681|NCT04457466|Mitogens|mitogens|mesh-list
43704682|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
43704683|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704684|NCT04393311|Urinastatin|urinastatin|mesh-list
43704685|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43704686|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43704717|NCT04325802|Naltrexone|naltrexone|mesh-list
43704825|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704826|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43704827|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43704828|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43704829|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704830|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43704831|NCT04071119|Oxytocin|oxytocin|mesh-list
43704832|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
43831079|NCT05331573|Apomorphine|apomorphine|mesh-list
43704910|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43704911|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43704912|NCT03792256|Doxorubicin|doxorubicin|mesh-list
43704913|NCT03792256|Methotrexate|methotrexate|mesh-list
43704914|NCT03792256|Vincristine|vincristine|mesh-list
43704915|NCT03792256|Palbociclib|palbociclib|mesh-list
43704916|NCT03792256|Pegaspargase|pegaspargase|mesh-list
43704917|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43704918|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704919|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43704920|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43704921|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704922|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704923|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704924|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
43704925|NCT03792256|Hormones|hormones|mesh-ancestor
43704926|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43704931|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43704932|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43704933|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
43704940|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
43705049|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43705050|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
43705060|NCT03612791|Atezolizumab|atezolizumab|mesh-list
43705225|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43705226|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705227|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
43705323|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705324|NCT05342792|Capecitabine|capecitabine|mesh-list
43705325|NCT05342792|Antibodies|antibodies|mesh-list
43705326|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
43705327|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705377|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705378|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705379|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43705380|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
43705381|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
43705382|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43705386|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705387|NCT05198791|Eplerenone|eplerenone|mesh-list
43705388|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43705389|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
43705390|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705391|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705392|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43705393|NCT05198791|Diuretics|diuretics|mesh-ancestor
43705394|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
43705395|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43705396|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
43705397|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43705398|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705399|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705400|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
43705401|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43705402|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705522|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43705557|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43705558|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705560|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705561|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705562|NCT04409860|Paclitaxel|paclitaxel|mesh-list
43705563|NCT04409860|Cisplatin|cisplatin|mesh-list
43705564|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43705565|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705617|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
43705618|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43705619|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705620|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705621|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43705622|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705623|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43705624|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
43705713|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705806|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705807|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
43705808|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43705809|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705810|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43705811|NCT03670056|Nivolumab|nivolumab|mesh-list
43705812|NCT03670056|Ipilimumab|ipilimumab|mesh-list
43705813|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705814|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705815|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43705816|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705817|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
43705818|NCT03666000|Fludarabine|fludarabine|mesh-list
43705819|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706017|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706018|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
43706019|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43706020|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706021|NCT02480803|Levodopa|levodopa|mesh-list
43706022|NCT02480803|Carbidopa|carbidopa|mesh-list
43706039|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43706040|NCT02415153|Growth Substances|growth substances|mesh-ancestor
43706041|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
43706042|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706043|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
43706044|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706046|NCT02330926|Ibuprofen|ibuprofen|mesh-list
43706103|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706192|NCT02988297|RNS60|rns60|mesh-list
43706254|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43706255|NCT02549170|Antibodies|antibodies|mesh-list
43706256|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
43706257|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
43706258|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43706259|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
43706260|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706261|NCT02494141|Curcumin|curcumin|mesh-list
43706262|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43706263|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706264|NCT02494141|Analgesics|analgesics|mesh-ancestor
43706327|NCT02131493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706442|NCT01029717|Rifampin|rifampin|mesh-list
43706534|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706535|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706536|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
43706537|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706538|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706539|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43706540|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
43706541|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43706542|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43706543|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43706580|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706581|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706749|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43706750|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43706890|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706891|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
43706892|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706893|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43706894|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706895|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706896|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
43706967|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706972|NCT02703571|Trametinib|trametinib|mesh-list
43707125|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707126|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707127|NCT02703090|Analgesics|analgesics|mesh-ancestor
43707128|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
43707129|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707130|NCT02702843|Xenon|xenon|mesh-list
43707131|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43707132|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
43707138|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707139|NCT02702817|Analgesics|analgesics|mesh-ancestor
43707140|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
43707141|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707142|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707143|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707144|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707145|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
43707146|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43707147|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707148|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707149|NCT02702700|Cisplatin|cisplatin|mesh-list
43707150|NCT02702700|Verteporfin|verteporfin|mesh-list
43707151|NCT02702700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707188|NCT02702778|Prednisone|prednisone|mesh-list
43707251|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43707252|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
43707277|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43707278|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707279|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43707280|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707281|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707282|NCT02701608|Levofloxacin|levofloxacin|mesh-list
43707283|NCT02701608|Ofloxacin|ofloxacin|mesh-list
43707284|NCT02701608|Rifampin|rifampin|mesh-list
43707285|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
43707286|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43707292|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707293|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707526|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43707655|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
43707726|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707727|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43707728|NCT02699138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43707729|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43707730|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707731|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707732|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707807|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707808|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
43707809|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707810|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
43707811|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43707812|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43707813|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43707814|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707830|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43707842|NCT02698514|Desflurane|desflurane|mesh-list
43707854|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
43707855|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707922|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
43707923|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707924|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43707925|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707926|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707927|NCT02698098|Methadone|methadone|mesh-list
43707928|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43707929|NCT02698098|Narcotics|narcotics|mesh-ancestor
43707930|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707931|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707932|NCT02698098|Analgesics|analgesics|mesh-ancestor
43707933|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
43707934|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707994|NCT02697851|Estrogens|estrogens|mesh-ancestor
43708070|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708071|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708072|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
43708073|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43708074|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43708075|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43708076|NCT05324618|Tacrolimus|tacrolimus|mesh-list
43708077|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708078|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
43708079|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708080|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43708084|NCT05324592|Aflibercept|aflibercept|mesh-list
43708139|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43708140|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708141|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831393|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43831394|NCT05314621|Analgesics|analgesics|mesh-ancestor
43831395|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
43831406|NCT05314101|Bevacizumab|bevacizumab|mesh-list
43831407|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43831408|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708231|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708232|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43831447|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831448|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831449|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
43831450|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708351|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708352|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
43708353|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
43708354|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
43708355|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708356|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
43708357|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43708358|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708473|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708474|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708475|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
43708476|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708477|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
43708478|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708479|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
43831455|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831456|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43831457|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43708598|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43708599|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43708600|NCT04430894|Dexamethasone|dexamethasone|mesh-list
43708601|NCT04430894|Lenalidomide|lenalidomide|mesh-list
43708602|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708603|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
43708604|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
43708605|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708607|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43708721|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43708722|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43708723|NCT04309552|Alovudine|alovudine|mesh-list
43708724|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
43708741|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
43708742|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708743|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708744|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
43708745|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
43708746|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708748|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43708831|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43708832|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43708833|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708834|NCT03915496|Abrocitinib|abrocitinib|mesh-list
43708835|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43708836|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708837|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708932|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708933|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
43708934|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708935|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43708936|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708937|NCT03535116|Ketorolac|ketorolac|mesh-list
43708938|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43709014|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709015|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709016|NCT02641873|Leucovorin|leucovorin|mesh-list
43709017|NCT02641873|Bevacizumab|bevacizumab|mesh-list
43709018|NCT02641873|Irinotecan|irinotecan|mesh-list
43709019|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
43709020|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43709021|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709022|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43709023|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43709024|NCT02641873|Growth Substances|growth substances|mesh-ancestor
43831509|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43831510|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831511|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831512|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831513|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831514|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
43831515|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43831516|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43831517|NCT05306548|Triamcinolone|triamcinolone|mesh-list
43831518|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43831519|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43831534|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
43831535|NCT05306470|Lidocaine|lidocaine|mesh-list
43831536|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
43831537|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
43831538|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
43709237|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709238|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43709239|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
43709240|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709241|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43709242|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43709243|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709244|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43709245|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43709246|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43709358|NCT00411138|Paclitaxel|paclitaxel|mesh-list
43709385|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43709386|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43709387|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43709388|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43709389|NCT02697331|Progesterone|progesterone|mesh-list
43709390|NCT02697331|Progestins|progestins|mesh-ancestor
43709391|NCT02697331|Hormones|hormones|mesh-ancestor
43709397|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
43709515|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709516|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
43709517|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43709518|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
43709519|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709520|NCT05368051|Capecitabine|capecitabine|mesh-list
43709522|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43709523|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
43709638|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43709639|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43709640|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709641|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709642|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709643|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43709644|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43709721|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43709722|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
43709723|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
43709724|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709725|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43709726|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43709727|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709728|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709729|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
43709920|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43709921|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709922|NCT04697485|Eplerenone|eplerenone|mesh-list
43709937|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43709938|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
43709939|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43709940|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709941|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
43709963|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709966|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
43710061|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710062|NCT04324229|Liraglutide|liraglutide|mesh-list
43710063|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43710064|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710065|NCT04324229|Incretins|incretins|mesh-ancestor
43710066|NCT04324229|Hormones|hormones|mesh-ancestor
43710067|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710068|NCT04321746|Ketamine|ketamine|mesh-list
43710069|NCT04321746|Analgesics|analgesics|mesh-ancestor
43710151|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710152|NCT03983018|Rituximab|rituximab|mesh-list
43710153|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710202|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43710408|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
43710409|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710410|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710411|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710412|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710413|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43710463|NCT02696720|Lidocaine|lidocaine|mesh-list
43644334|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644593|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644594|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641451|NCT00018044|Clofazimine|clofazimine|mesh-list
43644596|NCT04543071|Antiviral Agents|antiviral agents|mesh-ancestor
43644622|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43644623|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644624|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43644625|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
43644626|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43644646|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43644647|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
43644648|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644649|NCT04479657|Cefuroxime|cefuroxime|mesh-list
43644658|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644659|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644660|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43644661|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
43644662|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644663|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644664|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43823940|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644685|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43644686|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43644687|NCT04449861|Durvalumab|durvalumab|mesh-list
43644688|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644689|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644690|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
43644691|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43823941|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
43644700|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43644701|NCT04446039|Sertraline|sertraline|mesh-list
43644702|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43823942|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644705|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43846370|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43846371|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
43644707|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644708|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849042|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43644715|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43644718|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43849044|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644720|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43644722|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
43644725|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644729|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43644731|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
43644732|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
43644733|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43644735|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43644736|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
43644737|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43644738|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43644740|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
43644741|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
43644743|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644746|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43644747|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43644750|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644751|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
43644752|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43644753|NCT04434326|Vorolanib|vorolanib|mesh-list
43644754|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43644755|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849581|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43644762|NCT04431258|Folfirinox|folfirinox|mesh-list
43644765|NCT04430452|Ipilimumab|ipilimumab|mesh-list
43644766|NCT04430452|Tremelimumab|tremelimumab|mesh-list
43644767|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
43644768|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43644769|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
43644770|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644772|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
43644773|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644774|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43644775|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644776|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43644777|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
43644778|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644779|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
43644788|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644791|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644792|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43598268|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
43598269|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
43598270|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
43598271|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
43598272|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598273|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598274|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43598275|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
43598276|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43849155|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
43598559|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598896|NCT03295760|Vitamins|vitamins|mesh-ancestor
43599277|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
43599480|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599594|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43599722|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600547|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601065|NCT03267771|Hormones|hormones|mesh-ancestor
43601295|NCT03265795|Ether|ether|mesh-list
43601389|NCT03264625|Vitamin D|vitamin d|mesh-list
43601645|NCT03262727|Estradiol|estradiol|mesh-list
43602035|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
43602229|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602784|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603012|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603662|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603978|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604112|NCT03239860|Antibodies|antibodies|mesh-list
43604259|NCT03238482|Xhance|xhance|mesh-list
43604517|NCT03236610|Tenofovir|tenofovir|mesh-list
43605762|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43606578|NCT03211065|Antibodies|antibodies|mesh-list
43606797|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43607308|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607526|NCT03202186|Hormones|hormones|mesh-ancestor
43607680|NCT03200691|Antibodies|antibodies|mesh-list
43607948|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608113|NCT03197779|Aspirin|aspirin|mesh-list
43608234|NCT03197493|Levodopa|levodopa|mesh-list
43608340|NCT03196934|Cannabidiol|cannabidiol|mesh-list
43608366|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43608367|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
43608368|NCT03196817|Lidocaine|lidocaine|mesh-list
43608369|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43608370|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
43608371|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
43608372|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608993|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609136|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609403|NCT03188445|Vitamins|vitamins|mesh-ancestor
43609573|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43609910|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
43610084|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
43610235|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
43610400|NCT03180346|Laxatives|laxatives|mesh-ancestor
43610522|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610847|NCT03176628|Vitamins|vitamins|mesh-ancestor
43610973|NCT03175666|Vitamins|vitamins|mesh-ancestor
43611130|NCT03174236|Metronidazole|metronidazole|mesh-list
43611369|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611542|NCT03171610|Sufentanil|sufentanil|mesh-list
43611576|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
43611690|NCT03170050|Lidocaine|lidocaine|mesh-list
43611797|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43611944|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612084|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612085|NCT03168100|Dexamethasone|dexamethasone|mesh-list
43612359|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613064|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613065|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43613066|NCT05676294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43613067|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43613068|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43613196|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43613295|NCT05674877|Narcotics|narcotics|mesh-ancestor
43613470|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613741|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614051|NCT04483960|Nafamostat|nafamostat|mesh-list
43615155|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615595|NCT03147638|Warfarin|warfarin|mesh-list
43615845|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43616136|NCT04762459|Cisplatin|cisplatin|mesh-list
43616266|NCT04469959|Levodopa|levodopa|mesh-list
43616733|NCT03144778|Durvalumab|durvalumab|mesh-list
43616825|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617778|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43618240|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618802|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43618923|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619110|NCT03126097|Estrogens|estrogens|mesh-ancestor
43619912|NCT05464745|Perindopril|perindopril|mesh-list
43620223|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620389|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620667|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43621010|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43621233|NCT03117595|Fentanyl|fentanyl|mesh-list
43621477|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621609|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
43621748|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43621885|NCT03112382|Vitamins|vitamins|mesh-list
43622140|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622270|NCT03109379|Trospium chloride|trospium chloride|mesh-list
43622543|NCT03107702|Melatonin|melatonin|mesh-list
43622933|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623405|NCT04591626|Dulaglutide|dulaglutide|mesh-list
43623524|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43623713|NCT03994731|Hormones|hormones|mesh-ancestor
43623843|NCT03576716|Calcifediol|calcifediol|mesh-list
43624402|NCT04745351|Remdesivir|remdesivir|mesh-list
43625280|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43625724|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43626365|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626455|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
43626532|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43626791|NCT03081949|Trace Elements|trace elements|mesh-ancestor
43627175|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627325|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760791|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761035|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43761058|NCT02441673|Ephedrine|ephedrine|mesh-list
43761120|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43761121|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43761122|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
43761123|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43761124|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43761125|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43761127|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43761128|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43761129|NCT02441816|Growth Substances|growth substances|mesh-ancestor
43761131|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
43565675|NCT00872885|Morphine|morphine|mesh-list
43761277|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
43761353|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43761448|NCT02438852|Ropivacaine|ropivacaine|mesh-list
43761519|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761721|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761722|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761723|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837485|NCT04905446|Niacin|niacin|mesh-list
43761842|NCT02435771|Vitamins|vitamins|mesh-ancestor
43761943|NCT02434952|Piperaquine|piperaquine|mesh-list
43762020|NCT02433847|Mosapride|mosapride|mesh-list
43762174|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43762184|NCT02433730|Testosterone|testosterone|mesh-list
43762220|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43762221|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
43762222|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43762223|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43762224|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762225|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43762226|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43762227|NCT02433184|Analgesics|analgesics|mesh-ancestor
43762228|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
43762231|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43762232|NCT02432885|Enalapril|enalapril|mesh-list
43762233|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43762234|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
43762238|NCT02432911|Cytarabine|cytarabine|mesh-list
43762306|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762307|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43762308|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43762309|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43762310|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762311|NCT02432781|Insulin|insulin|mesh-list
43762312|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43762314|NCT02432599|Choline|choline|mesh-list
43762447|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43762725|NCT02429921|Selenium|selenium|mesh-list
43762813|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43763013|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43763147|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763148|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763149|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
43763150|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763151|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43763152|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43763153|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
43763154|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43763155|NCT02428283|Narcotics|narcotics|mesh-ancestor
43763156|NCT02428283|Analgesics|analgesics|mesh-ancestor
43763157|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43763158|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
43567831|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43763181|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
43763226|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43763366|NCT02426619|Fluorides|fluorides|mesh-list
43763465|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43763466|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43763641|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763645|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
43763886|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764092|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43764093|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764094|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
43764095|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
43764096|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
43764097|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764098|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43764099|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
43764100|NCT02422706|Metronidazole|metronidazole|mesh-list
43764101|NCT02422706|Clarithromycin|clarithromycin|mesh-list
43764102|NCT02422706|Levofloxacin|levofloxacin|mesh-list
43764103|NCT02422706|Ofloxacin|ofloxacin|mesh-list
43764104|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
43764192|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43764193|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43764194|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
43764195|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764196|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43764197|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43837712|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837713|NCT04892693|Talazoparib|talazoparib|mesh-list
43837714|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43837715|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764202|NCT02421913|Ketamine|ketamine|mesh-list
43764203|NCT02421913|Analgesics|analgesics|mesh-ancestor
43764209|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
43764374|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764447|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764522|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43764523|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
43764524|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764525|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764526|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43764527|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764528|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43764529|NCT02419261|Analgesics|analgesics|mesh-list
43764530|NCT02419261|Ropivacaine|ropivacaine|mesh-list
43764531|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
43764599|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764600|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43764601|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43764602|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
43764603|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
43764604|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43764605|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43764606|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43764607|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764608|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764609|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43764610|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43764611|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43764612|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
43764613|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764614|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43764615|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43837747|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43765006|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765010|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765011|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43765012|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765013|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
43765014|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
43765015|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765097|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43765098|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43765099|NCT02415335|Dexamethasone|dexamethasone|mesh-list
43765100|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
43765101|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43765102|NCT02415335|BB 1101|bb 1101|mesh-list
43765103|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765104|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
43765105|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
43765106|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765107|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765108|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43765109|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
43765110|NCT02415335|Hormones|hormones|mesh-ancestor
43765113|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765118|NCT02415270|Nicotine|nicotine|mesh-list
43837769|NCT04887506|Prednisone|prednisone|mesh-list
43765413|NCT02413853|Leucovorin|leucovorin|mesh-list
43765520|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765522|NCT02412813|Trace Elements|trace elements|mesh-ancestor
43765523|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
43765524|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765525|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
43765527|NCT02412566|SMOFlipid|smoflipid|mesh-list
43765542|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765544|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765545|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43765546|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765547|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43765548|NCT02412449|Glycine|glycine|mesh-list
43765549|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
43765550|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765551|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765552|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765553|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
43765554|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765555|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
43765556|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765557|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43765558|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43765559|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
43765560|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570532|NCT00401011|Bortezomib|bortezomib|mesh-list
43765581|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
43765582|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43765583|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
43765584|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43765585|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
43765586|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765587|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
43765886|NCT02410655|Oxytocin|oxytocin|mesh-list
43765940|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
43766034|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43766035|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43766036|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
43766037|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766038|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766039|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766040|NCT02410135|Urological Agents|urological agents|mesh-ancestor
43766041|NCT02409849|Octreotide|octreotide|mesh-list
43766042|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766043|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766050|NCT02409862|Oxytocin|oxytocin|mesh-list
43766120|NCT02409199|Docetaxel|docetaxel|mesh-list
43766444|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766445|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
43766446|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766447|NCT02407548|Protective Agents|protective agents|mesh-ancestor
43766448|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
43766449|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43766450|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766451|NCT02407210|Olmesartan|olmesartan|mesh-list
43766452|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43766453|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43766454|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43766455|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43766456|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43766470|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766471|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766472|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43766473|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766474|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
43766511|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766512|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43766513|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
43766514|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
43766515|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
43766516|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
43766539|NCT02406690|Leuprolide|leuprolide|mesh-list
43766650|NCT02406066|Oxazepam|oxazepam|mesh-list
43766784|NCT02405364|Hormones|hormones|mesh-ancestor
43766890|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
43766974|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
43767103|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43767104|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43767105|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
43767106|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
43767107|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
43767108|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43767109|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43767113|NCT02403713|Fluticasone|fluticasone|mesh-list
43767165|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767302|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43767577|NCT02400645|Analgesics|analgesics|mesh-ancestor
43767682|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
43767702|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767703|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767704|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767705|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
43767706|NCT02400047|Hormones|hormones|mesh-ancestor
43767707|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767708|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43767709|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767710|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
43767711|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767712|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767713|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43767720|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43767721|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43767722|NCT02399800|Bupivacaine|bupivacaine|mesh-list
43767723|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43767724|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
43767725|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
43767726|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767727|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767728|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
43767729|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767730|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767732|NCT02399800|Hormones|hormones|mesh-ancestor
43767733|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767922|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767923|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767924|NCT02398552|Sunitinib|sunitinib|mesh-list
43767925|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767926|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43767927|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43767928|NCT02398552|Growth Substances|growth substances|mesh-ancestor
43767929|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767930|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
43767931|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43767932|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767933|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767937|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43767938|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767940|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43768192|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768193|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
43768194|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43768195|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43768196|NCT02396888|Insulin|insulin|mesh-list
43768197|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43768198|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768199|NCT02396563|Ropivacaine|ropivacaine|mesh-list
43768200|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
43768201|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
43768202|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768203|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768204|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
43768205|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768207|NCT02396862|Coagulants|coagulants|mesh-ancestor
43768208|NCT02396225|Voriconazole|voriconazole|mesh-list
43768209|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
43768280|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43768281|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
43768282|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
43768283|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768284|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768285|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
43768286|NCT02396043|Hormones|hormones|mesh-ancestor
43768287|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43768288|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43768289|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768290|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43768291|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
43768292|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768294|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
43768341|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43768342|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43768343|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768344|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43768345|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768346|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768347|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43768348|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43768350|NCT02395510|Vortioxetine|vortioxetine|mesh-list
43768366|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43768367|NCT02395237|Glimepiride|glimepiride|mesh-list
43768368|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43768369|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43768370|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768444|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43768445|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768458|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768459|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768460|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43768461|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43768462|NCT02394145|Clopidogrel|clopidogrel|mesh-list
43768463|NCT02394145|Ticagrelor|ticagrelor|mesh-list
43768464|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43768465|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43768466|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43768467|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43768468|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
43768469|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768472|NCT02394158|Metformin|metformin|mesh-list
43838098|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
43838099|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838101|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43838102|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838103|NCT04871594|Nivolumab|nivolumab|mesh-list
43838104|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838105|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838106|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43838107|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838108|NCT04871204|Octreotide|octreotide|mesh-list
43838109|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43838110|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43838111|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838112|NCT04870866|Niacinamide|niacinamide|mesh-list
43768558|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43768559|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768560|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768561|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43768562|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
43768569|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43768570|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
43768571|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768572|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
43768573|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43768574|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43768575|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768763|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768764|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768765|NCT02392793|Irinotecan|irinotecan|mesh-list
43768766|NCT02392793|Temozolomide|temozolomide|mesh-list
43768767|NCT02392793|Talazoparib|talazoparib|mesh-list
43768768|NCT02392793|Lenograstim|lenograstim|mesh-list
43768769|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43768770|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43768771|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768773|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768970|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43768971|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768972|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43768973|NCT02390921|Hematinics|hematinics|mesh-ancestor
43768974|NCT02390882|Tamsulosin|tamsulosin|mesh-list
43768975|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43768976|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43768977|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43768978|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
43769065|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
43769157|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769158|NCT02389582|Enoxaparin|enoxaparin|mesh-list
43769159|NCT02389582|Dabigatran|dabigatran|mesh-list
43769169|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43769170|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
43769171|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43769172|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769173|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43769174|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
43769175|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769176|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769177|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
43769178|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769179|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43769180|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769181|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
43769182|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769183|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43769184|NCT02389439|Artesunate|artesunate|mesh-list
43769185|NCT02389439|Pyronaridine|pyronaridine|mesh-list
43769186|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
43769187|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43769188|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43769286|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769300|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43769301|NCT02388061|Plasminogen|plasminogen|mesh-list
43769302|NCT02388061|Tenecteplase|tenecteplase|mesh-list
43769303|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43769304|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43769305|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769306|NCT02388035|Cefotaxime|cefotaxime|mesh-list
43769307|NCT02388035|Cefoxitin|cefoxitin|mesh-list
43769308|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43769309|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769310|NCT02387892|Vitamin D|vitamin d|mesh-list
43769311|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
43769312|NCT02387892|Vitamins|vitamins|mesh-ancestor
43769380|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769381|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43769382|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43769383|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43769384|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43769385|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43769386|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43769388|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
43769389|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43769390|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43769394|NCT02387086|Aspirin|aspirin|mesh-list
43574865|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
43769522|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
43769523|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769524|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769525|NCT02386449|Mannitol|mannitol|mesh-list
43769526|NCT02386449|Bisacodyl|bisacodyl|mesh-list
43769527|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
43769528|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
43769529|NCT02386449|Citric Acid|citric acid|mesh-list
43769530|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
43769531|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43769532|NCT02386449|Diuretics|diuretics|mesh-ancestor
43769533|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
43769547|NCT02386293|Irbesartan|irbesartan|mesh-list
43769635|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43769636|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43769637|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43769638|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
43769639|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769640|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769641|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769642|NCT02386072|Urological Agents|urological agents|mesh-ancestor
43769643|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
43769644|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
43769668|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
43769827|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769908|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43769910|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
43769911|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769912|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43769913|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43769917|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769918|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43769920|NCT02384499|Coagulants|coagulants|mesh-ancestor
43769928|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
43770013|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770014|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770015|NCT02383212|Paclitaxel|paclitaxel|mesh-list
43770016|NCT02383212|Docetaxel|docetaxel|mesh-list
43770113|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770114|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
43770115|NCT02382328|Vitamins|vitamins|mesh-ancestor
43770116|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
43770117|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
43770118|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43770119|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43770120|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43770121|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
43770122|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770123|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770124|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770125|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43770126|NCT02382523|Hormones|hormones|mesh-ancestor
43770127|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770128|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770129|NCT02382432|Meperidine|meperidine|mesh-list
43770130|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
43770131|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43770132|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770133|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770134|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43770135|NCT02382432|Analgesics|analgesics|mesh-ancestor
43770136|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
43770137|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770138|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43770140|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43770150|NCT02382146|BB 1101|bb 1101|mesh-list
43770151|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770152|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
43770153|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
43770154|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770247|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770248|NCT02381314|Ipilimumab|ipilimumab|mesh-list
43770249|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43770250|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770251|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43838274|NCT04856215|Antibodies|antibodies|mesh-list
43770509|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43770626|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770636|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43770637|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
43770638|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770639|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770640|NCT02378532|Amebicides|amebicides|mesh-ancestor
43770641|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43838332|NCT04848220|APD791|apd791|mesh-list
43770642|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43838353|NCT04845217|Peppermint oil|peppermint oil|mesh-list
43770772|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43770773|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770774|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43770775|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43770776|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43770777|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
43770778|NCT02376881|Hematinics|hematinics|mesh-ancestor
43770779|NCT02376985|Everolimus|everolimus|mesh-list
43770780|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770781|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770782|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
43770783|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770784|NCT02376803|Warfarin|warfarin|mesh-list
43770785|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
43770786|NCT02376478|Folic Acid|folic acid|mesh-list
43770787|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
43770788|NCT02376478|Adalimumab|adalimumab|mesh-list
43576432|NCT03498963|Dimercaprol|dimercaprol|mesh-list
43848036|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
43770860|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770861|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770862|NCT02376296|Docetaxel|docetaxel|mesh-list
43770863|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770864|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
43770865|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
43770866|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
43838407|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43770932|NCT02376075|Hormones|hormones|mesh-ancestor
43838416|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43838417|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43838418|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43838419|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43838420|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43838421|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43838422|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
43838425|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
43838426|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771214|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43771215|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
43771216|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
43771217|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
43771218|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
43771219|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771220|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771221|NCT02374567|Analgesics|analgesics|mesh-ancestor
43771222|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
43771223|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771224|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
43771225|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43771311|NCT02374008|Dexamethasone|dexamethasone|mesh-list
43576902|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43771312|NCT02374008|Ketorolac|ketorolac|mesh-list
43771314|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771315|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
43771316|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
43771317|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771318|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771431|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43771432|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771433|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771434|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43771435|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771436|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771437|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43771438|NCT02373254|Narcotics|narcotics|mesh-ancestor
43771439|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838450|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771648|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771649|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771747|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771748|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43771749|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43771750|NCT02371590|Growth Substances|growth substances|mesh-ancestor
43771820|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43771824|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43771825|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43771826|NCT02370680|Analgesics|analgesics|mesh-ancestor
43771827|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
43771828|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771829|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771830|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771835|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43771838|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
43771899|NCT02369978|Benzonidazole|benzonidazole|mesh-list
43771900|NCT02369978|Nifurtimox|nifurtimox|mesh-list
43771901|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43771902|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
43771903|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771904|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43771905|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43771906|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43771907|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771908|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43771909|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
43771910|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43771911|NCT02369965|Ritonavir|ritonavir|mesh-list
43771912|NCT02369965|Lopinavir|lopinavir|mesh-list
43771913|NCT02369965|Tenofovir|tenofovir|mesh-list
43771924|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43771925|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43771926|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43771927|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43771929|NCT02369939|Mitomycins|mitomycins|mesh-list
43771930|NCT02369939|Mitomycin|mitomycin|mesh-list
43771931|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
43772035|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43772036|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
43772037|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43772038|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772039|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43772040|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43772041|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772042|NCT02368795|Indomethacin|indomethacin|mesh-list
43772254|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772255|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
43772256|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43772257|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43577899|NCT03485482|Bisoprolol|bisoprolol|mesh-list
43772258|NCT02367560|Prednisolone|prednisolone|mesh-list
43772259|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
43772260|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43772420|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772421|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43772422|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43772423|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43772424|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
43772425|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772426|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772590|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43772591|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772592|NCT02365402|Entecavir|entecavir|mesh-list
43772593|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
43772594|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772595|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
43772596|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772597|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43772598|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772599|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838574|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43838575|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43838582|NCT04834310|Clindamycin|clindamycin|mesh-list
43772994|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772997|NCT02362165|Hormones|hormones|mesh-ancestor
43773031|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
43773032|NCT02361879|Leuprolide|leuprolide|mesh-list
43773033|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
43773034|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43773035|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
43773036|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773037|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773038|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43773039|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773040|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43773041|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
43773174|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773222|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
43773223|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
43773224|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43773225|NCT02360982|Narcotics|narcotics|mesh-ancestor
43773226|NCT02360982|Analgesics|analgesics|mesh-ancestor
43773227|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
43773229|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43773420|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773421|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43773422|NCT02359266|Vitamin D|vitamin d|mesh-list
43773423|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
43773424|NCT02359266|Vitamins|vitamins|mesh-ancestor
43773425|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
43773426|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773432|NCT02359500|Octreotide|octreotide|mesh-list
43773462|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43773463|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773464|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773465|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773466|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43579218|NCT03473210|Ampicillin|ampicillin|mesh-list
43773467|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43773468|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43773470|NCT02358850|Acetaminophen|acetaminophen|mesh-list
43773471|NCT02358850|Oxycodone|oxycodone|mesh-list
43773472|NCT02358850|Hydromorphone|hydromorphone|mesh-list
43773473|NCT02358850|Hydrocodone|hydrocodone|mesh-list
43773475|NCT02358850|Analgesics|analgesics|mesh-ancestor
43773596|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773598|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773644|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773645|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
43773646|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
43773647|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
43773648|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848069|NCT04053712|Glucagon|glucagon|mesh-list
43773700|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773701|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773702|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773703|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43773704|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773706|NCT02357732|Nivolumab|nivolumab|mesh-list
43773712|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773713|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43773714|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773800|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773801|NCT02357212|Adenosine|adenosine|mesh-list
43773802|NCT02357212|Analgesics|analgesics|mesh-ancestor
43773803|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
43773813|NCT02357004|Carvedilol|carvedilol|mesh-list
43773814|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
43773815|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43773816|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43773817|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
43773818|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773822|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
43773955|NCT02355678|Hormones|hormones|mesh-ancestor
43773956|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773957|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43773958|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773959|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773960|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43773961|NCT02355678|Analgesics|analgesics|mesh-ancestor
43773962|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
43773963|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
43773964|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43773965|NCT02355678|Narcotics|narcotics|mesh-ancestor
43773966|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43773967|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773976|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773977|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773978|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
43773979|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773980|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43773981|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43774170|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774171|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43774172|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43774173|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774212|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43774213|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
43774214|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774215|NCT02353936|Afatinib|afatinib|mesh-list
43774216|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774217|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43774234|NCT02353702|Ropivacaine|ropivacaine|mesh-list
43774331|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
43774332|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774333|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774334|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774335|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43774336|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43774337|NCT02353078|Sucralfate|sucralfate|mesh-list
43774338|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43774339|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774340|NCT02353026|Artesunate|artesunate|mesh-list
43774423|NCT02352701|Renal Agents|renal agents|mesh-ancestor
43774606|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774607|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774608|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774610|NCT02351622|Hormones|hormones|mesh-ancestor
43774611|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774612|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43774919|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774920|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774923|NCT02349828|Acyclovir|acyclovir|mesh-list
43774925|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774926|NCT02349490|Hemostatics|hemostatics|mesh-list
43774927|NCT02349490|Coagulants|coagulants|mesh-ancestor
43774928|NCT02349516|Squalamine|squalamine|mesh-list
43774929|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43774930|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43774931|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43774932|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774933|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43774934|NCT02349516|Protective Agents|protective agents|mesh-ancestor
43774935|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774946|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43775007|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43775008|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775009|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775010|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
43775011|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
43775012|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775013|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775014|NCT02349165|Riboflavin|riboflavin|mesh-list
43775016|NCT02349165|Vitamins|vitamins|mesh-ancestor
43775156|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43775157|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43775158|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
43775159|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775160|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
43775161|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
43775252|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775367|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775368|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775369|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43775370|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
43775371|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43775372|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43775373|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43775374|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43775376|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43775377|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
43775379|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775440|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43775441|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
43775442|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775443|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775444|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43775445|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
43775446|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
43775447|NCT02345616|Protective Agents|protective agents|mesh-ancestor
43775448|NCT02345681|Furosemide|furosemide|mesh-list
43775449|NCT02345681|Diuretics|diuretics|mesh-ancestor
43775450|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
43775451|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43581524|NCT03454945|Doxycycline|doxycycline|mesh-list
43775506|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43775507|NCT02345044|Eplerenone|eplerenone|mesh-list
43848087|NCT04051320|Estrogens|estrogens|mesh-ancestor
43775508|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43775772|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775773|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775774|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
43775775|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775776|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775777|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
43775778|NCT02343432|Hormones|hormones|mesh-ancestor
43775780|NCT02343484|Ethanol|ethanol|mesh-list
43775868|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43775894|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775895|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43775896|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43775897|NCT02342717|Itraconazole|itraconazole|mesh-list
43775898|NCT02342717|BI 425809|bi 425809|mesh-list
43775899|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
43775900|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775901|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43775902|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43775903|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776279|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43776280|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43776281|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43776282|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43776283|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43776310|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
43776311|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43776312|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43776313|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43776314|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
43776315|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
43776316|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776317|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776318|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776319|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43776320|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43776321|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776322|NCT02339753|Carboplatin|carboplatin|mesh-list
43776323|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776324|NCT02339662|Gabapentin|gabapentin|mesh-list
43776380|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43776381|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
43776382|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
43776383|NCT02339441|Methotrexate|methotrexate|mesh-list
43776384|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776385|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
43776386|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776387|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776388|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43776389|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
43776390|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776391|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776468|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43776470|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
43776565|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776566|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776625|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776739|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43776740|NCT02336477|Mexiletine|mexiletine|mesh-list
43776741|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43776742|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43776743|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43776782|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43776783|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
43776784|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776785|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776788|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
43776876|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776877|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43776878|NCT02335372|Protective Agents|protective agents|mesh-ancestor
43776879|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776880|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43776881|NCT02335255|Naftifine|naftifine|mesh-list
43776882|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
43776883|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776884|NCT02335151|Desflurane|desflurane|mesh-list
43776885|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43776886|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
43776887|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
43776888|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776889|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776930|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776931|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43776932|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
43776933|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43776934|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43776935|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43776983|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
43777216|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777217|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
43777218|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43777219|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43777220|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777221|NCT02333188|Antidotes|antidotes|mesh-ancestor
43777222|NCT02333188|Protective Agents|protective agents|mesh-ancestor
43777223|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
43777224|NCT02333188|Vitamins|vitamins|mesh-ancestor
43777225|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
43777226|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
43838937|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43838938|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
43838939|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43838944|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838945|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43777646|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43777647|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777648|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43777649|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43777650|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
43777651|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43777652|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
43777653|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43777654|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777659|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43777660|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777661|NCT02330640|Clopidogrel|clopidogrel|mesh-list
43777662|NCT02330640|Ticagrelor|ticagrelor|mesh-list
43777663|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43777785|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777916|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777917|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777918|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777919|NCT02328794|Varenicline|varenicline|mesh-list
43777920|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43777921|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43777922|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
43777923|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778075|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778076|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43778077|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43778078|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778079|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778080|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43778081|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43778083|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
43778124|NCT02327793|Labetalol|labetalol|mesh-list
43778251|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43778252|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778253|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778254|NCT02327299|Fesoterodine|fesoterodine|mesh-list
43778255|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43778256|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43778257|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
43778258|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778259|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778260|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778261|NCT02327299|Urological Agents|urological agents|mesh-ancestor
43778327|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
43778426|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43778427|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778428|NCT02326623|Anesthetics|anesthetics|mesh-list
43778429|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
43778430|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778431|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778432|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
43778433|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778434|NCT02326610|Hormones|hormones|mesh-list
43778436|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778465|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43584856|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778577|NCT05076461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43778578|NCT05076019|Atorvastatin|atorvastatin|mesh-list
43778579|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43778580|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43778581|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
43778692|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778693|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43778694|NCT04102241|Hemay005|hemay005|mesh-list
43778695|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
43778696|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43778697|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43778698|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778699|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778700|NCT04083014|Bortezomib|bortezomib|mesh-list
43778701|NCT04083014|Antibodies|antibodies|mesh-list
43778702|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
43778703|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778704|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778705|NCT04026945|Lidocaine|lidocaine|mesh-list
43778706|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
43778707|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
43778710|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
43778773|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778774|NCT02823990|Analgesics|analgesics|mesh-ancestor
43778775|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
43778776|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778777|NCT02624128|Cisplatin|cisplatin|mesh-list
43778778|NCT02624128|Cetuximab|cetuximab|mesh-list
43778779|NCT02624128|Valproic Acid|valproic acid|mesh-list
43778780|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778781|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43778782|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
43779002|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43779003|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779004|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779005|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43779006|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
43779007|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43779008|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779111|NCT04925427|Naloxone|naloxone|mesh-list
43779187|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43779188|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
43779189|NCT04662723|Hormones|hormones|mesh-ancestor
43779190|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43779191|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43779192|NCT04662723|Protective Agents|protective agents|mesh-ancestor
43779193|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43779194|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779195|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779196|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43779197|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43779198|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43779199|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43779200|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43779201|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43779328|NCT03971474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779329|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
43779330|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
43779331|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
43779332|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43779334|NCT03968562|Doxycycline|doxycycline|mesh-list
43779375|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779376|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43779377|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43779532|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43779533|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
43779534|NCT03252626|Urological Agents|urological agents|mesh-ancestor
43779568|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43779569|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779570|NCT02951013|Analgesics|analgesics|mesh-ancestor
43779571|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
43779572|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779573|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779574|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779575|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779577|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43779578|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779658|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779750|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43779751|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779752|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779753|NCT04571697|Methotrexate|methotrexate|mesh-list
43779754|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43779755|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
43779756|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43779757|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779758|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43779759|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
43779761|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779782|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43779783|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
43779845|NCT03778671|Fentanyl|fentanyl|mesh-list
43779848|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43779849|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779850|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779851|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779852|NCT03778671|Analgesics|analgesics|mesh-ancestor
43779853|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
43779854|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780131|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780132|NCT05049902|Expectorants|expectorants|mesh-ancestor
43780133|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
43780135|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43780136|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43780137|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
43780138|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780139|NCT05048069|Protective Agents|protective agents|mesh-ancestor
43780140|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780141|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780142|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
43780143|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43780145|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43780265|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43780266|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
43780267|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43780268|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43780269|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43780270|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43780271|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780272|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780273|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43780274|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43780298|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
43780299|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780300|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43780301|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43780302|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43780410|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43780411|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43780412|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
43780413|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780414|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43780416|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
43780417|NCT05318157|Emedastine|emedastine|mesh-list
43839339|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43839418|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43839419|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43839420|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43839421|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839422|NCT04776369|Analgesics|analgesics|mesh-ancestor
43839423|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
43780571|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43780572|NCT04534257|Sirolimus|sirolimus|mesh-list
43780573|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43839460|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839461|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848173|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43848174|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43848175|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848176|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848177|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43848178|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
43848180|NCT04044131|Cathartics|cathartics|mesh-ancestor
43848182|NCT04044001|Isoniazid|isoniazid|mesh-list
43780753|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43780754|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780755|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780756|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43780757|NCT03355534|Analgesics|analgesics|mesh-ancestor
43780758|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
43780759|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780760|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43780761|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43780762|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43780763|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
43780764|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780765|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780848|NCT02624596|Midazolam|midazolam|mesh-list
43781009|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781010|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781011|NCT04447118|Docetaxel|docetaxel|mesh-list
43781012|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781013|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781014|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781015|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781016|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781017|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
43781018|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43781019|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839462|NCT04771130|Posaconazole|posaconazole|mesh-list
43839463|NCT04771130|Azacitidine|azacitidine|mesh-list
43839464|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43839465|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
43781020|NCT04406415|Nafamostat|nafamostat|mesh-list
43781108|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43781109|NCT03227263|Growth Substances|growth substances|mesh-ancestor
43781110|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781111|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
43781112|NCT03147378|Docetaxel|docetaxel|mesh-list
43781113|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781114|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781115|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781116|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781117|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781118|NCT03136640|Docetaxel|docetaxel|mesh-list
43781119|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781120|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781281|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43781397|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781398|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43781399|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
43781400|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781401|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781402|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43781403|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43781404|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43781405|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43781406|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
43781408|NCT05008510|Camptothecin|camptothecin|mesh-list
43781467|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781517|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43781518|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43781519|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43781520|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
43781526|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
43781585|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
43781586|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781587|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781588|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
43781589|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
43781590|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
43781591|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43781592|NCT04505670|Protective Agents|protective agents|mesh-ancestor
43781749|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781750|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
43781751|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781959|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43781960|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43781961|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781962|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781963|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781964|NCT05043077|Protective Agents|protective agents|mesh-ancestor
43781965|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43781966|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43781967|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
43781968|NCT04945213|Biperiden|biperiden|mesh-list
43782150|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782162|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43782163|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782445|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782446|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43782447|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43782448|NCT02531932|Carboplatin|carboplatin|mesh-list
43782449|NCT02531932|Everolimus|everolimus|mesh-list
43782450|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782470|NCT05094492|Fluorides|fluorides|mesh-list
43782488|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
43782489|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782568|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782843|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782844|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
43782845|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43782846|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782847|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
43782848|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43782849|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43782851|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
43782885|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
43782886|NCT05096676|Oxytocin|oxytocin|mesh-list
43782887|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
43782888|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43782890|NCT05096520|Lidocaine|lidocaine|mesh-list
43783063|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43783064|NCT04430985|Antidotes|antidotes|mesh-ancestor
43783065|NCT04430985|Protective Agents|protective agents|mesh-ancestor
43783066|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
43783067|NCT04430985|Vitamins|vitamins|mesh-ancestor
43783068|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
43783069|NCT04262869|Paclitaxel|paclitaxel|mesh-list
43783070|NCT04262869|Carboplatin|carboplatin|mesh-list
43783071|NCT04262869|Pemetrexed|pemetrexed|mesh-list
43783072|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43783073|NCT04262869|Durvalumab|durvalumab|mesh-list
43783074|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
43783075|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43783076|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
43783227|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
43783228|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
43783229|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43783230|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43783231|NCT02758431|Acyline|acyline|mesh-list
43783232|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
43590720|NCT03369119|Montelukast|montelukast|mesh-list
43783406|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43783407|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783408|NCT04853004|Antibodies|antibodies|mesh-list
43783409|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
43783410|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783411|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
43783412|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43783413|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839909|NCT04742075|Durvalumab|durvalumab|mesh-list
43839910|NCT04742075|Olaparib|olaparib|mesh-list
43839911|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43839912|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839913|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839914|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
43839915|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839917|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839921|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839922|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
43839923|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
43839924|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
43839925|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839927|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43839928|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43839961|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43839962|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43839963|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43839964|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43839965|NCT04739371|Insulin|insulin|mesh-list
43839966|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43839967|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43839968|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839969|NCT04739150|Nintedanib|nintedanib|mesh-list
43839970|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839971|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43839972|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839973|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839974|NCT04738318|Dexamethasone|dexamethasone|mesh-list
43839975|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
43783414|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
43839999|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43840000|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43840001|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43840002|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43840003|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783594|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783595|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783596|NCT03945721|Niraparib|niraparib|mesh-list
43783597|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43783598|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783599|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783687|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43783688|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
43783689|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783690|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783691|NCT02806687|Antiviral Agents|antiviral agents|mesh-ancestor
43783692|NCT02806687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783693|NCT02806687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783695|NCT02806687|Immunologic Factors|immunologic factors|mesh-ancestor
43783696|NCT02806687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783697|NCT02632396|Rituximab|rituximab|mesh-list
43783698|NCT02632396|Ixazomib|ixazomib|mesh-list
43783699|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783806|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43783807|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
43783808|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43591213|NCT03364075|Analgesics|analgesics|mesh-ancestor
43783810|NCT05099718|Protective Agents|protective agents|mesh-ancestor
43783811|NCT05099614|Naloxone|naloxone|mesh-list
43783812|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43783813|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783814|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
43783815|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783816|NCT05099601|Silymarin|silymarin|mesh-list
43783817|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
43783819|NCT05099601|Protective Agents|protective agents|mesh-ancestor
43783835|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783836|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43783837|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43783838|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
43783839|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
43783840|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43783845|NCT05092152|Propofol|propofol|mesh-list
43783894|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784002|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784003|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43784004|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784005|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
43784006|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43784007|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43784008|NCT04176718|Growth Substances|growth substances|mesh-ancestor
43784009|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
43784051|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43784052|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840063|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
43784053|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784080|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43784081|NCT02718833|Growth Substances|growth substances|mesh-ancestor
43784082|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
43784083|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
43784084|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43784085|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
43591639|NCT03360279|Paclitaxel|paclitaxel|mesh-list
43840089|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840090|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840091|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43840092|NCT04730609|Analgesics|analgesics|mesh-ancestor
43840093|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
43840094|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840095|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43840096|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43840097|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43840098|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
43840099|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840100|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840101|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
43840102|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43784345|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784444|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43784445|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
43784446|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784447|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43784448|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
43784449|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43784450|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
43784451|NCT02615119|Protective Agents|protective agents|mesh-ancestor
43784508|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43784509|NCT05103254|Ezetimibe|ezetimibe|mesh-list
43784510|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43784511|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43784605|NCT04949412|Vitamin D|vitamin d|mesh-list
43784777|NCT05106517|Denosumab|denosumab|mesh-list
43784904|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784905|NCT05087732|Lidocaine|lidocaine|mesh-list
43784906|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
43784907|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
43784908|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784909|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784910|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
43784911|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784912|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43784913|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43784914|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43784915|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43784916|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784948|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43784949|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784950|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784951|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43784952|NCT04528667|Abivertinib|abivertinib|mesh-list
43784953|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784956|NCT04434001|Thrombin|thrombin|mesh-list
43840254|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43840255|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840256|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
43840257|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
43840258|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
43840262|NCT04720716|Sorafenib|sorafenib|mesh-list
43840273|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43840274|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43840275|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840276|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840277|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43840278|NCT04718480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43840279|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43840280|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43785220|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785221|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785222|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43785223|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785224|NCT04576767|Anesthetics|anesthetics|mesh-list
43785225|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785226|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840335|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840336|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43840337|NCT04712539|Oseltamivir|oseltamivir|mesh-list
43840338|NCT04712539|Baloxavir|baloxavir|mesh-list
43840339|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
43785477|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785478|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43785479|NCT05109312|Analgesics|analgesics|mesh-ancestor
43785480|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
43785481|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43785482|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43785483|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785484|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43785485|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785486|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785487|NCT05109299|Fluorides|fluorides|mesh-list
43785567|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785568|NCT04456322|Cisplatin|cisplatin|mesh-list
43785569|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
43785570|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785571|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785572|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
43785573|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43785574|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
43785575|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785576|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43785577|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43785578|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
43593520|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
43785729|NCT03517735|Propofol|propofol|mesh-list
43840383|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840384|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840385|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43593651|NCT03341988|Ritonavir|ritonavir|mesh-list
43785788|NCT05111444|Paclitaxel|paclitaxel|mesh-list
43785789|NCT05111444|Capecitabine|capecitabine|mesh-list
43785790|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
43785791|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43785792|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785793|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
43785794|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
43785795|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
43785796|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785823|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43785824|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785825|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43785882|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
43785883|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785886|NCT05079802|Chitosan|chitosan|mesh-list
43786064|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
43786066|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
43786067|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
43786068|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
43786137|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
43786138|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43786139|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
43786140|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786141|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43786142|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43786143|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43786144|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786186|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
43786187|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
43786189|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786191|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43786209|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786210|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
43840391|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840392|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840393|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43840395|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
43786489|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786490|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43786491|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
43786492|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43786498|NCT04314050|Tramadol|tramadol|mesh-list
43786518|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840460|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786778|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43786779|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43786780|NCT05118048|Chrysarobin|chrysarobin|mesh-list
43786781|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43786782|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786783|NCT05118048|Analgesics|analgesics|mesh-ancestor
43786784|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
43786785|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786786|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786787|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787129|NCT02774590|Timolol|timolol|mesh-list
43787130|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43787131|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43787132|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
43787133|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787134|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787135|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787136|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43787137|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43787138|NCT02195947|Hormones|hormones|mesh-list
43787139|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787193|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43787389|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43787413|NCT01758614|Clopidogrel|clopidogrel|mesh-list
43787414|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43787415|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43787416|NCT01758614|Analgesics|analgesics|mesh-ancestor
43787417|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
43787418|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787796|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43787797|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43787798|NCT02144857|Analgesics|analgesics|mesh-ancestor
43787799|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
43787800|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787801|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787802|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787803|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43787804|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43787805|NCT01462578|Azacitidine|azacitidine|mesh-list
43787806|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43787807|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
43787859|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787861|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43788167|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43788168|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43788169|NCT04441762|Analgesics|analgesics|mesh-ancestor
43788170|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
43788171|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788172|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788173|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788450|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
43788451|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788452|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788453|NCT03267498|Cisplatin|cisplatin|mesh-list
43788454|NCT03267498|Nivolumab|nivolumab|mesh-list
43788455|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788456|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43788457|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43788458|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788459|NCT03251729|Progesterone|progesterone|mesh-list
43788460|NCT03251729|Progestins|progestins|mesh-ancestor
43788461|NCT03251729|Hormones|hormones|mesh-ancestor
43788463|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788695|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788696|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788697|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
43788698|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
43788754|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788755|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840637|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840638|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43840639|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43840640|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
43840641|NCT04681833|Vaccines|vaccines|mesh-list
43840642|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
43840643|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788757|NCT04562558|Dactinomycin|dactinomycin|mesh-list
43788758|NCT04562558|Methotrexate|methotrexate|mesh-list
43788798|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43788935|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788936|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
43788937|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788938|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788944|NCT03501576|Vaccines|vaccines|mesh-list
43788946|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788947|NCT03490903|Fentanyl|fentanyl|mesh-list
43788948|NCT03490903|Midazolam|midazolam|mesh-list
43788949|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43788950|NCT03490903|Narcotics|narcotics|mesh-ancestor
43788951|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788952|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788953|NCT03490903|Analgesics|analgesics|mesh-ancestor
43788954|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
43840689|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
43840690|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840691|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43840692|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43840693|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43840694|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
43840695|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840697|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43789752|NCT04941508|Analgesics|analgesics|mesh-ancestor
43840760|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43840761|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789955|NCT04435691|Azacitidine|azacitidine|mesh-list
43789956|NCT04435691|Venetoclax|venetoclax|mesh-list
43789957|NCT04435691|Magrolimab|magrolimab|mesh-list
43789958|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43789959|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
43789991|NCT04264663|Tinidazole|tinidazole|mesh-list
43840762|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790319|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790320|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43790321|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43790322|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790323|NCT05073562|Folic Acid|folic acid|mesh-list
43790324|NCT05073562|Mebendazole|mebendazole|mesh-list
43790325|NCT05073562|Piperazine|piperazine|mesh-list
43790326|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
43790327|NCT05073562|DMP 777|dmp 777|mesh-list
43790328|NCT05073562|Hematinics|hematinics|mesh-ancestor
43790329|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
43790330|NCT05073562|Vitamins|vitamins|mesh-ancestor
43790398|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
43790399|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
43790400|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790401|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790402|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
43790403|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43790404|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43790405|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
43790406|NCT04330664|Adagrasib|adagrasib|mesh-list
43790407|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790408|NCT04227314|Apremilast|apremilast|mesh-list
43790493|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790494|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
43790554|NCT03933007|Midazolam|midazolam|mesh-list
43790555|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43790556|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43790557|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790558|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790559|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43790667|NCT01794520|Venetoclax|venetoclax|mesh-list
43790702|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790742|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43790743|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43790744|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43790745|NCT05131841|Vinorelbine|vinorelbine|mesh-list
43790746|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43790747|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790752|NCT05131295|Dapsone|dapsone|mesh-list
43790866|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43790867|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790868|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43790869|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
43790870|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790871|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790872|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
43790873|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790874|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43790875|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790876|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
43790877|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790878|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43790886|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790893|NCT04353128|Melatonin|melatonin|mesh-list
43599383|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
43840865|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43790942|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790943|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43790945|NCT03520231|Denosumab|denosumab|mesh-list
43790946|NCT03520231|Gemcitabine|gemcitabine|mesh-list
43790947|NCT03520231|Cisplatin|cisplatin|mesh-list
43790948|NCT03520231|Carboplatin|carboplatin|mesh-list
43790949|NCT03520231|Calcium|calcium|mesh-list
43790950|NCT03520231|Vitamins|vitamins|mesh-ancestor
43790951|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
43790952|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790953|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790954|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43790955|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
43790957|NCT03520231|Antiviral Agents|antiviral agents|mesh-ancestor
43791055|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791056|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
43791057|NCT00094016|Hormones|hormones|mesh-ancestor
43791058|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791059|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791060|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43791061|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791062|NCT05134350|Omeprazole|omeprazole|mesh-list
43791063|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43840886|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840887|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43840888|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
43840889|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
43840890|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43840892|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43840893|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
43840894|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840895|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43840896|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
43840897|NCT04666129|Prednisone|prednisone|mesh-list
43791158|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791159|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43791160|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43791161|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791162|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791163|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43791164|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43791277|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791283|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
43791284|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43791285|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791286|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791287|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43791288|NCT04912518|Analgesics|analgesics|mesh-ancestor
43791289|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
43791293|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43599798|NCT03287076|Exenatide|exenatide|mesh-list
43791324|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
43791325|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
43791339|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791340|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791341|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43791342|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791344|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43791345|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791346|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43791428|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791429|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791431|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
43791432|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791433|NCT02313194|Buspirone|buspirone|mesh-list
43791434|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43791435|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43791436|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791437|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791454|NCT00085774|Albuterol|albuterol|mesh-list
43791564|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43791565|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
43791566|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791567|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791568|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791569|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43791570|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43791571|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791572|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
43791573|NCT05122169|Iodine|iodine|mesh-list
43791574|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
43791575|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43791576|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
43791651|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43791652|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43791653|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43791654|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
43791655|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43791656|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791657|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791668|NCT04886453|Morphine|morphine|mesh-list
43600205|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
43791692|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
43791693|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791694|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43791695|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43791696|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791697|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791698|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43791699|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
43791700|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848424|NCT04021043|Nivolumab|nivolumab|mesh-list
43848431|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848432|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43848433|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848434|NCT04019834|Bupivacaine|bupivacaine|mesh-list
43848435|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
43848436|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
43848437|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848438|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791759|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791760|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
43791761|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
43791762|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791763|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43791764|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43791765|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43791766|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791767|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791768|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791769|NCT04556357|Protective Agents|protective agents|mesh-ancestor
43791770|NCT04553939|Gemcitabine|gemcitabine|mesh-list
43791772|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
43791822|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43791823|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43791824|NCT04287855|Growth Substances|growth substances|mesh-ancestor
43791912|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791913|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791914|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
43791915|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791916|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43791917|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43791927|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791928|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
43791931|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
43792006|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43792007|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792008|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792009|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43792010|NCT02529904|Vaccines|vaccines|mesh-list
43792011|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
43792095|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
43840967|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840968|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43840969|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43840970|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43840971|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43840972|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
43840973|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43792236|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43792237|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792238|NCT05305131|Gemcitabine|gemcitabine|mesh-list
43792239|NCT05305131|Bevacizumab|bevacizumab|mesh-list
43792240|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
43792241|NCT05305131|Cisplatin|cisplatin|mesh-list
43792242|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792243|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792244|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43792245|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43792246|NCT05305131|Growth Substances|growth substances|mesh-ancestor
43792247|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792248|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
43792280|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792281|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43792282|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43792283|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43792284|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
43792285|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792286|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792357|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792358|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43792359|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
43792360|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792361|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
43792362|NCT05303272|Abatacept|abatacept|mesh-list
43792363|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43848455|NCT04018105|Metformin|metformin|mesh-list
43841042|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841043|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
43841045|NCT04654689|Curcumin|curcumin|mesh-list
43841063|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
43841064|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792505|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43792506|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792508|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792625|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792626|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43792627|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43792628|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792630|NCT05217758|Mifepristone|mifepristone|mesh-list
43792631|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43792632|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
43792691|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43792692|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792693|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
43792694|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
43792695|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
43792696|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792697|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43792698|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
43792708|NCT05121168|Bupivacaine|bupivacaine|mesh-list
43792760|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43792761|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43792762|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43792763|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43792764|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43792765|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43841137|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841138|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
43841139|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841140|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43841141|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43841142|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43792807|NCT04969237|Vitamin D|vitamin d|mesh-list
43792808|NCT04969237|Vitamins|vitamins|mesh-ancestor
43792922|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
43792923|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
43792924|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43792925|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43792926|NCT04741334|Anticoagulants|anticoagulants|mesh-list
43792927|NCT04741334|Dicumarol|dicumarol|mesh-list
43792928|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43792929|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792930|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792950|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792951|NCT04719221|Evolocumab|evolocumab|mesh-list
43792952|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43792953|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43793046|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43793047|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43793048|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
43793049|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841201|NCT04645004|Analgesics|analgesics|mesh-ancestor
43841202|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
43841203|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841204|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841205|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841206|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43793109|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793162|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43793163|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43793164|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793165|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793166|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
43793167|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793199|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793203|NCT04201873|Laxatives|laxatives|mesh-ancestor
43793323|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793324|NCT05431257|Venetoclax|venetoclax|mesh-list
43793325|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793326|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
43793327|NCT05431218|Vitamin D|vitamin d|mesh-list
43793328|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43793329|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793330|NCT05431218|Vitamins|vitamins|mesh-ancestor
43793396|NCT05426252|Sirolimus|sirolimus|mesh-list
43793490|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602377|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
43793491|NCT05239884|Nicotine|nicotine|mesh-list
43793492|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43793493|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
43793494|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793571|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793572|NCT04884139|Tenofovir|tenofovir|mesh-list
43793573|NCT04884139|Lamivudine|lamivudine|mesh-list
43793574|NCT04884139|Emtricitabine|emtricitabine|mesh-list
43793575|NCT04884139|Dolutegravir|dolutegravir|mesh-list
43793576|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
43793577|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793578|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43793579|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43793580|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793581|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793582|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43793583|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43793598|NCT04833907|Prednisone|prednisone|mesh-list
43793599|NCT04833907|Levetiracetam|levetiracetam|mesh-list
43793600|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43793601|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
43793602|NCT04833907|Hormones|hormones|mesh-ancestor
43793603|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602507|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
43793616|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43793617|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43793618|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43793619|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
43793620|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793621|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793622|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
43793623|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43793624|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
43841284|NCT04638400|Ezetimibe|ezetimibe|mesh-list
43841285|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43841286|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43841290|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43841291|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841293|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43841294|NCT04634838|Trace Elements|trace elements|mesh-ancestor
43841295|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
43841296|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841297|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841298|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43841299|NCT04633122|Sunitinib|sunitinib|mesh-list
43841300|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841301|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43841302|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43841303|NCT04633122|Growth Substances|growth substances|mesh-ancestor
43841304|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841305|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
43841306|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43841307|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841309|NCT04632433|Cemiplimab|cemiplimab|mesh-list
43841315|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841316|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
43841317|NCT04631263|Protective Agents|protective agents|mesh-ancestor
43841318|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43841319|NCT04630821|Eusol|eusol|mesh-list
43841320|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
43841321|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841322|NCT04630808|Latanoprost|latanoprost|mesh-list
43841323|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43841324|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43841325|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
43841326|NCT04629729|Fludarabine|fludarabine|mesh-list
43841327|NCT04629729|Interleukin-2|interleukin-2|mesh-list
43841328|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43841329|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
43602555|NCT03252665|Nicorandil|nicorandil|mesh-list
43793643|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793644|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793645|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43793646|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43793647|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
43793648|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793649|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793650|NCT04688294|Valsartan|valsartan|mesh-list
43793651|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43793661|NCT04622917|Prednisolone|prednisolone|mesh-list
43793696|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43793697|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
43793698|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793699|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
43793700|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43793701|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793702|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793723|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43793725|NCT04132791|Analgesics|analgesics|mesh-ancestor
43793726|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
43793727|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793728|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793729|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43793730|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43793731|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43793738|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
43793739|NCT04121507|Thiotepa|thiotepa|mesh-list
43793740|NCT04121507|Fludarabine|fludarabine|mesh-list
43793742|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
43793743|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793744|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43793746|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
43793748|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793749|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43793750|NCT04065009|Ropivacaine|ropivacaine|mesh-list
43793768|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43793769|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43793771|NCT03915964|Etanercept|etanercept|mesh-list
43793772|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43793773|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43793774|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43793775|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43793776|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43793777|NCT03915964|Analgesics|analgesics|mesh-ancestor
43793778|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
43793779|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793780|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793781|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43793782|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849582|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793783|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
43793784|NCT03892395|Vitamin D|vitamin d|mesh-list
43793785|NCT03892395|Vitamins|vitamins|mesh-list
43793788|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793789|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43793790|NCT03718559|Edoxaban|edoxaban|mesh-list
43793791|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43793799|NCT03694249|Ifetroban|ifetroban|mesh-list
43841347|NCT04629547|Suvorexant|suvorexant|mesh-list
43841348|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43841349|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43841350|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841351|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841352|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43841353|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841354|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841355|NCT04629196|Ustekinumab|ustekinumab|mesh-list
43841356|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
43841357|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
43841374|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
43793931|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793932|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
43793933|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793934|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43793935|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43793936|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793937|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793938|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43793992|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793993|NCT00136435|Antidotes|antidotes|mesh-ancestor
43793994|NCT00136435|Protective Agents|protective agents|mesh-ancestor
43793995|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
43793996|NCT00136435|Vitamins|vitamins|mesh-ancestor
43793997|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
43793998|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43793999|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
43794000|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
43794001|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
43794002|NCT04064918|Timolol|timolol|mesh-list
43794003|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43794035|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794036|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43794037|NCT03998839|Renal Agents|renal agents|mesh-ancestor
43841378|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43841379|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43841380|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841381|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
43841382|NCT04625530|Coagulants|coagulants|mesh-ancestor
43841383|NCT04625530|Hematinics|hematinics|mesh-ancestor
43841384|NCT04624399|Atezolizumab|atezolizumab|mesh-list
43841385|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841396|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43841397|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841399|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
43841428|NCT04620759|Psilocybin|psilocybin|mesh-list
43841429|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43841430|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
43841431|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841432|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43841433|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43841434|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
43841435|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841436|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841438|NCT04620343|Anesthetics|anesthetics|mesh-list
43794181|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794182|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794183|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43794184|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
43849583|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
43794185|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794186|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794187|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43794188|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794189|NCT03832049|Vaccines|vaccines|mesh-list
43794192|NCT03810105|Durvalumab|durvalumab|mesh-list
43794200|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
43794201|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43794202|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794203|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794204|NCT03806751|Diuretics|diuretics|mesh-ancestor
43794205|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
43794206|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794207|NCT03800979|Tofacitinib|tofacitinib|mesh-list
43794209|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794235|NCT03748966|Vitamins|vitamins|mesh-ancestor
43794236|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
43794237|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43794238|NCT03748433|Insulin|insulin|mesh-list
43794239|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43794240|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794241|NCT03657342|Cyclosporine|cyclosporine|mesh-list
43794242|NCT03657342|Cyclosporins|cyclosporins|mesh-list
43794252|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43794253|NCT03656926|Cyclosporine|cyclosporine|mesh-list
43794254|NCT03656926|Cyclosporins|cyclosporins|mesh-list
43794255|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794256|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794257|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794258|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
43794259|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794260|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
43794266|NCT03646617|Ipilimumab|ipilimumab|mesh-list
43841454|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841455|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43841456|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43841457|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841458|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841459|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43841460|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43841461|NCT04616014|Insulin|insulin|mesh-list
43794333|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794334|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
43794335|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794337|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794338|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
43794339|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
43794340|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
43794341|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794342|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794343|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43794344|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43794345|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
43794372|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43794373|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43794374|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
43794375|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794376|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794377|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43794378|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794379|NCT03294694|Fulvestrant|fulvestrant|mesh-list
43794380|NCT03294694|Spartalizumab|spartalizumab|mesh-list
43794381|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43794382|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794383|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43794384|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43794385|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
43794408|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794410|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43794411|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
43794412|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794413|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794414|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43794415|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
43794416|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43794417|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43794418|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794429|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794430|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
43794431|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794432|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794433|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794434|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794435|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43794436|NCT03113942|Thalidomide|thalidomide|mesh-list
43794437|NCT03113942|Pomalidomide|pomalidomide|mesh-list
43794438|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
43794439|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794440|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43794441|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43794443|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
43794444|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794445|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794446|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
43794448|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794449|NCT03109093|Blinatumomab|blinatumomab|mesh-list
43794450|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794451|NCT03104270|Dexamethasone|dexamethasone|mesh-list
43794452|NCT03104270|Pomalidomide|pomalidomide|mesh-list
43794453|NCT03104270|Elotuzumab|elotuzumab|mesh-list
43794454|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794455|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
43794456|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
43794457|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794461|NCT03104270|Hormones|hormones|mesh-ancestor
43794527|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794528|NCT02838745|Cisplatin|cisplatin|mesh-list
43794533|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43794534|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43794535|NCT02809820|Metoprolol|metoprolol|mesh-list
43794536|NCT02809820|Carvedilol|carvedilol|mesh-list
43794537|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43794538|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43794549|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
43794572|NCT02729116|Ertapenem|ertapenem|mesh-list
43794573|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
43794574|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43794575|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794576|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43794577|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43794578|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794579|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794591|NCT02592707|Ondansetron|ondansetron|mesh-list
43794592|NCT02592707|Antiemetics|antiemetics|mesh-list
43794593|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43794594|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794595|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
43794596|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794597|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794598|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43794599|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
43794600|NCT02592707|Hormones|hormones|mesh-ancestor
43794621|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43794622|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43794623|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794624|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794626|NCT02455141|Carboplatin|carboplatin|mesh-list
43794627|NCT02455141|Epirubicin|epirubicin|mesh-list
43794629|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794630|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
43794631|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794632|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794757|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794759|NCT01764711|Hormones|hormones|mesh-ancestor
43794760|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794761|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794762|NCT01553071|Fenretinide|fenretinide|mesh-list
43794763|NCT01553071|Safingol|safingol|mesh-list
43794764|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794765|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43794766|NCT01553071|Protective Agents|protective agents|mesh-ancestor
43794809|NCT01347970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43794810|NCT01187810|Cytarabine|cytarabine|mesh-list
43794811|NCT01187810|Methotrexate|methotrexate|mesh-list
43794812|NCT01187810|Fenretinide|fenretinide|mesh-list
43794813|NCT01187810|Retinamide|retinamide|mesh-list
43794814|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43794815|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
43794816|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43794817|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794818|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794819|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
43794820|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794821|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794822|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794823|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794824|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43794825|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794829|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
43794830|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794831|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43794832|NCT01187810|Protective Agents|protective agents|mesh-ancestor
43794834|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
43794846|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794847|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43794848|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43841519|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43841520|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43841522|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43841523|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43841524|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
43841525|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
43848491|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848492|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848493|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43794919|NCT05015608|Cisplatin|cisplatin|mesh-list
43794944|NCT04968158|Tramadol|tramadol|mesh-list
43794945|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43794946|NCT04968158|Analgesics|analgesics|mesh-ancestor
43794947|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
43794948|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794949|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794950|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
43794951|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43794952|NCT04968158|Narcotics|narcotics|mesh-ancestor
43794953|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794954|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43795017|NCT04248465|Ravulizumab|ravulizumab|mesh-list
43794959|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794960|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794961|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
43794962|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43794963|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794964|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794965|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43795018|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43795019|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795020|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
43795021|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795022|NCT05245227|Misoprostol|misoprostol|mesh-list
43795023|NCT05245227|Oxytocin|oxytocin|mesh-list
43795024|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
43795025|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43795026|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795027|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43795028|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
43795051|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43795052|NCT05244811|Hormones|hormones|mesh-ancestor
43795053|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43795054|NCT05244811|Estrogens|estrogens|mesh-ancestor
43795055|NCT05244694|Insulin|insulin|mesh-list
43795056|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43795057|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795058|NCT05244577|Olanzapine|olanzapine|mesh-list
43795081|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795082|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795083|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795084|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
43795085|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795086|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795087|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795130|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
43795131|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795132|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795133|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
43795134|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43795135|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43795136|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43795137|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43795139|NCT05196945|Clarithromycin|clarithromycin|mesh-list
43795140|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
43795141|NCT05196945|Esomeprazole|esomeprazole|mesh-list
43795142|NCT05196945|Bismuth|bismuth|mesh-list
43795143|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795144|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43795145|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795146|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43795147|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43795153|NCT05196945|Antacids|antacids|mesh-ancestor
43795158|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
43795159|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
43849586|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43795160|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43604304|NCT03238131|Ivermectin|ivermectin|mesh-list
43795161|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
43795162|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
43795163|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43795164|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795165|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43795166|NCT05167331|Analgesics|analgesics|mesh-ancestor
43795183|NCT05129475|Ritonavir|ritonavir|mesh-list
43795184|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43795197|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795198|NCT04920344|Cisplatin|cisplatin|mesh-list
43795199|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795200|NCT04799015|Dexamethasone|dexamethasone|mesh-list
43795201|NCT04799015|Metoclopramide|metoclopramide|mesh-list
43795202|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795293|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43795294|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43795295|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43795296|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
43795297|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43795298|NCT04313166|Copper|copper|mesh-list
43795299|NCT04313166|Trace Elements|trace elements|mesh-ancestor
43795300|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
43795316|NCT04268849|Vitamins|vitamins|mesh-ancestor
43795317|NCT04268849|Micronutrients|micronutrients|mesh-ancestor
43795318|NCT04268849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795319|NCT04268849|Antioxidants|antioxidants|mesh-ancestor
43795320|NCT04268849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795321|NCT04268849|Protective Agents|protective agents|mesh-ancestor
43795322|NCT04268849|Hematinics|hematinics|mesh-ancestor
43795323|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43841562|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43841565|NCT04605393|Cannabidiol|cannabidiol|mesh-list
43841573|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841574|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43841575|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43841576|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841577|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841578|NCT04605393|Hormones|hormones|mesh-ancestor
43841580|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
43795337|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43795338|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43795339|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
43795340|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795341|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795342|NCT04126135|Nicotine|nicotine|mesh-list
43795343|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43795344|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
43795345|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795346|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795347|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43795348|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43795349|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795350|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795351|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795352|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43795364|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
43795365|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795366|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795367|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
43795368|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849590|NCT03909412|Lenograstim|lenograstim|mesh-list
43795369|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795370|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
43795371|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43795372|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43795373|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43795374|NCT03885921|Atorvastatin|atorvastatin|mesh-list
43795375|NCT03885921|Simvastatin|simvastatin|mesh-list
43795377|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795378|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795379|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
43795380|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795475|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43795476|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43795477|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43795478|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795479|NCT03498378|Cetuximab|cetuximab|mesh-list
43795480|NCT03498378|Avelumab|avelumab|mesh-list
43795481|NCT03498378|Palbociclib|palbociclib|mesh-list
43795482|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795483|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795484|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43795485|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795486|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795487|NCT03466801|Prednisone|prednisone|mesh-list
43795488|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
43795489|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43795490|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795505|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43795506|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795507|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43795508|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43795509|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43795511|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
43604716|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795512|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795513|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795515|NCT03415854|Paclitaxel|paclitaxel|mesh-list
43795516|NCT03415854|Cisplatin|cisplatin|mesh-list
43795517|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43795518|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43795519|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795520|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
43795521|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
43795522|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
43849591|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795559|NCT03321045|Trastuzumab|trastuzumab|mesh-list
43795567|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43795568|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43795569|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795570|NCT03221400|Leucovorin|leucovorin|mesh-list
43795571|NCT03221400|Folic Acid|folic acid|mesh-list
43795572|NCT03221400|Fluorouracil|fluorouracil|mesh-list
43795573|NCT03221400|Niraparib|niraparib|mesh-list
43795574|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
43795575|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
43795576|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849592|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
43795600|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43795601|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
43795605|NCT03138720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795606|NCT03138720|Immunologic Factors|immunologic factors|mesh-ancestor
43795607|NCT03138720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795608|NCT03137888|Temozolomide|temozolomide|mesh-list
43795609|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43795616|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795631|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
43795632|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
43795633|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43795634|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
43795635|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795636|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795637|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43795638|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
43795639|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43795640|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43795641|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43795642|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
43795643|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795644|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795645|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43795658|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
43795659|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
43795660|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795661|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43795662|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
43795663|NCT02178436|Antiviral Agents|antiviral agents|mesh-ancestor
43795664|NCT02178436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795671|NCT02086604|Lenalidomide|lenalidomide|mesh-list
43841623|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43841624|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841625|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841626|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43841627|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841628|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43841629|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43841630|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841631|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43841632|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43841634|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841640|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
43841641|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841643|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
43841644|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
43841645|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841646|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841647|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43841648|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43841649|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
43841650|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841651|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795682|NCT01554410|Cisplatin|cisplatin|mesh-list
43795753|NCT00794846|Desloratadine|desloratadine|mesh-list
43795754|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795755|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795756|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795757|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795759|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795760|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795761|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795762|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795763|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795780|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795781|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795782|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
43795783|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795784|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795785|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795786|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795814|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795815|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795816|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795817|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795818|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795819|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795820|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795821|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795822|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
43795823|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
43795824|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795842|NCT00779636|Desloratadine|desloratadine|mesh-list
43795867|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795868|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795869|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795911|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795912|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
43795913|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795914|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795915|NCT00651391|Simvastatin|simvastatin|mesh-list
43795916|NCT00651391|Ezetimibe|ezetimibe|mesh-list
43795917|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795920|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795921|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795959|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795960|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795961|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
43795962|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795963|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795964|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795965|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795966|NCT00398294|Simvastatin|simvastatin|mesh-list
43795967|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795968|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795969|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
43795974|NCT00396175|Finasteride|finasteride|mesh-list
43795998|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795999|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43796000|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
43796001|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796002|NCT00370890|Antiviral Agents|antiviral agents|mesh-ancestor
43796003|NCT00370890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796004|NCT00370890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796005|NCT00370890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43796017|NCT04095845|Tacrine|tacrine|mesh-list
43796018|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43796019|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796021|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
43796058|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796059|NCT03945812|Lenograstim|lenograstim|mesh-list
43796060|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43796061|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
43796062|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796063|NCT03913845|Lidocaine|lidocaine|mesh-list
43796064|NCT03913845|Epinephrine|epinephrine|mesh-list
43796065|NCT03913845|Racepinephrine|racepinephrine|mesh-list
43796066|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
43796067|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
43796089|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43796090|NCT03903939|Iloprost|iloprost|mesh-list
43796091|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43796092|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
43796093|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
43796094|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43796097|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
43796134|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43796135|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
43796136|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841692|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
43796201|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796202|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796203|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796204|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
43796205|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43796206|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
43796207|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796208|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
43796209|NCT05072899|Protective Agents|protective agents|mesh-ancestor
43796210|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
43796211|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43796215|NCT05072860|Coagulants|coagulants|mesh-ancestor
43796216|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
43796217|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43796218|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43796219|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796220|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
43796221|NCT05072873|Coagulants|coagulants|mesh-ancestor
43796222|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
43796223|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43796224|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43796225|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43796256|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43796257|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796258|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
43796259|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796260|NCT05072106|Bosentan|bosentan|mesh-list
43796261|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43796264|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
43796265|NCT05071482|HH-GV-678|hh-gv-678|mesh-list
43796270|NCT05071781|Hormones|hormones|mesh-list
43796273|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796274|NCT05071339|Ganirelix|ganirelix|mesh-list
43796275|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796276|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796277|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796278|NCT05071118|Pregabalin|pregabalin|mesh-list
43796279|NCT05071118|Analgesics|analgesics|mesh-ancestor
43796280|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
43796281|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796282|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796347|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43796348|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
43796349|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796350|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796351|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43796352|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796353|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841712|NCT04594772|Paclitaxel|paclitaxel|mesh-list
43841713|NCT04594772|Fluorouracil|fluorouracil|mesh-list
43841719|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
43841720|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
43841721|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
43841722|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841723|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43841724|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
43841725|NCT04594772|Antiviral Agents|antiviral agents|mesh-ancestor
43841726|NCT04594772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841727|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841728|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43841729|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
43841730|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841731|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43848502|NCT04013672|Sargramostim|sargramostim|mesh-list
43848503|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43848504|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848505|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848506|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
43848507|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848508|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43848509|NCT04012827|Doxorubicin|doxorubicin|mesh-list
43848510|NCT04012827|Apatinib|apatinib|mesh-list
43848511|NCT04012827|Ifosfamide|ifosfamide|mesh-list
43848512|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43848513|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848514|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43848515|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43848516|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796356|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
43796358|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796359|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43796360|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43796361|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796362|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796363|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43796364|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796365|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796456|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796457|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43796458|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796459|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796460|NCT05067153|Heparin|heparin|mesh-list
43796461|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43796462|NCT05067153|Tinzaparin|tinzaparin|mesh-list
43796463|NCT05067153|Dalteparin|dalteparin|mesh-list
43796472|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796473|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796589|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796590|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43796591|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43796592|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43796593|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796594|NCT05063422|Laxatives|laxatives|mesh-ancestor
43796595|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43796596|NCT05063318|Itraconazole|itraconazole|mesh-list
43796597|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
43796598|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796599|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43796600|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43796601|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796651|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796652|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
43796653|NCT05062486|Protective Agents|protective agents|mesh-ancestor
43796654|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43796655|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
43796656|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43796657|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43796658|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796721|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796722|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796723|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43796724|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43796725|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796726|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796727|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796728|NCT05060809|Vitamin K|vitamin k|mesh-list
43796775|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796776|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796777|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
43796778|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43796779|NCT05059145|Fluconazole|fluconazole|mesh-list
43796780|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43796781|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796782|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
43796863|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796864|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
43796865|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796866|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796868|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796870|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43796871|NCT05057351|Protective Agents|protective agents|mesh-ancestor
43796901|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796902|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43796903|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796904|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796905|NCT05056025|Vitamins|vitamins|mesh-list
43796906|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
43796907|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796908|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43796909|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
43796910|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796972|NCT05053009|Ibuprofen|ibuprofen|mesh-list
43796973|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43796974|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43796975|NCT05053009|Analgesics|analgesics|mesh-ancestor
43797049|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797051|NCT05051956|Palbociclib|palbociclib|mesh-list
43797052|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797053|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43797054|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797055|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797056|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
43797057|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
43841892|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43841893|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841894|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43841895|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841896|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848528|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848529|NCT04010968|Venetoclax|venetoclax|mesh-list
43848530|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848531|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
43848532|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43848533|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848534|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848535|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43848536|NCT04010305|Analgesics|analgesics|mesh-ancestor
43797153|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
43797154|NCT05049473|Rituximab|rituximab|mesh-list
43797156|NCT05049473|Methotrexate|methotrexate|mesh-list
43797157|NCT05049473|Etoposide|etoposide|mesh-list
43797168|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43797335|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43797336|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43797337|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43797338|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43797339|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
43797340|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43797341|NCT05046262|Calcium|calcium|mesh-list
43797342|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43797343|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797344|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
43797345|NCT05046457|Provitamins|provitamins|mesh-ancestor
43797346|NCT05046457|Vitamins|vitamins|mesh-ancestor
43797347|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
43797509|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797607|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43797608|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43797609|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797643|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797644|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
43797645|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797646|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43797648|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43797649|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
43797650|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43797704|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43797705|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43797706|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43797707|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797717|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
43797718|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
43797719|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797720|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797721|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
43797722|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797723|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
43797724|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43797725|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797726|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797727|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43797728|NCT05038111|Analgesics|analgesics|mesh-ancestor
43797738|NCT05038202|Bromides|bromides|mesh-list
43797902|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797903|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797904|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
43797905|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
43797906|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
43797907|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43797908|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43797909|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43797910|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
43797914|NCT05035472|Phenylephrine|phenylephrine|mesh-list
43797976|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43797977|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43797978|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797979|NCT05034055|Atezolizumab|atezolizumab|mesh-list
43798065|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43798068|NCT05032118|Analgesics|analgesics|mesh-ancestor
43798069|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
43798070|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607845|NCT03199690|Rifampin|rifampin|mesh-list
43798180|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
43798181|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
43798182|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798183|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798184|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43798185|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
43798186|NCT05028907|Hormones|hormones|mesh-ancestor
43798187|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798188|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43798189|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798190|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43798238|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43798239|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798240|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
43798241|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43798242|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
43798247|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
43798248|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43842055|NCT04555577|Temozolomide|temozolomide|mesh-list
43798481|NCT05023408|Bleomycin|bleomycin|mesh-list
43798569|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842101|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842102|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
43842103|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842104|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43842105|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
43842106|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43842107|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43842108|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43842109|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43842110|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842117|NCT04552743|Plerixafor|plerixafor|mesh-list
43798737|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43798862|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43798863|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
43798864|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43798865|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43798866|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43798867|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43798868|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
43798869|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43798870|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43798871|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
43798937|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
43798938|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798939|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798940|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43798947|NCT05015361|Propofol|propofol|mesh-list
43799014|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43799015|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799016|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799017|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
43799018|NCT05014464|Crizotinib|crizotinib|mesh-list
43799019|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799020|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43799021|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799101|NCT05013164|Vitamins|vitamins|mesh-ancestor
43799185|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
43799186|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799187|NCT05010434|Bevacizumab|bevacizumab|mesh-list
43799188|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43799189|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799190|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43799200|NCT05009953|Irinotecan|irinotecan|mesh-list
43799201|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
43799249|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799250|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43799251|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799252|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43799417|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799418|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
43609281|NCT03190642|Prednisolone|prednisolone|mesh-list
43799432|NCT05007223|Doxycycline|doxycycline|mesh-list
43799433|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43799434|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799435|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
43799436|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43799437|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43799438|NCT05006469|Dexamethasone|dexamethasone|mesh-list
43799439|NCT05006469|Doxorubicin|doxorubicin|mesh-list
43799440|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43799441|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43799443|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
43799485|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43799486|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43799487|NCT05006287|Warfarin|warfarin|mesh-list
43799488|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
43799489|NCT05006287|Dabigatran|dabigatran|mesh-list
43799490|NCT05006287|Apixaban|apixaban|mesh-list
43799491|NCT05006287|Anticoagulants|anticoagulants|mesh-list
43799492|NCT05006287|Edoxaban|edoxaban|mesh-list
43799493|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43799532|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
43799533|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799534|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799535|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
43799536|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609392|NCT03188835|Glycerol|glycerol|mesh-list
43799576|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799717|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43799718|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43799719|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43799720|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799721|NCT05002673|Anesthetics|anesthetics|mesh-list
43799722|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799723|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799724|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
43799725|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43799726|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43799727|NCT05002517|Prednisolone|prednisolone|mesh-list
43799728|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
43799729|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43799783|NCT05001919|Mitogens|mitogens|mesh-list
43799784|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
43799785|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799786|NCT05001763|Prucalopride|prucalopride|mesh-list
43799787|NCT05001763|Laxatives|laxatives|mesh-ancestor
43799788|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799789|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43799790|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43799791|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
43609650|NCT03186664|Nabiximols|nabiximols|mesh-list
43799792|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799793|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799794|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799795|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
43799796|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799797|NCT05001672|Tenofovir|tenofovir|mesh-list
43799798|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
43799800|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43799801|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43799979|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799980|NCT04999137|Antioxidants|antioxidants|mesh-ancestor
43799981|NCT04999137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799982|NCT04999137|Protective Agents|protective agents|mesh-ancestor
43799983|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
43799984|NCT04998838|Tenofovir|tenofovir|mesh-list
43799985|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
43799986|NCT04998838|Antibodies|antibodies|mesh-list
43799987|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
43799988|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43799989|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43799990|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
43799991|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800000|NCT04998071|Bupivacaine|bupivacaine|mesh-list
43800001|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
43800002|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
43800005|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
43800157|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800159|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800160|NCT04996498|Oxytocin|oxytocin|mesh-list
43610006|NCT03183739|ASP8062|asp8062|mesh-list
43800161|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
43800162|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43800163|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800164|NCT04996160|Dexamethasone|dexamethasone|mesh-list
43800165|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
43800166|NCT04996160|Doxorubicin|doxorubicin|mesh-list
43800167|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43800168|NCT04996160|Bortezomib|bortezomib|mesh-list
43842197|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800285|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43800286|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800287|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
43800288|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
43800289|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
43800290|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800292|NCT04992468|Hormones|hormones|mesh-ancestor
43800307|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
43800308|NCT04992481|Fluorides|fluorides|mesh-list
43800309|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
43800310|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
43800383|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43800384|NCT04991155|Zamicastat|zamicastat|mesh-list
43800385|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800386|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800387|NCT04991298|Fentanyl|fentanyl|mesh-list
43800388|NCT04991298|Midazolam|midazolam|mesh-list
43800389|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43800390|NCT04991298|Narcotics|narcotics|mesh-ancestor
43800391|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800392|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800393|NCT04991298|Analgesics|analgesics|mesh-ancestor
43800394|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
43800529|NCT04988945|Tremelimumab|tremelimumab|mesh-list
43800530|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800531|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800532|NCT04989270|Anesthetics|anesthetics|mesh-list
43800533|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800534|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800535|NCT04989257|Clopidogrel|clopidogrel|mesh-list
43800536|NCT04989257|Ticagrelor|ticagrelor|mesh-list
43800537|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43800538|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43800539|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43842274|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
43842275|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43842276|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43842277|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43800808|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800809|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800810|NCT04983615|Analgesics|analgesics|mesh-ancestor
43800811|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
43800812|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800813|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43800814|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43800815|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
43800816|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
43800817|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43800840|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
43800841|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800842|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43800843|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43800847|NCT04982809|Betamethasone|betamethasone|mesh-list
43800848|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800849|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
43800850|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
43800855|NCT04982809|Hormones|hormones|mesh-ancestor
43800886|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43800986|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43800987|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800988|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800989|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
43800990|NCT05635162|Rituximab|rituximab|mesh-list
43800991|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
43800992|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800993|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800994|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
43800995|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800996|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43800997|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43801056|NCT05629702|Nabiximols|nabiximols|mesh-list
43801057|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43801139|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43801140|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801141|NCT05491278|Remifentanil|remifentanil|mesh-list
43801142|NCT05491278|Propofol|propofol|mesh-list
43801143|NCT05491278|Fospropofol|fospropofol|mesh-list
43801144|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43801145|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801146|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801147|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43801251|NCT05431270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801253|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
43801254|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
43801255|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801256|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801257|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
43801258|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801259|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43801267|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
43801268|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801269|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801270|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801271|NCT05371886|Midazolam|midazolam|mesh-list
43801272|NCT05371886|Morphine|morphine|mesh-list
43801273|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43801274|NCT05371886|Narcotics|narcotics|mesh-ancestor
43801276|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801297|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43801298|NCT05359861|Growth Substances|growth substances|mesh-ancestor
43801299|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801300|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
43848606|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43848607|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43848608|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43801329|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
43801330|NCT05294055|Etoposide|etoposide|mesh-list
43801362|NCT05214911|Loratadine|loratadine|mesh-list
43801420|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43801421|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
43801422|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801423|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801424|NCT05104866|Antiviral Agents|antiviral agents|mesh-ancestor
43801425|NCT05104866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801426|NCT05104866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801427|NCT05104866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611669|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43801428|NCT05104866|Immunologic Factors|immunologic factors|mesh-ancestor
43801429|NCT05104866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801430|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43801432|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
43801433|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
43801434|NCT05017610|Lomustine|lomustine|mesh-list
43801435|NCT05017610|Methimazole|methimazole|mesh-list
43801436|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43801437|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
43801438|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801439|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801440|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
43801441|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
43801442|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801443|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801444|NCT05010304|Amoxicillin|amoxicillin|mesh-list
43801445|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43801446|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801447|NCT05004116|Irinotecan|irinotecan|mesh-list
43801589|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43801706|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43801707|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801708|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
43801709|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
43801710|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
43801711|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801787|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43801788|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
43801789|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801790|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801820|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43801821|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801822|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43801823|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
43801824|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801825|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43801832|NCT04147494|FAPI-46|fapi-46|mesh-list
43802007|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43802008|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
43802009|NCT03593044|Atropine|atropine|mesh-list
43802010|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43802011|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43802012|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43802014|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802015|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802016|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43802017|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
43802018|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
43802019|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
43802088|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43802187|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802188|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
43802189|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
43802190|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802191|NCT02658981|Nivolumab|nivolumab|mesh-list
43802192|NCT02658981|Antibodies|antibodies|mesh-list
43802193|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43802194|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
43802226|NCT02595424|Etoposide|etoposide|mesh-list
43802227|NCT02595424|Temozolomide|temozolomide|mesh-list
43802228|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802229|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802230|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
43802231|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802232|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43802233|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43802234|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43802235|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802461|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802462|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
43802463|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43802464|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43802465|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43802466|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43802467|NCT04981899|Carboplatin|carboplatin|mesh-list
43802468|NCT04981899|Nivolumab|nivolumab|mesh-list
43802469|NCT04981899|Etoposide|etoposide|mesh-list
43802470|NCT04981899|Ifosfamide|ifosfamide|mesh-list
43842570|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43842571|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43842572|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43842573|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612889|NCT03161977|Mannitol|mannitol|mesh-list
43802584|NCT04980404|Decitabine|decitabine|mesh-list
43802586|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
43848609|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
43802587|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802588|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802589|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802590|NCT04980170|Amoxicillin|amoxicillin|mesh-list
43802591|NCT04980170|Clindamycin|clindamycin|mesh-list
43802592|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
43802593|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
43802595|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
43802671|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802955|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43802956|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802957|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43802958|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802959|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802960|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43802961|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43802962|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
43802963|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842618|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803066|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803067|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
43803068|NCT04972032|Estrogens|estrogens|mesh-list
43803069|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
43803070|NCT04972032|Hormones|hormones|mesh-ancestor
43803071|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43803072|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803073|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43803074|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
43803075|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
43803076|NCT04972032|Protective Agents|protective agents|mesh-ancestor
43803146|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803147|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43803148|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43803149|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842656|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43842657|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43842658|NCT04516993|Analgesics|analgesics|mesh-ancestor
43803234|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803235|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803236|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803237|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803238|NCT04970121|Analgesics|analgesics|mesh-ancestor
43803239|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
43803240|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803241|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
43803252|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43803253|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613809|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
43803325|NCT04968132|Analgesics|analgesics|mesh-ancestor
43803326|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
43803327|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842708|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842709|NCT04516057|Nabilone|nabilone|mesh-list
43842710|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
43842711|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
43842712|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842713|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842714|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43803343|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803348|NCT04967469|Vitamins|vitamins|mesh-ancestor
43803414|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803503|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803504|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
43803505|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43803506|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43803507|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803508|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803509|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43803511|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803512|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803520|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803521|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43803522|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43803523|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43803524|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803525|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803526|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43803527|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803528|NCT04964180|Analgesics|analgesics|mesh-ancestor
43803552|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43803681|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803683|NCT04961918|Lenvatinib|lenvatinib|mesh-list
43803684|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803685|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803686|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803687|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803688|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803689|NCT04961931|Empagliflozin|empagliflozin|mesh-list
43803690|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43803691|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803692|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43803693|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803694|NCT04961788|Antibodies|antibodies|mesh-list
43803795|NCT04957927|Fluticasone|fluticasone|mesh-list
43803796|NCT04957927|Xhance|xhance|mesh-list
43803797|NCT04957927|Montelukast|montelukast|mesh-list
43803798|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803799|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43803800|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
43803801|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803802|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803917|NCT04952194|Levodopa|levodopa|mesh-list
43804142|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43804143|NCT04948801|Velpatasvir|velpatasvir|mesh-list
43804144|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
43804145|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804146|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
43804147|NCT04948567|Analgesics|analgesics|mesh-ancestor
43804148|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
43804149|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804164|NCT04948125|Apatinib|apatinib|mesh-list
43804242|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43804482|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43804585|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43804586|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804596|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804597|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804598|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804599|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
43804600|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43804601|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804602|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43804718|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804719|NCT04942769|Trace Elements|trace elements|mesh-ancestor
43804720|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
43804721|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
43804722|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43804723|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43804724|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804725|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
43804726|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
43804727|NCT04942301|Endostar protein|endostar protein|mesh-list
43804728|NCT04942301|Endostatins|endostatins|mesh-list
43843017|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848678|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848679|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43848680|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848681|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
43804935|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804936|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43804937|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805028|NCT04937894|Tigecycline|tigecycline|mesh-list
43805110|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43805111|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
43805112|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805113|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
43805114|NCT04936204|Protective Agents|protective agents|mesh-ancestor
43805115|NCT04936126|Amantadine|amantadine|mesh-list
43805116|NCT04936126|Pramipexole|pramipexole|mesh-list
43805117|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43805118|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
43805119|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43805120|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43805121|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43805122|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805124|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
43805141|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805142|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43805143|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843022|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
43843023|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43843024|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43843025|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43843026|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
43805322|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805323|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43805324|NCT04932746|Analgesics|analgesics|mesh-ancestor
43805325|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
43805326|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805327|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43805328|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43843100|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
43843103|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
43805464|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43805615|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43805616|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805618|NCT04926155|Metformin|metformin|mesh-list
43805746|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
43805747|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805748|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805749|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805750|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43805751|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43805752|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805753|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617015|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
43805848|NCT04920669|Analgesics|analgesics|mesh-ancestor
43805849|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43805850|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43805851|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43805852|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805853|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805854|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805855|NCT04920604|Anesthetics|anesthetics|mesh-list
43805856|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805857|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805858|NCT04920708|Fulvestrant|fulvestrant|mesh-list
43805859|NCT04920708|Palbociclib|palbociclib|mesh-list
43805860|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43805861|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805862|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43805863|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43805864|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
43805865|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805866|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805903|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43805904|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
43805905|NCT04919174|Remifentanil|remifentanil|mesh-list
43805906|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43805907|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805908|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805909|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43805910|NCT04919174|Analgesics|analgesics|mesh-ancestor
43806119|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806120|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43806121|NCT04916951|Amoxicillin|amoxicillin|mesh-list
43806122|NCT04916951|Cephalexin|cephalexin|mesh-list
43806123|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43806124|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806125|NCT04916899|Rifampin|rifampin|mesh-list
43806126|NCT04916899|Isoniazid|isoniazid|mesh-list
43806127|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
43806129|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43806130|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
43806131|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43806409|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806410|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
43806411|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
43806412|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806413|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806424|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43806425|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
43806426|NCT04912193|Antithrombins|antithrombins|mesh-list
43806427|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
43806574|NCT04909775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806575|NCT04909775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806576|NCT04909775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806577|NCT04909775|Immunologic Factors|immunologic factors|mesh-ancestor
43806578|NCT04909775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806580|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43806581|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43806582|NCT04908982|Analgesics|analgesics|mesh-ancestor
43806583|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
43806584|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806585|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806586|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806624|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43806625|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43806626|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43806627|NCT04908566|Folfirinox|folfirinox|mesh-list
43806628|NCT04908566|Antibodies|antibodies|mesh-list
43806629|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
43806630|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
43806631|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806633|NCT04908813|Capecitabine|capecitabine|mesh-list
43843376|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
43843377|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
43806772|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43806773|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43806774|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
43806775|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806776|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806777|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43806778|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43806779|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43806780|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
43806827|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806828|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
43806829|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43806830|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
43806921|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43807008|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43807009|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807010|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807011|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43807012|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43807013|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
43807014|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807015|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807016|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
43807017|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
43807018|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807019|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807020|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43843474|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807197|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807342|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43807344|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
43807345|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
43807346|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807347|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807348|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807349|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43807350|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
43807351|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807352|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807353|NCT04899674|Bupropion|bupropion|mesh-list
43807354|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43807512|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43807513|NCT04897516|Benzonidazole|benzonidazole|mesh-list
43807514|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807524|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807525|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43807526|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43807528|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43807587|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807588|NCT04895423|Cyclosporine|cyclosporine|mesh-list
43807589|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
43807590|NCT04895423|Methotrexate|methotrexate|mesh-list
43807591|NCT04895423|Cyclosporins|cyclosporins|mesh-list
43807592|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43807593|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
43807597|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
43807764|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
43807852|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43807853|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
43807854|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807855|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807856|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807857|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43807858|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43807860|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
43807861|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807862|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
43807863|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807865|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43807874|NCT04891458|Propofol|propofol|mesh-list
43807994|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808003|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808004|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808005|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43808007|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
43808072|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
43808073|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808074|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808075|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43808076|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43808077|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808078|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808079|NCT04888403|Paclitaxel|paclitaxel|mesh-list
43808080|NCT04888403|Nedaplatin|nedaplatin|mesh-list
43808081|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43808082|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619810|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43808207|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
43808208|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
43808209|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808210|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808211|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
43808212|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808213|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43808214|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43808215|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43808216|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808217|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808218|NCT04885660|Lisinopril|lisinopril|mesh-list
43808219|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43808377|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
43808378|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808379|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808380|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
43808381|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
43808440|NCT04882163|Hormones|hormones|mesh-ancestor
43843751|NCT04429555|Ibudilast|ibudilast|mesh-list
43808575|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808576|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808577|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
43808578|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808579|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
43808580|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
43808598|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808599|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43843763|NCT04429347|Gabapentin|gabapentin|mesh-list
43808766|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43808767|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808768|NCT05231941|Lidocaine|lidocaine|mesh-list
43808990|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43808991|NCT04389073|Growth Substances|growth substances|mesh-ancestor
43808992|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
43809204|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809205|NCT01243190|Ofatumumab|ofatumumab|mesh-list
43809206|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809207|NCT00806390|Metoprolol|metoprolol|mesh-list
43809208|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43809209|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43809210|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
43809211|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
43809212|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843925|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843926|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843927|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43843928|NCT04418856|Methamphetamine|methamphetamine|mesh-list
43843929|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43843930|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843931|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
43809359|NCT04875819|Vaccines|vaccines|mesh-list
43809427|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809646|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43809647|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
43809648|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
43809649|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809650|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809651|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
43809652|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809653|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
43809654|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
43809655|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809656|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809657|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43809666|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43809668|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809672|NCT04871802|Taxifolin|taxifolin|mesh-list
43809732|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
43809733|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809734|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43809735|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43809736|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809737|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809738|NCT04871269|Hormones|hormones|mesh-ancestor
43809739|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809740|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43809741|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43809991|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809992|NCT04867252|Protective Agents|protective agents|mesh-ancestor
43809993|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809994|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43809995|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
43809996|NCT04867252|Vitamins|vitamins|mesh-ancestor
43809997|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
43843990|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43843991|NCT04412876|Imipramine|imipramine|mesh-list
43843994|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43843995|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843996|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843997|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843998|NCT04412876|Analgesics|analgesics|mesh-ancestor
43843999|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
43810027|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810028|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43844042|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844043|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
43844044|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
43844045|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
43844046|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844047|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43844048|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43810253|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43810263|NCT04862767|Aldesleukin|aldesleukin|mesh-list
43844059|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844060|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
43844061|NCT04410978|Teriflunomide|teriflunomide|mesh-list
43844062|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43844063|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844064|NCT04410978|Analgesics|analgesics|mesh-ancestor
43844065|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
43844066|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844067|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844068|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810397|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810398|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
43810399|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43810400|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43810401|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43810402|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43810405|NCT04860076|Ipilimumab|ipilimumab|mesh-list
43810406|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810407|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810408|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43810409|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810410|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
43810411|NCT04860011|Metolazone|metolazone|mesh-list
43810412|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43810414|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43810469|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43810676|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810677|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43810678|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43810679|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43810692|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
43810693|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810694|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810695|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43810696|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43810697|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844177|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
43810809|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43810810|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810811|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43810812|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810813|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
43810814|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810815|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810816|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43844209|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844210|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43844211|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43810916|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810917|NCT04851392|Hormones|hormones|mesh-ancestor
43623041|NCT05375305|Narcotics|narcotics|mesh-ancestor
43810918|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810919|NCT04851015|Trimethoprim|trimethoprim|mesh-list
43810920|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43810944|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
43810945|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810946|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810947|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43810949|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
43811052|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811053|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43811054|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811055|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811056|NCT04850001|Aspirin|aspirin|mesh-list
43811057|NCT04850001|Clopidogrel|clopidogrel|mesh-list
43811058|NCT04850001|Atorvastatin|atorvastatin|mesh-list
43811059|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43811060|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43811061|NCT04850001|Analgesics|analgesics|mesh-ancestor
43811062|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
43811063|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811064|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811065|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811158|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43844232|NCT04393285|Letrozole|letrozole|mesh-list
43844233|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844234|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43844235|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43844236|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844237|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844238|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43844239|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
43844240|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844241|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844242|NCT04393207|Dexamethasone|dexamethasone|mesh-list
43844243|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
43844244|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
43844245|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43844246|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43844247|NCT04393207|Prednisolone|prednisolone|mesh-list
43844248|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
43844249|NCT04393207|Bupivacaine|bupivacaine|mesh-list
43844254|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
43811164|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811307|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43811308|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43811309|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811310|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43811311|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43811312|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43811313|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811314|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43811315|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
43844331|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43811371|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
43811372|NCT04845880|Paraproteins|paraproteins|mesh-list
43811373|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
43811377|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
43811481|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43811482|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811483|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811484|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43811485|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
43811486|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811487|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811488|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43623804|NCT03906721|Oxycodone|oxycodone|mesh-list
43811522|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811523|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811524|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811525|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43811526|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43811527|NCT04842838|Paclitaxel|paclitaxel|mesh-list
43811528|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43811578|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811579|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811599|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
43811685|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43811686|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811687|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811688|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
43811781|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
43811782|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811783|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43811784|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811785|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
43811786|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811787|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43811788|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43811860|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811861|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
43811862|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811863|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811864|NCT04837170|Ketamine|ketamine|mesh-list
43811865|NCT04837170|Esketamine|esketamine|mesh-list
43811866|NCT04837170|Analgesics|analgesics|mesh-ancestor
43811867|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
43811868|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811869|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811870|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43811882|NCT04837261|Amiodarone|amiodarone|mesh-list
43811995|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43811996|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43811997|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43811998|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812107|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812108|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43812109|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
43812110|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
43812112|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812113|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43812151|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43812154|NCT04834674|Antibodies|antibodies|mesh-list
43812282|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844499|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812412|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43812413|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
43812414|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812418|NCT04829773|Midazolam|midazolam|mesh-list
43812439|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43812440|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43812441|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812442|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812443|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
43812444|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
43812445|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43812446|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
43812553|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43844570|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844571|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812675|NCT04824924|Venetoclax|venetoclax|mesh-list
43812676|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812677|NCT04825093|Vitamin D|vitamin d|mesh-list
43812678|NCT04825093|Vitamins|vitamins|mesh-ancestor
43812685|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812693|NCT04824898|Simvastatin|simvastatin|mesh-list
43812694|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43812695|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43812696|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
43812757|NCT04823390|Analgesics|analgesics|mesh-ancestor
43812825|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812826|NCT04822415|Mepivacaine|mepivacaine|mesh-list
43812827|NCT04822415|Carticaine|carticaine|mesh-list
43812828|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
43812829|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
43812830|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812831|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812832|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
43813003|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813004|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
43813005|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813006|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43813007|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813008|NCT04819971|Docetaxel|docetaxel|mesh-list
43813009|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
43813010|NCT04819971|Trastuzumab|trastuzumab|mesh-list
43813011|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813012|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
43813013|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
43813014|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
43813015|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813025|NCT04820010|Insulin|insulin|mesh-list
43813055|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43813056|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43813057|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813058|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813059|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813060|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43813061|NCT04819438|Protective Agents|protective agents|mesh-ancestor
43813062|NCT04819828|Diclofenac|diclofenac|mesh-list
43813063|NCT04819828|Tamsulosin|tamsulosin|mesh-list
43813089|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813090|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43813091|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
43813112|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43813113|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813114|NCT04818736|Vaccines|vaccines|mesh-list
43813115|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
43813183|NCT04817800|Hormones|hormones|mesh-ancestor
43813242|NCT04816461|Renal Agents|renal agents|mesh-ancestor
43813349|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43813350|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813351|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
43813352|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
43813353|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
43813354|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844683|NCT04352439|Analgesics|analgesics|mesh-ancestor
43813383|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813384|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813397|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43813398|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
43813399|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
43813400|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813401|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43813402|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43813403|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813404|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813405|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43813458|NCT04813653|Hormones|hormones|mesh-ancestor
43844720|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43813607|NCT04809818|Clopidogrel|clopidogrel|mesh-list
43813755|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43813756|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813757|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813758|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
43813759|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
43813760|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813761|NCT04808687|Paclitaxel|paclitaxel|mesh-list
43813762|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43813763|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813764|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
43813765|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
43813766|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
43813767|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813768|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
43813769|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
43813770|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813771|NCT04808622|Protective Agents|protective agents|mesh-ancestor
43813772|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813774|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813775|NCT04807829|Nabilone|nabilone|mesh-list
43813776|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
43813777|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
43813780|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813786|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43813895|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43813896|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813897|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813898|NCT04806737|Teriflunomide|teriflunomide|mesh-list
43813899|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43813900|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813901|NCT04806737|Analgesics|analgesics|mesh-ancestor
43813902|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
43813903|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813904|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813905|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813906|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844772|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43844773|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
43844774|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844775|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844776|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43844777|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
43844778|NCT04338984|Fentanyl|fentanyl|mesh-list
43844779|NCT04338984|Ropivacaine|ropivacaine|mesh-list
43844780|NCT04338984|Anesthetics|anesthetics|mesh-list
43844786|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844787|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43844788|NCT04338984|Narcotics|narcotics|mesh-ancestor
43844789|NCT04338984|Analgesics|analgesics|mesh-ancestor
43844790|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43814050|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43814051|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
43814052|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814053|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814054|NCT04803539|Capecitabine|capecitabine|mesh-list
43814071|NCT04803318|Lenvatinib|lenvatinib|mesh-list
43814072|NCT04803318|Trametinib|trametinib|mesh-list
43814073|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844802|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844803|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43844804|NCT04338321|Esketamine|esketamine|mesh-list
43844805|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
43814296|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43814411|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43814412|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43814414|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
43814415|NCT04797546|Morphine|morphine|mesh-list
43814416|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43814417|NCT04797546|Narcotics|narcotics|mesh-ancestor
43814418|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814419|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814420|NCT04797546|Analgesics|analgesics|mesh-ancestor
43814421|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
43814423|NCT04797793|Adapalene|adapalene|mesh-list
43814501|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43814502|NCT04796025|Growth Substances|growth substances|mesh-ancestor
43814503|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814504|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
43814505|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
43814506|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43814507|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814508|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43814509|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43814510|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814557|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43814558|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814559|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43814560|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
43814561|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814562|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814563|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
43814564|NCT04793529|Vitamin D|vitamin d|mesh-list
43814565|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43814566|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814567|NCT04793529|Vitamins|vitamins|mesh-ancestor
43814568|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
43814576|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814673|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814674|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
43814675|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814676|NCT04791774|Caseins|caseins|mesh-list
43814677|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
43814678|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
43814776|NCT04790708|Edotreotide|edotreotide|mesh-list
43814777|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
43814778|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43814779|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814780|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814781|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43814782|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814783|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
43814784|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
43814785|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
43814786|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43814795|NCT04790448|Cetuximab|cetuximab|mesh-list
43814812|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814890|NCT04788745|Trimetazidine|trimetazidine|mesh-list
43815028|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815029|NCT04785768|Morphine|morphine|mesh-list
43815030|NCT04785768|Hydromorphone|hydromorphone|mesh-list
43815031|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43815032|NCT04785768|Narcotics|narcotics|mesh-ancestor
43815033|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815034|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815035|NCT04785768|Analgesics|analgesics|mesh-ancestor
43815036|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
43815037|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815038|NCT04785547|Blinatumomab|blinatumomab|mesh-list
43815039|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815040|NCT04785183|Melatonin|melatonin|mesh-list
43815041|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
43815162|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815163|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815164|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43815165|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844994|NCT04315558|Ipratropium|ipratropium|mesh-list
43844995|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
43844996|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43844997|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
43844998|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845006|NCT04315272|Azithromycin|azithromycin|mesh-list
43845013|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845014|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815220|NCT05281614|Vedolizumab|vedolizumab|mesh-list
43815221|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43815222|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43815223|NCT05281614|Analgesics|analgesics|mesh-ancestor
43815434|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815435|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43815436|NCT04429022|Analgesics|analgesics|mesh-ancestor
43815437|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
43815438|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43815439|NCT04429022|Narcotics|narcotics|mesh-ancestor
43815440|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43628480|NCT03066544|Hormones|hormones|mesh-ancestor
43845076|NCT04310930|Renal Agents|renal agents|mesh-ancestor
43815573|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815574|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815575|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
43815576|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43815577|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43815578|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815960|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815961|NCT02531906|Analgesics|analgesics|mesh-ancestor
43815962|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
43815963|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815964|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
43815965|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43815966|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43815967|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43815968|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43815971|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815972|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
43815973|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
43815974|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
43815975|NCT02460042|Paclitaxel|paclitaxel|mesh-list
43815976|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43815977|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815978|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816232|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816233|NCT05458726|Paclitaxel|paclitaxel|mesh-list
43816234|NCT05458726|Carboplatin|carboplatin|mesh-list
43816235|NCT05458726|Pemetrexed|pemetrexed|mesh-list
43816241|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
43816242|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816243|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816244|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43816245|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43816246|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816247|NCT05455294|Decitabine|decitabine|mesh-list
43816248|NCT05455294|Venetoclax|venetoclax|mesh-list
43629473|NCT03059316|Labetalol|labetalol|mesh-list
43816340|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
43816341|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
43816342|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816343|NCT05195177|Anesthetics|anesthetics|mesh-list
43816419|NCT05040568|Fludarabine|fludarabine|mesh-list
43816491|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43816492|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816493|NCT04776148|Trifluridine|trifluridine|mesh-list
43816494|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
43816496|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816497|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816498|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816499|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816500|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816579|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816580|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816581|NCT04589208|Ketamine|ketamine|mesh-list
43816582|NCT04589208|Analgesics|analgesics|mesh-ancestor
43816583|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
43816584|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816585|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816586|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43816587|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43816588|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
43816589|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
43816590|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816886|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43816887|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
43816888|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43816892|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43816893|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43816894|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43816895|NCT03544606|Diuretics|diuretics|mesh-ancestor
43816896|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
43816897|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816947|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816948|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43816949|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816950|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817119|NCT01730638|Glycine|glycine|mesh-list
43817134|NCT01318317|Plerixafor|plerixafor|mesh-list
43845235|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845236|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845237|NCT04294654|Vortioxetine|vortioxetine|mesh-list
43845238|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
43845239|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43845240|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43848833|NCT03986970|Emtricitabine|emtricitabine|mesh-list
43817206|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817207|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817209|NCT00476190|Hormones|hormones|mesh-ancestor
43817210|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43817436|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43817437|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
43817438|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
43817439|NCT05555641|Nafamostat|nafamostat|mesh-list
43817440|NCT05555641|Heparin|heparin|mesh-list
43817441|NCT05555641|Calcium heparin|calcium heparin|mesh-list
43817442|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
43817443|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43845272|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
43817627|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43817628|NCT05553665|Lidocaine|lidocaine|mesh-list
43817629|NCT05553665|Fentanyl|fentanyl|mesh-list
43817630|NCT05553665|Midazolam|midazolam|mesh-list
43817631|NCT05553665|Complement System Proteins|complement system proteins|mesh-list
43817632|NCT05553665|Complement C4|complement c4|mesh-list
43817675|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43817676|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817678|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
43817679|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817680|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817681|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
43817682|NCT05553496|Hormones|hormones|mesh-ancestor
43817683|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43817821|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817822|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
43817860|NCT05551221|Tamsulosin|tamsulosin|mesh-list
43818038|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43818039|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43818040|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818041|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818042|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43818043|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
43818044|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818060|NCT05549466|Docetaxel|docetaxel|mesh-list
43818104|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818105|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
43818106|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43818107|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
43845432|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
43845433|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845434|NCT04278729|Apixaban|apixaban|mesh-list
43845435|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43845436|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
43845437|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43845438|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
43845439|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818184|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43818185|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43818186|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818187|NCT05547789|Analgesics|analgesics|mesh-ancestor
43818337|NCT05546060|Dexamethasone|dexamethasone|mesh-list
43818338|NCT05546060|Etoposide|etoposide|mesh-list
43818339|NCT05546060|Venetoclax|venetoclax|mesh-list
43818340|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818381|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818382|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43818383|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43818384|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818385|NCT05545592|Estrogens|estrogens|mesh-list
43818386|NCT05545592|Hormones|hormones|mesh-ancestor
43818387|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818391|NCT05545527|Hematinics|hematinics|mesh-ancestor
43818507|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818508|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818509|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
43818510|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
43845501|NCT04274179|Lamotrigine|lamotrigine|mesh-list
43845502|NCT04274179|Valproic Acid|valproic acid|mesh-list
43845503|NCT04274179|Ethosuximide|ethosuximide|mesh-list
43845504|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
43845505|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43845506|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818560|NCT05543122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43818605|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818606|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43818607|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818608|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818609|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818610|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818612|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
43818613|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43818614|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43818619|NCT05542394|Curcumin|curcumin|mesh-list
43818688|NCT05541419|Hormones|hormones|mesh-ancestor
43818774|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818775|NCT05540587|Warfarin|warfarin|mesh-list
43818776|NCT05540587|Edoxaban|edoxaban|mesh-list
43818777|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
43818778|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43818779|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
43818780|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43818781|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
43818782|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818783|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818784|NCT05540470|Chloroquine|chloroquine|mesh-list
43818785|NCT05540470|Primaquine|primaquine|mesh-list
43818786|NCT05540470|Tafenoquine|tafenoquine|mesh-list
43818787|NCT05540470|Amebicides|amebicides|mesh-ancestor
43818788|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43818789|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43818790|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818791|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
43818792|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818793|NCT05540431|Charcoal|charcoal|mesh-list
43818794|NCT05540431|Antidotes|antidotes|mesh-ancestor
43818863|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43818864|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818865|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818866|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
43818867|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818868|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818869|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
43818870|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43818871|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43818872|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
43818873|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43818874|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43818949|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43818950|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
43818951|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818952|NCT05537220|Expectorants|expectorants|mesh-ancestor
43818953|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
43819006|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819007|NCT05536596|Protective Agents|protective agents|mesh-ancestor
43819008|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819009|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819010|NCT05536596|Hematinics|hematinics|mesh-ancestor
43819011|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
43819012|NCT05536596|Vitamins|vitamins|mesh-ancestor
43819013|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
43819014|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43819015|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43819016|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819146|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43819147|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
43819148|NCT05535738|Ustekinumab|ustekinumab|mesh-list
43819149|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43819150|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
43819151|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43819152|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819154|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
43848848|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43848849|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848850|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
43848851|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43848852|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43848853|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848854|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848855|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845786|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845787|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845788|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845789|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43845790|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43845791|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
43845792|NCT04248452|Leucovorin|leucovorin|mesh-list
43845793|NCT04248452|Folic Acid|folic acid|mesh-list
43845824|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
43819771|NCT03745144|Cladribine|cladribine|mesh-list
43819889|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43820031|NCT05679102|Amlodipine|amlodipine|mesh-list
43820140|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
43848907|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43820310|NCT05674305|Cisplatin|cisplatin|mesh-list
43820311|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820312|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
43820313|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43820314|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
43820443|NCT05609682|Gabapentin|gabapentin|mesh-list
43820444|NCT05609682|Analgesics|analgesics|mesh-ancestor
43820445|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
43820446|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820448|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
43820452|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43820453|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43820454|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43820455|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845903|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
43820456|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820601|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820602|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43820603|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
43820604|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820609|NCT05405387|Hormones|hormones|mesh-ancestor
43821225|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
43821351|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821353|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821357|NCT04431453|Remdesivir|remdesivir|mesh-list
43821877|NCT03199053|Incretins|incretins|mesh-ancestor
43822182|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822592|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43822593|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43822594|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822595|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822596|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43822597|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43822598|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822599|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822610|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
43846195|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43846212|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43823333|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43823500|NCT05522491|Olaparib|olaparib|mesh-list
43846300|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43823607|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
43823608|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
43641991|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43641992|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43641993|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641994|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
43641995|NCT05529173|Povidone|povidone|mesh-list
43641996|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
43641997|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
43641998|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43642075|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642359|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642447|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43823729|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642963|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643182|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643271|NCT05133765|Insulin|insulin|mesh-list
43643378|NCT05071183|Trametinib|trametinib|mesh-list
43643549|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
43823854|NCT05518383|Melphalan|melphalan|mesh-list
43644050|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43644051|NCT04770272|Paclitaxel|paclitaxel|mesh-list
43644052|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
43644053|NCT04770272|Carboplatin|carboplatin|mesh-list
43644054|NCT04770272|Atezolizumab|atezolizumab|mesh-list
43644067|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43644068|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
43644069|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43849645|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43849767|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849970|NCT05702853|Fludarabine|fludarabine|mesh-list
43849971|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849988|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43850008|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850062|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43536575|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536576|NCT04717765|Protective Agents|protective agents|mesh-ancestor
43536577|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536578|NCT04717765|Vitamins|vitamins|mesh-ancestor
43536579|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
43536580|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
43536645|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536646|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
43536719|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536720|NCT04322669|Pidotimod|pidotimod|mesh-list
43536721|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43536722|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
43538591|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43538592|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538593|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43538595|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538596|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43538597|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538598|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542622|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
43543291|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
43543978|NCT03689075|Tacrolimus|tacrolimus|mesh-list
43547489|NCT03651947|Denosumab|denosumab|mesh-list
43548090|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548149|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
43548150|NCT03645109|Vitamins|vitamins|mesh-ancestor
43548151|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
43551141|NCT03616691|Bevacizumab|bevacizumab|mesh-list
43552220|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43552276|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
43554655|NCT03570294|Atosiban|atosiban|mesh-list
43560064|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560065|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
43560066|NCT05292339|Hormones|hormones|mesh-ancestor
43560067|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43560075|NCT05292339|Analgesics|analgesics|mesh-ancestor
43562449|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562526|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
43562601|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43562602|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562603|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43565110|NCT00945646|Dexamethasone|dexamethasone|mesh-list
43566518|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43567402|NCT00751803|Eletriptan|eletriptan|mesh-list
43571084|NCT00345618|Vitamins|vitamins|mesh-ancestor
43572193|NCT00052598|Aldesleukin|aldesleukin|mesh-list
43572722|NCT00002371|Zidovudine|zidovudine|mesh-list
43574949|NCT03511820|Amebicides|amebicides|mesh-ancestor
43577427|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43577428|NCT03489928|Misoprostol|misoprostol|mesh-list
43577455|NCT03489668|Metformin|metformin|mesh-list
43577669|NCT03487562|Clarithromycin|clarithromycin|mesh-list
43580927|NCT03465423|Propofol|propofol|mesh-list
43587254|NCT03396315|Alendronate|alendronate|mesh-list
43588370|NCT03388541|Analgesics|analgesics|mesh-ancestor
43590503|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43590504|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43590505|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43590512|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
43592262|NCT03355014|Metformin|metformin|mesh-list
43593017|NCT03347890|Hormones|hormones|mesh-ancestor
43594316|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43594317|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594318|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43594319|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43594320|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43594321|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594322|NCT03335124|Vitamins|vitamins|mesh-list
43594323|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
43594324|NCT03335124|Thiamine|thiamine|mesh-list
43594325|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
43594326|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
43594327|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594328|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43594329|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
43594330|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43594405|NCT03334513|Bevacizumab|bevacizumab|mesh-list
43594406|NCT03334513|Ranibizumab|ranibizumab|mesh-list
43594407|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43594408|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594409|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43594410|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43594411|NCT03334513|Growth Substances|growth substances|mesh-ancestor
43594413|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
43594558|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594559|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
43594999|NCT03328728|Hylan|hylan|mesh-list
43595425|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
43597254|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597255|NCT03310242|Vitamin D|vitamin d|mesh-list
43597256|NCT03310242|Vitamins|vitamins|mesh-ancestor
43597932|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43597933|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43597934|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43597935|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
43597936|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43598259|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43598260|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43598261|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43598262|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598263|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598264|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43598265|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43598266|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43598267|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43627432|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627502|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
43627503|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43627504|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43627572|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627573|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43627574|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43627641|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627642|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
43627643|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627644|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43627645|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43627646|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43627647|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43627708|NCT03072199|Rituximab|rituximab|mesh-list
43630314|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
43631329|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631330|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43631331|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43631332|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631333|NCT03044587|Leucovorin|leucovorin|mesh-list
43631334|NCT03044587|Gemcitabine|gemcitabine|mesh-list
43631335|NCT03044587|Cisplatin|cisplatin|mesh-list
43631336|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43631337|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43637072|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43637796|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637797|NCT04440280|Expectorants|expectorants|mesh-ancestor
43637798|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
43637799|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43637800|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
43639237|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43639238|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
43639239|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639240|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
43639241|NCT03434769|Fludarabine|fludarabine|mesh-list
43639242|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43639401|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43640371|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640372|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640373|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640374|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
43640375|NCT02389543|Hormones|hormones|mesh-ancestor
43640376|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640377|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640378|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640579|NCT02170090|Cisplatin|cisplatin|mesh-list
43849571|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849575|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
43849577|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
43849578|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43849579|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43849585|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849593|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849594|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849603|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
